PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Zhou, W; Sun, W; Yung, MMH; Dai, S; Cai, YH; Chen, CW; Meng, YX; Lee, JB; Braisted, JC; Xu, YH; Southall, NT; Shinn, P; Huang, XF; Song, ZF; Chen, XL; Kai, Y; Cai, X; Li, ZZ; Hao, Q; Cheung, ANY; Ngan, HYS; Liu, SS; Barak, S; Hao, J; Dai, ZJ; Tzatsos, A; Peng, WQ; Pei, HD; Han, ZY; Chan, DW; Zheng, W; Zhu, WG				Zhou, Wei; Sun, Wei; Yung, Mingo M. H.; Dai, Sheng; Cai, Yihua; Chen, Chi-Wei; Meng, Yunxiao; Lee, Jennifer B.; Braisted, John C.; Xu, Yinghua; Southall, Noel T.; Shinn, Paul; Huang, Xuefeng; Song, Zhangfa; Chen, Xiulei; Kai, Yan; Cai, Xin; Li, Zongzhu; Hao, Qiang; Cheung, Annie N. Y.; Ngan, Hextan Y. S.; Liu, Stephanie S.; Barak, Stephanie; Hao, Jing; Dai, Zhijun; Tzatsos, Alexandros; Peng, Weiqun; Pei, Huadong; Han, Zhiyong; Chan, David W.; Zheng, Wei; Zhu, Wenge			Autocrine activation of JAK2 by IL-11 promotes platinum drug resistance	ONCOGENE			English	Article							OVARIAN-CANCER; MYELOPROLIFERATIVE NEOPLASMS; POLYCYTHEMIA-VERA; MOLECULAR-MECHANISMS; DNA-DAMAGE; STAGE-III; CISPLATIN; MUTATIONS; PACLITAXEL; INHIBITORS	Antineoplastic platinum agents are used in first-line treatment of ovarian cancer, but treatment failure frequently results from platinum drug resistance. Emerging observations suggest a role of reactive oxygen species (ROS) in the resistance of cancer drugs including platinum drugs. However, the molecular link between ROS and cellular survival pathway is poorly understood. Using quantitative high-throughput combinational screen (qHTCS) and genomic sequencing, we show that in platinum-resistant ovarian cancer elevated ROS levels sustain high level of IL-11 by stimulating FRA1-mediated IL-11 expression and increased IL-11 causes resistance to platinum drugs by constitutively activating JAK2-STAT5 via an autocrine mechanism. Inhibition of JAK2 by LY2784544 or IL-11 by anti-IL-11 antibody overcomes the platinum resistance in vitro or in vivo. Significantly, clinic studies also confirm the activated IL-11-JAK2 pathway in platinum-resistant ovarian cancer patients, which highly correlates with poor prognosis. These findings not only identify a novel ROS-IL-11-JAK2-mediated platinum resistance mechanism but also provide a new strategy for using LY2784544- or IL-11-mediated immunotherapy to treat platinum-resistant ovarian cancer.	[Zhou, Wei; Cai, Yihua; Chen, Chi-Wei; Meng, Yunxiao; Lee, Jennifer B.; Cai, Xin; Li, Zongzhu; Hao, Qiang; Hao, Jing; Pei, Huadong; Han, Zhiyong; Zhu, Wenge] George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20037 USA; [Zhou, Wei; Dai, Sheng; Huang, Xuefeng; Song, Zhangfa] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Colorectal Surg, Hangzhou 310016, Zhejiang, Peoples R China; [Zhou, Wei; Cai, Yihua; Chen, Chi-Wei; Meng, Yunxiao; Lee, Jennifer B.; Kai, Yan; Cai, Xin; Li, Zongzhu; Hao, Qiang; Tzatsos, Alexandros; Pei, Huadong; Zhu, Wenge] George Washington Univ, GW Canc Ctr, Washington, DC 20052 USA; [Sun, Wei; Dai, Sheng; Braisted, John C.; Southall, Noel T.; Shinn, Paul; Zheng, Wei] Natl Ctr Adv Translat Sci, Natl Inst Hlth, Bethesda, MD 20892 USA; [Yung, Mingo M. H.; Chan, David W.] Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China; [Xu, Yinghua] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Med Oncol, Hangzhou 310016, Zhejiang, Peoples R China; [Chen, Xiulei] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Clin Lab, Hangzhou 310016, Zhejiang, Peoples R China; [Kai, Yan; Peng, Weiqun] George Washington Univ, Columbian Coll Arts & Sci, Dept Phys, Washington, DC 20052 USA; [Cheung, Annie N. Y.; Ngan, Hextan Y. S.; Liu, Stephanie S.] Univ Hong Kong, LKS Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Barak, Stephanie] George Washington Univ, Sch Med & Hlth Sci, Dept Pathol, Washington, DC 20037 USA; [Dai, Zhijun] Xi An Jiao Tong Univ, Affiliated Hosp 2, Dept Oncol, Xian 710004, Shaanxi, Peoples R China; [Tzatsos, Alexandros] George Washington Univ, Sch Med & Hlth Sci, Dept Anat & Regenerat Biol, Washington, DC 20037 USA	George Washington University; Zhejiang University; George Washington University; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Hong Kong; Zhejiang University; Zhejiang University; George Washington University; University of Hong Kong; George Washington University; Xi'an Jiaotong University; George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med & Hlth Sci, Dept Biochem & Mol Med, Washington, DC 20037 USA.; Zhu, WG (corresponding author), George Washington Univ, GW Canc Ctr, Washington, DC 20052 USA.; Zheng, W (corresponding author), Natl Ctr Adv Translat Sci, Natl Inst Hlth, Bethesda, MD 20892 USA.; Chan, DW (corresponding author), Univ Hong Kong, LKS Fac Med, Dept Obstet & Gynecol, Hong Kong, Hong Kong, Peoples R China.	dwchan@hku.hk; wzheng@mail.nih.gov; wz6812@gwu.edu	Zheng, Wei/GQQ-8951-2022; /AAI-2516-2019; Zheng, Wei/GOE-5990-2022; Kai, Yan/ABH-8469-2020; YUNG, Mingo Ming Ho/AHB-5775-2022; dai, sheng/AGQ-0059-2022; Chan, David/O-9896-2018; Southall, Noel/H-8991-2012; Dai, Zhi-Jun/O-6826-2014; Cheung, Annie Nga Yin/C-4231-2009	Kai, Yan/0000-0003-3262-4160; YUNG, Mingo Ming Ho/0000-0003-0903-1164; Chan, David/0000-0002-6951-3467; Ngan, Hextan Y S/0000-0003-3945-159X; Chen, Chi-Wei/0000-0001-8658-055X; Southall, Noel/0000-0003-4500-880X; Dai, Zhi-Jun/0000-0001-5209-8626; Peng, Weiqun/0000-0001-5521-9091; dai, sheng/0000-0002-5387-8517; Cheung, Annie Nga Yin/0000-0002-1584-7568	National Institutes of Health [CA177898, CA184717]; McCormick Genomic and Proteomic Center; intramural research program at the National Center for Advancing Translational Sciences (NCATS); American Cancer Society [RSG-13-214-01-DMC]; National Natural Science Foundation of China [81402580]; NATIONAL CANCER INSTITUTE [R01CA184717, R01CA177898, R21CA182662, R03CA212068] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [ZIATR000018, ZICTR000242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McCormick Genomic and Proteomic Center; intramural research program at the National Center for Advancing Translational Sciences (NCATS); American Cancer Society(American Cancer Society); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was partially supported by funding from the National Institutes of Health (CA177898 and CA184717 to W. Zhu), the McCormick Genomic and Proteomic Center, and intramural research program at the National Center for Advancing Translational Sciences (NCATS). W Zhu was supported by a Research Scholar Grant, RSG-13-214-01-DMC from the American Cancer Society. This work was supported by the National Natural Science Foundation of China grant 81402580 to W Zhou.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Buchert M, 2016, ONCOGENE, V35, P939, DOI 10.1038/onc.2015.150; Burger RA, 2011, NEW ENGL J MED, V365, P2473, DOI 10.1056/NEJMoa1104390; Choi YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135083; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Dasari S, 2014, EUR J PHARMACOL, V740, P364, DOI 10.1016/j.ejphar.2014.07.025; Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230; Ernst M, 2014, CLIN CANCER RES, V20, P5579, DOI 10.1158/1078-0432.CCR-13-2492; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Hanker LC, 2012, ANN ONCOL, V23, P2605, DOI 10.1093/annonc/mds203; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Kang MA, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.134; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; LANGDON SP, 1988, CANCER RES, V48, P6166; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ma L, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.6; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; McGuire WP, 1996, NEW ENGL J MED, V334, P1, DOI 10.1056/NEJM199601043340101; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Onnis B, 2013, J CLIN INVEST, V123, P1615, DOI 10.1172/JCI59623; Ozols RF, 2003, J CLIN ONCOL, V21, P3194, DOI 10.1200/JCO.2003.02.153; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Park CY, 2015, BIOINFORMATICS, V31, P1093, DOI 10.1093/bioinformatics/btu786; Quintas-Cardama A, 2013, CLIN CANCER RES, V19, P1933, DOI 10.1158/1078-0432.CCR-12-0284; Quintas-Cardama A, 2011, NAT REV DRUG DISCOV, V10, P127, DOI 10.1038/nrd3264; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sun W, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.123; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Tasdogan A, 2016, CELL STEM CELL, V19, P752, DOI 10.1016/j.stem.2016.08.007; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Tyner JW, 2010, BLOOD, V115, P5232, DOI 10.1182/blood-2009-05-223727; Vichai V, 2006, NAT PROTOC, V1, P1112, DOI 10.1038/nprot.2006.179; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wu SC, 2015, CANCER CELL, V28, P29, DOI 10.1016/j.ccell.2015.06.005; Yu X, 2012, CANCER CELL, V21, P614, DOI 10.1016/j.ccr.2012.03.042	40	21	23	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					3981	3997		10.1038/s41388-018-0238-8	http://dx.doi.org/10.1038/s41388-018-0238-8			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29662190	Green Accepted, Green Submitted			2022-12-26	WOS:000439101300006
J	Chen, LS; Lian, DS; Wang, B				Chen, Lusi; Lian, Dashuai; Wang, Bei			Factors associated with disclosing men who have sex with men (MSM) sexual behaviors and HIV-positive status: A study based on a social network analysis in Nanjing, China	PLOS ONE			English	Article							AFRICAN-AMERICAN; SELF-DISCLOSURE; RISK BEHAVIORS; FAMILY MATTER; ORIENTATION; SEROSTATUS; GAY; PREDICTORS; SAMPLE	Objective We explored the factors associated with disclosure of men who have with sex with men (MSM) behaviors and HIV-positive status among HIV-positive MSM in Nanjing, China. Methods Social network analysis and epidemiological methods were combined in this pilot study. Information about participants' (egos') characteristics and behaviors and their social network members (alters) were collected through interview-administered questionnaires. General estimating equation logistic regression analysis was applied in both univariate and multivariate analysis. Results Eighty-seven HIV-positive MSM participated. Their mean age was 35.9 +/- 13.81years. They were more likely to disclose their MSM behavior to their friends [adjust Odds Ratio (AOR) = 6.43, 95% confidence interval (CI): 3.08-13.42] or to the social network members who were not heterosexual [AOR = 4.40, 95% CI: 2.17-8.91]. Being participants' friends [AOR = 5.16, 95% CI: 2.03-13.10] or family members [AOR = 6.22, 95% CI: 2.52-15.33] was significantly associated with HIV-positive status disclosure. Conclusion HIV-positive MSM tended to disclose their MSM behaviors and HIV positive status to close friends, family members or other individuals who were HIV-positive, engaging in MSM behavior, or both. Consequently, it will be an effective way to implement HIV prevention and intervention strategies in both MSM population and their trusted social networks.	[Chen, Lusi; Lian, Dashuai; Wang, Bei] Southeast Univ, Dept Epidemiol & Hlth Stat, Key Lab Environm Med Engn, Minist Educ,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China	Southeast University - China	Wang, B (corresponding author), Southeast Univ, Dept Epidemiol & Hlth Stat, Key Lab Environm Med Engn, Minist Educ,Sch Publ Hlth, Nanjing, Jiangsu, Peoples R China.	wangbeilxb@163.com		Wang, Bei/0000-0002-5232-0933	Doctoral Program Foundation of Institutions of Higher Education of China [20130092110048]; China Scholarship Council	Doctoral Program Foundation of Institutions of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Scholarship Council(China Scholarship Council)	This work received support from the Doctoral Program Foundation of Institutions of Higher Education of China (Project No. 20130092110048). BW received this grant. URLs: http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index.1.htm. LC received the grant from China Scholarship Council. http://www.csc.edu.cn/.	Bird JDP, 2013, AM J PUBLIC HEALTH, V103, P2193, DOI 10.2105/AJPH.2013.301437; Brown MJ, 2015, AIDS PATIENT CARE ST, V29, P625, DOI 10.1089/apc.2015.0133; Brown MJ, 2015, CHILD ABUSE NEGLECT, V46, P89, DOI 10.1016/j.chiabu.2015.02.019; Cheung DH, 2014, AIDS BEHAV, V18, P2423, DOI 10.1007/s10461-014-0821-0; Choi KH, 2013, JAIDS-J ACQ IMM DEF, V64, P496, DOI 10.1097/QAI.0b013e3182a7ee52; Crepaz N, 2004, JAMA-J AM MED ASSOC, V292, P224, DOI 10.1001/jama.292.2.224; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Daskalopoulou M, 2017, AIDS BEHAV, V21, P184, DOI 10.1007/s10461-016-1541-4; Dewaele A, 2017, J HOMOSEXUAL, V64, P1832, DOI 10.1080/00918369.2016.1267467; Douglas-Vail M., 2016, INT J MED SOCIOLOGY, V4; Earnshaw VA, 2009, AIDS BEHAV, V13, P1160, DOI 10.1007/s10461-009-9593-3; Guo Y, 2014, PSYCHOL HEALTH MED, V19, P190, DOI 10.1080/13548506.2013.793367; Henry E, 2012, ARCH SEX BEHAV, V41, P525, DOI 10.1007/s10508-012-9916-8; Holtzman S, 2016, AIDS CARE, V28, P705, DOI 10.1080/09540121.2016.1164288; Huang ZJ, 2012, AIDS BEHAV, V16, P858, DOI 10.1007/s10461-011-0119-4; Latkin C, 2012, AIDS BEHAV, V16, P535, DOI 10.1007/s10461-011-0014-z; Latkin Carl, 2011, Am J Public Health, V101, pe18, DOI 10.2105/AJPH.2011.300281; Latkin CA, 2013, JAIDS-J ACQ IMM DEF, V63, pS54, DOI 10.1097/QAI.0b013e3182928e2a; Li L, 2007, J FAM PSYCHOL, V21, P307, DOI 10.1037/0893-3200.21.2.307; Li L, 2008, DEV WORLD BIOETH, V8, P235, DOI 10.1111/j.1471-8847.2007.00220.x; Lin XY, 2016, COMMUNITY MENT HLT J, V52, P457, DOI 10.1007/s10597-015-9879-z; Nanjing SOotNBoSi, INC URB RES NANJ INC; NCAIDS N and China CDC, 2015, CHIN J AIDS STD, V21, P87, DOI 10.13419/j.cnki.aids.2015.02.01; NCAIDS NCC, 2016, CHIN J AIDS STD, V22, P401; NCAIDS NCSTD and China CDC, 2016, CHIN J AIDS STD, V22; NCAIDS NCSTD China CDC, 2016, CHIN J AIDS STD, V22, P585; Peng YC, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-69; Serovich JM, 2011, J MARITAL FAM THER, V37, P290, DOI 10.1111/j.1752-0606.2009.00177.x; Smith KP, 2008, ANNU REV SOCIOL, V34, P405, DOI 10.1146/annurev.soc.34.040507.134601; Steward WT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071778; Sullivan KM, 2005, J ASSOC NURSE AIDS C, V16, P33, DOI 10.1016/j.jana.2005.09.005; Tang WM, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21416; Tieu HV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134085; UNAIDS, 2016, UNAIDS FACTSHEET; Valente TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131712; van Wijngaarden JWD, 2016, CULT HEALTH SEX, V18, P377, DOI 10.1080/13691058.2015.1087595; Wah-Shan C, 2001, J HOMOSEXUAL, V40, P27, DOI 10.1300/J082v40n03_03; Wei CY, 2012, AIDS BEHAV, V16, P1970, DOI 10.1007/s10461-011-0105-x; World Health Organisation, 2021, CONSOLIDATED GUIDELI; World Health Organization, 2015, HIV YOUNG MEN WHO HA; World Health Organization, 2016, CONS GUID US ANT DRU; Xu RW, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2987472; Yoshioka MR, 2001, AIDS PATIENT CARE ST, V15, P77, DOI 10.1089/108729101300003672; Zang CP, 2015, AIDS BEHAV, V19, P72, DOI 10.1007/s10461-014-0840-x; Zea MC, 2005, AIDS BEHAV, V9, P15, DOI 10.1007/s10461-005-1678-z; [张严 Zhang Yan], 2011, [中国临床心理学杂志, Chinese Journal of Clinical Psychology], V19, P628; Zhao Y, 2016, AIDS BEHAV, V20, P193, DOI 10.1007/s10461-015-1135-6	47	5	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196116	10.1371/journal.pone.0196116	http://dx.doi.org/10.1371/journal.pone.0196116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672596	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800089
J	Kaiyala, KJ; Ramsay, DS				Kaiyala, Karl J.; Ramsay, Douglas S.			Concentration-related metabolic rate and behavioral thermoregulatory adaptations to serial administrations of nitrous oxide in rats	PLOS ONE			English	Article							HUMAN TEMPERATURE REGULATION; INDIVIDUAL-DIFFERENCES; ADIPOSE-TISSUE; INITIAL SENSITIVITY; INDUCED HYPOTHERMIA; BODY-TEMPERATURE; INDUCED NARCOSIS; ACUTE TOLERANCE; SIGN-REVERSAL; LOW-LEVEL	Background Initial administration of >= 60% nitrous oxide (N2O) to rats evokes hypothermia, but after repeated administrations the gas instead evokes hyperthermia. This sign reversal is driven mainly by increased heat production. To determine whether rats will behaviorally oppose or assist the development of hyperthermia, we previously performed thermal gradient testing. Inhalation of N2O at >= 60% causes rats to select cooler ambient temperatures both during initial administrations and during subsequent administrations in which the hyperthermic state exists. Thus, an available behavioral response opposes (but does not completely prevent) the acquired hyperthermia that develops over repeated high-concentration N2O administrations. However, recreational and clinical uses of N2O span a wide range of concentrations. Therefore, we sought to determine the thermoregulatory adaptations to chronic N2O administration over a wide range of concentrations. Methods This study had two phases. In the first phase we adapted rats to twelve 3-h N2O administrations at either 0%, 15%, 30%, 45%, 60% or 75% N2O (n = 12 per group); outcomes were core temperature (via telemetry) and heat production (via respirometry). In the second phase, we used a thermal gradient (range 8 degrees C-38 degrees C) to assess each adapted group's thermal preference, core temperature and locomotion on a single occasion during N2O inhalation at the assigned concentration. Results In phase 1, repeated N2O administrations led to dose related hyperthermic and hypermetabolic states during inhalation of >= 45% N2O compared to controls (>= 30% N2O compared to baseline). In phase 2, rats in these groups selected cooler ambient temperatures during N2O inhalation but still developed some hyperthermia. However, a concentration-related increase of locomotion was evident in the gradient, and theoretical calculations and regression analyses both suggest that locomotion contributed to the residual hyperthermia. Conclusions Acquired N2O hyperthermia in rats is remarkably robust, and occurs even despite the availability of ambient temperatures that might fully counter the hyperthermia. Increased locomotion in the gradient may contribute to hyperthermia. Our data are consistent with an allostatic dis-coordination of autonomic and behavioral thermoregulatory mechanisms during drug administration. Our results have implications for research on N2O abuse as well as research on the role of allostasis in drug addiction.	[Kaiyala, Karl J.; Ramsay, Douglas S.] Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Kaiyala, KJ (corresponding author), Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA.	kkaiyala@uw.edu		Ramsay, Douglas/0000-0001-8343-5111	National Institutes of Health (NIH) NIDA [DA023484]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023484] Funding Source: NIH RePORTER	National Institutes of Health (NIH) NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institutes of Health (NIH) NIDA grant DA023484.	Al-Noori S, 2018, STRESS, V21, P274, DOI 10.1080/10253890.2017.1402175; Al-Noori S, 2016, J THERM BIOL, V60, P195, DOI 10.1016/j.jtherbio.2016.07.018; Arch JRS, 2006, INT J OBESITY, V30, P1322, DOI 10.1038/sj.ijo.0803280; Astrand P-O, 1970, TXB WORK PHYSL, Vxvii; Balding DJ, 2004, APPL LONGITUDINAL AN; Brown JW, 2005, SHOCK, V23, P239, DOI 10.1097/01.shk.0000152972.78297.72; CHEUNG SS, 1995, J APPL PHYSIOL, V78, P2301, DOI 10.1152/jappl.1995.78.6.2301; Ciammaichella RA, 2000, EUR J APPL PHYSIOL, V82, P333, DOI 10.1007/s004210000203; Danel T, 2001, AM J PHYSIOL-REG I, V281, pR52, DOI 10.1152/ajpregu.2001.281.1.R52; Dashdorj N, 2013, ANESTHESIOLOGY, V118, P577, DOI 10.1097/ALN.0b013e3182800d58; Edwards S, 2010, FUTUR NEUROL, V5, P393, DOI 10.2217/FNL.10.14; Garakani A, 2016, AM J ADDICTION, V25, P358, DOI 10.1111/ajad.12372; Gardell LR, 2006, NEUROSCI LETT, V396, P44, DOI 10.1016/j.neulet.2005.11.009; George O, 2012, PHYSIOL BEHAV, V106, P58, DOI 10.1016/j.physbeh.2011.11.004; Gisolfi CV, 2000, HOT BRAIN SURVIVAL T, Vx; Gordon C., 2005, TEMPERATURE TOXICOLO, DOI 10.1201/9781420037906; Gordon CJ, 2008, TOXICOLOGY, V244, P87, DOI 10.1016/j.tox.2007.10.030; Gordon Christopher J, 2010, Front Biosci (Elite Ed), V2, P293, DOI 10.2741/e91; GORDON CJ, 1983, LIFE SCI, V32, P1285, DOI 10.1016/0024-3205(83)90802-0; GORDON CJ, 1990, PHYSIOL BEHAV, V47, P963, DOI 10.1016/0031-9384(90)90025-Y; Gordon CJ, 1993, TEMPERATURE REGULATI, Vxiv; HAEFELY W, 1986, PHARMACOPSYCHIATRY, V19, P353, DOI 10.1055/s-2007-1025061; Jevtovic-Todorovic V, 1998, NAT MED, V4, P460, DOI 10.1038/nm0498-460; Kaar SJ, 2016, J PSYCHOPHARMACOL, V30, P395, DOI 10.1177/0269881116632375; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P243, DOI 10.1007/s00213-006-0657-z; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P233, DOI 10.1007/s00213-006-0655-1; Kaiyala Karl J, 2014, Temperature (Austin), V1, P268; Kaiyala KJ, 2012, J THERM BIOL, V37, P30, DOI 10.1016/j.jtherbio.2011.10.004; Kaiyala KJ, 2011, COMP BIOCHEM PHYS A, V158, P252, DOI 10.1016/j.cbpa.2010.04.013; Kaiyala KJ, 2011, DIABETES, V60, P17, DOI 10.2337/db10-0909; Kaiyala KJ, 2005, AM J PHYSIOL-REG I, V288, pR692, DOI 10.1152/ajpregu.00412.2004; Kaiyala KJ, 2001, PHARMACOL BIOCHEM BE, V68, P691, DOI 10.1016/S0091-3057(01)00488-9; Kiyatkin EA, 2005, BRAIN RES REV, V50, P27, DOI 10.1016/j.brainresrev.2005.04.001; KOBLIN DD, 1980, J PHARMACOL EXP THER, V213, P309; Koteja P, 1996, FUNCT ECOL, V10, P675, DOI 10.2307/2390179; Krystal JH, 2017, INT J NEUROPSYCHOPH, V20, DOI 10.1093/ijnp/pyw118; Lehmberg J, 2008, BRAIN RES, V1246, P88, DOI 10.1016/j.brainres.2008.09.064; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; MANSELL PI, 1990, AM J PHYSIOL, V258, pR1347, DOI 10.1152/ajpregu.1990.258.6.R1347; Marks A, 2009, AM J PHYSIOL-REG I, V296, pR1239, DOI 10.1152/ajpregu.90723.2008; MATHENY J L, 1991, Anesthesia Progress, V38, P57; MEKJAVIC IB, 1992, J APPL PHYSIOL, V73, P2246, DOI 10.1152/jappl.1992.73.6.2246; Nishida KS, 2016, BEHAV BRAIN RES, V313, P315, DOI 10.1016/j.bbr.2016.07.038; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; QUOCK RM, 1987, LIFE SCI, V41, P683; Ramsay Douglas S, 2014, Temperature (Austin), V1, P257; Ramsay Douglas S, 2014, Temperature (Austin), V1, P248; Ramsay Douglas S, 2014, Temperature (Austin), V1, P157, DOI 10.4161/23328940.2014.982048; Ramsay DS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124740; Ramsay DS, 2014, PSYCHOL REV, V121, P225, DOI 10.1037/a0035942; Ramsay DS, 2011, PHYSIOL BEHAV, V103, P79, DOI 10.1016/j.physbeh.2010.12.018; Ramsay DS, 2005, PSYCHOPHARMACOLOGY, V181, P48, DOI 10.1007/s00213-005-2219-1; Ramsay DS, 2003, PHARMACOL BIOCHEM BE, V74, P623, DOI 10.1016/S0091-3057(02)01048-1; Romanovsky AA, 2004, AM J PHYSIOL-REG I, V287, pR992, DOI 10.1152/ajpregu.00068.2004; Romanovsky AA, 2007, AM J PHYSIOL-REG I, V292, pR37, DOI 10.1152/ajpregu.00668.2006; Savage S, 2014, BRAIN SCI, V4, P73, DOI 10.3390/brainsci4010073; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schuckit MA, 2016, J STUD ALCOHOL DRUGS, V77, P25, DOI 10.15288/jsad.2016.77.25; Slot LAB, 2002, J THEOR BIOL, V215, P169, DOI 10.1006/jtbi.2001.2509; TAYLOR CR, 1982, J EXP BIOL, V97, P1; Trudell J.R., 1985, NITROUS OXIDE N2O, P203; Ukropec J, 2006, J BIOL CHEM, V281, P31894, DOI 10.1074/jbc.M606114200; van Amsterdam J, 2015, REGUL TOXICOL PHARM, V73, P790, DOI 10.1016/j.yrtph.2015.10.017; Walsh K, 2017, INT J NEUROPSYCHOPH, V20, DOI 10.1093/ijnp/pyw063; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Wu J, 2013, GENE DEV, V27, P234, DOI 10.1101/gad.211649.112; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	67	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194794	10.1371/journal.pone.0194794	http://dx.doi.org/10.1371/journal.pone.0194794			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672605	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800015
J	Gillmann, C; Coras, R; Rossler, K; Doerfler, A; Uder, M; Blumcke, I; Bauerie, T				Gillmann, Clarissa; Coras, Roland; Roessler, Karl; Doerfler, Arnd; Uder, Michael; Bluemcke, Ingmar; Baeuerie, Tobias			Ultra-high field MRI of human hippocampi: Morphological and multiparametric differentiation of hippocampal sclerosis subtypes	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; HUMAN BRAIN; FORMALIN FIXATION; RELAXATION-TIMES; PATHOLOGY; SURGERY; PATTERNS; OUTCOMES; GLIOSIS; VIVO	The aim of the present study is to differentiate subtypes of hippocampal sclerosis (HS) using ex vivo ultra-high field magnetic resonance imaging (MRI). Included were 14 surgically resected hippocampi of patients with medically intractable temporal lobe epilepsy. The resected hippocampi were histologically categorized into subtypes of hippocampal sclerosis (HS type 1 (n = 10), HS type 2 (n = 2) and no-HS (n = 2)) and subsequently scanned on a preclinical 7T MRI acquiring T2-weighted morphology, relaxometry and diffusion tensor imaging. On the morphological images, the pyramidal cell layer (PCL) of the hippocampus was segmented and the following parameters were derived: T2 signal intensity, Ti-, T2- and T2*-relaxation times, apparent diffusion coefficient (ADC), fractional anisotropy (FA) and mean diffusivity (MD). Furthermore, the area of the PCL was determined, as well as the parameter product which refers to the widths of the PCL parallel and perpendicular to the stratum moleculare. Spearman correlation coefficient was used to demonstrate relationships between MR-parameters and type of sclerosis. In comparison to no-HS specimens, the PCL was significantly narrower in HS type 1 and HS type 2 hippocampi. This narrowing affected the entire cornu ammonis sector (CA) 1 in HS type 1, while it was limited to the upper half of CA1 in direction to CA2 in HS type 2. The parameter product median increased from 0.43 to 1.67 and 2.91 mm(2) for HS type 1, HS type 2 and no-HS, respectively. Correlation coefficients were significant for the PCL parameters product (0.73), area (0.71), T2*-time (-0.67), FA (0.65) and ADC (0.55). Our initial results suggest that HS type 1, HS type 2 and no-HS subtypes can be distinguished from each other using ex vivo UHF MRI based on T2-weighted morphologic images and the assessment of the parameter product. Upon clinical translation, UHF-MRI may provide a promising technique for the preoperative differentiation of HS subtypes in patients.	[Gillmann, Clarissa; Uder, Michael; Baeuerie, Tobias] Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Coras, Roland; Bluemcke, Ingmar] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany; [Roessler, Karl] Univ Hosp Erlangen, Dept Neurosurg, Erlangen, Germany; [Doerfler, Arnd] Univ Hosp Erlangen, Dept Neuroradiol, Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Gillmann, C (corresponding author), Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany.	clarissa.gillmann@gmx.de	Rössler, Karl/AAN-5096-2021	Rössler, Karl/0000-0002-9249-8082; Bauerle, Tobias/0000-0002-0206-6199	Erlanger Leistungsbezogene Anschubfinanzierung (ELAN) [DR-14-09-10-1]; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	Erlanger Leistungsbezogene Anschubfinanzierung (ELAN); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	This work was supported by the Erlanger Leistungsbezogene Anschubfinanzierung (ELAN; DR-14-09-10-1-Gillmann), Dr. Clarissa Gillmann, University of Erlangen-Nuremberg, Germany and by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing.	Al Sufiani Fahd, 2012, Epilepsy Res Treat, V2012, P624519, DOI 10.1155/2012/624519; Balchandani P, 2015, AM J NEURORADIOL, V36, P1204, DOI 10.3174/ajnr.A4180; Birkl C, 2016, NMR BIOMED, V29, P458, DOI 10.1002/nbm.3477; Blumcke I, 2013, EPILEPSIA, V54, P1315, DOI 10.1111/epi.12220; Briellmann RS, 2002, NEUROLOGY, V58, P265, DOI 10.1212/WNL.58.2.265; Coras R, 2015, NEUROSCIENCE, V309, P153, DOI 10.1016/j.neuroscience.2015.08.003; Coras R, 2014, EPILEPSIA, V55, P2003, DOI 10.1111/epi.12828; Dawe RJ, 2009, MAGN RESON MED, V61, P810, DOI 10.1002/mrm.21909; de Tisi J, 2011, LANCET, V378, P1388, DOI 10.1016/S0140-6736(11)60890-8; Deleo F, 2016, EPILEPSIA, V57, P306, DOI 10.1111/epi.13277; ENGEL J, 1992, CLIN NEUR, V38, P514; Goubran M, 2016, HUM BRAIN MAPP, V37, P1103, DOI 10.1002/hbm.23090; Hennessy MJ, 2000, BRAIN, V123, P2445, DOI 10.1093/brain/123.12.2445; JACKSON GD, 1995, MAGN RESON IMAGING, V13, P1081, DOI 10.1016/0730-725X(95)02016-M; JACKSON GD, 1993, NEUROLOGY, V43, P1793, DOI 10.1212/WNL.43.9.1793; JACKSON GD, 1990, NEUROLOGY, V40, P1869, DOI 10.1212/WNL.40.12.1869; KUZNIECKY R, 1987, ANN NEUROL, V22, P341, DOI 10.1002/ana.410220310; Liacu D, 2010, NEUROPHYSIOL CLIN, V40, P151, DOI 10.1016/j.neucli.2010.01.003; Mueller SG, 2007, NEUROBIOL AGING, V28, P719, DOI 10.1016/j.neurobiolaging.2006.03.007; Peixoto-Santos JE, 2017, EPILEPSIA, V58, P149, DOI 10.1111/epi.13620; Prada Jardim A, 2017, BRAIN PATHOL; Salmenpera TM, 2006, EPILEPSY RES, V71, P102, DOI 10.1016/j.eplepsyres.2006.05.020; Santyr BG, 2017, J MAGN RESON IMAGING, V45, P1359, DOI 10.1002/jmri.25447; Shepherd TM, 2009, MAGN RESON MED, V62, P26, DOI 10.1002/mrm.21977; Stefanits H, 2017, INVEST RADIOL, V52, P666, DOI 10.1097/RLI.0000000000000388; Thivard L, 2005, NEUROIMAGE, V28, P682, DOI 10.1016/j.neuroimage.2005.06.045; Thom M, 2010, EPILEPSIA, V51, P1801, DOI 10.1111/j.1528-1167.2010.02681.x; TOVI M, 1992, ACTA RADIOL, V33, P400; Wiebe S, 2001, NEW ENGL J MED, V345, P311, DOI 10.1056/NEJM200108023450501; Wieser HG, 2003, J NEUROSURG, V98, P751, DOI 10.3171/jns.2003.98.4.0751; Yong-Hing CJ, 2005, MAGN RESON MED, V54, P324, DOI 10.1002/mrm.20578	31	11	11	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196008	10.1371/journal.pone.0196008	http://dx.doi.org/10.1371/journal.pone.0196008			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668721	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200074
J	Dias, RSG; Soares, JHN; Castro, DDE; Gress, MAKD; Machado, ML; Otero, PE; Ascoli, FO				Goncalves Dias, Raquel Sartori; Neves Soares, Joao Henrique; Castro, Douglas dos Santos e; Kuster de Albuquerque Gress, Maria Alice; Machado, Marcela Lemos; Otero, Pablo E.; Ascoli, Fabio Otero			Cardiovascular and respiratory effects of lumbosacral epidural bupivacaine in isoflurane-anesthetized dogs: The effects of two volumes of 0.25% solution	PLOS ONE			English	Article							ANESTHESIA; ANALGESIA; SURGERY; MORPHINE; HYPOTENSION; PRESSURE; BLOCK; CATS; ROPIVACAINE; EPINEPHRINE	The purpose of this study was to compare cardiovascular and respiratory effects of two volumes of bupivacaine 0.25% (0.2 mL kg(-1)-treatment BUP02-and 0.4 mL kg(-1) treatment BUP04) administered epidurally at the lumbosacral intervertebral space in dogs anesthetized with isoflurane. This experimental prospective randomized crossover design trial used six mixed breed adult dogs, four neutered males and two spayed females. Each dog was anesthetized on three different occasions: the first for isoflurane minimum alveolar concentration (MAC) measurement, and the following two assigned treatments (BUP02 or BUP04). On the two treatment days, anesthesia was induced and maintained with isoflurane at 1.3 MAC during the experiments. Cardiovascular and respiratory measurements were recorded before (TO) and 5, 15, 30, 60 and 90 minutes after the epidural administration of bupivacaine. Comparisons between and within groups were performed by a mixed-model ANOVA and Friedman's test when appropriate followed by Bonferroni post-hoc test or Dunnet's test to compare time points within each treatment with TO (p < 0.05). Mean arterial pressure decreased significantly from 15 to 90 minutes after the administration of BUP02 and from 5 to 60 minutes in BUP04, with lower values in BUP04 than in BUP02 lasting up to 30 minutes after bupivacaine administration. No significant changes in cardiac output and systemic vascular resistance were observed in either treatment. Hypoventilation was only detected in BUP04. Hemoglobin concentration and arterial oxygen content decreased after both treatment of bupivacaine with no significant decrease in oxygen delivery. Two dogs in BUP04 developed Horner's syndrome. The epidural administration of 0.4 mL.kg(-1) of bupivacaine to dogs in sternal recumbency anesthetized with isoflurane 1.3 MAC caused more cardiovascular and respiratory depression than 0.2 mL.kg(-1).	[Goncalves Dias, Raquel Sartori; Machado, Marcela Lemos; Ascoli, Fabio Otero] Fluminense Fed Univ UFF, Coll Med, Grad Program Cardiovasc Sci, Niteroi, RJ, Brazil; [Neves Soares, Joao Henrique] Virginia Tech, Dept Small Anim Clin Sci, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA; [Castro, Douglas dos Santos e] Univ Florida, Dept Large Anim Clin Sci, Anesthesia & Pain Management Serv, Gainesville, FL USA; [Kuster de Albuquerque Gress, Maria Alice] Fluminense Fed Univ, Lab Anim Res, Vet Sch, Niteroi, RJ, Brazil; [Otero, Pablo E.] Univ Buenos Aires, Fac Ciencias Vet, Catedra Anestesiol & Algiol, Buenos Aires, DF, Argentina; [Ascoli, Fabio Otero] Fluminense Fed Univ, Biomed Inst, Dept Physiol & Pharmacol, Niteroi, RJ, Brazil	Universidade Federal Fluminense; Virginia Polytechnic Institute & State University; State University System of Florida; University of Florida; Universidade Federal Fluminense; University of Buenos Aires; Universidade Federal Fluminense	Soares, JHN (corresponding author), Virginia Tech, Dept Small Anim Clin Sci, Virginia Maryland Reg Coll Vet Med, Blacksburg, VA 24061 USA.	jhsoares@vt.edu	Soares, Joao/AAD-7928-2019; Otero, Pablo Ezequiel/I-4638-2019	Otero, Pablo Ezequiel/0000-0002-0901-7269	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [110.507/2011]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior [114.339.947-12]; Virginia TEch Open Access Subvention Fund	Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Virginia TEch Open Access Subvention Fund	This work was supported by Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro - n.o 110.507/2011, http://www.faperj.br - FOA; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - n.o 114.339.947-12, http://www.capes.gov.br - RSGD; the Virginia TEch Open Access Subvention Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida RM, 2010, VET ANAESTH ANALG, V37, P542, DOI 10.1111/j.1467-2995.2010.00563.x; Biki B, 2008, ANESTHESIOLOGY, V109, P180, DOI 10.1097/ALN.0b013e31817f5b73; Borghi B, 2002, J CLIN ANESTH, V14, P102, DOI 10.1016/S0952-8180(01)00362-2; Bornscheuer A, 1996, J EXP ANIM SCI, V38, P20; Bosmans T, 2012, VET ANAESTH ANALG, V39, P618, DOI 10.1111/j.1467-2995.2012.00744.x; Bosmans T, 2011, VET ANAESTH ANALG, V38, P146, DOI 10.1111/j.1467-2995.2011.00595.x; BROMAGE PR, 1962, BRIT J ANAESTH, V34, P161, DOI 10.1093/bja/34.3.161; Capdevila X, 1999, ANESTHESIOLOGY, V91, P8, DOI 10.1097/00000542-199907000-00006; Castro DS, 2016, VET ANAESTH ANALG, V43, P235, DOI 10.1111/vaa.12320; Figueiro MR, 2016, VET ANAESTH ANALG, V43, P464, DOI 10.1111/vaa.12341; Freire CD, 2010, VET ANAESTH ANALG, V37, P63, DOI 10.1111/j.1467-2995.2009.00493.x; Freise H, 2008, ANESTHESIOLOGY, V109, P1107, DOI 10.1097/ALN.0b013e31818db16c; de Segura IAG, 2009, VET ANAESTH ANALG, V36, P485, DOI 10.1111/j.1467-2995.2009.00469.x; GREITZ T, 1983, ACTA ANAESTH SCAND, V27, P211, DOI 10.1111/j.1399-6576.1983.tb01937.x; Hodgson PS, 1999, ANESTHESIOLOGY, V91, P1687, DOI 10.1097/00000542-199912000-00021; Hogan QH, 1998, ANESTHESIOLOGY, V88, P761, DOI 10.1097/00000542-199803000-00028; HURLEY RJ, 1991, REGION ANESTH, V16, P303; Iff I, 2007, VET REC, V161, P22, DOI 10.1136/vr.161.1.22; Iff I, 2008, VET ANAESTH ANALG, V35, P265, DOI [10.1111/j.1467-2995.2007.00373.x, 10.1111/j.1467-2987.2007.00373.x]; Igarashi T, 1998, ACTA ANAESTH SCAND, V42, P698, DOI 10.1111/j.1399-6576.1998.tb05304.x; Ilkiw JE, 1999, CLIN TECH SMALL AN P, V14, P27, DOI 10.1016/S1096-2867(99)80024-3; JONG RHD, 1975, ANESTHESIOLOGY, V42, P384, DOI 10.1097/00000542-197504000-00003; KLIDE AM, 1968, J AM VET MED ASSOC, V153, P165; Kona-Boun JJ, 2006, JAVMA-J AM VET MED A, V229, P1103, DOI 10.2460/javma.229.7.1103; Korkmaz M, 2013, ACTA SCI VET, V41; LEBEAUX MI, 1973, BRIT J ANAESTH, V45, P549, DOI 10.1093/bja/45.6.549; Meissner A, 1999, ANESTH ANALG, V89, P1378, DOI 10.1097/00000539-199912000-00009; Missant C, 2010, BRIT J ANAESTH, V104, P143, DOI 10.1093/bja/aep354; Monteiro ER, 2010, AM J VET RES, V71, P1133, DOI 10.2460/ajvr.71.10.1133; NAKAO S, 1986, CIRCULATION, V73, P579, DOI 10.1161/01.CIR.73.3.579; NESS TJ, 1990, PAIN, V41, P167, DOI 10.1016/0304-3959(90)90021-5; Otero PE, 2013, SMALL ANIMAL REGIONAL ANESTHESIA AND ANALGESIA, P227; Otero PE, 2009, 10 WORLD C VET AN 31; Penderis J, 2015, IN PRACTICE, V37, DOI 10.1136/inp.h861; PETERS J, 1990, ANESTHESIOLOGY, V73, P694, DOI 10.1097/00000542-199010000-00015; Romano M, 2016, VET ANAESTH ANALG, V43, P44, DOI 10.1111/vaa.12275; SHIBATA K, 1994, ANESTHESIOLOGY, V81, P1454, DOI 10.1097/00000542-199412000-00021; Sibanda S, 2006, VET ANAESTH ANALG, V33, P246, DOI 10.1111/j.1467-2995.2005.00261.x; STEFFEY EP, 1977, AM J VET RES, V38, P1833; TAKASAKI M, 1980, BRIT J ANAESTH, V52, P1271, DOI 10.1093/bja/52.12.1271; Troncy E, 2002, J AM VET MED ASSOC, V221, P666, DOI 10.2460/javma.2002.221.666; Valverde A, 2008, VET CLIN N AM-SMALL, V38, P1205, DOI 10.1016/j.cvsm.2008.06.004; Veering B Th, 2003, Minerva Anestesiol, V69, P433	43	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195867	10.1371/journal.pone.0195867	http://dx.doi.org/10.1371/journal.pone.0195867			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668768	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200063
J	Loveday, M; Wallengren, K; Reddy, T; Besada, D; Brust, JCM; Voce, A; Desai, H; Ngozo, J; Radebe, Z; Master, I; Padayatchi, N; Daviaud, E				Loveday, Marian; Wallengren, Kristina; Reddy, Tarylee; Besada, Donela; Brust, James C. M.; Voce, Anna; Desai, Harsha; Ngozo, Jacqueline; Radebe, Zanele; Master, Iqbal; Padayatchi, Nesri; Daviaud, Emmanuelle			MDR-TB patients in KwaZulu-Natal, South Africa: Cost-effectiveness of 5 models of care	PLOS ONE			English	Article							DRUG-RESISTANT TUBERCULOSIS; HOSPITALIZATION; IMPACT	Background South Africa has a high burden of MDR-TB, and to provide accessible treatment the government has introduced different models of care. We report the most cost-effective model after comparing cost per patient successfully treated across 5 models of care: centralized hospital, district hospitals (2), and community-based care through clinics or mobile injection teams. Methods In an observational study five cohorts were followed prospectively. The cost analysis adopted a provider perspective and economic cost per patient successfully treated was calculated based on country protocols and length of treatment per patient per model of care. Logistic regression was used to calculate propensity score weights, to compare pairs of treatment groups, whilst adjusting for baseline imbalances between groups. Propensity score weighted costs and treatment success rates were used in the ICER analysis. Sensitivity analysis focused on varying treatment success and length of hospitalization within each model. Results In 1,038 MDR-TB patients 75% were HIV-infected and 56% were successfully treated. The cost per successfully treated patient was 3 to 4.5 times lower in the community-based models with no hospitalization. Overall, the Mobile model was the most cost-effective. Conclusion Reducing the length of hospitalization and following community-based models of care improves the affordability of MDR-TB treatment without compromising its effectiveness.	[Loveday, Marian; Besada, Donela; Daviaud, Emmanuelle] South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa; [Loveday, Marian; Padayatchi, Nesri] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, SA Med Res Council, Extramural TB Pathogenesis Res Unit, Durban, South Africa; [Wallengren, Kristina] TB & HIV Invest Network Think, Durban, South Africa; [Reddy, Tarylee] South African Med Res Council, Biostat Unit, Cape Town, South Africa; [Brust, James C. M.] Montefiore Med Ctr, 111 E 210th St, Bronx, NY 10467 USA; [Brust, James C. M.] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Voce, Anna] Univ KwaZulu Natal, Discipline Publ Hlth Med, Durban, South Africa; [Desai, Harsha] Deloitte Consulting, Johannesburg, South Africa; [Ngozo, Jacqueline; Radebe, Zanele] KwaZulu Natal Dept Hlth, Pietermaritzburg, South Africa; [Master, Iqbal] King Dinuzulu Hosp, KwaZulu Natal Dept Hlth, Durban, South Africa	South African Medical Research Council; South African Medical Research Council; University of Kwazulu Natal; South African Medical Research Council; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Kwazulu Natal; Deloitte Touche Tohmatsu Limited	Loveday, M (corresponding author), South African Med Res Council, Hlth Syst Res Unit, Cape Town, South Africa.; Loveday, M (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, SA Med Res Council, Extramural TB Pathogenesis Res Unit, Durban, South Africa.	marian.loveday@mrc.ac.za	Loveday, Marian/M-8016-2013; padayatchi, nesri/Q-2780-2019; Voce, Anna Silvia/AAF-9039-2020	Loveday, Marian/0000-0001-9205-9314; padayatchi, nesri/0000-0003-2543-9071; Voce, Anna Silvia/0000-0001-9082-4449; Reddy, Tarylee/0000-0002-9521-2692; Besada, Donela/0000-0002-2020-5244	South African Medical Research Council; Izumi Foundation; University Research Co-operation (URC); United Way Worldwide grant [17245]; National Institute of Allergy and Infectious Diseases [K23AI083088, P30AI051519]	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Izumi Foundation; University Research Co-operation (URC); United Way Worldwide grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The work was funded by the South African Medical Research Council (www.mrc.ac.za), Izumi Foundation (http://izumi.org), University Research Co-operation (URC) and a United Way Worldwide grant (grant ID #: 17245) made possible by the Lilly Foundation on behalf of the Lilly MDR TB Partnership (https://www.lilly.com/who-we-are). JCMB is supported by the National Institute of Allergy and Infectious Diseases (K23AI083088, P30AI051519). The funders had no role in study design, the collection, analysis, or interpretation of data; in report writing; or the decision to submit the paper for publication. All researchers were independent of funders and sponsors. The funders provided support in the form of salaries for authors ML and ED, they did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. HD is employed by Deloitte Consulting. Her contribution to this manuscript was done in her own time and her employee had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the author contributions section.	Ahmed S, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-015-0361-7; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bang HJ, 2012, J STAT THEORY PRACT, V6, P428, DOI 10.1080/15598608.2012.695571; Bassili A, 2013, AM J TROP MED HYG, V89, P271, DOI 10.4269/ajtmh.13-0004; Colvin CJ, 2015, INT J TUBERC LUNG D, V19, P1326, DOI 10.5588/ijtld.15.0262; Cox H, 2014, INT J TUBERC LUNG D, V18, P441, DOI 10.5588/ijtld.13.0742; Cox H, 2015, TROP MED INT HEALTH, V20, P1337, DOI 10.1111/tmi.12544; Day C, 2012, DISTRICT HLTH BAROME; Department of Public Service and Administration, 2012, SAL SCAL ANN C NURS; Fitzpatrick C, 2012, PHARMACOECONOMICS, V30, P63, DOI 10.2165/11595340-000000000-00000; Floyd K, 2012, EUR RESPIR J, V40, P133, DOI 10.1183/09031936.00169411; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Gandhi NR, 2012, INT J TUBERC LUNG D, V16, P90, DOI 10.5588/ijtld.11.0153; KwaZulu-Natal Department of Health, 2012, KWAZULU NAT FIN REP; Laserson KF, 2005, INT J TUBERC LUNG D, V9, P640; Lawn SD, 2009, AIDS, V23, P1717, DOI 10.1097/QAD.0b013e32832d3b6d; Loveday M, 2018, INT J TUBERC LUNG D, V22, P40, DOI 10.5588/ijtld.17.0371; Loveday M, 2015, INT J TUBERC LUNG D, V19, P163, DOI 10.5588/ijtld.14.0369; Loveday M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094016; National Department of Health, 2011, MULT RES TUB POL FRA; National Health Laboratory Service, 2014, GENEXPERT MTB RIF PR; National Institute for Communicable Diseases, 2016, S AFR TUB DRUG RES S; Pooran A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054587; Schnippel K, 2013, TROP MED INT HEALTH, V18, P109, DOI 10.1111/tmi.12018; Sinanovic E, 2015, INT J TUBERC LUNG D, V19, P172, DOI 10.5588/ijtld.14.0421; Statistics South Africa, 2013, CENS 2011 STAT REL P; StatsSA, 2014, CONS PRIC IND REL P0; Toczek A, 2013, INT J TUBERC LUNG D, V17, P299, DOI 10.5588/ijtld.12.0537; United Nations, 2015, UN OP RAT EXCH; Wallengren K, 2011, EMERG INFECT DIS, V17, P1913, DOI 10.3201/eid1710.100952; WHO, 2015, END TB STRAT GLOB ST; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organisation, 2017, WHOHTMTB2017232017; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2016, WHOHTMTB201604	35	17	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196003	10.1371/journal.pone.0196003	http://dx.doi.org/10.1371/journal.pone.0196003			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668748	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200073
J	Wang, M; Gong, WW; Hu, RY; Wang, H; Guo, Y; Bian, Z; Lv, J; Chen, ZM; Li, LM; Yu, M				Wang, Meng; Gong, Wei-Wei; Hu, Ru-Ying; Wang, Hao; Guo, Yu; Bian, Zheng; Lv, Jun; Chen, Zheng-Ming; Li, Li-Ming; Yu, Min			Age at natural menopause and associated factors in adult women: Findings from the China Kadoorie Biobank study in Zhejiang rural area	PLOS ONE			English	Article							REPRODUCTIVE FACTORS; OVARIAN-CANCER; FOLLOW-UP; RISK; DETERMINANTS; TRANSITION; PREMATURE; METAANALYSIS; PREDICTORS; SYMPTOMS	Objectives To investigate the factors associated with age at natural menopause in a large population of Chinese adult women. Methods This cross-sectional study was part of the baseline survey of China Kadoorie Biobank in Zhejiang Province. A total of 17,076 postmenopausal women were included in the present study. Relevant data of socio-demographic, lifestyle, dietary and reproductive characteristics were collected. Multinomial logistic regression models were used to examine the associated factors of age at natural menopause with adjusted odds ratios (ORs) and their 95% confidence intervals (CIs) were reported. Results The mean age at natural menopause was 48.94 years, with 3.40% of the women experienced premature menopause and 6.75% early menopause. Younger age, higher education, consumption of meat (1-3 days per week) and increased parity were associated with late menopause. Current smoking, underweight, higher physical activity, consumption of sea food (1-3 days per week), fresh eggs (>4 days per week), fresh fruits (>= 1 day per week), taking vitamins, experiencing severe food shortage, earlier age at menarche and older age at first birth were associated with earlier age at natural menopause. Conclusions These results suggest that certain factors involved with socio-demographic, lifestyle, dietary and reproductive characteristics are related to the age at natural menopause in Chinese women.	[Wang, Meng; Gong, Wei-Wei; Hu, Ru-Ying; Wang, Hao; Yu, Min] Zhejiang Prov Ctr Dis Control & Prevent, Dept NCDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Guo, Yu; Bian, Zheng] Chinese Acad Med Sci, Beijing, Peoples R China; [Lv, Jun; Li, Li-Ming] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol, Beijing, Peoples R China; [Chen, Zheng-Ming] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England; [Chen, Zheng-Ming] Univ Oxford, Nuffield Dept Populat Hlth, Epidemiol Studies Unit CTSU, Oxford, England	Zhejiang Provincial Center for Disease Control & Prevention; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking University; University of Oxford; University of Oxford	Yu, M (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Dept NCDs Control & Prevent, Hangzhou, Zhejiang, Peoples R China.	mycdc1234@163.com	Lv, Jun/O-4746-2019	Lv, Jun/0000-0001-7916-3870; Yu, Min/0000-0001-5473-0736	National Key Research and Development Program of China [2016YFC0900500, 2016YFC0900501, 2016YFC0900502, 2016YFC0900504]; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK [088158/Z/09/Z, 104085/Z/14/Z]; MRC [MC_UU_12026/2, MC_U137686851] Funding Source: UKRI	National Key Research and Development Program of China; Kadoorie Charitable Foundation in Hong Kong; Wellcome Trust in the UK(Instituto de Salud Carlos IIIWellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The National Key Research and Development Program of China (grants 2016YFC0900500, 2016YFC0900501, 2016YFC0900502, 2016YFC0900504), to LML, were in the role of study design, data collection and analysis, decision to publish and preparation of the manuscript. Grants from the Kadoorie Charitable Foundation in Hong Kong were in the role of study design. Grants (088158/Z/09/Z, 104085/Z/14/Z) from Wellcome Trust in the UK to ZMC were in the role of study design and decision to publish.	Ali AT, 2014, INT J GYNECOL CANCER, V24, P384, DOI 10.1097/IGC.0000000000000075; Bosetti C, 2001, J CLIN EPIDEMIOL, V54, P902, DOI 10.1016/S0895-4356(01)00362-6; Cairns BJ, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-7; Cassou B, 2007, AM J EPIDEMIOL, V166, P429, DOI 10.1093/aje/kwm104; Cauley JA, 2012, MENOPAUSE, V19, P1200, DOI 10.1097/gme.0b013e31825ae17e; Chen ZM, 2011, INT J EPIDEMIOL, V40, P1652, DOI 10.1093/ije/dyr120; Chen ZM, 2005, INT J EPIDEMIOL, V34, P1243, DOI 10.1093/ije/dyi174; Dorjgochoo T, 2008, MENOPAUSE, V15, P924, DOI 10.1097/gme.0b013e3181786adc; Dratva J, 2009, MENOPAUSE, V16, P385, DOI 10.1097/gme.0b013e31818aefef; Ebong IA, 2015, MENOPAUSE, V22, P527, DOI [10.1097/GME.0000000000000342, 10.1097/gme.0000000000000342]; Gold EB, 2001, AM J EPIDEMIOL, V153, P865, DOI 10.1093/aje/153.9.865; Gold EB, 2013, AM J EPIDEMIOL, V178, P70, DOI 10.1093/aje/kws421; Gold EB, 2011, OBSTET GYN CLIN N AM, V38, P425, DOI 10.1016/j.ogc.2011.05.002; Hardy R, 2005, BJOG-INT J OBSTET GY, V112, P346, DOI 10.1111/j.1471-0528.2004.00348.x; Henderson KD, 2008, AM J EPIDEMIOL, V167, P1287, DOI 10.1093/aje/kwn046; Kaczmarek M, 2007, MATURITAS, V57, P139, DOI 10.1016/j.maturitas.2006.12.001; Lewington S, 2014, INT J EPIDEMIOL, V43, P1252, DOI 10.1093/ije/dyu035; Li H, 2017, J EPIDEMIOL, V27, P143, DOI 10.1016/j.je.2016.05.002; Li Li-ming, 2012, Zhonghua Liu Xing Bing Xue Za Zhi, V33, P249; Li L, 2012, MATURITAS, V73, P354, DOI 10.1016/j.maturitas.2012.09.008; Li Y, 2008, MATURITAS, V61, P238, DOI 10.1016/j.maturitas.2008.09.002; Luborsky JL, 2003, HUM REPROD, V18, P199, DOI 10.1093/humrep/deg005; MATTISON DR, 1978, LANCET, V1, P187; McKnight KK, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.05.014; McTiernan A, 2004, CANCER RES, V64, P2923, DOI 10.1158/0008-5472.CAN-03-3393; Meek MD, 1999, ENVIRON RES, V80, P9, DOI 10.1006/enrs.1998.3872; Mishra GD, 2017, HUM REPROD, V32, P679, DOI 10.1093/humrep/dew350; Mishra GD, 2009, WOMENS HEALTH, V5, P175, DOI 10.2217/17455057.5.2.175; Muka T, 2016, JAMA CARDIOL, V1, P767, DOI 10.1001/jamacardio.2016.2415; Nagel G, 2005, MATURITAS, V52, P337, DOI 10.1016/j.maturitas.2005.05.013; Ogden CL, 2007, GASTROENTEROLOGY, V132, P2087, DOI 10.1053/j.gastro.2007.03.052; Parazzini F, 2007, MATURITAS, V56, P280, DOI 10.1016/j.maturitas.2006.09.003; Pokoradi AJ, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.02.059; Rodstrom K, 2005, MENOPAUSE, V12, P275, DOI 10.1097/01.GME.0000135247.11972.B3; Schoenaker DAJM, 2014, INT J EPIDEMIOL, V43, P1542, DOI 10.1093/ije/dyu094; SOBERON J, 1966, AM J OBSTET GYNECOL, V96, P96, DOI 10.1016/S0002-9378(16)34647-6; Stepaniak U, 2013, MATURITAS, V75, P87, DOI 10.1016/j.maturitas.2013.02.008; Sun L, 2012, MENOPAUSE, V19, P126, DOI 10.1097/gme.0b013e318224f9ac; Szegda KL, 2017, HUM REPROD, V32, P2522, DOI 10.1093/humrep/dex304; Tao XY, 2015, MENOPAUSE, V22, P469, DOI [10.1097/GME.0000000000000324, 10.1097/gme.0000000000000324]; TORGERSON DJ, 1994, MATURITAS, V19, P83, DOI 10.1016/0378-5122(94)90057-4; Tsilidis KK, 2011, BRIT J CANCER, V105, P1436, DOI 10.1038/bjc.2011.371; Yasui T, 2012, MATURITAS, V72, P249, DOI 10.1016/j.maturitas.2012.04.002	43	32	33	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195658	10.1371/journal.pone.0195658	http://dx.doi.org/10.1371/journal.pone.0195658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668705	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200052
J	Aguayo-Ortiz, A; Mendoza, S; Olvera, D				Aguayo-Ortiz, A.; Mendoza, S.; Olvera, D.			A direct Primitive Variable Recovery Scheme for hyperbolic conservative equations: The case of relativistic hydrodynamics	PLOS ONE			English	Article								In this article we develop a Primitive Variable Recovery Scheme (PVRS) to solve any system of coupled differential conservative equations. This method obtains directly the primitive variables applying the chain rule to the time term of the conservative equations. With this, a traditional finite volume method for the flux is applied in order avoid violation of both, the entropy and "Rankine-Hugoniot" jump conditions. The time evolution is then computed using a forward finite difference scheme. This numerical technique evades the recovery of the primitive vector by solving an algebraic system of equations as it is often used and so, it generalises standard techniques to solve these kind of coupled systems. The article is presented bearing in mind special relativistic hydrodynamic numerical schemes with an added pedagogical view in the appendix section in order to easily comprehend the PVRS. We present the convergence of the method for standard shock-tube problems of special relativistic hydrodynamics and a graphical visualisation of the errors using the fluctuations of the numerical values with respect to exact analytic solutions. The PVRS circumvents the sometimes arduous computation that arises from standard numerical methods techniques, which obtain the desired primitive vector solution through an algebraic polynomial of the charges.	[Aguayo-Ortiz, A.; Mendoza, S.] Univ Nacl Autonoma Mexico, Inst Astron, AP 70-264, Mexico City 04510, DF, Mexico; [Olvera, D.] Univ Bristol, Sch Math, Univ Walk, Bristol BS8 1TW, Avon, England	Universidad Nacional Autonoma de Mexico; University of Bristol	Aguayo-Ortiz, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Astron, AP 70-264, Mexico City 04510, DF, Mexico.	aaguayo@astro.unam.mx	Mendoza, Sergio/AAI-8250-2021	Olvera Cabrera, Daniel/0000-0002-7935-9715; Aguayo-Ortiz, Alejandro/0000-0001-5729-7958; Mendoza, Sergio/0000-0002-2143-5973	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM project) [IN112616]; Consejo Nacional de Ciencia y Tecnologia (CONACyT) [CB-2014-1, 240512]; CONACyT [788898, 26344, 255602]	Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM project); Consejo Nacional de Ciencia y Tecnologia (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by Direccion General de Asuntos del Personal Academico Universidad Nacional Autonoma de Mexico (DGAPA-UNAM project number IN112616, http://dgapa.unam.mx) and Consejo Nacional de Ciencia y Tecnologia (CONACyT project ID:CB-2014-1 #240512 http://www.conacyt.gob.mx). MO, SM and DO acknowledge economic support from CONACyT (788898, 26344, 255602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOOK DL, 1975, J COMPUT PHYS, V18, P248, DOI 10.1016/0021-9991(75)90002-9; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; FONT JA, 1994, ASTRON ASTROPHYS, V282, P304; Godunov S.K., 1959, MAT SB, V47; Harten A, 1983, SIAM REV, V04, P25, DOI [10.2307/2030019, DOI 10.2307/2030019]; Laney, 1998, COMPUTATIONAL GASDYN; Lea Rezzolla, 2013, RELATIVISTIC HYDRODY; LeVeque RJ, 2002, CAMBRIDGE TEXTS APPL, V31, DOI DOI 10.1017/CBO9780511791253; Lora-Clavijo F. D., 2013, Rev. mex. fís. E, V59, P28; Lora-Clavijo FD, 2015, ASTROPHYS J SUPPL S, V218, DOI 10.1088/0067-0049/218/2/24; MacCormack RW, 1972, COMPUTATIONAL EFFICI; Miyoshi T, 2005, J COMPUT PHYS, V208, P315, DOI 10.1016/j.jcp.2005.02.017; Muller E, 2003, LIVING REV RELATIVIT, V6; Radice D, 2012, ASTRON ASTROPHYS, V547, DOI 10.1051/0004-6361/201219735; Riccardi G, 2008, INT MATH FORUM, V42, P2081; ROE PL, 1986, ANNU REV FLUID MECH, V18, P337, DOI 10.1146/annurev.fl.18.010186.002005; SOD GA, 1978, J COMPUT PHYS, V27, P1, DOI 10.1016/0021-9991(78)90023-2; St-Cyr A, 2008, MON WEATHER REV, V136, P1898, DOI 10.1175/2007MWR2108.1; TOOPER RF, 1965, ASTROPHYS J, V142, P1541, DOI 10.1086/148435; Toro E.F., 2009, RIEMANN SOLVERS NUME, Vthird, DOI DOI 10.1007/B79761; VAN LEER B, 1977, J COMPUT PHYS, V23, P276, DOI [10.1016/0021-9991(77)90095-X, 10.1016/0021-9991(77)90094-8]; VONNEUMANN J, 1950, J APPL PHYS, V21, P232, DOI 10.1063/1.1699639; Weinberg S., 1972, GRAVITATION COSMOLOG; Yousaf M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128698	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195494	10.1371/journal.pone.0195494	http://dx.doi.org/10.1371/journal.pone.0195494			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659602	Green Published, Green Submitted, gold			2022-12-26	WOS:000430061100018
J	Finnegan, L; Pigeon, KE; Cranston, J; Hebblewhite, M; Musiani, M; Neufeld, L; Schmiegelow, F; Duval, J; Stenhouse, GB				Finnegan, Laura; Pigeon, Karine E.; Cranston, Jerome; Hebblewhite, Mark; Musiani, Marco; Neufeld, Lalenia; Schmiegelow, Fiona; Duval, Julie; Stenhouse, Gordon B.			Natural regeneration on seismic lines influences movement behaviour of wolves and grizzly bears	PLOS ONE			English	Article							BIALOWIEZA-PRIMEVAL-FOREST; WOODLAND CARIBOU; HABITAT SELECTION; RESOURCE SELECTION; PREDATION; VEGETATION; ECOSYSTEM; PATTERNS; FEATURES; ALBERTA	Across the boreal forest of Canada, habitat disturbance is the ultimate cause of caribou (Rangifer tarandus caribou) declines. Habitat restoration is a focus of caribou recovery efforts, with a goal to finding ways to reduce predator use of disturbances, and caribou-predator encounters. One of the most pervasive disturbances within caribou ranges in Alberta, Canada are seismic lines cleared for energy exploration. Seismic lines facilitate predator movement, and although vegetation on some seismic lines is regenerating, it remains unknown whether vegetation regrowth is sufficient to alter predator response. We used Light Detection and Ranging (LiDAR) data, and GPS locations, to understand how vegetation and other attributes of seismic lines influence movements of two predators, wolves (Canis lupus) and grizzly bears (Ursus arctos). During winter, wolves moved towards seismic lines regardless of vegetation height, while during spring wolves moved towards seismic lines with higher vegetation. During summer, wolves moved towards seismic lines with lower vegetation and also moved faster near seismic lines with vegetation <0.7 m. Seismic lines with lower vegetation height were preferred by grizzly bears during spring and summer, but there was no relationship between vegetation height and grizzly bear movement rates. These results suggest that wolves use seismic lines for travel during summer, but during winter wolf movements relative to seismic lines could be influenced by factors additional to movement efficiency; potentially enhanced access to areas frequented by ungulate prey. Grizzly bears may be using seismic lines for movement, but could also be using seismic lines as a source of vegetative food or ungulate prey. To reduce wolf movement rate, restoration could focus on seismic lines with vegetation <1 m in height. However our results revealed that seismic lines continue to influence wolf movement behaviour decades after they were built, and even at later stages of regeneration. Therefore it remains unknown at what stage of natural regeneration, if any, wolves cease to respond to seismic lines. To reduce wolf response to seismic lines, active restoration tactics like blocking seismic lines and tree planting, along with management of alternate prey, could be evaluated.	[Finnegan, Laura; Pigeon, Karine E.] fRI Res, Caribou Program, Hinton, AB, Canada; [Cranston, Jerome] Arctos Ecol Consultants, Edmonton, AB, Canada; [Hebblewhite, Mark] Univ Montana, WA Franke Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA; [Musiani, Marco] Univ Calgary, Dept Biol Sci, Fac Sci, Calgary, AB, Canada; [Neufeld, Lalenia] Jasper Natl Pk, Parks Canada, Jasper, AB, Canada; [Schmiegelow, Fiona] Univ Alberta, Dept Renewable Resources, Edmonton, AB, Canada; [Duval, Julie] fRI Res, GIS Program, Hinton, AB, Canada; [Stenhouse, Gordon B.] fRI Res, Grizzly Bear Program, Hinton, AB, Canada	University of Montana System; University of Montana; University of Calgary; Parks Canada; University of Alberta	Finnegan, L (corresponding author), fRI Res, Caribou Program, Hinton, AB, Canada.	lfinnegan@friresearch.ca	Hebblewhite, Mark/AAI-8101-2020; Pigeon, Karine E./C-6336-2014; hebblewhite, mark/G-6164-2013; Musiani, Marco/ABB-9387-2021	Hebblewhite, Mark/0000-0001-5382-1361; Pigeon, Karine E./0000-0002-7409-5511; Musiani, Marco/0000-0002-6097-5841; Finnegan, Laura/0000-0002-4797-6284	Government of Canada/Dans le cadre du Plan de conservation national, ce projet a ete realise avec l'appui financier du gouvernement du Canada [HSP6617, 6699, 7195]; Alberta Environment and Parks; Foothills Landscape Management Forum; Sustainable Forestry Initiative [2013-003]; fRI Research Caribou Program; fRI Research Grizzly Bear Program; fRI Research; Government of Alberta (GoA); fRI Research Grizzly Bear Program partners; University of Alberta and University of Montana; NASA's Arctic Boreal Vulnerability Experiment (ABOVE) grant [NNX15AW71A]	Government of Canada/Dans le cadre du Plan de conservation national, ce projet a ete realise avec l'appui financier du gouvernement du Canada; Alberta Environment and Parks; Foothills Landscape Management Forum; Sustainable Forestry Initiative; fRI Research Caribou Program; fRI Research Grizzly Bear Program; fRI Research; Government of Alberta (GoA); fRI Research Grizzly Bear Program partners; University of Alberta and University of Montana; NASA's Arctic Boreal Vulnerability Experiment (ABOVE) grant	Part of the National Conservation Plan, this project was undertaken with the financial support of the Government of Canada/Dans le cadre du Plan de conservation national, ce projet a ete realise avec l'appui financier du gouvernement du Canada (HSP6617, 6699, 7195) [www.ec.gc.ca/hsp-pih]. Additional support was provided by Alberta Environment and Parks [http://aep.alberta.ca/], the Foothills Landscape Management Forum [https.//friresearch.ca/content/foothills-landscape-management-forum-flmf], the Sustainable Forestry Initiative (2013-003) [http.//www.sfiprogram.org/], partners of the fRI Research Caribou and Grizzly Bear Programs, and fRI Research [www.frireseamh.ca]. Animal GPS data were collected as part of research supported by the Government of Alberta (GoA), fRI Research Grizzly Bear Program partners, and funders of graduate research at the University of Alberta and University of Montana. MH was also funded by NASA's Arctic Boreal Vulnerability Experiment (ABOVE) grant # NNX15AW71A [www.nasa.goy]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton K., 2015, MUMIN MULTIMODEL INF; Basille M, 2015, HAB HABITAT MOVEMENT; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bowman J, 2010, CAN J ZOOL, V88, P454, DOI 10.1139/Z10-019; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Bradley Mark, 2012, Rangifer, V32, P183; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Canada Environment, 2012, REC STRAT WOODL CAR; Canadell J, 1996, Oecologia, V108, P583, DOI 10.1007/BF00329030; Canadian Council on Animal Care, 2003, CCAC GUID CAR US WIL; Cattet M, 2008, J MAMMAL, V89, P973, DOI 10.1644/08-MAMM-A-095.1; Cattet MRL, 2003, J WILDLIFE DIS, V39, P649, DOI 10.7589/0090-3558-39.3.649; Cattet MRL, 2003, URSUS-SERIES, V14, P88; Courbin N, 2014, ECOL MONOGR, V84, P265, DOI 10.1890/12-2118.1; Courbin N, 2009, LANDSCAPE ECOL, V24, P1375, DOI 10.1007/s10980-009-9389-x; Cristescu B, 2015, GLOB ECOL CONSERV, V4, P207, DOI 10.1016/j.gecco.2015.06.007; Dawe CA, 2017, FORESTS, V8, DOI 10.3390/f8100398; DeCesare NJ, 2010, ANIM CONSERV, V13, P353, DOI 10.1111/j.1469-1795.2009.00328.x; DeCesare N. J, 2012, RESOURCE SELECTION P; DeCesare NJ, 2012, P ROY SOC B-BIOL SCI, V279, P4626, DOI 10.1098/rspb.2012.1698; DeMars CA, 2017, J ANIM ECOL, DOI [10.1111/13, DOI 10.1111/13]; Dickie M, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1936; Dickie M, 2017, J APPL ECOL, V54, P253, DOI 10.1111/1365-2664.12732; Downing D. J., 2006, NATURAL REGIONS COMM, VT/852; Droghini A, 2018, CAN J ZOOL, V96, P39, DOI 10.1139/cjz-2017-0041; Duchesne T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122947; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; Environment Canada, 2011, BOR POP CAN 2011 UPD, P102; Environment Canada, 2014, SPECIES RISK ACT REC; ESRI, 2015, ARCGIS DESKT REL 10; Fieberg J, 2010, PHILOS T R SOC B, V365, P2233, DOI 10.1098/rstb.2010.0079; Finnegan L, 2018, FOREST ECOL MANAG, V409, P634, DOI 10.1016/j.foreco.2017.12.010; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Gustine DD, 2006, J WILDLIFE MANAGE, V70, P1601, DOI 10.2193/0022-541X(2006)70[1601:IRSADS]2.0.CO;2; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Hebblewhite M, 2009, FOREST ECOL MANAG, V257, P1053, DOI 10.1016/j.foreco.2008.11.009; Hebblewhite M, 2007, J WILDLIFE MANAGE, V71, P2026, DOI 10.2193/2006-238; Hebblewhite M, 2005, OIKOS, V111, P101, DOI 10.1111/j.0030-1299.2005.13858.x; Hebblewhite M, 2010, LINEAR FEATURES FORE; Hebblewhite M, 2017, BIOL CONSERV, V206, P102, DOI 10.1016/j.biocon.2016.12.014; Hervieux D, 2013, CAN J ZOOL, V91, P872, DOI 10.1139/cjz-2013-0123; James ARC, 2004, J WILDLIFE MANAGE, V68, P799, DOI 10.2193/0022-541X(2004)068[0799:SSOCFM]2.0.CO;2; Jedrzejewski W, 2001, CAN J ZOOL, V79, P1993, DOI 10.1139/z01-147; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Latham ADM, 2011, CAN J ZOOL, V89, P267, DOI [10.1139/z10-115, 10.1139/Z10-115]; Latham ADM, 2011, ECOL APPL, V21, P2854, DOI 10.1890/11-0666.1; Latham ADM, 2011, J WILDLIFE MANAGE, V75, P204, DOI 10.1002/jwmg.28; Lee P, 2006, J ENVIRON MANAGE, V78, P240, DOI 10.1016/j.jenvman.2005.03.016; Mazerolle M. C., 2013, AICCMODAVG MODEL SEL; McDermid GJ, 2009, FOREST ECOL MANAG, V257, P2262, DOI 10.1016/j.foreco.2009.03.005; Mckay T, 2014, WILDLIFE BIOL, V20, P310, DOI 10.2981/wlb.00046; McKenzie HW, 2012, INTERFACE FOCUS, V2, P205, DOI 10.1098/rsfs.2011.0086; McKenzie HW, 2009, ENVIRON ECOL STAT, V16, P531, DOI 10.1007/s10651-008-0095-7; Mech L. David, 2003, P1; Melin M, 2013, INT J APPL EARTH OBS, V23, P389, DOI 10.1016/j.jag.2012.11.004; Metz MC, 2012, J ANIM ECOL, V81, P553, DOI 10.1111/j.1365-2656.2011.01945.x; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; Mumma MA, 2017, ECOL EVOL, V7, P10266, DOI 10.1002/ece3.3563; Munro RHM, 2006, J MAMMAL, V87, P1112, DOI 10.1644/05-MAMM-A-410R3.1; Murtaugh PA, 2007, ECOLOGY, V88, P56, DOI 10.1890/0012-9658(2007)88[56:SACIED]2.0.CO;2; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Neufeld L., 2006, SPATIAL DYNAMICS WOL; Nielsen S.E., 2009, J CONSERVATION PLANN, V5, P38; Nielsen SE, 2010, BIOL CONSERV, V143, P1623, DOI 10.1016/j.biocon.2010.04.007; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; Nielsen SE, 2004, FOREST ECOL MANAG, V199, P51, DOI 10.1016/j.foreco.2004.04.014; Nielson SE, 2002, URSUS, V13, P45; Noss R, 2009, SPATIAL CONSERVATION, P158; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; R Core Team, 2021, R LANGUAGE ENV STAT; Revel RD., 1984, FOREST GROWTH REVEGE; Roever CL, 2008, FOREST ECOL MANAG, V256, P1253, DOI 10.1016/j.foreco.2008.06.040; Roever CL, 2010, ECOGRAPHY, V33, P1113, DOI 10.1111/j.1600-0587.2010.06077.x; Roffler GH, 2018, FOREST ECOL MANAG, V409, P190, DOI 10.1016/j.foreco.2017.11.025; Rowcliffe JM, 2012, METHODS ECOL EVOL, V3, P653, DOI 10.1111/j.2041-210X.2012.00197.x; Serrouya R, 2017, PEERJ, V5, DOI 10.7717/peerj.3736; Serrouya R, 2015, J ANIM ECOL, V84, P1600, DOI 10.1111/1365-2656.12413; Serrouya R, 2011, J APPL ECOL, V48, P935, DOI 10.1111/j.1365-2664.2011.01998.x; Singh NJ, 2010, BIOL CONSERV, V143, P1770, DOI 10.1016/j.biocon.2010.04.026; Sonderegger D.L., 2012, SIZER SIGNIFICANT ZE; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Stenhouse G, 2005, URSUS, V16, P31, DOI 10.2192/1537-6176(2005)016[0031:GBAATE]2.0.CO;2; Therneau T., 2015, PACKAGE SURVIVAL ANA; Thurfjell H, 2014, MOV ECOL, V2, DOI 10.1186/2051-3933-2-4; Tigner J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118720; Tigner J, 2014, J WILDLIFE MANAGE, V78, P282, DOI 10.1002/jwmg.664; van Rensen CK, 2015, BIOL CONSERV, V184, P127, DOI 10.1016/j.biocon.2015.01.020; Visscher DR, 2006, FOREST ECOL MANAG, V222, P348, DOI 10.1016/j.foreco.2005.10.035; Vors LS, 2009, GLOBAL CHANGE BIOL, V15, P2626, DOI 10.1111/j.1365-2486.2009.01974.x; Webb NF, 2008, J WILDLIFE MANAGE, V72, P798, DOI 10.2193/2006-566; White B, 2012, CAN WATER RESOUR J, V37, P333, DOI 10.4296/cwrj2011-909; Whittington J, 2011, J APPL ECOL, V48, P1535, DOI 10.1111/j.1365-2664.2011.02043.x; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wittmer HU, 2007, J ANIM ECOL, V76, P568, DOI 10.1111/j.1365-2656.2007.01220.x; Wittmer HU, 2005, OECOLOGIA, V144, P257, DOI 10.1007/s00442-005-0055-y; Zuur Alain F., 2009, P1	100	24	25	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195480	10.1371/journal.pone.0195480	http://dx.doi.org/10.1371/journal.pone.0195480			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659615	gold, Green Published, Green Submitted			2022-12-26	WOS:000430061100016
J	Wu, W; Yang, MF; Xu, M; Ding, C; Li, YT; Xu, KJ; Shen, JF; Li, LJ				Wu, Wei; Yang, Meifang; Xu, Min; Ding, Cheng; Li, Yongtao; Xu, Kaijin; Shen, Jifang; Li, Lanjuan			Diagnostic delay and mortality of active tuberculosis in patients after kidney transplantation in a tertiary care hospital in China	PLOS ONE			English	Article							SOLID-ORGAN TRANSPLANTATION; MATCHED COHORT; RECIPIENTS; INFECTIONS; OUTCOMES; POPULATION; CANDIDATES; EXPERIENCE; DISEASES; COUNTRY	TB infection in patients after kidney transplantation remains a concern in a successful long-term outcome. This retrospective, descriptive study was performed on tuberculosis infection after kidney transplantation in the Department of Infectious Disease of the First Affiliated Hospital of Zhejiang University, a tertiary care hospital in China, from January 2011 to April 2017, with the aim to explain the clinical features of active tuberculosis after kidney transplantation and explore the correlated factors for diagnostic delay and mortality. It included 48 cases. All these cases were followed up for at least 12 months after anti-tuberculosis therapy, except the ones who died during this period. The median time of transplantation to active tuberculosis of these 48 patients was about 5.4 years. The time from a first hospital visit to the diagnosis (diagnostic delay) of 12 (25%) cases was more than 30 days. The correlated factors for the diagnostic delay more than 30 days were a fever for more than 2 weeks and antibiotic use for more than 2 weeks. Nine (18.8%) cases died during the anti-tuberculosis therapy or following-up period due to TB relapse. The risk factors for mortality were severe complications, such as encephaledema, severe pneumonia, intestinal perforation, liver function failure, and the following multiple-organ failure. In conclusion, the possibility of tuberculosis infection should be carefully assessed and sometimes diagnostic anti-tuberculosis therapy may be required for patients who had a fever for more than 2 weeks or used antibiotics for more than 2 weeks after kidney transplantation. Severe complications and the following multiple-organ failure might increase the mortality among these patients.	[Wu, Wei; Yang, Meifang; Xu, Min; Ding, Cheng; Li, Yongtao; Xu, Kaijin; Shen, Jifang; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wu, Wei; Yang, Meifang; Ding, Cheng; Li, Yongtao; Xu, Kaijin; Shen, Jifang; Li, Lanjuan] Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Li, LJ (corresponding author), Zhejiang Univ, Affiliated Hosp 1, State Key Lab Diag & Treatment Infect Dis, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Li, LJ (corresponding author), Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou, Zhejiang, Peoples R China.	ljli@zju.edu.cn		Wu, Wei/0000-0003-4657-4088				Agarwal SK, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12626; Aguado JM, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.TNMI7-0005-2016; Benito N, 2015, CLIN MICROBIOL INFEC, V21, P651, DOI 10.1016/j.cmi.2015.03.010; Bumbacea D, 2012, EUR RESPIR J, V40, P990, DOI 10.1183/09031936.00000712; Chee CBE, 2012, SINGAP MED J, V53, P505; Chen CY, 2015, AM J TRANSPLANT, V15, P2180, DOI 10.1111/ajt.13235; de Castilla DL, 2010, TRANSPL INFECT DIS, V12, P106, DOI 10.1111/j.1399-3062.2009.00475.x; Gondos AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144266; Green M, 2013, AM J TRANSPLANT, V13, P3, DOI 10.1111/ajt.12093; Grim SA, 2015, TRANSPL INFECT DIS, V17, P768, DOI 10.1111/tid.12436; HSE National Drug Treatment Centre, 2016, CERV SMEAR GUID; Iliyasu G, 2016, TRANSPL INFECT DIS, V18, P566, DOI 10.1111/tid.12548; Jambaldorj E, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-017-0506-9; Kant S, 2017, RURAL REMOTE HEALTH, V17, DOI [10.22605/rrh4158, 10.22605/RRH4158]; Lange B, 2010, EUR RESPIR J, V35, P1179, DOI 10.1183/09031936.00122109; Lewinsohn DM, 2017, CLIN INFECT DIS, V64, P111, DOI 10.1093/cid/ciw778; Li Y, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-156; Lin J, 2013, J CLIN EXP MED, V12, P680; Mathur M, 2017, CLIN DIAGN RES, V11, pTC06; Meinerz G, 2016, TRANSPL INFECT DIS, V18, P176, DOI 10.1111/tid.12501; Morris MI, 2012, AM J TRANSPLANT, V12, P2288, DOI 10.1111/j.1600-6143.2012.04205.x; Subramanian AK, 2013, AM J TRANSPLANT, V13, P68, DOI 10.1111/ajt.12100; Subramanian AK, 2014, CURR OPIN INFECT DIS, V27, P316, DOI 10.1097/QCO.0000000000000082; Ulubay G, 2015, EXP CLIN TRANSPLANT, V13, P214, DOI 10.6002/ect.mesot2014.P16; Virenfeldt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004818; Williams E, 2018, INTERN MED J, V48, P184, DOI 10.1111/imj.13551; Wu XR, 2012, PEDIATRICS, V130, pE1433, DOI 10.1542/peds.2011-3742; Yoo JW, 2016, TRANSPL INT, V29, P549, DOI 10.1111/tri.12752; Zhang XL, 2015, TROP MED INT HEALTH, V20, P1431, DOI 10.1111/tmi.12566; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	30	5	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195695	10.1371/journal.pone.0195695	http://dx.doi.org/10.1371/journal.pone.0195695			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659613	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100026
J	Prince, MJ; Acosta, D; Guerra, M; Huang, YQ; Jimenez-Velazquez, IZ; Rodriguez, JJL; Salas, A; Sosa, AL; Dewey, ME; Guerchet, MM; Liu, ZR; Guerra, JJL; Prina, AM				Prince, Martin J.; Acosta, Daisy; Guerra, Mariella; Huang, Yueqin; Jimenez-Velazquez, Ivonne Z.; Llibre Rodriguez, Juan J.; Salas, Aquiles; Luisa Sosa, Ana; Dewey, Michael E.; Guerchet, Maelenn M.; Liu, Zhaorui; Llibre Guerra, Jorge J.; Prina, A. Matthew			Leg length, skull circumference, and the incidence of dementia in Latin America and China: A 10/66 population-based cohort study	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; HEAD CIRCUMFERENCE; BIRTH COHORT; INTRACRANIAL VOLUME; ALZHEIMERS-DISEASE; KOREAN POPULATION; TRUNK LENGTH; LIFE-COURSE; RISK; ASSOCIATIONS	Background Adult leg length is influenced by nutrition in the first few years of life. Adult head circumference is an indicator of brain growth. Cross-sectional studies indicate inverse associations with dementia risk, but there have been few prospective studies. Methods Population-based cohort studies in urban sites in Cuba, Dominican Republic Puerto Rico and Venezuela, and rural and urban sites in Peru, Mexico and China. Sociodemographic and risk factor questionnaires were administered to all participants, and anthropometric measures taken, with ascertainment of incident dementia, and mortality, three to five years later. Results Of the original at risk cohort of 13,587 persons aged 65 years and over, 2,443 (18.0%) were lost to follow-up; 10,540 persons with skull circumference assessments were followed up for 40,466 person years, and 10,400 with leg length assessments were followed up for 39,954 person years. There were 1,009 cases of incident dementia, and 1,605 dementia free deaths. The fixed effect pooled meta-analysed adjusted subhazard ratio (ASHR) for leg length (highest vs. lowest quarter) was 0.80 (95% CI, 0.66-0.97) and for skull circumference was 1.02 (95% CI, 0.84-1.25), with no heterogeneity of effect between sites (I-2 = 0%). Leg length measurements tended to be shorter at follow-up, particularly for those with baseline cognitive impairment and dementia. However, leg length change was not associated with dementia incidence (ASHR, per cm 1.006, 95% CI 0.992-1.020), and the effect of leg length was little altered after adjusting for baseline frailty (ASHR 0.82, 95% CI 0.67-0.99). A priori hypotheses regarding effect modification by gender or educational level were not supported. However, the effect of skull circumference was modified by gender (M vs F ASHR 0.86, 95% CI 0.75-0.98), but in the opposite direction to that hypothesized with a greater protective effect of larger skull dimensions in men. Conclusions Consistent findings across settings provide quite strong support for an association between adult leg length and dementia incidence in late-life. Leg length is a relatively stable marker of early life nutritional programming, which may confer brain reserve and protect against neurodegeneration in later life through mitigation of cardiometabolic risk. Further clarification of these associations could inform predictive models for future dementia incidence in the context of secular trends in adult height, and invigorate global efforts to improve childhood nutrition, growth and development.	[Prince, Martin J.; Dewey, Michael E.; Guerchet, Maelenn M.; Prina, A. Matthew] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London, England; [Acosta, Daisy] UNPHU, Dept Internal Med, Geriatr Sect, Santo Domingo, Dominican Rep; [Guerra, Mariella] Natl Inst Mental Hlth Honorio Delgado Hideyo Nogu, Psychogeriatr Unit, Lima, Peru; [Guerra, Mariella] Inst Memoria & Desordenes Relacionados, Lima, Peru; [Huang, Yueqin; Liu, Zhaorui] Peking Univ, Inst Mental Hlth, Beijing, Peoples R China; [Jimenez-Velazquez, Ivonne Z.] Univ Puerto Rico, Sch Med, Dept Internal Med, Geriatr Program, Med Sci Campus, San Juan, PR 00936 USA; [Llibre Rodriguez, Juan J.] Med Univ Havana, Fac Med Finley Albarran, Havana, Cuba; [Salas, Aquiles] Univ Cent Venezuela, Dept Med, Caracas Univ Hosp, Fac Med, Caracas, Venezuela; [Luisa Sosa, Ana] Autonomous Natl Univ Mexico, Lab Dementias, Natl Inst Neurol & Neurosurg Mexico, Mexico City, DF, Mexico; [Llibre Guerra, Jorge J.] Inst Neurol Dr Rafael Estrada, Havana, Cuba	University of London; King's College London; Universidad Nacional Pedro Henriquez Urena; Peking University; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Central Venezuela; Universidad Nacional Autonoma de Mexico	Prince, MJ (corresponding author), Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat Psychol & Neurosci, London, England.	martin.prince@kcl.ac.uk	Prince, Martin J/A-9170-2010; Dewey, Michael E/E-2049-2010; Ortiz, Ana Luisa Sosa/AAU-9376-2021; Prina, Matthew/B-4188-2013; Guerchet, Maëlenn/ABB-5594-2020; Llibre Rodriguez, Juan/D-2380-2010	Prince, Martin J/0000-0003-1379-7146; Dewey, Michael E/0000-0002-7522-3677; Ortiz, Ana Luisa Sosa/0000-0003-3930-3618; Prina, Matthew/0000-0001-6698-3263; Guerchet, Maëlenn/0000-0002-0470-5556; Guerra, Mariella/0000-0001-8923-349X; Llibre Rodriguez, Juan/0000-0002-8215-3160; Llibre Guerra, Jorge Jesus/0000-0002-2137-7750	Wellcome Trust [GR066133, GR080002]; World Health Organization; US Alzheimer's Association [IIRG - 04 - 1286]; FONACIT/CDCH/UCV; Puerto Rico Legislature; European Research Council [ERC-2013-ADG 340755 LIFE2YEARS1066]; MRC [MR/K021907/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); World Health Organization(World Health Organization); US Alzheimer's Association(Alzheimer's Association); FONACIT/CDCH/UCV; Puerto Rico Legislature; European Research Council(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funded by Wellcome Trust (GR066133-Prevalence phase in Cuba; GR080002- Incidence phase in Peru, Mexico, Cuba, Dominican Republic, Venezuela and China and data analysis across all centres) - http://www.wellcome.ac.uk/, World Health Organization (Prevalence phase in Dominican Republic and China) - www.who.int, US Alzheimer's Association (IIRG - 04 - 1286 - Prevalence phase in Peru, and Mexico) - http://www.alz.org/research/alzheimers_grants!, FONACIT/CDCH/UCV (data collection in Venezuela) - http://www.fonacit.gob.ve/, and Puerto Rico Legislature (data collection in Puerto Rico). European Research Council ERC-2013-ADG 340755 LIFE2YEARS1066. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartholomeusz HH, 2002, NEUROPEDIATRICS, V33, P239, DOI 10.1055/s-2002-36735; Baten J, 2012, ECON HIST DEV REG, V27, pS66, DOI 10.1080/20780389.2012.657489; Bickel H, 2006, PSYCHIAT PRAX, V33, P138, DOI 10.1055/s-2005-915464; COPELAND JRM, 1986, PSYCHOL MED, V16, P89, DOI 10.1017/S0033291700057779; Edland SD, 2002, NEUROLOGY, V59, P272, DOI 10.1212/WNL.59.2.272; Ferri CP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001179; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Ganguli M, 1996, Int Psychogeriatr, V8, P507, DOI 10.1017/S1041610296002852; Gigante DP, 2009, EUR J CLIN NUTR, V63, P375, DOI 10.1038/sj.ejcn.1602949; Grasset L, 2015, ALZHEIMERS DEMENT, V10; Graves AB, 2001, NEUROLOGY, V57, P1453, DOI 10.1212/WNL.57.8.1453; HALL KS, 1993, INT J METHOD PSYCH, V3, P1; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huang TL, 2008, NEUROLOGY, V70, P1818, DOI 10.1212/01.wnl.0000311444.20490.98; Jenkins R, 2000, ARCH NEUROL-CHICAGO, V57, P220, DOI 10.1001/archneur.57.2.220; Jotheeswaran AT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0378-4; Jotheeswaran AT, 2011, INT PSYCHOGERIATR, V23, P328, DOI 10.1017/S1041610210001171; Kim JM, 2008, INT J GERIATR PSYCH, V23, P41, DOI 10.1002/gps.1833; Kim JM, 2003, J NEUROL NEUROSUR PS, V74, P427, DOI 10.1136/jnnp.74.4.427; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Mak Z, 2006, INT J GERIATR PSYCH, V21, P266, DOI 10.1002/gps.1458; Miller DB, 2008, METABOLISM, V57, pS44, DOI 10.1016/j.metabol.2008.07.011; Mortimer JA, 2003, J CLIN EXP NEUROPSYC, V25, P671, DOI 10.1076/jcen.25.5.671.14584; Prina AM, 2016, INT J EPIDEMIOL; Prince M, 2003, LANCET, V361, P909, DOI 10.1016/S0140-6736(03)12772-9; Prince M, 2010, INT PSYCHOGERIATR, P1; Prince M, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-165; Prince M, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0188-8; Prince M, 2012, LANCET, V380, P50, DOI 10.1016/S0140-6736(12)60399-7; Raikkonen K, 2009, AM J EPIDEMIOL, V170, P447, DOI 10.1093/aje/kwp132; Richards M, 2002, INT J EPIDEMIOL, V31, P342, DOI 10.1093/ije/31.2.342; Rodriguez JJL, 2008, LANCET, V372, P464, DOI 10.1016/S0140-6736(08)61002-8; Satizabal CL, 2016, NEW ENGL J MED, V374, P523, DOI 10.1056/NEJMoa1504327; Scazufca M, 2008, INT J EPIDEMIOL, V37, P879, DOI 10.1093/ije/dyn125; Schofield PW, 1997, NEUROLOGY, V49, P30, DOI 10.1212/WNL.49.1.30; Smith GD, 2001, J EPIDEMIOL COMMUN H, V55, P867, DOI 10.1136/jech.55.12.867; Stewart R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124163; TANNER JM, 1982, ANN HUM BIOL, V9, P411, DOI 10.1080/03014468200005951; Wadsworth MEJ, 2002, INT J EPIDEMIOL, V31, P383, DOI 10.1093/ije/31.2.383; Whalley LJ, 2006, LANCET NEUROL, V5, P87, DOI 10.1016/S1474-4422(05)70286-6	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195133	10.1371/journal.pone.0195133	http://dx.doi.org/10.1371/journal.pone.0195133			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649337	gold, Green Submitted, Green Published			2022-12-26	WOS:000429791900026
J	Weng, LC; Roetker, NS; Lutsey, PL; Alonso, A; Guan, WH; Pankow, JS; Folsom, AR; Steffen, LM; Pankratz, N; Tang, WH				Weng, Lu-Chen; Roetker, Nicholas S.; Lutsey, Pamela L.; Alonso, Alvaro; Guan, Weihua; Pankow, James S.; Folsom, Aaron R.; Steffen, Lyn M.; Pankratz, Nathan; Tang, Weihong			Evaluation of the relationship between plasma lipids and abdominal aortic aneurysm: A Mendelian randomization study	PLOS ONE			English	Article							IMPROVED LIPOLYTIC EFFICIENCY; RISK-FACTORS; LIPOPROTEIN CHOLESTEROL; ENZYMATIC DETERMINATION; ATHEROSCLEROSIS RISK; INSTRUMENTS; METAANALYSIS; ASSOCIATION; COMMUNITIES; SMOKING	Studies have reported that higher circulating levels of total cholesterol (TC), low-density lipoprotein (LDL) cholesterol and lower of high-density lipoprotein (HDL) cholesterol may be associated with increased risk of abdominal aortic aneurysm (AAA). Whether dyslipidemia causes AAA is still unclear and is potentially testable using a Mendelian randomization (MR) approach. We investigated the associations between blood lipids and AAA using two-sample MR analysis with SNP-lipids association estimates from a published genome-wide association study of blood lipids (n = 188,577) and SNP-AAA association estimates from European Americans (EAs) of the Atherosclerosis Risk in Communities (ARIC) study (n = 8,793). We used inverse variance weighted (IVW) MR as the primary method and MR Egger regression and weighted median MR estimation as sensitivity analyses. Over a median of 22.7 years of follow-up, 338 of 8,793 ARIC participants experienced incident clinical AAA. Using the IVW method, we observed positive associations of plasma LDL cholesterol and TC with the risk of AAA (odds ratio (OR) = 1.55, P = 0.02 for LDL cholesterol and OR = 1.61, P = 0.01 for TC per 1 standard deviation of lipid increment). Using the MR-Egger regression and weighted median methods, we were able to validate the association of AAA risk with TC, although the associations were less consistent for LDL cholesterol due to wider confidence intervals. Triglycerides and HDL cholesterol were not associated with AAA in any of the MR methods. Assuming instrumental variable assumptions are satisfied, our finding suggests that higher plasma TC and LDL cholesterol are causally associated with the increased risk of AAA in EAs.	[Weng, Lu-Chen; Roetker, Nicholas S.; Lutsey, Pamela L.; Alonso, Alvaro; Pankow, James S.; Folsom, Aaron R.; Steffen, Lyn M.; Tang, Weihong] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Guan, Weihua] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Pankratz, Nathan] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Weng, Lu-Chen] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Alonso, Alvaro] Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Emory University	Tang, WH (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	tang0097@umn.edu	Alonso, Alvaro/A-4917-2010	Alonso, Alvaro/0000-0002-2225-8323; Steffen, Lyn M/0000-0002-4053-6729; Pankow, James/0000-0001-7076-483X; Lutsey, Pamela/0000-0002-1572-1340	National Heart, Lung, and Blood Institute (NHLBI) [R01 HL103695]; National Heart, Lung, and Blood Institute [HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C, UL1RR025005]; NIH Roadmap for Medical Research	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The National Heart, Lung, and Blood Institute (NHLBI) supported this research through R01 HL103695. The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367 and R01HL086694; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AUERBACH O, 1980, CHEST, V78, P805, DOI 10.1378/chest.78.6.805; Baumgartner I, 2008, J VASC SURG, V48, P808, DOI 10.1016/j.jvs.2008.05.026; Bowden J, 2016, GENET EPIDEMIOL, V40, P304, DOI 10.1002/gepi.21965; Bowden J, 2015, INT J EPIDEMIOL, V44, P512, DOI 10.1093/ije/dyv080; BROWN SA, 1993, ARTERIOSCLER THROMB, V13, P1139, DOI 10.1161/01.ATV.13.8.1139; Burgess S, 2016, GENET EPIDEMIOL, V40, P597, DOI 10.1002/gepi.21998; Cornuz J, 2004, EUR J PUBLIC HEALTH, V14, P343, DOI 10.1093/eurpub/14.4.343; ERNST CB, 1993, NEW ENGL J MED, V328, P1167; Forsdahl SH, 2009, CIRCULATION, V119, P2202, DOI 10.1161/CIRCULATIONAHA.108.817619; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Golledge J, 2013, CURR OPIN CARDIOL, V28, P290, DOI 10.1097/HCO.0b013e32835f0d55; Harrison SC, 2018, JAMA CARDIOL, V3, P26, DOI 10.1001/jamacardio.2017.4293; Haycock PC, 2017, JAMA ONCOL, V3, P636, DOI 10.1001/jamaoncol.2016.5945; Holmes MV, 2015, EUR HEART J, V36, P539, DOI 10.1093/eurheartj/eht571; Jahangir E, 2015, J EPIDEMIOL COMMUN H, V69, P481, DOI 10.1136/jech-2014-204920; JOHNSON G, 1985, ARCH SURG-CHICAGO, V120, P1138; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Lindblad B, 2005, EUR J VASC ENDOVASC, V30, P346, DOI 10.1016/j.ejvs.2005.04.021; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Pankow JS, 2017, ARTERIOSCL THROM VAS, V37, P589, DOI 10.1161/ATVBAHA.116.308109; Pierce BL, 2013, AM J EPIDEMIOL, V178, P1177, DOI 10.1093/aje/kwt084; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rodin MB, 2003, HYPERTENSION, V42, P61, DOI 10.1161/01.HYP.0000078829.02288.98; Sandiford P, 2012, J EPIDEMIOL COMMUN H, V66, P1097, DOI 10.1136/jech-2011-200754; SIEDEL J, 1983, CLIN CHEM, V29, P1075; Tang WH, 2016, ARTERIOSCL THROM VAS, V36, P2468, DOI 10.1161/ATVBAHA.116.308147; Thompson RW, 2006, ANN NY ACAD SCI, V1085, P59, DOI 10.1196/annals.1383.029; Tornwall ME, 2001, EPIDEMIOLOGY, V12, P94; Van Kuijk JP, 2009, J CARDIOVASC SURG, V50, P599; WARNICK GR, 1982, AM J CLIN PATHOL, V78, P718; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	33	26	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195719	10.1371/journal.pone.0195719	http://dx.doi.org/10.1371/journal.pone.0195719			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649275	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900076
J	Liu, JY; Zeng, QH; Cao, PG; Xie, D; Yang, F; He, LY; Dai, YB; Li, JJ; Liu, XM; Zeng, HL; Fan, XJ; Liu, L; Zhu, YX; Gong, L; Cheng, Y; Zhou, JD; Hu, J; Bo, H; Xu, ZZ; Cao, K				Liu, J. Y.; Zeng, Q. H.; Cao, P. G.; Xie, D.; Yang, F.; He, L. Y.; Dai, Y. B.; Li, J. J.; Liu, X. M.; Zeng, H. L.; Fan, X. J.; Liu, L.; Zhu, Y. X.; Gong, L.; Cheng, Y.; Zhou, J. D.; Hu, J.; Bo, H.; Xu, Z. Z.; Cao, K.			SPAG5 promotes proliferation and suppresses apoptosis in bladder urothelial carcinoma by upregulating Wnt3 via activating the AKT/mTOR pathway and predicts poorer survival	ONCOGENE			English	Article							RADICAL CYSTECTOMY; SIGNALING PATHWAY; EAU GUIDELINES; CANCER; CHEMOTHERAPY; EXPRESSION; ASTRIN; PROGRESSION; RECURRENCE; PROTEINS	Sperm-associated antigen 5 (SPAG5) is involved in various biological processes. However, the roles of SPAG5 in bladder urothelial carcinoma (BUC) are unknown. This study showed that upregulation of SPAG5 was detected frequently in primary BUC tissues, and was associated with significantly worse survival among the 112 patients that underwent radical cystectomy (RC). Up and downregulating the expression of SPAG5 enhanced or inhibited, respectively, the proliferation of BUC cells in vitro and in vivo, and suppressed or enhanced, respectively, apoptosis in vitro and in vivo. Moreover, SPAG5 increased the resistance of BUC cells to chemotherapy-induced apoptosis. Mechanistic investigations showed that SPAG5 promotes proliferation and suppresses apoptosis in BUC at least partially via upregulating Wnt3 through activating the AKT/mTOR signaling pathway. The importance of the SPAG5/AKT-mTOR/Wnt3 axis identified in BUC cell models was confirmed via immunohistochemical analysis of a cohort of human BUC specimens that underwent RC. Collectively, our data suggested that in patients with BUC who underwent RC, high SPAG5 expression is associated with poor survival. In addition, targeting SPAG5 might represent a novel therapeutic strategy to improve the survival of patients with BUC.	[Liu, J. Y.; He, L. Y.; Dai, Y. B.] Cent South Univ, Xiangya Hosp 3, Dept Urol, Changsha, Hunan, Peoples R China; [Liu, J. Y.; He, L. Y.; Dai, Y. B.] Cent South Univ, Inst Prostate Dis, Changsha, Hunan, Peoples R China; [Zeng, Q. H.] Cent South Univ, Xiangya Hosp 3, Dept Dermatol, Changsha, Hunan, Peoples R China; [Cao, P. G.; Zhu, Y. X.; Gong, L.; Cao, K.] Cent South Univ, Xiangya Hosp 3, Dept Onol, Changsha, Hunan, Peoples R China; [Xie, D.] Sun Yat Sen Univ Canc Ctr, Dept Pathol, Guangzhou, Guangdong, Peoples R China; [Xie, D.] State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China; [Yang, F.] Cent South Univ, Sch Publ Hlth, Changsha, Hunan, Peoples R China; [Li, J. J.; Zhou, J. D.] Cent South Univ, Xiangya Hosp 3, Dept Plast Surg, Changsha, Hunan, Peoples R China; [Liu, X. M.] Cent South Univ, Xiangya Hosp 3, Dept Gastroenterol, Changsha, Hunan, Peoples R China; [Zeng, H. L.] Hunan Key Lab Pharmacodynam & Safety Evaluat New, Changsha, Hunan, Peoples R China; [Fan, X. J.] Cent South Univ, Xiangya Hosp 3, Res Serv Off, Changsha, Hunan, Peoples R China; [Liu, L.] Cent South Univ, Xiangya Hosp 3, Outpatient Serv Off, Changsha, Hunan, Peoples R China; [Cheng, Y.] Cent South Univ, Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Hunan, Peoples R China; [Hu, J.] Hunan Canc Hosp, Dept Tissue Bank, Changsha, Hunan, Peoples R China; [Bo, H.] Cent South Univ, Inst Reprod & Stem Cell Engn, Changsha, Hunan, Peoples R China; [Xu, Z. Z.] Hunan Canc Hosp, Dept Urol, Changsha, Hunan, Peoples R China	Central South University; Central South University; Central South University; Central South University; Sun Yat Sen University; State Key Lab Oncology South China; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University; Central South University	Cao, K (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Onol, Changsha, Hunan, Peoples R China.	CSUcaoke@163.com			Natural Science Foundation of China [81301688, 81572965, 81572689]; Innovation-Driven Project of Central South University [2017CX012]; "125 Talent Project" of the Third Xiangya Hospital of Central South University; "New Xiangya Talent Project" of the Third Xiangya Hospital of Central South University; New Xiangya Talent Projects of the Third Xiangya Hospital of Central South University [JY201615]; Scientific Projects of Health and Family Planning Commision of Hunan Province [B2017034]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation-Driven Project of Central South University; "125 Talent Project" of the Third Xiangya Hospital of Central South University; "New Xiangya Talent Project" of the Third Xiangya Hospital of Central South University; New Xiangya Talent Projects of the Third Xiangya Hospital of Central South University; Scientific Projects of Health and Family Planning Commision of Hunan Province	This work was supported by the Natural Science Foundation of China (Grant nos. 81301688, 81572965, and 81572689), the Innovation-Driven Project of Central South University (Grant no. 2017CX012), the "125 Talent Project" and "New Xiangya Talent Project" of the Third Xiangya Hospital of Central South University, the New Xiangya Talent Projects of the Third Xiangya Hospital of Central South University (Grant no. JY201615), and the Scientific Projects of Health and Family Planning Commision of Hunan Province (Grant no. B2017034).	Abdel-Fatah TMA, 2016, LANCET ONCOL, V17, P1004, DOI 10.1016/S1470-2045(16)00174-1; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Babjuk M, 2017, EUR UROL, V71, P447, DOI 10.1016/j.eururo.2016.05.041; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Buechler S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-243; Chang MS, 2001, BIOCHEM BIOPH RES CO, V287, P116, DOI 10.1006/bbrc.2001.5554; Chen WJ, 2017, ONCOTARGET, V8, P61282, DOI 10.18632/oncotarget.18058; Cornen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081843; Diamandis M, 2010, MOL CANCER RES, V8, P1175, DOI 10.1158/1541-7786.MCR-10-0264; Easton JB, 2006, ONCOGENE, V25, P6436, DOI 10.1038/sj.onc.1209886; Gao C, 2010, NAT CELL BIOL, V12, P781, DOI 10.1038/ncb2082; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Johansson I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078299; Kaufman DS, 2009, LANCET, V374, P239, DOI 10.1016/S0140-6736(09)60491-8; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Kim SE, 2007, CELL SIGNAL, V19, P511, DOI 10.1016/j.cellsig.2006.08.008; Leow JJ, 2014, EUR UROL, V66, P42, DOI 10.1016/j.eururo.2013.08.033; Liu PP, 2014, CELL DEATH DIFFER, V21, P124, DOI 10.1038/cdd.2013.131; Lotan Y, 2005, J CLIN ONCOL, V23, P6533, DOI 10.1200/JCO.2005.05.516; Lotan Y, 2013, EUR UROL, V64, P465, DOI 10.1016/j.eururo.2013.03.043; Mack GJ, 2001, P NATL ACAD SCI USA, V98, P14434, DOI 10.1073/pnas.261371298; Manning AL, 2010, EMBO J, V29, P3531, DOI 10.1038/emboj.2010.230; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Peng Y, 2014, CELL SIGNAL, V26, P2782, DOI 10.1016/j.cellsig.2014.08.021; Poppova L, 2016, BRIT J HAEMATOL, V175, P851, DOI 10.1111/bjh.14312; Samarin J, 2016, HEPATOLOGY, V63, P813, DOI 10.1002/hep.28357; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Siu MK, 2015, ONCOGENE, V34, P4767, DOI 10.1038/onc.2014.414; Slomovitz BM, 2012, CLIN CANCER RES, V18, P5856, DOI 10.1158/1078-0432.CCR-12-0662; Steele LP, 2006, CELL DEATH DIFFER, V13, P1564, DOI 10.1038/sj.cdd.4401846; Stein JP, 2001, J CLIN ONCOL, V19, P666, DOI 10.1200/JCO.2001.19.3.666; Sternberg CN, 2015, LANCET ONCOL, V16, P76, DOI 10.1016/S1470-2045(14)71160-X; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Valk K, 2010, ONCOLOGY-BASEL, V79, P283, DOI 10.1159/000322116; Witjes JA, 2017, EUR UROL, V71, P462, DOI 10.1016/j.eururo.2016.06.020; Yuan LJ, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.222	38	36	37	3	20	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					3937	3952		10.1038/s41388-018-0223-2	http://dx.doi.org/10.1038/s41388-018-0223-2			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29662193				2022-12-26	WOS:000439101300003
J	Martin-Garrido, A; Biesiadecki, BJ; Salhi, HE; Shaifta, Y; dos Remedios, CG; Ayaz-Guner, S; Cai, WX; Ge, Y; Avkiran, M; Kentish, JC				Martin-Garrido, Abel; Biesiadecki, Brandon J.; Salhi, Hussam E.; Shaifta, Yasin; dos Remedios, Cristobal G.; Ayaz-Guner, Serife; Cai, Wenxuan; Ge, Ying; Avkiran, Metin; Kentish, Jonathan C.			Monophosphorylation of cardiac troponin-I at Ser-23/24 is sufficient to regulate cardiac myofibrillar Ca2+ sensitivity and calpain-induced proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						troponin; phosphorylation; protein kinase D (PKD); calpain; cardiac muscle; cardiomyocyte; Ca2+ sensitivity; myofibril; sarcomere	BINDING-PROTEIN-C; FAILING HUMAN HEART; KINASE-D; PHOSPHORYLATION SITE; MYOFILAMENT FUNCTION; MYOSIN; MYOCARDIUM; AFFINITY; MUSCLE; CARDIOMYOPATHY	The acceleration of myocardial relaxation produced by -adrenoreceptor stimulation is mediated in part by protein kinase A (PKA)-mediated phosphorylation of cardiac troponin-I (cTnI), which decreases myofibrillar Ca2+ sensitivity. Previous evidence suggests that phosphorylation of both Ser-23 and Ser-24 in cTnI is required for this Ca2+ desensitization. PKA-mediated phosphorylation also partially protects cTnI from proteolysis by calpain. Here we report that protein kinase D (PKD) phosphorylates only one serine of cTnI Ser-23/24. To explore the functional consequences of this monophosphorylation, we examined the Ca2+ sensitivity of force production and susceptibility of cTnI to calpain-mediated proteolysis when Ser-23/24 of cTnI in mouse cardiac myofibrils was nonphosphorylated, mono-phosphorylated, or bisphosphorylated (using sequential incubations in -phosphatase, PKD, and PKA, respectively). Phos-tag gels, Western blotting, and high-resolution MS revealed that PKD produced >90% monophosphorylation of cTnI, primarily at Ser-24, whereas PKA led to cTnI bisphosphorylation exclusively. PKD markedly decreased the Ca2+ sensitivity of force production in detergent-permeabilized ventricular trabeculae, whereas subsequent incubation with PKA produced only a small further fall of Ca2+ sensitivity. Unlike PKD, PKA also substantially phosphorylated myosin-binding protein-C and significantly accelerated cross-bridge kinetics (k(tr)). After phosphorylation by PKD or PKA, cTnI in isolated myofibrils was partially protected from calpain-mediated degradation. We conclude that cTnI monophosphorylation at Ser-23/24 decreases myofibrillar Ca2+ sensitivity and partially protects cTnI from calpain-induced proteolysis. In healthy cardiomyocytes, the basal monophosphorylation of cTnI may help tonically regulate myofibrillar Ca2+ sensitivity.	[Martin-Garrido, Abel; Shaifta, Yasin; Avkiran, Metin; Kentish, Jonathan C.] Kings Coll London, British Heart Fdn Ctr Excellence, Sch Cardiovasc Med & Sci, London SE1 7EH, England; [Biesiadecki, Brandon J.; Salhi, Hussam E.] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [dos Remedios, Cristobal G.] Univ Sydney, Discipline Anat & Histol, Bosch Inst, Sydney, NSW 2006, Australia; [Ayaz-Guner, Serife; Cai, Wenxuan; Ge, Ying] Univ Wisconsin, Dept Cell & Regenerat Biol, Pharmacol Training Program, Madison, WI 53705 USA; [Ge, Ying] Univ Wisconsin, Dept Chem, Pharmacol Training Program, Madison, WI 53705 USA; [Cai, Wenxuan] Univ Wisconsin, Dept Mol & Cellular, Pharmacol Training Program, Madison, WI 53705 USA; [Ge, Ying] Univ Wisconsin, Human Prote Program, Madison, WI 53705 USA; [Martin-Garrido, Abel] Univ Cambridge, Div Cardiovasc Med, Cambridge CB2 0QQ, England	University of London; King's College London; University System of Ohio; Ohio State University; University of Sydney; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Cambridge	Avkiran, M; Kentish, JC (corresponding author), Kings Coll London, St Thomas Hosp, British Heart Fdn Ctr Res Excellence, Rayne Inst, London SE1 7EH, England.	metin.avkiran@kcl.ac.uk; jon.kentish@kcl.ac.uk	AYAZ-GUNER, Serife/ABE-6237-2020; Ayaz-Guner, Serife/K-4139-2019	Ayaz-Guner, Serife/0000-0002-1052-0961; Cai, Wenxuan/0000-0001-7117-2449; Avkiran, Metin/0000-0003-2392-6343	British Heart Foundation [PG/11/100/29211, RE/13/2/30182]; National Institutes of Health [R01 HL109810, R01 HL096971, S10OD018475, R01 HL114940]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096971, R01HL114940, R01HL109810] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018475] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by British Heart Foundation grants PG/11/100/29211 and RE/13/2/30182 (to J. K. and M. A) and National Institutes of Health Grants R01 HL109810, R01 HL096971, and S10OD018475 (to Y. G.) and R01 HL114940 to (B. J. B.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Avkiran M, 2008, CIRC RES, V102, P157, DOI 10.1161/CIRCRESAHA.107.168211; Ayaz-Guner S, 2009, BIOCHEMISTRY-US, V48, P8161, DOI 10.1021/bi900739f; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; BRENNER B, 1986, P NATL ACAD SCI USA, V83, P3542, DOI 10.1073/pnas.83.10.3542; Cuello F, 2007, CIRC RES, V100, P864, DOI 10.1161/01.RES.0000260809.15393.fa; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; DILISA F, 1995, BIOCHEM J, V308, P57, DOI 10.1042/bj3080057; Feng HZ, 2008, J BIOL CHEM, V283, P33384, DOI 10.1074/jbc.M803302200; Fitzsimons DP, 2001, J PHYSIOL-LONDON, V530, P263, DOI 10.1111/j.1469-7793.2001.0263l.x; Fukuda N, 2004, CURR VASC PHARMACOL, V2, P135, DOI 10.2174/1570161043476357; Gao WD, 1997, CIRC RES, V80, P393, DOI 10.1161/01.res.0000435855.49359.47; Gross SM, 2016, PHYSIOL GENOMICS, V48, P377, DOI 10.1152/physiolgenomics.00112.2015; Haworth RS, 2004, CIRC RES, V95, P1091, DOI 10.1161/01.RES.0000149299.34793.3c; Hinken AC, 2007, PHYSIOLOGY, V22, P73, DOI 10.1152/physiol.00043.2006; Jensen BC, 2011, J MOL CELL CARDIOL, V51, P518, DOI 10.1016/j.yjmcc.2010.11.014; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Layland J, 2004, J PHYSIOL-LONDON, V556, P835, DOI 10.1113/jphysiol.2004.061176; Martell A. E., 1974, CRIT STABILITY CONST, V1, P270; McDonough JL, 1999, CIRC RES, V84, P9; Messer AE, 2007, J MOL CELL CARDIOL, V42, P247, DOI 10.1016/j.yjmcc.2006.08.017; Messer AE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00315; Messer AE, 2009, PROTEOM CLIN APPL, V3, P1371, DOI 10.1002/prca.200900071; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Solaro RJ, 2011, J BIOL CHEM, V286, P9935, DOI 10.1074/jbc.R110.197731; van der Velden J, 2011, PFLUG ARCH EUR J PHY, V462, P155, DOI 10.1007/s00424-011-0960-3; van Dijk SJ, 2012, CIRC-HEART FAIL, V5, P36, DOI 10.1161/CIRCHEARTFAILURE.111.963702; Wijnker PJM, 2015, J MOL CELL CARDIOL, V82, P93, DOI 10.1016/j.yjmcc.2015.03.006; Wijnker PJM, 2013, AM J PHYSIOL-HEART C, V304, pH260, DOI 10.1152/ajpheart.00498.2012; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Yu ZB, 2001, J BIOL CHEM, V276, P15753, DOI 10.1074/jbc.M011048200; Zachariou M, 1996, J PHYS CHEM-US, V100, P12680, DOI 10.1021/jp9601476; Zaremba R, 2007, PROTEOM CLIN APPL, V1, P1285, DOI 10.1002/prca.200600891; Zhang PB, 2012, CIRCULATION, V126, P1828, DOI 10.1161/CIRCULATIONAHA.112.096388; Zhang R, 1995, J BIOL CHEM, V270, P30773, DOI 10.1074/jbc.270.51.30773; Zhuo SQ, 1997, PROTEIN ENG, V10, P1445, DOI 10.1093/protein/10.12.1445	40	17	18	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8588	8599		10.1074/jbc.RA117.001292	http://dx.doi.org/10.1074/jbc.RA117.001292			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669813	hybrid, Green Published			2022-12-26	WOS:000434205700022
J	Miyanokoshi, M; Yokosawa, T; Wakasugi, K				Miyanokoshi, Miki; Yokosawa, Takumi; Wakasugi, Keisuke			Tryptophanyl-tRNA synthetase mediates high-affinity tryptophan uptake into human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl tRNA synthetase; tryptophan; amino acid transport; interferon; indoleamine-pyrrole 2; 3-dioxygenase (IDO1); tryptophanyl-tRNA synthetase; mutagenesis	HUMAN INDOLEAMINE 2,3-DIOXYGENASE; AMINO-ACID TRANSPORTER; INTERFERON-GAMMA; CRYSTAL-STRUCTURE; ANGIOSTATIC ACTIVITY; DENDRITIC CELLS; ACTIVE-SITE; HUMAN TRPRS; PROTEIN; IDENTIFICATION	The tryptophan (Trp) transport system has a high affinity and selectivity toward Trp, and has been reported to exist in both human and mouse macrophages. Although this system is highly expressed in interferon- (IFN-)-treated cells and indoleamine 2,3-dioxygenase 1 (IDO1)-expressing cells, its identity remains incompletely understood. Tryptophanyl-tRNA synthetase (TrpRS) is also highly expressed in IFN--treated cells and also has high affinity and selectivity for Trp. Here, we investigated the effects of human TrpRS expression on Trp uptake into IFN--treated human THP-1 monocytes or HeLa cells. Inhibition of human TrpRS expression by TrpRS-specific siRNAs decreased and overexpression of TrpRS increased Trp uptake into the cells. Of note, the TrpRS-mediated uptake system had more than hundred-fold higher affinity for Trp than the known System L amino acid transporter, promoted uptake of low Trp concentrations, and had very high Trp selectivity. Moreover, site-directed mutagenesis experiments indicated that Trp- and ATP-binding sites, but not tRNA-binding sites, in TrpRS are essential for TrpRS-mediated Trp uptake into the human cells. We further demonstrate that the addition of purified TrpRS to cell culture medium increases Trp uptake into cells. Taken together, our results reveal that TrpRS plays an important role in high-affinity Trp uptake into human cells.	[Miyanokoshi, Miki; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan; [Yokosawa, Takumi; Wakasugi, Keisuke] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo	Wakasugi, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.; Wakasugi, K (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	wakasugi@bio.c.u-tokyo.ac.jp	Wakasugi, Keisuke/AAQ-1642-2020	Wakasugi, Keisuke/0000-0002-8408-5616	Kurata Memorial Hitachi Science and Technology Foundation Kurata Grant; Smoking Research Foundation research grant; Japan Society for the Promotion of Science (JSPS) KAKENHI [21570129, 26440047, 17K07329, 16J09853]	Kurata Memorial Hitachi Science and Technology Foundation Kurata Grant; Smoking Research Foundation research grant; Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by the Kurata Memorial Hitachi Science and Technology Foundation Kurata Grant (to K.W.), the Smoking Research Foundation research grant (to K.W.), and Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 21570129, 26440047, and 17K07329 (to K.W.) and 16J09853 (to M.M.). The authors declare that they have no conflicts of interest with the contents of this article.	Ahn YH, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.191; AIDA Y, 1990, J IMMUNOL METHODS, V132, P191, DOI 10.1016/0022-1759(90)90029-U; Bhutia YD, 2015, BBA-BIOMEMBRANES, V1848, P453, DOI 10.1016/j.bbamem.2014.10.021; Brown JR, 1997, J MOL EVOL, V45, P9, DOI 10.1007/PL00006206; del Amo EM, 2008, EUR J PHARM SCI, V35, P161, DOI 10.1016/j.ejps.2008.06.015; dePouplana LR, 1996, P NATL ACAD SCI USA, V93, P166, DOI 10.1073/pnas.93.1.166; DOUBLIE S, 1995, STRUCTURE, V3, P17, DOI 10.1016/S0969-2126(01)00132-0; Ewalt KL, 2005, BIOCHEMISTRY-US, V44, P4216, DOI 10.1021/bi048116l; Ewalt KL, 2002, BIOCHEMISTRY-US, V41, P13344, DOI 10.1021/bi020537k; FLECKNER J, 1995, CYTOKINE, V7, P70, DOI 10.1006/cyto.1995.1009; FLECKNER J, 1991, P NATL ACAD SCI USA, V88, P11520, DOI 10.1073/pnas.88.24.11520; FROLOVA LY, 1991, GENE, V109, P291, DOI 10.1016/0378-1119(91)90624-K; Johnson JD, 2002, FEMS MICROBIOL LETT, V216, P111, DOI 10.1111/j.1574-6968.2002.tb11423.x; Kapoor M, 2008, J BIOL CHEM, V283, P2070, DOI 10.1074/jbc.M706028200; Kise Y, 2004, NAT STRUCT MOL BIOL, V11, P149, DOI 10.1038/nsmb722; KISSELEV L, 1993, TRENDS BIOCHEM SCI, V18, P263, DOI 10.1016/0968-0004(93)90178-P; Kisselev L L, 1979, Methods Enzymol, V59, P234; Krause SW, 1996, J LEUKOCYTE BIOL, V60, P540, DOI 10.1002/jlb.60.4.540; Kudo Y, 2003, AM J OBSTET GYNECOL, V188, P719, DOI 10.1067/mob.2003.156; Kudo Y, 2001, J PHYSIOL-LONDON, V535, P207, DOI 10.1111/j.1469-7793.2001.00207.x; Kwidzinski E, 2005, FASEB J, V19, P1347, DOI 10.1096/fj.04-3228fje; Lee CW, 2015, ONCOTARGET, V6, P21979, DOI 10.18632/oncotarget.4273; Littlejohn TK, 2003, J BIOL CHEM, V278, P29525, DOI 10.1074/jbc.M301700200; Liu JM, 2004, NUCLEIC ACIDS RES, V32, P719, DOI 10.1093/nar/gkh240; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Matsunaga T, 2002, SCAND J IMMUNOL, V56, P593, DOI 10.1046/j.1365-3083.2002.01179.x; Miyanokoshi M, 2013, SCI REP-UK, V3, DOI 10.1038/srep03477; Munn DH, 1998, SCIENCE, V281, P1191, DOI 10.1126/science.281.5380.1191; Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363; Nakamoto T, 2016, SCI REP-UK, V6, DOI 10.1038/srep24750; NATHAN CF, 1983, J EXP MED, V158, P670, DOI 10.1084/jem.158.3.670; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Paley EL, 2011, J ALZHEIMERS DIS, V26, P263, DOI 10.3233/JAD-2011-110176; Papadopoulou ND, 2005, BIOCHEMISTRY-US, V44, P14318, DOI 10.1021/bi0513958; REANO A, 1993, J INVEST DERMATOL, V100, P775, DOI 10.1111/1523-1747.ep12476463; RUBIN BY, 1991, J BIOL CHEM, V266, P24245; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; SCHIMMEL PR, 1979, ANNU REV BIOCHEM, V48, P601, DOI 10.1146/annurev.bi.48.070179.003125; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Seymour RL, 2006, J LEUKOCYTE BIOL, V80, P1320, DOI 10.1189/jlb.1205727; Shaw AC, 1999, ELECTROPHORESIS, V20, P984, DOI 10.1002/(SICI)1522-2683(19990101)20:4/5<984::AID-ELPS984>3.0.CO;2-R; SHIMIZU T, 1978, J BIOL CHEM, V253, P4700; Silk JD, 2011, J IMMUNOL, V187, P1617, DOI 10.4049/jimmunol.1000815; Sugimoto H, 2006, P NATL ACAD SCI USA, V103, P2611, DOI 10.1073/pnas.0508996103; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; TOLSTRUP AB, 1995, J BIOL CHEM, V270, P397, DOI 10.1074/jbc.270.1.397; Turpaev KT, 1996, EUR J BIOCHEM, V240, P732, DOI 10.1111/j.1432-1033.1996.0732h.x; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Wakasugi K, 2005, BIOCHEMISTRY-US, V44, P225, DOI 10.1021/bi048313k; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Wakasugi K, 2007, BIOCHEMISTRY-US, V46, P11291, DOI 10.1021/bi7012068; Wakasugi K, 2010, BIOCHEMISTRY-US, V49, P3156, DOI 10.1021/bi1000239; Wakasugi K, 2010, FEBS LETT, V584, P229, DOI 10.1016/j.febslet.2009.11.073; Xu F, 2001, NUCLEIC ACIDS RES, V29, P4125, DOI 10.1093/nar/29.20.4125; Yanagida O, 2001, BBA-BIOMEMBRANES, V1514, P291, DOI 10.1016/S0005-2736(01)00384-4; Yang XL, 2007, STRUCTURE, V15, P793, DOI 10.1016/j.str.2007.05.009; Yang XL, 2006, EMBO J, V25, P2919, DOI 10.1038/sj.emboj.7601154; Yang XL, 2004, TRENDS BIOCHEM SCI, V29, P250, DOI 10.1016/j.tibs.2004.03.002; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Yang XL, 2002, P NATL ACAD SCI USA, V99, P15369, DOI 10.1073/pnas.242611799; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	66	22	24	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8428	8438		10.1074/jbc.RA117.001247	http://dx.doi.org/10.1074/jbc.RA117.001247			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666190	hybrid, Green Published			2022-12-26	WOS:000434205700008
J	Tam, P; Nijjar, AP; Fok, M; Little, C; Shingina, A; Bittman, J; Raghavan, R; Khan, NA				Tam, Penny; Nijjar, Aman P.; Fok, Mark; Little, Chris; Shingina, Alexandra; Bittman, Jesse; Raghavan, Rashmi; Khan, Nadia A.			Structured patient handoff on an internal medicine ward: A cluster randomized control trial	PLOS ONE			English	Article							IMPLEMENTATION; CURRICULUM; PROGRAM; ERRORS; SYSTEM; CARE	Background The effect of a multi-faceted handoff strategy in a high volume internal medicine inpatient setting on process and patient outcomes has not been clearly established. We set out to determine if a multi-faceted handoff intervention consisting of education, standardized handoff procedures, including fixed time and location for face-to-face handoff would result in improved rates of handoff compared with usual practice. We also evaluated resident satisfaction, health resource utilization and clinical outcomes. Methods This was a cluster randomized controlled trial in a large academic tertiary care center with 18 inpatient internal medicine ward teams from January-April 2013. We randomized nine inpatient teams to an intervention where they received an education session standardizing who and how to handoff patients, with practice and feedback from facilitators. The control group of 9 teams continued usual non-standardized handoffs. The primary process outcome was the rate of patients handed over per 1000 patient nights. Other process outcomes included perceptions of inadequate handoff by overnight physicians, resource utilization overnight and hospital length of stay. Clinical outcomes included medical errors, frequency of patients requiring higher level of care overnight, and in-hospital mortality. Results The intervention group demonstrated a significant increase in the rate of patients handed over to the overnight physician (62.90/1000 person-nights vs. 46.86/1000 person-nights, p = 0.002). There was no significant difference in other process outcomes except resource utilization was increased in the intervention group (26.35/1000 person-days vs. 17.57/1000 person-days, p-value = 0.01). There was no significant difference between groups in medical errors (4.8% vs. 4.1%), need for higher level of care or in hospital mortality. Limitations include a dependence of accurate record keeping by the overnight physician, the possibility of cross-contamination in the handoff process, analysis at the cluster level and an overall low number of clinical events. Conclusions Implementation of a multi-faceted resident handoff intervention did not result in a significant improvement in patient safety although did improve number of patients handed off. Novel methods to improve handoff need to be explored.	[Tam, Penny; Nijjar, Aman P.; Little, Chris; Bittman, Jesse; Khan, Nadia A.] Univ British Columbia, Dept Med, Div Gen Internal Med, Vancouver, BC, Canada; [Fok, Mark] Univ British Columbia, Div Geriatr Med, Dept Med, Vancouver, BC, Canada; [Shingina, Alexandra] Univ Toronto, Dept Med, Toronto, ON, Canada; [Raghavan, Rashmi] Univ British Columbia, Div Family Practice, Dept Med, Vancouver, BC, Canada; [Khan, Nadia A.] Univ British Columbia, Ctr Hlth Evaluat & Outcomes Sci, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Toronto; University of British Columbia; University of British Columbia	Nijjar, AP (corresponding author), Univ British Columbia, Dept Med, Div Gen Internal Med, Vancouver, BC, Canada.	apnijjar@gmail.com			Canadian Medical Protective Agency [GRNT-2706]; Michael Smith Foundation for Health Research	Canadian Medical Protective Agency; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by the Canadian Medical Protective Agency GRNT-2706 to PT and the Michael Smith Foundation for Health Research to NAK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accreditation Council for Graduate Medical Education, COMM PROGR REQ; Allen S, 2014, ACAD MED, V89, P1366, DOI 10.1097/ACM.0000000000000462; [Anonymous], 2014, POL STAT HAND ED CAN; Bittman J, 2017, POSTGRAD MED J, V93, P313, DOI 10.1136/postgradmedj-2016-133999; Borowitz SM, 2008, QUAL SAF HEALTH CARE, V17, P6, DOI 10.1136/qshc.2006.019273; Chu ES, 2009, ACAD MED, V84, P347, DOI 10.1097/ACM.0b013e3181970829; Clanton J, 2017, AM J SURG, V213, P299, DOI 10.1016/j.amjsurg.2016.10.015; Colligan L, 2015, NEW ENGL J MED, V372, P490, DOI 10.1056/NEJMc1414788; Gakhar B, 2010, ACAD MED, V85, P1182, DOI 10.1097/ACM.0b013e3181da8370; Horwitz LI, 2007, J GEN INTERN MED, V22, P1470, DOI 10.1007/s11606-007-0331-0; Johnson David P, 2015, Hosp Pediatr, V5, P154, DOI 10.1542/hpeds.2014-0050; *JOINT COMM, 2009 HOSP NAT PAT SA; Pattani R, 2014, CAN MED ASSOC J, V186, P761, DOI 10.1503/cmaj.131053; Payne CE, 2012, BMJ QUAL SAF, V21, P925, DOI 10.1136/bmjqs-2011-000308; Rayar M, 2014, 2014 CAN C MED ED OT; Riebschleger M, ACGME ENHANCING QUAL; Riesenberg LA, 2009, ACAD MED, V84, P1775, DOI 10.1097/ACM.0b013e3181bf51a6; Schouten WM, 2015, J HOSP MED, V10, P137, DOI 10.1002/jhm.2293; Starmer AJ, 2014, NEW ENGL J MED, V371, P1803, DOI 10.1056/NEJMsa1405556; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; Starmer AJ, 2012, PEDIATRICS, V129, P201, DOI 10.1542/peds.2011-2966; Van Eaton EG, 2005, J AM COLL SURGEONS, V200, P538, DOI 10.1016/j.jamcollsurg.2004.11.009; WHO, 2010, HIGH 5S PROJ ACT PAT	23	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195216	10.1371/journal.pone.0195216	http://dx.doi.org/10.1371/journal.pone.0195216			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672526	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800023
J	Wronski, S; Dannenmaier, J; Schild, S; Macke, O; Muller, L; Burmeister, Y; Seilheimer, B; Muller, M				Wronski, Sabine; Dannenmaier, Julia; Schild, Sabine; Macke, Olaf; Mueller, Laura; Burmeister, Yvonne; Seilheimer, Bernd; Mueller, Meike			Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity	PLOS ONE			English	Article							ALVEOLAR MACROPHAGES; IN-VITRO; INFECTION; PATHOGENESIS; RECRUITMENT; IMMUNITY; GAMMA; CELLS; RSV; IFN	Background Respiratory viruses such as respiratory syncytial virus (RSV) or rhinovirus are one of the major causes for respiratory tract infections causing common cold disease. Respiratory viral infections range from mild symptoms in adults to serious illness especially in the very young or elderly as well as patients suffering from lung diseases or being immunocompromised due to other reasons. Engystol (EGY-2) is a multicomponent, multitarget preparation consisting of Vincetoxicum hirundinaria and Sulfur in various dilutions. The study objective was to test the effect of EGY-2 on the innate immune response during the early onset of respiratory viral infection in vivo as exemplified in a mouse model of RSV-induced respiratory inflammation. Methods Naive BALB/c mice were infected with 1x10(6) infectious units RSV A2 intranasally to cause a mild respiratory infection. EGY-2 was administered daily per oral gavage starting seven days prior to RSV infection at doses of 0.4 to 5.1 tablets/kg. Control groups received placebo treatment. Animals were sacrificed 1 to 3 days post infection (p.i.) to analyse the infection and induced immune response in the lung. Viral load in bronchoalveolar lavage fluid (BALF) and lung homogenate was determined by TCID50 assay as well as immunofluorescence staining of BALF cells using anti-RSV antibody and microscopic analysis. The RSV induced immune response was assessed by evaluation of BALF differential cell count, BALF cytokine secretion and analysis of the phagocytic capacity of alveolar macrophages. Results EGY-2 significantly reduced the RSV induced neutrophil and early lymphocyte influx on day 1 p.i. in BALF. EGY-2 treatment significantly diminished the RSV induced secretion of pro-inflammatory cytokines such as IFN-gamma, IL-1 beta, IL-6, KC and TNF-alpha at day 1. EGY-2 treatment was not protective for RSV infection per se, as no alteration in the viral load in lung and BALF was detected. Enhanced numbers of phagocytic-active macrophages were observed in EGY-2 treated animals on day 1 and this macrophage population showed strongly enhanced phagocytic activity on day 1 and day 3. Conclusion The data suggest a beneficial immunomodulatory effect of EGY-2 during early onset of respiratory viral infection in vivo, mediated by stimulation of macrophage phagocytosis, resulting in a reduced innate inflammatory response in terms of neutrophil and early lymphocyte infiltration as well as reduced inflammatory cytokine secretion.	[Wronski, Sabine; Schild, Sabine; Macke, Olaf; Mueller, Laura; Mueller, Meike] Fraunhofer Inst Toxicol & Expt Med, Dept Preclin Pharmacol & Immunol, Hannover, Germany; [Wronski, Sabine; Schild, Sabine; Macke, Olaf; Mueller, Laura; Mueller, Meike] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany; [Dannenmaier, Julia; Burmeister, Yvonne; Seilheimer, Bernd] Biol Heilmittel Heel GmbH, Baden, Switzerland	Fraunhofer Gesellschaft	Wronski, S (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Dept Preclin Pharmacol & Immunol, Hannover, Germany.; Wronski, S (corresponding author), German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis Hannover, Hannover, Germany.	sabine.wronski@item.fraunhofer.de			Biologische Heilmittel Heel GmbH, Baden-Baden, Germany	Biologische Heilmittel Heel GmbH, Baden-Baden, Germany	The study was funded by Biologische Heilmittel Heel GmbH, Baden-Baden, Germany, which employed authors JD, YB and BS at the time this work was generated and reviewed, and authorized the manuscript. The funder provided support in form of salaries for the authors JD, YB, and BS, and provided the test substance and placebo, but was not actively involved in practical implementation data collection, analysis and decision to publish. The specific roles of these authors are articulated in the 'authors contributions' section.	BECKER S, 1991, J IMMUNOL, V147, P4307; Caballero MT, 2018, PEDIAT PULMONOL, V65, P73; Divangahi M, 2015, TRENDS IMMUNOL, V36, P307, DOI 10.1016/j.it.2015.03.005; FRANKEULLMANN G, 1995, J IMMUNOL, V154, P268; Goritzka M, 2015, J EXP MED, V212, P699, DOI 10.1084/jem.20140825; Heikkinen T, 2003, LANCET, V361, P51, DOI 10.1016/S0140-6736(03)12162-9; Heilmann A., 1994, BIOMED THER, V12, P249; Herzberger G, 1997, BIOMEDICAL THERAPY, V15, P123; Hussell T, 1998, J GEN VIROL, V79, P2593, DOI 10.1099/0022-1317-79-11-2593; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jafri HS, 2004, J INFECT DIS, V189, P1856, DOI 10.1086/386372; Kolli D, 2014, AM J RESP CELL MOL, V51, P502, DOI 10.1165/rcmb.2013-0414OC; Lay MK, 2013, MICROBES INFECT, V15, P230, DOI 10.1016/j.micinf.2012.11.012; Loebbermann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032371; Makris S, 2016, J INNATE IMMUN, V8, P452, DOI 10.1159/000446824; Michel T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051230; Miller AL, 2004, J INFECT DIS, V189, P1419, DOI 10.1086/382958; Monto AS, 2002, AM J MED, V112, p4S; Oberbaum M, 2005, J ALTERN COMPLEM MED, V11, P855, DOI 10.1089/acm.2005.11.855; PANUSKA JR, 1995, J CLIN INVEST, V96, P2445, DOI 10.1172/JCI118302; Passioti M, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0413-5; Piedimonte G, 2015, CLEV CLIN J MED, V82, pS13, DOI 10.3949/ccjm.82.s1.03; Roeska Kerstin, 2010, J Immune Based Ther Vaccines, V8, P6, DOI 10.1186/1476-8518-8-6; Schmiedel V, 2006, EXPLORE-NY, V2, P109, DOI 10.1016/j.explore.2005.12.008; Tayyari F, 2012, EXPERT REV RESP MED, V6, P215, DOI [10.1586/ERS.12.8, 10.1586/ers.12.8]; Thompson TM, 2015, CLIN MICROBIOL, V4, DOI [10.4172/2327-5073.1000206, DOI 10.4172/2327-5073.1000206]; van Schaik SM, 2000, J MED VIROL, V62, P257, DOI 10.1002/1096-9071(200010)62:2<257::AID-JMV19>3.0.CO;2-M	27	3	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195822	10.1371/journal.pone.0195822	http://dx.doi.org/10.1371/journal.pone.0195822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672626	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800047
J	Sheffield, PE; Speranza, R; Chiu, YHM; Hsu, HHL; Curtin, PC; Renzetti, S; Pajak, A; Coull, B; Schwartz, J; Kloog, I; Wright, RJ				Sheffield, Perry E.; Speranza, Rosa; Chiu, Yueh-Hsiu Mathilda; Hsu, Hsiao-Hsien Leon; Curtin, Paul C.; Renzetti, Stefano; Pajak, Ashley; Coull, Brent; Schwartz, Joel; Kloog, Itai; Wright, Rosalind J.			Association between particulate air pollution exposure during pregnancy and postpartum maternal psychological functioning	PLOS ONE			English	Article							POSTNATAL DEPRESSION SCALE; WOMEN; COMMUNITY; SYMPTOMS; ANXIETY; STRESS; PREVALENCE; PREDICTORS; ANHEDONIA; DISEASE	Postpartum psychological functioning impacts both women's health and outcomes in children. Lower income, ethnic minority women may be at particular risk for adverse postpartum mental health outcomes. Studies link ambient air pollution exposure with psychological dysfunction in adults although this association has not been examined among postpartum women. Methods We studied associations between prenatal exposure to particulate matter with diameter <= 2.5 pm (PM2.5) and postpartum psychological functioning in a lower income, ethnically mixed sample of urban US women enrolled in a pregnancy cohort study. Analyses included 557 mothers who delivered at >= 37 weeks gestation. Daily estimates of residential PM2.5 over gestation were derived using a satellite-based spatio-temporally resolved model. Outcomes included the Edinburgh Postnatal Depression Scale (EPDS) score from 6 or 12 months postpartum and subscale scores for anhedonia, depressive and anxiety symptoms. Associations were also examined within racial/ethnic groups. Distributed lag models (DLMs) were implemented to identify windows of vulnerability during pregnancy. Results Most mothers had less than a high school education (64%) and were primarily Hispanic (55%) and Black (29%). In the overall sample, a DLM adjusted for age, race, education, prenatal smoking, and season of delivery, we found significant associations between higher PM2.5 exposure in the second trimester and increased anhedonia subscale scores postpartum. In race stratified analyses, mid-pregnancy PM2.5 exposure was significantly associated with increased total EPDS scores as well as higher anhedonia and depressive symptom subscale scores among Black women. Conclusions Increased PM2.5 exposure in mid-pregnancy was associated with increased depressive and anhedonia symptoms, particularly in Black women.	[Sheffield, Perry E.; Chiu, Yueh-Hsiu Mathilda; Hsu, Hsiao-Hsien Leon; Curtin, Paul C.; Pajak, Ashley] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Sheffield, Perry E.; Chiu, Yueh-Hsiu Mathilda; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Sheffield, Perry E.; Wright, Rosalind J.] Icahn Sch Med Mt Sinai, Inst Expos Res, New York, NY 10029 USA; [Speranza, Rosa] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA; [Renzetti, Stefano] Univ Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Brescia, Italy; [Coull, Brent; Schwartz, Joel] Harvard Univ, Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Kloog, Itai] Ben Gurion Univ Negev, Dept Geog & Environm Dev, Fac Humanities & Social Sci, Beer Sheva, Israel	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Oregon Health & Science University; University of Brescia; Harvard University; Harvard T.H. Chan School of Public Health; Ben Gurion University	Sheffield, PE (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.; Sheffield, PE (corresponding author), Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA.; Sheffield, PE (corresponding author), Icahn Sch Med Mt Sinai, Inst Expos Res, New York, NY 10029 USA.	perry.sheffield@mssm.edu		Renzetti, Stefano/0000-0002-4467-765X; Chiu, Yueh-Hsiu Mathilda/0000-0003-1656-660X; Sheffield, Perry/0000-0001-9156-1193; Hsu, Hsiao-Hsien/0000-0001-8704-197X	National Institutes of Health [R01 ES010932, U01 HL072494, R21ES021318, R01 HL080674]; NIH [P30 ES023515, P30 ES000002, K23 ES024127]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080674, U01HL072494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000002, R21ES021318, K23ES024127, P30ES023515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The Asthma Coalition on Community, Environment, and Social Stress (ACCESS) project has been funded by the National Institutes of Health [grant numbers R01 ES010932, U01 HL072494, R21ES021318, and R01 HL080674 (Wright RJ, PI)], and phenotyping and biostatistical support was funded by the NIH [grant numbers P30 ES023515 and P30 ES000002]. During preparation of this manuscript, PS was supported by the NIH [grant number K23 ES024127]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Backes CH, 2013, TOXICOL LETT, V216, P47, DOI 10.1016/j.toxlet.2012.11.007; Chiu YHM, 2017, ARCH WOMEN MENT HLTH, V20, P803, DOI 10.1007/s00737-017-0765-2; Cho J, 2014, J AFFECT DISORDERS, V157, P45, DOI 10.1016/j.jad.2014.01.002; Clark C, 2008, J URBAN HEALTH, V85, P22, DOI 10.1007/s11524-007-9229-8; Coates R, 2017, PSYCHOL ASSESSMENT, V29, P1016, DOI 10.1037/pas0000397; Costa Lucio G, 2014, Biomed Res Int, V2014, P736385, DOI 10.1155/2014/736385; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Cunningham NK, 2015, ARCH WOMEN MENT HLTH, V18, P793, DOI 10.1007/s00737-014-0485-9; Entringer S, 2010, STRESS, V13, P258, DOI 10.3109/10253890903349501; Frumkin H., 2022, J CLIMATE CHANGE HLT, V5, DOI [10.1016/j.joclim.2022.100115, DOI 10.1016/J.JOCLIM.2022.100115]; Fung J, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0428-7; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Grevendonk L, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0095-2; Hartley CM, 2014, J CLIN PSYCHOL, V70, P1240, DOI 10.1002/jclp.22101; Hou RH, 2017, BRAIN BEHAV IMMUN, V62, P212, DOI 10.1016/j.bbi.2017.01.021; Howell EA, 2005, OBSTET GYNECOL, V105, P1442, DOI 10.1097/01.AOG.0000164050.34126.37; Hsu HHL, 2015, AM J RESP CRIT CARE, V192, P1052, DOI 10.1164/rccm.201504-0658OC; Kanazawa Asako, 2007, Cultur Divers Ethnic Minor Psychol, V13, P35, DOI 10.1037/1099-9809.13.1.35; King PAL, 2012, ARCH WOMEN MENT HLTH, V15, P77, DOI 10.1007/s00737-012-0260-8; Kloog I, 2014, ATMOS ENVIRON, V95, P581, DOI 10.1016/j.atmosenv.2014.07.014; Lim YH, 2012, ENVIRON HEALTH PERSP, V120, P1023, DOI 10.1289/ehp.1104100; Liu CH, 2014, EPIDEMIOL PSYCH SCI, V23, P201, DOI 10.1017/S2045796013000413; Mokoena ML, 2015, PSYCHOPHARMACOLOGY, V232, P2921, DOI 10.1007/s00213-015-3928-8; Oudin A, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010004; Pan Z, CURR PHARM DESIGN, DOI [10.1289/ehp.1408549, DOI 10.1289/EHP.1408549]; Paradies Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138511; Pawluski JL, 2017, TRENDS NEUROSCI, V40, P106, DOI 10.1016/j.tins.2016.11.009; Posillico CK, 2016, BEHAV BRAIN RES, V298, P218, DOI 10.1016/j.bbr.2015.11.011; Power MC, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1111; Pun VC, 2017, ENVIRON HEALTH PERSP, V125, P342, DOI 10.1289/EHP494; Rich-Edwards JW, 2006, J EPIDEMIOL COMMUN H, V60, P221, DOI 10.1136/jech.2005.039370; Rier Sherry E, 2008, Fertil Steril, V89, pe103, DOI 10.1016/j.fertnstert.2007.12.040; Saenen ND, 2015, ENVIRON HEALTH PERSP, V123, P834, DOI 10.1289/ehp.1408549; Salimi S, 2015, J SUBST ABUSE TREAT, V56, P34, DOI 10.1016/j.jsat.2015.03.004; Sibitz I, 2010, J AFFECT DISORDERS, V126, P245, DOI 10.1016/j.jad.2010.03.023; Stewart DE, 2016, NEW ENGL J MED, V375, P2177, DOI 10.1056/NEJMcp1607649; Sylven SM, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.022; Treadway MT, 2011, NEUROSCI BIOBEHAV R, V35, P537, DOI 10.1016/j.neubiorev.2010.06.006; Vigod SN, 2010, BJOG-INT J OBSTET GY, V117, P540, DOI 10.1111/j.1471-0528.2009.02493.x; Weetman AP, 2010, NAT REV ENDOCRINOL, V6, P311, DOI 10.1038/nrendo.2010.46; Wilson A, 2017, AM J EPIDEMIOL, V186, P1281, DOI 10.1093/aje/kwx184; Wright RJ, 2008, CIENC SAUDE COLETIVA, V13, P1729, DOI 10.1590/S1413-81232008000600008; Zhang X, 2015, INT J ENV RES PUB HE, V12, P15692, DOI 10.3390/ijerph121215011	44	24	24	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195267	10.1371/journal.pone.0195267	http://dx.doi.org/10.1371/journal.pone.0195267			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668689	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200036
J	Igarashi, Y; Tagami, T; Hagiwara, J; Kanaya, T; Kido, N; Omura, M; Tosa, R; Yokota, H				Igarashi, Yutaka; Tagami, Takashi; Hagiwara, Jun; Kanaya, Takahiro; Kido, Norihiro; Omura, Mariko; Tosa, Ryoichi; Yokota, Hiroyuki			Long-term outcomes of patients evacuated from hospitals near the Fukushima Daiichi nuclear power plant after the Great East Japan Earthquake	PLOS ONE			English	Article							HURRICANE-KATRINA; DISASTER RESPONSE; TRAUMA CENTER; LESSONS; CARE; EMERGENCY; ACCIDENT	Introduction After the accident of the Fukushima Daiichi nuclear power plant due to the Great East Japan Earthquake in March 2011, the Japanese government issued a mandatory evacuation order for people living within a 20 km radius of the nuclear power plant. The aim of the current study was to investigate long-term outcomes of these patients and identify factors related to mortality. Materials and methods Patients who were evacuated from hospitals near the Fukushima Daiichi nuclear power plant to the Aizu Chuo Hospital from 15 to 26 March, 2011 were included in this study. The following data were collected from medical records: age, sex, activities of daily life, hospital they were admitted in at the time of earthquake, distance between the facility and the nuclear power plant, reasons of evacuation and number of transfers. The patient outcomes were collected from medical records and/or investigated on the telephone in January 2012. Results A total of 97 patients (28 men and 69 women) were transferred from 10 hospitals via ambulances or buses. No patients died or experienced exacerbation during transfer. Median age of the patients was 86 years. Of the total, 36 patients were not able to obey commands, 44 were bed-ridden and 61 were unable to sustain themselves via oral intake of food. Among 86 patients who were followed-up, 41 (48%) died at the end of 2011. Multiple-regression analysis showed that non-oral intake [Hazard Ratio (HR): 6.07, 95% Confidence interval (CI): 1.94 +/- 19.0] and male sex [HR: 8.35, 95% CI: 2.14 +/- 32.5] had significant impact on mortality. Conclusion This study found that 48% of the evacuated patients died 9 months after the earthquake and they had significantly higher mortality rate than the nursing home residents. Non-oral intake and male sex had significant impact on mortality. These patients should be considered as especially vulnerable in case of hospital evacuation.	[Igarashi, Yutaka; Hagiwara, Jun; Kanaya, Takahiro; Yokota, Hiroyuki] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Tagami, Takashi] Duke NUS Med Sch, Hlth Serv & Syst Res, Singapore, Singapore; [Tagami, Takashi] Nippon Med Sch, Tama Nagayama Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan; [Kido, Norihiro] Nippon Med Sch, Musashi Kosugi Hosp, Dept Emergency & Crit Care Med, Kawasaki, Kanagawa, Japan; [Omura, Mariko; Tosa, Ryoichi] Aizu Chuo Hosp, Dept Emergency & Crit Care Med, Fukushima, Japan; [Igarashi, Yutaka] Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo, Japan	Nippon Medical School; National University of Singapore; Nippon Medical School; Nippon Medical School; Nippon Medical School	Igarashi, Y (corresponding author), Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Tokyo, Japan.; Igarashi, Y (corresponding author), Nippon Med Coll Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo, Japan.		Tagami, Takashi/HGA-3038-2022	Tagami, Takashi/0000-0001-6953-1932				Adini B, 2012, J PUBLIC HEALTH POL, V33, P257, DOI 10.1057/jphp.2012.2; [Anonymous], 2007, ED Manag, V19, P37; Augustine Jim, 2005, Disaster Manag Response, V3, P68, DOI 10.1016/j.dmr.2005.05.005; Barnett J, 2009, ORTHOP NURS, V28, P17, DOI 10.1097/01.NOR.0000345849.32424.0a; Bernard M, 2008, MCN-AM J MATERN-CHIL, V33, P213, DOI 10.1097/01.NMC.0000326075.03999.11; Brevard SB, 2008, J TRAUMA, V65, P1126, DOI 10.1097/TA.0b013e318188d6e5; Burgess JL, 1999, AM J EMERG MED, V17, P50, DOI 10.1016/S0735-6757(99)90016-5; Chavez C W, 1996, J Emerg Med, V14, P445, DOI 10.1016/0736-4679(96)00083-2; Cocanour CS, 2002, ARCH SURG-CHICAGO, V137, P1141, DOI 10.1001/archsurg.137.10.1141; DOSA D, 2012, J AM MED DIR ASSOC, V13; Gallagher JJ, 2006, J BURN CARE RES, V27, P596, DOI 10.1097/01.BCR.0000235462.17349.03; Gautam S, 2009, DISASTER MED PUBLIC, V3, P144, DOI 10.1097/DMP.0b013e3181b9db91; Gray BH, 2007, J HEALTH CARE POOR U, V18, P283, DOI 10.1353/hpu.2007.0031; Henderson J, 1998, Nurs BC, V30, P18; HENRY S, 1980, CAN MED ASSOC J, V122, P582; Hogan Catherine, 2002, AORN J, V75, P793, DOI 10.1016/S0001-2092(06)61635-9; Kawakami Y, 2012, RESP CARE, V57, P1674, DOI 10.4187/respcare.01701; Lai TI, 2003, ACAD EMERG MED, V10, P1109, DOI 10.1197/S1069-6563(03)00368-3; Little M, 2012, ACAD EMERG MED, V19, pE1088, DOI 10.1111/j.1553-2712.2012.01439.x; Martchenke J, 1994, Prehosp Disaster Med, V9, P146; MAXWELL C, 1982, AM J PUBLIC HEALTH, V72, P275, DOI 10.2105/AJPH.72.3.275; Maybauer DM, 2009, ANAESTHESIST, V58, P1244, DOI 10.1007/s00101-009-1643-8; Murakami M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137906; Nakagawa I, 2009, HEART, V95, P2009, DOI 10.1136/hrt.2009.174201; Nates JL, 2004, CRIT CARE MED, V32, P686, DOI 10.1097/01.CCM.0000114995.14120.6D; Nomura S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010080; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Ogawa K, 2000, INT J EPIDEMIOL, V29, P449, DOI 10.1093/ije/29.3.449; Okie S, 2008, NEW ENGL J MED, V358, P1, DOI 10.1056/NEJMp0707917; Perrin K, 2006, PEDIATRICS, V117, pS381, DOI 10.1542/peds.2006-0099H; Schultz CH, 2003, NEW ENGL J MED, V348, P1349, DOI 10.1056/NEJMsa021807; Seale GS, 2010, REHABIL PSYCHOL, V55, P247, DOI 10.1037/a0020599; Sexton KH, 2007, ACAD MED, V82, P792, DOI 10.1097/ACM.0b013e3180d096b9; Siders C, 1998, J Healthc Risk Manag, V18, P33; Tagami T, 2012, CIRCULATION, V126, P589, DOI 10.1161/CIRCULATIONAHA.111.086173; Tanigawa K, 2012, LANCET, V379, P889, DOI 10.1016/S0140-6736(12)60384-5; Taylor Ian L, 2007, Trans Am Clin Climatol Assoc, V118, P69; Thomas J, 2008, J PSYCHOSOC NURS MEN, V46, P35, DOI 10.3928/02793695-20080101-13; Yanagawa Y, 2011, PREHOSP DISASTER MED, V26, P391, DOI 10.1017/S1049023X11006418	39	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195684	10.1371/journal.pone.0195684	http://dx.doi.org/10.1371/journal.pone.0195684			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664960	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300027
J	Andriessen, P; Zwanenburg, A; van Laar, JOEH; Vullings, R; Hermans, BM; Niemarkt, HJ; Jellema, RK; Ophelders, DRMG; Wolfs, TGAM; Kramer, BW; Delhaas, T				Andriessen, Peter; Zwanenburg, Alex; van Laar, Judith O. E. H.; Vullings, Rik; Hermans, Ben J. M.; Niemarkt, Hendrik J.; Jellema, Reint K.; Ophelders, Daan R. M. G.; Wolfs, Tim G. A. M.; Kramer, Boris W.; Delhaas, Tammo			ST waveform analysis for monitoring hypoxic distress in fetal sheep after prolonged umbilical cord occlusion	PLOS ONE			English	Article							HEART-RATE; ANIMAL-MODELS; ECG; ELECTROCARDIOGRAM; LABOR; ISCHEMIA; PATTERNS; INSIGHTS; SEGMENT; INJURY	Introduction The inconclusive clinical results for ST-waveform analysis (STAN) in detecting fetal hypoxemia may be caused by the signal processing of the STAN-device itself. We assessed the performance of a clinical STAN device in signal processing and in detecting hypoxemia in a fetal sheep model exposed to prolonged umbilical cord occlusion (UCO). Methods Eight fetal lambs were exposed to 25 minutes of UCO. ECG recordings were analyzed during a baseline period and during UCO. STAN-event rates and timing of episodic T/QRS rise, baseline T/QRS rise and the occurrence of biphasic ST-waveforms, as well as signal loss, were assessed. Results During baseline conditions of normoxemia, a median of 40 (IQR, 25-70) STAN-events per minute were detected, compared to 10 (IQR, 2-22) during UCO. During UCO STAN-events were detected in five subjects within 10 minutes and in six subjects after 18 minutes, respectively. Two subjects did not generate any STAN-event during UCO. Biphasic ST event rate was reduced during UCO (median 0, IQR 0-5), compared to baseline (median 32, IQR, 6-55). ST-waveforms could not be assessed in 62% of the recording time during UCO, despite a good quality of the ECG signal. Conclusions The STAN device showed limitations in detecting hypoxemia in fetal sheep after prolonged UCO. The STAN device produced high false positive event rates during baseline and did not detect T/QRS changes adequately after prolonged fetal hypoxemia. During 14% of baseline and 62% of the UCO period, the STAN-device could not process the ECG signal, despite its good quality. Resolving these issues may improve the clinical performance of the STAN device.	[Andriessen, Peter; Niemarkt, Hendrik J.; Jellema, Reint K.] Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands; [Andriessen, Peter; Jellema, Reint K.; Ophelders, Daan R. M. G.; Wolfs, Tim G. A. M.; Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Zwanenburg, Alex; Hermans, Ben J. M.; Wolfs, Tim G. A. M.; Delhaas, Tammo] Maastricht Univ, Dept Biomed Engn, Maastricht, Netherlands; [Zwanenburg, Alex; Delhaas, Tammo] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands; [Zwanenburg, Alex; Ophelders, Daan R. M. G.; Wolfs, Tim G. A. M.; Kramer, Boris W.] Maastricht Univ, Sch Mental Hlth & Neurosci, Maastricht, Netherlands; [van Laar, Judith O. E. H.] Maxima Med Ctr, Dept Obstet & Gynecol, Veldhoven, Netherlands; [Vullings, Rik] Eindhoven Univ Technol, Dept Elect Engn, Signal Proc Syst Grp, Eindhoven, Netherlands	Maxima Medical Center; Maastricht University; Maastricht University; Maastricht University; Maastricht University; Maxima Medical Center; Eindhoven University of Technology	Andriessen, P (corresponding author), Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands.; Andriessen, P (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.	p.andriessen@mmc.nl	Kramer, Boris/AAO-3183-2021; Jellema, Reint/AAW-1214-2020; Zwanenburg, Alex/AAF-6476-2020; Hermans, Ben/AAN-4280-2020; Vullings, Rik/GQP-6225-2022; Niemarkt, Hendrik/AAN-5063-2020	Jellema, Reint/0000-0002-6918-0930; Zwanenburg, Alex/0000-0002-0342-9545; Hermans, Ben/0000-0001-7780-4427; Vullings, Rik/0000-0002-2392-6098; Niemarkt, Hendrik/0000-0002-0844-7208; Wolfs, Tim/0000-0003-4417-4144; Ophelders, Daan/0000-0001-7410-5102; Andriessen, Peter/0000-0002-5159-6874				Alfirevic Z, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006066.pub3; Amer-Wahlin I, 2005, EUR CLIN OBSTET GYNA, V1, P61; Back SA, 2012, NEUROTHERAPEUTICS, V9, P359, DOI 10.1007/s13311-012-0108-y; BALL RH, 1992, AM J OBSTET GYNECOL, V166, P1683, DOI 10.1016/0002-9378(92)91557-Q; Becker JH, 2015, ACTA OBSTET GYN SCAN, V94, P175, DOI 10.1111/aogs.12548; Becker JH, 2012, ACTA OBSTET GYN SCAN, V91, P189, DOI 10.1111/j.1600-0412.2011.01320.x; Belfort MA, 2015, NEW ENGL J MED, V373, P632, DOI 10.1056/NEJMoa1500600; Bennet L, 2009, CLIN PERINATOL, V36, P655, DOI 10.1016/j.clp.2009.06.009; Doria V, 2007, BJOG-INT J OBSTET GY, V114, P1202, DOI 10.1111/j.1471-0528.2007.01480.x; GREENE KR, 1982, AM J OBSTET GYNECOL, V144, P950, DOI 10.1016/0002-9378(82)90190-9; Gunn AJ, 2009, CLIN PERINATOL, V36, P579, DOI 10.1016/j.clp.2009.06.007; Jellema RK, 2013, EXP NEUROL, V250, P293, DOI 10.1016/j.expneurol.2013.09.026; Jellema RK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073031; Jellema RK, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-13; Anneke K, 2007, EUR J OBSTET GYN R B, V135, P28, DOI 10.1016/j.ejogrb.2006.10.022; LILJA H, 1984, J PERINAT MED, V12, P115, DOI 10.1515/jpme.1984.12.3.115; Melin M, 2008, BJOG-INT J OBSTET GY, V115, P1669, DOI 10.1111/j.1471-0528.2008.01949.x; Neilson JP., 2013, COCHRANE DB SYST REV, V3; Remme CA, 2001, J CARDIOVASC PHARM, V38, P406, DOI 10.1097/00005344-200109000-00009; Rosen KG, 2004, BEST PRACT RES CL OB, V18, P485, DOI 10.1016/j.bpobgyn.2004.02.008; ROSEN KG, 1976, BIOL NEONATE, V30, P17; ROSEN KG, 1975, ACTA PHYSIOL SCAND, V93, P59, DOI 10.1111/j.1748-1716.1975.tb05790.x; Salmelin A, 2013, ACTA OBSTET GYN SCAN, V92, P28, DOI 10.1111/aogs.12009; Verdurmen KMJ, 2016, EUR J OBSTET GYN R B, V207, P243, DOI 10.1016/j.ejogrb.2016.10.030; Vullings R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175823; Wassink G, 2014, OBSTET GYNECOL INT, V2014, DOI 10.1155/2014/314159; Welin AK, 2005, ACTA OBSTET GYN SCAN, V84, P122, DOI 10.1111/j.0001-6349.2005.00594.x; Westerhuis MEMH, 2007, BJOG-INT J OBSTET GY, V114, P1194, DOI 10.1111/j.1471-0528.2007.01236.x; Zwanenburg A, 2016, PEDIATR RES, V79, P907, DOI 10.1038/pr.2016.21	29	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195978	10.1371/journal.pone.0195978	http://dx.doi.org/10.1371/journal.pone.0195978			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659625	gold, Green Submitted, Green Published			2022-12-26	WOS:000430061100045
J	Rubenstein, BL; MacFarlane, M; Jensen, C; Stark, L				Rubenstein, Beth L.; MacFarlane, Matthew; Jensen, Celina; Stark, Lindsay			Measuring movement into residential care institutions in Haiti after Hurricane Matthew: A pilot study	PLOS ONE			English	Article							CHILDREN; INTERVENTION	Background Governments have an ethical imperative to safeguard children in residential care institutions at all times, including in the aftermath of an emergency. Yet, a lack of accurate data about how the magnitude and characteristics of this population may change due to an emergency impedes leaders' ability to formulate responsive policies and services, mobilize resources and foster accountability. The purpose of this study was therefore to determine the feasibility of evaluating movement of children into residential care following an emergency. Methods The pilot study took place in Les Cayes commune in the Sud Department of Haiti in April 2017. Six months prior to the pilot, the area was severely affected by Hurricane Matthew, with widespread devastation to property, livestock and livelihoods. Using a two-stage process, the team created a comprehensive list of residential care institutions in Les Cayes. At each facility, the data collectors attempted to administer four separate tools: a group count tool, a record review tool, interviews with staff, and interviews with children 10 years of age and older. Results Out of 27 known institutions in Les Cayes, 22 institutions consented to participate in the research. Within these 22 institutions, the prevalence of new arrivals to residential care since Hurricane Matthew varied significantly across the four tools, ranging from 0.69% according to the aggregated child interviews to 20.96% according to the aggregated staff interviews. Record availability and quality was very poor and child participation was difficult to arrange due to travel and scheduling constraints. Interpretation Robust measurement of new arrivals to residential care institutions was not feasible in Haiti following Hurricane Matthew. Moreover, many of the challenges encountered are likely to be encountered in humanitarian emergencies in other settings. Therefore, the research team does not recommend scale-up of these methods in most humanitarian settings. Alternative approaches that incorporate household survey methods to ascertain movement into residential care based on reports from caregivers may be more realistic in places with poor pre-existing governance systems and weak registries and records for residential care institutions.	[Rubenstein, Beth L.; MacFarlane, Matthew; Stark, Lindsay] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA; [Rubenstein, Beth L.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Jensen, Celina] Save Children UK, London, England	Columbia University; Columbia University; Save the Children	Stark, L (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA.	ls2302@cumc.columbia.edu			 [AID-OFDA15-00176]		This work was supported by AID-OFDA15-00176 (https://www.usaid.gov/who-we-are/organization/bureaus/bureau-democracy-conflict-and-humanitarian-assistance/office-us), administered via the Office of U.S. Foreign Disaster Assistance. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addley E., 2010, HAITI EARTHQUAKE AID; Bakermans-Kranenburg MJ, 2012, CHILD DEV PERSPECT, V6, P174, DOI 10.1111/j.1750-8606.2011.00231.x; Bick J., 2015, JAMA PEDIAT; Dozier M, 2012, SOC ISS POLICY REV, V6, P1, DOI 10.1111/j.1751-2409.2011.01033.x; Kendrick A., 2011, CHILDREN BEHAV BADLY, P71, DOI [DOI 10.1002/9780470976586.CH6, 10.1002/9780470976586.ch6]; Martin F., 2007, SOMEONE MATTERS QUAL; McCall RB, 2013, CHILD DEV, V84, P1734, DOI 10.1111/cdev.12098; Merz EC, 2013, J CLIN CHILD ADOLESC, V42, P726, DOI 10.1080/15374416.2013.764826; Mulheir G., 2016, ORPHANAGE ENTREPRENE; Nelson CA, 2007, SCIENCE, V318, P1937, DOI 10.1126/science.1143921; Padgett T, 2010, MAGNITUDE 7 0 HUMAN; Petrowski N, 2017, CHILD ABUSE NEGLECT; Powell G, 2004, CHILDREN RESIDENTIAL; Robinson C, 2015, SYSTEMATIC LIT REV C; Rubenstein BL, 2015, CHILD ABUSE NEGLECT; Saboula N.E., 2015, IOSR J NURSING HLTH, V4, P26; Stark L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013888; Stark L, 2016, CHILD ABUSE NEGLECT, V52, P38, DOI 10.1016/j.chiabu.2015.12.012; vanDoore K., 2015, BUSINESS ORPHANAGES; Williamson John, 2010, FAMILIES NOT ORPHANA	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195515	10.1371/journal.pone.0195515	http://dx.doi.org/10.1371/journal.pone.0195515			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659597	Green Published, Green Submitted, gold			2022-12-26	WOS:000430061100020
J	Boo, G; Leyk, S; Brunsdon, C; Graf, R; Pospischil, A; Fabrikant, SI				Boo, Gianluca; Leyk, Stefan; Brunsdon, Christopher; Graf, Ramona; Pospischil, Andreas; Fabrikant, Sara Irina			The importance of regional models in assessing canine cancer incidences in Switzerland	PLOS ONE			English	Article							GEOGRAPHICALLY WEIGHTED REGRESSION; SPATIAL NON-STATIONARITY; TUMOR REGISTRY; DOGS; DISEASE; SIZE; OVERDISPERSION; EPIDEMIOLOGY; ASSOCIATIONS; SENTINELS	Fitting canine cancer incidences through a conventional regression model assumes constant statistical relationships across the study area in estimating the model coefficients. However, it is often more realistic to consider that these relationships may vary over space. Such a condition, known as spatial non-stationarity, implies that the model coefficients need to be estimated locally. In these kinds of local models, the geographic scale, or spatial extent, employed for coefficient estimation may also have a pervasive influence. This is because important variations in the local model coefficients across geographic scales may impact the understanding of local relationships. In this study, we fitted canine cancer incidences across Swiss municipal units through multiple regional models. We computed diagnostic summaries across the different regional models, and contrasted them with the diagnostics of the conventional regression model, using value-by-alpha maps and scalograms. The results of this comparative assessment enabled us to identify variations in the goodness-of-fit and coefficient estimates. We detected spatially non-stationary relationships, in particular, for the variables related to biological risk factors. These variations in the model coefficients were more important at small geographic scales, making a case for the need to model canine cancer incidences locally in contrast to more conventional global approaches. However, we contend that prior to undertaking local modeling efforts, a deeper understanding of the effects of geographic scale is needed to better characterize and identify local model relationships.	[Boo, Gianluca; Fabrikant, Sara Irina] Univ Zurich, Dept Geog, Zurich, Switzerland; [Boo, Gianluca; Graf, Ramona; Pospischil, Andreas] Univ Zurich, Coll Helveticum, Zurich, Switzerland; [Boo, Gianluca; Graf, Ramona; Pospischil, Andreas] Swiss Fed Inst Technol Zurich, Zurich, Switzerland; [Leyk, Stefan] Univ Colorado, Dept Geog, Boulder, CO 80309 USA; [Brunsdon, Christopher] Univ Maynooth, Natl Ctr Geocomputat, Maynooth, Kildare, Ireland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Colorado System; University of Colorado Boulder; Maynooth University	Boo, G (corresponding author), Univ Zurich, Dept Geog, Zurich, Switzerland.; Boo, G (corresponding author), Univ Zurich, Coll Helveticum, Zurich, Switzerland.; Boo, G (corresponding author), Swiss Fed Inst Technol Zurich, Zurich, Switzerland.	gianluca.boo@geo.uzh.ch	Leyk, Stefan/S-4945-2019; Fabrikant, Sara/B-9320-2014	Fabrikant, Sara/0000-0003-1263-8792; Boo, Gianluca/0000-0002-4078-8221	University of Zurich; Swiss Federal Institute of Technology in Zurich; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD066613] Funding Source: NIH RePORTER	University of Zurich; Swiss Federal Institute of Technology in Zurich; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was founded by the Collegium Helveticum Zurich a joint initiative by the University of Zurich and the Swiss Federal Institute of Technology in Zurich through a grant accorded to its fellows Andreas Pospischil and Kay W. Axhausen, and by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MP, 1997, UNDERSTANDING REGRES, P160; ANIS. Animal Identity Service AG, 2017, AN ID SERV AG; [Anonymous], 2016, PLYR TOOLS SPLITTING; Atkinson PM, 2000, PROF GEOGR, V52, P607, DOI 10.1111/0033-0124.00250; Bartlett PC, 2010, PREV VET MED, V94, P264, DOI 10.1016/j.prevetmed.2010.01.007; Beale L, 2008, ENVIRON HEALTH PERSP, V116, P1105, DOI 10.1289/ehp.10816; Berk R, 2008, J QUANT CRIMINOL, V24, P269, DOI 10.1007/s10940-008-9048-4; Bivand R., 2017, RGDAL BINDINGS GEOSP; Bivand R., 2017, MAPTOOLS TOOLS READI; Bonnett BN, 2010, J COMP PATHOL, V141, pS33, DOI 10.1016/j.jcpa.2009.10.008; Boo G, 2015, ISPRS ANN PHOTO REM, VII-3, P263, DOI 10.5194/isprsannals-II-3-W5-263-2015; Boo G, 2016, 9 INT C GISCIENCE SH, P29; Boo G, 2017, GEOSPATIAL HEALTH, V12, P121, DOI 10.4081/gh.2017.539; Bronden LB, 2007, VET COMP ONCOL, V5, P133, DOI 10.1111/j.1476-5829.2007.00126.x; Bronden LB, 2010, VET REC, V166, P586, DOI 10.1136/vr.b4808; Brunsdon C, 1996, GEOGR ANAL, V28, P281, DOI 10.1111/j.1538-4632.1996.tb00936.x; Cameron A. C., 1986, J APPL ECONOMET, V1, P29, DOI DOI 10.1002/JAE.3950010104; CAMERON AC, 1990, J ECONOMETRICS, V46, P347, DOI 10.1016/0304-4076(90)90014-K; Cameron AC, 1996, J BUS ECON STAT, V14, P209, DOI 10.2307/1392433; Cameron AC, 1997, J ECONOMETRICS, V77, P329; Champely S., 2018, PACKAGE PWR; Cho SH, 2010, APPL ECON LETT, V17, P767, DOI 10.1080/13504850802314452; Cressie N, 1993, STAT SPATIAL DATA, P453; Delamater PL, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-15; Dobson Jane M, 2013, ISRN Vet Sci, V2013, P941275, DOI 10.1155/2013/941275; Domencich TA, 1975, URBAN TRAVEL DEMAND, P101; Dykes J, 2007, IEEE T VIS COMPUT GR, V13, P1161, DOI 10.1109/TVCG.2007.70558; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Ferguson CJ, 2009, PROF PSYCHOL-RES PR, V40, P532, DOI 10.1037/a0015808; Fotheringham AS, 1998, ENVIRON PLANN A, V30, P1905, DOI 10.1068/a301905; Fox J, 2015, APPL REGRESSION ANAL, P307; FROME EL, 1985, AM J EPIDEMIOL, V121, P309, DOI 10.1093/oxfordjournals.aje.a114001; FROME EL, 1983, BIOMETRICS, V39, P665, DOI 10.2307/2531094; Gavazza A, 2001, J VET INTERN MED, V15, P190, DOI 10.1892/0891-6640(2001)015&lt;0190:ABCMLL&gt;2.3.CO;2; Gruntzig K, 2015, J COMP PATHOL, V152, P161, DOI 10.1016/j.jcpa.2015.02.005; Gruntzig K, 2016, J COMP PATHOL, V155, P156, DOI 10.1016/j.jcpa.2016.05.011; Gujarati D., 2003, BASIC ECONOMETRICS, P341; Lee L.H., 2015, **DATA OBJECT**; Lewis F, 2011, METHODS ECOL EVOL, V2, P155, DOI 10.1111/j.2041-210X.2010.00063.x; Leyk S, 2012, SPAT SPATIO-TEMPORAL, V3, P95, DOI 10.1016/j.sste.2012.04.003; Lloyd CD, 2010, LOCAL MODELS SPATIAL, P23; Maclaurin G, 2015, T GIS, V19, P877, DOI 10.1111/tgis.12134; Maimon OZ, 2005, DATA MINING KNOWLEDG; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Mohebbi M, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-133; MORGENSTERN H, 1982, AM J PUBLIC HEALTH, V72, P1336, DOI 10.2105/AJPH.72.12.1336; Neyman J, 1933, PHILOS T R SOC LOND, V231, P289, DOI 10.1098/rsta.1933.0009; Nodtvedt A, 2012, VET COMP ONCOL, V10, P95, DOI 10.1111/j.1476-5829.2011.00279.x; O'Neill Dan G, 2014, Canine Genet Epidemiol, V1, P2, DOI 10.1186/2052-6687-1-2; Openshaw S, 1984, MODIFIABLE AREAL UNI; P Elliott, 1996, METHODS SMALL AREA S, P10; Pardo B., 2002, Computer Music Journal, V26, P27, DOI 10.1162/014892602760137167; PIANTADOSI S, 1988, AM J EPIDEMIOL, V127, P893, DOI 10.1093/oxfordjournals.aje.a114892; Pinho SS, 2012, TRANSL RES, V159, P165, DOI 10.1016/j.trsl.2011.11.005; Pospischil A, 2013, SCHWEIZ ARCH TIERH, V155, P219, DOI 10.1024/0036-7281/a000450; Pospischil A, 2015, P GRF 1 HLTH SUMM 20, P108; Reif JS, 2011, PUBLIC HEALTH REP, V126, P50, DOI 10.1177/00333549111260S108; Roth RE, 2010, CARTOGR J, V47, P130, DOI 10.1179/000870409X12488753453372; Rowell JL, 2011, TRENDS MOL MED, V17, P380, DOI 10.1016/j.molmed.2011.02.004; Schmidt PL, 2009, VET CLIN N AM-SMALL, V39, P241, DOI 10.1016/j.cvsm.2008.10.010; Swisscom Ltd, 2017, OFF PHON YELL PAG SW; Tate N, 2001, MODELLING SCALE GEOG, P159; Team RStudio, 2016, RSTUDIO INT DEV ENV; Tiefelsdorf M., 2006, MODELLING SPATIAL PR; van Etten J, 2017, GDISTANCE DISTANCES; Vascellari M, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-39; Wall MM, 2004, J STAT PLAN INFER, V121, P311, DOI 10.1016/S0378-3758(03)00111-3; Wan X, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-135; Wickham H., 2016, GGPLOT2 CREATE ELEGA; Wickham H, 2017, RESHAPE FLEXIBLY RES; Zeileis A, 2017, SANDWICH ROBUST COVA	71	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195970	10.1371/journal.pone.0195970	http://dx.doi.org/10.1371/journal.pone.0195970			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652921	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000430026900050
J	Rejmund, M; Mrozek-Wilczkiewicz, A; Malarz, K; Pyrkosz-Bulska, M; Gajcy, K; Sajewicz, M; Musiol, R; Polanski, J				Rejmund, Marta; Mrozek-Wilczkiewicz, Anna; Malarz, Katarzyna; Pyrkosz-Bulska, Monika; Gajcy, Kamila; Sajewicz, Mieczyslaw; Musiol, Robert; Polanski, Jaroslaw			Piperazinyl fragment improves anticancer activity of Triapine	PLOS ONE			English	Article							3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE 3-AP; RIBONUCLEOTIDE REDUCTASE INHIBITOR; SELECTIVE ANTITUMOR-ACTIVITY; IRON OVERLOAD DISEASE; PHASE-I; ANTIPROLIFERATIVE ACTIVITY; BIOLOGICAL-PROPERTIES; LUNG-CANCER; CHELATORS; METABOLISM	A new class of TSCs containing piperazine (piperazinylogs) of Triapine, was designed to fulfill the di-substitution pattern at the TSCs N4 position, which is a crucial prerequisite for the high activity of the previously obtained TSC compounds-DpC and Dp44mT. We tested the important physicochemical characteristics of the novel compounds L-1-L-12. The studied ligands are neutral at physiological pH, which allows them to permeate cell membranes and bind cellular Fe pools more readily than less lipid-soluble ligands, e.g. DFO. The selectivity and anti-cancer activity of the novel TSCs were examined in a variety of cancer cell types. In general, the novel compounds demonstrated the greatest promise as anti-cancer agents with both a potent and selective anti-proliferative activity. We investigated the mechanism of action more deeply, and revealed that studied compounds inhibit the cell cycle (G1/S phase). Additionally we detected apoptosis, which is dependent on cell line's specific genetic profile. Accordingly, structure-activity relationship studies suggest that the combination of the piperazine ring with Triapine allows potent and selective anticancer chelators that warrant further in vivo examination to be identified. Significantly, this study proved the importance of the di-substitution pattern of the amine N4 function.	[Rejmund, Marta; Malarz, Katarzyna; Pyrkosz-Bulska, Monika; Gajcy, Kamila; Sajewicz, Mieczyslaw; Musiol, Robert; Polanski, Jaroslaw] Univ Silesia, Inst Chem, Katowice, Poland; [Mrozek-Wilczkiewicz, Anna] Univ Silesia, A Chelkowski Inst Phys, Katowice, Poland; [Mrozek-Wilczkiewicz, Anna; Malarz, Katarzyna] Univ Silesia, Silesian Ctr Educ & Interdisciplinary Res, Chorzow, Poland	University of Silesia in Katowice; University of Silesia in Katowice; University of Silesia in Katowice	Polanski, J (corresponding author), Univ Silesia, Inst Chem, Katowice, Poland.	jaroslaw.polanski@us.edu.pl	Malarz, Katarzyna/AAA-2689-2020; Musioł, Robert/J-4790-2019	Malarz, Katarzyna/0000-0003-4283-3126; Polanski, Jaroslaw/0000-0001-7361-2671; Pyrkosz-Bulska, Monika/0000-0002-3524-6065; Gajcy, Kamila/0000-0003-3141-6562; Musiol, Robert/0000-0002-6219-7369; Sajewicz, Mieczyslaw/0000-0001-7575-0760; Mrozek-Wilczkiewicz, Anna/0000-0003-2228-1475	National Center of Science [2014/13/D/NZ7/00322, 2013/09/B/NZ7/00423]; NCBiR Warsaw ORGANOMET [PBS2/A5/40/2014]	National Center of Science(National Science Centre, Poland); NCBiR Warsaw ORGANOMET	The financial support of the National Center of Science grants 2014/13/D/NZ7/00322 (AMW), 2013/09/B/NZ7/00423 (RM) and NCBiR Warsaw ORGANOMET No: PBS2/A5/40/2014 (JP) is greatly appreciated.; The financial support of the National Center of Science grants 2014/13/D/NZ7/00322 (AMW), 2013/09/B/NZ7/00423 (RM) and NCBiR Warsaw ORGANOMET No: PBS2/A5/40/2014 (JP) is greatly appreciated.	Ae N., 2011, [No title captured], Patent No. [US 20110263847 A1, 20110263847, U.S. 20110263847 A1]; Alderighi L, 1999, COORDIN CHEM REV, V184, P311, DOI 10.1016/S0010-8545(98)00260-4; [Anonymous], 1991, STRUCT BOND; Attia S, 2008, INVEST NEW DRUG, V26, P369, DOI 10.1007/s10637-008-9123-6; ATTWOOD D, 1981, J PHARM PHARMACOL, V33, P136, DOI 10.1111/j.2042-7158.1981.tb13735.x; Aye Y, 2012, J BIOL CHEM, V287, P35768, DOI 10.1074/jbc.M112.396911; Bacher F, 2015, DALTON T, V44, P9071, DOI 10.1039/c5dt01076d; Beck MT, 1990, CHEMISTRY OF COMPLEX; Becker EM, 2003, BRIT J PHARMACOL, V138, P819, DOI 10.1038/sj.bjp.0705089; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; BROCKMAN RW, 1956, CANCER RES, V16, P167; Chao J, 2012, CANCER CHEMOTH PHARM, V69, P835, DOI 10.1007/s00280-011-1779-5; Chaston TB, 2003, AM J HEMATOL, V73, P200, DOI 10.1002/ajh.10348; Chekhun VF, 2013, INT J ONCOL, V43, P1481, DOI 10.3892/ijo.2013.2063; Cheng MG, 1999, EMBO J, V18, P1571, DOI 10.1093/emboj/18.6.1571; Easmon J, 2001, J MED CHEM, V44, P2164, DOI 10.1021/jm000979z; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Enyedy EA, 2012, EUR J INORG CHEM, P4036, DOI 10.1002/ejic.201200360; Enyedy EA, 2011, DALTON T, V40, P5895, DOI 10.1039/c0dt01835j; Enyedy EA, 2010, EUR J INORG CHEM, P1717, DOI 10.1002/ejic.200901174; Evans RW, 2012, BBA-GEN SUBJECTS, V1820, P282, DOI 10.1016/j.bbagen.2011.11.007; Faist J, 2012, EUR J MED CHEM, V47, P510, DOI 10.1016/j.ejmech.2011.11.022; Feun L, 2002, CANCER CHEMOTH PHARM, V50, P223, DOI 10.1007/s00280-002-0480-0; Fischer B, 2016, RSC ADV, V6, P55848, DOI 10.1039/c6ra07659a; Gans P, 2000, HYPSPEC; Gao HL, 2003, MOL PHARMACOL, V63, P1382, DOI 10.1124/mol.63.6.1382; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Giles FJ, 2003, LEUKEMIA RES, V27, P1077, DOI 10.1016/S0145-2126(03)00118-8; GomezManzano C, 1997, J NATL CANCER I, V89, P1036, DOI 10.1093/jnci/89.14.1036; Gosselaar PH, 2002, EUR J CLIN INVEST, V32, P61, DOI 10.1046/j.1365-2362.2002.0320s1061.x; Hou XL, 2006, BIOORG MED CHEM LETT, V16, P4214, DOI 10.1016/j.bmcl.2006.05.085; Hu WX, 2006, BIOORG MED CHEM LETT, V16, P2213, DOI 10.1016/j.bmcl.2006.01.048; Hua LM, 2016, BIOORG MED CHEM LETT, V26, P5830, DOI 10.1016/j.bmcl.2016.10.007; Kalinowski DS, 2005, PHARMACOL REV, V57, P547, DOI 10.1124/pr.57.4.2; Knox JJ, 2007, INVEST NEW DRUG, V25, P471, DOI 10.1007/s10637-007-9044-9; Kovacevic Z, 2011, MOL PHARMACOL, V80, P598, DOI 10.1124/mol.111.073627; Kowol CR, 2009, J MED CHEM, V52, P5032, DOI 10.1021/jm900528d; Kubicek V, 2010, INORG CHEM, V49, P10960, DOI 10.1021/ic101378s; Lacivita E, 2009, BIOORGAN MED CHEM, V17, P1339, DOI 10.1016/j.bmc.2008.12.015; Le NTV, 2004, BLOOD, V104, P2967, DOI 10.1182/blood-2004-05-1866; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lee JC, 2016, INT J MOL SCI, V17, P1; Legendre C, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2074-y; Legendre C, 2015, TRENDS ENDOCRIN MET, V26, P322, DOI 10.1016/j.tem.2015.03.008; Liang Y, 2001, ONCOGENE, V20, P6570, DOI 10.1038/sj.onc.1204815; LIU MC, 1992, J MED CHEM, V35, P3672, DOI 10.1021/jm00098a012; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Lovejoy DB, 2012, J MED CHEM, V55, P7230, DOI 10.1021/jm300768u; Ma B, 2008, INVEST NEW DRUG, V26, P169, DOI 10.1007/s10637-007-9085-0; Mackenzie MJ, 2007, INVEST NEW DRUG, V25, P553, DOI 10.1007/s10637-007-9066-3; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Miller LD, 2011, CANCER RES, V71, P6728, DOI 10.1158/0008-5472.CAN-11-1870; Mrozek-Wilczkiewicz A, 2014, ACS MED CHEM LETT, V5, P336, DOI 10.1021/ml400422a; Ochi T, 2005, BIOORG MED CHEM LETT, V15, P1055, DOI 10.1016/j.bmcl.2004.12.028; Odenike OM, 2008, INVEST NEW DRUG, V26, P233, DOI 10.1007/s10637-008-9115-6; Omuro A, 2013, JAMA-J AM MED ASSOC, V310, P1842, DOI 10.1001/jama.2013.280319; Perrin DD, 1981, PK A PREDICTION FOR; Pinnix ZK, 2010, SCI TRANSL MED, V2; Proschak Ewgenij, 2008, P217, DOI 10.1039/9781847558879-00217; Rathi AK, 2016, EXPERT OPIN THER PAT, V26, P777, DOI 10.1080/13543776.2016.1189902; Richardson DR, 2006, J MED CHEM, V49, P6510, DOI 10.1021/jm0606342; RICHARDSON DR, 1990, INORG CHIM ACTA, V170, P165, DOI 10.1016/S0020-1693(00)80471-5; Schiller DS, 2007, CLIN THER, V29, P1862, DOI 10.1016/j.clinthera.2007.09.015; Serda M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110291; Serda M, 2013, J MOL STRUCT, V1037, P63, DOI 10.1016/j.molstruc.2012.11.050; Serda M, 2012, MOLECULES, V17, P13483, DOI 10.3390/molecules171113483; Serda M, 2012, BIOORG MED CHEM LETT, V22, P5527, DOI 10.1016/j.bmcl.2012.07.030; Sestak V, 2015, ONCOTARGET, V6, P42411, DOI 10.18632/oncotarget.6389; Shen J, 2014, CELL REP, V7, P180, DOI 10.1016/j.celrep.2014.02.042; SIEGERS CP, 1992, CANCER LETT, V65, P245, DOI 10.1016/0304-3835(92)90239-R; SMYTH MR, 1976, ANAL CHIM ACTA, V86, P185, DOI 10.1016/S0003-2670(01)83033-6; Stanojkovic TP, 2010, J INORG BIOCHEM, V104, P467, DOI 10.1016/j.jinorgbio.2009.12.021; Tarushi A, 2011, DALTON T, V40, P9461, DOI 10.1039/c1dt10870k; THELANDER L, 1983, BIOCHEM BIOPH RES CO, V110, P859, DOI 10.1016/0006-291X(83)91040-9; Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435; Wang YX, 2011, J MED CHEM, V54, P2127, DOI 10.1021/jm101340q; Xie WL, 2014, EUR J MED CHEM, V81, P22, DOI 10.1016/j.ejmech.2014.05.001; Yen Y, 2004, CANCER CHEMOTH PHARM, V54, P331, DOI 10.1007/s00280-004-0821-2; Yu K, 2009, CANCER RES, V69, P6232, DOI 10.1158/0008-5472.CAN-09-0299; Yu Y, 2012, BRIT J PHARMACOL, V165, P148, DOI 10.1111/j.1476-5381.2011.01526.x; Yu Y, 2007, CELL CYCLE, V6, P1982, DOI 10.4161/cc.6.16.4603; Yu Y, 2009, J MED CHEM, V52, P5271, DOI 10.1021/jm900552r; Yuan J, 2004, BLOOD, V104, P1450, DOI 10.1182/blood-2004-03-0868	83	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0188767	10.1371/journal.pone.0188767	http://dx.doi.org/10.1371/journal.pone.0188767			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652894	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900001
J	Nam, SY; Ko, ES; Lim, Y; Han, BK; Ko, EY; Choi, JS; Lee, JE				Nam, Sang Yu; Ko, Eun Sook; Lim, Yaeji; Han, Boo-Kyung; Ko, Eun Young; Choi, Ji Soo; Lee, Jeong Eon			Preoperative dynamic breast magnetic resonance imaging kinetic features using computer-aided diagnosis: Association with survival outcome and tumor aggressiveness in patients with invasive breast cancer	PLOS ONE			English	Article							ENHANCED SPECTRAL MAMMOGRAPHY; CONTRAST ENHANCEMENT; MICROVESSEL DENSITY; MRI PARAMETERS; CAD SYSTEM; LESIONS; ANGIOGENESIS; METASTASIS; ULTRASOUND; CARCINOMA	Objectives To evaluate whether preoperative breast dynamic contrast-enhanced (DCE) magnetic resonance (MR) imaging kinetic features, assessed using computer-aided diagnosis (CAD), can predict survival outcome and tumor aggressiveness in patients with invasive breast cancer. Materials and methods Between March and December 2011, 301 women who underwent preoperative DCE MR imaging for invasive breast cancer, with CAD data, were identified. All MR images were retrospectively evaluated using a commercially available CAD system. The following kinetic parameters were prospectively recorded for each lesion: initial peak enhancement, the proportion of early phase medium and rapid enhancement, and the proportion of delayed phase persistent, plateau, and washout enhancement. The Cox proportional hazards model was used to determine the association between the kinetic features assessed by CAD and disease-free survival (DFS). The peak signal intensity and kinetic enhancement profiles were compared with the clinical-pathological variables. Results There were 32 recurrences during a mean follow-up time of 55.2 months (range, 5-72 months). Multivariate analysis revealed that a higher peak enhancement (DFS hazard ratio, 1.004 [95% confidence interval (CI): 1.001, 1.006]; P = .013) on DCE MR imaging and a triple-negative subtype (DFS hazard ratio, 21.060 [95% CI: 2.675, 165.780]; P = .004) were associated with a poorer DFS. Higher peak enhancement was significantly associated with a higher tumor stage, clinical stage, and histologic grade. Conclusions Patients with breast cancer who showed higher CAD-derived peak enhancement on breast MR imaging had worse DFS. Peak enhancement and volumetric analysis of kinetic patterns were useful for predicting tumor aggressiveness.	[Nam, Sang Yu] Gachon Univ Med & Sci, Gachon Univ, Dept Radiol, Gil Med Ctr, Incheon, South Korea; [Ko, Eun Sook; Han, Boo-Kyung; Ko, Eun Young; Choi, Ji Soo] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 81 Irwon Ro, Seoul, South Korea; [Lim, Yaeji] Chung Ang Univ, Dept Appl Stat, 84 Heukseok Ro, Seoul, South Korea; [Lee, Jeong Eon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, 81 Irwon Ro, Seoul, South Korea	Gachon University; Sungkyunkwan University (SKKU); Samsung Medical Center; Chung Ang University; Sungkyunkwan University (SKKU); Samsung Medical Center	Ko, ES (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, 81 Irwon Ro, Seoul, South Korea.	mathilda0330@gmail.com		Ko, Eun Sook/0000-0002-0399-7956				American College of Radiology, 2013, BREAST IM REP DAT SY; Meinel LA, 2007, J MAGN RESON IMAGING, V25, P89, DOI 10.1002/jmri.20794; Baltzer PAT, 2012, TECHNOL CANCER RES T, V11, P553, DOI 10.7785/tcrt.2012.500266; Baltzer PAT, 2009, ACAD RADIOL, V16, P1070, DOI 10.1016/j.acra.2009.03.017; Bhooshan N, 2010, RADIOLOGY, V254, P680, DOI 10.1148/radiol.09090838; Blaschke E, 2015, J MAGN RESON IMAGING, V42, P920, DOI 10.1002/jmri.24884; Chaudhury B, 2015, J MAGN RESON IMAGING, V42, P1421, DOI 10.1002/jmri.24921; Choi WWL, 2005, MODERN PATHOL, V18, P143, DOI 10.1038/modpathol.3800253; Dietzel M, 2013, J MAGN RESON IMAGING, V37, P146, DOI 10.1002/jmri.23812; Dromain C, 2013, EUR J RADIOL, V82, P417, DOI 10.1016/j.ejrad.2012.03.005; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Fallenberg EM, 2014, EUR RADIOL, V24, P256, DOI 10.1007/s00330-013-3007-7; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Huang J, 2016, ONCOL LETT, V11, P3522, DOI 10.3892/ol.2016.4422; Jansen SA, 2009, AM J ROENTGENOL, V193, P832, DOI 10.2214/AJR.08.2025; Kim JJ, 2017, RADIOLOGY, V284, P45, DOI 10.1148/radiol.2017162079; Kuhl CK, 2006, RADIOLOGY, V239, P666, DOI 10.1148/radiol.2392050509; Kuhl CK, 1999, RADIOLOGY, V211, P101, DOI 10.1148/radiology.211.1.r99ap38101; Lee SH, 2008, KOREAN J RADIOL, V9, P10, DOI 10.3348/kjr.2008.9.1.10; Lehman CD, 2006, AM J ROENTGENOL, V187, P51, DOI 10.2214/AJR.05.0269; Leng XL, 2017, MED SCI MONITOR, V23, P3428, DOI 10.12659/MSM.901734; Leong LCH, 2015, AM J ROENTGENOL, V204, pW348, DOI 10.2214/AJR.13.11486; Liu H, 2008, BREAST, V17, P532, DOI 10.1016/j.breast.2008.04.004; Lobbes MBI, 2014, EUR RADIOL, V24, P1668, DOI 10.1007/s00330-014-3154-5; Loiselle CR, 2011, J MAGN RESON IMAGING, V33, P96, DOI 10.1002/jmri.22389; Loiselle CR, 2010, INT J RADIAT ONCOL, V76, P1314, DOI 10.1016/j.ijrobp.2009.03.053; Meeuwis C, 2010, EUR RADIOL, V20, P522, DOI 10.1007/s00330-009-1573-5; Pineda FD, 2015, BRIT J RADIOL, V88, DOI 10.1259/bjr.20150021; Rahbar H, 2016, MAGN RESON IMAGING C, V24, P223, DOI 10.1016/j.mric.2015.08.012; Saphner T, 1996, J CLIN ONCOL, V14, P2738, DOI 10.1200/JCO.1996.14.10.2738; Song SE, 2015, CANCER IMAGING, V15, DOI 10.1186/s40644-015-0036-2; Sourbron SP, 2011, MAGN RESON MED, V66, P735, DOI 10.1002/mrm.22861; Stomper PC, 1997, BREAST CANCER RES TR, V45, P39, DOI 10.1023/A:1005897227030; Su MY, 2003, J MAGN RESON IMAGING, V18, P467, DOI 10.1002/jmri.10380; Taylor JS, 1999, J MAGN RESON IMAGING, V10, P903, DOI 10.1002/(SICI)1522-2586(199912)10:6<903::AID-JMRI1>3.0.CO;2-A; Tennant SL, 2016, CLIN RADIOL, V71, P1148, DOI 10.1016/j.crad.2016.05.009; Tuncbilek Nermin, 2003, Breast J, V9, P403, DOI 10.1046/j.1524-4741.2003.09508.x; Tuncbilek N, 2012, EUR J RADIOL, V81, P863, DOI 10.1016/j.ejrad.2011.02.021; Turetschek K, 2001, RADIOLOGY, V218, P562, DOI 10.1148/radiology.218.2.r01fe37562; Vajuvalli NN, 2016, PHYS MED BIOL, V61, P8462, DOI 10.1088/0031-9155/61/24/8462; Wan CF, 2012, RADIOLOGY, V262, P450, DOI 10.1148/radiol.11110789; Warner E, 2008, ANN INTERN MED, V148, P671, DOI 10.7326/0003-4819-148-9-200805060-00007; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Yi A, 2013, RADIOLOGY, V268, P662, DOI 10.1148/radiol.13121801; Zahra MA, 2007, LANCET ONCOL, V8, P63, DOI 10.1016/S1470-2045(06)71012-9; Zhao YX, 2017, ONCOTARGETS THER, V10, P1123, DOI 10.2147/OTT.S124134; Zwiener I, 2011, DTSCH ARZTEBL INT, V108, P163, DOI [10.3238/arztebl.2011.0163, 10.3238/arztebl.2010.0163]	47	11	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195756	10.1371/journal.pone.0195756	http://dx.doi.org/10.1371/journal.pone.0195756			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649266	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900080
J	Niazi, MKK; Tavolara, TE; Arole, V; Hartman, DJ; Pantanowitz, L; Gursan, MN				Niazi, Muhammad Khalid Khan; Tavolara, Thomas Erol; Arole, Vidya; Hartman, Douglas J.; Pantanowitz, Liron; Gursan, Metin N.			Identifying tumor in pancreatic neuroendocrine neoplasms from Ki67 images using transfer learning	PLOS ONE			English	Article							NEURAL-NETWORKS; DIAGNOSIS	The World Health Organization (WHO) has clear guidelines regarding the use of Ki67 index in defining the proliferative rate and assigning grade for pancreatic neuroendocrine tumor (NET). WHO mandates the quantification of Ki67 index by counting at least 500 positive tumorcells in a hotspot. Unfortunately, Ki67 antibody may stain both tumor and non-tumor cells as positive depending on the phase of the cell cycle. Likewise, the counter stain labels both tumor and non-tumor as negative. This non-specific nature of Ki67 stain and counter stain therefore hinders the exact quantification of Ki67 index. To address this problem, we present a deep learning method to automatically differentiate between NET and non-tumor regions based on images of Ki67 stained biopsies. Transfer learning was employed to recognize and apply relevant knowledge from previous learning experiences to differentiate between tumor and non-tumor regions. Transfer learning exploits a rich set of features previously used to successfully categorize non-pathology data into 1,000 classes. The method was trained and validated on a set of whole-slide images including 33 NETs subject to Ki67 immunohistochemical staining using a leave-one-out cross-validation. When applied to 30 high power fields (HPF) and assessed against a gold standard (evaluation by two expert pathologists), the method resulted in a high sensitivity of 97.8% and specificity of 88.8%. The deep learning method developed has the potential to reduce pathologists' workload by directly identifying tumor boundaries on images of Ki67 stained slides. Moreover, it has the potential to replace sophisticated and expensive imaging methods which are recently developed for identification of tumor boundaries in images of Ki67-stained NETs.	[Niazi, Muhammad Khalid Khan; Tavolara, Thomas Erol; Gursan, Metin N.] Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA; [Arole, Vidya] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Hartman, Douglas J.; Pantanowitz, Liron] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA	Wake Forest University; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Niazi, MKK (corresponding author), Wake Forest Sch Med, Ctr Biomed Informat, Winston Salem, NC 27101 USA.	khalid.niazi@gmail.com	Pantanowitz, Liron/AFP-8163-2022	Gurcan, Metin/0000-0002-2421-8229; Niazi, Muhammad Khalid Khan/0000-0002-1278-7512	National Institute of Allergy and Infectious Diseases [R01CA134451, U24CA199374, U01 CM 98945, R21 A1115038]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported in part by awards number R01CA134451 (Pls: Gurcan, Lozanski), U24CA199374 (Pls: Gurcan, Madabushi, Martel), and U01 CM 98945 (PI: Bilgin) from the National Cancer Institute, and by number R21 A1115038 (Pls: Campos-Neto, Beamer) from the National Institute of Allergy and Infectious Diseases. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute, the National Institute of Allergy and Infectious Diseases, or the National Institutes of Health.	Alsidawi S, 2017, PANCREATIC NEUROENDO; Belhomme P, 2015, COMPUT MED IMAG GRAP, V42, P51, DOI 10.1016/j.compmedimag.2014.11.006; Bosman F. T., 2010, WHO CLASSIFICATION T; Chefd'hotel c, 2014, INT WORKSH MACH LEAR; Ciresan DC, 2013, IT C MED IM COMP COM; Deng L, 2013, IEEE INT NEW CIRC; Goodell PP, 2012, AM J CLIN PATHOL, V137, P576, DOI 10.1309/AJCP92UCXPJMMSDU; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Kingeter LM, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-49; Kloppel G, 2007, BEST PRACT RES CL EN, V21, P15, DOI 10.1016/j.beem.2007.01.004; Kloppel G, 2017, AJSP-REV REP, V22, P233, DOI 10.1097/PCR.0000000000000211; Krizhevsky A., 2012, ADV NEURAL INF PROCE; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914; Lopez XM, 2012, CYTOM PART A, V81A, P765, DOI 10.1002/cyto.a.22085; MKKNGBMN Gurcan, 2018, SPIE MED IMAGI UNPUB; Niazi MKK, 2014, J MICROSC-OXFORD, V256, P213, DOI 10.1111/jmi.12176; Niazi MKK, 2017, SPIE MED IMAGING; Niazi MKK, 2014, SPIE MED IMAGING; Niazi MKK, 2013, SPIE MED IMAGING; Niazi MKK, 2016, SPIE MED IMAGING, V2016; Nystrom I, 2010, IEEE INT C PATT REC; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Phan AT, 2010, PANCREAS, V39, P784, DOI 10.1097/MPA.0b013e3181ec1380; Polley MYC, 2015, MODERN PATHOL, V28, P778, DOI 10.1038/modpathol.2015.38; Roge R, 2016, BREAST CANCER RES TR, V158, P11, DOI 10.1007/s10549-016-3852-6; Ruskey Frank, 1997, ELECTRON J COMB, V4, P3; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shin HC, 2016, IEEE T MED IMAGING, V35, P1285, DOI 10.1109/TMI.2016.2528162; Smialowski P, 2010, BIOINFORMATICS, V26, P440, DOI 10.1093/bioinformatics/btp621; Sobecki M, 2017, CANC RES; Sutskever I., 2013, P 30 INT C MACH LEAR, V28, P1139, DOI DOI 10.1007/S00287-015-0911-Z; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Toomey D, 2015, SPIE MED IMAGING; Torrey Lisa, HDB RES MACHINE LEAR, P242; Vincent P, 2010, J MACH LEARN RES, V11, P3371; Wang L-W, 2016, SCI REPORTS, V6; Yuan JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122734	40	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195621	10.1371/journal.pone.0195621	http://dx.doi.org/10.1371/journal.pone.0195621			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649302	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900061
J	Coant, N; Garcia-Barros, M; Zhang, QF; Obeid, LM; Hannun, YA				Coant, Nicolas; Garcia-Barros, Monica; Zhang, Qifeng; Obeid, Lina M.; Hannun, Yusuf A.			AKT as a key target for growth promoting functions of neutral ceramidase in colon cancer cells	ONCOGENE			English	Article							ADJUVANT TREATMENT; PATHWAY; SPHINGOLIPIDS; MECHANISM; LINES; GENE; FLUOROURACIL; SPHINGOSINE; OXALIPLATIN; LEUCOVORIN	Despite advances in the field, colorectal cancer (CRC) remains a leading cause of cancer-related mortality worldwide. Research into bioactive sphingolipids over the past two decades has played an important role in increasing our understanding of the pathogenesis and therapeutics of CRC. In the complex metabolic network of sphingolipids, ceramidases (CDases) have a key function. These enzymes hydrolyze ceramides into sphingosine (SPH) which in turn is phosphorylated by sphingosine kinases (SK) 1 and 2 to generate sphingosine-1 phosphate (S1P). Importantly, we have recently shown that inhibition of neutral CDase (nCDase) induces an increase of ceramide in colon cancer cells which decreases cellular growth, increases apoptosis and modulates the WNT/beta-catenin pathway. We have also shown that the deletion of nCDase protected mice from the onset and progression of colorectal cancer in the AOM carcinogen model. Here, we demonstrate that AKT is a key target for the growth suppressing functions of ceramide. The results show that inhibition of nCDase activates GSK3 beta through dephosphorylation, and thus is required for the subsequent phosphorylation and degradation of beta-catenin. Our findings show that inhibition of nCDase also inhibits the basal activation status of AKT, and we further establish that a constitutively active AKT (AKT T308D, S473D; AKT(DD)) reverses the effect of nCDase on beta-catenin degradation. Functionally, the AKT(DD) mutant is able to overcome the growth suppressive effects of nCDase inhibition in CRC cells. Moreover, nCDase inhibition induces a growth delay of xenograft tumors from control cells, whereas xenograft tumors from constitutively active AKT cells become resistant to nCDase inhibition. Taken together, these results provide important mechanistic insight into how nCDase regulates cell proliferation. These findings demonstrate a heretofore unappreciated, but critical, role for nCDase in enabling/maintaining basal activation of AKT and also suggest that nCDase is a suitable novel target for colon cancer therapy.	[Coant, Nicolas; Garcia-Barros, Monica; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Zhang, Qifeng] Babraham Inst, Signalling Programme, Babraham Res Campus, Cambridge, England; [Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Obeid, Lina M.] Northport VA Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Hannun, YA (corresponding author), SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA.	Yusuf.Hannun@stonybrookmedicine.edu		COANT, Nicolas/0000-0001-9237-2132	NCI [CA172517, CA97132]; Research Histology Core Laboratory, Department of Pathology, Stony Brook University; NATIONAL CANCER INSTITUTE [R01CA172517, P01CA097132] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Research Histology Core Laboratory, Department of Pathology, Stony Brook University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by NCI grants CA172517 and CA97132. We acknowledge the support from the "Research Histology Core Laboratory, Department of Pathology, Stony Brook University". We would like to thank Ayanna Lewis, MD for proof reading the manuscript.	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Airola MV, 2015, STRUCTURE, V23, P1482, DOI 10.1016/j.str.2015.06.013; Anderson Karen E., 2016, Advances in Biological Regulation, V62, P18, DOI 10.1016/j.jbior.2015.11.002; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Berg KCG, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0691-y; Carrato Alfredo, 2008, Gastrointest Cancer Res, V2, pS42; Clark J, 2011, NAT METHODS, V8, P267, DOI 10.1038/NMETH.1564; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Fakih MG, 2015, J CLIN ONCOL, V33, P1809, DOI 10.1200/JCO.2014.59.7633; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Garcia-Barros M, 2016, FASEB J, V30, P4159, DOI 10.1096/fj.201600611R; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Hafsi S, 2012, INT J ONCOL, V40, P639, DOI 10.3892/ijo.2011.1312; Halder K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091656; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Jiang BH, 2008, CURR CANCER DRUG TAR, V8, P19, DOI 10.2174/156800908783497122; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; KIM JH, 1986, CANCER RES, V46, P1120; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Knowles MA, 2009, CANCER METAST REV, V28, P305, DOI 10.1007/s10555-009-9198-3; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Kumar A, 2012, CARCINOGENESIS, V33, P1726, DOI 10.1093/carcin/bgs174; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mao CG, 2008, BBA-MOL CELL BIOL L, V1781, P424, DOI 10.1016/j.bbalip.2008.06.002; Muller EJ, 2008, J INVEST DERMATOL, V128, P501, DOI 10.1038/sj.jid.5701248; Nelson VM, 2013, J GASTROINTEST ONCOL, V4, P245, DOI 10.3978/j.issn.2078-6891.2013.035; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Oaks J, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00388; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Rahman A, 2016, FREE RADICAL BIO MED, V96, P273, DOI 10.1016/j.freeradbiomed.2016.05.001; Sasaki AT, 2006, EUR J CELL BIOL, V85, P873, DOI 10.1016/j.ejcb.2006.04.007; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Stewart B, 2014, WORLD CANC REPORT 20, P619; Stoica BA, 2003, MOL CELL NEUROSCI, V22, P365, DOI 10.1016/S1044-7431(02)00028-3; Symolon H, 2011, MOL CANCER THER, V10, P648, DOI 10.1158/1535-7163.MCT-10-0754; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Verdaguer H, 2016, THER ADV MED ONCOL, V8, P230, DOI 10.1177/1758834016635888; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Yeang CH, 2008, FASEB J, V22, P2605, DOI 10.1096/fj.08-108985; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhou HL, 1998, J BIOL CHEM, V273, P16568, DOI 10.1074/jbc.273.26.16568	51	15	18	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3852	3863		10.1038/s41388-018-0236-x	http://dx.doi.org/10.1038/s41388-018-0236-x			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29662189	Green Accepted			2022-12-26	WOS:000438465600007
J	Schoener, E; Uebleis, SS; Cuk, C; Nawratil, M; Obwaller, AG; Zechmeister, T; Lebl, K; Radrova, J; Zittra, C; Votypka, J; Fuehrer, HP				Schoener, Ellen; Uebleis, Sarah Susanne; Cuk, Claudia; Nawratil, Michaels; Obwaller, Adelheid G.; Zechmeister, Thomas; Lebl, Karin; Radrova, Jana; Zittra, Carina; Votypka, Jan; Fuehrer, Hans-Peter			Trypanosomatid parasites in Austrian mosquitoes	PLOS ONE			English	Article							MONOXENOUS TRYPANOSOMATIDS; INSECT TRYPANOSOMATIDS; HOST-SPECIFICITY; AVIUM DANILEWSKY; RIBOSOMAL-RNAS; N. SP; PHYLOGENY; TRANSMISSION; EVOLUTION; DIVERSITY	Trypanosomatid flagellates have not been studied in Austria in any detail. In this study, specific nested PCR, targeted on the ribosomal small subunit, was used to determine the occurrence and diversity of trypanosomatids in wild-caught mosquitoes sampled across Eastern Austria in the years 2014-2015. We collected a total of 29,975 mosquitoes of 19 species divided in 1680 pools. Of these, 298 (17.7%), representing 12 different mosquito species, were positive for trypanosomatid DNA. In total, seven trypanosomatid spp. were identified (three Trypanosoma, three Crithidia and one Herpetomonas species), with the highest parasite species diversity found in the mosquito host Coquillettidia richiardii. The most frequent parasite species belonged to the mammalian Trypanosoma theileri/cervi species complex (found in 105 pools; 6.3%). The avian species T. culicavium (found in 69 pools; 4.1%) was only detected in mosquitoes of the genus Culex, which corresponds to their preference for avian hosts. Monoxenous trypanosomatids of the genus Crithidia and Herpetomonas were found in 20 (1.3%) mosquito pools. One third (n = 98) of the trypanosomatid positive mosquito pools carried more than one parasite species. This is the first large scale study of trypanosomatid parasites in Austrian mosquitoes and our results are valuable in providing an overview of the diversity of these parasites in Austria.	[Schoener, Ellen; Uebleis, Sarah Susanne; Cuk, Claudia; Nawratil, Michaels; Zittra, Carina; Fuehrer, Hans-Peter] Univ Vet Med Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria; [Obwaller, Adelheid G.] Fed Minist Def & Sports, Div Sci Res & Dev, Vienna, Austria; [Zechmeister, Thomas] Biol Stn Lake Neusiedl, Burgenland, Austria; [Lebl, Karin] Univ Vet Med Vienna, Inst Vet Publ Hlth, Dept Farm Anim & Vet Publ Hlth, Vienna, Austria; [Radrova, Jana; Votypka, Jan] Charles Univ Prague, Dept Parasitol, Fac Sci, Prague, Czech Republic; [Votypka, Jan] Czech Acad Sci, Biol Ctr, Inst Parasitol, Ceske Budejovice, Czech Republic	University of Veterinary Medicine Vienna; University of Veterinary Medicine Vienna; Charles University Prague; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences	Fuehrer, HP (corresponding author), Univ Vet Med Vienna, Inst Parasitol, Dept Pathobiol, Vienna, Austria.	Hans-Peter.Fuehrer@vetmeduni.ac.at	Bakran-Lebl, Karin/B-8519-2014; Brzoňová, Jana/C-2032-2017; Fuehrer, Hans-Peter/J-9055-2019; Votypka, Jan/C-5313-2012; Zittra, Carina/O-1445-2019	Bakran-Lebl, Karin/0000-0001-8818-2483; Brzoňová, Jana/0000-0002-3303-8756; Fuehrer, Hans-Peter/0000-0002-4178-0133; Votypka, Jan/0000-0002-0552-9363; Zittra, Carina/0000-0002-8963-6421	ERA-Net BiodivERsA; FWF [I-1437, ANR-13-EBID-0007-01]; DFG as part of the BiodivERsA [BiodivERsA KL 2087/6-1]; ERD Funds, project CePaViP [CZ.02.1.01/0.0/0.0/16_019/0000759]	ERA-Net BiodivERsA; FWF(Austrian Science Fund (FWF)); DFG as part of the BiodivERsA(German Research Foundation (DFG)); ERD Funds, project CePaViP	This research was funded by the ERA-Net BiodivERsA, with the national funders FWF I-1437, ANR-13-EBID-0007-01 and DFG BiodivERsA KL 2087/6-1 as part of the 2012-13 BiodivERsA call for research proposals as well as by ERD Funds, project CePaViP (CZ.02.1.01/0.0/0.0/16_019/0000759).	BAKER JR, 1956, PARASITOLOGY, V46, P321, DOI 10.1017/S0031182000026536; Barratt J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005215; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; BENNETT GF, 1970, CAN J ZOOLOG, V48, P803, DOI 10.1139/z70-140; BENNETT GF, 1970, CAN J ZOOLOG, V48, P945, DOI 10.1139/z70-169; BENNETT GF, 1961, CAN J ZOOLOG, V39, P17, DOI 10.1139/z61-003; Borstler J, 2016, PARASITE VECTOR, P9; BOSE R, 1987, PARASITOL RES, V73, P421, DOI 10.1007/BF00538199; Buguet A, 2015, SLEEP MED, P159, DOI [10.1007/978-1-4939-2089-1, DOI 10.1007/978-1-4939-2089-1]; d'Avila-Levy CM, 2015, MEM I OSWALDO CRUZ, V110, P956, DOI 10.1590/0074-02760150253; Fampa P, 2003, INT J PARASITOL, V33, P1019, DOI 10.1016/S0020-7519(03)00124-3; FERNANDES AP, 1993, P NATL ACAD SCI USA, V90, P11608, DOI 10.1073/pnas.90.24.11608; Flegontov P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23704; Flegontov P, 2013, CURR BIOL, V23, P1787, DOI 10.1016/j.cub.2013.07.045; FRIEDHOFF KT, 1984, ZBL BAKT-INT J MED M, V256, P286, DOI 10.1016/S0174-3031(84)80003-7; GARNHAM P. C. C., 1958, Trans. I. Int. Conf. Insect Pathology & Biol. Control., P287; Grybchuk-Ieremenko A, 2014, FOLIA PARASIT, V61, P495, DOI 10.14411/fp.2014.064; Guindon S, 2009, INFECT GENET EVOL, V9, P384; Hamilton PT, 2015, MBIO, V6, DOI 10.1128/mBio.01356-15; Hedley L, 2016, BRIT J HOSP MED, V77, pC157, DOI 10.12968/hmed.2016.77.10.C157; Hoare C, 1972, TRYPANOSOMES MAMMALS; Holmstad PR, 2003, J WILDLIFE DIS, V39, P354, DOI 10.7589/0090-3558-39.2.354; Kaufer A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2204-7; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kostygov AY, 2016, MBIO, V7, DOI 10.1128/mBio.01985-15; Kostygov AY, 2014, PROTIST, V165, P594, DOI 10.1016/j.protis.2014.07.001; Kozminsky E, 2015, PROTIST, V166, P551, DOI 10.1016/j.protis.2015.08.004; Lassmann T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-298; LOSOS GJ, 1972, VET PATHOL, V9, P1, DOI 10.1177/030098587200901s01; Lukes J, 2014, MOL BIOCHEM PARASIT, V195, P115, DOI 10.1016/j.molbiopara.2014.05.007; Maslov DA, 1996, MOL BIOCHEM PARASIT, V75, P197, DOI 10.1016/0166-6851(95)02526-X; Maslov DA, 2013, TRENDS PARASITOL, V29, P43, DOI 10.1016/j.pt.2012.11.001; Merino S, 1995, AUK, V112, P1041, DOI 10.2307/4089037; MOLYNEUX DH, 1983, PARASITOLOGY, V87, P49, DOI 10.1017/S0031182000052409; Podlipaev S, 2004, J PARASITOL, V90, P342, DOI 10.1645/GE-156R; Podlipaev S.A., 1990, Trudy Zoologicheskogo Instituta, V217, P1; Poinar G, 2004, VECTOR-BORNE ZOONOT, V4, P281, DOI 10.1089/vbz.2004.4.281; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Rodrigues AC, 2006, PARASITOLOGY, V132, P215, DOI 10.1017/S0031182005008929; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; SCHLAFER DH, 1979, CORNELL VET, V69, P411; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Schonenberger AC, 2016, MED VET ENTOMOL, V30, P39, DOI 10.1111/mve.12155; Sehgal RNM, 2001, MOL ECOL, V10, P2319, DOI 10.1046/j.1365-294X.2001.01339.x; Seward EA, 2017, PROTIST, V168, P71, DOI 10.1016/j.protis.2016.11.002; Shurulinkov P, 2009, PARASITOL RES, V104, P1453, DOI 10.1007/s00436-009-1349-5; Simpson AGB, 2006, TRENDS PARASITOL, V22, P168, DOI 10.1016/j.pt.2006.02.006; Slapeta J, 2016, PARASITOLOGY, V143, P1012, DOI 10.1017/S0031182016000329; STABLER RM, 1966, J PARASITOL, V52, P1141, DOI 10.2307/3276358; Svobodova M, 2015, MED VET ENTOMOL, V29, P444, DOI 10.1111/mve.12130; Svobodova M, 2007, INT J SYST EVOL MICR, V57, P423, DOI 10.1099/ijs.0.64557-0; Svobodova M, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2158-9; Svobodova M, 2015, PARASITOL RES, V114, P551, DOI 10.1007/s00436-014-4217-x; Teixeira MMG, 2011, PROTIST, V162, P503, DOI 10.1016/j.protis.2011.01.001; Van Dyken M, 2006, INT J PARASITOL, V36, P1015, DOI 10.1016/j.ijpara.2006.05.003; VANDENINGH TSGAM, 1976, VET PARASITOL, V2, P237, DOI 10.1016/0304-4017(76)90082-0; Volf P, 2004, INT J PARASITOL, V34, P1221, DOI 10.1016/j.ijpara.2004.07.010; Votypka J, 2004, ACTA PROTOZOOL, V43, P225; Votypka J, 2004, PARASITOL RES, V92, P147, DOI 10.1007/s00436-003-1034-z; Votypka J, 2002, PARASITOLOGY, V125, P253, DOI 10.1017/S0031182002002093; Votypka J, 2001, EXP PARASITOL, V99, P104, DOI 10.1006/expr.2001.4648; Votypka J, 2015, TRENDS PARASITOL, V31, P460, DOI 10.1016/j.pt.2015.06.015; Votypka J, 2014, PROTIST, V165, P825, DOI 10.1016/j.protis.2014.09.002; Votypka J, 2012, INT J SYST EVOL MICR, V62, P745, DOI 10.1099/ijs.0.032110-0; Votypka J, 2010, MOL PHYLOGENET EVOL, V54, P243, DOI 10.1016/j.ympev.2009.10.014; Wallace F., 1902, J PARASITOL, V1943, P196; WALLACE FG, 1966, EXP PARASITOL, V18, P124, DOI 10.1016/0014-4894(66)90015-4; Wita I, 1999, ACTA PARASITOL, V44, P93; Yurchenko V, 2014, FOLIA PARASIT, V61, P97, DOI 10.14411/fp.2014.023; ZIdkova A L, 2012, INFECT GENET EVOL, P12; Zidkova L, 2010, INT J SYST EVOL MICR, V60, P2236, DOI 10.1099/ijs.0.014555-0; Zittra C, 2016, PARASITE VECTOR, P9; Zittra C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2140-6	74	11	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196052	10.1371/journal.pone.0196052	http://dx.doi.org/10.1371/journal.pone.0196052			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672618	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800074
J	Ponsonby, AL; Pezic, A; Cameron, FJ; Rodda, C; Kemp, AS; Carlin, JB; Hyoty, H; Sioofy-Khojine, A; Dwyer, T; Ellis, JA; Craig, ME				Ponsonby, Anne-Louise; Pezic, Angela; Cameron, Fergus J.; Rodda, Christine; Kemp, Andrew S.; Carlin, John B.; Hyoty, Heikki; Sioofy-Khojine, Amirbabak; Dwyer, Terence; Ellis, Justine A.; Craig, Maria E.			Higher parental occupational social contact is associated with a reduced risk of incident pediatric type 1 diabetes: Mediation through molecular enteroviral indices	PLOS ONE			English	Article							DIFFERENT EUROPEAN POPULATIONS; INFECTION; PLASMA; SERUM; EXPOSURE; RNA; VARICELLA; RESPONSES; CHILDREN; ZOSTER	We aimed to examine the association between parental occupational social contact and hygiene factors on type 1 diabetes (T1D) risk and possible mediation of these effects through child enteroviral infection. We interviewed 333 incident T1D cases and 660 controls from 2008-2011 in Melbourne, Australia. Enteroviral indices (ribonucleic acid by reverse transcription polymerase chain reaction and Coxsackie B virus antibody levels) in peripheral blood were measured in nested case control samples. Parent occupational social contact was assessed by the number of well or sick children, adults or animals contacted daily through work. Higher parental occupational social contact was strongly associated with reduced T1D risk with evidence of dose response (contact with the well or sick score, Adjusted odds ratio (AOR) per category: 0.73 (95% Confidence Interval (CI): 0.66, 0.81); P<0.001 or AOR 0.63 (95% CI: 0.53, 0.75); P<0.001) respectively). Nine of the ten parental social contact indices, were significant mediated through one or more enteroviral indices. The strength of association between enterovirus presence and T1D onset increased with child age (1.2 fold increase per year; P = 0.05). Lower child hand hygiene enhanced the adverse effect of low parental occupational contact with the sick; Synergy Index 5.16 (95% CI: 3.61, 7.36). The interaction between hand washing and parental occupational contact is more consistent with protection against parental enteroviral shedding than the sharing of a protective infectious agent or microbiome.	[Ponsonby, Anne-Louise; Pezic, Angela; Cameron, Fergus J.; Rodda, Christine; Kemp, Andrew S.; Carlin, John B.; Dwyer, Terence; Ellis, Justine A.] Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Flemington Rd, Parkville, Vic, Australia; [Ponsonby, Anne-Louise] Australian Natl Univ, Natl Ctr Epidemiol, Canberra, ACT, Australia; [Rodda, Christine] Sunshine Hosp, Western Ctr Hlth Res & Educ, St Albans, Vic, Australia; [Hyoty, Heikki; Sioofy-Khojine, Amirbabak] Univ Tampere, Sch Med, Virol, Laakarinkatu, Finland; [Dwyer, Terence] Univ Oxford, George Inst Global Hlth, Oxford Martin Sch, Oxford, England; [Ellis, Justine A.] Deakin Univ, Fac Hlth, Ctr Social & Early Emot Dev, Burwood, Vic, Australia; [Craig, Maria E.] Univ New South Wales, Sch Womens & Childrens Hlth, Kensington, NSW, Australia; [Craig, Maria E.] Univ Sydney, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; Australian National University; Tampere University; University of Oxford; Deakin University; University of New South Wales Sydney; University of Sydney	Ponsonby, AL (corresponding author), Univ Melbourne, Murdoch Childrens Res Inst, Royal Childrens Hosp, Flemington Rd, Parkville, Vic, Australia.; Ponsonby, AL (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol, Canberra, ACT, Australia.	anne-louise.ponsonby@mcri.edu.au	Sioofy-Khojine, Amir-Babak/M-6008-2019; Carlin, John B/B-3492-2012; Carlin, John/AAG-4332-2020; Ponsonby, Anne-Louise/AAE-4351-2019	Sioofy-Khojine, Amir-Babak/0000-0001-5538-5153; Carlin, John B/0000-0002-2694-9463; Carlin, John/0000-0002-2694-9463; Hyoty, Heikki/0000-0003-0370-4145; Ellis, Justine/0000-0003-4103-4445; Craig, Maria E/0000-0001-6004-576X; Ponsonby, Anne-Louise/0000-0002-6581-3657	National Health and Medical Research Council of Australia; Australian Research Council; Arthritis Australia; Diabetes Australia; Rebecca L Cooper Medical Research Foundation; L.E.W. Carty Charitable Fund; ANZ Medical Research and Technologies in Victoria Fund; Equity Trustees Lynne Quayle Charitable Trust Fund; Australian Academy of Science; Victorian State Government Operational Infrastructure Support Program; Murdoch Childrens Research Institute; National Health and Medical Research Council	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Arthritis Australia; Diabetes Australia; Rebecca L Cooper Medical Research Foundation; L.E.W. Carty Charitable Fund; ANZ Medical Research and Technologies in Victoria Fund; Equity Trustees Lynne Quayle Charitable Trust Fund; Australian Academy of Science; Victorian State Government Operational Infrastructure Support Program; Murdoch Childrens Research Institute; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	Funding was obtained from the National Health and Medical Research Council of Australia, the Australian Research Council, Arthritis Australia, Diabetes Australia, Rebecca L Cooper Medical Research Foundation, L.E.W. Carty Charitable Fund, ANZ Medical Research and Technologies in Victoria Fund, Equity Trustees Lynne Quayle Charitable Trust Fund, the Australian Academy of Science, The Victorian State Government Operational Infrastructure Support Program, and the Murdoch Childrens Research Institute Internal Grant Scheme. JAE was supported by an Australian Research Council Future Fellowship. ALP was supported by a National Health and Medical Research Council Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alidjinou EK, 2014, DISCOV MED, V18, P273; Blacksell SD, 2012, AM J TROP MED HYG, V87, P573, DOI 10.4269/ajtmh.2012.12-0043; Boom R, 1999, J CLIN MICROBIOL, V37, P1489, DOI 10.1128/JCM.37.5.1489-1497.1999; Cairns CJS, 2002, INTENS CARE MED, V28, P1357, DOI 10.1007/s00134-002-1399-y; Carr EJ, 2016, NAT IMMUNOL, V17, P461, DOI 10.1038/ni.3371; Dink B., 2006, INTRO SOCIOECONMIC I; Ejemot-Nwadiaro RI, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004265.pub3; Elfaitouri A, 2007, J MED VIROL, V79, P1861, DOI 10.1002/jmv.21008; Fear NT, 1999, DIABETIC MED, V16, P1025, DOI 10.1046/j.1464-5491.1999.00204.x; Fouchet D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002306; Gillespie KM, 2004, LANCET, V364, P1699, DOI 10.1016/S0140-6736(04)17357-1; Ginocchio CC, 1997, J CLIN MICROBIOL, V35, P2886, DOI 10.1128/JCM.35.11.2886-2893.1997; He XX, 2003, BIOMED ENVIRON SCI, V16, P40; Hicks R, 2011, STATA J, V11, P605, DOI 10.1177/1536867X1101100407; Juhela S, 2000, DIABETES, V49, P1308, DOI 10.2337/diabetes.49.8.1308; Kaila B, 2001, DIABETES CARE, V24, P1353, DOI 10.2337/diacare.24.8.1353; Kinlen LJ, 1997, BRIT J CANCER, V76, P1539, DOI 10.1038/bjc.1997.592; Krogvold L, 2015, DIABETES, V64, P1682, DOI 10.2337/db14-1370; Little R.J.A., 2002, STAT ANAL MISSING DA; McIver CJ, 2005, J CLIN MICROBIOL, V43, P5102, DOI 10.1128/JCM.43.10.5102-5110.2005; Miller J, 2015, ARTHRITIS RHEUMATOL, V67, P1951, DOI 10.1002/art.39129; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nair S, 2010, J MED VIROL, V82, P1950, DOI 10.1002/jmv.21900; Needell JC, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-016-0781-z; Ogunjimi B, 2014, CLIN VACCINE IMMUNOL, V21, P417, DOI 10.1128/CVI.00818-13; Oikarinen M, 2012, DIABETES, V61, P687, DOI 10.2337/db11-1157; Oikarinen S, 2014, DIABETES, V63, P655, DOI 10.2337/db13-0620; Oikarinen S, 2011, DIABETES, V60, P276, DOI 10.2337/db10-0186; Parslow RC, 2001, INT J EPIDEMIOL, V30, P533, DOI 10.1093/ije/30.3.533; Parslow RC, 2001, INT J EPIDEMIOL, V30, P8; Ponsonby AL, 2014, NATURE, V507, P169, DOI 10.1038/507169b; Ponsonby Anne-Louise, 2012, Results Immunol, V2, P125, DOI 10.1016/j.rinim.2012.06.002; Rodriguez RJ, 1997, J ACQ IMMUN DEF SYND, V15, P49, DOI 10.1097/00042560-199705010-00008; Salvatoni A, 2013, PEDIATR DIABETES, V14, P407, DOI 10.1111/pedi.12056; Sherriff A, 2002, ARCH DIS CHILD, V87, P26, DOI 10.1136/adc.87.1.26; Siev M, 2011, CLIN VACCINE IMMUNOL, V18, P173, DOI 10.1128/CVI.00325-10; Skrondal A, 2003, AM J EPIDEMIOL, V158, P251, DOI 10.1093/aje/kwg113; STAGNO S, 1984, J MED VIROL, V13, P347, DOI 10.1002/jmv.1890130405; Stata Corp, 2015, STAT STAT SOFTW REL; Sun C, 2017, CANCER EPIDEM BIOMAR, V26, P1146, DOI [10.1158/1055-9965.EPI-16-0846, 10.1158/1055-9965.epi-16-0846]; Thomas SL, 2002, LANCET, V360, P678, DOI 10.1016/S0140-6736(02)09837-9; VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402; Viskari H, 2004, J MED VIROL, V72, P610, DOI 10.1002/jmv.20033; Weldon WC, 2016, METHODS MOL BIOL, V1387, P145, DOI 10.1007/978-1-4939-3292-4_8; YEUNG WCG, 2011, BMJ-BRIT MED J, V342, DOI DOI 10.1136/BMJ.D35; Ziegler AG, 2011, J AUTOIMMUN, V37, P3, DOI 10.1016/j.jaut.2011.02.004	46	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0193992	10.1371/journal.pone.0193992	http://dx.doi.org/10.1371/journal.pone.0193992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664909	Green Published, gold			2022-12-26	WOS:000430262300005
J	Gardner, JK; Cornwall, SMJ; Musk, AW; Alvarez, J; Mamotte, CDS; Jackaman, C; Nowak, AK; Nelson, DJ				Gardner, Joanne K.; Cornwall, Scott M. J.; Musk, Arthur W.; Alvarez, John; Mamotte, Cyril D. S.; Jackaman, Connie; Nowak, Anna K.; Nelson, Delia J.			Elderly dendritic cells respond to LPS/IFN-gamma and CD40L stimulation despite incomplete maturation	PLOS ONE			English	Article							INTERFERON-GAMMA; AGED MICE; IMMUNITY; INNATE; MACROPHAGES; EXPRESSION; SECRETION; MONOCYTES; INFECTION; EXPANSION	There is evidence that dendritic cells (DCs) undergo age-related changes that modulate their function with their key role being priming antigen-specific effector T cells. This occurs once DCs develop into antigen-presenting cells in response to stimuli/danger signals. However, the effects of aging on DC responses to bacterial lipopolysaccharide (LPS), the proinflammatory cytokine interferon (IFN)-gamma and CD40 ligand (CD40L) have not yet been systematically evaluated. We examined responses of blood myeloid (m) DC1s, mDC2s, plasmacytoid (p) DCs, and monocyte-derived DCs (MoDCs) from young (21 +/- 40 years) and elderly (60 +/- 84 years) healthy human volunteers to LPS/IFN-gamma or CD40L stimulation. All elderly DC subsets demonstrated comparable up-regulation of co-stimulatory molecules (CD40, CD80 and/or CD86), intracellular pro-inflammatory cytokine levels (IFN-gamma, tumour necrosis factor (TNF)-alpha, IL-6 and/or IL-12), and/or secreted cytokine levels (IFN-alpha, IFN-gamma, TNF-alpha, and IL-12) to their younger counterparts. Furthermore, elderly-derived LPS/IFN-gamma or CD40L-activated MoDCs induced similar or increased levels of CD8(+) and CD4(+) T cell proliferation, and similar T cell functional phenotypes, to their younger counterparts. However, elderly LPS/IFN-gamma-activated MoDCs were unreliable in their ability to up-regulate chemokine (IL-8 and monocyte chemoattractant protein (MCP)-1) and IL-6 secretion, implying an inability to dependably induce an inflammatory response. A key age-related difference was that, unlike young-derived MoDCs that completely lost their ability to process antigen, elderly-derived MoDCs maintained their antigen processing ability after LPS/IFN-gamma maturation, measured using the DQ-ovalbumin assay; this response implies incomplete maturation that may enable elderly DCs to continuously present antigen. These differences may impact on the efficacy of anti-pathogen and anti-tumour immune responses in the elderly.	[Gardner, Joanne K.; Cornwall, Scott M. J.; Mamotte, Cyril D. S.; Jackaman, Connie; Nelson, Delia J.] Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA, Australia; [Gardner, Joanne K.; Cornwall, Scott M. J.; Mamotte, Cyril D. S.; Jackaman, Connie; Nelson, Delia J.] Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Musk, Arthur W.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA, Australia; [Alvarez, John] Mt Hosp, Perth, WA, Australia; [Nowak, Anna K.] Univ WA, Sch Med, Perth, WA, Australia; [Nowak, Anna K.] Sir Charles Gairdner Hosp, Dept Med Oncol, Perth, WA, Australia	Curtin University; University of Western Australia; University of Western Australia; University of Western Australia	Nelson, DJ (corresponding author), Curtin Univ, Sch Pharm & Biomed Sci, Bentley, WA, Australia.; Nelson, DJ (corresponding author), Curtin Hlth Innovat Res Inst, Bentley, WA, Australia.	Delia.Nelson@curtin.edu.au	Mamotte, Cyril/AAF-9603-2020; Nowak, Anna K/B-2487-2013	Nowak, Anna K/0000-0002-9317-9526; Mamotte, Cyril/0000-0003-1831-3921; Jackaman, Connie/0000-0002-4583-7029; Nelson, Delia/0000-0002-8698-5300	School of Biomedical Sciences, Curtin University; Cancer Council Western Australia; Cancer Council Western Australia PhD Topup Scholarship	School of Biomedical Sciences, Curtin University; Cancer Council Western Australia(Cancer Council Western Australia); Cancer Council Western Australia PhD Topup Scholarship	This study was funded by the School of Biomedical Sciences, Curtin University, and the Cancer Council Western Australia (DJN). JKG was supported by a Cancer Council Western Australia PhD Top-up Scholarship. DJN is wholly salaried by Curtin University and also acts as Chief Scientific Officer for Selvax. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Curtin Health Innovation Research Institute and the School of Biomedical Sciences, Curtin University for provision of research facilities and technology platforms utilised in this study. The authors gratefully acknowledge the School of Biomedical Sciences, Curtin University, and the Cancer Council Western Australia for the financial support to conduct this study. Joanne K. Gardner was supported by a Cancer Council Western Australia PhD Topup Scholarship. The authors also thank all volunteers who donated blood samples for this study.	Agrawal A, 2008, J CLIN IMMUNOL, V28, P14, DOI 10.1007/s10875-007-9127-6; Agrawal A, 2007, EXP GERONTOL, V42, P421, DOI 10.1016/j.exger.2006.11.007; Agrawal A, 2007, J IMMUNOL, V178, P6912, DOI 10.4049/jimmunol.178.11.6912; Agrawal A, 2012, EXPERT REV CLIN IMMU, V8, P73, DOI [10.1586/ECI.11.77, 10.1586/eci.11.77]; Agrawal A, 2011, AGEING RES REV, V10, P336, DOI 10.1016/j.arr.2010.06.004; Antonioli L, 2013, NAT REV CANCER, V13, P842, DOI 10.1038/nrc3613; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Ciaramella A, 2011, CELL IMMUNOL, V269, P82, DOI 10.1016/j.cellimm.2011.04.010; DAVILA DR, 1990, FASEB J, V4, P2906, DOI 10.1096/fasebj.4.11.2165948; Della Bella S, 2007, CLIN IMMUNOL, V122, P220, DOI 10.1016/j.clim.2006.09.012; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Diehl S, 2002, MOL IMMUNOL, V39, P531, DOI 10.1016/S0161-5890(02)00210-9; DING A, 1994, J IMMUNOL, V153, P2146; Grolleau-Julius A, 2006, J GERONTOL A-BIOL, V61, P1039, DOI 10.1093/gerona/61.10.1039; Gupta S, 2014, EXP GERONTOL, V54, P47, DOI 10.1016/j.exger.2013.12.009; Haynes L, 2009, CURR OPIN IMMUNOL, V21, P414, DOI 10.1016/j.coi.2009.05.009; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Hopp AK, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00055; Hubo M, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00082; Janssen N, 2016, J GERONTOL A-BIOL, V71, P1117, DOI 10.1093/gerona/glv119; Jing Y, 2009, HUM IMMUNOL, V70, P777, DOI 10.1016/j.humimm.2009.07.005; Jones SC, 2010, J IMMUNOL, V185, P6783, DOI 10.4049/jimmunol.0901296; Keir ME, 2007, CURR OPIN IMMUNOL, V19, P309, DOI 10.1016/j.coi.2007.04.012; Khong A, 2012, INT REV IMMUNOL, V31, P246, DOI 10.3109/08830185.2012.698338; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuchroo VK, 2008, NAT REV IMMUNOL, V8, P577, DOI 10.1038/nri2366; Lee N, 2012, J GERONTOL A-BIOL, V67, P254, DOI 10.1093/gerona/glr237; Li G, 2012, AGING CELL, V11, P968, DOI 10.1111/j.1474-9726.2012.00867.x; Lung TL, 2000, VACCINE, V18, P1606, DOI 10.1016/S0264-410X(99)00494-6; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; McColl SR, 2002, IMMUNOL CELL BIOL, V80, P489, DOI 10.1046/j.1440-1711.2002.01113.x; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Murakami N, 2014, TRANSPLANTATION, V98, P3, DOI 10.1097/TP.0000000000000169; Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569; PALACIOS R, 1982, J IMMUNOL, V128, P337; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Pereira LF, 2011, MECH AGEING DEV, V132, P187, DOI 10.1016/j.mad.2011.03.005; Prakash S, 2013, AGE, V35, P1785, DOI 10.1007/s11357-012-9477-8; Qian F, 2011, J INFECT DIS, V203, P1415, DOI 10.1093/infdis/jir048; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Salam N, 2013, INDIAN J MED RES, V138, P595; Sansom DM, 2003, TRENDS IMMUNOL, V24, P314, DOI 10.1016/S1471-4906(03)00111-X; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shurin MR, 2007, CRIT REV ONCOL HEMAT, V64, P90, DOI 10.1016/j.critrevonc.2007.03.002; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Tesar BM, 2006, AGING CELL, V5, P473, DOI 10.1111/j.1474-9726.2006.00245.x; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x; Wong CP, 2010, EXP GERONTOL, V45, P163, DOI 10.1016/j.exger.2009.11.005; Wong C, 2013, CURR OPIN IMMUNOL, V25, P535, DOI 10.1016/j.coi.2013.05.016; Wordsworth DTHJ, 2011, REV CLIN GERONTOL, V21, P110, DOI 10.1017/S0959259810000407; Workman CJ, 2002, J IMMUNOL, V169, P5392, DOI 10.4049/jimmunol.169.10.5392; Yoon P, 2004, MECH AGEING DEV, V125, P137, DOI 10.1016/j.mad.2003.11.010; You JL, 2013, IMMUNOBIOLOGY, V218, P1077, DOI 10.1016/j.imbio.2013.02.002; You J, 2013, J APPL MATH, DOI 10.1155/2013/840628; Zacca ER, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140672; Zhao JC, 2011, J CLIN INVEST, V121, P4921, DOI 10.1172/JCI59777	60	9	12	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195313	10.1371/journal.pone.0195313	http://dx.doi.org/10.1371/journal.pone.0195313			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652910	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900021
J	Wong, W; Kim, YM; Kim, A; Cloutier, M; Gauthier-Loiselle, M; Gagnon-Sanschagrin, P; Guerin, A				Wong, William; Kim, Yeun Mi; Kim, Ashley; Cloutier, Martin; Gauthier-Loiselle, Marjolaine; Gagnon-Sanschagrin, Patrick; Guerin, Annie			Assessment of costs associated with adverse events in patients with cancer	PLOS ONE			English	Article							METASTATIC BREAST-CANCER; ECONOMIC BURDEN; UNITED-STATES; CARE; CHEMOTHERAPY; MELANOMA; IMPACT	Adverse event (AE)-related costs represent an important component of economic models for cancer care. However, since previous studies mostly focused on specific AEs, treatments, or cancer types, limited information is currently available. Therefore, this study assessed the incremental healthcare costs associated with a large number of AEs among patients diagnosed with some of the most prevalent types of cancer. Data were obtained from a large US claims database. Adult patients were included if diagnosed with and treated for one of the following cancer types: breast, digestive organs and peritoneum, genitourinary organs (including bladder and ovary and other uterine adnexa), lung, lymphatic and hematopoietic tissue, and skin. Treatment episodes were defined as the period from initiation of the first antineoplastic pharmacologic therapy to discontinuation (i.e., gap of >= 45 days), or change in treatment regimen, or end of data availability. A total of 36 AEs were selected from the product inserts of 104 treatments recommended by practice guidelines. A retrospective matched cohort design was used, matching a treatment episode with a certain AE with a treatment episode without that AE. A total of 412,005 patients were selected, for a total of 794,243 treatment episodes, resulting in 1,617,368 matched treatment episodes across all 36 AEs. Incremental healthcare costs associated with AEs of any severity ranged from $546 for cough/upper respiratory infections to $24,633 for gastrointestinal perforation. The three most costly AEs when considering any severity were gastrointestinal perforation ($24,633), central nervous system hemorrhage ($24,322), and sepsis/septicemia ($23,510). Incremental healthcare costs associated with severe AEs ranged from $15,709 for dermatitis and rash to $48,538 for gastrointestinal fistula. The three most costly severe AEs were gastrointestinal fistula ($48,538), gastrointestinal perforation ($41,281), and central nervous system hemorrhage ($38,428). In conclusion, AEs during treatment episodes for cancer were frequent and associated with a substantial economic burden.	[Wong, William; Kim, Yeun Mi; Kim, Ashley] Genentech Inc, Hlth Econ & Outcomes Res, US Med Affairs, San Francisco, CA 94080 USA; [Cloutier, Martin; Gauthier-Loiselle, Marjolaine; Gagnon-Sanschagrin, Patrick; Guerin, Annie] Anal Grp Inc, Montreal, PQ, Canada	Roche Holding; Genentech; Analysis Group Inc.	Cloutier, M (corresponding author), Anal Grp Inc, Montreal, PQ, Canada.	martin.cloutier@analysisgroup.com		Wong, William/0000-0002-6054-278X	Genentech, Inc.; Genentech	Genentech, Inc.(Roche HoldingGenentech); Genentech(Roche HoldingGenentech)	This study was funded by Genentech, Inc. The sponsor (Genentech, Inc.) was involved in study design, data collection, analysis and interpretation, preparation of the manuscript, and decision to publish. Analysis Group, Inc. received consulting fees from Genentech for this study. MC, MGL, PGS, and AG are employees of Analysis Group, Inc. Analysis Group, Inc. is not a funder of this study. The specific roles of all authors are articulated in the 'author contributions' section.	Arondekar Bhakti, 2015, J Manag Care Spec Pharm, V21, P158; Banz K, 2011, LUNG CANCER, V74, P529, DOI 10.1016/j.lungcan.2011.04.010; Bilir SP, 2016, AM HEALTH DRUG BENEF, V9, P203; Borovicka JH, 2011, ARCH DERMATOL, V147, P1403, DOI 10.1001/archdermatol.2011.719; Caggiano V, 2005, CANCER-AM CANCER SOC, V103, P1916, DOI 10.1002/cncr.20983; Clement FM, 2009, HEALTH ECON, V18, P377, DOI 10.1002/hec.1363; Fishman PA, 2009, MED CARE, V47, pS70, DOI 10.1097/MLR.0b013e3181a75a7f; Frick KD, 2009, MED CARE, V47, pS76, DOI 10.1097/MLR.0b013e31819bc064; Hansen RN, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-259; Heerey Adrienne, 2002, Expert Rev Pharmacoecon Outcomes Res, V2, P29, DOI 10.1586/14737167.2.1.29; Hurvitz S, 2014, ONCOLOGIST, V19, P901, DOI 10.1634/theoncologist.2014-0059; Institute for Clinical and Economic Review (ICER), OV ICER VAL ASS FRAM; Latremouille-Viau D, 2017, J MED ECON, V20, P54, DOI 10.1080/13696998.2016.1225577; Mariotto AB, 2011, JNCI-J NATL CANCER I, V103, P117, DOI 10.1093/jnci/djq495; Nazer Lama H, 2013, J Oncol Pharm Pract, V19, P298, DOI 10.1177/1078155212465995; Pike Crystal T, 2012, Chemother Res Pract, V2012, P913848, DOI 10.1155/2012/913848; Rashid N, 2015, J MANAG CARE SPEC PH, V21, P863, DOI 10.18553/jmcp.2015.21.10.863; SCHNIPPER L.E., 2015, J CLIN ONCOL, V2015, P6706, DOI DOI 10.1200/JC0.2015.61.6706; Schnipper LE, 2016, ONCOLOGIST, V21, P654, DOI 10.1634/theoncologist.2016-0177; Sullivan SD, 2014, VALUE HEALTH, V17, P5, DOI 10.1016/j.jval.2013.08.2291; Tachi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124169; Vouk K, 2016, J MED ECON, V19, P900, DOI 10.1080/13696998.2016.1184155; Weycker D, 2008, ANN ONCOL, V19, P454, DOI 10.1093/annonc/mdm525; Weycker D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-362; Xu X, 2014, SYST REV-LONDON, V3, DOI 10.1186/2046-4053-3-47	25	61	61	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0196007	10.1371/journal.pone.0196007	http://dx.doi.org/10.1371/journal.pone.0196007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652926	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900053
J	Lee, JS; Cho, KS; Lee, SH; Yoon, YE; Kang, DH; Jeong, WS; Jung, HD; Kwon, JK; Lee, JY				Lee, Jong Soo; Cho, Kang Su; Lee, Seung Hwan; Yoon, Young Eun; Kang, Dong Hyuk; Jeong, Won Sik; Jung, Hae Do; Kwon, Jong Kyou; Lee, Joo Yong			Stone heterogeneity index on single-energy noncontrast computed tomography can be a positive predictor of urinary stone composition	PLOS ONE			English	Article							SHOCK-WAVE LITHOTRIPSY; CALCIUM; CALCULI; UROLITHIASIS; FRAGILITY	The aim of this study was to investigate the correlation between stone composition and single-energy noncontrast computed tomography (NCCT) parameters, including stone heterogeneity index (SHI) and mean stone density (MSD), in patients with urinary calculi. We retrospectively reviewed medical records of 255 patients who underwent operations or procedures for urinary stones or had spontaneous stone passage between December 2014 and October 2015. Among these, 214 patients with urinary calculi who underwent NCCT and stone composition analyses were included in the study. Maximal stone length (MSL), mean stone density (MSD), and stone heterogeneity index (SHI) were determined on pretreatment NCCT. The mean MSD (454.68 +/- 177.80 HU) and SHI (115.82 +/- 96.31 HU) of uric acid stones were lower than those of all other types. Based on post hoc tests, MSD was lower for uric acid stones than for the other types (vs. CaOx: P<0.001; vs. infection stones: P<0.001). SHI was lower for uric acid stones than for the other types (vs. CaOx: P<0.001; vs. infection stones: P<0.001) Receiver operating characteristic curves of uric acid stones for MSD and SHI demonstrated that SHI (cut-off value: 140.4 HU) was superior to MSD (cut-off value: 572.3 HU) in predicting uric acid stones (P<0.001).	[Lee, Jong Soo; Lee, Seung Hwan; Lee, Joo Yong] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea; [Cho, Kang Su] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Urol,Urol Sci Inst, Seoul, South Korea; [Yoon, Young Eun] Hanyang Univ, Coll Med, Dept Urol, Seoul, South Korea; [Kang, Dong Hyuk] Inha Univ, Dept Urol, Sch Med, Incheon, South Korea; [Jeong, Won Sik] Kwangju Christian Hosp, Dept Urol, Gwangju, South Korea; [Jung, Hae Do] Yonsei Univ Hlth Syst, Yongin Severance Hosp, Dept Urol, Yongin, South Korea; [Kwon, Jong Kyou] Yonsei Univ Hlth Syst, Severance Check Up, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Hanyang University; Inha University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Lee, JY (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol,Severance Hosp, Seoul, South Korea.	joouro@yuhs.ac	; Lee, Joo Yong/C-3851-2013	Lee, Jongsoo/0000-0002-9984-1138; Yoon, Young Eun/0000-0001-8059-6649; Cho, Kang Su/0000-0002-3500-8833; Lee, Seung Hwan/0000-0001-7358-8544; Lee, Joo Yong/0000-0002-3470-1767	Yonsei University College of Medicine [6-2016-0119]	Yonsei University College of Medicine(General Electric)	This study was supported by a faculty research grant from the Yonsei University College of Medicine for 2016 (6-2016-0119).	Ahn SH, 2015, KOREAN J UROL, V56, P644, DOI 10.4111/kju.2015.56.9.644; Bres-Niewada E, 2014, CENT EUR J UROL, V67, P392, DOI 10.5173/ceju.2014.04.art15; Cho KS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144912; Chung DY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123800; Eliahou R, 2010, SEMIN ULTRASOUND CT, V31, P315, DOI 10.1053/j.sult.2010.05.002; Gucuk Adnan, 2014, World J Nephrol, V3, P282, DOI 10.5527/wjn.v3.i4.282; Han DH, 2016, INVESTIG CLIN UROL, V57, P229, DOI 10.4111/icu.2016.57.4.229; Kachrilas S, 2013, UROLITHIASIS, V41, P323, DOI 10.1007/s00240-013-0575-6; Kang DH, 2016, INVESTIG CLIN UROL, V57, P408, DOI 10.4111/icu.2016.57.6.408; Kang SK, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009119; Kim JH, 2015, BMC UROL, V15, DOI 10.1186/s12894-015-0013-x; Lee JY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23988; Marchini GS, 2013, UROLOGY, V82, P539, DOI 10.1016/j.urology.2013.03.092; Mostafavi MR, 1998, J UROLOGY, V159, P673, DOI 10.1016/S0022-5347(01)63698-X; Motley G, 2001, UROLOGY, V58, P170, DOI 10.1016/S0090-4295(01)01115-3; Narepalem N, 2002, J UROLOGY, V167, P1235, DOI 10.1016/S0022-5347(05)65272-X; Park SH, 2014, KOREAN J UROL, V55, P581, DOI 10.4111/kju.2014.55.9.581; Patel SR, 2009, UROL INT, V83, P175, DOI 10.1159/000230020; Ringden I, 2007, SCAND J UROL NEPHROL, V41, P316, DOI 10.1080/00365590601154551; Spek A, 2016, WORLD J UROL; Spettel S, 2013, UROLOGY, V82, P22, DOI 10.1016/j.urology.2013.01.015; Turk C, 2016, EUR UROL, V69, P475, DOI 10.1016/j.eururo.2015.07.041; Williams JC, 2003, UROLOGY, V61, P1092, DOI 10.1016/S0090-4295(03)00349-2; Wolf JS, 2007, UROL CLIN N AM, V34, P421, DOI 10.1016/j.ucl.2007.04.010; Zarse CA, 2007, UROL RES, V35, P201, DOI 10.1007/s00240-007-0104-6	25	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0193945	10.1371/journal.pone.0193945	http://dx.doi.org/10.1371/journal.pone.0193945			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649219	Green Published, gold			2022-12-26	WOS:000429791900006
J	Saito, H; Hirayama, A; Umemura, T; Joshita, S; Mukawa, K; Suga, T; Tanaka, E; Ota, M				Saito, Hiromi; Hirayama, Atsuhiro; Umemura, Takeji; Joshita, Satoru; Mukawa, Kenji; Suga, Tomoaki; Tanaka, Eiji; Ota, Masao			Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RECEPTOR GENES; GENOTYPE; POLYMORPHISMS; SELECTION; ALLELES; LIGAND	Inflammatory bowel disease (IBD) consists of ulcerative colitis (UC) and Crohn's disease (CD). Natural killer cell responses play a crucial role in autoimmune disease through innate immunity, in which killer cell immunoglobulin-like receptors (KIRs) are closely involved. Although the genetic combination of KIRs with their specific HLA class I ligands has been associated with IBD in Caucasians, such KIR-HLA receptor-ligand combinations are not fully understood in the Japanese. We investigated 14 KIR genes along with HLA-Bw and -C ligands in 90 patients with UC and 50 patients with CD and compared them with the characteristics of 325 healthy control subjects. The frequency of HLA-Bw4 was significantly increased in patients with UC (P = 1.3 x 10(-6); odds ratio [OR] = 3.39) and CD (P = 0.0065; OR = 2.32) versus controls. The UC group had a significantly higher frequency of KIR2DS3 (P = 0.024; OR = 1.94) and lower frequency of KIR2DS4 (P = 0.019; OR = 0.40) and KIR2DL1-HLA-C2 (P = 0.035; OR = 0.47). The Tel-A/B haplotype was significantly decreased in UC patients (P = 0.0056; OR = 0.49). The frequency of KIR3DL1-HLA-Bw4 was significantly higher in patients with UC (P = 4.3 x 10(-6); OR = 3.12) and CD (P = 0.0067; OR = 2.30). In conclusion, HLA-Bw4 and KIR-HLA pairs may play an important role in the genetic susceptibility to IBD in the Japanese.	[Saito, Hiromi; Hirayama, Atsuhiro; Umemura, Takeji; Joshita, Satoru; Suga, Tomoaki; Tanaka, Eiji; Ota, Masao] Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano, Japan; [Mukawa, Kenji] Suwa Red Cross Hosp, Dept Gastroenterol, Suwa, Japan	Shinshu University	Umemura, T (corresponding author), Shinshu Univ, Sch Med, Dept Med, Div Gastroenterol & Hepatol, Matsumoto, Nagano, Japan.	tumemura@shinshu-u.ac.jp	Joshita, Satoru/K-5679-2019	Joshita, Satoru/0000-0002-6364-9654; Umemura, Takeji/0000-0001-7985-919X	Japan Society for the Promotion of Science KAKENHI [17K09416]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported in a part by a research grant from the Japan Society for the Promotion of Science KAKENHI (17K09416) (TU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Asano K, 2009, NAT GENET, V41, P1325, DOI 10.1038/ng.482; CELLA M, 1994, J EXP MED, V180, P1235, DOI 10.1084/jem.180.4.1235; COLONNA M, 1993, P NATL ACAD SCI USA, V90, P12000, DOI 10.1073/pnas.90.24.12000; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Diaz-Pena R, 2016, HUM IMMUNOL, V77, P104, DOI 10.1016/j.humimm.2015.10.020; Dignass A, 2012, J CROHNS COLITIS, V6, P965, DOI 10.1016/j.crohns.2012.09.003; Fuyuno Y, 2016, J GASTROENTEROL, V51, P672, DOI 10.1007/s00535-015-1135-3; Hollenbach JA, 2009, IMMUNOGENETICS, V61, P663, DOI 10.1007/s00251-009-0396-5; Jones DC, 2006, GENES IMMUN, V7, P576, DOI 10.1038/sj.gene.6364333; Lin L, 2014, J IMMUNOL, V193, P940, DOI 10.4049/jimmunol.1400093; Lopez-Hernandez R, 2016, MICROBIOL IMMUNOL, V60, P787, DOI 10.1111/1348-0421.12447; Mandelboim O, 1996, J EXP MED, V184, P913, DOI 10.1084/jem.184.3.913; Moesta AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00336; Nozawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083381; Okada Y, 2011, GASTROENTEROLOGY, V141, P864, DOI 10.1053/j.gastro.2011.05.048; Saito H, 2018, ONCOTARGET IN PRESS; Tajik N, 2010, INT J IMMUNOGENET, V37, P159, DOI 10.1111/j.1744-313X.2010.00906.x; Umemura T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29770; Umemura T, 2014, HUM IMMUNOL, V75, P822, DOI 10.1016/j.humimm.2014.06.003; Van Assche G, 2010, J CROHNS COLITIS, V4, P7, DOI 10.1016/j.crohns.2009.12.003; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Wagtmann N, 1995, IMMUNITY, V3, P801, DOI 10.1016/1074-7613(95)90069-1; Wilson TJ, 2010, HUM IMMUNOL, V71, P293, DOI 10.1016/j.humimm.2009.12.006; Yamazaki K, 2005, HUM MOL GENET, V14, P3499, DOI 10.1093/hmg/ddi379; Yamazaki K, 2013, GASTROENTEROLOGY, V144, P781, DOI 10.1053/j.gastro.2012.12.021; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884	28	17	17	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195778	10.1371/journal.pone.0195778	http://dx.doi.org/10.1371/journal.pone.0195778			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649328	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900085
J	Silva, FD; Liotti, RG; Boleti, APD; Reis, ED; Passos, MBS; dos Santos, EL; Sampaio, OM; Januario, AH; Branco, CLB; da Silva, GF; de Mendonca, EAF; Soares, MA				Silva, Fabio de Azevedo; Liotti, Rhavena Graziela; de Araujo Boleti, Ana Paula; Reis, Erica de Melo; Silva Passos, Marilene Borges; dos Santos, Edson Lucas; Sampaio, Olivia Moreira; Januario, Ana Helena; Bassi Branco, Carmen Lucia; da Silva, Gilvan Ferreira; Furtado de Mendonca, Elisabeth Aparecida; Antonio Soares, Marcos			Diversity of cultivable fungal endophytes in Paullinia cupana (Mart.) Ducke and bioactivity of their secondary metabolites	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; DARK SEPTATE ENDOPHYTES; IN-VITRO; 3-HYDROXYPROPIONIC ACID; TRICHODERMA-HARZIANUM; DI-(2-ETHYLHEXYL) PHTHALATE; FUSARIUM-OXYSPORUM; THEOBROMA-CACAO; COLLETOTRICHUM-GLOEOSPORIOIDES; XYLOGONE-GANODERMOPHTHORA	Paullinia cupana is associated with a diverse community of pathogenic and endophytic microorganisms. We isolated and identified endophytic fungal communities from the roots and seeds of P. cupana genotypes susceptible and tolerant to anthracnose that grow in two sites of the Brazilian Amazonia forest. We assessed the antibacterial, antitumor and genotoxic activity in vitro of compounds isolated from the strains Trichoderma asperellum (1BDA) and Diaporthe phaseolorum (8S). In concert, we identified eight fungal species not previously reported as endophytes; some fungal species capable of inhibiting pathogen growth; and the production of antibiotics and compounds with bacteriostatic activity against Pseudomonas aeruginosa in both susceptible and multiresistant host strains. The plant genotype, geographic location and specially the organ influenced the composition of P. cupana endophytic fungal community. Together, our findings identify important functional roles of endophytic species found within the microbiome of P. cupana. This hypothesis requires experimental validation to propose management of this microbiome with the objective of promoting plant growth and protection.	[Silva, Fabio de Azevedo; Liotti, Rhavena Graziela; Antonio Soares, Marcos] Univ Fed Mato Grosso, Inst Biociencias, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil; [Liotti, Rhavena Graziela] Inst Fed Mato Grosso, Caceres, Mato Grosso, Brazil; [de Araujo Boleti, Ana Paula; dos Santos, Edson Lucas] Fundacao Univ Fed Grande Dourados, Escola Ciencias Biol & Ambientais, Dourados, MS, Brazil; [Reis, Erica de Melo; Silva Passos, Marilene Borges; Bassi Branco, Carmen Lucia] Univ Fed Mato Grosso, Fac Med, Cuiaba, Mato Grosso, Brazil; [Sampaio, Olivia Moreira] Univ Fed Mato Grosso, Dept Quim, Cuiaba, Mato Grosso, Brazil; [Januario, Ana Helena] Univ Franca, Ctr Pesquisa Ciencias Exatas & Tecnol, Sao Paulo, Brazil; [da Silva, Gilvan Ferreira] Embrapa Amazonia Ocidental, Manaus, Amazonas, Brazil; [Furtado de Mendonca, Elisabeth Aparecida] Univ Fed Mato Grosso, Fac Agron, Cuiaba, Mato Grosso, Brazil	Universidade Federal de Mato Grosso; Instituto Federal de Mato Grosso (IFMT); Universidade Federal da Grande Dourados; Universidade Federal de Mato Grosso; Universidade Federal de Mato Grosso; Universidad de Franca; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Federal de Mato Grosso	Soares, MA (corresponding author), Univ Fed Mato Grosso, Inst Biociencias, Dept Bot & Ecol, Cuiaba, Mato Grosso, Brazil.	drmasoares@gmail.com	Sampaio, Olívia Moreira/V-1187-2019; Soares, Marcos/Y-7844-2019; dos Santos, Edson Lucas/AAU-5857-2020; Januario, Ana Helena AH/G-9375-2012; Januario, Ana Helena/U-2283-2019; Soares, Marcos A/B-7683-2013	Sampaio, Olívia Moreira/0000-0001-9624-6029; Soares, Marcos/0000-0002-8938-3188; dos Santos, Edson Lucas/0000-0002-6557-7914; Januario, Ana Helena AH/0000-0002-3815-6903; Januario, Ana Helena/0000-0002-3815-6903; Soares, Marcos A/0000-0002-8938-3188	Comissao de Aperfeicoamento de Pessoal do Nivel Superior - CAPES [3348/2013]	Comissao de Aperfeicoamento de Pessoal do Nivel Superior - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by Comissao de Aperfeicoamento de Pessoal do Nivel Superior - CAPES - grant number: 3348/2013 (MAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adsul MG, 2007, BIORESOURCE TECHNOL, V98, P1467, DOI 10.1016/j.biortech.2006.02.036; Akonda MMR, 2016, PLANT SCI TODAY, V3, P267, DOI 10.14719/pst.2016.3.3.194; Al-Bari MAA, 2005, INT J SYST EVOL MICR, V55, P1973, DOI 10.1099/ijs.0.63516-0; Alvares CA, 2013, METEOROL Z, V22, P711, DOI 10.1127/0941-2948/2013/0507; AMADE P, 1994, J ANTIBIOT, V47, P201, DOI 10.7164/antibiotics.47.201; [Anonymous], 2015, PLOS ONE, DOI DOI 10.1371/journal.pone.0118204; Arevalo J, 2009, TROP PLANT PATHOL, V34, P158, DOI 10.1590/S1982-56762009000300004; Arivudainambi USE, 2011, FEMS IMMUNOL MED MIC, V61, P340, DOI 10.1111/j.1574-695X.2011.00780.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Arnold AE, 2003, MYCOLOGIA, V95, P388, DOI 10.2307/3761880; AYER WA, 1989, J NAT PROD, V52, P119, DOI 10.1021/np50061a015; Azevedo J.L., 2014, MICROBIAL DIVERSITY, P17, DOI 10.1007/978-81-322-1801-2_2; Bailey BA, 2009, MYCOL RES, V113, P1365, DOI 10.1016/j.mycres.2009.09.004; Bais HP, 2006, ANNU REV PLANT BIOL, V57, P233, DOI 10.1146/annurev.arplant.57.032905.105159; Ballhorn DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005450; Barata RA, 2002, J BIOSCI BIOENG, V94, P304, DOI 10.1016/S1389-1723(02)80168-2; Barnett H.L., 1955, T BR MYCOL SOC, V47, P616, DOI [10.2307/3755678, DOI 10.1016/S0007-1536(55)80058-7]; Basile A, 2013, NAT PROD RES, V27, P2084, DOI 10.1080/14786419.2013.784868; Batista BD, 2017, DIVERSITY AND BENEFITS OF MICROORGANISMS FROM THE TROPICS, P293, DOI 10.1007/978-3-319-55804-2_13; Bech L., 2015, FUNGAL GENOM BIOL, V5, P126, DOI 10.4172/2165-8056.1000116; Bhatti HN, 2007, APPL MICROBIOL BIOT, V73, P1290, DOI 10.1007/s00253-006-0597-x; Bittencourt LS, 2013, FOOD CHEM TOXICOL, V53, P119, DOI 10.1016/j.fct.2012.11.041; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Bogas AC, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1037-0; Bonatelli ML, 2016, J PLANT PATHOL, V98, P197, DOI 10.4454/JPP.V98I2.029; Bottomly T, 2004, DIVERSITY ENDOPHYTIC; Brader G, 2017, ANNU REV PHYTOPATHOL, V55, P61, DOI 10.1146/annurev-phyto-080516-035641; Brissow ER, 2017, PARASITOL RES, V116, P1823, DOI 10.1007/s00436-017-5451-9; Brodie EL, 2007, P NATL ACAD SCI USA, V104, P299, DOI 10.1073/pnas.0608255104; Broeckling CD, 2008, APPL ENVIRON MICROB, V74, P738, DOI 10.1128/AEM.02188-07; BYDLOWSKI SP, 1991, BRAZ J MED BIOL RES, V24, P421; BYDLOWSKI SP, 1988, BRAZ J MED BIOL RES, V21, P535; Cai L, 2006, MYCOL RES, V110, P137, DOI 10.1016/j.mycres.2005.09.014; Cai L, 2010, MYCOL PROG, V9, P337, DOI 10.1007/s11557-009-0641-1; CAPPELLINI RA, 1966, B TORREY BOT CLUB, V93, P52, DOI 10.2307/2483885; CARROLL G, 1995, CAN J BOT, V73, pS1316, DOI 10.1139/b95-393; Casella TM, 2013, PHYTOCHEMISTRY, V96, P370, DOI 10.1016/j.phytochem.2013.10.004; Lopez DC, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0103891, 10.1371/journal.pone.0093811]; Celinska E, 2010, BIOTECHNOL ADV, V28, P519, DOI 10.1016/j.biotechadv.2010.03.003; Chandrasekaran M, 2016, J GEN PLANT PATHOL, V82, P233, DOI 10.1007/s10327-016-0672-9; Channabasava, 2014, BANGL J PHARMACOL, V9, P129, DOI 10.3329/bjp.v9i1.15622; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chen SH, 2018, PHYTOCHEMISTRY, V146, P8, DOI 10.1016/j.phytochem.2017.11.011; de Souza ADC, 2012, CROP BREED APPL BIOT, V12, P47, DOI 10.1590/S1984-70332012000500006; Crous PW, 2014, PERSOONIA, V32, P184, DOI 10.3767/003158514X682395; da Costa WM, 2012, RESOURCES AND ENVIRO, V2, P253, DOI [10.5923/j.re.20120206.02, DOI 10.5923/J.RE.20120206.02]; da Mota PR, 2016, BIOL CONTROL, V95, P1, DOI 10.1016/j.biocontrol.2015.12.013; da Silva IP, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2228-3; Dalonso N, 2012, FOOD CHEM, V134, P1804, DOI 10.1016/j.foodchem.2012.03.088; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; de Melo Sette Claudia Vaz, 2018, Journal of Dietary Supplements, V15, P673, DOI 10.1080/19390211.2017.1384781; de Oliveira AN, 2010, BRAZ ARCH BIOL TECHN, V53, P653, DOI 10.1590/S1516-89132010000300021; de Siqueira KA, 2017, SYMBIOSIS, V71, P211, DOI 10.1007/s13199-016-0427-6; De Stefano S, 1999, PHYTOCHEMISTRY, V52, P1399, DOI 10.1016/S0031-9422(99)00320-9; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; del Giglio A, 2015, BIOACTIVE NUTRACEUTICALS AND DIETARY SUPPLEMENTS IN NEUROLOGICAL AND BRAIN DISEASE: PREVENTION AND THERAPY, P57, DOI 10.1016/B978-0-12-411462-3.00006-0; Dighton J., 2017, FUNGAL COMMUNITY ITS, V4th ed., DOI [10.1201/9781315119496, DOI 10.1201/9781315119496]; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Marinho AMD, 2011, HELV CHIM ACTA, V94, P835, DOI 10.1002/hlca.201000309; Domsch K.H., 2008, EUROPEAN J SOIL SCI, V59, P1007, DOI [10.1111/j.1365-2389.2008.01052_1.x, DOI 10.1111/J.1365-2389.2008.01052_1.X]; Driche EH, 2015, ANN MICROBIOL, V65, P1341, DOI 10.1007/s13213-014-0972-2; Duarte O., 2015, Exotic fruits and nuts of the New World, DOI 10.1079/9781780645056.0000; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; El-Sayed M. H., 2012, World Applied Sciences Journal, V20, P1202; ELEK SD, 1954, J CLIN PATHOL, V7, P37, DOI 10.1136/jcp.7.1.37; Elena K, 2006, PLANT PATHOL, V55, P300, DOI 10.1111/j.1365-3059.2005.01265.x; Erexson GL, 2001, MUTAT RES-GEN TOX EN, V495, P75, DOI 10.1016/S1383-5718(01)00199-1; ERICKSON HT, 1984, ECON BOT, V38, P273, DOI 10.1007/BF02859006; Erythropel HC, 2014, APPL MICROBIOL BIOT, V98, P9967, DOI 10.1007/s00253-014-6183-8; Evans Harry C., 2003, Mycological Progress, V2, P149, DOI 10.1007/s11557-006-0053-4; Feng Hang, 2013, African Journal of Microbiology Research, V7, P1311; Fernandes PI, 2013, REV BIOL TROP, V61, P991; Ferreira MC, 2015, BIOCHEM SYST ECOL, V59, P36, DOI 10.1016/j.bse.2014.12.017; Franzetti A, 2011, APPL MICROBIOL BIOT, V90, P745, DOI 10.1007/s00253-010-3048-7; Frohlich-Nowoisky J, 2009, P NATL ACAD SCI USA, V106, P12814, DOI 10.1073/pnas.0811003106; Fukuda T, 2011, J NAT PROD, V74, P1327, DOI 10.1021/np200035m; Fukumasu H, 2011, PHYTOTHER RES, V25, P11, DOI 10.1002/ptr.3216; Garrido-Jurado I, 2017, J PEST SCI, V90, P319, DOI 10.1007/s10340-016-0767-2; Gazis R, 2010, FUNGAL ECOL, V3, P240, DOI 10.1016/j.funeco.2009.12.001; Girija Smiline, 2014, Int Sch Res Notices, V2014, P820745, DOI 10.1155/2014/820745; Gonzaga LL, 2015, J APPL MICROBIOL, V118, P485, DOI 10.1111/jam.12696; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; GUNASEKA.M, 1972, MYCOLOGIA, V64, P1180, DOI 10.2307/3758087; Guzman-Trampe S, 2015, ANTIBIOTICS: CURRENT INNOVATIONS AND FUTURE TRENDS, P175; Habib M. Rowshanul, 2009, Mycobiology, V37, P31, DOI 10.4489/MYCO.2009.37.1.031; HAGERMAN AE, 1985, ANAL BIOCHEM, V151, P334, DOI 10.1016/0003-2697(85)90184-8; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hanada RE, 2010, FUNGAL BIOL-UK, V114, P901, DOI 10.1016/j.funbio.2010.08.006; Hancock, 2014, DICT BIOINFORMATICS, DOI [10.1002/9780471650126.dob0956, DOI 10.1002/9780471650126.DOB0956]; HANKIN L, 1975, MYCOLOGIA, V67, P597, DOI 10.2307/3758395; Hayasaka Y, 2014, J CHROMATOGR A, V1372, P120, DOI 10.1016/j.chroma.2014.10.096; HELANDER ML, 1995, NEW PHYTOL, V131, P223, DOI 10.1111/j.1469-8137.1995.tb05723.x; Posada RH, 2012, FUNGAL BIOL-UK, V116, P747, DOI 10.1016/j.funbio.2012.04.003; Herrera J, 2013, FUNGAL ECOL, V6, P65, DOI 10.1016/j.funeco.2012.08.002; Herrera J, 2011, MICROB ECOL, V61, P239, DOI 10.1007/s00248-010-9744-0; Higgins KL, 2014, FUNGAL ECOL, V8, P1, DOI 10.1016/j.funeco.2013.12.005; HIROTA A, 1993, BIOSCI BIOTECH BIOCH, V57, P492, DOI 10.1271/bbb.57.492; Hoffman MT, 2008, MYCOL RES, V112, P331, DOI 10.1016/j.mycres.2007.10.014; Hoffman MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073132; Hoyos-Carvajal L, 2009, BIOL CONTROL, V51, P409, DOI 10.1016/j.biocontrol.2009.07.018; ICHIKAWA T, 1971, FOLIA MICROBIOL, V16, P218, DOI 10.1007/BF02884210; Jaber LR, 2018, BIOL CONTROL, V116, P36, DOI 10.1016/j.biocontrol.2017.01.018; Ji SH, 2014, MICROBIOL RES, V169, P83, DOI 10.1016/j.micres.2013.06.003; Jia M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00906; Jian ZY, 2017, MEDICINE, V96, DOI [10.1097/md.0000000000007406, 10.1097/MD.0000000000007406]; Jiang XL, 2009, APPL MICROBIOL BIOT, V82, P995, DOI 10.1007/s00253-009-1898-7; Joshi BK, 2002, J NAT PROD, V65, P1734, DOI 10.1021/np020295p; Jumpponen A, 2010, NEW PHYTOL, V186, P496, DOI 10.1111/j.1469-8137.2010.03197.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2001, MYCORRHIZA, V11, P207, DOI 10.1007/s005720100112; Kang HJ, 2013, Patent No. [US 8591911 B2, 8591911]; Kang HJ, 2011, PLANT PATHOLOGY J, V27, P138, DOI 10.5423/PPJ.2011.27.2.138; Kang HJ, 2010, MYCOLOGIA, V102, P1167, DOI 10.3852/09-304; Kang Z, 2000, PHYSIOL MOL PLANT P, V57, P255, DOI 10.1006/pmpp.2000.0305; Katoch M, 2014, BRAZ ARCH BIOL TECHN, V57, P714, DOI 10.1590/S1516-8913201402502; Katoch M, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-52; Kern ME, 1999, MICOLOGIA MEADICA; Kim JE, 2005, APPL ENVIRON MICROB, V71, P1701, DOI 10.1128/AEM.71.4.1701-1708.2005; 강효중, 2015, [Research in Plant Disease, 식물병 연구], V21, P309, DOI 10.5423/RPD.2015.21.4.309; Koske RE., 1983, MYCOL SOC AM NEWSL, V34, P59, DOI DOI 10.1007/S00265-005-0945-3; Kovics GJ, 2014, CRIT REV MICROBIOL, V40, P49, DOI 10.3109/1040841X.2012.755948; Krishnamurthy YL, 2008, MICROBES ENVIRON, V23, P24, DOI 10.1264/jsme2.23.24; Kumar V, 2013, BIOTECHNOL ADV, V31, P945, DOI 10.1016/j.biotechadv.2013.02.008; Kytoviita MM, 2007, AM J BOT, V94, P1309, DOI 10.3732/ajb.94.8.1309; Kytoviita MM, 2005, FEMS MICROBIOL ECOL, V53, P27, DOI 10.1016/j.femsec.2004.09.014; Lee KH, 2000, J PHARM PHARMACOL, V52, P593, DOI 10.1211/0022357001774246; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Leveau JHJ, 2015, PRINCIPLES PLANT MIC, P17; Li XC, 2015, REC NAT PROD, V9, P503; Liew ECY, 2002, MYCOLOGIA, V94, P803, DOI 10.2307/3761695; Liotti RG, 2018, MICROBIOL RES, V207, P8, DOI 10.1016/j.micres.2017.10.011; Loro M, 2012, J ARID ENVIRON, V85, P46, DOI 10.1016/j.jaridenv.2012.04.009; LOUGHMAN R, 1986, PLANT PATHOL, V35, P443, DOI 10.1111/j.1365-3059.1986.tb02041.x; Lowe RGT, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00962; Maeda RN, 2011, PROCESS BIOCHEM, V46, P1196, DOI 10.1016/j.procbio.2011.01.022; Mandeel Q, 1999, PHARM BIOL, V37, P181, DOI 10.1076/phbi.37.3.181.6301; Mandyam K, 2005, STUD MYCOL, P173; Mandyam K, 2010, MYCOLOGIA, V102, P813, DOI 10.3852/09-212; Manter DK, 2010, MICROB ECOL, V60, P157, DOI 10.1007/s00248-010-9658-x; Marega M, 2013, J CHROMATOGR A, V1273, P105, DOI 10.1016/j.chroma.2012.11.076; Marfori EC, 2002, Z NATURFORSCH C, V57, P465; Marinelli E., 2012, Asian Journal of Plant Pathology, V6, P66, DOI 10.3923/ajppaj.2012.66.74; Maroldi MMC, 2018, APPL BIOCHEM BIOTECH, V184, P806, DOI 10.1007/s12010-017-2590-5; Martinez-Klimova E, 2017, BIOCHEM PHARMACOL, V134, P1, DOI 10.1016/j.bcp.2016.10.010; Martinez-Medina A, 2014, J CHEM ECOL, V40, P804, DOI 10.1007/s10886-014-0478-1; Martins M., 2014, African Journal of Biotechnology, V13, P131; MATHUR SP, 1974, J ENVIRON QUAL, V3, P189, DOI 10.2134/jeq1974.00472425000300030001x; Matsumura E, 2013, FUNGAL BIOL-UK, V117, P191, DOI 10.1016/j.funbio.2013.01.007; Mishra PD, 2015, LETT APPL MICROBIOL, V60, P387, DOI 10.1111/lam.12384; Mithofer A, 2017, TOXINOLOGY, P3, DOI 10.1007/978-94-007-6464-4_21; Mohamed SA, 2014, MOLECULES, V19, P8027, DOI 10.3390/molecules19068027; Mohan JE, 2014, FUNGAL ECOL, V10, P3, DOI 10.1016/j.funeco.2014.01.005; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOUBASHER AH, 1991, J BASIC MICROB, V31, P59, DOI 10.1002/jobm.3620310113; Muharni, 2014, INDONES J CHEM, V14, P290, DOI 10.22146/ijc.21241; Murali TS, 2006, CAN J MICROBIOL, V52, P673, DOI 10.1139/W06-020; Nguyen DH, 2008, KOREAN J CHEM ENG, V25, P1136, DOI 10.1007/s11814-008-0186-z; Nutaratat P, 2014, FUNGAL BIOL-UK, V118, P683, DOI 10.1016/j.funbio.2014.04.010; Ogorek R, 2016, EUR J PLANT PATHOL, V145, P469, DOI 10.1007/s10658-016-0860-7; Ola ARB, 2014, TETRAHEDRON LETT, V55, P3147, DOI 10.1016/j.tetlet.2014.03.110; Oliveira AN, 2004, REV BRAS CIENC SOLO, V28, P1063, DOI 10.1590/S0100-06832004000600015; Padhi S, 2013, ANN MICROBIOL, V63, P793, DOI 10.1007/s13213-012-0534-4; Pashley CH, 2012, FUNGAL BIOL-UK, V116, P214, DOI 10.1016/j.funbio.2011.11.004; Peterson RA, 2009, LETT APPL MICROBIOL, V48, P218, DOI 10.1111/j.1472-765X.2008.02513.x; Peterson R, 2011, MYCOL PROG, V10, P207, DOI 10.1007/s11557-010-0690-5; PETRINI L E, 1986, Mycologia Helvetica, V1, P501; Petrini O, 1991, MICROBIAL ECOLOGY LE, P179, DOI DOI 10.1007/978-1-4612-3168-4_9; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Photita W, 2001, MYCOL RES, V105, P1508, DOI 10.1017/S0953756201004968; Piernas V, 1997, J FOOD SCI, V62, P611, DOI 10.1111/j.1365-2621.1997.tb04443.x; Polishook JD, 1996, J IND MICROBIOL, V17, P284, DOI 10.1007/BF01574703; Porras-Alfaro A, 2011, MYCOLOGIA, V103, P10, DOI 10.3852/09-297; PRESTON PN, 1983, J CHEM SOC PERK T 1, P1001, DOI 10.1039/p19830001001; Punja ZK, 2003, ELSEVIER CURRENT TRE, P400, DOI [10.1016/S0167-7799(03)00193-8, DOI 10.1016/S0167-7799(03)00193-8]; Qadri M, 2015, WORLD J MICROB BIOT, V31, P1647, DOI 10.1007/s11274-015-1910-6; Raghuwanshi S, 2014, FUEL, V124, P183, DOI 10.1016/j.fuel.2014.01.107; Rajeshkumar KC, 2016, MYCOL PROG, V15, P1119, DOI 10.1007/s11557-016-1234-4; Ramos AM, 2009, NORMAIS CLIMATOLO A; Redman RS, 2001, NEW PHYTOL, V151, P705, DOI 10.1046/j.0028-646x.2001.00210.x; Reid AM, 2007, INT J ENVIRON AN CH, V87, P125, DOI 10.1080/03067310601071183; Renfrew EC, 2016, CHEMISTRY AND TECHNOLOGY OF SOFT DRINKS AND FRUIT JUICES, 3RD EDITION, P15; Rinnan R, 2005, GLOBAL CHANGE BIOL, V11, P564, DOI 10.1111/j.1365-2486.2005.00933.x; Rodgers K, 2014, TOXICANTS IN FOOD PA, DOI [10.1007/978-1-4471-6500-2, DOI 10.1007/978-1-4471-6500-2]; Rojas EI, 2010, MYCOLOGIA, V102, P1318, DOI 10.3852/09-244; Roncon CM, 2011, PLANTA MED, V77, P236, DOI 10.1055/s-0030-1250315; Rosa L. H., 2012, American Journal of Plant Sciences, V3, P1105, DOI 10.4236/ajps.2012.38133; Rosa LH, 2009, POLAR BIOL, V32, P161, DOI 10.1007/s00300-008-0515-z; Rossman Amy Y., 2007, Mycoscience, V48, P135, DOI 10.1007/s10267-007-0347-7; ROTH B, 1988, EUR J PEDIATR, V147, P41, DOI 10.1007/BF00442609; Rudrappa T, 2007, PLANT SIGNAL BEHAV, V2, P349, DOI 10.4161/psb.2.5.4117; Silva MCSE, 2016, MICROB PATHOGENESIS, V98, P16, DOI 10.1016/j.micpath.2016.06.023; Saucedo-Garcia A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098454; Schimpl FC, 2013, J ETHNOPHARMACOL, V150, P14, DOI 10.1016/j.jep.2013.08.023; Schlegel M, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3369-8; Schroth G, 2000, AGROFOREST SYST, V50, P199, DOI 10.1023/A:1006468103914; Schulz B, 2005, MYCOL RES, V109, P661, DOI 10.1017/S095375620500273X; Schwarz M, 2004, PHYTOCHEMISTRY, V65, P2239, DOI 10.1016/j.phytochem.2004.06.035; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Sebastianes FLS, 2012, CURR MICROBIOL, V65, P622, DOI 10.1007/s00284-012-0206-4; Setala H, 2004, OECOLOGIA, V139, P98, DOI 10.1007/s00442-003-1478-y; Shannon C, 2009, A MATHEMATICAL THEOR, DOI [10.1109/9780470544242.ch1, DOI 10.1109/9780470544242.CH1]; Shearer JF, 2010, WEED TECHNOL, V24, P202, DOI 10.1614/WT-D-09-00001.1; Sia ED, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-579; SIEBER TN, 1989, MYCOL RES, V92, P322, DOI 10.1016/S0953-7562(89)80073-5; SIERRA GONZALO, 1957, ANTONIE VAN LEEUWENHOEK JOUR MICROBIOL AND SEROL, V23, P15; Silva HSA, 2012, BIOL CONTROL, V63, P62, DOI 10.1016/j.biocontrol.2012.06.005; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Smetanina OF, 2004, RUSS CHEM B+, V53, P2643, DOI 10.1007/s11172-005-0167-x; Soares MA, 2016, MICROB ECOL, V72, P407, DOI 10.1007/s00248-016-0793-x; Soares MA, 2016, PLANT SOIL, V405, P107, DOI 10.1007/s11104-015-2638-7; Soares MA, 2016, BIOL INVASIONS, V18, P2689, DOI 10.1007/s10530-016-1160-z; Soares MA, 2014, EUR J PLANT PATHOL, V140, P769, DOI 10.1007/s10658-014-0508-4; Speit G, 2016, MUTAT RES-GEN TOX EN, V803, P22, DOI 10.1016/j.mrgentox.2016.05.001; Stevens KJ, 2010, AQUAT BOT, V92, P105, DOI 10.1016/j.aquabot.2009.10.013; Su MY, 2015, BIOTECHNOL LETT, V37, P717, DOI 10.1007/s10529-014-1730-z; Syed A, 2013, SPECTROCHIM ACTA A, V106, P41, DOI 10.1016/j.saa.2013.01.002; Tan RX, 2001, NAT PROD REP, V18, P448, DOI 10.1039/b100918o; Tayung K, 2011, MYCOSPHERE, V2, P203; Tchameni SN, 2011, CROP PROT, V30, P1321, DOI 10.1016/j.cropro.2011.05.003; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; Tickner JA, 2001, AM J IND MED, V39, P100, DOI 10.1002/1097-0274(200101)39:1<100::AID-AJIM10>3.3.CO;2-H; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; U'Ren JM, 2012, AM J BOT, V99, P898, DOI 10.3732/ajb.1100459; Udayanga D, 2011, FUNGAL DIVERS, V50, P189, DOI 10.1007/s13225-011-0126-9; UECKER FA, 1991, MYCOLOGIA, V83, P192, DOI 10.2307/3759934; Uzor PF, 2017, DRUG RES, V67, P308, DOI 10.1055/s-0042-122777; VAJNA L, 1985, PHYTOPATHOL Z, V114, P338; Varma A, 1998, MYCORRHIZA MANUAL, P541, DOI [10.1007/978-3-642-60268-9, DOI 10.1007/978-3-642-60268-9]; Vaz ABM, 2012, APPL SOIL ECOL, V61, P288, DOI 10.1016/j.apsoil.2011.10.017; Vega FE, 2005, J BASIC MICROB, V45, P371, DOI 10.1002/jobm.200410551; Vega FE, 2008, BIOL CONTROL, V46, P72, DOI 10.1016/j.biocontrol.2008.01.008; Vega FE, 2010, FUNGAL ECOL, V3, P122, DOI [10.1016/j.funeco.2009.05.001, 10.1016/j.funeco.2009.07.002]; Vidal S, 2015, CURR SCI INDIA, V109, P46; Vieira MLA, 2012, CAN J MICROBIOL, V58, P54, DOI [10.1139/w11-105, 10.1139/W11-105]; Viterbo A, 2004, FEMS MICROBIOL LETT, V238, P151, DOI 10.1016/j.femsle.2004.07.028; [Wang Jie 王洁], 2015, [微生物学通报, Microbiology China], V42, P238; Wang LW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01251; Wani ZA, 2015, APPL MICROBIOL BIOT, V99, P2955, DOI 10.1007/s00253-015-6487-3; Wearn JA, 2012, J ECOL, V100, P1085, DOI 10.1111/j.1365-2745.2012.01997.x; Wellensiek Brian P, 2013, Open Virol J, V7, P72, DOI 10.2174/1874357920130624002; West ER, 2010, CAN J MICROBIOL, V56, P209, DOI [10.1139/w10-004, 10.1139/W10-004]; WHITE JF, 1987, PLANT DIS, V71, P340, DOI 10.1094/PD-71-0340; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WOOD TM, 1971, BIOCHEM J, V121, P353, DOI 10.1042/bj1210353; Wu LS, 2013, CURR MICROBIOL, V66, P40, DOI 10.1007/s00284-012-0235-z; Xu JX, 2015, BIORESOURCE TECHNOL, V181, P18, DOI 10.1016/j.biortech.2014.12.080; Yamaguti-Sasaki E, 2007, MOLECULES, V12, P1950, DOI 10.3390/12081950; Yang CA, 2011, FEBS J, V278, P3381, DOI 10.1111/j.1742-4658.2011.08262.x; Yang ZY, 2014, ACTA HORTIC, V1029, P301, DOI 10.17660/ActaHortic.2014.1029.37; Yeo TC, 2014, COMB CHEM HIGH T SCR, V17, P192, DOI 10.2174/1386207317666140109114553; Yin JY, 2012, ACTA HORTIC, V950, P293; Zabalgogeazcoa I, 2008, SPAN J AGRIC RES, V6, P138, DOI 10.5424/sjar/200806S1-382; Zeidan-Chulia F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/791795; Zereini F, 2011, URBAN AIRBORNE PARTI, DOI [10.1007/978-3-642-12278-1, DOI 10.1007/978-3-642-12278-1]; Zhang GJ, 2011, PHYTOCHEMISTRY, V72, P1436, DOI 10.1016/j.phytochem.2011.04.014; Zhang RY, 2015, CHEM REV, V115, P3803, DOI 10.1021/acs.chemrev.5b00067; Zhao Y, 2005, EUR J SOIL BIOL, V41, P21, DOI 10.1016/j.ejsobi.2005.03.002; Zheng P, 2006, PROCESS BIOCHEM, V41, P2160, DOI 10.1016/j.procbio.2006.06.012; Zolfaghari M, 2014, ENVIRON POLLUT, V194, P281, DOI 10.1016/j.envpol.2014.07.014	261	30	31	7	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195874	10.1371/journal.pone.0195874	http://dx.doi.org/10.1371/journal.pone.0195874			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649297	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900100
J	Beekman, C; Janson, AA; Baghat, A; van Deutekom, JC; Datson, NA				Beekman, Chantal; Janson, Anneke A.; Baghat, Aabed; van Deutekom, Judith C.; Datson, Nicole A.			Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy	PLOS ONE			English	Article							MOLECULAR-BASIS; MUTATIONS; SEVERITY; PROTEINS; DELETION; GENE	Duchenne muscular dystrophy (DMD) is a neuromuscular disease characterized by progressive weakness of the skeletal and cardiac muscles. This X-linked disorder is caused by open reading frame disrupting mutations in the DMD gene, resulting in strong reduction or complete absence of dystrophin protein. In order to use dystrophin as a supportive or even surrogate biomarker in clinical studies on investigational drugs aiming at correcting the primary cause of the disease, the ability to reliably quantify dystrophin expression in muscle biopsies of DMD patients pre- and post-treatment is essential. Here we demonstrate the application of the ProteinSimple capillary immunoassay (Wes) method, a gel-and blot-free method requiring less sample, antibody and time to run than conventional Western blot assay. We optimized dystrophin quantification by Wes using 2 different antibodies and found it to be highly sensitive, reproducible and quantitative over a large dynamic range. Using a healthy control muscle sample as a reference and a-actinin as a protein loading/muscle content control, a panel of skeletal muscle samples consisting of 31 healthy controls, 25 Becker Muscle dystrophy (BMD) and 17 DMD samples was subjected to Wes analysis. In healthy controls dystrophin levels varied 3 to 5-fold between the highest and lowest muscle samples, with the reference sample representing the average of all 31 samples. In BMD muscle samples dystrophin levels ranged from 10% to 90%, with an average of 33% of the healthy muscle average, while for the DMD samples the average dystrophin level was 1.3%, ranging from 0.7% to 7% of the healthy muscle average. In conclusion, Wes is a suitable, efficient and reliable method for quantification of dystrophin expression as a biomarker in DMD clinical drug development.	[Beekman, Chantal; Janson, Anneke A.; Baghat, Aabed; van Deutekom, Judith C.; Datson, Nicole A.] BioMarin Nederland BV, Leiden, Netherlands		Datson, NA (corresponding author), BioMarin Nederland BV, Leiden, Netherlands.	nicole.datson@bmm.com	Datson, Nicole A./O-8797-2014	Datson, Nicole/0000-0003-2887-0238				Abbs Stephen, 2010, Neuromuscul Disord, V20, P422, DOI 10.1016/j.nmd.2010.04.005; Allen DG, 2016, PHYSIOL REV, V96, P253, DOI 10.1152/physrev.00007.2015; Anthony K, 2014, NEUROLOGY, V83, P2062, DOI 10.1212/WNL.0000000000001025; Anthony K, 2011, BRAIN, V134, P3544, DOI 10.1093/brain/awr291; Arechavala-Gomeza V, 2010, NEUROMUSCULAR DISORD, V20, P295, DOI 10.1016/j.nmd.2010.03.007; Beekman C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107494; BEGGS AH, 1991, AM J HUM GENET, V49, P54; Brown K, 2013, J INTERV STATEBUILD, V7, P492, DOI 10.1080/17502977.2012.727539; BYERS TJ, 1991, J CELL BIOL, V115, P411, DOI 10.1083/jcb.115.2.411; Carr S, 2017, PROTEOMICS CLIN APPL; Chen JQ, 2013, ANAL BIOCHEM, V442, P97, DOI 10.1016/j.ab.2013.07.022; Cirak S, 2011, LANCET, V378, P595, DOI 10.1016/S0140-6736(11)60756-3; COMI GP, 1994, BRAIN, V117, P1, DOI 10.1093/brain/117.1.1-a; Doriguzzi C, 1997, EUR J CLIN INVEST, V27, P352, DOI 10.1046/j.1365-2362.1997.1090650.x; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; ENGLAND SB, 1990, NATURE, V343, P180, DOI 10.1038/343180a0; Fung P.A., 2011, NAT METHODS, V8; Gautel M, 2011, CURR OPIN CELL BIOL, V23, P39, DOI 10.1016/j.ceb.2010.12.001; HOKIM MA, 1992, FEBS LETT, V304, P187, DOI 10.1016/0014-5793(92)80615-N; Hulsker Margriet, 2016, J Neuromuscul Dis, V3, P77; Kaspar RW, 2009, CIRC-CARDIOVASC GENE, V2, P544, DOI 10.1161/CIRCGENETICS.109.867242; KOENIG M, 1989, AM J HUM GENET, V45, P498; Lapidos KA, 2004, CIRC RES, V94, P1023, DOI 10.1161/01.RES.0000126574.61061.25; McCourt JL, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0040-z; MIYATAKE M, 1989, J NEUROL SCI, V93, P11, DOI 10.1016/0022-510X(89)90157-3; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Ryder S, 2017, ORPHANET J RARE DIS, V12, DOI 10.1186/s13023-017-0631-3; Taylor LE, 2012, NEUROPATH APPL NEURO, V38, P591, DOI 10.1111/j.1365-2990.2012.01250.x; van den Bergen JC, 2014, J NEUROL NEUROSUR PS, V85, P747, DOI 10.1136/jnnp-2013-306350	30	49	50	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195850	10.1371/journal.pone.0195850	http://dx.doi.org/10.1371/journal.pone.0195850			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641567	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900095
J	Frohlich, L; Plontke, SK; Rahne, T				Froehlich, Laura; Plontke, Stefan K.; Rahne, Torsten			Influence of transducer types on bone conduction hearing thresholds	PLOS ONE			English	Article							ACOUSTIC RADIATION; VIBRATORS	Objective Different types of bone conduction transducers with different physical and electro-acoustic properties are available for audiometric hearing threshold measurements. The reference equivalent threshold vibratory force levels (RETVFL) specified in ISO 389-3 are based on measurements conducted with the B71 and KH70 transducers but apply to all types of transducers available for bone conduction audiometry. The objective of this study was to compare bone conduction hearing thresholds measured by different transducers. Design In a prospective study the hearing thresholds were measured psychometrically between 125 Hz and 8000 Hz using the Radioear B71, B81 and Pracitronic KH70 transducers. Study sample Twenty-one normal hearing participants and fifteen hearing impaired participants. Results In both groups significant differences were found between the thresholds measured with the different transducers at the low frequencies 125 Hz and 250 Hz and the high frequencies 3000 Hz, 4000 Hz, 6000 Hz and 8000 Hz. In the normal hearing group, deviations from the reference threshold 0 dB HL towards lower thresholds were observed for the B71 and B81 at 125 Hz and at the high frequencies 3000 Hz, 4000 Hz, 6000 Hz and 8000 Hz. Conclusions RETVFL-values should be reassessed and provided specifically for the different transducers.	[Froehlich, Laura; Plontke, Stefan K.; Rahne, Torsten] Martin Luther Univ Halle Wittenberg, Dept Otorhinolaryngol Head & Neck Surg, Univ Hosp Halle Saale, Halle, Germany	Martin Luther University Halle Wittenberg	Frohlich, L (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Otorhinolaryngol Head & Neck Surg, Univ Hosp Halle Saale, Halle, Germany.	laura.froehlich@uk-halle.de	Rahne, Torsten/AAD-1369-2021					Brinkmann K, 1983, AUDIOLOGICAL ACOUSTI, P114; DIRKS DD, 1979, J SPEECH HEAR DISORD, V44, P143, DOI 10.1044/jshd.4402.143; Eichenauer A, 2014, J ACOUST SOC AM, V136, pEL96, DOI 10.1121/1.4885771; Fagelson M, 1994, J Am Acad Audiol, V5, P379; FRANK T, 1986, EAR HEARING, V7, P344, DOI 10.1097/00003446-198610000-00010; FRANK T, 1981, EAR HEARING, V2, P59, DOI 10.1097/00003446-198103000-00001; FRANK T, 1988, J SPEECH HEAR DISORD, V53, P295, DOI 10.1044/jshd.5303.295; Harkrider A W, 1998, J Am Acad Audiol, V9, P410; IEC, 2001, EL AUD EQ 1; ISO, 2016, 3893 ISO; ISO, 2011, 82531 ISO; Jansson KJF, 2015, INT J AUDIOL, V54, P334, DOI 10.3109/14992027.2014.980521; Margolis RH, 2016, EAR HEARING, V37, P177, DOI 10.1097/AUD.0000000000000246; RICHTER U, 1981, SCAND AUDIOL, V10, P235, DOI 10.3109/01050398109076186; Richter U., 1992, KENNDATEN SCHALLWAND; ROBINSON DW, 1982, AUDIOLOGY, V21, P61; Sauer U, 1976, VERKEHRSMEDIZIN, P143; Shipton M S, 1980, Br J Audiol, V14, P86, DOI 10.3109/03005368009078908; STUDEBAKER GA, 1967, J SPEECH HEAR DISORD, V32, P82, DOI 10.1044/jshd.3201.82	19	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195233	10.1371/journal.pone.0195233	http://dx.doi.org/10.1371/journal.pone.0195233			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641550	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900062
J	Gentile, D; Fornai, M; Colucci, R; Pellegrini, C; Tirotta, E; Benvenuti, L; Segnani, C; Ippolito, C; Duranti, E; Virdis, A; Carpi, S; Nieri, P; Nemeth, ZH; Pistelli, L; Bernardini, N; Blandizzi, C; Antonioli, L				Gentile, Daniela; Fornai, Matteo; Colucci, Rocchina; Pellegrini, Carolina; Tirotta, Erika; Benvenuti, Laura; Segnani, Cristina; Ippolito, Chiara; Duranti, Emiliano; Virdis, Agostino; Carpi, Sara; Nieri, Paola; Nemeth, Zoltan H.; Pistelli, Laura; Bernardini, Nunzia; Blandizzi, Corrado; Antonioli, Luca			The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity	PLOS ONE			English	Article							MOUSE MODEL; NEUROMUSCULAR-TRANSMISSION; OXIDATIVE STRESS; BOWEL-DISEASE; INHIBITION; COLITIS	Background and purpose Apigenin can exert beneficial actions in the prevention of obesity. However, its putative action on obesity-associated bowel motor dysfunctions is unknown. This study examined the effects of apigenin on colonic inflammatory and motor abnormalities in a mouse model of diet-induced obesity. Experimental approach Male C57BL/6J mice were fed with standard diet (SD) or high-fat diet (HFD). SD or HFD mice were treated with apigenin (10 mg/Kg/day). After 8 weeks, body and epididymal fat weight, as well as cholesterol, triglycerides and glucose levels were evaluated. Malondialdehyde (MDA), IL-1 beta and IL-6 levels, and let-7f expression were also examined. Colonic infiltration by eosinophils, as well as substance P (SP) and inducible nitric oxide synthase (iNOS) expressions were evaluated. Motor responses elicited under blockade of NOS and tachykininergic contractions were recorded in vitro from colonic longitudinal muscle preparations. Key results When compared to SD mice, HFD animals displayed increased body weight, epididymal fat weight and metabolic indexes. HFD mice showed increments in colonic MDA, IL-1 beta and IL-6 levels, as well as a decrease in let-7f expression in both colonic and epididymal tissues. HFD mice displayed an increase in colonic eosinophil infiltration. Immunohistochemistry revealed an increase in SP and iNOS expression in myenteric ganglia of HFD mice. In preparations from HFD mice, electrically evoked contractions upon NOS blockade or mediated by tachykininergic stimulation were enhanced. In HFD mice, Apigenin counteracted the increase in body and epididymal fat weight, as well as the alterations of metabolic indexes. Apigenin reduced also MDA, IL-1 beta and IL-6 colonic levels as well as eosinophil infiltration, SP and iNOS expression, along with a normalization of electrically evoked tachykininergic and nitrergic contractions. In addition, apigenin normalized let-7f expression in epididymal fat tissues, but not in colonic specimens. Conclusions and implications Apigenin prevents systemic metabolic alterations, counteracts enteric inflammation and normalizes colonic dysmotility associated with obesity.	[Gentile, Daniela; Fornai, Matteo; Pellegrini, Carolina; Tirotta, Erika; Benvenuti, Laura; Segnani, Cristina; Ippolito, Chiara; Duranti, Emiliano; Virdis, Agostino; Bernardini, Nunzia; Blandizzi, Corrado; Antonioli, Luca] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Colucci, Rocchina] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Carpi, Sara; Nieri, Paola] Univ Pisa, Dept Pharm, Pisa, Italy; [Nieri, Paola; Pistelli, Laura; Bernardini, Nunzia] Univ Pisa, Interdept Res Ctr Nutraceut & Food Hlth, Pisa, Italy; [Nemeth, Zoltan H.] Morristown Med Ctr, Dept Surg, Morristown, NJ USA; [Pistelli, Laura] Univ Pisa, DAFE, Pisa, Italy	University of Pisa; University of Padua; University of Pisa; University of Pisa; Atlantic Health System; University of Pisa	Fornai, M (corresponding author), Univ Pisa, Dept Clin & Expt Med, Pisa, Italy.	mfornai74@gmail.com	Nieri, Paola/K-5814-2016; Bernardini, Nunzia/AAC-4602-2021; Pistelli, Laura/H-3070-2011; Blandizzi, Corrado/AAB-8736-2019; Virdis, Agostino/K-5315-2016; carpi, sara/AAG-7683-2021; Pellegrini, Carolina/ABE-3462-2021	Pistelli, Laura/0000-0002-3943-2797; Pellegrini, Carolina/0000-0003-2644-5430; FORNAI, MATTEO/0000-0002-0812-3959; BERNARDINI, NUNZIA/0000-0001-9061-9402; COLUCCI, ROCCHINA LUCIA/0000-0002-2593-5457; Benvenuti, Laura/0000-0001-6576-5053; BLANDIZZI, CORRADO/0000-0001-9927-5386	University of Pisa [PRA_2016_20]	University of Pisa	The present research program has been supported by the PRA_2016_20 granted by the University of Pisa (CB).	Al Mushref M, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.11.01; Anitha M, 2016, CELL MOL GASTROENTER, V2, P328, DOI 10.1016/j.jcmgh.2015.12.008; Antonioli L, 2007, J PHARMACOL EXP THER, V322, P435, DOI 10.1124/jpet.107.122762; Antonioli L, 2017, PURINERG SIGNAL, V13, P497, DOI 10.1007/s11302-017-9577-0; Babu PVA, 2013, J NUTR BIOCHEM, V24, P1777, DOI 10.1016/j.jnutbio.2013.06.003; Bhattarai Y, 2016, AM J PHYSIOL-GASTR L, V311, pG210, DOI 10.1152/ajpgi.00085.2016; Bondia-Pons I, 2012, J PHYSIOL BIOCHEM, V68, P701, DOI 10.1007/s13105-012-0154-2; Bouchoucha M, 2015, OBES SURG, V25, P2143, DOI 10.1007/s11695-015-1679-6; Bumke-Vogt C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104321; Chandrasekharan B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003304; Chapman CG, 2015, THER ADV GASTROENTER, V8, P4, DOI 10.1177/1756283X14547360; Chinetti-Gbaguidi G, 2011, CURR OPIN LIPIDOL, V22, P365, DOI 10.1097/MOL.0b013e32834a77b4; Choi JS, 2014, FOOD CHEM TOXICOL, V64, P27, DOI 10.1016/j.fct.2013.11.020; Choi M. S., 2016, NUTRIENTS, V8; Clere Nicolas, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P62; Deiuliis JA, 2016, INT J OBESITY, V40, P88, DOI 10.1038/ijo.2015.170; Della Vedova MC, 2016, NUTR METAB INSIGHTS, V9, P93, DOI 10.4137/NMI.S32907; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139; Feng XJ, 2016, EBIOMEDICINE, V9, P61, DOI 10.1016/j.ebiom.2016.06.017; Fornai M, 2014, BRIT J PHARMACOL, V171, P3728, DOI 10.1111/bph.12733; Gonzalez R, 2011, CRIT REV FOOD SCI, V51, P331, DOI 10.1080/10408390903584094; Ho Wayne, 2008, Gastroenterol Hepatol (N Y), V4, P572; Hossain MK, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040569; Ippolito C, 2015, J CELL MOL MED, V19, P485, DOI 10.1111/jcmm.12428; Kang X, 2016, CLIN SCI, V130, P1257, DOI 10.1042/CS20160192; Khan WI, 2006, CLIN EXP IMMUNOL, V143, P389, DOI 10.1111/j.1365-2249.2005.02979.x; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kim MA, 2014, LIFE SCI, V101, P64, DOI 10.1016/j.lfs.2014.02.012; Kolbus D, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-58; Laurila A, 2001, ARTERIOSCL THROM VAS, V21, P991, DOI 10.1161/01.ATV.21.6.991; Le Pluart D, 2015, ALIMENT PHARM THER, V41, P758, DOI 10.1111/apt.13143; Lee J, 2015, SCI REP-UK, V5, DOI 10.1038/srep18174; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Moya-Perez A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126976; Myoung HJ, 2010, ARCH PHARM RES, V33, P1741, DOI 10.1007/s12272-010-1105-5; Neunlist M, 2003, GUT, V52, P84, DOI 10.1136/gut.52.1.84; Olivo-Marston SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094765; Ono M, 2011, J AGR FOOD CHEM, V59, P13346, DOI 10.1021/jf203490a; Patel D, 2007, INT J ONCOL, V30, P233; Pellegrini C, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0608-5; Pendyala S, 2011, AM J CLIN NUTR, V93, P234, DOI 10.3945/ajcn.110.002683; Raybould HE, 2012, J PHYSIOL-LONDON, V590, P441, DOI 10.1113/jphysiol.2011.222133; Ridha M, 2015, HYPERTENSION, V65, P949, DOI 10.1161/HYPERTENSIONAHA.114.04926; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Savini I, 2013, INT J MOL SCI, V14, P10497, DOI 10.3390/ijms140510497; Shang HX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154373; Soares A, 2015, BMC GASTROENTEROL, V15, DOI 10.1186/s12876-015-0228-z; Stenman LK, 2012, WORLD J GASTROENTERO, V18, P923, DOI 10.3748/wjg.v18.i9.923; Sung TS, 2006, J VET SCI, V7, P143, DOI 10.4142/jvs.2006.7.2.143; ter Beek WP, 2007, NEUROPEPTIDES, V41, P301, DOI 10.1016/j.npep.2007.05.002; Van Crombruggen K, 2008, EUR J PHARMACOL, V579, P337, DOI 10.1016/j.ejphar.2007.10.021; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27	54	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195502	10.1371/journal.pone.0195502	http://dx.doi.org/10.1371/journal.pone.0195502			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641549	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900072
J	Li, JR; Zhao, YS; Chang, Y; Yang, SC; Guo, YJ; Ji, ES				Li, Jie-Ru; Zhao, Ya-Shuo; Chang, Yue; Yang, Sheng-Chang; Guo, Ya-Jing; Ji, En-Sheng			Fasudil improves endothelial dysfunction in rats exposed to chronic intermittent hypoxia through RhoA/ROCK/NFATc3 pathway	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; RHO-KINASE; NITRIC-OXIDE; CARDIOVASCULAR-DISEASE; COMBINATION THERAPY; ANGIOTENSIN-II; MECHANISMS; HYPERTENSION; INHIBITION; ISCHEMIA	Endothelial dysfunction is one of the main pathological changes in Obstructive sleep apnoea (OSA). The Rho kinase (ROCK) pathway is associated with endothelial dysfunction. However, the interaction between ROCK and nuclear factor of activated T cells isoform c3 (NFATc3) in the development of this pathological response under chronic intermittent hypoxia (CIH) is unclear. To simulate the OSA model, we established a moderate CIH rat model by administering the fraction of inspired O-2 (FiO(2)) from 21% to 9%, 20 times/h, 8 h/day for 3 weeks. Fasudil (ROCK inhibitor, 8 mg/kg/d, i.p.) was administrated in the rats exposed to CIH for 3 weeks. Our results demonstrated that CIH caused significantly endothelial dysfunction, accompanying with increased ET-1 level, decreased eNOS expression and NO production, which reduced ACh-induced vascular relaxation responses. Moreover, RhoA/ROCK-2/NFATc3 expressions were up-regulated. Fasudil significantly improved CIH induced endothelial dysfunction. Data suggested that the ROCK activation is necessary for endothelial dysfunction during CIH.	[Li, Jie-Ru; Chang, Yue; Yang, Sheng-Chang; Ji, En-Sheng] Hebei Univ Chinese Med, Dept Physiol, Shijiazhuang, Hebei, Peoples R China; [Zhao, Ya-Shuo; Guo, Ya-Jing] Hebei Univ Chinese Med, Sci Res Ctr, Shijiazhuang, Hebei, Peoples R China	Hebei University of Chinese Medicine; Hebei University of Chinese Medicine	Ji, ES (corresponding author), Hebei Univ Chinese Med, Dept Physiol, Shijiazhuang, Hebei, Peoples R China.	jesphy@126.com	Zhao, Yashuo/CAH-2686-2022	Ji, ensheng/0000-0002-5858-7567; Zhao, Yashuo/0000-0002-5793-5574	National Natural Science Foundation of China [30971195, 81170069]; Education Department, Hebei Province [ZD2014043, ZD2014005]; Natural Science Foundation of Hebei Province [C2011206031, C2009001053]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Education Department, Hebei Province; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This work was supported by grants from the National Natural Science Foundation of China (Numbers 30971195 and 81170069), the Education Department, Hebei Province (Number ZD2014043 and ZD2014005) and the Natural Science Foundation of Hebei Province (Numbers C2011206031 and C2009001053) (ESJ).	Cleland SJ, 2000, CLIN SCI, V98, P531, DOI 10.1042/CS20000013; Daskoulidou N, 2015, J MOL MED, V93, P511, DOI 10.1007/s00109-014-1234-2; de Frutos S, 2008, AM J PHYSIOL-HEART C, V294, pH2382, DOI 10.1152/ajpheart.00132.2008; de Frutos S, 2007, J BIOL CHEM, V282, P15081, DOI 10.1074/jbc.M702679200; de Frutos S, 2009, AM J PHYSIOL-LUNG C, V297, pL475, DOI 10.1152/ajplung.00060.2009; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Duchna HW, 2006, WIEN MED WOCHENSCHR, V156, P596, DOI 10.1007/s10354-006-0341-2; Dumitrascu R, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/234631; Duong-Quy S, 2013, PHARMACOL THERAPEUT, V137, P352, DOI 10.1016/j.pharmthera.2012.12.003; Durand MJ, 2010, AM J PHYSIOL-HEART C, V299, pH1024, DOI 10.1152/ajpheart.00328.2010; Durgan DJ, 2015, J CEREBR BLOOD F MET, V35, P402, DOI 10.1038/jcbfm.2014.214; Durgan DJ, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.111.000091; Elias-Al-Mamun M, 2014, CIRC J, V78, P967, DOI 10.1253/circj.CJ-13-1174; Fava C, 2011, SEMIN THROMB HEMOST, V37, P280, DOI 10.1055/s-0031-1273092; Finch J, 2016, CARDIOVASC TOXICOL, V16, P260, DOI 10.1007/s12012-015-9334-y; Gentry PL KS, 2006, J PHARMACOLOGY TOXIC, V1, P19, DOI [10.3923/jpt.2006.19.32, DOI 10.3923/JPT.2006.19.32]; Gkaliagkousi E, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-015-0596-3; Guilluy C, 2010, NAT MED, V16, P183, DOI 10.1038/nm.2079; Guo QH, 2013, CLIN EXP PHARMACOL P, V40, P449, DOI 10.1111/1440-1681.12109; Hadi HAR, 2007, VASC HEALTH RISK MAN, V3, P853; Halcox JPJ, 2009, CIRCULATION, V119, P1005, DOI 10.1161/CIRCULATIONAHA.108.765701; Hartmann S, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00276; Hassona MDH, 2010, AM J PHYSIOL-HEART C, V298, pH2112, DOI 10.1152/ajpheart.00016.2010; Hernandez-Guerra M, 2013, HEPATOLOGY, V57, P1564, DOI 10.1002/hep.26152; Nguyen H, 2013, CARDIOVASC RES, V97, P696, DOI 10.1093/cvr/cvs422; Kanbay A, 2015, ANN THORAC MED, V10, P199, DOI 10.4103/1817-1737.160840; Kohler M, 2010, NAT REV CARDIOL, V7, P677, DOI 10.1038/nrcardio.2010.145; Konukoglu D, 2017, ADV EXP MED BIOL, V956, P511, DOI 10.1007/5584_2016_90; Leguina-Ruzzi A, 2015, METAB SYNDR RELAT D, V13, P373, DOI 10.1089/met.2015.0061; Liu HX, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2916017; Lurie A, 2011, ADV CARDIOL, V46, P1, DOI 10.1159/000327660; Maspero C, 2015, MINERVA STOMATOL, V64, P97; Ohike Y, 2005, CIRC J, V69, P221, DOI 10.1253/circj.69.221; Philippi NR, 2010, RESP PHYSIOL NEUROBI, V170, P157, DOI 10.1016/j.resp.2009.12.003; Pietropaoli N, 2015, SLEEP BREATH, V19, P1431, DOI 10.1007/s11325-015-1157-3; Satoh S, 2012, BIOCHEM BIOPH RES CO, V424, P338, DOI 10.1016/j.bbrc.2012.06.136; Shin HK, 2007, J CEREBR BLOOD F MET, V27, P998, DOI 10.1038/sj.jcbfm.9600406; Smith CJ, 2013, MICROVASC RES, V87, P58, DOI 10.1016/j.mvr.2013.02.005; Soga J, 2011, ARTERIOSCL THROM VAS, V31, P2353, DOI 10.1161/ATVBAHA.111.227892; Sugimoto M, 2007, BIOCHEM BIOPH RES CO, V361, P462, DOI 10.1016/j.bbrc.2007.07.030; Surma M, 2011, FUTUR CARDIOL, V7, P657, DOI [10.2217/fca.11.51, 10.2217/FCA.11.51]; Tahawi Z, 2001, J APPL PHYSIOL, V90, P2007, DOI 10.1152/jappl.2001.90.5.2007; Teramoto S, 2003, SLEEP MED, V4, P403, DOI 10.1016/S1389-9457(03)00102-3; Thapa Amrit, 2015, Med J Armed Forces India, V71, pS369, DOI 10.1016/j.mjafi.2014.07.001; Tsounapi P, 2012, EUR J PHARMACOL, V691, P182, DOI 10.1016/j.ejphar.2012.07.016; Varadharaj S, 2015, RESP PHYSIOL NEUROBI, V207, P40, DOI 10.1016/j.resp.2014.12.012; Wang QM, 2012, VASC MED, V17, P379, DOI 10.1177/1358863X12459790; Wu N, 2014, PHARMAZIE, V69, P704, DOI 10.1692/ph.2014.4562; Yaghi A, 2005, AM J PHYSIOL-LUNG C, V289, pL1061, DOI 10.1152/ajplung.00096.2005; Zamarron C, 2013, PULM MED, V2013, DOI 10.1155/2013/521087; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002; Zhou Q, 2009, CURR PHARM DESIGN, V15, P3108, DOI 10.2174/138161209789057986	52	8	10	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195604	10.1371/journal.pone.0195604	http://dx.doi.org/10.1371/journal.pone.0195604			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641598	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900077
J	Samuelsen, S; Jorgensen, CD; Mellins, ED; Torok, KS; Astakhova, K				Samuelsen, Simone; Jorgensen, Christian Damsgaard; Mellins, Elizabeth D.; Torok, Kathryn S.; Astakhova, Kira			Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens	PLOS ONE			English	Article							LOCKED NUCLEIC-ACIDS; IN-VIVO; DISEASE; APTAMERS; CHILDHOOD	In this study, we developed a series of synthetic oligonucleotides that allowed us to investigate the details on the antigen recognition by autoimmune antibodies in localized scleroderma subjects. Besides dramatically improved analytical specificity of the assay, our data suggests a potential linking for antibodies to DNA to the biological status of disease state in localized scleroderma. Moreover, introducing chemical modifications into short synthetic deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) molecules completely changed the binding titers of corresponding antibodies and their clinical relevance. The strongest observed effect was registered for the localized scleroderma skin damage index (LoSDI) on the IgG antibodies to TC dinucleotide-rich double-stranded antigen (p < 0.001). In addition to providing valuable tools for diagnosis of clinically relevant biomarkers, we believe that this work opens up new opportunities for research on antibodies to nucleic acids in localized scleroderma and other autoimmune diseases.	[Samuelsen, Simone; Astakhova, Kira] Tech Univ Denmark, Dept Chem, Lyngby, Region Hovedsta, Denmark; [Jorgensen, Christian Damsgaard] Univ Southern Denmark, Dept Math & Comp Sci, Odense, Region Syddanma, Denmark; [Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Sch Med, Program Immunol, Stanford, CA 94305 USA; [Torok, Kathryn S.] Univ Pittsburgh, Dept Pediat, Div Rheumatol, Childrens Hosp Pittsburgh, Pittsburgh, PA 15260 USA	Technical University of Denmark; University of Southern Denmark; Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Astakhova, K (corresponding author), Tech Univ Denmark, Dept Chem, Lyngby, Region Hovedsta, Denmark.	kiraas@kemi.dtu.dk	Torok, Kathryn/AAI-5810-2020; Astakhova, Kira/D-1432-2014	Torok, Kathryn/0000-0002-1662-143X; Jorgensen, Christian Damsgaard/0000-0002-8425-8388; Mellins, Elizabeth/0000-0003-2577-139X; Astakhova, Kira/0000-0003-4878-0301	Villum Foundation [13152]	Villum Foundation(Villum Fonden)	This work was supported by the Villum Foundation, grant no. 13152; URL: http://veluxfoundations.dk/en. None of the individuals employed or contracted by the funders played any role in: study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin K, 2017, WORLD J GASTROENTERO, V23, P1345, DOI 10.3748/wjg.v23.i8.1345; [Anonymous], 2021, LANG ENV STAT COMP; Arkachaisri T, 2010, RHEUMATOLOGY, V49, P373, DOI 10.1093/rheumatology/kep361; Arkachaisri T, 2009, J RHEUMATOL, V36, P2819, DOI 10.3899/jrheum.081284; Arkachaisri T, 2008, J RHEUMATOL, V35, P2439, DOI 10.3899/jrheum.080098; Bonat WH, 2016, J R STAT SOC C-APPL, V65, P649, DOI 10.1111/rssc.12145; Cao QH, 2008, DNA CELL BIOL, V27, P91, DOI 10.1089/dna.2007.0633; Careta MF, 2015, AN BRAS DERMATOL, V90, P62, DOI 10.1590/abd1806-4841.20152890; Castro C, 2010, J ALLERGY CLIN IMMUN, V125, pS238, DOI 10.1016/j.jaci.2009.09.041; Chang T-C, 2011, Fluorescent carbazole compounds for cancer diagnosis, Patent No. [EP2319842, 6001657, 6,001,657]; FALANGA V, 1987, ARCH DERMATOL, V123, P350, DOI 10.1001/archderm.123.3.350; FALANGA V, 1986, ANN INTERN MED, V104, P849, DOI 10.7326/0003-4819-104-6-849; Jorgensen B, 2004, SCAND J STAT, V31, P93, DOI 10.1111/j.1467-9469.2004.00375.x; KIKUCHI K, 1994, ARCH DERMATOL, V130, P1269, DOI 10.1001/archderm.130.10.1269; Kumar Y, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-1; Kurzinski K, 2014, ARTHRITIS RHEUM, V66, pS1324; Lakhin AV, 2013, ACTA NATURAE, V5, P34, DOI 10.32607/20758251-2013-5-4-34-43; Leitenberger JJ, 2009, ARCH DERMATOL, V145, P545, DOI 10.1001/archdermatol.2009.79; Nezlin R, 2016, MOL IMMUNOL, V70, P149, DOI 10.1016/j.molimm.2015.12.009; Pavlovic M, 2010, AUTOIMMUN DIS, V2010, DOI 10.4061/2010/462841; Pisetsky DS, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3282; Radice A, 2006, AUTOIMMUNITY, V39, P113, DOI 10.1080/08916930500448422; RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993; Romero-Lopez C, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010032; Samuelsen SV, 2016, SCI REP-UK, V6, DOI 10.1038/srep35827; SATO S, 1994, J AM ACAD DERMATOL, V31, P567, DOI 10.1016/S0190-9622(94)70217-9; Schmidt KS, 2004, NUCLEIC ACIDS RES, V32, P5757, DOI 10.1093/nar/gkh862; Takehara K, 2005, RHEUMATOLOGY, V44, P274, DOI 10.1093/rheumatology/keh487; TAKEHARA K, 1983, ARTHRITIS RHEUM, V26, P612, DOI 10.1002/art.1780260506; Torok KS, 2012, PEDIATR CLIN N AM, V59, P381, DOI 10.1016/j.pcl.2012.03.011; Weibel L, 2011, BRIT J DERMATOL, V165, P1308, DOI 10.1111/j.1365-2133.2011.10600.x; Zar JH., 2010, BIOSTAT ANAL, V5th; Zhou JH, 2017, NAT REV DRUG DISCOV, V16, P181, DOI 10.1038/nrd.2016.199; ZOUALI M, 1986, J CLIN INVEST, V78, P1173, DOI 10.1172/JCI112699; Zulian F, 2005, ARTHRITIS RHEUM-US, V52, P2873, DOI 10.1002/art.21264	37	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195381	10.1371/journal.pone.0195381	http://dx.doi.org/10.1371/journal.pone.0195381			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641558	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900067
J	Kytidou, K; Beekwilder, J; Artola, M; van Meel, E; Wilbers, RHP; Moolenaar, GF; Goosen, N; Ferraz, MJ; Katzy, R; Voskamp, P; Florea, BI; Hokke, CH; Overkleeft, HS; Schots, A; Bosch, D; Pannu, N; Aerts, JMFG				Kytidou, Kassiani; Beekwilder, Jules; Artola, Marta; van Meel, Eline; Wilbers, Ruud H. P.; Moolenaar, Geri F.; Goosen, Nora; Ferraz, Maria J.; Katzy, Rebecca; Voskamp, Patrick; Florea, Bogdan I.; Hokke, Cornelis H.; Overkleeft, Herman S.; Schots, Arjen; Bosch, Dirk; Pannu, Navraj; Aerts, Johannes M. F. G.			Nicotiana benthamiana -galactosidase A1.1 can functionally complement human -galactosidase A deficiency associated with Fabry disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						glycoside hydrolase; plant; human; enzyme inhibitor; glycolipid; fluorescence; protein expression; enzyme purification; enzyme structure; -galactosidase; enzyme-replacement therapy; Fabry disease; glycosphingolipids; Nicotiana benthamiana; homologue; lysosomal storage disorder; recombinant enzyme; glycosphingolipid	HUMAN ALPHA-GALACTOSIDASE; ACTIVITY-BASED PROBES; ENZYME REPLACEMENT THERAPY; GLYCOSYL HYDROLASES; BETA-GLUCOSIDASES; AGALSIDASE-ALPHA; GAUCHER-DISEASE; MELON FRUIT; QUANTIFICATION; PURIFICATION	alpha-Galactosidases (EC 3.2.1.22) are retaining glycosidases that cleave terminal -linked galactose residues from glycoconjugate substrates. -Galactosidases take part in the turnover of cell wall-associated galactomannans in plants and in the lysosomal degradation of glycosphingolipids in animals. Deficiency of human -galactosidase A (-Gal A) causes Fabry disease (FD), a heritable, X-linked lysosomal storage disorder, characterized by accumulation of globotriaosylceramide (Gb3) and globotriaosylsphingosine (lyso-Gb3). Current management of FD involves enzyme-replacement therapy (ERT). An activity-based probe (ABP) covalently labeling the catalytic nucleophile of -Gal A has been previously designed to study -galactosidases for use in FD therapy. Here, we report that this ABP labels proteins in Nicotiana benthamiana leaf extracts, enabling the identification and biochemical characterization of an N. benthamiana -galactosidase we name here A1.1 (gene accession ID GJZM-1660). The transiently overexpressed and purified enzyme was a monomer lacking N-glycans and was active toward 4-methylumbelliferyl--d-galactopyranoside substrate (K-m = 0.17 mm) over a broad pH range. A1.1 structural analysis by X-ray crystallography revealed marked similarities with human -Gal A, even including A1.1's ability to hydrolyze Gb3 and lyso-Gb3, which are not endogenous in plants. Of note, A1.1 uptake into FD fibroblasts reduced the elevated lyso-Gb3 levels in these cells, consistent with A1.1 delivery to lysosomes as revealed by confocal microscopy. The ease of production and the features of A1.1, such as stability over a broad pH range, combined with its capacity to degrade glycosphingolipid substrates, warrant further examination of its value as a potential therapeutic agent for ERT-based FD management.	[Kytidou, Kassiani; van Meel, Eline; Ferraz, Maria J.; Katzy, Rebecca; Aerts, Johannes M. F. G.] Leiden Inst Chem, Dept Med Biochem, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Artola, Marta; Florea, Bogdan I.; Overkleeft, Herman S.] Leiden Inst Chem, Dept Bioorgan Synth, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Voskamp, Patrick; Pannu, Navraj] Leiden Inst Chem, Dept Biophys Struct Chem, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Moolenaar, Geri F.; Goosen, Nora] Leiden Inst Chem, Dept Cloning & Prot Purificat Facil, Einsteinweg 55, NL-2333 CC Leiden, Netherlands; [Beekwilder, Jules; Wilbers, Ruud H. P.; Schots, Arjen; Bosch, Dirk] Wageningen Univ & Res, Plant Sci Grp, Droevendaalsesteeg 1, NL-6708 PB Wageningen, Netherlands; [Hokke, Cornelis H.] Leiden Univ, Med Ctr, Ctr Infect Dis, Dept Parasitol, Albinusdreef 2, NL-2333 ZA Leiden, Netherlands	Leiden University; Leiden University; Leiden University; Leiden University; Wageningen University & Research; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Aerts, JMFG (corresponding author), Leiden Inst Chem, Dept Med Biochem, Einsteinweg 55, NL-2333 CC Leiden, Netherlands.	j.m.f.g.aerts@lic.leidenuniv.nl	Wilbers, Ruud/O-1844-2019; Aerts, Johannes/A-1028-2009; Florea, Bogdan I./AAM-9975-2020; Artola, Marta/AAI-3603-2021; Hokke, Cornelis Hendrik/AAQ-4712-2021; Schots, Arjen/ABF-8014-2020; Beekwilder, Jules/A-6802-2011	Wilbers, Ruud/0000-0003-1149-9268; Aerts, Johannes/0000-0001-8168-2565; Artola, Marta/0000-0002-3051-3902; Hokke, Cornelis Hendrik/0000-0003-3545-7804; Schots, Arjen/0000-0002-6036-7088; Florea, Bogdan Iulius/0000-0001-7114-2266; Katzy, Rebecca Elisabeth/0000-0002-4188-5795; Beekwilder, Jules/0000-0003-3238-4427; Ferraz, Maria Joao/0000-0002-5765-9645	NWO ZonMW [91116025]	NWO ZonMW(Netherlands Organization for Scientific Research (NWO)Netherlands Organization for Health Research and Development)	This work was supported by NWO ZonMW Grant 91116025. The authors declare that they have no conflicts of interest with the contents of this article.	AERTS JMFG, 1986, CLIN CHIM ACTA, V158, P155, DOI 10.1016/0009-8981(86)90231-7; Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Arends M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182379; BISHOP DF, 1988, P NATL ACAD SCI USA, V85, P3903, DOI 10.1073/pnas.85.11.3903; Blom D, 2003, AM J HUM GENET, V72, P23, DOI 10.1086/345309; CARCHON H, 1975, CARBOHYD RES, V41, P175, DOI 10.1016/S0008-6215(00)87017-2; Carmi N, 2003, PLANT J, V33, P97, DOI 10.1046/j.1365-313X.2003.01609.x; Chandrasekar B, 2014, MOL CELL PROTEOMICS, V13, P2787, DOI 10.1074/mcp.O114.041616; Chien SF, 2008, PLANT MOL BIOL REP, V26, P213, DOI 10.1007/s11105-008-0035-6; Choi L, 2015, NEUROSCI LETT, V594, P163, DOI 10.1016/j.neulet.2015.01.084; Daldoul S, 2012, ACTA PHYSIOL PLANT, V34, P891, DOI 10.1007/s11738-011-0887-5; Desnick R. J., 1995, METAB MOL BASIS INHE; Eng C, 2007, MOL GENET METAB, V92, pS20, DOI 10.1016/j.ymgme.2007.08.044; Ferraz MJ, 2016, FEBS LETT, V590, P716, DOI 10.1002/1873-3468.12104; Ferraz MJ, 2014, BBA-MOL CELL BIOL L, V1841, P811, DOI 10.1016/j.bbalip.2013.11.004; Fujimoto Z, 2003, J BIOL CHEM, V278, P20313, DOI 10.1074/jbc.M302292200; Gao ZF, 1999, PLANT PHYSIOL, V119, P979, DOI 10.1104/pp.119.3.979; Garman SC, 2002, STRUCTURE, V10, P425, DOI 10.1016/S0969-2126(02)00726-8; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Guce AI, 2010, J BIOL CHEM, V285, P3625, DOI 10.1074/jbc.M109.060145; HAIBACH F, 1991, BIOCHEM BIOPH RES CO, V181, P1564, DOI 10.1016/0006-291X(91)92117-3; HAMERS MN, 1977, HUM GENET, V36, P289, DOI 10.1007/BF00446279; HENRISSAT B, 1995, BIOCHEM J, V311, P350, DOI 10.1042/bj3110350; Ioannou YA, 2001, AM J HUM GENET, V68, P14, DOI 10.1086/316953; Jiang JB, 2016, ACS CENTRAL SCI, V2, P351, DOI 10.1021/acscentsci.6b00057; Jiang JB, 2015, CHEM SCI, V6, P2782, DOI 10.1039/c4sc03739a; Kallemeijn WW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170268; Kallemeijn WW, 2014, J BIOL CHEM, V289, P35351, DOI 10.1074/jbc.M114.593376; Kim WD, 2002, PHYTOCHEMISTRY, V61, P621, DOI 10.1016/S0031-9422(02)00368-0; Kizhner T, 2015, MOL GENET METAB, V114, P259, DOI 10.1016/j.ymgme.2014.08.002; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kytidou K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01026; Lenders M, 2016, J AM SOC NEPHROL, V27, P256, DOI 10.1681/ASN.2014121226; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Maranville E, 2000, ARCH BIOCHEM BIOPHYS, V373, P225, DOI 10.1006/abbi.1999.1532; Marques ARA, 2016, J LIPID RES, V57, P451, DOI 10.1194/jlr.M064923; Marraccini P, 2005, PLANT PHYSIOL BIOCH, V43, P909, DOI 10.1016/j.plaphy.2005.08.010; MATHEW CD, 1987, PHYTOCHEMISTRY, V26, P1299, DOI 10.1016/S0031-9422(00)81798-7; Mirzaian M, 2017, CLIN CHIM ACTA, V466, P178, DOI 10.1016/j.cca.2017.01.014; Mirzaian M, 2016, CLIN CHIM ACTA, V459, P36, DOI 10.1016/j.cca.2016.05.017; Motabar Omid, 2010, Curr Chem Genomics, V4, P67, DOI 10.2174/1875397301004010067; MURALI R, 1994, J MOL BIOL, V239, P578, DOI 10.1006/jmbi.1994.1397; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rezende RM, 2017, SEMIN IMMUNOL, V30, P3, DOI 10.1016/j.smim.2017.07.004; Sakuraba H, 2006, J HUM GENET, V51, P180, DOI 10.1007/s10038-005-0342-9; Sanchez-Nino MD, 2015, HUM MOL GENET, V24, P5720, DOI 10.1093/hmg/ddv291; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Shen JS, 2016, J INHERIT METAB DIS, V39, P293, DOI 10.1007/s10545-015-9886-9; SWEELEY CC, 1963, J BIOL CHEM, V238, P3148; Westerhof LB, 2014, PLANT BIOTECHNOL J, V12, P1333, DOI 10.1111/pbi.12251; Westerhof LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046460; Wilbers RHP, 2017, SCI REP-UK, V7, DOI 10.1038/srep45910; Willems LI, 2014, EUR J ORG CHEM, V2014, P6044, DOI 10.1002/ejoc.201402589; Willems LI, 2014, CHEM-EUR J, V20, P10864, DOI 10.1002/chem.201404014; Willems LI, 2014, J AM CHEM SOC, V136, P11622, DOI 10.1021/ja507040n; Witte MD, 2011, ORG BIOMOL CHEM, V9, P5908, DOI 10.1039/c1ob05531c; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Wu L, 2017, NAT CHEM BIOL, V13, P867, DOI 10.1038/nchembio.2395; Zha HG, 2012, ANN BOT-LONDON, V109, P735, DOI 10.1093/aob/mcr321; ZHU A, 1995, BBA-PROTEIN STRUCT M, V1247, P260, DOI 10.1016/0167-4838(94)00228-9; ZHU A, 1994, GENE, V140, P227, DOI 10.1016/0378-1119(94)90548-7	62	12	13	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 29	2018	293	26					10042	10058		10.1074/jbc.RA118.001774	http://dx.doi.org/10.1074/jbc.RA118.001774			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL4DA	29674318	Green Published, hybrid			2022-12-26	WOS:000437096700010
J	Damasceno, FC; Condeles, AL; Lopes, AKB; Facci, RR; Linares, E; Truzzi, DR; Augusto, O; Toledo, JC				Damasceno, Fernando Cruvinel; Condeles, Andre Luis; Bueno Lopes, Angelica Kodama; Facci, Romulo Rodrigues; Linares, Edlaine; Truzzi, Daniela Ramos; Augusto, Ohara; Toledo, Jose Carlos, Jr.			The labile iron pool attenuates peroxynitrite-dependent damage and can no longer be considered solely a pro-oxidative cellular iron source	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nitric oxide; nitrosative stress; nitrosylation; oxidative stress; superoxide ion; chelatable iron pool; Fenton; hydrogen peroxide; labile iron pool; peroxynitrite	NITRIC-OXIDE; CHELATABLE IRON; HYDROGEN-PEROXIDE; COMPLEX-FORMATION; FERRIC IRON; ISONICOTINOYL HYDRAZONE; MANGANESE PORPHYRINS; SUPEROXIDE-DISMUTASE; MEDIATED OXIDATION; CARBON-DIOXIDE	The ubiquitous cellular labile iron pool (LIP) is often associated with the production of the highly reactive hydroxyl radical, which forms through a redox reaction with hydrogen peroxide. Peroxynitrite is a biologically relevant peroxide produced by the recombination of nitric oxide and superoxide. It is a strong oxidant that may be involved in multiple pathological conditions, but whether and how it interacts with the LIP are unclear. Here, using fluorescence spectroscopy, we investigated the interaction between the LIP and peroxynitrite by monitoring peroxynitrite-dependent accumulation of nitrosated and oxidized fluorescent intracellular indicators. We found that, in murine macrophages, removal of the LIP with membrane-permeable iron chelators sustainably accelerates the peroxynitrite-dependent oxidation and nitrosation of these indicators. These observations could not be reproduced in cell-free assays, indicating that the chelator-enhancing effect on peroxynitrite-dependent modifications of the indicators depended on cell constituents, presumably including LIP, that react with these chelators. Moreover, neither free nor ferrous-complexed chelators stimulated intracellular or extracellular oxidative and nitrosative chemistries. On the basis of these results, LIP appears to be a relevant and competitive cellular target of peroxynitrite or its derived oxidants, and thereby it reduces oxidative processes, an observation that may change the conventional notion that the LIP is simply a cellular source of pro-oxidant iron.	[Damasceno, Fernando Cruvinel; Condeles, Andre Luis; Bueno Lopes, Angelica Kodama; Facci, Romulo Rodrigues; Toledo, Jose Carlos, Jr.] Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil; [Facci, Romulo Rodrigues; Linares, Edlaine; Truzzi, Daniela Ramos; Augusto, Ohara] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-05508000 Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Toledo, JC (corresponding author), Univ Sao Paulo, Fac Filosofia Ciencias & Letras Ribeirao Preto, Dept Quim, BR-14040901 Ribeirao Preto, SP, Brazil.	toledo@ffclrp.usp.br	Damasceno, Fernando Cruvinel/P-7029-2019; Toledo, Jose C/J-4360-2015; Linares, Edlaine/AAR-8753-2020; Truzzi, Daniela R/B-2540-2014; Augusto, Ohara/D-3839-2012	Damasceno, Fernando Cruvinel/0000-0002-3814-2712; Linares, Edlaine/0000-0001-8164-3013; Truzzi, Daniela R/0000-0003-4421-9621; Augusto, Ohara/0000-0002-7220-4286; Toledo Junior, Jose Carlos/0000-0003-0818-0846	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2010/00550-2, 2013/07937-8]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Grants 2010/00550-2 and 2013/07937-8. The authors declare that they have no conflicts of interest with the contents of this article.	Alamdari DH, 2005, FREE RADICAL BIO MED, V39, P1362, DOI 10.1016/j.freeradbiomed.2005.06.023; AUGUSTO O, 1994, ARCH BIOCHEM BIOPHYS, V310, P118, DOI 10.1006/abbi.1994.1147; Balavoine GGA, 1997, NITRIC OXIDE-BIOL CH, V1, P507, DOI 10.1006/niox.1997.0153; Balcerczyk A, 2007, FREE RADICAL RES, V41, P563, DOI 10.1080/10715760601175353; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bonini MG, 2001, J BIOL CHEM, V276, P9749, DOI 10.1074/jbc.M008456200; Bonini MG, 1999, J BIOL CHEM, V274, P10802, DOI 10.1074/jbc.274.16.10802; Breuer W, 1996, FEBS LETT, V382, P304, DOI 10.1016/0014-5793(96)00190-1; Breuer W, 1997, FEBS LETT, V403, P213, DOI 10.1016/S0014-5793(97)00056-2; Briviba K, 1998, CHEM RES TOXICOL, V11, P1398, DOI 10.1021/tx980086y; Buss H, 1997, FREE RADICAL BIO MED, V23, P361, DOI 10.1016/S0891-5849(97)00104-4; Carballal S, 2014, BBA-GEN SUBJECTS, V1840, P768, DOI 10.1016/j.bbagen.2013.07.005; Coddington JW, 1999, J AM CHEM SOC, V121, P2438, DOI 10.1021/ja982887t; Collins HL, 2002, J IMMUNOL, V168, P3458, DOI 10.4049/jimmunol.168.7.3458; Crow JP, 2000, FREE RADICAL BIO MED, V28, P1487, DOI 10.1016/S0891-5849(00)00249-5; Damasceno FC, 2014, FREE RADICAL BIO MED, V77, P270, DOI 10.1016/j.freeradbiomed.2014.09.012; De Domenico I, 2008, NAT REV MOL CELL BIO, V9, P72, DOI 10.1038/nrm2295; DUBOIS JE, 1992, INORG CHEM, V31, P853, DOI 10.1021/ic00031a030; Epsztejn S, 1997, ANAL BIOCHEM, V248, P31, DOI 10.1006/abio.1997.2126; Espey MG, 2002, P NATL ACAD SCI USA, V99, P11127, DOI 10.1073/pnas.152157599; Exner M, 2000, CHEM RES TOXICOL, V13, P287, DOI 10.1021/tx990201k; Feelisch M., 1996, METHODS NITRIC OXIDE, P455; Ferrer-Sueta G, 2002, METHOD ENZYMOL, V349, P23, DOI 10.1016/S0076-6879(02)49318-4; Ferrer-Sueta G, 1999, CHEM RES TOXICOL, V12, P442, DOI 10.1021/tx980245d; Ferrer-Sueta G, 2006, FREE RADICAL BIO MED, V41, P503, DOI 10.1016/j.freeradbiomed.2006.04.028; Fritsche G, 2001, J INFECT DIS, V183, P1388, DOI 10.1086/319860; Furtmuller PG, 2005, BIOCHEM BIOPH RES CO, V337, P944, DOI 10.1016/j.bbrc.2005.09.138; Ganz T, 2015, NAT REV IMMUNOL, V15, P500, DOI 10.1038/nri3863; Gerasimov OV, 1999, INORG CHEM, V38, P4317, DOI 10.1021/ic990384y; Goldstein S, 1997, NITRIC OXIDE-BIOL CH, V1, P417, DOI 10.1006/niox.1997.0142; GOLDSTEIN S, 1995, INORG CHEM, V34, P4041, DOI 10.1021/ic00120a006; HAMED MY, 1983, INORG CHIM A-BIOINOR, V80, P237, DOI 10.1016/S0020-1693(00)91289-1; HAMED MY, 1983, INORG CHIM A-BIOINOR, V78, P1, DOI 10.1016/S0020-1693(00)86480-4; HAMED MY, 1983, INORG CHIM A-BIOINOR, V80, P115, DOI 10.1016/S0020-1693(00)91271-4; Herold S, 2003, CHEM RES TOXICOL, V16, P390, DOI 10.1021/tx025595l; ISCHIROPOULOS H, 1995, FEBS LETT, V364, P279, DOI 10.1016/0014-5793(95)00307-U; Keefer LK, 1996, METHOD ENZYMOL, V268, P281; Kissner R, 1997, CHEM RES TOXICOL, V10, P1285, DOI 10.1021/tx970160x; Kojima H, 1998, ANAL CHEM, V70, P2446, DOI 10.1021/ac9801723; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Li Q, 2014, J BIOL CHEM, V289, P19917, DOI 10.1074/jbc.M114.569764; Li Q, 2009, NITRIC OXIDE-BIOL CH, V21, P69, DOI 10.1016/j.niox.2009.04.001; Lobysheva II, 1999, BIOCHEMISTRY-MOSCOW+, V64, P153; Lomonosova EE, 1998, FREE RADICAL BIO MED, V24, P522, DOI 10.1016/S0891-5849(97)00295-5; Lu CY, 2005, J BIOL INORG CHEM, V10, P732, DOI 10.1007/s00775-005-0019-z; LYMAR SV, 1995, J AM CHEM SOC, V117, P8867, DOI 10.1021/ja00139a027; Martins D, 2015, FREE RADICAL BIO MED, V85, P138, DOI 10.1016/j.freeradbiomed.2015.04.010; Masumoto H, 1996, CHEM RES TOXICOL, V9, P262, DOI 10.1021/tx950115u; Masumoto K, 1996, FEBS LETT, V398, P179, DOI 10.1016/S0014-5793(96)01237-9; MCDONALD CC, 1965, J AM CHEM SOC, V87, P3319, DOI 10.1021/ja01093a007; Meczynska S, 2008, HEMOGLOBIN, V32, P157, DOI 10.1080/03630260701699821; OTTOLENGHI M, 1968, J PHYS CHEM-US, V72, P593, DOI 10.1021/j100848a600; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Pantopoulos K., 1995, BIOL NITRIC OXIDE EN, P24; Petrat F, 1999, HEPATOLOGY, V29, P1171, DOI 10.1002/hep.510290435; PONKA P, 1979, BIOCHIM BIOPHYS ACTA, V586, P278, DOI 10.1016/0304-4165(79)90100-4; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P481, DOI 10.1016/0003-9861(91)90224-7; RADI R, 1991, J BIOL CHEM, V266, P4244; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; Sergent O, 1997, HEPATOLOGY, V25, P122, DOI 10.1002/hep.510250123; SHI MM, 1994, J BIOL CHEM, V269, P26512; Shimanovich R, 2001, ARCH BIOCHEM BIOPHYS, V387, P307, DOI 10.1006/abbi.2000.2247; Sikora A, 2009, FREE RADICAL BIO MED, V47, P1401, DOI 10.1016/j.freeradbiomed.2009.08.006; Simunek T, 2005, J MOL CELL CARDIOL, V39, P345, DOI 10.1016/j.yjmcc.2005.05.008; Spasojevic I, 2007, FREE RADICAL BIO MED, V42, P1193, DOI 10.1016/j.freeradbiomed.2007.01.019; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Toledo JC, 2008, J BIOL CHEM, V283, P28926, DOI 10.1074/jbc.M707862200; Toledo JC, 2011, FREE RADICAL BIO MED, V50, P1032, DOI 10.1016/j.freeradbiomed.2011.02.020; Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Zielonka J, 2012, CHEM RES TOXICOL, V25, P1793, DOI 10.1021/tx300164j	72	13	14	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8530	8542		10.1074/jbc.RA117.000883	http://dx.doi.org/10.1074/jbc.RA117.000883			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29661935	Green Published, hybrid			2022-12-26	WOS:000434205700017
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW; Reed, B				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William; Reed, Bruce			The Dyad-Adaptive Paced Auditory Serial Addition Test (DA-PASAT): Normative data and the effects of repeated testing, simulated malingering, and traumatic brain injury	PLOS ONE			English	Article							INFORMATION-PROCESSING CAPACITY; TEST ADJUSTING-PSAT; MINOR HEAD-INJURY; MULTIPLE-SCLEROSIS; NEUROPSYCHOLOGICAL ASSESSMENT; CLINICAL NEUROPSYCHOLOGISTS; COMPUTERIZED MEASURES; COGNITIVE FATIGUE; SPEED DEFICITS; UNITED-STATES	The Paced Auditory Serial Addition Test (PASAT) is widely used to evaluate processing speed and executive function in patients with multiple sclerosis, traumatic brain injury, and other neurological disorders. In the PASAT, subjects listen to sequences of digits while continuously reporting the sum of the last two digits presented. Four different stimulus onset asynchronies (SOAs) are usually tested, with difficulty increasing as SOAs are reduced. Ceiling effects are common at long SOAs, while the digit delivery rate often exceeds the subject's processing capacity at short SOAs, causing some subjects to stop performing altogether. In addition, subjects may adopt an "alternate answer" strategy at short SOAs, which reduces the test's demands on working-memory and processing speed. Consequently, studies have shown that the number of dyads (consecutive correct answers) is a more sensitive measure of PASAT performance than the overall number of correct sums. Here, we describe a 2.5-minute computerized test, the Dyad-Adaptive PASAT (DA-PASAT), where SOAs are adjusted with a 2:1 staircase, decreasing after each pair of correct responses and increasing after misses. Processing capacity is reflected in the minimum SOA (minSOA) achieved in 54 trials. Experiment 1 gathered normative data in two large populations: 1617 subjects in New Zealand ranging in age from 18 to 65 years, and 214 Californians ranging in age from 18 to 82 years. Minimum SOAs were influenced by age, education, and daily hours of computer-use. Minimum SOA z-scores, calculated after factoring out the influence of these factors, were virtually identical in the two control groups, as were response times (RTs) and dyad ratios (the proportion of hits occurring in dyads). Experiment 2 measured the test-retest reliability of the DA-PASAT in 44 young subjects who underwent three test sessions at weekly intervals. High intraclass correlation coefficients (ICCs) were found for minSOAs (0.87), response times (0.76), and dyad ratios (0.87). Performance improved across test sessions for all measures. Experiment 3 investigated the effects of simulated malingering in 50 subjects: 42% of simulated malingerers produced abnormal (p<0.05) minSOA z-scores. Simulated malingerers with abnormal scores were distinguished with 87% sensitivity and 69% specificity from control subjects with abnormal scores by excessive differences between training performance and the actual test. Experiment 4 investigated patients with traumatic brain injury (TBI): patients with mild TBI performed within the normal range while patients with severe TBI showed deficits. The DA-PASAT reduces the time and stress of PASAT assessment while gathering sensitive measures of dyad processing that reveal the effects of aging, malingering, and traumatic brain injury on performance.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.; Reed, Bruce] Univ Calif Davis, Dept Neurol, Sacramento, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA; [Woods, David L.] NeuroBehav Syst Inc, Berkeley, CA 94704 USA; [Reed, Bruce] Alzheimers Dis Ctr, Davis, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.; Woods, DL (corresponding author), Univ Calif Davis, Dept Neurol, Sacramento, CA 95616 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Mind & Brain, Davis, CA 95616 USA.; Woods, DL (corresponding author), NeuroBehav Syst Inc, Berkeley, CA 94704 USA.	dlwoods@ucdavis.edu		Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X; Yund, E./0000-0002-6833-0052	VA Research and Development Grants [CX000583, CX001000]; National Institute of Environmental Health Sciences [R01ES014038]; Neurobehavioral Systems (NBS), Inc.	VA Research and Development Grants; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Neurobehavioral Systems (NBS), Inc.	This research was supported by a VA Research and Development Grants grant CX000583 and CX001000 to DLW and by R01ES014038 from the National Institute of Environmental Health Sciences to Michael Bates. Neurobehavioral Systems (NBS), Inc. provided salary support for authors DLW and JMW, but NBS did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of Department of Veterans Affairs or the U.S. Government.	Amato MP, 2006, MULT SCLER, V12, P787, DOI 10.1177/1352458506070933; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Baird BJ, 2007, APPL NEUROPSYCHOL, V14, P88, DOI 10.1080/09084280701319912; Balzano J, 2006, ARCH CLIN NEUROPSYCH, V21, P819, DOI 10.1016/j.acn.2006.09.002; Bate AJ, 2001, CLIN NEUROPSYCHOL, V15, P405, DOI 10.1076/clin.15.3.405.10279; Beglinger LJ, 2005, ARCH CLIN NEUROPSYCH, V20, P517, DOI 10.1016/j.acn.2004.12.003; Boringa JB, 2001, MULT SCLER, V7, P263, DOI 10.1177/135245850100700409; Brandt J., 1991, CLIN NEUROPSYCHOL, V5, P125, DOI [10.1080/13854049108403297, DOI 10.1080/13854049108403297]; Brenner LA, 2009, MIL MED, V174, P347, DOI 10.7205/MILMED-D-01-5808; Brittain J.L., 1991, CLIN NEUROPSYCHOL, V5, P163, DOI DOI 10.1080/13854049108403300; Bryant D, 2004, REHABIL PSYCHOL, V49, P114, DOI 10.1037/0090-5550.49.2.114; Chronicle EP, 1998, NEUROPSYCHOL REHABIL, V8, P273; Cicerone KD, 2002, CLIN NEUROPSYCHOL, V16, P280, DOI 10.1076/clin.16.3.280.13849; Coo H, 2005, MULT SCLER J, V11, P85, DOI 10.1191/1352458505ms1124oa; Crawford JR, 1998, NEUROPSYCHOL REHABIL, V8, P255, DOI 10.1080/713755575; CRAWFORD JR, 1990, BRIT J CLIN PSYCHOL, V29, P435, DOI 10.1111/j.2044-8260.1990.tb00908.x; Cutter GR, 1999, BRAIN, V122, P871, DOI 10.1093/brain/122.5.871; Diehr MC, 2003, J CLIN EXP NEUROPSYC, V25, P571, DOI 10.1076/jcen.25.4.571.13876; Diehr MC, 1998, ASSESSMENT, V5, P375, DOI 10.1177/107319119800500407; Drake A, 2009, MULTIPLE SCLEROSIS; DYCHE GM, 1991, PERCEPT MOTOR SKILL, V72, P563, DOI 10.2466/PMS.72.2.563-572; Fisher JS, 2001, MULTIPLE SCLEROSIS F; Fisk JD, 2001, J INT NEUROPSYCH SOC, V7, P363, DOI 10.1017/S1355617701733103; Gonzalez R, 2006, ASSESSMENT, V13, P381, DOI 10.1177/1073191106286567; Gonzalez R, 2006, CLIN NEUROPSYCHOL, V20, P396, DOI 10.1080/13854040590967559; GRONWALL D, 1981, J NEUROL NEUROSUR PS, V44, P889, DOI 10.1136/jnnp.44.10.889; GRONWALL D, 1974, LANCET, V2, P605; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; JOHNSON DA, 1988, J CHILD PSYCHOL PSYC, V29, P199, DOI 10.1111/j.1469-7610.1988.tb00704.x; Lapshin H, 2013, MULT SCLER J, V19, P1905, DOI 10.1177/1352458513488841; LEININGER BE, 1990, J NEUROL NEUROSUR PS, V53, P293, DOI 10.1136/jnnp.53.4.293; Levin H. S., 1982, NEUROBEHAVIORAL CONS; LEVIN HS, 1987, J NEUROSURG, V66, P234, DOI 10.3171/jns.1987.66.2.0234; Levitt H., 1971, J ACOUST SOC AM S, V49, DOI [10.1076/jcen.25.4.571.13876, DOI 10.1076/JCEN.25.4.571.13876]; Lopez-Gongora M, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0296-2; Macciocchi SN, 1996, NEUROSURGERY, V39, P510, DOI 10.1097/00006123-199609000-00014; Maddocks D, 1996, BRAIN INJURY, V10, P99, DOI 10.1080/026990596124584; McCaffrey RJ, 2001, ARCH CLIN NEUROPSYCH, V16, P9, DOI 10.1016/S0887-6177(99)00055-4; McNally RJ, 2012, J TRAUMA STRESS, V25, P454, DOI 10.1002/jts.21713; Morrow SA, 2013, CAN J NEUROL SCI, V40, P842, DOI 10.1017/S0317167100015997; Ozakbas S, 2016, CLIN NEUROL NEUROSUR, V140, P97, DOI 10.1016/j.clineuro.2015.11.014; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rabin LA, 2016, ARCH CLIN NEUROPSYCH, V31, P206, DOI 10.1093/arclin/acw007; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; Reed BR, 2014, NEUROTOXICOL TERATOL, V42, P68, DOI 10.1016/j.ntt.2014.02.002; Roman DD, 1991, CLIN NEUROPSYCHOL, V5, P33, DOI DOI 10.1080/13854049108401840; Rosti E, 2006, MULT SCLER J, V12, P586, DOI 10.1177/1352458506070624; Royan J, 2004, ARCH CLIN NEUROPSYCH, V19, P131, DOI 10.1016/S0887-6177(02)00216-0; Sandry J, 2016, J INT NEUROPSYCH SOC, V22, P375, DOI 10.1017/S1355617715001307; Sherman EMS, 1997, CLIN NEUROPSYCHOL, V11, P34, DOI 10.1080/13854049708407027; Snyder PJ, 2001, BRAIN COGNITION, V46, P279, DOI 10.1016/S0278-2626(01)80084-1; Snyder PJ, 2001, NEUROPSYCHOLOGY, V15, P617, DOI 10.1037//0894-4105.15.4.617; Solari A, 2007, MULT SCLER J, V13, P1020, DOI 10.1177/1352458507077619; Sonder JM, 2013, MULT SCLER J; Spikman JM, 1999, J CLIN EXP NEUROPSYC, V21, P585, DOI 10.1076/jcen.21.5.585.874; Spreen O., 1991, PROFILE TEST RESULTS; STRAUSS E, 1994, ARCH CLIN NEUROPSYCH, V9, P483, DOI 10.1016/0887-6177(94)90039-6; Stuss D, 1987, CLIN NEUROPSYCHOL, V1, P139, DOI [10.1080/13854048708520046, DOI 10.1080/13854048708520046]; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P53, DOI 10.1016/j.acn.2005.07.006; Tombaugh TN, 2004, J CLIN EXP NEUROPSYC, V26, P257, DOI 10.1076/jcen.26.2.257.28080; Tombaugh TN, 2006, ARCH CLIN NEUROPSYCH, V21, P753, DOI 10.1016/j.acn.2006.08.009; Cores EV, 2015, APPL NEUROPSYCH-ADUL, V22, P241, DOI 10.1080/23279095.2014.910214; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanotti S, 2016, APPL NEUROPSYCHOL, P1; Walker LAS, 2012, J NEUROL SCI, V316, P86, DOI 10.1016/j.jns.2012.01.021; Webbe FM, 2003, APPL NEUROPSYCHOL, V10, P31, DOI 10.1207/S15324826AN1001_5; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Wiens AN, 1997, J CLIN EXP NEUROPSYC, V19, P473, DOI 10.1080/01688639708403737; Wingenfeld SA, 1999, CLIN NEUROPSYCHOL, V13, P268, DOI 10.1076/clin.13.3.268.1736; Woods DL, 2017, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00654; Woods DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166439; Woods DL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153952; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00690; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00131; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149	86	5	5	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0178148	10.1371/journal.pone.0178148	http://dx.doi.org/10.1371/journal.pone.0178148			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD6SO	29677192	Green Submitted, Green Published, gold			2022-12-26	WOS:000430638900001
J	Wu, HW; Li, J; Li, XY; He, B; Liu, JZ; Jiang, ZY; Zhang, CC				Wu, Huawu; Li, Jing; Li, Xiao-Yan; He, Bin; Liu, Jinzhao; Jiang, Zhiyun; Zhang, Cicheng			Contrasting response of coexisting plant's water-use patterns to experimental precipitation manipulation in an alpine grassland community of Qinghai Lake watershed, China	PLOS ONE			English	Article							SOIL-WATER; SUMMER PRECIPITATION; WINTER DROUGHT; GREAT-BASIN; DEPTH; PLATEAU; ECOSYSTEMS; SYSTEMS; PULSES	Understanding species-specific changes in water-use patterns under recent climate scenarios is necessary to predict accurately the responses of seasonally dry ecosystems to future climate. In this study, we conducted a precipitation manipulation experiment to investigate the changes in water-use patterns of two coexisting species (Achnatherum splendens and Allium tanguticum) to alterations in soil water content (SWC) resulting from increased and decreased rainfall treatments. The results showed that the leaf water potential (Psi) of A. splendens and A. tanguticum responded to changes in shallow and middle SWC at both the control and treatment plots. However, A. splendens proportionally extracted water from the shallow soil layer (0-10cm) when it was available but shifted to absorbing deep soil water (30-60 cm) during drought. By contrast, the A. tanguticum did not differ significantly in uptake depth between treatment and control plots but entirely depended on water from shallow soil layers. The flexible water-use patterns of A. splendens may be a key factor facilitating its dominance and it better acclimates the recent climate change in the alpine grassland community around Qinghai Lake.	[Wu, Huawu; He, Bin] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China; [Wu, Huawu; He, Bin] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China; [Wu, Huawu] Gansu Agr Univ, Minist Educ, Key Lab Grassland Ecosyst, Lanzhou, Gansu, Peoples R China; [Li, Jing; Zhang, Cicheng] Jiujiang Coll, Tourism Sch, Jiujiang, Peoples R China; [Li, Xiao-Yan] Beijing Normal Univ, State Key Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China; [Li, Xiao-Yan] Beijing Normal Univ, Fac Geog Sci, Sch Nat Resources, Beijing, Peoples R China; [Liu, Jinzhao] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Shaanxi, Peoples R China; [Jiang, Zhiyun] South China Normal Univ, Sch Geog, Guangzhou, Guangdong, Peoples R China	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Gansu Agricultural University; Jiujiang University; Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Earth Environment, CAS; South China Normal University	Wu, HW (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China.; Wu, HW (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Nanjing, Jiangsu, Peoples R China.; Wu, HW (corresponding author), Gansu Agr Univ, Minist Educ, Key Lab Grassland Ecosyst, Lanzhou, Gansu, Peoples R China.	wuhuawu416@163.com	Li, Xiao-Yan/K-8544-2012; Zhiyun, Jiang/ABF-3554-2021		National Natural Science Foundation of China [NSFC: 41701036, 91625101, 91425301]; "One-Three-Five" Strategic Planning of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences [2017-Q-02, NIGLAS2017GH07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "One-Three-Five" Strategic Planning of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences	The study was financially supported by the National Natural Science Foundation of China (NSFC: 41701036 to Huawu Wu, 91625101 to to Xiao-Yan Li and 91425301 to to Xiao-Yan Li), and (2017-Q-02), by "One-Three-Five" Strategic Planning of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (Grant No. NIGLAS2017GH07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was financially supported by the National Natural Science Foundation of China (NSFC: 41701036, 91625101 and 91425301), and (2017-Q-02), by "One-Three-Five" Strategic Planning of Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (Grant No. NIGLAS2017GH07). Sincere thanks go to Ph.D. Huiying Chen for collecting field data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Z, 2012, SCI REP-UK, V2, DOI 10.1038/srep00388; Asbjornsen H, 2008, PLANT SOIL, V308, P69, DOI 10.1007/s11104-008-9607-3; Baez S, 2013, OECOLOGIA, V172, P1117, DOI 10.1007/s00442-012-2552-0; Barbeta A, 2015, GLOBAL CHANGE BIOL, V21, P1213, DOI 10.1111/gcb.12785; Beier C, 2012, ECOL LETT, V15, P899, DOI 10.1111/j.1461-0248.2012.01793.x; Chen G, 1993, ACTA BOT BOREALI-OCC, V13, P154; Collins DBG, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR005541; Collins SL, 2012, FUNCT ECOL, V26, P1450, DOI 10.1111/j.1365-2435.2012.01995.x; Craine JM, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00246; DAWSON TE, 1991, NATURE, V350, P335, DOI 10.1038/350335a0; Dawson TE, 1996, OECOLOGIA, V107, P13, DOI 10.1007/BF00582230; DONOVAN LA, 1994, FUNCT ECOL, V8, P289, DOI 10.2307/2389821; Duan DY, 2008, J INTEGR PLANT BIOL, V50, P257, DOI 10.1111/j.1744-7909.2007.00633.x; Eggemeyer KD, 2009, TREE PHYSIOL, V29, P157, DOI 10.1093/treephys/tpn019; Ehleringer JR, 1999, PHYSIOLOGICAL PLANT ECOLOGY, P347; Goedhart CM, 2010, PLANT SOIL, V327, P213, DOI 10.1007/s11104-009-0048-4; Grieu P, 2001, PLANT SOIL, V230, P197, DOI 10.1023/A:1010363532118; Hoekstra NJ, 2014, BIOGEOSCIENCES, V11, P4493, DOI 10.5194/bg-11-4493-2014; Huai H., 2008, FRONT BIOL CHINA, V3, P477, DOI DOI 10.3321/J.ISSN:1000-0933.2007.02.011; Jongen M, 2013, AGR FOREST METEOROL, V171, P163, DOI 10.1016/j.agrformet.2012.11.020; Knapp AK, 2002, SCIENCE, V298, P2202, DOI 10.1126/science.1076347; Knapp AK, 2015, GLOBAL CHANGE BIOL, V21, P2624, DOI 10.1111/gcb.12888; Kray JA, 2012, J ARID ENVIRON, V83, P25, DOI 10.1016/j.jaridenv.2012.03.009; Kulmatiski Andrew, 2013, Oecologia, V171, P25, DOI 10.1007/s00442-012-2390-0; Leng X, 2013, J VEG SCI, V24, P138, DOI 10.1111/j.1654-1103.2012.01439.x; Lin GH, 1996, OECOLOGIA, V106, P8, DOI 10.1007/BF00334402; Nippert JB, 2007, OECOLOGIA, V153, P261, DOI 10.1007/s00442-007-0745-8; Noy-Meir I., 1973, Annual Review of Ecology and Systematics, V4, P25, DOI 10.1146/annurev.es.04.110173.000325; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Prechsl UE, 2015, OECOLOGIA, V177, P97, DOI 10.1007/s00442-014-3092-6; Pugnaire FI, 1996, FUNCT ECOL, V10, P265, DOI 10.2307/2389852; Qin PH, 2016, J GEOPHYS RES-ATMOS, V121, P6802, DOI 10.1002/2016JD024776; Reynolds JF, 2004, OECOLOGIA, V141, P194, DOI 10.1007/s00442-004-1524-4; Schenk HJ, 2008, NEW PHYTOL, V178, P223, DOI 10.1111/j.1469-8137.2008.02427.x; Schwendenmann L, 2015, ECOHYDROLOGY, V8, P1, DOI 10.1002/eco.1479; Schwinning S, 2005, J ARID ENVIRON, V60, P547, DOI 10.1016/j.jaridenv.2004.07.003; Schwinning S, 2005, J ARID ENVIRON, V61, P61, DOI 10.1016/j.jaridenv.2004.07.013; Snyder KA, 2004, OECOLOGIA, V141, P325, DOI 10.1007/s00442-003-1403-4; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sun Y., 2007, ARID METEOROL, V25, P7; Unger S., 2015, PROGR BOT PROGR BOT, V76, P347, DOI [10.1007/978-3-319-08807-5_14, DOI 10.1007/978-3-319-08807-5_14]; [汪青春 Wang Qingchun], 2015, [干旱区研究, Arid Zone Research], V32, P65; West AG, 2006, RAPID COMMUN MASS SP, V20, P1317, DOI 10.1002/rcm.2456; Williams DG, 2000, ECOL MONOGR, V70, P517, DOI 10.1890/0012-9615(2000)070[0517:IAIVFS]2.0.CO;2; Yang HJ, 2011, GLOBAL CHANGE BIOL, V17, P2936, DOI 10.1111/j.1365-2486.2011.02423.x; Yang H, 2011, PLANT SOIL, V340, P303, DOI 10.1007/s11104-010-0307-4; [翟颖佳 Zhai Yingjia], 2016, [高原气象, Plateau Meteorology], V35, P94; Zhou G, 2002, ACTA BOT BOREALI-OCC, V23, P1956; Zhou GuoYing, 2010, Arid Land Geography, V33, P434	49	8	8	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0194242	10.1371/journal.pone.0194242	http://dx.doi.org/10.1371/journal.pone.0194242			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677195	Green Submitted, Green Published, gold			2022-12-26	WOS:000430638900005
J	Campbell, DH; Lund, ME; Nocon, AL; Cozzi, PJ; Frydenberg, M; De Souza, P; Schiller, B; Beebe-Dimmer, JL; Ruterbusch, JJ; Walsh, BJ				Campbell, Douglas H.; Lund, Maria E.; Nocon, Aline L.; Cozzi, Paul J.; Frydenberg, Mark; De Souza, Paul; Schiller, Belinda; Beebe-Dimmer, Jennifer L.; Ruterbusch, Julie J.; Walsh, Bradley J.			Detection of glypican-1 (GPC-1) expression in urine cell sediments in prostate cancer	PLOS ONE			English	Article							CARCINOMA; DIAGNOSIS; PROGNOSIS; CYTOLOGY; ANTIGEN; TRIAL; PCA3	While measurement of serum prostate specific antigen (PSA) is an important screening tool for prostate cancer, new biomarkers are necessary for better discrimination between presence and absence of disease. The MIL-38 monoclonal antibody is specific for the membrane glycoprotein glypican 1 (GPC-1) and binds to prostate cancer tissue. Urine is known to be a source of cellular material. Thus, we hypothesized that detection of GPC-1 in urine cellular material may identify individuals with prostate cancer. Urine samples from patients with prostate cancer, benign prostatic hyperplasia (BPH), or normal controls were collected and cell sediments prepared. GPC-1-positive cells were detected using a MIL-38 immunofluorescence assay (IFA) and samples were classed positive or negative for GPC-1 expressing cells. Assay sensitivity and specificity, stratified by PSA, was reported. A total of 125 patient samples were analyzed (N = 41 prostate cancer; N = 37 BPH; N = 47 normal controls). The use of MIL-38 to detect GPC-1 by IFA discriminated between prostate cancer and BPH urine specimens with a sensitivity and specificity of 71% and 76%, respectively. Assay specificity increased with increasing PSA, with the highest specificity (89%) for patients with PSA >= 4 ng/ml. At lower PSA (<2 ng/ml) specificity decreased, as evidenced by a greater number of false positives in this concentration range. The odds ratio (OR) and 95% confidence intervals (CIs) for GPC-1-positive cells in patients with prostate cancer, adjusted for PSA, was greatest at the lowest serum PSA (<2 ng/ml; OR = 13.4; 95% CI: 4.0-44.7) compared with no adjustment for PSA (OR = 6.4; 95% CI: 2.8-14.9). The use of MIL-38 for detection of GPC-1 may be a useful tool for detection of prostate cancer.	[Campbell, Douglas H.; Lund, Maria E.; Nocon, Aline L.; Schiller, Belinda; Walsh, Bradley J.] Minomic Int Ltd, Sydney, NSW, Australia; [Cozzi, Paul J.] Univ New South Wales, St George & Sutherland Clin Sch, Sydney, NSW, Australia; [Cozzi, Paul J.] St George Hosp, Dept Surg, Sydney, NSW, Australia; [Frydenberg, Mark] Epworth Healthcare, Melbourne, Vic, Australia; [Frydenberg, Mark] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [De Souza, Paul] Liverpool Hosp, Dept Med Oncol, Sydney, NSW, Australia; [De Souza, Paul] Univ Western Sydney, Sch Med, Sydney, NSW, Australia; [Beebe-Dimmer, Jennifer L.; Ruterbusch, Julie J.] Karmanos Canc Inst, Detroit, MI USA; [Beebe-Dimmer, Jennifer L.; Ruterbusch, Julie J.] Wayne State Univ, Sch Med, Dept Oncol, Detroit, MI USA	University of New South Wales Sydney; St George Hospital; Monash University; Liverpool Hospital; Western Sydney University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Walsh, BJ (corresponding author), Minomic Int Ltd, Sydney, NSW, Australia.	brad.walsh@minomic.com	de Souza, Paul/P-5069-2019	Walsh, Brad/0000-0003-3571-4399; Campbell, Douglas/0000-0001-9699-1854	Minomic International Ltd.; NATIONAL CANCER INSTITUTE [P30CA022453] Funding Source: NIH RePORTER	Minomic International Ltd.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded by Minomic International Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bokhorst LP, 2012, BJU INT, V110, P1654, DOI 10.1111/j.1464-410X.2012.11481.x; CATALONA WJ, 1994, J UROLOGY, V151, P1283, DOI 10.1016/S0022-5347(17)35233-3; Fujita K, 2009, HUM PATHOL, V40, P924, DOI 10.1016/j.humpath.2009.01.004; Groskopf J, 2006, CLIN CHEM, V52, P1089, DOI 10.1373/clinchem.2005.063289; Hara H, 2016, BRIT J CANCER, V115, P66, DOI 10.1038/bjc.2016.183; Karakiewicz PI, 2006, BJU INT, V97, P997, DOI 10.1111/j.1464-410X.2006.06036.x; Lin DW, 2013, CLIN CANCER RES, V19, P2442, DOI 10.1158/1078-0432.CCR-12-3283; Loeb S, 2015, J UROLOGY, V193, P1163, DOI 10.1016/j.juro.2014.10.121; Lu HZ, 2017, CANCER MED-US, V6, P1181, DOI 10.1002/cam4.1064; Marks Leonard S, 2008, Rev Urol, V10, P175; Truong M, 2013, J UROLOGY, V189, P422, DOI 10.1016/j.juro.2012.04.143; Nickens KP, 2015, PROSTATE, V75, P969, DOI 10.1002/pros.22981; Pal RP, 2016, BJU INT, V117, P686, DOI 10.1111/bju.13184; Russell PJ, 2004, CANCER IMMUNOL IMMUN, V53, P995, DOI 10.1007/s00262-004-0527-7; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; SHARIFI R, 1983, UROLOGY, V21, P417, DOI 10.1016/0090-4295(83)90170-X; Thompson I, 2007, GUIDELINE MANAGEMENT; Truong Q, 2016, J CANCER, V7, P1002, DOI 10.7150/jca.14645; Yafi FA, 2014, UROL ONCOL-SEMIN ORI, V32, DOI 10.1016/j.urolonc.2012.09.011	19	18	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196017	10.1371/journal.pone.0196017	http://dx.doi.org/10.1371/journal.pone.0196017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672570	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800069
J	Ising, E; Dahlin, LB; Larsson, HE				Ising, Erik; Dahlin, Lars B.; Larsson, Helena Elding			Impaired vibrotactile sense in children and adolescents with type 1 diabetes - Signs of peripheral neuropathy	PLOS ONE			English	Article							CORNEAL CONFOCAL MICROSCOPY; STAGE RENAL-DISEASE; YOUNG-PATIENTS; GLYCEMIC VARIABILITY; PACINIAN CORPUSCLES; NERVE-CONDUCTION; LOW-FREQUENCIES; FOOT; VIBRATION; COMPLICATIONS	Objective To investigate whether multi-frequency vibrometry can identify individuals with elevated vibration perception thresholds (VPTs), reflecting impaired vibrotactile sense, among children and adolescents with type 1 diabetes. Methods In 72 pediatric patients with type 1 diabetes, VPTs were evaluated for seven frequencies on two sites of the hand, and five frequencies on two sites of the foot. Z-scores, based on previously collected reference data, were calculated. Perception to light touch was investigated using monofilaments. Subjects' characteristics were analyzed in comparison to normal and impaired vibrotactile sense. Results Subjects' median age, disease duration and age at disease onset were 12.8, 5.3 and 6.9 years, respectively. A total of 13 out of 72 (18%) subjects had impaired vibrotactile sense on at least one foot site. Impaired vibrotactile sense was more common among subjects treated with multiple daily insulin injections (MDI) compared to subjects treated with continuous subcutaneous insulin infusion (CSII) (p = 0.013). Age at disease onset was higher among subjects with impaired vibrotactile sense (p = 0.046). No significant correlations were found with gender, HbA1c or duration of diabetes. Conclusions Impaired vibrotactile sense, mirroring diabetic peripheral neuropathy, was found in 1/5 of the children and adolescents in the study, and was more common in patients treated with MDI than in subjects treated with CSII.	[Ising, Erik; Larsson, Helena Elding] Lund Univ, Dept Clin Sci Pediat Endocrinol, Malmo, Sweden; [Dahlin, Lars B.] Lund Univ, Dept Translat Med Hand Surg, Malmo, Sweden; [Dahlin, Lars B.] Sickle Univ Hosp, Dept Hand Surg, Malmo, Sweden; [Larsson, Helena Elding] Skane Univ Hosp, Dept Pediat, Malmo, Sweden	Lund University; Lund University; Lund University; Skane University Hospital	Ising, E (corresponding author), Lund Univ, Dept Clin Sci Pediat Endocrinol, Malmo, Sweden.	eric.ising@med.lu.se		Elding Larsson, Helena/0000-0003-3306-1742; Ising, Erik/0000-0002-5116-1635	Lund University; Skane County Council for Research and Development; VINNOVA; Sydvastra Skanes Diabetesforening; Swedish Diabetes Foundation; Swedish Childhood Diabetes Foundation	Lund University; Skane County Council for Research and Development; VINNOVA(Vinnova); Sydvastra Skanes Diabetesforening; Swedish Diabetes Foundation; Swedish Childhood Diabetes Foundation	Grants were received from Lund University and Skane County Council for Research and Development (LD). Funds were received as well from VINNOVA (LD), Sydvastra Skanes Diabetesforening (LD), the Swedish Diabetes Foundation (LD) and the Swedish Childhood Diabetes Foundation (HEL and EI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, DIABETES CARE, V11, P592, DOI 10.2337/diacare.11.7.592; Azmi S, 2015, DIABETES CARE, V38, pE3, DOI 10.2337/dc14-1698; Barkai L, 2000, DIABETES CARE, V23, P1044, DOI 10.2337/diacare.23.7.1044; BELL J, 1994, PROG NEUROBIOL, V42, P79, DOI 10.1016/0301-0082(94)90022-1; Blankenburg M, 2012, DIABETIC MED, V29, P1425, DOI 10.1111/j.1464-5491.2012.03685.x; Bragd J, 2008, DIABETES METAB, V34, P612, DOI 10.1016/j.diabet.2008.04.005; Bruce DG, 2005, DIABETES CARE, V28, P2441, DOI 10.2337/diacare.28.10.2441; Callaghan BC, 2012, COCHRANE DB SYST REV, DOI [DOI 10.1002/14651858.CD007543.pub2, 10.1002/14651858.CD007543.pub2]; Chemnitz A, 2013, J BONE JOINT SURG AM, V95A, P329, DOI 10.2106/JBJS.L.00074; Chemnitz A, 2015, EUR J NEUROSCI, V42, P2022, DOI 10.1111/ejn.12917; Cinar N, 2013, J AM PODIAT MED ASSN, V103, P43, DOI 10.7547/1030043; Currie CJ, 2006, DIABETOLOGIA, V49, P2272, DOI 10.1007/s00125-006-0380-7; Dahlin E, 2013, DIABETES RES CLIN PR, V100, pE46, DOI 10.1016/j.diabres.2013.01.026; Dahlin LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119753; Donaghue KC, 2014, PEDIATR DIABETES, V15, P257, DOI 10.1111/pedi.12180; Finne P, 2005, JAMA-J AM MED ASSOC, V294, P1782, DOI 10.1001/jama.294.14.1782; Gerhardsson L, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/s12995-014-0038-1; Hajas G, 2016, PEDIATR DIABETES, V17, P632, DOI 10.1111/pedi.12382; Hirschfeld G, 2015, DIABETIC MED, V32, P786, DOI 10.1111/dme.12684; Hirschfeld G, 2014, PEDIATRICS, V133, pE1324, DOI 10.1542/peds.2013-3645; JOHANSSON RS, 1983, TRENDS NEUROSCI, V6, P27, DOI 10.1016/0166-2236(83)90011-5; Kerr M, 2014, DIABETIC MED, V31, P1498, DOI 10.1111/dme.12545; Kiziltan ME, 2007, J NEUROL SCI, V258, P75, DOI 10.1016/j.jns.2007.02.028; Louraki M, 2014, PRIM CARE DIABETES, V8, P147, DOI 10.1016/j.pcd.2013.11.002; Louraki M, 2012, DIABETES METAB, V38, P281, DOI 10.1016/j.diabet.2012.02.006; Mollsten A, 2010, DIABETES, V59, P1803, DOI 10.2337/db09-1744; Morbach S, 2004, DIABETIC MED, V21, P91, DOI 10.1046/j.1464-5491.2003.01069.x; Nelander J, 2012, DIABETIC MED, V29, pe449, DOI 10.1111/dme.12024; Nelson D, 2006, PEDIATR DIABETES, V7, P305, DOI 10.1111/j.1399-5448.2006.00208.x; Petropoulos IN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123517; Pop-Busui R, 2017, DIABETES CARE, V40, P136, DOI 10.2337/dc16-2042; SATO M, 1961, J PHYSIOL-LONDON, V159, P391, DOI 10.1113/jphysiol.1961.sp006817; Schaper NC, 2017, DIABETES RES CLIN PR, V124, P84, DOI 10.1016/j.diabres.2016.12.007; Siegelaar SE, 2009, DIABETOLOGIA, V52, P2229, DOI 10.1007/s00125-009-1473-x; Soupal J, 2014, DIABETES TECHNOL THE, V16, P198, DOI 10.1089/dia.2013.0205; Szalai E, 2016, INVEST OPHTH VIS SCI, V57, P853, DOI 10.1167/iovs.15-18735; Tesfaye S, 2010, DIABETES CARE, V33, P2285, DOI 10.2337/dc10-1303; The National Board of Health and Welfare S, 2017, NAT RIKTL DIAB STOD, V116; The National Board of Health and Welfare S, 2015, NAT GUID DIAB CAR SU; Weintrob N, 2007, J DIABETES COMPLICAT, V21, P13, DOI 10.1016/j.jdiacomp.2005.11.002; Zabeen B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153033	41	15	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196243	10.1371/journal.pone.0196243	http://dx.doi.org/10.1371/journal.pone.0196243			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672623	gold, Green Submitted, Green Published			2022-12-26	WOS:000430446800102
J	Jeong, SM; Choi, S; Kim, K; Kim, SM; Lee, G; Son, JS; Yun, JM; Park, SM				Jeong, Su-Min; Choi, Seulggie; Kim, Kyuwoong; Kim, Sung-Min; Lee, Gyeongsil; Son, Joung Sik; Yun, Jae-Moon; Park, Sang Min			Association of change in total cholesterol level with mortality: A population-based study	PLOS ONE			English	Article							SERUM-CHOLESTEROL; CARDIOVASCULAR-DISEASE; LIPID PROFILE; FOLLOW-UP; RISK; PROGRAM; EVENTS; CANCER; INDEX; MEN	Background Hypercholesterolemia is a well-established risk factor for coronary heart disease, but the association between cholesterol level change and mortality is not fully understood. We aimed to investigate the association of 2 year (2002-2003 to 2004-2005) change in cholesterol with all-cause and cause-specific mortality in a population-based cohort study. Methods and findings The study population consisted of 269,391 participants aged more than 40 years who were free of myocardial infarction, stroke and cancer using the Korean National Health Insurance Service-National Health Screening Cohort. Cholesterol levels were classified into 1st, 2nd and 3rd tertiles during each of the first and second health examinations, respectively. The participants were followed-up for all-cause and cause-specific mortality from 1 January 2006 to 31 December 2013. Compared to participants who stayed within the 2nd tertile group for cholesterol during both the first and second examinations, participants who became or maintained cholesterol levels to the 1st tertile during the second examination had increased risk of all-cause mortality [adjusted hazard ratio (aHR) with 95% confidence interval (95% CI) = 1.28 (1.18-1.38) in 1st/1st, 1.16 (1.07-1.26) in 2nd/1st and 1.47 (1.32-1.64) in 3rd/1st tertile levels, respectively]. In addition, increased or persistent high cholesterol levels to the 3rd tertile was associated with elevated risk for all-cause mortality [aHR (95% CI) = 1.10 (1.01-1.20) in 1st/2nd, 1.16(1.03-1.31) in 1st/3rd and 1.15(1.05-1.25) in 3rd/3rd tertile levels]. Conclusions Changes in cholesterol levels in either direction to low cholesterol or persistently low cholesterol levels were associated with higher risk of mortality. Particularly, spontaneous decline in cholesterol levels may be a marker for worsening health conditions.	[Jeong, Su-Min; Son, Joung Sik; Yun, Jae-Moon; Park, Sang Min] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Choi, Seulggie; Kim, Kyuwoong; Kim, Sung-Min; Park, Sang Min] Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea; [Park, Sang Min] Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea; [Lee, Gyeongsil] Chung Ang Univ Hosp, Dept Family Med, Hlth Promot Ctr, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital	Park, SM (corresponding author), Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Dept Biomed Sci, Grad Sch, Seoul, South Korea.; Park, SM (corresponding author), Seoul Natl Univ, Dept Family Med, Coll Med, Seoul, South Korea.	smpark.snuh@gmail.com	Park, Sang Min/V-9194-2019	Lee, Gyeongsil/0000-0003-1910-9658; Park, Sang Min/0000-0002-7498-4829; Son, Joung Sik/0000-0003-2460-3378				ANDERSON KM, 1987, JAMA-J AM MED ASSOC, V257, P2176, DOI 10.1001/jama.257.16.2176; Bae JM, 2012, J KOREAN MED SCI, V27, P58, DOI 10.3346/jkms.2012.27.1.58; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Barnett AG, 2005, INT J EPIDEMIOL, V34, P215, DOI 10.1093/ije/dyh299; Bathum L, 2013, SCAND J PRIM HEALTH, V31, P172, DOI 10.3109/02813432.2013.824157; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; BOOKSTEIN L, 1990, ARCH INTERN MED, V150, P1653, DOI 10.1001/archinte.150.8.1653; Brescianini S, 2003, J AM GERIATR SOC, V51, P991, DOI 10.1046/j.1365-2389.2003.51313.x; Chou R, 2016, JAMA-J AM MED ASSOC, V316, P2008, DOI 10.1001/jama.2015.15629; Collins R, 2016, LANCET, V388, P2532, DOI 10.1016/S0140-6736(16)31357-5; Ghadir MR, 2010, HEPAT MON, V10, P285; Ghasemzadeh Z, 2016, NUTR METAB, V13, DOI 10.1186/s12986-016-0102-1; IRIBARREN C, 1995, CIRCULATION, V92, P2396, DOI 10.1161/01.CIR.92.9.2396; JACOBS D, 1992, CIRCULATION, V86, P1046, DOI 10.1161/01.CIR.86.3.1046; Khan HA, 2013, BIOMARK INSIGHTS, V8, P1, DOI 10.4137/BMI.S11015; Kronmal R A, 1992, Ann Epidemiol, V2, P129, DOI 10.1016/1047-2797(92)90047-T; Lee WC, 2010, J KOREAN MED ASSOC, V53, P363, DOI 10.5124/jkma.2010.53.5.363; Lim DH, 2018, MOD RHEUMATOL, V28, P168, DOI 10.1080/14397595.2017.1325034; Liu YM, 2004, JAMA-J AM MED ASSOC, V291, P451, DOI 10.1001/jama.291.4.451; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Menotti A, 2005, EUR J EPIDEMIOL, V20, P597, DOI 10.1007/s10654-005-7918-8; Nagasawa S, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.001974; Nago N, 2011, J EPIDEMIOL, V21, P67, DOI 10.2188/jea.JE20100065; Newson RS, 2011, J AM GERIATR SOC, V59, P1779, DOI 10.1111/j.1532-5415.2011.03593.x; Noh J, 2016, ENDOCRINOL METAB, V31, P349, DOI 10.3803/EnM.2016.31.3.349; Ravnskov U, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010401; Roh E, 2013, DIABETES METAB J, V37, P433, DOI 10.4093/dmj.2013.37.6.433; Seong SC, 2017, INT J EPIDEMIOL, V46, P799, DOI 10.1093/ije/dyw253; SHERWIN RW, 1987, JAMA-J AM MED ASSOC, V257, P943; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tuikkala P, 2010, SCAND J PRIM HEALTH, V28, P121, DOI 10.3109/02813432.2010.487371; WeverlingRijnsburger AWE, 1997, LANCET, V350, P1119, DOI 10.1016/S0140-6736(97)04430-9	32	20	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196030	10.1371/journal.pone.0196030	http://dx.doi.org/10.1371/journal.pone.0196030			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672595	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800070
J	Lortz, J; Tsagakis, K; Rammos, C; Horacek, M; Schlosser, T; Jakob, H; Rassaf, T; Janosi, RA				Lortz, Julia; Tsagakis, Konstantinos; Rammos, Christos; Horacek, Michael; Schlosser, Thomas; Jakob, Heinz; Rassaf, Tienush; Janosi, Rolf Alexander			Intravascular ultrasound assisted sizing in thoracic endovascular aortic repair improves aortic remodeling in Type B aortic dissection	PLOS ONE			English	Article							ANEURYSM; MANAGEMENT; INJURY; TRIAL; ENTRY	The precise sizing of the stent graft in thoracic endovascular aortic repair (TEVAR) affects aortic remodeling and hence, further outcome. Covering the proximal entry tear is essential for successful treatment of Type B aortic dissection. Intravascular ultrasound (IVUS) enables real-time aortic diameter assessment, and is especially useful when computed tomography (CT) image quality is poor. IVUS, however, is not routinely utilized due to cost inefficiency. We investigated the impact of IVUS-assisted stent graft sizing on aortic remodeling in TEVAR. In this single-center retrospective study we evaluated patients with Type B aortic dissection undergoing both CT and IVUS before TEVAR. We assessed the aortic diameter at the level of the left subclavian artery via both methods before stent implantation and analyzed due to which method the implanted stent graft was chosen, retrospectively. To determine the degrees of aortic remodeling involved, we evaluated true lumen and false lumen diameters, and total aortic remodeling in CT. We analyzed 45 patients with Type B aortic dissection undergoing TEVAR. The mean ages were 66.9 +/- 10.0 years fo0072 IVUS (n = 20) and 62.3 +/- 14.2 years for CT-assisted TEVAR (n = 25; p = 0.226). The follow-up time for both groups did not differ between the two groups (IVUS: 22.9 +/- 23.1 months, CT: 25.6 +/- 23.0 months; p = 0.700). While both methods were associated with advantages regarding aortic remodeling, IVUS-assisted sizing yielded a greater increase in true lumen (30.4 +/- 6.2 vs. 25.6 +/- 5.3; p = 0.008) and reductions in false lumen (14.4 +/- 8.5 vs. 23.9 +/- 9.3; p = 0.001) and total aortic diameter (35.5 +/- 6.0 vs. 39.9 +/- 8.1; p = 0.045). IVUS-guided stent graft sizing in Type B aortic dissection shows beneficial effects on aortic remodeling and might be of additional advantage in aortic diseases, especially when CT image quality is poor.	[Lortz, Julia; Rammos, Christos; Horacek, Michael; Rassaf, Tienush; Janosi, Rolf Alexander] Univ Duisburg Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, Essen, Germany; [Tsagakis, Konstantinos; Jakob, Heinz] Univ Duisburg Essen, West German Heart & Vasc Ctr Essen, Dept Thorac & Cardiovasc Surg, Essen, Germany; [Schlosser, Thomas] Univ Duisburg Essen, Univ Hosp Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Janosi, RA (corresponding author), Univ Duisburg Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, Essen, Germany.	alexander.janosi@uk-essen.de	Janosi, Rolf Alexander/J-7810-2019	Janosi, Rolf Alexander/0000-0002-9966-6886; Lortz, Julia/0000-0002-5798-3728	University of Duisburg-Essen	University of Duisburg-Essen	This study was funded in part by the Open Access Publication Fund of the University of Duisburg-Essen. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Brunkwall J, 2014, EUR J VASC ENDOVASC, V48, P285, DOI 10.1016/j.ejvs.2014.05.012; Ciccone MM, 2016, VASC MED, V21, P239, DOI 10.1177/1358863X16631419; Czermak BV, 2004, J ENDOVASC THER, V11, P1, DOI 10.1583/1545-1550(2004)011<0001:SCVATL>2.0.CO;2; ERBEL R, 1993, CIRCULATION, V87, P1604, DOI 10.1161/01.CIR.87.5.1604; Erbel R, 2014, EUR HEART J, V35, P2873, DOI 10.1093/eurheartj/ehu281; Fernandez JD, 2008, J ENDOVASC THER, V15, P68, DOI 10.1583/07-2215.1; Hiratzka Loren F, 2010, Ann Thorac Surg, V90, P1521, DOI 10.1016/j.athoracsur.2010.07.004; Huang CY, 2018, ANN THORAC SURG, V105, P785, DOI 10.1016/j.athoracsur.2017.08.039; Husainy MA, 2016, EMERG RADIOL, V23, P397, DOI 10.1007/s10140-016-1409-y; Jain V, 2016, EXPERT REV CARDIOVAS, V14, P1043, DOI 10.1080/14779072.2016.1199955; Janosi RA, 2015, MINIM INVASIV THER, V24, P289, DOI 10.3109/13645706.2015.1051053; Janosi RA, 2015, CATHETER CARDIO INTE, V85, pE43, DOI 10.1002/ccd.25614; Janosi Rolf Alexander, 2012, Expert Opin Med Diagn, V6, P529, DOI 10.1517/17530059.2012.704362; Lee WA, 2011, J VASC SURG, V53, P187, DOI 10.1016/j.jvs.2010.08.027; Leshnower BG, 2017, ANN THORAC SURG, V103, P1878, DOI 10.1016/j.athoracsur.2016.09.057; Nienaber CA, 2013, CIRC-CARDIOVASC INTE, V6, P407, DOI 10.1161/CIRCINTERVENTIONS.113.000463; Rajani RR, 2014, ANN VASC SURG, V28, P433, DOI 10.1016/j.avsg.2013.06.029; Shi ZY, 2016, VASA, V45, P331, DOI 10.1024/0301-1526/a000546; Wallace GA, 2015, J VASC SURG, V61, P630, DOI 10.1016/j.jvs.2014.10.014	19	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196180	10.1371/journal.pone.0196180	http://dx.doi.org/10.1371/journal.pone.0196180			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672613	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800099
J	Rosli, R; Amiruddin, N; Ab Halim, MA; Chan, PL; Chan, KL; Azizi, N; Morris, PE; Low, ETL; Ong-Abdullah, M; Sambanthamurthi, R; Singh, R; Murphy, DJ				Rosli, Rozana; Amiruddin, Nadzirah; Ab Halim, Mohd Amin; Chan, Pek-Lan; Chan, Kuang-Lim; Azizi, Norazah; Morris, Priscilla E.; Low, Eng-Ti Leslie; Ong-Abdullah, Meilina; Sambanthamurthi, Ravigadevi; Singh, Rajinder; Murphy, Denis J.			Comparative genomic and transcriptomic analysis of selected fatty acid biosynthesis genes and CNL disease resistance genes in oil palm	PLOS ONE			English	Article							ACYL CARRIER PROTEIN; SEQUENCE ALIGNMENT; DESATURASE; ANNOTATION; EXPRESSION; FAMILY; EVOLUTION; ISOFORMS; TOPHAT; FUTURE	Comparative genomics and transcriptomic analyses were performed on two agronomically important groups of genes from oil palm versus other major crop species and the model organism, Arabidopsis thaliana. The first analysis was of two gene families with key roles in regulation of oil quality and in particular the accumulation of oleic acid, namely stearoyl ACP desaturases (SAD) and acyl-acyl carrier protein (ACP) thioesterases (FAT). In both cases, these were found to be large gene families with complex expression profiles across a wide range of tissue types and developmental stages. The detailed classification of the oil palm SAD and FAT genes has enabled the updating of the latest version of the oil palm gene model. The second analysis focused on disease resistance (R) genes in order to elucidate possible candidates for breeding of pathogen tolerance/resistance. Ortholog analysis showed that 141 out of the 210 putative oil palm R genes had homologs in banana and rice. These genes formed 37 clusters with 634 orthologous genes. Classification of the 141 oil palm R genes showed that the genes belong to the Kinase (7), CNL (95), MLO-like (8), RLK (3) and Others (28) categories. The CNL R genes formed eight clusters. Expression data for selected R genes also identified potential candidates for breeding of disease resistance traits. Furthermore, these findings can provide information about the species evolution as well as the identification of agronomically important genes in oil palm and other major crops.	[Rosli, Rozana; Murphy, Denis J.] Univ South Wales, Genom & Computat Biol Res Grp, Pontypridd, M Glam, Wales; [Rosli, Rozana; Amiruddin, Nadzirah; Ab Halim, Mohd Amin; Chan, Pek-Lan; Chan, Kuang-Lim; Azizi, Norazah; Morris, Priscilla E.; Low, Eng-Ti Leslie; Ong-Abdullah, Meilina; Sambanthamurthi, Ravigadevi; Singh, Rajinder] Malaysian Palm Oil Board, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia	University of South Wales; Malaysian Palm Oil Board	Murphy, DJ (corresponding author), Univ South Wales, Genom & Computat Biol Res Grp, Pontypridd, M Glam, Wales.	denis.murphy@southwales.ac.uk	Low, Eng Ti Leslie/AHD-7011-2022; Murphy, Denis J/ABC-1734-2020	Low, Eng Ti Leslie/0000-0003-3414-8401; Murphy, Denis J/0000-0002-5291-2445; Ong-Abdullah, Meilina/0000-0003-4825-5021	Malaysian Palm Oil Board; MPOB	Malaysian Palm Oil Board; MPOB	Funding was provided by a PhD studentship grant from Malaysian Palm Oil Board.; We thank the Director General of MPOB, Dr. Ahmad Kushairi Din, for his support and encouragement throughout the project. The first author would like to acknowledge MPOB for the Ph.D. sponsorship. Special thanks to MPOB Bioinformatics team member for their kind assistance. We also extend our appreciation to Dr. David Marshall and colleagues at the James Hutton Institute, Dundee, UK for their valuable advice and assistance with the comparative genome analysis and to Kirstie Goggin, USW, for helpful comments on the manuscript.	Abrizah O., 1999, Journal of Oil Palm Research, P81; Akmar ASN, 2008, J OIL PALM RES, P1; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreou A, 2009, PROG LIPID RES, V48, P148, DOI 10.1016/j.plipres.2009.02.002; Basiron Y., 2015, PALM OIL TRADE FAIR; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Chan KL, 2017, BIOL DIRECT, V12, DOI 10.1186/s13062-017-0191-4; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Dehesh K, 1996, PLANT J, V9, P167, DOI 10.1046/j.1365-313X.1996.09020167.x; Delteil A, 2010, RICE, V3, P56, DOI 10.1007/s12284-009-9035-x; DORMANN P, 1993, PLANTA, V189, P425, DOI 10.1007/BF00194441; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Facciotti MT, 1998, FETT-LIPID, V100, P167; Fickett JW, 2000, CURR OPIN BIOTECH, V11, P19, DOI 10.1016/S0958-1669(99)00049-X; Han YJ, 2017, THEOR APPL GENET, V130, P151, DOI 10.1007/s00122-016-2800-5; Haralampidis K, 1998, J EXP BOT, V49, P1661, DOI 10.1093/jexbot/49.327.1661; Huang RM, 2017, J AGR FOOD CHEM, V65, P4223, DOI 10.1021/acs.jafc.7b00922; Jia YX, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0208-x; Jin JJ, 2016, DNA RES, V23, P527, DOI 10.1093/dnares/dsw036; Jing FY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-44; JONES A, 1995, PLANT CELL, V7, P359, DOI 10.1105/tpc.7.3.359; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Koch MA, 2000, COMP GENOMICS REGULA, P1882; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Lim FH, 2014, J OIL PALM RES, V26, P170; Liu Q, 2017, PLANT BIOTECHNOL J, V15, P132, DOI 10.1111/pbi.12598; Low E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100973; Meyers BC, 1999, PLANT J, V20, P317, DOI 10.1046/j.1365-313X.1999.t01-1-00606.x; Murphy DJ, 2007, EUR J LIPID SCI TECH, V109, P296, DOI 10.1002/ejlt.200600229; Murphy DJ, 2014, J OIL PALM RES, V26, P1; Murphy DJ, 1999, CURR OPIN BIOTECH, V10, P175, DOI 10.1016/S0958-1669(99)80031-7; NAGAI J, 1968, J BIOL CHEM, V243, P4626; Nurnadiah E, 2014, AGRIC AGRIC SCI PROC, V2, P90, DOI 10.1016/j.aaspro.2014.11.013; Parveez G. K. A., 2003, AgBiotechNet, V5, P1; Peraza-Echeverria S, 2007, MOL GENET GENOMICS, V278, P443, DOI 10.1007/s00438-007-0262-9; Rasid OA, 2014, J OIL PALM RES, V26, P265; Sambanthamurthi R, 2000, PROG LIPID RES, V39, P507, DOI 10.1016/S0163-7827(00)00015-1; Sambanthamurthi R, 1999, J OIL PALM RES, P23; Sambanthamurthi R, 1990, PLANT LIPID BIOCH ST; Sambanthamurthi R, 2010, MPOB INF SER; Sambanthamurthi R, 2011, BRIT J NUTR, V106, P1655, DOI 10.1017/S0007114511002121; Sanseverino W, 2013, NUCLEIC ACIDS RES, V41, pD1167, DOI 10.1093/nar/gks1183; Shah FH, 2000, PLANT SCI, V152, P27, DOI 10.1016/S0168-9452(99)00209-5; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Song WY, 1997, PLANT CELL, V9, P1279, DOI 10.1105/tpc.9.8.1279; Tamura K, 2013, MOL BIOL EVOLUTION N, V30; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tisne S, 2017, G3-GENES GENOM GENET, V7, P1683, DOI 10.1534/g3.117.041764; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2015, NUCLEIC ACIDS RES, V43, pW78, DOI 10.1093/nar/gkv487; Yun ChoongHyo, 1999, Plant Pathology Journal, V15, P105	57	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194792	10.1371/journal.pone.0194792	http://dx.doi.org/10.1371/journal.pone.0194792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672525	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800013
J	Kaur, A; Singh, B; Ohri, P; Wang, J; Wadhwa, R; Kau, SC; Pati, PK; Kaurl, A				Kaur, Amandeep; Singh, Baldev; Ohri, Puja; Wang, Jia; Wadhwa, Renu; Kau, Sunil C.; Pati, Pratap Kumar; Kaurl, Arvinder			Organic cultivation of Ashwagandha with improved biomass and high content of active Withanolides: Use of Vermicompost	PLOS ONE			English	Article							WITHANIA-SOMNIFERA; PLANT-GROWTH; HUMIC SUBSTANCES; CANCER-CELLS; LEAF EXTRACT; FOOD WASTE; GERMINATION; ACIDS; LEACHATE; SOIL	Withania somnifera (Ashwagandha) has recently been studied extensively for its health-supplementing and therapeutic activities against a variety of ailments. Several independent studies have experimentally demonstrated pharmaceutical potential of its active Withanolides, Withaferin A (Wi-A), Withanone (Wi-N) and Withanolide A (Wil-A). However, to promote its use in herbal industry, an environmentally sustainable cultivation and high yield are warranted. In modern agriculture strategies, there has been indiscriminate use of chemical fertilizers to boost the crop-yield, however the practice largely ignored its adverse effect on the quality of soil and the environment. In view of these, we attempted to recruit Vermicompost (Vcom, 20-100%) as an organic fertilizer of choice during the sowing and growing phases of Ashwagandha plants. We report that (i) pre-soaking of seeds for 12 h in Vermicompost leachate (Vcom-L) and Vermicompost tea (Vcom-T) led to higher germination, (ii) binary combination of pre-soaking of seeds and cultivation in Vcom (up to 80%) resulted in further improvement both in germination and seedling growth, (iii) cultivated plants in the presence of Vcom+Vcom-L showed higher leaf and root mass, earlier onset of flowering and fruiting and (iv) leaves from the Vcom+Vcom-L cultivated plants showed higher level of active Withanolides, Withanone (Wi-N), Withanolide A (Wil-A) and Withaferin A (Wi-A) and showed anticancer activities in cell culture assays. Taken together, we report a simple and inexpensive method for improving the yield and pharmaceutical components of Ashwagandha leaves.	[Kaur, Amandeep; Ohri, Puja; Kaurl, Arvinder] Guru Nanak Dev Univ, Dept Zool, Amritsar, Punjab, India; [Singh, Baldev; Pati, Pratap Kumar] Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India; [Wang, Jia; Wadhwa, Renu; Kau, Sunil C.] Natl Inst Adv Ind Sci & Technol, DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan	Guru Nanak Dev University; Guru Nanak Dev University; National Institute of Advanced Industrial Science & Technology (AIST)	Kaurl, A (corresponding author), Guru Nanak Dev Univ, Dept Zool, Amritsar, Punjab, India.; Pati, PK (corresponding author), Guru Nanak Dev Univ, Dept Biotechnol, Amritsar, Punjab, India.; Kau, SC (corresponding author), Natl Inst Adv Ind Sci & Technol, DAILAB, Drug Discovery & Assets Innovat Lab, Tsukuba, Ibaraki, Japan.	s-kaul@aist.go.jp; pkpati@yahoo.com; arvinder165@gmail.com	Wadhwa, Renu/L-8898-2018; Kaul, Sunil/L-8671-2018	Wadhwa, Renu/0000-0001-8248-5192; Kaul, Sunil/0000-0002-0046-3916; pati, pratap/0000-0001-9017-7608; Ohri, Puja/0000-0002-4528-2385	INSPIRE Fellowship (Department of Science and Technology, Government of India); UPE grant (UGC); SAP grant (UGC); DBT (Govt. of India); AIST (Japan) funds	INSPIRE Fellowship (Department of Science and Technology, Government of India); UPE grant (UGC); SAP grant (UGC); DBT (Govt. of India)(Department of Biotechnology (DBT) India); AIST (Japan) funds	Financial assistance in the form of INSPIRE Fellowship (Department of Science and Technology, Government of India) to AmK as well as UPE and SAP grants (UGC) are duly acknowledged. The work was supported by DBT (Govt. of India) and AIST (Japan) funds.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arancon NQ, 2008, APPL SOIL ECOL, V39, P91, DOI 10.1016/j.apsoil.2007.11.010; Arancon NQ, 2006, EUR J SOIL BIOL, V42, pS65, DOI 10.1016/j.ejsobi.2006.06.004; Arancon NQ, 2012, HORTSCIENCE, V47, P1722, DOI 10.21273/HORTSCI.47.12.1722; Arancon NQ, 2004, BIORESOURCE TECHNOL, V93, P139, DOI 10.1016/j.biortech.2003.10.015; Aremu AO, 2015, PLANT GROWTH REGUL, V75, P483, DOI 10.1007/s10725-014-0011-0; Aremu AO, 2014, ACTA PHYSIOL PLANT, V36, P721, DOI 10.1007/s11738-013-1450-3; Atiyeh RM, 2000, PEDOBIOLOGIA, V44, P579, DOI 10.1078/S0031-4056(04)70073-6; Atiyeh RM, 2002, BIORESOURCE TECHNOL, V84, P7, DOI 10.1016/S0960-8524(02)00017-2; Ayyobi H., 2014, International Journal of Vegetable Science, V20, P21, DOI 10.1080/19315260.2012.753496; Bhattacharya SK, 2003, PHARMACOL BIOCHEM BE, V75, P547, DOI 10.1016/S0091-3057(03)00110-2; Biau A, 2012, EUR J SOIL BIOL, V53, P56, DOI 10.1016/j.ejsobi.2012.08.008; Campbell BJ, 2008, ENVIRON MICROBIOL, V12, P1842; Canellas LP, 2002, PLANT PHYSIOL, V130, P1951, DOI 10.1104/pp.007088; Canellas LP, 2013, PLANT SOIL, V366, P119, DOI 10.1007/s11104-012-1382-5; Chatterjee S, 2010, PHYTOCHEMISTRY, V71, P1085, DOI 10.1016/j.phytochem.2010.04.001; Chen Y., 1990, Humic substances in soil and crop sciences: selected readings. Proceedings of a symposium cosponsored by the International Humic Substances Society, Chicago, Illinois, December 2, 1985., P161; Clapp CE., 2010, UNDERSTANDING MANAGI, P243; Coolon JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067884; Dinesh Giri, 2012, Scientific Research and Essays, V7, P1835, DOI 10.5897/SRE11.1349; Dominguez Jorge, 2004, P401; Garcia Martinez Ignacio, 2002, Crop Research (Hisar), V24, P323; Gupta R., 2011, INT J RECYCL ORG WAS, V3, P47, DOI [10.1007/s40093-014-0047-1, DOI 10.1007/S40093-014-0047-1]; Kattimani KN, 1999, SEED SCI TECHNOL, V27, P483; Kaul SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166945; Kaur A, 2010, BIORESOURCE TECHNOL, V101, P8192, DOI 10.1016/j.biortech.2010.05.041; KHAN A A, 1978, Acta Horticulturae (Wageningen), P267; Kuboyama T, 2005, BRIT J PHARMACOL, V144, P961, DOI 10.1038/sj.bjp.0706122; Lazcano C, 2011, J SCI FOOD AGR, V91, P1244, DOI 10.1002/jsfa.4306; Matejovic I, 1997, COMMUN SOIL SCI PLAN, V28, P1499, DOI 10.1080/00103629709369892; Matsuda H, 2001, BIOORGAN MED CHEM, V9, P1499, DOI 10.1016/S0968-0896(01)00024-4; Mirjalili MH, 2009, MOLECULES, V14, P2373, DOI 10.3390/molecules14072373; Mishra L C, 2000, Altern Med Rev, V5, P334; Muscolo A, 1999, SOIL BIOL BIOCHEM, V31, P1303, DOI 10.1016/S0038-0717(99)00049-8; Muscolo A, 1998, SOIL BIOL BIOCHEM, V30, P1199, DOI 10.1016/S0038-0717(98)00005-4; Najar I., 2013, ACTA BIOL MALAYS, V2, P12; Powell KI, 2009, INT J PLANT SCI, V170, P918, DOI 10.1086/600140; Reigosa MJ, 1999, PLANT GROWTH REGUL, V28, P83, DOI 10.1023/A:1006269716762; Sangwan Pritam, 2010, Environmentalist, V30, P123, DOI 10.1007/s10669-009-9251-3; Sangwan RS, 2008, PHYSIOL PLANTARUM, V133, P278, DOI 10.1111/j.1399-3054.2008.01076.x; Savci S, 2012, APCBEE PROC, V1, P287, DOI 10.1016/j.apcbee.2012.03.047; Singh J, 2010, ECOTOX ENVIRON SAFE, V73, P430, DOI 10.1016/j.ecoenv.2009.08.019; Singh P, 2015, BIOTECHNOL GENET ENG, V31, P1, DOI 10.1080/02648725.2015.1020467; Singh R, 2010, SCI HORTIC-AMSTERDAM, V124, P34, DOI 10.1016/j.scienta.2009.12.002; Singh R, 2008, BIORESOURCE TECHNOL, V99, P8507, DOI 10.1016/j.biortech.2008.03.034; Singh S, 2014, SEED SCI RES, V24, P63, DOI 10.1017/S0960258513000408; Sinha R. K., 2010, Agricultural Sciences, V1, P76, DOI 10.4236/as.2010.12011; Tattini M., 1991, Acta Horticulturae, P75; Trevisan S, 2011, ENVIRON EXP BOT, V74, P45, DOI 10.1016/j.envexpbot.2011.04.017; Vadiraj B. A., 1998, Journal of Spices and Aromatic Crops, V7, P141; Widodo N, 2008, CANCER LETT, V262, P37, DOI 10.1016/j.canlet.2007.11.037; Widodo N, 2007, CLIN CANCER RES, V13, P2298, DOI 10.1158/1078-0432.CCR-06-0948; Winters M, 2006, ALTERN MED REV, V11, P269; Yeoung YR, 1996, SEED SCI TECHNOL, V24, P429; Yu Y, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.33	55	13	15	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194314	10.1371/journal.pone.0194314	http://dx.doi.org/10.1371/journal.pone.0194314			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659590	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100002
J	Logroscino, G; Marin, B; Piccininni, M; Arcuti, S; Chio, A; Hardiman, O; Rooney, J; Zoccolella, S; Couratier, P; Preux, PM; Beghi, E				Logroscino, Giancarlo; Marin, Benoit; Piccininni, Marco; Arcuti, Simona; Chio, Adriano; Hardiman, Orla; Rooney, James; Zoccolella, Stefano; Couratier, Philippe; Preux, Pierre-Marie; Beghi, Ettore		EURALS	Referral bias in ALS epidemiological studies	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; EL-ESCORIAL; ASSESSING SURVIVAL; CLINICAL-TRIALS; POPULATION; CRITERIA; IRELAND; DIAGNOSIS; PROGNOSIS; DISEASE	Background Despite concerns about the representativeness of patients from ALS tertiary centers as compared to the ALS general population, the extent of referral bias in clinical studies remains largely unknown. Using data from EURALS consortium we aimed to assess nature, extent and impact of referral bias. Methods Four European ALS population-based registries located in Ireland, Piedmont, Puglia, Italy, and Limousin, France, covering 50 million person-years, participated. Demographic and clinic characteristics of ALS patients diagnosed in tertiary referral centers were contrasted with the whole ALS populations enrolled in registries in the same geographical areas. Results Patients referred to ALS centers were younger (with difference ranging from 1.1 years to 2.4 years), less likely to present a bulbar onset, with a higher proportion of familial antecedents and a longer survival (ranging from 11% to 15%) when compared to the entire ALS population in the same geographic area. Conclusions A trend for referral bias is present in cohorts drawn from ALS referral centers. The magnitude of the possible referral bias in a particular tertiary center can be estimated through a comparison with ALS patients drawn from registry in the same geographic area. Studies based on clinical cohorts should be cautiously interpreted. The presence of a registry in the same area may improve the complete ascertainment in the referral center.	[Logroscino, Giancarlo; Marin, Benoit; Zoccolella, Stefano] Univ Ban Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy; [Logroscino, Giancarlo; Marin, Benoit; Piccininni, Marco; Arcuti, Simona; Preux, Pierre-Marie] Univ Ban Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Lecce, Italy; [Marin, Benoit; Couratier, Philippe; Preux, Pierre-Marie] INSERM, UMR1094, Trop Neuroepidemiol, Limoges, France; [Marin, Benoit; Couratier, Philippe; Preux, Pierre-Marie] Univ Limoges, Sch Med, Inst Neuroepidemiol & Trop Neurol, CNRS,FR 3503,GEIST, Limoges, France; [Marin, Benoit] CHU Limoges, Ctr Epiderniol Biostat & Methodol Rech, Limoges, France; [Marin, Benoit; Beghi, Ettore] IRCCS Ist Ric Farmacol Mario Negri, Dipartimento Neurosci, La Malattie Neurol, Milan, Italy; [Chio, Adriano] Univ Turin, Dept Neurosci, ALS Ctr, Turin, Italy; [Chio, Adriano] NIT, Turin, Italy; [Chio, Adriano] CNR, Inst Cognit Sci & Technol, Rome, Italy; [Hardiman, Orla; Rooney, James] Trinity Coll Dublin, Trinity Biomed Sci Inst, Acad Unit Neurol, Dublin, Ireland; [Couratier, Philippe] CHU Limoges, Serv Neurol, Ctr Expert SLA, Limoges, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Franche-Comte; Universite de Limoges; CHU Limoges; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Turin; Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze e Tecnologie della Cognizione (ISTC-CNR); Trinity College Dublin; CHU Limoges	Logroscino, G (corresponding author), Univ Ban Aldo Moro, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy.; Logroscino, G (corresponding author), Univ Ban Aldo Moro, Pia Fdn Cardinale G Panico, Dept Clin Res Neurol, Unit Neurodegenerat Dis, Lecce, Italy.	giancarlo.logroscino@uniba.it	Rooney, James/J-9190-2019; Hardiman, Orla/Y-3441-2019; Preux, Pierre-Marie/N-3538-2019; MARIN, Benoit/E-2356-2015; Beghi, Ettore/AAA-7426-2020; zoccolella, stefano/AAA-2515-2020; Logroscino, Giancarlo/K-5148-2016	Rooney, James/0000-0001-6346-0731; Hardiman, Orla/0000-0003-2610-1291; Preux, Pierre-Marie/0000-0002-2171-2977; MARIN, Benoit/0000-0001-8857-0910; Beghi, Ettore/0000-0003-2542-0469; Chio, Adriano/0000-0001-9579-5341; Logroscino, Giancarlo/0000-0003-0423-3242; Piccininni, Marco/0000-0002-1397-0060	Health Research Programme Clinical Fellowship Programme; Health Research Board Clinician Scientist Programme; Euro-MOTOR FP7 [259867]; Motor Neurone Disease Association; ALS Association; National Institute for Health Research; European Commission; Medical Research Council; Economic and Social Research Council; Italian Ministry of Health (Ricerca Finalizzata); University of Turin; Fondazione Vialli e Mauro onlus	Health Research Programme Clinical Fellowship Programme; Health Research Board Clinician Scientist Programme; Euro-MOTOR FP7; Motor Neurone Disease Association; ALS Association; National Institute for Health Research(National Institute for Health Research (NIHR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Italian Ministry of Health (Ricerca Finalizzata)(Ministry of Health, Italy); University of Turin; Fondazione Vialli e Mauro onlus	James Rooney was funded by the Health Research Programme Clinical Fellowship Programme. Marwa Elamin, Alice Vajda and Mark Heverin report no disclosures and no conflicts of interest. Orla Hardiman is funded by the Health Research Board Clinician Scientist Programme. Prof. Hardiman has received speaking honoraria from Novarits, Biogen Idec, Sanofi Aventis and Merck-Serono. She has been a member of advisory panels for Biogen Idec, Allergen, Ono Pharmaceuticals, Novartis, Cytokinetics and Sanofi Aventis. She serves as Editor-in-Chief of Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. She funded by Euro-MOTOR FP7/2007-2013, grant agreement 259867 Giancarlo Logroscino, serves as associate editor for the Neuroepidemiolgy journal, Karger. He received founding from Ministry of Health, Ministry of University and Research, Regione Puglia Special program for research. He funded by Euro-MOTOR FP7/2007-2013, grant agreement 259867. Adriano Chia has grants from the Motor Neurone Disease Association, ALS Association, National Institute for Health Research, European Commission, Medical Research Council and Economic and Social Research Council. He has grants from Italian Ministry of Health (Ricerca Finalizzata), University of Turin, and Fondazione Vialli e Mauro onlus. Ettore Beghi reports research grants from European Union [Euro-MOTOR (FP7/2007-2013, grant agreement 259867)], The American ALS Association, UCB-Pharma, the Italian Ministry of Health, the Italian Drug Agency, the Fondazione Borgonovo, and the Associazione IDIC-15, outside the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beghi E, 2007, NEUROLOGY, V68, P141, DOI 10.1212/01.wnl.0000250339.14392.bb; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Byrne S, 2013, ANN NEUROL, V74, P699, DOI 10.1002/ana.23969; Byrne S, 2011, J NEUROL NEUROSUR PS, V82, P623, DOI 10.1136/jnnp.2010.224501; Chio A, 2001, NEUROLOGY, V56, P239; Chio A, 2006, J NEUROL NEUROSUR PS, V77, P948, DOI 10.1136/jnnp.2005.083402; Chio A, 2011, NEUROLOGY, V77, P1432, DOI 10.1212/WNL.0b013e318232ab9b; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P310, DOI 10.3109/17482960802566824; Dandaba M, 2017, NEUROEPIDEMIOLOGY, V49, P64, DOI 10.1159/000479969; Di Poggio MB, 2013, AMYOTROPH LAT SCL FR, V14, P52, DOI 10.3109/17482968.2012.729062; Donaghy C, 2010, AMYOTROPH LATERAL SC, V11, P374, DOI 10.3109/17482960903329569; Dreyer P, 2014, AMYOTROPH LAT SCL FR, V15, P62, DOI 10.3109/21678421.2013.837929; Forbes RB, 2004, AGE AGEING, V33, P131, DOI 10.1093/ageing/afh013; Gladman M, 2014, AMYOTROPH LAT SCL FR, V15, P426, DOI 10.3109/21678421.2014.932382; HAVERKAMP LJ, 1995, BRAIN, V118, P707, DOI 10.1093/brain/118.3.707; KURLAND LT, 1955, NEUROLOGY, V5, P249, DOI 10.1212/WNL.5.4.249; Langefeld CD, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.07.017; LEE JRJ, 1995, J NEUROL SCI, V132, P207, DOI 10.1016/0022-510X(95)00154-T; Liu MS, 2014, ACTA NEUROL SCAND, V129, P163, DOI 10.1111/ane.12157; Logroscino G, 2008, J NEUROL NEUROSUR PS, V79, P6, DOI 10.1136/jnnp.2006.104828; Logroscino G, 2007, NEUROLOGY, V69, P939, DOI 10.1212/01.wnl.0000281904.21495.cb; Logroscino G, 2005, J NEUROL NEUROSUR PS, V76, P1094, DOI 10.1136/jnnp.2004.039180; Logroscino G, 2010, J NEUROL NEUROSUR PS, V81, P385, DOI 10.1136/jnnp.2009.183525; Mandrioli J, 2014, AMYOTROPH LAT SCL FR, V15, P262, DOI 10.3109/21678421.2013.865752; Marin B, 2014, EUR J NEUROL, V21, P1292, DOI 10.1111/ene.12474; Marin B, 2016, EUR J EPIDEMIOL, V31, P229, DOI 10.1007/s10654-015-0090-x; Millul A, 2005, NEUROEPIDEMIOLOGY, V25, P114, DOI 10.1159/000086353; Mitsumoto H, 2014, LANCET NEUROL, V13, P1127, DOI 10.1016/S1474-4422(14)70129-2; Ng L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007425.pub2; Pradas J, 2013, AMYOTROPH LAT SCL FR, V14, P278, DOI 10.3109/21678421.2012.749915; Renton AE, 2014, NAT NEUROSCI, V17, P17, DOI 10.1038/nn.3584; Rooney J, 2015, J NEUROL NEUROSUR PS, V86, P496, DOI 10.1136/jnnp-2014-309601; Rooney J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074733; Rooney JPK, 2017, NEUROLOGY, V88, P2321, DOI 10.1212/WNL.0000000000004038; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Sabatelli M, 2013, CLIN GENET, V83, P408, DOI 10.1111/cge.12117; Sorenson EJ, 2007, NEUROLOGY, V68, P600, DOI 10.1212/01.wnl.0000254501.58158.e7; Spataro R, 2011, J NEUROL SCI, V304, P44, DOI 10.1016/j.jns.2011.02.016; STRONG MJ, 1991, CAN J NEUROL SCI, V18, P45, DOI 10.1017/S0317167100031280; Traynor BJ, 2000, ARCH NEUROL-CHICAGO, V57, P1171, DOI 10.1001/archneur.57.8.1171; Traynor BJ, 1999, NEUROLOGY, V52, P504, DOI 10.1212/WNL.52.3.504; Traynor BJ, 2003, J NEUROL NEUROSUR PS, V74, P1258, DOI 10.1136/jnnp.74.9.1258; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Yu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101186; Zoccolella S, 2007, J NEUROL, V254, P1107, DOI 10.1007/s00415-006-0401-y	46	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195821	10.1371/journal.pone.0195821	http://dx.doi.org/10.1371/journal.pone.0195821			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659621	Green Submitted, Green Published, gold			2022-12-26	WOS:000430061100034
J	Baker, J; Falconer, AMD; Wilkinson, DJ; Europe-Finner, GN; Litherland, GJ; Rowan, AD				Baker, Jonathan; Falconer, Adrian M. D.; Wilkinson, David J.; Europe-Finner, G. Nicholas; Litherland, Gary J.; Rowan, Andrew D.			Protein kinase D3 modulates MMP1 and MMP13 expression in human chondrocytes	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; CARTILAGE COLLAGEN BREAKDOWN; ONCOSTATIN-M; MATRIX METALLOPROTEINASES; PROINFLAMMATORY CYTOKINES; TRANSCRIPTION FACTORS; SIGNALING PATHWAY; GENE-EXPRESSION; FACTOR-ALPHA; IN-VITRO	Many catabolic stimuli, including interleukin-1 (IL-1) in combination with oncostatin M (OSM), promote cartilage breakdown via the induction of collagen-degrading collagenases such as matrix metalloproteinase 1 (MMP1) and MMP13 in human articular chondrocytes. Indeed, joint diseases with an inflammatory component are characterised by excessive extracellular matrix (ECM) catabolism. Importantly, protein kinase C (PKC) signalling has a primary role in cytokine-induced MMP1/13 expression, and is known to regulate cellular functions associated with pathologies involving ECM remodelling. At present, substrates downstream of PKC remain undefined. Herein, we show that both IL-1-and OSM-induced phosphorylation of protein kinase D (PKD) in human chondrocytes is strongly associated with signalling via the atypical PKC. isoform. Consequently, inhibiting PKD activation with a pan-PKD inhibitor significantly reduced the expression of MMP1/13. Specific gene silencing of the PKD isoforms revealed that only PKD3 (PRKD3) depletion mirrored the observed MMP repression, indicative of the pharmacological inhibitor specifically affecting only this isoform. PRKD3 silencing was also shown to reduce serine phosphorylation of signal transducer and activator of transcription 3 (STAT3) as well as phosphorylation of all three mitogen-activated protein kinase groups. This altered signalling following PRKD3 silencing led to a significant reduction in the expression of the activator protein-1 (AP-1) genes FOS and JUN, critical for the induction of many MMPs including MMP1/13. Furthermore, the AP-1 factor activating transcription factor 3 (ATF3) was also reduced concomitant with the observed reduction in MMP13 expression. Taken together, we highlight an important role for PKD3 in the pro-inflammatory signalling that promotes cartilage destruction.	[Baker, Jonathan; Falconer, Adrian M. D.; Wilkinson, David J.; Europe-Finner, G. Nicholas; Litherland, Gary J.; Rowan, Andrew D.] Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Baker, Jonathan] Imperial Coll, Natl Heart & Lung Inst, Airway Dis Sect, London, England; [Litherland, Gary J.] Univ West Scotland, Sch Sci & Sport, Paisley Campus, Paisley, Renfrew, Scotland	Newcastle University - UK; Imperial College London; University of West Scotland	Rowan, AD (corresponding author), Newcastle Univ, Inst Med Genet, Skeletal Res Grp, Newcastle Upon Tyne, Tyne & Wear, England.	drew.rowan@ncl.ac.uk	Litherland, Gary J/K-9755-2015	Falconer, Adrian/0000-0001-7362-0313; Wilkinson, David/0000-0002-6262-3575	Arthritis Research UK [19322]; NIHR Newcastle Biomedical Research Centre; Northumberland, Tyne and Wear Comprehensive Local Research Network	Arthritis Research UK(Versus Arthritis); NIHR Newcastle Biomedical Research Centre; Northumberland, Tyne and Wear Comprehensive Local Research Network	ADR and GJL received funding from Arthritis Research UK (grant 19322; http//www.arthritisresearchuk.org/), and the NIHR Newcastle Biomedical Research Centre. Clinical and translational research was supported by the Northumberland, Tyne and Wear Comprehensive Local Research Network. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barksby HE, 2006, ARTHRITIS RHEUM-US, V54, P540, DOI 10.1002/art.21574; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Catterall JB, 2001, ARTHRITIS RHEUM-US, V44, P2296, DOI 10.1002/1529-0131(200110)44:10<2296::AID-ART392>3.0.CO;2-9; Chan CM, 2017, J BIOL CHEM, V292, P1625, DOI 10.1074/jbc.M116.756601; Cimica V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020188; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Cleaver CS, 2001, ANN RHEUM DIS, V60, P150, DOI 10.1136/ard.60.2.150; Eiseler T, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2232; Ellwanger K, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-47; Gavriilidis C, 2013, ARTHRITIS RHEUM-US, V65, P378, DOI 10.1002/art.37782; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; Hayashi A, 1999, BBA-MOL CELL RES, V1450, P99, DOI 10.1016/S0167-4889(99)00040-3; Higashiyama R, 2010, MOD RHEUMATOL, V20, P11, DOI 10.1007/s10165-009-0224-7; Huesa C, 2016, ANN RHEUM DIS, V75, P1989, DOI 10.1136/annrheumdis-2015-208268; Hui W, 2003, ARTHRITIS RHEUM-US, V48, P3404, DOI 10.1002/art.11333; Hui W, 2003, ANN RHEUM DIS, V62, P172, DOI 10.1136/ard.62.2.172; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jeong YJ, 2015, INT IMMUNOPHARMACOL, V25, P400, DOI 10.1016/j.intimp.2015.02.021; Jones SW, 2006, OSTEOARTHR CARTILAGE, V14, P597, DOI 10.1016/j.joca.2006.01.007; JUBB RW, 1980, J PATHOL, V130, P159, DOI 10.1002/path.1711300304; Kim YI, 2010, J IMMUNOL, V184, P3145, DOI 10.4049/jimmunol.0903718; Knauper V, 1996, J BIOL CHEM, V271, P1544, DOI 10.1074/jbc.271.3.1544; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Koshy PJ, 2002, ANN RHEUM DIS, V61, P704, DOI 10.1136/ard.61.8.704; Koshy PJT, 2002, ARTHRITIS RHEUM, V46, P961, DOI 10.1002/art.10212; Litherland GJ, 2008, J BIOL CHEM, V283, P14221, DOI 10.1074/jbc.M710136200; Litherland GJ, 2010, J BIOL CHEM, V285, P22414, DOI 10.1074/jbc.M110.120121; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; McEneaney V, 2010, J STEROID BIOCHEM, V118, P18, DOI 10.1016/j.jsbmb.2009.09.014; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Park JE, 2009, J IMMUNOL, V182, P6316, DOI 10.4049/jimmunol.0804239; Rey O, 2006, J BIOL CHEM, V281, P5149, DOI 10.1074/jbc.M508014200; Rogers EM, 2005, MECH DEVELOP, V122, P1194, DOI 10.1016/j.mod.2005.07.002; Rowan AD, 2003, AM J PATHOL, V162, P1975, DOI 10.1016/S0002-9440(10)64330-1; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Rowan AD, 2007, FRONT BIOSCI-LANDMRK, V12, P536, DOI 10.2741/2080; Sakkas LI, 2007, ARTHRITIS RHEUM-US, V56, P409, DOI 10.1002/art.22369; Staunton D, 1998, PROTEIN ENG, V11, P1093, DOI 10.1093/protein/11.11.1093; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; Waldron RT, 2007, BIOCHEM BIOPH RES CO, V356, P361, DOI 10.1016/j.bbrc.2007.02.142; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	46	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195864	10.1371/journal.pone.0195864	http://dx.doi.org/10.1371/journal.pone.0195864			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652915	gold, Green Submitted, Green Published			2022-12-26	WOS:000430026900041
J	Wurschinger, F; Wittmann, S; Goldfuss, S; Zech, N; Debl, K; Hilker, M; Graf, BM; Zausig, YA				Wurschinger, Fabian; Wittmann, Sigrid; Goldfuss, Sophia; Zech, Nina; Debl, Kurt; Hilker, Michael; Graf, Bernhard M.; Zausig, York A.			Complications after transcatheter aortic valve implantation using transfemoral and transapical approach in general anaesthesia	PLOS ONE			English	Article							PERMANENT PACEMAKER IMPLANTATION; REPLACEMENT; STENOSIS; MANAGEMENT; DISEASE; RISK; PREDICTORS; OUTCOMES; SURGERY; PATIENT	Background Transcatheter aortic valve implantation (TAVI) is a minimally invasive procedure used to treat degenerative heart valve disease. The implantation requires a highly specific and interdisciplinary management approach. Currently, TAVI is performed with the patient under local or general anaesthesia. Methods This study was a retrospective analysis of all TAVI procedures performed at the University Hospital of Regensburg between January 2009 and July 2015. All pre-, intra and postoperative data focusing on perioperative complications were recorded. Results A total of 853 transfemoral-and transapical-TAVI patients were included in the study. All patients underwent general anaesthesia. The ASA classifications were primarily 3-4. The average logistic EuroScores for the transfemoral-and transapical-TAVI patients were 18 +/- 12% and 21 +/- 15% (p = 0.002), respectively. The anaesthesia coverage time was 170 +/- 49 min., including 37 +/- 12 minutes for anaesthetic management. Overall, 458 complications were recorded; with pneumonia, acute renal failure, indication for a permanent pacemaker and non-extubation in the operating theatre the most frequently recorded complications. Conclusion In the present study, we showed that our patients' outcomes are comparable to those reported in the available literature. Compared to TF, TA patients show an overall worse physical condition as well as a higher perioperative morbidity and mortality. Consequently TA patients need additional care and should only be operated in appropriately experienced medical centres.	[Wurschinger, Fabian; Wittmann, Sigrid; Goldfuss, Sophia; Zech, Nina; Graf, Bernhard M.; Zausig, York A.] Univ Klinikum Regensburg, Klin Andsthesiol, Regensburg, Germany; [Debl, Kurt] Univ Klinikum Regensburg, Med Klin 2, Intens Med, Regensburg, Germany; [Hilker, Michael] Univ Klinikum Regensburg, Klin Herz Thorax Chirurg, Regensburg, Germany	University of Regensburg; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Regensburg; University of Regensburg	Zausig, YA (corresponding author), Univ Klinikum Regensburg, Klin Andsthesiol, Regensburg, Germany.	York.zausig@ukr.de						Barbash IM, 2012, AM HEART J, V163, P1031, DOI 10.1016/j.ahj.2012.01.009; Biancari F, 2016, AM J CARDIOL, V117, P245, DOI 10.1016/j.amjcard.2015.10.036; Brecker SJD, 2016, AM J CARDIOL, V117, P1332, DOI 10.1016/j.amjcard.2016.01.027; Covello RD, 2010, MINERVA ANESTESIOL, V76, P100; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Erdogan HB, 2006, J CARDIAC SURG, V21, P211, DOI 10.1111/j.1540-8191.2006.00216.x; Frohlich GM, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-41; Hamm CW, 2016, INTERNIST, V57, P304, DOI 10.1007/s00108-016-0028-8; Hamm CW, 2016, EUR HEART J, V37, P803, DOI 10.1093/eurheartj/ehv574; Hare GMT, 2013, CAN J ANESTH, V60, P168, DOI 10.1007/s12630-012-9861-y; Hausman MS, 2015, ANESTH ANALG, V120, P1405, DOI 10.1213/ANE.0000000000000574; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Klein AA, 2014, ANESTH ANALG, V119, P784, DOI 10.1213/ANE.0000000000000400; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Lynch JP, 2001, CHEST, V119, p373S, DOI 10.1378/chest.119.2_suppl.373S; Martinsson A, 2015, CIRCULATION, V131, P988, DOI 10.1161/CIRCULATIONAHA.114.012906; Oguri A, 2014, CIRC-CARDIOVASC INTE, V7, P602, DOI 10.1161/CIRCINTERVENTIONS.113.000403; Pascual I, 2017, J THORAC DIS, V9, pS478, DOI 10.21037/jtd.2017.05.73; Polanczyk CA, 2001, ANN INTERN MED, V134, P637, DOI 10.7326/0003-4819-134-8-200104170-00008; Riediger C, 2011, ANAESTHESIST, V60, P1095, DOI 10.1007/s00101-011-1972-2; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Siontis GCM, 2014, J AM COLL CARDIOL, V64, P129, DOI 10.1016/j.jacc.2014.04.033; Stahli BE, 2013, CARDIOLOGY, V126, P15, DOI 10.1159/000351438; Steinberg BA, 2012, AM HEART J, V164, P664, DOI 10.1016/j.ahj.2012.07.028; Walther T, 2012, ANN CARDIOTHORAC SUR, V1, P216, DOI 10.3978/j.issn.2225-319X.2012.07.10	26	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0193558	10.1371/journal.pone.0193558	http://dx.doi.org/10.1371/journal.pone.0193558			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652895	gold, Green Published, Green Submitted			2022-12-26	WOS:000430026900003
J	Choi, SY; Lim, HA; Yim, HW; Park, YH				Choi, Seung Yong; Lim, Hyun-A.; Yim, Hyeon Woo; Park, Young-Hoon			Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea	PLOS ONE			English	Article							ASSOCIATION; OFLOXACIN; CIPROFLOXACIN; PENETRATION; FLUMEQUINE; METFORMIN; TENDON	Purpose To investigate the association between oral fluoroquinolones (FQ) and the risk of rhegmatogenous retinal detachment (RRD) using a nationwide population-based study in Korea, designed to control for time-related bias. Methods As a nested case-control study within a cohort, the KNHIS-NSC 2002-2013 (Korean National Health Insurance Service National Sample Cohort) data used for the investigation. The subjects who visited an ophthalmologist were included in a cohort. Subjects with infectious ocular diseases, severe ocular trauma, and congenital diseases were excluded. Within the cohort, subjects who underwent surgery for RRD were defined as cases, and controls were matched by age group, sex, and cohort entry date using an incidence density sampling method. After investigating the exposure to oral FQ, the odds ratio was calculated by the FQ exposure rate of both groups and adjusted by the confounding factors of demography, health service utilization, and comorbidities. Results A total of 1,151 subjects in the case group and 11,470 subjects in the control group were included. There were intergroup differences in household income, numbers of ophthalmologic visits and drug prescriptions, events of intraocular surgeries, and prevalence of diabetes and degenerative myopia (all P's<0.05). The crude odds ratio of the total group was 1.06 (P = 0.53, 95% CI 0.88-1.28), and the odds ratio adjusted for all pre-defined confounders was 1.00 (P = 0.99, 95% CI 0.81-1.24). The crude and adjusted odds ratios were not showed statistical significance (all P's>0.05). Conclusions By the nested case-control design, this study showed that oral administration of FQ was not associated with the increased risk of development of RRD.	[Choi, Seung Yong; Park, Young-Hoon] Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Lim, Hyun-A.; Yim, Hyeon Woo] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Park, Young-Hoon] Catholic Univ Korea, Catholic Inst Visual Sci, Coll Med, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea	Park, YH (corresponding author), Catholic Univ Korea, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.; Park, YH (corresponding author), Catholic Univ Korea, Catholic Inst Visual Sci, Coll Med, Seoul, South Korea.	parkyh@catholic.ac.kr			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1A6A1A03010528]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	Young-Noon Park was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A1A03010528) for data preparation.r This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1A6A1A03010528) for data preparation.	Alves C, 2016, ACTA OPHTHALMOL, V94, pe251, DOI 10.1111/aos.12931; Bidell MR, 2016, PHARMACOTHERAPY, V36, P679, DOI 10.1002/phar.1761; Bu SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134325; Cekic O, 1999, BRIT J OPHTHALMOL, V83, P1183, DOI 10.1136/bjo.83.10.1183; Cekic O, 2000, BRIT J OPHTHALMOL, V84, P1061, DOI 10.1136/bjo.84.9.1061; Chan EW, 2015, BRIT J CLIN PHARMACO, V80, P855, DOI 10.1111/bcp.12474; Chien LN, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007611; Chui CSL, 2014, J ANTIMICROB CHEMOTH, V69, P2563, DOI 10.1093/jac/dku145; Cohen SM, 2005, AM J OPHTHALMOL, V139, P777, DOI 10.1016/j.ajo.2005.01.014; Collins B, 2016, PHARMACOECONOMICS, V34, P101, DOI 10.1007/s40273-015-0306-7; Combs J L, 1982, Trans Am Ophthalmol Soc, V80, P64; Daneman N, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-010077; DELIGNY BH, 1984, THERAPIE, V39, P595; Douros A, 2015, EXPERT OPIN DRUG MET, V11, P25, DOI 10.1517/17425255.2014.970166; Eftekhari K, 2014, PHARMACOEPIDEM DR S, V23, P745, DOI 10.1002/pds.3623; Essebag Vidal, 2005, BMC Med Res Methodol, V5, P5, DOI 10.1186/1471-2288-5-5; Etminan M, 2012, JAMA-J AM MED ASSOC, V307, P1414, DOI 10.1001/jama.2012.383; Fife D, 2014, DRUG SAFETY, V37, P171, DOI 10.1007/s40264-014-0138-y; Fu P.K, 2015, THESIS NATL TAIWAN U, DOI [10.6342/NTU.2015.00289, DOI 10.6342/NTU.2015.00289]; Golozar A, 2016, CURR DIABETES REP, V16, DOI 10.1007/s11892-015-0697-z; Kapoor KG, 2014, OPHTHALMOLOGY, V121, P1269, DOI 10.1016/j.ophtha.2013.12.006; Kim L, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014008; Kuo SC, 2014, CLIN INFECT DIS, V58, P197, DOI 10.1093/cid/cit708; Levesque LE, 2010, BRIT MED J, V340, DOI 10.1136/bmj.b5087; Ohneberg K, 2015, METHOD INFORM MED, V54, P505, DOI 10.3414/ME14-01-0113; Pasternak B, 2013, JAMA-J AM MED ASSOC, V310, P2184, DOI 10.1001/jama.2013.280500; Raguideau F, 2016, JAMA OPHTHALMOL, V134, P415, DOI 10.1001/jamaophthalmol.2015.6205; Rampal S, 2008, HUM EXP TOXICOL, V27, P409, DOI 10.1177/0960327108092295; Rim TH, 2015, OPHTHALMOLOGY, V122, P1187, DOI 10.1016/j.ophtha.2015.01.020; Shakibaei M, 2001, ARCH TOXICOL, V75, P97, DOI 10.1007/s002040000203; SIRBAT D, 1983, J FR OPHTALMOL, V6, P829; Suissa S, 2012, DIABETES CARE, V35, P2665, DOI 10.2337/dc12-0788; Tsai WC, 2011, J ORTHOP RES, V29, P67, DOI 10.1002/jor.21196; U.S. Department of Health and Human Services Food and Drug Administration, 2011, 21158S018 NDA US DEP; Verbraeken H, 1996, GRAEF ARCH CLIN EXP, V234, pS59, DOI 10.1007/BF02343049; Walsh MC, 2012, CANCER EPIDEM BIOMAR, V21, P881, DOI 10.1158/1055-9965.EPI-11-1066	36	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195563	10.1371/journal.pone.0195563	http://dx.doi.org/10.1371/journal.pone.0195563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649310	gold, Green Submitted, Green Published			2022-12-26	WOS:000429791900057
J	Lian, HY; Lum, H; Alvarez, A; Garduno-Garcia, JD; Daniel, BJ; Musi, N				Lian, Hanyu; Lum, Helen; Alvarez, Andrea; Garduno-Garcia, Jose de Jesus; Daniel, Benjamin J.; Musi, Nicolas			A low dose lipid infusion is sufficient to induce insulin resistance and a pro-inflammatory response in human subjects	PLOS ONE			English	Article							SATURATED FATTY-ACIDS; ADIPOSE-TISSUE; PROTEIN-KINASE; OBESITY; ACTIVATION; EXPRESSION; MONOCYTES; MUSCLE; TYPE-2; CELLS	Objective The root cause behind the low-grade inflammatory state seen in insulin resistant (obesity and type 2 diabetes) states is unclear. Insulin resistant subjects have elevations in plasma free fatty acids (FFA), which are ligands for the pro-inflammatory toll-like receptor (TLR)4 pathway. We tested the hypothesis that an experimental elevation in plasma FFA (within physiological levels) in lean individuals would upregulate TLR4 and activate downstream pathways (e.g., MAPK) in circulating monocytes. Research design and methods Twelve lean, normal glucose-tolerant subjects received a low dose (30 ml/h) 48 h lipid or saline infusion on two different occasions. Monocyte TLR4 protein level, MAPK phosphorylation, and expression of genes in the TLR pathway were determined before and after each infusion. Results The lipid infusion significantly increased monocyte TLR4 protein and phosphorylation of JNK and p38 MAPK. Lipid-mediated increases in TLR4 and p38 phosphorylation directly correlated with reduced peripheral insulin sensitivity (M value). Lipid increased levels of multiple genes linked to inflammation, including several TLRs, CD180, MAP3K7, and CXCL10. Monocytes exposed in vivoto lipid infusion exhibited enhanced in vitro basal and LPS-stimulated IL-1 beta secretion. Conclusions In lean subjects, a small increase in plasma FFA (as seen in insulin resistant subjects) is sufficient to upregulate TLR4 and stimulate inflammatory pathways (MAPK) in monocytes. Moreover, lipids prime monocytes to endotoxin. We provide proof-of-concept data in humans indicating that the low-grade inflammatory state characteristic of obesity and type 2 diabetes could be caused (at least partially) by pro-inflammatory monocytes activated by excess lipids present in these individuals.	[Lian, Hanyu; Lum, Helen; Musi, Nicolas] UT Hlth San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Lian, Hanyu; Lum, Helen; Alvarez, Andrea; Garduno-Garcia, Jose de Jesus; Musi, Nicolas] UT Hlth San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA; [Lian, Hanyu; Lum, Helen; Musi, Nicolas] Audie L Murphy VA Med Ctr, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA; [Daniel, Benjamin J.] UT Hlth San Antonio, Dept Microbiol, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Geriatric Research Education & Clinical Center; University of Texas System; University of Texas Health San Antonio	Musi, N (corresponding author), UT Hlth San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.; Musi, N (corresponding author), UT Hlth San Antonio, Dept Med, Diabet Div, San Antonio, TX 78229 USA.; Musi, N (corresponding author), Audie L Murphy VA Med Ctr, Geriatr Res Educ & Clin Ctr, San Antonio, TX 78229 USA.	musi@uthscsa.edu	de Jesus Garduño Garcia, Jose/AAK-2413-2020; de Jesus Garduño Garcia, Jose/AAQ-7154-2021	de Jesus Garduño Garcia, Jose/0000-0003-2823-5955	National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK80157, R01-DK089229]; American Diabetes Association (GlaxoSmithKline) [7-13-GSK-01]; UTHSCSA, NIH-NCI [P30 CA054174-20, UL1TR001120];  [UL1TR000149];  [P30 AG044271];  [AG013319]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK089229, R01DK080157] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association (GlaxoSmithKline); UTHSCSA, NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; ; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases (R01-DK80157 and R01-DK089229), and the American Diabetes Association (GlaxoSmithKline grant number 7-13-GSK-01) to N.M. This work also was supported by grants UL1TR000149, P30 AG044271, and AG013319. This work was the result of work supported with resources and the use of facilities at South Texas Veterans Health Care System, San Antonio, Texas. Data for TLR cell surface expression and intracellular MAPK phosphorylation were generated in the Flow Cytometry Shared Resource Facility which is supported by UTHSCSA, NIH-NCI P30 CA054174-20 (CTRC at UTHSCSA) and UL1TR001120 (CTSA grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chow JC, 1999, J BIOL CHEM, V274, P10689, DOI 10.1074/jbc.274.16.10689; Chow S, 2005, CYTOM PART A, V67A, P4, DOI 10.1002/cyto.a.20167; Clemente-Postigo M, 2012, J LIPID RES, V53, P973, DOI 10.1194/jlr.P020909; Coen PM, 2010, METABOLISM, V59, P1775, DOI 10.1016/j.metabol.2010.05.002; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; de Mello VDF, 2008, DIABETOLOGIA, V51, P2060, DOI 10.1007/s00125-008-1132-7; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Haversen L, 2009, ATHEROSCLEROSIS, V202, P382, DOI 10.1016/j.atherosclerosis.2008.05.033; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Hussey SE, 2014, DIABETOLOGIA, V57, P582, DOI 10.1007/s00125-013-3111-x; Hussey SE, 2013, BIOSCIENCE REP, V33, P37, DOI 10.1042/BSR20120098; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Ley K, 2011, ARTERIOSCL THROM VAS, V31, P1506, DOI 10.1161/ATVBAHA.110.221127; Liang HY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0063983, 10.1371/journal.pone.0074121]; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Mudgett JS, 2000, P NATL ACAD SCI USA, V97, P10454, DOI 10.1073/pnas.180316397; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; REAVEN GM, 1988, AM J MED, V85, P106, DOI 10.1016/0002-9343(88)90402-0; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Reyna SM, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/107805; Segura M, 2002, CLIN EXP IMMUNOL, V127, P243, DOI 10.1046/j.1365-2249.2002.01768.x; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; van Oostrom AJ, 2004, NETH J MED, V62, P320; Viardot A, 2012, DIABETES-METAB RES, V28, P447, DOI 10.1002/dmrr.2302; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yin MJ, 1998, NATURE, V396, P77, DOI 10.1038/23948; Zhang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132575	35	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195810	10.1371/journal.pone.0195810	http://dx.doi.org/10.1371/journal.pone.0195810			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649324	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900092
J	Roberts, JM; Maniskas, ME; Bix, GJ				Roberts, Jill M.; Maniskas, Michael E.; Bix, Gregory J.			Bilateral carotid artery stenosis causes unexpected early changes in brain extracellular matrix and blood-brain barrier integrity in mice	PLOS ONE			English	Article							CHRONIC CEREBRAL HYPOPERFUSION; WHITE-MATTER LESIONS; SMALL VESSEL DISEASE; MOUSE MODEL; ALPHA-5-BETA-1 INTEGRIN; ISCHEMIC-STROKE; ACTIVATION; ENCEPHALOMYELITIS; MECHANISMS; REDUCTION	Bilateral carotid artery stenosis (BCAS) is one experimental model of vascular dementia thought to preferentially impact brain white matter. Indeed, few studies report hippocampal and cortical pathology prior to 30 days post-stenosis; though it is unclear whether those studies examined regions outside the white matter. Since changes in the blood-brain barrier (BBB) permeability precede more overt brain pathology in various diseases, we hypothesized that changes within the BBB and/or BBB-associated extracellular matrix (ECM) could occur earlier after BCAS in the hippocampus, cortex and striatum and be a precursor of longer term pathology. Here, C57BI/6 mice underwent BCAS or sham surgeries and changes in the BBB and ECM were analyzed by collagen IV (vascular basement membrane component), alpha 5 integrin (marker of endothelial activation), claudin-5 and occludin (tight junction proteins), Evans blue (permeability marker), Ki-67 (cell proliferation marker), and GFAP and CD11b (glial cell markers) immunohistochemistry after 14 days. Significant changes in markers of cerebrovascular integrity and glial activation were detected, not only in the striatum, but also in the hippocampus and cortex. In conclusion, this study demonstrates for the first time that changes in the BBB/ECM occur shortly after BCAS and within multiple brain regions and suggests such changes might underlie the gradual development of BCAS non-white matter pathology.	[Roberts, Jill M.; Maniskas, Michael E.; Bix, Gregory J.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA; [Roberts, Jill M.; Maniskas, Michael E.; Bix, Gregory J.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [Maniskas, Michael E.; Bix, Gregory J.] Univ Kentucky, Dept Neurosurg, Lexington, KY 40506 USA; [Bix, Gregory J.] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Maniskas, Michael E.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of Texas System; University of Texas Health Science Center Houston	Bix, GJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurosurg, Lexington, KY 40506 USA.; Bix, GJ (corresponding author), Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA.	gregorybix@uky.edu			National Institutes of Health [1 R01 NS089515-01]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS089515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institutes of Health (www.nih.gov), Grant # 1 R01 NS089515-01 to GJB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Clarke DN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045257; Floris S, 2004, BRAIN, V127, P616, DOI 10.1093/brain/awh068; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hattori Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32179; Holland PR, 2015, J CEREBR BLOOD F MET, V35, P1005, DOI 10.1038/jcbfm.2015.12; Hunt BJ, 1998, BRIT MED J, V316, P1328, DOI 10.1136/bmj.316.7141.1328; Huveneers S, 2007, INT J RADIAT BIOL, V83, P743, DOI 10.1080/09553000701481808; Ilzecka J, 1996, Ann Univ Mariae Curie Sklodowska Med, V51, P123; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Lee B, 2011, J CLIN INVEST, V121, P3005, DOI 10.1172/JCI46358; Levine DA, 2011, NEUROTHERAPEUTICS, V8, P361, DOI 10.1007/s13311-011-0047-z; Li LX, 2012, EXP NEUROL, V237, P46, DOI 10.1016/j.expneurol.2012.06.005; Li YW, 2008, NAT PROTOC, V3, P1703, DOI 10.1038/nprot.2008.172; Matter ML, 1998, J CELL BIOL, V141, P1019, DOI 10.1083/jcb.141.4.1019; Miki K, 2009, J NEUROSCI RES, V87, P1270, DOI 10.1002/jnr.21925; Miyamoto N, 2014, NEUROSCI LETT, V573, P40, DOI 10.1016/j.neulet.2014.05.005; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Morita K, 1999, J CELL BIOL, V145, P579, DOI 10.1083/jcb.145.3.579; Paul D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0755-8; Roberts J, 2017, J CEREBR BLOOD F MET, V37, P85, DOI 10.1177/0271678X15616979; Ronaldson PT, 2012, CURR PHARM DESIGN, V18, P3624; Shibata M, 2004, STROKE, V35, P2598, DOI 10.1161/01.STR.0000143725.19053.60; Toyama K, 2014, ARTERIOSCL THROM VAS, V34, P616, DOI 10.1161/ATVBAHA.113.302440; Wang D, 2016, J NEUROPHYSIOL, V116, P2173, DOI 10.1152/jn.00510.2016; Yang Z, 2014, CURR NEUROVASC RES, V11, P223, DOI 10.2174/1567202611666140520124407; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	27	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195765	10.1371/journal.pone.0195765	http://dx.doi.org/10.1371/journal.pone.0195765			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649307	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900084
J	Gildea, JJ; Xu, P; Kemp, BA; Carlson, JM; Tran, HT; Wang, DB; Langouet-Astrie, CJ; McGrath, HE; Carey, RM; Jose, PA; Felder, RA				Gildea, John J.; Xu, Peng; Kemp, Brandon A.; Carlson, Julia M.; Tran, Hanh T.; Wang, Dora Bigler; Langouet-Astrie, Christophe J.; McGrath, Helen E.; Carey, Robert M.; Jose, Pedro A.; Felder, Robin A.			Sodium bicarbonate cotransporter NBCe2 gene variants increase sodium and bicarbonate transport in human renal proximal tubule cells	PLOS ONE			English	Article							SPONTANEOUSLY HYPERTENSIVE-RAT; SERUM ANION GAP; BLOOD-PRESSURE; SALT SENSITIVITY; NA+-HCO3-COTRANSPORTER; EPITHELIAL-CELLS; ANGIOTENSIN-II; DEPENDENT REGULATION; CL-/HCO3-EXCHANGER; AFRICAN-AMERICAN	Rationale Salt sensitivity of blood pressure affects >30% of the hypertensive and >15% of the normo-tensive population. Variants of the electrogenic sodium bicarbonate cotransporter NBCe2 gene, SLC4A5, are associated with increased blood pressure in several ethnic groups. SLC4A5 variants are also highly associated with salt sensitivity, independent of hypertension. However, little is known about how NBCe2 contributes to salt sensitivity, although NBCe2 regulates renal tubular sodium bicarbonate transport. We hypothesized that SLC4A5 rs10177833 and rs7571842 increase NBCe2 expression and human renal proximal tubule cell (hRPTC) sodium transport and may be a cause of salt sensitivity of blood pressure. Objective To characterize the hRPTC ion transport of wild-type (WT) and homozygous variants (HV) of SLC4A5. Methods and results The expressions of NBCe2 mRNA and protein were not different between hRPTCs carrying WT or HV SLC4A5 before or after dopaminergic or angiotensin (II and III) stimulation. However, luminal to basolateral sodium transport, NHE3 protein, and Cl-/HCO3- exchanger activity in hRPTCs were higher in HV than WT SLC4A5. Increasing intracellular sodium enhanced the apical location of NBCe2 in HV hRPTCs (4.24 +/- 0.35% to 11.06 +/- 1.72% (P<0.05, N = 3, 2-way ANOVA, Holm-Sidak test)) as determined by Total Internal Reflection Fluorescence Microscopy (TIRFM). In hRPTCs isolated from kidney tissue, increasing intracellular sodium enhanced bicarbonate-dependent pH recovery rate and increased NBCe2 mRNA and protein expressions to a greater extent in HV than WT SLC4A5 (+38.00 +/- 6.23% vs HV normal salt (P<0.01, N = 4, 2-way ANOVA, Holm-Sidak test)). In hRPTCs isolated from freshly voided urine, bicarbonate-dependent pH recovery was also faster in those from salt-sensitive and carriers of HV SLC4A5 than from salt-resistant and carriers of WT SLC4A5. The faster NBCe2-specific bicarbonate-dependent pH recovery rate in HV SCL4A5 was normalized by SLC4A5-but not SLC4A4-shRNA. The binding of purified hepatocyte nuclear factor type 4A (HNF4A) to DNA was increased in hRPTCs carrying HV SLC4A5 rs7571842 but not rs10177833. The faster NBCe2-specific bicarbonate-dependent pH recovery rate in HV SCL4A5 was abolished by HNF4A antagonists. Conclusion NBCe2 activity is stimulated by an increase in intracellular sodium and is hyper-responsive in hRPTCs carrying HV SLC4A5 rs7571842 through an aberrant HNF4A-mediated mechanism.	[Gildea, John J.; Xu, Peng; Carlson, Julia M.; Tran, Hanh T.; Wang, Dora Bigler; Langouet-Astrie, Christophe J.; McGrath, Helen E.; Felder, Robin A.] Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA; [Kemp, Brandon A.; Carey, Robert M.] Univ Virginia, Dept Med, Charlottesville, VA USA; [Jose, Pedro A.] George Washington Univ, Dept Med, Sch Med & Hlth Sci, Div Renal Dis & Hypertens, Washington, DC USA; [Jose, Pedro A.] George Washington Univ, Dept Pharmacol & Physiol, Washington, DC USA	University of Virginia; University of Virginia; George Washington University; George Washington University	Felder, RA (corresponding author), Univ Virginia, Dept Pathol, Charlottesville, VA 22903 USA.	raf7k@virginia.edu		Langouet-Astrie, Christophe/0000-0002-1867-3815	National Heart Lung and Blood Institute [HL074940]; National Institute of Diabetes, Digestive Diseases and Kidney [DK039308]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL074940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039308] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes, Digestive Diseases and Kidney; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Heart Lung and Blood Institute HL074940, and National Institute of Diabetes, Digestive Diseases and Kidney DK039308.	Abramowitz MK, 2012, KIDNEY INT, V81, P1033, DOI 10.1038/ki.2011.479; Abuladze N, 2004, AM J PHYSIOL-CELL PH, V287, pC781, DOI 10.1152/ajpcell.00590.2003; Amlal H, 2001, KIDNEY INT, V60, P1824, DOI 10.1046/j.1523-1755.2001.00995.x; Banday AA, 2015, HYPERTENSION, V65, P1064, DOI 10.1161/HYPERTENSIONAHA.115.05255; Barkley RA, 2004, HYPERTENSION, V43, P477, DOI 10.1161/01.HYP.0000111585.76299.f7; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; BOYER MJ, 1992, CANCER RES, V52, P4441; Carey RM, 2012, HYPERTENSION, V60, P1359, DOI 10.1161/HYPERTENSIONAHA.112.196071; Chen LJ, 2013, J CELL MOL MED, V17, P437, DOI 10.1111/jcmm.12031; Chiolero A, 2000, HYPERTENSION, V36, P631, DOI 10.1161/01.HYP.36.4.631; Cooper RS, 2002, HYPERTENSION, V40, P629, DOI 10.1161/01.HYP.0000035708.02789.39; Damkier HH, 2007, AM J PHYSIOL-REG I, V293, pR2136, DOI 10.1152/ajpregu.00356.2007; Diarra A, 2001, AM J PHYSIOL-CELL PH, V280, pC1623, DOI 10.1152/ajpcell.2001.280.6.C1623; Doris PA, 2000, J HYPERTENS, V18, P509, DOI 10.1097/00004872-200018050-00002; Du ZP, 2012, AM J PHYSIOL-RENAL, V303, pF386, DOI 10.1152/ajprenal.00531.2011; Efendiev R, 2007, BRIT J PHARMACOL, V151, P1006, DOI 10.1038/sj.bjp.0707304; Efendiev R, 2002, J BIOL CHEM, V277, P11489, DOI 10.1074/jbc.M108182200; Felder RA, 2013, CURR OPIN NEPHROL HY, V22, P65, DOI 10.1097/MNH.0b013e32835b3693; FerrerMartinez A, 1996, BIOCHEM J, V319, P337, DOI 10.1042/bj3190337; Findeisen HM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0319-7; Forman JP, 2008, J HUM HYPERTENS, V22, P122, DOI 10.1038/sj.jhh.1002286; Furey TS, 2013, SCIENCE, V342, P705, DOI 10.1126/science.1246755; Gallegos TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040796; Gildea JJ, 2008, HYPERTENSION, V51, P360, DOI 10.1161/HYPERTENSIONAHA.107.100099; Gildea JJ, 2015, AM J PHYSIOL-REG I, V309, pR1447, DOI 10.1152/ajpregu.00150.2015; Gildea JJ, 2013, CLIN CHIM ACTA, V421, P236, DOI 10.1016/j.cca.2013.02.021; Gildea John J, 2013, Methods Mol Biol, V945, P329, DOI 10.1007/978-1-62703-125-7_20; Gildea JJ, 2012, HYPERTENSION, V60, P396, DOI 10.1161/HYPERTENSIONAHA.112.194175; Gildea JJ, 2009, HYPERTENSION, V54, P1070, DOI 10.1161/HYPERTENSIONAHA.109.134338; GOOD DW, 1993, SEMIN NEPHROL, V13, P225; Groger N, 2012, HUM MOL GENET, V21, P1025, DOI 10.1093/hmg/ddr533; Guo L, 2016, J HUM HYPERTENS, V30, P543, DOI 10.1038/jhh.2015.113; HABER RS, 1987, AM J PHYSIOL, V253, pF26, DOI 10.1152/ajprenal.1987.253.1.F26; Hahn-Windgassen A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000553; Horita S, 2002, HYPERTENSION, V40, P707, DOI 10.1161/01.HYP.0000036449.70110.DE; Hrdlickova B, 2014, BBA-MOL BASIS DIS, V1842, P1910, DOI 10.1016/j.bbadis.2014.03.011; Hunt SC, 2006, HYPERTENSION, V47, P532, DOI 10.1161/01.HYP.0000196949.26088.3c; Igarashi T, 1999, NAT GENET, V23, P264, DOI 10.1038/15440; Joe B, 2005, PHYSIOL GENOMICS, V23, P318, DOI 10.1152/physiolgenomics.00164.2004; Jose PA, 2010, BBA-MOL BASIS DIS, V1802, P1259, DOI 10.1016/j.bbadis.2010.02.004; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Kempson S, 2007, NITRIC OXIDE-BIOL CH, V17, P33, DOI 10.1016/j.niox.2007.05.002; Kowolik CM, 2004, ONCOGENE, V23, P5950, DOI 10.1038/sj.onc.1207801; Kunimi M, 2000, KIDNEY INT, V57, P534, DOI 10.1046/j.1523-1755.2000.00873.x; Kurtz I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00350; LaPointe MS, 2002, KIDNEY INT, V62, P157, DOI 10.1046/j.1523-1755.2002.00406.x; Lee SH, 2013, STEM CELLS, V31, P2396, DOI 10.1002/stem.1496; Lifton R. P., 2005, HARVEY LECT, V100, P71; Lynn KS, 2009, BIOINFORMATICS, V25, P981, DOI 10.1093/bioinformatics/btp106; Martovetsky G, 2013, MOL PHARMACOL, V84, P808, DOI 10.1124/mol.113.088229; McLean LA, 2000, AM J PHYSIOL-CELL PH, V278, pC676, DOI 10.1152/ajpcell.2000.278.4.C676; MOORE EDW, 1993, P NATL ACAD SCI USA, V90, P8058, DOI 10.1073/pnas.90.17.8058; Nakamura M, 2015, KIDNEY INT, V87, P535, DOI 10.1038/ki.2014.351; Nakamura M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/504808; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Ortiz PA, 2001, HYPERTENSION, V38, P621, DOI 10.1161/hy09t1.093361; Pedrosa R, 2004, AM J PHYSIOL-RENAL, V286; Pedrosa R, 2008, HYPERTENSION, V51, P1332, DOI 10.1161/HYPERTENSIONAHA.107.102434; Pedrosa R, 2007, HYPERTENSION, V49, P1186, DOI 10.1161/HYPERTENSIONAHA.106.083444; Perry C, 2008, AM J PHYSIOL-CELL PH, V295, pC1385, DOI 10.1152/ajpcell.00153.2008; Rao DC, 2003, AM J HYPERTENS, V16, P148, DOI 10.1016/S0895-7061(02)03247-8; Rice T, 2006, AM J HYPERTENS, V19, P270, DOI 10.1016/j.amjhyper.2005.09.006; Rice T, 2002, HYPERTENSION, V39, P1037, DOI 10.1161/01.HYP.0000018911.46067.6E; Romero MF, 2013, MOL ASPECTS MED, V34, P159, DOI 10.1016/j.mam.2012.10.008; SHARMA AM, 1993, HYPERTENSION, V22, P884, DOI 10.1161/01.HYP.22.6.884; Sharma AM, 1994, AM J MED SCI S1, V307, DOI [10.1038/ki.2011.479, DOI 10.1038/KI.2011.479]; Simao S, 2010, BIOCHEM PHARMACOL, V80, P913, DOI 10.1016/j.bcp.2010.05.013; Simao S, 2008, BIOCHEM PHARMACOL, V75, P2224, DOI 10.1016/j.bcp.2008.03.003; Simao S, 2013, LIFE SCI, V93, P435, DOI 10.1016/j.lfs.2013.07.026; Soleimani M, 2015, KIDNEY INT, V87, P497, DOI 10.1038/ki.2014.392; Stutz AM, 2009, EUR J HUM GENET, V17, P1481, DOI 10.1038/ejhg.2009.64; Svetkey LP, 1996, HYPERTENSION, V28, P854, DOI 10.1161/01.HYP.28.5.854; Taylor EN, 2007, HYPERTENSION, V50, P320, DOI 10.1161/HYPERTENSIONAHA.107.092643; Taylor JY, 2013, BIOL RES NURS, V15, P105, DOI 10.1177/1099800411419026; Taylor JY, 2009, BIOL RES NURS, V11, P53, DOI 10.1177/1099800409334817; Thiagarajan RD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017286; Turban S, 2006, KIDNEY INT, V70, P660, DOI 10.1038/sj.ki.5001571; Udali S, 2013, MOL ASPECTS MED, V34, P883, DOI 10.1016/j.mam.2012.08.001; Wang T, 1999, AM J PHYSIOL-RENAL, V277, pF298, DOI 10.1152/ajprenal.1999.277.2.F298; Wang XY, 2009, CURR OPIN NEPHROL HY, V18, P412, DOI 10.1097/MNH.0b013e32832f5775; Wang YC, 2012, J NEUROPHYSIOL, V108, P2024, DOI 10.1152/jn.00361.2012; Weinberger MH, 2001, HYPERTENSION, V37, P429, DOI 10.1161/01.HYP.37.2.429; Weinberger Myron H, 2006, J Cardiometab Syndr, V1, P217, DOI 10.1111/j.1559-4564.2006.05613.x; Wen DH, 2015, HYPERTENSION, V66, P68, DOI 10.1161/HYPERTENSIONAHA.115.05394; Whitehead A, 2012, J EXP BIOL, V215, P1293, DOI 10.1242/jeb.062075; Xu J, 2003, AM J PHYSIOL-RENAL, V284, pF41, DOI 10.1152/ajprenal.00055.2002; Yanai K, 1999, J BIOL CHEM, V274, P34605, DOI 10.1074/jbc.274.49.34605; Zhang HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep16188; Zhang MZ, 2011, J CLIN INVEST, V121, P2845, DOI 10.1172/JCI57324; Zhuo JL, 2013, COMPR PHYSIOL, V3, P1079, DOI 10.1002/cphy.c110061	90	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0189464	10.1371/journal.pone.0189464	http://dx.doi.org/10.1371/journal.pone.0189464			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29642240	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900004
J	Nikalje, GC; Variyar, PS; Joshi, MV; Nikam, TD; Suprasanna, P				Nikalje, Ganesh C.; Variyar, P. S.; Joshi, M. V.; Nikam, T. D.; Suprasanna, P.			Temporal and spatial changes in ion homeostasis, antioxidant defense and accumulation of flavonoids and glycolipid in a halophyte Sesuvium portulacastrum (L.) L.	PLOS ONE			English	Article							VACUOLAR NA+/H+ ANTIPORTER; SALT STRESS; SALINITY TOLERANCE; WATER-STRESS; H+-ATPASE; RESPONSES; PLANT; TRANSPORT; GROWTH; PROLINE	Salinity is an important environmental constraint limiting plant productivity. Understanding adaptive responses of halophytes to high saline environments may offer clues to manage and improve salt stress in crop plants. We have studied physiological, biochemical and metabolic changes in a perennial, fast growing halophyte, Sesuvium portulacastrum under 0 mM (control), 150 mM (low salt, LS) and 500 mM (high salt, HS) NaCl treatments. The changes in growth, relative water content, cation, osmolyte accumulation, H2O2 and antioxidant enzyme activity (SOD, CAT and APX) were observed under different treatment conditions. A positive correlation was revealed for sodium ion accumulation with malondialdehyde (r(2) = 0.77), proline (r(2) = 0.88) and chlorophyll content (r(2) = 0.82) under salt treatment while a negative correlation was observed with relative tissue water content (r(2) = -0.73). The roots and leaves showed contrasting accumulation of potassium and sodium ions under LS treatment. Temporal and spatial study of sodium and potassium ion content indicated differential accumulation pattern in roots and leaves, and, high potassium levels in root. Higher H2O2 content was recorded in roots than leaves and the antioxidant enzyme activities also showed significant induction under salt treatment conditions. Gene expression profiling of sodium transporters, Sodium proton exchanger (NHX3), Vacuolar ATPase (vATPase) and Salt overly sensitive1 (SOS1) showed up regulation under salt stress after 6-24 hr of NaCl treatment. Metabolite changes in the salt stressed leaves showed increased accumulation of flavonoids (3,5-dihydroxy-6,4'-dimethoxy-flavone-7-O-[alpha-L-rhamnopyranosyl-(1 -> 6)-beta-D-glucopyranoside], and 3,5-dihydroxy-6,3',4'-trimethoxy-flavone-7-O-[alpha-L-rhamnopyranosyl-(1 -> 6)-beta-D-glucopyranoside] in both LS and HS treatments, while a glycolipid, 1-O-linolenyl-2-O-(palmitoyl)-3-O-galactopyranosyl glycerol, accumulated more in LS over HS treatments and control. The results suggest that differential spatial and temporal cation levels in roots and leaves, and accumulation of flavanoid and glycolipid could be responsible for salt adaptation of S. portulacastrum.	[Nikalje, Ganesh C.; Nikam, T. D.] Savitribai Phule Pune Univ, Dept Bot, Pune, Maharashtra, India; [Nikalje, Ganesh C.; Suprasanna, P.] Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India; [Nikalje, Ganesh C.] RK Talreja Coll Arts Sci & Commerce, Dept Bot, Ulhasnagar, Thane, India; [Variyar, P. S.] Bhabha Atom Res Ctr, Food Technol Div, Bombay, Maharashtra, India; [Joshi, M. V.] Tata Inst Fundamental Res, Natl Facil High Field NMR, Bombay, Maharashtra, India	Savitribai Phule Pune University; Bhabha Atomic Research Center (BARC); Bhabha Atomic Research Center (BARC); Tata Institute of Fundamental Research (TIFR)	Suprasanna, P (corresponding author), Bhabha Atom Res Ctr, Nucl Agr & Biotechnol Div, Bombay, Maharashtra, India.	prasanna@barc.gov.in	Nikalje, Ganesh/X-2455-2019; PENNA, Suprasanna/AAE-1208-2022		Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai; Savitribai Phule Pune University, Pune	Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai; Savitribai Phule Pune University, Pune	GN is thankful to Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai and Savitribai Phule Pune University, Pune for the Ph.D. fellowship grant. No other funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; GN is thankful to Department of Atomic Energy, Government of India, Bhabha Atomic Research Centre, Trombay, Mumbai and Savitribai Phule Pune University, Pune for the Ph.D. fellowship grant and Dr. Archana Rai, Bhabha Atomic research Centre, Mumbai for guiding the expression analysis work.	Abideen Z, 2014, ENVIRON EXP BOT, V105, P70, DOI 10.1016/j.envexpbot.2014.04.009; Aebi H., 1974, METHOD ENZYMAT AN, V2, P674; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Agoramoorthy G, 2008, ASIAN J CHEM, V20, P1311; Al Hassan M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00473; Al-fadhli AA, 2008, THESIS; Alexieva V, 2001, PLANT CELL ENVIRON, V24, P1337, DOI 10.1046/j.1365-3040.2001.00778.x; Apse MP, 2007, FEBS LETT, V581, P2247, DOI 10.1016/j.febslet.2007.04.014; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Blumwald E, 2000, BBA-BIOMEMBRANES, V1465, P140, DOI 10.1016/S0005-2736(00)00135-8; Boscaiu M, 2013, J PLANT ECOL, V6, P177, DOI 10.1093/jpe/rts017; Bose J, 2014, J EXP BOT, V65, P1241, DOI 10.1093/jxb/ert430; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Das K, 2014, FRONT ENV SCI-SWITZ, V2, DOI 10.3389/fenvs.2014.00053; Demidchik V, 2010, J CELL SCI, V123, P1468, DOI 10.1242/jcs.064352; DIAZPEREZ JC, 1995, J EXP BOT, V46, P111, DOI 10.1093/jxb/46.1.111; Fini A, 2011, PLANT SIGNAL BEHAV, V6, P709, DOI 10.4161/psb.6.5.15069; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; Gargallo-Garriga A, 2014, SCI REP-UK, V4, DOI 10.1038/srep06829; Golldack D, 2001, PLANT PHYSIOL, V125, P1643, DOI 10.1104/pp.125.4.1643; Guo R, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-0994-6; Gupta B, 2014, INT J GENOMICS, V2014, DOI 10.1155/2014/701596; Hariadi Y, 2011, J EXP BOT, V62, P185, DOI 10.1093/jxb/erq257; Hasanuzzaman M, 2013, INT J MOL SCI, V14, P9643, DOI 10.3390/ijms14059643; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; Hernandez I, 2009, TRENDS PLANT SCI, V14, P125, DOI 10.1016/j.tplants.2008.12.003; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; Hsiao TC, 2000, J EXP BOT, V51, P1595, DOI 10.1093/jexbot/51.350.1595; Iwanaga F, 2015, LANDSC ECOL ENG, V11, P199, DOI 10.1007/s11355-014-0265-8; Jithesh MN, 2006, J GENET, V85, P237, DOI 10.1007/BF02935340; Joshi R., 2015, ELUCIDATION ABIOTIC; Kannan PR, 2013, APPL BIOCHEM BIOTECH, V171, P1925, DOI 10.1007/s12010-013-0475-9; Katschnig D, 2015, PLANT SCI, V234, P144, DOI 10.1016/j.plantsci.2015.02.011; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Kosova K, 2013, FUNCT PLANT BIOL, V40, P775, DOI 10.1071/FP12375; Kumari A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00537; Lokhande VH, 2013, AGRON SUSTAIN DEV, P4; Lokhande VH, 2010, PLANT CELL TISS ORG, V102, P17, DOI 10.1007/s11240-010-9699-3; Lowry OH, 1951, PROTEIN MEASUREMENT, P265; Maathuis FJM, 2014, J EXP BOT, V65, P849, DOI 10.1093/jxb/ert326; Mane AV, 2011, J ENVIRON BIOL, V32, P753; Mansour MMF, 2013, BIOL PLANTARUM, V57, P1, DOI 10.1007/s10535-012-0144-9; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Moshaei MR, 2014, SAUDI J BIOL SCI, V21, P394, DOI 10.1016/j.sjbs.2014.05.001; Mostofa MG, 2015, SCI REP-UK, V5, DOI 10.1038/srep11433; Muchate NS, 2016, BOT REV, V82, P371, DOI 10.1007/s12229-016-9173-y; Muchate NS, 2016, FLORA, V224, P96, DOI 10.1016/j.flora.2016.07.009; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Negrao S, 2017, ANN BOT-LONDON, V119, P1, DOI 10.1093/aob/mcw191; Nikalje GC, 2017, CURR GENOMICS, V18, P542, DOI [10.2174/1389201918666170228143007, 10.2174/1389202918666170228143007]; Nikalje GC, 2018, PLANT GENE, V13, P18, DOI DOI 10.1016/J.PLGENE.2017.11.003; Nikalje GC, 2017, LAND DEGRAD DEV, P1, DOI [10.1002/19r.2819, DOI 10.1002/19R.2819]; Ogawa A, 2006, PLANT PROD SCI, V9, P27, DOI 10.1626/pps.9.27; Pandey S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144469; Pardo-Domenech LL, 2016, PLANT BIOSYST, V150, P904, DOI 10.1080/11263504.2014.990943; Parida AK, 2005, ECOTOX ENVIRON SAFE, V60, P324, DOI 10.1016/j.ecoenv.2004.06.010; Parida AK, 2004, PLANT GROWTH REGUL, V42, P213, DOI 10.1023/B:GROW.0000026508.63288.39; Parida AK, 2013, J PLANT GROWTH REGUL, V32, P342, DOI 10.1007/s00344-012-9303-7; Parks GE, 2002, J EXP BOT, V53, P1055, DOI 10.1093/jexbot/53.371.1055; Popova OV, 2007, J PLANT PHYSIOL, V164, P1278, DOI 10.1016/j.jplph.2006.08.011; Qiu NW, 2007, PLANT SCI, V172, P1218, DOI 10.1016/j.plantsci.2007.02.013; Rabhi M, 2009, AFR J ECOL, V47, P463, DOI 10.1111/j.1365-2028.2008.00989.x; Rakhmankulova ZF, 2015, RUSS J PLANT PHYSL+, V62, P71, DOI 10.1134/S1021443715010112; Ramani B, 2004, Z NATURFORSCH C, V59, P835; Reginato MA, 2014, AOB PLANTS, V6, DOI 10.1093/aobpla/plu042; Sanadhya P, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv055; Sanchez DH, 2008, PHYSIOL PLANTARUM, V132, P209, DOI 10.1111/j.1399-3054.2007.00993.x; Sengupta S, 2009, PLANTA, V229, P911, DOI 10.1007/s00425-008-0878-y; Shabala L, 2012, PHYSIOL PLANTARUM, V146, P26, DOI 10.1111/j.1399-3054.2012.01599.x; Shabala S, 2014, PHYSIOL PLANTARUM, V151, P257, DOI 10.1111/ppl.12165; Shabala S, 2011, ADV BOT RES, V57, P151, DOI 10.1016/B978-0-12-387692-8.00005-9; Shi HZ, 2002, PLANT MOL BIOL, V50, P543, DOI 10.1023/A:1019859319617; Silva P, 2009, PLANT SIGNAL BEHAV, V48, P718; Slama I, 2015, ANN BOT-LONDON, V115, P433, DOI 10.1093/aob/mcu239; Srivastava AK, 2015, FRONT ENV SCI-SWITZ, V3, DOI 10.3389/fenvs.2015.00019; Stankovic MS, 2015, J ARID ENVIRON, V120, P26, DOI 10.1016/j.jaridenv.2015.04.008; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; STEWART GR, 1974, PLANTA, V120, P279, DOI 10.1007/BF00390296; Tester M, 2003, ANN BOT-LONDON, V91, P503, DOI 10.1093/aob/mcg058; Upchurch RG, 2008, BIOTECHNOL LETT, V30, P967, DOI 10.1007/s10529-008-9639-z; Vera-Estrella R, 2005, PLANT PHYSIOL, V139, P1507, DOI 10.1104/pp.105.067850; Wang SW, 2014, PLANT PHYSIOL, V165, P1144, DOI 10.1104/pp.114.238899; Watanabe S, 2000, PLANT CELL TISS ORG, V63, P199, DOI 10.1023/A:1010619503680; Yang CW, 2007, PLANT SOIL, V294, P263, DOI 10.1007/s11104-007-9251-3; Yang J, 2002, PLANT PHYSIOL, V130, P1032, DOI 10.1104/pp.004325; Yang YL, 2010, J PLANT GROWTH REGUL, V29, P465, DOI 10.1007/s00344-010-9158-8; Yi LP, 2007, SCI CHINA SER D, V50, P97, DOI 10.1007/s11430-007-5012-7; Yu BZ, 2014, PHYTOCHEMISTRY, V108, P77, DOI 10.1016/j.phytochem.2014.09.012; Yu JJ, 2011, J PROTEOME RES, V10, P3852, DOI 10.1021/pr101102p; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	93	16	18	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193394	10.1371/journal.pone.0193394	http://dx.doi.org/10.1371/journal.pone.0193394			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641593	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900013
J	Shimono, J; Miyoshi, H; Kiyasu, J; Kamimura, T; Eto, T; Miyagishima, T; Nagafuji, K; Seto, M; Teshima, T; Ohshima, K				Shimono, Joji; Miyoshi, Hiroaki; Kiyasu, Junichi; Kamimura, Tomohiko; Eto, Tetsuya; Miyagishima, Takuto; Nagafuji, Koji; Seto, Masao; Teshima, Takanori; Ohshima, Koichi			Clinicopathological analysis of polyploid diffuse large B-cell lymphoma	PLOS ONE			English	Article							CHOP CONSORTIUM PROGRAM; CHROMOSOMAL INSTABILITY; DNA-PLOIDY; GENOMIC INSTABILITY; POOR-PROGNOSIS; CANCER; HETEROGENEITY; EVOLUTION; SURVIVAL; EXPRESSION	Polyploid chromosomes are those with more than two sets of homologous chromosomes. Polyploid chromosomal abnormalities are observed in various malignant tumors. The prognosis in such cases is generally poor. However, there are no studies examining the prognosis of diffuse large B-cell lymphoma (DLBCL) with polyploid chromosomal abnormalities. Therefore, we statistically compared the clinicopathological features between polyploid DLBCL and DLBCL without polyploid abnormalities. Herein, 51 polyploid DLBCL and 53 control (without polyploid chromosomal abnormalities) cases were examined. G-banding method was employed to define polyploidy by cytogenetic analysis. Subsequently, flow cytometric immunophenotyping and immunohistochemical staining were performed. Polyploid DLBCL was defined as DLBCL with either near-tetraploid or greater number of chromosomes, as detected by the G-band. In a survival analysis, a significantly worse overall survival (OS) was observed for polyploid DLBCL (p = 0.04; p = 0.02 in cases who received R-CHOP regimens). In a multivariate analysis of OS, polyploid chromosomal abnormalities were an independent prognostic factor. Our results suggest that polyploid chromosomal abnormalities detected through G-band may represent a new poor prognostic factor for DLBCL.	[Shimono, Joji; Miyoshi, Hiroaki; Seto, Masao; Ohshima, Koichi] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan; [Shimono, Joji; Teshima, Takanori] Hokkaido Univ, Fac Med, Dept Hematol, Sapporo, Hokkaido, Japan; [Kiyasu, Junichi] Iizuka Hosp, Dept Hematol, Iizuka, Fukuoka, Japan; [Kamimura, Tomohiko] Harasanshin Hosp, Dept Hematol, Fukuoka, Japan; [Eto, Tetsuya] Hamanomachi Hosp, Dept Hematol, Fukuoka, Japan; [Miyagishima, Takuto] Kushiro Rosai Hosp, Dept Hematol, Kushiro, Hokkaido, Japan; [Nagafuji, Koji] Kurume Univ, Sch Med, Dept Hematol, Kurume, Fukuoka, Japan	Kurume University; Hokkaido University; Kurume University	Miyoshi, H (corresponding author), Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan.	miyoshi_hiroaki@med.kurume-u.ac.jp						Araujo SEA, 2007, DIS COLON RECTUM, V50, P1800, DOI 10.1007/s10350-007-9013-6; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Coiffier B, 2001, CURR OPIN ONCOL, V13, P325, DOI 10.1097/00001622-200109000-00003; Davaadelger B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110844; Dewhurst SM, 2014, CANCER DISCOV, V4, P175, DOI 10.1158/2159-8290.CD-13-0285; Falzetti D, 1999, HAEMATOLOGICA, V84, P298; Furuya T, 2000, CLIN CANCER RES, V6, P2815; Hans CP, 2004, BLOOD, V103, P275, DOI 10.1182/blood-2003-05-1545; Horn H, 2015, LEUKEMIA, V29, P1564, DOI 10.1038/leu.2015.43; Huang LS, 2017, LEUKEMIA RES, V53, P20, DOI 10.1016/j.leukres.2016.11.016; Kiyasu J, 2015, BLOOD, V126, P2193, DOI 10.1182/blood-2015-02-629600; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lipinski KA, 2016, TRENDS CANCER, V2, P49, DOI 10.1016/j.trecan.2015.11.003; Liu YY, 2010, LEUKEMIA LYMPHOMA, V51, P1692, DOI 10.3109/10428194.2010.502584; McGranahan N, 2015, CANCER CELL, V27, P15, DOI 10.1016/j.ccell.2014.12.001; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; Miyazaki M, 1999, CANCER RES, V59, P5283; Niitsu N, 2009, CANCER SCI, V100, P233, DOI 10.1111/j.1349-7006.2008.01035.x; Pantic M, 2006, ONCOGENE, V25, P4413, DOI 10.1038/sj.onc.1209486; Pinto AE, 2013, ANN SURG ONCOL, V20, P1530, DOI 10.1245/s10434-012-2804-6; Rossi Davide, 2002, Hematology, V7, P239, DOI 10.1080/1024533021000024058; Sawyer JR, 2005, GENE CHROMOSOME CANC, V42, P95, DOI 10.1002/gcc.20109; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shimono J, 2017, PATHOL INT, V67, P17, DOI 10.1111/pin.12478; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Suguro M, 2014, CANCER SCI, V105, P897, DOI 10.1111/cas.12442; Swerdlow SH, 2008, WHO CLASSIFICATION T; Umino A, 2011, BLOOD, V117, P5473, DOI 10.1182/blood-2010-12-327791; Xie Y, 2014, AM J CLIN PATHOL, V141, P593, DOI 10.1309/AJCPPHMZ6VHF0WQV; Xu-Monette ZY, 2013, BLOOD, V122, P2630, DOI 10.1182/blood-2012-12-473702; Xu-Monette ZY, 2012, BLOOD, V120, P3986, DOI 10.1182/blood-2012-05-433334; Yoshida M, 2015, PATHOL INT, V65, P519, DOI 10.1111/pin.12335; Yoshida M, 2012, PATHOL INT, V62, P518, DOI 10.1111/j.1440-1827.2012.02835.x; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	35	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194525	10.1371/journal.pone.0194525	http://dx.doi.org/10.1371/journal.pone.0194525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641580	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900034
J	Huang, LP; Yue, PP; Wu, XF; Yu, T; Wang, Y; Zhou, J; Kong, DR; Chen, KY				Huang, Liping; Yue, Pingping; Wu, Xuefei; Yu, Ting; Wang, Yang; Zhou, Ji; Kong, Derun; Chen, Keyang			Combined intervention of swimming plus metformin ameliorates the insulin resistance and impaired lipid metabolism in murine gestational diabetes mellitus	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; SKELETAL-MUSCLE; EXERCISE; PREGNANCY; MANAGEMENT; WOMEN; RISK; OBESITY	Gestational diabetes mellitus (GDM) has short-and long-term influence on pregnant women and fetus. Swimming, as an aerobic exercise, can effectively improve the blood glucose level in GDM, but the effect of mild swimming alone was not very substantial. Metformin, as an oral antidiabetic drug, has obvious hypoglycemic effect, and is economic also, but the long-term effect on pregnant women and fetus has not been completely clear. We hypothesize that combined intervention of mild swimming and low dose of metformin, may effectively reduce blood glucose, improve the pregnancy outcomes in GDM dams, but simultaneously avoiding the adverse effects caused by overdose of drug and impotence of mild swimming. The streptozotocin was used to stimulate C57BL/6J mice to develop GDM, by which serum glucose, TC, TG, LDL-C were increased significantly, meanwhile HDL-C was decreased significantly in the GDM control (DC) group compared with the normal control group. Swimming or metformin intervention slightly or moderately improves hyperglycemia, insulin sensitivity and lipid metabolism both in liver and skeletal muscle from GDM mice, while combined therapy of swimming plus metformin markedly ameliorated hyperglycemia (FPG, decreased by 22.2-59.5% from G10 to G18 versus DC group), insulin sensitivity (2.1 and 2.8 fold increase, respectively, in AKT activity versus DC group) and de novo lipogenesis (3.2 and 7.0 fold decrease, respectively, in ACC activity, and 1.94 and 5.1 fold decrease, respectively, in SREBP2 level, versus DC group) both in liver and skeletal muscle from GDM mice. We conclude that the combined intervention by metformin plus swimming may be more effective than single action to ameliorate glucose and lipid metabolism via improving insulin sensitivity in GDM mice.	[Huang, Liping; Yu, Ting; Wang, Yang] Anhui Med Univ, Sch Publ Hlth, Dept Maternal Child & Adolescent Hlth, Hefei, Anhui, Peoples R China; [Yue, Pingping; Kong, Derun] Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei, Anhui, Peoples R China; [Wu, Xuefei; Zhou, Ji; Chen, Keyang] Anhui Med Univ, Sch Publ Hlth, Dept Hyg Inspect & Quarantine, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University; Anhui Medical University	Kong, DR (corresponding author), Anhui Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Hefei, Anhui, Peoples R China.; Chen, KY (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Hyg Inspect & Quarantine, Hefei, Anhui, Peoples R China.	kongderun168@163.com; chenkeyang@ahmu.edu.cn			National Natural Science Foundation of China (NSFC) [81570786]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (NSFC, 81570786 to KC). The funder had role in study design and decision to publish.	Ajala O, 2015, DIABETES RES CLIN PR, V110, P309, DOI 10.1016/j.diabres.2015.10.004; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Ashwal E, 2015, CLIN CHIM ACTA, V451, P14, DOI 10.1016/j.cca.2015.01.021; Bao W, 2014, JAMA INTERN MED, V174, P1047, DOI 10.1001/jamainternmed.2014.1795; Colomiere M, 2010, J MOL ENDOCRINOL, V44, P213, DOI 10.1677/JME-09-0091; Comm Obstet Practice, 2015, OBSTET GYNECOL, V126, pe135, DOI 10.1097/AOG.0000000000001214; Cordero Y, 2015, MED SCI SPORT EXER, V47, P1328, DOI 10.1249/MSS.0000000000000547; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Dabelea D, 2007, DIABETES CARE, V30, pS169, DOI 10.2337/dc07-s211; Damm P, 2016, DIABETOLOGIA, V59, P1396, DOI 10.1007/s00125-016-3985-5; Dehghan F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25139; DeMaio M, 2009, J AM ACAD ORTHOP SUR, V17, P504, DOI 10.5435/00124635-200908000-00004; DEVLIN JT, 1992, DIABETES CARE, V15, P1690, DOI 10.2337/diacare.15.11.1690; Downs DS, 2017, PSYCHOL SPORT EXERC, V30, P73, DOI 10.1016/j.psychsport.2017.02.003; Ehrlich SF, 2017, DIABETES METAB, V43, P416, DOI 10.1016/j.diabet.2017.01.006; Gray SG, 2017, DIABETES OBES METAB, V19, P765, DOI 10.1111/dom.12893; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Gui J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064585; Hernandez TL, 2014, DIABETES CARE, V37, P1254, DOI 10.2337/dc13-2411; Hod M, 2015, INT J GYNECOL OBSTET, V131, pS173, DOI [10.1016/S0020-7292(15)30007-2, 10.1016/S0020-7292(15)30033-3]; Katz VL, 1996, SEMIN PERINATOL, V20, P285, DOI 10.1016/S0146-0005(96)80021-8; Kim C, 2010, INT J WOMENS HEALTH, V2, P339, DOI 10.2147/IJWH.S13333; Krycer JR, 2010, TRENDS ENDOCRIN MET, V21, P268, DOI 10.1016/j.tem.2010.01.001; Lappas M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115854; Li T, 2017, PEDIATR RES, V81, P663, DOI 10.1038/pr.2016.273; LOKEY E A, 1991, Medicine and Science in Sports and Exercise, V23, P1234; Luu W, 2012, BBA-MOL CELL RES, V1823, P458, DOI 10.1016/j.bbamcr.2011.09.017; Mulla WR, 2010, CURR DIABETES REP, V10, P224, DOI 10.1007/s11892-010-0109-3; Nikoulina SE, 2000, DIABETES, V49, P263, DOI 10.2337/diabetes.49.2.263; Niromanesh S, 2012, DIABETES RES CLIN PR, V98, P422, DOI 10.1016/j.diabres.2012.09.031; Pereira TJ, 2015, BIOCHEM CELL BIOL, V93, P438, DOI 10.1139/bcb-2014-0141; Pu J, 2015, PAEDIATR PERINAT EP, V29, P436, DOI 10.1111/ppe.12209; Qi J, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/1564386; Quilter CR, 2014, FASEB J, V28, P4868, DOI 10.1096/fj.14-255240; Reece EA, 2009, LANCET, V373, P1789, DOI 10.1016/S0140-6736(09)60515-8; Russo LM, 2015, OBSTET GYNECOL, V125, P576, DOI 10.1097/AOG.0000000000000691; Sivalingam VN, 2014, HUM REPROD UPDATE, V20, P853, DOI 10.1093/humupd/dmu037; Sreelakshmi P R, 2015, J Family Med Prim Care, V4, P395, DOI 10.4103/2249-4863.161331; Tertti K, 2013, DIABETES OBES METAB, V15, P246, DOI 10.1111/dom.12017; Tutino GE, 2014, DIABETIC MED, V31, P302, DOI 10.1111/dme.12396; Valvi D, 2017, ENVIRON INT, V107, P205, DOI 10.1016/j.envint.2017.07.016; Viana LV, 2014, DIABETES CARE, V37, P3345, DOI 10.2337/dc14-1530; Volpato GT, 2009, REPROD BIOMED ONLINE, V19, P852, DOI 10.1016/j.rbmo.2009.09.027; Wasinski F, 2015, NUTR METAB, V12, DOI 10.1186/s12986-015-0052-z; Wiernsperger N. F., 1999, DRUGS S1, V58, P75; Wiernsperger NF, 1999, DRUGS, V58, P31, DOI 10.2165/00003495-199958001-00009; Wysham WZ, 2016, TARGET ONCOL, V11, P763, DOI 10.1007/s11523-016-0442-9; Zhang C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049257	48	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195609	10.1371/journal.pone.0195609	http://dx.doi.org/10.1371/journal.pone.0195609			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677194	Green Submitted, gold, Green Published			2022-12-26	WOS:000430638900014
J	Duval, BD; Ghimire, R; Hartman, MD; Marsalis, MA				Duval, Benjamin D.; Ghimire, Rajan; Hartman, Melannie D.; Marsalis, Mark A.			Water and nitrogen management effects on semiarid sorghum production and soil trace gas flux under future climate	PLOS ONE			English	Article							OXIDE EMISSIONS; SWEET SORGHUM; US; FERTILIZER; MAIZE; YIELD; MODEL; ACCUMULATION; SENSITIVITY; SORGOLEONE	External inputs to agricultural systems can overcome latent soil and climate constraints on production, while contributing to greenhouse gas emissions from fertilizer and water management inefficiencies. Proper crop selection for a given region can lessen the need for irrigation and timing of N fertilizer application with crop N demand can potentially reduce N2O emissions and increase N use efficiency while reducing residual soil N and N leaching. However, increased variability in precipitation is an expectation of climate change and makes predicting biomass and gas flux responses to management more challenging. We used the DayCent model to test hypotheses about input intensity controls on sorghum (Sorghum bicolor (L.) Moench) productivity and greenhouse gas emissions in the southwestern United States under future climate. Sorghum had been previously parameterized for DayCent, but an inverse-modeling via parameter estimation method significantly improved model validation to field data. Aboveground production and N2O flux were more responsive to N additions than irrigation, but simulations with future climate produced lower values for sorghum than current climate. We found positive interactions between irrigation at increased N application for N2O and CO2 fluxes. Extremes in sorghum production under future climate were a function of biomass accumulation trajectories related to daily soil water and mineral N. Root C inputs correlated with soil organic C pools, but overall soil C declined at the decadal scale under current weather while modest gains were simulated under future weather. Scaling biomass and N2O fluxes by unit N and water input revealed that sorghum can be productive without irrigation, and the effect of irrigating crops is difficult to forecast when precipitation is variable within the growing season. These simulation results demonstrate the importance of understanding sorghum production and greenhouse gas emissions at daily scales when assessing annual and decadal-scale management decisions' effects on aspects of arid and semiarid agroecosystem biogeochemistry.	[Duval, Benjamin D.] New Mexico Inst Min & Technol, Dept Biol, Socorro, NM 87801 USA; [Ghimire, Rajan] New Mexico State Univ, Agr Sci Ctr, Clovis, NM USA; [Hartman, Melannie D.] Colorado State Univ, Nat Resource Ecol Lab, Ft Collins, CO 80523 USA; [Marsalis, Mark A.] New Mexico State Univ, Agr Sci Ctr, Los Lunas, NM USA	New Mexico Institute of Mining Technology; New Mexico State University; Colorado State University; New Mexico State University	Duval, BD (corresponding author), New Mexico Inst Min & Technol, Dept Biol, Socorro, NM 87801 USA.	benjamin.duval@nmt.edu	Ghimire, Rajan/AAF-6487-2020; Ghimire, Rajan/D-6947-2011	Ghimire, Rajan/0000-0002-6962-6066; 	Office of Research and Development at New Mexico Institute of Mining and Technology	Office of Research and Development at New Mexico Institute of Mining and Technology	Completion of this work was facilitated by an initial institutional award to B. Duval from the Office of Research and Development at New Mexico Institute of Mining and Technology.	Abalos D, 2016, AGR ECOSYST ENVIRON, V221, P214, DOI 10.1016/j.agee.2016.01.044; ADAMS RM, 1990, NATURE, V345, P219, DOI 10.1038/345219a0; Almodares A, 2006, J ENVIRON BIOL, V27, P601; Almodares A, 2014, J ENVIRON BIOL, V35, P733; [Anonymous], 2010, APPROACHES HIGHLY PA; Blanc E, EARTHS FUTURE; Brady NC, 2002, NATURE PROPERTY SOIL, V13; Chavan U., 2009, INDONES J AGRIC SCI, V10, P80, DOI [10.21082/ijas.v10n2.2009.p80-87, DOI 10.21082/IJAS.V10N2.2009.P80-87]; Chen ZC, 2016, GLOBAL BIOGEOCHEM CY, V30, P1192, DOI 10.1002/2015GB005313; Crawley M. J., 2012, R BOOK, DOI DOI 10.1111/j.1365-294X.2008.03806.x; Darapuneni MK, 2017, CROP FORAGE TURFGRAS, V3; Dayan FE, 2010, PHYTOCHEMISTRY, V71, P1032, DOI 10.1016/j.phytochem.2010.03.011; DEWET JMJ, 1978, AM J BOT, V65, P477, DOI 10.2307/2442706; Di HJ, 2002, NUTR CYCL AGROECOSYS, V64, P237, DOI 10.1023/A:1021471531188; Doherty J.E., 2015, WATERMARK NUMERICAL; Duval BD, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00546.1; Eltelib HA, THESIS; Fienen MN, 2013, GROUND WATER, V51, P157, DOI 10.1111/gwat.12018; Firestone M.K., 1989, EXCHANGE TRACE GASES, V47, P7, DOI DOI 10.1017/CBO9781107415324.004; Gealy DV, 2016, IEEE INT C AUT SCI E; Getachew G., 2016, American Journal of Plant Sciences, V7, P1106, DOI 10.4236/ajps.2016.77106; Gimsing AL, 2009, CHEMOSPHERE, V76, P1041, DOI 10.1016/j.chemosphere.2009.04.048; Grennell JL, THESIS; Headey D, 2011, FOOD POLICY, V36, P136, DOI 10.1016/j.foodpol.2010.10.003; Jamali H, 2015, AGR FOREST METEOROL, V208, P32, DOI 10.1016/j.agrformet.2015.04.010; Jung JS, 2016, KOREAN SOC GRASSLAND, V36, P215; Kebede H., 2014, Agricultural Sciences, V5, P1305, DOI 10.4236/as.2014.513139; Kozlowski T. T., 1984, Flooding and plant growth, P165; Kurukulasuriya P, 2008, AFR J AGRIC RESOUR E, V2, P105; Li A, 2016, J ENVIRON QUAL, V45, P675, DOI 10.2134/jeq2015.07.0404; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2014, SCIENCE, V344, P516, DOI 10.1126/science.1251423; Maharjan B, 2014, AGRON J, V106, P703, DOI 10.2134/agronj2013.0179; Marsalis MA, 2010, FIELD CROP RES, V116, P52, DOI 10.1016/j.fcr.2009.11.009; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Necpalova M, 2015, ENVIRON MODELL SOFTW, V66, P110, DOI 10.1016/j.envsoft.2014.12.011; Oates LG, 2016, GCB BIOENERGY, V8, P539, DOI 10.1111/gcbb.12268; Parton WJ, 1998, GLOBAL PLANET CHANGE, V19, P35, DOI 10.1016/S0921-8181(98)00040-X; Ramirez-Villegas J, 2013, AGR FOREST METEOROL, V170, P67, DOI 10.1016/j.agrformet.2011.09.005; Scharf PC, 2002, AGRON J, V94, P435; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Shukla S, 2017, FIELD CROP RES, V203, P181, DOI 10.1016/j.fcr.2016.12.004; Simons M, 2014, J EXP BOT, V65, P5657, DOI 10.1093/jxb/eru227; Stewart CE, 2015, GCB BIOENERGY, V7, P288, DOI 10.1111/gcbb.12142; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Stoner AMK, 2013, INT J CLIMATOL, V33, P2473, DOI 10.1002/joc.3603; Storlien JO, 2014, SOIL SCI SOC AM J, V78, P1694, DOI 10.2136/sssaj2014.04.0176; Team RC, 2014, R LANG ENV STAT COMP; Tesfamariam T, 2014, PLANT SOIL, V379, P325, DOI 10.1007/s11104-014-2075-z; Thivierge MN, 2015, NUTR CYCL AGROECOSYS, V102, P195, DOI 10.1007/s10705-015-9689-2; Thornton MM, DAYMET STATION LEVEL; Tolk JA, 2003, AGR WATER MANAGE, V59, P97, DOI 10.1016/S0378-3774(02)00157-9; Wang SJ, 2016, AGR ECOSYST ENVIRON, V220, P21, DOI 10.1016/j.agee.2015.12.030; Wang Y, 2017, PROGR SOIL SCI, P167, DOI 10.1007/978-3-319-43394-3_15; Web Soil Survey [internet] Soil Survey Staff, 2017, NAT RES CONS SERV; Zhang Y, 2013, J ENVIRON QUAL, V42, P1100, DOI 10.2134/jeq2012.0486	58	4	4	6	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195782	10.1371/journal.pone.0195782	http://dx.doi.org/10.1371/journal.pone.0195782			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672548	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800045
J	Tucker, S; Li, SR; Kaukinen, KH; Patterson, DA; Miller, KM				Tucker, Strahan; Li, Shaorong; Kaukinen, Karia H.; Patterson, David A.; Miller, Kristina M.			Distinct seasonal infectious agent profiles in life-history variants of juvenile Fraser River Chinook salmon: An application of high-throughput genomic screening	PLOS ONE			English	Article							VIRAL ERYTHROCYTIC NECROSIS; PROLIFERATIVE KIDNEY-DISEASE; PARASITE CERATOMYXA-SHASTA; NORTHEAST PACIFIC-OCEAN; HERRING CLUPEA-PALLASII; ONCORHYNCHUS-TSHAWYTSCHA; ATLANTIC SALMON; BRITISH-COLUMBIA; PUGET-SOUND; RENIBACTERIUM-SALMONINARUM	Disease-causing infectious agents are natural components of ecosystems and considered a major selective force driving the evolution of host species. However, knowledge of the presence and abundance of suites of infectious agents in wild populations has been constrained by our ability to easily screen for them. Using salmon as a model, we contrasted seasonal pathogenic infectious agents in life history variants of juvenile Chinook salmon from the Fraser River system (N = 655), British Columbia (BC), through the application of a novel high-throughput quantitative PCR monitoring platform. This included freshwater hatchery origin fish and samples taken at sea between ocean entry in spring and over-winter residence in coastal waters. These variants currently display opposite trends in productivity, with yearling stocks generally in decline and sub-yearling stocks doing comparatively well. We detected the presence of 32 agents, 21 of which were at > 1% prevalence. Variants carried a different infectious agent profile in terms of (1) diversity, (2) origin or transmission environment of infectious agents, and (3) prevalence and abundance of individual agents. Differences in profiles tended to reflect differential timing and residence patterns through freshwater, estuarine and marine habitats. Over all seasons, individual salmon carried an average of 3.7 agents. Diversity changed significantly, increasing upon saltwater entrance, increasing through the fall and decreasing slightly in winter. Diversity varied between life history types with yearling individuals carrying 1.3-times more agents on average. Shifts in prevalence and load over time were examined to identify agents with the greatest potential for impact at the stock level; those displaying concurrent decrease in prevalence and load truncation with time. Of those six that had similar patterns in both variants, five reached higher prevalence in yearling fish while only one reached higher prevalence in sub-yearling fish; this pattern was present for an additional five agents in yearling fish only.	[Tucker, Strahan; Li, Shaorong; Kaukinen, Karia H.; Miller, Kristina M.] Fisheries & Oceans Canada, Nanaimo, BC, Canada; [Patterson, David A.] Simon Fraser Univ, Cooperat Resource Management Inst, Sch Resource & Environm Management, Fisheries & Oceans Canada,Sci Branch, Burnaby, BC, Canada; [Miller, Kristina M.] Univ British Columbia, Forest & Conservat Sci, Vancouver, BC, Canada	Fisheries & Oceans Canada; Fisheries & Oceans Canada; Simon Fraser University; University of British Columbia	Tucker, S (corresponding author), Fisheries & Oceans Canada, Nanaimo, BC, Canada.	strahan.tucker@dfo-mpo.gc.ca			Pacific Salmon Foundation "Salish Sea Marine Survival" project; Genome British Columbia; Department of Fisheries and Oceans (DFO), Canada	Pacific Salmon Foundation "Salish Sea Marine Survival" project; Genome British Columbia; Department of Fisheries and Oceans (DFO), Canada	This project was part of the Strategic Salmon Health Initiative, co-funded by the Pacific Salmon Foundation "Salish Sea Marine Survival" project, Genome British Columbia, and the Department of Fisheries and Oceans (DFO), Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, 2016038 DFO CAN SCI; Bakke TA, 1998, CAN J FISH AQUAT SCI, V55, P247, DOI 10.1139/cjfas-55-S1-247; Bartholomew JL, 2006, J PARASITOL, V92, P742, DOI 10.1645/GE-781R.1; Bartholomew JL, 1997, J PARASITOL, V83, P859, DOI 10.2307/3284281; Bass AL, 2017, J FISH DIS, V40, P453, DOI 10.1111/jfd.12607; Beacham TD, 2006, T AM FISH SOC, V135, P861, DOI 10.1577/T05-241.1; Beamish R. J., 2013, N PACIFIC ANADROMOUS, V9, P38; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Borcard D, 2012, ECOLOGY, V93, P1473; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Chambers JM, 2013, SODA FUNCTIONS EXAMP; Chasco B, 2017, CANADIAN J FISHERIES, DOI [10.1139/cjfas-2016-0396, DOI 10.1139/CJFAS-2016-0396]; Claxton A, 2013, HYDROBIOLOGIA, V717, P27, DOI 10.1007/s10750-013-1564-z; CROFTON HD, 1971, PARASITOLOGY, V62, P179, DOI 10.1017/S0031182000071420; Daly EA, 2009, T AM FISH SOC, V138, P1420, DOI 10.1577/T08-226.1; DFO, 2016, 2016042 DFO CAN SCI; DFO, 2015, 2015039 DFO CAN SCI; Di Cicco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171471; Duesund H, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-19; Duffy EJ, 2010, T AM FISH SOC, V139, P803, DOI 10.1577/T08-244.1; Eizaguirre C, 2010, J FISH BIOL, V77, P2023, DOI 10.1111/j.1095-8649.2010.02819.x; Fujiwara M, 2011, T AM FISH SOC, V140, P1380, DOI 10.1080/00028487.2011.621811; FUREY NB, 2016, THESIS; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; GORDON DM, 1982, PARASITOLOGY, V84, P41, DOI 10.1017/S0031182000051647; Groot C., 1991, PACIFIC SALMON LIFE; Gunnarsson GS, 2017, AQUACULTURE, V468, P126, DOI 10.1016/j.aquaculture.2016.10.011; Hallett SL, 2012, APPL ENVIRON MICROB, V78, P3724, DOI 10.1128/AEM.07801-11; HANEY D C, 1992, Journal of Aquatic Animal Health, V4, P48, DOI 10.1577/1548-8667(1992)004&lt;0048:PAHCIC&gt;2.3.CO;2; Hanson M. Bradley, 2010, Endangered Species Research, V11, P69, DOI 10.3354/esr00263; Healey M., 1982, ESTUARINE COMP, P315; Hedrick R. P., 1993, Annual Review of Fish Diseases, V3, P277, DOI 10.1016/0959-8030(93)90039-E; Hershberger PK, 2009, J AQUAT ANIM HEALTH, V21, P1, DOI 10.1577/H08-035.1; Hershberger P, 2006, DIS AQUAT ORGAN, V70, P201, DOI 10.3354/dao070201; Hershberger P, 2013, FISHERIES, V38, P402, DOI 10.1080/03632415.2013.826202; Hertz E, 2015, MAR ECOL PROG SER, V537, P247, DOI 10.3354/meps11440; Hostetter NJ, 2011, T AM FISH SOC, V140, P1158, DOI 10.1080/00028487.2011.613303; Jacobson KC, 2008, MAR ECOL PROG SER, V354, P235, DOI 10.3354/meps07232; Jeffries KM, 2014, MOL ECOL, V23, P5803, DOI 10.1111/mec.12980; Jones S, 2006, J PARASITOL, V92, P1313, DOI 10.1645/GE-940R.1; Jones SRM, 2012, J EUKARYOT MICROBIOL, V59, P206, DOI 10.1111/j.1550-7408.2011.00614.x; Jones SRM, 2003, DIS AQUAT ORGAN, V54, P49, DOI 10.3354/dao054049; Kalbe M, 2002, J FISH BIOL, V60, P1529, DOI [10.1111/j.1095-8649.2002.tb02445.x, 10.1006/jfbi.2002.2013]; Kent M., 2011, 1 COH COMM, V1; Kent ML, 2005, FOLIA PARASIT, V52, P63, DOI 10.14411/fp.2005.009; Kocan RM, 2010, J PARASITOL, V96, P348, DOI 10.1645/GE-2292.1; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kotob MH, 2016, VET RES, V47, DOI 10.1186/s13567-016-0383-4; Krkosek M, 2006, P NATL ACAD SCI USA, V103, P15506, DOI 10.1073/pnas.0603525103; LaPatra SE, 2016, J AQUAT ANIM HEALTH, V28, P107, DOI 10.1080/08997659.2016.1159623; Legendre P., 2012, NUMERICAL ECOLOGY; Lenth R., 2016, LEAST SQUARES MEANS; MACMILLAN JR, 1979, J FISH RES BOARD CAN, V36, P1097, DOI 10.1139/f79-153; Maechler M., 2015, CLUSTER CLUSTER ANAL; Mesa MG, 1998, CAN J FISH AQUAT SCI, V55, P1599, DOI 10.1139/cjfas-55-7-1599; MEYERS TR, 1986, J FISH DIS, V9, P479, DOI 10.1111/j.1365-2761.1986.tb01045.x; Michelet L, 2014, FRONTIERS CELLULAR I, V4, P13, DOI [10.3389/fcimb.2014.00013, DOI 10.3389/FCIMB.2014.00013]; Miller KM, 2017, CONSERVATION PHYSL, V5; Miller KM, 2014, EVOL APPL, V7, P812, DOI 10.1111/eva.12164; Miller KM, 2011, SCIENCE, V331, P214, DOI 10.1126/science.1196901; Mitchell SO, 2013, DIS AQUAT ORGAN, V103, P35, DOI 10.3354/dao02563; Moles A, 1998, J FISH BIOL, V52, P146, DOI 10.1006/jfbi.1997.0571; Murray AG, 2003, DIS AQUAT ORGAN, V54, P1, DOI 10.3354/dao054001; Nylund S, 2011, DIS AQUAT ORGAN, V94, P41, DOI 10.3354/dao02313; Odegard J, 2011, AQUAC RES, V42, P103, DOI 10.1111/j.1365-2109.2010.02669.x; Okamura B, 2011, FRESHWATER BIOL, V56, P735, DOI 10.1111/j.1365-2427.2010.02465.x; Oksanen J., 2022, VEGAN COMMUNITY ECOL; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Porter M, SO CHINOOK CONSERVAT; R Development Core Team, 2016, R LANG ENV STAT COMP; Rahimian H, 1996, DIS AQUAT ORGAN, V27, P187, DOI 10.3354/dao027187; Rhodes LD, 2011, MAR ECOL PROG SER, V432, P161, DOI 10.3354/meps09160; Riddell B., 2013, ASSESSMENT STATUS FA; Saksida SM, 2012, J FISH DIS, V35, P137, DOI 10.1111/j.1365-2761.2011.01330.x; Sandell TA, 2015, J FISH DIS, V38, P365, DOI 10.1111/jfd.12243; Schmidt-Posthaus H, 2015, DIS AQUAT ORGAN, V114, P139, DOI 10.3354/dao02855; Schnute JT, 2008, PBS MAPPING 2 55 USE; Scott ME., 1994, PARASITIC INFECT DIS; SMITH JM, 1976, Q REV BIOL, V51, P277, DOI 10.1086/409311; Steinum T, 2010, DIS AQUAT ORGAN, V91, P201, DOI 10.3354/dao02266; Stocking RW, 2006, J AQUAT ANIM HEALTH, V18, P194, DOI 10.1577/H05-036.1; Sweeting RM, 2003, N AM J FISH MANAGE, V23, P492, DOI 10.1577/1548-8675(2003)023<0492:ROWCSB>2.0.CO;2; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; Teel DJ, 2014, N AM J FISH MANAGE, V34, P621, DOI 10.1080/02755947.2014.901258; Teffer AK, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox017; Tibshirani R, 2015, BOOTSTRAP FUNCTIONS; Toenshoff ER, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032696; Torchiano M., 2016, PERMUTATION TESTS LI; Traxler G.S., 1999, AM FISH SOC FISH HLT, V27, P4; Trudel M, 2009, T AM FISH SOC, V138, P1369, DOI 10.1577/T08-181.1; Tucker S, 2012, MAR ECOL PROG SER, V449, P245, DOI 10.3354/meps09528; Tucker S, 2011, T AM FISH SOC, V140, P1101, DOI 10.1080/00028487.2011.607035; Urawa S, 2011, DIS AQUAT ORGAN, V96, P229, DOI 10.3354/dao02398; Waples RS, 2004, EVOLUTION, V58, P386, DOI 10.1111/j.0014-3820.2004.tb01654.x; Wessel O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183781; Wilber MQ, 2016, INT J PARASITOL, V46, P59, DOI 10.1016/j.ijpara.2015.08.009; Wolf K., 1988, VIRAL ERYTHROCYTIC N, P389	98	26	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195472	10.1371/journal.pone.0195472	http://dx.doi.org/10.1371/journal.pone.0195472			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672620	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800029
J	Araujo, T; Mendonca, AM; Campilho, A				Araujo, Teresa; Mendonca, Ana Maria; Campilho, Aurelio			Parametric model fitting-based approach for retinal blood vessel caliber estimation in eye fundus images	PLOS ONE			English	Article								Background Changes in the retinal vessel caliber are associated with a variety of major diseases, namely diabetes, hypertension and atherosclerosis. The clinical assessment of these changes in fundus images is tiresome and prone to errors and thus automatic methods are desirable for objective and precise caliber measurement. However, the variability of blood vessel appearance, image quality and resolution make the development of these tools a non-trivial task. Metholodogy A method for the estimation of vessel caliber in eye fundus images via vessel cross-sectional intensity profile model fitting is herein proposed. First, the vessel centerlines are determined and individual segments are extracted and smoothed by spline approximation. Then, the corresponding cross-sectional intensity profiles are determined, post-processed and ultimately fitted by newly proposed parametric models. These models are based on Difference-of-Gaussians (DoG) curves modified through a multiplying line with varying inclination. With this, the proposed models can describe profile asymmetry, allowing a good adjustment to the most difficult profiles, namely those showing central light reflex. Finally, the parameters of the best-fit model are used to determine the vessel width using ensembles of bagged regression trees with random feature selection. Results and conclusions The performance of our approach is evaluated on the REVIEW public dataset by comparing the vessel cross-sectional profile fitting of the proposed modified DoG models with 7 and 8 parameters against a Hermite model with 6 parameters. Results on different goodness of fitness metrics indicate that our models are constantly better at fitting the vessel profiles. Furthermore, our width measurement algorithm achieves a precision close to the observers, outperforming state-of-the art methods, and retrieving the highest precision when evaluated using cross-validation. This high performance supports the robustness of the algorithm and validates its use in retinal vessel width measurement and possible integration in a system for retinal vasculature assessment.	[Araujo, Teresa; Mendonca, Ana Maria; Campilho, Aurelio] Univ Porto, Fac Engn, P-4200465 Porto, Portugal; [Araujo, Teresa; Mendonca, Ana Maria; Campilho, Aurelio] Inst Engn Sistemas & Comp Tecnol & Ciencia INESC, P-4200 Porto, Portugal	Universidade do Porto; INESC TEC	Araujo, T (corresponding author), Univ Porto, Fac Engn, P-4200465 Porto, Portugal.; Araujo, T (corresponding author), Inst Engn Sistemas & Comp Tecnol & Ciencia INESC, P-4200 Porto, Portugal.	tfaraujo@inesctec.pt	Mendonça, Ana Maria/AIC-8438-2022; Araújo, Teresa/F-5629-2016; Mendonça, Ana Maria/M-7629-2013; Campilho, Aurelio/M-4869-2013	Mendonça, Ana Maria/0000-0002-4319-738X; Araújo, Teresa/0000-0001-9687-528X; Mendonça, Ana Maria/0000-0002-4319-738X; Campilho, Aurelio/0000-0002-5317-6275	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/122365/2016]; ERDF European Regional Development Fund through the Operational Programme for Competitiveness and Internationalisation - COMPETE Programme; FCT [CMUP-ERI/TIC/0028/2014]; Doctoral Program in Electrical and Computer Engineering (PDEEC) from Faculdade de Engenharia da Universidade do Porto (FEUP)	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ERDF European Regional Development Fund through the Operational Programme for Competitiveness and Internationalisation - COMPETE Programme; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Doctoral Program in Electrical and Computer Engineering (PDEEC) from Faculdade de Engenharia da Universidade do Porto (FEUP)	Teresa Araujo is funded by the Fundacao para a Ciencia e a Tecnologia (FCT) grant contract SFRH/BD/122365/2016. This work is financed by the ERDF European Regional Development Fund through the Operational Programme for Competitiveness and Internationalisation - COMPETE 2020 Programme, and by National Funds through the FCT within project CMUP-ERI/TIC/0028/2014. Publication fees are partially financed by the Doctoral Program in Electrical and Computer Engineering (PDEEC) from Faculdade de Engenharia da Universidade do Porto (FEUP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; Al-Diri B, 2009, IEEE T MED IMAGING, V28, P1488, DOI 10.1109/TMI.2009.2017941; Al-Diri B, 2008, IEEE ENG MED BIO, P2262, DOI 10.1109/IEMBS.2008.4649647; Aliahmad B., 2012, P BIOS BIOR C, P1; Araujo T, 2017, SPIE MED IMAGING; Arlinghaus S. L., 1994, PRACTICAL HDB CURVE; Bankhead P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032435; Besenczi R, 2016, COMPUT STRUCT BIOTEC, V14, P371, DOI 10.1016/j.csbj.2016.10.001; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brinchmann-Hansen O., 2009, ACTA OPHTHALMOL, V64, P33, DOI [DOI 10.1111/J.1755-3768.1986.TB00701.X, 10.1111/j.1755-3768.1986.tb00701.x]; Cavinato A, 2013, I S BIOMED IMAGING, P872; Chapman N, 2001, BRIT J OPHTHALMOL, V85, P74, DOI 10.1136/bjo.85.1.74; Coleman T., 1999, USE MATLAB USERS GUI; Elhami M, 2017, J MED IMAGING, V4; Gang L, 2002, IEEE T BIO-MED ENG, V49, P168, DOI 10.1109/10.979356; Gao XH, 2001, 2001 INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, VOL II, PROCEEDINGS, P881, DOI 10.1109/ICIP.2001.958635; Girard F, 2014, P OPHTH MED IM AN 1, P41, DOI DOI 10.17077/OMIA; Gonzalez R.C., 2017, DIGITAL IMAGE PROCES, V4th ed.; GREGSON PH, 1995, COMPUT BIOMED RES, V28, P291, DOI 10.1006/cbmr.1995.1020; Hunter A, 2005, P 3 EUR MED BIOL ENG, V11, P3; Ikram MK, 2013, OPHTHALMOLOGICA, V229, P125, DOI 10.1159/000342158; Kumar Dinesh K, 2012, ISRN Ophthalmol, V2012, P151369, DOI [10.5402/2012/474830, 10.5402/2012/151369]; LAM L, 1992, IEEE T PATTERN ANAL, V14, P869, DOI 10.1109/34.161346; LEE ETY, 1989, COMPUT AIDED DESIGN, V21, P363, DOI 10.1016/0010-4485(89)90003-1; Leontidis G, 2016, COMPUT BIOL MED, V72, P65, DOI 10.1016/j.compbiomed.2016.03.006; Li HQ, 2003, IEEE IMAGE PROC, P1069; Li YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087505; Lowell J, 2004, IEEE T MED IMAGING, V23, P1196, DOI 10.1109/TMI.2004.830524; Lupascu CA, 2013, MED IMAGE ANAL, V17, P1164, DOI 10.1016/j.media.2013.07.006; Martinez-Perez ME, 2000, COMPUTER ANAL GEOMET; Mendonca AM, 2014, IMAGE ANALYSIS AND MODELING IN OPHTHALMOLOGY, P85; Nguyen TT, 2007, DIABETES CARE, V30, P2708, DOI 10.2337/dc07-0732; Poletti E, 2012, IEEE ENG MED BIO, P4958, DOI 10.1109/EMBC.2012.6347105; Rice J. R., 1969, APPROXIMATION FUNCTI, V2; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Trucco E, 2013, ISSNIP BIOSIG BIOROB, P363; Vazquez SG, 2013, COMP MED SY, P71, DOI 10.1109/CBMS.2013.6627767; Wang L, 2007, IEEE T MED IMAGING, V26, P137, DOI 10.1109/TMI.2006.889732; Xu X, 2011, I S BIOMED IMAGING, P641, DOI 10.1109/ISBI.2011.5872488; Yin Y, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/260410; Yuan Y., 2000, P 4 INT C IND APPL M, P271; ZHOU LA, 1994, IEEE T MED IMAGING, V13, P619, DOI 10.1109/42.363106	43	9	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194702	10.1371/journal.pone.0194702	http://dx.doi.org/10.1371/journal.pone.0194702			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668759	gold, Green Submitted, Green Published			2022-12-26	WOS:000430290200013
J	McIntosh, J; Alonso, A; MacLure, K; Stewart, D; Kempen, T; Mair, A; Castel-Branco, M; Codina, C; Fernandez-Llimos, F; Fleming, G; Gennimata, D; Gillespie, U; Harrison, C; Illario, M; Junius-Walker, U; Kampolis, CF; Kardas, P; Lewek, P; Malva, J; Menditto, E; Scullin, C; Wiese, B				McIntosh, Jennifer; Alonso, Albert; MacLure, Katie; Stewart, Derek; Kempen, Thomas; Mair, Alpana; Castel-Branco, Margarida; Codina, Carles; Fernandez-Llimos, Fernando; Fleming, Glenda; Gennimata, Dimitra; Gillespie, Ulrika; Harrison, Cathy; Illario, Maddalena; Junius-Walker, Ulrike; Kampolis, Christos F.; Kardas, Przemyslaw; Lewek, Pawel; Malva, Joao; Menditto, Enrica; Scullin, Claire; Wiese, Birgitt		SIMPATHY Consortium	A case study of polypharmacy management in nine European countries: Implications for change management and implementation	PLOS ONE			English	Article							ADVERSE DRUG EVENTS; CARE MANAGEMENT; RISK-FACTORS; HEALTH-CARE; PREVALENCE; MULTIMORBIDITY; DISEASE; BURDEN	Background Multimorbidity and its associated polypharmacy contribute to an increase in adverse drug events, hospitalizations, and healthcare spending. This study aimed to address: what exists regarding polypharmacy management in the European Union (EU); why programs were, or were not, developed; and, how identified initiatives were developed, implemented, and sustained. Methods Change management principles (Kotter) and normalization process theory (NPT) informed data collection and analysis. Nine case studies were conducted in eight EU countries: Germany (Lower Saxony), Greece, Italy (Campania), Poland, Portugal, Spain (Catalonia), Sweden (Uppsala), and the United Kingdom (Northern Ireland and Scotland). The workflow included a review of country/region specific polypharmacy policies, key informant interviews with stakeholders involved in policy development and implementation and, focus groups of clinicians and managers. Data were analyzed using thematic analysis of individual cases and framework analysis across cases. Results Polypharmacy initiatives were identified in five regions (Catalonia, Lower Saxony, Northern Ireland, Scotland, and Uppsala) and included all care settings. There was agreement, even in cases without initiatives, that polypharmacy is a significant issue to address. Common themes regarding the development and implementation of polypharmacy management initiatives were: locally adapted solutions, organizational culture supporting innovation and teamwork, adequate workforce training, multidisciplinary teams, changes in workflow, redefinition of roles and responsibilities of professionals, policies and legislation supporting the initiative, and data management and information and communication systems to assist development and implementation. Depending on the setting, these were considered either facilitators or barriers to implementation. Conclusion Within the studied EU countries, polypharmacy management was not widely addressed. These results highlight the importance of change management and theory-based implementation strategies, and provide examples of polypharmacy management initiatives that can assist managers and policymakers in developing new programs or scaling up existing ones, particularly in places currently lacking such initiatives.	[McIntosh, Jennifer; Alonso, Albert] Fundacio Clin Recerca Biorned, Dept Recerca & Innovacio, Barcelona, Spain; [MacLure, Katie; Stewart, Derek] Robert Gordon Univ, Sch Pharm & Life Sci, Aberdeen, Scotland; [Kempen, Thomas; Gillespie, Ulrika] Uppsala Univ Hosp, Pharm Dept, Uppsala, Sweden; [Mair, Alpana] Scottish Govt, Effect Prescribing & Therapeut, Hlth & Social Care Directorate, Edinburgh, Midlothian, Scotland; [Castel-Branco, Margarida] Univ Coimbra, Lab Pharmacol & Pharmaceut Care, Fac Pharm, Coimbra, Portugal; [Codina, Carles] Hosp Clin Barcelona, Serv Farm, Barcelona, Spain; [Fernandez-Llimos, Fernando] Univ Lisbon, Inst Med Res, Dept Social Pharm, Fac Pharm, Lisbon, Portugal; [Fleming, Glenda] Northern Hlth & Social Care Trust, Pharm Dept, Belfast, Antrim, North Ireland; [Fleming, Glenda] Northern Hlth & Social Care Trust, Reg Med Optimisat Innovat Ctr MOIC, Belfast, Antrim, North Ireland; [Gennimata, Dimitra; Kampolis, Christos F.] Univ Peloponnese, Dept Social & Educ Policy, Korinthos, Greece; [Gennimata, Dimitra; Kampolis, Christos F.] Ist Reg Hlth Author Attica, eHlth Innovat Unit, Athens, Greece; [Harrison, Cathy] Dept Hlth, Belfast, Antrim, North Ireland; [Illario, Maddalena] Federico II Univ Hosp, Naples, Italy; [Junius-Walker, Ulrike; Wiese, Birgitt] Hannover Med Sch, Inst Gen Practice, Hannover, Germany; [Kardas, Przemyslaw; Lewek, Pawel] Med Univ Lodz, Dept Family Med, Lodz, Poland; [Malva, Joao] Univ Coimbra, Fac Med, Inst Biomed Imaging & Life Sci, Coimbra, Portugal; [Malva, Joao] Univ Coimbra, Fac Med, Inst Pharmacol & Expt Therapeut, Coimbra, Portugal; [Menditto, Enrica] Univ Naples Federico II, Ctr Pharmacoecon, CIRFF, Naples, Italy; [Scullin, Claire] Queens Univ, Sch Pharm, Clin & Practice Res Grp, Belfast, Antrim, North Ireland	Robert Gordon University; Uppsala University; Uppsala University Hospital; Universidade de Coimbra; University of Barcelona; Hospital Clinic de Barcelona; Universidade de Lisboa; University of Peloponnese; University of Naples Federico II; Hannover Medical School; Medical University Lodz; Universidade de Coimbra; Universidade de Coimbra; University of Naples Federico II; Queens University Belfast	McIntosh, J (corresponding author), Fundacio Clin Recerca Biorned, Dept Recerca & Innovacio, Barcelona, Spain.	mcintosh@clinic.cat	Castel-Branco, Maria Margarida/A-2093-2017; iMed.ULisboa, PEPSocPh/B-4101-2014; Fernandez-Llimos, Fernando/B-8931-2008; MacLure, Katie/GRJ-8912-2022; Malva, Joao/L-3557-2014	Castel-Branco, Maria Margarida/0000-0002-6533-9932; Fernandez-Llimos, Fernando/0000-0002-8529-9595; fleming, glenda/0000-0001-7321-8092; McIntosh, Jenifer/0000-0002-8140-9304; MacLure, Katie/0000-0003-0686-948X; Alonso, Albert/0000-0003-0921-8033; menditto, enrica/0000-0001-8633-5650; Lewek, Pawel/0000-0003-3690-7096; Kardas, Przemyslaw/0000-0002-6078-2628; Malva, Joao/0000-0002-5438-4447; orlando, valentina/0000-0002-8209-8878; Kempen, Thomas/0000-0001-5173-5005	SIMPATHY project [663082]; European Commission CHAFEA Health Program	SIMPATHY project; European Commission CHAFEA Health Program	This work has been supported by the SIMPATHY project, grant agreement number 663082 to AM, co-funded by the European Commission CHAFEA Health Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Benziger CP, 2016, GLOB HEART, V11, P393, DOI 10.1016/j.gheart.2016.10.024; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Canadian Electronic Library (Firm), BETT HLTH BETT CAR B; Cooper JA, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009235; Craig P, 2006, DEV EVALUATING COMPL; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Field TS, 2004, J AM GERIATR SOC, V52, P1349, DOI 10.1111/j.1532-5415.2004.52367.x; Field TS, 2001, ARCH INTERN MED, V161, P1629, DOI 10.1001/archinte.161.13.1629; Fortin M, 2006, ANN FAM MED, V4, P104, DOI 10.1370/afm.516; Fortin Martin, 2004, Health Qual Life Outcomes, V2, P51, DOI 10.1186/1477-7525-2-51; Foster M, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1270-4; Fu S, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140205; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Guiding principles for the care of older adults with multimorbidity: an approach for clinicians, 2012, J Am Geriatr Soc, V60, pE1, DOI 10.1111/j.1532-5415.2012.04188.x; Holtrop JS, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1613-1; Iles V, 2001, NATL COORDINATING CT; Institute of Medicine (U. S.), 2001, COMM QUAL HLTH CAR A, pxx; Jager C, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-016-0535-y; Kojima G, 2012, JAMDA, V13, pe11; Kotter J. P, 2012, LEADING CHANGE; Lee JK, 2013, J AM GERIATR SOC, V61, P1119, DOI 10.1111/jgs.12323; Loffler C, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0151-7; Mair AF-LF, 2017, SIMPATHY CONSORTIUM; Marcum ZA, 2012, J AM GERIATR SOC, V60, P34, DOI 10.1111/j.1532-5415.2011.03772.x; May CR, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-29; Menotti A, 2001, J CLIN EPIDEMIOL, V54, P680, DOI 10.1016/S0895-4356(00)00368-1; Molokhia M, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0642-0; OECD/EU, 2016, 2016 STAT HLTH EU CY; Patterson SM, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD008165.pub3, 10.1002/14651858.CD008165.pub4]; Payne RA, 2011, BRIT J GEN PRACT, V61, P83, DOI 10.3399/bjgp11X556146; Petrovic M, 2016, DRUG AGING, V33, P179, DOI 10.1007/s40266-016-0352-7; Rollason V, 2003, DRUG AGING, V20, P817, DOI 10.2165/00002512-200320110-00003; Stewart D, 2017, PLOS ONE; Stewart D, 2017, EXPERT OPIN DRUG SAF, V16, P203, DOI 10.1080/14740338.2017.1265503; Stewart D, 2016, INT J CLIN PHARM-NET, V38, P615, DOI 10.1007/s11096-015-0216-y; Stoehr GP, 2008, AM J GERIATR PHARMAC, V6, P255, DOI 10.1016/j.amjopharm.2008.11.001; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Valentijn PP, 2013, INT J INTEGR CARE, V13; Valentijn PP, 2015, BMC FAM PRACT, V16, DOI 10.1186/s12875-015-0278-x; van den Bussche H, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-54; van Oostrom SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160264; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; World Health Organization, 2017, MED HARM; World Health Organization, 2016, MULT TECHN SER SAF P; Yin R.K., 2017, APPL CASE STUDY RES; Yuksel I., 2012, IJBM, V7, P14; Zulman DM, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-007771	50	25	25	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195232	10.1371/journal.pone.0195232	http://dx.doi.org/10.1371/journal.pone.0195232			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668763	Green Published, gold			2022-12-26	WOS:000430290200034
J	Scanga, SE; Hasanspahic, B; Zvornicanin, E; Kozenjic, JS; Rahme, AK; Shinn-Thomas, JH				Scanga, Sara E.; Hasanspahic, Bilal; Zvornicanin, Edin; Kozenjic, Jasmina Samardzic; Rahme, Andrew K.; Shinn-Thomas, Jessica H.			Erythritol, at insecticidal doses, has harmful effects on two common agricultural crop plants	PLOS ONE			English	Article							SPOTTED WING DROSOPHILA; SUGAR ALCOHOLS; SWEETENERS; SURVIVAL; SUZUKII; STRESS; METABOLISM; LUFENURON; MANNITOL; POLYOLS	Erythritol, a non-nutritive polyol, is the main component of the artificial sweetener Truvia (R). Recent research has indicated that erythritol may have potential as an organic insecticide, given its harmful effects on several insects but apparent safety for mammals. However, for erythritol to have practical use as an insecticide in agricultural settings, it must have neutral to positive effects on crop plants and other non-target organisms. We examined the dose-dependent effects of erythritol (0, 5, 50, 500, 1000, and 2000 mM) on corn (Zea mays) and tomato (Solanum lycopersicum) seedling growth and seed germination. Erythritol caused significant reductions in both belowground (root) and aboveground (shoot) dry weight at and above the typical minimum insecticidal dose (500 mM erythritol) in tomato plants, but not in corn plants. Both corn and tomato seed germination was inhibited by erythritol but the tomato seeds appeared to be more sensitive, responding at concentrations as low as 50 mM erythritol (in contrast to a minimum damaging dose of 1000 mM erythritol for corn seeds). Our results suggest erythritol may have damaging non-target effects on certain plant crops when used daily at the typical doses needed to kill insect pests. Furthermore, if erythritol's damaging effects extend to certain weed species, it also may have potential as an organic herbicide.	[Scanga, Sara E.; Hasanspahic, Bilal; Zvornicanin, Edin; Kozenjic, Jasmina Samardzic; Rahme, Andrew K.; Shinn-Thomas, Jessica H.] Utica Coll, Dept Biol, Utica, NY 13502 USA; [Kozenjic, Jasmina Samardzic] Salus Univ, Elkins Pk, PA USA		Scanga, SE (corresponding author), Utica Coll, Dept Biol, Utica, NY 13502 USA.	sescanga@utica.edu						Barthlott W, 1997, PLANTA, V202, P1, DOI 10.1007/s004250050096; Barthlott W, 2017, NANO-MICRO LETT, V9, DOI 10.1007/s40820-016-0125-1; Baudier KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098949; Bernt WO, 1996, REGUL TOXICOL PHARM, V24, pS191, DOI 10.1006/rtph.1996.0098; Burgess ER, 2017, J ECON ENTOMOL, V110, P2252, DOI 10.1093/jee/tox190; Choi MY, 2017, J INSECT PHYSIOL, V99, P86, DOI 10.1016/j.jinsphys.2017.04.001; Claeys H, 2014, PLANT PHYSIOL, V165, P519, DOI 10.1104/pp.113.234641; Dayan FE, 2010, WEED SCI, V58, P340, DOI 10.1614/WS-09-092.1; de Cock P, 2016, INT J DENT, V2016, DOI 10.1155/2016/9868421; FARMER AM, 1993, ENVIRON POLLUT, V79, P63, DOI 10.1016/0269-7491(93)90179-R; Fisher ML, 2017, J MED ENTOMOL, V54, P999, DOI 10.1093/jme/tjw241; Goffin J, 2017, ACTA HORTIC, V1156, P843, DOI [10.17660/actahortic.2017.1156.124, 10.17660/ActaHortic.2017.1156.124]; Jeffree CE, 2006, ANNU PLANT REV, V23, P11; Kaya C, 2013, J PLANT INTERACT, V8, P234, DOI 10.1080/17429145.2012.725480; Kuroda K, 2008, PLANT BIOTECHNOL-NAR, V25, P489, DOI 10.5511/plantbiotechnology.25.489; LEWIS DH, 1967, NEW PHYTOL, V66, P143, DOI 10.1111/j.1469-8137.1967.tb05997.x; O'Donnell S, 2018, J APPL ENTOMOL, V142, P37, DOI 10.1111/jen.12409; O'Donnell S, 2016, J INSECT SCI, V16, DOI 10.1093/jisesa/iew031; Patel TK, 2016, TRENDS PLANT SCI, V21, P486, DOI 10.1016/j.tplants.2016.01.006; Sampson BJ, 2017, J ECON ENTOMOL, V110, P530, DOI 10.1093/jee/tow307; Sampson BJ, 2017, J APPL ENTOMOL, V141, P8, DOI 10.1111/jen.12350; SHINDOU T, 1989, J AGR FOOD CHEM, V37, P1474, DOI 10.1021/jf00090a004; Stoop JMH, 1996, TRENDS PLANT SCI, V1, P139, DOI 10.1016/S1360-1385(96)80048-3; Sturaro M, 2005, PLANT PHYSIOL, V138, P478, DOI 10.1104/pp.104.058164; Tang SB, 2017, J INSECT PHYSIOL, V101, P178, DOI 10.1016/j.jinsphys.2017.07.015; Vranova E, 2013, ANNU REV PLANT BIOL, V64, P665, DOI 10.1146/annurev-arplant-050312-120116; Williamson JD, 2002, J AM SOC HORTIC SCI, V127, P467, DOI 10.21273/JASHS.127.4.467; Yeats TH, 2013, PLANT PHYSIOL, V163, P5, DOI 10.1104/pp.113.222737; Zhang XQ, 2017, J ECON ENTOMOL, V110, P593, DOI 10.1093/jee/tox038; Zheng CY, 2016, PEST MANAG SCI, V72, P990, DOI 10.1002/ps.4079	30	8	8	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0192749	10.1371/journal.pone.0192749	http://dx.doi.org/10.1371/journal.pone.0192749			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664905	Green Submitted, Green Published, gold			2022-12-26	WOS:000430262300002
J	Kwan, BCH; McBain, RA; Luu, BL; Butler, JE; Bilston, LE; Gandevia, SC				Kwan, Benjamin C. H.; McBain, Rachel A.; Luu, Billy L.; Butler, Jane E.; Bilston, Lynne E.; Gandevia, Simon C.			Influence of respiratory mechanics and drive on genioglossus movement under ultrasound imaging	PLOS ONE			English	Article							OBSTRUCTIVE SLEEP-APNEA; UPPER AIRWAY-RESISTANCE; CROSS-SECTIONAL AREA; MUSCLE ACTIVATION; LUNG-VOLUME; FLOW DYNAMICS; NEGATIVE-PRESSURE; HEALTHY HUMANS; NORMAL MEN; TONGUE	Genioglossus is the largest upper airway dilator and its dilatory movement can be measured non-invasively with magnetic resonance imaging and ultrasound. The present study used a novel ultrasound method to assess genioglossus movement in conditions in which ventilatory drive or respiratory mechanics were changed. Methods Twenty healthy subjects (10 males, age 28 +/- 5 years [mean +/- SD]) lay supine, awake, with the head in a neutral position. Ventilation was monitored with inductance bands. Real-time B-mode ultrasound movies were analysed. We measured genioglossus motion (i) during spontaneous breathing, voluntary targeted breathing (normal tidal volume Vt), and voluntary hyperpnoea (at 1.5Vt and 2 Vt); (ii) during inspiratory flow resistive loading; (iii) with changes in end-expiratory lung volume (EELV). Results Average peak inspiratory displacement of the infero-posterior region of genioglossus was 0.89 +/- 0.56 mm; 1.02 +/- 0.88 mm; 1.27 +/- 0.70 mm respectively for voluntary Vt, and during voluntary hyperpnoea at 1.5Vt and 2Vt. A change in genioglossus motion was observed with increased Vt. During increasing inspiratory resistive loading, the genioglossus displaced less anteriorly (p = 0.005) but more inferiorly (p = 0.027). When lung volume was altered, no significant changes in genioglossus movement were observed (p = 0.115). Conclusion In healthy subjects, we observed non-uniform heterogeneous inspiratory motion within the inferoposterior part of genioglossus during spontaneous quiet breathing with mean peak displacement between 0.5-2 mm, with more displacement in the posterior region than the anterior. This regional heterogeneity disappeared during voluntary targeted breathing. This may be due to different neural drive to genioglossus during voluntary breathing. During inspiratory resistive loading, the observed genioglossus motion may serve to maintain upper airway patency by balancing intraluminal negative pressure with positive pressure generated by upper airway dilatory muscles. In contrast, changes in EELV were not accompanied by major changes in genioglossus motion.	[Kwan, Benjamin C. H.; McBain, Rachel A.; Luu, Billy L.; Butler, Jane E.; Bilston, Lynne E.; Gandevia, Simon C.] Neurosci Res Australia NeuRA, Barker St, Sydney, NSW, Australia; [Kwan, Benjamin C. H.; Bilston, Lynne E.; Gandevia, Simon C.] Univ New South Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney	Kwan, BCH (corresponding author), Neurosci Res Australia NeuRA, Barker St, Sydney, NSW, Australia.; Kwan, BCH (corresponding author), Univ New South Wales, Fac Med, Prince Wales Clin Sch, Sydney, NSW, Australia.	ben.kwan@health.nsw.gov.au	Butler, Jane E/D-4186-2011; Bilston, Lynne/C-9665-2011	Luu, Billy/0000-0002-2529-6560; Butler, Jane/0000-0002-5834-8152; Bilston, Lynne/0000-0001-8250-9019	NHMRC (National Health and Medical Research Council) Australia	NHMRC (National Health and Medical Research Council) Australia	Jane Butler, Lynne Bilston, Simon Gandevia are supported by fellowship funding from NHMRC (National Health and Medical Research Council) Australia, https://www.nhmrc.gov.au/.	Abrishami A, 2010, CAN J ANAESTH, V57, P423, DOI 10.1007/s12630-010-9280-x; Amis TC, 1999, J PHYSIOL-LONDON, V515, P293, DOI 10.1111/j.1469-7793.1999.293ad.x; BADR MS, 1990, J APPL PHYSIOL, V68, P1195, DOI 10.1152/jappl.1990.68.3.1195; Bailey EF, 2005, AM J RESP CRIT CARE, V171, P1403, DOI 10.1164/rccm.200411-1550OC; Bailey EF, 2004, J APPL PHYSIOL, V96, P440, DOI 10.1152/japplphysiol.00733.2003; Bilston LE, 2014, J APPL PHYSIOL, V116, P314, DOI 10.1152/japplphysiol.00539.2013; BONNEFOUS O, 1986, ULTRASONIC IMAGING, V8, P73, DOI 10.1016/0161-7346(86)90001-5; BROOKS LJ, 1992, AM REV RESPIR DIS, V146, P1394, DOI 10.1164/ajrccm/146.6.1394; Brown EC, 2013, SLEEP, V36, P1069, DOI 10.5665/sleep.2812; BROWN IG, 1986, J APPL PHYSIOL, V61, P890, DOI 10.1152/jappl.1986.61.3.890; Cai MS, 2016, J APPL PHYSIOL, V120, P758, DOI 10.1152/japplphysiol.00382.2015; Cheng S, 2008, J PHYSIOL-LONDON, V586, P4283, DOI 10.1113/jphysiol.2008.156430; Cheng S, 2011, J APPL PHYSIOL, V110, P69, DOI 10.1152/japplphysiol.00413.2010; Daugherty M, 2012, J SPEECH LANG HEAR R, V55, P609, DOI 10.1044/1092-4388(2011/10-0287); Davidson TM, 2003, SLEEP MED, V4, P185, DOI 10.1016/S1389-9457(02)00237-X; DAVIS J N, 1975, Journal of Physiology (Cambridge), V249, P561; Dilley A, 2001, ULTRASOUND MED BIOL, V27, P1211, DOI 10.1016/S0301-5629(01)00413-6; DOUGLAS NJ, 1993, AM REV RESPIR DIS, V148, P1341, DOI 10.1164/ajrccm/148.5.1341; Dutschmann M, 2012, COMPR PHYSIOL, V2, P2443, DOI 10.1002/cphy.c100015; Eastwood PR, 2003, J APPL PHYSIOL, V94, P1849, DOI 10.1152/japplphysiol.01017.2002; Fogel RB, 2001, AM J RESP CRIT CARE, V164, P2025, DOI 10.1164/ajrccm.164.11.2102048; Fregosi RF, 2014, J APPL PHYSIOL, V116, P291, DOI 10.1152/japplphysiol.00670.2013; HAMLET SL, 1972, IEEE T BIO-MED ENG, VBM19, P34, DOI 10.1109/TBME.1972.324156; HOFFSTEIN V, 1984, AM REV RESPIR DIS, V130, P175; HORNER RL, 1991, J PHYSIOL-LONDON, V436, P15, DOI 10.1113/jphysiol.1991.sp018536; HORNER RL, 1991, J PHYSIOL-LONDON, V436, P31, DOI 10.1113/jphysiol.1991.sp018537; How SC, 2007, RESP PHYSIOL NEUROBI, V157, P270, DOI 10.1016/j.resp.2007.01.008; HUDGEL DW, 1987, J APPL PHYSIOL, V63, P603, DOI 10.1152/jappl.1987.63.2.603; IBER C, 1982, J APPL PHYSIOL, V52, P607, DOI 10.1152/jappl.1982.52.3.607; Johns MW, 2002, J SLEEP RES, V11, P61, DOI 10.1046/j.1365-2869.2002.00274.x; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jordan AS, 2002, J APPL PHYSIOL, V92, P410, DOI 10.1152/japplphysiol.00461.2001; KELSEY CA, 1969, J SPEECH HEAR RES, V12, P564, DOI 10.1044/jshr.1203.564; Klawe J J, 2003, J Physiol Pharmacol, V54 Suppl 1, P14; Kundra P, 2011, INDIAN J ANAESTH, V55, P456, DOI 10.4103/0019-5049.89868; Kwan BCH, 2014, J APPL PHYSIOL, V117, P556, DOI 10.1152/japplphysiol.01257.2013; Laine CM, 2011, J NEUROPHYSIOL, V105, P380, DOI 10.1152/jn.00766.2010; LIISTRO G, 1988, J APPL PHYSIOL, V64, P1285, DOI 10.1152/jappl.1988.64.3.1285; Malhotra A, 2000, AM J RESP CRIT CARE, V161, P1746, DOI 10.1164/ajrccm.161.5.9907109; Malhotra A, 2002, AM J RESP CRIT CARE, V165, P71, DOI 10.1164/ajrccm.165.1.2011065; Martelli D, 2013, RESP PHYSIOL NEUROBI, V188, P318, DOI 10.1016/j.resp.2013.06.019; Martin SE, 1997, EUR RESPIR J, V10, P2087, DOI 10.1183/09031936.97.10092087; Mateika JH, 1999, AM J RESP CRIT CARE, V160, P1976, DOI 10.1164/ajrccm.160.6.9903001; MATHEW OP, 1982, J APPL PHYSIOL, V52, P445, DOI 10.1152/jappl.1982.52.2.445; MEZZANOTTE WS, 1992, J CLIN INVEST, V89, P1571, DOI 10.1172/JCI115751; Mu LC, 2000, ANAT REC, V260, P308, DOI 10.1002/1097-0185(20001101)260:3<308::AID-AR70>3.0.CO;2-N; Mu LC, 2010, CLIN ANAT, V23, P777, DOI 10.1002/ca.21011; Nakayama K, 1998, J COMP NEUROL, V398, P459; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; ONAL E, 1981, AM REV RESPIR DIS, V124, P215; PARISI RA, 1987, AM REV RESPIR DIS, V135, P378; Pataka A, 2014, SLEEP MED, V15, P776, DOI 10.1016/j.sleep.2014.03.012; PATRICK GB, 1982, J APPL PHYSIOL, V53, P1133, DOI 10.1152/jappl.1982.53.5.1133; Pillar F, 2000, AM J RESP CRIT CARE, V162, P1627, DOI 10.1164/ajrccm.162.5.2003131; Pillar G, 2001, RESP PHYSIOL, V127, P23, DOI 10.1016/S0034-5687(01)00230-4; POPOVIC RM, 1995, AM J RESP CRIT CARE, V152, P725, DOI 10.1164/ajrccm.152.2.7633734; Prasad A, 2011, J ULTRAS MED, V30, P965, DOI 10.7863/jum.2011.30.7.965; REMMERS JE, 1978, J APPL PHYSIOL, V44, P931, DOI 10.1152/jappl.1978.44.6.931; Rowley JA, 1996, J APPL PHYSIOL, V80, P2171, DOI 10.1152/jappl.1996.80.6.2171; RUBINSTEIN I, 1989, EUR RESPIR J, V2, P344; RYAN CF, 1991, AM REV RESPIR DIS, V144, P939, DOI 10.1164/ajrccm/144.4.939; Saboisky JP, 2013, OPTIMAL LENGTH TONGU; Saigusa H, 2001, ANN OTO RHINOL LARYN, V110, P779, DOI 10.1177/000348940111000815; Sawczuk A, 2001, CRIT REV ORAL BIOL M, V12, P18, DOI 10.1177/10454411010120010101; SCHWAB RJ, 1993, AM REV RESPIR DIS, V148, P1385, DOI 10.1164/ajrccm/148.5.1385; Schwab RJ, 1998, CLIN CHEST MED, V19, P33, DOI 10.1016/S0272-5231(05)70430-5; Schwab RJ, 1996, SLEEP, V19, pS170; SERIES F, 1990, J APPL PHYSIOL, V68, P2159, DOI 10.1152/jappl.1990.68.5.2159; Sha BFB, 2000, J APPL PHYSIOL, V88, P1678, DOI 10.1152/jappl.2000.88.5.1678; Shepherd KL, 2006, CHEST, V130, P1757, DOI 10.1378/chest.130.6.1757; SPANN RW, 1971, J APPL PHYSIOL, V31, P708, DOI 10.1152/jappl.1971.31.5.708; Stanchina ML, 2003, SLEEP, V26, P851, DOI 10.1093/sleep/26.7.851; Stone M, 2005, CLIN LINGUIST PHONET, V19, P455, DOI 10.1080/02699200500113558; SURATT PM, 1988, AM REV RESPIR DIS, V137, P889, DOI 10.1164/ajrccm/137.4.889; Sustic A, 2007, CRIT CARE MED, V35, pS173, DOI 10.1097/CCM.0000260628.88402.8A; THUT DC, 1993, J APPL PHYSIOL, V75, P2084, DOI 10.1152/jappl.1993.75.5.2084; Trinder J, 1997, J APPL PHYSIOL, V83, P1986, DOI 10.1152/jappl.1997.83.6.1986; Tsui BCH, 2008, CAN J ANAESTH, V55, P790, DOI 10.1007/BF03016357; VANDEGRAAFF WB, 1988, J APPL PHYSIOL, V65, P2124, DOI 10.1152/jappl.1988.65.5.2124; VANDEGRAAFF WB, 1991, J APPL PHYSIOL, V70, P1328, DOI 10.1152/jappl.1991.70.3.1328; Vranish JR, 2015, J NEUROPHYSIOL, V113, P2692, DOI 10.1152/jn.00975.2014; WHEATLEY JR, 1993, AM REV RESPIR DIS, V148, P597, DOI 10.1164/ajrccm/148.3.597; WHITE DP, 1985, J APPL PHYSIOL, V58, P365, DOI 10.1152/jappl.1985.58.2.365; Wojtczak JA, 2012, J ULTRAS MED, V31, P523, DOI 10.7863/jum.2012.31.4.523; YILDIRIM N, 1991, AM REV RESPIR DIS, V144, P845, DOI 10.1164/ajrccm/144.4.845	85	5	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195884	10.1371/journal.pone.0195884	http://dx.doi.org/10.1371/journal.pone.0195884			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659626	gold, Green Submitted, Green Published			2022-12-26	WOS:000430061100039
J	Mitchell, R; Buckingham, L; Cobleigh, M; Rotmensch, J; Burgess, K; Usha, L				Mitchell, Rachel; Buckingham, Lela; Cobleigh, Melody; Rotmensch, Jacob; Burgess, Kelly; Usha, Lydia			Can chimerism explain breast/ovarian cancers in BRCA non-carriers from BRCA-positive families?	PLOS ONE			English	Article							BILATERAL PROPHYLACTIC MASTECTOMY; FETAL CELL MICROCHIMERISM; BREAST-CANCER; OVARIAN-CANCER; GLIOBLASTOMA-MULTIFORME; MUTATION CARRIERS; DONOR TRANSMISSION; MALIGNANT-MELANOMA; GENE MUTATION; RISK	Hereditary breast and ovarian cancer syndrome (HBOC) is most frequently caused by mutations in BRCA1 or BRCA2 (in short, BRCA) genes. The incidence of hereditary breast and ovarian cancer in relatives of BRCA mutation carriers who test negative for the familial mutation (non-carriers) may be increased. However, the data is controversial, and at this time, these individuals are recommended the same cancer surveillance as general population. One possible explanation for BRCA phenocopies (close relatives of BRCA carriers who have developed cancer consistent with HBOC but tested negative for a familial mutation) is natural chimerism where lack of detectable mutation in blood may not rule out the presence of the mutation in the other tissues. To test this hypothesis, archival tumor tissue from eleven BRCA phenocopies was investigated. DNA from the tumor tissue was analyzed using sequence-specific PCR, capillary electrophoresis, and pyrosequencing. The familial mutations were originally detected in the patients' first-degree relatives by commercial testing. The same testing detected no mutations in the blood of the patients under study. The test methods targeted only the known familial mutation in the tumor tissue. Tumor diagnoses included breast, ovarian, endometrial and primary peritoneal carcinoma. None of the familial mutations were found in the tumor samples tested. These results do not support, but do not completely exclude, the possibility of chimerism in these patients. Further studies with comprehensive sequence analysis in a larger patient group are warranted as a chimeric state would further refine the predictive value of genetic testing to include BRCA phenocopies.	[Mitchell, Rachel; Cobleigh, Melody; Burgess, Kelly; Usha, Lydia] Rush Univ, Med Ctr, Dept Internal Med, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA; [Buckingham, Lela] Rush Univ, Med Ctr, Dept Pathol, Div Med Lab Sci, Chicago, IL 60612 USA; [Rotmensch, Jacob] Rush Univ, Med Ctr, Dept Obstet & Gynecol, Div Gynecol, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Usha, L (corresponding author), Rush Univ, Med Ctr, Dept Internal Med, Div Hematol Oncol & Cell Therapy, Chicago, IL 60612 USA.	Lydia_usha@rush.edu						Abuelo D, 2009, AM J MED GENET C, V151C, P148, DOI 10.1002/ajmg.c.30213; Adams KM, 2004, JAMA-J AM MED ASSOC, V291, P1127, DOI 10.1001/jama.291.9.1127; [Anonymous], 2017, THE MYR ADV; [Anonymous], WHAT AR SINGL NUCL P; [Anonymous], 2017, GENETIC FAMILIAL HIG; Antoniou A, 2003, AM J HUM GENET, V72, P1117, DOI 10.1086/375033; Azzollini J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171663; Bajaj NS, 2010, TRANSPL INT, V23, pe26, DOI 10.1111/j.1432-2277.2010.01090.x; Broestl L, 2018, BRAIN PATHOL, V28, P484, DOI 10.1111/bpa.12557; Brose MS, 2002, J NATL CANCER I, V94, P1365, DOI 10.1093/jnci/94.18.1365; Chen SN, 2006, J CLIN ONCOL, V24, P863, DOI 10.1200/JCO.2005.03.6772; Cirello V, 2016, J CANCER RES CLIN, V142, P1697, DOI 10.1007/s00432-015-2110-3; Cuzick J, 2017, J CLIN ONCOL, V35, P743, DOI 10.1200/JCO.2016.69.8944; Daly MB, 2010, J NATL COMPR CANC NE, V8, P562, DOI 10.6004/jnccn.2010.0043; Dhillon KK, 2011, CANCER SCI, V102, P663, DOI 10.1111/j.1349-7006.2010.01840.x; Domchek SM, 2010, BREAST CANCER RES TR, V119, P409, DOI 10.1007/s10549-009-0611-y; Domchek SM, 2010, JAMA-J AM MED ASSOC, V304, P967, DOI 10.1001/jama.2010.1237; EASTON DF, 1995, AM J HUM GENET, V56, P265; Evans DG, 2017, J MED GENET, V54, P104, DOI 10.1136/jmedgenet-2016-104125; Fatt MA, 2008, J COMPUT ASSIST TOMO, V32, P407, DOI 10.1097/RCT.0b013e318076b472; Fischer C, 2012, CLIN GENET, V82, P478, DOI 10.1111/j.1399-0004.2011.01788.x; Ford D, 1998, AM J HUM GENET, V62, P676, DOI 10.1086/301749; Gadi VK, 2007, CANCER RES, V67, P9035, DOI 10.1158/0008-5472.CAN-06-4209; Gadi VK, 2010, BREAST CANCER RES TR, V121, P241, DOI 10.1007/s10549-009-0548-1; Geiger AM, 2005, ARCH INTERN MED, V165, P516, DOI 10.1001/archinte.165.5.516; Goldgar D, 2007, J MED GENET, V44; Gronwald J, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.048462; Hamdi Y, 2017, BREAST CANCER RES TR, V161, P117, DOI 10.1007/s10549-016-4018-2; Hartmann LC, 2001, JNCI-J NATL CANCER I, V93, P1633, DOI 10.1093/jnci/93.21.1633; Hartmann LC, 1999, NEW ENGL J MED, V340, P77, DOI 10.1056/NEJM199901143400201; Heemskerk-Gerritsen BAM, 2007, ANN SURG ONCOL, V14, P3335, DOI 10.1245/s10434-007-9449-x; Hilton JL, 2002, JNCI-J NATL CANCER I, V94, P1396; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Jackish Christian, 2003, Archives of Gynecology and Obstetrics, V268, P69; Jonas S, 1996, TRANSPLANT INT, V9, P426, DOI 10.1111/j.1432-2277.1996.tb00903.x; Kallenbach LR, 2011, CANCER RES, V71, P8, DOI 10.1158/0008-5472.CAN-10-0618; Kim JK, 2009, CLIN TRANSPLANT, V23, P571, DOI 10.1111/j.1399-0012.2008.00928.x; Korde LA, 2011, BREAST CANCER RES TR, V125, P169, DOI 10.1007/s10549-010-0923-y; Kuchenbaecker KB, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw302; Kurian AW, 2011, J CLIN ONCOL, V29, P4505, DOI 10.1200/JCO.2010.34.4440; Lipsker D, 2008, ARCH DERMATOL, V144, P327, DOI 10.1001/archderm.144.3.327; Malone KE, 2010, J CLIN ONCOL, V28, P2404, DOI 10.1200/JCO.2009.24.2495; Mangold KA, 2010, J MOL DIAGN, V12, P20, DOI 10.2353/jmoldx.2010.090023; Marcus JN, 1996, CANCER-AM CANCER SOC, V77, P697, DOI 10.1002/(SICI)1097-0142(19960215)77:4<697::AID-CNCR16>3.0.CO;2-W; Maurel MC, 2008, BIOL REPROD, V79, P2, DOI 10.1095/biolreprod.107.065607; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; Metcalfe K, 2004, J CLIN ONCOL, V22, P2328, DOI 10.1200/JCO.2004.04.033; Metcalfe KA, 2009, BRIT J CANCER, V100, P421, DOI 10.1038/sj.bjc.6604830; Miura K, 2005, J HUM GENET, V50, P1, DOI 10.1007/s10038-004-0216-6; Nemescu D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147675; O'Donovan PJ, 2010, CARCINOGENESIS, V31, P961, DOI 10.1093/carcin/bgq069; Peters HE, 2017, TWIN RES HUM GENET, V20, P161, DOI 10.1017/thg.2017.4; Pinborg A, 2005, HUM REPROD, V20, P2821, DOI 10.1093/humrep/dei142; Pinborg A, 2006, BRIT J HOSP MED, V67, P417, DOI 10.12968/hmed.2006.67.8.21976; Rebbeck TR, 2004, J CLIN ONCOL, V22, P1055, DOI 10.1200/JCO.2004.04.188; Rinkevich Baruch, 2011, Chimerism, V2, P1, DOI 10.4161/chim.2.1.14725; Robson M, 2011, J CLIN ONCOL, V29, P4477, DOI 10.1200/JCO.2011.37.6483; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Satagopan JM, 2001, CANCER EPIDEM BIOMAR, V10, P467; Sawicki JA, 2008, CANCER RES, V68, P9567, DOI 10.1158/0008-5472.CAN-08-3008; Schorge JO, 2010, GYNECOL ONCOL, V119, P7, DOI 10.1016/j.ygyno.2010.06.003; Smith A, 2007, J MED GENET, V44, P10, DOI 10.1136/jmg.2006.043091; Struewing JP, 1997, NEW ENGL J MED, V336, P1401, DOI 10.1056/NEJM199705153362001; Thompson D, 2002, JNCI-J NATL CANCER I, V94, P1358, DOI 10.1093/jnci/94.18.1358; Thorlacius S, 1998, LANCET, V352, P1337, DOI 10.1016/S0140-6736(98)03300-5; Uysal NS, 2018, J OBSTET GYNAECOL RE, V44, P576, DOI 10.1111/jog.13514; VALBERNAL F, 1993, HUM PATHOL, V24, P1256, DOI 10.1016/0046-8177(93)90224-5; Venkitaraman AR, 2002, CELL, DOI [10.1073/pnas.171174298, DOI 10.1073/PNAS.171174298]; von Boehmer L, 2012, LUNG CANCER, V76, P118, DOI 10.1016/j.lungcan.2011.10.001; Williams CA, 2004, HUM REPROD, V19, P2816, DOI 10.1093/humrep/deh533; Win AK, 2012, J CLIN ONCOL, V30, P958, DOI 10.1200/JCO.2011.39.5590; Ye Y, 2010, INT J MOL EPIDEMIOL, V1, P350; Yunis EJ, 2007, IMMUNOL RES, V38, P213, DOI 10.1007/s12026-007-0013-3; Zhang LY, 2009, J MOL DIAGN, V11, P176, DOI 10.2353/jmoldx.2009.080137; Zheng L, 2001, P NATL ACAD SCI USA, V98, P9587, DOI 10.1073/pnas.171174298	76	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195497	10.1371/journal.pone.0195497	http://dx.doi.org/10.1371/journal.pone.0195497			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659587	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100019
J	Rivera, SF; Vasselon, V; Ballorain, K; Carpentier, A; Wetzel, CE; Ector, L; Bouchez, A; Rimet, F				Rivera, Sinziana F.; Vasselon, Valentin; Ballorain, Katia; Carpentier, Alice; Wetzel, Carlos E.; Ector, Luc; Bouchez, Agnes; Rimet, Frederic			DNA metabarcoding and microscopic analyses of sea turtles biofilms: Complementary to understand turtle behavior	PLOS ONE			English	Article							THROUGHPUT SEQUENCING HTS; MARINE TURTLES; EPIZOAN COMMUNITIES; GREEN TURTLES; BARNACLES CIRRIPEDIA; NOV. BACILLARIOPHYTA; SPATIAL-DISTRIBUTION; DIATOM COMMUNITIES; BENTHIC DIATOMS; CHELONIA-MYDAS	Sea turtles are distributed in tropical and subtropical seas worldwide. They play several ecological roles and are considered important indicators of the health of marine ecosystems. Studying epibiotic diatoms living on turtle shells suggestively has great potential in the study of turtle behavior because diatoms are always there. However, diatom identification at the species level is time consuming, requires well-trained specialists, and there is a high probability of finding new taxa growing on turtle shells, which makes identification tricky. An alternative approach based on DNA barcoding and high throughput sequencing (HTS), metabarcoding, has been developed in recent years to identify species at the community level by using a DNA reference library. The suitabilities of morphological and molecular approaches were compared. Diatom assemblages were sampled from seven juvenile green turtles (Chelonia mydas) from Mayotte Island, France. The structures of the epibiotic diatom assemblages differed between both approaches. This resulted in different clustering of the turtles based on their diatom communities. Metabarcoding allowed better discrimination between turtles based on their epibiotic diatom assemblages and put into evidence the presence of a cryptic diatom diversity. Microscopy, for its part, provided more ecological information of sea turtles based on historical bibliographical data and the abundances of ecological guilds of the diatom species present in the samples. This study shows the complementary nature of these two methods for studying turtle behavior.	[Rivera, Sinziana F.; Vasselon, Valentin; Bouchez, Agnes; Rimet, Frederic] Univ Savoie Mt Blanc, INRA, UMR CARRTEL, Thonon Les Bains, France; [Ballorain, Katia] Agence Francaise Biodiversite, Parc Nat Marin Mayotte,14 Lot Darine Montjoly, Iloni, Mayotte, France; [Ballorain, Katia; Carpentier, Alice] Assoc Escale, 13 Bis Rue Foundi Madi Attoumani, Mronabeja, Mayotte, France; [Wetzel, Carlos E.; Ector, Luc] LIST, 41 Rue Brill, Belvaux, Luxembourg	INRAE; Luxembourg Institute of Science & Technology	Rivera, SF (corresponding author), Univ Savoie Mt Blanc, INRA, UMR CARRTEL, Thonon Les Bains, France.	sinzianaflorina@gmail.com	Vasselon, Valentin/Q-7670-2019; RIMET, Frédéric/S-2702-2018; Vasselon, Valentin/X-8504-2018	Vasselon, Valentin/0000-0001-5038-7918; RIMET, Frédéric/0000-0002-5514-869X; Vasselon, Valentin/0000-0001-5038-7918; Carpentier, Alice/0000-0001-9673-7864; Rivera, Sinziana F./0000-0002-0812-9031; Bouchez, Agnes/0000-0001-8802-6966	French Agency for Biodiversity (AFB, Agence Francaise de la Biodiversite); French Agency for Biodiversity (AFB, Agence Francaise pour la Biodiversite)	French Agency for Biodiversity (AFB, Agence Francaise de la Biodiversite); French Agency for Biodiversity (AFB, Agence Francaise pour la Biodiversite)	This work was supported by the French Agency for Biodiversity (AFB, Agence Francaise de la Biodiversite). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the French Agency for Biodiversity (AFB, Agence Francaise pour la Biodiversite) for its support.	Apotheloz-Perret-Gentil L, 2017, MOL ECOL RESOUR, V17, P1231, DOI 10.1111/1755-0998.12668; Ballorain K, 2013, MAR ECOL PROG SER, V483, P289, DOI 10.3354/meps10301; Ballorain K, 2010, MAR BIOL, V157, P2581, DOI 10.1007/s00227-010-1520-7; BIGGS BJF, 1993, NEW ZEAL J MAR FRESH, V27, P39, DOI 10.1080/00288330.1993.9516544; Bjorndal KA, 2003, CRC MAR BIOL SER, P259; Bjorndal Karen A., 1997, P199; Bouchard SS, 2000, ECOLOGY, V81, P2305, DOI 10.1890/0012-9658(2000)081[2305:STABTO]2.0.CO;2; Bourjea Jerome, 2006, Western Indian Ocean Journal of Marine Science, V5, P209; Bugoni L, 2001, MAR POLLUT BULL, V42, P1330, DOI 10.1016/S0025-326X(01)00147-3; Casale P, 2012, CRUSTACEANA, V85, P533, DOI 10.1163/156854012X634393; CEN, 2016, 230N1008 CENTC, P7; CEN, 2002, 13946 CEN, P718; CEN, 2003, 14407 CEN, P13; Chessman B, 1999, FRESHWATER BIOL, V41, P317, DOI 10.1046/j.1365-2427.1999.00433.x; Cox E.J., 1984, VERH INT VER LIMNOL, V22, P924; Eckert Scott A., 1999, P88; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; El Semary NA, 2016, BANGL J BOT, V45, P1113; Enstipp MR, 2011, J EXP BIOL, V214, P4010, DOI 10.1242/jeb.062943; Epperly SP, 1996, OCEANOGR LIT REV, V1, P61; Evans KM, 2008, J PHYCOL, V44, P215, DOI 10.1111/j.1529-8817.2007.00454.x; Fayolle S, 2016, CRYPTOGAMIE ALGOL, V37, P221, DOI 10.7872/crya/v37.iss4.2016.221; Frankovich TA, 2016, PHYTOTAXA, V272, P101, DOI 10.11646/phytotaxa.272.2.1; Frankovich TA, 2015, PHYTOTAXA, V234, P227, DOI 10.11646/phytotaxa.234.3.3; Frankovich TA, 2015, PHYTOTAXA, V204, P33, DOI 10.11646/phytotaxa.204.1.3; FRAZIER J, 1985, MAR ECOL-P S Z N I, V6, P127, DOI 10.1111/j.1439-0485.1985.tb00134.x; Frazier J., 1999, USITC PUBL, V4; FRAZIER JG, 1992, B MAR SCI, V51, P1; FRAZIER JG, 1991, B MAR SCI, V48, P763; Fukuoka T, 2015, ENDANGER SPECIES RES, V28, P1, DOI 10.3354/esr00671; Fuller WJ, 2010, J NAT HIST, V44, P1743, DOI 10.1080/00222931003624820; Gerrodette T, 1999, USITC PUBL, V4; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guilcher A, 1965, RECIFS CORALLIENS LA; Hannan LB, 2007, ECOLOGY, V88, P1053, DOI 10.1890/06-0629; Hayashi R, 2008, ECOL RES, V23, P121, DOI 10.1007/s11284-007-0349-0; Hayashi R, 2013, J MAR BIOL ASSOC UK, V93, P143, DOI 10.1017/S0025315412000847; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hein Michael K., 2008, V19; Henwood TA, 1999, USITC PUBL, V4; Jean C, 2010, ORYX, V44, P223, DOI 10.1017/S003060530999072X; Kahlert M, 2009, J APPL PHYCOL, V21, P471, DOI 10.1007/s10811-008-9394-5; Keck F, 2017, FRONT ECOL ENVIRON, V15, P266, DOI 10.1002/fee.1490; Keck F, 2016, ECOL APPL, V26, P861, DOI 10.1890/14-1966; Kelly MG, 2015, DIATOM RES, V30, P27, DOI 10.1080/0269249X.2014.951398; Kermarrec L, 2014, FRESHW SCI, V33, P349, DOI 10.1086/675079; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Letunic I, 2016, NUCLEIC ACIDS RES, V44, pW242, DOI 10.1093/nar/gkw290; Levkov Z., 2009, DIATOMS EUROPE, V5, P916; Majewska R, 2016, DIATOMEDEDELINGEN, V40, P35; Majewska R, 2017, NOVA HEDWIGIA, V146, P221; Majewska R, 2017, MICROB ECOL, V74, P969, DOI 10.1007/s00248-017-0987-x; Majewska R, 2017, BOT MAR, V60, P303, DOI 10.1515/bot-2016-0114; Majewska R, 2015, PHYTOTAXA, V233, P236, DOI 10.11646/phytotaxa.233.3.2; Majewska R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130351; Mann DG, 2013, J EUKARYOT MICROBIOL, V60, P414, DOI 10.1111/jeu.12047; Mann DG, 2004, PHYCOLOGIA, V43, P459, DOI 10.2216/i0031-8884-43-4-459.1; MEDLIN LK, 1991, J PHYCOL, V27, P514, DOI 10.1111/j.0022-3646.1991.00514.x; Medlin LK, 1997, PLANT SYST EVOL, P187; Pavlov A, 2016, DIATOM RES, V31, P85, DOI 10.1080/0269249X.2016.1157376; Pike DA, 2013, GLOBAL ECOL BIOGEOGR, V22, P555, DOI 10.1111/geb.12025; Riaux-Gobin C, 2017, 2 NEW TURSIOCOLA SPE; Riaux-Gobin C, 2015, FOTTEA, V15, P139, DOI 10.5507/fot.2015.015; Riaux-Gobin C, 2012, FOTTEA, V12, P199, DOI 10.5507/fot.2012.015; Richard M., 1987, ATLAS PHYTOPLANKTON, P285; Rimet F, ORG DIVERS EVOL, P1; Rimet F, 2018, FOTTEA, V18, P37, DOI 10.5507/fot.2017.013; Rimet F, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw016; Rimet F, 2012, HYDROBIOLOGIA, V683, P1, DOI 10.1007/s10750-011-0949-0; Rimet F, 2012, ECOL INDIC, V15, P92, DOI 10.1016/j.ecolind.2011.09.014; Rivera SF, 2018, HYDROBIOLOGIA, V807, P37, DOI 10.1007/s10750-017-3381-2; Robinson DP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184286; Robinson NJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157011; Roos D, 2005, AQUAT LIVING RESOUR, V18, P193, DOI 10.1051/alr:2005021; Rovira L, 2015, J EUKARYOT MICROBIOL, V62, P815, DOI 10.1111/jeu.12240; Schroeder B, 1999, USITC PUBL, V4; Schwartz FJ, 1978, FLORIDA MARINE RES P, V33, P16; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Souffreau C, 2013, PROTIST, V164, P101, DOI 10.1016/j.protis.2012.04.001; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tapolczai K, 2017, SCI TOTAL ENVIRON, V607, P1293, DOI 10.1016/j.scitotenv.2017.07.093; Tison J, 2005, WATER RES, V39, P3177, DOI 10.1016/j.watres.2005.05.029; Trobajo R, 2013, DIATOM RES, V28, P37, DOI 10.1080/0269249X.2012.734531; Vanelslander B, 2009, J PHYCOL, V45, P1278, DOI 10.1111/j.1529-8817.2009.00762.x; Vasselon V, 2018, METHODS ECOL EVOL, V9, P1060, DOI 10.1111/2041-210X.12960; Vasselon V, 2017, ECOL INDIC, V82, P1, DOI 10.1016/j.ecolind.2017.06.024; Vasselon V, 2017, FRESHW SCI, V36, P162, DOI 10.1086/690649; Visco JA, 2015, ENVIRON SCI TECHNOL, V49, P7597, DOI 10.1021/es506158m; Wetzel CE, 2010, VIE MILIEU, V60, P177; Wetzel CE, 2012, DIATOM RES, V27, P1, DOI 10.1080/0269249X.2011.642498; Witkowski A, 2000, ICONOGRAPHIA DIATOMO, V7; Wu SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171910; Zimmermann J, 2015, MOL ECOL RESOUR, V15, P526, DOI 10.1111/1755-0998.12336	93	34	37	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195770	10.1371/journal.pone.0195770	http://dx.doi.org/10.1371/journal.pone.0195770			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659610	gold, Green Published, Green Submitted			2022-12-26	WOS:000430061100029
J	Tomasi, G; Veronese, M; Bertoldo, A; Smith, CB; Schmidt, KC				Tomasi, Giampaolo; Veronese, Mattia; Bertoldo, Alessandra; Smith, Carolyn Beebe; Schmidt, Kathleen C.			Effects of shortened scanning intervals on calculated regional rates of cerebral protein synthesis determined with the L-[1-C-11] leucine PET method	PLOS ONE			English	Article							TISSUE AMINO-ACIDS; SPECTRAL-ANALYSIS; BRAIN; MODEL; IMPLEMENTATION; (CO2)-C-11; VALIDATION; PARAMETERS; DESIGN; PH	To examine effects of scan duration on estimates of regional rates of cerebral protein synthesis (rCPS), we reanalyzed data from thirty-nine previously reported L-[1-C-11] leucine PET studies. Subjects consisted of 12 healthy volunteers studied twice, awake and under propofol sedation, and 15 subjects with fragile X syndrome (FXS) studied once under propofol sedation. All scans were acquired on a high resolution scanner. We used a basis function method for voxelwise estimation of parameters of the kinetic model of L-[1-C-11] leucine and rCPS over the interval beginning at the time of tracer injection and ending 30, 45, 60, 75 or 90 min later. For each study and scan interval, regional estimates in nine regions and whole brain were obtained by averaging voxelwise estimates over all voxels in the region. In all three groups rCPS was only slightly affected by scan interval length and was very stable between 60 and 90 min. Furthermore, statistical comparisons of rCPS between awake and sedated healthy volunteers provided almost identical results when they were based on 60 min scan data as when they were based on data from the full 90 min interval. Statistical comparisons between sedated healthy volunteers and sedated subjects with FXS also yielded almost identical results when based on 60 and 90 min scan intervals. We conclude that, under the conditions of our studies, scan duration can be shortened to 60 min without loss of precision.	[Tomasi, Giampaolo; Smith, Carolyn Beebe; Schmidt, Kathleen C.] NIMH, Sect Neuroadaptat & Prot Metab, Bethesda, MD 20892 USA; [Veronese, Mattia] Kings Coll London, IoPPN, Dept Neu roimaging, London, England; [Bertoldo, Alessandra] Univ Padua, Dept Informat Engn, Padua, Italy	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University of London; King's College London; University of Padua	Schmidt, KC (corresponding author), NIMH, Sect Neuroadaptat & Prot Metab, Bethesda, MD 20892 USA.	KSchmidt@mail.nih.gov	Veronese, Mattia/A-6012-2013	Veronese, Mattia/0000-0003-3562-0683	Intramural Research Program of the National Institute of Mental Health [NIMH ZIA MH00889]; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002935] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from the Intramural Research Program of the National Institute of Mental Health. Project No NIMH ZIA MH00889 DIRP to CBS (https://irp.nih.gov/) and by funding from the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London to MV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishu S, 2008, J CEREBR BLOOD F MET, V28, P1502, DOI 10.1038/jcbfm.2008.43; Bishu S, 2009, J CEREBR BLOOD F MET, V29, P1035, DOI 10.1038/jcbfm.2009.7; Bloomfield PM, 2003, PHYS MED BIOL, V48, P959, DOI 10.1088/0031-9155/48/8/301; BROOKS DJ, 1984, J CEREBR BLOOD F MET, V4, P458, DOI 10.1038/jcbfm.1984.65; BUXTON RB, 1987, J CEREBR BLOOD F MET, V7, P709, DOI 10.1038/jcbfm.1987.125; Carson RE, 2004, IEEE NUCL SCI CONF R, P3281, DOI 10.1109/NSSMIC.2003.1352597; Collins R C, 1980, Trans Am Neurol Assoc, V105, P43; Fischer B, 2004, METHOD INFORM MED, V43, P327; Gunn RN, 2000, J NUCL MED, V41, P706; IIDA H, 1988, J CEREBR BLOOD F MET, V8, P285, DOI 10.1038/jcbfm.1988.60; INGVAR MC, 1985, BRAIN, V108, P155, DOI 10.1093/brain/108.1.155; Levkovitz R, 2001, IEEE T MED IMAGING, V20, P633, DOI 10.1109/42.932747; Nakanishi H, 1997, EUR J NEUROSCI, V9, P271, DOI 10.1111/j.1460-9568.1997.tb01397.x; Qin M, 2005, J NEUROSCI, V25, P5087, DOI 10.1523/JNEUROSCI.0093-05.2005; Qin M, 2013, J CEREBR BLOOD F MET, V33, P499, DOI 10.1038/jcbfm.2012.205; SCHMIDT K, 1991, J CEREBR BLOOD F MET, V11, P10, DOI 10.1038/jcbfm.1991.2; SCHMIDT K, 1992, J CEREBR BLOOD F MET, V12, P823, DOI 10.1038/jcbfm.1992.114; Schmidt KC, 2005, J CEREBR BLOOD F MET, V25, P617, DOI 10.1038/sj.jcbfm.9600067; SIESJO BK, 1964, EXPERIENTIA, V20, P98, DOI 10.1007/BF02151265; Smith CB, 2000, P NATL ACAD SCI USA, V97, P11014, DOI 10.1073/pnas.97.20.11014; Smith CB, 2005, J CEREBR BLOOD F MET, V25, P629, DOI 10.1038/sj.jcbfm.9600066; SUN Y, 1995, AM J PHYSIOL-REG I, V268, pR549, DOI 10.1152/ajpregu.1995.268.2.R549; Tomasi G, 2009, J CEREBR BLOOD F MET, V29, P1317, DOI 10.1038/jcbfm.2009.52; Veronese M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18890-x; Veronese M, 2012, J CEREBR BLOOD F MET, V32, P1073, DOI 10.1038/jcbfm.2012.27; Veronese M, 2010, J CEREBR BLOOD F MET, V30, P1460, DOI 10.1038/jcbfm.2010.26; WIDMANN R, 1992, J NEUROCHEM, V59, P18, DOI 10.1111/j.1471-4159.1992.tb08870.x; WIDMANN R, 1991, J NEUROCHEM, V56, P789, DOI 10.1111/j.1471-4159.1991.tb01993.x; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34	29	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195580	10.1371/journal.pone.0195580	http://dx.doi.org/10.1371/journal.pone.0195580			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659612	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100023
J	Dudhate, A; Shinde, H; Tsugama, D; Liu, SK; Takano, T				Dudhate, Ambika; Shinde, Harshraj; Tsugama, Daisuke; Liu, Shen Kui; Takano, Tetsuo			Transcriptomic analysis reveals the differentially expressed genes and pathways involved in drought tolerance in pearl millet [Pennisetum glaucum (L.) R. Br]	PLOS ONE			English	Article							STRESS TOLERANCE; ABSCISIC-ACID; PHOTOSYNTHESIS; PROTEINS; SEQUENCE; FAMILY; MEMBER; COLD	y Pearl millet is a cereal crop known for its high tolerance to drought, heat and salinity stresses as well as for its nutritional quality. The molecular mechanism of drought tolerance in pearl millet is unknown. Here we attempted to unravel the molecular basis of drought tolerance in two pearl millet inbred lines, ICMB 843 and ICMB 863 using RNA sequencing. Under greenhouse condition, ICMB 843 was found to be more tolerant to drought than ICMB 863. We sequenced the root transcriptome from both lines under control and drought conditions using an Illumina Hi-Seq platform, generating 139.1 million reads. Mapping of sequenced reads against the foxtail millet genome, which has been relatively well-annotated, led to the identification of several differentially expressed genes under drought stress. Total of 6799 and 1253 differentially expressed genes were found in ICMB 843 and ICMB 863, respectively. Pathway and gene function analysis by KEGG online tool revealed that the drought response in pearl millet is mainly regulated by pathways related to photosynthesis, plant hormone signal transduction and mitogen-activated protein kinase signaling. The changes in expression of drought-responsive genes determined by RNA sequencing were confirmed by reverse-transcription PCR for 7 genes. These results are a first step to understanding the molecular mechanisms of drought tolerance in pearl millet and lay a foundation for its genetic improvement.	[Dudhate, Ambika; Shinde, Harshraj; Takano, Tetsuo] Univ Tokyo, Asian Nat Environm Sci Ctr ANESC, Nishitokyo, Tokyo, Japan; [Tsugama, Daisuke] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Liu, Shen Kui] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Hangzhou, Zhejiang, Peoples R China	University of Tokyo; Hokkaido University; Zhejiang A&F University	Takano, T (corresponding author), Univ Tokyo, Asian Nat Environm Sci Ctr ANESC, Nishitokyo, Tokyo, Japan.	takano@anesc.u-tokyo.ac.jp	Liu, Shenkui/AAC-5405-2019; Tsugama, Daisuke/N-6054-2014	Liu, Shenkui/0000-0001-5294-4765; Dudhate, Ambika/0000-0003-1448-2461; Tsugama, Daisuke/0000-0002-4946-678X				Agarwal P, 2010, MOL BIOL REP, V37, P1125, DOI 10.1007/s11033-009-9885-8; APELBAUM A, 1981, PLANT PHYSIOL, V68, P594, DOI 10.1104/pp.68.3.594; Atwell BJ, 2015, EMISSION RATE PLANTS, P2; Baldoni E, 2016, RICE, V9, DOI 10.1186/s12284-016-0098-1; Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; Bates B.C., 2008, CLIMATE CHANGE WATER; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Chen YE, 2016, PHYSIOL PLANTARUM, V158, P225, DOI 10.1111/ppl.12438; Choudhary M, 2015, PHYSIOL MOL BIOL PLA, V21, P187, DOI 10.1007/s12298-015-0287-1; de Carvalho MHC, 2008, PLANT SIGNAL BEHAV, V3, P156, DOI 10.4161/psb.3.3.5536; Du H, 2012, J EXP BOT, V63, P6467, DOI 10.1093/jxb/ers300; Islam T, 2015, PLOS ONE, V10, P1; Jonak C, 1996, P NATL ACAD SCI USA, V93, P11274, DOI 10.1073/pnas.93.20.11274; Jongeneel V., 2001, BIOINFORMA PRACT GUI, V10, P57; Jung H, 2015, PLANT SCI, V236, P304, DOI 10.1016/j.plantsci.2015.04.018; Kerr TCC, 2018, PLANT CELL ENVIRON, V41, P898, DOI 10.1111/pce.12906; Kudo M, 2017, PLANT BIOTECHNOL J, V15, P458, DOI 10.1111/pbi.12644; Kulik A, 2011, OMICS, V15, P859, DOI 10.1089/omi.2011.0091; KUMAR S, 2016, FRONT PLANT SCI, V7, P1636, DOI DOI 10.3389/FPLS.2016.01636; Liu G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125001; Liu HQ, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/564149; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu CM, 1999, J EXP BOT, V50, P1199, DOI 10.1093/jexbot/50.336.1199; Min HW, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01080; Mishra RN, 2007, PLANT MOL BIOL, V64, P713, DOI 10.1007/s11103-007-9193-4; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Rajaram V, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-159; Riemann M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01077; Saglam A, 2014, ACTA BIOL HUNG, V65, P178, DOI 10.1556/ABiol.65.2014.2.6; Scheller HV, 2001, BBA-BIOENERGETICS, V1507, P41, DOI 10.1016/S0005-2728(01)00196-7; Shivhare R, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02069; Shivhare R, 2016, SCI REP-UK, V6, DOI 10.1038/srep23036; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Song K, 2017, FRONT PLANT SCI, V8, P1, DOI [10.3389/fpls.2017.00267/full, DOI 10.3389/FPLS.2017.00267/FULL]; Sun XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep31654; Suorsa M, 2006, J BIOL CHEM, V281, P145, DOI 10.1074/jbc.M510600200; Thornton LE, 2004, PLANT CELL, V16, P2164, DOI 10.1105/tpc.104.023515; Tullberg A, 2000, PLANT CELL PHYSIOL, V41, P1045, DOI 10.1093/pcp/pcd031; Tuteja N, 2007, PLANT SIGNAL BEHAV, V2, P135, DOI 10.4161/psb.2.3.4156; Vadez V, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00386; Varshney RK, 2017, NAT BIOTECHNOL, V35, P969, DOI 10.1038/nbt.3943; Wei T, 2017, FRONT PLANT SCI, V8, DOI [10.3389/fpls.2017.00052, 10.3389/fpls.2017.00526]; Wilkinson S, 2012, J EXP BOT, V63, P3499, DOI 10.1093/jxb/ers148; Woo NS, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-27; Wydrzynski T, 2007, PHOTOSYNTH RES, V94, P225, DOI 10.1007/s11120-007-9271-0; Xiang YL, 2017, MOL PLANT, V10, P456, DOI 10.1016/j.molp.2016.10.003; Zhang JH, 2013, MOL BIOL REP, V40, P2633, DOI 10.1007/s11033-012-2350-0	48	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195908	10.1371/journal.pone.0195908	http://dx.doi.org/10.1371/journal.pone.0195908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652907	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900046
J	Kingston, D; Kehler, H; Austin, MP; Mughal, MK; Wajid, A; Vermeyden, L; Benzies, K; Brown, S; Stuart, S; Giallo, R				Kingston, Dawn; Kehler, Heather; Austin, Marie-Paule; Mughal, Muhammad Kashif; Wajid, Abdul; Vermeyden, Lydia; Benzies, Karen; Brown, Stephanie; Stuart, Scott; Giallo, Rebecca			Trajectories of maternal depressive symptoms during pregnancy and the first 12 months postpartum and child externalizing and internalizing behavior at three years	PLOS ONE			English	Article							PROJECT ICE STORM; PHYSICAL AGGRESSION; POSTNATAL DEPRESSION; CANADIAN CHILDREN; CENTRAL ADIPOSITY; COMMUNITY SAMPLE; RISK-FACTORS; ANXIETY; METAANALYSIS; PSYCHOPATHOLOGY	Background Most evidence of the association between maternal depression and children's development is limited by being cross-sectional. To date, few studies have modelled trajectories of maternal depressive symptoms from pregnancy through the early postpartum years and examined their association with social emotional and behavior functioning in preschool children. The objectives of this study were to: 1) identify distinct groups of women defined by their trajectories of depressive symptoms across four time points from mid-pregnancy to one year postpartum; and 2) examine the associations between these trajectories and child internalizing and externalizing behaviors. Methods We analyzed data from the All Our Families (AOF) study, a large, population based pregnancy cohort of mother-child dyads in Alberta, Canada. The AOF study is an ongoing pregnancy cohort study designed to investigate relationships between the prenatal and early life period and outcomes for children and mothers. Maternal depressive symptoms were assessed using the Edinburgh Postnatal Depression Scale. Children's behavioral functioning at age 3 was assessed using the Behavior Scales developed for the Canadian National Longitudinal Survey of Children and Youth. Longitudinal latent class analysis was conducted to identify trajectories of women's depressive symptoms across four time points from pregnancy to 1 year postpartum. We used multivariable logistic regression to assess the relationship between trajectories of maternal depressive symptoms and children's behavior, while adjusting for other significant maternal, child and psychosocial factors. Results 1983 participants met eligibility criteria. We identified four distinct trajectories of maternal depressive symptoms: low level (64.7%); early postpartum (10.9%); subclinical (18.8%); and persistent high (5.6%). In multivariable models, the proportion of children with elevated behavior symptoms was highest for children whose mothers had persistent high depressive symptoms, followed by mothers with moderate symptoms (early postpartum and subclinical trajectories) and lowest for minimal symptoms. After accounting for demographic, child and psychosocial factors, the relationships between depression trajectories and child hyperactivity/inattention, physical aggression (subclinical trajectory only) and separation anxiety symptoms remained significant. Conclusion These findings suggest both externalizing and internalizing children's behaviors are associated with prolonged maternal depressive symptoms. There is a good case for the need to move beyond overly simplistic clinical cutoff approaches of depressed/not depressed in screening for perinatal depression. Women with elevated depressive symptoms at clinical and subclinical levels need to be identified, provided with evidence-based treatment, and monitored with repeat screening to improve maternal mental health outcomes and reduce the risk of associated negative outcomes on children's early social-emotional and behavior development.	[Kingston, Dawn; Kehler, Heather; Mughal, Muhammad Kashif; Wajid, Abdul; Vermeyden, Lydia; Benzies, Karen] Univ Calgary, Fac Nursing, Calgary, AB, Canada; [Austin, Marie-Paule] St John God Hlth Care, Burwood, Australia; [Austin, Marie-Paule] Univ New South Wales, Sydney, NSW, Australia; [Brown, Stephanie; Giallo, Rebecca] Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Stuart, Scott] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA	University of Calgary; St John of God Health Care; University of New South Wales Sydney; Murdoch Children's Research Institute; University of Iowa	Kingston, D (corresponding author), Univ Calgary, Fac Nursing, Calgary, AB, Canada.	dawn.kingston@ucalgary.ca	Brown, Stephanie/AAE-1662-2019; Mughal, M. Kashif/O-1018-2019; Wajid, Abdul/AAN-1011-2020	Mughal, M. Kashif/0000-0002-1321-0619; Wajid, Abdul/0000-0001-9594-620X; Stuart, Scott/0000-0003-2301-3405; Giallo, Rebecca/0000-0002-1065-2921; Kingston, Dawn/0000-0002-7183-2803; Brown, Stephanie/0000-0001-9812-0067	NHMRC Career Development Fellowship; Victorian Government's Operational Infrastructure Support Program; Alberta Innovates Interdisciplinary Team Grant [200700595]; Alberta Children's Hospital Foundation; Max Bell Foundation	NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; Alberta Innovates Interdisciplinary Team Grant; Alberta Children's Hospital Foundation; Max Bell Foundation	DK holds a CIHR New Investigator Award and the Lois Hole Hospital for Women Cross Provincial Chair in Perinatal Mental Health. RG is supported by NHMRC Career Development Fellowship and the Victorian Government's Operational Infrastructure Support Program. M-PA holds the St. John of God Chair in Perinatal and Women's Mental Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the (non-financial) contribution and support of All Our Families participants and team. (All Our Families is funded through Alberta Innovates Interdisciplinary Team Grant #200700595, the Alberta Children's Hospital Foundation, and the Max Bell Foundation.)	Achenbach TM, 1983, MANUAL CHILD BEHAV C; Atzaba-Poria N, 2004, INT J BEHAV DEV, V28, P449, DOI 10.1080/01650250444000171; Beck CT, 1999, J ADV NURS, V29, P623, DOI 10.1046/j.1365-2648.1999.00943.x; Benzies K, 2009, CAN J PSYCHIAT, V54, P55, DOI 10.1177/070674370905400109; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bogels SM, 2006, CLIN PSYCHOL REV, V26, P834, DOI 10.1016/j.cpr.2005.08.001; CAMPBELL SB, 1995, J CHILD PSYCHOL PSYC, V36, P113, DOI 10.1111/j.1469-7610.1995.tb01657.x; Cao-Lei L, 2017, NEUROSCI BIOBEHAV R, DOI [10.1016/j.neubiorev.2017.05.016, DOI 10.1016/J.NEUBIOREV.2017.05.016]; Cao-Lei L, 2016, EARLY HUM DEV, V103, P189, DOI 10.1016/j.earlhumdev.2016.09.013; Cao-Lei L, 2015, EPIGENETICS-US, V10, P749, DOI 10.1080/15592294.2015.1063771; Cents RAM, 2013, PSYCHOL MED, V43, P13, DOI 10.1017/S0033291712000657; Cote SM, 2006, J ABNORM CHILD PSYCH, V34, P71, DOI 10.1007/s10802-005-9001-z; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Gavin NI, 2005, OBSTET GYNECOL, V106, P1071, DOI 10.1097/01.AOG.0000183597.31630.db; Giallo R, 2017, INT J BEHAV DEV; Giallo R, 2015, EUR CHILD ADOLES PSY, V24, P1233, DOI 10.1007/s00787-014-0672-2; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Goodman SH, 1999, PSYCHOL REV, V106, P458, DOI 10.1037/0033-295X.106.3.458; Goodman SH, 2011, CLIN CHILD FAM PSYCH, V14, P1, DOI 10.1007/s10567-010-0080-1; Gracie SK, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-87; Grant KA, 2008, J AFFECT DISORDERS, V108, P101, DOI 10.1016/j.jad.2007.10.002; Grover RL, 2005, CHILD PSYCHIAT HUM D, V36, P133, DOI 10.1007/s10578-005-3491-3; Heron J, 2004, J AFFECT DISORDERS, V80, P65, DOI 10.1016/j.jad.2003.08.004; Kingston D, 2014, MATERN CHILD HLTH J, V18, P1728, DOI 10.1007/s10995-013-1418-3; Lee AM, 2007, OBSTET GYNECOL, V110, P1102, DOI 10.1097/01.AOG.0000287065.59491.70; Lei CL, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0219-0; McDonald SW, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-S1-S2; McHale JP, 1998, DEV PSYCHOPATHOL, V10, P39, DOI 10.1017/S0954579498001527; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Murray D, 1990, J REPROD INFANT PSYC, V8, P99, DOI DOI 10.1080/02646839008403615; Muthen L.K., 2010, MPLUS USERS GUIDE ST; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Park M, 2018, ARCH WOMEN MENT HLTH, V21, P353, DOI 10.1007/s00737-017-0803-0; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P22; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rubin KH, 2003, DEV PSYCHOL, V39, P164, DOI 10.1037//0012-1649.39.1.164; Santos H, 2016, ARCH WOMEN MENT HLTH, P1, DOI DOI 10.1007/S00737-016-0670-0; Smeekens S, 2007, J ABNORM CHILD PSYCH, V35, P347, DOI 10.1007/s10802-006-9095-y; Spielberger C.D., 1983, MANUAL STATE TRAIT A; StataCorp, 2013, STATA STAT SOFTW REL; Statistics Canada, 2007, MICR US GUID NAT LON; Stuart S, 1998, J NERV MENT DIS, V186, P420, DOI 10.1097/00005053-199807000-00006; Tough SC, 2017, INT J EPIDEMIOL; Tremblay RE, 2004, PEDIATRICS, V114, pE43, DOI 10.1542/peds.114.1.e43; van der Waerden J, 2015, J PEDIATR-US, V166, P1440, DOI 10.1016/j.jpeds.2015.03.002; Woolhouse H, 2015, BJOG-INT J OBSTET GY, V122, P312, DOI 10.1111/1471-0528.12837; Yap MBH, 2015, J AFFECT DISORDERS, V175, P424, DOI 10.1016/j.jad.2015.01.050	47	81	82	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195365	10.1371/journal.pone.0195365	http://dx.doi.org/10.1371/journal.pone.0195365			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652937	Green Published, gold			2022-12-26	WOS:000430026900022
J	Sela, I; Wolf, YI; Koonin, EV				Sela, Itamar; Wolf, Yuri I.; Koonin, Eugene V.			Estimation of universal and taxon-specific parameters of prokaryotic genome evolution	PLOS ONE			English	Article							HORIZONTAL GENE-TRANSFER; DELETIONAL BIAS; DNA LOSS; BACTERIAL; DATABASE; ATGC	The results of our recent study on mathematical modeling of microbial genome evolution indicate that, on average, genomes of bacteria and archaea evolve in the regime of mutation-selection balance defined by positive selection coefficients associated with gene acquisition that is counter-acted by the intrinsic deletion bias. This analysis was based on the strong assumption that parameters of genome evolution are universal across the diversity of bacteria and archaea, and yielded extremely low values of the selection coefficient. Here we further refine the modeling approach by taking into account evolutionary factors specific for individual groups of microbes using two independent fitting strategies, an ad hoc hard fitting scheme and a mixture model. The resulting estimate of the mean selection coefficient of s similar to 10(-10) associated with the gain of one gene implies that, on average, acquisition of a gene is beneficial, and that microbial genomes typically evolve under a weak selection regime that might transition to strong selection in highly abundant organisms with large effective population sizes. The apparent selective pressure towards larger genomes is balanced by the deletion bias, which is estimated to be consistently greater than unity for all analyzed groups of microbes. The estimated values of s are more realistic than the lower values obtained previously, indicating that global and group-specific evolutionary factors synergistically affect microbial genome evolution that seems to be driven primarily by adaptation to existence in diverse niches.	[Sela, Itamar; Wolf, Yuri I.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Koonin, EV (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	koonin@ncbi.nlm.nih.gov		Wolf, Yuri/0000-0002-0247-8708	US Department of Health and Human Services	US Department of Health and Human Services	The authors' research is supported by intramural funds of the US Department of Health and Human Services (funding to the National Library of Medicine). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Doolittle WF, 1999, TRENDS CELL BIOL, V9, pM5, DOI 10.1016/S0962-8924(99)01664-5; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gelman Andrew, 1995, BAYESIAN DATA ANAL; Gweon HS, 2017, ISME J, V11, P821, DOI 10.1038/ismej.2016.142; Hurst LD, 2002, TRENDS GENET, V18, P486, DOI 10.1016/S0168-9525(02)02722-1; Iranzo J, 2017, P NATL ACAD IN PRESS; Koonin EV, 2009, INT J BIOCHEM CELL B, V41, P298, DOI 10.1016/j.biocel.2008.09.015; Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668; Koonin EV, 2003, NAT REV MICROBIOL, V1, P127, DOI 10.1038/nrmicro751; Koonin EV, 2001, ANNU REV MICROBIOL, V55, P709, DOI 10.1146/annurev.micro.55.1.709; Kristensen DM, 2017, NUCLEIC ACIDS RES, V45, pD210, DOI 10.1093/nar/gkw934; Kryazhimskiy S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000304; Kuo CH, 2009, GENOME BIOL EVOL, V1, P145, DOI 10.1093/gbe/evp016; Kuo CH, 2009, GENOME RES, V19, P1450, DOI 10.1101/gr.091785.109; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; Lynch M, 2007, ORIGINS GENOME ARCHI; Lynch M, 2006, ANNU REV MICROBIOL, V60, P327, DOI 10.1146/annurev.micro.60.080805.142300; Lynch M, 2015, P NATL ACAD SCI USA, V112, P15690, DOI 10.1073/pnas.1514974112; McCandlish DM, 2015, THEOR POPUL BIOL, V99, P98, DOI 10.1016/j.tpb.2014.11.004; Mira A, 2001, TRENDS GENET, V17, P589, DOI 10.1016/S0168-9525(01)02447-7; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Petrov DA, 2000, SCIENCE, V287, P1060, DOI 10.1126/science.287.5455.1060; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; Puigbo P, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0066-4; Sela I, 2016, P NATL ACAD SCI USA, V113, P11399, DOI 10.1073/pnas.1614083113; Soucy SM, 2015, NAT REV GENET, V16, P472, DOI 10.1038/nrg3962; Treangen TJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001284; van Kampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Wolf YI, 2016, NATURE MICR IN PRESS; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	32	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195571	10.1371/journal.pone.0195571	http://dx.doi.org/10.1371/journal.pone.0195571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652909	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900029
J	Suma, S; Naito, M; Wakai, K; Naito, T; Kojima, M; Umemura, O; Yokota, M; Hanada, N; Kawamura, T				Suma, Shino; Naito, Mariko; Wakai, Kenji; Naito, Toru; Kojima, Masaaki; Umemura, Osami; Yokota, Makoto; Hanada, Nobuhiro; Kawamura, Takashi			Tooth loss and pneumonia mortality: A cohort study of Japanese dentists	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PERIODONTAL-DISEASE; RISK-FACTORS; INFECTION	Although associations between oral health and pneumonia have been reported in previous studies, particularly in the institutionalized elderly, few prospective studies have investigated the association between oral condition and pneumonia among community-dwelling people and whether the findings among inpatients or patients in nursing homes are applicable to the general population is still unclear. The oral bacteria propagated in the periodontal regions may drop into the lung and increase the risk of pneumonia. We, therefore, investigated the association of tooth loss with mortality from pneumonia in a cohort study of Japanese dentists. Members of the Japan Dental Association (JDA) participated in the LEMONADE (Longitudinal Evaluation of Multi-phasic, Odontological and Nutritional Associations in Dentists) Study. From 2001 to 2006, they completed a baseline questionnaire on lifestyle and health factors including the number of teeth lost (excluding third molars). We followed 19,775 participants (mean age +/- standard deviation, 51.4 +/- 11.7 years; 1,573 women [8.0%] and 18,202 men [92.0%]) for mortality from pneumonia (ICD-10, J12-J18). Mortality data were collected via the fraternal insurance program of the JDA. The hazard ratios (HRs) were estimated with adjustment for sex, age, body mass index, smoking status, physical activity and diabetes history. During the median follow-up period of 9.5 years, we documented 68 deaths from pneumonia. Participants who were edentulous at baseline were at significantly increased risk of mortality from pneumonia. The multivariable-adjusted HRs were 2.07 (95% confidence interval [CI], 1.09 +/- 3.95) for the edentulous and 1.60 (95% CI, 0.83 +/- 3.10) for loss of 15 +/- 27 teeth relative to loss of 0 +/- 14 teeth (trend p = 0.026). The HR per one tooth loss was also significant; 1.031 (95% CI, 1.004 +/- 1.060). In conclusion, a large number of teeth lost may indicate an increased risk of mortality from pneumonia in community-dwelling populations.	[Suma, Shino; Naito, Mariko; Wakai, Kenji] Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi, Japan; [Suma, Shino] Kyushu Univ, Fac Dent, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Fukuoka, Japan; [Naito, Mariko] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Maxillofacial Funct Dev, Hiroshima, Hiroshima, Japan; [Naito, Toru] Fukuoka Dent Coll, Sect Geriatr Dent, Dept Gen Dent, Fukuoka, Fukuoka, Japan; [Kojima, Masaaki; Umemura, Osami] Aichi Dent Assoc, Nagoya, Aichi, Japan; [Yokota, Makoto] Yokota Dent Private Sch, Fukuoka, Fukuoka, Japan; [Hanada, Nobuhiro] Tsurumi Univ, Dept Translat Res, Sch Dent Med, Yokohama, Kanagawa, Japan; [Kawamura, Takashi] Kyoto Univ Hlth Serv, Kyoto, Kyoto, Japan	Nagoya University; Kyushu University; Hiroshima University; Fukuoka Dental College (FDC); Tsurumi University; Kyoto University	Suma, S (corresponding author), Nagoya Univ, Grad Sch Med, Dept Prevent Med, Nagoya, Aichi, Japan.; Suma, S (corresponding author), Kyushu Univ, Fac Dent, Div Oral Hlth Growth & Dev, Sect Prevent & Publ Hlth Dent, Fukuoka, Fukuoka, Japan.	suma.shino@dent.kyushu-u.ac.jp	NAITO, Mariko/I-7264-2014; Hanada, Nobuhiro/C-5308-2011; Hanada, Nobuhiro/HHM-6735-2022	NAITO, Mariko/0000-0003-3794-2643; Hanada, Nobuhiro/0000-0002-9130-7256	8020 (20 teeth until 80 years old) Promotion Foundation; Ministry of Health, Labour and Welfare of Japan [H19-Iryo-Ippan-008]; Ministry of Education, Culture, Sports, Science and Technology of Japan [14770166, 16390189, 20590642, 23590788, 26463161]	8020 (20 teeth until 80 years old) Promotion Foundation; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the 8020 (20 teeth until 80 years old) Promotion Foundation [KW] and from the Ministry of Health, Labour and Welfare of Japan (H19-Iryo-Ippan-008) [NH]. The LEMONADE study was supported by Grants for Scientific Research (nos. 14770166 [KW], 16390189 [KW], 20590642 [KW], 23590788 [KW] and 26463161 [MN]) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2006, J EPIDEMIOL, V16, P214, DOI 10.2188/jea.16.214; [Anonymous], 2004, LETS START OR CAR; [Anonymous], 2014, CORR VAR ISS SURR AC; [Anonymous], 2014, STOP PNEUM; [Anonymous], 2014, PNEUM INF ELD; [Anonymous], 2015, OR CAR PROM MAN LONG; [Anonymous], 2015, CAUS SPEC MORT RAT G; [Anonymous], 2015, RANK CAUS DEATH YEAR; Arnold FW, 2013, RESP MED, V107, P1101, DOI 10.1016/j.rmed.2013.04.003; Awano S, 2008, J DENT RES, V87, P334, DOI 10.1177/154405910808700418; Bansal M, 2013, J Med Life, V6, P244; Beck J, 1996, J PERIODONTOL, V67, P1123, DOI 10.1902/jop.1996.67.10s.1123; Buhlin K, 2002, COMMUNITY DENT ORAL, V30, P431, DOI 10.1034/j.1600-0528.2002.00014.x; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; D'Aiuto F, 2005, J DENT RES, V84, P269, DOI 10.1177/154405910508400312; D'Aiuto F, 2004, J DENT RES, V83, P156, DOI 10.1177/154405910408300214; Neto JPD, 2013, EUR J CLIN MICROBIOL, V32, P27, DOI 10.1007/s10096-012-1710-y; Ding M, 2015, CIRCULATION, V132, P2305, DOI 10.1161/CIRCULATIONAHA.115.017341; Figueredo CMS, 2000, J CLIN PERIODONTOL, V27, P572, DOI 10.1034/j.1600-051x.2000.027008572.x; Geurs NC, 2003, PERIODONTOL 2000, V32, P105, DOI 10.1046/j.0906-6713.2003.03208.x; Gomes-Filho Isaac S, 2010, J Oral Microbiol, V2, DOI 10.3402/jom.v2i0.5811; Gomes-Filho IS, 2014, J PERIODONTOL, V85, pE82, DOI [10.1902/jop.2013.130369, 10.1902/jop.2013.130509]; Grau AJ, 2004, STROKE, V35, P496, DOI 10.1161/01.STR.0000110789.20526.9D; Holm-Pedersen P, 2008, J AM GERIATR SOC, V56, P429, DOI 10.1111/j.1532-5415.2007.01602.x; Kelaiditi E, 2014, J AM MED DIR ASSOC, V15, P588, DOI 10.1016/j.jamda.2014.04.012; Marcenes Wagner, 2003, Cad. Saúde Pública, V19, P809, DOI 10.1590/S0102-311X2003000300013; Mufson Maurice A., 1999, American Journal of Medicine, V107, p34S, DOI 10.1016/S0002-9343(99)00098-4; Offenbacher S, 1996, J PERIODONTOL, V67, P1103, DOI 10.1902/jop.1996.67.10s.1103; Paju S, 2007, ORAL DIS, V13, P508, DOI 10.1111/j.1601-0825.2007.01410a.x; Riquelme R, 1997, AM J RESP CRIT CARE, V156, P1908, DOI 10.1164/ajrccm.156.6.9702005; Saremi A, 2005, DIABETES CARE, V28, P27, DOI 10.2337/diacare.28.1.27; Scannapieco F A, 1998, Ann Periodontol, V3, P251, DOI 10.1902/annals.1998.3.1.251; Scannapieco FA, 1996, J PERIODONTOL, V67, P1114, DOI 10.1902/jop.1996.67.10s.1114; Scannapieco FA, 1999, J PERIODONTOL, V70, P793, DOI 10.1902/jop.1999.70.7.793; Scannapieco Frank A, 2003, Ann Periodontol, V8, P54, DOI 10.1902/annals.2003.8.1.54; Shah Divyang, 2009, Indian J Occup Environ Med, V13, P77, DOI 10.4103/0019-5278.55123; Singanayagam A, 2013, EUR RESPIR J, V42, P180, DOI 10.1183/09031936.00115312; Suzuki I, 1998, J Epidemiol, V8, P152; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Torres A, 2013, THORAX, V68, P1057, DOI 10.1136/thoraxjnl-2013-204282; van der Maarel-Wierink CD, 2013, GERODONTOLOGY, V30, P3, DOI 10.1111/j.1741-2358.2012.00637.x; van der Maarel-Wierink CD, 2011, J AM MED DIR ASSOC, V12, P344, DOI 10.1016/j.jamda.2010.12.099; Wakai K, 2010, COMMUNITY DENT ORAL, V38, P43, DOI 10.1111/j.1600-0528.2009.00512.x; Wakai K, 2009, J EPIDEMIOL, V19, P72, DOI 10.2188/jea.JE20070458; Wilson M, 1996, J PERIODONTAL RES, V31, P393, DOI 10.1111/j.1600-0765.1996.tb00508.x; Yoneyama T, 2002, J AM GERIATR SOC, V50, P430, DOI 10.1046/j.1532-5415.2002.50106.x; Yoshida M, 2001, Nihon Ronen Igakkai Zasshi, V38, P481	47	17	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195813	10.1371/journal.pone.0195813	http://dx.doi.org/10.1371/journal.pone.0195813			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652898	gold, Green Published, Green Submitted			2022-12-26	WOS:000430026900038
J	Paquette, SJ; Stanford, K; Thomas, J; Reuter, T				Paquette, Sarah-Jo; Stanford, Kim; Thomas, James; Reuter, Tim			Quantitative surveillance of shiga toxins 1 and 2, Escherichia coli O178 and O157 in feces of western-Canadian slaughter cattle enumerated by droplet digital PCR with a focus on seasonality and slaughterhouse location	PLOS ONE			English	Article							PREVALENCE; INFECTIONS; STEC; O145; O111; O103; IDENTIFICATION; SEROGROUPS; PATHOGEN; CULTURE	Often Escherichia coliare harmless and/or beneficial bacteria inhabiting the gastrointestinal tract of livestock and humans. However, Shiga toxin-producing E. coli (STEC) have been linked to human disease. Cattle are the primary reservoir for STEC and STEC "super-shedders" are considered to be a major contributor in animal to animal transmission. Among STEC, O157:H7 is the most recognized serotype, but in recent years, non-O157 STEC have been increasingly linked to human disease. In Argentina and Germany, O178 is considered an emerging pathogen. Our objective was to compare populations of E. coli O178, O157, shiga toxin 1 and 2 in western Canadian cattle feces from a sampling pool of similar to 80,000 beef cattle collected at two slaughterhouses. Conventional PCR was utilized to screen 1,773 samples for presence/absence of E. coli O178. A subset of samples (n = 168) was enumerated using droplet digital PCR (ddPCR) and proportions of O178, O157 and shiga toxins 1 & 2 specific-fragments were calculated as a proportion of generic E. coli (GEC) specific-fragments. Distribution of stx(1) and stx(2) was determined by comparing stx(1), stx(2) and O157 enumerations. Conventional PCR detected the presence of O178 in 873 of 1,773 samples and ddPCR found the average proportion of O178, O157, stx(1) and stx(2) in the samples 2.8%, 0.6%, 1.4% and 0.5%, respectively. Quantification of stx(1) and stx(2) revealed more virulence genes than could be exclusively attributed to O157. Our results confirmed the presence of E. coli O178 in western Canadian cattle and ddPCR revealed O178 as a greater proportion of GEC than was O157. Our results suggests: I) O178 may be an emerging subgroup in Canada and II) monitoring virulence genes may be a more relevant target for food-safety STEC surveillance compared to current serogroup screening.	[Paquette, Sarah-Jo; Stanford, Kim; Reuter, Tim] Alberta Agr & Forestry, Lethbridge, AB, Canada; [Paquette, Sarah-Jo; Thomas, James] Univ Lethbridge, Lethbridge, AB, Canada	University of Lethbridge	Reuter, T (corresponding author), Alberta Agr & Forestry, Lethbridge, AB, Canada.	tim.reuter@gov.ab.ca	Reuter, Tim/AAA-6443-2020	Reuter, Tim/0000-0002-0593-3163; Stanford, Kim/0000-0001-8784-0042	Growing Forward 2 grant, TR [9037070]	Growing Forward 2 grant, TR	This work was supported by the Growing Forward 2 grant, TR, 9037070. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FED REG; Baker CA, 2016, FOOD CONTROL, V59, P407, DOI 10.1016/j.foodcont.2015.06.011; Bielaszewska M, 2011, LANCET INFECT DIS, V11, P671, DOI 10.1016/S1473-3099(11)70165-7; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Brusa V, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2012.00171; CALLAWAY TR, 2013, AGR FOOD ANAL BACTER, V3, P39; Chase-Topping M, 2008, NAT REV MICROBIOL, V6, P904, DOI 10.1038/nrmicro2029; Chui L, 2011, J CLIN MICROBIOL, V49, P4307, DOI 10.1128/JCM.05211-11; Cleary Thomas G, 2004, Semin Pediatr Infect Dis, V15, P260, DOI 10.1053/j.spid.2004.07.007; Conrad CC, 2014, J MICROBIOL METH, V105, P22, DOI 10.1016/j.mimet.2014.06.020; Dewsbury DM, 2015, FOODBORNE PATHOG DIS, V12, P726, DOI 10.1089/fpd.2015.1987; Dong HJ, 2017, GUT PATHOG, V9, DOI 10.1186/s13099-017-0169-x; Ekong PS, 2015, PREV VET MED, V121, P74, DOI 10.1016/j.prevetmed.2015.06.019; Fernandez D, 2010, LETT APPL MICROBIOL, V51, P377, DOI 10.1111/j.1472-765X.2010.02904.x; Fernandez D, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00009; Gannon VPJ, 2002, EPIDEMIOL INFECT, V129, P163, DOI 10.1017/S0950268802007100; Heiman KE, 2015, EMERG INFECT DIS, V21, P1293, DOI 10.3201/eid2108.141364; Kanki M, 2011, LETT APPL MICROBIOL, V53, P167, DOI 10.1111/j.1472-765X.2011.03085.x; Karch H, 1999, DIAGN MICR INFEC DIS, V34, P229, DOI 10.1016/S0732-8893(99)00031-0; Karmali MA, 2004, MOL BIOTECHNOL, V26, P117, DOI 10.1385/MB:26:2:117; Karmali MA, 2017, CLIN INFECT DIS, V64, P371, DOI 10.1093/cid/ciw708; Karmali MA, 2010, VET MICROBIOL, V140, P360, DOI 10.1016/j.vetmic.2009.04.011; Khalil RKS, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw037; Lindsey RL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00766; Maheux AF, 2009, WATER RES, V43, P3019, DOI 10.1016/j.watres.2009.04.017; Martin A, 2011, INT J FOOD MICROBIOL, V146, P99, DOI 10.1016/j.ijfoodmicro.2011.01.041; Masana MO, 2011, J FOOD PROTECT, V74, P2008, DOI 10.4315/0362-028X.JFP-11-189; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; Mcpherson AS, 2015, EPIDEMIOL INFECT, V143, P2733, DOI 10.1017/S0950268815000011; Miko A, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00078; Munns KD, 2014, FOODBORNE PATHOG DIS, V11, P329, DOI 10.1089/fpd.2013.1621; Murphy BP, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01850; Omisakin F, 2003, APPL ENVIRON MICROB, V69, P2444, DOI 10.1128/AEM.69.5.2444-2447.2003; Pearce MC, 2006, APPL ENVIRON MICROB, V72, P653, DOI 10.1128/AEM.72.1.653-659.2006; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Russo TA, 2003, MICROBES INFECT, V5, P449, DOI 10.1016/S1286-4579(03)00049-2; Sodha SV, 2015, EPIDEMIOL INFECT, V143, P267, DOI 10.1017/S0950268814000880; Soysal N, 2016, EMERG INFECT DIS, V22, P1604, DOI 10.3201/eid2209.160304; Stanford K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159866; Stanford K, 2014, FOODBORNE PATHOG DIS, V11, P379, DOI 10.1089/fpd.2013.1693; Tahamtan Y, 2010, IRAN J MICROBIOL, V2, P9; Tanaro JD, 2012, FOODBORNE PATHOG DIS, V9, P878, DOI 10.1089/fpd.2012.1182; Venegas-Vargas C, 2016, APPL ENVIRON MICROB, V82, P5049, DOI 10.1128/AEM.00829-16; Verhaegen B, 2016, TOXINS, V8, DOI 10.3390/toxins8050157; Vimont A, 2007, VET MICROBIOL, V123, P274, DOI 10.1016/j.vetmic.2007.02.003; Yang R, 2017, AUST VET J, V95, P143, DOI 10.1111/avj.12572	46	7	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195880	10.1371/journal.pone.0195880	http://dx.doi.org/10.1371/journal.pone.0195880			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649278	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900101
J	Russell, B; Garmo, H; Beckmann, K; Stettin, P; Adolfsson, J; Van Hemelrijck, M				Russell, Beth; Garmo, Hans; Beckmann, Kerri; Stettin, Par; Adolfsson, Jan; Van Hemelrijck, Mieke			A case-control study of lower urinary-tract infections, associated antibiotics and the risk of developing prostate cancer using PCBaSe 3.0	PLOS ONE			English	Article							PROPIONIBACTERIUM-ACNES; COHORT PROFILE; ANTIBODIES; INFLAMMATION; REGISTER; DISEASES; SWEDEN	Objectives To investigate the association between lower urinary-tract infections, their associated antibiotics and the subsequent risk of developing PCa. Subjects/Patients (or materials) and methods Using data from the Swedish PCBaSe 3.0, we performed a matched case-control study (8762 cases and 43806 controls). Conditional logistic regression analysis was used to assess the association between lower urinary-tract infections, related antibiotics and PCa, whilst adjusting for civil status, education, Charlson Comorbidity Index and time between lower urinary-tract infection and PCa diagnosis. Results It was found that lower urinary-tract infections did not affect PCa risk, however, having a lower urinary-tract infection or a first antibiotic prescription 6-12 months before PCa were both associated with an increased risk of PCa (OR: 1.50, 95% CI: 1.23-1.82 and 1.96, 1.71-2.25, respectively), as compared to men without lower urinary-tract infections. Compared to men with no prescriptions for antibiotics, men who were prescribed >10 antibiotics, were 15% less likely to develop PCa (OR: 0.85, 95% CI: 0.78-0.91). Conclusion PCa was not found to be associated with diagnosis of a urinary-tract infection or frequency, but was positively associated with short time since diagnoses of lower urinary-tract infection or receiving prescriptions for antibiotics. These observations can likely be explained by detection bias, which highlights the importance of data on the diagnostic work-up when studying potential risk factors for PCa.	[Russell, Beth; Garmo, Hans; Beckmann, Kerri; Van Hemelrijck, Mieke] Kings Coll London, Div Canc Studies Translat Oncol & Urol Res TOUR, London, England; [Garmo, Hans] Reg Canc Ctr, Uppsala, Sweden; [Beckmann, Kerri] Univ South Australia, Ctr Populat Hlth Res, Adelaide, SA, Australia; [Stettin, Par] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Adolfsson, Jan] Karolinska Inst, CLINTEC Dept, Stockholm, Sweden	University of London; King's College London; University of South Australia; Uppsala University; Karolinska Institutet	Russell, B (corresponding author), Kings Coll London, Div Canc Studies Translat Oncol & Urol Res TOUR, London, England.	beth.russell@kcl.ac.uk		Van Hemelrijck, Mieke/0000-0002-7317-0858; Adolfsson, Jan/0000-0003-2992-1869; Russell, Beth/0000-0001-5640-8425; Beckmann, Kerri/0000-0002-9798-1479	Swedish Research Council for Working Life, Health, and Welfare [825-2012-5047]; Swedish Cancer Society [14-0570]; Cancer Society in Stockholm; Uppsala County council; National Institute for Health Research (NIHR); St Thomas' NHS Foundation Trust; King's College London	Swedish Research Council for Working Life, Health, and Welfare; Swedish Cancer Society(Swedish Cancer Society); Cancer Society in Stockholm; Uppsala County council; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); St Thomas' NHS Foundation Trust; King's College London	This work was supported by the Swedish Research Council for Working Life, Health, and Welfare (825-2012-5047), the Swedish Cancer Society (14-0570), the Cancer Society in Stockholm, and Uppsala County council. The research was also supported by the National Institute for Health Research (NIHR) BRC based at Guy's and St Thomas' NHS Foundation Trust and King's College London.	Anttila T, 2005, CANCER EPIDEM BIOMAR, V14, P385, DOI 10.1158/1055-9965.EPI-03-0325; Boehm K, 2016, WORLD J UROL, V34, P425, DOI 10.1007/s00345-015-1625-1; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Cohen RJ, 2005, J UROLOGY, V173, P1969, DOI 10.1097/01.ju.0000158161.15277.78; Davidsson S, 2016, INFECT AGENTS CANCER, V11, DOI 10.1186/s13027-016-0074-9; Fan C-Y, 2017, PLOS ONE, V12; Hamoya T, 2017, J CLIN BIOCHEM NUTR, V60, P199, DOI 10.3164/jcbn.16-107; Jhamb M, 2007, CANCER CAUSE CONTROL, V18, P839, DOI 10.1007/s10552-007-9028-2; Korodi Z, 2005, CANCER EPIDEM BIOMAR, V14, P2952, DOI 10.1158/1055-9965.EPI-05-0602; Longhi C, 2016, NEW MICROBIOL, V39, P146; Masajtis-Zagajewska A, 2017, CLIN CHIM ACTA; NHS, 2017, ANT NHS CHOIC; Pelucchi C, 2006, EUR J CANCER PREV, V15, P254, DOI 10.1097/01.cej.0000198897.40303.d4; Severi G, 2010, BRIT J CANCER, V103, P411, DOI 10.1038/sj.bjc.6605757; Sfanos KS, 2012, HISTOPATHOLOGY, V60, P199, DOI 10.1111/j.1365-2559.2011.04033.x; Stamm WE, 2002, AM J MED, V113, p1S; Sundaram S, 2017, J CLIN DIAGN RES, V11, pOC1, DOI 10.7860/JCDR/2017/24202.9333; Sutcliffe S, 2006, CANCER EPIDEM BIOMAR, V15, P939, DOI 10.1158/1055-9965.EPI-05-0781; Van Hemelrijck M, 2016, INT J EPIDEMIOL, V45, P73, DOI 10.1093/ije/dyv305; Van Hemelrijck M, 2013, INT J EPIDEMIOL, V42, P956, DOI 10.1093/ije/dys068	20	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195690	10.1371/journal.pone.0195690	http://dx.doi.org/10.1371/journal.pone.0195690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649268	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000429791900071
J	Silver, JD; Sutherland, MF; Johnston, FH; Lampugnani, ER; McCarthy, MA; Jacobs, SJ; Pezza, AB; Newbigin, EJ				Silver, Jeremy D.; Sutherland, Michael F.; Johnston, Fay H.; Lampugnani, Edwin R.; McCarthy, Michael A.; Jacobs, Stephanie J.; Pezza, Alexandre B.; Newbigin, Edward J.			Seasonal asthma in Melbourne, Australia, and some observations on the occurrence of thunderstorm asthma and its predictability	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; GRASS-POLLEN; CHILDHOOD ASTHMA; RISK-FACTORS; EPIDEMICS; AIR; EXACERBATIONS; VARIABILITY; CHILDREN; MODELS	We examine the seasonality of asthma-related hospital admissions in Melbourne, Australia, in particular the contribution and predictability of episodic thunderstorm asthma. Using a time-series ecological approach based on asthma admissions to Melbourne metropolitan hospitals, we identified seasonal peaks in asthma admissions that were centred in late February, June and mid-November. These peaks were most likely due to the return to school, winter viral infections and seasonal allergies, respectively. We performed non-linear statistical regression to predict daily admission rates as functions of the seasonal cycle, weather conditions, reported thunderstorms, pollen counts and air quality. Important predictor variables were the seasonal cycle and mean relative humidity in the preceding two weeks, with higher humidity associated with higher asthma admissions. Although various attempts were made to model asthma admissions, none of the models explained substantially more variation above that associated with the annual cycle. We also identified a list of high asthma admissions days (HAADs). Most HAADs fell in the late-February return-to-school peak and the November allergy peak, with the latter containing the greatest number of daily admissions. Many HAADs in the spring allergy peak may represent episodes of thunderstorm asthma, as they were associated with rainfall, thunderstorms, high ambient grass pollen levels and high humidity, a finding that suggests thunderstorm asthma is a recurrent phenomenon in Melbourne that occurs roughly once per five years. The rarity of thunderstorm asthma events makes prediction challenging, underscoring the importance of maintaining high standards of asthma management, both for patients and health professionals, especially during late spring and early summer.	[Silver, Jeremy D.] Univ Melbourne, Sch Earth Sci, Parkville, Vic, Australia; [Sutherland, Michael F.] Univ Melbourne, Inst Breathing & Sleep, Dept Med, Parkville, Vic, Australia; [Sutherland, Michael F.] Austin Hlth, Heidelberg, Vic, Australia; [Johnston, Fay H.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Lampugnani, Edwin R.; McCarthy, Michael A.; Newbigin, Edward J.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Jacobs, Stephanie J.] Monash Univ, Sch Earth Atmosphere & Environm, Clayton, Vic, Australia; [Pezza, Alexandre B.] Greater Wellington Reg Council, Wellington, New Zealand; [Pezza, Alexandre B.] Victoria Univ Wellington, Sch Geog Environm & Earth Sci, Wellington, New Zealand	University of Melbourne; Institute for Breathing & Sleep (IBAS); University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Tasmania; Menzies Institute for Medical Research; University of Melbourne; Monash University; Victoria University Wellington	Silver, JD (corresponding author), Univ Melbourne, Sch Earth Sci, Parkville, Vic, Australia.	jeremy.silver@unimelb.edu.au	Silver, Jeremy/Y-4174-2019; Lampugnani, Edwin/AAF-4238-2019; McCarthy, Michael/O-5655-2014	Silver, Jeremy/0000-0003-1502-6249; Lampugnani, Edwin/0000-0002-3666-7240; McCarthy, Michael/0000-0003-1039-7980; Johnston, Fay Helena/0000-0002-5150-8678	University of Melbourne; ARC [FT100100923]	University of Melbourne(University of Melbourne); ARC(Australian Research Council)	JD Silver's work was funded by the MacKenzie Postdoctoral Fellowship scheme of the University of Melbourne: https://research.unimelb.edu.au/support/funding/internal/mckenzie-fellowship. GPATS lightning data was purchased with fund from ARC Future Fellowship FT100100923 awarded to MA McCarthy (http://www.arc.gov.au/future-fellowships). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2013, GREATER CAPITAL CITY; ABS, 2014, AUSTRALIAN HISTORICA; ABS, 2017, COMMUNITY PROFILES; ABS, 2016, ESTIMATED RESIDENT P; AMS. Thunderstorm, 2012, GLOSSARY OF METEOROL; Atkinson RW, 2014, THORAX, V69, P660, DOI 10.1136/thoraxjnl-2013-204492; BELLOMO R, 1992, MED J AUSTRALIA, V156, P834, DOI 10.5694/j.1326-5377.1992.tb136994.x; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; Bunn R, 2016, LIGHTNING STROKE COU; Chen CH, 2006, J ASTHMA, V43, P287, DOI 10.1080/02770900600622935; Cohen HA, 2014, PEDIATRICS, V133, pE923, DOI 10.1542/peds.2013-2022; D'Amato G, 2005, CLIN EXP ALLERGY, V35, P1113, DOI 10.1111/j.1365-2222.2005.02328.x; Dabrera G, 2013, QJM-INT J MED, V106, P207, DOI 10.1093/qjmed/hcs234; de Morton J, 2011, INT J BIOMETEOROL, V55, P613, DOI 10.1007/s00484-010-0361-x; Denning DW, 2006, EUR RESPIR J, V27, P615, DOI 10.1183/09031936.06.00074705; EGAN P, 1985, MED J AUSTRALIA, V142, P330, DOI 10.5694/j.1326-5377.1985.tb113389.x; Eggo RM, 2016, P NATL ACAD SCI USA, V113, P2194, DOI 10.1073/pnas.1518677113; Erbas B, 2012, CLIN EXP ALLERGY, V42, P799, DOI 10.1111/j.1365-2222.2012.03995.x; Erbas B, 2014, WEEKLY POLLEN COUNT, DOI [10.4227/05/5344E4980DAF6, DOI 10.4227/05/5344E4980DAF6]; Graham B, 2016, ASTHMA REGISTER; Grundstein A, 2009, GEOGR COMPASS, V3, P45, DOI 10.1111/j.1749-8198.2008.00195.x; Haberle SG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097925; Hamill TM, 2006, Q J ROY METEOR SOC, V132, P2905, DOI 10.1256/qj.06.25; Hekking PPW, 2014, J ALLER CL IMM-PRACT, V2, P671, DOI 10.1016/j.jaip.2014.09.007; Hoch H, 2015, B27 VIRAL INFECT PED, pA2639; Howden ML, 2011, MED J AUSTRALIA, V195, P512, DOI 10.5694/mja11.11044; IGEM, 2017, FINAL REPORT; Johnston SL, 1996, AM J RESP CRIT CARE, V154, P654, DOI 10.1164/ajrccm.154.3.8810601; Kappos AD, 2004, INT J HYG ENVIR HEAL, V207, P399, DOI 10.1078/1438-4639-00306; Kim HY, 2010, NAT IMMUNOL, V11, P577, DOI 10.1038/ni.1892; Kim KH, 2013, ENVIRON INT, V59, P41, DOI 10.1016/j.envint.2013.05.007; KNOX RB, 1993, CLIN EXP ALLERGY, V23, P354, DOI 10.1111/j.1365-2222.1993.tb00339.x; Kuleshov Y, 2002, AUST METEOROL MAG, V51, P145; Lincoln D, 2006, PUBLIC HEALTH, V120, P854, DOI 10.1016/j.puhe.2006.05.015; Lindstrom SJ, 2017, MED J AUSTRALIA, V207, P235, DOI 10.5694/mja17.00285; Marks GB, 2001, THORAX, V56, P468, DOI 10.1136/thorax.56.6.468; MCEVOY RJ, 1992, MED J AUSTRALIA, V157, P352, DOI 10.5694/j.1326-5377.1992.tb137214.x; Nasser SM, 2009, CURR ALLERGY ASTHM R, V9, P384, DOI 10.1007/s11882-009-0056-8; Natekin A, 2013, FRONT NEUROROBOTICS, V7, DOI 10.3389/fnbot.2013.00021; Ong E. K., 1995, Aerobiologia, V11, P51, DOI 10.1007/BF02136145; Qiu H, 2015, SCI TOTAL ENVIRON, V505, P508, DOI 10.1016/j.scitotenv.2014.10.003; R. Core Team, 2015, R A LANGUAGE AND ENV; REED BC, 1994, J VEG SCI, V5, P703, DOI 10.2307/3235884; Rice MB, 2015, AM J RESP CRIT CARE, V191, P501, DOI 10.1164/rccm.201411-1976ED; Sabariego S, 2000, INT J BIOMETEOROL, V44, P1, DOI 10.1007/s004840050131; Schaefer JT., 1986, WEA FORECASTING, V1, P164, DOI [10.1175/1520-0434(1986)0012.0.CO;2, DOI 10.1175/1520-0434(1986)001, 2.0.co;2]; Silverman RA, 2003, ANN EMERG MED, V42, P577, DOI 10.1067/S0196-0644(03)00410-4; SKOBELOFF EM, 1992, JAMA-J AM MED ASSOC, V268, P3437, DOI 10.1001/jama.268.24.3437; Sofiev M, 2013, ALLERGENIC POLLEN A; Soyiri IN, 2013, CHRON RESP DIS, V10, P85, DOI 10.1177/1479972313482847; Teach SJ, 2015, J ALLERGY CLIN IMMUN, V135, P1465, DOI 10.1016/j.jaci.2014.12.1942; Tham R., 2016, J ALLERGY CLIN IMMUN; University of Wyoming, 2016, ATMOSPHERIC SOUNDING; Victorian Department of Health and Human Services, 2017, EPIDEMIC THUNDERSTOR; Wisniewski JA, 2016, ALLERGY ASTHMA PROC, V37, P475, DOI 10.2500/aap.2016.37.3994; Wood S., 2006, GEN ADDITIVE MODELS, DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zhang Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102475	58	39	39	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194929	10.1371/journal.pone.0194929	http://dx.doi.org/10.1371/journal.pone.0194929			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649224	Green Accepted, Green Published, gold			2022-12-26	WOS:000429791900019
J	Soukupova, J; Zemankova, P; Lhotova, K; Janatova, M; Borecka, M; Stolarova, L; Lhota, F; Foretova, L; Machackova, E; Stranecky, V; Tavandzis, S; Kleiblova, P; Vocka, M; Hartmannova, H; Hodanova, K; Kmoch, S; Kleibl, Z				Soukupova, Jana; Zemankova, Petra; Lhotova, Klara; Janatova, Marketa; Borecka, Marianna; Stolarova, Lenka; Lhota, Filip; Foretova, Lenka; Machackova, Eva; Stranecky, Viktor; Tavandzis, Spiros; Kleiblova, Petra; Vocka, Michal; Hartmannova, Hana; Hodanova, Katerina; Kmoch, Stanislav; Kleibl, Zdenek			Validation of CZECANCA (CZEch CAncer paNel for Clinical Application) for targeted NGS-based analysis of hereditary cancer syndromes	PLOS ONE			English	Article							BREAST-CANCER; GENETIC-VARIANTS; BRCA1 GENE; PREDISPOSITION GENES; SEQUENCE VARIATION; COLORECTAL-CANCER; MEDICAL GENETICS; AMERICAN-COLLEGE; HIGH PROPORTION; OVARIAN-CANCER	Background Carriers of mutations in hereditary cancer predisposition genes represent a small but clinically important subgroup of oncology patients. The identification of causal germline mutations determines follow-up management, treatment options and genetic counselling in patients' families. Targeted next-generation sequencing-based analyses using cancer-specific panels in high-risk individuals have been rapidly adopted by diagnostic laboratories. While the use of diagnosis-specific panels is straightforward in typical cases, individuals with unusual phenotypes from families with overlapping criteria require multiple panel testing. Moreover, narrow gene panels are limited by our currently incomplete knowledge about possible genetic dispositions. Methods We have designed a multi-gene panel called CZECANCA (CZEch CAncer paNel for Clinical Application) for a sequencing analysis of 219 cancer-susceptibility and candidate predisposition genes associated with frequent hereditary cancers. Results The bioanalytical and bioinformatics pipeline was validated on a set of internal and commercially available DNA controls showing high coverage uniformity, sensitivity, specificity and accuracy. The panel demonstrates a reliable detection of both single nucleotide and copy number variants. Inter-laboratory, intra- and inter-run replicates confirmed the robustness of our approach. Conclusion The objective of CZECANCA is a nationwide consolidation of cancer-predisposition genetic testing across various clinical indications with savings in costs, human labor and turnaround time. Moreover, the unified diagnostics will enable the integration and analysis of genotypes with associated phenotypes in a national database improving the clinical interpretation of variants.	[Soukupova, Jana; Zemankova, Petra; Lhotova, Klara; Janatova, Marketa; Borecka, Marianna; Stolarova, Lenka; Lhota, Filip; Kleiblova, Petra; Kleibl, Zdenek] Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic; [Lhota, Filip] Gennet, Ctr Med Genet & Reprod Med, Prague, Czech Republic; [Foretova, Lenka; Machackova, Eva] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Stranecky, Viktor; Hartmannova, Hana; Hodanova, Katerina; Kmoch, Stanislav] Charles Univ Prague, Fac Med 1, Dept Paediat & Adolescent Med, Res Unit Rare Dis, Prague, Czech Republic; [Stranecky, Viktor; Kleiblova, Petra; Vocka, Michal; Hartmannova, Hana; Hodanova, Katerina; Kmoch, Stanislav] Gen Univ Hosp Prague, Prague, Czech Republic; [Tavandzis, Spiros] AGEL Res & Training Inst, Dept Med Genet, AGEL Labs, Novy Jicin, Czech Republic; [Kleiblova, Petra] Charles Univ Prague, Fac Med 1, Inst Biol & Med Genet, Prague, Czech Republic; [Vocka, Michal] Charles Univ Prague, Fac Med 1, Dept Oncol, Prague, Czech Republic	Charles University Prague; Masaryk Memorial Cancer Institute; Charles University Prague; General University Hospital Prague; Charles University Prague; Charles University Prague	Soukupova, J; Kleibl, Z (corresponding author), Charles Univ Prague, Inst Biochem & Expt Oncol, Fac Med 1, Prague, Czech Republic.	jana.soukupova@lf1.cuni.cz; zdekleje@lf1.cuni.cz	Kleibl, Zdenek/A-2009-2008; Soukupová, Jana/ABI-2077-2020; Borecka, Marianna/K-5127-2016; Kleiblova, Petra/K-9899-2017; Stranecky, Viktor/I-8524-2017	Kleibl, Zdenek/0000-0003-2050-9667; Borecka, Marianna/0000-0001-6413-222X; Janatova, Marketa/0000-0003-2816-6769; Machackova, Eva/0000-0002-0246-1471; Soukupova, Jana/0000-0003-2413-1542; Foretova, Lenka/0000-0003-0494-2620; Kleiblova, Petra/0000-0002-4806-9854; Stranecky, Viktor/0000-0002-2599-6479; Zemankova, Petra/0000-0001-7315-1975	Ministry of Health [15-27695A, 15-28830A, 16-29959A]; DRO MMCI [00209805]; Charles University [PROGRES Q28/LF1, SVV2017/260367]; Ministry of Education, Youth and Sports [CZ.02.1.01/0.0/0.0/16_013/0001634]	Ministry of Health; DRO MMCI; Charles University; Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This study was supported by the grants of Ministry of Health (www.mzcr.cz) 15-27695A (JS), 15-28830A (ZK), 16-29959A (ZK), and DRO MMCI, 00209805 (LF), grants of Charles University (www.cuni.cz) PROGRES Q28/LF1 (ZK), and SVV2017/260367 (SK) and Ministry of Education, Youth and Sports (www.msmt.cz) project CZ.02.1.01/0.0/0.0/16_013/0001634 (SK).	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Azimi M, 2016, MOL GENET GENOM MED, V4, P292, DOI 10.1002/mgg3.204; Borecka M, 2016, CANCER GENET-NY, V209, P199, DOI 10.1016/j.cancergen.2016.03.003; Chun S, 2009, GENOME RES, V19, P1553, DOI 10.1101/gr.092619.109; Cooper GM, 2005, GENOME RES, V15, P901, DOI 10.1101/gr.3577405; Das R, 2017, DNA REPAIR, V52, P92, DOI 10.1016/j.dnarep.2017.02.013; Easton DF, 2015, NEW ENGL J MED, V372, P2243, DOI 10.1056/NEJMsr1501341; Espenschied CR, 2017, J CLIN ONCOL, V35, P2568, DOI 10.1200/JCO.2016.71.9260; Feero WG, 2014, JAMA-J AM MED ASSOC, V311, P1017, DOI 10.1001/jama.2014.1718; Foulkes WD, 2008, NEW ENGL J MED, V359, P2143, DOI 10.1056/NEJMra0802968; Grindedal EM, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3422-2; Hardwick SA, 2017, NAT REV GENET, V18, P473, DOI 10.1038/nrg.2017.44; Havranek O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140819; Janatova M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127711; Janatova M, 2013, CANCER EPIDEM BIOMAR, V22, P2323, DOI 10.1158/1055-9965.EPI-13-0745-T; Kalia SS, 2017, GENET MED, V19, P249, DOI 10.1038/gim.2016.190; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Kleibl Z, 2009, NEOPLASMA, V56, P303, DOI 10.4149/neo_2009_04_303; Kleibl Z, 2009, EUR J CANCER, V45, P618, DOI 10.1016/j.ejca.2008.09.022; Kleiblova P, 2013, J CELL BIOL, V201, P511, DOI 10.1083/jcb.201210031; Kulkarni A, 2016, BRIT MED BULL, V120, P123, DOI 10.1093/bmb/ldw046; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Lhota F, 2016, CLIN GENET, V90, P324, DOI 10.1111/cge.12748; Machackova E, 2016, Klin Onkol, V29 Suppl 1, pS35; Majewski J, 2011, J MED GENET, V48, P580, DOI 10.1136/jmedgenet-2011-100223; Matthijs G, 2016, EUR J HUM GENET, V24, P2, DOI 10.1038/ejhg.2015.226; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Moran O, 2017, BREAST CANCER RES TR, V161, P135, DOI 10.1007/s10549-016-4038-y; Pearlman R, 2017, JAMA ONCOL, V3, P464, DOI 10.1001/jamaoncol.2016.5194; Pohlreich P, 2005, BREAST CANCER RES, V7, pR728, DOI 10.1186/bcr1282; Pohlreich P, 2003, MED PRIN PRACT, V12, P23, DOI 10.1159/000068163; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rahman N, 2014, CLIN MED, V14, P436, DOI 10.7861/clinmedicine.14-4-436; Rahman N, 2014, NATURE, V505, P302, DOI 10.1038/nature12981; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shah PD, 2017, ANNU REV GENOM HUM G, V18, P201, DOI 10.1146/annurev-genom-091416-035305; Sims D, 2014, NAT REV GENET, V15, P121, DOI 10.1038/nrg3642; Soukupova J, 2016, Klin Onkol, V29 Suppl 1, pS46; Soukupova J, 2008, ONCOL REP, V19, P1505; Stoffel EM, 2016, SEMIN ONCOL, V43, P527, DOI 10.1053/j.seminoncol.2016.09.003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ticha I, 2010, BREAST CANCER RES TR, V124, P337, DOI 10.1007/s10549-010-0745-y; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wildeman M, 2008, HUM MUTAT, V29, P6, DOI 10.1002/humu.20654; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhao M, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S11-S1	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195761	10.1371/journal.pone.0195761	http://dx.doi.org/10.1371/journal.pone.0195761			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649263	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900083
J	Wanat, JJ; Logsdon, GA; Driskill, JH; Deng, Z; Lieberman, PM; Johnson, FB				Wanat, Jennifer J.; Logsdon, Glennis A.; Driskill, Jordan H.; Deng, Zhong; Lieberman, Paul M.; Johnson, F. Brad			TERRA and the histone methyltransferase Dot1 cooperate to regulate senescence in budding yeast	PLOS ONE			English	Article							REPEAT-CONTAINING RNA; CEREVISIAE CDC13-1 MUTANTS; DNA-DAMAGE RESPONSE; DOMAIN PROTEIN MPS3; SINGLE-STRANDED-DNA; SACCHAROMYCES-CEREVISIAE; TELOMERE-LENGTH; NUCLEAR PERIPHERY; H3K79 METHYLATION; GENE-EXPRESSION	The events underlying senescence induced by critical telomere shortening are not fully understood. Here we provide evidence that TERRA, a non-coding RNA transcribed from subtelomeres, contributes to senescence in yeast lacking telomerase (tlc1 Delta). Levels of TERRA expressed from multiple telomere ends appear elevated at senescence, and expression of an artificial RNA complementary to TERRA (anti-TERRA) binds TERRA in vivo and delays senescence. Anti-TERRA acts independently from several other mechanisms known to delay senescence, including those elicited by deletions of EXO1, TEL1, SAS2, and genes encoding RNase H enzymes. Further, it acts independently of the senescence delay provided by RAD52-dependent recombination. However, anti-TERRA delays senescence in a fashion epistatic to inactivation of the conserved histone methyltransferase Dot1. Dot1 associates with TERRA, and anti-TERRA disrupts this interaction in vitro and in vivo. Surprisingly, the anti-TERRA delay is independent of the C-terminal methyltransferase domain of Dot1 and instead requires only its N-terminus, which was previously found to facilitate release of telomeres from the nuclear periphery. Together, these data suggest that TERRA and Dot1 cooperate to drive senescence.	[Wanat, Jennifer J.; Logsdon, Glennis A.; Driskill, Jordan H.; Johnson, F. Brad] Univ Penn, Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wanat, Jennifer J.] Washington Coll, Dept Biol, Chestertown, MD USA; [Logsdon, Glennis A.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Driskill, Jordan H.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX USA; [Deng, Zhong; Lieberman, Paul M.] Wistar Inst Anat & Biol, Gene Express & Regulat, 3601 Spruce St, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Texas System; University of Texas Southwestern Medical Center Dallas; The Wistar Institute	Johnson, FB (corresponding author), Univ Penn, Sch Med, Pathol & Lab Med, Philadelphia, PA 19104 USA.	johnsonb@pennmedicine.upenn.edu		Driskill, Jordan/0000-0003-4319-3845; Logsdon, Glennis/0000-0003-2396-0656	Ellison/AFAR postdoctoral fellowship; Penn-PORT IRACDA Grant; UPenn Cell and Molecular Biology Training Grant [GM007229]; American Heart Association [11SDG5330017]; Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences;  [R01 AG021521];  [P01 AG031862];  [R01 CA140652]; NATIONAL CANCER INSTITUTE [R01CA140652, R50CA221838] Funding Source: NIH RePORTER	Ellison/AFAR postdoctoral fellowship; Penn-PORT IRACDA Grant; UPenn Cell and Molecular Biology Training Grant; American Heart Association(American Heart Association); Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	JJW was funded by an Ellison/AFAR postdoctoral fellowship and the Penn-PORT IRACDA Grant. FBJ, JJW, and JHD are funded by R01 AG021521 and P01 AG031862. JHD is also funded by the Roy and Diana Vagelos Scholars Program in the Molecular Life Sciences. GAL is funded by the UPenn Cell and Molecular Biology Training Grant (GM007229). PL is funded by R01 CA140652 and ZD was supported by an American Heart Association Grant (11SDG5330017).	Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Armanios M, 2013, J CLIN INVEST, V123, P996, DOI 10.1172/JCI66370; Arnoult N, 2012, NAT STRUCT MOL BIOL, V19, P948, DOI 10.1038/nsmb.2364; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bah A, 2012, NUCLEIC ACIDS RES, V40, P2995, DOI 10.1093/nar/gkr1153; Balk B, 2014, RNA BIOL, V11, P95, DOI 10.4161/rna.27798; Balk B, 2013, NAT STRUCT MOL BIOL, V20, P1199, DOI 10.1038/nsmb.2662; Batey RT, 2007, RNA, V13, P1384, DOI 10.1261/rna.528007; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Bonetti D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000966; Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040; Caslini C, 2009, MOL CELL BIOL, V29, P4519, DOI 10.1128/MCB.00195-09; Chu HP, 2017, CELL, V170, P86, DOI 10.1016/j.cell.2017.06.017; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Collart M A, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1312s23; Cusanelli E, 2013, MOL CELL, V51, P780, DOI 10.1016/j.molcel.2013.08.029; Dang W, 2014, CELL METAB, V19, P952, DOI 10.1016/j.cmet.2014.04.004; Deng Z, 2009, MOL CELL, V35, P403, DOI 10.1016/j.molcel.2009.06.025; Dunn B, 2001, Curr Protoc Mol Biol, VChapter 13, DOI 10.1002/0471142727.mb1313s23; Enomoto S, 2002, MOL BIOL CELL, V13, P2626, DOI 10.1091/mbc.02-02-0012; Fallet E, 2014, NUCLEIC ACIDS RES, V42, P3648, DOI 10.1093/nar/gkt1328; Feldmann H, 1996, J BIOL CHEM, V271, P27765, DOI 10.1074/jbc.271.44.27765; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Gartenberg MR, 2009, GENE DEV, V23, P1027, DOI 10.1101/gad.1805309; Gilson E, 2007, NAT REV MOL CELL BIO, V8, P825, DOI 10.1038/nrm2259; Graf M, 2017, CELL, V170, P72, DOI 10.1016/j.cell.2017.06.006; Grandin N, 2005, BIOL CELL, V97, P799, DOI 10.1042/BC20040526; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Hector RE, 2007, MOL CELL, V27, P851, DOI 10.1016/j.molcel.2007.08.007; Iglesias N, 2011, EMBO REP, V12, P587, DOI 10.1038/embor.2011.73; Ijpma AS, 2003, MOL BIOL CELL, V14, P987, DOI 10.1091/mbc.02-04-0057; Jia XD, 2004, GENETICS, V166, P753, DOI 10.1534/genetics.166.2.753; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Khadaroo B, 2009, NAT CELL BIOL, V11, P980, DOI 10.1038/ncb1910; Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Kozak ML, 2010, EMBO J, V29, P158, DOI 10.1038/emboj.2009.314; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Le S, 1999, GENETICS, V152, P143; Lee JY, 2007, PLOS BIOL, V5, P1334, DOI 10.1371/journal.pbio.0050160; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; LOUIS EJ, 1990, GENETICS, V124, P533; Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Maicher A, 2012, NUCLEIC ACIDS RES, V40, P6649, DOI 10.1093/nar/gks358; Maringele L, 2004, GENETICS, V166, P1641, DOI 10.1534/genetics.166.4.1641; Mekhail K, 2008, NATURE, V456, P667, DOI 10.1038/nature07460; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Nautiyal S, 2002, P NATL ACAD SCI USA, V99, P9316, DOI 10.1073/pnas.142162499; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Oza P, 2009, GENE DEV, V23, P912, DOI 10.1101/gad.1782209; Pfeiffer V, 2013, EMBO J, V32, P2861, DOI 10.1038/emboj.2013.217; Pfeiffer V, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002747; Platt JM, 2013, GENE DEV, V27, P1406, DOI 10.1101/gad.218776.113; Raschenberger J, 2013, ATHEROSCLEROSIS, V229, P469, DOI 10.1016/j.atherosclerosis.2013.05.027; Ritchie KB, 1999, MOL CELL BIOL, V19, P6065; Sabourin M, 2007, MOL CELL, V27, P550, DOI 10.1016/j.molcel.2007.07.016; Sagie S, 2014, HUM MOL GENET, V23, P3629, DOI 10.1093/hmg/ddu071; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; SANDELL LL, 1994, P NATL ACAD SCI USA, V91, P12061, DOI 10.1073/pnas.91.25.12061; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Schober H, 2009, GENE DEV, V23, P928, DOI 10.1101/gad.1787509; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Shah PP, 2013, GENE DEV, V27, P1787, DOI 10.1101/gad.223834.113; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; SINGER MS, 1994, SCIENCE, V266, P404, DOI 10.1126/science.7545955; Sperka T, 2012, NAT REV MOL CELL BIO, V13, P579, DOI 10.1038/nrm3420; Steger DJ, 2008, MOL CELL BIOL, V28, P2825, DOI 10.1128/MCB.02076-07; Stulemeijer IJE, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-2; Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Takahashi YH, 2011, MOL CELL, V42, P118, DOI 10.1016/j.molcel.2011.03.006; Teng SC, 1999, MOL CELL BIOL, V19, P8083; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; Vodenicharov MD, 2010, EMBO J, V29, P3007, DOI 10.1038/emboj.2010.155; Vrbsky J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000986; Wellinger RJ, 2012, GENETICS, V191, P1073, DOI 10.1534/genetics.111.137851; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Xu Z, 2013, GENETICS, V194, P847, DOI 10.1534/genetics.113.152322; Yehezkel S, 2008, HUM MOL GENET, V17, P2776, DOI 10.1093/hmg/ddn177; Zubko MK, 2004, GENETICS, V168, P103, DOI 10.1534/genetics.104.027904	85	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195698	10.1371/journal.pone.0195698	http://dx.doi.org/10.1371/journal.pone.0195698			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649255	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900073
J	Gumbs, R; Gray, CL; Wearn, OR; Owen, NR				Gumbs, Rikki; Gray, Claudia L.; Wearn, Oliver R.; Owen, Nisha R.			Tetrapods on the EDGE: Overcoming data limitations to identify phylogenetic conservation priorities	PLOS ONE			English	Article							FUNCTIONAL DIVERSITY; EVOLUTIONARY DISTINCTIVENESS; POPULATION DECLINES; TAXONOMIC BIAS; THREAT STATUS; BIODIVERSITY; MADAGASCAR; ALLOCATION; LIKELIHOOD; PRIMATES	The scale of the ongoing biodiversity crisis requires both effective conservation prioritisation and urgent action. As extinction is non-random across the tree of life, it is important to prioritise threatened species which represent large amounts of evolutionary history. The EDGE metric prioritises species based on their Evolutionary Distinctiveness (ED), which measures the relative contribution of a species to the total evolutionary history of their taxonomic group, and Global Endangerment (GE), or extinction risk. EDGE prioritisations rely on adequate phylogenetic and extinction risk data to generate meaningful priorities for conservation. However, comprehensive phylogenetic trees of large taxonomic groups are extremely rare and, even when available, become quickly out-of-date due to the rapid rate of species descriptions and taxonomic revisions. Thus, it is important that conservationists can use the available data to incorporate evolutionary history into conservation prioritisation. We compared published and new methods to estimate missing ED scores for species absent from a phylogenetic tree whilst simultaneously correcting the ED scores of their close taxonomic relatives. We found that following artificial removal of species from a phylogenetic tree, the new method provided the closest estimates of their "true" ED score, differing from the true ED score by an average of less than 1%, compared to the 31% and 38% difference of the previous methods. The previous methods also substantially under- and over-estimated scores as more species were artificially removed from a phylogenetic tree. We therefore used the new method to estimate ED scores for all tetrapods. From these scores we updated EDGE prioritisation rankings for all tetrapod species with IUCN Red List assessments, including the first EDGE prioritisation for reptiles. Further, we identified criteria to identify robust priority species in an effort to further inform conservation action whilst limiting uncertainty and anticipating future phylogenetic advances.	[Gumbs, Rikki] Imperial Coll London, Sci & Solut Changing Planet DTP, Silwood Pk Campus, Ascot, Berks, England; [Gumbs, Rikki] Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England; [Gumbs, Rikki; Gray, Claudia L.; Wearn, Oliver R.; Owen, Nisha R.] Zool Soc London, EDGE Existence Programme, Regents Pk, London, England; [Wearn, Oliver R.] Zool Soc London, Inst Zool, Regents Pk, London, England	Imperial College London; Imperial College London; Zoological Society of London; Zoological Society of London	Gumbs, R (corresponding author), Imperial Coll London, Sci & Solut Changing Planet DTP, Silwood Pk Campus, Ascot, Berks, England.; Gumbs, R (corresponding author), Imperial Coll London, Dept Life Sci, Silwood Pk Campus, Ascot, Berks, England.; Gumbs, R (corresponding author), Zool Soc London, EDGE Existence Programme, Regents Pk, London, England.	r.gumbs@imperial.ac.uk		Wearn, Oliver/0000-0001-8258-3534	Natural Environment Research Council Science and Solutions [NE/L002515/1]; Zoological Society of London; Natural Environment Research Council [1823139] Funding Source: researchfish	Natural Environment Research Council Science and Solutions; Zoological Society of London; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	RG is funded by the Natural Environment Research Council Science and Solutions for a Changing Planet Doctoral Training Programme (grant number NE/L002515/1), the CASE component of which is funded by the Zoological Society of London - https://www.imperial.ac.uk/grantham/education/science-and-solutions-for-achanging-planet-dtp/. The Zoological Society of London paid the salary of NRO, ORW and CLG during the time period of the study - https://www.zsl.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beastall C, 2016, BIRD CONSERV INT, V26, P137, DOI 10.1017/S0959270916000010; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BirdLife, 2017, BIRDLIFE TAX CHECKL; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Chavanich S, 2015, ZOOLOGY, V118, P132, DOI 10.1016/j.zool.2015.01.002; Clark JA, 2002, SCIENCE, V297, P191; Clough Y, 2011, P NATL ACAD SCI USA, V108, P8311, DOI 10.1073/pnas.1016799108; Clucas B, 2008, BIODIVERS CONSERV, V17, P1517, DOI 10.1007/s10531-008-9361-0; Collar N.J., 2015, BirdingASIA, V24, P12; Collen B, 2011, PHILOS T R SOC B, V366, P2611, DOI 10.1098/rstb.2011.0109; Curnick DJ, 2015, ANIM CONSERV, V18, P303, DOI 10.1111/acv.12185; Devictor V, 2010, ECOL LETT, V13, P1030, DOI 10.1111/j.1461-0248.2010.01493.x; Diaz S, 2001, TRENDS ECOL EVOL, V16, P646, DOI 10.1016/S0169-5347(01)02283-2; Diaz S, 2007, P NATL ACAD SCI USA, V104, P20684, DOI 10.1073/pnas.0704716104; Dickman AJ, 2015, CONSERV BIOL, V29, P854, DOI 10.1111/cobi.12494; Faith DP, 2008, CONSERV BIOL, V22, P1461, DOI 10.1111/j.1523-1739.2008.01068.x; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; FAITH DP, 2015, PHILOS T R SOC B, V370, DOI DOI 10.1098/RSTB.2014.0011; Faurby S, 2015, MOL PHYLOGENET EVOL, V84, P14, DOI 10.1016/j.ympev.2014.11.001; Frishkoff LO, 2014, SCIENCE, V345, P1343, DOI 10.1126/science.1254610; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Guillon JM, 2012, CONTRIB ZOOL, V81, P147, DOI 10.1163/18759866-08103002; Harrison CJ, 2006, PLANT J, V45, P561, DOI 10.1111/j.1365-313X.2005.02611.x; Hedges SB, 2015, MOL BIOL EVOL, V32, P835, DOI 10.1093/molbev/msv037; Hotaling S, 2016, MOL ECOL, V25, P2029, DOI 10.1111/mec.13604; Huang S, 2015, EVOLUTION, V69, P621, DOI 10.1111/evo.12611; Iqbal Muhammad, 2015, BirdingASIA, V24, P132; Isaac NJB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000296; Isaac NJB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043912; Jaffe AL, 2011, BIOL LETTERS, V7, P558, DOI 10.1098/rsbl.2010.1084; Jetz W, 2012, NATURE, V491, P444, DOI 10.1038/nature11631; Jetz W, 2014, CURR BIOL, V24, P919, DOI 10.1016/j.cub.2014.03.011; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Kuhn TS, 2011, METHODS ECOL EVOL, V2, P427, DOI 10.1111/j.2041-210X.2011.00103.x; Li BBV, 2016, CONSERV BIOL, V30, P329, DOI 10.1111/cobi.12618; Lips KR, 2005, BIOTROPICA, V37, P222, DOI 10.1111/j.1744-7429.2005.00029.x; Magnuson-Ford K, 2009, BIOL CONSERV, V142, P1787, DOI 10.1016/j.biocon.2009.03.020; Marin J, 2016, J BIOGEOGR, V43, P1069, DOI 10.1111/jbi.12709; Marshall AJ, 2016, FRONT ECOL ENVIRON, V14, P13, DOI 10.1002/14-0195.1; Mazel F, 2018, BIORXIV, DOI DOI 10.1101/243923; Meiri S, 2016, BIOL CONSERV, V204, P6, DOI 10.1016/j.biocon.2016.03.009; Mouillot D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10359; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nunes LA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0004; Oaks JL, 2004, NATURE, V427, P630, DOI 10.1038/nature02317; Ogada D, 2016, CONSERV LETT, V9, P89, DOI 10.1111/conl.12182; Pavoine S, 2005, ECOL LETT, V8, P579, DOI 10.1111/j.1461-0248.2005.00752.x; Pearse WD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126524; Poole C, 2003, CONSERV BIOL, V17, P661, DOI [10.1046/j.1523-1739.2003.01740.x, DOI 10.1046/J.1523-1739.2003.01740.X]; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Prum RO, 2015, NATURE, V526, P569, DOI 10.1038/nature15697; Pyron RA, 2014, SYST BIOL, V63, P779, DOI 10.1093/sysbio/syu042; Rabosky DL, 2015, EVOLUTION, V69, P3207, DOI 10.1111/evo.12817; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Redding DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141435; Redding DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113490; Redding DW, 2010, CONSERV BIOL, V24, P1052, DOI 10.1111/j.1523-1739.2010.01532.x; Rosauer D, 2009, MOL ECOL, V18, P4061, DOI 10.1111/j.1365-294X.2009.04311.x; Rowley JJL, 2013, ZOOTAXA, V 3737, P415, DOI 10.11646/zootaxa.3737.4.5; Safi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063582; Schwitzer C, 2014, SCIENCE, V343, P842, DOI 10.1126/science.1245783; Secretariat of the Convention on Biological Diversity, 2006, GLOB BIOD OUTL 2; Seddon PJ, 2005, ANIM CONSERV, V8, P51, DOI 10.1017/S1367943004001799; Shirley MH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2483; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Stattersfield A, 1998, ENDEMIC BIRDS WORLD; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; Steel M, 2007, EVOL BIOINFORM, V3, P237; Stein RW, 2018, NAT ECOL EVOL, V2, P288, DOI 10.1038/s41559-017-0448-4; Swenson NG, 2014, ECOGRAPHY, V37, P105, DOI 10.1111/j.1600-0587.2013.00528.x; Tapley B, 2018, BIOL CONSERV, V220, P209, DOI 10.1016/j.biocon.2018.01.022; Thomas GH, 2013, METHODS ECOL EVOL, V4, P1011, DOI 10.1111/2041-210X.12117; Tonini JFR, 2016, BIOL CONSERV, V204, P23, DOI 10.1016/j.biocon.2016.03.039; van Balen S., 2011, BIRD CONSERV INT, V23, P91; VANDIJK PP, 2014, CHELONIAN RES MONOGR, V5, P329, DOI DOI 10.3854/CRM.5.000.CHECKLIST.V7.2014; Veron S, 2017, BIOL REV, V92, P271, DOI 10.1111/brv.12228; Vieites DR, 2009, P NATL ACAD SCI USA, V106, P8267, DOI 10.1073/pnas.0810821106; Whitfield SM, 2016, COPEIA, V104, P351, DOI 10.1643/CH-15-300; Wilson D.E., 1993, TAXONOMIC GEOGRAPHIC, V2nd ed.; Yoder AD, 2000, P NATL ACAD SCI USA, V97, P11325, DOI 10.1073/pnas.200121897; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	86	37	38	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194680	10.1371/journal.pone.0194680	http://dx.doi.org/10.1371/journal.pone.0194680			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641585	Green Submitted, gold, Green Published			2022-12-26	WOS:000429742900039
J	Provenzani, R; Tarvainen, I; Brandoli, G; Lempinen, A; Artes, S; Turku, A; Jantti, MH; Talman, V; Yli-Kauhaluoma, J; Tuominen, RK; af Gennas, GB				Provenzani, Riccardo; Tarvainen, Ilari; Brandoli, Giulia; Lempinen, Antti; Artes, Sanna; Turku, Ainoleena; Jantti, Maria Helena; Talman, Virpi; Yli-Kauhaluoma, Jari; Tuominen, Raimo K.; af Gennas, Gustav Boije			Scaffold hopping from (5-hydroxymethyl) isophthalates to multisubstituted pyrimidines diminishes binding affinity to the C1 domain of protein kinase C	PLOS ONE			English	Article							PHORBOL ESTER RECEPTORS; BIOLOGICAL-ACTIVITY; DIACYLGLYCEROL DAG; CHEMICAL SPACE; PKC-ALPHA; DESIGN; SELECTIVITY; LIGAND; RASGRP; DERIVATIVES	Protein kinase C (PKC) isoforms play a pivotal role in the regulation of numerous cellular functions, making them extensively studied and highly attractive drug targets. Utilizing the crystal structure of the PKC delta C1B domain, we have developed hydrophobic isophthalic acid derivatives that modify PKC functions by binding to the C1 domain of the enzyme. In the present study, we aimed to improve the drug-like properties of the isophthalic acid derivatives by increasing their solubility and enhancing the binding affinity. Here we describe the design and synthesis of a series of multisubstituted pyrimidines as analogs of C1 domain - targeted isophthalates and characterize their binding affinities to the PKC alpha isoform. In contrast to our computational predictions, the scaffold hopping from phenyl to pyrimidine core diminished the binding affinity. Although the novel pyrimidines did not establish improved binding affinity for PKC alpha compared to our previous isophthalic acid derivatives, the present results provide useful structure-activity relationship data for further development of ligands targeted to the C1 domain of PKC.	[Provenzani, Riccardo; Brandoli, Giulia; Lempinen, Antti; Artes, Sanna; Turku, Ainoleena; Yli-Kauhaluoma, Jari; af Gennas, Gustav Boije] Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Drug Res Program, Helsinki, Finland; [Tarvainen, Ilari; Jantti, Maria Helena; Talman, Virpi; Tuominen, Raimo K.] Univ Helsinki, Fac Pharm, Div Pharmacol & Pharmacotherapy, Drug Res Program, Helsinki, Finland	University of Helsinki; University of Helsinki	Yli-Kauhaluoma, J (corresponding author), Univ Helsinki, Fac Pharm, Div Pharmaceut Chem & Technol, Drug Res Program, Helsinki, Finland.	jari.yli-kauhaluoma@helsinki.fi	Talman, Virpi/AAP-5146-2020; Provenzani, Riccardo/C-9940-2014; Boije af Gennas, Gustav/N-4545-2015	Provenzani, Riccardo/0000-0002-6780-1924; Turku, Ainoleena/0000-0003-0959-7221; Tarvainen, Ilari/0000-0003-3386-465X; Talman, Virpi/0000-0002-2702-6505; Yli-Kauhaluoma, Jari/0000-0003-0370-7653; Boije af Gennas, Gustav/0000-0002-0099-6085	Finnish Cultural Foundation; Jane and Aatos Erkko Foundation [4703673]; Academy of Finland [305533]; Finnish Foundation for Cardiovascular Research	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research	This work was supported by Finnish Cultural Foundation, RP, www.skr.fi; Magnus Ehrnrooth Foundation, RP, https://www.magnusehrnroothinsaatio.fi/; Jane and Aatos Erkko Foundation, RKT, 4703673, http://jaes.fi/; Academy of Finland, GBG, 305533, www.aka.fi; and Finnish Foundation for Cardiovascular Research, VT, http//www.sydantutkimussaatio.fi.	af Gennas GB, 2011, CURR TOP MED CHEM, V11, P1370, DOI 10.2174/156802611795589584; af Gennas GB, 2009, J MED CHEM, V52, P3969, DOI 10.1021/jm900229p; Alkon DL, 2007, TRENDS PHARMACOL SCI, V28, P51, DOI 10.1016/j.tips.2006.12.002; Anderson ED, 2014, ORG LETT, V16, P5084, DOI 10.1021/ol502436n; ARECES LB, 1994, J BIOL CHEM, V269, P19553; Blumberg PM, 2008, CURR DRUG TARGETS, V9, P641, DOI 10.2174/138945008785132376; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; DRIEDGER PE, 1980, P NATL ACAD SCI-BIOL, V77, P567, DOI 10.1073/pnas.77.1.567; Duerfeldt AS, 2014, J AM CHEM SOC, V136, P2119, DOI 10.1021/ja412298c; Elhalem E, 2017, BIOORGAN MED CHEM, V25, P2971, DOI 10.1016/j.bmc.2017.03.022; Garcia LC, 2014, BIOORGAN MED CHEM, V22, P3123, DOI 10.1016/j.bmc.2014.04.024; Garg R, 2014, ONCOGENE, V33, P5225, DOI 10.1038/onc.2013.524; Glide S, 2016, SCHRODINGER RELEASE; Goel G, 2007, INT J TOXICOL, V26, P279, DOI 10.1080/10915810701464641; GOPALAKRISHNA R, 1992, ANAL BIOCHEM, V206, P24, DOI 10.1016/S0003-2697(05)80006-5; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Irie K, 2005, CHEM REC, V5, P185, DOI 10.1002/tcr.20044; Kedei N, 2004, CANCER RES, V64, P3243, DOI 10.1158/0008-5472.CAN-03-3403; Larsson J, 2005, J NAT PROD, V68, P985, DOI 10.1021/np049655u; Larsson J, 2007, J NAT PROD, V70, P789, DOI 10.1021/np070002y; Lee J, 1998, ARCH PHARM RES, V21, P452, DOI 10.1007/BF02974642; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Nacro K, 2000, J MED CHEM, V43, P921, DOI 10.1021/jm9904607; Ohashi N, 2017, BIOCONJUGATE CHEM, V28, P2135, DOI 10.1021/acs.bioconjchem.7b00299; OTSUKA M, 1985, CHEM PHARM BULL, V33, P515; Pettit GR, 1996, J NAT PROD, V59, P286, DOI 10.1021/np960100b; Roffey J, 2009, CURR OPIN CELL BIOL, V21, P268, DOI 10.1016/j.ceb.2009.01.019; Rosen J, 2009, J COMPUT AID MOL DES, V23, P253, DOI 10.1007/s10822-008-9255-y; Shao L, 2001, J MED CHEM, V44, P3872, DOI 10.1021/jm010258f; Sigano DM, 2003, J MED CHEM, V46, P1571, DOI 10.1021/jm020476o; Talman V, 2014, BIOCHEM SOC T, V42, P1543, DOI 10.1042/BST20140181; Talman V, 2014, EUR J PHARM SCI, V55, P46, DOI 10.1016/j.ejps.2014.01.002; Talman V, 2013, PHARMACOL RES, V73, P44, DOI 10.1016/j.phrs.2013.04.008; Talman V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020053; Tammela P, 2004, DRUG DEVELOP RES, V63, P76, DOI 10.1002/ddr.10399; Wender PA, 2008, ORG LETT, V10, P3331, DOI 10.1021/ol801235h; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X	40	5	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195668	10.1371/journal.pone.0195668	http://dx.doi.org/10.1371/journal.pone.0195668			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641588	gold, Green Published, Green Submitted			2022-12-26	WOS:000429742900083
J	Pruksaphon, K; Intaramat, A; Ratanabanangkoon, K; Nosanchuk, JD; Vanittanakom, N; Youngchim, S				Pruksaphon, Kritsada; Intaramat, Akarin; Ratanabanangkoon, Kavi; Nosanchuk, Joshua D.; Vanittanakom, Nongnuch; Youngchim, Sirida			Development and characterization of an immunochromatographic test for the rapid diagnosis of Talaromyces (Penicillium) marneffei	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; MONOCLONAL-ANTIBODIES; URINARY ANTIGEN; SOUTHEAST-ASIA; IMMUNODEFICIENCY; IDENTIFICATION; ASSAY; SERODIAGNOSIS; QUANTITATION; SERUM	Talaromyces (Penicillium) marneffei is a thermally dimorphic fungus that can cause opportunistic systemic mycoses in patients infected with the human immunodeficiency virus (HIV). It has also been reported among patients with other causes of immunodeficiency, such as systemic lupus erythematosus, cancer, organ transplanted patients receiving immunosuppressive drug and adult onset immunodeficiency syndromes. Recent studies indicate that the clinical manifestations, laboratory findings and treatment strategies of talaromycosis (penicilliosis) marneffei are different between patients with and without HIV infection. Therefore early and accurate diagnosis of talaromycosis marneffei is crucial to the proper management and treatment. Since current diagnostic methods are currently inadequate, the aim of this study was to develop an immunochromatographic test (ICT) for the detection of T. marneffei yeast antigens in urine samples. The highly T. marneffei-specific monoclonal antibody 4D1 (MAb 4D1) conjugated with gold colloid at pH 6.5 was used as signal generator. The nitrocellulose membrane was lined with T. marneffei cytoplasmic yeast antigen (TM CYA) to serve as the test line, and rabbit anti-mouse IgG was the control line. Subjecting the assembled test strip to urine samples containing T. marneffei antigen produced a visible result within 20 minutes. The sensitivity limit of the assay was 3.125 mu g/ ml of TM CYA. The ICT was used to test urine samples from 66 patients with blood culture confirmed talaromycosis marneffei, 42 patients with other fungal or bacterial infections, and 70 normal healthy individuals from endemic area of T. marneffei. The test exhibited sensitivity, specificity and accuracy of 87.87%, 100% and 95.5%, respectively. This rapid, user-friendly test holds great promise for the serodiagnosis of T. marneffei infection.	[Pruksaphon, Kritsada; Vanittanakom, Nongnuch; Youngchim, Sirida] Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai, Thailand; [Intaramat, Akarin; Ratanabanangkoon, Kavi] Chulabhorn Res Inst, Lab Immunol, Bangkok, Thailand; [Intaramat, Akarin; Ratanabanangkoon, Kavi] Chulabhorn Grad Inst, Bangkok, Thailand; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Med Infect Dis, Bronx, NY 10467 USA; [Nosanchuk, Joshua D.] Albert Einstein Coll Med, Dept Microbiol Immunol, Bronx, NY 10467 USA; [Ratanabanangkoon, Kavi] Mahidol Univ, Dept Microbiol, Fac Sci, Bangkok, Thailand	Chiang Mai University; Chulabhorn Research Institute; Chulabhorn Graduate Institute; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Mahidol University	Youngchim, S (corresponding author), Chiang Mai Univ, Dept Microbiol, Fac Med, Chiang Mai, Thailand.	syoungchim@gmail.com	Pruksaphon, Kritsada/AAZ-6487-2020; Nosanchuk, Joshua/AAS-7801-2021	Pruksaphon, Kritsada/0000-0002-1391-7163; youngchim, sirida/0000-0001-9013-0543	National Research University Project under Thailand's Office of the Higher Education Commission; Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Chulabhorn Research Institute, Thailand [CRI 474/2552]	National Research University Project under Thailand's Office of the Higher Education Commission; Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; Chulabhorn Research Institute, Thailand	This work was supported by the National Research University Project under Thailand's Office of the Higher Education Commission for financial support, The Research Fund of Faculty of Medicine, Chiang Mai University, Chiang Mai, 50200, Thailand (SY); Chulabhorn Research Institute, Thailand Grant number CRI 474/2552 (Al).	Aybay C, 2000, J IMMUNOL METHODS, V233, P77, DOI 10.1016/S0022-1759(99)00195-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browne SK, 2012, NEW ENGL J MED, V367, P725, DOI 10.1056/NEJMoa1111160; Chaiyaroj SC, 2003, J CLIN MICROBIOL, V41, P432, DOI 10.1128/JCM.41.1.432-434.2003; Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.18; Chan JFW, 2015, EMERG INFECT DIS, V21, P1101, DOI 10.3201/eid2107.150138; DENG ZL, 1988, REV INFECT DIS, V10, P640; Desakorn V, 1999, J CLIN MICROBIOL, V37, P117, DOI 10.1128/JCM.37.1.117-121.1999; Desakorn V, 2002, J CLIN MICROBIOL, V40, P3179, DOI 10.1128/JCM.40.9.3179-3183.2002; Drouhet E., 1993, Journal de Mycologie Medicale, V3, P195; Duong TA, 1996, CLIN INFECT DIS, V23, P125, DOI 10.1093/clinids/23.1.125; ESTRADA JA, 1992, INT J DERMATOL, V31, P410, DOI 10.1111/j.1365-4362.1992.tb02670.x; Hearn VM, 1997, FUNGAL DIS; Hien TV, 2001, CLIN INFECT DIS, V32, pE78, DOI 10.1086/318703; Intaramat A, 2016, MED MYCOL, V54, P641, DOI 10.1093/mmy/myw018; Jeavons L, 1998, J CLIN MICROBIOL, V36, P949, DOI 10.1128/JCM.36.4.949-954.1998; Kawila R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-464; Kozel Thomas R, 2012, Expert Opin Med Diagn, V6, P245, DOI 10.1517/17530059.2012.681300; Mabey D, 2001, SEX TRANSM INFECT, V77, P397, DOI 10.1136/sti.77.6.397; Panichakul T, 2002, AM J TROP MED HYG, V67, P443, DOI 10.4269/ajtmh.2002.67.443; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; Prakit K, 2016, EUR J CLIN MICROBIOL, V35, P647, DOI 10.1007/s10096-016-2583-2; Rafferty K., 2002, Mycoses, V45, P49; Rafferty K., 2004, THESIS; Ranjana KH, 2002, J INFECTION, V45, P268, DOI 10.1053/jinf.2002.1062; SUPPARATPINYO K, 1994, LANCET, V344, P110, DOI 10.1016/S0140-6736(94)91287-4; Trewatcharegon S, 2000, MED MYCOL, V38, P91, DOI 10.1080/mmy.38.1.91.96; Tse E, 2015, ANN HEMATOL, V94, P165, DOI 10.1007/s00277-014-2120-2; TSUI WMS, 1992, HISTOPATHOLOGY, V20, P287, DOI 10.1111/j.1365-2559.1992.tb00985.x; Vanittanakom N, 2006, CLIN MICROBIOL REV, V19, P95, DOI 10.1128/CMR.19.1.95-110.2006; Vanittanakom Nongnuch, 1997, Current Topics in Medical Mycology, V8, P35; Viviani AM, 1998, TOPLEY WILSONS MICRO, P409; Wong SSY, 1999, J MED MICROBIOL, V48, P973, DOI 10.1099/00222615-48-11-973; Wong SSY, 2001, J CLIN MICROBIOL, V39, P4535, DOI 10.1128/JCM.39.12.4535-4540.2001; YUEN KY, 1994, LANCET, V344, P444, DOI 10.1016/S0140-6736(94)91771-X	35	15	19	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195596	10.1371/journal.pone.0195596	http://dx.doi.org/10.1371/journal.pone.0195596			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641620	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900076
J	O'Neill, S; Mathis, M; Kovacic, L; Zhang, SS; Reinhardt, J; Scholz, D; Schopfer, U; Bouhelal, R; Knaus, UG				O'Neill, Sharon; Mathis, Magalie; Kovacic, Lidija; Zhang, Suisheng; Reinhardt, Jurgen; Scholz, Dimitri; Schopfer, Ulrich; Bouhelal, Rochdi; Knaus, Ulla G.			Quantitative interaction analysis permits molecular insights into functional NOX4 NADPH oxidase heterodimer assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						NADPH oxidase maturation; reactive oxygen species (ROS); genetic disease; dimerization; protein-protein interaction; NanoBit; NOX complex; NOX4; p22(phox); NanoLuc; hydrogen peroxide (H2O2)	PROTEIN-PROTEIN INTERACTION; FLAVOCYTOCHROME B(558); P22(PHOX) SUBUNIT; B-LOOP; INHIBITORS; CELLS; IDENTIFICATION; LOCALIZATION; MUTAGENESIS; MATURATION	Protein-protein interactions critically regulate many biological systems, but quantifying functional assembly of multipass membrane complexes in their native context is still challenging. Here, we combined modeling-assisted protein modification and information from human disease variants with a minimal-size fusion tag, split-luciferase-based approach to probe assembly of the NADPH oxidase 4 (NOX4)-p22(phox) enzyme, an integral membrane complex with unresolved structure, which is required for electron transfer and generation of reactive oxygen species (ROS). Integrated analyses of heterodimerization, trafficking, and catalytic activity identified determinants for the NOX4-p22(phox) interaction, such as heme incorporation into NOX4 and hot spot residues in transmembrane domains 1 and 4 in p22(phox). Moreover, their effect on NOX4 maturation and ROS generation was analyzed. We propose that this reversible and quantitative protein-protein interaction technique with its small split-fragment approach will provide a protein engineering and discovery tool not only for NOX research, but also for other intricate membrane protein complexes, and may thereby facilitate new drug discovery strategies for managing NOX-associated diseases.	[O'Neill, Sharon; Kovacic, Lidija; Zhang, Suisheng; Scholz, Dimitri; Knaus, Ulla G.] Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [O'Neill, Sharon; Kovacic, Lidija; Zhang, Suisheng; Knaus, Ulla G.] Univ Coll Dublin, Sch Med, Dublin 4, Ireland; [Mathis, Magalie; Reinhardt, Jurgen; Schopfer, Ulrich; Bouhelal, Rochdi] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland; [Kovacic, Lidija] Novartis Pharmaceut, Elm Pk Business Campus,Merr Rd, Dublin 4, Ireland	University College Dublin; University College Dublin; Novartis	Knaus, UG (corresponding author), Univ Coll Dublin, Conway Inst, Dublin 4, Ireland.	ulla.knaus@ucd.ie			Science Foundation Ireland	Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	This work was supported by a grant from the Science Foundation Ireland (to U.G.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Altenhofer S, 2015, ANTIOXID REDOX SIGN, V23, P406, DOI 10.1089/ars.2013.5814; Ambasta RK, 2004, J BIOL CHEM, V279, P45935, DOI 10.1074/jbc.M406486200; Aoyama T, 2012, HEPATOLOGY, V56, P2316, DOI 10.1002/hep.25938; Beaumerl S, 2014, BIOCHEM J, V464, P425, DOI 10.1042/BJ20140555; Borbely G, 2010, J MED CHEM, V53, P6758, DOI 10.1021/jm1004368; Campion Y, 2009, J INNATE IMMUN, V1, P556, DOI 10.1159/000231977; Casbon AJ, 2009, J IMMUNOL, V182, P2325, DOI 10.4049/jimmunol.0803476; De Vries SJ, 2010, NAT PROTOC, V5, P883, DOI 10.1038/nprot.2010.32; DeLeo FR, 2000, J BIOL CHEM, V275, P13986, DOI 10.1074/jbc.275.18.13986; Dixon AS, 2016, ACS CHEM BIOL, V11, P400, DOI 10.1021/acschembio.5b00753; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gaggini F, 2011, BIOORGAN MED CHEM, V19, P6989, DOI 10.1016/j.bmc.2011.10.016; Gianni D, 2010, ACS CHEM BIOL, V5, P981, DOI 10.1021/cb100219n; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hayes P, 2015, CELL MOL GASTROENTER, V1, P489, DOI 10.1016/j.jcmgh.2015.06.005; Hecker L, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2015.12.45; Heumuller S, 2008, HYPERTENSION, V51, P211, DOI 10.1161/HYPERTENSIONAHA.107.100214; Hirano K, 2015, ANTIOXID REDOX SIGN, V23, P358, DOI 10.1089/ars.2014.6202; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jackson HM, 2010, J BIOL CHEM, V285, P10281, DOI 10.1074/jbc.M109.084939; Jaquet V, 2011, BRIT J PHARMACOL, V164, P507, DOI 10.1111/j.1476-5381.2011.01439.x; Kawahara T, 2007, BMC EVOL BIOL, V7, DOI 10.1186/147-2148-7-109; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Laleu B, 2010, J MED CHEM, V53, P7715, DOI 10.1021/jm100773e; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Luxen S, 2009, J CELL SCI, V122, P1238, DOI 10.1242/jcs.044123; Magnani F, 2017, P NATL ACAD SCI USA, V114, P6764, DOI 10.1073/pnas.1702293114; Martyn KD, 2006, CELL SIGNAL, V18, P69, DOI 10.1016/j.cellsig.2005.03.023; Meijles DN, 2012, COMPUT BIOL CHEM, V39, P6, DOI 10.1016/j.compbiolchem.2012.05.001; Nakano Y, 2008, J CLIN INVEST, V118, P1176, DOI 10.1172/JCI33835; ODONNELL VB, 1993, BIOCHEM J, V290, P41, DOI 10.1042/bj2900041; Petronio MS, 2013, MOLECULES, V18, P2821, DOI 10.3390/molecules18032821; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Piirila H, 2006, HUM MUTAT, V27, P1200, DOI 10.1002/humu.20405; Price MO, 2002, BLOOD, V99, P2653, DOI 10.1182/blood.V99.8.2653; Prior KK, 2016, J BIOL CHEM, V291, P7045, DOI 10.1074/jbc.M115.710772; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Strengert M, 2014, ANTIOXID REDOX SIGN, V20, P2695, DOI 10.1089/ars.2013.5353; Stynen B, 2012, MICROBIOL MOL BIOL R, V76, P331, DOI 10.1128/MMBR.05021-11; Takac I, 2011, J BIOL CHEM, V286, P13304, DOI 10.1074/jbc.M110.192138; Taylor RM, 2004, J IMMUNOL, V173, P7349, DOI 10.4049/jimmunol.173.12.7349; TAYLOR WR, 1993, PROTEIN SCI, V2, P1675, DOI 10.1002/pro.5560021013; van den Berg JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005234; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; Vlachantoni D, 2011, HUM MOL GENET, V20, P322, DOI 10.1093/hmg/ddq467; von Lohneysen K, 2012, J BIOL CHEM, V287, P8737, DOI 10.1074/jbc.M111.332494; von Lohneysen K, 2010, MOL CELL BIOL, V30, P961, DOI 10.1128/MCB.01393-09; Von Lohneysen K, 2008, J BIOL CHEM, V283, P35273, DOI 10.1074/jbc.M804200200; Zhen L, 1998, J BIOL CHEM, V273, P6575, DOI 10.1074/jbc.273.11.6575; Zhu YM, 2006, J BIOL CHEM, V281, P30336, DOI 10.1074/jbc.M607191200	51	9	10	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8750	8760		10.1074/jbc.RA117.001045	http://dx.doi.org/10.1074/jbc.RA117.001045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29674345	Green Published, hybrid			2022-12-26	WOS:000434941900003
J	Adal, M; Howe, R; Kassa, D; Aseffa, A; Petros, B				Adal, Melaku; Howe, Rawleigh; Kassa, Desta; Aseffa, Abraham; Petros, Beyene			Malnutrition and lipid abnormalities in antiretroviral naive HIV-infected adults in Addis Ababa: A cross-sectional study	PLOS ONE			English	Article							CARDIOVASCULAR RISK; EARLY MORTALITY; THERAPY; OBESITY; HYPERLIPIDEMIA; DYSLIPIDEMIA; PROFILE; IMPACT	Background Both under-and over-nutrition may occur among human immunodeficiency virus (HIV)-infected individuals and impact on the course of the acquired immune deficiency syndrome (AIDS) and its management due to the close interaction between immunity and nutrition. We investigated occurrence of undernutrition, excess weight and lipid abnormalities among antiretroviral naive HIV-infected adults in Addis Ababa, Ethiopia. Methods A cross-sectional study on 594 antiretroviral therapy (ART) naive HIV-infected adults was conducted in four hospitals in Addis Ababa from February to September 2013. Hematological parameters (CD4+ T cell count and hemoglobin concentration), fasting serum glucose, total cholesterol (TC) and triglycerides (TG) were determined. Information on socio-demographic, anthropometric and World Health Organization (WHO) clinical stages was collected from patient clinical records, and triangulated by structured questionnaire. Height and weight measurements were taken and body mass index (BMI), undernutrition (BMI < 18.5 kg/m(2)) and excess weight (BMI >= 25 kg/m(2)) determined. Statistical comparisons were made to identify significant factors associated with nutritional status and lipid profiles. Results The prevalence of undernutrition was 15.1%, and the prevalence of excess weight was 22.1%, including 5.4% who were obese. The prevalence of hypercholesterolemia was 16.6% and it was higher in women (18.9%) than in men (11.0%) (p<0.05). However, the prevalence of hypertriglyceridemia was 29.8%. There was significant positive Spearman correlation between CD4+ T cell count and serum TC (r = 0.210, p<0.001), but no correlation was observed between CD4+ T cell count and TG (r = -0.007, p>0.05). Age categories 30-39 and 40-79, and WHO clinical stages III/IV for undernutrition; age categories 30-39 and 40-79, WHO clinical stages III/IV and TC >= 200 mg/dL for excess weight; and being female, age categories 30-39 and 40-79, and hypertriglyceridemia for hypercholesterolemia were found to be independent predictors by binomial logistic regression analysis. Conclusion Undernutrition, excess weight, hypercholesterolemia and hypertriglyceridemia were variably prevalent in ART naive HIV-infected populations. This emphasizes the need for targeted nutritional programs as an integral part of HIV/AIDS care. Lipid levels need to be monitored regularly in patients whether on or off ART. In addition, improvement on household income and positive change in lifestyle and/or nutritional treatment to reduce morbidity and mortality are necessary interventions in HIV/AIDs patient management.	[Adal, Melaku; Petros, Beyene] Addis Ababa Univ, Microbial Cellular & Mol Biol Dept, Addis Ababa, Ethiopia; [Adal, Melaku; Howe, Rawleigh; Aseffa, Abraham] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Kassa, Desta] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia	Addis Ababa University	Adal, M (corresponding author), Addis Ababa Univ, Microbial Cellular & Mol Biol Dept, Addis Ababa, Ethiopia.; Adal, M (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.	melakuadal@gmail.com	Adal, Melaku/AAC-6675-2022; Aseffa, Abraham/J-3248-2016	Aseffa, Abraham/0000-0002-8028-1150	Armauer Hansen Research Institute; Addis Ababa University	Armauer Hansen Research Institute; Addis Ababa University	The study was financed by Armauer Hansen Research Institute and Addis Ababa University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe Molla, 2014, BMC Res Notes, V7, P380, DOI 10.1186/1756-0500-7-380; Armstrong C, 2011, JAIDS-J ACQ IMM DEF, V57, P141, DOI 10.1097/QAI.0b013e318219a3d1; Baker J, 2010, J INFECT DIS, V201, P285, DOI 10.1086/649560; Buchacz K, 2008, JAIDS-J ACQ IMM DEF, V47, P304, DOI 10.1097/QAI.0b013e31815e7453; Carr A, 1999, LANCET, V353, P2093, DOI 10.1016/S0140-6736(98)08468-2; Chang MH, 2010, BMC MED GENET, V11, DOI 10.1186/1471-2350-11-62; Crum-Cianflone N, 2008, AIDS PATIENT CARE ST, V22, P925, DOI 10.1089/apc.2008.0082; Daniyam CA, 2013, ANN MED HEALTH SCI R, V3, P26, DOI 10.4103/2141-9248.109468; De Andrade FM, 2011, NUTR METAB CARDIOVAS, V21, P584, DOI 10.1016/j.numecd.2009.12.013; Deyessa N, 2008, SCAND J PUBLIC HEALT, V36, P589, DOI 10.1177/1403494808086976; Eren Esin, 2012, Open Biochem J, V6, P78, DOI 10.2174/1874091X01206010078; Feeney ER, 2013, J INFECT DIS, V207, P628, DOI 10.1093/infdis/jis723; Feeney Eoin R, 2011, Open Cardiovasc Med J, V5, P49, DOI 10.2174/1874192401105010049; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Fourie CMT, 2010, LIPIDS, V45, P73, DOI 10.1007/s11745-009-3369-4; Giannarelli C, 2011, ATHEROSCLEROSIS, V219, P384, DOI 10.1016/j.atherosclerosis.2011.06.003; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grunfeld Carl, 2010, Top HIV Med, V18, P112; Hadgu TH, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-943; Hailemariam S, 2013, ARCH PUBLIC HEALTH, V71, DOI 10.1186/0778-7367-71-13; HAPCO, 2007, GUID IMPL ANT THER P; Helleberg M, 2012, ANTIVIR THER, DOI [10.3851/IMP436, DOI 10.3851/IMP436]; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; Kosmiski L, 2011, AM J CLIN NUTR, V94, p1677S, DOI 10.3945/ajcn.111.012625; Kroll AF, 2012, ARQ BRAS ENDOCRINOL, V56, P137, DOI 10.1590/S0004-27302012000200007; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Macallan DC, 1999, J NUTR, V129, p238S, DOI 10.1093/jn/129.1.238S; Malaza A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047761; Marazzi MC, 2008, AIDS RES HUM RETROV, V24, P555, DOI 10.1089/aid.2007.0217; Morse CG, 2006, JAMA-J AM MED ASSOC, V296, P844, DOI 10.1001/jama.296.7.844; Obi SN, 2010, J INFECT DEV COUNTR, V4, P745, DOI 10.3855/jidc.863; Packard CJ, 2003, BIOCHEM SOC T, V31, P1066; Paton NI, 2006, HIV MED, V7, P323, DOI 10.1111/j.1468-1293.2006.00383.x; Rawat R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-316; Riddler SA, 2003, JAMA-J AM MED ASSOC, V289, P2978, DOI 10.1001/jama.289.22.2978; Rotger M, 2009, CIRC-CARDIOVASC GENE, V2, P621, DOI 10.1161/CIRCGENETICS.109.874412; Segerer S, 1999, INFECTION, V27, P77, DOI 10.1007/BF02560501; Subramanian S, 2012, BBA-MOL CELL BIOL L, V1821, P819, DOI 10.1016/j.bbalip.2011.10.003; Tadewos A, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-31; Veloso S, 2010, CURR PHARM DESIGN, V16, P3379, DOI 10.2174/138161210793563518; WHO, 1994, IND STRAT IR DEF AN, P33; Williams KJ, 2010, CURR OPIN LIPIDOL, V21, P218, DOI 10.1097/MOL.0b013e328338cabc; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; World Health Organization, 1995, PHYS STAT US INT ANT; Yone EWP, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-33; Young J, 2005, ANTIVIR THER, V10, P585	46	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195942	10.1371/journal.pone.0195942	http://dx.doi.org/10.1371/journal.pone.0195942			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672576	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800063
J	Hugenholtz, F; Davids, M; Schwarz, J; Muller, M; Tome, D; Schaap, P; Hooiveld, GJEJ; Smidt, H; Kleerebezem, M				Hugenholtz, Floor; Davids, Mark; Schwarz, Jessica; Muller, Michael; Tome, Daniel; Schaap, Peter; Hooiveld, Guido J. E. J.; Smidt, Hauke; Kleerebezem, Michiel			Metatranscriptome analysis of the microbial fermentation of dietary milk proteins in the murine gut	PLOS ONE			English	Article							PROTEOLYSIS; MICROFLORA; BACTERIA; GENES; MODEL; RNA; DNA	Undigestible food ingredients are converted by the microbiota into a large range of metabolites, predominated by short chain fatty acids (SCFA). These microbial metabolites are subsequently available for absorption by the host mucosa and can serve as an energy source. Amino acids fermentation by the microbiota expands the spectrum of fermentation end-products beyond acetate, propionate and butyrate, to include in particular branched-SCFA. Here the long-term effects of high protein-diets on microbial community composition and functionality in mice were analyzed. Determinations of the microbiota composition using phylogenetic microarray (MITChip) technology were complemented with metatranscriptome and SCFA analyses to obtain insight in in situ expression of protein fermentation pathways and the phylogenetic groups involved. High protein diets led to increased luminal concentrations of branched-SCFA, in accordance with protein fermentation in the gut. Bacteria dominantly participating in protein catabolism belonged to the Lachnospiraceae, Erysipelotrichaceae and Clostridiaceae families in both normal- and high-protein diet regimes. This study identifies the microbial groups involved in protein catabolism in the intestine and underpins the value of in situ metatranscriptome analyses as an approach to decipher locally active metabolic networks and pathways as a function of the dietary regime, as well as the phylogeny of the microorganisms executing them.	[Hugenholtz, Floor; Smidt, Hauke] Wageningen Univ, Lab Microbiol, Wageningen, Netherlands; [Hugenholtz, Floor; Davids, Mark; Hooiveld, Guido J. E. J.; Smidt, Hauke] Netherlands Consortium Syst Biol, Amsterdam, Netherlands; [Davids, Mark; Schaap, Peter] Wageningen Univ, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Schwarz, Jessica; Muller, Michael; Hooiveld, Guido J. E. J.] Wageningen Univ, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Tome, Daniel] AgroParisTech, INRA, Nutr Physiol & Ingest Behav UMR914, Paris, France; [Schaap, Peter; Smidt, Hauke; Kleerebezem, Michiel] TI Food & Nutr, Wageningen, Netherlands; [Kleerebezem, Michiel] Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands; [Muller, Michael] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Top Institute Food & Nutrition; Wageningen University & Research; University of East Anglia	Kleerebezem, M (corresponding author), TI Food & Nutr, Wageningen, Netherlands.; Kleerebezem, M (corresponding author), Wageningen Univ, Host Microbe Interact Grp, Wageningen, Netherlands.	michiel.kleerebezem@wur.nl	Muller, Michael/M-5724-2019; Smidt, Hauke/D-7054-2014; Hooiveld, Guido JEJ/F-4912-2010; Kleerebezem, Michiel/AAT-2078-2021; Muller, Michael/B-5795-2008	Muller, Michael/0000-0002-5930-9905; Smidt, Hauke/0000-0002-6138-5026; Hooiveld, Guido JEJ/0000-0003-1954-3542; Muller, Michael/0000-0002-5930-9905; Schwarz, Jessica/0000-0002-2594-2200; Davids, Mark/0000-0003-3081-9124; Schaap, Peter/0000-0002-4346-6084; Kleerebezem, Michiel/0000-0001-8552-2235	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organization for Scientific Research	Netherlands Consortium for Systems Biology (NCSB), Netherlands Genomics Initiative / Netherlands Organization for Scientific Research	This work was (co)financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative / Netherlands Organization for Scientific Research.; This work was (co)financed by the Netherlands Consortium for Systems Biology (NCSB), which is part of the Netherlands Genomics Initiative / Netherlands Organization for Scientific Research.	Cani PD, 2014, M S-MED SCI, V30, P125, DOI 10.1051/medsci/20143002003; CHACKO A, 1988, GUT, V29, P809, DOI 10.1136/gut.29.6.809; Davids M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146423; El Aidy S, 2013, ISME J, V7, P743, DOI 10.1038/ismej.2012.142; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; GIBSON SAW, 1989, APPL ENVIRON MICROB, V55, P679, DOI 10.1128/AEM.55.3.679-683.1989; IJssennagger N, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043260, 10.1371/journal.pone.0049868]; Kiilerich P, 2016, AM J PHYSIOL-ENDOC M, V310, pE886, DOI 10.1152/ajpendo.00363.2015; Kim Eunjung, 2016, Prev Nutr Food Sci, V21, P57, DOI [10.3746/pnf.2016.21.1.73, 10.3746/pnf.2016.21.1.57]; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Leimena MM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-530; Leimena MM, 2012, APPL ENVIRON MICROB, V78, P4141, DOI 10.1128/AEM.00470-12; Liu CX, 2008, INT J SYST EVOL MICR, V58, P1896, DOI 10.1099/ijs.0.65208-0; Liu XX, 2014, AM J PHYSIOL-GASTR L, V307, pG459, DOI 10.1152/ajpgi.00400.2013; Louis P, 2007, APPL ENVIRON MICROB, V73, P2009, DOI 10.1128/AEM.02561-06; MACFARLANE GT, 1986, J GEN MICROBIOL, V132, P1647; MACFARLANE GT, 1988, J APPL BACTERIOL, V64, P37, DOI 10.1111/j.1365-2672.1988.tb02427.x; Mu CL, 2017, ANAEROBE, V47, P218, DOI 10.1016/j.anaerobe.2017.06.003; Rajilic-Stojanovic M, 2009, ENVIRON MICROBIOL, V11, P1736, DOI 10.1111/j.1462-2920.2009.01900.x; Schmidt D, 2009, METHODS, V48, P240, DOI 10.1016/j.ymeth.2009.03.001; Schwarz J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047303; Seedorf H, 2008, P NATL ACAD SCI USA, V105, P2128, DOI 10.1073/pnas.0711093105; Smith EA, 1997, MICROBIAL ECOL, V33, P180, DOI 10.1007/s002489900020; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Turroni F, 2014, CELL MOL LIFE SCI, V71, P183, DOI 10.1007/s00018-013-1318-0; Van den Abbeele P, 2010, APPL ENVIRON MICROB, V76, P5237, DOI 10.1128/AEM.00759-10; van den Bogert B, 2011, APPL ENVIRON MICROB, V77, P2071, DOI 10.1128/AEM.02477-10; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Vital M, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-8; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Westerterp-Plantenga MS, 2009, ANNU REV NUTR, V29, P21, DOI 10.1146/annurev-nutr-080508-141056; Westerterp-Plantenga MS, 2012, BRIT J NUTR, V108, pS105, DOI 10.1017/S0007114512002589; Windey K, 2012, MOL NUTR FOOD RES, V56, P184, DOI 10.1002/mnfr.201100542; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yoder-Himes DR, 2009, P NATL ACAD SCI USA, V106, P3976, DOI 10.1073/pnas.0813403106; Yu ZT, 2004, BIOTECHNIQUES, V36, P808, DOI 10.2144/04365ST04; Zoetendal EG, 2006, NAT PROTOC, V1, P954, DOI 10.1038/nprot.2006.143; Zoetendal EG, 2014, CURR OPIN GASTROEN, V30, P189, DOI 10.1097/MOG.0000000000000048	38	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194066	10.1371/journal.pone.0194066	http://dx.doi.org/10.1371/journal.pone.0194066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664912	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000430262300006
J	Komenda, P; Tangri, N; Klajncar, E; Eng, A; Di Nella, M; Hiebert, B; Strome, T; de Faria, RL; Zacharias, JM; Verrelli, M; Sood, MM; Rigatto, C				Komenda, Paul; Tangri, Navdeep; Klajncar, Evan; Eng, Amanda; Di Nella, Michelle; Hiebert, Brett; Strome, Trevor; de Faria, Ricardo Lobato; Zacharias, James M.; Verrelli, Mauro; Sood, Manish M.; Rigatto, Claudio			Patterns of emergency department utilization by patients on chronic dialysis: A population-based study	PLOS ONE			English	Article							PATIENTS RECEIVING HEMODIALYSIS; STAGE RENAL-DISEASE; HEART-FAILURE; FREQUENT USERS; HOSPITAL READMISSION; RANDOMIZED-TRIAL; OUTCOMES; MANAGEMENT; MORTALITY; HEALTH	Importance Patients on dialysis are often elderly and frail, with multiple comorbid conditions, and are heavy users of Emergency Department (ED) services. However, objective data on the frequency and pattern of ED utilization by dialysis patients are sparse. Such data could identify periods of highest risk for ED visits and inform health systems interventions to mitigate these risks and improve outcomes Objective To describe the pattern and frequency of presentation to ER by dialysis patients Design Retrospective cohort study using administrative data collected over ten years (2000-2009) in the Province of Manitoba, Canada. Setting Patients presenting to any of 9 ED's in Winnipeg and Brandon Manitoba. These departments serve >90% of the population of Manitoba, Canada (population 1.2 million). Participants All patients presenting to an ED in any of 9 emergency departments in Manitoba, Canada. Exposure Dialysis status Main outcomes Presentation to the ED Results Over 2.1 million ED visits by more than 1.2 million non-dialysis patients and 17,782 ED visits by 3257 dialysis patients were included. Dialysis patients presented 8.5 times more frequently to the ED than the general population (age and sex adjusted, p<0.001). For dialysis patients, ED utilization was significantly higher following the long interdialytic interval (33.6% higher Mondays and 19.5% higher Tuesdays vs. other days of the week, p<0.001) and was 10-fold higher in the 7 days before and after the initiation of dialysis. Conclusion and relevance The heavy use of ED services by dialysis patients spikes upward following the long interdialytic interval and also in the week before and after dialysis initiation. The relative risks associated with these vulnerable periods were much higher than those reported for clinical patient characteristics. We propose that intrinsic gaps in the structure of care delivery (e.g. 3 times a week dialysis, imperfect surveillance and clinical monitoring of patients with low GFR) may be the fundamental drivers of this periodicity. Strategies to mitigate this excess health risk are needed.	[Komenda, Paul; Tangri, Navdeep; Klajncar, Evan; Eng, Amanda; Zacharias, James M.; Verrelli, Mauro; Rigatto, Claudio] Univ Manitoba, Fac Med, Winnipeg, MB, Canada; [Komenda, Paul; Tangri, Navdeep; Zacharias, James M.; Verrelli, Mauro; Rigatto, Claudio] Manitoba Renal Program, Winnipeg, MB, Canada; [Komenda, Paul; Tangri, Navdeep; Di Nella, Michelle; Zacharias, James M.; Sood, Manish M.; Rigatto, Claudio] Seven Oaks Gen Hosp, Chron Dis Innovat Ctr, Winnipeg, MB, Canada; [Hiebert, Brett] St Boniface Gen Hosp, Cardiac Sci Program, Winnipeg, MB, Canada; [Strome, Trevor; de Faria, Ricardo Lobato] Winnipeg Reg Hlth Author, Emergency Dept Program, Winnipeg, MB, Canada; [Sood, Manish M.] Univ Ottawa, Ottawa, ON, Canada	University of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Ottawa	Rigatto, C (corresponding author), Univ Manitoba, Fac Med, Winnipeg, MB, Canada.; Rigatto, C (corresponding author), Manitoba Renal Program, Winnipeg, MB, Canada.; Rigatto, C (corresponding author), Seven Oaks Gen Hosp, Chron Dis Innovat Ctr, Winnipeg, MB, Canada.	crigatto@sbgh.mb.ca	Sood, Manish M/H-3134-2019	Sood, Manish M/0000-0002-9146-2344	University of Manitoba Rady Faculty of Medicine BSc Medicine Studentships	University of Manitoba Rady Faculty of Medicine BSc Medicine Studentships	This work was supported by the University of Manitoba Rady Faculty of Medicine BSc Medicine Studentships (EK, AE).	Antonicelli R, 2008, J TELEMED TELECARE, V14, P300, DOI 10.1258/jtt.2008.071213; Breton M, 2014, IMPLEMENT SCI, V9, DOI 10.1186/s13012-014-0117-9; Canadian Institute for Health Information, 2006, CORR REP DIAL REN TR; Castillo EM, 2014, J EMERG MED, V47, P343, DOI 10.1016/j.jemermed.2014.03.014; Clermont G, 2002, KIDNEY INT, V62, P986, DOI 10.1046/j.1523-1755.2002.00509.x; Dendale P, 2012, EUR J HEART FAIL, V14, P333, DOI 10.1093/eurjhf/hfr144; Doupe M, 2008, INITIAL ANAL EMERGEN, V1, DOI [10.1681/ASN.2013080879, DOI 10.1681/ASN.2013080879]; Doupe MB, 2012, ANN EMERG MED, V60, P24, DOI 10.1016/j.annemergmed.2011.11.036; Erickson KF, 2014, J AM SOC NEPHROL, V25, P2079, DOI 10.1681/ASN.2013080879; Foley RN, 2011, NEW ENGL J MED, V365, P1099, DOI 10.1056/NEJMoa1103313; Giordano A, 2009, INT J CARDIOL, V131, P192, DOI 10.1016/j.ijcard.2007.10.027; Gordon JA, 2001, J URBAN HEALTH, V78, P104, DOI 10.1093/jurban/78.1.104; Hutchison CA, 2007, CRIT CARE, V11, DOI 10.1186/cc5785; Kasper EK, 2002, J AM COLL CARDIOL, V39, P471, DOI 10.1016/S0735-1097(01)01761-2; Kitsiou S, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.4174; Leventhal ME, 2011, SWISS MED WKLY, V141, DOI 10.4414/smw.2011.13171; Lovasik BP, 2016, JAMA INTERN MED, V176, P1563, DOI 10.1001/jamainternmed.2016.4975; Mandelberg JH, 2000, ACAD EMERG MED, V7, P637, DOI 10.1111/j.1553-2712.2000.tb02037.x; Miller JB, 2013, AM J EMERG MED, V31, P16, DOI 10.1016/j.ajem.2012.05.001; Niska Richard, 2010, Natl Health Stat Report, P1; Ondler C, 2014, AM J EMERG MED, V32, P1215, DOI 10.1016/j.ajem.2014.07.013; Ostermann M, 2008, CRIT CARE, V12, DOI 10.1186/cc7085; Pines Jesse M, 2011, Acad Emerg Med, V18, pe64, DOI 10.1111/j.1553-2712.2011.01086.x; Sood MM, 2011, NEPHROL DIAL TRANSPL, V26, P2965, DOI 10.1093/ndt/gfq835; Sood MM, 2010, CAN MED ASSOC J, V182, P1433, DOI 10.1503/cmaj.100105; Strijack B, 2009, J AM SOC NEPHROL, V20, P2441, DOI 10.1681/ASN.2009040366; Sun BC, 2003, ACAD EMERG MED, V10, P320, DOI 10.1111/j.1553-2712.2003.tb01344.x; U. S. Renal Data System, 2008, ATL CHRON KIDN END S	28	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195323	10.1371/journal.pone.0195323	http://dx.doi.org/10.1371/journal.pone.0195323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664922	Green Published, gold, Green Submitted			2022-12-26	WOS:000430262300017
J	Nemoto, Y; Sato, S; Takahashi, M; Takeda, N; Matsushita, M; Kitabatake, Y; Maruo, K; Arao, T				Nemoto, Yuta; Sato, Shinichiro; Takahashi, Masaki; Takeda, Noriko; Matsushita, Munehiro; Kitabatake, Yoshinori; Maruo, Kazushi; Arao, Takashi			The association of single and combined factors of sedentary behavior and physical activity with subjective cognitive complaints among community-dwelling older adults: Cross-sectional study	PLOS ONE			English	Article							INTERVENTIONS; RELIABILITY; DEPRESSION; EXERCISE; VALIDITY; HEALTH; SCALE; RISK	Subjective cognitive complaints (SCC) might be a meaningful indicator of dementia onset or mild cognitive impairment, and identifying the related factors of SCC could contribute to preventing these diseases. However, the relationship between SCC and lifestyle factors remains largely unproven. The purpose of this study was to examine the association of type of sedentary behavior, physical activity, or their combination with SCC among community-dwelling older adults. In 2016, 6677 community-living elderly were recruited to participate in a survey investigating cognition, physical activity, and sedentary behavior. In total, 5328 participants responded to the questionnaire (79.8% valid response rate). SCC was assessed using the National Functional Survey Questionnaire (Kihon checklist). The relationships between SCC and physical activity, sedentary behavior (reading books or newspapers, and television viewing), or combined physical activity and sedentary behavior were examined via multiple logistic regression analysis. The analysis revealed that moderate-to-vigorous physical activity (>= 150 min/week) was significantly related with a lower risk of SCC (odds ratio [OR] = 0.85; 95% confidence interval [CI] = 0.74-0.97), and that reading behavior showed a dose-response relationship with SCC (OR for 10-20 min/day = 0.63; 95% CI = 0.53-0.75; OR for 20-30 min/day = 0.59; 95% CI = 0.49-0.71; OR for >= 30 min/day = 0.47; 95% CI = 0.39-0.57). In addition, among those reporting high physical activity and >= 30 min/day for reading time, the OR for SCC was 0.40 (95% CI = 0.32-0.50) compared with the combined group reporting lower physical activity and non-readers. The present study shows that increased physical activity and reading time may be related to a reduced risk for SCC among community-dwelling older adults.	[Nemoto, Yuta] Waseda Univ, Grad Sch Sport Sci, Saitama, Japan; [Sato, Shinichiro] Univ Human Arts & Sci, Fac Hlth Sci, Saitama, Japan; [Takahashi, Masaki] Waseda Univ, Org Univ Res Initiat, Tokyo, Japan; [Takeda, Noriko] Kogakuin Univ, Div Liberal Arts, Tokyo, Japan; [Matsushita, Munehiro] Dokkyo Med Univ, Dept Publ Hlth, Mibu, Tochigi, Japan; [Kitabatake, Yoshinori] Saitama Prefectural Univ, Dept Hlth Sci, Saitama, Japan; [Maruo, Kazushi] Univ Tsukuba, Fac Med, Ibaraki, Japan; [Arao, Takashi] Waseda Univ, Fac Sport Sci, Saitama, Japan	Waseda University; Waseda University; Kogakuin University; Dokkyo Medical University; University of Tsukuba; Waseda University	Arao, T (corresponding author), Waseda Univ, Fac Sport Sci, Saitama, Japan.	tarao@waseda.jp	Nemoto, Yuta/AAC-9489-2020; Maruo, Kazushi/I-2538-2014	Nemoto, Yuta/0000-0002-6439-0015; Maruo, Kazushi/0000-0002-3093-0386; Takahashi, Masaki/0000-0002-4038-8164; Arao, Takashi/0000-0002-4790-5021	Japan Society for the Promotion of Science [15H03089]; Meiji Yasuda Life Foundation of Health and Welfare	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare)	This study was supported by Grant-in-Aid for Scientific Research (15H03089) from the Japan Society for the Promotion of Science and Health science research grant for young researchers from Meiji Yasuda Life Foundation of Health and Welfare. TA and YN received the funding, and the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai H, 2015, GERIATR GERONTOL INT, V15, P518, DOI 10.1111/ggi.12397; Bakrania K, 2018, AM J EPIDEMIOL, V187, P441, DOI 10.1093/aje/kwx273; Bakrania K, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2694-9; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Bauman A, 2016, GERONTOLOGIST, V56, pS268, DOI 10.1093/geront/gnw031; Blondell SJ, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-510; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; Burmester B, 2016, NEUROPSYCHOL REV, V26, P376, DOI 10.1007/s11065-016-9332-2; Canevelli M, 2013, AM J ALZHEIMERS DIS, V28, P560, DOI 10.1177/1533317513494441; Chomistek AK, 2013, J AM COLL CARDIOL, V61, P2346, DOI 10.1016/j.jacc.2013.03.031; Demirtas H, 2008, STAT MED, V27, P4086, DOI 10.1002/sim.3239; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Falck RS, 2017, BRIT J SPORT MED, V51, P800, DOI 10.1136/bjsports-2015-095551; Geda YE, 2011, J NEUROPSYCH CLIN N, V23, P149, DOI 10.1176/appi.neuropsych.23.2.149; Hamer M, 2014, MED SCI SPORT EXER, V46, P718, DOI 10.1249/MSS.0000000000000156; Hiura M, 2014, J CEREBR BLOOD F MET, V34, P389, DOI 10.1038/jcbfm.2013.220; Kesse-Guyot E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047831; Kikuchi H, 2017, GERIATR GERONTOL INT, V17, P1921, DOI 10.1111/ggi.12995; Kikuchi H, 2014, PREV MED, V67, P335, DOI 10.1016/j.ypmed.2014.08.011; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Meguro K., 2012, JPN J GERIATR PSYCHI, V23, P725; Nyunt MSZ, 2009, AGING MENT HEALTH, V13, P376, DOI 10.1080/13607860902861027; Oltmanns J, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00117; Rosenberg DE, 2016, J GERONTOL A-BIOL, V71, P78, DOI 10.1093/gerona/glv103; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Saito Tami, 2015, Nihon Koshu Eisei Zasshi, V62, P596, DOI 10.11236/jph.62.10_596; Schmid D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119591; Tomata Y, 2017, GERIATR GERONTOL INT, V17, P1300, DOI 10.1111/ggi.12864; Tomioka K, 2011, J EPIDEMIOL, V21, P459, DOI 10.2188/jea.JE20110003; Vance DE, 2005, J AGING PHYS ACTIV, V13, P294, DOI 10.1123/japa.13.3.294; World Health Organization, GLOB REC PHYS ACT HL; World Health Organization and Alzheimer's Disease International, 2012, DEM PUBL HLTH PRIOR	32	17	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195384	10.1371/journal.pone.0195384	http://dx.doi.org/10.1371/journal.pone.0195384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659622	Green Published, Green Submitted, gold			2022-12-26	WOS:000430061100014
J	Gray, B; Gnanappa, GK; Bagnall, RD; Femia, G; Yeates, L; Ingles, J; Burns, C; Puranik, R; Grieve, SM; Semsarian, C; Sy, RW				Gray, Belinda; Gnanappa, Ganesh Kumar; Bagnall, Richard D.; Femia, Giuseppe; Yeates, Laura; Ingles, Jodie; Burns, Charlotte; Puranik, Rajesh; Grieve, Stuart M.; Semsarian, Christopher; Sy, Raymond W.			Relations between right ventricular morphology and clinical, electrical and genetic parameters in Brugada Syndrome	PLOS ONE			English	Article							ST-SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; BUNDLE-BRANCH BLOCK; EPICARDIAL SUBSTRATE; SYNDROME PHENOTYPE; CATHETER ABLATION; SCN5A MUTATIONS; ECG PHENOTYPE; OUTFLOW TRACT; DISEASE	Background Increasing evidence suggests the presence of structural changes affecting the right ventricular outflow tract (RVOT) in patients with Brugada Syndrome (BrS). The aim of this study was to characterise the RV morphology in BrS and explore associations between morphologic, clinical, electrical, and genetic parameters using non-invasive multimodality testing. Methods Consecutive BrS patients (recruited 2013 +/- 2015) underwent clinical assessment, dedicated RV imaging using cardiac magnetic resonance (CMR) imaging (unless contra-indicated), electrical assessment (electrocardiogram, Holter monitoring, signal-averaged ECG [SAECG]) and genotyping. Morphologic data were compared to matched control and unmatched ARVC (arrhythmogenic right ventricular cardiomyopathy) cohorts, and potential associations between morphologic parameters and other variables were explored. Results BrS patients (n = 42, male 86%, age 46 +/- 12 years) exhibited normal global RV volume and function, comparable to control, in contrast to significantly larger, impaired RVs in ARVC cohort (RVESV p = 0.0001; RVEDV p<0.0001, RVEF p = 0.002). Compared with control, BrS patients exhibited larger RVOT volumes (7.4 +/- 0.7 vs 5.8 +/- 0.7 mL/m(2), p<0.0001) and wall motion abnormalities (RWMA) (31% vs 0%, p = 0.005); compared with ARVC cohort, the RVOT volumes were similar (7.4 +/- 0.7 vs, 8.1 +/- 1.7, p = 0.52) and there were less RWMA (31% vs 76%, p = 0.01). Overall 67% BrS patients had abnormal RVOT morphology. Patients with abnormal RVOT tended to be older (48 +/- 12 y vs 41 +/- 12y, p = 0.06). Rare genetic variants were only observed in patients with abnormal RVOT morphology (36% vs 0%, p = 0.02). Conclusions Patients with BrS frequently exhibit structural abnormalities localised to the RVOT and these changes may be age- and gene-dependent.	[Gray, Belinda; Femia, Giuseppe; Yeates, Laura; Ingles, Jodie; Burns, Charlotte; Puranik, Rajesh; Grieve, Stuart M.; Semsarian, Christopher; Sy, Raymond W.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Gray, Belinda; Bagnall, Richard D.; Ingles, Jodie; Burns, Charlotte; Puranik, Rajesh; Grieve, Stuart M.; Semsarian, Christopher; Sy, Raymond W.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Gray, Belinda; Bagnall, Richard D.; Yeates, Laura; Ingles, Jodie; Burns, Charlotte; Semsarian, Christopher] Centenary Inst, Agnes Ginges Ctr Mol Cardiol, Sydney, NSW, Australia; [Gnanappa, Ganesh Kumar; Puranik, Rajesh] Cardiovasc Magnet Resonance, Newtown, Tas, Australia	University of Sydney; University of Sydney; University of Sydney; Centenary Institute	Sy, RW (corresponding author), Royal Prince Alfred Hosp, Sydney, NSW, Australia.; Sy, RW (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia.	raymond.sy01@gmail.com	Ingles, Jodie/J-3113-2019; gray, belinda/AFN-8884-2022; Grieve, Stuart/A-5093-2012	Ingles, Jodie/0000-0002-4846-7676; Grieve, Stuart/0000-0002-2712-157X	Heart Foundation Health Professionals PhD Scholarship [100294]; National Heart Foundation of Australia Future Leader Fellowship [100833]; National Health and Medical Research Council (NHMRC) Practitioner Fellowship [1059156]	Heart Foundation Health Professionals PhD Scholarship; National Heart Foundation of Australia Future Leader Fellowship(National Heart Foundation of Australia); National Health and Medical Research Council (NHMRC) Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	BG is the recipient of a Heart Foundation Health Professionals PhD Scholarship (#100294). JI is the recipient of a National Heart Foundation of Australia Future Leader Fellowship (#100833). CS is the recipient of a National Health and Medical Research Council (NHMRC) Practitioner Fellowship (#1059156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antzelevitch C, 2016, HEART RHYTHM; Bastiaenen R, 2017, HEART RHYTHM, V14, P583, DOI 10.1016/j.hrthm.2016.12.004; Bezzina CR, 2013, NAT GENET, V45, P1044, DOI 10.1038/ng.2712; Brugada J, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1373, DOI 10.1161/CIRCEP.115.003220; BRUGADA P, 1992, J AM COLL CARDIOL, V20, P1391, DOI 10.1016/0735-1097(92)90253-J; Catalano O, 2009, EUR HEART J, V30, P2241, DOI 10.1093/eurheartj/ehp252; Cerrone M, 2014, CIRCULATION, V129, P1092, DOI 10.1161/CIRCULATIONAHA.113.003077; Coronel R, 2005, CIRCULATION, V112, P2769, DOI 10.1161/CIRCULATIONAHA.105.532614; Corrado D, 2001, CIRCULATION, V103, P710; Doesch C, 2014, HELL J CARDIOL, V55, P107; Frustaci A, 2005, CIRCULATION, V112, P3680, DOI 10.1161/CIRCULATIONAHA.105.520999; Gotschy A, 2017, EUR HEART J CARDIOVA; Gray B, 2016, HEART RHYTHM; Gray B, 2014, J CARDIOVASC ELECTR, V25, P450, DOI 10.1111/jce.12366; Haas J, 2015, EUR HEART J, V36, P1123, DOI 10.1093/eurheartj/ehu301; Ingles J, 2013, INT J CARDIOL, V168, pE127, DOI 10.1016/j.ijcard.2013.08.036; Marcus FI, 2010, CIRCULATION, V121, P1533, DOI 10.1161/CIRCULATIONAHA.108.840827; Morita H, 2008, CIRCULATION, V118, P1697, DOI 10.1161/CIRCULATIONAHA.108.770917; Nademanee K, 2015, J AM COLL CARDIOL, V66, P1976, DOI 10.1016/j.jacc.2015.08.862; Nademanee K, 2011, CIRCULATION, V123, P1270, DOI 10.1161/CIRCULATIONAHA.110.972612; Papavassiliu T, 2004, J CARDIOVASC ELECTR, V15, P1133, DOI 10.1046/j.1540-8167.2004.03681.x; Papavassiliu T, 2010, HEART RHYTHM, V7, P1790, DOI 10.1016/j.hrthm.2010.09.004; Peters S, 2004, INT J CARDIOL, V95, P207, DOI 10.1016/j.ijcard.2003.04.032; Priori SG, 2013, HEART RHYTHM, V10, P1932, DOI 10.1016/j.hrthm.2013.05.014; Priori SG, 2012, J AM COLL CARDIOL, V59, P37, DOI 10.1016/j.jacc.2011.08.064; Probst V, 2009, CIRC-CARDIOVASC GENE, V2, P552, DOI 10.1161/CIRCGENETICS.109.853374; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Royer A, 2005, CIRCULATION, V111, P1738, DOI 10.1161/01.CIR.0000160853.19867.61; Rudic B, 2016, J AM HEART ASSOC, V5, P11; Rudic B, 2016, EUROPACE, V18, P1411, DOI 10.1093/europace/euv300; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Saguner AM, 2015, BMC CARDIOVASC DISOR, V15, DOI 10.1186/1471-2261-15-4; Sarkozy A, 2009, CIRC-ARRHYTHMIA ELEC, V2, P154, DOI 10.1161/CIRCEP.108.795153; te Riele ASJM, 2017, CARDIOVASC RES, V113, P102, DOI 10.1093/cvr/cvw234; Teske AJ, 2009, J AM SOC ECHOCARDIOG, V22, P920, DOI 10.1016/j.echo.2009.05.014; Tessa C, 2012, INT J CARDIOVAS IMAG, V28, P1961, DOI 10.1007/s10554-012-0009-5; van Hoorn F, 2012, J CARDIOVASC MAGN S1, V14, P141; van Hoorn F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042037; Veltmann C, 2012, HEART RHYTHM, V9, P414, DOI 10.1016/j.hrthm.2011.10.032; Zhang JJ, 2015, CIRCULATION, V131, P1950, DOI 10.1161/CIRCULATIONAHA.114.013698; Zhang P, 2016, HEART RHYTHM, V13, P2151, DOI 10.1016/j.hrthm.2016.07.025	41	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195594	10.1371/journal.pone.0195594	http://dx.doi.org/10.1371/journal.pone.0195594			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652902	gold, Green Published, Green Submitted			2022-12-26	WOS:000430026900032
J	Kosuth, M; Mason, SA; Wattenberg, EV				Kosuth, Mary; Mason, Sherri A.; Wattenberg, Elizabeth V.			Anthropogenic contamination of tap water, beer, and sea salt	PLOS ONE			English	Article								Plastic pollution has been well documented in natural environments, including the open waters and sediments within lakes and rivers, the open ocean and even the air, but less attention has been paid to synthetic polymers in human consumables. Since multiple toxicity studies indicate risks to human health when plastic particles are ingested, more needs to be known about the presence and abundance of anthropogenic particles in human foods and beverages. This study investigates the presence of anthropogenic particles in 159 samples of globally sourced tap water, 12 brands of Laurentian Great Lakes beer, and 12 brands of commercial sea salt. Of the tap water samples analyzed, 81% were found to contain anthropogenic particles. The majority of these particles were fibers (98.3%) between 0.1-5 mm in length. The range was 0 to 61 particles/L, with an overall mean of 5.45 particles/L. Anthropogenic debris was found in each brand of beer and salt. Of the extracted particles, over 99% were fibers. After adjusting for particles found in lab blanks for both salt and beer, the average number of particles found in beer was 4.05 particles/L with a range of 0 to 14.3 particles/L and the average number of particles found in each brand of salt was 212 particles/kg with a range of 46.7 to 806 particles/kg. Based on consumer guidelines, our results indicate the average person ingests over 5,800 particles of synthetic debris from these three sources annually, with the largest contribution coming from tap water (88%).	[Kosuth, Mary; Wattenberg, Elizabeth V.] Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA; [Mason, Sherri A.] SUNY Coll Fredonia, Dept Chem & Biochem, Fredonia, NY 14063 USA	University of Minnesota System; University of Minnesota Twin Cities; State University of New York (SUNY) System; SUNY Fredonia	Kosuth, M (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Environm Hlth Sci, Minneapolis, MN 55455 USA.	kosu0003@umn.edu		Kosuth, Mary/0000-0001-8673-9620	University of Minnesota's School of Public Health, Division of Environmental Health Sciences	University of Minnesota's School of Public Health, Division of Environmental Health Sciences	Funding for this study was provided by the James W. Wright Scholarship which was provided by the University of Minnesota's School of Public Health, Division of Environmental Health Sciences. This scholarship was awarded to Mary Kosuth in 2016.	Acosta-Coley I, 2014, ENVIRON MONIT ASSESS, P435; Andrady AL, 2009, PHILOS T R SOC B, V364, P1977, DOI 10.1098/rstb.2008.0304; Atsdr. cdc. gov, 2018, ATSDR TOX SUBST POL; Bakir A, 2013, ENV POLLUT C, V185C, P16; Baldwin AK, 2016, ENVIRON SCI TECHNOL, V50, P10377, DOI 10.1021/acs.est.6b02917; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Buchanan J.B, 1971, MAR POLLUT BULL, V2, P23, DOI [10.1016/0025-326X(71)90136-6, DOI 10.1016/0025-326X(71)90136-6]; CARPENTER EJ, 1972, SCIENCE, V175, P1240, DOI 10.1126/science.175.4027.1240; Cousin HR, 2015, FREQUENCY INGESTED P, P6; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; Dris R, 2015, ENVIRON CHEM, P2015; Eerkes-Medrano D, 2015, SCI DIRECT, P63, DOI DOI https://doi.org/10.1016/j.watres.2015.02.012; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Eriksen M, 2013, MAR POLLUT BULL, V77, P177, DOI 10.1016/j.marpolbul.2013.10.007; Europe Plastics, 2016, PLASTICS FACTS 2016, V2016; Fossi MC, 2012, MAR POLLUT BULL, V64, P2374, DOI 10.1016/j.marpolbul.2012.08.013; Heilongjiang People's Government, 2017, IMPL OP HEIL PROV MU; Iniguez ME, 2017, SCI REPORTS; Karageorge A., 2017, SUPPORT CARE CANCER, P1; Liebezeit G, 2014, FOOD ADDIT CONTAM A, V31, P1574, DOI 10.1080/19440049.2014.945099; Lusher AL, 2013, MAR POLLUT BULL, V67, P94, DOI 10.1016/j.marpolbul.2012.11.028; Lyke R., 2012, ALL BEER MAGAZINE; Mason S, 2017, J GREAT LAKES RES, P753; Mato Y, 2001, ENVIRON SCI TECHNOL, V35, P318, DOI 10.1021/es0010498; McCormick A, 2014, ENVIRON SCI TECHNOL, V48, P11863, DOI 10.1021/es503610r; Obbard RW, 2014, EARTHS FUTURE, V2, P315, DOI 10.1002/2014EF000240; Reisser J, 2014, PLOS ONE; Rochman CM, 2015, SCI REP-UK, V5, DOI 10.1038/srep14340; Rochman CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085433; Schirinzi G.F, 2017, ENVIRON RES, V67, P579; Sharma S, 2017, MICROPLASTIC POLLUTI, P21530; Taylor M. L., 2016, SCI REPORTS, P6; Teuten EL, 2009, TRANSPORT RELEASE CH, P2027; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Van Cauwenberghe L, 2013, ENVIRON POLLUT, V182, P495, DOI 10.1016/j.envpol.2013.08.013; van Franeker JA, 2015, ENVIRON POLLUT, V203, P89, DOI 10.1016/j.envpol.2015.02.034; Wagner M, 2014, ENV SCI EUROPE; Woodall LC, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140317; Yang D, 2015, ENVIRON SCI TECHNOL, P13622; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	40	376	394	34	217	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194970	10.1371/journal.pone.0194970	http://dx.doi.org/10.1371/journal.pone.0194970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641556	gold, Green Submitted, Green Published			2022-12-26	WOS:000429742900057
J	Pinazza, M; Ghisi, M; Minuzzo, S; Agnusdei, V; Fossati, G; Ciminale, V; Pezze, L; Ciribilli, Y; Pilotto, G; Venturoli, C; Amadori, A; Indraccolo, S				Pinazza, Marica; Ghisi, Margherita; Minuzzo, Sonia; Agnusdei, Valentina; Fossati, Gianluca; Ciminale, Vincenzo; Pezze, Laura; Ciribilli, Yari; Pilotto, Giorgia; Venturoli, Carolina; Amadori, Alberto; Indraccolo, Stefano			Histone deacetylase 6 controls Notch3 trafficking and degradation in T-cell acute lymphoblastic leukemia cells	ONCOGENE			English	Article							ACTIVATING MUTATIONS; ACETYLATION; ENDOCYTOSIS; RECEPTOR	Several studies have revealed that endosomal sorting controls the steady-state levels of Notch at the cell surface in normal cells and prevents its inappropriate activation in the absence of ligands. However, whether this highly dynamic physiologic process can be exploited to counteract dysregulated Notch signaling in cancer cells remains unknown. T-ALL is a malignancy characterized by aberrant Notch signaling, sustained by activating mutations in Notch1 as well as overexpression of Notch3, a Notch paralog physiologically subjected to lysosome-dependent degradation in human cancer cells. Here we show that treatment with the pan-HDAC inhibitor Trichostatin A (TSA) strongly decreases Notch3 full-length protein levels in T-ALL cell lines and primary human T-ALL cells xenografted in mice without substantially reducing NOTCH3 mRNA levels. Moreover, TSA markedly reduced the levels of Notch target genes, including pT alpha, CR2, and DTX-1, and induced apoptosis of T-ALL cells. We further observed that Notch3 was post-translationally regulated following TSA treatment, with reduced Notch3 surface levels and increased accumulation of Notch3 protein in the lysosomal compartment. Surface Notch3 levels were rescued by inhibition of dynein with ciliobrevin D. Pharmacologic studies with HDAC1, 6, and 8-specific inhibitors disclosed that these effects were largely due to inhibition of HDAC6 in TALL cells. HDAC6 silencing by specific shRNA was followed by reduced Notch3 expression and increased apoptosis of TALL cells. Finally, HDAC6 silencing impaired leukemia outgrowth in mice, associated with reduction of Notch3 full-length protein in vivo. These results connect HDAC6 activity to regulation of total and surface Notch3 levels and suggest HDAC6 as a potential novel therapeutic target to lower Notch signaling in T-ALL and other Notch3-addicted tumors.	[Pinazza, Marica; Agnusdei, Valentina; Ciminale, Vincenzo; Venturoli, Carolina; Amadori, Alberto; Indraccolo, Stefano] Ist Oncol Veneto IOV IRCCS, Padua, Italy; [Ghisi, Margherita; Minuzzo, Sonia; Ciminale, Vincenzo; Pilotto, Giorgia; Amadori, Alberto] Univ Padua, Dept Surg Oncol & Gastroenterol Sci, Padua, Italy; [Fossati, Gianluca] Italfarmaco SPA, Milan, Italy; [Pezze, Laura; Ciribilli, Yari] Univ Trento, Lab Mol Canc Genet, CIBIO, Trento, Italy; [Ghisi, Margherita] CRCT, Toulouse, France	IRCCS Istituto Oncologico Veneto (IOV); University of Padua; Italfarmaco; University of Trento; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Indraccolo, S (corresponding author), Ist Oncol Veneto IOV IRCCS, Padua, Italy.	stefano.indraccolo@unipd.it	Ghisi, Margherita/G-2756-2017; Minuzzo, Sonia Anna/AAP-2062-2020; Ciminale, Vincenzo/L-1416-2016; Ciribilli, Yari/K-2751-2018; Indraccolo, Stefano/AAE-6261-2021; Agnusdei, Valentina/I-1137-2018	Minuzzo, Sonia Anna/0000-0003-2588-6058; Ciminale, Vincenzo/0000-0001-6197-1802; Ciribilli, Yari/0000-0001-9231-379X; Indraccolo, Stefano/0000-0002-4810-7136; Agnusdei, Valentina/0000-0002-2617-360X; Pezze, Laura/0000-0001-8924-0083; Ghisi, Margherita/0000-0003-0583-9879	AIRC [IG18803]	AIRC(Fondazione AIRC per la ricerca sul cancro)	AIRC (IG18803 to SI).	Agnusdei V, 2014, LEUKEMIA, V28, P278, DOI 10.1038/leu.2013.183; Aldana-Masangkay GI, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/875824; Amati B, 2007, NAT CELL BIOL, V9, P729, DOI 10.1038/ncb0707-729; Bellavia D, 2000, EMBO J, V19, P3337, DOI 10.1093/emboj/19.13.3337; Bellavia D, 2003, SEMIN IMMUNOL, V15, P107, DOI 10.1016/S1044-5323(03)00007-1; Bernasconi-Elias P, 2016, ONCOGENE, V35, P6077, DOI 10.1038/onc.2016.133; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Chambers AE, 2003, EUR J CANCER, V39, P1165, DOI 10.1016/S0959-8049(03)00072-8; Conner SD, 2016, INT REV CEL MOL BIO, V323, P107, DOI 10.1016/bs.ircmb.2015.12.002; Deribe YL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000576; Fortini ME, 2009, DEV CELL, V16, P633, DOI 10.1016/j.devcel.2009.03.010; Gao YS, 2010, J BIOL CHEM, V285, P11219, DOI 10.1074/jbc.M109.042754; Graux C, 2006, LEUKEMIA, V20, P1496, DOI 10.1038/sj.leu.2404302; Gu YS, 2016, ONCOTARGET, V7, P29804, DOI 10.18632/oncotarget.7772; Jia LJ, 2009, INT J BIOCHEM CELL B, V41, P2594, DOI 10.1016/j.biocel.2009.08.019; Kanwar R, 2004, CURR BIOL, V14, pR1043, DOI 10.1016/j.cub.2004.11.041; Liu J, 2016, CRIT REV ONCOL HEMAT, V104, P21, DOI 10.1016/j.critrevonc.2016.05.010; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Masiero M, 2011, LEUKEMIA, V25, P588, DOI 10.1038/leu.2010.323; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Pacheco MTF, 2016, EXP CELL RES, V340, P248, DOI 10.1016/j.yexcr.2015.12.016; Palermo R, 2012, ONCOGENE, V31, P3807, DOI 10.1038/onc.2011.533; Pasto A, 2014, CANCER RES, V74, P2106, DOI 10.1158/0008-5472.CAN-13-2022; Pinazza M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.394; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Schroter CJ, 1999, J IMMUNOL METHODS, V227, P161, DOI 10.1016/S0022-1759(99)00079-4; Serafin V, 2011, J PATHOL, V224, P448, DOI 10.1002/path.2895; Seugnet L, 1997, DEV BIOL, V192, P585, DOI 10.1006/dbio.1997.8723; Singh BN, 2010, EXPERT REV ANTICANC, V10, P935, DOI [10.1586/era.10.62, 10.1586/ERA.10.62]; Sorensen EB, 2010, TRAFFIC, V11, P1234, DOI 10.1111/j.1600-0854.2010.01090.x; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; Wang ZW, 2012, FEBS LETT, V586, P1409, DOI 10.1016/j.febslet.2012.03.017; Weber U, 2003, DEV CELL, V5, P559, DOI 10.1016/S1534-5807(03)00273-9; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilkin MB, 2004, CURR BIOL, V14, P2237, DOI 10.1016/j.cub.2004.11.030; Windler SL, 2010, CURR BIOL, V20, P538, DOI 10.1016/j.cub.2010.01.049	36	18	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3839	3851		10.1038/s41388-018-0234-z	http://dx.doi.org/10.1038/s41388-018-0234-z			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29643474	Green Published, hybrid			2022-12-26	WOS:000438465600006
J	Gu, WD; Hong, XC; Le Bras, A; Nowak, WN; Bhaloo, SI; Deng, JC; Xie, Y; Hu, YH; Ruan, XZ; Xu, QB				Gu, Wenduo; Hong, Xuechong; Le Bras, Alexandra; Nowak, Witold N.; Bhaloo, Shirin Issa; Deng, Jiacheng; Xie, Yao; Hu, Yanhua; Ruan, Xiong Z.; Xu, Qingbo			Smooth muscle cells differentiated from mesenchymal stem cells are regulated by microRNAs and suitable for vascular tissue grafts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mesenchymal stem cells (MSCs); vascular smooth muscle cells; cell differentiation; microRNA mechanism; transforming growth factor beta (TGF-); tissue engineering; umbilical cord mesenchymal stem cells	GROWTH-FACTOR-BETA; NEOINTIMAL FORMATION; MIRNA-ASTERISK; MODULATION; PHENOTYPE; MECHANISM; THERAPY; DISEASE; INJURY; GENES	Tissue-engineered vascular grafts with long-term patency are greatly needed in the clinical settings, and smooth muscle cells (SMCs) are a critical graft component. Human mesenchymal stem cells (MSCs) are used for generating SMCs, and understanding the underlying regulatory mechanisms of the MSC-to-SMC differentiation process could improve SMC generation in the clinic. Here, we found that in response to stimulation of transforming growth factor-1 (TGF1), human umbilical cord-derived MSCs abundantly express the SMC markers -smooth muscle actin (SMA), smooth muscle protein 22 (SM22), calponin, and smooth muscle myosin heavy chain (SMMHC) at both gene and protein levels. Functionally, MSC-derived SMCs displayed contracting capacity in vitro and supported vascular structure formation in the Matrigel plug assay in vivo. More importantly, SMCs differentiated from human MSCs could migrate into decellularized mouse aorta and give rise to the smooth muscle layer of vascular grafts, indicating the potential of utilizing human MSC-derived SMCs to generate vascular grafts. Of note, microRNA (miR) array analysis and TaqMan microRNA assays identified miR-503 and miR-222-5p as potential regulators of MSC differentiation into SMCs at early time points. Mechanistically, miR-503 promoted SMC differentiation by directly targeting SMAD7, a suppressor of SMAD-related, TGF1-mediated signaling pathways. Moreover, miR-503 expression was SMAD4-dependent. SMAD4 was enriched at the miR-503 promoter. Furthermore, miR-222-5p inhibited SMC differentiation by targeting and down-regulating ROCK2 and SMA. In conclusion, MSC differentiation into SMCs is regulated by miR-503 and miR-222-5p and yields functional SMCs for use in vascular grafts.	[Gu, Wenduo; Hong, Xuechong; Le Bras, Alexandra; Nowak, Witold N.; Bhaloo, Shirin Issa; Deng, Jiacheng; Xie, Yao; Hu, Yanhua; Xu, Qingbo] Kings Coll London, Sch Cardiovasc Med & Sci, British Heart Fdn Ctr, London SE5 9NU, England; [Ruan, Xiong Z.] Chongqing Med Univ, Ctr Lipid Res, Key Lab Mol Biol Infect Dis, Minist Educ,Dept Infect Dis,Affiliated Hosp 2, Chongqing, Peoples R China; [Ruan, Xiong Z.] UCL, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England	University of London; King's College London; Chongqing Medical University; University of London; University College London	Ruan, XZ (corresponding author), Chongqing Med Univ, Ctr Lipid Res, Key Lab Mol Biol Infect Dis, Minist Educ,Dept Infect Dis,Affiliated Hosp 2, Chongqing, Peoples R China.; Ruan, XZ (corresponding author), UCL, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.; Xu, QB (corresponding author), Kings Coll London, Sch Cardiovasc Med & Sci, Kings BHF Ctr, 125 Coldharbour Lane, London SE5 9NU, England.	x.ruan@ucl.ac.uk; qingbo.xu@kcl.ac.uk	Ruan, Xiong Zhong/GZA-5963-2022	Ruan, Xiong Zhong/0000-0001-5199-4971; Le Bras, Alexandra/0000-0001-7898-4618; Gu, Wenduo/0000-0002-3859-3150; Deng, Jiacheng/0000-0002-3216-3774; Nowak, Witold/0000-0002-1526-3511	British Heart Foundation [RG/14/6/31144]; National Nature Science Foundation of China [81390354]	British Heart Foundation(British Heart Foundation); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by British Heart Foundation Grant RG/14/6/31144 and the National Nature Science Foundation of China Grant Number 81390354. The authors declare that they have no conflicts of interest with the contents of this article.	Abu Kasim NH, 2015, J TISSUE ENG REGEN M, V9, pE252, DOI 10.1002/term.1663; Adams B, 2007, TRENDS CARDIOVAS MED, V17, P246, DOI 10.1016/j.tcm.2007.08.005; Bang C, 2014, J CLIN INVEST, V124, P2136, DOI 10.1172/JCI70577; Bhayani MK, 2012, MUTAT RES-FUND MOL M, V731, P14, DOI 10.1016/j.mrfmmm.2011.10.014; Campagnolo P, 2015, BIOMATERIALS, V60, P53, DOI 10.1016/j.biomaterials.2015.04.055; Caporali A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9024; Chen SY, 2006, J BIOL CHEM, V281, P1765, DOI 10.1074/jbc.M507771200; Chen WX, 2013, TUMOR BIOL, V34, P1361, DOI 10.1007/s13277-013-0750-y; Chen YK, 2013, ARTERIOSCL THROM VAS, V33, P1844, DOI 10.1161/ATVBAHA.113.300902; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Davis-Dusenbery BN, 2011, ARTERIOSCL THROM VAS, V31, P2370, DOI 10.1161/ATVBAHA.111.226670; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; Guo L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/907420; Guo L, 2012, GENE, V511, P187, DOI 10.1016/j.gene.2012.09.066; Guo L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011387; Heinrich EM, 2012, CIRC RES, V110, P1014, DOI 10.1161/CIRCRESAHA.111.243394; Kamato D, 2013, CELL SIGNAL, V25, P2017, DOI 10.1016/j.cellsig.2013.06.001; Kan X, 2016, MOL MED REP, V13, P4315, DOI 10.3892/mmr.2016.5048; Karamariti E, 2013, CIRC RES, V112, P1433, DOI 10.1161/CIRCRESAHA.111.300415; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kim MR, 2009, STEM CELLS, V27, P191, DOI 10.1634/stemcells.2008-0363; Lanford RE, 2010, SCIENCE, V327, P198, DOI 10.1126/science.1178178; Lee A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02852-4; Lee MS, 2011, JACC-CARDIOVASC INTE, V4, P831, DOI 10.1016/j.jcin.2011.05.014; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin Y, 2009, J BIOL CHEM, V284, P7903, DOI 10.1074/jbc.M806920200; Liu XJ, 2012, J MOL CELL CARDIOL, V52, P245, DOI 10.1016/j.yjmcc.2011.11.008; Lo Furno D, 2018, J CELL PHYSIOL, V233, P3982, DOI 10.1002/jcp.26192; Maguire EM, 2017, ARTERIOSCL THROM VAS, V37, P2026, DOI 10.1161/ATVBAHA.117.309196; Mah SM, 2010, CRIT REV EUKAR GENE, V20, P141, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.40; Matsushita R, 2016, ONCOTARGET, V7, P28460, DOI 10.18632/oncotarget.8668; Merlet E, 2013, CARDIOVASC RES, V98, P458, DOI 10.1093/cvr/cvt045; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Reid G, 2016, EPIGENOMICS-UK, V8, P1079, DOI 10.2217/epi-2016-0035; Rothuizen TC, 2016, TISSUE ENG PART C-ME, V22, P923, DOI [10.1089/ten.tec.2016.0173, 10.1089/ten.TEC.2016.0173]; Secco M, 2008, STEM CELLS, V26, P146, DOI 10.1634/stemcells.2007-0381; Shende P, 2017, BIOMED PHARMACOTHER, V91, P693, DOI 10.1016/j.biopha.2017.04.126; Togliatto G, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000376; Uccelli A, 2006, EUR J IMMUNOL, V36, P2566, DOI 10.1002/eji.200636416; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; Wang C, 2010, TISSUE ENG PT A, V16, P1201, DOI 10.1089/ten.TEA.2009.0303; Wong MM, 2015, JOVE-J VIS EXP, DOI 10.3791/52565; Xu J, 2013, MOL BIOSYST, V9, P217, DOI 10.1039/c2mb25360g; Yang JS, 2011, RNA, V17, P312, DOI 10.1261/rna.2537911; Zhao Y, 2008, TRENDS GENET, V24, P323, DOI 10.1016/j.tig.2008.04.004; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065153; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007	56	37	40	2	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8089	8102		10.1074/jbc.RA118.001739	http://dx.doi.org/10.1074/jbc.RA118.001739			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29643181	Green Published, hybrid			2022-12-26	WOS:000433224600015
J	Borday, C; Parain, K; Tran, HT; Vleminckx, K; Perron, M; Monsoro-Burq, AH				Borday, Caroline; Parain, Karine; Hong Thi Tran; Vleminckx, Kris; Perron, Muriel; Monsoro-Burq, Anne H.			An atlas of Wnt activity during embryogenesis in Xenopus tropicalis	PLOS ONE			English	Article							NEURAL CREST INDUCTION; CYCLIN D1 GENE; BETA-CATENIN; SIGNALING PATHWAYS; CILIARY MARGIN; PLATE BORDER; STEM-CELLS; OPTIC CUP; EXPRESSION; ZEBRAFISH	Wnt proteins form a family of highly conserved secreted molecules that are critical mediators of cell-cell signaling during embryogenesis. Partial data on Wnt activity in different tissues and at different stages have been reported in frog embryos. Our objective here is to provide a coherent and detailed description of Wnt activity throughout embryo development. Using a transgenic Xenopus tropicalis line carrying a Wnt-responsive reporter sequence, we depict the spatial and temporal dynamics of canonical Wnt activity during embryogenesis. We provide a comprehensive series of in situ hybridization in whole-mount embryos and in cross-sections, from gastrula to tadpole stages, with special focus on neural tube, retina and neural crest cell development. This collection of patterns will thus constitute a valuable resource for developmental biologists to picture the dynamics of Wnt activity during development.	[Borday, Caroline; Monsoro-Burq, Anne H.] Univ Paris 11, Univ Paris Saclay, CNRS UMR 3347, Ctr Univ,INSERM U1021, Orsay, France; [Borday, Caroline; Monsoro-Burq, Anne H.] PSL Res Univ, CNRS UMR 3347, Inst Curie Res Div, INSERM, Orsay, France; [Parain, Karine; Perron, Muriel] Univ Paris 11, Univ Paris Saclay, CNRS, Paris Saclay Inst Neurosci, Orsay, France; [Hong Thi Tran; Vleminckx, Kris] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Monsoro-Burq, Anne H.] Inst Univ France, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Ghent University; Institut Universitaire de France	Monsoro-Burq, AH (corresponding author), Univ Paris 11, Univ Paris Saclay, CNRS UMR 3347, Ctr Univ,INSERM U1021, Orsay, France.; Monsoro-Burq, AH (corresponding author), PSL Res Univ, CNRS UMR 3347, Inst Curie Res Div, INSERM, Orsay, France.; Perron, M (corresponding author), Univ Paris 11, Univ Paris Saclay, CNRS, Paris Saclay Inst Neurosci, Orsay, France.; Monsoro-Burq, AH (corresponding author), Inst Univ France, Paris, France.	muriel.perron@u-psud.fr; anne-helene.monsoro-burq@curie.u-psud.fr	Perron, Muriel/F-6795-2019; Vleminckx, Kris/AAZ-4170-2020	Perron, Muriel/0000-0002-1558-8236; Monsoro-Burq, Anne H./0000-0003-2427-982X	Fondation pour la Recherche Medicale [DEQ20150331733, DEQ20150331739]; Agence Nationale de la Recherche [ANR-Blanc e SVSE2 -2011-CRESTNET, ANR-15-CE13-0012-01-CRESTNETMETABO]	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by Fondation pour la Recherche Medicale [https://www.fun.org/] (grant number DEQ20150331733), Funding to AHMB; Agence Nationale de la Recherche [www. agence-nationale-recherche.fr] (grant number ANR-Blanc e SVSE2 -2011-CRESTNET, ANR-15-CE13-0012-01-CRESTNETMETABO), Funding to AHMB; Fondation pour la Recherche Medicale [https://www.frm.org/] (grant number DEQ20150331739), Funding to MP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Alam D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023139; Rabadan MA, 2016, DEVELOPMENT, V143, P2194, DOI 10.1242/dev.134981; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Borday C, 2012, DEVELOPMENT, V139, P3499, DOI 10.1242/dev.079582; Boutros M, 2016, DEV CELL, V36, P485, DOI 10.1016/j.devcel.2016.02.018; Cavodeassi F, 2005, NEURON, V47, P43, DOI 10.1016/j.neuron.2005.05.026; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Cho SH, 2006, DEVELOPMENT, V133, P3167, DOI 10.1242/dev.02474; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cohen B, 2010, BREAST CANCER RES TR, V123, P113, DOI 10.1007/s10549-009-0621-9; Currier N, 2010, GENESIS, V48, P183, DOI 10.1002/dvg.20604; de Croze N, 2011, P NATL ACAD SCI USA, V108, P155, DOI 10.1073/pnas.1010740107; Denayer T, 2006, FEBS LETT, V580, P393, DOI 10.1016/j.febslet.2005.11.084; Denayer T, 2008, STEM CELLS, V26, P2063, DOI 10.1634/stemcells.2007-0900; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; El Yakoubi W, 2012, STEM CELLS, V30, P2784, DOI 10.1002/stem.1231; Esteve P, 2006, CURR OPIN NEUROBIOL, V16, P13, DOI 10.1016/j.conb.2006.01.001; Fan CM, 1997, DEV BIOL, V191, P160, DOI 10.1006/dbio.1997.8713; Ferrer-Vaquer A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-121; Fuhrmann Sabine, 2008, Organogenesis, V4, P60; Fujimura N, 2009, DEV BIOL, V334, P31, DOI 10.1016/j.ydbio.2009.07.002; Geng X, 2003, FEBS LETT, V547, P1, DOI 10.1016/S0014-5793(03)00639-2; Grammer TC, 2000, DEV BIOL, V228, P197, DOI 10.1006/dbio.2000.9945; Grove EA, 1998, DEVELOPMENT, V125, P2315; Grove EA, 2008, SCIENCE, V319, P288, DOI 10.1126/science.1153743; Hagglund AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081158; Heavner WE, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-27; HEMMATIBRIVANLOU A, 1991, DEVELOPMENT, V111, P715; Tran HT, 2014, METHODS, V66, P422, DOI 10.1016/j.ymeth.2013.06.028; HOPWOOD ND, 1989, CELL, V59, P893, DOI 10.1016/0092-8674(89)90612-0; Howard JM, 2014, DEVELOPMENT, V141, P3143, DOI 10.1242/dev.106989; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Klein EA, 2008, J CELL SCI, V121, P3853, DOI 10.1242/jcs.039131; LaBonne C, 1998, DEVELOPMENT, V125, P2403; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lewis JL, 2004, DEVELOPMENT, V131, P1299, DOI 10.1242/dev.01007; Liu H, 2007, DEV BIOL, V308, P54, DOI 10.1016/j.ydbio.2007.04.052; Liu H, 2006, INVEST OPHTH VIS SCI, V47, P5088, DOI 10.1167/iovs.06-0403; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maj E, 2016, DEV BIOL, V417, P77, DOI 10.1016/j.ydbio.2016.06.022; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Mayor R, 2014, BIOCHEM J, V457, P19, DOI 10.1042/BJ20131182; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Milet C, 2012, DEV BIOL, V366, P22, DOI 10.1016/j.ydbio.2012.01.013; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017; Monsoro-Burq AH, 2003, DEVELOPMENT, V130, P3111, DOI 10.1242/dev.00531; Monsoro-Burq Anne H, 2007, CSH Protoc, V2007, DOI 10.1101/pdb.prot4809; Moriyama A, 2007, GENESIS, V45, P90, DOI 10.1002/dvg.20268; Moro E, 2012, DEV BIOL, V366, P327, DOI 10.1016/j.ydbio.2012.03.023; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; NIETO MA, 1991, DEVELOPMENT, P59; Nieuwkoop N, 1994, NORMAL TABLE XENOPUS; Parain K, 2012, DEV NEUROBIOL, V72, P491, DOI 10.1002/dneu.20973; Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890; Pegoraro C, 2011, GENE EXPR PATTERNS, V11, P122, DOI 10.1016/j.gep.2010.10.006; Perron M, 1998, DEV BIOL, V199, P185, DOI 10.1006/dbio.1998.8939; Plouhinec JL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004045; Pourebrahim R, 2011, J BIOL CHEM, V286, P37732, DOI 10.1074/jbc.M111.242826; Riley BB, 2004, DEV DYNAM, V231, P278, DOI 10.1002/dvdy.20133; Rodriguez-Seguel E, 2009, DEV BIOL, V329, P258, DOI 10.1016/j.ydbio.2009.02.028; Selvadurai HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023012; Shimizu N, 2012, DEV BIOL, V370, P71, DOI 10.1016/j.ydbio.2012.07.016; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Stanganello E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6846; Steventon B, 2012, DEV BIOL, V365, P196, DOI 10.1016/j.ydbio.2012.02.029; Tran HT, 2010, P NATL ACAD SCI USA, V107, P16160, DOI 10.1073/pnas.1007725107; Trimarchi JM, 2009, DEV DYNAM, V238, P2327, DOI 10.1002/dvdy.21973; Tucker AS, 2004, DEV DYNAM, V230, P461, DOI 10.1002/dvdy.20071; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; Veien ES, 2008, DEVELOPMENT, V135, P4101, DOI 10.1242/dev.027367; Wagner J, 2000, DEV BIOL, V228, P86, DOI 10.1006/dbio.2000.9921; Walentek P, 2017, GENESIS, V55, DOI 10.1002/dvg.23001; Walentek P, 2015, DEV BIOL, V408, P292, DOI 10.1016/j.ydbio.2015.03.013; Westenskow P, 2009, DEVELOPMENT, V136, P2505, DOI 10.1242/dev.032136; Westenskow PD, 2010, INVEST OPHTH VIS SCI, V51, P5328, DOI 10.1167/iovs.09-5015; Wills BD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132440; Zhang SW, 2014, DEVELOPMENT, V141, P4794, DOI 10.1242/dev.115691	82	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0193606	10.1371/journal.pone.0193606	http://dx.doi.org/10.1371/journal.pone.0193606			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672592	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800007
J	Cifuentes-Canorea, P; Ruiz-Medrano, J; Gutierrez-Bonet, R; Pena-Garcia, P; Saenz-Frances, F; Garcia-Feijoo, J; Martinez-de-la-Casa, JM				Cifuentes-Canorea, Pilar; Ruiz-Medrano, Jorge; Gutierrez-Bonet, Rosa; Pena-Garcia, Pablo; Saenz-Frances, Federico; Garcia-Feijoo, Julian; Maria Martinez-de-la-Casa, Jose			Analysis of inner and outer retinal layers using spectral domain optical coherence tomography automated segmentation software in ocular hypertensive and glaucoma patients	PLOS ONE			English	Article							NERVE-FIBER LAYER; OPEN-ANGLE GLAUCOMA; DIAGNOSTIC ABILITY; DISC MEASUREMENTS; MACULAR VOLUME; CIRRUS HD; THICKNESS; DAMAGE; REPRODUCIBILITY; OCT	Objective To analyse the morphological features and diagnostic ability of eight macular retinal layers using a new segmentation software Heidelberg's Spectralis Optical Coherence Tomography (SD-OCT) in healthy, ocular hypertensive and primary open angle glaucoma patients. Methods Single-center, cross-sectional, non-interventional study. 193 eyes from 193 consecutive patients (56 controls, 63 ocular hypertensives, 32 early primary open glaucoma patients and 42 moderate-advanced primary open glaucoma patients). Those patients presenting any retinal disease were excluded. Macular segmentation of the retinal layers was automatically performed using the new segmentation Heidelberg's Spectralis OCT software providing measurements for eight retinal layers. The software provides thickness maps divided into nine subfields. Results Statistically significant differences in inner layers' thickness was found between all 4 four groups. Superior and inferior sectors of macular retinal nerve fiber layer; nasal, temporal, superior and inferior sectors of ganglion cell layer and inner plexiform layer were significantly different when comparing ocular hypertensive patients and early glaucoma patients. Areas under the ROC curves for early glaucoma diagnosis were 0.781 +/- 0.052 for macular retinal nerve fiber layer outer inferior sector, 0.760 +/- 0.050 for ganglion cell layer outer temporal sector, 0.767 +/- 0.049 for the inner plexiform layer outer temporal sector and 0.807 +/- 0.048 for the combination of all three. No differences were found between groups when considering outer retinal layers. Conclusions The automated segmentation software from Heidelberg's Spectralis OCT provides a new diagnostic tool for the diagnosis of ocular hypertensive and glaucoma patients.	[Cifuentes-Canorea, Pilar; Ruiz-Medrano, Jorge; Saenz-Frances, Federico; Garcia-Feijoo, Julian; Maria Martinez-de-la-Casa, Jose] Univ Complutense Madrid, Fac Med, Dept Oftalmol, Serv Oftalmol,Hosp Clin San Carlos, Madrid, Spain; [Cifuentes-Canorea, Pilar; Ruiz-Medrano, Jorge; Saenz-Frances, Federico; Garcia-Feijoo, Julian; Maria Martinez-de-la-Casa, Jose] Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain; [Gutierrez-Bonet, Rosa] Hosp Puerta de Hierro, Madrid, Spain; [Pena-Garcia, Pablo] Miguel Hernandez Univ, Div Ophtalmol, Alicante, Spain	Complutense University of Madrid; Hospital Clinico San Carlos; Hospital Clinico San Carlos; Hospital Puerta de Hierro-Majadahonda; Universidad Miguel Hernandez de Elche	Cifuentes-Canorea, P (corresponding author), Univ Complutense Madrid, Fac Med, Dept Oftalmol, Serv Oftalmol,Hosp Clin San Carlos, Madrid, Spain.; Cifuentes-Canorea, P (corresponding author), Hosp Clin San Carlos, Inst Invest Sanitaria, Madrid, Spain.	pilarcifuca@gmail.com	PEÑA, PABLO/AAQ-2552-2021; Ruiz-Medrano, Jorge/N-6256-2016; Saenz-Frances, Federico/A-3350-2012	Ruiz-Medrano, Jorge/0000-0002-1105-9265; Saenz-Frances, Federico/0000-0002-3196-1491; Martinez-de-la-Casa, Jose Maria/0000-0001-9441-0542				Choi SS, 2011, BRIT J OPHTHALMOL, V95, P131, DOI 10.1136/bjo.2010.183756; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Colombo L, 2016, J GLAUCOMA, V25, pE455, DOI 10.1097/IJG.0000000000000291; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Ehnes A, 2014, TRANSL VIS SCI TECHN, V3, DOI 10.1167/tvst.3.1.1; Fan N, 2011, J OPHTHALMOL, V2011, DOI 10.1155/2011/264803; Garas A, 2011, EYE, V25, P57, DOI 10.1038/eye.2010.139; GLOVINSKY Y, 1993, INVEST OPHTH VIS SCI, V34, P395; GOLDMANN H, 1972, BRIT J OPHTHALMOL, V56, P242, DOI 10.1136/bjo.56.3.242; Harwerth RS, 1999, INVEST OPHTH VIS SCI, V40, P2242; Hodapp E, 1993, CLIN DECISIONS GLAUC, P52; Hood DC, 2013, PROG RETIN EYE RES, V32, P1, DOI 10.1016/j.preteyeres.2012.08.003; Huang JJ, 2011, J GLAUCOMA, V20, P118, DOI 10.1097/IJG.0b013e3181d786f8; Ishikawa H, 2006, INVEST OPHTH VIS SCI, V47, P964, DOI 10.1167/iovs.05-0748; Ishikawa H, 2005, INVEST OPHTH VIS SCI, V46, P2012, DOI 10.1167/iovs.04-0335; Kita Y, 2013, CLIN EXP OPHTHALMOL, V41, P674, DOI 10.1111/ceo.12089; Kita Y, 2013, J GLAUCOMA, V22, P757, DOI 10.1097/IJG.0b013e31825af58a; Leung CKS, 2013, OPHTHALMOLOGY, V120, P2485, DOI 10.1016/j.ophtha.2013.07.021; Leung CKS, 2005, OPHTHALMOLOGY, V112, P391, DOI 10.1016/j.ophtha.2004.10.020; Martinez-De-La-Casa JM, 2014, INVEST OPHTH VIS SCI, V55, P8343, DOI 10.1167/iovs.14-15501; Miglior S, 2003, OPHTHALMOLOGY, V110, P340, DOI 10.1016/S0161-6420(02)01754-2; Miglior S, 2015, AM J OPHTHALMOL, V159, P265, DOI 10.1016/j.ajo.2014.10.028; Mori S, 2010, J GLAUCOMA, V19, P528, DOI 10.1097/IJG.0b013e3181ca7acf; Mwanza JC, 2011, INVEST OPHTH VIS SCI, V52, P8323, DOI 10.1167/iovs.11-7962; Nork TM, 2000, ARCH OPHTHALMOL-CHIC, V118, P235; Ojima T, 2007, JPN J OPHTHALMOL, V51, P197, DOI 10.1007/s10384-006-0433-y; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; QUIGLEY HA, 1982, ARCH OPHTHALMOL-CHIC, V100, P135, DOI 10.1001/archopht.1982.01030030137016; Rao HL, 2010, OPHTHALMOLOGY, V117, P1692, DOI 10.1016/j.ophtha.2010.01.031; Sakamoto A, 2008, OPHTHALMOLOGY, V115, P1071, DOI 10.1016/j.ophtha.2007.09.001; Schulze A, 2011, GRAEF ARCH CLIN EXP, V249, P1039, DOI 10.1007/s00417-010-1585-5; Sung KR, 2009, OPHTHALMOLOGY, V116, P1264, DOI 10.1016/j.ophtha.2008.12.045; SWANSON EA, 1993, OPT LETT, V18, P1864, DOI 10.1364/OL.18.001864; Tan O, 2008, OPHTHALMOLOGY, V115, P949, DOI 10.1016/j.ophtha.2007.08.011; Tan O, 2009, OPHTHALMOLOGY, V116, P2305, DOI 10.1016/j.ophtha.2009.05.025; Vajaranant TS, 2011, EYE, V25, P612, DOI 10.1038/eye.2011.17; Wollstein G, 2004, AM J OPHTHALMOL, V138, P218, DOI 10.1016/j.ajo.2004.03.019; Zangwill LM, 2005, ARCH OPHTHALMOL-CHIC, V123, P1188, DOI 10.1001/archopht.123.9.1188; Zeimer R, 1998, OPHTHALMOLOGY, V105, P224, DOI 10.1016/S0161-6420(98)92743-9	39	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e196112	10.1371/journal.pone.0196112	http://dx.doi.org/10.1371/journal.pone.0196112			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672563	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800087
J	Sakr, S; Elshawi, R; Ahmed, A; Qureshi, WT; Brawner, C; Keteyian, S; Blaha, MJ; Al-Mallah, MH				Sakr, Sherif; Elshawi, Radwa; Ahmed, Amjad; Qureshi, Waqas T.; Brawner, Clinton; Keteyian, Steven; Blaha, Michael J.; Al-Mallah, Mouaz H.			Using machine learning on cardiorespiratory fitness data for predicting hypertension: The Henry Ford Exercise Testing (FIT) Project	PLOS ONE			English	Article							PROBABILISTIC NETWORKS; BAYESIAN NETWORKS; CLASSIFICATION; REGRESSION; KNOWLEDGE	This study evaluates and compares the performance of different machine learning techniques on predicting the individuals at risk of developing hypertension, and who are likely to benefit most from interventions, using the cardiorespiratory fitness data. The dataset of this study contains information of 23,095 patients who underwent clinician-referred exercise treadmill stress testing at Henry Ford Health Systems between 1991 and 2009 and had a complete 10-year follow-up. The variables of the dataset include information on vital signs, diagnosis and clinical laboratory measurements. Six machine learning techniques were investigated: LogitBoost (LB), Bayesian Network classifier (BN), Locally Weighted Naive Bayes (LWB), Artificial Neural Network (ANN), Support Vector Machine (SVM) and Random Tree Forest (RTF). Using different validation methods, the RTF model has shown the best performance (AUC = 0.93) and outperformed all other machine learning techniques examined in this study. The results have also shown that it is critical to carefully explore and evaluate the performance of the machine learning models using various model evaluation methods as the prediction accuracy can significantly differ.	[Sakr, Sherif; Ahmed, Amjad; Al-Mallah, Mouaz H.] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia; [Sakr, Sherif; Ahmed, Amjad; Al-Mallah, Mouaz H.] King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [Brawner, Clinton; Keteyian, Steven; Al-Mallah, Mouaz H.] Henry Ford Hosp Syst, Heart & Vasc Inst, Detroit, MI USA; [Elshawi, Radwa] Princess Nourah Bint Abdulrahman Univ, Riyadh, Saudi Arabia; [Qureshi, Waqas T.] Wake Forest Sch Med, Med Ctr Blvd, Winston Salem, NC USA; [Blaha, Michael J.] Johns Hopkins Med, Baltimore, MD USA; [Sakr, Sherif; Elshawi, Radwa] Univ Taru, Taru, Estonia	King Saud Bin Abdulaziz University for Health Sciences; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Henry Ford Health System; Princess Nourah bint Abdulrahman University; Wake Forest University; Johns Hopkins University; Johns Hopkins Medicine	Sakr, S (corresponding author), King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia.; Sakr, S (corresponding author), King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia.; Sakr, S (corresponding author), Univ Taru, Taru, Estonia.	sakrs@ksau-hs.edu.sa	Qureshi, Waqas/H-3498-2019; Shawi, Radwa/AAB-9237-2020; Brawner, Clinton A./K-6859-2019; Sakr, Sherif/B-1439-2018; Ahmed, Amjad M./AAW-7624-2020	Qureshi, Waqas/0000-0002-5189-4417; Sakr, Sherif/0000-0002-2503-523X; Ahmed, Amjad M./0000-0002-8711-4865; Al-Mallah, Mouaz/0000-0003-2348-0484; El Shawi, Radwa/0000-0002-5679-9099	King Abdullah International Medical Research Center [SP16/100]	King Abdullah International Medical Research Center	Funding was provided by King Abdullah International Medical Research Center. Funding grant number SP16/100 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah AA, 2011, 2011 2 INT C INT SYS, P113; Abramovici M, 2008, P IPMU, V8, P379; Aggarwal CC, 2014, CH CRC DATA MIN KNOW, P457; Al-Mallah MH, 2014, CLIN CARDIOL, V37, P456, DOI 10.1002/clc.22302; Al-Nozha MM, 2007, SAUDI MED J, V28, P77; Alghamdi M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179805; Arbib MA., 2003, HDB BRAIN THEORY NEU; Blake C L, 1998, UCI REPOSITORY MACHI, P55; Bouckaert RR, 2001, BAYESIAN BELIEF NETW; BRUCE RA, 1973, AM HEART J, V85, P546, DOI 10.1016/0002-8703(73)90502-4; Buntine W, 1996, IEEE T KNOWL DATA EN, V8, P195, DOI 10.1109/69.494161; Carson JL, 2015, LANCET, V385, P1183, DOI 10.1016/S0140-6736(14)62286-8; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chawla NV, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P875, DOI 10.1007/978-0-387-09823-4_45; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; Cheng J, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P101; Chowdhury R, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1903; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Echouffo-Tcheugui Justin B, 2013, PLoS One, V8, pe67370, DOI 10.1371/journal.pone.0067370; Frank E., 2002, P 19 C UNC ART INT A, P249; Friedman J, 2000, ANN STAT, V28, P337, DOI 10.1214/aos/1016218223; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Haykin S., 1994, NEURAL NETWORKS COMP; Hearst MA, 1998, IEEE INTELL SYST APP, V13, P18, DOI 10.1109/5254.708428; HECKERMAN D, 1995, MACH LEARN, V20, P197, DOI 10.1007/BF00994016; Hung RK, 2014, MAYO CLIN PROC, V89, P1644, DOI 10.1016/j.mayocp.2014.07.011; Jeppesen J, 2000, HYPERTENSION, V36, P226, DOI 10.1161/01.HYP.36.2.226; Juraschek SP, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001268; Juraschek SP, 2015, DIABETES CARE, V38, P1075, DOI 10.2337/dc14-2714; KAYYALI Basel, 2013, BIG DATA REVOLUTION; KENT JT, 1983, BIOMETRIKA, V70, P163, DOI 10.1093/biomet/70.1.163; Kubat M., 1997, ADDRESSING CURSE IMB, P179, DOI DOI 10.1007/S13398-014-0173-7.2; Kung Hsiang-Ching, 2015, NCHS Data Brief, P1; Kurgan L, 2001, IC-AI'2001: PROCEEDINGS OF THE INTERNATIONAL CONFERENCE ON ARTIFICIAL INTELLIGENCE, VOLS I-III, P980; Lee SM, 2003, J BIOMED INFORM, V36, P389, DOI 10.1016/j.jbi.2003.09.022; Marsland S, 2015, MACHINE LEARNING ALG, DOI DOI 10.1201/B17476; Members C, 2002, J AM COLL CARDIOL, V40, P1531, DOI [10.1016/S0735-1097(02)02164-2, DOI 10.1016/S0735-1097(02)02164-2]; Organization WH, 2005, CLIN GUID MAN HYP; Platt J., 1998, ADV KERNEL METHODS S, P41, DOI [10.1109/iske.2008.4731075, DOI 10.1109/ISKE.2008.4731075]; POLI R, 1991, COMPUTER, V24, P64, DOI 10.1109/2.73514; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; Qureshi WT, 2015, CIRCULATION, V132, pE395, DOI 10.1161/CIRCULATIONAHA.115.018758; Raghupathi W, 2014, HEALTH INF SCI SYST, V2, DOI 10.1186/2047-2501-2-3; Ross K, 2009, ENCY DATABASE SYSTEM; Sakr S, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0566-6; Samant R, 2013, INT J COMPUTER APPL, V81, DOI [10.5120/14067-2331, DOI 10.5120/14067-2331]; Su CT, 2008, EXPERT SYST APPL, V34, P754, DOI 10.1016/j.eswa.2006.10.010; Tin Kam Ho, 1995, Proceedings of the Third International Conference on Document Analysis and Recognition, P278, DOI 10.1109/ICDAR.1995.598994; Ture M, 2005, EXPERT SYST APPL, V29, P583, DOI 10.1016/j.eswa.2005.04.014; Waljee AK, 2010, AM J GASTROENTEROL, V105, P1224, DOI 10.1038/ajg.2010.173; Walker S. John, 2014, BIG DATA REVOLUTION; Whelton Paul K, 2018, J Am Soc Hypertens, V12, DOI [10.1161/HYP.0000000000000065, 10.1016/j.jash.2018.06.010]; Yuret D., 1993, 2 TURK S ART INT NEU, P208	56	48	50	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195344	10.1371/journal.pone.0195344	http://dx.doi.org/10.1371/journal.pone.0195344			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668729	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200039
J	Seifi, M; Walter, MA				Seifi, Morteza; Walter, Michael A.			Accurate prediction of functional, structural, and stability changes in PITX2 mutations using in silico bioinformatics algorithms	PLOS ONE			English	Article							AXENFELD-RIEGER-SYNDROME; SINGLE NUCLEOTIDE POLYMORPHISMS; AMINO-ACID SUBSTITUTIONS; PROTEIN STABILITY; MOLECULAR-MECHANISMS; GENETIC-VARIANTS; SPECTRUM; FOXC1; SERVER; SEQUENCE	Mutations in PITX2 have been implicated in several genetic disorders, particularly Axenfeld-Rieger syndrome. In order to determine the most reliable bioinformatics tools to assess the likely pathogenicity of PITX2 variants, the results of bioinformatics predictions were compared to the impact of variants on PITX2 structure and function. The MutPred, Provean, and PMUT bioinformatic tools were found to have the highest performance in predicting the pathogenicity effects of all 18 characterized missense variants in PITX2, all with sensitivity and specificity >93%. Applying these three programs to assess the likely pathogenicity of 13 previously uncharacterized PITX2 missense variants predicted 12/13 variants as deleterious, except A30V which was predicted as benign variant for all programs. Molecular modeling of the PITX2 homoedomain predicts that of the 31 known PITX2 variants, L54Q, F58L, V83F, V83L, W86C, W86S, and R91P alter PITX2's structure. In contrast, the remaining 24 variants are not predicted to change PITX2's structure. The results of molecular modeling, performed on all the PITX2 missense mutations located in the homeodomain, were compared with the findings of eight protein stability programs. CUPSAT was found to be the most reliable in predicting the effect of missense mutations on PITX2 stability. Our results showed that for PITX2, and likely other members of this homeodomain transcription factor family, MutPred, Provean, PMUT, molecular modeling, and CUPSAT can reliably be used to predict PITX2 missense variants pathogenicity.	[Seifi, Morteza; Walter, Michael A.] Univ Alberta, Dept Med Genet, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta	Walter, MA (corresponding author), Univ Alberta, Dept Med Genet, Fac Med & Dent, Edmonton, AB, Canada.	mwalter@ualberta.ca	Seifi, Moretza/B-4507-2015	Seifi, Moretza/0000-0002-1609-8490	Canadian Institute for Health Research [G118160216]; Alberta Innovates Health Solutions graduate studentship [201500029]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Health Solutions graduate studentship	This work was supported by the Canadian Institute for Health Research (MA. Walter, [grant number G118160216], http://www.cihr-irsc.gc.ca/e/193.html) and Alberta Innovates Health Solutions graduate studentship (M. Seifi, [award number 201500029], http://www.aihealthsolutions.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alward WLM, 1998, AM J OPHTHALMOL, V125, P98, DOI 10.1016/S0002-9394(99)80242-6; Amendt BA, 1998, J BIOL CHEM, V273, P20066, DOI 10.1074/jbc.273.32.20066; Amendt BA, 2000, CELL MOL LIFE SCI, V57, P1652, DOI 10.1007/PL00000647; Aydin H, 2014, PROTEIN SCI, V23, P603, DOI 10.1002/pro.2442; Bao L, 2005, NUCLEIC ACIDS RES, V33, pW480, DOI 10.1093/nar/gki372; Bao L, 2005, BIOINFORMATICS, V21, P2185, DOI 10.1093/bioinformatics/bti365; Brooks Brian P, 2004, Ophthalmic Genet, V25, P57, DOI 10.1076/opge.25.1.57.29002; Calloni G, 2005, J BIOL CHEM, V280, P10607, DOI 10.1074/jbc.M412951200; Campuzano O, 2015, SCI REP-UK, V5, DOI 10.1038/srep07953; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Chaney BA, 2005, BIOCHEMISTRY-US, V44, P7497, DOI 10.1021/bi0473253; Chen CW, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S5; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; D'haene B, 2011, INVEST OPHTH VIS SCI, V52, P324, DOI 10.1167/iovs.10-5309; Doss CGP, 2012, APPL TRANSL GENOM, V1, P37, DOI 10.1016/j.atg.2012.06.002; Dressler S, 2010, CASE REP MED, V2010, DOI 10.1155/2010/621984; Espinoza HM, 2002, HUM MOL GENET, V11, P743, DOI 10.1093/hmg/11.7.743; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Flanagan SE, 2010, GENET TEST MOL BIOMA, V14, P533, DOI 10.1089/gtmb.2010.0036; Footz T, 2009, INVEST OPHTH VIS SCI, V50, P2599, DOI 10.1167/iovs.08-3251; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Geourjon C, 2001, PROTEIN SCI, V10, P788, DOI 10.1110/ps.30001; Gromiha MM, 2007, BIOCHEM SOC T, V35, P1569, DOI 10.1042/BST0351569; Gunderson KL, 2006, METHOD ENZYMOL, V410, P359, DOI 10.1016/S0076-6879(06)10017-8; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; Huang XB, 2015, INT J MOL MED, V36, P1111, DOI 10.3892/ijmm.2015.2325; Idrees F, 2006, AM J MED GENET B, V141B, P184, DOI 10.1002/ajmg.b.30237; Ioannidis NM, 2016, AM J HUM GENET, V99, P877, DOI 10.1016/j.ajhg.2016.08.016; Jia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138022; Judkins T, 2005, MUTAT RES-FUND MOL M, V573, P168, DOI 10.1016/j.mrfmmm.2004.07.024; Khan S, 2010, HUM MUTAT, V31, P675, DOI 10.1002/humu.21242; Kimura Masashi, 2014, Hum Genome Var, V1, P14005, DOI 10.1038/hgv.2014.5; Kniestedt C, 2006, OPHTHALMOLOGY, V113, P1791, DOI 10.1016/j.ophtha.2006.05.017; KORNBERG TB, 1993, J BIOL CHEM, V268, P26813; Kozlowski K, 2000, HUM MOL GENET, V9, P2131, DOI 10.1093/hmg/9.14.2131; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kulak SC, 1998, HUM MOL GENET, V7, P1113, DOI 10.1093/hmg/7.7.1113; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Laskowski RA, 2016, HUM MOL GENET, V25, P927, DOI 10.1093/hmg/ddv625; Li B, 2009, BIOINFORMATICS, V25, P2744, DOI 10.1093/bioinformatics/btp528; Li DD, 2008, MOL VIS, V14, P2205; Lindberg MJ, 2005, P NATL ACAD SCI USA, V102, P9754, DOI 10.1073/pnas.0501957102; Lines MA, 2002, HUM MOL GENET, V11, P1177, DOI 10.1093/hmg/11.10.1177; Mayer S, 2007, J MOL BIOL, V372, P268, DOI 10.1016/j.jmb.2007.06.044; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer-Marcotty P, 2008, J ORAL PATHOL MED, V37, P504, DOI 10.1111/j.1600-0714.2008.00650.x; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Pace CN, 2014, PROTEIN SCI, V23, P652, DOI 10.1002/pro.2449; Pandurangan AP, 2017, NUCLEIC ACIDS RES, V45, pW229, DOI 10.1093/nar/gkx439; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Perveen R, 2000, INVEST OPHTH VIS SCI, V41, P2456; Phillips JC, 2002, OPHTHALMIC RES, V34, P324, DOI 10.1159/000065602; Pires DEV, 2014, NUCLEIC ACIDS RES, V42, pW314, DOI 10.1093/nar/gku411; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Priston M, 2001, HUM MOL GENET, V10, P1631, DOI 10.1093/hmg/10.16.1631; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Randles LG, 2006, J BIOL CHEM, V281, P24216, DOI 10.1074/jbc.M603593200; Reis LM, 2012, EUR J HUM GENET, V20, P1224, DOI 10.1038/ejhg.2012.80; Saadi I, 2006, BIRTH DEFECTS RES A, V76, P175, DOI 10.1002/bdra.20226; Saadi I, 2001, J BIOL CHEM, V276, P23034, DOI 10.1074/jbc.M008592200; Schwarz JM, 2014, NAT METHODS, V11, P361, DOI 10.1038/nmeth.2890; Seifi M, 2017, HUM MUTAT, V38, P169, DOI 10.1002/humu.23141; Seifi M, 2016, ACTA OPHTHALMOL, V94, pE571, DOI 10.1111/aos.13030; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shields M B, 1983, Trans Am Ophthalmol Soc, V81, P736; Shihab HA, 2013, HUM MUTAT, V34, P57, DOI 10.1002/humu.22225; Stefl S, 2013, J MOL BIOL, V425, P3919, DOI 10.1016/j.jmb.2013.07.014; Stenson PD, 2014, HUM GENET, V133, P1, DOI 10.1007/s00439-013-1358-4; Strungaru MH, 2007, INVEST OPHTH VIS SCI, V48, P228, DOI 10.1167/iovs.06-0472; Sun Y., 2015, MATH PROBL ENG, V3, P1, DOI DOI 10.1016/J.GENE.2015.12.001; Tang HM, 2016, BIOINFORMATICS, V32, P2230, DOI 10.1093/bioinformatics/btw222; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Vagenende V, 2009, BIOCHEMISTRY-US, V48, P11084, DOI 10.1021/bi900649t; VAUX C, 1992, J MED GENET, V29, P256, DOI 10.1136/jmg.29.4.256; Vieira V, 2006, MOL VIS, V12, P1448; Wallqvist A, 2000, BIOINFORMATICS, V16, P988, DOI 10.1093/bioinformatics/16.11.988; Wang J, 2013, DNA CELL BIOL, V32, P708, DOI 10.1089/dna.2013.2185; Wang J, 2014, EUR J MED GENET, V57, P25, DOI 10.1016/j.ejmg.2013.11.004; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Wei D, 2014, INT J MOL MED, V33, P1201, DOI 10.3892/ijmm.2014.1689; Weisschuh N, 2006, INVEST OPHTH VIS SCI, V47, P3846, DOI 10.1167/iovs.06-0343; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Worth CL, 2011, NUCLEIC ACIDS RES, V39, pW215, DOI 10.1093/nar/gkr363; Xia K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022434; Yang YQ, 2013, INT J CARDIOL, V168, P2873, DOI 10.1016/j.ijcard.2013.03.141; Young DL, 2015, MOL BIOL CELL, V26, P3904, DOI 10.1091/mbc.E15-03-0153; Yuan F, 2013, INT J MED SCI, V10, P1422, DOI 10.7150/ijms.6809; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141	96	22	22	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195971	10.1371/journal.pone.0195971	http://dx.doi.org/10.1371/journal.pone.0195971			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664915	Green Submitted, gold, Green Published			2022-12-26	WOS:000430262300046
J	Taberna, M; Mena, M; Tous, S; Pavon, MA; Oliva, M; Leon, X; Garcia, J; Guix, M; Hijano, R; Bonfill, T; Aguila, A; Alemany, L; Mesia, R				Taberna, Miren; Mena, Marisa; Tous, Sara; Angel Pavon, Miguel; Oliva, Marc; Leon, Xavier; Garcia, Jacinto; Guix, Marta; Hijano, Rafael; Bonfill, Teresa; Aguila, Anton; Alemany, Laia; Mesia, Ricard			HPV-relatedness definitions for classifying HPV-related oropharyngeal cancer patient do impact on TNM classification and patients' survival	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS; STAGING SYSTEM; CARCINOMAS; HEAD	Background Given the different nature and better outcomes of oropharyngeal carcinoma (OPC) associated with human papillomavirus (HPV) infection, a novel clinical stage classification for HPV-related OPC has been accepted for the 8 th edition AJCC TNM (ICON-S model). However, it is still unclear the HPV-relatedness definition with best diagnostic accuracy and prognostic value. Material and methods The aim of this study was to compare different staging system models proposed for HPV-related OPC patients: 7 th edition AJCC TNM, RPA stage with non-anatomic factors (Princess Margaret), RPA with N categories for nasopharyngeal cancer (MD-Anderson) and AHR-new (ICON-S), according to different HPV-relatedness definitions: HPV-DNA detection plus an additional positive marker (p16(INK4a) or HPV-mRNA), p16(INK4a) positivity alone or the combination of HPV-DNA/p16(INK4a) positivity as diagnostic tests. Results A total of 788 consecutive OPC cases diagnosed from 1991 to 2013 were considered eligible for the analysis. Of these samples, 66 (8.4%) were positive for HPV-DNA and (p16(INK4a) or HPV-mRNA), 83 (10.5%) were p16(INK4a) positive and 58 (7.4%) were double positive for HPV-DNA/p16(INK4a). ICON-S model was the staging system, which performed better in our series when using at least two biomarkers to define HPV-causality. When the same analysis was performed considering only p16(INK4a)-positivity, RPA stage with non-anatomic factors (Princess Margaret) has the best classification based on AIC criteria. Conclusion HPV-relatedness definition for classifying HPV-related OPC patient do impact on TNM classification and patients' survival. Further studies assessing HPV-relatedness definitions are warranted to better classify HPV-related OPC patients in the era of de-escalation clinical trials.	[Taberna, Miren; Oliva, Marc] IDIBELL, ONCOBELL, Catalan Inst Oncol ICO, Dept Med Oncol, Barcelona, Spain; [Taberna, Miren; Mena, Marisa; Tous, Sara; Angel Pavon, Miguel; Alemany, Laia] IDIBELL, Canc Epidemiol Res Program, Catalan Inst Oncol ICO, Barcelona, Spain; [Taberna, Miren; Mesia, Ricard] Univ Barcelona, Barcelona, Spain; [Mena, Marisa; Tous, Sara] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Angel Pavon, Miguel; Alemany, Laia] Ctr Invest Biomed Red Canc CIBERESP, Madrid, Spain; [Leon, Xavier; Garcia, Jacinto] Hosp Santa Creu & Sant Pau, Dept Otorhinolaryngol, Barcelona, Spain; [Leon, Xavier] CIBER BBN, Madrid, Spain; [Guix, Marta] Hosp del Mar, Canc Res Program, IMIM, Barcelona, Spain; [Guix, Marta] Hosp del Mar, Dept Med Oncol, Barcelona, Spain; [Hijano, Rafael] Hosp del Mar, Dept Otorhinolaryngol, Barcelona, Spain; [Bonfill, Teresa] Hosp Univ Parc Tauli, Dept Med Oncol, Barcelona, Spain; [Aguila, Anton] Hosp Univ Parc Tauli, Dept Otorhinolaryngol, Barcelona, Spain; [Mesia, Ricard] Catalan Inst Oncol ICO, Dept Med Oncol, Barcelona, Spain	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Autonomous University of Barcelona; Parc Tauli Hospital Universitari; Catalan Institute of Oncology	Taberna, M (corresponding author), IDIBELL, ONCOBELL, Catalan Inst Oncol ICO, Dept Med Oncol, Barcelona, Spain.; Taberna, M (corresponding author), IDIBELL, Canc Epidemiol Res Program, Catalan Inst Oncol ICO, Barcelona, Spain.; Taberna, M (corresponding author), Univ Barcelona, Barcelona, Spain.	mtaberna@iconcologia.net	Alemany, Laia/G-9643-2015; León, Xavier/AAB-7837-2019; Lorenzo, Jacinto Garcia/H-9124-2017; Pavon, Miguel Angel/N-3538-2014; Tous, Sara/G-5052-2015	Alemany, Laia/0000-0003-0945-6015; León, Xavier/0000-0001-6286-630X; Lorenzo, Jacinto Garcia/0000-0002-6123-7808; Guix, Marta/0000-0002-2143-0697; Pavon, Miguel Angel/0000-0003-3677-5329; Taberna, Miren/0000-0002-2446-186X; Oliva Bernal, Marc/0000-0001-5352-8130; Tous, Sara/0000-0002-5423-7092	Institute de Salud Carlos III-ISCIII (Spanish Government) - FEDER funds/European Regional Development Fund (ERDF) [PI14/01819, PI15/00500, PI11/02096]; Ayudas Merck Serono-Fundacion Salud de investigacion; Agenda de Gestio d'Ajuts Universitaris i de Recerca, AGAUR [2017SGR1085, 2017SGR1718]; European Commission 7th Framework Programme COHEAHR [Health-F3-2013-603019]; Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology)	Institute de Salud Carlos III-ISCIII (Spanish Government) - FEDER funds/European Regional Development Fund (ERDF); Ayudas Merck Serono-Fundacion Salud de investigacion; Agenda de Gestio d'Ajuts Universitaris i de Recerca, AGAUR; European Commission 7th Framework Programme COHEAHR; Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology)	This work was partially supported by grants from the Institute de Salud Carlos III-ISCIII (Spanish Government) cofunded by FEDER funds/European Regional Development Fund (ERDF) - a way to build Europe (PI14/01819, PI15/00500 and PI11/02096); Ayudas Merck Serono-Fundacion Salud 2000 de investigacion 2015; Agenda de Gestio d'Ajuts Universitaris i de Recerca, AGAUR (2017SGR1085 and 2017SGR1718), European Commission 7th Framework Programme COHEAHR (Health-F3-2013-603019) and Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology) (personal grant to MT). The funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MT gratefully acknowledges the Rio Hortega-SEOM (ISCIII-Spanish Society of Medical Oncology) grant.	Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; [Anonymous], 2017, TNM CLASSIFICATION M; Begum S, 2005, CLIN CANCER RES, V11, P5694, DOI 10.1158/1078-0432.CCR-05-0587; Boscolo-Rizzo P, 2017, INT J CANCER, V141, P1490, DOI 10.1002/ijc.30837; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Dahlstrom KR, 2016, J CLIN ONCOL, V34, P1848, DOI 10.1200/JCO.2015.64.6448; Gillison Maura L., 2016, J CLIN ONCOL, V34, DOI [10.1200/JCO.2016.66.6081, DOI 10.1200/JCO.2016.66.6081]; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Halec G, 2013, INT J CANCER, V132, P63, DOI 10.1002/ijc.27605; Huang SH, 2015, J CLIN ONCOL, V33, P836, DOI 10.1200/JCO.2014.58.6412; Larsen CG, 2014, BRIT J CANCER, V110, P1587, DOI 10.1038/bjc.2014.42; Marur S, 2016, E1308 PHASE 2 TRIAL; Mena M, 2018, ORAL ONCOL IN PRESS; Nauta IH, 2018, ANN ONCOL, V29, P1273, DOI 10.1093/annonc/mdy060; O'Sullivan B, 2016, LANCET ONCOL, V17, P440, DOI 10.1016/S1470-2045(15)00560-4; Prigge ES, 2017, INT J CANCER, V140, P1186, DOI 10.1002/ijc.30516; Rietbergen MM, 2013, ANN ONCOL, V24, P2740, DOI 10.1093/annonc/mdt319; Smeets SJ, 2007, INT J CANCER, V121, P2465, DOI 10.1002/ijc.22980; St Guily JL, 2011, J CLIN VIROL, V51, P100, DOI 10.1016/j.jcv.2011.03.003; Taberna M., 2017, ANN ONCOL, P1	20	8	8	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194107	10.1371/journal.pone.0194107	http://dx.doi.org/10.1371/journal.pone.0194107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664911	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300007
J	Valero, C; Amaveda, H; Mora, M; Garcia-Aznar, JM				Valero, Clara; Amaveda, Hippolyte; Mora, Mario; Manuel Garcia-Aznar, Jose			Combined experimental and computational characterization of crosslinked collagen-based hydrogels	PLOS ONE			English	Article							SEMIFLEXIBLE BIOPOLYMER NETWORKS; TENSILE MECHANICAL-PROPERTIES; CELL-MIGRATION; DEFORMATION MECHANISMS; MATRIX STIFFNESS; ACTIN NETWORKS; ELASTIC-MODULI; LINKING; GELS; BEHAVIOR	Collagen hydrogels are widely used for in-vitro experiments and tissue engineering applications. Their use has been extended due to their biocompatibility with cells and their capacity to mimic biological tissues; nevertheless their mechanical properties are not always optimal for these purposes. Hydrogels are formed by a network of polymer filaments embedded on an aqueous substrate and their mechanical properties are mainly defined by the filament network architecture and the individual filament properties. To increase properties of native collagen, such as stiffness or strain-stiffening, these networks can be modified by adding crosslinking agents that alter the network architecture, increasing the unions between filaments. In this work, we have investigated the effect of one crosslinking agent, transglutaminase, in collagen hydrogels with varying collagen concentration. We have observed a linear dependency of the gel rigidity on the collagen concentration. Moreover, the addition of transglutaminase has induced an earlier strain-stiffening of the collagen gels. In addition, to better understand the mechanical implications of collagen concentration and crosslinkers inclusion, we have adapted an existing computational model, based on the worm-like chain model (WLC), to reproduce the mechanical behavior of the collagen gels. With this model we can estimate the parameters of the biopolymer networks without more sophisticated techniques, such as image processing or network reconstruction, or, inversely, predict the mechanical properties of a defined collagen network.	[Valero, Clara; Manuel Garcia-Aznar, Jose] Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Mech Engn, M2BE, Zaragoza, Spain; [Amaveda, Hippolyte; Mora, Mario] Univ Zaragoza, Inst Ciencia Mat Aragon, CSIC, Dept Ciencia & Tecnol Mat & Fluidos, Zaragoza, Spain	University of Zaragoza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); University of Zaragoza	Valero, C (corresponding author), Univ Zaragoza, Aragon Inst Engn Res I3A, Dept Mech Engn, M2BE, Zaragoza, Spain.	claraval@unizar.es	Garcia-Aznar, Jose Manuel/F-8256-2010; Alfonso, Mario Juan Mora/K-9646-2015; Angurel, Luis Alberto/L-8491-2014; Valero, Clara/AAY-9640-2021	Garcia-Aznar, Jose Manuel/0000-0002-9864-7683; Alfonso, Mario Juan Mora/0000-0003-4747-7327; Angurel, Luis Alberto/0000-0001-5685-2366; Valero Lazaro, Clara/0000-0001-9318-7107; Amaveda Metonou, Hippolyte/0000-0003-2212-447X	European Research Council (ERC) [ERC-2012-StG 306571]; Spanish Ministry of Economy and Competitiveness [DPI2015-64221-C2-1-R]; Gobierno de Aragon (research group T86); Spanish Ministry of Economy and Competitiveness; European FEDER Program [ENE1014-52105-R]; Gobierno de Aragon (research group T12)	European Research Council (ERC)(European Research Council (ERC)European Commission); Spanish Ministry of Economy and Competitiveness(Spanish Government); Gobierno de Aragon (research group T86)(Gobierno de Aragon); Spanish Ministry of Economy and Competitiveness(Spanish Government); European FEDER Program(European Commission); Gobierno de Aragon (research group T12)	The work corresponding to C. Valero and J.M. Garcia-Aznar was supported by the European Research Council (ERC) through project ERC-2012-StG 306571 and the Spanish Ministry of Economy and Competitiveness through the project DPI2015-64221-C2-1-R and by the Gobierno de Aragon (research group T86). The work corresponding to H. Amaveda and M.Mora was supported by the Spanish Ministry of Economy and Competitiveness and the European FEDER Program (project ENE1014-52105-R) and by the Gobierno de Aragon (research group T12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUDA EM, 1993, J MECH PHYS SOLIDS, V41, P389, DOI 10.1016/0022-5096(93)90013-6; Aznar JMG, 2016, BIOMANUFACTURING REV, V1, P2, DOI DOI 10.1007/S40898-016-0002-1; Bishop C.M., 1995, NEURAL NETWORKS PATT; Broedersz CP, 2014, REV MOD PHYS, V86, P995, DOI 10.1103/RevModPhys.86.995; Broedersz CP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.238101; Broedersz CP, 2010, SOFT MATTER, V6, P4120, DOI 10.1039/c0sm00285b; Buehler MJ, 2007, BIOPHYS J, V93, P37, DOI 10.1529/biophysj.106.102616; Castro APG, 2016, J MATER SCI-MATER M, V27, DOI 10.1007/s10856-016-5688-3; Chau DYS, 2005, BIOMATERIALS, V26, P6518, DOI 10.1016/j.biomaterials.2005.04.017; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Cyron CJ, 2013, J COMPUT PHYS, V244, P236, DOI 10.1016/j.jcp.2012.10.025; Del Amo C, 2017, INTEGR BIOL-UK, V9, P339, DOI 10.1039/c7ib00022g; Del Amo C, 2016, J BIOMECH, V49, P1340, DOI 10.1016/j.jbiomech.2015.10.026; Depalle B, 2015, J MECH BEHAV BIOMED, V52, P1, DOI 10.1016/j.jmbbm.2014.07.008; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Doyle AD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9720; Doyle AD, 2013, CURR OPIN CELL BIOL, V25, P642, DOI 10.1016/j.ceb.2013.06.004; Ehrbar M, 2011, BIOPHYS J, V100, P284, DOI 10.1016/j.bpj.2010.11.082; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erler JT, 2009, CANCER CELL, V15, P35, DOI 10.1016/j.ccr.2008.11.012; Fortunati D, 2014, AMINO ACIDS, V46, P1751, DOI 10.1007/s00726-014-1732-0; Fratzl P, 2007, PROG MATER SCI, V52, P1263, DOI 10.1016/j.pmatsci.2007.06.001; Frauchiger DA, 2017, EUR CELLS MATER, V34, P271, DOI 10.22203/eCM.v034a17; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; Garijo N, 2014, COMPUT METHOD APPL M, V268, P437, DOI 10.1016/j.cma.2013.10.005; GREENBERG CS, 1991, FASEB J, V5, P3071, DOI 10.1096/fasebj.5.15.1683845; Holzapfel GA, 2014, J MECH BEHAV BIOMED, V38, P78, DOI 10.1016/j.jmbbm.2014.05.014; Islam MM, 2015, ACTA BIOMATER, V12, P70, DOI 10.1016/j.actbio.2014.10.035; Janmey PA, 2007, NAT MATER, V6, P48, DOI 10.1038/nmat1810; Jones CAR, 2014, SOFT MATTER, V10, P8855, DOI 10.1039/c4sm01772b; Kook YM, 2017, J TISSUE ENG, V8, DOI 10.1177/2041731417724640; Kuhl E, 2005, J MECH PHYS SOLIDS, V53, P1552, DOI 10.1016/j.jmps.2005.03.002; Kurniawan NA, 2012, BIOMACROMOLECULES, V13, P691, DOI 10.1021/bm2015812; Kwansa AL, 2016, BIOPHYS CHEM, V214, P1, DOI 10.1016/j.bpc.2016.04.001; Lee B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111896; Licup AJ, 2015, P NATL ACAD SCI USA, V112, P9573, DOI 10.1073/pnas.1504258112; Lin SM, 2015, MATERIALS, V8, P551, DOI 10.3390/ma8020551; MACKINTOSH FC, 1995, PHYS REV LETT, V75, P4425, DOI 10.1103/PhysRevLett.75.4425; Moreno-Arotzena O, 2015, ANN BIOMED ENG, V43, P3025, DOI 10.1007/s10439-015-1343-2; Moreno-Arotzena O, 2015, MATERIALS, V8, P1636, DOI 10.3390/ma8041636; Movilla N, 2017, BONE; Munster S, 2013, P NATL ACAD SCI USA, V110, P12197, DOI 10.1073/pnas.1222787110; Orban JM, 2004, J BIOMED MATER RES A, V68A, P756, DOI 10.1002/jbm.a.20110; Palmer JS, 2008, ACTA BIOMATER, V4, P597, DOI 10.1016/j.actbio.2007.12.007; Petrie RJ, 2012, J CELL SCI, V125, P5917, DOI 10.1242/jcs.093732; Piechocka IK, 2011, BIOMACROMOLECULES, V12, P2797, DOI 10.1021/bm200553x; Raab M, 2016, MATRIX RIGIDITY REGU; Reddy N, 2015, TRENDS BIOTECHNOL, V33, P362, DOI 10.1016/j.tibtech.2015.03.008; Rens R, 2016, J PHYS CHEM B, V120, P5831, DOI 10.1021/acs.jpcb.6b00259; Roeder BA, 2002, J BIOMECH ENG-T ASME, V124, P214, DOI 10.1115/1.1449904; Sanami M, 2016, J BIOMED MATER RES B, V104, P914, DOI 10.1002/jbm.b.33445; Schrader J, 2011, HEPATOLOGY, V53, P1192, DOI 10.1002/hep.24108; Sharma A, 2016, NAT PHYS, V12, P584, DOI [10.1038/nphys3628, 10.1038/NPHYS3628]; Sheu MT, 2001, BIOMATERIALS, V22, P1713, DOI 10.1016/S0142-9612(00)00315-X; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Stein AM, 2011, COMPLEXITY, V16, P22, DOI 10.1002/cplx.20332; Storm C, 2005, NATURE, V435, P191, DOI 10.1038/nature03521; Sunyer R, 2016, SCIENCE, V353, P1157, DOI 10.1126/science.aaf7119; Ulrich TA, 2010, BIOMATERIALS, V31, P1875, DOI 10.1016/j.biomaterials.2009.10.047; Umashankar P R, 2012, Toxicol Int, V19, P51, DOI 10.4103/0971-6580.94513; van Oosten ASG, 2016, SCI REP-UK, V6, DOI 10.1038/srep19270; Van Vlierberghe S, 2011, BIOMACROMOLECULES, V12, P1387, DOI 10.1021/bm200083n; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; von der Heydt A, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032701; Wells RG, 2008, HEPATOLOGY, V47, P1394, DOI 10.1002/hep.22193; Wen Q, 2012, SOFT MATTER, V8, P8039, DOI 10.1039/c2sm25364j; Yang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13710; Yang YL, 2009, BIOPHYS J, V97, P2051, DOI 10.1016/j.bpj.2009.07.035; Zeugolis DI, 2009, J BIOMED MATER RES A, V89A, P895, DOI 10.1002/jbm.a.32031	69	46	47	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195820	10.1371/journal.pone.0195820	http://dx.doi.org/10.1371/journal.pone.0195820			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664953	Green Published, gold			2022-12-26	WOS:000430262300035
J	Pasupa, K; Kudisthalert, W				Pasupa, Kitsuchart; Kudisthalert, Wasu			Virtual screening by a new Clustering-based Weighted Similarity Extreme Learning Machine approach	PLOS ONE			English	Article							BINARY KERNEL DISCRIMINATION; NETWORKS	Machine learning techniques are becoming popular in virtual screening tasks. One of the powerful machine learning algorithms is Extreme Learning Machine (ELM) which has been applied to many applications and has recently been applied to virtual screening. We propose the Weighted Similarity ELM (WS-ELM) which is based on a single layer feed-forward neural network in a conjunction of 16 different similarity coefficients as activation function in the hidden layer. It is known that the performance of conventional ELM is not robust due to random weight selection in the hidden layer. Thus, we propose a Clustering-based WS-ELM (CWS-ELM) that deterministically assigns weights by utilising clustering algorithms i.e. k-means clustering and support vector clustering. The experiments were conducted on one of the most challenging datasets-Maximum Unbiased Validation Dataset-which contains 17 activity classes carefully selected from PubChem. The proposed algorithms were then compared with other machine learning techniques such as support vector machine, random forest, and similarity searching. The results show that CWS-ELM in conjunction with support vector clustering yields the best performance when utilised together with Sokal/Sneath(1) coefficient. Furthermore, ECFP_6 fingerprint presents the best results in our framework compared to the other types of fingerprints, namely ECFP_4, FCFP_4, and FCFP_6.	[Pasupa, Kitsuchart; Kudisthalert, Wasu] King Mongkuts Inst Technol Ladkrabang, Fac Informat Technol, Bangkok 10520, Thailand	King Mongkuts Institute of Technology Ladkrabang	Pasupa, K (corresponding author), King Mongkuts Inst Technol Ladkrabang, Fac Informat Technol, Bangkok 10520, Thailand.	kitsuchart@it.kmitl.ac.th	Pasupa, Kitsuchart/ABB-2573-2020; Pasupa, Kitsuchart/A-8902-2010	Pasupa, Kitsuchart/0000-0001-8359-9888; Pasupa, Kitsuchart/0000-0001-8359-9888				Ben-Hur A, 2002, J MACH LEARN RES, V2, P125, DOI 10.1162/15324430260185565; Cao JW, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/103054; Certara LP, 2017, UNITY FINGERPRINTS; Chen BN, 2006, J CHEM INF MODEL, V46, P478, DOI 10.1021/ci0505426; Chorowski J, 2014, NEUROCOMPUTING, V128, P507, DOI 10.1016/j.neucom.2013.08.009; Czarnecki WM, 2015, IEEE COMPUT INTELL M, V10, P19, DOI 10.1109/MCI.2015.2437312; Daylight Chemical Information Systems Inc, 2017, DAYL FING; Digital Chemistry Ltd, 2017, BCI FING; Edgar SJ, 2000, J MOL GRAPH MODEL, V18, P343, DOI 10.1016/S1093-3263(00)00061-9; Ellis D, 1993, PERSPECTIVES INFORM, V3, P128; Gardiner EJ, 2011, FUTURE MED CHEM, V3, P405, DOI [10.4155/fmc.11.4, 10.4155/FMC.11.4]; Han LY, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-401; Holliday JD, 2002, COMB CHEM HIGH T SCR, V5, P155; Huang GB, 2004, IEEE IJCNN, P985; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Jain AN, 2008, J COMPUT AID MOL DES, V22, P133, DOI 10.1007/s10822-008-9196-5; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Kudisthalert W, 2016, LECT NOTES COMPUT SC, V9947, P441, DOI 10.1007/978-3-319-46687-3_49; Kudisthalert W, 2016, INT CONF KNOWL SMART, P43, DOI 10.1109/KST.2016.7440525; Kurczab R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175410; Lan Y, 2008, IEEE IJCNN, P1859, DOI 10.1109/IJCNN.2008.4634051; Leach A. R., 2007, INTRO CHEMOINFORMATI; Lima AN, 2016, EXPERT OPIN DRUG DIS, V11, P225, DOI 10.1517/17460441.2016.1146250; Muegge I., 2006, DRUG DISCOV TODAY-TE, V3, P405, DOI [10.1016/j.ddtec.2006.12.002, DOI 10.1016/j.ddtec.2006.12.002, DOI 10.1016/J.DDTEC.2006.12.002]; Myint KZ, 2012, MOL PHARMACEUT, V9, P2912, DOI 10.1021/mp300237z; Nicholls A, 2008, J COMPUT AID MOL DES, V22, P239, DOI 10.1007/s10822-008-9170-2; Pasupa K., 2013, 13 IEEE INT C BIOINF, P1, DOI [10.1109/BIBE.2013.6701529, DOI 10.1109/BIBE.2013.6701529]; Pasupa K, 2012, KMITL J INFORM TECHN, V1, P60; Patra BK, 2015, KNOWL-BASED SYST, V82, P163, DOI 10.1016/j.knosys.2015.03.001; Riniker S, 2013, J CHEMINFORMATICS, V5, DOI 10.1186/1758-2946-5-26; Rohrer SG, 2009, J CHEM INF MODEL, V49, P169, DOI 10.1021/ci8002649; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Truchon JF, 2007, J CHEM INF MODEL, V47, P488, DOI 10.1021/ci600426e; Wang G, NEUROCOMPUTING; Wilton DJ, 2006, J CHEM INF MODEL, V46, P471, DOI 10.1021/ci050397w; Xu D., 2015, ANN DATA SCI, V2, P165, DOI [10.1007/s40745-015-0040-1, DOI 10.1007/S40745-015-0040-1]	36	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195478	10.1371/journal.pone.0195478	http://dx.doi.org/10.1371/journal.pone.0195478			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652912	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900023
J	Chae, MS; Moon, KU; Chung, HS; Park, CS; Lee, J; Choi, JH; Hong, SH				Chae, Min Suk; Moon, Kwang Uck; Chung, Hyun Sik; Park, Chul Soo; Lee, Jaemin; Choi, Jong Ho; Hong, Sang Hyun			Serum interleukin-6 and tumor necrosis factor-alpha are associated with early graft regeneration after living donor liver transplantation	PLOS ONE			English	Article							PARTIAL-HEPATECTOMY; INFLAMMATORY RESPONSE; ACUTE REJECTION; MICE; CYTOKINES; FAILURE; DISEASE; PROLIFERATION; METAANALYSIS; DYSFUNCTION	Background Liver graft regeneration is orchestrated by specific and sequential stimuli, including hepatocyte growth factors, cytokines, and catecholamines. We evaluated the association between preoperative serum cytokines and early liver graft regeneration in human living donor liver transplantation (LDLT). Patients and methods We retrospectively reviewed the data of adult patients who underwent LDLT from January 2010 to December 2014. Serum cytokines, including interleukin (IL)-2, 6, 10, 12, 17, interferon (IFN)-gamma and tumor necrosis factor (TNF)-alpha were measured in the recipients 1 day before surgery and on postoperative day (POD) 7. Liver graft volume was estimated using abdominal computed tomography images of the donors and recipients. Results In total, 226 patients were analyzed in this study. Median preoperative levels of serum cytokines were as follows: IL-2, 0.1 (0.1-1.6) pg/mL; IL-6, 7.3 (0.1-30.2) pg/mL; IL-10, 0.5 (0.111.0) pg/mL; IL-12, 0.1 (0.1-0.1) pg/mL; IL-17, 2.0 (0.1-16.4) pg/mL; IFN-gamma, 3.2 (0.1-16.0) pg/mL; and TNF-alpha, 9.8 (5.4-17.9) pg/mL. Higher preoperative serum levels of IL-6, IL-10, and TNF-alpha, dichotomized at the median, were associated with increased relative liver volumes by POD 7. Multivariate analysis revealed that higher levels of serum IL-6 and TNF-alpha were independently associated with increased graft volume during the first 1 week after LDLT, based on the lower levels of those cytokines. Conclusions IL-6 and TNF-alpha were important mediators of the success of early graft regeneration in patients who underwent LDLT.	[Chae, Min Suk; Moon, Kwang Uck; Chung, Hyun Sik; Park, Chul Soo; Lee, Jaemin; Choi, Jong Ho; Hong, Sang Hyun] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Hong, SH (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Seoul, South Korea.	shhong7272@gmail.com		Hong, Sang Hyun/0000-0002-7091-8963; Chung, Hyun Sik/0000-0001-7527-1866				BELLOMO R, 1993, CRIT CARE MED, V21, P522, DOI 10.1097/00003246-199304000-00011; BELLOMO R, 1995, RENAL FAILURE, V17, P457, DOI 10.3109/08860229509037609; Blindenbacher A, 2003, HEPATOLOGY, V38, P674, DOI 10.1053/jhep.2003.50378; Brown RS, 2002, LIVER TRANSPLANT, V8, P278, DOI 10.1053/jlts.2002.31340; Cazzaniga M, 2009, J HEPATOL, V51, P475, DOI 10.1016/j.jhep.2009.04.017; Chae MS, 2017, ANN TRANSPL, V22, P83, DOI 10.12659/AOT.902103; Cressman DE, 1996, SCIENCE, V274, P1379, DOI 10.1126/science.274.5291.1379; Demetris AJ, 1997, HEPATOLOGY, V25, P658; DIEHL AM, 1994, AM J PHYSIOL-GASTR L, V267, pG552, DOI 10.1152/ajpgi.1994.267.4.G552; Fabrega E, 2009, LIVER TRANSPLANT, V15, P629, DOI 10.1002/lt.21724; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Grenz A, 2000, CLIN CHEM LAB MED, V38, P1183, DOI 10.1515/CCLM.2000.184; Heinemann A, 1999, LIVER TRANSPLANT SUR, V5, P366, DOI 10.1002/lt.500050516; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Kamath PS, 2007, HEPATOLOGY, V45, P797, DOI 10.1002/hep.21563; Karakhanova S, 2016, TRANSPL IMMUNOL, V34, P14, DOI 10.1016/j.trim.2015.12.001; Karimi MH, 2011, MOL BIOL REP, V38, P4437, DOI 10.1007/s11033-010-0572-6; Kim SJ, 2012, J GASTROINTEST SURG, V16, P1160, DOI 10.1007/s11605-012-1865-y; Kitaoka S, 2003, HEPATO-GASTROENTEROL, V50, P1569; Kiuchi T, 2003, LIVER TRANSPLANT, V9, pS29, DOI 10.1053/jlts.2003.50198; KUMA S, 1990, IMMUNOBIOLOGY, V180, P235, DOI 10.1016/S0171-2985(11)80331-1; Le Moine O, 2000, HEPATOLOGY, V31, P1266, DOI 10.1053/jhep.2000.7881; LEMOINE O, 1994, HEPATOLOGY, V20, P889; Levy DE, 2002, J CLIN INVEST, V109, P1143, DOI 10.1172/JCI200215650; Marcos A, 2000, TRANSPLANTATION, V69, P1375, DOI 10.1097/00007890-200004150-00028; Matsushita T, 1999, INT IMMUNOL, V11, P657, DOI 10.1093/intimm/11.5.657; Na GH, 2016, HPB, V18, P98, DOI 10.1016/j.hpb.2015.08.008; Nishizaki T, 2001, ANN SURG, V233, P575, DOI 10.1097/00000658-200104000-00014; OHZATO H, 1993, SURG TODAY, V23, P521, DOI 10.1007/BF00730628; Olthoff KM, 2015, LIVER TRANSPLANT, V21, P79, DOI 10.1002/lt.23966; Olthoff KM, 2003, LIVER TRANSPLANT, V9, pS35, DOI 10.1053/jlts.2003.50229; Peng YZ, 2005, BURNS, V31, P623, DOI 10.1016/j.burns.2005.02.004; Rattanasiri S, 2013, TRANSPL IMMUNOL, V28, P62, DOI 10.1016/j.trim.2012.10.003; Sasturkar SV, 2016, LIVER TRANSPLANT, V22, P344, DOI 10.1002/lt.24373; Selzner N, 2003, GASTROENTEROLOGY, V124, P692, DOI 10.1053/gast.2003.50098; Streetz KL, 2000, GUT, V47, P309, DOI 10.1136/gut.47.2.309; Tarakcioglu M, 2003, MEDIAT INFLAMM, V12, P15, DOI 10.1080/0962935031000096935; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Thai N L, 1997, Liver Transpl Surg, V3, P118, DOI 10.1002/lt.500030204; van den Broek MAJ, 2008, LIVER INT, V28, P767, DOI 10.1111/j.1478-3231.2008.01777.x; Wieckowska A, 2008, AM J GASTROENTEROL, V103, P1372, DOI 10.1111/j.1572-0241.2007.01774.x; Yagi S, 2005, LIVER TRANSPLANT, V11, P68, DOI 10.1002/lt.20317; Yamada Y, 1997, P NATL ACAD SCI USA, V94, P1441, DOI 10.1073/pnas.94.4.1441; Yin S, 2011, AM J PATHOL, V178, P1614, DOI 10.1016/j.ajpath.2011.01.001; Zhang JM, 2007, INT ANESTHESIOL CLIN, V45, P27, DOI 10.1097/AIA.0b013e318034194e; Zhang Y, 2017, ANN MED, V49, P365, DOI 10.1080/07853890.2016.1257862	47	17	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195262	10.1371/journal.pone.0195262	http://dx.doi.org/10.1371/journal.pone.0195262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649247	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900035
J	Van Meulebroek, L; Wauters, J; Pomian, B; Bussche, JV; Delahaut, P; Fichant, E; Vanhaecke, L				Van Meulebroek, Lieven; Wauters, Jella; Pomian, Beata; Bussche, Julie Vanden; Delahaut, Philippe; Fichant, Eric; Vanhaecke, Lynn			Discovery of urinary biomarkers to discriminate between exogenous and semi-endogenous thiouracil in cattle: A parallel-like randomized design	PLOS ONE			English	Article							MASS-SPECTRA; IDENTIFICATION; VALIDATION; LIVESTOCK	In the European Union, the use of thyreostats for animal fattening purposes has been banned and monitoring plans have been established to detect potential abuse. However, this is not always straightforward as thyreostats such as thiouracil may also have a semi-endogenous origin. Therefore, this study aimed at defining urinary metabolites, which may aid in defining the origin of detected thiouracil. Hereto, a parallel-like randomized in vivo study was conducted in which calves (n = 8) and cows (n = 8) were subjected to either a control treatment, rapeseed-enriched diet to induce semi-endogenous formation, or thiouracil treatment. Urine samples (n = 330) were assessed through metabolic fingerprinting, employing liquid chromatography and Q-Exactive (TM) Orbitrap mass spectrometry. Urinary fingerprints comprised up to 40,000 features whereby multivariate discriminant analysis was able to point out significant metabolome differences between treatments (Q(2)(Y) >= 0.873). Using the validated models, a total of twelve metabolites (including thiouracil) were assigned marker potential. Combining these markers into age-dependent biomarker panels rendered a tool by which sample classification could be improved in comparison with thiouracil-based thresholds, and this during on-going thiouracil treatment (specificities >= 95.2% and sensitivities >= 85.7%), post-treatment (sensitivities >= 80% for >= 24 h after last administration), and simulated low-dose thiouracil treatment (exogenous thiouracil below 30 ng mu L-1). Moreover, the metabolic relevance of revealed markers was supported by the suggested identities, for which a structural link with thiouracil could be determined in most cases. The proposed biomarker panels may contribute to a more justified decision-making in monitoring thiouracil abuse.	[Van Meulebroek, Lieven; Wauters, Jella; Pomian, Beata; Bussche, Julie Vanden; Vanhaecke, Lynn] Univ Ghent, Chem Anal Lab, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Salisburylaan, Merelbeke, Belgium; [Delahaut, Philippe; Fichant, Eric] CER Grp, Dept Hlth, Rue Point Jour, Marloie, Belgium	Ghent University	Van Meulebroek, L (corresponding author), Univ Ghent, Chem Anal Lab, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Salisburylaan, Merelbeke, Belgium.	lieven.vanmeulenbroek@ugent.be	Delahaut, Philippe/ABC-8350-2021; Vanhaecke, Lynn/N-1061-2017	Vanhaecke, Lynn/0000-0003-0400-2188; Delahaut, Philippe/0000-0003-2328-3042; Wauters, Jella/0000-0002-7046-1764	Federal Public Service Health [RF 12/6260]	Federal Public Service Health	This work was supported by Federal Public Service Health (RF 12/6260); URL https://www.health.belgium.be/en. LVM, JW, and JVB received the funding. The funders contributed to this project with regard to the study design and supervision. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Anizan S, 2012, J MASS SPECTROM, V47, P131, DOI 10.1002/jms.2035; Batjoens P, 1996, J CHROMATOGR A, V750, P127, DOI 10.1016/0021-9673(96)00406-2; Bussche JV, 2012, ANAL BIOANAL CHEM, V403, P2973, DOI 10.1007/s00216-012-5739-7; Bussche JV, 2011, FOOD ADDIT CONTAM A, V28, P166, DOI 10.1080/19440049.2010.544681; Bussche JV, 2010, J CHROMATOGR A, V1217, P4285, DOI 10.1016/j.chroma.2010.04.030; Bussche JV, 2011, J AGR FOOD CHEM, V59, P5786, DOI 10.1021/jf200556x; Cho HW, 2008, INT J DATA MIN BIOIN, V2, P176, DOI 10.1504/IJDMB.2008.019097; De Clercq N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-015-0887-3; DEBRABANDER HF, 1984, TRAC-TREND ANAL CHEM, V3, P162, DOI 10.1016/0165-9936(84)88011-5; Dervilly-Pinel G, 2015, METABOLOMICS, V11, P403, DOI 10.1007/s11306-014-0705-3; Dervilly-Pinel G, 2011, ANAL CHIM ACTA, V700, P144, DOI 10.1016/j.aca.2011.02.008; Duhrkop K, 2015, P NATL ACAD SCI USA, V112, P12580, DOI 10.1073/pnas.1509788112; EFSA . (European Food Safety Authority) and RIVM (the Dutch National Institute for Public health and the Environment), 2015, EFSA J, V12, P1, DOI DOI 10.2903/SP.EFSA.2015.EN-824; Egli CP, 1998, J VET MED A, V45, P99, DOI 10.1111/j.1439-0442.1998.tb00806.x; Eriksson L, 2008, J CHEMOMETR, V22, P594, DOI 10.1002/cem.1187; *EUR COMM, 1981, OFFICIAL J EUROPEA L, V222, P32; Frolkis A, 2010, NUCLEIC ACIDS RES, V38, pD480, DOI 10.1093/nar/gkp1002; Hardikar W, 2003, MED PHYSL, P975; Hawkins DM, 2003, J CHEM INF COMP SCI, V43, P579, DOI 10.1021/ci025626i; International Agency for Research on Cancer, IARC MONOGRAPHS EVAL; Kiebooms JAL, 2012, J AGR FOOD CHEM, V60, P7769, DOI 10.1021/jf3017145; Laparre J, 2017, ANAL CHIM ACTA, V951, P99, DOI 10.1016/j.aca.2016.11.055; Le Bizec B, 2011, FOOD ADDIT CONTAM A, V28, P840, DOI 10.1080/19440049.2011.565483; Melanie Spornraft, 2015, Biomol Detect Quantif, V5, P15, DOI 10.1016/j.bdq.2015.08.001; Pinel G, 2006, FOOD ADDIT CONTAM A, V23, P974, DOI 10.1080/02652030600806370; Pluskal T, 2012, ANAL CHEM, V84, P4396, DOI 10.1021/ac3000418; Ridder L, 2012, RAPID COMMUN MASS SP, V26, P2461, DOI 10.1002/rcm.6364; Scarth JP, 2010, CHROMATOGRAPHIA, V72, P297, DOI 10.1365/s10337-010-1652-4; Shankar BP, 2010, VET WORLD, V3, P241, DOI 10.5455/vetworld.2010.241-246; Sterk S. S., 2014, EURL REFLECTION PAPE, P1; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Theodoridis GA, 2012, ANAL CHIM ACTA, V711, P7, DOI 10.1016/j.aca.2011.09.042; Trygg J, 2007, J PROTEOME RES, V6, P469, DOI 10.1021/pr060594q; Wager S, 2013, RANDOM FORESTS, V15, P1625, DOI [10.1016/j.surg.2006.10.010, DOI 10.1016/J.SURG.2006.10.010]; Wauters J, 2017, J AGR FOOD CHEM, V65, P6231, DOI 10.1021/acs.jafc.7b01920; Wauters J, 2015, J AGR FOOD CHEM, V63, P1339, DOI 10.1021/jf504475f; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510; Wozniak B, 2012, B VET I PULAWY, V56, P611, DOI 10.2478/v10213-012-0108-z; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xie GX, 2008, METABOLOMICS, V4, P248, DOI 10.1007/s11306-008-0115-5	40	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195351	10.1371/journal.pone.0195351	http://dx.doi.org/10.1371/journal.pone.0195351			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649241	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900039
J	Gnimassou, O; Fernandez-Verdejo, R; Brook, M; Naslain, D; Balan, E; Sayda, M; Cegielski, J; Nielens, H; Decottignies, A; Demoulin, JB; Smith, K; Atherton, PJ; Francaux, M; Deldicque, L				Gnimassou, Olouyomi; Fernandez-Verdejo, Rodrigo; Brook, Matthew; Naslain, Damien; Balan, Estelle; Sayda, Mariwan; Cegielski, Jessica; Nielens, Henri; Decottignies, Anabelle; Demoulin, Jean-Baptiste; Smith, Kenneth; Atherton, Philip J.; Francaux, Marc; Deldicque, Louise			Environmental hypoxia favors myoblast differentiation and fast phenotype but blunts activation of protein synthesis after resistance exercise in human skeletal muscle	FASEB JOURNAL			English	Article						hypoxia-inducible factor; deuterium; autophagy; redd1; tissue oxygenation index	BLOOD-FLOW RESTRICTION; UBIQUITIN LIGASES; SATELLITE CELL; HYPERTROPHY; ADAPTATIONS; ALTITUDE; INSULIN; PHOSPHORYLATION; TRANSCRIPTION; MYOGENESIS	We hypothesized that a single session of resistance exercise performed in moderate hypoxic (FiO(2): 14%) environmental conditions would potentiate the anabolic response during the recovery period spent in normoxia. Twenty subjects performed a 1-leg knee extension session in normoxic or hypoxic conditions. Muscle biopsies were taken 15 min and 4 h after exercise in the vastus lateralis of the exercised and the nonexercised legs. Blood and saliva samples were taken at regular intervals before, during, and after the exercise session. The muscle fractional-protein synthetic rate was determined by deuterium incorporation into proteins, and the protein-degradation rate was determined by methylhistidine release from skeletal muscle. We found that: 1) hypoxia blunted the activation of protein synthesis after resistance exercise; 2) hypoxia down-regulated the transcriptional program of autophagy; 3) hypoxia regulated the expression of genes involved in glucose metabolism at rest and the genes involved in myoblast differentiation and fusion and in muscle contraction machinery after exercise; and 4) the hypoxia-inducible factor-1 pathway was not activated at the time points studied. Contrary to our hypothesis, environmental hypoxia did not potentiate the short-term anabolic response after resistance exercise, but it initiated transcriptional regulations that could potentially translate into satellite cell incorporation and higher force production in the long term.Gnimassou, O., Fernandez-Verdejo, R., Brook, M., Naslain, D., Balan, E., Sayda, M., Cegielski, J., Nielens, H., Decottignies, A., Demoulin, J.-B., Smith, K., Atherton, P. J., Fancaux, M., Deldicque, L. Environmental hypoxia favors myoblast differentiation and fast phenotype but blunts activation of protein synthesis after resistance exercise in human skeletal muscle.	[Gnimassou, Olouyomi; Fernandez-Verdejo, Rodrigo; Naslain, Damien; Balan, Estelle; Nielens, Henri; Francaux, Marc; Deldicque, Louise] Catholic Univ Louvain, Inst Neurosci, Pl Pierre Coubertin,1 Box L08-10-01, B-1348 Louvain, Belgium; [Fernandez-Verdejo, Rodrigo] Pontificia Univ Catolica Chile, Fac Med, Dept Ciencias Salud, Carrera Nutr & Dietet, Santiago, Chile; [Brook, Matthew; Sayda, Mariwan; Cegielski, Jessica; Smith, Kenneth; Atherton, Philip J.] Univ Nottingham, Med Res Council, Arthrit Res UK Ctr Excellence Musculoskeletal Age, Derby, England; [Brook, Matthew; Sayda, Mariwan; Cegielski, Jessica; Smith, Kenneth; Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp, Clin Metab & Mol Physiol, Derby, England; [Decottignies, Anabelle; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Brussels, Belgium	Universite Catholique Louvain; Pontificia Universidad Catolica de Chile; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Nottingham; University of Nottingham; Universite Catholique Louvain	Deldicque, L (corresponding author), Catholic Univ Louvain, Inst Neurosci, Pl Pierre Coubertin,1 Box L08-10-01, B-1348 Louvain, Belgium.	louise.deldicque@uclouvain.be	Brook, Matthew/W-4689-2019	Fernandez-Verdejo, Rodrigo/0000-0002-5948-2281; Atherton, Philip/0000-0002-7286-046X; Brook, Matthew/0000-0002-9245-3095; Deldicque, Louise/0000-0003-3393-5278	Fonds National de la Recherche Scientifique [J.0050.16]; Agence Francaise de Lutte contre le Dopage; Sports Ministry of the Brussels-Wallonia Federation	Fonds National de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Agence Francaise de Lutte contre le Dopage; Sports Ministry of the Brussels-Wallonia Federation	The authors thank the participants and Adelie Jadot (Institute of Neuroscience, Universite Catholique de Louvain) for technical assistance and organization of the experiments. This work was supported by the Fonds National de la Recherche Scientifique (Grant J.0050.16) and by the Agence Francaise de Lutte contre le Dopage. M.F. was supported by the Sports Ministry of the Brussels-Wallonia Federation. Data collection took place at Universite Catholique de Louvain, and data analyses took place at Universite Catholique de Louvain and the University of Nottingham. The authors declare no conflicts of interest.	Ameln H, 2005, FASEB J, V19, P1009, DOI 10.1096/fj.04-2304fje; Baldi Simonetta, 2010, Int J Chron Obstruct Pulmon Dis, V5, P29; Beall CM, 2013, AM J HUM BIOL, V25, P141, DOI 10.1002/ajhb.22355; Beaudry M, 2016, J CELL SCI, V129, P2887, DOI 10.1242/jcs.188904; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Brocherie F, 2015, MED SCI SPORT EXER, V47, P2140, DOI 10.1249/MSS.0000000000000630; BROOKS GA, 1991, J APPL PHYSIOL, V70, P919, DOI 10.1152/jappl.1991.70.2.919; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chaillou T, 2016, FASEB J, V30, P3929, DOI 10.1096/fj.201600757R; Chaudhary P, 2012, AVIAT SPACE ENVIR MD, V83, P1037, DOI 10.3357/ASEM.3278.2012; D'Hulst G, 2013, ACTA PHYSIOL, V208, P251, DOI 10.1111/apha.12086; D'Hulst G, 2017, J APPL PHYSIOL, V122, P406, DOI 10.1152/japplphysiol.00264.2016; D'Hulst G, 2015, EUR J APPL PHYSIOL, V115, P1219, DOI 10.1007/s00421-015-3103-2; Doria C, 2011, J APPL PHYSIOL, V111, P1597, DOI 10.1152/japplphysiol.01439.2010; Etheridge T, 2011, AM J PHYSIOL-ENDOC M, V301, pE697, DOI 10.1152/ajpendo.00276.2011; Flueck M, 2009, HIGH ALT MED BIOL, V10, P183, DOI 10.1089/ham.2008.1104; Francaux M., 2013, CELL MOL EXERC PHYSL, V2, pE5; Fujita S, 2007, J APPL PHYSIOL, V103, P903, DOI 10.1152/japplphysiol.00195.2007; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Greenhaff PL, 2008, AM J PHYSIOL-ENDOC M, V295, pE595, DOI 10.1152/ajpendo.90411.2008; Greer SN, 2012, EMBO J, V31, P2448, DOI 10.1038/emboj.2012.125; Gundermann DM, 2014, AM J PHYSIOL-ENDOC M, V306, pE1198, DOI 10.1152/ajpendo.00600.2013; HOPPELER H, 1990, INT J SPORTS MED, V11, pS3, DOI 10.1055/s-2007-1024846; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Koumenis C, 2006, MOL CANCER RES, V4, P423, DOI 10.1158/1541-7786.MCR-06-0150; Kurobe K, 2015, CLIN PHYSIOL FUNCT I, V35, P197, DOI 10.1111/cpf.12147; Lee WH, 2009, MOL CANCER THER, V8, P2791, DOI 10.1158/1535-7163.MCT-09-0420; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; MACDOUGALL JD, 1991, ACTA PHYSIOL SCAND, V142, P421, DOI 10.1111/j.1748-1716.1991.tb09176.x; Manimmanakorn A, 2013, EUR J APPL PHYSIOL, V113, P1767, DOI 10.1007/s00421-013-2605-z; Masschelein E, 2014, FASEB J, V28, P1022, DOI 10.1096/fj.13-239863; McGee SL, 2010, CLIN SCI, V118, P507, DOI 10.1042/CS20090533; Mizuno M, 2008, HIGH ALT MED BIOL, V9, P311, DOI 10.1089/ham.2008.1009; Nishimura A, 2010, INT J SPORT PHYSIOL, V5, P497, DOI 10.1123/ijspp.5.4.497; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Santos JL, 2001, NUTRITION, V17, P305, DOI 10.1016/S0899-9007(00)00551-7; Sheffield-Moore M, 2014, J CACHEXIA SARCOPENI, V5, P19, DOI 10.1007/s13539-013-0117-7; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; Wilkinson D. J., 2015, PHYSL REP, V3, P3; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zanou N, 2013, CELL MOL LIFE SCI, V70, P4117, DOI 10.1007/s00018-013-1330-4; Zoll J, 2006, J APPL PHYSIOL, V100, P1258, DOI 10.1152/japplphysiol.00359.2005	46	15	15	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5272	5284		10.1096/fj.201800049RR	http://dx.doi.org/10.1096/fj.201800049RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29672220	Green Submitted, Bronze			2022-12-26	WOS:000447972500007
J	Vaniotis, G; Rayes, RF; Qi, S; Milette, S; Wang, N; Perrino, S; Bourdeau, F; Nystrom, H; He, Y; Lamarche-Vane, N; Brodt, P				Vaniotis, George; Rayes, Roni F.; Qi, Shu; Milette, Simon; Wang, Ni; Perrino, Stephanie; Bourdeau, France; Nystrom, Hanna; He, Yi; Lamarche-Vane, Nathalie; Brodt, Pnina			Collagen IV-conveyed signals can regulate chemokine production and promote liver metastasis	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; NF-KAPPA-B; COLON-CANCER; CARCINOMA-CELLS; PATHWAYS; MICROENVIRONMENT; EXPRESSION; CROSSTALK; INVASION; 3-KINASE/AKT	Liver metastases remain a major cause of death from gastrointestinal tract cancers as well as from other malignancies such as breast and lung carcinomas and melanoma. Understanding the underlying biology is essential for the design of effective targeted therapies. We previously reported that collagen IV alpha 1/alpha 2 overexpression in non-metastatic lung carcinoma (M27(colIV)) cells increased their metastatic ability, specifically to the liver and documented high collagen IV levels in surgical resections of liver metastases from diverse tumor types. Here, we aimed to elucidate the functional relevance of collagen IV to metastatic outgrowth in the liver. Gene expression profiling revealed in M27(colIV) cells significant increases in the expression of chemokines CCL5 (5.7-fold) and CCL7 (2.6-fold) relative to wild-type cells, and this was validated by qPCR and western blotting. Similarly, in human colon carcinoma KM12C and KM12SM cells with divergent liver-colonizing potentials, CCL7 and CCL5 production correlated with type IV collagen expression and the metastatic phenotype. CCL7 silencing by short hairpin RNA (shRNA) reduced experimental liver metastasis in both cell types, whereas CCL5 silencing reduced metastasis of M27(colIV) cells, implicating these cytokines in metastatic expansion in the liver. Subsequent functional analyses implicated both MEK/ERK and PI3K signaling upstream of CCL7 upregulation and identified CCL7 (but not CCL5) as a critical migration/invasion factor, acting via the chemokine receptor CCR3. Chemokine CCL5 was identified as a regulator of the T-cell immune response in the liver. Loss of CCL7 in KM12SM cells was also associated with altered E-cadherin and reduced vimentin and Snail expression, implicating it in epithelial-to-mesenchymal transition in these cells. Moreover, in clinical specimens of colon cancer liver metastases analyzed by immunohistochemistry, CCL5 and CCL7 levels paralleled those of collagen IV. The results identify the chemokines CCL5 and CCL7 as type IV collagen-regulated genes that promote liver metastasis by distinct and complementary mechanisms.	[Vaniotis, George; Rayes, Roni F.; Qi, Shu; Wang, Ni; Perrino, Stephanie; Bourdeau, France; Brodt, Pnina] McGill Univ, Ctr Hlth, Dept Surg, Res Inst, Montreal, PQ, Canada; [Milette, Simon; Brodt, Pnina] McGill Univ, Ctr Hlth, Med & Res Inst, Montreal, PQ, Canada; [Nystrom, Hanna] Umea Univ, Dept Surg, Dept Surg & Perioperat Sci, Umea, Sweden; [He, Yi; Lamarche-Vane, Nathalie] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada; [He, Yi; Lamarche-Vane, Nathalie] McGill Univ, Ctr Hlth, Montreal, PQ, Canada; [He, Yi; Lamarche-Vane, Nathalie; Brodt, Pnina] McGill Univ, Ctr Hlth, Canc Res Program, Res Inst, Montreal, PQ, Canada; [Brodt, Pnina] McGill Univ, Ctr Hlth, Res Inst, Dept Oncol, Montreal, PQ, Canada	McGill University; McGill University; Umea University; McGill University; McGill University; McGill University; McGill University	Brodt, P (corresponding author), McGill Univ, Ctr Hlth, Dept Surg, Res Inst, Montreal, PQ, Canada.; Brodt, P (corresponding author), McGill Univ, Ctr Hlth, Med & Res Inst, Montreal, PQ, Canada.; Brodt, P (corresponding author), McGill Univ, Ctr Hlth, Canc Res Program, Res Inst, Montreal, PQ, Canada.; Brodt, P (corresponding author), McGill Univ, Ctr Hlth, Res Inst, Dept Oncol, Montreal, PQ, Canada.	pnina.brodt@mcgill.ca	Nystrom, Hanna/AAK-4743-2021	Rayes, Roni/0000-0001-7508-020X	Canadian Institute for Health Research [MOP 80201]; Quebec Ministere de l'Economie, de l'Innovation et des Exportations [PSR-SIIRI-843]; Swedish Research Council; Vasterbotten County Council; Henry R. Shibata fellowship from the Cedars Cancer Institute; MITACS	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Quebec Ministere de l'Economie, de l'Innovation et des Exportations; Swedish Research Council(Swedish Research CouncilEuropean Commission); Vasterbotten County Council; Henry R. Shibata fellowship from the Cedars Cancer Institute; MITACS	We thank Dr. Julia Burnier for the initial analysis of the microarray data, Ms. Anette Berglund for skillful technical assistance with immunohistochemistry, and the laboratory of Dr. Jean-Jacques Lebrun for help and advice. This work was supported mainly by grants MOP 80201 from the Canadian Institute for Health Research and a PSR-SIIRI-843 grant from the Quebec Ministere de l'Economie, de l'Innovation et des Exportations (to P.B.) and also by grants from the Swedish Research Council and Vasterbotten County Council (to H.N.). R.F.R. was supported by the Henry R. Shibata fellowship from the Cedars Cancer Institute. R.F.R. and G.V. were supported by MITACS internships.	Akram IG, 2016, TUMOR BIOL, V37, P2461, DOI 10.1007/s13277-015-4089-4; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Brodt P, 2001, J BIOL CHEM, V276, P33608, DOI 10.1074/jbc.M102754200; Brodt P, 2016, CLIN CANCER RES, V22, P5971, DOI 10.1158/1078-0432.CCR-16-0460; Brunner PM, 2015, EXP DERMATOL, V24, P522, DOI 10.1111/exd.12709; Burnier JV, 2011, ONCOGENE, V30, P3766, DOI 10.1038/onc.2011.89; Cambien B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028842; Chang LY, 2012, CANCER RES, V72, P1092, DOI 10.1158/0008-5472.CAN-11-2493; Cho YB, 2012, ONCOL REP, V28, P689, DOI 10.3892/or.2012.1815; Eefsen RL, 2012, J ONCOL, V2012, DOI 10.1155/2012/907971; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Fidler IJ, 2008, LANCET ONCOL, V9, P808, DOI 10.1016/S1470-2045(08)70201-8; Frentzas S, 2016, NAT MED, V22, P1294, DOI 10.1038/nm.4197; Goos JACM, 2016, ONCOTARGET, V7, P2123, DOI 10.18632/oncotarget.6188; Guan XM, 2015, ACTA PHARM SIN B, V5, P402, DOI 10.1016/j.apsb.2015.07.005; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Hirai H, 2014, CLIN EXP METASTAS, V31, P977, DOI 10.1007/s10585-014-9684-z; Hoyer Morten, 2011, Clin Epidemiol, V3 Suppl 1, P11, DOI 10.2147/CLEP.S20613; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Jung DW, 2010, INT J CANCER, V127, P332, DOI 10.1002/ijc.25060; Kim SH, 2011, J ENDOCRINOL, V209, P139, DOI 10.1530/JOE-10-0377; KITADAI Y, 1995, AM J PATHOL, V147, P1238; Lee YS, 2016, ONCOTARGET, V7, P36842, DOI 10.18632/oncotarget.9209; Li S, 2015, GROWTH HORM IGF RES, V25, P253, DOI 10.1016/j.ghir.2015.07.008; Luo J, 2015, ONCOTARGET, V6, P27555, DOI 10.18632/oncotarget.4515; Yamada M, 2008, CLIN CANCER RES, V14, P2351, DOI 10.1158/1078-0432.CCR-07-4499; Moreno-Layseca P, 2014, MATRIX BIOL, V34, P144, DOI 10.1016/j.matbio.2013.10.011; MORIKAWA K, 1988, CANCER RES, V48, P6863; Mrowietz U, 1999, BRIT J CANCER, V79, P1025, DOI 10.1038/sj.bjc.6690164; Nystrom H, 2015, TUMOR BIOL, V36, P9839, DOI 10.1007/s13277-015-3729-z; PAGET S, 1989, CANCER METAST REV, V8, P98; Proudfoot AEI, 2015, CYTOKINE, V74, P259, DOI 10.1016/j.cyto.2015.02.011; Samani AA, 2004, CANCER RES, V64, P3380, DOI 10.1158/0008-5472.CAN-03-3780; Samani AA, 2007, ENDOCR REV, V28, P20, DOI 10.1210/er.2006-0001; Shen XJ, 2016, ONCOL LETT, V12, P3250, DOI 10.3892/ol.2016.5122; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Stormes KA, 2005, BREAST CANCER RES TR, V89, P209, DOI 10.1007/s10549-004-5328-3; Struyf S, 2001, EUR J IMMUNOL, V31, P2170, DOI 10.1002/1521-4141(200107)31:7<2170::AID-IMMU2170>3.0.CO;2-D; Su BX, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-206; Turdean S, 2012, ACTA MED MARISIENSIS, V58, P254; Van den Eynden GG, 2014, CLIN CANCER RES, V20, P5140, DOI 10.1158/1078-0432.CCR-14-0158; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931; Vellinga TT, 2016, ONCOGENE, V35, P5263, DOI 10.1038/onc.2016.60; Yoshimura K, 2009, CANCER RES, V69, P7320, DOI 10.1158/0008-5472.CAN-09-0315; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197	46	26	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3790	3805		10.1038/s41388-018-0242-z	http://dx.doi.org/10.1038/s41388-018-0242-z			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29651051				2022-12-26	WOS:000438465600003
J	Papizan, JB; Vidal, AH; Bezprozvannaya, S; Bassel-Duby, R; Olson, EN				Papizan, James B.; Vidal, Alexander H.; Bezprozvannaya, Svetlana; Bassel-Duby, Rhonda; Olson, Eric N.			Cullin-3-RING ubiquitin ligase activity is required for striated muscle function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						E3 ubiquitin ligase; proteostasis; cardiomyopathy; cardiac metabolism; skeletal muscle; Cullin-3; muscle damage; myopathy; protein degradation	RECESSIVE NEMALINE MYOPATHY; SPINAL MUSCULAR-ATROPHY; MYOFIBRILLAR MYOPATHY; CYCLIN-E; PROTEIN; PROTEOSTASIS; MUTATIONS; GENE; IDENTIFICATION; DEGRADATION	Control of protein homeostasis is an essential cellular process that, when perturbed, can result in the deregulation or toxic accumulation of proteins. Owing to constant mechanical stress, striated muscle proteins are particularly prone to wear and tear and require several protein quality-control mechanisms to coordinate protein turnover and removal of damaged proteins. Kelch-like proteins, substrate adapters for the Cullin-3 (Cul3)-RING ligase (CRL3) complex, are emerging as critical regulators of striated muscle development and function, highlighting the importance of Cul3-mediated proteostasis in muscle function. To explore the role of Cul3-mediated proteostasis in striated muscle, here we deleted Cul3 specifically in either skeletal muscle (SkM-Cul3 KO) or cardiomyocytes (CM-Cul3 KO) of mice. The loss of Cul3 caused neonatal lethality and dramatic alterations in the proteome, which were unique to each striated muscle type. Many of the proteins whose expression was significantly changed in the SkM-Cul3 KO were components of the extracellular matrix and sarcomere, whereas proteins altered in the CM-Cul3 KO were involved in metabolism. These findings highlight the requirement for striated muscle-specific CRL3 activity and indicate how the CRL3 complex can control different nodes of protein interaction networks in different types of striated muscle. Further identification of Cul3 substrates, and how these substrates are targeted, may reveal therapeutic targets and treatment regimens for striated muscle diseases.	[Papizan, James B.; Vidal, Alexander H.; Bezprozvannaya, Svetlana; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Hamon Ctr Regenerat Sci & Med, Senator Paul D Wellstone Muscular Dystrophy Coope, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Dept Mol Biol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Eric.olson@utsouthwestern.edu		Papizan, James/0000-0003-4257-6246; Vidal, Alexander/0000-0002-2805-3687	National Institutes of Health [AR-067294, HL-130253, DK-099653]; Robert A. Welch Foundation [1-0025]; Ruth L. Kirschstein NRSA F32 National Institutes of Health Training Grant [5F32HL123323-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR067294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099653] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); Ruth L. Kirschstein NRSA F32 National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants AR-067294, HL-130253, and DK-099653 and Robert A. Welch Foundation Grant 1-0025 (to E. N. O.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Ruth L. Kirschstein NRSA F32 National Institutes of Health Training Grant 5F32HL123323-03.	Ackermann B, 2013, HUM MOL GENET, V22, P1328, DOI 10.1093/hmg/dds540; Agah R, 1997, J CLIN INVEST, V100, P169, DOI 10.1172/JCI119509; Anderson DM, 2016, P NATL ACAD SCI USA, V113, pE4494, DOI 10.1073/pnas.1608423113; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Blondelle J, 2017, J MOL BIOL, V429, P1045, DOI 10.1016/j.jmb.2017.02.012; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Chen YZ, 2009, MOL CELL, V35, P841, DOI 10.1016/j.molcel.2009.09.004; Chorley BN, 2012, NUCLEIC ACIDS RES, V40, P7416, DOI 10.1093/nar/gks409; Cirak S, 2010, BRAIN, V133, P2123, DOI 10.1093/brain/awq108; Davis J, 2012, CIRC RES, V111, P761, DOI 10.1161/CIRCRESAHA.111.262717; Dhanoa BS, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-13; Emanuele MJ, 2011, CELL, V147, P459, DOI 10.1016/j.cell.2011.09.019; Garg A, 2014, J CLIN INVEST, V124, P3529, DOI 10.1172/JCI74994; Goldfarb LG, 2008, ADV EXP MED BIOL, V642, P131; Gupta VA, 2014, SKELET MUSCLE, V4, DOI 10.1186/2044-5040-4-11; Gupta VA, 2013, AM J HUM GENET, V93, P1108, DOI 10.1016/j.ajhg.2013.10.020; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Korovila I, 2017, REDOX BIOL, V13, P550, DOI 10.1016/j.redox.2017.07.008; Kulak NA, 2017, MOL CELL PROTEOMICS, V16, P694, DOI 10.1074/mcp.O116.065136; Lee YR, 2010, EMBO J, V29, P1748, DOI 10.1038/emboj.2010.62; Lehtokari VL, 2006, HUM MUTAT, V27, P946, DOI 10.1002/humu.20370; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Liu N, 2014, P NATL ACAD SCI USA, V111, P4109, DOI 10.1073/pnas.1401732111; Lo SC, 2006, MOL CELL BIOL, V26, P1235, DOI 10.1128/MCB.26.4.1235-1244.2006; McEvoy JD, 2007, MOL CELL BIOL, V27, P3651, DOI 10.1128/MCB.00720-06; Morimoto RI, 2014, J GERONTOL A-BIOL, V69, pS33, DOI 10.1093/gerona/glu049; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Nam S, 2009, J BIOL CHEM, V284, P8192, DOI 10.1074/jbc.M808230200; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Papizan JB, 2017, J CLIN INVEST, V127, P3730, DOI 10.1172/JCI93445; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Ramirez-Martinez A, 2017, ELIFE, V6, DOI 10.7554/eLife.26439; Ravenscroft G, 2013, AM J HUM GENET, V93, P6, DOI 10.1016/j.ajhg.2013.05.004; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Sambuughin N, 2010, AM J HUM GENET, V87, P842, DOI 10.1016/j.ajhg.2010.10.020; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Sandri M, 2013, INT J BIOCHEM CELL B, V45, P2121, DOI 10.1016/j.biocel.2013.04.023; Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75; Shibata S, 2013, P NATL ACAD SCI USA, V110, P7838, DOI 10.1073/pnas.1304592110; Singer JD, 1999, GENE DEV, V13, P2375, DOI 10.1101/gad.13.18.2375; Sorimachi H, 2012, CARDIOVASC RES, V96, P11, DOI 10.1093/cvr/cvs157; TAKESHIMA H, 1994, NATURE, V369, P556, DOI 10.1038/369556a0; Uruno A, 2016, MOL CELL BIOL, V36, P1655, DOI 10.1128/MCB.01095-15; Vilchez D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6659; Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Zhang DD, 2005, J BIOL CHEM, V280, P30091, DOI 10.1074/jbc.M501279200; Zhang HL, 2013, CARDIOVASC RES, V98, P248, DOI 10.1093/cvr/cvt050; Zhu Y, 2017, BIOCHEM BIOPH RES CO, V484, P827, DOI 10.1016/j.bbrc.2017.01.182	56	19	19	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8802	8811		10.1074/jbc.RA118.002104	http://dx.doi.org/10.1074/jbc.RA118.002104			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29653945	Green Published, hybrid			2022-12-26	WOS:000434941900007
J	Bijvelds, MJC; Tresadern, G; Hellemans, A; Smans, K; Nieuwenhuijze, NDA; Meijsen, KF; Bongartz, JP; Ver Donck, L; de Jonge, HR; Schuurkes, JAJ; De Maeyer, JH				Bijvelds, Marcel J. C.; Tresadern, Gary; Hellemans, Ann; Smans, Karine; Nieuwenhuijze, Natascha D. A.; Meijsen, Kelly F.; Bongartz, Jean-Pierre; Ver Donck, Luc; de Jonge, Hugo R.; Schuurkes, Jan A. J.; De Maeyer, Joris H.			Selective inhibition of intestinal guanosine 3,5-cyclic monophosphate signaling by small-molecule protein kinase inhibitors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein kinase G; PKG; drug discovery; signal transduction; intestinal epithelium; cyclic GMP; cGMP; CFTR; cystic fibrosis transmembrane conductance regulator; enterotoxigenic E; coli; ETEC; secretory diarrhea; vasodilator-stimulated phosphoprotein	TRANSMEMBRANE CONDUCTANCE REGULATOR; GUANYLYL CYCLASE-C; ION-TRANSPORT; IN-VITRO; CGMP; SECRETION; ACTIVATION; EXPRESSION; DWARFISM; MICE	The guanosine 3,5-cyclic monophosphate (cGMP)-dependent protein kinase II (cGKII) serine/threonine kinase relays signaling through guanylyl cyclase C (GCC) to control intestinal fluid homeostasis. Here, we report the discovery of small-molecule inhibitors of cGKII. These inhibitors were imidazole-aminopyrimidines, which blocked recombinant human cGKII at submicromolar concentrations but exhibited comparatively little activity toward the phylogenetically related protein kinases cGKI and cAMP-dependent protein kinase (PKA). Whereas aminopyrimidyl motifs are common in protein kinase inhibitors, molecular modeling of these imidazole-aminopyrimidines in the ATP-binding pocket of cGKII indicated an unconventional binding mode that directs their amine substituent into a narrow pocket delineated by hydrophobic residues of the hinge and the C-helix. Crucially, this set of residues included the Leu-530 gatekeeper, which is not conserved in cGKI and PKA. In intestinal organoids, these compounds blocked cGKII-dependent phosphorylation of the vasodilator-stimulated phosphoprotein (VASP). In mouse small intestinal tissue, cGKII inhibition significantly attenuated the anion secretory response provoked by the GCC-activating bacterial heat-stable toxin (STa), a frequent cause of infectious secretory diarrhea. In contrast, both PKA-dependent VASP phosphorylation and intestinal anion secretion were unaffected by treatment with these compounds, whereas experiments with T84 cells indicated that they weakly inhibit the activity of cAMP-hydrolyzing phosphodiesterases. As these protein kinase inhibitors are the first to display selective inhibition of cGKII, they may expedite research on cGMP signaling and may aid future development of therapeutics for managing diarrheal disease and other pathogenic syndromes that involve cGKII.	[Bijvelds, Marcel J. C.; Nieuwenhuijze, Natascha D. A.; Meijsen, Kelly F.; de Jonge, Hugo R.] Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, POB 2040, NL-3000CA Rotterdam, Netherlands; [Tresadern, Gary; Smans, Karine; Bongartz, Jean-Pierre; Ver Donck, Luc] Janssen Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium; [Hellemans, Ann; Schuurkes, Jan A. J.; De Maeyer, Joris H.] Shire Movetis NV, Veedijk 58, B-2300 Turnhout, Belgium	Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Janssen Pharmaceuticals; Shire Pharmaceuticals Limited	Bijvelds, MJC (corresponding author), Erasmus MC Univ Med Ctr, Dept Gastroenterol & Hepatol, POB 2040, NL-3000CA Rotterdam, Netherlands.	m.bijvelds@erasmusmc.nl		Tresadern, Gary/0000-0002-4801-1644; Bijvelds, Marcel/0000-0003-0814-188X	Movetis NV; Agency for Innovation by Science and Technology (IWT), Belgium	Movetis NV; Agency for Innovation by Science and Technology (IWT), Belgium(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by Movetis NV with support from the Agency for Innovation by Science and Technology (IWT), Belgium. The authors declare that they have no conflicts of interest with the contents of this article.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Benz PM, 2009, J CELL SCI, V122, P3954, DOI 10.1242/jcs.044537; Bijvelds MJC, 2015, J INFECT DIS, V212, P1806, DOI 10.1093/infdis/jiv300; Bijvelds MJC, 2009, GASTROENTEROLOGY, V137, P976, DOI 10.1053/j.gastro.2009.05.037; Burkhardt M, 2000, J BIOL CHEM, V275, P33536, DOI 10.1074/jbc.M005670200; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cheung J, 2015, P NATL ACAD SCI USA, V112, P1374, DOI 10.1073/pnas.1424206112; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; DEJONGE HR, 1976, NATURE, V262, P590, DOI 10.1038/262590a0; DEJONGE HR, 1981, ADV CYCLIC NUCL PROT, V14, P315; Dekkers JF, 2013, NAT MED, V19, P939, DOI 10.1038/nm.3201; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; ELHUSSEINI AED, 1995, J NEUROCHEM, V64, P2814; Field M, 2003, J CLIN INVEST, V111, P931, DOI 10.1172/JCI200318326; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; FORTE LR, 1992, AM J PHYSIOL, V263, pC607, DOI 10.1152/ajpcell.1992.263.3.C607; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Gambaryan S, 2012, BRIT J PHARMACOL, V167, P826, DOI 10.1111/j.1476-5381.2012.02044.x; Gong R, 2011, SCIENCE, V333, P1642, DOI 10.1126/science.1207675; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Hogenauer C, 2000, AM J HUM GENET, V67, P1422, DOI 10.1086/316911; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; KAUFFMAN RF, 1987, J PHARMACOL EXP THER, V242, P864; Koltes JE, 2009, P NATL ACAD SCI USA, V106, P19250, DOI 10.1073/pnas.0904513106; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lawrence DW, 2002, AM J PHYSIOL-CELL PH, V282, pC1235, DOI 10.1152/ajpcell.00288.2001; Lohmann SM, 2005, FRONT BIOSCI, V10, P1313, DOI 10.2741/1621; Medina JR, 2011, J MED CHEM, V54, P1871, DOI 10.1021/jm101527u; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pierce AC, 2008, J MED CHEM, V51, P1972, DOI 10.1021/jm701248t; POHLER D, 1995, FEBS LETT, V374, P419, DOI 10.1016/0014-5793(95)01168-E; Romi H, 2012, AM J HUM GENET, V90, P893, DOI 10.1016/j.ajhg.2012.03.022; SLICE LW, 1989, J BIOL CHEM, V264, P20940; Taylor MK, 2002, J BIOL CHEM, V277, P37242, DOI 10.1074/jbc.M202060200; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Tsuchida A, 2008, COMPARATIVE MED, V58, P560; Vaandrager AB, 2000, GASTROENTEROLOGY, V118, P108, DOI 10.1016/S0016-5085(00)70419-7; Vaandrager AB, 2005, FRONT BIOSCI-LANDMRK, V10, P2150, DOI 10.2741/1687; Vaandrager AB, 1998, P NATL ACAD SCI USA, V95, P1466, DOI 10.1073/pnas.95.4.1466; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; Valentino MA, 2011, J CLIN INVEST, V121, P3578, DOI 10.1172/JCI57925; Werner C, 2004, EUR J NEUROSCI, V20, P3498, DOI 10.1111/j.1460-9568.2004.03793.x; Wincott CM, 2014, NEUROBIOL LEARN MEM, V114, P32, DOI 10.1016/j.nlm.2014.04.007; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764	44	8	8	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8173	8181		10.1074/jbc.RA118.002835	http://dx.doi.org/10.1074/jbc.RA118.002835			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29653944	Green Published, hybrid			2022-12-26	WOS:000433224600022
J	Pan, GD; Munukutla, S; Kar, A; Gardinier, J; Thandavarayan, RA; Palaniyandi, SS				Pan, Guodong; Munukutla, Srikar; Kar, Ananya; Gardinier, Joseph; Thandavarayan, Rajarajan A.; Palaniyandi, Suresh Selvaraj			Type-2 diabetic aldehyde dehydrogenase 2 mutant mice (ALDH 2*2) exhibiting heart failure with preserved ejection fraction phenotype can be determined by exercise stress echocardiography	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIAC-FUNCTION; CARDIOVASCULAR-DISEASE; RAT HEARTS; POPULATION; PREVALENCE; PHOSPHORYLATION; POLYMORPHISM; ASSOCIATION; METABOLISM	E487K point mutation of aldehyde dehydrogenase (ALDH) 2 (ALDH2*2) in East Asians intrinsically lowers ALDH2 activity. ALDH2*2 is associated with diabetic cardiomyopathy. Diabetic patients exhibit heart failure of preserved ejection fraction (HFpEF) i.e. while the systolic heart function is preserved in them, they may exhibit diastolic dysfunction, implying a jeopardized myocardial health. Currently, it is challenging to detect cardiac functional deterioration in diabetic mice. Stress echocardiography (echo) in the clinical set-up is a procedure used to measure cardiac reserve and impaired cardiac function in coronary artery diseases. Therefore, we hypothesized that high-fat diet fed type-2 diabetic ALDH2*2 mutant mice exhibit HFpEF which can be measured by cardiac echo stress test methodology. We induced type-2 diabetes in 12-week-old male C57BL/6 and ALDH2*2 mice through a high-fat diet. At the end of 4 months of DM induction, we measured the cardiac function in diabetic and control mice of C57BL/6 and ALDH2*2 genotypes by conscious echo. Subsequently, we imposed exercise stress by allowing the mice to run on the treadmill until exhaustion. Post-stress, we measured their cardiac function again. Only after treadmill running, but not at rest, we found a significant decrease in % fractional shortening and % ejection fraction in ALDH2*2 mice with diabetes compared to C57BL/6 diabetic mice as well as non-diabetic (control) ALDH2*2 mice. The diabetic ALDH2*2 mice also exhibited poor maximal running speed and distance. Our data suggest that high-fat fed diabetic ALDH2*2 mice exhibit HFpEF and treadmill exercise stress echo test is able to determine this HFpEF in the diabetic ALDH2*2 mice.	[Pan, Guodong; Munukutla, Srikar; Kar, Ananya; Palaniyandi, Suresh Selvaraj] Henry Ford Hlth Syst, Dept Internal Med, Div Hypertens & Vasc Res, Detroit, MI 48202 USA; [Gardinier, Joseph] Henry Ford Hlth Syst, Ctr Bone & Joint, Detroit, MI USA; [Thandavarayan, Rajarajan A.] Houston Methodist Res Inst, Ctr Cardiovasc Regenerat, Dept Cardiovasc Sci, Houston, TX USA; [Palaniyandi, Suresh Selvaraj] Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital; The Methodist Hospital System; The Methodist Hospital - Houston; Wayne State University	Palaniyandi, SS (corresponding author), Henry Ford Hlth Syst, Dept Internal Med, Div Hypertens & Vasc Res, Detroit, MI 48202 USA.; Palaniyandi, SS (corresponding author), Wayne State Univ, Dept Physiol, Detroit, MI 48202 USA.	spalani2@hfhs.org			American Heart Association [SDG 14SDG20050030]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [1R56HL131891-01A1]; Henry Ford Health System [A10249]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R56HL131891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Henry Ford Health System; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partially supported by American Heart Association SDG 14SDG20050030 (SSP), NATIONAL HEART, LUNG, AND BLOOD INSTITUTE: 1R56HL131891-01A1 (SSP), Internal grant from Henry Ford Health System A10249 (SSP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amamoto K, 2002, HYPERTENS RES, V25, P857; Anneleen Daniels MvB, 2010, FASEB J S, V24; Bassett DR, 1997, MED SCI SPORT EXER, V29, P591, DOI 10.1097/00005768-199705000-00002; Batalli A, 2017, CARDIOVASC ULTRASOUN, V15, DOI 10.1186/s12947-017-0103-x; BELESLIN BD, 1994, CIRCULATION, V90, P1168, DOI 10.1161/01.CIR.90.3.1168; Borlaug BA, 2010, CIRC-HEART FAIL, V3, P588, DOI 10.1161/CIRCHEARTFAILURE.109.930701; Brainard RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083174; Chen CH, 2008, SCIENCE, V321, P1493, DOI 10.1126/science.1158554; Chen CH, 2014, PHYSIOL REV, V94, P1, DOI 10.1152/physrev.00017.2013; Choy CK, 2008, PHARMACOTHERAPY, V28, P170, DOI 10.1592/phco.28.2.170; Conceicao G, 2016, NETH HEART J, V24, P275, DOI 10.1007/s12471-016-0815-9; Curtis JM, 2010, DIABETES CARE, V33, P901, DOI 10.2337/dc09-1787; Faglia E, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.07.027; Furfaro AL, 2005, BIOFACTORS, V24, P291, DOI 10.1002/biof.5520240134; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gando S, 1997, J PHARMACOL EXP THER, V282, P475; Gupte Anisha A, 2016, Methodist Debakey Cardiovasc J, V12, P105, DOI 10.14797/mdcj-12-2-105; International Diabetes Federation (IDF), IDF DIABETES ATLAS, V10th; JH CSaC, 1999, DIABETES, V17; Jo SA, 2007, CLIN CHIM ACTA, V382, P43, DOI 10.1016/j.cca.2007.03.016; Kasznicki J, 2014, ARCH MED SCI, V10, P546, DOI 10.5114/aoms.2014.43748; Kitzman DW, 2001, AM J CARDIOL, V87, P413, DOI 10.1016/S0002-9149(00)01393-X; Kober F, 2004, MAGN RESON MATER PHY, V17, P157, DOI 10.1007/s10334-004-0086-0; Lagranha CJ, 2010, CIRC RES, V106, P1681, DOI 10.1161/CIRCRESAHA.109.213645; Lujan HL, 2012, AM J PHYSIOL-REG I, V302, pR68, DOI 10.1152/ajpregu.00340.2011; Mali VR, 2014, EXP BIOL MED, V239, P610, DOI 10.1177/1535370213520109; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Marwick TH, 2003, HEART, V89, P113, DOI 10.1136/heart.89.1.113; Melchior T, 2001, EUR J HEART FAIL, V3, P83, DOI 10.1016/S1388-9842(00)00117-3; Murata C, 2004, DIABETES RES CLIN PR, V66, pS145, DOI 10.1016/j.diabres.2003.11.022; Ostler JE, 2014, AM J PHYSIOL-ENDOC M, V306, pE592, DOI 10.1152/ajpendo.00277.2013; Petrosino JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148010; Platt C, 2015, CELL METAB, V21, P227, DOI 10.1016/j.cmet.2015.01.014; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Sanchez MA, 2002, REV ESP CARDIOL, V55, P1083, DOI 10.1016/S0300-8932(02)76759-6; SAVARESE JJ, 1979, LIFE SCI, V25, P2075, DOI 10.1016/0024-3205(79)90200-5; Suzuki Y, 2004, ALCOHOL CLIN EXP RES, V28, p111S, DOI 10.1097/01.ALC.0000133583.44581.99; Takagi S, 2002, HYPERTENS RES, V25, P677; Vasiliou V, 2000, CHEM-BIOL INTERACT, V129, P1, DOI 10.1016/S0009-2797(00)00211-8; Baroncini LAV, 2015, CARDIOVASC ULTRASOUN, V13, DOI 10.1186/s12947-015-0030-7; Wang C, 2016, J MOL MED, V94, P1229, DOI 10.1007/s00109-016-1449-5; Yang XP, 1999, AM J PHYSIOL-HEART C, V277, pH1967, DOI 10.1152/ajpheart.1999.277.5.H1967; Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009	43	18	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195796	10.1371/journal.pone.0195796	http://dx.doi.org/10.1371/journal.pone.0195796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677191	Green Published, Green Submitted, gold			2022-12-26	WOS:000430638900016
J	Wilke, J; Niederer, D; Vogt, L; Banzer, W				Wilke, Jan; Niederer, Daniel; Vogt, Lutz; Banzer, Winfried			Is the message getting through? Awareness and use of the 11+injury prevention programme in amateur level football clubs	PLOS ONE			English	Article							TIME-MOTION ANALYSIS; WARM-UP PROGRAM; INJURY PREVENTION; FIFA 11+; PLAYERS; IMPLEMENTATION; ADHERENCE; IMPACT; METAANALYSIS; NONRESPONSE	A large body of evidence suggests that the 11+ warm-up programme is effective in preventing football-related musculoskeletal injuries. However, despite considerable efforts to promote and disseminate the programme, it is unclear as to whether team head coaches are familiar with the 11+ and how they rate its feasibility. The present study aimed to gather information on awareness and usage among German amateur level football coaches. A questionnaire was administered to 7893 individuals who were in charge of youth and adult nonprofessional teams. Descriptive and inferential statistics were used to analyse the obtained data. A total of 1223 coaches (16%) returned the questionnaire. There was no risk of a non-response bias (p>.05). At the time of the survey, nearly half of the participants (42.6%) knew the 11+. Among the coaches who were familiar with the programme, three of four reported applying it regularly (at least once per week). Holding a license (phi=.28, p<.0001), high competitive level (Cramer-V=.13, p=.007), and coaching a youth team (phi=.1, p=.001) were associated with usage of 11+. Feasibility and suitability of the 11+ were rated similarly by aware and unaware coaches. Although a substantial share of German amateur level coaches is familiar with the 11+, more than half of the surveyed participants did not know the programme. As the non-usage does not appear to stem from a lack of rated feasibility and suitability, existing communication strategies might need to be revised.	[Wilke, Jan; Niederer, Daniel; Vogt, Lutz; Banzer, Winfried] Goethe Univ Frankfurt Main, Dept Sports Med, Frankfurt, Germany	Goethe University Frankfurt	Wilke, J (corresponding author), Goethe Univ Frankfurt Main, Dept Sports Med, Frankfurt, Germany.	wilke@sport.uni-frankfurt.de	Wilke, Jan/X-8022-2019; Niederer, Daniel/Z-1577-2019	Wilke, Jan/0000-0001-9147-2369; Niederer, Daniel/0000-0002-7690-5418				Al Attar WSA, 2016, SPORTS MED, V46, P205, DOI 10.1007/s40279-015-0404-x; Al Attar WS, 2017, SPORTS SCI COACH, P1; Barengo NC, 2014, INT J ENV RES PUB HE, V11, P11986, DOI 10.3390/ijerph111111986; Bizzini M, 2015, SPORTS INJURIES PREV, P199, DOI DOI 10.1007/978-4-431-55318-2; Bizzini M, 2015, BRIT J SPORT MED, V49, P577, DOI 10.1136/bjsports-2015-094765; Bizzini M, 2013, BRIT J SPORT MED, V47, P803, DOI 10.1136/bjsports-2012-092124; Castellano J, 2011, INT J SPORTS MED, V32, P415, DOI 10.1055/s-0031-1271771; Curtin R, 2000, PUBLIC OPIN QUART, V64, P413, DOI 10.1086/318638; Deutscher Fussball-Bund, 2015, TRAIN; Fort R, 2000, SCOT J POLIT ECON, V47, P431, DOI 10.1111/1467-9485.00172; Fradkin AJ, 2010, J STRENGTH COND RES, V24, P140, DOI 10.1519/JSC.0b013e3181c643a0; Joy EA, 2013, J STRENGTH COND RES, V27, P2263, DOI 10.1519/JSC.0b013e31827ef12e; Junge A, 2011, AM J SPORT MED, V39, P57, DOI 10.1177/0363546510377424; Keeter S, 2006, PUBLIC OPIN QUART, V70, P759, DOI 10.1093/poq/nfl035; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Leppanen M, 2014, SPORTS MED, V44, P473, DOI 10.1007/s40279-013-0136-8; Lewis EF, 2013, EVAL HEALTH PROF, V36, P330, DOI 10.1177/0163278713496565; Matthew D, 2009, J SPORT SCI, V27, P813, DOI 10.1080/02640410902926420; McKay CD, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070657; Mckay CD, 2014, BRIT J SPORT MED, V48, P1281, DOI 10.1136/bjsports-2014-093543; Miller L.E., 1983, J EXT, V21, P45; Norcross MF, 2016, J SCI MED SPORT, V19, P299, DOI 10.1016/j.jsams.2015.03.009; O'Brien J., 2016, BMJ OPEN SPORT EXERC, V2, DOI DOI 10.1136/BMJSEM-2015-000075; Owoeye O. B. A., 2013, South African Journal of Sports Medicine, V25, P77, DOI 10.7196/sajsm.471; Povoas SCA, 2012, J STRENGTH COND RES, V26, P3365, DOI 10.1519/JSC.0b013e318248aeee; Saunders N, 2010, BRIT J SPORT MED, V44, P1128, DOI 10.1136/bjsm.2009.069039; Soligard T, 2008, BMJ, V337; Soligard T, 2010, BRIT J SPORT MED, V44, P787, DOI 10.1136/bjsm.2009.070672; Steffen K, 2013, BRIT J SPORT MED, V47, P794, DOI 10.1136/bjsports-2012-091886; Steffen K, 2013, BRIT J SPORT MED, V47, P480, DOI 10.1136/bjsports-2012-091887; Thorborg K, 2017, BRIT J SPORT MED, V51, P562, DOI 10.1136/bjsports-2016-097066	31	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195998	10.1371/journal.pone.0195998	http://dx.doi.org/10.1371/journal.pone.0195998			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672579	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800067
J	Kim, S; Oh, J; Heo, J; Lee, HY; Lee, JK; Subramanian, SV; Kang, D				Kim, Sujin; Oh, Juhwan; Heo, Jongho; Lee, Hwa-Young; Lee, Jong-Koo; Subramanian, S. V.; Kang, Daehee			Socioeconomic inequalities in the prevalence of biomarkers of cardio-metabolic disease in South Korea: Comparison of the Health Examinees Study to a nationally representative survey	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; CARDIOVASCULAR-DISEASE; GENDER; ASSOCIATION; DISPARITIES; POSITION; BELIEFS; OBESITY; COHORT; AGE	Background/Objectives This study aimed to examine socioeconomic inequalities in the prevalence of biomarkers of cardiovascular disease and diabetes in the newly developed large-scale genomic cohort study of Korean adults, the Health Examinees-Gem (HEXA-G), with a comparison of the nationally representative cross-sectional study, the Korea National Health and Nutrition Examination Survey (K-NHANES). Subjects/Methods Using the HEXA-G and the K-NHANES from 2007-2012, we analyzed the age-adjusted relative risk (RR) and prevalence of enlarged waist circumference (EWC), elevated triglycerides (ET), low HDL cholesterol (LHC), elevated blood pressure (EBP) and elevated blood glucose (EBG) by income and educational groups for adults at age 40-69. Results For men, the prevalence of risk factors was similar across different income and educational groups (p>0.1), and between the K-NHANES and the HEXA-G. Among five risk factors, EBG showed the greatest discrepancy by 7 to 11 percentage points (i.e., the prevalence of 0.43 and 0.36 for college graduates, respectively, in K-NHANES and HEXA-G). For women, socioeconomic inequalities appeared for the five risk factors. Prevalence of risk factors was mostly lower in the HEXA-G than the K-NHANES, by approximately 11.0 percentage points. Especially, the discrepancy between K-NHANES and HEXA-G was largest in EBG (i.e., the prevalence of 0.31 and 0.20 for the lowest income groups, respectively). Conclusion The HEXA-G shows broadly similar socioeconomic inequality in prevalence of cardio-metabolic risk factors to the nationally representative sample with more modest socioeconomic inequality among women in the HEXA-G than the K-NHANES.	[Kim, Sujin] Korea Inst Hlth & Social Affairs, Sejong City, South Korea; [Kim, Sujin] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Oh, Juhwan; Heo, Jongho; Lee, Hwa-Young; Lee, Jong-Koo] Seoul Natl Univ, Coll Med, JW Lee Ctr Global Med, Seoul, South Korea; [Lee, Hwa-Young] Harvard TH Chan Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA USA; [Lee, Jong-Koo] Seoul Natl Univ, Coll Med, Dept Family Med, Seoul, South Korea; [Subramanian, S. V.] Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA; [Kang, Daehee] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kang, Daehee] Seoul Natl Univ, Med Res Ctr, Inst Environm Med, Seoul, South Korea	Korea Institute for Health and Social Affairs; Seoul National University (SNU); Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health; Seoul National University (SNU); Harvard University; Harvard T.H. Chan School of Public Health; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Oh, J (corresponding author), Seoul Natl Univ, Coll Med, JW Lee Ctr Global Med, Seoul, South Korea.; Subramanian, SV (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA USA.	oh328@snu.ac.kr; svsubram@hsph.harvard.edu	Oh, Juhwan/O-6517-2019	Oh, Juhwan/0000-0003-0983-4872; Kim, Sujin/0000-0002-4251-6318; Heo, Jongho/0000-0002-6405-3860; Kang, Daehee/0000-0003-4031-5878; Lee, Hwa-Young/0000-0003-2591-1436	National Genome Research Institute, Korea Centers for Disease Control and Prevention; Seoul National University Hospital	National Genome Research Institute, Korea Centers for Disease Control and Prevention; Seoul National University Hospital	This study was supported by the National Genome Research Institute, Korea Centers for Disease Control and Prevention, and by a grant from the Seoul National University Hospital (2017).	Andreeva VA, 2015, J EPIDEMIOL COMMUN H, V69, P893, DOI 10.1136/jech-2014-205263; Choi YJ, 2009, DIABETES CARE, V32, P2016, DOI 10.2337/dc08-2228; Darmon N, 2015, NUTR REV, V73, P643, DOI 10.1093/nutrit/nuv027; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Health Examinees Study Group, 2015, Asian Pac J Cancer Prev, V16, P1591; Khang YH, 2006, PREV MED, V42, P415, DOI 10.1016/j.ypmed.2006.02.010; Kim YJ, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014070; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee HK, 2010, ALCOHOL, V44, P297, DOI 10.1016/j.alcohol.2010.02.005; Lim H, 2012, DIABETES CARE, V35, P2028, DOI 10.2337/dc11-1841; Lim S, 2011, DIABETES CARE, V34, P1323, DOI 10.2337/dc10-2109; Loucks EB, 2007, ANN EPIDEMIOL, V17, P19, DOI 10.1016/j.annepidem.2006.07.002; Madsen M, 2014, SOC SCI MED, V118, P182, DOI 10.1016/j.socscimed.2014.04.016; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Park HS, 2008, OBES REV, V9, P104, DOI 10.1111/j.1467-789X.2007.00421.x; Park HS, 2004, INT J EPIDEMIOL, V33, P328, DOI 10.1093/ije/dyh032; Park MJ, 2007, ANN EPIDEMIOL, V17, P320, DOI 10.1016/j.annepidem.2006.10.007; Puhl RM, 2009, OBESITY, V17, P941, DOI 10.1038/oby.2008.636; Rosenquist JN, 2015, P NATL ACAD SCI USA, V112, P354, DOI 10.1073/pnas.1411893111; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Shin S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9070687; Silveira PP, 2016, JAMA PEDIATR, V170, P359, DOI 10.1001/jamapediatrics.2015.4253; Song YM, 2006, AM J PUBLIC HEALTH, V96, P152, DOI [10.2105/AJPH.2005.061853, 10.2105/AJPH.2004.061853]; Thurston RC, 2005, AM J EPIDEMIOL, V162, P57, DOI 10.1093/aje/kwi159; Vernay M, 2013, INT J PUBLIC HEALTH, V58, P855, DOI 10.1007/s00038-013-0501-2; Walter S, 2016, JAMA-J AM MED ASSOC, V316, P63, DOI 10.1001/jama.2016.8729; Wardle J, 2004, ANN BEHAV MED, V27, P107, DOI 10.1207/s15324796abm2702_5; Wardle J, 2003, J EPIDEMIOL COMMUN H, V57, P440, DOI 10.1136/jech.57.6.440; Wu HF, 2017, ANN EPIDEMIOL, V27, P315, DOI 10.1016/j.annepidem.2017.04.003; Young AI, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12724; Zhan YQ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-921	33	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195091	10.1371/journal.pone.0195091	http://dx.doi.org/10.1371/journal.pone.0195091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668714	Green Submitted, gold, Green Published			2022-12-26	WOS:000430290200026
J	Wagner, S; Helmreich, I; Wollschlager, D; Meyer, K; Kaaden, S; Reiff, J; Rolls, SC; Braus, D; Tuscher, O; Muller-Dahlhaus, F; Tadic, A; Lieb, K				Wagner, Stefanie; Helmreich, Isabella; Wollschlaeger, Daniel; Meyer, Konstantin; Kaaden, Sabine; Reiff, Julia; Rolls, Sibylle C.; Braus, Dieter; Tuescher, Oliver; Muller-Dahlhaus, Florian; Tadic, Andre; Lieb, Klaus			Early improvement of executive test performance during antidepressant treatment predicts treatment outcome in patients with Major Depressive Disorder	PLOS ONE			English	Article							COGNITIVE DYSFUNCTION; TRAIL; METAANALYSIS; IMPAIRMENT	Executive dysfunctions frequently occur in patients with Major Depressive Disorder and have been shown to improve during effective antidepressant treatment. However, the time course of improvement and its relationship to treatment outcome is unknown. The aim of the study was to assess the test performance and clinical outcome by repetitive assessments of executive test procedures during antidepressant treatment. Executive test performance was assessed in 209 patients with Major Depressive Disorder (mean age 39.3 +/- 11.4 years) and 84 healthy controls five times in biweekly intervals from baseline to week 8. Patients were treated by a defined treatment algorithm within the early medication change study (EMC trial; ClinicalTrials.gov NCT00974155), controls did not receive any intervention. Cognitive domains were processing speed, cognitive flexibility, phonemic and semantic verbal fluency. Intelligence was assessed at baseline. Depression severity was tested once a week by the Hamilton Depression Rating Scale (HAMD(17)). 130 patients (62%) showed executive dysfunctions in at least one of four tests at baseline. Linear mixed regression models revealed that the course of depression severity was associated to the course of cognitive flexibility (p = 0.004) and semantic verbal fluency (p = 0.020). Cognitive flexibility and semantic verbal fluency may be candidates easily to apply for therapy response prediction in clinical routine, which should be tested in further prospective studies.	[Wagner, Stefanie; Helmreich, Isabella; Tuescher, Oliver; Muller-Dahlhaus, Florian; Tadic, Andre; Lieb, Klaus] Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany; [Wollschlaeger, Daniel] Univ Med Ctr, IMBEI, Mainz, Germany; [Meyer, Konstantin] Sana Klinikum Offenbach, Offenbach, Germany; [Kaaden, Sabine; Reiff, Julia; Braus, Dieter] HELIOS Dr Horst Schmidt Kliniken, Dept Psychiat & Psychotherapy, Wiesbaden, Germany; [Rolls, Sibylle C.] Vitos Rheingau, Dept Psychiat & Psychotherapy, Eltville, Germany; [Tadic, Andre] Agaplesion Elisabethenstift, Dept Psychiat Psychosomat & Psychotherapy, Darmstadt, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Sana Klinikum Offenbach	Wagner, S; Lieb, K (corresponding author), Univ Med Ctr, Dept Psychiat & Psychotherapy, Mainz, Germany.	stefwagn@uni-mainz.de; Klaus.lieb@unimedizin-mainz.de	Tuescher, Oliver/F-9903-2014; Helmreich, Isabella/CAF-3562-2022		German Federal Ministry for Education and Research (BMBF) [01 KG 0906]; German Research Foundation ("Deutsche Forschungsgemeinschaft, DFG") [WA 2970/1-1]	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation ("Deutsche Forschungsgemeinschaft, DFG")(German Research Foundation (DFG))	The EMC trial was funded by the German Federal Ministry for Education and Research (BMBF grant no: 01 KG 0906; applicants: KL, AT, CH, ND, KK); the herein presented additional investigations are not part of the funding. The BMBF had no role in the conception of the study design, in the writing of the manuscript or the decision to submit the manuscript for publication. The assessment of neuropsychological functioning was funded by the German Research Foundation ("Deutsche Forschungsgemeinschaft, DFG" (funding number: WA 2970/1-1). The DFG had no role in the conception of the study design, in the writing of the manuscript or the decision to submit the manuscript for publication.	Ackenheil M, 1998, INT NEUROPSYCHIATRIC; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beblo T., 1999, COGN NEUROPSYCHIATRY, V4, P333, DOI [10.1080/135468099395864, DOI 10.1080/135468099395864]; Beblo T, 2011, NEUROPSYCHOL REV, V21, P337, DOI 10.1007/s11065-011-9171-0; Bortolato B, 2014, CNS NEUROL DISORD-DR, V13, P1804; Christensen H, 1997, J Int Neuropsychol Soc, V3, P631; CIPS, 1977, INT SKALEN PSYCHIAT; GAUDINO EA, 1995, J CLIN EXP NEUROPSYC, V17, P529, DOI 10.1080/01688639508405143; Halekoh U, 2014, J STAT SOFTW, V59, P1; Hammar A, 2010, SCAND J PSYCHOL, V51, P304, DOI 10.1111/j.1467-9450.2009.00765.x; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Henry JD, 2005, J CLIN EXP NEUROPSYC, V27, P78, DOI 10.1080/138033990513654; Herrera-Guzman I, 2010, PSYCHIAT RES, V177, P323, DOI 10.1016/j.psychres.2010.03.006; Hinkelmann K, 2012, PSYCHONEUROENDOCRINO, V37, P685, DOI 10.1016/j.psyneuen.2011.08.012; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Lehrl S., 1969, MEHRFACHWAHL WORTSCH; Leuchter Andrew F, 2009, Dialogues Clin Neurosci, V11, P435; LINN BS, 1968, J AM GERIATR SOC, V16, P622, DOI 10.1111/j.1532-5415.1968.tb02103.x; Mayberg HS, 2003, BRIT MED BULL, V65, P193, DOI 10.1093/bmb/65.1.193; Mayberg HS, 2000, BIOL PSYCHIAT, V48, P830, DOI 10.1016/S0006-3223(00)01036-2; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakano Y, 2011, J AFFECT DISORDERS, V111, P46; Neu P, 2005, J PSYCHIAT RES, V39, P129, DOI 10.1016/j.jpsychires.2004.06.004; Nicod N, 2016, BIOL PSYCHIAT, V26, P165; Pachet AK, 2003, PSYCHOPHARMACOLOGY, V170, P225, DOI 10.1007/s00213-003-1592-x; R Core Team, 2021, R LANGUAGE ENV STAT; Reitan RM., 1979, TRAIL MAKING TEST MA; Reppermund S, 2009, PSYCHOL MED, V39, P603, DOI 10.1017/S003329170800411X; Reppermund S, 2007, BIOL PSYCHIAT, V62, P400, DOI 10.1016/j.biopsych.2006.09.027; Rosenblat JD, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyv082; Shilyansky C, 2016, LANCET PSYCHIAT, V3, P425, DOI 10.1016/S2215-0366(16)00012-2; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Snyder HR, 2013, PSYCHOL BULL, V139, P81, DOI 10.1037/a0028727; Stassen HH, 2007, J CLIN PSYCHIAT, V68, P1195, DOI 10.4088/JCP.v68n0805; Szegedi A, 2009, J CLIN PSYCHIAT, V70, P344, DOI 10.4088/JCP.07m03780; Tadic A, 2016, EUR NEUROPSYCHOPHARM, V26, P705, DOI 10.1016/j.euroneuro.2016.02.003; Tadic A, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-16; Tadic A, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-21; Thomas AJ, 2009, PSYCHOL MED, V39, P725, DOI 10.1017/S0033291708004042; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tombaugh TN, 2003, ARCH CLIN NEUROPSYCH, V8, P1; Wagner S, 2012, ACTA PSYCHIAT SCAND, V125, P281, DOI 10.1111/j.1600-0447.2011.01762.x; Wagner S, 2011, ARCH CLIN NEUROPSYCH, V26, P314, DOI 10.1093/arclin/acr024; Wagner S, 2011, PSYCHOPATHOLOGY, V44, P68, DOI 10.1159/000318162; Wittchen HU, 1996, SKID 1 2 STRUKTURIER	48	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194574	10.1371/journal.pone.0194574	http://dx.doi.org/10.1371/journal.pone.0194574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668746	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200011
J	Bogaert, KA; Manoharan-Basil, SS; Perez, E; Levine, RD; Remacle, F; Remacle, C				Bogaert, Kenny A.; Manoharan-Basil, Sheeba S.; Perez, Emilie; Levine, Raphael D.; Remacle, Francoise; Remacle, Claire			Surprisal analysis of genome-wide transcript profiling identifies differentially expressed genes and pathways associated with four growth conditions in the microalga Chlamydomonas	PLOS ONE			English	Article							REINHARDTII; METABOLISM; RESPONSES; COHORTS; SYSTEM	The usual cultivation mode of the green microalga Chlamydomonas is liquid medium and light. However, the microalga can also be grown on agar plates and in darkness. Our aim is to analyze and compare gene expression of cells cultivated in these different conditions. For that purpose, RNA-seq data are obtained from Chlamydomonas samples of two different labs grown in four environmental conditions (agar@light, agar@dark, liquid@light, liquid@dark). The RNA-seq data are analyzed by surprisal analysis, which allows the simultaneous meta-analysis of all the samples. First we identify a balance state, which defines a state where the expression levels are similar in all the samples irrespectively of their growth conditions, or lab origin. In addition our analysis identifies additional constraints needed to quantify the deviation with respect to the balance state. The first constraint differentiates the agar samples versus the liquid ones; the second constraint the dark samples versus the light ones. The two constraints are almost of equal importance. Pathways involved in stress responses are found in the agar phenotype while the liquid phenotype comprises ATP and NADH production pathways. Remodeling of membrane is suggested in the dark phenotype while photosynthetic pathways characterize the light phenotype. The same trends are also present when performing purely statistical analysis such as K-means clustering and differentially expressed genes.	[Bogaert, Kenny A.; Remacle, Francoise] Univ Liege, Theoret Phys Chem, UR MOLSYS, Liege, Belgium; [Manoharan-Basil, Sheeba S.; Perez, Emilie; Remacle, Claire] Univ Liege, Genet & Physiol Microalgae, UR InBios, Liege, Belgium; [Levine, Raphael D.] Hebrew Univ Jerusalem, Inst Chem, Fritz Haber Res Ctr Mol Dynam, Jerusalem, Israel; [Levine, Raphael D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of Liege; University of Liege; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Remacle, F (corresponding author), Univ Liege, Theoret Phys Chem, UR MOLSYS, Liege, Belgium.; Remacle, C (corresponding author), Univ Liege, Genet & Physiol Microalgae, UR InBios, Liege, Belgium.	fremacle@ulg.ac.be; c.remacle@ulg.ac.be	Basil, Sheeba Santhini/ABG-2141-2020; bogaert, kenny/AAK-6095-2021	Basil, Sheeba Santhini/0000-0001-8421-5137; bogaert, kenny/0000-0003-1482-7618; Remacle, Francoise/0000-0001-7434-5245; Remacle, Claire/0000-0002-5016-9547	FP7-Future and Emerging Technologies-Open Project: BAMBI project [GA 618024]; FRS-FNRS [CDR J.0265.17]	FP7-Future and Emerging Technologies-Open Project: BAMBI project; FRS-FNRS(Fonds de la Recherche Scientifique - FNRS)	This study was supported by FP7-Future and Emerging Technologies-Open Project: BAMBI project, GA 618024, http//cordis.europa.eu/fp7/ict/fet-open/home_en.html, to KB, SM-B, EP, RL, FR, CR (all the authors); and FRS-FNRS: CDR J.0265.17, http://www.fnrs.be, to CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beale SI, 2009, CHLAMYDOMONAS SOURCE, P731; Benstein R, 2014, MAR BIOTECHNOL, V16, P621, DOI 10.1007/s10126-014-9581-0; Blaby IK, 2014, TRENDS PLANT SCI, V19, P672, DOI 10.1016/j.tplants.2014.05.008; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brumfield KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008659; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Duanmu D, 2013, P NATL ACAD SCI USA, V110, P3621, DOI 10.1073/pnas.1222375110; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; Hohner R, 2013, MOL CELL PROTEOMICS, V12, P2774, DOI 10.1074/mcp.M113.029991; Kim KS, 2005, GENETICS, V170, P631, DOI 10.1534/genetics.105.041574; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; Kravchenko-Balasha N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108549; Kravchenko-Balasha N, 2012, P NATL ACAD SCI USA, V109, P4702, DOI 10.1073/pnas.1200790109; Kravchenko-Balasha N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-42; Levine R. D., 2004, MOL REACTION DYNAMIC; Lopez D, 2015, PLANT PHYSIOL, V169, P2730, DOI 10.1104/pp.15.00861; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Moseley JL, 2006, EUKARYOT CELL, V5, P26, DOI 10.1128/EC.5.1.26-44.2006; NEWMAN SM, 1990, GENETICS, V126, P875; Page MD, 2012, PLANT CELL, V24, P2649, DOI 10.1105/tpc.112.098962; Piras V, 2015, GENOMICS, V105, P137, DOI 10.1016/j.ygeno.2014.12.007; Plancke C, 2014, PLANT J, V77, P404, DOI 10.1111/tpj.12392; Pootakham W, 2010, PLANT PHYSIOL, V153, P1653, DOI 10.1104/pp.110.157875; Proschold T, 2005, GENETICS, V170, P1601, DOI 10.1534/genetics.105.044503; Remacle F, 2015, EUR BIOPHYS J BIOPHY, V44, P709, DOI 10.1007/s00249-015-1069-y; Remacle F, 2010, P NATL ACAD SCI USA, V107, P10324, DOI 10.1073/pnas.1005283107; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Rochaix JD, 2002, FEBS LETT, V529, P34, DOI 10.1016/S0014-5793(02)03181-2; Rosenberg JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092460; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SMITH SJ, 1993, YEAST, V9, P1177, DOI 10.1002/yea.320091104; Sole A, 2016, CHEMOSPHERE, V164, P516, DOI 10.1016/j.chemosphere.2016.08.047; Strenkert D, 2016, J BIOL CHEM, V291, P19118, DOI 10.1074/jbc.M116.717413; Tardif M, 2012, MOL BIOL EVOL, V29, P3625, DOI 10.1093/molbev/mss178; Tibiletti T, 2016, PLANT PHYSIOL, V171, P2717, DOI 10.1104/pp.16.00572; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang YJ, 2015, PLANT J, V82, P429, DOI 10.1111/tpj.12829; Willamme R, 2015, J BIOTECHNOL, V215, P20, DOI 10.1016/j.jbiotec.2015.04.013; Zadran S, 2013, P NATL ACAD SCI USA, V110, P19160, DOI 10.1073/pnas.1316991110	39	5	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195142	10.1371/journal.pone.0195142	http://dx.doi.org/10.1371/journal.pone.0195142			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664904	Green Submitted, Green Published, gold			2022-12-26	WOS:000430262300014
J	McCoy, KS; Williams, ID; Friedlander, AM; Ma, HG; Teneva, L; Kittinger, JN				McCoy, Kaylyn S.; Williams, Ivor D.; Friedlander, Alan M.; Ma, Hongguang; Teneva, Lida; Kittinger, John N.			Estimating nearshore coral reef-associated fisheries production from the main Hawaiian Islands	PLOS ONE			English	Article							SUSTAINABILITY; COMANAGEMENT; CATCH	Currently, information on nearshore reef-associated fisheries is frequently disparate or incomplete, creating a challenge for effective management. This study utilized an existing non-commercial fishery dataset from Hawai'i, covering the period 2004 +/- 13, to estimate a variety of fundamental fishery parameters, including participation, effort, gear use, and catch per unit effort. We then used those data to reconstruct total catches per island. Non-commercial fisheries in this case comprise recreational, subsistence, and cultural harvest, which may be exchanged, but are not sold. By combining those data with reported commercial catch data, we estimated annual catch of nearshore reef-associated fisheries in the main Hawaiian Islands over the study period to be 1,167,758 +/- 43,059 kg year(-1) (mean +/- standard error). Average annual commercial reef fish catch over the same time period-184,911 kg year-1-was 16% of the total catch, but that proportion varied greatly among islands, ranging from 23% on O'ahu to 5% on Moloka'i. These results emphasize the importance of reef fishing in Hawai'i for reasons beyond commerce, such as food security and cultural practice, and highlight the large differences in fishing practices across the Hawaiian Islands.	[McCoy, Kaylyn S.] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [McCoy, Kaylyn S.; Friedlander, Alan M.] Univ Hawaii Manoa, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA; [McCoy, Kaylyn S.; Williams, Ivor D.] Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Program, Ecosyst Sci Div, Honolulu, HI 96818 USA; [Friedlander, Alan M.] Natl Geog Soc, Pristine Seas, Washington, DC USA; [Ma, Hongguang] Pacific Isl Fisheries Sci Ctr, Insular Fisheries Monitoring Program, Fisheries Res & Monitoring Div, Honolulu, HI USA; [Teneva, Lida; Kittinger, John N.] Ctr Oceans, Conservat Int, Honolulu, HI USA; [Kittinger, John N.] Arizona State Univ, Ctr Biodivers Outcomes, Julie Ann Wrigley Global Inst Sustainabil, Life Sci Ctr, Tempe, AZ USA; [Kittinger, John N.] Betty & Gordon Moore Ctr Sci, Conservat Int, Arlington, VA USA	University of Hawaii System; University of Hawaii Manoa; University of Hawaii System; University of Hawaii Manoa; National Geographic Society; Conservation International; Arizona State University; Arizona State University-Tempe; Conservation International	McCoy, KS (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.; McCoy, KS (corresponding author), Univ Hawaii Manoa, Fisheries Ecol Res Lab, Honolulu, HI 96822 USA.; McCoy, KS (corresponding author), Pacific Isl Fisheries Sci Ctr, Coral Reef Ecosyst Program, Ecosyst Sci Div, Honolulu, HI 96818 USA.	Kaylyn.mccoy@noaa.gov		McCoy, Kaylyn/0000-0002-4875-9863	National Oceanic and Atmospheric Administration's Saltonstall-Kennedy Grant Program [NA15NMF4270332]	National Oceanic and Atmospheric Administration's Saltonstall-Kennedy Grant Program	This work was supported by the National Oceanic and Atmospheric Administration's Saltonstall-Kennedy Grant Program, award NA15NMF4270332 https:/www.fisheries.noaa.gov/grant/salton stalI-kennedy-grant-program) to Dr. John N Kittinger. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews R., 2014, DEV TESTING RECREATI; Ayers AL, 2017, INT J COMMONS, V11, P388, DOI 10.18352/ijc.709; Bellwood DR, 2012, P ROY SOC B-BIOL SCI, V279, P1621, DOI 10.1098/rspb.2011.1906; Brander LM, 2007, ECOL ECON, V63, P209, DOI 10.1016/j.ecolecon.2006.11.002; Cinner JE, 2012, P NATL ACAD SCI USA, V109, P5219, DOI 10.1073/pnas.1121215109; Dalzell P., 1996, REEF FISHERIES, P161, DOI DOI 10.1007/978-94-015-8779-2; Delaney DG, 2017, PATTERNS ARTISANAL C; Everson A, 2001, P 2001 FISH S AM FIS, P108; Friedlander Alan M., 2015, P208; Friedlander AM, 2014, ADV MAR BIOL, V69, P153, DOI 10.1016/B978-0-12-800214-8.00005-0; Friedlander AM, 2013, PAC SCI, V67, P441, DOI 10.2984/67.3.10; Friedlander AM, 2014, MARINE HSITORICAL EC; Grafeld S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182104; Johannes RE, 2002, ANNU REV ECOL SYST, V33, P317, DOI 10.1146/annurev.ecolsys.33.010802.150524; Jupiter S. D., 2011, J MARINE BIOL, V2011, DOI [10.1155/2011/940765, 940710.941155/942011/940765, DOI 10.1155/2011/940765]; JUVIK SP, 1998, ATLAS HAWAII; Kittinger JN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123856; Laurans Y, 2013, J ENV MANAGE; Ma H, 2015, RESULTS PILOT STUDY; Ma H, 2016, HAWAII MARINE RECREA, DOI [10.7289/V5/TM-PIFSC-55, DOI 10.7289/V5/TM-PIFSC-55]; Ma HG, 2018, FISH RES, V204, P197, DOI 10.1016/j.fishres.2018.02.010; Ma Hongguang, 2013, REN POW GEN C RPG 20, P1; McCoy K., 2015, ESTIMATING NEARSHORE; Nadon MO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133960; Nadon MO, 2017, STOCK ASSESSMENT COR; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pauly D, 2014, CURR OPIN ENV SUST, V7, P44, DOI 10.1016/j.cosust.2013.11.027; Pooley SG, 1993, MAR FISH REV, V55, P12; Schemmel E, 2016, ECOL SOC, V21, DOI 10.5751/ES-08818-210434; Schug D., 2001, HAWAIIAN J HIST, V35, P15; Severance C, 2013, PAC SCI, V67, P383, DOI 10.2984/67.3.6; Smith M. Kimberly, 1994, U S National Marine Fisheries Service Marine Fisheries Review, V55, P34; Turner RA, 2007, CORAL REEFS, V26, P997, DOI 10.1007/s00338-007-0238-6; Vaughan MB, 2013, PAC SCI, V67, P329, DOI 10.2984/67.3.3; Weijerman M, 2016, FISH B-NOAA, V114, P237, DOI 10.7755/FB.114.2.9; Williams I, 2013, H1304 NOAA PAC ISL F, P53; Williams ID, 2008, ENVIRON CONSERV, V35, P261, DOI 10.1017/S0376892908004876; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8; Zeller D, 2008, FISH RES, V91, P88, DOI 10.1016/j.fishres.2007.11.010	40	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195840	10.1371/journal.pone.0195840	http://dx.doi.org/10.1371/journal.pone.0195840			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659616	gold, Green Published, Green Submitted			2022-12-26	WOS:000430061100035
J	de Jaeger, L; Carreres, BM; Springer, J; Schaap, PJ; Eggink, G; Dos Santos, VAPM; Wijffels, RH; Martens, DE				de Jaeger, Lenny; Carreres, Benoit M.; Springer, Jan; Schaap, Peter J.; Eggink, Gerrit; Dos Santos, Vitor A. P. Martins; Wijffels, Rene H.; Martens, Dirk E.			Neochloris oleoabundans is worth its salt: Transcriptomic analysis under salt and nitrogen stress	PLOS ONE			English	Article							DIACYLGLYCEROL ACYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; LIPID-ACCUMULATION; WATER-STRESS; GREEN-ALGAE; TOLERANCE; PROLINE; GENES; MECHANISMS; EXPRESSION	Neochloris oleoabundans is an oleaginous microalgal species that can be cultivated in fresh water as well as salt water. Using salt water gives the opportunity to reduce production costs and the fresh water footprint for large scale cultivation. Production of triacylglycerols (TAG) usually includes a biomass growth phase in nitrogen-replete conditions followed by a TAG accumulation phase under nitrogen-deplete conditions. This is the first report that provides insight in the saline resistance mechanism of a fresh water oleaginous microalgae. To better understand the osmoregulatory mechanism of N. oleoabundans during growth and TAG accumulating conditions, the transcriptome was sequenced under four different conditions: fresh water nitrogen-replete and -deplete conditions, and salt water (525 mM dissolved salts, 448mM extra NaCl) nitrogen-replete and -deplete conditions. In this study, several pathways are identified to be responsible for salt water adaptation of N. oleoabundans under both nitrogen-replete and -deplete conditions. Proline and the ascorbate-glutathione cycle seem to be of importance for successful osmoregulation in N. oleoabundans. Genes involved in Proline biosynthesis were found to be upregulated in salt water. This was supported by Nuclear magnetic resonance (NMR) spectroscopy, which indicated an increase in proline content in the salt water nitrogen-replete condition. Additionally, the lipid accumulation pathway was studied to gain insight in the gene regulation in the first 24 hours after nitrogen was depleted. Oil accumulation is increased under nitrogen- deplete conditions in a comparable way in both fresh and salt water. The mechanism behind the biosynthesis of compatible osmolytes can be used to improve N. oleoabundans and other industrially relevant microalgal strains to create a more robust and sustainable production platform for microalgae derived products in the future.	[de Jaeger, Lenny; Eggink, Gerrit; Wijffels, Rene H.; Martens, Dirk E.] Wageningen Univ & Res, Bioproc Engn & AlgaePARC, Wageningen, Netherlands; [Carreres, Benoit M.; Schaap, Peter J.; Dos Santos, Vitor A. P. Martins] Wageningen Univ & Res, Lab Syst & Synthet Biol, Wageningen, Netherlands; [Springer, Jan; Eggink, Gerrit] Wageningen Univ & Res, Food & Biobased Res & AlgaePARC, Wageningen, Netherlands; [Dos Santos, Vitor A. P. Martins] LifeGlimmer GmbH, Berlin, Germany; [Wijffels, Rene H.] Nord Univ, Bodo, Norway	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Nord University	Martens, DE (corresponding author), Wageningen Univ & Res, Bioproc Engn & AlgaePARC, Wageningen, Netherlands.	dirk.martens@wur.nl		Carreres, Benoit/0000-0002-7532-7572; Wijffels, Rene/0000-0001-7630-4295; Schaap, Peter/0000-0002-4346-6084	Food and Nutrition Delta program of Agentschap: NL [FND10007]; Unilever; Wageningen University and Research Systems Biology [KB-17-003.02-29]	Food and Nutrition Delta program of Agentschap: NL; Unilever(Unilever); Wageningen University and Research Systems Biology	This study was supported by the Food and Nutrition Delta program of Agentschap: NL (FND10007), Unilever, and Wageningen University and Research Systems Biology (KB-17-003.02-29). Author VMDS is affiliated with LifeGlimmer GmbH but is not an employee nor has any financial or competing conflict whatsoever. The funders did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1984, PLANT PHYSIOL, V74, P1010, DOI 10.1104/pp.74.4.1010; Al-Karaki GN, 2000, J PLANT NUTR, V23, P1, DOI 10.1080/01904160009381992; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Azachi M, 2002, PLANT PHYSIOL, V129, P1320, DOI 10.1104/pp.001909; BAND CJ, 1992, PLANT CELL ENVIRON, V15, P129, DOI 10.1111/j.1365-3040.1992.tb01466.x; Bhargava P, 2005, J PLANT PHYSIOL, V162, P1220, DOI 10.1016/j.jplph.2004.12.006; BLUMWALD E, 1982, ARCH MICROBIOL, V132, P168, DOI 10.1007/BF00508725; Bohnert HJ, 1996, TRENDS BIOTECHNOL, V14, P89, DOI 10.1016/0167-7799(96)80929-2; Bold, 1962, SOME ALGAE ARID SOIL; Boratyn GM, 2012, BIOL DIRECT, V7, DOI 10.1186/1745-6150-7-12; Bremauntz M. D. P., 2011, NAT RESOUR, V2, P173, DOI DOI 10.4236/NR.2011.23023; Breuer G, 2014, BIOTECHNOL BIOFUELS, V7, DOI [10.1186/1754-6834-7-69, 10.1186/1754-6834-7-70]; Breuer G, 2013, JOVE-J VIS EXP, DOI 10.3791/50628; Breuer G, 2013, BIORESOURCE TECHNOL, V143, P1, DOI 10.1016/j.biortech.2013.05.105; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; Chaurasia N, 2008, BIOCHEM BIOPH RES CO, V376, P225, DOI 10.1016/j.bbrc.2008.08.129; Chen M, 2010, PLANT CELL, V22, P77, DOI 10.1105/tpc.109.071837; Chisti Y, 2007, BIOTECHNOL ADV, V25, P294, DOI 10.1016/j.biotechadv.2007.02.001; Conesa A., 2008, INT J PLANT GENOMICS; CSONKA LN, 1988, GENE, V64, P199, DOI 10.1016/0378-1119(88)90335-6; Curatti L, 2000, PLANTA, V211, P729, DOI 10.1007/s004250000343; de Fraiture C, 2008, WATER POLICY, V10, P67, DOI 10.2166/wp.2008.054; de Winter L, 2013, ALGAL RES, V2, P313, DOI 10.1016/j.algal.2013.09.001; Deng XD, 2012, MOL PLANT, V5, P945, DOI 10.1093/mp/sss040; Desplats P, 2005, PLANT PHYSIOL BIOCH, V43, P133, DOI 10.1016/j.plaphy.2005.01.008; Dunahay TG, 1996, APPL BIOCHEM BIOTECH, V57-8, P223, DOI 10.1007/BF02941703; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fargione J, 2008, SCIENCE, V319, P1235, DOI 10.1126/science.1152747; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Gao CF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-582; Gouveia L, 2009, J IND MICROBIOL BIOT, V36, P821, DOI 10.1007/s10295-009-0559-2; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Griffiths MJ, 2009, J APPL PHYCOL, V21, P493, DOI 10.1007/s10811-008-9392-7; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hauser F, 2010, PLANT CELL ENVIRON, V33, P552, DOI 10.1111/j.1365-3040.2009.02056.x; HELLEBUST JA, 1976, ANNU REV PLANT PHYS, V27, P485, DOI 10.1146/annurev.pp.27.060176.002413; HELLEBUST JA, 1989, PLANT CELL ENVIRON, V12, P621, DOI 10.1111/j.1365-3040.1989.tb01230.x; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Horton P, 2006, WORLD SCI, P39; HOWE G, 1992, PLANT PHYSIOL, V98, P127, DOI 10.1104/pp.98.1.127; Hsieh HJ, 2012, J MICROBIOL, V50, P526, DOI 10.1007/s12275-012-2041-5; Hu SX, 2001, PLANT SCI, V161, P987, DOI 10.1016/S0168-9452(01)00501-5; Jia J, 2015, ALGAL RES, V7, P66, DOI 10.1016/j.algal.2014.11.005; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kim HK, 2010, PHYTOCHEMISTRY, V71, P773, DOI 10.1016/j.phytochem.2010.02.001; Kim HK, 2010, NAT PROTOC, V5, P536, DOI 10.1038/nprot.2009.237; Klok AJ, 2013, BIORESOURCE TECHNOL, V134, P233, DOI 10.1016/j.biortech.2013.02.006; Krell A, 2007, J PHYCOL, V43, P753, DOI 10.1111/j.1529-8817.2007.00366.x; La Russa M, 2012, J BIOTECHNOL, V162, P13, DOI 10.1016/j.jbiotec.2012.04.006; Li J, 2014, PLANT CELL, V26, P1645, DOI 10.1105/tpc.113.121418; Lunn JE, 2002, PLANT PHYSIOL, V128, P1490, DOI 10.1104/pp.010898; MACKAY MA, 1983, MAR BIOL, V73, P301, DOI 10.1007/BF00392256; Mallick N, 2004, J PLANT PHYSIOL, V161, P591, DOI 10.1078/0176-1617-01230; Marrs KA, 1996, ANNU REV PLANT PHYS, V47, P127, DOI 10.1146/annurev.arplant.47.1.127; Mastrobuoni G, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-215; Mehta SK, 1999, NEW PHYTOL, V143, P253, DOI 10.1046/j.1469-8137.1999.00447.x; Morales-Sanchez D, 2016, ALGAL RES, V20, P22, DOI 10.1016/j.algal.2016.09.006; Moya JL, 2003, J EXP BOT, V54, P825, DOI 10.1093/jxb/erg064; Nikolau BJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P211, DOI 10.1016/S0003-9861(03)00156-5; Niu YF, 2013, MAR DRUGS, V11, P4558, DOI 10.3390/md11114558; Ohlrogge JB, 1997, ANNU REV PLANT PHYS, V48, P109, DOI 10.1146/annurev.arplant.48.1.109; Page-Sharp M, 1999, BBA-GEN SUBJECTS, V1472, P519, DOI 10.1016/S0304-4165(99)00155-5; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Rangasamy D, 2000, PLANT PHYSIOL, V122, P1225, DOI 10.1104/pp.122.4.1225; Rathmann R, 2010, RENEW ENERG, V35, P14, DOI 10.1016/j.renene.2009.02.025; Rismani-Yazdi H, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-74; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roesler K, 1997, PLANT PHYSIOL, V113, P75, DOI 10.1104/pp.113.1.75; Santos AM, 2012, BIORESOURCE TECHNOL, V104, P593, DOI 10.1016/j.biortech.2011.10.084; Sappl PG, 2009, PLANT J, V58, P53, DOI 10.1111/j.1365-313X.2008.03761.x; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Sharma P, 2005, J PLANT PHYSIOL, V162, P854, DOI 10.1016/j.jplph.2004.09.011; Singer MA, 1998, TRENDS BIOTECHNOL, V16, P460, DOI 10.1016/S0167-7799(98)01251-7; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Streeter JG, 2001, PLANT CELL ENVIRON, V24, P429, DOI 10.1046/j.1365-3040.2001.00690.x; Tardif M, 2012, MOL BIOL EVOLUTION, V178; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Trentacoste EM, 2013, P NATL ACAD SCI USA, V110, P19748, DOI 10.1073/pnas.1309299110; Vigeolas H, 2007, PLANT BIOTECHNOL J, V5, P431, DOI 10.1111/j.1467-7652.2007.00252.x; Wang DM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004094; WEGMANN K, 1986, FEMS MICROBIOL LETT, V39, P37; Wijffels RH, 2010, SCIENCE, V329, P796, DOI 10.1126/science.1189003; Zhang HY, 2005, PLANT SCI, V169, P1059, DOI 10.1016/j.plantsci.2005.07.010; Zhang LP, 2008, PLANT CELL PHYSIOL, V49, P411, DOI 10.1093/pcp/pcn017; Zhang YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069225	87	21	21	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194834	10.1371/journal.pone.0194834	http://dx.doi.org/10.1371/journal.pone.0194834			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652884	Green Submitted, gold, Green Published			2022-12-26	WOS:000430026900011
J	Feng, B; Yi, SV; Zhang, MM; Zhou, XY				Feng, Bing; Yi, Soojin V.; Zhang, Manman; Zhou, Xiaoyun			Development of novel EST-SSR markers for ploidy identification based on de novo transcriptome assembly for Misgurnus anguillicaudatus	PLOS ONE			English	Article							GENETIC DIVERSITY; TETRAPLOID LOACH; MICROSATELLITE LOCI; NATURAL OCCURRENCE; HEXAPLOID LOACH; HUBEI PROVINCE; CRUCIAN CARP; 1ST RECORD; CHINA; VALIDATION	The co-existence of several ploidy types in natural populations makes the cyprinid loach Misgurnus anguillicaudatus an exciting model system to study the genetic and phenotypic consequences of ploidy variations. A first step in such effort is to identify the specific ploidy of an individual. Currently popular methods of karyotyping via cytological preparation or flow cytometry require a large amount of tissue (such as blood) samples, which can be damaging or fatal to the fishes. Here, we developed novel microsatellite markers (SSR markers) from M. anguillicaudatus and show that they can effectively discriminate ploidy using samples collected in a minimally invasive way. Specifically, we generated whole genome transcriptomes from multiple M. anguillicaudatus using the Illumina paired-end sequencing. Approximately 150 million raw reads were assembled into 76,544 non-redundant unigenes. A total of 8,194 potential SSR markers were identified. We selected 98 pairs with more than five tandem repeats for further assays. Out of 45 putative EST-SSR markers that successfully amplified and harbored polymorphism in diploids, 11 markers displayed high variability in tetraploids. We further demonstrate that a set of five EST-SSR markers selected from these are sufficient to distinguish ploidy levels, by first validating them on 69 reference specimens with known ploidy levels and then subsequently using fresh-collected 96 ploidy-unknown specimens. The results from EST-SSR markers are highly concordant with those from independent flow cytometry analysis. The novel EST-SSR markers developed here should facilitate genetic studies of polyploidy in the emerging model system M. anguillicaudatus.	[Feng, Bing; Zhang, Manman; Zhou, Xiaoyun] Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China; [Yi, Soojin V.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	Huazhong Agricultural University; University System of Georgia; Georgia Institute of Technology	Zhou, XY (corresponding author), Huazhong Agr Univ, Coll Fisheries, Key Lab Agr Anim Genet Breeding & Reprod, Minist Educ, Wuhan, Hubei, Peoples R China.	zhouxy@mail.hzau.edu.cn		Zhou, Xiaoyun/0000-0002-8488-3829	National Natural Science Foundation of China [31472267]; Georgia Tech Zoo Atlanta Collaborative grant	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Georgia Tech Zoo Atlanta Collaborative grant	This study is supported by the National Natural Science Foundation of China (No. 31472267) to Xiaoyun Zhou and a Georgia Tech Zoo Atlanta Collaborative grant to Soojin V. Yi. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas K, 2009, J FISH BIOL, V75, P435, DOI 10.1111/j.1095-8649.2009.02320.x; ARAI K, 1993, AQUACULTURE, V117, P227, DOI 10.1016/0044-8486(93)90322-P; Arai K, 2003, FOLIA BIOL-KRAKOW, V51, P107; ARAI K, 1991, NIPPON SUISAN GAKK, V57, P2173; Arai K, 1999, FISHERIES SCI, V65, P186, DOI 10.2331/fishsci.65.186; Arai K, 1995, AQUACULTURE, V137, P131, DOI 10.1016/0044-8486(95)01106-4; Bai ZY, 2011, INT J BIOL SCI, V7, P279, DOI 10.7150/ijbs.7.279; Biasi A, 2015, J MICROBIOL METH, V110, P61, DOI 10.1016/j.mimet.2015.01.012; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boron A, 2000, FOLIA ZOOL, V49, P37; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cui L, 2013, FOLIA ZOOL, V62, P14; Drozd B, 2010, J FISH BIOL, V77, P2163, DOI 10.1111/j.1095-8649.2010.02794.x; Ellis JR, 2007, HEREDITY, V99, P125, DOI 10.1038/sj.hdy.6801001; Ene C, 2000, FOLIA ZOOL, V49, P91; Esselink GD, 2004, THEOR APPL GENET, V109, P402, DOI 10.1007/s00122-004-1645-5; Feng B, 2017, ENVIRON BIOL FISH, V100, P815, DOI 10.1007/s10641-017-0608-z; Ferrante SP, 2010, EUPHYTICA, V173, P223, DOI 10.1007/s10681-009-0093-3; Flajoulot S, 2005, THEOR APPL GENET, V111, P1420, DOI 10.1007/s00122-005-0074-4; Ghose K, 2013, SCI HORTIC-AMSTERDAM, V160, P251, DOI 10.1016/j.scienta.2013.01.016; Glover KA, 2016, BIOL INVASIONS, V18, P1287, DOI 10.1007/s10530-016-1066-9; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo W, 2016, SCI REP-UK, V6, DOI 10.1038/srep37702; Hernandez-Urcera J, 2012, AQUACULTURE, V330, P179, DOI 10.1016/j.aquaculture.2011.11.039; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Lampert KP, 2006, J GENET, V85, P67, DOI 10.1007/BF02728973; Leggatt RA, 2003, REV FISH BIOL FISHER, V13, P237, DOI 10.1023/B:RFBF.0000033049.00668.fe; Lemer S, 2011, J HERED, V102, P243, DOI 10.1093/jhered/esq123; Li Kang, 1983, Zoological Research, V4, P75; Li YJ, 2008, NIPPON SUISAN GAKK, V74, P177, DOI 10.2331/suisan.74.177; Li YJ, 2011, GENETICA, V139, P805, DOI 10.1007/s10709-011-9585-x; Li Ya-juan, 2009, Dalian Shuichan Xueyuan Xuebao, V24, P236; Li YH, 2011, INDIAN J EXP BIOL, V49, P953; Lopez-Pujol J, 2004, ANN BOT-LONDON, V93, P323, DOI 10.1093/aob/mch039; Lopez-Pujol J, 2007, BOT J LINN SOC, V155, P211, DOI 10.1111/j.1095-8339.2007.00689.x; Mishina T, 2014, ICHTHYOL RES, V61, P169, DOI 10.1007/s10228-014-0388-9; Mousavi S, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01283; Nie HT, 2014, BIOCHEM SYST ECOL, V54, P326, DOI 10.1016/j.bse.2014.03.007; Ohara K, 1999, ZOOL SCI, V16, P909, DOI 10.2108/zsj.16.909; Ohara K, 2000, ZOOL SCI, V17, P357, DOI 10.2108/jsz.17.357; OJIMA Y, 1979, P JPN ACAD B-PHYS, V55, P487, DOI 10.2183/pjab.55.487; Palop-Esteban M, 2011, GENETICA, V139, P1309, DOI 10.1007/s10709-012-9632-2; Park SDE, 2001, THESIS; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Rungis D, 2004, THEOR APPL GENET, V109, P1283, DOI 10.1007/s00122-004-1742-5; Smith JSC, 1997, THEOR APPL GENET, V95, P163, DOI 10.1007/s001220050544; Spoz A, 2017, FOLIA BIOL-KRAKOW, V65, P62, DOI 10.3409/fb65_1.63; Van Puyvelde K, 2010, MOL ECOL RESOUR, V10, P331, DOI 10.1111/j.1755-0998.2009.02748.x; Yu YY, 2014, PAK J AGR SCI, V51, P273; Zala HN, 2017, J PLANT BIOCHEM BIOT, V26, P356, DOI 10.1007/s13562-017-0398-6; Zhong Jia, 2015, Journal of Fisheries of China, V39, P1089; Zhou XY, 2008, J APPL ICHTHYOL, V24, P664, DOI 10.1111/j.1439-0426.2008.01116.x	54	9	13	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195829	10.1371/journal.pone.0195829	http://dx.doi.org/10.1371/journal.pone.0195829			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649332	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900096
J	Gunnarsen, KS; Hoydahl, LS; Neumann, RS; Bjerregaard-Andersen, K; Nilssen, NR; Sollid, LM; Sandlie, I; Loset, GA				Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Bjerregaard-Andersen, Kaare; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age			Soluble T-cell receptor design influences functional yield in an E. coli chaperone-assisted expression system	PLOS ONE			English	Article							ESCHERICHIA-COLI; CELIAC-DISEASE; CANCER-IMMUNOTHERAPY; PHAGE DISPLAY; RECOGNITION; AFFINITY; BINDING; ANTIBODIES; COMPLEXES; PEPTIDES	There is a quest for production of soluble protein of high quality for the study of T-cell receptors (TCRs), but expression often results in low yields of functional molecules. In this study, we used an E. coli chaperone-assisted periplasmic production system and compared expression of 4 different soluble TCR formats: single-chain TCR (scTCR), two different disulfide-linked TCR (dsTCR) formats, and chimeric Fab (cFab). A stabilized version of scTCR was also included. Additionally, we evaluated the influence of host (XL1-Blue or RosettaBlue (TM)) and the effect of IPTG induction on expression profiles. A celiac disease patient-derived TCR with specificity for gluten was used, and we achieved detectable expression for all formats and variants. We found that expression in RosettaBlue (TM) without IPTG induction resulted in the highest periplasmic yields. Moreover, after large-scale expression and protein purification, only the scTCR format was obtained in high yields. Importantly, stability engineering of the scTCR was a prerequisite for obtaining reliable biophysical characterization of the TCR-pMHC interaction. The scTCR format is readily compatible with high-throughput screening approaches that may enable both development of reagents allowing for defined peptide MHC (pMHC) characterization and discovery of potential novel therapeutic leads.	[Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age] Univ Oslo, Ctr Immune Regulat, Oslo, Norway; [Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age] Natl Hosp Norway, Oslo Univ Hosp, Oslo, Norway; [Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Neumann, Ralf Stefan; Nilssen, Nicolay Rustad; Sollid, Ludvig Magne; Sandlie, Inger; Loset, Geir Age] Univ Oslo, Dept Immunol, Oslo, Norway; [Gunnarsen, Kristin Stoen; Hoydahl, Lene Stokken; Nilssen, Nicolay Rustad; Sandlie, Inger; Loset, Geir Age] Univ Oslo, Dept Biosci, Oslo, Norway; [Bjerregaard-Andersen, Kaare] Univ Oslo, Dept Chem, Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, KG Jebsen Coeliac Dis Res Ctr, Oslo, Norway; [Sollid, Ludvig Magne] Univ Oslo, Dept Immunol, Oslo, Norway; [Loset, Geir Age] Nextera AS, Oslo, Norway	University of Oslo; University of Oslo; National Hospital Norway; University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Loset, GA (corresponding author), Univ Oslo, Ctr Immune Regulat, Oslo, Norway.; Loset, GA (corresponding author), Natl Hosp Norway, Oslo Univ Hosp, Oslo, Norway.; Loset, GA (corresponding author), Univ Oslo, Dept Immunol, Oslo, Norway.; Loset, GA (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.; Loset, GA (corresponding author), Nextera AS, Oslo, Norway.	g.a.loset@ibv.uio.no	Høydahl, Lene/AAN-6511-2021; Løset, Geir/I-6413-2015	Løset, Geir/0000-0002-5257-8571; Bjerregaard-Andersen, Kaare/0000-0003-3609-3408; Hoydahl, Lene Stokken/0000-0001-6070-1413	South-Eastern Norway Regional Health Authority [2012046]; Research Council of Norway [197085]; Research Council of Norway through its Centers of Excellence funding scheme [179573N40]	South-Eastern Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Research Council of Norway through its Centers of Excellence funding scheme	The study was funded with grants from South-Eastern Norway Regional Health Authority (grant 2012046, https://www.helse-sorost.no/, KSG), the Research Council of Norway (grant number 197085, https://www.forskningsradet.no/en/Home_page/1177315753906 LSH), and the Research Council of Norway through its Centers of Excellence funding scheme, project number 179573N40, LSH and GAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. GAL is in part employed by the commercial company Nextera AS. The funder provided support in the form of salary for author GAL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Bailey LJ, 2018, J MOL BIOL, V430, P337, DOI 10.1016/j.jmb.2017.12.012; Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029; Boulter JM, 2003, PROTEIN ENG, V16, P707, DOI 10.1093/protein/gzg087; Broughton SE, 2012, IMMUNITY, V37, P611, DOI 10.1016/j.immuni.2012.07.013; Cameron BJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006034; CHANG HC, 1994, P NATL ACAD SCI USA, V91, P11408, DOI 10.1073/pnas.91.24.11408; CHUNG S, 1994, P NATL ACAD SCI USA, V91, P12654, DOI 10.1073/pnas.91.26.12654; Cole DK, 2007, J IMMUNOL, V178, P5727, DOI 10.4049/jimmunol.178.9.5727; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; Fallang LE, 2008, J IMMUNOL, V181, P5451, DOI 10.4049/jimmunol.181.8.5451; Gunnarsen KS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01162; Gunnarsen KS, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-8; Gunnarsen KS, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95193; June CH, 2017, NAT MED, V23, P540, DOI 10.1038/nm.4321; Kipriyanov SM, 1997, J IMMUNOL METHODS, V200, P69, DOI 10.1016/S0022-1759(96)00188-3; Lebowitz MS, 1999, CELL IMMUNOL, V192, P175, DOI 10.1006/cimm.1999.1441; Liddy N, 2010, MOL BIOTECHNOL, V45, P140, DOI 10.1007/s12033-010-9250-0; Loset GA, 2007, PROTEIN ENG DES SEL, V20, P461, DOI 10.1093/protein/gzm044; Lunde E, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-61; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Maynard J, 2005, IMMUNITY, V22, P81, DOI 10.1016/j.immuni.2004.11.015; Mazor Y, 2007, NAT BIOTECHNOL, V25, P563, DOI 10.1038/nbt1296; Molloy PE, 2005, CURR OPIN PHARMACOL, V5, P438, DOI 10.1016/j.coph.2005.02.004; Nieba L, 1997, PROTEIN ENG, V10, P435, DOI 10.1093/protein/10.4.435; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; NOVOTNY J, 1991, P NATL ACAD SCI USA, V88, P8646, DOI 10.1073/pnas.88.19.8646; Pecorari F, 1999, J MOL BIOL, V285, P1831, DOI 10.1006/jmbi.1998.2422; Petersen J, 2016, STRUCTURE, V24, P1643, DOI 10.1016/j.str.2016.07.010; Petersen J, 2014, NAT STRUCT MOL BIOL, V21, P480, DOI 10.1038/nsmb.2817; Qiao SW, 2011, J IMMUNOL, V187, P3064, DOI 10.4049/jimmunol.1101526; Quarsten H, 2001, J IMMUNOL, V167, P4861, DOI 10.4049/jimmunol.167.9.4861; Raman MCC, 2016, SCI REP-UK, V6, DOI 10.1038/srep18851; Richman SA, 2009, MOL IMMUNOL, V46, P902, DOI 10.1016/j.molimm.2008.09.021; Robinson MP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9072; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Schmitt TM, 2017, NAT BIOTECHNOL, V35, P1188, DOI 10.1038/nbt.4004; Sharma P., 2016, F1000RESEARCH, V5, P2344, DOI [DOI 10.12688/F1000RESEARCH.9073.1, 10.12688/f1000research.9073.1]; Shusta EV, 2000, NAT BIOTECHNOL, V18, P754, DOI 10.1038/77325; Simmons LC, 2002, J IMMUNOL METHODS, V263, P133, DOI 10.1016/S0022-1759(02)00036-4; Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085; VIKEN HD, 1995, HUM IMMUNOL, V42, P319, DOI 10.1016/0198-8859(94)00110-C; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0; Welschof M, 1997, P NATL ACAD SCI USA, V94, P1902, DOI 10.1073/pnas.94.5.1902; Willcox BE, 1999, PROTEIN SCI, V8, P2418	44	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195868	10.1371/journal.pone.0195868	http://dx.doi.org/10.1371/journal.pone.0195868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649333	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900099
J	Kilsdonk, MJ; Siesling, S; van Dijk, BAC; Wouters, MW; van Hartenm, WH				Kilsdonk, Melvin J.; Siesling, Sabine; van Dijk, Boukje A. C.; Wouters, Michel W.; van Hartenm, Wim H.			What drives centralisation in cancer care?	PLOS ONE			English	Article							HOSPITAL VOLUME; SURGEON VOLUME; MORTALITY; OUTCOMES; QUALITY; REGISTRATION; IMPACT	Background To improve quality of care, centralisation of cancer services in high-volume centres has been stimulated. Studies linking specialisation and high (surgical) volumes to better outcomes already appeared in the 1990's. However, actual centralisation was a difficult process in many countries. In this study, factors influencing the centralisation of cancer services in the Netherlands were determined. Material and methods Centralisation patterns were studied for three types of cancer that are known to benefit from high surgical caseloads: oesophagus-, pancreas- and bladder cancer. The Netherlands Cancer Registry provided data on tumour and treatment characteristics from 2000-2013 for respectively 8037,4747 and 6362 patients receiving surgery. By plotting timelines of centralisation of cancer surgery, relations with the appearance of (inter)national scientific evidence, actions of medical specialist societies, specific regulation and other important factors on the degree of centralisation were ascertained. Results For oesophagus and pancreas cancer, a gradual increase in centralisation of surgery is seen from 2005 and 2006 onwards following (inter)national scientific evidence. Centralisation steps for bladder cancer surgery can be seen in 2010 and 2013 anticipating on the publication of norms by the professional society. The most influential stimulus seems to have been regulations on minimum volumes. Conclusion Scientific evidence on the relationship between volume and outcome lead to the start of centralisation of surgical cancer care in the Netherlands. Once a body of evidence has been established on organisational change that influences professional practice, in addition some form of regulation is needed to ensure widespread implementation.	[Kilsdonk, Melvin J.; Siesling, Sabine; van Dijk, Boukje A. C.] Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands; [Kilsdonk, Melvin J.; Siesling, Sabine; van Hartenm, Wim H.] Univ Twente, Sch Management & Governance, Dept Hlth Technol & Serv Res, Enschede, Netherlands; [van Dijk, Boukje A. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Wouters, Michel W.; van Hartenm, Wim H.] Netherlands Canc Inst, Amsterdam, Netherlands	University of Twente; University of Groningen; Netherlands Cancer Institute	Kilsdonk, MJ (corresponding author), Netherlands Comprehens Canc Org, Dept Res, Utrecht, Netherlands.; Kilsdonk, MJ (corresponding author), Univ Twente, Sch Management & Governance, Dept Hlth Technol & Serv Res, Enschede, Netherlands.	mkilsdonk@hotmail.com	Wouters, Michel/B-5882-2019	Wouters, Michel/0000-0001-6173-0662				[Anonymous], 2015, CBS STAT NETHERLANDS; Billingsley KG, 2007, ARCH SURG-CHICAGO, V142, P23, DOI 10.1001/archsurg.142.1.23; Birkmeyer JD, 2003, NEW ENGL J MED, V349, P2117, DOI 10.1056/NEJMsa035205; Birkmeyer JD, 2002, NEW ENGL J MED, V346, P1128, DOI 10.1056/NEJMsa012337; de Vries RR, 2010, WORLD J UROL, V28, P431, DOI 10.1007/s00345-010-0512-z; Dudley RA, 2000, JAMA-J AM MED ASSOC, V283, P1159, DOI 10.1001/jama.283.9.1159; Dutch Society for Urology, 2015, KWAL BLAASC; Elting LS, 2005, CANCER-AM CANCER SOC, V104, P975, DOI 10.1002/cncr.21273; Goossens-Laan C A, 2010, Eur J Surg Oncol, V36 Suppl 1, pS100, DOI 10.1016/j.ejso.2010.06.003; Goossens-Laan CA, 2012, BJU INT, V110, P226, DOI 10.1111/j.1464-410X.2011.10694.x; Gouma D J, 1997, Ned Tijdschr Geneeskd, V141, P1738; Gouma DJ, 2000, ANN SURG, V232, P786, DOI 10.1097/00000658-200012000-00007; Halm EA, 2002, ANN INTERN MED, V137, P511, DOI 10.7326/0003-4819-137-6-200209170-00012; Hillner BE, 2000, J CLIN ONCOL, V18, P2327, DOI 10.1200/JCO.2000.18.11.2327; Ho VKY, 2008, EUR J CANCER, V44, P683, DOI 10.1016/j.ejca.2008.01.027; Hollenbeck BK, 2007, J UROLOGY, V177, P2095, DOI 10.1016/j.juro.2007.01.153; Killeen SD, 2005, BRIT J SURG, V92, P389, DOI 10.1002/bjs.4954; Liu CJ, 2015, CANCER-AM CANCER SOC, V121, P2782, DOI 10.1002/cncr.29356; LUFT HS, 1979, NEW ENGL J MED, V301, P1364, DOI 10.1056/NEJM197912203012503; SCHOUTEN LJ, 1993, BRIT J CANCER, V68, P974, DOI 10.1038/bjc.1993.464; SCHOUTEN LJ, 1993, INT J EPIDEMIOL, V22, P369, DOI 10.1093/ije/22.3.369; Schrag D, 2003, J SURG ONCOL, V83, P68, DOI 10.1002/jso.10244; Smolders KHA, 2012, INT J QUAL HEALTH C, V24, P129, DOI 10.1093/intqhc/mzs003; Stichting Oncologische Samenwerking, 2015, MULT NORM ONC ZORG N; van Heek NT, 2005, ANN SURG, V242, P781, DOI 10.1097/01.sla.0000188462.00249.36; van Lanschot JJB, 2001, CANCER-AM CANCER SOC, V91, P1574, DOI 10.1002/1097-0142(20010415)91:8<1574::AID-CNCR1168>3.0.CO;2-2; Wouters M W J M, 2010, Eur J Surg Oncol, V36 Suppl 1, pS3, DOI 10.1016/j.ejso.2010.06.004; Wouters MWJM, 2009, ANN SURG ONCOL, V16, P1789, DOI 10.1245/s10434-009-0458-9	28	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195673	10.1371/journal.pone.0195673	http://dx.doi.org/10.1371/journal.pone.0195673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649250	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900069
J	An, WD; Du, YF; Ye, KQ				An, Weidong; Du, Yifei; Ye, Keqiong			Structural and functional analysis of Utp24, an endonuclease for processing 18S ribosomal RNA	PLOS ONE			English	Article							PIN DOMAIN; EARLIEST PRECURSORS; 90S PRERIBOSOME; ASSEMBLY EVENTS; YEAST; NUCLEASE; PROTEINS; SITE; BIOGENESIS; SUBUNITS	The precursor ribosomal RNA is processed by multiple steps of nucleolytic cleavage to generate mature rRNAs. Utp24 is a PIN domain endonuclease in the early 90S precursor of small ribosomal subunit and is proposed to cleave at sites A1 and A2 of pre-rRNA. Here we determine the crystal structure of Utp24 from Schizosaccharomyces pombe at 2.1 angstrom resolution. Utp24 structurally resembles the ribosome assembly factor Utp23 and both contain a Zn-finger motif. Functional analysis in Saccharomyces cerevisiae shows that depletion of Utp24 disturbs the assembly of 90S and abolishes cleavage at sites A0, A1 and A2. The 90S assembled with inactivated Utp24 is arrested at a post-A0-cleavage state and contains enriched nuclear exosome for degradation of 5' ETS. Despite of high sequence conservation, Utp24 from other organisms is unable to form an active 90S in S. cerevisiae, suggesting that Utp24 needs to be precisely positioned in 90S. Our study provides biochemical and structural insight into the role of Utp24 in 90S assembly and activity.	[An, Weidong] China Agr Univ, Coll Biol Sci, Beijing, Peoples R China; [An, Weidong] Natl Inst Biol Sci, Beijing, Peoples R China; [An, Weidong; Du, Yifei; Ye, Keqiong] Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China; [Du, Yifei; Ye, Keqiong] Univ Chinese Acad Sci, Beijing, Peoples R China	China Agricultural University; National Institute of Biological Sciences, Beijing; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Ye, KQ (corresponding author), Chinese Acad Sci, Inst Biophys, CAS Ctr Excellence Biomacromol, Key Lab RNA Biol, Beijing, Peoples R China.; Ye, KQ (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.	yekeqiong@ibp.ac.cn		Du, Yifei/0000-0002-9362-8766; Ye, Keqiong/0000-0001-6169-7049	Strategic Priority Research Program of Chinese Academy of Sciences [XDB08010203]; National Key R&D Program of China [2017YFA0504600]; National Natural Science Foundation of China [31430024, 91540201, 31325007]; 100 Talents Program of CAS	Strategic Priority Research Program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 100 Talents Program of CAS(Chinese Academy of Sciences)	The study was supported by Strategic Priority Research Program of Chinese Academy of Sciences [XDB08010203], National Key R&D Program of China [2017YFA0504600], National Natural Science Foundation of China [31430024, 91540201, 31325007] and 100 Talents Program of CAS to Keqiong Ye. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arcus VL, 2004, J BIOL CHEM, V279, P16471, DOI 10.1074/jbc.M313833200; Barandun J, 2017, NAT STRUCT MOL BIOL, V24, P944, DOI 10.1038/nsmb.3472; Bleichert F, 2006, P NATL ACAD SCI USA, V103, P9464, DOI 10.1073/pnas.0603673103; Campbell MS, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016986, 10.1371/journal.pone.0018283]; Chaker-Margot M, 2017, SCIENCE, V355, DOI 10.1126/science.aal1880; Chaker-Margot M, 2015, NAT STRUCT MOL BIOL, V22, P920, DOI 10.1038/nsmb.3111; Chen W, 2017, NUCLEIC ACIDS RES, V45, P6837, DOI 10.1093/nar/gkx254; Cheng JD, 2017, NAT STRUCT MOL BIOL, V24, P954, DOI 10.1038/nsmb.3476; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; de la Cruz J, 2015, ANNU REV BIOCHEM, V84, P93, DOI 10.1146/annurev-biochem-060614-033917; Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erijman A, 2011, J STRUCT BIOL, V175, P171, DOI 10.1016/j.jsb.2011.04.005; Fatica A, 2004, RNA, V10, P1698, DOI 10.1261/rna.7123504; Glavan F, 2006, EMBO J, V25, P5117, DOI 10.1038/sj.emboj.7601377; Grandi P, 2002, MOL CELL, V10, P105, DOI 10.1016/S1097-2765(02)00579-8; Henras AK, 2015, WIRES RNA, V6, P225, DOI 10.1002/wrna.1269; Hoareau-Aveilla C, 2011, NUCLEIC ACIDS RES, V40, P3641; Horn DM, 2011, J BIOL CHEM, V286, P34082, DOI 10.1074/jbc.M111.268649; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Kornprobst M, 2016, CELL, V166, P380, DOI 10.1016/j.cell.2016.06.014; Kos-Braun IC, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000245; Lin JZ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001669; Lu J, 2013, RNA, V19, P1815, DOI 10.1261/rna.040808.113; Osheim YN, 2004, MOL CELL, V16, P943, DOI 10.1016/j.molcel.2004.11.031; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perez-Fernandez J, 2007, MOL CELL BIOL, V27, P5414, DOI 10.1128/MCB.00380-07; Perez-Fernandez J, 2011, NUCLEIC ACIDS RES, V39, P8105, DOI 10.1093/nar/gkr508; Rempola B, 2006, BIOCHEM BIOPH RES CO, V346, P546, DOI 10.1016/j.bbrc.2006.05.140; Schafer T, 2003, EMBO J, V22, P1370, DOI 10.1093/emboj/cdg121; Schafer T, 2006, NATURE, V441, P651, DOI 10.1038/nature04840; Senissar M, 2017, PROTEIN SCI, V26, P1474, DOI 10.1002/pro.3193; Sun Q, 2017, ELIFE, V6, DOI 10.7554/eLife.22086; Tanaka N, 2011, RNA, V17, P595, DOI 10.1261/rna.2571811; Thoms M, 2015, CELL, V162, P1029, DOI 10.1016/j.cell.2015.07.060; Tomecki R, 2015, RNA BIOL, V12, P1010, DOI 10.1080/15476286.2015.1073437; Wang B, 2017, NUCLEIC ACIDS RES, V45, P3559, DOI 10.1093/nar/gkw1323; Wells GR, 2017, NUCLEIC ACIDS RES, V45, P4796, DOI 10.1093/nar/gkw1344; Wells GR, 2016, NUCLEIC ACIDS RES, V44, P5399, DOI 10.1093/nar/gkw213; Woolford JL, 2013, GENETICS, V195, P643, DOI 10.1534/genetics.113.153197; Zhang LM, 2016, GENE DEV, V30, P718, DOI 10.1101/gad.274688.115; Zhu JY, 2016, MOL CELL BIOL, V36, P965, DOI 10.1128/MCB.00773-15	44	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195723	10.1371/journal.pone.0195723	http://dx.doi.org/10.1371/journal.pone.0195723			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641590	gold, Green Published			2022-12-26	WOS:000429742900088
J	Deb, D; Mackey, D; Opiyo, SO; McDowell, JM				Deb, Devdutta; Mackey, David; Opiyo, Stephen O.; McDowell, John M.			Application of alignment-free bioinformatics methods to identify an oomycete protein with structural and functional similarity to the bacterial AvrE effector protein	PLOS ONE			English	Article							PLANT IMMUNE-SYSTEM; STEWARTII SUBSP STEWARTII; PARTIAL LEAST-SQUARES; PSEUDOMONAS-SYRINGAE; PATHOGEN EFFECTORS; ERWINIA-AMYLOVORA; PHYTOPHTHORA-INFESTANS; DISEASE SUSCEPTIBILITY; ARABIDOPSIS-THALIANA; VIRULENCE EFFECTORS	Diverse plant pathogens export effector proteins to reprogram host cells. One of the most challenging goals in the molecular plant-microbe field is to functionally characterize the complex repertoires of effectors secreted by these pathogens. For bacterial pathogens, the predominant class of effectors is delivered to host cells by Type III secretion. For oomycetes, the predominant class of effectors is defined by a signal peptide that mediates secretion from the oomycete and a conserved RxLR motif. Downy mildew pathogens and Phytophthora species maintain hundreds of candidate RxLR effector genes in their genomes. Although no primary sequence similarity is evident between bacterial Type III effectors (T3Es) and oomycete RXLR effectors, some bacterial and oomycete effectors have convergently evolved to target the same host proteins. Such effectors might have evolved domains that are functionally similar but sequence-unrelated. We reasoned that alignment-free bioinformatics approaches could be useful to identify structural similarities between bacterial and oomycete effectors. To test this approach, we used partial least squares regression, alignment-free bioinformatics methods to identify effector proteins from the genome of the oomycete Hyaloperonospora arabidopsidis that are similar to the well-studied AvrE1 effector from Pseudomonas syringae. This approach identified five RxLR proteins with putative structural similarity to AvrE1. We focused on one, HaRxL23, because it is an experimentally validated effector and it is conserved between distantly related oomycetes. Several experiments indicate that HaRxL23 is functionally similar to AvrE1, including the ability to partially rescue an AvrE1 loss-of-function mutant. This study provides an example of how an alignment-free bioinformatics approach can identify functionally similar effector proteins in the absence of primary sequence similarity. This approach could be useful to identify effectors that have convergently evolved regardless of whether the shared host target is known.	[Deb, Devdutta; McDowell, John M.] Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA; [Mackey, David] Ohio State Univ, Dept Hort, Columbus, OH 43210 USA; [Mackey, David] Ohio State Univ, Dept Crop Sci, Columbus, OH 43210 USA; [Mackey, David] Ohio State Univ, Dept Mol Genet, Columbus, OH 43210 USA; [Opiyo, Stephen O.] Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol & Cellular Imaging Ctr Columbus, Columbus, OH 43210 USA	Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	McDowell, JM (corresponding author), Virginia Tech, Dept Plant Pathol Physiol & Weed Sci, Blacksburg, VA 24061 USA.; Opiyo, SO (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Mol & Cellular Imaging Ctr Columbus, Columbus, OH 43210 USA.	opiyo.1@osu.edu; johnmcd@vt.edu		McDowell, John/0000-0002-9070-4874	National Science Foundation Division of Integrative Organismal Systems Grant [IOS-1353366]; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2009-03008, 2016-67013-24727]	National Science Foundation Division of Integrative Organismal Systems Grant; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture	This work was supported by the National Science Foundation Division of Integrative Organismal Systems Grant no. IOS-1353366 (JM) and by Agriculture and Food Research Initiative Competitive Grant nos. 2009-03008 (JM) and 2016-67013-24727 (DM) from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano JR, 2000, P NATL ACAD SCI USA, V97, P4856, DOI 10.1073/pnas.97.9.4856; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amaro TMMM, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00099; Anderson RG, 2015, MOL PLANT MICROBE IN, V28, P1063, DOI 10.1094/MPMI-01-15-0022-CR; Badel JL, 2006, MOL PLANT MICROBE IN, V19, P99, DOI 10.1094/MPMI-19-0099; Baxter L, 2010, SCIENCE, V330, P1549, DOI 10.1126/science.1195203; Bent AF, 2007, ANNU REV PHYTOPATHOL, V45, P399, DOI 10.1146/annurev.phyto.45.062806.094427; Bogdanove AJ, 1998, J BACTERIOL, V180, P2244, DOI 10.1128/JB.180.8.2244-2247.1998; Bozkurt TO, 2012, CURR OPIN PLANT BIOL, V15, P483, DOI 10.1016/j.pbi.2012.03.008; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cohn M, 2014, MOL PLANT MICROBE IN, V27, P1186, DOI 10.1094/MPMI-06-14-0161-R; Cook DE, 2015, ANNU REV PHYTOPATHOL, V53, P541, DOI 10.1146/annurev-phyto-080614-120114; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Cumbie JS, 2010, 10 JAP US SEM GEN EN; Da Cunha L, 2007, CURR OPIN PLANT BIOL, V10, P349, DOI 10.1016/j.pbi.2007.04.018; Dalio RJD, 2018, MOL PLANT MICROBE IN, V31, P22, DOI 10.1094/MPMI-07-17-0174-FI; Deb D, 2018, MOL PLANT MICROBE IN, V31, P374, DOI 10.1094/MPMI-07-17-0169-FI; DebRoy S, 2004, P NATL ACAD SCI USA, V101, P9927, DOI 10.1073/pnas.0401601101; Feng F, 2012, CURR OPIN PLANT BIOL, V15, P469, DOI 10.1016/j.pbi.2012.03.004; Gangadharan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082032; Garbutt CC, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00312; Gaudriault S, 1997, MOL MICROBIOL, V26, P1057, DOI 10.1046/j.1365-2958.1997.6442015.x; GELADI P, 1986, ANAL CHIM ACTA, V185, P1, DOI 10.1016/0003-2670(86)80028-9; Geng XQ, 2012, PLANT CELL, V24, P4763, DOI 10.1105/tpc.112.105312; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Ham JH, 2008, MOL PLANT PATHOL, V9, P633, DOI 10.1111/J.1364-3703.2008.00489.X; Ham JH, 2006, MOL PLANT MICROBE IN, V19, P1092, DOI 10.1094/MPMI-19-1092; Ham JH, 2009, MOL PLANT MICROBE IN, V22, P703, DOI 10.1094/MPMI-22-6-0703; Hein I, 2009, MOL PLANT PATHOL, V10, P547, DOI [10.1111/J.1364-3703.2009.00547.X, 10.1111/j.1364-3703.2009.00547.x]; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang RHY, 2012, ANNU REV PHYTOPATHOL, V50, P295, DOI 10.1146/annurev-phyto-081211-172912; Jin L, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005609; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kale SD, 2010, CELL, V142, P284, DOI 10.1016/j.cell.2010.06.008; Kamoun S, 2015, MOL PLANT PATHOL, V16, P413, DOI 10.1111/mpp.12190; Karchin R, 2002, BIOINFORMATICS, V18, P147, DOI 10.1093/bioinformatics/18.1.147; Katagiri F, 2010, MOL PLANT MICROBE IN, V23, P1531, DOI 10.1094/MPMI-04-10-0099; Kemen E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001094; Khan M, 2016, CURR OPIN MICROBIOL, V29, P49, DOI 10.1016/j.mib.2015.10.006; Levesque CA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r73; LINDGREN PB, 1986, J BACTERIOL, V168, P512, DOI 10.1128/jb.168.2.512-522.1986; Links MG, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-503; LORANG JM, 1995, MOL PLANT MICROBE IN, V8, P49, DOI 10.1094/MPMI-8-0049; Lozano-Torres JL, 2012, P NATL ACAD SCI USA, V109, P10119, DOI 10.1073/pnas.1202867109; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; McDowell JM, 2014, GENOMICS PLANT ASS F, P209; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Opiyo S. O., 2013, African Journal of Biotechnology, V12, P5804; Opiyo SO, 2007, J PROTEOME RES, V6, P846, DOI 10.1021/pr060534k; Petre B, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001801; Petsko G.A., 2003, PROTEIN STRUCTURE FU; Raffaele S, 2010, SCIENCE, V330, P1540, DOI 10.1126/science.1193070; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Siamer S, 2013, FEMS MICROBIOL LETT, V342, P54, DOI 10.1111/1574-6968.12108; Sohn KH, 2007, PLANT CELL, V19, P4077, DOI 10.1105/tpc.107.054262; Song J, 2009, P NATL ACAD SCI USA, V106, P1654, DOI 10.1073/pnas.0809201106; Streubel J, 2013, NEW PHYTOL, V200, P808, DOI 10.1111/nph.12411; Thines M, 2010, CURR OPIN PLANT BIOL, V13, P427, DOI 10.1016/j.pbi.2010.04.001; Torto TA, 2003, GENOME RES, V13, P1675, DOI 10.1101/gr.910003; Toruno TY, 2016, ANNU REV PHYTOPATHOL, V54, P419, DOI 10.1146/annurev-phyto-080615-100204; Tyler B.M., 2014, GENOMICS PLANT ASS F, P133, DOI [10.1007/978-3-662-44056-8_7, DOI 10.1007/978-3-662-44056-8_7]; Tyler BM, 2006, SCIENCE, V313, P1261, DOI 10.1126/science.1128796; Tyler BM, 2013, MOL PLANT MICROBE IN, V26, P611, DOI 10.1094/MPMI-02-13-0051-IA; van der Biezen EA, 1998, TRENDS BIOCHEM SCI, V23, P454, DOI 10.1016/S0968-0004(98)01311-5; van der Hoorn RAL, 2008, PLANT CELL, V20, P2009, DOI 10.1105/tpc.108.060194; Verdier V, 2012, NEW PHYTOL, V196, P1197, DOI 10.1111/j.1469-8137.2012.04367.x; Wawra S, 2013, MOL PLANT MICROBE IN, V26, P528, DOI 10.1094/MPMI-08-12-0200-R; Wehrens R., 2007, PLS PARTIAL LEAST SQ; Wessling R, 2014, CELL HOST MICROBE, V16, P364, DOI 10.1016/j.chom.2014.08.004; Wright CA, 2004, P NATL ACAD SCI USA, V101, P3269, DOI 10.1073/pnas.0400461101; Xin XF, 2016, NATURE, V539, P524, DOI 10.1038/nature20166; Xin XF, 2015, PLANT PHYSIOL, V169, P793, DOI 10.1104/pp.15.00547; Xin XF, 2013, ANNU REV PHYTOPATHOL, V51, P473, DOI 10.1146/annurev-phyto-082712-102321; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588	79	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195559	10.1371/journal.pone.0195559	http://dx.doi.org/10.1371/journal.pone.0195559			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641586	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900073
J	Zhang, XR; Duan, HF; Yu, Y; Ma, CL; Ren, ZL; Lei, YX; He, TP; Zhang, M				Zhang, Xirong; Duan, Haifeng; Yu, Yong; Ma, Chunling; Ren, Zhanli; Lei, Yuxin; He, Taiping; Zhang, Ming			Differential diagnosis between benign and malignant pleural effusion with dual-energy spectral CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; ATTENUATION VALUES; THORACOSCOPY	Purpose To investigate the value of spectral CT in the differential diagnosis of benign from malignant pleural effusion. Method and materials 14 patients with benign pleural effusion and 15 patients with malignant pleural effusion underwent non-contrast spectral CT imaging. These patients were later verified by the combination of disease history, clinical signs and other information with the consensus of surgeons and radiologists. Various Spectral CT image parameters measured for the effusion were as follows: CT numbers of the polychromatic 140kVp images, monochromatic images at 40keV and 100keV, the material density contents from the water, fat and blood-based material decomposition images, the effective atomic number and the spectral curve slope. These values were statistically compared with t test and logistic regression analysis between benign and malignant pleural effusion. Results The CT value of benign and malignant pleural effusion in the polychromatic 140kVp images showed no differences (12.61 +/- 3.39HU vs. 14.71 +/- 5.03HU) (P>0.05), however, they were statistically different on the monochromatic images at 40keV (43.15 +/- 3.79 vs. 39.42 +/- 2.60, p=0.005) and 100keV (9.11 +/- 1.38 vs. 6.52 +/- 2.04, p< 0.001). There was difference in the effective atomic number value between the benign (7.87 +/- 0.08) and malignant pleural effusion (7.90 +/- 0.02) (P=0.02). Using 6.32HU as the threshold for CT value measurement at 100keV, one could obtain sensitivity of 100% and specificity of 66.7% with area-under-curve of 0.843 for differentiating benign from malignant effusion. In addition, age and disease history were potential confounding factors for differentiating malignant pleural effusion from benign, since the older age (61.13 +/- 12.51 year-old vs48.57 +/- 12.33 year-old) as well as longer disease history (70.00 +/- 49.28 day vs. 28.36 +/- 21.64 day) were more easily to be found in the malignant pleural effusion group than those in the benign pleural effusion group. By combining above five factors, one could obtain sensitivity of 100% and specificity of 71.4% with area-under-curve of 0.933 for differentiating benign from malignant effusion. Conclusion The CT value measurement at both high and low energy levels and the effective atomic number obtained in a single spectral CT scan can assist the differential diagnosis of benign from malignant pleural effusion. Combining them with patient age and disease history can further improve diagnostic performance. Clinical relevance/Application Clinical findings and Spectral CT imaging can provide significant evidences about the nature of pleural effusion.	[Zhang, Xirong; Zhang, Ming] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China; [Zhang, Xirong; Duan, Haifeng; Yu, Yong; Ma, Chunling; Ren, Zhanli; Lei, Yuxin; He, Taiping] Shaanxi Univ Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China; [Zhang, Xirong] Shaanxi Univ Chinese Med, Dept Med Tech, Xianyang City, Shaanxi, Peoples R China; [Duan, Haifeng] Dept Med Imaging, 2 Weiyangxi Rd, Xianyang City, Shaanxi, Peoples R China	Xi'an Jiaotong University; Shaanxi University of Chinese Medicine; Shaanxi University of Chinese Medicine	Zhang, M (corresponding author), Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Radiol, Xian, Shaanxi, Peoples R China.; He, TP (corresponding author), Shaanxi Univ Chinese Med, Affiliated Hosp, Dept Radiol, Xianyang City, Shaanxi, Peoples R China.	htpkeyan@163.com; zhangming01@mail.xjtu.edu.cn						Abramowitz Y, 2009, AM J ROENTGENOL, V192, P618, DOI 10.2214/AJR.08.1286; Aleman C, 2007, QJM-INT J MED, V100, P351, DOI 10.1093/qjmed/hcm032; Chen S, 2015, CLIN CHIM ACTA, V441, P142, DOI 10.1016/j.cca.2014.12.029; Cullu N, 2014, DIAGN INTERV RADIOL, V20, P116, DOI 10.5152/dir.2013.13066; Deng K, 2012, KOREAN J RADIOL, V13, P743, DOI 10.3348/kjr.2012.13.6.743; Dong Y, 2015, EUR J RADIOL, V84, P901, DOI 10.1016/j.ejrad.2015.01.007; Han D, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160632; Heffner JE, 2008, MAYO CLIN PROC, V83, P235, DOI 10.4065/83.2.235; Li MY, 2014, J CARDIOTHORAC SURG, V9, DOI 10.1186/1749-8090-9-118; Liao P, 2017, STAT BIOSCIENCES, V1-14, DOI [10.1007/s12561-016-9144-1, DOI 10.1007/S12561-016-9144-1]; Liu JY, 2017, J THORAC DIS, V9, P406, DOI 10.21037/jtd.2017.02.39; Ma GM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150985; Maskell NA, 2003, THORAX, V58, pII8, DOI 10.1136/thorax.58.suppl_2.ii8; Matsumoto K, 2011, RADIOLOGY, V259, P257, DOI 10.1148/radiol.11100978; McCollough CH, 2015, RADIOLOGY, V276, P637, DOI 10.1148/radiol.2015142631; Nandalur KR, 2005, ACAD RADIOL, V12, P987, DOI 10.1016/j.acra.2005.05.002; Porcel JM, 2015, RESPIROLOGY, V20, P654, DOI 10.1111/resp.12496; Rahman NM, 2010, THORAX, V65, P54, DOI 10.1136/thx.2010.137018; Traill ZC, 2001, CLIN RADIOL, V56, P193, DOI 10.1053/crad.2000.0573; Wang MS, 2014, CLINICS, V69, P799, DOI 10.6061/clinics/2014(12)02; YAO JH, 2009, P IEEE ISBI, P241, DOI DOI 10.1109/SBI.2009.5193028; Yilmaz U, 2005, Monaldi Arch Chest Dis, V63, P17; Zaric B, 2008, LUNG, V186, P233, DOI 10.1007/s00408-008-9085-7	23	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193714	10.1371/journal.pone.0193714	http://dx.doi.org/10.1371/journal.pone.0193714			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641601	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900017
J	Long, NE; Sullivan, BJ; Ding, HM; Doll, S; Ryan, MA; Hitchcock, CL; Martin, EW; Kumar, K; Tweedle, MF; Magliery, TJ				Long, Nicholas E.; Sullivan, Brandon J.; Ding, Haiming; Doll, Stephanie; Ryan, Michael A.; Hitchcock, Charles L.; Martin, Edward W., Jr.; Kumar, Krishan; Tweedle, Michael F.; Magliery, Thomas J.			Linker engineering in anti-TAG-72 antibody fragments optimizes biophysical properties, serum half-life, and high-specificity tumor imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-CHAIN-FV; SCFV MULTIMERS; V-H; CANCER; EXPRESSION; STABILITY; DIABODIES; CC49; BIODISTRIBUTION; PROTEINS	Antibody (Ab) fragments have great clinical potential as cancer therapeutics and diagnostics. Their small size allows for fast clearance from blood, low immunoreactivity, better tumor penetration, and simpler engineering and production. The smallest fragment derived from a full-length IgG that retains binding to its antigen, the single-chain variable fragment (scF(V)), is engineered by fusing the variable light and variable heavy domains with a peptide linker. Along with switching the domain orientation, altering the length and amino acid sequence of the linker can significantly affect scF(V) binding, stability, quaternary structure, and other biophysical properties. Comprehensive studies of these attributes in a single scaffold have not been reported, making design and optimization of Ab fragments challenging. Here, we constructed libraries of 3E8, an Ab specific to tumor-associated glycoprotein 72 (TAG-72), a mucinous glycoprotein overexpressed in 80% of adenocarcinomas. We cloned, expressed, and characterized scF(V) s, diabodies, and higher-order multimer constructs with varying linker compositions, linker lengths, and domain orientations. These constructs dramatically differed in their oligomeric states and stabilities, not only because of linker and orientation but also related to the purification method. For example, protein L-purified constructs tended to have broader distributions and higher oligomeric states than has been reported previously. From this library, we selected an optimal construct, 3E8.G(4)S, for biodistribution and pharmacokinetic studies and in vivo xenograft mouse PET imaging. These studies revealed significant tumor targeting of 3E8.G(4)S with a tumor-to-background ratio of 29:1. These analyses validated 3E8.G(4)S as a fast, accurate, and specific tumor-imaging agent.	[Long, Nicholas E.; Sullivan, Brandon J.; Ryan, Michael A.; Magliery, Thomas J.] Ohio State Univ, Coll Med, Dept Chem & Biochem, Columbus, OH 43210 USA; [Long, Nicholas E.; Ryan, Michael A.] Ohio State Univ, Coll Med, Ohio State Biochem Program, Columbus, OH 43210 USA; [Ding, Haiming; Doll, Stephanie; Kumar, Krishan; Tweedle, Michael F.] Ohio State Univ, Coll Med, Lab Translat Res Imaging Pharmaceut, Wright Ctr Innovat Biomed Imaging,Dept Radiol, Columbus, OH 43210 USA; [Hitchcock, Charles L.] Ohio State Univ, Coll Med, Dept Pathol, Columbus, OH 43210 USA; [Martin, Edward W., Jr.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Magliery, TJ (corresponding author), Dept Chem & Biochem, 100 W 18th Ave, Columbus, OH 43210 USA.	magliery.1@osu.edu			Enlyton, Ltd.; National Institutes of Health [R01 GM083114]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083114, T32GM086252] Funding Source: NIH RePORTER	Enlyton, Ltd.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a research contract from Enlyton, Ltd. (to T. J. M. and M. F. T.). Protein stability studies were supported by National Institutes of Health Grant R01 GM083114 (to T. J. M.). N. E. L, B. J. S., C. L. H., E. W. M., and T. J. M. are inventors on patents related to this work that have been licensed by Enlyton, Ltd. E. W. M. and T. J. M. are officers of Enlyton, Ltd., and C. L. H., E. W. M., and T. J. M. are shareholders of Enlyton, Ltd. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALFTHAN K, 1995, PROTEIN ENG, V8, P725, DOI 10.1093/protein/8.7.725; Atwell JL, 1999, PROTEIN ENG, V12, P597, DOI 10.1093/protein/12.7.597; Bailey G. S., 1996, LODOGEN METHOD RADIO; Brannon-Peppas L, 2004, ADV DRUG DELIVER REV, V56, P1649, DOI 10.1016/j.addr.2004.02.014; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Cuesta AM, 2012, MABS-AUSTIN, V4, P226, DOI 10.4161/mabs.4.2.19140; DESPLANCQ D, 1994, PROTEIN ENG, V7, P1027, DOI 10.1093/protein/7.8.1027; Dolezal O, 2000, PROTEIN ENG, V13, P565, DOI 10.1093/protein/13.8.565; DORAI H, 1994, BIO-TECHNOL, V12, P890, DOI 10.1038/nbt0994-890; Durani V, 2012, PROTEIN EXPRES PURIF, V85, P9, DOI 10.1016/j.pep.2012.06.007; Goel A, 2001, J NUCL MED, V42, P1519; Goel A, 2000, CANCER RES, V60, P6964; Gong L, 2018, MOL IMAGING BIOL, V20, P47, DOI 10.1007/s11307-017-1096-4; Hitchcock C. L., 2017, CLIN SURG, V2, P1491; HOLLIGER P, 1993, P NATL ACAD SCI USA, V90, P6444, DOI 10.1073/pnas.90.14.6444; HUSTON JS, 1991, METHOD ENZYMOL, V203, P46; Julien S, 2012, BIOMOLECULES, V2, P435, DOI 10.3390/biom2040435; KING DJ, 1993, BIOCHEM J, V290, P723, DOI 10.1042/bj2900723; Kora A. A., 1997, PROTEIN ENG, V10, P423; Mammen JMV, 2007, AM J SURG, V194, P349, DOI 10.1016/j.amjsurg.2006.08.092; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moran N, 2011, NAT BIOTECHNOL, V29, P5, DOI 10.1038/nbt0111-5; PANTOLIANO MW, 1991, BIOCHEMISTRY-US, V30, P10117, DOI 10.1021/bi00106a007; Pavlinkova G, 1999, J NUCL MED, V40, P1536; PLUCKTHUN A, 1991, BIO-TECHNOL, V9, P545, DOI 10.1038/nbt0691-545; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shankar LK, 2006, J NUCL MED, V47, P1059; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tang Y, 1996, J BIOL CHEM, V271, P15682, DOI 10.1074/jbc.271.26.15682; Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Yoon SO, 2006, J BIOL CHEM, V281, P6985, DOI 10.1074/jbc.M511165200	34	11	14	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9030	9040		10.1074/jbc.RA118.002538	http://dx.doi.org/10.1074/jbc.RA118.002538			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29669811	hybrid, Green Published			2022-12-26	WOS:000434941900025
J	McAvoy, CZ; Siegel, A; Piszkiewicz, S; Miaou, E; Yu, MS; Nguyen, T; Moradian, A; Sweredoski, MJ; Hess, S; Shan, SO				McAvoy, Camille Z.; Siegel, Alex; Piszkiewicz, Samantha; Miaou, Emily; Yu, Mansen; Thang Nguyen; Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja; Shan, Shu-Ou			Two distinct sites of client protein interaction with the chaperone cpSRP43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL RECOGNITION PARTICLE; CHLOROPLAST SRP; POSTTRANSLATIONAL INTEGRATION; REPEAT PROTEINS; STRESS-PROTEINS; SUBSTRATE; BINDING; AGGREGATE; COMPLEX; ACTIVATION	Integral membrane proteins are prone to aggregation and misfolding in aqueous environments and therefore require binding by molecular chaperones during their biogenesis. Chloroplast signal recognition particle 43 (cpSRP43) is an ATP-independent chaperone required for the biogenesis of the most abundant class of membrane proteins, the light-harvesting chlorophyll a/b-binding proteins (LHCPs). Previous work has shown that cpSRP43 specifically recognizes an L18 loop sequence conserved amongLHCPparalogs. However, howcpSRP43 protects the transmembrane domains (TMDs) of LHCP from aggregation was unclear. In this work, alkylation-protection and site-specific cross-linking experiments found that cpSRP43 makes extensive contacts with all the TMDs in LHCP. Site-directed mutagenesis identified a class of cpSRP43 mutants that bind tightly to the L18 sequence but are defective in chaperoning full-length LHCP. These mutations mapped to hydrophobic surfaces on or near the bridging helix and the beta-hairpins lining the ankyrin repeat motifs of cpSRP43, suggesting that these regions are potential sites for interaction with the client TMDs. Our results suggest a working model for client protein interactions in this membrane protein chaperone.	[McAvoy, Camille Z.; Siegel, Alex; Piszkiewicz, Samantha; Miaou, Emily; Yu, Mansen; Thang Nguyen; Shan, Shu-Ou] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Proteome Explorat Lab, Pasadena, CA 91125 USA; [Moradian, Annie; Sweredoski, Michael J.; Hess, Sonja] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Piszkiewicz, Samantha] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Yu, Mansen] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 2B4, Canada; [Thang Nguyen] Mt San Antonio Coll, Dept Chem, Walnut, CA 91789 USA; [Hess, Sonja] Medimmune Inc, Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA	California Institute of Technology; California Institute of Technology; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; McGill University; AstraZeneca; Medimmune	Shan, SO (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	sshan@caltech.edu		Yu, Mansen/0000-0002-1353-4154; Siegel, Alexander/0000-0003-3601-5178; Piszkiewicz, Samantha/0000-0003-4391-776X	Betty and Gordon Moore Foundation [94-3397785]; National Institutes of Health [R01 GM114390, 2 T32 GM 7616-36]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616, R01GM114390] Funding Source: NIH RePORTER	Betty and Gordon Moore Foundation(Gordon and Betty Moore Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Betty and Gordon Moore Foundation Grant 94-3397785 and National Institutes of Health Grant R01 GM114390 (to S.-o. S.) and by National Institutes of Health Training Grant 2 T32 GM 7616-36 (to C. Z. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barrick D, 2008, CURR OPIN STRUC BIOL, V18, P27, DOI 10.1016/j.sbi.2007.12.004; Binz HK, 2004, NAT BIOTECHNOL, V22, P575, DOI 10.1038/nbt962; Binz HK, 2003, J MOL BIOL, V332, P489, DOI 10.1016/S0022-2836(03)00896-9; Cain P, 2011, BIOCHEM J, V437, P149, DOI 10.1042/BJ20110270; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DESHAIES RJ, 1988, TRENDS BIOCHEM SCI, V13, P384, DOI 10.1016/0968-0004(88)90180-6; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; Dunschede B, 2011, J BIOL CHEM, V286, P35187, DOI 10.1074/jbc.M111.250746; Eichacker LA, 2001, BBA-MOL CELL RES, V1541, P120, DOI 10.1016/S0167-4889(01)00151-3; Falk S, 2010, J BIOL CHEM, V285, pLE25, DOI 10.1074/jbc.L110.160093; Falk S, 2010, J BIOL CHEM, V285, P21655, DOI 10.1074/jbc.C110.132746; Falk S, 2010, J BIOL CHEM, V285, P5954, DOI 10.1074/jbc.M109.084996; Gao F, 2015, J BIOL CHEM, V290, P15462, DOI 10.1074/jbc.M114.624346; Hennecke G, 2005, J BIOL CHEM, V280, P23540, DOI 10.1074/jbc.M413742200; Horn R, 2002, J MOL BIOL, V318, P547, DOI 10.1016/S0022-2836(02)00115-8; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Jaru-Ampornpan P, 2013, J BIOL CHEM, V288, P13431, DOI 10.1074/jbc.M113.462861; Jaru-Ampornpan P, 2010, NAT STRUCT MOL BIOL, V17, P696, DOI 10.1038/nsmb.1836; Jonas-Straube E, 2001, J BIOL CHEM, V276, P24654, DOI 10.1074/jbc.M100153200; Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594; Klimyuk VI, 1999, PLANT CELL, V11, P87, DOI 10.1105/tpc.11.1.87; Kuhn A, 2003, TRENDS CELL BIOL, V13, P510, DOI 10.1016/j.tcb.2003.08.005; Lewis NE, 2010, J BIOL CHEM, V285, P34220, DOI 10.1074/jbc.M110.160093; LI XX, 1995, P NATL ACAD SCI USA, V92, P3789, DOI 10.1073/pnas.92.9.3789; Liang FC, 2016, P NATL ACAD SCI USA, V113, pE1615, DOI 10.1073/pnas.1524777113; Marcos E, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000738; Mihara K, 1996, TRENDS CELL BIOL, V6, P104, DOI 10.1016/0962-8924(96)81000-2; Moore M, 2000, J BIOL CHEM, V275, P1529, DOI 10.1074/jbc.275.3.1529; Nguyen TX, 2013, J BIOL CHEM, V288, P13420, DOI 10.1074/jbc.M113.462812; Nguyen TX, 2011, BIOCHEMISTRY-US, V50, P7208, DOI 10.1021/bi200742a; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Peracchi A, 1998, RNA, V4, P1332, DOI 10.1017/S1355838298980979; Peracchi A, 1998, BIOCHEMISTRY-US, V37, P14765, DOI 10.1021/bi980867y; Randall LL, 2002, CELL MOL LIFE SCI, V59, P1617, DOI 10.1007/PL00012488; Reinsberg D, 2000, BIOCHEMISTRY-US, V39, P14305, DOI 10.1021/bi001365z; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Saraogi I, 2011, J AM CHEM SOC, V133, P14936, DOI 10.1021/ja206626g; Schuenemann D, 1998, P NATL ACAD SCI USA, V95, P10312, DOI 10.1073/pnas.95.17.10312; Schunemann D, 2004, CURR GENET, V44, P295, DOI 10.1007/s00294-003-0450-z; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stengel KF, 2008, SCIENCE, V321, P253, DOI 10.1126/science.1158640; Thoma J, 2015, NAT STRUCT MOL BIOL, V22, P795, DOI 10.1038/nsmb.3087; Tu CJ, 2000, J BIOL CHEM, V275, P13187, DOI 10.1074/jbc.C000108200; Tu CJ, 1999, J BIOL CHEM, V274, P27219, DOI 10.1074/jbc.274.38.27219; Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106; Wang P., 2018, P NATL ACAD SCI US; Wittelsberger A, 2008, CHEM BIOL DRUG DES, V71, P380, DOI 10.1111/j.1747-0285.2008.00646.x; Young TS, 2010, J MOL BIOL, V395, P361, DOI 10.1016/j.jmb.2009.10.030; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zahnd C, 2007, J MOL BIOL, V369, P1015, DOI 10.1016/j.jmb.2007.03.028	52	4	4	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8861	8873		10.1074/jbc.RA118.002215	http://dx.doi.org/10.1074/jbc.RA118.002215			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29669809	hybrid, Green Published, Green Accepted			2022-12-26	WOS:000434941900011
J	Fujiwara, S; Matsui, TS; Ohashi, K; Deguchi, S; Mizuno, K				Fujiwara, Sachiko; Matsui, Tsubasa S.; Ohashi, Kazumasa; Deguchi, Shinji; Mizuno, Kensaku			Solo, a RhoA-targeting guanine nucleotide exchange factor, is critical for hemidesmosome formation and acinar development in epithelial cells	PLOS ONE			English	Article							INTEGRIN ALPHA-6-BETA-4; MAMMARY EPITHELIUM; MECHANOTRANSDUCTION; MORPHOGENESIS; APOPTOSIS; STIFFNESS; PLECTIN; PROTEIN; ARCHITECTURE; HOMEOSTASIS	Cell-substrate adhesions are essential for various physiological processes, including embryonic development and maintenance of organ functions. Hemidesmosomes (HDs) are multiprotein complexes that attach epithelial cells to the basement membrane. Formation and remodeling of HDs are dependent on the surrounding mechanical environment; however, the upstream signaling mechanisms are not well understood. We recently reported that Solo (also known as ARHGEF40), a guanine nucleotide exchange factor targeting RhoA, binds to keratin8/18 (K8/K18) intermediate filaments, and that their interaction is important for force-induced actin and keratin cytoskeletal reorganization. In this study, we show that Solo co-precipitates with an HD protein, beta 4-integrin. Co-precipitation assays revealed that the central region (amino acids 330-1057) of Solo binds to the C-terminal region (1451-1752) of beta 4-integrin. Knockdown of Solo significantly suppressed HD formation in MCF10A mammary epithelial cells. Similarly, knockdown of K18 or treatment with Y-27632, a specific inhibitor of Rho-associated kinase (ROCK), suppressed HD formation. As Solo knockdown or Y-27632 treatment is known to disorganize K8/K18 filaments, these results suggest that Solo is involved in HD formation by regulating K8/K18 filament organization via the RhoA-ROCK signaling pathway. We also showed that knockdown of Solo impairs acinar formation in MCF10A cells cultured in 3D Matrigel. In addition, Solo accumulated at the site of traction force generation in 2D-cultured MCF10A cells. Taken together, these results suggest that Solo plays a crucial role in HD formation and acinar development in epithelial cells by regulating mechanical force-induced RhoA activation and keratin filament organization.	[Fujiwara, Sachiko; Matsui, Tsubasa S.; Deguchi, Shinji] Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Toyonaka, Osaka, Japan; [Fujiwara, Sachiko] Japanese Soc Promot Sci, Chiyoda Ku, Kojimachi, Tokyo, Japan; [Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi, Japan	Osaka University; Japan Society for the Promotion of Science; Tohoku University	Fujiwara, S; Deguchi, S (corresponding author), Osaka Univ, Grad Sch Engn Sci, Div Bioengn, Toyonaka, Osaka, Japan.; Fujiwara, S (corresponding author), Japanese Soc Promot Sci, Chiyoda Ku, Kojimachi, Tokyo, Japan.; Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi, Japan.	sfujiwara@me.es.osaka-u.ac.jp; deguchi@me.es.osaka-u.ac.jp; kmizuno@biology.tohoku.ac.jp	Ohashi, Kazumasa/U-7028-2019; Matsui, Tsubasa S/B-6337-2009	Ohashi, Kazumasa/0000-0001-7617-403X; Matsui, Tsubasa S/0000-0002-6699-9131; Fujiwara, Sachiko/0000-0002-5620-637X; Deguchi, Shinji/0000-0002-0556-4599	Japan Society for the Promotion of Science (JSPS) [JPA16J041330]; Agency for Medical Research and Development [JP17gm5810015]; JSPS KAKENHI [JPT17K151180, JP16H05907, JP23112005, JP16K07335, JP15K14469, JP16H00749, JP15H03004, JP16K12872]; Grants-in-Aid for Scientific Research [16J04133] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Agency for Medical Research and Development; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) Fellows (JPA16J041330, URL: http://www.jsps.go.jp/j-pd/) to S.F., Agency for Medical Research and Development (JP17gm5810015, URL: https://www.amed.go.jp/) to K.O., and JSPS KAKENHI (JPT17K151180 to S.F., JP16H05907 to T.S.M., JP23112005 and JP16K07335 to K.O., JP15K14469 and JP16H00749 to K.M., JP15H03004 and JP16K12872 to S.D. (URL: http://www.jsps.go.jp/j-grantsinaid/).	Abiko H, 2015, J CELL SCI, V128, P1683, DOI 10.1242/jcs.157503; Aznar S, 2001, CANCER LETT, V165, P1, DOI 10.1016/S0304-3835(01)00412-8; Bosher JM, 2003, J CELL BIOL, V161, P757, DOI 10.1083/jcb.200302151; Bouameur JE, 2014, J INVEST DERMATOL, V134, P2776, DOI 10.1038/jid.2014.255; Chaudhuri O, 2014, NAT MATER, V13, P970, DOI [10.1038/nmat4009, 10.1038/NMAT4009]; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Curtis C, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-10; de Pereda JM, 2009, EMBO J, V28, P1180, DOI 10.1038/emboj.2009.48; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; DuFort CC, 2011, NAT REV MOL CELL BIO, V12, P308, DOI 10.1038/nrm3112; Faure E, 2012, J CELL SCI, V125, P4264, DOI 10.1242/jcs.097600; Fujiwara S, 2016, MOL BIOL CELL, V27, P954, DOI 10.1091/mbc.E15-06-0417; Giancotti FG, 2007, TRENDS PHARMACOL SCI, V28, P506, DOI 10.1016/j.tips.2007.08.004; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Ichikawa T, 2017, J CELL SCI, V130, P3517, DOI 10.1242/jcs.200691; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Koster J, 2004, MOL BIOL CELL, V15, P1211, DOI 10.1091/mbc.E03-09-0697; Litjens SHM, 2006, TRENDS CELL BIOL, V16, P376, DOI 10.1016/j.tcb.2006.05.004; Osmani N, 2015, CURR OPIN CELL BIOL, V32, P30, DOI 10.1016/j.ceb.2014.10.004; Pulkkinen L, 1998, EXP DERMATOL, V7, P46, DOI 10.1111/j.1600-0625.1998.tb00304.x; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Seltmann K, 2015, J INVEST DERMATOL, V135, P1609, DOI 10.1038/jid.2015.46; Seltmann K, 2013, P NATL ACAD SCI USA, V110, P18507, DOI 10.1073/pnas.1310493110; SONNENBERG A, 1990, J CELL SCI, V96, P207; Tse SW, 2005, GENE, V359, P63, DOI 10.1016/j.gene.2005.06.025; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Walko G, 2015, CELL TISSUE RES, V360, P529, DOI 10.1007/s00441-015-2216-6; Wang H, 2013, P NATL ACAD SCI USA, V110, P163, DOI 10.1073/pnas.1201141110; Weaver VM, 2002, CANCER CELL, V2, P205, DOI 10.1016/S1535-6108(02)00125-3; Wilhelmsen K, 2006, MOL CELL BIOL, V26, P2877, DOI 10.1128/MCB.26.8.2877-2886.2006; Yokoyama S, 2017, BIOCHEM BIOPH RES CO, V482, P975, DOI 10.1016/j.bbrc.2016.11.142; Yu OM, 2015, MOL PHARMACOL, V88, P171, DOI 10.1124/mol.115.097857; Zhang HM, 2011, NATURE, V471, P99, DOI 10.1038/nature09765	35	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195124	10.1371/journal.pone.0195124	http://dx.doi.org/10.1371/journal.pone.0195124			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672603	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800018
J	Leao-Pires, TA; Luiz, AM; Sawaya, RJ				Leao-Pires, Thiago A.; Luiz, Amom Mendes; Sawaya, Ricardo J.			The complex roles of space and environment in structuring functional, taxonomic and phylogenetic beta diversity of frogs in the Atlantic Forest	PLOS ONE			English	Article							SPATIAL SCALE; METACOMMUNITY STRUCTURE; COMMUNITY ECOLOGY; DISPERSAL; HETEROGENEITY; CONSERVATION; COMPONENTS; GRADIENT; TRAITS; LEVEL	Ecological communities are complex entities that can be maintained and structured by niche-based processes such as environmental conditions, and spatial processes such as dispersal. Thus, diversity patterns may be shaped simultaneously at different spatial scales by very distinct processes. Herein we assess whether and how functional, taxonomic, and phylogenetic beta diversities of frog tadpoles are explained by environmental and/or spatial predictors. We implemented a distance-based redundancy analysis to explore variation in components of beta diversity explained by pure environmental and pure spatial predictors, as well as their interactions, at both fine and broad spatial scales. Our results indicated important but complex roles of spatial and environmental predictors in structuring phylogenetic, taxonomic and functional beta diversities. The pure fine-scales spatial fraction was more important in structuring all beta diversity components, especially to functional and tax-onomical spatial turnover. Environmental variables such as canopy cover and vegetation structure were important predictors of all components, but especially to functional and taxonomic beta diversity. We emphasize that distinct factors related to environment and space are affecting distinct components of beta diversity in different ways. Although weaker, phylogenetic beta diversity, which is structured more on biogeographical scales, and thus can be represented by spatially structured processes, was more related to broad spatial processes than other components. However, selected fine-scale spatial predictors denoted negative autocorrelation, which may be revealing the existence of differences in unmeasured habitat variables among samples. Although overall important, local environmental-based processes explained better functional and taxonomic beta diversity, as these diversity components carry an important ecological value. We highlight the importance of assessing different components of diversity patterns at different scales by spatially explicit models in order to improve our understanding of community structure and help to unravel the complex nature of biodiversity.	[Leao-Pires, Thiago A.; Luiz, Amom Mendes] Univ Estadual Campinas, UNICAMP, Inst Biol, Programa Posgrad Ecol, Campinas, SP, Brazil; [Sawaya, Ricardo J.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Bernardo Do Campo, SP, Brazil	Universidade de Sao Paulo; Universidade Estadual de Campinas	Leao-Pires, TA (corresponding author), Univ Estadual Campinas, UNICAMP, Inst Biol, Programa Posgrad Ecol, Campinas, SP, Brazil.	leaopires.ta@gmail.com	Leao-Pires, Thiago/N-2330-2019	Leao-Pires, Thiago/0000-0001-8317-4767	Master scholarship - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq [563075/2010-4]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP [2008/54472-2, 2014/23677-9]; SISBIOTA Project FAPESP [2010/52321-7]; Graduate Program in Ecology (UNICAMP)	Master scholarship - Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); SISBIOTA Project FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao Amazonia de Amparo a Estudos e Pesquisas (FAPESPA)); Graduate Program in Ecology (UNICAMP)	TALP and AML were supported by a Master scholarship funded by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). RJS thanks Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - CNPq (CNPq proc. 563075/2010-4) for financial support. The study design, data collection and analysis of the project was funded by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - FAPESP 2008/54472-2 and 2014/23677-9 and SISBIOTA Project FAPESP proc. 2010/52321-7 and Graduate Program in Ecology (UNICAMP).	Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Arnan X, 2015, PEERJ, V3, DOI 10.7717/peerj.1241; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Becker CG, 2007, SCIENCE, V318, P1775, DOI 10.1126/science.1149374; Beisner BE, 2006, ECOLOGY, V87, P2985, DOI 10.1890/0012-9658(2006)87[2985:TROEAS]2.0.CO;2; Bernard-Verdier M, 2013, J VEG SCI, V24, P877, DOI 10.1111/jvs.12048; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Both C, 2011, AUSTRAL ECOL, V36, P530, DOI 10.1111/j.1442-9993.2010.02183.x; Cadotte MW, 2017, TRENDS ECOL EVOL, V32, P429, DOI 10.1016/j.tree.2017.03.004; Cadotte MW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005695; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Cottenie K, 2004, ECOLOGY, V85, P114, DOI 10.1890/03-3004; da Silva FR, 2012, J BIOGEOGR, V39, P1720, DOI 10.1111/j.1365-2699.2012.02726.x; da Silva FR, 2011, WETLANDS, V31, P1079, DOI 10.1007/s13157-011-0217-0; de Bello F, 2010, J VEG SCI, V21, P992, DOI 10.1111/j.1654-1103.2010.01195.x; De Bie T, 2012, ECOL LETT, V15, P740, DOI 10.1111/j.1461-0248.2012.01794.x; Diamond J.M., 1975, P342; Diniz JAF, 2012, OIKOS, V121, P201, DOI 10.1111/j.1600-0706.2011.19563.x; Dray S, 2012, ECOL MONOGR, V82, P257, DOI 10.1890/11-1183.1; Dray S, 2006, ECOL MODEL, V196, P483, DOI 10.1016/j.ecolmodel.2006.02.015; Duarte LDS, 2014, GLOBAL ECOL BIOGEOGR, V23, P213, DOI 10.1111/geb.12089; Fatorelli P, 2008, QUARENTA ANOS OECOLO, V12, P734; GASCON C, 1991, ECOLOGY, V72, P1731, DOI 10.2307/1940972; Griffith DA, 2006, ECOLOGY, V87, P2603, DOI 10.1890/0012-9658(2006)87[2603:SMIETF]2.0.CO;2; Haddad CFB, 2005, BIOSCIENCE, V55, P207, DOI 10.1641/0006-3568(2005)055[0207:RMIFAT]2.0.CO;2; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Hubbell Stephen P., 2001, V32, pi; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Johnson RK, 2007, FRESHWATER BIOL, V52, P939, DOI 10.1111/j.1365-2427.2006.01692.x; Johnson RK, 2002, FRESHWATER BIOL, V47, P1840, DOI 10.1046/j.1365-2427.2002.00932.x; Jorge RF, 2016, BIOTROPICA, P1; Leao-Pires TA, ENV CONSTRAINTS TRAI; Lebrija-Trejos E, 2010, ECOLOGY, V91, P386, DOI 10.1890/08-1449.1; Leprieur F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042760; Luiz AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153977; MACARTHUR R, 1967, AM NAT, V101, P377, DOI 10.1086/282505; Marques MCM, 2011, BIODIVERS CONSERV, V20, P153, DOI 10.1007/s10531-010-9952-4; McDiarmid R.W., 1994, MEASURING MONITORING, P289; McDiarmid R. W., 1999, TADPOLES BIOL ANURAN; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; Meynard CN, 2011, GLOBAL ECOL BIOGEOGR, V20, P893, DOI 10.1111/j.1466-8238.2010.00647.x; Moreira LFB, 2010, J NAT HIST, V44, P1493, DOI 10.1080/00222931003632690; MOSS B. R., 2009, ECOLOGY FRESH WATERS; Paavola R, 2006, ECOL APPL, V16, P368, DOI 10.1890/03-5410; Pavoine S, 2009, OIKOS, V118, P391, DOI 10.1111/j.1600-0706.2008.16668.x; Peres-Neto PR, 2010, GLOBAL ECOL BIOGEOGR, V19, P174, DOI 10.1111/j.1466-8238.2009.00506.x; Petchey OL, 2006, ECOL LETT, V9, P741, DOI 10.1111/j.1461-0248.2006.00924.x; Prado VHM, 2014, AUSTRAL ECOL, V39, P540, DOI 10.1111/aec.12114; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Relyea RA, 2002, ECOL MONOGR, V72, P77, DOI 10.1890/0012-9615(2002)072[0077:LPDIPP]2.0.CO;2; Relyea RA, 2002, ECOLOGY, V83, P1953, DOI 10.2307/3071778; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Ricklefs Robert E., 1993, P215; Ricotta C, 2005, BASIC APPL ECOL, V6, P479, DOI 10.1016/j.baae.2005.02.008; Rossa-Feres DC, 2011, BIOTA NEOTROP, V11, P47, DOI 10.1590/S1676-06032011000400018; Schiesari L, 2006, FRESHWATER BIOL, V51, P412, DOI 10.1111/j.1365-2427.2005.01497.x; Segalla MV, 2014, BRAZ AMPH LIST SPEC, P37; Silva FR, 2012, LANDSCAPE ECOL, V27, P87, DOI 10.1007/s10980-011-9670-7; Skelly DK, 2014, ECOL APPL, V24, P340, DOI 10.1890/13-1042.1; Smith MA, 2005, ECOGRAPHY, V28, P110; Sokal RR, 1995, FREEMAN, V3, P1995, DOI DOI 10.1016/J.JIP.2003.08.007; Strauss A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151744; Strauss Axel, 2010, BMC Ecology, V10, P12, DOI 10.1186/1472-6785-10-12; Suguio K, 1978, SPECIAL PUBLICATION, V1, P57; Suguio K, 2013, GEONOMOS, V4, P45; Tokeshi M., 2009, SPECIES COEXISTENCE; Tuomisto H, 2006, ECOLOGY, V87, P2697, DOI 10.1890/0012-9658(2006)87[2697:AOEBDU]2.0.CO;2; Vasconcelos TS, 2009, CAN J ZOOL, V87, P699, DOI 10.1139/Z09-058; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; Villeger S, 2013, GLOBAL ECOL BIOGEOGR, V22, P671, DOI 10.1111/geb.12021; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB, DOI 10.7208/chicago/9780226893334.001.0001; Werner EE, 2007, OIKOS, V116, P1697, DOI 10.1111/j.2007.0030-1299.15935.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2011, ECOL LETT, V14, P643, DOI 10.1111/j.1461-0248.2011.01625.x	76	16	16	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196066	10.1371/journal.pone.0196066	http://dx.doi.org/10.1371/journal.pone.0196066			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672575	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800077
J	Quintanilla-Ahumada, D; Quijon, PA; Navarro, JM; Pulgar, J; Duarte, C				Quintanilla-Ahumada, Diego; Quijon, Pedro A.; Navarro, Jorge M.; Pulgar, Jose; Duarte, Cristian			Living on a trophic subsidy: Algal quality drives an upper-shore herbivore's consumption, preference and absorption but not growth rates	PLOS ONE			English	Article							AMPHIPOD ORCHESTOIDEA-TUBERCULATA; SEA-URCHIN; FEEDING PREFERENCES; CHEMICAL DEFENSES; SANDY BEACH; NUTRITIONAL QUALITY; CAPITELLA-CAPITATA; FOOD PREFERENCE; ORGANIC-MATTER; CHILEAN COAST	The transfer of seaweeds from subtidal bottoms to nearby intertidal rocky shores is a common but often overlooked phenomenon. Freshly detached seaweeds often represent critical trophic subsidies for herbivores living in upper-shore rocky intertidal areas, such as the marine snail Diloma nigerrima. This species relies on three species of seaweeds for food and displays feeding strategies to deal with a resource that is scarce and at times unpredictable. This study focused on the nutritional quality of freshly detached algae (Durvillaea antarctica, Lessonia spicata and Lessonia trabeculata) and measured Diloma nigerrima's algal consumption rates in trials with and without choice. Absorption efficiency and growth of individual snails fed on each alga were also measured. Durvillaea antarctica had the highest nutritional quality and was the most consumed algae in both single and multiple-choice trials. Absorption efficiency was also highest for D. antarctica but growth rates of snails fed with this species were similar to those fed with the other algae. Combined, these results suggest that D. nigerrima has the ability to discriminate among seaweeds based on their nutritional quality. A potential increase in oxygen uptake when D. nigerrima is consuming the preferred food item is also proposed as a plausible hypothesis to explain the mismatch between snails' preference and growth rate. These results aim to guide further studies on trophic subsidies and their role in coastal systems.	[Quintanilla-Ahumada, Diego] Univ Andres Bello, Fac Ecol & Recursos Nat, Escuela Ciencias Mar, Santiago, Chile; [Quijon, Pedro A.] Univ Prince Edward Isl, Dept Biol, Coastal Ecol Lab, Charlottetown, PE, Canada; [Navarro, Jorge M.] Univ Austral Chile, Fac Ciencias, Inst Ciencias Marinas & Limnol, Valdivia, Chile; [Navarro, Jorge M.] Ctr Fondap Invest Ecosistemas Marinos Altas Latiu, Valdivia, Chile; [Pulgar, Jose; Duarte, Cristian] Univ Andres Bello, Fac Ecol & Recursos Nat, Dept Ecol & Biodiversidad, Santiago, Chile; [Duarte, Cristian] Univ Concepcion, Ctr Study Multiple Drivers Marine Socioecol Syst, Concepcion, Chile	Universidad Andres Bello; University of Prince Edward Island; Universidad Austral de Chile; Universidad Andres Bello; Universidad de Concepcion	Duarte, C (corresponding author), Univ Andres Bello, Fac Ecol & Recursos Nat, Dept Ecol & Biodiversidad, Santiago, Chile.; Duarte, C (corresponding author), Univ Concepcion, Ctr Study Multiple Drivers Marine Socioecol Syst, Concepcion, Chile.	cristian.duarte@unab.cl		Duarte, Cristian/0000-0002-7033-3551	CONICYT-CHILE (Proyecto FONDECYT) [1171056]; Natural Sciences and Engineering Research Council, Canada (NSERC); UPEI's Research Office	CONICYT-CHILE (Proyecto FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Natural Sciences and Engineering Research Council, Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); UPEI's Research Office	This study was supported by CONICYT-CHILE (Proyecto FONDECYT no 1171056 to CD). PAQ thanks the Natural Sciences and Engineering Research Council, Canada (NSERC), and UPEI's Research Office for their support during the preparation of this ms.	Adin R, 2003, ESTUAR COAST SHELF S, V56, P91, DOI 10.1016/S0272-7714(02)00124-5; Alamo V., 1987, B EXTRAORDINARIO I M; Amarasekare P, 2008, ECOLOGY, V89, P2786, DOI 10.1890/07-1508.1; Barile PJ, 2004, J EXP MAR BIOL ECOL, V303, P65, DOI 10.1016/j.jembe.2003.11.004; Benitez S, 2016, MAR POLLUT BULL, V112, P375, DOI 10.1016/j.marpolbul.2016.07.016; Bertness MD, 1997, ECOLOGY, V78, P1976, DOI 10.1890/0012-9658(1997)078[1976:TROPII]2.0.CO;2; Bolser RC, 1996, ECOLOGY, V77, P2269, DOI 10.2307/2265730; BOWEN SH, 1995, ECOLOGY, V76, P899, DOI 10.2307/1939355; Britton-Simmons KH, 2009, AQUAT BIOL, V5, P233, DOI 10.3354/ab00154; Bustamante RH, 1996, J EXP MAR BIOL ECOL, V196, P1, DOI 10.1016/0022-0981(95)00093-3; BUSTAMANTE RH, 1995, ECOLOGY, V76, P2314, DOI 10.2307/1941704; Colombini I, 2000, MAR BIOL, V136, P531, DOI 10.1007/s002270050713; CONOVER RJ, 1966, LIMNOL OCEANOGR, V11, P338, DOI 10.4319/lo.1966.11.3.0338; Cronin G, 1996, OECOLOGIA, V105, P361, DOI 10.1007/BF00328739; Cruz-Rivera E, 2000, OECOLOGIA, V123, P252, DOI 10.1007/s004420051012; Cruz-Rivera E, 2003, ECOL MONOGR, V73, P483, DOI 10.1890/0012-9615(2003)073[0483:PNQIWC]2.0.CO;2; Cruz-Rivera E, 2000, ECOLOGY, V81, P201; Cruz-Rivera E, 2001, MAR ECOL PROG SER, V218, P249, DOI 10.3354/meps218249; DAYTON PK, 1985, ANNU REV ECOL SYST, V16, P215, DOI 10.1146/annurev.es.16.110185.001243; Donald KM, 2011, J EXP MAR BIOL ECOL, V396, P224, DOI 10.1016/j.jembe.2010.10.028; Duarte C, 2014, J SEA RES, V87, P1, DOI 10.1016/j.seares.2013.12.003; Duarte C, 2011, J SEA RES, V66, P215, DOI 10.1016/j.seares.2011.07.007; Duarte C, 2009, REV BIOL MAR OCEANOG, V44, P691; Fernandez C, 2000, MAR ECOL PROG SER, V204, P131, DOI 10.3354/meps204131; Fink P, 2006, OIKOS, V115, P484, DOI 10.1111/j.2006.0030-1299.14951.x; Gonzalez SJ, 2008, REV CHIL HIST NAT, V81, P575; Griffiths C.L., 1983, SANDY BEACHES ECOSYS, P547, DOI DOI 10.1007/978-94-017-2938-3; HORN MH, 1984, T AM FISH SOC, V113, P388, DOI 10.1577/1548-8659(1984)113&lt;388:PANAAA&gt;2.0.CO;2; Jimenez EG, 1996, BIOL BULL, V191, P323, DOI 10.1086/BBLv191n2p323; Jimenez RS, 2015, PHYCOLOGIA, V54, P530, DOI 10.2216/15-39.1; Krumhansl KA, 2012, MAR ECOL PROG SER, V467, P281, DOI 10.3354/meps09940; Lastra M, 2008, MAR BIOL, V154, P163, DOI 10.1007/s00227-008-0913-3; Lastra M, 2015, MAR BIOL, V162, P221, DOI 10.1007/s00227-014-2562-z; LEWIN R, 1986, SCIENCE, V234, P25, DOI 10.1126/science.234.4772.25; Lily G., 1975, THESIS; LOWE EF, 1976, J EXP MAR BIOL ECOL, V21, P223, DOI 10.1016/0022-0981(76)90117-9; Lucas PW, 2000, ANN BOT-LONDON, V86, P913, DOI 10.1006/anbo.2000.1261; Lyons DA, 2007, J EXP MAR BIOL ECOL, V349, P194, DOI 10.1016/j.jembe.2007.05.012; MacMillan MR, 2012, J SEA RES, V72, P28, DOI 10.1016/j.seares.2012.05.004; Marincovich L. Jr., 1973, Natural Hist Mus Los Angeles Co Sci Bull, VNo. 16, P1; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; NICOTRI ME, 1980, J EXP MAR BIOL ECOL, V42, P13, DOI 10.1016/0022-0981(80)90163-X; Pavia H, 2000, ECOLOGY, V81, P3212; Pennings SC, 2000, CAN J ZOOL, V78, P1918, DOI 10.1139/cjz-78-11-1918; Pennings SC, 1998, ECOLOGY, V79, P1968; PENNINGS SC, 1993, ECOLOGY, V74, P879, DOI 10.2307/1940813; PEREIRA R. C., 2002, Braz. J. Biol., V62, P33, DOI 10.1590/S1519-69842002000100005; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Poore AGB, 1999, ECOL MONOGR, V69, P443, DOI 10.1890/0012-9615(1999)069[0443:PPRAEO]2.0.CO;2; Quijon PA, 2017, MAR POLLUT BULL, V116, P538, DOI 10.1016/j.marpolbul.2017.01.020; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; Rodil IF, 2015, MAR ECOL PROG SER, V531, P167, DOI 10.3354/meps11304; Rodriguez SR, 2003, MAR ECOL PROG SER, V251, P141, DOI 10.3354/meps251141; Rodriguez SR, 2000, REV CHIL HIST NAT, V73, P199; ROUGHGARDEN J, 1994, PHILOS T ROY SOC B, V343, P79, DOI 10.1098/rstb.1994.0010; ROUGHGARDEN JS, 1988, ORG COMMUNITIES PRES, P459; Silva J, 2004, AQUACULTURE, V231, P279, DOI 10.1016/j.aquaculture.2003.09.053; Simpson S.J., 1990, P111; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; TENORE KR, 1977, LIMNOL OCEANOGR, V22, P936, DOI 10.4319/lo.1977.22.5.0936; TENORE KR, 1981, ESTUAR COAST SHELF S, V12, P39, DOI 10.1016/S0302-3524(81)80116-8; Van Alstyne KL, 1999, MAR ECOL PROG SER, V180, P179, DOI 10.3354/meps180179; Vanderklift MA, 2008, OECOLOGIA, V157, P327, DOI 10.1007/s00442-008-1061-7; Verges A, 2007, OECOLOGIA, V151, P675, DOI 10.1007/s00442-006-0606-x; White T. C. R., 1993, INADEQUATE ENV NITRO; Xia S., 2012, AQUACULTURE, P344; YATES JL, 1993, ECOLOGY, V74, P1757, DOI 10.2307/1939934; Zar JH, 1999, BIOSTATISTICAL ANAL	70	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196121	10.1371/journal.pone.0196121	http://dx.doi.org/10.1371/journal.pone.0196121			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672599	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800092
J	Hwang, SG; Hong, JK; Sharma, A; Pollack, GH; Bahng, G				Hwang, Seong G.; Hong, Jun Ki; Sharma, Abha; Pollack, Gerald H.; Bahng, GunWoong			Exclusion zone and heterogeneous water structure at ambient temperature	PLOS ONE			English	Article							LIQUID WATER	Earlier studies have reported the formation of an exclusion zone devoid of microspheres at the interface of water with a hydrophilic surface such as Nafion or the hydrophilic ceramic powder. We now report the formation of a 'three-dimensional cell-like structured exclusion zone' in water prepared by two different methods. In the first, the hydrophilic powder was agitated with deionized water and allowed to rest (contact method). Subsequently, the 'powder -supernatant water' was collected and termed 'contact water'. In the second method, deionized water in a closed container was kept in the close vicinity of the hydrophilic powder for an extended time-period and it was termed 'non-contact water'. The two kinds of waters were tested by standard methods for various physical properties. In addition, we carried out cryogenic scanning-electron microscopy of frozen samples of the two kinds of water. The powder-supernatant water showed a cell-like heterogeneous ice structure with the high density exclusion-zone water forming the walls of a cell-like structure. A similar cell-like ice structure was formed for water treated with the hydrophilic powder in a non-contact manner; the unit cell size depended on the 'degree of structure' in the water. When highly structured, the unit cell size was smaller with a concurrently enhanced dielectric constant and reduced redox potential. It was found that the electrical properties are more sensitive to the change in water structure compared to other physical properties such as surface tension, density, and specific heat. Based on our findings of an electric potential difference between the heterogeneous structured water and the ordinary water, we propose a new model to explain the relationship between heterogeneous, structured water and its electrical properties.	[Hwang, Seong G.] Hankyong Natl Univ, Dept Anim Life & Environm Sci, Anseong, South Korea; [Hong, Jun Ki] Ctr Excellence Wireless & Informat Technol, Incheon, South Korea; [Sharma, Abha; Pollack, Gerald H.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Bahng, GunWoong] State Univ New York Korea, Dept Mech Engn, Incheon, South Korea	Hankyong National University; University of Washington; University of Washington Seattle	Bahng, G (corresponding author), State Univ New York Korea, Dept Mech Engn, Incheon, South Korea.	gwbahng@sunykorea.ac.kr			Quantum energy Co. Ltd. through SUNY Korea;  [2014-RD-01]	Quantum energy Co. Ltd. through SUNY Korea; 	This research work was conducted by a grant from the Quantum energy Co. Ltd. through SUNY Korea to GWB. The grant number is 2014-RD-01. The URL of the company is http://www.quantumenergy.co.kr/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder supplied only the hydrophillic ceramic materials used in this research work.	Bahng GW, 2014, TEXT RES J, V84, P1220, DOI 10.1177/0040517513503732; Ball P, 2017, P NATL ACAD SCI USA, V114, P13327, DOI 10.1073/pnas.1703781114; Chai BH, 2010, J PHYS CHEM B, V114, P5371, DOI 10.1021/jp100200y; Chai BH, 2009, J PHYS CHEM B, V113, P13953, DOI 10.1021/jp908163w; Chen CS, 2012, J BIOL PHYS, V38, P113, DOI 10.1007/s10867-011-9237-5; Clark GNI, 2010, MOL PHYS, V108, P1415, DOI 10.1080/00268971003762134; Delgado AV, 2005, PURE APPL CHEM, V77, P1753, DOI 10.1351/pac200577101753; Despa F, 2005, ANN NY ACAD SCI, V1066, P1, DOI 10.1196/annals.1363.023; Dixit S, 2002, NATURE, V416, P829, DOI 10.1038/416829a; FALK M, 1966, CAN J CHEMISTRY, V44, P1699, DOI 10.1139/v66-255; Huang C, 2009, P NATL ACAD SCI USA, V106, P15214, DOI 10.1073/pnas.0904743106; Hwang Seong Gu, 2017, Int J Cell Biol, V2017, P1917239, DOI 10.1155/2017/1917239; Lee JD, 2012, Korean Patent, Patent No. [10 1172018, 101172018]; Leung T. K., 2014, Hydrology: Current Research, V5, P174; Leung TK, 2012, J CHIN CHEM SOC-TAIP, V59, P589, DOI 10.1002/jccs.201100491; Mallamace F, 2009, P NATL ACAD SCI USA, V106, P15097, DOI 10.1073/pnas.0908198106; Nilsson A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9998; Palmer JC, 2014, NATURE, V510, P385, DOI 10.1038/nature13405; Pollack G.H., 2006, WATER CELL, P165, DOI DOI 10.1007/1-4020-4927-7_8; Pollack G.H., 2013, 4 PHASE WATER; Santana-Blank L, 2013, PHOTOMED LASER SURG, V31, P461, DOI 10.1089/pho.2013.3583; Sharma A, 2017, ADV MATER SCI ENG, V2017, DOI 10.1155/2017/2410794; Shimokawa S, 2004, JPN J APPL PHYS 2, V43, pL545, DOI 10.1143/JJAP.43.L545; Soper AK, 2000, PHYS REV LETT, V84, P2881, DOI 10.1103/PhysRevLett.84.2881; Tokushima T, 2008, CHEM PHYS LETT, V460, P387, DOI 10.1016/j.cplett.2008.04.077; Vatansever Fatma, 2012, Photonics Lasers Med, V4, P255; Vogler EA, 1998, ADV COLLOID INTERFAC, V74, P69, DOI 10.1016/S0001-8686(97)00040-7; Wernet P, 2004, SCIENCE, V304, P995, DOI 10.1126/science.1096205; Zhao Q, 2009, J PHYS CHEM B, V113, P10708, DOI 10.1021/jp9021568; Zheng JM, 2006, ADV COLLOID INTERFAC, V127, P19, DOI 10.1016/j.cis.2006.07.002	30	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195057	10.1371/journal.pone.0195057	http://dx.doi.org/10.1371/journal.pone.0195057			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668733	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200023
J	Rylova, SN; Stoykow, C; Del Pozzo, L; Abiraj, K; Tamma, ML; Kiefer, Y; Fani, M; Maecke, HR				Rylova, Svetlana N.; Stoykow, Christian; Del Pozzo, Luigi; Abiraj, Keelara; Tamma, Maria Luisa; Kiefer, Yvonne; Fani, Melpomeni; Maecke, Helmut R.			The somatostatin receptor 2 antagonist Cu-64-NODAGA-JR11 outperforms Cu-64-DOTA-TATE in a mouse xenograft model	PLOS ONE			English	Article							COPPER RADIOPHARMACEUTICALS; NEUROENDOCRINE TUMORS; IN-VIVO; RADIONUCLIDE THERAPY; PET; AGONIST; CU-64; INTERNALIZATION; CHELATORS; ANALOGS	Copper-64 is an attractive radionuclide for PET imaging and is frequently used in clinical applications. The aim of this study was to perform a side-by-side comparison of the in vitro and in vivo performance of Cu-64-NODAGA-JR11 (NODAGA = 1,4,7-triazacyclononane,1-glutaric acid,4,7-acetic acid, JR11 = p-Cl-Phe-cyclo(D-Cys-Aph(Hor)-D-Aph(cbm)-Lys-Thr-Cys)D-Tyr-NH2), a somatostatin receptor 2 antagonist, with the clinically used sst2 agonist Cu-64-DOTA-TATE ((TATE = D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)Thr). In vitro studies demonstrated K-d values of 5.7 +/- 0.95 nM (Bmax = 4.1 +/- 0.18 nM) for the antagonist Cu-64/nat-NODAGA-JR11 and 20.1 +/- 4.4. nM (Bmax = 0.48 +/- 0.18 nM) for the agonist Cu-64/nat-DOTA-TATE. Cell uptake studies showed the expected differences between agonists and antagonists. Whereas Cu-64-DOTA-TATE (the agonist) showed very effective internalization in the cell culture assay (with 50% internalized at 4 hours post-peptide addition under the given experimental conditions), Cu-64-NODAGA-JR11 (the antagonist) showed little internalization but strong receptor-mediated uptake at the cell membrane. Biodistribution studies of Cu-64-NODAGA-JR11 showed rapid blood clearance and tumor uptake with increasing tumor-to-relevant organ ratios within the first 4 hours and in some cases, 24 hours, respectively. The tumor washout was slow or non-existent in the first 4 hours, whereas the kidney washout was very efficient, leading to high and increasing tumor-to-kidney ratios over time. Specificity of tumor uptake was proven by co-injection of high excess of non-radiolabeled peptide, which led to >80% tumor blocking. Cu-64-DOTA-TATE showed less favorable pharmacokinetics, with the exception of lower kidney uptake. Blood clearance was distinctly slower and persistent higher blood values were found at 24 hours. Uptake in the liver and lung was relatively high and also persistent. The tumor uptake was specific and similar to that of Cu-64-NODAGA-JR11 at 1 h, but release from the tumor was very fast, particularly between 4 and 24 hours. Tumor-to-normal organ ratios were distinctly lower after 1 hour. This is indicative of insufficient in vivo stability. PET studies of Cu-64-NODAGA-JR11 reflected the biodistribution data with nicely delineated tumor and low background. Cu-64-NODAGA-JR11 shows promising pharmacokinetic properties for further translation into the clinic.	[Rylova, Svetlana N.] German Canc Consortium DKTK, Heidelberg, Germany; [Rylova, Svetlana N.; Stoykow, Christian; Kiefer, Yvonne; Maecke, Helmut R.] Univ Freiburg, Dept Nucl Med, Med Ctr, Fac Med, Freiburg, Germany; [Rylova, Svetlana N.] German Canc Res Ctr, Heidelberg, Germany; [Del Pozzo, Luigi; Abiraj, Keelara; Tamma, Maria Luisa; Fani, Melpomeni] Univ Hosp Basel, Div Radiol Chem, Basel, Switzerland	Helmholtz Association; German Cancer Research Center (DKFZ); University of Freiburg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Basel	Maecke, HR (corresponding author), Univ Freiburg, Dept Nucl Med, Med Ctr, Fac Med, Freiburg, Germany.	helmut.maecke@uniklinik.freiberg.de		Fani, Melpomeni/0000-0002-9309-1604	German Consortium for Translational Cancer Research (DKTK)	German Consortium for Translational Cancer Research (DKTK)	This work was supported by the German Consortium for Translational Cancer Research (DKTK).; We thank the German Consortium for Translational Cancer Research (DKTK) for financial support, Prof. Schulz for providing the cell line and Wolfgang Weber for bringing up the idea of species difference to explain the obvious Cu(II)DOTA stability difference in mice and men.	Cescato R, 2008, J MED CHEM, V51, P4030, DOI 10.1021/jm701618q; Cooper MS, 2012, BIOCONJUGATE CHEM, V23, P1029, DOI 10.1021/bc300037w; de Jong M, 1998, CANCER RES, V58, P437; Deupi X, 2014, NAT CHEM, V6, P7, DOI 10.1038/nchem.1832; Duijzentkunst DAS, 2017, J NUCL MED, V58, p54S, DOI 10.2967/jnumed.117.191015; Fani M, 2012, J NUCL MED, V53, P1481, DOI 10.2967/jnumed.112.102764; Fani M, 2011, J NUCL MED, V52, P1110, DOI 10.2967/jnumed.111.087999; Ghosh SC, 2015, NUCL MED BIOL, V42, P177, DOI 10.1016/j.nucmedbio.2014.09.009; Ginj M, 2006, P NATL ACAD SCI USA, V103, P16436, DOI 10.1073/pnas.0607761103; Gotzmann C, 2016, RSC ADV, V6, P119, DOI 10.1039/c5ra21131j; Hao GY, 2011, CURR RADIOPHARM, V4, P109, DOI 10.2174/1874471011104020109; Hu LY, 2014, MOL IMAGING BIOL, V16, P567, DOI 10.1007/s11307-013-0717-9; Isokawa M, 2016, J CHROMATOGR B, V1019, P59, DOI 10.1016/j.jchromb.2015.11.038; Isokawa M, 2013, ANALYST, V138, P3802, DOI 10.1039/c3an00527e; Johnbeck CB, 2017, J NUCL MED, V58, P451, DOI 10.2967/jnumed.116.180430; Kunz PL, 2015, J CLIN ONCOL, V33, P1855, DOI 10.1200/JCO.2014.60.2532; Lappchen T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170435; Marciniak A, 2017, J RADIOANAL NUCL CH, V313, P279, DOI 10.1007/s10967-017-5323-x; McCarthy DW, 1997, NUCL MED BIOL, V24, P35, DOI 10.1016/S0969-8051(96)00157-6; Nicolas GP, 2017, J NUCL MED, Vpii, DOI [10.29679numed.117.199760, DOI 10.29679/JNUMED.117.199760]; Nicolas GP, 2018, J NUCL MED, V59, P909, DOI 10.2967/jnumed.117.199737; Nicolas GP, 2017, J NUCL MED, V58, P1435, DOI 10.2967/jnumed.117.191684; Paterson BM, 2014, DALTON T, V43, P1386, DOI 10.1039/c3dt52647j; Pfeifer A, 2015, J NUCL MED, V56, P847, DOI 10.2967/jnumed.115.156539; Reubi JC, 2017, J NUCL MED, V58, P300, DOI 10.2967/jnumed.116.177733; Shokeen M, 2011, MED CHEM, V7, P413, DOI 10.2174/157340611796799177; Shokeen M, 2009, ACCOUNTS CHEM RES, V42, P832, DOI 10.1021/ar800255q; Sprague JE, 2007, J MED CHEM, V50, P2527, DOI 10.1021/jm070204r; Storch D, 2005, J NUCL MED, V46, P1561; Wadas TJ, 2007, CURR PHARM DESIGN, V13, P3, DOI 10.2174/138161207779313768; Waser B, 2009, J NUCL MED, V50, P936, DOI 10.2967/jnumed.108.061457; Wild D, 2014, J NUCL MED, V55, P1248, DOI 10.2967/jnumed.114.138834; Wild D, 2011, J NUCL MED, V52, P1412, DOI 10.2967/jnumed.111.088922; Woodin KS, 2005, EUR J INORG CHEM, P4829, DOI 10.1002/ejic.200500579	34	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195802	10.1371/journal.pone.0195802	http://dx.doi.org/10.1371/journal.pone.0195802			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668724	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200059
J	Scott, AB; Singh, M; Groves, P; Hernandez-Jover, M; Barnes, B; Glass, K; Moloney, B; Black, A; Toribio, JA				Scott, Angela Bullanday; Singh, Mini; Groves, Peter; Hernandez-Jover, Marta; Barnes, Belinda; Glass, Kathryn; Moloney, Barbara; Black, Amanda; Toribio, Jenny-Ann			Biosecurity practices on Australian commercial layer and meat chicken farms: Performance and perceptions of farmers	PLOS ONE			English	Article							AVIAN INFLUENZA; POULTRY FARMS; VIRUSES	This paper describes the level of adoption of biosecurity practices performed on Australian commercial chicken meat and layer farms and farmer-perceived importance of these practices. On-farm interviews were conducted on 25 free range layer farms, nine cage layer farms, nine barn layer farms, six free range meat chicken farms and 15 barn meat chicken farms in the Sydney basin bioregion and South East Queensland. There was a high level of treatment of drinking water across all farm types; town water was the most common source. In general, meat chicken farms had a higher level of adoption of biosecurity practices than layer farms. Cage layer farms had the shortest median distance between sheds (7.75m) and between sheds and waterbodies (30m). Equipment sharing between sheds was performed on 43% of free range meat chicken farms compared to 92% of free range layer farms. There was little disinfection of this shared equipment across all farm types. Footbaths and visitor recording books were used by the majority of farms for all farm types except cage layer farms (25%). Wild birds in sheds were most commonly reported in free range meat chicken farms (73%). Dogs and cats were kept across all farm types, from 56% of barn layer farms to 89% of cage layer farms, and they had access to the sheds in the majority (67%) of cage layer farms and on the range in some free range layer farms (44%). Most biosecurity practices were rated on average as 'very important' by farmers. A logistic regression analysis revealed that for most biosecurity practices, performing a practice was significantly associated with higher perceived farmer importance of that biosecurity practice. These findings help identify farm types and certain biosecurity practices with low adoption levels. This information can aid decision-making on efforts used to improve adoption levels.	[Scott, Angela Bullanday; Singh, Mini; Groves, Peter; Toribio, Jenny-Ann] Univ Sydney, Camden, NSW, Australia; [Hernandez-Jover, Marta] Charles Sturt Univ, Wagga Wagga, NSW, Australia; [Barnes, Belinda] Dept Agr, Canberra, ACT, Australia; [Glass, Kathryn] Australian Natl Univ, Canberra, ACT, Australia; [Moloney, Barbara; Black, Amanda] New South Wales Dept Primary Ind, Sydney, NSW, Australia	University of Sydney; Charles Sturt University; Australian National University; NSW Department of Primary Industries	Scott, AB (corresponding author), Univ Sydney, Camden, NSW, Australia.	angela.scott@sydney.edu.au	Moloney, Barbara Jean/G-2003-2011; Singh, Mini/AAE-5906-2019; Hernandez-Jover, Marta/F-8688-2016; Toribio, Jenny-Ann LML/B-5032-2011	Moloney, Barbara Jean/0000-0002-4416-3579; Groves, Peter/0000-0002-8984-3156; Glass, Kathryn/0000-0001-5905-1310; Hernandez-Jover, Marta/0000-0001-8803-9062; Barnes, Belinda/0000-0003-3295-4063	CRC; Woolworths Limited; Poultry CRC; Poultry Cooperative Research Centre (CRC)	CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Woolworths Limited; Poultry CRC(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Poultry Cooperative Research Centre (CRC)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was conducted within the Poultry Cooperative Research Centre (CRC) http://www.chhivken.org.au/page.php?id=26) that provided the majority of funding with support from the CRC and Woolworths Limited (http://www.woolworths.com.au/). The first author, ABS, is also a recipient of a Post-graduate Scholarship and stipend from the Poultry CRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors extend thanks to the egg and chicken meat companies and producers for their participation. This research was conducted within the Poultry Cooperative Research Centre (CRC) with support from the CRC and Woolworths Limited. The first author is also a recipient of a Post-graduate Scholarship from the Poultry CRC.	ACMF, 2011, AUSTR CHICK MEAT IND; AECL, 2015, AUSTR EGG CORP LTD A; AECL, 2015, AUSTR EGG IND OV DEC; Agnew-Crumpton R, 2016, INFECT GENET EVOL, V43, P67, DOI 10.1016/j.meegid.2016.05.023; Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Andres VM, 2015, COMPR REV FOOD SCI F, V14, P317, DOI 10.1111/1541-4337.12137; Animal Health Australia (AHA), 2015, AUSVETPLAN 2015; Animal Health Australia (AHA), 2015, EM AN DIS 2015; Animal Health Australia (AHA) Plant Health Australia (PHA), 2013, FARM BIOS PROGR 2013; Animal Welfare, 2008, AN WELF COMM REP CON; [Anonymous], 2015, VET REC, V176, P505, DOI 10.1136/vr.h2582; Atzeni M, 2016, DETERRENCE WILD WATE; Barnes H, 2009, DIS POULTRY, P941; Beltrame MAV, 2012, VET PARASITOL, V188, P225, DOI 10.1016/j.vetpar.2012.03.053; Bommel Lv, 2014, PLOS ONE, V9; CFFR (Council on Federal Financial Relations), 2014, HIGH PATH AV INFL LA; DAFF (Department of Agriculture Fisheries and Forestry), 2009, NAT FARM BIOS MAN PO; Department of Agriculture Fisheries and Forestry (DAFF), 2009, NAT WAT BIOS MAN POU; East IJ, 2007, AUST VET J, V85, P107, DOI 10.1111/j.1751-0813.2007.00113.x; East IJ, 2008, GEOSPATIAL HEALTH, V3, P17, DOI 10.4081/gh.2008.228; Fasina FO, 2012, PREV VET MED, V103, P178, DOI 10.1016/j.prevetmed.2011.09.016; Food and Agriculture Organization of the United Nations (FAO), 2011, 5 REP JAN 2011 JAN 2; Grillo T, 2015, CONTRIBUTION 2012 AV; Hansbro PM, 2010, EMERG INFECT DIS, V16, P1896, DOI 10.3201/eid1612.100776; Jonges M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125401; Lee DH, 2017, EMERG INFECT DIS, V23, P365, DOI 10.3201/eid2302.161616; Ma Wenjun, 2008, J Mol Genet Med, V3, P158; Mino MH, 2007, INT J PEST MANAGE, V53, P311, DOI 10.1080/09670870601105949; Morrison V., 2008, INTRO HLTH PSYCHOL A; Nespeca R, 1997, PREV VET MED, V31, P73, DOI 10.1016/S0167-5877(96)01122-1; Racicot M, 2012, PREV VET MED, V103, P201, DOI 10.1016/j.prevetmed.2011.08.011; Saif Y, 2009, DIS POULTRY; Scott AB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188505; Scott P., 2009, STRUCTURE DYNAMICS A; Swayne D.E., 2008, AVIAN INFLUENZA; The Australian Chicken Meat Industry, 2013, AUSTR CHICK MEAT IND; VANSAMBEEK F, 1995, AVIAN DIS, V39, P145, DOI 10.2307/1591994	37	29	29	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195582	10.1371/journal.pone.0195582	http://dx.doi.org/10.1371/journal.pone.0195582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668707	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200049
J	Betiku, OC; Yeoman, CJ; Gaylord, TG; Americus, B; Olivo, S; Duff, GC; Seeley, WM				Betiku, Omolola C.; Yeoman, Carl J.; Gaylord, T. Gibson; Americus, Benjamin; Olivo, Sarah; Duff, Glenn C.; Seeley, Wendy M.			Water system is a controlling variable modulating bacterial diversity of gastrointestinal tract and performance in rainbow trout	PLOS ONE			English	Article							ONCORHYNCHUS-MYKISS WALBAUM; SALMO-SALAR L.; SALVELINUS-ALPINUS L.; FLAVOBACTERIUM-PSYCHROPHILUM; ATLANTIC SALMON; GUT MICROBIOTA; COLDWATER DISEASE; FRY SYNDROME; COHO SALMON; COD LARVAE	A two-phase feeding study evaluating performance of rainbow trout and comparing luminal and mucosal gastrointestinal tract (GIT) bacterial community compositions when fed two alternative protein diets in two rearing systems was conducted. Alternative protein diets (animal protein and plant protein diets) balanced with crystalline amino acids: lysine, methionine and threonine or unbalanced, were fed to rainbow trout in two separate water systems (recirculating (RR) and flow-through (FF)) for a period of 16 weeks. The four diets, each contained 38% digestible protein and 20% fats, were fed to rainbow trout with an average weight of 12.02 +/- 0.61 g, and sorted at 30 fish/tank and 12 tanks per dietary treatment. Phase 1 lasted for 8 weeks after which fish from each tank were randomly divided, with one-half moved to new tanks of the opposing system (i.e. from RR to FF and vice versa). The remaining halves were retained in their initial tank and system, and fed their original diets for another 8 weeks (phase 2). After the 16th week, 3 fish/tank were sampled for each of proximate analysis, body indexes and 16S rRNA analysis of GIT microbiota. Fish weight (P = 0.0008, P = 0.0030, P<0.0010) and body fat (P = 0.0008, P = 0.0041, P = 0.0177) were significantly affected by diet, diet quality (balanced or unbalanced) and system, respectively. Feed intake (P = 0.0008) and body energy (P<0.0010) were altered by system. Body indexes were not affected by dietary treatment and water systems. Compositional dissimilarities existed between samples from the rearing water and GIT locations (ANOSIM: (R = 0.29, P = 0.0010), PERMANOVA: R = 0.39, P = 0.0010), but not in dietary samples (ANOSIM: R = 0.004, P = 0.3140, PERMANOVA: R = 0.008, P = 0.4540). Bacteria were predominantly from the phyla Proteobacteria, Firmicutes and Bacteroidetes. Their abundance differed with more dissimilarity in the luminal samples (ANOSIM: R = 0.40, P = 0.0010, PERMANOVA: R = 0.56, P = 0.0010) than those from the mucosal intestine (ANOSIM: R = 0.37, P = 0.0010, PERMANOVA: R = 0.41, P = 0.0010). Bacteria generally associated with carbohydrate and certain amino acids metabolism were observed in the mucosal intestine while rearing water appeared to serve as the main route of colonization of Aeromonas and Acinetobacter in the rainbow trout.	[Betiku, Omolola C.; Gaylord, T. Gibson; Seeley, Wendy M.] US Fish & Wildlife Serv, Bozeman Fish Technol Ctr, Bozeman, MT 59715 USA; [Betiku, Omolola C.; Yeoman, Carl J.; Americus, Benjamin; Olivo, Sarah] Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA; [Duff, Glenn C.] New Mexico State Univ, Dept Anim & Range Sci, Las Cruces, NM 88003 USA	United States Department of the Interior; US Fish & Wildlife Service; Montana State University System; Montana State University Bozeman; New Mexico State University	Betiku, OC (corresponding author), US Fish & Wildlife Serv, Bozeman Fish Technol Ctr, Bozeman, MT 59715 USA.; Betiku, OC (corresponding author), Montana State Univ, Dept Anim & Range Sci, Bozeman, MT 59717 USA.	ocbetiku@gmail.com	Yeoman, Carl/ABA-1906-2021	Yeoman, Carl/0000-0002-8775-7879; Betiku, Omolola/0000-0002-8325-8474; Gaylord, Gibson/0000-0003-3037-0451	Western Regional Aquaculture Center from the USDA-NIFA (PI: WMS) [2010-38500-13198, 2011-38500-14698, 2012-38500-15812, 2013-38500-17048]; USDA-NIFA [2014-67004-2163]; Montana Institute on Ecosystems award; Schlumberger Foundation	Western Regional Aquaculture Center from the USDA-NIFA (PI: WMS); USDA-NIFA(United States Department of Agriculture (USDA)); Montana Institute on Ecosystems award; Schlumberger Foundation(Schlumberger)	This study was funded by Western Regional Aquaculture Center through grant numbers 2010-38500-13198, 2011-38500-14698, 2012-38500-15812, and grant number 2013-38500-17048 from the USDA-NIFA (PI: WMS) as well as USDA-NIFA award 2014-67004-2163 (PI: CJY), a Montana Institute on Ecosystems award (PI: CJY). OCB gratefully acknowledges the fellowship and grant from Schlumberger Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by Western Regional Aquaculture Center through grant numbers 2010-38500-13198, 2011-38500-14698, 2012-38500-15812, and grant number 2013-38500-17048 from the USDA-NIFA (PI: WMS) as well as USDA-NIFA award 2014-67004-2163 (PI: CJY), a Montana Institute on Ecosystems award (PI: CJY). OCB gratefully acknowledges the fellowship and grant from Schlumberger Foundation. OCB thank Dr. Rick Barrows, Jason Frost and Carly Stone for their assistance in feed manufacturing. Also, the assistance of Matt Toner, and Jason Ilgen in sampling, and Zachariah B. Conley, Sam Sawicki with laboratory analyses are greatly appreciated by OCB.	Allendorf F.W., 1988, Conservation Biology, V2, P145, DOI 10.1111/j.1523-1739.1988.tb00165.x; [Anonymous], 2008, FRESHWATER FISHERY; Attramadal KJK, 2014, AQUACULTURE, V432, P483, DOI 10.1016/j.aquaculture.2014.05.052; Attramadal KJK, 2012, AQUACULT ENG, V46, P27, DOI 10.1016/j.aquaeng.2011.10.003; Bakke I, 2013, ENV MICROBIOL REP, V5, P537, DOI 10.1111/1758-2229.12042; Baldo L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127462; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Betiku OC, 2017, FRONTIERS MICROBIOLO; Buddington RK, 1996, ACTA PHYSL SCANDIN S, V638, P67; Burr G, 2005, J WORLD AQUACULT SOC, V36, P425, DOI 10.1111/j.1749-7345.2005.tb00390.x; Chen W, 2016, AQUAC RES, V26, P831; Chen YC, 2008, J FISH DIS, V31, P765, DOI 10.1111/j.1365-2761.2008.00950.x; CHO CY, 1982, COMP BIOCHEM PHYS B, V73, P25, DOI 10.1016/0305-0491(82)90198-5; Clements Kendall D., 1997, P156; d'Orbcastel ER, 2009, AQUACULT ENG, V40, P113, DOI 10.1016/j.aquaeng.2008.12.002; DABROWSKI K, 1989, AQUACULTURE, V77, P29, DOI 10.1016/0044-8486(89)90019-7; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Desai AR, 2012, AQUACULTURE, V350, P134, DOI 10.1016/j.aquaculture.2012.04.005; Gajardo K, 2016, SCI REP-UK, V6, DOI 10.1038/srep30893; Gatlin DM, 2007, AQUAC RES, V38, P551, DOI 10.1111/j.1365-2109.2007.01704.x; Gaylord TG, 2009, AQUACULTURE, V287, P180, DOI 10.1016/j.aquaculture.2008.10.037; Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259; Hu X, 2014, FORESTS, V5, P455, DOI 10.3390/f5030455; Huber I, 2004, J APPL MICROBIOL, V96, P117, DOI 10.1046/j.1365-2672.2003.02109.x; Ingerslev HC, 2014, AQUACULTURE, V424, P24, DOI [10.1016/j.actuaculture.2013.12.032, 10.1016/j.aquaculture.2013.12.032]; Kim DH, 2007, J APPL MICROBIOL, V102, P1654, DOI 10.1111/j.1365-2672.2006.03185.x; Krogdahl A, 2005, COMP BIOCHEM PHYS A, V141, P450, DOI 10.1016/j.cbpb.2005.06.002; LaFrentz BR, 2003, J FISH DIS, V26, P377, DOI 10.1046/j.1365-2761.2003.00468.x; Lee SH, 2008, FEMS MICROBIOL LETT, V285, P263, DOI 10.1111/j.1574-6968.2008.01232.x; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Lorenzen E, 1997, DIS AQUAT ORGAN, V31, P197, DOI 10.3354/dao031197; Mahious AS, 2006, AQUACULT INT, V14, P219, DOI 10.1007/s10499-005-9003-4; Merrifield DL, 2009, J FISH DIS, V32, P755, DOI 10.1111/j.1365-2761.2009.01052.x; Michaud L, 2006, AQUACULT ENG, V34, P224, DOI 10.1016/j.aquaeng.2005.07.005; Michaud L, 2009, J APPL MICROBIOL, V107, P1935, DOI 10.1111/j.1365-2672.2009.04378.x; Navarrete P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031335; Nayak SK, 2010, AQUAC RES, V41, P1553, DOI 10.1111/j.1365-2109.2010.02546.x; NIETO TP, 1984, AQUACULTURE, V42, P193, DOI 10.1016/0044-8486(84)90100-5; NRC (National Research Council), 2011, NUTR REQ FISH SHRIMP; Nyholm SV, 2000, P NATL ACAD SCI USA, V97, P10231, DOI 10.1073/pnas.97.18.10231; Perez T, 2010, MUCOSAL IMMUNOLOGY, DOI [10.1038/mi.2010, DOI 10.1038/MI.2010]; Rawls JF, 2006, CELL, V127, P423, DOI 10.1016/j.cell.2006.08.043; Ray AK, 2012, AQUACULT NUTR, V18, P465, DOI 10.1111/j.1365-2095.2012.00943.x; Refstie S, 1999, ANIM FEED SCI TECH, V79, P331, DOI 10.1016/S0377-8401(99)00026-7; Ringo E, 1999, J APPL MICROBIOL, V86, P22, DOI 10.1046/j.1365-2672.1999.00631.x; Ringo E, 2001, J APPL MICROBIOL, V90, P294, DOI 10.1046/j.1365-2672.2001.01246.x; Ringo E, 2016, AQUACULTURE NUTR; Romero J, 2006, MICROB ECOL, V51, P422, DOI 10.1007/s00248-006-9037-9; Starliper CE, 2011, J ADV RES, V2, P97, DOI 10.1016/j.jare.2010.04.001; Sullam KE, 2012, MOL ECOL, V21, P3363, DOI 10.1111/j.1365-294X.2012.05552.x; USDA, 2013, TROUT PROD; Venkat HK, 2004, AQUAC RES, V35, P501, DOI 10.1111/j.1365-2109.2004.01045.x; Wang AR, 2018, REV AQUACULT, V10, P626, DOI 10.1111/raq.12191; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833; Zarkasi KZ, 2014, J APPL MICROBIOL, V117, P18, DOI 10.1111/jam.12514; Zarkasi KZ, 2017, RES MICROBIOL, V168, P751, DOI 10.1016/j.resmic.2017.07.003; Ziaei-Nejad S, 2006, AQUACULTURE, V252, P516, DOI 10.1016/j.aquaculture.2005.07.021	58	14	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195967	10.1371/journal.pone.0195967	http://dx.doi.org/10.1371/journal.pone.0195967			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664968	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300045
J	Chai, JH; Lee, CK; Lee, HK; Wong, N; Teo, K; Tan, CS; Thokala, P; Tang, JWT; Tambyah, PA; Sen Oh, VM; Loh, TP; Yoong, J				Chai, Jia Hui; Lee, Chun Kiat; Lee, Hong Kai; Wong, Nicholas; Teo, Kahwee; Tan, Chuen Seng; Thokala, Praveen; Tang, Julian Wei-Tze; Tambyah, Paul Anantharajah; Sen Oh, Vernon Min; Loh, Tze Ping; Yoong, Joanne			Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin	PLOS ONE			English	Article							PRETERM INFANTS; FEVER; IDENTIFICATION; INFECTIONS; SPECIMENS; DIAGNOSIS; DNA; ENCEPHALITIS; OUTBREAK; DIARRHEA	Pyrexia of unknown origin (PUO) is defined as a temperature of >38.3 degrees C that lasts for > 3 weeks, where no cause can be found despite appropriate investigation. Existing protocols for the work-up of PUO can be extensive and costly, motivating the application of recent advances in molecular diagnostics to pathogen testing. There have been many reports describing various analytical methods and performance of metagenomic pathogen testing in clinical samples but the economics of it has been less well studied. This study pragmatically evaluates the feasibility of introducing metagenomic testing in this setting by assessing the relative cost of clinically-relevant strategies employing this investigative tool under various cost and performance scenarios using Singapore as a demonstration case, and assessing the price and performance benchmarks, which would need to be achieved for metagenomic testing to be potentially considered financially viable relative to the current diagnostic standard. This study has some important limitations: we examined only impact of introducing the metagenomic test to the overall diagnostic cost and excluded costs associated with hospitalization and makes assumptions about the performance of the routine diagnostic tests, limiting the cost of metagenomic test, and the lack of further work-up after positive pathogen detection by the metagenomic test. However, these assumptions were necessary to keep the model within reasonable limits. In spite of these, the simplified presentation lends itself to the illustration of the key insights of our paper. In general, we find the use of metagenomic testing as second-line investigation is effectively dominated, and that use of metagenomic testing at first-line would typically require higher rates of detection or lower cost than currently available in order to be justifiable purely as a cost-saving measure. We conclude that current conditions do not warrant a widespread rush to deploy metagenomic testing to resolve any and all uncertainty, but rather as a front-line technology that should be used in specific contexts, as a supplement to rather than a replacement for careful clinical judgement.	[Chai, Jia Hui; Tan, Chuen Seng; Yoong, Joanne] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Lee, Chun Kiat; Lee, Hong Kai; Loh, Tze Ping] Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore; [Wong, Nicholas; Tang, Julian Wei-Tze] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Teo, Kahwee] Univ Hosp Leicester NHS Trust, Dept Paediat, Leicester, Leics, England; [Thokala, Praveen] Univ Sheffield, Sch Hlth & Related Res, Hlth Econ & Decis Sci, Sheffield, S Yorkshire, England; [Tang, Julian Wei-Tze] Univ Leicester, Dept Infect Immun Inflammat, Leicester, Leics, England; [Tambyah, Paul Anantharajah; Sen Oh, Vernon Min] Natl Univ Singapore, Dept Med, Singapore, Singapore	National University of Singapore; National University of Singapore; University Hospitals of Leicester NHS Trust; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Sheffield; University of Leicester; National University of Singapore	Loh, TP (corresponding author), Natl Univ Singapore Hosp, Dept Lab Med, Singapore, Singapore.	tploh@hotmail.com	Teo, Kah Wee/AFY-5401-2022; Tan, Chuen Seng/K-1078-2013	Tan, Chuen Seng/0000-0002-6513-2309; Teo, Kah Wee/0000-0003-4986-171X; Loh, Tze Ping/0000-0002-4272-0001; Tang, Julian/0000-0002-4963-1028; Thokala, Praveen/0000-0003-4122-2366	Centre for Personalised and Precision Health (National University Health System)	Centre for Personalised and Precision Health (National University Health System)	This work was supported by the Pitch for Funds (2015) from the Centre for Personalised and Precision Health (National University Health System) to HKL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316; Bleeker-Rovers CP, 2007, MEDICINE, V86, P26, DOI 10.1097/md.0b013e31802fe858; Chung Pei-Wen, 2001, Journal of Microbiology Immunology and Infection, V34, P167; Feigelman R, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0234-1; Frey KG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-96; Fukui Yuto, 2015, J Infect Chemother, V21, P882, DOI 10.1016/j.jiac.2015.08.007; Gao D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1363-2; Graf EH, 2016, J CLIN MICROBIOL, V54, P1000, DOI 10.1128/JCM.03060-15; Hasan MR, 2016, J CLIN MICROBIOL, V54, P919, DOI 10.1128/JCM.03050-15; Hayakawa K, 2012, AM J MED SCI, V344, P307, DOI 10.1097/MAJ.0b013e31824ae504; Hilton SK, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00484; Hoyle E, 2016, AM J INFECT CONTROL, V44, P602, DOI 10.1016/j.ajic.2015.11.032; Jalal H, 2005, J CLIN MICROBIOL, V43, P2575, DOI 10.1128/JCM.43.6.2575-2580.2005; Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13; Moore NE, 2015, J CLIN MICROBIOL, V53, P15, DOI 10.1128/JCM.02029-14; Mourad O, 2003, ARCH INTERN MED, V163, P545, DOI 10.1001/archinte.163.5.545; Mukhopadhya I, 2013, J MED VIROL, V85, P1661, DOI 10.1002/jmv.23641; Mulders-Manders C, 2015, CLIN MED, V15, P280, DOI 10.7861/clinmedicine.15-3-280; Naccache SN, 2015, CLIN INFECT DIS, V60, P919, DOI 10.1093/cid/ciu912; Nicastri E, 2016, EUROSURVEILLANCE, V11, P21; Roth AR, 2003, AM FAM PHYSICIAN, V68, P2223; Sauvage V, 2016, BLOOD TRANSFUS-ITALY, V14, P400, DOI 10.2450/2016.0160-15; Schlaberg R, 2017, ARCH PATHOL LAB MED, V141, P776, DOI 10.5858/arpa.2016-0539-RA; Sorensen HT, 2005, LANCET ONCOL, V6, P851, DOI 10.1016/S1470-2045(05)70346-6; Teunis PFM, 2015, EPIDEMIOL INFECT, V143, P1710, DOI 10.1017/S095026881400274X; Thoendel M, 2016, J MICROBIOL METH, V127, P141, DOI 10.1016/j.mimet.2016.05.022; Doan T, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0344-6; Unger M, 2016, WIEN KLIN WOCHENSCHR, V128, P796, DOI 10.1007/s00508-016-1083-9; Vanderschueren S, 2003, ARCH INTERN MED, V163, P1033, DOI 10.1001/archinte.163.9.1033; Vochem M, 1998, PEDIATR INFECT DIS J, V17, P53, DOI 10.1097/00006454-199801000-00012; Ward DV, 2016, CELL REP, V14, P2912, DOI 10.1016/j.celrep.2016.03.015; Wilson MR, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14058; Wilson MR, 2015, ANN NEUROL, V78, P722, DOI 10.1002/ana.24499; Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268; Zhou YF, 2016, AM J TROP MED HYG, V95, P663, DOI 10.4269/ajtmh.16-0062; Zhou YJ, 2016, J CLIN MICROBIOL, V54, P368, DOI 10.1128/JCM.01965-15	36	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194648	10.1371/journal.pone.0194648	http://dx.doi.org/10.1371/journal.pone.0194648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664913	Green Published, gold, Green Accepted			2022-12-26	WOS:000430262300009
J	Dangi, N; Lim, UT				Dangi, Naresh; Lim, Un Taek			Identification and evaluation of a new entomopathogenic fungal strain against Riptortus pedestris (Hemiptera: Alydidae) and its two egg parasitoids	PLOS ONE			English	Article							MARMORATED STINK BUG; BEAUVERIA-BASSIANA; BIOLOGICAL-CONTROL; HETEROPTERA; PATHOGENICITY; SUSCEPTIBILITY; METARHIZIUM; COLEOPTERA; SELECTION; VIRULENCE	A strain (ARP14) of the entomopathogenic fungus Beauveria bassiana (Balsamo) Vuillemin was isolated from field-collected Riptortus pedestris (Fabricius) (Hemiptera: Alydidae). The lethal median concentration of the ARP14 strain was compared with that of a commercialized strain (GHA) of the same fungus against R. pedestris and its two egg parasitoids, Ooencyrtus nezarae Ishii (Hymenoptera: Encyrtidae) and Gryon japonicum (Ashmead) (Hymenoptera: Platygastridae). Mortality and mycosis rates were evaluated after exposure to five concentrations of the fungus, i.e., 1x10(9), 1x10(8), 1x10(7), 1x10(6), and 1x10(5) conidia/mL, using a glass scintillation vial as an exposure arena in 25.0 +/- 0.5 degrees C and 93.7 +/- 2.9% RH. The lethal median concentrations (LC50) for 2 nd and 4 th instar nymphs, and adults of R. pedestris were not significantly different between the two strains of B. bassiana. However, the mycosis rate of ARP14 was 1.3 and 1.8 times higher than that of the GHA strain in 4 th instar nymphs and adult females of R. pedestris, respectively, at the 1x10(8) conidia/mL concentration. More interestingly, the mycosis rates at 1x10(8) conidia/mL concentration in the parasitoids G. japonicum and O. nezarae were much lower in the ARP14 strain (15.0 and 0%) than in the GHA strain (73.3 and 66.0%), respectively, suggesting that the B. bassiana strain ARP14 is less virulent to these parasitoids than the commercially available strain. Our results suggest that B. bassiana ARP14 may be a potential new biopesticide against R. pedestris with fewer negative effects on beneficial parasitoids than currently available options.	[Dangi, Naresh] Nepal Agr Res Council, Div Entomol, Khumaltar, Lalitpur, Nepal; [Lim, Un Taek] Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea; [Lim, Un Taek] Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea	Andong National University; Andong National University	Lim, UT (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong, South Korea.; Lim, UT (corresponding author), Andong Natl Univ, Inst Agr Sci & Technol, Andong, South Korea.	utlim@andong.ac.kr	Dangi/AAY-2559-2020	Dangi, Naresh/0000-0002-9583-8855	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) - Ministry of Agriculture, Food, and Rural Affairs (MAFRA) [116089-03-1-HD030]	Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) - Ministry of Agriculture, Food, and Rural Affairs (MAFRA)	This work was supported by Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry, and Fisheries (IPET) through Agri-Bio Industry Technology Development Program, funded by Ministry of Agriculture, Food, and Rural Affairs (MAFRA) (116089-03-1-HD030) awarded to UTL.	Alim MA, 2010, J ASIA-PAC ENTOMOL, V13, P139, DOI 10.1016/j.aspen.2010.01.004; BALTENSWEILER W, 1986, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V59, P267; Barta Marek, 2010, Czech Mycology, V62, P67; Bidochka MJ, 1990, MELANOPLUS SANGUINIP, V56, P362; Chi MH, 2009, PLANT PATHOLOGY J, V25, P108, DOI 10.5423/PPJ.2009.25.1.108; Cottrell TE, 2003, J INVERTEBR PATHOL, V84, P137, DOI 10.1016/j.jip.2003.09.003; Dean KM, 2012, J INVERTEBR PATHOL, V109, P303, DOI 10.1016/j.jip.2011.12.004; Down RE, 2009, BIOL CONTROL, V50, P172, DOI 10.1016/j.biocontrol.2009.03.010; Ekesi S, 1999, MYCOPATHOLOGIA, V148, P131, DOI 10.1023/A:1007122622650; FERRON P, 1978, ANNU REV ENTOMOL, V23, P409, DOI 10.1146/annurev.en.23.010178.002205; Gao YL, 2012, BIOCONTROL SCI TECHN, V22, P491, DOI 10.1080/09583157.2012.662478; Godonou I, 2009, CROP PROT, V28, P220, DOI 10.1016/j.cropro.2008.10.009; Goettel Mark S., 1997, P213, DOI 10.1016/B978-012432555-5/50013-0; Gore J, 2006, ENVIRON ENTOMOL, V35, P531, DOI 10.1603/0046-225X-35.2.531; Gouli V, 2012, PEST MANAG SCI, V68, P155, DOI 10.1002/ps.2310; Hu WJ, 1996, APPL ENTOMOL ZOOL, V31, P187, DOI 10.1303/aez.31.187; Humber RA, 2008, J INVERTEBR PATHOL, V98, P262, DOI 10.1016/j.jip.2008.02.017; KCPA, 2017, AGR US GUID BOOK; Kikuhara Yusaku, 2005, Japanese Journal of Systematic Entomology, V11, P299; Kim E, 2014, J ECON ENTOMOL, V107, P1785, DOI 10.1603/EC14236; Lee HeungSu, 2009, Korean Journal of Applied Entomology, V48, P485; Leland JE, 2005, BIOL CONTROL, V35, P104, DOI 10.1016/j.biocontrol.2005.06.005; Leland JE, 2005, BIOCONTROL SCI TECHN, V15, P309, DOI 10.1080/09583150400016936; Lim Un Taek, 2013, Korean Journal of Applied Entomology, V52, P437, DOI 10.5656/KSAE.2013.08.0.038; Liu HP, 2002, J ECON ENTOMOL, V95, P675, DOI 10.1603/0022-0493-95.4.675; Lohmeyer KH, 2006, J ECON ENTOMOL, V99, P1943, DOI 10.1603/0022-0493-99.6.1943; Ludwig SW, 2001, J AGR URBAN ENTOMOL, V18, P169; Mascarin GM, 2016, WORLD J MICROB BIOT, V32, DOI 10.1007/s11274-016-2131-3; McGuire MR, 2006, BIOL CONTROL, V38, P390, DOI 10.1016/j.biocontrol.2005.12.010; Parker BL, 2015, INSECTS, V6, P319, DOI 10.3390/insects6020319; Pedrini N, 2007, COMP BIOCHEM PHYS C, V146, P124, DOI 10.1016/j.cbpc.2006.08.003; Rahman MM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176187; Rehner SA, 2005, MYCOLOGIA, V97, P84, DOI 10.3852/mycologia.97.1.84; Rehner SA, 2011, MYCOLOGIA, V103, P1055, DOI 10.3852/10-302; Rohde C, 2006, NEOTROP ENTOMOL, V35, P231, DOI 10.1590/S1519-566X2006000200012; ROMANA CA, 1992, MEM I OSWALDO CRUZ, V87, P363, DOI 10.1590/S0074-02761992000300005; SAS Institute, 1995, SAS WIND REL 6 11; Strasser H, 2000, BIOCONTROL SCI TECHN, V10, P717, DOI 10.1080/09583150020011690; SUN YP, 1950, J ECON ENTOMOL, V43, P45, DOI 10.1093/jee/43.1.45; Wang JP, 2012, MICROBIOL RES, V167, P116, DOI 10.1016/j.micres.2011.05.002; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; Zar J.H., 1999, ZAR KUHR 5 2019, V4th; Zhukovskaya Marianna, 2013, Insects, V4, P609, DOI 10.3390/insects4040609; Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006	45	5	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195848	10.1371/journal.pone.0195848	http://dx.doi.org/10.1371/journal.pone.0195848			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664929	Green Submitted, Green Published, gold			2022-12-26	WOS:000430262300037
J	Saint-Laurent, C; Garcia, S; Sarrazy, V; Dumas, K; Authier, F; Sorel, S; Tran, A; Gual, P; Gennero, I; Salles, JP; Gouze, E				Saint-Laurent, Celine; Garcia, Stephanie; Sarrazy, Vincent; Dumas, Karine; Authier, Florence; Sorel, Sophie; Tran, Albert; Gual, Philippe; Gennero, Isabelle; Salles, Jean-Pierre; Gouze, Elvire			Early postnatal soluble FGFR3 therapy prevents the atypical development of obesity in achondroplasia	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR-3; BODY-MASS INDEX; INSULIN-RESISTANCE; REFERENCE VALUES; ADIPOSE-TISSUE; FAT RATIO; CHILDREN; WEIGHT; AGE; COMPLICATIONS	Background Achondroplasia is a rare genetic disease is characterized by abnormal bone development and early obesity. While the bone aspect of the disease has been thoroughly studied, early obesity affecting approximately 50% of them during childhood has been somewhat neglected. It nevertheless represents a major health problem in these patients, and is associated to life-threatening complications including increasing risk of cardiovascular pathologies. We have thus decided to study obesity in patients and to use the mouse model to evaluate if soluble FGFR3 therapy, an innovative treatment approach for achondroplasia, could also impact the development of this significant complication. Methods and findings To achieve this, we have first fully characterized the metabolic deregulations in these patients by conducting a longitudinal retrospective study, in children with achondroplasia Anthropometric, densitometric measures as well as several blood parameters were recorded and compared between three age groups ranging from [0 +/- 3], [4 +/- 8] and [9 +/- 18] years old. Our results show unexpected results with the development of an atypical obesity with preferential fat deposition in the abdomen that is remarkably not associated with classical complications of obesity such as diabetes or hypercholosterolemia. Because it is not associated with diabetes, the atypical obesity has not been studied in the past even though it is recognized as a real problem in these patients. These results were validated in a murine model of achondroplasia (Fgfr3(ach/+)) where similar visceral adiposity was observed. Unexpected alterations in glucose metabolism were highlighted during high-fat diet. Glucose, insulin or lipid levels remained low, without the development of diabetes. Very interestingly, in achondroplasia mice treated with soluble FGFR3 during the growth period (from D3 to D22), the development of these metabolic deregulations was prevented in adult animals between 4 and 14 weeks of age). The lean-over-fat tissues ratio was restored and glucose metabolism showed normal levels. Treating Fgfr3(ach/+) mice with soluble FGFR3 during the growth period, prevented the development of these metabolic deregulations in adult animals and restored lean-over-fat tissues ratio as well as glucose metabolism in adult animals. Conclusion This study demonstrate that achondroplasia patients develop an atypical obesity with preferential abdominal obesity not associated with classical complications. These results suggest that achondroplasia induces an uncommon metabolism of energy, directly linked to the FGFR3 mutation. These data strongly suggest that this common complication of achondroplasia should be included in the clinical management of patients. In this context, sFGFR3 proved to be a promising treatment for achondroplasia by normalizing the biology at different levels, not only restoring bone growth but also preventing the atypical visceral obesity and some metabolic deregulations.	[Saint-Laurent, Celine; Authier, Florence; Sorel, Sophie; Gouze, Elvire] Univ Cote Azur, CNRS, INSERM, iBV, Nice, France; [Saint-Laurent, Celine; Garcia, Stephanie; Sarrazy, Vincent; Dumas, Karine; Tran, Albert; Gual, Philippe; Gouze, Elvire] Univ Cote Azur, CHU, INSERM, C3M, Nice, France; [Gennero, Isabelle; Salles, Jean-Pierre] Univ Paul Sabatier Toulouse III, INSERM, CPTP, Toulouse, France; [Gennero, Isabelle] Toulouse Univ Hosp, Inst Federatif Biol, Biochem Lab, Toulouse, France; [Salles, Jean-Pierre] Toulouse Univ Hosp, Childrens Hosp, Endocrine Bone Dis & Genet Unit, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; CHU de Toulouse	Gouze, E (corresponding author), Univ Cote Azur, CNRS, INSERM, iBV, Nice, France.; Gouze, E (corresponding author), Univ Cote Azur, CHU, INSERM, C3M, Nice, France.	elvire.gouze@inserm.fr	Gual, Philippe/M-8787-2017; Gual, Philippe/P-9833-2019	Gual, Philippe/0000-0001-7393-8356; Gual, Philippe/0000-0001-7393-8356; SALLES, jean Pierre/0000-0002-0941-8951; Albert, TRAN/0000-0003-0003-5361; Saint-Laurent, Celine/0000-0002-9829-0178; Sarrazy, Vincent/0000-0003-4598-6005	IRG Marie Curie, FP7 [PIRG03-GA-2008-226132]; Fondation pour la Recherche Medicale [FDT20170437294]	IRG Marie Curie, FP7; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Elvire Gouze was supported by IRG Marie Curie, FP7 (Grant number PIRG03-GA-2008-226132). Celine Saint-Laurent was supported by Fondation pour la Recherche Medicale (Grant number FDT20170437294). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatzoglou KS, 2009, J CLIN ENDOCR METAB, V94, P3959, DOI 10.1210/jc.2009-0322; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aucouturier J, 2009, ARCH PEDIAT ADOL MED, V163, P826, DOI 10.1001/archpediatrics.2009.148; COLLIPP PJ, 1972, AM J DIS CHILD, V124, P682, DOI 10.1001/archpedi.1972.02110170060008; CRONK CE, 1982, AM J CLIN NUTR, V35, P347, DOI 10.1093/ajcn/35.2.347; Fischer DC, 2012, ANN CLIN BIOCHEM, V49, P546, DOI 10.1258/acb.2012.011274; Garcia S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006247; Haine E, 2015, J BONE MINER RES, V30, P1369, DOI 10.1002/jbmr.2471; HECHT JT, 1988, AM J MED GENET, V31, P597, DOI 10.1002/ajmg.1320310314; Hoover-Fong JE, 2007, AM J MED GENET A, V143A, P2227, DOI 10.1002/ajmg.a.31873; Hoover-Fong JE, 2008, AM J CLIN NUTR, V88, P364, DOI 10.1093/ajcn/88.2.364; Horton W A, 1977, Birth Defects Orig Artic Ser, V13, P101; Horton WA, 2007, LANCET, V370, P162, DOI 10.1016/S0140-6736(07)61090-3; Hunter AGW, 1996, AM J MED GENET, V62, P255, DOI 10.1002/(SICI)1096-8628(19960329)62:3<255::AID-AJMG10>3.0.CO;2-J; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kursawe R, 2010, DIABETES, V59, P2288, DOI 10.2337/db10-0113; L'Hote CGM, 2005, EXP CELL RES, V304, P417, DOI 10.1016/j.yexcr.2004.11.012; Lafontan M, 2014, DIABETES METAB, V40, P16, DOI 10.1016/j.diabet.2013.08.002; Mellerio H, 2012, PEDIATRICS, V129, pE1020, DOI 10.1542/peds.2011-0449; Naski MC, 1998, DEVELOPMENT, V125, P4977; Nies VJM, 2016, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00193; Ornitz DM, 2005, CYTOKINE GROWTH F R, V16, P205, DOI 10.1016/j.cytogfr.2005.02.003; Pirgon O, 2008, J PAEDIATR CHILD H, V44, P602, DOI 10.1111/j.1440-1754.2008.01392.x; REVICKI DA, 1986, AM J PUBLIC HEALTH, V76, P992, DOI 10.2105/AJPH.76.8.992; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; Samsell L, 2014, J OBES, V2014, DOI 10.1155/2014/846578; Schlueter N, 2014, PHARMACOL THERAPEUT, V144, P12, DOI 10.1016/j.pharmthera.2014.04.007; Schulze KJ, 2013, AM J MED GENET A, V161, P2110, DOI 10.1002/ajmg.a.35947; Smith U, 2015, J CLIN INVEST, V125, P1790, DOI 10.1172/JCI81507; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; STOKES DC, 1983, J PEDIATR-US, V102, P534, DOI 10.1016/S0022-3476(83)80180-2; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Trotter TL, 2005, PEDIATRICS, V116, P771, DOI 10.1542/peds.2005-1440; Unger S, 2017, CURR OSTEOPOROS REP, V15, P53, DOI 10.1007/s11914-017-0347-2; van der Sluis IM, 2002, ARCH DIS CHILD, V87, P341, DOI 10.1136/adc.87.4.341; WALTON C, 1995, AM J MED, V99, P459, DOI 10.1016/S0002-9343(99)80220-4; Webster MK, 1996, EMBO J, V15, P520, DOI 10.1002/j.1460-2075.1996.tb00384.x; Wendt DJ, 2015, J PHARMACOL EXP THER, V353, P132, DOI 10.1124/jpet.114.218560; Yamashita A, 2014, NATURE, V513, P507, DOI 10.1038/nature13775; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	41	14	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195876	10.1371/journal.pone.0195876	http://dx.doi.org/10.1371/journal.pone.0195876			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652901	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900043
J	Stein, K; Hieggelke, L; Schneiker, B; Lysson, M; Stoffels, B; Nuding, S; Wehkamp, J; Kikhney, J; Moter, A; Kalff, JC; Wehner, S				Stein, Kathy; Hieggelke, Lena; Schneiker, Bianca; Lysson, Mariola; Stoffels, Burkhard; Nuding, Sabine; Wehkamp, Jan; Kikhney, Judith; Moter, Annette; Kalff, Joerg C.; Wehner, Sven			Intestinal manipulation affects mucosal antimicrobial defense in a mouse model of postoperative ileus	PLOS ONE			English	Article							TARGETED OLIGONUCLEOTIDE PROBES; INFLAMMATORY-BOWEL-DISEASE; IN-SITU HYBRIDIZATION; LECTIN REGIII-GAMMA; BACTERIAL TRANSLOCATION; GASTROINTESTINAL-TRACT; PEPTIDE EXPRESSION; GUT FLORA; MUSCULARIS; CELLS	Aim To explore the effects of abdominal surgery and interleukin-1 signaling on antimicrobial defense in a model of postoperative ileus. Methods C57BL/6 and Interleukin-1 receptor type I (IL-1R1) deficient mice underwent intestinal manipulation to induce POI. Expression of mucosal IL-1 alpha, IL-1 beta and IL-1R1 and several antimicrobial peptides and enzymes were measured by quantitative PCR or ELISA, western blotting or immunohistochemistry. Bacterial overgrowth was determined by fluorescent in-situ hybridization and counting of jejunal luminal bacteria. Translocation of aerobic and anaerobic bacteria into the intestinal wall, mesenteric lymph nodes, liver and spleen was determined by counting bacterial colonies on agar plates 48h after plating of tissue homogenates. Antimicrobial activity against E. coli and B. vulgatus was analyzed in total and cationic fractions of small bowel mucosal tissue homogenates by a flow cytometry-based bacterial depolarization assay. Results Jejunal bacterial overgrowth was detected 24h after surgery. At the same time point, but not in the early phase 3h after surgery, bacterial translocation into the liver and mesenteric lymph nodes was observed. Increased antimicrobial activity against E. coli was induced within early phase of POI. Basal antimicrobial peptide and enzyme gene expression was higher in the ileal compared to the jejunal mucosa. The expression of lysozyme 1, cryptdin 1, cryptdin 4 and mucin 2 were reduced 24h after surgery in the ileal mucosa and mucin 2 was also reduced in the jejunum. Postoperative IL-1 alpha and IL-1 beta were increased in the postoperative mucosa. Deficiency of IL-1R1 affected the expression of antimicrobial peptides during homeostasis and POI. Conclusion Small bowel antimicrobial capacity is disturbed during POI which is accompanied by bacterial overgrowth and translocation. IL-1R1 is partially involved in the gene expression of mucosal antimicrobial peptides. Altered small bowel antimicrobial activity may contribute also to POI development and manifestation in patients undergoing abdominal surgery.	[Stein, Kathy; Hieggelke, Lena; Schneiker, Bianca; Lysson, Mariola; Stoffels, Burkhard; Kalff, Joerg C.; Wehner, Sven] Univ Hosp Bonn, Dept Surg, Bonn, Germany; [Nuding, Sabine] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Wehkamp, Jan] Univ Hosp Tubingen, Internal Med 1, Tubingen, Germany; [Kikhney, Judith; Moter, Annette] Charite, Inst Microbiol & Hyg, Biofilmctr, Berlin, Germany	University of Bonn; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Wehner, S (corresponding author), Univ Hosp Bonn, Dept Surg, Bonn, Germany.	sven.wehner@ukbonn.de	Stoffels, Burkhard/L-1415-2018; Kalff, Joerg C/U-8580-2017; Wehner, Sven/X-6326-2019	Kikhney, Judith/0000-0002-4849-7947; Hieggelke, Lena/0000-0002-1831-0387; Moter, Annette/0000-0003-1318-5780	BONFOR student grant from the University of Bonn [0-112.0054]; Flow Cytometry Core Facility (Medical faculty, University Bonn)	BONFOR student grant from the University of Bonn; Flow Cytometry Core Facility (Medical faculty, University Bonn)	This work was supported by a BONFOR student grant from the University of Bonn (0-112.0054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for the support of the Flow Cytometry Core Facility (Medical faculty, University Bonn). KS, JCK and SW are members of the ImmunoSensation Cluster of Excellence.	AMANN RI, 1990, APPL ENVIRON MICROB, V56, P1919, DOI 10.1128/AEM.56.6.1919-1925.1990; Andus T, 1997, GUT, V41, P651, DOI 10.1136/gut.41.5.651; Asgeirsson T, 2010, J AM COLL SURGEONS, V210, P228, DOI 10.1016/j.jamcollsurg.2009.09.028; Bando M, 2007, IMMUNOL CELL BIOL, V85, P532, DOI 10.1038/sj.icb.7100078; Barletta JF, 2014, WORLD J SURG, V38, P1966, DOI 10.1007/s00268-014-2506-2; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Berg Rodney D., 1995, Trends in Microbiology, V3, P149, DOI 10.1016/S0966-842X(00)88906-4; Boeckxstaens GE, 2009, GUT, V58, P1300, DOI 10.1136/gut.2008.169250; Brandl K, 2007, J EXP MED, V204, P1891, DOI 10.1084/jem.20070563; Bures J, 2010, WORLD J GASTROENTERO, V16, P2978, DOI 10.3748/wjg.v16.i24.2978; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Cobo ER, 2015, MUCOSAL IMMUNOL, V8, P1360, DOI 10.1038/mi.2015.27; Daims Holger, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5253; DEITCH EA, 1990, J TRAUMA, V30, pS184; Deitch EA, 2012, SURG-J R COLL SURG E, V10, P350, DOI 10.1016/j.surge.2012.03.003; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Gong JF, 2010, CLIN IMMUNOL, V136, P245, DOI 10.1016/j.clim.2010.04.001; Guilloteau K, 2010, J IMMUNOL, V184, P5263, DOI 10.4049/jimmunol.0902464; Heimesaat MM, 2006, J IMMUNOL, V177, P8785, DOI 10.4049/jimmunol.177.12.8785; Hiroshima Y, 2011, ARCH ORAL BIOL, V56, P761, DOI 10.1016/j.archoralbio.2011.01.004; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kalff JC, 2003, ANN SURG, V237, P301, DOI 10.1097/00000658-200303000-00003; Kalff JC, 1998, J LEUKOCYTE BIOL, V63, P683, DOI 10.1002/jlb.63.6.683; Klag T, 2013, DIGEST DIS, V31, P310, DOI 10.1159/000354858; Lehotzky RE, 2010, P NATL ACAD SCI USA, V107, P7722, DOI 10.1073/pnas.0909449107; Ludwiczek O, 2004, CLIN EXP IMMUNOL, V138, P323, DOI 10.1111/j.1365-2249.2004.02599.x; Mallmann C, 2010, CLIN MICROBIOL INFEC, V16, P767, DOI 10.1111/j.1469-0691.2009.02936.x; McGuckin MA, 2011, NAT REV MICROBIOL, V9, P265, DOI 10.1038/nrmicro2538; Moter A, 1998, MICROBIOL-UK, V144, P2459, DOI 10.1099/00221287-144-9-2459; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Schwarz NT, 2002, ANN SURG, V235, P31, DOI 10.1097/00000658-200201000-00005; Sims JE, 2010, NAT REV IMMUNOL, V10, P89, DOI 10.1038/nri2691; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Snoek SA, 2012, NEUROGASTROENT MOTIL, V24, P172, DOI 10.1111/j.1365-2982.2011.01820.x; Stoffels B, 2014, GASTROENTEROLOGY, V146, P176, DOI 10.1053/j.gastro.2013.09.030; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Vaishnavi C, 2013, INDIAN J MED MICROBI, V31, P334, DOI 10.4103/0255-0857.118870; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Weber A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3105cm1; Wehner S, 2012, LANGENBECK ARCH SURG, V397, P591, DOI 10.1007/s00423-012-0915-y; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2016, CURR BIOL, V26, pR14, DOI 10.1016/j.cub.2015.11.017	48	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195516	10.1371/journal.pone.0195516	http://dx.doi.org/10.1371/journal.pone.0195516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652914	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900024
J	Almeida, ACF; de Paula, FJA; Monteiro, JP; Nogueira-de-Almeida, CA; Del Ciampo, LA; Aragon, DC; Ferraz, IS				Fayao Almeida, Ane Cristina; Albuquerque de Paula, Francisco Jose; Monteiro, Jacqueline Pontes; Nogueira-de-Almeida, Carlos Alberto; Del Ciampo, Luiz Antonio; Aragon, Davi Casale; Ferraz, Ivan Savioli			Do all infants need vitamin D supplementation?	PLOS ONE			English	Article							D DEFICIENCY; HEALTHY-CHILDREN; D INSUFFICIENCY; SERUM; RISK; PREVENTION; MANAGEMENT; EXPOSURE; CALCIUM; AGE	A high prevalence of vitamin D deficiency (VDD) in children has been observed worldwide, but there are few studies on the nutritional status of vitamin D (VD) in healthy infants. The main cause of deficiency in healthy children is breastfeeding without supplementation and lack or insufficiency of sun exposure. The aims of this study were to determine serum concentrations of 25(OH)D and verify its association with parathyroid hormone (PTH) concentrations and use of VD supplementation in healthy infants aged >= 6 to <= 24 months attended at two Primary Health Care Units in Ribeirao Preto city, Sao Paulo, Brazil. A crosssectional, observational and analytical study was performed in which serum concentrations of 25(OH)D, PTH, alkaline phosphatase (AP), calcium (Ca), phosphorus (P) and albumin were determined in 155 healthy infants. Information on sun exposure, sociodemographic aspects of mothers and clinical and nutritional characteristics of infants were obtained through interviews with responsible infants's legal representatives. Ten infants (6%) presented deficient 25(OH)D serum concentration (<= 20ng/ml) and 46 (30%), insufficient (21 to 29ng/ml). No changes in serum P, Ca and albumin concentrations were detected. Only one infant had an increase in PTH serum concentrations. 35% (55/155) of infants had high AP e 40% (22/55) presented insufficient serum concentrations of 25(OH)D but none presented deficient ones. There was a weak association between serum concentrations of 25(OH)D and PTH and an association between serum concentrations of 25(OH)D and P when adjusted for sex, age and BMI. There were no associations between inadequate serum concentrations of 25(OH)D (deficient ou insufficient), sun exposure and VD supplementation. This study found a low prevalence of deficient 25(OH)D serum concentration and high prevalence of insufficient ones which was not associated with changes in serum PTH, AP, P, Ca and albumin concentrations, VD supplementation and the formula volume intake.	[Fayao Almeida, Ane Cristina; Albuquerque de Paula, Francisco Jose; Monteiro, Jacqueline Pontes; Del Ciampo, Luiz Antonio; Aragon, Davi Casale; Ferraz, Ivan Savioli] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pediat, Ribeirao Preto, Brazil; [Nogueira-de-Almeida, Carlos Alberto] Fed Univ Sao Carlos UFSCAR, Dept Med, Ribeirao Preto, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Carlos	Nogueira-de-Almeida, CA (corresponding author), Fed Univ Sao Carlos UFSCAR, Dept Med, Ribeirao Preto, Brazil.	dr.nogueira@me.com	Nogueira-de-Almeida, Carlos Alberto/C-4421-2013; de Paula, Francisco/D-5026-2012; Aragon, Davi C/R-6604-2016; Ferraz, Ivan S/F-5355-2014	Nogueira-de-Almeida, Carlos Alberto/0000-0003-1272-4404; de Paula, Francisco/0000-0003-1262-3486; Aragon, Davi C/0000-0003-1019-3654; Ferraz, Ivan/0000-0003-3464-6523	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (CNPq) of Ministry of Innovation, Technology and Sciences of Brazil	National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (CNPq) of Ministry of Innovation, Technology and Sciences of Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF))	This work was granted scholarships by the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico) (CNPq) of Ministry of Innovation, Technology and Sciences of Brazil to ACFA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAD, 2008, POS STAT VIT D; Abrams SA, 2011, PEDIATRICS, V127, P566, DOI 10.1542/peds.2010-3576; Absoud M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022179; Alonso MA, 2015, PEDIATR NEPHROL, V30, P327, DOI 10.1007/s00467-014-2927-z; Akman AO, 2011, PEDIATR INT, V53, P968, DOI 10.1111/j.1442-200X.2011.03486.x; Alimentarius C., 721981 CODEX; Andersson Bjorn, 2016, Bone Rep, V5, P150, DOI 10.1016/j.bonr.2016.03.002; Atas E, 2013, EUR J PEDIATR, V172, P1039, DOI 10.1007/s00431-013-1997-4; Balasubramanian S, 2008, INDIAN J MED RES, V127, P250; Bassrawi Rolan, 2014, Sudan J Paediatr, V14, P85; Bener A, 2014, J PEDIATR NEUROSCI, V9, P227, DOI 10.4103/1817-1745.147574; Bener A, 2009, INT J FOOD SCI NUTR, V60, P60, DOI 10.1080/09637480802400487; BESSEY OA, 1946, J BIOL CHEM, V164, P321; Binks MJ, 2016, MED J AUSTRALIA, V204, DOI 10.5694/mja15.00798; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Braegger C, 2013, J PEDIATR GASTR NUTR, V56, P692, DOI 10.1097/MPG.0b013e31828f3c05; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Carpenter TO, 2012, AM J CLIN NUTR, V95, P137, DOI 10.3945/ajcn.111.018721; Carroll A, 2014, CLIN PEDIATR, V53, P1345, DOI 10.1177/0009922814541999; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Center for Disease Control, 2012, 2 NAT REP BIOCH IND; Cetinkaya M, 2015, J PERINATOL, V35, P39, DOI 10.1038/jp.2014.146; Cole CR, 2010, PEDIATRICS, V125, P633, DOI 10.1542/peds.2009-1928; DALY JA, 1972, CLIN CHEM, V18, P263; Dori N, 2010, PEDIATR INT, V52, P866, DOI 10.1111/j.1442-200X.2010.03265.x; DOUMAS BT, 1971, CLIN CHIM ACTA, V31, P87, DOI 10.1016/0009-8981(71)90365-2; Dyson A, 2014, J PAEDIATR CHILD H, V50, P47, DOI 10.1111/jpc.12413; Grant CC, 2009, PUBLIC HEALTH NUTR, V12, P1893, DOI 10.1017/S1368980009004820; Grant WB, 2008, PEDIATR INFECT DIS J, V27, P853, DOI 10.1097/INF.0b013e3181817bc1; Halicioglu O, 2012, PEDIATRICS, V130, pE921, DOI 10.1542/peds.2012-0017; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; IBGE, 2017, CONC COL RAC; INMET, 2017, MET NIO; Institute S, 2010, SAS STAT 9; IOM, 2011, DIETARY REFERENCE IN; Khor GL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-95; Kleinman RE, 2014, PEDIAT NUTR, P495; Koletzko B., 2008, NUTR PRACTICE; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; Manson JE, 2016, NEW ENGL J MED, V375, P1817, DOI 10.1056/NEJMp1608005; McDonnell SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180483; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; MORGAN BR, 1993, CLIN CHEM, V39, P1608; Munns CF, 2016, HORM RES PAEDIAT, V85, P83, DOI [10.1159/000443136, 10.1210/jc.2015-2175]; Ozkan Behzat, 2010, J Clin Res Pediatr Endocrinol, V2, P137, DOI 10.4274/jcrpe.v2i4.137; Pludowski P, 2011, J PEDIATR GASTR NUTR, V53, P93, DOI 10.1097/MPG.0b013e318216920f; Poh BK, 2016, ASIA PAC J CLIN NUTR, V25, P538, DOI 10.6133/apjcn.092015.02; Prentice A, 2008, NUTR REV, V66, pS153, DOI 10.1111/j.1753-4887.2008.00100.x; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Reichrath J., SUNLIGHT VITAMIN D S; Sai AJ, 2011, J CLIN ENDOCR METAB, V96, pE436, DOI 10.1210/jc.2010-1886; Slominski AT, 2017, J STEROID BIOCHEM, V173, P42, DOI 10.1016/j.jsbmb.2016.09.024; Slominski AT, 2016, EXP DERMATOL, V25, P231, DOI 10.1111/exd.12872; Slominski AT, 2015, SCI REP-UK, V5, DOI 10.1038/srep14875; Slominski AT, 2012, FASEB J, V26, P3901, DOI 10.1096/fj.12-208975; Thorisdottir B, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020075; Valcour A, 2012, J CLIN ENDOCR METAB, V97, P3989, DOI 10.1210/jc.2012-2276; Vogiatzi MG, 2014, J CLIN ENDOCR METAB, V99, P1132, DOI 10.1210/jc.2013-3655; Wacker M, 2013, DERM-ENDOCRINOL, V5, DOI [10.4161/derm.24476, 10.4161/derm.24494]; Wagner CL, 2016, J STEROID BIOCHEM, V155, P245, DOI 10.1016/j.jsbmb.2015.10.022; WHO, 2006, WHO CHILD GROWTH STA; WHO, 2017, INF NUTR; Yorita KL, 2007, PEDIATR INFECT DIS J, V26, P1081, DOI 10.1097/INF.0b013e31812e62c2	66	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195368	10.1371/journal.pone.0195368	http://dx.doi.org/10.1371/journal.pone.0195368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649273	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900040
J	Khan, MT; Dalvin, S; Waheed, Q; Nilsen, F; Male, R				Khan, Muhammad Tanveer; Dalvin, Sussie; Waheed, Qaiser; Nilsen, Frank; Male, Rune			Molecular characterization of the lipophorin receptor in the crustacean ectoparasite Lepeophtheirus salmonis	PLOS ONE			English	Article							LIGAND-BINDING REPEAT; LIPID TRANSPORT; FAMILIAL HYPERCHOLESTEROLEMIA; MEDIATED ENDOCYTOSIS; GALLERIA-MELLONELLA; INSECT LIPOPROTEIN; ATLANTIC SALMON; KNOCK-DOWN; WAX MOTH; SEA LICE	The Salmon louse (Lepeophtheirus salmonis) is a marine ectoparasite of salmonid fish in the Northern Hemisphere and considered as a major challenge in aquaculture and a threat to wild populations of salmonids. Adult female lice produce a large number of lipid-rich eggs, however, the mechanism of maternal lipid transport into developing eggs during salmon louse reproduction has not been described. In the present study, a full-length L. salmonis lipophorin receptor (LsLpR) consisting of 16 exons was obtained by RACE and RT-PCR. The predicted ORF was 952 amino acids and structural analysis showed five functional domains that are similar to LpR of insects and decapods. Phylogenetic analysis placed the LsLpR together with LpRs from decapods and insects. Expression analysis revealed that the relative abundance of LsLpR transcripts was highest in the larvae and adult female lice. In adult females, the LsLpR transcripts and protein were found in the ovary and vitellogenic oocytes whereas, in larvae, the LsLpR transcripts were found in the neuronal somata of the brain and the intestine. Oil Red O stain results revealed that storage of neutral lipids was found in vitellogenic oocytes and ovaries of adult females, and in the yolk of larvae. Moreover, RNA interference (RNAi) was conducted to demonstrate the function of LsLpR in reproduction and lipid metabolism in L. salmonis. In larvae, the transcription of LsLpR was decreased by 44-54% while in an experiment LsLpR knockdown female lice produced 72% less offspring than control lice.	[Khan, Muhammad Tanveer; Nilsen, Frank] Univ Bergen, Dept Biol Sci, Sea Lice Res Ctr, Bergen, Norway; [Dalvin, Sussie] Inst Marine Res, Sea Lice Res Ctr, Bergen, Norway; [Waheed, Qaiser; Male, Rune] Univ Bergen, Dept Biol Sci, Computat Biol Unit, Bergen, Norway	University of Bergen; Institute of Marine Research - Norway; University of Bergen	Male, R (corresponding author), Univ Bergen, Dept Biol Sci, Computat Biol Unit, Bergen, Norway.	rune.male@uib.no	Dalvin, Sussie/AAL-6893-2021	Dalvin, Sussie/0000-0002-6092-4710; Male, Rune/0000-0003-2415-8462; Waheed, Qaiser/0000-0002-7566-2506	Research Council of Norway [203513/O30]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway, Grant Number 203513/O30 (https://www.forskningsradet.no/en/Home_page/1177315753906) to MTK, SD, FN, and RM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], J MOL BIOCH; Atkins AR, 1998, BIOCHEMISTRY-US, V37, P1662, DOI 10.1021/bi972529n; BEENAKKERS AMT, 1988, INSECT BIOCHEM, V18, P1, DOI 10.1016/0020-1790(88)90029-7; Benoit JB, 2011, J INSECT PHYSIOL, V57, P1553, DOI 10.1016/j.jinsphys.2011.08.009; Blacklow SC, 1996, NAT STRUCT BIOL, V3, P758, DOI 10.1038/nsb0996-758; BUJO H, 1994, EMBO J, V13, P5165, DOI 10.1002/j.1460-2075.1994.tb06847.x; Canavoso LE, 2001, ANNU REV NUTR, V21, P23, DOI 10.1146/annurev.nutr.21.1.23; Cheon HM, 2001, INSECT BIOCHEM MOLEC, V31, P753, DOI 10.1016/S0965-1748(01)00068-6; CHINO H, 1981, INSECT BIOCHEM, V11, P491, DOI 10.1016/0020-1790(81)90085-8; Ciudad L, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-53; Costello MJ, 2009, P ROY SOC B-BIOL SCI, V276, P3385, DOI 10.1098/rspb.2009.0771; Dalvin S, 2013, J NAT HIST, V47, P889, DOI 10.1080/00222933.2012.738830; Dalvin S, 2011, DIS AQUAT ORGAN, V94, P211, DOI 10.3354/dao02331; Dalvin S, 2009, INT J PARASITOL, V39, P1407, DOI 10.1016/j.ijpara.2009.04.004; Dantuma NP, 1999, J LIPID RES, V40, P973; Dantuma NP, 1997, J LIPID RES, V38, P254; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Eichner C, 2015, EXP PARASITOL, V159, P79, DOI 10.1016/j.exppara.2015.09.001; Eichner C, 2014, EXP PARASITOL, V140, P44, DOI 10.1016/j.exppara.2014.03.014; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Fruttero LL, 2011, J INSECT PHYSIOL, V57, P475, DOI 10.1016/j.jinsphys.2011.01.009; GOLDSTEIN JL, 1974, J BIOL CHEM, V249, P5153; Goldstein JL, 2009, ARTERIOSCL THROM VAS, V29, P431, DOI 10.1161/ATVBAHA.108.179564; Gopalapillai R, 2006, J LIPID RES, V47, P1005, DOI 10.1194/jlr.M500462-JLR200; Guidugli-Lazzarini KR, 2008, J INSECT PHYSIOL, V54, P1138, DOI 10.1016/j.jinsphys.2008.04.021; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Herz J, 2002, ANNU REV BIOCHEM, V71, P405, DOI 10.1146/annurev.biochem.71.110601.135342; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Innerarity TL, 2002, SCIENCE, V298, P2337, DOI 10.1126/science.1080669; Jeon H, 2003, STRUCTURE, V11, P133, DOI 10.1016/S0969-2126(03)00010-8; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; KAWOOYA JK, 1988, J BIOL CHEM, V263, P8748; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khan MT, 2017, J LIPID RES, V58, P1613, DOI 10.1194/jlr.M076430; Kvamme BO, 2004, INT J PARASITOL, V34, P823, DOI 10.1016/j.ijpara.2004.02.004; Lee CS, 2003, ARCH INSECT BIOCHEM, V54, P14, DOI 10.1002/arch.10095; Lee CS, 2003, INSECT BIOCHEM MOLEC, V33, P761, DOI 10.1016/S0965-1748(03)00066-3; Lee JY, 2013, BIOFABRICATION, V5, DOI 10.1088/1758-5082/5/4/045003; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Maddison WP., 2019, CHROMASEQ MESQUITE P; Parra-Peralbo E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001297; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Ravikumar G, 2013, RESONANCE; Roosendaal SD, 2008, FEBS J, V275, P1751, DOI 10.1111/j.1742-4658.2008.06334.x; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Ryan RO, 2000, ANNU REV ENTOMOL, V45, P233, DOI 10.1146/annurev.ento.45.1.233; Seo SJ, 2003, J BIOL CHEM, V278, P41954, DOI 10.1074/jbc.M308200200; SOULAGES JL, 1994, ADV PROTEIN CHEM, V45, P371; Sun JX, 2000, INSECT BIOCHEM MOLEC, V30, P1161, DOI 10.1016/S0965-1748(00)00093-X; Tocher JA, 2010, COMP BIOCHEM PHYS B, V156, P107, DOI 10.1016/j.cbpb.2010.02.010; TSUCHIDA K, 1988, INSECT BIOCHEM, V18, P263, DOI 10.1016/0020-1790(88)90090-X; Tucker CS, 2000, FISH PATHOL, V35, P137, DOI 10.3147/jsfp.35.137; Tufail M, 2009, INSECT MOL BIOL, V18, P281, DOI 10.1111/j.1365-2583.2009.00865.x; Tufail M, 2009, J INSECT PHYSIOL, V55, P87, DOI 10.1016/j.jinsphys.2008.11.007; van der Horst DJ, 2002, MOL CELL BIOCHEM, V239, P113, DOI 10.1023/A:1020541010547; Van Hoof D, 2005, INSECT BIOCHEM MOLEC, V35, P117, DOI 10.1016/j.ibmb.2004.09.009; Van Hoof D, 2002, J CELL SCI, V115, P4001, DOI 10.1242/jcs.00113; VANANTWERPEN R, 1990, BIOL CHEM H-S, V371, P159, DOI 10.1515/bchm3.1990.371.1.159; VANHANDEL E, 1993, J INSECT PHYSIOL, V39, P831, DOI 10.1016/0022-1910(93)90115-8; Westcott JD, 2004, AQUAC RES, V35, P784, DOI 10.1111/j.1365-2109.2004.01101.x; Willnow TE, 1999, J MOL MED-JMM, V77, P306, DOI 10.1007/s001090050356; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024; Yang JY, 2013, BIOINFORMATICS, V29, P2588, DOI 10.1093/bioinformatics/btt447; Ziegler R, 2006, INSECT BIOCHEM MOLEC, V36, P264, DOI 10.1016/j.ibmb.2006.01.014; Zou P, 2011, ACS CHEM BIOL, V6, P308, DOI 10.1021/cb100361k	68	5	7	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195783	10.1371/journal.pone.0195783	http://dx.doi.org/10.1371/journal.pone.0195783			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649335	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900087
J	Li, YM; Quigley, MA; Dattani, N; Gray, R; Jayaweera, H; Kurinczuk, JJ; Macfarlane, A; Hollowell, J				Li, Yangmei; Quigley, Maria A.; Dattani, Nirupa; Gray, Ron; Jayaweera, Hiranthi; Kurinczuk, Jennifer J.; Macfarlane, Alison; Hollowell, Jennifer			The contribution of gestational age, area deprivation and mother's country of birth to ethnic variations in infant mortality in England and Wales: A national cohort study using routinely collected data	PLOS ONE			English	Article							PRETERM BIRTH; RACIAL DISPARITIES; BACTERIAL-COLONIZATION; PERINATAL-MORTALITY; SOCIAL DETERMINANTS; UNITED-STATES; PREGNANCY; WOMEN; RISK; TERMINATION	Objectives We aimed to describe ethnic variations in infant mortality and explore the contribution of area deprivation, mother's country of birth, and prematurity to these variations. Methods We analyzed routine birth and death data on singleton live births (gestational age >= 22 weeks) in England and Wales, 2006-2012. Infant mortality by ethnic group was analyzed using logistic regression with adjustment for sociodemographic characteristics and gestational age. Results In the 4,634,932 births analyzed, crude infant mortality rates were higher in Pakistani, Black Caribbean, Black African, and Bangladeshi infants (6.92, 6.00, 5.17 and 4.40 per 1,000 live births, respectively vs. 2.87 in White British infants). Adjustment for maternal sociodemographic characteristics changed the results little. Further adjustment for gestational age strongly attenuated the risk in Black Caribbean (OR 1.02, 95% CI 0.89-1.17) and Black African infants (1.17, 1.06-1.29) but not in Pakistani (2.32, 2.15-2.50), Bangladeshi (1.47, 1.28-1.69), and Indian infants (1.24, 1.11-1.38). Ethnic variations in infant mortality differed significantly between term and preterm infants. At term, South Asian groups had higher risks which cannot be explained by sociodemographic characteristics. In preterm infants, adjustment for degree of prematurity (<28, 28-31, 32-33, 34-36 weeks) fully explained increased risks in Black but not Pakistani and Bangladeshi infants. Sensitivity analyses with further adjustment for small for gestational age, or excluding deaths due to congenital anomalies did not fully explain the excess risk in South Asian groups. Conclusions Higher infant mortality in South Asian and Black infants does not appear to be explained by sociodemographic characteristics. Higher proportions of very premature infants appear to explain increased risks in Black infants but not in South Asian groups. Strategies targeting the prevention and management of preterm birth in Black groups and suboptimal birthweight and modifiable risk factors for congenital anomalies in South Asian groups might help reduce ethnic inequalities in infant mortality.	[Li, Yangmei; Quigley, Maria A.; Gray, Ron; Kurinczuk, Jennifer J.; Hollowell, Jennifer] Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, England; [Dattani, Nirupa; Macfarlane, Alison] Univ London, Sch Hlth Sci, Ctr Maternal & Child Hlth Res, London, England; [Jayaweera, Hiranthi] Univ Oxford, Sch Anthropol, Oxford, England	University of Oxford; University of London; University of Oxford	Li, YM (corresponding author), Univ Oxford, Policy Res Unit Maternal Hlth & Care, Natl Perinatal Epidemiol Unit, Nuffield Dept Populat Hlth, Oxford, England.	yangmei.li@npeu.ox.ac.uk	Hollowell, Jennifer/B-5052-2009	Hollowell, Jennifer/0000-0002-4041-5732; Quigley, Maria/0000-0002-8058-6181	Policy Research Programme in the Department of Health [PRP 108/0001]; Policy Research Programme in the Department of Health	Policy Research Programme in the Department of Health; Policy Research Programme in the Department of Health	This work was supported by the Policy Research Programme in the Department of Health, Award Number: PRP 108/0001 to JJK. This paper reports on an independent study which is funded by the Policy Research Programme in the Department of Health. The views expressed are not necessarily those of the Department. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alio AP, 2010, MATERN CHILD HLTH J, V14, P557, DOI 10.1007/s10995-009-0495-9; Alsulaiman A, 2012, PRENATAL DIAG, V32, P1109, DOI 10.1002/pd.3967; [Anonymous], 2015, TECHNICAL REPORT; Aveyard P, 2002, BJOG-INT J OBSTET GY, V109, P894, DOI 10.1016/S1470-0328(02)01197-7; Bakeo AC, 2006, PAEDIATR PERINAT EP, V20, P127, DOI 10.1111/j.1365-3016.2006.00708.x; Balchin I, 2007, EARLY HUM DEV, V83, P749, DOI 10.1016/j.earlhumdev.2007.09.003; Balchin I, 2007, BRIT MED J, V334, P833, DOI 10.1136/bmj.39132.482025.80; Berman S, 1996, AM J OBSTET GYNECOL, V175, P73, DOI 10.1016/S0002-9378(96)70253-3; Chen HY, 2013, AM J PERINAT, V30, P469, DOI 10.1055/s-0032-1326992; Datta-Nemdharry P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001088; Dattani N, 2002, HLTH STAT Q, P16; Ethnic group national identity and religion, MEAS EQ GUID COLL CL; Fieldhouse EA, 1996, ENVIRON PLANN A, V28, P237, DOI 10.1068/a280237; Fiscella K, 1996, PUBLIC HEALTH REP, V111, P104; GILLIES DRN, 1984, J EPIDEMIOL COMMUN H, V38, P214, DOI 10.1136/jech.38.3.214; Goldenberg R L, 1996, Am J Obstet Gynecol, V174, P1618; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; GRIFFITHS R, 1989, BRIT MED J, V298, P94, DOI 10.1136/bmj.298.6666.94; GRIFFITHS R, 1989, BRIT MED J, V298, P1099, DOI 10.1136/bmj.298.6680.1099-c; Hauck FR, 2011, SEMIN PERINATOL, V35, P209, DOI 10.1053/j.semperi.2011.02.018; HAY PE, 1994, BRIT MED J, V308, P295, DOI 10.1136/bmj.308.6924.295; Hessol NA, 2005, PEDIATRICS, V115, pE44, DOI 10.1542/peds.2004-0478; Hewison J, 2007, PRENATAL DIAG, V27, P419, DOI 10.1002/pd.1701; Hilder Lisa, 2007, Health Stat Q, P25; Hollowell J, 2011, SEMIN PERINATOL, V35, P240, DOI 10.1053/j.semperi.2011.02.021; Khalil A, 2013, ULTRASOUND OBST GYN, V41, P278, DOI 10.1002/uog.12313; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2014, LANCET, V384, P189, DOI 10.1016/S0140-6736(14)60496-7; Loggins S, 2014, J COMMUN HEALTH, V39, P118, DOI 10.1007/s10900-013-9747-0; Lorch SA, 2016, PEDIATR RES, V79, P141, DOI 10.1038/pr.2015.199; MacDorman Marian F, 2011, NCHS Data Brief, P1; MacDorman MF, 2011, SEMIN PERINATOL, V35, P200, DOI 10.1053/j.semperi.2011.02.017; Moser Kath, 2008, Health Stat Q, P15; Moser Kath, 2008, Health Stat Q, P22; Moser Kath, 2009, Health Stat Q, P78; Norman Paul, 2008, Health Stat Q, P18; Oakley Laura, 2009, Health Stat Q, P22; Office for National Statistics, 2016, PARENTS COUNTRY OF B; Payne R. A., 2012, Health Statistics Quarterly, P22; Puthussery S, 2016, BEST PRACT RES CL OB, V32, P39, DOI 10.1016/j.bpobgyn.2015.09.003; Rowley DL, 2012, ANNU REV PUBL HEALTH, V33, P75, DOI 10.1146/annurev-publhealth-031811-124542; Schaaf JM, 2013, AM J PERINAT, V30, P433, DOI 10.1055/s-0032-1326988; Sheridan E, 2013, LANCET, V382, P1350, DOI 10.1016/S0140-6736(13)61132-0; Sidebotham P, 2014, LANCET, V384, P915, DOI 10.1016/S0140-6736(14)60581-X; Spong CY, 2011, OBSTET GYNECOL, V117, P948, DOI 10.1097/AOG.0b013e318211726f; StataCorp, 2013, PANCREATOLOGY; TERRY PB, 1987, ARCH DIS CHILD, V62, P709, DOI 10.1136/adc.62.7.709; TERRY PB, 1985, ARCH DIS CHILD, V60, P866, DOI 10.1136/adc.60.9.866; Troe EJWM, 2006, PAEDIATR PERINAT EP, V20, P140, DOI 10.1111/j.1365-3016.2006.00699.x; Vang ZM, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0101-5; Villadsen SF, 2009, J EPIDEMIOL COMMUN H, V63, P106, DOI 10.1136/jech.2008.078741; Weightman AL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-000964; Welsh Government, 2014, WELSH INDEX MULTIPLE; WIGGLESWORTH JS, 1980, LANCET, V2, P684; Wilcox AJ, 2001, INT J EPIDEMIOL, V30, P1233, DOI 10.1093/ije/30.6.1233; Willis E, 2014, CLIN PERINATOL, V41, P847, DOI 10.1016/j.clp.2014.08.008; Yu JP, 2012, HEALTH SOC CARE COMM, V20, P329, DOI 10.1111/j.1365-2524.2011.01036.x	57	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195146	10.1371/journal.pone.0195146	http://dx.doi.org/10.1371/journal.pone.0195146			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649290	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900027
J	Liu, YY; Sowmya, A; Khamis, H				Liu, Yingying; Sowmya, Arcot; Khamis, Heba			Single camera multi-view anthropometric measurement of human height and mid-upper arm circumference using linear regression	PLOS ONE			English	Article							PHOTOGRAMMETRY; RISK	Background Manually measured anthropometric quantities are used in many applications including human malnutrition assessment. Training is required to collect anthropometric measurements manually, which is not ideal in resource-constrained environments. Photogrammetric methods have been gaining attention in recent years, due to the availability and affordability of digital cameras. Objective The primary goal is to demonstrate that height and mid-upper arm circumference (MUAC) indicators of malnutrition can be accurately estimated by applying linear regression to distance measurements from photographs of participants taken from five views, and determine the optimal view combinations. A secondary goal is to observe the effect on estimate error of two approaches which reduce complexity of the setup, computational requirements and the expertise required of the observer. Methods Thirty-one participants (11 female, 20 male; 18-37 years) were photographed from five views. Distances were computed using both camera calibration and reference object techniques from manually annotated photos. To estimate height, linear regression was applied to the distances between the top of the participants head and the floor, as well as the height of a bounding box enclosing the participant's silhouette which eliminates the need to identify the floor. To estimate MUAC, linear regression was applied to the mid-upper arm width. Estimates were computed for all view combinations and performance was compared to other photogrammetric methods from the literature linear distance method for height, and shape models for MUAC. Results The mean absolute difference (MAD) between the linear regression estimates and manual measurements were smaller compared to other methods. For the optimal view combinations (smallest MAD), the technical error of measurement and coefficient of reliability also indicate the linear regression methods are more reliable. The optimal view combination was the front and side views. When estimating height by linear regression of the distance from the head to the floor, the mean MAD was 10.51 mm +/- 6.52 mm SD, and when estimating height from the bounding box using the reference object, the mean MAD per participant was 11.53 mm +/- 6.43 mm SD. When estimating MUAC from the mid-upper arm radius using the reference object, the mean MAD was 7.24 mm +/- 4.79 mm SD. The mean MAD for all methods when using camera calibration was 2-3 mm smaller. Conclusions Applying linear regression to distance measurements from photos of adults taken from multiple view angles has been shown to accurately estimate height and MUAC to within the accuracy required for nutrition assessment. Future work will focus on automating the landmark detection, and validating the methods on populations that include undernourished adults and children of all nutrition statuses. These future works will improve the practicality of this method as a potential tool for nutrition assessment by novice users.	[Liu, Yingying; Khamis, Heba] Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia; [Sowmya, Arcot] Univ New South Wales, Sch Comp Sci & Engn, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Khamis, H (corresponding author), Univ New South Wales, Grad Sch Biomed Engn, Sydney, NSW, Australia.	h.khamis@unsw.edu.au	LIU, YING/GZL-7252-2022		Bill & Melinda Gates Foundation [OPP1140536]	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This work was supported by the Bill & Melinda Gates Foundation, Grant Number OPP1140536, awarded to HK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayele B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030345; Ayma VA, 2016, NUTR ASSESSMENT CHIL, P1; BenAbdelkader C, 2008, STAT BODY HEIGHT EST, P1; BRIEND A, 1986, NUTR RES, V6, P249, DOI 10.1016/S0271-5317(86)80129-4; Chagomoka T, 2016, FOOD NUTR RES, V60, DOI 10.3402/fnr.v60.29425; Chaput J. P., 2016, PEDIAT OBESITY; CHEN LC, 1980, AM J CLIN NUTR, V33, P1836, DOI 10.1093/ajcn/33.8.1836; Chen Y, 2016, IEEE T VIS COMPUT GR, V22, P2000, DOI 10.1109/TVCG.2015.2478779; Criminisi A, 2000, INT J COMPUT VISION, V40, P123, DOI 10.1023/A:1026598000963; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Dediu H., 2014, WILL SMARTPHONES SAT; GSMA, 2016, MOB EC AFR 2016; GURNEY JM, 1973, AM J CLIN NUTR, V26, P912, DOI 10.1093/ajcn/26.9.912; Herianto PS, 2010, DEV DIGITAL ANTHROPO, P7; Hung C., 2004, P 7 INT C WORK COMP, V29, P764; Jeges E, 2008, MEASURING HUMAN HEIG, P755; Li J, 2012, NORTHEAST BIOENGIN C, P426, DOI 10.1109/NEBC.2012.6206923; Li ZX, 2013, IEEE ENG MED BIO, P366, DOI 10.1109/EMBC.2013.6609513; Liu H, 2008, J ENG DESIGN, V19, P45, DOI 10.1080/09544820601186088; Liu XB, 2017, ADV MATER INTERFACES, V4, DOI 10.1002/admi.201601227; Liu ZB, 2017, IEEE T CYBERNETICS, V47, P695, DOI 10.1109/TCYB.2016.2524406; Madden AM, 2016, J HUM NUTR DIET, V29, P7, DOI 10.1111/jhn.12278; MathWorks, 2017, SINGL CAM CAL APP; Meunier P, 2000, APPL ERGON, V31, P445, DOI 10.1016/S0003-6870(00)00023-5; Mwangome MK, 2012, TROP MED INT HEALTH, V17, P622, DOI 10.1111/j.1365-3156.2012.02959.x; Onyango AW, 2006, ACTA PAEDIATR, V95, P38, DOI 10.1080/08035320500494464; Penders B, 2015, J PEDIATR ENDOCR MET, V28, P1357, DOI 10.1515/jpem-2015-0172; Pesce M, 2016, VIRTUAL PHYS PROTOTY, V11, P49, DOI 10.1080/17452759.2015.1101872; Peyer KE, 2015, PEERJ, V3, DOI 10.7717/peerj.831; Sicotte M, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-102; Sultana T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121456; Ulijaszek SJ, 1999, BRIT J NUTR, V82, P165, DOI 10.1017/S0007114599001348; WHO Multicentre Growth Reference Study Group, 2006, WHO CHILD GROWTH STA; World Health Organization, 2008, WHO CHILD GROWTH STA	35	3	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195600	10.1371/journal.pone.0195600	http://dx.doi.org/10.1371/journal.pone.0195600			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649306	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900059
J	Moeeni, M; Rashidian, A; Aghajanian, A				Moeeni, Maryam; Rashidian, Arash; Aghajanian, Akbar			Women's relative status and childbearing intentions: Empirical evidence from Iran	PLOS ONE			English	Article							FERTILITY INTENTIONS; PREFERENCE THEORY; ASIAN COUNTRIES; BEHAVIOR; BIRTH	Childbearing intentions are primary predictor of childbearing behaviors, particularly in low fertility societies. This study examined the role of relative status of women in childbearing intentions in Iran where fertility has been declining since 1986 and it has been around the replacement level during the last two decades. Data from the 2010 Iran's Multiple Indicator Demographic and Health Survey (IrMIDHS) were used to estimate the effect of relative status of women on intention to have more children among women with one child and those with two children. The results showed modest effect of relative status of women on future childbearing intentions at both parity one and two controlling for socioeconomic and demographic factors. One implication from this finding is that within low fertility regimes where fertility level is around or below replacement level, the relative status of women is no more as important determinant of childbearing intention as in situations of high fertility regimes. This interpretation is consistent with the fact that most of the studies showing strong effect from relative status of women on childbearing are based on data from the situations where fertility level has been at the pre-transitional level.	[Moeeni, Maryam] Isfahan Univ Med Sci, Social Determinants Hlth Res Ctr, Esfahan, Iran; [Moeeni, Maryam] Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran; [Rashidian, Arash] Univ Tehran Med Sci, Sch Publ Hlth, Dept Hlth Management & Econ, Tehran, Iran; [Aghajanian, Akbar] FSU UNC, Dept Sociol, Fayetteville, NC USA	Isfahan University Medical Science; Isfahan University Medical Science; Tehran University of Medical Sciences	Moeeni, M (corresponding author), Isfahan Univ Med Sci, Social Determinants Hlth Res Ctr, Esfahan, Iran.; Moeeni, M (corresponding author), Isfahan Univ Med Sci, Hlth Management & Econ Res Ctr, Esfahan, Iran.	mmoeini1387@gmail.com	Moeeni, Maryam/K-3589-2016; Moeeni, Maryam/I-1344-2018	Moeeni, Maryam/0000-0002-4525-6574; 				Abbasi-Shavazi MJ, 2009, NATL PROVINCIAL LEVE; Abbasi-Shavazi MJ, 2007, ASIA PACIFIC POPULAT, V22; AbbasiShavazi MJ, 2009, FERTILITY TRANSITION IN IRAN: REVOLUTION AND REPRODUCTION, P1; Balbo N, 2013, EUR J POPUL, V29, P1, DOI 10.1007/s10680-012-9277-y; Barber JS, 2001, SOC PSYCHOL QUART, V64, P101, DOI 10.2307/3090128; BECKER GS, 1988, Q J ECON, V103, P1, DOI 10.2307/1882640; BECKER GS, 1992, J POPUL ECON, V5, P185; Behboodi-Moghadam Z, 2015, IRAN J PUBLIC HEALTH, V44, P1126; BULATAO RA, 1981, DEMOGRAPHY, V18, P1, DOI 10.2307/2061046; CHIAPPORI PA, 1988, ECONOMETRICA, V56, P63, DOI 10.2307/1911842; Erfani A, 2008, J BIOSOC SCI, V40, P459, DOI 10.1017/S002193200700243X; Erfani A, 2014, BIODEMOGR SOC BIOL, V60, P67, DOI 10.1080/19485565.2014.899428; Farzanegan MR, 2016, REV ECON HOUSEHOLD, V14, P1029, DOI 10.1007/s11150-014-9279-0; Freedman R., 1974, COMMUNITY LEVEL DATA; Gillmore MR, 2002, J MARRIAGE FAM, V64, P885, DOI 10.1111/j.1741-3737.2002.00885.x; GOLDBERG D, 1975, SOC FORCES, V54, P84, DOI 10.2307/2576079; Haddad GK, 2015, EMPIR ECON, V48, P1365, DOI 10.1007/s00181-014-0828-4; Hakim C, 1998, BRIT J SOCIOL, V49, P137, DOI 10.2307/591267; Hakim C, 2003, POPUL DEV REV, V29, P349, DOI 10.1111/j.1728-4457.2003.00349.x; Hayford SR, 2009, DEMOGRAPHY, V46, P765, DOI 10.1353/dem.0.0073; Heiland F, 2008, EUR J POPUL, V24, P129, DOI 10.1007/s10680-008-9162-x; Hindin MJ, 2000, POPUL RES POLICY REV, V19, P255, DOI 10.1023/A:1026590717779; HIRSCHMAN C, 1990, DEMOGRAPHY, V27, P369, DOI 10.2307/2061374; Iacovou M, 2011, POPUL DEV REV, V37, P89, DOI 10.1111/j.1728-4457.2011.00391.x; Komura M, 2013, J POPUL ECON, V26, P943, DOI 10.1007/s00148-012-0460-6; Liefbroer AC, 2009, EUR J POPUL, V25, P363, DOI 10.1007/s10680-008-9173-7; Mason KO, 2000, DEMOGRAPHY, V37, P299, DOI 10.2307/2648043; McQuillan J, 2015, SOCIOL PERSPECT, V58, P20, DOI 10.1177/0731121414534393; Moeeni M, 2014, INT J HEALTH POLICY, V3, P135, DOI 10.15171/ijhpm.2014.78; Namboodiri NK., 1983, SEQUENTIAL FERTILITY; Rocca CH, 2010, PERSPECT SEX REPRO H, V42, P186, DOI 10.1363/4218610; Samari G., 2017, POPULATION RES POLIC, P1; Samari G., 2015, WOMENS STATUS AUTONO; Samari G, 2015, CCPR WORKING PAPERS; Schoen R, 1999, J MARRIAGE FAM, V61, P790, DOI 10.2307/353578; Shreffler KM, 2013, J FAM ECON ISS, V34, P285, DOI 10.1007/s10834-012-9331-2; UDRY JR, 1983, DEMOGRAPHY, V20, P117, DOI 10.2307/2061230; Upadhyay UD, 2005, SOC SCI MED, V60, P2641, DOI 10.1016/j.socscimed.2004.11.032; Upadhyay UD, 2012, INT PERSPECT SEX R H, V38, P78, DOI 10.1363/3807812; YAMAGUCHI K, 1995, AM SOCIOL REV, V60, P272, DOI 10.2307/2096387	40	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195428	10.1371/journal.pone.0195428	http://dx.doi.org/10.1371/journal.pone.0195428			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649246	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900044
J	Ryu, DH; Jung, YH; Jeung, KW; Lee, BK; Jeong, YW; Geun Yun, J; Lee, DH; Lee, SM; Heo, T; Min, YI				Ryu, Dong Hyun; Jung, Yong Hun; Jeung, Kyung Woon; Lee, Byung Kook; Jeong, Young Won; Geun Yun, Jong; Lee, Dong Hun; Lee, Sung Min; Heo, Tag; Min, Yong Il			Effect of one-lung ventilation on end-tidal carbon dioxide during cardiopulmonary resuscitation in a pig model of cardiac arrest	PLOS ONE			English	Article							HEART-ASSOCIATION GUIDELINES; LIFE-SUPPORT; INDICATOR; PRESSURE	Unrecognized endobronchial intubation frequently occurs after emergency intubation. However, no study has evaluated the effect of one-lung ventilation on end-tidal carbon dioxide (ETCO2) during cardiopulmonary resuscitation (CPR). We compared the hemodynamic parameters, blood gases, and ETCO2 during one-lung ventilation with those during conventional two-lung ventilation in a pig model of CPR, to determine the effect of the former on ETCO2. A randomized crossover study was conducted in 12 pigs intubated with double lumen endobronchial tube to achieve lung separation. During CPR, the animals underwent three 5-min ventilation trials based on a randomized crossover design: left-lung, right-lung, or two-lung ventilation. Arterial blood gases were measured at the end of each ventilation trial. Ventilation was provided using the same tidal volume throughout the ventilation trials. Comparison using generalized linear mixed model revealed no significant group effects with respect to aortic pressure, coronary perfusion pressure, and carotid blood flow; however, significant group effect in terms of ETCO2 was found (P < 0.001). In the post hoc analyses, ETCO2 was lower during the right-lung ventilation than during the two-lung (P = 0.006) or left-lung ventilation (P < 0.001). However, no difference in ETCO2 was detected between the left-lung and two-lung ventilations. The partial pressure of arterial carbon dioxide (PaCO2), partial pressure of arterial oxygen (PaO2), and oxygen saturation (SaO(2)) differed among the three types of ventilation (P = 0.003, P = 0.001, and P = 0.001, respectively). The post hoc analyses revealed a higher PaCO2, lower PaO2, and lower SaO(2) during right-lung ventilation than during two-lung or left-lung ventilation. However, the levels of these blood gases did not differ between the left-lung and two-lung ventilations. In a pig model of CPR, ETCO2 was significantly lower during right-lung ventilation than during two-lung ventilation. However, interestingly, ETCO2 during left-lung ventilation was comparable to that during two-lung ventilation.	[Ryu, Dong Hyun; Jung, Yong Hun; Jeung, Kyung Woon; Lee, Byung Kook; Jeong, Young Won; Lee, Dong Hun; Lee, Sung Min; Heo, Tag; Min, Yong Il] Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea; [Geun Yun, Jong] Honam Univ, Dept Emergency Med Serv, Gwangju, South Korea	Chonnam National University; Chonnam National University Hospital; Honam University	Jeung, KW (corresponding author), Chonnam Natl Univ Hosp, Dept Emergency Med, Gwangju, South Korea.	neoneti@hanmail.net	Lee, Byung Kook/M-2236-2018	Lee, Byung Kook/0000-0003-3571-9448	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2015R1D1A1A09057248]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A09057248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BISSINGER U, 1989, ANN EMERG MED, V18, P853, DOI 10.1016/S0196-0644(89)80211-2; BRUNEL W, 1989, CHEST, V96, P1043, DOI 10.1378/chest.96.5.1043; CALLAHAM M, 1990, CRIT CARE MED, V18, P358, DOI 10.1097/00003246-199004000-00002; Cheng Christopher P, 2006, Congenit Heart Dis, V1, P210, DOI 10.1111/j.1747-0803.2006.00037.x; Cho YC, 2011, EMERG MED J, V28, P40, DOI 10.1136/emj.2010.099911; DRONEN S, 1982, ANN EMERG MED, V11, P116, DOI 10.1016/S0196-0644(82)80328-4; GANDHI SK, 1991, J CLIN MONITOR, V7, P35, DOI 10.1007/BF01617896; Hamrick JL, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000450; Jin XH, 2000, CRIT CARE MED, V28, P2415, DOI 10.1097/00003246-200007000-00037; JOHNSON DH, 1992, CAN J ANAESTH, V39, P184, DOI 10.1007/BF03008654; Kolar M, 2008, CRIT CARE, V12, DOI 10.1186/cc7009; Link MS, 2015, CIRCULATION, V132, pS444, DOI 10.1161/CIR.0000000000000261; Markstaller K, 2002, RESUSCITATION, V53, P307, DOI 10.1016/S0300-9572(02)00031-X; Markstaller K, 2008, RESUSCITATION, V79, P125, DOI 10.1016/j.resuscitation.2008.03.228; Neumar RW, 2010, CIRCULATION, V122, pS729, DOI 10.1161/CIRCULATIONAHA.110.970988; ORNATO JP, 1983, CRIT CARE MED, V11, P79, DOI 10.1097/00003246-198302000-00004; Rubertsson S, 1998, ACTA ANAESTH SCAND, V42, P32, DOI 10.1111/j.1399-6576.1998.tb05077.x; Ryu SJ, 2016, ACTA ANAESTH SCAND, V60, P1012, DOI 10.1111/aas.12728; SANDERS AB, 1989, JAMA-J AM MED ASSOC, V262, P1347, DOI 10.1001/jama.262.10.1347; Sheak KR, 2015, RESUSCITATION, V89, P149, DOI 10.1016/j.resuscitation.2015.01.026; Sitzwohl C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c5943; Spindelboeck W, 2013, RESUSCITATION, V84, P770, DOI 10.1016/j.resuscitation.2013.01.012; Timmermann A, 2007, ANESTH ANALG, V104, P619, DOI 10.1213/01.ane.0000253523.80050.e9; WEIL MH, 1985, CRIT CARE MED, V13, P907, DOI 10.1097/00003246-198511000-00011	24	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195826	10.1371/journal.pone.0195826	http://dx.doi.org/10.1371/journal.pone.0195826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649316	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900094
J	Chu, LSW; John, EM; Yang, BY; Kurian, AW; Zia, Y; Yu, K; Ingles, SA; Stanczyk, FZ; Hsing, AW				Chu, Lisa W.; John, Esther M.; Yang, Baiyu; Kurian, Allison W.; Zia, Yasaman; Yu, Kai; Ingles, Sue A.; Stanczyk, Frank Z.; Hsing, Ann W.			Measuring serum melatonin in postmenopausal women: Implications for epidemiologic studies and breast cancer studies	PLOS ONE			English	Article							PHASE-SHIFTS; MULTIETHNIC POPULATION; URINARY MELATONIN; MAGNETIC-FIELDS; HORMONE-LEVELS; BRIGHT LIGHT; NIGHT-WORK; RISK; 6-SULFATOXYMELATONIN; PROGESTERONE	Background Circulating melatonin is a good candidate biomarker for studies of circadian rhythms and circadian disruption. However, epidemiologic studies on circulating melatonin are limited because melatonin is secreted at night, yet most epidemiologic studies collect blood during the day when melatonin levels are very low, and assays are lacking that are ultrasensitive to detect low levels of melatonin reliably. Objective To assess the performance of a refined radioimmunoassay in measuring morning melatonin among women. Methods We used morning serum samples from 47 postmenopausal women ages 48 +/- 80 years without a history of breast cancer who participated in the San Francisco Bay Area Breast Cancer Study, including 19 women who had duplicate measurements. The coefficient of variation (CV) and intraclass coefficient (ICC) were estimated using the random effect model. Results Reproducibility for the assay was satisfactory, with a CV of 11.2% and an ICC of 98.9%; correlation between the replicate samples was also high (R = 0.96). In the 47 women, serum melatonin levels ranged from 0.6 to 62.6 pg/ml, with a median of 7.0 pg/ml. Conclusion Our results suggest that it is possible to reliably measure melatonin in postmenopausal women in morning serum samples in large epidemiologic studies to evaluate the role of melatonin in cancer etiology or prognosis.	[Chu, Lisa W.; John, Esther M.; Zia, Yasaman] Canc Prevent Inst Calif, Fremont, CA USA; [Chu, Lisa W.; John, Esther M.; Yang, Baiyu; Kurian, Allison W.; Hsing, Ann W.] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA; [John, Esther M.; Kurian, Allison W.; Hsing, Ann W.] Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA; [Kurian, Allison W.; Hsing, Ann W.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Yu, Kai] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Ingles, Sue A.] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Ingles, Sue A.; Stanczyk, Frank Z.] Univ Southern Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Hsing, Ann W.] Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA	Cancer Prevention Institute of California; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Southern California; University of Southern California; Stanford University	Hsing, AW (corresponding author), Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA.; Hsing, AW (corresponding author), Stanford Univ, Sch Med, Dept Hlth Res & Policy Epidemiol, Stanford, CA 94305 USA.; Hsing, AW (corresponding author), Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA.; Hsing, AW (corresponding author), Stanford Univ, Stanford Prevent Res Ctr, Sch Med, Stanford, CA 94305 USA.	annhsing@stanford.edu	; Kurian, Allison/A-4560-2019	Zia, Yasaman/0000-0001-6049-3706; Stanczyk, Frank/0000-0002-3607-121X; Kurian, Allison/0000-0002-6175-9470	Stanford Cancer Institute [CA63446]; National Cancer Institute [CA77305]; U.S. Department of Defense [DAMD1796-1-6071]	Stanford Cancer Institute; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); U.S. Department of Defense(United States Department of Defense)	This study was supported by a Development Cancer Research Award (to AWH) from the Stanford Cancer Institute (http://med.stanford.eduicancer.htd) and by grants (to EMJ) CA63446 and CA77305 from the National Cancer Institute (httpsiAmw.cancer.govi) and DAMD1796-1-6071 from the U.S. Department of Defense (https://www.defenselov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonde JP, 2012, SCAND J WORK ENV HLT; Davis S, 2001, AM J EPIDEMIOL, V154, P591, DOI 10.1093/aje/154.7.591; DEACON SJ, 1994, CLIN ENDOCRINOL, V40, P413; Dijk DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030037; Erren TC, 2009, J PINEAL RES, V46, P245, DOI 10.1111/j.1600-079X.2009.00665.x; Figueiro MG, 2013, NAT SCI SLEEP, V5, P133, DOI 10.2147/NSS.S52203; FOLKARD S, 1985, CHRONOBIOLOGIA, V12, P31; Forman JP, 2010, J HYPERTENS, V28, P446, DOI 10.1097/HJH.0b013e3283340c16; Gail MH, 1996, CANCER EPIDEM BIOMAR, V5, P835; He CL, 2015, INT ARCH OCC ENV HEA, V88, P533, DOI 10.1007/s00420-014-0986-x; Hsing AW, 2010, CANCER EPIDEM BIOMAR, V19, P932, DOI 10.1158/1055-9965.EPI-10-0004; John EM, 2003, CANCER EPIDEM BIOMAR, V12, P1143; John EM, 2007, AM J EPIDEMIOL, V166, P1409, DOI 10.1093/aje/kwm259; Langley A, 2011, EPIDEMIOLOGY, V22, pS108, DOI 10.1097/01.ede.0000391999.63861.49; Levallois P, 2001, AM J EPIDEMIOL, V154, P601, DOI 10.1093/aje/154.7.601; Mantele S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037123; Nogueira LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083208; Qin YY, 2014, INT J CANCER, V134, P1166, DOI 10.1002/ijc.28452; Schernhammer ES, 2006, J PINEAL RES, V40, P116, DOI 10.1111/j.1600-079X.2005.00285.x; Schernhammer ES, 2004, CANCER EPIDEM BIOMAR, V13, P936; Sharkey KM, 2002, AM J PHYSIOL-REG I, V282, pR454, DOI 10.1152/ajpregu.00135.2001; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Toffol E, 2014, MATURITAS; Toffol E, 2013, MENOPAUSE; Travis RC, 2004, JNCI-J NATL CANCER I, V96, P475, DOI 10.1093/jnci/djh077; Travis RC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw169; WEBLEY GE, 1986, J CLIN ENDOCR METAB, V63, P323, DOI 10.1210/jcem-63-2-323; WEITZMAN ED, 1978, J NEURAL TRANSM, P325; Wirz-Justice A, 2004, J PINEAL RES, V36, P192, DOI 10.1111/j.1600-079X.2004.00117.x	29	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195666	10.1371/journal.pone.0195666	http://dx.doi.org/10.1371/journal.pone.0195666			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641614	Green Submitted, gold, Green Published			2022-12-26	WOS:000429742900082
J	Masuda, K; Tanabe, K; Ujike, H; Hinamoto, N; Miyake, H; Tanimura, S; Sugiyama, H; Sato, Y; Maeshima, Y; Wada, J				Masuda, Kana; Tanabe, Katsuyuki; Ujike, Haruyo; Hinamoto, Norikazu; Miyake, Hiromasa; Tanimura, Satoshi; Sugiyama, Hitoshi; Sato, Yasufumi; Maeshima, Yohei; Wada, Jun			Deletion of pro-angiogenic factor vasohibin-2 ameliorates glomerular alterations in a mouse diabetic nephropathy model	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; NEGATIVE FEEDBACK REGULATOR; RENAL ALTERATIONS; MESANGIAL CELLS; TUMOR-GROWTH; TGF-BETA; EXPRESSION; VEGF; DISEASE; INJURY	Angiogenesis has been implicated in glomerular alterations in the early stage of diabetic nephropathy. We previously reported the renoprotective effects of vasohibin-1 (VASH1), which is a novel angiogenesis inhibitor derived from endothelial cells, on diabetic nephropathy progression. Vasohibin-2 (VASH2) was originally identified as a VASH1 homolog and possesses pro-angiogenic activity in contrast to VASH1. In addition, VASH2 was recently shown to promote epithelial-to-mesenchymal transition via enhanced transforming growth factor (TGF)-beta signaling in cancer cells. Herein, we investigated the pathogenic roles of VASH2 in diabetic nephropathy using VAHS2-deficient mice. The type 1 diabetes model was induced by intraperitoneal injections of streptozotocin in VASH2 homozygous knockout (VASH2 LacZ/LacZ) or wild-type mice. These mice were euthanized 16 weeks after inducing hyperglycemia. Increased urine albumin excretion and creatinine clearance observed in diabetic wild-type mice were significantly prevented in diabetic VASH2-deficient mice. Accordingly, diabetes-induced increase in glomerular volume and reduction in glomerular slit-diaphragm density were significantly improved in VASH2 knockout mice. Increased glomerular endothelial area was also suppressed in VASH2-deficient mice, in association with inhibition of enhanced vascular endothelial growth factor (VEGF) receptor 2 (VEGFR2), but not VEGF level. Furthermore, glomerular accumulation of mesangial matrix, including type IV collagen, and increased expression of TGF-beta were improved in diabetic VASH2 knockout mice compared with diabetic wild-type mice. Based on the immunofluorescence findings, endogenous VASH2 localization in glomeruli was consistent with mesangial cells. Human mesangial cells (HMCs) were cultured under high glucose condition in in vitro experiments. Transfection of VASH2 small interfering RNA (siRNA) into the HMCs resulted in the suppression of type IV collagen production induced by high glucose compared with control siRNA. These results indicate that VASH2 may be involved in diabetes-induced glomerular alterations, particularly impaired filtration barrier and mesangial expansion. Therefore, VASH2 is likely to represent a promising therapeutic target for diabetic nephropathy.	[Masuda, Kana; Tanabe, Katsuyuki; Ujike, Haruyo; Hinamoto, Norikazu; Miyake, Hiromasa; Tanimura, Satoshi; Maeshima, Yohei; Wada, Jun] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan; [Sugiyama, Hitoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Human Resource Dev Dialysis Therapy Kidney D, Okayama, Japan; [Sato, Yasufumi] Tohoku Univ, Inst Dev Aging & Canc, Dept Vasc Biol, Sendai, Miyagi, Japan	Okayama University; Okayama University; Tohoku University	Tanabe, K (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Nephrol Rheumatol Endocrinol & Metab, Okayama, Japan.	tanabek@okayama-u.ac.jp	Sato, Yasufumi/AAF-3367-2019; Sugiyama, Hitoshi/B-2252-2011; WADA, Jun/B-2023-2011; Tanabe, Katsuyuki/J-1341-2019	Sugiyama, Hitoshi/0000-0002-4127-6471; WADA, Jun/0000-0003-1468-5170; Tanabe, Katsuyuki/0000-0003-4767-5892	Japan Society for the Promotion of Science, KAKENHI [JP23591193, JP26461228]; Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	Japan Society for the Promotion of Science, KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University	Support was provided by the Japan Society for the Promotion of Science, KAKENHI Grant Number JP23591193 and JP26461228 (2011-2014 to YM) and the Cooperative Research Project Program of Joint Usage/Research Center at the Institute of Development, Aging and Cancer, Tohoku University (2014-2015 and 2017 to KT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cooper ME, 1999, DIABETES, V48, P2229, DOI 10.2337/diabetes.48.11.2229; De Vriese A, 2001, J AM SOC NEPHROL, V12, P993, DOI 10.1681/ASN.V125993; Dimke H, 2015, CURR OPIN NEPHROL HY, V24, P231, DOI 10.1097/MNH.0000000000000117; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Gilbert RE, 1998, LAB INVEST, V78, P1017; Guo M, 2005, J ANAT, V207, P813, DOI 10.1111/j.1469-7580.2005.00492.x; Hinamoto N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107934; Kim JC, 2015, HEPATO-GASTROENTEROL, V62, P251, DOI 10.5754/hge141015; Kimura H, 2009, BLOOD, V113, P4810, DOI 10.1182/blood-2008-07-170316; Kitahara S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-99; Koyanagi T, 2017, CANCER SCI, V108, P512, DOI 10.1111/cas.13149; Koyanagi T, 2013, ONCOL LETT, V5, P1058, DOI 10.3892/ol.2013.1119; Lanaspa MA, 2014, J AM SOC NEPHROL, V25, P2526, DOI 10.1681/ASN.2013080901; Makino H, 1996, DIABETES, V45, P488, DOI 10.2337/diabetes.45.4.488; Miyashita H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046459; Nakagawa T, 2011, NAT REV NEPHROL, V7, P36, DOI 10.1038/nrneph.2010.152; Nasu T, 2009, DIABETES, V58, P2365, DOI 10.2337/db08-1790; Norita R, 2017, CANCER SCI, V108, P419, DOI 10.1111/cas.13157; NYENGAARD JR, 1993, DIABETOLOGIA, V36, P189, DOI 10.1007/BF00399948; Olmer R, 2010, STEM CELL RES, V5, P51, DOI 10.1016/j.scr.2010.03.005; Riser BL, 2000, J AM SOC NEPHROL, V11, P25, DOI 10.1681/ASN.V11125; Saito D, 2011, AM J PHYSIOL-RENAL, V300, pF873, DOI 10.1152/ajprenal.00503.2010; Sato W, 2011, AM J PATHOL, V179, P155, DOI 10.1016/j.ajpath.2011.03.024; Shankland SJ, 1998, MINER ELECTROL METAB, V24, P168, DOI 10.1159/000057366; Sharma K, 1996, DIABETES, V45, P522, DOI 10.2337/diabetes.45.4.522; Shen ZL, 2012, MED ONCOL, V29, P2718, DOI 10.1007/s12032-012-0212-1; Shibuya T, 2006, ARTERIOSCL THROM VAS, V26, P1051, DOI 10.1161/01.ATV.0000216747.66660.26; Suzuki Y, 2017, CANCER SCI, V108, P2342, DOI 10.1111/cas.13411; Takahashi Y, 2012, MOL CANCER RES, V10, P1135, DOI 10.1158/1541-7786.MCR-12-0098-T; Tanabe K, 2007, KIDNEY INT, V71, P227, DOI 10.1038/sj.ki.5002040; Tanabe K, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5724069; Tanabe K, 2012, AM J PHYSIOL-RENAL, V303, pF1264, DOI 10.1152/ajprenal.00227.2012; Tanabe K, 2012, AM J PHYSIOL-RENAL, V302, pF1151, DOI 10.1152/ajprenal.00596.2011; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wada J, 2013, CLIN SCI, V124, P139, DOI 10.1042/CS20120198; Wang B, 2017, AM J TRANSL RES, V9, P2911; Watanabe K, 2004, J CLIN INVEST, V114, P898, DOI 10.1172/JC1200421152; Watatani H, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12054; Watatani H, 2015, ACTA MED OKAYAMA, V69, P1; Xue XF, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/s12964-014-0062-x; Yamasaki H, 2011, PROSTAG LEUKOTR ESS, V84, P99, DOI 10.1016/j.plefa.2010.11.005	41	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195779	10.1371/journal.pone.0195779	http://dx.doi.org/10.1371/journal.pone.0195779			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641565	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900091
J	Yu, Y; Rahmanto, YS; Lee, MH; Wu, PH; Phillip, JM; Huang, CH; Vitolo, MI; Gaillard, S; Martin, SS; Wirtz, D; Shih, IM; Wang, TL				Yu, Yu; Rahmanto, Yohan Suryo; Lee, Meng-Horng; Wu, Pei-Hsun; Phillip, Jude M.; Huang, Chuan-Hsiang; Vitolo, Michele I.; Gaillard, Stephanie; Martin, Stuart S.; Wirtz, Denis; Shih, Ie-Ming; Wang, Tian-Li			Inhibition of ovarian tumor cell invasiveness by targeting SYK in the tyrosine kinase signaling pathway	ONCOGENE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKIN-LYMPHOMA; BREAST-CANCER CELLS; RHEUMATOID-ARTHRITIS; PHOSPHOINOSITIDE 3-KINASE; ACTIN CYTOSKELETON; EPITHELIAL-CELLS; PROTEIN; PHOSPHORYLATION; METASTASIS	Cell motility and invasiveness are prerequisites for dissemination, and largely account for cancer mortality. We have identified an actionable kinase, spleen tyrosine kinase (SYK), which is keenly tightly associated with tumor progression in ovarian cancer. Here, we report that active recombinant SYK directly phosphorylates cortactin and cofilin, which are critically involved in assembly and dynamics of actin filament through phosphorylation signaling. Enhancing SYK activity by inducing expression of a constitutively active SYK mutant, SYK130E, increased growth factor-stimulated migration and invasion of ovarian cancer cells, which was abrogated by cortactin knockdown. Similarly, SYK inhibitors significantly decreased invasion of ovarian cancer cells across basement membrane in real-time transwell assays and in 3D tumor spheroid models. SYK inactivation by targeted gene knockout or by small molecule inhibition reduced actin polymerization. Collectively, this study reported a new mechanism by which SYK signaling regulates ovarian cancer cell motility and invasiveness, and suggest a target-based strategy to prevent or suppress the advancement of ovarian malignancies.	[Yu, Yu; Rahmanto, Yohan Suryo; Gaillard, Stephanie; Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Yu, Yu; Rahmanto, Yohan Suryo; Huang, Chuan-Hsiang; Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; [Lee, Meng-Horng; Wu, Pei-Hsun; Phillip, Jude M.; Wirtz, Denis] Johns Hopkins Univ, Dept Chem & Biomol Engn, Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Lee, Meng-Horng; Wu, Pei-Hsun; Phillip, Jude M.; Wirtz, Denis] Johns Hopkins Univ, Inst NanoBioTechol, Baltimore, MD 21218 USA; [Vitolo, Michele I.; Martin, Stuart S.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Vitolo, Michele I.; Martin, Stuart S.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Natl Canc Inst, Ctr Canc, Baltimore, MD 21201 USA; [Gaillard, Stephanie; Shih, Ie-Ming; Wang, Tian-Li] Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University System of Maryland; University of Maryland Baltimore; Johns Hopkins University; Johns Hopkins Medicine	Shih, IM; Wang, TL (corresponding author), Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA.; Shih, IM; Wang, TL (corresponding author), Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA.; Shih, IM; Wang, TL (corresponding author), Johns Hopkins Med Inst, Dept Gynecol & Obstet, Baltimore, MD 21287 USA.	shihie@yahoo.com; tlw@jhmi.edu	Phillip, Jude/AAR-6240-2020; Suryo Rahmanto, Yohan/K-8043-2018; sdsd, shihieih/ABE-6190-2020; Yu, Yu/AAD-7947-2019	Suryo Rahmanto, Yohan/0000-0003-1453-7872; Yu, Yu/0000-0002-0209-0586; Huang, Chuan-Hsiang/0000-0001-9993-8004	NIH/NCI [RO1CA215483, UO1CA200469, RO1CA148826, R21CA187512, K22CA212060, KO1-CA166576]; Richard W. TeLinde Research Program; Ovarian Cancer Research Foundation Alliance (OCRFA) [458972]; Honorable Tina Brozman Foundation; TEAL award; US Department of Defense Ovarian Cancer Consortium [W81XWH-11-2-0230]; NATIONAL CANCER INSTITUTE [R01CA215483, K01CA166576, K22CA212060, R21CA187512, U01CA200469, R01CA174388, R01CA148826] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Richard W. TeLinde Research Program; Ovarian Cancer Research Foundation Alliance (OCRFA); Honorable Tina Brozman Foundation; TEAL award; US Department of Defense Ovarian Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by NIH/NCI grants, RO1CA215483 (I.M.S.), UO1CA200469 (I.M.S.), RO1CA148826 (T.L.W.), R21CA187512 (T.L.W.), K22CA212060 (C.H.H.), KO1-CA166576 (M.I.V.), Richard W. TeLinde Research Program (www.gynecologycancer.org), Ovarian Cancer Research Foundation Alliance (OCRFA) Grant # 458972 (I.M.S.), The Honorable Tina Brozman Foundation (I.M.S. and T.L.W.), TEAL award (T.L.W.), and US Department of Defense Ovarian Cancer Consortium grant W81XWH-11-2-0230 (I.M.S. and T.L.W.).	Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Beitz LO, 1999, J BIOL CHEM, V274, P32662, DOI 10.1074/jbc.274.46.32662; Bordeleau F, 2014, AM J PHYSIOL-CELL PH, V306, pC110, DOI 10.1152/ajpcell.00283.2013; Cheng SH, 2011, BLOOD, V118, P6342, DOI 10.1182/blood-2011-02-333773; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Cox D, 1996, J BIOL CHEM, V271, P16597, DOI 10.1074/jbc.271.28.16597; Friedberg JW, 2010, BLOOD, V115, P2578, DOI 10.1182/blood-2009-08-236471; Gagliardi PA, 2015, SCI REP-UK, V5, DOI 10.1038/srep10206; Ghotra VPS, 2015, CANCER RES, V75, P230, DOI 10.1158/0008-5472.CAN-14-0629; Hastie EL, 2016, EUR J CELL BIOL, V95, P441, DOI 10.1016/j.ejcb.2016.06.006; Hatton O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042610; Hoon JL, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020017; Huang C, 1998, J BIOL CHEM, V273, P25770, DOI 10.1074/jbc.273.40.25770; Inagaki N, 2017, TRENDS CELL BIOL, V27, P515, DOI 10.1016/j.tcb.2017.02.003; Jaumouille V, 2014, DEV CELL, V29, P534, DOI 10.1016/j.devcel.2014.04.031; Kunwar S, 2016, RHEUMATOL INT, V36, P1077, DOI 10.1007/s00296-016-3482-7; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Layton T, 2009, AM J PATHOL, V175, P2625, DOI 10.2353/ajpath.2009.090543; Li Y, 2012, J BIOL CHEM, V287, P31116, DOI 10.1074/jbc.M112.373647; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Lu J, 2006, J BIOL CHEM, V281, P8806, DOI 10.1074/jbc.M507305200; Lua BL, 2005, FEBS LETT, V579, P577, DOI 10.1016/j.febslet.2004.12.055; Luangdilok S, 2007, CANCER RES, V67, P7907, DOI 10.1158/0008-5472.CAN-07-0331; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moon KD, 2005, J BIOL CHEM, V280, P1543, DOI 10.1074/jbc.M407805200; Ocana-Morgner C, 2009, BLOOD, V113, P1474, DOI 10.1182/blood-2008-04-152587; Paz H, 2014, ONCOGENE, V33, P4193, DOI 10.1038/onc.2013.393; Pearce G, 2011, BLOOD, V117, P1574, DOI 10.1182/blood-2010-07-295659; Pohl G, 2005, CANCER RES, V65, P1994, DOI 10.1158/0008-5472.CAN-04-3625; Prinos P, 2011, NAT STRUCT MOL BIOL, V18, P673, DOI 10.1038/nsmb.2040; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Ruschel A, 2004, CELL SIGNAL, V16, P1249, DOI 10.1016/j.cellsig.2004.03.007; Sharman J, 2015, BLOOD, V125, P2336, DOI 10.1182/blood-2014-08-595934; Stephens LR, 2001, J BIOL CHEM, V276, P42767, DOI 10.1074/jbc.M107194200; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Wu PH, 2015, SCI REP-UK, V5, DOI 10.1038/srep18437; Xue L, 2012, P NATL ACAD SCI USA, V109, P5615, DOI 10.1073/pnas.1119418109; Yamaguchi H, 2007, BBA-MOL CELL RES, V1773, P642, DOI 10.1016/j.bbamcr.2006.07.001; Yap KL, 2012, CANCER RES, V72, P4085, DOI 10.1158/0008-5472.CAN-12-0302; Yoo Y, 2010, ONCOGENE, V29, P263, DOI 10.1038/onc.2009.319; Young RM, 2009, BLOOD, V113, P2508, DOI 10.1182/blood-2008-05-158618; Yu L, 2014, INT J GYNECOL CANCER, V24, P1158, DOI 10.1097/IGC.0000000000000179; Yu Y, 2015, CANCER CELL, V28, P82, DOI 10.1016/j.ccell.2015.05.009; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371	49	15	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3778	3789		10.1038/s41388-018-0241-0	http://dx.doi.org/10.1038/s41388-018-0241-0			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29643476	Green Accepted			2022-12-26	WOS:000438465600002
J	Zhu, JH; Lu, XR; Feng, QP; Stathopulos, PB				Zhu, Jinhui; Lu, Xiangru; Feng, Qingping; Stathopulos, Peter B.			A charge-sensing region in the stromal interaction molecule 1 luminal domain confers stabilization-mediated inhibition of SOCE in response to S-nitrosylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; CA2+ STORE; STIM1 COUPLES; ORAI1; OLIGOMERIZATION; GLUTATHIONYLATION; CYSTEINE; SENSOR; DEGRADATION; DEPLETION	Store-operated Ca2+ entry (SOCE) is a major Ca2+ signaling pathway facilitating extracellular Ca2+ influx in response to the initial release of intracellular endo/sarcoplasmic reticulum (ER/SR) Ca2+ stores. Stromal interaction molecule 1 (STIM1) is the Ca2+ sensor that activates SOCE following ER/SR Ca2+ depletion. The EF-hand and the adjacent sterile alpha-motif (EFSAM) domains of STIM1 are essential for detecting changes in luminal Ca2+ concentrations. Low ER Ca2+ levels trigger STIM1 destabilization and oligomerization, culminating in the opening of Orai1-composed Ca2+ channels on the plasma membrane. NOmediated S-nitrosylation of cysteine thiols regulates myriad protein functions, but its effects on the structural mechanisms that regulate SOCE are unclear. Here, we demonstrate that S-nitrosylation of Cys 49 and Cys 56 in STIM1 enhances the thermodynamic stability of its luminal domain, resulting in suppressed hydrophobic exposure and diminished Ca2+ depletion-dependent oligomerization. Using solution NMR spectroscopy, we pinpointed a structural mechanism for STIM1 stabilization driven by complementary charge interactions between an electropositive patch on the core EFSAM domain and the S-nitrosylated nonconserved region of STIM1. Finally, using live cells, we found that the enhanced luminal domain stability conferred by either Cys 49 and Cys 56 S-nitrosylation or incorporation of negatively charged residues into the EFSAM electropositive patch in the full-length STIM1 context significantly suppresses SOCE. Collectively, our results suggest that S-nitrosylation of STIM1 inhibits SOCE by interacting with an electropositive patch on the EFSAM core, which modulates the thermodynamic stability of the STIM1 luminal domain.	[Zhu, Jinhui; Lu, Xiangru; Feng, Qingping; Stathopulos, Peter B.] Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St N, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Feng, QP; Stathopulos, PB (corresponding author), Univ Western Ontario, Dept Physiol & Pharmacol, 1151 Richmond St N, London, ON N6A 5C1, Canada.	qingping.feng@schulich.uwo.ca; peter.stathopulos@schulich.uwo.ca		Stathopulos, Peter B./0000-0002-0536-6656; Feng, Qingping/0000-0001-9739-2765	Natural Sciences and Engineering Research Council of Canada [05239]; Canadian Foundation for Innovation/Ontario Research Fund [34113]; Canadian Institutes of Health Research [MOP-142383]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Foundation for Innovation/Ontario Research Fund(Canada Foundation for Innovation); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by Natural Sciences and Engineering Research Council of Canada Grant 05239 (to P. B. S.), Canadian Foundation for Innovation/Ontario Research Fund Grant 34113 (to P. B. S.), and Canadian Institutes of Health Research Grant MOP-142383 (to Q. F.). The authors declare that they have no conflicts of interest with the contents of this article.	Albertos P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9669; Aracena-Parks P, 2006, J BIOL CHEM, V281, P40354, DOI 10.1074/jbc.M600876200; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Barnett SD, 2017, CRIT REV BIOCHEM MOL, V52, P340, DOI 10.1080/10409238.2017.1304353; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bocedi A, 2004, BIOCHEM BIOPH RES CO, V315, P710, DOI 10.1016/j.bbrc.2004.01.113; Broniowska KA, 2013, BBA-GEN SUBJECTS, V1830, P3173, DOI 10.1016/j.bbagen.2013.02.004; Cai ZJ, 2015, ARTERIOSCL THROM VAS, V35, P2366, DOI 10.1161/ATVBAHA.115.305796; Choi YJ, 2017, BBA-MOL CELL RES, V1864, P1054, DOI 10.1016/j.bbamcr.2016.11.015; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Collins HE, 2013, AM J PHYSIOL-HEART C, V305, pH446, DOI 10.1152/ajpheart.00104.2013; Covington ED, 2010, MOL BIOL CELL, V21, P1897, DOI 10.1091/mbc.E10-02-0145; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Eichmann C, 2016, J MOL BIOL, V428, P3737, DOI 10.1016/j.jmb.2016.07.010; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Feng JH, 2011, BIOSCI TRENDS, V5, P17, DOI 10.5582/bst.2011.v5.1.17; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Frischauf I, 2009, J BIOL CHEM, V284, P21696, DOI 10.1074/jbc.M109.018408; Giustarini D, 2005, ANTIOXID REDOX SIGN, V7, P930, DOI 10.1089/ars.2005.7.930; Gould N, 2013, J BIOL CHEM, V288, P26473, DOI 10.1074/jbc.R113.460261; Gui L, 2018, J MOL BIOL; Guo CJ, 2008, PLOS BIOL, V6, P2414, DOI 10.1371/journal.pbio.0060266; Haldar SM, 2013, J CLIN INVEST, V123, P101, DOI 10.1172/JCI62854; Hao G, 2004, J BIOL CHEM, V279, P36192, DOI 10.1074/jbc.M404866200; HART TW, 1985, TETRAHEDRON LETT, V26, P2013, DOI 10.1016/S0040-4039(00)98368-0; Hawkins BJ, 2010, J CELL BIOL, V190, P391, DOI 10.1083/jcb.201004152; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hunton DL, 2002, J BIOL CHEM, V277, P14266, DOI 10.1074/jbc.M107167200; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kohr MJ, 2014, J MOL CELL CARDIOL, V69, P67, DOI 10.1016/j.yjmcc.2014.01.010; Kumar R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44558; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li Y, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3592581; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Liu L, 2002, EUR J BIOCHEM, V269, P4277, DOI 10.1046/j.1432-1033.2002.03118.x; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Ma GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8826; Martinez-Ruiz A, 2007, CARDIOVASC RES, V75, P220, DOI 10.1016/j.cardiores.2007.03.016; Martinez-Ruiz A, 2013, ANTIOXID REDOX SIGN, V19, P1220, DOI 10.1089/ars.2012.5066; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Miao Y, 2013, ELIFE, V2, DOI 10.7554/eLife.00802; Muik M, 2011, EMBO J, V30, P1678, DOI 10.1038/emboj.2011.79; Muik M, 2009, J BIOL CHEM, V284, P8421, DOI 10.1074/jbc.C800229200; Okamoto S, 2014, CELL REP, V8, P217, DOI 10.1016/j.celrep.2014.06.005; Pace C N, 1986, Methods Enzymol, V131, P266; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prins D, 2011, EMBO REP, V12, P1182, DOI 10.1038/embor.2011.173; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Qu J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001085; Renganathan M, 2002, J NEUROPHYSIOL, V87, P761, DOI 10.1152/jn.00369.2001; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sievers F, 2014, CURR PROTOC BIOINFOR, V48; Stathopulos PB, 2008, CELL, V135, P110, DOI 10.1016/j.cell.2008.08.006; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stathopulos PB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3963; Stathopulos PB, 2009, J BIOL CHEM, V284, P728, DOI 10.1074/jbc.C800178200; STRYER LUBERT, 1965, J MOL BIOL, V13, P482; Sun JH, 2006, ANTIOXID REDOX SIGN, V8, P1693, DOI 10.1089/ars.2006.8.1693; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zheng L, 2011, P NATL ACAD SCI USA, V108, P1337, DOI 10.1073/pnas.1015125108; Zhou YD, 2009, J BIOL CHEM, V284, P19164, DOI 10.1074/jbc.C109.010900; Zhou YB, 2013, NAT STRUCT MOL BIOL, V20, P973, DOI 10.1038/nsmb.2625; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107; Zhou YB, 2010, NAT STRUCT MOL BIOL, V17, P112, DOI 10.1038/nsmb.1724	73	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8900	8911		10.1074/jbc.RA117.000503	http://dx.doi.org/10.1074/jbc.RA117.000503			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29661937	Green Published, hybrid			2022-12-26	WOS:000434941900014
J	Belchev, Z; Bodner, GE; Fawcett, JM				Belchev, Zorry; Bodner, Glen E.; Fawcett, Jonathan M.			Inducing preference reversals in aesthetic choices for paintings: Introducing the contrast paradigm	PLOS ONE			English	Article							DECISION-MAKING; COGNITIVE-DISSONANCE; MUSIC PREFERENCES; CONTEXT; ASSIMILATION; ATTRACTIVENESS; APPRECIATION; ALTERNATIVES; PSYCHOLOGY; JUDGMENTS	Understanding what leads people to reverse their choices is important in many domains. We introduce a contrast paradigm for studying reversals in choices-here between pairs of abstract paintings-implemented in both within-subject (Experiment 1; N = 320) and between-subject (Experiment 2; N = 384) designs. On each trial, participants chose between a pair of paintings. A critical pair of average-beauty paintings was presented before and after either a reversal or control block. In the reversal block, we made efforts to bias preference away from the chosen average-beauty painting (by pairing it with more-beautiful paintings) and toward the non-chosen average-beauty painting (by pairing it with less-beautiful paintings). Meta-analysis revealed more reversals after reversal blocks than after control blocks, though only when the biasing manipulations succeeded. A second meta-analysis revealed that reversals were generally more likely for participants who later misidentified their initial choice, demonstrating that memory for initial choices influences later choices. Thus, the contrast paradigm has utility both for inducing choice reversals and identifying their causes.	[Belchev, Zorry; Bodner, Glen E.] Univ Calgary, Dept Psychol, Calgary, AB, Canada; [Fawcett, Jonathan M.] Mem Univ Newfoundland, Dept Psychol, St John, NF, Canada; [Belchev, Zorry] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Bodner, Glen E.] Flinders Univ S Australia, Psychol, Adelaide, SA, Australia	University of Calgary; Memorial University Newfoundland; University of Toronto; Flinders University South Australia	Bodner, GE (corresponding author), Univ Calgary, Dept Psychol, Calgary, AB, Canada.; Bodner, GE (corresponding author), Flinders Univ S Australia, Psychol, Adelaide, SA, Australia.	glen.bodner@flinders.edu.au		Belchev, Zorry/0000-0002-9361-0865; Bodner, Glen/0000-0001-7837-4879	Natural Sciences and Engineering Research Council of Canada [RGPIN 238599-2015]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This research was supported by the Natural Sciences and Engineering Research Council of Canada through Discovery Grant RGPIN 238599-2015 to GEB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, LANG ENV STAT COMP; Arielli E, 2012, EMPIR STUD ARTS, V30, P59, DOI 10.2190/EM.30.1.f; Belchev Z., 2015, THESIS; BOSTIC R, 1990, J ECON BEHAV ORGAN, V13, P193, DOI 10.1016/0167-2681(90)90086-S; BREHM JW, 1956, J ABNORM SOC PSYCH, V52, P384, DOI 10.1037/h0041006; Burkley E, 2008, PERS SOC PSYCHOL B, V34, P419, DOI 10.1177/0146167207310458; Busemeyer JR., 2007, MARKETING THEOR, V7, P39, DOI [10.1177/1470593107073844, DOI 10.1177/1470593107073844]; Chammat M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41320; Chen MK, 2010, J PERS SOC PSYCHOL, V99, P573, DOI 10.1037/a0020217; Dolese M., 2005, B PSYCHOL ARTS, V5, P21; Engelmann JB, 2013, PROG BRAIN RES, V202, P215, DOI 10.1016/B978-0-444-62604-2.00013-7; Fechner G.T., 1876, PRESCHOOL AESTHETICS; Festinger L., 1957, THEORY COGNITIVE DIS, V2; FOX WS, 1974, PUBLIC OPIN QUART, V38, P352, DOI 10.1086/268171; GEISELMAN RE, 1984, J EXP SOC PSYCHOL, V20, P409, DOI 10.1016/0022-1031(84)90035-0; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 2021, BAYESIAN DATA ANAL; GIRGUS JS, 1982, PERCEPT PSYCHOPHYS, V32, P555, DOI 10.3758/BF03204210; Graf LKM, 2015, PERS SOC PSYCHOL REV, V19, P395, DOI 10.1177/1088868315574978; HOVLAND CI, 1957, J ABNORM SOC PSYCH, V55, P244, DOI 10.1037/h0048480; Ito T, 2014, SOC COGN AFFECT NEUR, V9, P1546, DOI 10.1093/scan/nst147; Izuma K, 2010, P NATL ACAD SCI USA, V107, P22014, DOI 10.1073/pnas.1011879108; Jacobsen T, 2006, LEONARDO, V39, P155, DOI 10.1162/leon.2006.39.2.155; Kahneman D., 2011, THINKING FAST SLOW; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; LICHTENSTEIN S, 1971, J EXP PSYCHOL, V89, P46, DOI 10.1037/h0031207; Lindell AK, 2011, J COGN PSYCHOL, V23, P453, DOI 10.1080/20445911.2011.539556; Mallon B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00161; Parker S., 2008, PSYCHOL AESTHET CREA, V2, P171, DOI DOI 10.1037/1931-3896.2.3.171; Pine A, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01051; Redies C, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00218; Rentfrow PJ, 2003, J PERS SOC PSYCHOL, V84, P1236, DOI 10.1037/0022-3514.84.6.1236; Rhodes G, 2006, ANNU REV PSYCHOL, V57, P199, DOI 10.1146/annurev.psych.57.102904.190208; Salti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108579; Scherer KR, 2005, SOC SCI INFORM, V44, P695, DOI 10.1177/0539018405058216; Shimojo S, 2003, NAT NEUROSCI, V6, P1317, DOI 10.1038/nn1150; Sidhu DM, PLOS ONE REV; SIMONSON I, 1989, J CONSUM RES, V16, P158, DOI 10.1086/209205; Stan Development Team, 2016, RSTAN BAYES APPL REG; SVENSON O, 1992, ACTA PSYCHOL, V80, P143, DOI 10.1016/0001-6918(92)90044-E; SVENSON O, 1992, J ECON PSYCHOL, V13, P315, DOI 10.1016/0167-4870(92)90036-7; Tousignant C, 2017, PSYCHOL AES IN PRESS, DOI [10.1037/aca0000146, DOI 10.1037/ACA0000146]; Tousignant C, 2014, PSYCHOL AESTHET CREA, V8, P81, DOI 10.1037/a0034942; Trueblood J., 2015, DECISION, V2, P13, DOI [DOI 10.1037/DEC0000015, 10.1037/dec0000015]; Trueblood JS, 2013, PSYCHOL SCI, V24, P901, DOI 10.1177/0956797612464241; Trueblood JS, 2012, PSYCHON B REV, V19, P962, DOI 10.3758/s13423-012-0288-9; Tsetsos K, 2010, PSYCHOL REV, V117, P1275, DOI 10.1037/a0020580; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; TVERSKY A, 1993, MANAGE SCI, V39, P1179, DOI 10.1287/mnsc.39.10.1179; Vessel EA, 2010, J VISION, V10, DOI 10.1167/10.2.18; Voigt K, 2017, J EXP PSYCHOL LEARN, V43, P1872, DOI 10.1037/xlm0000415; WEDELL DH, 1991, J EXP PSYCHOL LEARN, V17, P767, DOI 10.1037/0278-7393.17.4.767; ZAJONC RB, 1982, J CONSUM RES, V9, P123, DOI 10.1086/208905; ZAJONC RB, 1968, J PERS SOC PSYCHOL, V9, P1, DOI 10.1037/h0025848; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zellner DA, 2006, PSYCHON B REV, V13, P235, DOI 10.3758/BF03193836; Zellner DA, 2014, ATTEN PERCEPT PSYCHO, V76, P2189, DOI 10.3758/s13414-014-0768-2; Zellner DA, 2010, ATTEN PERCEPT PSYCHO, V72, P1261, DOI 10.3758/APP.72.5.1261; Zellner DA, 2009, ATTEN PERCEPT PSYCHO, V71, P1228, DOI 10.3758/APP.71.6.1228	59	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196246	10.1371/journal.pone.0196246	http://dx.doi.org/10.1371/journal.pone.0196246			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672641	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800103
J	Campos, R; Monica, FZ; Justo, AFO; Cogo, JC; Oliveira, ED; Moreno, RA; Antunes, E; De Nucci, G				Campos, Rafael; Monica, Fabiola Z.; Oliveira Justo, Alberto Fernando; Cogo, Jose Carlos; Oliveira, Edvana de Toledo; Moreno, Ronilson Agnaldo; Antunes, Edson; De Nucci, Gilberto			Electrical field stimulation-induced contractions on Pantherophis guttatus corpora cavernosa and aortae	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ALPHA-ADRENERGIC VASOCONSTRICTION; RESISTANT SODIUM-CHANNELS; SHEAR-STRESS; BLOOD-FLOW; ENDOTHELIAL-CELLS; CORPUS CAVERNOSUM; IN-VITRO; RELEASE; CATECHOLAMINES	A tetrodotoxin (TTX)-resistant mechanism is responsible for the electrical field stimulation (EFS)-induced contractions and relaxations of Crotalus durissus terrificus corpora cavernosa. Here it was investigated whether this mechanism also occurs in corpora cavernosa and aortae of the non-venomous snake Pantherophis guttatus corpora cavernosa and aortae. Corpora cavernosa and aortic rings isolated from Pantherophis guttatus snake were mounted in organ bath system for isometric tension recording. EFS-induced contractions in both tissues were performed in the presence and absence of guanethidine (30 mu M), phentolamine (10 mu M) and tetrodotoxin (1 mu M). In another set of experiments, the endothelium was removed from aortic rings and EFS-induced contractions were performed in the denuded rings. Electrical field stimulation-induced contractions were frequency-dependent in Pantherophis guttatus corpora cavernosa and aortic rings. The contractions were significantly reduced in the presence of guanethidine (30 mu M) or phentolamine (10 mu M). Pre-treatment with tetrodotoxin had no effect on the EFS-induced contractions of either corpora cavernosa or aortic rings. Surprisingly, the EFS-induced contractions of aortic rings denuded of endothelium were almost abolished. These results indicate that the TTX-resistant mechanism is present in EFS-induced contractions of Pantherophis guttatus corpora cavernosa and aortae. The experiments performed in the aorta indicate that the endothelium is the main source for the release of catecholamines induced by EFS.	[Campos, Rafael; Monica, Fabiola Z.; Oliveira Justo, Alberto Fernando; Moreno, Ronilson Agnaldo; Antunes, Edson; De Nucci, Gilberto] Univ Estadual Campinas, UNICAMP, Dept Pharmacol, Fac Med Sci, Campinas, SP, Brazil; [Cogo, Jose Carlos] Brazil Univ, Fac Biomed Engn, Itaquera, SP, Brazil; [Oliveira, Edvana de Toledo] Univ Vale Paraiba UNIVAP, Sao Jose Dos Campos, Brazil; [De Nucci, Gilberto] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade do Vale do Paraiba; Universidade de Sao Paulo	Campos, R (corresponding author), Univ Estadual Campinas, UNICAMP, Dept Pharmacol, Fac Med Sci, Campinas, SP, Brazil.	rafaelcampos.vet@gmail.com	Monica, Fabiola Zakia/B-4191-2013; De Nucci, Gilberto/ABB-7380-2021; Justo, Alberto/AAI-1394-2021; Campos, Rafael/F-2471-2017; De Nucci, Gilberto/J-5990-2012	Monica, Fabiola Zakia/0000-0002-8449-6677; De Nucci, Gilberto/0000-0002-4346-7941; Campos, Rafael/0000-0002-9816-2061; De Nucci, Gilberto/0000-0002-4346-7941; Oliveira Justo, Alberto Fernando/0000-0001-5531-0485	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [Fapesp: 2011/11828-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [CNPq: 140731/2013-0]; Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP) [2011/11828-4]; Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq) [140731/2013-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (Fapesp: 2011/11828-4) (GDN) (http://www.fapesp.br/) and by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq: 140731/2013-0) (RC) (http://cnpq.br/). The funders had no role in study design and data collection.; This study was supported by Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP; 2011/11828-4) and by Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq; 140731/2013-0).	BUGA GM, 1991, HYPERTENSION, V17, P187, DOI 10.1161/01.HYP.17.2.187; Campos R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183766; Capel RO, 2011, J SEX MED, V8, P1616, DOI 10.1111/j.1743-6109.2011.02246.x; Corson MA, 1996, CIRC RES, V79, P984, DOI 10.1161/01.RES.79.5.984; DAIL WG, 1987, J AUTON PHARMACOL, V7, P287, DOI 10.1111/j.1474-8673.1987.tb00157.x; Dinenno FA, 2001, J PHYSIOL-LONDON, V536, P977, DOI 10.1111/j.1469-7793.2001.00977.x; EGAN B, 1987, J CLIN INVEST, V80, P812, DOI 10.1172/JCI113138; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; GODFRAIND T, 1985, CLIN SCI, V68, pS65, DOI 10.1042/cs068s065; Gratzke C, 2010, EUR UROL, V57, P342, DOI 10.1016/j.eururo.2008.12.024; Grote L, 2000, AM J RESP CRIT CARE, V162, P1480, DOI 10.1164/ajrccm.162.4.9912028; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; Hopman MTE, 1996, ADV EXP MED BIOL, V388, P379; KHURANA JP, 1987, PLANT PHYSIOL, V85, P10, DOI 10.1104/pp.85.1.10; Kooijman M, 2003, CIRCULATION, V108, P2361, DOI 10.1161/01.CIR.0000096480.55857.3C; Monica FZ, 2012, COMP BIOCHEM PHYS C, V155, P433, DOI 10.1016/j.cbpc.2011.11.003; NARAHASHI T, 1964, J GEN PHYSIOL, V47, P965, DOI 10.1085/jgp.47.5.965; Nash MS, 1996, ARCH PHYS MED REHAB, V77, P1260, DOI 10.1016/S0003-9993(96)90190-2; Pfeil U, 2014, J PHYSIOL-LONDON, V592, P1745, DOI 10.1113/jphysiol.2013.262626; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Sorriento D, 2012, HYPERTENSION, V60, P129, DOI 10.1161/HYPERTENSIONAHA.111.189605; Teixeira CE, 2004, UROLOGY, V63, P184, DOI 10.1016/S0090-4295(03)00785-4; UDENFRIEND S, 1959, ARCH BIOCHEM BIOPHYS, V85, P487, DOI 10.1016/0003-9861(59)90516-8; Uematsu M, 1995, AM J PHYSIOL-CELL PH, V269, pC1371, DOI 10.1152/ajpcell.1995.269.6.C1371; VENTER JC, 1988, PROG NEUROBIOL, V30, P105, DOI 10.1016/0301-0082(88)90004-4; WAALKES TP, 1958, SCIENCE, V127, P648, DOI 10.1126/science.127.3299.648	27	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196123	10.1371/journal.pone.0196123	http://dx.doi.org/10.1371/journal.pone.0196123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672643	gold, Green Submitted, Green Published			2022-12-26	WOS:000430446800093
J	Zhang, H; Xie, XH; Liu, PH; Liang, T; Lu, YB; Qin, CL				Zhang, Hua; Xie, Xiaohua; Liu, Peihong; Liang, Tian; Lu, Yongbo; Qin, Chunlin			Transgenic expression of dentin phosphoprotein (DPP) partially rescued the dentin defects of DSPP-null mice	PLOS ONE			English	Article							SIALOPHOSPHOPROTEIN DSPP; MINERAL INDUCTION; SIALOPROTEIN DSP; DENTINOGENESIS; PROTEINS; CLEAVAGE; BONE; BIOMINERALIZATION; PREDENTIN; BINDING	Mutations in the dentin sialophosphoprotein (DSPP) gene cause dentinogenesis imperfecta. After synthesis, DSPP is proteolytically processed into NH2- and COOH-terminal fragments. The NH2(-)terminal fragment of DSPP is highly glycosylated but not phosphorylated, whereas the COOH-terminal fragment (named "dentin phosphoprotein" or "DPP")is highly phosphorylated but not glycosylated. These two fragments are believed to perform distinct roles in dentin formation. To analyze the functions of DPP in dentinogenesis, we created "Dspp(-/-); DPP Tg mice", which expressed transgenic DPP driven by a Type I collagen promoter but lacked the endogenous Dspp gene. We characterized the dentin of the Dspp(-/-); DPP Tg mice using X-ray radiography, histology, scanning electron microscopy, double fluorochrome labeling, immunohistochemistry and in situ hybridization. Micro-computed tomography analyses revealed that at postnatal 6 months, the transgenic expression of DPP increased the dentin thickness of the Dspp-null mice by 97.1% and restored the dentin material density by 29.5%. Histological analyses showed that the Dspp-null mice manifested an abnormal widening of the predentin while the predentin in Dspp(-/-); DPP Tg mice was narrower than in the Dspp-null mice. Scanning electron microscopy analyses showed that the dentinal tubules in the Dspp(-/-); DPP Tg mice were better organized than in the Dspp-null mice. The double fluorochrome labeling analyses demonstrated that the dentin mineral deposition rate in the Dspp(-/-); DPP Tg mice was significantly improved compared to that in the Dspp-null mice. These findings indicate that the transgenic expression of DPP partially rescued the dentin defects of the DSPP-null mice, suggesting that DPP may promote dentin formation and that the coordinated actions between DPP and the NH2-terminal fragment of DSPP may be necessary for dentinogenesis.	[Zhang, Hua; Liang, Tian; Lu, Yongbo; Qin, Chunlin] Texas A&M Univ, Coll Dent, Dept Biomed Sci, Dallas, TX 77843 USA; [Xie, Xiaohua] Harbin Med Univ, Affiliated Hosp 2, Dept Stomatol, Harbin, Heilongjiang, Peoples R China; [Liu, Peihong] Harbin Med Univ, Sch Stomatol, Dept Periodont, Harbin, Heilongjiang, Peoples R China	Texas A&M University System; Harbin Medical University; Harbin Medical University	Lu, YB; Qin, CL (corresponding author), Texas A&M Univ, Coll Dent, Dept Biomed Sci, Dallas, TX 77843 USA.	ylu@tamhsc.edu; cqin@tamhsc.edu		Zhang, Hua/0000-0002-6789-9343; Liang, Tian/0000-0002-3429-7821; Qin, Chunlin/0000-0002-2906-9074; Lu, Yongbo/0000-0003-3692-1736	USA National Institute of Health [DE022549, DE023365]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE022549, R01DE023365] Funding Source: NIH RePORTER	USA National Institute of Health; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by USA National Institute of Health Grant DE022549 to CQ and USA National Institute of Health Grant DE023365 to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boskey A, 2000, CALCIFIED TISSUE INT, V67, P472, DOI 10.1007/s002230001169; BOSKEY AL, 1990, BONE MINER, V11, P55, DOI 10.1016/0169-6009(90)90015-8; BUTLER WT, 1983, ARCH BIOCHEM BIOPHYS, V225, P178, DOI 10.1016/0003-9861(83)90021-8; BUTLER WT, 1992, MATRIX, V12, P343, DOI 10.1016/S0934-8832(11)80030-2; BUTLER WT, 1995, INT J DEV BIOL, V39, P169; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; Dahl T, 1998, J STRUCT BIOL, V123, P162, DOI 10.1006/jsbi.1998.4025; Fisher LW, 2001, BIOCHEM BIOPH RES CO, V280, P460, DOI 10.1006/bbrc.2000.4146; George A, 1996, J BIOL CHEM, V271, P32869, DOI 10.1074/jbc.271.51.32869; Gibson MP, 2013, EUR J ORAL SCI, V121, P76, DOI 10.1111/eos.12020; Gibson MP, 2013, J BIOL CHEM, V288, P7204, DOI 10.1074/jbc.M112.445775; Goldberg M, 2003, CONNECT TISSUE RES, V44, P184, DOI 10.1080/03008200390152304; JONSSON M, 1978, J CHROMATOGR, V157, P235, DOI 10.1016/S0021-9673(00)92338-0; Leighton M, 2003, J BIOL CHEM, V278, P18478, DOI 10.1074/jbc.M213021200; LINDE A, 1989, CALCIFIED TISSUE INT, V44, P286, DOI 10.1007/BF02553763; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; MacDougall M, 1997, J BIOL CHEM, V272, P835, DOI 10.1074/jbc.272.2.835; Prasad M, 2010, CONNECT TISSUE RES, V51, P404, DOI 10.3109/03008200903329789; Saito T, 1997, BONE, V21, P305, DOI 10.1016/S8756-3282(97)00149-X; Sreenath T, 2003, J BIOL CHEM, V278, P24874, DOI 10.1074/jbc.M303908200; Sun Y, 2010, J DENT RES, V89, P498, DOI 10.1177/0022034510363109; TRAUB W, 1992, MATRIX, V12, P197, DOI 10.1016/S0934-8832(11)80062-4; VEIS A, 1993, J BONE MINER RES, V8, pS493; Wang XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002708; Xiao SX, 2001, NAT GENET, V27, P201, DOI 10.1038/84848; Zhang H, 2016, EUR J HISTOCHEM, V60, P44, DOI 10.4081/ejh.2016.2587; Zhang XH, 2001, NAT GENET, V27, P151, DOI 10.1038/84765; Zhu Q, 2010, J DENT RES, V89, P808, DOI 10.1177/0022034510366902; Zhu QL, 2012, J BIOL CHEM, V287, P30426, DOI 10.1074/jbc.M112.388587; Zhu QL, 2012, CONNECT TISSUE RES, V53, P307, DOI 10.3109/03008207.2011.650301	30	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195854	10.1371/journal.pone.0195854	http://dx.doi.org/10.1371/journal.pone.0195854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672573	gold, Green Submitted, Green Published			2022-12-26	WOS:000430446800051
J	Fuertinger, DH; Kappel, F; Zhang, HJ; Thijssen, S; Kotanko, P				Fuertinger, Doris H.; Kappel, Franz; Zhang, Hanjie; Thijssen, Stephan; Kotanko, Peter			Prediction of hemoglobin levels in individual hemodialysis patients by means of a mathematical model of erythropoiesis	PLOS ONE			English	Article							PARAMETER-ESTIMATION; EPOETIN ALPHA; ANEMIA; RATS; MICE; NEOCYTOLYSIS; RELEVANCE	Anemia commonly occurs in people with chronic kidney disease (CKD) and is associated with poor clinical outcomes. The management of patients with anemia in CKD is challenging, due to its severity, frequent hypo-responsiveness to treatment with erythropoiesis stimulating agents (ESA) and common hemoglobin cycling. Nonlinear dose-response curves and long delays in the effect of treatment on red blood cell population size complicate predictions of hemoglobin (Hgb) levels in individual patients. A comprehensive physiology based mathematical model for erythropoiesis was adapted individually to 60 hemodialysis patients treated with ESAs by identifying physiologically meaningful key model parameters from temporal Hgb data. Crit-Line (R) Ill monitors provided non-invasive Hgb measurements for every hemodialysis treatment. We used Hgb data during a 150-day baseline period together to estimate a patient's individual red blood cell lifespan, effects of the ESA on proliferation of red cell progenitor cells, endogenous erythropoietin production and ESA half-life. Estimated patient specific parameters showed excellent alignment with previously conducted clinical studies in hemodialysis patients. Further, the model qualitatively and quantitatively reflected empirical hemoglobin dynamics in demographically, anthropometrically and clinically diverse patients and accurately predicted the Hgb response to ESA therapy in individual patients for up to 21 weeks. The findings suggest that estimated model parameters can be used as a proxy for parameters that are clinically very difficult to quantify. The presented method has the potential to provide new insights into the individual pathophysiology of renal anemia and its association with clinical outcomes and can potentially be used to guide personalized anemia treatment.	[Fuertinger, Doris H.; Zhang, Hanjie; Thijssen, Stephan; Kotanko, Peter] Renal Res Inst, New York, NY 10065 USA; [Kappel, Franz] Karl Franzens Univ Graz, Inst Math & Sci Comp, Graz, Austria; [Kotanko, Peter] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Fuertinger, Doris H.] Fresenius Med Care Germany, Global Res & Dev, Bad Homburg, Germany	Renal Research Institute; University of Graz; Icahn School of Medicine at Mount Sinai	Fuertinger, DH (corresponding author), Renal Res Inst, New York, NY 10065 USA.; Fuertinger, DH (corresponding author), Fresenius Med Care Germany, Global Res & Dev, Bad Homburg, Germany.	doris.fueritnger@fmc-ag.com	Kotanko, Peter/AAE-5721-2019	Kotanko, Peter/0000-0003-4373-412X; Zhang, Hanjie/0000-0002-0015-5614; Fuertinger, Doris/0000-0001-6321-2367				Ackleh AS, 2006, MATH BIOSCI, V204, P21, DOI 10.1016/j.mbs.2006.08.004; Ackleh AS, 2008, MATH BIOSCI ENG, V5, P601, DOI 10.3934/mbe.2008.5.601; Adimy M, 2006, B MATH BIOL, V68, P2321, DOI 10.1007/s11538-006-9121-9; Alfrey CP, 2007, NEPHRON CLIN PRACT, V106, P149, DOI 10.1159/000104425; Artunc F, 2007, NEPHROL DIAL TRANSPL, V22, P2900, DOI 10.1093/ndt/gfm316; Banks HT, 2004, MATH BIOSCI ENG, V1, P15, DOI 10.3934/mbe.2004.1.15; BELAIR J, 1995, MATH BIOSCI, V128, P317, DOI 10.1016/0025-5564(94)00078-E; Besarab A, 2002, AM J KIDNEY DIS, V40, P439, DOI 10.1053/ajkd.2002.34881; Collins AJ, 2005, AM J KIDNEY DIS, V46, P481, DOI 10.1053/j.ajkd.2005.05.018; Crauste F, 2008, J THEOR BIOL, V250, P322, DOI 10.1016/j.jtbi.2007.09.041; Crauste F, 2010, J THEOR BIOL, V263, P303, DOI 10.1016/j.jtbi.2009.12.026; Cross AR, BLOOD FACTS STAT; Davidian M, 2009, CH CRC HANDB MOD STA, P107; Demin I., 2010, Journal of Biological Dynamics, V4, P59, DOI 10.1080/17513750902777642; Fishbane S, 2005, KIDNEY INT, V68, P1337, DOI 10.1111/j.1523-1755.2005.00532.x; Floege Jr, 2010, COMPREHENSIVE CLIN N, Vxxii; Fuertinger DH, 2013, LECT NOTES ENG COMPU; Fuertinger DH, 2013, J MATH BIOL, V66, P1209, DOI 10.1007/s00285-012-0530-0; Greer JP, 2014, WINTROBES CLIN HEMAT, Vxxvii; Grenier E, 2014, ESAIM-MATH MODEL NUM, V48, P1303, DOI 10.1051/m2an/2013140; Group KAW, 2012, KIDNEY INT, V2, P279, DOI DOI 10.1038/kisup.2012.37; Jones E., 2001, SCIPY OPEN SOURCE SC; Kaushansky K, 2010, WILLIAMS HEMATOLOGY, Vxxiii; LOEFFLER M, 1989, CELL TISSUE KINET, V22, P13, DOI 10.1111/j.1365-2184.1989.tb00198.x; Ma J, 2017, BLOOD PURIFICAT, V43, P200, DOI 10.1159/000452728; Macdougall IC, 1999, J AM SOC NEPHROL, V10, P2392; Mahaffy J.M., 1999, AGE STRUCTURED MODEL; Mahaffy JM, 1998, J THEOR BIOL, V190, P135, DOI 10.1006/jtbi.1997.0537; Nachman PH., 2012, BRENNER RECTORS KIDN, V9, P1121; NADLER SB, 1962, SURGERY, V51, P224; Owen JS, 2014, INTRODUCTION TO POPULATION PHARMACOKINETIC/PHARMACODYNAMIC ANALYSIS WITH NONLINEAR MIXED EFFECTS MODELS, P250; Rice L, 2005, CELL PHYSIOL BIOCHEM, V15, P245, DOI 10.1159/000087234; Rice L, 1999, AM J KIDNEY DIS, V33, P59, DOI 10.1016/S0272-6386(99)70258-1; Roeder I, 2002, EXP HEMATOL, V30, P853, DOI 10.1016/S0301-472X(02)00832-9; Roeder I, 2006, CURR OPIN HEMATOL, V13, P222, DOI 10.1097/01.moh.0000231418.08031.48; United States Renal Data System, 2015, USRDS ANN DAT REP EP; WICHMANN HE, 1989, CELL TISSUE KINET, V22, P31, DOI 10.1111/j.1365-2184.1989.tb00199.x; WULFF H, 1989, CELL TISSUE KINET, V22, P51, DOI 10.1111/j.1365-2184.1989.tb00200.x	38	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195918	10.1371/journal.pone.0195918	http://dx.doi.org/10.1371/journal.pone.0195918			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668766	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200066
J	von Tscharner, V; Ullrich, M; Mohr, M; Marquez, DC; Nigg, BM				von Tscharner, Vinzenz; Ullrich, Martin; Mohr, Maurice; Marquez, Daniel Comaduran; Nigg, Benno M.			A wavelet based time frequency analysis of electromyograms to group steps of runners into clusters that contain similar muscle activation patterns	PLOS ONE			English	Article							MOTOR-UNIT SYNCHRONIZATION; FIBER CONDUCTION-VELOCITY; MEAN POWER FREQUENCY; SURFACE EMG; ELECTROMECHANICAL DELAY; ISOMETRIC CONTRACTIONS; DYNAMIC CONTRACTIONS; VASTUS LATERALIS; SYNAPTIC INPUT; SPECTRUM	Purpose To wavelet transform the electromyograms of the vastii muscles and generate wavelet intensity patterns (WIP) of runners. Test the hypotheses: 1) The WIP of the vastus medialis (VM) and vastus lateralis (VL) of one step are more similar than the WIPs of these two muscles, offset by one step. 2) The WIPs within one muscle differ by having maximal intensities in specific frequency bands and these intensities are not always occurring at the same time after heel strike. 3) The WIPs that were recorded form one muscle for all steps while running can be grouped into clusters with similar WIPs. It is expected that clusters might have distinctly different, cluster specific mean WIPs. Methods The EMG of the vastii muscles from at least 1000 steps from twelve runners were recorded using a bipolar current amplifier and yielded WIPs. Based on the weights obtained after a principal component analysis the dissimilarities (1-correlation) between the WIPs were computed. The dissimilarities were submitted to a hierarchical cluster analysis to search for groups of steps with similar WIPs. The clusters formed by random surrogate WIPs were used to determine whether the groups were likely to be created in a non-random manner. Results The steps were grouped in clusters showing similar WIPs. The grouping was based on the frequency bands and their timing showing that they represented defining parts of the WIPs. The correlations between the WIPs of the vastii muscles that were recorded during the same step were higher than the correlations of WPIs that were recorded during consecutive steps, indicating the non-randomness of the WIPs. Conclusions The spectral power of EMGs while running varies during the stance phase in time and frequency, therefore a time averaged power spectrum cannot reflect the timing of events that occur while running. It seems likely that there might be a set of predefined patterns that are used upon demand to stabilize the movement.	[von Tscharner, Vinzenz; Ullrich, Martin; Mohr, Maurice; Marquez, Daniel Comaduran; Nigg, Benno M.] Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada	University of Calgary	von Tscharner, V (corresponding author), Univ Calgary, Fac Kinesiol, Human Performance Lab, Calgary, AB, Canada.	tvvon@ucalgary.ca	Mohr, Maurice/AAA-1436-2020; Ullrich, Martin/AAJ-5581-2020	Mohr, Maurice/0000-0003-3726-730X; von Tscharner, Vinzenz/0000-0002-5779-6244	Biomechanigg Sport & Health Research Inc. Calgary; German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes)	Biomechanigg Sport & Health Research Inc. Calgary; German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes)	This project was supported by Biomechanigg Sport & Health Research Inc. Calgary. The funder provided support in the form of salaries for authors [MM, BMN], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. MU was a visiting student from Friedrich Alexander University Erlangen-Nuremberg, Germany, supervised by WT and was supported by the German Academic Scholarship Foundation (Studienstiftung des deutschen Volkes).	ARENDTNIELSEN L, 1985, ELECTROEN CLIN NEURO, V60, P130, DOI 10.1016/0013-4694(85)90019-7; Barandun M, 2009, J ELECTROMYOGR KINES, V19, P65, DOI 10.1016/j.jelekin.2007.07.003; BIGLANDRITCHIE B, 1981, J APPL PHYSIOL, V51, P1300, DOI 10.1152/jappl.1981.51.5.1300; Chen HY, 2012, J ORTHOP SPORT PHYS, V42, P791, DOI 10.2519/jospt.2012.3973; Duchateau J, 2006, J APPL PHYSIOL, V101, P1766, DOI 10.1152/japplphysiol.00543.2006; Farina D, 2004, J APPL PHYSIOL, V96, P1486, DOI 10.1152/japplphysiol.01070.2003; Farina D, 2008, J APPL PHYSIOL, V105, P1683, DOI 10.1152/japplphysiol.91174.2008; Farina D, 2006, EXERC SPORT SCI REV, V34, P121, DOI 10.1249/00003677-200607000-00006; Farina D, 2015, EXERC SPORT SCI REV, V43, P23, DOI 10.1249/JES.0000000000000032; GERDLE B, 1991, ACTA PHYSIOL SCAND, V142, P457, DOI 10.1111/j.1748-1716.1991.tb09180.x; Hermens H, 1999, ROESSINGH RES; Karlsson S, 2001, J ELECTROMYOGR KINES, V11, P131, DOI 10.1016/S1050-6411(00)00046-8; Keenan KG, 2005, J APPL PHYSIOL, V98, P120, DOI 10.1152/japplphysiol.00894.2004; Kudina LP, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00075; Laine CM, 2015, J NEUROSCI, V35, P12207, DOI 10.1523/JNEUROSCI.0240-15.2015; Maurer C, 2013, J ELECTROMYOGR KINES, V23, P673, DOI 10.1016/j.jelekin.2013.01.007; Merletti R, 1997, J ELECTROMYOGR KINES, V7, P241, DOI 10.1016/S1050-6411(97)00010-2; Merlo E, 2005, J NEUROSCI METH, V142, P267, DOI 10.1016/j.jneumeth.2004.09.002; Mohr M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142048; PAN ZS, 1989, MED BIOL ENG COMPUT, V27, P14, DOI 10.1007/BF02442164; Potvin JR, 2004, J ELECTROMYOGR KINES, V14, P389, DOI 10.1016/j.jelekin.2003.10.005; Sacco ICN, 2014, J BIOMECH, V47, P2475, DOI 10.1016/j.jbiomech.2014.04.007; Stirling LM, 2011, J ELECTROMYOGR KINES, V21, P566, DOI 10.1016/j.jelekin.2011.02.005; VANBOXTEL A, 1984, EUR J APPL PHYSIOL O, V52, P207, DOI 10.1007/BF00433394; von Tscharner V, 2000, J ELECTROMYOGR KINES, V10, P433, DOI 10.1016/S1050-6411(00)00030-4; von Tscharner V, 2008, J APPL PHYSIOL, V105, P1671, DOI 10.1152/japplphysiol.90598.2008; von Tscharner V, 2013, J ELECTROMYOGR KINES, V23, P1044, DOI 10.1016/j.jelekin.2013.07.011; von Tscharner V, 2010, J ELECTROMYOGR KINES, V20, P1021, DOI 10.1016/j.jelekin.2010.04.002; VOS EJ, 1990, EUR J APPL PHYSIOL O, V60, P467, DOI 10.1007/BF00705038; Wakeling JM, 2009, J ELECTROMYOGR KINES, V19, P199, DOI 10.1016/j.jelekin.2007.09.006; Wakeling JM, 2004, J EXP BIOL, V207, P2519, DOI 10.1242/jeb.01042; Yao WX, 2000, J NEUROPHYSIOL, V83, P441, DOI 10.1152/jn.2000.83.1.441	32	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195125	10.1371/journal.pone.0195125	http://dx.doi.org/10.1371/journal.pone.0195125			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668731	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200028
J	Pokhoday, M; Scheepers, C; Shtyrov, Y; Myachykov, A				Pokhoday, Mikhail; Scheepers, Christoph; Shtyrov, Yury; Myachykov, Andriy			Motor (but not auditory) attention affects syntactic choice	PLOS ONE			English	Article							VISUAL-SPATIAL ATTENTION; SENTENCE PRODUCTION; STRUCTURAL CHOICE; PARIETAL CORTEX; CUES; INTEGRATION; SALIENCE; LANGUAGE; ENGLISH; TACTILE	Understanding the determinants of syntactic choice in sentence production is a salient topic in psycholinguistics. Existing evidence suggests that syntactic choice results from an interplay between linguistic and non-linguistic factors, and a speaker's attention to the elements of a described event represents one such factor. Whereas multimodal accounts of attention suggest a role for different modalities in this process, existing studies examining attention effects in syntactic choice are primarily based on visual cueing paradigms. Hence, it remains unclear whether attentional effects on syntactic choice are limited to the visual modality or are indeed more general. This issue is addressed by the current study. Native English participants viewed and described line drawings of simple transitive events while their attention was directed to the location of the agent or the patient of the depicted event by means of either an auditory (monaural beep) or a motor (unilateral key press) lateral cue. Our results show an effect of cue location, with participants producing more passive-voice descriptions in the patient-cued conditions. Crucially, this cue location effect emerged in the motor-cue but not (or substantially less so) in the auditory-cue condition, as confirmed by a reliable interaction between cue location (agent vs. patient) and cue type (auditory vs. motor). Our data suggest that attentional effects on the speaker's syntactic choices are modality-specific and limited to the visual and motor, but not the auditory, domain.	[Pokhoday, Mikhail; Shtyrov, Yury; Myachykov, Andriy] Natl Res Univ, Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia; [Scheepers, Christoph] Univ Glasgow, Inst Neurosci & Psychol, Glasgow, Lanark, Scotland; [Shtyrov, Yury] Aarhus Univ, CFIN, Dept Clin Med, Aarhus, Denmark; [Myachykov, Andriy] Northumbria Univ, Dept Psychol, Newcastle Upon Tyne, Tyne & Wear, England	HSE University (National Research University Higher School of Economics); University of Glasgow; Aarhus University; Northumbria University	Pokhoday, M (corresponding author), Natl Res Univ, Higher Sch Econ, Ctr Cognit & Decis Making, Moscow, Russia.	mpokhoday@hse.ru	Pokhoday, Mikhail Y/K-3351-2015; Shtyrov, Yury/ABI-2266-2020; Myachykov, Andriy/ABA-7129-2020; Pokhoday, Mikhail/M-7482-2019	Pokhoday, Mikhail Y/0000-0002-9688-7704; Shtyrov, Yury/0000-0001-7203-4902; Pokhoday, Mikhail/0000-0002-9688-7704	Russian Academic Excellence Project '5-100'	Russian Academic Excellence Project '5-100'(Ministry of Education and Science, Russian FederationProject 5-100, Ministry of Education and Science, Russian Federation)	The article was prepared within the framework of the Basic Research Program at the National Research University Higher School of Economics (HSE) and supported within the framework of a subsidy by the Russian Academic Excellence Project '5-100'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anton-Mendez I, 2017, APPL PSYCHOLINGUIST, V38, P601, DOI 10.1017/S0142716416000345; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Caffarra S, 2013, COGN NEUROSCI-UK, V4, P217, DOI 10.1080/17588928.2013.823392; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; FERREIRA F, 1994, J MEM LANG, V33, P715, DOI 10.1006/jmla.1994.1034; Garagnani M, 2008, EUR J NEUROSCI, V27, P492, DOI 10.1111/j.1460-9568.2008.06015.x; Giard MH, 1999, J COGNITIVE NEUROSCI, V11, P473, DOI 10.1162/089892999563544; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; GOLDBERG ME, 1987, NEUROPSYCHOLOGIA, V25, P107, DOI 10.1016/0028-3932(87)90047-9; Hilgetag CC, 2001, NAT NEUROSCI, V4, P953, DOI 10.1038/nn0901-953; Ho C, 2006, COMPUT HUM BEHAV, V22, P733, DOI 10.1016/j.chb.2005.12.008; Ho C, 2005, TRANSPORT RES F-TRAF, V8, P397, DOI 10.1016/j.trf.2005.05.002; Ho C, 2006, ACCIDENT ANAL PREV, V38, P988, DOI 10.1016/j.aap.2006.04.002; Hwang H, 22 CUNY C SENT PROC; Hwang H, 2015, J MEM LANG, V84, P190, DOI 10.1016/j.jml.2015.06.004; Iacoboni M, 2006, NEUROPSYCHOLOGIA, V44, P2691, DOI 10.1016/j.neuropsychologia.2006.04.029; Ibbotson P, 2013, COGN LINGUIST, V24, P457, DOI 10.1515/cog-2013-0020; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Iwabuchi T, 2013, NEUROREPORT, V24, P298, DOI 10.1097/WNR.0b013e32835f8826; Koelewijn T, 2010, ACTA PSYCHOL, V134, P372, DOI 10.1016/j.actpsy.2010.03.010; Kong LQ, 2014, CEREB CORTEX, V24, P773, DOI 10.1093/cercor/bhs359; Kostov K, 2012, COGN PROCESS, V13, pS215, DOI 10.1007/s10339-012-0452-1; Rayleigh,, 1907, PHILOS MAG, V13, P214, DOI 10.1080/14786440709463595; Macaluso E, 2000, SCIENCE, V289, P1206, DOI 10.1126/science.289.5482.1206; Molholm S, 2002, COGNITIVE BRAIN RES, V14, P115, DOI 10.1016/S0926-6410(02)00066-6; Montag JL, CHOICE REFERRING EXP; Myachykov A, 2018, DISCOURSE PROCESS, V55, P218, DOI 10.1080/0163853X.2017.1330044; Myachykov A, 2008, J COGN SCI, V9, P31; Myachykov A, 2012, ACTA PSYCHOL, V141, P304, DOI 10.1016/j.actpsy.2012.09.006; Myachykov A, 2011, LANG LINGUIST COMPAS, V5, P95, DOI 10.1111/j.1749-818x.2010.00265.x; Posner M.I., 1978, CHRONOMETRIC EXPLORA; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Roland D, 2007, J MEM LANG, V57, P348, DOI 10.1016/j.jml.2007.03.002; Rommers J, 2017, NEUROPSYCHOLOGIA, V95, P101, DOI 10.1016/j.neuropsychologia.2016.12.013; Rushworth MFS, 2001, NAT NEUROSCI, V4, P656, DOI 10.1038/88492; Santangelo V, 2007, J EXP PSYCHOL HUMAN, V33, P1311, DOI 10.1037/0096-1523.33.6.1311; Scott JJ, 2008, HUM FACTORS, V50, P264, DOI 10.1518/001872008X250674; Shinn-Cunningham BG, 2008, TRENDS COGN SCI, V12, P182, DOI 10.1016/j.tics.2008.02.003; Spence C, 2001, EXP BRAIN RES, V141, P324, DOI 10.1007/s002210100883; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Spence C, 2009, HEARING RES, V258, P134, DOI 10.1016/j.heares.2009.04.015; SPENCE CJ, 1994, J EXP PSYCHOL HUMAN, V20, P555, DOI 10.1037/0096-1523.20.3.555; Talsma D, 2010, TRENDS COGN SCI, V14, P400, DOI 10.1016/j.tics.2010.06.008; Tomlin R. S., 1997, LANGUAGE CONCEPTUALI, P162, DOI DOI 10.1017/CBO9781139086677.007; Tomlin R. S., 1995, WORD ORDER DISCOURSE, P517, DOI [DOI 10.1075/TS1.30.18TOM, 10.1075/TSL.30.18TOM, DOI 10.1075/TSL.30.18TOM]; Tomlin RS, 2015, HANDB SPRACH KOMMUN, V39, P31; Yates MJ, 2009, ATTEN PERCEPT PSYCHO, V71, P847, DOI 10.3758/APP.71.4.847	47	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195547	10.1371/journal.pone.0195547	http://dx.doi.org/10.1371/journal.pone.0195547			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659592	gold, Green Accepted, Green Published, Green Submitted			2022-12-26	WOS:000430061100021
J	Ab Rahman, SK; Yusof, NA; Abdullah, AH; Mohammad, F; Idris, A; Al-Lohedan, HA				Ab Rahman, Siti Khadijah; Yusof, Nor Azah; Abdullah, Abdul Halim; Mohammad, Faruq; Idris, Azni; Al-Lohedan, Hamad A.			Evaluation of porogen factors for the preparation of ion imprinted polymer monoliths used in mercury removal	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; CAPILLARY COLUMN; PRECONCENTRATION; RECOGNITION; SEPARATION; SAMPLES	In the present study, ion imprinted polymer monoliths (IIPMs) were developed to overcome the limitations of ion imprinted polymer particles (IIPPs) used for the removal of Hg(II) ions from waste water samples. The adsorbents preparation, characterization and Hg(II) removal were very well reported. The IIPMs on porogen optimization was prepared using the molding technique with Hg(II) as a template ion, [2-(methacryloyloxy)ethyl]trimethylammonium cysteine (MAETC) as ligand, methacrylic acid (MAA) as functional monomer, ethylene glycol dimethacrylamide (EGDMA) as cross-linker, benzoyl peroxide as an initiator and methanol and acetonitrile as porogen in the polypropylene tube (drinking straw) as mold. The IIPMs prepared with higher volumes of porogen were indicated to have a good adsorption rate for the Hg(II) removal along with good water permeability and larger porosity as compared to a lower volume of porogen. The IIPMs prepared using the binary porogen were able to improve the porosity and surface area of the monolithic polymers as compared to the single porogen added IIPMs. Finally, we indicate from our analysis that the IIPM having the efficient capacity for the Hg(II) ions is easy to prepare, and has higher water permeability along with high porosity and high adsorption capacity and all these factors making it one of the suitable adsorbent for the successful removal of Hg(II) ions.	[Ab Rahman, Siti Khadijah; Yusof, Nor Azah; Abdullah, Abdul Halim] Univ Putra Malaysia, Dept Chem, Fac Sci, Serdang, Selangor, Malaysia; [Yusof, Nor Azah; Abdullah, Abdul Halim] Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia; [Mohammad, Faruq; Al-Lohedan, Hamad A.] King Saud Univ, Dept Chem, Coll Sci, Surfactant Res, Riyadh, Saudi Arabia; [Idris, Azni] Univ Putra Malaysia, Chem Engn & Environm Dept, Fac Engn, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; King Saud University; Universiti Putra Malaysia	Yusof, NA (corresponding author), Univ Putra Malaysia, Dept Chem, Fac Sci, Serdang, Selangor, Malaysia.; Yusof, NA (corresponding author), Univ Putra Malaysia, Inst Adv Technol, Serdang, Selangor, Malaysia.; Mohammad, F (corresponding author), King Saud Univ, Dept Chem, Coll Sci, Surfactant Res, Riyadh, Saudi Arabia.	azahy@upm.edu.my; fmohammad@ksu.edu.sa	Ab Rahman, Siti Khadijah/AAM-2268-2021; Mohammad, Faruq/F-9654-2019	Ab Rahman, Siti Khadijah/0000-0003-2490-6176; Mohammad, Faruq/0000-0002-9318-9986; Yusof, Nor Azah/0000-0002-1400-5764	Ministry of Higher Education (MOHE); Deanship of Scientific Research, King Saud University	Ministry of Higher Education (MOHE)(Ministry of Higher Education & Scientific Research (MHESR)); Deanship of Scientific Research, King Saud University(King Saud University)	The authors (SKAR, NAY, AHA, and Al) acknowledge the Ministry of Higher Education (MOHE) for the financial support in the form of Prototype Research Grant Scheme (PRGS) and My Brain 15. Also, Drs. FM and HAAL are grateful to the Deanship of Scientific Research, King Saud University for funding through Vice Deanship of Scientific Research Chairs program.	Alizadeh T, 2011, ANAL CHIM ACTA, V689, P52, DOI 10.1016/j.aca.2011.01.036; Asanuma H, 2004, J INCL PHENOM MACRO, V50, P51, DOI 10.1007/10.1007/s10847-003-8838-4; Dakova I, 2009, TALANTA, V78, P523, DOI 10.1016/j.talanta.2008.12.005; Deng QL, 2011, CHINESE CHEM LETT, V22, P1351, DOI 10.1016/j.cclet.2011.05.044; Hu YL, 2013, TRAC-TREND ANAL CHEM, V43, P37, DOI 10.1016/j.trac.2012.08.014; Jin YF, 2013, J CHEM-NY, V2013, DOI 10.1155/2013/903210; Lin ZA, 2013, J CHROMATOGR A, V1284, P8, DOI 10.1016/j.chroma.2013.02.042; Liu YW, 2005, ANAL CHIM ACTA, V538, P85, DOI 10.1016/j.aca.2005.02.017; Lohani MB, 2008, J HAZARD MATER, V159, P626, DOI 10.1016/j.jhazmat.2008.02.072; Mane S., 2016, CAN CHEM T, V4, P210, DOI DOI 10.13179/canchemtrans.2016.04.02.0304; Mondal D.K., 2013, J ENVIRON CHEM ENG, V1, P891, DOI [10.1016/j.jece.2013.07.034, DOI 10.1016/J.JECE.2013.07.034]; Mu LN, 2011, J CHROMATOGR A, V1218, P9236, DOI 10.1016/j.chroma.2011.10.079; Singh DK, 2010, DESALINATION, V257, P177, DOI 10.1016/j.desal.2010.02.026; Sun XL, 2009, TALANTA, V79, P926, DOI 10.1016/j.talanta.2009.05.033; Tan J, 2012, TRAC-TREND ANAL CHEM, V39, P207, DOI 10.1016/j.trac.2012.05.009; Xie XY, 2016, REV ANAL CHEM, V35, P87, DOI 10.1515/revac-2016-0005; Yang JJ, 2015, ANAL CHIM ACTA, V872, P35, DOI 10.1016/j.aca.2015.02.058; Zhai HY, 2015, ANAL CHIM ACTA, V865, P16, DOI 10.1016/j.aca.2015.01.028	18	9	9	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195546	10.1371/journal.pone.0195546	http://dx.doi.org/10.1371/journal.pone.0195546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649325	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900053
J	Lorenz, MW; Gao, L; Ziegelbauer, K; Norata, GD; Empana, JP; Schmidtmann, I; Lin, HJ; McLachlan, S; Bokemark, L; Ronkainen, K; Amato, M; Schminke, U; Srinivasan, SR; Lind, L; Okazaki, S; Stehouwer, CDA; Willeit, P; Polak, JF; Steinmetz, H; Sander, D; Poppert, H; Desvarieux, M; Ikram, MA; Johnsen, SH; Staub, D; Sirtori, CR; Igiseder, B; Beloqui, O; Engstrom, G; Friera, A; Rozza, F; Xie, WX; Parraga, G; Grigore, L; Plichart, M; Blankenberg, S; Su, TC; Schmidt, C; Tuomainen, TP; Veglia, F; Volzke, H; Nijpels, G; Willeit, J; Sacco, RL; Franco, OH; Uthoff, H; Hedblad, B; Suarez, C; Izzo, R; Zhao, D; Wannarong, T; Catapano, A; Ducimetiere, P; Espinola-Klein, C; Chien, KL; Price, JF; Bergstrom, G; Kauhanen, J; Tremoli, E; Dorr, M; Berenson, G; Kitagawa, K; Dekker, JM; Kiechl, S; Sitzer, M; Bickel, H; Rundek, T; Hofman, A; Mathiesen, EB; Castelnuovo, S; Landecho, MF; Rosvall, M; Gabriel, R; de Luca, N; Liu, J; Baldassarre, D; Kavousi, M; de Groot, E; Bots, ML; Yanez, DN; Thompson, SG				Lorenz, Matthias W.; Gao, Lu; Ziegelbauer, Kathrin; Norata, Giuseppe Danilo; Empana, Jean Philippe; Schmidtmann, Irene; Lin, Hung-Ju; McLachlan, Stela; Bokemark, Lena; Ronkainen, Kimmo; Amato, Mauro; Schminke, Ulf; Srinivasan, Sathanur R.; Lind, Lars; Okazaki, Shuhei; Stehouwer, Coen D. A.; Willeit, Peter; Polak, Joseph F.; Steinmetz, Helmuth; Sander, Dirk; Poppert, Holger; Desvarieux, Moise; Ikram, M. Arfan; Johnsen, Stein Harald; Staub, Daniel; Sirtori, Cesare R.; Igiseder, Bernhard; Beloqui, Oscar; Engstrom, Gunnar; Friera, Alfonso; Rozza, Francesco; Xie, Wuxiang; Parraga, Grace; Grigore, Liliana; Plichart, Matthieu; Blankenberg, Stefan; Su, Ta-Chen; Schmidt, Caroline; Tuomainen, Tomi-Pekka; Veglia, Fabrizio; Voelzke, Henry; Nijpels, Giel; Willeit, Johann; Sacco, Ralph L.; Franco, Oscar H.; Uthoff, Heiko; Hedblad, Bo; Suarez, Carmen; Izzo, Raffaele; Zhao, Dong; Wannarong, Thapat; Catapano, Alberico; Ducimetiere, Pierre; Espinola-Klein, Christine; Chien, Kuo-Liong; Price, Jackie F.; Bergstrom, Goren; Kauhanen, Jussi; Tremoli, Elena; Doerr, Marcus; Berenson, Gerald; Kitagawa, Kazuo; Dekker, Jacqueline M.; Kiechl, Stefan; Sitzer, Matthias; Bickel, Horst; Rundek, Tatjana; Hofman, Albert; Mathiesen, Ellisiv B.; Castelnuovo, Samuela; Landecho, Manuel F.; Rosvall, Maria; Gabriel, Rafael; de Luca, Nicola; Liu, Jing; Baldassarre, Damiano; Kavousi, Maryam; de Groot, Eric; Bots, Michiel L.; Yanez, David N.; Thompson, Simon G.		PROG-IMT Study Grp	Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration	PLOS ONE			English	Article							ARTERY INTIMA; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; FOLLOW-UP; METABOLIC SYNDROME; HYPERTENSIVE MEN; VASCULAR RISK; PROGRESSION; POPULATION; DISEASE	Aims Carotid intima media thickness (CIMT) predicts cardiovascular (CVD) events, but the predictive value of CIMT change is debated. We assessed the relation between CIMT change and events in individuals at high cardiovascular risk. Methods and results From 31 cohorts with two CIMT scans (total n = 89070) on average 3.6 years apart and clinical follow-up, subcohorts were drawn: (A) individuals with at least 3 cardiovascular risk factors without previous CVD events, (B) individuals with carotid plaques without previous CVD events, and (C) individuals with previous CVD events. Cox regression models were fit to estimate the hazard ratio (HR) of the combined endpoint (myocardial infarction, stroke or vascular death) per standard deviation (SD) of CIMT change, adjusted for CVD risk factors. These HRs were pooled across studies. In groups A, B and C we observed 3483, 2845 and 1165 endpoint events, respectively. Average common CIMT was 0.79mm (SD 0.16mm), and annual common CIMT change was 0.01mm (SD 0.07mm), both in group A. The pooled HR per SD of annual common CIMT change (0.02 to 0.43mm) was 0.99 (95% confidence interval: 0.95-1.02) in group A, 0.98 (0.93-1.04) in group B, and 0.95 (0.89-1.04) in group C. The HR per SD of common CIMT (average of the first and the second CIMT scan, 0.09 to 0.75mm) was 1.15 (1.07-1.23) in group A, 1.13 (1.05-1.22) in group B, and 1.12 (1.05-1.20) in group C. Conclusions We confirm that common CIMT is associated with future CVD events in individuals at high risk. CIMT change does not relate to future event risk in high-risk individuals.	[Lorenz, Matthias W.; Ziegelbauer, Kathrin; Steinmetz, Helmuth] Goethe Univ, Dept Neurol, Frankfurt, Germany; [Gao, Lu] Univ Forvie Site, MRC, Biostat Unit, Inst Publ Hlth, Cambridge, England; [Norata, Giuseppe Danilo; Tremoli, Elena; Baldassarre, Damiano] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Norata, Giuseppe Danilo] Bassini Hosp, SISA Ctr Study Atherosclerosis, Cinisello Balsamo, Italy; [Empana, Jean Philippe] Univ Paris 05, Sorbonne Paris Cite, UMR, Paris Cardiovasc Res Ctr PARCC, Paris, France; [Schmidtmann, Irene] Univ Med Mainz, IMBEI, Mainz, Germany; [Lin, Hung-Ju; Su, Ta-Chen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei, Taiwan; [McLachlan, Stela; Price, Jackie F.] Univ Edinburgh, Usher Inst Populat Hlth Sci & Informat, Edinburgh, Midlothian, Scotland; [Bokemark, Lena] Gothenburg Univ, Sahlgrenska Acad, Dept Mol & Clin Med, Wallenberg Lab Cardiovasc Res,Inst Medicin, Gothenburg, Sweden; [Ronkainen, Kimmo; Tuomainen, Tomi-Pekka; Kauhanen, Jussi] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio Campus, Kuopio, Finland; [Amato, Mauro; Veglia, Fabrizio; Tremoli, Elena; Baldassarre, Damiano] IRCCS, Ctr Cardiol Monzino, Milan, Italy; [Schminke, Ulf] Greifswald Univ Clin, Dept Neurol, Greifswald, Germany; [Srinivasan, Sathanur R.] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Cardiovasc Hlth, Dept Epidemiol,Biochem, New Orleans, LA USA; [Lind, Lars] Uppsala Univ, Dept Med, Uppsala, Sweden; [Okazaki, Shuhei] Osaka Univ, Grad Sch Med, Dept Neurol, Osaka, Japan; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Dept Internal Med, Maastricht, Netherlands; [Stehouwer, Coen D. A.] Maastricht Univ, Med Ctr, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Willeit, Peter; Willeit, Johann; Kiechl, Stefan] Med Univ Innsbruck, Dept Neurol, Innsbruck, Austria; [Willeit, Peter; Thompson, Simon G.] Univ Cambridge, Sch Clin Med, Dept Publ Hlth & Primary Care, Cambridge, England; [Polak, Joseph F.] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA; [Sander, Dirk] Benedictus Hosp Tutzing & Feldafing, Dept Neurol, Feldafing, Germany; [Poppert, Holger] Tech Univ Munich, Dept Neurol, Munich, Germany; [Desvarieux, Moise] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Ikram, M. Arfan; Hofman, Albert] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan] Erasmus Univ, Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Johnsen, Stein Harald; Mathiesen, Ellisiv B.] Uit, Dept Clin Med, Tromso, Norway; [Johnsen, Stein Harald] Univ Hosp Northern Norway, Dept Neurol, Tromso, Norway; [Staub, Daniel; Uthoff, Heiko] Univ Basel Hosp, Dept Angiol, Basel, Switzerland; [Sirtori, Cesare R.; Castelnuovo, Samuela] Osped Niguarda Ca Granda, Ctr Dyslipidemias, Milan, Italy; [Igiseder, Bernhard] Parcelsus Med Univ, Salzburg, Austria; [Igiseder, Bernhard] Gemeinnutzige Salzburger Landeskliniken Betriebsg, Doppler Klin, Dept Geriatr Med, Salzburg, Austria; [Beloqui, Oscar; Landecho, Manuel F.] Univ Navarra Clin, Dept Internal Med, Navarra, Spain; [Engstrom, Gunnar; Hedblad, Bo] Lund Univ, Dept Clin Sci, Malmo, Sweden; [Friera, Alfonso] Univ Autonoma Madrid, Hosp Univ La Princesa, Dept Radiol, Madrid, Spain; [Rozza, Francesco; Izzo, Raffaele; de Luca, Nicola] Univ Naples Federico II, Sch Med, Naples, Italy; [Xie, Wuxiang; Zhao, Dong; Liu, Jing] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Dept Epidemiol, Beijing, Peoples R China; [Parraga, Grace] Western Univ, Roberts Res Inst, London, ON, Canada; [Grigore, Liliana] Bassini Hosp, Ctr Sisa Studio Aterosclerosi, Cinisello Balsamo, Italy; [Plichart, Matthieu] Hop Broca, AP HP, Paris, France; [Blankenberg, Stefan] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany; [Blankenberg, Stefan] Univ Hosp Hamburg Eppendorf, Dept Cardiol, Hamburg, Germany; [Schmidt, Caroline] Univ Gothenburg, Wallenberg Lab Cardiovasc Res, Gothenburg, Sweden; [Voelzke, Henry] German Ctr Cardiovasc Res DZHK, Partner Site Greifswald, Greifswald, Germany; [Voelzke, Henry] Inst Community Med, SHIP Clin Epidemiol Res, Greifswald, Germany; [Nijpels, Giel] Vrije Univ Amsterdam, Dept Gen Practice, Medial Ctr, Amsterdam, Netherlands; [Nijpels, Giel] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Amsterdam, Netherlands; [Sacco, Ralph L.; Rundek, Tatjana] Univ Miami, Miller Sch Med, Dept Neurol, Miami, FL 33136 USA; [Franco, Oscar H.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Suarez, Carmen] Univ Autonoma Madrid, Hosp Univ La Princesa, Dept Internal Med, Madrid, Spain; [Wannarong, Thapat] Western Univ, Stroke Prevent & Atherosclerosis Res Ctr, Roberts Res Inst, London, ON, Canada; [Wannarong, Thapat] Mahidol Univ, Dept Internal Med, Fac Med, Siriraj Hosp, Bangkok, Thailand; [Catapano, Alberico] IRCSS Multimed, Milan, Italy; [Catapano, Alberico] Univ Milan, Dept Pharmacol & Biomol Sci, Milan, Italy; [Ducimetiere, Pierre] Univ Paris Sud Xi, Le Kremlin Bicetre, France; [Espinola-Klein, Christine] Johannes Gutenberg Univ Mainz, Dept Med 2, Mainz, Germany; [Chien, Kuo-Liong] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei, Taiwan; [Bergstrom, Goren] Gothenburg Univ, Wallenberg Lab Cardiovasc Res, Sahlgrenska Acad, Gotheborg, Sweden; [Doerr, Marcus] Univ Med Greifswald, Dept Internal Med B, Greifswald, Germany; [Berenson, Gerald] Tulane Univ, Sch Med, Dept Med, Pediat,Biochem,Epidemiol, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Berenson, Gerald] Sch Publ Hlth & Trop Med, New Orleans, LA USA; [Kitagawa, Kazuo] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan; [Dekker, Jacqueline M.] Vrije Univ Amsterdam, Med Ctr, EMGO Inst Hlth & Care Res, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Sitzer, Matthias] Klinikum Herford, Dept Neuol, Herford, Germany; [Bickel, Horst] Tech Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany; [Rosvall, Maria] Lund Univ, Dept Clin Sci Malmo, Malmo, Sweden; [Gabriel, Rafael] Inst Salud Carlos III, Escuela Natl Sanidad, Madrid, Spain; [Kavousi, Maryam] Erasmus MC, Dept Epidemiol & Biostat, Rotterdam, Netherlands; [de Groot, Eric] Imagelabonline & Cardiovasc, Eindhoven, Netherlands; [de Groot, Eric] Imagelabonline & Cardiovasc, Lunteren, Netherlands; [de Groot, Eric] Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands; [Bots, Michiel L.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Yanez, David N.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA	Goethe University Frankfurt; MRC Biostatistics Unit; University of Cambridge; University of Milan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Johannes Gutenberg University of Mainz; National Taiwan University; National Taiwan University Hospital; University of Edinburgh; University of Gothenburg; University of Eastern Finland; IRCCS Centro Cardiologico Monzino; Tulane University; Uppsala University; Osaka University; Maastricht University; Maastricht University; Medical University of Innsbruck; University of Cambridge; Tufts Medical Center; Tufts University; Technical University of Munich; Columbia University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Basel; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda; Paracelsus Private Medical University; University of Navarra; Lund University; Autonomous University of Madrid; University of Naples Federico II; Capital Medical University; Western University (University of Western Ontario); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite; Johannes Gutenberg University of Mainz; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Gothenburg; German Centre for Cardiovascular Research; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; University of Miami; Erasmus University Rotterdam; Erasmus MC; Autonomous University of Madrid; Western University (University of Western Ontario); Mahidol University; University of Milan; UDICE-French Research Universities; Universite Paris Saclay; Johannes Gutenberg University of Mainz; National Taiwan University; University of Gothenburg; Greifswald Medical School; Tulane University; Tokyo Women's Medical University; Vrije Universiteit Amsterdam; Ruhr University Bochum; Technical University of Munich; University of Munich; Lund University; Instituto de Salud Carlos III; Erasmus University Rotterdam; Erasmus MC; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; University of Washington; University of Washington Seattle	Lorenz, MW (corresponding author), Goethe Univ, Dept Neurol, Frankfurt, Germany.	matthias.lorenz@em.uni-frankfurt.de	Zhao, D/AAX-5040-2021; Franco, Óscar H/ABE-2305-2020; Liu, Jing/AAH-8079-2021; Amato, Mauro/J-3289-2016; Kauhanen, Jussi/ABC-4064-2021; Stehouwer, Coen/AAB-3435-2021; Desvarieux, Moise/C-4991-2019; Xie, Wuxiang/GYU-3990-2022; Willeit, Peter/HCI-7091-2022; Ikram, M. Arfan/AAM-5225-2021; Norata, Giuseppe Danilo/AAC-2863-2019; Dörr, Marcus/F-1919-2010; Parraga, Grace/K-6465-2013; Empana, Jean-Philippe/AAF-6923-2021; AMATO, Mauro/N-2058-2019; Catapano, alberico/AAC-2827-2019; Sacco, Ralph/Y-9278-2019; Kavousi, Maryam/F-1174-2018; TREMOLI, ELENA/I-8126-2018; Izzo, Raffaele/G-4892-2011; Baldassarre, Damiano/J-3295-2016	Franco, Óscar H/0000-0002-4606-4929; Liu, Jing/0000-0002-3311-0818; Amato, Mauro/0000-0002-0118-5719; Willeit, Peter/0000-0002-1866-7159; Dörr, Marcus/0000-0001-7471-475X; Empana, Jean-Philippe/0000-0002-1469-7772; Catapano, alberico/0000-0002-7593-2094; Kavousi, Maryam/0000-0001-5976-6519; Norata, Giuseppe Danilo/0000-0002-6081-1257; Uthoff, Heiko/0000-0003-4787-5659; Nijpels, Giel/0000-0002-3679-9710; Poppert, Holger/0000-0003-2189-7681; Bergstrom, Goran/0000-0003-4289-5722; TREMOLI, ELENA/0000-0002-0929-6106; SU, TA-CHEN/0000-0001-7523-7166; Izzo, Raffaele/0000-0002-0308-2836; Baldassarre, Damiano/0000-0002-2766-8882; Price, Jackie/0000-0003-3251-3970; Stehouwer, Coen/0000-0001-8752-3223; Blankenberg, Stefan/0000-0001-6488-2362; WANNARONG, THAPAT/0000-0003-1839-1903	German Research Foundation (Deutsche Forschungsgemeinschaft) [DFG Lo 1569/2-1, DFG Lo 1569/2-3]; British heart Foundation [CH/12/2/29428]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC015103, N01HC035129, N01HC045133] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013094] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS029993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020098, R01AG015928, R01AG027058, R56AG023629, R01AG023629, R01AG020098] Funding Source: NIH RePORTER; MRC [MR/L003120/1] Funding Source: UKRI	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); British heart Foundation(British Heart Foundation); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The PROG-IMT project, which includes this publication, has been funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, www.dfg.de) under the grants DFG Lo 1569/2-1 and DFG Lo 1569/2-3, received by MWL. The DFG had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Simon Thompson is supported by the British heart Foundation (CH/12/2/29428). Some of the contributing studies were funded by different parties, as listed in the acknowledgement section. Here, too, the funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agewall S, 2001, J INTERN MED, V249, P305, DOI 10.1046/j.1365-2796.2001.00818.x; Baldassarre D, 2000, STROKE, V31, P2426, DOI 10.1161/01.STR.31.10.2426; Baldassarre D, 2010, EUR HEART J, V31, P614, DOI 10.1093/eurheartj/ehp496; Behre CJ, 2006, J INTERN MED, V260, P238, DOI 10.1111/j.1365-2796.2006.01683.x; Beller GA, 2009, J NUCL CARDIOL, V16, P681, DOI 10.1007/s12350-009-9139-0; BonithonKopp C, 1996, ARTERIOSCL THROM VAS, V16, P310, DOI 10.1161/01.ATV.16.2.310; BonithonKopp C, 1996, STROKE, V27, P654, DOI 10.1161/01.STR.27.4.654; Bots ML, 2006, CURR MED RES OPIN, V22, P2181, DOI 10.1185/030079906X148472; Bots ML, 1997, STROKE, V28, P2442, DOI 10.1161/01.STR.28.12.2442; Chambless LE, 1997, AM J EPIDEMIOL, V146, P483, DOI 10.1093/oxfordjournals.aje.a009302; Costanzo P, 2010, J AM COLL CARDIOL, V56, P2006, DOI 10.1016/j.jacc.2010.05.059; CROUSE JR, 1994, STROKE, V25, P1354, DOI 10.1161/01.STR.25.7.1354; del Sol AI, 2002, EUR HEART J, V23, P934, DOI 10.1053/euhj.2001.2965; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Espinola-Klein C, 2000, STROKE, V31, P2127, DOI 10.1161/01.STR.31.9.2127; Fagerberg B, 1998, AM J HYPERTENS, V11, P14, DOI 10.1016/S0895-7061(97)00363-4; Falk E, 2011, CURR ATHEROSCLER REP, V13, P345, DOI 10.1007/s11883-011-0195-y; Gabriel R, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-360; GLAGOV S, 1988, ARCH PATHOL LAB MED, V112, P1018; Goldberger ZD, 2010, AM HEART J, V160, P701, DOI 10.1016/j.ahj.2010.06.029; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Johnsen Stein Harald, 2009, Curr Cardiol Rep, V11, P21; Kiechl S, 2001, CIRCULATION, V103, P1064, DOI 10.1161/01.CIR.103.8.1064; Kiechl S, 1999, ARTERIOSCL THROM VAS, V19, P1484, DOI 10.1161/01.ATV.19.6.1484; Kitagawa K, 2007, CEREBROVASC DIS, V24, P35, DOI 10.1159/000103114; Landecho MF, 2011, REV ESP CARDIOL, V64, P373, DOI 10.1016/j.recesp.2010.11.011; Lembo G, 2001, STROKE, V32, P735, DOI 10.1161/01.STR.32.3.735; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Li SX, 2003, JAMA-J AM MED ASSOC, V290, P2271, DOI 10.1001/jama.290.17.2271; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lloyd KD, 2012, INT J VASC MED, V2012, DOI 10.1155/2012/169323; Lorenz MW, 2012, LANCET, V379, P2053, DOI 10.1016/S0140-6736(12)60441-3; Lorenz MW, 2010, AM HEART J, V159, P730, DOI 10.1016/j.ahj.2010.02.008; Lorenz MW, 2006, STROKE, V37, P87, DOI 10.1161/01.STR.0000196964.24024.ea; Lynch J, 1997, ARTERIOSCL THROM VAS, V17, P513, DOI 10.1161/01.ATV.17.3.513; Norata GD, 2006, STROKE, V37, P1558, DOI 10.1161/01.STR.0000221803.16897.22; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Rodriguez-Macias KA, 2006, ATHEROSCLEROSIS, V189, P393, DOI 10.1016/j.atherosclerosis.2006.02.020; Rosvall M, 2005, J INTERN MED, V257, P430, DOI 10.1111/j.1365-2796.2005.01485.x; Rundek T, 2008, NEUROLOGY, V70, P1200, DOI 10.1212/01.wnl.0000303969.63165.34; Sander D, 2000, CIRCULATION, V102, P1536, DOI 10.1161/01.CIR.102.13.1536; Schmidt C, 2003, J INTERN MED, V253, P430, DOI 10.1046/j.1365-2796.2003.01129.x; Sitzer M, 2003, STROKE, V34, P950, DOI 10.1161/01.STR.0000060895.38298.C4; Sourij H, 2008, STROKE, V39, P1349, DOI 10.1161/STROKEAHA.107.502799; Spijkerman AMW, 2004, J INTERN MED, V256, P429, DOI 10.1111/j.1365-2796.2004.01395.x; Staub D, 2006, STROKE, V37, P800, DOI 10.1161/01.STR.0000202589.47401.c6; Stensland-Bugge E, 2000, STROKE, V31, P574, DOI 10.1161/01.STR.31.3.574; Su TC, 2001, STROKE, V32, P2265, DOI 10.1161/str.32.10.2265; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; von Sarnowski B, 2010, STROKE, V41, P2375, DOI 10.1161/STROKEAHA.110.593244; Wallenfeldt K, 2004, STROKE, V35, P2248, DOI 10.1161/01.STR.0000140629.65145.3c; Wannarong T, 2013, STROKE, V44, P1859, DOI 10.1161/STROKEAHA.113.001461	53	45	47	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0191172	10.1371/journal.pone.0191172	http://dx.doi.org/10.1371/journal.pone.0191172			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649236	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900002
J	Ortega, JL; Rajapakse, W; Bagga, S; Apodaca, K; Lucero, Y; Sengupta-Gopalan, C				Ortega, Jose Luis; Rajapakse, Wathsala; Bagga, Suman; Apodaca, Kimberly; Lucero, Yvonne; Sengupta-Gopalan, Champa			An intragenic approach to confer glyphosate resistance in chile (Capsicum annuum) by introducing an in vitro mutagenized chile EPSPS gene encoding for a glyphosate resistant EPSPS protein	PLOS ONE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; ESCHERICHIA-COLI; HERBICIDE GLYPHOSATE; TRANSGENIC TOBACCO; PROVIDES INSIGHTS; STRUCTURAL BASIS; EVOLUTION; PLANTS; SUBSTITUTION	Chile pepper (Capsicum annuum) is an important high valued crop worldwide, and when grown on a large scale has problems with weeds. One important herbicide used is glyphosate. Glyphosate inactivates the enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS), a key enzyme in the synthesis of aromatic amino acids. A transgenic approach towards making glyphosate resistant plants, entails introducing copies of a gene encoding for glyphosate-resistant EPSPS enzyme into the plant. The main objective of our work was to use an intragenic approach to confer resistance to glyphosate in chile which would require using only chile genes for transformation including the selectable marker. Tobacco was used as the transgenic system to identify different gene constructs that would allow for the development of the intragenic system for chile, since chile transformation is inefficient. An EPSPS gene was isolated from chile and mutagenized to introduce substitutions that are known to make the encoded enzyme resistant to glyphosate. The promoter for EPSPS gene was isolated from chile and the mutagenized chile EPSPS cDNA was engineered behind both the CaMV35S promoter and the EPSPS promoter. The leaves from the transformants were checked for resistance to glyphosate using a cut leaf assay. In tobacco, though both gene constructs exhibited some degree of resistance to glyphosate, the construct with the CaMV35S promoter was more effective and as such chile was transformed with this gene construct. The chile transformants showed resistance to low concentrations of glyphosate. Furthermore, preliminary studies showed that the mutated EPSPS gene driven by the CaMV35S promoter could be used as a selectable marker for transformation. We have shown that an intragenic approach can be used to confer glyphosate-resistance in chile. However, we need a stronger chile promoter and a mutated chile gene that encodes for a more glyphosate resistant EPSPS protein.	[Ortega, Jose Luis; Rajapakse, Wathsala; Bagga, Suman; Apodaca, Kimberly; Lucero, Yvonne; Sengupta-Gopalan, Champa] New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA	New Mexico State University	Sengupta-Gopalan, C (corresponding author), New Mexico State Univ, Dept Plant & Environm Sci, Las Cruces, NM 88003 USA.	csgopalan@nmsu.edu		Apodaca, Kimberly/0000-0002-4218-3728	New Mexico Chile Association; New Mexico State University, Agricultural Experiment Station; New Mexico State University, Graduate Research Enhancement Grant; Howard Hughes Medical Institute, Science Education Grant [52008103]	New Mexico Chile Association; New Mexico State University, Agricultural Experiment Station; New Mexico State University, Graduate Research Enhancement Grant; Howard Hughes Medical Institute, Science Education Grant	Funded by New Mexico Chile Association. New Mexico State University, Agricultural Experiment Station. New Mexico State University, Graduate Research Enhancement Grant, supported WR. Howard Hughes Medical Institute, Science Education Grant # 52008103, supported KA.	Aza-Gonzalez C, 2011, PLANT CELL REP, V30, P695, DOI 10.1007/s00299-010-0968-8; Cao GY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038718; Clemente TE, 2000, CROP SCI, V40, P797, DOI 10.2135/cropsci2000.403797x; COMAI L, 1983, SCIENCE, V221, P370, DOI 10.1126/science.221.4608.370; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Dill GM, 2005, PEST MANAG SCI, V61, P219, DOI 10.1002/ps.1008; Dong YF, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00885; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Dun BQ, 2007, APPL ENVIRON MICROB, V73, P7997, DOI 10.1128/AEM.00956-07; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Green JM, 2009, WEED SCI, V57, P108, DOI 10.1614/WS-08-030.1; He M, 2003, BIOSCI BIOTECH BIOCH, V67, P1405, DOI 10.1271/bbb.67.1405; Healy-Fried ML, 2007, J BIOL CHEM, V282, P32949, DOI 10.1074/jbc.M705624200; Holme IB, 2012, PLANT BIOTECHNOL J, V10, P237, DOI 10.1111/j.1467-7652.2011.00660.x; Howe AR, 2002, MOL BREEDING, V10, P153, DOI 10.1023/A:1020396708088; Huang ZF, 2014, MOL BIOL REP, V41, P2077, DOI 10.1007/s11033-014-3056-2; Imran M, 2017, PHYSIOL MOL BIOL PLA, V23, P453, DOI 10.1007/s12298-017-0424-0; Kahrizi D, 2007, PLANT CELL REP, V26, P95, DOI 10.1007/s00299-006-0208-4; Kim S, 2014, NAT GENET, V46, P270, DOI 10.1038/ng.2877; Kost TD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143980; Kothari SL, 2010, BIOTECHNOL ADV, V28, P35, DOI 10.1016/j.biotechadv.2009.08.005; Liu JX, 2009, AGR SCI CHINA, V8, P947, DOI 10.1016/S1671-2927(08)60299-0; Liu YJ, 2015, TRANSGENIC RES, V24, P753, DOI 10.1007/s11248-015-9874-8; Ochoa-Alejo N, 2001, IN VITRO CELL DEV-PL, V37, P701; PADGETTE SR, 1995, CROP SCI, V35, P1451, DOI 10.2135/cropsci1995.0011183X003500050032x; PADGETTE SR, 1991, J BIOL CHEM, V266, P22364; PILANEE V, 2007, PROCESS BIOCHEM, V42, P592; Powles SB, 2010, P NATL ACAD SCI USA, V107, P955, DOI 10.1073/pnas.0913433107; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Rajapakse W, 2015, TRANSGENIC CISGENIC; Schmidt GW, 2010, MOL GENET GENOMICS, V283, P233, DOI 10.1007/s00438-010-0511-1; Schonbrunn E, 2001, P NATL ACAD SCI USA, V98, P1376, DOI 10.1073/pnas.98.4.1376; Schouten HJ, 2006, NAT BIOTECHNOL, V24, P753, DOI 10.1038/nbt0706-753; Seger M, 2009, PLANT SCI, V176, P119, DOI 10.1016/j.plantsci.2008.10.006; SHAH DM, 1986, SCIENCE, V233, P478, DOI 10.1126/science.233.4762.478; Sundar IK, 2008, J PLANT PHYSIOL, V165, P1698, DOI 10.1016/j.jplph.2008.08.002; Tian YS, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0327-0; Tian YS, 2013, WORLD J MICROB BIOT, V29, P549, DOI 10.1007/s11274-012-1209-9; Tian YS, 2011, APPL ENVIRON MICROB, V77, P8409, DOI 10.1128/AEM.05271-11; Vanblaere T, 2014, PLANT BIOTECHNOL J, V12, P2, DOI 10.1111/pbi.12110; Wang HY, 2003, J PLANT RES, V116, P455, DOI 10.1007/s10265-003-0120-8; Yang X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175820; Yu Q, 2015, PLANT PHYSIOL, V167, P1440, DOI 10.1104/pp.15.00146; Zhang XB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158384	46	7	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194666	10.1371/journal.pone.0194666	http://dx.doi.org/10.1371/journal.pone.0194666			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649228	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900012
J	Boatman, TG; Davey, PA; Lawson, T; Geider, RJ				Boatman, Tobias G.; Davey, Phillip A.; Lawson, Tracy; Geider, Richard J.			The physiological cost of diazotrophy for Trichodesmium erythraeum IMS101	PLOS ONE			English	Article							MARINE CYANOBACTERIUM TRICHODESMIUM; PHOTOSYNTHETIC ELECTRON-TRANSPORT; NORTH PACIFIC-OCEAN; NITROGEN-FIXATION; OXYGEN EVOLUTION; PHOTOSYSTEM-II; CULTURED POPULATIONS; COMMUNITY STRUCTURE; CO2 ASSIMILATION; EUKARYOTIC ALGAE	Trichodesmium plays a significant role in the oligotrophic oceans, fixing nitrogen in an area corresponding to half of the Earth's surface, representing up to 50% of new production in some oligotrophic tropical and subtropical oceans. Whilst Trichodesmium blooms at the surface exhibit a strong dependence on diazotrophy, colonies at depth or at the surface after a mixing event could be utilising additional N-sources. We conducted experiments to establish how acclimation to varying N-sources affects the growth, elemental composition, light absorption coefficient, N-2 fixation, PSII electron transport rate and the relationship between net and gross photosynthetic O-2 exchange in T. erythraeum IMS101. To do this, cultures were acclimated to growth medium containing NH4 (+) and NO3 -(replete concentrations) or N-2 only (diazotrophic control). The light dependencies of O-2 evolution and O-2 uptake were measured using membrane inlet mass spectrometry (MIMS), while PSII electron transport rates were measured from fluorescence light curves (FLCs). We found that at a saturating light intensity, Trichodesmium growth was similar to 10% and 13% lower when grown on N-2 than with NH4 (+) and NO3 (-), respectively. Oxygen uptake increased linearly with net photosynthesis across all light intensities ranging from darkness to 1100 mu mol photons m(-2) s(-1). The maximum rates and initial slopes of light response curves for C-specific gross and net photosynthesis and the slope of the relationship between gross and net photosynthesis increased significantly under non-diazotrophic conditions. We attribute these observations to a reduced expenditure of reductant and ATP for nitrogenase activity under non-diazotrophic conditions which allows NADPH and ATP to be re-directed to CO2 fixation and/ or biosynthesis. The energy and reductant conserved through utilising additional N-sources could enhance Trichodesmium's productivity and growth and have major implications for its role in ocean C and N cycles.	[Boatman, Tobias G.; Davey, Phillip A.; Lawson, Tracy; Geider, Richard J.] Univ Essex, Sch Biol Sci, Colchester, Essex, England	University of Essex	Boatman, TG (corresponding author), Univ Essex, Sch Biol Sci, Colchester, Essex, England.	tboatman@chelsea.co.uk			UK Natural Environment Research Council PhD studentship [NE/J500379/1]	UK Natural Environment Research Council PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Tobias Boatman was supported by a UK Natural Environment Research Council PhD studentship (NE/J500379/1 DTB). Funding obtained by RJG and TL.	Baker NR, 2007, PLANT CELL ENVIRON, V30, P1107, DOI 10.1111/j.1365-3040.2007.01680.x; Bergman B, 2013, FEMS MICROBIOL REV, V37, P286, DOI 10.1111/j.1574-6976.2012.00352.x; Berman-Frank I, 2001, LIMNOL OCEANOGR, V46, P1249, DOI 10.4319/lo.2001.46.6.1249; Berman-Frank I, 2001, SCIENCE, V294, P1534, DOI 10.1126/science.1064082; Berman-Frank I, 2007, LIMNOL OCEANOGR, V52, P2260, DOI 10.4319/lo.2007.52.5.2260; Boatman TG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168796; Breitbarth E, 2008, MAR ECOL PROG SER, V359, P25, DOI 10.3354/meps07241; Brown CM, 2008, MAR BIOL, V154, P413, DOI 10.1007/s00227-008-0933-z; Campbell D, 1998, MICROBIOL MOL BIOL R, V62, P667, DOI 10.1128/MMBR.62.3.667-683.1998; Campbell L, 2005, VIE MILIEU, V55, P185; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; CAPONE DG, 1990, APPL ENVIRON MICROB, V56, P3532, DOI 10.1128/AEM.56.11.3532-3536.1990; CARPENTER EJ, 1992, NATO ADV SCI I C-MAT, V362, P211; CARPENTER EJ, 1975, LIMNOL OCEANOGR, V20, P389, DOI 10.4319/lo.1975.20.3.0389; Carr H, 2003, J PHYCOL, V39, P1125, DOI 10.1111/j.0022-3646.2003.02-077.x; Chen YB, 1996, J PHYCOL, V32, P916, DOI 10.1111/j.0022-3646.1996.00916.x; Coles VJ, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001754; Davis CS, 2006, SCIENCE, V312, P1517, DOI 10.1126/science.1123570; Doney SC, 2006, NATURE, V444, P695, DOI 10.1038/444695a; DUGDALE RC, 1967, LIMNOL OCEANOGR, V12, P196, DOI 10.4319/lo.1967.12.2.0196; Edwards G., 1983, C3 C4 MECH CELLULAR; Eichner M, 2014, PHYSIOL PLANTARUM, V152, P316, DOI 10.1111/ppl.12172; FALKOWSKI PG, 1986, BIOCHIM BIOPHYS ACTA, V849, P183, DOI 10.1016/0005-2728(86)90024-1; Finzi-Hart JA, 2009, P NATL ACAD SCI USA, V106, P6345, DOI 10.1073/pnas.0810547106; Flameling IA, 1998, LIMNOL OCEANOGR, V43, P284, DOI 10.4319/lo.1998.43.2.0284; Fryer MJ, 1998, PLANT PHYSIOL, V116, P571, DOI 10.1104/pp.116.2.571; Geel C, 1997, PHOTOSYNTH RES, V51, P61, DOI 10.1023/A:1005779112140; Glibert P, 1988, EOS, V69, P3996; Goering JJ, 1966, LIMNOLOGY OCEANOGRAP, P614; Grosskopf T, 2012, FRONT AQUAT MICROBIO, V3, P1; Gruber N, 1997, GLOBAL BIOGEOCHEM CY, V11, P235, DOI 10.1029/97GB00077; Guerrero M. G., 1987, The Cyanobacteria., P163; Helbling EW, 1994, EFFECTS ULTRAVIOLET; Holl CM, 2005, J PHYCOL, V41, P1178, DOI 10.1111/j.1529-8817.2005.00146.x; Hood RR, 2004, J GEOPHYS RES, V109, DOI DOI 10.1029/2002JC001753; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Karl D, 2002, BIOGEOCHEMISTRY, V57, P47, DOI 10.1023/A:1015798105851; Kolber ZS, 2000, NATURE, V407, P177, DOI 10.1038/35025044; Kranz SA, 2010, PLANT PHYSIOL, V154, P334, DOI 10.1104/pp.110.159145; Kromkamp JC, 2003, EUR J PHYCOL, V38, P103, DOI 10.1080/0967026031000094094; Kupper H, 2004, PLANT PHYSIOL, V135, P2120, DOI 10.1104/pp.104.045963; Kupper H, BIOCH BIOPHYSICA ACT; Letelier RM, 1996, MAR ECOL PROG SER, V133, P263, DOI 10.3354/meps133263; Levitan O, 2007, GLOBAL CHANGE BIOL, V13, P531, DOI 10.1111/j.1365-2486.2006.01314.x; Levitan O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015104; LUQUE I, 1994, EMBO J, V13, P2862, DOI 10.1002/j.1460-2075.1994.tb06580.x; McGillicuddy DJ, 2014, GLOBAL BIOGEOCHEM CY, V28, P103, DOI 10.1002/2013GB004652; McKew BA, 2013, NEW PHYTOLOGIST, DOI 10.1111/nph.12352; Milligan AJ, 2007, J PHYCOL, V43, P845, DOI 10.1111/j.1529-8817.2007.00395.x; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Moore JK, 2006, TELLUS B, V58, P560, DOI 10.1111/j.1600-0889.2006.00209.x; MOREL A, 1978, DEEP-SEA RES, V25, P673, DOI 10.1016/0146-6291(78)90623-9; Mulholland MR, 2001, J PHYCOL, V37, P1001, DOI 10.1046/j.1529-8817.2001.00080.x; Mulholland MR, 2001, LIMNOL OCEANOGR, V46, P436, DOI 10.4319/lo.2001.46.2.0436; Mulholland MR, 1999, J PHYCOL, V35, P977, DOI 10.1046/j.1529-8817.1999.3550977.x; Mulholland MR, 1999, MAR ECOL PROG SER, V188, P33, DOI 10.3354/meps188033; Mulholland MR, 2000, TRENDS PLANT SCI, V5, P148, DOI 10.1016/S1360-1385(00)01576-4; OHKI K, 1991, ARCH MICROBIOL, V156, P335, DOI 10.1007/BF00248706; PLATT T, 1976, J PHYCOL, V12, P421, DOI 10.1111/j.1529-8817.1976.tb02866.x; RADMER RJ, 1976, PLANT PHYSIOL, V58, P336, DOI 10.1104/pp.58.3.336; RAVEN JA, 1991, LIMNOL OCEANOGR, V36, P1701, DOI 10.4319/lo.1991.36.8.1701; Sandh G, 2011, PROTEOMICS, V11, P406, DOI 10.1002/pmic.201000382; Silsbe GM, 2015, LIMNOL OCEANOGR-METH, V13, P138, DOI 10.1002/lom3.10014; Suggett DJ, 2009, AQUAT MICROB ECOL, V56, P147, DOI 10.3354/ame01303; Suggett DJ, 2004, LIMNOL OCEANOGR-METH, V2, P316, DOI 10.4319/lom.2004.2.316; Sundberg B, 1997, PLANTA, V201, P138, DOI 10.1007/BF01007698; Villareal TA, 2003, MICROB ECOL, V45, P1, DOI 10.1007/s00248-002-1012-5; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Woniak B., 1999, OCEANOLOGIA, V41, P187; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	72	7	7	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195638	10.1371/journal.pone.0195638	http://dx.doi.org/10.1371/journal.pone.0195638			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641568	gold, Green Accepted, Green Submitted, Green Published			2022-12-26	WOS:000429742900079
J	Costa, T; Barri, F				Costa, Thiago; Barri, Fernando			Lama guanicoe remains from the Chaco ecoregion (Cordoba, Argentina): An osteological approach to the characterization of a relict wild population	PLOS ONE			English	Article							CONSERVATION BIOLOGY; GRAN CHACO; GUANACO; ARTIODACTYLA; PALEOZOOLOGY; PALEOBIOLOGY; PERSPECTIVE; VEGETATION; EXPANSION; CAMELIDAE	Guanacos (Lama guanicoe) are large ungulates that have been valued by human populations in South America since the Late Pleistocene. Even though they were very abundant until the end of the 19th century (before the high deforestation rate of the last decades), guanacos have nearly disappeared in the Gran Chaco ecoregion, with relicts and isolated populations surviving in some areas, such as the shrubland area near the saline depressions of Cordoba province, Argentina. In this report, we present the first data from a locally endangered guanaco wild population, through the study of skeletal remains recovered in La Providencia ranch. Our results showed that most of the elements belonged to adults aged between 36 and 96 months; sex evaluation showed similar numbers of males and females. Statistical analysis of the body size of modern samples from Cordoba demonstrated that guanacos from the Chaco had large dimensions and presented lower size variability than the modern and archaeological specimens in our database. Moreover, they exhibited dimensions similar to those of modern guanacos from Patagonia and San Juan, and to archaeological specimens from Ongamira and Cerro Colorado, although further genetic studies are needed to corroborate a possible phylogenetic relationship. Finally, we used archaeozoological techniques to provide a first characterization of a relict guanaco population from the Chaco ecoregion, demonstrating its value to the study of modern skeletal remains and species conservation biology.	[Costa, Thiago] Univ Nacl Cordoba, CONICET, Fac Filosofia & Humanidades, IDACOR,Museo Antropol, Cordoba, Argentina; [Barri, Fernando] Univ Nacl Cordoba, CONICET, Inst Diversidad & Ecol Anim, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Costa, T (corresponding author), Univ Nacl Cordoba, CONICET, Fac Filosofia & Humanidades, IDACOR,Museo Antropol, Cordoba, Argentina.	thfcosta@gmail.com	Costa, Thiago/V-4015-2019	Costa, Thiago/0000-0003-3476-102X	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	Financial support was provided by Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET).	Acebes P, 2010, MAMMALIA, V74, P57, DOI 10.1515/MAMM.2009.071; Barnosky AD, 2017, SCIENCE, V355, DOI 10.1126/science.aah4787; Borrero Luis Alberto, 2007, BAR International Series, V1601, P219; Bradshaw RHW, 2003, FOREST ECOL MANAG, V181, P267, DOI 10.1016/S0378-1127(03)00138-5; Calder WA., 1984, SIZE FUNCTION LIFE H; Cattaneo GR, 2015, PATRIMONIO ARQUEOLOG; Cattaneo R, 2013, RELACIONES, V38, P559; Ceballos G, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400253; Costa T., REV MUS ANTROPOL, V9, P93; Costa T, 2016, INT J OSTEOARCHAEOL, DOI [10.1002/oa.2531, DOI 10.1002/OA.2531]; Costa T., 2016, ARQUEOLOGIA VALLE ON, P117; Cuéllar Erika, 2014, Therya, V5, P39, DOI 10.12933/therya-14-181; De Nigris ME, 2005, INTERSEC ANTROPOL; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Fabra M, 2012, REV ARG ANTROPOL BIO, V14; Flores CE, 2012, RANGELAND J, V34, P439, DOI 10.1071/RJ12040; Franklin W.L., 1983, Special Publication American Society of Mammalogists, P573; Gentile M., 2012, ANUARIO JURIDICO EC, VXLV, P581; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Gonzalez ME, 2012, INT J OSTEOARCHAEOL, V22, P523, DOI 10.1002/oa.1271; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Izeta A. D., 2012, GUIA OSTEOMETRICA CA; Izeta AD, 2007, BAR INT SERIES, P47; Izeta Andres D., 2009, REV MUSEO ANTROPOLOG, V2, P169, DOI DOI 10.31048/1852.4826.V2.N1.5416; KAUFMANN C. L. G., 2009, THESIS; Kaufmann Cristian A, 2013, Mastozool. neotrop., V20, P47; Kent JD, 1982, THESIS; Kufner Maura B., 2001, Boletin de la Academia Nacional de Ciencias (Cordoba), V66, P109; Lefevre C, 2003, EXPLOTACION RECURSOS, V31, P63; Leynaud GC, 2005, FOREST ECOL MANAG, V213, P384, DOI 10.1016/j.foreco.2005.04.003; LINDSTEDT SL, 1985, AM NAT, V125, P873, DOI 10.1086/284385; Lyman RL, 2012, BIOL REV, V87, P513, DOI 10.1111/j.1469-185X.2011.00207.x; Lyman RL, 2006, EVOL ANTHROPOL, V15, P11, DOI 10.1002/evan.20083; Malmierca M.P., 1997, RELAC SOC ARGENT ANT, VXXII, P389; Martinez Gustavo, 2004, BAR International Series, V1298, P81; Massigoge A, 2010, MAMUL MAPU PASADO PR, VI, P309; Medina ME, 2014, INTERSECCIONES ANTRO, V15, P339; Mengoni Gonalons G.L., 1999, THESIS; Mengoni Gorialons GL, 2014, ICAZ 2014 12 INT C A, P108; Metcalf JL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501682; Monchot H, 1999, QUATERNARY RES, V52, P259, DOI 10.1006/qres.1999.2066; Nacuzzi LR, 2007, CHUNGARA, V39, P221, DOI 10.4067/S0717-73562007000200005; Neme G, 2012, ARCHAEOFAUNA, V21, P207; Nores R., 2011, REV MUSEO ANTROPOLOG, V4, P187; Nori J, 2016, DIVERS DISTRIB, V22, P1212, DOI 10.1111/ddi.12497; Nori J, 2013, BIOL CONSERV, V159, P507, DOI 10.1016/j.biocon.2012.11.020; Olivera D., 2009, REV MUS ANTROPOL, V2, p151?168, DOI [10.31048/1852.4826.v2.n1.5415, DOI 10.31048/1852.4826.V2.N1.5415]; Oporto N., 1979, REV ARGENTINA PRODUC, V4, P965; Otaola C, 2008, MAGALLANIA, V36, P205, DOI 10.4067/S0718-22442008000200016; Periago ME, 2015, MAMMAL REV, V45, P41, DOI 10.1111/mam.12031; Politis GG, 2011, J ARCHAEOL SCI, V38, P1405, DOI 10.1016/j.jas.2011.01.013; Raedeke K., 1979, THESIS; Grau HR, 2015, J ARID ENVIRON, V123, P40, DOI 10.1016/j.jaridenv.2014.12.006; Rick TC, 2013, CONSERV BIOL, V27, P45, DOI 10.1111/j.1523-1739.2012.01920.x; Rio M, 1905, GEOGRAFIA PROVINCIA, VII, P690; Rio ME, 1904, GEOGRAFIA PROVINCIA, VI, P570; Rivals F, 2013, J ARCHAEOL SCI, V40, P2971, DOI 10.1016/j.jas.2013.03.005; Rivero D, 2013, SAMAR SERIES, V24, P76; Rivero DE., 2010, ZOOARQUEOLOGIA PRINC, P321; Romero J, 2016, PLAN CONSERVAC UNPUB, P55; Silva LCR, 2011, PLANT SOIL, V349, P261, DOI 10.1007/s11104-011-0868-x; Szabo P, 2010, ENVIRON CONSERV, V37, P380, DOI 10.1017/S0376892910000718; Todd Lawrence C., 1987, HORNER SITE TYPE SIT, P107, DOI DOI 10.1016/B978-0-12-268566-8.50012-9; WHEELER J, 1982, LLAMA WORLD, V1, P12; Yacobaccio H.D., 2010, ZOOARQUEOLOGIA PRINC, VXXI, P65; Yanes Y, 2014, HOLOCENE, V24, P1193, DOI 10.1177/0959683614540959; Zak MR, 2008, ENVIRON MANAGE, V42, P181, DOI 10.1007/s00267-008-9101-y; Zak MR, 2002, APPL VEG SCI, V5, P213, DOI 10.1111/j.1654-109X.2002.tb00551.x	68	6	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194727	10.1371/journal.pone.0194727	http://dx.doi.org/10.1371/journal.pone.0194727			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641579	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900041
J	Guarnieri, AL; Towers, CG; Drasin, DJ; Oliphant, MUJ; Andrysik, Z; Hotz, TJ; Vartuli, RL; Linklater, ES; Pandey, A; Khanal, S; Espinosa, JM; Ford, HL				Guarnieri, A. L.; Towers, C. G.; Drasin, D. J.; Oliphant, M. U. J.; Andrysik, Z.; Hotz, T. J.; Vartuli, R. L.; Linklater, E. S.; Pandey, A.; Khanal, S.; Espinosa, J. M.; Ford, H. L.			The miR-106b-25 cluster mediates breast tumor initiation through activation of NOTCH1 via direct repression of NEDD4L	ONCOGENE			English	Article							CANCER STEM-CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; DOWN-REGULATION; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; THERAPEUTIC IMPLICATIONS; SIGNALING PATHWAY; MICRORNA CLUSTER; LUNG-CANCER; IN-VITRO	Tumor-initiating cells (TIC) represent a subset of tumor cells with increased self-renewal capability. TICs display resistance to frontline cancer treatment and retain the ability to repopulate a tumor after therapy, leading to cancer relapse. NOTCH signaling has been identified as an important driver of the TIC population, yet mechanisms governing regulation of this pathway in cancer remain to be fully elucidated. Here we identify a novel mechanism of NOTCH regulation and TIC induction in breast cancer via the miR-106b-25 miRNA cluster. We show that the miR-106b-25 cluster upregulates NOTCH1 in multiple breast cancer cell lines, representing both estrogen receptor (ER+) and triple negative breast cancer (TNBC) through direct repression of the E3 ubiquitin ligase, NEDD4L. We further show that upregulation of NOTCH1 is necessary for TIC induction downstream of miR-106b-25 in both ER + and TNBC breast cancer cells, and that re-expression of NEDD4L is sufficient to reverse miR106b-25-mediated NOTCH1 upregulation and TIC induction. Importantly, we demonstrate a significant positive correlation between miR-106b-25 and NOTCH1 protein, yet a significant inverse correlation between miR-106b-25 and NEDD4L mRNA in human breast cancer, suggesting a critical role for the miR106b-25/NEDD4L/ NOTCH1 axis in the disease. Further, we show for the first time that NEDD4L expression alone is significantly associated with a better relapse-free prognosis for breast cancer patients. These data expand our knowledge of the mechanisms underlying NOTCH activation and TIC induction in breast cancer, and may provide new avenues for the development of therapies targeting this resistant subset of tumor cells.	[Guarnieri, A. L.; Towers, C. G.; Drasin, D. J.; Vartuli, R. L.; Linklater, E. S.; Ford, H. L.] Univ Colorado, Program Mol Biol, Anschutz Med Campus, Aurora, CO 80045 USA; [Guarnieri, A. L.; Towers, C. G.; Oliphant, M. U. J.; Andrysik, Z.; Hotz, T. J.; Vartuli, R. L.; Pandey, A.; Khanal, S.; Espinosa, J. M.; Ford, H. L.] Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA; [Oliphant, M. U. J.; Ford, H. L.] Univ Colorado, Integrated Physiol Program, Anschutz Med Campus, Aurora, CO 80045 USA; [Andrysik, Z.; Espinosa, J. M.] Univ Colorado, Linda Crnic Inst Syndrome, Anschutz Med Campus, Aurora, CO 80045 USA; [Espinosa, J. M.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder	Ford, HL (corresponding author), Univ Colorado, Program Mol Biol, Anschutz Med Campus, Aurora, CO 80045 USA.; Ford, HL (corresponding author), Univ Colorado, Dept Pharmacol, Anschutz Med Campus, Aurora, CO 80045 USA.; Ford, HL (corresponding author), Univ Colorado, Integrated Physiol Program, Anschutz Med Campus, Aurora, CO 80045 USA.	Heide.Ford@ucdenver.edu			METAvivor Foundation; Department of Defense Breast Cancer Research Program [W81XWH-10-1-0296]; Ruth L. Kirschstein National Service Research Award (F32) [1F32CA199716-01]; Ruth L. Kirschstein National Service Research Award (F31) [5F31CA210622-02]; NCI [F99 CA223023]; NIH-RO1 Diversity Supplement [R01-CA157790]; UNCF/MERCK Graduate Fellowship; T32 Cancer Biology training grant [CA190216-1 A1]; UC Denver AMC Molecular Biology Program T32 training grant [T32 GM008730];  [R01CA095277];  [R01CA117907]; NATIONAL CANCER INSTITUTE [F31CA210622, F99CA223023, R01CA157790, R01CA095277, R01CA117907, T32CA190216, F32CA199716, P30CA046934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008730] Funding Source: NIH RePORTER	METAvivor Foundation; Department of Defense Breast Cancer Research Program(United States Department of Defense); Ruth L. Kirschstein National Service Research Award (F32); Ruth L. Kirschstein National Service Research Award (F31); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-RO1 Diversity Supplement; UNCF/MERCK Graduate Fellowship; T32 Cancer Biology training grant; UC Denver AMC Molecular Biology Program T32 training grant; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Paul Jedlicka for the generous gift of mice for limiting dilution experiments. We also want to thank the University of Colorado Cancer center flow cytometry shared resource for performing flow cytometry experiments needed for this work (P30CA046934), the Functional Genomics Facility for shRNA constructs, and The Cancer Genome Atlas (TCGA) for use of their breast cancer patient data set. This work was supported by R01CA095277 (HLF), R01CA117907 (JME), the METAvivor Foundation (HLF), the Department of Defense Breast Cancer Research Program W81XWH-10-1-0296 (ALG), the Ruth L. Kirschstein National Service Research Award (F32) 1F32CA199716-01 (ALG), the Ruth L. Kirschstein National Service Research Award (F31) 5F31CA210622-02 (MUJO), the NCI fellow transition award F99 CA223023 (MUJO), UC Denver AMC Molecular Biology Program T32 training grant T32 GM008730 (CGT), NIH-RO1 Diversity Supplement to R01-CA157790 (CGT), the UNCF/MERCK Graduate Fellowship (CGT), and the T32 Cancer Biology training grant CA190216-1 A1 (CGT).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Pires BRB, 2016, ANTICANCER RES, V36, P5681, DOI 10.21873/anticanres.11151; Brett JO, 2011, AGING-US, V3, P108, DOI 10.18632/aging.100285; Brooks MD, 2015, CELL STEM CELL, V17, P260, DOI 10.1016/j.stem.2015.08.014; Capaccione KM, 2013, CARCINOGENESIS, V34, P1420, DOI 10.1093/carcin/bgt127; Chastagner P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002735; Chen S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165776; Choi N, 2015, ONCOTARGET, V6, P23533, DOI 10.18632/oncotarget.4372; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Espinoza I, 2013, CANCER LETT, V341, P41, DOI 10.1016/j.canlet.2013.08.027; Espinoza I, 2013, PHARMACOL THERAPEUT, V139, P95, DOI 10.1016/j.pharmthera.2013.02.003; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Gao S, 2009, MOL CELL, V36, P457, DOI 10.1016/j.molcel.2009.09.043; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Goel P, 2015, GENE, V557, P1, DOI 10.1016/j.gene.2014.11.051; Gong C, 2015, ONCOGENE, V34, P84, DOI 10.1038/onc.2013.525; Gravgaard KH, 2012, BREAST CANCER RES TR, V134, P207, DOI 10.1007/s10549-012-1969-9; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Kolch W, 2015, NAT REV CANCER, V15, P515, DOI 10.1038/nrc3983; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Li C, 2015, THORAC CANCER, V6, P524, DOI 10.1111/1759-7714.12242; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liu S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002537; Liu YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep28329; Lo Sardo F, 2017, CARCINOGENESIS, V38, P64, DOI 10.1093/carcin/bgw110; Mazaleyrat SL, 2003, DEV BIOL, V255, P363, DOI 10.1016/S0012-1606(02)00086-6; Micalizzi DS, 2009, J CLIN INVEST, V119, P2678, DOI 10.1172/JCI37815; Ni XJ, 2014, CANCER SCI, V105, P18, DOI 10.1111/cas.12309; Ntziachristos P, 2014, CANCER CELL, V25, P318, DOI 10.1016/j.ccr.2014.02.018; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Poliseno L, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000594; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Qian S, 2008, BIOCHEM BIOPH RES CO, V377, P668, DOI 10.1016/j.bbrc.2008.10.052; Qu MH, 2016, TUMOR BIOL, V37, P5645, DOI 10.1007/s13277-015-4328-8; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Schrijver WAME, 2017, ONCOTARGET, V8, P3111, DOI 10.18632/oncotarget.13623; Shyamasundar S, 2016, INT J ONCOL, V49, P2629, DOI 10.3892/ijo.2016.3761; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Visvader JE, 2011, NATURE, V469, P314, DOI 10.1038/nature09781; Wang ZW, 2009, CANCER LETT, V279, P8, DOI 10.1016/j.canlet.2008.09.030; Xu X, 2016, SCI REP-UK, V6, DOI 10.1038/srep31267; Yang F, 2017, CELL MOL LIFE SCI, V74, P951, DOI 10.1007/s00018-016-2334-7; Yau WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057882; Yen CS, 2016, WORLD J GASTROENTERO, V22, P5183, DOI 10.3748/wjg.v22.i22.5183; Yu D, 2014, LAB INVEST, V94, P1370, DOI 10.1038/labinvest.2014.125; Zhang RP, 2016, TUMOR BIOL, V37, P10507, DOI 10.1007/s13277-016-4937-x	53	37	38	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3879	3893		10.1038/s41388-018-0239-7	http://dx.doi.org/10.1038/s41388-018-0239-7			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29662198	Green Accepted			2022-12-26	WOS:000438465600009
J	Liu, YP; Lan, WX; Wang, CX; Cao, CY				Liu, Yaping; Lan, Wenxian; Wang, Chunxi; Cao, Chunyang			A putative G-quadruplex structure in the proximal promoter of VEGFR-2 has implications for drug design to inhibit tumor angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIMERIC G-QUADRUPLEX; INTRAMOLECULAR G-QUADRUPLEX; HUMAN TELOMERE; K+ SOLUTION; IN-VIVO; DNA; REGION; RECEPTOR; SEQUENCE	Tumor angiogenesis is mainly regulated by vascular endothelial growth factor (VEGF) produced by cancer cells. It is active on the endothelium via VEGF receptor 2 (VEGFR-2). G-quadruplexes are DNA secondary structures formed by guanine-rich sequences, for example, within gene promoters where they may contribute to transcriptional activity. The proximal promoter of VEGFR-2 contains a G-quadruplex, which has been suggested to interact with small molecules that inhibit VEGFR-2 expression and thereby tumor angiogenesis. However, its structure is not known. Here, we determined its NMR solution structure, which is composed of three stacked G-tetrads containing three syn guanines. The first guanine (G(1)) is positioned within the central G-tetrad. We also observed that a noncanonical, V-shaped loop spans three G-tetrad planes, including no bridging nucleotides. A long and diagonal loop, which includes six nucleotides, connects reversal double chains. With a melting temperature of 54.51 degrees C, the scaffold of this quadruplex is stabilized by one G-tetrad plane stacking with one nonstandard bp, G(3)-C-8, whose bases interact with each other through only one hydrogen bond. In summary, the NMR solution structure of the G-quadruplex in the proximal promoter region of the VEGFR-2 gene reported here has uncovered its key features as a potential anticancer drug target.	[Liu, Yaping; Lan, Wenxian; Wang, Chunxi; Cao, Chunyang] Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Ctr Excellence Mol Synth, Shanghai Inst Organ Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China; [Liu, Yaping; Cao, Chunyang] Chinese Acad Sci, Collaborat Innovat Ctr Chem Life Sci, 345 Lingling Rd, Shanghai 200032, Peoples R China; [Lan, Wenxian; Wang, Chunxi; Cao, Chunyang] Univ Chinese Acad Sci, 19 A Yuquan Rd, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cao, CY (corresponding author), Chinese Acad Sci, State Key Lab Bioorgan & Nat Prod Chem, Ctr Excellence Mol Synth, Shanghai Inst Organ Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.; Cao, CY (corresponding author), Chinese Acad Sci, Collaborat Innovat Ctr Chem Life Sci, 345 Lingling Rd, Shanghai 200032, Peoples R China.; Cao, CY (corresponding author), Univ Chinese Acad Sci, 19 A Yuquan Rd, Beijing 100049, Peoples R China.	ccao@mail.sioc.ac.cn		Liu, Yaping/0000-0003-0375-0889	National Key Research and Development Program of China [2017YPE0108200, 2016YFA0502302]; Chinese Academy of Sciences Strategic Priority Research Program [XDB 20000000]; National Science Foundation of China [91753119, 21472229, 21778065]	National Key Research and Development Program of China; Chinese Academy of Sciences Strategic Priority Research Program; National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Research and Development Program of China Grants 2017YPE0108200 and 2016YFA0502302; Chinese Academy of Sciences Strategic Priority Research Program Grant XDB 20000000; and National Science Foundation of China Grants 91753119, 21472229, and 21778065. The authors declare that they have no conflicts of interest with the contents of this article.	Amrane S, 2012, J AM CHEM SOC, V134, P5807, DOI 10.1021/ja208993r; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Brunger A. T, 1993, X PLOR VERSION 31 SY; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Crnugelj M, 2003, J AM CHEM SOC, V125, P7866, DOI 10.1021/ja0348694; Dai JX, 2006, NUCLEIC ACIDS RES, V34, P5133, DOI 10.1093/nar/gkl610; Dai JX, 2006, J AM CHEM SOC, V128, P1096, DOI 10.1021/ja055636a; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; FOLKMAN J, 1990, JNCI-J NATL CANCER I, V82, P4, DOI 10.1093/jnci/82.1.4; GLEAVE ME, 1993, CANCER RES, V53, P5300; Goddard T. D, 2009, SPARKY 3; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Jain RK, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.37265; Kuryavyi V, 2010, NUCLEIC ACIDS RES, V38, P6757, DOI 10.1093/nar/gkq558; Kuryavyi V, 2010, STRUCTURE, V18, P73, DOI 10.1016/j.str.2009.10.015; Kuszewski J, 2000, J MAGN RESON, V146, P249, DOI 10.1006/jmre.2000.2142; LIOTTA LA, 1974, CANCER RES, V34, P997; Luu KN, 2006, J AM CHEM SOC, V128, P9963, DOI 10.1021/ja062791w; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; MARTINYBARON G, 1995, CURR OPIN BIOTECH, V6, P675, DOI 10.1016/0958-1669(95)80111-1; Marusic M, 2012, NUCLEIC ACIDS RES, V40, P6946, DOI 10.1093/nar/gks329; MUSTONEN T, 1995, J CELL BIOL, V129, P895, DOI 10.1083/jcb.129.4.895; Nambiar M, 2011, NUCLEIC ACIDS RES, V39, P936, DOI 10.1093/nar/gkq824; Neidle S, 2009, CURR OPIN STRUC BIOL, V19, P239, DOI 10.1016/j.sbi.2009.04.001; NICOSIA RF, 1994, AM J PATHOL, V145, P1023; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P3099, DOI 10.1002/anie.200806244; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Patel DJ, 2007, NUCLEIC ACIDS RES, V35, P7429, DOI 10.1093/nar/gkm711; Phan AT, 2006, NUCLEIC ACIDS RES, V34, P5715, DOI 10.1093/nar/gkl726; Phan AT, 2002, J AM CHEM SOC, V124, P1160, DOI 10.1021/ja011977m; Phan AT, 2000, J BIOMOL NMR, V16, P175, DOI 10.1023/A:1008355231085; Piazza A, 2017, ELIFE, V6, DOI 10.7554/eLife.26884; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; Salvati E, 2014, NUCLEIC ACIDS RES, V42, P2945, DOI 10.1093/nar/gkt1289; Shibuya Masaubmi, 2006, Angiogenesis, V9, P225, DOI 10.1007/s10456-006-9055-8; Shirude PS, 2007, J AM CHEM SOC, V129, P7484, DOI 10.1021/ja070497d; Siddiqui-Jain A, 2002, P NATL ACAD SCI USA, V99, P11593, DOI 10.1073/pnas.182256799; Sun DY, 2005, NUCLEIC ACIDS RES, V33, P6070, DOI 10.1093/nar/gki917; WANG Y, 1993, J MOL BIOL, V234, P1171, DOI 10.1006/jmbi.1993.1668; Zhang N, 2005, J AM CHEM SOC, V127, P17277, DOI 10.1021/ja0543090; Zhang N, 2001, J MOL BIOL, V311, P1063, DOI 10.1006/jmbi.2001.4916	46	15	16	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8947	8955		10.1074/jbc.RA118.002666	http://dx.doi.org/10.1074/jbc.RA118.002666			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29666187	hybrid, Green Published			2022-12-26	WOS:000434941900018
J	Ujfalusi, Z; Vera, CD; Mijailovich, SM; Svicevic, M; Yu, EC; Kawana, M; Ruppel, KM; Spudich, JA; Geeves, MA; Leinwand, LA				Ujfalusi, Zoltan; Vera, Carlos D.; Mijailovich, Srbolujub M.; Svicevic, Marina; Yu, Elizabeth Choe; Kawana, Masataka; Ruppel, Kathleen M.; Spudich, James A.; Geeves, Michael A.; Leinwand, Leslie A.			Dilated cardiomyopathy myosin mutants have reduced force-generating capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-I PHOSPHORYLATION; CROSS-BRIDGE CYCLE; CARDIAC MYOSIN; HYPERTROPHIC CARDIOMYOPATHY; MOLECULAR-MECHANISM; MUSCLE-CONTRACTION; PROTEIN GENES; MUTATIONS; SKELETAL; ALPHA	Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) can cause arrhythmias, heart failure, and cardiac death. Here, we functionally characterized the motor domains of five DCM-causing mutations in human beta-cardiac myosin. Kinetic analyses of the individual events in the ATPase cycle revealed that each mutation alters different steps in this cycle. For example, different mutations gave enhanced or reduced rate constants of ATP binding, ATP hydrolysis, or ADP release or exhibited altered ATP, ADP, or actin affinity. Local effects dominated, no common pattern accounted for the similar mutant phenotype, and there was no distinct set of changes that distinguished DCM mutations from previously analyzed HCM myosin mutations. That said, using our data to model the complete ATPase contraction cycle revealed additional critical insights. Four of the DCM mutations lowered the duty ratio (the ATPase cycle portion when myosin strongly binds actin) because of reduced occupancy of the force-holding A center dot M center dot D complex in the steady state. Under load, the A center dot M center dot D state is predicted to increase owing to a reduced rate constant for ADP release, and this effect was blunted for all five DCM mutations. We observed the opposite effects for two HCM mutations, namely R403Q and R453C. Moreover, the analysis predicted more economical use of ATP by the DCM mutants than by WT and the HCM mutants. Our findings indicate that DCM mutants have a deficit in force generation and force-holding capacity due to the reduced occupancy of the force-holding state.	[Ujfalusi, Zoltan; Geeves, Michael A.] Univ Kent, Sch Biosci, Canterbury CT2 7NJ, Kent, England; [Vera, Carlos D.; Leinwand, Leslie A.] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Vera, Carlos D.; Leinwand, Leslie A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Mijailovich, Srbolujub M.] IIT, Dept Biol, Chicago, IL 60616 USA; [Svicevic, Marina] Univ Kragujevac, Fac Sci, Kragujevac 34000, Serbia; [Yu, Elizabeth Choe] Stanford Univ, Dept Pediat Cardiol, Sch Med, Stanford, CA 94305 USA; [Kawana, Masataka; Ruppel, Kathleen M.; Spudich, James A.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Ujfalusi, Zoltan] Univ Pecs, Sch Med, Dept Biophys, Szigeti St 12, H-7624 Pecs, Hungary	University of Kent; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Illinois Institute of Technology; University of Kragujevac; Stanford University; Stanford University; University of Pecs	Leinwand, LA (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	leslie.leinwand@Colorado.edu	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Vera, Carlos/0000-0003-1207-4878; Svicevic, Marina/0000-0003-2791-3849	MyoKardia, Inc.; National Institutes of Health [HL117138, GM33289]; British Heart Foundation [PG-175-30200]	MyoKardia, Inc.; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation)	J. A. S. is a founder of and owns stock in MyoKardia, Inc. L A. L is a founder of, owns stock in, and has a sponsored research agreement with MyoKardia, Inc. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by National Institutes of Health Grant HL117138.; Supported by National Institutes of Health Grant GM33289.; Supported by British Heart Foundation Grant PG-175-30200.	Adamek N, 2011, CELL MOL LIFE SCI, V68, P139, DOI 10.1007/s00018-010-0448-x; Adhikari AS, 2016, CELL REP, V17, P2857, DOI 10.1016/j.celrep.2016.11.040; Aksel T, 2015, CELL REP, V11, P910, DOI 10.1016/j.celrep.2015.04.006; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Baig MK, 1998, J AM COLL CARDIOL, V31, P195, DOI 10.1016/S0735-1097(97)00433-6; Bloemink MJ, 2007, J MOL BIOL, V373, P1184, DOI 10.1016/j.jmb.2007.08.050; Bloemink M, 2014, J BIOL CHEM, V289, P5158, DOI 10.1074/jbc.M113.511204; Bloemink MJ, 2013, J BIOL CHEM, V288, P27469, DOI 10.1074/jbc.M113.488130; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; CRIDDLE AH, 1985, BIOCHEM J, V232, P343, DOI 10.1042/bj2320343; Daehmlow S, 2002, BIOCHEM BIOPH RES CO, V298, P116, DOI 10.1016/S0006-291X(02)02374-4; De La Cruz E.M, 2009, KINETIC EQUILIBRIUM; Deacon JC, 2012, CELL MOL LIFE SCI, V69, P2261, DOI 10.1007/s00018-012-0927-3; Debold EP, 2007, AM J PHYSIOL-HEART C, V293, pH284, DOI 10.1152/ajpheart.00128.2007; Dellefave L, 2010, CURR OPIN CARDIOL, V25, P198, DOI 10.1097/HCO.0b013e328337ba52; Egelman E.H., 2012, COMPREHENSIVE BIOPHY, V4, P251; Fenn WO, 1923, J PHYSIOL-LONDON, V58, P0175; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; Geeves MA, 2005, CELL MOL LIFE SCI, V62, P1462, DOI 10.1007/s00018-005-5015-5; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenberg MJ, 2014, BIOPHYS J, V107, pL41, DOI 10.1016/j.bpj.2014.11.005; Hershberger RE, 2008, CTS-CLIN TRANSL SCI, V1, P21, DOI 10.1111/j.1752-8062.2008.00017.x; Hershberger RE, 2010, GENET MED, V12, P655, DOI 10.1097/GIM.0b013e3181f2481f; Huang J, 2009, BIOCHEMISTRY-US, V48, P11834, DOI 10.1021/bi901756n; Irving M, 2017, BIOPHYS J, V113, P2579, DOI 10.1016/j.bpj.2017.09.037; Kalabokis VN, 1997, BIOCHEMISTRY-US, V36, P15834, DOI 10.1021/bi971932r; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Liu C., 2018, 258020 BIORXIV; Lowey S, 2008, J BIOL CHEM, V283, P20579, DOI 10.1074/jbc.M800554200; McConnell BK, 2001, CIRC RES, V88, P383; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; Memo M, 2013, CARDIOVASC RES, V99, P65, DOI 10.1093/cvr/cvt071; Messer AE, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00315; Mijailovich SM, 2017, BIOPHYS J, V112, P984, DOI 10.1016/j.bpj.2017.01.021; Minamisawa S, 1999, CELL, V99, P313, DOI 10.1016/S0092-8674(00)81662-1; Molkentin JD, 2001, ANNU REV PHYSIOL, V63, P391, DOI 10.1146/annurev.physiol.63.1.391; Nag S, 2017, NAT STRUCT MOL BIOL, V24, P525, DOI 10.1038/nsmb.3408; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Nyitrai M, 2003, BIOPHYS J, V85, P1053, DOI 10.1016/S0006-3495(03)74544-5; Parvari R, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/639250; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; SMITH DA, 1995, BIOPHYS J, V69, P538, DOI 10.1016/S0006-3495(95)79927-1; Smith DA, 2014, J MUSCLE RES CELL M, V35, P295, DOI 10.1007/s10974-014-9391-z; Sommese RF, 2013, P NATL ACAD SCI USA, V110, P12607, DOI 10.1073/pnas.1309493110; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Sung JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8931; Sweeney HL, 2010, ANNU REV BIOPHYS, V39, P539, DOI 10.1146/annurev.biophys.050708.133751; Trivedi Darshan V, 2018, Biophys Rev, V10, P27, DOI 10.1007/s12551-017-0274-6; Trybus KM, 2000, METHODS, V22, P327, DOI 10.1006/meth.2000.1085; Vikstrom KL, 1996, MOL MED, V2, P556, DOI 10.1007/BF03401640; Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193; Walklate J, 2016, J BIOL CHEM, V291, P10318, DOI 10.1074/jbc.M115.707489; Wendt T, 2001, P NATL ACAD SCI USA, V98, P4361, DOI 10.1073/pnas.071051098; Westfall MV, 2002, CIRC RES, V91, P525, DOI 10.1161/01.RES.0000034710.46739.C0	59	34	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					9017	9029		10.1074/jbc.RA118.001938	http://dx.doi.org/10.1074/jbc.RA118.001938			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29666183	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000434941900024
J	Martin, EM; Jackson, MP; Gamerdinger, M; Gense, K; Karamonos, TK; Humes, JR; Deuerling, E; Ashcroft, AE; Radford, SE				Martin, Esther M.; Jackson, Matthew P.; Gamerdinger, Martin; Gense, Karina; Karamonos, Theodoros K.; Humes, Julia R.; Deuerling, Elke; Ashcroft, Alison E.; Radford, Sheena E.			Conformational flexibility within the nascent polypeptide-associated complex enables its interactions with structurally diverse client proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein folding; protein misfolding; protein cross-linking; chaperone; molecular chaperone; NAC native mass spectrometry (MS); nuclear magnetic resonance (NMR)	RIBOSOME-ASSOCIATED CHAPERONES; MOBILITY-MASS SPECTROMETRY; COLLISION CROSS-SECTIONS; ALPHA-SYNUCLEIN; NMR-SPECTROSCOPY; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; SECONDARY STRUCTURE; CRYSTAL-STRUCTURE; NAC	As newly synthesized polypeptides emerge from the ribosome, it is crucial that they fold correctly. To prevent premature aggregation, nascent chains interact with chaperones that facilitate folding or prevent misfolding until protein synthesis is complete. Nascent polypeptide-associated complex (NAC) is a ribosome-associated chaperone that is important for protein homeostasis. However, how NAC binds its substrates remains unclear. Using native electrospray ionization MS (ESI-MS), limited proteolysis, NMR, and cross-linking, we analyzed the conformational properties of NAC from Caenorhabditis elegans and studied its ability to bind proteins in different conformational states. Our results revealed that NAC adopts an array of compact and expanded conformations and binds weakly to client proteins that are unfolded, folded, or intrinsically disordered, suggestive of broad substrate compatibility. Of note, we found that this weak binding retards aggregation of the intrinsically disordered protein -synuclein both in vitro and in vivo. These findings provide critical insights into the structure and function of NAC. Specifically, they reveal the ability of NAC to exploit its conformational plasticity to bind a repertoire of substrates with unrelated sequences and structures, independently of actively translating ribosomes.	[Martin, Esther M.; Jackson, Matthew P.; Karamonos, Theodoros K.; Humes, Julia R.; Ashcroft, Alison E.; Radford, Sheena E.] Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [Gamerdinger, Martin; Gense, Karina; Deuerling, Elke] Univ Konstanz, Inst Mol Microbiol, Dept Biol, D-78454 Constance, Germany; [Martin, Esther M.] MedImmune Ltd, Granta Pk, Cambridge CB21 6GH, England	University of Leeds; University of Konstanz; AstraZeneca; Medimmune	Radford, SE (corresponding author), Univ Leeds, Fac Biol Sci, Astbury Ctr Struct Mol Biol, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	s.e.radford@leeds.ac.uk		Radford, Sheena/0000-0002-3079-8039; Humes, Julia/0000-0002-1407-7880; Gamerdinger, Martin/0000-0003-1483-8181	Wellcome Trust [094232/Z/10/Z]; Biotechnology and Biological Sciences Research Council (BBSRC) Research Equipment Initiative Grant [BB/E012558/1]; BBSRC Alert 14 Grant [BB/M012573/1]; University of Leeds; BBSRC [BB/M012573/1, BB/E012558/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council (BBSRC) Research Equipment Initiative Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC Alert 14 Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Leeds; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank the members of our laboratories for helpful discussions. We also thank Renate Schlomer and Nasir Khan for technical assistance. The Chirascan CD spectrometer and the Jeol electron microscope were purchased with funding from Wellcome Trust Grant 094232/Z/10/Z; the Synapt HDMS and Synapt HDMS G2Si mass spectrometers were purchased with funding from the Biotechnology and Biological Sciences Research Council (BBSRC) Research Equipment Initiative Grant BB/E012558/1 and BBSRC Alert 14 Grant BB/M012573/1, respectively. We also thank the University of Leeds for funding NMR instrumentation.	Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Beatrix B, 2000, J BIOL CHEM, V275, P37838, DOI 10.1074/jbc.M006368200; BRENNER S, 1974, GENETICS, V77, P71; Bush MF, 2010, ANAL CHEM, V82, P9557, DOI 10.1021/ac1022953; Cabrita LD, 2016, NAT STRUCT MOL BIOL, V23, P278, DOI 10.1038/nsmb.3182; Cabrita LD, 2009, P NATL ACAD SCI USA, V106, P22239, DOI 10.1073/pnas.0903750106; Calabrese A. N., 2018, METHODS, V2018, pS1046, DOI [10.1016/j.ymeth.2018.1002.1020, DOI 10.1016/J.YMETH.2018.1002.1020]; Calabrese AN, 2015, METHODS, V89, P38, DOI 10.1016/j.ymeth.2015.02.018; Deckert A, 2016, P NATL ACAD SCI USA, V113, P5012, DOI 10.1073/pnas.1519124113; Devine PWA, 2017, J AM SOC MASS SPECTR, V28, P1855, DOI 10.1007/s13361-017-1689-9; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Friel CT, 2009, NAT STRUCT MOL BIOL, V16, P318, DOI 10.1038/nsmb.1562; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; Gautschi M, 2001, P NATL ACAD SCI USA, V98, P3762, DOI 10.1073/pnas.071057198; Gotze M, 2012, J AM SOC MASS SPECTR, V23, P76, DOI 10.1007/s13361-011-0261-2; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Heck AJR, 2008, NAT METHODS, V5, P927, DOI 10.1038/nmeth.1265; Hoffmann A, 2010, BBA-MOL CELL RES, V1803, P650, DOI 10.1016/j.bbamcr.2010.01.017; Jurneczko E, 2011, ANALYST, V136, P20, DOI 10.1039/c0an00373e; Kaiser CM, 2006, NATURE, V444, P455, DOI 10.1038/nature05225; Kang LJ, 2012, PROTEIN SCI, V21, P911, DOI 10.1002/pro.2088; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kogan GL, 2014, MOL BIOL+, V48, P189, DOI 10.1134/S0026893314020095; Konijnenberg A, 2013, BBA-PROTEINS PROTEOM, V1834, P1239, DOI 10.1016/j.bbapap.2012.11.013; Koplin A, 2010, J CELL BIOL, V189, P57, DOI 10.1083/jcb.200910074; Kramer G, 2009, NAT STRUCT MOL BIOL, V16, P589, DOI 10.1038/nsmb.1614; Lambert W, 2013, CELL STRESS CHAPERON, V18, P75, DOI 10.1007/s12192-012-0360-4; Leitner A, 2010, MOL CELL PROTEOMICS, V9, P1634, DOI 10.1074/mcp.R000001-MCP201; Liu YW, 2010, BIOCHEMISTRY-US, V49, P2890, DOI 10.1021/bi902050p; Marklund EG, 2015, STRUCTURE, V23, P791, DOI 10.1016/j.str.2015.02.010; Meng FC, 2017, CELL MOL LIFE SCI, V74, P3069, DOI 10.1007/s00018-017-2555-4; Min K, 2010, BIOTECHNIQUES, V48, P229, DOI 10.2144/000113365; Ott AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143457; Pashley CL, 2012, J MOL BIOL, V416, P300, DOI 10.1016/j.jmb.2011.12.041; Preissler S, 2012, TRENDS BIOCHEM SCI, V37, P274, DOI 10.1016/j.tibs.2012.03.002; Radwan M, 2017, IUBMB LIFE, V69, P49, DOI 10.1002/iub.1597; Rand KD, 2009, ANAL CHEM, V81, P10019, DOI 10.1021/ac901897x; Rospert S, 2002, CELL MOL LIFE SCI, V59, P1632, DOI 10.1007/PL00012490; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Saio T, 2014, SCIENCE, V344, P597, DOI 10.1126/science.1250494; Schiffrin B, 2016, NAT STRUCT MOL BIOL, V23, P786, DOI 10.1038/nsmb.3266; Sharma SK, 2017, CELL MOL LIFE SCI, V74, P617, DOI 10.1007/s00018-016-2340-9; Sinz A, 2015, PROTEIN SCI, V24, P1193, DOI 10.1002/pro.2696; Smith DP, 2010, P NATL ACAD SCI USA, V107, P6794, DOI 10.1073/pnas.0913046107; Spreter T, 2005, J BIOL CHEM, V280, P15849, DOI 10.1074/jbc.M500160200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Stull F, 2016, NAT STRUCT MOL BIOL, V23, P53, DOI 10.1038/nsmb.3133; Suss O, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00043; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang LF, 2010, PROTEIN CELL, V1, P406, DOI 10.1007/s13238-010-0049-3; WANG S, 1995, J CELL BIOL, V130, P519, DOI 10.1083/jcb.130.3.519; Wegrzyn RD, 2006, J BIOL CHEM, V281, P2847, DOI 10.1074/jbc.M511420200; Wegrzyn RD, 2005, CELL MOL LIFE SCI, V62, P2727, DOI 10.1007/s00018-005-5292-z; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WIEDMANN B, 1994, NATURE, V370, P434, DOI 10.1038/370434a0; Woods WS, 2007, J BIOL CHEM, V282, P34555, DOI 10.1074/jbc.M705283200; Xu GH, 2007, CHEM REV, V107, P3514, DOI 10.1021/cr0682047; Young LM, 2015, NAT CHEM, V7, P73, DOI [10.1038/nchem.2129, 10.1038/NCHEM.2129]; Zhang YX, 2014, NAT STRUCT MOL BIOL, V21, P1042, DOI 10.1038/nsmb.2908	61	18	20	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8554	8568		10.1074/jbc.RA117.001568	http://dx.doi.org/10.1074/jbc.RA117.001568			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29650757	Green Published, hybrid			2022-12-26	WOS:000434205700019
J	Bock, P; Fatti, G; Ford, N; Jennings, K; Kruger, J; Gunst, C; Louis, F; Grobbelaar, N; Shanaube, K; Floyd, S; Grimwood, A; Hayes, R; Ayles, H; Fidler, S; Beyers, N				Bock, Peter; Fatti, Geoffrey; Ford, Nathan; Jennings, Karen; Kruger, James; Gunst, Colette; Louis, Francoise; Grobbelaar, Nelis; Shanaube, Kwame; Floyd, Sian; Grimwood, Ashraf; Hayes, Richard; Ayles, Helen; Fidler, Sarah; Beyers, Nulda		HPTN 071 PopART Trial Team	Attrition when providing antiretroviral treatment at CD4 counts >500cells/mu L at three government clinics included in the HPTN 071 (PopART) trial in South Africa	PLOS ONE			English	Article							FOLLOW-UP; INCOME COUNTRIES; ADULT PATIENTS; CAPE-TOWN; THERAPY; HIV; INITIATION; OUTCOMES; PREVENTION; MORTALITY	Introduction WHO recommends antiretroviral treatment (ART) for all HIV-positive individuals. This study evaluated the association between baseline CD4 count and attrition in a cohort of HIV positive adults initiating ART at three department of health (DOH) clinics routinely providing ART at baseline CD4 counts >500cells/mu L for the HPTN 071 (PopART) trial. Methods All clients attending the DOH clinics were managed according to standard care guidelines with the exception that those starting ART outside of pertinent local guidelines signed research informed consent. DOH data on all HIV-positive adult clients recorded as having initiated ART between January 2014 and November 2015 at the three study clinics was analysed. Attrition, included clients lost to follow up or died, and was defined as 'being three or more months late for an antiretroviral pharmacy pick-up appointment'. All clients were followed until attrition, transfer out or end May 2016. Results A total of 2423 clients with a median baseline CD4 count of 328 cells/mu L (IQR 195-468) were included of whom 631 (26.0%) experienced attrition and 140 (5.8%) were TFO. Attrition was highest during the first six months of ART (IR 38.3/100 PY; 95% CI 34.8-42.1). Higher attrition was found amongst those with baseline CD4 counts > 500 cells/mu L compared to those with baseline CD4 counts of 0-500 cells/mu L (aHR 1.26, 95% CI 1.05 to 1.52) This finding was confirmed on subset analyses when restricted to individuals non-pregnant at baseline and when restricted to individuals with follow up of > 12months. Conclusions Attrition in this study was high, particularly during the first six months of treatment. Attrition was highest amongst clients starting ART at baseline CD4 counts > 500 cells/mu L. Strategies to improve retention amongst ART clients, particularly those starting ART at baseline CD4 counts > 500cells/mu L, need strengthening. Improved monitoring of clients moving in and out of ART care and between clinics will assist in better understanding attrition and ART coverage in high burden countries.	[Bock, Peter; Beyers, Nulda] Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Tygerberg Campus, Western Cape, South Africa; [Fatti, Geoffrey; Louis, Francoise; Grimwood, Ashraf] Kheth Impilo, Cape Town, South Africa; [Ford, Nathan] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Jennings, Karen] City Cape Town Hlth Serv, Cape Town, South Africa; [Kruger, James] Western Cape Dept Hlth HIV Treatment & PMTCT Prog, Cape Town, South Africa; [Gunst, Colette] Cape Winelands Dist Brewelskloof Hosp, Western Cape Dept Hlth, Worcester, South Africa; [Gunst, Colette] Stellenbosch Univ, Div Family Med & Primary Hlth Care, Fac Med & Hlth Sci, Tygerberg Campus, Western Cape, South Africa; [Grobbelaar, Nelis] ANOVA Healthcare, Paarl, South Africa; [Shanaube, Kwame; Ayles, Helen] Univ Zambia, Zambart, Ridgeway Campus, Lusaka, Zambia; [Floyd, Sian; Hayes, Richard] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Ayles, Helen] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Fidler, Sarah] Imperial Coll London, Dept Med, St Marys Campus, London, England	Stellenbosch University; University of Cape Town; Stellenbosch University; University of Zambia; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; Imperial College London	Bock, P (corresponding author), Stellenbosch Univ, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Fac Med & Hlth Sci, Tygerberg Campus, Western Cape, South Africa.	peterb@sun.ac.za	Fatti, Geoffrey/AAA-9217-2019	Fatti, Geoffrey/0000-0002-6467-662X; Bock, Peter/0000-0003-3211-6078; Ayles, Helen/0000-0003-4108-2842; Shanaube, Kwame/0000-0001-7899-0890; Fidler, Sarah/0000-0003-1676-7583; Hayes, Richard/0000-0002-1729-9892	National Institute of Allergy and Infectious Diseases (NIAID) [UM1-AI068619, UM1-AI068617, UM1-AI068613]; U.S. President's Emergency Plan for AIDS Relief (PEPFAR); NIAID; National Institute of Mental Health (NIMH); National Institute on Drug Abuse (NIDA); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068617] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); International Initiative for Impact Evaluation (3ie); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	HPTN 071 is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1-AI068617, and UM1-AI068613, with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Additional funding is provided through NIAID, the National Institute of Mental Health (NIMH), the National Institute on Drug Abuse (NIDA), and the International Initiative for Impact Evaluation (3ie) with support from the Bill & Melinda Gates Foundation to RH.	Berheto TM, 2014, N AM J MED SCI, V6, P453, DOI 10.4103/1947-2714.141636; Bond V, 2016, AIDS PATIENT CARE ST, V30, P425, DOI 10.1089/apc.2016.0114; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Clouse K, 2013, AIDS, V27, P645, DOI 10.1097/QAD.0b013e32835c12f9; Cornell M, 2010, AIDS, V24, P2263, DOI 10.1097/QAD.0b013e32833d45c5; Danel C, 2015, NEW ENGL J MED, V373, P808, DOI 10.1056/NEJMoa1507198; Fatti G, 2011, JAIDS-J ACQ IMM DEF, V58, pE17, DOI 10.1097/QAI.0b013e318229baab; Fox MP, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20888; Fox MP, 2015, JAIDS-J ACQ IMM DEF, V69, P98, DOI 10.1097/QAI.0000000000000553; Grimsrud A, 2016, J EPIDEMIOL COMMUN H, V70, P549, DOI 10.1136/jech-2015-206629; Grimsrud A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19984; Gupta S, 2013, JAIDS-J ACQ IMM DEF, V62, pE87, DOI 10.1097/QAI.0b013e31827e4992; Hayes R, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-57; Hennessey C., 2016, LOST FOUND SILENT TR; Kaplan R, 2014, SAMJ S AFR MED J, V104, P204, DOI [10.7196/samj.7696, 10.7196/SAMJ.7696]; Koole O, 2014, TROP MED INT HEALTH, V19, P1397, DOI 10.1111/tmi.12386; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Lockman S, 2012, CURR OPIN HIV AIDS, V7, P131, DOI 10.1097/COH.0b013e32834fcf6b; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Matyanga CMJ, 2016, PUBLIC HEALTH ACTION, V6, P97, DOI 10.5588/pha.15.0077; Ndagijimana A, 2015, PUBLIC HEALTH ACTION, V5, P209, DOI 10.5588/pha.15.0093; Okoboi S, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.5.20841; Osler M, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18908; Stinson K, 2014, CLIN INFECT DIS, V58, P1344, DOI 10.1093/cid/ciu072; Thida A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108615; UNAIDS, 2014, 90 90 90 AMB TREATM; UNAIDS, 2016, AIDSINFO DAT; Western Cape Department of Health, 2015, W CAP ANT TREATM GUI; Western Cape Department of Health, 2016, W CAP PROV HAST DIR; Western Cape Department of Health, 2015, GUID ART CLUBS; Wilkinson LS, 2015, TROP MED INT HEALTH, V20, P365, DOI 10.1111/tmi.12434; World Health Organization, 2015, GUID START ANT THER; Yiannoutsos CT, 2012, SEX TRANSM INFECT, V88, pI33, DOI 10.1136/sextrans-2012-050658	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195127	10.1371/journal.pone.0195127	http://dx.doi.org/10.1371/journal.pone.0195127			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672542	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000430446800019
J	Nishio, M; Nishizawa, M; Sugiyama, O; Kojima, R; Yakami, M; Kuroda, T; Togashi, K				Nishio, Mizuho; Nishizawa, Mitsuo; Sugiyama, Osamu; Kojima, Ryosuke; Yakami, Masahiro; Kuroda, Tomohiro; Togashi, Kaori			Computer-aided diagnosis of lung nodule using gradient tree boosting and Bayesian optimization	PLOS ONE			English	Article							CANCER; CLASSIFICATION	We aimed to evaluate a computer-aided diagnosis (CADx) system for lung nodule classification focussing on (i) usefulness of the conventional CADx system (hand-crafted imaging feature + machine learning algorithm), (ii) comparison between support vector machine (SVM) and gradient tree boosting (XGBoost) as machine learning algorithms, and (iii) effectiveness of parameter optimization using Bayesian optimization and random search. Data on 99 lung nodules (62 lung cancers and 37 benign lung nodules) were included from public databases of CT images. A variant of the local binary pattern was used for calculating a feature vector. SVM or XGBoost was trained using the feature vector and its corresponding label. Tree Parzen Estimator (TPE) was used as Bayesian optimization for parameters of SVM and XGBoost. Random search was done for comparison with TPE. Leave-one-out cross-validation was used for optimizing and evaluating the performance of our CADx system. Performance was evaluated using area under the curve (AUC) of receiver operating characteristic analysis. AUC was calculated 10 times, and its average was obtained. The best averaged AUC of SVM and XGBoost was 0.850 and 0.896, respectively; both were obtained using TPE. XGBoost was generally superior to SVM. Optimal parameters for achieving high AUC were obtained with fewer numbers of trials when using TPE, compared with random search. Bayesian optimization of SVM and XGBoost parameters was more efficient than random search. Based on observer study, AUC values of two board-certified radiologists were 0.898 and 0.822. The results show that diagnostic accuracy of our CADx system was comparable to that of radiologists with respect to classifying lung nodules.	[Nishio, Mizuho; Yakami, Masahiro; Togashi, Kaori] Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, Kyoto, Kyoto, Japan; [Nishio, Mizuho; Sugiyama, Osamu; Yakami, Masahiro] Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Sakyo Ku, Kyoto, Kyoto, Japan; [Nishizawa, Mitsuo] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka, Japan; [Kojima, Ryosuke] Kyoto Univ, Dept Biomed Data Intelligence, Grad Sch Med, Sakyo Ku, Kyoto, Kyoto, Japan; [Kuroda, Tomohiro] Kyoto Univ Hosp, Div Med Informat Technol & Adm Plannnig, Sakyo Ku, Kyoto, Kyoto, Japan	Kyoto University; Kyoto University; Osaka Medical College; Kyoto University; Kyoto University	Nishio, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Diagnost Imaging & Nucl Med, Sakyo Ku, Kyoto, Kyoto, Japan.; Nishio, M (corresponding author), Kyoto Univ Hosp, Preempt Med & Lifestyle Dis Res Ctr, Sakyo Ku, Kyoto, Kyoto, Japan.	nmizuha@kuhp.kyota-u.ac.jp	Nishio, Mizuho/ACC-0897-2022; Nishizawa, Mitsuo/AAT-4154-2021; Kuroda, Tomohiro/F-7041-2010	Kuroda, Tomohiro/0000-0003-1472-7203	JSPS KAKENHI [JP16K19883]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by JSPS KAKENHI (Grant Number JP16K19883). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle DR, 2013, J CLIN ONCOL, V31, P1002, DOI 10.1200/JCO.2012.43.3110; Aberle DR, 2011, NEW ENGL J MED, V365, P395, DOI 10.1056/NEJMoa1102873; Arai K, 2012, INT J ADV COMPUT SC, V3, P89; Armato III S. G., 2015, **DATA OBJECT**, DOI [10.7937/K9/TCIA.2015.UZLSU3FL, DOI 10.7937/K9/TCIA.2015.UZLSU3FL]; Armato SG, 2016, J MED IMAGING, V3, DOI 10.1117/1.JMI.3.4.044506; Armato SG, 2015, J MED IMAGING, V2, DOI 10.1117/1.JMI.2.2.020103; Benzakoun J, 2016, EUR J RADIOL, V85, P1728, DOI 10.1016/j.ejrad.2016.07.011; Bergstra J, 2012, 25 ANN C NEUR INF PR; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Cao P, 2017, PATTERN RECOGN, V64, P327, DOI 10.1016/j.patcog.2016.11.007; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Ciompi F, 2017, SCI REP-UK, V7, DOI 10.1038/srep46479; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; de Carvalho Filho AO, 2017, J DIGIT IMAGING, P1; Doi K, 2007, COMPUT MED IMAG GRAP, V31, P198, DOI 10.1016/j.compmedimag.2007.02.002; El-Baz A, 2013, INT J BIOMED IMAGING, V2013, DOI [10.1155/2013/517632, 10.1155/2013/942353]; Gevaert O, 2012, RADIOLOGY, V264, P387, DOI 10.1148/radiol.12111607; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Hui Chen, 2010, Academic Radiology, V17, P595, DOI 10.1016/j.acra.2009.12.009; Kawagishi M, 2017, INT J COMPUT ASS RAD, V12, P767, DOI 10.1007/s11548-017-1554-0; Lee SLA, 2012, MACH VISION APPL, V23, P151, DOI 10.1007/s00138-010-0271-2; Liang MZ, 2016, RADIOLOGY, V281, P279, DOI 10.1148/radiol.2016150063; Lin D, 2016, NEUROCOMPUTING, V216, P700, DOI 10.1016/j.neucom.2016.08.039; Liu Y, 2017, J BIOMED INFORM, V75, pS105, DOI 10.1016/j.jbi.2017.05.015; Lorenz R, 2015, STOPPING CRITERIA BO; Mahersia H., 2015, International Journal of Advanced Research in Artificial Intelligence, V4, P38; Matsumoto S, 2006, MED IMAGE ANAL, V10, P343, DOI 10.1016/j.media.2005.07.001; Monti R, 2016, INT WORKSHOP PATTERN, P13; Nishio M, 2017, ACAD RADIOL, V24, P328, DOI 10.1016/j.acra.2016.11.007; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Sandy Napel, NSCLC RADIOGENOMICS, DOI [10.7937/K9/TCIA.2014.X7ONY6B1, DOI 10.7937/K9/TCIA.2014.X7ONY6B1]; Schubert T, 2016, IEEE INT CONF ROBOT, P5548, DOI 10.1109/ICRA.2016.7487771; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith LN, ARXIV170401568; Suzuki K, 2017, IMAGE BASED COMPUTER, P9, DOI [10.1007/978-981-10-2945-5_2, DOI 10.1007/978-981-10-2945-5_2]; Suzuki K, 2012, QUANT IMAG MED SURG, V2, P163, DOI 10.3978/j.issn.2223-4292.2012.09.02; Torlay L, 2017, BRAIN INFORM, P1, DOI [10.1007/s40708-017-0065-7, DOI 10.1007/S40708-017-0065-7]; Way T, 2010, ACAD RADIOL, V17, P323, DOI 10.1016/j.acra.2009.10.016; Wei B, 2013, CHINESE SCI BULL, V58, P2828, DOI 10.1007/s11434-012-5475-6; Zhao GY, 2007, IEEE T PATTERN ANAL, V29, P915, DOI 10.1109/TPAMI.2007.1110	42	46	47	5	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195875	10.1371/journal.pone.0195875	http://dx.doi.org/10.1371/journal.pone.0195875			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672639	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800054
J	Vidondo, B				Vidondo, Beatriz			Amplification of the basic reproduction number in cattle farm networks	PLOS ONE			English	Article							DISEASE-CONTROL; MOVEMENTS	The popularly known 20-80 rule or Pareto rule states that 20% of efforts leads to 80% of results. This rule has been applied to the study of infection transmission in contact networks, and specifically, contact networks between cattle farms. Woolhouse and collaborators showed that targeting interventions for disease control and prevention to the 20% of the farms that contribute the most to the basic reproduction number (Ro), could reduce it by 80%. The rule results from the number of incoming and outgoing contacts per farm being highly heterogeneous. Besides, Woolhouse and collaborators showed that this high contact heterogeneity, together with a high positive correlation between the number of incoming and outgoing animal movements per farm leads to an amplification in the Ro. Two previous studies carried out with Scottish cattle transport data found either no correlation or only a weak correlation (rho up to 0.33) when using weighted data. Using data from the contacts between Swiss cattle farms in 2015, we found that the 20-80 rule applies with respect to Ro, although the proportion of highly active farms is smaller (11%). Besides, a positive strong correlation (rho = 0.64, weighted data) between the incoming and outgoing contacts of farms exists. This means that the amplification of Ro (due to the contact heterogeneities and the existing correlation) in cattle contact networks can be much higher than known until now. Our results highlight the importance of an effective active surveillance, more so than in other countries were these amplification mechanisms are absent.	[Vidondo, Beatriz] Univ Bern, Vet Publ Hlth Inst, Bern, Switzerland	University of Bern	Vidondo, B (corresponding author), Univ Bern, Vet Publ Hlth Inst, Bern, Switzerland.	beatriz.vidondo@gmx.ch		Vidondo, Beatriz/0000-0001-9693-2301				Amaral LAN, 2000, P NAT ACAD SCI US, V97, DOI [10.1073?pnas.200327197, DOI 10.1073?PNAS.200327197]; ANDERSON R M, 1991; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Dutta BL, 2014, PREV VET MED, V117, P79, DOI 10.1016/j.prevetmed.2014.09.005; European Food Safety Authority, 2016, EUR FOOD SAF AUTH J, V14, DOI [10.2903/j.efsa.2016.4573/full, DOI 10.2903/J.EFSA.2016.4573/FULL]; Gillespie CS, 2014, J STAT SOFTW, V64, P1, DOI [DOI 10.18637/JSS.V064.I02, 10.18637/jss.v064.i02]; Identitas AG, 2015, TAT; Kao RR, 2007, J R SOC INTERFACE, V4, P907, DOI 10.1098/rsif.2007.1129; Klugman S., 2004, LOSS MODELS DATA DEC; Mweu MM, 2013, PREV VET MED, V110, P379, DOI 10.1016/j.prevetmed.2013.02.015; Noremark M, 2011, PREV VET MED, V99, P78, DOI 10.1016/j.prevetmed.2010.12.009; Scharrer S, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0468-8; Swiss Confederation, SWISS CONF; Swiss Federal Food Safety and Veterinary Office, 2016, TIERG 2015; Volkova VV, 2010, EPIDEMICS-NETH, V2, P116, DOI 10.1016/j.epidem.2010.05.004; Volkova VV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011185; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2005, BIOL LETTERS, V1, P350, DOI 10.1098/rsbl.2005.0331	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0191257	10.1371/journal.pone.0191257	http://dx.doi.org/10.1371/journal.pone.0191257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672512	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800001
J	Bier, G; Bier, S; Bongers, MN; Othman, A; Ernemann, U; Hempel, JM				Bier, Georg; Bier, Simone; Bongers, Malte Niklas; Othman, Ahmed; Ernemann, Ulrike; Hempel, Johann-Martin			Value of computed tomography texture analysis for prediction of perioperative complications during laparoscopic partial nephrectomy in patients with renal cell carcinoma	PLOS ONE			English	Article							INVASIVE PARTIAL NEPHRECTOMY; MAYO ADHESIVE PROBABILITY; ADHERENT PERINEPHRIC FAT; TUMOR HETEROGENEITY; SCORING SYSTEM; PELVIC SCORE; CT; OUTCOMES; CLASSIFICATION; VARIABILITY	Purpose Tumorous texture is a marker for tumor tissue inhomogeneity. Based on this assumption, this study aims to evaluate the value of computed tomography texture analysis for imaging-based prediction of perioperative complications during laparoscopic partial tumor nephrectomy. Methods A total of 106 patients with histologically confirmed renal cell carcinoma and pre-operative CT were included and volumetric texture analysis of the tumors was performed by two readers. Texture analysis parameter ratios and differences were calculated using the kidney parenchyma as reference ("reference-corrected"). Regression analysis was performed, regarding the value of the texture analysis parameters, for assessment of the tumor nuclear grade and the prediction of peri- and postoperative complications and approximated blood loss. Moreover, the inter-rater agreement in terms of the intra-class correlation coefficient (ICC) was calculated. Results Regarding the reference-corrected values, the predictive value of texture analysis parameters for severe perioperative complications was highest for the standard deviation of the mean attenuation (Area under curve/AUC, .615; sensitivity, 93.8%, specificity, 30.0%), followed by the uniformity (AUC, .599; sensitivity, 62.5%, specificity, 60.0%), and the uniformity of distribution of positive pixels (AUC, .597; sensitivity, 62.5%; specificity, 61.1%). Regarding the blood loss, the uniformity of positive pixel values (UPP; AUC, 0.638), uniformity (AUC, 0.635), and entropy (AUC, 0.633) yielded the best predictive values, whilst the tumor grade was a weaker predictor (AUC, 0.574). The applied texture analysis parameters did not correlate with the time of surgery or the warm ischemic time. All measured parameters were better predictors for complications than the tumor diameter alone. The inter-rater agreement was almost perfect (ICC, .982). Conclusion CT and CT texture analysis parameters are valuable for prediction of perioperative outcome before laparoscopic partial nephrectomy in patients with renal cell carcinoma.	[Bier, Georg; Ernemann, Ulrike; Hempel, Johann-Martin] Eberhard Karls Univ Tuebingen, Dept Neuroradiol, Tubingen, Germany; [Bier, Simone] Eberhard Karls Univ Tuebingen, Dept Urol, Tubingen, Germany; [Bongers, Malte Niklas; Othman, Ahmed] Eberhard Karls Univ Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Bier, G (corresponding author), Eberhard Karls Univ Tuebingen, Dept Neuroradiol, Tubingen, Germany.	georg.bier@med.uni-tuebingen.de		othman, ahmed mohamed abdel ghany/0000-0002-0405-8918; Bier, Georg/0000-0002-1034-5681; Othman, Ahmed/0000-0002-3827-8695				Benway BM, 2009, J UROLOGY, V182, P866, DOI 10.1016/j.juro.2009.05.037; Bier S, 2017, ANTICANCER RES, V37, P1369, DOI 10.21873/anticanres.11457; Chang XF, 2015, J UROLOGY, V194, P897, DOI 10.1016/j.juro.2015.03.095; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Davidiuk AJ, 2014, EUR UROL, V66, P1165, DOI 10.1016/j.eururo.2014.08.054; Delahunt B, 2013, AM J SURG PATHOL, V37, P1490, DOI 10.1097/PAS.0b013e318299f0fb; Dercle L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08310-5; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Ganeshan B, 2013, CANCER IMAGING, V13, P140, DOI 10.1102/1470-7330.2013.0015; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Haider MA, 2017, CANCER IMAGING, V17, DOI 10.1186/s40644-017-0106-8; Hempel JM, 2017, J NEURO-ONCOL, V131, P93, DOI 10.1007/s11060-016-2272-0; Hodgdon T, 2015, RADIOLOGY, V276, P787, DOI 10.1148/radiol.2015142215; Jain S, 2013, J UROLOGY, V189, P1643, DOI 10.1016/j.juro.2012.11.170; Kayser K, 1999, CELL TISSUE RES, V296, P443, DOI 10.1007/s004410051305; Kocher NJ, 2016, BJU INT, V117, P636, DOI 10.1111/bju.13378; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Lam JS, 2007, EUR UROL, V52, P155, DOI 10.1016/j.eururo.2007.01.106; Lubner MG, 2016, AM J ROENTGENOL, V207, P96, DOI 10.2214/AJR.15.15451; Mathieu R, 2013, BJU INT, V112, pE283, DOI 10.1111/bju.12222; Monn MF, 2014, J ENDOUROL, V28, P1132, DOI 10.1089/end.2014.0259; Raman SP, 2014, ACAD RADIOL, V21, P1587, DOI 10.1016/j.acra.2014.07.023; Ramani AP, 2005, J UROLOGY, V173, P42, DOI 10.1097/01.ju.0000147177.20458.73; Schieda N, 2015, AM J ROENTGENOL, V204, P1013, DOI 10.2214/AJR.14.13279; Shannon CE, 1997, M D COMPUT, V14, P306; Simmons MN, 2010, J UROLOGY, V183, P1708, DOI 10.1016/j.juro.2010.01.005; Spaliviero M, 2016, EUR UROL, V69, P72, DOI 10.1016/j.eururo.2015.08.008; Spaliviero M, 2015, WORLD J UROL, V33, P853, DOI 10.1007/s00345-014-1376-4; Tomaszewski JJ, 2014, UROLOGY, V84, P351, DOI 10.1016/j.urology.2014.05.001; Vilaseca Richard Mast, 2017, Radiol Bras, V50, P7, DOI 10.1590/0100-3984.2015.0174; Yagasaki H, 2003, INT J UROL, V10, P220, DOI 10.1046/j.0919-8172.2003.00608.x; Yasaka K, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006993	32	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195270	10.1371/journal.pone.0195270	http://dx.doi.org/10.1371/journal.pone.0195270			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668695	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200037
J	Monteiro, JGM; Torres, DDC; da Silva, MCFC; Martins, CMD; da Silva, IK; do Nascimento, MEM; dos Santos, ACO; Montarroyos, UR; Sobral, DC				de Moura Monteiro Junior, Jose Gildo; Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Holanda Martins, Cyntia Maria; da Silva, Izadora Karina; Mendonca do Nascimento, Monique Evelyn; Oliveira dos Santos, Ana Celia; Montarroyos, Ulisses Ramos; Sobral Filho, Dario Celestino			Prognostic value of hematological parameters in patients with acute myocardial infarction: Intrahospital outcomes	PLOS ONE			English	Article							TO-LYMPHOCYTE RATIO; CORONARY-ARTERY-DISEASE; MEAN PLATELET VOLUME; RED-BLOOD-CELLS; TERM PROGNOSIS; NEUTROPHIL; SEVERITY; ASSOCIATION; MORTALITY; INTERVENTION	Background The intensity of the inflammatory response and hemodynamic repercussion in acute myocardial infarction causing the presence in the peripheral circulation of nucleated red blood cells (NRBCs), increases in mean platelet volume (MPV) and neutrophil to lymphocyte ratio (NLR) are associated with a poorer prognosis. The aim of this study was to assess the role of these hematological biomarkers as predictors of all causes of mortality during the hospitalization of patients with acute myocardial infarction. Methods Nucleated red blood cells, mean platelet volume and neutrophil to lymphocyte ratio were measured daily during the hospitalization of the patients with acute myocardial infarction. We excluded patients younger than 18 years, on glucocorticoid therapy, with cancer or hematological diseases and those that were readmitted after hospital discharge. We performed a multiple logistic analysis to identify independent predictors of mortality. Results We included 466 patients (mean age 64.2 +/- 12.8 years, 61.6% male). The prevalence of NRBCs in the sample was 9.1% (42 patients), with levels > 200/mu L in 27 patients (5.8%). The mean MPV value was 10.9 +/- 0,9 and the mean NLR value was 3.71 (2,38; 5,72). In a multivariate analysis of serum NRBCs (HR 2.42, 95% CI: 1.35-4.36, p = 0.003), MPV (HR 2.97, 95% CI: 1.15-7.67, p = 0.024) and NLR (HR 5.02, 95% CI: 1.68-15.0, p = 0.004). The presence in the peripheral blood of NRBCs, increased in mean platelet volume and neutrophil to lymphocyte ratio were associated with higher mortality. Conclusions Nucleated red blood cells, mean platelet volume and neutrophil to lymphocyte ratio are independent predictors of intrahospital mortality. Therefore, an important tool in intrahospital clinical surveillance.	[de Moura Monteiro Junior, Jose Gildo; da Silva, Izadora Karina; Mendonca do Nascimento, Monique Evelyn] Univ Pernambuco UPE, Pernambuco Cardiac Emergency Hosp, Coronary Care Unit PROCAPE, Recife, PE, Brazil; [Cipriano Torres, Dilenia de Oliveira; Freire Clementino da Silva, Maria Cleide; de Holanda Martins, Cyntia Maria] Univ Pernambuco, Lab PROCAPE, Recife, PE, Brazil; [Oliveira dos Santos, Ana Celia; Montarroyos, Ulisses Ramos; Sobral Filho, Dario Celestino] Univ Pernambuco, Recife, PE, Brazil	Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE)	Monteiro, JGM (corresponding author), Univ Pernambuco UPE, Pernambuco Cardiac Emergency Hosp, Coronary Care Unit PROCAPE, Recife, PE, Brazil.	jgildojunior@uol.com.br	Filho, Dario Sobral/H-8624-2019; de Moura Monteiro Júnior, José Gildo/R-3977-2017; Montarroyos, Ulisses/AAJ-7527-2020; Santos, Ana/ABC-5276-2021	Filho, Dario Sobral/0000-0002-5301-7741; de Moura Monteiro Júnior, José Gildo/0000-0002-8983-8744; SANTOS, ANA CELIA OLIVEIRA DOS/0000-0002-9170-5684				Acet H, 2016, CLIN APPL THROMB-HEM, V22, P60, DOI 10.1177/1076029614533145; Acet H, 2015, ANATOL J CARDIOL, V15, P648, DOI 10.5152/akd.2014.5592; Akin F, 2013, ANGIOLOGY, V64, P592, DOI 10.1177/0003319712461931; Anderson JL, 2017, NEW ENGL J MED, V376, P2053, DOI 10.1056/NEJMra1606915; Ayca B, 2015, PLATELETS, V26, P816, DOI 10.3109/09537104.2015.1015410; Azab B, 2010, AM J CARDIOL, V106, P470, DOI 10.1016/j.amjcard.2010.03.062; Bekler A, 2015, ANGIOLOGY, V66, P638, DOI 10.1177/0003319714545779; Bolca O, 2015, CORONARY ARTERY DIS, V26, P402, DOI 10.1097/MCA.0000000000000254; Budzianowski J, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/3041565; Choi YH, 2014, J KOREAN MED SCI, V29, P950, DOI 10.3346/jkms.2014.29.7.950; Monteiro JGD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144259; Dehghani Mohammad Reza, 2014, Indian Heart J, V66, P622, DOI 10.1016/j.ihj.2014.10.415; Desai S, 2012, SURG INFECT, V13, P360, DOI 10.1089/sur.2011.089; Gazi E, 2015, CLIN APPL THROMB-HEM, V21, P155, DOI 10.1177/1076029613492011; Hartopo AB, 2015, ACTA MED INDONES, V47, P3; He JY, 2014, INT J CLIN EXP PATHO, V7, P4045; Hudzik B, 2016, J DIABETES COMPLICAT, V30, P1097, DOI 10.1016/j.jdiacomp.2016.04.010; Kalay N, 2012, ANGIOLOGY, V63, P213, DOI 10.1177/0003319711412763; Kaya H, 2014, CLIN APPL THROMB-HEM, V20, P221, DOI 10.1177/1076029613499821; Klovaite J, 2011, J THROMB HAEMOST, V9, P49, DOI 10.1111/j.1538-7836.2010.04110.x; Kuert S, 2011, CLIN CHEM LAB MED, V49, P257, DOI 10.1515/CCLM.2011.041; Kurtul A, 2017, AM J CARDIOL, V120, P534, DOI 10.1016/j.amjcard.2017.05.020; Kurtul A, 2014, AM J CARDIOL, V114, P972, DOI 10.1016/j.amjcard.2014.07.005; Kurtul A, 2014, AM J CARDIOL, V114, P342, DOI 10.1016/j.amjcard.2014.04.045; Kurtul S, 2015, INT HEART J, V56, P18, DOI 10.1536/ihj.14-175; Larsen SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085566; Murat SN, 2013, ANGIOLOGY, V64, P131, DOI 10.1177/0003319711436247; Nakul-Aquaronne D, 2003, J CLIN LAB ANAL, V17, P113, DOI 10.1002/jcla.10083; Nunez J, 2010, CORONARY ARTERY DIS, V21, P1, DOI 10.1097/MCA.0b013e328332ee15; Oncel RC, 2015, CLIN APPL THROMB-HEM, V21, P383, DOI 10.1177/1076029613505763; Pipitone S, 2012, CLIN CHEM LAB MED, V50, P1857, DOI 10.1515/cclm-2012-0148; Rechcinski T, 2013, CARDIOL J, V20, P491, DOI 10.5603/CJ.2013.0134; Sabatine MS, 2002, J AM COLL CARDIOL, V40, P1761, DOI 10.1016/S0735-1097(02)02484-1; Sahin DY, 2013, ANGIOLOGY, V64, P423, DOI 10.1177/0003319712453305; Soylu K, 2015, REV PORT CARDIOL, V34, P465, DOI 10.1016/j.repc.2015.01.013; Stachon A, 2007, CRIT CARE, V11, DOI 10.1186/cc5932; Taskesen T, 2017, AM J CARDIOL, V119, P192, DOI 10.1016/j.amjcard.2016.09.042; Uysal HB, 2016, KOREAN J INTERN MED, V31, P1093, DOI 10.3904/kjim.2015.199; Verdoia M, 2016, ANGIOLOGY, V67, P75, DOI 10.1177/0003319715577529; Williams BA, 2013, HEART LUNG, V42, P436, DOI 10.1016/j.hrtlng.2013.07.013; Yalcinkaya E, 2015, ARQ BRAS CARDIOL, V104, P112, DOI 10.5935/abc.20140179; Zhang GY, 2014, GENET MOL RES, V13, P9382, DOI 10.4238/2014.November.11.4	42	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194897	10.1371/journal.pone.0194897	http://dx.doi.org/10.1371/journal.pone.0194897			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668734	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200018
J	Nguyen, DT; Jenkins, HE; Graviss, EA				Nguyen, Duc T.; Jenkins, Helen E.; Graviss, Edward A.			Prognostic score to predict mortality during TB treatment in TB/HIV co-infected patients	PLOS ONE			English	Article							BAYESIAN MODEL SELECTION; LONG-TERM MORTALITY; TUBERCULOSIS; ADULTS; DIAGNOSIS; DEATH	Background Estimating mortality risk during TB treatment in HIV co-infected patients is challenging for health professionals, especially in a low TB prevalence population, due to the lack of a standardized prognostic system. The current study aimed to develop and validate a simple mortality prognostic scoring system for TB/HIV co-infected patients. Methods Using data from the CDC's Tuberculosis Genotyping Information Management System of TB patients in Texas reported from 01/2010 through 12/2016, age >= 15 years, HIV(+), and outcome being "completed" or "died", we developed and internally validated a mortality prognostic score using multiple logistic regression. Model discrimination was determined by the area under the receiver operating characteristic (ROC) curve (AUC). The model's good calibration was determined by a non-significant Hosmer-Lemeshow's goodness of fit test. Results Among the 450 patients included in the analysis, 57 (12.7%) died during TB treatment. The final prognostic score used six characteristics (age, residence in long-term care facility, meningeal TB, chest x-ray, culture positive, and culture not converted/unknown), which are routinely collected by TB programs. Prognostic scores were categorized into three groups that predicted mortality: low-risk (< 20 points), medium-risk (20-25 points) and high-risk (> 25 points). The model had good discrimination and calibration (AUC = 0.82; 0.80 in bootstrap validation), and a non-significant Hosmer-Lemeshow test p = 0.71. Conclusion Our simple validated mortality prognostic scoring system can be a practical tool for health professionals in identifying TB/HIV co-infected patients with high mortality risk.	[Nguyen, Duc T.; Graviss, Edward A.] Houston Methodist Hosp Inst, Houston, TX 77030 USA; [Jenkins, Helen E.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA	The Methodist Hospital System; The Methodist Hospital - Houston; Boston University	Graviss, EA (corresponding author), Houston Methodist Hosp Inst, Houston, TX 77030 USA.	eagraviss@houstonmethodist.org	Nguyen, Duc/AAX-1819-2021; Nguyen, Duc T/ABH-7913-2020	Nguyen, Duc/0000-0002-5059-4404; Nguyen, Duc T/0000-0002-5059-4404; Jenkins, Helen/0000-0003-4749-1591	U.S. National Institutes of Health (US NIH) [K01AI102944]	U.S. National Institutes of Health (US NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HEJ was supported by the U.S. National Institutes of Health (US NIH K01AI102944 award). The content is solely the responsibility of the authors and does not necessarily represent the views of the U.S. National Institute of Allergy and Infectious Diseases or the U.S. National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anonymous, 2010, Morbidity and Mortality Weekly Report, V59, P626; Bastos HN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162797; Boscoe FP, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.140395; *CDCP, 2009, REP VER CAS TUB RVCT, DOI DOI 10.5588/IJTLD.12.0476; Centers for Disease Control and Prevention, 2015, REP TUB US; Centers for Disease Control and Prevention, 2015, NTSS DAT REF GUID; Centers for Disease Control and Prevention, 2013, COR CURR TUB WHAT CL; Christensen ASH, 2014, CLIN EPIDEMIOL, V6, P405, DOI 10.2147/CLEP.S65331; Djouma FN, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0876-1; Dunson DB, 2005, LIFETIME DATA ANAL, V11, P213, DOI 10.1007/s10985-004-0384-x; Flacker JM, 2003, J AM GERIATR SOC, V51, P213, DOI 10.1046/j.1532-5415.2003.51060.x; Horita N, 2013, INT J TUBERC LUNG D, V17, P54, DOI 10.5588/ijtld.12.0476; Lee HG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1640-x; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Lui G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092077; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Cruz-Hervert LP, 2012, AGE AGEING, V41, P488, DOI 10.1093/ageing/afs028; Padyana M, 2012, N AM J MED SCI, V4, P221, DOI 10.4103/1947-2714.95904; Podlekareva DN, 2013, INT J TUBERC LUNG D, V17, P198, DOI 10.5588/ijtld.12.0224; Podlekareva DN, 2014, EUR RESPIR J, V43, P166, DOI 10.1183/09031936.00138712; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Texas Department of State Health Services, TB HANS DIS BRANCH T; Texas Department of State Health Services. Epidemiology and Supplemental Projects Group, 2016, TEX TB SURV ANN REP; Texas Department of State Health Services. Epidemiology and Supplemental Projects Group, 2015, TEX TB SURV ANN REP; Thomas JM, 2013, J AM GERIATR SOC, V61, P902, DOI 10.1111/jgs.12273; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wasserman L, 2000, J MATH PSYCHOL, V44, P92, DOI 10.1006/jmps.1999.1278; World Health Organization, GLOB TUB REP 2017	28	13	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0196022	10.1371/journal.pone.0196022	http://dx.doi.org/10.1371/journal.pone.0196022			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659636	gold, Green Published			2022-12-26	WOS:000430061100046
J	Ramli, NM; Giatsis, C; Yusoff, FM; Verreth, J; Verdegem, M				Ramli, Norulhuda Mohamed; Giatsis, Christos; Yusoff, Fatimah Md; Verreth, Johan; Verdegem, Marc			Resistance and resilience of small-scale recirculating aquaculture systems (RAS) with or without algae to pH perturbation	PLOS ONE			English	Article							SP NOV.; HETEROTROPHIC NITRIFICATION; AEROBIC DENITRIFICATION; PHYLUM VERRUCOMICROBIA; NITROGEN REMOVAL; BACTERIA; COMMUNITY	The experimental set-up of this study mimicked recirculating aquaculture systems (RAS) where water quality parameters such as dissolved oxygen, pH, temperature, and turbidity were controlled and wastes produced by fish and feeding were converted to inorganic forms. A key process in the RAS was the conversion of ammonia to nitrite and nitrite to nitrate through nitrification. It was hypothesized that algae inclusion in RAS would improve the ammonia removal from the water; thereby improving RAS water quality and stability. To test this hypothesis, the stability of the microbiota community composition in a freshwater RAS with (RAS+A) or without algae (RAS-A) was challenged by introducing an acute pH drop (from pH 7 to 4 during three hours) to the system. Stigeoclonium nanum, a periphytic freshwater microalga was used in this study. No significant effect of the algae presence was found on the resistance to the acute pH drop on ammonia conversion to nitrite and nitrite conversion to nitrate. Also the resilience of the ammonia conversion to the pH drop disruption was not affected by the addition of algae. This could be due to the low biomass of algae achieved in the RAS. However, with regard to the conversion step of nitrite to nitrate, RAS+A was significantly more resilient than RAS-A. In terms of overall bacterial communities, the composition and predictive function of the bacterial communities was significantly different between RAS+A and RAS-A.	[Ramli, Norulhuda Mohamed; Giatsis, Christos; Verreth, Johan; Verdegem, Marc] Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands; [Ramli, Norulhuda Mohamed] Univ Putra Malaysia, Fac Engn, Dept Biol & Agr Engn, Serdang, Selangor, Malaysia; [Yusoff, Fatimah Md] Univ Putra Malaysia, Inst Biosci, Lab Marine Biotechnol, Serdang, Selangor, Malaysia; [Yusoff, Fatimah Md] Univ Putra Malaysia, Fac Agr, Dept Aquaculture, Serdang, Selangor, Malaysia	Wageningen University & Research; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Ramli, NM (corresponding author), Wageningen Univ, Aquaculture & Fisheries Grp, Wageningen, Netherlands.; Ramli, NM (corresponding author), Univ Putra Malaysia, Fac Engn, Dept Biol & Agr Engn, Serdang, Selangor, Malaysia.	norul49huda@gmail.com	Ramli, Norulhuda/Y-7734-2019; Verreth, Johan/ABD-7198-2020; Yusoff, Fatimah M/N-7065-2018; Verdegem, Marc/C-6659-2014	Verreth, Johan/0000-0001-7277-5129; Yusoff, Fatimah M/0000-0003-4438-9065; Verdegem, Marc/0000-0002-2058-3894	Ministry of Higher Education, Malaysia (Skim Latihan Akademik IPTA); International Foundation for Science [A/5348-1 - NMR]; Malaysia-Japan Collaborative Research SATREPS on COSMOS (Continuous Operating System for Microalgae Culture Optimized for Sustainable Tropical Aquaculture)	Ministry of Higher Education, Malaysia (Skim Latihan Akademik IPTA); International Foundation for Science(International Foundation for Science); Malaysia-Japan Collaborative Research SATREPS on COSMOS (Continuous Operating System for Microalgae Culture Optimized for Sustainable Tropical Aquaculture)	This study was supported by Ministry of Higher Education, Malaysia (Skim Latihan Akademik IPTA) -NMR; International Foundation for Science grant number A/5348-1 - NMR; Malaysia-Japan Collaborative Research SATREPS on COSMOS (Continuous Operating System for Microalgae Culture Optimized for Sustainable Tropical Aquaculture)- FMY.	Amengual-Morro C, 2012, J ENVIRON MANAGE, V95, pS71, DOI 10.1016/j.jenvman.2011.07.008; APHA, 1999, STANDARD METHOD EXAM, DOI [10.1089/acm.2013.0216, DOI 10.1089/ACM.2013.0216]; Attramadal KJK, 2014, AQUACULTURE, V432, P483, DOI 10.1016/j.aquaculture.2014.05.052; Baath E, 2015, APPL ENVIRON MICROB, V81, P7411, DOI 10.1128/AEM.02236-15; Blancheton JP, 2013, AQUACULT ENG, V53, P30, DOI 10.1016/j.aquaeng.2012.11.009; Brenner A., 2013, Handbook of microalgal culture: applied phycology and biotechnology, P595; Chen PZ, 2012, BIORESOURCE TECHNOL, V116, P266, DOI 10.1016/j.biortech.2012.02.050; Cotter PD, 2003, MICROBIOL MOL BIOL R, V67, P429, DOI 10.1128/MMBR.67.3.429-453.2003; Cytryn E, 2012, APPL ENVIRON MICROB, V78, P6576, DOI 10.1128/AEM.01545-12; D'Argenio V, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-384; Dandie CE, 2004, J APPL MICROBIOL, V97, P246, DOI 10.1111/j.1365-2672.2004.02087.x; Ebeling JM, 2006, AQUACULTURE, V257, P346, DOI 10.1016/j.aquaculture.2006.03.019; Gan HM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-431; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Grossart HP, 2005, ENVIRON MICROBIOL, V7, P860, DOI 10.1111/j.1462-2920.2005.00759.x; Hartzell P., 2006, PROKARYOTES, P82; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Krohn-Molt I, 2013, APPL ENVIRON MICROB, V79, P6196, DOI 10.1128/AEM.01641-13; Kundu P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/436056; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lee J, 2014, INT J SYST EVOL MICR, V64, P663, DOI 10.1099/ijs.0.052787-0; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Martinez-Cordova LR, 2015, REV AQUACULT, V7, P131, DOI 10.1111/raq.12058; Miyashita M, 2010, INT J SYST EVOL MICR, V60, P344, DOI 10.1099/ijs.0.009365-0; Narwal SK, 2017, ADV ENV ENG GREEN TE, P186, DOI 10.4018/978-1-5225-2325-3.ch008; Natrah FMI, 2014, REV AQUACULT, V6, P48, DOI 10.1111/raq.12024; Orwin KH, 2004, SOIL BIOL BIOCHEM, V36, P1907, DOI 10.1016/j.soilbio.2004.04.036; Park J, 2013, INT J SYST EVOL MICR, V63, P1891, DOI 10.1099/ijs.0.046664-0; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Pomeroy LR, 2007, OCEANOGRAPHY, V20, P28, DOI 10.5670/oceanog.2007.45; Ramli NM, 2017, AQUACULT ENV INTERAC, V9, P213, DOI 10.3354/aei00225; Rurangwa E, 2015, REV AQUACULT, V7, P117, DOI 10.1111/raq.12057; Ryu BG, 2015, BIORESOURCE TECHNOL, V191, P496, DOI 10.1016/j.biortech.2015.03.136; Staley C, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00414; Takeuchi M, 2001, INT J SYST EVOL MICR, V51, P1405, DOI 10.1099/00207713-51-4-1405; Timmons M. B., 2002, RECIRCULATING AQUACU; Unnithan VV, 2014, ALGAL RES, V4, P35, DOI 10.1016/j.algal.2013.11.009; Vadstein O, 2012, MAR ECOL PROG SER, V447, P55, DOI 10.3354/meps09473; Wang XH, 2011, BIORESOURCE TECHNOL, V102, P2352, DOI 10.1016/j.biortech.2010.10.095; Yang XP, 2011, BIORESOURCE TECHNOL, V102, P854, DOI 10.1016/j.biortech.2010.09.007; Yoon J, 2008, INT J SYST EVOL MICR, V58, P998, DOI 10.1099/ijs.0.65520-0; Yoon J, 2007, INT J SYST EVOL MICR, V57, P2337, DOI 10.1099/ijs.0.65243-0; Zhang JB, 2011, BIORESOURCE TECHNOL, V102, P9866, DOI 10.1016/j.biortech.2011.07.118; Zhao B, 2010, BIORESOURCE TECHNOL, V101, P5194, DOI 10.1016/j.biortech.2010.02.043	44	7	8	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195862	10.1371/journal.pone.0195862	http://dx.doi.org/10.1371/journal.pone.0195862			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659617	Green Submitted, Green Published, gold			2022-12-26	WOS:000430061100038
J	Loyen, A; Chey, T; Engelen, L; Bauman, A; Lakerveld, J; van der Ploeg, HP; Brug, J; Chau, JY				Loyen, Anne; Chey, Tien; Engelen, Lina; Bauman, Adrian; Lakerveld, Jeroen; van der Ploeg, Hidde P.; Brug, Johannes; Chau, Josephine Y.			Recent trends in population levels and correlates of occupational and leisure sitting time in full-time employed Australian adults	PLOS ONE			English	Article							SEDENTARY BEHAVIOR; MORTALITY; EPIDEMIOLOGY; ASSOCIATION; RISK	This study aimed to explore the trend in population levels, as well as the correlates, of occupational and leisure sitting time in full-time employed Australian adults between 2007 and 2015. We used data from the 2007/08, 2011/12 and 2014/15 Australian Health Surveys, in which nationally representative samples of the Australian population were interviewed. Fulltime (>= 35 hours/week) employed respondents reported sitting time at work and during leisure on a usual workday. Trends over time and associations between socio-demographic and health-related characteristics and sitting time were analysed in the combined dataset using multivariable logistic regression models. Over 21,000 observations were included in the analyses. Across the three surveys, approximately 51% of the respondents reported >= 4 hours/workday occupational sitting time, 40% reported >= 4 hours/workday leisure sitting time, and 55% reported >= 7 hours/workday combined occupational and leisure sitting time. There were no clear trends over time. All potential correlates were associated with occupational sitting time and all but educational level were associated with leisure sitting time. The directions of the associations with gender, age and leisure-time physical activity were reversed for occupational sitting time and leisure sitting time. These findings show that the average levels of occupational and leisure sitting time on workdays were high but stable over the past decade. The observed differences in correlates of occupational and leisure sitting time demonstrate the need to assess and address sedentary behaviour domains separately in research and policy.	[Loyen, Anne; van der Ploeg, Hidde P.] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands; [Chey, Tien; Engelen, Lina; Bauman, Adrian; van der Ploeg, Hidde P.; Chau, Josephine Y.] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW, Australia; [Chey, Tien; Engelen, Lina; Bauman, Adrian; van der Ploeg, Hidde P.; Chau, Josephine Y.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Lakerveld, Jeroen; Brug, Johannes] Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Biostat, Amsterdam, Netherlands; [Brug, Johannes] Univ Amsterdam, Amsterdam Sch Commun Res, Amsterdam, Netherlands	Vrije Universiteit Amsterdam; University of Sydney; University of Sydney; Vrije Universiteit Amsterdam; University of Amsterdam	Loyen, A (corresponding author), Vrije Univ Amsterdam, Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Publ & Occupat Hlth, Amsterdam, Netherlands.	a.loyen@vumc.nl	van der Ploeg, Hidde P/B-2599-2013; Brug, Johannes/A-8242-2018; Engelen, Lina/S-3572-2019; van der Ploeg, Hidde/ABD-6402-2021	van der Ploeg, Hidde P/0000-0002-3719-5249; Brug, Johannes/0000-0002-1904-7349; Engelen, Lina/0000-0003-1631-6328; Lakerveld, Jeroen/0000-0002-8551-6748; Chau, Josephine/0000-0001-6261-2545	National Heart Foundation of Australia [100567]	National Heart Foundation of Australia(National Heart Foundation of Australia)	JYC was supported by a Postdoctoral Fellowship (#100567) from the National Heart Foundation of Australia (https://www.heartfoundation.org.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2013, SCAND J PUBLIC HEALT, V41, P706, DOI 10.1177/1403494813493151; [Anonymous], 2000, WHO TECH REP SER, P894; [Anonymous], 2017, DUTCH PHYS ACTIVITY; Atkin AJ, 2012, INT J EPIDEMIOL, V41, P1460, DOI 10.1093/ije/dys118; Bauman A, 2011, AM J PREV MED, V41, P228, DOI 10.1016/j.amepre.2011.05.003; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Chau JY, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-76; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Gebel Klaus, 2017, Prev Med Rep, V5, P289, DOI 10.1016/j.pmedr.2017.01.015; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Loyen A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149320; Marshall AL, 2010, MED SCI SPORT EXER, V42, P1094, DOI 10.1249/MSS.0b013e3181c5ec18; Milton K, 2015, PREV MED, V77, P11, DOI 10.1016/j.ypmed.2015.04.016; O'Donoghue G, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2841-3; Pavey TG, 2015, BRIT J SPORT MED, V49, P95, DOI 10.1136/bjsports-2012-091676; Rhodes RE, 2012, AM J PREV MED, V42, pE3, DOI 10.1016/j.amepre.2011.10.020; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; van der Ploeg HP, 2013, AM J PREV MED, V44, P382, DOI 10.1016/j.amepre.2012.11.034; van der Ploeg HP, 2012, ARCH INTERN MED, V172, P494, DOI 10.1001/archinternmed.2011.2174; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1	21	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195177	10.1371/journal.pone.0195177	http://dx.doi.org/10.1371/journal.pone.0195177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649243	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900032
J	Siddarth, P; Burggren, AC; Eyre, HA; Small, GW; Merrill, DA				Siddarth, Prabha; Burggren, Alison C.; Eyre, Harris A.; Small, Gary W.; Merrill, David A.			Sedentary behavior associated with reduced medial temporal lobe thickness in middle-aged and older adults	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; ENTORHINAL CORTEX NEURONS; MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CORTICAL THICKNESS; AEROBIC FITNESS; HEALTH OUTCOMES; SITTING TIME; EXERCISE; RISK	Atrophy of the medial temporal lobe (MTL) occurs with aging, resulting in impaired episodic memory. Aerobic fitness is positively correlated with total hippocampal volume, a heavily studied memory-critical region within the MTL. However, research on associations between sedentary behavior and MTL subregion integrity is limited. Here we explore associations between thickness of the MTL and its subregions (namely CA1, CA23DG, fusiform gyrus, subiculum, parahippocampal, perirhinal and entorhinal cortex,), physical activity, and sedentary behavior. We assessed 35 non-demented middle-aged and older adults (25 women, 10 men; 45-75 years) using the International Physical Activity Questionnaire for older adults, which quantifies physical activity levels in MET-equivalent units and asks about the average number of hours spent sitting per day. All participants had high resolution MRI scans performed on a Siemens Allegra 3T MRI scanner, which allows for detailed investigation of the MTL. Controlling for age, total MTL thickness correlated inversely with hours of sitting/day (r = -0.37, p = 0.03). In MTL subregion analysis, parahippocampal (r = -0.45, p = 0.007), entorhinal (r = -0.33, p = 0.05) cortical and subiculum (r = -0.36, p = .04) thicknesses correlated inversely with hours of sitting/day. No significant correlations were observed between physical activity levels and MTL thickness. Though preliminary, our results suggest that more sedentary non-demented individuals have less MTL thickness. Future studies should include longitudinal analyses and explore mechanisms, as well as the efficacy of decreasing sedentary behaviors to reverse this association.	[Siddarth, Prabha; Small, Gary W.; Merrill, David A.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Burggren, Alison C.] Univ Calif Los Angeles, Ctr Cognit Neurosci, Los Angeles, CA USA; [Eyre, Harris A.] Univ Adelaide, Discipline Psychiat, Adelaide, SA, Australia	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Adelaide	Siddarth, P (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	psiddarth@mednet.ucla.edu	Eyre, Harris/AAT-2457-2021		National Institutes of Health [MH077650, AT003480, P01-AG024831, AG13308, P50 AG 16570, MH/AG58156, AG10123, M01-RR00865]; Department of Energy [DE-FC03-87-ER60615]; McLoughlin Gift Fund for Cognitive Health; Larry L. Hillblom Foundation; Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Ahmanson Foundation; Lovelace Foundation; Sence Foundation; UCLA Claude Pepper Older Americans Independence Center - National Institute on Aging [5P30AG028748]; AFAR; John A. Hartford Foundation; Centers of Excellence National Program, National Institutes of Health/National Center for Advancing Translational Science (NCATS) University of California Los Angeles Center for Translational Science Investigation [UL1TR000124]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); McLoughlin Gift Fund for Cognitive Health; Larry L. Hillblom Foundation; Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research; Ahmanson Foundation; Lovelace Foundation; Sence Foundation; UCLA Claude Pepper Older Americans Independence Center - National Institute on Aging; AFAR; John A. Hartford Foundation; Centers of Excellence National Program, National Institutes of Health/National Center for Advancing Translational Science (NCATS) University of California Los Angeles Center for Translational Science Investigation	The following agencies supported the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation of the manuscript: National Institutes of Health grants MH077650, AT003480, P01-AG024831, AG13308, P50 AG 16570, MH/AG58156, AG10123, M01-RR00865, Department of Energy contract DE-FC03-87-ER60615, the McLoughlin Gift Fund for Cognitive Health, the Larry L. Hillblom Foundation, Fran and Ray Stark Foundation Fund for Alzheimer's Disease Research, Ahmanson Foundation, Lovelace Foundation, the Sence Foundation, the UCLA Claude Pepper Older Americans Independence Center funded by the National Institute on Aging (5P30AG028748), AFAR, the John A. Hartford Foundation and the Centers of Excellence National Program, National Institutes of Health/National Center for Advancing Translational Science (NCATS) University of California Los Angeles Center for Translational Science Investigation Grant Number UL1TR000124. These agencies were not involved in the approval and review of the manuscript nor in the decision to submit the manuscript for publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or other funding agencies.	Ahlskog JE, 2011, MAYO CLIN PROC, V86, P876, DOI 10.4065/mcp.2011.0252; Apostolova LG, 2007, NEUROTHERAPEUTICS, V4, P387, DOI 10.1016/j.nurt.2007.05.009; Arnardottir NY, 2016, BEHAV BRAIN RES, V296, P118, DOI 10.1016/j.bbr.2015.09.005; Barnes DE, 2011, LANCET NEUROL, V10, P819, DOI 10.1016/S1474-4422(11)70072-2; Beckett MW, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0007-2; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Booth M, 2000, RES Q EXERCISE SPORT, V71, pS114; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Burggren A, 2014, BRAIN IMAGING BEHAV, V8, P251, DOI 10.1007/s11682-013-9278-4; Chastin SFM, 2014, PHYSIOL MEAS, V35, P2319, DOI 10.1088/0967-3334/35/11/2319; Craft LL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-122; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Dickerson BC, 2009, NEUROBIOL AGING, V30, P432, DOI 10.1016/j.neurobiolaging.2007.07.022; Donix M, 2013, PSYCHIAT RES-NEUROIM, V214, P212, DOI 10.1016/j.pscychresns.2013.09.006; Donix M, 2010, AM J PSYCHIAT, V167, P1399, DOI 10.1176/appi.ajp.2010.09111575; Donix M, 2010, NEUROIMAGE, V53, P37, DOI 10.1016/j.neuroimage.2010.06.009; Eichenbaum H, 2012, NEUROSCI BIOBEHAV R, V36, P1597, DOI 10.1016/j.neubiorev.2011.07.006; Ekstrom AD, 2009, NEUROIMAGE, V47, P42, DOI 10.1016/j.neuroimage.2009.03.017; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Falck RS, 2017, BRIT J SPORT MED, V51, P800, DOI 10.1136/bjsports-2015-095551; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GomezIsla T, 1996, J NEUROSCI, V16, P4491; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hurtig-Wennlof A, 2010, PUBLIC HEALTH NUTR, V13, P1847, DOI 10.1017/S1368980010000157; Jensen CS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00187; Kordower JH, 2001, ANN NEUROL, V49, P202, DOI 10.1002/1531-8249(20010201)49:2<202::AID-ANA40>3.3.CO;2-V; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; de Rezende LFM, 2014, BMC PUBLIC HEALTH, V14, DOI [10.1186/1471-2458-14-485, 10.1186/1471-2458-14-333]; Nishijima T, 2013, BEHAV BRAIN RES, V245, P34, DOI 10.1016/j.bbr.2013.02.009; Pereira AC, 2007, P NATL ACAD SCI USA, V104, P5638, DOI 10.1073/pnas.0611721104; Rovio S, 2010, NEUROBIOL AGING, V31, P1927, DOI 10.1016/j.neurobiolaging.2008.10.007; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Tan ZS, 2017, J GERONTOL A-BIOL, V72, P789, DOI 10.1093/gerona/glw130; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Thorp AA, 2011, AM J PREV MED, V41, P207, DOI 10.1016/j.amepre.2011.05.004; Tian Q, 2014, J GERONTOL A-BIOL, V69, P1284, DOI 10.1093/gerona/glt287; Voelcker-Rehage C, 2013, NEUROSCI BIOBEHAV R, V37, P2268, DOI 10.1016/j.neubiorev.2013.01.028; Voss MW, 2014, MENT HEALTH PHYS ACT, V7, P9, DOI 10.1016/j.mhpa.2014.01.001; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2013, TRENDS COGN SCI, V17, P525, DOI 10.1016/j.tics.2013.08.001; Wheeler Michael J, 2017, Alzheimers Dement (N Y), V3, P291, DOI 10.1016/j.trci.2017.04.001; Whiteman AS, 2016, NEUROIMAGE, V126, P229, DOI 10.1016/j.neuroimage.2015.11.049; Zlatar ZZ, 2014, J ALZHEIMERS DIS, V41, P809, DOI 10.3233/JAD-132252	45	37	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195549	10.1371/journal.pone.0195549	http://dx.doi.org/10.1371/journal.pone.0195549			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649304	Green Submitted, gold, Green Published			2022-12-26	WOS:000429791900054
J	Wang, SF; Yue, YT				Wang, Shunfang; Yue, Yaoting			Protein subnuclear localization based on a new effective representation and intelligent kernel linear discriminant analysis by dichotomous greedy genetic algorithm	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PREDICTING SUBCELLULAR-LOCALIZATION; DIMENSIONALITY REDUCTION; ENSEMBLE CLASSIFIER; LOCATION PREDICTION; WEB-SERVER; PSEAAC; PLATFORM; MODES; PLOC	A wide variety of methods have been proposed in protein subnuclear localization to improve the prediction accuracy. However, one important trend of these means is to treat fusion representation by fusing multiple feature representations, of which, the fusion process takes a lot of time. In view of this, this paper novelly proposed a method by combining a new single feature representation and a new algorithm to obtain good recognition rate. Specifically, based on the position-specific scoring matrix (PSSM), we proposed a new expression, correlation position-specific scoring matrix (CoPSSM) as the protein feature representation. Based on the classic nonlinear dimension reduction algorithm, kernel linear discriminant analysis (KLDA), we added a new discriminant criterion and proposed a dichotomous greedy genetic algorithm (DGGA) to intelligently select its kernel bandwidth parameter. Two public datasets with Jackknife test and KNN classifier were used for the numerical experiments. The results showed that the overall success rate (OSR) with single representation CoPSSM is larger than that with many relevant representations. The OSR of the proposed method can reach as high as 87.444% and 90.3361% for these two datasets, respectively, outperforming many current methods. To show the generalization of the proposed algorithm, two extra standard datasets of protein subcellular were chosen to conduct the expending experiment, and the prediction accuracy by Jackknife test and Independent test is still considerable.	[Wang, Shunfang; Yue, Yaoting] Yunnan Univ, Sch Informat Sci & Engn, Kunming, Yunnan, Peoples R China	Yunnan University	Wang, SF (corresponding author), Yunnan Univ, Sch Informat Sci & Engn, Kunming, Yunnan, Peoples R China.	sfwang_66@ynu.edu.cn			National Natural Science Foundation of China [11661081]; Natural Science Foundation of Yunnan Province [2017FA032]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Yunnan Province(Natural Science Foundation of Yunnan Province)	This research is supported by grants from National Natural Science Foundation of China (11661081) and Natural Science Foundation of Yunnan Province (2017FA032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balamurugan M, 2017, BIOMED PHARMACOL J, V10, P1823, DOI [10.13005/bpj/1299, DOI 10.13005/bpj/1299]; Cao DS, 2013, BIOINFORMATICS, V29, P960, DOI 10.1093/bioinformatics/btt072; Chen J, 2016, BIOSYSTEMS, V139, P37, DOI 10.1016/j.biosystems.2015.12.002; Chou KC, 2005, J CHEM INF MODEL, V45, P407, DOI 10.1021/ci049686v; Chou KC, 2005, BIOINFORMATICS, V21, P10, DOI 10.1093/bioinformatics/bth466; Chou KC, 2001, PROTEINS, V43, P246, DOI 10.1002/prot.1035; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Chou KC, 2006, J PROTEOME RES, V5, P3420, DOI 10.1021/pr060404b; CLAYS K, 1993, SCIENCE, V262, P1419, DOI 10.1126/science.262.5138.1419; Ding YR, 2004, FEBS LETT, V569, P284, DOI 10.1016/j.febslet.2004.06.009; Du PF, 2014, INT J MOL SCI, V15, P3495, DOI 10.3390/ijms15033495; Du PF, 2012, ANAL BIOCHEM, V425, P117, DOI 10.1016/j.ab.2012.03.015; Fan YN, 2014, INT J MOL SCI, V15, P4915, DOI 10.3390/ijms15034915; Feng ZP, 2002, INT J BIOCHEM CELL B, V34, P298, DOI 10.1016/S1357-2725(01)00121-2; Garg A, 2005, J BIOL CHEM, V280, P14427, DOI 10.1074/jbc.M411789200; Gomez-Chova L, 2011, GEOSCIENCE REMOTE SE, V9, P312; Han GS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057225; Hasan MA, 2017, MOL BIOSYST, V13, P785, DOI 10.1039/c6mb00860g; Hilario M, 2008, BRIEF BIOINFORM, V9, P102, DOI 10.1093/bib/bbn005; Jenssen R, 2013, IEEE SIGNAL PROC MAG, V30, P30, DOI 10.1109/MSP.2013.2249692; Jenssen R, 2010, IEEE T PATTERN ANAL, V32, P847, DOI 10.1109/TPAMI.2009.100; Kumar R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098345; Li LQ, 2014, BIOCHIMIE, V104, P100, DOI 10.1016/j.biochi.2014.06.001; Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974; Mika S., 1999, Neural Networks for Signal Processing IX: Proceedings of the 1999 IEEE Signal Processing Society Workshop (Cat. No.98TH8468), P41, DOI 10.1109/NNSP.1999.788121; NAKASHIMA H, 1994, J MOL BIOL, V238, P54, DOI 10.1006/jmbi.1994.1267; Nasibov E, 2008, COMPUT BIOL CHEM, V32, P448, DOI 10.1016/j.compbiolchem.2008.07.011; Powers D. M, 2011, ARXIV201016061; Reinhardt A, 1998, NUCLEIC ACIDS RES, V26, P2230, DOI 10.1093/nar/26.9.2230; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shekar BH, 2011, NEUROCOMPUTING, V74, P1053, DOI 10.1016/j.neucom.2010.10.012; Shen HB, 2008, ANAL BIOCHEM, V373, P386, DOI 10.1016/j.ab.2007.10.012; Shen HB, 2007, PROTEIN ENG DES SEL, V20, P561, DOI 10.1093/protein/gzm057; Shen HB, 2007, BIOCHEM BIOPH RES CO, V355, P1006, DOI 10.1016/j.bbrc.2007.02.071; Shen HB, 2006, BIOINFORMATICS, V22, P1717, DOI 10.1093/bioinformatics/btl170; Shen HB, 2006, J THEOR BIOL, V240, P9, DOI 10.1016/j.jtbi.2005.08.016; Thakur A, 2016, MOL BIOSYST, V12, P2572, DOI 10.1039/c6mb00241b; Wang SF, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122718; Wang SF, 2015, INT J MOL SCI, V16, P30343, DOI 10.3390/ijms161226237; Wang T, 2010, PROTEIN PEPTIDE LETT, V17, P32, DOI 10.2174/092986610789909494; Wang T, 2009, MOL DIVERS, V13, P475, DOI 10.1007/s11030-009-9134-z; Wei LY, 2017, INFORM SCIENCES, V384, P135, DOI 10.1016/j.ins.2016.06.026; Xiang QL, 2017, ARTIF INTELL MED, V78, P41, DOI 10.1016/j.artmed.2017.05.007; Xiao X, 2011, J THEOR BIOL, V284, P42, DOI 10.1016/j.jtbi.2011.06.005; Xie ZB, 2013, IEEE INT S MULTIMEDI, V7, P1; Xu YY, 2016, BIOINFORMATICS, V32, P2184, DOI 10.1093/bioinformatics/btw219; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zamani B, 2014, INFORM SCIENCES, V274, P95, DOI 10.1016/j.ins.2014.02.140; Zhang YP, 2016, NEUROCOMPUTING, V173, P518, DOI 10.1016/j.neucom.2015.07.011; Zhang Z, 2012, INT J PATTERN RECOGN, V26; Zhao Jian-hua, 2014, Computer Engineering and Design, V35, P631	52	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195636	10.1371/journal.pone.0195636	http://dx.doi.org/10.1371/journal.pone.0195636			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649330	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900065
J	Minard, G; Tran, FH; Van, VT; Fournier, C; Potier, P; Roiz, D; Mavingui, P; Moro, CV				Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Roiz, David; Mavingui, Patrick; Moro, Claire Valiente			Shared larval rearing environment, sex, female size and genetic diversity shape Ae. albopictus bacterial microbiota	PLOS ONE			English	Article							AEDES-ALBOPICTUS; WING LENGTH; WOLBACHIA; INFECTION; AEGYPTI; DIPTERA; VECTOR; ASAIA; TRANSMISSION; MOSQUITOS	The Asian tiger mosquito Aedes albopictus became of public health concern as it can replicate and transmit viral and filarial pathogens with a strong invasive success over the world. Various strategies have been proposed to reduce mosquito population's vectorial capacity. Among them, symbiotic control of mosquito borne disease offers promising perspectives. Such method is likely to be affected by the dynamics of mosquito-associated symbiotic communities, which might in turn be affected by host genotype and environment. Our previous study suggested a correlation between mosquitoes' origin, genetic diversity and midgut bacterial diversity. To distinguish the impact of those factors, we have been studying the midgut bacterial microbiota of two Ae. albopictus populations from tropical (La Re A union) and temperate (Montpellier) origins under controlled laboratory conditions. the two populations experienced random mating or genetic bottleneck. Microbiota composition did not highlight any variation of the alpha and beta-diversities in bacterial communities related to host's populations. However, sizes of the mosquitoes were negatively correlated with the bacterial a-diversity of females. Variations in mosquito sex were associated with a shift in the composition of bacterial microbiota. The females' mosquitoes also exhibited changes in the microbiota composition according to their size and after experiencing a reduction of their genetic diversity. These results provide a framework to investigate the impact of population dynamics on the symbiotic communities associated with the tiger mosquito.	[Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] Univ Lyon, Lyon, France; [Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] Univ Lyon 1, Villeurbanne, France; [Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] CNRS, UMR 5557, Ecol Microbienne, Villeurbanne, France; [Minard, Guillaume; Tran, Florence-Helene; Van Tran Van; Fournier, Corentin; Potier, Patrick; Mavingui, Patrick; Moro, Claire Valiente] INRA, UMR 1418, Villeurbanne, France; [Minard, Guillaume] Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, Helsinki, Finland; [Roiz, David] IRD, Infect Dis & Vectors, Ecol Genet Evolut & Control, Montpellier, France; [Mavingui, Patrick] Univ La Reunion, Unite Mixte Proc Infectieux Milieu Insulaire Trop, Plateforme Technol CYROI, INSERM,CNRS 9192,U1187,IRD 249, St Clotilde, Reunion, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); VetAgro Sup; INRAE; University of Helsinki; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); University of La Reunion	Minard, G (corresponding author), Univ Lyon, Lyon, France.; Minard, G (corresponding author), Univ Lyon 1, Villeurbanne, France.; Minard, G (corresponding author), CNRS, UMR 5557, Ecol Microbienne, Villeurbanne, France.; Minard, G (corresponding author), INRA, UMR 1418, Villeurbanne, France.; Minard, G (corresponding author), Univ Helsinki, Dept Biosci, Metapopulat Res Ctr, Helsinki, Finland.	guillaume_minard_86@hotmail.com	Roiz, David/F-2082-2011	Roiz, David/0000-0002-5819-3648; valiente moro, claire/0000-0002-7193-405X; Minard, Guillaume/0000-0002-2079-8844	ERA NET BiodivERsA [ANR-13-EBID-0007-01]; FWF [1-1437]; DFG [KL 2087/6-1]; Academy of Finland [273098, 265641]	ERA NET BiodivERsA; FWF(Austrian Science Fund (FWF)); DFG(German Research Foundation (DFG)); Academy of Finland(Academy of Finland)	This research plan was funded by ERA NET BiodivERsA with the national funders ANR-13-EBID-0007-01, FWF 1-1437, and DFG KL 2087/6-1 as part of the 2012-2013 BiodivERsA call for research proposals (http://www.biodiversa.org/) and recieved by PM. The authors acknowledge the contribution of the DTAMB platform of the FR41 Bio-Environment and Health (University Lyon 1) and the Academy of Finland (Decision numbers 273098 and 265641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This publication is dedicated to the memory of our beloved colleague and friend Florence H. TRAN. We acknowledge the contribution of the DTAMB platform of the FR41 Bio-Environment and Health (University Lyon 1) and the Academy of Finland (Decision numbers 273098 and 265641). We also acknowledge Marion Journiac and Morgane Guegan for their help with wings measurements and insectary management respectively.	Zeileis A, 2016, BETAREG BETA REGRESS; Alto BW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004370; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361; Berticat C, 2002, P ROY SOC B-BIOL SCI, V269, P1413, DOI 10.1098/rspb.2002.2022; Bisi DC, 2011, APPL ENVIRON MICROB, V77, P4669, DOI 10.1128/AEM.00514-11; Blackmore MS, 2000, J VECTOR ECOL, V25, P212; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Boyer S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042040; Brackney DE, 2008, AM J TROP MED HYG, V79, P267, DOI 10.4269/ajtmh.2008.79.267; Bright M, 2010, NAT REV MICROBIOL, V8, P218, DOI 10.1038/nrmicro2262; Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2; Calvitti M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121813; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Chaston JM, 2016, APPL ENVIRON MICROB, V82, P671, DOI 10.1128/AEM.03301-15; Chavshin AR, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-419; Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618; Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]; Coon KL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1660-9; Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468; Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x; Diaz-Nieto LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153133; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Favia G, 2008, ADV EXP MED BIOL, V627, P49, DOI 10.1007/978-0-387-78225-6_4; Forrester NL, 2014, VIRUSES-BASEL, V6, P3991, DOI 10.3390/v6103991; Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795; Gobet A, 2014, ENVIRON MICROBIOL, V16, P2672, DOI 10.1111/1462-2920.12308; Goubert C, 2016, HEREDITY, V117, P125, DOI 10.1038/hdy.2016.35; Hothorn T., 2015, PACKAGE LMTEST; Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111; Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294; Kittayapong P, 2002, AM J TROP MED HYG, V66, P108, DOI 10.4269/ajtmh.2002.66.108; Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347; Linenberg I, 2016, SCI REP-UK, V6, DOI 10.1038/srep38230; Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970; Minard G, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-146; Minard G, 2013, FEMS MICROBIOL ECOL, V83, P63, DOI 10.1111/j.1574-6941.2012.01455.x; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; NASCI RS, 1990, J MED ENTOMOL, V27, P716, DOI 10.1093/jmedent/27.4.716; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Petersen V, 2016, REV SOC BRAS MED TRO, V49, P508, DOI 10.1590/0037-8682-0039-2016; Powell JE, 2016, P NATL ACAD SCI USA, V113, P13887, DOI 10.1073/pnas.1610856113; Price DP, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0863-9; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398; Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561; Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004; Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026; THIERY I, 1991, APPL ENVIRON MICROB, V57, P1354, DOI 10.1128/AEM.57.5.1354-1359.1991; Tortosa P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009700; VANHANDEL E, 1989, J AM MOSQUITO CONTR, V5, P180; Vega-Rua A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059716; Wagner MR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12151; Wang YG, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0023495, 10.1371/journal.pone.0020422]; Wood S. N., 2016, MGCV MIXED GAM COMPU; Xue RD, 2010, J MED ENTOMOL, V47, P778, DOI 10.1603/ME09222; Yadav KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167409; Yun JH, 2014, APPL ENVIRON MICROB, V80, P5254, DOI 10.1128/AEM.01226-14; Zouache K, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1078; Zouache K, 2011, FEMS MICROBIOL ECOL, V75, P377, DOI 10.1111/j.1574-6941.2010.01012.x; Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388	65	19	19	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194521	10.1371/journal.pone.0194521	http://dx.doi.org/10.1371/journal.pone.0194521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641577	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900033
J	Li, ZH; Jiang, P; Li, J; Peng, MJ; Zhao, X; Zhang, X; Chen, K; Zhang, YJ; Liu, H; Gan, L; Bi, HQ; Zhen, P; Zhu, J; Li, XW				Li, Zhonghu; Jiang, Peng; Li, Jie; Peng, Minjie; Zhao, Xin; Zhang, Xi; Chen, Kai; Zhang, Yujun; Liu, Hui; Gan, Lang; Bi, Huaqiang; Zhen, Ping; Zhu, Jin; Li, Xiaowu			Tumor-derived exosomal lnc-Sox2ot promotes EMT and stemness by acting as a ceRNA in pancreatic ductal adenocarcinoma	ONCOGENE			English	Article							MESENCHYMAL TRANSITION; CANCER; RNA; METASTASIS; CELLS; BIOMARKERS; MARKERS; MIRNA; GENE; SOX2	Long noncoding RNAs (lncRNAs) or exosomes have recently been shown to play vital regulatory or communication roles in cancer biology. However, the roles and mechanisms of exosomal lncRNAs in tumor invasion or metastasis of pancreatic ductal adenocarcinoma (PDAC) remain unknown. In this study, we aimed to investigate the detailed roles and mechanisms of tumor-generated exosomes in progression and metastasis of PDAC in vitro and in vivo. We identified a lncRNA-Sox2ot from exosomes of highly invasive PDAC cells, and analyzed the expression of Sox2ot in the plasma samples and found that the plasma exosomal Sox2ot expression was high and correlated with TNM stage and overall survival rate of PDAC patients. Further research showed that Sox2ot promotes epithelial-mesenchymal transition (EMT) and stem cell like properties by regulating Sox2 expression. Sox2ot competitively binds to the miR-200 family to regulate the expression of Sox2, thus promoting invasion and metastasis of PDAC. We also confirmed the transmission of the exosomes from producer cells to recipient PDAC cells, exosomal Sox2ot can promote tumor invasion and metastasis in vitro and in vivo. We further confirmed tumor generated exosomes could excrete to tumor cell or blood circulation in vivo condition. Finally, we observed a decreased exosomal Sox2ot expression in postoperative blood samples of PDAC patients. The exosomal lncRNA Sox2ot plays important roles in tumor progression and may be a useful maker for pancreatic cancer prognosis.	[Li, Zhonghu; Jiang, Peng; Li, Jie; Peng, Minjie; Zhao, Xin; Zhang, Xi; Chen, Kai; Zhang, Yujun; Liu, Hui; Gan, Lang; Bi, Huaqiang; Zhen, Ping; Zhu, Jin; Li, Xiaowu] Third Mil Med Univ, Southwest Hosp, Hepatobiliary Surg Inst, Chongqing, Peoples R China	Army Medical University	Li, XW (corresponding author), Third Mil Med Univ, Southwest Hosp, Hepatobiliary Surg Inst, Chongqing, Peoples R China.	lixw1966@163.com	Li, Xiaowu/AAF-2769-2020; bi, huaqiang/GYJ-5005-2022		National Natural Science Foundation of China [81430063]; Natural Science Foundation of Southwest Hospital [SWH2016JCYB-46]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Southwest Hospital	This work was supported by the National Natural Science Foundation of China under Grant 81430063, and the Natural Science Foundation of Southwest Hospital under Grant SWH2016JCYB-46.	Azmi AS, 2013, CANCER METAST REV, V32, P623, DOI 10.1007/s10555-013-9441-9; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chen IH, 2017, P NATL ACAD SCI USA, V114, P3175, DOI 10.1073/pnas.1618088114; Chen T, 2017, J CELL PHYSIOL, V232, P3261, DOI 10.1002/jcp.25797; Conroy T, 2016, EUR J CANCER, V57, P10, DOI 10.1016/j.ejca.2015.12.026; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Dhamija S, 2016, INT J CANCER, V139, P269, DOI 10.1002/ijc.30039; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Henderson MC, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00038; Herreros-Villanueva M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.23; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Joyce DP, 2016, INT J CANCER, V139, P1443, DOI 10.1002/ijc.30179; Lennon AM, 2014, CANCER RES, V74, P3381, DOI 10.1158/0008-5472.CAN-14-0734; Li XF, 2013, CANCER LETT, V336, P379, DOI 10.1016/j.canlet.2013.03.027; Lugea A, 2017, PANCREAS, V46, P1, DOI 10.1097/MPA.0000000000000686; Madhavan B, 2015, INT J CANCER, V136, P2616, DOI 10.1002/ijc.29324; Matsushita H, 2016, GASTROENTEROLOGY, V150, pS1086, DOI 10.1053/j.gastro.2016.02.051; Momen-Heravi F, 2014, NANOMED-NANOTECHNOL, V10, P1517, DOI 10.1016/j.nano.2014.03.014; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Pope SM, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22484; Qu L, 2016, CANCER CELL, V29, P653, DOI 10.1016/j.ccell.2016.03.004; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosa A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1797692; Schaeffer D, 2010, ADV EXP MED BIOL, V702, P79, DOI 10.1007/978-1-4419-7841-7_7; Schmitz SU, 2016, CELL MOL LIFE SCI, V73, P2491, DOI 10.1007/s00018-016-2174-5; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh SK, 2015, EMBO J, V34, P517, DOI 10.15252/embj.201489574; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Syn N, 2016, TRENDS PHARMACOL SCI, V37, P606, DOI 10.1016/j.tips.2016.04.006; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TRAMS EG, 1981, BIOCHIM BIOPHYS ACTA, V645, P63, DOI 10.1016/0005-2736(81)90512-5; Umezu T, 2013, ONCOGENE, V32, P2747, DOI 10.1038/onc.2012.295; van den Boorn JG, 2013, ADV DRUG DELIVER REV, V65, P331, DOI 10.1016/j.addr.2012.06.011; Velpula KK, 2011, ONCOTARGET, V2, P1028; Wolfgang CL, 2013, CA-CANCER J CLIN, V63, P318, DOI 10.3322/caac.21190; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zou YK, 2015, CARCINOGENESIS, V36, P676, DOI 10.1093/carcin/bgv027	42	158	162	2	38	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3822	3838		10.1038/s41388-018-0237-9	http://dx.doi.org/10.1038/s41388-018-0237-9			17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29643475				2022-12-26	WOS:000438465600005
J	Endo, H; Tanaka, S; Adegawa, S; Ichino, F; Tabunoki, H; Kikuta, S; Sato, R				Endo, Haruka; Tanaka, Shiho; Adegawa, Satomi; Ichino, Fumika; Tabunoki, Hiroko; Kikuta, Shingo; Sato, Ryoichi			Extracellular loop structures in silkworm ABCC transporters determine their specificities for Bacillus thuringiensis Cry toxins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacillus; bacterial toxin; ABC transporter; insect; Bombyx mori; Bacillus thuringiensis; Cry toxin; ABC transporter C2 (ABCC2); ABC transporter C3 (ABCC3); binding affinity	RECEPTOR FUNCTION; CROSS-RESISTANCE; DOMAIN-II; BINDING; INSECT; LARVAE; MODE; C2	Bacillus thuringiensis Cry toxins are insecticidal proteins used widely for pest control. They are lethal to a restricted range of insects via specific interactions with insect receptors such as the ABC transporter subfamily members C2 (ABCC2) and C3 (ABCC3). However, it is still unclear how these different receptors contribute to insect susceptibility to Cry1A toxins. Here, we investigated the differences between the silkworm (Bombyx mori) ABCC2 (BmABCC2_S) and ABCC3 (BmABCC3) receptors in mediating Cry toxicity. Compared with BmABCC2_S, BmABCC3 exhibited 80- and 267-fold lower binding affinities to Cry1Aa and Cry1Ab, respectively, and these decreased affinities correlated well with the lower receptor activities of BmABCC3 for these Cry1A toxins. To identify the amino acid residues responsible for these differences, we constructed BmABCC3 variants containing a partial amino acid replacement with extracellular loops (ECLs) from BmABCC2_S. Replacing three amino acids from ECL 1 or 3 increased BmABCC3 activity toward Cry1Aa and enabled its activity toward Cry1Ab. Meanwhile, BmABCC2_S and BmABCC3 exhibited no receptor activities for Cry1Ca, Cry1Da, and Cry3Bb, correlating with markedly lower binding affinities for these Cry toxins. ABCC2 from a Cry1Ab-resistant B. mori strain (BmABCC2_R), which has a tyrosine insertion in ECL 2, displayed 93-fold lower binding affinity to Cry1Ab compared with BmABCC2_S but maintained high binding affinity to Cry1Aa. These results indicate that the Cry toxin-binding affinities of ABCC transporters are largely linked to the level of Cry susceptibility of ABCC-expressing cells and that the ABCC ECL structures determine the specificities to Cry toxins.	[Endo, Haruka; Tanaka, Shiho; Adegawa, Satomi; Kikuta, Shingo; Sato, Ryoichi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Ichino, Fumika; Tabunoki, Hiroko] Tokyo Univ Agr & Technol, Grad Sch Agr, Dept Sci Biol Prod, Saiwai Cho 3-5-8, Fuchu, Tokyo 1838509, Japan; [Endo, Haruka] Kashiwanoha 5-1-5, Kashiwa, Chiba 2778562, Japan	Tokyo University of Agriculture & Technology; Tokyo University of Agriculture & Technology	Sato, R (corresponding author), Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan.	ryoichi@cc.tuat.ac.jp	Endo, Haruka/L-2082-2019; TABUNOKI, Hiroko/H-6593-2013; Kikuta, Shingo/J-5219-2013; Adegawa, Satomi/S-7957-2018; Sato, Ryoichi/G-1074-2013	TABUNOKI, Hiroko/0000-0003-1823-9952; Kikuta, Shingo/0000-0002-3925-576X; Endo, Haruka/0000-0002-5900-7077	Japan Society for the Promotion of Science (JSPS) KAKENHI [15H02837, 15J08610]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was financially supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grants 15H02837 (to R. S.) and 15J08610 (to H. E.). The authors declare that they have no conflicts of interest with the contents of this article.	Adegawa S, 2017, BBA-PROTEINS PROTEOM, V1865, P220, DOI 10.1016/j.bbapap.2016.11.011; Atsumi S, 2012, P NATL ACAD SCI USA, V109, pE1591, DOI 10.1073/pnas.1120698109; Bravo A, 2011, INSECT BIOCHEM MOLEC, V41, P423, DOI 10.1016/j.ibmb.2011.02.006; Bretschneider A, 2016, INSECT BIOCHEM MOLEC, V76, P109, DOI 10.1016/j.ibmb.2016.07.008; Chen ZM, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/S12929-015-0197-0; Endo H, 2017, PEPTIDES, V98, P86, DOI 10.1016/j.peptides.2017.04.003; Endo H, 2017, FEBS LETT, V591, P56, DOI 10.1002/1873-3468.12506; Guo ZJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005124; Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Masson L, 2002, BBA-PROTEIN STRUCT M, V1594, P266, DOI 10.1016/S0167-4838(01)00312-0; Obata F, 2009, FEBS J, V276, P5949, DOI 10.1111/j.1742-4658.2009.07275.x; Park Y, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-46; Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06; Suetsugu Y, 2013, G3-GENES GENOM GENET, V3, P1481, DOI 10.1534/g3.113.006239; Tabashnik BE, 1996, APPL ENVIRON MICROB, V62, P2839, DOI 10.1128/AEM.62.8.2839-2844.1996; Tanaka S, 2017, INSECT BIOCHEM MOLEC, V91, P44, DOI 10.1016/j.ibmb.2017.11.002; Tanaka S, 2016, FEBS J, V283, P4474, DOI 10.1111/febs.13952; Tanaka S, 2016, PEPTIDES, V78, P99, DOI 10.1016/j.peptides.2016.01.006; Tanaka S, 2013, FEBS J, V280, P1782, DOI 10.1111/febs.12200; Zhao JZ, 2001, J ECON ENTOMOL, V94, P1547, DOI 10.1603/0022-0493-94.6.1547	21	27	30	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8569	8577		10.1074/jbc.RA118.001761	http://dx.doi.org/10.1074/jbc.RA118.001761			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666188	Green Published, hybrid			2022-12-26	WOS:000434205700020
J	Kulkarni, K; Xie, XY; de Velasco, EMF; Anderson, A; Martemyanov, KA; Wickman, K; Tolkacheva, EG				Kulkarni, Kanchan; Xie, Xueyi; de Velasco, Ezequiel Marron Fernandez; Anderson, Allison; Martemyanov, Kirill A.; Wickman, Kevin; Tolkacheva, Elena G.			The influences of the M2R-GIRK4-RGS6 dependent parasympathetic pathway on electrophysiological properties of the mouse heart	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; I-KACH; RESTITUTION; ACTIVATION; REGULATOR; ALTERNANS; PROTECTS; RECEPTOR; RGS6	A large body of work has established the prominent roles of the atrial M2R-I-KAch signaling pathway, and the negative regulatory protein RGS6, in modulating critical aspects of parasympathetic influence on cardiac function, including pace-making, heart rate (HR) variability (HRV), and atrial arrhythmogenesis. Despite increasing evidence of its innervation of the ventricles, and the expression of M2R, I-KACh channel subunits, and RGS6 in ventricle, the effects of parasympathetic modulation on ventricular electrophysiology are less clear. The main objective of our study was to investigate the contribution of M2R-I-KAch signaling pathway elements in murine ventricular electrophysiology, using in-vivo ECG measurements, isolated whole-heart optical mapping and constitutive knockout mice lacking I-KACh (Girk4(-/-) or RGS6 (Rgs6(-/-). Consistent with previous findings, mice lacking GIRK4 exhibited diminished HR and HRV responses to the cholinergic agonist carbachol (CCh), and resistance to CCh-induced arrhythmic episodes. In line with its role as a negative regulator of atrial M2R-I-KACh signaling, loss of RGS6 correlated with a mild resting bradycardia, enhanced HR and HRV responses to CCh, and increased propensity for arrhythmic episodes. Interestingly, ventricles from mice lacking GIRK4 or RGS6 both exhibited increased action potential duration (APD) at baseline, and APD was prolonged by CCh across all genotypes. Similarly, CCh significantly increased the slope of APD restitution in all genotypes. There was no impact of genotype or CCh on either conduction velocity or heterogeneity. Our data suggests that altered parasympathetic signaling through the M2R-I-KAch pathway can affect ventricular electrophysiological properties distinct from its influence on atrial physiology.	[Kulkarni, Kanchan; Xie, Xueyi; Tolkacheva, Elena G.] Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA; [de Velasco, Ezequiel Marron Fernandez; Anderson, Allison; Wickman, Kevin] Univ Minnesota, Dept Pharmacol, Minneapolis, MN USA; [Martemyanov, Kirill A.] Scripps Res Inst, Dept Neurosci, Jupiter, FL USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Scripps Research Institute	Tolkacheva, EG (corresponding author), Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA.	talkacal@umn.edu	Kulkarni, Kanchan/AAZ-9557-2021	Kulkarni, Kanchan/0000-0002-3185-0484; Marron Fernandez de Velasco, Ezequiel/0000-0003-0257-4457; Anderson, Allison/0000-0001-9841-8672	National Science Foundation [CAREER PHY-125541, DCSD-1662250]; National Institute of Health [HL128790, HL105550, HL139090]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105550, F31HL139090, R21HL128790] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the National Science Foundation grant CAREER PHY-125541 (EGT); National Science Foundation grant DCSD-1662250 (EGT); National Institute of Health grant HL128790 (EGT); National Institute of Health grant HL105550 (KW and KAM) and the National Institute of Health grant HL139090 (AA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19719-x; Annoni EM, 2015, PHYSL REP; Armour JA, 1997, ANAT REC, V247, P289, DOI 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L; Beaumont E, 2015, AM J PHYSIOL-HEART C, V309, pH1198, DOI 10.1152/ajpheart.00393.2015; Bibevski S, 2011, HEART FAIL REV, V16, P129, DOI 10.1007/s10741-010-9190-6; Brack KE, 2007, J PHYSIOL-LONDON, V583, P695, DOI 10.1113/jphysiol.2007.138461; Brack KE, 2011, CARDIOVASC RES, V91, P437, DOI 10.1093/cvr/cvr105; Chu V, 2001, BMC PHYSL; Coote JH, 2013, J PHYSIOL-LONDON, V591, P4073, DOI 10.1113/jphysiol.2013.257758; De Ferrari GM, 2011, HEART FAIL REV, V16, P195, DOI 10.1007/s10741-010-9216-0; DIFRANCESCO D, 1989, SCIENCE, V243, P669, DOI 10.1126/science.2916119; Glaza I, 2011, POSTEP HIG MED DOSW, V65, P478, DOI 10.5604/17322693.954785; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Huang J, 2011, CANCER RES, V71, P6310, DOI 10.1158/0008-5472.CAN-10-3397; Kovoor P, 2001, J AM COLL CARDIOL, V37, P2136, DOI 10.1016/S0735-1097(01)01304-3; Kulkarni K, 2016, IEEE ENG MED BIO, P149, DOI 10.1109/EMBC.2016.7590662; Kulkarni K, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/170768; Lee SW, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12786; Liang B, 2014, CARDIOVASC RES, V101, P175, DOI 10.1093/cvr/cvt240; McIntyre SD, 2014, J THEOR BIOL, V350, P90, DOI 10.1016/j.jtbi.2014.02.015; Posokhova E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076973; Posokhova E, 2010, CIRC RES, V107, P1350, DOI 10.1161/CIRCRESAHA.110.224212; Randall DC, 2003, AM J PHYSIOL-REG I, V285, pR1066, DOI 10.1152/ajpregu.00167.2003; Riccio ML, 1999, CIRC RES, V84, P955; Rorabaugh BR, 2017, J PHARMACOL EXP THER, V360, P409, DOI 10.1124/jpet.116.238345; Roth DM, 2002, AM J PHYSIOL-HEART C, V282, pH2134, DOI 10.1152/ajpheart.00845.2001; Sava C, 2014, REV FARMACIA; Schwartz PJ, 2009, HEART RHYTHM, V6, pS76, DOI 10.1016/j.hrthm.2009.08.012; Sved AF, 2003, CURR HYPERTENS REP, V5, P262, DOI 10.1007/s11906-003-0030-0; Tolkacheva EG, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031904; Ulphani JS, 2010, HEART RHYTHM, V7, P1113, DOI 10.1016/j.hrthm.2010.03.043; Visweswaran R, 2013, J CARDIOVASC ELECTR, V24, P1287, DOI 10.1111/jce.12200; Wickman K, 1998, NEURON, V20, P103, DOI 10.1016/S0896-6273(00)80438-9; WICKMAN KD, 1995, CURR OPIN NEUROBIOL, V5, P278, DOI 10.1016/0959-4388(95)80039-5; Yang JQ, 2013, CANCER RES, V73, P1662, DOI 10.1158/0008-5472.CAN-12-3453; Yang JQ, 2010, CIRC RES, V107, P1345, DOI 10.1161/CIRCRESAHA.110.224220; Zhang YH, 2009, CIRC-HEART FAIL, V2, P692, DOI 10.1161/CIRCHEARTFAILURE.109.873968	37	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0193798	10.1371/journal.pone.0193798	http://dx.doi.org/10.1371/journal.pone.0193798			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668674	gold, Green Published			2022-12-26	WOS:000430290200005
J	Martins, MP; Gomes, EV; Sanches, PR; Pedersoli, WR; Martinez-Rossi, NM; Rossi, A				Martins, Maira P.; Gomes, Eriston V.; Sanches, Pablo R.; Pedersoli, Wellington R.; Martinez-Rossi, Nilce M.; Rossi, Antonio			mus-52 disruption and metabolic regulation in Neurospora crassa: Transcriptional responses to extracellular phosphate availability	PLOS ONE			English	Article							REPRESSIBLE ALKALINE-PHOSPHATASE; INTEGRATIVE GENOMICS VIEWER; REVEALS FUNCTIONS; CIRCADIAN CLOCK; GENE-EXPRESSION; PROTEIN; NUCLEOLUS; IDENTIFICATION; PH; DEFICIENT	Advances in the understanding of molecular systems depend on specific tools like the disruption of genes to produce strains with the desired characteristics. The disruption of any mutagen sensitive (mus) genes in the model fungus Neurospora crassa, i.e. mus-51, mus-52, or mus-53, orthologous to the human genes KU70, KU80, and LIG4, respectively, provides efficient tools for gene targeting. Accordingly, we used RNA-sequencing and reverse transcription-quantitative polymerase chain reaction amplification techniques to evaluate the effects of mus-52 deletion in N. crassa gene transcriptional modulation, and thus, infer its influence regarding metabolic response to extracellular availability of inorganic phosphate (Pi). Notably, the absence of MUS-52 affected the transcription of a vast number of genes, highlighting the expression of those coding for transcription factors, kinases, circadian clocks, oxi-reduction balance, and membrane- and nucleolus-related proteins. These findings may provide insights toward the KU molecular mechanisms, which have been related to telomere maintenance, apoptosis, DNA replication, and gene transcription regulation, as well as associated human conditions including immune system disorders, cancer, and aging.	[Martins, Maira P.; Gomes, Eriston V.; Sanches, Pablo R.; Pedersoli, Wellington R.; Martinez-Rossi, Nilce M.; Rossi, Antonio] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo	Rossi, A (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Genet, Ribeirao Preto, SP, Brazil.	nmmrossi@usp.br	Martins, Maíra/GQZ-2806-2022; Martinez-Rossi, Nilce Maria/AAL-2964-2021; Gomes, Eriston V/L-7063-2015; Martinez-Rossi, Nilce M/C-2234-2013; Martins, Maíra Pompeu/AAD-3482-2022	Martinez-Rossi, Nilce Maria/0000-0002-5723-4276; Gomes, Eriston V/0000-0002-5538-0106; Martins, Maíra Pompeu/0000-0002-9462-5145; Ramos Pedersoli, Wellington/0000-0002-3982-0626	Brazilian Funding Agency: Sao Paulo Research Foundation (FAPESP) [2014/03847-7, 2016/04274-6]; Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [305252/2013-5, 304222/2013-5]; Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Brazilian Funding Agency: Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA)	Brazilian Funding Agency: Sao Paulo Research Foundation (FAPESP); Brazilian Funding Agency: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Funding Agency: Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Brazilian Funding Agency: Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA)	This work was supported by the following Brazilian Funding Agencies: Sao Paulo Research Foundation (FAPESP, http://www.fapesp.br/en/) grant No. 2014/03847-7 and Postdoctoral Fellowship to EVG No. 2016/04274-6; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, http://www.cnpq.br/) grant Nos. 305252/2013-5 and 304222/2013-5; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, http://www.capes.gov.br/) fellowships to MPM, and WRP; and Fundacao de Apoio ao Ensino, Pesquisa e Assistencia (FAEPA, http://www.faepa.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian D, 2013, ANNU REV BIOCHEM, V82, P693, DOI 10.1146/annurev-biochem-072711-164732; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; ARMENTROUT VN, 1978, PHYTOPATHOLOGY, V68, P1597, DOI 10.1094/Phyto-68-1597; Becker K, 2015, MOL MICROBIOL, V96, P1002, DOI 10.1111/mmi.12987; Berg JM, 1997, ANNU REV BIOPH BIOM, V26, P357, DOI 10.1146/annurev.biophys.26.1.357; Blake J. A., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0702S23; Bourgon R, 2010, P NATL ACAD SCI USA, V107, P9546, DOI 10.1073/pnas.0914005107; BROWN RS, 1985, FEBS LETT, V186, P271, DOI 10.1016/0014-5793(85)80723-7; Antonieto ACC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169796; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; DELANGE AM, 1981, GENETICS, V97, P247; Dent KC, 2009, APPL MICROBIOL BIOT, V82, P271, DOI 10.1007/s00253-008-1735-4; Dick CF, 2014, BBA-GEN SUBJECTS, V1840, P2123, DOI 10.1016/j.bbagen.2014.03.014; Ezzi MI, 2005, ENZYME MICROB TECH, V36, P849, DOI 10.1016/j.enzmictec.2004.03.030; Fabbro D, 2015, BRIT J PHARMACOL, V172, P2675, DOI 10.1111/bph.13096; Fell VL, 2015, MUTAT RES-REV MUTAT, V763, P15, DOI 10.1016/j.mrrev.2014.06.002; Freitag M, 2002, P NATL ACAD SCI USA, V99, P8802, DOI 10.1073/pnas.132212899; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GLEASON MK, 1974, GENETICS, V78, P645; Gorl M, 2001, EMBO J, V20, P7074, DOI 10.1093/emboj/20.24.7074; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gras DE, 2007, FEMS MICROBIOL LETT, V269, P196, DOI 10.1111/j.1574-6968.2006.00613.x; Gras DE, 2013, FUNGAL GENET BIOL, V60, P140, DOI 10.1016/j.fgb.2013.05.007; Gras DE, 2009, MICROBIOL RES, V164, P658, DOI 10.1016/j.micres.2008.12.005; Gullo C, 2006, BBA-REV CANCER, V1765, P223, DOI 10.1016/j.bbcan.2006.01.001; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hoi JWS, 2010, EUKARYOT CELL, V9, P480, DOI 10.1128/EC.00333-09; INOUE H, 1984, MUTAT RES, V125, P185, DOI 10.1016/0027-5107(84)90068-X; Inoue H, 2011, MUTAT RES-REV MUTAT, V728, P1, DOI 10.1016/j.mrrev.2011.06.003; Ishibashi K, 2006, P NATL ACAD SCI USA, V103, P14871, DOI 10.1073/pnas.0604477103; Kafer E, 1980, CAN J GENET CYTOL; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Leal J, 2009, FEBS LETT, V583, P180, DOI 10.1016/j.febslet.2008.11.050; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mendes NS, 2016, FEBS OPEN BIO, V6, P358, DOI 10.1002/2211-5463.12047; METZENBERG RL, 1979, MICROBIOL REV, V43, P361, DOI 10.1128/MMBR.43.3.361-383.1979; NAHAS E, 1984, PHYTOCHEMISTRY, V23, P507, DOI 10.1016/S0031-9422(00)80368-4; NAHAS E, 1982, J GEN MICROBIOL, V128, P2017; Neuwald AF, 1999, GENOME RES, V9, P27; Ninomiya Y, 2004, P NATL ACAD SCI USA, V101, P12248, DOI 10.1073/pnas.0402780101; NYC JF, 1966, J BIOL CHEM, V241, P1468; Olson MOJ, 2005, HISTOCHEM CELL BIOL, V123, P203, DOI 10.1007/s00418-005-0754-9; Olson MOJ, 2002, INT REV CYTOL, V219, P199; PALMA MS, 1989, PHYTOCHEMISTRY, V28, P3281, DOI 10.1016/0031-9422(89)80331-0; Park G, 2011, EUKARYOT CELL, V10, P1553, DOI 10.1128/EC.05140-11; Paul JA, 2014, EUKARYOT CELL, V13, P1328, DOI 10.1128/EC.00150-14; Persson BL, 2003, CURR GENET, V43, P225, DOI 10.1007/s00294-003-0400-9; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roche CM, 2014, AM J BOT, V101, P2022, DOI 10.3732/ajb.1400377; Rossi A, 2013, IUBMB LIFE, V65, P930, DOI 10.1002/iub.1217; Sakai W, 2003, DNA REPAIR, V2, P337, DOI 10.1016/S1568-7864(02)00223-9; Sawamura R, 2014, BIOCHEM BIOPH RES CO, V443, P997, DOI 10.1016/j.bbrc.2013.12.084; SCHUTGENS RBH, 1986, EUR J PEDIATR, V144, P430, DOI 10.1007/BF00441734; Shaw P, 2005, CELL CYCLE, V4, P102, DOI 10.4161/cc.4.1.1467; Smith PM, 2012, BBA-BIOENERGETICS, V1817, P276, DOI 10.1016/j.bbabio.2011.11.009; Squina FM, 2010, CELL STRESS CHAPERON, V15, P225, DOI 10.1007/s12192-009-0131-z; Sun YJ, 2016, FUNGAL GENET BIOL, V95, P58, DOI 10.1016/j.fgb.2016.08.006; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Todd RB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-214; Toh-e A, 2015, FUNGAL GENET BIOL, V80, P19, DOI 10.1016/j.fgb.2015.04.019; Vencio RZN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-86; Vitalini MW, 2006, J BIOL RHYTHM, V21, P432, DOI 10.1177/0748730406294396; Wang Lei, 2010, Virologica Sinica, V25, P151, DOI 10.1007/s12250-010-3093-5; Wang Z, 2012, FUNGAL GENET BIOL, V49, P533, DOI 10.1016/j.fgb.2012.05.004; Xiong Y, 2014, FUNGAL GENET BIOL, V72, P21, DOI 10.1016/j.fgb.2014.05.005; Yang YH, 2003, MOL CELL BIOL, V23, P6221, DOI 10.1128/MCB.23.17.6221-6228.2003; Zeilinger S, 2016, FEMS MICROBIOL REV, V40, P182, DOI 10.1093/femsre/fuv045	70	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195871	10.1371/journal.pone.0195871	http://dx.doi.org/10.1371/journal.pone.0195871			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668735	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200064
J	Nagymate, G; Orlovits, Z; Kiss, RM				Nagymate, Gergely; Orlovits, Zsanett; Kiss, Rita M.			Reliability analysis of a sensitive and independent stabilometry parameter set	PLOS ONE			English	Article							TEST-RETEST RELIABILITY; INTRACLASS CORRELATION-COEFFICIENT; AGE-RELATED DIFFERENCES; POSTURAL CONTROL; PRESSURE MEASURES; KNEE OSTEOARTHRITIS; FORCE-PLATFORM; STANDING BALANCE; LEG STANCE; FOOT TYPES	Recent studies have suggested reduced independent and sensitive parameter sets for stabilometry measurements based on correlation and variance analyses. However, the reliability of these recommended parameter sets has not been studied in the literature or not in every stance type used in stabilometry assessments, for example, single leg stances. The goal of this study is to evaluate the test-retest reliability of different time-based and frequency- based parameters that are calculated from the center of pressure (CoP) during bipedal and single leg stance for 30-and 60-second measurement intervals. Thirty healthy subjects performed repeated standing trials in a bipedal stance with eyes open and eyes closed conditions and in a single leg stance with eyes open for 60 seconds. A force distribution measuring plate was used to record the CoP. The reliability of the CoP parameters was characterized by using the intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimal detectable change (MDC), coefficient of variation (CV) and CV compliance rate (CVCR). Based on the ICC, SEM and MDC results, many parameters yielded fair to good reliability values, while the CoP path length yielded the highest reliability (smallest ICC > 0.67 (0.54-0.79), largest SEM% = 19.2%). Usually, frequency type parameters and extreme value parameters yielded poor reliability values. There were differences in the reliability of the maximum CoP velocity (better with 30 seconds) and mean power frequency (better with 60 seconds) parameters between the different sampling intervals.	[Nagymate, Gergely; Kiss, Rita M.] Budapest Univ Technol & Econ, Dept Mechatron Opt & Mech Engn Informat, Budapest, Hungary; [Orlovits, Zsanett] Budapest Univ Technol & Econ, Inst Math, Budapest, Hungary	Budapest University of Technology & Economics; Budapest University of Technology & Economics	Kiss, RM (corresponding author), Budapest Univ Technol & Econ, Dept Mechatron Opt & Mech Engn Informat, Budapest, Hungary.	rikiss@mail.bme.hu	; Kiss, Rita/G-4315-2015	Nagymate, Gergely/0000-0002-3327-5049; Kiss, Rita/0000-0003-3607-8435	Hungarian Scientific Research Fund (OTKA) [K115894]; New National Excellence Program of the Hungarian Ministry of Human Resources [UNKP-16-3-I]	Hungarian Scientific Research Fund (OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); New National Excellence Program of the Hungarian Ministry of Human Resources	This work was supported by the Hungarian Scientific Research Fund (OTKA), grant number: K115894, (http://nkfih.gov.hu/palyazatok/palyazati-archivum/otka) and the New National Excellence Program of the Hungarian Ministry of Human Resources, grant number: UNKP-16-3-I (http://www.kormany.hu/hu/emberi-eratorrasok-miniszteriuma/oktatasert-felelos-allamtitkarsag/hirek/az-uj-nemzeti-kivalosag-program-2017- 2018-tanevi-palyazati-kiirasai). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson G, 1998, SPORTS MED, V26, P217, DOI 10.2165/00007256-199826040-00002; Baldini A, 2013, J ELECTROMYOGR KINES, V23, P1474, DOI 10.1016/j.jelekin.2013.08.003; Bujang MA, 2017, ARCH OROFAC SCI, V12, P1; Carpenter MG, 2001, GAIT POSTURE, V13, P35, DOI 10.1016/S0966-6362(00)00093-X; Chiari L, 2002, CLIN BIOMECH, V17, P666, DOI 10.1016/S0268-0033(02)00107-9; Cobb SC, 2004, J ORTHOP SPORT PHYS, V34, P79, DOI 10.2519/jospt.2004.34.2.79; da Silva RA, 2013, J ELECTROMYOGR KINES, V23, P634, DOI 10.1016/j.jelekin.2013.01.008; Duffell LD, 2013, GAIT POSTURE, V38, P745, DOI 10.1016/j.gaitpost.2013.03.015; Ferreira AD, 2014, J BIOMECH, V47, P2919, DOI 10.1016/j.jbiomech.2014.07.010; Fleiss J. L., 2011, DESIGN ANAL CLIN EXP, P1, DOI DOI 10.1002/9781118032923.CH1; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; GEURTS ACH, 1993, ARCH PHYS MED REHAB, V74, P1144; Gray VL, 2014, GAIT POSTURE, V40, P198, DOI 10.1016/j.gaitpost.2014.03.191; HAGEMAN PA, 1995, ARCH PHYS MED REHAB, V76, P961, DOI 10.1016/S0003-9993(95)80075-1; Hernandez ME, 2012, CLIN BIOMECH, V27, P910, DOI 10.1016/j.clinbiomech.2012.06.007; Hertel J, 2002, J ATHL TRAINING, V37, P129; Hoffman M, 1998, J ATHL TRAINING, V33, P319; Jorgensen MG, 2012, GAIT POSTURE, V35, P653, DOI 10.1016/j.gaitpost.2011.12.018; Kapteyn T S, 1983, Agressologie, V24, P321; Karlsson A, 2000, CLIN BIOMECH, V15, P365, DOI 10.1016/S0268-0033(99)00096-0; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kottner J, 2011, INT J NURS STUD, V48, P661, DOI 10.1016/j.ijnurstu.2011.01.016; Lafond D, 2004, ARCH PHYS MED REHAB, V85, P896, DOI 10.1016/j.apmr.2003.08.089; Laroche D, 2015, OSTEOARTHR CARTILAGE, V23, P1357, DOI 10.1016/j.joca.2015.03.029; Lawson T, 2015, CLIN BIOMECH, V30, P330, DOI 10.1016/j.clinbiomech.2015.02.011; Lin DD, 2008, GAIT POSTURE, V28, P337, DOI 10.1016/j.gaitpost.2008.01.005; Nagy E, 2004, EUR J APPL PHYSIOL, V92, P407, DOI 10.1007/s00421-004-1157-7; Nagymate G, 2016, PERIOD POLYTECH-MECH, V60, P238, DOI [10.3311/PPme.8999, DOI 10.3311/PPME.8999]; Nagymate G, 2015, 11 ANN INT C KIN EX, P24; Nagymate G, 2016, BIOMEDICAL ENG, P12; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Oskoei MA, 2008, IEEE T BIO-MED ENG, V55, P1956, DOI 10.1109/TBME.2008.919734; Pinsault N, 2009, MED ENG PHYS, V31, P276, DOI 10.1016/j.medengphy.2008.08.003; Ruhe A, 2010, GAIT POSTURE, V32, P436, DOI 10.1016/j.gaitpost.2010.09.012; Salavati M, 2009, GAIT POSTURE, V29, P460, DOI 10.1016/j.gaitpost.2008.11.016; Santos BR, 2008, GAIT POSTURE, V27, P408, DOI 10.1016/j.gaitpost.2007.05.008; Scoppa F, 2013, GAIT POSTURE, V37, P290, DOI 10.1016/j.gaitpost.2012.07.009; Sorensen RR, 2014, GAIT POSTURE, V39, P1040, DOI 10.1016/j.gaitpost.2014.01.002; Takacs J, 2014, GAIT POSTURE, V40, P270, DOI 10.1016/j.gaitpost.2014.03.016; Tamburella F, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-86; TEREKHOV Y, 1976, CAN MED ASSOC J, V115, P631; Tsai LC, 2006, J ORTHOP SPORT PHYS, V36, P942, DOI 10.2519/jospt.2006.2336; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1	43	31	31	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195995	10.1371/journal.pone.0195995	http://dx.doi.org/10.1371/journal.pone.0195995			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664938	Green Published, gold, Green Submitted			2022-12-26	WOS:000430262300048
J	Torres, M; Reina, JC; Fuentes-Monteverde, JC; Fernandez, G; Rodriguez, J; Jimenez, C; Llamas, I				Torres, Marta; Carlos Reina, Jose; Carlos Fuentes-Monteverde, Juan; Fernandez, Gerardo; Rodriguez, Jaime; Jimenez, Carlos; Llamas, Inmaculada			AHL-lactonase expression in three marine emerging pathogenic Vibrio spp. reduces virulence and mortality in brine shrimp (Artemia salina) and Manila clam (Venerupis philippinarum)	PLOS ONE			English	Article							QUORUM-SENSING SIGNAL; ACYLATED HOMOSERINE LACTONES; IN-VITRO; SP-NOV.; ANTIMICROBIAL RESISTANCE; BACTERIAL DISEASE; GENE-EXPRESSION; MOLECULES; IDENTIFICATION; HARVEYI	Bacterial infectious diseases produced by Vibrio are the main cause of economic losses in aquaculture. During recent years it has been shown that the expression of virulence genes in some Vibrio species is controlled by a population-density dependent gene-expression mechanism known as quorum sensing (QS), which is mediated by the diffusion of signal molecules such as N-acylhomoserine lactones (AHLs). QS disruption, especially the enzymatic degradation of signalling molecules, known as quorum quenching (QQ), is one of the novel therapeutic strategies for the treatment of bacterial infections. In this study, we present the detection of AHLs in 34 marine Vibrionaceae strains. Three aquaculture-related pathogenic Vibrio strains, V. mediterranei VibC-Oc-097, V. owensii VibC-Oc-106 and V. coralliilyticus VibC-Oc-193 were selected for further studies based on their virulence and high production of AHLs. This is the first report where the signal molecules have been characterized in these emerging marine pathogens and correlated to the expression of virulence factors. Moreover, the results of AHL inactivation in the three selected strains have been confirmed in vivo against brine shrimps (Artemia salina) and Manila clams (Venerupis philippinarum). This research contributes to the development of future therapies based on AHL disruption, the most promising alternatives for fighting infectious diseases in aquaculture.	[Torres, Marta; Carlos Reina, Jose; Llamas, Inmaculada] Univ Granada, Dept Microbiol, Fac Pharm, Granada, Spain; [Torres, Marta; Llamas, Inmaculada] Univ Granada, Inst Biotechnol, Biomed Res Ctr CIBM, Granada, Spain; [Carlos Fuentes-Monteverde, Juan; Rodriguez, Jaime; Jimenez, Carlos] Univ A Coruna, Fac Sci, Dept Chem, La Coruna, Spain; [Carlos Fuentes-Monteverde, Juan; Rodriguez, Jaime; Jimenez, Carlos] Univ A Coruna, Ctr Adv Sci Res CICA, La Coruna, Spain; [Fernandez, Gerardo] Univ A Coruna, Res Support Serv SAI, Cent Serv ESCI, La Coruna, Spain; [Torres, Marta] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell,CEA, Gif Sur Yvette, France	University of Granada; University of Granada; Universidade da Coruna; Universidade da Coruna; Universidade da Coruna; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Llamas, I (corresponding author), Univ Granada, Dept Microbiol, Fac Pharm, Granada, Spain.; Llamas, I (corresponding author), Univ Granada, Inst Biotechnol, Biomed Res Ctr CIBM, Granada, Spain.	illamas@ugr.es	Llamas, Inmaculada/AAE-8460-2020; Rodriguez, Jaime/AAY-9780-2021; Llamas, Inmaculada/I-2410-2015; Torres, Marta/O-2749-2016; Jimenez, Carlos/G-9622-2015; Rodriguez, Jaime/G-8984-2015	Llamas, Inmaculada/0000-0001-6333-5033; Rodriguez, Jaime/0000-0001-5348-6970; Llamas, Inmaculada/0000-0001-6333-5033; Torres, Marta/0000-0002-0609-9123; Jimenez, Carlos/0000-0003-2628-303X; Rodriguez, Jaime/0000-0001-5348-6970; Reina Cabello, Jose Carlos/0000-0002-6418-9805; Fuentes-Monteverde, Juan Carlos/0000-0003-3239-3868	Ministerio de Economia y Competitividad (Spain) [AGL2012-39274-C02-02, AGL2015-68806-R, AGL2015-63740-C2-2-R]; FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Spain) [FPU15-01717]; University of Granada (Spain)	Ministerio de Economia y Competitividad (Spain); FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Spain); University of Granada (Spain)	This research was supported in part by grants from the Ministerio de Economia y Competitividad (Spain) (http://www.mineco.gob.es/portal/site/inineco/idi)(AGL2012-39274-C02-02; AGL2015-68806-R; AGL2015-63740-C2-2-R). Jose Carlos Reina is supported by a FPU fellowship from the Ministerio de Educacion, Cultura y Deporte (Spain) (https://www.mecd.gob.es/portada-macd/) (FPU15-01717) and a Initiation to Research fellowship for Master Students (2016) from the University of Granada (Spain) (http://www.ugr.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbowale OL, 2006, J APPL MICROBIOL, V100, P1103, DOI 10.1111/j.1365-2672.2006.02812.x; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Austin B., 1999, BACTERIAL PATHOGENS, V3rd, P13; BAIRDPARKER AC, 1963, J GEN MICROBIOL, V30, P409, DOI 10.1099/00221287-30-3-409; Balado M, 2015, ACS CHEM BIOL, V10, P2850, DOI 10.1021/acschembio.5b00624; Barrow G.I., 1993, COWAN STEELS MANUAL, V3rd; Beaz-Hidalgo R, 2010, SYST APPL MICROBIOL, V33, P311, DOI 10.1016/j.syapm.2010.06.007; Ben-Haim Y, 2003, INT J SYST EVOL MICR, V53, P309, DOI 10.1099/ijs.0.02402-0; Bjarnsholt T, 2010, NAT PROTOC, V5, P282, DOI 10.1038/nprot.2009.205; Bruhn JB, 2005, DIS AQUAT ORGAN, V65, P43, DOI 10.3354/dao065043; Buchholtz C, 2006, SYST APPL MICROBIOL, V29, P433, DOI 10.1016/j.syapm.2005.12.007; Cano-Gomez A, 2011, SYST APPL MICROBIOL, V34, P561, DOI 10.1016/j.syapm.2011.09.001; Cano-Gomez A, 2010, FEMS MICROBIOL LETT, V302, P175, DOI 10.1111/j.1574-6968.2009.01850.x; CHILTON MD, 1974, P NATL ACAD SCI USA, V71, P3672, DOI 10.1073/pnas.71.9.3672; Choopun N, 2002, APPL ENVIRON MICROB, V68, P995, DOI 10.1128/AEM.68.2.995-998.2002; Chu WH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05446; Cordero D, 2017, SCI REP, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Croxatto A, 2004, MOL MICROBIOL, V52, P1677, DOI 10.1111/j.1365-2958.2004.04083.x; Defoirdt T, 2008, J APPL MICROBIOL, V104, P1480, DOI 10.1111/j.1365-2672.2007.03672.x; Defoirdt T, 2004, AQUACULTURE, V240, P69, DOI 10.1016/j.aquaculture.2004.06.031; Defoirdt T, 2011, CURR OPIN MICROBIOL, V14, P251, DOI 10.1016/j.mib.2011.03.004; Dong YH, 2005, J MICROBIOL, V43, P101; Dong YH, 2000, P NATL ACAD SCI USA, V97, P3526, DOI 10.1073/pnas.060023897; Drummond LC, 2007, J INVERTEBR PATHOL, V95, P1, DOI 10.1016/j.jip.2006.11.010; Dubert J, 2017, J FISH DIS, V40, P1185, DOI 10.1111/jfd.12593; Dubert J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00762; Espada A, 2011, J CHROMATOGR A, V1218, P1790, DOI 10.1016/j.chroma.2011.01.072; Food and Agriculture Organization of the United Nations FAO, 2016, STAT WORLD FISH AQ; Garcia-Aljaro C, 2012, J APPL MICROBIOL, V112, P383, DOI 10.1111/j.1365-2672.2011.05199.x; Golberg K, 2011, MICROB ECOL, V61, P783, DOI 10.1007/s00248-011-9848-1; Gomez-Leon J, 2005, APPL ENVIRON MICROB, V71, P98, DOI 10.1128/AEM.71.1.98-104.2005; Gonzalez JE, 2003, MICROBIOL MOL BIOL R, V67, P574, DOI 10.1128/MMBR.67.4.574-592.2003; Goulden EF, 2012, APPL ENVIRON MICROB, V78, P2841, DOI 10.1128/AEM.07274-11; Ha C, 2014, MICROB PATHOGENESIS, V71-72, P8, DOI 10.1016/j.micpath.2014.04.001; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232; Igbinosa EO, 2008, RES MICROBIOL, V159, P495, DOI 10.1016/j.resmic.2008.07.001; Jayaraman A, 2008, ANNU REV BIOMED ENG, V10, P145, DOI 10.1146/annurev.bioeng.10.061807.160536; JEFFRIES CD, 1957, J BACTERIOL, V73, P590, DOI 10.1128/JB.73.4.590-591.1957; Kalia VC, 2011, CRIT REV MICROBIOL, V37, P121, DOI 10.3109/1040841X.2010.532479; Kesarcodi-Watson A, 2009, J FISH DIS, V32, P499, DOI 10.1111/j.1365-2761.2009.01006.x; Kushmaro A, 2001, INT J SYST EVOL MICR, V51, P1383, DOI 10.1099/00207713-51-4-1383; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; Li J, 2017, CORAL REEFS, V36, P1235, DOI 10.1007/s00338-017-1616-3; Lilley BN, 2000, MOL MICROBIOL, V36, P940, DOI 10.1046/j.1365-2958.2000.01913.x; Llamas I, 2005, EXTREMOPHILES, V9, P333, DOI 10.1007/s00792-005-0448-1; Llamas I, 2004, APPL ENVIRON MICROB, V70, P3715, DOI [10.1128/AEM.70.6.3715-3723.2004, 10.1128/aem.70.6.3715-3723.2004]; Manefield M, 1999, MICROBIOL-SGM, V145, P283, DOI 10.1099/13500872-145-2-283; Marketon MM, 2002, J BACTERIOL, V184, P3466, DOI 10.1128/JB.184.13.3466-3475.2002; McClean KH, 1997, MICROBIOL-UK, V143, P3703, DOI 10.1099/00221287-143-12-3703; Meron D, 2009, APPL ENVIRON MICROB, V75, P5704, DOI 10.1128/AEM.00198-09; Milton DL, 1997, J BACTERIOL, V179, P3004, DOI 10.1128/jb.179.9.3004-3012.1997; Morelle G, 1989, FOCUS, V11, P7; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; MOUREY A, 1976, J APPL BACTERIOL, V40, P47, DOI 10.1111/j.1365-2672.1976.tb00589.x; Natrah FMI, 2011, MAR BIOTECHNOL, V13, P109, DOI 10.1007/s10126-010-9346-3; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; O'May C, 2011, APPL ENVIRON MICROB, V77, P3061, DOI 10.1128/AEM.02677-10; Osorio CR, 2015, APPL ENVIRON MICROB, V81, P5867, DOI 10.1128/AEM.01580-15; Paillard C, 2004, AQUAT LIVING RESOUR, V17, P477, DOI 10.1051/alr:2004054; Park SY, 2005, APPL ENVIRON MICROB, V71, P2632, DOI 10.1128/AEM.71.5.2632-2641.2005; Pesci EC, 1997, J BACTERIOL, V179, P3127, DOI 10.1128/jb.179.10.3127-3132.1997; PICKETT MJ, 1991, J CLIN MICROBIOL, V29, P2322, DOI 10.1128/JCM.29.10.2322-2325.1991; PIKOVSKAIA R. I., 1948, Mikrobiologiya, V17, P362; Prado S, 2015, SYST APPL MICROBIOL, V38, P26, DOI 10.1016/j.syapm.2014.11.005; Purohit AA, 2013, J APPL MICROBIOL, V115, P835, DOI 10.1111/jam.12264; Rasmussen BB, 2014, MAR DRUGS, V12, P5527, DOI 10.3390/md12115527; Richards GP, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01252-14; Richards GP, 2015, APPL ENVIRON MICROB, V81, P292, DOI 10.1128/AEM.02930-14; Rojas R, 2016, FRONT MICROBIOL, V7, P1, DOI [10.3389/fmicb.2016.00001, DOI 10.3389/FMICB.2016.00001]; Romalde JL, 2014, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00413; Romero M, 2011, FEMS MICROBIOL ECOL, V75, P205, DOI 10.1111/j.1574-6941.2010.01011.x; Rosenberg E, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P451, DOI 10.1007/978-94-007-0114-4_26; Rubio-Portillo E, 2014, ISME J, V8, P1794, DOI 10.1038/ismej.2014.33; Rui HP, 2008, FEMS MICROBIOL LETT, V285, P155, DOI 10.1111/j.1574-6968.2008.01185.x; Ruwandeepika HAD, 2011, ENVIRON MICROBIOL, V13, P506, DOI 10.1111/j.1462-2920.2010.02354.x; Sambrook J., 2001, MOL CLONING LAB MANU; Saurav K, 2017, MAR DRUGS, V15, DOI 10.3390/md15030053; Shaw PD, 1997, P NATL ACAD SCI USA, V94, P6036, DOI 10.1073/pnas.94.12.6036; Smith P, 2008, REV SCI TECH OIE, V27, P243, DOI 10.20506/rst.27.1.1799; SORGELOOS P, 1975, AQUACULTURE, V6, P303, DOI 10.1016/0044-8486(75)90110-6; Steindler L, 2007, FEMS MICROBIOL LETT, V266, P1, DOI 10.1111/j.1574-6968.2006.00501.x; Tahrioui Ali, 2013, Life-Basel, V3, P260, DOI 10.3390/life3010260; Tait K, 2010, ENV MICROBIOL REP, V2, P145, DOI 10.1111/j.1758-2229.2009.00122.x; Tarazona E, 2014, SYST APPL MICROBIOL, V37, P320, DOI 10.1016/j.syapm.2014.05.005; Thompson FL, 2001, SYST APPL MICROBIOL, V24, P516, DOI 10.1078/0723-2020-00065; Tinh NTN, 2008, MAR BIOTECHNOL, V10, P1, DOI 10.1007/s10126-007-9054-9; Torres M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01176-7; Torres M, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00646; Torres M, 2013, MICROBIOL RES, V168, P547, DOI 10.1016/j.micres.2013.04.011; Uroz S, 2005, MICROBIOL-SGM, V151, P3313, DOI 10.1099/mic.0.27961-0; Uroz S, 2003, MICROBIOL-SGM, V149, P1981, DOI 10.1099/mic.0.26375-0; Uroz S, 2008, FEMS MICROBIOL ECOL, V65, P271, DOI 10.1111/j.1574-6941.2008.00477.x; Uroz S, 2009, CHEMBIOCHEM, V10, P205, DOI 10.1002/cbic.200800521; Ushijima B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046717; Valiente E, 2009, FEMS MICROBIOL ECOL, V69, P16, DOI 10.1111/j.1574-6941.2009.00691.x; Wang YD, 2013, J BACTERIOL, V195, P3583, DOI 10.1128/JB.00508-13; Whitehead NA, 2001, FEMS MICROBIOL REV, V25, P365, DOI 10.1111/j.1574-6976.2001.tb00583.x; Wu YJ, 2009, J CHIN CHEM SOC-TAIP, V56, P688, DOI 10.1002/jccs.200900103; Yang Q, 2011, J APPL MICROBIOL, V110, P1438, DOI 10.1111/j.1365-2672.2011.04998.x; Zhang HB, 2002, P NATL ACAD SCI USA, V99, P4638, DOI 10.1073/pnas.022056699; Zhao J, 2015, J FISH DIS, V38, P771, DOI 10.1111/jfd.12299; Zhu J, 2002, P NATL ACAD SCI USA, V99, P3129, DOI 10.1073/pnas.052694299	103	17	18	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195176	10.1371/journal.pone.0195176	http://dx.doi.org/10.1371/journal.pone.0195176			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664914	gold, Green Published, Green Submitted			2022-12-26	WOS:000430262300016
J	Wall, NA; Dominguez-Medina, CC; Faustini, SE; Cook, CN; McClean, A; Jesky, MD; Perez-Toledo, M; Morgan, MD; Richter, AG; Ferro, CJ; Cocicwell, P; Moss, PA; Henderson, IR; Harper, L; Cunningham, AF				Wall, Nadezhda A.; Dominguez-Medina, C. Coral; Faustini, Sian E.; Cook, Charlotte N.; McClean, Andrew; Jesky, Mark D.; Perez-Toledo, Marisol; Morgan, Matthew D.; Richter, Alexandra G.; Ferro, Charles J.; Cocicwell, Paul; Moss, Paul A.; Henderson, Ian R.; Harper, Lorraine; Cunningham, Adam F.			Humoral immunity to memory antigens and pathogens is maintained in patients with chronic kidney disease	PLOS ONE			English	Article							STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; COLLABORATIVE METAANALYSIS; CYTOMEGALOVIRUS-INFECTION; HEMODIALYSIS-PATIENTS; PERITONEAL-DIALYSIS; POPULATION COHORTS; GENERAL-POPULATION; T-CELLS; VACCINATION	Patients with chronic kidney disease (CKD) have an increased risk of infection and poorer responses to vaccination. This suggests that CKD patients have an impaired responsiveness to all antigens, even those first encountered before CKD onset. To examine this we evaluated antibody responses against two childhood vaccine antigens, tetanus (TT) and diphtheria toxoids (DT) and two common pathogens, cytomegalovirus (CMV) and Salmonella enterica serovar Enteritidis (SEn) in two independent cohorts consisting of age-matched individuals with and without CKD. Sera were evaluated for antigen-specific IgG titres and the functionality of antibody to SEn was assessed in a serum bactericidal assay. Surprisingly, patients with CKD and control subjects had comparable levels of IgG against TT and DT, suggesting preserved humoral memory responses to antigens encountered early in life. Lipopolysaccharide-specific IgG titres and serum bactericidal activity in patients with CKD were also not inferior to controls. CMV-specific IgG titres in seropositive CKD patients were similar or even increased compared to controls. Therefore, whilst responses to new vaccines in CKD are typically lower than expected, antibody responses to antigens commonly encountered prior to CKD onset are not. The immunodeficiency of CKD is likely characterised by failure to respond to new antigenic challenges and efforts to improve patient outcomes should be focussed here.	[Wall, Nadezhda A.; Dominguez-Medina, C. Coral; Faustini, Sian E.; Cook, Charlotte N.; Jesky, Mark D.; Perez-Toledo, Marisol; Morgan, Matthew D.; Richter, Alexandra G.; Ferro, Charles J.; Cocicwell, Paul; Moss, Paul A.; Henderson, Ian R.; Harper, Lorraine; Cunningham, Adam F.] Univ Birmingham, Birmingham, W Midlands, England; [McClean, Andrew] Univ Hosp North Midlands NHS Trust, Stoke On Trent, Staffs, England; [Jesky, Mark D.; Morgan, Matthew D.; Richter, Alexandra G.; Ferro, Charles J.; Cocicwell, Paul; Moss, Paul A.; Harper, Lorraine] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Wall, NA (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.	Nadya.Wall@nhs.net	Moss, Paul/D-1728-2009; Morgan, Matthew David/K-2240-2019; ferro, charles/L-7250-2019; Ferro, Charles J./O-8912-2016; Henderson, Ian/AAD-5369-2019	Moss, Paul/0000-0002-6895-1967; Morgan, Matthew David/0000-0002-7831-2245; ferro, charles/0000-0003-0577-7081; Ferro, Charles J./0000-0003-0577-7081; harper, lorraine/0000-0003-1343-9234; Henderson, Ian/0000-0002-9954-4977; Cockwell, Paul/0000-0003-1975-266X; Cunningham, Adam/0000-0003-0248-964X	NIHR Academic Clinical Fellowship; Wellcome Trust Joint Basic and Clinical PhD Studentship [105479/Z/14/Z]; JABBS Foundation (Birmingham, United Kingdom); Queen Elizabeth Hospital Birmingham Charity; MRC [MR/N027027/1, MR/N023706/1] Funding Source: UKRI	NIHR Academic Clinical Fellowship; Wellcome Trust Joint Basic and Clinical PhD Studentship; JABBS Foundation (Birmingham, United Kingdom); Queen Elizabeth Hospital Birmingham Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was supported by an NIHR Academic Clinical Fellowship and subsequently a Wellcome Trust Joint Basic and Clinical PhD Studentship (105479/Z/14/Z; www.wellcome.ac.uk) awarded to NW. The RIISC study, from which some samples were sourced, is supported by the JABBS Foundation (Birmingham, United Kingdom) and The Queen Elizabeth Hospital Birmingham Charity (www.qehb.org). The funders had no role in the design of this study, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S K, 1999, J Assoc Physicians India, V47, P183; Aitken Grant R, 2014, BMJ Open, V4, pe005480, DOI 10.1136/bmjopen-2014-005480; Arias RA, 2013, J VIROL, V87, P4486, DOI 10.1128/JVI.02425-12; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; [Anonymous], 2013, DIPHTH GREEN BOOK IM; [Anonymous], 2013, TET GREEN BOOK IMM I; [Anonymous], 2006, WKLY EPIDEMIOL REC, V20, P197; Astor BC, 2011, KIDNEY INT, V79, P1331, DOI 10.1038/ki.2010.550; ATKINS RC, 1978, AUST NZ J MED, V8, P222; Betjes MGH, 2008, KIDNEY INT, V74, P760, DOI 10.1038/ki.2008.301; Betjes MGH, 2007, NEPHROL DIAL TRANSPL, V22, P3298, DOI 10.1093/ndt/gfm348; Betjes MGH, 2014, CURR UROL REP, V16, DOI 10.1007/s11934-014-0471-9; Betjes MGH, 2010, NEPHROL DIAL TRANSPL, V25, P3640, DOI 10.1093/ndt/gfq203; Bouts AHM, 2004, CLIN EXP IMMUNOL, V137, P589, DOI 10.1111/j.1365-2249.2004.02571.x; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Dalrymple LS, 2008, CLIN J AM SOC NEPHRO, V3, P1487, DOI 10.2215/CJN.01290308; Dalrymple LS, 2012, AM J KIDNEY DIS, V59, P356, DOI 10.1053/j.ajkd.2011.07.012; DaRoza G, 2003, AM J KIDNEY DIS, V42, P1184, DOI 10.1053/j.ajkd.2003.08.019; Ferraro AJ, 2008, EUR J IMMUNOL, V38, P292, DOI 10.1002/eji.200737557; Hart PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145945; Ishigami J, 2017, AM J KIDNEY DIS, V69, P752, DOI 10.1053/j.ajkd.2016.09.018; Janus N, 2008, NEPHROL DIAL TRANSPL, V23, P800, DOI 10.1093/ndt/gfm851; JOHNSON DW, 1992, CLIN PHARMACOKINET, V22, P434, DOI 10.2165/00003088-199222060-00003; Koch S, ANN NEW YORK ACAD SC, V11142007, P23; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; MacLennan CA, 2008, J CLIN INVEST, V118, P1553, DOI 10.1172/JCI33998; MacLennan CA, 2010, SCIENCE, V328, P508, DOI 10.1126/science.1180346; Mastalerz-Migas A, 2013, MED SCI MONITOR, V19, P1013, DOI 10.12659/MSM.889671; Mathew R, 2014, EXPERT REV VACCINES, V13, P285, DOI 10.1586/14760584.2014.874950; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; McClean A, 2016, ARTHRIT CARE RES, V68, P1332, DOI 10.1002/acr.22827; MCVOY MA, 1989, J INFECT DIS, V160, P1, DOI 10.1093/infdis/160.1.1; National. Institute. for. Health. and. Care. Excellence, 2014, CHRON KIDN DIS AD AS; Pahl MV, 2010, NEPHROL DIAL TRANSPL, V25, P205, DOI 10.1093/ndt/gfp397; Parry HM, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-015-0056-6; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Pertosa G, 2000, KIDNEY INT, V58, pS104, DOI 10.1046/j.1523-1755.2000.07613.x; Pourfarziani V, 2008, ANN TRANSPL, V13, P43; Prosch S, 2000, VIROLOGY, V272, P357, DOI 10.1006/viro.2000.0367; Saad K, 2014, RENAL FAILURE, V36, P502, DOI 10.3109/0886022X.2013.875833; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Savva GM, 2013, AGING CELL, V12, P381, DOI 10.1111/acel.12059; Steenkamp R, 2016, NEPHRON, V132, P111, DOI 10.1159/000444819; Stringer S, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-95; Teng YKO, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3770; Trebicka E, 2013, CLIN VACCINE IMMUNOL, V20, P1491, DOI 10.1128/CVI.00289-13; Tsouchnikas I, 2007, CLIN NEPHROL, V68, P228; Wall NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055686; Wells TJ, 2014, J EXP MED, V211, P1893, DOI 10.1084/jem.20132444; Whitelegg AME, 2012, J IMMUNOL METHODS, V377, P37, DOI 10.1016/j.jim.2012.01.007; WHO, 2006, WKLY EPIDEMIOL REC, V81, P21; Yadav AK, 2011, NEPHROL DIAL TRANSPL, V26, P1689, DOI 10.1093/ndt/gfr010	52	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195730	10.1371/journal.pone.0195730	http://dx.doi.org/10.1371/journal.pone.0195730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659606	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100027
J	Langellotti, S; Romano, G; Feiguin, F; Barolle, FE; Romano, M				Langellotti, Simona; Romano, Giulia; Feiguin, Fabian; Barolle, Francisco Ernesto; Romano, Maurizio			RhoGAPp190: A potential player in tbph-mediated neurodegeneration in Drosophila	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; NUCLEAR FACTOR TDP-43; IN-VIVO; BINDING-PROPERTIES; SIGNALING PATHWAY; CFTR EXON-9; P190 RHOGAP; PROTEINS; MELANOGASTER	TDP-43 is an ubiquitous and highly conserved ribonucleoprotein involved in several cellular processes including pre-mRNA splicing, transcription, mRNA stability and transport. Not-withstanding the evidence of TDP-43 involvement in the pathogenesis of different neurodegenerative disorders (i.e. ALS and FTLD), the underlying mechanisms are still unclear. Given the high degree of functional similarity between the human and fly orthologs of TDP-43, Drosophila melanogaster is a simple and useful model to study the pathophysiological role of this protein in vivo. It has been demonstrated that the depletion of the TDP-43 fly ortholog (tbph) induces deficient locomotive behaviors and reduces life span and anatomical defects at the neuromuscular junction. In this study, using the known binding specificity of TDP-43/ tbph for (UG) repeated sequences, we performed a bioinformatic screening for fly genes with at least 6 (TG) repeats in a row within the 3'-UTR regions in order to identify the genes that might be regulated by this factor. Among these genes, we were able to identify RhoGAPp190 as a potential target of the tbph-mediated neurodegeneration. RhoGAPp190 is a negative regulator of Drosophila RhoA, a GTPase protein implicated in the fine modulation of critical cellular processes including axon branch stability and motor axon defasciculation at muscle level and cognitive processes. We were able to demonstrate that the RhoGAPp190 expression is upregulated in a tbph-null fly model, providing evidence that this deregulation is associated to tbph silencing. Our results introduce RhoGAPp190 as a novel potential mediator in the complex scenario of events resulting from in vivo tbph loss-of-function.	[Langellotti, Simona; Romano, Giulia; Feiguin, Fabian; Barolle, Francisco Ernesto] Int Ctr Genet Engn & Biotechnol, Trieste, Italy; [Romano, Maurizio] Univ Trieste, Dept Life Sci, Trieste, Italy	International Center for Genetic Engineering & Biotechnology (ICGEB); University of Trieste	Romano, M (corresponding author), Univ Trieste, Dept Life Sci, Trieste, Italy.	mromano@units.it	Romano, Giulia/U-4156-2018; Feiguin, Fabian/ABC-2514-2020; Romano, Maurizio/G-9431-2012	Romano, Giulia/0000-0003-0356-4947; Romano, Maurizio/0000-0002-4820-2897	AriSLA (CHRONOS)	AriSLA (CHRONOS)	This work was supported by AriSLA (CHRONOS, to F.F.); This work was supported by AriSLA (CHRONOS, to F.F.). The Authors thank Dr. Flavia Baralle for proofreading the article.	Ambegaokar SS, 2010, NEUROBIOL DIS, V40, P29, DOI 10.1016/j.nbd.2010.05.026; Appocher C, 2017, NUCLEIC ACIDS RES, V45, P8026, DOI 10.1093/nar/gkx477; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Arthur LL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14112; Ayala YM, 2005, J MOL BIOL, V348, P575, DOI 10.1016/j.jmb.2005.02.038; Billuart P, 2001, CELL, V107, P195, DOI 10.1016/S0092-8674(01)00522-0; Broeck LV, 2014, TRENDS MOL MED, V20, P66, DOI 10.1016/j.molmed.2013.11.003; Brouns MR, 2001, NAT CELL BIOL, V3, P361, DOI 10.1038/35070042; Budini M, 2015, HUM MOL GENET, V24, P9, DOI 10.1093/hmg/ddu415; Buratti E, 2001, J BIOL CHEM, V276, P36337, DOI 10.1074/jbc.M104236200; Buratti E, 2001, EMBO J, V20, P1774, DOI 10.1093/emboj/20.7.1774; Cragnaz L, 2014, NEUROBIOL DIS, V71, P74, DOI 10.1016/j.nbd.2014.07.009; D'Ambrogio A, 2009, NUCLEIC ACIDS RES, V37, P4116, DOI 10.1093/nar/gkp342; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Feiguin F, 2009, FEBS LETT, V583, P1586, DOI 10.1016/j.febslet.2009.04.019; Godena VK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017808; Iguchi Y, 2009, J BIOL CHEM, V284, P22059, DOI 10.1074/jbc.M109.012195; Jeong S, 2012, NEURON, V76, P721, DOI 10.1016/j.neuron.2012.09.018; Li Y, 2010, P NATL ACAD SCI USA, V107, P3169, DOI 10.1073/pnas.0913602107; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lu YB, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-30; Majumder P, 2012, ACTA NEUROPATHOL, V124, P231, DOI 10.1007/s00401-012-1006-4; Mishra A, 2017, BRAIN, V140, P1437, DOI 10.1093/brain/awx066; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Romano G, 2014, NEUROBIOL DIS, V71, P95, DOI 10.1016/j.nbd.2014.07.007; Romano M, 2014, J BIOL CHEM, V289, P7121, DOI 10.1074/jbc.M114.548859; Romano Maurizio, 2012, J Amino Acids, V2012, P356081, DOI 10.1155/2012/356081; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SETTLEMAN J, 1992, CELL, V69, P539, DOI 10.1016/0092-8674(92)90454-K; Skoko N, 2016, EMBO J, V35, P115, DOI 10.15252/embj.201593603; Van Langenhove T, 2012, ANN MED, V44, P817, DOI 10.3109/07853890.2012.665471	36	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195845	10.1371/journal.pone.0195845	http://dx.doi.org/10.1371/journal.pone.0195845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652933	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900040
J	Lee, SM; Park, JY; Park, MS; Park, JH; Park, M; Yoon, HJ				Lee, Seung Min; Park, Ju-Young; Park, Min-Su; Park, Jong Heon; Park, Minseon; Yoon, Hyung-Jin			Association of renal hyperfiltration with incident proteinuria - A nationwide registry study	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR OUTCOMES; DIABETIC-NEPHROPATHY; GENERAL-POPULATION; FASTING GLUCOSE; RISK-FACTORS; MEN; METAANALYSIS	To elucidate the association between renal hyperfiltration (RHF) and incident proteinuria, the data from 11,559,520 Korean adults who had undergone health screenings >= 3 times between 2009 and 2014 and had glomerular filtration rate (GFR) >= 60 mL/min/1.73m(2) and negative dipstick test for proteinuria at baseline, were retrospectively analyzed. GFR was estimated with the Chronic Kidney Disease Epidemiology Collaboration equation based on serum creatinine, and RHF was defined as GFR >95th percentile adjusted for sex, age, body size, and diabetes and/or hypertension medication. The adjusted hazard ratio (aHR) of incident proteinuria in the RHF was 1.083 (95% CI, 1.069 similar to 1.097) compared to that of the non-RHF with Cox regression model. The association between RHF and incident proteinuria was not only in diabetic but also in non-diabetic subjects. This association was not observed in women (p for interaction <0.001). A reverse J-shaped association was found between the adjusted GFR slope and aHR of incident proteinuria. Both lower and higher GFR were associated with incident proteinuria in men. In conclusion, RHF was associated with incident proteinuria in men. Clinical studies are necessary to study whether the alleviation of RHF can prevent incident proteinuria.	[Lee, Seung Min; Park, Ju-Young; Yoon, Hyung-Jin] Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea; [Park, Min-Su] Yonsei Univ, Coll Med, Dept Biomed Syst Informat, Seoul, South Korea; [Park, Jong Heon] Natl Hlth Insurance Serv, Big Data Steering Dept, Wonju, Gangwon, South Korea; [Park, Minseon] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; National Health Insurance Service; Seoul National University (SNU); Seoul National University Hospital	Yoon, HJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Engn, Seoul, South Korea.	hjyoon@snu.ac.kr		Yoon, Hyung-Jin/0000-0003-4432-4894; Park, Ju-young/0000-0003-0782-614X; Lee, SeungMin/0000-0001-5762-2618	Korean Meteorological Administration's Research and Development Program [KMIPA 2015-5120]	Korean Meteorological Administration's Research and Development Program	This work was funded by the Korean Meteorological Administration's Research and Development Program under Grant KMIPA 2015-5120. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal V, 2009, NAT REV CARDIOL, V6, P301, DOI 10.1038/nrcardio.2009.11; Astor BC, 2009, J AM SOC NEPHROL, V20, P2214, DOI 10.1681/ASN.2008090980; Ayodele OE, 2010, ADV CHRONIC KIDNEY D, V17, P215, DOI 10.1053/j.ackd.2010.02.001; Brenner BM, 1996, KIDNEY INT, V49, P1774, DOI 10.1038/ki.1996.265; Chagnac A, 2003, J AM SOC NEPHROL, V14, P1480, DOI 10.1097/01.ASN.0000068462.38661.89; Cheol Seong S, 2016, INT J EPIDEMIOL; Donfrancesco C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078475; Endlich N, 2012, SEMIN NEPHROL, V32, P327, DOI 10.1016/j.semnephrol.2012.06.004; Fox CS, 2012, LANCET, V380, P1662, DOI 10.1016/S0140-6736(12)61350-6; Hallan SI, 2012, JAMA-J AM MED ASSOC, V308, P2349, DOI 10.1001/jama.2012.16817; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Jerums G, 2010, DIABETOLOGIA, V53, P2093, DOI 10.1007/s00125-010-1794-9; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Katsiki N, 2015, CURR MED CHEM, V22, P3565, DOI 10.2174/0929867322666150904110053; Kwakernaak AJ, 2013, NEPHROL DIAL TRANSPL, V28, P42, DOI 10.1093/ndt/gft331; Maeda I, 2011, CLIN J AM SOC NEPHRO, V6, P2462, DOI 10.2215/CJN.00700111; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Matsushita K, 2015, LANCET DIABETES ENDO, V3, P514, DOI 10.1016/S2213-8587(15)00040-6; Matsushita K, 2012, JAMA-J AM MED ASSOC, V307, P1941, DOI 10.1001/jama.2012.3954; Matsushita K, 2010, AM J KIDNEY DIS, V55, P648, DOI 10.1053/j.ajkd.2009.12.016; Melsom T, 2016, CLIN J AM SOC NEPHRO, V11, P2186, DOI 10.2215/CJN.04940516; Melsom T, 2012, CLIN J AM SOC NEPHRO, V7, P1801, DOI 10.2215/CJN.02980312; Melsom T, 2011, DIABETES CARE, V34, P1546, DOI 10.2337/dc11-0235; MOGENSEN CE, 1984, NEW ENGL J MED, V311, P89, DOI 10.1056/NEJM198407123110204; Nelson RG, 1996, NEW ENGL J MED, V335, P1636, DOI 10.1056/NEJM199611283352203; Nitsch D, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f324; Okada R, 2014, NUTR METAB CARDIOVAS, V24, P277, DOI 10.1016/j.numecd.2013.08.004; Okada R, 2012, NEPHROL DIAL TRANSPL, V27, P1821, DOI 10.1093/ndt/gfr651; Park M, 2015, J AM SOC NEPHROL, V26, P1426, DOI 10.1681/ASN.2014010115; Park M, 2013, MED SCI SPORT EXER, V45, P217, DOI 10.1249/MSS.0b013e318271b39f; Pisoni Roberto, 2002, Saudi J Kidney Dis Transpl, V13, P250; Porrini E, 2015, LANCET DIABETES ENDO, V3, P382, DOI 10.1016/S2213-8587(15)00094-7; Pugliese G, 2014, ACTA DIABETOL, V51, P905, DOI 10.1007/s00592-014-0650-7; Ruggenenti P, 2012, DIABETES CARE, V35, P2061, DOI 10.2337/dc11-2189; Sarnak MJ, 2011, ADV CHRONIC KIDNEY D, V18, P258, DOI 10.1053/j.ackd.2011.04.002; SCHMIEDER RE, 1990, JAMA-J AM MED ASSOC, V264, P2775, DOI 10.1001/jama.264.21.2775; So R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166495; Thomas G, 2015, CLEV CLIN J MED, V82, P716, DOI 10.3949/ccjm.82a.15038; Turin TC, 2013, KIDNEY INT, V83, P684, DOI 10.1038/ki.2012.443	39	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195784	10.1371/journal.pone.0195784	http://dx.doi.org/10.1371/journal.pone.0195784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652920	gold, Green Published, Green Submitted			2022-12-26	WOS:000430026900035
J	Wang, SF; Jiao, XY; Guo, WH; Lu, J; Bai, YG; Wang, LP				Wang, Shufang; Jiao, Xiyun; Guo, Weihua; Lu, Jian; Bai, Yungang; Wang, Liping			Adaptability of shallow subsurface drip irrigation of alfalfa in an arid desert area of Northern Xinjiang	PLOS ONE			English	Article							WATER-USE EFFICIENCY; PRODUCTIVITY; YIELD; POTATO; CROP; ROOT	A suitable irrigation method adopted to arid desert conditions, including a special soil structure and specialized plants, has been continuously studied and improved. A field study was conducted in the Awei irrigation area of Aletai in Xinjiang in 2015 and 2016 to investigate the applicability of shallow subsurface drip irrigation (SSDI) in an arid desert area. A completely randomized block design with three replications and three treatments for drip tape subsurface depths at 5, 10, 20 cm was established. The results indicated that the vertical distribution of the soil moisture of subsurface drip irrigation (SDI, buried depth at 20 cm) was mainly concentrated at 0-60 cm, while SSDI (buried depth at 5 and 10 cm) was concentrated at 0-30 cm. However, the roots distributions were concentrated at 0-30 cm for SDI and SSDI. The chlorophyll content and water consumption intensity for alfalfa first increased and then decreased in arid desert conditions. The dry yield and water use efficiency (WUE) of SSDI (buried depth at 10 cm) were higher than those of SDI. The SSDI was practical in arid desert conditions and the recommended buried depth was 10 cm.	[Wang, Shufang; Jiao, Xiyun; Guo, Weihua] Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China; [Lu, Jian] Minist Water Resources, Sci & Technol Promot Ctr, Beijing, Peoples R China; [Bai, Yungang] Xinjiang Inst Water Resources & Hydropower Res, Urumqi, Peoples R China; [Wang, Liping] Yunnan Agr Univ, Coll Water Conservancy, Kunming, Yunnan, Peoples R China	Hohai University; China Institute of Water Resources & Hydropower Research; Ministry of Water Resources; Yunnan Agricultural University	Jiao, XY (corresponding author), Hohai Univ, Coll Water Conservancy & Hydropower Engn, Nanjing, Jiangsu, Peoples R China.	xyjiao@hhu.edu.cn		SALAHOU, Mohamed Khaled/0000-0001-5604-8589	Science & Technology Program of Xinjiang [201431107]	Science & Technology Program of Xinjiang	This research was supported by a grant from Science & Technology Program of Xinjiang (No.201431107) to XJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2002, J AM WATER RESOUR AS, V38, P1715, DOI 10.1111/j.1752-1688.2002.tb04376.x; Ayars JE, 2015, AGR WATER MANAGE, V157, P39, DOI 10.1016/j.agwat.2015.01.001; Ayars JE, 1999, AGR WATER MANAGE, V42, P1, DOI 10.1016/S0378-3774(99)00025-6; Ayars JE, 2001, AGR WATER MANAGE, V47, P243, DOI 10.1016/S0378-3774(00)00106-2; Borza I., 2014, Analele Universitatii din Oradea, Fascicula: Protectia Mediului, V23, P25; Bozkurt S, 2018, AGR WATER MANAGE, V197, P1, DOI 10.1016/j.agwat.2017.11.009; Camp CR, 1998, T ASAE, V41, P1353, DOI 10.13031/2013.17309; Camp CR, 2000, NATIONAL IRRIGATION SYMPOSIUM, PROCEEDINGS, P363; Charlesworth PB, 2003, IRRIGATION SCI, V22, P171, DOI 10.1007/s00271-003-0082-6; [陈洪松 Chen Hongsong], 2003, [水科学进展, Advances in Water Science], V14, P513; ESTILL K, 1991, CROP SCI, V31, P1229, DOI 10.2135/cropsci1991.0011183X003100050030x; Finger L, 2015, IRRIGATION SCI, V33, P141, DOI 10.1007/s00271-014-0454-0; FOX R. L., 1955, SOIL SCI SOC AMER PROC, V19, P468; Godoy A. C., 2003, AGROCIENCIA, V37, P107; Guo ZG, 2014, PHILIPPINE AGRICULTU, V96, P370; Han QingFang, 2005, Pratacultural Science, V22, P22; Hussain K, 2010, AFR J AGR RES, V5, P3026; Ismail SM, 2013, IRRIG DRAIN, V62, P57, DOI 10.1002/ird.1705; Jeremiah Attram, 2016, CAN J PLANT SCI, V96, P165; Kandelous MM, 2012, AGR WATER MANAGE, V109, P81, DOI 10.1016/j.agwat.2012.02.009; Kazumba S, 2010, WATER SCI TECHNOL, V61, P625, DOI 10.2166/wst.2010.904; KOSMAS CS, 1993, SOIL TECHNOL, V6, P337, DOI 10.1016/0933-3630(93)90024-9; Lamm FR, 2012, T ASABE, V55, P1203; Lei ZD, 1992, SOIL HYDRODYNAMICS; [李扬 LI Yang], 2011, [草地学报, Acta Agrestia Sinica], V19, P872; Lu WeiHua, 2014, Transactions of the Chinese Society of Agricultural Engineering, V30, P128; Montemayor Trejo José Alfredo, 2010, Rev. mex. de cienc. pecuarias, V1, P145; Pablo RG, 2007, J SUSTAIN AGR, V30, P153, DOI 10.1300/J064v30n01_10; Patel N, 2008, AGR WATER MANAGE, V95, P1335, DOI 10.1016/j.agwat.2008.06.002; Patel N, 2007, AGR WATER MANAGE, V88, P209, DOI 10.1016/j.agwat.2006.10.017; PENG SB, 1993, AGRON J, V85, P987, DOI 10.2134/agronj1993.00021962008500050005x; Rasse DP, 2000, SOIL SCI SOC AM J, V64, P725, DOI 10.2136/sssaj2000.642725x; Ren LD, 2016, SOIL RES, V54, P730, DOI 10.1071/SR15126; Reyes-Cabrera J, 2016, AGR WATER MANAGE, V169, P183, DOI 10.1016/j.agwat.2016.03.001; Santos LNS, 2014, VII CONGRESO IBERICO DE AGROINGENIERIA Y CIENCIAS HORTICOLAS, P1134; Sun HR, 2008, ACTA AGRESTIA SINICA, V16, P3; Wang J. Q., 2015, SCI WORLD J, V2015, P1, DOI [DOI 10.1371/J0URNAL.P0NE.0124261, DOI 10.2118/174392-MS]	37	7	9	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195965	10.1371/journal.pone.0195965	http://dx.doi.org/10.1371/journal.pone.0195965			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652935	Green Published, gold			2022-12-26	WOS:000430026900049
J	Sheridan, D; Yu, ZX; Zhang, YC; Patel, R; Sun, F; Lasaro, MA; Bouchard, K; Andrien, B; Marozsan, A; Wang, Y; Tamburini, P				Sheridan, Douglas; Yu, Zhao-Xue; Zhang, Yuchun; Patel, Rekha; Sun, Fang; Lasaro, Melissa A.; Bouchard, Keith; Andrien, Bruce; Marozsan, Andre; Wang, Yi; Tamburini, Paul			Design and preclinical characterization of ALXN1210: A novel anti-C5 antibody with extended duration of action	PLOS ONE			English	Article							PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; HEMOLYTIC-UREMIC SYNDROME; SERUM HALF-LIFE; ECULIZUMAB TREATMENT; MONOCLONAL-ANTIBODY; 5TH COMPONENT; HUMAN IGG1; IN-VIVO; COMPLEMENT; DISEASE	Eculizumab, a monoclonal antibody (mAb) directed against complement protein C5, is considered to be the current standard of care for patients with paroxysmal nocturnal hemoglo-binuria (PNH) and atypical hemolytic uremic syndrome. This study describes the generation and preclinical attributes of ALXN1210, a new long-acting anti-C5 mAb, obtained through select modifications to eculizumab to both largely abolish target-mediated drug disposition (TMDD) and increase recycling efficiency via the neonatal Fc receptor (FcRn). To attenuate the effect of TMDD on plasma terminal half-life (t(1/2)), histidine substitutions were engineered into the complementarity-determining regions of eculizumab to enhance the dissociation rate of the mAb:C5 complex in the acidic early endosome relative to the slightly basic pH of blood. Antibody variants with optimal pH-dependent binding to C5 exhibited little to no TMDD in mice in the presence of human C5. To further enhance the efficiency of FcRn-mediated recycling of the antibody, two additional substitutions were introduced to increase affinity for human FcRn. These substitutions yielded an additional doubling of the t(1/2) of surrogate anti-mouse C5 antibodies with reduced TMDD in transgenic mice expressing the human FcRn. In conclusion, ALXN1210 is a promising new therapeutic candidate currently in clinical development for treatment of patients with PNH and atypical hemolytic uremic syndrome.	[Sheridan, Douglas; Yu, Zhao-Xue; Zhang, Yuchun; Sun, Fang; Lasaro, Melissa A.; Bouchard, Keith; Marozsan, Andre; Wang, Yi; Tamburini, Paul] Alexion Pharmaceut Inc, Res, New Haven, CT 06510 USA; [Patel, Rekha] Alexion Pharmaceut Inc, Prod Characterizat, New Haven, CT USA; [Andrien, Bruce] Alexion Pharmaceut Inc, Early Assay Dev, New Haven, CT USA		Sheridan, D (corresponding author), Alexion Pharmaceut Inc, Res, New Haven, CT 06510 USA.	douglas.sheridan@alexion.com		Sheridan, Douglas/0000-0001-9505-1668	Alexion Pharmaceuticals, Inc.	Alexion Pharmaceuticals, Inc.	This study was funded by Alexion Pharmaceuticals, Inc. (http://www.alexion.com/). Alexion Pharmaceuticals, Inc., was involved with study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Brodsky RA, 2014, BLOOD, V124, P2804, DOI 10.1182/blood-2014-02-522128; Chaparro-Riggers J, 2012, J BIOL CHEM, V287, P11090, DOI 10.1074/jbc.M111.319764; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Cugno M, 2014, J THROMB HAEMOST, V12, P1440, DOI 10.1111/jth.12615; FREI Y, 1987, MOL CELL PROBE, V1, P141, DOI 10.1016/0890-8508(87)90022-3; Fukuzawa T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01087-7; Groth M, 2017, ANN HEMATOL, V96, P171, DOI 10.1007/s00277-016-2867-8; Hillmen P, 2013, BRIT J HAEMATOL, V162, P62, DOI 10.1111/bjh.12347; Igawa T, 2010, NAT BIOTECHNOL, V28, P1203, DOI 10.1038/nbt.1691; Lee JW, 2016, HAEMATOLOGICA, V101, P414; LEE JW, 2016, BLOOD, V128; Licht C, 2015, KIDNEY INT, V87, P1061, DOI 10.1038/ki.2014.423; Mastellos D, 2001, J IMMUNOL, V166, P2479, DOI 10.4049/jimmunol.166.4.2479; Nakayama H, 2016, BIOL PHARM BULL, V39, P285, DOI 10.1248/bpb.b15-00703; Petkova SB, 2006, INT IMMUNOL, V18, P1759, DOI 10.1093/intimm/dxl110; Pyzik M, 2015, J IMMUNOL, V194, P4595, DOI 10.4049/jimmunol.1403014; RINDER CS, 1995, J CLIN INVEST, V96, P1564, DOI 10.1172/JCI118195; Roopenian DC, 2010, METHODS MOL BIOL, V602, P93, DOI 10.1007/978-1-60761-058-8_6; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; RUDDY S, 1975, MEDICINE, V54, P165, DOI 10.1097/00005792-197554020-00004; Sahelijo A.M. Leonardo, 2015, BLOOD, V126, P4777, DOI DOI 10.1182/blood.V126.23.4777.4777; Sarkar CA, 2002, NAT BIOTECHNOL, V20, P908, DOI 10.1038/nbt725; Schatz-Jakobsen JA, 2016, J IMMUNOL, V197, P337, DOI 10.4049/jimmunol.1600280; SISSONS JGP, 1977, J CLIN INVEST, V59, P704, DOI 10.1172/JCI108689; Suzuki T, 2010, J IMMUNOL, V184, P1968, DOI 10.4049/jimmunol.0903296; WANG Y, 1995, P NATL ACAD SCI USA, V92, P8955, DOI 10.1073/pnas.92.19.8955; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601	27	97	101	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195909	10.1371/journal.pone.0195909	http://dx.doi.org/10.1371/journal.pone.0195909			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649283	gold, Green Submitted, Green Published			2022-12-26	WOS:000429791900105
J	Olimpio, RMC; de Oliveira, M; De Sibio, MT; Moretto, FCF; Depra, IC; Mathias, LS; Goncalves, BM; Rodrigues, BM; Tilli, HP; Coscrato, VE; Costa, SMB; Mazeto, GMFS; Fernandes, CJC; Zambuzzi, WF; Saraiva, PP; Maria, DA; Nogueira, CR				Olimpio, Regiane M. C.; de Oliveira, Miriane; De Sibio, Maria T.; Moretto, Fernanda C. F.; Depra, Igor C.; Mathias, Lucas S.; Goncalves, Bianca M.; Rodrigues, Bruna M.; Tilli, Helena P.; Coscrato, Virginia E.; Costa, Sarah M. B.; Mazeto, Glaucia M. F. S.; Fernandes, Celio J. C.; Zambuzzi, Willian F.; Saraiva, Patricia P.; Maria, Durvanei A.; Nogueira, Celia R.			Cell viability assessed in a reproducible model of human osteoblasts derived from human adipose-derived stem cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; STROMAL CELLS; IN-VIVO; GENE-EXPRESSION; BONE-FORMATION; TISSUE; PROLIFERATION; FABRICATE; MINERALIZATION; REGENERATION	Human adipose tissue-derived stem cells (hASCs) have been subjected to extensive investigation because of their self-renewal properties and potential to restore damaged tissues. In the literature, there are several protocols for differentiating hASCs into osteoblasts, but there is no report on the control of cell viability during this process. In this study, we used osteoblasts derived from hASCs of patients undergoing abdominoplasty. The cells were observed at the beginning and end of bone matrix formation, and the expression of proteins involved in this process, including alkaline phosphatase and osteocalcin, was assessed. RANKL, Osterix, Runx2, Collagen3A1, Osteopontin and BSP expression levels were analyzed using real-time PCR, in addition to a quantitative assessment of protein levels of the markers CD45, CD105, STRO-1, and Nanog, using immunofluorescence. Rhodamine (Rho123), cytochrome-c, caspase-3, P-27, cyclin D1, and autophagy cell markers were analyzed by flow cytometry to demonstrate potential cellular activity and the absence of apoptotic and tumor cell processes before and after cell differentiation. The formation of bone matrix, along with calcium nodules, was observed after 16 days of osteoinduction. The gene expression levels of RANKL, Osterix, Runx2, Collagen3A1, Osteopontin, BSP and alkaline phosphatase activity were also elevated after 16 days of osteoinduction, whereas the level of osteocalcin was higher after 21 days of osteoinduction. Our data also showed that the cells had a high mitochondrial membrane potential and a low expression of apoptotic and tumor markers, both before and after differentiation. Cells were viable after the different phases of differentiation. This proposed methodology, using markers to evaluate cell viability, is therefore successful in assessing different phases of stem cell isolation and differentiation.	[Olimpio, Regiane M. C.; de Oliveira, Miriane; De Sibio, Maria T.; Moretto, Fernanda C. F.; Depra, Igor C.; Mathias, Lucas S.; Goncalves, Bianca M.; Rodrigues, Bruna M.; Tilli, Helena P.; Coscrato, Virginia E.; Costa, Sarah M. B.; Mazeto, Glaucia M. F. S.; Saraiva, Patricia P.; Nogueira, Celia R.] Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil; [Fernandes, Celio J. C.; Zambuzzi, Willian F.] Sao Paulo State Univ UNESP, Inst Biosci, Dept Chem & Biochem, Botucatu, SP, Brazil; [Maria, Durvanei A.] Butantan Inst, Biochem & Biophys Lab, Sao Paulo, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual Paulista; Instituto Butantan	Olimpio, RMC (corresponding author), Sao Paulo State Univ UNESP, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil.	m.regianemarques@gmail.com	Nogueira, Celia Regina/AAF-7440-2022; Gonçalves, Bianca Mariani/S-2058-2017; Mathias, Lucas Solla/AAS-8928-2020; Mazeto, Gláucia/E-7729-2012; Fernandes, Célio/AAD-1278-2019; De Sibio, Maria/AAM-4561-2020; Fernandes, Célio/L-3873-2018; Zambuzzi, Willian/ABD-8339-2020; Zambuzzi, Willian Fernando/F-9519-2012; Nogueira, Celia Regina/AFK-0463-2022	Nogueira, Celia Regina/0000-0002-4014-0660; Gonçalves, Bianca Mariani/0000-0001-9054-9125; Mathias, Lucas Solla/0000-0002-1415-9536; Mazeto, Gláucia/0000-0003-2129-7256; Fernandes, Célio/0000-0003-1009-3127; Fernandes, Célio/0000-0003-1009-3127; Zambuzzi, Willian Fernando/0000-0002-4149-5965; Nogueira, Celia Regina/0000-0002-4014-0660; Costa, Sarah/0000-0003-4108-7715	CNPQ National Council for Scientific and Technological Development; FAPESP - Foundation for Research Support of the State of Sao Paulo [2009 / 51727-2]	CNPQ National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP - Foundation for Research Support of the State of Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study was supported by CNPQ National Council for Scientific and Technological Development and FAPESP - Foundation for Research Support of the State of Sao Paulo (process no 2009 / 51727-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrari Iman, 2013, Iran Red Crescent Med J, V15, P324, DOI 10.5812/ircmj.4506; Bourin P, 2013, CYTOTHERAPY, V15, P641, DOI 10.1016/j.jcyt.2013.02.006; Calabrese G, 2015, INT J MOL SCI, V16, P15609, DOI 10.3390/ijms160715609; Chen CT, 2008, STEM CELLS, V26, P960, DOI 10.1634/stemcells.2007-0509; Chen L, 2014, STEM CELLS, V32, P902, DOI 10.1002/stem.1615; Connolly PF, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00149; Cowan CM, 2004, NAT BIOTECHNOL, V22, P560, DOI 10.1038/nbt958; De Francesco F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006537; Desiderio V, 2013, J CELL PHYSIOL, V228, P1762, DOI 10.1002/jcp.24336; Ferraro GA, 2013, J CELL BIOCHEM, V114, P1039, DOI 10.1002/jcb.24443; Prado AAF, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0531-5; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; Gronthos S, 1999, J BONE MINER RES, V14, P47, DOI 10.1359/jbmr.1999.14.1.47; Halvorsen Y D, 2000, Pharmacogenomics, V1, P179, DOI 10.1517/14622416.1.2.179; Halvorsen YDC, 2001, TISSUE ENG, V7, P729, DOI 10.1089/107632701753337681; Huang L, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0061-x; Jin ES, 2013, J KOREAN NEUROSURG S, V53, P207, DOI 10.3340/jkns.2013.53.4.207; Kassem M, 2008, ARCH BIOCHEM BIOPHYS, V473, P183, DOI 10.1016/j.abb.2008.03.028; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liu TM, 2009, STEM CELLS DEV, V18, P1013, DOI 10.1089/scd.2008.0335; Liu YS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056002; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lo Furno D, 2016, STEM CELLS DEV, V25, P1615, DOI 10.1089/scd.2016.0135; Luna Arthur C L, 2014, BMC Res Notes, V7, P552, DOI 10.1186/1756-0500-7-552; Mamalis A, 2011, ARCH ORAL BIOL, V56, P446, DOI 10.1016/j.archoralbio.2010.11.001; Manjithaya R, 2011, TRENDS CELL BIOL, V21, P67, DOI 10.1016/j.tcb.2010.09.009; Nishimura I, 2015, REGEN THER, V2, P24, DOI 10.1016/j.reth.2015.09.001; Nollet M, 2014, AUTOPHAGY, V10, P1965, DOI 10.4161/auto.36182; Okolicsanyi RK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137255; Paino F, 2017, CLIN SCI, V131, P699, DOI 10.1042/CS20170047; Roberts CL, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/1513281; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Shang FQ, 2014, BIOMATERIALS, V35, P2789, DOI 10.1016/j.biomaterials.2013.12.061; Togashi AY, 2007, J APPL ORAL SCI, V15, P442, DOI 10.1590/S1678-77572007000500013; Tsuji Wakako, 2014, World J Stem Cells, V6, P312, DOI 10.4252/wjsc.v6.i3.312; Wagner W, 2007, STEM CELL REV, V3, P239, DOI 10.1007/s12015-007-9001-1; Wall DM, 2014, CELL MICROBIOL, V16, P1746, DOI 10.1111/cmi.12368; Waters S, 2010, AUTOPHAGY, V6, P981, DOI 10.4161/auto.6.7.13155; Wyles CC, 2015, CLIN ORTHOP RELAT R, V473, P3080, DOI 10.1007/s11999-015-4385-8; Yamamoto M, 2014, STEM CELLS INT, V2014, DOI 10.1155/2014/576358; Yoon DS, 2011, CELL PROLIFERAT, V44, P428, DOI 10.1111/j.1365-2184.2011.00770.x; Zhang Chi, 2012, Beijing Da Xue Xue Bao Yi Xue Ban, V44, P659; Zhang F, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0599-7; Zhang Y, 2013, PLOS ONE, V18; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	46	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194847	10.1371/journal.pone.0194847	http://dx.doi.org/10.1371/journal.pone.0194847			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641603	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900049
J	Ordonez, C; Cabo, C; Menendez, A; Bello, A				Ordonez, Celestino; Cabo, Carlos; Menendez, Agustin; Bello, Antonio			Detection of human vital signs in hazardous environments by means of video magnification	PLOS ONE			English	Article								In cases of natural disasters, epidemics or even in dangerous situations like an act of terrorism, battle fields, a shooting or a mountain accident, finding survivors is a challenge. In these kind of situations it is sometimes critical to know if a person has vital signs or not, without the need to be in contact with the victim, thus avoiding jeopardizing the lives of the rescue workers. In this work, we propose the use of video magnification techniques to detect small movements in human bodies due to breathing that are invisible to the naked eye. Two different video magnification techniques, intensity-based and phase-based, were tested. The utility of these techniques to detect people who are alive but injured in risk situations was verified by simulating a scene with three people involved in an accident. Several factors such as camera stability, distance to the object, light conditions, magnification factor or computing time were analyzed. The results obtained were quite positive for both techniques, intensity-based method proving more adequate if the interest is in almost instant results whereas the phase-based method is more appropriate if processing time is not so relevant but the degree of magnification without excessive image noise.	[Ordonez, Celestino; Cabo, Carlos] Univ Oviedo, Dept Min Engn, Geomat & Comp Graph Res Grp, Mieres, Asturias, Spain; [Menendez, Agustin; Bello, Antonio] Univ Oviedo, Dept Mfg Engn, Gijon, Asturias, Spain	University of Oviedo; University of Oviedo	Ordonez, C (corresponding author), Univ Oviedo, Dept Min Engn, Geomat & Comp Graph Res Grp, Mieres, Asturias, Spain.	ordonezcelestino@uniovi.es	Garcia, Antonio Bello/L-7238-2014; Ordóñez, Celestino/AAP-9826-2020	Garcia, Antonio Bello/0000-0001-8691-3342; Ordóñez, Celestino/0000-0002-6912-6299; Cabo, Carlos/0000-0002-0387-9052	Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) (Spain) [FC-15-GRUPIN14-033]; FEDER	Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) (Spain); FEDER(European Commission)	This study was made possible by financial funding from FC-15-GRUPIN14-033 of the Fundacion para el Fomento en Asturias de la Investigacion Cientifica Aplicada y la Tecnologia (FICYT) (Spain), with FEDER support included. We thank Leticia Teran for helping us with the laboratory experiments.	Bhatia S, ALIVE HUMAN BODY DET; Cavagnini G, 2009, P SPIE INT SOC OPT E, V7239; Cocca P, 2016, SAFETY SCI, V84, P140, DOI 10.1016/j.ssci.2015.12.005; Freeman W. T., 1990, Proceedings. Third International Conference on Computer Vision (Cat. No.90CH2934-8), P406, DOI 10.1109/ICCV.1990.139562; FREEMAN WT, 1991, IEEE T PATTERN ANAL, V13, P891, DOI 10.1109/34.93808; Gao T, 2005, P ANN INT IEEE EMBS, P102; Kumar MB, 2015, INT J AD RES COMP EN, V4, P981; Li CT, 2015, SENSORS-BASEL, V15, P14830, DOI 10.3390/s150714830; Li J, 2014, IEEE J-STARS, V7, P783, DOI 10.1109/JSTARS.2013.2259801; Liao ZL, 2012, SAFETY SCI, V50, P150, DOI 10.1016/j.ssci.2011.07.014; Madheswari BJ, 2016, INT C INF ENG MAN SE, V2016, P116; Nakashima H, 2011, INT C MULT TECHN ICM, P2160; Nangalia V, 2010, CRIT CARE, V14, DOI 10.1186/cc9208; Poh M, 2011, IEEE T BIOMED ENG, V58, P4119, DOI [10.1109/TEME.2010.2086456, DOI 10.1109/TEME.2010.2086456]; Portilla J, 2000, INT J COMPUT VISION, V40, P49, DOI 10.1023/A:1026553619983; Purnima G, 2014, INT J AD ENG, V4, P624; Reyes BA, 2017, IEEE J BIOMED HEALTH, V21, P764, DOI 10.1109/JBHI.2016.2532876; SIMONCELLI EP, 1992, IEEE T INFORM THEORY, V38, P587, DOI 10.1109/18.119725; Wadhwa N, 2013, ACM T GRAPHIC, V32, DOI 10.1145/2461912.2461966; Wu HY, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185561; Zancajo-Blazquez S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118719	22	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195290	10.1371/journal.pone.0195290	http://dx.doi.org/10.1371/journal.pone.0195290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641613	gold, Green Published, Green Submitted			2022-12-26	WOS:000429742900064
J	Sherman, SM; Nailer, E				Sherman, Susan Mary; Nailer, Emma			Attitudes towards and knowledge about Human Papillomavirus (HPV) and the HPV vaccination in parents of teenage boys in the UK	PLOS ONE			English	Article							DECISION-MAKING; VALIDATION; MEN	The incidence of cancers attributable to Human Papillomavirus (HPV) that affect males is on the rise. Currently in the UK teenage boys are not vaccinated against HPV while teenage girls are. The rationale for not vaccinating boys is that vaccinating girls should provide herd immunity to boys, however this does not protect men who have sex with men or men who have sex with unvaccinated women. The issue of whether to vaccinate boys or not is a controversial one with considerable lobbying taking place to change the existing policy. On one side of the debate are financial considerations while on the other side health equality is important. One avenue that has not been presented is the parental perspective. The current study uses a self-report questionnaire to explore what parents of teenage boys know about HPV and the vaccine and whether they want the vaccine for their sons. Only half of the parents had heard of HPV prior to completing the survey. Of those who had heard of HPV, knowledge about the health sequelae of HPV for men was poor relative to their knowledge about its impact on female health. Parents who would be willing to vaccinate their sons had higher levels of knowledge about HPV than those parents who would be unwilling or unsure. Irrespective of whether they had previously heard of HPV or not, once provided with a brief description of HPV, the majority of parents thought that boys should be offered the vaccination. There is a pressing need for public education about the potential impact of HPV on male health in order to facilitate uptake of the vaccine in the event of the vaccination programme being extended to men or to facilitate informed decision making about seeking the vaccine privately in the event that it isn't.	[Sherman, Susan Mary; Nailer, Emma] Keele Univ, Sch Psychol, Keele, Staffs, England	Keele University	Sherman, SM (corresponding author), Keele Univ, Sch Psychol, Keele, Staffs, England.	s.m.sherman@keele.ac.uk	Sherman, Sue/ABH-3490-2020		Wellcome Small Grant [200281/Z/15/Z]	Wellcome Small Grant	This research was supported by Wellcome Small Grant 200281/Z/15/Z awarded to SS, https://wellcome.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gorjana R, 2017, PREV MED, V95, P26, DOI 10.1016/j.ypmed.2016.11.019; Gottvall M, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014255; Hartwig S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-30; Holman DM, 2014, JAMA PEDIATR, V168, P76, DOI 10.1001/jamapediatrics.2013.2752; JCVI, 2017, JCVI INT STAT EXT HP; Joint Committee on Vaccination and Immunisation (JCVI), 2015, JCVI STAT HPV VACC M; Krawczyk A, 2015, HUM VACC IMMUNOTHER, V11, P322, DOI 10.1080/21645515.2014.1004030; Marlow LAV, 2007, VACCINE, V25, P1945, DOI 10.1016/j.vaccine.2007.01.059; Mehanna H, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1439; Mortensen GL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1863-6; Muhwezi WW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106686; Newman PA, 2014, FUTURE VIROL, V9, P1033, DOI 10.2217/FVL.14.91; Newman PA, 2013, SEX TRANSM INFECT, V89, P568, DOI 10.1136/sextrans-2012-050980; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Perez S, 2017, VACCINE, V35, P4713, DOI 10.1016/j.vaccine.2017.07.043; Perez S, 2016, PREV MED, V91, P43, DOI 10.1016/j.ypmed.2016.07.017; Perez S, 2016, SEX TRANSM DIS, V43, P626, DOI 10.1097/OLQ.0000000000000506; Quadri-Sheriff M, 2012, PEDIATRICS, V130, P522, DOI 10.1542/peds.2012-0140; Sherman SM, 2016, J OBSTET GYNAECOL, V36, P76, DOI 10.3109/01443615.2015.1041886; Stanley M, 2006, VACCINE, V24, P106, DOI 10.1016/j.vaccine.2006.05.110; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Waller J, 2013, PREV MED, V56, P35, DOI 10.1016/j.ypmed.2012.10.028; WHO, 2017, WKLY EPIDEMIOL REC, P241, DOI DOI 10.1016/j.vaccine.2017.05.069; Zimet GD, 2010, GYNECOL ONCOL, V117, pS26, DOI 10.1016/j.ygyno.2010.01.028	24	22	23	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195801	10.1371/journal.pone.0195801	http://dx.doi.org/10.1371/journal.pone.0195801			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641563	Green Submitted, Green Accepted, gold, Green Published			2022-12-26	WOS:000429742900094
J	Zimmerli, D; Cecconi, V; Valenta, T; Hausmann, G; Cantu, C; Restivo, G; Hafner, J; Basler, K; van den Broek, M				Zimmerli, Dario; Cecconi, Virginia; Valenta, Tomas; Hausmann, George; Cantu, Claudio; Restivo, Gaetana; Hafner, Jurg; Basler, Konrad; van den Broek, Maries			WNT ligands control initiation and progression of human papillomavirus-driven squamous cell carcinoma	ONCOGENE			English	Article							STEM-CELLS; TUMOR MICROENVIRONMENT; DRUG-RESISTANCE; SKIN TUMORS; TGF-BETA; CANCER; INHIBITION; PORCUPINE; TUMORIGENESIS; INVASION	Human papillomavirus (HPV)-driven cutaneous squamous cell carcinoma (cSCC) is the most common cancer in immunosuppressed patients. Despite indications suggesting that HPV promotes genomic instability during cSCC development, the molecular pathways underpinning HPV-driven cSCC development remain unknown. We compared the transcriptome of HPV-driven mouse cSCC with normal skin and observed higher amounts of transcripts for Porcupine and WNT ligands in cSCC, suggesting a role for WNT signaling in cSCC progression. We confirmed increased Porcupine expression in human cSCC samples. Blocking the secretion of WNT ligands by the Porcupine inhibitor LGK974 significantly diminished initiation and progression of HPV-driven cSCC. Administration of LGK974 to mice with established cSCC resulted in differentiation of cancer cells and significant reduction of the cancer stem cell compartment. Thus, WNT/beta-catenin signaling is essential for HPV-driven cSCC initiation and progression as well as for maintaining the cancer stem cell niche. Interference with WNT secretion may thus represent a promising approach for therapeutic intervention.	[Zimmerli, Dario; Valenta, Tomas; Hausmann, George; Cantu, Claudio; Basler, Konrad] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Cecconi, Virginia; van den Broek, Maries] Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland; [Restivo, Gaetana; Hafner, Jurg] Univ Hosp Zurich, Dept Dermatol, CH-8091 Zurich, Switzerland; [Cantu, Claudio] Linkoping Univ, WCMM, Fac Hlth Sci, Dept Clin & Expt Med IKE, S-58185 Linkoping, Sweden	University of Zurich; University of Zurich; University of Zurich; University Zurich Hospital; Linkoping University	Basler, K (corresponding author), Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland.; van den Broek, M (corresponding author), Univ Zurich, Inst Expt Immunol, CH-8057 Zurich, Switzerland.	kb@imls.uzh.ch; vandenbroek@immunology.uzh.ch	van den Broek, Maries/L-6532-2019; Cantù, Claudio/AAB-7771-2019; van den Broek, Maries/G-4128-2016	Cantù, Claudio/0000-0003-1547-5415; Valenta, Tomas/0000-0002-3043-1835; van den Broek, Maries/0000-0002-9489-3692; Basler, Konrad/0000-0003-3534-1529; Restivo, Gaetana/0000-0003-4364-2364; , Dario/0000-0002-4920-0244	Swiss National Science Foundation (SNF); Swiss Cancer League; Promedica Foundation Zurich; University of Zurich Research Priority Program "Translational Cancer Research"; Kanton of Zurich	Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); Swiss Cancer League; Promedica Foundation Zurich; University of Zurich Research Priority Program "Translational Cancer Research"; Kanton of Zurich	We thank Karina Silina and Michal Beffinger (Institute of Experimental Immunology, UZH) for help with some experiments, Lukas Sommer (Institute of Anatomy, UZH) for reagents and discussions, Sabine Werner (Institute for Molecular Health Sciences, ETHZ) for discussions and sharing reagents, Herbert Pfister (Institute of Virology, University of Koln), for mouse strains (Krt14-HPV8-E6), Alexandra Franz for help with R and Martin Moser and Eliane Escher (Institute of Molecular Life Sciences, UZH) for technical support. We thank the personnel of the Laboratory Animal Service Center from the University of Zurich for expert animal care. This work was supported by the Swiss National Science Foundation (SNF) (K.B., M.v.d.B), Swiss Cancer League (K.B.), the Promedica Foundation Zurich (M.v.d.B.), University of Zurich Research Priority Program "Translational Cancer Research" and the Kanton of Zurich (K.B., M.v.d.B.). V.C and T.V. are fellows in the URPP Translational Cancer Research Program.	Accardi R, 2014, PRESSE MED, V43, pE435, DOI 10.1016/j.lpm.2014.08.008; Beck B, 2011, NATURE, V478, P399, DOI 10.1038/nature10525; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Boumahdi S, 2014, NATURE, V511, P246, DOI 10.1038/nature13305; Chockalingam R, 2015, J CLIN MED, V4, P1229, DOI 10.3390/jcm4061229; Connolly K, 2014, CANCER TREAT REV, V40, P205, DOI 10.1016/j.ctrv.2013.08.005; Melo FDE, 2016, CANCERS, V8, DOI 10.3390/cancers8070060; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Hofbauer GFL, 2010, EXP DERMATOL, V19, P473, DOI 10.1111/j.1600-0625.2010.01086.x; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Lapouge G, 2012, EMBO J, V31, P4563, DOI 10.1038/emboj.2012.312; Larsimont JC, 2015, CELL STEM CELL, V17, P60, DOI 10.1016/j.stem.2015.05.008; Latil M, 2017, CELL STEM CELL, V20, P191, DOI 10.1016/j.stem.2016.10.018; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Marcuzzi GP, 2009, J GEN VIROL, V90, P2855, DOI 10.1099/vir.0.012872-0; Nassar D, 2015, NAT MED, V21, P946, DOI 10.1038/nm.3878; Nichols AJ, 2017, JAMA DERMATOL, V153, P571, DOI 10.1001/jamadermatol.2016.5703; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Oshimori N, 2015, CELL, V160, P963, DOI 10.1016/j.cell.2015.01.043; Pourreyron C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031827; POWELL SM, 1992, NATURE, V359, P235, DOI 10.1038/359235a0; Proffitt KD, 2012, J BIOL CHEM, V287, P34167, DOI 10.1074/jbc.M112.381970; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Schober M, 2011, P NATL ACAD SCI USA, V108, P10544, DOI 10.1073/pnas.1107807108; Shiokawa D, 2017, CELL REP, V19, P981, DOI 10.1016/j.celrep.2017.04.017; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Sun Y, 2016, ONCOGENE, V35, P4321, DOI 10.1038/onc.2015.494; Sun Y, 2012, NAT MED, V18, P1359, DOI 10.1038/nm.2890; Tammela T, 2017, NATURE, V545, P355, DOI 10.1038/nature22334; Valenta T, 2016, CELL REP, V15, P911, DOI 10.1016/j.celrep.2016.03.088; Wang MS, 1997, ONCOGENE, V14, P2767, DOI 10.1038/sj.onc.1201245; Wicki A, 2007, BRIT J CANCER, V96, P1, DOI 10.1038/sj.bjc.6603518; Yanofsky Valerie R, 2011, J Skin Cancer, V2011, P210813, DOI 10.1155/2011/210813; Zeilstra J, 2008, CANCER RES, V68, P3655, DOI 10.1158/0008-5472.CAN-07-2940; Zimmerli D, 2017, BRIT J PHARMACOL, V174, P4600, DOI 10.1111/bph.13864; Zito G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4543	41	19	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 5	2018	37	27					3753	3762		10.1038/s41388-018-0244-x	http://dx.doi.org/10.1038/s41388-018-0244-x			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM3CM	29662191	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000437975200011
J	Sakr, M; Li, XY; Sabeh, F; Feinberg, TY; Tesmer, JJG; Tang, Y; Weiss, SJ				Sakr, Moustafa; Li, Xiao-Yan; Sabeh, Farideh; Feinberg, Tamar Y.; Tesmer, John J. G.; Tang, Yi; Weiss, Stephen J.			Tracking the Cartoon mouse phenotype: Hemopexin domain-dependent regulation of MT1-MMP pericellular collagenolytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						matrix metalloproteinase (MMP); mesenchymal stem cells (MSCs); collagen; fibroblast; intracellular trafficking; MT1-MMP; type I collagen; hemopexin domain	TYPE-1 MATRIX-METALLOPROTEINASE; CELL-SURFACE; I COLLAGEN; 1-MATRIX METALLOPROTEINASE; ENDOPLASMIC-RETICULUM; EXTRACELLULAR-MATRIX; SUCRASE-ISOMALTASE; BONE-RESORPTION; MEMBRANE; ACTIVATION	Following ENU mutagenesis, a phenodeviant line was generated, termed the Cartoon mouse, that exhibits profound defects in growth and development. Cartoon mice harbor a single S466P point mutation in the MT1-MMP hemopexin domain, a 200-amino acid segment that is thought to play a critical role in regulating MT1-MMP collagenolytic activity. Herein, we demonstrate that the MT1-MMPS466P mutation replicates the phenotypic status of Mt1-mmp-null animals as well as the functional characteristics of MT1-MMP-/- cells. However, rather than a loss-of-function mutation acquired as a consequence of defects in MT1-MMP proteolytic activity, the S466P substitution generates a misfolded, temperature-sensitive mutant that is abnormally retained in the endoplasmic reticulum (ER). By contrast, the WT hemopexin domain does not play a required role in regulating MT1-MMP trafficking, as a hemopexin domain-deletion mutant is successfully mobilized to the cell surface and displays nearly normal collagenolytic activity. Alternatively, when MT1-MMPS466P-expressing cells are cultured at a permissive temperature of 25 degrees C that depresses misfolding, the mutant successfully traffics from the ER to the trans-Golgi network (ER trans-Golgi network), where it undergoes processing to its mature form, mobilizes to the cell surface, and expresses type I collagenolytic activity. Together, these analyses define the Cartoon mouse as an unexpected gain-of-abnormal function mutation, wherein the temperature-sensitive mutant phenocopies MT1-MMP-/- mice as a consequence of eliciting a specific ER trans-Golgi network trafficking defect.	[Sakr, Moustafa] Univ Sadat City, GEBRI, Mol Diagnost & Therapeut Dept, Sadat City 32897, Egypt; [Li, Xiao-Yan; Sabeh, Farideh; Feinberg, Tamar Y.; Tang, Yi; Weiss, Stephen J.] Univ Michigan, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA; [Li, Xiao-Yan; Sabeh, Farideh; Feinberg, Tamar Y.; Tesmer, John J. G.; Tang, Yi; Weiss, Stephen J.] Univ Michigan, Life Sci Inst, 210 Washtenaw, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.; Weiss, Stephen J.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.; Weiss, Stephen J.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Tesmer, John J. G.; Weiss, Stephen J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	Egyptian Knowledge Bank (EKB); University of Sadat City; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Weiss, SJ (corresponding author), Univ Michigan, Life Sci Inst, 210 Washtenaw, Ann Arbor, MI 48109 USA.	sjweiss@umich.edu	Sakr, Moustafa/E-9276-2017	Sakr, Moustafa/0000-0002-5873-8468; Weiss, Stephen/0000-0002-1864-6075; Tesmer, John/0000-0003-1125-3727	National Institutes of Health [AR065524, CA071699, HL071818, HL122416]; Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE [R01CA071699] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122416, R01HL071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants AR065524 and CA071699 (to S. J. W.), HL071818 and HL122416 (to J. J. G. T.), and the Breast Cancer Research Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Atkinson JJ, 2005, DEV DYNAM, V232, P1079, DOI 10.1002/dvdy.20267; Atkinson SJ, 2006, BIOCHEM J, V398, P15, DOI 10.1042/BJ20060243; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Basu B, 2012, INT J BIOCHEM CELL B, V44, P393, DOI 10.1016/j.biocel.2011.11.015; Cao J, 2004, J BIOL CHEM, V279, P14129, DOI 10.1074/jbc.M312120200; Cerofolini L, 2016, SCI REP-UK, V6, DOI 10.1038/srep29511; Chan KM, 2012, DEV CELL, V22, P1176, DOI 10.1016/j.devcel.2012.04.014; Chun TH, 2006, CELL, V125, P577, DOI 10.1016/j.cell.2006.02.050; Cotterill SL, 2005, HUM MUTAT, V26, P557, DOI 10.1002/humu.20263; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; El Azzouzi K, 2016, J CELL BIOL, V213, P109, DOI 10.1083/jcb.201510043; Fields GB, 2013, J BIOL CHEM, V288, P8785, DOI 10.1074/jbc.R113.451211; Gonzalo P, 2010, DEV CELL, V18, P77, DOI 10.1016/j.devcel.2009.11.012; Gutierrez-Fernandez A, 2015, EMBO J, V34, P1875, DOI 10.15252/embj.201490594; Holmbeck K, 2005, J CELL SCI, V118, P147, DOI 10.1242/jcs.01581; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Hurst DR, 2004, BIOCHEM J, V377, P775, DOI 10.1042/bj20031067; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2001, EMBO J, V20, P4782, DOI 10.1093/emboj/20.17.4782; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jiang AX, 2001, P NATL ACAD SCI USA, V98, P13693, DOI 10.1073/pnas.241293698; Jin GX, 2011, EMBO J, V30, P2281, DOI 10.1038/emboj.2011.136; Lafleur MA, 2006, J BIOL CHEM, V281, P6826, DOI 10.1074/jbc.M513084200; Langenfurth A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32203; Lehti K, 2002, J BIOL CHEM, V277, P8440, DOI 10.1074/jbc.M109128200; Li XY, 2008, MOL BIOL CELL, V19, P3221, DOI 10.1091/mbc.E08-01-0016; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Mori H, 2002, EMBO J, V21, P3949, DOI 10.1093/emboj/cdf411; Mori H, 2013, DEVELOPMENT, V140, P343, DOI 10.1242/dev.084236; Mouw JK, 2014, NAT REV MOL CELL BIO, V15, P771, DOI 10.1038/nrm3902; Nehls S, 2000, NAT CELL BIOL, V2, P288, DOI 10.1038/35010558; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Ohtake Y, 2006, J CELL SCI, V119, P3822, DOI 10.1242/jcs.03158; Otani S, 2016, BIOCHEM BIOPH RES CO, V469, P1062, DOI 10.1016/j.bbrc.2015.12.105; Ouwendijk J, 1996, J CLIN INVEST, V97, P633, DOI 10.1172/JCI118459; Paulussen A, 2002, J BIOL CHEM, V277, P48610, DOI 10.1074/jbc.M206569200; Pei DQ, 1996, J BIOL CHEM, V271, P9135, DOI 10.1074/jbc.271.15.9135; Propsting MJ, 2003, J BIOL CHEM, V278, P16310, DOI 10.1074/jbc.C300093200; Remacle AG, 2012, CANCER RES, V72, P2339, DOI 10.1158/0008-5472.CAN-11-4149; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Rowe RG, 2011, AM J PHYSIOL-LUNG C, V301, pL683, DOI 10.1152/ajplung.00187.2011; Rowe RG, 2009, ANNU REV CELL DEV BI, V25, P567, DOI 10.1146/annurev.cellbio.24.110707.175315; Rozanov DV, 2002, J BIOL CHEM, V277, P9318, DOI 10.1074/jbc.M110711200; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Sabeh F, 2009, J BIOL CHEM, V284, P23001, DOI 10.1074/jbc.M109.002808; Saftig P, 1998, P NATL ACAD SCI USA, V95, P13453, DOI 10.1073/pnas.95.23.13453; Sakamoto T, 2014, MOL CELL BIOL, V34, P30, DOI 10.1128/MCB.01169-13; Schroder HM, 2013, INT J BIOCHEM CELL B, V45, P1133, DOI 10.1016/j.biocel.2013.02.020; Shenkman M, 1997, P NATL ACAD SCI USA, V94, P11363, DOI 10.1073/pnas.94.21.11363; Shimizu-Hirota R, 2012, GENE DEV, V26, P395, DOI 10.1101/gad.178749.111; Szabova L, 2010, BLOOD, V116, P5752, DOI 10.1182/blood-2009-10-249847; Szabova L, 2009, J BONE MINER RES, V24, P1905, DOI [10.1359/JBMR.090510, 10.1359/jbmr.090510]; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Taylor SH, 2015, ELIFE, V4, DOI 10.7554/eLife.09345; Taylor VG, 2016, J BIOL CHEM, V291, P5138, DOI 10.1074/jbc.M115.712075; Tochowicz A, 2011, J BIOL CHEM, V286, P7587, DOI 10.1074/jbc.M110.178434; Udi Y, 2015, STRUCTURE, V23, P104, DOI 10.1016/j.str.2014.10.012; Wang P, 2004, J BIOL CHEM, V279, P51148, DOI 10.1074/jbc.M409074200; Weaver SA, 2014, J CELL SCI, V127, P1203, DOI 10.1242/jcs.135236; Wong HLX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10824; Xu H, 2016, MATRIX BIOL, V52-54, P266, DOI 10.1016/j.matbio.2016.01.002; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zarrabi K, 2011, J BIOL CHEM, V286, P33167, DOI 10.1074/jbc.M111.256644; Zhao YC, 2015, STRUCTURE, V23, P257, DOI 10.1016/j.str.2014.11.021; Zhou ZJ, 2000, P NATL ACAD SCI USA, V97, P4052, DOI 10.1073/pnas.060037197	72	2	3	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 25	2018	293	21					8113	8127		10.1074/jbc.RA117.001503	http://dx.doi.org/10.1074/jbc.RA117.001503			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GH2IC	29643184	hybrid, Green Published			2022-12-26	WOS:000433224600017
J	Chen, WH; Wang, P; Ito, K; Fowles, J; Shusterman, D; Jaques, PA; Kumagai, K				Chen, Wenhao; Wang, Ping; Ito, Kazuhide; Fowles, Jeff; Shusterman, Dennis; Jaques, Peter A.; Kumagai, Kazukiyo			Measurement of heating coil temperature for e-cigarettes with a "top-coil" clearomizer	PLOS ONE			English	Article							CARBONYL-COMPOUNDS; PARAMETERS; TOPOGRAPHY; ALDEHYDES	Objectives To determine the effect of applied power settings, coil wetness conditions, and e-liquid compositions on the coil heating temperature for e-cigarettes with a "top-coil" clearomizer, and to make associations of coil conditions with emission of toxic carbonyl compounds by combining results herein with the literature. Methods The coil temperature of a second generation e-cigarette was measured at various applied power levels, coil conditions, and e-liquid compositions, including (1) measurements by thermocouple at three e-liquid fill levels (dry, wet-through-wick, and full-wet), three coil resistances (low, standard, and high), and four voltage settings (3-6 V) for multiple coils using propylene glycol (PG) as a test liquid; (2) measurements by thermocouple at additional degrees of coil wetness for a high resistance coil using PG; and (3) measurements by both thermocouple and infrared (IR) camera for high resistance coils using PG alone and a 1:1 (wt/wt) mixture of PG and glycerol (PG/GL). Results For single point thermocouple measurements with PG, coil temperatures ranged from 322 - 1008 degrees C, 145 - 334 degrees C, and 110 - 185 degrees C under dry, wet-through-wick, and full-wet conditions, respectively, for the total of 13 replaceable coil heads. For conditions measured with both a thermocouple and an IR camera, all thermocouple measurements were between the minimum and maximum across-coil IR camera measurements and equal to 74% - 115% of the across-coil mean, depending on test conditions. The IR camera showed details of the nonuniform temperature distribution across heating coils. The large temperature variations under wet-through-wick conditions may explain the large variations in formaldehyde formation rate reported in the literature for such "top-coil" clearomizers. Conclusions This study established a simple and straight-forward protocol to systematically measure e-cigarette coil heating temperature under dry, wet-through-wick, and full-wet conditions. In addition to applied power, the composition of e-liquid, and the devices' ability to efficiently deliver e-liquid to the heating coil are important product design factors effecting coil operating temperature. Precautionary temperature checks on e-cigarettes under manufacturer-recommended normal use conditions may help to reduce the health risks from exposure to toxic carbonyl emissions associated with coil overheating.	[Chen, Wenhao; Wang, Ping; Jaques, Peter A.; Kumagai, Kazukiyo] Calif Dept Publ Hlth, Indoor Air Qual Program, Environm Hlth Lab, Richmond, CA 94804 USA; [Ito, Kazuhide] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Kasuga, Fukuoka, Japan; [Fowles, Jeff] Calif Dept Publ Hlth, Exposure Assessment Sect, Environm Hlth Investigat Branch, Richmond, CA USA; [Shusterman, Dennis] Univ Calif San Francisco, Sch Med, Div Occupat & Environm Med, San Francisco, CA USA	California Department of Public Health; Kyushu University; California Department of Public Health; University of California System; University of California San Francisco	Chen, WH; Kumagai, K (corresponding author), Calif Dept Publ Hlth, Indoor Air Qual Program, Environm Hlth Lab, Richmond, CA 94804 USA.	wenhao.chen@cdph.ca.gov; Kazukiyo.Kumagai@cdph.ca.gov	Ito, Kazuhide/J-3550-2019	Ito, Kazuhide/0000-0002-7715-7896	Environmental Health Laboratory Branch; Cigarette and Tobacco Products Surtax Fund at CDPH	Environmental Health Laboratory Branch; Cigarette and Tobacco Products Surtax Fund at CDPH	The authors, WC, PW, JF, PJ and KK are employees of the California Department of Public Health (CDPH). Funding was provided internally through Environmental Health Laboratory Branch and Cigarette and Tobacco Products Surtax Fund at CDPH. The funder provided support in the form of salaries for authors WC, PW, PJ and KK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bekki K, 2014, INT J ENV RES PUB HE, V11, P11192, DOI 10.3390/ijerph111111192; Brown CJ, 2014, TOB CONTROL, V23, P4, DOI 10.1136/tobaccocontrol-2013-051476; Chapman R., 2015, CALIFORNIA DEP PUBLI; Farsalinos KE, 2015, ADDICTION, V110, P1352, DOI 10.1111/add.12942; Farsalinos KE, 2013, INT J ENV RES PUB HE, V10, P2500, DOI 10.3390/ijerph10062500; Flora JW, 2017, J CHROMATOGR SCI, V55, P142, DOI 10.1093/chromsci/bmw157; Geiss O, 2016, INT J HYG ENVIR HEAL, V219, P268, DOI 10.1016/j.ijheh.2016.01.004; Gillman IG, 2016, REGUL TOXICOL PHARM, V75, P58, DOI 10.1016/j.yrtph.2015.12.019; Jensen RP, 2015, NEW ENGL J MED, V372, P392, DOI 10.1056/NEJMc1413069; Kong AY, 2016, TOBACCO CONTROL; Kosmider L, 2014, NICOTINE TOB RES, V16, P1319, DOI 10.1093/ntr/ntu078; Pankow JF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173055; Putzhammer R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157337; Schripp T, 2013, INDOOR AIR, V23, P25, DOI 10.1111/j.1600-0668.2012.00792.x; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Talih S., 2015, NICOTINE TOB RES; Talih S, 2017, AEROSOL SCI TECH, V51, P1, DOI 10.1080/02786826.2016.1257853; U. S. Food and Drug Administration (FDA), 2009, EV E CIG; Wang P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169811; Zhao TK, 2016, ATMOS ENVIRON, V134, P61, DOI 10.1016/j.atmosenv.2016.03.027; Zhu SH, 2014, TOB CONTROL, V23, P3, DOI 10.1136/tobaccocontrol-2014-051670	21	50	51	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195925	10.1371/journal.pone.0195925	http://dx.doi.org/10.1371/journal.pone.0195925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672571	gold, Green Published			2022-12-26	WOS:000430446800060
J	Davies, TE; Epstein, G; Aguilera, SE; Brooke, CM; Cox, M; Evans, LS; Maxwell, SM; Nenadovic, M; Ban, NC				Davies, Tammy E.; Epstein, Graham; Aguilera, Stacy E.; Brooke, Cassandra M.; Cox, Michael; Evans, Louisa S.; Maxwell, Sara M.; Nenadovic, Mateja; Ban, Natalie C.			Assessing trade-offs in large marine protected areas	PLOS ONE			English	Article							SOCIAL-ECOLOGICAL SYSTEMS; ECOSYSTEM SERVICES; BIODIVERSITY CONSERVATION; MANAGEMENT; RESERVE; GOVERNANCE; SPILLOVER; COMMUNITY; FISHERIES; TOURISM	Large marine protected areas (LMPAs) are increasingly being established and have a high profile in marine conservation. LMPAs are expected to achieve multiple objectives, and because of their size are postulated to avoid trade-offs that are common in smaller MPAs. However, evaluations across multiple outcomes are lacking. We used a systematic approach to code several social and ecological outcomes of 12 LMPAs. We found evidence of three types of trade-offs: trade-offs between different ecological resources (supply trade-offs); trade-offs between ecological resource conditions and the well-being of resource users (supply-demand trade-offs); and trade-offs between the well-being outcomes of different resource users (demand trade-offs). We also found several divergent outcomes that were attributed to influences beyond the scope of the LMPA. We suggest that despite their size, trade-offs can develop in LMPAs and should be considered in planning and design. LMPAs may improve their performance across multiple social and ecological objectives if integrated with larger-scale conservation efforts.	[Davies, Tammy E.; Ban, Natalie C.] Univ Victoria, Sch Environm Studies, Victoria, BC, Canada; [Epstein, Graham] Univ Waterloo, Sch Environm Resources & Sustainabil, Environm Change & Governance Grp, Waterloo, ON, Canada; [Aguilera, Stacy E.] Univ Miami, Leonard & Jayne Abess Ctr Ecosyst Sci & Policy, Miami, FL USA; [Brooke, Cassandra M.] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA; [Cox, Michael] Dartmouth Coll, Environm Studies Program, Hanover, NH 03755 USA; [Evans, Louisa S.] Univ Exeter, Coll Life & Environm Sci, Geog, Exeter, Devon, England; [Evans, Louisa S.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld, Australia; [Maxwell, Sara M.] Old Dominion Univ, Dept Biol Sci, Norfolk, VA 23529 USA; [Nenadovic, Mateja] Duke Univ, Marine Lab, Nicholas Sch Environm, Beaufort, NC 28516 USA; [Davies, Tammy E.] BirdLife Int, Cambridge, England	University of Victoria; University of Waterloo; University of Miami; Stanford University; Dartmouth College; University of Exeter; James Cook University; Old Dominion University; Duke University; BirdLife International	Davies, TE (corresponding author), Univ Victoria, Sch Environm Studies, Victoria, BC, Canada.; Davies, TE (corresponding author), BirdLife Int, Cambridge, England.	tedavies23@gmail.com	Epstein, Graham/AAX-4385-2020	Davies, Tammy/0000-0003-2535-1328; Epstein, Graham/0000-0003-3431-8511; Cox, Michael/0000-0002-3462-7798; Ban, Natalie/0000-0002-4682-2144; Brooks, Cassandra/0000-0002-1397-0394	Social Science and Humanities Research Council of Canada [435-2013-0059]; Natural Sciences and Engineering Research Council of Canada [435785]	Social Science and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	NCB thanks the Social Science and Humanities Research Council of Canada (http://www.sshrc-crsh.gc.ca; 435-2013-0059), and Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsrg.gc.ca; 435785) for support.	Agardy T, 2003, AQUAT CONSERV, V13, P353, DOI 10.1002/aqc.583; Agardy T, 2011, MAR POLICY, V35, P226, DOI 10.1016/j.marpol.2010.10.006; Balmford A, 2004, P NATL ACAD SCI USA, V101, P9694, DOI 10.1073/pnas.0403239101; Ban NC, 2017, GLOBAL ENVIRON CHANG, V43, P82, DOI 10.1016/j.gloenvcha.2017.01.003; Ban NC, 2015, ECOL SOC, V20, DOI 10.5751/ES-07857-200402; Bejder L, 2006, CONSERV BIOL, V20, P1791, DOI 10.1111/j.1523-1739.2006.00540.x; Bennett NJ, 2014, MAR POLICY, V44, P107, DOI 10.1016/j.marpol.2013.08.017; Biggs D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148862; Boonzaier L, 2016, ORYX, V50, P27, DOI 10.1017/S0030605315000848; Brooks JS, 2017, CONSERV LETT, V10, P23, DOI 10.1111/conl.12231; Brown CJ, 2015, CONSERV LETT, V8, P180, DOI 10.1111/conl.12124; CBD, 2010, C PART 10 COP 10 DEC; Chavarro SB, 2014, ANIM CONSERV, V17, P133, DOI 10.1111/acv.12066; Christie P, 2007, CORAL REEFS, V26, P1047, DOI 10.1007/s00338-007-0235-9; Christie P., 2004, AM FISH SOC S; Cinner JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074321; Clifton J, 2013, MAR POLICY, V41, P80, DOI 10.1016/j.marpol.2012.12.015; Cox M, 2014, INT J COMMONS, V8, P265, DOI 10.18352/ijc.406; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Davies TE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08758-5; Daw TM, 2015, P NATL ACAD SCI USA, V112, P6949, DOI 10.1073/pnas.1414900112; Day J., 2015, STOCK ASSESSMENT MAC; Edgar GJ, 2011, AQUAT CONSERV, V21, P313, DOI 10.1002/aqc.1187; Emslie MJ, 2015, CURR BIOL, V25, P983, DOI 10.1016/j.cub.2015.01.073; Fabinyi M, 2008, MAR POLICY, V32, P898, DOI 10.1016/j.marpol.2008.01.004; GBRMPA (Great Barrier Reef Marine Park Authority), 2014, GREAT BARR REEF OUTL; Glew L., 2015, STATE BIRDS HEAD SEA; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Gruby RL, 2016, CONSERV LETT, V9, P153, DOI 10.1111/conl.12194; Halpern BS, 2009, ENVIRON CONSERV, V36, P268, DOI 10.1017/S0376892910000032; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Hicks CC, 2013, GLOBAL ENVIRON CHANG, V23, P1444, DOI 10.1016/j.gloenvcha.2013.07.028; Hirsch PD, 2011, CONSERV BIOL, V25, P259, DOI 10.1111/j.1523-1739.2010.01608.x; Jones PJS, 2013, MAR POLICY, V41, P65, DOI 10.1016/j.marpol.2012.12.019; Kittinger JN, 2011, J MARINE BIOL, V2010; Kittinger JN, 2010, MAR POLICY, V34, P208, DOI 10.1016/j.marpol.2009.06.007; Koch EW, 2009, FRONT ECOL ENVIRON, V7, P29, DOI 10.1890/080126; Koehn LE, 2017, ICES J MAR SCI, V74, P2448, DOI 10.1093/icesjms/fsx072; Leenhardt P, 2013, OCEAN COAST MANAGE, V85, P112, DOI 10.1016/j.ocecoaman.2013.08.013; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; Marine Conservation Institute, 2015, MPATLAS SEATTL; Martin-Lopez B, 2011, ECOL ECON, V70, P1481, DOI 10.1016/j.ecolecon.2011.03.009; Maxwell SM, 2014, ENDANGER SPECIES RES, V26, P59, DOI 10.3354/esr00617; Maxwell SM, 2013, NATURE COMMUNICATION, P4; McClanahan TR, 2000, ECOL APPL, V10, P1792, DOI 10.2307/2641239; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Micheli F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040832; Mouchet MA, 2014, GLOBAL ENVIRON CHANG, V28, P298, DOI 10.1016/j.gloenvcha.2014.07.012; Mullowney DRJ, 2014, REV FISH BIOL FISHER, V24, P639, DOI 10.1007/s11160-014-9349-7; Nakazawa M., 2015, FMSB FUNCTIONS MED S; Oracion EG, 2005, OCEAN COAST MANAGE, V48, P393, DOI 10.1016/j.ocecoaman.2005.04.013; Orams Mark, 1999, MARINE TOURISM DEV I; Ostrom E., 1990, GOVERNING COMMONS EV; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Palacios PH, 2013, TOURISM EC ALTERNATI; Peckham SH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001041; Persha L, 2011, SCIENCE, V331, P1606, DOI 10.1126/science.1199343; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; R Core Team, 2013, R LANG ENV STAT COMP; Rodriguez JP, 2006, ECOL SOC, V11; Samonte GP, 2016, J OCEAN COASTAL EC, V3, P2; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Smith MD, 2010, P NATL ACAD SCI USA, V107, P18300, DOI 10.1073/pnas.0907365107; Stobart B, 2009, MAR ECOL PROG SER, V384, P47, DOI 10.3354/meps08007; TEEB, 2009, EC EC BIOD NAT INT P; Toonen RJ, 2013, MAR POLLUT BULL, V77, P7, DOI 10.1016/j.marpolbul.2013.10.039; Toral-Granda V, 2008, SEA CUCUMBERS GLOBAL; Velando A, 2011, BIOL CONSERV, V144, P1167, DOI 10.1016/j.biocon.2011.01.004; Wagner D, 2013, SHARED RES AGENDA LA; Wakamatsu M, 2017, MAR POLICY, V77, P97, DOI 10.1016/j.marpol.2016.12.016; Wallace BP, 2016, MARINE REPTILES; Watson JEM, 2014, NATURE, V515, P67, DOI 10.1038/nature13947; Young HS, 2015, BIOL CONSERV, V181, P226, DOI 10.1016/j.biocon.2014.10.027	73	22	22	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195760	10.1371/journal.pone.0195760	http://dx.doi.org/10.1371/journal.pone.0195760			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668750	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000430290200055
J	Gentry, AD; Parham, JF; Ehret, DJ; Ebersole, JA				Gentry, Andrew D.; Parham, James F.; Ehret, Dana J.; Ebersole, Jun A.			A new species of Peritresius Leidy, 1856 (Testudines: Pan-Cheloniidae) from the Late Cretaceous (Campanian) of Alabama, USA, and the occurrence of the genus within the Mississippi Embayment of North America	PLOS ONE			English	Article							SHELL BONE-HISTOLOGY; SEA-TURTLES; MARINE TURTLES; EVOLUTION; FOSSIL; MORPHOLOGY; MIOCENE; SPAIN	Late Cretaceous members of Peritresius belong to a diverse clade of marine adapted turtles currently thought to be some of the earliest representatives of the lineage leading to modern hard-shelled sea turtles (Pan-Cheloniidae). Prior studies have suggested that Peritresius was monospecific, with a distribution restricted to Maastrichtian deposits in North America. However, new Peritresius specimens identified from Alabama and Mississippi, USA, show that the genus contains two taxa, Peritresius ornatus, and a new species Peritresius martini sp. nov. These two taxa are characterized by the presence of a generally cordiform carapace with moderately serrated peripherals, well-developed ventral flanges beginning at the third peripheral, squarish umbilical and lateral plastral fontanelles, and a narrow bridge formed by the contact between the hyoplastron and hypoplastron. Peritresius martini sp. nov. can be distinguished by its lack of dermal ornamentation and the presence of a 'rib-free' 10th peripheral. These new specimens represent the first occurrences of Peritresius from the Late Cretaceous Mississippi Embayment and extend the temporal range of this genus back to the early Campanian. When tested within a global phylogenetic context, Peritresius is placed on the stem of Cheloniidae (Pan-Cheloniidae) along with Ctenochelys and Allopleuron hofmanni. The heavily vascularized and uniquely sculptured dermal elements of P. ornatus are interpreted here as potentially relating to thermoregulation and therefore may have been one of the key factors contributing to the survival of Peritresius into the Maastrichtian, a period of cooling when other lineages of Campanian marine turtles (e.g., Protostegids, Toxochelys, and Ctenochelys) went extinct.	[Gentry, Andrew D.] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Parham, James F.] Calif State Univ Fullerton, Dept Geol Sci, Fullerton, CA 92634 USA; [Ehret, Dana J.] New Jersey State Museum, Trenton, NJ USA; [Ebersole, Jun A.] McWane Sci Ctr, Dept Collect, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; California State University System; California State University Fullerton	Gentry, AD (corresponding author), Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA.	gentryd@uab.edu		Ehret, Dana/0000-0002-5041-5699; Gentry, Andrew/0000-0002-4361-725X; Ebersole, Jun/0000-0003-2382-4806	University of Alabama at Birmingham	University of Alabama at Birmingham	The authors would like to thank George Phillips (MMNS) and David Parris (NJSM) for access to the specimens in their care, as well as Thomas Jorstad and Amanda Millhouse with the Department of Paleobiology at USNM, for providing the photograph of the Toxochelys weeksi holotype in Fig 10. The authors also thank Kenneth Whetstone for donating hard-copies of many historical fossil turtle manuscripts to the ALMNH along with Jason Robinson and L. Majure for their donations of Peritresius ornatus specimens to MMNS. We would especially like to thank George Martin for his donation of the Peritresius martini holotype to ALMNH and T. Lynn Harrell Jr. for the additional prep work performed on this specimen following its donation. We thank Sandy Ebersole of the Geological Survey of Alabama for providing the GIS shape files necessary to produce Fig 1. Walter Joyce, Don Brinkman, and Adan Perez-Garcia provided crucial review commentary that greatly improved the quality of the manuscript and figures. Finally, the authors thank Ed Hooks who initiated the study into the type specimen of P. martini and then graciously allowed us to continue and complete his work. Travel to the FMNH was funded in part by a Catherine P. Ireland Travel Grant to ADG from the University of Alabama at Birmingham.	Agassiz L., 1843, RECHERCHES POISSONS, V3; Agassiz L., 1849, P ACAD NAT SCI PHILA, V4, P169; Baird D., 1964, NEW JERSEY STATE MUS, V11, P3; Batsch A.J.G.C., 1788, VERSUCH ANLEITUNG KE, P528; BAUR G, 1893, AM NAT, V27, P672; BOLLL H., 1951, JOUR PALEONTOL, V25, P187; Brinkman Donald, 2006, Paludicola, V5, P111; Brinkman DB, 2015, CAN J EARTH SCI, V52, P581, DOI 10.1139/cjes-2014-0189; Cadena Edwin A., 2015, PALEOBIOS, V32, P1; Caron M., 1985, P17; CobbanWand Kennedy W., 1993, CRETACEOUS AMMONITES, V2073, pB1; COLLINS R. LEE, 1951, JOUR TENNESSEE ACAD SCI, V26, P262; CoPE E. D., 1869, P BOSTON SOC NATURAL, V12, P250; Cope E. D., 1869, AM NAT, V3, DOI DOI 10.1086/270371; Cope E.D., 1869, T AM PHIL SOC, V14, P1; Cope E. D., 1867, P NAT ACAD SCI PHIL, V1867, P41; Cope E. D, 1874, US GEOLOGICAL SURVEY, V1, P3; Cope E.D., 1869, GEOLOGY NEW JERSEY, P733; Cope E. D., 1871, P AM PHILOS SOC, V12, P174; Cope ED, 1873, P ACAD NAT SCI PHILA, V1873, P10; Cope ED., 1868, P ACAD NATURAL SCI, V1868, P242; Crawford NG, 2015, MOL PHYLOGENET EVOL, V83, P250, DOI 10.1016/j.ympev.2014.10.021; de Broin FD, 2014, GEOBIOS-LYON, V47, P111, DOI 10.1016/j.geobios.2014.02.002; Dockery III D, 2008, MISSISSIPPI GEOLOGY, V17, P1; DRANE CR, 1980, HERPETOLOGICA, V36, P60; Emmons E., 1858, REPORT N CAROLINA GE, VXV, P193; Gaffney E.S., 1972, American Museum Novitates, VNo. 2486, P1; Garman S., 1880, B MUS COMP ZOOL HARV, V6, P123; Gentry AD, 2017, J SYST PALAEONTOL, V15, P675, DOI 10.1080/14772019.2016.1217087; Gray JE, 1831, SYNOPSIS REPTILIUM 1, P85; Grigg G, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P297; Hall JT, 2008, PALAIOS, V23, P233, DOI 10.2110/palo.2006.p06-094r; Hay O., 1923, PAN AM GEOLOGIST, V39, p119 ; Hay O.P., 1908, CARNEGIE I WASHINGTO, V75, P568; Hay OP, 1905, B AM MUS NAT HIST, V21, P137; Hirayama R, 2003, PALAEONTOLOGY, V46, P845, DOI 10.1111/1475-4983.00322; Hirayama Ren, 1997, P225, DOI 10.1016/B978-012155210-7/50013-2; Hirayama Ren, 2006, Paleobios, V26, P1; Ikejiri Takehito, 2013, Bulletin Alabama Museum of Natural History, V31, P46; Joyce Walter G., 2007, Bulletin of the Peabody Museum of Natural History, V48, P3, DOI 10.3374/0079-032X(2007)48[3:PROMT]2.0.CO;2; Joyce WG, 2013, J PALEONTOL, V87, P612, DOI 10.1666/12-149; Joyce WG, 2004, J PALEONTOL, V78, P989, DOI 10.1666/0022-3360(2004)078<0989:DAPFTC>2.0.CO;2; Kaddumi H., 2006, NEW GENUS SPECIES GI, V3, P14; Laurenti J., 1768, SPECIMEN MEDICUM EXH, P215; Leidy J., 1855, P ACAD NAT SCI PHILA, V7, P395; Leidy J., 1870, P ACAD NAT SCI PHILA, V22, P12; Leidy J., 1856, P ACAD NAT SCI PHILA, V8, P303; Leriche M., 1906, MEMOIRES SOC GEOLOGI, V5, P430; Lindgren J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13187-5; Lydekker R., 1889, CATALOGUE FOSSIL REP, VIII, P239; Mancini EA, 1996, CRETACEOUS RES, V17, P645, DOI 10.1006/cres.1996.0035; Matzke AT, 2007, PALAEONTOLOGY, V50, P669, DOI 10.1111/j.1475-4983.2007.00650.x; Meyer von H., 1843, BRONN GERICHTET NEUE, V1843, P698; Miller H., 1955, J PALEONTOL, V34, p1 ; Mulder E., 2003, ALLOPLEURON HOFMANNI, p23 ; Nicholls E.L., 1988, Journal of Vertebrate Paleontology, V8, P181; Parham James F., 1997, Chelonian Conservation and Biology, V2, P548; Parham JF, 2010, J PALEONTOL, V84, P231, DOI 10.1666/09-077R.1; Parham JF, 2005, J VERTEBR PALEONTOL, V25, P71, DOI 10.1671/0272-4634(2005)025[0071:AROTRO]2.0.CO;2; Parris DC, 2014, P ACAD NAT SCI PHILA, V163, P85, DOI 10.1635/053.163.0105; Perez-Garcia A, 2013, CRETACEOUS RES, V44, P64, DOI 10.1016/j.cretres.2013.03.011; Polcyn MJ, 2014, PALAEOGEOGR PALAEOCL, V400, P17, DOI 10.1016/j.palaeo.2013.05.018; PUCKETT T. M., 1992, T GULF COAST ASS GEO, V42, P613; Puckett TM., 2005, STRATIGRAPHY, V2, P117; Pyenson ND, 2014, PALAEOGEOGR PALAEOCL, V400, P1, DOI 10.1016/j.palaeo.2014.02.018; Rabi M, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-203; Raymond D.E., 1988, CIRCULAR, V140, P97; Schein Jason P., 2013, Bulletin Alabama Museum of Natural History, V31, P78; Scheyer TM, 2015, ORG DIVERS EVOL, V15, P199, DOI 10.1007/s13127-014-0188-0; Scheyer TM, 2014, BIOL J LINN SOC, V112, P701, DOI 10.1111/bij.12265; SEIDEL MR, 1979, HERPETOLOGICA, V35, P375; Skutschas PP, 2017, CRETACEOUS RES, V79, P171, DOI 10.1016/j.cretres.2017.07.010; Texas Roemer C., 1849, NATURWISSENSCHAFTLIC, p[i, 1]; Villa A., 2015, B SOC PALEONTOLOGICA, V54, pI; WEEMS RE, 1988, P BIOL SOC WASH, V101, P109; WEEMS RE, 1974, J PALEONTOL, V48, P278; Weems RE, 2014, J VERTEBR PALEONTOL, V34, P80, DOI 10.1080/02724634.2013.792826; Wieland GR, 1896, AM J SCI, V212, P399, DOI DOI 10.2475/AJS.S4-2.12.399; Witzmann F, 2010, ZOOL J LINN SOC-LOND, V160, P302, DOI 10.1111/j.1096-3642.2009.00599.x; Wyneken, 2001, ANATOMY SEA TURTLES, P172; Zangerl R., 1960, Fieldiana Geology Memoir, V3, P279; ZANGERL R, 1980, AM ZOOL, V20, P585; Zangerl R., 1953, GEOLOGY MEMOIRS, V3, P137; Zangerl R, 1988, BISHOP MUSEUM B ZOOL, V1, P1	84	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195651	10.1371/journal.pone.0195651	http://dx.doi.org/10.1371/journal.pone.0195651			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668704	Green Published, gold			2022-12-26	WOS:000430290200051
J	Sun, XZ; Stewart, DA; Sandhu, R; Kirk, EL; Pathmasiri, WW; McRitchie, SL; Clark, RF; Troester, MA; Sumner, SJ				Sun, Xuezheng; Stewart, Delisha A.; Sandhu, Rupninder; Kirk, Erin L.; Pathmasiri, Wimal W.; McRitchie, Susan L.; Clark, Robert F.; Troester, Melissa A.; Sumner, Susan J.			Correlated metabolomic, genomic, and histologic phenotypes in histologically normal breast tissue	PLOS ONE			English	Article							PATTERNS; CELLS	Breast carcinogenesis is a multistep process accompanied by widespread molecular and genomic alterations, both in tumor and in surrounding microenvironment. It is known that tumors have altered metabolism, but the metabolic changes in normal or cancer-adjacent, nonmalignant normal tissues and how these changes relate to alterations in gene expression and histological composition are not well understood. Normal or cancer-adjacent normal breast tissues from 99 women of the Normal Breast Study (NBS) were evaluated. Data of metabolomics, gene expression and histological composition was collected by mass spectrometry, whole genome microarray, and digital image, respectively. Unsupervised clustering analysis determined metabolomics-derived subtypes. Their association with genomic and histological features, as well as other breast cancer risk factors, genomic and histological features were evaluated using logistic regression. Unsupervised clustering of metabolites resulted in two main clusters. The metabolite differences between the two clusters suggested enrichment of pathways involved in lipid metabolism, cell growth and proliferation, and migration. Compared with Cluster 1, subjects in Cluster 2 were more likely to be obese (body mass index >= 30 kg/m(2), p < 0.05), have increased adipose proportion (p < 0.01) and associated with a previously defined Active genomic subtype (p < 0.01). By the integrated analyses of histological, metabolomics and transcriptional data, we characterized two distinct subtypes of non-malignant breast tissue. Further research is needed to validate our findings, and understand the potential role of these alternations in breast cancer initiation, progression and recurrence.	[Sun, Xuezheng; Kirk, Erin L.; Troester, Melissa A.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC USA; [Stewart, Delisha A.; Pathmasiri, Wimal W.; McRitchie, Susan L.; Sumner, Susan J.] Univ North Carolina Chapel Hill, Nutr Res Inst, Natl Inst Hlth Eastern Reg Comprehens Metabol Res, Dept Nutr, Kannapolis, NC 27599 USA; [Sandhu, Rupninder; Troester, Melissa A.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Clark, Robert F.] RTI Int, Analyt Chem & Pharmaceut, Durham, NC USA; [Troester, Melissa A.] Univ North Carolina Chapel Hill, Dept Pathol, Chapel Hill, NC USA; [Troester, Melissa A.] Univ North Carolina Chapel Hill, Lab Med, Chapel Hill, NC USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Research Triangle Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Sumner, SJ (corresponding author), Univ North Carolina Chapel Hill, Nutr Res Inst, Natl Inst Hlth Eastern Reg Comprehens Metabol Res, Dept Nutr, Kannapolis, NC 27599 USA.	susan_sumner@unc.edu		Clark, Robert/0000-0001-5091-8280; Pathmasiri, Wimal/0000-0002-5199-5744	Avon Foundation for Women; North Carolina University Cancer Research Fund; National Cancer Institute [R01 CA179715]; National Institute of Environmental Health Sciences [U01 ES019472]; NIH Common Fund award through the National Institute for Diabetes and Digestive and Kidney Diseases [1U24DK097193]; NATIONAL CANCER INSTITUTE [P30CA016086, U01CA179715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097193] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019472] Funding Source: NIH RePORTER	Avon Foundation for Women; North Carolina University Cancer Research Fund; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH Common Fund award through the National Institute for Diabetes and Digestive and Kidney Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Avon Foundation for Women (https://www.avonfoundation.org/grants/, PI-MAT), North Carolina University Cancer Research Fund (http://unclineberger.org/ucrf/, PI-MAT), National Cancer Institute (R01 CA179715, PI-MAT), the National Institute of Environmental Health Sciences (U01 ES019472, PI-MAT); and NIH Common Fund award through the National Institute for Diabetes and Digestive and Kidney Diseases to the NIH Eastern Regional Comprehensive Metabolomics Resource Core at UNC-Chapel Hill, Nutrition Research Institute (1U24DK097193, PI-SJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders provided support in the form of salaries for authors [XS, DAS, RS, ELK, WWP, SLM, RC, MAT and SJS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Brauer HA, 2013, CLIN CANCER RES, V19, P571, DOI 10.1158/1078-0432.CCR-12-2123; Brown I, 2011, PROSTAG LEUKOTR ESS, V85, P305, DOI 10.1016/j.plefa.2011.09.007; Budczies J, 2013, J PROTEOMICS, V94, P279, DOI 10.1016/j.jprot.2013.10.002; Casbas-Hernandez P, 2015, CANCER EPIDEM BIOMAR, V24, P406, DOI 10.1158/1055-9965.EPI-14-0934; Chandrasekaran S, 1999, J BIOL CHEM, V274, P11408, DOI 10.1074/jbc.274.16.11408; Figueroa JD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju286; Gaston R, 2017, ARCH MED RES, V48, P46, DOI 10.1016/j.arcmed.2017.01.009; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Jiralerspong S, 2016, J CLIN ONCOL, V34, P4203, DOI 10.1200/JCO.2016.68.4480; Kind T, 2009, ANAL CHEM, V81, P10038, DOI 10.1021/ac9019522; Kuemmerle NB, 2011, MOL CANCER THER, V10, P427, DOI 10.1158/1535-7163.MCT-10-0802; Louie SM, 2013, BBA-MOL CELL BIOL L, V1831, P1566, DOI 10.1016/j.bbalip.2013.07.008; Mishra P, 2015, MOL CELL ONCOL, V2, DOI 10.4161/23723556.2014.992217; Nassar A, 2015, BREAST CANCER RES TR, V153, P397, DOI 10.1007/s10549-015-3535-8; Nomura DK, 2010, CELL, V140, P49, DOI 10.1016/j.cell.2009.11.027; Penkert J, 2016, ONCOTARGET, V7, P67626, DOI 10.18632/oncotarget.11759; Pirone JR, 2012, CANCER EPIDEM BIOMAR, V21, P1735, DOI 10.1158/1055-9965.EPI-12-0451; Research WCRFAIfC, 2017, CONT UPD PROJ REP DI; Roman-Perez E, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3152; Sandhu R, 2016, HUM PATHOL, V48, P60, DOI 10.1016/j.humpath.2015.09.031; Sinicrope FA, 2011, J CLIN ONCOL, V29, P4, DOI 10.1200/JCO.2010.32.1752; Sun XZ, 2015, CANCER CAUSE CONTROL, V26, P1803, DOI 10.1007/s10552-015-0673-6; Sun XZ, 2013, CLIN CANCER RES, V19, P4972, DOI 10.1158/1078-0432.CCR-13-0029; Sun XZ, 2012, BREAST CANCER RES TR, V131, P1003, DOI 10.1007/s10549-011-1789-3; Tang XH, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0415-9; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Troester MA, 2016, NPJ BREAST CANCER, V2, DOI 10.1038/npjbcancer.2016.7	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0193792	10.1371/journal.pone.0193792	http://dx.doi.org/10.1371/journal.pone.0193792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668675	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200004
J	Nguyen, HM; Liu, SX; Daher, W; Tang, F; Besteiro, S				Hoa Mai Nguyen; Liu, Shuxian; Daher, Wassim; Tang, Feng; Besteiro, Sebastien			Characterisation of two Toxoplasma PROPPINs homologous to Atg18/WIPI suggests they have evolved distinct specialised functions	PLOS ONE			English	Article							AUTOPHAGOSOME FORMATION; PROTEIN; ATG21; CONJUGATION; FAMILY; PI3P; LOCALIZATION; COMPLEXES; MUTANTS; KINASES	Toxoplasma gondii is a parasitic protist possessing a limited set of proteins involved in the autophagy pathway, a self-degradative machinery for protein and organelle recycling. This distant eukaryote has even repurposed part of this machinery, centered on protein ATG8, for a non-degradative function related to the maintenance of the apicoplast, a parasite-specific organelle. However, some evidence also suggest Toxoplasma is able to generate autophagic vesicles upon stress, and that some autophagy-related proteins, such as ATG9, might be involved solely in the canonical autophagy function. Here, we have characterised TgPROP1 and TgPROP2, two Toxoplasma proteins containing WD-40 repeat that can bind lipids for their recruitment to vesicular structures upon stress. They belong to the PROPPIN family and are homologues to ATG18/WIPI, which are known to be important for the autophagic process. We conducted a functional analysis of these two Toxoplasma PROPPINs. One of them is dispensable for normal in vitro growth, although it may play a role for parasite survival in specific stress conditions or for parasite fitness in the host, through a canonical autophagy-related function. The other, however, seems important for parasite viability in normal growth conditions and could be primarily involved in a non-canonical function. These divergent roles for two proteins from the same family illustrate the functional versatility of the autophagy-related machinery in Toxoplasma.	[Hoa Mai Nguyen; Daher, Wassim; Besteiro, Sebastien] Univ Montpellier, CNRS, UMR5235, DIMNP, Montpellier, France; [Liu, Shuxian; Tang, Feng] Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou, Zhejiang, Peoples R China	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Wenzhou Medical University	Besteiro, S (corresponding author), Univ Montpellier, CNRS, UMR5235, DIMNP, Montpellier, France.; Tang, F (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Dept Parasitol, Wenzhou, Zhejiang, Peoples R China.	tanfengsong@163.com; sebastien.besteiro@inserm.fr	DAHER, Wassim/M-7166-2017; Besteiro, Sébastien/F-3622-2014; DAHER, Wassim/AAB-6720-2019	DAHER, Wassim/0000-0001-9026-5333; Besteiro, Sébastien/0000-0003-1853-1494; DAHER, Wassim/0000-0001-9026-5333; Nguyen, Hoa Mai/0000-0003-4624-6375	Agence Nationale de la Recherche [ANR-13-JSV3-0003]; Fondation pour la Recherche Medicale [Equipe FRMDEQ20130326508]; Labex Parafrap (Agence Nationale de la Recherche) [ANR-11-LABX-0024]; National Natural Science Foundation of China [81672052]; Zhejiang Natural Science Funds for Distinguished Young Scientists [LR17H190001]; Zhejiang Xinmiao talent plan [2017R413062]	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Labex Parafrap (Agence Nationale de la Recherche)(French National Research Agency (ANR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Natural Science Funds for Distinguished Young Scientists; Zhejiang Xinmiao talent plan	Work in S.B.'s laboratory is supported by a grant from Agence Nationale de la Recherche (ANR-13-JSV3-0003) and core support from the Fondation pour la Recherche Medicale (Equipe FRMDEQ20130326508) and the Labex Parafrap (Agence Nationale de la Recherche) (ANR-11-LABX-0024). Work in F.T.s laboratory is supported by grants from the National Natural Science Foundation of China (81672052), the Zhejiang Natural Science Funds for Distinguished Young Scientists (LR17H190001) and Zhejiang Xinmiao talent plan (2017R413062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2009, J BIOL CHEM, V284, P33683, DOI 10.1074/jbc.M109.044024; Bakula D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15637; Bansal P, 2017, MBIO, V8, DOI [10.1128/mBio.01468-17, 10.1128/mbio.01468-17]; Barth H, 2002, FEBS LETT, V512, P173, DOI 10.1016/S0014-5793(02)02252-4; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Besteiro S, 2017, CURR OPIN MICROBIOL, V40, P14, DOI 10.1016/j.mib.2017.10.008; Besteiro S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002416; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; COUVREUR G, 1988, PARASITOLOGY, V97, P1, DOI 10.1017/S0031182000066695; Daher W, 2015, CELL MICROBIOL, V17, P559, DOI 10.1111/cmi.12383; DeRocher AE, 2008, EUKARYOT CELL, V7, P1518, DOI 10.1128/EC.00081-08; Donald RGK, 1996, J BIOL CHEM, V271, P14010, DOI 10.1074/jbc.271.24.14010; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Dove SK, 2004, EMBO J, V23, P1922, DOI 10.1038/sj.emboj.7600203; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Gopaldass N, 2017, EMBO J, V36, P3274, DOI 10.15252/embj.201796859; Hettmann C, 2000, MOL BIOL CELL, V11, P1385, DOI 10.1091/mbc.11.4.1385; Nguyen HM, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx153; Jin N, 2008, EMBO J, V27, P3221, DOI 10.1038/emboj.2008.248; Juris L, 2015, EMBO J, V34, P955, DOI 10.15252/embj.201488957; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Kong-Hap MA, 2013, AUTOPHAGY, V9, P1334, DOI 10.4161/auto.25189; Krick R, 2008, AUTOPHAGY, V4, P896, DOI 10.4161/auto.6801; Leveque Maude F, 2016, Commun Integr Biol, V9, pe1197447, DOI 10.1080/19420889.2016.1197447; Leveque MF, 2016, SCI REP-UK, V6, DOI 10.1038/srep27809; Leveque MF, 2015, MBIO, V6, DOI 10.1128/mBio.01446-15; Matsumura H, 2012, J BIOL CHEM, V287, P26528, DOI 10.1074/jbc.M112.369652; Meiling-Wesse K, 2004, J BIOL CHEM, V279, P37741, DOI 10.1074/jbc.M401066200; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Nakatogawa H, 2013, ESSAYS BIOCHEM, V55, P39, DOI [10.1042/bse0550039, 10.1042/BSE0550039]; Narasimhan J, 2008, J BIOL CHEM, V283, P16591, DOI 10.1074/jbc.M800681200; Nguyen HM, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12712; Obara K, 2008, J BIOL CHEM, V283, P23972, DOI 10.1074/jbc.M803180200; Polson HEJ, 2010, AUTOPHAGY, V6, P506, DOI 10.4161/auto.6.4.11863; Proikas-Cezanne T, 2004, ONCOGENE, V23, P9314, DOI 10.1038/sj.onc.1208331; Proikas-Cezanne T, 2007, FEBS LETT, V581, P3396, DOI 10.1016/j.febslet.2007.06.040; Proikas-Cezanne T, 2015, J CELL SCI, V128, P207, DOI 10.1242/jcs.146258; Sheiner L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002392; Sidik SM, 2016, CELL, V166, P1423, DOI 10.1016/j.cell.2016.08.019; Smith Temple F., 2008, V48, P20, DOI 10.1007/978-0-387-09595-0_3; Stromhaug PE, 2004, MOL BIOL CELL, V15, P3553, DOI 10.1091/mbc.E04-02-0147; Suzuki K, 2013, J CELL SCI, V126, P2534, DOI 10.1242/jcs.122960; Tawk L, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001286; Thost AK, 2015, METHODS, V75, P69, DOI 10.1016/j.ymeth.2014.11.011; THUMM M, 1994, FEBS LETT, V349, P275, DOI 10.1016/0014-5793(94)00672-5; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Walczak M, 2017, ATG8 IS ESSENTIAL SP, DOI [10.1101/195578, DOI 10.1101/195578]; Yin ZY, 2016, MICROB CELL, V3, P457, DOI 10.15698/mic2016.12.546	50	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195921	10.1371/journal.pone.0195921	http://dx.doi.org/10.1371/journal.pone.0195921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659619	Green Submitted, Green Published, gold			2022-12-26	WOS:000430061100041
J	Shamoon, RP; Ali, MD; Shabila, NP				Shamoon, Rawand P.; Ali, Mohamad Dahir; Shabila, Nazar P.			Overview and outcome of Hodgkin's Lymphoma: Experience of a single developing country's oncology centre	PLOS ONE			English	Article							DISEASE; CHILDREN; SURVIVAL; EPIDEMIOLOGY; ADOLESCENTS; DIAGNOSIS; THERAPY; CYCLES; PET	Hodgkin's Lymphoma (HL) reveals variable epidemiological and clinico-pathological features in different geographical locations. In this retrospective study, we aimed to assess the epidemiological and clinic-pathological features, and outcome of HL patients treated at one hemato-oncology centre in Erbil, northern Iraq. Medical records of 103 HL patients treated over more than six years were reviewed. Treatment outcome was evaluated by measuring the 5-year overall and progression-free survival rates. The median age of patients was 23 years, children up to 17 years constituted 31.1%, and male to female ratio was 1:1.05. The majority (96.1%) of patients presented with lymphadenopathy. Nodular sclerosis subtype was the mostly encountered histologic type (48.5%); about half of the patients (49.5%) had stage II disease. Relapse occurred in 20 patients; the 5-year overall survival for children was better (89%) compared to adult patients (79%). The associated risk features found to have adverse effects on the survival, however, only high LDH level and presence of B-symptoms at presentation showed significant correlation. The epidemiological and clinical characteristics of HL in our locality followed the pattern in the western world. The 5-year overall and progression-free survivals were far below the international rates, a matter which may necessitate a revision to HL treatment strategy at our centre.	[Shamoon, Rawand P.] Hawler Med Univ, Dept Pathol, Coll Med, Erbil, Iraq; [Shamoon, Rawand P.] Nanakali Haematooncol Teaching Ctr, Dept Haematopathol, Erbil, Iraq; [Ali, Mohamad Dahir] Nanakali Haematooncol Teaching Ctr, Dept Clin Haematol, Erbil, Iraq; [Shabila, Nazar P.] Hawler Med Univ, Dept Community Med, Erbil, Iraq	Hawler Medical University; Hawler Medical University	Shamoon, RP (corresponding author), Hawler Med Univ, Dept Pathol, Coll Med, Erbil, Iraq.; Shamoon, RP (corresponding author), Nanakali Haematooncol Teaching Ctr, Dept Haematopathol, Erbil, Iraq.	rawand.shamoon@med.hmu.edu.krd	Shabila, Nazar/I-1314-2019	Shabila, Nazar/0000-0002-8921-195X; Shamoon, Rawand/0000-0002-8964-7497				[Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P265; [Anonymous], 2009, HODGKINS DIS LYMPHOM; Arya LS, 2006, PEDIATR BLOOD CANCER, V46, P26, DOI 10.1002/pbc.20157; Avagyan Armen, 2016, Asian Pac J Cancer Prev, V17, P101; Baez F, 1997, ANN ONCOL, V8, P247, DOI 10.1023/A:1008200210674; Bazzeh F, 2010, LEUKEMIA LYMPHOMA, V51, P2198, DOI 10.3109/10428194.2010.525724; Brepoels L, 2007, LEUKEMIA LYMPHOMA, V48, P270, DOI 10.1080/10428190601078118; Buyukpamukcu M, 2009, ACTA ONCOL, V48, P44, DOI 10.1080/02841860802310991; Buyukkapu-Bay S, 2015, TURK J PEDIAT, V57; CARBONE PP, 1971, CANCER RES, V31, P1860; Cerci JJ, 2010, J NUCL MED, V51, P1337, DOI 10.2967/jnumed.109.073197; Chen R, 2016, BLOOD, V128, P1562, DOI 10.1182/blood-2016-02-699850; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Eichenauer DA, 2014, ANN ONCOL, V25, P70, DOI 10.1093/annonc/mdu181; Engel M, 2000, J CLIN PATHOL, V53, P182, DOI 10.1136/jcp.53.3.182; Engert A, 2009, ANN ONCOL, V20, P108, DOI 10.1093/annonc/mdp144; Englund A, 2017, ACTA ONCOL IN PRESS; Fadhil MS, 2014, SAUDI MED J, V35, P448; Fadoo Zehra, 2010, J Pediatr Hematol Oncol, V32, pe14, DOI 10.1097/MPH.0b013e3181bdf1f3; Feldman AL, 2006, THE LYMPHOMAS; Friedmann AM, 2002, J CLIN ONCOL, V20, P3088, DOI 10.1200/JCO.2002.03.051; Geller SA, 2013, VIRCHOWS ARCH, V463, P353, DOI 10.1007/s00428-013-1442-0; Glaser SL, 1997, INT J CANCER, V70, P375, DOI 10.1002/(SICI)1097-0215(19970207)70:4&lt;375::AID-IJC1&gt;3.0.CO;2-T; Herbst C, 2010, HAEMATOL-HEMATOL J, V95, P494, DOI 10.3324/haematol.2009.015644; Hjalgrim H, 2003, NEW ENGL J MED, V349, P1324, DOI 10.1056/NEJMoa023141; Horwich A, 1997, EUR J CANCER, V33, P848, DOI 10.1016/S0959-8049(96)00518-7; Jachimowicz RD, 2014, ACTA HAEMATOL-BASEL, V132, P274, DOI 10.1159/000360205; Jain S, 2016, PEDIATR BLOOD CANCER, V63, P1024, DOI 10.1002/pbc.25935; KAPOOR G, 1995, PEDIATR HEMAT ONCOL, V12, P559, DOI 10.3109/08880019509030770; Kuppers R, 2005, EUR J HAEMATOL, V75, P26; Laskar S, 2004, J CLIN ONCOL, V22, P62, DOI 10.1200/JCO.2004.01.021; Miltenyi Z, 2011, ISRN HEMATOL; Noordijk EM, 2006, J CLIN ONCOL, V24, P3128, DOI 10.1200/JCO.2005.05.2746; Pourtsidis A, 2013, PEDIATR HEMAT ONCOL, V30, P532, DOI 10.3109/08880018.2013.823471; Salati M, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.048; Shafi RG, 2017, ONCOL RES TREAT, V40, P288, DOI 10.1159/000460819; Shamoon RP, 2010, ZANCO J MED SCI, V14, P85; Sherief LM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000670; Smith RS, 2003, J CLIN ONCOL, V21, P2026, DOI 10.1200/JCO.2003.07.124; Stefan DC, 2009, LEUKEMIA LYMPHOMA, V50, P196, DOI 10.1080/10428190802663205; Thomas RK, 2002, ANN ONCOL, V13, P147, DOI 10.1093/annonc/mdf652; Trehan A, 2013, J PEDIAT HEMATOL ONC, V35, P174, DOI 10.1097/MPH.0b013e318271f587; Uysal Kamer Mutafoglu, 2007, TURKISH J CANC, V37, P98; Yeole B B, 2001, Indian Pediatr, V38, P1270	44	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195629	10.1371/journal.pone.0195629	http://dx.doi.org/10.1371/journal.pone.0195629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649329	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900063
J	Wang, YM; Seppanen-Laakso, T; Rischer, H; Wiebe, MG				Wang, Yanming; Seppanen-Laakso, Tuulikki; Rischer, Heiko; Wiebe, Marilyn G.			Euglena gracilis growth and cell composition under different temperature, light and trophic conditions	PLOS ONE			English	Article							ALPHA-TOCOPHEROL; FATTY-ACIDS; MIXOTROPHIC CULTURE; LIPID PRODUCTION; CULTIVATION; PARAMYLON; BIOMASS; MICROALGAE; BIOTECHNOLOGY; CARBOHYDRATE	Background Euglena gracilis, a photosynthetic protist, produces protein, unsaturated fatty acids, wax esters, and a unique beta-1,3-glucan called paramylon, along with other valuable compounds. The cell composition of E. gracilis was investigated in this study to understand how light and organic carbon (photo-, mixo- and heterotrophic conditions) affected growth and cell composition (especially lipids). Comparisons were primarily carried out in cultures grown at 23 degrees C, but the effect of growth at higher temperatures (27 or 30 degrees C) was also considered. Cell growth Specific growth rates were slightly lower when E. gracilis was grown on glucose in either heterotrophic or mixotrophic conditions than when grown photoautotrophically, although the duration of exponential growth was longer. Temperature determined the rate of exponential growth in all cultures, but not the linear growth rate during light-limited growth in phototrophic conditions. Temperature had less effect on cell composition. Cell composition Although E. gracilis was not expected to store large amounts of paramylon when grown phototrophically, we observed that phototrophic cells could contain up to 50% paramylon. These cells contained up to 33% protein and less than 20% lipophilic compounds, as expected. The biomass contained about 8% fatty acids (measured as fatty acid methyl esters), most of which were unsaturated. The fatty acid content of cells grown in mixotrophic conditions was similar to that observed in phototrophic cells, but was lower in cells grown heterotrophically. Heterotrophic cells contained less unsaturated fatty acids than phototrophic or mixotrophic cells. alpha-Linolenic acid was present at 5 to 18 mg g(-1) dry biomass in cells grown in the presence of light, but at < 0.5 mg g(-1) biomass in cells grown in the dark. Eicosapentaenoic and docosahexaenoic acids were detected at 1 to 5 mg g(-1) biomass. Light was also important for the production of vitamin E and phytol.	[Wang, Yanming; Seppanen-Laakso, Tuulikki; Rischer, Heiko; Wiebe, Marilyn G.] VTT Tech Res Ctr Finland Ltd, Espoo, Finland; [Wang, Yanming] Univ Nottingham, Synthet Biol Res Ctr, Nottingham, England	VTT Technical Research Center Finland; University of Nottingham	Wiebe, MG (corresponding author), VTT Tech Res Ctr Finland Ltd, Espoo, Finland.	marilyn.wiebe@vtt.fi	Rischer, Heiko/ABB-4681-2020	Rischer, Heiko/0000-0002-8004-4526	TEKES; Finnish Funding Agency for Technology and Innovation through the ALGIND project [40149/11]; European Commission [311932]; Ella and Georg Ehrnrooth Foundation; EU FP7	TEKES(Finnish Funding Agency for Technology & Innovation (TEKES)); Finnish Funding Agency for Technology and Innovation through the ALGIND project; European Commission(European CommissionEuropean Commission Joint Research Centre); Ella and Georg Ehrnrooth Foundation; EU FP7(European Commission)	This work was supported by TEKES, the Finnish Funding Agency for Technology and Innovation (https://www.tekes.fi/en/tekes/), through the ALGIND (40149/11) project, and by the European Commission (grant no. 311932, project acronym: SeaBiotech, http://spider.science.strath.ac.uk/seabiotech/), and as a personal grant to YVV by the Ella and Georg Ehrnrooth Foundation (http://www.ellageorg.fi/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VTT (with funds from TEKES and the EU FP7) provided support in the form of salaries for authors [YW, TS-L, HR, MGW], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Albalasmeh AA, 2013, CARBOHYD POLYM, V97, P253, DOI 10.1016/j.carbpol.2013.04.072; Barsanti L, 2001, J APPL PHYCOL, V13, P59, DOI 10.1023/A:1008105416065; Bischoff H. W., 1963, PHYCOL STUD, V44, P1; CARELL EF, 1970, J CELL BIOL, V47, P525, DOI 10.1083/jcb.47.2.525; Certik M, 1999, J BIOSCI BIOENG, V87, P1, DOI 10.1016/S1389-1723(99)80001-2; CONSTANTOPOULOS G, 1967, J BIOL CHEM, V242, P3538; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuhashi T, 2015, METABOLOMICS, V11, P175, DOI 10.1007/s11306-014-0687-1; Gong MY, 2017, APPL BIOCHEM BIOTECH, V183, P652, DOI 10.1007/s12010-017-2537-x; Grimm P, 2015, J BIOTECHNOL, V215, P72, DOI 10.1016/j.jbiotec.2015.04.004; Hamed I, 2016, COMPR REV FOOD SCI F, V15, P1104, DOI 10.1111/1541-4337.12227; Harun R, 2010, RENEW SUST ENERG REV, V14, P1037, DOI 10.1016/j.rser.2009.11.004; HAYASHI M, 1993, BIOSCI BIOTECH BIOCH, V57, P352, DOI 10.1271/bbb.57.352; Ingebrigtsen RA, 2016, J APPL PHYCOL, V28, P939, DOI 10.1007/s10811-015-0631-4; Inui H, 2017, ADV EXP MED BIOL, V979, P269, DOI 10.1007/978-3-319-54910-1_13; Islam MT, 2015, CHEM-BIOL INTERACT, V240, P60, DOI 10.1016/j.cbi.2015.07.010; Jeong U-Cheol, 2016, [Korean Journal of Fisheries and Aquatic Sciences, 한국수산과학회지], V49, P38; Jones CS, 2012, CURR OPIN BIOTECH, V23, P346, DOI 10.1016/j.copbio.2011.10.013; KAWABATA A, 1982, J PROTOZOOL, V29, P421, DOI 10.1111/j.1550-7408.1982.tb05425.x; KAWABATA A, 1989, J GEN MICROBIOL, V135, P1461; Kitaya Y, 2005, ADV SPACE RES-SERIES, V35, P1584, DOI 10.1016/j.asr.2005.03.039; KOIZUMI N, 1993, ANTIVIR RES, V21, P1, DOI 10.1016/0166-3542(93)90063-O; KORN ED, 1964, J LIPID RES, V5, P352; Krajcovic J, 2015, J BIOTECHNOL, V202, P135, DOI 10.1016/j.jbiotec.2014.11.035; Kumar D, 2017, ENG LIFE SCI, V17, P1030, DOI 10.1002/elsc.201700014; Kunne A, 1996, BOT ACTA, V109, P57; Kusmic C, 1998, J APPL PHYCOL, V10, P555, DOI 10.1023/A:1008022305865; Li X, 2011, BIORESOURCE TECHNOL, V102, P3098, DOI 10.1016/j.biortech.2010.10.055; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Luo X, 2015, MAR DRUGS, V13, P4231, DOI 10.3390/md13074231; Matsuda F, 2011, BIOSCI BIOTECH BIOCH, V75, P2253, DOI 10.1271/bbb.110482; Millan-Oropeza A, 2017, ENVIRON SCI POLLUT R, V24, P25618, DOI 10.1007/s11356-016-7013-6; Miyatake K, 1985, NIPPON EIYO SHOKURYO, V38, P117, DOI DOI 10.4327/jsnfs.38.117; NAKANO Y, 1987, J BIOCHEM, V102, P1053, DOI 10.1093/oxfordjournals.jbchem.a122143; NICOLAS P, 1980, PLANT PHYSIOL, V65, P631, DOI 10.1104/pp.65.4.631; O'Neill EC, 2015, MOL BIOSYST, V11, P2808, DOI 10.1039/c5mb00319a; Ogawa T, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0264-5; Ogbonna JC, 2002, APPL MICROBIOL BIOT, V58, P532, DOI 10.1007/s00253-001-0901-8; OGBONNA JC, 1995, J FERMENT BIOENG, V80, P369, DOI 10.1016/0922-338X(95)94206-7; Ogbonna JC, 1998, J APPL PHYCOL, V10, P67, DOI 10.1023/A:1008011201437; Ogbonna JC, 2000, J APPL PHYCOL, V12, P207, DOI 10.1023/A:1008194627239; Olaveson MM, 2000, HYDROBIOLOGIA, V433, P39, DOI 10.1023/A:1004006401516; Rezic Tonci, 2013, Agriculturae Conspectus Scientificus, V78, P65; Romano G, 2017, MAR ENVIRON RES, V128, P58, DOI 10.1016/j.marenvres.2016.05.002; ROSENBERG A, 1963, BIOCHEMISTRY-US, V2, P1148, DOI 10.1021/bi00905a042; Schwarzhans JP, 2015, J APPL PHYCOL, V27, P1389, DOI 10.1007/s10811-014-0458-4; Slocombe SP, 2013, BIORESOURCE TECHNOL, V129, P51, DOI 10.1016/j.biortech.2012.10.163; Suzuki K, 2017, ADV EXP MED BIOL, V979, P285, DOI 10.1007/978-3-319-54910-1_14; Takeyama H, 1997, BIOTECHNOL BIOENG, V53, P185, DOI 10.1002/(SICI)1097-0290(19970120)53:2<185::AID-BIT8>3.0.CO;2-K; TANI Y, 1989, AGR BIOL CHEM TOKYO, V53, P305, DOI 10.1080/00021369.1989.10869324; Valverde F, 2016, EUR J PROTISTOL, V55, P95, DOI 10.1016/j.ejop.2016.03.002; Vismara R, 2000, TISSUE CELL, V32, P451, DOI 10.1016/S0040-8166(00)80001-4; Wang Y, 2013, BIORESOURCE TECHNOL, V144, P608, DOI 10.1016/j.biortech.2013.07.027; Ward OP, 2005, PROCESS BIOCHEM, V40, P3627, DOI 10.1016/j.procbio.2005.02.020; Watanabe T, 2013, FOOD FUNCT, V4, P1685, DOI 10.1039/c3fo60256g; Yamane Y, 2001, BIOTECHNOL LETT, V23, P1223, DOI 10.1023/A:1010573218863; Zeng M, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0279-4; Zhang RT, 2017, ALGAL RES, V27, P89, DOI 10.1016/j.algal.2017.08.026	58	31	31	9	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195329	10.1371/journal.pone.0195329	http://dx.doi.org/10.1371/journal.pone.0195329			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649233	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900038
J	Cross, MR; Lahti, J; Brown, SR; Chedati, M; Jimenez-Reyes, P; Samozino, P; Eriksrud, O; Morin, JB				Cross, Matt R.; Lahti, Johan; Brown, Scott R.; Chedati, Mehdi; Jimenez-Reyes, Pedro; Samozino, Pierre; Eriksrud, Ola; Morin, Jean-Benoit			Training at maximal power in resisted sprinting: Optimal load determination methodology and pilot results in team sport athletes	PLOS ONE			English	Article							FORCE-VELOCITY PROFILE; MECHANICAL-PROPERTIES; SOCCER PLAYERS; RUGBY UNION; PERFORMANCE; KINEMATICS; INJURY	Aims In the current study we investigated the effects of resisted sprint training on sprinting performance and underlying mechanical parameters (force-velocity-power profile) based on two different training protocols: (i) loads that represented maximum power output (L-opt) and a 50% decrease in maximum unresisted sprinting velocity and (ii) lighter loads that represented a 10% decrease in maximum unresisted sprinting velocity, as drawn from previous research (L-10). Methods Soccer [n = 15 male] and rugby [n = 21; 9 male and 12 female] club-level athletes were individually assessed for horizontal force-velocity and load-velocity profiles using a battery of resisted sprints, sled or robotic resistance respectively. Athletes then performed a 12-session resisted (10 x 20-m; and pre-post-profiling) sprint training intervention following the L-10 or Lopt protocol. Results Both L-10 and L-opt training protocols had minor effects on sprinting performance (average of-1.4 to-2.3% split-times respectively), and provided trivial, small and unclear changes in mechanical sprinting parameters. Unexpectedly, L-opt impacted velocity dominant variables to a greater degree than L-10 (trivial benefit in maximum velocity; small increase in slope of the force-velocity relationship), while L-10 improved force and power dominant metrics (trivial benefit in maximal power; small benefit in maximal effectiveness of ground force orientation). Conclusions Both resisted-sprint training protocols were likely to improve performance after a short training intervention in already sprint trained athletes. However, widely varied individualised results indicated that adaptations may be dependent on pre-training force-velocity characteristics.	[Cross, Matt R.; Samozino, Pierre] Univ Savoie Mt Blanc, Lab Interuniv Biol Motricite, EA, Chambery, France; [Cross, Matt R.] Federat Francaise Ski, Dept Sci & Sportif, Annecy, France; [Cross, Matt R.; Brown, Scott R.; Morin, Jean-Benoit] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Lahti, Johan; Chedati, Mehdi; Morin, Jean-Benoit] Univ Cote Azur, LAMHESS, Nice, France; [Lahti, Johan] Univ Jyvaskyla, Fac Sports & Hlth Sci, Jyvaskyla, Finland; [Brown, Scott R.] Univ Michigan, Med Sch, Dept Phys Med & Rehabil, Neuromuscular & Rehabil Robot Lab NeuRRo Lab, Ann Arbor, MI 48109 USA; [Jimenez-Reyes, Pedro] Catholic Univ San Antonio, Fac Phys Sci & Sport, Murcia, Spain; [Eriksrud, Ola] Norwegian Sch Sports Sci, Dept Phys Performance, Oslo, Norway	Auckland University of Technology; UDICE-French Research Universities; Universite Cote d'Azur; University of Jyvaskyla; University of Michigan System; University of Michigan; Universidad Catolica de Murcia; Norwegian School of Sport Sciences	Morin, JB (corresponding author), Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand.; Morin, JB (corresponding author), Univ Cote Azur, LAMHESS, Nice, France.	jean-benoit.morin@unice.fr	Samozino, Pierre/R-1927-2019; Eriksrud, Ola/AAK-1328-2020; Cross, Matthew/AAP-8022-2021; Jimenez-Reyes, Pedro/P-1075-2016	Eriksrud, Ola/0000-0003-4971-6723; Cross, Matthew/0000-0003-1579-3720; Jimenez-Reyes, Pedro/0000-0002-8156-243X; Morin, Jean-Benoit/0000-0003-3808-6762	1080 Motion AB	1080 Motion AB	From the onset of the study to present, co-author Ola Eriksrud holds a position with 1080 Motion AB. 1080 Motion AB provided support for this project via shipping costs and use of the 1080 Sprint machine for data collection, and monetary support to the Universite Cote d'Azur via a collaboration contract. None of the authors received any commercial funding or salary in any form that would influence the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaraz PE, 2009, J STRENGTH COND RES, V23, P480, DOI 10.1519/JSC.0b013e318198f92c; Chelly SM, 2001, MED SCI SPORT EXER, V33, P326; Cormie P, 2011, SPORTS MED, V41, P125, DOI 10.2165/11538500-000000000-00000; Cormie P, 2011, SPORTS MED, V41, P17, DOI 10.2165/11537690-000000000-00000; Cronin JB, 2005, J STRENGTH COND RES, V19, P349; Cross MR, 2018, EUR J APPL PHYSIOL, V118, P563, DOI 10.1007/s00421-017-3796-5; Cross MR, 2017, INT J SPORT PHYSIOL, V12, P1069, DOI 10.1123/ijspp.2016-0362; Cross MR, 2017, J SPORT SCI, V35, P2198, DOI 10.1080/02640414.2016.1261178; Cross MR, 2017, SPORTS MED, V47, P1255, DOI 10.1007/s40279-016-0653-3; Cross MR, 2015, INT J SPORT PHYSIOL, V10, P695, DOI 10.1123/ijspp.2014-0151; Dorel S, 2012, MED SCI SPORT EXER, V44, P2154, DOI 10.1249/MSS.0b013e3182625423; Dorel S, 2010, MED SCI SPORT EXER, V42, P1174, DOI 10.1249/MSS.0b013e3181c91f35; Giroux C, 2016, J APPL BIOMECH, V32, P59, DOI 10.1123/jab.2015-0070; Haugen T, 2018, INT J SPORT PHYSIOL, V13, P678, DOI 10.1123/ijspp.2017-0441; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Jimenez-Reyes P, 2017, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00677; Kawamori N, 2014, J SPORT SCI, V32, P1139, DOI 10.1080/02640414.2014.886129; Lockie RG, 2003, J STRENGTH COND RES, V17, P760; Mangine GT, 2018, J STRENGTH COND RES, V32, P1531, DOI 10.1519/JSC.0000000000002030; Marrier B, 2017, INT J SPORT PHYSIOL, V12, P1163, DOI 10.1123/ijspp.2016-0607; Mendiguchia J, 2016, J SPORT SCI, V34, P535, DOI 10.1080/02640414.2015.1122207; Mendiguchia J, 2014, INT J SPORTS MED, V35, P690, DOI 10.1055/s-0033-1363192; Morin JB, 2017, INT J SPORT PHYSIOL, V12, P840, DOI 10.1123/ijspp.2016-0444; Morin JB, 2016, INT J SPORT PHYSIOL, V11, P267, DOI 10.1123/ijspp.2015-0638; Morin JB, 2011, MED SCI SPORT EXER, V43, P1680, DOI 10.1249/MSS.0b013e318216ea37; Petrakos G, 2016, SPORTS MED, V46, P381, DOI 10.1007/s40279-015-0422-8; Samozino P, 2016, SCAND J MED SCI SPOR, V26, P648, DOI 10.1111/sms.12490; Samozino P, 2014, INT J SPORTS MED, V35, P505, DOI 10.1055/s-0033-1354382; Samozino P, 2012, MED SCI SPORT EXER, V44, P313, DOI 10.1249/MSS.0b013e31822d757a; Spinks CD, 2007, J STRENGTH COND RES, V21, P77, DOI 10.1519/00124278-200702000-00015	30	46	46	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195477	10.1371/journal.pone.0195477	http://dx.doi.org/10.1371/journal.pone.0195477			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641589	gold, Green Published, Green Submitted			2022-12-26	WOS:000429742900071
J	Ayaz, A; Nergiz-Unal, R; Dedebayraktar, D; Akyol, A; Pekcan, AG; Besler, HT; Buyuktuncer, Z				Ayaz, Aylin; Nergiz-Unal, Reyhan; Dedebayraktar, Damla; Akyol, Asli; Pekcan, A. Gulden; Besler, Halit Tanju; Buyuktuncer, Zehra			How does food addiction influence dietary intake profile?	PLOS ONE			English	Article							BODY-MASS INDEX; EATING ATTITUDES; OBESITY; ENERGY; ASSOCIATION; ACTIVATION; CUTOFF; HEALTH; SUGAR	This study aimed to investigate whether there was any difference in eating pattern, abnormal eating behaviour, obesity and the number of food addiction symptoms according to food addiction presence. A total sample of 851 healthy subjects living in Ankara (n = 360 male, n = 491 female) aged 19 +/- 65 years were included in this cross-sectional survey. Data on demographic information, 24-hour dietary recalls, Yale Food Addiction Scale (YFAS), Eating Attitudes Test-26 (EAT-26), and anthropometric measurements were collected through face-to-face interviews. Overall, 11.4% of participants were identified as "food addicted" (F: 13.0%; M: 9.2%). Subjects meeting criteria for 'food addiction' had higher body mass index (35.1% were obese and 3.1% were underweight), compared to subjects without food addiction (13.1% were obese and 10.2% were underweight) (p<0.05). Abnormal eating attitudes estimated with EAT-26 were determined as 45.5% in males, 37.5% in females and 40.2% in total, among subjects with food addiction. Daily energy, protein and fat intakes were significantly higher in food addicted females, compared to non-addicted females (p<0.05). Participants with food addiction reported significantly more problems with foods, which contain high amounts of fat and sugar, compared to the participants without food addiction. Food addiction behaviour should be considered as a part of efforts towards reducing food related problems involving obesity.	[Ayaz, Aylin; Nergiz-Unal, Reyhan; Dedebayraktar, Damla; Buyuktuncer, Zehra] Hacettepe Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey; [Pekcan, A. Gulden; Besler, Halit Tanju] Hasan Kalyoncu Univ, Fac Hlth Sci, Dept Nutr & Dietet, Gaziantep, Turkey; [Pekcan, A. Gulden; Besler, Halit Tanju] Eastern Mediterranean Univ, Fac Hlth Sci, Dept Nutr & Dietet, Mersin 10, Famagusta, North Cyprus, Turkey	Hacettepe University; Hasan Kalyoncu University; Eastern Mediterranean University	Ayaz, A (corresponding author), Hacettepe Univ, Fac Hlth Sci, Dept Nutr & Dietet, Ankara, Turkey.	baylin@hacettepe.edu.tr	Akyol, Aslı/I-9987-2013; Pekcan, A Gulden/AAI-6040-2021; Nergiz Unal, Reyhan/I-9967-2013; Besler, Halit Tanju/I-9965-2013	Akyol, Aslı/0000-0001-6301-6358; Pekcan, A Gulden/0000-0002-2037-3037; Nergiz Unal, Reyhan/0000-0002-3143-7710; Besler, Halit Tanju/0000-0002-6523-7995				[Anonymous], 1991, ANTHROPOMETRIC STAND; Avena NM, 2012, METHODS MOL BIOL, V829, P351, DOI 10.1007/978-1-61779-458-2_23; Avena NM, 2009, J NUTR, V139, P623, DOI 10.3945/jn.108.097584; Bas M, 2004, ADOLESCENCE, V39, P593; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Buyuktuncer Z, TURKISH VERSION YALE; Corsica JA, 2010, CURR OPIN GASTROEN, V26, P165, DOI 10.1097/MOG.0b013e328336528d; Curtis C, 2014, EAT DISORD, V22, P19, DOI 10.1080/10640266.2014.857515; Davis C, 2011, APPETITE, V57, P711, DOI 10.1016/j.appet.2011.08.017; FAO/WHO/UNU, 1985, REP JOINT FAO WHO UN, V724; Fortuna JL, 2012, J PSYCHOACTIVE DRUGS, V44, P56, DOI 10.1080/02791072.2012.662092; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Gearhardt AN, 2014, EAT BEHAV, V15, P427, DOI 10.1016/j.eatbeh.2014.05.001; Gearhardt AN, 2014, SOC COGN AFFECT NEUR, V9, P932, DOI 10.1093/scan/nst059; Gearhardt Ashley N, 2011, Curr Drug Abuse Rev, V4, P140; Gearhardt AN, 2011, ARCH GEN PSYCHIAT, V68, P808, DOI 10.1001/archgenpsychiatry.2011.32; Gearhardt AN, 2011, ADDICTION, V106, P1208, DOI 10.1111/j.1360-0443.2010.03301.x; Gearhardt AN, 2009, APPETITE, V52, P430, DOI 10.1016/j.appet.2008.12.003; Gold MS, 2003, PSYCHIAT ANN, V33, P117, DOI 10.3928/0048-5713-20030201-08; GOLDBERG GR, 1991, EUR J CLIN NUTR, V45, P569; Hebebrand J, 2014, NEUROSCI BIOBEHAV R, V47, P295, DOI 10.1016/j.neubiorev.2014.08.016; Johnson PM, 2010, NAT NEUROSCI, V13, P635, DOI 10.1038/nn.2519; Keser A, 2015, TURKISH J PEDIATR, V57, P219; Lerma-Cabrera JM, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0124-6; Obregon A, 2015, REV MED CHILE, V143, P589, DOI 10.4067/S0034-98872015000500006; Organization WH, 2011, WAIST CIRCUMFERENCE; Pandit R, 2011, EUR J PHARMACOL, V660, P28, DOI 10.1016/j.ejphar.2011.01.034; Pedram P, 2015, NUTRIENTS, V7, P223, DOI 10.3390/nu7010223; Pedram P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074832; Pekcan AG, 2017, PROG NUTR, V19, P248, DOI 10.23751/pn.v19i3.5607; Prentice RL, 2011, AM J EPIDEMIOL, V174, P591, DOI 10.1093/aje/kwr140; Pursey KM, 2016, PHYSIOL BEHAV, V157, P9, DOI 10.1016/j.physbeh.2016.01.018; Pursey Kirrilly M, 2015, Addict Behav Rep, V2, P41, DOI 10.1016/j.abrep.2015.05.007; Pursey KM, 2014, NUTRIENTS, V6, P4552, DOI 10.3390/nu6104552; Pursey KM., 2017, CURR ADDICT REP, V4, P142, DOI [10.1007/s40429-017-0139-x, DOI 10.1007/S40429-017-0139-X]; Rakicioglu N., 2012, PHOTOGRAPHIC ATLAS F; RODIN J, 1991, APPETITE, V17, P177, DOI 10.1016/0195-6663(91)90020-S; Sanlier N, 2016, ECOL FOOD NUTR, V55, P491, DOI 10.1080/03670244.2016.1219951; Savasir I., 1989, PSIKOLOJI DERG, V7, P19; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Schulte EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117959; Stoeckel LE, 2008, NEUROIMAGE, V41, P636, DOI 10.1016/j.neuroimage.2008.02.031; Wolz I, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00061; Yu ZP, 2016, NUTRIENTS, V8, DOI 10.3390/nu8110673; Ziauddeen H, 2013, OBES REV, V14, P19, DOI 10.1111/j.1467-789X.2012.01046.x	45	23	25	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195541	10.1371/journal.pone.0195541	http://dx.doi.org/10.1371/journal.pone.0195541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD6SO	29677203	Green Published, gold, Green Submitted			2022-12-26	WOS:000430638900012
J	Krysciak, K; Majerczak, J; Krysciak, J; Tochynski, D; Kaczmarek, D; Drzymala-Celichowska, H; Krutki, P; Gawedzka, A; Guzik, M; Korostynski, M; Szkutnik, Z; Pyza, E; Jarmuszkiewicz, W; Zoladz, JA; Celichowski, J				Krysciak, Katarzyna; Majerczak, Joanna; Krysciak, Jakub; Tochynski, Dawid; Kaczmarek, Dominik; Drzymala-Celichowska, Hanna; Krutki, Piotr; Gawedzka, Anna; Guzik, Magdalena; Korostynski, Michel; Szkutnik, Zbigniew; Pyza, Elzbieta; Jarmuszkiewicz, Wieslawa; Zoladz, Jerzy A.; Celichowski, Jan			Adaptation of motor unit contractile properties in rat medial gastrocnemius to treadmill endurance training: Relationship to muscle mitochondrial biogenesis	PLOS ONE			English	Article							LIGHT-CHAIN PHOSPHORYLATION; ATROPHIED SKELETAL-MUSCLE; BIOCHEMICAL ADAPTATIONS; OXYGEN-UPTAKE; SARCOPLASMIC-RETICULUM; FREQUENCY-RELATIONSHIP; METABOLIC ADAPTATIONS; HINDLIMB MOTONEURONS; INDUCED ACCELERATION; UNFUSED TETANUS	This study aimed at investigating the effects of 2, 4 and 8 weeks of endurance training on the contractile properties of slow (S), fast fatigue resistant (FR) and fast fatigable (FF) motor units (MUs) in rat medial gastrocnemius (MG) in relation to the changes in muscle mitochondrial biogenesis. The properties of functionally isolated MUs were examined in vivo. Mitochondrial biogenesis was judged based on the changes in mitochondrial DNA copy number (mtDNA), the content of the electron transport chain (ETC) proteins and PGC-1 alpha in the MG. Moreover, the markers of mitochondria remodeling mitofusins (Mfn1, Mfn2) and dynamin-like protein (Opa1) were studied using qPCR. A proportion of FR MUs increased from 37.9% to 50.8% and a proportion of FF units decreased from 44.7% to 26.6% after 8 weeks of training. The increased fatigue resistance, shortened twitch duration, and increased ability to potentiate force were found as early as after 2 weeks of endurance training, predominantly in FR MUs. Moreover, just after 2 weeks of the training an enhancement of the mitochondrial network remodeling was present as judged by an increase in expression of Mfn1, Opa1 and an increase in PGC-1 alpha in the slow part of MG. Interestingly, no signs of intensification of mitochondrial biogenesis assessed by ETC proteins content and mtDNA in slow and fast parts of gastrocnemius were found at this stage of the training. Nevertheless, after 8 weeks of training an increase in the ETC protein content was observed, but mainly in the slow part of gastrocnemius. Concluding, the functional changes in MUs' contractile properties leading to the enhancement of muscle performance accompanied by an activation of signalling that controls the muscle mitochondrial network reorganisation and mitochondrial biogenesis belong to an early muscle adaptive responses that precede an increase in mitochondrial ETC protein content.	[Krysciak, Katarzyna; Tochynski, Dawid; Kaczmarek, Dominik; Drzymala-Celichowska, Hanna; Krutki, Piotr; Celichowski, Jan] Poznan Univ Phys Educ, Dept Neurobiol, Poznan, Poland; [Majerczak, Joanna; Gawedzka, Anna; Guzik, Magdalena; Zoladz, Jerzy A.] Univ Sch Phys Educ, Fac Rehabil, Dept Muscle Physiol, Krakow, Poland; [Krysciak, Jakub] Poznan Univ Phys Educ, Dept Physiol, Poznan, Poland; [Tochynski, Dawid] Poznan Univ Phys Educ, Dept Musculoskeletal Rehabil, Poznan, Poland; [Kaczmarek, Dominik; Drzymala-Celichowska, Hanna] Poznan Univ Phys Educ, Dept Biochem, Poznan, Poland; [Korostynski, Michel] Polish Acad Sci, Inst Pharmacol, Dept Mol Neuropharmacol, Krakow, Poland; [Szkutnik, Zbigniew] AGH Univ Sci & Technol, Fac Appl Math, Krakow, Poland; [Pyza, Elzbieta] Jagiellonian Univ, Inst Zool, Dept Cell Biol & Imaging, Krakow, Poland; [Jarmuszkiewicz, Wieslawa] Adam Mickiewicz Univ, Dept Bioenerget, Poznan, Poland	Polish Academy of Sciences; AGH University of Science & Technology; Jagiellonian University; Adam Mickiewicz University	Krysciak, K (corresponding author), Poznan Univ Phys Educ, Dept Neurobiol, Poznan, Poland.	krysciak@awf.poznan.pl	Majerczak, Joanna/V-7492-2019; Kaczmarek, Dominik/C-6392-2011; Drzymała-Celichowska, Hanna/T-1009-2018; Celichowski, Jan/R-1162-2018; Szkutnik, Zbigniew/B-2214-2014; Korostynski, Michal/AAS-2626-2021; Krutki, Piotr/W-4011-2018	Majerczak, Joanna/0000-0003-0898-1707; Drzymała-Celichowska, Hanna/0000-0002-5090-8346; Celichowski, Jan/0000-0002-0394-3309; Szkutnik, Zbigniew/0000-0002-4607-6268; Korostynski, Michal/0000-0002-4273-7401; Krutki, Piotr/0000-0003-4193-5171; Gawedzka, Anna/0000-0002-5009-8494; Zoladz, Jerzy A./0000-0002-1143-5590; Lochynski, Dawid/0000-0002-4274-0950; Kaczmarek, Dominik/0000-0002-4044-3952; Krysciak, Katarzyna/0000-0003-3728-7562; Jarmuszkiewicz, Wieslawa/0000-0001-8550-8337; Krysciak, Jakub/0000-0001-9071-1882; Zmudzka, Magdalena/0000-0001-7401-9386	JC National Science Center [2013/09/B/NZ7/02555]; JM University School of Physical Education [74/BS/KFiB/2015]	JC National Science Center; JM University School of Physical Education	This work was supported by JC National Science Center (2013/09/B/NZ7/02555) and JM University School of Physical Education (74/BS/KFiB/2015).	Andreu AL, 2009, MITOCHONDRION, V9, P242, DOI 10.1016/j.mito.2009.02.006; BAUMANN H, 1987, PFLUG ARCH EUR J PHY, V409, P349, DOI 10.1007/BF00583788; Beaumont E, 2003, MUSCLE NERVE, V27, P228, DOI 10.1002/mus.10308; Beaumont E, 2002, J PHYSIOL-LONDON, V540, P129, DOI 10.1113/jphysiol.2001.013084; BURKE RE, 1973, J PHYSIOL-LONDON, V234, P723, DOI 10.1113/jphysiol.1973.sp010369; Cartoni R, 2005, J PHYSIOL-LONDON, V567, P349, DOI 10.1113/jphysiol.2005.092031; CELICHOWSKI J, 1992, ACTA NEUROBIOL EXP, V52, P17; CELICHOWSKI J, 1992, ARCH ITAL BIOL, V130, P315; Celichowski J, 1997, ARCH ITAL BIOL, V135, P229; Celichowski J, 2000, J PHYSIOL PHARMACOL, V51, P291; CELICHOWSKI J, 1992, ACTA NEUROBIOL EXP, V52, P99; Celichowski J, 2006, EXP PHYSIOL, V91, P887, DOI 10.1113/expphysiol.2005.033076; Celichowski J, 2010, J ELECTROMYOGR KINES, V20, P532, DOI 10.1016/j.jelekin.2009.07.003; Cogliati S, 2016, TRENDS BIOCHEM SCI, V41, P261, DOI 10.1016/j.tibs.2016.01.001; COHEN AH, 1975, J MORPHOL, V146, P177, DOI 10.1002/jmor.1051460202; DEHAAN A, 1993, ACTA PHYSIOL SCAND, V147, P347; DeRuiter CJ, 1995, J APPL PHYSIOL, V79, P1855, DOI 10.1152/jappl.1995.79.6.1855; Dominy JE, 2013, COLD SPRING HARB PER, V5, P7; DUDLEY GA, 1982, J APPL PHYSIOL, V53, P844, DOI 10.1152/jappl.1982.53.4.844; DUDLEY GA, 1987, J BIOL CHEM, V262, P9109; GARDINER PF, 1991, J APPL PHYSIOL, V71, P558, DOI 10.1152/jappl.1991.71.2.558; Gordon T, 1997, J NEUROPHYSIOL, V77, P2585, DOI 10.1152/jn.1997.77.5.2585; Grassi B, 2015, EXERC SPORT SCI REV, V43, P75, DOI 10.1249/JES.0000000000000043; GREEN HJ, 1991, J APPL PHYSIOL, V70, P2032, DOI 10.1152/jappl.1991.70.5.2032; GREEN HJ, 1984, PFLUG ARCH EUR J PHY, V400, P432, DOI 10.1007/BF00587545; Green HJ, 2003, J APPL PHYSIOL, V94, P2034, DOI 10.1152/japplphysiol.00244.2002; GREEN HJ, 1992, J APPL PHYSIOL, V72, P484, DOI 10.1152/jappl.1992.72.2.484; Grottel K, 1999, EXP BRAIN RES, V127, P298, DOI 10.1007/s002210050799; HENNIG R, 1985, NATURE, V314, P164, DOI 10.1038/314164a0; Hicks A, 1997, AM J PHYSIOL-CELL PH, V273, pC297, DOI 10.1152/ajpcell.1997.273.1.C297; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; KERNELL D, 1983, EXP BRAIN RES, V50, P220; Korzeniewski B, 2015, BBA-BIOENERGETICS, V1847, P1310, DOI 10.1016/j.bbabio.2015.07.007; Krutki P, 2008, J PHYSIOL PHARMACOL, V59, P353; Krysciak K, 2016, MUSCLE NERVE, V53, P96, DOI 10.1002/mus.24690; KYROLAINEN H, 1994, EUR J APPL PHYSIOL O, V69, P233, DOI 10.1007/BF01094794; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Leterme D, 1996, PFLUG ARCH EUR J PHY, V432, P313, DOI 10.1007/s004240050138; Lindman HR., 1974, ANAL VARIANCE COMPLE; Lochynski D, 2013, J MUSCULOSKEL NEURON, V13, P430; Lochynski D, 2008, EXP GERONTOL, V43, P218, DOI 10.1016/j.exger.2007.11.003; Lochynski D, 2016, J APPL PHYSIOL, V121, P858, DOI 10.1152/japplphysiol.00330.2016; Lundby AKM, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12905; MACINTOSH BR, 1988, CAN J PHYSIOL PHARM, V66, P707, DOI 10.1139/y88-113; Maffiuletti NA, 2001, J APPL PHYSIOL, V90, P3, DOI 10.1152/jappl.2001.90.1.3; Majerczak J, 2008, J PHYSIOL PHARMACOL, V59, P589; Majerczak J, 2012, EXP PHYSIOL, V97, P386, DOI 10.1113/expphysiol.2011.062992; Mettler JA, 2016, EXP BRAIN RES, V234, P267, DOI 10.1007/s00221-015-4455-x; Mrowczynski W, 2006, J PHYSIOL PHARMACOL, V57, P491; Mrowczynski W, 2010, J ELECTROMYOGR KINES, V20, P523, DOI 10.1016/j.jelekin.2009.07.004; Nielsen J, 2017, J PHYSIOL-LONDON, V595, P2839, DOI 10.1113/JP273040; NOBLE EG, 1989, J APPL PHYSIOL, V67, P2049, DOI 10.1152/jappl.1989.67.5.2049; OLHA AE, 1988, J NEUROPHYSIOL, V60, P2138, DOI 10.1152/jn.1988.60.6.2138; PEROT C, 1991, EUR J APPL PHYSIOL O, V63, P368, DOI 10.1007/BF00364464; Pette D, 2001, J APPL PHYSIOL, V90, P1119, DOI 10.1152/jappl.2001.90.3.1119; Pogrzebna M, 2008, ACTA PHYSIOL, V193, P367, DOI 10.1111/j.1748-1716.2008.01848.x; Taborowska M, 2016, SOMATOSENS MOT RES, V33, P200, DOI 10.1080/08990220.2016.1254609; Tubman LA, 1997, PFLUG ARCH EUR J PHY, V434, P848, DOI 10.1007/s004240050474; Tubman LA, 1996, CAN J PHYSIOL PHARM, V74, P723, DOI 10.1139/cjpp-74-6-723; Vandenboom R, 2013, J MUSCLE RES CELL M, V34, P317, DOI 10.1007/s10974-013-9363-8; Vila-Cha C, 2010, J APPL PHYSIOL, V109, P1455, DOI 10.1152/japplphysiol.01213.2009; Zoladz JA, 2006, J PHYSIOL PHARMACOL, V57, P67; Zoladz JA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189456; Zoladz JA, 2016, PFLUG ARCH EUR J PHY, V468, P1709, DOI 10.1007/s00424-016-1867-9; Zoladz JA, 2015, EXP PHYSIOL, V100, P1229, DOI 10.1113/EP085372; Zoladz JA, 2014, AM J PHYSIOL-REG I, V307, pR1101, DOI 10.1152/ajpregu.00046.2014; Zoladz JA, 2013, EXP PHYSIOL, V98, P883, DOI 10.1113/expphysiol.2012.069443; Zorzano A, 2009, INT J BIOCHEM CELL B, V41, P1846, DOI 10.1016/j.biocel.2009.02.004	69	7	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195704	10.1371/journal.pone.0195704	http://dx.doi.org/10.1371/journal.pone.0195704			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672614	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800036
J	Sampurna, MTA; Ratnasari, KA; Etika, R; Hulzebos, CV; Dijk, PH; Bos, AF; Sauer, PJJ				Sampurna, Mahendra T. A.; Ratnasari, Kinanti A.; Etika, Risa; Hulzebos, Christian V.; Dijk, Peter H.; Bos, Arend F.; Sauer, Pieter J. J.			Adherence to hyperbilirubinemia guidelines by midwives, general practitioners, and pediatricians in Indonesia	PLOS ONE			English	Article							NEONATAL HYPERBILIRUBINEMIA; TERM INFANTS; JAUNDICE; MANAGEMENT; NEWBORN; RISK	Severe hyperbilirubinemia, which may result in kernicterus, is seen more frequently in low and middle-income countries, such as Indonesia, than in high-income countries. In Indonesia midwives, general practitioners (GPs), and pediatricians are involved in the care of jaundiced newborn infants. It is unknown whether the high incidence of severe hyperbilirubinemia in this country is related to a lack of awareness of existing hyperbilirubinemia guidelines issued by, for example, the World Health Organization, the American Academy of Pediatrics, or the Indonesian Health Ministry, or to a lack of adherence to such guidelines. The aim of this questionnaire study was to assess health professionals' awareness of existing guidelines and their adherence to these guidelines in daily practice. We handed out a ten-question questionnaire to midwives, GPs, and pediatricians that included questions about the professionals themselves as well as clinical questions. The midwives completed 291 questionnaires, the GPs 206, and the pediatricians 154, all of which we used for our analysis. Almost 30% of the midwives and 23% of the GPs were either unaware of any existing guidelines or they did not adhere to them. Only 54% of the midwives recognized the warning signs of severe hyperbilirubinemia correctly, compared to 68% of the GPs and 89% of the pediatricians. Twenty-eight percent of the midwives and 31% of the GPs indicated that their first follow-up visit was after 72 hours, while 90% of them discharged infants after less than 48 hours after birth. The awareness of and adherence to guidelines for preventing and treating hyperbilirubinemia is low amongst the midwives and GPs in Indonesia. This may be an important contributing factor in the high incidence of severe hyperbilirubinemia in Indonesia.	[Sampurna, Mahendra T. A.; Ratnasari, Kinanti A.; Etika, Risa] Airlangga Univ, Dr Soetomo Gen Hosp, Dept Pediat, Fac Med, Surabaya, Indonesia; [Hulzebos, Christian V.; Dijk, Peter H.; Bos, Arend F.; Sauer, Pieter J. J.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Children Hosp, Dept Pediat, Groningen, Netherlands	Airlangga University; Dr Soetomo General Hospital Surabaya; University of Groningen	Sampurna, MTA (corresponding author), Airlangga Univ, Dr Soetomo Gen Hosp, Dept Pediat, Fac Med, Surabaya, Indonesia.	mahendrasampurna.ms@gmail.com	Hulzebos, Christian Victor/AAY-6803-2021; Sampurna, Mahendra/AAA-5853-2021	Hulzebos, Christian Victor/0000-0002-8159-7501; Sampurna, Mahendra Tri Arif/0000-0002-7529-8142				Atkinson LR, 2003, PEDIATRICS, V111, pE555, DOI 10.1542/peds.111.5.e555; Bhutani VK, 2013, PEDIATR RES, V74, P86, DOI 10.1038/pr.2013.208; Bhutani VK, 2013, J PEDIATR-US, V162, P477, DOI 10.1016/j.jpeds.2012.08.022; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Darling EK, 2014, PAED CHILD HEALT-CAN, V19, P133, DOI 10.1093/pch/19.3.133; Dewi R, 2011, PEDOMAN PELAYANAN ME, P114; Greco C, 2016, NEONATOLOGY, V110, P172, DOI 10.1159/000445708; Kementerian Kesehatan RI, 2010, BUK SAK PEL KES NEON, pxviii; Keren R, 2008, PEDIATRICS, V121, pE170, DOI 10.1542/peds.2006-3499; KRAMER LI, 1969, AM J DIS CHILD, V118, P454, DOI 10.1001/archpedi.1969.02100040456007; Lain SJ, 2015, PEDIATRICS, V135, P314, DOI 10.1542/peds.2014-2388; Maisels J, 2014, PEDIATRICS, V134, pE340, DOI 10.1542/peds.2013-4299; Maisels MJ, 2015, CAN MED ASSOC J, V187, P335, DOI 10.1503/cmaj.122117; Mateo PC, 2013, CAN FAM PHYSICIAN, V59, pE379; Olusanya BO, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0358-z; Olusanya BO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117229; Sgro M, 2016, J PEDIATR-US, V171, P43, DOI 10.1016/j.jpeds.2015.12.067; Tartaglia M, 2015, HOSP PEDIAT, V3, P251; [World Health Organization WHO], 2013, WHO POCK HOSP CHILDR, P64; Yu CF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179550	20	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196076	10.1371/journal.pone.0196076	http://dx.doi.org/10.1371/journal.pone.0196076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672616	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800080
J	Savaskan, E; Summermatter, D; Schroeder, C; Schachinger, H				Savaskan, Egemen; Summermatter, Daniel; Schroeder, Clemens; Schaechinger, Hartmut			Memory deficits for facial identity in patients with amnestic mild cognitive impairment (MCI)	PLOS ONE			English	Article							EMOTION RECOGNITION; ALZHEIMERS-DISEASE; SOCIAL COGNITION; DIAGNOSIS; FACES	Faces are among the most relevant social stimuli revealing an encounter's identity and actual emotional state. Deficits in facial recognition may be an early sign of cognitive decline leading to social deficits. The main objective of the present study is to investigate if individuals with amnestic mild cognitive impairment show recognition deficits in facial identity. Thirty-seven individuals with amnestic mild cognitive impairment, multiple-domain (15 female; age: 75 +/- 8 yrs.) and forty-one healthy volunteers (24 female; age 71 +/- 6 yrs.) participated. All participants completed a human portrait memory test presenting unfamiliar faces with happy and angry emotional expressions. Five and thirty minutes later, old and new neutral faces were presented, and discrimination sensitivity (d') and response bias (C) were assessed as signal detection parameters of cued facial identity recognition. Memory performance was lower in amnestic mild cognitive impairment as compared to control subjects, mainly because of an altered response bias towards an increased false alarm rate (favoring false OLD ascription of NEW items). In both groups, memory performance declined between the early and later testing session, and was always better for acquired happy than angry faces. Facial identity memory is impaired in patients with amnestic mild cognitive impairment. Liberalization of the response bias may reflect a socially motivated compensatory mechanism maintaining an almost identical recognition hit rate of OLD faces in individuals with amnestic mild cognitive impairment.	[Savaskan, Egemen; Summermatter, Daniel; Schroeder, Clemens] Univ Hosp Psychiat, Dept Geriatr Psychiat, Zurich, Switzerland; [Schaechinger, Hartmut] Univ Trier, Inst Psychobiol, Div Clin Psychophysiol, Trier, Germany	Universitat Trier	Savaskan, E (corresponding author), Univ Hosp Psychiat, Dept Geriatr Psychiat, Zurich, Switzerland.	egemen.savaskan@puk.zh.ch			University Hospital of Psychiatry, University of Zurich	University Hospital of Psychiatry, University of Zurich	The research project was supported by the University Hospital of Psychiatry, University of Zurich.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; Bora E, 2017, J GERIATR PSYCH NEUR, V30, P206, DOI 10.1177/0891988717710337; Brueckner K, 2009, J INT NEUROPSYCH SOC, V15, P268, DOI 10.1017/S135561770909047X; D'Argembeau A, 2011, EMOTION, V11, P199, DOI 10.1037/a0022592; Dohnel K, 2008, NEUROPSYCHOLOGIA, V46, P37, DOI 10.1016/j.neuropsychologia.2007.08.012; Feldman HH, 2005, AM J GERIAT PSYCHIAT, V13, P645, DOI 10.1176/appi.ajgp.13.8.645; Langa KM, 2014, JAMA-J AM MED ASSOC, V312, P2551, DOI 10.1001/jama.2014.13806; McCade D, 2013, PSYCHOL AGING, V28, P840, DOI 10.1037/a0033077; McCade D, 2013, J GERIATR PSYCH NEUR, V26, P165, DOI 10.1177/0891988713491832; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Pernigo S, 2015, BEHAV BRAIN RES, V294, P111, DOI 10.1016/j.bbr.2015.07.047; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Petersen RC, 1999, ARCH NEUROL-CHICAGO, V56, P303, DOI 10.1001/archneur.56.3.303; Savaskan E, 2008, INT J NEUROPSYCHOPH, V11, P381, DOI 10.1017/S1461145707007997; Savaskan E, 2007, PSYCHOGERIATRICS, V7, P49, DOI 10.1111/j.1479-8301.2007.00179.x; Schefter M, 2013, AGING NEUROPSYCHOL C, V20, P49, DOI 10.1080/13825585.2012.665021; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Stanislaw H, 1999, BEHAV RES METH INS C, V31, P137, DOI 10.3758/BF03207704; Teng E, 2007, DEMENT GERIATR COGN, V23, P271, DOI 10.1159/000100829; Tierney MC, 1996, NEUROLOGY, V46, P661, DOI 10.1212/WNL.46.3.661; Weiss EM, 2008, AM J GERIAT PSYCHIAT, V16, P974, DOI 10.1097/JGP.0b013e318186bd53; Werheid K, 2010, PSYCHOL AGING, V25, P1, DOI 10.1037/a0018358; Wickens Thomas D., 2002, ELEMENTARY SIGNAL DE; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x; Yang LL, 2015, NEUROPSYCH DIS TREAT, V11, P1973, DOI 10.2147/NDT.S85169; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195693	10.1371/journal.pone.0195693	http://dx.doi.org/10.1371/journal.pone.0195693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672553	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800035
J	Vaidya, G; Lepage, D; Guralnick, R				Vaidya, Gaurav; Lepage, Denis; Guralnick, Robert			The tempo and mode of the taxonomic correction process: How taxonomists have corrected and recorrected North American bird species over the last 127 years	PLOS ONE			English	Article							ORNITHOLOGISTS UNION CHECKLIST; SUPPLEMENT; INFLATION; PROGRESS; NUMBERS; RATES	While studies of taxonomy usually focus on species description, there is also a taxonomic correction process that retests and updates existing species circumscriptions on the basis of new evidence. These corrections may themselves be subsequently retested and recorrected. We studied this correction process by using the Check-List of North and Middle American Birds, a well-known taxonomic checklist that spans 130 years. We identified 142 lumps and 95 splits across sixty-three versions of the Check-List and found that while lumping rates have markedly decreased since the 1970s, splitting rates are accelerating. We found that 74% of North American bird species recognized today have never been corrected (i.e., lumped or split) over the period of the checklist, while 16% have been corrected exactly once and 10% have been corrected twice or more. Since North American bird species are known to have been extensively lumped in the first half of the 20th century with the advent of the biological species concept, we determined whether most splits seen today were the result of those lumps being recorrected. We found that 5% of lumps and 23% of splits fully reverted previous corrections, while a further 3% of lumps and 13% of splits are partial reversions. These results show a taxonomic correction process with moderate levels of recorrection, particularly of previous lumps. However, 81% of corrections do not revert any previous corrections, suggesting that the majority result in novel circumscriptions not previously recognized by the Check-List. We could find no order or family with a significantly higher rate of correction than any other, but twenty-two genera as currently recognized by the AOU do have significantly higher rates than others. Given the currently accelerating rate of splitting, prediction of the end-point of the taxonomic recorrection process is difficult, and many entirely new taxonomic concepts are still being, and likely will continue to be, proposed and further tested.	[Vaidya, Gaurav] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Lepage, Denis] Bird Studies Canada, Port Rowan, ON, Canada; [Guralnick, Robert] Univ Florida, Dept Nat Hist, Gainesville, FL USA; [Guralnick, Robert] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Vaidya, G (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	gaurav@ggvaidya.com	Vaidya, Gaurav/E-9766-2010	Vaidya, Gaurav/0000-0003-0587-0454	National Evolutionary Synthesis Center (NESCent, NSF) [EF-0905606]	National Evolutionary Synthesis Center (NESCent, NSF)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	GV's initial work on this project was funded by a graduate fellowship at the National Evolutionary Synthesis Center (NESCent, NSF #EF-0905606) under the supervision of Hilmar Lapp. Some of the very early planning and design of this project was carried out there, but NESCent had no later role in any aspect of this work. No other authors received specific funding for this work.	Agapow PM, 2004, Q REV BIOL, V79, P161, DOI 10.1086/383542; Aldrich J. W., 1946, Wilson Bulletin Ann Arbor, V58, P94; Alroy J, 2002, P NATL ACAD SCI USA, V99, P3706, DOI 10.1073/pnas.062691099; American Ornithologists Union, 1998, CHECK LIST N AM BIRD, V7th; American Ornithologists' Union, 1998, COMM CLASS NOM CHECK; American Ornithologists' Union, 1931, CHECK LIST N AM BIRD, DOI [10.5962/bhl.title.6394, DOI 10.5962/BHL.TITLE.6394]; American Ornithologists' Union, 1983, CHECKL N AM BIRDS, DOI [10.5962/bhl.title.50892, DOI 10.5962/BHL.TITLE.50892]; American Ornithologists' Union (aou), 1976, AUK, V93, P875; AOU Committee, 1923, Auk Lancaster Pa, V40, P513; Audubon John James, 1834, ORNITHOLOGICAL BIOGR, V2, DOI [10.5962/bhl.title.48976, DOI 10.5962/BHL.TITLE.48976]; Banks RC, 2004, AUK, V121, P985, DOI 10.1642/0004-8038(2004)121[0985:FSTTAO]2.0.CO;2; Barrowclough GF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166307; Bebber DP, 2007, P R SOC B, V274, P1651, DOI 10.1098/rspb.2007.0464; California Academy of Sciences, 2017, INATURALIST; Catesby Mark, 1771, NATURAL HIST CAROLIN; Chen M., 2014, CORR, P1; Chesser RT, 2016, AUK, V133, P544, DOI 10.1642/AUK-16-77.1; Chesser RT, 2015, AUK, V132, P748, DOI 10.1642/AUK-15-73.1; Chesser RT, 2013, AUK, V130, P558, DOI 10.1525/auk.2013.130.3.1; Chesser RT, 2011, AUK, V128, P600, DOI 10.1525/auk.2011.128.3.600; Chesser RT, 2014, AUK, V131, pCSi, DOI [10.1642/AUK-14-124.1, DOI 10.1642/AUK-14-124.1]; Costello MJ, 2013, SYST BIOL, V62, P616, DOI 10.1093/sysbio/syt024; Costello MJ, 2012, SYST BIOL, V61, P871, DOI 10.1093/sysbio/syr080; Cracraft J., 1983, Current Ornithology, V1, P159; Cui H, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1352-7; EISENMANN E, 1973, AUK, V90, P411; Eisenmann E., 1982, AUK, V99, p1CC; Franz NM, 2009, SYST BIODIVERS, V7, P5, DOI 10.1017/S147720000800282X; Franz NM, 2008, SYST ASSOC SPEC VOL, V76, P63; Franz NM, 2016, SYST BIOL, V65, P561, DOI 10.1093/sysbio/syw023; Gill FB, 2014, AUK, V131, P150, DOI 10.1642/AUK-13-206.1; Grinnell J., 1935, CONDOR, V37, P90, DOI [10.2307/1363882, DOI 10.2307/1363882]; Groves CP, 2014, ANNU REV ANTHROPOL, V43, P27, DOI 10.1146/annurev-anthro-102313-030232; Heller R, 2013, SYST BIOL, V62, P490, DOI 10.1093/sysbio/syt004; IISE, 2011, RETR SOS 2000 2009 D; Isaac NJB, 2004, TRENDS ECOL EVOL, V19, P464, DOI 10.1016/j.tree.2004.06.004; Johnson NK, 1999, P INT ORN C, P1470; Joppa LN, 2011, TRENDS ECOL EVOL, V26, P551, DOI 10.1016/j.tree.2011.07.010; Laurenne N, 2014, J BIOMED SEMANT, V5, DOI 10.1186/2041-1480-5-40; Lepage D., 2015, BIRD STUDIES CANADA; Lepage D, 2014, ZOOKEYS, P117, DOI 10.3897/zookeys.420.7089; Mayr E, 1942, SYSTEMATICS ORIGIN S; McNEILL J., 2012, INT CODE NOMENCLATUR; Miller JA, 2015, BIODIVERS DATA J, V3, DOI 10.3897/BDJ.3.e5063; Mitchell KJ, 2014, SCIENCE, V344, P898, DOI 10.1126/science.1251981; National Audubon Society, 2017, AUD BIRD GUID APP; OLSON SL, 1987, AUK, V104, P538, DOI 10.2307/4087560; Padial JM, 2006, SYST BIOL, V55, P859, DOI 10.1080/1063515060081588; Page RDM, 2013, PEERJ, V1, DOI 10.7717/peerj.190; Remsen D, 2016, ZOOKEYS, P207, DOI 10.3897/zookeys.550.9546; Remsen JV, 2015, J FIELD ORNITHOL, V86, DOI 10.1111/jofo.12102; Ride W. D. L., 1999, INT CODE ZOOLOGICAL; Ridgway R., 1923, AUK, V40, P375; RISING JD, 1972, SYST ZOOL, V21, P438, DOI 10.2307/2412436; Sangster G, 2015, SYST BIOL, V64, P144, DOI 10.1093/sysbio/syu069; Sangster G, 2014, BIOL REV, V89, P199, DOI 10.1111/brv.12051; Sangster G, 2009, P ROY SOC B-BIOL SCI, V276, P3185, DOI 10.1098/rspb.2009.0582; Schulenberg TS, 2014, UPDATING EBIRD CLEME; Sibley D., 2012, NAME CHANGES BIRDS 2; Sluys R, 2013, BIODIVERS CONSERV, V22, P1095, DOI 10.1007/s10531-013-0472-x; Stan Development Team, 2017, RSTAN R INT STAN; STONE WITMER, 1935, AUK, V52, P31; Swainson W, 1831, BIRDS FAUNA BOREAL 2, DOI [10.5962/bhl.title.63874, DOI 10.5962/BHL.TITLE.63874]; Swarth H. S., 1931, Condor Berkeley, V33, P160, DOI 10.2307/1363682; Swick N., 2016, 2016 AOU CHECK LIS 1; Tancoigne E, 2013, CLADISTICS, V29, P567, DOI 10.1111/cla.12019; Taxonomic Names and Concepts interest group, 2006, TAX CONC TRANSF SCHE; The American Ornithologists' Union, 2017, COMM CLASS NOM N MID; Weakley AS, 2015, FLORA SO MIDATLANTIC; Wetmore A, 1944, AUK, V63, P428	70	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195736	10.1371/journal.pone.0195736	http://dx.doi.org/10.1371/journal.pone.0195736			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672539	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800041
J	Makunts, T; Cohen, IV; Lee, KC; Abagyan, R				Makunts, Tigran; Cohen, Isaac V.; Lee, Kelly C.; Abagyan, Ruben			Population scale retrospective analysis reveals distinctive antidepressant and anxiolytic effects of diclofenac, ketoprofen and naproxen in patients with pain	PLOS ONE			English	Article							TO-MODERATE DEPRESSION; CANCER-PATIENTS; DOUBLE-BLIND; SODIUM; DRUGS; PHARMACOKINETICS; BIOAVAILABILITY	Currently approved monoamine modulating antidepressant and anxiolytic pharmaceutics fail in over one third of patients due to delayed and variable therapeutic effect, adverse reactions preceding the therapeutic action, and adherence issues. Even with adequate adherence to the regimen and tolerability, one third of the patients do not respond to any class of antidepressants. There is a strong correlation between treatment resistant depression and increase in inflammatory cytokines in plasma and cerebrospinal fluid. Furthermore, epidemiological studies suggest that depression and anxiety are commonly comorbid with pain and inflammation. While a link between pain, inflammation and depression has been suggested it remains unclear which anti-inflammatory treatment may be beneficial to patients with depression and anxiety due to pain. Here, we analyzed 430,783 FDA adverse effect reports of patients treated for pain to identify potential antidepressant and anxiolytic effects of various anti-inflammatory medications. Patients treated for depression or patients taking any known antidepressants were excluded. The odds ratio analysis of 139,072 NSAID reports revealed that ketoprofen was associated with decreased reports of depression by a factor of 2.32 (OR 0.43 and 95% Confidence Interval [0.31, 0.59]) and decreased reports of anxiety by a factor of 2.86 (OR 0.35 [0.22, 0.56]), diclofenac with decreased depression reports by a factor of 2.22 (OR 0.45 [0.40, 0.49]) and anxiety by a factor of 2.13 (OR 0.47 [0.41, 0.54]), while naproxen decreased depression reports by a factor of 1.92 (OR 0.52 [0.49, 0.57]) and anxiety by a factor of 1.23 (OR 0.81 [0.75, 0.88]). Other NSAIDs did not exhibit any noticeable antidepressant and/or anxiolytic effect.	[Makunts, Tigran; Cohen, Isaac V.; Lee, Kelly C.; Abagyan, Ruben] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Abagyan, R (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	ruben@ucsd.edu	Lee, Kelly/Q-9073-2018	Cohen, Isaac/0000-0003-1827-2429; Abagyan, Ruben/0000-0001-9309-2976; Makunts, Tigran/0000-0001-5536-1266; Lee, Kelly/0000-0002-1674-4210	USA NIH NIGMS (National Institutes of Health, National Institute of General Medical Sciences), of the United States National Institutes of Health [GM071872]	USA NIH NIGMS (National Institutes of Health, National Institute of General Medical Sciences), of the United States National Institutes of Health	This work was supported by the USA NIH NIGMS (National Institutes of Health, National Institute of General Medical Sciences), of the United States National Institutes of Health, grant number GM071872). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alatawi YM, 2017, EXPERT OPIN DRUG SAF, V16, P761, DOI 10.1080/14740338.2017.1323867; Alberich S, 2016, REV PSIQUIATR SALUD; Altman R, 2015, DRUGS, V75, P859, DOI 10.1007/s40265-015-0392-z; Andrade L, 2003, INT J METH PSYCH RES, V12, P3, DOI 10.1002/mpr.138; BANNWARTH B, 1989, BIOMED PHARMACOTHER, V43, P121, DOI 10.1016/0753-3322(89)90140-6; BANNWARTH B, 1988, EUR J CLIN PHARMACOL, V33, P643, DOI 10.1007/BF00542503; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Bromet E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-90; Bruce Travis O, 2008, Curr Psychiatry Rep, V10, P258, DOI 10.1007/s11920-008-0042-1; Cohen IV, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01590-x; De La Garza R, 2003, BRAIN RES, V977, P70, DOI 10.1016/S0006-8993(03)02757-4; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Ferguson JM, 2001, J CLIN PSYCHIAT, V62, P22; GAMST ON, 1984, INT J CLIN PHARM TH, V22, P99; Gold PW, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/581976; Husain MI, 2017, NEUROPSYCH DIS TREAT, V13, P1, DOI 10.2147/NDT.S115002; Jafarinia M, 2016, J AFFECT DISORDERS, V204, P1, DOI 10.1016/j.jad.2016.05.076; Kohler O, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.338; Leo Raphael J, 2005, Curr Treat Options Neurol, V7, P403, DOI 10.1007/s11940-005-0032-0; Maciejewski M, 2017, ELIFE, V6, DOI 10.7554/eLife.25818; Maes M, 1997, CYTOKINE, V9, P853, DOI 10.1006/cyto.1997.0238; Marzo A, 2000, ARZNEIMITTEL-FORSCH, V50, P43; Mohammadinejad P, 2015, ANN PHARMACOTHER, V49, P953, DOI 10.1177/1060028015592215; Muller N, 2008, CURR PHARM DESIGN, V14, P1452, DOI 10.2174/138161208784480243; Musselman DL, 2001, AM J PSYCHIAT, V158, P1252, DOI 10.1176/appi.ajp.158.8.1252; Novakova I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086806; O'Brien SM, 2007, J PSYCHIAT RES, V41, P326, DOI 10.1016/j.jpsychires.2006.05.013; Rahola JG, 2012, CURR NEUROPHARMACOL, V10, P139, DOI 10.2174/157015912800604533; Rosenblat JD, 2016, BIPOLAR DISORD, V18, P89, DOI 10.1111/bdi.12373; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sansone Randy A, 2012, Innov Clin Neurosci, V9, P41; Savitz J, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000643; SEVELIUS H, 1980, BRIT J CLIN PHARMACO, V10, P259, DOI 10.1111/j.1365-2125.1980.tb01753.x	34	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195521	10.1371/journal.pone.0195521	http://dx.doi.org/10.1371/journal.pone.0195521			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668764	gold, Green Published			2022-12-26	WOS:000430290200045
J	Raine, A; Liljedahl, U; Nordlund, J				Raine, Amanda; Liljedahl, Ulrike; Nordlund, Jessica			Data quality of whole genome bisulfite sequencing on Illumina platforms	PLOS ONE			English	Article							DNA METHYLATION; SITES	The powerful HiSeq X sequencers with their patterned flowcell technology and fast turnaround times are instrumental for many large-scale genomic and epigenomic studies. However, assessment of DNA methylation by sodium bisulfite treatment results in sequencing libraries of low diversity, which may impact data quality and yield. In this report we assess the quality of WGBS data generated on the HiSeq X system in comparison with data generated on the HiSeq 2500 system and the newly released NovaSeq system. We report a systematic issue with low basecall quality scores assigned to guanines in the second read of WGBS when using certain Real Time Analysis (RTA) software versions on the HiSeq X sequencer, reminiscent of an issue that was previously reported with certain HiSeq 2500 software versions. However, with the HD.3.4.0 /RTA 2.7.7 software upgrade for the HiSeq X system, we observed an overall improved quality and yield of the WGBS data generated, which in turn empowers cost-effective and high quality DNA methylation studies.	[Raine, Amanda; Liljedahl, Ulrike; Nordlund, Jessica] Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden	Uppsala University	Raine, A; Nordlund, J (corresponding author), Uppsala Univ, Dept Med Sci, Mol Med & Sci Life Lab, Uppsala, Sweden.	Amanda.Raine@medsci.uu.se; Jessica.Nordlund@medsciu.uu.se	Raine, Amanda/L-1354-2019	Raine, Amanda/0000-0002-2775-6516; Nordlund, Jessica/0000-0001-8699-9959	Swedish Council for Research Infrastructures and Science for Life Laboratory	Swedish Council for Research Infrastructures and Science for Life Laboratory	Sequencing was performed at the SNP&SEQ Technology Platform in Uppsala, which is part of the National Genomics Infrastructure (NGI) funded by the Swedish Council for Research Infrastructures and Science for Life Laboratory. Computational analysis was performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) through the Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX).	Ewels Philip, 2016, F1000Res, V5, P2824, DOI 10.12688/f1000research.10335.2; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Illumina, 2014, LOW DIV SEQ ILL HISE; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Krueger F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016607; Kunze S, 2018, METHODS MOL BIOL, V1708, P515, DOI 10.1007/978-1-4939-7481-8_26; Mitra A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120520; Miura F, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks454; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Raine A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw1110; ROSENFELD C, 1977, EUR J CANCER, V13, P377, DOI 10.1016/0014-2964(77)90085-8; Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184; Toh H, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3392-9	16	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195972	10.1371/journal.pone.0195972	http://dx.doi.org/10.1371/journal.pone.0195972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668744	Green Submitted, gold, Green Published			2022-12-26	WOS:000430290200071
J	Sanchez-Dalmau, B; Martinez-Lapiscina, EH; Pulido-Valdeolivas, I; Zubizarreta, I; Llufriu, S; Blanco, Y; Sola-Valls, N; Sepulveda, M; Guerrero, A; Alba, S; Andorra, M; Camos, A; Sanchez-Vela, L; Alfonso, V; Saiz, A; Villoslada, P				Sanchez-Dalmau, Bernardo; Martinez-Lapiscina, Elena H.; Pulido-Valdeolivas, Irene; Zubizarreta, Irati; Llufriu, Sara; Blanco, Yolanda; Sola-Valls, Nuria; Sepulveda, Maria; Guerrero, Ana; Alba, Salut; Andorra, Magi; Camos, Anna; Sanchez-Vela, Laura; Alfonso, Veronica; Saiz, Albert; Villoslada, Pablo			Predictors of vision impairment in Multiple Sclerosis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; COLOR-VISION; VISUAL PATHWAY; DISABILITY; MS; RECOMMENDATIONS; NEURITIS; COHORT	Visual impairment significantly alters the quality of life of people with Multiple Sclerosis (MS). The objective of this study was to identify predictors (independent variables) of visual outcomes, and to define their relationship with neurological disability and retinal atrophy when assessed by optical coherence tomography (OCT). We performed a cross-sectional analysis of 119 consecutive patients with MS, assessing vision using high contrast visual acuity (Log-Mar), 2.5% and 1.25% low contrast visual acuity (Sloan charts), and color vision (Hardy-Rand-Rittler plates). Quality of vision is a patient reported outcome based on an individual's unique perception of his or her vision and was assessed with the Visual Functioning Questionnaire- 25 (VFQ-25) with the 10 neuro-ophthalmologic items. MS disability was assessed using the expanded disability status scale (EDSS), the MS functional composite (MSFC) and the brief repetitive battery-neuropsychology (BRB-N). Retinal atrophy was assessed using spectral domain OCT, measuring the thickness of the peripapillar retinal nerve fiber layer (pRNFL) and the volume of the ganglion cell plus inner plexiform layer (GCIPL). The vision of patients with MS was impaired, particularly in eyes with prior optic neuritis. Retinal atrophy (pRNFL and GCIPL) was closely associated with impaired low contrast vision and color vision, whereas the volume of the GCIPL showed a trend (p = 0.092) to be associated with quality of vision. Multiple regression analysis revealed that EDSS was an explanatory variable for high contrast vision after stepwise analysis, GCIPL volume for low contrast vision, and GCIPL volume and EDSS for color vision. The explanatory variables for quality of vision were high contrast vision and color vision. In summary, quality of vision in MS depends on the impairment of high contrast visual acuity and color vision due to the disease.	[Sanchez-Dalmau, Bernardo; Camos, Anna] Hosp Clin Barcelona, Dept Ophthalmol, Barcelona, Spain; [Martinez-Lapiscina, Elena H.; Pulido-Valdeolivas, Irene; Zubizarreta, Irati; Llufriu, Sara; Blanco, Yolanda; Sola-Valls, Nuria; Sepulveda, Maria; Guerrero, Ana; Alba, Salut; Andorra, Magi; Sanchez-Vela, Laura; Saiz, Albert; Villoslada, Pablo] Univ Barcelona, Dept Neurol, Barcelona, Spain; [Martinez-Lapiscina, Elena H.; Pulido-Valdeolivas, Irene; Zubizarreta, Irati; Llufriu, Sara; Blanco, Yolanda; Sola-Valls, Nuria; Sepulveda, Maria; Guerrero, Ana; Alba, Salut; Andorra, Magi; Sanchez-Vela, Laura; Saiz, Albert; Villoslada, Pablo] Univ Barcelona, IDIBAPS, Barcelona, Spain; [Alfonso, Veronica] Trial Form Support, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Villoslada, P (corresponding author), Univ Barcelona, Dept Neurol, Barcelona, Spain.; Villoslada, P (corresponding author), Univ Barcelona, IDIBAPS, Barcelona, Spain.	pvilloslada@clinic.ub.es	Villoslada, Pablo/AAF-9547-2019; Llufriu, Sara/T-6761-2019; Martinez-Lapiscina, Elena H/L-1161-2014; Llufriu, Sara/K-2987-2014; Andorra, Magi/D-8726-2015	Martinez-Lapiscina, Elena H/0000-0003-4272-0826; Sanchez-Dalmau, Bernardo F./0000-0001-8950-9759; Llufriu, Sara/0000-0003-4273-9121; Zubizarreta Nafarrate, Irati/0000-0001-7637-7830; Andorra, Magi/0000-0002-0491-3144; PULIDO-VALDEOLIVAS, IRENE/0000-0003-0188-2458	Institute de Salud Carlos III; FEDER funds ("Otra forma de hacer Europa") from the European Commission [PI15/0061, PI15/00587]; Spanish MS Network [REEM: RD16/0015/0002, RD16/0015/0003]; CERCA Programme / Generalitat de Catalunya; TFS	Institute de Salud Carlos III(Instituto de Salud Carlos III); FEDER funds ("Otra forma de hacer Europa") from the European Commission; Spanish MS Network; CERCA Programme / Generalitat de Catalunya; TFS	This work was supported by the Institute de Salud Carlos III with FEDER funds ("Otra forma de hacer Europa") from the European Commission (PI15/0061, to PV; PI15/00587 to SL and AS), the Spanish MS Network (REEM: RD16/0015/0002 to AS; and RD16/0015/0003 to PV), and CERCA Programme / Generalitat de Catalunya. VA is an employee of Trial Form Support (TFS) and she was in charge of the statistical analysis. TFS provided support in the form of salaries for authors [VA], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. The corresponding author has full access to data and analysis.	Balcer LJ, 2017, MULT SCLER J, V23, P734, DOI 10.1177/1352458517690822; Balcer LJ, 2015, BRAIN, V138, P11, DOI 10.1093/brain/awu335; Balcer LJ, 2000, MULT SCLER J, V6, P163, DOI 10.1191/135245800701566025; Balk LJ, 2018, MULT SCLER J, V24, P767, DOI 10.1177/1352458517708463; Cole BL, 2006, CLIN EXP OPTOM, V89, P73, DOI 10.1111/j.1444-0938.2006.00015.x; Costello F, 2016, SEMIN NEUROL, V36, P185, DOI 10.1055/s-0036-1579692; Cruz-Herranz A, 2016, NEUROLOGY, V86, P2303, DOI 10.1212/WNL.0000000000002774; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gabilondo I, 2014, ANN NEUROL, V75, P98, DOI 10.1002/ana.24030; GALETTA SL, 2015, NEUR R NEUR NEUR, V2, DOI DOI 10.1212/NXI.0000000000000135; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Jasse L, 2013, MULT SCLER J, V19, P1618, DOI 10.1177/1352458513479840; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Lampert EJ, 2015, J NEUROL, V262, P2491, DOI 10.1007/s00415-015-7876-3; Longbrake EE, 2016, MULT SCLER RELAT DIS, V10, P198, DOI 10.1016/j.msard.2016.10.009; Ma SL, 2002, AM J OPHTHALMOL, V133, P686, DOI 10.1016/S0002-9394(02)01337-5; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; Martinez-Lapiscina Elena H, 2014, BMC Res Notes, V7, P910, DOI 10.1186/1756-0500-7-910; Martinez-Lapiscina EH, 2014, MULT SCLER J, V20, P1207, DOI 10.1177/1352458513517591; Owidzka M, 2014, GRAEF ARCH CLIN EXP, V252, P673, DOI 10.1007/s00417-014-2590-x; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Raphael BA, 2006, AM J OPHTHALMOL, V142, P1026, DOI 10.1016/j.ajo.2006.06.060; Rudick R, 1997, ANN NEUROL, V42, P379, DOI 10.1002/ana.410420318; Salter AR, 2013, MULT SCLER J, V19, P953, DOI 10.1177/1352458512469694; Sanchez-Dalmau B, 2018, MULT SCLER J, V24, P1196, DOI 10.1177/1352458517718628; Schinzel J, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-31; Sepulcre J, 2006, MULT SCLER J, V12, P187, DOI 10.1191/1352458506ms1258oa; Tewarie P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034823; Villoslada P, 2012, MULT SCLER J, V18, P991, DOI 10.1177/1352458511431972; Walter SD, 2012, OPHTHALMOLOGY, V119, P1250, DOI 10.1016/j.ophtha.2011.11.032	30	14	14	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195856	10.1371/journal.pone.0195856	http://dx.doi.org/10.1371/journal.pone.0195856			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664921	Green Published, gold, Green Submitted			2022-12-26	WOS:000430262300038
J	Hoffmann, B; Gruat-Henry, C; Mulinti, P; Jiang, L; Brooks, BD; Brooks, AE				Hoffmann, Bradley; Gruat-Henry, Catherine; Mulinti, Pranothi; Jiang, Long; Brooks, Benjamin D.; Brooks, Amanda E.			Using hydrodynamic focusing to predictably alter the diameter of synthetic silk fibers	PLOS ONE			English	Article							MAJOR AMPULLATE SILK; SPIDER SILK; MECHANICAL-PROPERTIES; AQUEOUS-SOLUTIONS; ARGIOPE-AURANTIA; TERMINAL DOMAIN; FIBROIN; PROTEINS; SEQUENCE; BIOMATERIALS	Spiders and silkworms provide a model of superior processing for multifunctional and highly versatile high-performance fibers. Mimicking the spider's complex control system for chemical and mechanical gradients has remained an ongoing obstacle for synthetic silk production. In this study, the use of hydrodynamic fluid focusing within a 3D printed biomimetic spinning system to recapitulate the biological spinneret is explored and shown to produce predictable, small diameter fibers. Mirroring in silico fluid flow simulations using a hydrodynamic microfluidic spinning technique, we have developed a model correlating spinning rates, solution viscosity and fiber diameter outputs that will significantly advance the field of synthetic silk fiber production. The use of hydrodynamic focusing to produce controlled output fiber diameter simulates the natural silk spinning process and continues to build upon a 3D printed biomimetic spinning platform.	[Hoffmann, Bradley; Jiang, Long] North Dakota State Univ, Dept Mech Engn, Fargo, ND USA; [Gruat-Henry, Catherine; Brooks, Benjamin D.] North Dakota State Univ, Dept Elect Engn, Fargo, ND USA; [Mulinti, Pranothi; Brooks, Amanda E.] North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA	North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo	Brooks, AE (corresponding author), North Dakota State Univ, Dept Pharmaceut Sci, Fargo, ND 58105 USA.	Amanda.e.brooks@ndsu.edu	Mulinti, Pranothi/GLT-9446-2022	Hoffmann, Bradley/0000-0002-3855-5939	North Dakota State University Department of Mechanical Engineering; North Dakota NASA Experimental Program Stimulate Competitive Research; North Dakota Department of Commerce Phase 1 Venture grant; National Science Foundation [1746111]; North Dakota State University Department of Mechanical Engineering, ND NASA EPSCoR	North Dakota State University Department of Mechanical Engineering; North Dakota NASA Experimental Program Stimulate Competitive Research; North Dakota Department of Commerce Phase 1 Venture grant; National Science Foundation(National Science Foundation (NSF)); North Dakota State University Department of Mechanical Engineering, ND NASA EPSCoR	This work was funded by North Dakota State University Department of Mechanical Engineering, North Dakota NASA Experimental Program Stimulate Competitive Research (http://ndnasaepscor.und.edu/), the North Dakota Department of Commerce Phase 1 Venture grant (https://www.commerce.nd.gov/research/Programs/), and the National Science Foundation (grant # 1746111) (https://www.nsf.gov/).; This work was funded by North Dakota State University Department of Mechanical Engineering, ND NASA EPSCoR, the North Dakota Department of Commerce Phase 1 Venture grant and the National Science Foundation (grant # 1746111).	Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Andersson M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081290; [Anonymous], 1980, VISCOELASTIC PROPERT; Brooks AE, 2007, J APPL BIOMATER BIOM, V5, P158; Brooks AE, 2005, BIOMACROMOLECULES, V6, P3095, DOI 10.1021/bm050421e; Brooks AE, 2008, BIOMACROMOLECULES, V9, P1506, DOI 10.1021/bm701124p; Brooks Amanda E., 2005, V41, P1; Creager MS, 2010, BIOMACROMOLECULES, V11, P2039, DOI 10.1021/bm100399x; Cubaud T, 2008, PHYS FLUIDS, V20, DOI 10.1063/1.2911716; Doblhofer E, 2015, APPL MICROBIOL BIOT, V99, P9361, DOI 10.1007/s00253-015-6948-8; Ebrahimi D, 2015, ACS BIOMATER SCI ENG, V1, P864, DOI 10.1021/acsbiomaterials.5b00152; Eisoldt L, 2012, BIOPOLYMERS, V97, P355, DOI 10.1002/bip.22006; Eisoldt L, 2011, MATER TODAY, V14, P80, DOI 10.1016/S1369-7021(11)70057-8; Gaines WA, 2010, J BIOL CHEM, V285, P40745, DOI 10.1074/jbc.M110.163121; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hoffmann B, 2016, BIOMED SCI INSTRUM, V52; Hoffmann B, 2017, BIOMED SCI INSTRUM, V53; Holland C, 2006, NAT MATER, V5, P870, DOI 10.1038/nmat1762; Ittah S, 2006, BIOMACROMOLECULES, V7, P1790, DOI 10.1021/bm060120k; Kang E, 2011, NAT MATER, V10, P877, DOI [10.1038/NMAT3108, 10.1038/nmat3108]; Kinahan ME, 2011, BIOMACROMOLECULES, V12, P1504, DOI 10.1021/bm1014624; Lee GB, 2006, J MICROMECH MICROENG, V16, P1024, DOI 10.1088/0960-1317/16/5/020; Lewis RV, 2006, CHEM REV, V106, P3762, DOI 10.1021/cr010194g; Luo J, 2014, INT J BIOL MACROMOL, V66, P319, DOI 10.1016/j.ijbiomac.2014.02.049; Madurga R, 2017, EUR POLYM J, V97, P26, DOI 10.1016/j.eurpolymj.2017.09.037; Madurga R, 2017, GREEN CHEM, V19, P3380, DOI 10.1039/c7gc01254c; Malay AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27573; Min BM, 2004, BIOMATERIALS, V25, P1289, DOI 10.1016/j.biomaterials.2003.08.045; Parkhe AD, 1997, J MOL RECOGNIT, V10, P1, DOI 10.1002/(SICI)1099-1352(199701/02)10:1<1::AID-JMR338>3.0.CO;2-7; Perez-Rigueiro J, 1998, J APPL POLYM SCI, V70, P2439, DOI 10.1002/(SICI)1097-4628(19981219)70:12<2439::AID-APP16>3.0.CO;2-J; Perez-Rigueiro J, 2000, J APPL POLYM SCI, V75, P1270, DOI 10.1002/(SICI)1097-4628(20000307)75:10<1270::AID-APP8>3.3.CO;2-3; Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/nchembio.1789, 10.1038/NCHEMBIO.1789]; Sampath S, 2015, RSC ADV, V5, P1462, DOI 10.1039/c4ra13936d; Slotta U, 2012, CHEM ENG PROG, V108, P43; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Tokareva O, 2014, ACTA BIOMATER, V10, P1612, DOI 10.1016/j.actbio.2013.08.020; Tow KH, 2015, 146401 ESA EPFL; Vollrath F, 2000, J Biotechnol, V74, P67; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P81, DOI 10.1016/S0141-8130(98)00076-2; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wei W, 2011, J MATER RES, V26, P1100, DOI 10.1557/jmr.2011.47; Yan JP, 2010, BIOMACROMOLECULES, V11, P1, DOI 10.1021/bm900840h; Zhou GQ, 2009, ADV MATER, V21, P366, DOI 10.1002/adma.200800582; Zhu JX, 2008, POLYMER, V49, P2880, DOI 10.1016/j.polymer.2008.04.049	45	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195522	10.1371/journal.pone.0195522	http://dx.doi.org/10.1371/journal.pone.0195522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649239	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900051
J	Karjalainen, M; Kontunen, A; Saari, S; Ronkko, T; Lekkala, J; Roine, A; Oksala, N				Karjalainen, Markus; Kontunen, Anton; Saari, Sampo; Ronkko, Topi; Lekkala, Jukka; Roine, Antti; Oksala, Niku			The characterization of surgical smoke from various tissues and its implications for occupational safety	PLOS ONE			English	Article							OPERATING-ROOM; PARTICULATE MATTER; AIR-POLLUTION; TERM EXPOSURE; STROKE; RISK; CLEARANCE; PARTICLE; PLUME; LUNG	Electrosurgery produces surgical smoke. Different tissues produce different quantities and types of smoke, so we studied the particle characteristics of this surgical smoke in order to analyze the implications for the occupational health of the operation room personnel. We estimated the deposition of particulate matter (PM) from surgical smoke on the respiratory tract of operation room personnel using clinically relevant tissues from Finnish landrace porcine tissues including skeletal muscle, liver, subcutaneous fat, renal pelvis, renal cortex, lung, bronchus, cerebral gray and white matter, and skin. In order to standardize the electro-surgical cuts and smoke concentrations, we built a customized computer-controlled platform. The smoke particles were analyzed with an electrical low pressure impactor (ELPI), which measures the concentration and aerodynamic size distribution of particles with a diameter between 7 nm and 10 mu m. There were significant differences in the mass concentration and size distribution of the surgical smoke particles depending on the electrocauterized tissue. Of the various tissues tested, liver yielded the highest number of particles. In order to better estimate the health hazard, we propose that the tissues can be divided into three distinct classes according to their surgical smoke production: 1) high-PM tissue for liver; 2) medium-PM tissues for renal cortex, renal pelvis, and skeletal muscle; and 3) low PM tissues for skin, gray matter, white matter, bronchus, and subcutaneous fat.	[Karjalainen, Markus; Kontunen, Anton; Lekkala, Jukka] Tampere Univ Technol, BioMediTech Inst, Tampere, Finland; [Karjalainen, Markus; Kontunen, Anton; Lekkala, Jukka] Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland; [Saari, Sampo; Ronkko, Topi] Tampere Univ Technol, Aerosol Phys, Fac Nat Sci, Tampere, Finland; [Roine, Antti] Hatanpaa Hosp, Dept Surg, Tampere, Finland; [Oksala, Niku] Univ Tampere, Div Vasc Surg, Tampere Univ Hosp, Tampere, Finland; [Oksala, Niku] Univ Tampere, Fac Med & Life Sci, Tampere, Finland	Tampere University; Tampere University; Tampere University; Tampere University; Tampere University Hospital; Tampere University	Karjalainen, M (corresponding author), Tampere Univ Technol, BioMediTech Inst, Tampere, Finland.; Karjalainen, M (corresponding author), Tampere Univ Technol, Fac Biomed Sci & Engn, Tampere, Finland.	markus.karjalainen@tut.fi	Roine, Antti/AAU-5071-2020; Lekkala, Jukka/G-4263-2014	Roine, Antti/0000-0002-1811-2671; Ronkko, Topi/0000-0002-1555-3367; Lekkala, Jukka/0000-0001-9293-2240; Kontunen, Anton/0000-0002-2220-1351	Finnish Foundation for Technology Promotion (TES); Tampereen Tuberkuloosisaatio (Tampere Tuberculosis Foundation); Emil Aaltonen foundation; Pirkanmaan sairaanhoitopiiri (PSHP) [9s045, 1511303, 9T044, 9U042, 150618, 9V044]	Finnish Foundation for Technology Promotion (TES); Tampereen Tuberkuloosisaatio (Tampere Tuberculosis Foundation); Emil Aaltonen foundation; Pirkanmaan sairaanhoitopiiri (PSHP)	This study was supported by grants from following foundations: Finnish Foundation for Technology Promotion (TES) to M.K., Tampereen Tuberkuloosisaatio (Tampere Tuberculosis Foundation), Emil Aaltonen foundation, and Pirkanmaan sairaanhoitopiiri (PSHP) grants 9s045, 1511303, 9T044, 9U042, 150618, and 9V044 to N. O., which were used partially for salaries for authors M.K. and A.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Olfactomics Ltd did not provide any funding for the study and did not play any role in the study design.	Beelen R, 2015, ENVIRON HEALTH PERSP, V123, P525, DOI 10.1289/ehp.1408095; Bellmann B, 1994, ANN OCCUP HYG     S1, V38, P303; Bruske-Hohlfeld Irene, 2008, J Occup Med Toxicol, V3, P31, DOI 10.1186/1745-6673-3-31; Capizzi PJ, 1998, LASER SURG MED, V23, P172, DOI 10.1002/(SICI)1096-9101(1998)23:3<172::AID-LSM7>3.0.CO;2-M; Charvet A, 2015, AEROSOL SCI TECH, V49, P1263, DOI 10.1080/02786826.2015.1117568; Choi SH, 2014, SURG ENDOSC, V28, P2374, DOI 10.1007/s00464-014-3472-3; Desikan A, 2016, STROKE, V47, P2916, DOI 10.1161/STROKEAHA.116.014242; Garden JM, 2002, ARCH DERMATOL, V138, P1303, DOI 10.1001/archderm.138.10.1303; Gates MA, 2007, SCAND J WORK ENV HEA, V33, P140, DOI 10.5271/sjweh.1117; Gonzalez-Bayon L, 2006, EJSO-EUR J SURG ONC, V32, P619, DOI 10.1016/j.ejso.2006.03.019; Hill DS, 2012, J PLAST RECONSTR AES, V65, P911, DOI 10.1016/j.bjps.2012.02.012; Hinds W.C., 2012, AEROSOL TECHNOLOGY P; Hinz KP, 2011, ANAL BIOANAL CHEM, V401, P3165, DOI 10.1007/s00216-011-5465-6; KESKINEN J, 1992, J AEROSOL SCI, V23, P353, DOI 10.1016/0021-8502(92)90004-F; Krones CJ, 2007, EUR SURG, V39, P118, DOI 10.1007/s10353-006-0305-1; Le Moual N, 2013, J OCCUP ENVIRON MED, V55, P973, DOI 10.1097/JOM.0b013e318297325b; LEHNERT BE, 1989, AM J RESP CELL MOL, V1, P145, DOI 10.1165/ajrcmb/1.2.145; Lin HL, 2017, STROKE, V48, P1191, DOI [10.1161/STROKEAHA.116.015739, 10.1161/strokeaha.116.015739]; Ljungman PL, 2014, STROKE, V45, P3734, DOI 10.1161/STROKEAHA.114.003130; Maheswaran R, 2005, STROKE, V36, P239, DOI 10.1161/01.STR.0000151363.71221.12; Maheswaran R, 2011, STROKE, P43; Marjamaki M, 2005, AEROSOL SCI TECH, V39, P575, DOI 10.1080/027868291009189; Massarweh NN, 2006, J AM COLL SURGEONS, V202, P520, DOI 10.1016/j.jamcollsurg.2005.11.017; Matsuo R, 2016, STROKE, V47, P3032, DOI 10.1161/STROKEAHA.116.015303; Munro MG, 2012, SAGES MANUAL ON THE FUNDAMENTAL USE OF SURGICAL ENERGY (FUSE), P15, DOI 10.1007/978-1-4614-2074-3_2; Oberg T, 2008, AM J INFECT CONTROL, V36, P276, DOI 10.1016/j.ajic.2007.07.008; Pillinger SH, 2003, BRIT J SURG, V90, P1068, DOI 10.1002/bjs.4214; Pirjola L, 2012, ATMOS ENVIRON, V63, P156, DOI 10.1016/j.atmosenv.2012.09.022; Saari S, 2016, ATMOS ENVIRON, V126, P136, DOI 10.1016/j.atmosenv.2015.11.047; Semmler M, 2004, INHAL TOXICOL, V16, P453, DOI 10.1080/08958370490439650; Spearman J, 2007, ANN ROY COLL SURG, V89, P162, DOI 10.1308/003588407X155752; Tokar JL, 2013, GASTROINTEST ENDOSC, V78, P197, DOI 10.1016/j.gie.2013.04.164; van den Elshout S, 2014, SCI TOTAL ENVIRON, V488, P463, DOI 10.1016/j.scitotenv.2013.10.060; Wake D, 1997, ANN OCCUP HYG, V41, P636, DOI DOI 10.1093/ANNHYG/41.INHALED_PARTICLES_VIII.636; Wang HK, 2015, INT UROL NEPHROL, V47, P1671, DOI 10.1007/s11255-015-1080-3; Wardoyo A., 2012, INT J ENG SCI, V1, P161; Yli-Ojanpera J, 2010, AEROSOL AIR QUAL RES, V10, P360, DOI 10.4209/aaqr.2009.10.0060	37	40	40	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195274	10.1371/journal.pone.0195274	http://dx.doi.org/10.1371/journal.pone.0195274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649244	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900036
J	Oyebamiji, OK; Wilkinson, DJ; Jayathilake, PG; Rushton, SP; Bridgens, B; Li, BW; Zuliani, P				Oyebamiji, Oluwole K.; Wilkinson, Darren J.; Jayathilake, Pahala Gedara; Rushton, Steve P.; Bridgens, Ben; Li, Bowen; Zuliani, Paolo			A Bayesian approach to modelling the impact of hydrodynamic shear stress on biofilm deformation	PLOS ONE			English	Article							PARTICLE-SIZE ANALYSIS; DETACHMENT; GROWTH	We investigate the feasibility of using a surrogate-based method to emulate the deformation and detachment behaviour of a biofilm in response to hydrodynamic shear stress. The influence of shear force, growth rate and viscoelastic parameters on the patterns of growth, structure and resulting shape of microbial biofilms was examined. We develop a statistical modelling approach to this problem, using combination of Bayesian Poisson regression and dynamic linear models for the emulation. We observe that the hydrodynamic shear force affects biofilm deformation in line with some literature. Sensitivity results also showed that the expected number of shear events, shear flow, yield coefficient for heterotrophic bacteria and extracellular polymeric substance (EPS) stiffness per unit EPS mass are the four principal mechanisms governing the bacteria detachment in this study. The sensitivity of the model parameters is temporally dynamic, emphasising the significance of conducting the sensitivity analysis across multiple time points. The surrogate models are shown to perform well, and produced 480 fold increase in computational efficiency. We conclude that a surrogate-based approach is effective, and resulting biofilm structure is determined primarily by a balance between bacteria growth, viscoelastic parameters and applied shear stress.	[Oyebamiji, Oluwole K.; Wilkinson, Darren J.] Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Jayathilake, Pahala Gedara; Bridgens, Ben] Newcastle Univ, Sch Engn, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Rushton, Steve P.] Newcastle Univ, Sch Nat & Environm Sci, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Li, Bowen; Zuliani, Paolo] Newcastle Univ, Sch Comp Sci, Newcastle Upon Tyne NE4 5TG, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK	Oyebamiji, OK (corresponding author), Newcastle Univ, Sch Math Stat & Phys, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England.	wolemi2@yahoo.com	Oyebamiji, Oluwole/ABF-8407-2020	Oyebamiji, Oluwole/0000-0002-6561-9459; Wilkinson, Darren James/0000-0003-0736-802X; Jayathilake, Pahala Gedara/0000-0001-7691-0949; Bridgens, Benjamin/0000-0002-9461-100X	EPSRC under the Newcastle University Frontiers in Engineering Biology (NUFEB) project [EP/K039083/1]; EPSRC [EP/K039083/1] Funding Source: UKRI	EPSRC under the Newcastle University Frontiers in Engineering Biology (NUFEB) project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was funded by the EPSRC (grant No EP/K039083/1) under the Newcastle University Frontiers in Engineering Biology (NUFEB) project.	Breyers JD., 1988, PHYSL MODELS MICROBI, V2, P109; CASELLA G, 1992, AM STAT, V46, P167, DOI 10.2307/2685208; Celler K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03649; Chan AB, 2009, IEEE I CONF COMP VIS, P545, DOI 10.1109/ICCV.2009.5459191; CHIB S, 1995, AM STAT, V49, P327, DOI 10.2307/2684568; Choi YC, 2003, WATER SCI TECHNOL, V47, P69, DOI 10.2166/wst.2003.0284; Doss H, 1994, TECHNICAL REPORT; Geyer CJ, 1991, MARKOV CHAIN MONTE C, P156; Head DA, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.032702; Jayathilake PG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01865; Jayathilake PG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181965; Kennedy MC, 2001, J R STAT SOC B, V63, P425, DOI 10.1111/1467-9868.00294; Kommedal R, 2003, MODELING PSEUDOMONAS, P3; Kreft JU, 1998, MICROBIOL-UK, V144, P3275, DOI 10.1099/00221287-144-12-3275; Li C, 2015, RSC ADV, V5, P79001, DOI 10.1039/c5ra11041f; Liu Y, 2002, WATER RES, V36, P1653, DOI 10.1016/S0043-1354(01)00379-7; Ma JM, 2006, TRANSPORT RES REC, P24, DOI 10.3141/1950-04; Martin A. D., 2005, MARKOV CHAIN MONTE C; Merkey BV, 2011, ENVIRON MICROBIOL, V13, P2435, DOI 10.1111/j.1462-2920.2011.02535.x; Ni BJ, 2009, WATER RES, V43, P1350, DOI 10.1016/j.watres.2008.12.004; Oakley JE, 2004, J R STAT SOC B, V66, P751, DOI 10.1111/j.1467-9868.2004.05304.x; Oyebamiji OK, 2017, J COMPUT SCI-NETH, V22, P69, DOI 10.1016/j.jocs.2017.08.006; Oyebamiji OK, 2015, STAT MODEL, V15, P499, DOI 10.1177/1471082X14568248; Paul E, 2012, WATER RES, V46, P5499, DOI 10.1016/j.watres.2012.07.029; Petris G, 2009, USE R, P31, DOI 10.1007/b135794_2; Picioreanu C, 2000, BIOTECHNOL BIOENG, V69, P504, DOI 10.1002/1097-0290(20000905)69:5<504::AID-BIT5>3.0.CO;2-S; Picioreanu C, 2001, BIOTECHNOL BIOENG, V72, P205; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; RITTMANN BE, 1992, WATER SCI TECHNOL, V26, P585, DOI 10.2166/wst.1992.0438; Saltelli A, 2002, COMPUT PHYS COMMUN, V145, P280, DOI 10.1016/S0010-4655(02)00280-1; Santner TJ, 2013, DESIGN ANAL COMPUTER; Schluter J, 2015, ISME J, V9, P139, DOI 10.1038/ismej.2014.174; Shi JQ, 2003, INT J ADAPT CONTROL, V17, P149, DOI 10.1002/acs.744; Stoodley P, 2002, J IND MICROBIOL BIOT, V29, P361, DOI 10.1038/sj.jim.7000282; Walter M, 2013, CHEM ENG J, V228, P1140, DOI 10.1016/j.cej.2013.05.071; Wanner O, 1996, BIOTECHNOL BIOENG, V49, P172; Wingender J., 1999, MICROBIAL EXTRACELLU, P1; Xavier JD, 2005, BIOTECHNOL BIOENG, V91, P651, DOI 10.1002/bit.20544; Young PC, 2011, TECHNOMETRICS, V53, P29, DOI 10.1198/TECH.2010.07151	39	10	10	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195484	10.1371/journal.pone.0195484	http://dx.doi.org/10.1371/journal.pone.0195484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649240	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900048
J	Rodger, YS; Greenbaum, G; Silver, M; Bar-David, S; Winters, G				Rodger, Yael S.; Greenbaum, Gili; Silver, Micha; Bar-David, Shirli; Winters, Gidon			Detecting hierarchical levels of connectivity in a population of Acacia tortilis at the northern edge of the species' global distribution: Combining classical population genetics and network analyses	PLOS ONE			English	Article							LARGE MAMMALIAN HERBIVORES; F-STATISTICS; CONSERVATION; DIVERSITY; NEGEV; CENTRALITY; DYNAMICS; LATITUDE; DESERT; NUMBER	Genetic diversity and structure of populations at the edge of the species' spatial distribution are important for potential adaptation to environmental changes and consequently, for the long-term survival of the species. Here, we combined classical population genetic methods with newly developed network analyses to gain complementary insights into the genetic structure and diversity of Acacia tortilis, a keystone desert tree, at the northern edge of its global distribution, where the population is under threat from climatic, ecological, and anthropogenic changes. We sampled A. tortilis from 14 sites along the Dead Sea region and the Arava Valley in Israel and in Jordan. In addition, we obtained samples from Egypt and Sudan, the hypothesized origin of the species. Samples from all sites were genotyped using six polymorphic microsatellite loci. Our results indicate a significant genetic structure in A. tortilis along the Arava Valley. This was detected at different hierarchical levels from the basic unit of the subpopulation, corresponding to groups of trees within ephemeral rivers (wadis), to groups of subpopulations (communities) that are genetically more connected relative to others. The latter structure mostly corresponds to the partition of the major drainage basins in the area. Network analyses, combined with classical methods, allowed for the identification of key A. tortilis subpopulations in this region, characterized by their relatively high level of genetic diversity and centrality in maintaining gene flow in the population. Characterizing such key subpopulations may enable conservation managers to focus their efforts on certain subpopulations that might be particularly important for the population's long-term persistence, thus contributing to species conservation within its peripheral range.	[Rodger, Yael S.; Bar-David, Shirli] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Mitrani Dept Desert Ecol, Midreshet Ben Gurion, Israel; [Rodger, Yael S.; Winters, Gidon] Tamar Reg Council, Dead Sea Arava Sci Ctr, Neve Zohar, Israel; [Greenbaum, Gili] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Silver, Micha] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, Remote Sensing Lab, Midreshet Ben Gurion, Israel	Ben Gurion University; Stanford University; Ben Gurion University	Winters, G (corresponding author), Tamar Reg Council, Dead Sea Arava Sci Ctr, Neve Zohar, Israel.	wintersg@adssc.org	Silver, Micha/AAD-5367-2019; BAR-DAVID, SHIRLI/F-1512-2012	Silver, Micha/0000-0002-1128-1325; BAR-DAVID, SHIRLI/0000-0001-8103-041X; Winters, Gidon/0000-0001-9997-2034; Rodger, Yael/0000-0003-4248-3058				Adgaba N, 2017, SAUDI J BIOL SCI, V24, P180, DOI 10.1016/j.sjbs.2016.05.002; Allendorf F., 2007, CONSERVATION GENETIC; Ashkenazi S., 1995, ACACIA TREES NEGEV A, pXVII; Avise J, 2004, MOL MARKERS NATURAL; Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; Channell R, 2000, NATURE, V403, P84, DOI 10.1038/47487; Charlesworth B., 1998, MOL BIOL EVOL; Cheng E, 2014, MOL ECOL, V23, P2929, DOI 10.1111/mec.12790; Clauset A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026132; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Danin A, 1999, BOT REV, V65, P93, DOI 10.1007/BF02857625; Diekmann OE, 2012, MOL ECOL, V21, P1647, DOI 10.1111/j.1365-294X.2012.05500.x; Donnelly P., 2000, GENETICS; Dyer RJ, 2004, MOL ECOL; Dyer RJ, 2015, ANNU REV ECOL EVOL S, V46, P327, DOI 10.1146/annurev-ecolsys-112414-054150; Dyer RJ, 2010, MOL ECOL, V19, P3746, DOI 10.1111/j.1365-294X.2010.04748.x; Edge MD, 2014, THEOR POPUL BIOL, V97, P20, DOI 10.1016/j.tpb.2014.08.001; Eguiarte LE, 1999, AM J BOT; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Franssen SU, 2014, MAR GENOM, V15, P65, DOI 10.1016/j.margen.2014.03.004; Galil Y, 1972, TEVA VAARETZ, V14, P139; Gapare WJ, 2005, BIOL CONSERV, V123, P113, DOI 10.1016/j.biocon.2004.11.002; Garroway CJ, 2008, EVOL APPL, V1, P620, DOI 10.1111/j.1752-4571.2008.00047.x; Ge XJ, 2005, ANN BOT; Gibson SY, 2009, CONSERV BIOL; Ginat H., 2011, J DEAD SEA ARAV RES, V1, P1; Goldreich Yair, 2001, Israel Journal of Earth Sciences, V50, P53, DOI 10.1560/1V61-FPGF-Y5VK-ADAG; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenbaum G, 2017, MOL ECOL, V26, P2850, DOI 10.1111/mec.14059; Greenbaum G, 2016, GENETICS, V202, P1299, DOI 10.1534/genetics.115.182626; Groner E., 2017, NEGEV DEAD SEA ARAVA, V9, P1; Hackett TD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052999; HEDRICK PW, 1986, ANNU REV ECOL SYST, V17, P535; Hedrick PW., 2006, ANN REV ECOLOGY EVOL; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Hubisz MJ, 2009, MOL ECOL RESOUR; Jakobsson M, 2013, GENETICS; Kark S, 2008, EVOL ECOL RES, V10, P391; KIMURA M, 1964, GENETICS, V49, P561; Klutsch CFC, 2012, CONSERV GENET; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kyalangalilwa B, 2013, BOT J LINN SOC, V172, P500, DOI 10.1111/boj.12047; LESICA P, 1995, CONSERV BIOL, V9, P753, DOI 10.1046/j.1523-1739.1995.09040753.x; Herrera-Arroyo ML, 2013, AM J BOT, V100, P1663, DOI 10.3732/ajb.1200396; Maki M, 1999, AM J BOT; Manel S, 2013, TRENDS ECOLOGY EVOLU; Milton SJ, 1995, Z OKOLOGIE NATURSCHU, V4, P47; Mulumba John W., 2012, International Journal of Botany, V8, P107, DOI 10.3923/ijb.2012.107.116; Munwes I, 2010, MOL ECOL; Munzbergova Z, 2002, J VEG SCI; Neiva J, 2012, J BIOGEOGR, V39, P1167, DOI 10.1111/j.1365-2699.2011.02670.x; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Or K, 2003, AFR J ECOL, V41, P257, DOI 10.1046/j.1365-2028.2003.00451.x; Peakall R., 2012, BIOINFORMATICS; Peterman WE, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1231; Polak T, 2014, ANIM CONSERV, V17, P565, DOI 10.1111/acv.12122; Rohner C, 1999, CONSERV BIOL, V13, P1162, DOI 10.1046/j.1523-1739.1999.97300.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F., 2008, MOL ECOL RESOUR; Rozenfeld AF, 2008, P NATL ACAD SCI USA, V105, P18824, DOI 10.1073/pnas.0805571105; Sheng Y, 2004, ACTA BOT SIN, V46, P675; Sher AA, 2010, J ARID ENVIRON, V74, P338, DOI 10.1016/j.jaridenv.2009.09.007; Shrestha MK, 2002, BIOL CONSERV, V108, P119, DOI 10.1016/S0006-3207(02)00100-3; Stavi I, 2014, CATENA, V114, P149, DOI 10.1016/j.catena.2013.10.006; VANOOSTERHOUT C, 2004, MOL ECOL NOTES; Wang J, 2011, ANN FOREST SCI, V68, P1143, DOI 10.1007/s13595-011-0119-6; Ward D, 1997, BIODIVERS CONSERV, V6, P877, DOI 10.1023/B:BIOC.0000010408.90955.48; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Winters G, 2015, J ARID ENVIRON, V121, P79, DOI 10.1016/j.jaridenv.2015.05.008; Winters G, 2013, CONSERV GENET RESOUR, V5, P807, DOI 10.1007/s12686-013-9913-9; Winters G, 2011, MAR ECOL PROG SER, V435, P83, DOI 10.3354/meps09213; Zaghloul M.S., 2007, CATRINA, V2, P51	74	6	6	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194901	10.1371/journal.pone.0194901	http://dx.doi.org/10.1371/journal.pone.0194901			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649222	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900016
J	Schafler, ED; Thomas, PA; Ha, S; Wang, Y; Bermudez-Hernandez, K; Tang, ZJ; Fenyo, D; Vigodner, M; Logan, SK				Schafler, Eric D.; Thomas, Phillip A.; Ha, Susan; Wang, Yu; Bermudez-Hernandez, Keria; Tang, Zuojian; Fenyo, David; Vigodner, Margarita; Logan, Susan K.			UXT is required for spermatogenesis in mice	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION; MOUSE SPERMATOGENESIS; GENE-EXPRESSION; KIT EXPRESSION; PROTEIN; SPERMATOGONIA; TRANSCRIPTION; IDENTIFICATION; COACTIVATOR; CHROMOSOME	Male mammals must simultaneously produce prodigious numbers of sperm and maintain an adequate reserve of stem cells to ensure continuous production of gametes throughout life. Failures in the mechanisms responsible for balancing germ cell differentiation and spermatogonial stem cell (SSC) self-renewal can result in infertility. We discovered a novel requirement for Ubiquitous Expressed Transcript (UXT) in spermatogenesis by developing the first knockout mouse model for this gene. Constitutive deletion of Uxt is embryonic lethal, while conditional knockout in the male germline results in a Sertoli cell-only phenotype during the first wave of spermatogenesis that does not recover in the adult. This phenotype begins to manifest between 6 and 7 days post-partum, just before meiotic entry. Gene expression analysis revealed that Uxt deletion downregulates the transcription of genes governing SSC self-renewal, differentiation, and meiosis, consistent with its previously defined role as a transcriptional co-factor. Our study has revealed the first in vivo function for UXT in the mammalian germline as a regulator of distinct transcriptional programs in SSCs and differentiating spermatogonia.	[Schafler, Eric D.; Thomas, Phillip A.; Ha, Susan; Fenyo, David; Logan, Susan K.] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA; [Schafler, Eric D.] NYU, Sch Med, Pathobiol & Translat Med Training Program, New York, NY USA; [Ha, Susan; Wang, Yu; Logan, Susan K.] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Wang, Yu] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Bermudez-Hernandez, Keria; Tang, Zuojian; Fenyo, David] NYU, Inst Syst Genet, Langone Med Ctr, New York, NY USA; [Bermudez-Hernandez, Keria; Tang, Zuojian; Fenyo, David] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY USA; [Vigodner, Margarita] Yeshiva Univ, Stern Coll, Dept Biol, New York, NY 10033 USA; [Vigodner, Margarita] Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10467 USA	New York University; New York University; New York University; New York University; New York University; NYU Langone Medical Center; New York University; Yeshiva University; Yeshiva University; Albert Einstein College of Medicine	Logan, SK (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10003 USA.; Logan, SK (corresponding author), NYU, Sch Med, Dept Urol, New York, NY 10003 USA.	susan.logan@nyumc.org		THOMAS, PHILLIP A/0000-0003-1704-5072; Logan, Susan/0000-0002-7904-5927	National Institutes of Health [R01CA112226]; Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center [NIH/NCI P30CA016087]; NYSTEM [C026719]; NATIONAL CANCER INSTITUTE [R01CA112226] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant at the Laura and Isaac Perlmutter Cancer Center; NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01CA112226) (SL). We would like to acknowledge the shared resources of the NYUMC Genome Technology Center, High Throughput Biology Core (HTB), Histopathology Core, and Immunohistochemistry Core, which are all partially supported by the Cancer Center Support Grant NIH/NCI P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. The HTB is also supported by NYSTEM Contract C026719. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health (R01CA112226) (SL). We would like to acknowledge the shared resources of the NYUMC Genome Technology Center, High Throughput Biology Core (HTB), Histopathology Core, and Immunohistochemistry Core, which are all partially supported by the Cancer Center Support Grant NIH/NCI P30CA016087 at the Laura and Isaac Perlmutter Cancer Center. The HTB is also supported by NYSTEM Contract C026719. We also thank David Kahler, Yuxuan Xiao, Benjamin E. Lucas, and Sanny S.W. Chung for helpful discussion.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Barrios F, 2012, J CELL SCI, V125, P1455, DOI 10.1242/jcs.092593; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Busada JT, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.114645; Carter DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095253; Chakraborty P, 2014, STEM CELLS, V32, P860, DOI 10.1002/stem.1584; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Coelho L.P., 2013, JORS, V1, pe3, DOI [10.5334/jors.ac, DOI 10.5334/JORS.AC]; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Desimio MG, 2015, CELL CYCLE, V14, P1036, DOI 10.1080/15384101.2015.1007721; Drumond AL, 2011, REPRODUCTION, V142, P145, DOI 10.1530/REP-10-0431; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gely-Pernot A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005501; Ghyselinck NB, 2006, DEV DYNAM, V235, P1608, DOI 10.1002/dvdy.20795; Green DR, 2005, CELL, V121, P671, DOI 10.1016/j.cell.2005.05.019; Hermann BP, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.125757; Imai T, 2004, MOL CELL ENDOCRINOL, V214, P107, DOI 10.1016/j.mce.2003.10.065; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kirchner J, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-36; Kou Y, 2013, AVAILABILITY RELIABI, P416; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; LAMPRON C, 1995, DEVELOPMENT, V121, P539; Laronda MM, 2011, ENDOCRINOLOGY, V152, P1606, DOI 10.1210/en.2010-1249; LaVoie HA, 2003, EXP BIOL MED, V228, P1282, DOI 10.1177/153537020322801107; Liao HF, 2014, DEVELOPMENT, V141, P2402, DOI 10.1242/dev.105130; Liu LY, 2002, GENOMICS, V79, P124, DOI 10.1006/geno.2001.6679; Liu YC, 2013, BIOINFORMATICS, V29, P308, DOI [10.1093/bioinformatics/btt688, 10.1093/bioinformatics/bts690]; Markus SM, 2002, MOL BIOL CELL, V13, P670, DOI 10.1091/mbc.01-10-0513; McGilvray R, 2007, FEBS J, V274, P3960, DOI 10.1111/j.1742-4658.2007.05928.x; MCGUINNESS MP, 1992, ANAT REC, V233, P527, DOI 10.1002/ar.1092330406; Mita P, 2011, MOL CELL BIOL, V31, P3639, DOI 10.1128/MCB.05429-11; Moss TN, 2007, IN VITRO CELL DEV-AN, V43, P139, DOI 10.1007/s11626-007-9016-6; Nwachukwu JC, 2009, CANCER RES, V69, P3140, DOI 10.1158/0008-5472.CAN-08-3738; O'Shaughnessy PJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035136; OAKBERG EF, 1971, ANAT REC, V169, P515, DOI 10.1002/ar.1091690305; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Parusel CT, 2006, DEVELOPMENT, V133, P621, DOI 10.1242/dev.02235; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saunders PTK, 2003, REPRODUCTION, V126, P589, DOI 10.1530/rep.0.1260589; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schroer A, 1999, GENOMICS, V56, P340, DOI 10.1006/geno.1998.5712; Shinoda G, 2013, STEM CELLS, V31, P1001, DOI 10.1002/stem.1343; Siegert R, 2000, CELL, V103, P621, DOI 10.1016/S0092-8674(00)00165-3; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Su SK, 2016, J CELL SCI, V129, P2343, DOI 10.1242/jcs.185546; Sui SG, 2007, J CELL BIOL, V178, P231, DOI 10.1083/jcb.200611081; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tanaka H, 1997, INT J ANDROL, V20, P361; Taneja SS, 2004, J BIOL CHEM, V279, P13944, DOI 10.1074/jbc.M306576200; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Vizan P, 2015, FEBS J, V282, P1723, DOI 10.1111/febs.13083; Wolgemuth DJ, 2013, INT J DEV BIOL, V57, P159, DOI 10.1387/ijdb.130047av; Wu X, 2009, P NATL ACAD SCI USA, V106, P21672, DOI 10.1073/pnas.0912432106; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195747	10.1371/journal.pone.0195747	http://dx.doi.org/10.1371/journal.pone.0195747			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649254	Green Submitted, gold, Green Published			2022-12-26	WOS:000429791900078
J	Klema, VJ; Sepuru, KM; Fullbrunn, N; Farris, TR; Dunphy, PS; McBride, JW; Rajarathnam, K; Choi, KH				Klema, Valerie J.; Sepuru, Krishna Mohan; Fullbrunn, Nadia; Farris, Tierra R.; Dunphy, Paige S.; McBride, Jere W.; Rajarathnam, Krishna; Choi, Kyung H.			Ehrlichia chaffeensis TRP120 nucleomodulin binds DNA with disordered tandem repeat domain	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; INTRINSICALLY UNSTRUCTURED PROTEINS; RECOMBINANT 120-KILODALTON PROTEIN; SEQUENCE-SPECIFIC RECOGNITION; AMINO-ACID-SEQUENCE; TAL EFFECTORS; TRANSCRIPTION FACTOR; SERVER; PROTEOMICS; REGIONS	Ehrlichia chaffeensis, the causative agent of human monocytotropic ehrlichiosis, secretes several effector proteins that bind host DNA to modulate host gene expression. The tandem repeat protein 120 (TRP120), one of the largest effector proteins, has four nearly identical tandem repeat (TR) regions that each consists of 80 amino acids. In addition to playing a role in ehrlichial binding and internalization, TRP120 translocates to the host nucleus where it is thought to function as a transcription factor that modulates gene expression. However, sequence analysis of TRP120 does not identify the presence of DNA-binding or trans-activation domains typical of classical eukaryotic transcription factors. Thus, the mechanism by which TRP120 binds DNA and modulates gene expression remains elusive. Herein, we expressed the TR regions of the TRP120 protein, and characterized its solution structure and ability to bind DNA. TRP120, expressed as either a one or two TR repeat, is a monomer in solution, and is mostly disordered as determined by circular dichroism (CD) and nuclear magnetic resonance (NMR) spectroscopy. Using NMR spectroscopy, we further show that the 1 TR construct selectively binds GC-rich DNA. Although low pH was required for TRP120 TR-DNA interaction, acidic pH alone does not induce any significant structural changes in the TR region. This suggests that TRP120 folds into an ordered structure upon forming a protein-DNA complex, and thus folding of TRP120 TR is coupled with DNA binding.	[Klema, Valerie J.; Sepuru, Krishna Mohan; Fullbrunn, Nadia; Rajarathnam, Krishna; Choi, Kyung H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA; [Farris, Tierra R.; Dunphy, Paige S.; McBride, Jere W.] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Sealy Ctr Vaccine Dev, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Choi, KH (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.	kychoi@utmb.edu	Sepuru, Krishna Mohan/K-5321-2014	Sepuru, Krishna Mohan/0000-0002-3675-6294	Sealy and Smith Foundation; University of Texas Medical Branch SCBMB-IHII pilot grant; National Institute of Allergy and Infectious Diseases [AI106859]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106859] Funding Source: NIH RePORTER	Sealy and Smith Foundation; University of Texas Medical Branch SCBMB-IHII pilot grant; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a Sealy and Smith Foundation grant to the Sealy Center for Structural Biology and Molecular Biophysics, a University of Texas Medical Branch SCBMB-IHII pilot grant (to KHC and JWM) and National Institute of Allergy and Infectious Diseases grant AI106859 (JWM).	ANDERSON BE, 1992, J CLIN MICROBIOL, V30, P775, DOI 10.1128/JCM.30.4.775-780.1992; ANDERSON BE, 1993, AM J TROP MED HYG, V49, P239, DOI 10.4269/ajtmh.1993.49.239; ARMSTRONG DJ, 1993, BIOCHEM BIOPH RES CO, V192, P1380, DOI 10.1006/bbrc.1993.1569; Barnewall RE, 1997, INFECT IMMUN, V65, P1455, DOI 10.1128/IAI.65.4.1455-1461.1997; Blane A, 2015, BIOCHEMISTRY-US, V54, P4001, DOI 10.1021/acs.biochem.5b00155; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Deng D, 2012, SCIENCE, V335, P720, DOI 10.1126/science.1215670; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Dunphy PS, 2013, MICROBES INFECT, V15, P1005, DOI 10.1016/j.micinf.2013.09.011; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Farris TR, 2016, INFECT IMMUN, V84, P3182, DOI 10.1128/IAI.00657-16; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Heitman KN, 2016, AM J TROP MED HYG, V94, P52, DOI 10.4269/ajtmh.15-0540; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; KRIWACKI RW, 1992, P NATL ACAD SCI USA, V89, P9759, DOI 10.1073/pnas.89.20.9759; Lina TT, 2016, MBIO, V7, DOI 10.1128/mBio.00672-16; Linding R, 2003, STRUCTURE, V11, P1453, DOI 10.1016/j.str.2003.10.002; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Luo T, 2011, INFECT IMMUN, V79, P4382, DOI 10.1128/IAI.05608-11; Mak ANS, 2013, CURR OPIN STRUC BIOL, V23, P93, DOI 10.1016/j.sbi.2012.11.001; Mak ANS, 2012, SCIENCE, V335, P716, DOI 10.1126/science.1216211; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Mikles DC, 2013, FEBS J, V280, P3669, DOI 10.1111/febs.12360; Olano JR, 2003, EMERG INFECT DIS, V9, P1579, DOI 10.3201/eid0912.020733; Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003; Pollastri G, 2005, BIOINFORMATICS, V21, P1719, DOI 10.1093/bioinformatics/bti203; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Szilagyi A, 2006, J MOL BIOL, V358, P922, DOI 10.1016/j.jmb.2006.02.053; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Wakeel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009552; Yachdav G, 2014, NUCLEIC ACIDS RES, V42, pW337, DOI 10.1093/nar/gku366; Yu XJ, 1996, J CLIN MICROBIOL, V34, P2853, DOI 10.1128/JCM.34.11.2853-2855.1996; Yu XJ, 2000, J CLIN MICROBIOL, V38, P369; Zhu B, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00290-17, 10.1128/iai.00290-17]; Zhu B, 2011, INFECT IMMUN, V79, P4370, DOI 10.1128/IAI.05422-11	43	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194891	10.1371/journal.pone.0194891	http://dx.doi.org/10.1371/journal.pone.0194891			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641592	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900054
J	Le Blay, K; Preau, L; Morvan-Dubois, G; Demeneix, B				Le Blay, Karine; Preau, Laetitia; Morvan-Dubois, Ghislaine; Demeneix, Barbara			Expression of the inactivating deiodinase, Deiodinase 3, in the pre-metamorphic tadpole retina	PLOS ONE			English	Article							THYROID-HORMONE RECEPTOR; CONE OPSIN EXPRESSION; XENOPUS-LAEVIS; RAINBOW-TROUT; ULTRAVIOLET PHOTOSENSITIVITY; AMPHIBIAN METAMORPHOSIS; EYE DEVELOPMENT; PHOTORECEPTORS; DISRUPTION; THYROXINE	Thyroid hormone (TH) orchestrates amphibian metamorphosis. Thus, this developmental phase is often used to study TH-dependent responses in specific tissues. However, TH signaling appears early in development raising the question of the control of TH availability in specific cell types prior to metamorphosis. TH availability is under strict temporal and tissue-specific control by deiodinases. We examined the expression of the TH-inactivating enzyme, deiodinase type 3 (D3), during early retinal development. To this end we created a Xenopus laevis transgenic line expressing GFP from the Xenopus dio3 promoter region (pdio3) and followed pdio3-GFP expression in pre-metamorphic tadpoles. To validate retinal GFP expression in the transgenic line as a function of dio3 promoter activity, we used in situ hybridization to compare endogenous dio3 expression to reporter-driven GFP activity. Retinal expression of dio3 increased during pre-metamorphosis through stages NF41, 45 and 48. Both sets of results show dio3 to have cell-specific, dynamic expression in the pre-metamorphic retina. At stage NF48, dio3 expression co-localised with markers for photoreceptors, rods, Opsin-S cones and bipolar neurons. In contrast, in post-metamorphic juveniles dio3 expression was reduced and spatially confined to certain photoreceptors and amacrine cells. We compared dio3 expression at stages NF41 and NF48 with TH-dependent transcriptional responses using another transgenic reporter line: THbZIP-GFP and by analyzing the expression of T-3-regulated genes in distinct TH availability contexts. At stage NF48, the majority of retinal cells expressing dio3 were negative for T-3 signaling. Notably, most ganglion cells were virtually both dio3-free and T-3-responsive. The results show that dio3 can reduce TH availability at the cellular scale. Further, a reduction in dio3 expression can trigger fine-tuned T-3 action in cell-type specific maturation at the right time, as exemplified here in photoreceptor survival in the pre-metamorphic retina.	[Le Blay, Karine; Morvan-Dubois, Ghislaine; Demeneix, Barbara] Museum Natl Hist Nat, UMR CNRS, Dept Adaptat Vivant, Evolut Regulat Endocriniennes, Paris, France; [Preau, Laetitia] KIT, Zool Inst, Zell & Entwicklungsbiol, Karlsruhe, Germany; [Morvan-Dubois, Ghislaine] UPMC, Neurosci Paris Seine IBPS, Sorbonne Univ, CNRS UMR8246,Inserm U1130, Paris, France	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); Helmholtz Association; Karlsruhe Institute of Technology; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Le Blay, K; Morvan-Dubois, G; Demeneix, B (corresponding author), Museum Natl Hist Nat, UMR CNRS, Dept Adaptat Vivant, Evolut Regulat Endocriniennes, Paris, France.; Morvan-Dubois, G (corresponding author), UPMC, Neurosci Paris Seine IBPS, Sorbonne Univ, CNRS UMR8246,Inserm U1130, Paris, France.	le.blay@mnhn.fr; ghislaine.morvan-dubois@upmc.fr; bdem@mnhn.fr	morvan-dubois, ghislaine/AAI-1765-2019	Morvan-Dubois, ghislaine/0000-0003-1285-9130	Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); French ANR "Thrast"; Agence Nationale de la Recherche [11BSV2019 02]; PERSU grant [SU-14-R-PERSU-04]; French Ministry of Research and Education; PERSU grant (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche) [SU-14-R-PERSU-04]	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Museum National d'Histoire Naturelle (MNHN); French ANR "Thrast"(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); PERSU grant; French Ministry of Research and Education; PERSU grant (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche)	This work was supported by the Centre National de la Recherche Scientifique (CNRS), the Museum National d'Histoire Naturelle (MNHN), the French ANR "Thrast," Agence Nationale de la Recherche (11BSV2019 02) and a PERSU grant (SU-14-R-PERSU-04) to BAD. Laetitia Preau received a PhD grant from the French Ministry of Research and Education and support from the PERSU grant (Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche) (SU-14-R-PERSU-04) to BAD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison WT, 2006, J COMP NEUROL, V499, P702, DOI 10.1002/cne.21164; Alvarez-Hernan G, 2013, SCI WORLD J, DOI 10.1155/2013/740420; Amaya E, 1999, METH MOL B, V97, P393, DOI 10.1385/1-59259-270-8:393; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bessodes N, 2017, NEURAL DEV, V12, DOI 10.1186/s13064-017-0093-2; Bilitou A, 2010, DEV DYNAM, V239, P727, DOI 10.1002/dvdy.22223; BROWMAN HI, 1992, VISION RES, V32, P2303, DOI 10.1016/0042-6989(92)90094-Y; BROWMAN HI, 1994, VISION RES, V34, P1397, DOI 10.1016/0042-6989(94)90139-2; Brown DD, 2005, THYROID, V15, P815, DOI 10.1089/thy.2005.15.815; Cabochette P, 2015, ELIFE, V4, DOI 10.7554/eLife.08488; Chang WS, 1998, J NEUROBIOL, V35, P227; Cossette SMM, 2004, DIFFERENTIATION, V72, P239, DOI 10.1111/j.1432-0436.2004.07205006.x; D'Autilia S, 2006, DEV GENES EVOL, V216, P829, DOI 10.1007/s00427-006-0109-0; Darras VM, 1998, ANN NY ACAD SCI, V839, P80, DOI 10.1111/j.1749-6632.1998.tb10736.x; Dullin JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-110; Fini JB, 2012, ENDOCRINOLOGY, V153, P5068, DOI 10.1210/en.2012-1463; Fini JB, 2007, ENVIRON SCI TECHNOL, V41, P5908, DOI 10.1021/es0704129; Harpavat S, 2003, THYROID, V13, P1013, DOI 10.1089/105072503770867183; Havis E, 2006, EMBO J, V25, P4943, DOI 10.1038/sj.emboj.7601356; Houbrechts AM, 2016, ENDOCRINOLOGY, V157, P3668, DOI 10.1210/en.2016-1077; Houbrechts AM, 2016, MOL CELL ENDOCRINOL, V424, P81, DOI 10.1016/j.mce.2016.01.018; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; LELOUP J, 1977, CR ACAD SCI D NAT, V284, P2261; Ma HW, 2016, ADV EXP MED BIOL, V854, P613, DOI 10.1007/978-3-319-17121-0_81; Mader M, 2006, MOL VIS, V12, P915; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Nunez J, 2008, MOL CELL ENDOCRINOL, V287, P1, DOI 10.1016/j.mce.2008.03.006; Parker RO, 2010, ANAT REC, V293, P383, DOI 10.1002/ar.21079; Pessoa CN, 2008, INVEST OPHTH VIS SCI, V49, P2039, DOI 10.1167/iovs.07-0908; Preau L, 2016, MOL CELL ENDOCRINOL, V420, P138, DOI 10.1016/j.mce.2015.11.026; Raine JC, 2010, J EXP BIOL, V213, P493, DOI 10.1242/jeb.036301; Raine JC, 2009, J EXP BIOL, V212, P2781, DOI 10.1242/jeb.030866; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; SJOBERG M, 1992, DEVELOPMENT, V114, P39; Tata JR, 2006, MOL CELL ENDOCRINOL, V246, P10, DOI 10.1016/j.mce.2005.11.024; Turque N, 2005, ENVIRON HEALTH PERSP, V113, P1588, DOI 10.1289/ehp.7992; Wong LL, 2009, DEVELOPMENT, V136, P1707, DOI 10.1242/dev.027607	39	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195374	10.1371/journal.pone.0195374	http://dx.doi.org/10.1371/journal.pone.0195374			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641587	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900066
J	Oakley, RH; Ramamoorthy, S; Foley, JF; Busada, JT; Lu, NZ; Cidlowski, JA				Oakley, Robert H.; Ramamoorthy, Sivapriya; Foley, Julie F.; Busada, Jonathan T.; Lu, Nick Z.; Cidlowski, John A.			Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice	FASEB JOURNAL			English	Article						translational isoforms; knockin mice; respiratory distress	CHROMAFFIN CELL-DEVELOPMENT; TRANSLATIONAL ISOFORMS; HUMAN MONOCYTES; MECHANISMS; EXPRESSION; STRESS; SEPSIS; SYSTEM	Glucocorticoids are primary stress hormones, and their synthetic derivatives are widely used clinically. The therapeutic efficacy of these steroids is limited by side effects and glucocorticoid resistance. Multiple glucocorticoid receptor (GR) isoforms are produced from a single gene by alternative translation initiation; however, the role individual isoforms play in tissue-specific responses to glucocorticoids is unknown. We have generated knockin mice that exclusively express the most active receptor isoform, GR-C3. GR-C3 knockin mice die at birth due to respiratory distress. Microarray analysis of fibroblasts from wild-type and GR-C3 mice indicated that most genes regulated by GR-C3 were unique to this isoform. Antenatal glucocorticoid administration rescued GR-C3 knockin mice from neonatal death. Dual-energy X-ray absorptiometry revealed no major alterations in body composition for rescued knockin mice. Rescued female, but not male, GR-C3 mice exhibited increased wheel running activity in the light portion of the day. LPS administration induced premature mortality in rescued GR-C3 knockin mice, and gene expression studies revealed a deficiency in the ability of GR-C3 to repress a large cohort of immune and inflammatory response genes. These findings demonstrate that specific GR translational isoforms can influence development, circadian rhythm, and inflammation through the regulation of distinct gene networks.Oakley, R. H., Ramamoorthy, S., Foley, J. F., Busada, J. T., Lu, N. Z., Cidlowski, J. A. Glucocorticoid receptor isoform-specific regulation of development, circadian rhythm, and inflammation in mice.	[Oakley, Robert H.; Ramamoorthy, Sivapriya; Busada, Jonathan T.; Lu, Nick Z.; Cidlowski, John A.] NIEHS, Signal Transduct Lab, Dept Hlth & Human Serv, NIH, Res Triangle Pk, NC USA; [Foley, Julie F.] NIEHS, Cellular & Mol Pathol Branch, Dept Hlth & Human Serv, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Cidlowski, JA (corresponding author), NIEHS, NIH, 111 TW Alexander Dr,MD F3-07, Res Triangle Pk, NC 27709 USA.	cidlows1@niehs.nih.gov	Cidlowski, John A/G-2548-2019	Cidlowski, John A/0000-0003-1420-0516	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of General Medical Sciences Postdoctoral Research Associate Training Program Grant [1Fi2GM123974-01]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES090057, ZICES102445, ZIAES090079] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of General Medical Sciences Postdoctoral Research Associate Training Program Grant; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Dr. Kevin Gerrish and Rick D. Fannin (Molecular Genomics Core Laboratory, National Institute of Environmental Health Sciences) for assistance with microarray and nanostring analyses. This work was supported by the Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences, and by NIH National Institute of General Medical Sciences Postdoctoral Research Associate Training Program Grant 1Fi2GM123974-01 (to J.T.B). The authors declare no conflicts of interest.	Almli LM, 2013, AM J MED GENET B, V162B, P262, DOI 10.1002/ajmg.b.32145; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Beck IME, 2009, ENDOCR REV, V30, P830, DOI 10.1210/er.2009-0013; Bender IK, 2013, MOL ENDOCRINOL, V27, P1577, DOI 10.1210/me.2013-1009; Bianchini R, 2006, J PHARMACOL EXP THER, V319, P887, DOI 10.1124/jpet.106.108480; Blotta MH, 1997, J IMMUNOL, V158, P5589; Cao Y, 2013, BLOOD, V121, P1553, DOI 10.1182/blood-2012-05-432336; CHAMPIGNY G, 1994, EMBO J, V13, P2177, DOI 10.1002/j.1460-2075.1994.tb06494.x; Chapin WJ, 2015, PHARMACOGENET GENOM, V25, P126, DOI 10.1097/FPC.0000000000000116; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; COLE TJ, 1995, GENE DEV, V9, P1608, DOI 10.1101/gad.9.13.1608; Crawford LW, 2010, TOXICOL PATHOL, V38, P872, DOI 10.1177/0192623310374329; Dendoncker K, 2017, CYTOKINE GROWTH F R, V35, P85, DOI 10.1016/j.cytogfr.2017.04.002; Kulkarni NN, 2016, IMMUNOBIOLOGY, V221, P245, DOI 10.1016/j.imbio.2015.09.001; Lambert WM, 2013, MOL CELL BIOL, V33, P3700, DOI 10.1128/MCB.00150-13; Landgraf D, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0483-7; Li CYC, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002269; LIGGINS GC, 1994, REPROD FERT DEVELOP, V6, P141, DOI 10.1071/RD9940141; Lu NZ, 2007, MOL CELL BIOL, V27, P7143, DOI 10.1128/MCB.00253-07; Lu NZ, 2005, MOL CELL, V18, P331, DOI 10.1016/j.molcel.2005.03.025; McKay LI, 1999, ENDOCR REV, V20, P435, DOI 10.1210/er.20.4.435; Nehme A, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-58; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Peffer ME, 2014, MOL CELL BIOL, V34, P2611, DOI 10.1128/MCB.01121-13; Ressler KJ, 2011, NATURE, V470, P492, DOI 10.1038/nature09856; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Sinclair D, 2011, MOL PSYCHIATR, V16, P504, DOI 10.1038/mp.2010.28; Sinclair D, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-84; Sinclair D, 2011, NEUROPSYCHOPHARMACOL, V36, P2698, DOI 10.1038/npp.2011.160; Smoak KA, 2004, MECH AGEING DEV, V125, P697, DOI 10.1016/j.mad.2004.06.010; Unsicker K, 2013, MECH DEVELOP, V130, P324, DOI 10.1016/j.mod.2012.11.004; Whirledge S, 2013, ENDOCRINOLOGY, V154, P499, DOI 10.1210/en.2012-1748	33	9	10	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5258	5271		10.1096/fj.201701153R	http://dx.doi.org/10.1096/fj.201701153R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29672221	Green Published			2022-12-26	WOS:000447972500006
J	Drees, SL; Ernst, S; Belviso, BD; Jagmann, N; Hennecke, U; Fetzner, S				Drees, Steffen Lorenz; Ernst, Simon; Belviso, Benny Danilo; Jagmann, Nina; Hennecke, Ulrich; Fetzner, Susanne			PqsL uses reduced flavin to produce 2-hydroxylaminobenzoylacetate, a preferred PqsBC substrate in alkyl quinolone biosynthesis in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						flavin; biosynthesis; secondary metabolism; quorum sensing; crystal structure; Pseudomonas aeruginosa; 2-alkyl-4-hydroxyquinoline-N-oxide; p-hydroxybenzoate 3-hydroxylase; monooxygenase	P-HYDROXYBENZOATE HYDROXYLASE; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; RESPIRATORY-CHAIN; BINDING-SITES; OXIDATION; ENZYME; NADPH; FLUORESCENS; COMPETITION	Alkyl hydroxyquinoline N-oxides (AQNOs) are antibiotic compounds produced by the opportunistic bacterial pathogen Pseudomonas aeruginosa. They are products of the alkyl quinolone (AQ) biosynthetic pathway, which also generates the quorum-sensing molecules 2-heptyl-4(1H)-quinolone (HHQ) and 2-heptyl-3-hydroxy-4(1H)-quinolone (PQS). Although the enzymatic synthesis of HHQ and PQS had been elucidated, the route by which AQNOs are synthesized remained elusive. Here, we report on PqsL, the key enzyme for AQNO production, which structurally resembles class A flavoprotein monooxygenases such as p-hydroxybenzoate 3-hydroxylase (pHBH) and 3-hydroxybenzoate 6-hydroxylase. However, we found that unlike related enzymes, PqsL hydroxylates a primary aromatic amine group, and it does not use NAD(P)H as cosubstrate, but unexpectedly required reduced flavin as electron donor. We also observed that PqsL is active toward 2-aminobenzoylacetate (2-ABA), the central intermediate of the AQ pathway, and forms the unstable compound 2-hydroxylaminobenzoylacetate, which was preferred over 2-ABA as substrate of the downstream enzyme PqsBC. In vitro reconstitution of the PqsL/PqsBC reaction was feasible by using the FAD reductase HpaC, and we noted that the AQ:AQNO ratio is increased in an hpaC-deletion mutant of P. aeruginosa PAO1 compared with the ratio in the WT strain. A structural comparison with pHBH, the model enzyme of class A flavoprotein monooxygenases, revealed that structural features associated with NAD(P)H binding are missing in PqsL. Our study completes the AQNO biosynthetic pathway in P. aeruginosa, indicating that PqsL produces the unstable product 2-hydroxylaminobenzoylacetate from 2-ABA and depends on free reduced flavin as electron donor instead of NAD(P)H.	[Drees, Steffen Lorenz; Ernst, Simon; Jagmann, Nina; Fetzner, Susanne] Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany; [Hennecke, Ulrich] Univ Munster, Inst Organ Chem, D-48149 Munster, Germany; [Belviso, Benny Danilo] CNR, Inst Crystallog, I-70126 Bari, Italy	University of Munster; University of Munster; Consiglio Nazionale delle Ricerche (CNR); Istituto Di Cristallografia (IC-CNR)	Drees, SL; Fetzner, S (corresponding author), Univ Munster, Inst Mol Microbiol & Biotechnol, D-48149 Munster, Germany.	s.drees@uni-muenster.de; fetzner@uni-muenster.de	Drees, Steffen Lorenz/Q-3510-2019; Hennecke, Ulrich/A-7723-2010	Drees, Steffen Lorenz/0000-0001-9140-0111; Hennecke, Ulrich/0000-0002-4904-6793; Fetzner, Susanne/0000-0002-7228-1871; Belviso, Benny Danilo/0000-0003-2880-1064; Ernst, Simon/0000-0002-4794-213X	Deutsche Forschungsgemeinschaft [INST 211/646-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Prof. B. Philipp (University of Munster) for access to the electrospray ionization ion trap mass spectrometer (Deutsche Forschungsgemeinschaft Grant INST 211/646-1).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ARUNACHALAM U, 1994, J BIOL CHEM, V269, P150; BELAND FA, 1985, ENVIRON HEALTH PERSP, V62, P19, DOI 10.2307/3430089; Bendova L, 2007, J PHYS CHEM B, V111, P9975, DOI 10.1021/jp072859+; BORENFREUND E, 1964, J NATL CANCER I, V32, P667; Buedenbender S, 2009, J MOL BIOL, V385, P520, DOI 10.1016/j.jmb.2008.10.057; Cao H, 2001, P NATL ACAD SCI USA, V98, P14613, DOI 10.1073/pnas.251465298; Cardenas ML, 2001, METHODS, V24, P175, DOI 10.1006/meth.2001.1178; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Coleman JP, 2008, J BACTERIOL, V190, P1247, DOI 10.1128/JB.01140-07; Cooley JW, 2005, BIOCHEMISTRY-US, V44, P10520, DOI 10.1021/bi050571+; Crozier-Reabe K, 2012, INT J MOL SCI, V13, P15601, DOI 10.3390/ijms131215601; D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002; Deziel E, 2004, P NATL ACAD SCI USA, V101, P1339, DOI 10.1073/pnas.0307694100; Drees SL, 2016, J BIOL CHEM, V291, P6610, DOI 10.1074/jbc.M115.708453; Drees SL, 2015, CHEM BIOL, V22, P611, DOI 10.1016/j.chembiol.2015.04.012; Dulcey CE, 2013, CHEM BIOL, V20, P1481, DOI 10.1016/j.chembiol.2013.09.021; EINARSDOTTIR GH, 1989, BIOCHEMISTRY-US, V28, P4161, DOI 10.1021/bi00436a006; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eppink MHM, 1999, J MOL BIOL, V292, P87, DOI 10.1006/jmbi.1999.3015; Eppink MHM, 1999, FEBS LETT, V443, P251, DOI 10.1016/S0014-5793(98)01726-8; Eppink MHM, 1998, EUR J BIOCHEM, V253, P194, DOI 10.1046/j.1432-1327.1998.2530194.x; Eppink MHM, 1998, J BIOL CHEM, V273, P21031, DOI 10.1074/jbc.273.33.21031; Filkins LM, 2015, J BACTERIOL, V197, P2252, DOI 10.1128/JB.00059-15; Galan B, 2000, J BACTERIOL, V182, P627, DOI 10.1128/JB.182.3.627-636.2000; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Green Laura K, 2013, Cancers (Basel), V5, P985, DOI 10.3390/cancers5030985; Hammer PE, 1997, APPL ENVIRON MICROB, V63, P2147, DOI 10.1128/AEM.63.6.2147-2154.1997; Hazan R, 2016, CURR BIOL, V26, P195, DOI 10.1016/j.cub.2015.11.056; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; HUMPHREYS WG, 1992, P NATL ACAD SCI USA, V89, P8278, DOI 10.1073/pnas.89.17.8278; HUNTRESS EH, 1956, J AM CHEM SOC, V78, P419, DOI 10.1021/ja01583a046; HUSAIN M, 1979, J BIOL CHEM, V254, P6657; Jagmann N, 2010, ENVIRON MICROBIOL, V12, P1787, DOI 10.1111/j.1462-2920.2010.02271.x; Kamm O., 2003, ORG SYNTH, P57, DOI [10.1039/j29710002398, DOI 10.1039/J29710002398]; Kim YH, 2013, J BACTERIOL, V195, P180, DOI 10.1128/JB.02016-12; KITA K, 1984, J BIOL CHEM, V259, P3368; KRIEK E, 1974, BIOCHIM BIOPHYS ACTA, V355, P177, DOI 10.1016/0304-419X(74)90003-1; Mascotti ML, 2016, J MOL BIOL, V428, P3131, DOI 10.1016/j.jmb.2016.07.003; Lepine F, 2004, J AM SOC MASS SPECTR, V15, P862; Lepine F, 2003, BBA-GEN SUBJECTS, V1622, P36, DOI 10.1016/S0304-4165(03)00103-X; Louie TM, 2003, BIOCHEMISTRY-US, V42, P7509, DOI 10.1021/bi034092r; Massey V., 1991, SIMPLE METHOD DETERM, P59; MILLEN MH, 1971, J CHEM SOC B, P2398, DOI 10.1039/j29710002398; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Needham ER, 1904, J CHEM SOC, V85, P148, DOI 10.1039/ct9048500148; Oke Muse, 2010, Journal of Structural and Functional Genomics, V11, P167, DOI 10.1007/s10969-010-9090-y; Ortori CA, 2011, ANAL BIOANAL CHEM, V399, P839, DOI 10.1007/s00216-010-4341-0; Otto K, 2004, J BACTERIOL, V186, P5292, DOI 10.1128/JB.186.16.5292-5302.2004; Palfey B. A., 1995, ACTIVE OXYGEN BIOCH, P37, DOI DOI 10.1007/978-94-011-0609-2_2; Palfey BA, 1997, BIOCHEMISTRY-US, V36, P15713; Palmer GC, 2013, MICROBIOL-SGM, V159, P959, DOI 10.1099/mic.0.063065-0; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; POCKLINGTON T, 1969, BIOCHEM J, V112, P331, DOI 10.1042/bj1120331; Rampioni G, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006029; Schauble S, 2013, FEBS LETT, V587, P2818, DOI 10.1016/j.febslet.2013.06.025; Schnell S, 2000, J MATH CHEM, V27, P155, DOI 10.1023/A:1019139423811; SCHOPF C, 1956, CHEM BER-RECL, V89, P2877, DOI 10.1002/cber.19560891233; SCHREUDER HA, 1994, BIOCHEMISTRY-US, V33, P10161, DOI 10.1021/bi00199a044; Sena FV, 2015, MOL MICROBIOL, V98, P272, DOI 10.1111/mmi.13120; SICKER D, 1988, COLLECT CZECH CHEM C, V53, P839, DOI 10.1135/cccc19880839; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sucharitakul J, 2014, ARCH BIOCHEM BIOPHYS, V555, P33, DOI 10.1016/j.abb.2014.05.009; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Tu SC, 2001, ANTIOXID REDOX SIGN, V3, P881, DOI 10.1089/15230860152665046; Unversucht S, 2005, ADV SYNTH CATAL, V347, P1163, DOI 10.1002/adsc.200505029; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; van Pee KH, 2006, APPL MICROBIOL BIOT, V70, P631, DOI 10.1007/s00253-005-0232-2; VANBERKEL WJH, 1988, EUR J BIOCHEM, V176, P449; Verna L, 1996, PHARMACOL THERAPEUT, V71, P83, DOI 10.1016/0163-7258(96)00063-0; Wang J, 2002, P NATL ACAD SCI USA, V99, P608, DOI 10.1073/pnas.022640199; WHITBY LG, 1953, BIOCHEM J, V54, P437, DOI 10.1042/bj0540437; WILLIAMSON G, 1988, BIOCHIM BIOPHYS ACTA, V953, P258, DOI 10.1016/0167-4838(88)90033-7; WIMPENNY JW, 1972, J BACTERIOL, V11, P24, DOI 10.1128/JB.111.1.24-32.1972; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Xun LY, 2000, APPL ENVIRON MICROB, V66, P481, DOI 10.1128/AEM.66.2.481-486.2000; Yap LL, 2010, BBA-BIOENERGETICS, V1797, P1924, DOI 10.1016/j.bbabio.2010.04.011; Zhang YM, 2008, J BIOL CHEM, V283, P28788, DOI 10.1074/jbc.M804555200; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	80	21	21	3	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9345	9357		10.1074/jbc.RA117.000789	http://dx.doi.org/10.1074/jbc.RA117.000789			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29669807	Green Published, hybrid			2022-12-26	WOS:000435441400020
J	Zhou, Q; Dong, G; Li, ZY				Zhou, Qing; Dong, Gang; Li, Ziyin			Flagellum inheritance in Trypanosoma brucei requires a kinetoplastid-specific protein phosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Trypanosoma brucei; parasite; parasitology; protein phosphatase; protein kinase; basal body; flagellum; Hemoflagellate; Polo-like kinase; Trypanosomiasis	POLO-LIKE KINASE; ATTACHMENT ZONE FILAMENT; BASAL BODY DUPLICATION; CELL MORPHOGENESIS; COILED-COIL; CYTOKINESIS; SEGREGATION; BIOGENESIS; PHOSPHORYLATION; DIVISION	Trypanosoma brucei causes sleeping sickness in humans and nagana in cattle in sub-Saharan Africa and alternates between its mammalian hosts and its insect vector, the tsetse fly. T. brucei uses a flagellum for motility, cell division, and cell-cell communication. Proper positioning and attachment of the newly assembled flagellum rely on the faithful duplication and segregation of flagellum-associated cytoskeletal structures. These processes are regulated by the polo-like kinase homolog TbPLK, whose activity and abundance are under stringent control to ensure spatiotemporally regulated phosphorylation of its substrates. However, it remains unclear whether a protein phosphatase that counteracts TbPLK activity is also involved in this regulation. Here, we report that a putative kinetoplastid-specific protein phosphatase, named KPP1, has essential roles in regulating flagellum positioning and attachment in T. brucei. KPP1 localized to multiple flagellum-associated cytoskeletal structures and co-localized with TbPLK in several cytoskeletal structures at different cell-cycle stages. KPP1 depletion abolished basal body segregation, inhibited the duplication of the centrin arm and the hook complex of the bilobe structure, and disrupted the elongation of the flagellum attachment zone, leading to flagellum misplacement and detachment and cytokinesis arrest. Importantly, KPP1-depleted cells lacked dephosphorylation of TbCentrin2, a TbPLK substrate, at late cell-cycle stages. Together, these results suggest that KPP1-mediated protein dephosphorylation regulates the duplication and segregation of flagellum-associated cytoskeletal structures, thereby promoting flagellum positioning and attachment. These findings highlight the requirement of reversible protein phosphorylation, mediated by TbPLK and KPP1, in regulating flagellum inheritance in T. brucei.	[Zhou, Qing; Li, Ziyin] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Dong, Gang] Med Univ Vienna, Vienna Bioctr, Max F Perutz Labs, Dr Bohr Gasse 9, A-1030 Vienna, Austria	University of Texas System; University of Texas Health Science Center Houston; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Li, ZY (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Microbiol & Mol Genet, Houston, TX 77030 USA.	Ziyin.Li@uth.tmc.edu	Zhou, Qing/I-6223-2019; Zhou, Qing/A-8296-2019	Zhou, Qing/0000-0003-2096-1960; Zhou, Qing/0000-0003-2096-1960; Li, Ziyin/0000-0002-3960-9716; Dong, Gang/0000-0001-9745-8103	National Institutes of Health [AI101437, AI118736]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI118736, R01AI101437] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health R01 Grants AI101437 and AI118736 (to Z. L.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Absalon S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000437; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bonhivers M, 2008, PLOS BIOL, V6, P1033, DOI 10.1371/journal.pbio.0060105; Briggs LJ, 2004, J CELL SCI, V117, P1641, DOI 10.1242/jcs.00995; de Graffenried CL, 2008, J CELL BIOL, V181, P431, DOI 10.1083/jcb.200708082; de Graffenried CL, 2013, MOL BIOL CELL, V24, P1947, DOI 10.1091/mbc.E12-12-0911; de Jong RN, 2008, STRUCTURE, V16, P149, DOI 10.1016/j.str.2007.10.018; Eliaz D, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006245; Foley EA, 2011, NAT CELL BIOL, V13, P1265, DOI 10.1038/ncb2327; Gull K, 1999, ANNU REV MICROBIOL, V53, P629, DOI 10.1146/annurev.micro.53.1.629; Hammarton TC, 2007, MOL MICROBIOL, V65, P1229, DOI 10.1111/j.1365-2958.2007.05866.x; He CY, 2005, SCIENCE, V310, P1196, DOI 10.1126/science.1119969; Hu HQ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006146; Hu HQ, 2015, J BIOL CHEM, V290, P25012, DOI 10.1074/jbc.M115.674796; Hu HQ, 2015, EUKARYOT CELL, V14, P898, DOI 10.1128/EC.00083-15; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Ikeda KN, 2012, J CELL SCI, V125, P3173, DOI 10.1242/jcs.101162; Imhof Simon, 2016, F1000Res, V5, P682, DOI 10.12688/f1000research.8249.1; Kohl L, 2003, EMBO J, V22, P5336, DOI 10.1093/emboj/cdg518; Kohl L, 1999, J EUKARYOT MICROBIOL, V46, P105, DOI 10.1111/j.1550-7408.1999.tb04592.x; McAllaster MR, 2015, MOL BIOL CELL, V26, P3013, DOI 10.1091/mbc.E15-04-0219; Moreira BP, 2017, J CELL SCI, V130, P1179, DOI 10.1242/jcs.194308; Morgan GW, 2005, MOL CELL BIOL, V25, P3774, DOI 10.1128/MCB.25.9.3774-3783.2005; Morriswood B, 2009, MOL BIOCHEM PARASIT, V167, P95, DOI 10.1016/j.molbiopara.2009.05.001; Perry JA, 2018, MOL MICROBIOL, V107, P344, DOI 10.1111/mmi.13885; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Schimanski B, 2005, EUKARYOT CELL, V4, P1942, DOI 10.1128/EC.4.11.1942-1950.2005; Selvapandiyan A, 2007, MOL BIOL CELL, V18, P3290, DOI 10.1091/mbc.E07-01-0022; Shi J, 2008, J CELL SCI, V121, P3062, DOI 10.1242/jcs.030643; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Szoor B, 2010, MOL BIOCHEM PARASIT, V173, P53, DOI 10.1016/j.molbiopara.2010.05.017; Umeyama T, 2008, EUKARYOT CELL, V7, P1582, DOI 10.1128/EC.00150-08; Urbaniak MD, 2013, J PROTEOME RES, V12, P2233, DOI 10.1021/pr400086y; Vaughan S, 2008, BIOCHEM SOC T, V36, P421, DOI 10.1042/BST0360421; Vaughan S, 2008, PROTIST, V159, P127, DOI 10.1016/j.protis.2007.08.005; Wang ZF, 2000, J BIOL CHEM, V275, P40174, DOI 10.1074/jbc.M008405200; Wier AD, 2013, P NATL ACAD SCI USA, V110, P17290, DOI 10.1073/pnas.1314754110; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yamashiro S, 2008, DEV CELL, V14, P787, DOI 10.1016/j.devcel.2008.02.013; Yu ZL, 2012, J CELL SCI, V125, P1519, DOI 10.1242/jcs.094243; Zhou Q, 2016, J BIOL CHEM, V291, P14395, DOI 10.1074/jbc.M116.726133; Zhou Q, 2016, P NATL ACAD SCI USA, V113, P3287, DOI 10.1073/pnas.1601596113; Zhou Q, 2015, J CELL SCI, V128, P2361, DOI 10.1242/jcs.168377; Zhou Q, 2011, J CELL SCI, V124, P3848, DOI 10.1242/jcs.087676; Zhou Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009660	45	12	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8508	8520		10.1074/jbc.RA118.002106	http://dx.doi.org/10.1074/jbc.RA118.002106			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666191	Green Published, hybrid			2022-12-26	WOS:000434205700015
J	Tang, Y; Kwon, H; Neel, BA; Kasher-Meron, M; Pessin, JB; Yamada, E; Pessin, JE				Tang, Yan; Kwon, Hyokjoon; Neel, Brian A.; Kasher-Meron, Michal; Pessin, Jacob B.; Yamada, Eijiro; Pessin, Jeffrey E.			The fructose-2,6-bisphosphatase TIGAR suppresses NF-B signaling by directly inhibiting the linear ubiquitin assembly complex LUBAC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS REGULATOR TIGAR; KAPPA-B; TP53-INDUCED GLYCOLYSIS; GLUCOSE-METABOLISM; CELL-DEATH; IKK-BETA; ACTIVATION; INFLAMMATION; PATHWAY; STRESS	The systems integration of whole-body metabolism and immune signaling are central homeostatic mechanisms necessary for maintenance of normal physiology, and dysregulation of these processes leads to a variety of chronic disorders. However, the intracellular mechanisms responsible for cell-autonomous cross-talk between the inflammatory signaling pathways and metabolic flux have remained enigmatic. In this study, we discovered that the fructose-2,6-bisphosphatase TIGAR (Tp53-induced glycolysis and apoptosis regulator) critically regulates NF-B activation. We found that TIGAR potently inhibits NF-B-dependent gene expression by suppressing the upstream activation of IKK phosphorylation and kinase activation. This inhibition occurred through a direct binding competition between NEMO and TIGAR for association with the linear ubiquitination assembly complex (LUBAC). This competition prevented linear ubiquitination of NEMO, which is required for activation of IKK and other downstream targets. Furthermore, a TIGAR phosphatase activity-deficient mutant was equally effective as WT TIGAR in inhibiting NEMO linear ubiquitination, IKK phosphorylation/activation, and NF-B signaling, indicating that TIGAR's effect on NF-B signaling is due to its interaction with LUBAC. Physiologically, TIGAR knockout mice displayed enhanced adipose tissue NF-B signaling, whereas adipocyte-specific overexpression of TIGAR suppressed adipose tissue NF-B signaling. Together, these results demonstrate that TIGAR has a nonenzymatic molecular function that modulates the NF-B signaling pathway by directly inhibiting the E3 ligase activity of LUBAC.	[Tang, Yan; Kasher-Meron, Michal; Pessin, Jacob B.; Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Kwon, Hyokjoon] Rutgers State Univ, Rutgers Robert Wood Johnson Sch Med, Piscataway, NJ 08854 USA; [Neel, Brian A.] BGB Grp, New York, NY 10013 USA; [Yamada, Eijiro] Gunma Univ, Grad Sch Med, Dept Med & Mol Sci, Maebashi, Gunma 3718511, Japan; [Pessin, Jeffrey E.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center; Gunma University; Yeshiva University; Albert Einstein College of Medicine	Pessin, JE (corresponding author), Albert Einstein Coll Med, Dept Med & Mol Pharmacol, Bronx, NY 10461 USA.	Jeffrey.pessin@einstein.yu.edu		Kwon, Hyok Joon/0000-0002-3436-0608	National Institutes of Health [DK033823, DK020541]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020541, R37DK033823, P30DK020541, R01DK033823] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK033823 and DK020541. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Cai DS, 2012, AGING-US, V4, P98, DOI 10.18632/aging.100431; Cheung EC, 2013, DEV CELL, V25, P463, DOI 10.1016/j.devcel.2013.05.001; Emmerich CH, 2013, P NATL ACAD SCI USA, V110, P15247, DOI 10.1073/pnas.1314715110; Fujita H, 2014, MOL CELL BIOL, V34, P1322, DOI 10.1128/MCB.01538-13; Gerin I, 2014, BIOCHEM J, V458, P439, DOI 10.1042/BJ20130841; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Hoshino A, 2012, J MOL CELL CARDIOL, V52, P175, DOI 10.1016/j.yjmcc.2011.10.008; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ikeda F, 2011, NATURE, V471, P637, DOI 10.1038/nature09814; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Kawauchi K, 2008, NAT CELL BIOL, V10, P611, DOI 10.1038/ncb1724; Kong XX, 2017, METHODS MOL BIOL, V1566, P99, DOI 10.1007/978-1-4939-6820-6_10; Kwon H, 2014, CELL REP, V9, P1574, DOI 10.1016/j.celrep.2014.10.068; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Lechtenberg BC, 2016, NATURE, V529, P546, DOI 10.1038/nature16511; Li H, 2009, J BIOL CHEM, V284, P1748, DOI 10.1074/jbc.M807821200; Lui VWY, 2011, ONCOGENE, V30, P1127, DOI 10.1038/onc.2010.490; Martinez-Outschoorn UE, 2010, CELL CYCLE, V9, P3515, DOI 10.4161/cc.9.17.12928; Meininger I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11292; Meyerovich K, 2016, J MOL ENDOCRINOL, V57, pR1, DOI 10.1530/JME-15-0306; Mor I, 2011, COLD SH Q B, V76, P211, DOI 10.1101/sqb.2011.76.010868; Nakajima S, 2013, FREE RADICAL BIO MED, V65, P162, DOI 10.1016/j.freeradbiomed.2013.06.020; Niu JX, 2011, EMBO J, V30, P3741, DOI 10.1038/emboj.2011.264; Okar DO, 2001, TRENDS BIOCHEM SCI, V26, P30, DOI 10.1016/S0968-0004(00)01699-6; Patni N, 2015, NAT REV ENDOCRINOL, V11, P522, DOI 10.1038/nrendo.2015.123; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; Rigden DJ, 2008, BIOCHEM J, V409, P333, DOI 10.1042/BJ20071097; Ruland J, 2011, NAT IMMUNOL, V12, P709, DOI 10.1038/ni.2055; Salminen A, 2010, J CELL PHYSIOL, V224, P1, DOI 10.1002/jcp.22119; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Sasaki K, 2015, IMMUNOL REV, V266, P175, DOI 10.1111/imr.12308; Schaeffer V, 2014, MOL CELL, V54, P349, DOI 10.1016/j.molcel.2014.03.016; Shimizu Y, 2015, IMMUNOL REV, V266, P190, DOI 10.1111/imr.12309; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sinha S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.128; Staal J, 2011, EMBO J, V30, P1742, DOI 10.1038/emboj.2011.85; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Tokunaga F, 2011, NATURE, V471, P633, DOI 10.1038/nature09815; Tokunaga F, 2009, NAT CELL BIOL, V11, P123, DOI 10.1038/ncb1821; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Wang SJ, 2014, CURR OPIN ONCOL, V26, P78, DOI 10.1097/CCO.0000000000000024; Wang YC, 2015, J BIOL CHEM, V290, P24772, DOI 10.1074/jbc.M115.687020; Wanka C, 2012, J BIOL CHEM, V287, P33436, DOI 10.1074/jbc.M112.384578; Yu HP, 2015, SCI REP-UK, V5, DOI 10.1038/srep09853; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444; Zhao LQ, 2016, ONCOTARGET, V7, P31572, DOI 10.18632/oncotarget.7765	54	13	13	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 18	2018	293	20					7578	7591		10.1074/jbc.RA118.002727	http://dx.doi.org/10.1074/jbc.RA118.002727			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GL5ZW	29650758	Green Published, hybrid			2022-12-26	WOS:000437256500011
J	Garcia-Lucio, J; Peinado, VI; de Jover, L; del Pozo, R; Blanco, I; Bonjoch, C; Coll-Bonfill, N; Paul, T; Tura-Ceide, O; Barbera, JA				Garcia-Lucio, Jessica; Peinado, Victor I.; de Jover, Lluis; del Pozo, Roberto; Blanco, Isabel; Bonjoch, Cristina; Coll-Bonfill, Nuria; Paul, Tanja; Tura-Ceide, Olga; Albert Barbera, Joan			Imbalance between endothelial damage and repair capacity in chronic obstructive pulmonary disease	PLOS ONE			English	Article							CIRCULATING PROGENITOR CELLS; POTENTIAL BIOMARKER; SMOKING-CESSATION; COPD PATIENTS; MICROPARTICLES; ATHEROSCLEROSIS; EMPHYSEMA; ARTERIES; SMOKERS; IDENTIFICATION	Background Circulating endothelial microparticles (EMPs) and progenitor cells (PCs) are biological markers of endothelial function and endogenous repair capacity. The study was aimed to investigate whether COPD patients have an imbalance between EMPs to PCs compared to controls and to evaluate the effect of cigarette smoke on these circulating markers. Methods Circulating EMPs and PCs were determined by flow cytometry in 27 nonsmokers, 20 smokers and 61 COPD patients with moderate to severe airflow obstruction. We compared total EMPs (CD31(+)CD42b(-)), apoptotic if they co-expressed Annexin-V+ or activated if they co-expressed CD62E(+), circulating PCs (CD34(+)CD133(+)CD45(+)) and the EMPs/PCs ratio between groups. Results COPD patients presented increased levels of total and apoptotic circulating EMPs, and an increased EMPs/PCs ratio, compared with nonsmokers. Women had less circulating PCs than men through all groups and those with COPD showed lower levels of PCs than both control groups. In smokers, circulating EMPs and PCs did not differ from nonsmokers, being the EMPs/PCs ratio in an intermediate position between COPD and nonsmokers. Conclusions We conclude that COPD patients present an imbalance between endothelial damage and repair capacity that might explain the frequent concurrence of cardiovascular disorders. Factors related to the disease itself and gender, rather than cigarette smoking, may account for this imbalance.	[Garcia-Lucio, Jessica; Peinado, Victor I.; del Pozo, Roberto; Blanco, Isabel; Bonjoch, Cristina; Coll-Bonfill, Nuria; Paul, Tanja; Tura-Ceide, Olga; Albert Barbera, Joan] Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Dept Pulm Med, Barcelona, Spain; [Peinado, Victor I.; Blanco, Isabel; Paul, Tanja; Tura-Ceide, Olga; Albert Barbera, Joan] Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain; [de Jover, Lluis] Univ Barcelona, Dept Publ Hlth, Sch Med, Biostat Unit, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; University of Barcelona	Barbera, JA (corresponding author), Univ Barcelona, Inst Invest Biomed August Pi & Sunyer IDIBAPS, Hosp Clin, Dept Pulm Med, Barcelona, Spain.; Barbera, JA (corresponding author), Ctr Invest Biomed Red Enfermedades Resp CIBERES, Madrid, Spain.	jbarbera@clinic.ub.es	Coll-Bonfill, Nuria/AAM-7251-2020; Tura-Ceide, Olga/D-6120-2014; Jover, Lluis/D-2192-2011	Tura-Ceide, Olga/0000-0003-4334-9790; Jover, Lluis/0000-0003-0631-1398; Peinado, Victor Ivo/0000-0001-9793-9433	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (ISCIII) [PS09/00536, PI12/00510]; ISCIII; Marie Curie Post-Doctoral Fellowship Award BIOTRACK: IDIBAPS	Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos III); ISCIII(Instituto de Salud Carlos III); Marie Curie Post-Doctoral Fellowship Award BIOTRACK: IDIBAPS	Supported by grants from the Fondo de Investigacion Sanitaria, Instituto de Salud Carlos III (ISCIII) (PS09/00536) and (PI12/00510). JGL was the recipient of a predoctoral research fellowship (PFIS) from the ISCIII, and OTC was the recipient of Marie Curie Post-Doctoral Fellowship Award BIOTRACK: IDIBAPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amabile N, 2005, J AM SOC NEPHROL, V16, P3381, DOI 10.1681/ASN.2005050535; Aryal S, 2014, INT J CHRONIC OBSTR, V9, P1145, DOI 10.2147/COPD.S54476; Barbera JA, 2001, AM J RESP CRIT CARE, V164, P709, DOI 10.1164/ajrccm.164.4.2101023; Bartoloni E, 2015, RHEUMATOLOGY, V54, P536, DOI 10.1093/rheumatology/keu320; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Brittan M, 2013, AM J PHYSIOL-LUNG C, V305, pL964, DOI 10.1152/ajplung.00183.2013; Burger D, 2012, J AM SOC HYPERTENS, V6, P85, DOI 10.1016/j.jash.2011.11.003; Caramori G, 2010, THORAX, V65, P554, DOI 10.1136/thx.2009.121640; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; Coxson HO, 2013, LANCET RESP MED, V1, P129, DOI 10.1016/S2213-2600(13)70006-7; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Fadini GP, 2006, STEM CELLS, V24, P1806, DOI 10.1634/stemcells.2005-0440; Feher K, 2014, BIOINFORMATICS, V30, P3372, DOI 10.1093/bioinformatics/btu575; Gordon C, 2011, AM J RESP CRIT CARE, V184, P224, DOI 10.1164/rccm.201012-2061OC; Han MK, 2007, AM J RESP CRIT CARE, V176, P1179, DOI 10.1164/rccm.200704-553CC; Huertas A, 2010, RESP PHYSIOL NEUROBI, V170, P23, DOI 10.1016/j.resp.2009.10.003; Janssen WJ, 2014, COPD, V11, P277, DOI 10.3109/15412555.2013.841668; Jimenez JJ, 2003, THROMB RES, V109, P175, DOI 10.1016/S0049-3848(03)00064-1; Kondo T, 2004, ARTERIOSCL THROM VAS, V24, P1442, DOI 10.1161/01.ATV.0000135655.52088.c5; Lacedonia D, 2016, INT J CHRONIC OBSTR, V11, P527, DOI 10.2147/COPD.S99547; Lee SL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045512; Masuda H, 2007, CIRC RES, V101, P598, DOI 10.1161/CIRCRESAHA.106.144006; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; Minhajat R, 2015, ACTA MED INDONES, V47, P340; Mobarrez F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090314; Mondul AM, 2005, AM J EPIDEMIOL, V162, P1089, DOI 10.1093/aje/kwi324; Nevzati Edin, 2015, Acta Neurochir Suppl, V120, P141, DOI 10.1007/978-3-319-04981-6_24; Palange P, 2006, EUR RESPIR J, V27, P529, DOI 10.1183/09031936.06.00120604; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Peinado VI, 1998, AM J PHYSIOL-LUNG C, V274, pL908, DOI 10.1152/ajplung.1998.274.6.L908; Pirro M, 2006, ARTERIOSCL THROM VAS, V26, P2530, DOI 10.1161/01.ATV.0000243941.72375.15; Pirro M, 2015, EUR J PREV CARDIOL, V22, P1027, DOI 10.1177/2047487314538858; Pizarro S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106163; Pourhoseingholi Mohamad Amin, 2012, Gastroenterol Hepatol Bed Bench, V5, P79; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Sabatier F, 2009, J CELL MOL MED, V13, P454, DOI 10.1111/j.1582-4934.2008.00639.x; Salter BM, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/1472823; Schmidt-Lucke C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013790; Serban KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep31596; Strulovici-Barel Y, 2016, THORAX, V71, P1137, DOI 10.1136/thoraxjnl-2015-208274; Takahashi T, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004571; Takahashi T, 2013, EXP LUNG RES, V39, P155, DOI 10.3109/01902148.2013.784932; Takahashi T, 2012, THORAX, V67, P1067, DOI 10.1136/thoraxjnl-2011-201395; Thomashow MA, 2013, AM J RESP CRIT CARE, V188, P60, DOI 10.1164/rccm.201209-1697OC; Voelkel Norbert F, 2011, Pulm Circ, V1, P320, DOI 10.4103/2045-8932.87295; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Yang Y, 2013, CHIN MED J	48	16	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195724	10.1371/journal.pone.0195724	http://dx.doi.org/10.1371/journal.pone.0195724			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672621	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800039
J	Kibret, S; Wilson, GG; Ryder, D; Tekie, H; Petros, B				Kibret, Solomon; Wilson, G. Glenn; Ryder, Darren; Tekie, Habte; Petros, Beyene			Can water-level management reduce malaria mosquito abundance around large dams in sub-Saharan Africa?	PLOS ONE			English	Article							ENVIRONMENTAL-MANAGEMENT; DETERMINANTS; TRANSMISSION; BURDEN	Background Water level management has been suggested as a potential tool to reduce malaria around large reservoirs. However, no field-based test has been conducted to assess the effect of water level management on mosquito larval abundance in African settings. The objective of the present study is to evaluate the effects of water level drawdown rates on mosquito larval abundance. Methods Twelve experimental dams were constructed on the foreshore of the Koka Dam in Ethiopia. These were grouped into four daily water drawdown treatments, each with three replicates: no water-level drawdown (Group 1; Control), 10 mm.d(-1) (Group 2), 15 mm.d(-1) (Group 3) and 20 mm.d(-1) (Group 4). Larval sampling was conducted weekly for a period of 6 weeks each in the main malaria transmission season (October to November 2013) and subsequent dry season (February to March 2014). Larval densities were compared among treatments over time using repeated measures Analysis of Variance (ANOVA). Results A total of 284 Anopheles mosquito larvae were collected from the experimental dams during the study period. Most (63.4%; n = 180) were collected during the main malaria transmission season while the remaining (36.6%; n = 104) were collected during the dry season. Larvae comprised four Anopheles species, dominated by Anopheles arabiensis (48.1% of total larval samples; n = 136) and An. pharoensis (33.2%; n = 94). Mean larval density was highest in control treatment dams with stable water levels throughout the study, and decreased significantly (P < 0.05) with increasing water drawdown rates in both seasons. During the main transmission season, anopheline larval density was generally lower by 30%, 70% and 84% in Groups 2, Group 3 and Group 4, respectively, compared with the control dams (Group 1). In the dry season, larval density was reduced by 45%, 70% and 84% in Groups 2, Group 3 and Group 4, respectively, when compared to the control dams. Conclusion Increased water drawdown rates were associated with lower mosquito larval abundance. Water level management could thus serve as a potential control measure for malaria vectors around reservoirs by regulating the persistence of shallow shoreline breeding habitats. Dam operators and water resource managers should consider incorporating water level management as a malaria control mechanism into routine dam operations to manage the risk of malaria transmission to human populations around reservoirs.	[Kibret, Solomon; Wilson, G. Glenn; Ryder, Darren] Univ New England, Ecosyst Management, Armidale, NSW, Australia; [Tekie, Habte] Addis Ababa Univ, Dept Zool Sci, Coll Nat Sci, Addis Ababa, Ethiopia; [Petros, Beyene] Addis Ababa Univ, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Kibret, Solomon] Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA; [Wilson, G. Glenn] Univ Southern Denmark, Dept Biol, Campusvej, Odense, Denmark	University of New England; Addis Ababa University; Addis Ababa University; University of California System; University of California Irvine; University of Southern Denmark	Kibret, S (corresponding author), Univ New England, Ecosyst Management, Armidale, NSW, Australia.; Kibret, S (corresponding author), Univ Calif Irvine, Program Publ Hlth, Irvine, CA 92697 USA.	s.kibret@gmail.com	Kibret, Solomon/I-7770-2019	Kibret, Solomon/0000-0003-1793-6908; Wilson, Glenn/0000-0002-8683-4721; Maasho, Habte Tekie/0000-0003-2228-5249	International Foundation for Science [W/4752-2]; University of New England (IPRS scholarship)	International Foundation for Science(International Foundation for Science); University of New England (IPRS scholarship)	SK received funding from the International Foundation for Science (grant no. W/4752-2) and University of New England (IPRS scholarship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	African Union, 2015, PROGR INFR DEV AFR; [Anonymous], WAT RES SECT STRAT O; [Anonymous], 2009, INT WATER MANAGEMENT; [Anonymous], TANZANIA HLTH RES S; Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Carter R, 2000, B WORLD HEALTH ORGAN, V78, P1401; CHRISTOPHER GRIGSBY S., 1957, MOSQUITO NEWS, V17, P273; Endo N., 2014, THESIS; Endo N, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2197-5; Endo N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0644-5; Gemperli A, 2006, TROP MED INT HEALTH, V11, P1032, DOI 10.1111/j.1365-3156.2006.01640.x; Ghebreyesus TA, 1999, BRIT MED J, V319, P663, DOI 10.1136/bmj.319.7211.663; HESS A. D., 1944, Journal of the National Malaria Society, V3, P181; Kaufmann C, 2004, J VECTOR ECOL, V29, P140; Keiser J, 2005, LANCET INFECT DIS, V5, P695, DOI 10.1016/S1473-3099(05)70268-1; Keiser J, 2005, AM J TROP MED HYG, V72, P392, DOI 10.4269/ajtmh.2005.72.392; Kibret S., 2016, THESIS; Kibret S, 2017, ECOHEALTH, V14, P408, DOI 10.1007/s10393-015-1029-0; Kibret S, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0873-2; Kibret S, 2012, TROP MED INT HEALTH, V17, P1320, DOI 10.1111/j.1365-3156.2012.03077.x; KITRON U, 1989, REV INFECT DIS, V11, P391; Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13; Reis J, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR010166; Ribeiro JMC, 1996, B WORLD HEALTH ORGAN, V74, P299; Roll Back Malaria, 2015, GLOB PARTN MAL FREE; Silver J, 2007, MOSQUITO ECOLOGY FIE, Vthird; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Tusting LS, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008923.pub2; Utzinger J, 2001, TROP MED INT HEALTH, V6, P677, DOI 10.1046/j.1365-3156.2001.00769.x; VERRONE G. A., 1962, Mosquito News, V22, P394; World Commission on Dams, 2000, DAMS DEV NEW FRAMEWO; World Health Organization, 2015, 2014 WORLD MAL REP; World Health Organization, 2012, HDB INT VECT MAN; Worrall E, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-338; Zarfl C, 2015, AQUAT SCI, V77, P161, DOI 10.1007/s00027-014-0377-0	36	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196064	10.1371/journal.pone.0196064	http://dx.doi.org/10.1371/journal.pone.0196064			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672560	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800075
J	O'Rand, MG; Hamil, KG; Adevai, T; Zelinski, M				O'Rand, Michael G.; Hamil, Katherine G.; Adevai, Tiffany; Zelinski, Mary			Inhibition of sperm motility in male macaques with EP055, a potential non-hormonal male contraceptive	PLOS ONE			English	Article							EMBRYO-TRANSFER; RHESUS-MONKEY; HUMAN EPPIN; FERTILIZATION; ASSOCIATION; SEMENOGELIN; PROTEIN; SEMEN	Men have two practical choices for contraception; the condom which has a high typical use failure rate or vasectomy. New male hormonal and non-hormonal contraceptives are under development that target either the production of sperm (spermatogenesis) or the delivery of sperm. One particular target is the sperm protein EPPIN, which is present on the surface of human spermatozoa. EP055 is a small organic compound that targets EPPIN on the surface of sperm and inhibits motility. EP055 was tested in cynomolgus (Macaca fascicularis) males to determine its plasma half-life after intravenous (i.v.) infusion of a single dose and for binding to its target tissues. Our initial study demonstrated a plasma half-life for EP055 of 10.6 minutes. In a second study examination of macaque testis, epididymis, and plasma after i.v. infusion of a single dose of compound EP055 (63.25 mg/kg) demonstrated that EP055 was detected in testis and epididymis two hours and six hours post-infusion. We initiated a trial in rhesus (Macaca mulatta) males to assess the availability of EP055 in semen and its effect on sperm motility as a measure of the drug's efficacy. Four macaques were infused with a low dose (75-80 mg/kg) followed by a recovery period and a subsequent high dose (125-130 mg/kg) of EP055. After high dose administration, sperm motility fell to approximately 20% of pretreatment levels within 6 hours post-infusion; no normal motility was observed at 30 hours post-infusion. Recovery of sperm motility was obvious by 78 hours post-infusion; with full recovery in all animals by 18 days post-infusion. EP055 has the potential to be a male contraceptive that would provide a reversible, short-lived pharmacological alternative.	[O'Rand, Michael G.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA; [O'Rand, Michael G.; Hamil, Katherine G.] Eppin Pharma Inc, Res & Dev, Chapel Hill, NC 27514 USA; [Adevai, Tiffany; Zelinski, Mary] Oregon Natl Primate Res Ctr, Div Reprod & Dev Sci, Beaverton, OR USA; [Zelinski, Mary] Oregon Hlth & Sci Univ, Dept Obstet & Gynecol, Portland, OR 97201 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Oregon Health & Science University; Oregon National Primate Research Center; Oregon Health & Science University	O'Rand, MG (corresponding author), Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC 27599 USA.; O'Rand, MG (corresponding author), Eppin Pharma Inc, Res & Dev, Chapel Hill, NC 27514 USA.	morand@eppin.com		Zelinski, Mary/0000-0002-8513-1549; O'Rand, Michael/0000-0002-4540-926X	NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development [R41HD084077]; North Carolina Biotechnology Center; Office of the Director, National Institutes of Health of the National Institutes of Health [P510D011092]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011092] Funding Source: NIH RePORTER	NIH from the Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); North Carolina Biotechnology Center; Office of the Director, National Institutes of Health of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R41HD084077 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to Michael G. O'Rand and in part by the North Carolina Biotechnology Center. Research reported in this publication was supported by the Office of the Director, National Institutes of Health of the National Institutes of Health under Award Number P510D011092. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Eppin Pharma Inc. provided general laboratory supplies and lab space, and financial support in for the form of a salary for Katherine G. Hamil. The specific role of this author is articulated in the 'author contributions' section. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAVISTER BD, 1983, BIOL REPROD, V28, P235, DOI 10.1095/biolreprod28.1.235; Chao JH, 2016, PHARMACOL THERAPEUT, V163, P109, DOI 10.1016/j.pharmthera.2016.03.012; Colagross-Schouten A, 2017, BASIC CLIN ANDROL, V27, DOI 10.1186/s12610-017-0048-9; Contraceptive Use in the United States, 2004, CONTR US US; Du Plessis Stefan Stephanus, 2013, Front Biosci (Elite Ed), V5, P224; DUNCAN JR, 1994, VET LAB MED CLIN PAT; Emami N, 2009, BIOL CHEM, V390, P921, DOI 10.1515/BC.2009.094; Esfandiari N, 2008, FERTIL STERIL, V90, P1739, DOI 10.1016/j.fertnstert.2007.09.032; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; LANZENDORF SE, 1990, MOL REPROD DEV, V25, P61, DOI 10.1002/mrd.1080250111; Mannowetz N, 2017, P NATL ACAD SCI USA, V114, P5743, DOI 10.1073/pnas.1700367114; Marques PI, 2016, HUM REPROD, V31, P2881, DOI 10.1093/humrep/dew267; Mitra A, 2010, BIOL REPROD, V82, P489, DOI 10.1095/biolreprod.109.081331; Nusser KD, 2001, HUM REPROD, V16, P130, DOI 10.1093/humrep/16.1.130; O'Rand MG, 2006, MOL CELL ENDOCRINOL, V250, P157, DOI 10.1016/j.mce.2005.12.039; O'Rand MG, 2004, SCIENCE, V306, P1189, DOI 10.1126/science.1099743; O'Rand MG, 2016, PHARMACOL THERAPEUT, V157, P105, DOI 10.1016/j.pharmthera.2015.11.004; O'Rand MG, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094227; O'Rand MG, 2011, J ANDROL, V32, P698, DOI 10.2164/jandrol.110.012781; O'Rand MG, 2009, BIOL REPROD, V80, P279, DOI 10.1095/biolreprod.108.072942; Richardson RT, 2001, GENE, V270, P93, DOI 10.1016/S0378-1119(01)00462-0; Silva EJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082014; Waller D, 2016, BASIC CLIN ANDROL, P26, DOI [10.1186/s12610-016-0033, DOI 10.1186/S12610-016-0033]; Wang ZJ, 2005, BIOL REPROD, V72, P1064, DOI 10.1095/biolreprod.104.036483; WOLF DP, 1990, MOL REPROD DEV, V27, P261, DOI 10.1002/mrd.1080270313; Yenugu S, 2004, BIOL REPROD, V71, P1484, DOI 10.1095/biolreprod.104.031567	26	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195953	10.1371/journal.pone.0195953	http://dx.doi.org/10.1371/journal.pone.0195953			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672554	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800065
J	Park, SK; Garland, CF; Gorham, ED; BuDoff, L; Barrett-Connor, E				Park, Sue K.; Garland, Cedric F.; Gorham, Edward D.; BuDoff, Luke; Barrett-Connor, Elizabeth			Plasma 25-hydroxyvitamin D concentration and risk of type 2 diabetes and pre-diabetes: 12-year cohort study	PLOS ONE			English	Article							PARATHYROID-HORMONE LEVELS; BONE-MINERAL DENSITY; VITAMIN-D DEFICIENCY; SERUM 25-HYDROXYVITAMIN-D; METABOLIC SYNDROME; INTENSE EXERCISE; PROGRESSION; ASSOCIATION; PREVENTION; HYPERPARATHYROIDISM	Background It has been reported that higher plasma 25-hydroxyvitamin D is associated with lower risk of type 2 diabetes. However the results to date have been mixed and no adequate data based on a cohort are available for the high end of the normal range, above approximately 32 ng/ml or 80 nmol/L. Methods We performed a cohort study of 903 adults who were known to be free of diabetes or prediabetes during a 1997-1999 visit to a NIH Lipid Research Centers clinic. Plasma 25(OH) D was measured at Visit 8 in 1977-1979. The mean age was 74 years. The visit also included fasting plasma glucose and oral glucose tolerance testing. Follow-up continued through 2009. Results There were 47 cases of diabetes and 337 cases of pre-diabetes. Higher 25(OH) D concentrations (> 30 ng/ml) were associated with lower hazard ratios (HR) for diabetes: 30-39 ng/ml or 75-98 nmol/L: HR = 0.31, 95% CI = 0.14-0.70; for 40-49 ng/ml or 100-122 nmol/L: HR = 0.29, CI = 0.12-0.68; for > 50 ng/ml or 125 nmol/L: HR = 0.19, CI = 0.06-0.56. All HRs are compared to < 30 ng/ml or 75 nmol/L. There was an inverse dose-response gradient between 25(OH) D concentration and risk of diabetes with a p for trend of 0.005. Each 10 ng/mL or 25 nmol/L higher 25(OH) D concentration was associated with a HR of 0.64, CI = 0.48-0.86. 25(OH) D concentrations were more weakly inversely associated with pre-diabetes risk, and the trend was not significant. Conclusion Further research is needed on whether high 25(OH) D might prevent type 2 diabetes or transition of prediabetes to diabetes.	[Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Garland, Cedric F.; Gorham, Edward D.; BuDoff, Luke; Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); University of California System; University of California San Diego	Garland, CF (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.	cgarland@ucsd.edu			National Institutes of Health/National Institute on Aging [AG07181, AG028507]; National Institute of Diabetes and Digestive and Kidney Diseases [DK31801]	National Institutes of Health/National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health/National Institute on Aging grants AG07181 and AG028507 (EBC); National Institute of Diabetes and Digestive and Kidney Diseases, grant DK31801 (EBC).	Afzal S, 2013, CLIN CHEM, V59, P381, DOI 10.1373/clinchem.2012.193003; Anderson JL, 2010, AM J CARDIOL, V106, P963, DOI 10.1016/j.amjcard.2010.05.027; [Anonymous], 1976, Prev Med, V5, P207; Antoniucci DM, 2005, CLIN CHEM, V51, P258; Barker T, 2014, CYTOKINE, V65, P134, DOI 10.1016/j.cyto.2013.12.004; Binkley N, 2004, J CLIN ENDOCR METAB, V89, P3152, DOI 10.1210/jc.2003-031979; Bischoff-Ferrari Heike A, 2014, Adv Exp Med Biol, V810, P500; Bouillon R, 2008, ENDOCR REV, V29, P726, DOI 10.1210/er.2008-0004; Burgi AA, 2011, J BONE MINER RES, V26, P2371, DOI 10.1002/jbmr.451; Chacko SA, 2011, AM J CLIN NUTR, V94, P209, DOI 10.3945/ajcn.110.010272; Chamberlain JJ, 2016, ANN INTERN MED, V164, P542, DOI 10.7326/M15-3016; CHEN TC, 1990, J NUTR BIOCHEM, V1, P315, DOI 10.1016/0955-2863(90)90067-U; Chiu KC, 2000, METABOLISM, V49, P1501, DOI 10.1053/meta.2000.17708; Conroy S, 2003, AGE AGEING, V32, P571, DOI 10.1093/ageing/afg122; Deleskog A, 2012, DIABETOLOGIA, V55, P1668, DOI 10.1007/s00125-012-2529-x; Forouhi NG, 2012, DIABETOLOGIA, V55, P2173, DOI 10.1007/s00125-012-2544-y; Gagnon C, 2011, DIABETES CARE, V34, P1133, DOI 10.2337/dc10-2167; Garland CF, 2009, ANN EPIDEMIOL, V19, P468, DOI 10.1016/j.annepidem.2009.03.021; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Giovannucci E, 2008, ARCH INTERN MED, V168, P1174, DOI 10.1001/archinte.168.11.1174; Gonzalez-Molero I, 2012, CLIN NUTR, V31, P571, DOI 10.1016/j.clnu.2011.12.001; Grimnes G, 2010, DIABETIC MED, V27, P1107, DOI 10.1111/j.1464-5491.2010.03092.x; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Heikes KE, 2008, DIABETES CARE, V31, P1040, DOI 10.2337/dc07-1150; Hidayat Rudy, 2010, Acta Med Indones, V42, P123; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Husemoen LLN, 2012, EUR J CLIN NUTR, V66, P1309, DOI 10.1038/ejcn.2012.134; Jorde R, 2016, J CLIN ENDOCR METAB, V101, P1647, DOI 10.1210/jc.2015-4013; Kahn HS, 2009, ANN INTERN MED, V150, P741, DOI 10.7326/0003-4819-150-11-200906020-00002; Khan H, 2013, P NUTR SOC, V72, P89, DOI 10.1017/S0029665112002765; Knekt P, 2008, EPIDEMIOLOGY, V19, P666, DOI 10.1097/EDE.0b013e318176b8ad; LaDochy S, 2007, CLIM RES, V33, P159, DOI 10.3354/cr033159; Lips P, 2001, ENDOCR REV, V22, P477, DOI 10.1210/er.22.4.477; Lips P, 2007, J BONE MINER RES, V22, P1668, DOI 10.1359/JBMR.070716; Marliss EB, 2002, DIABETES, V51, pS271, DOI 10.2337/diabetes.51.2007.S271; Pittas AG, 2012, DIABETES CARE, V35, P565, DOI 10.2337/dc11-1795; Pittas AG, 2010, DIABETES CARE, V33, P2021, DOI 10.2337/dc10-0790; Reis JP, 2007, DIABETES CARE, V30, P1549, DOI 10.2337/dc06-2438; Robinson JG, 2011, DIABETES CARE, V34, P628, DOI 10.2337/dc10-1632; Saquib N, 2006, OSTEOPOROSIS INT, V17, P1734, DOI 10.1007/s00198-006-0191-1; Schafer AL, 2014, DIABETIC MED, V31, P564, DOI 10.1111/dme.12368; Schottker B, 2013, EUR J EPIDEMIOL, V28, P267, DOI 10.1007/s10654-013-9769-z; SIMPSON RU, 1985, J BIOL CHEM, V260, P8882; Song YQ, 2013, DIABETES CARE, V36, P1422, DOI 10.2337/dc12-0962; STAMP TCB, 1974, NATURE, V247, P563, DOI 10.1038/247563a0; Thorand B, 2011, DIABETES CARE, V34, P2320, DOI 10.2337/dc11-0775; Tohidi M, 2013, DIABETIC MED, V30, P934, DOI 10.1111/dme.12180; Tsur A, 2013, DIABETES CARE, V36, P1361, DOI 10.2337/dc12-1050; von Muhlen DG, 2005, OSTEOPOROSIS INT, V16, P1721, DOI 10.1007/s00198-005-1910-8; Wolden-Kirk H, 2011, MOL CELL ENDOCRINOL, V347, P106, DOI 10.1016/j.mce.2011.08.016	52	33	33	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0193070	10.1371/journal.pone.0193070	http://dx.doi.org/10.1371/journal.pone.0193070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672520	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800005
J	Berg, L; Brannstrom, L				Berg, Lisa; Brannstrom, Lars			Evicted children and subsequent placement in out-of-home care: A cohort study	PLOS ONE			English	Article							FAMILY STRESS MODEL; FOSTER-CARE; FINANCIAL CRISIS; PUBLIC CARE; HEALTH; RISK; MALTREATMENT; FORECLOSURE; INVOLVEMENT; EVICTIONS	Background Evictions may have serious consequences for individuals' health and wellbeing. Even though an eviction may be experienced as a significant crisis for the family, there is little previous knowledge on consequences for evicted children. This study represents the first attempt to examine to what extent children from evicted households were separated from their parents and placed in out-of-home care (foster family or residential care) using population-based data, net of observed confounding factors related to the socioeconomic and psychosocial circumstances of their parents. Methods This study takes advantage of information from a Swedish national database, consisting of about 8 000 evicted individuals and a random sample of 770 000 individuals from the national population, linked to individual-level, longitudinal data from Swedish national registers. Our analytical sample consists of information for more than 250 000 children born in 1995-2008, including 2 224 children from evicted households. We used binary logistic regression based on the Karlson/Holm/Breen method to account for observed imbalances at baseline between evicted and non-evicted children. Results Compared to non-evicted children, the crude odds ratio for placement in out-of-home care in evicted children was 12.10 (95% CI 8.54-17.14). Net of observed confounding factors related to the socioeconomic and psychosocial circumstances of the parents, evicted children had a twofold elevated risk of being placed in out-of-home care (odds ratio 2.26, 95% CI 1.55-3.27). Crude OR for evicted children in comparison with children under threat of eviction (eviction not formally executed) was 1.71 (95% CI 1.17-2.49) and adjusted OR 1.58 (95% CI 1.06-2.35). Conclusion Children who experience eviction constitute a disadvantaged group and are at significant risk of being separated from their parents and placed in out-of-home care. These results demonstrate the importance of providing support for these children and their parents. Strategies to prevent households with children from being evicted seem to be an important and viable intervention path.	[Berg, Lisa] Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equ Studies, Stockholm, Sweden; [Berg, Lisa] Stockholm Univ, Swedish Inst Social Res, Stockholm, Sweden; [Brannstrom, Lars] Stockholm Univ, Dept Social Work, Stockholm, Sweden	Stockholm University; Stockholm University; Stockholm University	Berg, L (corresponding author), Stockholm Univ, Dept Publ Hlth Sci, Ctr Hlth Equ Studies, Stockholm, Sweden.; Berg, L (corresponding author), Stockholm Univ, Swedish Inst Social Res, Stockholm, Sweden.	lisa.berg@su.se		Berg, Lisa/0000-0002-8707-180X	Swedish Research Council for Health, Working Life and Welfare [2013-0452]	Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This work was supported by the Swedish Research Council for Health, Working Life and Welfare, grant number 2013-0452, http://forte.se/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SH, 2014, SOC FORCES, V93, P269, DOI 10.1093/sf/sou027; Angrist JD, 2009, MOSTLY HARMLESS ECONOMETRICS: AN EMPIRICISTS COMPANION, P1; [Anonymous], 2014, THESIS; Berger LM, 2015, PEDIATRICS, V136, P299, DOI 10.1542/peds.2014-2832; Bergstrom M, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-868; Brannstrom L, 2017, CHILD MALTREATMENT, V22, P205, DOI 10.1177/1077559517701855; Caliendo M, 2017, LABOUR ECON, V46, P14, DOI 10.1016/j.labeco.2017.02.001; Cameron CA, 2011, HDB EMPIRICAL EC FIN, P1; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; Coulton CJ, 1999, CHILD ABUSE NEGLECT, V23, P1019, DOI 10.1016/S0145-2134(99)00076-9; Coulton CJ, 2007, CHILD ABUSE NEGLECT, V31, P1117, DOI 10.1016/j.chiabu.2007.03.023; Cowal K, 2002, AM J COMMUN PSYCHOL, V30, P711, DOI 10.1023/A:1016325332527; Crane M, 2000, HOUSING STUD, V15, P757, DOI 10.1080/02673030050134592; Culhane JF, 2003, J SOCIOLOGY SOCIAL W, V30; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Desmond M, 2016, URBAN AFF REV, V52, P421, DOI 10.1177/1078087415589192; Desmond M, 2016, SOC PROBL, V63, P46, DOI 10.1093/socpro/spv025; Desmond M, 2015, SOC FORCES, V94, P295, DOI 10.1093/sf/sov044; Desmond M, 2012, AM J SOCIOL, V118, P88, DOI 10.1086/666082; Eisenstein Qvarfordt, 2016, THESIS; Fernandez E., 2010, DOES FOSTER CARE WOR; Fowler KA, 2015, AM J PUBLIC HEALTH, V105, P311, DOI 10.2105/AJPH.2014.301945; Fowler PJ, 2013, AM J COMMUN PSYCHOL, V52, P106, DOI 10.1007/s10464-013-9580-8; Fox O'Mahony L., 2006, CONCEPTUALISING HOME; Fransson E, 2016, SCAND J PUBLIC HEALT, V44, P177, DOI 10.1177/1403494815614463; Franzen E, 2008, BRIT J SOC WORK, V38, P1043, DOI 10.1093/bjsw/bcl380; Hartman C, 2003, HOUS POLICY DEBATE, V14, P461; Hertzman C., 2010, CHAOS ITS INFLUENCE; Kaariala A, 2017, CHILD YOUTH SERV REV, V79, P107, DOI 10.1016/j.childyouth.2017.05.030; Karlson KB, 2012, SOCIOL METHODOL, V42, P286, DOI 10.1177/0081175012444861; Kenna P, 2016, PILOT PROJECT PROMOT; Kling S, 2016, ACTA PAEDIATR, V105, P416, DOI 10.1111/apa.13304; Kohler M, 2015, ACTA PAEDIATR, V104, P508, DOI 10.1111/apa.12901; Kohler U, 2011, STATA J, V11, P420, DOI 10.1177/1536867X1101100306; Kronofogdemyndigheten [Swedish Enforment Agency], 2015, AVHYSN 1982 2015; McLaughlin KA, 2012, PSYCHOL MED, V42, P1441, DOI 10.1017/S0033291711002613; Molnar BE, 2016, CHILD ABUSE NEGLECT, V51, P41, DOI 10.1016/j.chiabu.2015.11.007; Neppl TK, 2016, J FAM PSYCHOL, V30, P12, DOI 10.1037/fam0000168; Nilsson A, 2004, EKONOMISKT UTSATTA B, V2004, P41; Nilsson A, 2004, MARGINALISERINGSPROC, V1, P14; Park JM, 2004, CHILD WELFARE, V83, P423; Pollack CE, 2009, AM J PUBLIC HEALTH, V99, P1833, DOI 10.2105/AJPH.2009.161380; Rodriguez JM, 2016, CHILD ABUSE NEGLECT, V57, P41, DOI 10.1016/j.chiabu.2016.06.004; Rojas Y, 2016, J EPIDEMIOL COMMUN H, V70, P409, DOI 10.1136/jech-2015-206419; Rosenberg R, 2018, J PUBLIC CHILD WELF, V12, P99, DOI 10.1080/15548732.2017.1347551; Shah BR, 2005, J CLIN EPIDEMIOL, V58, P550, DOI 10.1016/j.jclinepi.2004.10.016; Shuey EA, 2017, CHILD YOUTH SERV REV, V72, P52, DOI 10.1016/j.childyouth.2016.09.031; Simkiss DE, 2013, CHILD CARE HLTH DEV, V39, P628, DOI 10.1111/cch.12010; Stenberg S, 2011, VARFOR VRAKS BARN FO; Swann CA, 2006, DEMOGRAPHY, V43, P309, DOI 10.1353/dem.2006.0019; Tsai AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123182; Turney K, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-1118; van Laere IR, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-3; Vasquez-Vera H, 2017, SOC SCI MED, V175, P199, DOI 10.1016/j.socscimed.2017.01.010; Viner RM, 2005, PEDIATRICS, V115, P894, DOI 10.1542/peds.2004-1311; von Otter C., 2017, EUROPEAN J HOMELESSN, V11, P1; Wallgren A, 2007, ADM DATA STAT PURPOS; Warren EJ, 2015, SOC SERV REV, V89, P9, DOI 10.1086/680043; Zlotnick C, 1998, AM J PUBLIC HEALTH, V88, P1368, DOI 10.2105/AJPH.88.9.1368; Zlotnick C, 2003, ADDICT BEHAV, V28, P1373, DOI 10.1016/S0306-4603(02)00261-7	60	6	6	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195295	10.1371/journal.pone.0195295	http://dx.doi.org/10.1371/journal.pone.0195295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668737	gold, Green Submitted, Green Published			2022-12-26	WOS:000430290200038
J	Levi, A; Sabuco, J; Small, M; Sanjuan, MAF				Levi, Asaf; Sabuco, Juan; Small, Michael; Sanjuan, Miguel A. F.			From local uncertainty to global predictions: Making predictions on fractal basins	PLOS ONE			English	Article							WADA BASINS; BOUNDARIES; DIMENSION	In nonlinear systems long term dynamics is governed by the attractors present in phase space. The presence of a chaotic saddle gives rise to basins of attraction with fractal boundaries and sometimes even to Wada boundaries. These two phenomena involve extreme difficulties in the prediction of the future state of the system. However, we show here that it is possible to make statistical predictions even if we do not have any previous knowledge of the initial conditions or the time series of the system until it reaches its final state. In this work, we develop a general method to make statistical predictions in systems with fractal basins. In particular, we have applied this new method to the Duffing oscillator for a choice of parameters where the system possesses the Wada property. We have computed the statistical properties of the Duffing oscillator for different phase space resolutions, to obtain information about the global dynamics of the system. The key idea is that the fraction of initial conditions that evolve towards each attractor is scale free-which we illustrate numerically. We have also shown numerically how having partial information about the initial conditions of the system does not improve in general the predictions in the Wada regions.	[Levi, Asaf; Sabuco, Juan; Sanjuan, Miguel A. F.] Univ Rey Juan Carlos, Dept Fis, Nonlinear Dynam Chaos & Complex Syst Grp, Madrid, Spain; [Sabuco, Juan] Univ Oxford, Inst New Econ Thinking, Math Inst, Oxford Martin Sch, Oxford, England; [Small, Michael] Univ Western Australia, Sch Math & Stat, Crawley, Australia; [Sanjuan, Miguel A. F.] Kaunas Univ Technol, Dept Appl Informat, Kaunas, Lithuania; [Sanjuan, Miguel A. F.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	Universidad Rey Juan Carlos; University of Oxford; University of Western Australia; Kaunas University of Technology; University System of Maryland; University of Maryland College Park	Sabuco, J (corresponding author), Univ Rey Juan Carlos, Dept Fis, Nonlinear Dynam Chaos & Complex Syst Grp, Madrid, Spain.; Sabuco, J (corresponding author), Univ Oxford, Inst New Econ Thinking, Math Inst, Oxford Martin Sch, Oxford, England.	juan.sabuco@urjc.es	Sanjuán, Miguel AF/B-7709-2011; Small, Michael/C-9807-2010	Sanjuán, Miguel AF/0000-0003-3515-0837; Small, Michael/0000-0001-5378-1582	Spanish Ministry of Economy and Competitiveness [FIS2013-40653-P]; Spanish State Research Agency (AEI); European Regional Development Fund (FEDER) [FIS2016-76883-P]; Fulbright Program; Spanish Ministry of Education [FMECD-ST-2016]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish State Research Agency (AEI)(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Fulbright Program; Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness under project number FIS2013-40653-P and by the Spanish State Research Agency (AEI) and the European Regional Development Fund (FEDER) under project number FIS2016-76883-P. MAFS acknowledges the jointly sponsored financial support by the Fulbright Program and the Spanish Ministry of Education (Program No. FMECD-ST-2016).	Aguirre J, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066208; Aguirre J, 2002, PHYSICA D, V171, P41, DOI 10.1016/S0167-2789(02)00565-1; Aguirre J, 2009, REV MOD PHYS, V81, P333, DOI 10.1103/RevModPhys.81.333; Caflisch R. E., 1998, Acta Numerica, V7, P1, DOI 10.1017/S0962492900002804; Cuomo K. M., 1993, ICASSP-93. 1993 IEEE International Conference on Acoustics, Speech, and Signal Processing (Cat. No.92CH3252-4), P137, DOI 10.1109/ICASSP.1993.319454; Daza A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31416; Dudul SV, 2005, APPL SOFT COMPUT, V5, P333, DOI 10.1016/j.asoc.2004.07.005; Duffing G., 1918, ZAMM Z ANGEW MATH ME; El-Dib Y. O., 2017, NONLINEAR SCI LETT A, V9, P352; He JH, 2016, NONLINEAR SCI LETT, V7, P77; Kapitaniak M, 2012, CHAOS, V22, DOI 10.1063/1.4746038; KENNEDY J, 1991, PHYSICA D, V51, P213, DOI 10.1016/0167-2789(91)90234-Z; MANDELBROT B, 1967, SCIENCE, V156, P636, DOI 10.1126/science.156.3775.636; Mandelbrot B.B, 1982, FRACTAL GEOMETRY NAT; MCDONALD SW, 1985, PHYSICA D, V17, P125, DOI 10.1016/0167-2789(85)90001-6; Menck PJ, 2013, NAT PHYS, V9, P89, DOI 10.1038/nphys2516; Metze K, 2013, EXPERT REV MOL DIAGN, V13, P719, DOI 10.1586/14737159.2013.828889; Poon L, 1996, INT J BIFURCAT CHAOS, V6, P251, DOI 10.1142/S0218127496000035; SOMMERER JC, 1995, J HOPKINS APL TECH D, V16, P333; Toroczkai Z, 1997, PHYSICA A, V239, P235, DOI 10.1016/S0378-4371(96)00482-7; Ungar S, 2007, AM MATH MON, V114, P61, DOI 10.1080/00029890.2007.11920392	21	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194926	10.1371/journal.pone.0194926	http://dx.doi.org/10.1371/journal.pone.0194926			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668687	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200019
J	Brunwasser, SM; Gebretsadik, T; Gold, DR; Turi, KN; Stone, CA; Datta, S; Gern, JE; Hertert, TV				Brunwasser, Steven M.; Gebretsadik, Tebeb; Gold, Diane R.; Turi, Kedir N.; Stone, Cosby A., Jr.; Datta, Soma; Gern, James E.; Hertert, Tina V.			A new model of wheezing severity in young children using the validated ISAAC wheezing module: A latent variable approach with validation in independent cohorts	PLOS ONE			English	Article							ASTHMA CONTROL; CHILDHOOD ASTHMA; FIT INDEXES; RISK-FACTORS; RMSEA; INVARIANCE; ALLERGIES; EXPOSURE; BIRTH	Background The International Study of Asthma and Allergies in Children (ISAAC) Wheezing Module is commonly used to characterize pediatric asthma in epidemiological studies, including nearly all airway cohorts participating in the Environmental Influences on Child Health Outcomes (ECHO) consortium. However, there is no consensus model for operationalizing wheezing severity with this instrument in explanatory research studies. Severity is typically measured using coarsely-defined categorical variables, reducing power and potentially underestimating etiological associations. More precise measurement approaches could improve testing of etiological theories of wheezing illness. Methods We evaluated a continuous latent variable model of pediatric wheezing severity based on four ISAAC Wheezing Module items. Analyses included subgroups of children from three independent cohorts whose parents reported past wheezing: infants ages 0-2 in the INSPIRE birth cohort study (Cohort 1; n = 657), 6-7-year-old North American children from Phase One of the ISAAC study (Cohort 2; n = 2,765), and 5-6-year-old children in the EHAAS birth cohort study (Cohort 3; n = 102). Models were estimated using structural equation modeling. Results In all cohorts, covariance patterns implied by the latent variable model were consistent with the observed data, as indicated by non-significant chi(2) goodness of fit tests (no evidence of model misspecification). Cohort 1 analyses showed that the latent factor structure was stable across time points and child sexes. In both cohorts 1 and 3, the latent wheezing severity variable was prospectively associated with wheeze-related clinical outcomes, including physician asthma diagnosis, acute corticosteroid use, and wheeze-related outpatient medical visits when adjusting for confounders Conclusion We developed an easily applicable continuous latent variable model of pediatric wheezing severity based on items from the well-validated ISAAC Wheezing Module. This model prospectively associates with asthma morbidity, as demonstrated in two ECHO birth cohort studies, and provides a more statistically powerful method of testing etiologic hypotheses of childhood wheezing illness and asthma.	[Brunwasser, Steven M.; Turi, Kedir N.; Stone, Cosby A., Jr.; Hertert, Tina V.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, T-1218 Med Ctr North, Nashville, TN 37235 USA; [Brunwasser, Steven M.] Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, B-1118 MCN, Nashville, TN 37232 USA; [Gebretsadik, Tebeb] Vanderbilt Univ, Med Ctr, Dept Biostat, Nashville, TN USA; [Gold, Diane R.] Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Gold, Diane R.] Harvard Med Sch, Dept Environm Hlth, Boston, MA USA; [Gold, Diane R.; Datta, Soma] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Gern, James E.] Univ Wisconsin, Dept Pediat, Sch Med & Publ Hlth, K4-918 CSC, Madison, WI USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; University of Wisconsin System; University of Wisconsin Madison	Brunwasser, SM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med, T-1218 Med Ctr North, Nashville, TN 37235 USA.; Brunwasser, SM (corresponding author), Vanderbilt Univ, Med Ctr, Dept Obstet & Gynecol, B-1118 MCN, Nashville, TN 37232 USA.	steven.brunwasser@vanderbilt.edu		Turi, Kedir/0000-0002-3853-9357; Brunwasser, Steven/0000-0002-3476-5437	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U19 Al 095227]; National Institutes of Health/Office of the Director [UG3 0D023282]; National Institutes of Health Midcareer Investigator Award [K24 Al 077930]; Agency for Healthcare Research and Quality [K12 HS022990]; National Institute of Allergy and Infectious Diseases [RO1 A1035786]; CREW consortium, Office of The Director, National Institutes of Health [UG3 0D023282]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS022990] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445, UL1TR002243] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI095227, K24AI077930] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018921] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [UG3OD023282] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000624] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health/Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Midcareer Investigator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CREW consortium, Office of The Director, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by U19 Al 095227, National Institutes of Health/National Institute of Allergy and Infectious Diseases (https://www.niaidsiih.gov/) to TVH; UG3 0D023282, National Institutes of Health/Office of the Director (https://www.nih.gov/institutes-nihinih-office-director) to JEG; K24 Al 077930, National Institutes of Health Midcareer Investigator Award (https:// www.nih.gov/) to TVH; K12 HS022990, Agency for Healthcare Research and Quality (https://www.ahm.gov/) to SMB; RO1 A1035786, National Institute of Allergy and Infectious Diseases to DRG. Research reported in this publication was supported by the CREW consortium, Office of The Director, National Institutes of Health under award number UG3 0D023282. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher I, 2007, PEDIATR PULM, V42, P100, DOI 10.1002/ppul.20525; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Asparouhov T., 2010, MPLUSTECHNICAL APPEN; Bagozzi RP, 2012, J ACAD MARKET SCI, V40, P8, DOI 10.1007/s11747-011-0278-x; BAILEY WC, 1992, AM J MED, V93, P263, DOI 10.1016/0002-9343(92)90231-Y; Barnett SBL, 2011, J ALLERGY CLIN IMMUN, V127, P145, DOI 10.1016/j.jaci.2010.10.020; Bauer DJ, 2003, J EDUC BEHAV STAT, V28, P135, DOI 10.3102/10769986028002135; Bentler P M, 1992, Stat Methods Med Res, V1, P159, DOI 10.1177/096228029200100203; Bentler PM, 2007, PERS INDIV DIFFER, V42, P825, DOI 10.1016/j.paid.2006.09.024; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239; Bollen KA, 1989, STRUCTURAL EQUATIONS; Bollen KA, 2011, PSYCHOL METHODS, V16, P265, DOI 10.1037/a0024448; Burke H, 2012, PEDIATRICS, V129, P735, DOI 10.1542/peds.2011-2196; Castro-Rodriguez JA, 2000, AM J RESP CRIT CARE, V162, P1403, DOI 10.1164/ajrccm.162.4.9912111; Castro-Rodriguez JA, 2016, J ALLER CL IMM-PRACT, V4, P1111, DOI 10.1016/j.jaip.2016.05.003; Chen FN, 2008, SOCIOL METHOD RES, V36, P462, DOI 10.1177/0049124108314720; Cloutier MM, 2012, J ALLERGY CLIN IMMUN, V129, pS24, DOI 10.1016/j.jaci.2011.12.980; Cockcroft DW, 1996, J ALLERGY CLIN IMMUN, V98, P1016, DOI 10.1016/S0091-6749(96)80185-0; Cole DA, 2014, PSYCHOL METHODS, V19, P300, DOI 10.1037/a0033805; Correia MAD, 2017, J PEDIAT-BRAZIL, V93, P148, DOI [10.1016/j.jped.2016.05.006, 10.1015/j.jped.2016.05.006]; Ellwood P, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.01605-2016; Geier DA, 2019, J MATERN-FETAL NEO M, V32, P833, DOI 10.1080/14767058.2017.1393068; Gold DR, 1999, AM J RESP CRIT CARE, V160, P227, DOI 10.1164/ajrccm.160.1.9807104; Hirschfeld G, 2014, PRACT ASSESS RES EVA, P19; Horner SD, 2006, J ASTHMA, V43, P533, DOI 10.1080/02770900600857192; Hox J, 2004, MATH MODEL-THEOR APP, V19, P135; Hu LT, 1998, PSYCHOL METHODS, V3, P424, DOI 10.1037/1082-989X.3.4.424; Larkin EK, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0040-0; Lim RH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010134; Little TD, 2007, INT J BEHAV DEV, V31, P357, DOI 10.1177/0165025407077757; Liu AH, 2007, J ALLERGY CLIN IMMUN, V119, P817, DOI 10.1016/j.jaci.2006.12.662; Liu Y, 2017, PSYCHOL METHODS, V22, P486, DOI 10.1037/met0000075; Ly NP, 2006, PEDIATRICS, V117, pE1132, DOI 10.1542/peds.2005-2271; Magzoub A, 2017, INT J MED SCI PUBLIC, P6; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Moncrief T, 2014, J ASTHMA, V51, P260, DOI 10.3109/02770903.2013.873806; MUTHEN B, 1984, PSYCHOMETRIKA, V49, P115, DOI 10.1007/BF02294210; Muthen B.O., 2004, MPLUS TECHNICAL APPE; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; MuthUn B., 2002, MPLUS WEB NOTES, V4, P4, DOI DOI 10.1007/S10519-008-9237-9; Nathan RA, 2004, J ALLERGY CLIN IMMUN, V113, P59, DOI 10.1016/j.jaci.2003.09.008; O'Byrne PM, 2010, EUR RESPIR J, V36, P269, DOI 10.1183/09031936.00124009; Oluwole O, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0352-8; Pearson WS, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.140139; RCore Team, 2020, R LANG ENV STAT COMP; Rigdon EE, 2012, LONG RANGE PLANN, V45, P341, DOI 10.1016/j.lrp.2012.09.010; Rigdon EE, 1996, STRUCT EQU MODELING, V3, P369, DOI 10.1080/10705519609540052; Rosas-Salazar C, 2016, J INFECT DIS, V214, P1924, DOI 10.1093/infdis/jiw456; ROSIER MJ, 1994, AM J RESP CRIT CARE, V149, P1434, DOI 10.1164/ajrccm.149.6.8004295; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Satorra A, 2000, ADV ST THEO, V36, P233; Schmidt CW, 2015, ENVIRON HEALTH PERSP, V123, pA260, DOI 10.1289/ehp.123-A260; Stapleton LM, 2016, J EDUC BEHAV STAT, V41, P481, DOI 10.3102/1076998616646200; Steiger J, 1980, M PSYCH SOC MAY LOW; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Steiger JH, 2000, STRUCT EQU MODELING, V7, P149, DOI 10.1207/S15328007SEM0702_1; Taylor AB, 2006, EDUC PSYCHOL MEAS, V66, P228, DOI 10.1177/0013164405278580; Thakur N, 2013, AM J RESP CRIT CARE, V188, P1202, DOI 10.1164/rccm.201306-1016OC; Thavagnanam S, 2008, CLIN EXP ALLERGY, V38, P629, DOI 10.1111/j.1365-2222.2007.02780.x; Toledo M F, 2016, Allergol Immunopathol (Madr), V44, P439, DOI 10.1016/j.aller.2016.02.006; Tse SM, 2016, J ALLERGY CLIN IMMUN, V138, P1561, DOI 10.1016/j.jaci.2016.04.005; Tse SM, 2015, PEDIATR PULM, V50, P955, DOI 10.1002/ppul.23113; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Westland JC, 2010, ELECTRON COMMER R A, V9, P476, DOI 10.1016/j.elerap.2010.07.003; Wildfire JJ, 2012, J ALLERGY CLIN IMMUN, V129, P694, DOI 10.1016/j.jaci.2011.12.962; Zein JG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157301	69	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194739	10.1371/journal.pone.0194739	http://dx.doi.org/10.1371/journal.pone.0194739			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664908	Green Submitted, gold, Green Published			2022-12-26	WOS:000430262300010
J	Chen, YM; Liu, XY; Zhang, FB; Liao, SF; He, XY; Zhuo, DX; Huang, HB; Wu, YY				Chen, YongMing; Liu, XinYu; Zhang, FaBiao; Liao, ShanFan; He, XiYuan; Zhuo, DeXiang; Huang, HuaiBin; Wu, YongYang			Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5	PLOS ONE			English	Article							CIRCULATING 25-HYDROXYVITAMIN D-3; CANCER-CELLS; BREAST-CANCER; COLORECTAL-CANCER; LUNG-CANCER; E-CADHERIN; RISK; METAANALYSIS; DIFFERENTIATION; SURVIVAL	We previously demonstrated that transient receptor potential vanilloid subfamily 5 (TRPV5) expression was decreased in renal cell carcinoma (RCC) compared with that in normal kidney tissues, a finding that was correlated with vitamin D receptor (VDR) expression, but further investigations is warranted. The aim of this study was to elucidate whether VDR could regulate the expression of TRPV5 and affect proliferation and metastasis in RCC. In this study, we used lentivirus to conduct the model of VDR overexpression and knockdown caki-1 and 786-O RCC cell lines in vitro. The results demonstrated that VDR overexpression significantly inhibited RCC cells proliferation, migration and invasion, and promoted apoptosis by the MTT, transwell cell migration/invasion and flow cytometry assays, respectively. However, VDR knockdown in RCC cells had the opposite effect. The RNA-sequence assay, which was assessed in caki-1 cells after VDR overexpression and knockdown, also indicated that significantly differentially expressed genes were associated with cell apoptotic, differentiation, proliferation and migration. RT-PCR and western blot analysis showed that VDR knockdown increased TRPV5 expression and VDR overexpression decreased TRPV5 expression in caki-1 cells. Furthermore, knockdown of TRPV5 expression suppressed the VDR knockdown-induced change in the proliferation, migration and invasion in caki-1 cells. Taken together, these findings confirmed that VDR functions as a tumour suppressor in RCC cells and suppresses the proliferation, migration and invasion of RCC through regulating the expression of TRPV5.	[Chen, YongMing; Zhang, FaBiao; Liao, ShanFan; He, XiYuan; Zhuo, DeXiang; Huang, HuaiBin; Wu, YongYang] Fujian Med Univ, Affiliated Sanming Hosp 1, Dept Urol, Sanming, Fujian, Peoples R China; [Liu, XinYu] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Sichuan, Peoples R China; [Liu, XinYu] Sichuan Univ, West China Hosp, Canc Ctr, Chengdu, Sichuan, Peoples R China; [Liu, XinYu] Collaborat Innovat Ctr Biotherapy, Chengdu, Sichuan, Peoples R China	Fujian Medical University; Sichuan University; Sichuan University	Wu, YY (corresponding author), Fujian Med Univ, Affiliated Sanming Hosp 1, Dept Urol, Sanming, Fujian, Peoples R China.	wuyyfj@126.com		YongYang, Wu/0000-0001-5375-9422; Wu, YongYang/0000-0001-5212-6033	National Natural Science Foundation of China [81372734]; Special Foundation of Fujian Medical University for Scientific and Technological Development [FZS13035Y]; Trained Foundation of Fujian Provincial Health Family Planning Commission for the Young and Middle-aged Core Talent [2014-ZQN-ZD-30]; Natural Science Foundation of Fujian Province, China [2014J01440]; Sichuan University; Collaborative Innovation Center for Biotherapy	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation of Fujian Medical University for Scientific and Technological Development; Trained Foundation of Fujian Provincial Health Family Planning Commission for the Young and Middle-aged Core Talent; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Sichuan University(Sichuan University); Collaborative Innovation Center for Biotherapy	This work was supported by "National Natural Science Foundation of China" (No.81372734) to YYW, "Special Foundation of Fujian Medical University for Scientific and Technological Development" (No.FZS13035Y) to YYW, "Trained Foundation of Fujian Provincial Health Family Planning Commission for the Young and Middle-aged Core Talent" (No.2014-ZQN-ZD-30) to YYW and "Natural Science Foundation of Fujian Province, China" (No.2014J01440) to YYW which provided funds for our research.	Aguilera O, 2007, CARCINOGENESIS, V28, P1877, DOI 10.1093/carcin/bgm094; Blomberg Jensen M, 2010, J STEROID BIOCHEM, V121, P376, DOI DOI 10.1016/J.JSBMB.2010.03.069; Chen PZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049312; Chiang KC, 2011, J GASTROEN HEPATOL, V26, P1597, DOI 10.1111/j.1440-1746.2011.06892.x; Daniel C, 2007, J CELL BIOCHEM, V102, P1420, DOI 10.1002/jcb.21361; den Dekker E, 2003, CELL CALCIUM, V33, P497, DOI 10.1016/S0143-4160(03)00065-4; Ditsch N, 2012, J HISTOCHEM CYTOCHEM, V60, P121, DOI 10.1369/0022155411429155; Dutcher JP, 2013, THER ADV UROL, V5, P338, DOI 10.1177/1756287213505672; Fan H, 2014, ASIAN PAC J CANCER P, V15, P2559, DOI 10.7314/APJCP.2014.15.6.2559; Fleet JC, 2002, AM J PHYSIOL-GASTR L, V283, pG618, DOI 10.1152/ajpgi.00269.2001; Fujioka T, 1998, J UROLOGY, V160, P247, DOI 10.1016/S0022-5347(01)63098-2; Giusti L, 2014, J CELL MOL MED, V18, P1944, DOI 10.1111/jcmm.12372; Hendrickson WK, 2011, J CLIN ONCOL, V29, P2378, DOI 10.1200/JCO.2010.30.9880; Hoenderop JGJ, 2001, J AM SOC NEPHROL, V12, P1342, DOI 10.1681/ASN.V1271342; Joh HK, 2013, JNCI-J NATL CANCER I, V105, P726, DOI 10.1093/jnci/djt082; Kanemaru M, 2013, HEPATO-GASTROENTEROL, V60, P1199, DOI 10.5754/hge11073; Kim Y, 2014, BRIT J CANCER, V110, P2772, DOI 10.1038/bjc.2014.175; Liao Y, 2015, TUMOR BIOL, V36, P1567, DOI 10.1007/s13277-014-2728-9; Liu WH, 2006, HUM PATHOL, V37, P1268, DOI 10.1016/j.humpath.2006.04.029; Ma YL, 2011, J CLIN ONCOL, V29, P3775, DOI 10.1200/JCO.2011.35.7566; Muller DC, 2015, CANCER EPIDEM BIOMAR, V24, P1277, DOI 10.1158/1055-9965.EPI-14-1351; Muller DC, 2014, AM J EPIDEMIOL, V180, P810, DOI 10.1093/aje/kwu204; Nijenhuis T, 2005, PFLUG ARCH EUR J PHY, V451, P181, DOI 10.1007/s00424-005-1430-6; Obara W, 2007, J UROLOGY, V178, P1497, DOI 10.1016/j.juro.2007.05.119; Palmer HG, 2001, J CELL BIOL, V154, P369, DOI 10.1083/jcb.200102028; Sanchez-Gastaldo A, 2017, CANCER TREAT REV, V60, P77, DOI 10.1016/j.ctrv.2017.08.010; Schwarz EC, 2006, CELL CALCIUM, V39, P163, DOI 10.1016/j.ceca.2005.10.006; Serra R, 1996, NAT MED, V2, P390, DOI 10.1038/nm0496-390; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Sozucan Y., 2015, Experimental Oncology, V37, P208; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Tong ZT, 2012, ONCOGENE, V31, P583, DOI 10.1038/onc.2011.254; Van Cromphaut SJ, 2001, P NATL ACAD SCI USA, V98, P13324, DOI 10.1073/pnas.231474698; Vanoverberghe K, 2004, CELL DEATH DIFFER, V11, P321, DOI 10.1038/sj.cdd.4401375; Verlinden L, 2000, CANCER RES, V60, P2673; Wang W, 2015, CELL PHYSIOL BIOCHEM, V35, P1999, DOI 10.1159/000374007; Wu YY, 2011, J UROLOGY, V186, P2419, DOI 10.1016/j.juro.2011.07.086; Zhang LQ, 2015, CELL PHYSIOL BIOCHEM, V36, P299, DOI 10.1159/000374072; Zheng Y, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.23; Zhou Q, 2017, MOL IMMUNOL, V91, P156, DOI 10.1016/j.molimm.2017.09.006	40	21	21	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195844	10.1371/journal.pone.0195844	http://dx.doi.org/10.1371/journal.pone.0195844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659618	Green Submitted, Green Published, gold			2022-12-26	WOS:000430061100036
J	Fleuren, M; Quicazan-Rubio, EM; van Leeuwen, JL; Pollux, BJA				Fleuren, Mike; Quicazan-Rubio, Elsa M.; van Leeuwen, Johan L.; Pollux, Bart J. A.			Why do placentas evolve? Evidence for a morphological advantage during pregnancy in live-bearing fish	PLOS ONE			English	Article							MOLECULAR PHYLOGENETIC-RELATIONSHIPS; HISTORY FACILITATION HYPOTHESIS; GUPPY POECILIA-RETICULATA; LIFE-HISTORY; SWIMMING PERFORMANCE; GENUS POECILIOPSIS; LIVEBEARING FISH; CYPRINODONTIFORMES POECILIIDAE; VERTEBRATE VIVIPARITY; INDEPENDENT ORIGINS	A live-bearing reproductive strategy can induce large morphological changes in the mother during pregnancy. The evolution of the placenta in swimming animals involves a shift in the timing of maternal provisioning from pre-fertilization (females supply their eggs with sufficient yolk reserves prior to fertilization) to post-fertilization (females provide all nutrients via a placenta during the pregnancy). It has been hypothesised that this shift, associated with the evolution of the placenta, should confer a morphological advantage to the females leading to a more slender body shape during the early stages of pregnancy. We tested this hypothesis by quantifying three-dimensional shape and volume changes during pregnancy and in full-grown virgin controls of two species within the live-bearing fish family Poeciliidae: Poeciliopsis gracilis (non-placental) and Poeciliopsis turneri (placental). We show that P. turneri is more slender than P. gracilis at the beginning of the interbrood interval and in virgins, and that these differences diminish towards the end of pregnancy. This study provides the first evidence for an adaptive morphological advantage of the placenta in live-bearing fish. A similar morphological benefit could drive the evolution of placentas in other live-bearing (swimming) animal lineages.	[Fleuren, Mike; Quicazan-Rubio, Elsa M.; van Leeuwen, Johan L.; Pollux, Bart J. A.] Wageningen Univ & Res, Dept Anim Sci, Expt Zool Chair Grp, Wageningen, Netherlands	Wageningen University & Research	Pollux, BJA (corresponding author), Wageningen Univ & Res, Dept Anim Sci, Expt Zool Chair Grp, Wageningen, Netherlands.	bart.pollux@wur.nl	van Leeuwen, Johan L/B-7897-2011; van Leeuwen, Johan/N-3437-2019; Fleuren, Mike/S-5575-2018	van Leeuwen, Johan/0000-0002-4433-880X; Fleuren, Mike/0000-0002-3186-3840; Quicazan-Rubio, Elsa M./0000-0002-7320-8924	ALW Open Programme [821.02.024]; VIDI grant of the Netherlands Organisation for Scientific Research [864.14.008]; Francisco Jose de Caldas doctorate grant from the Administrative Department of Science, Technology and Innovation (COLCIENCIAS) [512-2010]	ALW Open Programme; VIDI grant of the Netherlands Organisation for Scientific Research; Francisco Jose de Caldas doctorate grant from the Administrative Department of Science, Technology and Innovation (COLCIENCIAS)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This study was supported by ALW Open Programme grant 821.02.024 to J.L.V.L. and VIDI grant 864.14.008 of the Netherlands Organisation for Scientific Research to B.J.A.P. and a Francisco Jose de Caldas doctorate grant from the Administrative Department of Science, Technology and Innovation (COLCIENCIAS) call 512-2010 to E.M.Q. The authors declare no conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, REPROD BIOL PHYLOGEN; Banet AI, 2008, FUNCT ECOL, V22, P323, DOI 10.1111/j.1365-2435.2007.01367.x; Banet AI, 2016, OECOLOGIA, V181, P87, DOI 10.1007/s00442-015-3542-9; Banet AI, 2010, EVOLUTION, V64, P3172, DOI 10.1111/j.1558-5646.2010.01059.x; Bassar RD, 2014, FUNCT ECOL, V28, P999, DOI 10.1111/1365-2435.12233; Belk MC, 2010, OIKOS, V119, P163, DOI 10.1111/j.1600-0706.2009.17742.x; Blackburn DG, 2015, J MORPHOL, V276, P961, DOI 10.1002/jmor.20272; BLACKBURN DG, 1984, P NATL ACAD SCI-BIOL, V81, P4860, DOI 10.1073/pnas.81.15.4860; Blake RW, 2005, J FISH BIOL, V67, P834, DOI 10.1111/j.0022-1112.2005.00788.x; Uribe MC, 2014, J MORPHOL, V275, P1406, DOI 10.1002/jmor.20315; Dulvy NK, 1997, P ROY SOC B-BIOL SCI, V264, P1309, DOI 10.1098/rspb.1997.0181; Frias-Alvarez P, 2016, OECOLOGIA, V181, P645, DOI 10.1007/s00442-015-3477-1; Ghalambor CK, 2004, AM NAT, V164, P38, DOI 10.1086/421412; Hamlett William C., 2005, P395; Holbrook GL, 2004, P NATL ACAD SCI USA, V101, P5595, DOI 10.1073/pnas.0400209101; Hrbek T, 2007, MOL PHYLOGENET EVOL, V43, P986, DOI 10.1016/j.ympev.2006.06.009; Ingley SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090274; James RS, 1998, J FISH BIOL, V53, P485, DOI 10.1006/jfbi.1998.0722; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2009, BIOL LETTERS, V5, P488, DOI 10.1098/rsbl.2009.0179; Meredith RW, 2011, MOL PHYLOGENET EVOL, V59, P148, DOI 10.1016/j.ympev.2011.01.014; Meredith RW, 2010, MOL PHYLOGENET EVOL, V55, P631, DOI 10.1016/j.ympev.2009.11.006; Mossman HW, 1937, CONTRIB EMBRYOL, V26, P133; Noren SR, 2011, J EXP BIOL, V214, P4151, DOI 10.1242/jeb.059121; Ostrovsky AN, 2016, BIOL REV, V91, P673, DOI 10.1111/brv.12189; Pettersson LB, 2000, P ROY SOC B-BIOL SCI, V267, P759, DOI 10.1098/rspb.2000.1068; Pires MN, 2011, FUNCT ECOL, V25, P757, DOI 10.1111/j.1365-2435.2011.01842.x; Pires MN, 2010, BIOL J LINN SOC, V99, P784, DOI 10.1111/j.1095-8312.2010.01391.x; Plaut I, 2002, FUNCT ECOL, V16, P290, DOI 10.1046/j.1365-2435.2002.00638.x; Pollux BJA, 2014, NATURE, V513, P233, DOI 10.1038/nature13451; Pollux BJA, 2009, ANNU REV ECOL EVOL S, V40, P271, DOI 10.1146/annurev.ecolsys.110308.120209; Pollux BJA, 2011, FUNCT ECOL, V25, P747, DOI 10.1111/j.1365-2435.2011.01831.x; REZNICK D, 1993, ECOLOGY, V74, P2011, DOI 10.2307/1940844; Reznick D.N., 1989, P125; Reznick D, 2007, EVOLUTION, V61, P2570, DOI 10.1111/j.1558-5646.2007.00207.x; Reznick DN, 2002, SCIENCE, V298, P1018, DOI 10.1126/science.1076018; Schindler JF, 2015, J MORPHOL, V276, P991, DOI 10.1002/jmor.20292; Schrader M, 2005, COPEIA, P649; Schwarzkopf L, 2010, AUSTRAL ECOL, V35, P82, DOI 10.1111/j.1442-9993.2009.02015.x; Scrimshaw Nevin S., 1944, COPEIA, V1944, P180, DOI 10.2307/1437814; Sfakiotakis M, 1999, IEEE J OCEANIC ENG, V24, P237, DOI 10.1109/48.757275; Shaffer LR, 1996, ANIM BEHAV, V51, P1017, DOI 10.1006/anbe.1996.0104; SHINE R, 1980, Oecologia (Berlin), V46, P92, DOI 10.1007/BF00346972; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Singer JD, 1998, J EDUC BEHAV STAT, V23, P323; THIBAULT RE, 1978, EVOLUTION, V32, P320, DOI 10.1111/j.1558-5646.1978.tb00648.x; Tokic G, 2012, P ROY SOC B-BIOL SCI, V279, P3065, DOI 10.1098/rspb.2012.0057; Trexler JC, 1997, ECOLOGY, V78, P1370, DOI 10.1890/0012-9658(1997)078[1370:RAAPIO]2.0.CO;2; Trexler JC, 2003, AM NAT, V162, P574, DOI 10.1086/378822; TURNER C. L., 1940, COPEIA, V1940, P88, DOI 10.2307/1439048; Turner CL, 1937, BIOL BULL-US, V72, P145, DOI 10.2307/1537249; Tytell ED, 2010, INTEGR COMP BIOL, V50, P1140, DOI 10.1093/icb/icq057; Uribe M.C., 2010, VIVIPAROUS FISHES; Van Wassenbergh S, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0461; Videler JJ, 1993, FISH SWIMMING, P1, DOI [10.1007/978-94-011-1580-3, DOI 10.1007/978-94-011-1580-3]; Voesenek CJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146682; WAKE MH, 1992, AM ZOOL, V32, P256; Walker JA, 2005, FUNCT ECOL, V19, P808, DOI 10.1111/j.1365-2435.2005.01033.x; Weihs D, 2002, INTEGR COMP BIOL, V42, P127, DOI 10.1093/icb/42.1.127; Wesner JS, 2011, BIOL J LINN SOC, V104, P386, DOI 10.1111/j.1095-8312.2011.01715.x; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Winne CT, 2006, FUNCT ECOL, V20, P1054, DOI 10.1111/j.1365-2435.2006.01180.x; Wourms J.P., 1988, P1; WOURMS JP, 1992, AM ZOOL, V32, P276; WOURMS JP, 1981, AM ZOOL, V21, P473; Wu WH, 2004, CLIN BIOMECH, V19, P480, DOI 10.1016/j.clinbiomech.2004.02.003; Zuniga-Vega JJ, 2011, J FISH BIOL, V79, P1029, DOI 10.1111/j.1095-8649.2011.03081.x; Zuniga-Vega JJ, 2007, OIKOS, V116, P995, DOI 10.1111/j.2007.0030-1299.15763.x	68	12	12	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195976	10.1371/journal.pone.0195976	http://dx.doi.org/10.1371/journal.pone.0195976			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659620	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100044
J	Katchanov, J; Asar, L; Klupp, EM; Both, A; Rothe, C; Konig, C; Rohde, H; Kluge, S; Maurer, FP				Katchanov, Juri; Asar, Lucia; Klupp, Eva-Maria; Both, Anna; Rothe, Camilla; Koenig, Christina; Rohde, Holger; Kluge, Stefan; Maurer, Florian P.			Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel beta-lactam/beta-lactamase inhibitor combinations	PLOS ONE			English	Article							MULTICENTER EVALUATION; KLEBSIELLA-PNEUMONIAE; MULTIPLEX PCR; ORGANISMS; ENTEROBACTERIACEAE; INFECTIONS; CEFTOLOZANE/TAZOBACTAM; AVIBACTAM; STRATEGY; BACTERIA	Objectives To determine the spectrum of infections with multidrug-resistant Gram-negative bacteria (MDR-GNB) and the clinical impact of the newly available betalactam/betalactamase inhibitor combinations ceftolozane/tazobactam and ceftazidime/avibactam in a German academic tertiary care center. Methods Retrospective analysis. Results Between September 1, 2015 and August 31, 2016, 119 individual patients (0.22% of all hospital admissions) were colonized or infected with carbapenem-resistant MDR-GNB. The species distribution was Pseudomonas aeruginosa, n = 66; Enterobacteriaceae spp., n = 44; and Acinetobacter baumannii, n = 18. In 9 patients, carbapenem-resistant isolates belonging to more than one species were detected. Infection was diagnosed in 50 patients (total: 42.0%; nosocomial pneumonia: n = 23, 19.3%; bloodstream infection: n = 11, 9.2%). Antimicrobial treatment with broad-spectrum antibiotics prior to detection of a carbapenem-resistant isolate was documented in 105 patients (88.2%, prior administration of carbapenems: 62.2%). Nosocomial transmission was documented in 29 patients (24.4%). In 26 patients (21.8%), at least one carbapenem-susceptible, third-generation cephalosporin non-susceptible isolate was documented prior to detection of a carbapenem-resistant isolate belonging to the same species (median 38 days, IQR 23-78). 12 patients (10.1%) had documented previous contact to the healthcare system in a country with high burden of carbapenemase-producing strains. Genes encoding carbapenemases were detected in 60/102 patient isolates (58.8%; VIM-2, n = 25; OXA-48, n = 21; OXA-23-like, n = 10). Susceptibility to colistin was 94.3%. Ceftolozane/tazobactam and ceftazidime/avibactam were administered to 3 and 5 patients, respectively (in-hospital mortality: 66% and 100%). Development of drug-resistance under therapy was observed for both antimicrobials. Conclusions i) The major predisposing factors for acquisition of carbapenem-resistant MDR-GNB were selective pressure due to preceding antimicrobial therapy and nosocomial transmission. ii) Colistin remains the backbone of antimicrobial chemotherapy for infections caused by carbapenem-resistant MDR-GNB. iii) Novel beta-lactam/beta-lactamase inhibitor combinations are of limited usefulness in our setting because of the high prevalence of Ambler class B carbapenemases and the emergence of nonsusceptibility under therapy.	[Katchanov, Juri; Koenig, Christina; Kluge, Stefan] Univ Med Ctr Hamburg Eppendorf, Dept Intens Care Med, Hamburg, Germany; [Asar, Lucia; Klupp, Eva-Maria; Both, Anna; Rohde, Holger; Maurer, Florian P.] Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany; [Rothe, Camilla] Univ Med Ctr Hamburg Eppendorf, Div Infect Dis & Trop Med, Med Dept 1, Hamburg, Germany; [Koenig, Christina] Univ Med Ctr Hamburg Eppendorf, Hosp Pharm, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Maurer, FP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Med Microbiol Virol & Hyg, Hamburg, Germany.	f.maurer@uke.de	König, Christina/G-4743-2016; Maurer, Florian/ABA-1918-2020; Maurer, Florian/Z-5028-2019	Maurer, Florian/0000-0001-8353-5964; Maurer, Florian/0000-0001-8353-5964; Rohde, Holger/0000-0001-8587-4433				Andes D, 2005, CLIN MICROBIOL INFEC, V11, P10, DOI 10.1111/j.1469-0691.2005.01265.x; [Anonymous], 2012, BUNDESGESUNDHEITSBLA, V55, P1311, DOI 10.1007/s00103-012-1549-5; Biedenbach DJ, 2015, ANTIMICROB AGENTS CH, V59, P4239, DOI 10.1128/AAC.00206-15; Both A, 2017, J ANTIMICROB CHEMOTH, V72, P2483, DOI 10.1093/jac/dkx179; Carmeli Y, 2016, LANCET INFECT DIS, V16, P661, DOI 10.1016/S1473-3099(16)30004-4; Castanheira M, 2014, ANTIMICROB AGENTS CH, V58, P6844, DOI 10.1128/AAC.03681-14; Dalfino L, 2012, CLIN INFECT DIS, V54, P1720, DOI 10.1093/cid/cis286; European Committee on Antimicrobial Susceptibility Testing (EUCAST), ANT SUSC TEST COL PR; Falagas ME, 2014, ANTIMICROB AGENTS CH, V58, P654, DOI 10.1128/AAC.01222-13; Fussen R, 2016, MED KLIN-INTENSIVMED, V111, P743, DOI 10.1007/s00063-016-0223-3; Gatermann S., 2014, EPIDEMIOL B, P421; Grundmann H, 2017, LANCET INFECT DIS, V17, P153, DOI 10.1016/S1473-3099(16)30257-2; Hentschke M, 2011, DIAGN MICR INFEC DIS, V71, P312, DOI 10.1016/j.diagmicrobio.2011.07.011; Heudorf U, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.2.30109; Heudorf U, 2016, GMS HYG INFECT CONTR, V11, DOI 10.3205/dgkh000270; Hogardt M, 2015, EURO SURVEILL, V20; Humphries RM, 2015, ANTIMICROB AGENTS CH, V59, P6605, DOI 10.1128/AAC.01165-15; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; Livermore DM, 2017, J ANTIMICROB CHEMOTH, V72, P2278, DOI 10.1093/jac/dkx136; Lubbert C, 2014, INFECTION, V42, P309, DOI 10.1007/s15010-013-0547-3; Maechler F, 2015, INFECTION, V43, P163, DOI 10.1007/s15010-014-0701-6; Marshall S, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02243-16; Martin-Loeches I, 2014, CURR OPIN CRIT CARE, V20, P516, DOI 10.1097/MCC.0000000000000124; Munita JM, 2017, CLIN INFECT DIS, V65, P158, DOI 10.1093/cid/cix014; Mutters NT, 2016, J HOSP INFECT, V93, P191, DOI 10.1016/j.jhin.2016.02.013; Mutters NT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1173-8; Mutters R, 2016, MED KLIN-INTENSIVMED, V111, P261, DOI 10.1007/s00063-016-0155-y; Perez F, 2016, EXPERT OPIN PHARMACO, V17, P761, DOI 10.1517/14656566.2016.1145658; Ruhnke M, 2014, LANCET ONCOL, V15, pE606, DOI 10.1016/S1470-2045(14)70344-4; Schroter M, 2004, APPL ENVIRON MICROB, V70, P613, DOI 10.1128/AEM.70.1.613-615.2004; Stocker H, 2013, INTERNIST, V54, P936, DOI 10.1007/s00108-012-3141-3; Tenenbaum T, 2016, INFECT CONT HOSP EP, V37, P1310, DOI 10.1017/ice.2016.179; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van der Zee A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-27; van Duin D, 2016, CLIN INFECT DIS, V63, P234, DOI 10.1093/cid/ciw243; van Duin D, 2013, DIAGN MICR INFEC DIS, V75, P115, DOI 10.1016/j.diagmicrobio.2012.11.009; Woodford N, 2006, INT J ANTIMICROB AG, V27, P351, DOI 10.1016/j.ijantimicag.2006.01.004	37	38	39	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195757	10.1371/journal.pone.0195757	http://dx.doi.org/10.1371/journal.pone.0195757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649276	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900081
J	Massolt, ET; Chaker, L; Visser, TJ; Gillis, AJM; Dorssers, LCJ; Beukhof, CM; Kam, BLR; Franssen, GJ; Brigante, G; van Ginhoven, TM; Visser, WE; Looijenga, LHJ; Peeters, RP				Massolt, Elske T.; Chaker, Layal; Visser, Theo J.; Gillis, Ad J. M.; Dorssers, Lambert C. J.; Beukhof, Carolien M.; Kam, Boen L. R.; Franssen, Gaston J.; Brigante, Giulia; van Ginhoven, Tessa M.; Visser, W. Edward; Looijenga, Leendert H. J.; Peeters, Robin P.			Serum microRNA profiles in athyroid patients on and off levothyroxine therapy	PLOS ONE			English	Article							CIRCULATING MICRORNAS; THYROXINE; CANCER; DIAGNOSIS; MIRNA; REPLACEMENT; BIOMARKERS	Background Levothyroxine replacement treatment in hypothyroidism is unable to restore physiological thyroxine and triiodothyronine concentrations in serum and tissues completely. Normal serum thyroid stimulating hormone (TSH) concentrations reflect only pituitary euthyroidism and, therefore, novel biomarkers representing tissue-specific thyroid state are needed. MicroRNAs (miRNAs), small non-coding regulatory RNAs, exhibit tissue-specific expression patterns and can be detectable in serum. Previous studies have demonstrated differential expression of (precursors of) miRNAs in tissues under the influence of thyroid hormone. Objective To study if serum miRNA profiles are changed in different thyroid states. Design and methods We studied 13 athyroid patients (6 males) during TSH suppressive therapy and after 4 weeks of thyroid hormone withdrawal. A magnetic bead capture system was used to isolate 384 defined miRNAs from serum. Subsequently, the TaqMan Array Card 3.0 platform was used for profiling after individual target amplification. Results Mean age of the subjects was 44.0 years (range 20-61 years). Median TSH levels were 88.9 mU/I during levothyroxine withdrawal and 0.006 mU/I during LT4 treatment with a median dosage of 2.1 fag/kg. After normalization to allow inter-sample analysis, a paired analysis did not demonstrate a significant difference in expression of any of the 384 miRNAs analyzed on and off LT4 treatment. Conclusion Although we previously showed an up-regulation of pri-miRNAs 133b and 206 in hypothyroid state in skeletal muscle, the present study does not supply evidence that thyroid state also affects serum miRNAs in humans.	[Massolt, Elske T.; Chaker, Layal; Visser, Theo J.; Beukhof, Carolien M.; Brigante, Giulia; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Div Endocrinol, Rotterdam, Netherlands; [Massolt, Elske T.; Chaker, Layal; Visser, Theo J.; Beukhof, Carolien M.; Brigante, Giulia; Visser, W. Edward; Peeters, Robin P.] Erasmus MC, Acad Ctr Thyroid Dis, Dept Internal Med, Rotterdam, Netherlands; [Chaker, Layal] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Gillis, Ad J. M.; Dorssers, Lambert C. J.; Looijenga, Leendert H. J.] Erasmus MC, Dept Pathol, Rotterdam, Netherlands; [Kam, Boen L. R.] Erasmus MC, Dept Nucl Med, Rotterdam, Netherlands; [Franssen, Gaston J.; van Ginhoven, Tessa M.] Erasmus MC, Inst Canc, Dept Surg, Div Surg Oncol, Rotterdam, Netherlands; [Brigante, Giulia] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Unit Endocrinol, Modena, Italy	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Universita di Modena e Reggio Emilia	Massolt, ET (corresponding author), Erasmus MC, Div Endocrinol, Rotterdam, Netherlands.; Massolt, ET (corresponding author), Erasmus MC, Acad Ctr Thyroid Dis, Dept Internal Med, Rotterdam, Netherlands.	e.massolt@erasmusmc.nl	Brigante, Giulia/J-8775-2018; Looijenga, Leendert/B-8145-2019	Brigante, Giulia/0000-0001-8426-4502; Looijenga, Leendert/0000-0002-8146-1911; Peeters, Robin/0000-0001-7732-9371	Zon-MW TOP grant [91212044]; Erasmus MC MRACE grant	Zon-MW TOP grant; Erasmus MC MRACE grant	R.P.P. is supported by a Zon-MW TOP grant (number 91212044) and an Erasmus MC MRACE grant.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Carreras-Badosa G, 2015, J CLIN ENDOCR METAB, V100, pE1446, DOI 10.1210/jc.2015-2872; Celano M, 2017, INT J GENOMICS, V2017, DOI 10.1155/2017/6496570; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Dong HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012136; Ebert MS, 2012, CELL, V149, P515, DOI 10.1016/j.cell.2012.04.005; EscobarMorreale HF, 1996, ENDOCRINOLOGY, V137, P2490, DOI 10.1210/en.137.6.2490; Gillis AJM, 2013, MOL ONCOL, V7, P1083, DOI 10.1016/j.molonc.2013.08.002; Gullo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022552; Hiratsuka I, 2016, THYROID, V26, P1431, DOI 10.1089/thy.2016.0062; Hoermann R, 2013, EUR J ENDOCRINOL, V168, P271, DOI 10.1530/EJE-12-0819; Janssen R, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00171; Ladenson PW, 2002, CLIN ENDOCRINOL, V57, P575, DOI 10.1046/j.1365-2265.2002.01682.x; Le Carre J, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00413; Lee JC, 2013, CANCER-AM CANCER SOC, V119, P4358, DOI 10.1002/cncr.28254; Links T P, 2007, Ned Tijdschr Geneeskd, V151, P1777; Lodewijk L, 2012, CANCER BIOMARK, V11, P229, DOI 10.3233/CBM-2012-0273; Looijenga LH, 2016, ONCOTARGET; Massolt ET, 2018, J CLIN ENDOCR METAB, V103, P169, DOI 10.1210/jc.2017-01144; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mestdagh P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-r64; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Moldovan L, 2014, J CELL MOL MED, V18, P371, DOI 10.1111/jcmm.12236; Panicker V, 2009, CLIN ENDOCRINOL, V71, P574, DOI 10.1111/j.1365-2265.2008.03521.x; Reiner A, 2003, BIOINFORMATICS, V19, P368, DOI 10.1093/bioinformatics/btf877; Rijlaarsdam MA, 2015, ANDROLOGY-US, V3, P85, DOI 10.1111/andr.298; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x; Taft RJ, 2010, J PATHOL, V220, P126, DOI 10.1002/path.2638; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visser WE, 2009, J CLIN ENDOCR METAB, V94, P3487, DOI 10.1210/jc.2009-0782; Weetman AP, 2006, CLIN ENDOCRINOL, V64, P231, DOI 10.1111/j.1365-2265.2006.02478.x; Wekking EM, 2005, EUR J ENDOCRINOL, V153, P747, DOI 10.1530/eje.1.02025; Yamada H, 2014, CLIN ENDOCRINOL, V81, P276, DOI 10.1111/cen.12432; Yu S, 2012, J CLIN ENDOCR METAB, V97, P2084, DOI 10.1210/jc.2011-3059	36	6	6	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194259	10.1371/journal.pone.0194259	http://dx.doi.org/10.1371/journal.pone.0194259			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649216	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900009
J	Gustafsson, MK; Romundstad, PR; Stafne, SN; Helvik, AS; Stunes, AK; Morkved, S; Salvesen, KA; Thorsby, PM; Syversen, U				Gustafsson, Miriam K.; Romundstad, Pal R.; Stafne, Signe Nilssen; Helvik, Anne-Sofie; Stunes, Astrid Kamilla; Morkved, Siv; Salvesen, Kjell Asmund; Thorsby, Per Medboe; Syversen, Unni			Alterations in the vitamin D endocrine system during pregnancy: A longitudinal study of 855 healthy Norwegian women	PLOS ONE			English	Article							D-BINDING PROTEIN; D SUPPLEMENTATION; D DEFICIENCY; PARATHYROID-HORMONE; 25-HYDROXYVITAMIN D; NEONATAL OUTCOMES; TOTAL 25(OH)D; FETAL; SERUM; LACTATION	To ensure optimal calcium accrual in the fetal skeleton, a substantial rise occurs in 1,25-dihydroxyvitamin D (1,25(OH)(2)D), but is dependent on sufficient 25-hydroxyvitamin (25(OH)D). Large longitudinal studies addressing free 25(OH) D and 1,25(OH)(2)D during pregnancy are scarce. We aimed to assess levels of and relationship between 25(OH) D, 1,25(OH)(2)D, vitamin D-binding protein (DBP), parathyroid hormone (PTH), and free 25(OH) D during pregnancy; determinants of vitamin D status; and association between vitamin D indices or PTH and pregnancy outcomes (gestational diabetes mellitus and birthweight). Altogether 855 pregnant Norwegian Caucasian women from Trondheim and Stavanger (latitude 63 degrees N and 58 degrees N) were recruited; 94 were lost to follow-up. The study was originally a randomized controlled trial (2007-2009)with gestational diabetes as primary outcome. Data were collected in second and third trimester. In third trimester, 246 (34%) had vitamin D insufficiency and 52 (7%) deficiency (25(OH) D < 50 and <30nmol/L, respectively). During wintertime in third trimester, 61 (47%) from Trondheim and 23 (51%) from Stavanger exhibited vitamin D insufficiency. PTH was elevated in 27 (3.7%). Estimate of change between trimesters was (95% CI): 25(OH)D -1.8 (-2.8 to -0.7) nmol/L, DBP 0.62 (0.57 to 0.66) mu mol/L, calculated free 25(OH) D -1.7 (-2.0 to -1.4) pmol/L, PTH 0.81 (0.72 to 0.90) pmol/L, 1,25(OH)(2)D (subanalysis) 31.4 (CI 24.7 to 38.2) pmol/L. A decrease in 1,25(OH)(2)D occurred in 45% of those with vitamin D deficiency, and they also exhibited lower levels than women with adequate vitamin D status. No association of vitamin D indices and PTH with pregnancy outcomes was observed. Women in Trondheim displayed lower 25(OH) D levels, despite minor latitudinal differences. Less than one-fifth adhered to the authorities' vitamin D recommendations. These findings demonstrate that hypovitaminosis D is prevalent among pregnant women living in northern latitudes, especially during the dark season, and there is an unmet need to ensure adequate vitamin D intake.	[Gustafsson, Miriam K.; Romundstad, Pal R.; Stafne, Signe Nilssen; Helvik, Anne-Sofie; Morkved, Siv] Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway; [Gustafsson, Miriam K.] St Olays Hosp, Trondheim Univ Hosp, Div Mental Hlth Care, Trondheim, Norway; [Stafne, Signe Nilssen] St Olays Hosp, Trondheim Univ Hosp, Clin Clin Serv, Trondheim, Norway; [Stunes, Astrid Kamilla; Salvesen, Kjell Asmund; Syversen, Unni] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, Fac Med & Hlth Sci, Trondheim, Norway; [Stunes, Astrid Kamilla; Morkved, Siv] St Olays Hosp, Trondheim Univ Hosp, Trondheim, Norway; [Salvesen, Kjell Asmund] St Olays Hosp, Trondheim Univ Hosp, Dept Obstet & Gynaecol, Trondheim, Norway; [Thorsby, Per Medboe] Oslo Univ Hosp, Dept Med Biochem, Hormone Lab, Oslo, Norway; [Syversen, Unni] St Olays Hosp, Trondheim Univ Hosp, Dept Endocrinol, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo; Norwegian University of Science & Technology (NTNU)	Gustafsson, MK (corresponding author), Norwegian Univ Sci & Technol NTNU, Fac Med & Hlth Sci, Dept Publ Hlth & Nursing, Trondheim, Norway.; Gustafsson, MK (corresponding author), St Olays Hosp, Trondheim Univ Hosp, Div Mental Hlth Care, Trondheim, Norway.	miriam.gustafsson@ntnu.no	Thorsby, Per Medbøe/A-1268-2017; Stunes, Astrid Kamilla/B-9901-2008; St Olav Hospital, Medisinsk Klinikk -/AAD-6414-2022	Thorsby, Per Medbøe/0000-0002-9615-1035; Stunes, Astrid Kamilla/0000-0003-1074-5199; Gustafsson, Miriam K./0000-0003-4151-393X	Liaison Committee	Liaison Committee	The study was supported by the Liaison Committee between the Central Norway Regional Health Authority (RHA) and the Norwegian University of Science and Technology (NTNU).	AGHAJAFARI F, 2013, BMJ CLIN RES ED, V346, DOI DOI 10.1136/BMJ.F1169; Aloia J, 2015, J CLIN ENDOCR METAB, V100, P3356, DOI 10.1210/JC.2015-2066; Andersen LF, 2005, BRIT J NUTR, V93, P519, DOI 10.1079/BJN20041381; Andersen LF, 1999, AM J EPIDEMIOL, V150, P75, DOI 10.1093/oxfordjournals.aje.a009921; Awad AB, 2012, CRIT REV FOOD SCI, V52, P103, DOI 10.1080/10408391003785458; Baird J, 2017, HEALTHCARE-BASEL, V5, DOI 10.3390/healthcare5010014; Barebring L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152198; Bikle D, 2017, J STEROID BIOCHEM, V173, P105, DOI 10.1016/j.jsbmb.2017.01.007; BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; Bouillon R, 2016, J BONE MINER RES, V31, P1124, DOI 10.1002/jbmr.2871; Bouillon R, 2013, J CLIN ENDOCR METAB, V98, pE1283, DOI 10.1210/jc.2013-1195; Brembeck P, 2013, BRIT J NUTR, V110, P856, DOI 10.1017/S0007114512005855; Cooper C, 2016, LANCET DIABETES ENDO, V4, P393, DOI 10.1016/S2213-8587(16)00044-9; De-Regil LM, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008873.pub2; Dror DK, 2010, NUTR REV, V68, P465, DOI 10.1111/j.1753-4887.2010.00306.x; Elder CJ, 2014, LANCET, V383, P1665, DOI 10.1016/S0140-6736(13)61650-5; Gernand AD, 2013, J CLIN ENDOCR METAB, V98, P398, DOI 10.1210/jc.2012-3275; Gezmish O, 2013, J CARDIOVASC TRANSL, V6, P588, DOI 10.1007/s12265-013-9475-y; Gunasekara FI, 2014, INT J EPIDEMIOL, V43, P264, DOI 10.1093/ije/dyt221; Hacker AN, 2012, NUTR REV, V70, P397, DOI 10.1111/j.1753-4887.2012.00491.x; Haggarty P, 2013, BRIT J NUTR, V109, P898, DOI 10.1017/S0007114512002255; Hart PH, 2015, PEDIATRICS, V135, pE167, DOI 10.1542/peds.2014-1860; Harvey NC, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18450; Helsedirektoratet, KOSTH GRAV GRAV FODS; Herrmann M, 2017, CLIN CHEM LAB MED, V55, P3, DOI 10.1515/cclm-2016-0264; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick Michael F, 2011, J Clin Endocrinol Metab, V96, P1; Hollis BW, 2017, BONE RES, V5, DOI 10.1038/boneres.2017.30; Hollis BW, 2017, MOL CELL ENDOCRINOL, V453, P113, DOI 10.1016/j.mce.2017.01.039; Hollis BW, 2011, J BONE MINER RES, V26, P2341, DOI 10.1002/jbmr.463; Holmes VA, 2009, BRIT J NUTR, V102, P876, DOI 10.1017/S0007114509297236; Hossain N, 2014, J CLIN ENDOCR METAB, V99, P2448, DOI 10.1210/jc.2013-3491; Javaid MK, 2006, LANCET, V367, P36, DOI 10.1016/S0140-6736(06)67922-1; Johansson L, 1999, 2199984 NORW STAT CO; Karlsson T, 2015, CLIN NUTR, V34, P892, DOI 10.1016/j.clnu.2014.09.012; Karras SN, 2016, THER ADV MUSCULOSKEL, V8, P124, DOI 10.1177/1759720X16656810; Kim HJ, 2017, ANN LAB MED, V37, P34, DOI 10.3343/alm.2017.37.1.34; Kothari P., 2015, DATA ANAL STATA; Kovacs CS, 2008, AM J CLIN NUTR, V88, p520S, DOI 10.1093/ajcn/88.2.520S; Kovacs CS, 2016, PHYSIOL REV, V96, P449, DOI 10.1152/physrev.00027.2015; Kramer CK, 2016, J CLIN ENDOCR METAB, V101, P1729, DOI 10.1210/jc.2015-4060; Kramer CK, 2014, J CLIN ENDOCR METAB, V99, P4506, DOI 10.1210/jc.2014-2341; Lawlor DA, 2013, LANCET, V382, P684; Leffelaar ER, 2010, BRIT J NUTR, V104, P108, DOI 10.1017/S000711451000022X; Lundqvist A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150385; McDonnell SL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180483; Minisola S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2723; Moon RJ, 2015, EUR J ENDOCRINOL, V173, pR69, DOI 10.1530/EJE-14-0826; Morley R, 2006, J CLIN ENDOCR METAB, V91, P906, DOI 10.1210/jc.2005-1479; Nordic Council of Ministers, 2014, NORDIC NUTR RECOMMEN, V5th, DOI [10.6027/Nord2014-002, DOI 10.6027/NORD2014-002]; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Palacios C, 2014, J STEROID BIOCHEM, V144, P138, DOI 10.1016/j.jsbmb.2013.11.003; Papapetrou PD, 2010, HORM-INT J ENDOCRINO, V9, P136, DOI 10.14310/horm.2002.1263; PEARCE SHS, 2010, BMJ CLIN RES ED, V340, DOI DOI 10.1136/BMJ.B5664; Powe CE, 2011, J BONE MINER RES, V26, P1609, DOI 10.1002/jbmr.387; Ross AC, 2011, DIETARY REFERENCE INTAKES FOR CALCIUM AND VITAMIN D, P35; Schwartz JB, 2014, J CLIN ENDOCR METAB, V99, P1631, DOI 10.1210/jc.2013-3874; Sollid ST, 2016, EUR J ENDOCRINOL, V174, P445, DOI 10.1530/EJE-15-1089; Spiro A, 2014, NUTR BULL, V39, P322, DOI 10.1111/nbu.12108; Stafne SN, 2012, OBSTET GYNECOL, V119, P29, DOI 10.1097/AOG.0b013e3182393f86; Vandevijvere S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043868; VERHAEGHE J, 1992, J STEROID BIOCHEM, V41, P469, DOI 10.1016/0960-0760(92)90372-P; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Yu CKH, 2009, CLIN ENDOCRINOL, V70, P685, DOI 10.1111/j.1365-2265.2008.03403.x; Zhang JY, 2014, BRIT J NUTR, V112, P1081, DOI 10.1017/S0007114514001883; Zhu K, 2014, J BONE MINER RES, V29, P1088, DOI 10.1002/jbmr.2138	66	28	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195041	10.1371/journal.pone.0195041	http://dx.doi.org/10.1371/journal.pone.0195041			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641551	gold, Green Submitted, Green Published			2022-12-26	WOS:000429742900059
J	Lee, J; Noh, Y; Lee, S				Lee, Jimin; Noh, Yoojin; Lee, Sukhyang			Evaluation of preventable adverse drug reactions by implementation of the nationwide network of prospective drug utilization review program in Korea	PLOS ONE			English	Review							MEDICATION USE; SYSTEMS; EVENTS	Background A prospective Drug Utilization Review (DUR) program has been implemented in Korea to improve the quality and safety of medication use. Objective To evaluate the influence of the DUR program in reducing incidence of preventable adverse drug reactions (pADRs). Methods This study was performed using administrative data from the Health Insurance Review and Assessment Service (HIRA). The claims data for all adult patients with adverse drug events (ADE)-related diagnoses from 2009 to 2014 were obtained. Incidence rates of first-time and repeat pADRs prior to and after DUR program implementation were evaluated. Quarterly trends in incidence rates of overall ADE, allergic reactions, and ADRs were analyzed. Results Data extraction covering the period from 2009 to 2014 led to the identification of 3,927,662 records. First-time pADR rates decreased gradually after implementation of the DUR program (change in slope: -0.016, p = 0.02). The program had a similar influence on repeat pADR rates (change in slope: -0.006, p <= 0.01). The program did not decrease rates of firsttime or repeat allergic reactions (change in slope: 0.018, p = 0.07 and 0.003, p = 0.04, respectively). In the cohort aged <= 65 years, first-time pADR rate reduction was significant (28.2% [27.1-29.3] in <= 18 years, and 19.8% [18.1-21.5] in 19-64 years). In contrast, firsttime pADR rate was increased by 0.6% [-0.7-1.9] in patients >= 65 years. Conclusion Implementation of the prospective DUR program effectively reduced the number of pADRs. In the future, to reduce non-preventable ADRs such as allergic reactions, provision of clinical information including allergy history should be added to the DUR program.	[Lee, Jimin; Noh, Yoojin; Lee, Sukhyang] Ajou Univ, Coll Pharm, Suwon, South Korea	Ajou University	Lee, S (corresponding author), Ajou Univ, Coll Pharm, Suwon, South Korea.	suklee@ajou.ac.kr			Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT & Future Planning, Republic of Korea [2013M3A9B5075838]; Health Insurance Review and Assessment Service [2015-99]	Bio & Medical Technology Development Program of the National Research Foundation - Ministry of Science, ICT & Future Planning, Republic of Korea; Health Insurance Review and Assessment Service	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation funded by the Ministry of Science, ICT & Future Planning, Republic of Korea (No. 2013M3A9B5075838) and the Health Insurance Review and Assessment Service (No. 2015-99).	Angalakuditi M, 2011, CLINICOECONOMIC OUTC, V3, P105, DOI 10.2147/CEOR.S21789; Armstrong EP, 1996, ANN PHARMACOTHER, V30, P1088, DOI 10.1177/106002809603001004; Ducoffe AR, 2016, AM J MED QUAL, V31, P476, DOI 10.1177/1062860615588105; Fick D, 2012, J AM GERIATR SOC, V60, P616, DOI 10.1111/j.1532-5415.2012.03923.x; Fulda Thomas R, 2004, J Am Pharm Assoc (2003), V44, P69, DOI 10.1331/154434504322713255; Hennessy S, 2003, JAMA-J AM MED ASSOC, V290, P1494, DOI 10.1001/jama.290.11.1494; Heo JH, 2013, INT J MED INFORM, V82, P987, DOI 10.1016/j.ijmedinf.2013.07.001; Hohl CM, 2014, J AM MED INFORM ASSN, V21, P547, DOI 10.1136/amiajnl-2013-002116; Impicciatore P, 2001, BRIT J CLIN PHARMACO, V52, P77, DOI 10.1046/j.0306-5251.2001.01407.x; Kim DS, 2015, INT J CLIN PHARM TH, V53, P819, DOI 10.5414/CP202429; Kohn LT, 2000, ERR IS HUMAN BUILDIN, Vxxi; Kongkaew C, 2008, ANN PHARMACOTHER, V42, P1017, DOI 10.1345/aph.1L037; Laatikainen O, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00358; Lee S., 2016, MOB INF SYST, V2016, P1, DOI DOI 10.1016/J.SMRV.2016.02.001; O'Mahony D, 2010, EUR GERIATR MED, V1, P45, DOI 10.1016/j.eurger.2010.01.007; Patel Hitesh, 2007, BMC Clin Pharmacol, V7, P9, DOI 10.1186/1472-6904-7-9; Song I, 2017, PEDIATR INT, V59, P720, DOI 10.1111/ped.13258; Stausberg J, 2010, DTSCH ARZTEBL INT, V107, P23, DOI 10.3238/arztebl.2010.0023; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Yang JH, 2015, INT J MED INFORM, V84, P912, DOI 10.1016/j.ijmedinf.2015.08.007; Yu YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132916; Zhen CL, 2001, JAMA-J AM MED ASSOC, V286, P2823, DOI 10.1001/jama.286.22.2823	22	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195434	10.1371/journal.pone.0195434	http://dx.doi.org/10.1371/journal.pone.0195434			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641617	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900069
J	Parmar, MM; Sachdeva, KS; Dewan, PK; Rade, K; Nair, SA; Pant, R; Khaparde, SD				Parmar, Malik M.; Sachdeva, Kuldeep Singh; Dewan, Puneet K.; Rade, Kiran; Nair, Sreenivas A.; Pant, Rashmi; Khaparde, Sunil D.			Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement	PLOS ONE			English	Article							AFRICA; IMPACT	Background Globally, India has the world's highest burden of multidrug-resistant tuberculosis (MDR-TB). Programmatic Management of Drug Resistant TB (PMDT) in India began in 2007 and nationwide coverage was achieved in early 2013. Poor initial microbiological outcomes under the Revised National Tuberculosis Control Programme (RNTCP) prompted detailed analysis. This is the first study on factors significantly associated with poor outcomes in MDR-TB patients treated under the RNTCP. Objective To evaluate initial sputum culture conversion, culture reversion and final treatment outcomes among MDR-TB patients registered in India from 2007 to early 2011 who were treated with a standard 24-month regimen under daily-observed treatment. Methods This is a retrospective cohort study. Clinical and microbiological data were abstracted from PMDT records. Initial sputum culture conversion, culture reversion and treatment outcomes were defined by country adaptation of the standard WHO definitions (2008). Cox proportional hazards modeling with logistic regression, multinomial logistic regression and adjusted odds ratio was used to evaluate factors associated with interim and final outcomes respectively, controlling for demographic and clinical characteristics. Results In the cohort of 3712 MDR-TB patients, 2735 (73.6%) had initial sputum culture conversion at 100 median days (IQR 92-125), of which 506 (18.5%) had culture reversion at 279 median days (IQR 202-381). Treatment outcomes were available for 2264 (60.9%) patients while 1448 (39.0%) patients were still on treatment or yet to have a definite outcome at the time of analysis. Of 2264 patients, 781 (34.5%) had treatment success, 644 (28.4%) died, 670 (29.6%) were lost to follow up, 169 (7.5%) experienced treatment failure or were changed to XDR-TB treatment. Factors significantly associated with either culture non-conversion, culture reversion and/or unfavorable treatment outcomes were baseline BMI < 18; >= seven missed doses in intensive phase (IP) and continuation phase (CP); cavitary disease; prior treatment episodes characterized by re-treatment regimen taken twice, longer duration and more episodes of treatment; any weight loss during treatment; males and additional resistance to first line drugs (Ethambutol, Streptomycin). In a subgroup of 104 MDR-TB patients, 62 (59.6%) had Ofloxacin resistance among whom only 25.8% had treatment success, half of the success (54.8%) seen in Ofloxacin sensitive patients. Baseline susceptibility to Ofloxacin (HR 2.04) and Kanamycin (HR 4.55) significantly doubled and quadrupled the chances for culture conversion respectively while baseline susceptibility to Ofloxacin (AOR 0.37) also significantly reduced the odds of unfavorable treatment outcomes (p value <= 0.05) in multinomial logistic regression model. Conclusion India's initial MDR-TB patients' cohort treated under the RNTCP experienced poor treatment outcomes. To address the factors associated with poor treatment outcomes revealed in our study, a systematic multi-pronged approach would be needed. A series of policies and interventions have been developed to address these factors to improve DR-TB treatment outcomes and are being scaled-up in India.	[Parmar, Malik M.; Rade, Kiran; Nair, Sreenivas A.] WHO, Country Off India, New Delhi, India; [Sachdeva, Kuldeep Singh] Govt India, Minist Hlth & Family Welf, Natl AIDS Control Org, New Delhi, India; [Dewan, Puneet K.] India Country Off, Bill & Melinda Gates Fdn, New Delhi, India; [Pant, Rashmi] Publ Hlth Fdn India, Hyderabad, Andhra Pradesh, India; [Khaparde, Sunil D.] Govt India, Minist Hlth & Family Welf, Cent TB Div, New Delhi, India	World Health Organization; Public Health Foundation of India	Parmar, MM (corresponding author), WHO, Country Off India, New Delhi, India.	parmarm@who.int	Pant, Rashmi/AAU-6881-2021; Rade, Kiran/AAU-9564-2020; Pant, Rashmi/AAH-5146-2019	Rade, Kiran/0000-0001-7601-0780; Nair, Sreenivas/0000-0002-2586-6797	National Institute of Tuberculosis and Respiratory Diseases, New Delhi	National Institute of Tuberculosis and Respiratory Diseases, New Delhi	We are thankful to the Central TB Division; State Programme Managers of Gujarat, Maharashtra, Andhra Pradesh, New Delhi, West Bengal, Kerala, Rajasthan and their technical staff for providing the necessary support for the study. We are grateful to the Central TB Division, WHO India and the WHO RNTCP Medical Consultants who have contributed to this effort. We thank the National Institute of Tuberculosis and Respiratory Diseases, New Delhi for their support in training of the key programme staff in the study protocol and the National Institute for Research in Tuberculosis, Chennai for their support in proving second line drug susceptibility test results in the initial year of PMDT implementation to the state of Gujarat.	[Anonymous], 2000, CROFTON DOUGLASS RES, P517; [Anonymous], 2016, PREVENTION MANAGEMEN; Brust JCM, 2010, INT J TUBERC LUNG D, V14, P413; Central TB Division, 2010, DOTS PLUS GUID; Central TB Division, 2011, RNTCP PERF REP; Central TB Division, 2014, TB IND 2014 RNTCP AN; Central TB Division, TB IND 2016 D RNTCP; Central TB Division Directorate General of Health Services, TECHN OP GUID TB CON; Central TB Division Directorate General of Health Services, 2016, GUID US BED RNTCP CO; Cox HS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001126; Dalal A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116798; Debieu M, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0061075, 10.1371/journal.pone.0082943]; Deshmukh RD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135802; Drug Controller General of India, 2013, 1945 4 AMM; Farley JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020436; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Joseph P, 2011, INDIAN J MED RES, V133, P529; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Liu CC, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020005, 10.1371/journal.pone.0021464]; Liu XF, 2015, ADV METEOROL, V2015, DOI 10.1155/2015/950262; Masjedi MR, 2008, INT J TUBERC LUNG D, V12, P750; Meressa D, 2015, THORAX, V70, P1181, DOI 10.1136/thoraxjnl-2015-207374; Metcalfe JZ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001877; Paresh Dave, 2013, National Journal of Community Medicine, V4, P189; Podewils LJ, 2011, EPIDEMIOL INFECT, V139, P113, DOI 10.1017/S0950268810000907; Podewils LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070064; Ramachandran R, 2009, INT J TUBERC LUNG D, V13, P1154; Salvo F, 2014, INT J TUBERC LUNG D, V18, P655, DOI 10.5588/ijtld.13.0516; Satti H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046943; Satyanarayana S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024160; Soman Rajeev, 2014, J Assoc Physicians India, V62, P567; Subbaraman R, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002149; Sudarsanam TD, 2011, TROP MED INT HEALTH, V16, P699, DOI 10.1111/j.1365-3156.2011.02761.x; THISTLETHWAITE DL, 1960, J EDUC PSYCHOL, V51, P309, DOI 10.1037/h0044319; Udwadia ZF, 2016, LUNG INDIA, V33, P253, DOI 10.4103/0970-2113.180800; Udwadia ZF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012023; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; *WHO, 2016, SHORT MDR TB REG; WHO, 2017, GLOB TUB REP 2017; World Health Organisation Geneva, 2014, DRUG RES TB D SURV R; World Health Organisation Geneva, 2016, MOL LIN PROB ASS DET; World Health Organization, 2014, COMP HDB WHO GUID PR; World Health Organization, 2008, WHOHTMTB2008402; World Health Organization, 2016, AMBIENT AIR POLLUTIO, DOI DOI 10.1017/CBO9781107415324.004; World Health Organization, GLOB STRAT TARG TUB; World Health Organization Geneva, 2007, DIG HLTH END TB STRA, V1, P7	47	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0193903	10.1371/journal.pone.0193903	http://dx.doi.org/10.1371/journal.pone.0193903			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641576	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900019
J	Rabilloud, T				Rabilloud, Thierry			Optimization of the cydex blue assay: A one-step colorimetric protein assay using cyclodextrins and compatible with detergents and reducers	PLOS ONE			English	Article							BETA-CYCLODEXTRIN; ELECTROPHORESIS; QUANTITATION; SENSITIVITY; G-250	Sodium dodecyl sulfate electrophoresis (SDS) is a protein separation technique widely used, for example, prior to immunoblotting. Samples are usually prepared in a buffer containing both high concentrations of reducers and high concentrations of SDS. This conjunction renders the samples incompatible with common protein assays. By chelating the SDS, cyclodextrins make the use of simple, dye-based colorimetric assays possible. In this paper, we describe the optimization of the assay, focussing on the cyclodextrin/SDS ratio and the use of commercial assay reagents. The adaptation of the assay to a microplate format and using other detergent-containing conventional extraction buffers is also described.	[Rabilloud, Thierry] Univ Grenoble Alpes, Chem & Biol Met, UMR5249, CNRS,CEA,BIG LCBM, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Rabilloud, T (corresponding author), Univ Grenoble Alpes, Chem & Biol Met, UMR5249, CNRS,CEA,BIG LCBM, Grenoble, France.	thierry.rabilloud@cea.fr						Atger VM, 1997, J CLIN INVEST, V99, P773, DOI 10.1172/JCI119223; BENSADOUN A, 1976, ANAL BIOCHEM, V70, P241, DOI 10.1016/S0003-2697(76)80064-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Del Valle EMM, 2004, PROCESS BIOCHEM, V39, P1033, DOI 10.1016/S0032-9592(03)00258-9; Eaton SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072457; FRIEDENAUER S, 1989, ANAL BIOCHEM, V178, P263, DOI 10.1016/0003-2697(89)90636-2; FUJITA Y, 1984, CHEM PHARM BULL, V32, P4161; Ghosh R, 2014, EXPERT REV PROTEOMIC, V11, P549, DOI 10.1586/14789450.2014.939635; Hagner-McWhirter A, 2015, ANAL BIOCHEM, V486, P54, DOI 10.1016/j.ab.2015.06.017; LOWRY OH, 1951, J BIOL CHEM, V193, P265; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; OHTANI Y, 1989, EUR J BIOCHEM, V186, P17, DOI 10.1111/j.1432-1033.1989.tb15171.x; OLSON BJ, 2007, CURR PROTOC PROTEIN; PALEPU R, 1988, CAN J CHEM, V66, P325, DOI 10.1139/v88-056; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; PIERCE J, 1977, ANAL BIOCHEM, V81, P478, DOI 10.1016/0003-2697(77)90723-0; Pineiro A, 2007, J PHYS CHEM B, V111, P4383, DOI 10.1021/jp0688815; Rabilloud T, 2016, ELECTROPHORESIS, V37, P2595, DOI 10.1002/elps.201600270; RAMAGLI LS, 1985, ELECTROPHORESIS, V6, P559, DOI 10.1002/elps.1150061109; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; STOSCHECK CM, 1990, ANAL BIOCHEM, V184, P111, DOI 10.1016/0003-2697(90)90021-Z; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; WATANABE N, 1986, CLIN CHEM, V32, P1551; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; Yamamoto E, 2008, ANAL BIOCHEM, V381, P273, DOI 10.1016/j.ab.2008.06.010; Zeng L, 2013, ELECTROPHORESIS, V34, P2234, DOI 10.1002/elps.201300140	28	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195755	10.1371/journal.pone.0195755	http://dx.doi.org/10.1371/journal.pone.0195755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641569	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900089
J	Crum, AJ; Akinola, M; Turnwald, BP; Kaptchuk, TJ; Hall, KT				Crum, Alia J.; Akinola, Modupe; Turnwald, Bradley P.; Kaptchuk, Ted J.; Hall, Kathryn T.			Catechol-O-Methyltransferase moderates effect of stress mindset on affect and cognition	PLOS ONE			English	Article							WORKING-MEMORY PERFORMANCE; DIFFERENTIAL SUSCEPTIBILITY; PSYCHOLOGICAL STRESS; VAL(158)MET GENOTYPE; INCREASED DOPAMINE; ATTENTIONAL BIAS; COMT; CORTEX; RESPONSES; GENE	There is evidence that altering stress mindset D the belief that stress is enhancing vs. debilitating D can change cognitive, affective and physiological responses to stress. However individual differences in responsiveness to stress mindset manipulations have not been explored. Given the previously established role of catecholamines in both placebo effects and stress, we hypothesized that genetic variation in catechol-O-methyltransferase (COMT), an enzyme that metabolizes catecholamines, would moderate responses to an intervention intended to alter participants' mindsets about stress. Participants (N = 107) were exposed to a stress mindset manipulation (videos highlighting either the enhancing or debilitating effects of stress) prior to engaging in a Trier Social Stress task and subsequent cognitive tasks. The associations of the COMT rs4680 polymorphism with the effect of stress mindset video manipulations on cognitive and affective responses were examined. Genetic variation at rs4680 modified the effects of stress mindset on affective and cognitive responses to stress. Individuals homozygous for rs4680 low-activity allele (met/met) were responsive to the stress-is-enhancing mindset manipulation as indicated by greater increases in positive affect, improved cognitive functioning, and happiness bias in response to stress. Conversely, individuals homozygous for the high-activity allele (val/val) were not as responsive to the stress mindset manipulation. These results suggest that responses to stress mindset intervention may vary with COMT genotype. These findings contribute to the understanding of gene by environment interactions for mindset interventions and stress reactivity and therefore warrant further investigations.	[Crum, Alia J.; Turnwald, Bradley P.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Akinola, Modupe] Columbia Univ, Columbia Business Sch, New York, NY USA; [Kaptchuk, Ted J.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA USA; [Kaptchuk, Ted J.; Hall, Kathryn T.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Program Placebo Studies, Boston, MA USA; [Hall, Kathryn T.] Harvard Med Sch, Brigham & Womens Hosp, Div Prevent Med, Boston, MA USA	Stanford University; Columbia University; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Crum, AJ (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	crum@stanford.edu			NIH/NCCIH Grant [DP2AT009511, 2K24 AT004095]; NIH/NIHLB Grant [K01 HL130625]; NSF/GRFP Grant [DGE-114747]; National Center for Complementary & Integrative Health [K24AT004095] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL130625] Funding Source: NIH RePORTER	NIH/NCCIH Grant; NIH/NIHLB Grant; NSF/GRFP Grant(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NCCIH Grant # DP2AT009511 to AJC; NIH/NIHLB Grant # K01 HL130625 to KTH; NIH/NCCIH Grant # 2K24 AT004095 to TJK; and NSF/GRFP Grant # DGE-114747 to BPT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AJC supported by NIH/NCCIH Grant # DP2AT009511; KTH supported by NIH/NIHLB Grant # K01 HL130625; TJK supported by NIH/NCCIH Grant # 2K24 AT004095; BPT supported by NSF/GRFP Grant # DGE-114747.	Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Bakermans-Kranenburg MJ, 2006, DEV PSYCHOBIOL, V48, P406, DOI 10.1002/dev.20152; Belsky J, 2007, CURR DIR PSYCHOL SCI, V16, P300, DOI 10.1111/j.1467-8721.2007.00525.x; Belsky J, 2015, DEV PSYCHOPATHOL, V27, P1, DOI 10.1017/S0954579414001254; Blackwell LS, 2007, CHILD DEV, V78, P246, DOI 10.1111/j.1467-8624.2007.00995.x; Bouma EMC, 2012, MOL PSYCHIATR, V17, P119, DOI 10.1038/mp.2011.115; Boyle EA, 2017, CELL, V169, P1177, DOI 10.1016/j.cell.2017.05.038; Bradley BP, 1998, COGNITION EMOTION, V12, P737, DOI 10.1080/026999398379411; Buckert M, 2012, PSYCHONEUROENDOCRINO, V37, P1810, DOI 10.1016/j.psyneuen.2012.03.014; Crum AJ, 2017, ANXIETY STRESS COPIN, P1; Crum AJ, 2013, J PERS SOC PSYCHOL, V104, P716, DOI 10.1037/a0031201; Crum AJ, 2011, HEALTH PSYCHOL, V30, P424, DOI 10.1037/a0023467; Damian MF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00765; de Frias CM, 2004, BEHAV GENET, V34, P533, DOI 10.1023/B:BEGE.0000038491.06972.8c; DEUTCH AY, 1990, PROG BRAIN RES, V85, P367; Doll BB, 2011, J NEUROSCI, V31, P6188, DOI 10.1523/JNEUROSCI.6486-10.2011; Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396; Egan MF, 2001, P NATL ACAD SCI USA, V98, P6917, DOI 10.1073/pnas.111134598; Enoch MA, 2008, DEPRESS ANXIETY, V25, P383, DOI 10.1002/da.20378; FINLAY JM, 1995, NEUROSCIENCE, V64, P619, DOI 10.1016/0306-4522(94)00331-X; Flint J, 2013, CURR OPIN NEUROBIOL, V23, P57, DOI 10.1016/j.conb.2012.07.005; Gaunt TR, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-428; Gaunt TR, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-227; Goldstein David S, 2003, Endocr Regul, V37, P69; Goldstein LE, 1996, J NEUROSCI, V16, P4787; Hall KT, 2015, TRENDS MOL MED, V21, P285, DOI 10.1016/j.molmed.2015.02.009; Hall KT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048135; Harrison PJ, 2008, NEUROPSYCHOPHARMACOL, V33, P3037, DOI 10.1038/sj.npp.1301543; Heinz A, 2006, REV NEUROSCIENCE, V17, P359; Hernaus D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065662; Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002; Hygen BW, 2015, DEV PSYCHOL, V51, P1098, DOI 10.1037/dev0000020; Job V., 2010, PSYCHOL SCI; KIRSCHBAUM C, 1993, NEUROPSYCHOBIOLOGY, V28, P76, DOI 10.1159/000119004; Koban L, 2017, NEUROSCI BIOBEHAV R, V81, P29, DOI 10.1016/j.neubiorev.2017.02.014; Lovallo WR, 2017, PSYCHOSOM MED, V79, P631, DOI 10.1097/PSY.0000000000000481; MACLEOD C, 1986, J ABNORM PSYCHOL, V95, P15, DOI 10.1037/0021-843X.95.1.15; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Mattay VS, 2003, P NATL ACAD SCI USA, V100, P6186, DOI 10.1073/pnas.0931309100; Murphy BL, 1996, P NATL ACAD SCI USA, V93, P1325, DOI 10.1073/pnas.93.3.1325; Papaleo F, 2008, J NEUROSCI, V28, P8709, DOI 10.1523/JNEUROSCI.2077-08.2008; Qin SZ, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00016; Raz A, 2008, CORTEX, V44, P1336, DOI 10.1016/j.cortex.2007.07.011; Raz N, 2009, NEUROPSYCHOLOGY, V23, P105, DOI 10.1037/a0013487; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Thierry A, 1976, NATURE; THIERRY AM, 1973, BRAIN RES, V50, P230, DOI 10.1016/0006-8993(73)90614-8; Tunbridge EM, 2010, INT REV NEUROBIOL, V95, P7, DOI [10.1016/B978-0-12-381326-8-00002-8, 10.1016/B978-0-12-381326-8.00002-8]; Turnwald BP, 2017, HEALTH PSYCHOL, V36, P1034, DOI 10.1037/hea0000501; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; WATSON D, 1994, EMOTIONS MOODS TRAIT; Witte AV, 2012, BRAIN RES BULL, V88, P418, DOI 10.1016/j.brainresbull.2011.11.012; Zahrt J, 1997, J NEUROSCI, V17, P8528; Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546	54	12	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195883	10.1371/journal.pone.0195883	http://dx.doi.org/10.1371/journal.pone.0195883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD6SO	29677196	Green Published, Green Submitted, gold			2022-12-26	WOS:000430638900017
J	Zhao, J; Xia, HX; Yu, TY; Jin, L; Li, XH; Zhang, YH; Shu, LP; Zeng, LW; He, ZX				Zhao, Jin; Xia, Haixiong; Yu, Tingyu; Jin, Lu; Li, Xuehua; Zhang, Yinghui; Shu, Liping; Zeng, Lingwen; He, Zhixu			A colorimetric assay for vanillin detection by determination of the luminescence of o-toluidine condensates	PLOS ONE			English	Article							LIQUID-CHROMATOGRAPHY; ELECTROCHEMICAL DETECTION; VOLTAMMETRIC DETERMINATION; MODIFIED ELECTRODE; MASS-SPECTROMETRY; FLAVOR ENHANCERS; GC-OLFACTOMETRY; ETHYL VANILLIN; EXTRACT; COMPOSITE	Vanillin (4-hydroxy-3-methoxybenzaldehyde), a food additive with rich milk flavor, is commonly used in the food, beverage and cosmetic industries. However, excessive consumption of vanillin may cause liver and kidney damage. Therefore, methods for detecting and controlling the level of vanillin in food, especially in infant powder, have important practical significance. In this study, we established a colorimetric assay for vanillin detection. The detection was performed under high-temperature and acidic conditions, which can induce the reaction of the aldehyde group of vanillin with the amino group of o-toluidine. The resulting product had a maximum absorption at 363 nm, which was quantified by a UV spectrophotometer. This assay had a limit of detection (LOD) of 1 pg mL(-1) and a linear range between 1 mu g mL(-1) and 100 mu g mL(-1). The average recoveries at three spiked levels were in the range from 91.1% to 101.6% with a relative standard deviation (RSD) of 4.62% similar to 7.27%.	[Zhao, Jin; Xia, Haixiong; Jin, Lu; Li, Xuehua; Shu, Liping; He, Zhixu] Guizhou Med Univ, Sch Basic Med, Dept Immunol, Tissue Engn & Stem Cell Res Ctr,Guizhou Prov Key, Guiyang, Guizhou, Peoples R China; [Zhao, Jin; He, Zhixu] Guizhou Med Univ, State Key Lab Med Plant Efficacy & Utilizat, Affiliated Hosp, Guiyang, Guizhou, Peoples R China; [Yu, Tingyu] Guangzhou Univ Chinese Med, Clin Med Coll 2, Guangzhou, Guangdong, Peoples R China; [Zhang, Yinghui; Zeng, Lingwen] Foshan Univ, Sch Food Sci & Engn, Foshan, Guangdong, Peoples R China; [Zeng, Lingwen] Chinese Acad Sci, Guangzhou Inst Biomed, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Zeng, Lingwen] Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China; [Zhao, Jin] Guizhou Med Univ, Tissue Engn & Stem Cell Res Ctr, Guizhou Prov Key Lab Regenerat Med, Guiyang, Guizhou, Peoples R China	Guizhou Medical University; Guizhou Medical University; Guangzhou University of Chinese Medicine; Foshan University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guizhou Medical University	He, ZX (corresponding author), Guizhou Med Univ, Sch Basic Med, Dept Immunol, Tissue Engn & Stem Cell Res Ctr,Guizhou Prov Key, Guiyang, Guizhou, Peoples R China.; He, ZX (corresponding author), Guizhou Med Univ, State Key Lab Med Plant Efficacy & Utilizat, Affiliated Hosp, Guiyang, Guizhou, Peoples R China.; Zeng, LW (corresponding author), Foshan Univ, Sch Food Sci & Engn, Foshan, Guangdong, Peoples R China.; Zeng, LW (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China.; Zeng, LW (corresponding author), Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou, Guangdong, Peoples R China.	zeng_lingwen@gibh.ac.cn; hzx@gmc.edu.cn		Zhao, Jin/0000-0003-1442-6873	Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Stem Cell and Molecular Diagnostic Laboratory; Guangdong Science and Technology Foundation [20146020212011]	Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Stem Cell and Molecular Diagnostic Laboratory; Guangdong Science and Technology Foundation	This work was supported by Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Stem Cell and Molecular Diagnostic Laboratory. This study was also supported by the Guangdong Science and Technology Foundation (20146020212011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by Key Laboratory of Regenerative Biology, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Stem Cell and Molecular Diagnostic Laboratory. This study was also supported by the Guangdong Science and Technology Foundation (2014B020212011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. and analysis, decision to publish, or preparation of the manuscript.	Ali L, 2008, J AOAC INT, V91, P383; [Anonymous], 2011, 27602011 GB; Bagheri H, 2015, ANAL CHIM ACTA, V870, P56, DOI 10.1016/j.aca.2015.03.004; Barghini P, 2007, MICROB CELL FACT, V6, DOI 10.1186/1475-2859-6-13; Beaudry F, 2007, BIOMED CHROMATOGR, V21, P113, DOI 10.1002/bmc.744; Bononi M, 2015, J AGR FOOD CHEM, V63, P4777, DOI 10.1021/acs.jafc.5b02136; Cantalapiedra A, 2014, PHYTOCHEM ANALYSIS, V25, P247, DOI 10.1002/pca.2500; de Jager LS, 2007, J CHROMATOGR A, V1145, P83, DOI 10.1016/j.chroma.2007.01.039; Deng PH, 2015, FOOD CHEM, V180, P156, DOI 10.1016/j.foodchem.2015.02.035; Furuya T, 2017, J BIOTECHNOL, V243, P25, DOI 10.1016/j.jbiotec.2016.12.021; Gallage NJ, 2015, MOL PLANT, V8, P40, DOI 10.1016/j.molp.2014.11.008; Goodner KL, 2000, J AGR FOOD CHEM, V48, P2882, DOI 10.1021/jf990561d; Huang LH, 2014, MAT SCI ENG C-MATER, V38, P39, DOI 10.1016/j.msec.2014.01.037; Li Q, 2002, J AOAC INT, V85, P456; Longares-Patron A, 2006, TALANTA, V69, P882, DOI 10.1016/j.talanta.2005.11.030; Ma J, 2014, J SEP SCI, V37, P920, DOI 10.1002/jssc.201301367; Minematsu Saaya, 2013, J Environ Sci (China), V25 Suppl 1, pS8, DOI 10.1016/S1001-0742(14)60617-3; Mohamed GG, 2011, ANALYST, V136, P1488, DOI 10.1039/c0an00662a; Negishi O, 2009, J AGR FOOD CHEM, V57, P9956, DOI 10.1021/jf901204m; Perez-Silva A, 2006, FOOD CHEM, V99, P728, DOI 10.1016/j.foodchem.2005.08.050; Shang L, 2014, FOOD CHEM, V151, P53, DOI 10.1016/j.foodchem.2013.11.044; Shao XT, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1388-7; Tai A, 2011, BBA-GEN SUBJECTS, V1810, P170, DOI 10.1016/j.bbagen.2010.11.004; Takahashi M, 2013, BIOSCI BIOTECH BIOCH, V77, P595, DOI 10.1271/bbb.120835; Walton NJ, 2003, PHYTOCHEMISTRY, V63, P505, DOI 10.1016/S0031-9422(03)00149-3; Wu JH, 2015, J COLLOID INTERF SCI, V442, P22, DOI 10.1016/j.jcis.2014.11.025; Yardim Y, 2013, FOOD CHEM, V141, P1821, DOI 10.1016/j.foodchem.2013.04.085; Zou Xiaoli, 2003, Sichuan Da Xue Xue Bao Yi Xue Ban, V34, P580	28	11	11	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0194010	10.1371/journal.pone.0194010	http://dx.doi.org/10.1371/journal.pone.0194010			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677193	Green Submitted, gold, Green Published			2022-12-26	WOS:000430638900004
J	Lan, Y; Mai, ZL; Zhou, SY; Liu, Y; Li, SJ; Zhao, ZJ; Duan, XL; Cai, C; Deng, T; Zhu, W; Wu, WQ; Zeng, GH				Lan, Yu; Mai, Zanlin; Zhou, Shiyu; Liu, Yang; Li, Shujue; Zhao, Zhijian; Duan, Xiaolu; Cai, Cao; Deng, Tuo; Zhu, Wei; Wu, Wenqi; Zeng, Guohua			Prevalence of metabolic syndrome in China: An up-dated cross-sectional study	PLOS ONE			English	Article							SERUM URIC-ACID; NATIONAL-HEALTH; US ADULTS; EDUCATION; OBESITY; AGE	Metabolic syndrome (MS) is an increasing public health concern because of rapid lifestyle changes. Although there have been previous studies on the prevalence of MS in China, the prevalence may have changed with lifestyle changes over the last decade. To update this prevalence, we performed a cross-sectional survey among adults over 18 years old across China from May 2013 to July 2014. Participants underwent questionnaires and provided blood and urine samples for analysis. MS was defined according to the criteria of the China Diabetes Society. A total of 12570 individuals (45.2% men) with an average age of 48.8 15.3 (18-96) years were selected and invited to participate in the study. In total, 9310 (40.7% men) individuals completed the investigation, with a response rate of 74.1%. The prevalence of MS in China was 14.39% [95% confidence interval (CI): -3.75-32.53%], and the age-adjusted prevalence was 9.82% (95% CI: 9.03-10.61%; 7.78% in men and 6.76% in women; 7.39% in rural residents and 6.98% in urban residents). The highest prevalence occurred among adults aged 50-59 years (1.95%, 95% CI: 1.40-2.50%), and the lowest prevalence occurred among adults aged 40-49 years (0.74%, 95% CI: 0.38-1.10%); the prevalence was the highest in the south region and lowest in the east region (4.46% and 1.23%, respectively). The results of logistic regression analyses showed that age, urolithiasis, hyperuricemia, coronary artery disease, thiazide drugs intake, family history of diabetes and hypertension were all significantly associated with an increased risk of metabolic syndrome (OR>1). In addition, education, vitamin D intake and family history of urolithiasis are all protective factors (OR<1). Our results indicate that there was a high prevalence of MS in Chinese adults. Compared to the previous study 10 years ago, some preventive strategies have worked; however, further work on the prevention and treatment of MS remains necessary.	[Lan, Yu; Mai, Zanlin; Liu, Yang; Li, Shujue; Zhao, Zhijian; Duan, Xiaolu; Cai, Cao; Deng, Tuo; Zhu, Wei; Wu, Wenqi; Zeng, Guohua] Guangzhou Med Univ, Dept Urol, Minimally Invas Surg Ctr, Guangdong Key Lab Urol,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Zhou, Shiyu] Guangzhou Med Univ, Inst Chem Carcinogenesis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Zhou, Shiyu] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China	Guangzhou Medical University; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University	Zeng, GH (corresponding author), Guangzhou Med Univ, Dept Urol, Minimally Invas Surg Ctr, Guangdong Key Lab Urol,Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	gzgyzgh@vip.tom.com			National Natural Science Foundation of China [81670643, 81600542, 81570633]; Guangzhou Science Technology and Innovation Commission [201604020001, 201704020193]; Collaborative Innovation Project of Guangzhou Education Bureau [1201620011]; Science and Technology Project of Guangdong Province [2014A020209085, 20176030314108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Science Technology and Innovation Commission; Collaborative Innovation Project of Guangzhou Education Bureau; Science and Technology Project of Guangdong Province	Our work was financed by these following grants: The National Natural Science Foundation of China (NO. 81670643, NO. 81600542 and NO. 81570633.), the Guangzhou Science Technology and Innovation Commission (No. 201604020001 and No. 201704020193), the Collaborative Innovation Project of Guangzhou Education Bureau (NO. 1201620011) and the Science and Technology Project of Guangdong Province (NO. 2014A020209085 and No.20176030314108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Antonelli JA, 2014, EUR UROL, V66, P724, DOI 10.1016/j.eururo.2014.06.036; Borrell LN, 2006, AM J PUBLIC HEALTH, V96, P1637, DOI 10.2105/AJPH.2005.072884; Chen JH, 2016, J NUTR HEALTH AGING, V20, P912, DOI 10.1007/s12603-015-0633-6; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Ford ES, 2002, JAMA-J AM MED ASSOC, V287, P356, DOI 10.1001/jama.287.3.356; Further Study Of Risk Factors For Stroke And Coronary Heart Disease group, 2002, Zhonghua Yu Fang Yi Xue Za Zhi, V36, P298; Ghanei L, 2015, J RES HEALTH SCI, V15, P32; Gu DF, 2005, LANCET, V365, P1398, DOI 10.1016/S0140-6736(05)66375-1; He SJ, 2017, GYNECOL ENDOCRINOL, V33, P141, DOI 10.1080/09513590.2016.1214261; James P T, 2001, Obes Res, V9 Suppl 4, p228S, DOI 10.1038/oby.2001.123; Kassi E, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-48; Maki KC, 2012, METAB SYNDR RELAT D, V10, P363, DOI 10.1089/met.2012.0020; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Tal S, 2014, J NUTR HEALTH AGING, V18, P22, DOI 10.1007/s12603-013-0360-9; The census office of the state council, TAB 2010 POP CENS PE; WHO, 2011, WHO TECHN REP SER, V894; Xi B, 2013, PREV MED, V57, P867, DOI 10.1016/j.ypmed.2013.09.023; Yan LJL, 2006, JAMA-J AM MED ASSOC, V295, P1793, DOI 10.1001/jama.295.15.1793; Zeng GH, 2017, BJU INT, V120, P109, DOI 10.1111/bju.13828	20	35	38	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196012	10.1371/journal.pone.0196012	http://dx.doi.org/10.1371/journal.pone.0196012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668762	gold, Green Submitted, Green Published			2022-12-26	WOS:000430290200075
J	Ma, ZL; Zhao, WQ; Zhao, CZ; Wang, D; Liu, M; Li, DD; Liu, Q				Ma, Zhiliang; Zhao, Wenqiang; Zhao, Chunzhang; Wang, Dong; Liu, Mei; Li, Dandan; Liu, Qing			Plants regulate the effects of experimental warming on the soil microbial community in an alpine scrub ecosystem	PLOS ONE			English	Article							QINGHAI-TIBET PLATEAU; SIBIRAEA-ANGUSTATA SCRUB; TERM N ADDITION; CLIMATE-CHANGE; NITROGEN-FERTILIZATION; TALLGRASS PRAIRIE; RESPONSES; CARBON; BIOMASS; FOREST	Information on how soil microbial communities respond to warming is still scarce for alpine scrub ecosystems. We conducted a field experiment with two plant treatments (plant removal or undisturbed) subjected to warmed or unwarmed conditions to examine the effects of warming and plant removal on soil microbial community structures during the growing season in a Sibiraea angustata scrubland of the eastern Qinghai Tibetan Plateau. The results indicate that experimental warming significantly influenced soil microbial biomass carbon (MBC) and microbial biomass nitrogen (MBN), but the warming effects were dependent on the plant treatments and sampling seasons. In the plant-removal plots, warming did not affect most of the microbial variables, while in the undisturbed plots, warming significantly increased the abundances of actinomycete and Gram-positive bacterial groups during the mid-growing season (July), but it did not affect the fungi groups. Plant removal significantly reduced fungal abundance throughout the growing season and significantly altered the soil microbial community structure in July. The interaction between warming and plant removal significantly influenced the soil MBC and MBN and the abundances of total microbes, bacteria and actinomycete throughout the growing season. Experimental warming significantly reduced the abundance of rare taxa, while the interaction between warming and plant removal tended to have strong effects on the abundant taxa. These findings suggest that the responses of soil microbial communities to warming are regulated by plant communities. These results provide new insights into how soil microbial community structure responds to climatic warming in alpine scrub ecosystems.	[Ma, Zhiliang; Zhao, Wenqiang; Zhao, Chunzhang; Wang, Dong; Liu, Mei; Li, Dandan; Liu, Qing] Chinese Acad Sci, Chengdu Inst Biol, Key Lab Sichuan Prov, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Sichuan, Peoples R China; [Ma, Zhiliang] Sichuan Univ, Coll Life Sci, Chengdu, Sichuan, Peoples R China; [Ma, Zhiliang] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chengdu Institute of Biology, CAS; Sichuan University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, Q (corresponding author), Chinese Acad Sci, Chengdu Inst Biol, Key Lab Sichuan Prov, Key Lab Mt Ecol Restorat & Bioresource Utilizat &, Chengdu, Sichuan, Peoples R China.	liuqing@cib.ac.cn	Ma, Zhiliang/GXV-4296-2022		National Key R&D Program of China [2017YFC0505000]; National Natural Science Foundation of China [31570476, 31400424]; National Science and Technology Basic Work Project [2015FY110300]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science and Technology Basic Work Project	This study was funded by the National Key R&D Program of China (2017YFC0505000 to Qing Liu), the National Natural Science Foundation of China (31570476 to Qing Liu; 31400424 to Dandan Li), and the National Science and Technology Basic Work Project (2015FY110300) to Qing Liu. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison SD, 2008, GLOBAL CHANGE BIOL, V14, P2898, DOI 10.1111/j.1365-2486.2008.01716.x; Bai E, 2013, NEW PHYTOL, V199, P441, DOI 10.1111/nph.12252; Bardgett RD, 2008, ISME J, V2, P805, DOI 10.1038/ismej.2008.58; Barnard RL, 2015, ISME J, V9, P946, DOI 10.1038/ismej.2014.192; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Crowther TW, 2016, NATURE, V540, P104, DOI 10.1038/nature20150; de Vries FT, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00265; Frey SD, 2008, SOIL BIOL BIOCHEM, V40, P2904, DOI 10.1016/j.soilbio.2008.07.020; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Fu G, 2012, APPL SOIL ECOL, V61, P158, DOI 10.1016/j.apsoil.2012.05.002; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Hodge A, 2000, TRENDS PLANT SCI, V5, P304, DOI 10.1016/S1360-1385(00)01656-3; Hopkins FM, 2014, SOIL BIOL BIOCHEM, V76, P57, DOI 10.1016/j.soilbio.2014.04.028; IPCC, 2007, CLIM CHANG 2007 PHYS; Joergensen RG, 2011, SOIL BIOL BIOCHEM, V43, P873, DOI 10.1016/j.soilbio.2010.09.024; Joergensen RG, 2008, SOIL BIOL BIOCHEM, V40, P2977, DOI 10.1016/j.soilbio.2008.08.017; Jonathan R, 2017, ECOSYSTEMS, V19, P339; Kirschbaum MUF, 2004, GLOBAL CHANGE BIOL, V10, P1870, DOI 10.1111/j.1365-2486.2004.00852.x; Klein JA, 2005, GLOBAL CHANGE BIOL, V11, P1440, DOI 10.1111/j.1365-2486.2005.00994.x; Liu WX, 2009, GLOBAL CHANGE BIOL, V15, P184, DOI 10.1111/j.1365-2486.2008.01728.x; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; Manzoni S, 2014, SOIL BIOL BIOCHEM, V73, P69, DOI 10.1016/j.soilbio.2014.02.008; Manzoni S, 2012, ECOLOGY, V93, P930, DOI 10.1890/11-0026.1; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Preusser S, 2017, SOIL BIOL BIOCHEM, V105, P138, DOI 10.1016/j.soilbio.2016.11.021; Rawlins BG, 2015, SOIL USE MANAGE, V31, P46, DOI 10.1111/sum.12079; Rinnan R, 2007, GLOBAL CHANGE BIOL, V13, P28, DOI 10.1111/j.1365-2486.2006.01263.x; Romero-Olivares AL, 2017, SOIL BIOL BIOCHEM, V107, P32, DOI 10.1016/j.soilbio.2016.12.026; Rui JP, 2015, APPL ENVIRON MICROB, V81, P6070, DOI 10.1128/AEM.00557-15; Schindlbacher A, 2011, SOIL BIOL BIOCHEM, V43, P1417, DOI 10.1016/j.soilbio.2011.03.005; Solly EF, 2017, NEW PHYTOL, V215, P766, DOI 10.1111/nph.14603; Streit K, 2014, GLOBAL CHANGE BIOL, V20, P1327, DOI 10.1111/gcb.12396; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Wan S, 2002, GLOBAL CHANGE BIOL, V8, P754, DOI 10.1046/j.1365-2486.2002.00510.x; Wang D, 2017, EUR J SOIL SCI, V68, P212, DOI 10.1111/ejss.12414; Wang D, 2017, AGR FOREST METEOROL, V247, P151, DOI 10.1016/j.agrformet.2017.07.026; Xiong JB, 2014, FEMS MICROBIOL ECOL, V89, P281, DOI 10.1111/1574-6941.12289; Xiong QL, 2016, APPL SOIL ECOL, V101, P72, DOI 10.1016/j.apsoil.2016.01.011; Xu MH, 2014, POL J ECOL, V62, P493; Xu ZF, 2010, PLANT SOIL, V336, P183, DOI 10.1007/s11104-010-0461-8; Xue X, 2014, ARCT ANTARCT ALP RES, V46, P441, DOI 10.1657/1938-4246-46.2.441; Yang Lin, 2016, Yingyong Shengtai Xuebao, V27, P2855, DOI 10.13287/j.1001-9332.201609.026; Yin HJ, 2013, GLOBAL CHANGE BIOL, V19, P2158, DOI 10.1111/gcb.12161; Yu CQ, 2014, SCI WORLD J, DOI 10.1155/2014/152576; Yuge K, 2016, J AGR METEOROL, V60, P717; Zhang NL, 2011, SOIL BIOL BIOCHEM, V43, P2053, DOI 10.1016/j.soilbio.2011.06.001; Zhang W, 2005, GLOBAL CHANGE BIOL, V11, P266, DOI 10.1111/j.1365-2486.2005.00902.x; Zhao CZ, 2014, PLANT SOIL, V382, P189, DOI 10.1007/s11104-014-2153-2; Zhao J, 2015, EUR J SOIL BIOL, V68, P61, DOI 10.1016/j.ejsobi.2015.03.008; Zhou JZ, 2012, NAT CLIM CHANGE, V2, P106, DOI 10.1038/NCLIMATE1331; Zhou XQ, 2013, GEODERMA, V206, P24, DOI 10.1016/j.geoderma.2013.04.020	53	8	18	10	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195079	10.1371/journal.pone.0195079	http://dx.doi.org/10.1371/journal.pone.0195079			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668711	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200025
J	Brockett, AT; Kane, GA; Monari, PK; Briones, BA; Vigneron, PA; Barber, GA; Bermudez, A; Dieffenbach, U; Kloth, AD; Buschman, TJ; Gould, E				Brockett, Adam T.; Kane, Gary A.; Monari, Patrick K.; Briones, Brandy A.; Vigneron, Pierre-Antoine; Barber, Gabriela A.; Bermudez, Andres; Dieffenbach, Uma; Kloth, Alexander D.; Buschman, Timothy J.; Gould, Elizabeth			Evidence supporting a role for astrocytes in the regulation of cognitive flexibility and neuronal oscillations through the Ca2+ binding protein S100 beta	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PREFRONTAL CORTEX; MOOD DISORDERS; D-SERINE; IN-VIVO; GAMMA; SCHIZOPHRENIA; PATHOLOGY; RELEASE; PERSPECTIVE	The medial prefrontal cortex (mPFC) is important for cognitive flexibility, the ability to switch between two task-relevant dimensions. Changes in neuronal oscillations and alterations in the coupling across frequency ranges have been correlated with attention and cognitive flexibility. Here we show that astrocytes in the mPFC of adult male Sprague Dawley rats, participate in cognitive flexibility through the astrocyte-specific Ca2+ binding protein S100 beta, which improves cognitive flexibility and increases phase amplitude coupling between theta and gamma oscillations. We further show that reduction of astrocyte number in the mPFC impairs cognitive flexibility and diminishes delta, alpha and gamma power. Conversely, chemogenetic activation of astrocytic intracellular Ca2+ signaling in the mPFC enhances cognitive flexibility, while inactivation of endogenous S100 beta among chemogenetically activated astrocytes in the mPFC prevents this improvement. Collectively, our work suggests that astrocytes make important contributions to cognitive flexibility and that they do so by releasing a Ca2+ binding protein which in turn enhances coordinated neuronal oscillations.	[Brockett, Adam T.; Kane, Gary A.; Monari, Patrick K.; Briones, Brandy A.; Vigneron, Pierre-Antoine; Barber, Gabriela A.; Bermudez, Andres; Dieffenbach, Uma; Buschman, Timothy J.; Gould, Elizabeth] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Brockett, Adam T.; Kane, Gary A.; Monari, Patrick K.; Briones, Brandy A.; Vigneron, Pierre-Antoine; Barber, Gabriela A.; Bermudez, Andres; Dieffenbach, Uma; Buschman, Timothy J.; Gould, Elizabeth] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA; [Kloth, Alexander D.] Univ North Carolina Chapel Hill, Dept Cell Biol & Physiol, Chapel Hill, NC USA; [Kloth, Alexander D.] Univ North Carolina Chapel Hill, Neurosci Ctr, Chapel Hill, NC USA	Princeton University; Princeton University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Gould, E (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Gould, E (corresponding author), Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.	goulde@princeton.edu	Core, Vector/CAF-4832-2022; Buschman, Timothy J/B-3056-2009	Buschman, Timothy J/0000-0003-1298-2761; Briones, Brandy/0000-0003-4692-3399; Monari, Patrick/0000-0003-4699-3004; Vigneron, Pierre-Antoine/0000-0003-2918-0909				Anderson CM, 2000, GLIA, V32, P1; Attwell D, 2010, NATURE, V468, P232, DOI 10.1038/nature09613; Banasr M, 2008, BIOL PSYCHIAT, V64, P863, DOI 10.1016/j.biopsych.2008.06.008; Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013; Ben Haim L, 2017, NAT REV NEUROSCI, V18, P31, DOI [10.1038/nrn.2016.159, 10.1038/nm.2016.159]; Birrell JM, 2000, J NEUROSCI, V20, P4320; Brockett AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124859; Bull C, 2014, NEUROPSYCHOPHARMACOL, V39, P2835, DOI 10.1038/npp.2014.135; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Clasadonte J, 2017, NEURON, V95, P1365, DOI 10.1016/j.neuron.2017.08.022; Dajani DR, 2015, TRENDS NEUROSCI, V38, P571, DOI 10.1016/j.tins.2015.07.003; Gomez JL, 2017, SCIENCE, V357, P503, DOI 10.1126/science.aan2475; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Khakh BS, 2015, NAT NEUROSCI, V18, P942, DOI 10.1038/nn.4043; Khurgel M, 1996, GLIA, V16, P351, DOI 10.1002/(SICI)1098-1136(199604)16:4<351::AID-GLIA7>3.0.CO;2-2; Lee HS, 2014, P NATL ACAD SCI USA, V111, pE3343, DOI 10.1073/pnas.1410893111; Lima A, 2014, MOL PSYCHIATR, V19, P834, DOI 10.1038/mp.2013.182; Magistretti PJ, 2015, NEURON, V86, P883, DOI 10.1016/j.neuron.2015.03.035; Morquette P, 2015, NAT NEUROSCI, V18, P844, DOI 10.1038/nn.4013; Newman LA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028427; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Parpura V, 2012, ASN NEURO, V4, P201, DOI 10.1042/AN20120019; Piguet C, 2016, HUM BRAIN MAPP, V37, P1335, DOI 10.1002/hbm.23104; Plume A., 2014, SCI ENG ETHICS, V38, P16, DOI DOI 10.1016/J.TICS.2013.10.010; Poskanzer KE, 2016, P NATL ACAD SCI USA, V113, pE2675, DOI 10.1073/pnas.1520759113; Rajkowska G, 2002, SCHIZOPHR RES, V57, P127, DOI 10.1016/S0920-9964(02)00339-0; Rajkowska G, 2013, CURR DRUG TARGETS, V14, P1225; Sakatani S, 2008, J NEUROSCI, V28, P10928, DOI 10.1523/JNEUROSCI.3693-08.2008; Sampedro-Piquero P, 2014, NEUROBIOL LEARN MEM, V114, P16, DOI 10.1016/j.nlm.2014.04.002; Sanacora G, 2013, BIOL PSYCHIAT, V73, P1172, DOI 10.1016/j.biopsych.2013.03.032; Schmitt A, 2009, ACTA NEUROPATHOL, V117, P395, DOI 10.1007/s00401-008-0430-y; Schummers J, 2008, SCIENCE, V320, P1638, DOI 10.1126/science.1156120; Scofield MD, 2015, BIOL PSYCHIAT, V78, P441, DOI 10.1016/j.biopsych.2015.02.016; Suzuki A, 2011, CELL, V144, P810, DOI 10.1016/j.cell.2011.02.018; Takano T, 2014, GLIA, V62, P78, DOI 10.1002/glia.22588; Takata N, 2011, J NEUROSCI, V31, P18155, DOI 10.1523/JNEUROSCI.5289-11.2011; Thoma P, 2007, SCHIZOPHR RES, V92, P168, DOI 10.1016/j.schres.2007.02.004; Tort ABL, 2009, P NATL ACAD SCI USA, V106, P20942, DOI 10.1073/pnas.0911331106; Verkhratsky A, 2016, PROG NEUROBIOL, V144, P188, DOI 10.1016/j.pneurobio.2015.09.003; Voloh B, 2015, P NATL ACAD SCI USA, V112, P8457, DOI 10.1073/pnas.1500438112; Weber B, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020396; Xie L, 2013, SCIENCE, V342, P272; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100	43	31	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195726	10.1371/journal.pone.0195726	http://dx.doi.org/10.1371/journal.pone.0195726			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664924	gold, Green Published, Green Submitted			2022-12-26	WOS:000430262300028
J	Ciurleo, R; Bonanno, L; De Salvo, S; Romeo, L; Rifici, C; Sessa, E; D'Aleo, G; Russo, M; Bramanti, P; Marino, S; Caminiti, F				Ciurleo, Roselle; Bonanno, Lilla; De Salvo, Simona; Romeo, Laura; Rifici, Carmela; Sessa, Edoardo; D'Aleo, Giangaetano; Russo, Margherita; Bramanti, Placido; Marino, Silvia; Caminiti, Fabrizia			Olfactory dysfunction as a prognostic marker for disability progression in Multiple Sclerosis: An olfactory event related potential study	PLOS ONE			English	Article							DISEASES	Multiple sclerosis (MS) is a chronic inflammatory disease and one of the leading causes of disability in young adults. Functional markers able to predict MS progression are still lacking. It is recognized that olfactory dysfunction may be an early symptom in MS. The aim of this study was to investigate whether alterations in olfactory event-related potentials could play a prognostic role in MS. Thirty patients affected by MS relapsing-remitting underwent an olfactory potential examination (T0). Three years after baseline (T1), 28 of 30 patients were clinically evaluated by expanded disability status scale. In addition, the number of Disease Modifying Therapies (DMTs) and the total number of relapses occurred in the last 3 years were collected. At T1, we observed a negative correlation between presence/absence of olfactory potentials and expanded disability status scale scores (rpb = -0.48; p = 0.009). A significant trend for a negative correlation between presence/absence of olfactory potentials and disease duration (rpb = -0.36; p = 0.06) and total number of relapses (rpb = -0.34; p = 0.08) was found. Only patients with olfactory potential absence showed a significant trend in the difference of the disability status scale (p = 0.06) between T0 and T1. In the sub-group of patients with reduced olfactory potential amplitude, we detected a trend for a negative correlation between the disability status scale and the amplitude of N1-P2 components more marked at T1 (r = -0.52; p = 0.06) than T0 (r = -0.47; p = 0.09). This is the first study that evaluated the prognostic role of olfactory event-related potentials in MS. Our results highlighted that olfactory alterations of MS patients were related to disability progression and, to a lesser extent, disease activity. The analysis of olfactory potential parameters confirmed the involvement in olfactory network damage of inflammatory and/or neurodegeneration processes which could predict the progressive course of the disease.	[Ciurleo, Roselle; Bonanno, Lilla; De Salvo, Simona; Romeo, Laura; Rifici, Carmela; Sessa, Edoardo; D'Aleo, Giangaetano; Russo, Margherita; Bramanti, Placido; Marino, Silvia; Caminiti, Fabrizia] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy; [Marino, Silvia] Univ Messina, Dept Biomed & Dent Sci & Morphol & Funct Imaging, Messina, Italy	IRCCS Bonino Pulejo; University of Messina	Ciurleo, R (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	rosella.ciurleo@irccsme.it	Russo, Margherita/AAB-8735-2019; Rifici, Carmela/ABH-4398-2020; Sessa, Edoardo/AAB-8544-2020; Ciurleo, Rosella/T-4590-2019; Caminiti, Fabrizia/B-9458-2017; Bonanno, Lilla/K-3937-2016; Bramanti, Placido/K-5117-2016; Marino, Silvia/T-5118-2019; De Salvo, Simona/K-3180-2016	Caminiti, Fabrizia/0000-0002-2527-8063; Bonanno, Lilla/0000-0002-0282-405X; Marino, Silvia/0000-0002-1088-6808; De Salvo, Simona/0000-0001-9501-3258; Romeo, Laura/0000-0002-5754-2244; Ciurleo, Rosella/0000-0003-0709-5914				Barresi M, 2012, J NEUROL SCI, V323, P16, DOI 10.1016/j.jns.2012.08.028; CAIN WS, 1988, LARYNGOSCOPE, V98, P83; Caminiti F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103151; Chard D, 2009, J NEUROL SCI, V282, P5, DOI 10.1016/j.jns.2009.01.012; Comi G, 1999, EEG CL N SU, V50, P349; Fleiner F, 2010, AM J RHINOL ALLERGY, V24, pE93, DOI 10.2500/ajra.2010.24.3506; Jordy SS, 2016, ARQ NEURO-PSIQUIAT, V74, P697, DOI 10.1590/0004-282X20160128; Joseph A, 2016, J NEUROL NEUROSUR PS, V87, P1146, DOI 10.1136/jnnp-2015-312600; Kuhlmann T, 2002, BRAIN, V125, P2202, DOI 10.1093/brain/awf235; Lee JY, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0097-7; Li LM, 2016, J NEUROL SCI, V365, P34, DOI 10.1016/j.jns.2016.03.045; Losy J, 2013, J NEURAL TRANSM, V120, P1459, DOI 10.1007/s00702-013-1079-9; Lucassen EB, 2016, MULT SCLER RELAT DIS, V6, P1, DOI 10.1016/j.msard.2015.12.002; Lutterotti A, 2011, MULT SCLER J, V17, P964, DOI 10.1177/1352458511399798; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Silva AM, 2012, MULT SCLER J, V18, P616, DOI 10.1177/1352458511427156; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Uecker FC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170492	18	8	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196006	10.1371/journal.pone.0196006	http://dx.doi.org/10.1371/journal.pone.0196006			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664936	Green Published, gold, Green Submitted			2022-12-26	WOS:000430262300049
J	Tee, JYH; Gan, WY; Tang, KA; Chin, YS				Tee, Joyce Ying Hui; Gan, Wan Ying; Tang, Kit-Aun; Chin, Yit Siew			Obesity and unhealthy lifestyle associated with poor executive function among Malaysian adolescents	PLOS ONE			English	Article							DAILY PHYSICAL-ACTIVITY; COGNITIVE PERFORMANCE; AEROBIC FITNESS; SLEEP DURATION; CHILDREN; CHILDHOOD; BRAIN; BEHAVIORS; QUALITY; AGE	The understanding on the roles of obesity and lifestyle behaviors in predicting executive function of adolescents has been limited. Low executive function proficiency may have adverse effects on adolescents' school academic performance. This cross-sectional study aimed to examine the relationship between BMI-for-age and multiple lifestyle behaviors (operationalized as meal consumption, physical activity, and sleep quality) with executive function (operationalized as inhibition, working memory, and cognitive flexibility) on a sample of Malaysian adolescents aged between 12 and 16 years (N = 513). Participants were recruited from two randomly selected schools in the state of Selangor in Malaysia. Using a self-administered questionnaire, parent participants provided information concerning their sociodemographic data, whereas adolescent participants provided information regarding their meal consumptions, physical activity, and sleep quality. The modified Harvard step test was used to assess adolescents' aerobic fitness, while Stroop color-word, digit span, and trail-making tests were used to assess adolescents' inhibition, working memory, and cognitive flexibility, respectively. Three separate hierarchical regression analyses were conducted for each outcome namely, inhibition, working memory, and cognitive flexibility. After adjusted for sociodemographic factors and BMI-for-age, differential predictors of inhibition and working memory were found. Habitual sleep efficiency significantly and positively predicted inhibition. Regular dinner intakes, physical activity levels, and sleep quality significantly and positively predicted working memory. Household income emerged as a consistent predictor for all executive function domains. In conclusion, an increased trend of obesity and unhealthy lifestyles among adolescents were found to be associated with poorer executive function. Regular dinner intakes, higher physical activity levels and better sleep quality predicted better executive function despite the inverse relationship between obesity and executive function. Future studies may explore how lifestyle modifications can optimize the development of executive function in adolescents as well as relieve the burden of obesity.	[Tee, Joyce Ying Hui; Gan, Wan Ying; Chin, Yit Siew] Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Tang, Kit-Aun] Univ Putra Malaysia, Dept Psychiat, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia; [Chin, Yit Siew] Univ Putra Malaysia, Res Ctr Excellence Nutr & Noncommunicable Dis, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia	Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Gan, WY (corresponding author), Univ Putra Malaysia, Dept Nutr & Dietet, Fac Med & Hlth Sci, Serdang, Selangor, Malaysia.	wanying@upm.edu.my	Gan, Wan Ying/J-2476-2015; Chin, Yit Siew/G-2001-2015; Tan, Kit-Aun/AFL-6254-2022; Gan, Wan Ying/N-2445-2019	Gan, Wan Ying/0000-0002-9016-3414; Chin, Yit Siew/0000-0002-7609-1944; Tan, Kit-Aun/0000-0002-4310-9087; Gan, Wan Ying/0000-0002-9016-3414	Universiti Putra Malaysia, Putra Grant-Postgraduate Initiative [GP/IPS/2017/9519900]	Universiti Putra Malaysia, Putra Grant-Postgraduate Initiative	This study was supported by a grant from the Universiti Putra Malaysia, Putra Grant-Postgraduate Initiative (GP/IPS/2017/9519900) to WYG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Bajaj A., 2008, ASAC, V29; Benitez A, 2012, CLIN NEUROPSYCHOL, V26, P214, DOI 10.1080/13854046.2012.658439; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; Best JR, 2009, DEV REV, V29, P180, DOI 10.1016/j.dr.2009.05.002; Blair C, 2011, CHILD DEV, V82, P1970, DOI 10.1111/j.1467-8624.2011.01643.x; Bocarsly ME, 2015, P NATL ACAD SCI USA, V112, P15731, DOI 10.1073/pnas.1511593112; Buck SM, 2008, MED SCI SPORT EXER, V40, P166, DOI 10.1249/mss.0b013e318159b035; Buysse D J, 1989, Psychiatry Res, V28, P193; Carneiro P, 2013, J EUR ECON ASSOC, V11, P123, DOI 10.1111/j.1542-4774.2012.01096.x; Chaddock L, 2012, J SPORT SCI, V30, P421, DOI 10.1080/02640414.2011.647706; Chen XL, 2008, OBESITY, V16, P265, DOI 10.1038/oby.2007.63; Chin Y. S., 2009, Pakistan Journal of Nutrition, V8, P425; Chong KH, 2016, ASIA-PAC J PUBLIC HE, V28, p59S, DOI 10.1177/1010539516654260; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Conger RD, 2007, ANNU REV PSYCHOL, V58, P175, DOI 10.1146/annurev.psych.58.110405.085551; Cooper SB, 2012, BRIT J NUTR, V107, P1823, DOI 10.1017/S0007114511005022; Crabtree VM, 2005, SLEEP MED, V6, P319, DOI 10.1016/j.sleep.2005.02.001; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Dan S P Jr, 2007, Malays J Nutr, V13, P109; Defeyter MA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00789; Delgado-Rico E, 2012, OBESITY, V20, P1604, DOI 10.1038/oby.2012.47; Dencker M, 2011, J SPORT SCI, V29, P887, DOI 10.1080/02640414.2011.578148; Dewald JF, 2010, SLEEP MED REV, V14, P179, DOI 10.1016/j.smrv.2009.10.004; Erola J, 2016, RES SOC STRAT MOBIL, V44, P33, DOI 10.1016/j.rssm.2016.01.003; Esteban-Cornejo I, 2015, J SCI MED SPORT, V18, P534, DOI 10.1016/j.jsams.2014.07.007; Fatima S, 2016, NEUROPSYCHOLOGY, V30, P65, DOI 10.1037/neu0000216; Ferraro FR, 2015, COMPUT HUM BEHAV, V49, P44, DOI 10.1016/j.chb.2015.02.043; Golden ZL, 2002, PSYCHOL SCHOOLS, V39, P489, DOI 10.1002/pits.10047; Gunstad J, 2008, APPETITE, V50, P246, DOI 10.1016/j.appet.2007.07.008; Hackman DA, 2015, DEVELOPMENTAL SCI, V18, P686, DOI 10.1111/desc.12246; Hackman DA, 2014, CHILD DEV, V85, P1433, DOI 10.1111/cdev.12242; Institute for Public Health (IPH), 2014, NAT HLTH MORB SURV 2, V2; KEEN EN, 1958, J APPL PHYSIOL, V13, P241, DOI 10.1152/jappl.1958.13.2.241; Kopasz M, 2010, SLEEP MED REV, V14, P167, DOI 10.1016/j.smrv.2009.10.006; Lee Y, 2010, INT PSYCHOGERIATR, V22, P174, DOI 10.1017/S1041610209991189; Liang J, 2014, INT J OBESITY, V38, P494, DOI 10.1038/ijo.2013.142; Lo JC, 2016, SLEEP MED, V17, P87, DOI 10.1016/j.sleep.2015.08.021; Maayan L, 2011, OBESITY, V19, P1382, DOI 10.1038/oby.2011.15; Matricciani L, 2012, SLEEP MED REV, V16, P203, DOI 10.1016/j.smrv.2011.03.005; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Moffitt TE, 2011, P NATL ACAD SCI USA, V108, P2693, DOI 10.1073/pnas.1010076108; Nasir MTM, 2012, APPETITE, V58, P525, DOI 10.1016/j.appet.2012.01.007; Nyberg L, 2009, EUR J COGN PSYCHOL, V21, P84, DOI 10.1080/09541440701862133; Olds T, 2010, SLEEP MED REV, V14, P371, DOI 10.1016/j.smrv.2009.12.002; Padilla C, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00049; Piccolo LD, 2016, PSICOL-REFLEX CRIT, V29, DOI 10.1186/s41155-016-0016-x; Poland SE, 2016, BRIT J DEV PSYCHOL, V34, P181, DOI 10.1111/bjdp.12122; Reinert KRS, 2013, J OBES, V2013, DOI 10.1155/2013/820956; REITAN RM, 1971, PERCEPT MOTOR SKILL, V33, P575, DOI 10.2466/pms.1971.33.2.575; Salimpoor V.N., 2006, DEV DISABILITIES B, V34, P15; Scudder MR, 2014, MED SCI SPORT EXER, V46, P1025, DOI 10.1249/MSS.0000000000000199; Smith E, 2011, OBES REV, V12, P740, DOI 10.1111/j.1467-789X.2011.00920.x; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stea TH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-829; Stillman CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162100; Telzer EH, 2013, NEUROIMAGE, V71, P275, DOI 10.1016/j.neuroimage.2013.01.025; Ursache A, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.531; van der Niet AG, 2015, J SCI MED SPORT, V18, P673, DOI 10.1016/j.jsams.2014.09.006; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Verdejo-Garcia A, 2010, OBESITY, V18, P1572, DOI 10.1038/oby.2009.475; Watkins J, 1984, Br J Sports Med, V18, P84; Wechsler D, 1974, WECHSLER INTELLIGENC; *WHO, 2007, WHO REF 2007 GROWTH; Yau PL, 2014, OBESITY, V22, P1865, DOI 10.1002/oby.20801	66	15	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195934	10.1371/journal.pone.0195934	http://dx.doi.org/10.1371/journal.pone.0195934			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664932	Green Submitted, gold, Green Published			2022-12-26	WOS:000430262300042
J	Keinan, Y; Braun, R; Keasar, T				Keinan, Yael; Braun, Rachel; Keasar, Tamar			Phenotypic plasticity of pre-adult egg maturation in a parasitoid: Effects of host-starvation and brood size	PLOS ONE			English	Article							POTATO-TUBER MOTH; COPIDOSOMA-KOEHLERI HYMENOPTERA; LIFE-HISTORY EVOLUTION; TRADE-OFFS; BODY-SIZE; PHTHORIMAEA-OPERCULELLA; OVIPOSITION SUCCESS; BIOLOGICAL-CONTROL; WASP; SUPERPARASITISM	Larvae of parasitoid wasps develop on a single arthropod host, and often face resource limitation that induces a tradeoff between egg maturation and somatic growth. Part of the variation in the growth-reproduction allocation was shown to be heritable, but how the larval developmental environment affects this allocation is not well-known. Detection of life history tradeoffs is often facilitated under stress conditions. We therefore exposed developing female larvae of the polyembryonic parasitoid Copidosoma koehleri (Hymenoptera: Encyrtidae) to laboratory manipulations aimed to restrict host resources (either host-starvation or high larval density). We compared the females' body sizes and egg loads shortly after adult emergence (<24 h) to those of closely related control females, which developed at a lower larval density within non-starved hosts. Host-starvation reduced the females' body sizes but not their initial egg loads. Females that experienced high larval density produced more eggs but were similar in body size to the low-density controls. Thus, the relative allocation to reproduction increased in response to both manipulations of host condition. Developmental duration and longevity were similar in all treatments. The negative correlation between body size and reproductive allocation, observed in the host-starvation treatment, is compatible with previous evidence from other parasitoids. In the high larval density treatment, however, reproductive allocation increased while body size was maintained, suggesting that the higher density increased rather than limited host resources per developing parasitoid female. The additional host resources that were diverted into egg production possibly resulted from increased feeding and body mass gain by hosts parasitized by large broods of wasps. Our results demonstrate phenotypic plasticity in resource allocation between growth and reproduction in a developing parasitoid. This plasticity may contribute to an adaptive balance between longevity and mobility vs. fecundity during the adult stage.	[Keinan, Yael] Univ Haifa, Evolutionary & Environm Biol, Haifa, Israel; [Braun, Rachel] Univ Haifa, Human Biol, Haifa, Israel; [Keasar, Tamar] Univ Haifa, Biol & Environm, Tivon, Israel	University of Haifa; University of Haifa; University of Haifa	Keasar, T (corresponding author), Univ Haifa, Biol & Environm, Tivon, Israel.	tkeasar@research.haifa.ac.il			Israel Science Foundation [414/10]	Israel Science Foundation(Israel Science Foundation)	The study was supported by the Israel Science Foundation, grant no. 414/10 to TK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram PK, 2016, BIOL J LINN SOC, V117, P620, DOI 10.1111/bij.12658; [Anonymous], 2021, LANG ENV STAT COMP; Baggen LR, 1998, BIOL CONTROL, V11, P9, DOI 10.1006/bcon.1997.0566; Berlinger M. J., 1997, TRENDS ENTOMOLOGY, V1, P137; Browder L.W., 1985, DEV BIOL COMPREHENSI; Cicero L, 2011, J INSECT PHYSIOL, V57, P1471, DOI 10.1016/j.jinsphys.2011.07.014; Cronin JT, 1996, HEREDITY, V76, P43, DOI 10.1038/hdy.1996.6; DOUTT R. L., 1952, CANADIAN ENT, V84, P247; DOUTT RL, 1947, AM NAT, V81, P435, DOI 10.1086/281554; Ellers J, 1997, J EVOLUTION BIOL, V10, P771, DOI 10.1007/s000360050053; Ellers J, 2003, OIKOS, V102, P164, DOI 10.1034/j.1600-0706.2003.12285.x; Ismail M, 2012, OIKOS, V121, P2072, DOI 10.1111/j.1600-0706.2012.20582.x; Jervis MA, 2003, FUNCT ECOL, V17, P375, DOI 10.1046/j.1365-2435.2003.00742.x; Jervis MA, 2001, J ANIM ECOL, V70, P442, DOI 10.1046/j.1365-2656.2001.00507.x; Jervis MA, 2008, ANNU REV ENTOMOL, V53, P361, DOI 10.1146/annurev.ento.53.103106.093433; Keasar T, 2008, BIOCONTROL SCI TECHN, V18, P325, DOI 10.1080/09583150801905596; Keasar T, 2007, BIOL CONTROL, V42, P55, DOI 10.1016/j.biocontrol.2007.03.012; Keasar T, 2006, ECOL ENTOMOL, V31, P277, DOI 10.1111/j.1365-2311.2006.00788.x; Keinan Y, 2017, ECOL ENTOMOL, V42, P587, DOI 10.1111/een.12422; Keinan Y, 2012, BEHAV ECOL, V23, P1263, DOI 10.1093/beheco/ars111; KFIR R, 1981, ANN APPL BIOL, V99, P225, DOI 10.1111/j.1744-7348.1981.tb04790.x; Laughton AM, 2011, J INSECT PHYSIOL, V57, P830, DOI 10.1016/j.jinsphys.2011.03.015; Llandres AL, 2015, ECOL MONOGR, V85, P353, DOI 10.1890/14-0976.1; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Pelosse P, 2011, BIOL J LINN SOC, V104, P621, DOI 10.1111/j.1095-8312.2011.01741.x; Roff DA, 2007, J EVOLUTION BIOL, V20, P433, DOI 10.1111/j.1420-9101.2006.01255.x; Saeki Y, 2013, FUNCT ECOL, V27, P155, DOI 10.1111/1365-2435.12014; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Segoli M, 2009, ARTHROPOD STRUCT DEV, V38, P84, DOI 10.1016/j.asd.2008.05.003; Segoli M, 2015, ECOL ENTOMOL, V40, P483, DOI 10.1111/een.12194; Segoli M, 2013, FUNCT ECOL, V27, P1224, DOI 10.1111/1365-2435.12109; Segoli M, 2010, EVOL ECOL RES, V12, P259; Segoli M, 2009, BEHAV ECOL, V20, P761, DOI 10.1093/beheco/arp057; Seltman H. J., 2018, EXPT DESIGN ANAL; STEARNS SC, 1989, FUNCT ECOL, V3, P259, DOI 10.2307/2389364; Thorne AD, 2006, P ROY SOC B-BIOL SCI, V273, P1099, DOI 10.1098/rspb.2005.3416; Visser B, 2010, P NATL ACAD SCI USA, V107, P8677, DOI 10.1073/pnas.1001744107; Wajnberg E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045915; Zera AJ, 2001, ANNU REV ECOL SYST, V32, P95, DOI 10.1146/annurev.ecolsys.32.081501.114006	39	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195767	10.1371/journal.pone.0195767	http://dx.doi.org/10.1371/journal.pone.0195767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659607	Green Published, Green Submitted, gold			2022-12-26	WOS:000430061100028
J	Salles, T; Ding, XS; Brocard, G				Salles, Tristan; Ding, Xuesong; Brocard, Gilles			pyBadlands: A framework to simulate sediment transport, landscape dynamics and basin stratigraphic evolution through space and time	PLOS ONE			English	Article							DEPENDENT RIVER INCISION; GREAT-BARRIER-REEF; SEQUENCE STRATIGRAPHY; EASTERN AUSTRALIA; FUZZY-LOGIC; SEA-LEVEL; MODEL; DRAINAGE; SLOPE; MORPHOLOGY	Understanding Earth surface responses in terms of sediment dynamics to climatic variability and tectonics forcing is hindered by limited ability of current models to simulate long-term evolution of sediment transfer and associated morphological changes. This paper presents pyBadlands, an open-source python-based framework which computes over geological time (1) sediment transport from landmasses to coasts, (2) reworking of marine sediments by longshore currents and (3) development of coral reef systems. pyBadlands is cross-platform, distributed under the GPLv3 license and available on GitHub (http://gthub.com/badlands-model). Here, we describe the underlying physical assumptions behind the simulated processes and the main options already available in the numerical framework. Along with the source code, a list of hands-on examples is provided that illustrates the model capabilities. In addition, pre and post-processing classes have been built and are accessible as a companion toolbox which comprises a series of workflows to efficiently build, quantify and explore simulation input and output files. While the framework has been primarily designed for research, its simplicity of use and portability makes it a great tool for teaching purposes.	[Salles, Tristan; Ding, Xuesong; Brocard, Gilles] Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia	University of Sydney	Salles, T (corresponding author), Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia.	tristan.salles@sydney.edu.au	Brocard, Gilles/K-4827-2019	Brocard, Gilles/0000-0002-0997-2995; Ding, Xuesong/0000-0003-3693-932X; Salles, Tristan/0000-0001-6095-7689	Australian Research Council [IH130200012]; ARC [IH130200012]; Australian Government; SIH at the University of Sydney	Australian Research Council(Australian Research Council); ARC(Australian Research Council); Australian Government(Australian GovernmentCGIAR); SIH at the University of Sydney	This work was supported by Australian Research Council Grant Number IH130200012 (Basin Genesis Hub).; The authors were supported by ARC IH130200012 grant. This research was undertaken with the assistance of resources from the National Computational Infrastructure (NCI), which is supported by the Australian Government and from Artemis HPC Grand Challenge supported by SIH at the University of Sydney.	Adams JM, 2017, GEOSCI MODEL DEV, V10, P1645, DOI 10.5194/gmd-10-1645-2017; Airy G. B., 1845, ENCY METROPOLITANA, V192, P241; ANDREWS DJ, 1987, J GEOPHYS RES-SOLID, V92, P12857, DOI 10.1029/JB092iB12p12857; [Anonymous], 1996, [No title captured], DOI DOI 10.1007/BFB0014497; Attal M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000893; Barrett SJ, 2017, MAR GEOL, V391, P108, DOI 10.1016/j.margeo.2017.07.007; Beaman R., 2010, CLIM CHANG AUSTR TEC; Braun J, 1997, BASIN RES, V9, P27, DOI 10.1046/j.1365-2117.1997.00030.x; Braun J, 2013, GEOMORPHOLOGY, V180, P170, DOI 10.1016/j.geomorph.2012.10.008; Campforts B, 2017, EARTH SURF DYNAM, V5, P47, DOI 10.5194/esurf-5-47-2017; Chen A, 2014, GEOMORPHOLOGY, V219, P68, DOI 10.1016/j.geomorph.2014.04.037; Collin A, 2015, ISPRS INT J GEO-INF, V4, P900, DOI 10.3390/ijgi4020900; Cowie PA, 2008, GEOLOGY, V36, P535, DOI 10.1130/G24681A.1; Crosby BT, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000566; Dechnik B, 2016, QUATERNARY RES, V85, P44, DOI 10.1016/j.yqres.2015.11.002; Dechnik B, 2015, MAR GEOL, V363, P174, DOI 10.1016/j.margeo.2015.02.014; Demicco RV, 2001, J PETROL SCI ENG, V31, P135, DOI 10.1016/S0920-4105(01)00126-7; Demicco RV, 1998, COMPUT GEOSCI, V24, P405, DOI 10.1016/S0098-3004(98)00024-7; DiBiase RA, 2010, EARTH PLANET SC LETT, V289, P134, DOI 10.1016/j.epsl.2009.10.036; Foufoula-Georgiou E, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001280; Gallop SL, 2014, CORAL REEFS, V33, P1167, DOI 10.1007/s00338-014-1205-7; Gasparini NM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000567; Gasparini NM, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2009JF001655; GRANJEON D., 1999, SEPM SPECIAL PUBLICA, V62, P197, DOI DOI 10.2110/PEC.99.62.0197; Green MO, 2014, REV GEOPHYS, V52, P77, DOI 10.1002/2013RG000437; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hattab T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076430; Helland-Hansen W, 2009, BASIN RES, V21, P454, DOI 10.1111/j.1365-2117.2009.00425.x; Hobley DEJ, 2017, EARTH SURF DYNAM, V5, P21, DOI 10.5194/esurf-5-21-2017; Hobley DEJ, 2011, J GEOPHYS RES-EARTH, V116, DOI 10.1029/2010JF001935; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; Hopley D., 1984, HOLOCENE HIGH ENERGY; Hopley D.H., 1982, GEOMORPHOLOGY GREAT; HOWARD AD, 1994, J GEOPHYS RES-SOL EA, V99, P13971, DOI 10.1029/94JB00744; Hughes K, 2017, J QUATERNARY SCI, V32, P744, DOI 10.1002/jqs.2956; KOMAR PD, 1975, J SEDIMENT PETROL, V45, P697; Kwang JS, 2017, EARTH SURF DYNAM, V5, P807, DOI 10.5194/esurf-5-807-2017; Lambeck K, 2014, P NATL ACAD SCI USA, V111, P15296, DOI 10.1073/pnas.1411762111; Larcombe P, 1999, AUST J EARTH SCI, V46, P141, DOI 10.1046/j.1440-0952.1999.00694.x; Larsen IJ, 2012, NAT GEOSCI, V5, P468, DOI 10.1038/ngeo1479; Lewis S., 2012, MAR GEOL, V32, P299; Longuet-Higgins M. S., 1970, J GEOPHYS RES, V75, P1, DOI DOI 10.1029/JC075I033P06790; MARSHALL JF, 1984, NATURE, V307, P44, DOI 10.1038/307044a0; Meesters EH, 1998, CONSERV BIOL, V12, P957, DOI 10.1046/j.1523-1739.1998.96421.x; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Moss PT, 2012, TERRA AUSTRALIS, V34, P329; Murphy BP, 2016, NATURE, V532, P223, DOI 10.1038/nature17449; Neal J, 2009, GEOLOGY, V37, P779, DOI 10.1130/G25722A.1; Neal JE, 2016, J GEOL SOC LONDON, V173, P803, DOI 10.1144/jgs2015-165; Nordlund U, 1999, COMPUT GEOSCI, V25, P449, DOI 10.1016/S0098-3004(98)00151-4; OCALLAGHAN JF, 1984, COMPUT VISION GRAPH, V28, P323, DOI [10.1016/S0734-189X(84)80011-0, 10.1016/0734-189X(89)90053-4]; Parker G., 2004, 118 U MINN ANTH FALL; Puga-Bernabeu A, 2014, MAR PETROL GEOL, V50, P40, DOI 10.1016/j.marpetgeo.2013.11.009; Puga-Bernabeu A, 2013, GEOMORPHOLOGY, V191, P35, DOI 10.1016/j.geomorph.2013.03.001; Roering JJ, 2001, J GEOPHYS RES-SOL EA, V106, P16499, DOI 10.1029/2001JB000323; Roering JJ, 2001, GEOLOGY, V29, P143, DOI 10.1130/0091-7613(2001)029<0143:HEBNCA>2.0.CO;2; Salles T, 2017, GEOCHEM GEOPHY GEOSY, V18, P280, DOI 10.1002/2016GC006617; Salles T, 2016, COMPUT GEOSCI-UK, V91, P77, DOI 10.1016/j.cageo.2016.03.011; Salles TB, 2011, MAR GEOL, V282, P268, DOI 10.1016/j.margeo.2011.02.014; Salles T, 2015, EARTH SURF PROC LAND, V40, P823, DOI 10.1002/esp.3674; Shulmeister J, 1999, QUATERN INT, V57-8, P81, DOI 10.1016/S1040-6182(98)00052-4; Sklar L, 1998, RIVERS ROCK FLUVIAL, P237, DOI DOI 10.1029/GM107P0237; Sklar LS, 2006, GEOMORPHOLOGY, V82, P58, DOI 10.1016/j.geomorph.2005.08.019; Sklar LS, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002496; Sklar LS, 2001, GEOLOGY, V29, P1087, DOI 10.1130/0091-7613(2001)029<1087:SARSCO>2.0.CO;2; Smith RB, 2004, J ATMOS SCI, V61, P1377, DOI 10.1175/1520-0469(2004)061<1377:ALTOOP>2.0.CO;2; Soulen RJ, 1995, INST PHYS CONF SER, V148, P23; SOULSBY RL, 1993, COAST ENG, V21, P41, DOI 10.1016/0378-3839(93)90045-A; Soulsby RL, 1997, DYNAMICS MARINE SAND, P429; STOKES G. G., 1847, MATH PHYS PAPERS, V8, P441, DOI DOI 10.1017/CBO9780511702242.013; Tetzlaff DM, 2005, J COASTAL RES, V21, P610, DOI 10.2112/04-704A.1; Thieulot C, 2014, GEOCHEM GEOPHY GEOSY, V15, P4936, DOI 10.1002/2014GC005490; Tucker G, 2001, CHANNEL HILLSLOPE IN, p349 ; Tucker GE, 1997, WATER RESOUR RES, V33, P2031, DOI 10.1029/97WR00409; Tucker GE, 2010, J GEOPHYS RES EARTH, V115; Tucker GE, 2010, EARTH SURF PROC LAND, V35, P28, DOI 10.1002/esp.1952; Turowski JM, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000697; VANRIJN LC, 1984, J HYDRAUL ENG-ASCE, V110, P1431, DOI 10.1061/(ASCE)0733-9429(1984)110:10(1431); Warrlich G, 2008, MAR PETROL GEOL, V25, P35, DOI 10.1016/j.marpetgeo.2007.04.005; Warrlich GMD, 2002, BASIN RES, V14, P379, DOI 10.1046/j.1365-2117.2002.00181.x; Watts K. F., 1993, P ODP SCI RESULTS; Webster JM, 2003, SEDIMENT GEOL, V159, P61, DOI 10.1016/S0037-0738(03)00095-2; Whipple KX, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2000JB000044; Wickert AD, 2016, GEOSCI MODEL DEV, V9, P997, DOI 10.5194/gmd-9-997-2016; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	85	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195557	10.1371/journal.pone.0195557	http://dx.doi.org/10.1371/journal.pone.0195557			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649301	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900055
J	Saxena, M; Delgado, Y; Sharma, RK; Sharma, S; Guzman, SLPD; Tinoco, AD; Griebenow, K				Saxena, Manoj; Delgado, Yamixa; Sharma, Rohit Kumar; Sharma, Shweta; Guzman, Solimar Liz Ponce De Leon; Tinoco, Arthur D.; Griebenow, Kai			Inducing cell death in vitro in cancer cells by targeted delivery of cytochrome c via a transferrin conjugate	PLOS ONE			English	Article							INTRACELLULAR DELIVERY; RECEPTOR EXPRESSION; DRUG-DELIVERY; LUNG-CANCER; APOPTOSIS; PROTEIN; NANOPARTICLES; ACTIVATION; CISPLATIN; TUMORS	One of the major drawbacks of many of the currently used cancer drugs are off-target effects. Targeted delivery is one method to minimize such unwanted and detrimental events. To actively target lung cancer cells, we have developed a conjugate of the apoptosis inducing protein cytochrome c with transferrin because the transferrin receptor is overexpressed by many rapidly dividing cancer cells. Cytochrome c and transferrin were cross-linked with a redox sensitive disulfide bond for the intra-cellular release of the protein upon endocytosis by the transferrin receptor. Confocal results demonstrated the cellular uptake of the cytochrome c-transferrin conjugate by transferrin receptor overexpressing A549 lung cancer cells. Localization studies further validated that this conjugate escaped the endosome. Additionally, an in vitro assay showed that the conjugate could induce apoptosis by activating caspase-3. The neo-conjugate not only maintained an IC50 value similar to the well known drug cisplatin (50 mu M) in A549 cancer cells but also was nontoxic to the normal lung (MRC5) cells. Our neo-conjugate holds promise for future development to target cancers with enhanced transferrin receptor expression.	[Saxena, Manoj; Sharma, Rohit Kumar; Sharma, Shweta] Univ Puerto Rico, Dept Environm Sci, Rio Piedras Campus, San Juan, PR 00936 USA; [Saxena, Manoj; Delgado, Yamixa; Guzman, Solimar Liz Ponce De Leon; Tinoco, Arthur D.; Griebenow, Kai] Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA; [Delgado, Yamixa] San Juan Bautista Sch Med, Biochem & Pharmacol Dept, Caguas, PR USA	University of Puerto Rico; University of Puerto Rico Rio Piedras; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico Rio Piedras	Griebenow, K (corresponding author), Univ Puerto Rico, Dept Chem, Rio Piedras Campus, San Juan, PR 00936 USA.	kai.griebenow@gmail.com	Griebenow, Kai H/AAS-2754-2021; Griebenow, Kai/AGK-1725-2022; Sharma, Rohit/L-8523-2018	Griebenow, Kai H/0000-0003-0495-9932; Delgado, Yamixa/0000-0002-0686-7145	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [P20GM103642]; NIH SC1 by NIGMS [5SC1CA190504-03]; NIH SC1 by NCI [5SC1CA190504-03]; Puerto Rico Science, Technology, and Research Trust [2013-000019]; University of Puerto Rico FIPI Grant from the office of the DEGI; NATIONAL CANCER INSTITUTE [SC1CA190504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103642] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH SC1 by NIGMS; NIH SC1 by NCI; Puerto Rico Science, Technology, and Research Trust; University of Puerto Rico FIPI Grant from the office of the DEGI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The confocal microscopy work was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) under Award Number P20GM103642. A.D.T. and Y.D. are supported by the NIH SC1 (5SC1CA190504-03) provided by the NIGMS and NCI. A.D.T. is also supported by funding from the Puerto Rico Science, Technology, and Research Trust (Agreement No. 2013-000019), the University of Puerto Rico FIPI Grant from the office of the DEGI.	Abes S, 2006, J CONTROL RELEASE, V110, P595, DOI 10.1016/j.jconrel.2005.10.026; Albanese A, 2012, ANNU REV BIOMED ENG, V14, P1, DOI [10.1146/annurev-bioeng-071811-150124, 10.1146/annurev.bioeng-071811-150124]; Antonsson B, 1997, SCIENCE, V277, P370, DOI 10.1126/science.277.5324.370; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Bansal R, 2011, J CONTROL RELEASE, V154, P233, DOI 10.1016/j.jconrel.2011.05.027; BLUM JS, 1991, J BIOL CHEM, V266, P22091; Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030; Deming PB, 2004, MOL CELL BIOL, V24, P10289, DOI 10.1128/MCB.24.23.10289-10299.2004; Derfus AM, 2007, BIOCONJUGATE CHEM, V18, P1391, DOI 10.1021/bc060367e; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200; Egbelakin A, 2011, PEDIATR BLOOD CANCER, V56, P361, DOI 10.1002/pbc.22845; GODWIN AK, 1992, P NATL ACAD SCI USA, V89, P3070, DOI 10.1073/pnas.89.7.3070; Hall MD, 2014, CANCER RES, V74, P3913, DOI 10.1158/0008-5472.CAN-14-0247; HARRIS WR, 1991, BIOCHEMISTRY-US, V30, P6930, DOI 10.1021/bi00242a017; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; INOUE T, 1993, J CELL PHYSIOL, V156, P212, DOI 10.1002/jcp.1041560128; IPPOLITI R, 1995, FASEB J, V9, P1220, DOI 10.1096/fasebj.9.12.7672515; JEFFERIES WA, 1984, NATURE, V312, P162, DOI 10.1038/312162a0; Jiang YY, 2007, J DRUG TARGET, V15, P672, DOI 10.1080/10611860701603414; Johnson CE, 2007, P NATL ACAD SCI USA, V104, P20820, DOI 10.1073/pnas.0709101105; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Jones S, 2010, CHEM BIOL, V17, P735, DOI 10.1016/j.chembiol.2010.05.018; Kamb A, 2007, NAT REV DRUG DISCOV, V6, P115, DOI 10.1038/nrd2155; Kelkar SS, 2011, BIOCONJUGATE CHEM, V22, P1879, DOI 10.1021/bc200151q; Kim SK, 2012, BIOMATERIALS, V33, P3959, DOI 10.1016/j.biomaterials.2012.02.010; Lai H, 2009, ANTICANCER RES, V29, P3807; Liu D, 2016, THERANOSTICS, V6, P1306, DOI 10.7150/thno.14858; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Meier R, 2010, RADIOLOGY, V255, P527, DOI 10.1148/radiol.10090050; Mendez J, 2014, MOL PHARMACEUT, V11, P102, DOI 10.1021/mp400400j; Merlen C, 2005, FEBS J, V272, P4385, DOI 10.1111/j.1742-4658.2005.04851.x; Monni O, 1997, BLOOD, V90, P1168, DOI 10.1182/blood.V90.3.1168.1168_1168_1174; Mootha VK, 2001, EMBO J, V20, P661, DOI 10.1093/emboj/20.4.661; Morales-Cruz M, 2014, J NANOBIOTECHNOL, V12, DOI 10.1186/s12951-014-0033-9; OTA E, 1995, BRIT J CANCER, V72, P550, DOI 10.1038/bjc.1995.372; Ozer I, 2017, BIOCONJUGATE CHEM, V28, P713, DOI 10.1021/acs.bioconjchem.6b00652; Piel DA, 2008, SHOCK, V29, P612, DOI 10.1097/SHK.0b013e318157e962; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; RASO V, 1984, J BIOL CHEM, V259, P1143; Salvati A, 2013, NAT NANOTECHNOL, V8, P137, DOI [10.1038/nnano.2012.237, 10.1038/NNANO.2012.237]; Santra S, 2010, MOL PHARMACEUT, V7, P1209, DOI 10.1021/mp100043h; Saxena M, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0050-9; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smith CV, 1996, TOXICOL APPL PHARM, V140, P1, DOI 10.1006/taap.1996.0191; Stirpe F, 2006, CELL MOL LIFE SCI, V63, P1850, DOI 10.1007/s00018-006-6078-7; Taguchi T, 2005, CONTRIB NEPHROL, V148, P107, DOI 10.1159/000086055; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tinoco AD, 2016, J AM CHEM SOC, V138, P5659, DOI 10.1021/jacs.6b01966; VANDERKOOI JM, 1985, J CELL BIOL, V100, P435, DOI 10.1083/jcb.100.2.435; Voets IK, 2010, J PHYS CHEM B, V114, P11875, DOI 10.1021/jp103515b; WAGNER E, 1990, P NATL ACAD SCI USA, V87, P3410, DOI 10.1073/pnas.87.9.3410; Wang SS, 2016, NANOMATERIALS-BASEL, V6, DOI 10.3390/nano6010003; WHITNEY JF, 1995, CANCER, V76, P20, DOI 10.1002/1097-0142(19950701)76:1<20::AID-CNCR2820760104>3.0.CO;2-3; Wiley DT, 2013, P NATL ACAD SCI USA, V110, P8662, DOI 10.1073/pnas.1307152110; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zhang Peilin, 2003, Mol Cancer, V2, P1; Zhivotovsky B, 1998, NATURE, V391, P449, DOI 10.1038/35060; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2	62	28	28	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195542	10.1371/journal.pone.0195542	http://dx.doi.org/10.1371/journal.pone.0195542			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649293	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900052
J	Taffon, P; Rossi, G; Kindermans, JM; Van den Bergh, R; Nguon, C; Debackere, M; Vernaevel, L; De Smet, M; Venables, E				Taffon, Pierluigi; Rossi, Gabriele; Kindermans, Jean-Marie; Van den Bergh, Rafael; Nguon, Chea; Debackere, Mark; Vernaevel, Lieven; De Smet, Martin; Venables, Emilie			'I could not join because I had to work for pay.': A qualitative evaluation of falciparum malaria pro-active case detection in three rural Cambodian villages	PLOS ONE			English	Article							LAO PDR LAOS; PLASMODIUM-FALCIPARUM; COMMUNITY ENGAGEMENT; ELIMINATION; RESISTANCE; STRATEGIES; PROVINCE; INFECTIONS	Background Pro-active case detection (Pro-ACD), in the form of voluntary screening and treatment (VSAT) following community mobilisation about 'asymptomatic malaria', is currently being evaluated as a tool for Plasmodium falciparum elimination in Preah Vihear Province, Cambodia. Methods A qualitative study was conducted to explore community understanding, perceptions, expectations and acceptability of the Pro-ACD intervention in order to identify aspects that could be improved in future Pro-ACD activities. This was ancillary to a three-round VSAT campaign, carried out in three villages between December 2015 and March 2016. Qualitative data collection began shortly after the end of the three rounds of screening. Purposive sampling was used to select participants. Nine focus group discussions with participants (n = 46) and non-participants (n = 40) in the Pro-ACD screening were conducted, in addition to in-depth interviews with key village figures (n = 9). Results Health promotion messages were well delivered and received, but it was difficult for many villagers to understand the messages around 'asymptomatic malaria'. Overall, villagers and village leaders had a positive opinion about the VSAT intervention. Acceptability was high, as a direct consequence of favourable perceptions towards the screening activity: the ProACD intervention was seen by the local population as an effective, inexpensive, reliable and readily available tool to protect individuals and the community from the insurgence of malaria. Physical absence and lack of time (both linked to work-related activities) were the main reasons for non-participation. Conclusions Although VSAT was generally well perceived and accepted, the 'time factor' related to the need to satisfy essential daily subsistence requirements played a significant role in determining participation in the screening. More well-adapted and meaningful Pro-ACD approaches could be implemented by improving the timing of the testing activites, and strengthening community participation and engagement to increase acceptability.	[Taffon, Pierluigi; Rossi, Gabriele; Debackere, Mark; Vernaevel, Lieven] Medecins Sans Frontieres, Phnom Penh, Cambodia; [Kindermans, Jean-Marie; Van den Bergh, Rafael; De Smet, Martin; Venables, Emilie] Medecins Sans Frontieres, Operat Ctr Belgium, Brussels, Belgium; [Nguon, Chea] Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia; [Venables, Emilie] Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa	Doctors Without Borders; National Center Parasitology, Entomology & Malaria Control; University of Cape Town	Venables, E (corresponding author), Medecins Sans Frontieres, Operat Ctr Belgium, Brussels, Belgium.; Venables, E (corresponding author), Univ Cape Town, Sch Publ Hlth & Family Med, Div Social & Behav Sci, Cape Town, South Africa.	emilie.venables@brussels.msf.org		Van den Bergh, Rafael/0000-0001-6277-8713				Adhikari B, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2070-y; Adhikari B, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1366136; Amaratunga C, 2016, LANCET INFECT DIS, V16, P357, DOI 10.1016/S1473-3099(15)00487-9; American Anthropological Association, AAA ETH BLOG; Atkinson JAM, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-93; Bosman P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-394; Canavati SE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1276-8; Cao J L, 2014, INT J PHOTOENERGY, V2014, P1, DOI DOI 10.1371/J0URNAL.PMED.1001642; Cook J, 2015, J INFECT DIS, V211, P1476, DOI 10.1093/infdis/jiu655; Cotter C, 2013, LANCET, V382, P900, DOI 10.1016/S0140-6736(13)60310-4; Edwards HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124300; Falq G, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1487-z; Galatas B, 2015, TRENDS PARASITOL, pS1471; Grietens KP, 2015, SCI REP-UK, V5, DOI 10.1038/srep16837; Kajeechiwa Ladda, 2017, Wellcome Open Res, V2, P59, DOI 10.12688/wellcomeopenres.12051.1; Lyttleton C, 2016, SOC SCI MED, V150, P144, DOI 10.1016/j.socscimed.2015.12.033; Malaria Consortium, 2013, STRAT ADDR MIGR MOB; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Parker DM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0921-y; Pell C, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1854-4; Phommasone K, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1336-0; Rossi G, CLIN INFECT IN PRESS; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sluydts V, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-387; Sturrock HJW, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001467; Thomas DR, 2006, AM J EVAL, V27, P237, DOI 10.1177/1098214005283748; Nguyen TN, 2017, MALARIA J, V16, DOI 10.1186/s12936-016-1662-2; Tripura R, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1703-5; Tynan A, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-204; Verschuere J, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1732-0; von Seidlein L, 2015, EXPERT REV ANTI-INFE, V13, P715, DOI 10.1586/14787210.2015.1031744; Whittaker M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0931-9; WHO, 2014, EM RESP ART RES GREA	33	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195809	10.1371/journal.pone.0195809	http://dx.doi.org/10.1371/journal.pone.0195809			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649317	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900091
J	Klakotskaia, D; Agca, C; Richardson, RA; Stopa, EG; Schachtman, TR; Agca, Y				Klakotskaia, Diana; Agca, Cansu; Richardson, Rachel A.; Stopa, Edward G.; Schachtman, Todd R.; Agca, Yuksel			Memory deficiency, cerebral amyloid angiopathy, and amyloid-beta plaques in APP+PS1 double transgenic rat model of Alzheimer's disease	PLOS ONE			English	Article							FLUID DRAINAGE PATHWAYS; 3XTG-AD MOUSE MODEL; A-BETA; IMPAIRMENT; PATHOLOGY; HIPPOCAMPAL; DYSFUNCTION	Transgenic rat models of Alzheimer's disease were used to examine differences in memory and brain histology. Double transgenic female rats (APP+PS1) over-expressing human amyloid precursor protein (APP) and presenilin 1 (PS1) and single transgenic rats (APP21) over-expressing human APP were compared with wild type Fischer rats (WT). The Barnes maze assessed learning and memory and showed that both APP21 and APP+PS1 rats made significantly more errors than the WT rats during the acquisition phase, signifying slower learning. Additionally, the APP+PS1 rats made significantly more errors following a retention interval, indicating impaired memory compared to both the APP21 and WT rats. Immunohistochemistry using an antibody against amyloid-beta (A beta) showed extensive and mostly diffuse A beta plaques in the hippocampus and dense plaques that contained tau in the cortex of the brains of the APP+PS1 rats. Furthermore, the APP+PS1 rats also showed vascular changes, including cerebral amyloid angiopathy with extensive A beta deposits in cortical and leptomeningeal blood vessel walls and venous collagenosis. In addition to the A beta accumulation observed in arterial, venous, and capillary walls, APP+PS1 rats also displayed enlarged blood vessels and perivascular space. Overall, the brain histopathology and behavioral assessment showed that the APP+PS1 rats demonstrated behavioral characteristics and vascular changes similar to those commonly observed in patients with Alzheimer's disease.	[Klakotskaia, Diana; Richardson, Rachel A.; Schachtman, Todd R.] Univ Missouri, Dept Psychol Sci, Columbia, MO USA; [Agca, Cansu; Agca, Yuksel] Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA; [Stopa, Edward G.] Rhode Isl Hosp, Dept Pathol, Providence, RI 02902 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; Lifespan Health Rhode Island; Rhode Island Hospital	Agca, Y (corresponding author), Univ Missouri, Coll Vet Med, Dept Vet Pathobiol, Columbia, MO 65211 USA.	agcay@missouri.edu		Klakotskaia, Diana/0000-0002-9851-5330	University of Missouri-Research Incentive Funds; National Institute of Health [P40 OD011062]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD011062] Funding Source: NIH RePORTER	University of Missouri-Research Incentive Funds; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the University of Missouri-Research Incentive Funds to Yuksel Agca and the National Institute of Health (grant no. P40 OD011062). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca C, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-28; Agca C, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0281-8; Alzheimer's Association, 2017, ALZHEIMERS DEMENT, V13, P325, DOI [DOI 10.1016/J.JALZ.2017.02.001, 10.1016/j.jalz.2017.02.001]; Attar A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080355; Attems J, 2005, ACTA NEUROPATHOL, V110, P345, DOI 10.1007/s00401-005-1074-9; BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Beauguis J, 2014, MEDICINA-BUENOS AIRE, V74, P282; Black S, 2009, STROKE, V40, pS48, DOI 10.1161/STROKEAHA.108.537704; Canete T, 2015, BEHAV BRAIN RES, V281, P156, DOI 10.1016/j.bbr.2014.11.004; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Gao F., 2008, ALZHEIMERS DEMENT, V4, pT368, DOI [DOI 10.1016/J.JALZ.2008.05.1090, 10.1016/j.jalz.2008.05.1090]; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Johnson C, 2004, CEREBROSPINAL FLUID, V1; Joo IL, 2017, SCI REP-UK, V7, DOI 10.1038/srep46427; Kesner RP, 2004, REV NEUROSCIENCE, V15, P333; Leclercq PD, 2005, J NEUROL NEUROSUR PS, V76, P229, DOI 10.1136/jnnp.2003.025528; Moody DM, 1997, ANN NY ACAD SCI, V826, P103, DOI 10.1111/j.1749-6632.1997.tb48464.x; O'Leary TP, 2009, BEHAV BRAIN RES, V201, P120, DOI 10.1016/j.bbr.2009.01.039; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Peng WG, 2016, NEUROBIOL DIS, V93, P215, DOI 10.1016/j.nbd.2016.05.015; Pietropaolo S, 2014, COGN AFFECT BEHAV NE, V14, P996, DOI 10.3758/s13415-014-0253-3; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; Roher AE, 2003, MOL MED, V9, P112, DOI 10.1007/BF03402043; Sandoval-Hernandez AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145467; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Silverberg GD, 2003, LANCET NEUROL, V2, P506, DOI 10.1016/S1474-4422(03)00487-3; Silverberg GD, 2015, FLUIDS BARRIERS CNS, V12, DOI 10.1186/2045-8118-12-2; Stepanichev MY, 2004, PHYSIOL BEHAV, V80, P647, DOI 10.1016/j.physbeh.2003.11.003; Sterniczuk R, 2010, BRAIN RES, V1348, P149, DOI 10.1016/j.brainres.2010.06.011; Stewart S, 2011, J ALZHEIMERS DIS, V26, P105, DOI 10.3233/JAD-2011-101827; Stover KR, 2015, BEHAV BRAIN RES, V289, P29, DOI 10.1016/j.bbr.2015.04.012; Van Dorpe J, 2000, AM J PATHOL, V157, P1283, DOI 10.1016/S0002-9440(10)64644-5; Vassar R, 2004, J MOL NEUROSCI, V23, P105, DOI 10.1385/JMN:23:1-2:105; Vest RS, 2013, HORM BEHAV, V63, P301, DOI 10.1016/j.yhbeh.2012.04.006; Walker JM, 2011, BEHAV BRAIN RES, V222, P169, DOI 10.1016/j.bbr.2011.03.049; Walker JM, 2015, J ALZHEIMERS DIS, V44, P561, DOI 10.3233/JAD-140981; Weller RO, 1998, AM J PATHOL, V153, P725, DOI 10.1016/S0002-9440(10)65616-7; Weller RO, 2000, ANN NY ACAD SCI, V903, P110, DOI 10.1111/j.1749-6632.2000.tb06356.x; Weller RO, 2009, ALZHEIMERS RES THER, V1, DOI 10.1186/alzrt6; Weller RO, 2009, ACTA NEUROPATHOL, V118, P87, DOI 10.1007/s00401-009-0498-z; Wright AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059586	42	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195469	10.1371/journal.pone.0195469	http://dx.doi.org/10.1371/journal.pone.0195469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641600	gold, Green Submitted, Green Published			2022-12-26	WOS:000429742900070
J	Lu, JQ; Liu, LS; Zheng, MJ; Li, XL; Wu, AL; Wu, QZ; Liao, C; Zou, J; Song, H				Lu, Jinqiu; Liu, Liansheng; Zheng, Mingjie; Li, Xiaoling; Wu, Ailing; Wu, Qingzhe; Liao, Cheng; Zou, Jian; Song, Hai			MEKK2 and MEKK3 suppress Hedgehog pathway-dependent medulloblastoma by inhibiting GLI1 function	ONCOGENE			English	Article							ACTIVATOR FUNCTION; PROTEINS; CANCER; OVEREXPRESSION; EXPRESSION; SITE	Hedgehog (Hh) pathway plays a pivotal role in diverse aspects of development and postnatal physiology. Perturbation of Hh signaling and activation of GLI1 (glioma-associated oncogene 1), a dedicated transcription factor for Hh pathway, are highly associated with several cancers, such as medulloblastoma and basal cell carcinoma. Dynamic and precise control of GLI1 activity is thus important to ensure proper homeostasis and tumorigenesis. Here we show that MEKK2 (MAP3K2) and MEKK3 (MAP3K3) inhibit GLI1 transcriptional activity and oncogenic function through phosphorylation on multiple Ser/Thr sites of GLI1, which reduces GLI1 protein stability, DNA-binding ability, and increases the association of GLI1 with SUFU. Interestingly, MEKK2 and MEKK3 are responsible for FGF2-mediated inhibition on Hh signaling. Moreover, expression of MEKK2 and MEKK3 inhibits medulloblastoma cell proliferation and negatively correlates with Hh pathway activity in medulloblastoma clinical samples. Together, these findings reveal a novel noncanonical GLI1 regulation and provide a potential therapeutic target for the treatment of cancers with aberrant Hh pathway activation, such as medulloblastoma.	[Lu, Jinqiu; Liu, Liansheng; Li, Xiaoling; Wu, Ailing; Wu, Qingzhe; Song, Hai] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Lu, Jinqiu; Liu, Liansheng; Li, Xiaoling; Wu, Ailing; Wu, Qingzhe; Song, Hai] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China; [Zheng, Mingjie; Zou, Jian] Zhejiang Univ, Inst Translat Med, Affiliated Hosp 2, Eye Ctr,Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Liao, Cheng] Janssen China Res & Dev Ctr, Lung Canc Translat Res, Discovery Ctr, 5F,Bldg 1 North,Jinchuang Mans 4560 Jinke, Shanghai 201210, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Song, H (corresponding author), Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China.; Song, H (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Hangzhou 310058, Zhejiang, Peoples R China.	haisong@zju.edu.cn		Zheng, Mingjie/0000-0003-0735-3995; Li, Xiaoling/0000-0002-1554-1569	National Natural Science Foundation of China [31471368]; Zhejiang Provincial Natural Science Foundation of China [LR16C120001, LZ15H120001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province)	We thank Bin Zhao and Zongping Xia (both Zhejiang University, China) for reagents, members of the Song laboratory for discussion, and Pao-Tien Chuang for critical reading of the manuscript. This work was supported by the National Natural Science Foundation of China (grant number 31471368), the Zhejiang Provincial Natural Science Foundation of China (grant number LR16C120001) to HS, and the Zhejiang Provincial Natural Science Foundation of China (grant number LZ15H120001) to JZ. HS is a scholar in the National 1000 Young Talents Program.	Aberger F, 2014, SEMIN CELL DEV BIOL, V33, P93, DOI 10.1016/j.semcdb.2014.05.003; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Barnfield PC, 2005, DIFFERENTIATION, V73, P397, DOI 10.1111/j.1432-0436.2005.00042.x; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Ding Q, 1999, CURR BIOL, V9, P1119, DOI 10.1016/S0960-9822(99)80482-5; Fan YH, 2014, J PATHOL, V232, P75, DOI 10.1002/path.4283; Fogarty MP, 2007, P NATL ACAD SCI USA, V104, P2973, DOI 10.1073/pnas.0605770104; Gotschel F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065403; Greenblatt MB, 2016, P NATL ACAD SCI USA, V113, pE1226, DOI 10.1073/pnas.1600813113; Hasan R, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-2; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Infante P, 2015, TRENDS PHARMACOL SCI, V36, P547, DOI 10.1016/j.tips.2015.05.006; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Jiang L, 2013, ONCOL LETT, V6, P1333, DOI 10.3892/ol.2013.1553; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lewis KE, 1999, DEV BIOL, V216, P469, DOI 10.1006/dbio.1999.9519; Lin CW, 2014, DEV BIOL, V392, P324, DOI 10.1016/j.ydbio.2014.05.014; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Neumann CJ, 1999, DEVELOPMENT, V126, P4817; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Scales SJ, 2009, TRENDS PHARMACOL SCI, V30, P303, DOI 10.1016/j.tips.2009.03.007; Umapathy G, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005470; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Zhang DY, 2006, EMBO J, V25, P97, DOI 10.1038/sj.emboj.7600913; Zhang WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031450	35	22	23	3	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3864	3878		10.1038/s41388-018-0249-5	http://dx.doi.org/10.1038/s41388-018-0249-5			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29662197	hybrid, Green Published			2022-12-26	WOS:000438465600008
J	Albadr, MAA; Tiun, S; Al-Dhief, FT; Sammour, MAM				Albadr, Musatafa Abbas Abbood; Tiun, Sabrina; AL-Dhief, Fahad Taha; Sammour, Mahmoud A. M.			Spoken language identification based on the enhanced self-adjusting extreme learning machine approach	PLOS ONE			English	Article							OPTIMIZATION; NETWORKS	Spoken Language Identification (LID) is the process of determining and classifying natural language from a given content and dataset. Typically, data must be processed to extract useful features to perform LID. The extracting features for LID, based on literature, is a mature process where the standard features for LID have already been developed using Mel-Frequency Cepstral Coefficients (MFCC), Shifted Delta Cepstral (SDC), the Gaussian Mixture Model (GMM) and ending with the i-vector based framework. However, the process of learning based on extract features remains to be improved (i.e. optimised) to capture all embedded knowledge on the extracted features. The Extreme Learning Machine (ELM) is an effective learning model used to perform classification and regression analysis and is extremely useful to train a single hidden layer neural network. Nevertheless, the learning process of this model is not entirely effective (i.e. optimised) due to the random selection of weights within the input hidden layer. In this study, the ELM is selected as a learning model for LID based on standard feature extraction. One of the optimisation approaches of ELM, the Self-Adjusting Extreme Learning Machine (SA-ELM) is selected as the benchmark and improved by altering the selection phase of the optimisation process. The selection process is performed incorporating both the Split-Ratio and K-Tournament methods, the improved SA-ELM is named Enhanced Self-Adjusting Extreme Learning Machine (ESA-ELM). The results are generated based on LID with the datasets created from eight different languages. The results of the study showed excellent superiority relating to the performance of the Enhanced Self-Adjusting Extreme Learning Machine LID (ESA-ELM LID) compared with the SA-ELM LID, with ESA-ELM LID achieving an accuracy of 96.25%, as compared to the accuracy of SA-ELM LID of only 95.00%.	[Albadr, Musatafa Abbas Abbood; Tiun, Sabrina] Univ Kebangsaan Malaysia, CAIT, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia; [AL-Dhief, Fahad Taha] Univ Teknol Malaysia, Fac Elect Engn, Dept Commun Engn, Utm Johor Bahru, Johor, Malaysia; [Sammour, Mahmoud A. M.] Univ Teknikal Malaysia Melaka, Fac Informat & Commun Technol, Melaka, Malaysia	Universiti Kebangsaan Malaysia; Universiti Teknologi Malaysia; Universiti Teknologi Malaysia; University Teknikal Malaysia Melaka	Albadr, MAA (corresponding author), Univ Kebangsaan Malaysia, CAIT, Fac Informat Sci & Technol, Bangi, Selangor, Malaysia.	mustafa_abbas1988@yahoo.com	Sammour, Mahmoud A. M./T-8716-2017; tiun, sabrina/M-4315-2019; Albadr, Musatafa Abbas Abbood/AAJ-6453-2020	Sammour, Mahmoud A. M./0000-0002-6860-2804; tiun, sabrina/0000-0002-1134-973X; Albadr, Musatafa/0000-0003-2062-688X	Malaysian government [FRGS/1/2016/ICT02/UKM/02/14]	Malaysian government	This project is funded by Malaysian government (to Mustafa Abbas Albadr) under research code FRGS/1/2016/ICT02/UKM/02/14; This project is funded by Malaysian government under research code FRGS/1/2016/ICT02/UKM/02/14.	Albadra MAA, 2017, INT J APPL ENG RES, V12, P4610; Ambikairajah E, 2011, IEEE CIRC SYST MAG, V11, P82, DOI 10.1109/MCAS.2011.941081; Bhasin V, 2013, 2013 INTERNATIONAL CONFERENCE ON ADVANCES IN COMPUTING, COMMUNICATIONS AND INFORMATICS (ICACCI), P1948, DOI 10.1109/ICACCI.2013.6637480; Deng CW, 2015, SCI CHINA INFORM SCI, V58, DOI 10.1007/s11432-014-5269-3; Garg Archana, 2014, Journal of Emerging Technologies in Web Intelligence, V6, P388, DOI 10.4304/jetwi.6.4.388-400; Hafen RP, 2012, MULTIMEDIA SYST, V18, P499, DOI 10.1007/s00530-012-0266-0; Han K., 2014, SPEECH EMOTION RECOG; Huang G, 2014, IEEE T CYBERNETICS, V44, P2405, DOI 10.1109/TCYB.2014.2307349; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2006, IEEE T NEURAL NETWOR, V17, P879, DOI 10.1109/TNN.2006.875977; Huang GB, 2014, COGN COMPUT, V6, P376, DOI 10.1007/s12559-014-9255-2; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Iosifidis A, 2016, IEEE T CYBERNETICS, V46, P311, DOI 10.1109/TCYB.2015.2401973; Jiang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100795; Lan Y, 2013, NEURAL COMPUT APPL, V22, P417, DOI 10.1007/s00521-012-0946-x; Lee KA, 2016, INTERSPEECH, P3211, DOI 10.21437/Interspeech.2016-624; Li JY, 2015, 2015 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P187, DOI 10.1109/ASRU.2015.7404793; Liang NY, 2006, IEEE T NEURAL NETWOR, V17, P1411, DOI 10.1109/TNN.2006.880583; Liu B, 2016, NEURAL COMPUT APPL, V27, P255, DOI 10.1007/s00521-014-1777-8; Lopez-Moreno I, 2016, COMPUT SPEECH LANG, V40, P46, DOI 10.1016/j.csl.2016.03.001; Minhas R, 2010, NEUROCOMPUTING, V73, P1906, DOI 10.1016/j.neucom.2010.01.020; Mohammed AA, 2011, PATTERN RECOGN, V44, P2588, DOI 10.1016/j.patcog.2011.03.013; Muthusamy H, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/394083; Nayak PK, 2016, NEURAL COMPUT APPL, V27, P2107, DOI 10.1007/s00521-015-2010-0; Niu PF, 2016, NEURAL PROCESS LETT, V44, P813, DOI 10.1007/s11063-016-9496-z; Pal M, 2013, REMOTE SENS LETT, V4, P853, DOI 10.1080/2150704X.2013.805279; Pan C, 2012, NEURAL COMPUT APPL, V21, P1217, DOI 10.1007/s00521-011-0522-9; Peng Y, 2015, NEUROCOMPUTING, V149, P340, DOI 10.1016/j.neucom.2013.12.065; Rao RV, 2011, COMPUT AIDED DESIGN, V43, P303, DOI 10.1016/j.cad.2010.12.015; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; van Heeswijk M, 2015, ADV EXTREME LEARNING; Wang YG, 2011, NEUROCOMPUTING, V74, P2483, DOI 10.1016/j.neucom.2010.11.030; Xiang J, 2014, USING EXTREME LEARNI, P73; Xu JM, 2015, EURASIP J AUDIO SPEE, DOI 10.1186/s13636-015-0066-5; Yang ZY, 2016, COGN NEURODYNAMICS, V10, P73, DOI 10.1007/s11571-015-9358-9; Zazo R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146917	36	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194770	10.1371/journal.pone.0194770	http://dx.doi.org/10.1371/journal.pone.0194770			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672546	Green Published, gold			2022-12-26	WOS:000430446800012
J	Han, A; Ahn, S; Min, SK; Ha, J; Kim, YS; Ahn, C; Mint, SI				Han, Ahram; Ahn, Sanghyun; Min, Seung-Kee; Ha, Jongwon; Kim, Yon Su; Ahn, Curie; Mint, Sang-il			Value of perioperative genitourinary screening culture and colonization status in predicting early urinary tract infection after renal transplantation	PLOS ONE			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; ASYMPTOMATIC BACTERIURIA; KIDNEY-TRANSPLANTATION; ALLOGRAFT RECIPIENTS; ESCHERICHIA-COLI; RISK; PYELONEPHRITIS; BACTEREMIA; RESISTANCE; IMPACT	Background We aimed to assess whether patients colonized with certain organisms in the genitourinary tract would have greater urinary tract infection (UTI) risk during the post-transplantation period, and whether information on the perioperatively colonized organisms may help identify the causal organisms during early UTI. Methods We retrospectively reviewed the culture results of preoperative urine, preoperative urethral swab, and postoperative urinary catheter tip specimens of 420 renal transplant recipients. The colonization status was compared to the culture results during the first UTI episode within 6 months after transplantation. Results Twenty six (6.2%) patients developed early UTI, and the presence of common uropathogens in the perioperative genitourinary specimen was positively associated with a higher early UTI risk odds ratio [OR], 3.23; 95% confidence interval [CI], 1.44 to 7.24; P = 0.003). However, the actual causal organism during UTI was observed perioperatively only in 15 patients (40.5%). Neither perioperative colonization nor early UTI was associated with subsequent acute cellular rejection or graft failure. Conclusions Renal transplantation patients who were colonized with common uropathogens were more likely to develop early UTI. However, the usefulness of the culture results of perioperative colonizers in predicting the causal organism during early UTI seems limited due to the low concordance rate.	[Han, Ahram; Ahn, Sanghyun; Min, Seung-Kee; Ha, Jongwon; Mint, Sang-il] Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea; [Kim, Yon Su; Ahn, Curie] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Mint, SI (corresponding author), Seoul Natl Univ, Dept Surg, Coll Med, Seoul, South Korea.	surgeonmsi@gmail.com		Min, Sang-il/0000-0002-0688-0278				Abbott KC, 2004, AM J KIDNEY DIS, V44, P353, DOI 10.1053/j.ajkd.2004.04.040; Bodro M, 2015, AM J TRANSPLANT, V15, P1021, DOI 10.1111/ajt.13075; Chuang P, 2005, CLIN TRANSPLANT, V19, P230, DOI 10.1111/j.1399-0012.2005.00327.x; Coussement J, 2014, NEPHROL DIAL TRANSPL, V29, P260, DOI 10.1093/ndt/gft432; Eckardt KU, 2009, AM J TRANSPLANT, V9, pS1, DOI 10.1111/j.1600-6143.2009.02834.x; Fishman JA, 2007, NEW ENGL J MED, V357, P2601, DOI 10.1056/NEJMra064928; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Fritzenwanker M, 2016, EXPERT REV ANTI-INFE, V14, P1047, DOI 10.1080/14787210.2016.1236685; Giral M, 2002, KIDNEY INT, V61, P1880, DOI 10.1046/j.1523-1755.2002.00323.x; Gozdowska J, 2016, TRANSPL P, V48, P1580, DOI 10.1016/j.transproceed.2016.01.061; Graversen ME, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1608-x; Green H, 2011, TRANSPL INFECT DIS, V13, P441, DOI 10.1111/j.1399-3062.2011.00644.x; Hayon J, 2002, AM J RESP CRIT CARE, V165, P41, DOI 10.1164/ajrccm.165.1.2105077; Hess AS, 2014, DIAGN MICR INFEC DIS, V79, P73, DOI 10.1016/j.diagmicrobio.2014.01.022; Honda H, 2010, INFECT CONT HOSP EP, V31, P584, DOI 10.1086/652530; Karam G, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1320-7; Kollef MH, 2014, CRIT CARE MED, V42, P2178, DOI 10.1097/CCM.0000000000000510; Lee JR, 2013, TRANSPLANTATION, V96, P732, DOI 10.1097/TP.0b013e3182a04997; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Naik AS, 2016, TRANSPL INT, V29, P241, DOI 10.1111/tri.12711; Origuen J, 2016, AM J TRANSPLANT, V16, P3303, DOI 10.1111/ajt.13919; Origuen J, 2016, TRANSPL INFECT DIS, V18, P575, DOI 10.1111/tid.12547; Ortega M, 2009, J ANTIMICROB CHEMOTH, V63, P568, DOI 10.1093/jac/dkn514; Parasuraman R, 2013, AM J TRANSPLANT, V13, P327, DOI 10.1111/ajt.12124; Parm U, 2011, J HOSP INFECT, V78, P327, DOI 10.1016/j.jhin.2011.03.025; Pelle G, 2007, AM J TRANSPLANT, V7, P899, DOI 10.1111/j.1600-6143.2006.01700.x; Singh R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1432-3; STAMEY TA, 1971, CALIF MED, V115, P1; Vidal E, 2015, ENFERM INFEC MICR CL, V33, P680, DOI 10.1016/j.eimc.2015.03.020; Wu XH, 2016, AM J INFECT CONTROL, V44, P1261, DOI 10.1016/j.ajic.2016.04.222; Yamamoto S, 1997, J UROLOGY, V157, P1127, DOI 10.1016/S0022-5347(01)65154-1	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196115	10.1371/journal.pone.0196115	http://dx.doi.org/10.1371/journal.pone.0196115			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672580	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800088
J	Herbener, P; Schonfeld, K; Konig, M; Germer, M; Przyborski, JM; Bernoster, K; Schuttrumpf, J				Herbener, Peter; Schoenfeld, Kurt; Koenig, Martin; Germer, Matthias; Przyborski, Jude M.; Bernoester, Katrin; Schuettrumpf, Joerg			Functional relevance of in vivo half antibody exchange of an IgG4 therapeutic antibody-drug conjugate	PLOS ONE			English	Article							FAB-ARM EXCHANGE; MULTIPLE-MYELOMA; SYNDECAN-1; CD138; DETERMINANTS; EXPRESSION; DYNAMICS; BIOLOGY; BINDING; PROFILE	An increasing number of monoclonal antibodies and derivatives such as antibody-drug conjugates (ADC) are of the IgG1 and IgG4 isotype with distinct structural and functional properties. In cases where antibody-mediated cytotoxicity is not desired, IgG4 is often used, as its Fc region is relatively poor at inducing antibody-dependent cell-mediated or complement-dependent cytotoxicity. IgG4 ADCs with highly cytotoxic drugs against proliferating target cells but which lack or have diminished antibody effector functions against quiescent cells may have a favorable safety profile compared to IgG1. Another unique property of the IgG4 subclass is the capability to exchange half antibodies in vivo creating randomly bispecific antibodies. To investigate the functional properties of process-derived antibody species, and determine the influence of shuffling on the therapeutic efficacy, several model antibodies on the basis of the anti-CD138 antibody-drug conjugate BT062 (Indatuximab ravtansine) were generated: (I) A wild type nBT062, (II) a stable nBT062 comprising mutations to prevent half-antibody exchange, (III) a half nBT062 lacking covalent binding between two heavy chains and (IV) a stabilized, bispecific nBT062-natalizumab antibody with a second, monovalent specificity against CD49d. All nBT062 model variants were capable of CD138-specific binding and antigen-mediated internalization into cells. Furthermore, all nBT062 models inhibited tumor growth in vitro after conjugation with the maytansinoid DM4. The in vivo effects of the different molecular variants were assessed in the MAXF1322 xenograft model. The bispecific nBT062-natalizumab-DM4 demonstrated the least efficacy and was only moderately active even without the co-administration of a human IgG preparation. Wild type, stable and half nBT062-DM4 models demonstrated great anti-tumor activities. The efficacy of wild type and half nBT062-DM4 was reduced in the presence of IgG, while stable nBT062-DM4 was only marginally influenced. These pre-clinical data demonstrate the advantage of introducing half-antibody exchange-preventing mutations into therapeutic IgG4-based antibody drug-conjugates.	[Herbener, Peter; Schoenfeld, Kurt; Koenig, Martin; Germer, Matthias; Schuettrumpf, Joerg] Biotest AG, Corp Res & Dev, Dreieich, Germany; [Przyborski, Jude M.] Philipps Univ Marburg, Parasitol, Fac Biol, Marburg, Germany; [Bernoester, Katrin] Biotest AG, Corp Project & Portfolio Management, Dreieich, Germany; [Przyborski, Jude M.] Heidelberg Univ Hosp, Ctr Infect Dis, Parasitol, Heidelberg, Germany	Biotest; Philipps University Marburg; Biotest; Ruprecht Karls University Heidelberg	Herbener, P (corresponding author), Biotest AG, Corp Res & Dev, Dreieich, Germany.	peter.herbener@biotest.com	Przyborski, Jude/ABC-9498-2021	Przyborski, Jude/0000-0002-3494-7767; Germer, Matthias/0000-0001-8565-1416	Biotest AG	Biotest AG	Biotest AG provided all funding for study design, data collection and analysis, and preparation of the manuscript including salaries for authors P.H., K.S., M.K., M.G., K.B. and J.S. This preclinical research is part of a development program for BT062 in malignant diseases. The development candidate is currently tested in phase II clinical trials in multiple myeloma, breast and bladder cancer.	Aalberse RC, 2002, IMMUNOLOGY, V105, P9, DOI 10.1046/j.0019-2805.2001.01341.x; ALEGRE ML, 1992, J IMMUNOL, V148, P3461; AUCOUTURIER P, 1984, J IMMUNOL METHODS, V74, P151, DOI 10.1016/0022-1759(84)90376-4; Bayer-Garner IB, 2001, MODERN PATHOL, V14, P1052, DOI 10.1038/modpathol.3880435; Bendig MM, 1995, Humanized antibodies against leukocyte adhesion molecule VLA- 4, Patent No. [US19950561521, 19950561521]; Bendig MM, 1995, Humanized antibodies against leukocyte adhesion molecule VLA-4, Patent No. [US19940186269, 19940186269]; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bleeker WK, 2001, BLOOD, V98, P3136, DOI 10.1182/blood.V98.10.3136; Broug E, 2010, NAT BIOTECHNOL, V28, P123, DOI 10.1038/nbt0210-123; Carter P, 2001, J IMMUNOL METHODS, V248, P7, DOI 10.1016/S0022-1759(00)00339-2; Chng J, 2015, MABS-AUSTIN, V7, P403, DOI 10.1080/19420862.2015.1008351; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; Debaene F, 2013, ANAL CHEM, V85, P9785, DOI 10.1021/ac402237v; Dore JM, 1998, FEBS LETT, V426, P67, DOI 10.1016/S0014-5793(98)00310-X; ELENIUS K, 1990, J BIOL CHEM, V265, P17837; Hansen K, 2009, MOL IMMUNOL, V46, P3269, DOI 10.1016/j.molimm.2009.07.031; Hutchinson Michael, 2007, Ther Clin Risk Manag, V3, P259, DOI 10.2147/tcrm.2007.3.2.259; Ikeda H, 2009, CLIN CANCER RES, V15, P4028, DOI 10.1158/1078-0432.CCR-08-2867; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kelly K., 2016, ASH, V128, P4486; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Labrijn AF, 2011, J IMMUNOL, V187, P3238, DOI 10.4049/jimmunol.1003336; Labrijn AF, 2009, NAT BIOTECHNOL, V27, P767, DOI 10.1038/nbt.1553; Lee JG, 2013, IMMUNOL LETT, V156, P38, DOI 10.1016/j.imlet.2013.09.004; Lewis SM, 2014, NAT BIOTECHNOL, V32, P191, DOI 10.1038/nbt.2797; Lopus M, 2010, MOL CANCER THER, V9, P2689, DOI 10.1158/1535-7163.MCT-10-0644; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; O'Connell FP, 2004, AM J CLIN PATHOL, V121, P254, DOI 10.1309/617DWB5GNFWXHW4L; Prabhu S, 2011, THER DELIV, V2, P769, DOI 10.4155/TDE.11.41; SANDERSON RD, 1989, CELL REGUL, V1, P27, DOI 10.1091/mbc.1.1.27; Schonfeld K, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0380-0; Schuurman J, 2001, MOL IMMUNOL, V38, P1, DOI 10.1016/S0161-5890(01)00050-5; Schuurman J, 1999, IMMUNOLOGY, V97, P693, DOI 10.1046/j.1365-2567.1999.00845.x; Schweighofer CD, 2012, CANCER IMMUNOL IMMUN, V61, P2367, DOI 10.1007/s00262-012-1362-x; Shabaneh TB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056132; Shakib F., 1990, HUMAN IGG SUBCLASSES; Siegel MB, 2015, ONCOTARGET, V6, P18921, DOI 10.18632/oncotarget.4214; VANDERZEE JS, 1986, CLIN EXP IMMUNOL, V64, P415; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Weill Claire O, 2008, Biotechniques, V44, pPvii, DOI 10.2144/000112832; Wijdenes J, 2002, J BIOL REG HOMEOS AG, V16, P152; Wijdenes J, 1996, BRIT J HAEMATOL, V94, P318, DOI 10.1046/j.1365-2141.1996.d01-1811.x; Young E, 2014, IMMUNOLOGY, V142, P406, DOI 10.1111/imm.12265	45	12	12	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e195823	10.1371/journal.pone.0195823	http://dx.doi.org/10.1371/journal.pone.0195823			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672587	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800048
J	Marcondes, L; Crawford, J; Earle, N; Smith, W; Hayes, I; Morrows, P; Donoghue, T; Graham, A; Love, D; Skinner, JR				Marcondes, Luciana; Crawford, Jackie; Earle, Nikki; Smith, Warren; Hayes, Ian; Morrows, Paul; Donoghue, Tom; Graham, Amanda; Love, Donald; Skinner, Jonathan R.		Cardiac Inherited Dis Grp New Zeal	Long QT molecular autopsy in sudden unexplained death in the young (1-40 years old): Lessons learnt from an eight year experience in New Zealand	PLOS ONE			English	Article							INFANT-DEATH; CARDIAC DEATH; CHANNEL DYSFUNCTION; DIAGNOSTIC YIELD; HIGH PREVALENCE; GENE VARIANTS; EXOME DATA; TRANSMISSION; RELATIVES; SCN5A	Background To review long QT syndrome molecular autopsy results in sudden unexplained death in young (SUDY) between 2006 and 2013 in New Zealand. Methods Audit of the LQTS molecular autopsy results, cardiac investigations and family screening data from gene- positive families. Results During the study period, 365 SUDY cases were referred for molecular autopsy. 128 cases (35%) underwent LQTS genetic testing. 31 likely pathogenic variants were identified in 27 cases (21%); SCN5A (14/31, 45%), KCNH2 (7/31, 22%), KCNQ1 (4/31, 13%), KCNE2 (3/ 31, 10%), KCNE1 (2/31, 7%), KCNJ2 (1/31, 3%). Thirteen variants (13/128, 10%) were ultimately classified as pathogenic. Most deaths (63%) occurred during sleep. Gene variant carriage was more likely with a positive medical history (mostly seizures, 63% vs 36%, p = 0.01), amongst females (36% vs 12%, p = 0.001) and whites more than Maori (31% vs 0, p = 0.0009). Children 1-12 years were more likely to be gene- positive (33% vs 14%, p = 0.02). Family screening identified 42 gene- positive relatives, 18 with definitive phenotypic expression of LQTS/Brugada. 76% of the variants were maternally inherited (p = 0.007). Further family investigations and research now support pathogenicity of the variant in 13/27 (48%) of gene-positive cases. Conclusion In New Zealand, variants in SCN5A and KCNH2, with maternal inheritance, predominate. A rare variant in LQTS genes is more likely in whites rather than Maori, females, children 1-12 years and those with a positive personal and family history of seizures, syncope or SUDY. Family screening supported the diagnosis in a third of the cases. The changing classification of variants creates a significant challenge.	[Marcondes, Luciana; Crawford, Jackie; Skinner, Jonathan R.] Starship Childrens Hosp, Greenlane Paediat & Congenital Cardiac Serv, Auckland, New Zealand; [Earle, Nikki; Skinner, Jonathan R.] Univ Auckland, Dept Med, Fac Med & Hlth Sci, Auckland, New Zealand; [Smith, Warren; Skinner, Jonathan R.] Auckland City Hosp, Greenlane Cardiovasc Serv, Auckland, New Zealand; [Hayes, Ian] Northern Reg Genet Serv, Genet, Auckland, New Zealand; [Morrows, Paul] Auckland City Hosp, Dept Forens Pathol, LabPlus, Auckland, New Zealand; [Donoghue, Tom] Wellington Hosp, Dept Cardiol, Wellington, New Zealand; [Graham, Amanda] Waikato Hosp, Dept Cardiol, Hamilton, New Zealand; [Love, Donald] Auckland City Hosp, Diagnost Genet, LabPlus, Auckland, New Zealand	Starship Children's Hospital; University of Auckland; Auckland City Hospital; Auckland City Hospital; Waikato Hospital; Auckland City Hospital	Skinner, JR (corresponding author), Starship Childrens Hosp, Greenlane Paediat & Congenital Cardiac Serv, Auckland, New Zealand.; Skinner, JR (corresponding author), Univ Auckland, Dept Med, Fac Med & Hlth Sci, Auckland, New Zealand.; Skinner, JR (corresponding author), Auckland City Hosp, Greenlane Cardiovasc Serv, Auckland, New Zealand.	jskinner@adhb.govt.nz	Tse, Rexson/Y-1939-2019	Tse, Rexson/0000-0002-1388-9537; Skinner, Jonathan Robert/0000-0002-3653-0412	CureKids	CureKids	CureKids part funded JRS, TD and AJG salary, during the period of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman MJ, 2011, HEART RHYTHM, V8, P1308, DOI [10.1016/j.hrthm.2011.05.020, 10.1093/europace/eur245]; Adzhubei I, 2013, CURR PROTOC HUM GENE, V76; Albert CM, 2008, CIRCULATION, V117, P16, DOI 10.1161/CIRCULATIONAHA.107.736330; [Anonymous], 2007, HUM GEN MUT DAT; Arnestad M, 2007, CIRCULATION, V115, P361, DOI 10.1161/CIRCULATIONAHA.106.658021; Bagnall RD, 2016, NEW ENGL J MED, V374, P2441, DOI 10.1056/NEJMoa1510687; Behr E, 2003, LANCET, V362, P1457, DOI 10.1016/S0140-6736(03)14692-2; Behr ER, 2008, EUR HEART J, V29, P1670, DOI 10.1093/eurheartj/ehn219; Chen LY, 2007, CLIN PHARMACOL THER, V81, P35, DOI 10.1038/sj.clpt.6100016; Crotti L, 2009, CIRCULATION, V120, P1657, DOI 10.1161/CIRCULATIONAHA.109.879643; Doolan A, 2004, MED J AUSTRALIA, V180, P110, DOI 10.5694/j.1326-5377.2004.tb05830.x; Earle N, 2013, HEART RHYTHM, V10, P233, DOI 10.1016/j.hrthm.2012.10.043; Fodstad H, 2004, J MOL CELL CARDIOL, V37, P593, DOI 10.1016/j.yjmcc.2004.05.011; Glengarry JM, 2014, ARCH DIS CHILD, V99, P635, DOI 10.1136/archdischild-2013-305331; Imboden M, 2006, NEW ENGL J MED, V355, P2744, DOI 10.1056/NEJMoa042786; Itoh H, 2016, EUR J HUM GENET, V24, P1160, DOI 10.1038/ejhg.2015.257; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lahrouchi N, 2017, J AM COLL CARDIOL, V69, P2134, DOI 10.1016/j.jacc.2017.02.046; Lestner JM, 2012, EUR J MED GENET, V55, P700, DOI 10.1016/j.ejmg.2012.08.003; MacCormick JM, 2009, ANN EMERG MED, V54, P26, DOI 10.1016/j.annemergmed.2009.01.031; Marquis-Nicholson R, 2014, CIRC-CARDIOVASC GENE, V7, P17, DOI 10.1161/CIRCGENETICS.113.000415; Neary MT, 2013, DIS MODEL MECH, V6, P503, DOI 10.1242/dmm.010587; Plant LD, 2006, J CLIN INVEST, V116, P430, DOI 10.1172/JCI25618; Priori SG, 2003, NEW ENGL J MED, V348, P1866, DOI 10.1056/NEJMoa022147; Puranik R, 2005, HEART RHYTHM, V2, P1277, DOI 10.1016/j.hrthm.2005.09.008; Refsgaard L, 2012, EUR J HUM GENET, V20, P905, DOI 10.1038/ejhg.2012.23; Risgaard B, 2013, CLIN GENET, V84, P489, DOI 10.1111/cge.12126; Skinner JR, 2014, CASE REP MED, V2014, DOI 10.1155/2014/647252; Skinner JR, 2011, HEART RHYTHM, V8, P412, DOI 10.1016/j.hrthm.2010.11.016; Tan HL, 2005, CIRCULATION, V112, P207, DOI 10.1161/CIRCULATIONAHA.104.522581; Tester DJ, 2007, J AM COLL CARDIOL, V49, P240, DOI 10.1016/j.jacc.2006.10.010; Tester DJ, 2012, MAYO CLIN PROC, V87, P524, DOI 10.1016/j.mayocp.2012.02.017; Trans-Tasman Response AGAinst sudden Death in the Young (TRAGADY), 2008, POST MORT SUDD UN DE; van der Werf C, 2010, HEART RHYTHM, V7, P1383, DOI 10.1016/j.hrthm.2010.05.036; Wang DW, 2007, CIRCULATION, V115, P368, DOI 10.1161/CIRCULATIONAHA.106.646513; Wilms HR, 2012, FORENSIC SCI MED PAT, V8, P380, DOI 10.1007/s12024-012-9340-3	36	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196078	10.1371/journal.pone.0196078	http://dx.doi.org/10.1371/journal.pone.0196078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672598	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800081
J	Sarkar, S; Alam, N; Mandal, SS; Chatterjee, K; Ghosh, S; Roychoudhury, S; Panda, CK				Sarkar, Shreya; Alam, Neyaz; Mandal, Syam Sundar; Chatterjee, Kabita; Ghosh, Supratim; Roychoudhury, Susanta; Panda, Chinmay Kumar			Differential transmission of the molecular signature of RBSP3, LIMD1 and CDC25A in basal/ parabasal versus spinous of normal epithelium during head and neck tumorigenesis: A mechanistic study	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; EARLY DYSPLASTIC LESIONS; INDIAN PATIENTS; PROGNOSTIC-SIGNIFICANCE; OROPHARYNGEAL CANCER; HUMAN-PAPILLOMAVIRUS; HPV INFECTION; LUNG-CANCER; STEM-CELLS; PROGRESSION	Head and neck squamous cell carcinoma (HNSCC) is a global disease and mortality burden, necessitating the elucidation of its molecular progression for effective disease management. The study aims to understand the molecular profile of three candidate cell cycle regulatory genes, RBSP3, LIMD1 and CDC25A in the basal/parabasal versus spinous layer of normal oral epithelium and during head and neck tumorigenesis. Immunohistochemical expression and promoter methylation was used to determine the molecular signature in normal oral epithelium. The mechanism of alteration transmission of this profile during tumorigenesis was then explored through additional deletion and mutation in HPV/tobacco etiological groups, followed byclinico-pathological correlation. In basal/parabasal layer, the molecular signature of the genes was low protein expression/high promoter methylation of RBSP3, high expression/low methylation of LIMD1 and high expression of CDC25A. Dysplastic epithelium maintained the signature of RBSP3 through high methylation/additional deletion with loss of the signatures of LIMD1 and CDC25A via deletion/additional methylation. Similarly, maintenance and/or loss of signature in invasive tumors was by recurrent deletion/methylation. Thus, differential patterns of alteration of the genes might be pre-requisite for the development of dysplastic and invasive lesions. Etiological factors played a key role in promoting genetic alterations and determining prognosis. Tobacco negative HNSCC patients had significantly lower alterations of LIMD1 and CDC25A, along with better survival among tobacco negative/HPV positive patients. Our data suggests the necessity for perturbation of normal molecular profile of RBSP3, LIMD1 and CDC25A in conjunction with etiological factors for head and neck tumorigenesis, implying their diagnostic and prognostic significance.	[Sarkar, Shreya; Panda, Chinmay Kumar] Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, India; [Alam, Neyaz] Chittaranjan Natl Canc Inst, Dept Surg Oncol, Kolkata, India; [Mandal, Syam Sundar] Chittaranjan Natl Canc Inst, Dept Epidemiol & Biostat, Kolkata, India; [Chatterjee, Kabita] Buddha Inst Dent Sci & Hosp, Dept Oral & Maxillofacial Pathol, Patna, Bihar, India; [Ghosh, Supratim] Burdwan Dent Coll & Hosp, Dept Oral & Maxillofacial Pathol, Burdwan, W Bengal, India; [Roychoudhury, Susanta] Saroj Gupta Canc Ctr & Res Inst, Basic Res, Kolkata, India; [Sarkar, Shreya] Dalhousie Med New Brunswick, Dept Biochem & Mol Biol, St John, NB, Canada		Panda, CK (corresponding author), Chittaranjan Natl Canc Inst, Dept Oncogene Regulat, Kolkata, India.	ckpanda.cnci@gmail.com	Roychoudhury, Susanta/AAD-7946-2021		CSIR-NET SRF Fellowship, Government of India [09/30 (0056)/2010-EMR-I]	CSIR-NET SRF Fellowship, Government of India	Financial support for this work was provided by CSIR-NET SRF Fellowship, Government of India, (grant no. 09/30 (0056)/2010-EMR-I) to Dr. S. Sarkar.	Al-Matouq J, 2017, CANCER LETT, V410, P41, DOI 10.1016/j.canlet.2017.09.023; Anedchenko EA, 2008, MOL BIOL+, V42, P859, DOI 10.1134/S0026893308060058; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Biswas K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03020-6; Bridge KS, 2017, CELL REP, V20, P173, DOI 10.1016/j.celrep.2017.06.027; Chakraborty C, 2016, BIOCHEM J, V473, P3221, DOI 10.1042/BCJ20160323; Chakraborty SB, 2003, CANCER GENET CYTOGEN, V146, P130, DOI 10.1016/S0165-4608(03)00127-4; Elrefaey S, 2014, ACTA OTORHINOLARYNGO, V34, P299; Fakhry C, 2014, J CLIN ONCOL, V32, P3365, DOI 10.1200/JCO.2014.55.1937; Ghosh A, 2010, CANCER SCI, V101, P1511, DOI 10.1111/j.1349-7006.2010.01551.x; Ghosh A, 2009, J PATHOL, V217, P408, DOI 10.1002/path.2464; Ghosh S, 2008, INT J CANCER, V123, P2594, DOI 10.1002/ijc.23834; Hackler Laszlo Jr, 2012, Methods Mol Biol, V884, P289, DOI 10.1007/978-1-61779-848-1_21; Hou XB, 2016, ONCOL RES, V24, P247, DOI 10.3727/096504016X14652175055765; Iamaroon Anak, 2006, J Oral Sci, V48, P105, DOI 10.2334/josnusd.48.105; Ibar C, 2018, J CELL SCI, V131, DOI 10.1242/jcs.214700; Jahchan NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055794; Jones KB, 2013, INT J ORAL SCI, V5, P121, DOI 10.1038/ijos.2013.46; Kaaij LT, 2010, GENOME BIOL, V14, pR50; Krasnov G S, 2017, Mol Biol (Mosk), V51, P849, DOI 10.7868/S0026898417050135; Kurasawa Y, 2008, ONCOL REP, V19, P1429; Liang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12431; Liu XQ, 2017, EMBO J, V36, P3666, DOI 10.15252/embj.201694443; Maiti GP, 2015, OR SURG OR MED OR PA, V119, P202, DOI 10.1016/j.oooo.2014.09.029; Maiti GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063440; Maiti GP, 2012, ASIAN PAC J CANCER P, V13, P4341, DOI 10.7314/APJCP.2012.13.9.4341; Marklund L, 2011, J ONCOL, V2011, DOI 10.1155/2011/509036; Mayank AK, 2014, CELL BIOL INT, V38, P809, DOI 10.1002/cbin.10266; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mitra S, 2010, GENE CHROMOSOME CANC, V49, P155, DOI 10.1002/gcc.20726; MUIR C, 1995, CANCER, V75, P147, DOI 10.1002/1097-0142(19950101)75:1+<147::AID-CNCR2820751304>3.0.CO;2-U; Perrone F, 2006, CLIN CANCER RES, V12, P6643, DOI 10.1158/1078-0432.CCR-06-1759; Pimenta FJ, 2006, INT J CANCER, V118, P1154, DOI 10.1002/ijc.21446; Sarkar S, 2017, MED MICROBIOL IMMUN, V206, P267, DOI 10.1007/s00430-017-0502-5; Sarkar S, 2013, ASIAN PAC J CANCER P, V14, P6419, DOI 10.7314/APJCP.2013.14.11.6419; Seelan RS, 2013, ANAL BIOCHEM, V442, P68, DOI 10.1016/j.ab.2013.07.029; Shao XJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-978; Sharp TV, 2008, P NATL ACAD SCI USA, V105, P19932, DOI 10.1073/pnas.0805003105; Sobin Leslie H, 2003, Semin Surg Oncol, V21, P19, DOI 10.1002/ssu.10017; Sur S, 2017, PATHOL RES PRACT, V213, P1477, DOI 10.1016/j.prp.2017.10.009; Takemasa I, 2000, CANCER RES, V60, P3043; Tripathi A, 2003, J EXP CLIN CANC RES, V22, P289; Winans S, 2017, ONCOTARGET, V8, P57302, DOI 10.18632/oncotarget.19328; Yuan P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.131; Zhang LL, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0679-5	45	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195937	10.1371/journal.pone.0195937	http://dx.doi.org/10.1371/journal.pone.0195937			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672635	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800061
J	Sulzyc-Bielicka, V; Kolodziejczyk, L; Jaczewska, S; Bielicki, D; Safranow, K; Bielicki, P; Kladny, J; Rogowski, W				Sulzyc-Bielicka, Violetta; Kolodziejczyk, Lidia; Jaczewska, Sylwia; Bielicki, Dariusz; Safranow, Krzysztof; Bielicki, Pawel; Kladny, Jozef; Rogowski, Wojciech			Colorectal cancer and Cryptosporidium spp. infection	PLOS ONE			English	Article							FULMINANT CRYPTOSPORIDIOSIS; PARVUM; MICE; ADENOCARCINOMA; PREVALENCE; PARASITES; GENDER; RISK	Transient or constant impaired immunity is often associated with neoplastic disease or oncological treatment. Among the most common pathogens found in patients with HIV or patients undergoing chemotherapy are protozoans of the Cryptosporidium genus, which cause diarrhea in humans and animals. The present study determined the frequency of Cryptosporidium spp. infections in patients with colorectal cancer (N = 108; 42 women; 66 men; median age, 65 years), before beginning oncological treatment, compared to a control group (N = 125; 56 women, 69 men; median age, 63 years) without colorectal cancer or a history of oncological disease. We also assessed whether Cryptosporidium spp. infections were associated with age, gender, cancer stage (based on Astler-Coller or TNM classification), histological grade, or cancer location. Patients were treated at the Pomeranian Medical University, in 2009-2014. The presence of Cryptosporidium spp. antigen was determined in stool samples, analyzed with a commercial immunoenzymatic test. Cryptosporidium spp. infections occurred significantly more often (p = 0.015) in patients (13%) compared to controls (4%). The patient group showed no significant relationship between Cryptosporidium spp. infection and sex, age, tumor location, cancer grade, or stage. A multivariate logistic regression analysis adjusted for age and sex that included all subjects (patient + control groups, n = 233) showed that the odds of a Cryptosporidium spp. infection were more than three-fold higher in patients than in controls, and more than six-fold higher among men than among women. Conclusions: 1) Cryptosporidium spp. infections occurred significantly more frequently in patients with colorectal cancer (before oncological treatment) compared to controls, independent of age and sex. 2) Cryptosporidium spp. infections were not associated with the colorectal cancer stage, grade, or location or with patient age. 3) Male gender was significantly related to the frequency of Cryptosporidium spp. infections, independent of age and the presence of colorectal cancer.	[Sulzyc-Bielicka, Violetta] Pomeranian Med Univ, Dept Clin Oncol, Szczecin, Poland; [Kolodziejczyk, Lidia] Pomeranian Med Univ, Chair & Dept Biol & Med Parasitol, Szczecin, Poland; [Jaczewska, Sylwia] Publ Hosp, Dept Clin Oncol, Szczecin, Poland; [Bielicki, Dariusz] Pomeranian Med Univ, Dept Gastroenterol, Szczecin, Poland; [Safranow, Krzysztof] Pomeranian Med Univ, Dept Biochem & Med Chem, Szczecin, Poland; [Bielicki, Pawel] West Pomeranian Oncol Ctr, Szczecin, Poland; [Kladny, Jozef] Pomeranian Med Univ, Dept Gen & Oncol Surg, Szczecin, Poland; [Rogowski, Wojciech] Magodent Warszawa, Dept Clin Oncol, Warsaw, Poland	Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University; Pomeranian Medical University	Sulzyc-Bielicka, V (corresponding author), Pomeranian Med Univ, Dept Clin Oncol, Szczecin, Poland.	violabielicka@icloud.com	Safranow, Krzysztof/B-5127-2015; Sulżyc-Bielicka, Violetta/AAE-7313-2021; Kołodziejczyk, Lidia/O-5978-2014	Safranow, Krzysztof/0000-0001-9415-2758; Kołodziejczyk, Lidia/0000-0002-4222-5887; Bielicki, Dariusz/0000-0001-9919-2695; Sulzyc-Bielicka, Violetta/0000-0001-7542-1414	Pomeranian Medical University [WLBiML-418-01/5/12/2017]	Pomeranian Medical University	This work was supported by Pomeranian Medical University, grant number WLBiML-418-01/5/12/2017, https://www.purn.edu.pl. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2013, INT J INFECT DIS, V 17, pE593, DOI 10.1016/j.ijid.2012.11.023; Al-Qobati S.A., 2012, YEMEN J EGYPT SOC PA, V42, P727; [Anonymous], INTERDISCIP PERSPECT; Baqai R, 2005, J Ayub Med Coll Abbottabad, V17, P38; Benamrouz S, 2012, PARASITE, V19, P101, DOI 10.1051/parasite/2012192101; Benamrouz S, 2014, DIS MODEL MECH, V7, P693, DOI 10.1242/dmm.013292; Benamrouz S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051232; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Carey CM, 2004, WATER RES, V38, P818, DOI 10.1016/j.watres.2003.10.012; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; Certad G, 2012, APPL ENVIRON MICROB, V78, P1746, DOI 10.1128/AEM.06457-11; Certad G, 2010, INT J PARASITOL, V40, P1469, DOI 10.1016/j.ijpara.2010.07.007; Certad G, 2010, AM J TROP MED HYG, V82, P257, DOI 10.4269/ajtmh.2010.09-0309; Certad Gabriela, 2007, Infect Agent Cancer, V2, P22, DOI 10.1186/1750-9378-2-22; Dehkordy AB, 2010, IRAN J PARASITOL, V5, P42; Desoubeaux G, 2012, J CLIN PATHOL, V65, P92, DOI 10.1136/jclinpath-2011-200403; Espinoza JL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00052; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hassan Soad I., 2002, Journal of the Egyptian Society of Parasitology, V32, P33; Heussler VT, 2001, INT J PARASITOL, V31, P1166, DOI 10.1016/S0020-7519(01)00271-5; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Izadi M, 2012, MICROBIOL IMMUNOL, V56, P836, DOI 10.1111/j.1348-0421.2012.00513.x; Keku TO, 2015, AM J PHYSIOL-GASTR L, V308, pG351, DOI 10.1152/ajpgi.00360.2012; Kerr J, 2017, LANCET ONCOL, V18, pE457, DOI 10.1016/S1470-2045(17)30411-4; Kim SE, 2015, WORLD J GASTROENTERO, V21, P5167, DOI 10.3748/wjg.v21.i17.5167; Kirkpatrick BD, 2006, CLIN INFECT DIS, V43, P604, DOI 10.1086/506565; Kumar KLR, 2013, J CLIN DIAGN RES, V7, P2716, DOI [10.7860/JCDR/2013/6384.3741, 10.7860/JCDR/2013/5339.3062]; Lima AA, 2011, TROPICAL INFECT DIS, P640; MACKENZIE WR, 1994, NEW ENGL J MED, V331, P161, DOI 10.1056/NEJM199407213310304; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Pellegrini P, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/819724; Perrone S, 2016, MEDITERR J HEMATOL I, V8, DOI 10.4084/MJHID.2016.006; Rehg JE, 1996, J INFECT DIS, V174, P229, DOI 10.1093/infdis/174.1.229; Rivera WL, 2005, PARASITOL RES, V98, P75, DOI 10.1007/s00436-005-0014-x; Ruskone -Fourmestraux A, 2011, GUT, V60, P747, DOI 10.1136/gut.2010.224949; Sanad M. M., 2014, Research Journal of Parasitology, V9, P55, DOI 10.3923/jp.2014.55.63; Sharma A, 2010, CYTOKINE, V50, P91, DOI 10.1016/j.cyto.2010.01.002; Shebl FM, 2012, AIDS RES HUM RETROV, V28, P794, DOI [10.1089/aid.2011.0185, 10.1089/AID.2011.0185]; Shrivastava Arpit Kumar, 2017, Trop Parasitol, V7, P8, DOI 10.4103/2229-5070.202290; Sreedharan A, 1996, J DIARRHOEAL DIS RES, V14, P211; Sulzyc-Bielicka V, 2007, J PARASITOL, V93, P722, DOI 10.1645/GE-1025R1.1; Sulzyc-Bielicka Violetta, 2012, Pol Przegl Chir, V84, P348, DOI 10.2478/v10035-012-0058-4; TILLEY M, 1995, PARASITE IMMUNOL, V17, P459, DOI 10.1111/j.1365-3024.1995.tb00915.x; Widerstrom M, 2014, EMERG INFECT DIS, V20, P581, DOI 10.3201/eid2004.121415; Xiao LH, 2010, EXP PARASITOL, V124, P80, DOI 10.1016/j.exppara.2009.03.018	45	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195834	10.1371/journal.pone.0195834	http://dx.doi.org/10.1371/journal.pone.0195834			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672572	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800049
J	Schmitt, DL; Sundaram, A; Jeon, M; Luu, BT; An, S				Schmitt, Danielle L.; Sundaram, Anand; Jeon, Miji; Bao Tran Luu; An, Songon			Spatial alterations of De Novo purine biosynthetic enzymes by Akt-independent PDK1 signaling pathways	PLOS ONE			English	Article							MULTIENZYME COMPLEX; GLUCOSE-METABOLISM; LIVING CELLS; GROWTH; INHIBITION; PURINOSOME; ACTIVATION; S6K1	A macromolecular complex of the enzymes involved in human de novo purine biosynthesis, the purinosome, has been shown to consist of a core assembly to regulate the metabolic activity of the pathway. However, it remains elusive whether the core assembly itself can be selectively controlled in the cytoplasm without promoting the purinosome. Here, we reveal that pharmacological inhibition of the cytoplasmic activity of 3-phosphoinositide-dependent protein kinase 1 (PDK1) selectively promotes the formation of the core assembly, but not the purinosome, in cancer cells. However, alternative signaling cascades that are associated with the plasma membrane-bound PDK1 activity, including Akt-mediated cascades, regulate neither the core assembly nor the purinosome in our conditions. Along with immunofluorescence microscopy and a knock-down study against PDK1 using small interfering RNAs, we reveal that cytoplasmic PDK1-associated signaling pathways regulate subcellular colocalization of three enzymes that form the core assembly of the purinosome in an Akt-independent manner. Collectively, this study reveals a new mode of compartmentalization of purine biosynthetic enzymes controlled by spatially resolved signaling pathways.	[Schmitt, Danielle L.; Sundaram, Anand; Jeon, Miji; Bao Tran Luu; An, Songon] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA	University System of Maryland; University of Maryland Baltimore County	An, S (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21228 USA.	san@umbc.edu		Schmitt, Danielle/0000-0002-7343-2125; An, Songon/0000-0003-2189-7374	UMBC; NIH/NIGMS Training Grant [T32GM066706]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706, R01GM125981] Funding Source: NIH RePORTER	UMBC; NIH/NIGMS Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank UMBC for providing the start-up fund (to S.A). D.L.S., AS., and M.J. were funded in part by NIH/NIGMS Training Grant (T32GM066706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; An S, 2010, J BIOL CHEM, V285, P11093, DOI 10.1074/jbc.M110.101139; Arsenic R, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-82; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Biondi RM, 2001, EMBO J, V20, P4380, DOI 10.1093/emboj/20.16.4380; Deng YJ, 2012, J BIOL CHEM, V287, P36201, DOI 10.1074/jbc.M112.407056; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Finlay DK, 2009, J EXP MED, V206, P2441, DOI 10.1084/jem.20090219; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; Fyffe Chanse, 2013, Cancer Manag Res, V5, P271, DOI 10.2147/CMAR.S35026; Gagliardi PA, 2012, NEOPLASIA, V14, P719, DOI 10.1593/neo.12856; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Henderson JF, 1972, REGULATION PURINE BI; Jeon M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20348-7; Kohnhorst CL, 2017, J BIOL CHEM, V292, P9191, DOI 10.1074/jbc.M117.783050; Komander D, 2004, EMBO J, V23, P3918, DOI 10.1038/sj.emboj.7600379; Kyoung M, 2015, BIOCHEMISTRY-US, V54, P870, DOI 10.1021/bi501480d; McLeod HL, 2000, CLIN CANCER RES, V6, P2677; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Pearce LR, 2010, BIOCHEM J, V431, P245, DOI 10.1042/BJ20101024; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Schmitt DL, 2017, BIOCHEMISTRY-US, V56, P3184, DOI 10.1021/acs.biochem.7b00249; Schmitt DL, 2016, ACS CHEM BIOL, V11, P1917, DOI 10.1021/acschembio.6b00039; Scortegagna M, 2014, ONCOGENE, V33, P4330, DOI 10.1038/onc.2013.383; Waugh C, 2009, MOL CELL BIOL, V29, P5952, DOI 10.1128/MCB.00585-09; Xie ZH, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-77; Yamaoka T, 2001, J BIOL CHEM, V276, P21285, DOI 10.1074/jbc.M011103200; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Zhao H, 2015, J BIOL CHEM, V290, P6705, DOI 10.1074/jbc.M114.628701	31	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195989	10.1371/journal.pone.0195989	http://dx.doi.org/10.1371/journal.pone.0195989			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668719	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200072
J	Boraas, LC; Pineda, ET; Ahsan, T				Boraas, Liana C.; Pineda, Emma T.; Ahsan, Tabassum			Actin and myosin II modulate differentiation of pluripotent stem cells	PLOS ONE			English	Article							SHEAR-STRESS; CYTOSKELETAL TENSION; MATRIX ELASTICITY; GENE-EXPRESSION; BINDING; SHAPE; RHOA	Use of stem cell-based therapies in tissue engineering and regenerative medicine is hindered by efficient means of directed differentiation. For pluripotent stem cells, an initial critical differentiation event is specification to one of three germ lineages: endoderm, mesoderm, and ectoderm. Differentiation is known to be regulated by numerous extracellular and intracellular factors, but the role of the cytoskeleton during specification, or early differentiation, is still unknown. In these studies, we used agonists and antagonists to modulate actin polymerization and the actin-myosin molecular motor during spontaneous differentiation of embryonic stem cells in embryoid bodies. We found that inhibiting either actin polymerization or actin-myosin interactions led to a decrease in differentiation to the mesodermal lineage and an increase in differentiation to the endodermal lineage. Thus, targeting processes that regulate cytoskeletal tension may be effective in enhancing or inhibiting differentiation towards cells of the endodermal or mesodermal lineages, which include hepatocytes, islets, cardiomyocytes, endothelial cells, and osteocytes. Therefore, these fundamental findings demonstrate that modulation of the cytoskeleton may be useful in production for a range of cell-based therapies, including for liver, pancreatic, cardiac, vascular, and orthopedic applications.	[Boraas, Liana C.; Pineda, Emma T.; Ahsan, Tabassum] Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA; [Ahsan, Tabassum] RoosterBio Inc, Frederick, MD 21703 USA	Tulane University	Ahsan, T (corresponding author), Tulane Univ, Dept Biomed Engn, New Orleans, LA 70118 USA.; Ahsan, T (corresponding author), RoosterBio Inc, Frederick, MD 21703 USA.	taby.ahsan@gmail.com		Ahsan, Tabassum/0000-0001-8679-0346	National Institutes of Health [P20 GM103629]; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health #P20 GM103629 (TA). The NIH provided support in the form of salaries for authors [LCB, ETP, TA], but had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. RoosterBio Inc. is the current affiliation of the senior author but did not fund any part of this study.; This work was funded by the National Institutes of Health (#P20 GM103629). The authors have no conflict of interest to report.	Arnsdorf EJ, 2009, J CELL SCI, V122, P546, DOI 10.1242/jcs.036293; Bao X, 2016, NATURE BIOMEDICAL EN, V1; Boraas LC, 2016, SCI REP-UK, V6, DOI 10.1038/srep30814; Boraas LC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145084; BUBB MR, 1994, J BIOL CHEM, V269, P14869; Buxboim A, 2010, J CELL SCI, V123, P297, DOI 10.1242/jcs.041186; Cai YF, 2010, J CELL SCI, V123, P413, DOI 10.1242/jcs.058297; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Cooper G. M., 2000, CELL MOL APPROACH, DOI DOI 10.1007/978-1-4615-6484-3_4; Daniels BR, 2010, BIOPHYS J, V99, P3563, DOI 10.1016/j.bpj.2010.10.007; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Feng TS, 2010, STEM CELL REV REP, V6, P74, DOI 10.1007/s12015-010-9115-8; Fletcher DA, 2010, NATURE, V463, P485, DOI 10.1038/nature08908; FRANKE RP, 1984, NATURE, V307, P648, DOI 10.1038/307648a0; GODDETTE DW, 1985, BIOCHEM BIOPH RES CO, V128, P1087, DOI 10.1016/0006-291X(85)91051-4; Han YL, 2014, DRUG DISCOV TODAY, V19, P763, DOI 10.1016/j.drudis.2014.01.015; Helmke BP, 2000, CIRC RES, V86, P745, DOI 10.1161/01.RES.86.7.745; Heo J, 2005, BIOCHEM BIOPH RES CO, V332, P1061, DOI 10.1016/j.bbrc.2005.04.173; INGBER DE, 1993, J CELL SCI, V104, P613; ISHIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P871, DOI 10.1016/0006-291X(89)92189-X; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; Kurpinski K, 2006, P NATL ACAD SCI USA, V103, P16095, DOI 10.1073/pnas.0604182103; Liang GY, 2013, CELL STEM CELL, V13, P149, DOI 10.1016/j.stem.2013.07.001; Liedert A., 2005, MECHANOSENSITIVITY C; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; Luo W, 2011, ACTA BIOCH BIOPH SIN, V43, P210, DOI 10.1093/abbs/gmr004; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McKee C, 2017, TISSUE ENG A; Pineda ET, 2013, CELLS TISSUES ORGANS, V197, P399, DOI 10.1159/000346166; Pourati J, 1998, AM J PHYSIOL-CELL PH, V274, pC1283, DOI 10.1152/ajpcell.1998.274.5.C1283; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432; Sun YB, 2012, ANNU REV BIOPHYS, V41, P519, DOI 10.1146/annurev-biophys-042910-155306; Teramura T, 2012, BIOCHEM BIOPH RES CO, V417, P836, DOI 10.1016/j.bbrc.2011.12.052; Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228; Thomas CH, 2002, P NATL ACAD SCI USA, V99, P1972, DOI 10.1073/pnas.032668799; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Walker A, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1074; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; WATT FM, 1988, P NATL ACAD SCI USA, V85, P5576, DOI 10.1073/pnas.85.15.5576; Wolfe RP, 2013, BIOTECHNOL BIOENG, V110, P1231, DOI 10.1002/bit.24782; Wolfe RP, 2012, INTEGR BIOL-UK, V4, P1263, DOI 10.1039/c2ib20040f	44	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195588	10.1371/journal.pone.0195588	http://dx.doi.org/10.1371/journal.pone.0195588			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664925	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300022
J	Mbondji-Wonje, C; Dong, M; Wang, X; Zhao, JQ; Ragupathy, V; Sanchez, AM; Denny, TN; Hewlett, I				Mbondji-Wonje, Christelle; Dong, Ming; Wang, Xue; Zhao, Jiangqin; Ragupathy, Viswanath; Sanchez, Ana M.; Denny, Thomas N.; Hewlett, Indira			Distinctive variation in the U3R region of the 5 ' Long Terminal Repeat from diverse HIV-1 strains	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; CELLULAR TRANSCRIPTION FACTOR; BINDING PROTEINS; GENE-EXPRESSION; TYPE-1 SUBTYPES; FUNCTIONAL INTERACTIONS; DISEASE PROGRESSION; SEQUENCE ELEMENTS; NUCLEAR FACTOR	Functional mapping of the 5'LTR has shown that the U3 and the R regions (U3R) contain a cluster of regulatory elements involved in the control of HIV-1 transcription and expression. As the HIV-1 genome is characterized by extensive variability, here we aimed to describe mutations in the U3R from various HIV-1 clades and CRFs in order to highlight strain specific differences that may impact the biological properties of diverse HIV-1 strains. To achieve our purpose, the U3R sequence of plasma derived virus belonging to different clades (A1, B, C, D, F2) and recombinants (CRF02_AG, CRF01_AE and CRF22_01A1) was obtained using Illumina technology. Overall, the R region was very well conserved among and across different strains, while in the U3 region the average inter-strains nucleotide dissimilarity was up to 25%. The TAR hairpin displayed a strain-distinctive cluster of mutations affecting the bulge and the loop, but mostly the stem. Like in previous studies we found a TATAA motif in U3 promoter region from the majority of HIV-1 strains and a TAAAA motif in CRF01_AE; but also in LTRs from CRF22_01A1 isolates. Although LTRs from CRF22_01A1 specimens were assigned CRF01_AE, they contained two NF-kB sites instead of the single TFBS described in CRF01_AE. Also, as previously describe in clade C isolates, we found no C/EBP binding site directly upstream of the enhancer region in CRF22_01A1 specimens. In our study, one-third of CRF02_AG LTRs displayed three NF-kB sites which have been mainly described in clade C isolates. Overall, the number, location and binding patterns of potential regulatory elements found along the U3R might be specific to some HIV-1 strains such as clade F2, CRF02_AG, CRF01_AE and CRF22_01A1. These features may be worth consideration as they may be involved in distinctive regulation of HIV-1 transcription and replication by different and diverse infecting strains.	[Mbondji-Wonje, Christelle; Wang, Xue; Zhao, Jiangqin; Ragupathy, Viswanath; Hewlett, Indira] US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Mbondji-Wonje, Christelle] Univ Douala, Dept Mol Biol, Fac Med Pharm & Biomed Sci, Douala, Cameroon; [Dong, Ming] US Mil HIV Res Program, Silver Spring, MD USA; [Sanchez, Ana M.; Denny, Thomas N.] Duke Univ, Med Ctr, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Mbondji-Wonje, Christelle; Hewlett, Indira] US FDA, Mol Virol Lab, CBER, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA); Walter Reed Army Institute of Research (WRAIR); Duke University; US Food & Drug Administration (FDA)	Mbondji-Wonje, C; Hewlett, I (corresponding author), US FDA, Mol Virol Lab, Div Emerging & Transfus Transmitted Dis, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.; Mbondji-Wonje, C (corresponding author), Univ Douala, Dept Mol Biol, Fac Med Pharm & Biomed Sci, Douala, Cameroon.; Mbondji-Wonje, C; Hewlett, I (corresponding author), US FDA, Mol Virol Lab, CBER, Silver Spring, MD 20993 USA.	Christelle.mbondji@fda.hhs.gov; Indira.hewlett@fda.hhs.gov	mbondji, christelle/Q-3145-2019; Ragupathy, Viswanath/ABA-3444-2021	mbondji, christelle/0000-0001-7222-9849; Zhao, Jiangqin/0000-0003-4672-0735; Denny, Thomas/0000-0002-7364-8276	National Heart, Lung, and Blood Institute (NHLBI) [A-HL-12-002]; Division of AIDS/National Institute of Allergy and Infectious Diseases [AAI 17073, HHSN272201700061C]; NHLBI [A-HL-12-002]; NIAID/DAIDS [AAI 17073]; EQAPOL/Duke University (NIH/DAIDS) [HHSN272201700061C]	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Division of AIDS/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID/DAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); EQAPOL/Duke University (NIH/DAIDS)	This work was supported by the National Heart, Lung, and Blood Institute (NHLBI) (IAA No A-HL-12-002), https://www.nhlbi.nih.gov/; Division of AIDS/National Institute of Allergy and Infectious Diseases: IAA No AAI 17073; HHSN272201700061C, https://www.niaid.nih.goviabout/daids. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to acknowledge NHLBI (IAA No A-HL-12-002), NIAID/DAIDS (IAA No AAI 17073) for funding this project, EQAPOL/Duke University (NIH/DAIDS Contract No. HHSN272201700061C) for providing genetically diverse viral isolates and New-York University for providing plasma sample used to generate additional viral isolates for this project. The authors would also want to thank Corinna Lin, Andrew Hwang, Alex Sposito, Krishnakumar Devadas and Mohan Haleyurgirisetty for their help and revision of this manuscript.	Agyingi L, 2014, J MED VIROL, V86, P385, DOI 10.1002/jmv.23846; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; Argyropoulos C, 2004, GENES IMMUN, V5, P16, DOI 10.1038/sj.gene.6364034; Bachu M, 2012, J BIOL CHEM, V287, P44714, DOI 10.1074/jbc.M112.397158; Baeten JM, 2007, J INFECT DIS, V195, P1177, DOI 10.1086/512682; Bassuk AG, 1997, J VIROL, V71, P3563, DOI 10.1128/JVI.71.5.3563-3573.1997; Beerens N, 2000, NUCLEIC ACIDS RES, V28, P4130, DOI 10.1093/nar/28.21.4130; Beerens N, 2000, J VIROL, V74, P2227, DOI 10.1128/JVI.74.5.2227-2238.2000; Beerenwinkel N, 2011, CURR OPIN VIROL, V1, P413, DOI 10.1016/j.coviro.2011.07.008; BERKHOUT B, 1995, VIROLOGY, V207, P276, DOI 10.1006/viro.1995.1077; Berkhout B, 1996, PROG NUCLEIC ACID RE, V54, P1, DOI 10.1016/S0079-6603(08)60359-1; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Brigati C, 2003, FEMS MICROBIOL LETT, V220, P57, DOI 10.1016/S0378-1097(03)00067-3; Burdo TH, 2004, DNA CELL BIOL, V23, P261, DOI 10.1089/104454904773819842; Churchill MJ, 2001, AIDS RES HUM RETROV, V17, P1481, DOI 10.1089/08892220152644188; Colin L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019084; Courtney CR, 2016, AIDS RES HUM RETROV, V32, P381, DOI 10.1089/aid.2015.0286; Cron RQ, 2000, CLIN IMMUNOL, V94, P179, DOI 10.1006/clim.1999.4831; Dahiya S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088116; De Arellano ER, 2005, AIDS RES HUM RETROV, V21, P949, DOI 10.1089/aid.2005.21.949; De Baar MP, 2000, AIDS RES HUM RETROV, V16, P499; DIFAGAGNA FD, 1995, J VIROL, V69, P2765, DOI 10.1128/JVI.69.5.2765-2775.1995; Drosten C, 2006, CLIN CHEM, V52, P1258, DOI 10.1373/clinchem.2006.066498; Duverger A, 2013, J VIROL, V87, P2264, DOI 10.1128/JVI.01594-12; ELKHARROUBI A, 1994, J BIOL CHEM, V269, P19916; Estable MC, 2007, INT J BIOL SCI, V3, P318; Estable MC, 1996, J VIROL, V70, P4053, DOI 10.1128/JVI.70.6.4053-4062.1996; Estable MC, 1998, J VIROL, V72, P6465, DOI 10.1128/JVI.72.8.6465-6474.1998; Estable MC, 1999, J BIOMED SCI, V6, P320, DOI 10.1007/BF02253521; Forns X, 1997, P NATL ACAD SCI USA, V94, P13909, DOI 10.1073/pnas.94.25.13909; FRANZA BR, 1988, SCIENCE, V239, P1150, DOI 10.1126/science.2964084; GARCIA JA, 1989, EMBO J, V8, P765, DOI 10.1002/j.1460-2075.1989.tb03437.x; GAYNOR R, 1992, AIDS, V6, P347, DOI 10.1097/00002030-199204000-00001; GAYNOR RB, 1995, CURR TOP MICROBIOL, V193, P51; Gonzalez-Alba JM, 2011, J VIROL, V85, P10755, DOI 10.1128/JVI.00454-11; Guimaraes ML, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-19; Gustavson MD, 2004, MOL CARCINOGEN, V41, P125, DOI 10.1002/mc.20049; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; HENDERSON AJ, 1995, J VIROL, V69, P5337, DOI 10.1128/JVI.69.9.5337-5344.1995; HOLZMEISTER J, 1993, BIOCHEM BIOPH RES CO, V197, P1229, DOI 10.1006/bbrc.1993.2608; Hora B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157340; IGNATIUS SH, 1995, J VIROL, V69, P3584, DOI 10.1128/JVI.69.6.3584-3596.1995; Imai K, 2006, J BIOL CHEM, V281, P12495, DOI 10.1074/jbc.M511773200; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; JONES KA, 1988, GENE DEV, V2, P1101, DOI 10.1101/gad.2.9.1101; JONES KA, 1986, SCIENCE, V232, P755, DOI 10.1126/science.3008338; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Karn J, 1999, J MOL BIOL, V293, P235, DOI 10.1006/jmbi.1999.3060; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Keller M, 2009, AIDS, V23, P731, DOI 10.1097/QAD.0b013e328326f77f; Kilareski EM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-118; Kingsman SM, 1996, EUR J BIOCHEM, V240, P491, DOI 10.1111/j.1432-1033.1996.0491h.x; Kinoshita S, 1997, IMMUNITY, V6, P235, DOI 10.1016/S1074-7613(00)80326-X; Kirch HC, 1999, ONCOGENE, V18, P2728, DOI 10.1038/sj.onc.1202626; Kiwanuka N, 2010, JAIDS-J ACQ IMM DEF, V54, P180, DOI 10.1097/QAI.0b013e3181c98fc0; Kiwanuka N, 2009, AIDS, V23, P2479, DOI 10.1097/QAD.0b013e328330cc08; Kozaczynska K, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-59; Krebs F., 2001, HIV SEQUENCE COMPEND, P29; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KUNANUSONT C, 1995, LANCET, V345, P1078, DOI 10.1016/S0140-6736(95)90818-8; Kurosu T, 2002, MICROBIOL IMMUNOL, V46, P787, DOI 10.1111/j.1348-0421.2002.tb02766.x; Kurosu T, 2001, AIDS RES HUM RETROV, V17, P863, DOI 10.1089/088922201750252061; Leal E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011833; Li YJ, 2014, AIDS, V28, P521, DOI 10.1097/QAD.0000000000000125; Liu YJ, 2010, BIOMED PHARMACOTHER, V64, P672, DOI 10.1016/j.biopha.2010.09.007; Liu Y, 2009, FUTURE MICROBIOL, V4, P299, DOI 10.2217/FMB.09.4; Liu YZ, 1997, BIOCHEM J, V322, P155, DOI 10.1042/bj3220155; Madge B., 2009, ENCY CANC, P947; MARKOVITZ DM, 1992, J VIROL, V66, P3961, DOI 10.1128/JVI.66.6.3961-3965.1992; McAllister JJ, 2000, VIROLOGY, V274, P262, DOI 10.1006/viro.2000.0476; MERIKA M, 1993, MOL CELL BIOL, V13, P3999, DOI 10.1128/MCB.13.7.3999; MONDAL D, 1994, J MOL NEUROSCI, V5, P241, DOI 10.1007/BF02736725; Montano MA, 1996, P NATL ACAD SCI USA, V93, P12376, DOI 10.1073/pnas.93.22.12376; Montano MA, 1997, J VIROL, V71, P8657, DOI 10.1128/JVI.71.11.8657-8665.1997; MOSES AV, 1994, J VIROL, V68, P298, DOI 10.1128/JVI.68.1.298-307.1994; Naghavi MH, 1999, AIDS RES HUM RETROV, V15, P1293, DOI 10.1089/088922299310197; Naghavi MH, 2001, J GEN VIROL, V82, P547, DOI 10.1099/0022-1317-82-3-547; Nonnemacher MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150835; Nonnemacher MR, 2004, J NEUROIMMUNOL, V157, P39, DOI 10.1016/j.jneuroim.2004.08.021; Ou S-HI, 1995, THE RETROVIRIDAE, P97; OU SHI, 1994, J VIROL, V68, P7188, DOI 10.1128/JVI.68.11.7188-7199.1994; Pai NP, 2012, JAIDS-J ACQ IMM DEF, V59, P382, DOI 10.1097/QAI.0b013e31824a0628; Palm AA, 2015, AIDS RES HUM RETROV, V31, P938, DOI [10.1089/aid.2015.0073, 10.1089/AID.2015.0073]; PALMER S, 1993, CLIN EXP IMMUNOL, V93, P344, DOI 10.1111/j.1365-2249.1993.tb08183.x; Panagoulias I, 2013, BLOOD, V122, DOI 10.1182/blood.V122.21.3477.3477; Pereira LA, 2002, J BIOMED SCI, V9, P68; Pereira LA, 2000, NUCLEIC ACIDS RES, V28, P663, DOI 10.1093/nar/28.3.663; PERKINS ND, 1994, J VIROL, V68, P6820, DOI 10.1128/JVI.68.10.6820-6823.1994; Powell RLR, 2009, JAIDS-J ACQ IMM DEF, V50, P84, DOI 10.1097/QAI.0b013e31818d5a40; Qu D, 2016, SCI REP-UK, V6, DOI 10.1038/srep34532; Ragupathy V, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-185; Rangsin R, 2007, AIDS, V21, pS39, DOI 10.1097/01.aids.0000299409.29528.23; Rodriguez MA, 2007, AIDS RES HUM RETROV, V23, P1428, DOI 10.1089/aid.2007.0152; ROEBUCK KA, 1993, J CLIN INVEST, V92, P1336, DOI 10.1172/JCI116707; Romanchikova N, 2003, IMMUNOBIOLOGY, V208, P361, DOI 10.1078/0171-2985-00283; Ross HL, 2001, J VIROL, V75, P1842, DOI 10.1128/JVI.75.4.1842-1856.2001; Ruocco MR, 1996, J BIOL CHEM, V271, P22479, DOI 10.1074/jbc.271.37.22479; Sanchez AM, 2014, J IMMUNOL METHODS, V409, P117, DOI 10.1016/j.jim.2014.01.004; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Schwartz C, 2000, J VIROL, V74, P65, DOI 10.1128/JVI.74.1.65-73.2000; Schwartz C, 1997, NUCLEIC ACIDS RES, V25, P1177, DOI 10.1093/nar/25.6.1177; Shah S, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-92; SHERIDAN PL, 1995, GENE DEV, V9, P2090, DOI 10.1101/gad.9.17.2090; Shiino T, 2014, C RETR OPP INF CROI; Sierra M, 2005, GENETICS EVOLUTION, V5, P209, DOI [10.1016/j.meegid.2004.07.010, DOI 10.1016/J.MEEGID.2004.07.010]; Stojanova A, 2004, J CELL BIOCHEM, V92, P400, DOI 10.1002/jcb.20065; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Terme JM, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-81; TESMER VM, 1993, P NATL ACAD SCI USA, V90, P7298, DOI 10.1073/pnas.90.15.7298; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; van Opijnen T, 2004, J VIROL, V78, P3675, DOI 10.1128/JVI.78.7.3675-3683.2004; VanLint C, 1997, J VIROL, V71, P6113, DOI 10.1128/JVI.71.8.6113-6127.1997; VANLINT C, 1991, J VIROL, V65, P7066, DOI 10.1128/JVI.65.12.7066-7072.1991; Vemula SV, 2015, VIRUSES-BASEL, V7, P543, DOI 10.3390/v7020543; Verhoef K, 1999, J VIROL, V73, P1331, DOI 10.1128/JVI.73.2.1331-1340.1999; Verma A, 2016, J VIROL, V90, P7046, DOI 10.1128/JVI.00308-16; Vrolijk MM, 2008, NUCLEIC ACIDS RES, V36, P4352, DOI 10.1093/nar/gkn364; WASYLYK B, 1993, EUR J BIOCHEM, V211, P7, DOI 10.1111/j.1432-1033.1993.tb19864.x; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; YAMAMOTO K, 1991, NUCLEIC ACIDS RES, V19, P6107, DOI 10.1093/nar/19.22.6107; YANG ZY, 1993, NUCLEIC ACIDS RES, V21, P2831, DOI 10.1093/nar/21.12.2831; Zhao JQ, 2012, JAIDS-J ACQ IMM DEF, V60, P344, DOI 10.1097/QAI.0b013e318258c7e3; Zhao JQ, 2010, AIDS RES HUM RETROV, V26, P1033, DOI 10.1089/aid.2009.0197; Zhao JR, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002449; ZOUMPOURLIS V, 1994, ONCOL REP, V1, P397	126	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195661	10.1371/journal.pone.0195661	http://dx.doi.org/10.1371/journal.pone.0195661			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664930	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300025
J	Ryu, YJ; Choi, YH; Cheon, JE; Park, JE; Kim, WS; Kim, IO				Ryu, Young Jin; Choi, Young Hun; Cheon, Jung-Eun; Park, Ji Eun; Kim, Woo Sun; Kim, In-One			Effect of arm position, presence of medical devices, and off-centering during acquisition of scout image on automatic tube voltage selection and current modulation in pediatric chest CT	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY EXAMINATIONS; DIAGNOSTIC REFERENCE LEVELS; RADIATION-EXPOSURE; NATIONWIDE SURVEY; MULTIDETECTOR CT; OPTIMIZATION; KILOVOLTAGE; ANGIOGRAPHY; CHILDREN; QUALITY	Purpose To evaluate the patients' morphologic factors affecting radiation dose in pediatric chest CT. Materials and methods From November 2013 to May 2015, 315 pediatric chest CT scans were obtained using a CT scanner, and classified into 5 groups according to the patients' age. For each age group, the chest CT scans were divided into two subgroups. A cut-off value used was the 75th percentile of size-specific dose estimates (SSDE), age-specific diagnostic reference level (DRL): less than the 75th percentile of SSDE (Group A, n = 238) and greater than the 75th percentile of SSDE (Group B, n = 77). All CT scans were performed with the same protocol using automatic tube voltage selection and current modulation techniques. The morphologic factors of the patients including body mass index (BMI), arm angles, presence of medical devices in the scan field, and degree of off-centering within the CT gantry were compared between groups A and B. Results Group B showed narrower arm angles on scout and coronal reformatted images, higher frequency of the presence of devices and higher BMI than group A (P < 0.001, P < 0.001; P = 0.018, and P < 0.001, respectively). In multivariate analysis, narrower arm angles, the presence of devices on the scout images and higher BMI were independently associated with higher SSDE (P = 0.001, P = 0.037, and P < 0.001, respectively). Conclusions During acquisition of the scout images, arms-down position and the presence of medical devices were associated with a high radiation dose above age-specific DRLs in pediatric chest CT, regardless of repositioning before the actual scanning. In addition, off-centering had no clinical impact on radiation dose in the routine practice.	[Ryu, Young Jin; Choi, Young Hun; Cheon, Jung-Eun; Kim, Woo Sun; Kim, In-One] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea; [Ryu, Young Jin; Choi, Young Hun; Cheon, Jung-Eun; Kim, Woo Sun; Kim, In-One] Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea; [Cheon, Jung-Eun; Kim, Woo Sun; Kim, In-One] Seoul Natl Univ, Inst Radiat Med, Med Res Ctr, Seoul, South Korea; [Park, Ji Eun] Kyung Hee Univ, Kyung Hee Univ Hosp, Grad Sch, Dept Radiol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Kyung Hee University; Kyung Hee University Hospital	Choi, YH (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea.; Choi, YH (corresponding author), Seoul Natl Univ, Dept Radiol, Coll Med, Seoul, South Korea.	iater@snu.ac.kr	Choi, Young Hun/O-3282-2015	Choi, Young Hun/0000-0002-1842-9062				Boone J, 2013, 204 AAPM; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brink M, 2008, RADIOLOGY, V249, P661, DOI 10.1148/radiol.2492080169; Cody DD, 2014, PEDIATR RADIOL, V44, P427, DOI 10.1007/s00247-014-3140-8; Coursey C, 2008, AM J ROENTGENOL, V190, pW54, DOI 10.2214/AJR.07.2017; Dougeni E, 2012, EUR J RADIOL, V81, pE665, DOI 10.1016/j.ejrad.2011.05.025; Fanucci E, 2007, EMERG RADIOL, V13, P251, DOI 10.1007/s10140-006-0554-0; Geleijns J, 2010, PEDIATR RADIOL, V40, P1744, DOI 10.1007/s00247-010-1808-2; Goo HW, 2012, KOREAN J RADIOL, V13, P1, DOI 10.3348/kjr.2012.13.1.1; Granata C, 2015, PEDIATR RADIOL, V45, P695, DOI 10.1007/s00247-014-3201-z; Hough DM, 2012, AM J ROENTGENOL, V199, P1070, DOI 10.2214/AJR.12.8637; Hwang JY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002146; Kaasalainen T, 2014, AM J ROENTGENOL, V203, P123, DOI 10.2214/AJR.13.12028; Kalra MK, 2004, RADIOLOGY, V233, P649, DOI 10.1148/radiol.2333031150; Karlo C, 2011, EMERG RADIOL, V18, P285, DOI 10.1007/s10140-011-0948-5; Kuo F, 2012, PEDIATR RADIOL, V42, P508, DOI 10.1007/s00247-011-2292-z; Lee CH, 2008, RADIOGRAPHICS, V28, P1451, DOI 10.1148/rg.285075075; Lee KH, 2012, RADIOLOGY, V265, P437, DOI 10.1148/radiol.12112434; Li JH, 2007, AM J ROENTGENOL, V188, P547, DOI 10.2214/AJR.06.0370; Matsubara K, 2009, AM J ROENTGENOL, V192, P862, DOI 10.2214/AJR.08.1472; Pearce MS, 2012, LANCET, V380, P499, DOI 10.1016/S0140-6736(12)60815-0; Pearce MS, 2011, J MED IMAG RADIAT ON, V55, P107, DOI 10.1111/j.1754-9485.2011.02240.x; Shrimpton PC, 2006, BRIT J RADIOL, V79, P968, DOI 10.1259/bjr/93277434; Siegel MJ, 2013, RADIOLOGY, V268, P538, DOI 10.1148/radiol.13122438; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Soderberg M, 2016, RADIAT PROT DOSIM, V169, P84, DOI 10.1093/rpd/ncv459; Strauss KJ, 2017, RADIOLOGY, V284, P219, DOI 10.1148/radiol.2017161530; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091; Takei Y, 2016, PEDIATR RADIOL, V46, P280, DOI 10.1007/s00247-015-3474-x; Verdun FR, 2008, EUR RADIOL, V18, P1980, DOI 10.1007/s00330-008-0963-4; Winklehner A, 2011, INVEST RADIOL, V46, P767, DOI 10.1097/RLI.0b013e3182266448	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195807	10.1371/journal.pone.0195807	http://dx.doi.org/10.1371/journal.pone.0195807			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664918	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300033
J	Sharma, NK; Sharma, K; Singh, R; Sharma, SK; Anand, A				Sharma, Neel Kamal; Sharma, Kaushal; Singh, Ramandeep; Sharma, Suresh Kumar; Anand, Akshay			CCL2 single nucleotide polymorphism of rs1024611 implicates prominence of inflammatory cascade by univariate modeling in Indian AMD	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOKINE RECEPTOR CX3CR1; GENE REGULATORY REGION; MACULAR DEGENERATION; SERUM-LEVELS; DISEASE; RISK	Background The role of chemotactic protein CCL2/MCP-1 has been widely explored in age related macular degeneration (AMD) patients as well as animal models through our previous studies. Aim Aim of the study was to examine the association of another variance of CCL2, rs1024611 in pathophysiology of AMD. Methods This particular SNP has been found to be involved in inflammatory processes in various diseases. Total 171 subjects were recruited in the study with all demographic details by administering a standard questionnaire. SNP analysis was performed with TaqMan assay. Linear univariate and ANCOVA modeling was performed to show the interaction of rs1024611 with another SNP variant of CCL-2/CCR-2 (rs4586 and rs1799865) and impact of individual genotypes on CCL-2 expression in the context of AMD pathology. Results Results showed that both heterozygous (AG, p = 0.01) and homozygous (GG, p = 0.0001) genotypes are associated with AMD pathology. Allele frequency analysis showed that 'G' allele is frequent in AMD patients as compared to controls (p = 0.0001). Moreover, AMD patients who smoke were found to be associated with 'AG' genotype (p = 0.0145). Although, we did not find any significant interaction between the SNP variants by linear univariate analysis but results show the effect of 'CT' genotype on 'TT' genotype in rs4586 by considering rs1024611 as covariate. Conclusion Based on these results it is imperative that CCL2 mediated pathology may be associated with AMD.	[Sharma, Neel Kamal; Sharma, Kaushal; Anand, Akshay] Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India; [Sharma, Neel Kamal] NEI, Neurobiol Neurodegenerat & Repair Lab, NIH, Bethesda, MD 20892 USA; [Sharma, Kaushal; Sharma, Suresh Kumar] Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh, India; [Singh, Ramandeep] Post Grad Inst Med Educ & Res, Dept Ophthalmol, Chandigarh, India; [Sharma, Suresh Kumar] Panjab Univ, Dept Stat, Chandigarh, India	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Panjab University; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Panjab University	Anand, A (corresponding author), Post Grad Inst Med Educ & Res, Dept Neurol, Neurosci Res Lab, Chandigarh, India.; Sharma, SK (corresponding author), Panjab Univ, Ctr Syst Biol & Bioinformat, Chandigarh, India.; Sharma, SK (corresponding author), Panjab Univ, Dept Stat, Chandigarh, India.	ssharma643@yahoo.co.in; akshay1anand@rediffmail.com	anand, Akshay/AAI-1586-2019	Anand, Akshay/0000-0001-9003-3532	Department of Science and Technology, New Delhi, India [SR/SO/HS-109/205]	Department of Science and Technology, New Delhi, India(Department of Science & Technology (India))	Funding was provided by Department of Science and Technology, New Delhi, India (F.No. SR/SO/HS-109/205 dated 1-05-2007). Funder had no role in study design, data collection and analysis of data.	Al-Odat I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103443; Allina J, 2011, J IMMUNOTOXICOL, V8, P258, DOI 10.3109/1547691X.2011.589412; Ambati J, 2003, NAT MED, V9, P1390, DOI 10.1038/nm950; Anand A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04114; Anand A, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/365046; Anand A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049905; Cho ML, 2004, AUTOIMMUNITY, V37, P77, DOI 10.1080/08916930310001609446; Combadiere C, 2007, J CLIN INVEST, V117, P2920, DOI 10.1172/JCI31692; Daoudi M, 2004, J BIOL CHEM, V279, P19649, DOI 10.1074/jbc.M313457200; Despriet DDG, 2008, INVEST OPHTH VIS SCI, V49, P364, DOI 10.1167/iovs.07-0656; Fenoglio C, 2004, NEUROBIOL AGING, V25, P1169, DOI 10.1016/j.neurobiolaging.2003.11.008; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gonzalez E, 2002, P NATL ACAD SCI USA, V99, P13795, DOI 10.1073/pnas.202357499; Jibiki T, 2001, ARTHRITIS RHEUM, V44, P2211, DOI 10.1002/1529-0131(200109)44:9<2211::AID-ART375>3.0.CO;2-A; Kim MP, 2007, ATHEROSCLEROSIS, V193, P366, DOI 10.1016/j.atherosclerosis.2006.06.029; Ma WX, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007945; McDermott DH, 2005, CIRCULATION, V112, P1113, DOI 10.1161/CIRCULATIONAHA.105.543579; Pham MHT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049498; Pola R, 2004, EXP GERONTOL, V39, P1249, DOI 10.1016/j.exger.2004.05.001; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Raoul W, 2008, J NEUROIMMUNOL, V198, P56, DOI 10.1016/j.jneuroim.2008.04.014; Raoul W, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-87; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Sharma K, 2015, ANN NEUROSCI, V22, P232, DOI 10.5214/ans.0972.7531.220408; Sharma K, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00151; Sharma NK, 2013, GENE, V523, P106, DOI 10.1016/j.gene.2013.03.052; Sharma NK, 2012, CURR NEUROVASC RES, V9, P256; Sharma NK, 2012, DNA CELL BIOL, V31, P1618, DOI 10.1089/dna.2012.1786; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651	29	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0193423	10.1371/journal.pone.0193423	http://dx.doi.org/10.1371/journal.pone.0193423			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664944	gold, Green Published, Green Submitted			2022-12-26	WOS:000430262300004
J	Jurgens, T; Hohmann, V; Buchner, A; Nogueira, W				Juergens, Tim; Hohmann, Volker; Buechner, Andreas; Nogueira, Waldo			The effects of electrical field spatial spread and some cognitive factors on speech-in-noise performance of individual cochlear implant users-A computer model study	PLOS ONE			English	Article							ELECTRODE DISCRIMINATION; SPECTRAL RIPPLE; RECEPTION THRESHOLD; NORMAL-HEARING; TUNING CURVES; RECOGNITION; PERCEPTION; RESOLUTION; EXCITATION; INTELLIGIBILITY	The relation of the individual speech-in-noise performance differences in cochlear implant (CI) users to underlying physiological factors is currently poorly understood. This study approached this research question by a step-wise individualization of a computer model of speech intelligibility mimicking the details of CI signal processing and some details of the physiology present in CI users. Two factors, the electrical field spatial spread and internal noise (as a coarse model of the individual cognitive performance) were incorporated. Internal representations of speech-in-noise mixtures calculated by the model were classified using an automatic speech recognizer backend employing Hidden Markov Models with a Gaussian probability distribution. One-dimensional electric field spatial spread functions were inferred from electrical field imaging data of 14 CI users. Simplified assumptions of homogenously distributed auditory nerve fibers along the cochlear array and equal distance between electrode array and nerve tissue were assumed in the model. Internal noise, whose standard deviation was adjusted based on either anamnesis data, or text-reception-threshold data, or a combination thereof, was applied to the internal representations before classification. A systematic model evaluation showed that predicted speech-reception-thresholds (SRTs) in stationary noise improved (decreased) with decreasing internal noise standard deviation and with narrower electric field spatial spreads. The model version that was individualized to actual listeners using internal noise alone (containing average spatial spread) showed significant correlations to measured SRTs, reflecting the high correlation of the text-reception threshold data with SRTs. However, neither individualization to spatial spread functions alone, nor a combined individualization based on spatial spread functions and internal noise standard deviation did produce significant correlations with measured SRTs.	[Juergens, Tim; Hohmann, Volker] Carl von Ossietzky Univ Oldenburg, Med Phys, Cluster Excellence Hearing4all, Oldenburg, Germany; [Juergens, Tim; Hohmann, Volker] Carl von Ossietzky Univ Oldenburg, Forschungszentrum Neurosensorik, Oldenburg, Germany; [Buechner, Andreas; Nogueira, Waldo] Hannover Med Sch, Cluster Excellence Hearing4all, Hannover, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; Hannover Medical School	Jurgens, T (corresponding author), Carl von Ossietzky Univ Oldenburg, Med Phys, Cluster Excellence Hearing4all, Oldenburg, Germany.; Jurgens, T (corresponding author), Carl von Ossietzky Univ Oldenburg, Forschungszentrum Neurosensorik, Oldenburg, Germany.	tim.juergens@uni-oldenburg.de	Jürgens, Tim/AAO-8994-2021	Jürgens, Tim/0000-0002-1481-6997	DFG Cluster of Excellence [EXC 1077/1]	DFG Cluster of Excellence(German Research Foundation (DFG))	This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4all" (http://www.hearing4all.eu). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the DFG Cluster of Excellence EXC 1077/1 "Hearing4a11". Special thanks to Nils Schreiber for performing the FADE model predictions. The authors appreciate thorough and constructive feedback by Manuel Malmierca, Arne Leijon, and one anonymous reviewer on an earlier version of the manuscript.	Abbas PJ, 2004, AUDIOL NEURO-OTOL, V9, P203, DOI 10.1159/000078390; Anderson ES, 2012, J ACOUST SOC AM, V132, P3925, DOI 10.1121/1.4763999; Anderson ES, 2011, J ACOUST SOC AM, V130, P364, DOI 10.1121/1.3589255; Berenstein CK, 2010, HEARING RES, V270, P28, DOI 10.1016/j.heares.2010.10.001; Biesheuvel JD, 2016, EAR HEARING, V37, P572, DOI 10.1097/AUD.0000000000000296; Bingabr M, 2008, HEARING RES, V241, P73, DOI 10.1016/j.heares.2008.04.012; Blamey P, 2013, AUDIOL NEURO-OTOL, V18, P36, DOI 10.1159/000343189; Boex C, 2003, J ACOUST SOC AM, V114, P2058, DOI 10.1121/1.1610452; Cohen LT, 2003, HEARING RES, V179, P72, DOI 10.1016/S0378-5955(03)00096-0; Collins LM, 1997, J ACOUST SOC AM, V101, P440, DOI 10.1121/1.417989; Firszt JB, 2004, EAR HEARING, V25, P375, DOI 10.1097/01.AUD.0000134552.22205.EE; Fredelake S, 2012, HEARING RES, V287, P76, DOI 10.1016/j.heares.2012.03.005; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2005, JARO-J ASSOC RES OTO, V6, P180, DOI 10.1007/s10162-005-5061-6; Hamacher V., 2003, THESIS RTWH AACHEN; Hanekom JJ, 1998, J ACOUST SOC AM, V104, P2372, DOI 10.1121/1.423772; Haumann S, 2012, AUDIOL RES, V2, P55, DOI 10.4081/audiores.2012.e12; Henry BA, 2005, J ACOUST SOC AM, V118, P1111, DOI 10.1121/1.1944567; Henry BA, 2003, J ACOUST SOC AM, V113, P2861, DOI 10.1121/1.1561900; Henry BA, 2000, J ACOUST SOC AM, V108, P1269, DOI 10.1121/1.1287711; Hughes ML, 2008, EAR HEARING, V29, P435, DOI 10.1097/AUD.0b013e31816a0d3d; Jurgens T, 2009, J ACOUST SOC AM, V126, P2635, DOI 10.1121/1.3224721; Khan AM, 2005, ANN OTO RHINOL LARYN, V114, P381, DOI 10.1177/000348940511400508; Kollmeier B, 2016, TRENDS HEAR, V20; Lazard DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048739; Litvak LM, 2007, J ACOUST SOC AM, V122, P982, DOI 10.1121/1.2749413; Long CJ, 2014, JARO-J ASSOC RES OTO, V15, P293, DOI 10.1007/s10162-013-0437-5; Nelson DA, 2011, J ACOUST SOC AM, V129, P3916, DOI 10.1121/1.3583503; Nogueira W, 2005, EURASIP J APPL SIG P, V2005, P3044, DOI 10.1155/ASP.2005.3044; Nogueira W, 2007, P INT, P2537; Nogueira W, 2015, BIOMEDICAL TECHNOLOG; Nogueira W, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00084; Schadler MR, 2015, INT J AUDIOL, V54, P100, DOI 10.3109/14992027.2015.1061708; Stadler S, 2009, EURASIP J ADV SIG PR, DOI 10.1155/2009/175243; Vanpoucke FJ, 2004, IEEE T BIO-MED ENG, V51, P2174, DOI 10.1109/TBME.2004.836518; Wagener K.C., 1999, Z AUDIOL, V38, P4; YOUNG S, 1995, HTK BOOK; Yousefian N, 2012, J ACOUST SOC AM, V132, P3399, DOI 10.1121/1.4754539; Zamaninezhad L, 2017, HEARING RES, V344, P50, DOI 10.1016/j.heares.2016.10.023; Zekveld AA, 2007, J SPEECH LANG HEAR R, V50, P576, DOI 10.1044/1092-4388(2007/040); Zwolan TA, 1997, J ACOUST SOC AM, V102, P3673, DOI 10.1121/1.420401	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0193842	10.1371/journal.pone.0193842	http://dx.doi.org/10.1371/journal.pone.0193842			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652892	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000430026900004
J	Zwitserlood, P; Boltel, J; Hofmann, R; Meier, CC; Dobel, C				Zwitserlood, Pienie; Boeltel, Jens; Hofmann, Reinhild; Meier, Claudine C.; Dobel, Christian			Seeing for speaking: Semantic and lexical information provided by briefly presented, naturalistic action scenes	PLOS ONE			English	Article							CASCADE MODEL; PICTURE; ACCESS; ONSET; INTERFERENCE; RECOGNITION; ACTIVATION; ENGLISH; OBJECTS; NAMES	At the interface between scene perception and speech production, we investigated how rapidly action scenes can activate semantic and lexical information. Experiment 1 examined how complex action-scene primes, presented for 150 ms, 100 ms, or 50 ms and subsequently masked, influenced the speed with which immediately following action-picture targets are named. Prime and target actions were either identical, showed the same action with different actors and environments, or were unrelated. Relative to unrelated primes, identical and same-action primes facilitated naming the target action, even when presented for 50 ms. In Experiment 2, neutral primes assessed the direction of effects. Identical and same-action scenes induced facilitation but unrelated actions induced interference. In Experiment 3, written verbs were used as targets for naming, preceded by action primes. When target verbs denoted the prime action, clear facilitation was obtained. In contrast, interference was observed when target verbs were phonologically similar, but otherwise unrelated, to the names of prime actions. This is clear evidence for word-form activation by masked action scenes. Masked action pictures thus provide conceptual information that is detailed enough to facilitate apprehension and naming of immediately following scenes. Masked actions even activate their word-form information-as is evident when targets are words. We thus show how language production can be primed with briefly flashed masked action scenes, in answer to long-standing questions in scene processing.	[Zwitserlood, Pienie; Boeltel, Jens; Meier, Claudine C.] Univ Munster, Inst Psychol, Munster, Germany; [Zwitserlood, Pienie; Boeltel, Jens] Univ Munster, Otto Creutzfeldt Ctr Cognit Neurosci, Munster, Germany; [Hofmann, Reinhild] Univ Munster, Clin Phoniatr & Pediat Audiol, Munster, Germany; [Dobel, Christian] Univ Jena, Med Fac, Dept Otorhinolaryngol, Jena, Germany	University of Munster; University of Munster; University of Munster; Friedrich Schiller University of Jena	Zwitserlood, P (corresponding author), Univ Munster, Inst Psychol, Munster, Germany.; Zwitserlood, P (corresponding author), Univ Munster, Otto Creutzfeldt Ctr Cognit Neurosci, Munster, Germany.	zwitser@uni-muenster.de		Zwitserlood, Pienie/0000-0003-2166-5397; Bolte, Jens/0000-0002-8128-0520; Hofmann, Reinhild/0000-0001-8630-3528	Deutsche Forschungsgemeinschaft [711/4-1]; University of Muenster	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); University of Muenster	This study was supported by Deutsche Forschungsgemeinschaft Project Do 711/4-1 to CD and the Open Access Publication Fund of the University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldassano C, 2016, BIORXIV, DOI [10.1101/057406, DOI 10.1101/057406]; BIEDERMAN I, 1993, J EXP PSYCHOL HUMAN, V19, P1162, DOI 10.1037/0096-1523.19.6.1162; Bogka N, 2003, EUR J COGN PSYCHOL, V15, P371, DOI 10.1080/09541440303607; Braun J, 2003, TRENDS COGN SCI, V7, P7, DOI 10.1016/S1364-6613(02)00008-6; Chabal S, 2015, J EXP PSYCHOL GEN, V144, P539, DOI 10.1037/xge0000075; Crouzet SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051471; Damian MF, 2009, LANG COGNITIVE PROC, V24, P685, DOI 10.1080/01690960802351260; Dobel C, 2007, ACTA PSYCHOL, V125, P129, DOI 10.1016/J.ACTPSY.2006.07.004; DREWS E, 1995, J EXP PSYCHOL HUMAN, V21, P1098, DOI 10.1037/0096-1523.21.5.1098; Glanemann R, 2008, THESIS; Glanemann R, 2016, PSYCHON B REV, V23, P1566, DOI 10.3758/s13423-016-1004-y; Gleitman LR, 2007, J MEM LANG, V57, P544, DOI 10.1016/j.jml.2007.01.007; Griffin ZM, 2000, PSYCHOL SCI, V11, P274, DOI 10.1111/1467-9280.00255; Hafri A, 2013, J EXP PSYCHOL GEN, V142, P880, DOI 10.1037/a0030045; Henderson J. M., 2004, INTERFACE LANGUAGE V, P1, DOI DOI 10.4324/9780203488430; JOLICOEUR P, 1984, COGNITIVE PSYCHOL, V16, P243, DOI 10.1016/0010-0285(84)90009-4; JONIDES J, 1988, PERCEPT PSYCHOPHYS, V43, P346, DOI 10.3758/BF03208805; Kirchner H, 2006, VISION RES, V46, P1762, DOI 10.1016/j.visres.2005.10.002; Kreysa H, 2010, EVENT REPRESENTATION, P189; Kreysa H, 2004, THESIS; Larson A, 2012, 12 ANN M VIS SCI SOC; Levelt W., 1989, SPEAKING INTENTION A; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1991, PSYCHOL REV, V98, P122, DOI 10.1037/0033-295X.98.1.122; Li FF, 2002, P NATL ACAD SCI USA, V99, P9596, DOI 10.1073/pnas.092277599; Loschky LC, 2010, VIS COGN, V18, P513, DOI 10.1080/13506280902937606; Mace MJM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005927; McQueen JM, 2014, ATTEN PERCEPT PSYCHO, V76, P190, DOI 10.3758/s13414-013-0560-8; Meyer AS, 2007, MEM COGNITION, V35, P494, DOI 10.3758/BF03193289; Meyer AS, 2003, MIND'S EYE: COGNITIVE AND APPLIED ASPECTS OF EYE MOVEMENT RESEARCH, P253, DOI 10.1016/B978-044451020-4/50015-3; Moore CM, LIMITS ATTENTION TEM; Morsella E, 2002, J EXP PSYCHOL LEARN, V28, P555, DOI 10.1037//0278-7393.28.3.555; Mousikou P, 2010, EUR J COGN PSYCHOL, V22, P725, DOI 10.1080/09541440903052798; Navarrete E, 2005, J MEM LANG, V53, P359, DOI 10.1016/j.jml.2005.05.001; Neely J. H., 1991, BASIC PROCESSES READ, P264; Oliva A, 2006, PROG BRAIN RES, V155, P23, DOI 10.1016/S0079-6123(06)55002-2; Oliva Aude, 2005, P251, DOI 10.1016/B978-012375731-9/50045-8; Papafragou A, 2015, CONCEPTUAL MIND: NEW DIRECTIONS IN THE STUDY OF CONCEPTS, P327; Potter MC, 2014, ATTEN PERCEPT PSYCHO, V76, P270, DOI 10.3758/s13414-013-0605-z; POTTER MC, 1976, J EXP PSYCHOL-HUM L, V2, P509, DOI 10.1037/0278-7393.2.5.509; Potter MC, 2004, J EXP PSYCHOL HUMAN, V30, P478, DOI 10.1037/0096-1523.30.3.478; Rosch E, 2004, COGNITIVE PSYCHOL KE, P448; Schiller NO, 2004, J MEM LANG, V50, P477, DOI 10.1016/j.jml.2004.02.004; SPERBER RD, 1979, MEM COGNITION, V7, P339, DOI 10.3758/BF03196937; TANAKA JW, 1991, COGNITIVE PSYCHOL, V23, P457, DOI 10.1016/0010-0285(91)90016-H; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2001, EUR J NEUROSCI, V14, P869, DOI 10.1046/j.0953-816x.2001.01717.x; Timmer K, 2012, BRAIN RES, V1483, P39, DOI 10.1016/j.brainres.2012.09.004; Van den Bussche E, 2009, EXP PSYCHOL, V56, P295, DOI 10.1027/1618-3169.56.5.295; van der Meulen FF, 2001, MEM COGNITION, V29, P512, DOI 10.3758/BF03196402; Vorberg D, 2003, P NATL ACAD SCI USA, V100, P6275, DOI 10.1073/pnas.0931489100; Wu CT, 2015, J COGNITIVE NEUROSCI, V27, P141, DOI 10.1162/jocn_a_00701; Wundt W., 1970, LANGUAGE PSYCHOL HIS, P20; Wurm MF, 2012, NEUROIMAGE, V59, P1551, DOI 10.1016/j.neuroimage.2011.08.038; Zwitserlood P, 1996, LANG COGNITIVE PROC, V11, P589, DOI 10.1080/016909696386980	55	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194762	10.1371/journal.pone.0194762	http://dx.doi.org/10.1371/journal.pone.0194762			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652939	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900010
J	Lee, J; Arisi, I; Puxeddu, E; Mramba, LK; Amicosante, M; Swaisgood, CM; Pallante, M; Brandy, ML; Skold, CM; Saltini, C				Lee, Jungnam; Arisi, Ivan; Puxeddu, Ermanno; Mramba, Lazarus K.; Amicosante, Massimo; Swaisgood, Carmen M.; Pallante, Marco; Brandy, Mark L.; Skold, C. Magnus; Saltini, Cesare			Bronchoalveolar lavage (BAL) cells in idiopathic pulmonary fibrosis express a complex pro-inflammatory, pro-repair, angiogenic activation pattern, likely associated with macrophage iron accumulation	PLOS ONE			English	Article							HFE GENE; POLARIZATION; HEMORRHAGE; DIAGNOSIS	Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease of unknown cause characterized by alveolar epithelial damage, patchy interstitial fibrosis and diffuse microvascular abnormalities. In IPF, alveolar clustering of iron-laden alveolar macrophages a common sign of microhemorrhage, has been associated with vascular abnormalities and worsening of pulmonary hypertension. As iron-dependent ROS generation has been shown to induce unrestrained macrophage activation in disease models of vascular damage, we explored alveolar macrophage activation phenotype in IPF patients (n = 16) and healthy controls (CTR, n = 7) by RNA sequencing of bronchoalveolar lavage (BAL) cells. The frequencies of macrophages in BAL cells were 86+4% and 83.4+8% in IPF and CTR groups, respectively (p-value = 0.41). In IPF patients, BAL cells showed increased iron-dependent ROS generation (p-value<0.05 vs CTR). Gene expression analysis showed overrepresentation of Gene Ontology processes/functions and KEGG pathways enriched in upregulated M1-type inflammatory (p-value<0.01), M2-type anti-inflammatory/tissue remodeling (p-value<0.0001), and MTPP-type chronic inflammatory/angiogenic (p-value<0.0001) chemokine and cytokine genes. The ex vivo finding was confirmed by the induction of iron-dependent ROS generation and chemokine/cytokine overexpression of Cc14, Cxcl10 (M1), ll1 rn (M2), Cxcl2, and Cxcl7 (MTPP) in MH-S murine immortalized alveolar macrophages exposed to ferric ammonium citrate in culture (p-value<0.05 vs CTR). The data show alveolar macrophage expression of a pro-inflammatory, tissue remodeling and angiogenic complex activation pattern, suggesting that iron accumulation may play a role in macrophage activation.	[Lee, Jungnam; Swaisgood, Carmen M.; Brandy, Mark L.; Saltini, Cesare] Univ Florida, Coll Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA; [Arisi, Ivan] European Brain Res Inst, Genom Facil, Rome, Italy; [Puxeddu, Ermanno; Amicosante, Massimo; Pallante, Marco] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Mramba, Lazarus K.] Univ Florida, Coll Med, Dept Med, Gainesville, FL USA; [Skold, C. Magnus] Karolinska Univ, Hosp Solna, Dept Med, Resp Med Unit, Stockholm, Sweden; [Skold, C. Magnus] Karolinska Univ, Hosp Solna, Lung Allergy Clin, Stockholm, Sweden	State University System of Florida; University of Florida; University of Rome Tor Vergata; State University System of Florida; University of Florida; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Saltini, C (corresponding author), Univ Florida, Coll Med, Div Pulm Crit Care & Sleep Med, Gainesville, FL 32611 USA.	cesare.saltini@medicine.ufl.edu	PUXEDDU, ERMANNO/AAA-7467-2019; Arisi, Ivan/AAM-1152-2021	PUXEDDU, ERMANNO/0000-0002-5486-7764; Arisi, Ivan/0000-0002-0536-2508	University of Florida [00127916, 00045513]; Department of Biomedicine and Prevention, University of Roma by PAINCAGE FP7 [603191]	University of Florida(University of Florida); Department of Biomedicine and Prevention, University of Roma by PAINCAGE FP7	This study was supported by University of Florida Departmental funds (UF project #00127916(C.S.) and #00045513(M.L.B)), by funds from the Department of Biomedicine and Prevention, University of Roma by PAINCAGE FP7 #603191 (I.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A, 2006, BIOINFORMATICS, V22, P1600, DOI 10.1093/bioinformatics/btl140; Becker M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13351; Bringardner BD, 2008, ANTIOXID REDOX SIGN, V10, P287, DOI 10.1089/ars.2007.1897; Capelli A, 2005, EUR RESPIR J, V25, P701, DOI 10.1183/09031936.05.00082604; Cloonan SM, 2017, AM J RESP CRIT CARE, V196, P1103, DOI 10.1164/rccm.201702-0311PP; Colombat M, 2007, HUM PATHOL, V38, P60, DOI 10.1016/j.humpath.2006.06.007; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; Foster MW, 2015, J PROTEOME RES, V14, P1238, DOI 10.1021/pr501149m; Fukihara J, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0376-8; Ghio AJ, 1997, J LAB CLIN MED, V129, P53, DOI 10.1016/S0022-2143(97)90161-X; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; GOLDE DW, 1975, BMJ-BRIT MED J, V2, P166, DOI 10.1136/bmj.2.5964.166; Ishii T, 2006, EUR RESPIR J, V27, P300, DOI 10.1183/09031936.06.00090405; Jackson AF, 2013, J PHARMACOL TOX MET, V68, P260, DOI 10.1016/j.vascn.2013.02.008; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Keane MP, 2001, AM J RESP CRIT CARE, V164, P2239, DOI 10.1164/ajrccm.164.12.2104106; Kim KH, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-37; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Ley B, 2015, EUR RESPIR J, V45, P1374, DOI 10.1183/09031936.00146314; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magro CM, 2006, HUM IMMUNOL, V67, P284, DOI 10.1016/j.humimm.2006.02.026; Meyer KC, 2012, AM J RESP CRIT CARE, V185, P1004, DOI 10.1164/rccm.201202-0320ST; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Montani D, 2009, EUR RESPIR J, V33, P189, DOI 10.1183/09031936.00090608; Nieuwenhuizen L, 2014, THROMB RES, V133, P390, DOI 10.1016/j.thromres.2013.10.039; Oda K, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0109-y; OLAKANMI O, 1993, J CLIN INVEST, V91, P889, DOI 10.1172/JCI116310; Persson HL, 2011, CHEST, V139, P361, DOI 10.1378/chest.10-0818; Pezzuto G, 2015, SARCOIDOSIS VASC DIF, V32, P32; Philippot Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096285; Puxeddu E, 2014, PULM PHARMACOL THER, V28, P35, DOI 10.1016/j.pupt.2013.12.002; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ren P, 2007, AM J RESP CRIT CARE, V175, P1151, DOI 10.1164/rccm.200607-958OC; Risso D, 2014, NAT BIOTECHNOL, V32, P896, DOI 10.1038/nbt.2931; Sangiuolo F, 2015, EUR RESPIR J, V45, P483, DOI 10.1183/09031936.00104814; Schupp JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116775; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; THOMPSON AB, 1991, J LAB CLIN MED, V117, P493; van der Schoot GGF, 2016, EUR J CANCER, V59, P134, DOI 10.1016/j.ejca.2016.02.013; Wijnen PA, 2013, LUNG, V191, P53, DOI 10.1007/s00408-012-9436-2; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zamboni P, 2006, FREE RADICAL BIO MED, V40, P1869, DOI 10.1016/j.freeradbiomed.2006.01.026	43	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194803	10.1371/journal.pone.0194803	http://dx.doi.org/10.1371/journal.pone.0194803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649237	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900015
J	Nagane, M; Kanai, E; Shibata, Y; Shimizu, T; Yoshioka, C; Maruo, T; Yamashita, T				Nagane, Masaki; Kanai, Eiichi; Shibata, Yuki; Shimizu, Takuto; Yoshioka, Chie; Maruo, Takuya; Yamashita, Tadashi			Sulfasalazine, an inhibitor of the cystineglutamate antiporter, reduces DNA damage repair and enhances radiosensitivity in murine B16F10 melanoma	PLOS ONE			English	Article							COMET ASSAY; MITOTIC CATASTROPHE; RADIATION; CELLS; TRANSPORTER; XCT; RADIORESISTANCE; SENESCENCE; TRIGGERS; SYSTEM	The sodium-independent cystine-glutamate antiporter plays an important role in extracellular cystine uptake. It comprises the transmembrane protein, xCT and its chaperone, CD98. Because glutathione is only weakly cell membrane permeable, cellular uptake of its precursor, cystine, is known to be a key step in glutathione synthesis. Moreover, it has been reported that xCT expression affects the progression of tumors and their resistance to therapy. Sulfasalazine is an inhibitor of xCT that is known to increase cellular oxidative stress, giving it anti-tumor potential. Here, we describe a radio-sensitizing effect of sulfasalazine using a B16F10 melanoma model. Sulfasalazine decreased glutathione concentrations and resistance to H2O2 in B16F10 melanoma cells, but not in mouse embryonic fibroblasts. It synergistically enhanced the cyto-killing effect of X-irradiation in B16F10 cells. It inhibited cellular DNA damage repair and prolonged cell cycle arrest after X-irradiation. Furthermore, in an in vivo transplanted melanoma model, sulfasalazine decreased intratumoral glutathione content, leading to enhanced susceptibility to radiation therapy. These results suggest the possibility of using SAS to augment the treatment of radio-resistant cancers.	[Nagane, Masaki; Shibata, Yuki; Shimizu, Takuto; Yamashita, Tadashi] Azabu Univ, Sch Vet Med, Biochem Lab, Sagamihara, Kanagawa, Japan; [Kanai, Eiichi] Azabu Univ, Sch Vet Med, Lab Vet Radiol, Sagamihara, Kanagawa, Japan; [Yoshioka, Chie; Maruo, Takuya] Azabu Univ, Teaching Anim Hosp, Sagamihara, Kanagawa, Japan	Azabu University; Azabu University; Azabu University	Yamashita, T (corresponding author), Azabu Univ, Sch Vet Med, Biochem Lab, Sagamihara, Kanagawa, Japan.	yamashita@azabu-u.ac.jp	; Nagane, Masaki/K-3431-2013	Yamashita, Tadashi/0000-0001-8022-0158; Shimizu, Takuto/0000-0002-6403-7959; Shibata, Yuki/0000-0002-2532-9916; Nagane, Masaki/0000-0002-3408-7656	Private University Research Branding Project (Ministry of Education, Culture, Sports, Science and Technology, Japan)	Private University Research Branding Project (Ministry of Education, Culture, Sports, Science and Technology, Japan)	This research was partially supported by Private University Research Branding Project (Ministry of Education, Culture, Sports, Science and Technology, Japan).	Bridges CC, 2001, INVEST OPHTH VIS SCI, V42, P47; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chabner B., 2018, CANC CHEMOTHERAPY BI; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; CLARK EP, 1984, RADIAT RES, V98, P370, DOI 10.2307/3576244; Day RM, 2014, CELL CYCLE, V13, P2011, DOI 10.4161/cc.29457; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; GUASTAVINO E, 1988, Acta Gastroenterologica Latinoamericana, V18, P107; Gyori BM, 2014, REDOX BIOL, V2, P457, DOI 10.1016/j.redox.2013.12.020; Hall EJ, 2011, RADIOBIOLOGY RADIOLO; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; KLOTZ U, 1980, NEW ENGL J MED, V303, P1499, DOI 10.1056/NEJM198012253032602; Kurashige T, 2016, J RADIAT RES, V57, P312, DOI 10.1093/jrr/rrw001; Lee Kyung Shik, 1992, Korean Journal of Internal Medicine (English Edition), V7, P111; Lu HQ, 2015, P NATL ACAD SCI USA, V112, pE4600, DOI 10.1073/pnas.1513433112; Marthandan S, 2016, BIOL RES, V49, DOI 10.1186/s40659-016-0095-2; Moiseeva O, 2006, MOL BIOL CELL, V17, P1583, DOI 10.1091/mbc.E05-09-0858; Nagane M, 2015, BIOCHEM BIOPH RES CO, V456, P541, DOI 10.1016/j.bbrc.2014.12.002; Nagane M, 2013, BIOCHEM BIOPH RES CO, V437, P420, DOI 10.1016/j.bbrc.2013.06.093; Nishida N, 2014, J RADIAT RES, V55, P455, DOI 10.1093/jrr/rrt142; O'Dell JR, 2002, ARTHRITIS RHEUM, V46, P1164, DOI 10.1002/art.10228; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Rodman SN, 2016, RADIAT RES, V186, P385, DOI 10.1667/RR14463.1; Sakai Y, 2015, BIOCHEM BIOPH RES CO, V461, P35, DOI 10.1016/j.bbrc.2015.03.163; Sleire L, 2015, ONCOGENE, V34, P5951, DOI 10.1038/onc.2015.60; Tagde A, 2014, BLOOD CANCER J, V4, DOI 10.1038/bcj.2014.45; Toyoda M, 2014, BRIT J CANCER, V110, P2506, DOI 10.1038/bjc.2014.178; Wada T, 2013, CANCER SCI, V104, P1323, DOI 10.1111/cas.12236; Xie L, 2011, J CANCER RES CLIN, V137, P1739, DOI 10.1007/s00432-011-1050-9; Yamamori T, 2015, MOL BIOL CELL, V26, P4607, DOI 10.1091/mbc.E15-03-0181; Yasui H, 2008, BRIT J CANCER, V99, P1442, DOI 10.1038/sj.bjc.6604720; Yasui H, 2017, CANCER LETT, V390, P160, DOI 10.1016/j.canlet.2017.01.006; Yasui H, 2014, CANCER LETT, V347, P151, DOI 10.1016/j.canlet.2014.02.005; Yoshikawa M, 2013, CANCER RES, V73, P1855, DOI 10.1158/0008-5472.CAN-12-3609-T	36	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195151	10.1371/journal.pone.0195151	http://dx.doi.org/10.1371/journal.pone.0195151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649284	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900029
J	Valdes, C; Bustos, G; Martinez, JL; Lauridolt, C				Valdes, Carlos; Bustos, Gonzalo; Martinez, Jose L.; Lauridolt, Claudio			Antinociceptive antibiotics-loaded into solid lipid nanoparticles of prolonged release: Measuring pharmacological efficiency and time span on chronic monoarthritis rats	PLOS ONE			English	Article							PAIN	Pain is a sensory experience of a complex physiological nature in which is not only involved the nervous system. Among its many features is the development of chronic pain that is more complicated to treat because of the central somatization processes involved, becoming inefficient treatments used in other forms of pain. Among them is the role of glial cells, whose participation is such that some authors have proposed to chronic pain as a gliopathy. Because of this, the drug target of possible treatments focuses on modulating nociceptive response affecting transduction into the central nervous system through affecting synapses in the dorsal horn of the spinal cord. Solid lipid nanoparticles enter the central nervous system, protecting the drug, and in addition to the advantage of having greater absorption surface, all factors that improve drug activity. This work is based on the development and characterization of lipid nanoparticles of solid phase incorporating two antibiotics, minocycline, and ciprofloxacin with antinociceptive properties and challenged them with a rat monoarthritis model using Sprague-Dawley adult male rats. The solid lipid nanoparticles were prepared to modify the lipid, and surfactant amounts to obtain the best encapsulation capacity of the antibiotics, size and z potential. By using the Randall-Selitto test, we measured its pharmacological efficiency as an anti-inflammatory and measuring the time span the antibiotics are active. The encapsulated antibiotics were at least 50% more efficient than the antibiotic alone, and that is possible to measure anti-inflammatory activity up to seven days after the antibiotic application. The former is important for example, in the veterinary field, since a single application of the antibiotic will be necessary for the complete treatment, avoiding excessive stress for the animals. We can conclude that antinociceptive antibiotics encapsulation is a very effective, environmentally safe and inexpensive method for improving the pharmacological efficiency and time span the antibiotics are acting. Since these antibiotics are both anti-microbial and antinociceptive, his use in the field of veterinary presents the advantage of being adequate in single doses, with the saving of time and stress to the animals under treatment.	[Valdes, Carlos; Bustos, Gonzalo; Lauridolt, Claudio] Univ Santiago Chile, Fac Chem & Biol, Dept Biol, Neurobiol Lab, Santiago, Chile; [Martinez, Jose L.] Univ Santiago Chile, Vicerrectory Res Dev & Innovat, Santiago, Chile	Universidad de Santiago de Chile; Universidad de Santiago de Chile	Martinez, JL (corresponding author), Univ Santiago Chile, Vicerrectory Res Dev & Innovat, Santiago, Chile.	joseluis.martinez@usach.cl	Martinez, Jose/AAA-1725-2020		Dicyt, Universidad de Santiago de Chile	Dicyt, Universidad de Santiago de Chile	This study was supported by Dicyt, Universidad de Santiago de Chile.	Abdelbary G, 2009, AAPS PHARMSCITECH, V10, P211, DOI 10.1208/s12249-009-9197-2; Attama AA, 2015, THER DELIV, V6, P669, DOI [10.4155/tde.15.23, 10.4155/TDE.15.23]; Basbaum A, 2005, PAIN 2005 UPDATED RE, P3; Bustos G, 2016, PAK VET J, V36, P366; Halassa MM, 2007, TRENDS MOL MED, V13, P54, DOI 10.1016/j.molmed.2006.12.005; Haney MJ, 2011, NANOMEDICINE-UK, V6, P1215, DOI [10.2217/nnm.11.32, 10.2217/NNM.11.32]; Herrero JF, 2000, PROG NEUROBIOL, V61, P169, DOI 10.1016/S0301-0082(99)00051-9; Hou DZ, 2003, BIOMATERIALS, V24, P1781, DOI 10.1016/S0142-9612(02)00578-1; Hu FQ, 2005, COLLOID SURFACE B, V45, P167, DOI 10.1016/j.colsurfb.2005.08.005; Ibrahim WM, 2014, INT J NANOMED, V9, P129, DOI 10.2147/IJN.S54413; KOEPPEN B.M., 2009, BERNE LEVY FISIOLOGI; Labro MT, 2000, CLIN MICROBIOL REV, V13, P615, DOI 10.1128/CMR.13.4.615-650.2000; Luger TJ, 2005, BASIC CLIN PHARMACOL, V96, P366, DOI 10.1111/j.1742-7843.2005.pto_05.x; McNeil SE, 2011, METHODS MOL BIOL, V697, P1, DOI 10.1007/978-1-60327-198-1; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Morales F, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4030; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Qi JP, 2012, CURR DRUG METAB, V13, P418, DOI 10.2174/138920012800166526; RANDALL LO, 1957, ARCH INT PHARMACOD T, V111, P409; Rojewska E, 2014, J NEUROIMMUNOL, V277, P57, DOI 10.1016/j.jneuroim.2014.09.020; Venkateswarlu V, 2004, J CONTROL RELEASE, V95, P627, DOI 10.1016/j.jconrel.2004.01.005; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	22	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0187473	10.1371/journal.pone.0187473	http://dx.doi.org/10.1371/journal.pone.0187473			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649262	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900001
J	Pan, CC; Hu, LY; Lu, T; Tu, MS; Shen, CC; Chen, ZJ				Pan, Chih-Chuan; Hu, Li-Yu; Lu, Ti; Tu, Ming-Shium; Shen, Cheng-Che; Chen, Zi-Jun			Risk of hip fractures in patients with depressive disorders: A nationwide, population-based, retrospective, cohort study	PLOS ONE			English	Article							LATE-LIFE DEPRESSION; DIABETIC COMPLICATIONS; POSTMENOPAUSAL WOMEN; BONE METABOLISM; OSTEOPOROSIS; MECHANISMS; DENSITY; DISEASE; DRUGS; MRI	Background Some studies have suggested that depressive disorders may play a vital role in the incidence of hip fractures. However, nationwide data are lacking regarding the association between depressive disorders and hip fractures. Objective We aimed to explore the association between depressive disorders and new-onset hip fractures. Methods We conducted a retrospective study of 11,207 patients with depressive disorders and 11,207 control patients using Taiwan's National Health Insurance Research Database. A Cox regression model was used to evaluate the risk of hip fractures in patients with depressive disorders. Results The incidence rate ratio of hip fractures between patients with depressive disorders and controls was 1.6 (95% confidence interval [CI] = 1.29-1.99, P < .001). After adjustment for potential confounders in multivariate analysis using the Cox regression model, patients with depressive disorders were found to have 1.34 times higher risk of hip fractures than controls (95% CI = 1.08-1.66, P = .008). Furthermore, age (hazard ratio [HR] = 7.43, 95% CI = 4.94-11.19, P < .001), hypertension (HR = 1.63, 95% CI = 1.17-2.28, P =.004), diabetes mellitus (HR = 1.47, 95% CI = 1.08-1.99, P = .014), cerebrovascular disease (HR = 1.76, 95% CI = 1.31-2.35, P < .001), living in rural areas (HR = 1.88, 95% CI = 1.30-2.70, P = .001), and low monthly income ( NT$0-NT$19,000: HR = 4.08, 95% CI = 1.79-9.29, P = .001 and NT $19,100-NT$42,000: HR = 4.09, 95% CI = 1.76-9.49, P =.001) were independent risk factors for new-onset hip fractures in patients with depressive disorders. Conclusion Depressive disorders might increase the risk of new-onset hip fractures, particularly in older patients and patients with hypertension, diabetes mellitus, cerebrovascular disease, or low socioeconomic status.	[Pan, Chih-Chuan; Hu, Li-Yu] Kaohsiung Vet Gen Hosp, Ctr Geriatr & Gerontol, Kaohsiung, Taiwan; [Pan, Chih-Chuan; Hu, Li-Yu; Lu, Ti] Kaohsiung Vet Gen Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Hu, Li-Yu; Shen, Cheng-Che] Natl Yang Ming Univ, Fac Med, Div Psychiat, Taipei, Taiwan; [Tu, Ming-Shium; Chen, Zi-Jun] Kaohsiung Vet Gen Hosp, Pingtung Branch, Dept Family Med, Pingtung, Taiwan; [Shen, Cheng-Che] Taichung Vet Gen Hosp, Dept Psychiat, Chiayi Branch, Chiayi, Taiwan; [Shen, Cheng-Che] Natl Chung Cheng Univ, Dept Informat Management, Chiayi, Taiwan	Kaohsiung Veterans General Hospital; Kaohsiung Veterans General Hospital; National Yang Ming Chiao Tung University; Kaohsiung Veterans General Hospital; Taichung Veterans General Hospital; National Chung Cheng University	Chen, ZJ (corresponding author), Kaohsiung Vet Gen Hosp, Pingtung Branch, Dept Family Med, Pingtung, Taiwan.	zijunchen@gmail.com						Andreescu C, 2008, NEUROPSYCHOPHARMACOL, V33, P2566, DOI 10.1038/sj.npp.1301655; Atteritano M, 2013, INTERN EMERG MED, V8, P485, DOI 10.1007/s11739-011-0628-1; Bacon WE, 2000, J AGING HEALTH, V12, P193, DOI 10.1177/089826430001200203; Bakken MS, 2013, AGE AGEING, V42, P514, DOI 10.1093/ageing/aft009; Beaupre GS, 2006, AM J PHYS MED REHAB, V85, P464, DOI 10.1097/01.phm.0000214275.69286.7a; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Beyer JL, 2002, BIPOLAR DISORD, V4, P89, DOI 10.1034/j.1399-5618.2002.01157.x; Butt DA, 2012, ARCH INTERN MED, V172, P1739, DOI 10.1001/2013.jamainternmed.469; Carriero FP, 2011, ANN INTERN MED, V155; Cauley JA, 2014, NAT REV ENDOCRINOL, V10, P338, DOI 10.1038/nrendo.2014.51; Cizza G, 2010, HORM METAB RES, V42, P467, DOI 10.1055/s-0030-1252020; Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73; Cizza G, 2009, TRENDS ENDOCRIN MET, V20, P367, DOI 10.1016/j.tem.2009.05.003; Corrao G, 2015, DRUG AGING, V32, P927, DOI 10.1007/s40266-015-0306-5; Coupland C, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4551; Cuijpers P, 2002, J AFFECT DISORDERS, V72, P227, DOI 10.1016/S0165-0327(01)00413-X; Eskandari F, 2007, ARCH INTERN MED, V167, P2329, DOI 10.1001/archinte.167.21.2329; Fazeli PK, 2013, PSYCHOSOM MED, V75, P117, DOI 10.1097/PSY.0b013e3182821e91; Fernandes BS, 2016, DRUG AGING, V33, P21, DOI 10.1007/s40266-015-0323-4; Fossati P, 2004, EUR NEUROPSYCHOPHARM, V14, pS503, DOI 10.1016/j.euroneuro.2004.09.001; Romero MJGDT, 2014, MATURITAS, V77, P282, DOI 10.1016/j.maturitas.2013.12.011; Gu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065356; Holick MF, 2004, AM J CLIN NUTR, V79, P362; Hong GRS, 2010, J ADV NURS, V66, P2014, DOI 10.1111/j.1365-2648.2010.05384.x; Hwang HF, 2011, OSTEOPOROSIS INT, V22, P2385, DOI 10.1007/s00198-010-1446-4; Johnston SS, 2012, DIABETES OBES METAB, V14, P634, DOI 10.1111/j.1463-1326.2012.01583.x; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Lesch KP, 2004, J PSYCHIATR NEUROSCI, V29, P174; Lin HL, 2015, ACTA NEUROL SCAND, V131, P158, DOI 10.1111/ane.12301; Malabu UH, 2014, CLIN EPIDEMIOL, V6, P287, DOI 10.2147/CLEP.S66821; Oderda LH, 2012, ANN PHARMACOTHER, V46, P917, DOI 10.1345/aph.1Q589; Oei L, 2015, CURR OSTEOPOROS REP, V13, P106, DOI 10.1007/s11914-015-0260-5; Pan CC, 2009, INT J GERIATR PSYCH, V24, P847, DOI 10.1002/gps.2206; Porto Carreiro F, 2011, ANN INTERN MED, V155; Pouwels S, 2009, STROKE, V40, P3281, DOI 10.1161/STROKEAHA.109.554055; Prieto-Alhambra D, 2014, OSTEOPOROSIS INT, V25, P847, DOI 10.1007/s00198-013-2612-2; Rathmann W, 2015, J DIABETES COMPLICAT, V29, P766, DOI 10.1016/j.jdiacomp.2015.05.007; Ressler KJ, 2000, DEPRESS ANXIETY, V12, P2, DOI 10.1002/1520-6394(2000)12:1+<2::AID-DA2>3.3.CO;2-W; Roshanaei-Moghaddam B, 2009, GEN HOSP PSYCHIAT, V31, P306, DOI 10.1016/j.genhosppsych.2009.04.002; Ruths S, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0154-5; Shatrugna V, 2005, OSTEOPOROSIS INT, V16, P1827, DOI 10.1007/s00198-005-1933-1; Shea MLO, 2013, OSTEOPOROSIS INT, V24, P1741, DOI 10.1007/s00198-012-2170-z; Shin CS, 2010, BONE, V47, P378, DOI 10.1016/j.bone.2010.03.017; Solomon DH, 2011, J BONE MINER RES, V26, P1561, DOI 10.1002/jbmr.356; Sterling RS, 2011, CLIN ORTHOP RELAT R, V469, P1913, DOI 10.1007/s11999-010-1736-3; Tolea MI, 2007, OSTEOPOROSIS INT, V18, P315, DOI 10.1007/s00198-006-0242-7; Tsapakis EM, 2012, EUR PSYCHIAT, V27, P156, DOI 10.1016/j.eurpsy.2010.10.006; Williams LJ, 2009, PSYCHOTHER PSYCHOSOM, V78, P16, DOI 10.1159/000162297; Wu Q, 2010, OSTEOPOROSIS INT, V21, P1627, DOI 10.1007/s00198-010-1181-x; Yang NP, 2003, J CLIN DENSITOM, V6, P131, DOI 10.1385/JCD:6:2:131; Zingmond DS, 2006, OSTEOPOROSIS INT, V17, P1562, DOI 10.1007/s00198-006-0161-7	51	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194961	10.1371/journal.pone.0194961	http://dx.doi.org/10.1371/journal.pone.0194961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641581	gold, Green Published, Green Submitted			2022-12-26	WOS:000429742900056
J	Santana, NB; Dias, JCT; Rezende, RP; Franco, M; Oliveira, LKS; Souza, LO				Santana, Nivio Batista; Teixeira Dias, Joao Carlos; Rezende, Rachel Passos; Franco, Marcelo; Silva Oliveira, Larissa Karen; Souza, Lucas Oliveira			Production of xylitol and bio-detoxification of cocoa pod husk hemicellulose hydrolysate by Candida boidinii XM02G	PLOS ONE			English	Article							ETHANOL-PRODUCTION; ATHENSENSIS SB18; BY-PRODUCTS; PRETREATMENT; ACID; XYLOSE; GUILLIERMONDII; FERMENTATION; TROPICALIS; BAGASSE	The use of cocoa pod husk hemicellulose hydrolysate (CPHHH) was evaluated for the production of xylitol by Candida boidinii XM02G yeast isolated from soil of cocoa-growing areas and decaying bark, as an alternative means of reusing this type of waste. Xylitol was obtained in concentrations of 11.34 g.L-1, corresponding to a yield (Y-p/s) of 0.52 g.g(-1) with a fermentation efficiency (epsilon) of 56.6%. The yeast was tolerant to inhibitor compounds present in CPHHH without detoxification in different concentration factors, and was able to tolerate phenolic compounds at approximately 6 g.L-1. The yeast was also able to metabolize more than 99% (p/v) of furfural and hydroxymethylfurfural present in the non-detoxified CPHHH without extension of the cell-growth lag phase, showing the potential of this microorganism for the production of xylitol. The fermentation of cocoa pod husk hydrolysates appears to provide an alternative use which may reduce the impact generated by incorrect disposal of this waste.	[Santana, Nivio Batista] State Univ Southwest Bahia UESB, Dept Anim & Rural Technol, Itapetinga, BA, Brazil; [Teixeira Dias, Joao Carlos; Rezende, Rachel Passos] State Univ Santa Cruz UESC, Dept Exact & Technol Sci, Ilheus, BA, Brazil; [Franco, Marcelo] State Univ Santa Cruz UESC, Dept Biol Sci, Ilheus, BA, Brazil; [Silva Oliveira, Larissa Karen] Univ Estadual Santa Cruz, Biomed, Ilheus, BA, Brazil; [Souza, Lucas Oliveira] State Univ Southwest Bahia UESB, Postgrad Program Food Sci & Engn, Itapetinga, BA, Brazil	Universidade Estadual do Sudoeste da Bahia; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade Estadual de Santa Cruz; Universidade Estadual do Sudoeste da Bahia	Dias, JCT (corresponding author), State Univ Santa Cruz UESC, Dept Exact & Technol Sci, Ilheus, BA, Brazil.	jctdias@uesc.br	Franco, Marcelo/U-4532-2019; Santana, Nívio Batista/AAD-8385-2019	Franco, Marcelo/0000-0002-7827-789X; Dias, Joao/0000-0002-4938-2666				Alemawor F, 2009, SCI RES ESSAYS, V4, P555; [Anonymous], 1995, OFFICIAL METHODS ANA; Aregheore EM, 2002, TROP ANIM HEALTH PRO, V34, P339, DOI 10.1023/A:1015638903740; Caes BR, 2015, ACS SUSTAIN CHEM ENG, V3, P2591, DOI 10.1021/acssuschemeng.5b00473; Canilha L, 2004, PROCESS BIOCHEM, V39, P1909, DOI 10.1016/j.procbio.2003.09.009; Canilha L, 2010, APPL BIOCHEM BIOTECH, V161, P84, DOI 10.1007/s12010-009-8792-8; Cortez DV, 2010, BIORESOURCE TECHNOL, V101, P1858, DOI 10.1016/j.biortech.2009.09.072; da Silva EA, 2005, J IND MICROBIOL BIOT, V32, P481, DOI 10.1007/s10295-005-0027-6; Daud Z, 2013, AUST J BASIC APPL SC, V7; El-Shekeil YA, 2014, MATER DESIGN, V64, P330, DOI 10.1016/j.matdes.2014.07.034; Felipe MGA, 1996, BIORESOURCE TECHNOL, V56, P281, DOI 10.1016/0960-8524(96)00031-4; Ge JP, 2011, AFR J MICROBIOL RES, V5, P1163; Goncalves DB, 2013, BIORESOURCE TECHNOL, V146, P261, DOI 10.1016/j.biortech.2013.07.075; Huang CF, 2011, BIORESOURCE TECHNOL, V102, P3322, DOI 10.1016/j.biortech.2010.10.111; Igbinadolor R. O., 2013, African Journal of Biotechnology, V12, P5375; Jonsson LJ, 2016, BIORESOURCE TECHNOL, V199, P103, DOI 10.1016/j.biortech.2015.10.009; Li HL, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0314-z; Salgado JM, 2012, NEW BIOTECHNOL, V29, P421, DOI 10.1016/j.nbt.2011.07.003; Misra S, 2013, CARBOHYD POLYM, V92, P1596, DOI 10.1016/j.carbpol.2012.11.033; Network Commodity, 2016, GLOB COC PROD 2015 2; Njoku VO, 2014, J ENVIRON CHEM ENG, V2, P881, DOI 10.1016/j.jece.2014.03.003; Oddoye EOK, 2010, SCI RES ESSAYS, V5, P1141; Ofori-Boateng C, 2013, CHEM ENG J, V220, P395, DOI 10.1016/j.cej.2013.01.046; Parajo JC, 1997, ENZYME MICROB TECH, V21, P18, DOI 10.1016/S0141-0229(96)00210-4; Ping Y, 2013, BIOCHEM ENG J, V75, P86, DOI 10.1016/j.bej.2013.03.022; Rocha MVP, 2014, CHEM ENG J, V243, P234, DOI 10.1016/j.cej.2013.12.099; PreziosiBelloy L, 1997, ENZYME MICROB TECH, V21, P124, DOI 10.1016/S0141-0229(96)00247-5; Pua FL, 2013, J ENVIRON CHEM ENG, V1, P460, DOI 10.1016/j.jece.2013.06.012; Rao LV, 2016, BIORESOURCE TECHNOL, V213, P299, DOI 10.1016/j.biortech.2016.04.092; Ravindran R, 2016, BIORESOURCE TECHNOL, V199, P92, DOI 10.1016/j.biortech.2015.07.106; Santos DT, 2008, J FOOD ENG, V86, P542, DOI 10.1016/j.jfoodeng.2007.11.004; Sindhu R, 2016, BIORESOURCE TECHNOL, V199, P76, DOI 10.1016/j.biortech.2015.08.030; Syamsiro M, 2012, ENERGY SUSTAIN DEV, V16, P74, DOI 10.1016/j.esd.2011.10.005; Tamanini C., 2004, SEMIN-CIENC AGRAR, V25, P315, DOI DOI 10.5433/1679-0359.2004v25n4p315; Uwagboe E. O., 2010, INT J SCI NAT, V1, P272; Vandeska E, 1996, PROCESS BIOCHEM, V31, P265, DOI 10.1016/0032-9592(95)00058-5; Villarreal MLM, 2006, ENZYME MICROB TECH, V40, P17, DOI 10.1016/j.enzmictec.2005.10.032; Vriesmann LC, 2012, LWT-FOOD SCI TECHNOL, V49, P108, DOI 10.1016/j.lwt.2012.04.018; Wang L., 2013, J APPL MATH, V2013, P12, DOI DOI 10.1186/1476-4598-12-173; Wang SZ, 2015, FUNGAL GENET BIOL, V82, P1, DOI 10.1016/j.fgb.2015.04.022; Wang W, 2015, PROCESS BIOCHEM, DOI [10.1016/j.procbio.2015.03.020, DOI 10.1016/J.PROCBIO.2015.03.020]; Zhang DX, 2012, CHEM ENG J, V181, P636, DOI 10.1016/j.cej.2011.12.030; Zhang JM, 2012, BIORESOURCE TECHNOL, V121, P369, DOI 10.1016/j.biortech.2012.07.020; Zhang JM, 2012, BIORESOURCE TECHNOL, V105, P134, DOI 10.1016/j.biortech.2011.11.119	44	22	23	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195206	10.1371/journal.pone.0195206	http://dx.doi.org/10.1371/journal.pone.0195206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641547	gold, Green Published, Green Submitted			2022-12-26	WOS:000429742900061
J	Ji, CD; Yang, L; Yi, WJ; Xiang, DF; Wang, YX; Zhou, ZH; Qian, F; Ren, Y; Cui, W; Zhang, X; Zhang, P; Wang, JM; Cui, YH; Bian, XW				Ji, Chengdong; Yang, Lang; Yi, Weijing; Xiang, Dongfang; Wang, Yanxia; Zhou, Zhihua; Qian, Feng; Ren, Yong; Cui, Wei; Zhang, Xia; Zhang, Peng; Wang, Ji Ming; Cui, Youhong; Bian, Xiuwu			Capillary morphogenesis gene 2 maintains gastric cancer stem-like cell phenotype by activating a Wnt/beta-catenin pathway	ONCOGENE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; ANTHRAX TOXIN RECEPTOR; GENERATES CELLS; MARKER CD44; WNT; PROGRESSION; DIFFERENTIATION; OVEREXPRESSION; IDENTIFICATION; ANGIOGENESIS	A growing body of evidence shows that the development and progression of gastric cancer (GC) is mainly associated to the presence of gastric cancer stem-like cells (GCSLCs). However, it is unclear how GCSLC population is maintained. This study aimed to explore the role of capillary morphogenesis gene 2 (CMG2) in GCSLC maintenance and the relevance to GC progression. We found that CMG2 was highly expressed in GC tissues and the expression levels were associated with the invasion depth and lymph node metastasis of GC, and inversely correlated with the survival of GC patients. Sorted CMG2(High) GC cells preferentially clustered in CD44(High) stem-like cell population, which expressed high levels of stemness-related genes with increased capabilities of self-renewal and tumorigenicity. Depletion of CMG2 gene resulted in reduction of GCSLC population with attenuated stemness and decrease of invasive and metastatic capabilities with subdued epithelial-mesenchymal transition phenotype in GC cells. Mechanistically, CMG2 interacted with LRP6 in GCSLCs to activate a Wnt/beta-catenin pathway. Thus, our results demonstrate that CMG2 promotes GC progression by maintaining GCSLCs and can serve as a new prognostic indicator and a target for human GC therapy.	[Ji, Chengdong; Yang, Lang; Yi, Weijing; Xiang, Dongfang; Wang, Yanxia; Zhou, Zhihua; Ren, Yong; Cui, Wei; Zhang, Xia; Zhang, Peng; Cui, Youhong; Bian, Xiuwu] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China; [Ji, Chengdong; Yang, Lang; Yi, Weijing; Xiang, Dongfang; Wang, Yanxia; Zhou, Zhihua; Ren, Yong; Cui, Wei; Zhang, Xia; Zhang, Peng; Cui, Youhong; Bian, Xiuwu] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China; [Ji, Chengdong; Yang, Lang; Yi, Weijing; Xiang, Dongfang; Wang, Yanxia; Zhou, Zhihua; Ren, Yong; Cui, Wei; Zhang, Xia; Zhang, Peng; Cui, Youhong; Bian, Xiuwu] Third Mil Med Univ, Army Med Univ, Southwest Hosp, Minist Educ China,Key Lab Tumor Immunopathol, Chongqing 400038, Peoples R China; [Zhou, Zhihua] 101 Hosp Peoples Liberat Army, Dept Pathol, Wuxi 214000, Jiangsu, Peoples R China; [Qian, Feng] Third Mil Med Univ, Southwest Hosp, Dept Gen Surg, Chongqing 400038, Peoples R China; [Wang, Ji Ming] Natl Canc Inst Frederick, Ctr Canc Res, Canc & Inflammat Program, Frederick, MD 21702 USA	Army Medical University; Army Medical University; Army Medical University; Ministry of Education, China; Army Medical University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Cui, YH; Bian, XW (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Inst Pathol, Chongqing 400038, Peoples R China.; Cui, YH; Bian, XW (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Southwest Canc Ctr, Chongqing 400038, Peoples R China.; Cui, YH; Bian, XW (corresponding author), Third Mil Med Univ, Army Med Univ, Southwest Hosp, Minist Educ China,Key Lab Tumor Immunopathol, Chongqing 400038, Peoples R China.	cuiyouhongx@yahoo.com; bianxiuwu@263.net	Yang, Lang/AAL-3025-2020; yang, lang/ABA-2517-2021; Zhang, Xia/B-8152-2008; Bian, Xiu-Wu/D-4736-2017	Yang, Lang/0000-0002-5234-7394; Zhang, Xia/0000-0002-9040-1486; Bian, Xiu-Wu/0000-0003-4383-0197	National Natural Science Foundation of China [81372555]; NATIONAL CANCER INSTITUTE [ZIABC010015] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the National Natural Science Foundation of China (81372555) to YC.	Ajani JA, 2016, J NATL COMPR CANC NE, V14, P1286, DOI 10.6004/jnccn.2016.0137; Bekaii-Saab T, 2017, CANCER-AM CANCER SOC, V123, P1303, DOI 10.1002/cncr.30538; Bell SE, 2001, J CELL SCI, V114, P2755; Bessede E, 2014, ONCOGENE, V33, P4123, DOI 10.1038/onc.2013.380; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bradley KA, 2001, NATURE, V414, P225, DOI 10.1038/n35101999; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Burgi J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15861; Cai C, 2012, MOL MED REP, V5, P1191, DOI 10.3892/mmr.2012.802; Cao SG, 2012, BIOORG MED CHEM LETT, V22, P5885, DOI 10.1016/j.bmcl.2012.07.075; Castanon I, 2013, NAT CELL BIOL, V15, P28, DOI 10.1038/ncb2632; Cervantes A, 2013, CANCER TREAT REV, V39, P60, DOI 10.1016/j.ctrv.2012.09.007; Chen KH, 2016, J BIOL CHEM, V291, P22021, DOI 10.1074/jbc.M116.753301; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cryan LM, 2013, J MED CHEM, V56, P1940, DOI 10.1021/jm301558t; Demitrack ES, 2015, EMBO J, V34, P2522, DOI 10.15252/embj.201490583; Deuquet J, 2012, EMBO J, V31, P3, DOI 10.1038/emboj.2011.442; Fan F, 2012, CANCER MED-US, V1, P5, DOI 10.1002/cam4.4; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gao YH, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0548-8; Guo ZJ, 2016, ONCOTARGET, V7, P20999, DOI 10.18632/oncotarget.8236; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Huang L, 2015, AM J TRANSL RES, V7, P2141; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ishimoto T, 2010, CANCER SCI, V101, P673, DOI 10.1111/j.1349-7006.2009.01430.x; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Jiang Y, 2012, GASTRIC CANCER, V15, P440, DOI 10.1007/s10120-012-0140-y; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kodama H, 2017, BRIT J CANCER, V116, P186, DOI 10.1038/bjc.2016.401; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Korinek V, 1998, MOL CELL BIOL, V18, P1248, DOI 10.1128/MCB.18.3.1248; Li LC, 2015, ONCOL LETT, V10, P3293, DOI 10.3892/ol.2015.3727; Li YH, 2001, MOL NEUROBIOL, V23, P53; Liu JJ, 2016, CANCER LETT, V376, P110, DOI 10.1016/j.canlet.2016.03.035; Liu SH, 2016, P NATL ACAD SCI USA, V113, pE4079, DOI 10.1073/pnas.1600982113; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Nishii T, 2009, CANCER SCI, V100, P1397, DOI 10.1111/j.1349-7006.2009.01211.x; Park JY, 2014, CLIN ENDOSC, V47, P478, DOI 10.5946/ce.2014.47.6.478; Peng Z, 2014, WORLD J GASTROENTERO, V20, P5403, DOI 10.3748/wjg.v20.i18.5403; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Rao J, 2015, CANCER LETT, V358, P76, DOI 10.1016/j.canlet.2014.12.040; Rasheed ZA, 2010, JNCI-J NATL CANCER I, V102, P340, DOI 10.1093/jnci/djp535; Reeves CV, 2010, ONCOGENE, V29, P789, DOI 10.1038/onc.2009.383; Rogers MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039911; Ryu HS, 2012, HUM PATHOL, V43, P520, DOI 10.1016/j.humpath.2011.07.003; Savagner P, 1994, Cancer Treat Res, V71, P229; Scobie HM, 2003, P NATL ACAD SCI USA, V100, P5170, DOI 10.1073/pnas.0431098100; Simon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035486; Singh SR, 2013, CANCER LETT, V338, P110, DOI 10.1016/j.canlet.2013.03.035; Song Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017687; Takaishi S, 2009, STEM CELLS, V27, P1006, DOI 10.1002/stem.30; Thiery JP, 1999, CANCER METAST REV, V18, P31, DOI 10.1023/A:1006256219004; Varga J, 2014, FEBS LETT, V588, P2422, DOI 10.1016/j.febslet.2014.06.019; Wang B, 2013, J GASTROENTEROL, V48, P798, DOI 10.1007/s00535-012-0711-z; Wang T, 2011, BRIT J CANCER, V105, P658, DOI 10.1038/bjc.2011.287; Wang W, 2014, INT J CLIN EXP MED, V7, P5059; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Xu GH, 2013, J GASTROENTEROL, V48, P781, DOI 10.1007/s00535-012-0712-y; Yang L, 2011, CANCER LETT, V310, P46, DOI 10.1016/j.canlet.2011.06.003; Ye L, 2014, INT J ONCOL, V45, P1565, DOI 10.3892/ijo.2014.2533; Ye L, 2014, ONCOL LETT, V7, P2149, DOI 10.3892/ol.2014.2038; Ye L, 2014, J CANCER RES CLIN, V140, P957, DOI 10.1007/s00432-014-1650-2; Yu D, 2014, ONCOL REP, V31, P673, DOI 10.3892/or.2013.2893; Zhang CJ, 2011, J CANCER RES CLIN, V137, P1679, DOI 10.1007/s00432-011-1038-5; Zhu L, 2017, ONCOTARGET, V8, P37633, DOI 10.18632/oncotarget.16839; Zou JW, 2014, BIOCHEM BIOPH RES CO, V452, P186, DOI 10.1016/j.bbrc.2014.06.001	67	23	23	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					3953	3966		10.1038/s41388-018-0226-z	http://dx.doi.org/10.1038/s41388-018-0226-z			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29662192	hybrid, Green Published			2022-12-26	WOS:000439101300004
J	Kar, A; Jones, N; Arat, NO; Fishel, R; Griffith, JD				Kar, Anirban; Jones, Nathan; Arat, N. Ozlem; Fishel, Richard; Griffith, Jack D.			Long repeating (TTAGGG)(n) single-stranded DNA self-condenses into compact beaded filaments stabilized by G-quadruplex formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						single-molecule biophysics; telomere; G-quadruplex; DNA; electron microscopy (EM)	TELOMERIC DNA; HOMOLOGOUS RECOMBINATION; MAMMALIAN TELOMERES; DISPLACEMENT ASSAY; PERSISTENCE LENGTH; MAGNETIC TWEEZERS; CRYSTAL-STRUCTURE; HUMAN-CHROMOSOMES; STRUCTURAL BASIS; PROTEIN	Conformations adopted by long stretches of single-stranded DNA (ssDNA) are of central interest in understanding the architecture of replication forks, R loops, and other structures generated during DNA metabolism in vivo. This is particularly so if the ssDNA consists of short nucleotide repeats. Such studies have been hampered by the lack of defined substrates greater than approximate to 150 nt and the absence of high-resolution biophysical approaches. Here we describe the generation of very long ssDNA consisting of the mammalian telomeric repeat (5-TTAGGG-3)(n), as well as the interrogation of its structure by EM and single-molecule magnetic tweezers (smMT). This repeat is of particular interest because it contains a run of three contiguous guanine residues capable of forming G quartets as ssDNA. Fluorescent-dye exclusion assays confirmed that this G-strand ssDNA forms ubiquitous G-quadruplex folds. EM revealed thick bead-like filaments that condensed the DNA approximate to 12-fold. The bead-like structures were 5 and 8 nm in diameter and linked by thin filaments. The G-strand ssDNA displayed initial stability to smMT force extension that ultimately released in steps that were multiples approximate to 28 nm at forces between 6 and 12 pN, well below the >20 pN required to unravel G-quadruplexes. Most smMT steps were consistent with the disruption of the beads seen by EM. Binding by RAD51 distinctively altered the force extension properties of the G-strand ssDNA, suggesting a stochastic G-quadruplex-dependent condensation model that is discussed.	[Kar, Anirban; Arat, N. Ozlem; Griffith, Jack D.] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Jones, Nathan; Fishel, Richard] Ohio State Univ, Dept Canc Biol & Genet, Wexner Med Ctr, Columbus, OH 43210 USA; [Jones, Nathan; Fishel, Richard] Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA; [Arat, N. Ozlem] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3T 1J4, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Universite de Montreal	Griffith, JD (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Fishel, R (corresponding author), Ohio State Univ, Dept Canc Biol & Genet, Wexner Med Ctr, Columbus, OH 43210 USA.; Fishel, R (corresponding author), Ohio State Univ, Interdisciplinary Biophys Grad Program, Columbus, OH 43210 USA.	fishel.7@osu.edu; jdg@med.unc.edu	Kar, Anirban/ABF-9178-2021	Jones, Nathan/0000-0002-2159-1394	National Institutes of Health [GM31819, ES013773, GM080176]; NATIONAL CANCER INSTITUTE [P30CA016058, P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R56ES013773, R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819, R01GM080176] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM31819 and ES013773 (to J. D. G.) and GM080176 (to R. F.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ambrus A, 2006, NUCLEIC ACIDS RES, V34, P2723, DOI 10.1093/nar/gkl348; Arnoult N, 2015, NAT STRUCT MOL BIOL, V22, P859, DOI 10.1038/nsmb.3092; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bochman ML, 2012, NAT REV GENET, V13, P770, DOI 10.1038/nrg3296; Bouchiat C, 1999, BIOPHYS J, V76, P409, DOI 10.1016/S0006-3495(99)77207-3; Brockman C, 2011, SOFT MATTER, V7, P8005, DOI 10.1039/c1sm05297g; Burger AM, 2005, CANCER RES, V65, P1489, DOI 10.1158/0008-5472.CAN-04-2910; Campbell NH, 2008, J AM CHEM SOC, V130, P6722, DOI 10.1021/ja8016973; Cesare AJ, 2010, NAT REV GENET, V11, P319, DOI 10.1038/nrg2763; Chi QJ, 2013, PHYSICA A, V392, P1072, DOI 10.1016/j.physa.2012.09.022; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; de Messieres M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.058101; De Vlaminck I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041432; FELLER W, 1971, INTRO PROBABILITY TH, V1; FUJIOKA K, 1993, NUCLEIC ACIDS RES, V21, P407, DOI 10.1093/nar/21.3.407; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; GLATTING G, 1995, COLLOID POLYM SCI, V273, P32; Goddard NL, 2000, PHYS REV LETT, V85, P2400, DOI 10.1103/PhysRevLett.85.2400; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hansel R, 2011, NUCLEIC ACIDS RES, V39, P5768, DOI 10.1093/nar/gkr174; Heyer WD, 2010, ANNU REV GENET, V44, P113, DOI 10.1146/annurev-genet-051710-150955; Kar A, 2016, NUCLEIC ACIDS RES, V44, P9369, DOI 10.1093/nar/gkw779; Largy E, 2012, CURR PHARM DESIGN, V18, P1992, DOI 10.2174/138161212799958350; Lee KS, 2014, J MOL BIOL, V426, P2413, DOI 10.1016/j.jmb.2014.04.023; Li J, 2005, NUCLEIC ACIDS RES, V33, P4649, DOI 10.1093/nar/gki782; Lionnet Timothee, 2012, Cold Spring Harb Protoc, V2012, P133, DOI 10.1101/pdb.prot067496; Lipfert J, 2009, BIOPHYS J, V96, P5040, DOI 10.1016/j.bpj.2009.03.055; Lynch S, 2009, CHEM-EUR J, V15, P8113, DOI 10.1002/chem.200901390; Ma WJ, 2013, P NATL ACAD SCI USA, V110, pE2895, DOI 10.1073/pnas.1301676110; Makarov VL, 1997, CELL, V88, P657, DOI 10.1016/S0092-8674(00)81908-X; MARSH TC, 1994, BIOCHEMISTRY-US, V33, P10718, DOI 10.1021/bi00201a020; MITRA S, 1966, J GEN PHYSIOL, V49, P59, DOI 10.1085/jgp.49.6.59; Mo YQ, 2003, CANCER RES, V63, P579; Monchaud D, 2006, BIOORG MED CHEM LETT, V16, P4842, DOI 10.1016/j.bmcl.2006.06.067; Monchaud D, 2010, METHODS MOL BIOL, V608, P257, DOI 10.1007/978-1-59745-363-9_15; Nicholas J, 1998, J Natl Cancer Inst Monogr, P79; Paeschke K, 2008, NAT STRUCT MOL BIOL, V15, P598, DOI 10.1038/nsmb.1422; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Paramasivan S, 2007, METHODS, V43, P324, DOI 10.1016/j.ymeth.2007.02.009; Parkinson GN, 2007, BIOCHEMISTRY-US, V46, P2390, DOI 10.1021/bi062244n; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Petraccone L, 2013, TOP CURR CHEM, V330, P23, DOI 10.1007/128_2012_350; Qureshi MH, 2012, J PHYS CHEM B, V116, P5588, DOI 10.1021/jp300546u; Rademakers R, 2012, NAT REV NEUROL, V8, P423, DOI 10.1038/nrneurol.2012.117; Randall A, 2009, J BIOL CHEM, V284, P13980, DOI 10.1074/jbc.M900631200; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rippe K, 2015, NAT STRUCT MOL BIOL, V22, P853, DOI 10.1038/nsmb.3078; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schaffitzel C, 2001, P NATL ACAD SCI USA, V98, P8572, DOI 10.1073/pnas.141229498; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; SEN D, 1990, NATURE, V344, P410, DOI 10.1038/344410a0; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; Senavirathne G, 2017, NUCLEIC ACIDS RES, V45, P685, DOI 10.1093/nar/gkw920; Shinohara A, 1999, MUTAT RES-DNA REPAIR, V435, P13, DOI 10.1016/S0921-8777(99)00033-6; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; Taylor DJ, 2011, J MOL BIOL, V410, P10, DOI 10.1016/j.jmb.2011.04.049; Thys RG, 2015, J BIOL CHEM, V290, P28953, DOI 10.1074/jbc.M115.660324; Tombline G, 2002, J BIOL CHEM, V277, P14434, DOI 10.1074/jbc.M109917200; Tomonaga T, 1996, P NATL ACAD SCI USA, V93, P5830, DOI 10.1073/pnas.93.12.5830; Wang QA, 2010, ANAL CHEM, V82, P9469, DOI 10.1021/ac102168m; WILLIAMSON JR, 1989, CELL, V59, P871, DOI 10.1016/0092-8674(89)90610-7; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Yu HQ, 2012, J AM CHEM SOC, V134, P20060, DOI 10.1021/ja305384c; Zhang Y, 2001, BIOPHYS J, V81, P1133, DOI 10.1016/S0006-3495(01)75770-0	68	15	15	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9473	9485		10.1074/jbc.RA118.002158	http://dx.doi.org/10.1074/jbc.RA118.002158			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29674319	Green Published, hybrid			2022-12-26	WOS:000435441400030
J	Su, ZD; Deshpande, V; James, DE; Stockli, J				Su, Zhiduan; Deshpande, Vinita; James, David E.; Stockli, Jacqueline			Tankyrase modulates insulin sensitivity in skeletal muscle cells by regulating the stability of GLUT4 vesicle proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						insulin resistance; glucose transport; glucose transporter type 4 (GLUT4); proteomics; skeletal muscle; GLUT4 storage vesicle; Tankyrase	3T3-L1 ADIPOCYTES; STORAGE-VESICLES; MAJOR PROTEIN; RAB-GAP; GLUT4-CONTAINING VESICLES; STIMULATED TRANSLOCATION; GLUCOSE TRANSPORTERS; PLASMA-MEMBRANE; AKT SUBSTRATE; AS160	Tankyrase 1 and 2, members of the poly(ADP-ribose) polymerase family, have previously been shown to play a role in insulin-mediated glucose uptake in adipocytes. However, their precise mechanism of action, and their role in insulin action in other cell types, such as myocytes, remains elusive. Treatment of differentiated L6 myotubes with the small molecule tankyrase inhibitor XAV939 resulted in insulin resistance as determined by impaired insulin-stimulated glucose uptake. Proteomic analysis of XAV939-treated myotubes identified down-regulation of several glucose transporter GLUT4 storage vesicle (GSV) proteins including RAB10, VAMP8, SORT1, and GLUT4. A similar effect was observed following knockdown of tankyrase 1 in L6 myotubes. Inhibition of the proteasome using MG132 rescued GSV protein levels as well as insulin-stimulated glucose uptake in XAV939-treated L6 myotubes. These studies reveal an important role for tankyrase in maintaining the stability of key GLUT4 regulatory proteins that in turn plays a role in regulating cellular insulin sensitivity.	[Su, Zhiduan; Deshpande, Vinita; James, David E.; Stockli, Jacqueline] Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia; [James, David E.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	James, DE; Stockli, J (corresponding author), Univ Sydney, Sch Life & Environm Sci, Charles Perkins Ctr, Sydney, NSW 2006, Australia.; James, DE (corresponding author), Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia.	david.james@sydney.edu.au; jacqueline.stoeckli@sydney.edu.au	Stoeckli, Jacqueline/Z-4443-2019; Stoeckli, Jacqueline/D-7053-2016	Stoeckli, Jacqueline/0000-0002-6446-7350; Stoeckli, Jacqueline/0000-0002-6446-7350; James, David/0000-0001-5946-5257	National Health and Medical Research Council (NHMRC) [GNT1061122, GNT1068469]	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council (NHMRC) project Grants GNT1061122 (to D. E. J.) and GNT1068469 (to J. S). The contents of the published material are solely the responsibility of the individual authors and do not reflect the view of NHMRC. The authors declare that they have no conflicts of interest with the contents of this article.	Adeva-Andany MM, 2016, BBA CLIN, V5, P85, DOI 10.1016/j.bbacli.2016.02.001; Brewer PD, 2016, J BIOL CHEM, V291, P773, DOI 10.1074/jbc.M115.694919; CAIN CC, 1992, J BIOL CHEM, V267, P11681; Chaudhuri R, 2015, NPJ SYST BIOL APPL, V1, DOI 10.1038/npjsba.2015.10; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Cisternas P, 2014, MOL NEUROBIOL, V49, P574, DOI 10.1007/s12035-013-8540-5; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DaRosa PA, 2015, NATURE, V517, P223, DOI 10.1038/nature13826; Dissanayake WC, 2018, EXP CELL RES, V366, P49, DOI 10.1016/j.yexcr.2018.03.011; Fazakerley DJ, 2015, J BIOL CHEM, V290, P23528, DOI 10.1074/jbc.M115.657361; Haikarainen T, 2014, CURR PHARM DESIGN, V20, P6472, DOI 10.2174/1381612820666140630101525; Hashiramoto M, 2000, MOL CELL BIOL, V20, P416, DOI 10.1128/MCB.20.1.416-427.2000; Holland A, 2013, EXPERT REV PROTEOMIC, V10, P239, DOI [10.1586/epr.13.20, 10.1586/EPR.13.20]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang GR, 2013, MOL BIOL CELL, V24, P3115, DOI 10.1091/mbc.E12-10-0765; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ishikura S, 2007, BIOCHEM BIOPH RES CO, V353, P1074, DOI 10.1016/j.bbrc.2006.12.140; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; Jedrychowski MP, 2010, J BIOL CHEM, V285, P104, DOI 10.1074/jbc.M109.040428; Junutula JR, 2004, MOL BIOL CELL, V15, P2218, DOI 10.1091/mbc.E03-10-0777; KANDROR KV, 1994, J BIOL CHEM, V269, P30777; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Li N, 2015, GENE DEV, V29, P157, DOI 10.1101/gad.251785.114; Lin BZ, 1997, J BIOL CHEM, V272, P24145, DOI 10.1074/jbc.272.39.24145; Ma JH, 2014, J BIOL CHEM, V289, P133, DOI [10.1074/jbc.M113.533240, 10.1074/jbc.A113.533240]; MASTICK CC, 1994, J BIOL CHEM, V269, P6089; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Morris NJ, 1998, J BIOL CHEM, V273, P3582, DOI 10.1074/jbc.273.6.3582; Ng Y, 2010, J BIOL CHEM, V285, P2255, DOI 10.1074/jbc.M109.060236; Olson AL, 1997, MOL CELL BIOL, V17, P2425, DOI 10.1128/MCB.17.5.2425; Pan X, 2017, MOL BIOL CELL, V28, P1667, DOI 10.1091/mbc.E16-11-0777; Peck GR, 2006, MOL ENDOCRINOL, V20, P2576, DOI 10.1210/me.2005-0476; PEDERSEN O, 1991, ENDOCRINOLOGY, V129, P771, DOI 10.1210/endo-129-2-771; PEDERSEN O, 1990, DIABETES, V39, P865, DOI 10.2337/diabetes.39.7.865; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROBINSON R, 1993, J BIOL CHEM, V268, P22119; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2008, BIOCHEM J, V411, P89, DOI 10.1042/BJ20071318; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Shewan AM, 2003, MOL BIOL CELL, V14, P973, DOI 10.1091/mbc.E02-06-0315; Shi J, 2005, DEV CELL, V9, P99, DOI 10.1016/j.devcel.2005.04.004; SINHA MK, 1991, DIABETES, V40, P472, DOI 10.2337/diabetes.40.4.472; Stockli J, 2015, DIABETES, V64, P1914, DOI 10.2337/db13-1489; Stockli J, 2011, J CELL SCI, V124, P4147, DOI 10.1242/jcs.097063; Sun Y, 2010, P NATL ACAD SCI USA, V107, P19909, DOI 10.1073/pnas.1009523107; Tan SX, 2012, J BIOL CHEM, V287, P6128, DOI 10.1074/jbc.M111.318238; Thorvaldsen TE, 2017, BASIC CLIN PHARMACOL, V121, P81, DOI 10.1111/bcpt.12786; Tsuchiya Y, 2010, J BIOL CHEM, V285, P34371, DOI 10.1074/jbc.M110.128520; URBE S, 1993, FEBS LETT, V334, P175, DOI 10.1016/0014-5793(93)81707-7; Vazirani RP, 2016, DIABETES, V65, P1577, DOI 10.2337/db15-1128; Wahlberg E, 2012, NAT BIOTECHNOL, V30, P283, DOI 10.1038/nbt.2121; Xie BX, 2016, DIABETES, V65, P3327, DOI 10.2337/db16-0416; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Zhang YJ, 2013, NAT METHODS, V10, P981, DOI 10.1038/nmeth.2603; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao P, 2009, J CELL SCI, V122, P3472, DOI 10.1242/jcs.047449; Zong HH, 2011, DIABETES, V60, P30, DOI 10.2337/db10-0231	62	18	19	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8578	8587		10.1074/jbc.RA117.001058	http://dx.doi.org/10.1074/jbc.RA117.001058			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669812	hybrid, Green Published			2022-12-26	WOS:000434205700021
J	Kharel, Y; Agah, S; Huang, T; Mendelson, AJ; Eletu, OT; Barkey-Bircannl, P; Gesualdil, J; Smith, JS; Santos, WL; Lynch, KR				Kharel, Yugesh; Agah, Sayeh; Huang, Tao; Mendelson, Anna J.; Eletu, Oluwafunmilayo T.; Barkey-Bircannl, Peter; Gesualdil, James; Smith, Jeffrey S.; Santos, Webster L.; Lynch, Kevin R.			Saccharomyces cerevisiae as a platform for assessing sphingolipid lipid kinase inhibitors	PLOS ONE			English	Article							SPHINGOSINE KINASE; ASSAY; 1-PHOSPHATE; DISCOVERY; POTENT; CELLS	Successful medicinal chemistry campaigns to discover and optimize sphingosine kinase inhibitors require a robust assay for screening chemical libraries and for determining rank order potencies. Existing assays for these enzymes are laborious, expensive and/or low throughput. The toxicity of excessive levels of phosphorylated sphingoid bases for the budding yeast, Saccharomyces cerevisiae, affords an assay wherein inhibitors added to the culture media rescue growth in a dose-dependent fashion. Herein, we describe our adaptation of a simple, inexpensive, and high throughput assay for assessing inhibitors of sphingosine kinase types 1 and 2 as well as ceramide kinase and for testing enzymatic activity of sphingosine kinase type 2 mutants. The assay was validated using recombinant enzymes and generally agrees with the rank order of potencies of existing inhibitors.	[Kharel, Yugesh; Agah, Sayeh; Huang, Tao; Mendelson, Anna J.; Eletu, Oluwafunmilayo T.; Barkey-Bircannl, Peter; Gesualdil, James; Lynch, Kevin R.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA; [Smith, Jeffrey S.] Univ Virginia, Biochem & Mol Genet, Charlottesville, VA USA; [Santos, Webster L.] Virginia Tech, Dept Chem, Blacksburg, VA USA; [Santos, Webster L.] Virginia Tech, VT Ctr Drug Discovery, Blacksburg, VA USA	University of Virginia; University of Virginia; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Lynch, KR (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.	krl2z@virginia.edu	; lynch, kevin/F-3996-2012	Santos, Webster/0000-0002-4731-8548; Kharel, Yugesh/0000-0001-9241-6860; Smith, Jeffrey/0000-0001-7129-5094; lynch, kevin/0000-0002-7376-922X	NIH/NIGMS [R01 GM104366, R01 GM121075]; NIH [R01 GM075240]; NIGMS; University of Virginia Summer Research Internship Program fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM121075, R01GM075240, R01GM104366] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); University of Virginia Summer Research Internship Program fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH/NIGMS R01 GM104366 & NIH/NIGMS R01 GM121075 to KRL & WLS, NIH R01 GM075240 to JSS, NIGMS: https://www.nigms.nih.gov/Pages/default.aspx; University of Virginia Summer Research Internship Program fellowships to JG and PBB https://med.virginia.edu/diversity/programs/srip/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker DL, 2013, BBA-MOL CELL BIOL L, V1831, P139, DOI 10.1016/j.bbalip.2012.09.006; Billich A, 2004, ANAL BIOCHEM, V326, P114, DOI 10.1016/j.ab.2003.11.018; Ernst R, 2005, METHOD ENZYMOL, V400, P460, DOI 10.1016/S0076-6879(05)00026-1; French KJ, 2010, J PHARMACOL EXP THER, V333, P129, DOI 10.1124/jpet.109.163444; French KJ, 2003, CANCER RES, V63, P5962; Graf C, 2008, MOL PHARMACOL, V74, P925, DOI 10.1124/mol.108.048652; Highkin MK, 2011, J BIOMOL SCREEN, V16, P272, DOI 10.1177/1087057110391656; Kashem MA, 2016, ASSAY DRUG DEV TECHN, V14, P39, DOI 10.1089/adt.2015.671; Kharel Y, 2015, J PHARMACOL EXP THER, V355, P23, DOI 10.1124/jpet.115.225862; Kharel Y, 2011, BIOCHEM J, V440, P345, DOI 10.1042/BJ20110817; Kharel Y, 2011, ANAL BIOCHEM, V411, P230, DOI 10.1016/j.ab.2011.01.003; Kim S, 2000, GENETICS, V156, P1519; Patwardhan NN, 2015, J MED CHEM, V58, P1879, DOI 10.1021/jm501760d; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Pitson SM, 2001, FEBS LETT, V509, P169; Roberts JL, 2004, ANAL BIOCHEM, V331, P122, DOI 10.1016/j.ab.2004.03.030; Schnute ME, 2012, BIOCHEM J, V444, P79, DOI 10.1042/BJ20111929; Skrzypek MS, 1999, J BACTERIOL, V181, P1134, DOI 10.1128/JB.181.4.1134-1140.1999; Wang J, 2014, ACS MED CHEM LETT, V5, P1329, DOI 10.1021/ml5004074; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Xiang YB, 2009, BIOORG MED CHEM LETT, V19, P6119, DOI 10.1016/j.bmcl.2009.09.022; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905; Zhang XP, 2001, CURR GENET, V40, P221, DOI 10.1007/s00294-001-0259-6	23	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0192179	10.1371/journal.pone.0192179	http://dx.doi.org/10.1371/journal.pone.0192179			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672528	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800003
J	Konno, N; Sugimoto, M; Takagi, T; Furuya, M; Asano, T; Sato, S; Kobayashi, H; Migita, K; Miura, Y; Aihara, T; Komatsuda, A; Ohira, H; Watanabe, H				Konno, Naoki; Sugimoto, Mitsuru; Takagi, Tadayuki; Furuya, Makiko; Asano, Tomoyuki; Sato, Shuzo; Kobayashi, Hiroko; Migita, Kiyoshi; Miura, Yoshiaki; Aihara, Taichi; Komatsuda, Atsushi; Ohira, Hiromasa; Watanabe, Hiroshi			Changes in N-glycans of IgG4 and its relationship with the existence of hypocomplementemia and individual organ involvement in patients with IgG4-related disease	PLOS ONE			English	Article							FC-GAMMA-RIII; RHEUMATOID-ARTHRITIS; COMPLEMENT ACTIVATION; IMMUNOGLOBULIN-G; SERUM IGG; TUBULOINTERSTITIAL NEPHRITIS; ANTIINFLAMMATORY ACTIVITY; RETROPERITONEAL FIBROSIS; AUTOIMMUNE PANCREATITIS; SCLEROSING PANCREATITIS	Background Although increased serum IgG4 level and tissue infiltration of IgG4-positive cells are key events in IgG4-related disease (IgG4RD), and nearly half of IgG4RD patients show hypocomplementemia, the role of IgG4 in the pathogenesis of IgG4RD remains unclear. Many reports show that altered IgG glycosylation, especially IgG with agalactosylated N-linked glycan (G0 N-glycan), have proinflammatory roles including complement activation, implicated in the pathogenesis of various inflammatory diseases. This study determined the concentration of N-linked glycans (N-glycan) released from serum IgG4 in IgG4RD patients and compared the difference of glycosylation changes to those in healthy controls. We also compared the concentration of each IgG4 glycoform between patients with and without hypocomplementemia and individual organ involvement (kidney, pancreas, lymph node) in IgG4RD. Methods We collected sera from 12 IgG4RD patients and 8 healthy controls. IgG4 was isolated from sera via Melon (TM) Gel IgG Spin Purification Kit followed by Capture Select IgG4 (Hu) Affinity Matrix. IgG4 N-glycans were analyzed by S-BIO GlycanMap (R) Xpress methodology. Results Significant increases of IgG4 G0 N-glycan and IgG4 fucosylated N-glycan (F1 N-glycan) concentrations were observed in IgG4RD compared with healthy controls. Although we observed decreased levels of IgG4 F0 glycan in IgG4RD with hypocomplementemia, there were no significant differences in the galactosylation and sialyation of IgG4 N-glycans. Furthermore, there were no significant differences in the glycosylation of IgG4 N-glycans between patients with and without individual organ involvement of IgG4RD. Conclusions Although IgG4 has anti-inflammatory properties, IgG4 G0 and F1 glycans were increased in patients with IgG4RD. Our results suggest that decreased galactosylation of IgG4 is not related to complement activation and the differences of individual organ involvement in IgG4RD. IgG4 fucosylation change may be related to complement activation in IgG4RD. Further investigation is needed to clarify the role of IgG4 in IgG4RD.	[Konno, Naoki; Sugimoto, Mitsuru; Takagi, Tadayuki; Ohira, Hiromasa] Fukushima Med Univ, Sch Med, Dept Gastroenterol, Fukushima, Japan; [Furuya, Makiko; Asano, Tomoyuki; Sato, Shuzo; Kobayashi, Hiroko; Migita, Kiyoshi; Watanabe, Hiroshi] Fukushima Med Univ, Sch Med, Dept Rheumatol, Fukushima, Japan; [Miura, Yoshiaki; Aihara, Taichi] Sumitomo Bakelite Co Ltd, S Bio, Hudson, NH USA; [Komatsuda, Atsushi] Akita Univ, Sch Med, Dept Hematol Nephrol & Rheumatol, Akita, Japan	Fukushima Medical University; Fukushima Medical University; Akita University	Watanabe, H (corresponding author), Fukushima Med Univ, Sch Med, Dept Rheumatol, Fukushima, Japan.	chiehiro@fmu.ac.jp	Sato, Shuzo/AAC-7025-2019; Sato, Shuzo/AAI-7862-2020	Sato, Shuzo/0000-0002-8110-8261; Sugimoto, Mitsuru/0000-0002-4223-613X	JSPS KAKENHI [JP15K09554]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research (C)), Grant Number: JP15K09554. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Although three authors in this study (YM, TA, AK) are employed by Sumitomo Bakelite Co. Ltd., this company is not a funding company, but an outsourcing company. Sumitomo Bakelite Co. Ltd. did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; Anumula KR, 2012, J IMMUNOL METHODS, V382, P167, DOI 10.1016/j.jim.2012.05.022; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; AXFORD JS, 1987, LANCET, V2, P1486; AXFORD JS, 1992, J CLIN INVEST, V89, P1021, DOI 10.1172/JCI115643; Banda NK, 2008, ARTHRITIS RHEUM-US, V58, P3081, DOI 10.1002/art.23865; Prados MB, 2011, IMMUNOL LETT, V137, P28, DOI 10.1016/j.imlet.2011.01.017; BOREL IM, 1991, J REPROD IMMUNOL, V20, P129, DOI 10.1016/0165-0378(91)90029-P; Borrok MJ, 2012, ACS CHEM BIOL, V7, P1596, DOI 10.1021/cb300130k; BRUGGEMANN M, 1987, J EXP MED, V166, P1351, DOI 10.1084/jem.166.5.1351; CANFIELD SM, 1991, J EXP MED, V173, P1483, DOI 10.1084/jem.173.6.1483; Chang SY, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/121702; Chen GQ, 2012, J PROTEOMICS, V75, P2824, DOI 10.1016/j.jprot.2012.02.001; Dahlgren M, 2010, ARTHRIT CARE RES, V62, P1312, DOI 10.1002/acr.20215; DANGL JL, 1988, EMBO J, V7, P1989, DOI 10.1002/j.1460-2075.1988.tb03037.x; Della-Torre E, 2015, CLIN EXP IMMUNOL, V181, P191, DOI 10.1111/cei.12641; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Ferrari S, 2009, J THROMB HAEMOST, V7, P1703, DOI 10.1111/j.1538-7836.2009.03568.x; Furukawa JI, 2008, ANAL CHEM, V80, P1094, DOI 10.1021/ac702124d; Gniadecki R, 2006, AUTOIMMUNITY, V39, P541, DOI 10.1080/08916930600971505; Gornik I, 1999, CLIN BIOCHEM, V32, P605, DOI 10.1016/S0009-9120(99)00060-0; Hamano H, 2002, LANCET, V359, P1403, DOI 10.1016/S0140-6736(02)08359-9; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Holland M, 2006, BBA-GEN SUBJECTS, V1760, P669, DOI 10.1016/j.bbagen.2005.11.021; Holland M, 2004, CLIN EXP IMMUNOL, V138, P183, DOI 10.1111/j.1365-2249.2004.02566.x; Holland M, 2002, CLIN EXP IMMUNOL, V129, P183, DOI 10.1046/j.1365-2249.2002.01864.x; Huijbers MG, 2013, P NATL ACAD SCI USA, V110, P20783, DOI 10.1073/pnas.1313944110; Hussain A, 2009, IMMUNOLOGY, V128, P236, DOI 10.1111/j.1365-2567.2009.03108.x; ISENMAN DE, 1975, J IMMUNOL, V114, P1726; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kawano M, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/609795; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; Kristic J, 2014, J GERONTOL A-BIOL, V69, P779, DOI 10.1093/gerona/glt190; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; MARGNI RA, 1988, ANNU REV IMMUNOL, V6, P535, DOI 10.1146/annurev.iy.06.040188.002535; Margni RA, 1998, IMMUNOL REV, V163, P77, DOI 10.1111/j.1600-065X.1998.tb01189.x; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Maverakis E, 2015, J AUTOIMMUN, V57, P1, DOI 10.1016/j.jaut.2014.12.002; Miura Y, 2007, CHEM-EUR J, V13, P4797, DOI 10.1002/chem.200601872; Muraki T, 2006, PANCREAS, V32, P16, DOI 10.1097/01.mpa.0000188308.75043.e4; Nagamachi S, 2011, CASE REP NEPHROL DIA, V1, P7, DOI 10.1159/000330664; Nimmerjahn F, 2007, P NATL ACAD SCI USA, V104, P8433, DOI 10.1073/pnas.0702936104; Nirula A, 2011, CURR OPIN RHEUMATOL, V23, P119, DOI 10.1097/BOR.0b013e3283412fd4; Nishimura SI, 2005, ANGEW CHEM INT EDIT, V44, P91, DOI 10.1002/anie.200461685; Okazaki K, 2011, J GASTROENTEROL, V46, P277, DOI 10.1007/s00535-011-0386-x; PAREKH R, 1989, J AUTOIMMUN, V2, P101, DOI 10.1016/0896-8411(89)90148-0; PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; Plomp JJ, 2012, ANN NY ACAD SCI, V1275, P114, DOI 10.1111/j.1749-6632.2012.06808.x; ROCK B, 1989, NEW ENGL J MED, V320, P1463, DOI 10.1056/NEJM198906013202206; ROOK GAW, 1991, J AUTOIMMUN, V4, P779, DOI 10.1016/0896-8411(91)90173-A; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Sjowall C, 2015, LUPUS, V24, P569, DOI 10.1177/0961203314558861; Stadlmann J, 2009, PROTEOMICS, V9, P4143, DOI 10.1002/pmic.200800931; Stone JH, 2012, NEW ENGL J MED, V366, P539, DOI 10.1056/NEJMra1104650; Sugimoto M, 2016, MOD RHEUMATOL, V26, P251, DOI 10.3109/14397595.2015.1076924; Takeda S, 2004, NEPHROL DIAL TRANSPL, V19, P474, DOI 10.1093/ndt/gfg477; TAO MH, 1993, J EXP MED, V178, P661, DOI 10.1084/jem.178.2.661; Uchiyama-Tanaka Y, 2004, AM J KIDNEY DIS, V43, DOI 10.1053/j.ajkd.2003.12.006; Umehara H, 2014, INT IMMUNOL, V26, P585, DOI 10.1093/intimm/dxu074; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; VANDERZEE JS, 1986, J IMMUNOL, V137, P3566; Wang J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.004655; Yamamoto M, 2004, SCAND J RHEUMATOL, V33, P432, DOI 10.1080/03009740410006439; Zen Y, 2009, AM J SURG PATHOL, V33, P1833, DOI 10.1097/PAS.0b013e3181b72882; Zou GZ, 2011, J AM CHEM SOC, V133, P18975, DOI 10.1021/ja208390n	69	18	21	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196163	10.1371/journal.pone.0196163	http://dx.doi.org/10.1371/journal.pone.0196163			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672582	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800097
J	Kumar, S; Saini, V; Maurya, IK; Sindhu, J; Kumari, M; Kataria, R; Kumar, V				Kumar, Sunil; Saini, Vikram; Maurya, Indresh K.; Sindhu, Jayant; Kumari, Mukesh; Kataria, Ramesh; Kumar, Vinod			Design, synthesis, DFT, docking studies and ADME prediction of some new coumarinyl linked pyrazolylthiazoles: Potential standalone or adjuvant antimicrobial agents	PLOS ONE			English	Article							SOLVENT-FREE SYNTHESIS; ANTIBACTERIAL ACTIVITY; PHARMACOLOGICAL EVALUATION; MOLECULAR HYBRIDIZATION; BIOLOGICAL EVALUATION; PYRAZOLE; DERIVATIVES; ANTIOXIDANT; BACILLAMIDE; CANDIDIASIS	The control of antimicrobial resistance (AMR) seems to have come to a dead end. The major consequences of the use and abuse of antibacterial drugs are the development of resistant strains due to genetic mutability of both pathogenic and nonpathogenic microorganisms. We, herein, report the synthesis, characterization and biological activities of coumarin-thiazole-pyrazole (CTP) molecular hybrids with an effort to explore and overcome the increasing antimicrobial resistance. The compounds were characterized by analyzing their IR, Mass, H-1 and C-13 NMR spectral data and elemental analysis. The in vitro antimicrobial activity of the synthesized compounds was investigated against various pathogenic strains; the results obtained were further explained with the help of DFT and molecular orbital calculations. Compound 1b and 1f displayed good antimicrobial activity and synergistic effects when used with kanamycin and amphotericin B. Furthermore, in vitro cytotoxicity of compounds 1b and 1f were studied against HeLa cells (cervical cancer cell) and Hek-293 cells. The results of molecular docking study were used to better rationalize the action and prediction of the binding modes of these compounds.	[Kumar, Sunil; Kataria, Ramesh] Panjab Univ, Dept Chem, Chandigarh, India; [Kumar, Sunil; Kataria, Ramesh] Panjab Univ, Ctr Adv Studies Chem, Chandigarh, India; [Saini, Vikram] AIIMS New Delhi, Dept Biotechnol, Delhi, India; [Maurya, Indresh K.] Panjab Univ, Dept Microbial Biotechnol, Chandigarh, India; [Sindhu, Jayant] KM Govt Coll, Narwana, India; [Kumari, Mukesh] Kurukshetra Univ, Dept Chem, Kurukshetra, Haryana, India; [Kumar, Vinod] MM Univ, Dept Chem, Mullana Ambala, India	Panjab University; Panjab University; All India Institute of Medical Sciences (AIIMS) New Delhi; Panjab University; Kurukshetra University; Maharishi Markandeshwar University	Kataria, R (corresponding author), Panjab Univ, Dept Chem, Chandigarh, India.; Kataria, R (corresponding author), Panjab Univ, Ctr Adv Studies Chem, Chandigarh, India.; Kumar, V (corresponding author), MM Univ, Dept Chem, Mullana Ambala, India.	rkataria@pu.ac.in; vinodbatan@gmail.com	Kumar, Sunil/GNP-7221-2022; Saini, Vikram/B-4547-2009; Kumar, Vinod/S-8316-2016	Saini, Vikram/0000-0002-0258-2871; KUMAR, SUNIL/0000-0003-0492-8597; Kumar, Vinod/0000-0002-8940-409X; Maurya, DST-INSPIRE FACULTY, Dr. Indresh Kumar/0000-0002-2377-3693	University Grant Commission, New Delhi, India [F.30- 86/2014 (BSR)]	University Grant Commission, New Delhi, India(University Grants Commission, India)	This work was financially supported by the University Grant Commission in the form of UGC-BSR research start up grant (F.30- 86/2014 (BSR)), New Delhi, India. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal R, 2006, BIOORGAN MED CHEM, V14, P1785, DOI 10.1016/j.bmc.2005.10.026; Aggarwal R, 2013, MED CHEM RES, V22, P3566, DOI 10.1007/s00044-012-0343-0; Aggarwal R, 2013, EUR J MED CHEM, V62, P508, DOI 10.1016/j.ejmech.2012.11.046; Aggarwal R, 2011, J FLUORINE CHEM, V132, P965, DOI 10.1016/j.jfluchem.2011.07.029; Anantharaman A, 2010, ANTIMICROB AGENTS CH, V54, P1693, DOI 10.1128/AAC.01231-09; [Anonymous], 2008, STAND A; Barnhill AE, 2012, ANTIMICROB AGENTS CH, V56, P4046, DOI 10.1128/AAC.00678-12; Bollenbach T, 2015, CURR OPIN MICROBIOL, V27, P1, DOI 10.1016/j.mib.2015.05.008; Bray CD, 2010, SYNLETT, P599, DOI 10.1055/s-0029-1219153; Brogden K.A., 2002, INTERACTIONS CANDIDA; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Chen LZ, 2017, EUR J MED CHEM, V138, P170, DOI 10.1016/j.ejmech.2017.06.044; Dawood KM, 2013, EUR J MED CHEM, V70, P740, DOI 10.1016/j.ejmech.2013.10.042; El-Sabbagh OI, 2009, EUR J MED CHEM, V44, P3746, DOI 10.1016/j.ejmech.2009.03.038; Frisch M.J., 2016, GAUSSIAN16 REV B01; GARG HG, 1969, J MED CHEM, V12, P1122, DOI 10.1021/jm00306a047; Hassan MZ, 2016, EUR J MED CHEM, V123, P236, DOI 10.1016/j.ejmech.2016.07.056; Higgins JA, 1974, YALE J BIOL MED, V47, P140; Jeong SY, 2003, TETRAHEDRON LETT, V44, P8005, DOI 10.1016/j.tetlet.2003.08.115; Jorgensen J. H., 2015, MANUAL CLIN MICROBIO, P1253, DOI [DOI 10.1128/9781555817381.CH71, 10.1128/9781555817381]; Kaur K, 2016, MED CHEM RES, V25, P2237, DOI 10.1007/s00044-016-1663-2; Kaur K, 2015, MED CHEM RES, V24, P4023, DOI 10.1007/s00044-015-1452-3; Kaur K, 2015, MED CHEM RES, V24, P3863, DOI 10.1007/s00044-015-1429-2; Khalil AM, 2009, EUR J MED CHEM, V44, P4434, DOI 10.1016/j.ejmech.2009.06.002; Khode S, 2009, EUR J MED CHEM, V44, P1682, DOI 10.1016/j.ejmech.2008.09.020; Kitara LD, 2011, AFR HEALTH SCI, V11, pS34; Klepser ME, 1998, ANTIMICROB AGENTS CH, V42, P1207, DOI 10.1128/AAC.42.5.1207; KOELSCH CF, 1950, J AM CHEM SOC, V72, P2993, DOI 10.1021/ja01163a053; Koopmans T., 1933, PHYSICA, V1, P104, DOI [DOI 10.1016/S0031-8914(34)90011-2, 10.1016/S0031-8914(34)90011-2]; Kucerova-Chlupacova M, 2016, MOLECULES, V21, DOI 10.3390/molecules21111421; Kumar D, 2004, HETEROCYCLES, V63, P145, DOI 10.3987/REV-03-569; Kumar M, 2015, MED CHEM RES, V24, P2862, DOI 10.1007/s00044-015-1340-x; Kumar S, 2016, EUR J MED CHEM, V123, P916, DOI 10.1016/j.ejmech.2016.07.076; Kumar S, 2016, EUR J MED CHEM, V123, P718, DOI 10.1016/j.ejmech.2016.07.033; Kumar S, 2015, SYNTHETIC COMMUN, V45, P2022, DOI 10.1080/00397911.2015.1062986; Kumar V, 2005, EUR J MED CHEM, V40, P922, DOI 10.1016/j.ejmech.2005.03.021; Kumar V, 2014, EUR J MED CHEM, V81, P267, DOI 10.1016/j.ejmech.2014.05.004; Kumar V, 2013, EUR J MED CHEM, V69, P735, DOI 10.1016/j.ejmech.2013.08.053; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lu JJ, 2004, J MED CHEM, V47, P6104, DOI 10.1021/jm0306529; Luepke KH, 2017, EXPERT REV ANTI-INFE, V15, P425, DOI 10.1080/14787210.2017.1308251; Mabkhot YN, 2015, CHEM CENT J, V9, DOI 10.1186/s13065-015-0100-9; Madhavan GR, 2003, BIOORG MED CHEM LETT, V13, P2547, DOI 10.1016/S0960-894X(03)00490-6; Maestro S, 2011, VERS 9 2; Manojkumar P, 2009, EUR J MED CHEM, V44, P4690, DOI 10.1016/j.ejmech.2009.07.004; Manojkumar P, 2009, ACTA PHARMACEUT, V59, P159, DOI 10.2478/v10007-009-0018-7; MARES D, 1989, MYCOPATHOLOGIA, V108, P37, DOI 10.1007/BF00436782; Maurya IK, 2013, BBA-GEN SUBJECTS, V1830, P5193, DOI 10.1016/j.bbagen.2013.07.016; McVicker G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003959; Mermel LA, 2001, CLIN INFECT DIS, V32, P1249, DOI 10.1086/320001; Mert S, 2014, EUR J MED CHEM, V78, P86, DOI 10.1016/j.ejmech.2014.03.033; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Oruc EE, 2006, ARCH PHARM, V339, P267, DOI 10.1002/ardp.200500202; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Padmavathi V, 2011, EUR J MED CHEM, V46, P5317, DOI 10.1016/j.ejmech.2011.08.032; PARR RG, 1984, J AM CHEM SOC, V106, P4049, DOI 10.1021/ja00326a036; Parrino B, 2017, EUR J MED CHEM, V138, P371, DOI 10.1016/j.ejmech.2017.06.052; Pathak S, 2011, ANTIMICROB AGENTS CH, V55, P2178, DOI 10.1128/AAC.01493-10; Pauling L, 1960, NATURE CHEM BOND, VThird, P644; Pfaller MA, 1996, CLIN INFECT DIS, V22, pS89, DOI 10.1093/clinids/22.Supplement_2.S89; Rane RA, 2010, BIOORG MED CHEM LETT, V20, P5681, DOI 10.1016/j.bmcl.2010.08.026; Reed JL, 1997, J PHYS CHEM A, V101, P7396, DOI 10.1021/jp9711050; Schelenz S, 2007, J ANTIMICROB CHEMOTH, V61, pI31, DOI 10.1093/jac/dkm430; Sharma PK, 1997, BIOORG MED CHEM LETT, V7, P2427, DOI 10.1016/S0960-894X(97)00449-6; Sharma RN, 2009, J ENZYM INHIB MED CH, V24, P890, DOI 10.1080/14756360802519558; Shi JB, 2015, EUR J MED CHEM, V90, P889, DOI 10.1016/j.ejmech.2014.12.013; Sindhu J, 2016, MED CHEM RES, V25, P1813, DOI 10.1007/s00044-016-1604-0; Sindhu J, 2015, CHINESE CHEM LETT, V26, P50, DOI 10.1016/j.cclet.2014.09.006; Singh K, 2014, EUR J MED CHEM, V87, P150, DOI 10.1016/j.ejmech.2014.09.055; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Viegas-Junior C, 2007, CURR MED CHEM, V14, P1829; Vijesh AM, 2013, EUR J MED CHEM, V62, P410, DOI 10.1016/j.ejmech.2012.12.057; Wu H, 2015, INT J ORAL SCI, V7, P1, DOI 10.1038/ijos.2014.65	74	41	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196016	10.1371/journal.pone.0196016	http://dx.doi.org/10.1371/journal.pone.0196016			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672633	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800068
J	Madehkhaksar, F; Klenk, J; Sczuka, K; Gordt, K; Melzer, I; Schwenk, M				Madehkhaksar, Forough; Klenk, Jochen; Sczuka, Kim; Gordt, Katharina; Melzer, Itshak; Schwenk, Michael			The effects of unexpected mechanical perturbations during treadmill walking on spatiotemporal gait parameters, and the dynamic stability measures by which to quantify postural response	PLOS ONE			English	Article							OLDER-ADULTS; BALANCE; FALLS; VARIABILITY; IMPACT; RISK	Most falls occur after a loss of balance following an unexpected perturbation such as a slip or a trip. Greater understanding of how humans control and maintain stability during perturbed walking may help to develop appropriate fall prevention programs. The aim of this study was to examine changes in spatiotemporal gait and stability parameters in response to sudden mechanical perturbations in medio-lateral (ML) and anterior-posterior (AP) direction during treadmill walking. Moreover, we aimed to evaluate which parameters are most representative to quantify postural recovery responses. Ten healthy adults (mean = 26.4, SD = 4.1 years) walked on a treadmill that provided unexpected discrete ML and AP surface horizontal perturbations. Participants walked under no perturbation (normal walking), and under left, right, forward, and backward sudden mechanical perturbation conditions. Gait parameters were computed including stride length (SL), step width (SW), and cadence, as well as dynamic stability in AP- (MoS-AP) and ML- (MoS-ML) directions. Gait and stability parameters were quantified by means, variability, and extreme values. Overall, participants walked with a shorter stride length, a wider step width, and a higher cadence during perturbed walking, but despite this, the effect of perturbations on means of SW and MoS-ML was not statistically significant. These effects were found to be significantly greater when the perturbations were applied toward the ML-direction. Variabilities, as well as extremes of gait-related parameters, showed strong responses to the perturbations. The higher variability as a response to perturbations might be an indicator of instability and fall risk, on the same note, an adaptation strategy and beneficial to recover balance. Parameters identified in this study may represent useful indicators of locomotor adaptation to successfully compensate sudden mechanical perturbation during walking. The potential association of the extracted parameters with fall risk needs to be determined in fall-prone populations.	[Madehkhaksar, Forough] Heidelberg Univ, Dept Sports Sci, Heidelberg, Germany; [Madehkhaksar, Forough; Klenk, Jochen; Sczuka, Kim; Gordt, Katharina; Schwenk, Michael] Robert Bosch Krankenhaus, Dept Clin Gerontol & Rehabil, Stuttgart, Germany; [Klenk, Jochen] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Gordt, Katharina; Schwenk, Michael] Heidelberg Univ, NAR, Heidelberg, Germany; [Melzer, Itshak] Ben Gurion Univ Negev, Dept Phys Therapy, Fac Hlth Sci, Beer Sheva, Israel	Ruprecht Karls University Heidelberg; Bosch; Robert Bosch Krankenhaus; Ulm University; Ruprecht Karls University Heidelberg; Ben Gurion University	Madehkhaksar, F (corresponding author), Heidelberg Univ, Dept Sports Sci, Heidelberg, Germany.; Madehkhaksar, F (corresponding author), Robert Bosch Krankenhaus, Dept Clin Gerontol & Rehabil, Stuttgart, Germany.	madehkhaksar@stud.uni-heidelberg.de	Klenk, Jochen/C-2164-2012; MELZER, ITSHAK/F-1972-2012; Klenk, Jochen/R-3614-2019	MELZER, ITSHAK/0000-0001-7769-845X; Klenk, Jochen/0000-0002-5987-447X; Madehkhaksar, Forough/0000-0002-2980-9335	Network Aging Research (NAR); Deutsche Forschungsmemeintschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Network Aging Research (NAR); Deutsche Forschungsmemeintschaft; Baden-Wurttemberg Ministry of Science, Research and the Arts; Ruprecht-Karls-Universitat Heidelberg	Forough Madehkhaksar was supported by Network Aging Research (NAR) during working on this project. We acknowledge financial support by Deutsche Forschungsmemeintschaft within the funding programme Open Access Publishing, by the Baden-Wurttemberg Ministry of Science, Research and the Arts and by Ruprecht-Karls-Universitat Heidelberg.	Brach JS, 2008, GAIT POSTURE, V27, P431, DOI 10.1016/j.gaitpost.2007.05.016; Brady RA, 2009, GAIT POSTURE, V29, P645, DOI 10.1016/j.gaitpost.2009.01.010; Caetano MJD, 2017, J GERONTOL A-BIOL, V72, P1257, DOI 10.1093/gerona/glw171; Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905; Espy DD, 2010, GAIT POSTURE, V32, P378, DOI 10.1016/j.gaitpost.2010.06.013; Francis CA, 2015, GAIT POSTURE, V42, P380, DOI 10.1016/j.gaitpost.2015.07.006; Hak L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082842; Hak L, 2013, J BIOMECH, V46, P905, DOI 10.1016/j.jbiomech.2012.12.017; Hak L, 2012, GAIT POSTURE, V36, P260, DOI 10.1016/j.gaitpost.2012.03.005; HAUSDORFF JM, 1994, J AM GERIATR SOC, V42, P1056, DOI 10.1111/j.1532-5415.1994.tb06209.x; Hof AL, 2010, J EXP BIOL, V213, P2655, DOI 10.1242/jeb.042572; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hof AL, 2008, HUM MOVEMENT SCI, V27, P112, DOI 10.1016/j.humov.2007.08.003; Hof AL, 2007, GAIT POSTURE, V25, P250, DOI 10.1016/j.gaitpost.2006.04.013; KING MB, 1995, J AM GERIATR SOC, V43, P1146, DOI 10.1111/j.1532-5415.1995.tb07017.x; Kuo AD, 1999, INT J ROBOT RES, V18, P917, DOI 10.1177/02783649922066655; LIPSITZ LA, 1990, CIRCULATION, V81, P1803, DOI 10.1161/01.CIR.81.6.1803; Maki BE, 1997, J AM GERIATR SOC, V45, P313, DOI 10.1111/j.1532-5415.1997.tb00946.x; Maki BE, 2008, J ELECTROMYOGR KINES, V18, P243, DOI 10.1016/j.jelekin.2007.06.005; McAndrew PM, 2010, J BIOMECH, V43, P1470, DOI 10.1016/j.jbiomech.2010.02.003; McCrum C, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12222; McIntosh EI, 2016, J MOTOR BEHAV, P1; O'Connor SM, 2009, J NEUROPHYSIOL, V102, P1411, DOI 10.1152/jn.00131.2009; Pai YC, 1997, J BIOMECH, V30, P347, DOI 10.1016/S0021-9290(96)00165-0; Punt M, 2017, J BIOMECH, V55, P56, DOI 10.1016/j.jbiomech.2017.02.010; Rispens SM, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.3931; Schonnop R, 2013, CAN MED ASSOC J, V185, pE803, DOI 10.1503/cmaj.130498; Schwenk M, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-50; Shapiro A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-32; Stokes HE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00942-x; Suptitz F, 2013, HUM MOVEMENT SCI, V32, P1404, DOI 10.1016/j.humov.2013.07.008; Suptitz F, 2012, J ELECTROMYOGR KINES, V22, P301, DOI 10.1016/j.jelekin.2011.12.007; Tay CS, 2016, GAIT POSTURE, V43, P17, DOI 10.1016/j.gaitpost.2015.10.010; Terry K, 2012, J BIOMECH, V45, P1979, DOI 10.1016/j.jbiomech.2012.05.006; Yang F, 2014, J BIOMECH, V47, P3876, DOI 10.1016/j.jbiomech.2014.10.006; Yang Y, 2016, OSTEOPOROSIS INT, V27, P537, DOI 10.1007/s00198-015-3268-x; Young PMM, 2012, J BIOMECH, V45, P1053, DOI 10.1016/j.jbiomech.2011.12.027; Zeni JA, 2008, GAIT POSTURE, V27, P710, DOI 10.1016/j.gaitpost.2007.07.007	38	34	34	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195902	10.1371/journal.pone.0195902	http://dx.doi.org/10.1371/journal.pone.0195902			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672558	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800058
J	Wegmann, E; Ostendort, S; Brand, M				Wegmann, Elisa; Ostendort, Sina; Brand, Matthias			Is it beneficial to use Internet-communication for escaping from boredom? Boredom proneness interacts with cue-induced craving and avoidance expectancies in explaining symptoms of Internet-communication disorder	PLOS ONE			English	Article							ONLINE SOCIAL NETWORKING; SENSATION SEEKING; LEISURE BOREDOM; SUBSTANCE USE; CYBERSEX ADDICTION; STRESS; PORNOGRAPHY; REACTIVITY; BEHAVIORS; USAGE	The use of online-communication applications including messengers (e.g. WhatsApp) or social networking services (e.g. Facebook) on the smartphone has turned into daily practice for billions of people, for example during waiting times. An increasing number of individuals show diminished control over their usage of these applications despite negative consequences in everyday life. This can be referred to as Internet-communication disorder (ICD). The current study investigated the effect of boredom proneness on symptoms of an ICD. It further examined the mediating role of cognitive and affective mechanisms, namely expectancies to avoid negative feelings online and cue-induced craving. The results of a structural equation model (N = 148) illustrate that boredom proneness is a risk factor for the development and maintenance of an ICD as it had a significant direct effect on ICD symptoms. Furthermore, boredom proneness predicted avoidance expectancies as well as cue-induced craving. Both in turn enhanced the risk of developing ICD tendencies. Moreover, both variables mediated the effect of boredom proneness on ICD and interacted among each other. In summary, the results demonstrate that people who have a higher susceptibility to experience boredom show higher expectancies to avoid negative emotions online, which promotes higher craving reactions when being confronted with specific cues (e.g. an incoming message), and could result in ICD tendencies.	[Wegmann, Elisa; Ostendort, Sina; Brand, Matthias] Univ Duisburg Essen, Dept Gen Psychol, Cognit, Duisburg, Germany; [Wegmann, Elisa; Ostendort, Sina; Brand, Matthias] Univ Duisburg Essen, Ctr Behav Addict Res CeBAR, Duisburg, Germany; [Brand, Matthias] Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Brand, M (corresponding author), Univ Duisburg Essen, Dept Gen Psychol, Cognit, Duisburg, Germany.; Brand, M (corresponding author), Univ Duisburg Essen, Ctr Behav Addict Res CeBAR, Duisburg, Germany.; Brand, M (corresponding author), Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany.	matthias.brand@uni-due.de	Wegmann, Elisa/GXH-7386-2022	Brand, Matthias/0000-0002-4831-9542; Wegmann, Elisa/0000-0002-9373-979X				Amichai-Hamburger Y, 2010, COMPUT HUM BEHAV, V26, P1289, DOI 10.1016/j.chb.2010.03.018; Anshel M. H., 1991, Journal of Sport Behavior, V14, P283; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Ben-Yehuda L., 2016, J REWARD DEFICIENCY, V2, P22, DOI [10.17756/jrdsas.2016-024, DOI 10.17756/JRDSAS.2016-024]; Billieux J., 2015, CURR ADDICT REP, V2, P156, DOI [10.1007/s40429-015-0054-y, DOI 10.1007/S40429-015-0054-Y]; Biolcati R, 2018, PSYCHOL REP, V121, P303, DOI 10.1177/0033294117724447; Biolcati Roberta, 2016, Addict Behav Rep, V3, P70, DOI 10.1016/j.abrep.2016.05.001; BLASZCZYNSKI A, 1990, PSYCHOL REP, V67, P35, DOI 10.2466/PR0.67.5.35-42; Brand M, 2016, NEUROSCI BIOBEHAV R, V71, P252, DOI 10.1016/j.neubiorev.2016.08.033; Brand M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01256; Brand M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00375; BRISSETT D, 1993, SYMB INTERACT, V16, P237, DOI 10.1525/si.1993.16.3.237; CALDWELL LL, 1995, LOISIR SOC-SOC LEIS, V18, P143, DOI 10.1080/07053436.1995.10715494; Carter BL, 1999, ADDICTION, V94, P327, DOI 10.1046/j.1360-0443.1999.9433273.x; Chaney MP, 2005, SEX ADDICT COMPULS, V12, P3, DOI 10.1080/10720160590933671; Choi SW, 2015, J BEHAV ADDICT, V4, P308, DOI 10.1556/2006.4.2015.043; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis RA, 2001, COMPUT HUM BEHAV, V17, P187, DOI 10.1016/S0747-5632(00)00041-8; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Dimitrov Dimiter M, 2006, Work, V26, P429; Drummond DC, 2001, ADDICTION, V96, P33, DOI 10.1046/j.1360-0443.2001.961333.x; Elhai JD, 2018, SOC SCI COMPUT REV, V36, P707, DOI 10.1177/0894439317741087; Fernie BA, 2014, ADDICT BEHAV, V39, P793, DOI 10.1016/j.addbeh.2014.01.010; Fortune EE, 2010, J GAMBL STUD, V26, P331, DOI 10.1007/s10899-009-9162-8; Gordon A., 1997, PSYCHOL STUD, V42, P85, DOI DOI 10.2466/pms.1990.71.3.963; Harris MB, 2000, J APPL SOC PSYCHOL, V30, P576, DOI 10.1111/j.1559-1816.2000.tb02497.x; Hormes J.M., 2017, CURRENT ADDICTION RE, V4, P132, DOI [10.1007/s40429-017-0138-y, DOI 10.1007/S40429-017-0138-Y]; Hu L T., 1995, STRUCTURAL EQUATION, P76, DOI DOI 10.1080/10705519909540118; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; ISOAHOLA SE, 1990, J LEISURE RES, V22, P1; Ko CH, 2013, J PSYCHIATR RES, V47, P486, DOI 10.1016/j.jpsychires.2012.11.008; Ko CH, 2013, ADDICT BIOL, V18, P559, DOI 10.1111/j.1369-1600.2011.00405.x; Kuss DJ, 2011, INT J ENV RES PUB HE, V8, P3528, DOI 10.3390/ijerph8093528; Laier C, 2013, J BEHAV ADDICT, V2, P100, DOI 10.1556/JBA.2.2013.002; LePera N., 2011, NEW SCH PSYCHOL B, V8, P15, DOI DOI 10.1037/E741452011-003; Lin CH, 2009, ADOLESCENCE, V44, P993; Lin CH, 2008, ADOLESCENCE, V43, P317; Little TD, 2002, STRUCT EQU MODELING, V9, P151, DOI 10.1207/S15328007SEM0902_1; Liu L, 2017, ADDICT BIOL, V22, P791, DOI 10.1111/adb.12338; Love A, 1998, ADDICTION, V93, P1091, DOI 10.1046/j.1360-0443.1998.937109113.x; Marsh HW, 2013, PSYCHOL METHODS, V18, P257, DOI 10.1037/a0032773; MIKULAS WL, 1993, PSYCHOL REC, V43, P3; Montag C, 2017, BEHAV BRAIN RES, V329, P221, DOI 10.1016/j.bbr.2017.04.035; Montag Christian, 2015, BMC Res Notes, V8, P331, DOI 10.1186/s13104-015-1280-z; Muthen L, 2011, MPLUS; Neubaum G, 2015, CYBERPSYCH BEH SOC N, V18, P443, DOI 10.1089/cyber.2014.0613; Niu GF, 2016, ADDICT BEHAV, V62, P1, DOI 10.1016/j.addbeh.2016.06.012; Park CB, 2015, ADDICT BEHAV, V41, P61, DOI 10.1016/j.addbeh.2014.09.027; Pawlikowski M, 2013, COMPUT HUM BEHAV, V29, P1212, DOI 10.1016/j.chb.2012.10.014; RAHMANI S, 2011, PROC D SOC BEHAV, V30, DOI DOI 10.1016/J.SBSPRO.2011.10.054; Sayette MA, 2016, ANNU REV CLIN PSYCHO, V12, P407, DOI 10.1146/annurev-clinpsy-021815-093351; Schiebener J, 2015, J BEHAV ADDICT, V4, P14, DOI 10.1556/JBA.4.2015.1.5; Skinner MD, 2010, NEUROSCI BIOBEHAV R, V34, P606, DOI 10.1016/j.neubiorev.2009.11.024; Snagowski J, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00653; Sommers J, 2000, J CLIN PSYCHOL, V56, P149, DOI 10.1002/(SICI)1097-4679(200001)56:1<149::AID-JCLP14>3.0.CO;2-Y; Spada MM, 2014, ADDICT BEHAV, V39, P3, DOI 10.1016/j.addbeh.2013.09.007; Statista, 2017, NUMB MONTHL ACT WHAT; Statista, 2020, NUMBER SMARTPHONE US; Statista (The Statistics Portal),, 2018, NUMB MONTHL ACT FAC; Struk AA, 2017, ASSESSMENT, V24, P346, DOI 10.1177/1073191115609996; Tavolacci MP, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-724; THACKRAY RI, 1981, PSYCHOSOM MED, V43, P165, DOI 10.1097/00006842-198104000-00008; Thalemann R, 2007, BEHAV NEUROSCI, V121, P614, DOI 10.1037/0735-7044.121.3.614; Tiffany ST, 2012, ANN NY ACAD SCI, V1248, P1, DOI 10.1111/j.1749-6632.2011.06298.x; Trotzke P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140296; Trotzke P, 2014, PSYCHOSOM MED, V76, P694, DOI 10.1097/PSY.0000000000000126; Turel O, 2017, PERS INDIV DIFFER, V108, P91, DOI 10.1016/j.paid.2016.12.005; Velezmoro R, 2010, COMPUT HUM BEHAV, V26, P1526, DOI 10.1016/j.chb.2010.05.020; Wegmann E, 2018, ADDICT RES THEORY, V26, P306, DOI 10.1080/16066359.2017.1367385; Wegmann Elisa, 2017, Addict Behav Rep, V5, P33, DOI 10.1016/j.abrep.2017.04.001; Wegmann E, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01747; Wegmann E, 2015, J BEHAV ADDICT, V4, P155, DOI 10.1556/2006.4.2015.021; Weybright EH, 2015, LEISURE SCI, V37, P311, DOI 10.1080/01490400.2015.1014530; Wiesner M, 2005, J OCCUP HEALTH PSYCH, V10, P83, DOI 10.1037/1076-8998.10.2.83; Young K, 1999, Cyberpsychol Behav, V2, P475, DOI 10.1089/cpb.1999.2.475; Zhou S. X., 2012, INT J CYBER BEHAV PS, V2, P34, DOI DOI 10.4018/IJCBPL.2012100103; ZUCKERMAN M, 1978, J CONSULT CLIN PSYCH, V46, P139, DOI 10.1037/0022-006X.46.1.139	77	38	38	5	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195742	10.1371/journal.pone.0195742	http://dx.doi.org/10.1371/journal.pone.0195742			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672574	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800042
J	Wright, T; Li, AQ; Lotterhand, J; Graham, AR; Huang, Y; Avila, N; Pan, J				Wright, Teresa; Li, Aiqun; Lotterhand, Jason; Graham, Anne-Renee; Huang, Yan; Avila, Nancy; Pan, Jing			Nonclinical comparability studies of recombinant human arylsulfatase A addressing manufacturing process changes	PLOS ONE			English	Article							LYSOSOMAL STORAGE DISORDERS; METACHROMATIC LEUKODYSTROPHY; GENE-THERAPY; SAFETY EVALUATION; MOUSE MODEL; BRAIN	Recombinant human arylsulfatase A (rhASA) is in clinical development for the treatment of patients with metachromatic leukodystrophy (MLD). Manufacturing process changes were introduced to improve robustness and efficiency, resulting in higher levels of mannose-6-phosphate and sialic acid in post-change (process B) compared with pre-change (process A) rhASA. A nonclinical comparability program was conducted to compare process A and process B rhASA. All doses were administered intrathecally. Pharmacodynamic comparability was evaluated in immunotolerant MLD mice, using immunohistochemical staining of lysosomal-associated membrane protein-1 (LAMP-1). Pharmacokinetic comparability was assessed in juvenile cynomolgus monkeys dosed once with 6.0 mg (equivalent to 100 mg/kg of brain weight) process A or process B rhASA. Biodistribution was compared by quantitative whole-body autoradiography in rats. Potential toxicity of process B rhASA was evaluated by repeated rhASA administration at doses of 18.6 mg in juvenile cynomolgus monkeys. The specific activities for process A and process B rhASA were 89 U/mg and 106 U/mg, respectively, which were both well within the target range for the assay. Pharmacodynamic assessments showed no statistically significant differences in LAMP-1 immunohistochemical staining in the spinal cord and in most of the brain areas assessed between process A and B rhASA-dosed mice. LAMP-1 staining was reduced with both process A and B rhASA compared with vehicle, supporting its activity. Concentration-time curves in cerebrospinal fluid and serum of cynomolgus monkeys were similar with process A and B rhASA. Process A and B rhASA were similar in terms of their pharmacokinetic parameters and biodistribution data. No process B rhASA-related toxicity was detected. In conclusion, manufacturing process changes did not affect the pharmacodynamic, pharmacokinetic or safety profiles of process B rhASA relative to process A rhASA.	[Wright, Teresa; Li, Aiqun; Lotterhand, Jason; Graham, Anne-Renee; Huang, Yan; Avila, Nancy; Pan, Jing] Shire, Lexington, MA 02421 USA; [Wright, Teresa; Lotterhand, Jason; Avila, Nancy] Homol Med, Bedford, MA 01730 USA; [Li, Aiqun] Sanofi US, Waltham, MA USA	Shire Pharmaceuticals Limited	Wright, T (corresponding author), Shire, Lexington, MA 02421 USA.; Wright, T (corresponding author), Homol Med, Bedford, MA 01730 USA.	tlwright@alum.mit.edu			Shire	Shire	This study was funded by Shire. The funders participated in the study design and conduct, data collection and analysis. The authors had the decision to publish and were involved in preparation of the manuscript.	[Anonymous], 2005, FED REGISTER, V70, P37861; [Anonymous], USE NONHUMAN PRIMATE; Batzios SP, 2012, MOL GENET METAB, V105, P56, DOI 10.1016/j.ymgme.2011.10.002; Beck M, 2010, IUBMB LIFE, V62, P33, DOI 10.1002/iub.284; Biffi A, 2006, J CLIN INVEST, V116, P3070, DOI 10.1172/JCI28873; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boucher AA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0313-y; Calias P, 2014, PHARMACOL THERAPEUT, V144, P114, DOI 10.1016/j.pharmthera.2014.05.009; Calias P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030341; ClinicalTrials. gov, MULT STUD HGT 1110 A; ClinicalTrials.gov, OP LAB EXT STUD EV S; Dali C, 2016, MOL GENET METAB, V117, pS38, DOI 10.1016/j.ymgme.2015.12.231; DEKABAN AS, 1978, ANN NEUROL, V4, P345, DOI 10.1002/ana.410040410; Felice BR, 2011, TOXICOL PATHOL, V39, P879, DOI 10.1177/0192623311409595; Gabrielsson J., 2007, PHARMACOKINETIC PHAR, V4th; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; Gieselmann V, 2010, NEUROPEDIATRICS, V41, P1, DOI 10.1055/s-0030-1253412; Gieselmann V, 2008, ACTA PAEDIATR, V97, P15, DOI 10.1111/j.1651-2227.2008.00648.x; Mahmood A, 2010, J CHILD NEUROL, V25, P572, DOI 10.1177/0883073809341669; Matzner U, 2007, MOL MED, V13, P471, DOI 10.2119/2007-00063.Matzner; Matzner U, 2009, MOL THER, V17, P600, DOI 10.1038/mt.2008.305; Mechler K, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0262-5; Meikle PJ, 1997, CLIN CHEM, V43, P1325; NEUFELD EF, 1991, ANNU REV BIOCHEM, V60, P257, DOI 10.1146/annurev.biochem.60.1.257; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Pfeifer RW, 2012, DRUG DELIV TRANSL RE, V2, P187, DOI 10.1007/s13346-011-0043-1; Piguet F, 2012, HUM GENE THER, V23, P903, DOI 10.1089/hum.2012.015; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Shire, 2013, OP LAB EXT STUD HGT; Shire, 2011, PHAS 1 2 MULT OP LAB; Steirer LM, 2009, J BIOL CHEM, V284, P3777, DOI 10.1074/jbc.M808689200; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research, 2008, GUID IND CGMP PHAS 1; U.S. Food Drug Administration, 2015, GOOD LAB PRACT NONCL; Wittke D, 2004, ACTA NEUROPATHOL, V108, P261, DOI 10.1007/s00401-004-0883-6	34	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195186	10.1371/journal.pone.0195186	http://dx.doi.org/10.1371/journal.pone.0195186			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672630	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800022
J	Tuominen, PPA; Raitanen, J; Husu, P; Kujala, UM; Luoto, RM				Tuominen, Pipsa P. A.; Raitanen, Jani; Husu, Pauliina; Kujala, Urho M.; Luoto, Riitta M.			The effects of mothers' musical background on sedentary behavior, physical activity, and exercise adherence in their 5-6-years-old children using movement-to-music video program	PLOS ONE			English	Article							ACTIVITY PARTICIPATION; INTERVENTIONS; ASSOCIATIONS; INSTRUMENT; ENJOYMENT; DOMAIN; DANCE	Objectives The purpose of this study was to examine whether mothers' musical background has an effect on their own and their children's sedentary behavior (SB) and physical activity (PA). The aim was also to assess children's and their mothers' exercise adherence when using movement-to-music video program. Design Sub-group analysis of an intervention group in a randomized controlled trial (ISRCTN33885819). Method Seventy-one mother-child-pairs were divided into two categories based on mothers' musical background. Each pair performed 8 weeks exercise intervention using movement-to-music video program. SB and PA were assessed objectively by accelerometer, and exercise activity, fidelity, and enjoyment were assessed via exercise diaries and questionnaires. Logistic regression model was used to analyze associations in the main outcomes between the groups. Results Those children whose mothers had musical background (MB) had greater probability to increase their light PA during the intervention, but not moderate-to-vigorous PA compared to those children whose mothers did not have musical background (NMB). SB increased in both groups. Mothers in the NMB group had greater probability to increase their light and moderate-to-vigorous PA and decrease their SB than mothers in the MB group. However, exercise adherence decreased considerably in all groups. Completeness, fidelity, and enjoyment were higher among the NMB group compared to the MB group. Conclusions The present results showed that mothers without musical background were more interested in movement-to-music exercises, as well as their children. For further studies it would be important to evaluate an effect of children's own music-based activities on their SB and PA.	[Tuominen, Pipsa P. A.; Raitanen, Jani; Husu, Pauliina; Luoto, Riitta M.] UKK Inst Hlth Promot Res, Tampere, Finland; [Tuominen, Pipsa P. A.; Kujala, Urho M.] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Raitanen, Jani; Luoto, Riitta M.] Univ Tampere, Fac Social Sci, Hlth Sci, Tampere, Finland	UKK Institute; University of Jyvaskyla; Tampere University	Tuominen, PPA (corresponding author), UKK Inst Hlth Promot Res, Tampere, Finland.; Tuominen, PPA (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland.	pipsa.p.a.tuominen@jyu.fi	Vähä-Ypyä, Henri/GSO-2044-2022; Raitanen, Jani/AAW-9233-2021; Kujala, Urho/AAP-2547-2020	Husu, Pauliina/0000-0003-1502-7428; Raitanen, Jani/0000-0001-7674-0978; Kujala, Urho/0000-0002-9262-1992	Academy of Finland [277079]; Pirkanmaa Hospital District [9S034]	Academy of Finland(Academy of Finland); Pirkanmaa Hospital District	Funding for this study was provided under an Academy of Finland research grant (number 277079, http://www.aka.fi/en) to Riitta M Luoto and via Competitive Research Funding from Pirkanmaa Hospital District (code 9S034, htps:// www.pshp.fi/en-US/Hospital_District) for Riitta M Luoto and the research group for 4 years' time (2014-2017) for NELLI - Lifestyle, counseling and exercise in maternity care project 5-year follow-up study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott G, 2016, J PHYS ACT HEALTH, V13, P269, DOI 10.1123/jpah.2015-0136; [Anonymous], 2016, REC PHYS ACT EARL CH, P21; [Anonymous], 2015, IST VAH VOI PAR KANS; Australian Government Department of Health, 2014, MAK YOUR MOV SIT LES; Briscoe D., 2016, MUSIC EDUC J, V103, P41; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Chin TC, 2012, MUSIC PERCEPT, V29, P429, DOI 10.1525/MP.2012.29.4.429; Clark IN, 2016, NORD J MUSIC THER, V25, P76, DOI 10.1080/08098131.2015.1008558; Denac O, 2008, EARLY CHILD EDUC J, V35, P439, DOI 10.1007/s10643-007-0205-4; Dieringer ST, 2013, PALAESTRA, V27, P42; Gao Z, 2013, J SPORT HEALTH SCI, V2, P122, DOI 10.1016/j.jshs.2012.07.001; Gao Z, 2013, J SPORT HEALTH SCI, V2, P146, DOI 10.1016/j.jshs.2013.01.005; Heisz JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168534; Huijg JM, 2015, PHYS THER, V95, P539, DOI 10.2522/ptj.20130457; Jago R, 2013, EUR J PEDIATR, V172, P1543, DOI 10.1007/s00431-013-2077-5; Jekauc D, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01145; Karageorghis C, 2008, INT J SPORTS MED, V29, P613, DOI 10.1055/s-2007-989266; Karageorghis CI, 2016, APPL MUSIC EXERCISE; Karageorghis CI., 2008, SPORT EXERCISE PSYCH, P109; Karageorghis CI, 2006, J SPORT SCI, V24, P899, DOI 10.1080/02640410500298107; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Lindsay AC, 2017, J SPEC PEDIATR NURS, V22, DOI 10.1111/jspn.12182; Mullensiefan D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089642; O'Dwyer MV, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-117; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Remmers T, 2015, J PHYS ACT HEALTH, V12, P1066, DOI 10.1123/jpah.2014-0011; Rhodes RE, 2015, ANN BEHAV MED, V49, P715, DOI 10.1007/s12160-015-9704-5; Saarikallio S, 2018, MUSIC SCI, V17, P27; Saarikallio S, 2013, MUSIC SCI, V17, P27, DOI 10.1177/1029864912462381; Saunders RP, 2017, HEALTH EDUC BEHAV; Temmerman N., 2000, BRIT J MUSIC EDUC, V17, P51, DOI [10.1017/S0265051700000140, DOI 10.1017/S0265051700000140]; Tremblay MS, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0525-8; Tremblay MS, 2010, APPL PHYSIOL NUTR ME, V35, P725, DOI 10.1139/H10-079; Tuominen PPA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183317; Tuominen PPA, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-1701-z; Tuominen PPA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2347-4; Vaha-Ypya H, 2017, SCAND J MED SCI SPOR; Vaha-Ypya H, 2015, CLIN PHYSIOL FUNCT I, V35, P64, DOI 10.1111/cpf.12127; Ward DS, 2010, MED SCI SPORT EXER, V42, P526, DOI 10.1249/MSS.0b013e3181cea406	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195837	10.1371/journal.pone.0195837	http://dx.doi.org/10.1371/journal.pone.0195837			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668726	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200061
J	Abras, A; Ballart, C; Llovet, T; Roig, C; Gutierrez, C; Tebar, S; Berenguer, P; Pinazo, MJ; Posada, E; Gascon, J; Schijman, AG; Gallego, M; Munoz, C				Abras, Alba; Ballart, Cristina; Llovet, Teresa; Roig, Carme; Gutierrez, Cristina; Tebar, Silvia; Berenguer, Pere; Pinazo, Maria-Jesus; Posada, Elizabeth; Gascon, Joaquim; Schijman, Alejandro G.; Gallego, Montserrat; Munoz, Carmen			Introducing automation to the molecular diagnosis of Trypanosoma cruzi infection: A comparative study of sample treatments, DNA extraction methods and real-time PCR assays	PLOS ONE			English	Article							NUCLEIC-ACID EXTRACTION; CHRONIC CHAGAS-DISEASE; ECONOMIC-EVALUATION; SATELLITE DNA; AMPLIFICATION; AGREEMENT; SEQUENCES	Background Polymerase chain reaction (PCR) has become a useful tool for the diagnosis of Trypanosoma cruzi infection. The development of automated DNA extraction methodologies and PCR systems is an important step toward the standardization of protocols in routine diagnosis. To date, there are only two commercially available Real-Time PCR assays for the routine laboratory detection of T. cruzi DNA in clinical samples: TCRUZIDNA. CE (Diagnostic Bioprobes Srl) and RealCycler CHAG (Progenie Molecular). Our aim was to evaluate the RealCycler CHAG assay taking into account the whole process. Methodology/Principal findings We assessed the usefulness of an automated DNA extraction system based on magnetic particles (EZ1 Virus Mini Kit v2.0, Qiagen) combined with a commercially available RealTime PCR assay targeting satellite DNA (SatDNA) of T. cruzi (RealCycler CHAG), a methodology used for routine diagnosis in our hospital. It was compared with a well-known strategy combining a commercial DNA isolation kit based on silica columns (High Pure PCR Template Preparation Kit, Roche Diagnostics) with an in-house Real-Time PCR targeting SatDNA. The results of the two methodologies were in almost perfect agreement, indicating they can be used interchangeably. However, when variations in protocol factors were applied (sample treatment, extraction method and Real-Time PCR), the results were less convincing. A comprehensive fine-tuning of the whole procedure is the key to successful results. Guanidine EDTA-blood (GEB) samples are not suitable for DNA extraction based on magnetic particles due to inhibition, at least when samples are not processed immediately. Conclusions/Significance This is the first study to evaluate the RealCycler CHAG assay taking into account the overall process, including three variables (sample treatment, extraction method and Real-Time PCR). Our findings may contribute to the harmonization of protocols between laboratories and to a wider application of Real-Time PCR in molecular diagnostic laboratories associated with health centers.	[Abras, Alba; Ballart, Cristina; Tebar, Silvia; Gallego, Montserrat] Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Biol Sanitat & Medi Ambient, Seccio Parasitol, Barcelona, Spain; [Abras, Alba; Ballart, Cristina; Tebar, Silvia; Pinazo, Maria-Jesus; Posada, Elizabeth; Gascon, Joaquim; Gallego, Montserrat] Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain; [Abras, Alba] Univ Girona, Dept Biol, Lab Ictiol Genet, Girona, Spain; [Llovet, Teresa; Roig, Carme; Gutierrez, Cristina; Berenguer, Pere; Munoz, Carmen] Hosp Santa Creu & Sant Pau, Serv Microbiol, Barcelona, Spain; [Llovet, Teresa; Munoz, Carmen] Univ Autonoma Barcelona, Dept Genet & Microbiol, Cerdanyola Del Valles, Spain; [Schijman, Alejandro G.] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol Dr Hector N Tor, LaBMECh, Buenos Aires, DF, Argentina; [Munoz, Carmen] Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau IB St Pau, Barcelona, Spain	University of Barcelona; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Universitat de Girona; Hospital of Santa Creu i Sant Pau; Autonomous University of Barcelona; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Hospital of Santa Creu i Sant Pau	Gallego, M (corresponding author), Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Biol Sanitat & Medi Ambient, Seccio Parasitol, Barcelona, Spain.; Gallego, M (corresponding author), Univ Barcelona, Hosp Clin, Barcelona Ctr Int Hlth Res CRESIB, ISGlobal, Barcelona, Spain.; Munoz, C (corresponding author), Hosp Santa Creu & Sant Pau, Serv Microbiol, Barcelona, Spain.; Munoz, C (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Cerdanyola Del Valles, Spain.; Munoz, C (corresponding author), Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau IB St Pau, Barcelona, Spain.	mgalIego@ub.edu; cmunoz@santpau.cat	Martinez, Silvia Tebar/C-8046-2019; Culleré, Montserrat Gállego/T-6246-2017; Abras, Alba/X-6320-2019; Gascon, Joaquim/M-3598-2015; Delgado, Maria Jesús Pinazo/X-6093-2018; Abras, Alba/J-6466-2017; Munoz, Carmen/P-9183-2015	Martinez, Silvia Tebar/0000-0002-2959-7555; Culleré, Montserrat Gállego/0000-0002-8143-9773; Abras, Alba/0000-0003-2002-1186; Gascon, Joaquim/0000-0002-5045-1585; Delgado, Maria Jesús Pinazo/0000-0002-4237-1075; Munoz-Batet, Carmen/0000-0002-4150-8834	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya [2014SGR026]; Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau); Plan Nacional de I +D+i; Institute de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competividad, Spanish Network for Research in Infectious Diseases [REIPI RD12/0015]; European Development Regional Fund (ERDF); RICET, a Tropical Disease Cooperative Research Network in Spain [RD12/0018/0010]	Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya; Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau); Plan Nacional de I +D+i; Institute de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competividad, Spanish Network for Research in Infectious Diseases; European Development Regional Fund (ERDF)(European Commission); RICET, a Tropical Disease Cooperative Research Network in Spain	This study was partially supported by Departament d'Universitats, Recerca i Societat de la Informacio de la Generalitat de Catalunya (grant 2014SGR026), Institut d'Investigacio Biomedica Sant Pau (IIB Sant Pau) and by Plan Nacional de I +D+i and Institute de Salud Carlos III, Subdireccion General de Redes y Centros de Investigacion Cooperativa, Ministerio de Economia y Competividad, Spanish Network for Research in Infectious Diseases (grant REIPI RD12/0015); cofinanced by European Development Regional Fund (ERDF) "A way to achieve Europe". A.A., C.B., S.T., M-J.P., E.P., J.G., and M.G. belong to RICET, a Tropical Disease Cooperative Research Network in Spain (grant RD12/0018/0010). ISGlobal is a member of the CERCA Programme, Generalitat de Catalunya. The supporters had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad-Franch F, 2015, ACTA TROP, V151, P126, DOI 10.1016/j.actatropica.2015.07.005; Abras A, 2017, J CLIN MICROBIOL, V55, P1396, DOI [10.1128/jcm.02248-16, 10.1128/JCM.02248-16]; Abras A, 2016, J CLIN MICROBIOL, V54, P1566, DOI 10.1128/JCM.00142-16; Aebischer A, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-137; Albajar-Vinas P, 2011, EUROSURVEILLANCE, V16, P19975, DOI DOI 10.2807/ESE.16.38.19975-EN; Alonso-Padilla J, 2017, EXPERT REV MOL DIAGN, V17, P699, DOI 10.1080/14737159.2017.1338566; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2002, WHO TECHN REP SER; Balouz V, 2017, ADV PARASIT, V97, P1, DOI 10.1016/bs.apar.2016.10.001; Berensmeier S, 2006, APPL MICROBIOL BIOT, V73, P495, DOI 10.1007/s00253-006-0675-0; Bern C, 2015, NEW ENGL J MED, V373, P1882, DOI [10.1056/NEJMra1410150, 10.1056/NEJMc1510996]; Besuschio SA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005779; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Bua J, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002476; Burd EM, 2010, CLIN MICROBIOL REV, V23, P550, DOI 10.1128/CMR.00074-09; Burgos JM, 2009, DIAGN MICR INFEC DIS, V65, P58, DOI 10.1016/j.diagmicrobio.2009.04.010; Burns MJ, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-31; Caballero ZC, 2007, CLIN VACCINE IMMUNOL, V14, P1045, DOI 10.1128/CVI.00127-07; Carlier Y, 2015, MEM I OSWALDO CRUZ, V110, P363, DOI [10.1590/0074-02760140410, 10.1590/0074-02760140405]; Carlier Y, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001250; Ramirez JC, 2015, J MOL DIAGN, V17, P605, DOI 10.1016/j.jmoldx.2015.04.010; Carolina M, 2003, MOL BIOCHEM PARASIT, V129, P1, DOI 10.1016/S0166-6851(03)00054-9; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cummings KL, 2003, MOL BIOCHEM PARASIT, V129, P53, DOI 10.1016/S0166-6851(03)00093-8; Cura CI, 2017, J MOL DIAGN, V19, P673, DOI 10.1016/j.jmoldx.2017.05.010; Duffy T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002000; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Dundas N, 2008, J MOL DIAGN, V10, P311, DOI 10.2353/jmoldx.2008.070149; Eguez KE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005501; Elias MCQB, 2005, MOL BIOCHEM PARASIT, V140, P221, DOI 10.1016/j.molbiopara.2004.12.016; Ferrer Elizabeth, 2015, Saber, V27, P359; Flores-Chavez M, 2010, ENFERM INFEC MICR CL, V28, P284, DOI 10.1016/j.eimc.2009.07.005; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Imaz-Iglesia I, 2015, ACTA TROP, V148, P77, DOI 10.1016/j.actatropica.2015.04.014; Santos FLN, 2016, AM J TROP MED HYG, V94, P1034, DOI 10.4269/ajtmh.15-0820; Otani MM, 2009, TRANSFUSION, V49, P1076, DOI 10.1111/j.1537-2995.2009.02107.x; Perez-Molina JA, 2018, LANCET, V391, P82, DOI 10.1016/S0140-6736(17)31612-4; Picado A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005148; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Poma HR, 2012, REV ARGENT MICROBIOL, V44, P144; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2012, INFECT DIS CLIN N AM, V26, P275, DOI 10.1016/j.idc.2012.03.002; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2017, LANCET GLOB HEALTH, V5, pE439, DOI 10.1016/s2214-109x(17)30073-6; Rivero R, 2017, DIAGN MICR INFEC DIS, V89, P26, DOI 10.1016/j.diagmicrobio.2017.06.012; Schijman AG, 2018, ACTA TROP, DOI [10.1016/J.ACTATR0PICA.2018.02.019, DOI 10.1016/J.ACTATR0PICA.2018.02.019]; Schijman AG, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000931; Seiringer P, 2017, DIAGN MICR INFEC DIS, V88, P225, DOI 10.1016/j.diagmicrobio.2017.04.003; Sicuri E, 2011, ACTA TROP, V118, P110, DOI 10.1016/j.actatropica.2011.02.012; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; STURM NR, 1989, MOL BIOCHEM PARASIT, V33, P205, DOI 10.1016/0166-6851(89)90082-0; Telleria J, 2006, EXP PARASITOL, V114, P279, DOI 10.1016/j.exppara.2006.04.005; Viotti R, 2014, ANTIMICROB AGENTS CH, V58, P635, DOI 10.1128/AAC.01662-13	53	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195738	10.1371/journal.pone.0195738	http://dx.doi.org/10.1371/journal.pone.0195738			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664973	gold, Green Published			2022-12-26	WOS:000430262300030
J	Sen, B; Borle, NC; Greiner, R; Brown, MRG				Sen, Bhaskar; Borle, Neil C.; Greiner, Russell; Brown, Matthew R. G.			A general prediction model for the detection of ADHD and Autism using structural and functional MRI	PLOS ONE			English	Article							BLIND SEPARATION; ATTENTION; CONNECTIVITY; NETWORK; CORTEX; FMRI	This work presents a novel method for learning a model that can diagnose Attention Deficit Hyperactivity Disorder (ADHD), as well as Autism, using structural texture and functional connectivity features obtained from 3-dimensional structural magnetic resonance imaging (MRI) and 4-dimensional resting-state functional magnetic resonance imaging (fMRI) scans of subjects. We explore a series of three learners: (1) The LEFMS learner first extracts features from the structural MRI images using the texture-based filters produced by a sparse autoencoder. These filters are then convolved with the original MRI image using an unsupervised convolutional network. The resulting features are used as input to a linear support vector machine (SVM) classifier. (2) The LEFMF learner produces a diagnostic model by first computing spatial non-stationary independent components of the fMRI scans, which it uses to decompose each subject's fMRI scan into the time courses of these common spatial components. These features can then be used with a learner by themselves or in combination with other features to produce the model. Regardless of which approach is used, the final set of features are input to a linear support vector machine (SVM) classifier. (3) Finally, the overall LEFMSF learner uses the combined features obtained from the two feature extraction processes in (1) and (2) above as input to an SVM classifier, achieving an accuracy of 0.673 on the ADHD-200 holdout data and 0.643 on the ABIDE holdout data. Both of these results, obtained with the same LEFMSF framework, are the best known, over all hold-out accuracies on these datasets when only using imaging data-exceeding previously-published results by 0.012 for ADHD and 0.042 for Autism. Our results show that combining multi-modal features can yield good classification accuracy for diagnosis of ADHD and Autism, which is an important step towards computer-aided diagnosis of these psychiatric diseases and perhaps others as well.	[Sen, Bhaskar; Borle, Neil C.; Greiner, Russell; Brown, Matthew R. G.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada; [Greiner, Russell] Alberta Machine Intelligence Inst, Edmonton, AB, Canada; [Brown, Matthew R. G.] Univ Alberta, Dept Psychiat, Edmonton, AB, Canada	University of Alberta; University of Alberta	Brown, MRG (corresponding author), Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada.; Brown, MRG (corresponding author), Univ Alberta, Dept Psychiat, Edmonton, AB, Canada.	mbrown2@ualberta.ca	Greiner, Russell/AAQ-4502-2020	Greiner, Russell/0000-0001-8327-934X	Alberta Machine Intelligence Institute (AMII); Canadian Institutes of Health Research [CSE125741]; Natural Sciences and Engineering Research Council of Canada (NSERC) [203245]; Canadian Institutes of Health Research; Alberta Innovates Technology Frontiers; Alberta Innovates Health Solutions; Alberta Machine Intelligence Institute	Alberta Machine Intelligence Institute (AMII); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates Technology Frontiers; Alberta Innovates Health Solutions; Alberta Machine Intelligence Institute	This work was supported by Alberta Machine Intelligence Institute (AMII), formerly the Alberta Innovates Centre for Machine Learning (AICML), Project Title: Patient Specific fMRI-based Psychiatric Diagnosis and Treatment, Recipient: RG, Website: www.aicml.ca; Canadian Institutes of Health Research, Recipient: RG, Grant Number: CSE125741, Website: www.cihr-irsc.gc.ca; and Natural Sciences and Engineering Research Council of Canada (NSERC), Recipient: RG, Grant Number: 203245, Website: www.nserc-crsng.gc.ca.; This research was supported by funding from the Canadian Institutes of Health Research, Alberta Innovates Technology Frontiers, Alberta Innovates Health Solutions, and the Alberta Machine Intelligence Institute. We thank the providers of the ADHD-200 and ABIDE datasets for generously sharing their data with the research community. We would also like to thank Compute Canada for the generous use of their computing resources.	Abraham A, 2017, NEUROIMAGE, V147, P736, DOI 10.1016/j.neuroimage.2016.10.045; Arlot S, 2010, STAT SURV, V4, P40, DOI 10.1214/09-SS054; Barkley RA, 1997, PSYCHOL BULL, V121, P65, DOI 10.1037/0033-2909.121.1.65; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Brown MRG, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00069; Calhoun VD, 2002, HUM BRAIN MAPP, V16, P131, DOI 10.1002/hbm.10044; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Christoff K, 2009, P NATL ACAD SCI USA, V106, P8719, DOI 10.1073/pnas.0900234106; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Dai D, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00063; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Deshpande G, 2015, IEEE T CYBERNETICS, V45, P2668, DOI 10.1109/TCYB.2014.2379621; Eloyan Ani, 2012, Front Syst Neurosci, V6, P61, DOI 10.3389/fnsys.2012.00061; Erhardt EB, 2011, HUM BRAIN MAPP, V32, P2075, DOI 10.1002/hbm.21170; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Ghiassian S., 2013, P 3 NIPS WORKSH MACH; Ghiassian S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166934; Hjelm RD, 2014, NEUROIMAGE, V96, P245, DOI 10.1016/j.neuroimage.2014.03.048; Hyvarinen A., 1999, NOT INT JOINT C NEUR; Just MA, 2007, CEREB CORTEX, V17, P951, DOI 10.1093/cercor/bhl006; Kawamoto M, 1998, NEUROCOMPUTING, V22, P157, DOI 10.1016/S0925-2312(98)00055-1; Konrad K, 2010, HUM BRAIN MAPP, V31, P904, DOI 10.1002/hbm.21058; Lai SH, 1999, MAGN RESON IMAGING, V17, P827, DOI 10.1016/S0730-725X(99)00038-7; Lecun Y., 1995, HDB BRAIN THEORY NEU, DOI DOI 10.1109/IJCNN.2004.1381049; Li SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049340; Ng A.., 2017, CS229 LECT NOTES; Nielsen JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00599; Olshausen B., 2001, SPARSE CODES SPIKES; Parra L, 2000, IEEE T SPEECH AUDI P, V8, P320, DOI 10.1109/89.841214; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Rish I., 2009, ADV NEURAL INFORM PR, V22, P252; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Shallice T, 2002, DEV NEUROPSYCHOL, V21, P43, DOI 10.1207/S15326942DN2101_3; Sidhu Gagan S, 2012, Front Syst Neurosci, V6, P74, DOI 10.3389/fnsys.2012.00074; SOULOUMIAC A, 1995, INT CONF ACOUST SPEE, P1912, DOI 10.1109/ICASSP.1995.480586; Souloumiac A, AC SPEECH SIGN PROC, V3, P745, DOI [10.1016/j.neuroimage.2016.10.045, DOI 10.1016/J.NEUROIMAGE.2016.10.045]; Tian LX, 2006, NEUROSCI LETT, V400, P39, DOI 10.1016/j.neulet.2006.02.022; Wang K, 2008, CEREB CORTEX, V18, P697, DOI 10.1093/cercor/bhm105	41	68	70	5	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194856	10.1371/journal.pone.0194856	http://dx.doi.org/10.1371/journal.pone.0194856			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664902	Green Published, gold, Green Submitted			2022-12-26	WOS:000430262300011
J	Thapa, S; Chitale, V; Rijal, SJ; Bisht, N; Shrestha, BB				Thapa, Sunil; Chitale, Vishwas; Rijal, Srijana Joshi; Bisht, Neha; Shrestha, Bharat Babu			Understanding the dynamics in distribution of invasive alien plant species under predicted climate change in Western Himalaya	PLOS ONE			English	Article							LANTANA-CAMARA L.; PARTHENIUM-HYSTEROPHORUS ASTERACEAE; POTENTIAL DISTRIBUTION; MAXIMUM-ENTROPY; DISTRIBUTION PATTERNS; BIOLOGICAL INVASIONS; SPATIAL-DISTRIBUTION; HABITAT MODELS; INDIA; IMPACTS	Invasive alien plant species (IAPS) can pose severe threats to biodiversity and stability of native ecosystems, therefore, predicting the distribution of the IAPS plays a crucial role in effective planning and management of ecosystems. In the present study, we use Maximum Entropy (MaxEnt) modelling approach to predict the potential of distribution of eleven IAPS under future climatic conditions under RCP 2.6 and RCP 8.5 in part of Kailash sacred landscape region in Western Himalaya. Based on the model predictions, distribution of most of these invasive plants is expected to expand under future climatic scenarios, which might pose a serious threat to the native ecosystems through competition for resources in the study area. Native scrublands and subtropical needle-leaved forests will be the most affected ecosystems by the expansion of these IAPS. The present study is first of its kind in the Kailash Sacred Landscape in the field of invasive plants and the predictions of potential distribution under future climatic conditions from our study could help decision makers in planning and managing these forest ecosystems effectively.	[Thapa, Sunil; Chitale, Vishwas; Rijal, Srijana Joshi; Bisht, Neha] Int Ctr Integrated Mt Dev ICIMOD, Kathmandu, Nepal; [Shrestha, Bharat Babu] Tribhuvan Univ, Kathmandu, Nepal	Tribhuvan University	Thapa, S; Chitale, V (corresponding author), Int Ctr Integrated Mt Dev ICIMOD, Kathmandu, Nepal.	sunil.thapa@icimod.org; vishwas.chitale@icimod.org	Shrestha, Bharat Babu/V-2006-2019	Shrestha, Bharat Babu/0000-0002-9457-2637	Department for International Development (DFID)-UK Aid; German Federal Ministry of Economic Cooperation and Development; German International Cooperation (GIZ); ICIMOD	Department for International Development (DFID)-UK Aid; German Federal Ministry of Economic Cooperation and Development; German International Cooperation (GIZ); ICIMOD	The study was carried out under the Kailash Sacred Landscape Conservation and Development Initiative (KSLCDI) of the International Centre for Integrated Mountain Development (ICIMOD). We would like to thank the Department for International Development (DFID)-UK Aid, German Federal Ministry of Economic Cooperation and Development and German International Cooperation (GIZ) for providing financial support for the KSLCDI. This study was partially supported by core funds from ICIMOD contributed by the Governments of Afghanistan, Australia, Austria, Bangladesh, Bhutan, China, India, Myanmar, Nepal, Norway, Pakistan, Switzerland and the UK. The authors would like to express their gratitude to the three anonymous reviewers whose comments helped us improve the manuscript.	Adhikari D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134665; Adkins S, 2014, PEST MANAG SCI, V70, P1023, DOI 10.1002/ps.3708; Aguirre-Gutierrez J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063708; Alexander JM, 2016, ALPINE BOT, V126, P89, DOI 10.1007/s00035-016-0172-8; [Anonymous], [No title captured]; [Anonymous], 2014, CLIM CHANG 2014 IMP; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bhattarai KR, 2014, J MT SCI-ENGL, V11, P688, DOI 10.1007/s11629-013-2821-3; Bisht N., 2016, MANUAL INVASIVE ALIE; Blossey B., 1999, Biological Invasions, V1, P301, DOI 10.1023/A:1010084724526; Chitale VS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115264; Choudhury MR, 2016, ECOL ENG, V97, P23, DOI 10.1016/j.ecoleng.2016.07.018; Christen D, 2006, CONSERV BIOL, V20, P385, DOI 10.1111/j.1523-1739.2006.00315.x; Dhileepan K, 2000, BIOL CONTROL, V19, P9, DOI 10.1006/bcon.2000.0847; Dhileepan K, 2009, WEED RES, V49, P557, DOI 10.1111/j.1365-3180.2009.00728.x; DiTomaso JM, 2000, WEED SCI, V48, P255, DOI 10.1614/0043-1745(2000)048[0255:IWIRSI]2.0.CO;2; Duggin JA, 1998, FOREST ECOL MANAG, V109, P279, DOI 10.1016/S0378-1127(98)00252-7; Early R, 2014, GLOBAL ECOL BIOGEOGR, V23, P1356, DOI 10.1111/geb.12208; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Fei SL, 2014, ANNU REV ECOL EVOL S, V45, P69, DOI 10.1146/annurev-ecolsys-120213-091928; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; Franklin J, 2013, GLOBAL CHANGE BIOL, V19, P473, DOI 10.1111/gcb.12051; Gallardo B, 2013, BIOL CONSERV, V160, P225, DOI 10.1016/j.biocon.2013.02.001; Gnanavel I., 2013, INT J AGR ENV BIOTEC, V6, P261; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hoffman JD, 2008, INVAS PLANT SCI MANA, V1, P359, DOI 10.1614/IPSM-07-048.1; IGES I, 2013, TECHN REP CLIM CHANG; Johnston FM, 2004, ARCT ANTARCT ALP RES, V36, P201, DOI 10.1657/1523-0430(2004)036[0201:IORDOS]2.0.CO;2; Kannan R, 2016, FOREST ECOL MANAG, V376, P166, DOI 10.1016/j.foreco.2016.06.016; Kohli RK, 2006, BIOL INVASIONS, V8, P1501, DOI 10.1007/s10530-005-5842-1; Kosaka Y, 2010, MT RES DEV, V30, P252, DOI 10.1659/MRD-JOURNAL-D-10-00036.1; Kotru R., 2016, KAILASH SACRED LANDS, P101; Kowarik I., 2003, BIOL INVASIONS, V5, P293, DOI DOI 10.1023/B:BINV.0000005574.15074.66; Leyequien E, 2007, INT J APPL EARTH OBS, V9, P1, DOI 10.1016/j.jag.2006.08.002; Love A, 2009, CURR SCI INDIA, V97, P1421; Lowe S., 2000, ENCY BIOL INVASIONS; Lutz AF, 2016, INT J CLIMATOL, V36, P3988, DOI 10.1002/joc.4608; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; McDougall KL, 2011, MT RES DEV, V31, P380, DOI 10.1659/MRD-JOURNAL-D-11-00082.1; Muhlfeld CC, 2014, NAT CLIM CHANGE, V4, P620, DOI [10.1038/NCLIMATE2252, 10.1038/nclimate2252]; Muniappan R, 2009, J AGR URBAN ENTOMOL, V26, P167, DOI 10.3954/1523-5475-26.4.167; Oli K.P., 2011, KAILASH SACRED LANDS, DOI [10.53055/ICIMOD.545, DOI 10.53055/ICIMOD.545]; Paini DR, 2016, P NATL ACAD SCI USA, V113, P7575, DOI 10.1073/pnas.1602205113; Pauchard A, 2009, FRONT ECOL ENVIRON, V7, P479, DOI 10.1890/080072; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pearce JL, 2006, J APPL ECOL, V43, P405, DOI 10.1111/j.1365-2664.2005.01112.x; Peterson AT, 2003, WEED SCI, V51, P863, DOI 10.1614/P2002-081; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pimentel D, 2000, BIOSCIENCE, V50, P53, DOI 10.1641/0006-3568(2000)050[0053:EAECON]2.3.CO;2; Qin Z, 2016, CLIMATIC CHANGE, V134, P193, DOI 10.1007/s10584-015-1500-5; Raxworthy CJ, 2003, NATURE, V426, P837, DOI 10.1038/nature02205; Reddy CS, 2008, LIFE SCI J, V5, P84; Reddy CS, 2012, BIOHERAL, V2, P110; Royle JA, 2012, METHODS ECOL EVOL, V3, P545, DOI 10.1111/j.2041-210X.2011.00182.x; Schapire, 2005, MAXENT SOFTWARE SPEC; Shrestha BB, 2015, WEED RES, V55, P132, DOI 10.1111/wre.12133; Shrestha B. B., 2016, FRONTIERS BOT, P269; Shrestha BB., 2014, DISTRIBUTION I UNPUB; Shrestha BB, 2018, INVENTORY I IN PRESS; Shrestha UB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036741; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Siwakoti M., 2005, INVENTORY ASSESSMENT; Sobek-Swant S, 2012, FOREST ECOL MANAG, V281, P23, DOI 10.1016/j.foreco.2012.06.017; Taylor S, 2013, J ENVIRON MANAGE, V114, P414, DOI 10.1016/j.jenvman.2012.10.039; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Vithanage M, 2014, J ENVIRON MANAGE, V141, P95, DOI 10.1016/j.jenvman.2014.02.030; Vitousek PM, 1996, AM SCI, V84, P468; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; Wabuyele Emily, 2014, Journal of East African Natural History, V103, P49; Wan FH, 2010, SCI CHINA LIFE SCI, V53, P1291, DOI 10.1007/s11427-010-4080-7; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Wilson CD, 2011, BIOL CONSERV, V144, P821, DOI 10.1016/j.biocon.2010.11.014; Wintle BA, 2006, ECOL APPL, V16, P1945, DOI 10.1890/1051-0761(2006)016[1945:MSRWSA]2.0.CO;2; Wisz MS, 2008, DIVERS DISTRIB, V14, P763, DOI 10.1111/j.1472-4642.2008.00482.x; Wittenberg R, 2001, INVASIVE ALIEN SPECI; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Yost AC, 2008, ECOL INFORM, V3, P375, DOI 10.1016/j.ecoinf.2008.08.004; Zhu L, 2007, LANDSCAPE ECOL, V22, P1143, DOI 10.1007/s10980-007-9096-4; Zomer RJ, 2014, CLIMATIC CHANGE, V125, P445, DOI 10.1007/s10584-014-1176-2	81	69	71	5	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195752	10.1371/journal.pone.0195752	http://dx.doi.org/10.1371/journal.pone.0195752			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664961	Green Submitted, Green Published, gold			2022-12-26	WOS:000430262300031
J	Lyam, PT; Duque-Lazo, J; Durka, W; Hauenschild, F; Schnitzler, J; Michalak, I; Ogundipe, OT; Muellner-Riehi, AN				Lyam, Paul Terwase; Duque-Lazo, Joaquin; Durka, Walter; Hauenschild, Frank; Schnitzler, Jan; Michalak, Ingo; Ogundipe, Oluwatoyin Temitayo; Muellner-Riehi, Alexandra Nora			Genetic diversity and distribution of Senegalia senegal (L.) Britton under climate change scenarios in West Africa	PLOS ONE			English	Article							ACACIA-SENEGAL; PLANT DIVERSITY; POPULATIONS; MARKERS; CHLOROPLAST; PREDICTION; INFERENCE; WOODLANDS; SOFTWARE; IMPACTS	Climate change is predicted to impact species' genetic diversity and distribution. We used Senegalia senegal (L.) Britton, an economically important species distributed in the Sudano-Sahelian savannah belt of West Africa, to investigate the impact of climate change on intraspecific genetic diversity and distribution. We used ten nuclear and two plastid micro-satellite markers to assess genetic variation, population structure and differentiation across thirteen sites in West Africa. We projected suitable range, and potential impact of climate change on genetic diversity using a maximum entropy approach, under four different climate change scenarios. We found higher genetic and haplotype diversity at both nuclear and plastid markers than previously reported. Genetic differentiation was strong for chloroplast and moderate for the nuclear genome. Both genomes indicated three spatially structured genetic groups. The distribution of Senegalia senegal is strongly correlated with extractable nitrogen, coarse fragments, soil organic carbon stock, precipitation of warmest and coldest quarter and mean temperature of driest quarter. We predicted 40.96 to 6.34 per cent of the current distribution to favourably support the species' ecological requirements under future climate scenarios. Our results suggest that climate change is going to affect the population genetic structure of Senegalia senegal, and that patterns of genetic diversity are going to influence the species' adaptive response to climate change. Our study contributes to the growing evidence predicting the loss of economically relevant plants in West Africa in the next decades due to climate change.	[Lyam, Paul Terwase; Hauenschild, Frank; Schnitzler, Jan; Michalak, Ingo; Muellner-Riehi, Alexandra Nora] Univ Leipzig, Inst Biol, Dept Mol Evolut & Plant Systemat, Leipzig, Germany; [Lyam, Paul Terwase; Hauenschild, Frank; Schnitzler, Jan; Michalak, Ingo; Muellner-Riehi, Alexandra Nora] Univ Leipzig, Inst Biol, Herbarium LZ, Leipzig, Germany; [Lyam, Paul Terwase] Natl Ctr Genet Resources & Biotechnol, Ibadan, Nigeria; [Lyam, Paul Terwase; Duque-Lazo, Joaquin; Durka, Walter; Muellner-Riehi, Alexandra Nora] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Duque-Lazo, Joaquin] Univ Cordoba, DendrodatLab ERSAF, Lab Dendrochronol Silviculture & Global Change, Dept Forest Engn, Campus Rabanales, Cordoba, Spain; [Duque-Lazo, Joaquin] Univ Leipzig, Inst Biol, Dept Systemat Bot & Funct Biodivers, Leipzig, Germany; [Durka, Walter] UFZ Helmholtz Ctr Environm Res, Dept Community Ecol BZF, Halle, Germany; [Ogundipe, Oluwatoyin Temitayo] Univ Lagos, Dept Bot, Lagos, Nigeria	Leipzig University; Leipzig University; Universidad de Cordoba; Leipzig University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); University of Lagos	Lyam, PT (corresponding author), Univ Leipzig, Inst Biol, Dept Mol Evolut & Plant Systemat, Leipzig, Germany.; Lyam, PT (corresponding author), Univ Leipzig, Inst Biol, Herbarium LZ, Leipzig, Germany.; Lyam, PT (corresponding author), Natl Ctr Genet Resources & Biotechnol, Ibadan, Nigeria.; Lyam, PT (corresponding author), German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany.	pauliam003@gmail.com	Michalak, Ingo/C-1487-2013; Duque-Lazo, Joaquín/L-3722-2019; Durka, Walter/E-4667-2010; Muellner-Riehl, Alexandra N/C-6261-2013	Michalak, Ingo/0000-0002-8664-3968; Duque-Lazo, Joaquín/0000-0003-4223-5070; Durka, Walter/0000-0002-6611-2246; Muellner-Riehl, Alexandra N/0000-0002-2710-469X; Schnitzler, Jan/0000-0002-0843-4503; Lyam, Paul/0000-0002-2215-7717	Alexander von Humboldt Foundation (AVH), Germany under the International Climate Protection Fellowship (ICPC); German Academic Exchange Service (DAAD); National Centre for Genetic resources and Biotechnology (NACGRAB) Ibadan, Nigeria	Alexander von Humboldt Foundation (AVH), Germany under the International Climate Protection Fellowship (ICPC)(Alexander von Humboldt Foundation); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); National Centre for Genetic resources and Biotechnology (NACGRAB) Ibadan, Nigeria	This work was funded by the Alexander von Humboldt Foundation (AVH), Germany under the auspices of an International Climate Protection Fellowship (ICPC), and partly by the German Academic Exchange Service (DAAD), both granted to Paul Terwase Lyam and hosted by Alexandra Muellner-Riehl. Field work and data collection was additionally supported by the National Centre for Genetic resources and Biotechnology (NACGRAB) Ibadan, Nigeria. Apart from this, the funders have no role in the study design, subsequent data collection and analysis, decision to publish or preparation of the manuscript.	Arnell NW, 2014, CLIMATIC CHANGE, V122, P127, DOI 10.1007/s10584-013-0948-4; Assoumane AA, 2009, MOL ECOL RESOUR, V9, P1380, DOI 10.1111/j.1755-0998.2009.02669.x; Assoumane A, 2012, GENET RESOUR CROP EV, V59, P39, DOI 10.1007/s10722-011-9665-x; Bernard-Reversat F., 1980, Nitrogen cycling in West African ecosystems., P363; BESHAI AA, 1984, OXFORD B ECON STAT, V46, P371, DOI 10.1111/j.1468-0084.1984.mp46004006.x; Bocksberger G, 2016, J VEG SCI, V27, P306, DOI 10.1111/jvs.12360; Bouchenak-Khelladi Y, 2010, MOL PHYLOGENET EVOL, V57, P495, DOI 10.1016/j.ympev.2010.07.019; Brenan JPM, 1983, MANUAL TAXONOMY ACAC; CHASE MW, 1991, TAXON, V40, P215, DOI 10.2307/1222975; Chidumayo EN., 2010, DRY FORESTS WOODLAND, P1; Duque-Lazo J, 2017, FOREST ECOL MANAG, V392, P90, DOI 10.1016/j.foreco.2017.02.047; Duque-Lazo J, 2016, ECOL MODEL, V320, P62, DOI 10.1016/j.ecolmodel.2015.09.019; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eisa MA, 2008, ACACIA SENEGAL GUM A; Eliades, 2009, HAPLOTYPE ANAL SOFTW; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fagg C., 2004, TROP FOR, V42, P261; Falush D, 2003, GENETICS, V164, P1567; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Gaisberger H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184457; Gent PR, 2011, J CLIMATE, V24, P4973, DOI 10.1175/2011JCLI4083.1; Githae E. W., 2011, African Journal of Plant Science, V5, P475; Goncalves-Oliveira RC, 2017, AM J BOT, V104, P868, DOI 10.3732/ajb.1600410; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gray A, 2013, PLANT SOIL, V369, P479, DOI 10.1007/s11104-013-1593-4; Gwali S., 2015, Forests, Trees and Livelihoods, V24, P163, DOI 10.1080/14728028.2014.956808; Habeballa RS, 2010, AFR J BIOTECHNOL, V9, P4655; Hamilton B., 1999, NATURE, V401, P129; Hengl T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169748; Heubes J, 2013, J ARID ENVIRON, V96, P48, DOI 10.1016/j.jaridenv.2013.04.008; Heywood HV, 1995, GLOBAL BIODIVERSITY; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Joker D., 2000, ACACIA SENEGAL L WIL; Josiah CC, 2008, AFR J BIOTECHNOL, V7, P2333; Kirk H, 2011, INT J MOL SCI, V12, P3966, DOI 10.3390/ijms12063966; Kundzewicz ZW, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P173; Kyalangalilwa B, 2013, BOT J LINN SOC, V172, P500, DOI 10.1111/boj.12047; Leadley P., 2010, CBD TECHNICAL SERIES; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Lewis PO, GENETIC DATA ANAL CO; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Liu WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161972; Calle ML, 2011, HUM HERED, V72, P121, DOI 10.1159/000330778; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Maundu P, 2005, TECHNICAL HDB; McClean CJ, 2005, ANN MO BOT GARD, V92, P139; Miller RL, 2014, J ADV MODEL EARTH SY, V6, P441, DOI 10.1002/2013MS000266; Mujawamariya G, 2013, INT FOREST REV, V15, P182, DOI 10.1505/146554813806948477; Mulumba John W., 2012, International Journal of Botany, V8, P107, DOI 10.3923/ijb.2012.107.116; Naimi B., UNCERTAINTY ANAL SPE, V1, P1; Nakicenovic N., 2000, IPCC SPECIAL REPORT, P570; Nazarenko L, 2015, J ADV MODEL EARTH SY, V7, P244, DOI 10.1002/2014MS000403; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Noreen AME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082632; Nvarro-Cerrillo RM, 2016, REV ECOSISTEMAS, V25, P6; Odee DW, 2012, HEREDITY, V109, P372, DOI 10.1038/hdy.2012.52; Omondi S. F., 2010, Tropical Plant Biology, V3, P59, DOI 10.1007/s12042-009-9037-2; Ouinsavi C., 2009, International Journal of Forestry Research, V2009, P210179; Pachauri RK., 2015, CLIMATE CHANGE SYNTH; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pfenninger M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-224; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Poczai P, 2012, MOL BASIS PLANT GENE, P3; Pritchard JK, 2000, GENETICS, V155, P945; Quinn GP, 2003, EXPT DESIGN DATA ANA; Raddad EY, 2005, PLANT SOIL, V275, P261, DOI 10.1007/s11104-005-2152-4; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Robledo-Arnuncio JJ, 2014, MOV ECOL, V2, DOI 10.1186/s40462-014-0016-3; Rozzi R, 1997, PLANT ECOL, V132, P171, DOI 10.1023/A:1009747118914; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Serdeczny O, 2017, REG ENVIRON CHANGE, V17, P1585, DOI 10.1007/s10113-015-0910-2; Sexton JP, 2014, EVOLUTION, V68, P1, DOI 10.1111/evo.12258; Sommer JH, 2010, P ROY SOC B-BIOL SCI, V277, P2271, DOI 10.1098/rspb.2010.0120; Stoeckel S, 2006, MOL ECOL, V15, P2109, DOI 10.1111/j.1365-294X.2006.02926.x; Tandon R, 2001, BOT J LINN SOC, V135, P251, DOI [10.1006/bojl.2000.0401, 10.1111/j.1095-8339.2001.tb01094.x]; Traore S, 2012, J ARID ENVIRON, V87, P144, DOI 10.1016/j.jaridenv.2012.07.010; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; van Vuuren DP, 2011, CLIMATIC CHANGE, V109, P95, DOI [10.1007/s10584-011-0152-3, 10.1007/s10584-011-0157-y]; Wang Z, 2014, CLIN INTERV AGING, V9, P1, DOI [10.2147/CIA.S41356, 10.1186/1556-276X-9-643]; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Weising K, 1999, GENOME, V42, P9, DOI 10.1139/gen-42-1-9; Winters G, 2013, CONSERV GENET RESOUR, V5, P807, DOI 10.1007/s12686-013-9913-9; Xu JP, 2008, MOL ECOL, V17, P1238, DOI 10.1111/j.1365-294X.2007.03665.x; Zerbo I., 2016, Journal of Botany, V2016, P9523685	89	6	6	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194726	10.1371/journal.pone.0194726	http://dx.doi.org/10.1371/journal.pone.0194726			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659603	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100005
J	Record, S; Strecker, A; Tuanmu, MN; Beaudrot, L; Zarnetske, P; Belmaker, J; Gerstner, B				Record, Sydne; Strecker, Angela; Tuanmu, Mao-Ning; Beaudrot, Lydia; Zarnetske, Phoebe; Belmaker, Jonathan; Gerstner, Beth			Does scale matter? A systematic review of incorporating biological realism when predicting changes in species distributions	PLOS ONE			English	Review							DISTRIBUTION MODELS; CLIMATE-CHANGE; GRAIN-SIZE; BIOTIC INTERACTIONS; DISPERSAL DISTANCE; PLANT-DISTRIBUTION; SENSITIVITY; MAMMALS; ACCOUNT; FUTURE	Background There is ample evidence that biotic factors, such as biotic interactions and dispersal capacity, can affect species distributions and influence species' responses to climate change. However, little is known about how these factors affect predictions from species distribution models (SDMs) with respect to spatial grain and extent of the models. Objectives Understanding how spatial scale influences the effects of biological processes in SDMs is important because SDMs are one of the primary tools used by conservation biologists to assess biodiversity impacts of climate change. Data sources and study eligibility criteria We systematically reviewed SDM studies published from 2003-2015 using ISI Web of Science searches to: (1) determine the current state and key knowledge gaps of SDMs that incorporate biotic interactions and dispersal; and (2) understand how choice of spatial scale may alter the influence of biological processes on SDM predictions. Synthesis methods and limitations We used linear mixed effects models to examine how predictions from SDMs changed in response to the effects of spatial scale, dispersal, and biotic interactions. Results There were important biases in studies including an emphasis on terrestrial ecosystems in northern latitudes and little representation of aquatic ecosystems. Our results suggest that neither spatial extent nor grain influence projected climate-induced changes in species ranges when SDMs include dispersal or biotic interactions. Conclusions We identified several knowledge gaps and suggest that SDM studies forecasting the effects of climate change should: 1) address broader ranges of taxa and locations; and 1) report the grain size, extent, and results with and without biological complexity. The spatial scale of analysis in SDMs did not affect estimates of projected range shifts with dispersal and biotic interactions. However, the lack of reporting on results with and without biological complexity precluded many studies from our analysis.	[Record, Sydne] Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA; [Strecker, Angela] Portland State Univ, Dept Environm Sci & Management, Portland, OR 97207 USA; [Tuanmu, Mao-Ning] Acad Sinica, Biodivers Res Ctr, Taipei, Taiwan; [Beaudrot, Lydia] Univ Michigan, Dept Ecol & Evolutionary Biol & Michigan Soc Fell, Ann Arbor, MI 48109 USA; [Zarnetske, Phoebe] Michigan State Univ, Dept Forestry, E Lansing, MI 48824 USA; [Zarnetske, Phoebe; Gerstner, Beth] Michigan State Univ, Ecol Evolutionary Biol & Behav Program, E Lansing, MI 48824 USA; [Belmaker, Jonathan] Tel Aviv Univ, Sch Zool, Tel Aviv, Israel; [Belmaker, Jonathan] Tel Aviv Univ, Steinhardt Museum Nat Hist, Tel Aviv, Israel; [Gerstner, Beth] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Bryn Mawr College; Portland State University; Academia Sinica - Taiwan; University of Michigan System; University of Michigan; Michigan State University; Michigan State University; Tel Aviv University; Tel Aviv University; Michigan State University	Record, S (corresponding author), Bryn Mawr Coll, Dept Biol, Bryn Mawr, PA 19010 USA.	srecord@brynmawr.edu	Zarnetske, Phoebe/V-3974-2019; Strecker, Angela/GWC-1818-2022; Belmaker, Jonathan/I-1004-2019; Tuanmu, Mao-Ning/ABI-5979-2020; Beaudrot, L./M-6936-2017	Zarnetske, Phoebe/0000-0001-6257-6951; Strecker, Angela/0000-0001-9387-1654; Belmaker, Jonathan/0000-0002-5618-7359; Tuanmu, Mao-Ning/0000-0002-8233-2935; Beaudrot, L./0000-0001-8135-7519; Record, Sydne/0000-0001-7293-2155	NSF EAGER collaborative grants [1550770, 1550786, 1550765]; Michigan State University (MSU); United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project [1010055]; MSU; Ecological Society of America	NSF EAGER collaborative grants; Michigan State University (MSU); United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project; MSU; Ecological Society of America	This work was funded by NSF EAGER collaborative grants 1550770 (awarded to SR), 1550786 (awarded to AS), and 1550765 (awarded to PLZ). PLZ was supported by Michigan State University (MSU) and the United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project 1010055. BG was supported by MSU. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Ecological Society of America for sponsoring the 2013 Scaling-Up: Continental Scale Ecology Workshop for Early Career Scientists, the planning committee, Deborah Goldberg, Matthew Fitzpatrick, Janet Franklin, Robert Guralnick and Katherine Suding, as well as Jill Petraglia Parsons, Clifford Duke and all of the workshop participants. This work was funded by NSF EAGER collaborative grants 1550770 (awarded to SR), 1550786 (awarded to AS), and 1550765 (awarded to PLZ). PLZ was supported by Michigan State University (MSU) and the United States Department of Agriculture National Institute of Food and Agriculture, Hatch Project 1010055. BG was supported by MSU.	Arau AjoMB, 2013, ECOGRAPHY; Araujo MB, 2007, GLOBAL ECOL BIOGEOGR, V16, P743, DOI 10.1111/j.1466-8238.2007.00359.x; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Bateman BL, 2013, DIVERS DISTRIB, V19, P1224, DOI 10.1111/ddi.12107; Beck J, 2012, ECOGRAPHY, V35, P673, DOI 10.1111/j.1600-0587.2012.07364.x; Belmaker J, 2015, GLOBAL ECOL BIOGEOGR, V24, P750, DOI 10.1111/geb.12311; Blois JL, 2013, SCIENCE, V341, P499, DOI 10.1126/science.1237184; Brooker RW, 2007, J THEOR BIOL, V245, P59, DOI 10.1016/j.jtbi.2006.09.033; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Evans MEK, 2016, TRENDS ECOL EVOL, V31, P860, DOI 10.1016/j.tree.2016.08.005; Feeley KJ, 2011, GLOBAL CHANGE BIOL, V17, P626, DOI 10.1111/j.1365-2486.2010.02239.x; Fitzpatrick MC, 2012, ECOL APPL, V22, P472, DOI 10.1890/11-0009.1; Franklin J., 2010, MAPPING SPECIES DIST, DOI DOI 10.1017/CBO9780511810602; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Godsoe W, 2012, ECOGRAPHY, V35, P811, DOI 10.1111/j.1600-0587.2011.07103.x; Gottschalk TK, 2011, ECOL MODEL, V222, P3403, DOI 10.1016/j.ecolmodel.2011.07.008; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Guisan A, 2007, DIVERS DISTRIB, V13, P332, DOI 10.1111/j.1472-4642.2007.00342.x; Hanberry BB, 2013, ECOL INFORM, V15, P8, DOI 10.1016/j.ecoinf.2013.02.003; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.2307/177062; Hellmann JJ, 2012, ANN NY ACAD SCI, V1249, P18, DOI 10.1111/j.1749-6632.2011.06410.x; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Kissling WD, 2012, J BIOGEOGR, V39, P2163, DOI 10.1111/j.1365-2699.2011.02663.x; Lauzeral C, 2013, ECOGRAPHY, V36, P778, DOI 10.1111/j.1600-0587.2013.07696.x; Lenoir J, 2015, ECOGRAPHY, V38, P15, DOI 10.1111/ecog.00967; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; Merow C, 2014, ECOGRAPHY, V37, P1267, DOI 10.1111/ecog.00845; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nobis MP, 2014, ECOGRAPHY, V37, P1282, DOI 10.1111/ecog.00930; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Randin CF, 2009, GLOBAL CHANGE BIOL, V15, P1557, DOI 10.1111/j.1365-2486.2008.01766.x; Record S, 2013, GLOBAL ECOL BIOGEOGR, V22, P760, DOI 10.1111/geb.12017; Ricciardi A, 1999, CONSERV BIOL, V13, P1220, DOI 10.1046/j.1523-1739.1999.98380.x; Romo H, 2014, ECOGRAPHY, P1063; Schloss CA, 2012, P NATL ACAD SCI USA, V109, P8606, DOI 10.1073/pnas.1116791109; Seo C, 2009, BIOL LETTERS, V5, P39, DOI 10.1098/rsbl.2008.0476; SHMIDA A, 1985, J BIOGEOGR, V12, P1, DOI 10.2307/2845026; Song W, 2013, ECOL MODEL, V248, P113, DOI 10.1016/j.ecolmodel.2012.09.012; Thomson FJ, 2011, J ECOL, V99, P1299, DOI 10.1111/j.1365-2745.2011.01867.x; Trakhtenbrot A, 2005, DIVERS DISTRIB, V11, P173, DOI 10.1111/j.1366-9516.2005.00156.x; Urban MC, 2013, ANN NY ACAD SCI, V1297, P44, DOI 10.1111/nyas.12184; Urban MC, 2012, P ROY SOC B-BIOL SCI, V279, P2072, DOI 10.1098/rspb.2011.2367; Vittoz P, BOT HELVETICA, V117, P109; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Whitmee S, 2013, J ANIM ECOL, V82, P211, DOI 10.1111/j.1365-2656.2012.02030.x; WIENS JA, 1989, FUNCT ECOL, V3, P385, DOI 10.2307/2389612; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Zarnetske PL, 2012, SCIENCE, V336, P1516, DOI 10.1126/science.1222732	52	20	20	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194650	10.1371/journal.pone.0194650	http://dx.doi.org/10.1371/journal.pone.0194650			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652936	gold, Green Published			2022-12-26	WOS:000430026900007
J	Ternman, E; Pastell, M; Hanninen, L; Agenas, S; Nielsen, PP				Ternman, Emma; Pastell, Matti; Hanninen, Laura; Agenas, Sigrid; Nielsen, Per P.			First-night effect on sleep time in dairy cows	PLOS ONE			English	Article							NIGHT; ADAPTATION; PATTERNS	In human sleep studies, the probability of discomfort from the electrodes and the change in environment usually results in first-night recordings being discarded. Sleep recordings from the first night in human subjects often differ in amount of REM (rapid eye movement) sleep and the overall sleep architecture. This study investigated whether recordings of sleep states in dairy cows also show a first-night effect. Non-invasive electrophysiological recordings were carried out on nine cows of the Swedish Red breed during three consecutive 24-hour periods (recording days 1 +/- 3). Overall, cows spent 12.9 +/- 1.4 hours awake, 8.2 +/- 1 hours ruminating, 57.2 +/- 20.3 min drowsing, 44.1 +/- 20.2 min in REM sleep and 64.3 +/- 38.1 min in NREM (non-rapid eye movement) sleep (mean +/- SD) and there were no significant differences between recording days in total duration for any of the sleep and awake states. However, the bouts of REM sleep and rumination were longer, and the awake bouts were shorter, at night time compared to daytime, regardless of recording day. The awake bouts also showed an interaction effect with longer bouts at daytime during day 1 compared to daytime on day 3. Data on sleep and awake states recorded in adult dairy cows during three consecutive 24-h periods showed great variation in sleep time between cows, but total time for each state was not significantly affected by recording day. Further and more detailed studies of how sleep architecture is affected by recording day is necessary to fully comprehend the first-night effect in dairy cows.	[Ternman, Emma] Aarhus Univ, Dept Anim Sci, Tjele, Denmark; [Pastell, Matti] Green Technol, Natl Resources Inst Finland Luke, Helsinki, Finland; [Hanninen, Laura] Univ Helsinki, Finland & Res Ctr Anim Welf, Dept Prod Anim Med, Helsinki, Finland; [Agenas, Sigrid] Swedish Univ Agr Sci, Dept Anim Nutr & Management, Uppsala, Sweden; [Nielsen, Per P.] Univ Copenhagen, Dept Vet & Anim Sci, Frederiksberg C, Denmark	Aarhus University; Natural Resources Institute Finland (Luke); University of Helsinki; Swedish University of Agricultural Sciences; University of Copenhagen	Ternman, E (corresponding author), Aarhus Univ, Dept Anim Sci, Tjele, Denmark.	emma.ternman@anis.au.dk	Ternman, Emma/Y-2917-2019; Pastell, Matti/T-5025-2018; Ternman, Emma/AAG-8684-2019; Hänninen, Laura Talvikki/E-6683-2011; Nielsen, Per Peetz/N-3454-2013	Ternman, Emma/0000-0001-6966-8621; Pastell, Matti/0000-0002-5810-4801; Hänninen, Laura Talvikki/0000-0001-5118-8451; Nielsen, Per Peetz/0000-0002-1359-2952	Swedish Research Council Formas [2011-1094]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was funded by the Swedish Research Council Formas and was given grant number 2011-1094, http://proj.formas.se/detail.asp?arendeid=25678&x=250&y=20&sprak=1&redovisning=0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew H W Jr, 1966, Psychophysiology, V2, P263, DOI 10.1111/j.1469-8986.1966.tb02650.x; BELL FR, 1973, PHYSIOL BEHAV, V11, P503, DOI 10.1016/0031-9384(73)90037-1; DeVries TJ, 2005, J DAIRY SCI, V88, P625, DOI 10.3168/jds.S0022-0302(05)72726-0; Fregonesi JA, 2007, J DAIRY SCI, V90, P3349, DOI 10.3168/jds.2006-794; Hanninen L, 2008, APPL ANIM BEHAV SCI, V111, P235, DOI 10.1016/j.applanim.2007.06.009; Ito K, 2009, J DAIRY SCI, V92, P4412, DOI 10.3168/jds.2009-2235; Kis A, 2014, BEHAV SLEEP MED, V12, P469, DOI 10.1080/15402002.2013.829062; Le Bon O, 2001, J PSYCHIATR RES, V35, P165, DOI 10.1016/S0022-3956(01)00019-X; Lee KA, 2000, OBSTET GYNECOL, V95, P14, DOI 10.1016/S0029-7844(99)00486-X; MENDELS J, 1967, ELECTROEN CLIN NEURO, V22, P556, DOI 10.1016/0013-4694(67)90063-6; RECHTSCHAFFEN A, 1964, PERCEPT MOTOR SKILL, V19, P947, DOI 10.2466/pms.1964.19.3.947; Ruckebusch Y., 1975, Applied Animal Ethology, V1, P207, DOI 10.1016/0304-3762(75)90100-5; RUCKEBUSCH Y, 1974, AM J VET RES, V35, P1309; RUCKEBUSCH Y, 1972, ANIM BEHAV, V20, P637, DOI 10.1016/S0003-3472(72)80136-2; Sporndly R., 2003, FOREDTABELLER IDISSL; Takeuchi T, 2002, BEHAV BRAIN RES, V136, P193, DOI 10.1016/S0166-4328(02)00123-7; Ternman E, 2012, APPL ANIM BEHAV SCI, V140, P25, DOI 10.1016/j.applanim.2012.05.005; von Keyserlingk MAG, 2008, J DAIRY SCI, V91, P1011, DOI 10.3168/jds.2007-0532; WAUQUIER A, 1991, BEHAV BRAIN RES, V42, P7, DOI 10.1016/S0166-4328(05)80034-8	19	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195593	10.1371/journal.pone.0195593	http://dx.doi.org/10.1371/journal.pone.0195593			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652904	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900031
J	Zhang, LJ; Hui, GY; Hu, YB; Zhao, ZH				Zhang, Lianjin; Hui, Gangying; Hu, Yanbo; Zhao, Zhonghua			Spatial structural characteristics of forests dominated by Pinus tabulaeformis Carr.	PLOS ONE			English	Article							NEAREST-NEIGHBOR INDEXES; BROAD-LEAVED FOREST; BIVARIATE DISTRIBUTION; NATURE-RESERVE; DIVERSITY; POPULATION; PLANTATION; MANAGEMENT; MOUNTAIN; PATTERNS	The Chinese pine (Pinus tabulaeformis Carr.) is an ecologically and economically important evergreen coniferous tree which dominates warm temperate forests throughout northern China. We established two permanent plots within the Chinese pine forest in the Jiulong Mountains, Beijing, China. To understand the structural characteristics and dynamics of these plots, we analyzed the spatial structural characteristics within nearest-neighbor relationships using the bivariate distributions of the stand spatial structural parameters: uniform angle index, W; mingling index, M; dominance index, U; and crowding index, C. Results revealed that most trees in the forest were randomly distributed. The predominant individuals and randomly arranged trees were in very dense areas and surrounded by the same species. In addition, both plots exhibited a uniform size differentiation pattern. The two plots differed mainly in the level of species mixture and dominance. The majority of reference trees in the pure Chinese pine forest (plot 1) exhibited poor species mingling and low dominance, whereas trees in the mixed Chinese pine forest (plot 2) were evenly distributed in each mingling class and most trees were of intermediate dominance. The study results are useful for optimizing forest management activities in the studied stands, promoting tree growth, regeneration and habitat diversity, and improving forest quality at a fine scale.	[Zhang, Lianjin] Chinese Acad Forestry, Expt Ctr Forestry North China, Beijing, Peoples R China; [Hui, Gangying; Hu, Yanbo; Zhao, Zhonghua] Chinese Acad Forestry, Res Inst Forestry, Beijing, Peoples R China; [Hui, Gangying; Hu, Yanbo; Zhao, Zhonghua] State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing, Peoples R China	Chinese Academy of Forestry; Chinese Academy of Forestry; Research Institute of Forestry, CAF	Zhang, LJ (corresponding author), Chinese Acad Forestry, Expt Ctr Forestry North China, Beijing, Peoples R China.	zlianjin1102@126.com		Zhang, Lianjin/0000-0001-6765-1391	Fundamental Research Funds for the Central Non-profit Research Institution of CAF [CAFYBB20140A035]; National Key Research and Development Program of China [2016YFD0600203]	Fundamental Research Funds for the Central Non-profit Research Institution of CAF; National Key Research and Development Program of China	This paper was financially supported by the Fundamental Research Funds for the Central Non-profit Research Institution of CAF (Grant No. CAFYBB20140A035) and the National Key Research and Development Program of China (Grant No.2016YFD0600203).	Aguirre O, 2003, FOREST ECOL MANAG, V183, P137, DOI 10.1016/S0378-1127(03)00102-6; CLARK PJ, 1954, ECOLOGY, V35, P445, DOI 10.2307/1931034; Daume S, 1995, DURCHFORSTUNGSSIMULA; Franklin JF, 2002, FOREST ECOL MANAG, V155, P399, DOI 10.1016/S0378-1127(01)00575-8; Gadow K. von, 1993, Forst und Holz, V48, P602; Gadow KV, 2012, FOREST STRUCTURE DIV, P29; Gao G, 2013, FOREST SYST, V22, P147, DOI 10.5424/fs/2013221-03294; Getzin S, 2006, ECOGRAPHY, V29, P671, DOI 10.1111/j.2006.0906-7590.04675.x; Hu Ercha, 2011, Forest Research, V24, P363; Hu Y, 2015, INT J ANTENN PROPAG, V2015, DOI 10.1155/2015/873134; Hui G., 2010, GUIDE STRUCTURE BASE; Hui G., 2003, QUANTITATIVE ANAL FO, P16; Hui G., 2016, PRINCIPLES STRUCTURE; Hui GY, 2002, ALLG FORST JAGDZTG, V173, P173; Hui GY, 2007, STURCTURE BASED FORE, P28; Corral-Rivas JJ, 2010, J FOREST RES-JPN, V15, P218, DOI 10.1007/s10310-010-0181-1; Kint V, 2003, FOREST SCI, V49, P36; Kuuluvainen Timo, 1996, Silva Fennica, V30, P315; Laarmann D, 2009, FOREST ECOL MANAG, V258, pS187, DOI 10.1016/j.foreco.2009.07.014; Lexerod NL, 2006, FOREST ECOL MANAG, V222, P17, DOI 10.1016/j.foreco.2005.10.046; Li YF, 2014, FOREST ECOL MANAG, V23, P1180; Li YF, 2017, IFOREST, V10, P561, DOI 10.3832/ifor2115-010; Li YF, 2014, FOREST ECOL MANAG, V314, P17, DOI 10.1016/j.foreco.2013.11.012; Li YF, 2012, J VEG SCI, V23, P1180, DOI 10.1111/j.1654-1103.2012.01431.x; Liu WenZhen, 2011, Forest Research, Beijing, V24, P437; Mason WL, 2007, FORESTRY, V80, P564, DOI 10.1093/forestry/cpm038; Morisita M, 1954, J ANIM ECOL, V36, P1; Ni RQ, 2014, FOREST ECOL MANAG, V316, P139, DOI 10.1016/j.foreco.2013.10.012; Pastorella F., 2013, Journal of Forest Science (Prague), V59, P159, DOI 10.17221/75/2012-JFS; Petritan AM, 2012, FOREST ECOL MANAG, V280, P140, DOI 10.1016/j.foreco.2012.06.007; Pommerening A, 2006, FOREST ECOL MANAG, V224, P266, DOI 10.1016/j.foreco.2005.12.039; Pommerening A, 2002, FORESTRY, V75, P305, DOI 10.1093/forestry/75.3.305; Pommerening A, 2008, THESIS, P36; RIPLEY BD, 1977, J ROY STAT SOC B MET, V39, P172; Spies TA, 1998, NORTHWEST SCI, V72, P34; State Forestry Administration of China, 2014, REP FOR RES CHIN 200; UPTON G, 1985, SPATIAL DATA ANAL EX, VI; Wang Luo-xin, 2016, Shengtaixue Zazhi, V35, P314; Wang Qing, 2014, Journal of Northeast Forestry University, V42, P32; Wiegand T, 2004, OIKOS, V104, P209, DOI 10.1111/j.0030-1299.2004.12497.x; Wu G, 1994, ACTA ECOLOGICA SINIC, V14, P415; Zenner EK, 2000, FOREST ECOL MANAG, V129, P75, DOI 10.1016/S0378-1127(99)00140-1; Zhang Lian-jin, 2015, Shengtaixue Zazhi, V34, P60; Zhang Yun, 2009, Chinese Journal of Applied and Environmental Biology, V15, P175, DOI 10.3724/SP.J.1145.2009.00175	44	20	25	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194710	10.1371/journal.pone.0194710	http://dx.doi.org/10.1371/journal.pone.0194710			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652916	gold, Green Published, Green Submitted			2022-12-26	WOS:000430026900008
J	Ajani, PA; Verma, A; Lassudrie, M; Doblin, MA; Murray, SA				Ajani, Penelope A.; Verma, Arjun; Lassudrie, Malwenn; Doblin, Martina A.; Murray, Shauna A.			A new diatom species P. hallegraeffii sp nov belonging to the toxic genus Pseudo-nitzschia (Bacillariophyceae) from the East Australian Current	PLOS ONE			English	Article							NEW-SOUTH-WALES; COMPLEX BACILLARIOPHYCEAE; DOMOIC ACID; DELICATISSIMA BACILLARIOPHYCEAE; PSEUDODELICATISSIMA COMPLEX; PUNGENS BACILLARIOPHYCEAE; MOLECULAR PHYLOGENY; MALAYSIAN BORNEO; COASTAL STATION; SIZE-REDUCTION	A new species belonging to the toxin producing diatom genus Pseudo-nitzschia, P. hallegraeffii sp. nov., is delineated and described from the East Australian Current (EAC). Clonal cultures were established by single cell isolation from phytoplankton net hauls collected as part of a research expedition in the EAC region in 2016 on the RV Investigator. Cultures were assessed for their morphological and genetic characteristics, their sexual compatibility with other Pseudo-nitzschia species, and their ability to produce domoic acid. Light and transmission electron microscopy revealed cells which differed from their closest relatives by their cell width, rows of poroids, girdle band structure and density of band straie. Phylogenetic analyses based on sequencing of nuclear-encoded ribosomal deoxyribonucleic acid (rDNA) regions showed this novel genotype clustered within the P. delicatissima complex, but formed a discrete Glade from its closest relatives P. dolorosa, P. simulans, P. micropora and P. delicatissima. Complementary base changes (CBCs) were observed in the secondary structure of the 3' nuclear ribosomal transcribed spacer sequence region (ITS2) between P. hallegraeffii sp. nov. and its closest related taxa, P. simulans and P. dolorosa. Under laboratory conditions, and in the absence of any zooplankton cues, strains of P. hallegraeffiisp. nov. did not produce domoic acid (DA) and were not sexually compatible with any other Pseudo-nitzschia clones tested. A total of 18 Pseudo-nitzschia species, including three confirmed toxigenic species (P. cuspidata, P. multistriata and P. australis) have now been unequivocally confirmed from eastern Australia.	[Ajani, Penelope A.; Verma, Arjun; Lassudrie, Malwenn; Doblin, Martina A.; Murray, Shauna A.] Univ Technol Sydney, C3, Broadway, NSW, Australia; [Lassudrie, Malwenn] IFREMER LER BO, Stn Biol Marine, Pl Croix, Concarneau, France	University of Technology Sydney; Ifremer	Ajani, PA (corresponding author), Univ Technol Sydney, C3, Broadway, NSW, Australia.	penelope.ajani@uts.edu.au	Verma, Arjun/J-7055-2019; Doblin, Martina/L-1804-2019; Malwenn, Lassudrie/V-9956-2018; Doblin, Martina A/E-8719-2013; Ajani, Penelope/K-9987-2019; Murray, Shauna A/K-5781-2015	Verma, Arjun/0000-0003-0119-9915; Doblin, Martina/0000-0001-8750-3433; Malwenn, Lassudrie/0000-0002-7004-926X; Doblin, Martina A/0000-0001-8750-3433; Murray, Shauna A/0000-0001-7096-1307; Ajani, Penelope/0000-0001-5364-9936	CSIRO [IN2016_V04]; Australian Research Council (LIEF) [LE140100055]; University of Technology Sydney Chancellor's Postdoctoral Fellowship	CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Australian Research Council (LIEF)(Australian Research Council); University of Technology Sydney Chancellor's Postdoctoral Fellowship	The authors would like to thank Australia's Marine National Facility for sea time on board the RV Investigator, management of the vessel and support of the IN2016_V04 voyage by MNF staff at CSIRO, and all of the officers and crew on board. We would also like to thank the deputy chief scientist, Prof lain Suthers, for his assistance, Christine Rees and Stephen Tibben (Oceans and Atmosphere Hydrochemistry, CSIRO) for environmental data acquisition and processing, Emmanuel Laurenceau-Cornec (Institute for Marine and Antarctic Studies, University of Tasmania) for assistance with map editing, and Katie McBean (Physics and Advanced Materials & Microstructural Analysis Unit, University of Technology Sydney) for transmission electron microscopy assistance. We would also like to thank the Sydney Institute of Marine Science for ongoing support. Finally, we would like to thank the Australian Research Council (LIEF grant LE140100055) for the LCMS facility and PA would also like to thank the University of Technology Sydney Chancellor's Postdoctoral Fellowship scheme for funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajani P, 2001, P LINN SOC N S W, V123, P1; Ajani P, 2016, PHYCOL RES, V64, P312, DOI 10.1111/pre.12142; Ajani P, 2013, J PHYCOL, V49, P765, DOI 10.1111/jpy.12087; Ajani P, 2013, PHYCOL RES, V61, P237, DOI 10.1111/pre.12020; Ajani PA, 2014, LIMNOL OCEANOGR, V59, P2240, DOI 10.4319/lo.2014.59.6.2240; Ajani PA, 2014, LIMNOL OCEANOGR, V59, P519, DOI 10.4319/lo.2014.59.2.0519; Amato A, 2005, J PHYCOL, V41, P542, DOI 10.1111/j.1529-8817.2005.00080.x; Amato A, 2008, PHYCOLOGIA, V47, P487, DOI 10.2216/07-92.1; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Ankenbrand MJ, 2015, MOL BIOL EVOL, V32, P3030, DOI 10.1093/molbev/msv174; ARMSTRONG FA, 1967, DEEP-SEA RES, V14, P381, DOI 10.1016/0011-7471(67)90082-4; BATES SS, 1989, CAN J FISH AQUAT SCI, V46, P1203, DOI 10.1139/f89-156; Casteleyn G, 2008, HARMFUL ALGAE, V7, P241, DOI 10.1016/j.hal.2007.08.004; Chepurnov VA, 2005, EUR J PHYCOL, V40, P379, DOI 10.1080/09670260500254735; Churro CI, 2009, DIATOM RES, V24, P35; Coleman AW, 2009, MOL PHYLOGENET EVOL, V50, P197, DOI 10.1016/j.ympev.2008.10.008; Darty K, 2009, BIOINFORMATICS, V25, P1974, DOI 10.1093/bioinformatics/btp250; Fernandes LF, 2014, DEEP-SEA RES PT II, V103, P139, DOI 10.1016/j.dsr2.2013.06.022; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HALLEGRAEFF GM, 1981, MAR BIOL, V61, P107, DOI 10.1007/BF00386650; HALLEGRAEFF GM, 1994, BOT MAR, V37, P397, DOI 10.1515/botm.1994.37.5.397; Haroardottir S, 2015, MAR DRUGS, V13, P3809, DOI 10.3390/md13063809; HASLE GR, 1970, T AM MICROSC SOC, V89, P469, DOI 10.2307/3224555; HASLE GR, 1995, J PHYCOL, V31, P428, DOI 10.1111/j.0022-3646.1995.00428.x; HASLE GR, 1994, J PHYCOL, V30, P1036, DOI 10.1111/j.0022-3646.1994.01036.x; Hasle Grethe R., 1997, P5, DOI 10.1016/B978-012693018-4/50004-5; Quijano-Scheggia SI, 2009, PHYCOLOGIA, V48, P492, DOI 10.2216/08-21.1; Jameson I., 2010, ALGAE AUSTR PHYTOPLA, P16; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kerouel R, 1997, J MARINE CHEM, V57; Kim JH, 2015, J PHYCOL, V51, P159, DOI 10.1111/jpy.12263; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LaJeunesse DR, 2001, GENETICS, V158, P667; Lapworth C., 2001, P 9 INT C HARMF ALG; Lelong A, 2012, PHYCOLOGIA, V51, P168, DOI 10.2216/11-37; Li Y, 2017, HARMFUL ALGAE, V67, P119, DOI 10.1016/j.hal.2017.06.008; Lim HC, 2013, J PHYCOL, V49, P902, DOI 10.1111/jpy.12101; Lim HC, 2012, J PHYCOL, V48, P1232, DOI 10.1111/j.1529-8817.2012.01213.x; Lundholm N, 2006, J PHYCOL, V42, P464, DOI 10.1111/j.1529-8817.2006.00211.x; Lundholm N, 2003, J PHYCOL, V39, P797, DOI 10.1046/j.1529-8817.2003.02031.x; Lundholm N, 2002, PHYCOLOGIA, V41, P480, DOI 10.2216/i0031-8884-41-5-480.1; Lundholm Nina, 2017, Harmful Algae News, V56, P5; Lundholm N, 2012, J PHYCOL, V48, P436, DOI 10.1111/j.1529-8817.2012.01132.x; McNabb P, 2005, J AOAC INT, V88, P761; Moschandreou KK, 2012, EUR J PHYCOL, V47, P321, DOI 10.1080/09670262.2012.713998; Moschandreou KK, 2010, BOT MAR, V53, P159, DOI 10.1515/BOT.2010.014; Muller T, 2007, RNA, V13, P1469, DOI 10.1261/rna.617107; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Nunn GB, 1996, J MOL EVOL, V42, P211, DOI 10.1007/BF02198847; Orive E, 2013, J PHYCOL, V49, P1192, DOI 10.1111/jpy.12130; Orsini L, 2004, MAR ECOL PROG SER, V271, P87, DOI 10.3354/meps271087; Ridgway KR, 1997, J GEOPHYS RES-OCEANS, V102, P22921, DOI 10.1029/97JC00227; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Sato SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021783; Scalco E, 2014, J PHYCOL, V50, P817, DOI 10.1111/jpy.12225; Scholin C. A., 1994, Natural Toxins, V2, P152, DOI 10.1002/nt.2620020403; Schultz J, 2009, MOL PHYLOGENET EVOL, V52, P520, DOI 10.1016/j.ympev.2009.01.008; Seibel PN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-498; Teng ST, 2016, J PHYCOL, V52, P973, DOI 10.1111/jpy.12448; Teng ST, 2015, J PHYCOL, V51, P706, DOI 10.1111/jpy.12313; Teng ST, 2014, HARMFUL ALGAE, V34, P17, DOI 10.1016/j.hal.2014.02.005; Trainer VL, 2012, HARMFUL ALGAE, V14, P271, DOI 10.1016/j.hal.2011.10.025; Verma A, 2016, HARMFUL ALGAE, V60, P116, DOI 10.1016/j.hal.2016.11.004; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; [No title captured]	66	19	21	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195622	10.1371/journal.pone.0195622	http://dx.doi.org/10.1371/journal.pone.0195622			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649303	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900062
J	Rylee, JC; Sinlard, DJ; Doucette, K; Zentner, GE; Zelhof, AC				Rylee, Johnathan C.; Sinlard, Dylan J.; Doucette, Kaitlin; Zentner, Gabriel E.; Zelhof, Andrew C.			Expanding the genetic toolkit of Tribolium castaneum	PLOS ONE			English	Article							TRANSGENE EXPRESSION; FLOUR BEETLE; EYE-COLOR; DROSOPHILA; INSECTS; REVEALS; LINKAGE; COLEOPTERA; PROMOTER; REVISION	The red flour beetle, Tribolium castaneum, is an important model insect and agricultural pest. However, many standard genetic tools are lacking or underdeveloped in this system. Here, we present a set of new reagents to augment existing Tribolium genetic tools. We demonstrate a new GAL4 driver line that employs the promoter of a ribosomal protein gene to drive expression of a UAS responder in the fat body. We also present a novel dual fluorescent reporter that labels cell membranes and nuclei with different fluorophores for the analysis of cellular morphology. This approach also demonstrates the functionality of the viral T2A peptide for bicistronic gene expression in Tribolium. To facilitate classical genetic analysis, we created lines with visible genetic markers by CRISPR-mediated disruption of the yellowand ebony body color loci with a cassette carrying an attP site, enabling future phi C31-mediated integration. Together, the reagents presented here will facilitate more robust genetic analysis in Tribolium and serve as a blueprint for the further development of this powerful model's genetic toolkit.	[Rylee, Johnathan C.; Sinlard, Dylan J.; Doucette, Kaitlin; Zentner, Gabriel E.; Zelhof, Andrew C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Sinlard, Dylan J.] Cincinnati Childrens Hosp Med Ctr, Div Asthma Res, Cincinnati, OH 45229 USA	Indiana University System; Indiana University Bloomington; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Zentner, GE; Zelhof, AC (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	gzentner@indiana.edu; azelhof@indiana.edu		Zelhof, Andrew/0000-0001-7085-822X; Zentner, Gabriel/0000-0002-0801-7646	Indiana University startup funds; National Science Foundation [IOS-1353267]	Indiana University startup funds; National Science Foundation(National Science Foundation (NSF))	This work was supported by Indiana University startup funds (to GEZ) and National Science Foundation grant IOS-1353267 (to ACZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakane Y, 2009, J BIOL CHEM, V284, P16584, DOI 10.1074/jbc.M901629200; BEEMAN RW, 1989, DEV BIOL, V133, P196, DOI 10.1016/0012-1606(89)90311-4; Beeman RW, 1996, J HERED, V87, P224, DOI 10.1093/oxfordjournals.jhered.a022989; Berghammer AJ, 1999, NATURE, V402, P370, DOI 10.1038/46463; Bortoluzzi S, 2001, BIOINFORMATICS, V17, P1152, DOI 10.1093/bioinformatics/17.12.1152; Broehan G, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-6; BROWN E, 1978, CAN J GENET CYTOL, V20, P139, DOI 10.1139/g78-014; Brown SJ, 1999, EVOL DEV, V1, P11, DOI 10.1046/j.1525-142x.1999.99013.x; Bucher G, 2002, CURR BIOL, V12, pR85, DOI 10.1016/S0960-9822(02)00666-8; DAWSON PS, 1984, CAN J GENET CYTOL, V26, P762, DOI 10.1139/g84-120; Dippel S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0304-z; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Gilles AF, 2015, DEVELOPMENT, V142, P2832, DOI 10.1242/dev.125054; Goodman CL, 2012, IN VITRO CELL DEV-AN, V48, P426, DOI 10.1007/s11626-012-9524-x; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Grubbs N, 2015, GENETICS, V199, P749, DOI 10.1534/genetics.114.173971; Guimaraes JC, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1104-z; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Lorenzen MD, 2007, INSECT MOL BIOL, V16, P265, DOI 10.1111/j.1365-2583.2007.00727.x; Lorenzen MD, 2002, GENETICS, V160, P225; Lorenzen MD, 2002, INSECT MOL BIOL, V11, P399, DOI 10.1046/j.1365-2583.2002.00349.x; MA J, 1987, CELL, V48, P847, DOI 10.1016/0092-8674(87)90081-X; Mocelin G, 1996, J HERED, V87, P27, DOI 10.1093/oxfordjournals.jhered.a022949; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Nie J, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0056-y; Osanai-Futahashi M, 2012, J BIOL CHEM, V287, P17706, DOI 10.1074/jbc.M111.321331; Sauert M, 2015, BIOCHIMIE, V114, P39, DOI 10.1016/j.biochi.2014.12.011; Schinko JB, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-53; Schmitt-Engel C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8822; Siebert KS, 2008, INSECT BIOCHEM MOLEC, V38, P749, DOI 10.1016/j.ibmb.2008.04.007; Silver K, 2014, SCI REP-UK, V4, DOI 10.1038/srep06840; SOKOLOFF A, 1987, J HERED, V78, P2, DOI 10.1093/oxfordjournals.jhered.a110299; Thorrez L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001854; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; Trauner J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-73; Viktorinova I, 2007, INSECT BIOCHEM MOLEC, V37, P246, DOI 10.1016/j.ibmb.2006.11.010	37	17	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195977	10.1371/journal.pone.0195977	http://dx.doi.org/10.1371/journal.pone.0195977			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649291	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900107
J	Seidi, K; Jahanban-Esfahlan, R; Monhemi, H; Zare, P; Minofar, B; Adli, ADF; Farajzadeh, D; Behzadi, R; Abbasi, MM; Neubauer, HA; Moriggl, R; Zarghami, N; Javaheri, T				Seidi, Khaled; Jahanban-Esfahlan, Rana; Monhemi, Hassan; Zare, Peyman; Minofar, Babak; Adli, Amir Daei Farshchi; Farajzadeh, Davoud; Behzadi, Ramezan; Abbasi, Mehran Mesgari; Neubauer, Heidi A.; Moriggl, Richard; Zarghami, Nosratollah; Javaheri, Tahereh			NGR (Asn-Gly-Arg)-targeted delivery of coagulase to tumor vasculature arrests cancer cell growth	ONCOGENE			English	Article							ANTI-ANGIOGENIC THERAPY; TISSUE FACTOR; TARGETING AGENTS; MOUSE MODEL; INFARCTION; STAPHYLOCOAGULASE; MICE; VESSELS; METASTASIS; ACTIVATION	Induction of selective thrombosis and infarction in tumor-feeding vessels represents an attractive strategy to combat cancer. Here we took advantage of the unique coagulation properties of staphylocoagulase and genetically engineered it to generate a new fusion protein with novel anti-cancer properties. This novel bi-functional protein consists of truncated coagulase (tCoa) and an NGR (GNGRAHA) motif that recognizes CD13 and alpha(v)beta(3) integrin receptors, targeting it to tumor endothelial cells. Herein, we report that tCoa coupled by its C-terminus to an NGR sequence retained its normal binding activity with prothrombin and alpha(v)beta(3) integrins, as confirmed in silico and in vitro. Moreover, in vivo biodistribution studies demonstrated selective accumulation of FITC-labeled tCoa-NGR fusion proteins at the site of subcutaneously implanted PC3 tumor xenografts in nude mice. Notably, systemic administration of tCoa-NGR to mice bearing 4T1 mouse mammary xenografts or PC3 human prostate tumors resulted in a significant reduction in tumor growth. These anti-tumor effects were accompanied by massive thrombotic occlusion of small and large tumor vessels, tumor infarction and tumor cell death. From these findings, we propose tCoa-NGR mediated tumor infarction as a novel and promising anti-cancer strategy targeting both CD13 and integrin alpha(v)beta(3) positive tumor neovasculature.	[Seidi, Khaled; Jahanban-Esfahlan, Rana; Adli, Amir Daei Farshchi; Zarghami, Nosratollah] Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Biotechnol, Tabriz, Iran; [Monhemi, Hassan] Univ Neyshabour, Dept Chem, Khorasan Razavi Prov, Neyshabour, Iran; [Zare, Peyman] Univ Tabriz, Fac Vet Sci, Dept Pathobiol, Tabriz, Iran; [Minofar, Babak] Acad Sci Czech Republ, Ctr Nanobiol & Struct Biol, Inst Microbiol, Zamek 136, Nove Hrady 37333, Czech Republic; [Minofar, Babak] Univ South Bohemia, Fac Sci, Branisovska 1760, Ceske Budejovice 37005, Czech Republic; [Farajzadeh, Davoud] Azarbaijan Shahid Madani Univ, Fac Biol Sci, Dept Cellular & Mol Biol, Tabriz, Iran; [Behzadi, Ramezan] Pasture Inst Iran, North Res Ctr, Amol, Iran; [Abbasi, Mehran Mesgari] Tabriz Univ Med Sci, Drug Appl Res Ctr, Tabriz, Iran; [Neubauer, Heidi A.; Moriggl, Richard; Javaheri, Tahereh] Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria; [Neubauer, Heidi A.; Moriggl, Richard; Javaheri, Tahereh] Univ Vet Med Vienna, Inst Anim Breeding & Genet, A-1210 Vienna, Austria; [Moriggl, Richard] Med Univ Vienna, A-1090 Vienna, Austria; [Zarghami, Nosratollah] Tabriz Univ Med Sci, Fac Med, Dept Clin Biochem, Tabriz, Iran; [Zarghami, Nosratollah] Tabriz Univ Med Sci, Fac Med, Lab Med, Tabriz, Iran; [Zarghami, Nosratollah] Iranian Natl Sci Fdn, Tehran, Iran	Tabriz University of Medical Science; University of Tabriz; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Azarbaijan Shahid Madani University; Tabriz University of Medical Science; Ludwig Boltzmann Institute; University of Veterinary Medicine Vienna; Medical University of Vienna; Tabriz University of Medical Science; Tabriz University of Medical Science	Zarghami, N (corresponding author), Tabriz Univ Med Sci, Fac Adv Med Sci, Dept Med Biotechnol, Tabriz, Iran.; Javaheri, T (corresponding author), Ludwig Boltzmann Inst Canc Res, A-1090 Vienna, Austria.; Javaheri, T (corresponding author), Univ Vet Med Vienna, Inst Anim Breeding & Genet, A-1210 Vienna, Austria.; Zarghami, N (corresponding author), Tabriz Univ Med Sci, Fac Med, Dept Clin Biochem, Tabriz, Iran.; Zarghami, N (corresponding author), Tabriz Univ Med Sci, Fac Med, Lab Med, Tabriz, Iran.; Zarghami, N (corresponding author), Iranian Natl Sci Fdn, Tehran, Iran.	Zarghami@tbzmed.ac.ir; Tahereh.Javaheri@lbicr.lbg.ac.at	Farajzadeh, Davoud/AAQ-5732-2021; Zare, Peyman/ABE-6329-2020; Moriggl, Richard/H-8118-2019; Minofar, Babak/I-4326-2012; Farajzadeh, Davoud/W-2236-2017; Neubauer, Heidi A./AAD-8727-2019; Minofar, Babak/I-4326-2012	Zare, Peyman/0000-0003-1291-1808; Moriggl, Richard/0000-0003-0918-9463; Minofar, Babak/0000-0002-0188-0471; Farajzadeh, Davoud/0000-0002-9267-4277; Neubauer, Heidi/0000-0001-7372-7786; Minofar, Babak/0000-0001-8096-2194	Drug Applied Research Center, Tabriz University of Medical Sciences; Iran National Science Foundation (INSF) [90007316]	Drug Applied Research Center, Tabriz University of Medical Sciences; Iran National Science Foundation (INSF)(Iran National Science Foundation (INSF))	This study was funded by Drug Applied Research Center, Tabriz University of Medical Sciences (IR) and the Iran National Science Foundation (INSF) (Grant No: 90007316).	Adli ADF, 2018, CHEM BIOL DRUG DES, V91, P996, DOI 10.1111/cbdd.13166; Bhagwat SV, 2001, BLOOD, V97, P652, DOI 10.1182/blood.V97.3.652; Bieker R, 2009, BLOOD, V113, P5019, DOI 10.1182/blood-2008-04-150318; Brand C, 2016, ONCOTARGET, V7, P6774, DOI 10.18632/oncotarget.6725; Chen J, 2001, THROMB HAEMOSTASIS, V86, P334; Cheng AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001036; Corti A, 2008, BLOOD, V112, P2628, DOI 10.1182/blood-2008-04-150862; Corti A, 2011, CURR PHARM BIOTECHNO, V12, P1128, DOI 10.2174/138920111796117373; Delano W.L., 2002, PYMOL MOL GRAPHICS S; Dreischaluck J, 2010, INT J ONCOL, V37, P1389, DOI 10.3892/ijo_00000790; Friedrich R, 2006, J BIOL CHEM, V281, P1188, DOI 10.1074/jbc.M507957200; Friedrich R, 2003, NATURE, V425, P535, DOI 10.1038/nature01962; Hashida H, 2002, GASTROENTEROLOGY, V122, P376, DOI 10.1053/gast.2002.31095; Hu PS, 2003, CANCER RES, V63, P5046; Huang FY, 2008, J ZHEJIANG UNIV-SC B, V9, P602, DOI 10.1631/jzus.B0820120; Huang XM, 1997, SCIENCE, V275, P547, DOI 10.1126/science.275.5299.547; Huang ZJ, 2013, SCI WORLD J, DOI 10.1155/2013/637086; Huang Zheng-jie, 2012, Zhonghua Zhong Liu Za Zhi, V34, P249, DOI 10.3760/cma.j.issn.0253-3766.2012.04.003; Jahanban-Esfahlan R, 2018, J CELL PHYSIOL, V233, P2982, DOI 10.1002/jcp.26051; Jahanban-Esfahlan R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05326-9; Jahanban-Esfahlan R, 2018, J CELL PHYSIOL, V233, P2019, DOI 10.1002/jcp.25859; Jahanban-Esfahlan R, 2017, INT J HEMATOL, V105, P244, DOI 10.1007/s12185-016-2171-3; Javaheri T, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.268; Kastrup CJ, 2008, NAT CHEM BIOL, V4, P742, DOI 10.1038/nchembio.124; Kazemi Z, 2016, MOL PHARMACOL, V89, P630, DOI 10.1124/mol.116.103267; Kerbel RS, 2000, CARCINOGENESIS, V21, P505, DOI 10.1093/carcin/21.3.505; Kessler T, 2005, CLIN CANCER RES, V11, P6317, DOI 10.1158/1078-0432.CCR-05-0389; Kubota Yoshiaki, 2012, Keio Journal of Medicine, V61, P47; Liu C, 2002, CANCER RES, V62, P5470; Liu ZF, 2008, DRUG DEVELOP RES, V69, P329, DOI 10.1002/ddr.20265; McAdow M, 2012, INFECT IMMUN, V80, P3389, DOI 10.1128/IAI.00562-12; Minas TZ, 2017, ONCOTARGET, V8, P34141, DOI 10.18632/oncotarget.9388; Minas TZ, 2015, ONCOTARGET, V6, P37678, DOI 10.18632/oncotarget.5520; MOJOVIC B, 1969, YALE J BIOL MED, V42, P11; Nierodzik ML, 2006, CANCER CELL, V10, P355, DOI 10.1016/j.ccr.2006.10.002; Nilsson F, 2001, CANCER RES, V61, P711; Panizzi P, 2006, J BIOL CHEM, V281, P1179, DOI 10.1074/jbc.M507956200; Panizzi P, 2004, CELL MOL LIFE SCI, V61, P2793, DOI 10.1007/s00018-004-4285-7; PENCIK J, 2015, NAT COMMUN, V6; Ran S, 1998, CANCER RES, V58, P4646; Seidi K, 2018, J CONTROL RELEASE, V275, P142, DOI 10.1016/j.jconrel.2018.02.020; Seidi K, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317691001; SMITH DD, 1958, BRIT J EXP PATHOL, V39, P165; Thorpe PE, 2004, CLIN CANCER RES, V10, P415, DOI 10.1158/1078-0432.CCR-0642-03; Tozer GM, 2005, NAT REV CANCER, V5, P423, DOI 10.1038/nrc1628; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vasudev NS, 2014, ANGIOGENESIS, V17, P471, DOI 10.1007/s10456-014-9420-y; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yokota N, 2014, J THROMB HAEMOST, V12, P71, DOI 10.1111/jth.12442	49	28	31	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					3967	3980		10.1038/s41388-018-0213-4	http://dx.doi.org/10.1038/s41388-018-0213-4			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29662195	hybrid, Green Published			2022-12-26	WOS:000439101300005
J	Aziz, Q; Finlay, M; Montaigne, D; Ojake, L; Li, YW; Anderson, N; Ludwig, A; Tinker, A				Aziz, Qadeer; Finlay, Malcolm; Montaigne, David; Ojake, Leona; Li, Yiwen; Anderson, Naomi; Ludwig, Andreas; Tinker, Andrew			ATP-sensitive potassium channels in the sinoatrial node contribute to heart rate control and adaptation to hypoxia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EARLY REPOLARIZATION; K+ CHANNELS; MECHANISM; MUTATION; SUBUNIT; ATRIAL; KIR6.1; GAIN	ATP-sensitive potassium channels (K-ATP) contribute to membrane currents in many tissues, are responsive to intracellular metabolism, and open as ATP falls and ADP rises. K-ATP channels are widely distributed in tissues and are prominently expressed in the heart. They have generally been observed in ventricular tissue, but they are also expressed in the atria and conduction tissues. In this study, we focused on the contribution and role of the inwardly rectifying K-ATP channel subunit, Kir6.1, in the sinoatrial node (SAN). To develop a murine, conduction-specific Kir6.1 KO model, we selectively deleted Kir6.1 in the conduction system in adult mice (cKO). Electrophysiological data in single SAN cells indicated that Kir6.1 underlies a K-ATP current in a significant proportion of cells and influences early repolarization during pacemaking, resulting in prolonged cycle length. Implanted telemetry probes to measure heart rate and electrocardiographic characteristics revealed that the cKO mice have a slow heart rate, with episodes of sinus arrest in some mice. The PR interval (time between the onset of the P wave to the beginning of QRS complex) was increased, suggesting effects on the atrioventricular node. Ex vivo studies of whole heart or dissected heart regions disclosed impaired adaptive responses of the SAN to hypoxia, and this may have had long-term pathological consequences in the cKO mice. In conclusion, Kir6.1-containing K-ATP channels in the SAN have a role in excitability, heart rate control, and the electrophysiological adaptation of the SAN to hypoxia.	[Aziz, Qadeer; Finlay, Malcolm; Ojake, Leona; Li, Yiwen; Anderson, Naomi; Tinker, Andrew] Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Ctr Heart, London EC1M 6BQ, England; [Ludwig, Andreas] Univ Erlangen Nurnberg, Inst Expt & Klin Pharmakol & Toxikol, D-91054 Erlangen, Germany; [Montaigne, David] CHU Lille, Dept Clin Physiol & Echocardiog, F-59000 Lille, France; [Montaigne, David] Univ Lille, EGID, INSERM, UMR1011, F-59000 Lille, France	University of London; Queen Mary University London; University of Erlangen Nuremberg; Universite de Lille - ISITE; CHU Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille	Tinker, A (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, Ctr Heart, Charterhouse Sq, London EC1M 6BQ, England.	a.tinker@qmul.ac.uk	Montaigne, David/R-6066-2018	Montaigne, David/0000-0002-2346-863X; Aziz, Qadeer/0000-0002-7636-6813	British Heart Foundation [RG/15/15/31742]	British Heart Foundation(British Heart Foundation)	This work was supported by British Heart Foundation Grant RG/15/15/31742) and was facilitated by the National Institute of Health Research Biomedical Research Centre at Barts. The authors declare that they have no conflicts of interest with the contents of this article.	AGUILARBRYAN L, 1995, SCIENCE, V268, P423, DOI 10.1126/science.7716547; ASHCROFT FM, 1987, FEBS LETT, V215, P9, DOI 10.1016/0014-5793(87)80103-5; Aziz Q, 2017, J BIOL CHEM, V292, P17587, DOI 10.1074/jbc.M117.810325; Aziz Q, 2014, HYPERTENSION, V64, P523, DOI 10.1161/HYPERTENSIONAHA.114.03116; Bao L, 2011, CIRC-ARRHYTHMIA ELEC, V4, P926, DOI 10.1161/CIRCEP.111.964643; Barajas-Martinez H, 2012, HEART RHYTHM, V9, P548, DOI 10.1016/j.hrthm.2011.10.035; Boyett MR, 2003, J CARDIOVASC ELECTR, V14, P104, DOI 10.1046/j.1540-8167.2003.02307.x; Cui Y, 2001, P NATL ACAD SCI USA, V98, P729, DOI 10.1073/pnas.011370498; Delaney JT, 2012, EUROPACE, V14, P1428, DOI 10.1093/europace/eus150; Fedorov VV, 2011, J MOL CELL CARDIOL, V51, P215, DOI 10.1016/j.yjmcc.2011.04.016; Flagg TP, 2008, CIRC RES, V103, P1458, DOI 10.1161/CIRCRESAHA.108.178186; Fukuzaki K, 2008, J PHYSIOL-LONDON, V586, P2767, DOI 10.1113/jphysiol.2007.148932; Giblin JP, 2002, J BIOL CHEM, V277, P13717, DOI 10.1074/jbc.M112209200; Glukhov AV, 2010, J MOL CELL CARDIOL, V48, P152, DOI 10.1016/j.yjmcc.2009.08.026; Han X, 1996, J PHYSIOL-LONDON, V490, P337, DOI 10.1113/jphysiol.1996.sp021148; Hoesl E, 2008, J MOL CELL CARDIOL, V45, P62, DOI 10.1016/j.yjmcc.2008.04.008; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Lakatta EG, 2010, CIRC RES, V106, P659, DOI 10.1161/CIRCRESAHA.109.206078; Lane JD, 2017, J MEMBRANE BIOL, V250, P471, DOI 10.1007/s00232-017-9973-y; Levin MD, 2016, P NATL ACAD SCI USA, V113, P6773, DOI 10.1073/pnas.1606465113; Levin MD, 2015, HEART RHYTHM, V12, P2316, DOI 10.1016/j.hrthm.2015.06.042; Li NN, 2017, CELL, V168, P101, DOI 10.1016/j.cell.2016.12.028; Mangoni ME, 2001, CARDIOVASC RES, V52, P51, DOI 10.1016/S0008-6363(01)00370-4; Martin GM, 2017, ELIFE, V6, DOI 10.7554/eLife.24149; Miki T, 2002, NAT MED, V8, P466, DOI 10.1038/nm0502-466; Monfredi O, 2010, PACE, V33, P1392, DOI 10.1111/j.1540-8159.2010.02838.x; NOMA A, 1983, NATURE, V305, P147, DOI 10.1038/305147a0; Quinn KV, 2004, CIRC RES, V94, P1359, DOI 10.1161/01.RES.0000128513.34817.c4; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Tester DJ, 2011, CIRC-CARDIOVASC GENE, V4, P510, DOI 10.1161/CIRCGENETICS.111.960195; Tinker A, 2014, BRIT J PHARMACOL, V171, P12, DOI 10.1111/bph.12407; Unudurthi SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002865; Zingman LV, 2007, J APPL PHYSIOL, V103, P1888, DOI 10.1152/japplphysiol.00747.2007; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199; Zuberi Z, 2008, AM J PHYSIOL-REG I, V295, pR1822, DOI 10.1152/ajpregu.90625.2008	36	12	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8912	8921		10.1074/jbc.RA118.002775	http://dx.doi.org/10.1074/jbc.RA118.002775			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29666184	hybrid, Green Submitted, Green Published			2022-12-26	WOS:000434941900015
J	Ma, TJ; Li, BY; Wang, R; Lau, PK; Huang, Y; Jiang, LW; Schekman, R; Guo, YS				Ma, Tianji; Li, Baiying; Wang, Ryan; Lau, Pik Ki; Huang, Yan; Jiang, Liwen; Schekman, Randy; Guo, Yusong			A mechanism for differential sorting of the planar cell polarity proteins Frizzled6 and Vangl2 at the trans-Golgi network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protein sorting; protein trafficking (Golgi); adaptor protein; protein secretion; vesicles	PLASMA MEMBRANE TRAFFICKING; CLATHRIN-COATED VESICLES; MOLECULAR-BASIS; RIGHT DIRECTION; EXPORT SIGNAL; ARF FAMILY; CARGO; EPSINR; ADAPTER; DROSOPHILA	In planar cell polarity (PCP), the epithelial cells are polarized along the plane of the cell surface perpendicular to the classical apical-basal axis, a process mediated by several conserved signaling receptors. Two PCP-signaling proteins, VANGL planar cell polarity protein 2 (Vangl2) and Frizzled6 (Fzd6), are located asymmetrically on opposite boundaries of the cell. Examining sorting of these two proteins at the trans-Golgi network (TGN), we demonstrated previously that the GTP-binding protein ADP-ribosylation factor-related protein 1 (Arfrp1) and the clathrin-associated adaptor protein complex 1 (AP-1) are required for Vangl2 transport from the TGN. In contrast, TGN export of Frizzled6 does not depend on Arfrp1 or AP-1. Here, to further investigate the TGN sorting process in mammalian cells, we reconstituted release of Vangl2 and Frizzled6 from the TGN into vesicles in vitro. Immunoblotting of released vesicles indicated that Vangl2 and Frizzled6 exit the TGN in separate compartments. Knockdown analysis revealed that a clathrin adaptor, epsinR, regulates TGN export of Frizzled6 but not of Vangl2. Protein interaction analysis suggested that epsinR forms a stable complex with clathrin and that this complex interacts with a conserved polybasic motif in the Frizzled6 cytosolic domain to package Frizzled6 into transport vesicles. Moreover, we found that Frizzled6-epsinR binding dissociates epsinR from AP-1, which may separate these two cargo adaptors from each other to perform distinct cargo-sorting functions. Our results suggest that Vangl2 and Frizzled6 are packaged into separate vesicles that are regulated by different clathrin adaptors at the TGN, which may contribute to their asymmetric localizations.	[Ma, Tianji; Lau, Pik Ki; Huang, Yan; Guo, Yusong] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Wang, Ryan; Schekman, Randy] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Li, Baiying; Jiang, Liwen] Chinese Univ Hong Kong, Ctr Cell & Dev Biol, State Key Lab Agrobiotechnol, Sch Life Sci, Shatin, Hong Kong, Peoples R China; [Wang, Ryan] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Schekman, Randy] Howard Hughes Med Inst, Chevy Chase, MD USA; [Schekman, Randy] Univ Calif Berkeley, Miller Inst, Berkeley, CA 94720 USA	Hong Kong University of Science & Technology; University of California System; University of California Berkeley; Chinese University of Hong Kong; Northwestern University; Feinberg School of Medicine; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Guo, YS (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	guoyusong@ust.hk	JIANG, Liwen/S-6046-2018; Guo, Yusong/AAD-7027-2019; Guo, Yusong/C-7705-2011	JIANG, Liwen/0000-0002-7829-1472; Guo, Yusong/0000-0002-5539-599X	Hong Kong Research Grants Council [26100315, 16101116, AoE/M-05/12]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	This work was supported in part by Hong Kong Research Grants Council Grants 26100315, 16101116, and AoE/M-05/12 (to Y.G.). The authors declare that they have no conflicts of interest with the contents of this article.	Aguilar RC, 2006, P NATL ACAD SCI USA, V103, P4116, DOI 10.1073/pnas.0510513103; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bayly R, 2011, NAT REV GENET, V12, P385, DOI 10.1038/nrg2956; Carvajal-Gonzalez JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7751; Chen WS, 2008, CELL, V133, P1093, DOI 10.1016/j.cell.2008.04.048; Chidambaram S, 2004, J BIOL CHEM, V279, P4175, DOI 10.1074/jbc.M308667200; Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708; Copic A, 2007, MOL BIOL CELL, V18, P1803, DOI 10.1091/mbc.E06-11-1000; Curwin AJ, 2012, MOL BIOL CELL, V23, P2327, DOI 10.1091/mbc.E11-09-0826; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; Devenport D, 2014, J CELL BIOL, V207, P171, DOI 10.1083/jcb.201408039; Dodd ME, 2009, DEVELOPMENT, V136, P2591, DOI 10.1242/dev.038448; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Frojmark AS, 2011, AM J HUM GENET, V88, P852, DOI 10.1016/j.ajhg.2011.05.013; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Guo YS, 2014, ANNU REV CELL DEV BI, V30, P169, DOI 10.1146/annurev-cellbio-100913-013012; Guo YS, 2013, ELIFE, V2, DOI 10.7554/eLife.00160; Harumoto T, 2010, DEV CELL, V19, P389, DOI 10.1016/j.devcel.2010.08.004; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; Henderson DJ, 2006, TRENDS CARDIOVAS MED, V16, P38, DOI 10.1016/j.tcm.2005.11.005; Hirst J, 2004, MOL BIOL CELL, V15, P5593, DOI 10.1091/mbc.E04-06-0468; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Hirst J, 2015, MOL BIOL CELL, V26, P3085, DOI 10.1091/mbc.E15-04-0245; Horvath CAJ, 2007, INT J BIOCHEM CELL B, V39, P1765, DOI 10.1016/j.biocel.2006.12.004; Kibar Z, 2001, NAT GENET, V28, P251, DOI 10.1038/90081; Kienzle C, 2014, J CELL BIOL, V206, P635, DOI 10.1083/jcb.201311052; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Lee JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046357; Lee JH, 2009, DEV BIOL, V331, P1, DOI 10.1016/j.ydbio.2009.03.029; Leventis PA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025466; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Mills IG, 2003, J CELL BIOL, V160, P213, DOI 10.1083/jcb.200208023; Montcouquiol M, 2003, J NEUROSCI, V23, P9469; Olofsson J, 2014, DEVELOPMENT, V141, P2866, DOI 10.1242/dev.105932; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Parmar HB, 2016, MOL BIOL CELL, V27, P1320, DOI 10.1091/mbc.E15-12-0845; Parmar HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094194; Parmar HB, 2014, MOL BIOL CELL, V25, P866, DOI 10.1091/mbc.E13-07-0364; Peng Y, 2012, CURR TOP DEV BIOL, V101, P33, DOI 10.1016/B978-0-12-394592-1.00002-8; Ponnambalam S, 1996, J CELL SCI, V109, P675; Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; Shimada Y, 2006, DEV CELL, V10, P209, DOI 10.1016/j.devcel.2005.11.016; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sonawane M, 2005, DEVELOPMENT, V132, P3255, DOI 10.1242/dev.01904; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; von Blume J, 2011, DEV CELL, V20, P652, DOI 10.1016/j.devcel.2011.03.014; von Blume J, 2009, J CELL BIOL, V187, P1055, DOI 10.1083/jcb.200908040; Wakana Y, 2012, EMBO J, V31, P3976, DOI 10.1038/emboj.2012.235; Wang J, 2011, P NATL ACAD SCI USA, V108, P12277, DOI 10.1073/pnas.1013101108; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Wu J, 2013, NAT CELL BIOL, V15, P1045, DOI 10.1038/ncb2806; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315	56	11	13	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8410	8427		10.1074/jbc.RA118.001906	http://dx.doi.org/10.1074/jbc.RA118.001906			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666182	Green Published, hybrid			2022-12-26	WOS:000434205700007
J	Forster, A; Wenz, R; Maros, ME; Bohme, J; Al-Zghloul, M; Alonso, A; Groden, C; Wenz, H				Foerster, Alex; Wenz, Ralf; Maros, Mate Eloed; Boehme, Johannes; Al-Zghloul, Mansour; Alonso, Angelika; Groden, Christoph; Wenz, Holger			Anatomical distribution of cerebral microbleeds and intracerebral hemorrhage in vertebrobasilar dolichoectasia	PLOS ONE			English	Article							INTRACRANIAL ARTERIAL DOLICHOECTASIA; SMALL VESSEL DISEASE; RISK-FACTORS; HUMAN BRAIN; STROKE; NEUROFIBROMATOSIS; COMPLICATIONS; TERRITORIES; ANGIOGRAPHY; ANTERIOR	Objectives Vertebrobasilar dolichoectasia (VBD) is a dilatative arteriopathy associated with intracerebral hemorrhage. In the present study, we sought to evaluate the frequency and anatomical distribution of cerebral microbleeds (cMBs) and intracerebral hemorrhage (ICH) in VBD. Methods From a MRI database 94 VBD patients were identified and analyzed with special emphasis on cMBs and ICH on T2*-weighted gradient echo images (GRE) in relation to the established diagnostic MRI criteria of VBD (diameter, height, and lateral position). cMBs/ICH location was categorized into anterior/posterior circulation. Clinical information like demographic details, clinical symptoms, and comorbidities were abstracted from the case records. An extensive modelling approach using generalized linear mixed-effects models was used. Results Overall, 79 (84.0%) patients (mean age 72.1 +/- 10.0 years, 74.7% male) with a standard stroke MRI protocol including T2*-weighted images were included in the analysis. cMBs were observed in 38/79 (48.1%) patients, ranging from 1 to 84 cMBs per patient. In the posterior circulation cMBs were observed more frequently (34/38 (89.5%)) in comparison to the anterior circulation (24/38 (63.2%)). cMBs were observed in the thalamus in 20/38 (52.6%), hippocampus in 1/38 (2.6%), occipital lobe in 18/38 (47.4%), pons in 6/38 (15.8%), medulla oblongata in 2/38 (5.2%), and cerebellum in 14/38 (36.8%) patients. ICH was observed in only 6/79 (7.6%) patients. There were significantly more cMBs in the posterior-(NCMBs-PC = 1.717, 95% CI: 1.336-2.208, p = 0.0315) than in the anterior circulation. Logistic regression model showed a significant positive effect of clinical symptoms such as ischemic, TIA and hemorrhagic stroke on the presence of cMBs (OR = 3.34, 95% CI [2.0-5.57], p = 0.0184; ndf = 78, AIC = 107.51). General linear model showed that clinical symptoms have a highly significant effect on the number of cMBs (N = 2.78, 95% CI [2.51-3.07], p<2*10-16; ndf = 78, AIC = 1218). Conclusion cMBs and ICH may be observed in the anterior and posterior circulation in VBD but they occur more frequently in the posterior circulation. Most common anatomical locations of cMBs in VBD were the thalamus, occipital lobe and cerebellum. This posterior dominance of cMBs and ICH in VBD might reflect a specific underlying vascular pathology.	[Foerster, Alex; Maros, Mate Eloed; Boehme, Johannes; Al-Zghloul, Mansour; Groden, Christoph; Wenz, Holger] Heidelberg Univ, Univ Hosp Mannheim, Dept Neuroradiol, Mannheim, Germany; [Wenz, Ralf] Imperial Coll London, Fac Nat Sci, Dept Life Sci, London, England; [Alonso, Angelika] Heidelberg Univ, Univ Hosp Mannheim, Dept Neurol, Mannheim, Germany	Ruprecht Karls University Heidelberg; Imperial College London; Ruprecht Karls University Heidelberg	Wenz, H (corresponding author), Heidelberg Univ, Univ Hosp Mannheim, Dept Neuroradiol, Mannheim, Germany.	Holger.Wenz@umm.de	Maros, Máté E./ABB-3203-2021	Maros, Máté E./0000-0002-1589-8699				Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brinjikji W, 2017, AM J NEURORADIOL, V38, P915, DOI 10.3174/ajnr.A5102; Charidimou A, 2017, NEUROLOGY, V89, P820, DOI 10.1212/WNL.0000000000004259; de Pablo-Fernandez E, 2012, J CLIN NEUROSCI, V19, P1046, DOI 10.1016/j.jocn.2011.05.033; Dornak T, 2015, INT J STROKE, V10, P1224, DOI 10.1111/ijs.12626; Forster A, 2014, CLIN NEURORADIOL, V24, P347, DOI 10.1007/s00062-013-0261-7; Forster A, 2011, CEREBROVASC DIS, V32, P349, DOI 10.1159/000330346; Forster A, 2015, J NEUROIMAGING, V25, P608, DOI 10.1111/jon.12177; Forster Alex, 2011, Curr Treat Options Cardiovasc Med, V13, P268, DOI 10.1007/s11936-011-0119-8; Garzuly F, 2005, BRAIN, V128, P2078, DOI 10.1093/brain/awh546; GIANG DW, 1988, NEURORADIOLOGY, V30, P518, DOI 10.1007/BF00339693; Graf S, 2002, NEPHROL DIAL TRANSPL, V17, P819, DOI 10.1093/ndt/17.5.819; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Ichikawa H, 2011, J STROKE CEREBROVASC, V20, P429, DOI 10.1016/j.jstrokecerebrovasdis.2010.02.015; Kim BJ, 2013, J STROKE, V15, P153, DOI 10.5853/jos.2013.15.3.153; Kim JS, 2012, STROKE, V43, P3313, DOI 10.1161/STROKEAHA.112.658500; Kleinig TJ, 2013, J CLIN NEUROSCI, V20, P919, DOI 10.1016/j.jocn.2012.12.002; Linn J, 2015, CLIN NEURORADIOL, V25, P167, DOI 10.1007/s00062-015-0458-z; Lou M, 2010, ANN NY ACAD SCI, V1184, P121, DOI 10.1111/j.1749-6632.2009.05114.x; Mahadevan A, 2008, CLIN NEUROPATHOL, V27, P37; Mitsias P, 1996, ANN NEUROL, V40, P8, DOI 10.1002/ana.410400105; Park JM, 2013, EUR J NEUROL, V20, P824, DOI 10.1111/ene.12075; Passero S, 2001, CLIN NEUROPHYSIOL, V112, P1531, DOI 10.1016/S1388-2457(01)00597-1; Passero SG, 2005, STROKE, V36, P1421, DOI 10.1161/01.STR.0000172311.64662.9c; Passero SG, 2008, NEUROLOGY, V70, P66, DOI 10.1212/01.wnl.0000286947.89193.f3; PESSIN MS, 1989, NEUROLOGY, V39, P16, DOI 10.1212/WNL.39.1.16; Pico F, 2003, NEUROLOGY, V61, P1736, DOI 10.1212/01.WNL.0000103168.14885.A8; Pico F, 2015, LANCET NEUROL, V14, P833, DOI 10.1016/S1474-4422(15)00089-7; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Roth C, 2007, NERVENARZT, V78, P1195, DOI 10.1007/s00115-007-2263-7; Roth W, 2017, STROKE, V48, P638, DOI 10.1161/STROKEAHA.116.015630; Schievink WI, 1997, J AM SOC NEPHROL, V8, P1298; Shams S, 2015, AM J NEURORADIOL, V36, P1089, DOI 10.3174/ajnr.A4248; Silverman I E, 2000, J Stroke Cerebrovasc Dis, V9, P196, DOI 10.1053/jscd.2000.7224; Tatu L, 1998, NEUROLOGY, V50, P1699, DOI 10.1212/WNL.50.6.1699; Tatu L, 1996, NEUROLOGY, V47, P1125, DOI 10.1212/WNL.47.5.1125; Thijs V, 2017, STROKE, V48, P2361, DOI 10.1161/STROKEAHA.117.017406; Ubogu EE, 2004, J NEUROL NEUROSUR PS, V75, P22; Vernooij MW, 2008, NEUROLOGY, V70, P1208, DOI 10.1212/01.wnl.0000307750.41970.d9; Yates PA, 2014, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00205; Zambrino CA, 1999, EUR NEUROL, V41, P10, DOI 10.1159/000007991	41	2	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196149	10.1371/journal.pone.0196149	http://dx.doi.org/10.1371/journal.pone.0196149			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672624	Green Submitted, gold, Green Published			2022-12-26	WOS:000430446800094
J	Monroe, AA; Ziegler, M; Roik, A; Rothig, T; Hardenstine, RS; Emms, MA; Jensen, T; Voolstra, CR; Berumen, ML				Monroe, Alison A.; Ziegler, Maren; Roik, Anna; Rothig, Till; Hardenstine, Royale S.; Emms, Madeleine A.; Jensen, Thor; Voolstra, Christian R.; Berumen, Michael L.			In situ observations of coral bleaching in the central Saudi Arabian Red Sea during the 2015/2016 global coral bleaching event	PLOS ONE			English	Article							FISH ASSEMBLAGES; CLIMATE-CHANGE; REEF; COMMUNITIES; DISTURBANCE; RESILIENCE; RECOVERY; IMPACTS; GROWTH; SHIFTS	Coral bleaching continues to be one of the most devastating and immediate impacts of climate change on coral reef ecosystems worldwide. In 2015, a major bleaching event was declared as the "3rd global coral bleaching event" by the United States National Oceanic and Atmospheric Administration, impacting a large number of reefs in every major ocean. The Red Sea was no exception, and we present herein in situ observations of the status of coral reefs in the central Saudi Arabian Red Sea from September 2015, following extended periods of high temperatures reaching upwards of 32.5 degrees C in our study area. We examined eleven reefs using line-intercept transects at three different depths, including all reefs that were surveyed during a previous bleaching event in 2010. Bleaching was most prevalent on inshore reefs (55.6% +/- 14.6% of live coral cover exhibited bleaching) and on shallower transects (41% +/- 10.2% of live corals surveyed at 5m depth) within reefs. Similar taxonomic groups (e.g., Agariciidae) were affected in 2015 and in 2010. Most interestingly, Acropora and Porites had similar bleaching rates (similar to 30% each) and similar relative coral cover (similar to 7% each) across all reefs in 2015. Coral genera with the highest levels of bleaching (>60%) were also among the rarest (<1% of coral cover) in 2015. While this bodes well for the relative retention of coral cover, it may ultimately lead to decreased species richness, often considered an important component of a healthy coral reef. The resultant long-term changes in these coral reef communities remain to be seen.	[Monroe, Alison A.; Ziegler, Maren; Roik, Anna; Rothig, Till; Hardenstine, Royale S.; Emms, Madeleine A.; Jensen, Thor; Voolstra, Christian R.; Berumen, Michael L.] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Roik, Anna] GEOMAR Helmholtz Ctr Ocean Res Kiel, Marine Microbiol, Dusternbrooker Weg 20, Kiel, Germany; [Rothig, Till] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China	King Abdullah University of Science & Technology; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Hong Kong	Monroe, AA (corresponding author), King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Red Sea Res Ctr, Thuwal, Saudi Arabia.	alison.monroe@kaust.edu.sa	Monroe, Alison/AAW-7651-2020; Voolstra, Christian R/H-7158-2014; Berumen, Michael/F-7745-2011	Monroe, Alison/0000-0002-9372-4889; Voolstra, Christian R/0000-0003-4555-3795; Berumen, Michael/0000-0003-2463-2742; Roik, Anna/0000-0002-8293-8339; Emms, Madeleine/0000-0002-1850-9919; Ziegler, Maren/0000-0003-2237-9261; Hardenstine, Royale/0000-0003-4693-7045	King Abdullah University of Science and Technology	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	Baseline research funds from King Abdullah University of Science and Technology were received by MLB and CRV. Both authors receiving the funding contributed to all aspects of this research project from study design to manuscript preparation.	Baird AH, 2002, MAR ECOL PROG SER, V237, P133, DOI 10.3354/meps237133; Berkelmans R, 1999, CORAL REEFS, V18, P55, DOI 10.1007/s003380050154; Berumen ML, 2006, CORAL REEFS, V25, P647, DOI 10.1007/s00338-006-0145-2; Berumen ML, 2005, MAR ECOL PROG SER, V287, P217, DOI 10.3354/meps287217; Bridge TCL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113079; Burt J, 2008, MAR BIOL, V154, P27, DOI 10.1007/s00227-007-0892-9; Burt J, 2011, MAR ENVIRON RES, V72, P225, DOI 10.1016/j.marenvres.2011.08.005; Cantin NE, 2010, SCIENCE, V329, P322, DOI 10.1126/science.1190182; Chaidez V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08146-z; Couch CS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185121; Davis KA, 2011, CORAL REEFS, V30, P25, DOI 10.1007/s00338-011-0740-8; DeCarlo TM, 2017, SCI REP-UK, V7, DOI 10.1038/srep44586; Devantier L, 2000, STATUS CORAL REEFS W; DiBattista JD, 2017, CORAL REEFS, V36, P1245, DOI 10.1007/s00338-017-1618-1; English S., 1999, SURVEY MANUAL TROPIC; Ferrari R, 2016, GLOBAL CHANGE BIOL, V22, P1965, DOI 10.1111/gcb.13197; Furby KA, 2013, CORAL REEFS, V32, P505, DOI 10.1007/s00338-012-0998-5; Goreau T, 2000, CONSERV BIOL, V14, P5, DOI 10.1046/j.1523-1739.2000.00011.x; Graham NAJ, 2015, NATURE, V518, P94, DOI 10.1038/nature14140; Guest JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033353; Halford A, 2004, ECOLOGY, V85, P1892, DOI 10.1890/03-4017; Heron SF, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8010059; Hobbs JPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070966; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; HOEKSEMA BW, 1991, MAR ECOL PROG SER, V74, P225, DOI 10.3354/meps074225; Huang DW, 2014, ZOOL J LINN SOC-LOND, V171, P277, DOI 10.1111/zoj12140; Hughes TP, 2018, SCIENCE, V359, P80, DOI 10.1126/science.aan8048; Hughes TP, 2017, NATURE, V543, P373, DOI 10.1038/nature21707; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jessen C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062091; Jin D, 2012, MAR RESOUR ECON, V27, P137, DOI 10.5950/0738-1360-27.2.137; Kennedy EV, 2018, MAR FRESHWATER RES, V69, P191, DOI 10.1071/MF16317; Khalil MT, 2013, ENVIRON BIOL FISH, V96, P1065, DOI 10.1007/s10641-012-0103-5; Kleypas JA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032257; Le Nohaic M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14794-y; Liu G, 2006, P 10 INT COR REEF S; Lozano-Cortes D., 2016, REEF ENCOUNTER, V31, P50, DOI DOI 10.1111/gcb.13895; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; NOAA Coral Reef Watch, 2000, NOAA COR REEF WATCH; NOAA Coral Reef Watch, 2013, NOAA COR REEF WATCH; Osman EO, 2018, GLOBAL CHANGE BIOL, V24, pE474, DOI 10.1111/gcb.13895; Perry CT, 2017, CORAL REEFS, V36, P1189, DOI 10.1007/s00338-017-1610-9; Pineda J, 2013, LIMNOL OCEANOGR, V58, P1531, DOI 10.4319/lo.2013.58.5.1531; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raitsos DE, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047984; Raitsos DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064909; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Roberts MB, 2016, MAR POLLUT BULL, V105, P558, DOI 10.1016/j.marpolbul.2015.11.024; RODGERS KS, 2017, PEERJ, V5, P23247, DOI DOI 10.7717/PEERJ.3355; Roik A, 2015, MIDEAST CORAL REEF S, P3; Roik A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163939; Roik A, 2016, CORAL REEFS, V35, P681, DOI 10.1007/s00338-015-1383-y; Sano M, 2000, MAR ECOL PROG SER, V198, P121, DOI 10.3354/meps198121; Sawall Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08940; Sheppard Charles, 2002, Aquatic Ecosystem Health & Management, V5, P395, DOI 10.1080/14634980290002020; Spalding M., 2009, V205, P69; Stella JS, 2011, CORAL REEFS, V30, P719, DOI 10.1007/s00338-011-0748-0; Xie JY, 2017, MAR POLLUT BULL, V124, P653, DOI 10.1016/j.marpolbul.2017.03.061; Ziegler M, 2017, J BIOGEOGR, V44, P674, DOI 10.1111/jbi.12913	59	54	54	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195814	10.1371/journal.pone.0195814	http://dx.doi.org/10.1371/journal.pone.0195814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672556	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000430446800046
J	Silberstein, E; Serna, C; Fragoso, SP; Nagarkatti, R; Debrabant, A				Silberstein, Erica; Serna, Carylinda; Fragoso, Stenio Perdigao; Nagarkatti, Rana; Debrabant, Alain			A novel nanoluciferase-based system to monitor Trypanosoma cruzi infection in mice by bioluminescence imaging	PLOS ONE			English	Article							CHRONIC CHAGAS-DISEASE; PARASITE PERSISTENCE; REPORTER; TISSUE; DYNAMICS; REPLICATION; STRAINS; HOST; TCI	Chagas disease, caused by the intracellular protozoan Trypanosoma cruzi, affects 8-10 million people worldwide and represents a major public health challenge. There is no effective treatment or vaccine to control the disease that is characterized by a mild acute phase followed by a chronic life-long infection. Approximately 30% of chronically infected individuals develop cardiac and/or digestive pathologies. T. cruzi can invade a wide variety of nucleated cells, but only persists at specific tissues in the host. However, the mechanisms that determine tissue tropism and the progression of the infection have not been fully described. Identification of infection niches in animal models has been difficult due to the limited quantity of parasite-infected cells and their focal distribution in tissues during the chronic phase. To better understand the course of chronic infections and parasite dissemination, we developed a bioluminescence imaging system based on the use of transgenic T. cruzi Colombiana strain parasites expressing nanoluciferase. Swiss Webster mice were infected with luminescent trypomastigotes and monitored for 126 days. Whole animal in vivo imaging showed parasites predominantly distributed in the abdominal cavity and surrounding areas throughout the infection. Bioluminescence signal reached a peak between 14 to 21 days post infection (dpi) and decreased progressively over time. Total animal luminescence could still be measured 126 dpi while parasites remained undetectable in blood by microscopy in most animals. Ex vivo imaging of specific tissues and organs dissected post-mortem at 126 dpi revealed a widespread parasite distribution in the skeletal muscle, heart, intestines and mesenteric fat. Parasites were also detected in lungs and liver. This noninvasive imaging model represents a novel tool to study host-parasite interactions and to identify parasite reservoirs of chronic Chagas Disease.	[Silberstein, Erica; Serna, Carylinda; Nagarkatti, Rana; Debrabant, Alain] US FDA, Ctr Biol Evaluat & Res, Lab Emerging Pathogens, Silver Spring, MD USA; [Fragoso, Stenio Perdigao] Fiocruz MS, Inst Carlos Chagas, Lab Mol Biol Trypanosomatids, Curitiba, Parana, Brazil; [Serna, Carylinda] NCI, Expt Transplantat & Immunol Branch, NIH, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA); Fundacao Oswaldo Cruz; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Debrabant, A (corresponding author), US FDA, Ctr Biol Evaluat & Res, Lab Emerging Pathogens, Silver Spring, MD USA.	alain.debrabant@fda.hhs.gov	Fragoso, Stenio/AAB-4703-2019	Fragoso, Stenio/0000-0002-0909-7940	US Food and Drug Administration	US Food and Drug Administration	Research was supported by intramural grants from the US Food and Drug Administration to AD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriani G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001298; Anez N, 1999, AM J TROP MED HYG, V60, P726, DOI 10.4269/ajtmh.1999.60.726; Barreto-de-Albuquerque J, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003849; BRENER Z., 1962, REV INST MED TROP SAO PAULO, V4, P389; Buckner FS, 1999, INFECT IMMUN, V67, P403, DOI 10.1128/IAI.67.1.403-409.1999; Caine EA, 2017, J VIROL, V91, DOI 10.1128/JVI.01759-16; Camandaroba Edson L.P., 2003, Rev. Soc. Bras. Med. Trop., V36, P201, DOI 10.1590/S0037-86822003000200002; Camandaroba Edson Luiz Paes, 2001, Revista da Sociedade Brasileira de Medicina Tropical, V34, P151, DOI 10.1590/S0037-86822001000200001; Canavaci AMC, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000740; CANÇADO J. Romeu, 2002, Rev. Inst. Med. trop. S. Paulo, V44, P29, DOI 10.1590/S0036-46652002000100006; Capewell P, 2016, ELIFE, V5; Chatelain E, 2015, DRUG DES DEV THER, V9, P4807, DOI 10.2147/DDDT.S90208; de Araujo FF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003451; England CG, 2016, BIOCONJUGATE CHEM, V27, P1175, DOI 10.1021/acs.bioconjchem.6b00112; Espinoza B, 2011, INT J BIOL SCI, V7, P1357, DOI 10.7150/ijbs.7.1357; FEDERICI EE, 1964, AM J TROP MED HYG, V13, P272, DOI 10.4269/ajtmh.1964.13.272; Francisco AF, 2015, ANTIMICROB AGENTS CH, V59, P4653, DOI 10.1128/AAC.00520-15; Germain-Genevois C, 2016, MOL IMAGING BIOL, V18, P62, DOI 10.1007/s11307-015-0864-2; Guarner J, 2001, AM J TROP MED HYG, V65, P152, DOI 10.4269/ajtmh.2001.65.152; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Henriques C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-89; Hyland KV, 2008, INT J PARASITOL, V38, P1391, DOI 10.1016/j.ijpara.2008.04.002; Kessler RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067441; Lewis MD, 2016, CELL MICROBIOL, V18, P1429, DOI 10.1111/cmi.12584; Lewis MD, 2014, CELL MICROBIOL, V16, P1285, DOI 10.1111/cmi.12297; LOPES MF, 1995, EXP PARASITOL, V80, P194, DOI 10.1006/expr.1995.1024; Manne-Goehler J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005033; Ferreira AVM, 2011, MICROBES INFECT, V13, P1002, DOI 10.1016/j.micinf.2011.06.002; McLatchie AP, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002571; Mello DB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003945; MELO RC, 1978, J PARASITOL, V64, P475, DOI 10.2307/3279787; Morrot A, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2076.00704, 10.3389/fmicb.2016.00704]; Nagajyothi F, 2012, CELL MICROBIOL, V14, P634, DOI 10.1111/j.1462-5822.2012.01764.x; Nagarkatti R, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002650; Andreu GLP, 2009, ARZNEIMITTELFORSCH, V59, P207; Nunes MCP, 2013, J AM COLL CARDIOL, V62, P767, DOI 10.1016/j.jacc.2013.05.046; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; Rassi A, 2010, LANCET, V375, P1388, DOI 10.1016/S0140-6736(10)60061-X; Requena-Mendez A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003540; Roffe E, 2016, INFECT IMMUN, V84, P1123, DOI 10.1128/IAI.01497-15; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Stacer AC, 2013, MOL IMAGING, V12, DOI 10.2310/7290.2013.00062; Sun CQ, 2014, J VIROL, V88, P2035, DOI 10.1128/JVI.02990-13; Tanowitz HB, 2017, TRENDS PARASITOL, V33, P276, DOI 10.1016/j.pt.2016.11.008; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Teixeira ARL, 2006, MEM I OSWALDO CRUZ, V101, P463, DOI 10.1590/S0074-02762006000500001; Traina Mahmoud, 2016, Curr Heart Fail Rep, V13, P295; Tran V, 2013, J VIROL, V87, P13321, DOI 10.1128/JVI.02381-13; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	50	22	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195879	10.1371/journal.pone.0195879	http://dx.doi.org/10.1371/journal.pone.0195879			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672535	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800055
J	Conrad, Z; Niles, MT; Neher, DA; Roy, ED; Tichenor, NE; Jahns, L				Conrad, Zach; Niles, Meredith T.; Neher, Deborah A.; Roy, Eric D.; Tichenor, Nicole E.; Jahns, Lisa			Relationship between food waste, diet quality, and environmental sustainability	PLOS ONE			English	Article							NUTRITION TRANSITION; GREENHOUSE-GAS; CONSUMPTION; IRRIGATION; PHOSPHORUS; DRIVERS; IMPACTS; WATER; LAND	Improving diet quality while simultaneously reducing environmental impact is a critical focus globally. Metrics linking diet quality and sustainability have typically focused on a limited suite of indicators, and have not included food waste. To address this important research gap, we examine the relationship between food waste, diet quality, nutrient waste, and multiple measures of sustainability: use of cropland, irrigation water, pesticides, and fertilizers. Data on food intake, food waste, and application rates of agricultural amendments were collected from diverse US government sources. Diet quality was assessed using the Healthy Eating Index-2015. A biophysical simulation model was used to estimate the amount of cropland associated with wasted food. This analysis finds that US consumers wasted 422g of food per person daily, with 30 million acres of cropland used to produce this food every year. This accounts for 30% of daily calories available for consumption, one-quarter of daily food (by weight) available for consumption, and 7% of annual cropland acreage. Higher quality diets were associated with greater amounts of food waste and greater amounts of wasted irrigation water and pesticides, but less cropland waste. This is largely due to fruits and vegetables, which are health-promoting and require small amounts of cropland, but require substantial amounts of agricultural inputs. These results suggest that simultaneous efforts to improve diet quality and reduce food waste are necessary. Increasing consumers' knowledge about how to prepare and store fruits and vegetables will be one of the practical solutions to reducing food waste.	[Conrad, Zach; Jahns, Lisa] ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58203 USA; [Niles, Meredith T.] Univ Vermont, Dept Nutr & Food Sci, Food Syst Program, Burlington, VT USA; [Neher, Deborah A.] Univ Vermont, Dept Plant & Soil Sci, Burlington, VT 05405 USA; [Roy, Eric D.] Univ Vermont, Rubenstein Sch Environm & Nat Resources, Burlington, VT USA; [Tichenor, Nicole E.] Univ New Hampshire, Sustainabil Inst, Durham, NH 03824 USA	United States Department of Agriculture (USDA); University of Vermont; University of Vermont; University of Vermont; University System Of New Hampshire; University of New Hampshire	Conrad, Z (corresponding author), ARS, USDA, Grand Forks Human Nutr Res Ctr, Grand Forks, ND 58203 USA.	zach.conard@ars.usda.gov	Neher, Deborah/H-2716-2019	Neher, Deborah/0000-0002-9647-8783; Conrad, Zach/0000-0001-5376-8775; Roy, Eric/0000-0001-6315-3061; Tichenor Blackstone, Nicole/0000-0001-8343-3650	United States Department of Agriculture, Agricultural Research Service [3062-51000-051-00D]	United States Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the United States Department of Agriculture, Agricultural Research Service, 3062-51000-051-00D. There was no additional external funding received for this study.	[Anonymous], 2015, AM FACT FINDER ANN E; [Anonymous], 2016, FOOD NUTR DATABASE D; [Anonymous], 1980, LOSS ADJUSTED FOOD A; [Anonymous], 2016, ADV SUST MAT MAN 201; [Anonymous], 2018, NASS AGR SURVEYS; Behrens P, 2017, P NATL ACAD SCI US; Birney CI, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8494; Buzby J.C., 2014, USDA ERS EC INFORM B, V121; Buzby JC, 2006, 31 USDA ERS; Camargo GGT, 2013, BIOSCIENCE, V63, P263, DOI 10.1525/bio.2013.63.4.6; Chen MP, 2016, GLOBAL ENVIRON CHANG, V36, P139, DOI 10.1016/j.gloenvcha.2015.12.005; Dietary Guidelines Advisory Committee, 2015, SCI REP 2015 DIET GU; Eshel G, 2014, P NATL ACAD SCI USA, V111, P11996, DOI 10.1073/pnas.1402183111; Fischer CG, 2016, PLATES PYRAMINDS PLA; Freedman LS, 2008, J NUTR, V138, P1725, DOI 10.1093/jn/138.9.1725; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gill M, 2015, FOOD SECUR, V7, P493, DOI 10.1007/s12571-015-0453-x; Gilliss D, 2013, MMWR-MORBID MORTAL W, V62, P283; Grocery Manufacturers Association, GROC IND LAUNCH NEW; Hebrok M, 2017, J CLEAN PROD, V151, P380, DOI 10.1016/j.jclepro.2017.03.069; Heller MC, 2015, J IND ECOL, V19, P391, DOI 10.1111/jiec.12174; Kummu M, 2012, SCI TOTAL ENVIRON, V438, P477, DOI 10.1016/j.scitotenv.2012.08.092; McGuire V.L., 2017, WATER LEVEL RECOVERA; Micha R, 2014, BMJ-BRIT MED J, P348; Micha R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175149; Moshfegh AJ, 2008, AM J CLIN NUTR, V88, P324; National Cancer Institute National Institutes for Health, HEI TOOLS RES; National Cancer Institute National Institutes for Health, OV BACKGR HLTH EAT I; National Cancer Institute National Institutes of Health, REC POT APPR DIET AS; Nelson ME, 2016, ADV NUTR, V7, P1005, DOI 10.3945/an.116.012567; Peters C, 2016, ELEMENTA, P4; Peters CJ, 2007, RENEW AGR FOOD SYST, V22, P145, DOI 10.1017/S1742170507001767; Pimentel D., 2013, INTEGRATED PEST MANA, V3, P47; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Ridoutt BG, 2017, ADV NUTR, V8, P933, DOI 10.3945/an.117.016691; Roark RA, 2013, PUBLIC HEALTH NUTR, V16, P2, DOI 10.1017/S1368980012000985; Rockstrom J, 2016, LANCET, V387, P2364, DOI 10.1016/S0140-6736(16)30681-X; Roe BE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191813; Romani S, 2018, APPETITE, V121, P215, DOI 10.1016/j.appet.2017.11.093; Ruini Luca Fernando, 2015, Front Nutr, V2, P9, DOI 10.3389/fnut.2015.00009; Schindler DW, 2016, ENVIRON SCI TECHNOL, V50, P8923, DOI 10.1021/acs.est.6b02204; Smith JL, 1998, J FOOD PROTECT, V61, P1229, DOI 10.4315/0362-028X-61.9.1229; Spiker ML, 2017, J ACAD NUTR DIET, V117, P1031, DOI 10.1016/j.jand.2017.03.015; Subar AF, 2015, J NUTR, V145, P2639, DOI 10.3945/jn.115.219634; Thyberg KL, 2016, RESOUR CONSERV RECY, V106, P110, DOI 10.1016/j.resconrec.2015.11.016; Thyberg KL, 2015, ENVIRON SCI TECHNOL, V49, P13946, DOI 10.1021/acs.est.5b03880; Tilman D, 2014, NATURE, V515, P518, DOI 10.1038/nature13959; US Department of Agriculture Economic Research Service, 2017, AGR TOT FACT PROD GR; US Department of Health and Human Services and US Department of Agriculture, 2015, DIET GUID AM 2015 20, V8th; US Department of Health and Human Services and US Department of Agriculture, 2015, DIET GUID AM; US Department of Health and Human Services Centers for Disease Control and Prevention (CDC), 2017, NAT HLTH NUTR EX SUR; US Department of Health and Human Services National Center for Health Statistics, 2011, NAT HLTH NUTR EX SUR; VTT Group, VTT SENS DET SPOIL F; Wichelns D, 2006, AGR WATER MANAGE, V86, P114, DOI 10.1016/j.agwat.2006.07.014; Wilson NLW, 2017, FOOD QUAL PREFER, V55, P35, DOI 10.1016/j.foodqual.2016.08.004; Woodside JV, 2013, P NUTR SOC, V72, P236, DOI 10.1017/S0029665112003059	57	102	103	8	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195405	10.1371/journal.pone.0195405	http://dx.doi.org/10.1371/journal.pone.0195405			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668732	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200041
J	Delihas, N				Delihas, Nicholas			A family of long intergenic non-coding RNA genes in human chromosomal region 22q11.2 carry a DNA translocation breakpoint/AT-rich sequence	PLOS ONE			English	Article							LOW-COPY REPEATS; TRANSPOSABLE ELEMENTS; HUMAN TRANSCRIPTOME; DELETION SYNDROME; NF1 GENE; EXPRESSION; EVOLUTION; GENOMICS; REARRANGEMENTS; POLYMORPHISMS	FAM230C, a long intergenic non-coding RNA (lincRNA) gene in human chromosome 13 (chr13) is a member of lincRNA genes termed family with sequence similarity 230. An analysis using bioinformatics search tools and alignment programs was undertaken to determine properties of FAM230C and its related genes. Results reveal that the DNA translocation element, the Translocation Breakpoint Type A (TBTA) sequence, which consists of satellite DNA, Alu elements, and AT-rich sequences is embedded in the FAM230C gene. Eight lincRNA genes related to FAM230C also carry the TBTA sequences. These genes were formed from a large segment of the 3' half of the FAM230C sequence duplicated in chr22, and are specifically in regions of low copy repeats (LCR22)s, in or close to the 22q.11.2 region. 22q11.2 is a chromosomal segment that undergoes a high rate of DNA translocation and is prone to genetic deletions. FAM230C-related genes present in other chromosomes do not carry the TBTA motif and were formed from the 5' half region of the FAM230C sequence. These findings identify a high specificity in lincRNA gene formation by gene sequence duplication in different chromosomes.	[Delihas, Nicholas] SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Delihas, N (corresponding author), SUNY Stony Brook, Sch Med, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA.	Nicholas.delihas@stonybrook.edu		Delihas, Nicholas/0000-0002-1704-2587				Babcock M, 2003, GENOME RES, V13, P2519, DOI 10.1101/gr.1549503; Babcock M, 2007, GENOME RES, V17, P451, DOI 10.1101/gr.5651507; Bacolla A, 2006, NUCLEIC ACIDS RES, V34, P2663, DOI 10.1093/nar/gkl354; Bacolla A, 2016, NUCLEIC ACIDS RES, V44, P5673, DOI 10.1093/nar/gkw261; Chen HJ, 2017, GENOM PROTEOM BIOINF, V15, P201, DOI 10.1016/j.gpb.2017.02.003; Chen LL, 2016, TRENDS BIOCHEM SCI, V41, P761, DOI 10.1016/j.tibs.2016.07.003; Delihas N, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1958-6; Demaerel W, 2017, AM J HUM GENET, V101, P616, DOI 10.1016/j.ajhg.2017.09.002; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Espinosa JM, 2017, TRENDS GENET, V33, P660, DOI 10.1016/j.tig.2017.07.005; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; FROMMER M, 1984, NUCLEIC ACIDS RES, V12, P2887, DOI 10.1093/nar/12.6.2887; Guna A, 2015, J NEURODEV DISORD, V7, DOI 10.1186/s11689-015-9113-x; Guo XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093972; Guo XY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-71; Hadjiargyrou M, 2013, INT J MOL SCI, V14, P13307, DOI 10.3390/ijms140713307; Hsiao MC, 2014, HUM MUTAT, V35, P891, DOI 10.1002/humu.22569; Huang RY, 2016, CELL PHYSIOL BIOCHEM, V40, P707, DOI 10.1159/000452582; Hubley R, 2016, NUCLEIC ACIDS RES, V44, pD81, DOI 10.1093/nar/gkv1272; Inagaki H, 2005, HUM MUTAT, V26, P332, DOI 10.1002/humu.20228; Inagaki H, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00125; Iyer MK, 2015, NAT GENET, V47, P199, DOI 10.1038/ng.3192; Jandura A, 2017, TRENDS GENET, V33, P665, DOI 10.1016/j.tig.2017.08.002; Johnson R, 2012, NEUROBIOL DIS, V46, P245, DOI 10.1016/j.nbd.2011.12.006; Kapusta A, 2014, TRENDS GENET, V30, P439, DOI 10.1016/j.tig.2014.08.004; Kasinathan S, 2018, MOL BIOL EVOL, V35, P949, DOI 10.1093/molbev/msy010; Kato T, 2012, CURR OPIN GENET DEV, V22, P221, DOI 10.1016/j.gde.2012.02.004; Kelley D, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r107; Kurahashi H, 2007, GENOME RES, V17, P461, DOI 10.1101/gr.5769507; Lian YF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07954-7; Liu WH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4156-x; Lv XY, 2018, INT J ONCOL, V52, P288, DOI 10.3892/ijo.2017.4195; McDonald-McGinn DM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.71; Mele M, 2015, SCIENCE, V348, P660, DOI 10.1126/science.aaa0355; Papatheodorou I, 2018, NUCLEIC ACIDS RES, V46, pD246, DOI 10.1093/nar/gkx1158; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; PROSSER J, 1986, J MOL BIOL, V187, P145, DOI 10.1016/0022-2836(86)90224-X; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Shaikh TH, 2000, HUM MOL GENET, V9, P489, DOI 10.1093/hmg/9.4.489; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Terracciano D, 2017, BBA-REV CANCER, V1868, P449, DOI 10.1016/j.bbcan.2017.09.001; Tong MQ, 2010, HUM MOL GENET, V19, P2630, DOI 10.1093/hmg/ddq150; Ulitsky I, 2016, NAT REV GENET, V17, P601, DOI 10.1038/nrg.2016.85; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wallace M, 2014, HUM MUTAT, V35, pV, DOI [10.1002/humu.22410, DOI 10.1002/HUMU.22410]; Yao K, 2017, H TUMOUR BIOL, V39, DOI [10.1177/1010428317707882, DOI 10.1177/1010428317707882]; Yuan ZX, 2016, INT J ONCOL, V48, P2675, DOI 10.3892/ijo.2016.3447; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhang J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141042	49	10	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195702	10.1371/journal.pone.0195702	http://dx.doi.org/10.1371/journal.pone.0195702			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668722	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200053
J	Locci, E; Noto, A; Puddu, M; Pomero, G; Demontis, R; Dalmazzo, C; Delogu, A; Fanos, V; d'Aloja, E; Gancia, P				Locci, Emanuela; Noto, Antonio; Puddu, Melania; Pomero, Giulia; Demontis, Roberto; Dalmazzo, Cristina; Delogu, Antonio; Fanos, Vassilios; d'Aloja, Ernesto; Gancia, Paolo			A longitudinal H-1-NMR metabolomics analysis of urine from newborns with hypoxic-ischemic encephalopathy undergoing hypothermia therapy. Clinical and medical legal insights	PLOS ONE			English	Article							NEONATAL ENCEPHALOPATHY; ASPHYXIA; INJURY; BRAIN; MODEL; INFANTS; BIRTH	Perinatal asphyxia is an event affecting around four million newborns worldwide. The 0.5 to 2 per 1000 of full term asphyxiated newborns suffer from hypoxic-ischemic encephalopathy (HIE), which is a frequent cause of death or severe disability and, as consequence, the most common birth injury claim for obstetrics, gynaecologists, and paediatricians. Perinatal asphyxia results from a compromised gas exchange that leads to hypoxemia, hypercapnia, and metabolic acidosis. In this work, we applied a metabolomics approach to investigate the metabolic profiles of urine samples collected from full term asphyxiated newborns with HIE undergoing therapeutic hypothermia (TH), with the aim of identifying a pattern of metabolites associated with HIE and to follow their modifications over time. Urine samples were collected from 10 HIE newborns at birth, during hypothermia (48 hours), at the end of the therapeutic treatment (72 hours), at 1 month of life, and compared with a matched control population of 16 healthy full term newborns. The metabolic profiles were investigated by H-1 NMR spectroscopy coupled with multivariate statistical methods such as principal component analysis and orthogonal partial least square discriminant analysis. Multivariate analysis indicated significant differences between the urine samples of HIE and healthy newborns at birth. The altered metabolic patterns, mainly originated from the depletion of cellular energy and homeostasis, seem to constitute a characteristic of perinatal asphyxia. The HIE urine metabolome changes over time reflected either the effects of TH and the physiological growth of the newborns. Of interest, the urine metabolic profiles of the HIE non-surviving babies, characterized by the increased excretion of lactate, resulted significantly different from the rest of HIE population.	[Locci, Emanuela; Demontis, Roberto; d'Aloja, Ernesto] Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy; [Noto, Antonio; Puddu, Melania; Fanos, Vassilios] Univ Cagliari, Dept Surg Sci, Cagliari, Italy; [Noto, Antonio; Puddu, Melania; Fanos, Vassilios] Azienda Osped Univ, Puericulture Inst, Neonatal Intens Care Unit, Cagliari, Italy; [Noto, Antonio; Puddu, Melania; Fanos, Vassilios] Azienda Ospedaliera Univ, Neonatal Sect, Cagliari, Italy; [Pomero, Giulia; Dalmazzo, Cristina; Delogu, Antonio; Gancia, Paolo] ASO S Croce & Carle, Neonatal Intens Care, Neonatol, Cuneo, Italy	University of Cagliari; University of Cagliari; University of Cagliari; Azienda Ospedaliero-Universitaria di Cagliari	Locci, E (corresponding author), Univ Cagliari, Dept Med Sci & Publ Hlth, Cagliari, Italy.	elocci@unica.it	Locci, Emanuela/G-6524-2018; Fanos, Vassilios/AHI-0685-2022; demontis, roberto/AAX-7153-2020; d'Aloja, Ernesto/P-4539-2017	Locci, Emanuela/0000-0003-0237-4228; d'Aloja, Ernesto/0000-0003-4456-6252; Noto, Antonio/0000-0003-3538-0050				Al Yazidi G, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0415-7; American College of Obstetricians and Gynecologists & American Academy of Pediatrics, 2003, NEON ENC CER PALS DE; Ancora G, 2012, RACCOMANDAZIONI ASSI; [Anonymous], 2014, NEONATAL ENCEPHALOPA, P896; Atzori L, 2010, J MATERN-FETAL NEO M, V23, P134, DOI 10.3109/14767058.2010.517033; Beckstrom AC, 2011, J CHROMATOGR A, V1218, P1899, DOI 10.1016/j.chroma.2011.01.086; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Brocker Chad, 2012, Biomol Concepts, V3, P345; Broer S, 2001, J NEUROCHEM, V77, P705, DOI 10.1046/j.1471-4159.2001.00322.x; Carpentieri AM, 2015, OVERVIEW 2015 AM C O, P1; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chu CY, 2006, CLIN BIOCHEM, V39, P203, DOI 10.1016/j.clinbiochem.2006.01.006; Chun PT, 2015, DEV NEUROSCI-BASEL, V37, P161, DOI 10.1159/000370147; d'Aloja E, 2009, J MATERN-FETAL NEO M, V22, P54, DOI 10.1080/14767050903198397; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; Denihan NM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/254076; Donn SM, 2012, MEDICOLEGAL ISSUES P, P58; Donn SM, 2014, SEMIN FETAL NEONAT M, V19, P317, DOI 10.1016/j.siny.2014.08.005; Edwards AD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c363; Fanos V, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/731620; Fattuoni C, 2015, MOLECULES, V20, P7000, DOI 10.3390/molecules20047000; Gebicki J, 2003, POL J PHARMACOL, V55, P109; Graham EM, 2008, AM J OBSTET GYNECOL, V199, P587, DOI 10.1016/j.ajog.2008.06.094; Ide Bergamaschi N, 2015, J PEDIAT NEONAT INDI, V4, P36; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Karlsson M, 2010, ACTA PAEDIATR, V99, P1139, DOI 10.1111/j.1651-2227.2010.01802.x; Liu J, 2011, J CEREBR BLOOD F MET, V31, P547, DOI 10.1038/jcbfm.2010.125; Logitharajah P, 2009, PEDIATR RES, V66, P222, DOI 10.1203/PDR.0b013e3181a9ef34; Longini M, 2015, CLIN CHIM ACTA, V444, P250, DOI 10.1016/j.cca.2015.02.004; Lou BS, 2014, HIGH ALT MED BIOL, V15, P192, DOI 10.1089/ham.2013.1130; MITCHELL GA, 1995, CLIN INVEST MED, V18, P193; Nicholson JK, 1999, XENOBIOTICA, V29, P1181, DOI 10.1080/004982599238047; Okereafor A, 2008, PEDIATRICS, V121, P906, DOI 10.1542/peds.2007-0770; Reinke SN, 2013, J PROTEOME RES, V12, P4230, DOI 10.1021/pr400617m; Rutherford M, 2010, LANCET NEUROL, V9, P39, DOI 10.1016/S1474-4422(09)70295-9; Sabir H, 2015, SEMIN FETAL NEONAT M, V20, P115, DOI 10.1016/j.siny.2014.10.006; Sanchez-Illana A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17202-7; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shah P, 2004, ARCH DIS CHILD-FETAL, V89, P152, DOI 10.1136/adc.2002.023093; Shah Sachin, 2004, J Perinatol, V24, P16, DOI 10.1038/sj.jp.7211023; Shankaran S, 2014, CLIN PERINATOL, V41, P149, DOI 10.1016/j.clp.2013.10.008; Sieber M, 2009, TOXICOL SCI, V109, P336, DOI 10.1093/toxsci/kfp070; Skappak C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065035; Solberg R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009606; Walsh BH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050520; Zheng Y, 2017, AM J NEURORADIOL, V38, P827, DOI 10.3174/ajnr.A5066	46	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194267	10.1371/journal.pone.0194267	http://dx.doi.org/10.1371/journal.pone.0194267			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668681	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200007
J	Schuster, TM; Setaro, SD; Tibbits, JFG; Batty, EL; Fowler, RM; McLay, TGB; Wilcox, S; Ades, PK; Bayly, MJ				Schuster, Tanja M.; Setaro, Sabrina D.; Tibbits, Josquin F. G.; Batty, Erin L.; Fowler, Rachael M.; McLay, Todd G. B.; Wilcox, Stephen; Ades, Peter K.; Bayly, Michael J.			Chloroplast variation is incongruent with classification of the Australian bloodwood eucalypts (genus Corymbia, family Myrtaceae)	PLOS ONE			English	Article							NUCLEAR RIBOSOMAL DNA; HIGHER-LEVEL RELATIONSHIPS; PHYLOGENETIC ANALYSIS; SEQUENCE DATA; PHYLOGEOGRAPHIC PATTERNS; RETICULATE EVOLUTION; TASMANIAN EUCALYPTS; ANGOPHORA CAV; SPECIES TREES; MORPHOLOGY	Previous molecular phylogenetic analyses have resolved the Australian bloodwood eucalypt genus Corymbia (similar to 100 species) as either monophyletic or paraphyletic with respect to Angophora (9-10 species). Here we assess relationships of Corymbia and Angophora using a large dataset of chloroplast DNA sequences (121,016 base pairs; from 90 accessions representing 55 Corymbia and 8 Angophora species, plus 33 accessions of related genera), skimmed from high throughput sequencing of genomic DNA, and compare results with new analyses of nuclear ITS sequences (119 accessions) from previous studies. Maximum likelihood and maximum parsimony analyses of cpDNA resolve well supported trees with most nodes having >95% bootstrap support. These trees strongly reject monophyly of Corymbia, its two subgenera (Corymbia and Blakella), most taxonomic sections (Abbreviatae, Maculatae, Naviculares, Septentrionales), and several species. ITS trees weakly indicate paraphyly of Corymbia (bootstrap support <50% for maximum likelihood, and 71% for parsimony), but are highly incongruent with the cpDNA analyses, in that they support monophyly of both subgenera and some taxonomic sections of Corymbia. The striking incongruence between cpDNA trees and both morphological taxonomy and ITS trees is attributed largely to chloroplast introgression between taxa, because of geographic sharing of chloroplast clades across taxonomic groups. Such introgression has been widely inferred in studies of the related genus Eucalyptus. This is the first report of its likely prevalence in Corymbia and Angophora, but this is consistent with previous morphological inferences of hybridisation between species. Our findings (based on continent-wide sampling) highlight a need for more focussed studies to assess the extent of hybridisation and introgression in the evolutionary history of these genera, and that critical testing of the classification of Corymbia and Angophora requires additional sequence data from nuclear genomes.	[Schuster, Tanja M.; Batty, Erin L.; Fowler, Rachael M.; McLay, Todd G. B.; Bayly, Michael J.] Univ Melbourne, Sch BioSci, Parkville, Vic, Australia; [Schuster, Tanja M.] Royal Bot Gardens Victoria, Natl Herbarium Victoria, Birdwood Ave, South Yarra, Vic, Australia; [Setaro, Sabrina D.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Tibbits, Josquin F. G.] La Trobe Univ, AgriBiosci Ctr, Dept Econ Dev Jobs Transport & Resources, Bundoora, Vic, Australia; [Wilcox, Stephen] Walter & Eliza Hall Inst Med Res, Genom Hub, 1G Royal Parade, Melbourne, Vic, Australia; [Ades, Peter K.] Univ Melbourne, Sch Ecosyst & Forest Sci, Melbourne, Vic, Australia	University of Melbourne; Wake Forest University; La Trobe University; University of Melbourne	Schuster, TM (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic, Australia.; Schuster, TM (corresponding author), Royal Bot Gardens Victoria, Natl Herbarium Victoria, Birdwood Ave, South Yarra, Vic, Australia.	tanja.schuster@unimelb.edu.au		Schuster, Tanja M./0000-0003-0851-3372; Bayly, Michael/0000-0001-6836-5493	Hermon Slade Foundation [HSF14-09]; Bjarne K. Dahl Trust; University of Melbourne Botany Foundation	Hermon Slade Foundation; Bjarne K. Dahl Trust; University of Melbourne Botany Foundation	This research was funded by The Hermon Slade Foundation (grant HSF14-09 to TMS and JFGT; http://www.hermonslade.org.au), The Bjarne K. Dahl Trust (grants in 2014 and 2015 to MJB and PKA; https://dahltrust.org.au), and The University of Melbourne Botany Foundation (TMS support funds; http://science.unimelb.edu.au/engage/giving-to-science/botany-foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachir O, 2006, CARYOLOGIA, V59, P207, DOI 10.1080/00087114.2006.10797916; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; Barbour RC, 2008, FOREST ECOL MANAG, V256, P1, DOI 10.1016/j.foreco.2008.03.028; Batish DR, 2008, FOREST ECOL MANAG, V256, P2166, DOI 10.1016/j.foreco.2008.08.008; Baum D.A., 2013, TREE THINKING INTRO; Bayly MJ, 2008, CLADISTICS, V24, P131, DOI 10.1111/j.1096-0031.2007.00175.x; Bayly MJ, 2007, MOL PHYLOGENET EVOL, V44, P346, DOI 10.1016/j.ympev.2006.10.027; Bayly Michael J., 2016, Proceedings of the Royal Society of Victoria, V128, P12, DOI 10.1071/RS16002; Bayly MJ, 2013, MOL PHYLOGENET EVOL, V69, P704, DOI 10.1016/j.ympev.2013.07.006; Bentham G., 1866, FLORA AUSTRALIENSIS, VIII; BLAKE S. T., 1977, AUSTROBAILEYA, V1, P43; Blakely WF., 1965, KEY EUCALYPTS; Boland DJ, 2006, FOREST TREES AUSTR; Brooker MIH, 2000, AUST SYST BOT, V13, P79, DOI 10.1071/SB98008; Burke JM, 2008, AUST SYST BOT, V21, P1, DOI 10.1071/SB07038; Carr DJ, 2002, BOT J LINN SOC, V139, P415, DOI 10.1046/j.1095-8339.2002.00062.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cavanilles A.J., 1797, ICONES DESCRIPTIONES, V4; CHAH, 2017, AUSTR PLANT CENSUS; Chippendale G.M., 1988, FLORA AUSTR, V19, P542; CRAVEN L A, 1990, Australian Systematic Botany, V3, P727, DOI 10.1071/SB9900727; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DAWSON J W, 1970, Blumea, V18, P431; Dickinson GR, 2012, ANN BOT-LONDON, V109, P1215, DOI 10.1093/aob/mcs050; Doyle J. J., 1987, PHYTOCHEM B, P11; DOYLE JJ, 1992, SYST BOT, V17, P144, DOI 10.2307/2419070; Gibbs AK, 2009, AUST SYST BOT, V22, P158, DOI 10.1071/SB08043; Gonzalez-Orozco CE, 2016, NAT CLIM CHANGE, V6, P1110, DOI [10.1038/NCLIMATE3126, 10.1038/nclimate3126]; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Grattapaglia D, 2012, TREE GENET GENOMES, V8, P463, DOI 10.1007/s11295-012-0491-x; GRIFFIN AR, 1988, AUST J BOT, V36, P41, DOI 10.1071/BT9880041; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hill K. D., 1995, Telopea, V6, P185; Holmes GD, 2014, AUST SYST BOT, V27, P56, DOI 10.1071/SB13045; Jackson HD, 1999, MOL ECOL, V8, P739, DOI 10.1046/j.1365-294X.1999.00614.x; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Ladiges PY, 2010, SPEC SYST, V3, P267; Ladiges PY, 2003, J BIOGEOGR, V30, P989, DOI 10.1046/j.1365-2699.2003.00881.x; LADIGES PY, 1984, AUST J BOT, V32, P561, DOI 10.1071/BT9840561; LADIGES PY, 1995, AUST SYST BOT, V8, P483, DOI 10.1071/SB9950483; Ladiges PY, 2000, AUST SYST BOT, V13, P149, DOI 10.1071/SB99011; LEACH G J, 1986, Telopea, V2, P749; LOW D, 1974, PLANTA MED, V26, P184, DOI 10.1055/s-0028-1097987; Macpherson J, 1939, MANKIND, V2, P175; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Maddison WP, 2013, MESQUITE VERSION 3 1; Maiden JH, 1892, BIBLIO AUSTR EC BOT; Mayol M, 2001, MOL PHYLOGENET EVOL, V19, P167, DOI 10.1006/mpev.2001.0934; McKinnon GE, 2010, MOL ECOL, V19, P1367, DOI 10.1111/j.1365-294X.2010.04579.x; McKinnon GE, 2004, PHILOS T R SOC B, V359, P275, DOI 10.1098/rstb.2003.1391; McKinnon GE, 2001, EVOLUTION, V55, P703, DOI 10.1554/0014-3820(2001)055[0703:CSITTE]2.0.CO;2; McKinnon GE, 1999, AM J BOT, V86, P1038, DOI 10.2307/2656621; McLay TGB, 2017, HIGH QUALITY DNA EXT; Meudt HM, 2008, MOL PHYLOGENET EVOL, V47, P319, DOI 10.1016/j.ympev.2007.12.019; Nevill PG, 2014, TREE GENET GENOMES, V10, P1079, DOI 10.1007/s11295-014-0744-y; Nicolle D, 2015, CLASSIFICATION EUCAL; Ochieng JW, 2007, GENET MOL BIOL, V30, P1125, DOI 10.1590/S1415-47572007000600016; Ochieng JW, 2007, MOL PHYLOGENET EVOL, V44, P752, DOI 10.1016/j.ympev.2007.04.017; Packer J, 2012, J ETHNOPHARMACOL, V139, P244, DOI 10.1016/j.jep.2011.11.008; Paiva JAP, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-137; Parra-O C, 2009, THESIS; Parra-O C, 2006, TAXON, V55, P653, DOI 10.2307/25065641; Parra-O C, 2009, AUST SYST BOT, V22, P384, DOI 10.1071/SB09028; Pollock LJ, 2015, AM NAT, V185, P784, DOI 10.1086/680983; Pollock LJ, 2013, J BIOGEOGR, V40, P155, DOI 10.1111/j.1365-2699.2012.02766.x; Pryor LD, 1971, CLASSIFICATION EUCAL; Rambaut A., 2016, FIGTREE TREE FIGURE; Ramezani H, 2002, FITOTERAPIA, V73, P261, DOI 10.1016/S0367-326X(02)00065-5; REID EJ, 1979, PLANTA MED, V36, P164, DOI 10.1055/s-0028-1097257; RIESEBERG LH, 1991, EVOL TREND PLANT, V5, P65; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Shepherd LD, 2011, J PLANT RES, V124, P311, DOI 10.1007/s10265-010-0379-5; Slee A.V., 2020, EUCLID EUCALYPTS AUS; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steane DA, 1998, AUST SYST BOT, V11, P25, DOI 10.1071/SB96028; Steane DA, 2002, AUST SYST BOT, V15, P49, DOI 10.1071/SB00039; Steane DA, 1999, MOL PHYLOGENET EVOL, V12, P215, DOI 10.1006/mpev.1999.0612; Steane DA, 2005, DNA RES, V12, P215, DOI 10.1093/dnares/dsi006; THIELE K, 1988, CLADISTICS, V4, P23, DOI 10.1111/j.1096-0031.1988.tb00466.x; Tsitrone A, 2003, EVOLUTION, V57, P1776, DOI 10.1111/j.0014-3820.2003.tb00585.x; UDOVICIC F, 1995, MOL PHYLOGENET EVOL, V4, P247, DOI 10.1006/mpev.1995.1023; Udovicic F., 2000, Kew Bulletin, V55, P633, DOI 10.2307/4118780; Whittock S, 2003, T ROY SOC SOUTH AUST, V127, P27; Williams J. E., 1997, EUCALYPT ECOLOGY IND; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y	86	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195034	10.1371/journal.pone.0195034	http://dx.doi.org/10.1371/journal.pone.0195034			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668710	Green Published, gold			2022-12-26	WOS:000430290200022
J	Figueiredo-Braga, M; Cornaby, C; Bernardes, M; Figueiredo, M; Mesquita, CD; Costa, L; Poole, BD				Figueiredo-Braga, Margarida; Cornaby, Caleb; Bernardes, Miguel; Figueiredo, Marta; Mesquita, Cristina Dos Santos; Costa, Lucia; Poole, Brian D.			Correlation between physical markers and psychiatric health in a Portuguese systemic lupus erythematosus cohort: The role of suffering in chronic autoimmune disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; QUALITY-OF-LIFE; DEPRESSIVE SYMPTOMS; COGNITIVE FUNCTION; SLEEP QUALITY; SELF-REPORT; FATIGUE; TELEPHONE; ANXIETY; SCALE	Background Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that affects a large number of people throughout the world. Anxiety, depression and fatigue are common symptoms of SLE that substantially contribute to decreased quality of life. This study investigates the interplay between physical and psychiatric manifestations of lupus. To this end, an SLE patient cohort was examined for correlations between clinical presentation, laboratory tests, and psychological indicators. Methods Seventy-two lupus patients were evaluated for psychological status using a battery of instruments, including assessments for fatigue (CFS & FSS), depression (HADS), anxiety (HADS), overall health (SF-36 & PSQI) and intimate relationship satisfaction (RAS & CSI). Scores from these assessments were correlated with lupus clinical profiles and laboratory test values. Results The prevalence of depression in the SLE patient cohort was 41.7%, as measured by the hospital depression and anxiety scale. The study identified that pain (p = 0.001), body mass index (p = 0.026), Chalder's fatigue scale (p < 0.001), fatigue severity scale (p < 0.001), and anxiety (p = 0.001) are all positively correlated with depression in SLE patients. Total complement (CH50) (p = 0.032), and SF-36 physical and mental characteristic assessments are negatively correlated with depression. Longitudinal analysis indicated that the disease related complaint alopecia (p = 0.008) and relationship assessment scale scores (p = 0.004) may also be correlated to depression in SLE patients. Multivariant scrutiny of the clinical and psychosocial characteristics identified the fatigue severity scale (p = 0.026), SF-36 physical function (p = 0.040), physical role function (0.030), and mental health (p = 0.002) as the best indicators directly correlated with depression for the SLE cohort. Conclusion These results reveal the influence of physical manifestations of lupus including fatigue, pain, body mass index and anxiety, as well as decreased physical and mental function, on depression. Fatigue is the strongest factor correlated with depression in SLE patients in the cohort. Both physical and social/psychological aspects likely contribute to the depression and anxiety in lupus.	[Figueiredo-Braga, Margarida; Figueiredo, Marta] Univ Porto, Fac Med, Dept Clin Neurosci & Mental Hlth, Med Psychol Unit, Porto, Portugal; [Figueiredo-Braga, Margarida] Inst Invest & Inovacao Saude I3S, Porto, Portugal; [Cornaby, Caleb; Poole, Brian D.] Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA; [Bernardes, Miguel; Costa, Lucia] Hosp Sao Joao EPE, Rheumatol Dept, Porto, Portugal; [Mesquita, Cristina Dos Santos] Univ Minho, DPA, Minho, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Brigham Young University; Sao Joao Hospital; Universidade do Minho	Poole, BD (corresponding author), Brigham Young Univ, Dept Microbiol & Mol Biol, Provo, UT 84602 USA.	bpoole@gmail.com	Figueiredo-Braga, Margarida M/L-8040-2013	Figueiredo-Braga, Margarida M/0000-0003-2374-4371; Mesquita, Cristina/0000-0003-3678-1200; Poole, Brian/0000-0002-3205-640X; Cornaby, Caleb/0000-0003-1098-1378	Fulbright commission: Portugal, scholar program; Fulbright scholar program	Fulbright commission: Portugal, scholar program; Fulbright scholar program	BLIP was funded by the Fulbright commission: Portugal, scholar program. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the Fulbright scholar program for funding Dr. Poole.	Alexander JJ, 2005, J IMMUNOL, V175, P8312, DOI 10.4049/jimmunol.175.12.8312; [Anonymous], 2007, ARTHRIT RHEUM-ARTHR, V57, P1348, DOI 10.1002/art.23113; Buysse D J, 1989, Psychiatry Res, V28, P193; Carpenter JS, 1998, J PSYCHOSOM RES, V45, P5, DOI 10.1016/S0022-3999(97)00298-5; CHALDER T, 1993, J PSYCHOSOM RES, V37, P147, DOI 10.1016/0022-3999(93)90081-P; Choi ST, 2012, CLIN EXP RHEUMATOL, V30, P665; COHEN BB, 1995, ALCOHOL CLIN EXP RES, V19, P1156, DOI 10.1111/j.1530-0277.1995.tb01595.x; Denburg SD, 1997, J RHEUMATOL, V24, P998; Ferreira P L, 2000, Acta Med Port, V13, P55; Figueiredo-Braga M, 2009, ANN NY ACAD SCI, V1173, P286, DOI 10.1111/j.1749-6632.2009.04647.x; Fonseca RB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/542678; Funk JL, 2007, J FAM PSYCHOL, V21, P572, DOI 10.1037/0893-3200.21.4.572; Gao HX, 2009, J NEUROIMMUNOL, V207, P45, DOI 10.1016/j.jneuroim.2008.11.009; HENDRICK SS, 1988, J MARRIAGE FAM, V50, P93, DOI 10.2307/352430; Inoue M, 2017, CLIN RHEUMATOL, V36, P1053, DOI 10.1007/s10067-017-3545-5; Iverson GL, 2001, J CLIN PSYCHOL, V57, P1579, DOI 10.1002/jclp.1120; Jorge A, 2017, ARTHRIT CARE RES, V69, P5, DOI 10.1002/acr.22992; Jump RL, 2005, J RHEUMATOL, V32, P1699; Karol DE, 2013, PSYCHOSOMATICS, V54, P443, DOI 10.1016/j.psym.2012.09.004; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Lapteva L, 2006, ARTHRITIS RHEUM, V54, P2505, DOI 10.1002/art.22031; Lawrence DA, 2007, J NEUROIMMUNOL, V182, P185, DOI 10.1016/j.jneuroim.2006.10.017; Lin EHB, 2003, JAMA-J AM MED ASSOC, V290, P2428, DOI 10.1001/jama.290.18.2428; Mak A, 2013, LUPUS, V22, P254, DOI 10.1177/0961203312471872; Manne S, 2010, PSYCHO-ONCOLOGY, V19, P941, DOI 10.1002/pon.1645; Marcolino José Álvaro Marques, 2007, Rev. Bras. Anestesiol., V57, P157, DOI 10.1590/S0034-70942007000200004; Monk TH, 2013, J SLEEP RES, V22, P201, DOI 10.1111/jsr.12003; Morris G, 2016, MOL NEUROBIOL, V53, P1195, DOI 10.1007/s12035-015-9090-9; Nery FG, 2007, COMPR PSYCHIAT, V48, P14, DOI 10.1016/j.comppsych.2006.04.002; Pais-Ribeiro J, 2007, Psychol Health Med, V12, P225, DOI 10.1080/13548500500524088; Palmieri PA, 2010, J CLIN SLEEP MED, V6, P557; Petri M, 2013, J RHEUMATOL, V40, P1865, DOI 10.3899/jrheum.130046; Postal M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-015-0471-9; Ramsey-Goldman R, 2010, PM&R, V2, P384, DOI 10.1016/j.pmrj.2010.03.026; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Sakic B, 2005, J NEUROIMMUNOL, V169, P68, DOI 10.1016/j.jneuroim.2005.08.010; Segui J, 2000, LUPUS, V9, P584, DOI 10.1191/096120300678828730; SIEMIATYCKI J, 1979, AM J PUBLIC HEALTH, V69, P238, DOI 10.2105/AJPH.69.3.238; Stock AD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00484; Stojanovich L, 2007, AUTOIMMUN REV, V6, P421, DOI 10.1016/j.autrev.2007.02.007; TSAI CY, 1994, SCAND J RHEUMATOL, V23, P57, DOI 10.3109/03009749409103028; van Exel E, 2013, LUPUS, V22, P1462, DOI 10.1177/0961203313508443; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wiseman SJ, 2017, LUPUS, V26, P588, DOI 10.1177/0961203316668417; Xie X, 2016, RHEUMATOL INT, V36, P1705, DOI 10.1007/s00296-016-3559-3; Yilmaz-Oner S, 2016, Z RHEUMATOL; Zhang LJ, 2017, BMC PSYCHIATRY, V17, DOI 10.1186/s12888-017-1234-1; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zonana-Nacach A, 2000, LUPUS, V9, P101, DOI 10.1191/096120300678828046	49	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195579	10.1371/journal.pone.0195579	http://dx.doi.org/10.1371/journal.pone.0195579			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8QO	29659589	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100022
J	Yap, TA; Koo, MS; Ambrose, RF; Vredenburg, VT				Yap, Tiffany A.; Koo, Michelle S.; Ambrose, Richard F.; Vredenburg, Vance T.			Introduced bullfrog facilitates pathogen invasion in the western United States	PLOS ONE			English	Article							FUNGUS BATRACHOCHYTRIUM-DENDROBATIDIS; LARVAL AMPHIBIAN COMMUNITIES; EMERGING INFECTIOUS-DISEASES; CHYTRID FUNGUS; RANA-CATESBEIANA; AMERICAN BULLFROG; CHYTRIDIOMYCOSIS; EMERGENCE; FROGS; BIODIVERSITY	Batrachochytrium dendrobatidis (Bd), a causal agent of the amphibian fungal skin disease chytridiomycosis, has been implicated in the decline and extinction of over 200 species worldwide since the 1970s. Despite almost two decades of research, the history of Bd and its global spread is not well understood. However, the spread of the Global Panzootic Line-age of Bd (Bd-GPL), the lineage associated with amphibian die-offs, has been linked with the American bullfrog (Rana [Aqurana] catesbeiana) and global trade. Interestingly, R. catesbeiana is native to the eastern U.S., where no Bd-related declines have been observed despite Bd's presence since the late 1800s. In contrast Bd has been found to have emerged in California and Mexico in the 1960s and 1970s, after which epizootics (i.e., epidemics in wildlife) ensued. We hypothesize that Bd-GPL spread from the eastern U.S. with the introduction of R. catesbeiana into the western US, resulting in epizootics and declines of native host species. Using museum records, we investigated the historical relationship between R. catesbeiana and Bd invasion in the western US and found that R. catesbeiana arrived in the same year or prior to Bd in most western watersheds that had data for both species, suggesting that Bd-GPL may have originated in the eastern US and R. catesbeiana may have facilitated Bd invasion in the western US. To predict areas with greatest suitability for Bd, we created a suitability model by integrating habitat suitability and host availability. When we incorporated invasion history with high Bd suitability, we found that watersheds with non-native R. catesbeiana in the mountain ranges of the West Coast have the highest disease risk. These findings shed light on the invasion history and disease dynamics of Bd in North America. Targeted historical surveys using archived specimens in natural history collections and present-day field surveys along with more localized, community-level studies, monitoring, and surveillance are needed to further test this hypothesis and grow our understanding of the disease ecology and host-pathogen dynamics of Bd.	[Yap, Tiffany A.; Ambrose, Richard F.] Univ Calif Los Angeles, Inst Environm & Sustainabil, Los Angeles, CA USA; [Yap, Tiffany A.; Koo, Michelle S.; Vredenburg, Vance T.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Yap, Tiffany A.; Vredenburg, Vance T.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Ambrose, Richard F.] Univ Calif Los Angeles, Dept Environm Hlth Sci, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Berkeley; California State University System; San Francisco State University; University of California System; University of California Los Angeles	Vredenburg, VT (corresponding author), Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA.; Vredenburg, VT (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.	vancev@sfsu.edu	KOO, Michelle S./AAD-8688-2020	KOO, Michelle S./0000-0003-0410-722X; Vredenburg, Vance/0000-0002-9682-1190	National Science Foundation [1258133, 1633948, 1441652]; NSF [1258133, 1633948, 1441652]	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF))	This work was supported by National Science Foundation 1258133, 1633948 (V.T.V.), and 1441652 (M.S.K.).; We thank Vredenburg Lab collaborators and Bd-Maps for georeferenced Bd occurrence data. We thank the IUCN and AmphibiaWeb for range map data. We thank the United States Geological Survey for R. catesbeiana range data and watershed boundary data. We thank Thomas Gillespie, James Lloyd-Smith, Richard Vance, and anonymous reviewers for valuable feedback and suggestions. We thank the AmphibiaWeb and Biodiversity Informatics undergraduate apprentices at the Museum of Vertebrate Zoology (University of California, Berkeley) for species range work, and we thank MVZ staff for technical support of this research. We thank Ben de Jesus for design assistance with the figures. Funding for this project was from NSF grants 1258133 and 1633948 to VTV. The spatial data was, in part, the product of NSF grant 1441652 ("VertLife Terrestrial") to MSK.	Alroy J, 2015, P NATL ACAD SCI USA, V112, P13003, DOI 10.1073/pnas.1508681112; AmphibiaWeb, 2016, INF AMPH BIOL CONS; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Bai CM, 2010, ECOHEALTH, V7, P127, DOI 10.1007/s10393-010-0307-0; Bales EK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116405; Bataille A, 2013, MOL ECOL, V22, P4196, DOI 10.1111/mec.12385; Bd-Maps, 2014, GLOB BD MAPP PROJ; Becker CG, 2011, P NATL ACAD SCI USA, V108, P9893, DOI 10.1073/pnas.1014497108; Bielby J, 2015, SCI REP-UK, V5, DOI 10.1038/srep10828; BLAUSTEIN AR, 1994, BIOL CONSERV, V67, P251, DOI 10.1016/0006-3207(94)90616-5; Boria RA, 2014, ECOL MODEL, V275, P73, DOI 10.1016/j.ecolmodel.2013.12.012; Borzee AEL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177860; Bradley GA, 2002, J WILDLIFE DIS, V38, P206, DOI 10.7589/0090-3558-38.1.206; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Cheng TL, 2011, P NATL ACAD SCI USA, V108, P9502, DOI 10.1073/pnas.1105538108; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Davidson C, 2007, ENVIRON SCI TECHNOL, V41, P1771, DOI 10.1021/es0611947; De Leon ME, 2017, ECOHEALTH, V14, P155, DOI 10.1007/s10393-016-1201-1; DiRenzo GV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093356; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher Matthew C., 2007, Fungal Biology Reviews, V21, P2, DOI 10.1016/j.fbr.2007.02.002; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Fites JS, 2013, SCIENCE, V342, P366, DOI 10.1126/science.1243316; Garner TWJ, 2006, BIOL LETTERS, V2, P455, DOI 10.1098/rsbl.2006.0494; Ghirardi R, 2017, BELG J ZOOL, V147, P81, DOI 10.26496/bjz.2017.7; Grant EHC, 2017, FRONT ECOL ENVIRON, V15, P214, DOI 10.1002/fee.1481; Grant EHC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25625; Hanselmann R, 2004, BIOL CONSERV, V120, P115, DOI 10.1016/j.biocon.2004.02.013; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Huss M, 2013, ECOHEALTH, V10, P339, DOI 10.1007/s10393-013-0895-6; James TY, 2015, ECOL EVOL, V5, P4079, DOI 10.1002/ece3.1672; Keesing F, 2006, ECOL LETT, V9, P485, DOI 10.1111/j.1461-0248.2006.00885.x; Lips KR, 2006, P NATL ACAD SCI USA, V103, P3165, DOI 10.1073/pnas.0506889103; Liu X, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2506; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Mainali KP, 2015, GLOBAL CHANGE BIOL, V21, P4464, DOI 10.1111/gcb.13038; Martel A, 2014, SCIENCE, V346, P630, DOI 10.1126/science.1258268; Martel A, 2013, P NATL ACAD SCI USA, V110, P15325, DOI 10.1073/pnas.1307356110; McMahon TA, 2014, NATURE, V511, P224, DOI 10.1038/nature13491; Merow C, 2013, PRACTICAL GUIDE MAXE, P1058, DOI [10.1111/j.1600-0587.2013.07872, DOI 10.1111/J.1600-0587.2013.07872]; Muletz C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103728; Murray KA, 2011, J APPL ECOL, V48, P163, DOI 10.1111/j.1365-2664.2010.01890.x; Muths E, 2003, BIOL CONSERV, V110, P357, DOI 10.1016/S0006-3207(02)00239-2; Olson DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056802; Ouellet M, 2005, CONSERV BIOL, V19, P1431, DOI 10.1111/j.1523-1739.2005.00108.x; Padgett-Flohr GE, 2008, HERPETOL CONSERV BIO, V3, P182; Parris MJ, 2004, OECOLOGIA, V140, P626, DOI 10.1007/s00442-004-1631-2; Parris MJ, 2004, ECOLOGY, V85, P3385, DOI 10.1890/04-0383; Phillips S.J, 2004, P 21 INT C MACH LEAR, P83, DOI [10.1145/1015330.1015412, DOI 10.1145/1015330.1015412]; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2013, ECOLOGY, V94, P1409, DOI 10.1890/12-1520.1; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Puschendorf R, 2009, DIVERS DISTRIB, V15, P401, DOI 10.1111/j.1472-4642.2008.00548.x; Rachowicz LJ, 2006, ECOLOGY, V87, P1671, DOI 10.1890/0012-9658(2006)87[1671:EIDAAP]2.0.CO;2; Rachowicz LJ, 2005, CONSERV BIOL, V19, P1441, DOI 10.1111/j.1523-1739.2005.00255.x; Reeder NMM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033567; Richgels KLD, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150616; Rodriguez D, 2014, MOL ECOL, V23, P774, DOI 10.1111/mec.12615; Rodder D, 2013, NORTH-WEST J ZOOL, V9, P178; Roedder Dennis, 2009, Diversity, V1, P52; Ron SR, 2005, BIOTROPICA, V37, P209, DOI 10.1111/j.1744-7429.2005.00028.x; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Rothermel BB, 2008, DIS AQUAT ORGAN, V82, P3, DOI 10.3354/dao01974; Savage AE, 2011, BIOL CONSERV, V144, P1910, DOI 10.1016/j.biocon.2011.03.018; Scheele BC, 2017, CONSERV BIOL, V31, P592, DOI 10.1111/cobi.12830; Schloegel LM, 2012, MOL ECOL, V21, P5162, DOI 10.1111/j.1365-294X.2012.05710.x; Schloegel LM, 2009, BIOL CONSERV, V142, P1420, DOI 10.1016/j.biocon.2009.02.007; Sette CM, 2015, BIOL CONSERV, V192, P20, DOI 10.1016/j.biocon.2015.08.039; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Spitzen-Van der Sluijs A, 2014, CONSERV BIOL, V28, P1302, DOI 10.1111/cobi.12281; Talley BL, 2015, BIOL CONSERV, V182, P254, DOI 10.1016/j.biocon.2014.12.007; Thorne LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043167; van Steenis W., 2021, IUCN RED LIST THREAT, pe.T149165436A149165446, DOI [10.2305/IUCN.UK.2021-3.RLTS.T149165436A149165446.en, DOI 10.2305/IUCN.UK.2021-1.RLTS.T49254712A49256721]; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558; Vredenburg VT, 2010, P NATL ACAD SCI USA, V107, P9689, DOI 10.1073/pnas.0914111107; Vredenburg VT, 2008, THREATENED AMPHIBIAN, P126; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746; Yap TA, 2015, SCIENCE, V349, P481, DOI 10.1126/science.aab1052; Yuan ZY, 2016, SYST BIOL, V65, P824, DOI 10.1093/sysbio/syw055	79	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0188384	10.1371/journal.pone.0188384	http://dx.doi.org/10.1371/journal.pone.0188384			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659568	Green Published, gold			2022-12-26	WOS:000430061100001
J	Hsu, TC; Yi, PJ; Lee, TY; Liu, JR				Hsu, Tsui-Chun; Yi, Ping-Jung; Lee, Ting-Yu; Liu, Je-Ruei			Probiotic characteristics and zearalenone-removal ability of a Bacillus licheniformis strain	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; AFLATOXIN B-1; LACTOBACILLUS-CASEI; SURFACE BINDING; MYCOTOXIN; DETOXIFICATION; DEGRADATION; ADHESION; METABOLISM; ADSORPTION	Zearalenone (ZEN) is a mycotoxin produced by Fusarium species, which is one of the main animal feed contaminants causing reproductive disorders in livestock. The aim of this study was to evaluate the probiotic characteristics and ZEN removal ability of a Bacillus licheniformis strain CK1. The probiotic properties, including acidic tolerance, bile salt tolerance, adherence capability, and anti-pathogenic activities of CK1 were evaluated. CK1 survived after incubation at pH 2.0 or 3.0 for 3 h, grew well in LB broth containing 0.3% oxgall, possessed adherence capability to Caco-2 cells, and inhibited the growth of Escherichia coli O157: H7 and Listeria monocytogenes. The ZEN removal ability of CK1 was compared with a mineral mycotoxin-adsorbing agent, hydrated sodium calcium aluminosilicate (HSCAS), and a well-characterized biological mycotoxin-adsorbing agent, Lactobacillus rhamnosus GG (LGG). At 37 E C in phosphate-buffered saline (PBS, pH 7.0) containing 5 mu g mL(-1) of ZEN, the ZEN removal percentage of CK1 was 73.0%, which was significantly higher than that of HSCAS and LGG (45.9% and 48.4%, respectively). In the pH range of 2.5-8.0, CK1 removed up to 65% of ZEN. At temperatures between 4 and 42 E C, CK1 removed more than 75% of ZEN. In the adsorption stability analysis, the amounts of ZEN removed by CK1 was over 30% even after five consecutive rounds of washing procedures. These findings demonstrated that CK1 displayed probiotic characteristics and removed ZEN effectively. Therefore, CK1 has a great potential for the development of feed additive to remove ZEN.	[Hsu, Tsui-Chun; Yi, Ping-Jung; Lee, Ting-Yu; Liu, Je-Ruei] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Liu, Je-Ruei] Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan; [Liu, Je-Ruei] Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan	National Taiwan University; National Taiwan University; Academia Sinica - Taiwan	Liu, JR (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.; Liu, JR (corresponding author), Natl Taiwan Univ, Inst Biotechnol, Taipei, Taiwan.; Liu, JR (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei, Taiwan.	jrliu@ntu.edu.tw		LIU, JE-RUEI/0000-0002-2152-7536	National Taiwan University; Ministry of Science and Technology [MOST 105-2313-B-002-042-MY3, MOST 106-3114-B-002-005]; Council of Agriculture, Executive Yuan, Republic of China [105AS-2.3.3-AD-U1, 106AS-2.3.3-AD-U1]	National Taiwan University(National Taiwan University); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Council of Agriculture, Executive Yuan, Republic of China	This research was conducted using funds provided by National Taiwan University, grant MOST 105-2313-B-002-042-MY3 and MOST 106-3114-B-002-005 from the Ministry of Science and Technology, and grants 105AS-2.3.3-AD-U1 and 106AS-2.3.3-AD-U1 from the Council of Agriculture, Executive Yuan, Republic of China. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altalhi AD, 2009, J HAZARD MATER, V161, P1166, DOI 10.1016/j.jhazmat.2008.04.068; [Anonymous], 2002, GUIDELINES EVALUATIO; Avantaggiato G, 2005, FOOD ADDIT CONTAM A, V22, P379, DOI 10.1080/02652030500058312; Ayscue P, 2009, FOODBORNE PATHOG DIS, V6, P461, DOI 10.1089/fpd.2008.0235; Belcoeil PA, 2003, VET RES, V34, P737, DOI 10.1051/vetres:2003031; Boudergue C., 2009, EFSA SUPP PUBL, V6, P22, DOI [DOI 10.2903/SP.EFSA.2009.EN-22, 10.2903/sp.efsa.2009.EN-22]; Bueno DJ, 2004, METH MOL B, V268, P133; Cho KJ, 2010, BIOTECHNOL LETT, V32, P1921, DOI 10.1007/s10529-010-0373-y; Danicke S, 2015, FOOD CHEM TOXICOL, V84, P225, DOI 10.1016/j.fct.2015.08.009; Diaz GJ, 2008, POULTRY SCI, V87, P727, DOI 10.3382/ps.2007-00403; DIEKMAN MA, 1992, J ANIM SCI, V70, P1615, DOI 10.2527/1992.7051615x; El-Nezami H, 2004, J AGR FOOD CHEM, V52, P4577, DOI 10.1021/jf049924m; El-Nezami H, 2002, APPL ENVIRON MICROB, V68, P3545, DOI 10.1128/AEM.68.7.3545-3549.2002; Fu GH, 2016, TOXINS, V8, DOI 10.3390/toxins8100300; Galvano F, 2001, J FOOD PROTECT, V64, P120, DOI 10.4315/0362-028X-64.1.120; Hancock IC, 1997, BIOCHEM SOC T, V25, P183, DOI 10.1042/bst0250183; Haskard C, 2000, CHEM-BIOL INTERACT, V128, P39, DOI 10.1016/S0009-2797(00)00186-1; Haskard CA, 2001, APPL ENVIRON MICROB, V67, P3086, DOI 10.1128/AEM.67.7.3086-3091.2001; Hsueh HY, 2010, J AGR FOOD CHEM, V58, P12182, DOI 10.1021/jf1035756; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Jouany JP, 2007, ANIM FEED SCI TECH, V137, P342, DOI 10.1016/j.anifeedsci.2007.06.009; Kakeya H, 2002, BIOSCI BIOTECH BIOCH, V66, P2723, DOI 10.1271/bbb.66.2723; Karlovsky P, 2011, APPL MICROBIOL BIOT, V91, P491, DOI 10.1007/s00253-011-3401-5; Khanafari A, 2007, Pak J Biol Sci, V10, P2553, DOI 10.3923/pjbs.2007.2553.2556; KUIPERGOODMAN T, 1987, REGUL TOXICOL PHARM, V7, P253, DOI 10.1016/0273-2300(87)90037-7; Lee A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182220; Liu JR, 2005, APPL ENVIRON MICROB, V71, P6769, DOI 10.1128/AEM.71.11.6769-6775.2005; Megharaj M, 1997, LETT APPL MICROBIOL, V24, P329, DOI 10.1046/j.1472-765X.1997.00053.x; Merchant HA, 2011, EUR J PHARM SCI, V42, P3, DOI 10.1016/j.ejps.2010.09.019; Molnar O, 2004, SYST APPL MICROBIOL, V27, P661, DOI 10.1078/0723202042369947; Mumpton FA, 1999, P NATL ACAD SCI USA, V96, P3463, DOI 10.1073/pnas.96.7.3463; Niderkorn V, 2009, J APPL MICROBIOL, V106, P977, DOI 10.1111/j.1365-2672.2008.04065.x; Peltonen K, 2001, J DAIRY SCI, V84, P2152, DOI 10.3168/jds.S0022-0302(01)74660-7; Phillips TD, 1999, TOXICOL SCI, V52, P118, DOI 10.1093/toxsci/52.suppl_1.118; Popiel D, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-82; Ramos AJ, 1996, ANIM FEED SCI TECH, V62, P263, DOI 10.1016/S0377-8401(96)00968-6; Rodrigues I, 2012, TOXINS, V4, P663, DOI 10.3390/toxins4090663; Sanchez B, 2009, MICROBIOL-SGM, V155, P1708, DOI 10.1099/mic.0.025288-0; Sanchez B, 2008, FEMS IMMUNOL MED MIC, V54, P1, DOI 10.1111/j.1574-695X.2008.00454.x; Schatzmayr G, 2006, MOL NUTR FOOD RES, V50, P543, DOI 10.1002/mnfr.200500181; Scott PM, 1985, MYCOTOXINS CANADIAN; Shi YH, 2005, ASIAN AUSTRAL J ANIM, V18, P1305, DOI 10.5713/ajas.2005.1305; Solomon EB, 2002, APPL ENVIRON MICROB, V68, P397, DOI 10.1128/AEM.68.1.397-400.2002; Streit E, 2013, J SCI FOOD AGR, V93, P2892, DOI 10.1002/jsfa.6225; Takahashi-Ando N, 2002, BIOCHEM J, V365, P1, DOI 10.1042/BJ20020450; Tinyiro SE, 2011, FOLIA MICROBIOL, V56, P321, DOI 10.1007/s12223-011-0047-8; Varga J, 2005, INT J FOOD MICROBIOL, V99, P321, DOI 10.1016/j.ijfoodmicro.2004.10.034; Vila-Donat P, 2018, FOOD CHEM TOXICOL, V114, P246, DOI 10.1016/j.fct.2018.02.044; Vinderola CG, 2000, J DAIRY SCI, V83, P1905, DOI 10.3168/jds.S0022-0302(00)75065-X; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Wu WJ, 2013, FOOD SCI BIOTECHNOL, V22, P433, DOI 10.1007/s10068-013-0098-5; Xu JH, 2016, FOOD CONTROL, V68, P244, DOI 10.1016/j.foodcont.2016.03.030; Yi PJ, 2011, WORLD J MICROB BIOT, V27, P1035, DOI 10.1007/s11274-010-0548-7; Zinedine A, 2007, FOOD CHEM TOXICOL, V45, P1, DOI 10.1016/j.fct.2006.07.030; Zoghi A, 2014, MINI-REV MED CHEM, V14, P84, DOI 10.2174/1389557513666131211105554	55	29	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194866	10.1371/journal.pone.0194866	http://dx.doi.org/10.1371/journal.pone.0194866			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641608	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900052
J	Takahashi, C; Miyatake, K; Kusakabe, M; Nishida, E				Takahashi, Chika; Miyatake, Koichi; Kusakabe, Morioh; Nishida, Eisuke			The atypical mitogen-activated protein kinase ERK3 is essential for establishment of epithelial architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mitogen-activated protein kinase (MAPK); cell biology; epithelial cell; epidermis; embryo; development; Xenopus	TRANSCRIPTION FACTOR AP-2; FROG XENOPUS-LAEVIS; GENE-EXPRESSION; BRANCHIOOCULOFACIAL SYNDROME; TERMINAL DIFFERENTIATION; KIDNEY DEVELOPMENT; SKIN EPIDERMIS; CANCER; PRONEPHROS; SIGNAL	Epithelia contribute to physical barriers that protect internal tissues from the external environment and also support organ structure. Accordingly, establishment and maintenance of epithelial architecture are essential for both embryonic development and adult physiology. Here, using gene knockout and knockdown techniques along with gene profiling, we show that extracellular signal-regulated kinase 3 (ERK3), a poorly characterized atypical mitogen-activated protein kinase (MAPK), regulates the epithelial architecture in vertebrates. We found that in Xenopus embryonic epidermal epithelia, ERK3 knockdown impairs adherens and tight-junction protein distribution, as well as tight-junction barrier function, resulting in epidermal breakdown. Moreover, in human epithelial breast cancer cells, inhibition of ERK3 expression induced thickened epithelia with aberrant adherens and tight junctions. Results from microarray analyses suggested that transcription factor AP-2 (TFAP2A), a transcriptional regulator important for epithelial gene expression, is involved in ERK3-dependent changes in gene expression. Of note, TFAP2A knockdown phenocopied ERK3 knockdown in both Xenopus embryos and human cells, and ERK3 was required for full activation of TFAP2A-dependent transcription. Our findings reveal that ERK3 regulates epithelial architecture, possibly together with TFAP2A.	[Takahashi, Chika; Miyatake, Koichi; Kusakabe, Morioh; Nishida, Eisuke] Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; [Nishida, Eisuke] Japan Agcy Med Res & Dev, AMED CREST, Chiyoda Ku, 1-7-1 Otemachi, Tokyo 1000004, Japan; [Takahashi, Chika] RIKEN, Lab Mol Biol Aging, Ctr Biosyst Dynam Res, Chuou Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan	Kyoto University; RIKEN	Kusakabe, M; Nishida, E (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Cell & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.	morioh@lif.kyoto-u.ac.jp; nishida@lif.kyoto-u.ac.jp			JSPS KAKENHI [JP26221101, JP26440123]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	;This work was supported by JSPS KAKENHI Grants JP26221101 (to E.N.) and JP26440123 (to M.K.). The authors declare that they have no conflicts of interest with the contents of this article.	Al-Mahdi R, 2015, CELL ADHES MIGR, V9, P483, DOI 10.1080/19336918.2015.1112485; Batsche E, 1998, MOL CELL BIOL, V18, P3647, DOI 10.1128/MCB.18.7.3647; BEHRENS J, 1991, P NATL ACAD SCI USA, V88, P11495, DOI 10.1073/pnas.88.24.11495; Bello V, 2008, DEV BIOL, V317, P106, DOI 10.1016/j.ydbio.2008.02.024; Bian K, 2016, ONCOTARGET, V7, P6665, DOI 10.18632/oncotarget.6682; BOSHER JM, 1995, P NATL ACAD SCI USA, V92, P744, DOI 10.1073/pnas.92.3.744; Brewer S, 2004, DEV BIOL, V267, P399, DOI 10.1016/j.ydbio.2003.11.021; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Cizelsky W, 2014, DEVELOPMENT, V141, P2064, DOI 10.1242/dev.107938; Costantini F, 2010, DEV CELL, V18, P698, DOI 10.1016/j.devcel.2010.04.008; Coulombe P, 2003, MOL CELL BIOL, V23, P4542, DOI 10.1128/MCB.23.13.4542-4558.2003; Coulombe P, 2007, BBA-MOL CELL RES, V1773, P1376, DOI 10.1016/j.bbamcr.2006.11.001; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; Desgrange A, 2015, CELLS-BASEL, V4, P483, DOI 10.3390/cells4030483; Ding L, 2011, METHODS MOL BIOL, V762, P91, DOI 10.1007/978-1-61779-185-7_7; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; El-Brolosy MA, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006780; Hennig G, 1996, J BIOL CHEM, V271, P595, DOI 10.1074/jbc.271.1.595; Howland RB, 1916, P NATL ACAD SCI USA, V2, P231, DOI 10.1073/pnas.2.4.231; Julien C, 2003, J BIOL CHEM, V278, P42615, DOI 10.1074/jbc.M302724200; Klinger S, 2009, P NATL ACAD SCI USA, V106, P16710, DOI 10.1073/pnas.0900919106; Kostenko Sergiy, 2012, J Mol Signal, V7, P9, DOI 10.1186/1750-2187-7-9; LEASK A, 1991, P NATL ACAD SCI USA, V88, P7948, DOI 10.1073/pnas.88.18.7948; Liang B, 2005, WORLD J GASTROENTERO, V11, P623, DOI 10.3748/wjg.v11.i5.623; Lienkamp SS, 2016, SEMIN CELL DEV BIOL, V51, P117, DOI 10.1016/j.semcdb.2016.02.002; Long WW, 2012, J CLIN INVEST, V122, P1869, DOI 10.1172/JCI61492; Luo T, 2002, DEV BIOL, V245, P136, DOI 10.1006/dbio.2002.0621; Marciano DK, 2017, PEDIATR NEPHROL, V32, P7, DOI 10.1007/s00467-016-3326-4; Matsuda Y, 2015, CYTOGENET GENOME RES, V145, P187, DOI 10.1159/000381292; Milunsky JM, 2008, AM J HUM GENET, V82, P1171, DOI 10.1016/j.ajhg.2008.03.005; Milunsky JM, 2011, AM J MED GENET A, V155A, P22, DOI 10.1002/ajmg.a.33783; MOODY SA, 1990, ANAT EMBRYOL, V182, P347, DOI 10.1007/BF02433495; MORIYA N, 1993, DEV GROWTH DIFFER, V35, P123; Rai R, 2004, ORAL ONCOL, V40, P705, DOI 10.1016/j.oraloncology.2004.01.010; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schorle H, 1996, NATURE, V381, P235, DOI 10.1038/381235a0; Schumacher S, 2004, EMBO J, V23, P4770, DOI 10.1038/sj.emboj.7600467; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Seternes OM, 2004, EMBO J, V23, P4780, DOI 10.1038/sj.emboj.7600489; Sinha S, 2000, MOL CELL BIOL, V20, P2543, DOI 10.1128/MCB.20.7.2543-2555.2000; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; SNAPE AM, 1991, DEVELOPMENT, V113, P283; Sun J, 2015, BIOCHEM BIOPH RES CO, V462, P178, DOI 10.1016/j.bbrc.2015.04.065; Wang X, 2006, J CELL BIOL, V172, P409, DOI 10.1083/jcb.200510002; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; WILLIAMS T, 1991, GENE DEV, V5, P670, DOI 10.1101/gad.5.4.670; WILLIAMS T, 1988, GENE DEV, V2, P1557, DOI 10.1101/gad.2.12a.1557; Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0; Zhang YH, 2006, GENE EXPR PATTERNS, V6, P589, DOI 10.1016/j.modgep.2005.11.011	50	1	2	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8342	8361		10.1074/jbc.RA117.000992	http://dx.doi.org/10.1074/jbc.RA117.000992			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29674317	hybrid, Green Published			2022-12-26	WOS:000434205700003
J	Grzeszczuk, MJ; Bak, A; Banas, AM; Urbanowicz, P; Dunin-Horkawicz, S; Gieldon, A; Czaplewski, C; Liwo, A; Jagusztyn-Krynicka, EK				Grzeszczuk, Magdalena Joanna; Bak, Aleksandra; Banas, Anna Marta; Urbanowicz, Pawel; Dunin-Horkawicz, Stanislaw; Gieldon, Artur; Czaplewski, Cezary; Liwo, Adam; Jagusztyn-Krynicka, Elibieta K.			Impact of selected amino acids of HP0377 (Helicobacter pylori thiol oxidoreductase) on its functioning as a CcmG (cytochrome c maturation) protein and Dsb (disulfide bond) isomerase	PLOS ONE			English	Article							EXTRACYTOPLASMIC THIOREDOXIN RESA; BACILLUS-SUBTILIS RESA; BRADYRHIZOBIUM-JAPONICUM; SUBSTRATE-SPECIFICITY; CYSTEINE RESIDUES; CRYSTAL-STRUCTURE; SECRETION SYSTEM; STRUCTURAL BASIS; BIOGENESIS; REDOX	Helicobacter pylori HP0377 is a thiol oxidoreductase, a member of the CcmG family involved in cytochrome biogenesis, as previously shown by in vitro experiments. In this report, we document that HP0377 also acts in vivo in the cytochrome assembly process in Bacillus subtilis, where it complements the lack of ResA. However, unlike other characterized proteins in this family, HP0377 is a dithiol reductase and isomerase. We elucidated how the amino acid composition of its active site modulates its functionality. We demonstrated that cis-proline (P156) is involved in its interaction with the redox partner (CcdA), as a P156T HP0377 variant is inactive in vivo and is present in the oxidized form in B. subtilis. Furthermore, we showed that engineering the HP0377 active motif by changing CSYC motif into CSYS or SSYC, clearly diminishes two activities (reduction and isomerization) of the protein. Whereas HP0377(CSYA) is inactive in reduction as well as in isomerization, HP0377(CSYS) retains reductive activity. Also, replacement of F95 by Q decreases its ability to regenerate scRNase and does not influence the reductive activity of HP0377(CSYS) towards apocytochrome c. HP0377 is also distinguished from other CcmGs as it forms a 2: 1 complex with apocytochrome c. Phylogenetic analyses showed that, although HP0377 is capable of complementing ResA in Bacillus subtilis, its thioredoxin domain has a different origin, presumably common to DsbC.	[Grzeszczuk, Magdalena Joanna; Bak, Aleksandra; Banas, Anna Marta; Urbanowicz, Pawel; Jagusztyn-Krynicka, Elibieta K.] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland; [Dunin-Horkawicz, Stanislaw] Univ Warsaw, Ctr New Technol, Struct Bioinformat Lab, Warsaw, Poland; [Gieldon, Artur; Czaplewski, Cezary; Liwo, Adam] Univ Gdansk, Fac Chem, Gdansk, Poland; [Urbanowicz, Pawel] Natl Med Inst, Dept Mol Microbiol, Warsaw, Poland	University of Warsaw; University of Warsaw; Fahrenheit Universities; University of Gdansk; National Medicines Institute Lekow (NIL)	Jagusztyn-Krynicka, EK (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland.	kjkryn@biol.uw.edu.pl	Czaplewski, Cezary/E-1503-2016; Urbanowicz, Paweł/U-8722-2018; Dunin-Horkawicz, Stanislaw/Z-4153-2019	Czaplewski, Cezary/0000-0002-0294-3403; Urbanowicz, Paweł/0000-0001-8622-706X; Dunin-Horkawicz, Stanislaw/0000-0002-4581-1558; Liwo, Adam/0000-0001-6942-2226; Jagusztyn-Krynicka, Elzbieta/0000-0003-0484-9290; Gieldon, Artur/0000-0003-0415-9214; Banas, Anna Marta/0000-0002-6043-2169	National Science Centre [2012/05/B/NZ1/00039, 2015/17/B/NZ1/00230]; Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw intramural grants [DSM13/2017]	National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw intramural grants	The work was supported by the National Science Centre (grants KJK no. 2012/05/B/NZ1/00039 and 2015/17/B/NZ1/00230) and by and by the Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw intramural grants (grant MJG DSM13/2017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was supported by the National Science Centre (grants no. 2012/05/B/NZ1/00039 and 2015/17/B/NZ1/00230) and by the Ministry of Science and Higher Education through the Faculty of Biology, University of Warsaw intramural grants (DSM13/2017). We would like to thank prof. JF Collet for providing E.coli strain for EcDsbC overexpression and purification and prof. NE Le Brun for providing B. subtilis strains. We also thank Dr. Jeffrey Hansen for critical reading of the	Abicht HK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.607127; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Atkinson HJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000541; Balmer Y, 2004, P NATL ACAD SCI USA, V101, P2642, DOI 10.1073/pnas.0308583101; Berka K, 2010, J CHEM THEORY COMPUT, V6, P2191, DOI 10.1021/ct100007y; Bocian-Ostrzycka KM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01158; Bocian-Ostrzycka KM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01065; Bonnard G, 2010, ANTIOXID REDOX SIGN, V13, P1385, DOI 10.1089/ars.2010.3161; Cho SH, 2013, ANTIOXID REDOX SIGN, V18, P1690, DOI 10.1089/ars.2012.4962; Cho SH, 2012, MBIO, V3, DOI 10.1128/mBio.00291-11; Colbert CL, 2006, P NATL ACAD SCI USA, V103, P4410, DOI 10.1073/PNAS.0600552103; Crow A, 2004, J BIOL CHEM, V279, P23654, DOI 10.1074/jbc.M402823200; Crow A, 2009, J BIOL CHEM, V284, P10056, DOI 10.1074/jbc.M809566200; Denoncin K, 2013, ANTIOXID REDOX SIGN, V19, P63, DOI 10.1089/ars.2012.4864; Denoncin Katleen, 2013, Methods Mol Biol, V966, P325, DOI 10.1007/978-1-62703-245-2_20; Denoncin K, 2010, J BIOL CHEM, V285, P29425, DOI 10.1074/jbc.M110.119321; Depuydt M, 2009, SCIENCE, V326, P1109, DOI 10.1126/science.1179557; Di Matteo A, 2010, PROTEINS, V78, P2213, DOI 10.1002/prot.22733; Edeling MA, 2002, STRUCTURE, V10, P973, DOI 10.1016/S0969-2126(02)00794-3; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erlendsson LS, 2003, J BIOL CHEM, V278, P17852, DOI 10.1074/jbc.M300103200; Fabianek RA, 1997, J BIOL CHEM, V272, P4467, DOI 10.1074/jbc.272.7.4467; Ferguson SJ, 2008, BBA-BIOENERGETICS, V1777, P980, DOI 10.1016/j.bbabio.2008.03.020; Fomenko DE, 2008, MOL CELLS, V26, P228; Frickey T, 2004, BIOINFORMATICS, V20, P3702, DOI 10.1093/bioinformatics/bth444; Gleiter S, 2008, BBA-MOL CELL RES, V1783, P530, DOI 10.1016/j.bbamcr.2008.02.009; Harwood CR, 1990, MOL BIOL METHODS BAC, pxxxv; He ZL, 2016, NUCLEIC ACIDS RES, V44, pW236, DOI 10.1093/nar/gkw370; Heras B, 2009, NAT REV MICROBIOL, V7, P215, DOI 10.1038/nrmicro2087; Hodson CTC, 2008, J BACTERIOL, V190, P4697, DOI 10.1128/JB.00145-08; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Jameson-Lee M, 2011, MOL MICROBIOL, V80, P835, DOI 10.1111/j.1365-2958.2011.07615.x; Kadokura H, 2005, J BACTERIOL, V187, P1519, DOI 10.1128/JB.187.4.1519-1522.2005; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2010, ANTIOXID REDOX SIGN, V13, P1231, DOI 10.1089/ars.2010.3187; Katzen F, 2002, EMBO J, V21, P3960, DOI 10.1093/emboj/cdf405; Krupa P, 2017, J CHEM INF MODEL, V57, P2364, DOI 10.1021/acs.jcim.7b00254; Lasica AM, 2007, FEMS MICROBIOL REV, V31, P626, DOI 10.1111/j.1574-6976.2007.00081.x; Le Brun NE, 2000, MOL MICROBIOL, V36, P638, DOI 10.1046/j.1365-2958.2000.01883.x; Lester J, 2015, MOL MICROBIOL, V96, P110, DOI 10.1111/mmi.12923; Leverrier P, 2011, J BIOL CHEM, V286, P16734, DOI 10.1074/jbc.M111.224865; Lewin A, 2008, BIOCHEM J, V414, P81, DOI 10.1042/BJ20080356; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu YW, 2015, MOL MICROBIOL, V96, P1298, DOI 10.1111/mmi.13008; Liwo A, 2014, J MOL MODEL, V20, DOI 10.1007/s00894-014-2306-5; Mohorko E, 2012, FEBS LETT, V586, P4094, DOI 10.1016/j.febslet.2012.10.026; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; Ouyang N, 2006, PROTEINS, V65, P1021, DOI 10.1002/prot.21184; Pei JM, 2007, NUCLEIC ACIDS RES, V35, pW649, DOI 10.1093/nar/gkm227; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin AP, 2016, VIRULENCE, V7, P882, DOI 10.1080/21505594.2016.1168550; Ren GP, 2009, J BIOL CHEM, V284, P10150, DOI 10.1074/jbc.M809509200; Roszczenko P, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0471-z; Roszczenko P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046563; Saleh M, 2013, EMBO MOL MED, V5, P1852, DOI 10.1002/emmm.201202435; Sambrook J., 2001, MOL CLONING LAB MANU; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Simon J, 2011, FEBS J, V278, P4179, DOI 10.1111/j.1742-4658.2011.08374.x; Stirnimann CU, 2005, STRUCTURE, V13, P985, DOI 10.1016/j.str.2005.04.014; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; THONYMEYER L, 1989, CELL, V57, P683, DOI 10.1016/0092-8674(89)90137-2; Williamson JA, 2015, NAT STRUCT MOL BIOL, V22, P809, DOI 10.1038/nsmb.3099; Yoon JY, 2013, ACTA CRYSTALLOGR D, V69, P735, DOI 10.1107/S0907444913001236	64	1	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195358	10.1371/journal.pone.0195358	http://dx.doi.org/10.1371/journal.pone.0195358			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677198	Green Published, gold, Green Submitted			2022-12-26	WOS:000430638900011
J	Adam, AAA; van der Mark, VA; Donkers, JM; Wildenberg, ME; Elferink, RPJO; Chamuleau, RAFM; Hoekstra, R				Adam, Aziza A. A.; van der Mark, Vincent A.; Donkers, Joanne M.; Wildenberg, Manon E.; Elferink, Ronald P. J. Oude; Chamuleau, Robert A. F. M.; Hoekstra, Ruurdtje			A practice-changing culture method relying on shaking substantially increases mitochondrial energy metabolism and functionality of human liver cell lines	PLOS ONE			English	Article							ENRICHED TRANSCRIPTION FACTORS; PRIMARY HUMAN HEPATOCYTES; EMBRYONIC STEM-CELLS; BIOARTIFICIAL LIVER; HEPARG CELLS; IN-VITRO; DRUG-METABOLISM; GENE-EXPRESSION; ENZYMES; DIFFERENTIATION	Practice-changing culturing techniques of hepatocytes are highly required to increase their differentiation. Previously, we found that human liver cell lines HepaRG and C3A acquire higher functionality and increased mitochondrial biogenesis when cultured in the AMC-Bioartificial liver (BAL). Dynamic medium flow (DMF) is one of the major contributors to this stimulatory effect. Recently, we found that DMF-culturing by shaking of HepaRG monolayers resulted in higher mitochondrial biogenesis. Here we further investigated the effect of DMF-culturing on energy metabolism and hepatic functionality of HepaRG and C3A monolayers. HepaRG and C3A DMF-monolayers were incubated with orbital shaking at 60 rpm during the differentiation phase, while control monolayers were maintained statically. Subsequently, energy metabolism and hepatic functionality were compared between static and DMF-cultures. DMF-culturing of HepaRG cells substantially increased hepatic differentiation; transcript levels of hepatic structural genes and hepatic transcription regulators were increased up to 15-fold (Cytochrome P450 3A4) and nuclear translocation of hepatic transcription factor CEBP alpha was stimulated. Accordingly, hepatic functions were positively affected, including ammonia elimination, urea production, bile acid production, and CYP3A4 activity. DMF-culturing shifted energy metabolism from aerobic glycolysis towards oxidative phosphorylation, as indicated by a decline in lactate production and glucose consumption, and an increase in oxygen consumption. Similarly, DMF-culturing increased mitochondrial energy metabolism and hepatic functionality of C3A cells. In conclusion, simple shaking of monolayer cultures substantially improves mitochondrial energy metabolism and hepatic differentiation of human liver cell lines. This practice-changing culture method may prove to prolong the in-vitro maintenance of primary hepatocytes and increase hepatic differentiation of stem cells.	[Adam, Aziza A. A.; van der Mark, Vincent A.; Donkers, Joanne M.; Wildenberg, Manon E.; Elferink, Ronald P. J. Oude; Chamuleau, Robert A. F. M.; Hoekstra, Ruurdtje] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands; [van der Mark, Vincent A.; Hoekstra, Ruurdtje] Univ Amsterdam, Acad Med Ctr, Expt Surg Lab, Amsterdam, Netherlands; [Wildenberg, Manon E.] Univ Amsterdam, Acad Med Ctr, Dept Gastroenterol & Hepatol, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Hoekstra, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, Amsterdam, Netherlands.; Hoekstra, R (corresponding author), Univ Amsterdam, Acad Med Ctr, Expt Surg Lab, Amsterdam, Netherlands.	r.hoekstra@amc.uva.nl	Sharma, Ashwani/AAK-3879-2020	Sharma, Ashwani/0000-0001-9835-1973; Wildenberg, Manon Elisabeth/0000-0003-0671-818X; Donkers, Joanne/0000-0002-3280-4703; Hoekstra, Ruurdtje/0000-0002-7325-2394	European Community's Seventh Framework Programme FP7 [n304914]; Netherlands Organisation for Health Research and Development, More Knowledge with Fewer Animals [114021009]	European Community's Seventh Framework Programme FP7; Netherlands Organisation for Health Research and Development, More Knowledge with Fewer Animals	The research leading to these results has received funding from the European Community's Seventh Framework Programme FP7/2007-2013 under grant agreement n304914 to RAFMC, and from the Netherlands Organisation for Health Research and Development, More Knowledge with Fewer Animals, grant 114021009 to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AAA, 2018, MITOCHONDRION, V39, P30, DOI 10.1016/j.mito.2017.08.011; Almada L, 2006, CRYOBIOLOGY, V52, P393, DOI 10.1016/j.cryobiol.2006.02.001; Appelman MD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170419; Bachour-El Azzi P, 2015, TOXICOL SCI, V145, P157, DOI 10.1093/toxsci/kfv041; Bader A, 2000, J BIOTECHNOL, V81, P95, DOI 10.1016/S0168-1656(00)00233-9; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Cho YM, 2006, BIOCHEM BIOPH RES CO, V348, P1472, DOI 10.1016/j.bbrc.2006.08.020; De Bartolo L, 2000, BIOTECHNOL PROGR, V16, P102, DOI 10.1021/bp990128o; Evans WE, 1999, SCIENCE, V286, P487, DOI 10.1126/science.286.5439.487; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Gao XG, 2017, CELL BIOL TOXICOL, V33, P407, DOI 10.1007/s10565-017-9383-z; Gerets HHJ, 2012, CELL BIOL TOXICOL, V28, P69, DOI 10.1007/s10565-011-9208-4; Gissen P, 2015, J HEPATOL, V63, P1023, DOI 10.1016/j.jhep.2015.06.015; Godoy P, 2015, J HEPATOL, V63, P934, DOI 10.1016/j.jhep.2015.05.013; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hart SN, 2008, PHARMACOGENET GENOM, V18, P11, DOI 10.1097/FPC.0b013e3282f2f121; HAUSSINGER D, 1986, ADV ENZYME REGUL, V25, P159, DOI 10.1016/0065-2571(86)90013-0; Hoeke MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088011; Hoekstra R, 2006, CELL TRANSPLANT, V15, P423, DOI 10.3727/000000006783981873; Hoekstra R, 2013, DRUG METAB DISPOS, V41, P562, DOI 10.1124/dmd.112.049098; Hoekstra R, 2011, INT J BIOCHEM CELL B, V43, P1483, DOI 10.1016/j.biocel.2011.06.011; Hu DG, 2014, DRUG METAB REV, V46, P421, DOI 10.3109/03602532.2014.973037; Iacob R, 2011, STEM CELL RES, V6, P251, DOI 10.1016/j.scr.2011.02.002; Jo A, 2014, GENES DIS, V1, P149, DOI 10.1016/j.gendis.2014.09.004; Kane BJ, 2006, ANAL CHEM, V78, P4291, DOI 10.1021/ac051856v; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Lauschke VM, 2016, HEPATOLOGY, V64, P1743, DOI 10.1002/hep.28780; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; Miyanaka K, 1998, HISTOCHEM J, V30, P741, DOI 10.1023/A:1003468726969; Nibourg GAA, 2013, INT J BIOCHEM CELL B, V45, P1860, DOI 10.1016/j.biocel.2013.05.038; Nibourg GAA, 2012, BIOTECHNOL BIOENG, V109, P3182, DOI 10.1002/bit.24586; Nibourg GAA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038778; Nibourg GAA, 2012, EXPERT OPIN BIOL TH, V12, P905, DOI 10.1517/14712598.2012.685714; Schrem H, 2004, PHARMACOL REV, V56, P291, DOI 10.1124/pr.56.2.5; Schrem H, 2002, PHARMACOL REV, V54, P129, DOI 10.1124/pr.54.1.129; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Tilles AW, 2001, BIOTECHNOL BIOENG, V73, P379, DOI 10.1002/bit.1071; Treyer A, 2013, COMPR PHYSIOL, V3, P243, DOI 10.1002/cphy.c120009; van Wenum M, 2018, J CELL COMMUN SIGNAL, V12, P575, DOI 10.1007/s12079-018-0456-4; van Wenum M, 2016, INT J BIOL SCI, V12, P964, DOI 10.7150/ijbs.15165; van Wenum M, 2014, EXPERT OPIN BIOL TH, V14, P1745, DOI 10.1517/14712598.2014.950651; Varum S, 2009, STEM CELL RES, V3, P142, DOI 10.1016/j.scr.2009.07.002; Wanet A, 2014, INT J BIOCHEM CELL B, V54, P174, DOI 10.1016/j.biocel.2014.07.015; Williams JA, 2002, DRUG METAB DISPOS, V30, P1266, DOI 10.1124/dmd.30.11.1266	46	13	13	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0193664	10.1371/journal.pone.0193664	http://dx.doi.org/10.1371/journal.pone.0193664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672606	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800008
J	Jung, YS; Oh, CM; Kim, Y; Jung, KW; Ryu, J; Won, YJ				Jung, Yuh-Seog; Oh, Chang-Mo; Kim, Yeol; Jung, Kyu-Won; Ryu, Junsun; Won, Young-Joo			Long-term survival of patients with thyroid cancer according to the methods of tumor detection: A nationwide cohort study in Korea	PLOS ONE			English	Article							OVERDIAGNOSIS; PREVALENCE; MICROCARCINOMA; STATISTICS; CARCINOMA; DIAGNOSIS; MORTALITY; EPIDEMIC; IMPACT	In this retrospective cohort study, we compared the survival of patients detected by screening with those detected based on symptoms, according to their tumor stages. After propensity score matching, 2,130 patients with papillary or follicular thyroid cancer, identified by screening detection (SD) and clinical detection (CD), were included. We compared the survival rates of patients identified by SD and CD in the early and advanced stages of thyroid cancer. Cox proportional hazard models were used to compare the hazard ratios (HRs) for mortality between the two groups. Of the 1,065 patients in each group, 12 (1.1%) died in the SD group, compared to 44 (4.1%) in the CD group, during an average 9.4 years (p<0.001). For early stage, there was no significant difference in all-cause and thyroid cancer-specific mortality between the two groups (p = 0.08, p = 0.0502). However, for advanced stage, the survival rates in the SD group were significantly higher than in the CD group (p<0.001, p = 0.004). Moreover, after adjusting for covariates, the HRs of all-cause mortality of the SD group was significantly lower than that of the CD group for the advanced stage patients (HRs: 0.37 [95% CIs: 0.17-0.80]), while no significant difference was observed in the early stage. While screening for thyroid cancer was not beneficial for early stage patients, our findings suggest that detection via screening is associated with better survival for patients with advanced stage cancer. However, the effects of selection bias and lead time bias could not be entirely excluded.	[Jung, Yuh-Seog; Ryu, Junsun] Natl Canc Ctr Hosp, Ctr Thyroid Canc, Head & Neck Oncol Clin, Goyang, South Korea; [Jung, Yuh-Seog; Ryu, Junsun] Natl Canc Ctr, Res Inst, Specif Organs Canc Branch, Goyang, South Korea; [Jung, Yuh-Seog; Kim, Yeol; Won, Young-Joo] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea; [Oh, Chang-Mo; Jung, Kyu-Won; Won, Young-Joo] Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea; [Oh, Chang-Mo] Kyung Hee Univ, Sch Med, Dept Prevent Med, Seoul, South Korea; [Kim, Yeol] Natl Canc Ctr, Natl Canc Control Inst, Div Canc Management & Policy, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Kyung Hee University; National Cancer Center - Korea (NCC)	Won, YJ (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea.; Won, YJ (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Canc Registrat & Stat Branch, Goyang, South Korea.	astra67@ncc.re.kr		Won, Young-Joo/0000-0001-9861-6740; Ryu, Junsun/0000-0002-6730-6755	National Cancer Center [NCC-1610170, 610200]	National Cancer Center	This work was supported by grants from the National Cancer Center (grant numbers NCC-1610170 and 1610200 to YJW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HS, 2014, NEW ENGL J MED, V371, P1765, DOI 10.1056/NEJMp1409841; Albertsen PC, 2011, J CLIN ONCOL, V29, P1335, DOI 10.1200/JCO.2010.31.2330; Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P1882, DOI 10.1001/jama.2017.4011; Byers TE, 2008, CANCER-AM CANCER SOC, V113, P582, DOI 10.1002/cncr.23567; Cham S, 2014, THYROID, V24, P975, DOI 10.1089/thy.2013.0470; Choi YJ, 2008, YONSEI MED J, V49, P748, DOI 10.3349/ymj.2008.49.5.748; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Chung WY, 2001, SURG TODAY, V31, P763, DOI 10.1007/s005950170044; CocaPerraillon M., 2007, SAS GLOB FOR ORL FL; Duffy SW, 2008, AM J EPIDEMIOL, V168, P98, DOI 10.1093/aje/kwn120; Egevad, 2007, CANC INCIDENCE 5 CON, P61; Greene F, 2002, AJCC CANC STAGING MA, P77; Hay ID, 2008, SURGERY, V144, P980, DOI 10.1016/j.surg.2008.08.035; Ho AS, 2015, CANCER-AM CANCER SOC, V121, P1793, DOI 10.1002/cncr.29289; ISHIDA T, 1988, JPN J CLIN ONCOL, V18, P289; Jung KW, 2015, CANCER RES TREAT, V47, P127, DOI 10.4143/crt.2015.060; Jung KW, 2013, CANCER RES TREAT, V45, P162, DOI 10.4143/crt.2013.45.3.162; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lee JH, 2014, LANCET, V384, P1848, DOI 10.1016/S0140-6736(14)62242-X; Lehtimaki T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3080; Loeb S, 2016, J CLIN ONCOL, V34, P2684, DOI 10.1200/JCO.2016.68.2138; Oh CM, 2016, CANCER RES TREAT, V48, P436, DOI 10.4143/crt.2016.089; Oh CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099054; Park S, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5745; US Preventive Services Task Force, 1996, GUID CLIN PREV SERV, P18; Vaccarella S, 2016, NEW ENGL J MED, V375, P614, DOI 10.1056/NEJMp1604412; Wada N, 2007, J CLIN ENDOCR METAB, V92, P215, DOI 10.1210/jc.2006-1443; Yamada H, 2000, Nihon Jibiinkoka Gakkai Kaiho, V103, P13; Yi KH, 2015, J KOREAN MED ASSOC, V58, P302, DOI 10.5124/jkma.2015.58.4.302	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0194743	10.1371/journal.pone.0194743	http://dx.doi.org/10.1371/journal.pone.0194743			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659584	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100006
J	Zhang, CH; Feng, RC; Ma, RJ; Shen, ZJ; Cai, ZX; Song, ZZ; Peng, B; Yu, ML				Zhang, Chunhua; Feng, Ruchao; Ma, Ruijuan; Shen, Zhijun; Cai, Zhixiang; Song, Zhizhong; Peng, Bin; Yu, Mingliang			Genome-wide analysis of basic helix-loop-helix superfamily members in peach	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; EVOLUTIONARY ANALYSIS; ARABIDOPSIS-THALIANA; BHLH; IDENTIFICATION; GENES; RICE; EXPRESSION; R2R3-MYB; MYB	The basic helix-loop-helix (bHLH) transcription factor family is a superfamily found in all eukaryotes that plays important roles in regulating growth and development. Over the past several decades, many bHLH superfamily genes have been identified and characterized in herbaceous and woody plants. However, the genes belonging to the bHLH superfamily in peach (Prunus persica) have not yet been comprehensively identified and characterized. Here, we identified 95 members of the bHLH superfamily in the peach genome, and these genes were classified into 19 subfamilies based on a phylogenetic comparison with bHLH proteins from Arabidopsis. The members within each subfamily were highly conserved according to the analysis of motif compositions and exon/intron organizations. The 95 bHLH genes were unevenly distributed on chromosomes 1 to 8 of the peach genome. We identified 57 pairs of bHLH members that were orthologous between peach and Arabidopsis. Additionally, 48 pairs of paralogous bHLH genes were identified on the eight chromosomes of the peach genome. Coupled with relative expression analysis of bHLH genes in red-fleshed peach fruit at five developmental stages, we identified several bHLH genes that might be involved in fruit development and anthocyanin biosynthesis. This study provides insight into the molecular mechanisms through which these genes are involved in the regulation of biological and biochemical processes in peach and lays the foundation for further studies on these genes.	[Zhang, Chunhua; Feng, Ruchao; Ma, Ruijuan; Shen, Zhijun; Cai, Zhixiang; Song, Zhizhong; Peng, Bin; Yu, Mingliang] Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Yu, ML (corresponding author), Jiangsu Acad Agr Sci, Inst Pomol, Jiangsu Key Lab Hort Crop Genet Improvement, Nanjing, Jiangsu, Peoples R China.	mly1008@aliyun.com	Song, Zhizhong/AAG-8447-2021		National Natural Science Foundation of China [31471848, 31401851]; China Agriculture Research System [CARS-30]; earmarked fund of the China Agriculture Research System [CARS-30]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Agriculture Research System; earmarked fund of the China Agriculture Research System	This work was supported by National Natural Science Foundation of China (No. 31471848), https://isisn.nsfc.gov.cn/egrantweb/, ML Yu received the funding; National Natural Science Foundation of China (No. 31401851), https://isisn.nsfc.gov.cn/egrantweb/, CH Zhang received the funding; and China Agriculture Research System (No. CARS-30), http://123.127.160.231/, ML Yu received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the National Natural Science Foundation of China (No. 31471848 and No. 31401851) and the earmarked fund of the China Agriculture Research System (No. CARS-30) for providing financial support.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Buck MJ, 2003, J MOL EVOL, V56, P742, DOI 10.1007/s00239-002-2449-3; Carretero-Paulet L, 2010, PLANT PHYSIOL, V153, P1398, DOI 10.1104/pp.110.153593; Chen YY, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0319-0; Feller A, 2011, PLANT J, V66, P94, DOI 10.1111/j.1365-313X.2010.04459.x; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fujisawa M, 2013, PLANT CELL, V25, P371, DOI 10.1105/tpc.112.108118; Gao C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181843; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Guo XJ, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1038-y; Hajiebrahimi A, 2017, GENOME, V60, P797, DOI 10.1139/gen-2017-0059; Heang D, 2012, BREEDING SCI, V62, P133, DOI 10.1270/jsbbs.62.133; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hou XJ, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2362-4; Kavas M, 2016, MOL GENET GENOMICS, V291, P129, DOI 10.1007/s00438-015-1095-6; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Liu T, 2015, SCI HORTIC-AMSTERDAM, V184, P142, DOI 10.1016/j.scienta.2015.01.003; Liu T, 2009, DEVELOPMENT, V136, P2265, DOI 10.1242/dev.032938; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao K, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00480; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Montefiori M, 2015, J EXP BOT, V66, P1427, DOI 10.1093/jxb/eru494; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Niu X, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4044-4; Ogo Y, 2007, PLANT J, V51, P366, DOI 10.1111/j.1365-313X.2007.03149.x; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Ravaglia D, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-68; Song XM, 2014, MOL GENET GENOMICS, V289, P77, DOI 10.1007/s00438-013-0791-3; Song Y, 2017, J INTEGR AGR, V16, P591, DOI 10.1016/S2095-3119(16)61461-2; Sun H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1209-2; Szecsi J, 2006, EMBO J, V25, P3912, DOI 10.1038/sj.emboj.7601270; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Trainotti L, 2006, PLANT SCI, V170, P606, DOI 10.1016/j.plantsci.2005.10.015; Verde I, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3606-9; Wang RQ, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010054; Xiang LL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143892; Xu GX, 2012, P NATL ACAD SCI USA, V109, P1187, DOI 10.1073/pnas.1109047109; Xu HF, 2017, PLANT MOL BIOL, V94, P149, DOI 10.1007/s11103-017-0601-0; Yamaoka S, 2018, CURR BIOL, V28, P479, DOI 10.1016/j.cub.2017.12.053; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331; Zhang CH, 2012, GENET MOL RES, V11, P4789, DOI 10.4238/2012.October.17.6; Zhang XY, 2015, SCI REP-UK, V5, DOI [10.1038/srep09940, 10.1038/srep09803]; Zhao H, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-017-2422-9; Zhou H, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00908; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Ziliotto F, 2005, ACTA HORTIC, P237, DOI 10.17660/ActaHortic.2005.682.25	48	35	37	8	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195974	10.1371/journal.pone.0195974	http://dx.doi.org/10.1371/journal.pone.0195974			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659634	Green Published, gold, Green Submitted			2022-12-26	WOS:000430061100043
J	Thorpe, M; Fu, ZR; Chahal, G; Akula, S; Kervinen, J; de Garavilla, L; Hellman, L				Thorpe, Michael; Fu, Zhirong; Chahal, Gurdeep; Akula, Srinivas; Kervinen, Jukka; de Garavilla, Lawrence; Hellman, Lars			Extended cleavage specificity of human neutrophil cathepsin G: A low activity protease with dual chymase and tryptase-type specificities	PLOS ONE			English	Article							MAST-CELL CHYMASE; SUBSTRATE RECOGNITION PROFILE; LUNG-PROTECTIVE IMMUNITY; ANGIOTENSIN-II; SERINE PROTEASES; STREPTOCOCCUS-PNEUMONIAE; MYCOBACTERIAL INFECTIONS; MAMMALIAN EVOLUTION; INNATE IMMUNITY; HOST-DEFENSE	Human neutrophils express at least four active serine proteases, cathepsin G, N-elastase, proteinase 3 and neutrophil serine protease 4 (NSP4). They have all been extensively studied due to their importance in neutrophil biology and immunity. However, their extended cleavage specificities have never been determined in detail. Here we present a detailed cleavage specificity analysis of human cathepsin G (hCG). The specificity was determined by phage display analysis and the importance of individual amino acids in and around the cleavage site was then validated using novel recombinant substrates. To provide a broader context to this serine protease, a comparison was made to the related mast cell protease, human chymase (HC). hCG showed similar characteristics to HC including both the primary and extended specificities. As expected, Phe, Tyr, Trp and Leu were preferred in the P1 position. In addition, both proteases showed a preference for negatively charged amino acids in the P2 A position of substrates and a preference for aliphatic amino acids both upstream and downstream of the cleavage site. However, overall the catalytic activity of hCG was similar to 10-fold lower than HC. hCG has previously been reported to have a dual specificity consisting of chymase and tryptase-type activities. In our analysis, tryptase activity against substrates with Lys in P1 cleavage position was indeed only 2-fold less efficient as compared to optimal chymase substrates supporting strong dual-type specificity. We hope the information presented here on extended cleavage specificities of hCG and HC will assist in the search for novel in vivo substrates for these proteases as well as aid in the efforts to better understand the role of hCG in immunity and bacterial defence.	[Thorpe, Michael; Fu, Zhirong; Chahal, Gurdeep; Akula, Srinivas; Hellman, Lars] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden; [Kervinen, Jukka] Fraunhofer USA Ctr Mol Biotechnol, Newark, DE USA; [de Garavilla, Lawrence] GDL Pharmaceut Consulting & Contracting, Downingtown, PA USA	Uppsala University	Hellman, L (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	Lars.Hellman@icm.uu.se	Akula, Srinivas/GYJ-1463-2022	Hellman, Lars/0000-0003-1459-3815; Chahal, Gurdeep/0000-0001-9601-3057	Swedish Research Council [621-2011-5007]; GDL Pharmaceutical Consulting and Contracting	Swedish Research Council(Swedish Research CouncilEuropean Commission); GDL Pharmaceutical Consulting and Contracting	This study was funded by the Swedish Research Council (621-2011-5007). GDL Pharmaceutical Consulting and Contracting provided support in the form of salary for Lawrence de Garavilla and the provision of reagents. The specific roles of this author are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143091; Andersson MK, 2008, MOL IMMUNOL, V45, P766, DOI 10.1016/j.molimm.2007.06.360; Andersson MK, 2010, FEBS J, V277, P2255, DOI 10.1111/j.1742-4658.2010.07642.x; Andersson MK, 2009, INT IMMUNOL, V21, P95, DOI 10.1093/intimm/dxn128; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Belaaouaj AA, 2000, SCIENCE, V289, P1185, DOI 10.1126/science.289.5482.1185; Benabid R, 2012, J BIOL CHEM, V287, P34883, DOI 10.1074/jbc.M112.361352; Borregaard N, 2005, J LEUKOCYTE BIOL, V77, P439, DOI 10.1189/jlb.0704381; Caughey GH, 2008, J BIOL CHEM, V283, P13943, DOI 10.1074/jbc.M710502200; Chahal G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129511; Cowland JB, 2016, IMMUNOL REV, V273, P11, DOI 10.1111/imr.12440; de Haar SF, 2006, INFECT IMMUN, V74, P5284, DOI 10.1128/IAI.02016-05; Eipper S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151509; Fu ZR, 2017, J IMMUNOL, V198, P1474, DOI 10.4049/jimmunol.1601223; Fu ZR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131720; Gale AJ, 2008, THROMB HAEMOSTASIS, V99, P44, DOI 10.1160/TH07-08-0495; Gallwitz M, 2006, IMMUNOGENETICS, V58, P655, DOI 10.1007/s00251-006-0126-1; Gallwitz M, 2006, IMMUNOGENETICS, V58, P641, DOI 10.1007/s00251-006-0123-4; Gallwitz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031756; Gallwitz M, 2010, INT IMMUNOL, V22, P421, DOI 10.1093/intimm/dxq021; Hahn I, 2011, INFECT IMMUN, V79, P4893, DOI 10.1128/IAI.05593-11; Hellman L, 2014, BIOL CHEM, V395, P15, DOI 10.1515/hsz-2013-0211; Itoh H, 1996, BIOCHEM J, V314, P923, DOI 10.1042/bj3140923; Karlson L, 2002, J BIOL CHEM, V277, P18579, DOI 10.1074/jbc.M110356200; Karlson U, 2003, J BIOL CHEM, V278, P39625, DOI 10.1074/jbc.M301512200; Kervinen J, 2008, J BIOL CHEM, V283, P427, DOI 10.1074/jbc.M707157200; KINOSHITA A, 1991, J BIOL CHEM, V266, P19192; Kobayashi SD, 2005, ARCH IMMUNOL THER EX, V53, P505; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Lopez-boado YS, 2004, J IMMUNOL, V172, P509, DOI 10.4049/jimmunol.172.1.509; Massberg S, 2010, NAT MED, V16, P887, DOI 10.1038/nm.2184; NEUHOFF V, 1988, ELECTROPHORESIS, V9, P255, DOI 10.1002/elps.1150090603; O'Donoghue AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075141; O'Donoghue AJ, 2012, NAT METHODS, V9, P1095, DOI [10.1038/NMETH.2182, 10.1038/nmeth.2182]; Ortega-Gomez A, 2016, CIRCULATION, V134, P1176, DOI 10.1161/CIRCULATIONAHA.116.024790; Owen CA, 1998, J IMMUNOL, V160, P1436; Papayannopoulos V, 2009, TRENDS IMMUNOL, V30, P513, DOI 10.1016/j.it.2009.07.011; PEREIRA HA, 1990, LIFE SCI, V46, P189, DOI 10.1016/0024-3205(90)90104-Y; Perera NC, 2012, EXPERT REV CLIN IMMU, V8, P501, DOI 10.1586/ECI.12.39; Perera NC, 2012, P NATL ACAD SCI USA, V109, P6229, DOI 10.1073/pnas.1200470109; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Polanowska J, 1998, BBA-PROTEIN STRUCT M, V1386, P189, DOI 10.1016/S0167-4838(98)00085-5; Raptis SZ, 2005, IMMUNITY, V22, P679, DOI 10.1016/j.immuni.2005.03.015; Raymond WW, 2010, J IMMUNOL, V185, P5360, DOI 10.4049/jimmunol.1002292; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; REILLY CF, 1982, J BIOL CHEM, V257, P8619; Reimer JM, 2008, MOL IMMUNOL, V45, P2116, DOI 10.1016/j.molimm.2007.10.015; Sanker S, 1997, J BIOL CHEM, V272, P2963, DOI 10.1074/jbc.272.5.2963; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Seignez C, 2017, CURR OPIN HEMATOL, V24, P3, DOI 10.1097/MOH.0000000000000300; Srivastava M, 2007, CELL MICROBIOL, V9, P738, DOI 10.1111/j.1462-5822.2006.00824.x; Standish AJ, 2009, J IMMUNOL, V183, P2602, DOI 10.4049/jimmunol.0900688; Steinwede K, 2012, J IMMUNOL, V188, P4476, DOI 10.4049/jimmunol.1103346; TANAKA T, 1985, BIOCHEMISTRY-US, V24, P2040, DOI 10.1021/bi00329a036; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Thorpe M, 2016, DEV COMP IMMUNOL, V63, P84, DOI 10.1016/j.dci.2016.05.013; Thorpe M, 2012, INT IMMUNOL, V24, P771, DOI 10.1093/intimm/dxs081; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9; Water K, 2015, J IMMUNOL, V195, P3325, DOI 10.4049/jimmunol.1501012; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yang H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00302	62	22	22	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195077	10.1371/journal.pone.0195077	http://dx.doi.org/10.1371/journal.pone.0195077			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652924	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900017
J	Bangley, CW; Paramore, L; Dedman, S; Rulifson, RA				Bangley, Charles W.; Paramore, Lee; Dedman, Simon; Rulifson, Roger A.			Delineation and mapping of coastal shark habitat within a shallow lagoonal estuary	PLOS ONE			English	Article							NORTHWEST ATLANTIC-OCEAN; JUVENILE SANDBAR SHARKS; LARGE MARINE ECOSYSTEM; MUSTELUS-CANIS; SMOOTH DOGFISH; NURSERY AREAS; SPINY DOGFISH; UNITED-STATES; BULL SHARKS; RHIZOPRIONODON-TERRAENOVAE	Estuaries function as important nursery and foraging habitats for many coastal species, including highly migratory sharks. Pamlico Sound, North Carolina, is one of the largest estuaries in the continental United States and provides a variety of potential habitats for sharks. In order to identify and spatially delineate shark habitats within Pamlico Sound, shark catch and environmental data were analyzed from the 2007-2014 North Carolina Division of Marine Fisheries (NCDMF) gillnet and longline surveys conducted within the estuary. Principal species were identified and environmental data recorded at survey sites (depth, temperature, salinity, dissolved oxygen, submerged aquatic vegetation (SAV) distance, and inlet distance) were interpolated across Pamlico Sound to create seasonal environmental grids with a 90-m(2) cell size. Boosted Regression Tree (BRT) analysis was used to identify the most important environmental factors and ranges associated with presence of each principal species, and the resulting models were used to predict shark capture probability based on the environmental values within the grid cells. The Atlantic Sharpnose Shark (Rhizoprionodon terraenovae), Blacktip Shark (Carcharhinus limbatus), Bull Shark (Carcharhinus leucas), Sandbar Shark (Carcharhinus plumbeus), Smooth Dogfish (Mustelus canis), and Spiny Dogfish (Squalus acanthias) were the principal species in Pamlico Sound. Most species were associated with proximity to the inlet and/or high salinity, and warm temperatures, but the Bull Shark preferred greater inlet distances and the Spiny Dogfish preferred lower temperatures than the other species. Extensive Smooth Dogfish habitat overlap with sea grass beds suggests that seagrass may be a critical part of nursery habitat for this species. Spatial delineation of shark habitat within the estuary will allow for better protection of essential habitat and assessment of potential interactions with other species.	[Bangley, Charles W.; Rulifson, Roger A.] East Carolina Univ, Inst Coastal Sci & Policy, Greenville, NC 27858 USA; [Bangley, Charles W.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA; [Paramore, Lee] Northern Dist Off, North Carolina Div Marine Fisheries, Elizabeth City, NC USA; [Dedman, Simon] Farallon Inst, Petaluma, CA USA; [Rulifson, Roger A.] East Carolina Univ, Dept Biol, Greenville, NC USA	University of North Carolina; East Carolina University; Smithsonian Institution; Smithsonian Environmental Research Center; University of North Carolina; East Carolina University	Bangley, CW (corresponding author), East Carolina Univ, Inst Coastal Sci & Policy, Greenville, NC 27858 USA.; Bangley, CW (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	bangleyc@si.edu	Dedman, Simon/E-9668-2017; Rulifson, Roger A./U-9659-2019	Dedman, Simon/0000-0002-9108-972X; Rulifson, Roger A./0000-0002-3591-9223; Bangley, Charles/0000-0002-6044-7694				[Anonymous], 2021, LANG ENV STAT COMP; Attrill MJ, 2002, ESTUAR COAST SHELF S, V55, P929, DOI 10.1006/ecss.2002.1036; Baillie CJ, 2015, ESTUAR COAST, V38, P1414, DOI 10.1007/s12237-014-9898-y; BEAMISH RJ, 1992, T AM FISH SOC, V121, P444, DOI 10.1577/1548-8659(1992)121<0444:SDPOCA>2.3.CO;2; Bethea DM, 2015, ENVIRON BIOL FISH, V98, P1233, DOI 10.1007/s10641-014-0355-3; Buchheister A, 2015, J FISH BIOL, V86, P967, DOI 10.1111/jfb.12621; Burkholder DA, 2013, J ANIM ECOL, V82, P1192, DOI 10.1111/1365-2656.12097; Bush A, 2002, J EXP MAR BIOL ECOL, V278, P157, DOI 10.1016/S0022-0981(02)00332-5; Carlson JK, 2008, ESTUAR COAST, V31, P931, DOI 10.1007/s12237-008-9075-2; Castro J. I, 2011, SHARKS N AM; Castro JI, 1996, B MAR SCI, V59, P508; CASTRO JI, 1993, ENVIRON BIOL FISH, V38, P37, DOI 10.1007/BF00842902; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Conrath CL, 2008, ENVIRON BIOL FISH, V82, P123, DOI 10.1007/s10641-007-9263-0; Conrath CL, 2002, FISH B-NOAA, V100, P674; Curtis TH, 2011, T AM FISH SOC, V140, P1213, DOI 10.1080/00028487.2011.618352; Dedman S, PLOS ONE IN PRESS; Dedman S, 2015, ECOL MODEL, V312, P77, DOI 10.1016/j.ecolmodel.2015.05.010; Dill LM, 2003, ECOLOGY, V84, P1151, DOI 10.1890/0012-9658(2003)084[1151:BMIIIM]2.0.CO;2; DUNSON WA, 1991, AM NAT, V138, P1067, DOI 10.1086/285270; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Fautin D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011914; FERGUSON RL, 1993, AQUAT BOT, V46, P91, DOI 10.1016/0304-3770(93)90066-6; Fodrie FJ, 2015, OECOLOGIA, V178, P75, DOI 10.1007/s00442-014-3212-3; Fonseca M. S., 2009, US NMFS MAR FISH REV, V71, P20; Froeschke J, 2010, MAR ECOL PROG SER, V407, P279, DOI 10.3354/meps08546; Gelsleichter J, 1999, ENVIRON BIOL FISH, V54, P205, DOI 10.1023/A:1007527111292; Grubbs R. Dean, 2007, V50, P63; Grubbs R. Dean, 2007, V50, P87; Guttridge TL, 2012, MAR ECOL PROG SER, V445, P279, DOI 10.3354/meps09423; Hare JA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146756; HAYDEN BP, 1984, ENVIRON CONSERV, V11, P199, DOI 10.1017/S0376892900014211; HAYDEN BP, 1979, J SEDIMENT PETROL, V49, P1061; Heihaus Michael R., 2007, V50, P3; Heithaus MR, 2012, MAR FRESHWATER RES, V63, P1039, DOI 10.1071/MF12024; Heithaus MR, 2001, OIKOS, V92, P542, DOI 10.1034/j.1600-0706.2001.920315.x; Heupel MR, 2006, ENVIRON BIOL FISH, V76, P47, DOI 10.1007/s10641-006-9007-6; Heupel MR, 2008, AQUAT BIOL, V1, P277, DOI 10.3354/ab00030; Heupel MR, 2014, MAR ECOL PROG SER, V495, P291, DOI 10.3354/meps10597; Heupel MR, 2011, MAR ECOL PROG SER, V433, P237, DOI 10.3354/meps09191; Heupel MR, 2002, MAR FRESHWATER RES, V53, P543, DOI 10.1071/MF01132; Hovgard H, 2000, FAO FISH TECH PAP; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Jensen C. F., 2002, SHARK NURSERY GROUND, P61; Jensen CF, 2001, EVALUATION BYCATCH N; Kajiura SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150911; Kenworthy W. J., 2012, DEV AQUATIC VEGETATI; Knip DM, 2010, MAR ECOL PROG SER, V402, P1, DOI 10.3354/meps08498; Lacroix GL, 2014, CAN J FISH AQUAT SCI, V71, P343, DOI 10.1139/cjfas-2013-0458; LIPCIUS RN, 1986, ECOLOGY, V67, P1361, DOI 10.2307/1938692; MAIN KL, 1987, ECOLOGY, V68, P170, DOI 10.2307/1938817; Matich P, 2014, J ANIM ECOL, V83, P199, DOI 10.1111/1365-2656.12106; McCandless C, 2007, AM FISHERIES SOC S; MCCANDLESS CT, 2002, SHARK NURSERY GROUND; Merson RR, 2001, ENVIRON BIOL FISH, V61, P13, DOI 10.1023/A:1011017109776; Paterson AW, 2000, ESTUAR COAST SHELF S, V51, P359, DOI 10.1006/ecss.2000.0640; Peterson CD, 2017, MAR ECOL PROG SER, V579, P81, DOI 10.3354/meps12288; ROELOFS E. W., 1953, BULL MARINE SCI GULF AND CARIBBEAN, V3, P181; ROSS ST, 1986, COPEIA, P352, DOI 10.2307/1444996; Ross SW, 2003, FISH B-NOAA, V101, P384; Rountree RA, 1996, FISH B-NOAA, V94, P522; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P847, DOI 10.1139/cjfas-2013-0342; Sagarese SR, 2014, CAN J FISH AQUAT SCI, V71, P567, DOI 10.1139/cjfas-2013-0259; Schlaff AM, 2014, REV FISH BIOL FISHER, V24, P1089, DOI 10.1007/s11160-014-9364-8; Schwartz Frank J., 2012, Journal of the North Carolina Academy of Science, V128, P88; Shaw AL, 2016, MAR COAST FISH, V8, P46, DOI 10.1080/19425120.2015.1121940; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Stehlik L.L., 2007, NOAA TECHNICAL MEMOR; Ulrich Glenn F., 2007, V50, P125; Vaudo JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061907; Ward-Paige CA, 2015, MAR ECOL-EVOL PERSP, V36, P419, DOI 10.1111/maec.12151; Wiley TR, 2007, B MAR SCI, V80, P189	72	8	8	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195221	10.1371/journal.pone.0195221	http://dx.doi.org/10.1371/journal.pone.0195221			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649261	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900034
J	Esposito, S; Loppi, S; Monaci, F; Paoli, L; Vannini, A; Sorbo, S; Maresca, V; Fusaro, L; Karam, EA; Lentini, M; De Lillo, A; Conte, B; Cianciullo, P; Basile, A				Esposito, Sergio; Loppi, Stefano; Monaci, Fabrizio; Paoli, Luca; Vannini, Andrea; Sorbo, Sergio; Maresca, Viviana; Fusaro, Lina; Karam, Elham Asadi; Lentini, Marco; De Lillo, Alessia; Conte, Barbara; Cianciullo, Piergiorgio; Basile, Adriana			In-field and in-vitro study of the moss Leptodictyum riparium as bioindicator of toxic metal pollution in the aquatic environment: Ultrastructural damage, oxidative stress and HSP70 induction	PLOS ONE			English	Article							GLUTATHIONE S-TRANSFERASES; SARNO RIVER-BASIN; HEAVY-METALS; ITALIAN TRIANGLE; BRYOPHYTA; LEAVES; DEATH; ACCUMULATION; RESPONSES; PLANTS	This study evaluates the effects of toxic metal pollution in the highly contaminated Sarno River (South Italy), by using the aquatic moss Leptodictyum riparium in bags at 3 representative sites of the river. Biological effects were assessed by metal bioaccumulation, ultra structural changes, oxidative stress, as Reactive Oxygen Species (ROS) production and Glutathione S-transferase (GST) activity, as well as Heat Shock Proteins 70 (HSP70s) induction. The results showed that L. riparium is a valuable bioindicator for toxic metal pollution of water ecosystem, accumulating different amounts of toxic metals from the aquatic environment. Toxic metal pollution caused severe ultrastructural damage, as well as increased ROS production and induction of GST and HSP70s, in the samples exposed at the polluted sites. To assess the role and the effect of toxic metals on L. riparium, were also cultured in vitro with Cd, Cr, Cu, Fe, Ni, Pb, Zn at the same concentrations as measured at the 3 sites. Ultrastructure, ROS, GST, and HSP70s resulted severely affected by toxic metals. Based on our findings, we confirm L. riparium as a model organism in freshwater biomonitoring surveys, and GST and HSP70s as promising biomarkers of metal toxicity.	[Esposito, Sergio; Maresca, Viviana; Lentini, Marco; De Lillo, Alessia; Conte, Barbara; Basile, Adriana] Univ Naples Federico II, Dipartimento Biol, Complesso Univ Monte St Angelo, Naples, Italy; [Loppi, Stefano; Monaci, Fabrizio; Paoli, Luca; Vannini, Andrea; Cianciullo, Piergiorgio] Univ Siena, Dipartimento Sci Vita, Siena, Italy; [Sorbo, Sergio] Univ Naples Federico II, CeSMA, Sect Microscopy, Complesso Univ Monte St Angelo, Naples, Italy; [Fusaro, Lina] Univ Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Karam, Elham Asadi] Shahid Bahonar Univ Kerman, Dept Biol, Kerman, Iran	University of Naples Federico II; University of Siena; University of Naples Federico II; Sapienza University Rome; Shahid Bahonar University of Kerman (SBUK)	Basile, A (corresponding author), Univ Naples Federico II, Dipartimento Biol, Complesso Univ Monte St Angelo, Naples, Italy.; Sorbo, S (corresponding author), Univ Naples Federico II, CeSMA, Sect Microscopy, Complesso Univ Monte St Angelo, Naples, Italy.	sersorbo@unina.it; adbasile@unina.it	BASILE, Adriana/ABC-8500-2021; Vannini, Andrea/AAE-1916-2021; Maresca, Viviana/AEP-6443-2022; Esposito, Sergio/I-4862-2014; Maresca, Viviana/AAW-9990-2021; Cianciullo, Piergiorgio/AAY-8040-2021; Monaci, Fabrizio/B-6611-2012; Conte, Barbara/H-8456-2019; FUSARO, LINA/Q-4369-2017	BASILE, Adriana/0000-0002-2001-8959; Vannini, Andrea/0000-0003-3789-6691; Maresca, Viviana/0000-0002-4656-320X; Esposito, Sergio/0000-0002-0899-1967; Monaci, Fabrizio/0000-0001-5489-1310; Conte, Barbara/0000-0003-0851-9985; Cianciullo, Piergiorgio/0000-0003-0292-8892; FUSARO, LINA/0000-0003-3316-707X				Albanese S, 2013, ENVIRON GEOCHEM HLTH, V35, P283, DOI 10.1007/s10653-012-9483-x; Arienzo M, 2001, WATER AIR SOIL POLL, V131, P349, DOI 10.1023/A:1011908019933; Basile A, 2015, ECOTOX ENVIRON SAFE, V114, P93, DOI 10.1016/j.ecoenv.2015.01.009; Basile A, 2012, ENVIRON POLLUT, V166, P208, DOI 10.1016/j.envpol.2012.03.018; Basile A, 2011, PLANT BIOSYST, V145, P77, DOI 10.1080/11263504.2010.509935; Basile A, 2001, ANN BOT-LONDON, V87, P537, DOI 10.1006/anbo.2001.1368; Basile A, 2008, FRESEN ENVIRON BULL, V17, P1956; Basile A, 2017, ENVIRON SCI POLLUT R, V24, P26185, DOI 10.1007/s11356-017-9304-y; Basile A, 2017, J TRACE ELEM MED BIO, V43, P80, DOI 10.1016/j.jtemb.2016.11.014; Basile A, 2013, ENVIRON POLLUT, V182, P209, DOI 10.1016/j.envpol.2013.07.014; Bassham DC, 2009, BBA-MOL CELL RES, V1793, P1397, DOI 10.1016/j.bbamcr.2009.01.001; Brehelin C, 2007, TRENDS PLANT SCI, V12, P260, DOI 10.1016/j.tplants.2007.04.003; Cardi M, 2013, PLANT PHYSIOL BIOCH, V73, P266, DOI 10.1016/j.plaphy.2013.10.008; Carginale V, 2004, PROTOPLASMA, V223, P53, DOI 10.1007/s00709-003-0028-0; Cesa M, 2015, ENVIRON SCI POLLUT R, V22, P5030, DOI 10.1007/s11356-015-4129-z; Ceschin S, 2012, ECOL INDIC, V14, P74, DOI 10.1016/j.ecolind.2011.08.020; Dalla Vecchia F, 2005, PLANT SCI, V168, P329, DOI 10.1016/j.plantsci.2004.07.025; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; Dazy M, 2009, CHEMOSPHERE, V75, P297, DOI 10.1016/j.chemosphere.2008.12.045; Esposit S, 2007, CARYOLOGIA, V60, P115, DOI 10.1080/00087114.2007.10589557; Esposito S, 2012, INT J PHYTOREMEDIAT, V14, P443, DOI 10.1080/15226514.2011.620904; Fujita M, 2003, PHYSIOL PLANTARUM, V117, P85, DOI 10.1034/j.1399-3054.2003.1170111.x; Gecheva G, 2011, B ENVIRON CONTAM TOX, V87, P480, DOI 10.1007/s00128-011-0377-x; Ghosh S, 2001, PLANT PHYSIOL BIOCH, V39, P777, DOI 10.1016/S0981-9428(01)01296-7; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Goletta del fiume Sarno, 2014, AN NUM RIFL SULL BAC; Gupta SC, 2010, LIFE SCI, V86, P377, DOI 10.1016/j.lfs.2009.12.015; Habig W H, 1981, Methods Enzymol, V77, P398; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Hossain MZ, 2006, BIOL PLANTARUM, V50, P210, DOI 10.1007/s10535-006-0009-1; Hu YL, 2009, PLANT GROWTH REGUL, V59, P51, DOI 10.1007/s10725-009-9387-7; Inupakutika MA, 2016, J EXP BOT, V67, P5933, DOI 10.1093/jxb/erw382; KELLY MG, 1987, WATER RES, V21, P1429, DOI 10.1016/0043-1354(87)90019-4; LEBEL CP, 1990, TOXICOL APPL PHARM, V104, P17, DOI 10.1016/0041-008X(90)90278-3; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Mullineaux PM, 2010, PLANT PHYSIOL, V154, P521, DOI 10.1104/pp.110.161406; Nath M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01574; Pinto E, 2003, J PHYCOL, V39, P1008, DOI 10.1111/j.0022-3646.2003.02-193.x; Sassmann S, 2015, ENVIRON EXP BOT, V110, P1, DOI 10.1016/j.envexpbot.2014.08.010; Schutzendubel A, 2002, J EXP BOT, V53, P1351, DOI 10.1093/jexbot/53.372.1351; Senior K, 2004, LANCET ONCOL, V5, P525, DOI 10.1016/S1470-2045(04)01561-X; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; Todeschini V, 2011, ENVIRON EXP BOT, V71, P50, DOI 10.1016/j.envexpbot.2010.10.018; Trocchia S., 2015, INT J SCI ENG RES, V6, P449; Uchimiya M, 2010, CHEMOSPHERE, V80, P935, DOI 10.1016/j.chemosphere.2010.05.020; Vidi PA, 2006, J BIOL CHEM, V281, P11225, DOI 10.1074/jbc.M511939200; Whitton B., 1981, HEAVY METALS NO ENGL; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhou QF, 2008, ANAL CHIM ACTA, V606, P135, DOI 10.1016/j.aca.2007.11.018	49	19	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195717	10.1371/journal.pone.0195717	http://dx.doi.org/10.1371/journal.pone.0195717			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649272	gold, Green Published			2022-12-26	WOS:000429791900074
J	Slingerland, BCGC; Keehnen, M; Ouwerling, B; Tavakol, M; Snijders, SV; Verbrugh, HA; Vos, MC; Remarque, EJ; Langermans, JAM; van Wamel, WJB				Slingerland, Bibi C. G. C.; Keehnen, Merei; Ouwerling, Boudewijn; Tavakol, Mehri; Snijders, Susan V.; Verbrugh, Henri A.; Vos, Margreet C.; Remarque, Edmond J.; Langermans, Jan A. M.; van Wamel, Willem J. B.			An experimental Staphylococcus aureus carriage and decolonization model in rhesus macaques (Macaca mulatto)	PLOS ONE			English	Article							PERSISTENT NASAL CARRIERS; COLONIZATION; LYSOSTAPHIN; INFECTIONS; STRAINS; RISK	Our human model of nasal colonization and eradication of S. aureus is limited by safety issues. As rhesus macaques are closely related to humans and natural hosts for S. aureus, we developed an experimental decolonization and inoculation protocol in these animals. Animals were screened for nasal carriage of S. aureus and 20 carriers were selected. Decolonization was attempted using nasal mupirocin (10 animals) or mupirocin plus trimethoprim/sulfadiazine intramuscularly (10 animals) both once daily for 5 days, and checked by followup cultures for 10 weeks. Intranasal inoculation was performed with S. aureus strain 8325-4 in culture-negative animals. 11/20 animals, of which 5 received mupirocin and 6 the combination treatment, became culture-negative for S. aureus for 10 weeks and these 11 animals were subsequently inoculated. Swabs were taken once a week for 5 weeks to test for the presence of the inoculated strain. In 3 animals, strain 8325-4 was cultured from the nose 1 week after inoculation, indicating short-term survival of this strain only, a finding similar to that previously found in our human model. These data demonstrate that rhesus macaques may constitute a relevant animal model to perform S. aureus eradication and inoculation studies with relatively limited invasive handling of the animals.	[Slingerland, Bibi C. G. C.; Tavakol, Mehri; Snijders, Susan V.; Verbrugh, Henri A.; Vos, Margreet C.; van Wamel, Willem J. B.] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Keehnen, Merei; Ouwerling, Boudewijn; Langermans, Jan A. M.] Biomed Primate Res Ctr, Dept Anim Sci, Rijswijk, Netherlands; [Remarque, Edmond J.] Biomed Primate Res Ctr, Dept Virol, Rijswijk, Netherlands	Erasmus University Rotterdam; Erasmus MC	Slingerland, BCGC (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	b.slingerland@erasmusmc.nl	Remarque, Ed/AAE-8643-2020	van Wamel, Willem/0000-0001-9145-9121; Langermans, Jan/0000-0002-4806-4412				Ammerlaan HSM, 2011, J ANTIMICROB CHEMOTH, V66, P2418, DOI 10.1093/jac/dkr250; Baur S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004089; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Burian M, 2010, J INFECT DIS, V201, P1414, DOI 10.1086/651619; Daniel A, 2010, ANTIMICROB AGENTS CH, V54, P1603, DOI 10.1128/AAC.01625-09; Desbois AP, 2013, J ANTIMICROB CHEMOTH, V68, P2569, DOI 10.1093/jac/dkt243; FERNANDEZ C, 1995, J ANTIMICROB CHEMOTH, V35, P399, DOI 10.1093/jac/35.3.399; Giachino P, 2001, J BACTERIOL, V183, P1843, DOI 10.1128/JB.183.6.1843-1852.2001; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kokai-Kun JF, 2003, ANTIMICROB AGENTS CH, V47, P1589, DOI 10.1128/AAC.47.5.1589-1597.2003; Mollema FPN, 2010, J CLIN MICROBIOL, V48, P202, DOI 10.1128/JCM.01499-09; Moodley A, 2011, EPIDEMIOL INFECT, V139, P1594, DOI 10.1017/S0950268810002888; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; Nouwen J, 2006, J CLIN MICROBIOL, V44, P2233, DOI 10.1128/JCM.02083-05; Nouwen JL, 2004, CLIN INFECT DIS, V39, P806, DOI 10.1086/423376; NOVICK RP, 1965, J BACTERIOL, V90, P467, DOI 10.1128/JB.90.2.467-480.1965; Park B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025880; Ritchie SR, 2016, J INFECTION, V72, P295, DOI 10.1016/j.jinf.2015.12.010; Slingerland BCGC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048896; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; van den Berg S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026170; Verhoeven PO, 2012, CLIN MICROBIOL INFEC, V18, P551, DOI 10.1111/j.1469-0691.2011.03611.x; Verkaik NJ, 2011, CLIN MICROBIOL INFEC, V17, P343, DOI 10.1111/j.1469-0691.2010.03227.x; Verstappen KM, 2014, VET MICROBIOL, V174, P483, DOI 10.1016/j.vetmic.2014.09.019; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Winstel V, 2015, MBIO, V6, DOI 10.1128/mBio.00632-15; Xu SX, 2015, TOXINS, V7, P1821, DOI 10.3390/toxins7051821	29	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194718	10.1371/journal.pone.0194718	http://dx.doi.org/10.1371/journal.pone.0194718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649257	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900013
J	Wang, ZY; Wu, YX; Bu, SH; Hang, PC; Zhang, GY				Wang, ZeYu; Wu, YanXia; Bu, ShuHui; Hang, PengCheng; Zhang, GuoYin			Structural inference embedded adversarial networks for scene parsing	PLOS ONE			English	Article							FEATURES	Explicit structural inference is one key point to improve the accuracy of scene parsing. Meanwhile, adversarial training method is able to reinforce spatial contiguity in output segmentations. To take both advantages of the structural learning and adversarial training simultaneously, we propose a novel deep learning network architecture called Structural Inference Embedded Adversarial Networks (SIEANs) for pixel-wise scene labeling. The generator of our SIEANs, a novel designed scene parsing network, makes full use of convolutional neural networks and long short-term memory networks to learn the global contextual information of objects in four different directions from RGB-(D) images, which is able to describe the (three-dimensional) spatial distributions of objects in a more comprehensive and accurate way. To further improve the performance, we explore the adversarial training method to optimize the generator along with a discriminator, which can not only detect and correct higher-order inconsistencies between the predicted segmentations and corresponding ground truths, but also exploit full advantages of the generator by fine-tuning its parameters so as to obtain higher consistencies. The experimental results demonstrate that our proposed SIEANs is able to achieve a better performance on PASCAL VOC 2012, SIFT FLOW, PASCAL Person-Part, Cityscapes, Stanford Background, NYUDv2, and SUNRGBD datasets compared to the most of state-of-the-art methods.	[Wang, ZeYu; Wu, YanXia; Zhang, GuoYin] Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Bu, ShuHui; Hang, PengCheng] Northwestern Polytech Univ, Sch Aeronaut, Xian, Shaanxi, Peoples R China; [Bu, ShuHui] Shaanxi Key Lab Integrated & Intelligent Nav, Xian, Shaanxi, Peoples R China	Harbin Engineering University; Northwestern Polytechnical University	Wu, YX (corresponding author), Harbin Engn Univ, Coll Comp Sci & Technol, Harbin, Heilongjiang, Peoples R China.	wuyanxia@hrbeu.edu.cn	Wu, yanxia/HGA-0318-2022		National Key Research and Development Program [2016YFB1000400]; Central University Free Exploration Fund [HEUCF170605]; Harbin Outstanding Young Talents Fund [2017RAYXJ016]; National Natural Science Foundation of China [60903098, 61573284]	National Key Research and Development Program; Central University Free Exploration Fund; Harbin Outstanding Young Talents Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program, http://program.most.gov.cn/, Award Number: 2016YFB1000400, Recipient: YanXia Wu; the Central University Free Exploration Fund, http://www.hrbeu.edu.cn/, Award Number: HEUCF170605, Recipient: YanXia Wu; the Harbin Outstanding Young Talents Fund, http://www.hljkjt.gov.cn/, Award Number: 2017RAYXJ016, Recipient: YanXia Wu; the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, Award Number: 60903098, Recipient: ShuHui Bu; and the National Natural Science Foundation of China, http://www.nsfc.gov.cn/, Award Number: 61573284, Recipient: ShuHui Bu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bojarski Mariusz, 2016, arXiv; Bu SH, 2016, PATTERN RECOGN, V59, P188, DOI 10.1016/j.patcog.2016.01.027; Chen L.C., 2014, ARXIV; Chen LC, 2018, IEEE T PATTERN ANAL, V40, P834, DOI 10.1109/TPAMI.2017.2699184; Chen LC, 2016, PROC CVPR IEEE, P3640, DOI 10.1109/CVPR.2016.396; Chen XJ, 2014, PROC CVPR IEEE, P1979, DOI 10.1109/CVPR.2014.254; Chen X, 2015, PROC CVPR IEEE, P2422, DOI 10.1109/CVPR.2015.7298856; Cordts M, 2016, PROC CVPR IEEE, P3213, DOI 10.1109/CVPR.2016.350; Dai JF, 2015, IEEE I CONF COMP VIS, P1635, DOI 10.1109/ICCV.2015.191; Everingham M, 2015, INT J COMPUT VISION, V111, P98, DOI 10.1007/s11263-014-0733-5; Fan H, 2016, ARXIV160702537; Farabet C, 2013, IEEE T PATTERN ANAL, V35, P1915, DOI 10.1109/TPAMI.2012.231; Ghiasi G, 2016, LECT NOTES COMPUT SC, V9907, P519, DOI 10.1007/978-3-319-46487-9_32; Goodfellow IJ, 2014, ADV NEUR IN, V27, P2672, DOI 10.1145/3422622; Gould S, 2009, IEEE I CONF COMP VIS, P1, DOI 10.1109/ICCV.2009.5459211; Graves A, 2012, STUD COMPUT INTELL, V385, P1, DOI [10.1007/978-3-642-24797-2, 10.1162/neco.1997.9.1.1]; Guclu U, 2017, ARXIV170303305; Gupta S, 2015, INT J COMPUT VISION, V112, P133, DOI 10.1007/s11263-014-0777-6; Hariharan B, 2011, IEEE I CONF COMP VIS, P991, DOI 10.1109/ICCV.2011.6126343; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Huang Q, 2016, ARXIV161107485; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Jin X, 2016, ARXIV160807706; Kendall A., 2015, ARXIV151102680; Khan SH, 2016, INT J COMPUT VISION, V117, P1, DOI 10.1007/s11263-015-0843-8; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Ledig C, 2017, PROC CVPR IEEE, P105, DOI 10.1109/CVPR.2017.19; Li C, 2016, LECT NOTES COMPUT SC, V9907, P702, DOI 10.1007/978-3-319-46487-9_43; Li Z, 2016, LECT NOTES COMPUT SC, V9906, P541, DOI 10.1007/978-3-319-46475-6_34; Liang M, 2015, ADV NEURAL INFORM PR, P937; Liang XD, 2016, PROC CVPR IEEE, P3185, DOI 10.1109/CVPR.2016.347; Liang XD, 2016, LECT NOTES COMPUT SC, V9905, P125, DOI 10.1007/978-3-319-46448-0_8; LIN GS, 2016, PROC CVPR IEEE, P3194, DOI DOI 10.1109/CVPR.2016.348; Lin GS, 2017, PROC CVPR IEEE, P5168, DOI 10.1109/CVPR.2017.549; Lin TY, 2014, LECT NOTES COMPUT SC, V8693, P740, DOI 10.1007/978-3-319-10602-1_48; Liu C, 2011, IEEE T PATTERN ANAL, V33, P978, DOI 10.1109/TPAMI.2010.147; Liu ZW, 2015, IEEE I CONF COMP VIS, P1377, DOI 10.1109/ICCV.2015.162; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Luc P., 2016, NIPS WORKSHOP ADVERS; Mostajahi M, 2015, PROC CVPR IEEE, P3376, DOI 10.1109/CVPR.2015.7298959; Pan J., 2017, ARXIV170101081; Pathak D, 2016, PROC CVPR IEEE, P2536, DOI 10.1109/CVPR.2016.278; Peng Z, 2016, ARXIV160401931; Pinheiro P H, 2013, ARXIV13062795, P2; Qin XL, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON PROGNOSTICS AND HEALTH MANAGEMENT (ICPHM), P1, DOI 10.1109/ICPHM.2017.7998297; Radford A., 2015, ARXIV151106434, DOI DOI 10.1051/0004-6361/201527329; Ren XF, 2012, PROC CVPR IEEE, P2759, DOI 10.1109/CVPR.2012.6247999; Schwing A. G., 2015, ARXIV PREPRINT ARXIV; Sharma S., 2015, ARXIV151104119; Shuai B, 2016, PROC CVPR IEEE, P3620, DOI 10.1109/CVPR.2016.394; Silberman N, 2012, LECT NOTES COMPUT SC, V7576, P746, DOI 10.1007/978-3-642-33715-4_54; Song SR, 2015, PROC CVPR IEEE, P567, DOI 10.1109/CVPR.2015.7298655; Szegedy C, 2015, IEEE C COMPUTER VISI, DOI 10.1109/CVPR.2015.7298594; Visin F., 2015, ARXIV150500393; Wang AR, 2015, IEEE T IMAGE PROCESS, V24, P4459, DOI 10.1109/TIP.2015.2465133; Wu C, 2014, ROBOTICS SCI SYSTEMS; Xia F., 2016, ECCV, P648; Yan ZC, 2016, ACM T GRAPHIC, V35, DOI 10.1145/2790296; Yu F., 2015, ARXIV, DOI DOI 10.16373/J.CNKI.AHR.150049.1511.07122; Zhang R, 2017, ARXIV170205839; Zheng S, 2015, IEEE I CONF COMP VIS, P1529, DOI 10.1109/ICCV.2015.179	62	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195114	10.1371/journal.pone.0195114	http://dx.doi.org/10.1371/journal.pone.0195114			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649294	gold, Green Submitted, Green Published			2022-12-26	WOS:000429791900025
J	Liefer, JD; Garg, A; Campbell, DA; Irwin, AJ; Finkel, ZV				Liefer, Justin D.; Garg, Aneri; Campbell, Douglas A.; Irwin, Andrew J.; Finkel, Zoe V.			Nitrogen starvation induces distinct photosynthetic responses and recovery dynamics in diatoms and prasinophytes	PLOS ONE			English	Article							PHOTOSYSTEM-II; CHLOROPHYLL-A; CELL-SIZE; CARBON ASSIMILATION; ENERGY-DISSIPATION; LUTEIN-EPOXIDE; SHADE LEAVES; PHYTOPLANKTON; GROWTH; PHOTOPROTECTION	Nitrogen stress is an important control on the growth of phytoplankton and varying responses to this common condition among taxa may affect their relative success within phytoplankton communities. We analyzed photosynthetic responses to nitrogen (N) stress in two classes of phytoplankton that often dominate their respective size ranges, diatoms and prasinophytes, selecting species of distinct niches within each class. Changes in photosynthetic structures appeared similar within each class during N stress, but photophysiological and growth responses were more species-or niche-specific. In the coastal diatom Thalassiosira pseudonana and the oceanic diatom T. weissflogii, N starvation induced large declines in photosynthetic pigments and Photosystem II (PSII) quantity and activity as well as increases in the effective absorption cross-section of PSII photochemistry (sigma'(PSII)). These diatoms also increased photoprotection through energy-dependent non-photochemical quenching (NPQ) during N starvation. Resupply of N in diatoms caused rapid recovery of growth and relaxation of NPQ, while recovery of PSII photochemistry was slower. In contrast, the prasinophytes Micromonas sp., an Arctic Ocean species, and Ostreococcus tauri, a temperate coastal eutrophile, showed little change in photosynthetic pigments and structures and a decline or no change, respectively, in sigma'(PSII) with N starvation. Growth and PSII function recovered quickly in Micromonas sp. after resupply of N while O. tauri failed to recover N-replete levels of electron transfer from PSII and growth, possibly due to their distinct photoprotective strategies. O. tauri induced energy-dependent NPQ for photoprotection that may suit its variable and nutrient-rich habitat. Micromonas sp. relies upon both energy-dependent NPQ and a sustained, energy-independent NPQ mechanism. A strategy in Micromonas sp. that permits photoprotection with little change in photosynthetic structures is consistent with its Arctic niche, where low temperatures and thus low biosynthetic rates create higher opportunity costs to rebuild photosynthetic structures.	[Liefer, Justin D.; Garg, Aneri; Finkel, Zoe V.] Mt Allison Univ, Dept Geog & Environm, Sackville, NB, Canada; [Campbell, Douglas A.] Mt Allison Univ, Dept Biol, Sackville, NB, Canada; [Irwin, Andrew J.] Mt Allison Univ, Dept Math & Comp Sci, Sackville, NB, Canada	Mount Allison University; Mount Allison University; Mount Allison University	Liefer, JD (corresponding author), Mt Allison Univ, Dept Geog & Environm, Sackville, NB, Canada.	jliefer@mta.ca	Campbell, Douglas A./B-3768-2010; Finkel, Zoe/B-9626-2008	Campbell, Douglas A./0000-0001-8996-5463; Irwin, Andrew/0000-0001-7784-2319; Finkel, Zoe/0000-0003-4212-3917; Liefer, Justin/0000-0001-5161-940X	Macromolecular Models of Marine Microbes grant from the Gordon and Betty Moore Foundation [3378]; Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs program	Macromolecular Models of Marine Microbes grant from the Gordon and Betty Moore Foundation; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs program(Canada Research Chairs)	This work was supported by the Macromolecular Models of Marine Microbes grant from the Gordon and Betty Moore Foundation, ID#3378, as well as Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chairs program (D.A.C and Z.V.F).	ADAMS WW, 1995, PLANT CELL ENVIRON, V18, P117, DOI 10.1111/j.1365-3040.1995.tb00345.x; Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; BANSE K, 1976, J PHYCOL, V12, P135; Berges JA, 1996, PLANT PHYSIOL, V110, P689, DOI 10.1104/pp.110.2.689; Berman-Frank I, 1999, BIOSCIENCE, V49, P29, DOI 10.2307/1313491; Breuer G, 2012, BIORESOURCE TECHNOL, V124, P217, DOI 10.1016/j.biortech.2012.08.003; BUMA AGJ, 1993, J PHYCOL, V29, P407, DOI 10.1111/j.1529-8817.1993.tb00141.x; Cardol P, 2008, P NATL ACAD SCI USA, V105, P7881, DOI 10.1073/pnas.0802762105; Cullen JJ, PRIMARY PRODUCTIVITY; Demmig-Adams B, 2012, PHOTOSYNTH RES, V113, P75, DOI 10.1007/s11120-012-9761-6; Dolhi JM, 2013, EXTREMOPHILES, V17, P711, DOI 10.1007/s00792-013-0571-3; EPPLEY RW, 1969, J PHYCOL, V5, P375, DOI 10.1111/j.1529-8817.1969.tb02628.x; Finkel ZV, 2010, J PLANKTON RES, V32, P119, DOI 10.1093/plankt/fbp098; Finkel ZV, 2001, LIMNOL OCEANOGR, V46, P86, DOI 10.4319/lo.2001.46.1.0086; Forster B, 2011, PLANT PHYSIOL, V156, P393, DOI 10.1104/pp.111.173369; FOYER CH, 1994, PLANT PHYSIOL, V104, P171, DOI 10.1104/pp.104.1.171; Geider RJ, 1998, EUR J PHYCOL, V33, P315, DOI 10.1080/09670269810001736813; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; Goldman J. C, 1988, THEORY BIOL PHYSICAL, P273, DOI [10.1007/978-94-009-3023-0_15, DOI 10.1007/978-94-009-3023-0_15]; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; GROVER JP, 1989, J PHYCOL, V25, P402, DOI 10.1111/j.1529-8817.1989.tb00138.x; Guillou L, 2004, PROTIST, V155, P193, DOI 10.1078/143446104774199592; Halsey KH, 2014, METABOLITES, V4, P260, DOI 10.3390/metabo4020260; Halsey KH, 2013, NEW PHYTOL, V198, P1030, DOI 10.1111/nph.12209; HEIN M, 1995, MAR ECOL PROG SER, V118, P247, DOI 10.3354/meps118247; Hockin NL, 2012, PLANT PHYSIOL, V158, P299, DOI 10.1104/pp.111.184333; Horton P, 2012, PHILOS T R SOC B, V367, P3455, DOI 10.1098/rstb.2012.0069; Huot Y, 2010, DEVEL APPL PHYCOL, V4, P31, DOI 10.1007/978-90-481-9268-7_3; Jahns P, 2012, BBA-BIOENERGETICS, V1817, P182, DOI 10.1016/j.bbabio.2011.04.012; Kamalanathan M, 2016, J APPL PHYCOL, V28, P1509, DOI 10.1007/s10811-015-0726-y; Key T, 2010, ENVIRON MICROBIOL, V12, P95, DOI 10.1111/j.1462-2920.2009.02046.x; Klughammer C, 2008, PAM APPL NOTES, V1, P27; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Kramer DM, 2004, PHOTOSYNTH RES, V79, P209, DOI 10.1023/B:PRES.0000015391.99477.0d; Latasa M, 2004, J PHYCOL, V40, P1149, DOI 10.1111/j.1529-8817.2004.03136.x; Lauritano C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12092-1; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Lavaud J, 2007, LIMNOL OCEANOGR, V52, P1188, DOI 10.4319/lo.2007.52.3.1188; LEGENDRE L, 1995, OPHELIA, V41, P153, DOI 10.1080/00785236.1995.10422042; Litchman E, 2008, ANNU REV ECOL EVOL S, V39, P615, DOI 10.1146/annurev.ecolsys.39.110707.173549; Loebl M, 2010, LIMNOL OCEANOGR, V55, P2150, DOI 10.4319/lo.2010.55.5.2150; Lovejoy C, 2007, J PHYCOL, V43, P78, DOI 10.1111/j.1529-8817.2006.00310.x; MacIntyre HL, 2002, J PHYCOL, V38, P17, DOI 10.1046/j.1529-8817.2002.00094.x; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; Matsubara S, 2005, J EXP BOT, V56, P461, DOI 10.1093/jxb/eri012; Miller R, 2010, PLANT PHYSIOL, V154, P1737, DOI 10.1104/pp.110.165159; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; Murphy CD, 2017, LIMNOL OCEANOGR-METH, V15, P54, DOI 10.1002/lom3.10142; Ni G, 2017, PHOTOSYNTH RES, V131, P203, DOI 10.1007/s11120-016-0310-6; Nilkens M, 2010, BBA-BIOENERGETICS, V1797, P466, DOI 10.1016/j.bbabio.2010.01.001; OTTANDER C, 1995, PLANTA, V197, P176, DOI 10.1007/BF00239954; Oxborough K, 1997, PHOTOSYNTH RES, V54, P135, DOI 10.1023/A:1005936823310; Parkhill JP, 2001, J PHYCOL, V37, P517, DOI 10.1046/j.1529-8817.2001.037004517.x; Pedersen MF, 1997, MAR ECOL PROG SER, V161, P155, DOI 10.3354/meps161155; Premvardhan L, 2010, BBA-BIOENERGETICS, V1797, P1647, DOI 10.1016/j.bbabio.2010.05.002; Richter M, 1999, BIOCHEMISTRY-US, V38, P12718, DOI 10.1021/bi983009a; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; SHOAF WT, 1976, LIMNOL OCEANOGR, V21, P926, DOI 10.4319/lo.1976.21.6.0926; Simionato D, 2013, EUKARYOT CELL, V12, P665, DOI 10.1128/EC.00363-12; Six C, 2008, LIMNOL OCEANOGR, V53, P255, DOI 10.4319/lo.2008.53.1.0255; Six C, 2009, PLANT PHYSIOL, V151, P379, DOI 10.1104/pp.109.140566; Strzepek RF, 2000, MAR ECOL PROG SER, V206, P107, DOI 10.3354/meps206107; Suggett DJ, 2009, MAR ECOL PROG SER, V376, P1, DOI 10.3354/meps07830; Swingley WD, 2010, BBA-BIOENERGETICS, V1797, P1458, DOI 10.1016/j.bbabio.2010.04.017; Szyszka B, 2007, BBA-BIOENERGETICS, V1767, P789, DOI 10.1016/j.bbabio.2006.12.001; Thompson P, 1999, J PHYCOL, V35, P1215, DOI 10.1046/j.1529-8817.1999.3561215.x; Tirichine L, 2011, PLANT J, V66, P45, DOI 10.1111/j.1365-313X.2011.04540.x; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; VANHEUKELEM L, 1994, MAR ECOL PROG SER, V114, P303, DOI 10.3354/meps114303; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Ware MA, 2015, PHOTOSYNTH RES, V126, P261, DOI 10.1007/s11120-015-0102-4; WELSCHMEYER NA, 1994, LIMNOL OCEANOGR, V39, P1985, DOI 10.4319/lo.1994.39.8.1985; Xu K, 2017, BBA-BIOENERGETICS, V1858, P459, DOI 10.1016/j.bbabio.2017.03.003; Young EB, 2003, J PHYCOL, V39, P897, DOI 10.1046/j.1529-8817.2003.03042.x; Young JN, 2015, NEW PHYTOL, V205, P172, DOI 10.1111/nph.13021; Zhu SN, 2014, BIORESOURCE TECHNOL, V152, P292, DOI 10.1016/j.biortech.2013.10.092; Zorz Jackie K., 2015, Life-Basel, V5, P403, DOI 10.3390/life5010403	78	29	30	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195705	10.1371/journal.pone.0195705	http://dx.doi.org/10.1371/journal.pone.0195705			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641594	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900086
J	de Santiago, L; Sanchez-Morla, E; Blanco, R; Miguel, JM; Amo, C; del Castillo, MO; Lopez, A; Boquete, L				de Santiago, Luis; Sanchez-Morla, Eva; Blanco, Roman; Manuel Miguel, Juan; Amo, Carlos; Ortiz del Castillo, Miguel; Lopez, Almudena; Boquete, Luciano			Empirical mode decomposition processing to improve multifocal-visual-evoked-potential signal analysis in multiple sclerosis	PLOS ONE			English	Article							OPTIC NEURITIS; VEP; LATENCY; FIELD; PATHWAY; DAMAGE; RISK; MRI; ECG	Objective To study the performance of multifocal-visual-evoked-potential (mfVEP) signals filtered using empirical mode decomposition (EMD) in discriminating, based on amplitude, between control and multiple sclerosis (MS) patient groups, and to reduce variability in interocular latency in control subjects. Methods MfVEP signals were obtained from controls, clinically definitive MS and MS-risk progression patients (radiologically isolated syndrome (RIS) and clinically isolated syndrome (CIS)). The conventional method of processing mfVEPs consists of using a 1-35 Hz bandpass frequency filter (X-DFT). The EMD algorithm was used to decompose the X-DFT signals into several intrinsic mode functions (IMFs). This signal processing was assessed by computing the amplitudes and latencies of the X-DFT and IMF signals (X-EMD). The amplitudes from the full visual field and from ring 5 (9.8-15 degrees eccentricity) were studied. The discrimination index was calculated between controls and patients. Interocular latency values were computed from the X-DFT and X-EMD signals in a control database to study variability. Results Using the amplitude of the mfVEP signals filtered with EMD (X-EMD) obtains higher discrimination index values than the conventional method when control, MS-risk progression (RIS and CIS) and MS subjects are studied. The lowest variability in interocular latency computations from the control patient database was obtained by comparing the X-EMD signals with the X-DFT signals. Even better results (amplitude discrimination and latency variability) were obtained in ring 5 (9.8-15 degrees eccentricity of the visual field). Conclusions Filtering mfVEP signals using the EMD algorithm will result in better identification of subjects at risk of developing MS and better accuracy in latency studies. This could be applied to assess visual cortex activity in MS diagnosis and evolution studies.	[de Santiago, Luis; Manuel Miguel, Juan; Amo, Carlos; Ortiz del Castillo, Miguel; Lopez, Almudena; Boquete, Luciano] Univ Alcala, Escuela Politecn, Dept Elect, Madrid, Spain; [Sanchez-Morla, Eva] Hosp 12 Octubre I 12, Inst Invest, Madrid, Spain; [Blanco, Roman] Univ Alcala, Dept Cirugia Ciencias Med & Sociales, Madrid, Spain	Universidad de Alcala; Hospital Universitario 12 de Octubre; Universidad de Alcala	Boquete, L (corresponding author), Univ Alcala, Escuela Politecn, Dept Elect, Madrid, Spain.	luciana.boquete@uah.es	Boquete, Luciano/GXN-4674-2022	Boquete, Luciano/0000-0001-8591-6103; Sanchez-Morla, Eva Maria/0000-0002-9438-2307; Ortiz del Castillo, Miguel/0000-0001-8431-3765	Secretaria de Estado de Investigacion, Desarrollo e Innovacion [DPI2017-88438-R]; Universidad de Alcala [UAH GC2016-004]	Secretaria de Estado de Investigacion, Desarrollo e Innovacion; Universidad de Alcala	This research was supported by Secretaria de Estado de Investigacion, Desarrollo e Innovacion (DPI2017-88438-R (AEI/FEDER,UE) to LB), and Universidad de Alcala (UAH GC2016-004 to LB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Uriguen JA, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/031001; Armstrong RA, 2013, OPHTHAL PHYSL OPT, V33, P7, DOI 10.1111/opo.12009; Bagheri A, 2014, MED BIOL ENG COMPUT, V52, P619, DOI 10.1007/s11517-014-1164-8; BAMBER D, 1975, J MATH PSYCHOL, V12, P387, DOI 10.1016/0022-2496(75)90001-2; Baseler HA, 1997, VISION RES, V37, P675, DOI 10.1016/S0042-6989(96)00209-X; BASELER HA, 1994, ELECTROEN CLIN NEURO, V90, P65, DOI 10.1016/0013-4694(94)90114-7; Blanco R, 2014, MULT SCLER J, V20, P183, DOI 10.1177/1352458513493683; Combaz A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121481; De Santiago L, 2016, CLIN NEUROPHYSIOL, V127, P1574, DOI 10.1016/j.clinph.2015.09.129; de Santiago L, 2015, COMPUT BIOL MED, V59, P134, DOI 10.1016/j.compbiomed.2015.02.004; Fan Q, 2011, INVEST OPHTH VIS SCI, V52, P6059, DOI 10.1167/iovs.10-7108; Fernandez A, 2015, COMPUT BIOL MED, V56, P13, DOI 10.1016/j.compbiomed.2014.10.023; Frohman EM, 2003, NEUROLOGY, V61, P602, DOI 10.1212/01.WNL.0000082654.99838.EF; Grippo TM, 2006, INVEST OPHTH VIS SCI, V47, P5331, DOI 10.1167/iovs.06-0527; Grover LK, 2008, DOC OPHTHALMOL, V117, P121, DOI 10.1007/s10633-007-9112-7; Hood DC, 2000, INVEST OPHTH VIS SCI, V41, P1580; Hood DC, 2003, PROG RETIN EYE RES, V22, P201, DOI 10.1016/S1350-9462(02)00061-7; Hood DC, 2004, DOC OPHTHALMOL, V109, P177, DOI 10.1007/s10633-004-5511-1; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Kim J, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/036010; Klistorner A, 2012, J NEUROL NEUROSUR PS, V83, P311, DOI 10.1136/jnnp-2011-300928; Klistorner A, 2009, MULT SCLER J, V15, P928, DOI 10.1177/1352458509105228; Klistorner AI, 1998, INVEST OPHTH VIS SCI, V39, P937; Klistorner A, 2008, ANN NEUROL, V64, P325, DOI 10.1002/ana.21474; Klistorner A, 2008, DOC OPHTHALMOL, V116, P19, DOI 10.1007/s10633-007-9072-y; Klistorner A, 2009, DOC OPHTHALMOL, V118, P129, DOI 10.1007/s10633-008-9147-4; Labate D, 2013, IEEE SENS J, V13, P2666, DOI 10.1109/JSEN.2013.2257742; Laron M, 2009, MULT SCLER J, V15, P1431, DOI 10.1177/1352458509350470; Liang HL, 2005, NEUROCOMPUTING, V65, P801, DOI 10.1016/j.neucom.2004.10.077; Liang HL, 2005, BIOL CYBERN, V92, P380, DOI 10.1007/s00422-005-0566-y; Mazinani BAE, 2011, JPN J OPHTHALMOL, V55, P396, DOI 10.1007/s10384-011-0040-4; Moore F, 2009, NEUROLOGY, V73, P1714, DOI 10.1212/WNL.0b013e3181bd69a9; del Castillo MO, 2015, BIOMED SIGNAL PROCES, V22, P119, DOI 10.1016/j.bspc.2015.06.015; Pal S, 2012, COMPUT BIOL MED, V42, P83, DOI 10.1016/j.compbiomed.2011.10.012; Perez-Rico C, 2014, INVEST OPHTH VIS SCI, V55, P6127, DOI 10.1167/iovs.14-14807; Polman Chris H, 2011, Ann Neurol, V69, P292, DOI 10.1002/ana.22366; Souza GS, 2012, BRAZ J MED BIOL RES, V45, P955, DOI 10.1590/S0100-879X2012007500112; Sriram P, 2012, DOC OPHTHALMOL, V125, P43, DOI 10.1007/s10633-012-9334-1; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thie J, 2012, VISION RES, V52, P79, DOI 10.1016/j.visres.2011.11.002; Tsai FF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168108; van der Walt A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121084; Vanegas MI, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/3/036003; Vergallo P, 2014, P 11 INT MULT SYST S, P1, DOI [10.1109/SSD.2014.6808848, DOI 10.1109/SSD.2014.6808848]; Yang EB, 2007, INVEST OPHTH VIS SCI, V48, P692, DOI 10.1167/iovs.06-0475; Zhang M, 2004, J VISION, V4, P32, DOI 10.1167/4.1.4	46	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0194964	10.1371/journal.pone.0194964	http://dx.doi.org/10.1371/journal.pone.0194964			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677200	Green Published, gold			2022-12-26	WOS:000430638900007
J	Esser, D; Geleijnse, JM; Matualatupauw, JC; Dower, JI; Kromhout, D; Hollman, PCH; Afman, LA				Esser, Diederik; Geleijnse, Johanna M.; Matualatupauw, Juri C.; Dower, James I.; Kromhout, Daan; Hollman, Peter C. H.; Afman, Lydia A.			Pure flavonoid epicatechin and whole genome gene expression profiles in circulating immune cells in adults with elevated blood pressure: A randomised double-blind, placebo-controlled, crossover trial	PLOS ONE			English	Article							VASCULAR FUNCTION; NITRIC-OXIDE; ENDOTHELIAL-CELLS; ADIPOSE-TISSUE; (-)-EPICATECHIN; COCOA; CHOCOLATE; HUMANS; HEALTH; SUPPLEMENTATION	Cocoa consumption has beneficial cardiometabolic effects, but underlying mechanisms remain unclear. Epicatechin, the cocoa major monomeric flavan-3-ol, is considered to contribute to these cardio-protective effects. We investigated effects of pure epicatechin supplementation on gene expression profiles of immune cells in humans. In a double blind, placebo-controlled cross-over trial, 32 (pre) hypertensive subjects aged 30 to 80, received two 4-week interventions, i.e. epicatechin (100mg/day) or placebo with a 4-week wash-out between interventions. Gene expression profiles of peripheral blood mononuclear cells were determined before and after both interventions. Epicatechin regulated 1180 genes, of which 234 differed from placebo. Epicatechin upregulated gene sets involved in transcription and tubulin folding and downregulated gene sets involved in inflammation, PPAR signalling and adipogenesis. Several negatively enriched genes within these gene sets were involved in insulin signalling. Most inhibited upstream regulators within the epicatechin intervention were cytokines or involved in inflammation. No upstream regulators were identified compared to placebo. Epicatechin, a cocoa flavan-3-ol, reduces gene expression involved in inflammation, PPAR-signalling and adipogenesis in immune cells. Effects were mild but our findings increase our understanding and provide new leads on how epicatechin rich products like cocoa may affect immune cells and exert cardiometabolic protective effects.	[Esser, Diederik; Geleijnse, Johanna M.; Dower, James I.; Hollman, Peter C. H.] Top Inst Food & Nutr, Wageningen, Netherlands; [Esser, Diederik; Geleijnse, Johanna M.; Matualatupauw, Juri C.; Dower, James I.; Kromhout, Daan; Hollman, Peter C. H.; Afman, Lydia A.] Wageningen Univ, Div Human Nutr, Wageningen, Netherlands	Top Institute Food & Nutrition; Wageningen University & Research	Afman, LA (corresponding author), Wageningen Univ, Div Human Nutr, Wageningen, Netherlands.	lydia.afman@wur.nl	Geleijnse, Johanna Marianna M/B-5749-2012	Geleijnse, Johanna Marianna M/0000-0001-7638-0589	Top Institute Food and Nutrition	Top Institute Food and Nutrition	This work was supported by Top Institute Food and Nutrition, a public-private partnership on precompetitive research in food and nutrition.	Actis-Goretta L, 2013, AM J CLIN NUTR, V98, P924, DOI 10.3945/ajcn.113.065789; Actis-Goretta L, 2012, FREE RADICAL BIO MED, V53, P787, DOI 10.1016/j.freeradbiomed.2012.05.023; Ali F, 2014, MOL NUTR FOOD RES, V58, P33, DOI 10.1002/mnfr.201300277; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Buitrago-Lopez A, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4488; Cifuentes-Gomez T, 2015, J AGR FOOD CHEM, V63, P7615, DOI 10.1021/acs.jafc.5b00443; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dang ZC, 2004, J BONE MINER RES, V19, P853, DOI 10.1359/JBMR.040120; Dang ZC, 2003, J BIOL CHEM, V278, P962, DOI 10.1074/jbc.M209483200; Dower JI, 2015, AM J CLIN NUTR, V101, P914, DOI 10.3945/ajcn.114.098590; Dower JI, 2015, CROSSOVER TRIAL J NU, DOI [10.3945/jn.115.211888, DOI 10.3945/JN.115.211888]; Esser D, 2015, MOL NUTR FOOD RES, V59, P1563, DOI 10.1002/mnfr.201400853; Esser D, 2014, FASEB J, V28, P1464, DOI 10.1096/fj.13-239384; European Food Safety Authority, 2012, EFSA J, V10, P2809, DOI DOI 10.2903/j.efsa.2012.2809; Fernandez-Millan E, 2014, FOOD CHEM TOXICOL, V66, P245, DOI 10.1016/j.fct.2014.01.044; Grassi D, 2005, HYPERTENSION, V46, P398, DOI 10.1161/01.HYP.0000174990.46027.70; Grassi D, 2008, J NUTR, V138, P1671, DOI 10.1093/jn/138.9.1671; Gu YY, 2013, MOL NUTR FOOD RES, V57, P948, DOI 10.1002/mnfr.201200837; Hooper L, 2012, AM J CLIN NUTR, V95, P740, DOI 10.3945/ajcn.111.023457; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Katz DL, 2011, ANTIOXID REDOX SIGN, V15, P2779, DOI 10.1089/ars.2010.3697; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Lizcano JM, 2002, CURR BIOL, V12, pR236, DOI 10.1016/S0960-9822(02)00777-7; Loke WM, 2008, AM J CLIN NUTR, V88, P1018, DOI 10.1093/ajcn/88.4.1018; Mann GE, 2007, CARDIOVASC RES, V75, P261, DOI 10.1016/j.cardiores.2007.04.004; Min SY, 2013, INT J OBESITY, V37, P584, DOI 10.1038/ijo.2012.85; Monagas M, 2010, FOOD FUNCT, V1, P233, DOI 10.1039/c0fo00132e; Moon HS, 2007, OBESITY, V15, P2571, DOI 10.1038/oby.2007.309; Morrison M, 2014, ATHEROSCLEROSIS, V233, P149, DOI 10.1016/j.atherosclerosis.2013.12.027; Rodriguez-Mateos A, 2014, ARCH BIOCHEM BIOPHYS, V559, P17, DOI 10.1016/j.abb.2014.03.014; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Schroeter H, 2006, P NATL ACAD SCI USA, V103, P1024, DOI 10.1073/pnas.0510168103; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Steffen Y, 2005, BIOCHEM BIOPH RES CO, V331, P1277, DOI 10.1016/j.bbrc.2005.04.035; Steffen Y, 2007, BIOCHEM BIOPH RES CO, V359, P828, DOI 10.1016/j.bbrc.2007.05.200; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; van der Velpen V, 2016, FOOD CHEM TOXICOL, V95, P203, DOI 10.1016/j.fct.2016.07.013; van der Velpen V, 2014, AM J CLIN NUTR, V100, P1269, DOI 10.3945/ajcn.114.088484; van der Velpen V, 2013, J NUTR, V143, P774, DOI 10.3945/jn.113.174037; Vazquez-Agell M, 2013, NUTR METAB CARDIOVAS, V23, P257, DOI 10.1016/j.numecd.2011.03.015; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]	43	18	19	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194229	10.1371/journal.pone.0194229	http://dx.doi.org/10.1371/journal.pone.0194229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672527	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800009
J	Skrivan, M; Marounek, M; Englmaierova, M; Cermak, L; Vlckova, J; Skrivanova, E				Skrivan, Milos; Marounek, Milan; Englmaierova, Michaels; Cermak, Ladislav; Vlckova, Jana; Skrivanova, Eva			Effect of dietary fat type on intestinal digestibility of fatty acids, fatty acid profiles of breast meat and abdominal fat, and mRNA expression of lipid-related genes in broiler chickens	PLOS ONE			English	Article							INTRAMUSCULAR-FAT; DEPOSITION; METABOLISM; DISEASE; TISSUES; HEALTH; N-3	A group of 240-day-old Ross cockerels were used in a 4-week experiment to assess the effect of the fat type on the intestinal digestibility of fatty acids (FAs), the FA profiles of breast meat and abdominal fat, and the mRNA expression of six hepatic lipid-related genes. Experimental diets were supplemented with rapeseed oil, pork lard or palm oil at 60 g/kg. In the control diet, wheat starch was substituted for the fat source. The highest ileal digestibility of the fat and all FAs (except stearic acid) was observed in chickens fed lard. The content of fat in the breast meat of chickens was not significantly influenced by the fat supplements. The FA profiles of breast meat and abdominal fat reflected the FA composition of the diet. In the meat of chickens fed rapeseed oil, oleic acid was the predominant FA. Palmitic acid was the most abundant FA in the meat of chickens fed lard or palm oil. Oleic acid was the most abundant FA in the abdominal fat of all chickens. The highest mRNA expression of desaturases (Delta 5-, Delta 6- and Delta 9-) was observed in chickens fed palm oil. The mRNA expression of hepatic FA synthase was higher in chickens fed palm oil or lard than in chickens fed rapeseed oil. The expression of HMG-CoA reductase was higher in chickens fed palm oil than in those fed rapeseed oil or lard. It can be concluded that rapeseed oil and lard are better sources of lipids than palm oil. These former two sources contain more digestible fatty acids and provide a lower concentration of SFAs in the meat and fat of chickens.	[Skrivan, Milos; Marounek, Milan; Englmaierova, Michaels; Cermak, Ladislav; Vlckova, Jana; Skrivanova, Eva] Inst Anim Sci, Dept Nutr Physiol & Anim Prod Qual, Prague, Czech Republic; [Marounek, Milan; Vlckova, Jana; Skrivanova, Eva] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Microbiol Nutr & Dietet, Prague, Czech Republic	Czech Research Institute of Animal Science; Czech University of Life Sciences Prague	Skrivan, M (corresponding author), Inst Anim Sci, Dept Nutr Physiol & Anim Prod Qual, Prague, Czech Republic.	skrivan.milos@vuzv.cz	Skrivanova, Eva/V-6389-2019	Skrivanova, Eva/0000-0001-9336-5436; Englmaierova, Michaela/0000-0003-2752-3170	Ministry of Agriculture of the Czech Republic [QJ1510192, MZER00714]	Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This study was supported by the Ministry of Agriculture of the Czech Republic (Projects QJ1510192 and MZER00714).	AOAC, 2003, OFFICIAL METHODS ANA, V17th; AOAC, 1997, OFFICIAL METHODS ANA; AOAC, 2005, OFFICIAL METHODS ANA; Berg J.M., 2007, BIOCHEMISTRY-US, V6th ed.; Blanch A, 2000, ARCH GEFLUGELKD, V64, P14; Crespo N, 2002, POULTRY SCI, V81, P1533, DOI 10.1093/ps/81.10.1533; Crespo N, 2001, POULTRY SCI, V80, P71, DOI 10.1093/ps/80.1.71; Cui HX, 2012, MOL BIOL REP, V39, P3479, DOI 10.1007/s11033-011-1120-8; Duskova D, 2001, J SCI FOOD AGR, V81, P36, DOI 10.1002/1097-0010(20010101)81:1&lt;36::AID-JSFA776&gt;3.0.CO;2-A; FOLCH J, 1957, J BIOL CHEM, V226, P497; Haug A, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-92; Hrdinka C, 1996, POULTRY SCI, V75, P208, DOI 10.3382/ps.0750208; Kouba M, 1998, REPROD NUTR DEV, V38, P31, DOI 10.1051/rnd:19980103; Musa H. H., 2007, Journal of Biological Sciences, V7, P693; Newman RE, 2002, BRIT J NUTR, V88, P19, DOI 10.1079/BJN2002581; PEARCE J, 1977, INT J BIOCHEM, V8, P269, DOI 10.1016/0020-711X(77)90132-X; Ravindran V, 2016, ANIM FEED SCI TECH, V213, P1, DOI 10.1016/j.anifeedsci.2016.01.012; Sanz M, 2000, J NUTR, V130, P3034, DOI 10.1093/jn/130.12.3034; SCAIFE JR, 1994, BRIT POULTRY SCI, V35, P107, DOI 10.1080/00071669408417675; Simopoulos AP, 2000, POULTRY SCI, V79, P961, DOI 10.1093/ps/79.7.961; Skrivan M, 2000, BRIT POULTRY SCI, V41, P608, DOI 10.1080/713654978; Smink W, 2010, POULTRY SCI, V89, P2432, DOI 10.3382/ps.2010-00665; Tancharoenrat P, 2014, POULTRY SCI, V93, P371, DOI 10.3382/ps.2013-03344; Tosi F, 2014, ADV EXP MED BIOL, V824, P61, DOI 10.1007/978-3-319-07320-0_7; Watts GF, 1996, AM J CLIN NUTR, V64, P202, DOI 10.1093/ajcn/64.2.202; Williams CM, 2000, ANN ZOOTECH, V49, P165, DOI 10.1051/animres:2000116	26	14	16	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196035	10.1371/journal.pone.0196035	http://dx.doi.org/10.1371/journal.pone.0196035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672634	Green Submitted, gold, Green Published			2022-12-26	WOS:000430446800071
J	Phillips, RC; Gorse, D				Phillips, Ross C.; Gorse, Denise			Cryptocurrency price drivers: Wavelet coherence analysis revisited	PLOS ONE			English	Article							EXUBERANCE	Cryptocurrencies have experienced recent surges in interest and price. It has been discovered that there are time intervals where cryptocurrency prices and certain online and social media factors appear related. In addition it has been noted that cryptocurrencies are prone to experience intervals of bubble-like price growth. The hypothesis investigated here is that relationships between online factors and price are dependent on market regime. In this paper, wavelet coherence is used to study co-movement between a cryptocurrency price and its related factors, for a number of examples. This is used alongside a well-known test for financial asset bubbles to explore whether relationships change dependent on regime. The primary finding of this work is that medium-term positive correlations between online factors and price strengthen significantly during bubble-like regimes of the price series; this explains why these relationships have previously been seen to appear and disappear over time. A secondary finding is that short-term relationships between the chosen factors and price appear to be caused by particular market events (such as hacks / security breaches), and are not consistent from one time interval to another in the effect of the factor upon the price. In addition, for the first time, wavelet coherence is used to explore the relationships between different cryptocurrencies.	[Phillips, Ross C.; Gorse, Denise] UCL, Dept Comp Sci, London, England	University of London; University College London	Phillips, RC (corresponding author), UCL, Dept Comp Sci, London, England.	r.phillips@cs.ucl.ac.uk			Engineering and Physical Sciences Research Council (EPSRC); DTC in Financial Computing Analytics [EP/L015129/1]	Engineering and Physical Sciences Research Council (EPSRC)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); DTC in Financial Computing Analytics	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC). The funding was received by Ross Phillips (RP) via the DTC in Financial Computing & Analytics; reference number: EP/L015129/1; http://gow.epsrc.ac.uk/ NGBOViewGrant.aspx?GrantRef=EP/L015129/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloui C, 2014, ECON MODEL, V36, P421, DOI 10.1016/j.econmod.2013.09.043; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; Balcilar M, 2017, ECON MODEL, V64, P74, DOI 10.1016/j.econmod.2017.03.019; Bouri E., 2017, FINANCE RES LETT; Brandvold M, 2015, J INT FINANC MARK I, V36, P18, DOI 10.1016/j.intfin.2015.02.010; Cheah ET, 2015, ECON LETT, V130, P32, DOI 10.1016/j.econlet.2015.02.029; Chen C.W., 2003, J ECON BUS, V55, P487, DOI DOI 10.1016/S0148-6195(03)00051-1; Garcia D, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150288; Garcia D, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0623; Gi Kim Jun, 2016, PLOS ONE, V11; Glaser F, 2014, P EUROPEAN C INFORM; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Kristoufek L., 2015, PLOS ONE, V10; Kristoufek L, 2013, SCI REP-UK, V3, DOI [10.1038/srep03415, 10.1038/srep02857]; Lim S.J., 2017, EXPLORING PORTFOLIO; Madaleno M, 2014, ENERG ECON, V45, P120, DOI 10.1016/j.eneco.2014.06.024; Mitchell J, 2001, J FUTURES MARKETS, V21, P395, DOI 10.1002/fut.2; MOORE T, 2013, LECT NOTES COMPUTER, V7859; Nakamoto S., 2019, BITCOIN PEER TO PEER, P21260; Phillips PCB, 2015, INT ECON REV, V56, P1043, DOI 10.1111/iere.12132; Phillips PCB, 2011, INT ECON REV, V52, P201, DOI 10.1111/j.1468-2354.2010.00625.x; Phillips R. C, 2017, IEEE S SERIES COMPUT; Shiller RJ, 2014, AM ECON REV, V104, P1486, DOI 10.1257/aer.104.6.1486; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Vacha L, 2012, ENERG ECON, V34, P241, DOI 10.1016/j.eneco.2011.10.007; Xu Y., 2017, PLOS ONE, V12	26	57	57	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195200	10.1371/journal.pone.0195200	http://dx.doi.org/10.1371/journal.pone.0195200			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668765	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200031
J	Vijarnsorn, C; Durongpisitkul, K; Chungsomprasong, P; Bositthipichet, D; Ketsara, S; Titaram, Y; Chanthong, P; Kanjanauthai, S; Soongswang, J				Vijarnsorn, Chodchanok; Durongpisitkul, Kritvikrom; Chungsomprasong, Paweena; Bositthipichet, Densiri; Ketsara, Salisa; Titaram, Yuttapon; Chanthong, Prakul; Kanjanauthai, Supaluck; Soongswang, Jarupim			Contemporary survival of patients with pulmonary arterial hypertension and congenital systemic to pulmonary shunts	PLOS ONE			English	Article							HEART-DISEASE; EISENMENGER-SYNDROME; PREDICTORS; DIAGNOSIS; OUTCOMES; ADULTS; EPIDEMIOLOGY; MORTALITY; DEATH	Objective To compare survival of patients with newly diagnosed pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD) according to various clinical classifications with classifications of anatomical-pathophysiological systemic to pulmonary shunts in a single-center cohort. Methods All prevalent cases of PAH-CHD with hemodynamic confirmation by cardiac catheterization in 1995 +/- 2015 were retrospectively reviewed. Patients who were younger than three months of age, or with single ventricle following surgery were excluded. Baseline characteristics and clinical outcomes were retrieved from the database. The survival analysis was performed at the end of 2016. Prognostic factors were identified using multivariate analysis. Results A total of 366 consecutive patients (24.5 +/- 17.6 years of age, 40% male) with PAH-CHD were analyzed. Most had simple shunts (85 pre-tricuspid, 105 post-tricuspid, 102 combined shunts). Patients with pre-tricuspid shunts were significantly older at diagnosis in comparison to post-tricuspid, combined, and complex shunts. Clinical classifications identified patients as having Eisenmenger syndrome (ES, 26.8%), prevalent left to right shunt (66.7%), PAH with small defect (3%), or PAH following defect correction (3.5%). At followup (median = 5.9 years; 0.1-20.7 years), no statistically significant differences in survival rate were seen among the anatomical-pathophysiological shunts (p = 0.1). Conversely, the clinical classifications revealed that patients with PAH-small defect had inferior survival compared to patients with ES, PAH post-corrective surgery, or PAH with prevalent left to right shunt (p = 0.01). Significant mortality risks were functional class III, age < 10 years, PAH-small defect, elevated right atrial pressure > 15 mmHg, and baseline PVR > 8 WU.m.(2) Conclusion Patients with PAH-CHD had a modest long-term survival. Different anatomical-pathophysiological shunts affect the natural presentation, while clinical classifications indicate treatment strategies and survival. Contemporary therapy improves survival in deliberately selected patients.	[Vijarnsorn, Chodchanok; Durongpisitkul, Kritvikrom; Chungsomprasong, Paweena; Bositthipichet, Densiri; Ketsara, Salisa; Titaram, Yuttapon; Chanthong, Prakul; Kanjanauthai, Supaluck; Soongswang, Jarupim] Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand	Mahidol University	Vijarnsorn, C (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Bangkok, Thailand.	cvijarnsorn@yahoo.corn	Chungsomprasong, Paweena/ABG-8953-2020	Vijarnsorn, Chodchanok/0000-0001-7124-2064				Alonso-Gonzalez R, 2015, INT J CARDIOL, V184, P717, DOI 10.1016/j.ijcard.2015.02.031; Arnott C, 2016, HEART ASIA, V8, P3, DOI 10.1136/heartasia-2015-010702; Barst RJ, 2014, AM J CARDIOL, V113, P147, DOI 10.1016/j.amjcard.2013.09.032; Beghetti M, 2010, REV ESP CARDIOL, V63, P1179, DOI 10.1016/S0300-8932(10)70250-5; Benza RL, 2012, CHEST, V142, P448, DOI 10.1378/chest.11-1460; Diller GP, 2007, CIRCULATION, V115, P1039, DOI 10.1161/CIRCULATIONAHA.105.592386; Diller GP, 2006, EUR HEART J, V27, P1737, DOI 10.1093/eurheartj/ehl116; Dimopoulos K, 2010, CIRCULATION, V121, P20, DOI 10.1161/CIRCULATIONAHA.109.883876; Duffels MGJ, 2007, INT J CARDIOL, V120, P198, DOI 10.1016/j.ijcard.2006.09.017; Engelfriet PM, 2007, HEART, V93, P682, DOI 10.1136/hrt.2006.098848; Farber HW, 2015, CHEST, V148, P1043, DOI 10.1378/chest.15-0300; Galie N, 2004, EUR HEART J, V25, P2243, DOI 10.1016/j.ehj.2004.09.014; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gatzoulis MA, 2014, INT J CARDIOL, V177, P340, DOI 10.1016/j.ijcard.2014.09.024; Hoeper MM, 2013, J AM COLL CARDIOL, V62, pD42, DOI 10.1016/j.jacc.2013.10.032; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Jansa P, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-45; Kempny A, 2017, CIRCULATION, V135, P1432, DOI 10.1161/CIRCULATIONAHA.116.023033; Ling Y, 2012, AM J RESP CRIT CARE, V186, P790, DOI 10.1164/rccm.201203-0383OC; Manes A, 2014, EUR HEART J, V35, P716, DOI 10.1093/eurheartj/eht072; Ramjug S, 2016, J HEART LUNG TRANSPL, V35, P610, DOI 10.1016/j.healun.2015.12.016; Schuijt MTU, 2017, INT J CARDIOL, V243, P449, DOI 10.1016/j.ijcard.2017.05.101; Schuuring MJ, 2015, INT J CARDIOL, V181, P270, DOI 10.1016/j.ijcard.2014.11.222; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; van Loon RLE, 2011, CIRCULATION, V124, P1755, DOI 10.1161/CIRCULATIONAHA.110.969584; Zhang R, 2011, CHEST, V140, P301, DOI 10.1378/chest.10-2327	26	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195092	10.1371/journal.pone.0195092	http://dx.doi.org/10.1371/journal.pone.0195092			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664959	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300013
J	Bougle, A; Bombled, C; Margetis, D; Lebreton, G; Vidal, C; Coroir, M; Hajage, D; Amour, J				Bougle, Adrien; Bombled, Camille; Margetis, Dimitri; Lebreton, Guillaume; Vidal, Charles; Coroir, Marine; Hajage, David; Amour, Julien			Ventilator-associated pneumonia in patients assisted by veno-arterial extracorporeal membrane oxygenation support: Epidemiology and risk factors of treatment failure	PLOS ONE			English	Article							CARDIOPULMONARY BYPASS; NOSOCOMIAL INFECTIONS; CARDIOGENIC-SHOCK; THERAPY; PHARMACOKINETICS; OUTCOMES	Introduction Ventilator-associated pneumonia (VAP) is frequent in Intensive Care Unit (ICU) patients. In the specific case of patients treated with Veno-Arterial Extracorporeal Membrane Oxygenation Support (VA-ECMO), VAP treatment failures (VAP-TF) have been incompletely investigated. Methods To investigate the risk factors of treatment failure (VAP-TF) in a large cohort of ICU patients treated with VA-ECMO, we conducted a retrospective study in a Surgical ICU about patients assisted with VA-ECMO between January 1, 2013, and December 31, 2014. Diagnosis of VAP was confirmed by a positive quantitative culture of a respiratory sample. VAP-TF was defined as composite of death attributable to pneumonia and relapse within 28 days of the first episode. Results In total, 152 patients underwent ECMO support for > 48h. During the VA-ECMO support, 85 (55.9%) patients developed a VAP, for a rate of 60.6 per 1000 ECMO days. The main pathogens identified were Pseudomonas aeruginosa and Enterobacteriaceae. VAP-TF occurred in 37.2% of patients and was associated with an increased 28-day mortality (Hazard Ratio 3.05 [1.66; 5.63], P<0.001), and VA-ECMO assistance duration (HR 1.47 [1.05-2.05], P = 0.025). Risk factors for VAP-TF were renal replacement therapy (HR 13.05 [1.73; 98.56], P = 0.013) and documentation of Pseudomonas aeruginosa (HR 2.36 [1.04; 5.35], P = 0.04). Conclusions VAP in patients treated with VA-ECMO is associated with an increased morbidity and mortality. RRT and infection by Pseudomonas aeruginosa appear as strong risks factors of treatment failure. Further studies seem necessary to precise the best antibiotic management in these patients.	[Bougle, Adrien; Bombled, Camille; Margetis, Dimitri; Vidal, Charles; Coroir, Marine; Amour, Julien] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care Med,Inst Cardiol, Paris, France; [Lebreton, Guillaume; Amour, Julien] Sorbonne Univ, Pitie Salpetriere Hosp, INSERM, UMR 1166,IHU ICAN, Paris, France; [Lebreton, Guillaume] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Thorac & Cardiovasc Surg,Inst Cardiol, Paris, France; [Hajage, David] Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Biostat Publ Hlth & Med Informat, Paris, France; [Hajage, David] Univ Paris Diderot, Sorbonne Paris Cite, ECEVE, UMR 1123, Paris, France; [Hajage, David] INSERM, UMR 1123, ECEVE, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Bougle, A (corresponding author), Sorbonne Univ, Pitie Salpetriere Hosp, AP HP, Dept Anesthesiol & Crit Care Med,Inst Cardiol, Paris, France.	adrien.bougle@aphp.fr	Hajage, David/D-5226-2014; Charles, Vidal/AAI-3248-2020	Hajage, David/0000-0002-8475-4090; Lebreton, Guillaume/0000-0003-4308-506X				Allou N, 2014, CRIT CARE MED, V42, P1150, DOI 10.1097/CCM.0000000000000143; Aubron C, 2013, INFECT CONT HOSP EP, V34, P24, DOI 10.1086/668439; Beumier M, 2014, CRIT CARE, V18, DOI 10.1186/cc13886; Bizzarro MJ, 2011, PEDIATR CRIT CARE ME, V12, P277, DOI 10.1097/PCC.0b013e3181e28894; Chalk K, 2013, CRIT CARE, V17, DOI 10.1186/cc13148; Cheng R, 2014, ANN THORAC SURG, V97, P610, DOI 10.1016/j.athoracsur.2013.09.008; Donadello K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0632-8; Donadello K, 2015, INT J ANTIMICROB AG, V45, P278, DOI 10.1016/j.ijantimicag.2014.11.005; Filsoufi F, 2008, CHEST, V133, P713, DOI 10.1378/chest.07-1028; Hadley JS, 2007, SHOCK, V27, P466, DOI 10.1097/01.shk.0000245033.69977.c5; Karagiannidis C, 2016, INTENS CARE MED, V42, P889, DOI 10.1007/s00134-016-4273-z; Lauzier F, 2008, J CRIT CARE, V23, P50, DOI 10.1016/j.jcrc.2008.01.006; Meduri GU, 1994, CHEST; Mekontso-Dessap A, 2005, SHOCK, V24, P109, DOI 10.1097/01.shk.0000171871.50524.81; O'Neill JM, 2001, INTENS CARE MED, V27, P1247, DOI 10.1007/s001340101029; Roberts DM, 2012, CRIT CARE MED, V40, P1523, DOI 10.1097/CCM.0b013e318241e553; Roberts JA, 2009, CRIT CARE MED, V37, P840, DOI 10.1097/CCM.0b013e3181961bff; Schmidt M, 2012, CLIN INFECT DIS, V55, P1633, DOI 10.1093/cid/cis783; Shekar K, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0565-2; SIMON R, 1984, STAT MED, V3, P35, DOI 10.1002/sim.4780030106; Sun HY, 2010, J THORAC CARDIOV SUR, V140, P1125, DOI 10.1016/j.jtcvs.2010.07.017; Vincent JL, 2009, JAMA-J AM MED ASSOC, V302, P2323, DOI 10.1001/jama.2009.1754; Wilhelm W, 2002, SHOCK, V17, P354, DOI 10.1097/00024382-200205000-00002	23	31	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194976	10.1371/journal.pone.0194976	http://dx.doi.org/10.1371/journal.pone.0194976			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652913	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900015
J	Ge, YQ; Zhong, YJ; Ji, GZ; Lu, QL; Dai, XY; Guo, ZR; Zhang, P; Peng, G; Zhang, KZ; Li, YT				Ge, Yaoqi; Zhong, Yuejiao; Ji, Guozhong; Lu, Qianling; Dai, Xinyu; Guo, Zhirui; Zhang, Peng; Peng, Gang; Zhang, Kangzhen; Li, Yuntao			Preparation and characterization of Fe3O4@Au-C225 composite targeted nanoparticles for MRI of human glioma	PLOS ONE			English	Article							GOLD NANOPARTICLES; BRAIN-TUMORS; IN-VIVO; ANTIBODIES; RECEPTOR; CELLS; SPECTROSCOPY; COMBINATION; ADSORPTION; ERLOTINIB	Objective To study the characterization of Fe3O4@Au-C225 composite targeted MNPs. Methods Fe3O4@Au-C225 was prepared by the absorption method. The immunosorbent assay was used to evaluate its absorption efficiency at C225 Fc. ZETA SIZER3000 laser particle size analyzer, ultraviolet photometer and its characteristics were analyzed by VSM. the targeting effect of Fe3O4@Au-C225 composite targeted MNPs on U251 cells in vitro were detected by 7.0 Tesla Micro-MR; and subcutaneous transplanted human glioma in nude mice were performed the targeting effect in vivo after tail vein injection of Fe3O4@Au-C225 composite targeted MNPs by MRI. Results The self-prepared Fe3O4@Au composite MNPs can adsorb C225 with high efficiency of adsorption so that Fe3O4@Au-C225 composite targeted MNPs were prepared successfully. Fe3O4@Au-C225 composite targeted MNPs favorably targeted human glioma cell line U251 in vitro; Fe3O4@Au-C225 composite targeted MNPs have good targeting ability to xenografted glioma on nude mice in vivo, and can be traced by MRI. Conclusion The Fe3O4@Au-C225 composite targeted MNPs have the potential to be used as a tracer for glioma in vivo.	[Ge, Yaoqi; Ji, Guozhong; Lu, Qianling; Dai, Xinyu; Guo, Zhirui; Zhang, Peng; Peng, Gang; Zhang, Kangzhen; Li, Yuntao] Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China; [Zhong, Yuejiao] Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Zhong, Yuejiao] Jiangsu Inst Canc Res, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Li, YT (corresponding author), Nanjing Med Univ, Affiliated Hosp 2, Nanjing, Jiangsu, Peoples R China.	422780515@qq.com	Li, Yuntao/AFE-3730-2022		National Natural Science Foundation of China [81301313]; Natural Science Foundation of Jiangsu Province [BK20131015, BK20141015]; Jiangsu Provincial College Students' Practical Innovation Training Program [201410312015Z]; Nanjing Developing Project of Medical Science [YKK13174]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Provincial College Students' Practical Innovation Training Program; Nanjing Developing Project of Medical Science	This work was supported by the National Natural Science Foundation of China [grant number: 81301313], the Natural Science Foundation of Jiangsu Province [grant number: BK20131015 and BK20141015], the Jiangsu Provincial College Students' Practical Innovation Training Program [grant number: 201410312015Z], and the Nanjing Developing Project of Medical Science [grant number: YKK13174]. We would like to thank Prof. Yang Shao, Dr. Xiao Tan and Dr. Jinyan Wang for the critical reading, advice, and comments of the manuscript.	Aioub M, 2016, J AM CHEM SOC, V138, P1258, DOI 10.1021/jacs.5b10997; Barth RF, 2016, ONCOTARGETS THER, V9, P2769, DOI 10.2147/OTT.S99242; Berger C, 2012, EXP CELL RES, V318, P2578, DOI 10.1016/j.yexcr.2012.09.001; Bos C, 2004, RADIOLOGY, V233, P781, DOI 10.1148/radiol.2333031714; Brandes AA, 2008, CLIN CANCER RES, V14, P957, DOI 10.1158/1078-0432.CCR-07-1810; Chung EJ, 2013, INT J ONCOL, V42, P2028, DOI 10.3892/ijo.2013.1890; de Robles P, 2015, NEURO-ONCOLOGY, V17, P776, DOI 10.1093/neuonc/nou283; England CG, 2015, EUR PHYS J PLUS, V130, DOI 10.1140/epjp/i2015-15231-1; Garcinuno RM, 2000, TALANTA, V52, P825, DOI 10.1016/S0039-9140(00)00435-5; Jin B, 2012, LANGMUIR, V28, P9460, DOI 10.1021/la300819u; John Mendelsohn, 2008, MOL TARGETING ONCOLO; Johnson BN, 2012, LANGMUIR, V28, P6928, DOI 10.1021/la3009128; Joshi PP, 2013, BIOCONJUGATE CHEM, V24, P878, DOI 10.1021/bc3004815; [居胜红 JU Shenghong], 2006, [中华放射学杂志, Chinese Journal of Radiology], V40, P127; Kao HW, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/29/295102; Karyakin AA, 2000, ANAL CHEM, V72, P3805, DOI 10.1021/ac9907890; Kelton C, 2012, ARCH BIOCHEM BIOPHYS, V526, P219, DOI 10.1016/j.abb.2012.03.005; Kim ES, 2001, CURR OPIN ONCOL, V13, P506, DOI 10.1097/00001622-200111000-00014; Klingler S, 2015, CANCER RES, V75, P2109, DOI 10.1158/0008-5472.CAN-14-3122; Kustermann E, 2005, NMR BIOMED, V18, P362, DOI 10.1002/nbm.967; Lee JR, 2013, EXPERT REV PROTEOMIC, V10, P65, DOI [10.1586/epr.12.67, 10.1586/EPR.12.67]; Li YT, 2011, INT J NANOMED, V6, P2805, DOI 10.2147/IJN.S24596; Llavero F, 2016, CELL SIGNAL, V28, P1713, DOI 10.1016/j.cellsig.2016.07.014; Pare-Brunet L, 2014, HUM MUTAT, V35, P227, DOI 10.1002/humu.22475; Porter KR, 2010, NEURO-ONCOLOGY, V12, P520, DOI 10.1093/neuonc/nop066; Sato MR, 2015, CURR TOP MED CHEM, V15, P287, DOI 10.2174/1568026615666150108145614; Serkova Natalie J., 2013, CURRENT MOL IMAGING, V2, P53, DOI [10.2174/2211555211302010007, DOI 10.2174/2211555211302010007]; Sokolov K, 2003, CANCER RES, V63, P1999; [汤俊琪 Tang Junqi], 2010, [食品与生物技术学报, Journal of Food Science and Biotechnology], V29, P533; Unger EC, 2003, RADIOLOGY, V229, P615, DOI 10.1148/radiol.2293031017; Wang Y, 2014, TALANTA, V119, P320, DOI 10.1016/j.talanta.2013.11.026; Wen PY, 2014, NEURO-ONCOLOGY, V16, P567, DOI 10.1093/neuonc/not247; Wu ZS, 2005, ANAL BIOCHEM, V337, P308, DOI 10.1016/j.ab.2004.10.051; Yung WKA, 2010, NEURO-ONCOLOGY, V12, P1061, DOI 10.1093/neuonc/noq072; Zhou Y, 2012, MOL CANCER THER, V11, P1467, DOI 10.1158/1535-7163.MCT-11-1038	35	13	13	9	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195703	10.1371/journal.pone.0195703	http://dx.doi.org/10.1371/journal.pone.0195703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652919	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900033
J	Yoshimura, EH; Santos, NW; Machado, E; Agustinho, BC; Pereira, LM; de Aguiar, SC; Sa-Nakanishi, AB; Mareze-da-Costa, CE; Zeoula, LM				Yoshimura, Emerson H.; Santos, Nadine W.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.; de Aguiar, Silvia C.; Sa-Nakanishi, Anacharis B.; Mareze-da-Costa, Cecilia E.; Zeoula, Lucia M.			Functionality of cow milk naturally enriched with polyunsaturated fatty acids and polyphenols in diets for diabetic rats	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; BROWN ADIPOSE-TISSUE; DAIRY CONSUMPTION; MEDICINAL-PLANTS; KIDNEY-DISEASE; INSULIN; RISK; SUPPLEMENTATION; COMPLICATIONS; METAANALYSIS	The increasing incidence of diabetes mellitus is becoming a serious threat to human health in various parts of the world. Studies with dairy products have shown a potential beneficial effect against diabetes. This experiment evaluated the supplementation of milk naturally enriched with polyunsaturated fatty acids (PUFA) and polyphenols in rats with streptozotocin-induced diabetes. Forty male 28-day-old Wistar rats were distributed in four experimental treatments of diabetic animals (streptozotocin induction) and a normal group (non-induced). Experimental treatments were: control (water), whole common milk (COM-M), milk enriched with PUFA (PUFA-M), milk enriched with PUFA and polyphenols (PUFA/P-M) through a special diet offered to dairy cows. Milk supplementation at a dose 5 mL/kg body weight was performed for 77 days, 42 days before and 35 days after diabetes induction. The COM-M supplementation increased brown fat deposits, reduced post-induction glucose levels, reduced blood fructosamine levels, and improved glucose tolerance. Milk enriched with PUFA reduced final fasting glucose, LDL levels, and improved blood antioxidant capacity. Milk enriched with PUFA and polyphenols promoted an increase in gastrocnemius muscle mass, and a reduction in mesenteric fat and LDL levels. Milk intake, with an emphasis on milk enriched with PUFA and polyphenols, attenuated the metabolic disorders of streptozotocin-induced diabetes in rats.	[Yoshimura, Emerson H.; Santos, Nadine W.; Machado, Erica; Agustinho, Bruna C.; Pereira, Lucelia M.] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil; [de Aguiar, Silvia C.] Univ Estado Mato Grosso, Dept Zootecnia, Pontes E Lacerda, Brazil; [Sa-Nakanishi, Anacharis B.] Univ Estadual Maringa, Dept Bioquim, Maringa, Parana, Brazil; [Mareze-da-Costa, Cecilia E.] Univ Estadual Maringa, Dept Ciencias Fisiol, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade do Estado de Mato Grosso; Universidade Estadual de Maringa; Universidade Estadual de Maringa	Santos, NW (corresponding author), Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil.	santos.woruby.n@gmail.com	Nakanishi, Anacharis/AAQ-1911-2020; de Aguiar, Silvia/N-1453-2019	Nakanishi, Anacharis/0000-0002-2300-1861; de Aguiar, Silvia/0000-0001-5497-2559; Calvo Agustinho, Bruna/0000-0001-5917-234X; Woruby Santos, Nadine/0000-0003-0996-8213	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, DF, Brazil) [485566/2012-5]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, DF, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brasilia, DF, Brazil), statement number 485566/2012-5, Universal/2012. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1994, REP HLTH SOC SUBJ LO, V46, P1; Aune D, 2013, AM J CLIN NUTR, V98, P1066, DOI 10.3945/ajcn.113.059030; Ballali S, 2012, INT J FOOD SCI NUTR, V63, P51, DOI 10.3109/09637486.2011.637487; BERNARDIS LL, 1968, J ENDOCRINOL, V40, P527, DOI 10.1677/joe.0.0400527; Brazilian Institute of Geography and Statistics, 2008, ANTHR NUTR STAT CHIL; Brazilian Ministry of Health, 2008, FEED GUID BRAZ POP P; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Connell JEO, 2001, SIGNIFICANCE APPL PH, V11, P103; DiGirolamo M, 1998, AM J PHYSIOL-REG I, V274, pR1460, DOI 10.1152/ajpregu.1998.274.5.R1460; Elwood PC, 2007, J EPIDEMIOL COMMUN H, V61, P695, DOI 10.1136/jech.2006.053157; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Faure P, 1995, ANAL FREE RADICALS B, P238; Flachs P, 2014, PHYSIOL RES, V63, pS93, DOI 10.33549/physiolres.932715; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gagnon N, 2009, BRIT J NUTR, V102, P1015, DOI 10.1017/S0007114509344104; Guadarrama-Lopez AL, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/860703; Harlev E, 2013, PLANTA MED, V79, P425, DOI 10.1055/s-0032-1328331; Hirahatake KM, 2014, METABOLISM, V63, P618, DOI 10.1016/j.metabol.2014.02.009; Horton WB, 2015, BMJ OPEN DIAB RES CA, V3, DOI [10.1136/bmjdrc-2015-000082, 10.1136/bmjdrc-2015000082]; Jakubowicz D, 2013, J NUTR BIOCHEM, V24, P1, DOI 10.1016/j.jnutbio.2012.07.008; Koga M, 2014, CLIN CHIM ACTA, V433, P96, DOI 10.1016/j.cca.2014.03.001; Kollias AN, 2010, DTSCH ARZTEBL INT, V107, P75, DOI 10.3238/arztebl.2010.0075; Lidell ME, 2014, J INTERN MED, V276, P364, DOI 10.1111/joim.12255; Malviya N, 2010, ACTA POL PHARM, V67, P113; Mirmiran P, 2014, WORLD J DIABETES, V5, P267, DOI 10.4239/wjd.v5.i3.267; Muley A, 2014, CURR DIABETES REV, V10, P158, DOI 10.2174/1573399810666140515113137; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Palsson R, 2014, ADV CHRONIC KIDNEY D, V21, P273, DOI 10.1053/j.ackd.2014.03.003; Patel D. K., 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P320, DOI 10.1016/S2221-1691(12)60032-X; Payne AJ, 2014, INT J MOL SCI, V15, P1865, DOI 10.3390/ijms15021865; Qidwai Waris, 2014, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V13, P3; Rice BH, 2013, NUTR REV, V71, P209, DOI 10.1111/nure.12007; Santos NW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172909; Santos NW, 2016, LIVEST SCI, V191, P132, DOI 10.1016/j.livsci.2016.07.012; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Silva S, 2015, AM J CLIN NUTR, V101, P44, DOI 10.3945/ajcn.114.094219; Smith-Palmer J, 2014, DIABETES RES CLIN PR, V105, P273, DOI 10.1016/j.diabres.2014.06.007; Sponer Pavel, 2013, Acta Medica (Hradec Kralove), V56, P3; Strahan Stephen, 2013, Asian Cardiovasc Thorac Ann, V21, P281, DOI 10.1177/0218492312451983; Struijk EA, 2013, NUTR METAB CARDIOVAS, V23, P822, DOI 10.1016/j.numecd.2012.05.011; Sun X, 2006, INT J OBESITY, V30, P1341, DOI 10.1038/sj.ijo.0803294; Turner RC, 1998, BMJ-BRIT MED J, V316, P823, DOI 10.1136/bmj.316.7134.823	43	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195839	10.1371/journal.pone.0195839	http://dx.doi.org/10.1371/journal.pone.0195839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652940	gold, Green Submitted, Green Published			2022-12-26	WOS:000430026900039
J	You, CH; Choi, JH; Kang, S; Oh, EH; Kwon, YD				You, Chang Hoon; Choi, Ji Heon; Kang, Sungwook; Oh, Eun-Hwan; Kwon, Young Dae			Association between supplementary private health insurance and visits to physician offices versus hospital outpatient departments among adults with diabetes in the universal public insurance system	PLOS ONE			English	Article							CARE; DEMAND; DETERMINANTS; SELECTION; SERVICES; COVERAGE	Background Diabetes mellitus is a chronic disease with a high prevalence across the world as well as in South Korea. Most cases of diabetes can be adequately managed at physician offices, but many diabetes patients receive outpatient care at hospitals. This study examines the relationship between supplementary private health insurance (SPHI) ownership and the use of hospitals among diabetes outpatients within the universal public health insurance scheme. Methods Data from the 2011 Korea Health Panel, a nationally representative sample of Korean individuals, was used. For the study, 6,379 visits for diabetes care were selected while controlling for clustered errors. Multiple logistic regression models were used to examine determinants of hospital outpatient services. Results This study demonstrated that the variables of self-rated health status, comorbidity, unmet need, and alcohol consumption significantly correlated with the choice to use a hospital services. Patients with SPHI were more likely to use medical services at hospitals by 1.71 times (95% CI 1.068-2.740, P = 0.026) compared to patients without SPHI. Conclusions It was confirmed that diabetic patients insured by SPHI had more use of hospital services than those who were not insured. People insured by SPHI seem to be more likely to use hospital services because SPHI lightens the economic burden of care.	[You, Chang Hoon] Catholic Univ Korea, Grad Sch Healthcare Management & Policy, Seoul, South Korea; [Choi, Ji Heon] Int Inst Hlth, Seoul, South Korea; [Kang, Sungwook] Daegu Haany Univ, Dept Publ Hlth, Gyongsan, South Korea; [Oh, Eun-Hwan] Hyupsung Univ, Dept Healthcare Management, Hwaseong, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea	Catholic University of Korea; Daegu Haany University; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.; Kwon, YD (corresponding author), Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832; You, Chang Hoon/0000-0001-7938-266X				Bausell RB, 2001, MED CARE, V39, P190, DOI 10.1097/00005650-200102000-00009; Bryan RN, 2013, EUR RADIOL, V23, P1, DOI 10.1007/s00330-012-2713-x; Buchmueller TC, 2004, HEALTH ECON, V13, P669, DOI 10.1002/hec.879; Casagrande SS, 2012, DIABETES CARE, V35, P2243, DOI 10.2337/dc12-0257; Doiron D, 2008, HEALTH ECON, V17, P317, DOI 10.1002/hec.1267; Emmerson C., 2001, SHOULD PRIVATE MEDIC, P49; HAYES TM, 1984, BRIT MED J, V289, P728, DOI 10.1136/bmj.289.6447.728; Jeon B, 2013, HEALTH POLICY, V113, P69, DOI 10.1016/j.healthpol.2013.05.007; Jung Y., 2010, REPORT KOREA HLTH PA; Kang S, 2009, J FORMOS MED ASSOC, V108, P912, DOI 10.1016/S0929-6646(10)60003-4; Kiil A, 2014, EUR J HEALTH ECON, V15, P813, DOI 10.1007/s10198-013-0526-8; King D, 2005, HEALTH SERV RES, V40, P195, DOI 10.1111/j.1475-6773.2005.00349.x; Korean Diabetes Association National Health Insurance Service, 2015, KOR DIAB FACT SHEET; Kwon S, 2009, HEALTH POLICY PLANN, V24, P63, DOI 10.1093/heapol/czn037; Lee JC, 2012, J KOREAN MED ASSOC, V55, P1215, DOI 10.5124/jkma.2012.55.12.1215; Liu TC, 2002, SOC SCI MED, V55, P755, DOI 10.1016/S0277-9536(01)00201-5; LOHR KN, 1986, MED CARE, V24, pUS1; MANNING WG, 1987, AM ECON REV, V77, P251; Oh HJ, 2011, J KOREAN MED ASSOC, V54, P205, DOI 10.5124/jkma.2011.54.2.205; POHLMEIER W, 1995, J HUM RESOUR, V30, P339, DOI 10.2307/146123; Rodriguez M, 2004, HEALTH ECON, V13, P689, DOI 10.1002/hec.832; Sapelli C, 2003, J HEALTH ECON, V22, P459, DOI 10.1016/S0167-6296(02)00121-2; Song Y.J., 2009, JAPAN MED ASS J, V52, P206, DOI 10.3345/kjp.2009.52.7.752; Vera-Hernandez AM, 1999, HEALTH ECON, V8, P579, DOI 10.1002/(SICI)1099-1050(199911)8:7<579::AID-HEC478>3.0.CO;2-P; Victoor A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-272; Wooldridge J., 2002, ECONOMETRIC ANAL CRO; Yip WC, 1998, HEALTH POLICY PLANN, V13, P311, DOI 10.1093/heapol/13.3.311; Yoon Chai-Hyun, 2007, J Prev Med Public Health, V40, P51; You CH, 2012, J KOREAN MED ASSOC, V55, P898, DOI 10.5124/jkma.2012.55.9.898; 박영희, 2012, [The Korean Journal of Health Service Management, 보건의료산업학회지], V6, P83	31	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0192205	10.1371/journal.pone.0192205	http://dx.doi.org/10.1371/journal.pone.0192205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652882	Green Submitted, gold, Green Published			2022-12-26	WOS:000430026900002
J	Dunne, EM; Murad, C; Sudigdoadi, S; Fadlyana, E; Tarigan, R; Indriyani, SAK; Pell, CL; Watts, E; Satzke, C; Hinds, J; Dewi, NE; Yani, FF; Rusmil, K; Mulholland, EK; Kartasasmita, C				Dunne, Eileen M.; Murad, Chrysanti; Sudigdoadi, Sunaryati; Fadlyana, Eddy; Tarigan, Rodman; Indriyani, Sang Ayu Kompiyang; Pell, Casey L.; Watts, Emma; Satzke, Catherine; Hinds, Jason; Dewi, Nurhandini Eka; Yani, Finny Fitry; Rusmil, Kusnandi; Mulholland, E. Kim; Kartasasmita, Cissy			Carriage of Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in Indonesian children: A cross-sectional study	PLOS ONE			English	Article							NASOPHARYNGEAL CARRIAGE; HEALTHY-CHILDREN; LOMBOK ISLAND; OTITIS-MEDIA; RESISTANCE; VACCINATION; PREVALENCE; BACTERIAL; DENSITY	Streptococcus pneumoniae is an important cause of infection and commonly colonizes the nasopharynx of young children, along with other potentially pathogenic bacteria. The objectives of this study were to estimate the carriage prevalence of S. pneumoniae, Haemophilus influenzae, Moraxella catarrhalis, and Staphylococcus aureus in young children in Indonesia, and to examine interactions between these bacterial species. 302 healthy children aged 12-24 months were enrolled in community health centers in the Bandung, Central Lombok, and Padang regions. Nasopharyngeal swabs were collected and stored according to World Health Organization recommendations, and bacterial species detected by qPCR. Pneumococcal serotyping was conducted by microarray and latex agglutination/Quellung. Overall carriage prevalence was 49.5% for S. pneumoniae, 27.5% for H. influenzae, 42.7% for M. catarrhalis, and 7.3% for S. aureus. Prevalence of M. catarrhalis and S. pneumoniae, as well as pneumococcal serotype distribution, varied by region. Positive associations were observed for S. pneumoniae and M. catarrhalis (OR 3.07 [95%CI 1.91-4.94]), and H. influenzae and M. catarrhalis (OR 2.34 [95%CI 1.40-3.91]), and a negative association was found between M. catarrhalis and S. aureus (OR 0.06 [95%CI 0.01-0.43]). Densities of S. pneumoniae, H. influenzae, and M. catarrhalis were positively correlated when two of these species were present. Prior to pneumococcal vaccine introduction, pneumococcal carriage prevalence and serotype distribution varies among children living in different regions of Indonesia. Positive associations in both carriage and density identified among S. pneumoniae, H. influenzae, and M. catarrhalis suggest a synergistic relationship among these species with potential clinical implications.	[Dunne, Eileen M.; Pell, Casey L.; Watts, Emma; Satzke, Catherine] Murdoch Childrens Res Inst, Pneumococcal Res, Parkville, Vic, Australia; [Dunne, Eileen M.; Satzke, Catherine; Mulholland, E. Kim] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Murad, Chrysanti; Sudigdoadi, Sunaryati] Univ Padjadjaran, Fac Med, Div Microbiol, Dept Biomed Sci, Bandung, West Java, Indonesia; [Fadlyana, Eddy; Tarigan, Rodman; Rusmil, Kusnandi; Kartasasmita, Cissy] Univ Padjadjaran, Dept Child Hlth, Hasan Sadikin Gen Hosp, Bandung, West Java, Indonesia; [Indriyani, Sang Ayu Kompiyang] West Nusa Tenggara Prov Gen Hosp, Mataram, West Nusa Tengg, Indonesia; [Satzke, Catherine] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Parkville, Vic, Australia; [Hinds, Jason] St Georges Univ London, Inst Infect & Immun, London, England; [Hinds, Jason] London Biosci Innovat Ctr, BUGS Biosci, London, England; [Dewi, Nurhandini Eka] Dist Hlth Off Cent Lombok, Praya, West Nusa Tengg, Indonesia; [Yani, Finny Fitry] Univ Andalas, Dept Child Hlth, Padang, West Sumatra, Indonesia; [Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England	Murdoch Children's Research Institute; University of Melbourne; Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran; University of Melbourne; St Georges University London; University of London; University of London Royal Veterinary College; Universitas Andalas; University of London; London School of Hygiene & Tropical Medicine	Kartasasmita, C (corresponding author), Univ Padjadjaran, Dept Child Hlth, Hasan Sadikin Gen Hosp, Bandung, West Java, Indonesia.	cbkarta@gmail.com	Dunne, Eileen M/M-3203-2019	Dunne, Eileen M/0000-0001-5542-0780	BUGS Bioscience; PATH Vaccine Solutions; Victorian Government's Operational Infrastructure Support Program	BUGS Bioscience; PATH Vaccine Solutions; Victorian Government's Operational Infrastructure Support Program	JH is affiliated with BUGS Bioscience, London Bioscience Innovation Centre but is not employed by and receives no personal income from BUGS Bioscience. This study was funded by PATH Vaccine Solutions https"//www.path.org/.Murdoch Children's Research Institute was supported by the Victorian Government's Operational Infrastructure Support Program. PATH Vaccine Solutions was involved in discussions relating to study design and provided salary support for EMD, CM, SS, RT, SAKI, CLP, EW, NED, FFY, KR, EKM, and CK. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript.	Adegbola RA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103293; [Anonymous], 2011, LAB METHODS DIAGNOSI, V2nd; Armbruster CE, 2010, MBIO, V1, DOI 10.1128/mBio.00102-10; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bosch AATM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003057; Carvalho MDS, 2007, J CLIN MICROBIOL, V45, P2460, DOI 10.1128/JCM.02498-06; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Chochua S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167725; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Dunne EM, 2012, J CLIN MICROBIOL, V50, P1034, DOI 10.1128/JCM.06589-11; Farida H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087431; Gessner BD, 1998, PEDIATR INFECT DIS J, V17, pS179, DOI 10.1097/00006454-199809001-00018; Habib M, 2014, JOVE-J VIS EXP, DOI 10.3791/51208; Hadinegoro SR, 2016, SE ASIAN J TROP MED, V47, P485; Huong TTV, 2011, PEDIATR INFECT DIS J, V30, P11, DOI 10.1097/INF.0b013e3181f111a2; Kandasamy R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114286; Lewnard JA, 2016, J INFECT DIS, V214, P1411, DOI 10.1093/infdis/jiw381; Mackenzie GA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-304; Manna S, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.06.031; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; O'Brien KL, 2001, J CLIN MICROBIOL, V39, P1021, DOI 10.1128/JCM.39.3.1021-1024.2001; Ortika Belinda D, 2013, BMC Res Notes, V6, P49, DOI 10.1186/1756-0500-6-49; Perez AC, 2014, PATHOG DIS, V70, P280, DOI 10.1111/2049-632X.12129; Porter BD, 2014, JOVE-J VIS EXP, DOI 10.3791/51747; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Ruohola A, 2013, J INFECTION, V66, P247, DOI 10.1016/j.jinf.2012.12.002; Salter SJ, 2012, MICROBIOL-SGM, V158, P1560, DOI 10.1099/mic.0.056580-0; Satzke C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001903; Satzke C, 2013, VACCINE, V32, P165, DOI 10.1016/j.vaccine.2013.08.062; Short KR, 2012, MBIO, V3, DOI 10.1128/mBio.00255-12; Simell B, 2012, EXPERT REV VACCINES, V11, P841, DOI [10.1586/ERV.12.53, 10.1586/erv.12.53]; Soewignjo S, 2001, CLIN INFECT DIS, V32, P1039, DOI 10.1086/319605; Turner P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038271; van Selm S, 2003, INFECT IMMUN, V71, P6192, DOI 10.1128/IAI.71.11.6192-6198.2003; Vergison A, 2008, VACCINE, V26, pG5, DOI 10.1016/j.vaccine.2008.11.006; Weimer KED, 2011, J INFECT DIS, V203, P549, DOI 10.1093/infdis/jiq087	36	29	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195098	10.1371/journal.pone.0195098	http://dx.doi.org/10.1371/journal.pone.0195098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649269	Green Published, Green Accepted, gold			2022-12-26	WOS:000429791900023
J	Erdei, Z; Schamberger, A; Torok, G; Szebenyi, K; Varady, G; Orban, TI; Homolya, L; Sarkadi, B; Apati, A				Erdei, Zsuzsa; Schamberger, Anita; Torok, Gyorgy; Szebenyi, Kornelia; Varady, Gyorgy; Orban, Tamas I.; Homolya, Laszlo; Sarkadi, Balks; Apati, Agota			Generation of multidrug resistant human tissues by overexpression of the ABCG2 multidrug transporter in embryonic stem cells	PLOS ONE			English	Article							SUBSTRATE-SPECIFICITY; PROTEIN TRANSPORTER; EXPRESSION PATTERN; DRUG TRANSPORTERS; NULL ALLELES; DIFFERENTIATION; SYSTEM; LOCALIZATION; BCRP/ABCG2; PHENOTYPE	The ABCG2 multidrug transporter provides resistance against various endo- and xenobiotics, and protects the stem cells against toxins and stress conditions. We have shown earlier that a GFP-tagged version of ABCG2 is fully functional and may be used to follow the expression, localization and function of this transporter in living cells. In the present work we have overexpressed GFP-ABCG2, driven by a constitutive (CAG) promoter, in HUES9 human embryonic stem cells. Stem cell clones were generated to express the wild-type and a substrate-mutant (R482G) GFP-ABCG2 variant, by using the Sleeping Beauty transposon system. We found that the stable overexpression of these transgenes did not change the pluripotency and growth properties of the stem cells, nor their differentiation capacity to hepatocytes or cardiomyocytes. ABCG2 overexpression provided increased toxin resistance in the stem cells, and protected the derived cardiomyocytes against doxorubicin toxicity. These studies document the potential of a stable ABCG2 expression for engineering toxin-resistant human pluripotent stem cells and selected stem cell derived tissues.	[Erdei, Zsuzsa; Schamberger, Anita; Torok, Gyorgy; Szebenyi, Kornelia; Varady, Gyorgy; Orban, Tamas I.; Homolya, Laszlo; Sarkadi, Balks; Apati, Agota] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary; [Sarkadi, Balks] Semmelweis Univ, Inst Biophys & Radiat Biol, Budapest, Hungary	Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University	Apati, A (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Enzymol, Budapest, Hungary.	apati@biomembranc.hu	György, Várady/J-8118-2017; Apáti, Ágota/N-1697-2019; Homolya, Laszlo/N-1154-2016; Orban, Tamas/N-1160-2016	Apáti, Ágota/0000-0003-0380-8139; Homolya, Laszlo/0000-0003-1639-8140; Orban, Tamas/0000-0002-3424-3428; Szebenyi, Kornelia/0000-0003-1558-8372	National Research, Development and Innovation Office [KTIAAIK 12-1-2012-0025]; OTKA (Hungary) [K115375, PD121287, K112112]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary); OTKA (Hungary)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	This research has been supported by National Research, Development and Innovation Office (http//nkfihgov.hu/english) grants KTIAAIK 12-1-2012-0025 (LH) and OTKA K115375 (BS), PD121287 (AS), K112112 (TIO) (Hungary). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apati A, 2016, EXPERT OPIN DRUG MET, V12, P77, DOI 10.1517/17425255.2016.1121382; Apati A, 2008, BBA-BIOMEMBRANES, V1778, P2700, DOI 10.1016/j.bbamem.2008.08.010; Asakura A, 2002, EXP HEMATOL, V30, P1339, DOI 10.1016/S0301-472X(02)00954-2; Cai J, 2008, PROTOCOL DIRECTED DI; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Das B, 2012, STEM CELLS, V30, P1685, DOI 10.1002/stem.1142; de Jonge-Peeters SDPWM, 2007, CRIT REV ONCOL HEMAT, V62, P214, DOI 10.1016/j.critrevonc.2007.02.003; Desuzinges-Mandon E, 2010, J BIOL CHEM, V285, P33123, DOI 10.1074/jbc.M110.139170; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; Doyle MJ, 2016, STEM CELLS DEV, V25, P277, DOI 10.1089/scd.2015.0272; Erdei Z, 2014, CYTOM PART B-CLIN CY, V86, P299, DOI 10.1002/cyto.b.21168; Erdei Z, 2013, EUR BIOPHYS J BIOPHY, V42, P169, DOI 10.1007/s00249-012-0838-0; Homolya L, 1996, BRIT J CANCER, V73, P849, DOI 10.1038/bjc.1996.151; Honjo Y, 2001, CANCER RES, V61, P6635; Huls M, 2008, KIDNEY INT, V73, P220, DOI 10.1038/sj.ki.5002645; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Kolacsek O, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-5; Krishnamurthy P, 2004, J BIOL CHEM, V279, P24218, DOI 10.1074/jbc.M313599200; Krishnamurthy P, 2011, CURR PHARM BIOTECHNO, V12, P647, DOI 10.2174/138920111795163995; Larderet G, 2006, STEM CELLS, V24, P965, DOI 10.1634/stemcells.2005-0196; Liang Y, 2015, PROTEIN CELL, V6, P334, DOI 10.1007/s13238-015-0148-2; Maillet A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25333; Maliepaard M, 2001, CANCER RES, V61, P3458; Matsuo H, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000237; Nerada Z, 2016, CYTOM PART A, V89A, P826, DOI 10.1002/cyto.a.22931; Orban TI, 2008, BIOCHEM BIOPH RES CO, V367, P667, DOI 10.1016/j.bbrc.2007.12.172; Orban TI, 2009, STEM CELLS, V27, P1077, DOI 10.1002/stem.45; Ozvegy C, 2002, J BIOL CHEM, V277, P47980, DOI 10.1074/jbc.M207857200; Padmanabhan R, 2012, STEM CELLS, V30, P2175, DOI 10.1002/stem.1195; Saison C, 2012, NAT GENET, V44, P174, DOI 10.1038/ng.1070; Sarkadi B, 2004, FEBS LETT, V567, P116, DOI 10.1016/j.febslet.2004.03.123; Sarkadi B, 2006, PHYSIOL REV, V86, P1179, DOI 10.1152/physrev.00037.2005; Sarkadi B, 2010, STEM CELLS, V28, P174, DOI 10.1002/stem.262; Schwabedissen HEMZ, 2011, HANDB EXP PHARMACOL, V201, P325, DOI 10.1007/978-3-642-14541-4_9; Si-Tayeb K, 2010, HEPATOLOGY, V51, P297, DOI 10.1002/hep.23354; Swierczek M, 2012, EXPERT OPIN BIOL TH, V12, P139, DOI 10.1517/14712598.2012.642358; Szebenyi K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12645; Telford WG, 2010, CURR PROTOC CYTOM; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Vander Borght S, 2006, J HISTOCHEM CYTOCHEM, V54, P1051, DOI 10.1369/jhc.5A6912.2006; Woodward OM, 2013, P NATL ACAD SCI USA, V110, P5223, DOI 10.1073/pnas.1214530110; Yellamilli A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00102; Zelinski T, 2012, NAT GENET, V44, P131, DOI 10.1038/ng.1075; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	45	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194925	10.1371/journal.pone.0194925	http://dx.doi.org/10.1371/journal.pone.0194925			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649238	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000429791900018
J	Jia, PL; Tang, L; Yu, JJ; Liu, JL; Kang, DY; Sun, X				Jia, Pengli; Tang, Li; Yu, Jiajie; Liu, Jiali; Kang, Deying; Sun, Xin			The quality of reporting in randomized controlled trials of acupuncture for knee osteoarthritis: A cross-sectional survey	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY	Objective To assess the reporting quality of acupuncture trials for knee osteoarthritis (KOA), and explore the factors associated with the reporting. Method Three English and four Chinese databases were searched from inception to December 2016 for randomized control trials testing effects of acupuncture for knee osteoarthritis. We used the standard CONSORT (2010 version), CONSORT Extension for Non-Pharmacological Treatments, and STRICTA for measuring the quality of reporting. Using pre-specified study characteristics, we undertook regression analyses to examine factors associated with the reporting quality. Results A total of 318 RCT reports were included. For the standard CONSORT, ten items were substantially under-reported (reported in less than 5% of RCTs), including specification of important changes to methods after trial commencement (0.6%), description of any changes to trial outcomes (0.0%), implementation of interim analyses and stopping guidelines (0.6%), statement about why the trial ended or was stopped (1.6%), statement about the registration status (4.4%), accessibility of full trial protocol (4.7%), implementation of randomization (4.7%), description of the similarity of interventions (3.5%), conduct of ancillary analyses (3.8%) and presentation of methods for additional analyses (4.4%). Four of the STRICTA items were under-reported (reported in less than 10% of RCTs), including description of acupuncture style (8.5%), presentation of extent to which treatment varied (1.3%), statement of practitioner background (7.2%) and rationale for the control (9.1%). For CONSORT Extension, the reporting was poor across all items (reported in less than 10% of trials). Trials including authors with expertise in epidemiology or statistics, published in English, or enrolling patients from multiple centers were more likely to have better reporting. Conclusions The reporting in RCTs of acupuncture for KOA was generally poor. To improve the reporting quality, journals should encourage strict adherence to the reporting guidelines.	[Jia, Pengli; Tang, Li; Yu, Jiajie; Liu, Jiali; Kang, Deying; Sun, Xin] Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China	Sichuan University	Sun, X (corresponding author), Sichuan Univ, West China Hosp, Chinese Evidence Based Med Ctr, Chengdu, Sichuan, Peoples R China.	sunx79@hotmail.com	jiajia, yu/AAP-4507-2020		National Natural Science Foundation of China [81590955]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China No. 81590955.	Adetugbo K, 2000, ARCH DERMATOL, V136, P381, DOI 10.1001/archderm.136.3.381; Adie S, 2013, ANN SURG, V258, P872, DOI 10.1097/SLA.0b013e31829664b9; Al Rashoud AS, 2014, PHYSIOTHERAPY, V100, P242, DOI 10.1016/j.physio.2013.09.007; Bala MM, 2013, J CLIN EPIDEMIOL, V66, P286, DOI 10.1016/j.jclinepi.2012.10.005; Bath FJ, 1998, STROKE, V29, P2203, DOI 10.1161/01.STR.29.10.2203; BERMAN BM, 1995, OSTEOARTHR CARTILAGE, V3, P139, DOI 10.1016/S1063-4584(05)80046-9; Berman BM, 1999, RHEUMATOLOGY, V38, P346, DOI 10.1093/rheumatology/38.4.346; Berman BM, 2004, ANN INTERN MED, V141, P901, DOI 10.7326/0003-4819-141-12-200412210-00006; Bhandari M, 2002, J BONE JOINT SURG AM, V84A, P388, DOI 10.2106/00004623-200203000-00009; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brinkhaus B, 2007, COMPLEMENT THER MED, V15, P180, DOI 10.1016/j.ctim.2006.04.003; Chen LX, 2013, JCR-J CLIN RHEUMATOL, V19, P308, DOI 10.1097/RHU.0b013e3182a21848; Chen RX, 2010, BMC COMPLEM ALTERN M, V10, DOI 10.1186/1472-6882-10-32; Chen XY, 2015, MOL PAIN, V11, DOI 10.1186/s12990-015-0071-9; Chen XY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06482; Foster NE, 2007, BMJ-BRIT MED J, V335, P436, DOI 10.1136/bmj.39280.509803.BE; Halpern SH, 2004, INT J OBSTET ANESTH, V13, P207, DOI 10.1016/j.ijoa.2004.03.009; He J, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-122; Hoffmann TC, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f3755; Huang W, 2010, J AM GERIATR SOC, V58, P1218, DOI 10.1111/j.1532-5415.2010.02886.x; Jubb RW, 2008, ACUPUNCT MED, V26, P69, DOI 10.1136/aim.26.2.69; Karner M, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/427265; Kim KH, 2014, BMJ OPEN, V7; Kim K, 2014, ADV MECH ENG, DOI 10.1155/2014/124037; Lansdown H, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-130; Liu Xue-Ting, 2015, J Evid Based Med, V8, P192, DOI 10.1111/jebm.12173; Lu LM, 2017, CHIN J INTEGR MED, V23, P10, DOI 10.1007/s11655-016-2451-z; Lu X, 2011, PLOS ONE, V2; Ma B, 2016, PLOS ONE, V1; MacPherson H., 2010, J EVID-BASED MED, V3, P140, DOI [10.1111/j.1756-5391.2010.01086.x, DOI 10.1111/J.1756-5391.2010.01086.X]; Magden ER, 2013, J AM ASSOC LAB ANIM, V52, P475; [毛兵 Mao Bing], 2006, [中国循证医学杂志, Chinese Journal of Evidence-Based Medicine], V6, P297; Martins F, 2014, CLIN J PAIN, V30, P953, DOI 10.1097/AJP.0000000000000062; Miao Edwin Yong, 2010, Zhong Xi Yi Jie He Xue Bao, V8, P1133; Moher D, 2001, JAMA-J AM MED ASSOC, V15, P1992, DOI DOI 10.1001/jama.285.15.1992; Paramore LC, 1997, J PAIN SYMPTOM MANAG, V13, P83, DOI 10.1016/S0885-3924(96)00299-0; Prady SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001577; Purepong N., 2008, ACUPUNCTURE MANAGEME; Purepong N, 2012, ACUPUNCT MED, V30, P187, DOI 10.1136/acupmed-2012-010140; Sangdee Chaichan, 2002, BMC Complement Altern Med, V2, P3, DOI 10.1186/1472-6882-2-3; Scharf HP, 2006, ANN INTERN MED, V145, P12, DOI 10.7326/0003-4819-145-1-200607040-00005; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Singh BB, 2001, ALTERN THER HEALTH M, V7, P58; Spaeth RB, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/204259; Tukmachi E, 2004, ACUPUNCT MED, V1, P14; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; Turner L, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000030.pub2; White Adrian, 2016, Pilot Feasibility Stud, V2, P10, DOI 10.1186/s40814-016-0051-5; White P, 2010, ACUPUNCT MED, V28, P120, DOI 10.1136/aim.2009.001768; Williamson L, 2007, RHEUMATOLOGY, V46, P1445, DOI 10.1093/rheumatology/kem119; Witt C, 2005, LANCET, V366, P136, DOI 10.1016/S0140-6736(05)66871-7	51	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195652	10.1371/journal.pone.0195652	http://dx.doi.org/10.1371/journal.pone.0195652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649270	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900067
J	Facente, SN; Grebe, E; Burk, K; Morris, MD; Murphy, EL; Mirzazadeh, A; Smith, AA; Sanchez, MA; Evans, JL; Nishimura, A; Raymond, HF				Facente, Shelley N.; Grebe, Eduard; Burk, Katie; Morris, Meghan D.; Murphy, Edward L.; Mirzazadeh, Ali; Smith, Aaron A.; Sanchez, Melissa A.; Evans, Jennifer L.; Nishimura, Amy; Raymond, Henry F.		End Hep CSF	Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination	PLOS ONE			English	Article							VIRUS-INFECTION; UNITED-STATES; GENDER-DIFFERENCES; CARE SERVICES; INJECT DRUGS; MEN; SEX; TRANSMISSION; PREVENTION; PEOPLE	Background Initiated in 2016, End Hep C SF is a comprehensive initiative to eliminate hepatitis C (HCV) infection in San Francisco. The introduction of direct-acting antivirals to treat and cure HCV provides an opportunity for elimination. To properly measure progress, an estimate of baseline HCV prevalence, and of the number of people in various subpopulations with active HCV infection, is required to target and measure the impact of interventions. Our analysis was designed to incorporate multiple relevant data sources and estimate HCV burden for the San Francisco population as a whole, including specific key populations at higher risk of infection. Methods Our estimates are based on triangulation of data found in case registries, medical records, observational studies, and published literature from 2010 through 2017. We examined subpopulations based on sex, age and/or HCV risk group. When multiple sources of data were available for subpopulation estimates, we calculated a weighted average using inverse variance weighting. Credible ranges (CRs) were derived from 95% confidence intervals of population size and prevalence estimates. Results We estimate that 21,758 residents of San Francisco are HCV seropositive (CR: 10,274-42,067), representing an overall seroprevalence of 2.5% (CR: 1.2%-4.9%). Of these, 16,408 are estimated to be viremic (CR: 6,505-37,407), though this estimate includes treated cases; up to 12,257 of these (CR: 2,354-33,256) are people who are untreated and infectious. People who injected drugs in the last year represent 67.9% of viremic HCV infections. Conclusions We estimated approximately 7,400 (51%) more HCV seropositive cases than are included in San Francisco's HCV surveillance case registry. Our estimate provides a useful baseline against which the impact of End Hep C SF can be measured.	[Facente, Shelley N.] Facente Consulting, Richmond, CA 94804 USA; [Facente, Shelley N.; Morris, Meghan D.; Murphy, Edward L.; Mirzazadeh, Ali; Evans, Jennifer L.; Raymond, Henry F.] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Grebe, Eduard] Stellenbosch Univ, SACEMA, Stellenbosch, South Africa; [Burk, Katie; Smith, Aaron A.; Sanchez, Melissa A.; Nishimura, Amy] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Murphy, Edward L.] Blood Syst Res Inst, San Francisco, CA USA; [Raymond, Henry F.] Rutgers State Univ, Sch Publ Hlth, Dept Epidemiol, Piscataway, NJ USA	University of California System; University of California San Francisco; Stellenbosch University; San Francisco Department of Public Health; Vitalant; Vitalant Research Institute; Rutgers State University New Brunswick	Facente, SN (corresponding author), Facente Consulting, Richmond, CA 94804 USA.; Facente, SN (corresponding author), Univ Calif San Francisco, San Francisco, CA 94143 USA.	shelley@facenteconsulting.com	Mirzazadeh, Ali/AAJ-5907-2021; Facente, Shelley/M-1147-2019	Raymond, Henry/0000-0001-8621-2749; Grebe, Eduard/0000-0001-7046-7245	AbbVie, Inc.; Facente Consulting	AbbVie, Inc.(Abbott LaboratoriesAbbVie); Facente Consulting	This study was supported through a charitable donation from AbbVie, Inc., awarded to End Hep C SF, which the initiative used to pay for the time of SNF and EG to execute this analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Shelley N. Facente is affiliated to Facente Consulting. Facente Consulting provided support in the form of salary for author SNF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Adams Deborah A, 2016, MMWR Morb Mortal Wkly Rep, V63, P1, DOI 10.15585/mmwr.mm6354a1; Atsma F, 2011, TRANSFUSION, V51, P1883, DOI 10.1111/j.1537-2995.2011.03270.x; Benova L, 2014, CLIN INFECT DIS, V59, P765, DOI 10.1093/cid/ciu447; Bertakis KD, 2000, J FAM PRACTICE, V49, P147; Burstow NJ, 2017, INT J GEN MED, V10, P39, DOI 10.2147/IJGM.S127689; Busch MP, 2005, CLIN INFECT DIS, V40, P959, DOI 10.1086/428583; Chen YH, 2016, AIDS BEHAV, V20, P2914, DOI 10.1007/s10461-015-1268-7; Dodd RY, 2016, TRANSFUSION; End Hep C SF, 2017, END HEP C SF STRAT P; Grey JA, 2016, JMIR PUBLIC HLTH SUR, V2, P1; Hagan LM, 2013, TRENDS MICROBIOL, V21, P625, DOI 10.1016/j.tim.2013.09.008; Hughes AJ, 2017, J URBAN HEALTH, V94, P350, DOI 10.1007/s11524-017-0145-2; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Martin NK, 2015, CURR OPIN HIV AIDS, V10, P374, DOI 10.1097/COH.0000000000000179; Mast EE, 2005, J INFECT DIS, V192, P1880, DOI 10.1086/497701; National Cancer Institute, 2014, STAT CANC PROF INC R; National Center for Health Statistics, 2012, NAT HLTH NUTR EX SUR; New York State Hepatitis C Elimination Campaign, 2017, END HEP C NY; Perlman DC, 2014, J ADDICT DIS, V33, P322, DOI 10.1080/10550887.2014.969623; Prasad M, 2012, AM J OBSTET GYNECOL, V206, pS270, DOI 10.1016/j.ajog.2011.10.615; Raymond HF, 2013, SEX TRANSM INFECT, V89, P383, DOI 10.1136/sextrans-2012-050675; Raymond HF, 2012, SEX TRANSM DIS, V39, P985, DOI 10.1097/OLQ.0b013e3182716e59; Rustgi VK, 2007, J GASTROENTEROL, V42, P513, DOI 10.1007/s00535-007-2064-6; San Francisco Department of Public Health, 2016, HIV EP ANN REP 2015; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Strom BL, 2017, NATL STRATEGY ELIMIN; United States Census Bureau/American Fact Finder, 2015, AG SEX 2015 AM COMM; Vaidya V, 2012, J WOMENS HEALTH, V21, P140, DOI 10.1089/jwh.2011.2876; Wesson P, 2017, INT J TRANSGENDERISM; World Health Organization, 2016, COMB HEP B C REACH E; World Health Organization U and the Global Fund to Fight AIDS Tuberculosis and Malaria, 2009, HIV TRIANG RES GUID; Yaphe S, 2012, SEX TRANSM INFECT, V88, P558, DOI 10.1136/sextrans-2012-050566; Yehia BR, 2014, PLOS ONE, V9, P3, DOI DOI 10.1371/J0URNAL.P0NE.0101554]	33	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195575	10.1371/journal.pone.0195575	http://dx.doi.org/10.1371/journal.pone.0195575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641546	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900074
J	Li, XZ; Mazaleuskaya, LL; Ballantyne, LL; Meng, H; FitzGerald, GA; Funk, CD				Li, Xinzhi; Mazaleuskaya, Liudmila L.; Ballantyne, Laurel L.; Meng, Hu; FitzGerald, Garret A.; Funk, Colin D.			Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions	FASEB JOURNAL			English	Article						eicosanoid; gene targeting; kidney development; kidney function	MEDULLARY INTERSTITIAL-CELLS; ANGIOTENSIN-II; BLOOD-PRESSURE; MACULA DENSA; PHYSIOLOGICAL REGULATION; ANTIINFLAMMATORY DRUGS; GENE DISRUPTION; RAT-KIDNEY; EXPRESSION; INHIBITION	The distinct functions of each cyclooxygenase (COX) isoform in renal homeostasis have been the subject of intense investigation for many years. We took the novel approach of using 3 characterized mouse lines, where the prostaglandin (PG)-endoperoxide synthase genes 1 and 2 (Ptgs1 and Ptgs2) substitute for one another to delineate distinct roles and the potential for COX isoform substitution. Flipped Ptgs genes generate a reversed COX-expression pattern in the kidney, where the knockin COX-2 is highly expressed. Normal nephrogenesis was sustained in all 3 strains at the postnatal stage d 8 (P8). Knockin COX-1 can temporally restore renal function and delay but not prevent renal pathology consequent to COX-2 deletion. Loss of COX-2 in adult COX-1 > COX-2 mice results in severe nephropathy, which leads to impaired renal function. These defects are partially rescued by the knockin COX-2 in Reversa mice, whereas COX-2 can compensate for the loss of COX-1 in COX-2 > COX-1 mice. Intriguingly, the highly expressed knockin COX-2 enzyme barely makes any PGs or thromboxane in neonatal P8 or adult mice, demonstrating that prostanoid biosynthesis requires native COX-1 and cannot be rescued by the knockin COX-2. In summary, the 2 COX isoforms can preferentially compensate for some renal functions, which appears to be independent of the PG-synthetic capacity.Li, X., Mazaleuskaya, L. L., Ballantyne, L. L., Meng, H., FitzGerald, G. A., Funk, C. D. Differential compensation of two cyclooxygenases in renal homeostasis is independent of prostaglandin-synthetic capacity under basal conditions.	[Li, Xinzhi; Ballantyne, Laurel L.; Funk, Colin D.] Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada; [Mazaleuskaya, Liudmila L.; Meng, Hu; FitzGerald, Garret A.] Univ Penn, Inst Translat Med & Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA	Queens University - Canada; University of Pennsylvania; Pennsylvania Medicine	Funk, CD (corresponding author), Queens Univ, Dept Biomed & Mol Sci, 433 Botterell Hall,18 Stuart St, Kingston, ON K7L 3N6, Canada.	funkc@queensu.ca	Li, Xinzhi/X-2650-2019	Funk, Colin/0000-0001-7029-4233	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [U54 HL117798]; Canadian Institutes of Health Research [MOP142476]; NIH [T32 HL07971]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007971, U54HL117798] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant U54 HL117798. C.D.F. holds a Tier 1 Canada Research Chair in Molecular, Cellular, and Physiological Medicine, and is supported by the Canadian Institutes of Health Research Grant MOP142476. G.A.F. is the McNeil Professor in Translational Medicine and Therapeutics. L.L.M. was supported by NIH Training Grant T32 HL07971. The authors declare no conflicts of interest.	Ahmetaj-Shala B, 2015, CIRCULATION, V131, P633, DOI 10.1161/CIRCULATIONAHA.114.011591; Athirakul K, 2001, KIDNEY INT, V60, P2324, DOI 10.1046/j.1523-1755.2001.00072.x; Campean V, 2003, AM J PHYSIOL-RENAL, V285, pF19, DOI 10.1152/ajprenal.00443.2002; Catella-Lawson F, 2001, NEW ENGL J MED, V345, P1809, DOI 10.1056/NEJMoa003199; Cheng HF, 1999, J CLIN INVEST, V103, P953, DOI 10.1172/JCI5505; DIBONA GF, 1986, AM J MED, V80, P12, DOI 10.1016/0002-9343(86)90928-9; DINCHUK JE, 1995, NATURE, V378, P406, DOI 10.1038/378406a0; DUNN MJ, 1980, KIDNEY INT, V18, P609, DOI 10.1038/ki.1980.179; FitzGerald GA, 2001, NEW ENGL J MED, V345, P433, DOI 10.1056/NEJM200108093450607; Frolich S, 2017, KIDNEY INT, V91, P818, DOI 10.1016/j.kint.2016.11.003; Gonzalez JD, 2000, J CARDIOVASC PHARM, V36, P236, DOI 10.1097/00005344-200008000-00014; Grosser T, 2006, THROMB HAEMOSTASIS, V96, P393, DOI 10.1160/TH06-08-0444; Guan YF, 1997, AM J PHYSIOL-RENAL, V273, pF18, DOI 10.1152/ajprenal.1997.273.1.F18; Hao CM, 2008, ANNU REV PHYSIOL, V70, P357, DOI 10.1146/annurev.physiol.70.113006.100614; Hao CM, 1999, AM J PHYSIOL-RENAL, V277, pF352, DOI 10.1152/ajprenal.1999.277.3.F352; Hao CM, 2000, J CLIN INVEST, V106, P973, DOI 10.1172/JCI9956; Harris Raymond C, 2013, Trans Am Clin Climatol Assoc, V124, P139; HARRIS RC, 1994, J CLIN INVEST, V94, P2504, DOI 10.1172/JCI117620; Harris RC, 2001, AM J PHYSIOL-RENAL, V281, pF1, DOI 10.1152/ajprenal.2001.281.1.F1; Khan KNM, 2002, KIDNEY INT, V61, P1210, DOI 10.1046/j.1523-1755.2002.00263.x; Komhoff M, 2000, KIDNEY INT, V57, P414; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; LARSSON C, 1973, EUR J PHARMACOL, V21, P30, DOI 10.1016/0014-2999(73)90202-1; Li XZ, 2018, J LIPID RES, V59, P102, DOI 10.1194/jlr.M080028; Li XZ, 2018, J LIPID RES, V59, P89, DOI 10.1194/jlr.M079996; Liu Y, 2014, AM J PHYSIOL-RENAL, V307, pF388, DOI 10.1152/ajprenal.00512.2013; Mann B, 2001, KIDNEY INT, V59, P62, DOI 10.1046/j.1523-1755.2001.00466.x; MORHAM SG, 1995, CELL, V83, P473, DOI 10.1016/0092-8674(95)90125-6; Mukherjee D, 2001, JAMA-J AM MED ASSOC, V286, P954, DOI 10.1001/jama.286.8.954; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; Qi ZH, 2006, HYPERTENSION, V48, P323, DOI 10.1161/01.HYP.0000231934.67549.b7; Rodriguez F, 2000, HYPERTENSION, V36, P276, DOI 10.1161/01.HYP.36.2.276; Seta F, 2009, AM J PHYSIOL-REG I, V296, pR1751, DOI 10.1152/ajpregu.90985.2008; Slattery P, 2016, AM J PHYSIOL-RENAL, V310, pF1113, DOI 10.1152/ajprenal.00430.2015; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Wang JL, 1999, HYPERTENSION, V34, P96, DOI 10.1161/01.HYP.34.1.96; Wolf K, 1999, HYPERTENSION, V34, P503, DOI 10.1161/01.HYP.34.3.503; Yang TX, 2017, FRONT BIOSCI-LANDMRK, V22, P128, DOI 10.2741/4476; Yang TX, 2000, AM J PHYSIOL-RENAL, V279, pF819, DOI 10.1152/ajprenal.2000.279.5.F819; Yang TX, 1999, AM J PHYSIOL-RENAL, V277, pF1, DOI 10.1152/ajprenal.1999.277.1.F1; Yang TX, 1998, AM J PHYSIOL-RENAL, V274, pF481, DOI 10.1152/ajprenal.1998.274.3.F481; Ye WL, 2006, AM J PHYSIOL-RENAL, V290, pF542, DOI 10.1152/ajprenal.00232.2005; Yu Y, 2005, J CLIN INVEST, V115, P986, DOI 10.1172/JCI23683; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200; Yu Y, 2006, NAT MED, V12, P699, DOI 10.1038/nm1412; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787; Yu Y, 2010, CIRC RES, V106, P337, DOI 10.1161/CIRCRESAHA.109.204529; Zhang JY, 2002, PROSTAG OTH LIPID M, V67, P121, DOI 10.1016/S0090-6980(01)00177-0	49	3	3	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2018	32	10					5326	5337		10.1096/fj.201800252R	http://dx.doi.org/10.1096/fj.201800252R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GX7RI	29676940	Green Published			2022-12-26	WOS:000447972500011
J	Halawani, D; Gogonea, V; DiDonato, JA; Pipich, V; Yao, P; China, A; Topbas, C; Vasu, K; Arif, A; Hazen, SL; Fox, PL				Halawani, Dalia; Gogonea, Valentin; DiDonato, Joseph A.; Pipich, Vitaliy; Yao, Peng; China, Arnab; Topbas, Celalettin; Vasu, Kommireddy; Arif, Abul; Hazen, Stanley L.; Fox, Paul L.			Structural control of caspase-generated glutamyl-tRNA synthetase by appended noncatalytic WHEP domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTESTINAL EPITHELIAL-CELLS; TRANSLATIONAL CONTROL; NONCANONICAL FUNCTION; SOLUTION SCATTERING; GENE-EXPRESSION; COMPLEX; APOPTOSIS; CLEAVAGE; PHOSPHORYLATION; BINDING	Aminoacyl-tRNA synthetases are ubiquitous, evolutionarily conserved enzymes catalyzing the conjugation of amino acids onto cognate tRNAs. During eukaryotic evolution, tRNA synthetases have been the targets of persistent structural modifications. These modifications can be additive, as in the evolutionary acquisition of noncatalytic domains, or subtractive, as in the generation of truncated variants through regulated mechanisms such as proteolytic processing, alternative splicing, or coding region polyadenylation. A unique variant is the human glutamyl- prolyl-tRNA synthetase (EPRS) consisting of two fused synthetases joined by a linker containing three copies of the WHEP domain (termed by its presence in tryptophanyl-, histidyl-, and glutamyl-prolyl-tRNA synthetases). Here, we identify site-selective proteolysis as a mechanism that severs the linkage between the EPRS synthetases in vitro and in vivo. Caspase action targeted Asp-929 in the third WHEP domain, thereby separating the two synthetases. Using a neoepitope antibody directed against the newly exposed C terminus, we demonstrate EPRS cleavage at Asp-929 in vitro and in vivo. Biochemical and biophysical characterizations of the N-terminally generated EPRS proteoform containing the glutamyl-tRNA synthetase and most of the linker, including two WHEP domains, combined with structural analysis by small-angle neutron scattering, revealed a role for the WHEP domains in modulating conformations of the catalytic core and GSH-S-transferase-C-terminal-like (GST-C) domain. WHEP-driven conformational rearrangement altered GST-C domain interactions and conferred distinct oligomeric states in solution. Collectively, our results reveal long-range conformational changes imposed by the WHEP domains and illustrate how noncatalytic domains can modulate the global structure of tRNA synthetases in complex eukaryotic systems.	[Halawani, Dalia; Gogonea, Valentin; DiDonato, Joseph A.; China, Arnab; Topbas, Celalettin; Vasu, Kommireddy; Arif, Abul; Hazen, Stanley L.; Fox, Paul L.] Cleveland Clin Fdn, Dept Cellular & Mol Med, Lerner Res Inst, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin Fdn, Ctr Cardiovasc Diagnost & Prevent, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin Fdn, Dept Cardiovasc Med, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Gogonea, Valentin; Topbas, Celalettin] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Pipich, Vitaliy] Forschungszentrum Julich, Julich Ctr Neutron Sci, Outstn Maier Leibnitz Zentrum, Lichtenbergstr 1, D-85747 Garching, Germany; [Yao, Peng] Univ Rochester, Dept Med, Aab Cardiovasc Res Inst, Rochester, NY 14642 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Helmholtz Association; Research Center Julich; University of Rochester	Gogonea, V (corresponding author), Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA.; Fox, PL (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, 9500 Euclid Ave, Cleveland, OH 44195 USA.	v.gogonea@csuohio.edu; foxp@ccf.org	Hazen, Stanley L/ABD-5845-2021; Halawani, Dalia/AAN-3261-2021; Kommireddy, Vasu/C-3928-2018; Yao, Peng/Y-8047-2019	Kommireddy, Vasu/0000-0002-7608-7566; Yao, Peng/0000-0002-1145-3967; Hazen, Stanley/0000-0001-7124-6639; Pipich, Vitaliy/0000-0002-3930-3602; Halawani, Dalia/0000-0003-4738-0656	National Institutes of Health [P01 HL029582, P01 HL076491, R01 GM086430, R01 GM115476, R01 HL128300, R01 HL128268]; American Heart Association National Center Scientist Development Grant [10SDG3930003]; Canadian Institute of Health Research Fellowship; American Heart Association [15POST22450016]; Cleveland State University through the Faculty Scholarship Initiative; Cleveland State University through Faculty Research Development Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128268, P01HL076491, R01HL128300, P01HL029582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086430, R01GM115476] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association National Center Scientist Development Grant(American Heart Association); Canadian Institute of Health Research Fellowship(Canadian Institutes of Health Research (CIHR)); American Heart Association(American Heart Association); Cleveland State University through the Faculty Scholarship Initiative; Cleveland State University through Faculty Research Development Awards; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants P01 HL029582, P01 HL076491, R01 GM086430, and R01 GM115476 (to P. L. F.) Grant R01 HL128300 (to S. L. H.), and Grant R01 HL128268, by American Heart Association National Center Scientist Development Grant 10SDG3930003 (to A. A.), by a Canadian Institute of Health Research Fellowship (to D. H.), and by an American Heart Association Fellowship Award 15POST22450016 (to K. V.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported by Cleveland State University through the Faculty Scholarship Initiative and Faculty Research Development Awards.	Arif A, 2017, NATURE, V542, P357, DOI 10.1038/nature21380; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Bonfils G, 2012, MOL CELL, V46, P105, DOI 10.1016/j.molcel.2012.02.009; Burgon P. G., 2017, SEMIN CELL DEV BIOL, V2017, p[S1084, 30111]; Chang CY, 2016, J BIOL CHEM, V291, P16567, DOI 10.1074/jbc.M116.730812; Chen J. H., 2008, NATURE, V94-97, P451; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Dias J, 2013, J BIOL CHEM, V288, P23979, DOI 10.1074/jbc.M113.489922; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Freist W, 1997, BIOL CHEM, V378, P1313; Grice SJ, 2015, HUM MOL GENET, V24, P4397, DOI 10.1093/hmg/ddv176; Grossmann J, 2002, AM J GASTROENTEROL, V97, P1421, DOI 10.1016/S0002-9270(02)04143-6; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Guinier A, 1938, CR HEBD ACAD SCI, V206, P1374; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Halawani D, 2010, J NEUROSCI, V30, P6132, DOI 10.1523/JNEUROSCI.5874-09.2010; Halawani D, 2009, MOL CELL BIOL, V29, P4484, DOI 10.1128/MCB.00252-09; Han JM, 2006, J BIOL CHEM, V281, P38663, DOI 10.1074/jbc.M605211200; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Havrylenko S, 2015, INT J MOL SCI, V16, P6571, DOI 10.3390/ijms16036571; He R, 2009, BBA-PROTEINS PROTEOM, V1794, P347, DOI 10.1016/j.bbapap.2008.11.003; He WW, 2015, NATURE, V526, P710, DOI 10.1038/nature15510; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; JACROT B, 1981, BIOPOLYMERS, V20, P2413, DOI 10.1002/bip.1981.360201110; Jeong EJ, 2000, BIOCHEMISTRY-US, V39, P15775, DOI 10.1021/bi001393h; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Ko YG, 2001, J BIOL CHEM, V276, P6030, DOI 10.1074/jbc.M006189200; Krajewska M, 1997, CANCER RES, V57, P1605; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Lee JY, 2014, J CELL SCI, V127, P4234, DOI 10.1242/jcs.152470; Lei HY, 2015, J BIOL CHEM, V290, P26314, DOI 10.1074/jbc.M115.681999; Lo WS, 2014, SCIENCE, V345, P328, DOI 10.1126/science.1252943; Mort JS, 2003, BIOCHEM SOC SYMP, V70, P107, DOI 10.1042/bss0700107; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Qin XJ, 2016, J MOL BIOL, V428, P3603, DOI 10.1016/j.jmb.2016.05.018; RABEN N, 1994, J BIOL CHEM, V269, P24277; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; RATINAUD MH, 1983, EUR J BIOCHEM, V135, P471, DOI 10.1111/j.1432-1033.1983.tb07675.x; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; Rho SB, 1996, P NATL ACAD SCI USA, V93, P10128, DOI 10.1073/pnas.93.19.10128; Rho SB, 1998, J BIOL CHEM, V273, P11267, DOI 10.1074/jbc.273.18.11267; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; SCHIMMEL P, 1987, ANNU REV BIOCHEM, V56, P125, DOI 10.1146/annurev.bi.56.070187.001013; Sekine S, 2003, EMBO J, V22, P676, DOI 10.1093/emboj/cdg053; Serdyuk I. N., 2007, METHODS MOL BIOPHYSI, P423; Shalak V, 2001, J BIOL CHEM, V276, P23769, DOI 10.1074/jbc.M100489200; Shalini S, 2015, CELL DEATH DIFFER, V22, P526, DOI 10.1038/cdd.2014.216; Song JN, 2010, BIOINFORMATICS, V26, P752, DOI 10.1093/bioinformatics/btq043; Stoehr G, 2013, MOL CELL PROTEOMICS, V12, P1436, DOI 10.1074/mcp.M112.024679; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; THOMES JC, 1983, EUR J BIOCHEM, V135, P479, DOI 10.1111/j.1432-1033.1983.tb07676.x; Turpaev KT, 1996, EUR J BIOCHEM, V240, P732, DOI 10.1111/j.1432-1033.1996.0732h.x; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Ward JR, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007051; Xu ZW, 2012, STRUCTURE, V20, P1470, DOI 10.1016/j.str.2012.08.001; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Yao P, 2012, CELL, V149, P88, DOI 10.1016/j.cell.2012.02.018; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774; Zhou QS, 2010, NAT STRUCT MOL BIOL, V17, P57, DOI 10.1038/nsmb.1706	66	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 8	2018	293	23					8843	8860		10.1074/jbc.M117.807503	http://dx.doi.org/10.1074/jbc.M117.807503			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ0JZ	29643180	Green Published, hybrid			2022-12-26	WOS:000434941900010
J	Feria, MG; Taborda, NA; Hernandez, JC; Rugeles, MT				Geronimo Feria, Manuel; Andrea Taborda, Natalia; Hernandez, Juan C.; Teresa Rugeles, Maria			HIV replication is associated to inflammasomes activation, IL-1 beta, IL-18 and caspase-1 expression in GALT and peripheral blood	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; CD4(+) T-CELLS; IMMUNE ACTIVATION; DENDRITIC CELLS; INFECTED INDIVIDUALS; RECEPTOR EXPRESSION; NLRP3 INFLAMMASOME; VIRAL REPLICATION; TH17 CELLS; INTERLEUKIN-18	Background Human immunodeficiency virus (HIV) promotes an inflammatory process, leading to the progressive loss of the functional capacity of the immune system. The HIV infection induces alterations in several tissues, but mainly in the gut-associated lymphoid tissue (GALT). However, the degree of GALT deterioration varies among infected individuals. In fact, it has been shown that HIV-controllers, who spontaneously control viral replication, exhibit a lower inflammatory response, and a relative normal frequency and function of most of the immune cells. Inflammasomes are molecular complexes involved in the inflammatory response, being NLRP1, NLRP3, NLRC4, AIM2 and Pyrin inflammasomes, the best characterized so far. These complexes regulate the maturation of cytokines of the IL-1 family, including IL-1 beta and IL-18. These cytokines have been associated with immune activation and expansion of HIV target cells, promoting viral replication. Interesting, some reports indicate that HIV induces the activation of the NLRP3 inflammasome, but the role of this, and other inflammasomes during HIV infection, especially in GALT, remains unclear. Objective To compare the relative expression of inflammasome components and the proinflammatory response related to their activity, between HIV-progressors and HIV-controllers. Methods GALT biopsies and peripheral blood mononuclear cells (PBMCs) from 15 HIV-controllers and 15 HIV-progressors were obtained. The relative expression of the following inflammasome components were evaluated by RT-PCR: NLRP3, NLRC4, NLRP1, AIM2, ASC, Caspase-1, IL-1 beta and IL-18. In addition, plasma concentration of IL-18 was evaluated as an indicator of baseline proinflammatory status. Finally, in supernatants of PBMCs in vitro stimulated with inflammasome agonists, the concentrations of IL-1 beta and IL-18 were quantified by ELISA. Results HIV-progressors exhibited higher expression of IL-1 beta, IL-18 and caspase-1 genes in GALT and PBMCs compared with HIV-controllers. In addition, HIV-progressors had also increased expression of ASC in PBMCs. When plasma levels were evaluated, IL-18 was increased in HIV-progressors. Interesting, these patients also showed an increased production of IL-1 beta in supernatants of PBMCs stimulated in vitro with the agonists of AIM2, NLRP1 and NLRC4 inflammasomes. Finally, the expression of caspase-1, NLRP1, IL-1 beta and IL-18 in GALT or peripheral blood was correlated with CD4+ T-cell count and viral load. Conclusion Our results suggest that during HIV-infection, the required signals to induce the expression of different components of the inflammasomes are produced, both in GALT and in periphery. The activation of these molecular complexes could increase the number of target cells, favoring HIV replication and cell death, promoting the disease progression.	[Geronimo Feria, Manuel; Andrea Taborda, Natalia; Hernandez, Juan C.; Teresa Rugeles, Maria] Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia; [Andrea Taborda, Natalia] Corp Univ Remington, Fac Ciencias Salud, Grp Invest Biomed Uniremington, Programa Med, Medellin, Colombia; [Hernandez, Juan C.] Univ Cooperat Colombia, Fac Med, Infettare, Medellin, Colombia	Universidad de Antioquia; Universidad Cooperativa de Colombia	Rugeles, MT (corresponding author), Univ Antioquia UdeA, Fac Med, Grp Inmunovirol, Medellin, Colombia.	maria.rugeles@udea.edu.co	Hernandez, Juan C./C-1621-2018	Hernandez, Juan C./0000-0002-9200-5698; Rugeles, Maria T./0000-0001-7855-1409; Taborda Vanegas, Natalia Andrea/0000-0001-6085-855X; Taborda, Natalia/0000-0002-6169-0119	Universidad de Antioquia UdeA, CODI UdeA [2014-927]; Universidad Cooperativa de Colombia [1551-VS6]; Corporacion Universitaria Remington - Uniremington [4000000059-16]	Universidad de Antioquia UdeA, CODI UdeA; Universidad Cooperativa de Colombia; Corporacion Universitaria Remington - Uniremington	This work was supported by Universidad de Antioquia UdeA, CODI UdeA (2014-927): Maria Teresa Rugeles Lopez; Universidad Cooperativa de Colombia (1551-VS6): Juan Carlos Hernandez; Corporacion Universitaria Remington - Uniremington (4000000059-16): Natalia Andrea Taborda. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Ahmad R, 2002, J VIROL, V76, P12448, DOI 10.1128/JVI.76.24.12448-12456.2002; Alvarez Y, 2013, J VIROL, V87, P10843, DOI 10.1128/JVI.01838-13; Atluri VSR, 2016, SCI REP, V6, P1, DOI [10.1038/s41598-016-0001-8, DOI 10.1038/S41598-016-0001-8]; Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chattergoon MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004082; Chavarria-Smith J, 2015, IMMUNOL REV, V265, P22, DOI 10.1111/imr.12283; Chivero ET, 2017, J NEUROSCI; Christensen-Quick A, 2016, J VIROL, V90, P7833, DOI 10.1128/JVI.02869-15; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Doyle T, 2015, NAT REV MICROBIOL, V13, P403, DOI 10.1038/nrmicro3449; Duewell P, 2011, J IMMUNOL, V187, P55, DOI 10.4049/jimmunol.1004114; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Gonzalez SM, 2016, IMMUNOL RES, V64, P765, DOI 10.1007/s12026-015-8775-5; Gracie JA, 2003, J LEUKOCYTE BIOL, V73, P213, DOI 10.1189/jlb.0602313; Guo HT, 2014, J BIOL CHEM, V289, P21716, DOI 10.1074/jbc.M114.566620; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hernandez JC, 2016, IMMUNOL RES, V64, P280, DOI 10.1007/s12026-015-8748-8; Hernandez JC, 2014, INTERVIROLOGY, V57, P36, DOI 10.1159/000353902; Hernandez JC, 2011, PROG INFLAMM RES SER, P197, DOI 10.1007/978-3-0348-0148-5_13; Hunt PW, 2012, CURR HIV-AIDS REP, V9, P139, DOI 10.1007/s11904-012-0118-8; Iannello A, 2010, J INFECT DIS, V201, P608, DOI 10.1086/650314; Kanneganti TD, 2007, IMMUNITY, V27, P549, DOI 10.1016/j.immuni.2007.10.002; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Lee TH, 2014, ASIA PAC ALLERGY, V4, P187, DOI 10.5415/apallergy.2014.4.4.187; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Lim HX, 2013, CYTOKINE, V63, P179, DOI 10.1016/j.cyto.2013.04.029; Mamik MK, 2016, J NEUROIMMUNE PHARM, P1; Maresca M, 2003, J BIOMED SCI, V10, P156, DOI 10.1159/000068089; Masters SL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001902; Masumoto J, 2001, J HISTOCHEM CYTOCHEM, V49, P1269, DOI 10.1177/002215540104901009; Mehandru S, 2007, PRN NOTEBOOK, V12, P1; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Neumann D, 2000, J IMMUNOL, V165, P3350, DOI 10.4049/jimmunol.165.6.3350; Neumann K, 2013, NAT IMMUNOL, V14, P1207, DOI 10.1038/ni.2763; Pontillo A, 2013, AIDS RES THER, V10, DOI 10.1186/1742-6405-10-35; Pontillo A, 2012, AIDS, V26, P11, DOI 10.1097/QAD.0b013e32834d697f; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Saylor D, 2016, NAT REV NEUROL, V12, P234, DOI [10.1038/nrneurol.2016.27, 10.1038/nrneurol.2016.53]; Stylianou E, 2003, CLIN EXP IMMUNOL, V132, P462, DOI 10.1046/j.1365-2249.2003.02179.x; Taborda NA, 2015, JAIDS-J ACQ IMM DEF, V70, P115, DOI 10.1097/QAI.0000000000000729; Taborda NA, 2015, AIDS RES HUM RETROV, V31, P636, DOI [10.1089/aid.2014.0325, 10.1089/AID.2014.0325]; Taborda NA, 2014, JAIDS-J ACQ IMM DEF, V66, P365, DOI 10.1097/QAI.0000000000000162; Tominaga K, 2000, INT IMMUNOL, V12, P151, DOI 10.1093/intimm/12.2.151; Veenhuis RT, 2017, CLIN INFECT DIS; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yoshimoto T, 1998, J IMMUNOL, V161, P3400; Zhao Y, 2015, IMMUNOL REV, V265, P85, DOI 10.1111/imr.12293	54	42	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0192845	10.1371/journal.pone.0192845	http://dx.doi.org/10.1371/journal.pone.0192845			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672590	gold, Green Submitted, Green Published			2022-12-26	WOS:000430446800004
J	Sales-Perez, RA; Saski, CA; Noorai, RE; Srivastava, SK; Lawton-Rauh, AL; Nichols, RL; Roma-Burgos, N				Sales-Perez, Reiofeli A.; Saski, Christopher A.; Noorai, Rooksana E.; Srivastava, Subodh K.; Lawton-Rauh, Amy L.; Nichols, Robert L.; Roma-Burgos, Nilda			RNA-Seq transcriptome analysis of Amaranthus palmeri with differential tolerance to glufosinate herbicide	PLOS ONE			English	Article							CONFERS GLYPHOSATE RESISTANCE; GLUTATHIONE S-TRANSFERASES; GOOSEGRASS ELEUSINE-INDICA; INHIBITING HERBICIDES; GLUTAMINE-SYNTHETASE; GENE AMPLIFICATION; PHOSPHINOTHRICIN GLUFOSINATE; CHLORSULFURON RESISTANCE; CYTOCHROME-P450 GENES; AMMONIUM ACCUMULATION	Amaranthus palmeri (Amaranthaceae) is a noxious weed in several agroecosystems and in some cases seriously threatens the sustainability of crop production in North America. Glyphosate-resistant Amaranthus species are widespread, prompting the use of alternatives to glyphosate such as glufosinate, in conjunction with glufosinate-resistant crop cultivars, to help control glyphosate-resistant weeds. An experiment was conducted to analyze the transcriptome of A. palmeri plants that survived exposure to 0.55 kg ha(-1) glufosinate. Since there was no record of glufosinate use at the collection site, survival of plants within the population are likely due to genetic expression that pre-dates selection; in the formal parlance of weed science this is described as natural tolerance. Leaf tissues from glufosinate-treated and non-treated seedlings were harvested 24 h after treatment (HAT) for RNA-Seq analysis. Global gene expression was measured using Illumina DNA sequence reads from non-treated and treated surviving (presumably tolerant, T) and susceptible (S) plants. The same plants were used to determine the mechanisms conferring differential tolerance to glufosinate. The S plants accumulated twice as much ammonia as did the T plants, 24 HAT. The relative copy number of the glufosinate target gene GS2 did not differ between T and S plants, with 1 to 3 GS2 copies in both biotypes. A reference cDNA transcriptome consisting of 72,780 contigs was assembled, with 65,282 sequences putatively annotated. Sequences of GS2 from the transcriptome assembly did not have polymorphisms unique to the tolerant plants. Five hundred sixty-seven genes were differentially expressed between treated T and S plants. Of the upregulated genes in treated T plants, 210 were more highly induced than were the upregulated genes in the treated S plants. Glufosinate-tolerant plants had greater induction of ABC transporter, glutathione S-transferase (GST), NAC transcription factor, nitronate monooxygenase (NMO), chitin elicitor receptor kinase (CERK1), heat shock protein 83, ethylene transcription factor, heat stress transcription factor, NADH-ubiquinone oxidoreductase, ABA 8'-hydroxylase, and cytochrome P450 genes (CYP72A, CYP94A1). Seven candidate genes were selected for validation using quantitative real time-PCR. While GST was upregulated in treated tolerant plants in at least one population, CYP72A219 was consistently highly expressed in all treated tolerant biotypes. These genes are candidates for contributing tolerance to glufosinate. Taken together, these results show that differential induction of stress-protection genes in a population can enable some individuals to survive herbicide application. Elevated expression of detoxification-related genes can get fixed in a population with sustained selection pressure, leading to evolution of resistance. Alternatively, sustained selection pressure could select for mutation(s) in the GS2 gene with the same consequence.	[Sales-Perez, Reiofeli A.; Roma-Burgos, Nilda] Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA; [Saski, Christopher A.; Noorai, Rooksana E.; Srivastava, Subodh K.; Lawton-Rauh, Amy L.] Clemson Univ, Dept Biochem & Genet, Clemson, SC USA; [Nichols, Robert L.] Cotton Inc, Cary, NC USA	University of Arkansas System; University of Arkansas Fayetteville; Clemson University; Cotton Incorporated	Roma-Burgos, N (corresponding author), Univ Arkansas, Dept Crop Soil & Environm Sci, Fayetteville, AR 72701 USA.	nburgos@uark.edu	Noorai, Rooksana E/E-9785-2019	Noorai, Rooksana E/0000-0002-9992-5198; Roma-Burgos, Nilda/0000-0002-6977-6873	Cotton Incorporated [13-773AR]; Cotton Inc.; Arkansas Soybean Promotion Board; National Institute of General Medical Sciences Grant [P20GM109094]; NIFA Hatch Project [ARK02416]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109094] Funding Source: NIH RePORTER	Cotton Incorporated(Cotton R&D Corp); Cotton Inc.(Cotton R&D Corp); Arkansas Soybean Promotion Board; National Institute of General Medical Sciences Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIFA Hatch Project; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Robert Nichols is affiliated, with and receives a salary from, Cotton Incorporated, which was one of the organizations funding the project (Grant #13-773AR to NRB). Funding from Cotton Inc. provided partial salary for the graduate student, Reiofeli Salas as well as research supplies and travel to collect samples. Prof. Nilda Roma Burgos is also supported by Arkansas Soybean Promotion Board. The inclusion of Dr. Robert Nichols as co-author is justified scientifically as he provided much needed broader perspective and technical insight based on years of experience with the genetics, evolution, and management of resistance in insects, nematodes, and plants. He participated in the final stages of manuscript preparation. The roles of Dr. Nichols and Ms. Salas are specified in the 'author contribution' section. Funding for personnel time (co-investigators, staff), computational resources, and research facilities was provided by: National Institute of General Medical Sciences Grant: P20GM109094 to Christopher Saski (CAS); NIFA Hatch Project #ARK02416 grant to Nilda Roma-Burgos (NRB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdeen A, 2009, PLANT BIOTECHNOL J, V7, P266, DOI [10.1111/j.1467-7652.2008.00398.x, 10.1111/j.1467-7652.2009.00398.x]; ANDERSON DM, 1993, WEED RES, V33, P139, DOI 10.1111/j.1365-3180.1993.tb01927.x; Aneja B, 2015, PHYSIOL MOL BIOL PLA, V21, P305, DOI 10.1007/s12298-015-0305-3; Antolin-Llovera M, 2014, NEW PHYTOL, V204, P791, DOI 10.1111/nph.13117; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avila-Garcia WV, 2012, PEST MANAG SCI, V68, P1248, DOI 10.1002/ps.3286; Avila-Garcia WV, 2011, WEED SCI, V59, P305, DOI 10.1614/WS-D-11-00012.1; Baerson SR, 2005, J BIOL CHEM, V280, P21867, DOI 10.1074/jbc.M500694200; Bartholomew DM, 2002, PLANT PHYSIOL, V130, P1562, DOI 10.1104/pp.008334; Bensch CN, 2003, WEED SCI, V51, P37, DOI 10.1614/0043-1745(2003)051[0037:IORPAR]2.0.CO;2; Benveniste I, 2005, PLANTA, V221, P881, DOI 10.1007/s00425-005-1503-y; Blumwald E, 2000, CURR OPIN CELL BIOL, V12, P431, DOI 10.1016/S0955-0674(00)00112-5; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bond JA, 2006, WEED TECHNOL, V20, P885, DOI 10.1614/WT-05-189.1; Botha GM, 2012, THESIS; Bravin F, 2001, WEED RES, V41, P461, DOI 10.1046/j.1365-3180.2001.00250.x; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Burgos NR, 2008, RES SERIES, V573; Burke IC, 2007, WEED TECHNOL, V21, P367, DOI 10.1614/WT-06-058.1; CHRISTOPHER JT, 1991, PLANT PHYSIOL, V95, P1036, DOI 10.1104/pp.95.4.1036; CHRISTOPHER JT, 1994, PESTIC BIOCHEM PHYS, V49, P172, DOI 10.1006/pest.1994.1045; Cocker KM, 2001, PEST MANAG SCI, V57, P587, DOI 10.1002/ps.330; Coetzer E, 2001, WEED SCI, V49, P454, DOI 10.1614/0043-1745(2001)049[0454:PIAAAI]2.0.CO;2; Corbett JL, 2004, WEED TECHNOL, V18, P443, DOI 10.1614/WT-03-139R; COUPLAND D, 1990, PESTIC BIOCHEM PHYS, V36, P61, DOI 10.1016/0048-3575(90)90021-S; Culpepper AS, 2006, WEED SCI, V54, P620, DOI 10.1614/WS-06-001R.1; Cummins I, 1999, PLANT J, V18, P285, DOI 10.1046/j.1365-313X.1999.00452.x; D'Auria JC, 2005, CURR OPIN PLANT BIOL, V8, P308, DOI 10.1016/j.pbi.2005.03.012; Dalton DA, 2009, PLANT PHYSIOL, V150, P521, DOI 10.1104/pp.109.136630; Davis MJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-498; Dayan FE, 2015, WEED SCI, V63, P23, DOI 10.1614/WS-D-13-00063.1; Delye C, 2011, WEED RES, V51, P433, DOI 10.1111/j.1365-3180.2011.00864.x; Delye C, 2013, PEST MANAG SCI, V69, P176, DOI 10.1002/ps.3318; DONN G, 1984, Journal of Molecular and Applied Genetics, V2, P621; DROGELASER W, 1994, PLANT PHYSIOL, V105, P159, DOI 10.1104/pp.105.1.159; EHLERINGER J, 1980, SCIENCE, V210, P1094, DOI 10.1126/science.210.4474.1094; Ehleringer JR, 1997, OECOLOGIA, V112, P285, DOI 10.1007/s004420050311; Everman WJ, 2007, WEED TECHNOL, V21, P695, DOI 10.1614/WT-06-164.1; Everman WJ, 2009, WEED SCI, V57, P357, DOI 10.1614/WS-09-015.1; Everman WJ, 2007, THESIS; Fast BJ, 2009, J COTTON SCI, V13, P32; GAILLARD C, 1994, FEBS LETT, V352, P219, DOI 10.1016/0014-5793(94)00961-9; Gaines TA, 2014, PLANT J, V78, P865, DOI 10.1111/tpj.12514; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Ge X, 2010, PEST MANAG SCI, V66, P345, DOI 10.1002/ps.1911; Ghanim M, 2007, PEST MANAG SCI, V63, P776, DOI 10.1002/ps.1410; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guo DJ, 2001, PLANT CELL, V13, P73, DOI 10.1105/tpc.13.1.73; Heap I, 2016, INT SURVEY HERBICIDE; Hidayat I, 2001, PESTIC BIOCHEM PHYS, V71, P190, DOI 10.1006/pest.2001.2576; Inman MD, 2016, WEED SCI, V64, P161, DOI 10.1614/WS-D-15-00058.1; Inui H, 2005, PEST MANAG SCI, V61, P286, DOI 10.1002/ps.1012; Ireland RJ, 1999, PLANTS AMINO ACIDS B; Iwakami S, 2014, PEST MANAG SCI, V70, P549, DOI 10.1002/ps.3572; Jalaludin A, 2010, WEED BIOL MANAG, V10, P256, DOI 10.1111/j.1445-6664.2010.00392.x; James C., 2013, GLOBAL STATUS COMMER; Jugulam M, 2014, PLANT PHYSIOL, V166, P1200, DOI 10.1104/pp.114.242826; Klein M, 1996, J BIOL CHEM, V271, P29666, DOI 10.1074/jbc.271.47.29666; Kondo S, 2012, J PLANT PHYSIOL, V169, P234, DOI 10.1016/j.jplph.2011.09.007; Kumaratilake AR, 2005, WEED SCI, V53, P10, DOI 10.1614/WS-03-140R; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; Letouze A, 2003, AGRONOMIE, V23, P601, DOI 10.1051/agro:2003036; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu XM, 2015, INT J MOL SCI, V16, P5975, DOI 10.3390/ijms16035975; LOGUSCH EW, 1991, PLANT PHYSIOL, V95, P1057, DOI 10.1104/pp.95.4.1057; Macedo AF, 2012, ABIOTIC STRESS RESPONSES IN PLANTS: METABOLISM, PRODUCTIVITY AND SUSTAINABILITY, P41, DOI 10.1007/978-1-4614-0634-1_3; Martinson K. B., 2005, Crop Management, P1; Massinga RA, 2001, WEED SCI, V49, P202, DOI 10.1614/0043-1745(2001)049[0202:IOPAIC]2.0.CO;2; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Merchant RM, 2014, WEED TECHNOL, V28, P291, DOI 10.1614/WT-D-13-00104.1; Meyer CJ, 2015, WEED TECHNOL, V29, P716, DOI 10.1614/WT-D-15-00045.1; Miflin BJ, 2002, J EXP BOT, V53, P979, DOI 10.1093/jexbot/53.370.979; Mithila J, 2013, ADV CROP SCI TECH, V1, P115, DOI [10.4172/2329-8863.1000115, DOI 10.4172/2329-8863.1000115]; Molin WT, 1995, PESTIC BIOCHEM PHYS, V53, P172, DOI 10.1006/pest.1995.1065; Muller M, 2015, PLANT PHYSIOL, V169, P32, DOI 10.1104/pp.15.00677; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Neve P, 2005, THEOR APPL GENET, V110, P1154, DOI 10.1007/s00122-005-1947-2; Neve P, 2009, NEW PHYTOL, V184, P783, DOI 10.1111/j.1469-8137.2009.03034.x; Nuruzzaman M, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00676; Nuruzzaman M, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00248; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pornprom T, 2000, PESTIC BIOCHEM PHYS, V68, P102, DOI 10.1006/pest.2000.2502; Powles SB, 2010, ANNU REV PLANT BIOL, V61, P317, DOI 10.1146/annurev-arplant-042809-112119; Price AJ, 2016, J SOIL WATER CONSERV, V71, P1, DOI 10.2489/jswc.71.1.1; Reade JPH, 2004, WEED SCI, V52, P468, DOI 10.1614/P2002-168D; Robineau T, 1998, PLANT PHYSIOL, V118, P1049, DOI 10.1104/pp.118.3.1049; Robinson MD, 2008, BIOSTATISTICS, V9, P321, DOI 10.1093/biostatistics/kxm030; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roxas VP, 1997, NAT BIOTECHNOL, V15, P988, DOI 10.1038/nbt1097-988; Saika H, 2014, PLANT PHYSIOL, V166, P1232, DOI 10.1104/pp.113.231266; Salas RA, 2016, PEST MANAG SCI, V72, P864, DOI 10.1002/ps.4241; Salas RA, 2012, PEST MANAG SCI, V68, P1223, DOI 10.1002/ps.3342; Sales MA, 2008, WEED SCI, V56, P485, DOI 10.1614/WS-07-165.1; Scarpeci TE, 2008, PLANT SIGNAL BEHAV, V3, P856, DOI 10.4161/psb.3.10.6021; Sellers BA, 2004, PESTIC BIOCHEM PHYS, V78, P9, DOI 10.1016/j.pestbp.2003.09.006; Seng CT, 2010, WEED BIOL MANAG, V10, P229, DOI 10.1111/j.1445-6664.2010.00388.x; SHIMABUKURO RH, 1971, PLANT PHYSIOL, V47, P10, DOI 10.1104/pp.47.1.10; Sosnoskie LM, 2012, WEED SCI, V60, P366, DOI 10.1614/WS-D-11-00151.1; Srivastava AC, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0403-z; Steckel GJ, 1997, WEED TECHNOL, V11, P484, DOI 10.1017/S0890037X00045292; Steckel LE, 2007, WEED TECHNOL, V21, P567, DOI 10.1614/WT-06-045.1; Sunil M, 2014, DNA RES, V21, P585, DOI 10.1093/dnares/dsu021; TACHIBANA K, 1986, J PESTIC SCI, V11, P33; Tehranchian P, 2017, WEED SCI, V65, P206, DOI 10.1017/wsc.2016.27; Tian Y, 2011, TRANSGENIC RES, V20, P857, DOI 10.1007/s11248-010-9463-9; Tranel PJ, 2002, WEED SCI, V50, P700, DOI 10.1614/0043-1745(2002)050[0700:RROWTA]2.0.CO;2; Tsai CJ, 2006, WEED SCI, V54, P634, DOI 10.1614/WS-06-017R.1; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; Veldhuis LJ, 2000, J AGR FOOD CHEM, V48, P2986, DOI 10.1021/jf990752g; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Ward SM, 2013, WEED TECHNOL, V27, P12, DOI 10.1614/WT-D-12-00113.1; Webster TM, 2012, WEED SCI, V60, P145, DOI 10.1614/WS-D-11-00092.1; WENDLER C, 1990, PHOTOSYNTH RES, V24, P55, DOI 10.1007/BF00032644; Werck-Reichhart D, 2000, TRENDS PLANT SCI, V5, P116, DOI 10.1016/S1360-1385(00)01567-3; Whitaker JR, 2010, WEED TECHNOL, V24, P403, DOI 10.1614/WT-D-09-00043.1; Wiggins MS, 2016, WEED TECHNOL, V30, P415, DOI 10.1614/WT-D-15-00113.1; Wiggins MS, 2015, WEED TECHNOL, V29, P412, DOI 10.1614/WT-D-14-00145.1; WILD A, 1993, Z NATURFORSCH C, V48, P367; WILD A, 1984, Z NATURFORSCH C, V39, P500; Xi J, 2012, PLANT J, V69, P782, DOI 10.1111/j.1365-313X.2011.04830.x; Yang XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075588; Yuan JS, 2007, TRENDS PLANT SCI, V12, P6, DOI 10.1016/j.tplants.2006.11.001; Yun MS, 2005, PESTIC BIOCHEM PHYS, V83, P107, DOI 10.1016/j.pestbp.2005.04.002; Zhai Y, 2013, GENE, V513, P174, DOI 10.1016/j.gene.2012.10.018; Zhang ZJ, 2010, PLANTA, V232, P765, DOI 10.1007/s00425-010-1208-8; Zhou XB, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku310; Zhu J., 2009, THESIS; Zhu JK, 2001, CURR OPIN PLANT BIOL, V4, P401, DOI 10.1016/S1369-5266(00)00192-8	134	23	23	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195488	10.1371/journal.pone.0195488	http://dx.doi.org/10.1371/journal.pone.0195488			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672568	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800030
J	Yang, SH; Wang, Y; Wang, LL; Shi, ZY; Ou, XQ; Wu, D; Zhang, XM; Hui, H; Yuan, J; Wang, W; Cao, FH; Liu, GQ				Yang, Shaohua; Wang, Ying; Wang, Lulu; Shi, Zhaoyuan; Ou, Xiaoqian; Wu, Dan; Zhang, Xinmiao; Hui, Hao; Yuan, Jia; Wang, Wei; Cao, Fuhu; Liu, Guoqing			RNA-Seq reveals differentially expressed genes affecting polyunsaturated fatty acids percentage in the Huangshan Black chicken population	PLOS ONE			English	Article							MEAT QUALITY TRAITS; IN-VIVO; DECORIN; IDENTIFICATION; TISSUES; FADS2; TRANSCRIPTOME; ADIPOGENESIS; ASSOCIATION; METABOLISM	Fatty acids metabolic products determine meat quality in chickens. Identifying genes associated with fatty acids composition could provide valuable information for the complex genetic networks of genes with underlying variations in fatty acids synthesis. RNA sequencing (RNA-Seq) was conducted to explore the chicken transcriptome from the thigh muscle tissue of 6 Huangshan Black Chickens with 3 extremely high and low phenotypic values for percentage of polyunsaturated fatty acids (PUFAs). In total, we obtained 41,139,108-44,901,729 uniquely mapped reads, which covered 74.15% of the current annotated transcripts including 18964 mRNA transcripts, across all the six thigh muscle tissue samples. Of these, we revealed 274 differentially expressed genes (DEGs) with a highly significant correlation with polyunsaturated fatty acids percentage between the comparison groups based on the ratio of PUFA/SFA. Gene ontology and pathway analysis indicated that the DEGs were enriched in particular biological processes affecting fatty acids metabolism, biosynthesis of unsaturated fatty acids (USFAs), and cell junction-related pathways. Integrated interpretation of differential gene expression and formerly reported quantitative trait loci (QTL) demonstrated that FADS2, DCN, FRZB, OGN, PRKAG3, LHFP, CHCHD10, CYTL1, FBLN5, and ADGRD1 are the most promising candidate genes affecting polyunsaturated fatty acids percentage.	[Yang, Shaohua; Wang, Ying; Wang, Lulu; Shi, Zhaoyuan; Ou, Xiaoqian; Wu, Dan; Zhang, Xinmiao; Hui, Hao; Yuan, Jia; Cao, Fuhu; Liu, Guoqing] Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China; [Wang, Wei] Agr Prod Qual & Safety Supervis & Management Bur, Xuancheng, Anhui, Peoples R China	Hefei University of Technology	Cao, FH; Liu, GQ (corresponding author), Hefei Univ Technol, Coll Food Sci & Engn, Hefei, Anhui, Peoples R China.	fhcao@hfut.edu.en; 13675512000@163.com		Cao, Fu-Hu/0000-0002-5484-700X	Industry University-Research in Hefei University of Technology [XC2016JZBZ03]; Fundamental Research Funds for the Central Universities [JZ2017HGTA0228]; innovation Project for College Students [2017CXCYS235]; Wanjiang Institute of Poultry Technology [XC2015AKKG002]; Science and Technology Bureau of AnHui [XC2015XKKJ02, XC2015AKKG003]	Industry University-Research in Hefei University of Technology; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); innovation Project for College Students; Wanjiang Institute of Poultry Technology; Science and Technology Bureau of AnHui	This work was supported by Industry University-Research in Hefei University of Technology XC2016JZBZ03 Dr Shaohua Yang; Fundamental Research Funds for the Central Universities JZ2017HGTA0228 Dr Shaohua Yang; the innovation Project for College Students 2017CXCYS235 Dr Shaohua Yang; Wanjiang Institute of Poultry Technology XC2015AKKG002 Dr Shaohua Yang; the Science and Technology Bureau of AnHui XC2015XKKJ02, XC2015AKKG003 Dr Shaohua Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An J, 2012, J BIOL CHEM, V287, P7411, DOI 10.1074/jbc.M111.277103; Bennett CN, 2002, J BIOL CHEM, V277, P30998, DOI 10.1074/jbc.M204527200; Blech-Hermoni Y, 2015, GENOM DATA, V6, P74, DOI 10.1016/j.gdata.2015.08.014; Buraschi Simone, 2010, J Biol Chem, V285, P42075, DOI 10.1074/jbc.M110.172841; Chan YF, 2012, CURR BIOL, V22, P794, DOI 10.1016/j.cub.2012.03.011; Chen SJ, 2011, EXP EYE RES, V92, P444, DOI 10.1016/j.exer.2010.05.008; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; Demeure O, 2004, ANIM GENET, V35, P123, DOI 10.1111/j.1365-2052.2004.01102.x; Donati G, 2014, P NATL ACAD SCI USA, V111, pE1501, DOI 10.1073/pnas.1312880111; Fan B, 2010, ASIAN AUSTRAL J ANIM, V23, P833, DOI 10.5713/ajas.2010.r.03; Fife MS, 2011, ANIM GENET, V42, P134, DOI 10.1111/j.1365-2052.2010.02090.x; Groenen MAM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-274; Gu XR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021872; Kartikasari LR, 2012, PROSTAG LEUKOTR ESS, V87, P103, DOI 10.1016/j.plefa.2012.07.005; Kongkham PN, 2010, ONCOGENE, V29, P3017, DOI 10.1038/onc.2010.32; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26813; Li WJ, 2009, BRIT POULTRY SCI, V50, P188, DOI 10.1080/00071660902755409; Liu L, 2017, ANIM REPROD SCI, V176, P1, DOI 10.1016/j.anireprosci.2016.11.002; Liu RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061172; Liu WB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028600; Lopes-Marques M, 2017, COMP BIOCHEM PHYS B, V203, P84, DOI 10.1016/j.cbpb.2016.09.007; Lorda-Diez CI, 2014, GENE EXPR PATTERNS, V15, P52, DOI 10.1016/j.gep.2014.04.003; Miao XY, 2015, BIOCHEM BIOPH RES CO, V467, P413, DOI 10.1016/j.bbrc.2015.09.129; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Ogluszka M, 2017, GENES NUTR, V12, DOI 10.1186/s12263-017-0552-8; Okuyama T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02535-0; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Ren LJ, 2009, BIOPROC BIOSYST ENG, V32, P837, DOI 10.1007/s00449-009-0310-4; Schiemann WP, 2002, J BIOL CHEM, V277, P27367, DOI 10.1074/jbc.M200148200; Schonherr E, 2005, J BIOL CHEM, V280, P15767, DOI 10.1074/jbc.M500451200; Solakivi T, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-80; Song ZK, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/928178; Soukas A, 2001, J BIOL CHEM, V276, P34167, DOI 10.1074/jbc.M104421200; Sun Y, 2016, J ANIM BREED GENET, V133, P197, DOI 10.1111/jbg.12186; Szostak A, 2016, GENES NUTR, V11, DOI 10.1186/s12263-016-0517-4; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Truong AD, 2015, VET IMMUNOL IMMUNOP, V166, P116, DOI 10.1016/j.vetimm.2015.06.008; Twining CW, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.165373; Wang J, 2017, COMP BIOCHEM PHYS D, V21, P56, DOI 10.1016/j.cbd.2016.12.003; Wang ZX, 2014, GENE, V543, P198, DOI 10.1016/j.gene.2014.04.023; Wardecka Barbara, 2002, Journal of Applied Genetics, V43, P319; Williamson RE, 2008, HEARING RES, V237, P57, DOI 10.1016/j.heares.2007.12.006; Winder WW, 2000, J APPL PHYSIOL, V88, P2219, DOI 10.1152/jappl.2000.88.6.2219; Xie L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030910; [徐晨希 Xu Chenxi], 2016, [中国农业科学, Scientia Agricultura Sinica], V49, P2194; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; Yang YZ, 2016, ANIM BIOTECHNOL, V27, P13, DOI 10.1080/10495398.2015.1069300; Zagris N, 2011, INT J DEV BIOL, V55, P633, DOI 10.1387/ijdb.113321nz; Zhang T, 2015, GENET MOL RES, V14, P10452, DOI 10.4238/2015.September.8.6; Zhao CJ, 2006, J ANIM BREED GENET, V123, P349, DOI 10.1111/j.1439-0388.2006.00607.x; Zhu SK, 2014, GENET MOL RES, V13, P3329, DOI 10.4238/2014.April.29.11	53	11	11	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195132	10.1371/journal.pone.0195132	http://dx.doi.org/10.1371/journal.pone.0195132			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672513	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800020
J	Aiba, H; Yamada, S; Mizutani, J; Yamamoto, N; Okamoto, H; Hayashi, K; Kimura, H; Takeuchi, A; Miwa, S; Higuchi, T; Abe, K; Taniguchi, Y; Araki, Y; Tsuchiya, H; Otsuka, T				Aiba, Hisaki; Yamada, Satoshi; Mizutani, Jun; Yamamoto, Norio; Okamoto, Hideki; Hayashi, Katsuhiro; Kimura, Hiroaki; Takeuchi, Akihiko; Miwa, Shinji; Higuchi, Takashi; Abe, Kensaku; Taniguchi, Yuta; Araki, Yoshihiro; Tsuchiya, Hiroyuki; Otsuka, Takanobu			Preoperative evaluation of the efficacy of radio-hyperthermo-chemotherapy for soft tissue sarcoma in a case series	PLOS ONE			English	Article							RESPONSE EVALUATION CRITERIA; NEOADJUVANT CHEMOTHERAPY; REGIONAL HYPERTHERMIA; HISTOLOGIC RESPONSE; IN-VITRO; TUMORS; RADIOTHERAPY; ADRIAMYCIN; SENSITIVITY; DEPENDENCE	Purpose Radio-hyperthermo-chemo (RHC) therapy, which combines radiotherapy, hyperthermia, and chemotherapy, for malignant soft tissue tumors has been introduced with the aim of decreasing the possibility of local recurrence after surgery. To avoid unnecessary neoadjuvant therapy and to plan the appropriate surgical treatment, surveillance of RHC therapeutic efficacy during treatment is necessary. In this study, we determined the optimal response criteria to evaluate the efficacy of RHC by comparing preoperative images before and after RHC with pathological evaluation of necrosis in the resected tumor. Patients and methods From 2004 to 2014, 20 patients were enrolled into this study. Needle biopsy revealed 6 cases of myxoid liposarcoma, 6 cases of undifferentiated pleomorphic sarcoma, 4 cases of myxofibrosarcoma, and 4 cases of synovial sarcoma. Based on the Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 or modified RECIST, we calculated the responses to RHC therapy by comparing pre-and post-RHC therapy images. In addition, resected specimens underwent pathological analysis to evaluate response based on tumor necrosis. The correlation between assessment based on preoperative images and resected tumors were evaluated by the Spearman's rank-order correlation coefficient. Result From the surgical specimens, pathological assessment of necrosis in resected tumor were assessed as less than 50% (2 cases), 50-90% (9 cases), 90-99% (6 cases), and total necrosis (3 cases). Use of the RECIST 1.1 underestimated good responders as stable disease (SD) or progressive disease (PD) in 5 out of 15 cases; on the other hand, use of the modified RECIST did not underestimate the pathological assessment of necrosis. The correlations between responses based on preoperative images and those based on histological assessments were 0.23 (RECIST 1.1) and 0.76 (modified RECIST). Conclusion Because pathological responses can be underestimated using the RECIST 1.1, the modified RECIST, which take into consideration tumor viability, as assessed by contrast MRI, should also be considered when evaluating the efficacy of RHC.	[Aiba, Hisaki; Yamada, Satoshi; Mizutani, Jun; Okamoto, Hideki; Kimura, Hiroaki; Miwa, Shinji; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Aiba, Hisaki; Yamamoto, Norio; Hayashi, Katsuhiro; Kimura, Hiroaki; Takeuchi, Akihiko; Miwa, Shinji; Higuchi, Takashi; Abe, Kensaku; Taniguchi, Yuta; Araki, Yoshihiro; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan	Nagoya City University; Kanazawa University	Yamada, S (corresponding author), Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan.	yamada_ncu_ortho@yahoo.co.jp	Takeuchi, Akihiko/AAJ-1563-2020; Hayashi, K/C-4685-2015; Miwa, Shinji/AAI-9309-2020	Takeuchi, Akihiko/0000-0002-4071-5620; Hayashi, K/0000-0001-8665-2154; Miwa, Shinji/0000-0002-5962-8287				Aiba H, 2016, HYPERTHERMIC ONCOLOG, P227; Aiba H, 2018, CANCER MED-US, V7, P1560, DOI 10.1002/cam4.1366; Canter RJ, 2010, ANN SURG ONCOL, V17, P2578, DOI 10.1245/s10434-010-1156-3; Chung PWM, 2009, CANCER-AM CANCER SOC, V115, P3254, DOI 10.1002/cncr.24375; Dalal KM, 2008, J SURG ONCOL, V97, P298, DOI 10.1002/jso.20975; Davis LE, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0346-4; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Haas RLM, 2016, RADIOTHER ONCOL, V119, P14, DOI 10.1016/j.radonc.2015.12.002; HAHN GM, 1975, P NATL ACAD SCI USA, V72, P937, DOI 10.1073/pnas.72.3.937; HAJDU SI, 1981, CA-CANCER J CLIN, V31, P271, DOI 10.3322/canjclin.31.5.271; HERMAN TS, 1983, CANCER RES, V43, P517; HEW L, 1994, J SURG ONCOL, V57, P111; Issels RD, 2010, LANCET ONCOL, V11, P561, DOI 10.1016/S1470-2045(10)70071-1; Jacobs Andrew J., 2015, Sarcoma, V2015, P279601, DOI 10.1155/2015/279601; Jolesch A, 2012, EUR J CELL BIOL, V91, P48, DOI 10.1016/j.ejcb.2011.02.001; Lindner LH, 2011, CURR TREAT OPTION ON, V12, P12, DOI 10.1007/s11864-011-0144-6; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Lucas DR, 2008, ONCOLOGIST, V13, P451, DOI 10.1634/theoncologist.2007-0220; NAGAOKA S, 1986, JPN J CANCER RES, V77, P205; O'Sullivan B, 2002, LANCET, V359, P2235, DOI 10.1016/S0140-6736(02)09292-9; Otsuka H, 2009, J MED INVESTIG, V56, P136, DOI 10.2152/jmi.56.136; Otsuka Takanobu, 2001, International Journal of Clinical Oncology, V6, P253, DOI 10.1007/PL00012114; Padhani AR, 2001, BRIT J RADIOL, V74, P983, DOI 10.1259/bjr.74.887.740983; RHEE JG, 1984, INT J RADIAT ONCOL, V10, P393, DOI 10.1016/0360-3016(84)90060-9; Stahl R, 2009, INT J HYPERTHER, V25, P289, DOI 10.1080/02656730902873616; Tanaka K, 2015, JPN J CLIN ONCOL, V45, P555, DOI 10.1093/jjco/hyv042; Tirkes T, 2013, RADIOGRAPHICS, V33, P1323, DOI 10.1148/rg.335125214; Ueda T, 2008, J ORTHOP SCI, V13, P304, DOI 10.1007/s00776-008-1235-5; URANO M, 1990, INT J HYPERTHER, V6, P563, DOI 10.3109/02656739009140952; WESTRA A, 1971, INT J RADIAT BIOL RE, V19, P467, DOI 10.1080/09553007114550601; WILLETT CG, 1987, CANCER, V60, P1500, DOI 10.1002/1097-0142(19871001)60:7<1500::AID-CNCR2820600716>3.0.CO;2-1	31	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195289	10.1371/journal.pone.0195289	http://dx.doi.org/10.1371/journal.pone.0195289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659611	gold, Green Published, Green Submitted			2022-12-26	WOS:000430061100011
J	Glippa, O; Engstrom-Ost, J; Kanerva, M; Rein, A; Vuori, K				Glippa, Olivier; Engstrom-Ost, Jonna; Kanerva, Mirella; Rein, Anni; Vuori, Kristiina			Oxidative stress and antioxidant defense responses in Acartia copepods in relation to environmental factors	PLOS ONE			English	Article							XYLENOL ORANGE METHOD; HISTORY TRADE-OFFS; BALTIC SEA; OCEAN ACIDIFICATION; CLIMATE-CHANGE; ULTRAVIOLET-RADIATION; MARINE-PHYTOPLANKTON; ENZYME-ACTIVITIES; GULF; TEMPERATURE	On a daily basis, planktonic organisms migrate vertically and thus experience widely varying conditions in their physico-chemical environment. In the Gulf of Finland, these changes are larger than values predicted by climate change scenarios predicted for the next century (up to 0.5 units in pH and 5 degrees C in temperature). In this work, we are interested in how temporal variations in physico-chemical characteristics of the water column on a daily and weekly scale influence oxidative stress level and antioxidant responses in the planktonic copepod of the genus Acartia. Responses were determined from samples collected during a two-week field survey in the western Gulf of Finland, Baltic Sea. Our results showed that GST (Glutathione-S-transferase) enzyme activity increased in the surface waters between Weeks I and II, indicating antioxidant defense mechanism activation. This is most likely due to elevating temperature, pH, and dissolved oxygen observed between these two weeks. During Week II also GSSG (oxidized glutathione) was detected, indicating that copepods responded to stressor(s) in the environment. Our results suggest that Acartia copepods seem fairly tolerant to weekly fluctuations in environmental conditions in coastal and estuarine areas, in terms of antioxidant defense and oxidative stress. This could be directly connected to a very efficient glutathione cycling system acting as antioxidant defense system for neutralizing ROS and avoiding elevated levels of LPX.	[Glippa, Olivier; Engstrom-Ost, Jonna; Rein, Anni] Novia Univ Appl Sci, Ekenas, Finland; [Kanerva, Mirella; Vuori, Kristiina] Univ Turku, Dept Biol, Physiol Anim Lab, Turku, Finland; [Kanerva, Mirella] Ehime Univ, Ctr Marine Environm Studies CMES, Matsuyama, Ehime, Japan	Novia University of Applied Sciences; University of Turku; Ehime University	Glippa, O (corresponding author), Novia Univ Appl Sci, Ekenas, Finland.	olivg62@gmail.com	Engström-Öst, Jonna/C-7373-2008	Engström-Öst, Jonna/0000-0003-1792-7702; GLIPPA, Olivier/0000-0001-8990-9461	Academy of Finland [276947]; Societas pro Fauna et Flora Fennica	Academy of Finland(Academy of Finland); Societas pro Fauna et Flora Fennica	This work was supported by the Academy of Finland (project nr. 276947, http://www.aka.fi.en) to Jonna Engstrom-Ost and Societas pro Fauna et Flora Fennica (http://www.societasfff.fi/?lang=en) to Anni Rein. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abele D, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P1; Abele D, 1998, MAR ECOL PROG SER, V163, P179, DOI 10.3354/meps163179; Almen AK, 2014, J EXP MAR BIOL ECOL, V460, P120, DOI 10.1016/j.jembe.2014.07.001; Alonso-Alvarez C, 2006, EVOLUTION, V60, P1913, DOI 10.1111/j.0014-3820.2006.tb00534.x; [Anonymous], 2014, PHYS SCI BAS WORK GR; Borgeraas J, 2000, J PLANKTON RES, V22, P1167, DOI 10.1093/plankt/22.6.1167; Bou R, 2008, ANAL BIOCHEM, V377, P1, DOI 10.1016/j.ab.2008.02.029; Brutemark A, 2011, OCEANOL HYDROBIOL ST, V40, P91, DOI 10.2478/s13545-011-0034-3; Cailleaud K, 2007, COMP BIOCHEM PHYS A, V147, P841, DOI 10.1016/j.cbpa.2006.09.012; Caramujo MJ, 2012, MAR DRUGS, V10, P998, DOI 10.3390/md10050998; Catoni C, 2008, ANIM BEHAV, V76, P1107, DOI 10.1016/j.anbehav.2008.05.027; de Almeida EA, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P381; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Doledec S, 1996, ENVIRON ECOL STAT, V3, P143, DOI 10.1007/BF02427859; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Elliott DT, 2011, MAR ECOL PROG SER, V427, P1, DOI 10.3354/meps09063; Engstrom-Ost J, 2015, J PLANKTON RES, V37, P388, DOI 10.1093/plankt/fbv004; Eymard S, 2003, EUR J LIPID SCI TECH, V105, P497, DOI 10.1002/ejlt.200300768; Feely RA, 2009, OCEANOGRAPHY, V22, P36, DOI 10.5670/oceanog.2009.95; Fritz KS, 2011, CHEM RES TOXICOL, V24, P1411, DOI 10.1021/tx200169n; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Fujii Toyonobu, 2012, Biology - Basel, V1, P597, DOI 10.3390/biology1030597; Gorokhova E, 2013, AQUAT TOXICOL, V127, P46, DOI 10.1016/j.aquatox.2012.01.022; Hader DP, 2000, ADV SPACE RES, V26, P2029, DOI DOI 10.1016/S0273-1177(00)00170-8; Halliwell B., 2007, FREE RADICALS BIOL M; Hansen PJ, 2002, AQUAT MICROB ECOL, V28, P279, DOI 10.3354/ame028279; Havenhand JN, 2012, AMBIO, V41, P637, DOI 10.1007/s13280-012-0326-x; Hermes-Lima M, 2015, FREE RADICAL BIO MED, V89, P1122, DOI 10.1016/j.freeradbiomed.2015.07.156; Hogfors H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112692; Kabel K, 2012, NAT CLIM CHANGE, V2, P871, DOI [10.1038/NCLIMATE1595, 10.1038/nclimate1595]; Kanerva M, 2014, THESIS; Kong XH, 2008, MAR BIOL, V154, P269, DOI 10.1007/s00227-008-0920-4; Kurihara H, 2008, MAR POLLUT BULL, V56, P1086, DOI 10.1016/j.marpolbul.2008.03.023; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lewis CN, 2013, P NATL ACAD SCI USA, V110, pE4960, DOI 10.1073/pnas.1315162110; Li EC, 2008, AQUACULTURE, V274, P80, DOI 10.1016/j.aquaculture.2007.11.001; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; Martinez M, 2017, J EXP MAR BIOL ECOL, V487, P79, DOI 10.1016/j.jembe.2016.11.016; Mauchline J, 1998, BIOL CALANOID COPEPO; McConville K, 2013, MAR POLLUT BULL, V73, P428, DOI 10.1016/j.marpolbul.2013.02.010; Monaghan P, 2009, ECOL LETT, V12, P75, DOI 10.1111/j.1461-0248.2008.01258.x; Moreira DC, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00702; Paital B, 2010, COMP BIOCHEM PHYS C, V151, P142, DOI 10.1016/j.cbpc.2009.09.007; Pinheiro LC, 2016, J EXP ZOOL PART A, V325, P318, DOI 10.1002/jez.2019; Prior RL, 2003, J AGR FOOD CHEM, V51, P3273, DOI 10.1021/jf0262256; Puthumana J, 2017, AQUAT TOXICOL, V184, P116, DOI 10.1016/j.aquatox.2017.01.011; Raja-aho S, 2012, PHYSIOL BIOCHEM ZOOL, V85, P148, DOI 10.1086/664826; Rodriguez-Grana L, 2010, MAR ECOL PROG SER, V401, P1, DOI 10.3354/meps08459; Saiz E, 2015, SCI REP-UK, V5, DOI 10.1038/srep14962; SALONEN K, 1981, WATER RES, V15, P403, DOI 10.1016/0043-1354(81)90049-X; Souza MS, 2010, LIMNOL OCEANOGR, V55, P1024, DOI 10.4319/lo.2010.55.3.1024; Tremblay N, 2012, OXIDATIVE STRESS IN AQUATIC ECOSYSTEMS, P89; Tremblay N, 2010, LIMNOL OCEANOGR, V55, P2570, DOI 10.4319/lo.2010.55.6.2570; Turja R, 2014, TOXICON, V78, P68, DOI 10.1016/j.toxicon.2013.11.015; Turja R, 2013, COMP BIOCHEM PHYS C, V157, P80, DOI 10.1016/j.cbpc.2012.09.006; Vehmaa A, 2013, ECOL EVOL, V3, P4548, DOI 10.1002/ece3.839; Vehmaa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048538; Vuori K, 2012, J FISH BIOL, V81, P1815, DOI 10.1111/j.1095-8649.2012.03386.x; Vuori KA, 2015, MAR ECOL PROG SER, V538, P131, DOI 10.3354/meps11471; Vuori KA, 2008, ENVIRON SCI TECHNOL, V42, P2668, DOI 10.1021/es702632c; Waldbusser GG, 2014, ANNU REV MAR SCI, V6, P221, DOI 10.1146/annurev-marine-121211-172238; Wang MJ, 2009, AQUAT TOXICOL, V95, P99, DOI 10.1016/j.aquatox.2009.08.006; Webster CN, 2015, MAR BIOL, V162, P1429, DOI 10.1007/s00227-015-2679-8; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; Whitfield AK, 2012, ESTUAR COAST SHELF S, V97, P78, DOI 10.1016/j.ecss.2011.11.026; Wilhelm D, 2001, AQUACULTURE, V203, P149, DOI 10.1016/S0044-8486(01)00599-3; Wolinski L, 2016, ENVIRON POLLUT, V213, P135, DOI 10.1016/j.envpol.2016.02.016; Wong-Ekkabut J, 2007, BIOPHYS J, V93, P4225, DOI 10.1529/biophysj.107.112565; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	69	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195981	10.1371/journal.pone.0195981	http://dx.doi.org/10.1371/journal.pone.0195981			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652897	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900052
J	Han, BF; Yuan, QL; Shi, YH; Wei, L; Hou, JL; Shang, J; Hans, Y; Jin, CD; Chan, PL; Zhuang, H; Li, J; Cui, FQ				Han, Bingfeng; Yuan, Qianli; Shi, Yuhui; Wei, Lai; Hou, Jinlin; Shang, Jia; Hans, Ying; Jin, Cunduo; Chan, Po-Lin; Zhuang, Hui; Li, Jie; Cui, Fuqiang			The experience of discrimination of individuals living with chronic hepatitis B in four provinces of China	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; KNOWLEDGE; STIGMA; PREVENTION; VIRUS; VACCINATION; INFECTION; MOTHERS; LIFE	Objectives To assess chronic hepatitis B (CHB) patients' knowledge about hepatitis B and their experience of discrimination with regard to study, work, and daily life. Methods We administered a questionnaire to 797 CHB patients in four provinces of China and used one-way analysis of variance (ANOVA) and a generalized linear model (GLM) to identify factors associated with discrimination. Results CHB patients had low levels of knowledge about hepatitis B. Patients under 40 years of age with a junior college education or above knew more about hepatitis B than CHB patients over 40 years of age who had only a high school education. Three-fourths of patients had experienced discrimination because of their hepatitis B infection, with no differences in the proportion experiencing discrimination by sex or age. People with more education reported less discrimination. Patients in Beijing and Henan province perceived less discrimination than those in Shaanxi and Guangdong provinces. Discrimination was significantly associated with negative emotions. CHB patients had little awareness of China's anti-discrimination laws and policies. Among patients who had experienced discrimination, fewer than 10% knew organizations or institutions that could offer help. Over 60% of CHB patients who experienced discrimination chose not to respond. Conclusion CHB patients in China commonly experienced discrimination, which was associated with significant, negative emotional stress. To mitigate the damaging effects of discrimination, our study suggests raising general population knowledge about hepatitis B, raising awareness of the availability of legal protection and organizations that can fight discrimination, and providing psychological support for CHB patients.	[Han, Bingfeng; Shi, Yuhui; Cui, Fuqiang] Peking Univ, Sch Publ Hlth, Dept Laboratorial Sci & Technol, Beijing, Peoples R China; [Yuan, Qianli] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing, Peoples R China; [Wei, Lai] Peking Univ, Hepatol Unit, Peoples Hosp, Beijing, Peoples R China; [Hou, Jinlin] Nanfang Hosp, Hepatol Unit, Guangzhou, Guangdong, Peoples R China; [Shang, Jia] Henan Prov Peoples Hosp, Hepatol Unit, Zhengzhou, Henan, Peoples R China; [Hans, Ying] Fourth Mil Med Univ, Xijing Hosp, Hepatol Unit, Xian, Shaanxi, Peoples R China; [Jin, Cunduo] 302 Mil Hosp China, Cent Sterile Supply Dept, Beijing, Peoples R China; [Chan, Po-Lin] World Hlth Org China, Beijing, Peoples R China; [Zhuang, Hui; Li, Jie] Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing, Peoples R China; [Zhuang, Hui; Li, Jie] Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing, Peoples R China	Peking University; Chinese Center for Disease Control & Prevention; Peking University; Southern Medical University - China; Zhengzhou University; Air Force Military Medical University; Fifth Medical Center of Chinese PLA General Hospital; World Health Organization; Peking University; Peking University	Cui, FQ (corresponding author), Peking Univ, Sch Publ Hlth, Dept Laboratorial Sci & Technol, Beijing, Peoples R China.; Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Microbiol, Hlth Sci Ctr, Beijing, Peoples R China.; Li, J (corresponding author), Peking Univ, Sch Basic Med Sci, Ctr Infect Dis, Hlth Sci Ctr, Beijing, Peoples R China.	jieli@bjmu.edu.cn; cuifug@126.com		Chan, Polin/0000-0003-1708-5170	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Chen Y, 2010, 13 NAT C PSYCH, V451; Cotler SJ, 2012, J VIRAL HEPATITIS, V19, P147, DOI 10.1111/j.1365-2893.2011.01462.x; Cui FQ, 2017, EMERG INFECT DIS, V23, P765, DOI 10.3201/eid2305.161477; Dam L, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/1910292; Dun-Dery F, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2490-x; Han ZY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178671; Haq N, 2014, VALUE HEALTH, V17, pA807, DOI 10.1016/j.jval.2014.08.529; Huang JX, 2016, LIVER INT, V36, P1595, DOI 10.1111/liv.13168; Hyun S, 2018, J IMMIGR MINOR HEALT, V20, P943, DOI 10.1007/s10903-017-0609-1; Kan QC, 2015, LANCET, V386, P245, DOI 10.1016/S0140-6736(15)61276-4; Leng AL, 2016, HUM VACC IMMUNOTHER, V12, P1164, DOI 10.1080/21645515.2015.1131883; Li C, 2006, CHIN J PUBL HLTH, V22, P132; Li YY, 2017, MILITARY MED RES, V4, DOI 10.1186/s40779-016-0110-5; Liu K, 2016, LIVER INT, V36, P1582, DOI 10.1111/liv.13189; Lu Y, 2017, VACCINE, V35, P40, DOI 10.1016/j.vaccine.2016.11.061; [莫显昆 Mo Xiankun], 2015, [中国卫生统计, Chinese Journal of Health Statistics], V32, P948; Modabbernia A, 2013, ARCH IRAN MED, V16, P114, DOI 013162/AIM.0013; Na L, 2013, J HEALTH COMMUN, V18, P71, DOI 10.1080/10810730.2012.688449; Ouyang D, 2013, J COMMUN HEALTH, V38, P471, DOI 10.1007/s10900-012-9631-3; Rafique I, 2014, E MEDITERR HEALTH J, V20, P796, DOI 10.26719/2014.20.12.796; Ren H, 2017, J VIRAL HEPATITIS, V24, P4, DOI 10.1111/jvh.12793; Shi JC, 2013, J APPL SOC PSYCHOL, V43, pE46, DOI 10.1111/jasp.12040; Valizadeh L, 2017, GASTROENTEROL NURS, V40, P143, DOI 10.1097/SGA.0000000000000223; Wang AL, 2015, B WORLD HEALTH ORGAN, V93, P52, DOI 10.2471/BLT.14.139626; WANG P, 2013, J NURSES TRAIN, V28, P1570; WHO, GLOB HEP REP 2017; Wu H, 2009, CAN J GASTROENTEROL, V23, P31, DOI 10.1155/2009/608352; Yang T, 2011, LANCET, V378, P1059, DOI 10.1016/S0140-6736(11)61460-8; Yu LJ, 2016, HUM VACC IMMUNOTHER, V12, P70, DOI 10.1080/21645515.2015.1069932; Yu Lijie, 2015, Zhonghua Yu Fang Yi Xue Za Zhi, V49, P771; Zhu FC, 2016, VACCINE, V34, P2656, DOI 10.1016/j.vaccine.2016.04.042	31	18	21	4	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195455	10.1371/journal.pone.0195455	http://dx.doi.org/10.1371/journal.pone.0195455			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649232	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900046
J	Lui, M; Hsu, M				Lui, Ming; Hsu, Ming			Viewing sexual images is associated with reduced physiological arousal response to gambling loss	PLOS ONE			English	Article							PICTURE-PROCESSING INTERFERES; DECISION-MAKING; LOSS AVERSION; NEURAL BASIS; RISK; TESTOSTERONE; AMYGDALA	Erotic imagery is one highly salient emotional signal that exists everywhere in daily life. The impact of sexual stimuli on human decision-making, however, has rarely been investigated. This study examines the impact of sexual stimuli on financial decision-making under risk. In each trial, either a sexual or neutral image was presented in a picture categorization task before a gambling task. Thirty-four men made gambling decisions while their physiological arousal, measured by skin conductance responses (SCRs), was recorded. Behaviorally, the proportion of gambling decisions did not differ between the sexual and neutral image trials. Physiologically, participants had smaller arousal differences, measured in micro-siemen per dollar, between losses and gains in the sexual rather than in the neutral image trials. Moreover, participants' SCRs to losses relative to gains predicted the proportion of gambling decisions in the neutral image trials but not in the sexual image trials. The results were consistent with the hypothesis that the presence of emotionally salient sexual images reduces attentional and arousal-related responses to gambling losses. Our results are consistent with the theory of loss attention involving increased cognitive investment in losses compared to gains. The findings also have potential practical implications for our understanding of the specific roles of sexual images in human financial decision making in everyday life, such as gambling behaviors in the casino.	[Lui, Ming] Hong Kong Baptist Univ, Dept Educ Studies, Hong Kong, Hong Kong, Peoples R China; [Hsu, Ming] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	Hong Kong Baptist University; University of California System; University of California Berkeley	Lui, M (corresponding author), Hong Kong Baptist Univ, Dept Educ Studies, Hong Kong, Hong Kong, Peoples R China.	m-lui@u.northwestern.edu		Lui, Ming/0000-0001-7996-0386	Hong Kong Baptist University Faculty Research Grants [FRG1/14-15/067]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH098023] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043196] Funding Source: NIH RePORTER	Hong Kong Baptist University Faculty Research Grants; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Hong Kong Baptist University Faculty Research Grants (FRG1/14-15/067) given to ML. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apicella CL, 2014, PSYCHONEUROENDOCRINO, V39, P58, DOI 10.1016/j.psyneuen.2013.09.025; Ariely D, 2006, J BEHAV DECIS MAKING, V19, P87, DOI 10.1002/bdm.501; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Bechara A, 2003, ANN NY ACAD SCI, V985, P356, DOI 10.1111/j.1749-6632.2003.tb07094.x; Berridge Kent C, 2009, Oxf Ser Soc Cogn Soc Neurosci, V2009, P509; Childress AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001506; Cueva C, 2015, SCI REP-UK, V5, DOI 10.1038/srep11206; Damasio AR, 1996, PHILOS T R SOC B, V351, P1413, DOI 10.1098/rstb.1996.0125; De Martino B, 2008, J NEUROSCI, V28, P10746, DOI 10.1523/JNEUROSCI.2895-08.2008; Dewitte S., 2006, P ROY SOC LOND B BIO, V273, P2091; Erev I, 2008, J BEHAV DECIS MAKING, V21, P575, DOI 10.1002/bdm.602; Hochman G, 2011, J BEHAV DECIS MAKING, V24, P140, DOI 10.1002/bdm.692; Ikemoto S, 1999, BRAIN RES REV, V31, P6, DOI 10.1016/S0165-0173(99)00023-5; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Knutson B, 2008, NEUROREPORT, V19, P509, DOI 10.1097/WNR.0b013e3282f85c01; Koepp MJ, 2009, NEUROIMAGE, V44, P252, DOI 10.1016/j.neuroimage.2008.08.032; Koritzky G, 2010, J BEHAV DECIS MAKING, V23, P83, DOI 10.1002/bdm.660; Kuhnen CM, 2005, NEURON, V47, P763, DOI 10.1016/j.neuron.2005.08.008; Laier C, 2014, ARCH SEX BEHAV, V43, P473, DOI 10.1007/s10508-013-0119-8; Laier C, 2013, J SEX RES, V50, P642, DOI 10.1080/00224499.2012.716873; Loewenstein GF, 2001, PSYCHOL BULL, V127, P267, DOI 10.1037//0033-2909.127.2.267; McGraw AP, 2010, PSYCHOL SCI, V21, P1438, DOI 10.1177/0956797610381504; Montague PR, 2006, ANNU REV NEUROSCI, V29, P417, DOI 10.1146/annurev.neuro.29.051605.112903; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/02699930600959340; Naqvi N, 2006, CURR DIR PSYCHOL SCI, V15, P260, DOI 10.1111/j.1467-8721.2006.00448.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Richter M, 2009, PSYCHOPHYSIOLOGY, V46, P451, DOI 10.1111/j.1469-8986.2009.00795.x; ROLLS ET, 1999, BRAIN EMOTION; Ronay R, 2010, SOC PSYCHOL PERS SCI, V1, P57, DOI 10.1177/1948550609352807; Scott-Van Zeeland AA, 2010, AUTISM RES, V3, P53, DOI 10.1002/aur.122; Sokol-Hessner P, 2009, P NATL ACAD SCI USA, V106, P5035, DOI 10.1073/pnas.0806761106; Stanton SJ, 2011, PSYCHOL SCI, V22, P447, DOI 10.1177/0956797611401752; Stanton SJ, 2011, HORM BEHAV, V59, P252, DOI 10.1016/j.yhbeh.2010.12.003; Tom SM, 2007, SCIENCE, V315, P515, DOI 10.1126/science.1134239; Van den Bergh B, 2008, J CONSUM RES, V35, P85, DOI 10.1086/525505; Wilson M, 2004, P ROY SOC B-BIOL SCI, V271, pS177, DOI 10.1098/rsbl.2003.0134; Yechiam E, 2007, J MATH PSYCHOL, V51, P75, DOI 10.1016/j.jmp.2006.11.002; Yechiam E, 2013, PSYCHOL BULL, V139, P497, DOI 10.1037/a0029383	39	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195748	10.1371/journal.pone.0195748	http://dx.doi.org/10.1371/journal.pone.0195748			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649287	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900079
J	Mayne, ES; Mayne, ALH; Louw, SJ				Mayne, Elizabeth S.; Mayne, Anthony L. H.; Louw, Susan J.			Pathogenic factors associated with development of disseminated intravascular coagulopathy (DIC) in a tertiary academic hospital in South Africa	PLOS ONE			English	Article							HIV-INFECTION; COAGULATION; SEPSIS; INFLAMMATION; MANAGEMENT; THROMBOSIS; PATIENT	Introduction Disseminated intravascular coagulopathy (DIC) is a thrombotic microangiopathy arising from consumption of both coagulation factors and platelets. DIC is triggered by a number of clinical conditions including severe infection, trauma and obstetric complications. Early diagnosis and treatment of the underlying condition is paramount. A high clinical index of suspicion is needed to ensure that patients at risk of developing DIC are appropriately investigated. Methods In order to establish the clinical conditions most frequently associated with DIC, we reviewed all DIC screens received at a tertiary hospital in Johannesburg, South Africa over a 1 year period. Results The commonest clinical condition associated with DIC in our population was infection with 84% of patients infected with an identified pathogen. The most frequently diagnosed pathogen was HIV followed by Mycobacterium tuberculosis and other bacterial infections. In the majority of cases, bacteria were isolated from blood cultures. In 47 patients, HIV was the only pathogen which could be isolated. A relative risk ratio of 2.73 and an odds ratio of 29.97 was attributed to HIV for development of a DIC. A malignancy was present in 51 of the patients of which approximately 60% had co-existing infection. No cause could be attributed in 30 patients. Conclusion Infection was identified in the majority of the patients diagnosed with DIC in this study. HIV showed the highest relative risk ratio of all pathogens although previous studies have not suggested that HIV was strongly associated with DIC. In almost half of the HIV infected patients, there was no other pathogen isolated despite extensive investigation. This suggests that HIV has a strong association with the development of DIC, warranting further research into the relationship between HIV and disseminated microvascular thrombosis.	[Mayne, Elizabeth S.; Mayne, Anthony L. H.; Louw, Susan J.] Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa; [Mayne, Elizabeth S.; Louw, Susan J.] Natl Hlth Lab Serv, Johannesburg, South Africa	University of Witwatersrand; National Health Laboratory Service	Mayne, ES (corresponding author), Univ Witwatersrand, Dept Mol Med & Haematol, Fac Hlth Sci, Johannesburg, South Africa.; Mayne, ES (corresponding author), Natl Hlth Lab Serv, Johannesburg, South Africa.	elizabeth.mayne@nhls.ac.za	mayne, anthony leland hamilton/GMW-6063-2022	mayne, anthony leland hamilton/0000-0003-4173-6340; Mayne, Elizabeth/0000-0002-6360-3488	National Research Foundation Thuthuka Grant [TTK20110801000022866]; Discovery Foundation Academic Award	National Research Foundation Thuthuka Grant; Discovery Foundation Academic Award	This work was supported by the National Research Foundation Thuthuka Grant TTK20110801000022866; Discovery Foundation Academic Award.	[Anonymous], 2013, J THROMB HAEMOST; Arildsen H, 2013, HIV MED, V14, P1, DOI 10.1111/j.1468-1293.2012.01027.x; Becker S, 2004, CLIN INFECT DIS, V39, pS267, DOI 10.1086/422363; Benjamin M, 2009, CLIN INFECT DIS, V48, P1129, DOI 10.1086/597471; Bick RL, 1999, HAEMOSTASIS, V29, P111; BILGRAMI S, 1994, TRANSFUSION, V34, P248, DOI 10.1046/j.1537-2995.1994.34394196624.x; Brecher ME, 2008, J CLIN APHERESIS, V23, P186, DOI 10.1002/jca.20176; Davies S, 1999, CAN J ANAESTH, V46, P456, DOI 10.1007/BF03012944; Dirajlal-Fargo S, 2017, AIDS, V31, P1917, DOI 10.1097/QAD.0000000000001556; FERA G, 1993, INFECTION, V21, P171, DOI 10.1007/BF01710541; Funderburg NT, 2014, THROMB RES, V133, pS21, DOI 10.1016/j.thromres.2014.03.012; Gando S, 1999, ANN SURG, V229, P121, DOI 10.1097/00000658-199901000-00016; Huson MAM, 2016, BRIT J HAEMATOL, V173, P918, DOI 10.1111/bjh.14006; Iba T, 2018, CLIN APPL THROMB-HEM, V24, P439, DOI 10.1177/1076029617720069; Kinasewitz GT, 2004, CRIT CARE, V8, pR82, DOI 10.1186/cc2459; Levi M, 1999, NEW ENGL J MED, V341, P586, DOI 10.1056/NEJM199908193410807; Levi M, 2009, BRIT J HAEMATOL, V145, P24, DOI [10.1111/j.1365-2141.2008.07445.x, 10.1111/j.1365-2141.2009.07600.x]; Ronit A, 2017, J INFECT DIS; Singer M, 2016, INTENS CARE MED, V42, P2027, DOI 10.1007/s00134-016-4600-4; Taylor FB, 2001, THROMB HAEMOSTASIS, V86, P1327, DOI 10.1055/s-0037-1616068; Toh CH, 2013, HEMATOL-AM SOC HEMAT, P286, DOI 10.1182/asheducation-2013.1.286; Vaughan JL, 2017, SAMJ S AFR MED J, V107, P264, DOI [10.7196/SAMJ.2017.v107i3.11206, 10.7196/samj.2017.v107i3.11206]; Wada H, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-15; Zimba S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2455-0	24	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195793	10.1371/journal.pone.0195793	http://dx.doi.org/10.1371/journal.pone.0195793			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649339	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900090
J	Sharma, H; Chinnappan, M; Agarwal, S; Dalvi, P; Gunewardena, S; O'Brien-Ladner, A; Dhillon, NK				Sharma, Himanshu; Chinnappan, Mahendran; Agarwal, Stuti; Dalvi, Pranjali; Gunewardena, Sumedha; O'Brien-Ladner, Amy; Dhillon, Navneet K.			Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse	FASEB JOURNAL			English	Article						HIV-PAH; pulmonary vascular remodelling; miR-130a; cocaine	PULMONARY ARTERIAL-HYPERTENSION; ANTIRETROVIRAL THERAPY; EXOSOMES INDUCE; CELL PROLIFERATION; ENDOTHELIAL-CELLS; UP-REGULATION; KAPPA-B; COCAINE; PTEN; MICRORNA	Our previous studies consistently demonstrate enhanced pulmonary vascular remodeling in HIV-infected intravenous drug users, and in simian immunodeficiency virus-infected macaques or HIV-transgenic rats exposed to opioids or cocaine. Although we reported an associated increase in perivascular inflammation, the exact role of inflammatory cells in the development of pulmonary vascular remodeling remains unknown. In this study, HIV-infected and cocaine (H+C)-treated human monocyte derived macrophages released a higher number of extracellular vesicles (EVs), compared to HIV-infected or uninfected cocaine-treated macrophages, with a significant increase in the particle size range to 100-150 nm. Treatment of primary human pulmonary arterial smooth muscle cells (HPASMCs) with these EVs resulted in a significant increase in smooth muscle proliferation. We also observed a significant increase in the miRNA-130a level in the EVs derived from H+C-treated macrophages that corresponded with the decrease in the expression of phosphatase and tensin homolog and tuberous sclerosis 1 and 2 and activation of PI3K/protein kinase B signaling in HPASMCs on addition of these EVs. Transfection of HPASMCs with antagomir-130a-ameliorated the EV-induced effect. Thus, we conclude that EVs derived from H+C-treated macrophages promote pulmonary smooth muscle proliferation by delivery of its prosurvival miRNA cargo, which may play a crucial role in the development of PAH.Sharma, H., Chinnappan, M., Agarwal, S., Dalvi, P., Gunewardena, S., O'Brien-Ladner, A., Dhillon, N. K. Macrophage-derived extracellular vesicles mediate smooth muscle hyperplasia: role of altered miRNA cargo in response to HIV infection and substance abuse.	[Sharma, Himanshu; Chinnappan, Mahendran; Agarwal, Stuti; Dalvi, Pranjali; O'Brien-Ladner, Amy; Dhillon, Navneet K.] Univ Kansas, Med Ctr, Dept Med, Div Pulm & Crit Care Med, 3901 Rainbow Blvd,Mail Stop 3007, Kansas City, KS 66160 USA; [Gunewardena, Sumedha; Dhillon, Navneet K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas Medical Center	Dhillon, NK (corresponding author), Univ Kansas, Med Ctr, Dept Med, Div Pulm & Crit Care Med, 3901 Rainbow Blvd,Mail Stop 3007, Kansas City, KS 66160 USA.	ndhillon@kumc.edu	Chinnappan, Mahendran/AAH-4930-2021; Dalvi, Pranjali/GRF-1132-2022	Dalvi, Pranjali/0000-0002-5247-9645; Agarwal, Stuti/0000-0002-4436-942X	Kansas Intellectual and Developmental Disabilities Research Center, U. S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant [U54 HD 090216]; Molecular Regulation of Cell Development and Differentiation Centers of Biomedical Research Excellence (COBRE) Grant (University of Kansas Medical Center for RNA Sequencing and Bioinformatics Services) [5P20GM104936-10]; NIH National Institute on Drug Abuse [R01DA034542, R01DA042715]; NIH National Heart, Blood, and Lung Institute [R01HL129875]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD090216] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL129875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA042715, R01DA034542] Funding Source: NIH RePORTER	Kansas Intellectual and Developmental Disabilities Research Center, U. S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant; Molecular Regulation of Cell Development and Differentiation Centers of Biomedical Research Excellence (COBRE) Grant (University of Kansas Medical Center for RNA Sequencing and Bioinformatics Services); NIH National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIH National Heart, Blood, and Lung Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank the Electron Microscopy Research Laboratory (EMRL) facility and Barbara Fegley for assistance with electron microscopy of isolate extracellular vesicles; Dr. Lane Christenson for providing access to NanoSight-LM10; the Kansas Intellectual and Developmental Disabilities Research Center, U. S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant U54 HD 090216; and the Molecular Regulation of Cell Development and Differentiation Centers of Biomedical Research Excellence (COBRE) Grant 5P20GM104936-10 (University of Kansas Medical Center for RNA Sequencing and Bioinformatics Services). This work was supported by NIH National Institute on Drug Abuse Grants R01DA034542 and R01DA042715, and NIH National Heart, Blood, and Lung Institute R01HL129875 (to N.K.D.). The authors declare no conflicts of interest.	Aga M, 2014, ONCOGENE, V33, P4613, DOI 10.1038/onc.2014.66; Aliotta JM, 2016, CARDIOVASC RES, V110, P319, DOI 10.1093/cvr/cvw054; Almodovar Sharilyn, 2011, Proc Am Thorac Soc, V8, P308, DOI 10.1513/pats.201006-046WR; Almodovar S, 2010, CHEST, V137, p6S, DOI 10.1378/chest.09-3065; Arenaccio C, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0216-y; Barclay RA, 2017, J BIOL CHEM, V292, P11682, DOI 10.1074/jbc.M117.793521; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bouhlal H, 2005, J IMMUNOL, V174, P7202, DOI 10.4049/jimmunol.174.11.7202; Brock M, 2015, INT J BIOCHEM CELL B, V61, P129, DOI 10.1016/j.biocel.2015.02.002; Chen JS, 2016, ONCOL REP, V35, P3285, DOI 10.3892/or.2016.4719; Colvin KL, 2013, AM J RESP CRIT CARE, V188, P1126, DOI 10.1164/rccm.201302-0403OC; Dalvi PN, 2015, AM J RESP CRIT CARE, V191; Dalvi P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10449-0; Dalvi P, 2016, AM J RESP CELL MOL, V55, P201, DOI 10.1165/rcmb.2015-0264OC; Dalvi P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085246; Dalvi P, 2013, ARTERIOSCL THROM VAS, V33, P2585, DOI 10.1161/ATVBAHA.113.302054; Dalvi PN, 2015, AM J RESP CELL MOL, V53, P336, DOI 10.1165/rcmb.2014-0369OC; Deng L, 2015, CIRC RES, V117, P870, DOI 10.1161/CIRCRESAHA.115.306806; Denzer K, 2000, J CELL SCI, V113, P3365; Dhillon NK, 2007, J NEUROVIROL, V13, P483, DOI 10.1080/13550280701528684; Dhillon NK, 2011, AM J RESP CELL MOL, V45, P40, DOI 10.1165/rcmb.2010-0097OC; Feng YQ, 2016, ARCH BIOCHEM BIOPHYS, V598, P57, DOI 10.1016/j.abb.2016.03.019; Fitzpatrick M, 2013, CLIN CHEST MED, V34, P325, DOI 10.1016/j.ccm.2013.01.010; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Gao YS, 2016, AM J RESP CELL MOL, V54, P451, DOI 10.1165/rcmb.2015-0323TR; Garat CV, 2013, J CARDIOVASC PHARM, V62, P539, DOI 10.1097/FJC.0000000000000014; Georgescu Maria-Magdalena, 2010, Genes Cancer, V1, P1170, DOI 10.1177/1947601911407325; HE LH, 1991, J APPL PHYSIOL, V70, P1861, DOI 10.1152/jappl.1991.70.4.1861; Horita H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10830; Humbert M, 2006, AM J RESP CRIT CARE, V173, P1023, DOI 10.1164/rccm.200510-1668OC; Humbert M, 2008, VASC PHARMACOL, V49, P113, DOI 10.1016/j.vph.2008.06.003; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Isasti G, 2013, AIDS RES HUM RETROV, V29, P231, DOI [10.1089/aid.2012.0166, 10.1089/AID.2012.0166]; Kang BY, 2017, AM J RESP CELL MOL, V56, P131, DOI 10.1165/rcmb.2016-0166OC; Konadu KA, 2015, J INFECT DIS, V211, P1712, DOI 10.1093/infdis/jiu676; Krepstakies M, 2012, J INFECT DIS, V205, P1654, DOI 10.1093/infdis/jis273; L'Huillier AG, 2015, FRONT PEDIATR, V3, DOI 10.3389/fped.2015.00025; Lane TE, 1996, MOL MED, V2, P27, DOI 10.1007/BF03402200; Langkilde A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051698; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee C, 2012, CIRCULATION, V126, P2601, DOI 10.1161/CIRCULATIONAHA.112.114173; Loyer X, 2014, CIRC RES, V114, P345, DOI 10.1161/CIRCRESAHA.113.300858; Madison MN, 2015, VIRUSES-BASEL, V7, P4093, DOI 10.3390/v7072810; Marecki J, 2005, CHEST, V128, p621S, DOI 10.1378/chest.128.6_suppl.621S-a; Marecki JC, 2006, AM J RESP CRIT CARE, V174, P437, DOI 10.1164/rccm.200601-005OC; McDonald RA, 2012, CARDIOVASC RES, V93, P594, DOI 10.1093/cvr/cvr299; Mermis J, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-103; Miao Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep41942; Morris A, 2012, AIDS, V26, P731, DOI 10.1097/QAD.0b013e32835099ae; Nemenoff RA, 2008, CIRC RES, V102, P1036, DOI 10.1161/CIRCRESAHA.107.169896; Niu F, 2014, J NEUROSCI, V34, P11812, DOI 10.1523/JNEUROSCI.1139-14.2014; Osada-Oka M, 2017, HYPERTENS RES, V40, P353, DOI 10.1038/hr.2016.163; Porter KM, 2013, PULM CIRC, V3, P58, DOI 10.4103/2045-8932.109915; Rasoulinejad Mehrnaz, 2014, Acta Med Iran, V52, P827; Reinsch N, 2008, HIV MED, V9, P550, DOI 10.1111/j.1468-1293.2008.00602.x; Roberts TC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089237; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roth WW, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010032; Sabatte J, 2007, J VIROL, V81, P13723, DOI 10.1128/JVI.01079-07; Savai R, 2012, AM J RESP CRIT CARE, V186, P897, DOI 10.1164/rccm.201202-0335OC; Selvendiran K, 2009, J PHARMACOL EXP THER, V329, P959, DOI 10.1124/jpet.108.150367; Sitbon O, 2008, AM J RESP CRIT CARE, V177, P108, DOI 10.1164/rccm.200704-541OC; Song CL, 2016, ONCOTARGET, V7, P71922, DOI 10.18632/oncotarget.12431; Spikes L, 2012, AM J RESP CRIT CARE, V185, P1235, DOI 10.1164/rccm.201110-1909OC; Stacher E, 2012, AM J RESP CRIT CARE, V186, P261, DOI 10.1164/rccm.201201-0164OC; Tang N, 2016, FASEB J, V30, P3097, DOI 10.1096/fj.201600368RR; Teow SY, 2016, ADV VIROL, V2016, DOI 10.1155/2016/9852494; Vlachos IS, 2015, NUCLEIC ACIDS RES, V43, pW460, DOI 10.1093/nar/gkv403; Wang YQ, 2017, CELL DEATH DIFFER, V24, P2089, DOI 10.1038/cdd.2017.129; Wei HJ, 2017, CANCER RES, V77, P6168, DOI 10.1158/0008-5472.CAN-17-0530; Willis GR, 2018, AM J RESP CRIT CARE, V197, P104, DOI 10.1164/rccm.201705-0925OC; Wu J, 2014, INT J MOL SCI, V15, P13738, DOI 10.3390/ijms150813738; Wu YT, 2015, ANALYST, V140, P6631, DOI 10.1039/c5an00688k; Xia XD, 2016, DNA CELL BIOL, V35, P599, DOI 10.1089/dna.2016.3342; Yu X, 2012, J MOL CELL CARDIOL, V53, P848, DOI 10.1016/j.yjmcc.2012.10.002; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhao L, 2017, CARDIOLOGY, V137, P43, DOI 10.1159/000453544; Zhou GF, 2015, AM J RESP CELL MOL, V52, P139, DOI 10.1165/rcmb.2014-0166TR; Zuber JP, 2004, CLIN INFECT DIS, V38, P1178, DOI 10.1086/383037	80	37	39	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2018	32	9					5174	5185		10.1096/fj.201701558R	http://dx.doi.org/10.1096/fj.201701558R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	GS6OR	29672222	Green Published, hybrid			2022-12-26	WOS:000443817700044
J	Zwirzitz, A; Reiter, M; Skrabana, R; Ohradanova-Repic, A; Majdic, O; Gutekova, M; Cehlar, O; Petrovcikova, E; Kutejova, E; Stanek, G; Stockinger, H; Leksa, V				Zwirzitz, Alexander; Reiter, Michael; Skrabana, Rostislav; Ohradanova-Repic, Anna; Majdic, Otto; Gutekova, Marianna; Cehlar, Ondrej; Petrovcikova, Eva; Kutejova, Eva; Stanek, Gerold; Stockinger, Hannes; Leksa, Vladimir			Lactoferrin is a natural inhibitor of plasminogen activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						protease; protease inhibitor; mannose 6-phosphate (M6P); tumor; bacteria; lactoferricin; Lyme disease; M6P; IGF2R; plasmin; transferrin; fibrinolysis; plasminogen; lactoferrin; insulin-like growth factor 2 receptor; cell invasion; Borrelia	FACTOR 2 RECEPTOR; BORRELIA-BURGDORFERI; HEMOSTATIC CHANGES; ENDOTHELIAL-CELLS; CATALYTIC DOMAIN; HUMAN SERUM; BINDING; STREPTOKINASE; PROTEIN; ALPHA-2-ANTIPLASMIN	The plasminogen system is essential for dissolution of fibrin clots, and in addition, it is involved in a wide variety of other physiological processes, including proteolytic activation of growth factors, cell migration, and removal of protein aggregates. On the other hand, uncontrolled plasminogen activation contributes to many pathological processes (e.g. tumor cells' invasion in cancer progression). Moreover, some virulent bacterial species (e.g. Streptococci or Borrelia) bind human plasminogen and hijack the host's plasminogen system to penetrate tissue barriers. Thus, the conversion of plasminogen to the active serine protease plasmin must be tightly regulated. Here, we show that human lactoferrin, an iron-binding milk glycoprotein, blocks plasminogen activation on the cell surface by direct binding to human plasminogen. We mapped the mutual binding sites to the N-terminal region of lactoferrin, encompassed also in the bioactive peptide lactoferricin, and kringle 5 of plasminogen. Finally, lactoferrin blocked tumor cell invasion in vitro and also plasminogen activation driven by Borrelia. Our results explain many diverse biological properties of lactoferrin and also suggest that lactoferrin may be useful as a potential tool for therapeutic interventions to prevent both invasive malignant cells and virulent bacteria from penetrating host tissues.	[Majdic, Otto] Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Immunol, A-1090 Vienna, Austria; [Skrabana, Rostislav; Cehlar, Ondrej] Slovak Acad Sci, Inst Neuroimmunol, Lab Struct Biol Neurodegenerat, Bratislava 81438, Slovakia; [Gutekova, Marianna; Petrovcikova, Eva; Kutejova, Eva; Leksa, Vladimir] Slovak Acad Sci, Inst Mol Biol, Lab Mol Immunol, Bratislava 81438, Slovakia	Medical University of Vienna; Slovak Academy of Sciences; Slovak Academy of Sciences	Leksa, V (corresponding author), Med Univ Vienna, Ctr Pathophysiol Infectiol & Immunol, Inst Hyg & Appl Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	vladimir.leksa@meduniwien.ac.at	Leksa, Vladimir/ABE-7876-2020; Kutejova, Eva/K-6550-2014; Stockinger, Hannes/E-5173-2011; Ohradanova-Repic, Anna/ABG-3709-2020; Kutejova, Eva/AAI-2544-2021; Skrabana, Rostislav/T-7382-2019	Kutejova, Eva/0000-0002-0973-679X; Stockinger, Hannes/0000-0001-6404-4430; Ohradanova-Repic, Anna/0000-0002-8005-8522; Kutejova, Eva/0000-0002-0973-679X; Skrabana, Rostislav/0000-0001-8200-5275; Reiter, Michael/0000-0002-7435-7999	Austrian Science Fund [P19014-B13, P22908, I00300]; Science and Technology Assistance Agency of the Slovak Republic [APVV-16-0452]; Slovak Grant Agency VEGA Grant [2/0020/17]; European Union Seventh Framework Program (FP7) [NMP4-LA-2009-228827 NANOFOL]; EU structural funds [ITMS 26240220008]; European Union's Horizon 2020 Research and Innovation Program [683356]	Austrian Science Fund(Austrian Science Fund (FWF)); Science and Technology Assistance Agency of the Slovak Republic; Slovak Grant Agency VEGA Grant; European Union Seventh Framework Program (FP7); EU structural funds; European Union's Horizon 2020 Research and Innovation Program	This work was supported by Austrian Science Fund Grants P19014-B13, P22908, and I00300; Science and Technology Assistance Agency of the Slovak Republic Grant APVV-16-0452; Slovak Grant Agency VEGA Grant 2/0020/17; the European Union Seventh Framework Program (FP7/2007-2013) under grant agreement NMP4-LA-2009-228827 NANOFOL; and the EU structural funds ITMS 26240220008. The research was also supported by the European Union's Horizon 2020 Research and Innovation Program under Grant Agreement 683356 (FOLSMART). The authors declare that they have no conflicts of interest with the contents of this article.	BAYNES RD, 1989, S AFR MED J, V76, P531; BENNETT RM, 1979, CLIN SCI, V57, P453, DOI 10.1042/cs0570453; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Binder BR, 2008, IMMUNOL LETT, V118, P116, DOI 10.1016/j.imlet.2008.03.017; Bournazou I, 2009, J CLIN INVEST, V119, P20, DOI 10.1172/JCI36226; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Bremme KA, 2003, BEST PRACT RES CL HA, V16, P153, DOI 10.1016/S1521-6926(03)00021-5; Brenner B, 2004, THROMB RES, V114, P409, DOI 10.1016/j.thromres.2004.08.004; BRUNETTI CR, 1994, J BIOL CHEM, V269, P17067; Bugge Thomas H., 2008, P183, DOI 10.1007/978-0-387-69057-5_10; Calle A, 2008, J VIROL, V82, P4762, DOI 10.1128/JVI.00077-08; CEDERHOLMWILLIAMS SA, 1981, J CLIN PATHOL, V34, P979, DOI 10.1136/jcp.34.9.979; Costello M, 1999, J CLIN ENDOCR METAB, V84, P611, DOI 10.1210/jc.84.2.611; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; Degryse B, 2011, CURR PHARM DESIGN, V17, P1872, DOI 10.2174/138161211796718161; Doeuvre L, 2010, BIOCHEM J, V432, P365, DOI 10.1042/BJ20100561; Dotti CG, 2004, NEURODEGENER DIS, V1, P205, DOI 10.1159/000080987; El-Shewy HM, 2009, VITAM HORM, V80, P667, DOI 10.1016/S0083-6729(08)00624-9; FUCHS H, 1994, P NATL ACAD SCI USA, V91, P12594, DOI 10.1073/pnas.91.26.12594; Gebbia JA, 1999, J CLIN INVEST, V103, P81, DOI 10.1172/JCI5171; Gifford JL, 2005, CELL MOL LIFE SCI, V62, P2588, DOI 10.1007/s00018-005-5373-z; Haney EF, 2009, BIOCHIMIE, V91, P141, DOI 10.1016/j.biochi.2008.04.013; HARIDAS M, 1995, ACTA CRYSTALLOGR D, V51, P629, DOI 10.1107/S0907444994013521; HASEGAWA K, 1994, JPN J MED SCI BIOL, V47, P73, DOI 10.7883/yoken1952.47.73; HU LT, 1995, INFECT IMMUN, V63, P3491, DOI 10.1128/IAI.63.9.3491-3496.1995; Kanyshkova TG, 2003, EUR J BIOCHEM, V270, P3353, DOI 10.1046/j.1432-1033.2003.03715.x; KLEMPNER MS, 1995, J INFECT DIS, V171, P1258, DOI 10.1093/infdis/171.5.1258; Lahteenmaki K, 2001, FEMS MICROBIOL REV, V25, P531, DOI 10.1111/j.1574-6976.2001.tb00590.x; Legrand D, 2005, CELL MOL LIFE SCI, V62, P2549, DOI 10.1007/s00018-005-5370-2; Legrand D, 2016, J PEDIATR-US, V173, pS10, DOI 10.1016/j.jpeds.2016.02.071; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Leksa V, 2012, J BIOL CHEM, V287, P22450, DOI 10.1074/jbc.M112.339663; Leksa V, 2011, CIRC RES, V108, P676, DOI 10.1161/CIRCRESAHA.110.234732; LIJNEN HR, 1981, EUR J BIOCHEM, V120, P149, DOI 10.1111/j.1432-1033.1981.tb05682.x; LUCAS MA, 1983, J BIOL CHEM, V258, P4249; MAGDOLEN V, 1995, ELECTROPHORESIS, V16, P813, DOI 10.1002/elps.11501601134; Majka G, 2013, ANAL BIOANAL CHEM, V405, P5191, DOI 10.1007/s00216-013-6943-9; MANGEL WF, 1990, SCIENCE, V248, P69, DOI 10.1126/science.2108500; Mayeur S, 2016, ANTIOXID REDOX SIGN, V24, P813, DOI 10.1089/ars.2015.6458; McArthur JD, 2012, CURR DRUG TARGETS, V13, P297; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; Myszyka DG, 1999, J MOL RECOGNIT, V12, P279, DOI 10.1002/(SICI)1099-1352(199909/10)12:5<279::AID-JMR473>3.0.CO;2-3; NEMET K, 1987, CLIN LAB HAEMATOL, V9, P137; Persson BA, 2010, BIOPHYS CHEM, V151, P187, DOI 10.1016/j.bpc.2010.06.005; PLOW EF, 1986, J CELL BIOL, V103, P2411, DOI 10.1083/jcb.103.6.2411; REED GL, 1995, BIOCHEMISTRY-US, V34, P10266, DOI 10.1021/bi00032a021; Reiter M, 2015, TICKS TICK-BORNE DIS, V6, P303, DOI 10.1016/j.ttbdis.2015.02.002; Schiller HB, 2009, MOL BIOL CELL, V20, P745, DOI 10.1091/mbc.E08-06-0569; Shatsky M, 2004, PROTEINS, V56, P143, DOI 10.1002/prot.10628; Sittampalam S., 2017, ASSAY GUIDANCE MANUA; Sleat DE, 2006, MOL CELL PROTEOMICS, V5, P1942, DOI 10.1074/mcp.M600030-MCP200; Sleat DE, 1997, BIOCHEM J, V324, P33, DOI 10.1042/bj3240033; Stillfried GE, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1647; Tarui T, 2002, J BIOL CHEM, V277, P33564, DOI 10.1074/jbc.M205514200; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Verhamme IM, 2014, J BIOL CHEM, V289, P28006, DOI 10.1074/jbc.M114.589077; Vogel HJ, 2012, BIOCHEM CELL BIOL, V90, P233, DOI [10.1139/O2012-016, 10.1139/o2012-016]; Wally J, 2007, BIOMETALS, V20, P249, DOI 10.1007/s10534-006-9062-7; Wang XQ, 1998, SCIENCE, V281, P1662, DOI 10.1126/science.281.5383.1662; WIMAN B, 1979, BIOCHIM BIOPHYS ACTA, V579, P142, DOI 10.1016/0005-2795(79)90094-1; WIMAN B, 1979, J BIOL CHEM, V254, P9291; Yang N, 2012, SCI REP-UK, V2, DOI 10.1038/srep00999; Young KC, 1998, J BIOL CHEM, V273, P3110, DOI 10.1074/jbc.273.5.3110	64	19	20	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8600	8613		10.1074/jbc.RA118.003145	http://dx.doi.org/10.1074/jbc.RA118.003145			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669808	Green Published, hybrid			2022-12-26	WOS:000434205700023
J	Dalmases, M; Benitez, ID; Mas, A; Garcia-Codina, O; Medina-Bustos, A; Escarrabill, J; Salto, E; Buysse, DJ; Roure, N; Sanchez-de-la-Torre, M; Rue, M; Barbe, F; de Batlle, J				Dalmases, Mireia; Benitez, Ivan D.; Mas, Anna; Garcia-Codina, Oriol; Medina-Bustos, Antonia; Escarrabill, Joan; Salto, Esteve; Buysse, Daniel J.; Roure, Nuria; Sanchez-de-la-Torre, Manuel; Rue, Montse; Barbe, Ferran; de Batlle, Jordi			Assessing sleep health in a European population: Results of the Catalan Health Survey 2015	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RISK-FACTOR; SHIFT WORK; DURATION; HYPERTENSION; ADULTS; METAANALYSIS; INSOMNIA; OBESITY	Objective To describe the overall sleep health of the Catalan population using data from the 2015 Catalan Health Survey and to compare the performance of two sleep health indicators: sleep duration and a 5-dimension sleep scale (SATED). Methods Multistage probability sampling representative of the non-institutionalized population aged 15 or more years, stratified by age, gender and municipality size, was used, excluding nightshift-workers. A total of 4385 surveys were included in the analyses. Associations between sleep health and the number of reported chronic diseases were assessed using non-parametric smoothed splines. Differences in the predictive ability of age-adjusted logistic regression models of self-rated health status were assessed. Multinomial logistic regression models were used to assess SATED determinants. Results Overall mean (SD) sleep duration was 7.18 (1.16) hours; and SATED score 7.91 (2.17) (range 0-10), lower (worse) scores were associated with increasing age and female sex. Alertness and efficiency were the most frequently impaired dimensions across age groups. SATED performed better than sleep duration when assessing self-rated health status (area under the curve = 0.856 vs. 0.798; p-value < 0.001), and had a linear relationship with the number of reported chronic diseases, while the sleep duration relationship was u-shaped. Conclusions Sleep health in Catalonia is associated with age and gender. SATED has some advantaged compared to sleep duration assessment, as it relates linearly to health indicators, has a stronger association with self-rated health status, and provides a more comprehensive assessment of sleep health. Therefore, the inclusion of multi-dimensional sleep health assessment tools in national surveys should be considered.	[Dalmases, Mireia; Benitez, Ivan D.; Mas, Anna; Roure, Nuria; Sanchez-de-la-Torre, Manuel; Barbe, Ferran; de Batlle, Jordi] Hosp Univ Amau Vilanova & Santa Maria, IRB Lleida, Grp Translat Res Resp Med, Lleida, Spain; [Dalmases, Mireia; Roure, Nuria; Sanchez-de-la-Torre, Manuel; Barbe, Ferran; de Batlle, Jordi] CIBERES, Madrid, Spain; [Garcia-Codina, Oriol; Medina-Bustos, Antonia; Salto, Esteve] Subdireccie Gen Planificacio Sanit & Profess, Catalan Hlth Dept, Barcelona, Spain; [Escarrabill, Joan] Master Plan Resp Dis PDMAR, Catalan Hlth Dept, Barcelona, Spain; [Buysse, Daniel J.] Univ Pittsburgh, Ctr Sleep & Circadian Sci, Pittsburgh, PA USA; [Rue, Montse] Univ Lleida, IRBLLEIDA, Basic Med Sci Dept, Lleida, Spain	Institut de Recerca Biomedica - IRB Lleida; University Hospital Arnau de Vilanova; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Universitat de Lleida	de Batlle, J (corresponding author), Hosp Univ Amau Vilanova & Santa Maria, IRB Lleida, Grp Translat Res Resp Med, Lleida, Spain.; de Batlle, J (corresponding author), CIBERES, Madrid, Spain.	jordidebatlle@gmail.com	Benítez, Iván David/AAI-9379-2020; Buysse, Daniel/AAJ-1608-2021; Barbé, Ferran/A-5988-2010; de la Torre, Manuel Sanchez/B-5578-2009; de Batlle, Jordi/G-6724-2016; Rue, Montserrat/B-5663-2009; Sanchez-de-la-Torre, Manuel/AAP-2663-2020; Sánchez-de-la-Torre, Manuel/AAC-9514-2022	Buysse, Daniel/0000-0002-3288-1864; Barbé, Ferran/0000-0002-2340-8928; de la Torre, Manuel Sanchez/0000-0002-5695-348X; de Batlle, Jordi/0000-0003-3500-6608; Rue, Montserrat/0000-0002-7862-9365; Sanchez-de-la-Torre, Manuel/0000-0002-5695-348X; Benitez, Ivan David/0000-0002-3558-5948	Ministerio de Economia y Competitividad [COFUND2014-51501]	Ministerio de Economia y Competitividad(Spanish Government)	This work was cofunded by Ministerio de Economia y Competitividad [COFUND2014-51501]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaniz-Zanon M, 2014, GAC SANIT, V28, P338, DOI 10.1016/j.gaceta.2013.12.004; [Anonymous], 2015, HLTH SURV CAT ESCA 2; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Buxton OM, 2010, SOC SCI MED, V71, P1027, DOI 10.1016/j.socscimed.2010.05.041; Buysse DJ, 2014, SLEEP, V37, P9, DOI 10.5665/sleep.3298; Campanini MZ, 2017, SLEEP MED, V35, P27, DOI 10.1016/j.sleep.2017.04.004; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cappuccio FP, 2010, SLEEP, V33, P585, DOI 10.1093/sleep/33.5.585; Centers for Disease Control and Prevention, 2013, NAT HLTH NUTR EX SUR; Chandola T, 2010, SLEEP, V33, P739, DOI 10.1093/sleep/33.6.739; Chen XL, 2014, QUAL LIFE RES, V23, P613, DOI 10.1007/s11136-013-0475-9; Croy I, 2017, BEHAV SLEEP MED, V15, P466, DOI 10.1080/15402002.2016.1163700; Domingo-Salvany A, 2013, GAC SANIT, V27, P263, DOI 10.1016/j.gaceta.2012.12.009; Furihata R, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw075; Gangwisch JE, 2006, HYPERTENSION, V47, P833, DOI 10.1161/01.HYP.0000217362.34748.e0; Johar H, 2016, SLEEP, V39, P217, DOI 10.5665/sleep.5352; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; King CR, 2008, JAMA-J AM MED ASSOC, V300, P2859, DOI 10.1001/jama.2008.867; Lakerveld J, 2016, OBES REV, V17, P62, DOI 10.1111/obr.12381; Latta F, 2005, SLEEP, V28, P1525, DOI 10.1093/sleep/28.12.1525; Laugsand LE, 2011, CIRCULATION, V124, P2073, DOI 10.1161/CIRCULATIONAHA.111.025858; Lim ASP, 2016, STROKE, V47, P516, DOI 10.1161/STROKEAHA.115.011608; Linden M, 2016, NAT SCI SLEEP, V8, P291, DOI 10.2147/NSS.S97241; Mompart-Penina Anna, 2011, Med Clin (Barc), V137 Suppl 2, P3, DOI 10.1016/S0025-7753(11)70021-5; Oishi M, 2005, J HYPERTENS, V23, P2173, DOI 10.1097/01.hjh.0000189870.55914.b3; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rod NH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091965; Smagula SF, 2016, SLEEP MED REV, V25, P21, DOI 10.1016/j.smrv.2015.01.003; Stranges S, 2010, J HYPERTENS, V28, P896, DOI 10.1097/HJH.0b013e328335d076; Suwazono Y, 2006, J OCCUP ENVIRON MED, V48, P455, DOI 10.1097/01.jom.0000214355.69182.fa; Thurston RC, 2016, SLEEP; Van Hoorde K, 2014, STAT MED, V33, P2585, DOI 10.1002/sim.6114; Vgontzas AN, 2009, SLEEP, V32, P491, DOI 10.1093/sleep/32.4.491; von Ruesten A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030972; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Zamanian Zahra, 2016, Electron Physician, V8, P1811, DOI 10.19082/1811	36	24	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194495	10.1371/journal.pone.0194495	http://dx.doi.org/10.1371/journal.pone.0194495			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668685	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200009
J	Fasmer, EE; Fasmer, OB; Berle, JO; Oedegaard, KJ; Hauge, ER				Fasmer, Erlend Eindride; Fasmer, Ole Bernt; Berle, Jan Oystein; Oedegaard, Ketil J.; Hauge, Erik R.			Graph theory applied to the analysis of motor activity in patients with schizophrenia and depression	PLOS ONE			English	Article							TIME-SERIES; SLEEP; MOOD	Depression and schizophrenia are defined only by their clinical features, and diagnostic separation between them can be difficult. Disturbances in motor activity pattern are central features of both types of disorders. We introduce a new method to analyze time series, called the similarity graph algorithm. Time series of motor activity, obtained from actigraph registrations over 12 days in depressed and schizophrenic patients, were mapped into a graph and we then applied techniques from graph theory to characterize these time series, primarily looking for changes in complexity. The most marked finding was that depressed patients were found to be significantly different from both controls and schizophrenic patients, with evidence of less regularity of the time series, when analyzing the recordings with one hour intervals. These findings support the contention that there are important differences in control systems regulating motor behavior in patients with depression and schizophrenia. The similarity graph algorithm we have described can easily be applied to the study of other types of time series.	[Fasmer, Ole Bernt; Berle, Jan Oystein; Oedegaard, Ketil J.; Hauge, Erik R.] Haukeland Hosp, Div Psychiat, Bergen, Norway; [Fasmer, Ole Bernt; Berle, Jan Oystein; Oedegaard, Ketil J.] Univ Bergen, Sect Psychiat, Dept Clin Med, Bergen, Norway; [Fasmer, Ole Bernt; Oedegaard, Ketil J.] KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen	Fasmer, OB (corresponding author), Haukeland Hosp, Div Psychiat, Bergen, Norway.; Fasmer, OB (corresponding author), Univ Bergen, Sect Psychiat, Dept Clin Med, Bergen, Norway.; Fasmer, OB (corresponding author), KG Jebsen Ctr Res Neuropsychiat Disorders, Bergen, Norway.	ole.fasmer@uib.no			Gerda Meyer Nyquist Gulbrandson AMP; Gerdt Meyer Nyquist; Western Norway Regional Health Authority	Gerda Meyer Nyquist Gulbrandson AMP; Gerdt Meyer Nyquist; Western Norway Regional Health Authority	This research has been supported by unrestricted grants from the legacy of Gerda Meyer Nyquist Gulbrandson & Gerdt Meyer Nyquist and from Western Norway Regional Health Authority. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar-San Juan B, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40762-2; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Bennabi D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/158746; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; Burton C, 2013, J AFFECT DISORDERS, V145, P21, DOI 10.1016/j.jad.2012.07.001; EHLERS CL, 1995, ARCH GEN PSYCHIAT, V52, P960; Fasmer OB, 2016, PSYCHIAT INVEST, V13, P112, DOI 10.4306/pi.2016.13.1.112; Ravetti MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108004; GOTTSCHALK A, 1995, ARCH GEN PSYCHIAT, V52, P947; Grierson AB, 2016, INT J BIPOLAR DISORD, V4, DOI 10.1186/s40345-015-0043-z; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; Hirjak D, 2015, SCHIZOPHR RES, V169, P217, DOI 10.1016/j.schres.2015.10.022; Jung SH, 2011, PSYCHIAT INVEST, V8, P22, DOI 10.4306/pi.2011.8.1.22; Kim TS, 2011, PSYCHIAT INVEST, V8, P1, DOI 10.4306/pi.2011.8.1.1; Krane-Gartiser K, 2015, J CLIN PSYCHIAT, V76, P1181, DOI 10.4088/JCP.14m09106; Krane-Gartiser K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089574; Lacasa L, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30001; Lacasa L, 2008, P NATL ACAD SCI USA, V105, P4972, DOI 10.1073/pnas.0709247105; Lian B., 2002, 1 COURSE DISCRETE MA; Littner M, 2002, SLEEP, V25, P143, DOI 10.1093/sleep/25.2.143; Luque B, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.046103; Luque B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022411; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; OVERALL JE, 1962, PSYCHOL REP, V10, P799; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Sacchet MD, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00021; Sedgewick R, 2015, GRAPH JAVA; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Van Someren EJW, 1999, CHRONOBIOL INT, V16, P505, DOI 10.3109/07420529908998724; VANHILTEN JJ, 1993, ELECTROEN CLIN NEURO, V89, P359, DOI 10.1016/0168-5597(93)90076-2; Walther S, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00010; Wittekind DA, 2016, BIPOLAR DISORD, V18, P502, DOI 10.1111/bdi.12440; Wulff K, 2012, BRIT J PSYCHIAT, V200, P308, DOI 10.1192/bjp.bp.111.096321	33	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194791	10.1371/journal.pone.0194791	http://dx.doi.org/10.1371/journal.pone.0194791			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668743	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200016
J	Mayhugh, RE; Rejeski, WJ; Petrie, MR; Laurienti, PJ; Gauvin, L				Mayhugh, Rhiannon E.; Rejeski, W. Jack; Petrie, Meredith R.; Laurienti, Paul J.; Gauvin, Lise			Differing patterns of stress and craving across the day in moderate-heavy alcohol consumers during their typical drinking routine and an imposed period of alcohol abstinence	PLOS ONE			English	Article							ECOLOGICAL MOMENTARY ASSESSMENT; EXPERIENCE QUESTIONNAIRE; TIME; CONSUMPTION; REACTIVITY; WITHDRAWAL; ADDICTION; RELAPSE; DESIRE	Background Stress is a known factor related to alcohol use. However, how the relationship between alcohol craving and stress varies across the day is not fully understood. As craving is a consistent predictor of alcohol use disorder (AUD), understanding stress and craving patterns across the day in routine, non-dependent, moderate-heavy alcohol consumers may help in understanding those who may be vulnerable to transitioning into AUD. Method Moderate-heavy drinkers were recruited from the local community (n = 32) and assessed for fluctuations in craving and stress intensity across the day via Ecological Momentary Assessment (EMA) during 3 consecutive days of imposed alcohol abstinence (abstained trial) and their normal drinking routine (normal trial). A multilevel modeling statistical approach assessed differences in diurnal craving and stress patterns with the Alcohol Craving Experience Questionnaire (ACE) examined as a moderator. Results Immediately following alcohol consumption on normal trials, EMA craving levels were significantly reduced compared to pre-drinking levels. Moreover, the post-drinking craving levels were lower than on abstained trials. Higher ACE scores were associated with significantly higher EMA craving across the day and higher peaks at midday. Higher ACE scores were also associated with greater EMA stress across the day. Drinking relieved stress relative to abstained trials, but not in individuals with higher ACE scores. Higher stress was associated with greater EMA craving, which was stronger among those with higher ACE scores. Conclusion These findings suggest that ACE scores are important to understanding patterns of stress and craving experienced across the day in routine, non-dependent, moderate-heavy drinkers and may provide new insights for vulnerability to transitioning into AUD.	[Mayhugh, Rhiannon E.; Laurienti, Paul J.] Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA; [Mayhugh, Rhiannon E.] Wake Forest Sch Med, Neurosci Program, Winston Salem, NC 27101 USA; [Rejeski, W. Jack; Petrie, Meredith R.] Wake Forest Univ, Dept Hlth & Exercise Sci, Winston Salem, NC 27109 USA; [Rejeski, W. Jack; Petrie, Meredith R.] Wake Forest Univ, Dept Psychol, Winston Salem, NC 27109 USA; [Rejeski, W. Jack; Laurienti, Paul J.] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA; [Rejeski, W. Jack] Wake Forest Univ, Dept Geriatr Med, Winston Salem, NC 27109 USA; [Laurienti, Paul J.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA; [Gauvin, Lise] CRCHUM, Montreal, PQ, Canada; [Gauvin, Lise] Univ Montreal, Ecole Sante Publ, Dept Med Sociale & Prevent, Montreal, PQ, Canada	Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Universite de Montreal; Universite de Montreal	Mayhugh, RE (corresponding author), Wake Forest Sch Med, Lab Complex Brain Networks, Winston Salem, NC 27101 USA.; Mayhugh, RE (corresponding author), Wake Forest Sch Med, Neurosci Program, Winston Salem, NC 27101 USA.	rmayhugh@wakehealth.edu		Gauvin, Lise/0000-0002-1562-1307	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health [T32AA007565, P01AA021099, P50AA026117]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P01AA021099, P50AA026117] Funding Source: NIH RePORTER	National Institute on Alcohol Abuse and Alcoholism of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the following: The National Institute on Alcohol Abuse and Alcoholism (www.niaaa.nih.gov/) of the National Institutes of Health under Award Number T32AA007565, P01AA021099, and P50AA026117. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Babor TF, 2000, ADDICTION, V95, P677, DOI 10.1046/j.1360-0443.2000.9556773.x; Becker HC, 2017, NEUROPHARMACOLOGY, V122, P115, DOI 10.1016/j.neuropharm.2017.04.028; Breese GR, 2005, ALCOHOL CLIN EXP RES, V29, P185, DOI 10.1097/01.ALC.0000153544.83656.3C; Cooney NL, 1997, J ABNORM PSYCHOL, V106, P243, DOI 10.1037/0021-843X.106.2.243; de Bruijn C, 2004, J NERV MENT DIS, V192, P494, DOI 10.1097/01.nmd.0000131912.71344.e4; Dua J K, 1993, Genet Soc Gen Psychol Monogr, V119, P515; Dvorak RD, 2016, DRUG ALCOHOL DEPEN, V163, pS46, DOI 10.1016/j.drugalcdep.2015.09.034; Epler AJ, 2014, ALCOHOL CLIN EXP RES, V38, P1461, DOI 10.1111/acer.12386; Fazzino TL, 2013, ALCOHOL CLIN EXP RES, V37, P2161, DOI 10.1111/acer.12191; Higley AE, 2011, PSYCHOPHARMACOLOGY, V218, P121, DOI 10.1007/s00213-011-2355-8; Juliano LM, 1998, EXP CLIN PSYCHOPHARM, V6, P45, DOI 10.1037/1064-1297.6.1.45; Kavanagh DJ, 2005, PSYCHOL REV, V112, P446, DOI 10.1037/0033-295X.112.2.446; May J, 2014, ADDICTION, V109, P728, DOI 10.1111/add.12472; Miranda R, 2014, ADDICT BIOL, V19, P941, DOI 10.1111/adb.12050; National Institute on Alcohol Abuse and Alcoholism (NIAAA), DRINK LEV DEF; Ray LA, 2010, J ABNORM PSYCHOL, V119, P115, DOI 10.1037/a0017550; Serre F, 2015, DRUG ALCOHOL DEPEN, V148, P1, DOI 10.1016/j.drugalcdep.2014.12.024; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Simons JS, 2010, ADDICT BEHAV, V35, P1045, DOI 10.1016/j.addbeh.2010.07.001; Sinha R, 2009, NEUROPSYCHOPHARMACOL, V34, P1198, DOI 10.1038/npp.2008.78; Sinha R, 2008, ANN NY ACAD SCI, V1141, P105, DOI 10.1196/annals.1441.030; Statham DJ, 2011, ADDICTION, V106, P1230, DOI 10.1111/j.1360-0443.2011.03442.x; SULLIVAN JT, 1989, BRIT J ADDICT, V84, P1353; Swendsen J, 2016, DIALOGUES CLIN NEURO, V18, P213; Vakili S, 2008, ADDICT BEHAV, V33, P1123, DOI 10.1016/j.addbeh.2008.03.009; WANG MQ, 1992, PHARMACOL BIOCHEM BE, V43, P641; Wray TB, 2014, ALCOHOL RES-CURR REV, V36, P19	27	12	12	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195063	10.1371/journal.pone.0195063	http://dx.doi.org/10.1371/journal.pone.0195063			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668736	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200024
J	Puente, C; Abian-Vicen, J; Del Coso, J; Lara, B; Salinero, JJ				Puente, Carlos; Abian-Vicen, Javier; Del Coso, Juan; Lara, Beatriz; Jose Salinero, Juan			The CYP1A2-163C > A polymorphism does not alter the effects of caffeine on basketball performance	PLOS ONE			English	Article							IMPROVES JUMP PERFORMANCE; ENERGY DRINK; SPRINT PERFORMANCE; ERGOGENICITY; RELIABILITY; VALIDITY; SPORTS	Purpose The aim of this investigation was to analyze the influence of the genetic variations of the - 163C>A polymorphism of the CYP1A2 gene on the ergogenic effects of caffeine in elite basketball players. Methods Nineteen elite basketball players (10 men and 9 women) ingested 3 mg-kg(-1) of caffeine or a placebo 60 min before performing 10 repetitions of the following series: the Abalakov jump test followed by the Change-of-Direction and Acceleration Test (CODAT). The players then competed in a 20-min simulated basketball game. Self-perceived performance and side effects were recorded by questionnaires after the trials. The effects of caffeine on basketball performance were established according to players' CYP1A2 genotype (rs762551): AA homozygotes (n = 10) and C-allele carriers (n = 9). Results In the 10 repetitions, caffeine increased Abalakov jump height by a mean of 2.9 +/- 3.6% in AA homozygotes (p = 0.03) while this effect did not reach statistical significance for C-allele carriers (2.3 +/- 6.8%; p = 0.33). Caffeine did not affect sprint time in the CODAT test in either genotype group but it increased the number of impacts performed during the simulated game in both AA homozygotes (4.1 +/- 5.3%; p = 0.02) and C-allele carriers (3.3 +/- 3.2%; p = 0.01). During the 24 h following the test, AA homozygotes tended to experience increased insomnia with caffeine while C-allele carriers did not present this effect. The remaining variables were unaffected by the genotype. Conclusion The CYP1A2 - 163C>A polymorphism minimally altered the ergogenicity derived from the consumption of a moderate dose of caffeine in elite basketball players.	[Puente, Carlos; Abian-Vicen, Javier; Del Coso, Juan; Lara, Beatriz; Jose Salinero, Juan] Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain; [Abian-Vicen, Javier] Univ Castilla La Mancha, Performance & Sport Rehabil Lab, Toledo, Spain	Camilo Jose Cela University; Universidad de Castilla-La Mancha	Del Coso, J (corresponding author), Camilo Jose Cela Univ, Exercise Physiol Lab, Madrid, Spain.	jdeicoso@ucjc.edu	Salinero, Juan J./GLT-1243-2022; Abián-Vicén, Javier/I-8509-2012; Lara, Beatriz/AAQ-5269-2021; Del Coso, Juan/AAC-7117-2020; MARTÍN, JUAN JOSÉ JJ SALINERO/I-4212-2012	Salinero, Juan J./0000-0003-4153-5100; Abián-Vicén, Javier/0000-0001-9635-3289; Del Coso, Juan/0000-0002-5785-984X; MARTÍN, JUAN JOSÉ JJ SALINERO/0000-0003-4153-5100; Lara, Beatriz/0000-0001-5516-4852	Camilo Jose Cela University, CAFEGEN project	Camilo Jose Cela University, CAFEGEN project	This investigation was funded by the Vice-Rectorate of Science of the Camilo Jose Cela University, CAFEGEN project (http://www.ucjc.edu/la-universidad/estructura-academica/vicerectorados/vicerectorado-de-innovacion/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abian P, 2015, J SPORT SCI, V33, P1042, DOI 10.1080/02640414.2014.981849; Abian-Vicen J, 2014, AMINO ACIDS, V46, P1333, DOI 10.1007/s00726-014-1702-6; Algrain Haya A., 2016, Journal of Caffeine Research, V6, P34, DOI 10.1089/jcr.2015.0029; Alsene K, 2003, NEUROPSYCHOPHARMACOL, V28, P1694, DOI 10.1038/sj.npp.1300232; Armstrong LE, 2002, INT J SPORT NUTR EXE, V12, P189, DOI 10.1123/ijsnem.12.2.189; Bishop D, 2010, SPORTS MED, V40, P995, DOI 10.2165/11536870-000000000-00000; Davis JK, 2009, SPORTS MED, V39, P813, DOI 10.2165/11317770-000000000-00000; Del Coso J, 2014, INT J SPORT PHYSIOL, V9, P1013, DOI 10.1123/ijspp.2013-0448; Del Coso J, 2013, AMINO ACIDS, V44, P1511, DOI 10.1007/s00726-013-1473-5; Del Coso J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031380; Djordjevic N, 2010, EUR J CLIN PHARMACOL, V66, P697, DOI 10.1007/s00228-010-0823-4; Doherty M, 2002, MED SCI SPORT EXER, V34, P1785, DOI 10.1097/00005768-200211000-00015; Duncan MJ, 2013, PHYSIOL BEHAV, V116, P60, DOI 10.1016/j.physbeh.2013.03.020; Ghotbi R, 2007, EUR J CLIN PHARMACOL, V63, P537, DOI 10.1007/s00228-007-0288-2; Hogervorst E, 2008, MED SCI SPORT EXER, V40, P1841, DOI 10.1249/MSS.0b013e31817bb8b7; Lara B, 2015, BRIT J NUTR, V114, P908, DOI 10.1017/S0007114515002573; Lockie RG, 2013, J SPORT SCI MED, V12, P88; Loy Bryan D., 2015, Journal of Caffeine Research, V5, P73, DOI 10.1089/jcr.2014.0035; Marfell-Jones M. J., 2012, INT STANDARDS ANTHRO; Meyers BM, 2005, J APPL PHYSIOL, V99, P1056, DOI 10.1152/japplphysiol.00937.2004; Pataky MW, 2016, SCAND J MED SCI SPOR, V26, P613, DOI 10.1111/sms.12501; Perera V, 2012, CURR DRUG METAB, V13, P667, DOI 10.2174/1389200211209050667; Perez-Lopez A, 2015, MED SCI SPORT EXER, V47, P850, DOI 10.1249/MSS.0000000000000455; Pickering C, 2018, SPORTS MED, V48, P7, DOI 10.1007/s40279-017-0776-1; Puente C, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091033; Renda G, 2015, EUR NEUROPSYCHOPHARM, V25, P798, DOI 10.1016/j.euroneuro.2015.03.001; Retey JV, 2007, CLIN PHARMACOL THER, V81, P692, DOI 10.1038/sj.clpt.6100102; Rodriguez-Rosell D, 2017, J STRENGTH COND RES, V31, P196, DOI 10.1519/JSC.0000000000001476; Salinero JJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030269; Salinero JJ, 2014, BRIT J NUTR, V112, P1494, DOI 10.1017/S0007114514002189; Saunders B, 2017, SCAND J MED SCI SPOR, V27, P1240, DOI 10.1111/sms.12793; Skinner TL, 2010, MED SCI SPORT EXER, V42, P571, DOI 10.1249/MSS.0b013e3181b6668b; Thomas RM, 2017, IRISH J MED SCI, V186, P285, DOI 10.1007/s11845-016-1478-7; Womack CJ, 2012, J INT SOC SPORT NUTR, V9, DOI 10.1186/1550-2783-9-7	34	32	32	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195943	10.1371/journal.pone.0195943	http://dx.doi.org/10.1371/journal.pone.0195943			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668752	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200070
J	Kawaguchi, K; Harimaya, K; Matsumoto, Y; Hayashida, M; Okada, S; Iida, K; Kato, G; Tsuchiya, K; Doi, T; Oda, Y; Iwamoto, Y; Nakashima, Y				Kawaguchi, Kenichi; Harimaya, Katsumi; Matsumoto, Yoshihiro; Hayashida, Mitsumasa; Okada, Seiji; Iida, Keiichiro; Kato, Go; Tsuchiya, Kuniyoshi; Doi, Toshio; Oda, Yoshinao; Iwamoto, Yukihide; Nakashima, Yasuharu			Effect of cartilaginous endplates on extruded disc resorption in lumbar disc herniation	PLOS ONE			English	Article							NUCLEUS PULPOSUS; INTERVERTEBRAL-DISK; NATURAL-HISTORY; GROWTH-FACTOR; NEOVASCULARIZATION; ANGIOGENESIS; CLASSIFICATION; DEGENERATION; COMPRESSION; INHIBITION	Objective The aim of this study was to investigate the clinicopathologic features of lumbar disc herniation (LDH) with endplate degeneration and the association between cartilaginous fragments and inflammatory response to the herniated disc. Summary of background data LDH often involves hyaline cartilage fragments pulled from the vertebral endplates. Modic changes are closely associated with LDH that contains hyaline cartilage, and cartilaginous endplates seem to affect resorption of the herniated disc. Methods A total of 78 patients who underwent microscopic discectomy between 9 and 16 weeks after an occurrence of LDH were reviewed. Modic changes, disc degeneration, high-intensity zone, and vertebral corner defect were evaluated using magnetic resonance imaging (MRI). Histopathological observations of cartilaginous endplates and inflamed granulation tissue in the herniated disc were made. In cases with inflamed granulation tissue, neovascularization and macrophage infiltration were also evaluated using immunohistochemical analysis. Results Modic changes were observed in approximately one-third of the patients (26 cases: type 1, 7; type 2, 17; and type 3, 2). Cartilaginous endplates were observed in 32 cases (41%) and in the majority of cases with Modic changes compared with cases without Modic changes (65%, p = 0.001). Although inflamed granulation tissue was observed in 60 cases (77%), no significant differences were detected in patient age and the composition of the herniated material. Immunohistochemical analysis showed that fewer CD34-positive capillaries and CD68-positive cells were found in cases with cartilaginous fragments compared with those without cartilaginous fragments (p < 0.001). In addition, a higher immunoreactivity to CD34 and CD68 was found in herniated discs <25% of whose area was occupied by cartilaginous endplates compared with discs whose area was occupied at 25% or more (p < 0.001). Conclusion There is an association between LDH with endplate degeneration and cartilaginous herniation, with Modic type 2 predominating. Furthermore, neovascularization and macrophage infiltration, especially if the amount of cartilage is high, are likely to be less frequent in cartilaginous herniation, leading to failure in the spontaneous remission of clinical symptoms.	[Kawaguchi, Kenichi; Harimaya, Katsumi; Matsumoto, Yoshihiro; Hayashida, Mitsumasa; Okada, Seiji; Iida, Keiichiro; Iwamoto, Yukihide; Nakashima, Yasuharu] Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan; [Kato, Go] Saga Ken Med Ctr, Dept Orthopaed Surg, Saga, Japan; [Tsuchiya, Kuniyoshi] JCHO Kyushu Hosp, Dept Orthopaed Surg, Fukuoka, Japan; [Doi, Toshio] Kyushu Univ, Dept Orthopaed Surg, Beppu Hosp, Oita, Japan; [Oda, Yoshinao] Kyushu Univ, Grad Sch Med Sci, Dept Anat Pathol, Pathol Sci, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University	Kawaguchi, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Fukuoka, Japan.	kawaken@ortho.med.kyushu-u.ac.jp		Kato, Go/0000-0002-3098-9759				ADAMS MA, 1982, SPINE, V7, P184, DOI 10.1097/00007632-198205000-00002; Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Akagi S, 2000, ORTHOPEDICS, V23, P445; APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Arai Y, 2000, J Orthop Sci, V5, P229, DOI 10.1007/s007760050156; Autio RA, 2006, SPINE, V31, P1247, DOI 10.1097/01.brs.0000217681.83524.4a; BOZZAO A, 1992, RADIOLOGY, V185, P135, DOI 10.1148/radiology.185.1.1523297; Carreon LY, 1997, SPINE, V22, P1429, DOI 10.1097/00007632-199707010-00001; HARADA Y, 1989, SPINE, V14, P1020, DOI 10.1097/00007632-198909000-00017; Haro H, 2002, J ORTHOP RES, V20, P409, DOI 10.1016/S0736-0266(01)00150-4; Hasegawa T, 2000, SPINE, V25, P937, DOI 10.1097/00007632-200004150-00007; Jensen TS, 2006, SPINE, V31, P1605, DOI 10.1097/01.brs.0000221992.77779.37; Joe E, 2015, AM J ROENTGENOL, V204, P1075, DOI 10.2214/AJR.14.13319; Johnson WEB, 2005, SPINE, V30, P1139, DOI 10.1097/01.brs.0000162624.95262.73; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; Kato T, 2004, J ORTHOP RES, V22, P895, DOI 10.1016/j.orthres.2003.11.008; Kawakami M, 2000, CLIN ORTHOP RELAT R, P268; Kobayashi S, 2009, SPINE, V34, P655, DOI 10.1097/BRS.0b013e31819c9d5b; Koike Y, 2003, SPINE, V28, P1928, DOI 10.1097/01.BRS.0000083324.65405.AE; Komori H, 1996, SPINE, V21, P225, DOI 10.1097/00007632-199601150-00013; Lama P, 2014, EUR SPINE J, V23, P1869, DOI 10.1007/s00586-014-3399-3; LIND B, 1993, SPINE, V18, P1550; McCulloch JA, 1990, LUMBAR SPINE, P393; Minamide A, 1999, SPINE, V24, P940, DOI 10.1097/00007632-199905150-00003; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; OLMARKER K, 1993, SPINE, V18, P1425; Olmarker K, 2001, SPINE, V26, P863, DOI 10.1097/00007632-200104150-00007; Ozaki S, 1999, J Orthop Sci, V4, P286, DOI 10.1007/s007760050105; PEDOWITZ RA, 1992, SPINE, V17, P194, DOI 10.1097/00007632-199202000-00013; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Ratsep T, 2013, EUR SPINE J, V22, P2474, DOI 10.1007/s00586-013-2842-1; Rajasekaran S, 2013, SPINE, V38, P1491, DOI 10.1097/BRS.0b013e31829a6fa6; Schmid G, 2004, RADIOLOGY, V231, P352, DOI 10.1148/radiol.2312021708; Seo JY, 2016, EUR SPINE J, V25, P1393, DOI 10.1007/s00586-014-3587-1; Shan Z, 2014, SPINE, V39, P736, DOI 10.1097/BRS.0000000000000259; Summers GC, 2008, BIORHEOLOGY, V45, P365, DOI 10.3233/BIR-2008-0495; Takebayashi T, 2001, SPINE, V26, P940, DOI 10.1097/00007632-200104150-00018; TANAKA M, 1993, SPINE, V18, P1456; URBAN JPG, 1981, CONNECT TISSUE RES, V9, P1, DOI 10.3109/03008208109160234; Veres SP, 2010, EUR SPINE J, V19, P1468, DOI 10.1007/s00586-010-1383-0; Willburger RE, 2004, SPINE, V29, P1655, DOI 10.1097/01.BRS.0000133645.94159.64; YASUMA T, 1993, SPINE, V18, P1761, DOI 10.1097/00007632-199310000-00008	42	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195946	10.1371/journal.pone.0195946	http://dx.doi.org/10.1371/journal.pone.0195946			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664923	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300043
J	Abdulai, I; Jassogne, L; Graefe, S; Asare, R; Van Asten, P; Laderach, P; Vaast, P				Abdulai, Issaka; Jassogne, Laurence; Graefe, Sophie; Asare, Richard; Van Asten, Piet; Laderach, Peter; Vaast, Philippe			Characterization of cocoa production, income diversification and shade tree management along a climate gradient in Ghana	PLOS ONE			English	Article							WEST-AFRICA; AGROFORESTRY; DEFORESTATION; SERVICES; FARMERS	Reduced climatic suitability due to climate change in cocoa growing regions of Ghana is expected in the coming decades. This threatens farmers' livelihood and the cocoa sector. Climate change adaptation requires an improved understanding of existing cocoa production systems and farmers' coping strategies. This study characterized current cocoa production, income diversification and shade tree management along a climate gradient within the cocoa belt of Ghana. The objectives were to 1) compare existing production and income diversification between dry, mid and wet climatic regions, and 2) identify shade trees in cocoa agroforestry systems and their distribution along the climatic gradient. Our results showed that current mean cocoa yield level of 288 kg ha(-1) yr(-1) in the dry region was significantly lower than in the mid and wet regions with mean yields of 712 and 849 kg ha(-1) yr(-1), respectively. In the dry region, farmers diversified their income sources with non-cocoa crops and off-farm activities while farmers at the mid and wet regions mainly depended on cocoa (over 80% of annual income). Two shade systems classified as medium and low shade cocoa agroforestry systems were identified across the studied regions. The medium shade system was more abundant in the dry region and associated to adaptation to marginal climatic conditions. The low shade system showed significantly higher yield in the wet region but no difference was observed between the mid and dry regions. This study highlights the need for optimum shade level recommendation to be climatic region specific.	[Abdulai, Issaka] Univ Gottingen, Trop Plant Prod & Agr Syst Modelling TROPAGS, Gottingen, Germany; [Jassogne, Laurence; Van Asten, Piet] IITA, Kampala, Uganda; [Graefe, Sophie] Univ Goettingen, Trop Silviculture & Forest Ecol, Busgenweg 1, Gottingen, Germany; [Asare, Richard] IITA, Accra, Ghana; [Laderach, Peter] Int Ctr Trop Agr CIAT, Hanoi, Vietnam; [Vaast, Philippe] Univ Montpellier, Ctr Cooperat Int Rech Agron Dev CIRAD, UMR Eco&Sols, Montpellier, France; [Vaast, Philippe] World Agroforestry Ctr ICRAF, Hanoi, Vietnam	University of Gottingen; University of Gottingen; Alliance; International Center for Tropical Agriculture - CIAT; Institut Agro; Montpellier SupAgro; CIRAD; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Abdulai, I (corresponding author), Univ Gottingen, Trop Plant Prod & Agr Syst Modelling TROPAGS, Gottingen, Germany.	iabdula@gwdg.de		Laderach, Peter/0000-0001-8708-6318	German Ministry for Economic Cooperation and Development (BMZ) [12.1433.7-001.00]; German Ministry for Economic Cooperation and Development (BMZ)	German Ministry for Economic Cooperation and Development (BMZ); German Ministry for Economic Cooperation and Development (BMZ)	This study was funded by the German Ministry for Economic Cooperation and Development (BMZ), project number: 12.1433.7-001.00.; This research is part of the CGIAR programs on Climate Change, Agriculture and Food Security (CCAFS) and Forest, Trees and Agriculture (FTA). The authors thank Mr Sander Muilerman (IITA Ghana), farmers, field assistant (Mr. Aikins Nyameky) and forester (Mr. Joseph Owusu) for their support in data collection. Professor Anthony Whitbread is also acknowledged for the co-establishment of the project at Goettingen University. Funding through the German Ministry for Economic Cooperation and Development (BMZ) is gratefully acknowledged. The project partners, Agro-Eco Louis Bulk Institute, Cocoa Research Institute of Ghana (CRIG) and Kuapa Kokoo Farmers Union are also acknowledged.	Abdulai I, 2018, GLOBAL CHANGE BIOL, V24, P273, DOI 10.1111/gcb.13885; Adjei-Nsiah S., 2012, British Journal of Environment and Climate Change, V2, P137; Alvarez S, 2014, REP CGIAR RES PROGR; Andersen E, 2007, J ENVIRON MANAGE, V82, P353, DOI 10.1016/j.jenvman.2006.04.021; Anim-Kwapong G.J., 2004, COCOA RES I GHANA, V2, P1; [Anonymous], 2014, ETFRN NEWS; Antwi-Agyei P, 2014, REG ENVIRON CHANGE, V14, P1615, DOI 10.1007/s10113-014-0597-9; Asante FA, 2015, CLIMATE, V3, P78, DOI 10.3390/cli3010078; Asante WA, 2017, LAND USE POLICY, V66, P374, DOI 10.1016/j.landusepol.2017.05.010; Asare R., 2005, COCOA AGROFORESTS W; Asare R, 2015, TREE DIVERSITY CANOP, DOI [10.1007/s11056-015-9515-3, DOI 10.1007/S11056-015-9515-3]; Asare R., 2008, STCP WORKING PAPER S, V9; Asare R, 2017, EXP AGR, V53, P416, DOI 10.1017/S0014479716000466; Asare R, 2014, AGROFOREST SYST, V88, P1143, DOI 10.1007/s10457-014-9688-3; Beer J, 1997, AGROFOREST SYST, V38, P139, DOI 10.1023/A:1005956528316; Bisseleua HBD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056115; Blaser WJ, 2017, AGR ECOSYST ENVIRON, V243, P83, DOI 10.1016/j.agee.2017.04.007; Damnyag L, 2013, BIOL CONSERV, V165, P86, DOI 10.1016/j.biocon.2013.05.024; FAO, 2015, SOC CONT ROL AGR, V717; Fountain AC, 2015, COCOA BAROMETER D LO; Giller KE, 2011, AGR SYST, V104, P191, DOI 10.1016/j.agsy.2010.07.002; Gockowski J., 2011, AGR INTENSIFICATION; Gockowski J, 2004, HABITAT, V29; Gockowski J, 2013, INT J AGR SUSTAIN, V11, P331, DOI 10.1080/14735903.2013.772714; Graefe S, 2017, HUM ECOL, V45, P321, DOI 10.1007/s10745-017-9899-0; Laderach P, 2013, CLIMATIC CHANGE, V119, P841, DOI 10.1007/s10584-013-0774-8; Nath CD, 2010, AGROFOREST SYST, V79, P223, DOI 10.1007/s10457-009-9255-5; Quagrainie K.K., 2009, J APPL SCI ENV MANAG, V13, P13, DOI [10.4314/jasem.v13i2.55294, DOI 10.4314/JASEM.V13I2.55294]; Ruf F, 2015, SUSTAIN SCI, V10, P101, DOI 10.1007/s11625-014-0282-4; Ruf FO, 2011, HUM ECOL, V39, P373, DOI 10.1007/s10745-011-9392-0; Schroth G, 2017, MITIG ADAPT STRAT GL, V22, P903, DOI 10.1007/s11027-016-9707-y; Schroth G, 2016, SCI TOTAL ENVIRON, V556, P231, DOI 10.1016/j.scitotenv.2016.03.024; Sheffield J, 2008, CLIM DYNAM, V31, P79, DOI 10.1007/s00382-007-0340-z; Taylor, 1960, SYNECOLOGY SILVICULT; Tscharntke T, 2011, J APPL ECOL, V48, P619, DOI 10.1111/j.1365-2664.2010.01939.x; Vaast P., 2016, CLIMATE CHANGE AGR W, P209, DOI DOI 10.1007/978-94-017-7462-8_16; Vaast P, 2014, AGROFOREST SYST, V88, P947, DOI 10.1007/s10457-014-9762-x; Volta Basin Authority, 2017, AV RAINF AM COURS YE; Waldron A, 2015, ECOL APPL, V25, P361, DOI 10.1890/13-0313.1; WTO, 2014, WTO POL REV GHAN, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]	40	43	43	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195777	10.1371/journal.pone.0195777	http://dx.doi.org/10.1371/journal.pone.0195777			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659629	Green Published, Green Submitted, gold			2022-12-26	WOS:000430061100031
J	Haruma, T; Nagasaka, T; Nakamura, K; Haraga, J; Nyuya, A; Nishida, T; Goel, A; Masuyama, H; Hiramatsu, Y				Haruma, Tomoko; Nagasaka, Takeshi; Nakamura, Keiichiro; Haraga, Junko; Nyuya, Akihiro; Nishida, Takeshi; Goel, Ajay; Masuyama, Hisashi; Hiramatsu, Yuji			Clinical impact of endometrial cancer stratified by genetic mutational profiles, POLE mutation, and microsatellite instability	PLOS ONE			English	Article							DNA MISMATCH REPAIR; COLORECTAL-CANCER; CLINICOPATHOLOGICAL SIGNIFICANCE; RISK-ASSESSMENT; LYNCH-SYNDROME; PHENOTYPE; CARCINOMA; TUMORS; MLH1; HYPERMETHYLATION	Background The molecular characterization of endometrial cancer (EC) can facilitate identification of various tumor subtypes. Although EC patients with POLE mutations reproducibly demonstrate better prognosis, the outcome of patients with microsatellite instability (MSI) remains controversial. This study attempted to interrogate whether genetic stratification of EC can identify distinct subsets with prognostic significance. Materials and methods A cohort of 138 EC patients who underwent surgical resection with curative intent was enrolled. Sanger sequencing was used to evaluate mutations in the POLE and KRAS genes. MSI analysis was performed using four mononucleotide repeat markers and methylation status of the MLH1 promoter was measured by a fluorescent bisulfite polymerase chain reaction (PCR). Protein expression for mismatch repair (MMR) proteins was evaluated by immunohistochemistry (IHC). Results Extensive hypermethylation of the MLH1 promoter was observed in 69.6% ECs with MLH1 deficiency and 3.5% with MMR proficiency, but in none of the ECs with loss of other MMR genes (P < .0001). MSI-positive and POLE mutations were found in 29.0% and 8.7% EC patients, respectively. Our MSI analysis showed a sensitivity of 92.7% for EC patients with MMR deficiency, and a specificity of 97.9% for EC patients with MMR proficiency. In univariate and multivariate analyses, POLE mutations and MSI status was significantly associated with progression-free survival (P = 0.0129 and 0.0064, respectively) but not with endometrial cancer-specific survival. Conclusions This study provides significant evidence that analyses of proofreading POLE mutations and MSI status based on mononucleotide repeat markers are potentially useful biomarkers to identify EC patients with better prognosis.	[Haruma, Tomoko; Nakamura, Keiichiro; Haraga, Junko; Nishida, Takeshi; Masuyama, Hisashi; Hiramatsu, Yuji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Obstet & Gynecol, Okayama, Japan; [Nagasaka, Takeshi; Nyuya, Akihiro] Kawasaki Med Sch, Dept Clin Oncol, Kurashiki, Okayama, Japan; [Goel, Ajay] Baylor Scott & White Res Inst, Ctr Translat Genom & Oncol, Ctr Gastrointestinal Res, Dallas, TX USA; [Goel, Ajay] Baylor Univ, Med Ctr, Charles A Sammons Canc Ctr, Dallas, TX USA	Okayama University; Kawasaki Medical School; Baylor Health Care System; Baylor University Medical Center; Baylor University; Baylor University Medical Center	Nagasaka, T (corresponding author), Kawasaki Med Sch, Dept Clin Oncol, Kurashiki, Okayama, Japan.	takeshin@med.kawasaki-m.ac.jp		Nagasaka, Takeshi/0000-0002-4236-350X	MEXT/JSPS KAKENHI [15K20144, 16K11141]	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI (15K20144 to TH and 16K11141 to KN).	Alkushi A, 2010, INT J GYNECOL PATHOL, V29, P343, DOI 10.1097/PGP.0b013e3181cd6552; Bendifallah S, 2015, BRIT J CANCER, V112, P793, DOI 10.1038/bjc.2015.35; Bilbao C, 2010, INT J RADIAT ONCOL, V76, P9, DOI 10.1016/j.ijrobp.2009.09.035; Billingsley CC, 2015, CANCER-AM CANCER SOC, V121, P386, DOI 10.1002/cncr.29046; Black D, 2006, J CLIN ONCOL, V24, P1745, DOI 10.1200/JCO.2005.04.1574; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; Boland CR, 1998, CANCER RES, V58, P5248; Buhard O, 2006, J CLIN ONCOL, V24, P241, DOI 10.1200/JCO.2005.02.7227; Church DN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju402; Colombo N, 2013, ANN ONCOL, V24, P33, DOI 10.1093/annonc/mdt353; Deng GR, 1999, CANCER RES, V59, P2029; Diaz-Padilla I, 2013, CRIT REV ONCOL HEMAT, V88, P154, DOI 10.1016/j.critrevonc.2013.03.002; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Goel A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009393; Hanse RJ, 2016, NAT MED, V22, P1342, DOI 10.1038/nm.4191; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Kato M, 2015, J GYNECOL ONCOL, V26, P40, DOI 10.3802/jgo.2015.26.1.40; Kong TW, 2015, J GYNECOL ONCOL, V26, P32, DOI 10.3802/jgo.2015.26.1.32; Kurman RJ, 2013, GYNECOL ONCOL, V129, P271, DOI 10.1016/j.ygyno.2013.03.029; Kwon JS, 2009, OBSTET GYNECOL, V114, P736, DOI 10.1097/AOG.0b013e3181b96ec6; Lancaster JM, 2015, GYNECOL ONCOL, V136, P3, DOI 10.1016/j.ygyno.2014.09.009; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Le Gallo M, 2012, NAT GENET, V44, P1310, DOI 10.1038/ng.2455; MacDonald ND, 2000, CANCER RES, V60, P1750; McAlpine JN, 2016, CANCER-AM CANCER SOC, V122, P2787, DOI 10.1002/cncr.30094; McConechy MK, 2015, GYNECOL ONCOL, V137, P306, DOI 10.1016/j.ygyno.2015.01.541; McMeekin DS, 2016, J CLIN ONCOL, V34, P3062, DOI 10.1200/JCO.2016.67.8722; Meng B, 2014, GYNECOL ONCOL, V134, P15, DOI 10.1016/j.ygyno.2014.05.006; Murali R, 2014, LANCET ONCOL, V15, pE268, DOI 10.1016/S1470-2045(13)70591-6; Nagasaka T, 2004, J CLIN ONCOL, V22, P4584, DOI 10.1200/JCO.2004.02.154; Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094; Nagasaka T, 2006, ACTA MED OKAYAMA, V60, P249; Nakagawa H, 2001, CANCER RES, V61, P6991; Resnick KE, 2010, GYNECOL ONCOL, V117, P234, DOI 10.1016/j.ygyno.2009.12.028; Salvesen HB, 2012, LANCET ONCOL, V13, pE353, DOI 10.1016/S1470-2045(12)70213-9; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Steinbakk A, 2010, ANAL CELL PATHOL, V33, P245, DOI [10.3233/ACP-CLO-2010-0550, 10.1155/2010/430389]; Stelloo E, 2016, CLIN CANCER RES, V22, P4215, DOI 10.1158/1078-0432.CCR-15-2878; Stelloo E, 2015, MODERN PATHOL, V28, P836, DOI 10.1038/modpathol.2015.43; Stoffel EM, 2015, J CLIN ONCOL, V33, P209, DOI 10.1200/JCO.2014.58.1322; Takehara Y, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-017-1376-4; Umar A, 2004, J NATL CANCER I, V96, P261, DOI 10.1093/jnci/djh034; van Gool IC, 2015, CLIN CANCER RES, V21, P3347, DOI 10.1158/1078-0432.CCR-15-0057; Zighelboim I, 2007, J CLIN ONCOL, V25, P2042, DOI 10.1200/JCO.2006.08.2107	46	23	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195655	10.1371/journal.pone.0195655	http://dx.doi.org/10.1371/journal.pone.0195655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659608	Green Submitted, Green Published, gold			2022-12-26	WOS:000430061100024
J	Jmel, H; Romdhane, L; Ben Halima, Y; Hechmi, M; Naouali, C; Dallali, H; Hamdi, Y; Shan, JX; Abid, A; Jamoussi, H; Trabelsi, S; Chouchane, L; Luiselli, D; Abdelhak, S; Kefi, R				Jmel, Haifa; Romdhane, Lilia; Ben Halima, Yosra; Hechmi, Meriem; Naouali, Chokri; Dallali, Hamza; Hamdi, Yosr; Shan, Jingxuan; Abid, Abdelmajid; Jamoussi, Henda; Trabelsi, Sameh; Chouchane, Lotfi; Luiselli, Donata; Abdelhak, Sonia; Kefi, Rym			Pharmacogenetic landscape of Metabolic Syndrome components drug response in Tunisia and comparison with worldwide populations	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; VIP VARIANTS; GENETIC POLYMORPHISMS; THERAPEUTIC RESPONSE; INFERENCE; CYP2C9; CYP2C9-ASTERISK-2; ACENOCOUMAROL; ASSOCIATION; DIVERSITY	Genetic variation is an important determinant affecting either drug response or susceptibility to adverse drug reactions. Several studies have highlighted the importance of ethnicity in influencing drug response variability that should be considered during drug development. Our objective is to characterize the genetic variability of some pharmacogenes involved in the response to drugs used for the treatment of Metabolic Syndrome (MetS) in Tunisia and to compare our results to the worldwide populations. A set of 135 Tunisians was genotyped using the Affymetrix Chip 6.0 genotyping array. Variants located in 24 Very Important Pharmacogenes (VIP) involved in MetS drug response were extracted from the genotyping data. Analysis of variant distribution in Tunisian population compared to 20 worldwide populations publicly available was performed using R software packages. Common variants between Tunisians and the 20 investigated populations were extracted from genotyping data. Multidimensional screening showed that Tunisian population is clustered with North African and European populations. The greatest divergence was observed with the African and Asian population. In addition, we performed Inter-ethnic comparison based on the genotype frequencies of five VIP biomarkers. The genotype frequencies of the biomarkers rs3846662, rs1045642, rs7294 and rs12255372 located respectively in HMGCR, ABCB1, VKORC1 and TCF7L2 are similar between Tunisian, Tuscan (TSI) and European (CEU). The genotype frequency of the variant rs776746 located in CYP3A5 gene is similar between Tunisian and African populations and different from CEU and TSI. The present study shows that the genetic make up of the Tunisian population is relatively complex in regard to pharmacogenes and reflects previous historical events. It is important to consider this ethnic difference in drug prescription in order to optimize drug response to avoid serious adverse drug reactions. Taking into account similarities with other neighboring populations, our study has an impact not only on the Tunisian population but also on North African population which are underrepresented in pharmacogenomic studies.	[Jmel, Haifa; Romdhane, Lilia; Ben Halima, Yosra; Hechmi, Meriem; Naouali, Chokri; Dallali, Hamza; Hamdi, Yosr; Abdelhak, Sonia; Kefi, Rym] Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, Tunis, Tunisia; [Jmel, Haifa; Romdhane, Lilia; Hechmi, Meriem; Dallali, Hamza] Univ Carthage, Tunis, Tunisia; [Ben Halima, Yosra; Naouali, Chokri; Abdelhak, Sonia; Kefi, Rym] Univ Tunis El Manar, Tunis, Tunisia; [Shan, Jingxuan; Chouchane, Lotfi] Qatar Fdn, Weill Cornell Med Coll Qatar, Lab Genet Med & Immunol, Doha, Qatar; [Abid, Abdelmajid; Jamoussi, Henda] Natl Inst Nutr & Food Technol, Dept External Consultat, Tunis, Tunisia; [Trabelsi, Sameh] Natl Pharmacovigilance Ctr, Clin Pharmacol Serv, Tunis, Tunisia; [Luiselli, Donata] Univ Bologna, Dept Biol Geol & Environm Sci BiGeA, Lab Mol Anthropol, Bologna, Italy	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage; Universite de Tunis-El-Manar; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Universite de Tunis-El-Manar; Institut National de Nutrition Technologie Alimentaire; Centre National de Pharmacovigilance; University of Bologna	Kefi, R (corresponding author), Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, Tunis, Tunisia.; Kefi, R (corresponding author), Univ Tunis El Manar, Tunis, Tunisia.	rym.kefi@pasteur.rns.tn	Chouchane, Lotfi/ABF-1360-2020; Romdhane, Lilia/S-4691-2019; jamoussi, henda/AAH-9354-2021; Hamdi, Yosr/GLT-7117-2022	Hechmi, Meriem/0000-0002-3949-0647; Hamdi, Yosr/0000-0002-2815-1834; Romdhane, Lilia/0000-0001-5310-7272	Ministry of Higher Education and Scientific Research [LR11IPT05]; European Commission [279171-1]	Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the Ministry of Higher Education and Scientific Research (LR11IPT05) to Sonia Abdelhak and the European Commission (grant agreement no. 279171-1 for FP7 project MEDIGENE) to Institut Pasteur in Tunis. The Tunisian Ministry of Public Health is the employer of: Abdelmajid Abid, Henda Jamoussi, affiliated with the National Institute of Nutrition and Food Technology, and Sonia Abdelhak and Rym Kefi, affiliated with the Institut Pasteur in Tunis.	Abdelhedi R, 2015, J GENET, V94, P765, DOI 10.1007/s12041-015-0581-2; Arbitrio M, 2016, ONCOTARGET, V7, P54028, DOI 10.18632/oncotarget.9927; Arnett DK, 2007, CIRCULATION, V115, P2878, DOI 10.1161/CIRCULATIONAHA.107.183679; Bains RK, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-34; Belfki H, 2013, PUBLIC HEALTH NUTR, V16, P582, DOI 10.1017/S1368980012003291; Bodin L, 2005, BLOOD, V106, P135, DOI 10.1182/blood-2005-01-0341; Bonifaz-Pena V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112640; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Burmester JK, 2010, METHODS MOL BIOL, V632, P99, DOI 10.1007/978-1-60761-663-4_7; Buzoianu AD, 2012, J CELL MOL MED, V16, P2919, DOI 10.1111/j.1582-4934.2012.01606.x; Cadamuro J, 2010, EUR J CLIN PHARMACOL, V66, P253, DOI 10.1007/s00228-009-0768-7; Carvalho B, 2009, GENOTYPING CRLMM PAC; Cherni L, 2016, AM J PHYS ANTHROPOL, V161, P62, DOI 10.1002/ajpa.23008; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; CROOP JM, 1993, CYTOTECHNOLOGY, V12, P1, DOI 10.1007/BF00744656; Dawed AY, 2016, DIABETES CARE, V39, P1902, DOI 10.2337/dc15-2464; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Evans WE, 2003, NEW ENGL J MED, V348, P538, DOI 10.1056/NEJMra020526; Evans WE, 2001, ANNU REV GENOM HUM G, V2, P9, DOI 10.1146/annurev.genom.2.1.9; Fadhlaoui-Zid K, 2011, AM J PHYS ANTHROPOL, V146, P271, DOI 10.1002/ajpa.21581; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Flynn AA, 2011, DRUG DISCOV TODAY, V16, P862, DOI 10.1016/j.drudis.2011.08.008; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Goudet J, 2005, MOL ECOL NOTES, V5, P184, DOI 10.1111/j.1471-8286.2004.00828.x; Guzzi PH, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-258; He YJ, 2015, INT J CLIN EXP PATHO, V8, P13293; Henn BM, 2012, P NATL ACAD SCI USA, V109, P17758, DOI 10.1073/pnas.1212380109; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Humphries SE, 2006, J MOL MED, V84, P1005, DOI 10.1007/s00109-006-0108-7; Israili Zafar H, 2007, Am J Ther, V14, P386, DOI 10.1097/01.pap.0000249936.05650.0c; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson JA, 2003, TRENDS GENET, V19, P660, DOI 10.1016/j.tig.2003.09.008; KALOW W, 1982, CLIN PHARMACOKINET, V7, P373, DOI 10.2165/00003088-198207050-00001; Kefi R, 2015, MITOCHONDR DNA, V26, P593, DOI 10.3109/19401736.2013.879649; Khouri C, 2016, BRIT J CLIN PHARMACO, V82, P549, DOI 10.1111/bcp.12980; Klen J, 2014, EUR J CLIN PHARMACOL, V70, P421, DOI 10.1007/s00228-014-1641-x; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Kurose K, 2012, DRUG METAB PHARMACOK, V27, P9, DOI 10.2133/dmpk.DMPK-11-RV-111; Lee SJ, 2003, PHARMACOGENETICS, V13, P461, DOI 10.1097/00008571-200308000-00004; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Li SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116463; Limdi NA, 2010, BLOOD, V115, P3827, DOI 10.1182/blood-2009-12-255992; Man M, 2010, J CLIN PHARMACOL, V50, P929, DOI 10.1177/0091270009355161; MATERSON BJ, 1993, NEW ENGL J MED, V328, P914, DOI 10.1056/NEJM199304013281303; McAlpine DE, 2011, THER DRUG MONIT, V33, P14, DOI 10.1097/FTD.0b013e3181fcf94d; Medina MW, 2008, CIRCULATION, V118, P355, DOI 10.1161/CIRCULATIONAHA.108.773267; Mega JL, 2010, JAMA-J AM MED ASSOC, V304, P1821, DOI 10.1001/jama.2010.1543; Millman AL, 2014, CUAJ-CAN UROL ASSOC, V8, P183, DOI 10.5489/cuaj.1884; Mizzi C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162866; Mizzi C, 2014, PHARMACOGENOMICS, V15, P1223, DOI [10.2217/PGS.14.102, 10.2217/pgs.14.102]; Pearson ER, 2007, DIABETES, V56, P2178, DOI 10.2337/db07-0440; Pirmohamed M, 2014, ANNU REV GENOM HUM G, V15, P349, DOI 10.1146/annurev-genom-090413-025419; Pollastro C, 2015, PPAR RES, V2015, DOI 10.1155/2015/415149; Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Semiz S, 2010, BOSNIAN J BASIC MED, V10, P287, DOI 10.17305/bjbms.2010.2662; Shan JX, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-121; Sivadas A, 2016, PHARMACOGENOMICS, V17, P1891, DOI 10.2217/pgs-2016-0130; Su J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046366; Verhoef TI, 2013, NEW ENGL J MED, V369, P2304, DOI 10.1056/NEJMoa1311388; Wang L, 2016, DRUG METAB PHARMACOK, V31, P82, DOI 10.1016/j.dmpk.2015.11.007; Wang L, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0232-x; Weinshilboum R, 2003, NEW ENGL J MED, V348, P529, DOI 10.1056/NEJMra020021; Wilke RA, 2005, PHARMACOGENET GENOM, V15, P415, DOI 10.1097/01213011-200506000-00007; Willrich MAV, 2008, CLIN CHIM ACTA, V398, P15, DOI 10.1016/j.cca.2008.07.032; Yasuda SU, 2008, CLIN PHARMACOL THER, V84, P417, DOI 10.1038/clpt.2008.141; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	70	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194842	10.1371/journal.pone.0194842	http://dx.doi.org/10.1371/journal.pone.0194842			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652911	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900012
J	Barker, SF; Zomer, E; O'Toole, J; Sinclair, M; Gibney, K; Liew, D; Leder, K				Barker, S. Fiona; Zomer, Ella; O'Toole, Joanne; Sinclair, Martha; Gibney, Katherine; Liew, Danny; Leder, Karin			Cost of gastroenteritis in Australia: A healthcare perspective	PLOS ONE			English	Article							ACUTE GASTROINTESTINAL ILLNESS; ROTAVIRUS VACCINATION; CASE-DEFINITION; BURDEN; COMMUNITY; DISEASE; HOSPITALIZATIONS	Background Acute gastroenteritis illness is a common illness that causes considerable morbidity, but current estimates of the cost to the Australian healthcare system are unknown. Objective To estimate the current healthcare utilisation and direct public healthcare system costs attributable to acute gastroenteritis illness in Australia. Methods This is an incidence-based cost-of-illness study focused on quantifying direct health care costs using a bottom-up approach. Data on general practitioner consultations, prescribed medications, diagnostic tests, specialist consultations, emergency department visits and hospital admissions were collected from national reports. Results Using 2016 prices, the estimated annual direct per capita cost of acute gastroenteritis illness was AUD$14.87 (USD$10.71), equating to AUD$20.27 (USD$14.59) per case. The estimated overall economic burden in Australia was AUD$359 million (USD$258 million; AUD $1.5 million per 100,000 people). The major contributors to this cost were hospital admissions (57.1%), emergency department visits (17.7%), and general practitioner consultations (14.0%). Children under five years of age have the highest per capita rates of acute gastroenteritis illness; however, service utilisation rates vary by age group and both young children and older adults accounted for a substantial proportion of the overall economic burden attributable to acute gastroenteritis illness. Conclusions Although chronic diseases comprise a large cost burden on the healthcare system, acute illnesses, including acute gastroenteritis illness, also impose substantial direct healthcare system costs. Providing data on current cost estimates is useful for prioritizing public health interventions, with our findings suggesting that it would be ideal if targeted interventions to reduce hospitalisation rates among young children and older adults were available.	[Barker, S. Fiona; Zomer, Ella; O'Toole, Joanne; Sinclair, Martha; Liew, Danny; Leder, Karin] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Gibney, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia	Monash University; University of Melbourne	Barker, SF (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia.	fiona.barker@monash.edu	Leder, Karin/AAD-2388-2019; Zomer, Ella/AAE-2462-2019; Barker, Fiona/K-7538-2015	Leder, Karin/0000-0003-1368-1039; Zomer, Ella/0000-0002-9993-4297; Barker, Fiona/0000-0002-9203-5766; Liew, Danny/0000-0002-0131-623X				ABS, 2016, 43900 ABS; ABS, 2015, 43900 ABS; ABS, 2010, 43900 ABS; AIHW, 2014, EM DEP CAR 2013 14 A; AIHW, 2015, EM DEP CAR 2014 15 A; AIHW, 2012, MED WORKF 2010; AIHW, 2015, AIHW NAT HOSP MORB D; AIHW, 2014, 4 2 CHRON DIS AUSTR; AIHW, 2017, MET ONL REG; [Anonymous], 2017, PHARM BEN SCHEM PBS; [Anonymous], 2016, AUSTR DEM STAT; [Anonymous], 2017, Q MED STAT TABL 2 NA; [Anonymous], 2017, NAT HOSP MORB DAT SE; Australian Institute of Health and Welfare (AIHW), HLTH EXP AUSTR 2014; Authority IHP, 2021, ROUND 22 NAT HOSP CO; Baumann-Popczyk A, 2012, EPIDEMIOL INFECT, V140, P1173, DOI 10.1017/S0950268811001853; BEACH. BEACH: Bettering the Evaluation and Care of Health, 2006, BEACH BEACH BETT EV; Chen Y, 2016, EPIDEMIOL INFECT, V144, P241, DOI 10.1017/S0950268815001375; Dey A, 2012, MED J AUSTRALIA, V197, P453, DOI 10.5694/mja12.10062; DH, 2016, MED BEN SCHED BOOK O; Edelstein M, 2016, EPIDEMIOL INFECT, V144, P2831, DOI 10.1017/S0950268816000467; Fischer TK, 2007, EMERG INFECT DIS, V13, P855, DOI 10.3201/eid1306.061432; Gibney K, 2012, 100409 WQRA; Gibney KB, 2014, INT J INFECT DIS, V28, P176, DOI 10.1016/j.ijid.2014.08.006; Hall G, 2010, EPIDEMIOL INFECT, V138, P117, DOI 10.1017/S0950268809990112; Hall GV, 2006, EPIDEMIOL INFECT, V134, P111, DOI 10.1017/S0950268805004656; Hellard ME, 2003, J GASTROEN HEPATOL, V18, P322, DOI 10.1046/j.1440-1746.2003.02959.x; Hendrix N, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-017347; Henson SJ, 2008, INT J FOOD MICROBIOL, V127, P43, DOI 10.1016/j.ijfoodmicro.2008.06.007; Henson SJ, 2011, INT J FOOD MICROBIOL, V147, P86, DOI 10.1016/j.ijfoodmicro.2011.03.008; Herikstad H, 2002, EPIDEMIOLOGY INFECT, V129; Ho SC, 2010, EPIDEMIOL INFECT, V138, P982, DOI 10.1017/S0950268809991087; Independent Hospital Pricing Authority (IHPA), 2014, NAT HOSP COST DAT CO; King D., 2013, PRIVATE PATIENTS PUB; Kirk M, 2014, FOODBORNE ILLNESS AU; Majowicz SE, 2008, EPIDEMIOL INFECT, V136, P886, DOI 10.1017/S0950268807009375; Muller L, 2012, EPIDEMIOL INFECT, V140, P290, DOI 10.1017/S0950268811000471; Najnin N, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-211; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Reyes JF, 2017, VACCINE, V35, P345, DOI 10.1016/j.vaccine.2016.11.056; Scavia G, 2012, EPIDEMIOL INFECT, V140, P1193, DOI 10.1017/S0950268811002020; Tam CC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0138526; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; van den Brandhof WE, 2004, EPIDEMIOL INFECT, V132, P211, DOI 10.1017/S0950268803001559; Hoang VM, 2015, J KOREAN MED SCI, V30, pS178, DOI 10.3346/jkms.2015.30.S2.S178; Wilcox S., 2014, CHRONIC DIS AUSTR CA; XE, 2017, CURR HIST RAT TABL 2	47	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195759	10.1371/journal.pone.0195759	http://dx.doi.org/10.1371/journal.pone.0195759			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649285	gold, Green Published			2022-12-26	WOS:000429791900082
J	Becker, F; Anokye, N; de Bekker-Grob, EW; Higgins, AL; Relton, C; Strong, M; Fox-Rushby, J				Becker, Frauke; Anokye, Nana; de Bekker-Grob, Esther W.; Higgins, Ai Lish; Relton, Clare; Strong, Mark; Fox-Rushby, Julia			Women's preferences for alternative financial incentive schemes for breastfeeding: A discrete choice experiment	PLOS ONE			English	Article							SMOKING-CESSATION; RANDOM UTILITY; OLDER-PEOPLE; HEALTH-CARE; ACCEPTABILITY; BEHAVIORS; PREGNANCY; PROGRAM; PAY	Background Increasing breastfeeding rates have been associated with reductions in disease in babies and mothers as well as in related costs. 'Nourishing Start for Health (NoSH)', a financial incentive scheme has been proposed as a potentially effective way to increase both the number of mothers breastfeeding and duration of breastfeeding. Aims To establish women's relative preferences for different aspects of a financial incentive scheme for breastfeeding and to identify importance of scheme characteristics on probability on participation in an incentive scheme. Methods A discrete choice experiment (DCE) obtained information on alternative specifications of the NoSH scheme designed to promote continued breastfeeding duration until at least 6 weeks after birth. Four attributes framed alternative scheme designs: value of the incentive; minimum breastfeeding duration required to receive incentive; method of verifying breastfeeding; type of incentive. Three versions of the DCE questionnaire, each containing 8 different choice sets, provided 24 choice sets for analysis. The questionnaire was mailed to 2,531 women in the South Yorkshire Cohort (SYC) aged 16-45 years in IMD quintiles 3-5. The analytic approach considered conditional and mixed effects logistic models to account for preference heterogeneity that may be associated with a variation in effects mediated by respondents' characteristics. Results 564 women completed the questionnaire and a response rate of 22% was achieved. Most of the included attributes were found to affect utility and therefore the probability to participate in the incentive scheme. Higher rewards were preferred, although the type of incentive significantly affected women's preferences on average. We found evidence for preference heterogeneity based on individual characteristics that mediated preferences for an incentive scheme. Conclusions Although participants' opinion in our sample was mixed, financial incentives for breastfeeding may be an acceptable and effective instrument to change behaviour. However, individual characteristics could mediate the effect and should therefore be considered when developing and targeting future interventions.	[Becker, Frauke] Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England; [Becker, Frauke; Anokye, Nana; Higgins, Ai Lish; Fox-Rushby, Julia] Brunel Univ, Hlth Econ Res Grp, Uxbridge, Middx, England; [de Bekker-Grob, Esther W.] Erasmus Univ, Sect Hlth Technol Assessment, Rotterdam, Netherlands; [de Bekker-Grob, Esther W.] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Erasmus Choice Modelling Ctr, Rotterdam, Netherlands; [Relton, Clare; Strong, Mark] Univ Sheffield, Sch Hlth & Related Res, Sheffield, S Yorkshire, England	University of Oxford; Brunel University; Erasmus University Rotterdam; Erasmus University Rotterdam; University of Sheffield	Becker, F (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth, Hlth Econ Res Ctr, Oxford, England.; Becker, F (corresponding author), Brunel Univ, Hlth Econ Res Grp, Uxbridge, Middx, England.	frauke.becker@dph.ox.ac.uk	Becker, Frauke/Q-7738-2018; Strong, Mark/A-4638-2010	Becker, Frauke/0000-0003-1175-3932; Strong, Mark/0000-0003-1486-8233; Fox-Rushby, Julia/0000-0003-0748-0871	Medical Research Council (MRC) National Prevention Research Initiative (NPRI) [MR/J000434/1]; MRC [MR/J000434/1] Funding Source: UKRI	Medical Research Council (MRC) National Prevention Research Initiative (NPRI); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors acknowledge financial support from the Medical Research Council (MRC) National Prevention Research Initiative (NPRI) (grant number MR/J000434/1). The funders had no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	Adams J, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19940; Bech M, 2005, HEALTH ECON, V14, P1079, DOI 10.1002/hec.984; Bech M, 2011, HEALTH ECON, V20, P273, DOI 10.1002/hec.1587; Bolling K, 2007, INFANT FEEDING SURVE; Cahill K, 2008, COCHRANE DB SYST REV; Clark MD, 2014, PHARMACOECONOMICS, V32, P883, DOI 10.1007/s40273-014-0170-x; Coast J, 2008, SOC SCI MED, V67, P874, DOI 10.1016/j.socscimed.2008.05.015; de Bekker-Grob EW, 2012, HEALTH ECON, V21, P145, DOI 10.1002/hec.1697; Department of Health, 2012, HLTH START SCHEM RES; Farooqui MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-141; Finch C, 2002, J AM DIET ASSOC, V102, P981, DOI 10.1016/S0002-8223(02)90224-5; Flynn Terry N, 2008, Popul Health Metr, V6, P6, DOI 10.1186/1478-7954-6-6; Giles EL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157403; Giles EL, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0549-5; Giles EL, 2015, PREV MED, V73, P145, DOI 10.1016/j.ypmed.2014.12.029; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Groves R.M., 2004, SURVEY ERRORS SURVEY; Hashemi A, 2015, J OBESITY WEIGHT LOS, V5; Hensher DA, 2003, TRANSPORTATION, V30, P133, DOI 10.1023/A:1022558715350; Hicks RL, 2000, LAND ECON, V76, P374, DOI 10.2307/3147035; Hoddinott P, 2014, LANCET, V384, P37; Lancsar E, 2004, HEALTH ECON, V13, P901, DOI 10.1002/hec.870; Lancsar E, 2013, SOC SCI MED, V76, P74, DOI 10.1016/j.socscimed.2012.10.007; Mantzari E, 2015, PREV MED, V75, P75, DOI 10.1016/j.ypmed.2015.03.001; McAndrew F, 2012, INFANT FEEDING SURVE; Morgan H, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19300; Ozdemir S, 2009, J HEALTH ECON, V28, P894, DOI 10.1016/j.jhealeco.2009.04.004; Pokhrel S, 2015, ARCH DIS CHILD, V100, P334, DOI 10.1136/archdischild-2014-306701; Promberger M, 2012, SOC SCI MED, V75, P2509, DOI 10.1016/j.socscimed.2012.09.033; Relton C, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010158; Relton C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-640; Renfrew M, 2012, PREVENTING DIS SAVIN; Ryan M, 2008, USING DISCRETE CHOIC, Vxix; Ryan M, 2006, J HEALTH ECON, V25, P927, DOI 10.1016/j.jhealeco.2006.01.001; SCIACCA JP, 1995, J AM DIET ASSOC, V95, P323, DOI 10.1016/S0002-8223(95)00083-6; Tappin D, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h134; Train K., 2003, DISCRETE CHOICE METH, Vvii; Watson V, 2016, DISCRETE CHOICE EXPT; Whelan B, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-355; World Health Organization, 2016, WHO INF YOUNG CHILDR	40	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194231	10.1371/journal.pone.0194231	http://dx.doi.org/10.1371/journal.pone.0194231			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649245	Green Published, gold, Green Accepted			2022-12-26	WOS:000429791900008
J	Jones, CS; Nielsen, JK; Schilling, KE; Weber, LJ				Jones, Christopher S.; Nielsen, Jacob K.; Schilling, Keith E.; Weber, Larry J.			Iowa stream nitrate and the Gulf of Mexico	PLOS ONE			English	Article							MISSISSIPPI RIVER; RACCOON RIVER; NITROGEN; HYPOXIA; NUTRIENT; REDUCTION; FLUX; EUTROPHICATION; CHALLENGES; POLICY	The main objective of this work was to quantify and update the U.S. Midwest agricultural state of Iowa's contribution of nitrate-nitrogen to the Mississippi River stream network against the backdrop of the ongoing problem of Gulf of Mexico hypoxia. To achieve this objective, we used stream nitrate and discharge data collected from 1999 until 2016 at 23 Iowa stream sites near watershed outlets, along with publicly-available data for sites downstream of Iowa on the Missouri and Mississippi Rivers. Our analysis shows that Iowa contributes between 11 and 52% of the long-term nitrate load to the Mississippi-Atchafalaya Basin, 20 to 63% to the Upper Mississippi River Basin, and 20 to 89% to the Missouri River Basin, with averages of 29, 45 and 55% respectively. Since 1999, nitrate loads in the Iowa inclusive basins have increased and these increases do not appear to be driven by changes in discharge and cropping intensity unique to Iowa. The 5-year running annual average of Iowa nitrate loading has been above the 2003 level for ten consecutive years, implying that Gulf hypoxic areal goals, also based on a 5-year running annual average, will be very difficult to achieve if nitrate retention cannot be improved in Iowa. An opportunity exists for land managers, policy makers and conservationists to manifest a positive effect on water quality by targeting and implementing nitrate reducing-practices in areas like Iowa while avoiding areas that are less likely to affect Gulf of Mexico hypoxia.	[Jones, Christopher S.; Nielsen, Jacob K.; Weber, Larry J.] Univ Iowa, IIHR Hydrosci & Engn, Iowa City, IA USA; [Schilling, Keith E.] Iowa Geol Survey, Iowa City, IA USA	University of Iowa	Jones, CS (corresponding author), Univ Iowa, IIHR Hydrosci & Engn, Iowa City, IA USA.	christopher-s-jones@uiowa.edu		weber, larry/0000-0001-7003-4714; Schilling, Keith/0000-0002-3499-220X	Iowa Nutrient Research Center	Iowa Nutrient Research Center	This work was supported by the Iowa Nutrient Research Center to CSJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HELP CROPS IOW FARM; [Anonymous], 2000, EOS, DOI [DOI 10.1029/00E000244, DOI 10.1029/00EO00244]; BAKER JL, 1975, J ENVIRON QUAL, V4, P406, DOI 10.2134/jeq1975.00472425000400030027x; Battaglin WA, 2010, 20095164 US GEOL SUR; Burkart MR, 1999, J ENVIRON QUAL, V28, P850, DOI 10.2134/jeq1999.00472425002800030016x; David MB, 2010, J ENVIRON QUAL, V39, P1657, DOI 10.2134/jeq2010.0115; Diaz R.J., 1999, ECOLOGICAL EC CONSEQ; Ferber D, 2001, SCIENCE, V291, P968, DOI 10.1126/science.291.5506.968; Gilliom R, 2013, AGU FALL M 2013; Goolsby DA, 2001, HYDROL PROCESS, V15, P1209, DOI 10.1002/hyp.210; Goolsby DA, 2000, SCI TOTAL ENVIRON, V248, P75, DOI 10.1016/S0048-9697(99)00532-X; Hatfield JL, 2009, J SOIL WATER CONSERV, V64, P190, DOI 10.2489/jswc.64.3.190; Howarth RW, 2006, LIMNOL OCEANOGR, V51, P364, DOI 10.4319/lo.2006.51.1_part_2.0364; Iowa Department of Natural Resources (IDNR), 2017, IOW AMB WAT QUAL MON; Iowa State University, 2017, IOW NUTR RED STRAT; Jones CS, 2016, J SOIL WATER CONSERV, V71, P206, DOI 10.2489/jswc.71.3.206; Jones CS, 2018, J AM WATER RESOUR AS, V54, P471, DOI 10.1111/1752-1688.12618; Jones CS, 2015, J SOIL WATER CONSERV, V70, p69A, DOI 10.2489/jswc.70.3.69A; JUSTIC D, 1995, MAR POLLUT BULL, V30, P41, DOI 10.1016/0025-326X(94)00105-I; Justic D, 2003, ESTUARIES, V26, P1, DOI 10.1007/BF02691688; Justic D, 2007, ESTUAR COAST, V30, P791, DOI 10.1007/BF02841334; Lee CJ, 2016, J HYDROL, V542, P185, DOI 10.1016/j.jhydrol.2016.08.059; LEMING TD, 1984, NATURE, V310, P136, DOI 10.1038/310136a0; Li D, 2013, J ENVIRON QUAL, V42, P1822, DOI 10.2134/jeq2013.03.0111; Libra R.D., 1998, IOWA GEOLOGY, V23, P4; LUCEY KJ, 1993, J ENVIRON QUAL, V22, P38, DOI 10.2134/jeq1993.00472425002200010005x; LUMCON Louisiana Universities Marine Consortium, 2017, HYP NO GULF MEX; McIsaac GF, 2003, J ENVIRON QUAL, V32, P2280, DOI 10.2134/jeq2003.2280; Oetking P, 1974033720 SW RES I; Prior J. C., 1991, LANDFORMS IOWA; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Rabotyagov SS, 2014, REV ENV ECON POLICY, V8, P58, DOI 10.1093/reep/ret024; RENAUD ML, 1986, FISH B-NOAA, V84, P19; Scavia D, 2003, LIMNOL OCEANOGR, V48, P951, DOI 10.4319/lo.2003.48.3.0951; Schilling K, 2004, J HYDROL, V295, P305, DOI 10.1016/j.jhydrol.2004.03.010; Schilling KE, 2017, J SOIL WATER CONSERV, V72, P317, DOI 10.2489/jswc.72.4.317; Schilling KE, 2000, J ENVIRON QUAL, V29, P1846, DOI 10.2134/jeq2000.00472425002900060016x; Schilling KE, 2017, ECOL ENG, V102, P98, DOI 10.1016/j.ecoleng.2017.02.006; Sprague LA, 2011, ENVIRON SCI TECHNOL, V45, P7209, DOI 10.1021/es201221s; Tesoriero AJ, 2013, ENVIRON SCI TECHNOL, V47, P3623, DOI 10.1021/es305026x; Turner RE, 2006, MAR POLLUT BULL, V52, P139, DOI 10.1016/j.marpolbul.2005.08.012; Turner RE, 2004, HYDROBIOLOGIA, V511, P79, DOI 10.1023/B:HYDR.0000014031.12067.1a; USDA, 2017, NAT AGR STAT SERV QU; USEPA, 1993, DET NITR NITR NITR A; USEPA, 2017, HIST HYP TASK FORC; USGS, 2017, NAT WAT INF SYST WEB; USGS, 2017, MISS RIV BAS REL NUT; Vymazal J, 2007, SCI TOTAL ENVIRON, V380, P48, DOI 10.1016/j.scitotenv.2006.09.014; WANDER MM, 1994, SOIL SCI SOC AM J, V58, P1130, DOI 10.2136/sssaj1994.03615995005800040018x; Zhao Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088732	50	49	49	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195930	10.1371/journal.pone.0195930	http://dx.doi.org/10.1371/journal.pone.0195930			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649312	Green Submitted, Green Published, gold			2022-12-26	WOS:000429791900106
J	Salazar, CL; Reyes, C; Cienfuegos-Gallet, AV; Best, E; Atehortua, S; Sierra, P; Correa, MM; Fawley, WN; Paredes-Sabja, D; Wilcox, M; Gonzalez, A				Lina Salazar, Clara; Reyes, Catalina; Vanessa Cienfuegos-Gallet, Astrid; Best, Emma; Atehortua, Santiago; Sierra, Patricia; Correa, Margarita M.; Fawley, Warren N.; Paredes-Sabja, Daniel; Wilcox, Mark; Gonzalez, Angel			Subtyping of Clostridium difficile PCR ribotypes 591, 106 and 002, the dominant strain types circulating in Medellin, Colombia	PLOS ONE			English	Article							TANDEM-REPEAT ANALYSIS; RESTRICTION-ENDONUCLEASE ANALYSIS; POLYMERASE-CHAIN-REACTION; INFECTION; EPIDEMIC; TOXIN; GENE; SUSCEPTIBILITY; TRANSMISSION; GUIDELINES	We aimed to achieve a higher typing resolution within the three dominant Clostridium difficile ribotypes (591,106 and 002) circulating in Colombia. A total of 50 C. difficile isolates we had previously typed by PCR-ribotyping, representing the major three ribotypes circulating in Colombia, were analyzed. Twenty-seven isolates of ribotype 591, 12 of ribotype 106 and 11 of ribotype 002 were subtyped by multiple locus variable-number tandem-repeat analysis (MLVA). The presence of the PaLoc genes (tcdA/tccB), toxin production in culture and antimicrobial susceptibility were also determined. From the total C. difficile ribotypes analyzed, 20 isolates (74%) of ribotype 591, nine (75%) of ribotype 106 and five (45.5%) of ribotype 002 were recovered from patients with Clostridium difficile infection (CDI). MLVA allowed us to recognize four and two different clonal complexes for ribotypes 591 and 002, respectively, having a summed tandem-repeat difference (STRD) <2, whereas none of the ribotype 106 isolates were grouped in a cluster or clonal complex having a STRD >10. Six ribotype 591 and three ribotype 002 isolates belonging to a defined clonal complex were isolated on the same week in two different hospitals. All ribotypes harbored either tcdA(+)/tccB(+) or tcdA(-)/tccB(+) PaLoc genes. Moreover, 94% of the isolates were positive for toxin in culture. All isolates were susceptible to vancomycin and metronidazole, while 75% to 100% of the isolates were resistant to clindamycin, and less than 14.8% of ribotype 591 isolates were resistant to moxifloxacina. No significant differences were found among ribotypes with respect to demographic and clinical patients' data; however, our results demonstrated a high molecular heterogeneity of C. difficile strains circulating in Colombia.	[Lina Salazar, Clara] Univ Antioquia, Sch Microbiol, Res Grp Anaerob Bacteria GIBA, Medellin, Colombia; [Reyes, Catalina; Vanessa Cienfuegos-Gallet, Astrid; Gonzalez, Angel] Univ Antioquia, Sch Microbiol, Basic & Appl Microbiol Res Grp MICROBA, Medellin, Colombia; [Best, Emma; Fawley, Warren N.; Wilcox, Mark] Leeds Teaching Hosp NHS Trust, Dept Microbiol, Leeds, W Yorkshire, England; [Atehortua, Santiago] San Vicente Fdn Univ Hosp, Medellin, Colombia; [Sierra, Patricia] Univ Antioquia, IPS Univ, Clin Leon 13, Medellin, Colombia; [Correa, Margarita M.] Univ Antioquia, Sch Microbiol, Mol Microbiol Grp, Medellin, Colombia; [Paredes-Sabja, Daniel] Univ Andres Bello, Dept Ciencias Biol, Microbiota Host Interact & Clostridia Res Grp, Santiago, Chile	Universidad de Antioquia; Universidad de Antioquia; University of Leeds; Universidad de Antioquia; Universidad de Antioquia; Universidad Andres Bello	Gonzalez, A (corresponding author), Univ Antioquia, Sch Microbiol, Basic & Appl Microbiol Res Grp MICROBA, Medellin, Colombia.	angel.gonzalez@udea.edu.co	Paredes-Sabja, Daniel/ABI-4293-2020; Gonzalez, Angel/ABG-7914-2020	Gonzalez, Angel/0000-0002-7052-7938; Cienfuegos Gallet, Astrid/0000-0002-3407-6463	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia [485-2012, 1115569344410]; Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT) [1151025]	Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias); Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Departamento Administrativo de Ciencia, Tecnologia e Innovacion (COLCIENCIAS), Bogota, Colombia, Project 485-2012 (Code number 1115569344410); and by a grant from Fondo Nacional de Ciencia y Tecnologia de Chile (FONDECYT Grant 1151025). The funders had no role in study design, analysis and interpretation of experiments, decision to publish, or preparation of the manuscript.	Bakker D, 2010, J CLIN MICROBIOL, V48, P3744, DOI 10.1128/JCM.01171-10; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; BOWMAN RA, 1986, FEMS MICROBIOL LETT, V34, P31, DOI 10.1016/0378-1097(86)90265-X; Clinical and Laboratory Standards Institute, 2013, M100S23 CLIN LAB STA; Davies KA, 2016, EUROSURVEILLANCE, V21, P1; Eckert C, 2011, J MED MICROBIOL, V60, P1088, DOI 10.1099/jmm.0.029009-0; Eyre DW, 2013, J CLIN MICROBIOL, V51, P4141, DOI 10.1128/JCM.01095-13; Fawley WN, 2008, J CLIN MICROBIOL, V46, P954, DOI 10.1128/JCM.01764-07; Fawley WN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118150; Fawley WN, 2011, J CLIN MICROBIOL, V49, P4333, DOI 10.1128/JCM.05873-11; Feher C, 2016, INFECT DIS THER, V5, P207, DOI 10.1007/s40121-016-0122-1; Freeman J, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.017; GURTLER V, 1993, J GEN MICROBIOL, V139, P3089, DOI 10.1099/00221287-139-12-3089; Hernandez-Rocha C, 2013, DIAGN MICR INFEC DIS, V75, P361, DOI 10.1016/j.diagmicrobio.2012.12.010; Hookman P, 2009, WORLD J GASTROENTERO, V15, P1554, DOI 10.3748/wjg.15.1554; Indra A, 2008, J MED MICROBIOL, V57, P702, DOI 10.1099/jmm.0.47476-0; Kato H, 1999, FEMS MICROBIOL LETT, V175, P197, DOI [10.1016/S0378-1097(99)00196-2, 10.1111/j.1574-6968.1999.tb13620.x]; KATO N, 1991, J CLIN MICROBIOL, V29, P33, DOI 10.1128/JCM.29.1.33-37.1991; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Kuijper E J, 2008, Euro Surveill, V13; Salazar CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184689; Lopez-Urena D, 2014, J MED MICROBIOL, V63, P322, DOI 10.1099/jmm.0.066399-0; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; Marsh JW, 2010, J CLIN MICROBIOL, V48, P412, DOI 10.1128/JCM.01315-09; Morfin-Otero R, 2016, BRAZ J INFECT DIS, V20, P8, DOI 10.1016/j.bjid.2015.09.008; Noren T, 2010, CLIN MICROBIOL INFEC, V16, P1104, DOI 10.1111/j.1469-0691.2009.03048.x; Plaza-Garrido A, 2016, EPIDEMIOL INFECT, V144, P976, DOI 10.1017/S0950268815002459; Quesada-Gomez C, 2012, ANAEROBE, V18, P581, DOI 10.1016/j.anaerobe.2012.10.002; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Rupnik M, 2003, J CLIN MICROBIOL, V41, P1118, DOI 10.1128/JCM.41.3.1118-1125.2003; Senchyna F, 2017, J CLIN MICROBIOL, V55, P2651, DOI [10.1128/JCM.00563-17, 10.1128/jcm.00563-17]; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Tanner HE, 2010, J CLIN MICROBIOL, V48, P985, DOI 10.1128/JCM.02012-09; Tickler IA, 2014, ANTIMICROB AGENTS CH, V58, P4214, DOI 10.1128/AAC.02775-13; van den Berg RJ, 2007, J CLIN MICROBIOL, V45, P1024, DOI 10.1128/JCM.02023-06; Villegas M, 2016, INFECTIO, V21, P9; Zaiss NH, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-6	39	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195694	10.1371/journal.pone.0195694	http://dx.doi.org/10.1371/journal.pone.0195694			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649308	Green Published, gold			2022-12-26	WOS:000429791900072
J	Toutain, J; Goutte-Gattat, D; Horovitz, J; Saura, R				Toutain, Jerome; Goutte-Gattat, Damien; Horovitz, Jacques; Saura, Robert			Confined placental mosaicism revisited: Impact on pregnancy characteristics and outcome	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; SAMPLING RISK-FACTORS; PRENATAL-DIAGNOSIS; CHORIONIC VILLI; UNIPARENTAL DISOMY; CVS MOSAICISM; FETAL; TRISOMY; AMNIOCENTESIS; CONFIRMATION	Objectives We wanted to re-evaluate the influence of confined placental mosaicism subtypes (type 2 and type 3) on pregnancy characteristics and outcome. Material and methods From July 2009 to December 2015, 5512 chorionic villus samplings were performed in our Fetal Medicine Center. Conventional karyotyping was performed after long-term and short-term cultured villi to define type 2 or type 3 confined placental mosaicisms. Karyotype after amniocentesis was performed to exclude true fetal mosaicism, when appropriate. Pregnancy characteristics and outcomes were collected and compared to a control population. Results Thirty-six (0.65%) confined placental mosaicisms were observed (13 type 2 and 23 type 3). Nuchal translucency was not increased for type 2 and type 3 confined placental mosaicisms. Pregnancy characteristics and outcomes were comparable between type 2 confined placental mosaicisms and the control population. In type 3 confined placental mosaicisms, median first trimester serum pregnancy-associated plasma protein A was lower than for the control population (p<0.001), preterm births were noticed in 56% (p<0.001), small for gestational age newborns in 74% (p<0.001), and adverse pregnancy outcome was reported in 35% (p<0.01). Conclusion Although type 2 confined placental mosaicisms appeared to have no influence on pregnancy characteristics and outcome, type 3 confined placental mosaicisms were associated with low levels of first trimester serum pregnancy-associated plasma protein A, preterm birth, small for gestational age newborns, and adverse pregnancy outcomes.	[Toutain, Jerome] CHU Bordeaux, Serv Genet Med, Bordeaux, France; [Goutte-Gattat, Damien; Horovitz, Jacques; Saura, Robert] Univ Bordeaux, Bordeaux, France	CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Toutain, J (corresponding author), CHU Bordeaux, Serv Genet Med, Bordeaux, France.	jerome.toutain@chu-bordeaux.fr		Toutain, Jerome/0000-0003-1236-1551; Goutte-Gattat, Damien/0000-0002-6095-8718				Amor DJ, 2006, PRENATAL DIAG, V26, P443, DOI 10.1002/pd.1433; Baffero GM, 2012, PRENATAL DIAG, V32, P1102, DOI 10.1002/pd.3965; Behrman RE, 2007, PRETERM BIRTH CAUSES; Eckmann-Scholz C, 2012, J PERINAT MED, V40, P215, DOI [10.1515/jpm.2011.130, 10.1515/JPM.2011.130]; Figueras F, 2014, FETAL DIAGN THER, V36, P86, DOI 10.1159/000357592; Gaudineau A, 2013, J GYNECOL OBST BIO R, V42, P895, DOI 10.1016/j.jgyn.2013.09.013; Goldberg JD, 1997, AM J OBSTET GYNECOL, V176, P1349, DOI 10.1016/S0002-9378(97)70356-9; Grimes DA, 2005, LANCET, V365, P1429, DOI 10.1016/S0140-6736(05)66379-9; Hahnemann JM, 1997, AM J MED GENET, V70, P179, DOI 10.1002/(SICI)1096-8628(19970516)70:2<179::AID-AJMG15>3.0.CO;2-G; Kalousek DK, 1996, J MED GENET, V33, P529, DOI 10.1136/jmg.33.7.529; KALOUSEK DK, 1991, PRENATAL DIAG, V11, P743, DOI 10.1002/pd.1970111002; Kotzot D, 2008, ULTRASOUND OBST GYN, V31, P100, DOI 10.1002/uog.5133; Krantz D, 2004, AM J OBSTET GYNECOL, V191, P1452, DOI 10.1016/j.ajog.2004.05.068; Malvestiti F, 2015, PRENATAL DIAG, V35, P1117, DOI 10.1002/pd.4656; Pertile MD, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1240; Robinson WP, 1997, AM J HUM GENET, V60, P917; ROLAND B, 1994, PRENATAL DIAG, V14, P589, DOI 10.1002/pd.1970140713; Rose S, 2009, INT J BIOSTAT, V5, DOI 10.2202/1557-4679.1127; Saura R, 2010, PRENATAL DIAG, V30, P387, DOI 10.1002/pd.2476; Sifakis S, 2010, PRENATAL DIAG, V30, P329, DOI 10.1002/pd.2457; SIMONI G, 1992, ANN GENET-PARIS, V35, P110; Spencer K, 2014, PRENATAL DIAG, V34, P291, DOI 10.1002/pd.4285; Stipoljev F, 2001, FETAL DIAGN THER, V16, P4, DOI 10.1159/000053871; Taglauer ES, 2014, PLACENTA, V35, pS64, DOI 10.1016/j.placenta.2013.11.014; Toutain J, 2010, EUR J OBSTET GYN R B, V149, P143, DOI 10.1016/j.ejogrb.2009.12.015; Toutain J, 2013, PRENATAL DIAG, V33, P301, DOI 10.1002/pd.4022; Toutain J, 2010, PRENATAL DIAG, V30, P1155, DOI 10.1002/pd.2631; Van Opstal D, 2016, EXPERT REV MOL DIAGN, V16, P513, DOI 10.1586/14737159.2016.1152890; Wilkins-Haug L, 2006, PRENATAL DIAG, V26, P428, DOI 10.1002/pd.1430; Wolstenholme J, 1996, PRENATAL DIAG, V16, P511, DOI 10.1002/(SICI)1097-0223(199606)16:6<511::AID-PD904>3.0.CO;2-8	30	36	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195905	10.1371/journal.pone.0195905	http://dx.doi.org/10.1371/journal.pone.0195905			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649318	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900104
J	Caramenti, M; Lafortuna, CL; Mugellini, E; Abou Khaled, O; Bresciani, JP; Dubois, A				Caramenti, Martina; Lafortuna, Claudio L.; Mugellini, Elena; Abou Khaled, Omar; Bresciani, Jean-Pierre; Dubois, Amandine			Matching optical flow to motor speed in virtual reality while running on a treadmill	PLOS ONE			English	Article							HUMAN WALKING; ENERGY-COST; PERCEPTION; GAIT; LOCOMOTION; PATTERN; MOTION; EXHAUSTION; KINEMATICS; ENERGETICS	We investigated how visual and kinaesthetic/efferent information is integrated for speed perception in running. Twelve moderately trained to trained subjects ran on a treadmill at three different speeds (8, 10, 12 km/h) in front of a moving virtual scene. They were asked to match the visual speed of the scene to their running speed-i.e., treadmill's speed. For each trial, participants indicated whether the scene was moving slower or faster than they were running. Visual speed was adjusted according to their response using a staircase until the Point of Subjective Equality (PSE) was reached, i.e., until visual and running speed were perceived as equivalent. For all three running speeds, participants systematically underestimated the visual speed relative to their actual running speed. Indeed, the speed of the visual scene had to exceed the actual running speed in order to be perceived as equivalent to the treadmill speed. The underestimation of visual speed was speed-dependent, and percentage of underestimation relative to running speed ranged from 15% at 8km/h to 31% at 12km/h. We suggest that this fact should be taken into consideration to improve the design of attractive treadmill-mediated virtual environments enhancing engagement into physical activity for healthier lifestyles and disease prevention and care.	[Caramenti, Martina; Bresciani, Jean-Pierre; Dubois, Amandine] Univ Fribourg, Dept Neurosci & Movement Sci, Fribourg, Switzerland; [Caramenti, Martina; Lafortuna, Claudio L.] CNR, Ist Bioimmagini & Fisiol Mol, Milan, Italy; [Caramenti, Martina; Mugellini, Elena; Abou Khaled, Omar] Univ Appl Sci & Arts Western Switzerland, HumanTech Inst, Fribourg, Switzerland	University of Fribourg; Consiglio Nazionale delle Ricerche (CNR); Istituto di Bioimmagini e Fisiologia Molecolare (IBFM-CNR)	Caramenti, M (corresponding author), Univ Fribourg, Dept Neurosci & Movement Sci, Fribourg, Switzerland.; Caramenti, M (corresponding author), CNR, Ist Bioimmagini & Fisiol Mol, Milan, Italy.; Caramenti, M (corresponding author), Univ Appl Sci & Arts Western Switzerland, HumanTech Inst, Fribourg, Switzerland.	martina.caramenti@unifr.ch	Caramenti, Martina/N-4755-2019; KHALED, Omar ABOU/O-6389-2019; Caramenti, Martina/H-7426-2018; Bresciani, Jean-Pierre/H-4340-2012	Caramenti, Martina/0000-0002-3345-0994; KHALED, Omar ABOU/0000-0002-0178-9037; Caramenti, Martina/0000-0002-3345-0994; Lafortuna, Claudio/0000-0002-8625-7653; Bresciani, Jean-Pierre/0000-0002-7242-5433				Abernethy B, 2002, GAIT POSTURE, V15, P256, DOI 10.1016/S0966-6362(01)00195-3; Alexander RM, 2002, AM J HUM BIOL, V14, P641, DOI 10.1002/ajhb.10067; Banton T, 2005, PRESENCE-TELEOP VIRT, V14, P394, DOI 10.1162/105474605774785262; Bhalla M, 1999, J EXP PSYCHOL HUMAN, V25, P1076, DOI 10.1037/0096-1523.25.4.1076; Brandt T, 2000, CURR OPIN NEUROL, V13, P3, DOI 10.1097/00019052-200002000-00002; Burgess N, 2002, ADV NEURAL INFORM PR; Candau R, 1998, EUR J APPL PHYSIOL, V77, P479, DOI 10.1007/s004210050363; Coon JT, 2011, ENVIRON SCI TECHNOL, V45, P1761, DOI 10.1021/es102947t; Dal Monte A, 1973, BIOMECHANICS, P359; Dal U, 2010, GAIT POSTURE, V31, P366, DOI 10.1016/j.gaitpost.2010.01.006; Durgin FH, 2005, J EXP PSYCHOL HUMAN, V31, P339, DOI 10.1037/0096-1523.31.2.339; Durgin FH, 2005, PERCEPTION LINEAR SE; Durgin FH, 2007, ACM T APPL PERCEPT, V4, DOI [10.1145/1227134.1227139, 10.1145/1227134/1227139]; Dutto DJ, 2002, MED SCI SPORT EXER, V34, P1324, DOI 10.1097/00005768-200208000-00014; Duysens J, 1998, GAIT POSTURE, V7, P131, DOI 10.1016/S0966-6362(97)00042-8; ELLIOTT BC, 1976, MED SCI SPORT EXER, V8, P84; Farris DJ, 2012, J R SOC INTERFACE, V9, P110, DOI 10.1098/rsif.2011.0182; Graff C, 2014, J MATH PSYCHOL, V60, P82, DOI 10.1016/j.jmp.2014.02.001; GRIEVE DW, 1966, ERGONOMICS, V9, P379, DOI 10.1080/00140136608964399; Hunter I, 2007, EUR J APPL PHYSIOL, V100, P653, DOI 10.1007/s00421-007-0456-1; Jacobs A, 2005, J EXP PSYCHOL HUMAN, V31, P157, DOI 10.1037/0096-1523.31.1.157; Jahn K, 2004, NEUROIMAGE, V22, P1722, DOI 10.1016/j.neuroimage.2004.05.017; Jahn K, 2001, EXP BRAIN RES, V141, P370, DOI 10.1007/s002210100884; Kassler L., 2010, P 7 S APPL PERC GRAP; Keller TS, 1996, CLIN BIOMECH, V11, P253, DOI 10.1016/0268-0033(95)00068-2; Kingdom F. A. A., 2010, PSYCHOPHYSICS PRACTI; Knapp JM, 1999, VISUAL PERCEPTION EG; Kong PW, 2012, GAIT POSTURE, V36, P46, DOI 10.1016/j.gaitpost.2012.01.001; Kong PW, 2009, SPORT BIOMECH, V8, P52, DOI 10.1080/14763140802629990; Lavcanska V, 2005, HUM MOVEMENT SCI, V24, P544, DOI 10.1016/j.humov.2005.08.001; Leek MR, 2001, PERCEPT PSYCHOPHYS, V63, P1279, DOI 10.3758/BF03194543; Loomis JM, 1999, WAYFINDING BEHAVIOR, P125; Loomis JM, 2003, VIRTUAL AND ADAPTIVE ENVIRONMENTS: APPLICATIONS, IMPLICATIONS, AND HUMAN PERFORMANCE ISSUES, P21; Loomis JM, 1996, CURR DIR PSYCHOL SCI, V5, P72, DOI 10.1111/1467-8721.ep10772783; Maguire EA, 1998, SCIENCE, V280, P921, DOI 10.1126/science.280.5365.921; MARGARIA R, 1963, J APPL PHYSIOL, V18, P367, DOI 10.1152/jappl.1963.18.2.367; Margaria R., 1976, BIOMECHANICS ENERGET; Marsh AP, 2006, MED SCI SPORT EXER, V38, P1157, DOI 10.1249/01.mss.0000222844.81638.35; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; Mohler BJ, 2007, ACM T APPL PERCEPT, V4, DOI 10.1145/1227134/1227138; NELSON RC, 1972, MED SCI SPORT EXER, V4, P233, DOI 10.1249/00005768-197200440-00029; NIGG BM, 1995, MED SCI SPORT EXER, V27, P98; PAILHOUS J, 1990, BEHAV BRAIN RES, V38, P275, DOI 10.1016/0166-4328(90)90181-D; Powell W., 2011, 3 IEEE VR 2011 WORKS; Pretto P, 2009, COMPUT GRAPH-UK, V33, P139, DOI 10.1016/j.cag.2009.01.003; Pretto P, 2012, ELIFE, V1, DOI 10.7554/eLife.00031; Proffitt DR, 1995, PSYCHON B REV, V2, P409, DOI 10.3758/BF03210980; Prokop T, 1997, EXP BRAIN RES, V114, P63, DOI 10.1007/PL00005624; Riley PO, 2008, MED SCI SPORT EXER, V40, P1093, DOI 10.1249/MSS.0b013e3181677530; Rybak IA, 2006, J PHYSIOL-LONDON, V577, P617, DOI 10.1113/jphysiol.2006.118703; Sekiya N, 1996, J HUM MOVEMENT STUD, V30, P241; Siegel ZD, 2015, IMPROVING DISTANCE P; SILER WL, 1991, INT J SPORT BIOMECH, V7, P12, DOI 10.1123/ijsb.7.1.12; Snowden RJ, 1998, NATURE, V392, P450, DOI 10.1038/33049; Souman JL, 2009, CURR BIOL, V19, P1538, DOI 10.1016/j.cub.2009.07.053; SPARROW WA, 1983, J MOTOR BEHAV, V15, P237; Sun HJ, 2004, EXP BRAIN RES, V154, P246, DOI 10.1007/s00221-003-1652-9; Terrier P, 2003, EUR J APPL PHYSIOL, V90, P554, DOI 10.1007/s00421-003-0906-3; Thompson WB, 2004, PRESENCE-TELEOP VIRT, V13, P560, DOI 10.1162/1054746042545292; Thurrell AEI, 1998, PERCEPTION, V27, P147; Turano KA, 2005, VISION RES, V45, P3117, DOI 10.1016/j.visres.2005.06.017; Varraine E, 2002, EXP BRAIN RES, V142, P374, DOI 10.1007/s00221-001-0934-3; Verbitsky O, 1998, J APPL BIOMECH, V14, P300, DOI 10.1123/jab.14.3.300; Waller D, 2008, J EXP PSYCHOL-APPL, V14, P61, DOI 10.1037/1076-898X.14.1.61; Wank V, 1998, INT J SPORTS MED, V19, P455, DOI 10.1055/s-2007-971944; Warren WH, 2001, NAT NEUROSCI, V4, P213, DOI 10.1038/84054; WARREN WH, 1988, NATURE, V336, P162, DOI 10.1038/336162a0; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011	68	17	17	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195781	10.1371/journal.pone.0195781	http://dx.doi.org/10.1371/journal.pone.0195781			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641564	Green Submitted, gold, Green Published			2022-12-26	WOS:000429742900092
J	Zhou, JJ; Wang, YM; Lee, VWS; Zhang, GY; Medbury, H; Williams, H; Wang, Y; Tan, TK; Harris, DCH; Alexander, SI; Durkan, AM				Zhou, Jimmy Jianheng; Wang, Yuan Min; Lee, Vincent W. S.; Zhang, Geoff Yu; Medbury, Heather; Williams, Helen; Wang, Ya; Tan, Thian Kui; Harris, David C. H.; Alexander, Stephen I.; Durkan, Anne M.			DEC205-DC targeted DNA vaccine against CX3CR1 protects against atherogenesis in mice	PLOS ONE			English	Article							ATHEROSCLEROTIC LESION FORMATION; FRACTALKINE RECEPTOR CX(3)CR1; SMOOTH-MUSCLE-CELLS; DENDRITIC CELLS; MACROPHAGE-MIGRATION; CHEMOKINE-RECEPTOR; HEYMANN NEPHRITIS; RENAL INJURY; IN-VIVO; CCL2	Studies disrupting the chemokine pathway CX3CL1 (fractalkine)/CX3CR1 have shown decreased atherosclerosis in animal models but the techniques used to interrupt the pathway have not been easily translatable into human trials. DNA vaccination potentially overcomes the translational difficulties. We evaluated the effect of a DNA vaccine, targeted to CX3CR1, on atherosclerosis in a murine model and examined possible mechanisms of action. DNA vaccination against CX3CR1, enhanced by dendritic cell targeting using DEC205 single chain variable region fragment (scFv), was performed in 8 week old ApoE-/mice, fed a normal chow diet. High levels of anti- CX3CR1 antibodies were induced in vaccinated mice. There were no apparent adverse reactions to the vaccine. Arterial vessels of 34 week old mice were examined histologically for atherosclerotic plaque size, macrophage infiltration, smooth muscle cell infiltration and lipid deposition. Vaccinated mice had significantly reduced atherosclerotic plaque in the brachiocephalic artery. There was less macrophage infiltration but no significant change to the macrophage phenotype in the plaques. There was less lipid deposition in the lesions, but there was no effect on smooth muscle cell migration. Targeted DNA vaccination to CX3CR1 was well tolerated, induced a strong immune response and resulted in attenuated atherosclerotic lesions with reduced macrophage infiltration. DNA vaccination against chemokine pathways potentially offers a potential therapeutic option for the treatment of atherosclerosis.	[Zhou, Jimmy Jianheng; Wang, Yuan Min; Zhang, Geoff Yu; Alexander, Stephen I.; Durkan, Anne M.] Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia; [Zhou, Jimmy Jianheng; Lee, Vincent W. S.; Harris, David C. H.; Alexander, Stephen I.; Durkan, Anne M.] Univ Sydney, Sydney, NSW, Australia; [Lee, Vincent W. S.; Wang, Ya; Tan, Thian Kui; Harris, David C. H.] Univ Sydney, Westmead Inst Med Res, Ctr Transplantat & Renal Res, Westmead, NSW, Australia; [Medbury, Heather; Williams, Helen] Univ Sydney, Westmead Hosp, Vasc Biol Res Ctr, Surg, Westmead, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Durkan, AM (corresponding author), Childrens Hosp Westmead, Ctr Kidney Res, Westmead, NSW, Australia.; Durkan, AM (corresponding author), Univ Sydney, Sydney, NSW, Australia.	anne.durkan@health.nsw.gov.au	Williams, Helen/AAW-9632-2021; wangwangwang, yuanyaun/HHN-6432-2022; Durkan, Anne/AAP-4205-2020; Lee, Vincent/H-6468-2019; Harris, David/W-4786-2019	Williams, Helen/0000-0001-8221-5766; Durkan, Anne/0000-0003-3739-2290; Lee, Vincent/0000-0002-9400-3696; 	Jacquot award from the Royal Australasian College of Physicians; National Health and Medical Research Council of Australia (NHMRC) [571343]	Jacquot award from the Royal Australasian College of Physicians; National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by a Jacquot award from the Royal Australasian College of Physicians and a research grant from the National Health and Medical Research Council of Australia (NHMRC grant 571343). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada G, 2001, NEW ENGL J MED, V345, P1042, DOI 10.1056/NEJMra011223; Ada Gordon, 2003, Expert Opin Emerg Drugs, V8, P27, DOI 10.1517/14728214.8.1.27; Ali MT, 2015, BIOMATERIALS, V69, P22, DOI 10.1016/j.biomaterials.2015.07.059; Alvarez-Lajonchere L, 2009, J VIRAL HEPATITIS, V16, P156, DOI 10.1111/j.1365-2893.2008.01058.x; Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Bonifaz LC, 2004, J EXP MED, V199, P815, DOI 10.1084/jem.20032220; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cho HI, 2012, CANCER IMMUNOL IMMUN, V61, P343, DOI 10.1007/s00262-011-1110-7; Combadiere C, 2003, CIRCULATION, V107, P1009, DOI 10.1161/01.CIR.0000057548.68243.42; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; Demangel C, 2005, MOL IMMUNOL, V42, P979, DOI 10.1016/j.molimm.2004.09.034; Fissolo N, 2012, CLIN IMMUNOL, V142, P76, DOI 10.1016/j.clim.2010.11.011; Flierl U, 2012, THROMB HAEMOSTASIS, V108, P457, DOI 10.1160/TH12-04-0271; Hauer AD, 2007, ARTERIOSCL THROM VAS, V27, P2050, DOI 10.1161/ATVBAHA.107.143743; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kumar AHS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057230, 10.1371/journal.pone.0064972]; Kumar AHS, 2010, FASEB J, V24, P81, DOI 10.1096/fj.09-132225; Landsman L, 2009, BLOOD, V113, P963, DOI 10.1182/blood-2008-07-170787; Lee VWS, 2008, AM J PHYSIOL-RENAL, V295, pF335, DOI 10.1152/ajprenal.00077.2008; Lesnik P, 2003, J CLIN INVEST, V111, P333, DOI 10.1172/JCI200315555; Liu H, 2010, CARDIOVASC DRUG THER, V24, P17, DOI 10.1007/s10557-009-6210-7; Lucas AD, 2003, CIRCULATION, V108, P2498, DOI 10.1161/01.CIR.0000097119.57756.EF; Monie A, 2009, EXPERT REV VACCINES, V8, P1221, DOI 10.1586/ERV.09.76; Nchinda G, 2008, J CLIN INVEST, V118, P1427, DOI 10.1172/JCI34224; Nchinda G, 2010, P NATL ACAD SCI USA, V107, P4281, DOI 10.1073/pnas.1000621107; Opriessnig T, 2011, MICROBIOL IMMUNOL, V55, P863, DOI 10.1111/j.1348-0421.2011.00385.x; Poupel L, 2013, ARTERIOSCL THROM VAS, V33, P2297, DOI 10.1161/ATVBAHA.112.300930; Quintar A, 2017, CIRC RES, V120, P1789, DOI 10.1161/CIRCRESAHA.117.310739; Riek AE, 2013, J STEROID BIOCHEM, V136, P309, DOI 10.1016/j.jsbmb.2012.12.019; Rowinska Z, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170644; Saederup N, 2008, CIRCULATION, V117, P1642, DOI 10.1161/CIRCULATIONAHA.107.743872; Sallberg M, 2009, EXPERT OPIN BIOL TH, V9, P805, DOI 10.1517/14712590902988444; Stoger JL, 2012, ATHEROSCLEROSIS, V225, P461, DOI 10.1016/j.atherosclerosis.2012.09.013; Stolla M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043572; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Teupser D, 2004, P NATL ACAD SCI USA, V101, P17795, DOI 10.1073/pnas.0408096101; Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005; van Wanrooij EJA, 2008, CARDIOVASC RES, V78, P590, DOI 10.1093/cvr/cvn025; Viola A, 2008, ANNU REV PHARMACOL, V48, P171, DOI 10.1146/annurev.pharmtox.48.121806.154841; Wang AYM, 2003, J AM SOC NEPHROL, V14, P159, DOI 10.1097/01.ASN.0000038685.95946.83; Wang Y, 2013, KIDNEY INT, V83, P223, DOI 10.1038/ki.2012.374; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; White GE, 2010, CARDIOVASC RES, V85, P825, DOI 10.1093/cvr/cvp341; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Wu HL, 2005, KIDNEY INT, V67, P2178, DOI 10.1111/j.1523-1755.2005.00323.x; Wu HL, 2003, J IMMUNOL, V171, P4824, DOI 10.4049/jimmunol.171.9.4824; Youssef S, 2000, J CLIN INVEST, V106, P361, DOI 10.1172/JCI9109; Zheng GP, 2006, J AM SOC NEPHROL, V17, P465, DOI 10.1681/ASN.2005020164; Zhou JJ, 2012, INT J CLIN EXP MED, V5, P24	51	7	10	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195657	10.1371/journal.pone.0195657	http://dx.doi.org/10.1371/journal.pone.0195657			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641559	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900080
J	Qiao, YJ; Tong, TT; Xue, J; Lin, WJ; Deng, ZX; Cheng, YQ; Zhu, DQ				Qiao, Yongjian; Tong, Tiantian; Xue, Jiao; Lin, Wenjing; Deng, Zixin; Cheng, Yi-Qiang; Zhu, Dongqing			Mechanistic studies of DepR in regulating FK228 biosynthesis in Chromobacterium violaceum no. 968	PLOS ONE			English	Article							RALSTONIA-EUTROPHA; TRANSCRIPTIONAL REGULATOR; PROTEUS-MIRABILIS; ESCHERICHIA-COLI; AEROMONAS-CAVIAE; PHAP PHASIN; DEPSIPEPTIDE; OXYR; GENE; POLYHYDROXYALKANOATE	DepR, a LysR-type transcriptional regulator encoded by the last gene of the putative min operon (orf21-20-19-depR) located at the downstream region of the anticancer agent FK228 biosynthetic gene cluster in Chromobacterium violaceum No. 968, positively regulates the biosynthesis of FK228. In this work, the mechanism underlining this positive regulation was probed by multiple approaches. Electrophoretic mobility shift assay (EMSA) and DNase I footprinting assay (DIFA) identified a conserved 35-nt DNA segment in the orf21-orf22 intergenic region where the purified recombinant DepR binds to. Quantitative reverse transcription PCR (RT-qPCR) and green fluorescent protein (GFP) promoter probe assays established that transcription of phasin gene orf22 increases in the depR deletion mutant of C. violaceum (Cv Delta depR) compared to the wild-type strain. FK228 production in the orf22-overexpressed strain C. violaceum was reduced compared with the wild-type strain. DepR has two conserved cysteine residues C199 and C208 presumed to form a disulfide bridge upon sensing oxidative stress. C199X point mutations that locked DepR in a reduced conformation decreased the DNA-binding affinity of DepR; T232A or R278A mutation also had a negative impact on DNA binding of DepR. Complementation of Cv Delta depR with any of those versions of depR carrying a single codon mutation was not able to restore FK228 production to the level of wild-type strain. All evidences collectively suggested that DepR positively regulates the biosynthesis of FK228 through indirect metabolic networking.	[Qiao, Yongjian; Tong, Tiantian; Xue, Jiao; Lin, Wenjing; Deng, Zixin; Cheng, Yi-Qiang; Zhu, Dongqing] Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan, Hubei, Peoples R China; [Cheng, Yi-Qiang] Univ North Texas, Hlth Sci Ctr, UNT Syst Coll Pharm, Ft Worth, TX USA	Wuhan University; University of North Texas System; University of North Texas Denton	Zhu, DQ (corresponding author), Wuhan Univ, Minist Educ, Key Lab Combinatorial Biosynth & Drug Discovery, Wuhan, Hubei, Peoples R China.	Dzhu2011@whu.edu.cn		Cheng, Eric/0000-0001-9336-2593	National Natural Science Foundation of China [NSFC 81373305, NSFC 31401057]; Hubei Provincial Natural Science Foundation of China [2017CFB618]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hubei Provincial Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (NSFC 81373305, NSFC 31401057) (D. Zhu) (http://www.nsfc.gov.cn/), and by Hubei Provincial Natural Science Foundation of China (2017CFB618) (D. Zhu) (http://www.hbstd.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhubalan K, 2011, APPL ENVIRON MICROB, V77, P2926, DOI 10.1128/AEM.01997-10; Biggins JB, 2011, ORG LETT, V13, P1536, DOI 10.1021/ol200225v; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Broetto L, 2006, APPL MICROBIOL BIOT, V71, P450, DOI 10.1007/s00253-005-0140-5; Bussmann M, 2010, J BIOL CHEM, V285, P29305, DOI 10.1074/jbc.M110.156372; Cheng YQ, 2007, APPL ENVIRON MICROB, V73, P3460, DOI 10.1128/AEM.01751-06; Cheson BD, 2011, CLIN ADV HEMATOL S26, V9, P5; Cheson Bruce D, 2011, Clin Adv Hematol Oncol, V9, P1; Davis JR, 2013, NUCLEIC ACIDS RES, V41, P3888, DOI 10.1093/nar/gkt009; Pescaretti MD, 2010, MICROBIOL-SGM, V156, P3513, DOI 10.1099/mic.0.041319-0; DEBOER PAJ, 1992, J BACTERIOL, V174, P63, DOI 10.1128/jb.174.1.63-70.1992; Fukui T, 2001, BIOMACROMOLECULES, V2, P148, DOI 10.1021/bm0056052; Furumai R, 2002, CANCER RES, V62, P4916; Gong FD, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006272; Hillion M, 2015, BIOL CHEM, V396, P415, DOI 10.1515/hsz-2015-0102; Howery KE, 2016, CURR GENET, V62, P775, DOI 10.1007/s00294-016-0579-1; Howery KE, 2015, J BACTERIOL, V197, P2499, DOI 10.1128/JB.00094-15; Hu ZL, 2003, MOL MICROBIOL, V47, P345, DOI 10.1046/j.1365-2958.2003.03321.x; Jia SX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103863; Jo I, 2015, P NATL ACAD SCI USA, V112, P6443, DOI 10.1073/pnas.1424495112; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kolibachuk D, 1999, APPL ENVIRON MICROB, V65, P3561; Koller Martin, 2017, Bioengineering-Basel, V4, P88, DOI 10.3390/bioengineering4040088; Ling SC, 2011, J APPL MICROBIOL, V111, P559, DOI 10.1111/j.1365-2672.2011.05084.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loose M, 2008, SCIENCE, V320, P789, DOI 10.1126/science.1154413; Mezzina MP, 2016, APPL ENVIRON MICROB, V82, P5060, DOI 10.1128/AEM.01161-16; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; Ortiz C, 2016, FEMS MICROBIOL REV, V40, P57, DOI 10.1093/femsre/fuv040; Panmanee W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189066; Parti RR, 2013, RES MICROBIOL, V164, P406, DOI 10.1016/j.resmic.2013.02.002; Potharla VY, 2014, J IND MICROBIOL BIOT, V41, P1457, DOI 10.1007/s10295-014-1474-8; Potharla VY, 2011, APPL ENVIRON MICROB, V77, P1508, DOI 10.1128/AEM.01512-10; Reen FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054479; Rowlett VW, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00478; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Seo SW, 2015, CELL REP, V12, P1289, DOI 10.1016/j.celrep.2015.07.043; STEINBUCHEL A, 1993, APPL MICROBIOL BIOT, V39, P443, DOI 10.1007/BF00205030; Tian SJ, 2005, FEMS MICROBIOL LETT, V244, P19, DOI 10.1016/j.femsle.2005.01.020; TOLEDANO MB, 1994, CELL, V78, P897, DOI 10.1016/S0092-8674(94)90702-1; UEDA H, 1994, J ANTIBIOT, V47, P301; UEDA H, 1994, BIOSCI BIOTECH BIOCH, V58, P1579, DOI 10.1271/bbb.58.1579; Ushimaru K, 2014, APPL ENVIRON MICROB, V80, P2867, DOI 10.1128/AEM.04179-13; VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35; Vazquez-Torres A, 2012, ANTIOXID REDOX SIGN, V17, P1201, DOI 10.1089/ars.2012.4522; Wang C, 2011, J NAT PROD, V74, P2031, DOI 10.1021/np200324x; Wang C, 2009, CHEM BIOL, V16, P585, DOI 10.1016/j.chembiol.2009.05.005; Wang XD, 2006, J BACTERIOL, V188, P8335, DOI 10.1128/JB.01318-06; Wang Y, 2012, J BACTERIOL, V194, P5237, DOI 10.1128/JB.00989-12; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Wesener SR, 2011, APPL ENVIRON MICROB, V77, P1501, DOI 10.1128/AEM.01513-10; York GM, 2002, J BACTERIOL, V184, P59, DOI 10.1128/JB.184.1.59-66.2002; York GM, 2001, J BACTERIOL, V183, P2394, DOI 10.1128/JB.183.7.2394-2397.2001; Zhu DQ, 2013, J BACTERIOL, V195, P1255, DOI 10.1128/JB.02079-12	54	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196173	10.1371/journal.pone.0196173	http://dx.doi.org/10.1371/journal.pone.0196173			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672625	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800098
J	Li, J; Wu, XP; Gebremikael, MT; Wu, HJ; Cai, DX; Wang, BS; Li, BG; Zhang, JC; Li, YS; Xi, JL				Li, Jing; Wu, Xueping; Gebremikael, Mesfin Tsegaye; Wu, Huijun; Cai, Dianxiong; Wang, Bisheng; Li, Baoguo; Zhang, Jiancheng; Li, Yongshan; Xi, Jilong			Response of soil organic carbon fractions, microbial community composition and carbon mineralization to high-input fertilizer practices under an intensive agricultural system	PLOS ONE			English	Article							INORGANIC FERTILIZERS; NITROGEN MINERALIZATION; FUNCTIONAL DIVERSITY; ENZYME-ACTIVITIES; TERM; BIOMASS; MATTER; SEQUESTRATION; CROP; POOLS	Microbial mechanisms associated with soil organic carbon (SOC) decomposition are poorly understood. We aim to determine the effects of inorganic and organic fertilizers on soil labile carbon (C) pools, microbial community structure and C mineralization rate under an intensive wheat-maize double cropping system in Northern China. Soil samples in 0-10 cm layer were collected from a nine-year field trial involved four treatments: no fertilizer, CK; nitrogen (N) and phosphorus (P) fertilizers, NP; maize straw combined with NP fertilizers, NPS; and manure plus straw and NP fertilizers, NPSM. Soil samples were analyzed to determine labile C pools (including dissolved organic C, DOC; light free organic C, LFOC; and microbial biomass C, MBC), microbial community composition (using phospholipid fatty acid (PLFA) profiles) and SOC mineralization rate (from a 124-day incubation experiment). This study demonstrated that the application of chemical fertilizers (NP) alone did not alter labile C fractions, soil microbial communities and SOC mineralization rate from those observed in the CK treatment. Whereas the use of straw in conjunction with chemical fertilizers (NPS) became an additional labile substrate supply that decreased C limitation, stimulated growth of all PLFA-related microbial communities, and resulted in 53% higher cumulative mineralization of C compared to that of CK. The SOC and its labile fractions explained 78.7% of the variance of microbial community structure. Further addition of manure on the top of straw in the NPSM treatment did not significantly increase microbial community abundances, but it did alter microbial community structure by increasing G+/G- ratio compared to that of NPS. The cumulative mineralization of C was 85% higher under NPSM fertilization compared to that of CK. Particularly, the NPSM treatment increased the mineralization rate of the resistant pool. This has to be carefully taken into account when setting realistic and effective goals for long-term soil C stabilization.	[Li, Jing; Wu, Xueping; Wu, Huijun; Cai, Dianxiong; Wang, Bisheng] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing, Peoples R China; [Li, Jing; Li, Baoguo] China Agr Univ, Coll Resources & Environm Sci, Beijing, Peoples R China; [Li, Jing; Gebremikael, Mesfin Tsegaye] Univ Ghent, Dept Soil Management, Ghent, Belgium; [Zhang, Jiancheng] Shanxi Acad Agr Sci, Wheat Res Inst, Linfen, Peoples R China; [Li, Yongshan; Xi, Jilong] Shanxi Acad Agr Sci, Cotton Res Inst, Yuncheng, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; China Agricultural University; Ghent University; Shanxi Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Shanxi Agricultural University	Wu, XP (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Key Lab Crop Nutr & Fertilizat, Minist Agr, Beijing, Peoples R China.	wuxueping@caas.cn	Gebremikael, Mesfin/AHE-1590-2022	Wu, Xueping/0000-0002-7772-0773; Gebremikael, Mesfin Tsegaye/0000-0001-8696-9960	Science and Technology Program [2015BAD22B03]; National Key Research and Development Program of China [2016YFD0300804]; National 863 Program of China [2013AA102901]; Special Fund for Agro-scientific Research in the Public Interest [201203077]	Science and Technology Program(Science and Technology Development Fund (STDF)United States Agency for International Development (USAID)US-Egypt Science and Technology Joint Fund); National Key Research and Development Program of China; National 863 Program of China; Special Fund for Agro-scientific Research in the Public Interest	This work was supported jointly by the Science and Technology Program (2015BAD22B03 to XW), the National Key Research and Development Program of China (2016YFD0300804 to XW), the National 863 Program of China (2013AA102901 to XW) and the Special Fund for Agro-scientific Research in the Public Interest (201203077 to HW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Bardgett RD, 1999, BIOL FERT SOILS, V29, P282, DOI 10.1007/s003740050554; Bastida F, 2013, SOIL BIOL BIOCHEM, V57, P892, DOI 10.1016/j.soilbio.2012.10.037; Brar BS, 2013, SOIL TILL RES, V128, P30, DOI 10.1016/j.still.2012.10.001; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Cookson WR, 2005, SOIL BIOL BIOCHEM, V37, P1726, DOI 10.1016/j.soilbio.2005.02.007; Dai XQ, 2017, SCI TOTAL ENVIRON, V580, P556, DOI 10.1016/j.scitotenv.2016.11.212; Demoling F, 2007, SOIL BIOL BIOCHEM, V39, P2485, DOI 10.1016/j.soilbio.2007.05.002; Ding XL, 2012, SOIL TILL RES, V122, P36, DOI 10.1016/j.still.2012.02.002; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; Dorodnikov M, 2011, SOIL BIOL BIOCHEM, V43, P579, DOI 10.1016/j.soilbio.2010.11.026; Dou X, 2016, SCI REP-UK, V6, DOI 10.1038/srep31737; Elfstrand S, 2007, APPL SOIL ECOL, V35, P610, DOI 10.1016/j.apsoil.2006.09.011; Eo J, 2016, AGR ECOSYST ENVIRON, V231, P176, DOI 10.1016/j.agee.2016.06.039; Fang X, 2016, BIOL FERT SOILS, V52, P353, DOI 10.1007/s00374-015-1081-5; Filep T, 2011, GEODERMA, V162, P312, DOI 10.1016/j.geoderma.2011.03.002; Geisseler D, 2014, SOIL BIOL BIOCHEM, V75, P54, DOI 10.1016/j.soilbio.2014.03.023; GOLCHIN A, 1994, AUST J SOIL RES, V32, P285, DOI 10.1071/SR9940285; Gong W, 2009, PLANT SOIL, V314, P67, DOI 10.1007/s11104-008-9705-2; Guo LJ, 2015, BIOL FERT SOILS, V51, P65, DOI 10.1007/s00374-014-0951-6; Huang ZQ, 2008, APPL SOIL ECOL, V40, P229, DOI 10.1016/j.apsoil.2008.04.009; Juarez S, 2013, BIOL FERT SOILS, V49, P939, DOI 10.1007/s00374-013-0784-8; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lazcano C, 2013, BIOL FERT SOILS, V49, P723, DOI 10.1007/s00374-012-0761-7; Li J, 2018, SOIL TILL RES, V175, P281, DOI 10.1016/j.still.2017.08.008; Li J, 2015, J INTEGR AGR, V14, P2500, DOI 10.1016/S2095-3119(15)61229-1; Lipson DA, 2009, BIOGEOCHEMISTRY, V95, P23, DOI 10.1007/s10533-008-9252-1; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Long GQ, 2015, SOIL TILL RES, V146, P270, DOI 10.1016/j.still.2014.09.020; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Mbuthia LW, 2015, SOIL BIOL BIOCHEM, V89, P24, DOI 10.1016/j.soilbio.2015.06.016; Mi J, 2015, LANDSCAPE ECOL, V30, P1683, DOI 10.1007/s10980-014-0040-0; Mohanty S, 2013, EUR J SOIL BIOL, V58, P113, DOI 10.1016/j.ejsobi.2013.07.004; Murphy DV, 2011, SOIL RES, V49, P582, DOI 10.1071/SR11203; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Ngosong C, 2010, APPL SOIL ECOL, V46, P134, DOI 10.1016/j.apsoil.2010.07.004; Peacock AD, 2001, SOIL BIOL BIOCHEM, V33, P1011, DOI 10.1016/S0038-0717(01)00004-9; Purakayastha TJ, 2008, GEODERMA, V144, P370, DOI 10.1016/j.geoderma.2007.12.006; Sleutel S, 2005, EUR J SOIL SCI, V56, P505, DOI 10.1111/j.1365-2389.2004.00685.x; Sollins P, 2007, BIOGEOCHEMISTRY, V85, P1, DOI 10.1007/s10533-007-9099-x; Stromberger ME, 2012, SOIL BIOL BIOCHEM, V46, P155, DOI 10.1016/j.soilbio.2011.11.024; Tu C, 2006, SOIL BIOL BIOCHEM, V38, P247, DOI 10.1016/j.soilbio.2005.05.002; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; von Lutzow M, 2006, EUR J SOIL SCI, V57, P426, DOI 10.1111/j.1365-2389.2006.00809.x; Wang JH, 2015, NUTR CYCL AGROECOSYS, V102, P371, DOI 10.1007/s10705-015-9710-9; Wang YD, 2015, BIOL FERT SOILS, V51, P583, DOI 10.1007/s00374-015-1007-2; Wu MN, 2011, BIOL FERT SOILS, V47, P397, DOI 10.1007/s00374-010-0535-z; Xu XF, 2013, GLOBAL ECOL BIOGEOGR, V22, P737, DOI 10.1111/geb.12029; Yang XY, 2014, J INTEGR AGR, V13, P402, DOI 10.1016/S2095-3119(13)60425-6; Yang XY, 2012, GEODERMA, V177, P49, DOI 10.1016/j.geoderma.2012.01.033; Yang ZC, 2015, SOIL TILL RES, V146, P47, DOI 10.1016/j.still.2014.06.011; Zhang HJ, 2015, BIOL FERT SOILS, V51, P137, DOI 10.1007/s00374-014-0957-0; Zhang HJ, 2013, SOIL BIOL BIOCHEM, V57, P228, DOI 10.1016/j.soilbio.2012.08.024	54	32	37	19	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195144	10.1371/journal.pone.0195144	http://dx.doi.org/10.1371/journal.pone.0195144			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668702	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200029
J	Tissier, J; Becker, D; Codrea, V; Costeur, L; Farcas, C; Solomon, A; Venczel, M; Maridet, O				Tissier, Jeremy; Becker, Damien; Codrea, Vlad; Costeur, Loic; Farcas, Cristina; Solomon, Alexandru; Venczel, Marton; Maridet, Olivier			New data on Amynodontidae (Mammalia, Perissodactyla) from Eastern Europe: Phylogenetic and palaeobiogeographic implications around the Eocene-Oligocene transition	PLOS ONE			English	Article							RHINOCEROTOIDEA MAMMALIA; FOSSIL MAMMALS; GENUS; CALIFORNIA; EVOLUTION; HISTORY; PALEOGEOGRAPHY; PALEOGENE; NORTHERN; PAKISTAN	Amynodontidae is a family of Rhinocerotoidea (Mammalia, Perissodactyla) known from the late Early Eocene to the latest Oligocene, in North America and Eurasia. European Amynodontidae are very rare, and all remains belong almost exclusively to a single post Grande Coupure genus from the Oligocene, Cadurcotherium. The "Grande Coupure" defines an extinctions and dispersal-generated originations event in Europe that is nearly contemporaneous with the Eocene-Oligocene transition. Perissodactyls are one of the major groups affected by this event: Palaeotheriidae went almost extinct during this crisis, whereas Rhino-cerotidae appeared for the first time in Europe. Study of fossiliferous Eastern-European localities from this age is crucial for the understanding of this crisis. We report here three new localities of Amynodontidae in Eastern Europe. Two of them are dated from the Eocene (Morlaca, Romania; Dorog, Hungary), whereas the other is either Late Eocene or Early Oligocene (Dobarca, Romania). The skull from this latter locality belongs unexpectedly to the same individual as a previously described mandible attributed to "Cadurcodon" zimborensis. As a result, this specimen can be allocated to its proper locality, Dobarca, and is assigned to a new genus, Sellamynodon gen. nov. It is characterised by an extraordinary growth of the nuchal crest, a unique character among amynodontids. Along with this remarkable material from Dobarca, two specimens from another Romanian locality, Morlaca, have been recently discovered and are dated from the Late Eocene. They belong, as well as new material from Dorog (Middle Eocene, Hungary), to the genus Amynodontopsis, also found in North America. The new Hungarian material represents the earliest occurrence of Amynodontidae in Europe. New phylogenetic hypotheses of Rhinocerotoidea are proposed, including the new material presented here, and show that Amynodontidae may be closer to the polyphyletic family 'Hyracodontidae' than to Rhinocerotidae. Amynodontidae, with their deep preorbital fossa and extremely reduced premolars, display in fact a very derived condition, compared to rhinocerotids.	[Tissier, Jeremy; Becker, Damien; Maridet, Olivier] Jurass Museum, Porrentruy, Switzerland; [Tissier, Jeremy; Becker, Damien; Maridet, Olivier] Univ Fribourg, Dept Geosci, Fribourg, Switzerland; [Codrea, Vlad; Solomon, Alexandru] Babea Bolyai Univ, Fac Biol Geol, Dept Geol, Cluj Napoca, Romania; [Costeur, Loic] Naturhist Museum Basel, Basel, Switzerland; [Farcas, Cristina] Babea Bolyai Univ, Fac Environm Sci, Cluj Napoca, Romania; [Venczel, Marton] Tarii Crisurilor Museum, Dept Nat Hist, Oradea, Romania	University of Fribourg	Tissier, J (corresponding author), Jurass Museum, Porrentruy, Switzerland.; Tissier, J (corresponding author), Univ Fribourg, Dept Geosci, Fribourg, Switzerland.	jeremy.tissier@unifr.ch	Venczel, Marton/C-3234-2011; Solomon, Alexandru A/A-2420-2017; Maridet, Olivier/H-5313-2019; Solomon, Alexandru/ABB-6672-2020; Tissier, Jérémy/ABE-5773-2020; Codrea, Vlad/C-2721-2011	Venczel, Marton/0000-0003-2200-3619; Maridet, Olivier/0000-0002-0956-0712; Solomon, Alexandru/0000-0002-7264-6527; Tissier, Jérémy/0000-0002-8517-1612; Codrea, Vlad/0000-0002-5575-4139; Costeur, Loic/0000-0001-6213-8556	SYNTHESYS Project by the European Community Research Infrastructure Action under the FP7 "Capacities" Program [HU-TAF-6724]; Swiss National Science Foundation [200021-162359]	SYNTHESYS Project by the European Community Research Infrastructure Action under the FP7 "Capacities" Program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research received support from the SYNTHESYS Project http://www.synthesys.info/ which is financed by European Community Research Infrastructure Action under the FP7 "Capacities" Program (HU-TAF-6724) (JT). DB, LC, OM and JT are financially supported by Swiss National Science Foundation (grant 200021-162359).	Antoine Pierre-Olivier, 2002, Memoires du Museum National d'Histoire Naturelle, V188, P1; Antoine PO, 2010, ZOOL J LINN SOC-LOND, V160, P139, DOI 10.1111/j.1096-3642.2009.00597.x; Antoine PO, 2003, CAN J EARTH SCI, V40, P365, DOI 10.1139/E02-101; Antoine PO, 2004, J ASIAN EARTH SCI, V24, P71, DOI 10.1016/j.jaes.2003.09.005; Averianov A, 2017, J SYST PALAEONTOL, V15, P927, DOI 10.1080/14772019.2016.1256914; Averianov AO, 2005, GEODIVERSITAS, V27, P221; Bai B, 2017, PALAEONTOLOGY, V60, P837, DOI 10.1111/pala.12319; Bai B, 2017, B AM MUS NAT HIST, P1; Bai Bin, 2012, Vertebrata Palasiatica, V50, P204; Bayshashov BU, 1994, SELEVINIA, V1, P74; Becker D, 2013, J SYST PALAEONTOL, V11, P947, DOI 10.1080/14772019.2012.699007; Becker D, 2009, SWISS J GEOSCI, V102, P489, DOI 10.1007/s00015-009-1330-4; Biryukov MD, 1961, AKAD NAUK KAZAKHSKOI, V3, P20; Bjork P. R., 1967, Journal of Paleontology, V41, P227; Boehme Madelaine, 2013, Zitteliana Reihe A Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Geologie, V53, P121; Borissiak AA, 1923, MEMOIRES SOC GEOLOGI, V59, P1; Borissiak AA, 1918, MONOGRAFYA ROSSIYSKO; Brunet M., 1979, GRANDS MAMMIFERES CH; BUCUR I., 2011, CALCAREOUS ALGAE ROM, P137; Campos C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142339; CHIU CHAN-SIANG, 1962, VERTEBR PALASIAT, V6, P57; Chow M., 1964, Vertebrata Palasiatica, V8, P355; Chow M., 1965, Vertebrata Palasiatica, V9, P190; Codrea AV., 2005, STUD U BABES-BOL GEO, V50, P19, DOI [10.5038/1937-8602.50.1.3, DOI 10.5038/1937-8602.50.1.3]; Codrea V, 1989, OLIGOCENE TRANSYLVAN, P319; Codrea V., 1998, MUZEUL BRUKENTHAL ST, V27, P121; Codrea V, 2000, RINOCERI SI TAPIRI T; Codrea Vlad, 1996, Acta Zoologica Cracoviensia, V39, P83; Colbert EH, 1938, B AM MUS NAT HIST, V74, P255; Crusafont M., 1973, B REAL SOC HIST NATU, V71, P21; De Bonis Louis, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V236, P157; De Bonis Louis, 1995, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V236, P177; Emry RJ, 1998, B CARNEGIE MUSEUM NA, V34, P298; Farcas C., 2011, THESIS; Forster-Cooper C, 1934, PHILOS T R SOC LON B, V223, P569, DOI 10.1098/rstb.1934.0013; Forster-Cooper C., 1924, PHILOS T R SOC B, V212, P35, DOI [10.1098/rstb.1924.0002, DOI 10.1098/RSTB.1924.0002]; Forster-Cooper C, 1924, PHILOS T ROY SOC LON, V212, P369, DOI [10.1098/rstb.1924.0009, DOI 10.1098/RSTB.1924.0009]; Forster-Cooper C., 1922, ANN MAG NAT HIST SER, V9, P617, DOI [10.1080/00222932208632717, DOI 10.1080/00222932208632717]; Forster-Cooper Clive, 1913, ANN MAG NAT HIST, V8, P376; FORSTERCOOPER C, 1911, ANN MAGAZINE NATURAL, V8, P711; Franzosa EA, 2007, TREEROT VERSION 3; Gervais P., 1873, J ZOOL, V2, P362; GINSBURG L, 1987, Annales de Paleontologie, V73, P83; Goloboff P, 2008, CLADISTICS, V24, P91; Grandi F, 2017, CR PALEVOL, DOI [10.1016/6crpv.2017.04.002, DOI 10.1016/6CRPV.2017.04.002]; Granger W, 1937, B AM MUS NAT HIST, V72, P1; Gray J.E., 1821, LONDON MED REPOSITOR, V15, P296; Gromova V., 1960, Travaux Inst Paleont Acad Sci URSS, V77, P128; Gromova V., 1954, AKAD NAUK SSSR T PAL, V55, P85; Gromova VI, 1958, VERTEBRAT PALASIATIC, VII, P110; Hanson B.C., 1989, EVOLUTION PERISSODAC, P379; Heissig K., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P101; Heissig Kurt, 2012, Zitteliana Reihe A, V52, P79; Holbrook LT, 1999, CLADISTICS, V15, P331, DOI 10.1111/j.1096-0031.1999.tb00270.x; Holbrook LT, 1997, J VERTEBR PALEONTOL, V17, P384, DOI 10.1080/02724634.1997.10010983; Holbrook LT, 2001, ZOOL J LINN SOC, V131, P0; Hooker J.J., 1992, P494; Hooker JJ, 2009, GEOL SOC AM SPEC PAP, V452, P179, DOI 10.1130/2009.2452(12); Hooker J. J., 1987, MUNCHNER GEOWISSENSC, V10, P109; Hooker JJ, 2004, J GEOL SOC LONDON, V161, P161, DOI 10.1144/0016-764903-091; HOOKER JJ, 1989, BIOL J LINN SOC, V38, P9, DOI 10.1111/j.1095-8312.1989.tb01558.x; Huang Xue-Shi, 2001, Vertebrata Palasiatica, V39, P197; Jimenez-Hidalgo E, 2015, J S AM EARTH SCI, V57, P39, DOI 10.1016/j.jsames.2014.12.001; Kocsis L, 2002, NEUES JAHRB GEOL P-M, P649; Kotsakis T, 2004, PALAEOGEOGR PALAEOCL, V210, P67, DOI 10.1016/j.palaeo.2004.03.013; KRETZOI MIKLOS, 1940, ANN MUS NATION HUNGARICI, V33, P87; KRETZOI MIKLOS, 1942, FOLDTANI KOZLONY, V72, P139; Legendre S., 1989, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V16, P1; Li Qian, 2003, Vertebrata Palasiatica, V41, P203; Lucas S.G., 1989, Oxford Monographs on Geology and Geophysics, P358; Lucas SG, 1996, J PALEONTOL, V70, P691, DOI 10.1017/S0022336000023647; Lucas SG, 2001, P BIOL SOC WASH, V114, P517; Lucas SG, 2004, NEW MEXICO MUSEUM NA, V26, P81; Lucas Spencer G., 2006, Paleobios, V26, P7; Lucas Spencer G., 1996, Tertiary Research, V17, P51; MacFadden B.J., 1992, FOSSIL HORSES SYSTEM; Maddison WP., 2019, CHROMASEQ MESQUITE P; Malez M., 1985, PALEONTOL JUGOSLAVIC, V34, P1; Manning E., 1985, Mississippi Geology, V6, P1; Maxim I., 1965, COMUNICARI GEOL, V3, P229; MCKENNA MC, 1975, ANN MO BOT GARD, V62, P335, DOI 10.2307/2395200; Mennecart B, PALAEOGEOGR IN PRESS, DOI [10.1016/j.palaeo.2018.01.011, DOI 10.1016/J.PALAEO.2018.01.011]; Menouret B, 2015, ANN PALEONTOL, V101, P241, DOI 10.1016/j.annpal.2015.06.002; Meszaros N., 1996, CONVERGENTE TRANSILV CONVERGENTE TRANSILV, V4, P42; Meszaros N, 1977, MUZ BRUKENTHAL STUD, V21, P9; Metais G, 2017, CR PALEVOL, V16, P382, DOI 10.1016/j.crpv.2017.01.001; Meulenkamp JE, 2003, PALAEOGEOGR PALAEOCL, V196, P209, DOI 10.1016/S0031-0182(03)00319-5; Mihlbachler MC, 2008, B AM MUS NAT HIST, P1; Mihlbachler MC, 2011, J VERTEBR PALEONTOL, V31, P202, DOI 10.1080/02724634.2011.539653; Nikolov I., 1985, Mitteilungen der Bayerischen Staatssammlung fuer Palaeontologie und Historische Geologie, V25, P61; Ogg J, 2017, TSCREATOR VISUALIZAT; Osborn H. F., 1923, American Museum Novitates, VNo. 78, P1; Osborn H. F., 1924, American Museum Novitates, Vno. 147, P1; OSBORN HENRY FAIRFIELD, 1936, AMER MUS NOVITATES, V859, P1; Owen R., 1848, ARCHETYPE HOMOLOGIES, DOI [10.5962/bhl.title.118611, DOI 10.5962/BHL.TITLE.118611]; Pandolfi L, 2015, ANN PALEONTOL, V101, P67, DOI 10.1016/j.annpal.2014.10.001; Peterson O. A., 1919, ANN CARNEGIE MUS, V12, P40; Popescu B., 1978, REV ROUM GEOL GEOPH, V22, P99; Popov S, 2004, COUR FORSCHUNGSINSTI, P250; Prothero D. R., 2005, EVOLUTION N AM RHINO; Prothero D. R., 2013, RHINOCEROS GIANTS PA; PROTHERO DR, 1986, ZOOL J LINN SOC-LOND, V87, P341, DOI 10.1111/j.1096-3642.1986.tb01340.x; Prothero DR, 1993, P INT RHIN C, P81; Qi Tao, 1992, Vertebrata Palasiatica, V30, P229; Qiu Z-X., 2007, PALAEONT SIN C, V29, P1; Radinsky L. B., 1967, Bulletin of the American Museum of Natural History, V136, P1; RADINSKY LB, 1966, J MAMMAL, V47, P631, DOI 10.2307/1377893; Radinsky LB., 1967, AM MUS NOVIT, V2316, P1; Rasser MW, 2008, GEOLOGY CENTRAL EURO, V2; Remy J.A., 1987, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V10, P169; RESHETOV V, 1993, GEOBIOS-LYON, V26, P715, DOI 10.1016/S0016-6995(93)80054-U; Rogl F, 1999, GEOL CARPATH, V50, P339; Roman F., 1909, ARCH MUSEUM HIST NAT, V10, P1; Roman MF, 1911, ARCH MUS HIST NAT LY, V11, P1; Schlosser M., 1902, GEOL PALAONT ABH, V3, P117; Scott W. B., 1887, B MUS COMP ZOOL HARV, V13, P151; Scott W. B., 1941, T AM PHILOS SOC, V28, P747, DOI [10.2307/, DOI 10.2307/]; Scott W. B., 1890, T AM PHILOS SOC, V16, P461; Scott WB, 1883, CONTRIBUTIONS E M MU, V3, P3; Scott William B., 1945, TRANS AMER PHIL SOC, V34, P209, DOI 10.2307/1005542; Stehlin HG., 1909, B SOC GEOLOGIQUE FRA, V4 e surie, Tome IX:, P488; Stock C, 1936, P NATL ACAD SCI USA, V22, P260, DOI 10.1073/pnas.22.5.260; Stock C, 1939, P NATL ACAD SCI USA, V25, P270, DOI 10.1073/pnas.25.6.270; Stock C, 1933, P NATL ACAD SCI USA, V19, P762, DOI 10.1073/pnas.19.8.762; Swofford D.L., 2002, PHYLOGENETIC ANAL US; TARI G, 1993, TECTONOPHYSICS, V226, P433, DOI 10.1016/0040-1951(93)90131-3; Tissier J, 2018, MORPHOMUSEUM, P3, DOI [10.18563/m3.3.4.e5, DOI 10.18563/M3.3.4.E5]; Tomida Yikimitsu, 1996, Bulletin of the National Science Museum Series C (Geology and Paleontology), V22, P117; Troxell EL, 1921, AM J SCI, V2, P34; Troxell EL, 1922, AM J SCI, V4, P38; Troxell EL, 1921, AM J SCI, V2, P21; Uhlig U., 1999, NEUE FOLGE; von Koenigswald W, 2011, ACTA PALAEONTOL POL, V56, P11, DOI 10.4202/app.2010.0021; von Linnaeus C., 1758, SYSTEMA NATURAE REGN; Wall W.P., 1989, Oxford Monographs on Geology and Geophysics, P341; Wall W. P., 1982, 3 N AM PAL CONV P, P563; WALL WP, 1982, J PALEONTOL, V56, P434; WALL WP, 1980, J PALEONTOL, V54, P968; WALL WP, 1986, J PALEONTOL, V60, P911, DOI 10.1017/S0022336000043079; Wang Banyue, 1992, P529; Wang HB, 2016, SCI REP-UK, V6, DOI 10.1038/srep39607; Wilson JA, 1981, PEARCE SELLARDS SERI, V33, P1; Wood H. E., 1929, American Museum Novitates, Vno. 395, P1; Wood HE, 1933, B AM MUS NAT HIST, V67, P181; WOOD HORACE E., 1963, AMER MUS NOVITATES, V2146, P1; Xu Y. X., 1966, VERTEBRAT PALASIATIC, V10, P123; Xu Y-X, 1961, VERTEBRAT PALASIATIC, V4, P315; XU YU-XUAN, 1965, VERTEBRATA PALASIAT, V9, P83; Young C. C., 1937, Bulletin of the Geological Society of China, V17, P413; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	150	12	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0193774	10.1371/journal.pone.0193774	http://dx.doi.org/10.1371/journal.pone.0193774			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668673	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200003
J	Alsos, IG; Lammers, Y; Yoccoz, NG; Jorgensen, T; Sjogren, P; Gielly, L; Edwards, ME				Alsos, Inger Greve; Lammers, Youri; Yoccoz, Nigel Giles; Jorgensen, Tina; Sjogren, Per; Gielly, Ludovic; Edwards, Mary E.			Plant DNA metabarcoding of lake sediments: How does it represent the contemporary vegetation	PLOS ONE			English	Article							ENVIRONMENTAL DNA; ANCIENT DNA; HOLOCENE VEGETATION; PERMAFROST SEDIMENTS; FLORISTIC DIVERSITY; ARCTIC VEGETATION; CLIMATE DYNAMICS; POLLEN; CONSERVATION; BIODIVERSITY	Metabarcoding of lake sediments have been shown to reveal current and past biodiversity, but little is known about the degree to which taxa growing in the vegetation are represented in environmental DNA (eDNA) records. We analysed composition of lake and catchment vegetation and vascular plant eDNA at 11 lakes in northern Norway. Out of 489 records of taxa growing within 2 m from the lake shore, 170-49% (mean 31%) of the identifiable taxa recorded were detected with eDNA. Of the 217 eDNA records of 47 plant taxa in the 11 lakes, 73% and 12% matched taxa recorded in vegetation surveys within 2 m and up to about 50 m away from the lakeshore, respectively, whereas 16% were not recorded in the vegetation surveys of the same lake. The latter include taxa likely overlooked in the vegetation surveys or growing outside the survey area. The percentages detected were 61, 47, 25, and 15 for dominant, common, scattered, and rare taxa, respectively. Similar numbers for aquatic plants were 88, 88, 33 and 62%, respectively. Detection rate and taxonomic resolution varied among plant families and functional groups with good detection of e.g. Ericaceae, Roseaceae, deciduous trees, ferns, club mosses and aquatics. The representation of terrestrial taxa in eDNA depends on both their distance from the sampling site and their abundance and is sufficient for recording vegetation types. For aquatic vegetation, eDNA may be comparable with, or even superior to, in-lake vegetation surveys and may therefore be used as an tool for biomonitoring. For reconstruction of terrestrial vegetation, technical improvements and more intensive sampling is needed to detect a higher proportion of rare taxa although DNA of some taxa may never reach the lake sediments due to taphonomical constrains. Nevertheless, eDNA performs similar to conventional methods of pollen and macrofossil analyses and may therefore be an important tool for reconstruction of past vegetation.	[Alsos, Inger Greve; Lammers, Youri; Jorgensen, Tina; Sjogren, Per; Edwards, Mary E.] Univ Tromso, Tromso Museum, Tromso, Norway; [Yoccoz, Nigel Giles] Univ Tromso, Dept Arctic & Marine Biol, Tromso, Norway; [Gielly, Ludovic] Univ Grenoble Alpes, LECA, Grenoble, France; [Gielly, Ludovic] CNRS, LECA, Grenoble, France; [Edwards, Mary E.] Univ Southampton, Geog & Environm, Southampton, Hants, England	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; University of Southampton	Alsos, IG (corresponding author), Univ Tromso, Tromso Museum, Tromso, Norway.	inger.g.alsos@uit.no	Alsos, Inger Greve/O-8154-2019; Yoccoz, Nigel/C-8561-2014; Alsos, Inger G/A-9507-2016; Gielly, Ludovic/ADQ-6036-2022	Alsos, Inger Greve/0000-0002-8610-1085; Yoccoz, Nigel/0000-0003-2192-1039; Alsos, Inger G/0000-0002-8610-1085; 	Research Council of Norway [213692/F20, 250963/F20, 230617/E10]	Research Council of Norway(Research Council of Norway)	The work was supported by the Research Council of Norway (grant nos. 213692/F20, 250963/F20 and 230617/E10 to Alsos). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JRM, 1999, J BIOGEOGR, V26, P55, DOI 10.1046/j.1365-2699.1999.00284.x; ALM T, 1993, BOREAS, V22, P171, DOI 10.1111/j.1502-3885.1993.tb00178.x; Alsos IG, 2016, HOLOCENE, V26, P627, DOI 10.1177/0959683615612563; Andersen K, 2012, MOL ECOL, V21, P1966, DOI 10.1111/j.1365-294X.2011.05261.x; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Birks HJB, 2016, REV PALAEOBOT PALYNO, V228, P1, DOI 10.1016/j.revpalbo.2015.12.011; Birks HJB, 2016, NEW PHYTOL, V209, P499, DOI 10.1111/nph.13657; Birks HH, 2012, SCIENCE, V338, DOI 10.1126/science.1225345; Birks HH, 2010, VEG HIST ARCHAEOBOT, V19, P325, DOI 10.1007/s00334-010-0256-0; Boessenkool S, 2014, CONSERV BIOL, V28, P446, DOI 10.1111/cobi.12195; Boessenkool S, 2012, MOL ECOL, V21, P1806, DOI 10.1111/j.1365-294X.2011.05306.x; Boyer F, 2016, MOL ECOL RESOUR, V16, P176, DOI 10.1111/1755-0998.12428; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Brown TA, 2015, J QUATERNARY SCI, V30, P144, DOI 10.1002/jqs.2770; Chambert T, 2015, ECOLOGY, V96, P332, DOI 10.1890/14-1507.1; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; De Barba M, 2014, MOL ECOL RESOUR, V14, P306, DOI 10.1111/1755-0998.12188; Deiner K, 2015, BIOL CONSERV, V183, P53, DOI 10.1016/j.biocon.2014.11.018; Deiner K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088786; Dieffenbacher-Krall AC, 2013, ENCY QUATERNARY SCI, P684; DRAKE H, 1980, NEW ZEAL J BOT, V18, P257, DOI 10.1080/0028825X.1980.10426924; DUNWIDDIE PW, 1987, ECOLOGY, V68, P1, DOI 10.2307/1938800; Elven R., 2005, NORSK FLORA; Elven R., 2011, ANNOTATED CHECKLIST; Epp LS, 2015, QUATERNARY SCI REV, V117, P152, DOI 10.1016/j.quascirev.2015.03.027; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Fahner NA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157505; Ficetola GF, 2015, MOL ECOL RESOUR, V15, P543, DOI 10.1111/1755-0998.12338; Giguet-Covex C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4211; Greenacre M, 2010, ECOLOGY, V91, P958, DOI 10.1890/09-0239.1; Guisan A, 2006, CONSERV BIOL, V20, P501, DOI 10.1111/j.1523-1739.2006.00354.x; Hiiesalu I, 2012, MOL ECOL, V21, P2004, DOI 10.1111/j.1365-294X.2011.05390.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jackson ST, 2007, ENCY QUATERNARY SCI, P2413; Jackson ST, 2012, QUATERNARY SCI REV, V49, P1, DOI 10.1016/j.quascirev.2012.05.020; Jensen C, 2002, REV PALAEOBOT PALYNO, V121, P113, DOI 10.1016/S0034-6667(02)00077-5; Jensen C, 2002, BOREAS, V31, P285, DOI 10.1080/030094802760260391; Jensen C, 2008, J QUATERNARY SCI, V23, P719, DOI 10.1002/jqs.1155; Jorgensen T, 2012, MOL ECOL, V21, P1989, DOI 10.1111/j.1365-294X.2011.05287.x; Kraaijeveld K, 2015, MOL ECOL RESOUR, V15, P8, DOI 10.1111/1755-0998.12288; Lahoz-Monfort JJ, 2016, MOL ECOL RESOUR, V16, P673, DOI 10.1111/1755-0998.12486; Lamb EG, 2016, PLANT SOIL, V404, P361, DOI 10.1007/s11104-016-2852-y; Lopes CM, 2017, MOL ECOL RESOUR, V17, P904, DOI 10.1111/1755-0998.12643; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; MCQUEEN D R, 1969, Tuatara, V17, P13; Meltsov V, 2011, REV PALAEOBOT PALYNO, V166, P344, DOI 10.1016/j.revpalbo.2011.06.008; Nguyen NH, 2015, NEW PHYTOL, V205, P1389, DOI 10.1111/nph.12923; Niemeyer B, 2017, MOL ECOL RESOUR, V17, pe46, DOI 10.1111/1755-0998.12689; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Orlando L, 2014, ANNU REV ECOL EVOL S, V45, P573, DOI 10.1146/annurev-ecolsys-120213-091712; Pansu J, 2015, MOL ECOL, V24, P1485, DOI 10.1111/mec.13136; Parducci L, 2017, NEW PHYTOL, V214, P924, DOI 10.1111/nph.14470; Parducci L, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0382; Parducci L, 2013, MOL ECOL, V22, P3511, DOI 10.1111/mec.12298; Parducci L, 2012, SCIENCE, V338, DOI 10.1126/science.1225476; Parducci L, 2012, SCIENCE, V335, P1083, DOI 10.1126/science.1216043; Paus A, 2015, QUATERNARY SCI REV, V121, P36, DOI 10.1016/j.quascirev.2015.05.004; Pedersen MW, 2016, NATURE, V537, P45, DOI 10.1038/nature19085; Pedersen MW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0383; Pedersen MW, 2013, QUATERNARY SCI REV, V75, P161, DOI 10.1016/j.quascirev.2013.06.006; Pelissier R, 2003, ECOLOGY, V84, P242, DOI 10.1890/0012-9658(2003)084[0242:CBOTAD]2.0.CO;2; Peres-Neto PR, 2001, OECOLOGIA, V129, P169, DOI 10.1007/s004420100720; Pinol J, 2015, MOL ECOL RESOUR, V15, P819, DOI 10.1111/1755-0998.12355; Rawlence NJ, 2014, J QUATERNARY SCI, V29, P610, DOI 10.1002/jqs.2740; Schmid S, 2017, METHODS ECOL EVOL, V8, P1374, DOI 10.1111/2041-210X.12785; Sjogren P, 2017, NEW PHYTOL, V213, P929, DOI 10.1111/nph.14199; Smith O, 2015, SCIENCE, V347, P998, DOI 10.1126/science.1261278; Smol JP, 2001, TERRESTRIAL ALGAL SI; Soininen EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115335; Soininen EM, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-16; Sonstebo JH, 2010, MOL ECOL RESOUR, V10, P1009, DOI 10.1111/j.1755-0998.2010.02855.x; Strickler KM, 2015, BIOL CONSERV, V183, P85, DOI 10.1016/j.biocon.2014.11.038; Suchan T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151651; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Thomsen PF, 2015, BIOL CONSERV, V183, P4, DOI 10.1016/j.biocon.2014.11.019; Torti A, 2015, MAR GENOM, V24, P185, DOI 10.1016/j.margen.2015.08.007; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vorren TO, 2013, BOREAS, V42, P876, DOI 10.1111/bor.12013; Weiss CL, 2015, ELIFE, V4, DOI 10.7554/eLife.10005.001; Wilcox TM, 2016, BIOL CONSERV, V194, P209, DOI 10.1016/j.biocon.2015.12.023; Willerslev E, 2014, NATURE, V506, P47, DOI 10.1038/nature12921; Wilmshurst JM, 2014, CONSERV BIOL, V28, P202, DOI 10.1111/cobi.12150; Yoccoz NG, 2012, MOL ECOL, V21, P3647, DOI 10.1111/j.1365-294X.2012.05545.x; Yoccoz NG, 2012, MOL ECOL, V21, P2031, DOI 10.1111/j.1365-294X.2012.05505.x; Zimmermann HH, 2017, GENES-BASEL, V8, DOI 10.3390/genes8100273; Zimmermann HH, 2017, BIOGEOSCIENCES, V14, P575, DOI 10.5194/bg-14-575-2017	91	71	76	13	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195403	10.1371/journal.pone.0195403	http://dx.doi.org/10.1371/journal.pone.0195403			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664954	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000430262300019
J	Capacci, S; Mazzocchi, M; Brasini, S				Capacci, Sara; Mazzocchi, Mario; Brasini, Sergio			Estimation of unobservable selection effects in on-line surveys through propensity score matching: An application to public acceptance of healthy eating policies	PLOS ONE			English	Article							FACE-TO-FACE; WEB SURVEYS; TELEPHONE SURVEYS; INTERNET SURVEYS; DATA-COLLECTION; BIAS; OBESITY; MODE; BEHAVIOR; SUPPORT	The use of model-based propensity scores as matching tools opens the way to the indirect estimation of mode-related measurement effects and selection effects in web surveys, including a component of selection that cannot be traced back to observable characteristics. By matching and comparing respondents from real independent surveys that use the same questionnaire, but different administration modes, it becomes possible to isolate the selection effect induced by unobservable (or unobserved) respondent characteristics. This study applies a stratification matching algorithm to compare a web survey from a proprietary panel with a computer-assisted telephone survey based on random digit-dialing. The experiment is run in two countries (UK and Italy) to check for consistencies across different cultures and different internet penetration rates. The application to the elicitation of support for healthy eating policies indicates large and significant measurement and selection effects. After controlling for differences in the observed characteristics of respondents and the intensity of internet use, findings suggest that web surveys record lower support and higher neutrality. Similarly, after controlling for administration mode and observed respondent characteristics, internet users are less likely to state support compared to non-users. This suggests that unobserved characteristics play a major role, and post-stratification weighting is not a sufficient countermeasure. As demonstrated by the cross-country comparison, rising internet penetration rates are not a guarantee against this type of error, as disparities in these unobserved characteristics are likely to increase at the same time.	[Capacci, Sara; Mazzocchi, Mario; Brasini, Sergio] Univ Bologna, Dept Stat Sci, Bologna, Italy	University of Bologna	Mazzocchi, M (corresponding author), Univ Bologna, Dept Stat Sci, Bologna, Italy.	m.mazzocchi@unibo.it	Mazzocchi, Mario/F-7067-2012	Mazzocchi, Mario/0000-0002-0498-8031	European Union Seventh Framework Programme (FP7) [226713]	European Union Seventh Framework Programme (FP7)	The authors (MM, SC, SB) received funding from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement no. 226713, Eatwell Project. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askegaard S., 1998, INT BUS REV, V7, P549, DOI [10.1016/S0969-5931(98)00028-6, DOI 10.1016/S0969-5931(98)00028-6]; Baker R., 2004, 8 C HLTH SURV RES ME, V34, P143; Barry CL, 2013, AM J PREV MED, V44, P158, DOI 10.1016/j.amepre.2012.09.065; Barry CL, 2009, MILBANK Q, V87, P7, DOI 10.1111/j.1468-0009.2009.00546.x; Becker SO, 2002, STATA J, V2, P358, DOI 10.1177/1536867X0200200403; Bethell C, 2004, J MED INTERNET RES, V6, DOI 10.2196/jmir.6.1.e2; Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x; Capacci S, 2012, NUTR REV, V70, P188, DOI 10.1111/j.1753-4887.2011.00442.x; Chang L, 2009, PUBLIC OPIN QUART, V73, P641, DOI 10.1093/poq/nfp075; Christian LM, 2007, ADV TELEPHONE SURVEY, P250; COCHRAN WG, 1968, BIOMETRICS, V24, P295, DOI 10.2307/2528036; Couper MP, 2007, SOC SCI RES, V36, P131, DOI 10.1016/j.ssresearch.2005.10.002; Couper MP, 2011, PUBLIC OPIN QUART, V75, P889, DOI 10.1093/poq/nfr046; Couper MP, 2000, PUBLIC OPIN QUART, V64, P464, DOI 10.1086/318641; de Leeuw ED, 1992, TELEPHONE FACE TO FA; Dehejia RH, 1999, J AM STAT ASSOC, V94, P1053, DOI 10.2307/2669919; Denscombe M, 2006, SOC SCI COMPUT REV, V24, P246, DOI 10.1177/0894439305284522; Dever J.A., 2008, SURV RES METHODS-GER, V2, DOI 10.18148/srm/2008.v2i2.128; Dillman DA, 2009, SOC SCI RES, V38, P3, DOI 10.1016/j.ssresearch.2008.03.007; Duffy B, 2005, INT J MARKET RES, V47, P615, DOI 10.1177/147078530504700602; Evans WD, 2005, AM J PREV MED, V28, P26, DOI 10.1016/j.amepre.2004.09.008; Fan WM, 2010, COMPUT HUM BEHAV, V26, P132, DOI 10.1016/j.chb.2009.10.015; Fricker S, 2005, PUBLIC OPIN QUART, V69, P370, DOI 10.1093/poq/nfi027; Heerwegh D, 2008, PUBLIC OPIN QUART, V72, P836, DOI 10.1093/poq/nfn045; Hilbert A, 2007, J EPIDEMIOL COMMUN H, V61, P585, DOI 10.1136/jech.2006.050906; Imbens GW, 2009, J ECON LIT, V47, P5, DOI 10.1257/jel.47.1.5; Klein JD, 2007, MED CARE, V45, P691, DOI 10.1097/MLR.0b013e3180326145; Kreuter F, 2008, PUBLIC OPIN QUART, V72, P847, DOI 10.1093/poq/nfn063; Lee S., 2006, J OFF STAT, V22, P329; Lee S, 2009, SOCIOL METHOD RES, V37, P319, DOI 10.1177/0049124108329643; Link MW, 2005, EPIDEMIOLOGY, V16, P701, DOI 10.1097/01.ede.0000172138.67080.7f; Little RJ, 2003, STAT MED, V22, P1589, DOI 10.1002/sim.1513; Loosveldt G., 2008, SURV RES METHODS-GER, V2, P93, DOI DOI 10.18148/SRM/2008.V2I2.82; Malhotra N, 2007, POLIT ANAL, V15, P286, DOI 10.1093/pan/mpm003; Malhotra N, 2008, PUBLIC OPIN QUART, V72, P914, DOI 10.1093/poq/nfn050; Mazzocchi M, 2015, HEALTH ECON POLICY L, V10, P267, DOI 10.1017/S1744133114000346; Morain S, 2013, HEALTH AFFAIR, V32, P486, DOI 10.1377/hlthaff.2012.0609; Oliver JE, 2005, J HEALTH POLIT POLIC, V30, P923, DOI 10.1215/03616878-30-5-923; Rizzo L, 2004, PUBLIC OPIN QUART, V68, P267, DOI 10.1093/poq/nfh014; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; ROSENBAUM PR, 1985, AM STAT, V39, P33, DOI 10.2307/2683903; Schonlau M, 2004, SOC SCI COMPUT REV, V22, P128, DOI 10.1177/0894439303256551; Schonlau M, 2009, SOCIOL METHOD RES, V37, P291, DOI 10.1177/0049124108327128; Schouten B, 2013, SOC SCI RES, V42, P1555, DOI 10.1016/j.ssresearch.2013.07.005; Sikorski C, 2012, PLOS ONE, P7; Sparrow N, 2004, INT J MARKET RES, V46, P23, DOI 10.1177/147078530404600107; Stephenson LB, 2011, INT J PUBLIC OPIN R, V23, P24, DOI 10.1093/ijpor/edq025; The American Association for Public Opinion Research, 2016, STAND DEF FIN DISP C; Thompson ME, 2013, POPULATION, V68, P511, DOI 10.3917/popu.1303.0511; Toepoel V, 2008, PUBLIC OPIN QUART, V72, P985, DOI 10.1093/poq/nfn060; Traill WB, 2010, OBES REV, V11, P895, DOI 10.1111/j.1467-789X.2010.00717.x; Yeager DS, 2011, PUBLIC OPIN QUART, V75, P709, DOI 10.1093/poq/nfr020; [No title captured]	54	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196020	10.1371/journal.pone.0196020	http://dx.doi.org/10.1371/journal.pone.0196020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664975	gold, Green Published, Green Submitted			2022-12-26	WOS:000430262300050
J	Simko, I; Hayes, RJ				Simko, Ivan; Hayes, Ryan J.			Accuracy, reliability, and timing of visual evaluations of decay in fresh-cut lettuce	PLOS ONE			English	Article							SHELF-LIFE; ROMAINE LETTUCE; ICEBERG LETTUCE; BREEDING LINES; RESISTANCE; SYMPTOMS; QUALITY; ASSESSMENTS; PERFORMANCE; SEVERITY	Visual assessments are used for evaluating the quality of food products, such as fresh-cut lettuce packaged in bags with modified atmosphere. We have compared the accuracy and the reliability of visual evaluations of decay on fresh-cut lettuce performed with experienced and inexperienced raters. In addition, we have analyzed decay data from over 4.5 thousand bags to determine the optimum timing for evaluations to detect differences among accessions. Lin's concordance coefficient (rho(c)) that takes into consideration both the closeness of the data and the conformance to the identity line showed high repeatability (intra-rater reliability, rho(c) = 0.97), reproducibility (inter-rater reliability, rho(c) = 0.92), and accuracy (rho(c) = 0.96) for experienced raters. Inexperienced raters did not perform as well and their ratings showed decreased repeatability (rho(c) = 0.93), but even larger reduction in reproducibility (rho(c) = 0.80) and accuracy (rho(c) = 0.90). We have detected that 5.3% of ratings were outside of the 95% limits of agreement. These under-or overestimates were predominantly found for bags with intermediate levels of decay, which corresponds to the middle of the rating scale. This occurs because intermediate amounts of decay are more difficult to discriminate than extremes. The frequencies of aberrant ratings for experienced raters ranged from 0.6% to 4.4% (mean = 2.1%), for inexperienced raters the frequencies were substantially higher, ranging from 6.1% to 15.6% (mean = 9.4%). Therefore, we recommend that new raters receive training that includes practical examples in this range of decay, use of standard area diagrams, and continuing interaction with experienced raters (consultation during actual rating). Very high agreement among experienced raters indicate that visual ratings can be successfully used for evaluations of decay, until a more objective, rapid, and affordable method is developed. We recommend evaluating samples at multiple time points until 42 days after processing (about 80% decay on average) and then combining these individual ratings into the area under the decay progress stairs (AUDePS) score. Applying this approach, experienced evaluators can accurately detect difference among lettuce accessions and identify lettuce cultivars with reduced decay.	[Simko, Ivan] ARS, USDA, US Agr Res Stn, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA; [Hayes, Ryan J.] USDA, Natl Forage Seed Prod Res Ctr, Corvallis, OR USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Simko, I (corresponding author), ARS, USDA, US Agr Res Stn, Crop Improvement & Protect Res Unit, Salinas, CA 93905 USA.	ivan.simko@ars.usda.gov	Simko, Ivan/N-4033-2019	Simko, Ivan/0000-0002-8769-8477				Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; [Anonymous], 2015, MONTEREY COUNTY CROP; Bardsley SJ, 2013, PLANT PATHOL, V62, P460, DOI 10.1111/j.1365-3059.2012.02651.x; Bland JM, 2003, ULTRASOUND OBST GYN, V22, P85, DOI 10.1002/uog.122; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bock CH, 2010, CRIT REV PLANT SCI, V29, P59, DOI 10.1080/07352681003617285; Bock CH, 2009, PLANT DIS, V93, P412, DOI 10.1094/PDIS-93-4-0412; Everitt B.S., 2010, CAMBRIDGE DICT STAT, DOI DOI 10.1017/CBO9780511779633; Glaser L. K., 2001, AGR INFORM B, V767; Hayes RJ, 2016, ACTA HORTIC, V1141, P65, DOI 10.17660/ActaHortic.2016.1141.7; Hayes RJ., 2017, CLUSTER RANDOMISED T, V2nd edn, P1; Hayes RJ, 2008, J AM SOC HORTIC SCI, V133, P228, DOI 10.21273/JASHS.133.2.228; Hayes RJ, 2014, J AM SOC HORTIC SCI, V139, P388, DOI 10.21273/JASHS.139.4.388; Hayes RJ, 2014, HORTSCIENCE, V49, P18, DOI 10.21273/HORTSCI.49.1.18; Hayes RJ, 2011, HORTSCIENCE, V46, P501, DOI 10.21273/HORTSCI.46.3.501; HORSFALL JG, 1945, PHYTOPATHOLOGY, V35, P655; Kim JG, 2005, J SCI FOOD AGR, V85, P1622, DOI 10.1002/jsfa.2158; Krouwer JS, 2008, STAT MED, V27, P778, DOI 10.1002/sim.3086; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Nita M, 2003, PHYTOPATHOLOGY, V93, P995, DOI 10.1094/PHYTO.2003.93.8.995; NUTTER FW, 1993, PHYTOPATHOLOGY, V83, P806, DOI 10.1094/Phyto-83-806; NUTTER FW, 1995, CAN J PLANT PATHOL, V17, P174, DOI 10.1080/07060669509500709; Simko I, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01985; Simko I, 2015, POSTHARVEST BIOL TEC, V106, P44, DOI 10.1016/j.postharvbio.2015.04.007; Simko I, 2014, CSSA SPEC PUBL, V33, P53, DOI 10.2135/cssaspecpub33.c4; Simko I, 2014, HORTSCIENCE, V49, P679, DOI 10.21273/HORTSCI.49.5.679; Simko I, 2012, CROP SCI, V52, P2131, DOI 10.2135/cropsci2012.02.0111; Simko I, 2012, PHYTOPATHOLOGY, V102, P381, DOI 10.1094/PHYTO-07-11-0216; Simko I, 2010, HORTSCIENCE, V45, P670, DOI 10.21273/HORTSCI.45.4.670; Smyth AB, 1998, J AGR FOOD CHEM, V46, P4556, DOI 10.1021/jf980208s; Toivonen P.M.A., 2009, MODIFIED CONTROLLED, P463; Tudela JA, 2016, POSTHARVEST BIOL TEC, V120, P36, DOI 10.1016/j.postharvbio.2016.05.009; Watson PF, 2010, THERIOGENOLOGY, V73, P1167, DOI 10.1016/j.theriogenology.2010.01.003; Yadav NVS, 2013, PLANT PATHOL, V62, P325, DOI 10.1111/j.1365-3059.2012.02641.x; Zaki R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037908; Zhang FZ, 2007, J EXP BOT, V58, P1433, DOI 10.1093/jxb/erm006	36	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0194635	10.1371/journal.pone.0194635	http://dx.doi.org/10.1371/journal.pone.0194635			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664945	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300008
J	Chaykovska, L; Heunisch, F; von Einem, G; Hocher, CF; Tsuprykov, O; Pavkovic, M; Sandner, P; Kretschmer, A; Chu, C; Elitok, S; Stasch, JP; Hocher, B				Chaykovska, Lyubov; Heunisch, Fabian; von Einem, Gina; Hocher, Carl-Friedrich; Tsuprykov, Oleg; Pavkovic, Mira; Sandner, Peter; Kretschmer, Axel; Chu, Chang; Elitok, Saban; Stasch, Johannes-Peter; Hocher, Berthold			Urinary cGMP predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus before exposure to contrast medium	PLOS ONE			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; CYCLIC GUANOSINE-MONOPHOSPHATE; ACUTE KIDNEY INJURY; SOLUBLE GUANYLATE-CYCLASE; INDUCED NEPHROPATHY; NITRIC-OXIDE; HEART-FAILURE; CARDIAC-CATHETERIZATION; REPLACEMENT THERAPY; CHRONIC HYPOXIA	Background The use of iodine-based contrast agents entails the risk of contrast induced nephropathy (CIN). Radiocontrast agents elicit the third most common cause of nephropathy among hospitalized patients, accounting for 11-12% of cases. CIN is connected with clinically significant consequences, including increased morbidity, prolonged hospitalization, increased risk of complications, potential need for dialysis, and increased mortality rate. The number of in hospital examinations using iodine-based contrast media has been significantly increasing over the last decade. In order to protect patients from possible complications of such examinations, new biomarkers are needed that are able to predict a risk of contrast-induced nephropathy. Urinary and plasma cyclic guanosine monophosphate (cGMP) concentrations are influenced by renal function. Urinary cGMP is primarily of renal cellular origin. Therefore, we assessed if urinary cGMP concentration may predict major adverse renal events (MARE) after contrast media exposure during coronary angiography. Methods Urine samples were prospectively collected from non-randomized consecutive patients with either diabetes or preexisting impaired kidney function receiving intra-arterial contrast medium (CM) for emergent or elective coronary angiography at the Charite Campus Mitte, University Hospital Berlin. Urinary cGMP concentration in spot urine was analyzed 24 hours after CM exposure. Patients were followed up over 90 days for occurrence of death, initiation of dialysis, doubling of plasma creatinine concentration or MARE. Results In total, 289 consecutive patients were included into the study. Urine cGMP/creatinine ratio 24 hours before CM exposure expressed as mean +/- SD was predictive for the need of dialysis (no dialysis: 89.77 +/- 92.85 mu M/mM, n = 277; need for dialysis: 140.3 +/- 82.90 mu M/mM, n = 12, p = 0.008), death (no death during follow-up: 90.60 +/- 92.50 mu M/mM, n = 280; death during follow-up: 169.88 +/- 81.52 mu M/mM, n = 9; p = 0.002), and the composite endpoint MARE (no MARE: 86.02 +/- 93.17 mu M/mM, n = 271; MARE: 146.64 +/- 74.68 mu M/mM, n = 18, p<0.001) during the follow-up of 90 days after contrast media application. cGMP/creatinine ratio stayed significantly increased at values exceeding 120 pM/mM in patients who developed MARE, required dialysis or died. Conclusions Urinary cGMP/creatinine ratio >= 120 mu M/mM before CM exposure is a promising biomarker for the need of dialysis and all-cause mortality 90 days after CM exposure in patients with preexisting renal impairment or diabetes.	[Chaykovska, Lyubov; Heunisch, Fabian; von Einem, Gina; Hocher, Carl-Friedrich] Charite Univ Med Berlin, Ctr Cardiovasc Res, Berlin, Germany; [Chaykovska, Lyubov] Univ Hosp Zurich, Dept Vasc Surg, Zurich, Switzerland; [Chaykovska, Lyubov; Tsuprykov, Oleg; Hocher, Berthold] Univ Potsdam, Inst Nutr Sci, Potsdam, Germany; [Pavkovic, Mira; Sandner, Peter; Kretschmer, Axel] Bayer AG, Biomarker Res, Wuppertal, Germany; [Chu, Chang] Jinan Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou, Guangdong, Peoples R China; [Elitok, Saban] Klinikum Ernst von Bergmann, Dept Nephrol & Endocrinol Diabetol, Potsdam, Germany; [Stasch, Johannes-Peter] Martin Luther Univ Halle Wittenberg, Sch Pharm, Dept Pharmacol, Halle, Germany; [Stasch, Johannes-Peter] Bayer AG, Cardiovasc Res, Wuppertal, Germany; [Hocher, Berthold] Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha, Hunan, Peoples R China; [Hocher, Berthold] Jinan Univ, Div Histol & Embryol, Coll Med, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Zurich; University Zurich Hospital; University of Potsdam; Bayer AG; Jinan University; Klinikum Ernst von Bergmann; Martin Luther University Halle Wittenberg; Bayer AG; Hunan Normal University; Jinan University	Hocher, B (corresponding author), Univ Potsdam, Inst Nutr Sci, Potsdam, Germany.; Hocher, B (corresponding author), Hunan Normal Univ, Sch Med, Key Lab Study & Discovery Small Targeted Mol Huna, Changsha, Hunan, Peoples R China.; Hocher, B (corresponding author), Jinan Univ, Div Histol & Embryol, Coll Med, Key Lab Regenerat Med,Minist Educ, Guangzhou, Guangdong, Peoples R China.	hocher@uni-potsdam.de	Hocher, Berthold/AAC-3510-2020; Chu, Chang/ABB-5967-2021	Hocher, Berthold/0000-0001-8143-0579; Chaykovska, Lyubov/0000-0002-6250-4007	Bayer Pharma AG, Wuppertal, Germany	Bayer Pharma AG, Wuppertal, Germany	This work was supported by Bayer Pharma AG, Wuppertal, Germany provided measurements of cGMP as well as salary for authors[MP, PS, AK, JPS], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO K, 1988, KLIN WOCHENSCHR, V66, P768, DOI 10.1007/BF01726575; Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/362725; Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872574; [Anonymous], 1968, World Health Organ Tech Rep Ser, V405, P5; [Anonymous], 2013, KIDNEY INT SUPPL, V3, P19, DOI DOI 10.1038/KISUP.2012.64; Au TH, 2014, ANN PHARMACOTHER, V48, P1332, DOI 10.1177/1060028014541996; Bae EH, 2011, KOREAN J PHYSIOL PHA, V15, P273, DOI 10.4196/kjpp.2011.15.5.273; BLONDE L, 1974, J CLIN INVEST, V53, P163, DOI 10.1172/JCI107534; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; BROADUS AE, 1970, J CLIN INVEST, V49, P2222, DOI 10.1172/JCI106441; BURNETT JC, 2007, BMC PHARM SUPPL 1, V7; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Chapman AB, 1998, KIDNEY INT, V54, P2056, DOI 10.1046/j.1523-1755.1998.00217.x; Chaykovska L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145723; Fine LG, 2008, KIDNEY INT, V74, P867, DOI 10.1038/ki.2008.350; Gami AS, 2004, MAYO CLIN PROC, V79, P211, DOI 10.4065/79.2.211; Glode A, 2017, MOL METAB, V6, P276, DOI 10.1016/j.molmet.2016.12.010; Go AS, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-22; Greene SJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000536; GUAN ZG, 1995, KIDNEY INT, V47, P1569, DOI 10.1038/ki.1995.220; Harel Z, 2013, KIDNEY INT, V83, P901, DOI 10.1038/ki.2012.451; HEIM JM, 1988, Z KARDIOL, V77, P41; HEIM JM, 1990, KLIN WOCHENSCHR, V68, P709, DOI 10.1007/BF01647578; Heunisch F, MEDICINE BALTIMORE, V96, pe6065; JAKOB G, 1994, CLIN CHEM, V40, P96; JAKOB G, 1994, HORM METAB RES, V26, P121, DOI 10.1055/s-2007-1000788; Jarocka IT, 2013, ADV MED SCI-POLAND, V58, P369, DOI 10.2478/ams-2013-0006; Klein SJ, 2018, INTENS CARE MED, V44, P323, DOI 10.1007/s00134-018-5126-8; Krawutschke C, 2015, ARTERIOSCL THROM VAS, V35, P2011, DOI 10.1161/ATVBAHA.115.306133; Kuno Y, 2011, BRIT J PHARMACOL, V162, P1389, DOI 10.1111/j.1476-5381.2010.01149.x; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mair J, 1998, CIRCULATION, V97, P1209, DOI 10.1161/01.CIR.97.12.1209; Maliborski A, 2011, MED SCI MONITOR, V17, pRA199, DOI 10.12659/MSM.881923; Malyszko J, 2009, RENAL FAILURE, V31, P910, DOI 10.3109/08860220903216113; MARUMO F, 1990, CLIN CHEM, V36, P1650; Matata BM, 2001, DIABETES, V50, P2603, DOI 10.2337/diabetes.50.11.2603; Mehran R, 2004, J AM COLL CARDIOL, V44, P1393, DOI 10.1016/j.jacc.2004.06.068; Neylon M, 1997, J PHYSIOL-LONDON, V501, P243, DOI 10.1111/j.1469-7793.1997.243bo.x; Richards AM, 1998, CIRCULATION, V97, P1921, DOI 10.1161/01.CIR.97.19.1921; Rodriguez-Iturbe B, 2005, KIDNEY INT, V68, P2131, DOI 10.1111/j.1523-1755.2005.00669.x; Sato A, 2017, INT J CARDIOL, V227, P424, DOI 10.1016/j.ijcard.2016.11.019; SIRAGY HM, 1992, HYPERTENSION, V19, P775, DOI 10.1161/01.HYP.19.6.775; Stasch JP, 2015, CURR OPIN PHARMACOL, V21, P95, DOI 10.1016/j.coph.2014.12.014; Stasch JP, 2002, BRIT J PHARMACOL, V135, P344, DOI 10.1038/sj.bjp.0704483; Takiyama Y, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/837421; Tsai EJ, 2009, PHARMACOL THERAPEUT, V122, P216, DOI 10.1016/j.pharmthera.2009.02.009; TSUTAMOTO T, 1994, CIRCULATION, V90, P823, DOI 10.1161/01.CIR.90.2.823; VORDERWINKLER KP, 1991, CLIN CHEM, V37, P186; Wald R, 2014, CRIT CARE MED, V42, P868, DOI 10.1097/CCM.0000000000000042; Wang YR, 2006, AM J PHYSIOL-RENAL, V290, pF167, DOI 10.1152/ajprenal.00197.2005; WONG KR, 1988, AM J PHYSIOL, V255, pF1220, DOI 10.1152/ajprenal.1988.255.6.F1220	51	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195828	10.1371/journal.pone.0195828	http://dx.doi.org/10.1371/journal.pone.0195828			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649334	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900095
J	Dolmatov, IY; Afanasyev, SV; Boyko, AV				Dolmatov, Igor Yu.; Afanasyev, Sergey V.; Boyko, Alexey V.			Molecular mechanisms of fission in echinoderms: Transcriptome analysis	PLOS ONE			English	Article							CUCUMBER STICHOPUS-JAPONICUS; CATCH CONNECTIVE-TISSUE; COLLAGEN CROSS-LINKING; SEA-CUCUMBER; ASEXUAL REPRODUCTION; BODY-WALL; MATRIX METALLOPROTEINASES; FIBRILLIN MICROFIBRILS; MULTIPOTENT EPITHELIUM; ANTERIOR REGENERATION	Echinoderms are capable of asexual reproduction by fission. An individual divides into parts due to changes in the strength of connective tissue of the body wall. The structure of connective tissue and the mechanisms of variations in its strength in echinoderms remain poorly studied. An analysis of transcriptomes of individuals during the process of fission provides a new opportunity to understand the mechanisms of connective tissue mutability. In the holothurian Cladolabes schmeltzii, we have found a rather complex organization of connective tissue. Transcripts of genes encoding a wide range of structural proteins of extracellular matrix, as well as various proteases and their inhibitors, have been discovered. All these molecules may constitute a part of the mechanism of connective tissue mutability. According to our data, the extracellular matrix of echinoderms is substantially distinguished from that of vertebrates by the lack of elastin, fibronectins, and tenascins. In case of fission, a large number of genes of transcription factors and components of different signaling pathways are expressed. Products of these genes are probably involved in regulation of asexual reproduction, connective tissue mutability, and preparation of tissues for subsequent regeneration. It has been shown that holothurian tensilins are a special group of tissue inhibitors of metalloproteinases, which has formed within the class Holothuroidea and is absent from other echinoderms. Our data can serve a basis for the further study of the mechanisms of extracellular matrix mutability, as well as the mechanisms responsible for asexual reproduction in echinoderms.	[Dolmatov, Igor Yu.; Boyko, Alexey V.] Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Natl Sci Ctr Marine Biol, Vladivostok, Russia; [Dolmatov, Igor Yu.; Boyko, Alexey V.] Far Eastern Fed Univ, Vladivostok, Russia; [Afanasyev, Sergey V.] Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia	Russian Academy of Sciences; National Scientific Center of Marine Biology, Far East Branch of the Russian Academy of Sciences; Far Eastern Federal University; Russian Academy of Sciences; Sechenov Institute of Evolutionary Physiology & Biochemistry	Dolmatov, IY (corresponding author), Russian Acad Sci, AV Zhirmunsky Inst Marine Biol, Far Eastern Branch, Natl Sci Ctr Marine Biol, Vladivostok, Russia.; Dolmatov, IY (corresponding author), Far Eastern Fed Univ, Vladivostok, Russia.	idolmatov@mail.ru	Boyko, Alexey/AAK-4081-2020; Dolmatov, Igor Yu/A-7704-2014; Afanasyev, Sergey V/K-9309-2015	Boyko, Alexey/0000-0003-0342-9104; Dolmatov, Igor Yu/0000-0003-3923-8131; Afanasyev, Sergey V/0000-0002-8393-820X	Russian Foundation for Basic Research [17-04-01334]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR))	This work was supported by the Russian Foundation for Basic Research (grant No 17-04-01334) for IYD, http://www.rfbr.ru/rffi/eng.	Adams JC, 2011, CSH PERSPECT BIOL, V3, DOI [10.1101/cshperspect.a009712, 10.1016/j.biocel.2004.01.004]; Angerer L, 2006, DEV BIOL, V300, P267, DOI 10.1016/j.ydbio.2006.07.046; Ba HZ, 2015, GENE, V565, P96, DOI 10.1016/j.gene.2015.03.071; Balavoine G, 2014, INT J DEV BIOL, V58, P469, DOI 10.1387/ijdb.140148gb; Balser E.J., 2004, P3, DOI 10.1201/9780203970881.pt1; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barbaglio A, 2015, ZOOLOGY, V118, P147, DOI 10.1016/j.zool.2014.10.003; Bein K, 2000, J BIOL CHEM, V275, P32167, DOI 10.1074/jbc.M003834200; Bely AE, 2001, DEVELOPMENT, V128, P2781; Birenheide R, 1998, BIOL BULL-US, V194, P253, DOI 10.2307/1543095; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Brusca RC, 2003, INVERTEBRATES; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cameron RA, 2009, NUCLEIC ACIDS RES, V37, pD750, DOI 10.1093/nar/gkn887; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chen L, 2016, CELL TISSUE RES, V366, P509, DOI 10.1007/s00441-016-2451-5; Chiquet-Ehrismann R, 2011, COLD SPRING HARB PER, V3; Chirco R, 2006, CANCER METAST REV, V25, P99, DOI 10.1007/s10555-006-7893-x; Clouse RM, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150377; Conand C, 1996, OCEANOL ACTA, V19, P209; Conand C., 1997, SPC BECHE DE MER INF, V9, P5; Cox TR, 2013, CANCER RES, V73, P1721, DOI 10.1158/0008-5472.CAN-12-2233; Crocker SJ, 2004, J NEUROSCI RES, V75, P1, DOI 10.1002/jnr.10836; Davies JA, 2001, EXTRACELLULAR MATRIX; de Vega S, 2009, CELL MOL LIFE SCI, V66, P1890, DOI 10.1007/s00018-009-8632-6; Dolmatov IY, 2014, RUSS J MAR BIOL+, V40, P228, DOI 10.1134/S1063074014030031; Dolmatov IY, 2012, RUSS J MAR BIOL+, V38, P243, DOI 10.1134/S1063074012030042; Dolmatov Igor Yu, 2014, ScientificWorldJournal, V2014, P527234, DOI 10.1155/2014/527234; Dolmatov IY, 2016, ZOOMORPHOLOGY, V135, P173, DOI 10.1007/s00435-015-0299-y; Eaves AA, 2003, NATURE, V425, P146, DOI 10.1038/425146a; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Elphick MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044492; EMSON RH, 1987, J EXP MAR BIOL ECOL, V111, P195, DOI 10.1016/0022-0981(87)90028-1; Engelstadter J, 2008, BIOESSAYS, V30, P1138, DOI 10.1002/bies.20833; English WR, 2001, J BIOL CHEM, V276, P42018, DOI 10.1074/jbc.M107783200; ERLINGER R, 1993, J ANAT, V183, P1; Esposito C, 2005, FEBS J, V272, P615, DOI 10.1111/j.1742-4658.2004.04476.x; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Faunes F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022569; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Fields GB, 2015, MATRIX BIOL, V44-46, P239, DOI 10.1016/j.matbio.2015.01.002; Finnerty JR, 2003, INT J DEV BIOL, V47, P523; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; FUJIWARA S, 1992, DEV GROWTH DIFFER, V34, P463; Gasparini F, 2016, MOL PHYLOGENET EVOL, V95, P46, DOI 10.1016/j.ympev.2015.11.001; Geng H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2551; Georges PC, 2007, AM J PHYSIOL-GASTR L, V293, pG1147, DOI 10.1152/ajpgi.00032.2007; Girich AS, 2017, WOUND REPAIR REGEN, V25, P828, DOI 10.1111/wrr.12591; Giusti B, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00237; Green KA, 2005, BIOESSAYS, V27, P894, DOI 10.1002/bies.20281; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hacker U, 2005, NAT REV MOL CELL BIO, V6, P530, DOI 10.1038/nrm1681; Halasz K, 2007, J BIOL CHEM, V282, P31166, DOI 10.1074/jbc.M705735200; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hyman LH, 1955, INVERTEBRATES ECHINO; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; Hynes RO., 2012, COLD SPRING HARB PER, V4, pA004903, DOI [10.1101/cshperspect.a004903, DOI 10.1101/CSHPERSPECT.A004903]; Itoh Y, 2015, MATRIX BIOL, V44-46, P207, DOI 10.1016/j.matbio.2015.03.004; Ivanova-Kazas O.M, 1977, ASEXUAL REPROD ANIMA; Janssen T, 2015, MOL PHYLOGENET EVOL, V92, P82, DOI 10.1016/j.ympev.2015.06.004; Jo J, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw006; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Kamenev YO, 2013, TISSUE CELL, V45, P126, DOI 10.1016/j.tice.2012.10.002; Kamenev YO, 2017, MICROSC RES TECHNIQ, V80, P183, DOI 10.1002/jemt.22786; Kamenev YO, 2015, MICROSC RES TECHNIQ, V78, P540, DOI 10.1002/jemt.22507; Kariya Y, 1997, CARBOHYD RES, V297, P273, DOI 10.1016/S0008-6215(96)00258-3; KARIYA Y, 1990, J BIOL CHEM, V265, P5081; KAWAMURA K, 1994, INT J DEV BIOL, V38, P369; Kawamura K, 2013, DEV BIOL, V384, P343, DOI 10.1016/j.ydbio.2013.10.004; Kielty CM, 2002, PHILOS T R SOC B, V357, P207, DOI 10.1098/rstb.2001.1029; Kikuchi M, 2015, DEV GENES EVOL, V225, P275, DOI 10.1007/s00427-015-0510-7; Kim YS, 2012, BIOMOL THER, V20, P133, DOI 10.4062/biomolther.2012.20.2.133; Klopfenstein D, 2016, TANGHAIBAO GOATOOLS, DOI [10.5281/zenodo.159493, DOI 10.5281/ZENODO.159493]; Kramer KL, 2003, ANNU REV GENET, V37, P461, DOI 10.1146/annurev.genet.37.061103.090226; Lamash NE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058433; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LAVERRIERE AC, 1994, J BIOL CHEM, V269, P23177; Lee NV, 2005, J BIOL CHEM, V280, P34796, DOI 10.1074/jbc.M506980200; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loeys BL, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000488; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Mashanov Vladimir S, 2012, Mob Genet Elements, V2, P244; Mashanov VS, 2012, GENE EXPR PATTERNS, V12, P24, DOI 10.1016/j.gep.2011.10.003; MENTON DN, 1973, J MORPHOL, V141, P185, DOI 10.1002/jmor.1051410206; Miller AK, 2017, MOL PHYLOGENET EVOL, V111, P110, DOI 10.1016/j.ympev.2017.02.014; Mladenov Philip V., 1994, P339; Mo J, 2016, P NATL ACAD SCI USA, V113, pE6362, DOI 10.1073/pnas.1609341113; Motokawa T, 2004, BIOL BULL-US, V206, P4, DOI 10.2307/1543193; Motokawa T, 2003, BIOL BULL-US, V205, P261, DOI 10.2307/1543290; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; MOTOKAWA T, 1982, J EXP BIOL, V99, P29; Motokawa T, 2015, J EXP BIOL, V218, P703, DOI 10.1242/jeb.115972; Motokawa T, 2012, BIOL BULL-US, V222, P150, DOI 10.1086/BBLv222n2p150; Munger JS, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005017; Myers JC, 2007, BIOCHEM J, V404, P535, DOI 10.1042/BJ20070201; Naba A, 2016, MATRIX BIOL, V49, P10, DOI 10.1016/j.matbio.2015.06.003; Nyberg KG, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-287; Ozpolat BD, 2015, DEV BIOL, V405, P123, DOI 10.1016/j.ydbio.2015.06.001; OLDBERG A, 1992, J BIOL CHEM, V267, P22346; Olivieri J, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-24; Olsen BR, 1997, INT J BIOCHEM CELL B, V29, P555, DOI 10.1016/S1357-2725(96)00100-8; Onai T, 2009, DEV BIOL, V332, P223, DOI 10.1016/j.ydbio.2009.05.571; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pavelitz T, 2013, MOBILE DNA-UK, V4, DOI 10.1186/1759-8753-4-23; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Pfeiffer BJ, 2005, MATRIX BIOL, V24, P451, DOI 10.1016/j.matbio.2005.07.001; Purwati P., 2004, SPC BECHE DE MER INF, V20, P26; Quinones JL, 2002, DEV BIOL, V250, P181, DOI 10.1006/dbio.2002.0778; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Ribeiro AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023364; Ribeiro AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049016; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Ryan JF, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-37; Sakurai T, 2012, INT J DEV BIOL, V56, P173, DOI 10.1387/ijdb.113439ts; Schwarzbauer JE, 2011, COLD SPRING HARB PER, V3; Scimone ML, 2016, ELIFE, V5, DOI 10.7554/eLife.12845; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Sherratt MJ, 2003, J MOL BIOL, V332, P183, DOI 10.1016/S0022-2836(03)00829-5; Shivdasani RA, 2002, DEV BIOL, V249, P191, DOI 10.1006/dbio.2002.0765; Sikes JM, 2013, NATURE, V500, P77, DOI 10.1038/nature12403; Smiley Scott, 1994, P401; Stetler-Stevenson WG, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127re6; Sun LN, 2013, GENET MOL RES, V12, P5321, DOI 10.4238/2013.November.7.7; Szulgit G, 2007, BIOESSAYS, V29, P645, DOI 10.1002/bies.20597; Takehana Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085644; Takemae N, 2009, BIOL BULL-US, V216, P45; Takeo M, 2013, NATURE, V499, P228, DOI 10.1038/nature12214; Tamori M, 2006, J EXP BIOL, V209, P1594, DOI 10.1242/jeb.02178; Tamori M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155673; Thurmond FA, 1996, J EXP BIOL, V199, P1817; Thurmond FA, 1997, CONNECT TISSUE RES, V36, P211, DOI 10.3109/03008209709160221; Tipper JR, 2002, MATRIX BIOL, V21, P625, DOI 10.1016/S0945-053X(02)00090-2; Trotter JA, 1996, MATRIX BIOL, V15, P99, DOI 10.1016/S0945-053X(96)90151-1; Trotter JA, 1999, MATRIX BIOL, V18, P569, DOI 10.1016/S0945-053X(99)00050-5; Trotter JA, 2000, COMP BIOCH PHYSL, V126, P95; Tucker RP, 2009, INT J BIOCHEM CELL B, V41, P424, DOI 10.1016/j.biocel.2008.08.003; Uthicke S, 2001, MAR FRESHWATER RES, V52, P205, DOI 10.1071/MF00064; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Vincenti MP, 2007, J CELL PHYSIOL, V213, P355, DOI 10.1002/jcp.21208; Wang Y, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S10-S5; Whittaker CA, 2006, DEV BIOL, V300, P252, DOI 10.1016/j.ydbio.2006.07.044; Wilkie IC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120339; Wilkie IC, 2005, PROG MOLEC, V39, P221; Wilkie IC, 2001, MICROSC RES TECHNIQ, V55, P369, DOI 10.1002/jemt.1185; WILKIE IC, 1984, MAR BEHAV PHYSIOL, V11, P1, DOI 10.1080/10236248409387032; Yamada A, 2010, J EXP BIOL, V213, P3416, DOI 10.1242/jeb.044149; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yan LJ, 2014, J AGR FOOD CHEM, V62, P4769, DOI 10.1021/jf500923y; Yang ZT, 2001, J BIOL CHEM, V276, P8403, DOI 10.1074/jbc.M008925200; Yang ZT, 2000, MOL BIOL CELL, V11, P3353, DOI 10.1091/mbc.11.10.3353; Yu CP, 2017, FISH SHELLFISH IMMUN, V70, P553, DOI 10.1016/j.fsi.2017.09.011; Yurchenco P.D., 2011, COLD SPRING HARB PER, V3; Zhang XJ, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003790; Zhou DY, 2014, FOOD CHEM, V158, P192, DOI 10.1016/j.foodchem.2014.02.105; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zorn AM, 2007, INT REV CYTOL, V259, P49, DOI 10.1016/S0074-7696(06)59002-3	166	18	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195836	10.1371/journal.pone.0195836	http://dx.doi.org/10.1371/journal.pone.0195836			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649336	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900097
J	Hsu, SH; Hsiao, CF; Tsai, SB				Hsu, Sheng-Hsun; Hsiao, Cheng-Fu; Tsai, Sang-Bing			Constructing a consumption model of fine dining from the perspective of behavioral economics	PLOS ONE			English	Article							CUSTOMER SATISFACTION; RESTAURANTS; QUALITY; CHOICE; SCALES; INTENTIONS; ATTRIBUTES; PERCEPTION; SAFETY; PRICE	Numerous factors affect how people choose a fine dining restaurant, including food quality, service quality, food safety, and hedonic value. A conceptual framework for evaluating restaurant selection behavior has not yet been developed. This study surveyed 150 individuals with fine dining experience and proposed the use of mental accounting and axiomatic design to construct a consumer economic behavior model. Linear and logistic regressions were employed to determine model correlations and the probability of each factor affecting behavior. The most crucial factor was food quality, followed by service and dining motivation, particularly regarding family dining. Safe ingredients, high cooking standards, and menu innovation all increased the likelihood of consumers choosing fine dining restaurants.	[Hsu, Sheng-Hsun] Chung Hua Univ, Dept Business Adm, Hsinchu, Taiwan; [Hsiao, Cheng-Fu] Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan; [Hsiao, Cheng-Fu] Hsing Wu Univ, Dept Hospitality Management, New Taipei, Taiwan; [Tsai, Sang-Bing] Univ Elect Sci & Technol China, Zhongshan Inst, Chengdu, Guangdong, Peoples R China	Chung Hua University; Chung Hua University; University of Electronic Science & Technology of China	Hsiao, CF (corresponding author), Chung Hua Univ, PhD Program Technol Management, Hsinchu, Taiwan.; Hsiao, CF (corresponding author), Hsing Wu Univ, Dept Hospitality Management, New Taipei, Taiwan.	haiso085009@yahoo.com.tw	Tsai, Sang-Bing/C-2978-2014	Tsai, Sang-Bing/0000-0001-6988-5829				Akaichi F, 2013, AM J AGR ECON, V95, P949, DOI 10.1093/ajae/aat013; Alonso AD, 2013, J HOSP MARKET MANAG, V22, P547, DOI 10.1080/19368623.2012.671562; ARNOULD EJ, 1994, J MARKETING RES, V31, P484, DOI 10.2307/3151878; Arora R., 2006, Services Marketing Quarterly, V28, P89, DOI 10.1300/J396v28n01_05; Auty S., 1992, Service Industries Journal, V12, P324, DOI 10.1080/02642069200000042; Back KJ, 2012, INT J HOSP MANAG, V31, P535, DOI 10.1016/j.ijhm.2011.07.013; Barbas S, 2003, J POP CULT, V36, P669, DOI 10.1111/1540-5931.00040; Brandt RD., 1987, ADD VALUE YOUR SERVI, P61; Carnevalli JA, 2010, INT J PROD ECON, V125, P1, DOI 10.1016/j.ijpe.2010.01.002; Chen A, 2015, INT J CONTEMP HOSP M, V27, P236, DOI 10.1108/IJCHM-07-2013-0280; Cheng CC, 2012, INT J HOSP MANAG, V31, P1155, DOI 10.1016/j.ijhm.2012.02.003; Chin JB, 2013, TOTAL QUAL MANAG BUS, V24, P1160, DOI 10.1080/14783363.2012.661132; Dawes J, 2008, INT J MARKET RES, V50, P61, DOI 10.1177/147078530805000106; FLAMER S, 1983, MULTIVAR BEHAV RES, V18, P275, DOI 10.1207/s15327906mbr1803_3; Glaser B.G., 1968, DISCOV GROUNDED THEO; Gourville JT, 1998, J CONSUM RES, V25, P160, DOI 10.1086/209533; Ha J, 2013, INT J HOSP MANAG, V32, P155, DOI 10.1016/j.ijhm.2012.05.007; Hair J.F., 2010, MULTIVARIANT DATA AN, V7th; Harrington R. J., 2013, Journal of Foodservice Business Research, V16, P219, DOI 10.1080/15378020.2013.782240; Harrington R. J., 2011, Journal of Foodservice Business Research, V14, P272, DOI 10.1080/15378020.2011.594388; HAUSER JR, 1988, HARVARD BUS REV, V66, P63; HENDERSON PW, 1992, ORGAN BEHAV HUM DEC, V51, P92, DOI 10.1016/0749-5978(92)90006-S; Henson S, 2006, J FOOD SAFETY, V26, P275, DOI 10.1111/j.1745-4565.2006.00049.x; Hsee CK, 2009, J MARKETING RES, V46, P396, DOI 10.1509/jmkr.46.3.396; Johnson C., 2005, Cornell Hotel and Restaurant Administration Quarterly, V46, P170, DOI 10.1177/0010880405275115; Jung HS, 2012, INT J HOSP MANAG, V31, P875, DOI 10.1016/j.ijhm.2011.10.006; Jung JM, 2015, INT J HOSP MANAG, V45, P88, DOI 10.1016/j.ijhm.2014.11.007; KAHNEMAN D, 1993, MANAGE SCI, V39, P17, DOI 10.1287/mnsc.39.1.17; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kim I, 2012, INT J CONTEMP HOSP M, V24, P402, DOI 10.1108/09596111211217888; Kim WG, 2009, INT J HOSP MANAG, V28, P144, DOI 10.1016/j.ijhm.2008.06.010; Koo L. C., 1999, International Journal of Contemporary Hospitality Management, V11, P242, DOI 10.1108/09596119910272784; Kozinets RV, 2002, J MARKETING RES, V39, P61, DOI 10.1509/jmkr.39.1.61.18935; Lane C, 2013, POETICS, V41, P342, DOI 10.1016/j.poetic.2013.05.003; Lee JH, 2011, INT J HOSP MANAG, V30, P658, DOI 10.1016/j.ijhm.2010.12.001; LEWIS RC, 1981, J ADVERTISING RES, V21, P69; LOKEN B, 1987, J MARKET RES SOC, V29, P353; MASLOW AH, 1954, J PERS, V22, P326, DOI 10.1111/j.1467-6494.1954.tb01136.x; Matzler K, 2004, IND MARKET MANAG, V33, P271, DOI 10.1016/S0019-8501(03)00055-5; McFadden D., 1974, J PUBLIC ECON, V3, P303, DOI [10.1016/0047-2727(74)90003-6, DOI 10.1016/0047-2727(74)90003-6]; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Netzer O, 2008, MARKET LETT, V19, P337, DOI 10.1007/s11002-008-9046-1; Njite D., 2008, Journal of Foodservice Business Research, V11, P237, DOI 10.1080/15378020801995523; Nunnally J., 1978, PSYCHOMETRIC THEORY; Ottenbacher M., 2007, INT J CONTEMP HOSP M, V19, P444, DOI DOI 10.1108/09596110710775110; Ponnam A, 2014, INT J HOSP MANAG, V37, P47, DOI 10.1016/j.ijhm.2013.10.004; Prelec D, 1998, MARKET SCI, V17, P4, DOI 10.1287/mksc.17.1.4; Rick SI, 2008, J CONSUM RES, V34, P767, DOI 10.1086/523285; Riviere P, 2006, FOOD QUAL PREFER, V17, P572, DOI 10.1016/j.foodqual.2006.04.002; Rohr A, 2005, FOOD CONTROL, V16, P649, DOI 10.1016/j.foodcont.2004.06.001; Scheidl R, 2010, MECHATRONICS, V20, P842, DOI 10.1016/j.mechatronics.2010.04.008; SPIGGLE S, 1994, J CONSUM RES, V21, P491, DOI 10.1086/209413; Stevens P., 1995, CORNELL HOTEL REST A, V36, P556; Suh NP, 1998, CIRP ANNALS 1998 - MANUFACTURING TECHNOLOGY, VOL 47/2/1998, P627; Suh NP., 2001, AXIOMATIC DESIGN ADV; Suh NP, 1990, PRINCIPLES DESIGN; Thaler RH, 1999, J BEHAV DECIS MAKING, V12, P183, DOI 10.1002/(SICI)1099-0771(199909)12:3<183::AID-BDM318>3.0.CO;2-F; Thaler RH, 2008, MARKET SCI, V27, P15, DOI 10.1287/mksc.1070.0330; Thrane C, 2007, J REVENUE PRICING MA, V5, P315, DOI 10.1057/palgrave.rpm.5160055; Tikkanen I, 2007, BRIT FOOD J, V109, P721, DOI 10.1108/00070700710780698; Tontini G, 2013, TOTAL QUAL MANAG BUS, V24, P1253, DOI 10.1080/14783363.2013.836790; Voon BH, 2012, PROCD SOC BEHV, V38, P388, DOI 10.1016/j.sbspro.2012.03.361; Wiedmann KP, 2009, PSYCHOL MARKET, V26, P625, DOI 10.1002/mar.20292; Yim ES, 2014, INT J HOSP MANAG, V39, P11, DOI 10.1016/j.ijhm.2014.01.010; ZEITHAML VA, 1988, J MARKETING, V52, P2, DOI 10.2307/1251446	65	4	4	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194886	10.1371/journal.pone.0194886	http://dx.doi.org/10.1371/journal.pone.0194886			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641554	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900053
J	Yetton, BD; McDevitt, EA; Cellini, N; Shelton, C; Mednick, SC				Yetton, Benjamin D.; McDevitt, Elizabeth A.; Cellini, Nicola; Shelton, Christian; Mednick, Sara C.			Quantifying sleep architecture dynamics and individual differences using big data and Bayesian networks	PLOS ONE			English	Article							OSTEOPOROTIC FRACTURES; STAGE TRANSITIONS; WAKE TRANSITIONS; RISK-FACTORS; MEMORY; AGE; CONSOLIDATION; COGNITION; CHILDREN; PATTERN	The pattern of sleep stages across a night (sleep architecture) is influenced by biological, behavioral, and clinical variables. However, traditional measures of sleep architecture such as stage proportions, fail to capture sleep dynamics. Here we quantify the impact of individual differences on the dynamics of sleep architecture and determine which factors or set of factors best predict the next sleep stage from current stage information. We investigated the influence of age, sex, body mass index, time of day, and sleep time on static (e.g. minutes in stage, sleep efficiency) and dynamic measures of sleep architecture (e.g. transition probabilities and stage duration distributions) using a large dataset of 3202 nights from a non-clinical population. Multi-level regressions show that sex effects duration of all Non-Rapid Eye Movement (NREM) stages, and age has a curvilinear relationship for Wake After Sleep Onset (WASO) and slow wave sleep (SWS) minutes. Bayesian network modeling reveals sleep architecture depends on time of day, total sleep time, age and sex, but not BMI. Older adults, and particularly males, have shorter bouts (more fragmentation) of Stage 2, SWS, and they transition less frequently to these stages. Additionally, we showed that the next sleep stage and its duration can be optimally predicted by the prior 2 stages and age. Our results demonstrate the potential benefit of big data and Bayesian network approaches in quantifying static and dynamic architecture of normal sleep.	[Yetton, Benjamin D.; Cellini, Nicola; Mednick, Sara C.] Univ Calif Irvine, Dept Psychol, Irvine, CA 92697 USA; [McDevitt, Elizabeth A.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Cellini, Nicola] Univ Padua, Dept Gen Psychol, Padua, Italy; [Shelton, Christian] Univ Calif Riverside, Dept Comp Sci, Riverside, CA 92521 USA	University of California System; University of California Irvine; Princeton University; University of Padua; University of California System; University of California Riverside	Mednick, SC (corresponding author), Univ Calif Irvine, Dept Psychol, Irvine, CA 92697 USA.	mednicks@uci.edu	Cellini, Nicola/AAB-3926-2019; Shelton, Christian/GQJ-1146-2022	Cellini, Nicola/0000-0003-0306-4408; Shelton, Christian/0000-0001-6698-7838; Yetton, Benjamin/0000-0001-7729-9723; McDevitt, Elizabeth/0000-0001-9112-3775	National Science Foundation [GRFP2015211602, IIS 1510741]; NIH [R01AG046646]	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A National Science Foundation Graduate Research Fellowship Program (https://www.nsfgrfp.org/) supported Ben Yetton (Fellow Number GRFP2015211602). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. For Sara Mednick's R01AG046646 (https://grants.nih.gov/grants/funding/r01.htm) NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Christian Shelton was supported by the National Science Foundation, IIS 1510741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann P, 1999, WIEN MED WOCHENSCHR, V145, P402; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; American Academy of Sleep Medicine, 2005, INT CLASS SLEEP DIS; Baker FC, 2015, PSYCHONEUROENDOCRINO, V60, P96, DOI 10.1016/j.psyneuen.2015.06.005; Berry RB, 2012, AASM MANUAL SCORING; BETTS TA, 1985, EUR J CLIN PHARMACOL, V28, P65, DOI 10.1007/BF00543712; Bianchi MT, 2012, J SLEEP RES, V21, P330, DOI 10.1111/j.1365-2869.2011.00937.x; Bianchi MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011356; BIRKELAND AJ, 1982, NEUROENDOCRINOLOGY, V34, P126, DOI 10.1159/000123289; Bizzotto R, 2010, J PHARMACOKINET PHAR, V37, P137, DOI 10.1007/s10928-009-9148-2; Blackwell T, 2011, J AM GERIATR SOC, V59, P2217, DOI 10.1111/j.1532-5415.2011.03731.x; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Borbely A.A, 1982, HUM NEUROBIOL; Buckelmuller J, 2006, NEUROSCIENCE, V138, P351, DOI 10.1016/j.neuroscience.2005.11.005; Carskadon MA, 2005, PRINCIPLES PRACTICE, P13, DOI DOI 10.1016/B0-72-160797-7/50009-4; Cellini N, 2014, NEUROBIOL LEARN MEM, V114, P141, DOI 10.1016/j.nlm.2014.06.006; Chu-Shore J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014204; Cohen-Zion M, 2009, ADDICT BEHAV, V34, P976, DOI 10.1016/j.addbeh.2009.05.011; COOPER GF, 1992, MACH LEARN, V9, P309, DOI 10.1007/BF00994110; Coyne KS, 2003, BJU INT, V92, P948, DOI 10.1111/j.1464-410X.2003.04527.x; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Alvares LD, 2013, NEUROSCIENCE, V244, P42, DOI 10.1016/j.neuroscience.2013.04.005; Dean DA, 2016, SLEEP, V39, P1151, DOI 10.5665/sleep.5774; Diekelmann S, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00074; Diekelmann S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077621; Diekelmann S, 2011, NEUROFORUM, V17, P74; Diekelmann S, 2013, SLEEP, V36, P149, DOI 10.5665/sleep.2322; Diekelmann S, 2012, NEUROBIOL LEARN MEM, V98, P103, DOI 10.1016/j.nlm.2012.07.002; Diekelmann S, 2010, BEHAV BRAIN RES, V208, P425, DOI 10.1016/j.bbr.2009.12.021; Drake C, 2013, J CLIN SLEEP MED, V9, P1195, DOI 10.5664/jcsm.3170; Drake CL, 2003, DEPRESS ANXIETY, V18, P163, DOI 10.1002/da.10151; EHLERS CL, 1989, ELECTROEN CLIN NEURO, V72, P118, DOI 10.1016/0013-4694(89)90172-7; El-Ad B, 2005, INT REV PSYCHIATR, V17, P277, DOI 10.1080/09540260500104508; Ferrillo F, 2007, SLEEP, V30, P157, DOI 10.1093/sleep/30.2.157; Fischer S, 2011, J SLEEP RES, V20, P267, DOI 10.1111/j.1365-2869.2010.00881.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; HEATH AC, 1990, SLEEP, V13, P318, DOI 10.1093/sleep/13.4.318; Hibbs AM, 2014, BEHAV SLEEP MED, V12, P412, DOI 10.1080/15402002.2013.825838; Hoffman MD, 2014, J MACH LEARN RES, V15, P1593; Iber C., 2007, AASM MANUAL SCORING; Kemp B, 2000, IEEE T BIO-MED ENG, V47, P1185, DOI 10.1109/10.867928; KEMP B, 1986, SLEEP, V9, P405, DOI 10.1093/sleep/9.3.405; Kishi A, 2008, AM J PHYSIOL-REG I, V294, pR1980, DOI 10.1152/ajpregu.00925.2007; Kishi A, 2011, SLEEP, V34, P1423, DOI 10.5665/SLEEP.1292; Kjellsson MC, 2011, PHARM RES-DORDR, V28, P2610, DOI 10.1007/s11095-011-0490-x; Ko PRT, 2015, J CLIN SLEEP MED, V11, P1455, DOI 10.5664/jcsm.5288; Kupfer DJ, 1981, ELECTRONEUROPHYSIOLO, P87; Landolt HP, 1996, BRAIN RES, V738, P205, DOI 10.1016/S0006-8993(96)00770-6; Latta F, 2005, SLEEP, V28, P1519, DOI 10.1093/sleep/28.12.1519; Lo CC, 2004, P NATL ACAD SCI USA, V101, P17545, DOI 10.1073/pnas.0408242101; Lo CC, 2002, EUROPHYS LETT, V57, P625, DOI 10.1209/epl/i2002-00508-7; Mander BA, 2017, NEURON, V94, P19, DOI 10.1016/j.neuron.2017.02.004; Mander BA, 2016, TRENDS NEUROSCI, V39, P552, DOI 10.1016/j.tins.2016.05.002; McArdle N, 2001, AM J RESP CRIT CARE, V164, P1459, DOI 10.1164/ajrccm.164.8.2008146; McClelland GH, 2015, J CONSUM PSYCHOL, V25, P679, DOI 10.1016/j.jcps.2015.05.006; Mednick SC, 2006, TAKE NAP CHANGE YOUR; Minakawa EN, 2017, NEUROSCI LETT, V653, P362, DOI 10.1016/j.neulet.2017.05.054; MOFFITT PF, 1991, J INTERN MED, V230, P245, DOI 10.1111/j.1365-2796.1991.tb00438.x; Mong JA, 2011, J NEUROSCI, V31, P16107, DOI 10.1523/JNEUROSCI.4175-11.2011; Moser D, 2009, SLEEP, V32, P139, DOI 10.1093/sleep/32.2.139; Murphy K., 2001, COMPUTING SCI STAT, V33, P1024; Nettersheim A, 2015, J NEUROSCI, V35, P6696, DOI 10.1523/JNEUROSCI.1236-14.2015; Novelli L, 2010, J SLEEP RES, V19, P238, DOI 10.1111/j.1365-2869.2009.00785.x; O'Reilly C, 2014, J SLEEP RES, V23, P628, DOI 10.1111/jsr.12169; Ohayon MM, 2003, SLEEP, V31, P20; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; PEARL J., 1988, PROBABILISTIC REASON, DOI 10.1016/B978-0-08-051489-5.50008-4; Quan SF, 1997, SLEEP, V20, P1077; Rao MN, 2009, SLEEP, V32, P483, DOI 10.1093/sleep/32.4.483; Rechtschaffen K, 1968, MANUAL STANDARDIZED; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Redline S, 1999, AM J RESP CRIT CARE, V159, P1527, DOI 10.1164/ajrccm.159.5.9809079; Redline S, 1998, SLEEP, V21, P759; Redline S, 2004, ARCH INTERN MED, V164, P406, DOI 10.1001/archinte.164.4.406; Resnick HE, 2003, DIABETES CARE, V26, P702, DOI 10.2337/diacare.26.3.702; Rosen CL, 2003, J PEDIATR-US, V142, P383, DOI 10.1067/mpd.2003.28; SACK RL, 1986, J PINEAL RES, V3, P379, DOI 10.1111/j.1600-079X.1986.tb00760.x; Salvatier J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.55; Sattari N, NEUROBIOL LEARN MEM, DOI [10.1523/JNEUROSCI.4175-11.2011, DOI 10.1523/JNEUROSCI.4175-11.2011]; Schlemmer A, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0093; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seibold M, 2017, MEMORY, P1; Serra J., 1982, IMAGE ANAL MATH MORP, pChap11; Spilsbury JC, 2005, SLEEP, V28, P1419, DOI 10.1093/sleep/28.11.1419; Spira AP, 2008, J AM GERIATR SOC, V56, P45, DOI 10.1111/j.1532-5415.2007.01506.x; Suh M, 2014, J CARDIOVASC NURS, V29, pE10, DOI 10.1097/JCN.0b013e318291ee43; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Terzano MG, 2002, SLEEP MED, V3, P187, DOI 10.1016/S1389-9457(02)00003-5; The MathWorks Inc, 2015, MATLAB, VR2015a; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wamsley EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165141; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; Wei Y, 2017, SLEEP, V40, P5; Wei Y, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx117; Whitehurst LN, 2016, P NATL ACAD SCI USA, DOI [10.1073/pnas.2016, DOI 10.1073/PNAS.2016]; Wilson S, 2012, BRIT J PSYCHIAT, V200, P273, DOI 10.1192/bjp.bp.111.104091; Young T, 2003, SLEEP, V26, P667, DOI 10.1093/sleep/26.6.667; Zhang L, 2006, AM J EPIDEMIOL, V164, P529, DOI 10.1093/aje/kwj231	100	25	27	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194604	10.1371/journal.pone.0194604	http://dx.doi.org/10.1371/journal.pone.0194604			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641599	gold, Green Published			2022-12-26	WOS:000429742900038
J	Yooyangket, T; Muangpat, P; Polseela, R; Tandhavanant, S; Thanwisai, A; Vitta, A				Yooyangket, Temsiri; Muangpat, Paramaporn; Polseela, Raxsina; Tandhavanant, Sarunporn; Thanwisai, Aunchalee; Vitta, Apichat			Identification of entomopathogenic nematodes and symbiotic bacteria from Nam Nao National Park in Thailand and larvicidal activity of symbiotic bacteria against Aedes aegypti and Aedes albopictus	PLOS ONE			English	Article							SP N.; PHOTORHABDUS-LUMINESCENS; DIPTERA-CULICIDAE; SOIL-TEMPERATURE; XENORHABDUS; STEINERNEMATIDAE; RHABDITIDA; MOISTURE; GROWTH; SEQUENCES	Entomopathogenic nematodes (EPNs) that are symbiotically associated with Xenorhabdus and Photorhabdus bacteria can kill target insects via direct infection and toxin action. There are limited reports identifying such organisms in the National Park of Thailand. Therefore, the objectives of this study were to identify EPNs and symbiotic bacteria from Nam Nao National Park, Phetchabun Province, Thailand and to evaluate the larvicidal activity of bacteria against Aedes aegypti and Ae. albopictus. A total of 12 EPN isolates belonging to Steinernema and Heterorhabditis were obtained form 940 soil samples between February 2014 and July 2016. EPNs were molecularly identified as S. websteri (10 isolates) and H. baujardi (2 isolates). Symbiotic bacteria were isolated from EPNs and molecularly identified as P. luminescens subsp. akhurstii (13 isolates), X. stockiae (11 isolates), X. vietnamensis (2 isolates) and X. japonica (1 isolate). For the bioassay, bacterial suspensions were evaluated for toxicity against third to early fourth instar larvae of Aedes spp. The larvae of both Aedes species were orally susceptible to symbiotic bacteria. The highest larval mortality of Ae. aegypti was 99% after exposure to X. stockiae (bNN112.3_TH) at 96 h, and the highest mortality of Ae. albopictus was 98% after exposure to P. luminescens subsp. akhurstii (bNN121.4_TH) at 96 h. In contrast to the control groups (Escherichia coli and distilled water), the mortality rate of both mosquito larvae ranged between 0 and 7% at 72 h. Here, we report the first observation of X. vietnamensis in Thailand. Additionally, we report the first observation of P. luminescens subsp. akhurstii associated with H. baujardi in Thailand. X. stockiae has potential to be a biocontrol agent for mosquitoes. This investigation provides a survey of the basic diversity of EPNs and symbiotic bacteria in the National Park of Thailand, and it is a bacterial resource for further studies of bioactive compounds.	[Yooyangket, Temsiri; Muangpat, Paramaporn; Polseela, Raxsina; Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand; [Polseela, Raxsina; Thanwisai, Aunchalee; Vitta, Apichat] Naresuan Univ, Fac Med Sci, CEMB, Phitsanulok, Thailand; [Tandhavanant, Sarunporn] Mahidol Univ, Fac Trop Med, Dept Microbiol & Immunol, Bangkok, Thailand	Naresuan University; Naresuan University; Mahidol University	Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, Dept Microbiol & Parasitol, Phitsanulok, Thailand.; Vitta, A (corresponding author), Naresuan Univ, Fac Med Sci, CEMB, Phitsanulok, Thailand.	apichatv@nu.ac.th	Vitta, Apichat/HHZ-5460-2022; Tandhavanant, Sarunporn/Q-7376-2019; Tandhavanant, Sarunporn/R-7620-2019	Vitta, Apichat/0000-0002-2483-0100; Tandhavanant, Sarunporn/0000-0003-0261-3233; Tandhavanant, Sarunporn/0000-0003-0261-3233	Naresuan University [R25586073]	Naresuan University	This work was supported by Naresuan University (Grant Number R25586073) to AV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate BA, 2016, NEMATOLOGY, V18, P235, DOI 10.1163/15685411-00002956; Ahantarig A, 2009, APPL ENVIRON MICROB, V75, P4627, DOI 10.1128/AEM.00221-09; BEDDING RA, 1975, NEMATOLOGICA, V21, P109, DOI 10.1163/187529275X00419; Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; BOEMARE NE, 1993, INT J SYST BACTERIOL, V43, P249, DOI 10.1099/00207713-43-2-249; Cimen H, 2015, J HELMINTHOL, V89, P415, DOI 10.1017/S0022149X14000182; Cimen H, 2014, ZOOTAXA, V3821, P337, DOI 10.11646/zootaxa.3821.3.3; Cimen H, 2016, J NEMATOL, V48, P148; Cimen H, 2016, NEMATOLOGY, V18, P439, DOI 10.1163/15685411-00002968; da Silva JJ, 2007, REV SOC BRAS MED TRO, V40, P612, DOI 10.1590/S0037-86822007000600002; da Silva OS, 2013, PARASITOL RES, V112, P2891, DOI 10.1007/s00436-013-3460-x; de Brida AL, 2017, SCI REP-UK, V7, DOI 10.1038/srep45254; Dillman AR, 2012, P NATL ACAD SCI USA, V109, pE2324, DOI 10.1073/pnas.1211436109; DUNPHY GB, 1984, J INSECT PHYSIOL, V30, P883, DOI 10.1016/0022-1910(84)90063-5; Eom S, 2014, J MICROBIOL, V52, P161, DOI 10.1007/s12275-014-3251-9; ffrench-Constant RH, 2007, TOXICON, V49, P436, DOI 10.1016/j.toxicon.2006.11.019; Forst S, 1997, ANNU REV MICROBIOL, V51, P47, DOI 10.1146/annurev.micro.51.1.47; Forst S, 1996, MICROBIOL REV, V60, P21, DOI 10.1128/MMBR.60.1.21-43.1996; Fukruksa C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2383-2; Glaeser SP, 2016, INT J SYST EVOL MICR, V67, P1046; Grant JA, 2003, ENVIRON ENTOMOL, V32, P80, DOI 10.1603/0046-225X-32.1.80; Grundmann F, 2014, J NAT PROD, V77, P779, DOI 10.1021/np4007525; Hominick WM, 1997, J HELMINTHOL, V71, P271, DOI 10.1017/S0022149X00016096; Jallouli W, 2010, PROCESS BIOCHEM, V45, P706, DOI 10.1016/j.procbio.2010.01.007; KAYA HK, 1993, ANNU REV ENTOMOL, V38, P181, DOI 10.1146/annurev.en.38.010193.001145; Phan KL, 2014, NEMATOLOGY, V16, P761, DOI 10.1163/15685411-00002806; Ke LP, 2001, RUSS J NEMATOL, V9, P1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; KUNG SP, 1991, J INVERTEBR PATHOL, V57, P242, DOI 10.1016/0022-2011(91)90123-8; Lee MM, 2010, J INVERTEBR PATHOL, V104, P67, DOI 10.1016/j.jip.2010.01.005; Lemine AMM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-1978-y; Li Xing-Yue, 2012, Zootaxa, V3569, P25; Lucia A, 2009, PARASITOL RES, V104, P1101, DOI 10.1007/s00436-008-1294-8; Malan AP, 2014, J HELMINTHOL, V88, P139, DOI 10.1017/S0022149X12000806; Maneesakorn P, 2015, INT J NEMATOL; Maneesakorn P, 2010, J NEMATOL, V42, P281; Maneesakorn P, 2011, MOL PHYLOGENET EVOL, V59, P271, DOI 10.1016/j.ympev.2011.02.012; MERRITT RW, 1992, ANNU REV ENTOMOL, V37, P349, DOI 10.1146/annurev.en.37.010192.002025; MOLYNEUX AS, 1986, EXP PARASITOL, V62, P169, DOI 10.1016/0014-4894(86)90021-4; Mratek Z, 2009, CHINA J INVERTEBR PA, V102, P69, DOI [10.1016/j.jip.2009.05.006, DOI 10.1016/J.JIP.2009.05.006]; Muangpat P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01142; Namsena P., 2016, BIORESOUR BIOPROCESS, V3, P19, DOI [10.1186/s40643-016-0097-5, DOI 10.1186/S40643-016-0097-5]; Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9; Nikdel M., 2011, Nematologia Mediterranea, V39, P17; Nthenga I, 2014, NEMATOLOGY, V16, P475, DOI 10.1163/15685411-00002780; Park Y, 2000, J INSECT PHYSIOL, V46, P1469, DOI 10.1016/S0022-1910(00)00071-8; Park Y, 2016, J ECON ENTOMOL, V109; Park Y, 2015, J ASIA-PAC ENTOMOL, V18, P459, DOI 10.1016/j.aspen.2015.05.002; Puza V, 2017, J HELMINTHOL, V91, P20, DOI 10.1017/S0022149X15001157; Rodou A, 2010, TOXINS, V2, P1250, DOI 10.3390/toxins2061250; Rohde C, 2010, NEOTROP ENTOMOL, V39, P608, DOI 10.1590/S1519-566X2010000400022; da Silva JLR, 2017, J ECON ENTOMOL, V110, P378, DOI 10.1093/jee/tow224; Salokhe SG, 2012, PARASITOL RES, V111, P1325, DOI 10.1007/s00436-012-2968-9; Stock SP, 1998, SYST PARASITOL, V41, P105, DOI 10.1023/A:1006087017195; Stock SP, 2001, J PARASITOL, V87, P877, DOI 10.2307/3285148; Tailliez P, 2006, INT J SYST EVOL MICR, V56, P2805, DOI 10.1099/ijs.0.64287-0; Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0; Tangchitsomkid Nuchanart, 1998, Kasetsart Journal Natural Sciences, V32, P347; Thanwisai A, 2012, THESIS; Thanwisai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043835; Villabona-Arenas CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062649; Vitta A, 2017, SE ASIAN J TROP MED, V48, P18; Vitta A, 2015, SE ASIAN J TROP MED, V46, P564; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a; World Health Organization, 2016, ZIK VIR; Yadav Arun K., 2012, Journal of Parasitic Diseases, V36, P175, DOI 10.1007/s12639-012-0099-y	68	30	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195681	10.1371/journal.pone.0195681	http://dx.doi.org/10.1371/journal.pone.0195681			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641570	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900085
J	Yang, H; Xu, M; Lu, F; Zhang, QN; Feng, YQ; Yang, CS; Li, N; Jia, XD				Yang, Hui; Xu, Miao; Lu, Fang; Zhang, Qiannan; Feng, Yongquan; Yang, Chung S.; Li, Ning; Jia, Xudong			Tocopherols inhibit esophageal carcinogenesis through attenuating NF-kappa B activation and CXCR3-mediated inflammation	ONCOGENE			English	Article							NUTRITION INTERVENTION TRIALS; VITAMIN-E; GAMMA-TOCOPHEROL; CANCER PREVENTION; PROSTATE-CANCER; COLON CARCINOGENESIS; ALPHA-TOCOPHEROL; DELTA-TOCOPHEROL; SELENIUM; PROMOTES	Esophageal cancer is one of the common causes of cancer mortality in the world. The predominant histological subtype, esophageal squamous cell carcinoma (ESCC), often results in poor prognosis due to the lack of effective approaches for the early diagnosis and treatment, highlighting the need for preventive intervention against this disease. Here we report that dietary tocopherols significantly prevents esophageal carcinogenesis by inhibiting the activation of NF-kappa B and the subsequent interaction of chemokine CXCL9/10/11 with their receptor CXCR3 in ESCC induced by N-nitrosomethylbenzylamine (NMBA) in murine models. Dietary supplementation with 0.15% alpha-tocopherol (alpha-T), d-tocopherol (delta-T), or gamma-tocopherol rich mixture (gamma-TmT) markedly suppressed the production of pro-inflammatory cytokines, as well as the induction of CXCR3+ effector T cells (CD4+ Th1 and CD8+ CTLs) infiltration, especially at the early stage of carcinogenesis. In experiments in vivo and in vitro, these events were tightly correlated with the blockade of NF-kappa B activation. Our results show that tocopherols decrease carcinogenesis through inhibiting NF-kappa B and CXCR3 signaling, as well as related inflammation in early premalignant lesions. This pathway may offer a novel target for chemoprevention of esophageal cancer.	[Yang, Hui; Zhang, Qiannan; Feng, Yongquan; Li, Ning; Jia, Xudong] Natl Ctr Food Safety Risk Assessment, Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China; [Xu, Miao] Sichuan Univ, West China Sch Publ Hlth, Chengdu, Sichuan, Peoples R China; [Lu, Fang] Beijing Agr Univ, Beijing, Peoples R China; [Yang, Chung S.] Rutgers State Univ, Ernest Mario Sch Pharm, Dept Biol Chem, Piscataway, NJ USA	Sichuan University; Beijing University of Agriculture; Rutgers State University New Brunswick	Yang, H; Jia, XD (corresponding author), Natl Ctr Food Safety Risk Assessment, Minist Hlth, Key Lab Food Safety Risk Assessment, Beijing, Peoples R China.	yanghui@cfsa.net.cn; jiaxudong@cfsa.net.cn	Yang, Hui/AAK-8492-2020	Yang, Hui/0000-0002-6025-338X	National Natural Science Foundation of China [81402679]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant from the National Natural Science Foundation of China (no. 81402679).	Arnold M, 2015, GUT, V64, P381, DOI 10.1136/gutjnl-2014-308124; Bak MJ, 2017, CANCER PREV RES, V10, P188, DOI [10.1158/1940-6207.capr-16-0223, 10.1158/1940-6207.CAPR-16-0223]; Billottet C, 2013, BBA-REV CANCER, V1836, P287, DOI 10.1016/j.bbcan.2013.08.002; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Chen JX, 2017, MOL CARCINOGEN, V56, P172, DOI 10.1002/mc.22481; Chen JX, 2016, CANCER LETT, V371, P71, DOI 10.1016/j.canlet.2015.11.010; Clark-Lewis I, 2003, J BIOL CHEM, V278, P289, DOI 10.1074/jbc.M209470200; Das Gupta S, 2015, CANCER PREV RES, V8, P807, DOI 10.1158/1940-6207.CAPR-15-0154; Dietrich M, 2006, J AM COLL NUTR, V25, P292, DOI 10.1080/07315724.2006.10719538; Eitenmiller T, 2004, VITAMIN E FOOD CHEM; Fong LYY, 1999, CANCER LETT, V143, P63, DOI 10.1016/S0304-3835(99)00191-3; Gaziano JM, 2009, JAMA-J AM MED ASSOC, V301, P52, DOI 10.1001/jama.2008.862; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Groom JR, 2011, EXP CELL RES, V317, P620, DOI 10.1016/j.yexcr.2010.12.017; Guan F, 2012, CANCER PREV RES, V5, P644, DOI 10.1158/1940-6207.CAPR-11-0521; Hannelien V, 2012, BBA-REV CANCER, V1825, P117, DOI 10.1016/j.bbcan.2011.10.008; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; HSIEH CS, 1993, SCIENCE, V260, P547, DOI 10.1126/science.8097338; IARC, 2012, SECT CANC INF; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Lee IM, 2005, JAMA-J AM MED ASSOC, V294, P56, DOI 10.1001/jama.294.1.56; Lee JH, 2012, CANCER RES, V72, P3175, DOI 10.1158/0008-5472.CAN-12-0481; Li GX, 2011, CANCER PREV RES, V4, P404, DOI 10.1158/1940-6207.CAPR-10-0130; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lunardi S, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1027473; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Malyak M, 1998, J IMMUNOL, V161, P1997; Malyak M, 1998, J IMMUNOL, V161, P2004; Maresso KC, 2015, CA-CANCER J CLIN, V65, P345, DOI 10.3322/caac.21287; Mark SD, 2000, J NATL CANCER I, V92, P1753, DOI 10.1093/jnci/92.21.1753; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Mulligan AM, 2013, CLIN CANCER RES, V19, P336, DOI 10.1158/1078-0432.CCR-11-3314; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Perez S, 2017, FREE RADICAL BIO MED, V104, P75, DOI 10.1016/j.freeradbiomed.2016.12.048; Qiao YL, 2009, JNCI-J NATL CANCER I, V101, P507, DOI 10.1093/jnci/djp037; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Sayin VI, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007653; Smolarek AK, 2012, CANCER PREV RES, V5, P1310, DOI 10.1158/1940-6207.CAPR-12-0263; Stoner GD, 2006, NUTR CANCER, V54, P33, DOI 10.1207/s15327914nc5401_5; Taylor PR, 2003, J NATL CANCER I, V95, P1414, DOI 10.1093/jnci/djg044; TAYLOR PR, 1994, CANCER RES, V54, pS2029; TRABER MG, 1989, AM J CLIN NUTR, V49, P517, DOI 10.1093/ajcn/49.3.517; Wang H, 2016, MOL CARCINOGEN, V55, P1728, DOI 10.1002/mc.22422; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Yang CS, 2016, MOL NUTR FOOD RES, V60, P1239, DOI 10.1002/mnfr.201500766; Yang CS, 2012, CANCER PREV RES, V5, P701, DOI 10.1158/1940-6207.CAPR-12-0045; Yang H, 2012, INT J CANCER, V131, P1517, DOI 10.1002/ijc.27423; Yang H, 2011, CARCINOGENESIS, V32, P381, DOI 10.1093/carcin/bgq279; Zhou HF, 2016, BIOMED PHARMACOTHER, V82, P479, DOI 10.1016/j.biopha.2016.04.069; Zipin-Roitman A, 2007, CANCER RES, V67, P3396, DOI 10.1158/0008-5472.CAN-06-3087	53	13	13	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 19	2018	37	29					3909	3923		10.1038/s41388-018-0246-8	http://dx.doi.org/10.1038/s41388-018-0246-8			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GN5LP	29662196				2022-12-26	WOS:000439101300001
J	Maun, HR; Liu, PS; Franke, Y; Eigenbrot, C; Forrest, WF; Schwartz, LB; Lazarus, RA				Maun, Henry R.; Liu, Peter S.; Franke, Yvonne; Eigenbrot, Charles; Forrest, William F.; Schwartz, Lawrence B.; Lazarus, Robert A.			Dual functionality of -tryptase protomers as both proteases and cofactors in the active tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; enzyme mechanism; heparin-binding protein; protein engineering; protein-protein interaction; serine protease; tryptase; tetramerization	MAST-CELL TRYPTASE; HUMAN BETA-TRYPTASE; SPONTANEOUS INACTIVATION; SECRETORY GRANULES; ZYMOGEN ACTIVATION; CRYSTAL-STRUCTURE; TISSUE FACTOR; HEPARIN; CONVERSION; STREPTOKINASE	Human -tryptase, a tetrameric trypsin-like serine protease, is an important mediator of the allergic inflammatory responses in asthma. During acute hypersensitivity reactions, mast cells degranulate, releasing active tetramer as a complex with proteoglycans. Extensive efforts have focused on developing therapeutic -tryptase inhibitors, but its unique activation mechanism is less well-explored. Tryptase is active only after proteolytic removal of the pro-domain followed by tetramer formation via two distinct symmetry-related interfaces. We show that the cleaved I16G mutant cannot tetramerize, likely due to impaired insertion of its N terminus into its activation pocket, indicating allosteric linkage at multiple sites on each protomer. We engineered cysteines into each of the two distinct interfaces (Y75C for small or I99C for large) to assess the activity of each tetramer and disulfide-locked dimer. Using size-exclusion chromatography and enzymatic assays, we demonstrate that the two large tetramer interfaces regulate enzymatic activity, elucidating the importance of this protein-protein interaction for allosteric regulation. Notably, the I99C large interface dimer is active, even in the absence of heparin. We show that a monomeric -tryptase mutant (I99C*/Y75A/Y37bA, where C* is cysteinylated Cys-99) cannot form a dimer or tetramer, yet it is active but only in the presence of heparin. Thus heparin both stabilizes the tetramer and allosterically conditions the active site. We hypothesize that each -tryptase protomer in the tetramer has two distinct roles, acting both as a protease and as a cofactor for its neighboring protomer, to allosterically regulate enzymatic activity, providing a rationale for direct correlation of tetramer stability with proteolytic activity.	[Maun, Henry R.; Lazarus, Robert A.] Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA; [Liu, Peter S.] Genentech Inc, Dept Microchem Prote & Lipid, San Francisco, CA 94080 USA; [Franke, Yvonne] Genentech Inc, Dept Biomol Resources, San Francisco, CA 94080 USA; [Eigenbrot, Charles] Genentech Inc, Dept Struct Biol, San Francisco, CA 94080 USA; [Forrest, William F.] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA 94080 USA; [Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Div Rheumatol Allergy & Immunol, Richmond, VA 23298 USA	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Virginia Commonwealth University	Lazarus, RA (corresponding author), Genentech Inc, Dept Early Discovery Biochem, 1 DNA Way, San Francisco, CA 94080 USA.	lazarus.bob@gene.com			United States Department of Energy, Office of Science, and Office of Basic Energy Sciences [DE-AC02-06CH11357]	United States Department of Energy, Office of Science, and Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Christine Tam for cloning expression constructs and Kyle Mortara and the Biomolecular Resources Department for expression of beta-tryptase in insect cells. We thank Daniel Kirchhofer and Terry Lipari for very helpful discussions and reagents. We thank Wendy Sandoval, Lawren Wu, and Tangsheng Yi for their support. We thank Jeff Holden for steered molecular dynamic simulations. We acknowledge the Antibody Production Group and Mark Ultsch for producing B12 IgG and Fab proteins. We thank Ping Wu for harvesting protein crystals and John J. Chrzas for data collection at the Advanced Photon Source. Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, and Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. Data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID beamline.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Addington AK, 1996, BIOCHEMISTRY-US, V35, P13511, DOI 10.1021/bi960042t; ALTER SC, 1987, BIOCHEM J, V248, P821, DOI 10.1042/bj2480821; ALTER SC, 1990, ARCH BIOCHEM BIOPHYS, V276, P26, DOI 10.1016/0003-9861(90)90005-J; Baici A., 2015, KINETICS ENZYME MODI; Banner DW, 1996, NATURE, V380, P41, DOI 10.1038/380041a0; BOTTS J, 1953, T FARADAY SOC, V49, P696, DOI 10.1039/tf9534900696; Boxrud PD, 2001, J BIOL CHEM, V276, P26084, DOI 10.1074/jbc.M101966200; Caughey GH, 2007, IMMUNOL REV, V217, P141, DOI 10.1111/j.1600-065X.2007.00509.x; Caughey GH, 2016, EUR J PHARMACOL, V778, P44, DOI 10.1016/j.ejphar.2015.04.045; Changeux JP, 2012, ANNU REV BIOPHYS, V41, P103, DOI 10.1146/annurev-biophys-050511-102222; Copeland RA., 2000, ENZYMES PRACTICAL IN, P137; Corvera CU, 1997, J CLIN INVEST, V100, P1383, DOI 10.1172/JCI119658; DAVIE EW, 1995, THROMB HAEMOSTASIS, V74, P1; DiCera E, 1996, BIOPHYS J, V70, P174, DOI 10.1016/S0006-3495(96)79558-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fajardo I, 2003, BIOCHEM J, V369, P603, DOI 10.1042/BJ20021418; Fukuoka Y, 2004, BIOCHEMISTRY-US, V43, P10757, DOI 10.1021/bi049486c; Fukuoka Y, 2007, INT IMMUNOPHARMACOL, V7, P1900, DOI 10.1016/j.intimp.2007.07.007; Fukuoka Y, 2006, J IMMUNOL, V176, P3165, DOI 10.4049/jimmunol.176.5.3165; GRUBER BL, 1989, J CLIN INVEST, V84, P1657, DOI 10.1172/JCI114344; Hallgren J, 2006, FEBS J, V273, P1871, DOI 10.1111/j.1742-4658.2006.05211.x; Hallgren J, 2004, J IMMUNOL, V173, P1868, DOI 10.4049/jimmunol.173.3.1868; Harris JL, 2001, J BIOL CHEM, V276, P34941, DOI 10.1074/jbc.M102997200; Hedstrom L, 1996, BIOCHEMISTRY-US, V35, P4515, DOI 10.1021/bi951928k; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Henzel WJ, 2003, J AM SOC MASS SPECTR, V14, P931, DOI 10.1016/S1044-0305(03)00214-9; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Khan AR, 1998, PROTEIN SCI, V7, P815; MAIER M, 1983, J IMMUNOL, V130, P2352; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath ME, 2006, BIOCHEMISTRY-US, V45, P5964, DOI 10.1021/bi060173m; McNeil HP, 2007, J BIOL CHEM, V282, P20785, DOI 10.1074/jbc.R700017200; Merdanovic M, 2013, ACS CHEM BIOL, V8, P19, DOI 10.1021/cb3005935; Molino M, 1997, J BIOL CHEM, V272, P4043, DOI 10.1074/jbc.272.7.4043; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mulloy B, 2017, GLYCOCONJUGATE J, V34, P351, DOI 10.1007/s10719-016-9749-0; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; NEMERSON Y, 1988, BLOOD, V71, P1; Paesen GC, 2007, J MOL BIOL, V368, P1172, DOI 10.1016/j.jmb.2007.03.011; Pereira PJB, 1998, NATURE, V392, P306, DOI 10.1038/32703; Pohlig G, 1996, EUR J BIOCHEM, V241, P619, DOI 10.1111/j.1432-1033.1996.00619.x; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; Reimer JM, 2010, IMMUNOGENETICS, V62, P369, DOI 10.1007/s00251-010-0443-2; Ren SL, 1998, J IMMUNOL, V160, P4561; Rivera J, 2008, ADV IMMUNOL, V98, P85, DOI 10.1016/S0065-2776(08)00403-3; Ronnberg E, 2012, J HISTOCHEM CYTOCHEM, V60, P950, DOI 10.1369/0022155412458927; Sakai K, 1996, J CLIN INVEST, V97, P988, DOI 10.1172/JCI118523; SCHECHTER NM, 1995, BIOCHEMISTRY-US, V34, P10628, DOI 10.1021/bi00033a038; SCHECHTER NM, 1993, BIOCHEMISTRY-US, V32, P2617, DOI 10.1021/bi00061a020; Schechter NM, 2007, BIOCHEMISTRY-US, V46, P9615, DOI 10.1021/bi7004625; Schiemann F, 2009, J IMMUNOL, V183, P2223, DOI 10.4049/jimmunol.0803587; SCHWARTZ LB, 1981, J IMMUNOL, V126, P1290; SCHWARTZ LB, 1985, J IMMUNOL, V135, P2762; SCHWARTZ LB, 1986, J BIOL CHEM, V261, P7372; SCHWARTZ LB, 1981, J BIOL CHEM, V256, P1939; SCHWARTZ LB, 1994, J CLIN IMMUNOL, V14, P190, DOI 10.1007/BF01533368; SCHWARTZ LB, 1990, J IMMUNOL, V144, P2304; Selwood T, 1998, BIOCHEMISTRY-US, V37, P13174, DOI 10.1021/bi980780c; Sommerhoff CP, 1999, P NATL ACAD SCI USA, V96, P10984, DOI 10.1073/pnas.96.20.10984; SOMMERHOFF CP, 1994, BIOL CHEM H-S, V375, P685, DOI 10.1515/bchm3.1994.375.10.685; STACK MS, 1994, J BIOL CHEM, V269, P9416; Stevens RL, 2007, IMMUNOL REV, V217, P155, DOI 10.1111/j.1600-065X.2007.00525.x; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; WANG DC, 1985, J MOL BIOL, V185, P595, DOI 10.1016/0022-2836(85)90074-9; Wang SG, 1999, BIOCHEMISTRY-US, V38, P5232, DOI 10.1021/bi981915h; Wang SG, 2000, EUR J BIOCHEM, V267, P3994, DOI 10.1046/j.1432-1327.2000.01434.x; Wang Y, 2015, MOL BIOSYST, V11, P252, DOI 10.1039/c4mb00381k; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	73	9	10	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 22	2018	293	25					9614	9628		10.1074/jbc.M117.812016	http://dx.doi.org/10.1074/jbc.M117.812016			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GK4CN	29661938	Green Published, hybrid			2022-12-26	WOS:000436102300006
J	David, DJ; Pagliuso, A; Radoshevich, L; Nahori, MA; Cossart, P				David, Daryl Jason; Pagliuso, Alessandro; Radoshevich, Lilliana; Nahori, Marie-Anne; Cossart, Pascale			Lmo1656 is a secreted virulence factor of Listeria monocytogenes that interacts with the sorting nexin 6-BAR complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						infection; host-pathogen interaction; virulence factor; sorting nexin (SNX); bacterial pathogenesis; host-pathogen interaction; Listeria monocytogenes; Lmo1656; sorting nexin 6; virulence factor	SALMONELLA-CONTAINING VACUOLE; TO-CELL SPREAD; INFECTION; RETROMER; MATURATION; PROTEINS; CLATHRIN; ENTERICA; NETWORK; TARGET	Listeria monocytogenes (Lm) is a facultative intracellular bacterial pathogen and the causative agent of listeriosis, a rare but fatal disease. During infection, Lm can traverse several physiological barriers; it can cross the intestine and placenta barrier and, in immunocompromised individuals, the blood-brain barrier. With the recent plethora of sequenced genomes available for Lm, it is clear that the complete repertoire of genes used by Lm to interact with its host remains to be fully explored. Recently, we focused on secreted Lm proteins because they are likely to interact with host cell components. Here, we investigated a putatively secreted protein of Lm, Lmo1656, that is present in most sequenced strains of Lm but absent in the nonpathogenic species Listeria innocua. lmo1656 gene is predicted to encode a small, positively charged protein. We show that Lmo1656 is secreted by Lm. Furthermore, deletion of the lmo1656 gene (lmo1656) attenuates virulence in mice infected orally but not intravenously, suggesting that Lmo1656 plays a role during oral listeriosis. We identified sorting nexin 6 (SNX6), an endosomal sorting component and BAR domain-containing protein, as a host cell interactor of Lmol656. SNX6 colocalizes with WT Lm during the early steps of infection. This colocalization depends on Lmo1656, and RNAi of SNX6 impairs infection in infected tissue culture cells, suggesting that SNX6 is utilized by Lm during infection. Our results reveal that Lmo1656 is a novel secreted virulence factor of Lm that facilitates recruitment of a specific member of the sorting nexin family in the mammalian host.	[David, Daryl Jason; Pagliuso, Alessandro; Radoshevich, Lilliana; Nahori, Marie-Anne; Cossart, Pascale] Inst Pasteur, Dept Cell Biol & Infect, Inst Natl Rech Agron,USC2020, INSERM,U604,Unite Interact Bacteries Cellules, 25 Rue Dr Roux, F-75015 Paris, France; [Radoshevich, Lilliana] Univ Iowa, Carver Coll Med, Dept Microbiol & Immunol, Iowa City, IA 52242 USA	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Iowa	Cossart, P (corresponding author), Inst Pasteur, Dept Cell Biol & Infect, Inst Natl Rech Agron,USC2020, INSERM,U604,Unite Interact Bacteries Cellules, 25 Rue Dr Roux, F-75015 Paris, France.	pascale.cossart@pasteur.fr		Radoshevich, Lilliana/0000-0003-0294-9300; David, Daryl Jason Verzosa/0000-0002-9253-4805; Cossart, Pascale/0000-0001-8871-6780; Marie-Anne, Nahori/0000-0002-4066-4528	Institut Pasteur; INSERM [Unite 604]; Institut National de la Recherche Agronomique (INRA Unite Sous Contrat 2020); Universite Paris Diderot; Region Ile-de-France; Fondation Le Roch Les Mousquetaires; European Research Council Advanced Grant [670823]; European Molecular Biology Organization (EMBO) Long Term Fellowship [ALTF 140-2014]; European Commission/Marie Curie Actions EMBOCOFUND;  [GA-2012-600394]	Institut Pasteur(European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Institut National de la Recherche Agronomique (INRA Unite Sous Contrat 2020); Universite Paris Diderot; Region Ile-de-France(Region Ile-de-France); Fondation Le Roch Les Mousquetaires; European Research Council Advanced Grant(European Research Council (ERC)); European Molecular Biology Organization (EMBO) Long Term Fellowship; European Commission/Marie Curie Actions EMBOCOFUND; 	This work was supported in part by the Institut Pasteur, INSERM (Unite 604), Institut National de la Recherche Agronomique (INRA Unite Sous Contrat 2020), Universite Paris Diderot, grants from Region Ile-de-France, Fondation Le Roch Les Mousquetaires, and European Research Council Advanced Grant 670823 BacCellEpi (to P. C.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by European Molecular Biology Organization (EMBO) Long Term Fellowship ALTF 140-2014 and European Commission/Marie Curie Actions EMBOCOFUND2012 and GA-2012-600394.	Archambaud C, 2005, MOL MICROBIOL, V56, P383, DOI 10.1111/j.1365-2958.2005.04551.x; Archambaud C, 2012, P NATL ACAD SCI USA, V109, P16684, DOI 10.1073/pnas.1212809109; Balestrino D, 2010, APPL ENVIRON MICROB, V76, P3625, DOI 10.1128/AEM.02612-09; Becavin C, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00186-16; Becavin C, 2014, MBIO, V5, DOI 10.1128/mBio.00969-14; Braun V, 2010, CELL MICROBIOL, V12, P1352, DOI 10.1111/j.1462-5822.2010.01476.x; Bujny MV, 2008, J CELL SCI, V121, P2027, DOI 10.1242/jcs.018432; David Daryl J V, 2017, F1000Res, V6, DOI 10.12688/f1000research.11363.1; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; Disson O, 2008, NATURE, V455, P1114, DOI 10.1038/nature07303; Elwell CA, 2017, ELIFE, V6, DOI [10.7554/eLife.22709, 10.7554/e.Life.22709]; Gallon M, 2015, BIOCHEM SOC T, V43, P33, DOI 10.1042/BST20140290; Gouin E, 2010, P NATL ACAD SCI USA, V107, P17333, DOI 10.1073/pnas.1007765107; Hamon MA, 2012, TRENDS MICROBIOL, V20, P360, DOI 10.1016/j.tim.2012.04.006; Henry R, 2006, CELL MICROBIOL, V8, P107, DOI 10.1111/j.1462-5822.2005.00604.x; Hoffmann M., 2015, GENOME ANNOUNC, V3; Kuhbacher A, 2015, MBIO, V6, DOI 10.1128/mBio.00598-15; Kuhbacher A, 2014, METHODS MOL BIOL, V1157, P167, DOI 10.1007/978-1-4939-0703-8_14; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Lecuit M, 2001, SCIENCE, V292, P1722, DOI 10.1126/science.1059852; Liss V, 2015, CELL MICROBIOL, V17, P639, DOI 10.1111/cmi.12441; Lou J, 2017, ONCOTARGET, V8, P53935, DOI 10.18632/oncotarget.19644; Malet JK, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12682; Maury MM, 2016, NAT GENET, V48, P308, DOI 10.1038/ng.3501; McCusker MP, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.01219-13; McGough IJ, 2013, J CELL SCI, V126, P45, DOI 10.1242/jcs.112904; McGourty K, 2012, SCIENCE, V338, P963, DOI 10.1126/science.1227037; MENGAUD J, 1991, MOL MICROBIOL, V5, P367, DOI 10.1111/j.1365-2958.1991.tb02118.x; Mirrashidi KM, 2015, CELL HOST MICROBE, V18, P109, DOI 10.1016/j.chom.2015.06.004; Monk IR, 2008, APPL ENVIRON MICROB, V74, P3921, DOI 10.1128/AEM.00314-08; Orsi RH, 2011, INT J MED MICROBIOL, V301, P79, DOI 10.1016/j.ijmm.2010.05.002; Paul B, 2017, ELIFE, V6, DOI 10.7554/eLife.22311; Pizarro-Cerda J, 2007, CELL MICROBIOL, V9, P2381, DOI 10.1111/j.1462-5822.2007.00967.x; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Radoshevich L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00313; Radoshevich L, 2015, ELIFE, V4, DOI 10.7554/eLife.06848; Rajabian T, 2009, NAT CELL BIOL, V11, P1212, DOI 10.1038/ncb1964; Ribet D, 2015, MICROBES INFECT, V17, P173, DOI 10.1016/j.micinf.2015.01.004; Ribet David, 2010, Virulence, V1, P532, DOI 10.4161/viru.1.6.13449; Rigano LA, 2014, CELL MICROBIOL, V16, P1068, DOI 10.1111/cmi.12260; Roberts A, 2006, MICROBIOL-SGM, V152, P685, DOI 10.1099/mic.0.28503-0; Santos MD, 2015, CELL MICROBIOL, V17, P164, DOI 10.1111/cmi.12399; Sierecki E, 2014, MOL CELL PROTEOMICS, V13, P2233, DOI 10.1074/mcp.M113.037275; Stavru F, 2011, P NATL ACAD SCI USA, V108, P3612, DOI 10.1073/pnas.1100126108; Sun Q., 2017, PROT CONTROL MOD POW, V2, P5, DOI DOI 10.1038/sigtrans.2017.30; Van Ngo H, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12768; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Veiga E, 2005, NAT CELL BIOL, V7, P894, DOI 10.1038/ncb1292; Vorwerk S, 2015, MOL CELL PROTEOMICS, V14, P81, DOI 10.1074/mcp.M114.041145; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Welch MD, 2013, CELL HOST MICROBE, V14, P242, DOI 10.1016/j.chom.2013.08.011; Zhou ZM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003471	52	2	3	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 15	2018	293	24					9265	9276		10.1074/jbc.RA117.000365	http://dx.doi.org/10.1074/jbc.RA117.000365			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GJ5SA	29666193	Green Published, hybrid			2022-12-26	WOS:000435441400013
J	Martins, A; Pfirrmann, T; Heessen, S; Sundqvist, G; Bulone, V; Andreasson, C; Ljungdahl, PO				Martins, Antonio; Pfirrmann, Thorsten; Heessen, Stijn; Sundqvist, Gustav; Bulone, Vincent; Andreasson, Claes; Ljungdahl, Per O.			Ssy5 is a signaling serine protease that exhibits atypical biogenesis and marked S1 specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Saccharomyces cerevisiae; serine protease; signal transduction; substrate specificity; yeast; enzyme structure; environmental sensing; receptor activated proteolysis; signaling protease; SPS sensor; zymogen; signaling protease	ALPHA-LYTIC PROTEASE; RECEPTOR-ACTIVATED PROTEOLYSIS; EXTRACELLULAR AMINO-ACIDS; NUCLEAR-MEMBRANE PROTEIN; CASEIN KINASE-I; TRANSCRIPTION FACTOR; SACCHAROMYCES-CEREVISIAE; PRO-REGION; ENDOPROTEOLYTIC ACTIVATION; SSY1P-PTR3P-SSY5P SENSOR	Ssy5 is a signaling endoprotease that plays a key role in regulating central metabolism, cellular aging, and morphological transitions important for growth and survival of yeast (Saccharomyces cerevisiae) cells. In response to extracellular amino acids, Ssy5 proteolytically activates the transcription factors Stp1 and Stp2, leading to enhanced Ssy1-Ptr3-Ssy5 (SPS) sensor-regulated gene expression. Ssy5 comprises a catalytic (Cat) domain and an extensive regulatory prodomain. Ssy5 is refractory to both broad-spectrum and serine protease-specific inhibitors, confounding its classification as a protease, and no information about Ssy5's cleavage-site preferences and its mechanism of substrate selection is available. Here, using mutational and inhibition experiments, we investigated the biogenesis and catalytic properties of Ssy5 and conclusively show that it is a serine protease. Atypical for the majority of serine proteases, Ssy5's prodomain was obligatorily required in cis during biogenesis for the maturation of the proteolytic activity of the Cat domain. Autolysis and Stp1 and Stp2 cleavage occurred between a cysteine (at the P1 site) and a serine or alanine (at the P1 site) and required residues with short side chains at the P1 site. Substitutions in the Cat domain affecting substrate specificity revealed that residues Phe-634, His-661, and Gly-671 in the S1-binding pocket of this domain are important for Ssy5 catalytic function. This study confirms that the signaling protease Ssy5 is a serine protease and provides a detailed understanding of the biogenesis and intrinsic properties of this key enzyme in yeast.	[Martins, Antonio; Pfirrmann, Thorsten; Heessen, Stijn; Andreasson, Claes; Ljungdahl, Per O.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden; [Sundqvist, Gustav; Bulone, Vincent] Royal Inst Technol KTH, AlbaNova Univ Ctr, Div Glycosci, SE-10691 Stockholm, Sweden; [Bulone, Vincent] Univ Adelaide, Sch Agr Food & Wine, ARC Ctr Excellence Plant Cell Walls, Urrbra, SA 5064, Australia; [Pfirrmann, Thorsten] Martin Luther Univ Halle Wittenberg, Inst Physiol Chem, D-06114 Halle, Germany; [Heessen, Stijn] Sanofi Aventis Deutschland GmbH, Global Business Dev & Licensing Consumer Healthca, D-65926 Frankfurt, Germany	Stockholm University; Royal Institute of Technology; University of Adelaide; Martin Luther University Halle Wittenberg; Sanofi-Aventis	Ljungdahl, PO (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, SE-10691 Stockholm, Sweden.	per.ljungdahl@su.se	Bulone, Vincent/D-7469-2013; Ljungdahl, Per O/M-5258-2013; Pfirrmann, Thorsten/AAC-5563-2019; Bulone, Vincent/C-8492-2019	Ljungdahl, Per O/0000-0002-6625-3540; Bulone, Vincent/0000-0003-2809-4160; Pfirrmann, Thorsten/0000-0002-9474-9535	Swedish Research Council [2007-3894, 2011-5925, 2015-04202]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by Swedish Research Council Grants 2007-3894, 2011-5925, and 2015-04202 (to P.O.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Abdel-Sater F, 2004, MOL CELL BIOL, V24, P9771, DOI 10.1128/MCB.24.22.9771-9785.2004; Andreasson C, 2004, MOL CELL BIOL, V24, P7503, DOI 10.1128/MCB.24.17.7503-7513.2004; Andreasson C, 2002, GENE DEV, V16, P3158, DOI 10.1101/gad.239202; Andreasson C., 2004, THESIS; Andreasson C, 2006, GENE DEV, V20, P1563, DOI 10.1101/gad.374206; ANTEBI A, 1992, MOL BIOL CELL, V3, P633, DOI 10.1091/mbc.3.6.633; BAKER D, 1992, NATURE, V356, P263, DOI 10.1038/356263a0; BARTEL B, 1990, EMBO J, V9, P3179, DOI 10.1002/j.1460-2075.1990.tb07516.x; Boban M, 2007, GENETICS, V176, P2087, DOI 10.1534/genetics.107.075077; Boban M, 2006, J CELL BIOL, V173, P695, DOI 10.1083/jcb.200601011; Cole SL, 2008, J BIOL CHEM, V283, P29621, DOI 10.1074/jbc.R800015200; Cunningham EL, 2004, PROTEIN SCI, V13, P325, DOI 10.1110/ps.03389704; Cunningham EL, 2003, BIOCHEMISTRY-US, V42, P13212, DOI 10.1021/bi035409q; Dean RA, 2007, MOL CELL BIOL, V27, P8454, DOI 10.1128/MCB.00821-07; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Forsberg H, 2001, MOL CELL BIOL, V21, P814, DOI 10.1128/MCB.21.3.814-826.2001; FUJISHIGE A, 1992, J CELL BIOL, V118, P33, DOI 10.1083/jcb.118.1.33; GRON H, 1992, BIOCHEMISTRY-US, V31, P6011, DOI 10.1021/bi00141a008; Hedstrom L, 2002, CHEM REV, V102, P4501, DOI 10.1021/cr000033x; Hooper NM, 2002, ESSAYS BIOCHEM, V38, P1; Jaswal SS, 2002, NATURE, V415, P343, DOI 10.1038/415343a; Kelch BA, 2007, J MOL BIOL, V370, P784, DOI 10.1016/j.jmb.2007.04.078; Keller UAD, 2010, MOL CELL PROTEOMICS, V9, P912, DOI 10.1074/mcp.M000032-MCP201; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kinter M., 2005, PROTEIN SEQUENCING I, P147; Klasson H, 1999, MOL CELL BIOL, V19, P5405; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lopez-Otin C, 2008, J BIOL CHEM, V283, P30433, DOI 10.1074/jbc.R800035200; Martinez P, 2005, MOL CELL BIOL, V25, P9435, DOI 10.1128/MCB.25.21.9435-9446.2005; Miramon P, 2016, CELL MICROBIOL, V18, P1611, DOI 10.1111/cmi.12600; NEURATH H, 1957, FED PROC, V16, P791; Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065; Omnus DJ, 2013, MOL BIOL CELL, V24, P1480, DOI 10.1091/mbc.E13-01-0019; Omnus DJ, 2011, MOL BIOL CELL, V22, P2754, DOI 10.1091/mbc.E11-04-0282; Page MJ, 2005, J THROMB HAEMOST, V3, P2401, DOI 10.1111/j.1538-7836.2005.01456.x; PERONA JJ, 1995, PROTEIN SCI, V4, P337; Peters RJ, 1998, BIOCHEMISTRY-US, V37, P12058, DOI 10.1021/bi980883v; Pfirrmann T., 2012, HDB PROTEOLYTIC ENZY, P3103; Pfirrmann T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064870; Pfirrmann T, 2010, MOL CELL BIOL, V30, P3299, DOI 10.1128/MCB.00323-10; PIZZI E, 1994, P NATL ACAD SCI USA, V91, P888, DOI 10.1073/pnas.91.3.888; Poulsen P, 2006, EUKARYOT CELL, V5, P601, DOI 10.1128/EC.5.3.601-608.2006; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Rockwell NC, 1998, BIOCHEMISTRY-US, V37, P3386, DOI 10.1021/bi972534r; Sauter NK, 1998, NAT STRUCT BIOL, V5, P945, DOI 10.1038/2919; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; SILEN JL, 1989, NATURE, V341, P462, DOI 10.1038/341462a0; SILVE S, 1991, MOL CELL BIOL, V11, P1114, DOI 10.1128/MCB.11.2.1114; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; STROUD RM, 1977, ANNU REV BIOPHYS BIO, V6, P177, DOI 10.1146/annurev.bb.06.060177.001141; Tetsch L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-74; Tumusiime S, 2011, J BIOL CHEM, V286, P4620, DOI 10.1074/jbc.M110.195313; Turk B, 2006, NAT REV DRUG DISCOV, V5, P785, DOI 10.1038/nrd2092; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Whitcomb DC, 2007, DIGEST DIS SCI, V52, P1, DOI 10.1007/s10620-006-9589-z; Wielemans K, 2010, J BIOL CHEM, V285, P855, DOI 10.1074/jbc.M109.015263; WILSON IA, 1984, CELL, V37, P767, DOI 10.1016/0092-8674(84)90412-4; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089	60	5	5	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8362	8378		10.1074/jbc.RA118.002457	http://dx.doi.org/10.1074/jbc.RA118.002457			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29661936	hybrid, Green Published			2022-12-26	WOS:000434205700004
J	Sun, H; Miao, ZQ; Zhang, X; Chan, UI; Su, SM; Guo, S; Wong, CKH; Xu, XL; Deng, CX				Sun, Heng; Miao, Zhengqiang; Zhang, Xin; Chan, Un In; Su, Sek Man; Guo, Sen; Wong, Chris Koon Ho; Xu, Xiaoling; Deng, Chu-Xia			Single-cell RNA-Seq reveals cell heterogeneity and hierarchy within mouse mammary epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mammary gland; development; breast cancer; biomarker; cell differentiation; stem cells; CDH5+cell; mammary stem cells (MaSCs); single cell RNA-seq	STEM-CELLS; GENE; IDENTIFICATION; EXPRESSION; MARKERS; ALPHA; PROLIFERATION; POPULATION; QUIESCENT; RECEPTOR	The mammary gland is very intricately and well organized into distinct tissues, including epithelia, endothelia, adipocytes, and stromal and immune cells. Many mammary gland diseases, such as breast cancer, arise from abnormalities in the mammary epithelium, which is mainly composed of two distinct lineages, the basal and luminal cells. Because of the limitation of traditional transcriptome analysis of bulk mammary cells, the hierarchy and heterogeneity of mammary cells within these two lineages remain unclear. To this end, using single-cell RNA-Seq coupled with FACS analysis and principal component analysis, we determined gene expression profiles of mammary epithelial cells of virgin and pregnant mice. These analyses revealed a much higher heterogeneity among the mammary cells than has been previously reported and enabled cell classification into distinct subgroups according to signature gene markers present in each group. We also identified and verified a rare CDH5(+) cell subpopulation within a basal cell lineage as quiescent mammary stem cells (MaSCs). Moreover, using pseudo-temporal analysis, we reconstructed the developmental trajectory of mammary epithelia and uncovered distinct changes in gene expression and in biological functions of mammary cells along the developmental process. In conclusion, our work greatly refines the resolution of the cellular hierarchy in developing mammary tissues. The discovery of CDH5(+) cells as MaSCs in these tissues may have implications for our understanding of the initiation, development, and pathogenesis of mammary tumors.	[Sun, Heng; Guo, Sen; Deng, Chu-Xia] Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China; [Sun, Heng] Univ Macau, Fac Hlth Sci, Zhuhai Res Inst, Taipa, Macau, Peoples R China; [Miao, Zhengqiang; Wong, Chris Koon Ho] Univ Macau, Fac Hlth Sci, Genom & Bioinformat Core, Taipa, Macau, Peoples R China; [Zhang, Xin; Chan, Un In; Su, Sek Man; Xu, Xiaoling] Univ Macau, Fac Hlth Sci, Transgen & Knockout Core, Taipa, Macau, Peoples R China	University of Macau; University of Macau; University of Macau; University of Macau	Deng, CX (corresponding author), Univ Macau, Fac Hlth Sci, Canc Ctr, Taipa, Macau, Peoples R China.	cxdeng@umac.mo	Wong, Koon/AAH-3021-2020; Wong, Koon Ho/P-3685-2018; wong, chris/GSN-0962-2022	Wong, Koon/0000-0002-9264-5118; Wong, Koon Ho/0000-0002-9264-5118; Guo, Sen/0000-0002-2681-0576	University of Macau, Macau SAR, China [CPG 2017-00016-FHS, SRG 2017-00045-FHS]; Macao Science and Technology Development Fund [065/2015/A2, 094/2015/A3]; National Natural Science Foundation of China [81602587]	University of Macau, Macau SAR, China; Macao Science and Technology Development Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chair Professor Grant CPG 2017-00016-FHS and Startup Research Grant SRG 2017-00045-FHS (to C.D.), by University of Macau, Macau SAR, China, Macao Science and Technology Development Fund Grants 065/2015/A2 and 094/2015/A3 (to C.D.), and by National Natural Science Foundation of China Grant 81602587 (to H.S.). The authors declare that they have no conflicts of interest with the contents of this article.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Brunskill EW, 2014, DEVELOPMENT, V141, P3093, DOI 10.1242/dev.110601; Cai S, 2017, CELL STEM CELL, V20, P247, DOI 10.1016/j.stem.2016.11.007; Cheng GJ, 2004, P NATL ACAD SCI USA, V101, P3739, DOI 10.1073/pnas.0307864100; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; dos Santos CO, 2013, P NATL ACAD SCI USA, V110, P7123, DOI 10.1073/pnas.1303919110; Ellison-Zelski SJ, 2009, MOL CELL BIOL, V29, P4949, DOI 10.1128/MCB.00383-09; FINA L, 1990, BLOOD, V75, P2417; Fu NY, 2017, NAT CELL BIOL, V19, P164, DOI 10.1038/ncb3471; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang SX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009707; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kolodziejczyk AA, 2015, MOL CELL, V58, P610, DOI 10.1016/j.molcel.2015.04.005; La Manno G, 2016, CELL, V167, P566, DOI 10.1016/j.cell.2016.09.027; LAMPUGNANI MG, 1992, J CELL BIOL, V118, P1511, DOI 10.1083/jcb.118.6.1511; Li G, 2016, DEV CELL, V39, P491, DOI 10.1016/j.devcel.2016.10.014; Li J, 2016, EMBO REP, V17, P178, DOI 10.15252/embr.201540946; Llorens-Bobadilla E, 2015, CELL STEM CELL, V17, P329, DOI 10.1016/j.stem.2015.07.002; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Morita K, 1999, J CELL BIOL, V147, P185, DOI 10.1083/jcb.147.1.185; NEWMAN PJ, 1990, SCIENCE, V247, P1219, DOI 10.1126/science.1690453; Pollen AA, 2014, NAT BIOTECHNOL, V32, P1053, DOI 10.1038/nbt.2967; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; Prater MD, 2014, NAT CELL BIOL, V16, P942, DOI 10.1038/ncb3025; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Prowse ABJ, 2011, STEM CELL RES, V6, P1, DOI 10.1016/j.scr.2010.09.005; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Saji S, 2000, P NATL ACAD SCI USA, V97, P337, DOI 10.1073/pnas.97.1.337; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013; Sims AH, 2007, NAT CLIN PRACT ONCOL, V4, P516, DOI 10.1038/ncponc0908; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Soady KJ, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0539-6; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang DS, 2015, NATURE, V517, P81, DOI 10.1038/nature13851; Xin YR, 2016, P NATL ACAD SCI USA, V113, P3293, DOI 10.1073/pnas.1602306113; Yu QC, 2016, CELL RES, V26, P1079, DOI 10.1038/cr.2016.85; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997	54	24	24	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8315	8329		10.1074/jbc.RA118.002297	http://dx.doi.org/10.1074/jbc.RA118.002297			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666189	hybrid, Green Published			2022-12-26	WOS:000434205700001
J	Wojciechowski, D; Thiemann, S; Schaal, C; Rahtz, A; de la Roche, J; Begemann, B; Becher, T; Fischer, M				Wojciechowski, Daniel; Thiemann, Stefan; Schaal, Christina; Rahtz, Alina; de la Roche, Jeanne; Begemann, Birgit; Becher, Toni; Fischer, Martin			Activation of renal ClC-K chloride channels depends on an intact N terminus of their accessory subunit barttin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloride channel; gating; intracellular trafficking; renal physiology; electrophysiology; patch clamp; confocal microscopy; protein expression; barttin; ClC-K	DISTAL NEPHRON; INNER-EAR; KIDNEY; DISEASE; GENE; MECHANISMS; EXPRESSION; MUTATIONS; SURFACE	ClC-K channels belong to the CLC family of chloride channels and chloride/proton antiporters. They contribute to sodium chloride reabsorption in Henle's loop of the kidney and to potassium secretion into the endolymph by the stria vascularis of the inner ear. Their accessory subunit barttin stabilizes the ClC-K/barttin complex, promotes its insertion into the surface membrane, and turns the pore-forming subunits into a conductive state. Barttin mutations cause Bartter syndrome type IV, a salt-wasting nephropathy with sensorineural deafness. Here, studying ClC-K/barttin channels heterologously expressed in MDCK-II and HEK293T cells with confocal imaging and patch-clamp recordings, we demonstrate that the eight-amino-acids-long barttin N terminus is required for channel trafficking and activation. Deletion of the complete N terminus (2-8 barttin) retained barttin and human hClC-Ka channels in intracellular compartments. Partial N-terminal deletions did not compromise subcellular hClC-Ka trafficking but drastically reduced current amplitudes. Sequence deletions encompassing Thr-6, Phe-7, or Arg-8 in barttin completely failed to activate hClC-Ka. Analyses of protein expression and whole-cell current noise revealed that inactive channels reside in the plasma membrane. Substituting the deleted N terminus with a polyalanine sequence was insufficient for recovering chloride currents, and single amino acid substitutions highlighted that the correct sequence is required for proper function. Fast and slow gate activation curves obtained from rat V166E rClC-K1/barttin channels indicated that mutant barttin fails to constitutively open the slow gate. Increasing expression of barttin over that of ClC-K partially recovered this insufficiency, indicating that N-terminal modifications of barttin alter both binding affinities and gating properties.	[Wojciechowski, Daniel; Thiemann, Stefan; Schaal, Christina; Rahtz, Alina; de la Roche, Jeanne; Begemann, Birgit; Becher, Toni; Fischer, Martin] Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany	Hannover Medical School	Fischer, M (corresponding author), Hannover Med Sch, Inst Neurophysiol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	fischer.martin@mh-hannover.de						Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; Accardi A, 2015, J PHYSIOL-LONDON, V593, P4129, DOI 10.1113/JP270575; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Fahlke C, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00155; Fischer M., 2017, NEUROFORUM S, V23, pT6; Fischer M, 2010, J AM SOC NEPHROL, V21, P1281, DOI 10.1681/ASN.2009121274; Hayama A, 2003, HISTOCHEM CELL BIOL, V119, P485, DOI 10.1007/s00418-003-0535-2; Hebert SC, 2003, CURR OPIN NEPHROL HY, V12, P527, DOI 10.1097/00041552-200309000-00008; Imbrici P, 2014, BBA-BIOMEMBRANES, V1838, P2484, DOI 10.1016/j.bbamem.2014.05.017; Janssen AGH, 2009, J AM SOC NEPHROL, V20, P145, DOI 10.1681/ASN.2008010102; Kobayashi K, 2002, J AM SOC NEPHROL, V13, P1992, DOI 10.1097/01.ASN.0000023434.47132.3D; Kramer BK, 2008, NAT CLIN PRACT NEPHR, V4, P38, DOI 10.1038/ncpneph0689; Park E, 2017, NATURE, V541, P500, DOI 10.1038/nature20812; Pinelli L, 2016, J GEN PHYSIOL, V148, P213, DOI 10.1085/jgp.201611623; Riazuddin S, 2009, AM J HUM GENET, V85, P273, DOI 10.1016/j.ajhg.2009.07.003; Scholl U, 2006, P NATL ACAD SCI USA, V103, P11411, DOI 10.1073/pnas.0601631103; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Seyberth HW, 2008, NAT CLIN PRACT NEPHR, V4, P560, DOI 10.1038/ncpneph0912; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Steinke KV, 2015, J BIOL CHEM, V290, P17390, DOI 10.1074/jbc.M114.631705; Stolting G, 2017, ACTA PHYSIOL, V219, P11, DOI 10.1111/apha.12802; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Tajima M, 2007, BIOCHEM BIOPH RES CO, V362, P858, DOI 10.1016/j.bbrc.2007.08.097; Uchida S, 2000, AM J PHYSIOL-RENAL, V279, pF802, DOI 10.1152/ajprenal.2000.279.5.F802; UCHIDA S, 1995, J CLIN INVEST, V95, P104, DOI 10.1172/JCI117626; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Waldegger S, 2002, PFLUG ARCH EUR J PHY, V444, P411, DOI 10.1007/s00424-002-0819-8; Wojciechowski D, 2015, J BIOL CHEM, V290, P18732, DOI 10.1074/jbc.M114.625376	30	6	6	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8626	8637		10.1074/jbc.RA117.000860	http://dx.doi.org/10.1074/jbc.RA117.000860			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29674316	Green Published, hybrid			2022-12-26	WOS:000434205700025
J	Zou, A; Magee, N; Deng, FY; Lehn, S; Zhong, CC; Zhang, YX				Zou, An; Magee, Nancy; Deng, Fengyan; Lehn, Sarah; Zhong, Cuncong; Zhang, Yuxia			Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						nuclear receptor; inflammation; liver injury; fibrosis; chemokine; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis; small heterodimer partner	SMALL HETERODIMER PARTNER; FATTY LIVER-DISEASE; PROTEIN-KINASE; FRUCTOSE CONSUMPTION; PROGRESSION; ACIDS; GENE; FXR; ACTIVATION; EXPRESSION	Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem worldwide, ranging from nonalcoholic fatty liver (NAFL, steatosis without hepatocellular injury) to the more aggressive nonalcoholic steatohepatitis (NASH, steatosis with ballooning, inflammation, or fibrosis). Although many studies have greatly contributed to the elucidation of NAFLD pathogenesis, the disease progression from NAFL to NASH remains incompletely understood. Nuclear receptor small heterodimer partner (Nr0b2, SHP) is a transcriptional regulator critical for the regulation of bile acid, glucose, and lipid metabolism. Here, we show that SHP levels are decreased in the livers of patients with NASH and in diet-induced mouse NASH. Exposing primary mouse hepatocytes to palmitic acid and lipopolysaccharide in vitro, we demonstrated that the suppression of Shp expression in hepatocytes is due to c-Jun N-terminal kinase (JNK) activation, which stimulates c-Jun-mediated transcriptional repression of Shp. Interestingly, in vivo induction of hepatocyte-specific SHP in steatotic mouse liver ameliorated NASH progression by attenuating liver inflammation and fibrosis, but not steatosis. Moreover, a key mechanism linking the anti-inflammatory role of hepatocyte-specific SHP expression to inflammation involved SHP-induced suppression of NF-B p65-mediated induction of chemokine (C-C motif) ligand 2 (CCL2), which activates macrophage proinflammatory polarization and migration. In summary, our results indicate that a JNK/SHP/NF-B/CCL2 regulatory network controls communications between hepatocytes and macrophages and contributes to the disease progression from NAFL to NASH. Our findings may benefit the development of new management or prevention strategies for NASH.	[Zou, An; Magee, Nancy; Deng, Fengyan; Lehn, Sarah; Zhang, Yuxia] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Zhong, Cuncong] Univ Kansas, Dept Elect Engn & Comp Sci, Lawrence, KS 66045 USA; [Zhang, Yuxia] Univ Kansas, Med Ctr, Liver Ctr, Kansas City, KS 66160 USA	University of Kansas; University of Kansas Medical Center; University of Kansas; University of Kansas; University of Kansas Medical Center	Zhang, YX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA.	lzhang5@kumc.edu			National Institutes of Health [NCI K22CA184146, P20GM103549, P30GM11824, P20GM103418, T32ES007079]; NATIONAL CANCER INSTITUTE [K22CA184146] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118247, P20GM103418, P20GM103549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants NCI K22CA184146, P20GM103549, P30GM11824, P20GM103418, and T32ES007079. The authors declare that they have no conflicts of interest with contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Aguilar-Olivos NE, 2015, ANN HEPATOL, V14, P487, DOI 10.1016/S1665-2681(19)31170-6; Ali AH, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2014.12.06; Anakk S, 2011, J CLIN INVEST, V121, P86, DOI 10.1172/JCI42846; Ansari AW, 2011, EUR J IMMUNOL, V41, P3412, DOI 10.1002/eji.201141676; Asgharpour A, 2016, J HEPATOL, V65, P579, DOI 10.1016/j.jhep.2016.05.005; Baeck C, 2012, GUT, V61, P416, DOI 10.1136/gutjnl-2011-300304; Baylin A, 2002, AM J CLIN NUTR, V76, P750, DOI 10.1093/ajcn/76.4.750; Bechmann LP, 2013, HEPATOLOGY, V57, P1394, DOI 10.1002/hep.26225; Benet M, 2015, MOL PHARMACOL, V87, P582, DOI 10.1124/mol.114.096313; Bettermann K, 2014, INT J MOL SCI, V15, P9924, DOI 10.3390/ijms15069924; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Chalasani N, 2012, AM J GASTROENTEROL, V107, P811, DOI 10.1038/ajg.2012.128; Chanda D, 2009, HEPATOLOGY, V50, P880, DOI 10.1002/hep.23049; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Clapper JR, 2013, AM J PHYSIOL-GASTR L, V305, pG483, DOI 10.1152/ajpgi.00079.2013; Dela Pena A, 2005, GASTROENTEROLOGY, V129, P1663, DOI 10.1053/j.gastro.2005.09.004; Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004; Farrell GC, 2012, GUT LIVER, V6, P149, DOI 10.5009/gnl.2012.6.2.149; Ganz M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0552-7; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hoeke MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088011; Huang JS, 2007, HEPATOLOGY, V46, P147, DOI 10.1002/hep.21632; Huang SR, 2012, J LIPID RES, V53, P2002, DOI 10.1194/jlr.D029546; Ibrahim SH, 2016, HEPATOLOGY, V63, P731, DOI 10.1002/hep.28252; Janssen AWF, 2017, J LIPID RES, V58, P1399, DOI 10.1194/jlr.M075713; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohli R, 2010, HEPATOLOGY, V52, P934, DOI 10.1002/hep.23797; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Leamy AK, 2013, PROG LIPID RES, V52, P165, DOI 10.1016/j.plipres.2012.10.004; Li GD, 2013, TOXICOL APPL PHARM, V272, P299, DOI 10.1016/j.taap.2013.06.016; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Magee N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5170402; McPherson S, 2015, J HEPATOL, V62, P1148, DOI 10.1016/j.jhep.2014.11.034; Miao J, 2009, GENE DEV, V23, P986, DOI 10.1101/gad.1773909; Nishigori H, 2001, P NATL ACAD SCI USA, V98, P575, DOI 10.1073/pnas.98.2.575; Ouyang X, 2008, J HEPATOL, V48, P993, DOI 10.1016/j.jhep.2008.02.011; Pais R, 2013, J HEPATOL, V59, P550, DOI 10.1016/j.jhep.2013.04.027; Park YJ, 2011, J LIPID RES, V52, P2234, DOI 10.1194/jlr.M016048; Saiman Y, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00213; Seok S, 2013, J BIOL CHEM, V288, P23252, DOI 10.1074/jbc.M113.452037; Smalling RV, 2013, AM J PHYSIOL-GASTR L, V305, pG364, DOI 10.1152/ajpgi.00077.2013; Suh JH, 2006, J BIOL CHEM, V281, P39169, DOI 10.1074/jbc.M605947200; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; Suzuki A, 2009, WOMENS HEALTH, V5, P191, DOI 10.2217/17455057.5.2.191; Temple JL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060947; Trevaskis JL, 2012, AM J PHYSIOL-GASTR L, V302, pG762, DOI 10.1152/ajpgi.00476.2011; Vrochides D, 1996, HEPATOLOGY, V23, P1650, DOI 10.1053/jhep.1996.v23.pm0008675189; Wang L, 2005, CELL METAB, V2, P227, DOI 10.1016/j.cmet.2005.08.010; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03; Win S, 2015, J HEPATOL, V62, P1367, DOI 10.1016/j.jhep.2015.01.032; Wong VWS, 2010, GUT, V59, P969, DOI 10.1136/gut.2009.205088; Yang CS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7115; Yang ZH, 2016, MOL CANCER THER, V15, P2294, DOI 10.1158/1535-7163.MCT-16-0153; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431; Yuk JM, 2011, NAT IMMUNOL, V12, P742, DOI 10.1038/ni.2064; Zhang YX, 2016, SCI REP-UK, V6, DOI 10.1038/srep20559; Zhang YX, 2014, HEPATOLOGY, V60, P919, DOI 10.1002/hep.27121; Zhang YX, 2011, BBA-MOL BASIS DIS, V1812, P893, DOI 10.1016/j.bbadis.2010.10.006; Zhang YX, 2010, MOL CELL BIOL, V30, P1341, DOI 10.1128/MCB.01076-09; Zou An, 2015, Nucl Receptor Res, V2	66	21	21	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8656	8671		10.1074/jbc.RA117.001653	http://dx.doi.org/10.1074/jbc.RA117.001653			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666185	hybrid, Green Published			2022-12-26	WOS:000434205700028
J	Bouletreau, S; Gaillagot, A; Carry, L; Tetard, S; De Oliveira, E; Santoul, F				Bouletreau, Stephanie; Gaillagot, Adeline; Carry, Laurent; Tetard, Stephane; De Oliveira, Eric; Santoul, Frederic			Adult Atlantic salmon have a new freshwater predator	PLOS ONE			English	Article							CATFISH SILURUS-GLANIS; EUROPEAN CATFISH; BIODIVERSITY; DIET; FISH; WEIR	The Atlantic salmon (Salmo salar) is one of the world's most emblematic freshwater fish. Despite conservation and rehabilitation plans, populations of this species are dramatically declining due to human impacts such as habitat fragmentation, overfishing and water pollution. Owing to their large body size, anadromous adults were historically invulnerable to fish predation during their spawning period migration. This invulnerability has disappeared in Western Europe with the introduction of a new freshwater predator, the European catfish (Silurus glanis). Here we report how adults of Atlantic salmon are predated in the fishway of a large river of SW France, where the delayed and narrow passage created by the structure increases the probability of predator-prey encounter. We assessed predation risk by monitoring salmon and catfish in one fishway of the River Garonne, using video fish-counting from 1993 to 2016. We analysed the predation strategy of catfish using observations made with acoustic camera and RFID telemetry in 2016. Our results demonstrate a high predation rate (35% - 14/39 ind.) on salmon inside the fishway during the 2016 spawning period migration. Our results suggest that a few specialized catfish individuals adapted their hunting behaviour to such prey, including their presence synchronized with that of salmon (i.e, more occurrences by the end of the day). Such results suggest that the spread of European catfish will potentially impact migration of anadromous species through anthropized systems.	[Bouletreau, Stephanie; Gaillagot, Adeline; Santoul, Frederic] Univ Toulouse, CNRS, EcoLab, Toulouse, France; [Carry, Laurent] MIGADO, St Orens De Gameville, France; [Tetard, Stephane; De Oliveira, Eric] EDF R&D, LNHE, Chatou, France	Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Universite Toulouse III - Paul Sabatier; Institut National Polytechnique de Toulouse; Centre National de la Recherche Scientifique (CNRS); Electricite de France (EDF)	Santoul, F (corresponding author), Univ Toulouse, CNRS, EcoLab, Toulouse, France.	frederic.santoul@univ-tlse3.fr	Bouletreau, Stephanie/T-2915-2019	Bouletreau, Stephanie/0000-0002-0094-0196; Santoul, Frederic/0000-0002-2932-2172	Adour-Garonne water agency (AEAG); Electricity of France (EDF); "EDF"	Adour-Garonne water agency (AEAG); Electricity of France (EDF); "EDF"(Electricite de France (EDF))	This study was funded by the Adour-Garonne water agency (AEAG) and Electricity of France (EDF). The funder "EDF" provided support in the form of salaries for authors [EDO and ST], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agostinho AA, 2012, NEOTROP ICHTHYOL, V10, P687, DOI 10.1590/S1679-62252012000400001; Baumgartner LJ, 2007, J FISH BIOL, V70, P879, DOI 10.1111/j.1095-8649.2007.01352.x; Bouletreau S, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1606; Bouletreau S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025732; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Croze O, 2008, FISHERIES MANAG ECOL, V15, P467, DOI 10.1111/j.1365-2400.2008.00628.x; Cucherousset J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050840; Downing AS, 2012, ECOL APPL, V22, P229, DOI 10.1890/11-0941.1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Forseth T, 2017, ICES J MAR SCI, V74, P1496, DOI 10.1093/icesjms/fsx020; Guillerault N, 2017, J FISH BIOL, V90, P2214, DOI 10.1111/jfb.13294; Guillerault N, 2015, FRESHWATER BIOL, V60, P922, DOI 10.1111/fwb.12545; Mihalik J., 1995, NEUE BREHM BUCHEREI; NEHLSEN W, 1991, FISHERIES, V16, P4, DOI 10.1577/1548-8446(1991)016&lt;0004:PSATCS&gt;2.0.CO;2; Orlova E. L., 1987, Journal of Ichthyology, V27, P54; Ovidio M, 2008, J APPL ICHTHYOL, V24, P256, DOI 10.1111/j.1439-0426.2008.01050.x; Parrish DL, 1998, CAN J FISH AQUAT SCI, V55, P281, DOI 10.1139/cjfas-55-S1-281; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Slavik O, 2007, J FISH BIOL, V71, P101, DOI 10.1111/j.1095-8649.2007.01471.x; Slavik O, 2012, J FISH BIOL, V81, P2223, DOI 10.1111/j.1095-8649.2012.03436.x; Syvaranta J, 2009, NATURWISSENSCHAFTEN, V96, P631, DOI 10.1007/s00114-009-0511-3; Thibault Max, 1994, P175; Travade F, 1996, ICES J MAR SC, V14, P1	25	21	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196046	10.1371/journal.pone.0196046	http://dx.doi.org/10.1371/journal.pone.0196046			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672636	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800072
J	Ebeling, M; Modig, K; Ahlbom, A; Rau, R				Ebeling, Marcus; Modig, Karin; Ahlbom, Anders; Rau, Roland			The effects of increasing longevity and changing incidence on lifetime risk differentials: A decomposition approach	PLOS ONE			English	Article							DEVELOPING CANCER; TRENDS	Increasing longevity can distort time trends in summary measures of health and mortality, such as the lifetime risk of getting diseased. If not observing a cohort, this lifetime risk is calculated with cross-sectional data on age-specific incidence and survival. In those instances, incidence and survival may work in opposite directions resulting in lifetime risk estimates where, reductions in incidence might be offset by a simultaneous longevity increase. The proposed method decomposes the difference between two lifetime risks into contributions of changing incidence and changing survival. The approach can be extended to measure the contributions of changes in disease related mortality and even case fatality. We illustrate the method with hypothetical examples as well as remaining lifetime risk at age 60 of experiencing a myocardial infarction, colorectal cancer and hip fractures for Swedish males. The empirical examples show that the influence of increasing longevity on the development of lifetime risk depends on the respective age profile of occurrence. In the cases of myocardial infarction and hip fracture, longevity increases of the general population counterbalanced or even exceeded the substantial gains in disease incidence, while for colorectal cancer, the lifetime risk was almost unaffected by the longevity improvement. This was because colorectal cancer has an on average earlier onset than myocardial infarction and hip fracture.	[Ebeling, Marcus; Rau, Roland] Univ Rostock, Chair Demog, Rostock, Germany; [Ebeling, Marcus; Rau, Roland] Max Planck Inst Demog Res, Rostock, Germany; [Modig, Karin; Ahlbom, Anders] Karolinska Inst, Inst Environm Med IMM, Stockholm, Sweden	University of Rostock; Max Planck Society; Karolinska Institutet	Ebeling, M (corresponding author), Univ Rostock, Chair Demog, Rostock, Germany.; Ebeling, M (corresponding author), Max Planck Inst Demog Res, Rostock, Germany.	ebeling@demogr.mpg.de	Modig, Karin/H-1542-2014	Modig, Karin/0000-0002-5151-4867; Ebeling, Marcus/0000-0002-6531-8525	Forte [2014-0231]	Forte(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	Financial support for Anders Ahlbom has been provided by Forte (Grant no.: 2014-0231). The funding institution had no influence on the design, analysis and interpretation of the outcomes of this study.	Ahmad AS, 2015, BRIT J CANCER, V112, P943, DOI 10.1038/bjc.2014.606; [Anonymous], 2015, HUM MORTALITY DATAB; Camarda CG, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i01; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Esteve J, 1994, STAT METHODS CANC RE; FEUER EJ, 1993, J NATL CANCER I, V85, P892, DOI 10.1093/jnci/85.11.892; GOLDBERG ID, 1956, J NATL CANCER I, V17, P155; Gupta, 1991, MATH POPUL STUD, V3, P105, DOI DOI 10.1080/08898489109525329; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Karampampa K, 2015, BONE, V78, P55, DOI 10.1016/j.bone.2015.04.032; KITAGAWA EM, 1955, J AM STAT ASSOC, V50, P1168, DOI 10.2307/2281213; Modig K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064928; R Core Team, 2013, R LANG ENV STAT COMP; Sasieni PD, 2011, BRIT J CANCER, V105, P460, DOI 10.1038/bjc.2011.250; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wun LM, 1998, LIFETIME DATA ANAL, V4, P169, DOI 10.1023/A:1009685507602	16	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195307	10.1371/journal.pone.0195307	http://dx.doi.org/10.1371/journal.pone.0195307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672532	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800024
J	Hamada, K; Saitoh, S; Nishino, N; Fukushima, D; Horikawa, Y; Nishida, S; Honda, M				Hamada, Koichi; Saitoh, Satoshi; Nishino, Noriyuki; Fukushima, Daizo; Horikawa, Yoshinori; Nishida, Shinya; Honda, Michitaka			Shear wave elastography predicts hepatocellular carcinoma risk in hepatitis C patients after sustained virological response	PLOS ONE			English	Article							TIME TISSUE ELASTOGRAPHY; LIVER FIBROSIS; INTERFERON THERAPY; TRANSIENT ELASTOGRAPHY; NONINVASIVE EVALUATION; ANTIVIRAL THERAPY; LONG-TERM; STIFFNESS; HCV; INFECTION	Aim To evaluate the relationship between fibrosis and HCC after sustained virological response (SVR) to treatment for chronic hepatitis C (HCV). Methods This single-center study retrospectively evaluated 196 patients who achieved SVR after HCV infection. The associations of risk factors with HCC development after HCV eradication were evaluated using univariate and multivariate Cox proportional hazards regression models. Results Among the 196 patients, 8 patients (4.1%) developed HCC after SVR during a median follow-up of 26 months. Multivariate analyses revealed that HCC development was independently associated with age of >= 75 years (risk ratio [RR] = 35.16), alpha-fetoprotein levels of >= 6 ng/mL (RR = 40.30), and SWE results of >= 11 kPa (RR = 28.71). Conclusions Our findings indicate that SWE may facilitate HCC surveillance after SVR and the identification of patients who have an increased risk of HCC after HCV clearance.	[Hamada, Koichi; Nishino, Noriyuki; Fukushima, Daizo; Horikawa, Yoshinori; Honda, Michitaka] Fukushima Med Univ, Dept Minimally Invas Surg & Med Oncol, Fukushima, Japan; [Hamada, Koichi; Nishida, Shinya; Honda, Michitaka] Southern Tohoku Gen Hosp, Dept Gastroenterol, Koriyama, Fukushima, Japan; [Saitoh, Satoshi] Toranomon Gen Hosp, Dept Hepatol, Tokyo, Japan	Fukushima Medical University; Toranomon Hospital	Hamada, K (corresponding author), Southern Tohoku Gen Hosp, Dept Gastroenterol, Koriyama, Fukushima, Japan.	koichi.hamada@mt.strins.or.jp	Honda, Michitaka/GRX-6955-2022					Aleman S, 2013, CLIN INFECT DIS, V57, P230, DOI 10.1093/cid/cit234; Arima Y, 2010, HEPATOL RES, V40, P383, DOI 10.1111/j.1872-034X.2009.00618.x; Asahina Y, 2013, HEPATOLOGY, V58, P1253, DOI 10.1002/hep.26442; Asahina Y, 2010, HEPATOLOGY, V52, P518, DOI 10.1002/hep.23691; Bavu E, 2011, ULTRASOUND MED BIOL, V37, P1361, DOI 10.1016/j.ultrasmedbio.2011.05.016; El-Serag H, 2003, ANN INTERN MED, V139, P817, DOI 10.7326/0003-4819-139-10-200311180-00009; Ferraioli G, 2012, HEPATOLOGY, V56, P2125, DOI 10.1002/hep.25936; Hezode C, 2011, ALIMENT PHARM THER, V34, P656, DOI 10.1111/j.1365-2036.2011.04765.x; Ikeda K, 1999, HEPATOLOGY, V29, P1124, DOI 10.1002/hep.510290439; Ikeda M, 2005, J GASTROENTEROL, V40, P148, DOI 10.1007/s00535-004-1519-2; Kobayashi M, 2017, J MED VIROL, V89, P476, DOI 10.1002/jmv.24663; Makiyama A, 2004, CANCER-AM CANCER SOC, V101, P1616, DOI 10.1002/cncr.20537; Nagaoki Y, 2011, J GASTROENTEROL, V46, P799, DOI 10.1007/s00535-011-0384-z; Ogawa E, 2013, J HEPATOL, V58, P495, DOI 10.1016/j.jhep.2012.10.017; Oze T, 2014, CLIN GASTROENTEROL H, V12, P1186, DOI 10.1016/j.cgh.2013.11.033; Poynard T, 2003, LANCET, V362, P2095, DOI 10.1016/S0140-6736(03)15109-4; Reig M, 2016, J HEPATOL, V65, P719, DOI 10.1016/j.jhep.2016.04.008; Shiraishi A, 2014, HEPATO-GASTROENTEROL, V61, P2084, DOI 10.5754/hge14574; Sporea I, 2011, Ultraschall Med, V32 Suppl 1, pS46, DOI 10.1055/s-0029-1245360; Suda T, 2017, WORLD J HEPATOL, V9, P64, DOI 10.4254/wjh.v9.i1.64; Tada T, 2017, HEPATOL RES, V47, P1021, DOI 10.1111/hepr.12839; Takaki S, 2014, HEPATOL RES, V44, P280, DOI 10.1111/hepr.12129; Talwalkar JA, 2007, CLIN GASTROENTEROL H, V5, P1214, DOI 10.1016/j.cgh.2007.07.020; Tapper EB, 2015, CURR OPIN GASTROEN, V31, P192, DOI 10.1097/MOG.0000000000000169; Tatsumi C, 2008, INTERVIROLOGY, V51, P27, DOI 10.1159/000122602; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Tsochatzis EA, 2011, J HEPATOL, V54, P650, DOI 10.1016/j.jhep.2010.07.033; Wang JH, 2016, LIVER INT, V36, P1793, DOI 10.1111/liv.13179	28	12	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195173	10.1371/journal.pone.0195173	http://dx.doi.org/10.1371/journal.pone.0195173			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672518	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800021
J	Herrmann, AS; Beutel, ME; Gerzymisch, K; Lane, RD; Pastore-Molitor, J; Wiltink, J; Zwerenz, R; Banerjeet, M; Subic-Wrana, C				Herrmann, Anna S.; Beutel, Manfred E.; Gerzymisch, Katharina; Lane, Richard D.; Pastore-Molitor, Janine; Wiltink, Joerg; Zwerenz, Ruediger; Banerjeet, Mita; Subic-Wrana, Claudia			The impact of attachment distress on affect-centered mentalization: An experimental study in psychosomatic patients and healthy adults	PLOS ONE			English	Article							BORDERLINE PERSONALITY-DISORDER; EMOTIONAL AWARENESS SCALE; CHILDHOOD EXPERIENCES; UNRESOLVED ATTACHMENT; MATERNAL SENSITIVITY; INFANT ATTACHMENT; COMPLEX EMOTIONS; GERMAN VERSION; MENTAL STATES; MOTHER-INFANT	Introduction We investigated the impact of attachment distress on affect-centered mentalization in a clinical and a non-clinical sample, comparing mentalization in a baseline condition to mentalization under a condition of attachment distress. Methods The sample consisted of 127 adults who underwent inpatient psychosomatic treatment, and 34 mentally healthy adults. Affect-centered mentalization was assessed by analyzing participants' narratives on interpersonal situations in a baseline condition with the Levels of Emotional Awareness Scale (LEAS), and an experimental condition inducing attachment distress with the Adult Attachment Projective Picture System (AAP). Unlike the LEAS, the AAP is specifically designed to trigger attachment distress. In both conditions, the narratives were evaluated using the LEAS scoring system. Additionally, we assessed the impact of childhood trauma on affect-centered mentalization with the Childhood Trauma Questionnaire (CTQ). Results While the non-clinical sample displayed the same level of affect-centered mentalization in both conditions, the majority of the clinical sample reached higher scores in the attachment distress condition. There was no strong relationship between reported trauma and mentalization scores. Discussion Our findings lend strong empirical support to the assumption that affect-centered mentalization is modulated by attachment-related distress. Several possible explanations for the differences between and within the clinical and the non-clinical sample are discussed.	[Herrmann, Anna S.] Univ Med Ctr Mainz, DFG Res Training Grp Life Sci, Life Writing GRK2015 1, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Beutel, Manfred E.; Gerzymisch, Katharina; Pastore-Molitor, Janine; Wiltink, Joerg; Zwerenz, Ruediger; Subic-Wrana, Claudia] Univ Med Ctr Mainz, Dept Psychosomat Med & Psychotherapy, Mainz, Germany; [Lane, Richard D.] Univ Arizona, Coll Med, Dept Psychiat, Tucson, AZ USA; [Banerjeet, Mita] Johannes Gutenberg Univ Mainz, Dept English & Linguist, Mainz, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; University of Arizona; Johannes Gutenberg University of Mainz	Herrmann, AS (corresponding author), Univ Med Ctr Mainz, DFG Res Training Grp Life Sci, Life Writing GRK2015 1, Dept Psychosomat Med & Psychotherapy, Mainz, Germany.	anna.herrmann@uni-mainz.de						[Anonymous], 1969, ATTACHMENT LOSS ATTA; Bader K, 2009, Z KLIN PSYCHOL PSYCH, V38; Baeza-Velasco C, 2012, J PSYCHOSOM RES, V73, P398, DOI 10.1016/j.jpsychores.2012.08.008; Baslet G, 2009, J NERV MENT DIS, V197, P655, DOI 10.1097/NMD.0b013e3181b3b20f; Bernstein DP, 1998, CHILDHOOD TRAUMA QUE; Berthoz S, 2000, ANN MED-PSYCHOL, V158, P665; Bigelow AE, 2006, INFANCY, V9, P313, DOI 10.1207/s15327078in0903_3; Bochand L, 2010, LENCEPHALE, V36, P334, DOI [10.1016/j.encep.2009.12.013, DOI 10.1016/J.ENCEP.2009.12.013]; Bowlby J., 1973, ATTACHMENT LOSS, V2; BOWLBY J, 1980, LOSS SADNESS DEPRESS, V3; Brune M, 2016, COMPR PSYCHIAT, V64, P29, DOI 10.1016/j.comppsych.2015.08.003; Buchheim A, 2008, PSYCHIAT RES-NEUROIM, V163, P223, DOI 10.1016/j.pscychresns.2007.07.001; Bydlowski S, 2005, INT J EAT DISORDER, V37, P321, DOI 10.1002/eat.20132; Carton S, 2010, J CLIN PSYCHOL; Consoli SM, 2010, AM J HYPERTENS, V23, P515, DOI 10.1038/ajh.2010.9; de Sampaio FTP, 2013, PSYCHIAT RES, V210, P1116, DOI 10.1016/j.psychres.2013.08.051; Demers I, 2010, INT J BEHAV DEV, V34, P529, DOI 10.1177/0165025410365802; Donges US, 2005, J NERV MENT DIS, V193, P331, DOI 10.1097/01.nmd.0000161683.02482.19; Dozier M., 2008, HDB ATTACHMENT THEOR, P718; Ensink K, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01471; Fertuck EA, 2009, PSYCHOL MED, V39, P1979, DOI 10.1017/S003329170900600X; Fizke E, 2013, PSIHOLOGIJA, V46, P161, DOI 10.2298/PSI1302161F; Fonagy P, 1997, DEV PSYCHOPATHOL, V9, P679, DOI 10.1017/S0954579497001399; FONAGY P, 1991, INFANT MENT HEALTH J, V12, P201, DOI 10.1002/1097-0355(199123)12:3<201::AID-IMHJ2280120307>3.0.CO;2-7; Fonagy P., 1998, REFLECTIVE FUNCTIONI; Fonagy P, 2002, AFFECT REGULATION ME, V400, DOI [10.1016/j.jpsychores.2012.08.008, DOI 10.1016/J.JPSYCHORES.2012.08.008]; Fonagy P, 2009, DEV PSYCHOPATHOL, V21, P1355, DOI 10.1017/S0954579409990198; Frewen P, 2008, PSYCHOSOM MED, V70, P27, DOI 10.1097/PSY.0b013e31815f66d4; Frick C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041650; Gandolphe MC, 2013, J BEHAV THER EXP PSY, V44, P114, DOI 10.1016/j.jbtep.2012.07.012; George C., 2012, ADULT ATTACHMENT PRO; Gergely G, 1996, INT J PSYCHOANAL, V77, P1181; Grienenberger J, 2005, ATTACH HUM DEV, V7, P299, DOI 10.1080/14616730500245963; Haag S, 2016, INT J BIPOLAR DISORD, V4, DOI 10.1186/s40345-016-0061-5; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Harrison A, 2010, PSYCHOL MED, V40, P1887, DOI 10.1017/S0033291710000036; Hesse E, 1999, PSYCHOANAL INQ, V19, P481, DOI 10.1080/07351699909534265; Kenyon M, 2012, INT J EAT DISORDER, V45, P377, DOI 10.1002/eat.20967; Labek K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00345; LANE RD, 1990, J PERS ASSESS, V55, P124, DOI 10.1207/s15327752jpa5501&2_12; Lane RD, 1998, COMPR PSYCHIAT, V39, P377, DOI 10.1016/S0010-440X(98)90051-7; LANE RD, 1987, AM J PSYCHIAT, V144, P133; LANE RD, 2015, BEHAV BRAIN SCI, V38; Lane RD, 2015, NEUROSCI BIOBEHAV R, V55, P594, DOI 10.1016/j.neubiorev.2015.06.007; Lane RD, 2011, PSYCHOSOM MED, V73, P185, DOI 10.1097/PSY.0b013e318203b86a; Levine D, 1997, J NERV MENT DIS, V185, P240, DOI 10.1097/00005053-199704000-00004; Lillaz C, 2012, ENCEPHALE, V38, P390, DOI 10.1016/j.encep.2011.11.009; Liotti G, 2011, PSYCHOL PSYCHOTHER-T, V84, P9, DOI 10.1348/147608310X520094; MacIntosh HB, 2013, PSIHOLOGIJA, V46, P193, DOI 10.2298/PSI1302193M; Maunder RG, 2001, PSYCHOSOM MED, V63, P556, DOI 10.1097/00006842-200107000-00006; Maurage P, 2011, PSYCHIAT RES, V190, P375, DOI 10.1016/j.psychres.2011.06.015; Mayes LC, 2000, SEMIN PERINATOL, V24, P267, DOI 10.1053/sper.2000.9121; Mayes LC, 2006, ANN NY ACAD SCI, V1094, P178, DOI 10.1196/annals.1376.018; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Mikulincer M, 2003, MOTIV EMOTION, V27, P77, DOI 10.1023/A:1024515519160; Moeller SJ, 2014, JAMA PSYCHIAT, V71, P61, DOI 10.1001/jamapsychiatry.2013.2833; Nazarov A, 2014, ACTA PSYCHIAT SCAND, V129, P193, DOI 10.1111/acps.12142; Nolte T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00816; Nolte T, 2010, J AM PSYCHOANAL ASS, V58, P566; Novick-Kline P, 2005, J ANXIETY DISORD, V19, P557, DOI 10.1016/j.janxdis.2004.06.001; Oppenheim D, 2001, INT J BEHAV DEV, V25, P16, DOI 10.1080/01650250042000096; Parling T, 2010, EAT BEHAV, V11, P205, DOI 10.1016/j.eatbeh.2010.04.001; Pasquier A, 2010, LENCEPHALE, V36, pD97, DOI [10.1016/j.encep.2009.01.007, DOI 10.1016/J.ENCEP.2009.01.007]; Petersen R, 2016, COMPR PSYCHIAT, V64, P12, DOI 10.1016/j.comppsych.2015.10.004; Piaget J., 1974, PSYCHOL INTELLIGENZ; Preissler S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00182; Preller KH, 2014, ADDICT BIOL, V19, P452, DOI 10.1111/adb.12070; Richman MJ, 2015, BRIT J PSYCHIAT, V207, P483, DOI 10.1192/bjp.bp.114.152108; Rommel D, 2013, BRIT J CLIN PSYCHOL, V52, P215, DOI 10.1111/bjc.12010; Sharp C, 2011, J AM ACAD CHILD PSY, V50, P563, DOI 10.1016/j.jaac.2011.01.017; Shu IW, 2014, J AFFECT DISORDERS, V155, P234, DOI 10.1016/j.jad.2013.06.057; Sprong M, 2007, BRIT J PSYCHIAT, V191, P5, DOI 10.1192/bjp.bp.107.035899; Stacks AM, 2014, ATTACH HUM DEV, V16, P515, DOI 10.1080/14616734.2014.935452; Stonnington CM, 2013, J PSYCHOSOM RES, V74, P479, DOI 10.1016/j.jpsychores.2013.04.004; Subic-Wrana C, 2005, PSYCHOSOM MED, V67, P483, DOI 10.1097/01.psy.0000160461.19239.13; Subic-Wrana C, 2015, J PSYCHOSOM RES, V78, P625, DOI 10.1016/j.jpsychores.2015.03.125; Subic-Wrana C, 2001, PSYCHOTHERAPEUT, V46, P176, DOI 10.1007/s002780100157; Subic-Wrana C, 2016, DTSCH K PSYCH MED PS; Subic-Wrana C, 2016, Z PSYCHOSOM MED PSYC, V62, P207, DOI 10.13109/zptm.2016.62.3.207; Subic-Wrana C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091846; Subic-Wrana C, 2011, Z PSYCHOSOM MED PSYC, V57, P325, DOI 10.13109/zptm.2011.57.4.325; Subic-Wrana C, 2011, INT J PSYCHOANAL, V92, P289, DOI 10.1111/j.1745-8315.2011.00392.x; Subic-Wrana C, 2010, PSYCHOSOM MED, V72, P404, DOI 10.1097/PSY.0b013e3181d35e83; Sutterby SR, 2012, PSYCHIAT RES, V197, P242, DOI 10.1016/j.psychres.2012.02.014; Taubner S., 2015, KONZEPT MENTALISIERE; Taubner S, 2014, PRAX KINDERPSYCHOL K, V63, P699, DOI 10.13109/prkk.2014.63.9.699; Taubner S, 2013, PSIHOLOGIJA, V46, P177, DOI 10.2298/PSI1302177T; Walker EA, 1999, ARCH GEN PSYCHIAT, V56, P609, DOI 10.1001/archpsyc.56.7.609; Waller E, 2004, J PSYCHOSOM RES, V57, P239, DOI 10.1016/S0022-3999(03)00613-5; Werner H., 1963, SYMBOL FORMATION ORG; Wingenfeld K, 2010, PSYCHOTHER PSYCH MED, V60, P442, DOI 10.1055/s-0030-1247564; Wittchen H.U., 1997, SKID STRUKTURIERTES; Zunhammer M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140016	93	6	6	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195430	10.1371/journal.pone.0195430	http://dx.doi.org/10.1371/journal.pone.0195430			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672540	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800027
J	Izadi, E; Bezuijen, A				Izadi, Ehsan; Bezuijen, Adam			Simulating direct shear tests with the Bullet physics library: A validation study	PLOS ONE			English	Article							GRANULAR-MATERIALS; DYNAMICS; FRICTION; BEHAVIOR; PARTICLE; PARALLEL	This study focuses on the possible uses of physics engines, and more specifically the Bullet physics library, to simulate granular systems. Physics engines are employed extensively in the video gaming, animation and movie industries to create physically plausible scenes. They are designed to deliver a fast, stable, and optimal simulation of certain systems such as rigid bodies, soft bodies and fluids. This study focuses exclusively on simulating granular media in the context of rigid body dynamics with the Bullet physics library. The first step was to validate the results of the simulations of direct shear testing on uniform-sized metal beads on the basis of laboratory experiments. The difference in the average angle of mobilized frictions was found to be only 1.0 degrees. In addition, a very close match was found between dilatancy in the laboratory samples and in the simulations. A comprehensive study was then conducted to determine the failure and post-failure mechanism. We conclude with the presentation of a simulation of a direct shear test on real soil which demonstrated that Bullet has all the capabilities needed to be used as software for simulating granular systems.	[Izadi, Ehsan; Bezuijen, Adam] Univ Ghent, Lab Geotech, Ghent, East Flanders, Belgium; [Bezuijen, Adam] Deltares, NL-2600 MH Delft, Netherlands	Ghent University; Deltares	Izadi, E (corresponding author), Univ Ghent, Lab Geotech, Ghent, East Flanders, Belgium.	Ehsan.Izadi@UGent.be		Izadi, Ehsan/0000-0002-6817-2664	Ghent University under BOF (special research funds) scholarship	Ghent University under BOF (special research funds) scholarship	This research was funded by Ghent University under BOF (special research funds) scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azema E, 2009, MECH MATER, V41, P729, DOI 10.1016/j.mechmat.2009.01.021; Azema E, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.031302; Azema E, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041301; Azema E, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.011301; Bartezzaghi A, 2015, COMPUT STRUCT, V154, P29, DOI 10.1016/j.compstruc.2015.03.005; Bender J, 2012, EUROGRAPHICS 2013 ST; Boeing A, 2007, GRAPHITE 2007: 5TH INTERNATIONAL CONFERENCE ON COMPUTER GRAPHICS AND INTERACTIVE TECHNIQUES IN AUSTRALASIA AND SOUTHERN ASIA, PROCEEDINGS, P281; Catto E, 2016, BOX2D PHYS ENGINE; Cerato AB, 2006, GEOTECH TEST J, V29, P507; Chareyre B., 2010, YADE DOC; Clark SK, 1979, HDB ROLLING RESISTAN; Coumans, 2015, BULLET 283 PHYS SDK; CUNDALL PA, 1979, GEOTECHNIQUE, V29, P47, DOI 10.1680/geot.1979.29.1.47; Cundall PA, 2001, P I CIVIL ENG-GEOTEC, V149, P41, DOI 10.1680/geng.2001.149.1.41; da Cruz F, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.021309; Damrath F, 2014, PROC CIRP, V23, P137, DOI 10.1016/j.procir.2014.10.082; Delaney GW, 2007, WORLD SCI LECT NOTES, V8, P169; Dippel S, 1996, PHYS REV E, V54, P6845, DOI 10.1103/PhysRevE.54.6845; Erleben K., 2005, PHYS BASED ANIMATION; Falagush O, 2004, INT J GEOMECH, P1; Girgis F, GPGPU ACCELERATION V; Hamano T, 2016, IEEE INT SYMP SAFE, P358, DOI 10.1109/SSRR.2016.7784327; Hummel J, 2012, LECT NOTES COMPUT SC, V7432, P346, DOI 10.1007/978-3-642-33191-6_34; Hung WH, 2013, ADV ENG SOFTW, V65, P1, DOI 10.1016/j.advengsoft.2013.04.013; Izadi E, 2015, GEOMECHANICS FROM MICRO TO MACRO, VOLS I AND II, P1565; Jean M, 1999, COMPUT METHOD APPL M, V177, P235, DOI 10.1016/S0045-7825(98)00383-1; Kim BS, 2012, KSCE J CIV ENG, V16, P1132, DOI 10.1007/s12205-012-1518-4; Lanier J, 2000, POWDER TECHNOL, V109, P206, DOI 10.1016/S0032-5910(99)00237-5; Lim KW, 2014, COMPUT METHOD APPL M, V268, P557, DOI 10.1016/j.cma.2013.10.004; Liu SH, 2005, COMPUT GEOTECH, V32, P317, DOI 10.1016/j.compgeo.2005.05.002; Ltd TR, 2002, HAV GAM DYN SDK; Moreau JJ, 1999, COMPUT METHOD APPL M, V177, P329, DOI 10.1016/S0045-7825(98)00387-9; NVIDIA&REG;, 2016, PHYSX SDK 3 3 4 DOC; O'Sullivan C, 2004, J ENG MECH, V130, P1140, DOI 10.1061/(ASCE)0733-9399(2004)130:10(1140); O'Sullivan C, 2002, J ENG MECH-ASCE, V128, P1182, DOI 10.1061/(ASCE)0733-9399(2002)128:11(1182); O'Sullivan C, 1997, THESIS; OSullivan C, 2011, APPL GEOTECH, V4, P1; Parsons JD., 1936, 1 INT C SOIL MECH FD, DOI 10.1145/1321261.1321312; Pinciroli C, 2012, SWARM INTELL-US, V6, P271, DOI 10.1007/s11721-012-0072-5; Pytlos M, 2015, GEOMECHANICS FROM MICRO TO MACRO, VOLS I AND II, P163; Pytlos M, 2015, GEOTECH LETT, V5, P243, DOI 10.1680/jgele.15.00067; Quezada JC, 2014, COMPUT GEOTECH, V55, P248, DOI 10.1016/j.compgeo.2013.09.006; Quezada JC, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.031308; Radjai F, 2009, MECH MATER, V41, P715, DOI 10.1016/j.mechmat.2009.01.028; Renouf M, 2004, J COMPUT APPL MATH, V168, P375, DOI 10.1016/j.cam.2003.05.019; Shibuya S, 1997, GEOTECHNIQUE, V47, P769, DOI 10.1680/geot.1997.47.4.769; Strahilov A, 2015, ROBOT CIM-INT MANUF, V36, P101, DOI 10.1016/j.rcim.2015.01.001; Weatherley D, 2012, ESYS PARTICLE TUTORI; Wolff R., 2011, 2011 IEEE/ACM 15th International Symposium on Distributed Simulation and Real Time Applications, P72, DOI 10.1109/DS-RT.2011.23; Xu Z, 2013, AUTOMAT CONSTR, V35, P471, DOI 10.1016/j.autcon.2013.06.006; Zhu HP, 2007, CHEM ENG SCI, V62, P3378, DOI 10.1016/j.ces.2006.12.089	51	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195073	10.1371/journal.pone.0195073	http://dx.doi.org/10.1371/journal.pone.0195073			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672557	Green Published, gold			2022-12-26	WOS:000430446800016
J	Loto, RT				Loto, Roland Tolulope			Electrochemical analysis of the corrosion inhibition effect of trypsin complex on the pitting corrosion of 420 martensitic stainless steel in 2M H2SO4 solution	PLOS ONE			English	Article							PASSIVE FILMS; RESISTANCE	Inhibition effect of trypsin complex (TC) on the pitting corrosion of martensitic stainless steel (type 420) in 1M H2SO4 solution was studied with potentiodynamic polarization, open circuit potential measurement and optical microscopy. TC reduced the corrosion rate of the steel with maximum inhibition efficiency of 80.75%. Corrosion potential shifted anodically due to the electrochemical action of TC. The pitting potential increased from 1.088V(Ag/AgCl) ((3M)) at 0% TC to 1.365V(Ag/AgCl(3M)) at 4% TC. TC shifts the open circuit corrosion potential from -0.270s at 0% TC concentration to -0.255V at 5% TC. The compound completely adsorbed onto the steel according to Langmuir, Frumkin and Temkin isotherms. ATF-FTIR spectroscopy confirmed the inhibition mode to be through surface coverage. Thermodynamic calculations showed physisorption molecular interaction. Corrosion pits are present on the uninhibited 420 morphology in comparison to TC inhibited surface which slightly deteriorated.	[Loto, Roland Tolulope] Covenant Univ, Dept Mech Engn, Ota, Ogun State, Nigeria	Covenant University	Loto, RT (corresponding author), Covenant Univ, Dept Mech Engn, Ota, Ogun State, Nigeria.	tolu.loto@gmail.com	Loto, Tolulope R/C-7956-2015	Loto, Roland Tolulope/0000-0002-1675-8989				Almarshad AI, 2004, J APPL ELECTROCHEM, V34, P67, DOI 10.1023/B:JACH.0000005579.84264.73; [Anonymous], 2011, G103 ASTM; Elayyachy M, 2006, CORROS SCI, V48, P2470, DOI 10.1016/j.corsci.2005.09.016; Guidelli R., 1992, ADSORPTION MOL METAL; Limousin G, 2007, APPL GEOCHEM, V22, P249, DOI 10.1016/j.apgeochem.2006.09.010; Loto RT, 2016, COGENT CHEM, V2, DOI 10.1080/23312009.2016.1268377; Loto RT, 2017, SURF REV LETT, V24, DOI 10.1142/S0218625X17501219; Loto RT, 2016, ORIENT J CHEM, V32, P2813, DOI 10.13005/ojc/320557; Loto RT, 2016, INT J IND CHEM, V7, P143, DOI 10.1007/s40090-015-0063-7; MAZILLE H, 1995, CORROS SCI, V37, P1365, DOI 10.1016/0010-938X(95)00036-J; Ramana KVS, 2009, MATER DESIGN, V30, P3770, DOI 10.1016/j.matdes.2009.01.039; RAMASUBRAMANIAN N, 1985, J ELECTROCHEM SOC, V132, P793, DOI 10.1149/1.2113959; Ramya S, 2010, CORROS SCI, V52, P2114, DOI 10.1016/j.corsci.2010.02.028; Refaey SAM, 2004, APPL SURF SCI, V236, P175, DOI 10.1016/j.apsusc.2004.04.016; Sastri VS, 1997, CORROSION, V53, P617, DOI 10.5006/1.3290294; Sastri VS., 1998, CORROSION INHIBITORS; Schweitzer P E, 2003, METALLIC MAT PHYS ME, V1, DOI [10.1201/9780203912423, DOI 10.1201/9780203912423]; Schweitzer PA, 2004, ENCY CORROSION TECHN, P432; Souto RM, 2001, CORROSION, V57, P300, DOI 10.5006/1.3290353	19	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195870	10.1371/journal.pone.0195870	http://dx.doi.org/10.1371/journal.pone.0195870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672541	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800052
J	Lestini, E; Andrei, C; Zerulla, D				Lestini, Elena; Andrei, Codrin; Zerulla, Dominic			Linear self-assembly and grafting of gold nanorods into arrayed micrometer-long nanowires on a silicon wafer via a combined top-down/bottom-up approach	PLOS ONE			English	Article							WET CHEMICAL SYNTHESIS; X-RAY PHOTOELECTRON; ASPECT-RATIO; SILVER NANORODS; NANOPARTICLES; SURFACES; MANIPULATION; REDUCTION; GROWTH; THIOL	Macroscopically long wire-like arrangements of gold nanoparticles were obtained by controlled evaporation and partial coalescence of an aqueous colloidal solution of capped CTAB-Au nanorods onto a functionalised 3-mercaptopropyl trimethoxysilane (MPTMS) silicon substrate, using a removable, silicon wafer with a hydrophobic surface that serves as a "handrail" for the initial nanorods' linear self-assembly. The wire-like structures display a quasi-continuous pattern by thermal annealing of the gold nanorods when the solvent (i.e. water) is evaporated at temperatures rising from 20 degrees C to 140 degrees C. Formation of both single and self-replicating parallel 1D-superstructures consisting of two or even three wires is observed and explained under such conditions.	[Lestini, Elena; Andrei, Codrin; Zerulla, Dominic] Univ Coll Dublin, Sch Phys, Sci Ctr North, Dublin, Ireland; [Andrei, Codrin] Univ Coll Dublin, Sch Math & Stat, Sci Ctr South, Dublin, Ireland	University College Dublin; University College Dublin	Zerulla, D (corresponding author), Univ Coll Dublin, Sch Phys, Sci Ctr North, Dublin, Ireland.	dominic.zerulla@ucd.ie	Zerulla, Dominic/L-6090-2018	Zerulla, Dominic/0000-0001-8479-9654	Science Foundation Ireland [11/RFP/MTR/3113]; Enterprise Ireland (Core VANTA project)	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Enterprise Ireland (Core VANTA project)	The authors acknowledge financial support of Science Foundation Ireland (Grant Number 11/RFP/MTR/3113) and Enterprise Ireland (Core VANTA project) to DZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge financial support of Science Foundation Ireland (Grant No 11/RFP/MTR/3113) and Enterprise Ireland (Core VANTA project).	Andrei C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109836; Ashall B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2806224; Aslan K, 2005, J PHYS CHEM B, V109, P3157, DOI 10.1021/jp045186t; Barmparis GD, 2016, MATERIALS, V9, DOI 10.3390/ma9040301; Busbee BD, 2003, ADV MATER, V15, P414, DOI 10.1002/adma.200390095; Carballido-Landeira J, 2012, CHEMPHYSCHEM, V5, P1347; Castner DG, 1996, LANGMUIR, V12, P5083, DOI 10.1021/la960465w; Caswell KK, 2003, J AM CHEM SOC, V125, P13914, DOI 10.1021/ja037969i; Courty A, 2007, NAT MATER, V6, P900, DOI 10.1038/nmat2004; Dewi MR, 2014, RSC ADV, V4, P34217, DOI 10.1039/c4ra05035e; Doyle G, 2007, APPL PHYS A-MATER, V89, P351, DOI 10.1007/s00339-007-4126-2; Dujardin E, 2001, CHEM COMMUN, P1264, DOI 10.1039/b102319p; ESUMI K, 1995, LANGMUIR, V11, P3285, DOI 10.1021/la00009a002; Farcau C, 2010, ACS NANO, V4, P7275, DOI 10.1021/nn102128w; Ferry DK, 2008, SCIENCE, V319, P579, DOI 10.1126/science.1154446; GRUNDNER M, 1986, APPL PHYS A-MATER, V39, P73, DOI 10.1007/BF00616822; Gui Chen, 2012, Cancer Biology Medicine, V9, P221, DOI 10.7497/j.issn.2095-3941.2012.04.002; Halder A, 2007, ADV MATER, V19, P1854, DOI 10.1002/adma.200602325; Hanafusa T., CONTROLLING SELFASSE; Hsieh SC, 2002, J PHYS CHEM B, V106, P231, DOI 10.1021/jp012747x; Hu JQ, 2004, ADV FUNCT MATER, V14, P183, DOI 10.1002/adfm.200304421; Hu MH, 2001, APPL SURF SCI, V181, P307, DOI 10.1016/S0169-4332(01)00399-3; Hu M, 2006, CHEM SOC REV, V35, P1084, DOI 10.1039/b517615h; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Huo ZY, 2008, NANO LETT, V8, P2041, DOI 10.1021/nl8013549; Isfort G, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.033408; Isfort G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.033404; Jana NR, 2001, CHEM COMMUN, P617, DOI 10.1039/b100521i; Jana NR, 2002, J MATER CHEM, V12, P2909, DOI 10.1039/b205225c; Jana NR, 2001, J PHYS CHEM B, V105, P4065, DOI 10.1021/jp0107964; de Aberasturi DJ, 2016, CHEM MATER, V28, P6779, DOI 10.1021/acs.chemmater.6b03349; Kim F, 2002, J AM CHEM SOC, V124, P14316, DOI 10.1021/ja028110o; Laurent G, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045430; Lee MT, 1998, LANGMUIR, V14, P6419, DOI 10.1021/la980724c; Li B, 2015, NANO LETT, V15, P6722, DOI 10.1021/acs.nanolett.5b02582; Li YN, 2011, LANGMUIR, V27, P98, DOI 10.1021/la104131y; Li YN, 2005, J AM CHEM SOC, V127, P3266, DOI 10.1021/ja043425k; Lin J, 2001, MATER LETT, V49, P282, DOI 10.1016/S0167-577X(00)00385-2; Lu XM, 2008, J AM CHEM SOC, V130, P8900, DOI 10.1021/ja803343m; Luderitz LAC, 2013, J COLLOID INTERF SCI, V402, P19, DOI 10.1016/j.jcis.2012.11.007; Mbindyo JKN, 2001, ADV MATER, V13, P249, DOI 10.1002/1521-4095(200102)13:4<249::AID-ADMA249>3.0.CO;2-9; Mikhlin Y, 2010, J ELECTRON SPECTROSC, V177, P24, DOI 10.1016/j.elspec.2009.12.007; Millstone JE, 2005, J AM CHEM SOC, V127, P5312, DOI 10.1021/ja043245a; Ming T, 2008, ANGEW CHEM INT EDIT, V47, P9685, DOI 10.1002/anie.200803642; Moon SY, 2010, NANOSCALE RES LETT, V5, P813, DOI 10.1007/s11671-010-9565-6; Munekata T, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052314; Niidome Y, 2003, CHEM COMMUN, P2376, DOI 10.1039/b307836a; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Nikoobakht B, 2000, J PHYS CHEM B, V104, P8635, DOI 10.1021/jp001287p; Norman TJ, 2002, J PHYS CHEM B, V106, P7005, DOI 10.1021/jp0204197; Ormonde A. D., NANOSPEHERE LITOGRAP; Perez-Juste J, 2005, COORDIN CHEM REV, V249, P1870, DOI 10.1016/j.ccr.2005.01.030; Perez-Juste J, 2004, ADV FUNCT MATER, V14, P571, DOI 10.1002/adfm.200305068; Pluchery O, 2016, MRS P, V1817, P60; Rawtani D, 2015, REV ADV MATER SCI, V40, P177; Rodriguez-Leon E, 2015, NANOSCALE RES LETT, V10, DOI 10.1186/s11671-015-0804-8; Scarabelli L, 2015, J PHYS CHEM LETT, V6, P4270, DOI 10.1021/acs.jpclett.5b02123; Schubert I, 2016, ADV OPT MATER, V4, P1838, DOI 10.1002/adom.201600430; Schwartzberg AM, 2007, J PHYS CHEM C, V111, P8892, DOI 10.1021/jp067697g; Shi DW, 2013, CHEM COMMUN, V49, P2533, DOI 10.1039/c3cc39093d; Smith PA, 2000, APPL PHYS LETT, V77, P1399, DOI 10.1063/1.1290272; Srivastava S, 2009, SOFT MATTER, V5, P1146, DOI 10.1039/b812115j; Sun YG, 2002, CHEM MATER, V14, P4736, DOI 10.1021/cm020587b; TORIGOE K, 1992, LANGMUIR, V8, P59, DOI 10.1021/la00037a013; Utgenannt A, 2016, ACS NANO, V10, P2232, DOI 10.1021/acsnano.5b06886; Wei ZQ, 2004, LANGMUIR, V20, P4322, DOI 10.1021/la049702i; Wirde M, 1997, NUCL INSTRUM METH B, V131, P245, DOI 10.1016/S0168-583X(97)00140-7; Xiao JY, 2014, NANOSCALE, V6, P996, DOI 10.1039/c3nr05343a; Xiong YJ, 2003, ADV MATER, V15, P405, DOI 10.1002/adma.200390092; Yu YY, 1997, J PHYS CHEM B, V101, P6661; Zerulla D, 1999, LANGMUIR, V15, P5285, DOI 10.1021/la980300i; Zerulla D, 1998, SURF SCI, V402, P604, DOI 10.1016/S0039-6028(98)00015-6; Zhang FX, 2004, LANGMUIR, V20, P2309, DOI 10.1021/la0354638; Zhang Y, 2012, LANGMUIR, V28, P17101, DOI 10.1021/la302290v; Zhang Y, 2012, ADV MATER, V24, P2485, DOI 10.1002/adma.201103991; Zhang Y, 2011, LANGMUIR, V27, P15292, DOI 10.1021/la203863p; Zweifel DA, 2005, CHEM MATER, V17, P4256, DOI 10.1021/cm0506858	77	3	3	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195859	10.1371/journal.pone.0195859	http://dx.doi.org/10.1371/journal.pone.0195859			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664920	gold, Green Submitted, Green Published			2022-12-26	WOS:000430262300039
J	Okamoto, M; Miyake, T; Kitai, K; Furukawa, S; Yamamoto, S; Senba, H; Kanzaki, S; Deguchi, A; Koizumi, M; Ishihara, T; Miyaoka, H; Yoshida, O; Hirooka, M; Kumagi, T; Abe, M; Matsuura, B; Hiasa, Y				Okamoto, Masashi; Miyake, Teruki; Kitai, Kohichiro; Furukawa, Shinya; Yamamoto, Shin; Senba, Hidenori; Kanzaki, Sayaka; Deguchi, Akiko; Koizumi, Mitsuhito; Ishihara, Toru; Miyaoka, Hiroaki; Yoshida, Osamu; Hirooka, Masashi; Kumagi, Teru; Abe, Masanori; Matsuura, Bunzo; Hiasa, Yoichi			Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: A longitudinal cohort study	PLOS ONE			English	Article							MODERATE ALCOHOL-CONSUMPTION; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; ACTIVE SMOKING; TRANSFERASE; ADIPONECTIN; POPULATION; PREVALENCE; PREDICTOR; NAFLD	Background The effect of cigarette smoking on the onset of nonalcoholic fatty liver disease (NAFLD) is unclear, especially that associated with drinking small amounts of alcohol. We conducted a longitudinal study to investigate the relationship between cigarette smoking and NAFLD onset, which was stratified according to the amount of alcohol consumed. Methods We enrolled 7,905 Japanese subjects who had received annual health checkups more than twice between April 2003 and August 2013, 4,045 of whom met at least one of the following exclusion criteria and were excluded: (a) fatty liver at baseline; (b) hepatitis B or hepatitis C; (c) alcohol consumption (men: >= 210 g/wk; women: >= 140 g/wk); (d) change in alcohol drinking status between baseline and the study's endpoint; (e) change in cigarette smoking habits between baseline and the study's endpoint; or (f) current treatment with antidiabetic agents, antihypertensive agents, and/or lipid-lowering agents. The remaining 3,860 subjects (1,512 men, 2,348 women) were divided into two groups based on average alcohol consumption. Results After adjusting for the variables associated with metabolic disease, smoking was associated with fatty liver disease onset compared with nonsmokers in nondrinkers (adjusted hazard ratio = 1.988, 95% confidence interval 1.057-3.595; p = 0.034). No association was found between smoking and fatty liver disease onset in the low alcohol consumption group (men: <210 g alcohol/week; women: <140 g alcohol/week). The fatty liver disease incidence increased significantly among the nondrinkers as the number of cigarettes smoked increased (p = 0.001). Conclusions Cigarette smoking may be a significant risk factor associated with NAFLD onset in nondrinkers. These results may help clinicians to identify patients who are at a high risk of developing NAFLD and to prevent the progression of NAFLD by promoting earlier interventions that help people discontinue unhealthy lifestyle habits.	[Okamoto, Masashi; Miyake, Teruki; Senba, Hidenori; Kanzaki, Sayaka; Deguchi, Akiko; Koizumi, Mitsuhito; Ishihara, Toru; Yoshida, Osamu; Hirooka, Masashi; Abe, Masanori; Hiasa, Yoichi] Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Ehime, Japan; [Kitai, Kohichiro; Koizumi, Mitsuhito; Ishihara, Toru] Ehime Gen Hlth Care Assoc, Matsuyama, Ehime, Japan; [Furukawa, Shinya] Ehime Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Toon, Ehime, Japan; [Furukawa, Shinya] Ehime Univ Hosp, Epidemiol & Med Stat Unit, Translat Res Ctr, Toon, Ehime, Japan; [Yamamoto, Shin; Matsuura, Bunzo] Ehime Univ, Dept Lifestyle Related Med & Endocrinol, Grad Sch Med, Toon, Ehime, Japan; [Miyaoka, Hiroaki] Saiseikai Matsuyama Hosp, Dept Internal Med, Matsuyama, Ehime, Japan; [Kumagi, Teru] Ehime Univ, Dept Community Med, Grad Sch Med, Toon, Ehime, Japan	Ehime University; Ehime University; Ehime University; Ehime University; Ehime University	Miyake, T (corresponding author), Ehime Univ, Dept Gastroenterol & Metabol, Grad Sch Med, Toon, Ehime, Japan.	teruki-ygc@umin.ac.jp	Furukawa, Shinya/ABB-2804-2020; Kumagi, Teru/AAS-7427-2021; Hiasa, Yoichi/ABD-2759-2021	Furukawa, Shinya/0000-0002-0041-7688; Kumagi, Teru/0000-0002-2292-7750; Hiasa, Yoichi/0000-0003-4117-339X; Miyake, Teruki/0000-0002-9905-5356	Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI) [15K00874, 15K09006]; Ehime University	Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ehime University	This work was supported in part by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI 15K00874 to T.M., 15K09006 to Y.H.), and a research grant from Ehime University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by a grant-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (JSPS KAKENHI 15K00874 to T.M., 15K09006 to Y.H.) and a research grant from Ehime University.	Akbar DH, 2003, DIABETES CARE, V26, P3351, DOI 10.2337/diacare.26.12.3351-a; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Azzalini L, 2010, HEPATOLOGY, V51, P1567, DOI 10.1002/hep.23516; Bae JC, 2011, DIABETES CARE, V34, P727, DOI 10.2337/dc10-1991; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Chavez-Tapia NC, 2006, WORLD J GASTROENTERO, V12, P5196; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Fromenty B, 2009, J PHARMACOL EXP THER, V331, P23, DOI 10.1124/jpet.109.155168; Gunji T, 2009, AM J GASTROENTEROL, V104, P2189, DOI 10.1038/ajg.2009.361; Hamabe A, 2011, J GASTROENTEROL, V46, P769, DOI 10.1007/s00535-011-0376-z; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Ishigami T, 2014, CLIN EXP NEPHROL, V18, P899, DOI 10.1007/s10157-014-0938-5; Kojima S, 2003, J GASTROENTEROL, V38, P954, DOI 10.1007/s00535-003-1178-8; Lin C, 2014, ENVIRON RES, V132, P264, DOI 10.1016/j.envres.2014.04.005; Liu Y, 2013, J EPIDEMIOL, V23, P115, DOI 10.2188/jea.JE20120067; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MENDELOFF AI, 1954, J CLIN INVEST, V33, P1298, DOI 10.1172/JCI103005; Moriya A, 2015, J HEPATOL, V62, P921, DOI 10.1016/j.jhep.2014.11.025; Oniki K, 2013, TOXICOL LETT, V220, P143, DOI 10.1016/j.toxlet.2013.04.019; Sierksma A, 2004, DIABETES CARE, V27, P184, DOI 10.2337/diacare.27.1.184; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; You M, 2005, HEPATOLOGY, V42, P568, DOI 10.1002/hep.20821; Yuan HW, 2009, J HEPATOL, V51, P535, DOI 10.1016/j.jhep.2009.03.026	26	22	23	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195147	10.1371/journal.pone.0195147	http://dx.doi.org/10.1371/journal.pone.0195147			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664906	Green Published, gold			2022-12-26	WOS:000430262300015
J	Dechner, A; Flesher, KM; Lindell, C; de Oliveira, TV; Maurer, BA				Dechner, Andrea; Flesher, Kevin M.; Lindell, Catherine; de Oliveira, Teo Vega; Maurer, Brian A.			Determining carnivore habitat use in a rubber/forest landscape in Brazil using multispecies occupancy models	PLOS ONE			English	Article							ESTIMATING SITE OCCUPANCY; ATLANTIC FOREST; SOUTHERN BAHIA; CAMERA TRAPS; NASUA-NASUA; WILDLIFE; SELECTION; IMPACTS; CONSERVATION; DISTURBANCE	Understanding the factors that influence the presence and distribution of carnivores in human-dominated agricultural landscapes is one of the main challenges for biodiversity conservation, especially in landscapes where setting aside large protected areas is not feasible. Habitat use models of carnivore communities in rubber plantations are lacking despite the critical roles carnivores play in structuring ecosystems and the increasing expansion of rubber plantations. We investigated the habitat use of a mammalian carnivore community within a 4,200-ha rubber plantation/forest landscape in Bahia, Brazil. We placed two different brands of camera traps in a 90-site grid. We used a multispecies occupancy model to determine the probabilities of habitat use by each species and the effect of different brands of camera traps on their detection probabilities. Species showed significant differences in habitat use with domestic dogs (Canis familiaris) and crab-eating foxes (Cerdocyon thous) having higher probabilities of using rubber groves and coatis (Nasua nasua) having a higher probability of using forest. The moderate level of captures and low detection probabilities (<= 0.1) of tayras (Eira barbara) and wildcats (Leopardus spp.) precluded a precise estimation of habitat use probabilities using the multispecies occupancy model. The different brands of camera traps had a significant effect on the detection probability of all species. Given that the carnivore community has persisted in this 70-year-old landscape, the results show the potential of rubber/forest landscapes to provide for the long-term conservation of carnivore communities in the Atlantic forest, especially in mosaics with 30-40% forest cover and guard patrolling systems. The results also provide insights for mitigating the impact of rubber production on biodiversity.	[Dechner, Andrea; Maurer, Brian A.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Dechner, Andrea; Lindell, Catherine; Maurer, Brian A.] Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA; [Flesher, Kevin M.] Reserva Ecol Michelin, Ctr Estudos Biodiversidade, Igrapiuna, BA, Brazil; [Lindell, Catherine] Michigan State Univ, Dept Integrat Biol, E Lansing, MI 48824 USA; [Lindell, Catherine] Michigan State Univ, Ctr Global Change & Earth Observat, E Lansing, MI 48824 USA; [de Oliveira, Teo Vega] Univ Estadual Feira de Santana, Div Mamiferos, Dept Ciencias Biol, Museu Zool, Feira De Santana, BA, Brazil; [Maurer, Brian A.] Michigan State Univ, Ctr Stat Training & Consulting, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University; Michigan State University; Universidade Estadual de Feira de Santana; Michigan State University	Dechner, A (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.; Dechner, A (corresponding author), Michigan State Univ, Program Ecol Evolutionary Biol & Behav, E Lansing, MI 48824 USA.	dechners@msu.edu		Dechner, Andrea/0000-0002-9704-6798	Reserva Ecologica Michelin, Bahia, Brazil; Michelin	Reserva Ecologica Michelin, Bahia, Brazil; Michelin	This work was funded in whole by a grant to AD from Reserva Ecologica Michelin, Bahia, Brazil. The funder also provided support in the form of salaries for KMF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.; We thank Michelin for logistical and financial support, and the Michelin personnel who helped on a daily basis, especially Sonia Freitas da Hora, Tipo da Lapa and Andre Souza dos Santos. We also thank Lauren Philips for her help identifying the Leopardus species, often difficult to distinguish in the photographs. We thank Bernardo Maestrini for his comments on the manuscript. Finally, we thank the editor and the anonymous reviewers who made valuable comments that improved the manuscript.	[Anonymous], 2015, BASIC STEPS GEOSTATI; Banks-Leite C, 2014, J APPL ECOL, V51, P849, DOI 10.1111/1365-2664.12272; Beissinger SR, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P413, DOI 10.1016/B978-0-12-387020-9.00013-4; Broms KM, 2016, ECOLOGY, V97, P1759, DOI 10.1890/15-1471.1; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Caruso N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150488; Cassano CR, 2012, BIOTROPICA, V44, P818, DOI 10.1111/j.1744-7429.2012.00870.x; Cassano CR, 2009, BIODIVERS CONSERV, V18, P577, DOI 10.1007/s10531-008-9526-x; Cove MV, 2013, TROP CONSERV SCI, V6, P781, DOI 10.1177/194008291300600606; DANIELSON BJ, 1992, EVOL ECOL, V6, P399, DOI 10.1007/BF02270700; DeMatteo KE, 2008, BIOL CONSERV, V141, P2494, DOI 10.1016/j.biocon.2008.07.010; Donald PF, 2004, CONSERV BIOL, V18, P17, DOI 10.1111/j.1523-1739.2004.01803.x; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Estevo CA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179489; FAO JRC, 2012, GLOB FOR LAND US CHA; Flesher K., 2006, BIOGEOGRAPHY MEDIUM; Flesher KM, 2013, TROP CONSERV SCI, V6, P181, DOI 10.1177/194008291300600202; Foster RJ, 2010, BIOTROPICA, V42, P724, DOI 10.1111/j.1744-7429.2010.00641.x; Frigeri E, 2014, TROP CONSERV SCI, V7, P508, DOI 10.1177/194008291400700310; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gompper Matthew E., 1998, Mammalian Species, V580, P1; Hughson DL, 2010, CALIF FISH GAME, V96, P101; Jansen P.A., 2014, PROTOCOL CAMERA TRAP; Jean Desbiez Arnaud Leonard, 2010, Small Carnivore Conservation, V42, P14; Kerry R, 2007, COMPUT GEOSCI-UK, V33, P1212, DOI 10.1016/j.cageo.2007.05.008; Kucera TE, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, P9, DOI 10.1007/978-4-431-99495-4_2; Lacerda ACR, 2009, ANIM CONSERV, V12, P477, DOI 10.1111/j.1469-1795.2009.00277.x; Lyra-Jorge MC, 2008, BIODIVERS CONSERV, V17, P1573, DOI 10.1007/s10531-008-9366-8; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Mackenzie DI, 2005, J APPL ECOL, V42, P1105, DOI 10.1111/j.1365-2664.2005.01098.x; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; McDonald PJ, 2017, CONSERV BIOL, V31, P1183, DOI 10.1111/cobi.12905; Meek P, 2016, ECOL EVOL, V6, P3216, DOI 10.1002/ece3.2111; Ministry of Agriculture of Brazil, GOV EST PROD BORR AT; Mudappa D, 2007, SMALL CARNIVORE CONS, V36, P18; O'Connell AF, 2006, J WILDLIFE MANAGE, V70, P1625, DOI 10.2193/0022-541X(2006)70[1625:ESOADP]2.0.CO;2; Paschoal AMO, 2012, MAMMALIA, V76, P67, DOI 10.1515/mammalia-2012-0501; RCore Team, 2020, R LANG ENV STAT COMP; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Ribeiro P.J, 2001, R NEWS, V1, P14, DOI DOI 10.1159/000323281; Rocha-Santos L, 2012, TROP CONSERV SCI, V5, P475, DOI 10.1177/194008291200500406; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Rovero F, 2013, HYSTRIX, V24, P148, DOI 10.4404/hystrix-24.2-6316; Russell RE, 2009, ECOL APPL, V19, P1253, DOI 10.1890/08-0910.1; Schlexer FV., 2008, NONINVASIVE SURVEY M; TEAM Network, 2011, TERRESTRIAL VERTEBRA; Tobler MW, 2008, ANIM CONSERV, V11, P169, DOI 10.1111/j.1469-1795.2008.00169.x; Tobler MW, 2015, J APPL ECOL, V52, P413, DOI 10.1111/1365-2664.12399; Trolle M, 2003, BIODIVERS CONSERV, V12, P823, DOI 10.1023/A:1022489426920; Trovati RG, 2010, REV BIOL TROP, V58, P1069; Vieira EM, 2007, J ZOOL, V272, P57, DOI 10.1111/j.1469-7998.2006.00237.x; Warren-Thomas E, 2015, CONSERV LETT, V8, P230, DOI 10.1111/conl.12170; Weather CP, 2000, USING STAT UNDERSTAN; Weingarth K, 2013, WALDOKOL LANDSCH FOR, V13, P87; Zipkin EF, 2009, J APPL ECOL, V46, P815, DOI 10.1111/j.1365-2664.2009.01664.x	55	7	9	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195311	10.1371/journal.pone.0195311	http://dx.doi.org/10.1371/journal.pone.0195311			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659594	Green Published, Green Submitted, gold			2022-12-26	WOS:000430061100013
J	Lopez-Lopez, J; Garay, J; Wandurraga, E; Camacho, PA; Higuera-Escalante, F; Cohen, D; Lopez-Jaramillo, P				Lopez-Lopez, Jose; Garay, Jennifer; Wandurraga, Edwin; Camacho, Paul A.; Higuera-Escalante, Fernando; Cohen, Daniel; Lopez-Jaramillo, Patricio			The simultaneous assessment of glycosylated hemoglobin, fasting plasma glucose and oral glucose tolerance test does not improve the detection of type 2 diabetes mellitus in Colombian adults	PLOS ONE			English	Article							A1C; PREVALENCE; DIAGNOSIS; HBA(1C)	Introduction Guidelines recommend early detection of type 2 diabetes mellitus (DM2). The objective of the present study was to evaluate the capacity to identify DM2 in subjects that were screened for DM2 simultaneously with all three of the tests recommended-fasting plasma glucose (FPG), glycosylated hemoglobin (HbA1c) and a 2-hour post 75-g oral glucose tolerance test (OGTT). Methods and results The present analysis of an anonymous database of 1113 adults from a reference clinical laboratory in Bucaramanga, Colombia, was an observational, descriptive, cross-sectional secondary source study. 259 individuals met at least one of the criteria for DM2: FPG >= 126mg/dL (7.0mmol/L), HbA1c >= 6.5% (48mmol/mol) and OGTT >= 200mg/dL (11.1mmol/L). 30 subjects (2.7%) were diabetic according to FPG, 56 subjects (5.0%) by HbA1c and 250 subjects (22.5%) by OGTT. In total 259 subjects (23.3% [IC 95%: 20.7%-25.8%] were diabetic either by FPG, OGTT or HbA1c. Discussion The largest number of patients were identified as diabetic with the OGTT. The combination of two or three tests did not increase the detection of new cases of DM2. Our findings suggest that routinely requesting FPG, OGTT and HbA1c at the same time may be inappropriate in at risk individuals, as this approach does not significantly improve the diagnostic capacity compared to using FPG+OGTT and substantially increases the financial burden on the health system, insurers or individual.	[Lopez-Lopez, Jose; Garay, Jennifer] Univ Autonoma Bucaramanga UNAB, Internal Med Residence Program, Bucaramanga, Colombia; [Wandurraga, Edwin] Fdn Oftalmol Santander Clin Carlos Ardila Lulle F, Endocrinol Serv, Floridablanca, Colombia; [Camacho, Paul A.; Cohen, Daniel; Lopez-Jaramillo, Patricio] Fdn Oftalmol Santander FOSCAL, Res Dept, Floridablanca, Colombia; [Camacho, Paul A.] Univ Autonoma Bucaramanga UNAB, Fac Ciencias Salud, Bucaramanga, Colombia; [Higuera-Escalante, Fernando] Higuera Escalante Lab, Floridablanca, Colombia; [Cohen, Daniel; Lopez-Jaramillo, Patricio] Univ Santander UDES, MASIRA Inst, Fac Salud, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Autonoma Bucaramanga UNAB, Fac Ciencias Salud, Bucaramanga, Colombia; [Lopez-Jaramillo, Patricio] Univ Tecnol Equinoccial, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador	Universidad Industrial de Santander	Lopez-Jaramillo, P (corresponding author), Fdn Oftalmol Santander FOSCAL, Res Dept, Floridablanca, Colombia.; Lopez-Jaramillo, P (corresponding author), Univ Santander UDES, MASIRA Inst, Fac Salud, Bucaramanga, Colombia.; Lopez-Jaramillo, P (corresponding author), Univ Autonoma Bucaramanga UNAB, Fac Ciencias Salud, Bucaramanga, Colombia.; Lopez-Jaramillo, P (corresponding author), Univ Tecnol Equinoccial, Fac Ciencias Salud Eugenio Espejo, Quito, Ecuador.	jplopezj@gmail.com		Lopez-Jaramillo, Patricio/0000-0002-9122-8742; Camacho, Paul Anthony/0000-0002-6233-9582				American Diabetes Association, 2017, Diabetes Care, V40, pS11, DOI 10.2337/dc15-S005; Aschner PMV, 2016, COLOMB MEDICA, V2, P109; Barengo NC, 2013, RES REV, DOI [10.1002/dmrr.2462/abstract;jsessionid=1A94693CE7178B9B15B98BB652FEA7D1.f01t04, DOI 10.1002/DMRR.2462/ABSTRACT;JSESSI0NID=]; Barry E, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6538; Bennett CM, 2007, DIABETIC MED, V24, P333, DOI 10.1111/j.1464-5491.2007.02106.x; Cavagnolli G, 2011, DIABETIC MED, V28, P31, DOI 10.1111/j.1464-5491.2010.03159.x; Choi SH, 2011, DIABETES CARE, V34, P944, DOI 10.2337/dc10-0644; Dagenais GR, 2016, DIABETES CARE, V39, P780, DOI 10.2337/dc15-2338; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Ehehalt S, 2017, EUR J PEDIATR, V176, P89, DOI 10.1007/s00431-016-2807-6; Gomez-Arbelaez D, 2015, WORLD J DIABETES, V6, P1337, DOI 10.4239/wjd.v6.i17.1337; International Diabetes Federation, 2012, GLOB GUID TYP 2 DIAB; Karnchanasorn R, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6195494; Kumaravel B, 2012, DIABETES RES CLIN PR, V96, P211, DOI 10.1016/j.diabres.2011.12.004; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Lopez-Jaramillo P, 2014, WORLD J DIABETES, V5, P747, DOI 10.4239/wjd.v5.i6.747; Man B, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.160106; Millard AV, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00135; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Shibata K, 2005, J CLIN EPIDEMIOL, V58, P1052, DOI 10.1016/j.jclinepi.2005.01.019; Tabak AG, 2012, LANCET, V379, P2279, DOI 10.1016/S0140-6736(12)60283-9; Tunceli K, 2005, DIABETES CARE, V28, P2662, DOI 10.2337/diacare.28.11.2662; Warren B, 2017, LANCET DIABETES ENDO, V5, P34, DOI 10.1016/S2213-8587(16)30321-7; World Health Organization, 2011, US GLYC HAEM HBA1C D	26	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194446	10.1371/journal.pone.0194446	http://dx.doi.org/10.1371/journal.pone.0194446			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652881	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900006
J	Tauras, JA; Xu, X; Huang, JD; King, B; Lavinghouze, SR; Sneegas, KS; Chaloupka, FJ				Tauras, John A.; Xu, Xin; Huang, Jidong; King, Brian; Lavinghouze, S. Rene; Sneegas, Karla S.; Chaloupka, Frank J.			State tobacco control expenditures and tax paid cigarette sales	PLOS ONE			English	Article							CONTROL PROGRAMS; IMPACT	This research is the first nationally representative study to examine the relationship between actual state-level tobacco control spending in each of the 5 CDC's Best Practices for Comprehensive Tobacco Control Program categories and cigarette sales. We employed several alternative two-way fixed-effects regression techniques to estimate the determinants of cigarette sales in the United States for the years 2008-2012. State spending on tobacco control was found to have a negative and significant impact on cigarette sales in all models that were estimated. Spending in the areas of cessation interventions, health communication interventions, and state and community interventions were found to have a negative impact on cigarette sales in all models that were estimated, whereas spending in the areas of surveillance and evaluation, and administration and management were found to have negative effects on cigarette sales in only some models. Our models predict that states that spend up to seven times their current levels could still see significant reductions in cigarette sales. The findings from this research could help inform further investments in state tobacco control programs.	[Tauras, John A.] Univ Illinois, Dept Econ, Chicago, IL 60680 USA; [Xu, Xin; King, Brian; Lavinghouze, S. Rene; Sneegas, Karla S.] Ctr Dis Control & Prevent, Off Smoking & Hlth, Atlanta, GA USA; [Huang, Jidong] Georgia State Univ, Dept Hlth Management & Policy, Atlanta, GA 30303 USA; [Chaloupka, Frank J.] Univ Illinois, Div Hlth Policy & Adm, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Centers for Disease Control & Prevention - USA; University System of Georgia; Georgia State University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tauras, JA (corresponding author), Univ Illinois, Dept Econ, Chicago, IL 60680 USA.	tauras@uic.edu		Xu, Xin/0000-0002-5219-499X				Abt Associates Inc, 1999, IND EV MASS TOB CONT; Arizona Department of Health Services, 1999, 1999 AR AD TOB SURV; Bauer UE, 2000, JAMA-J AM MED ASSOC, V284, P723, DOI 10.1001/jama.284.6.723; Biener L, 2000, BRIT MED J, V321, P351, DOI 10.1136/bmj.321.7257.351; Campaign for Tobacco Free Kids, 2015, BROK PROM OUR CHILDR; *CDCP, 1999, BEST PRACT COMPR TOB; Center for Disease Control and Prevention, 2014, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention, 2007, BEST PRACT COMPR TOB; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P140; Centers for Disease Control and Prevention (CDC), 1996, MMWR Morb Mortal Wkly Rep, V45, P966; Ciecierski CC, 2011, HEALTH ECON, V20, P253, DOI 10.1002/hec.1583; Farrelly MC, 2008, AM J PUBLIC HEALTH, V98, P304, DOI 10.2105/AJPH.2006.106377; Farrelly MC, 2003, J HEALTH ECON, V22, P843, DOI 10.1016/S0167-6296(03)00057-2; Florida Department of Health, 2001, 1 FLOR DEP HLTH BUR, V4; Gilpin EA, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015370; Hansen BE, 1999, J ECONOMETRICS, V93, P345, DOI 10.1016/S0304-4076(99)00025-1; Huang J, 2014, STATE TOBACCO CONTRO; Huang J., 2013, TOB CONTROL, V23, piii41, DOI DOI 10.1136/TOBACCONTROL-2013-051515; Institute of Medicine, 2007, END TOB PROBL BLUE P; Lavinghouze R, 2013, J PUBLIC HEALTH MAN, V19, pE28, DOI 10.1097/PHH.0b013e31828554c8; Lavinghouze SR, 2014, AM J PUBLIC HEALTH, V104, pE14, DOI 10.2105/AJPH.2014.302033; Lightwood J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047145; Mai SK, 2007, HLTH CONS SMOK REP S, V2, P30; MALLOWS CL, 1986, TECHNOMETRICS, V28, P313, DOI 10.2307/1268980; Manley M W, 1997, Tob Control, V6 Suppl 2, pS12, DOI 10.1136/tc.6.suppl_2.S12; Massachusetts Department of Public Health, 2000, AD TOB US MASS TREND; *NAT ASS ATT GEN, MAST SETTL AGR; Orzechowski W, 2013, TAX BURDEN TOBACCO H; Tauras JA, 2005, AM J PUBLIC HEALTH, V95, P338, DOI 10.2105/AJPH.2004.039727; U. S. Bureau of Labor Statistics, 2014, LOC AR UN STAT; U. S. Census Bureau, 2014, POP EST HIST DAT; U. S. Census Bureau, 2014, POP EST ED ATT; US Bureau of Labor Statistics, 2014, CONS PRIC IND; US Department of Health and Human Services, 2000, RED TOB US REP SURG; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; Wakefield M, 2000, TOB CONTROL, V9, P177, DOI 10.1136/tc.9.2.177	36	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e194914	10.1371/journal.pone.0194914	http://dx.doi.org/10.1371/journal.pone.0194914			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652890	gold, Green Published, Green Submitted			2022-12-26	WOS:000430026900014
J	Al-Serori, H; Ferk, F; Kundi, M; Bileck, A; Gerner, C; Misik, M; Nersesyan, A; Waldherr, M; Murbach, M; Lah, TT; Herold-Mende, C; Collins, AR; Knasmuller, S				Al-Serori, Halh; Ferk, Franziska; Kundi, Michael; Bileck, Andrea; Gerner, Christopher; Misik, Miroslav; Nersesyan, Armen; Waldherr, Monika; Murbach, Manuel; Lah, Tamara T.; Herold-Mende, Christel; Collins, Andrew R.; Knasmueller, Siegfried			Mobile phone specific electromagnetic fields induce transient DNA damage and nucleotide excision repair in serum-deprived human glioblastoma cells	PLOS ONE			English	Article							RNA-POLYMERASE-II; COMET ASSAY; IN-VITRO; STRAND BREAKS; CANCER; EXPOSURE; GENE; RECOGNITION; EXPRESSION; RADIATION	Some epidemiological studies indicate that the use of mobile phones causes cancer in humans (in particular glioblastomas). It is known that DNA damage plays a key role in malignant transformation; therefore, we investigated the impact of the UMTS signal which is widely used in mobile telecommunications, on DNA stability in ten different human cell lines (six brain derived cell lines, lymphocytes, fibroblasts, liver and buccal tissue derived cells) under conditions relevant for users (SAR 0.25 to 1.00 W/kg). We found no evidence for induction of damage in single cell gel electrophoresis assays when the cells were cultivated with serum. However, clear positive effects were seen in a p53 proficient glioblastoma line (U87) when the cells were grown under serum free conditions, while no effects were found in p53 deficient glioblastoma cells (U251). Further experiments showed that the damage disappears rapidly in U87 and that exposure induced nucleotide excision repair (NER) and does not cause double strand breaks (DSBs). The observation of NER induction is supported by results of a proteome analysis indicating that several proteins involved in NER are up-regulated after exposure to UMTS; additionally, we found limited evidence for the activation of the gamma-interferon pathway. The present findings show that the signal causes transient genetic instability in glioma derived cells and activates cellular defense systems.	[Al-Serori, Halh; Ferk, Franziska; Misik, Miroslav; Nersesyan, Armen; Waldherr, Monika; Knasmueller, Siegfried] Med Univ Vienna, Dept Internal Med 1, Inst Canc Res, Vienna, Austria; [Kundi, Michael] Med Univ Vienna, Dept Environm Hlth, Ctr Publ Hlth, Vienna, Austria; [Bileck, Andrea; Gerner, Christopher] Univ Vienna, Dept Analyt Chem, Fac Chem, Vienna, Austria; [Murbach, Manuel] IT IS Fdn, Zurich, Switzerland; [Lah, Tamara T.] Natl Inst Biol, Dept Genet Toxicol & Canc Biol, Ljubljana, Slovenia; [Herold-Mende, Christel] Heidelberg Univ, Dept Neurosurg, Expt Neurosurg, Heidelberg, Germany; [Collins, Andrew R.] Univ Oslo, Dept Nutr, Oslo, Norway	Medical University of Vienna; Medical University of Vienna; University of Vienna; National Institute of Biology - Slovenia; Ruprecht Karls University Heidelberg; University of Oslo	Knasmuller, S (corresponding author), Med Univ Vienna, Dept Internal Med 1, Inst Canc Res, Vienna, Austria.	siegfried.knasmueller@meduniwien.ac.at		Gerner, Christopher/0000-0003-4964-0642; Bileck, Andrea/0000-0002-7053-8856; Collins, Andrew/0000-0001-5916-6871	Austrian Workers Compensation Board (Allgemeine Unfallversicherungsanstalt, AUVA)	Austrian Workers Compensation Board (Allgemeine Unfallversicherungsanstalt, AUVA)	This study was supported by the Austrian Workers Compensation Board (Allgemeine Unfallversicherungsanstalt, AUVA).	Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Ahlbom A, 2009, EPIDEMIOLOGY, V20, P639, DOI 10.1097/EDE.0b013e3181b0927d; Al-Serori H, 2017, TOXICOL IN VITRO, V40, P264, DOI 10.1016/j.tiv.2017.01.012; Ames BN, 1997, ENVIRON HEALTH PERSP, V105, P865, DOI 10.2307/3433296; Araujo SJ, 2000, GENE DEV, V14, P349; Attia AMM, 2011, RADIAT PHYS CHEM, V80, P1178, DOI 10.1016/j.radphyschem.2011.06.010; Azqueta A, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00288; Bileck A, 2016, ARCH TOXICOL, V90, P1369, DOI 10.1007/s00204-015-1569-7; Bileck A, 2014, J PROTEOME RES, V13, P5989, DOI 10.1021/pr5008625; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Clarkson SG, 2005, DNA REPAIR, V4, P1068, DOI 10.1016/j.dnarep.2005.07.001; Collins AR, 2008, MUTAGENESIS, V23, P143, DOI 10.1093/mutage/gem051; Collins AR, 2015, MUTAGENESIS, V30, P1, DOI 10.1093/mutage/geu079; Collins AR, 2009, ISSUES TOXICOL, V5, P201, DOI 10.1039/9781847559746-00201; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Corbi N, 2002, FASEB J, V16, P1639, DOI 10.1096/fj.02-0123fje; Cox J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S16-S12; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dexheimer TS, 2013, DNA REPAIR CANC STEM; Ford JM, 2005, MUTAT RES-FUND MOL M, V577, P195, DOI 10.1016/j.mrfmmm.2005.04.005; Groessl M, 2014, J PROTEOME RES, V13, P4773, DOI 10.1021/pr500727h; Heo JH, 2004, BIOCHEM BIOPH RES CO, V325, P892, DOI 10.1016/j.bbrc.2004.10.101; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2013, IARC Monogr Eval Carcinog Risks Hum, V102, P1; Ivancsits S, 2002, MUTAT RES-GEN TOX EN, V519, P1, DOI 10.1016/S1383-5718(02)00109-2; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Janigro D, 2006, CELL CYCLE CENTRAL N; Kimura M, 1997, J BIOL CHEM, V272, P25851, DOI 10.1074/jbc.272.41.25851; Kundi M, 2009, ENVIRON HEALTH PERSP, V117, P316, DOI 10.1289/ehp.11902; Lee JE, 2002, ANN SURG ONCOL, V9, P587; Lerchl A, 2010, MUTAT RES, V583, p[178, 60]; Lerchl A, 2010, MUTAT RES-GEN TOX EN, V697, P60, DOI 10.1016/j.mrgentox.2010.01.010; Manna D, 2016, ELECTROMAGN BIOL MED, V35, P265, DOI 10.3109/15368378.2015.1092158; Morgan LL, 2015, INT J ONCOL, V46, P1865, DOI 10.3892/ijo.2015.2908; Overmeer RM, 2010, MOL CELL BIOL, V30, P4828, DOI 10.1128/MCB.00285-10; Sannino A, 2009, RADIAT RES, V171, P735, DOI 10.1667/RR1687.1; Schuderer J, 2004, IEEE T MICROW THEORY, V52, P2057, DOI 10.1109/TMTT.2004.832009; Schwarz C, 2008, INT ARCH OCC ENV HEA, V81, P755, DOI 10.1007/s00420-008-0305-5; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Sharma Arishya, 2012, Methods Mol Biol, V920, P613, DOI 10.1007/978-1-61779-998-3_40; Siddiqui MS, 2015, MUTAT RES-REV MUTAT, V766, P1, DOI 10.1016/j.mrrev.2015.07.001; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Sokal RR, 1994, BIOMETRY PRINCIPLES, V3rd; Speit G, 2013, MUTAT RES-GEN TOX EN, V755, P163, DOI 10.1016/j.mrgentox.2013.06.014; Tice RR, 2000, ENVIRON MOL MUTAGEN, V35, P206, DOI 10.1002/(SICI)1098-2280(2000)35:3<206::AID-EM8>3.0.CO;2-J; van Steeg H, 2001, TOXICOL LETT, V120, P209, DOI 10.1016/S0378-4274(01)00297-1; Vijayalaxmi, 2014, INT J ENV RES PUB HE, V11, P9376, DOI 10.3390/ijerph110909376; Wang BH, 2005, MUTAT RES-FUND MOL M, V578, P149, DOI 10.1016/j.mrfmmm.2005.05.001; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]	49	12	12	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0193677	10.1371/journal.pone.0193677	http://dx.doi.org/10.1371/journal.pone.0193677			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649215	Green Submitted, gold, Green Published			2022-12-26	WOS:000429791900005
J	Cruise, A; Watson, DW; Schal, C; Doucet, D				Cruise, Angela; Watson, David W.; Schal, Coby; Doucet, Daniel			Ecological succession of adult necrophilous insects on neonate Sus scrofa domesticus in central North Carolina	PLOS ONE			English	Article							GREEN BOTTLE FLY; ARTHROPOD SUCCESSION; LUCILIA-SERICATA; CARRION; DECOMPOSITION; CALLIPHORIDAE; DIPTERA; FLIES; PATTERNS; STRATEGIES	The necrophilous insect fauna on carcasses varies seasonally and geographically. The ecological succession of insects arriving to decaying neonate pig carcasses in central North Carolina during late summer was sampled using a novel vented-chamber collection method. We collected six blow fly species, flesh flies, house flies and 10 beetle taxa, including four species of scarab beetles. Necrophilous fly activity dominated the early decomposition stages, whereas beetle numbers remained low until day 4. By day 7, more than 50% of the pig carcasses were skeletonized and they attracted few insects. Differences in the taxa and successional patterns documented in this experiment and a previous study in the same location highlight the ecological variation in such investigations, and underscore the need for standardization, as well as for ecological succession studies on finer geographic scales.	[Cruise, Angela; Watson, David W.; Schal, Coby] North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA; [Schal, Coby] North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA; [Cruise, Angela] Carolina Biol Supply Co, Burlington, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Schal, C (corresponding author), North Carolina State Univ, Dept Entomol & Plant Pathol, Raleigh, NC 27695 USA.; Schal, C (corresponding author), North Carolina State Univ, WM Keck Ctr Behav Biol, Raleigh, NC 27695 USA.	coby@ncsu.edu	Schal, Coby/A-8717-2010	Schal, Coby/0000-0001-7195-6358	National Science Foundation (GRFP) [DGE-1252376]; Blanton J. Whitmire Endowment at NC State University	National Science Foundation (GRFP)(National Science Foundation (NSF)); Blanton J. Whitmire Endowment at NC State University	Partial funding for this work was from a Graduate Research Fellowship from the National Science Foundation (GRFP Award DGE-1252376) (AC) and the Blanton J. Whitmire Endowment at NC State University (CS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Almeida LM, 2009, REV BRAS ENTOMOL, V53, P227, DOI 10.1590/S0085-56262009000200006; Anderson GS, 1996, J FORENSIC SCI, V41, P617; Anderson GS, 2001, FORENSIC ENTOMOLOGY, V143, P76; [Anonymous], 2016, JMP PRO 13 1 0 JMP P; [Anonymous], 2012, SAS 9 4 STAT AN SYST; Archer MS, 2003, MED VET ENTOMOL, V17, P263, DOI 10.1046/j.1365-2915.2003.00430.x; Archer MS, 2003, AUST J ZOOL, V51, P165, DOI 10.1071/ZO02067; Brodie B, 2014, ENTOMOL EXP APPL, V153, P114, DOI 10.1111/eea.12238; Brundage A, 2014, ECOL ENTOMOL, V39, P539, DOI 10.1111/een.12128; Byrd JH, 2000, FORENSIC ENTOMOLOGY, P43; Cammack JA, 2016, J MED ENTOMOL, V53, P67, DOI 10.1093/jme/tjv183; Carter DO, 2007, NATURWISSENSCHAFTEN, V94, P12, DOI 10.1007/s00114-006-0159-1; Cruise AM, 2017, SAMPLING ECOLOGICAL; Cruise A, 2018, J MED ENTOMOL, V55, P947, DOI 10.1093/jme/tjx255; DENNO RF, 1976, ANN ENTOMOL SOC AM, V69, P109; EARLY M, 1986, J MED ENTOMOL, V23, P520, DOI 10.1093/jmedent/23.5.520; Gallagher MB, 2010, J FORENSIC SCI, V55, P438, DOI 10.1111/j.1556-4029.2009.01285.x; Gill-King H., 1996, FORENSIC TAPHONOMY P, P93; Goff M L, 1993, Forensic Sci Rev, V5, P81; Grassberger M, 2004, J MED ENTOMOL, V41, P511, DOI 10.1603/0022-2585-41.3.511; HEWADIKARAM KA, 1991, AM J FOREN MED PATH, V12, P235, DOI 10.1097/00000433-199109000-00013; Hocking MD, 2009, ECOL RES, V24, P1091, DOI 10.1007/s11284-009-0586-5; Hwang C, 2005, MED VET ENTOMOL, V19, P379, DOI 10.1111/j.1365-2915.2005.00583.x; KUUSELA S, 1982, HOLARCTIC ECOL, V5, P337; Lindquist A. W., 1933, Journal of the Kansas Entomological Society, V6, P109; Matuszewski S, 2016, INT J LEGAL MED, V130, P221, DOI 10.1007/s00414-015-1145-y; Merritt R. W., 2015, CARRION ECOLOGY EVOL, P65, DOI DOI 10.1201/B18819-6; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Paczkowski S, 2012, J FORENSIC SCI, V57, P1497, DOI 10.1111/j.1556-4029.2012.02245.x; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal J. L., 2015, FORENSIC ENTOMOLOGY, P347; Castro CPE, 2011, ANN SOC ENTOMOL FR, V47, P128; PUTMAN RJ, 1978, ECOL ENTOMOL, V3, P133, DOI 10.1111/j.1365-2311.1978.tb00911.x; SCHOENLY K, 1987, OECOLOGIA, V73, P192, DOI 10.1007/BF00377507; Sharanowski BJ, 2008, FORENSIC SCI INT, V179, P219, DOI 10.1016/j.forsciint.2008.05.019; Singh D, 2001, FORENSIC SCI INT, V120, P124, DOI 10.1016/S0379-0738(01)00419-4; Smith AE, 2002, THESIS; Smith KE, 1997, MED VET ENTOMOL, V11, P38, DOI 10.1111/j.1365-2915.1997.tb00287.x; Tabor Kreitlow K.L., 2010, FORENSIC ENTOMOLOGY, V2nd ed., P251; Tomberlin JK, 2011, ANNU REV ENTOMOL, V56, P401, DOI 10.1146/annurev-ento-051710-103143; Tomberlin J.K., 2012, J FORENSIC RES, V3, P1, DOI DOI 10.4172/2157-7145.1000147; Tomberlin JK, 2011, TRENDS ECOL EVOL, V26, P53, DOI 10.1016/j.tree.2010.12.001; Triplehorn C., 2005, BORRER DELONGS INTRO, V7; Villet M. H., 2011, Pest Technology, V5, P1; Whitworth T, 2006, P ENTOMOL SOC WASH, V108, P689	45	14	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195785	10.1371/journal.pone.0195785	http://dx.doi.org/10.1371/journal.pone.0195785			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649331	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900088
J	Elacqua, JJ; McGregor, AL; Lammerding, J				Elacqua, Joshua J.; McGregor, Alexandra L.; Lammerding, Jan			Automated analysis of cell migration and nuclear envelope rupture in confined environments	PLOS ONE			English	Article							BREAST-CANCER; LAMIN A/C; TRACTION FORCE; DEFORMATION; METASTASIS; CONSEQUENCES; PROTEOLYSIS; STIFFNESS; BARRIER; SQUEEZE	Recent in vitro and in vivo studies have highlighted the importance of the cell nucleus in governing migration through confined environments. Microfluidic devices that mimic the narrow interstitial spaces of tissues have emerged as important tools to study cellular dynamics during confined migration, including the consequences of nuclear deformation and nuclear envelope rupture. However, while image acquisition can be automated on motorized microscopes, the analysis of the corresponding time-lapse sequences for nuclear transit through the pores and events such as nuclear envelope rupture currently requires manual analysis. In addition to being highly time-consuming, such manual analysis is susceptible to person-to-person variability. Studies that compare large numbers of cell types and conditions therefore require automated image analysis to achieve sufficiently high throughput. Here, we present an automated image analysis program to register microfluidic constrictions and perform image segmentation to detect individual cell nuclei. The MATLAB program tracks nuclear migration over time and records constriction-transit events, transit times, transit success rates, and nuclear envelope rupture. Such automation reduces the time required to analyze migration experiments from weeks to hours, and removes the variability that arises from different human analysts. Comparison with manual analysis confirmed that both constriction transit and nuclear envelope rupture were detected correctly and reliably, and the automated analysis results closely matched a manual analysis gold standard. Applying the program to specific biological examples, we demonstrate its ability to detect differences in nuclear transit time between cells with different levels of the nuclear envelope proteins lamin A/C, which govern nuclear deformability, and to detect an increase in nuclear envelope rupture duration in cells in which CHMP7, a protein involved in nuclear envelope repair, had been depleted. The program thus presents a versatile tool for the study of confined migration and its effect on the cell nucleus.	[Elacqua, Joshua J.; McGregor, Alexandra L.; Lammerding, Jan] Cornell Univ, Weill Inst Cell & Mol Biol, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA	Cornell University	Lammerding, J (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Meinig Sch Biomed Engn, Ithaca, NY 14850 USA.	jan.lammerding@comell.edu	Lammerding, Jan/A-9498-2016	Lammerding, Jan/0000-0003-4335-8611	National Institutes of Health [R01 HL082792, U54 CA210184]; Department of Defense Breast Cancer Research Program (Congressionally Directed Medical Research Program) [BC150580]; National Science Foundation [CAREER] [CBET-1254846]; Cornell University College of Engineering; National Science Foundation [ECCS-1542081]; NATIONAL CANCER INSTITUTE [U54CA210184] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1254846] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program (Congressionally Directed Medical Research Program)(United States Department of Defense); National Science Foundation [CAREER](National Science Foundation (NSF)); Cornell University College of Engineering; National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by awards from the National Institutes of Health [R01 HL082792 (National Heart, Lung, and Blood Institute) and U54 CA210184 (National Cancer Institute), to J.L.]; the Department of Defense Breast Cancer Research Program (Congressionally Directed Medical Research Program) [Breakthrough Award BC150580, to J.L.], the National Science Foundation [CAREER Award CBET-1254846, to J.L.; GRFP Award DGE-1144153 to A.L.M.]; and the Cornell University College of Engineering [Engineering Learning Initiatives Grant, to J.E.]. This work was performed in part at the Cornell NanoScale Facility, a member of the National Nanotechnology Coordinated Infrastructure (NNCI), which is supported by the National Science Foundation (Grant ECCS-1542081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell ES, 2016, EUR J CELL BIOL, V95, P449, DOI 10.1016/j.ejcb.2016.06.007; Capo-chichi Callinice D, 2011, Chin J Cancer, V30, P415; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Davidson PM, 2015, INTEGR BIOL-UK, V7, P1534, DOI 10.1039/c5ib00200a; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Friedl P, 2011, CURR OPIN CELL BIOL, V23, P55, DOI 10.1016/j.ceb.2010.10.015; Fu Y, 2012, LAB CHIP, V12, P3774, DOI 10.1039/c2lc40477j; Harada T, 2014, J CELL BIOL, V204, P669, DOI 10.1083/jcb.201308029; Irianto J, 2016, CELL MOL BIOENG, V9, P258, DOI 10.1007/s12195-016-0437-8; Isermann P, 2017, NUCLEUS-PHILA, V8, P268, DOI 10.1080/19491034.2017.1292191; Krause M, 2015, CELL ADHES MIGR, V9, P357, DOI 10.1080/19336918.2015.1061173; Lammerding J, 2006, J BIOL CHEM, V281, P25768, DOI 10.1074/jbc.M513511200; Lautscham LA, 2015, BIOPHYS J, V109, P900, DOI 10.1016/j.bpj.2015.07.025; Lim S, 2016, MOL BIOL CELL, V27, P3210, DOI 10.1091/mbc.E16-02-0098; Malboubi M, 2015, MICROELECTRON ENG, V144, P42, DOI 10.1016/j.mee.2015.02.022; Matsumoto A, 2015, CANCER MED-US, V4, P1547, DOI 10.1002/cam4.495; McGregor AL, 2016, CURR OPIN CELL BIOL, V40, P32, DOI 10.1016/j.ceb.2016.01.011; Mekhdjian AH, 2017, MOL BIOL CELL, V28, P1467, DOI 10.1091/mbc.E16-09-0654; POSTE G, 1980, NATURE, V283, P139, DOI 10.1038/283139a0; Raab M, 2016, SCIENCE, V352, P359, DOI 10.1126/science.aad7611; Robijns J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30325; Rowat AC, 2013, J BIOL CHEM, V288, P8610, DOI 10.1074/jbc.M112.441535; Shah P, 2017, TRENDS CELL BIOL, V27, P546, DOI 10.1016/j.tcb.2017.02.008; Skau CT, 2016, CELL, V167, P1571, DOI 10.1016/j.cell.2016.10.023; Stephens AD, 2017, MOL BIOL CELL, V28, P1984, DOI 10.1091/mbc.E16-09-0653; Takaki T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16013; Thomas DG, 2015, J CELL BIOL, V210, P583, DOI 10.1083/jcb.201502039; Wazir U, 2013, CELL MOL BIOL LETT, V18, P595, DOI 10.2478/s11658-013-0109-9; Wolf K, 2013, J CELL BIOL, V201, P1069, DOI 10.1083/jcb.201210152; Zwerger M, 2013, HUM MOL GENET, V22, P2335, DOI 10.1093/hmg/ddt079	31	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195664	10.1371/journal.pone.0195664	http://dx.doi.org/10.1371/journal.pone.0195664			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649271	gold, Green Submitted, Green Published			2022-12-26	WOS:000429791900068
J	Bam, W; Hooper-Bui, LM; Strecker, RM; Adhikari, PL; Overton, EB				Bam, Wokil; Hooper-Bui, Linda M.; Strecker, Rachel M.; Adhikari, Puspa L.; Overton, Edward B.			Coupled effects of oil spill and hurricane on saltmarsh terrestrial arthropods	PLOS ONE			English	Article							WATER-HORIZON OIL; POLYCYCLIC AROMATIC-HYDROCARBONS; GRASSHOPPER ORTHOPTERA; TROPHIC DIVERSITY; IMPACTS; PLANT; CONSERVATION; DISTURBANCE; PREDATION; ABUNDANCE	Terrestrial arthropods play an important role in saltmarsh ecosystems, mainly affecting the saltmarsh's primary production as the main consumers of terrestrial primary production and decomposition. Some of these arthropods, including selected insects and spiders, can be used as ecological indicators of overall marsh environmental health, as they are differentially sensitive to ecological stressors, such as land loss, erosion, oil spills, and tropical storms. In the present study, we used terrestrial arthropods collected from seven (three lightly-oiled, four heavily-oiled) sites in Barataria Bay and from three unoiled reference sites in Delacroix, Louisiana, to determine the impacts of the distribution and re-distribution of Deepwater Horizon (DWH) oil on these saltmarsh ecosystems. A total of 9,476 and 12,256 insects were collected in 2013 and 2014, respectively. The results show that the terrestrial arthropods were negatively affected by the re-distribution of DWH oil by Hurricane Isaac in 2012, although the level of impacts varied among the arthropod groups. Moreover, the mean diversity index was higher (>1.5) in 2014 than in 2013 (<1.5) for all sites, suggesting a recovery trajectory of the saltmarsh arthropod population. The higher taxonomic richness observed in the reference sites compared to the oiled sites for both years also indicated long-term impacts of DWH oil to the saltmarsh arthropod community. Whereas a slow recovery of certain terrestrial arthropods was observed, long-term monitoring of arthropod communities would help better understand the recovery and succession of the marsh ecosystems.	[Bam, Wokil] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Hooper-Bui, Linda M.; Strecker, Rachel M.; Adhikari, Puspa L.; Overton, Edward B.] Louisiana State Univ, Dept Environm Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University	Bam, W (corresponding author), Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA.	wbam1@lsu.edu	Bui, Dr. Linda/AAW-7252-2021; Bam, Wokil/H-3162-2018	Bam, Wokil/0000-0002-7320-3496; Adhikari, Puspa/0000-0003-0170-685X	Gulf of Mexico Research Initiative [940264100]	Gulf of Mexico Research Initiative	This work was supported by Gulf of Mexico Research Initiative - 940264100 to LMHB through the Coastal Waters Consortium (CWC). http://research.gulfresearchinitiative.org/gomri-funded-researchers/person/?pid=841. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BJ, 2017, FLA ENTOMOL, V100, P366, DOI 10.1653/024.100.0236; Adhikari PL, 2016, ENVIRON POLLUT, V212, P413, DOI 10.1016/j.envpol.2016.01.064; Adhikari PL, 2015, MAR CHEM, V168, P60, DOI 10.1016/j.marchem.2014.11.001; Albrecht M, 2007, J ANIM ECOL, V76, P1015, DOI 10.1111/j.1365-2656.2007.01264.x; Bacosa HP, 2016, MAR POLLUT BULL, V109, P236, DOI 10.1016/j.marpolbul.2016.05.076; Bejarano AC, 2016, ENVIRON POLLUT, V218, P709, DOI 10.1016/j.envpol.2016.07.065; Bergqvist R, 2013, TRANSP SOC, P1; Boufadel MC, 2014, ENVIRON SCI TECHNOL, V48, P9496, DOI 10.1021/es5012862; Burns CMB, 2014, BIOSCIENCE, V64, P820, DOI 10.1093/biosci/biu124; CAMERON GN, 1972, ECOLOGY, V53, P58, DOI 10.2307/1935710; Chen X, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2049; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Day RH, 1997, ECOL APPL, V7, P593; Desender K, 1999, BIOL CONSERV, V87, P221, DOI 10.1016/S0006-3207(98)00058-5; Doxon ED, 2011, J FIELD ORNITHOL, V82, P60, DOI 10.1111/j.1557-9263.2010.00308.x; Evans M, 2017, MAR POLLUT BULL, V115, P47, DOI 10.1016/j.marpolbul.2016.11.022; Gros J, 2017, P NATL ACAD SCI USA, V114, P10065, DOI 10.1073/pnas.1612518114; Husseneder C, 2016, SCI REP-UK, V6, DOI 10.1038/srep18968; Jennings VH, 2006, ENVIRON ENTOMOL, V35, P1550, DOI 10.1603/0046-225X(2006)35[1550:CAAOGC]2.0.CO;2; Karr JR, 2003, NORTHWEST SCI, V77, P202; KEMP WP, 1991, ENVIRON ENTOMOL, V20, P1504, DOI 10.1093/ee/20.6.1504; KEMP WP, 1990, OECOLOGIA, V83, P299, DOI 10.1007/BF00317552; KREMEN C, 1993, CONSERV BIOL, V7, P796, DOI 10.1046/j.1523-1739.1993.740796.x; Larson DP, 1999, J AGR URBAN ENTOMOL, V16, P207; LARSSON S, 1989, OIKOS, V56, P277, DOI 10.2307/3565348; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Longcore T, 2003, RESTOR ECOL, V11, P397, DOI 10.1046/j.1526-100X.2003.rec0221.x; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; MATTSON WJ, 1987, BIOSCIENCE, V37, P110, DOI 10.2307/1310365; McCall BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032735; Mcgeogh MA, 2007, BIOL REV, V73, P181, DOI [DOI 10.1111/J.1469-185X.1997.TB00029.X, 10.1111/j.1469-185x.1997.tb00029.x]; McPhee JJ, 2015, ESTUAR COAST SHELF S, V167, P67, DOI 10.1016/j.ecss.2015.07.008; MENGE BA, 1987, AM NAT, V130, P730, DOI 10.1086/284741; Michel J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065087; MURDOCH WW, 1969, ECOL MONOGR, V39, P335, DOI 10.2307/1942352; Nixon Z, 2016, MAR POLLUT BULL, V107, P170, DOI 10.1016/j.marpolbul.2016.04.003; Olin JA, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1878; Pearson CV, 2006, J INSECT SCI, V6; Pennings SC, 2011, BASIC GUIDE IDENTIFY; Pennings SC, 2014, BIOSCIENCE, V64, P789, DOI 10.1093/biosci/biu118; Petchey OL, 2004, OIKOS, V104, P467, DOI 10.1111/j.0030-1299.2004.13257.x; Pfeiffer W.J., 1981, ECOLOGY SALT MARSH, P87, DOI DOI 10.1007/978-1-4612-5893-3_5; Preisser EL, 2004, AM NAT, V163, P754, DOI 10.1086/383620; Purvis A, 2000, NATURE, V405, P212, DOI 10.1038/35012221; Rabalais NN, 2016, OCEANOGRAPHY, V29, P150, DOI 10.5670/oceanog.2016.79; Ramsey E, 2014, MAR POLLUT BULL, V89, P85, DOI 10.1016/j.marpolbul.2014.10.032; Reed JT, 2010, J ENTOMOL SCI, V45, P111, DOI 10.18474/0749-8004-45.2.111; ROSENBERG DM, 1986, ENVIRON MANAGE, V10, P773, DOI 10.1007/BF01867730; SAS Institute Inc, 2013, SAS9 4 SOFTW; Sasser C. E., 2014, VEGETATION TYPES COA; Schmitz OJ, 1998, AM NAT, V151, P327, DOI 10.1086/286122; SCHMITZ OJ, 1992, THEOR POPUL BIOL, V41, P161, DOI 10.1016/0040-5809(92)90042-R; SCHOWALTER TD, 1981, OIKOS, V37, P126, DOI 10.2307/3544083; Sokolov IM, 2018, PSYCHE J ENTOMOLOGY, V2018, P1, DOI [10.1155/2018/1808370, DOI 10.1155/2018/1808370]; Speight M. R., 2009, ECOLOGY INSECTS CONC; Spiller DA, 2007, ECOLOGY, V88, P37, DOI 10.1890/0012-9658(2007)88[37:AOIFDF]2.0.CO;2; Stireman JO, 2005, P NATL ACAD SCI USA, V102, P17384, DOI 10.1073/pnas.0508839102; Stout SA, 2016, MAR POLLUT BULL, V108, P186, DOI 10.1016/j.marpolbul.2016.04.031; Tarr MA, 2016, OCEANOGRAPHY, V29, P126, DOI 10.5670/oceanog.2016.77; Triplehorn CA, 2006, BORROR DELONGS INTRO; Turner RE, 2014, MAR POLLUT BULL, V86, P291, DOI 10.1016/j.marpolbul.2014.07.003; Turner RE, 2014, MAR POLLUT BULL, V87, P57, DOI 10.1016/j.marpolbul.2014.08.011; Turney S, 2016, OIKOS, V125, P1224, DOI 10.1111/oik.03404; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Wheeler Alfred G., 2001, BIOL PLANT BUGS HEMI; Whipple Sean D., 2010, Journal of Orthoptera Research, V19, P75, DOI 10.1665/034.019.0113; Wimp GM, 2010, ECOLOGY, V91, P3303, DOI 10.1890/09-1291.1; Zengel S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132324	68	14	14	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194941	10.1371/journal.pone.0194941	http://dx.doi.org/10.1371/journal.pone.0194941			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641552	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900055
J	Taylor, AA				Taylor, Alexandra A.			Finding peroxiredoxin's reducing system in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							REDUCTASE					alexandraataylor@gmail.com						CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; CHAE HZ, 1994, J BIOL CHEM, V269, P27670; KIM KW, 1988, J BIOL CHEM, V263, P4704; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296	4	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					4228	4229		10.1074/jbc.CL118.002460	http://dx.doi.org/10.1074/jbc.CL118.002460			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29667929	Green Published, hybrid			2022-12-26	WOS:000427587500032
J	Chavez, DA; Greer, BH; Eichman, BF				Chavez, Diana A.; Greer, Briana H.; Eichman, Brandt F.			The HIRAN domain of helicase-like transcription factor positions the DNA translocase motor to drive efficient DNA fork regression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA replication; DNA repair; DNA damage response; DNA helicase; nucleic acid enzymology; DNA damage response; DNA repair; fork reversal; replication restart; stalled replication fork	STALLED REPLICATION FORKS; CELL NUCLEAR ANTIGEN; DAMAGE TOLERANCE; HUMAN HLTF; BINDING DOMAIN; ANNEALING HELICASE; GENOME STABILITY; STRESS; REVERSAL; PROTEIN	Helicase-like transcription factor (HLTF) is a central mediator of the DNA damage response and maintains genome stability by regressing stalled replication forks. The N-terminal HIRAN domain binds specifically to the 3-end of single-stranded DNA (ssDNA), and disrupting this function interferes with fork regression in vitro as well as replication fork progression in cells under replication stress. Here, we investigated the mechanism by which the HIRAN-ssDNA interaction facilitates fork remodeling. Our results indicated that HIRAN capture of a denatured nascent leading 3-end directs specific binding of HLTF to forks. DNase footprinting revealed that HLTF binds to the parental duplex ahead of the fork and at the leading edge behind the fork. Moreover, we found that the HIRAN domain is important for initiating regression of forks when both nascent strands are at the junction, but is dispensable when forks contain ssDNA regions on either template strand. We also found that HLTF catalyzes fork restoration from a partially regressed structure in a HIRAN-dependent manner. Thus, HIRAN serves as a substrate-recognition domain to properly orient the ATPase motor domain at stalled and regressed forks and initiates fork remodeling by guiding formation of a four-way junction. We discuss how these activities compare with those of two related fork remodelers, SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin, subfamily A-like 1 (SMARCAL1) and zinc finger RANBP2 type-containing 3 (ZRANB3) to provide insight into their nonredundant roles in DNA damage tolerance.	[Chavez, Diana A.; Greer, Briana H.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA.; Eichman, BF (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.	brandt.eichman@vanderbilt.edu	Classen, Scott/AAY-8176-2020	Eichman, Brandt/0000-0002-0965-2297	National Institutes of Health [P01CA092584, P30CA068485]; NATIONAL CANCER INSTITUTE [P01CA092584, P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM117299, R25GM062459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Miaw-Sheue Tsai for baculovirus production and insect cell expression of HLTF proteins (supported by Structural Cell Biology of DNA Repair Machines Grant P01CA092584 from the National Institutes of Health). We also thank Karlene Cimprich, David Cortez, and members of the Cortez laboratory for comments on the manuscript and for helpful discussions. Additional core facilities were supported by the Vanderbilt-Ingram Cancer Center, which was supported by National Institutes of Health Grant P30CA068485.	Achar YJ, 2015, NUCLEIC ACIDS RES, V43, P10277, DOI 10.1093/nar/gkv896; Achar YJ, 2011, P NATL ACAD SCI USA, V108, P14073, DOI 10.1073/pnas.1101951108; Ahuja AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10660; Ortiz-Bazan MA, 2014, CELL REP, V9, P460, DOI 10.1016/j.celrep.2014.09.005; Badu-Nkansah A, 2016, J BIOL CHEM, V291, P8251, DOI 10.1074/jbc.M115.709733; Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Berti M, 2016, NAT STRUCT MOL BIOL, V23, P103, DOI 10.1038/nsmb.3163; Betous R, 2013, CELL REP, V3, P1958, DOI 10.1016/j.celrep.2013.05.002; Betous R, 2012, GENE DEV, V26, P151, DOI 10.1101/gad.178459.111; Bhat KP, 2015, J BIOL CHEM, V290, P4110, DOI 10.1074/jbc.M114.627083; Blastyak A, 2010, MOL CELL BIOL, V30, P684, DOI 10.1128/MCB.00863-09; Branzei D, 2016, CURR OPIN CELL BIOL, V40, P137, DOI 10.1016/j.ceb.2016.03.015; Burkovics P, 2014, NUCLEIC ACIDS RES, V42, P1711, DOI 10.1093/nar/gkt1040; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chaudhuri AR, 2012, NAT STRUCT MOL BIOL, V19, P417, DOI 10.1038/nsmb.2258; Choi KY, 2015, NUCLEIC ACIDS RES, V43, P2666, DOI 10.1093/nar/gkv004; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Ding L, 2014, G3-GENES GENOM GENET, V4, P1373, DOI 10.1534/g3.114.011346; Fernandez-Leiro R, 2017, NAT STRUCT MOL BIOL, V24, P140, DOI 10.1038/nsmb.3348; Follonier C, 2013, NAT STRUCT MOL BIOL, V20, P486, DOI 10.1038/nsmb.2520; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Hishiki A, 2015, J BIOL CHEM, V290, P13215, DOI 10.1074/jbc.M115.643643; Kile AC, 2015, MOL CELL, V58, P1090, DOI 10.1016/j.molcel.2015.05.013; Kobbe D, 2016, PLANT J, V88, P521, DOI 10.1111/tpj.13283; Lin JR, 2011, MOL CELL, V42, P237, DOI 10.1016/j.molcel.2011.02.026; Manosas M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3368; Mason AC, 2014, P NATL ACAD SCI USA, V111, P7618, DOI 10.1073/pnas.1324143111; Minca EC, 2010, MOL CELL, V38, P649, DOI 10.1016/j.molcel.2010.03.020; Motegi A, 2008, P NATL ACAD SCI USA, V105, P12411, DOI 10.1073/pnas.0805685105; Neelsen KJ, 2015, NAT REV MOL CELL BIO, V16, P207, DOI 10.1038/nrm3935; Neelsen KJ, 2013, J CELL BIOL, V200, P699, DOI 10.1083/jcb.201212058; Poole LA, 2017, CRIT REV BIOCHEM MOL, V52, P696, DOI 10.1080/10409238.2017.1380597; Postow L, 2009, J BIOL CHEM, V284, P35951, DOI 10.1074/jbc.M109.048330; Unk I, 2008, P NATL ACAD SCI USA, V105, P3768, DOI 10.1073/pnas.0800563105; Yuan JS, 2012, MOL CELL, V47, P410, DOI 10.1016/j.molcel.2012.05.025; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Yusufzai T, 2008, SCIENCE, V322, P748, DOI 10.1126/science.1161233; Yusufzai T, 2010, P NATL ACAD SCI USA, V107, P20970, DOI 10.1073/pnas.1011196107; Yusufzai T, 2009, GENE DEV, V23, P2400, DOI 10.1101/gad.1831509; Zellweger R, 2015, J CELL BIOL, V208, P563, DOI 10.1083/jcb.201406099; Zeman MK, 2014, NAT CELL BIOL, V16, P2, DOI 10.1038/ncb2897	43	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8484	8494		10.1074/jbc.RA118.002905	http://dx.doi.org/10.1074/jbc.RA118.002905			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29643183	Green Published, hybrid			2022-12-26	WOS:000434205700013
J	Yavuz, H; Kattan, I; Hernandez, JM; Hofnagel, O; Witkowska, A; Raunser, S; Walla, PJ; Jahn, R				Yavuz, Halenur; Kattan, Iman; Hernandez, Javier M.; Hofnagel, Oliver; Witkowska, Agata; Raunser, Stefan; Walla, Peter J.; Jahn, Reinhard			Arrest of trans-SNARE zippering uncovers loosely and tightly docked intermediates in membrane fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						docking; exocytosis; membrane fusion; membrane reconstitution; SNARE proteins; soluble NSF attachment protein receptor (SNARE)	ALPHA-SNAP; NEUROTRANSMITTER RELEASE; SYNAPTIC VESICLES; CRYSTAL-STRUCTURE; COMPLEX; SYNAPTOBREVIN; PROTEINS; EXOCYTOSIS; DOCKING; RECONSTITUTION	Soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins mediate intracellular membrane fusion in the secretory pathway. They contain conserved regions, termed SNARE motifs, that assemble between opposing membranes directionally from their N termini to their membrane-proximal C termini in a highly exergonic reaction. However, how this energy is utilized to overcome the energy barriers along the fusion pathway is still under debate. Here, we have used mutants of the SNARE synaptobrevin to arrest trans-SNARE zippering at defined stages. We have uncovered two distinct vesicle docking intermediates where the membranes are loosely and tightly connected, respectively. The tightly connected state is irreversible and independent of maintaining assembled SNARE complexes. Together, our results shed new light on the intermediate stages along the pathway of membrane fusion.	[Yavuz, Halenur; Witkowska, Agata; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany; [Kattan, Iman; Walla, Peter J.] Max Planck Inst Biophys Chem, Biomol Spect & Single Mol Detect Res Grp, D-37077 Gottingen, Germany; [Walla, Peter J.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Phys & Theoret Chem, Dept Biophys Chem, D-38106 Braunschweig, Germany; [Hernandez, Javier M.; Hofnagel, Oliver; Raunser, Stefan] Max Planck Inst Mol Physiol, Dept Struct Biochem, D-44227 Dortmund, Germany	Max Planck Society; Max Planck Society; Braunschweig University of Technology; Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, Fassberg 11, D-37077 Gottingen, Germany.	rjahn@gwdg.de	Raunser, Stefan/AHE-1573-2022; Witkowska, Agata/AAR-3442-2020; Witkowska, Agata/K-2637-2013	Witkowska, Agata/0000-0001-6926-4707; Raunser, Stefan/0000-0001-9373-3016; Jahn, Reinhard/0000-0003-1542-3498	Deutsche Forschungsgemeinschaft [SFB 803]; National Institutes of Health [P01 GM72694]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM072694] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 803 (to R. J. and P. J. W.) and National Institutes of Health Grant P01 GM72694 (to R. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746; Baker RW, 2016, NAT REV MOL CELL BIO, V17, P465, DOI 10.1038/nrm.2016.65; Calder LJ, 2016, NAT STRUCT MOL BIOL, V23, P853, DOI 10.1038/nsmb.3271; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; Cypionka A, 2009, P NATL ACAD SCI USA, V106, P18575, DOI 10.1073/pnas.0906677106; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAYASHI T, 1994, EMBO J, V13, P5051, DOI 10.1002/j.1460-2075.1994.tb06834.x; Hernandez JM, 2012, SCIENCE, V336, P1581, DOI 10.1126/science.1221976; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Li F, 2016, P NATL ACAD SCI USA, V113, P10536, DOI 10.1073/pnas.1604000113; Ma C, 2013, SCIENCE, V339, P421, DOI 10.1126/science.1230473; Margittai M, 2001, J BIOL CHEM, V276, P13169, DOI 10.1074/jbc.M010653200; Mima J, 2009, P NATL ACAD SCI USA, V106, P16191, DOI 10.1073/pnas.0908694106; Min D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2692; Otto H, 1997, P NATL ACAD SCI USA, V94, P6197, DOI 10.1073/pnas.94.12.6197; Park Y, 2014, J BIOL CHEM, V289, P16326, DOI 10.1074/jbc.M114.556803; Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0; Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Strop P, 2008, J BIOL CHEM, V283, P1113, DOI 10.1074/jbc.M707912200; Stroupe C, 2009, P NATL ACAD SCI USA, V106, P17626, DOI 10.1073/pnas.0903801106; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; TOWBIN H, 1989, J CLIN CHEM CLIN BIO, V27, P495; Ungermann C, 1998, NATURE, V396, P543, DOI 10.1038/25069; Vennekate W, 2012, P NATL ACAD SCI USA, V109, P11037, DOI 10.1073/pnas.1116326109; Walter AM, 2010, J CELL BIOL, V188, P401, DOI 10.1083/jcb.200907018; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Wiederhold K, 2010, J BIOL CHEM, V285, P21549, DOI 10.1074/jbc.M110.105148; Winter U, 2009, J BIOL CHEM, V284, P31817, DOI 10.1074/jbc.M109.045286; Zhao ML, 2015, NATURE, V518, P61, DOI 10.1038/nature14148	46	20	20	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8645	8655		10.1074/jbc.RA118.003313	http://dx.doi.org/10.1074/jbc.RA118.003313			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29666192	Green Published, hybrid			2022-12-26	WOS:000434205700027
J	Poikonen, H; Toiviainen, P; Tervaniemi, M				Poikonen, Hanna; Toiviainen, Petri; Tervaniemi, Mari			Naturalistic music and dance: Cortical phase synchrony in musicians and dancers	PLOS ONE			English	Article							THETA-SYNCHRONIZATION; FUNCTIONAL-ROLE; BRAIN; DESYNCHRONIZATION; ALPHA; BAND; OSCILLATIONS; BETA; PERCEPTION; MOVEMENT	Expertise in music has been investigated for decades and the results have been applied not only in composition, performance and music education, but also in understanding brain plasticity in a larger context. Several studies have revealed a strong connection between auditory and motor processes and listening to and performing music, and music imagination. Recently, as a logical next step in music and movement, the cognitive and affective neuro-sciences have been directed towards expertise in dance. To understand the versatile and overlapping processes during artistic stimuli, such as music and dance, it is necessary to study them with continuous naturalistic stimuli. Thus, we used long excerpts from the contemporary dance piece Carmen presented with and without music to professional dancers, musicians, and laymen in an EEG laboratory. We were interested in the cortical phase synchrony within each participant group over several frequency bands during uni- and multimodal processing. Dancers had strengthened theta and gamma synchrony during music relative to silence and silent dance, whereas the presence of music decreased systematically the alpha and beta synchrony in musicians. Laymen were the only group of participants with significant results related to dance. Future studies are required to understand whether these results are related to some other factor (such as familiarity to the stimuli), or if our results reveal a new point of view to dance observation and expertise.	[Poikonen, Hanna; Tervaniemi, Mari] Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Fac Med, Helsinki, Finland; [Toiviainen, Petri] Univ Jyvaskyla, Dept Mus Art & Culture Studies, Jyvaskyla, Finland; [Tervaniemi, Mari] Univ Helsinki, Fac Educ Sci, Cicero Learning, Helsinki, Finland	University of Helsinki; University of Jyvaskyla; University of Helsinki	Poikonen, H (corresponding author), Univ Helsinki, Dept Psychol & Logoped, Cognit Brain Res Unit, Fac Med, Helsinki, Finland.	hanna.poikonen@helsinki.fi		Toiviainen, Petri/0000-0001-6962-2957; Tervaniemi, Mari/0000-0002-9651-2929; Poikonen, Hanna/0000-0001-7337-7042	Kone Foundation; Signe and Ane Gyllenberg Foundation; Academy of Finland; Finnish Cultural Foundation; Art and Science Association of Jyvaskyla, Finland	Kone Foundation; Signe and Ane Gyllenberg Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Art and Science Association of Jyvaskyla, Finland	This work was supported by Kone Foundation http://www.koneensaatio.fi/en/ (HP); Signe and Ane Gyllenberg Foundation http://gyllenbergs.fi/en/ (HP); Academy of Finland http://www.aka.fi/en/ (PT and MT); Finnish Cultural Foundation https://skr.fi/en (MT); The Art and Science Association of Jyvaskyla, Finland (HP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balconi M, 2006, NEUROSCI LETT, V392, P118, DOI 10.1016/j.neulet.2005.09.004; Bangert M, 2006, NEUROIMAGE, V30, P917, DOI 10.1016/j.neuroimage.2005.10.044; Bhattacharya J, 2001, NEUROREPORT, V12, P371, DOI 10.1097/00001756-200102120-00037; Blasing BE, 2014, FRONT PSYCHOL, V5, DOI [10.3389/fpsyg.2014.01008, 10.3389/fpsyg.2014.01500]; Bland BH, 2001, BEHAV BRAIN RES, V127, P119, DOI 10.1016/S0166-4328(01)00358-8; Brattico E, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00676; Bresin R, 2013, P 10 SOUND MUS COMP; Burunat I, 2014, CORTEX, V57, P254, DOI 10.1016/j.cortex.2014.04.012; Canolty RT, 2010, TRENDS COGN SCI, V14, P506, DOI 10.1016/j.tics.2010.09.001; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Di Nota PM, 2017, BMC NEUROSCI, V18, DOI 10.1186/s12868-017-0349-0; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Fujioka T, 2009, ANN NY ACAD SCI, V1169, P89, DOI 10.1111/j.1749-6632.2009.04779.x; Giacosa C, 2016, NEUROIMAGE, V135, P273, DOI 10.1016/j.neuroimage.2016.04.048; Gilbertson T, 2005, J NEUROSCI, V25, P7771, DOI 10.1523/JNEUROSCI.1762-05.2005; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Hobson HM, 2016, CORTEX, V82, P290, DOI 10.1016/j.cortex.2016.03.019; Hong B., 2006, INT J BIOELECTROMAG, V8, pVII/1; Hyde KL, 2009, ANN NY ACAD SCI, V1169, P182, DOI 10.1111/j.1749-6632.2009.04852.x; Kahana MJ, 2006, J NEUROSCI, V26, P1669, DOI 10.1523/JNEUROSCI.3737-05c.2006; Karpati FJ, 2017, BRAIN RES, V1657, P62, DOI 10.1016/j.brainres.2016.11.029; Karpati FJ, 2015, ANN NY ACAD SCI, V1337, P140, DOI 10.1111/nyas.12632; Klimesch W, 1997, PSYCHOPHYSIOLOGY, V34, P169, DOI 10.1111/j.1469-8986.1997.tb02128.x; Klimesch W, 2001, COGNITIVE BRAIN RES, V12, P33, DOI 10.1016/S0926-6410(01)00024-6; Knyazev GG, 2009, NEUROSCIENCE, V164, P1588, DOI 10.1016/j.neuroscience.2009.09.057; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Krause CM, 2000, NEUROSCI LETT, V286, P9, DOI 10.1016/S0304-3940(00)01092-2; Krause V, 2010, NEUROIMAGE, V52, P245, DOI 10.1016/j.neuroimage.2010.03.081; Laban R., 1950, MASTERY MOVEMENT; Luck G, 2008, MUSIC PERCEPT, V25, P225, DOI 10.1525/MP.2008.25.3.225; Luck G, 2010, MUSIC PERCEPT, V28, P47, DOI 10.1525/MP.2010.28.1.47; Luopajarvi R., 2012, THESIS; Mathewson KE, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00099; Muller V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073852; Pavlidou A, 2014, TRANSL NEUROSCI, V5, P286, DOI 10.2478/s13380-014-0236-4; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Poikonen H, 2018, EUR J NEUROSCI, V47, P433, DOI 10.1111/ejn.13838; Poikonen H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33056; Pollok B, 2009, HUM BRAIN MAPP, V30, P1783, DOI 10.1002/hbm.20762; Putkinen V, 2014, DEVELOPMENTAL SCI, V17, P282, DOI 10.1111/desc.12109; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Samaha J, 2015, P NATL ACAD SCI USA, V112, P8439, DOI 10.1073/pnas.1503686112; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Schoffelen JM, 2009, HUM BRAIN MAPP, V30, P1857, DOI 10.1002/hbm.20745; Sofianidis G, 2014, ACTA PSYCHOL, V150, P106, DOI 10.1016/j.actpsy.2014.05.002; Tass P, 1998, PHYS REV LETT, V81, P3291, DOI 10.1103/PhysRevLett.81.3291; van Driel J, 2014, NEUROIMAGE, V101, P404, DOI 10.1016/j.neuroimage.2014.07.022; Wang WY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158465; Wang Y, 2006, P 28 IEEE EMBS ANN I; Washburn A, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00800; Zarka D, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00169; Zatorre RJ, 2007, NAT REV NEUROSCI, V8, P547, DOI 10.1038/nrn2152	54	13	13	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196065	10.1371/journal.pone.0196065	http://dx.doi.org/10.1371/journal.pone.0196065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672597	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800076
J	Gotthelf, L; Chen, YT; Rajagopalan, S; Wu, ECT; Doshi, I; Addy, C				Gotthelf, Linda; Chen, Ya-Ting; Rajagopalan, Srinivasan; Wu, Elise Chi-Tao; Doshi, Ishita; Addy, Carol			High intensity lifestyle intervention and long-term impact on weight and clinical outcomes	PLOS ONE			English	Article							PRACTICE GUIDELINES; AMERICAN-COLLEGE; OBESE ADULTS; RISK-FACTORS; TASK-FORCE; OVERWEIGHT; MANAGEMENT; ASSOCIATION; PROGRAM; PHONE	Background Obesity increases the risk for diabetes and cardiovascular events, with a corresponding growth in medical costs. High intensity lifestyle intervention (HILI) is the cornerstone for weight management. We assessed the effectiveness of clinic-based HILI on weight loss and associated clinical outcomes by duration of program participation and comorbid conditions. Methods This was a retrospective cohort study of patients who enrolled in HILI weight management programs at Health Management Resources (HMR) clinics located across the U.S. Patients completed health risk assessments (HRA) and were enrolled for up to 24 months at the time of follow-up HRA. HMR programs provide weekly group coaching to achieve reduced calorie intake, increased fruit/vegetable intake, and physical activity >= 2,000 kcal/wk. A Markov model predicted avoidance of diabetes and cardiovascular events and projected cost savings due to weight loss. Results Of the 500 patients included in the analysis, 67% were female and mean age was 54.1 years (s.d. 11.6). The baseline weight and BMI were 243.5 lbs (range 144.0-545.0) and 38.8 kg/m(2) (range 25.4-85.0), respectively. Overall, patients lost an average of 47.4 lbs (18.9% of initial body weight [IBW]); the amount of weight loss was consistent among those with diabetes/pre-diabetes (50%), high/moderate risk for dyslipidemia (60%), hypertension/pre-hypertension (86%), and severe obesity (37%). The mean IBW lost was 16.4%, 19.3%, 20.7% for <= 6 months (n = 165), 7-12 months (n = 140), 13-24 months (n = 195) of program participation, respectively. The simulation model estimated 22 diabetes and 30 cardiovascular events and $1,992,370 medical costs avoided over 5 years in the 500 patients evaluated. Conclusion Patients in the HMR clinic-based HILI program achieved substantial weight loss regardless of duration of program participation, risk profile and comorbid status. The HMR program could be an effective strategy to prevent costly diabetes and cardiovascular events, particularly in high risk patients.	[Gotthelf, Linda; Addy, Carol] HMR Weight Management Serv Corp, Boston, MA 02110 USA; [Chen, Ya-Ting] Merck & Co Inc, Healthcare Serv & Solut, Ctr Outcomes Res & Real World Evidence, Kenilworth, NJ USA; [Rajagopalan, Srinivasan] Med Data Analyt Inc, Milltown, NJ USA; [Wu, Elise Chi-Tao] Merck & Co Inc, Ctr Outcomes Res & Real World Evidence, Econ & Data Sci, Kenilworth, NJ USA; [Doshi, Ishita] Merck & Co Inc, Ctr Outcomes Res & Real World Evidence, Study Management, Kenilworth, NJ USA	Merck & Company; Merck & Company; Merck & Company	Addy, C (corresponding author), HMR Weight Management Serv Corp, Boston, MA 02110 USA.	Caddy@HMRBoston.com			HMR Weight Management Services Corp; Healthcare Services and Solutions; Merck Co., Inc.; Med Data Analytics, Inc.	HMR Weight Management Services Corp; Healthcare Services and Solutions; Merck Co., Inc.(Merck & Company); Med Data Analytics, Inc.	The authors received no specific funding for this work. HMR Weight Management Services Corp, Healthcare Services and Solutions, Merck & Co., Inc., Med Data Analytics, Inc., Economics and Data Science, Merck & Co., Inc., and Study Management, Merck & Co. Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, P1033, DOI 10.2337/dc12-2625; Anderson JW, 2011, POSTGRAD MED, V123, P205, DOI 10.3810/pgm.2011.09.2476; [Anonymous], 2017, Circulation, V136, pe196, DOI 10.1161/CIR.0000000000000530; Balkau B, 2008, DIABETES, V57, P2613, DOI 10.2337/db07-1605; Castaneda C, 2002, DIABETES CARE, V25, P2335, DOI 10.2337/diacare.25.12.2335; Cawley J, 2015, PHARMACOECONOMICS, V33, P707, DOI 10.1007/s40273-014-0230-2; cdc.gov, 2017, OB OV; cdc.gov, BURD TOB US US; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Coleman CD, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0062-8; Diabetes Prevention Program Research Group, 2002, NEW ENGL J MED, V346, P393, DOI [10.1056/NEJMoa012512, DOI 10.1056/NEJMOA012512]; Donnelly JE, 2007, INT J OBESITY, V31, P1270, DOI 10.1038/sj.ijo.0803568; Donnelly Joseph E, 2013, Obesity (Silver Spring), V21, P1951, DOI 10.1002/oby.20334; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Framinghamheartstudy.org, 2017, FRAM HEART STUD; Furlow EA, 2009, J AM DIET ASSOC, V109, P1417, DOI 10.1016/j.jada.2009.05.003; Garvey WT, 2016, ENDOCR PRACT, V22, P842, DOI 10.4158/EP161356.ESGL; icer-review.org, ICER REL FIN REP US; Jensen MD, 2014, CIRCULATION, V129, pS102, DOI 10.1161/01.cir.0000437739.71477.ee; Keehan SP, 2017, HEALTH AFFAIR, V36, P553, DOI 10.1377/hlthaff.2016.1627; Kennedy RC, 2016, J DIAB OBES, V3, P1; Larson-Meyer DE, 2006, OBESITY, V14, P73, DOI 10.1038/oby.2006.10; Moyer VA, 2012, ANN INTERN MED, V157, P373, DOI 10.7326/0003-4819-157-5-201209040-00475; Ostbye T, 2014, OBESITY, V22, P1179, DOI 10.1002/oby.20669; Redmon JB, 2010, DIABETES CARE, V33, P1153, DOI 10.2337/dc09-2090; Unick JL, 2015, OBESITY, V23, P1353, DOI 10.1002/oby.21112; Yang L, 2015, JAMA INTERN MED, V175, P1412, DOI 10.1001/jamainternmed.2015.2405	27	2	2	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195794	10.1371/journal.pone.0195794	http://dx.doi.org/10.1371/journal.pone.0195794			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668741	gold, Green Submitted, Green Published			2022-12-26	WOS:000430290200057
J	Caughron, B; Yang, Y; Young, MRI				Caughron, Blaine; Yang, Yi; Young, M. Rita I.			Role of IL-23 signaling in the progression of premalignant oral lesions to cancer	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; T-CELLS; COLORECTAL-CANCER; TH17 CELLS; INFLAMMATION; HEAD; MICE; NECK; PREVENTION; PHENOTYPE	Mice bearing carcinogen-induced premalignant oral lesions were previously shown to have a pro-inflammatory phenotype, which is replaced with an immune inhibitory phenotype as lesions progress to cancer. Since Th17 cells are prominent at the premalignant lesion state and their levels are supported by IL-23, studies used mice that were IL-23 receptor deficient (IL-23R KO) to determine the requirement for IL-23 signaling in the immunological and clinical status of mice with premalignant oral lesions. The results showed a dependence on IL 23 signaling for the pro-inflammatory state of mice with oral lesions as levels of IL-2, IFN-y, IL-6, IL-17 and TNF-a were elevated in wildtype mice with premalignant oral lesions, but not in IL-23R KO mice. In contrast, as lesions progressed to cancer, the pro-inflammatory phenotype subsided and was replaced with the inhibitory mediator IL-10 and with Treg cells in wildtype mice, although not in IL-23R KO mice. Clinically, early progression of premalignant oral lesions to cancer was enhanced in IL-23R KO mice compared to progression in wildtype mice. These results show the importance of IL-23 signaling in both the pro-inflammatory phenotype characteristic of premalignant oral lesions and the inhibitory phenotype as lesions progress to cancer.	[Caughron, Blaine; Young, M. Rita I.] Ralph H Johnson VA Med Ctr, Res Serv, Charleston, SC 29401 USA; [Yang, Yi] Med Univ South Carolina, Dept Microbiol & Immunol, Charleston, SC USA; [Young, M. Rita I.] Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Medical University of South Carolina	Young, MRI (corresponding author), Med Univ South Carolina, Dept Otolaryngol Head & Neck Surg, Charleston, SC 29425 USA.	youngmr@musc.edu			Clinical Sciences Research Program of the Department of Veterans Affairs [I01 CX000851]	Clinical Sciences Research Program of the Department of Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the Clinical Sciences Research Program of the Department of Veterans Affairs; Grant number I01 CX000851. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amicarella F, 2017, GUT, V66, P692, DOI 10.1136/gutjnl-2015-310016; Courau T, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85974; De Costa AMA, 2012, INT IMMUNOPHARMACOL, V13, P322, DOI 10.1016/j.intimp.2012.05.004; De Costa AMA, 2012, CANCER IMMUNOL IMMUN, V61, P927, DOI 10.1007/s00262-011-1154-8; Duraiswamy J, 2013, CANCER RES, V73, P6900, DOI 10.1158/0008-5472.CAN-13-1550; Freeman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110928; Glosson-Byers NL, 2014, J IMMUNOL, V193, P2631, DOI 10.4049/jimmunol.1401202; Hardikar S, 2014, CANCER EPIDEM BIOMAR, V23, P2393, DOI 10.1158/1055-9965.EPI-14-0384; He YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079769; Johnson SD, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00379; Kathania M, 2016, NAT IMMUNOL, V17, P997, DOI 10.1038/ni.3488; Lee JY, 2017, J CANCER, V8, P1249, DOI 10.7150/jca.18230; Liu HP, 2015, EUR J IMMUNOL, V45, P1010, DOI 10.1002/eji.201444726; Liu SL, 2017, CANCER CELL INT, V17, DOI 10.1186/s12935-017-0406-x; Mohammed J, 2010, J INVEST DERMATOL, V130, P2295, DOI 10.1038/jid.2010.92; Mori K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1587-0; Ohman J, 2015, ANTICANCER RES, V35, P311; Samadder NJ, 2017, DIGEST DIS SCI, V62, P2126, DOI 10.1007/s10620-016-4435-4; Stritesky GL, 2008, J IMMUNOL, V181, P5948, DOI 10.4049/jimmunol.181.9.5948; Sun YJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/5715719; Thibaudin M, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1055444; Wakayama T, 1999, P NATL ACAD SCI USA, V96, P14984, DOI 10.1073/pnas.96.26.14984; Wang L, 2017, CANCER RES, V77, P1119, DOI 10.1158/0008-5472.CAN-16-1373; Wei L, 2016, MOL MED REP, V13, P1673, DOI 10.3892/mmr.2015.4694; Woodford Danielle, 2014, J Clin Cell Immunol, V5; Xia J, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/516395; Yan BL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00721-8; Yan YY, 2015, J IMMUNOTHER, V38, P341, DOI 10.1097/CJI.0000000000000094; Yoshida N, 2016, ANN SURG ONCOL, V23, P919, DOI 10.1245/s10434-015-4923-3; Young MRI, 2016, INT J CANCER, V138, P2487, DOI 10.1002/ijc.29989; Yu GT, 2015, ONCOTARGET, V6, P42067, DOI 10.18632/oncotarget.5955; Zhang QY, 2017, PROSTATE, V77, P888, DOI 10.1002/pros.23343; Zhou GY, 2017, GASTROENTEROLOGY, V153, P1107, DOI 10.1053/j.gastro.2017.06.017	33	13	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196034	10.1371/journal.pone.0196034	http://dx.doi.org/10.1371/journal.pone.0196034			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664967	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300051
J	Pairet, N; Mang, S; Fois, G; Keck, M; Kuhnbach, M; Gindele, J; Frick, M; Dietl, P; Lamb, DJ				Pairet, N.; Mang, S.; Fois, G.; Keck, M.; Kuehnbach, M.; Gindele, J.; Frick, M.; Dietl, P.; Lamb, D. J.			TRPV4 inhibition attenuates stretch-induced inflammatory cellular responses and lung barrier dysfunction during mechanical ventilation	PLOS ONE			English	Article							POTENTIAL VANILLOID 4; RESPIRATORY-DISTRESS-SYNDROME; RUTHENIUM RED; ALVEOLAR MACROPHAGES; CYTOKINE RELEASE; CATION CHANNEL; IN-VITRO; EPITHELIAL-CELLS; PULMONARY-EDEMA; INJURY	Mechanical ventilation is an important tool for supporting critically ill patients but may also exert pathological forces on lung cells leading to Ventilator-Induced Lung Injury (VILI). We hypothesised that inhibition of the force-sensitive transient receptor potential vanilloid (TRPV4) ion channel may attenuate the negative effects of mechanical ventilation. Mechanical stretch increased intracellular Ca2+ influx and induced release of pro-inflammatory cytokines in lung epithelial cells that was partially blocked by about 30% with the selective TRPV4 inhibitor GSK2193874, but nearly completely blocked with the pan-calcium channel blocker ruthenium red, suggesting the involvement of more than one calcium channel in the response to mechanical stress. Mechanical stretch also induced the release of pro-inflammatory cytokines from M1 macrophages, but in contrast this was entirely dependent upon TRPV4. In a murine ventilation model, TRPV4 inhibition attenuated both pulmonary barrier permeability increase and pro-inflammatory cytokines release due to high tidal volume ventilation. Taken together, these data suggest TRPV4 inhibitors may have utility as a prophylactic pharmacological treatment to improve the negative pathological stretch-response of lung cells during ventilation and potentially support patients receiving mechanical ventilation.	[Pairet, N.; Mang, S.; Keck, M.; Kuehnbach, M.; Gindele, J.; Lamb, D. J.] Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany; [Pairet, N.; Fois, G.; Gindele, J.; Frick, M.; Dietl, P.] Univ Ulm, Dept Gen Physiol, Ulm, Germany; [Mang, S.] Hannover Med Sch, Inst Immunol, Hannover, Germany	Boehringer Ingelheim; Ulm University; Hannover Medical School	Pairet, N (corresponding author), Boehringer Ingelheim Pharma GmbH & Co KG, Immunol & Resp Dis Res, Biberach, Germany.; Pairet, N (corresponding author), Univ Ulm, Dept Gen Physiol, Ulm, Germany.	nicolas.pairet@web.de	Frick, Manfred/E-1374-2012; Fois, Giorgio/AAD-5657-2022	Frick, Manfred/0000-0002-4763-1104; Fois, Giorgio/0000-0001-5414-1149	Boehringer Ingelheim Pharma GmbH Co. KG	Boehringer Ingelheim Pharma GmbH Co. KG(Boehringer Ingelheim)	Boehringer Ingelheim Pharma GmbH & Co. KG did not play a role in the study and only provided financial support in the form of authors' salaries and/or research materials. The funder provided support in the form of salaries for authors [N Pairet, D Lamb, J Gindele, M Keck, S Mang, M Kuhnbach], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Balakrishna S, 2014, AM J PHYSIOL-LUNG C, V307, pL158, DOI 10.1152/ajplung.00065.2014; Beitler JR, 2016, CRIT CARE MED, V44, P91, DOI 10.1097/CCM.0000000000001355; Bellani G, 2016, JAMA-J AM MED ASSOC, V315, P788, DOI 10.1001/jama.2016.0291; CARDOSO CM, 1993, BIOCHEM J, V296, P49, DOI 10.1042/bj2960049; Carrasco Loza R, 2015, Open Respir Med J, V9, P112, DOI 10.2174/1874306401509010112; Cheung M, 2017, ACS MED CHEM LETT, V8, P549, DOI 10.1021/acsmedchemlett.7b00094; DEINUM J, 1985, BIOCHIM BIOPHYS ACTA, V838, P197, DOI 10.1016/0304-4165(85)90079-0; Dos Santos CC, 2000, J APPL PHYSIOL, V89, P1645, DOI 10.1152/jappl.2000.89.4.1645; Dreyfuss D, 1998, AM J RESP CRIT CARE, V157, P294, DOI 10.1164/ajrccm.157.1.9604014; DREYFUSS D, 1993, AM REV RESPIR DIS, V148, P1194, DOI 10.1164/ajrccm/148.5.1194; Eyal FG, 2007, INTENS CARE MED, V33, P1212, DOI 10.1007/s00134-007-0651-x; Frank J, 2002, CRITICAL CARE, V7, P233, DOI DOI 10.1186/CC1829; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Gerstmair A, 2009, J APPL PHYSIOL, V107, P613, DOI 10.1152/japplphysiol.00012.2009; Halbertsma FJJ, 2005, NETH J MED, V63, P382; Hamanaka K, 2007, AM J PHYSIOL-LUNG C, V293, pL923, DOI 10.1152/ajplung.00221.2007; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Hegeman MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057374; Henry CO, 2016, AM J PHYSIOL-LUNG C, V311, pL664, DOI 10.1152/ajplung.00442.2015; Jurek SC, 2014, AM J RESP CELL MOL, V50, P1107, DOI 10.1165/rcmb.2013-0163OC; Kuebler WM, 2002, AM J PHYSIOL-LUNG C, V282, pL917, DOI 10.1152/ajplung.00275.2001; Mang S, 2018, AM J RESP C IN PRESS; Matthews BD, 2010, INTEGR BIOL-UK, V2, P435, DOI 10.1039/c0ib00034e; Michalick L, 2017, ANESTHESIOLOGY, V126, P300, DOI 10.1097/ALN.0000000000001443; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Mochizuki T, 2009, J BIOL CHEM, V284, P21257, DOI 10.1074/jbc.M109.020206; Nayak PS, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0224-4; Nilius B, 2001, PFLUG ARCH EUR J PHY, V443, P227, DOI 10.1007/s004240100676; Parker JC, 1998, J APPL PHYSIOL, V84, P1113, DOI 10.1152/jappl.1998.84.4.1113; Protti A, 2014, CURR OPIN CRIT CARE, V20, P33, DOI 10.1097/MCC.0000000000000047; Pugin J, 1998, AM J PHYSIOL-LUNG C, V275, pL1040, DOI 10.1152/ajplung.1998.275.6.L1040; Ranieri VM, 1999, JAMA-J AM MED ASSOC, V282, P54, DOI 10.1001/jama.282.1.54; ROYALL JA, 1989, AM J PHYSIOL, V257, pL399, DOI 10.1152/ajplung.1989.257.6.L399; SASAKI T, 1992, J BIOL CHEM, V267, P21518; Scheraga RG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00503; Scheraga RG, 2016, J IMMUNOL, V196, P428, DOI 10.4049/jimmunol.1501688; Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005; Slutsky AS, 2003, INTENS CARE MED, V29, P1218, DOI 10.1007/s00134-003-1793-0; Slutsky AS, 1998, AM J RESP CRIT CARE, V157, P1721, DOI 10.1164/ajrccm.157.6.9709092; SLUTSKY AS, 1993, CHEST, V104, P1833, DOI 10.1378/chest.104.6.1833; Strotmann R, 2000, NAT CELL BIOL, V2, P695, DOI 10.1038/35036318; Takahashi N, 2011, CELL CALCIUM, V50, P279, DOI 10.1016/j.ceca.2011.04.006; Tao F, 2002, AM J RESP CELL MOL, V26, P499, DOI 10.1165/ajrcmb.26.4.4749; Thorneloe KS, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004276; Tremblay LN, 1998, P ASSOC AM PHYSICIAN, V110, P482; Vincent F, 2009, BIOCHEM BIOPH RES CO, V389, P490, DOI 10.1016/j.bbrc.2009.09.007; Vlahakis NE, 1999, AM J PHYSIOL-LUNG C, V277, pL167, DOI 10.1152/ajplung.1999.277.1.L167; WEBB HH, 1974, AM REV RESPIR DIS, V110, P556; Yamada A, 2000, BIOCHEM J, V349, P797, DOI 10.1042/bj3490797; Yamashiro K, 2010, BIOCHEM BIOPH RES CO, V398, P284, DOI 10.1016/j.bbrc.2010.06.082; Yin J, 2016, AM J RESP CELL MOL, V54, P370, DOI 10.1165/rcmb.2014-0225OC; Yin J, 2010, CELL BIOCHEM BIOPHYS, V56, P1, DOI 10.1007/s12013-009-9067-2; Zhang F, 2007, J CELL PHYSIOL, V213, P730, DOI 10.1002/jcp.21141	55	30	34	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0196055	10.1371/journal.pone.0196055	http://dx.doi.org/10.1371/journal.pone.0196055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664963	Green Published, gold, Green Submitted			2022-12-26	WOS:000430262300052
J	Wang, LH; Zhang, YH; Xu, KY; Dong, T; Rowland-Jones, S; Yindom, LM				Wang, Linghang; Zhang, Yonghong; Xu, Keyi; Dong, Tao; Rowland-Jones, Sarah; Yindom, Louis-Marie			Killer-cell immunoglobulin-like receptors associate with HIV-1 infection in a narrow-source Han Chinese cohort	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HEPATITIS-C VIRUS; SLOW PROGRESSORS; DISEASE PROGRESSION; BLOOD-DONORS; GENE-CONTENT; NK CELLS; CLASS-I; HLA-B; KIR	Background The HIV pandemic remains the most serious challenge to public health worldwide. The hallmark characteristics of the disease is the eventual failure of the immune system to control opportunistic infections and death. However not everyone who has HIV develops the disease at the same rate and so we are studying how the immune system works to control the virus in those who have been infected for decades and remain relatively healthy without the need of anti-retroviral therapy (ART). Methods Genomic DNA samples from 513 Chinese Han individuals from Henan province were typed for 15 KIR and 3 HLA class I genes. Genotype frequencies were compared between a village cohort of 261 former plasma donors (SM cohort) infected with HIV-1 through an illegal plasma donor scheme who survived more than 10 years of infection without ART and 252 ethnically-matched healthy controls from a nearby village. KIR and HLA were molecularly typed using a combination of polymerase chain reaction (PCR) with sequence-specific primers (PCR-SSP) and sequence based techniques. Results All 15 KIR genes were observed in the study population at various frequencies. KIR2DL3 was significantly less common in the HIV-1 infected group (95.8% vs 99.2%, p = 0.021). The combination of KIR3DS1 with homozygosity for HLA-Bw4 alleles (the putative ligand for KIR3DS1) was significantly less frequent in the HIV-1 infected group than in the control group (6.0% vs 12.0% respectively, p = 0.023). Conclusion Specific KIR-HLA compound genotypes associate with differential outcomes to infection and disease progression following exposure to a narrow-source HIV-1.	[Wang, Linghang; Xu, Keyi] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Wang, Linghang; Dong, Tao; Rowland-Jones, Sarah; Yindom, Louis-Marie] Nuffield Dept Med, Oxford, England; [Wang, Linghang; Zhang, Yonghong; Dong, Tao] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Human Immunol Unit, Oxford, England; [Zhang, Yonghong] Capital Med Univ, Beijing You An Hosp, Beijing, Peoples R China	Capital Medical University; University of Oxford; University of Oxford; Capital Medical University	Yindom, LM (corresponding author), Nuffield Dept Med, Oxford, England.	louis-marie.yindom@ndm.ox.ac.uk		Wang, Linghang/0000-0002-1948-5461; Yindom, Louis-Marie/0000-0001-8078-7146; Dong, Tao/0000-0003-3545-3758	Medical Research Council UK; Li Ka Shing Foundation; National Key Clinical Department of Infectious Diseases; Beijing High-Level Healthcare Intelligent Culture Plan [2015-3-109]; National Natural Science Foundation of China [81320108017]; Beijing municipal administration of hospitals [XMLX201411, ZYLX201711]; Beijing Municipal Science & Technology Commission [Z171100001017078]; Beijing Key Laboratory [BZ0373]; MRC [MC_UU_00008/11, G0801751, G1001046, MR/L018942/1, G0600520] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Li Ka Shing Foundation; National Key Clinical Department of Infectious Diseases; Beijing High-Level Healthcare Intelligent Culture Plan; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing municipal administration of hospitals; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Key Laboratory; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK, the Li Ka Shing Foundation, the National Key Clinical Department of Infectious Diseases, the Beijing High-Level Healthcare Intelligent Culture Plan (2015-3-109), the National Natural Science Foundation of China (81320108017), the Beijing municipal administration of hospitals (XMLX201411 and ZYLX201711), the Beijing Municipal Science & Technology Commission (Z171100001017078), and the Beijing Key Laboratory (BZ0373).; This work was supported by the Medical Research Council UK, the Li Ka Shing Foundation, the National Key Clinical Department of Infectious Diseases, the Beijing High-Level Healthcare Intelligent Culture Plan (2015-3-109), the National Natural Science Foundation of China (81320108017), the Beijing municipal administration of hospitals (XMLX201411 and ZYLX201711), the Beijing Municipal Science & Technology Commission (Z171100001017078), and the Beijing Key Laboratory (BZ0373). We are very grateful to all participants in this study. We also thank all the clinical staff who made major contributions to establishing the SM cohort and collecting all the samples.	Alter G, 2007, J EXP MED, V204, P3027, DOI 10.1084/jem.20070695; Bao XJ, 2010, HUM IMMUNOL, V71, P289, DOI 10.1016/j.humimm.2009.12.004; Barbour JD, 2007, PLOS PATHOG, V3, P471, DOI 10.1371/journal.ppat.0030043; Burian A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163297; Carr WH, 2007, J IMMUNOL, V178, P647, DOI 10.4049/jimmunol.178.2.647; Carrington M, 2008, TRENDS MICROBIOL, V16, P620, DOI 10.1016/j.tim.2008.09.002; Cheent K, 2009, IMMUNOLOGY, V126, P449, DOI 10.1111/j.1365-2567.2009.03045.x; Cooley S, 2010, BLOOD, V116, P2411, DOI 10.1182/blood-2010-05-283051; Dong T, 2011, BLOOD, V118, P98, DOI 10.1182/blood-2010-06-291963; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Garcia-Beltran WF, 2016, NAT IMMUNOL, V17, P1067, DOI 10.1038/ni.3513; Gaudieri S, 2005, GENES IMMUN, V6, P683, DOI 10.1038/sj.gene.6364256; Gendzekhadze K, 2006, IMMUNOGENETICS, V58, P474, DOI 10.1007/s00251-006-0108-3; Gillespie GMA, 2002, AIDS, V16, P961, DOI 10.1097/00002030-200205030-00002; Gonzalez-Galarza FF, 2015, NUCLEIC ACIDS RES, V43, pD784, DOI 10.1093/nar/gku1166; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Jiang K, 2005, TISSUE ANTIGENS, V65, P556, DOI 10.1111/j.1399-0039.2005.00412.x; Jiang YJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-405; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Kaufman J, 2002, SCIENCE, V296, P2339, DOI 10.1126/science.1074479; Khakoo SI, 2004, SCIENCE, V305, P872, DOI 10.1126/science.1097670; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Lu ZM, 2008, CELL MOL IMMUNOL, V5, P457, DOI 10.1038/cmi.2008.57; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2013, IMMUNOL REV, V254, P245, DOI 10.1111/imr.12071; Martin Maureen P., 2008, V415, P49, DOI 10.1007/978-1-59745-570-1_3; Martin MP, 2002, NAT GENET, V31, P429, DOI 10.1038/ng934; Miyashita R, 2006, ARTHRITIS RHEUM-US, V54, P992, DOI 10.1002/art.21653; O'Connell KA, 2009, J VIROL, V83, P5028, DOI 10.1128/JVI.02551-08; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; Parham P, 2008, SEMIN IMMUNOL, V20, P311, DOI 10.1016/j.smim.2008.10.002; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Qi Y, 2006, PLOS PATHOG, V2, P741, DOI 10.1371/journal.ppat.0020079; Shilling HG, 2002, J IMMUNOL, V168, P2307, DOI 10.4049/jimmunol.168.5.2307; TROWSDALE J, 2001, GENES IMMUN, V15, P363; Uhrberg M, 1997, IMMUNITY, V7, P753, DOI 10.1016/S1074-7613(00)80394-5; Vilches C, 2000, IMMUNOGENETICS, V51, P639, DOI 10.1007/s002510000184; Wilson MJ, 2000, P NATL ACAD SCI USA, V97, P4778, DOI 10.1073/pnas.080588597; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yindom LM, 2010, J VIROL, V84, P8202, DOI 10.1128/JVI.00116-10; Zhang LQ, 2004, J VIROL, V78, P13591, DOI 10.1128/JVI.78.24.13591-13599.2004; Zhang ZN, 2010, MICROBIOL IMMUNOL, V54, P625, DOI 10.1111/j.1348-0421.2010.00259.x	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195452	10.1371/journal.pone.0195452	http://dx.doi.org/10.1371/journal.pone.0195452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664957	Green Published, gold, Green Submitted			2022-12-26	WOS:000430262300020
J	Tophoj, J; Wollenberg, RD; Sondergaard, TE; Eriksen, NT				Tophoj, Jakob; Wollenberg, Rasmus Dam; Sondergaard, Teis Esben; Eriksen, Niels Thomas			Feeding and growth of the marine heterotrophic nanoflagellates, Procryptobia sorokini and Paraphysomonas imperforata on a bacterium, Pseudoalteromonas sp with an inducible defence against grazing	PLOS ONE			English	Article							PROTIST PREDATION; SIZE-STRUCTURE; EFFICIENCIES; STRAIN; TEMPERATURE; ENERGETICS; ORGANISMS; KINETICS; PROTOZOA; ECOLOGY	Heterotrophic marine nanoflagellates are important grazers on bacteria in the water column. Some marine bacteria appear more resistant to grazing than do others. Marine nanoflagellates can be grown in the laboratory in batch cultures fed specific bacterial isolates. In some cultures, the flagellates appear unable to completely deplete the bacterial prey even when the bacterial strain otherwise is an excellent prey. This may indicate that some marine bacteria are able to induce defence mechanisms if they are grazed by nanoflagellates. Four morphologically distinct marine heterotrophic nanoflagellates, of which 3 were still identified as Procryptobia sorokini (Kinetoplastea) and one as Paraphysomonas imperforata (Chryso-phyceae) were isolated from a coastal location along with 3 isolates of the marine bacterium Pseudoalteromonas sp. Flagellate growth and grazing on bacterial prey were analysed in batch cultures. Pseudoalteromonas was a suitable prey for all 4 flagellate isolates. They grazed and grew on Pseudoalteromonas as sole prey with maximal cell-specific growth rates of 0.1 +/- 0.25 h(-1) and gross growth efficiencies of 38 +/- 61%. Exposure to dense flagellate cultures or their supernatants did, however, cause a fraction of the Pseudoalteromonas cells to aggregate and the bacterium became apparently resistant to grazing. Concentrations of suspended Pseudoalteromonas cells were therefore not decreased below 1,700 +/- 7,500 cells mu L-1 by any of the flagellate isolates. These results indicate that Pseudoalteromonas sp. can be an excellent prey to marine nanoflagellates but also that is in possession of inducible mechanisms that protect against flagellate grazing.	[Tophoj, Jakob; Wollenberg, Rasmus Dam; Sondergaard, Teis Esben; Eriksen, Niels Thomas] Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark	Aalborg University	Eriksen, NT (corresponding author), Aalborg Univ, Dept Chem & Biosci, Aalborg, Denmark.	nte@bio.aau.dk	Sondergaard, Teis/F-4122-2014; Eriksen, Niels T/I-6895-2012	Sondergaard, Teis/0000-0002-4455-7498; Eriksen, Niels T/0000-0003-0792-3601	Villum Fonden [9278]	Villum Fonden(Villum Fonden)	This work was supported by a research grant (9278) from Villum Fonden to NTE. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersen P., 1989, MAR MICRO FOOD WEBS, V3, P35; AZAM F, 1983, MAR ECOL PROG SER, V10, P257, DOI 10.3354/meps010257; Baumgartner M, 2016, J EVOLUTION BIOL, V29, P2297, DOI 10.1111/jeb.12957; Beardsley C, 2003, APPL ENVIRON MICROB, V69, P2624, DOI 10.1128/AEM.69.5.2624-2630.2003; Blom JF, 2010, APPL ENVIRON MICROB, V76, P6156, DOI 10.1128/AEM.01455-10; Blom JF, 2010, ENVIRON MICROBIOL, V12, P2486, DOI 10.1111/j.1462-2920.2010.02222.x; Boenigk J, 2000, AQUAT MICROB ECOL, V22, P243, DOI 10.3354/ame022243; Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004; CHOI JW, 1992, APPL ENVIRON MICROB, V58, P593, DOI 10.1128/AEM.58.2.593-599.1992; Corno G, 2006, APPL ENVIRON MICROB, V72, P78, DOI 10.1128/AEM.72.1.78-86.2006; Corno G, 2008, ENVIRON MICROBIOL, V10, P2857, DOI 10.1111/j.1462-2920.2008.01713.x; Corno G, 2008, J LIMNOL, V67, P107, DOI 10.4081/jlimnol.2008.107; ECCLESTONPARRY JD, 1994, MAR ECOL PROG SER, V105, P167, DOI 10.3354/meps105167; FENCHEL T, 1982, MAR ECOL PROG SER, V9, P35, DOI 10.3354/meps009035; FENCHEL T, 1982, MAR ECOL PROG SER, V8, P225, DOI 10.3354/meps008225; FERGUSON RL, 1976, LIMNOL OCEANOGR, V21, P141, DOI 10.4319/lo.1976.21.1.0141; Frolov Alexander O., 2001, Protistology, V2, P85; Fu YT, 2003, APPL ENVIRON MICROB, V69, P6848, DOI 10.1128/AEM.69.11.6848-6855.2003; GEIDER RJ, 1988, MAR ECOL PROG SER, V47, P169, DOI 10.3354/meps047169; Gonzalez JM, 1996, MAR BIOL, V126, P785, DOI 10.1007/BF00351345; GONZALEZ JM, 1990, APPL ENVIRON MICROB, V56, P583, DOI 10.1128/AEM.56.3.583-589.1990; Guiry, 2018, ALGAEBASE; Hahn MW, 1999, APPL ENVIRON MICROB, V65, P4863; Holmstrom C, 1999, FEMS MICROBIOL ECOL, V30, P285, DOI 10.1111/j.1574-6941.1999.tb00656.x; Ishigaki T, 2001, MICROB ECOL, V41, P264, DOI 10.1007/s002480000060; Jeuck A, 2013, PROTIST, V164, P842, DOI 10.1016/j.protis.2013.08.003; Martel CM, 2008, PROTIST, V159, P41, DOI 10.1016/j.protis.2007.05.003; Massana R, 2003, AQUAT MICROB ECOL, V32, P11, DOI 10.3354/ame032011; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Matz C, 2002, FEMS MICROBIOL ECOL, V39, P57, DOI 10.1111/j.1574-6941.2002.tb00906.x; Pelegri SP, 1999, MICROBIAL ECOL, V37, P276, DOI 10.1007/s002489900150; Peters F, 1996, MAR ECOL PROG SER, V134, P235, DOI 10.3354/meps134235; Rose JM, 2009, ISME J, V3, P252, DOI 10.1038/ismej.2008.96; SHERR BF, 1983, APPL ENVIRON MICROB, V45, P1196, DOI 10.1128/AEM.45.4.1196-1201.1983; SIBBALD MJ, 1988, APPL ENVIRON MICROB, V54, P613, DOI 10.1128/AEM.54.2.613-616.1988; Sleigh MA, 1998, EUR J PROTISTOL, V34, P273, DOI 10.1016/S0932-4739(98)80054-0; Snyder RA, 1996, HYDROBIOLOGIA, V341, P113, DOI 10.1007/BF00018115; Zubkov MV, 2000, J EUKARYOT MICROBIOL, V47, P62, DOI 10.1111/j.1550-7408.2000.tb00012.x	39	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195935	10.1371/journal.pone.0195935	http://dx.doi.org/10.1371/journal.pone.0195935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652905	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900048
J	Kim, MJ; Hur, BY; Lee, ES; Parka, B; Joo, J; Kim, MJ; Park, SC; Baek, JY; Chang, HJ; Kim, DY; Oh, JH				Kim, Min Ju; Hur, Bo Yun; Lee, Eun Sun; Parka, Boram; Joo, Jungnam; Kim, Min Jung; Park, Sung Chan; Baek, Ji Yeon; Chang, Hee Jin; Kim, Dae Yong; Oh, Jae Hwan			Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; APPARENT DIFFUSION-COEFFICIENT; RADIATION-THERAPY; CHEMORADIATION THERAPY; PERITONEAL REFLECTION; COLORECTAL-CANCER; CARCINOMA; DISSECTION; CHEMOTHERAPY; INVOLVEMENT	Purpose To investigate the predictive factors for lateral pelvic lymph node (LPLN) metastasis in patients with locally advanced rectal cancer treated with preoperative chemoradiotherapy (CRT). Materials and methods Fifty-seven patients with locally advanced rectal cancer and LPLNs larger than 5 mm underwent LPLN dissection (LPLD) after preoperative CRT. The MRI findings, including the apparent diffusion coefficient value and LPLN size reduction rate before/after CRT; clinical factors; and pathologic results were evaluated to identify the predictive factors associated with LPLN metastasis. Results LPLN metastasis was confirmed in 23 patients (40.4%). Metastasis was significantly higher in LPLNs with multiplicity, short-axis diameter >= 8 mm before CRT, short-axis diameter >5 mm after CRT, size reduction rate <= 33.3%, heterogeneous signal intensity, and irregular margin (P<0.05) on MR. Multivariable analysis showed that pre-CRT short-axis diameter of LPLNs >= 8 mm, size reduction rate <= 33.3%, and heterogeneous signal intensity were independently associated with LPLN metastasis. Conclusions The size and signal intensity of LPLN before and after CRT are useful MRI findings to predict LPLN metastasis and are helpful to determine the indications for LPLD.	[Kim, Min Ju; Hur, Bo Yun; Kim, Min Jung; Park, Sung Chan; Baek, Ji Yeon; Chang, Hee Jin; Kim, Dae Yong; Oh, Jae Hwan] Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang Si, South Korea; [Lee, Eun Sun] Chung Ang Univ Hosp, Dept Radiol, Seoul, South Korea; [Parka, Boram; Joo, Jungnam] Natl Canc Ctr, Res Inst & Hosp, Biometr Res Branch, Goyang Si, South Korea	National Cancer Center - Korea (NCC); Chung Ang University; Chung Ang University Hospital; National Cancer Center - Korea (NCC)	Oh, JH (corresponding author), Natl Canc Ctr, Res Inst & Hosp, Ctr Colorectal Canc, Goyang Si, South Korea.	jayoh@ncc.re.kr	Lee, Eun Sun/AAW-2726-2020	Kim, Min Jung/0000-0002-3105-9633; Park, Boram/0000-0003-2683-8795	National Cancer Center [1610460]	National Cancer Center	This study was supported by a grant (1610460) from the National Cancer Center. (http://www.ncc.re.kr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyoshi T, 2015, ANN SURG ONCOL, V22, pS614, DOI 10.1245/s10434-015-4565-5; Ali TFT, 2012, EGYPT J RADIOL NUC M, V43, P173, DOI 10.1016/j.ejrnm.2012.01.008; Barbaro B, 2010, RADIOGRAPHICS, V30, P699, DOI 10.1148/rg.303095085; Beets-Tan RGH, 2004, RADIOLOGY, V232, P335, DOI 10.1148/radiol.2322021326; Beets-Tan RGH, 2001, LANCET, V357, P497, DOI 10.1016/S0140-6736(00)04040-X; Berrak S, 2011, ACAD RADIOL, V18, P1225, DOI 10.1016/j.acra.2011.06.009; Brown G, 2003, RADIOLOGY, V227, P371, DOI 10.1148/radiol.2272011747; Brown G, 2003, BRIT J SURG, V90, P355, DOI 10.1002/bjs.4034; Cheng J, 2013, J MAGN RESON IMAGING, V37, P1436, DOI 10.1002/jmri.23925; Cho EY, 2013, EUR J RADIOL, V82, pE662, DOI 10.1016/j.ejrad.2013.08.007; Choi HJ, 2006, AM J ROENTGENOL, V187, P741, DOI 10.2214/AJR.05.0944; ENKER WE, 1995, J AM COLL SURGEONS, V181, P335; Fornasa F, 2012, J MAGN RESON IMAGING, V36, P858, DOI 10.1002/jmri.23706; Fujita S, 2009, INT J COLORECTAL DIS, V24, P1085, DOI 10.1007/s00384-009-0704-4; Georgiou P, 2009, LANCET ONCOL, V10, P1053, DOI 10.1016/S1470-2045(09)70224-4; Havenga K, 1999, EUR J SURG ONCOL, V25, P368, DOI 10.1053/ejso.1999.0659; Hosonuma Tomonori, 2006, Magn Reson Med Sci, V5, P173, DOI 10.2463/mrms.5.173; Kim DJ, 2010, RADIOGRAPHICS, V30, P503, DOI 10.1148/rg.302095046; Kim JK, 2008, J MAGN RESON IMAGING, V28, P714, DOI 10.1002/jmri.21480; Kim JH, 2004, EUR J RADIOL, V52, P78, DOI 10.1016/j.ejrad.2003.12.005; Kim Mi-Kyung, 2015, [JOURNAL OF MICE & TOURISM RESEARCH, MICE관광연구], V15, P111; Kim SH, 2009, RADIOLOGY, V253, P116, DOI 10.1148/radiol.2532090027; Kim SH, 2016, CANCER RES TREAT, V48, P998, DOI 10.4143/crt.2015.254; Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Kuo LJ, 2005, DIS COLON RECTUM, V48, P23, DOI 10.1007/s10350-004-0787-5; Kusters M, 2010, EJSO-EUR J SURG ONC, V36, P470, DOI 10.1016/j.ejso.2009.11.011; Matsuoka H, 2004, ANTICANCER RES, V24, P4097; Matsuoka H, 2007, ANTICANCER RES, V27, P3529; MORIKAWA E, 1994, DIS COLON RECTUM, V37, P219, DOI 10.1007/BF02048158; Nougaret S, 2013, RADIOLOGY, V268, P329, DOI 10.1148/radiol.13121361; Oh HK, 2014, ANN SURG ONCOL, V21, P2280, DOI 10.1245/s10434-014-3559-z; Park MJ, 2011, RADIOLOGY, V260, P771, DOI 10.1148/radiol.11102135; Park SO, 2009, J MAGN RESON IMAGING, V29, P383, DOI 10.1002/jmri.21635; Rao SX, 2008, EUR J RADIOL, V65, P299, DOI 10.1016/j.ejrad.2007.04.001; Rechichi G, 2013, EUR RADIOL, V23, P65, DOI 10.1007/s00330-012-2575-2; Roy C, 2010, EUR RADIOL, V20, P1803, DOI 10.1007/s00330-010-1736-4; Sato H, 2006, DIS COLON RECTUM, V49, pS3, DOI 10.1007/s10350-006-0699-7; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Shihab OC, 2011, BRIT J SURG, V98, P1798, DOI 10.1002/bjs.7662; Sugihara K, 1996, CANCER-AM CANCER SOC, V78, P1871, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1871::AID-CNCR5>3.3.CO;2-9; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; SUZUKI K, 1995, SURG TODAY, V25, P795, DOI 10.1007/BF00311455; Syk E, 2010, DIS COLON RECTUM, V53, P744, DOI 10.1007/DCR.0b013e3181cf8841; Takahashi T, 2000, DIS COLON RECTUM, V43, pS59, DOI 10.1007/BF02237228; Ueno H, 2001, ANN SURG, V234, P190, DOI 10.1097/00000658-200108000-00008; Ueno H, 2007, ANN SURG, V245, P80, DOI 10.1097/01.sla.0000225359.72553.8c; Ueno M, 2005, BRIT J SURG, V92, P756, DOI 10.1002/bjs.4975; Yasui O, 2009, TOHOKU J EXP MED, V218, P177, DOI 10.1620/tjem.218.177; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	49	23	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195815	10.1371/journal.pone.0195815	http://dx.doi.org/10.1371/journal.pone.0195815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649321	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900093
J	Watchorn, RT; Maechtle, T; Fedy, BC				Watchorn, Ryan T.; Maechtle, Thomas; Fedy, Bradley C.			Assessing the efficacy of fathead minnows (Pimephales promelas) for mosquito control	PLOS ONE			English	Article							GREATER SAGE-GROUSE; WEST-NILE-VIRUS; BIOLOGICAL-CONTROL; LARVIVOROUS FISH; HABITAT; POPULATIONS; ISOTOPES; IMPACTS; DISEASE; HEALTH	Mosquitoes function as important vectors for many diseases globally and can have substantial negative economic, environmental, and health impacts. Specifically, West Nile virus (WNv) is a significant and increasing threat to wildlife populations and human health throughout North America. Mosquito control is an important means of controlling the spread of WNv, as the virus is primarily spread between avian and mosquito vectors. This is of particular concern for avian host species such as the Greater sage-grouse (Centrocercus urophasianus), in which WNv negatively impacts fitness parameters. Most mosquito control methods focus on the larval stages. In North America, control efforts are largely limited to larvicides, which require repeated application and have potentially negative ecological impacts. There are multiple potential advantages to using indigenous fish species as an alternative for larval control including lowered environmental impact, decreased costs in terms of time and financial inputs, and the potential for the establishment of self-sustaining fish populations. We tested the efficacy of using fathead minnows (Pimephales promelas) as biological control for mosquito populations in livestock reservoirs of semiarid rangelands. We introduced minnows into 10 treatment reservoirs and monitored an additional 6 non treated reservoirs as controls over 3 years. Adult mosquitoes of species known to transmit WNv (e.g., Culex tarsalis) were captured at each site and mosquito larvae were also present at all sites. Stable isotope analysis confirmed that introduced fathead minnows were feeding at the mosquito larvae trophic level in all but one treatment pond. Treatment ponds demonstrated suppressed levels of mosquito larva over each season compared to controls with a model-predicted 114% decrease in larva density within treatment ponds. Minnows established self-sustaining populations throughout the study in all reservoirs that maintained sufficient water levels. Minnow survival was not influenced by water quality. Though minnows did not completely eradicate mosquito larvae, minnows are a promising alternative to controlling mosquito larvae density within reservoirs. We caution that careful site selection is critical to avoid potential negative impacts, but suggest the introduction of fathead minnows in reservoirs can dramatically reduce mosquito larva abundance and potentially help mitigate vector-borne disease transmission.	[Watchorn, Ryan T.; Fedy, Bradley C.] Univ Waterloo, Sch Environm Resources & Sustainabil, Waterloo, ON, Canada; [Maechtle, Thomas] Big Horn Environm Consultants, Sheridan, WY USA	University of Waterloo	Fedy, BC (corresponding author), Univ Waterloo, Sch Environm Resources & Sustainabil, Waterloo, ON, Canada.	bfedy@uwaterloo.ca	Fedy, Bradley C/A-6017-2015		Northeast Sage-Grouse Local Working Group; Wolf Creek Charitable Foundation	Northeast Sage-Grouse Local Working Group; Wolf Creek Charitable Foundation	This work received support from Northeast Sage-Grouse Local Working Group. Wolf Creek Charitable Foundation. BCF received all funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bighorn Environmental Consultants loaned the project a vehicle and provided logistical support. TM did not receive salary for his contributions to the research.	Aditya G, 2012, J VECTOR DIS, V49, P217; Aldridge CL, 2002, J WILDLIFE MANAGE, V66, P433, DOI 10.2307/3803176; Beasley DWC, 2013, ANTIVIR RES, V99, P1, DOI 10.1016/j.antiviral.2013.04.015; Chandra G, 2008, INDIAN J MED RES, V127, P13; Clark L, 2006, J WILDLIFE DIS, V42, P14, DOI 10.7589/0090-3558-42.1.14; Darsie RFJ, 2005, IDENTIFICATION GEOGR; DENNY JS, 1987, GUIDELINES CULTURE F; Donnelly JP, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1208; Eaton BR, 2005, CAN J ZOOL, V83, P1532, DOI 10.1139/Z05-151; Fedy BC, 2014, WILDLIFE MONOGR, V190, P1, DOI 10.1002/wmon.1014; Fedy BC, 2012, J WILDLIFE MANAGE, V76, P1062, DOI 10.1002/jwmg.337; FLETCHER M, 1992, ACTA TROP, V52, P155, DOI 10.1016/0001-706X(92)90032-S; France RL, 1995, LIMNOL OCEANOGR, V40, P1310, DOI 10.4319/lo.1995.40.7.1310; Grant SCH, 2002, CAN J FISH AQUAT SCI, V59, P759, DOI 10.1139/F02-054; Griffin LF, 2012, WETL ECOL MANAG, V20, P243, DOI 10.1007/s11273-012-9248-4; Hemingway J, 2006, TRENDS PARASITOL, V22, P308, DOI 10.1016/j.pt.2006.05.003; Howard AFV, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-199; IGRAM R, 1979, COMP BIOCHEM PHYS A, V62, P895, DOI 10.1016/0300-9629(79)90024-0; Irwin P, 2009, J AM MOSQUITO CONTR, V25, P301, DOI 10.2987/09-0013.1; KLINGER SA, 1982, ENVIRON BIOL FISH, V7, P113, DOI 10.1007/BF00001781; Lemon SM, 2008, WORKSH SUMM; Marra PP, 2004, BIOSCIENCE, V54, P393, DOI 10.1641/0006-3568(2004)054[0393:WNVAW]2.0.CO;2; Naugle DE, 2005, WILDLIFE SOC B, V33, P616, DOI 10.2193/0091-7648(2005)33[616:WNVASW]2.0.CO;2; Naugle DE, 2004, ECOL LETT, V7, P704, DOI 10.1111/j.1461-0248.2004.00631.x; Oli K., 2005, Tropical Biomedicine, V22, P249; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103; Rowland MM, 2006, BIOL CONSERV, V129, P323, DOI 10.1016/j.biocon.2005.10.048; Scott W.B., 1973, B FISHERIES RES BOAR, V184; Taylor RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071256; Tranchida MC, 2010, BIOL CONTROL, V53, P183, DOI 10.1016/j.biocontrol.2009.11.006; Walker BL, 2011, STUD AVIAN BIOL, P127; Zimmer KD, 2000, CAN J FISH AQUAT SCI, V57, P76, DOI 10.1139/cjfas-57-1-76; Zimmer KD, 2001, ECOSYSTEMS, V4, P346, DOI 10.1007/s10021-001-0016-1; Zou L, 2006, J MED ENTOMOL, V43, P1034, DOI 10.1603/0022-2585(2006)43[1034:MLHMUR]2.0.CO;2	35	0	0	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194304	10.1371/journal.pone.0194304	http://dx.doi.org/10.1371/journal.pone.0194304			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649226	Green Submitted, gold, Green Published			2022-12-26	WOS:000429791900010
J	Wilson, JL; Warburton, R; Taylor, L; Toksoz, D; Hill, N; Polgar, P				Wilson, Jamie L.; Warburton, Rod; Taylor, Linda; Toksoz, Deniz; Hill, Nicholas; Polgar, Peter			Unraveling endothelin-1 induced hypercontractility of human pulmonary artery smooth muscle cells from patients with pulmonary arterial hypertension	PLOS ONE			English	Article							RHO-KINASE INHIBITOR; SIGNAL-TRANSDUCTION; ACTIN-BINDING; INDUCED CONTRACTION; CALMODULIN-BINDING; ACTOMYOSIN-ATPASE; C-TERMINUS; CALDESMON; PHOSPHORYLATION; ACTIVATION	Contraction of human pulmonary artery smooth muscle cells (HPASMC) isolated from pulmonary arterial hypertensive (PAH) and normal (non-PAH) subject lungs was determined and measured with real-time electrical impedance. Treatment of HPASMC with vasoactive peptides, endothelin-1 (ET-1) and bradykinin (BK) but not angiotensin II, induced a temporal decrease in the electrical impedance profile mirroring constrictive morphological change of the cells which typically was more robust in PAH as opposed to non-PAH cells. Inhibition with LIMKi3 and a cofilin targeted motif mimicking cell permeable peptide (MMCPP) had no effect on ET-1 induced HPASMC contraction indicating a negligible role for these actin regulatory proteins. On the other hand, a MMCPP blocking the activity of caldesmon reduced ET-1 promoted contraction pointing to a regulatory role of this protein and its activation pathway in HPASMC contraction. Inhibition of this MEK/ERK/p9ORSK pathway, which is an upstream regulator of caldesmon phosphorylation, reduced ET-1 induced cell contraction. While the regulation of ET-1 induced cell contraction was found to be similar in PAH and non-PAH cells, a key difference was the response to pharmacological inhibitors and to siRNA knockdown of Rho kinases (ROCK1/ROCK2). The PAH cells required much higher concentrations of inhibitors to abrogate ET-1 induced contractions and their contraction was not affected by siRNA against either ROCK1 or ROCK2. Lastly, blocking of L-type and T-type Ca2+ channels had no effect on ET-1 or BK induced contraction. However, inhibiting the activity of the sarcoplasmic reticulum Ca2+ ATPase blunted ET-1 and BK induced HPASMC contraction in both PAH and non-PAH derived HPASMC. In summary, our findings here together with previous communications illustrate similarities and differences in the regulation PAH and non-PAH smooth muscle cell contraction relating to calcium translocation, RhoA/ROCK signaling and the activity of caldesmon. These findings may provide useful tools in achieving the regulation of the vascular hypercontractility taking place in PAH.	[Wilson, Jamie L.; Warburton, Rod; Taylor, Linda; Toksoz, Deniz; Hill, Nicholas; Polgar, Peter] Tufts Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA	Tufts Medical Center	Wilson, JL (corresponding author), Tufts Med Ctr, Dept Med, Div Pulm Crit Care & Sleep Med, Boston, MA 02111 USA.	jwilson8@tuftsmedicalcenter.org	Wilson, Jamie/J-5913-2019		National Heart, Lung, and Blood Institute of the National Institutes of Health [HL25776, HL133796]; Actelion Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL133796, R01HL025776] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Actelion Pharmaceuticals; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grants HL25776 (PP) and HL133796 (JW) from the National Heart, Lung, and Blood Institute of the National Institutes of Health. Additional funding to support this work was provided by Actelion Pharmaceuticals (NH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Alahyan M, 2006, J BIOL CHEM, V281, P19433, DOI 10.1074/jbc.M507602200; Baik J, 2014, INT J BIOL SCI, V10, P1108, DOI 10.7150/ijbs.9797; Barman SA, 2007, AM J PHYSIOL-LUNG C, V293, pL472, DOI 10.1152/ajplung.00101.2006; Bravo DD, 2018, J PHARMACOL TOX MET, V89, P47, DOI 10.1016/j.vascn.2017.10.006; Brozovich FV, 2016, PHARMACOL REV, V68, P476, DOI 10.1124/pr.115.010652; Cacoub P, 1997, CARDIOVASC RES, V33, P196, DOI 10.1016/S0008-6363(96)00189-7; Comhair SAA, 2012, AM J RESP CELL MOL, V46, P723, DOI 10.1165/rcmb.2011-0416TE; Dai YP, 2006, VASC PHARMACOL, V44, P275, DOI 10.1016/j.vph.2005.11.008; Dai YP, 2008, ADV PHARMACOL SCI, V2008, DOI 10.1155/2008/362741; Do E Z, 2009, CIRC J, V73, P1731, DOI 10.1253/circj.CJ-09-0135; Do KH, 2009, EXP MOL MED, V41, P569, DOI 10.3858/emm.2009.41.8.062; Eibert SM, 2004, P NATL ACAD SCI USA, V101, P1957, DOI 10.1073/pnas.0308282100; Frazier AA, 2012, SEMIN ULTRASOUND CT, V33, P535, DOI 10.1053/j.sult.2012.06.002; Fujita H, 2010, HEART VESSELS, V25, P144, DOI 10.1007/s00380-009-1176-8; Fukumoto Y, 2005, HEART, V91, P391, DOI 10.1136/hrt.2003.029470; Galie N, 2008, LANCET, V371, P2093, DOI 10.1016/S0140-6736(08)60919-8; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; GOTO K, 1989, P NATL ACAD SCI USA, V86, P3915, DOI 10.1073/pnas.86.10.3915; Guan RG, 2013, EUR J MED CHEM, V70, P613, DOI 10.1016/j.ejmech.2013.10.048; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Hedges JC, 2000, AM J PHYSIOL-CELL PH, V278, pC718, DOI 10.1152/ajpcell.2000.278.4.C718; HEMRIC ME, 1993, J BIOL CHEM, V268, P15305; Hong ZG, 2014, J MOL MED, V92, P995, DOI 10.1007/s00109-014-1162-1; Huang RJ, 2006, FEBS LETT, V580, P63, DOI 10.1016/j.febslet.2005.11.047; Ishikura K, 2006, CIRC J, V70, P174, DOI 10.1253/circj.70.174; Jernigan NL, 2008, AM J PHYSIOL-LUNG C, V295, pL515, DOI 10.1152/ajplung.00355.2007; Jiang QF, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-6; KATSUYAMA H, 1992, J BIOL CHEM, V267, P14555; Kawanabe Y, 2002, J CARDIOVASC PHARM, V40, P438, DOI 10.1097/00005344-200209000-00013; Kordowska J, 2006, J BIOMED SCI, V13, P159, DOI 10.1007/s11373-005-9060-8; Li JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013955; Liao MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056331; LINZ W, 1995, PHARMACOL REV, V47, P25; Louis SF, 2010, EXP CLIN CARDIOL, V15, pE75; Tu L, 2012, AM J RESP CRIT CARE, V186, P666, DOI 10.1164/rccm.201202-0309OC; MARSTON SB, 1991, BIOCHEM J, V279, P1; Mohacsi Attila, 2004, Current Vascular Pharmacology, V2, P53, DOI 10.2174/1570161043476528; Neylon CB, 1999, CLIN EXP PHARMACOL P, V26, P149, DOI 10.1046/j.1440-1681.1999.03013.x; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Patchell VB, 2002, BBA-PROTEIN STRUCT M, V1596, P121, DOI 10.1016/S0167-4838(02)00210-8; Paulin R, 2014, EUR RESPIR J, V43, P531, DOI 10.1183/09031936.00181312; Perros F, 2008, AM J RESP CRIT CARE, V178, P81, DOI 10.1164/rccm.200707-1037OC; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Sakao S, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-95; Savai R, 2014, NAT MED, V20, P1289, DOI 10.1038/nm.3695; Shao DM, 2011, PHARMACOL RES, V63, P504, DOI 10.1016/j.phrs.2011.03.003; Shin CY, 2002, J PHARMACOL EXP THER, V302, P924, DOI 10.1124/jpet.302.3.924; SOBUE K, 1985, BIOCHEM BIOPH RES CO, V132, P645, DOI 10.1016/0006-291X(85)91181-7; Steinbach SK, 2011, ARTERIOSCL THROM VAS, V31, P2938, DOI 10.1161/ATVBAHA.111.232975; STEWART DJ, 1991, ANN INTERN MED, V114, P464, DOI 10.7326/0003-4819-114-6-464; Tajsic T, 2011, COMPR PHYSIOL, V1, P295, DOI 10.1002/cphy.c100026; Tirapelli CR, 2005, BRIT J PHARMACOL, V146, P903, DOI 10.1038/sj.bjp.0706388; VELAZ L, 1990, J BIOL CHEM, V265, P2929; WANG CLA, 1991, J BIOL CHEM, V266, P9166; Wang YP, 2009, CIRC RES, V104, P531, DOI 10.1161/CIRCRESAHA.108.188524; Wang Z, 1997, J BIOL CHEM, V272, P16896, DOI 10.1074/jbc.272.27.16896; Wilson Jamie L, 2015, Curr Top Pept Protein Res, V16, P1; Wilson JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123662; Wilson JL, 2012, EXP CELL RES, V318, P1125, DOI 10.1016/j.yexcr.2012.03.029; Wynne BM, 2009, J AM SOC HYPERTENS, V3, P84, DOI 10.1016/j.jash.2008.09.002; Yamamura A, 2013, CIRC RES, V112, P640, DOI 10.1161/CIRCRESAHA.113.300897; YANAGISAWA M, 1988, J HYPERTENS, V6, pS188, DOI 10.1097/00004872-198812040-00056; Yao CX, 2015, INT J MASS SPECTROM, V378, P347, DOI 10.1016/j.ijms.2014.10.006; Yu J, 2013, J CELL PHYSIOL, V228, P322, DOI 10.1002/jcp.24132; Yu NC, 2006, ANAL CHEM, V78, P35, DOI 10.1021/ac051695v; Zhao YDD, 2012, AM J PATHOL, V180, P2268, DOI 10.1016/j.ajpath.2012.02.016	67	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195780	10.1371/journal.pone.0195780	http://dx.doi.org/10.1371/journal.pone.0195780			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649319	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900086
J	Bodmer, NK; Havranek, JJ				Bodmer, Nicholas K.; Havranek, James J.			Efficient minimization of multipole electrostatic potentials in torsion space	PLOS ONE			English	Article							POLARIZABLE FORCE-FIELD; ANALYTICAL MOLECULAR-SURFACE; SEQUENCE CULLING SERVER; PROTEIN-PROTEIN DOCKING; DRUDE OSCILLATOR MODEL; ATOMIC MULTIPOLE; LIGAND-BINDING; BIOMOLECULAR STRUCTURE; CONFORMATIONAL ENERGY; STRUCTURE PREDICTION	The development of models of macromolecular electrostatics capable of delivering improved fidelity to quantum mechanical calculations is an active field of research in computational chemistry. Most molecular force field development takes place in the context of models with full Cartesian coordinate degrees of freedom. Nevertheless, a number of macromolecular modeling programs use a reduced set of conformational variables limited to rotatable bonds. Efficient algorithms for minimizing the energies of macromolecular systems with torsional degrees of freedom have been developed with the assumption that all atom-atom interaction potentials are isotropic. We describe novel modifications to address the anisotropy of higher order multipole terms while retaining the efficiency of these approaches. In addition, we present a treatment for obtaining derivatives of atom-centered tensors with respect to torsional degrees of freedom. We apply these results to enable minimization of the Amoeba multipole electrostatics potential in a system with torsional degrees of freedom, and validate the correctness of the gradients by comparison to finite difference approximations. In the interest of enabling a complete model of electrostatics with implicit treatment of solvent-mediated effects, we also derive expressions for the derivative of solvent accessible surface area with respect to torsional degrees of freedom.	[Bodmer, Nicholas K.; Havranek, James J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Havranek, JJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.	jjhavranek@wustl.edu		Havranek, James/0000-0001-8241-5928	National Institute Of General Medical Sciences of the National Institutes of Health [R01GM101602]; Rosetta Commons; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101602] Funding Source: NIH RePORTER	National Institute Of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Rosetta Commons; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by National Institute Of General Medical Sciences of the National Institutes of Health under Award Number R01GM101602 to JJH. Grant from the Rosetta Commons. www.rosettacommons.org. The sponsors and funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; ABAGYAN RA, 1989, J BIOMOL STRUCT DYN, V6, P833, DOI 10.1080/07391102.1989.10507740; ABE H, 1984, COMPUT CHEM, V8, P239, DOI 10.1016/0097-8485(84)85015-9; Anandakrishnan R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067715; Antila HS, 2015, J COMPUT CHEM, V36, P739, DOI 10.1002/jcc.23850; Ashworth J, 2006, NATURE, V441, P656, DOI 10.1038/nature04818; Bryant R, 2004, DISCRETE COMPUT GEOM, V32, P293, DOI 10.1007/s00454-004-1099-1; Chen JH, 2005, J COMPUT CHEM, V26, P1565, DOI 10.1002/jcc.20293; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; FAERMAN CH, 1990, J AM CHEM SOC, V112, P4915, DOI 10.1021/ja00168a043; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; GIBSON KD, 1990, J COMPUT CHEM, V11, P468, DOI 10.1002/jcc.540110406; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Gresh N, 2004, J COMPUT CHEM, V25, P823, DOI 10.1002/jcc.20012; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Harder E, 2009, J AM CHEM SOC, V131, P2760, DOI 10.1021/ja806825g; Havranek JJ, 2004, J MOL BIOL, V344, P59, DOI 10.1016/j.jmb.2004.09.029; Izadi S, 2014, J PHYS CHEM LETT, V5, P3863, DOI 10.1021/jz501780a; Jiang L, 2008, SCIENCE, V319, P1387, DOI 10.1126/science.1152692; Jiang N, 2010, J PHYS CHEM B, V114, P11241, DOI 10.1021/jp102844h; Jiao D, 2008, P NATL ACAD SCI USA, V105, P6290, DOI 10.1073/pnas.0711686105; Jiao D, 2009, J COMPUT CHEM, V30, P1701, DOI 10.1002/jcc.21268; Klenin KV, 2011, J COMPUT CHEM, V32, P2647, DOI 10.1002/jcc.21844; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lemkul JA, 2016, J PHYS CHEM B, V120, P11436, DOI 10.1021/acs.jpcb.6b09262; Lemkul JA, 2014, J PHYS CHEM LETT, V5, P2077, DOI 10.1021/jz5009517; MAZUR AK, 1989, J BIOMOL STRUCT DYN, V6, P815, DOI 10.1080/07391102.1989.10507739; NOGUTI T, 1983, J PHYS SOC JPN, V52, P3685, DOI 10.1143/JPSJ.52.3685; O'Meara MJ, 2015, J CHEM THEORY COMPUT, V11, P609, DOI 10.1021/ct500864r; PEAR MR, 1979, J CHEM PHYS, V71, P212, DOI 10.1063/1.438119; PERROT G, 1992, J COMPUT CHEM, V13, P1, DOI 10.1002/jcc.540130102; Ren PY, 2002, J COMPUT CHEM, V23, P1497, DOI 10.1002/jcc.10127; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Savelyev A, 2014, J PHYS CHEM B, V118, P6742, DOI 10.1021/jp503469s; Savelyev A, 2014, J COMPUT CHEM, V35, P1219, DOI 10.1002/jcc.23611; Schnieders MJ, 2007, J CHEM THEORY COMPUT, V3, P2083, DOI 10.1021/ct7001336; Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413; Shi Y, 2013, J CHEM THEORY COMPUT, V9, P4046, DOI 10.1021/ct4003702; Shi Y, 2012, J PHYS CHEM B, V116, P1716, DOI 10.1021/jp210265d; Stone A. J, 2013, THEORY INTERMOLECULA, pxi; Totrov M, 1996, J STRUCT BIOL, V116, P138, DOI 10.1006/jsbi.1996.0022; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wedemeyer WJ, 2003, PROTEINS, V53, P262, DOI 10.1002/prot.10525; WILLIAMS DE, 1988, J COMPUT CHEM, V9, P745, DOI 10.1002/jcc.540090705; Wu JC, 2012, THEOR CHEM ACC, V131, DOI 10.1007/s00214-012-1138-6; Zhang CS, 2017, J CHEM THEORY COMPUT, V13, P666, DOI 10.1021/acs.jctc.6b00918	49	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195578	10.1371/journal.pone.0195578	http://dx.doi.org/10.1371/journal.pone.0195578			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641557	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900075
J	Miyazaki, K				Miyazaki, Kentaro			Molecular engineering of the salicylate-inducible transcription factor Sal7AR for orthogonal and high gene expression in Escherichia coli	PLOS ONE			English	Article							METAGENOME LIBRARIES; ADAPTATION	I have previously identified a metagenomic fragment (similar to 4 kb) containing the salicylate (2-hydroxybenzoate)-responsive transcriptional regulator Sal7AR. Taking advantage of the inert nature of salicylate to common genetic switches used in Escherichia coli, here I developed a salicylate-inducible high expression system in E. coli. I first applied a deletion analysis to the metagenomic fragment to identify the core region (similar to 1 kb) necessary for the salicylate-dependent expression. Sal7AR was subjected to an error-prone PCR, and a library was screened for an enhanced expression of a reporter green fluorescent protein (GFP) gene in the presence of 1 mM salicylate, where virtually no growth inhibition was observed. Three beneficial amino acid substitutions were identified (N282K, Q292R, and V295G), each of which improved the expression of GFP relative to the wildtype by several-fold. The three sites were then completely randomized by saturation mutagenesis either individually or combinatorially to identify three variants carrying a single point mutation, N282L, V295F, or V295S; no further improvements were observed by combining these mutations. Salicylate-dependent expression of these mutants was highly repressed in its absence and escalated in response to similar to 10 mu M salicylate, and gradually increased up to 1 mM salicylate; the induction rate was approximately 15 times greater than that achieved with a lactose promoter. Orthogonality to the lactose-based expression system was also confirmed. This salicylate-based expression system should thus be advantageously used for high-level production of recombinant proteins in combination with common lactose-dependent induction systems.	[Miyazaki, Kentaro] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan; [Miyazaki, Kentaro] Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan	National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Miyazaki, K (corresponding author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Tsukuba, Ibaraki, Japan.; Miyazaki, K (corresponding author), Univ Tokyo, Grad Sch Frontier Sci, Dept Computat Biol & Med Sci, Kashiwa, Chiba, Japan.	miyazaki-kentaro@aist.go.jp	Miyazaki, Kentaro/F-7022-2010	Miyazaki, Kentaro/0000-0002-4349-566X	ImPACT Program of Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan)	ImPACT Program of Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan)	This research was funded by ImPACT Program of Council for Science, Technology, and Innovation (Cabinet Office, Government of Japan).	Ahmadi MK, 2015, APPL ENVIRON MICROB, V81, P5290, DOI 10.1128/AEM.01373-15; Kelly CL, 2016, ACS SYNTH BIOL, V5, P1136, DOI 10.1021/acssynbio.6b00030; KUNIN CM, 1995, INFECT IMMUN, V63, P1796, DOI 10.1128/IAI.63.5.1796-1799.1995; Miyazaki K, 1999, J MOL EVOL, V49, P716, DOI 10.1007/PL00006593; Price CTD, 2000, INT J BIOCHEM CELL B, V32, P1029, DOI 10.1016/S1357-2725(00)00042-X; Springael D, 2004, TRENDS MICROBIOL, V12, P53, DOI 10.1016/j.tim.2003.12.010; Tang SY, 2008, J AM CHEM SOC, V130, P5267, DOI 10.1021/ja7109053; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; Uchiyama T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075795; Uchiyama T, 2010, METHODS MOL BIOL, V668, P153, DOI 10.1007/978-1-60761-823-2_10; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P7029, DOI 10.1128/AEM.00464-10; VANDERMEER JR, 1992, MICROBIOL REV, V56, P677, DOI 10.1128/MMBR.56.4.677-694.1992	12	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194090	10.1371/journal.pone.0194090	http://dx.doi.org/10.1371/journal.pone.0194090			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641575	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900024
J	Reguero, BG; Beck, MW; Bresch, DN; Calil, J; Meliane, I				Reguero, Borja G.; Beck, Michael W.; Bresch, David N.; Calil, Juliano; Meliane, Imen			Comparing the cost effectiveness of nature-based and coastal adaptation: A case study from the Gulf Coast of the United States	PLOS ONE			English	Article							SEA-LEVEL RISE; STORM-SURGE; FLOOD RISK; DAMAGE; INFRASTRUCTURE; MITIGATION; DEFENSE; IMPACT; FUTURE	Coastal risks are increasing from both development and climate change. Interest is growing in the protective role that coastal nature-based measures (or green infrastructure), such as reefs and wetlands, can play in adapting to these risks. However, a lack of quantitative information on their relative costs and benefits is one principal factor limiting their use more broadly. Here, we apply a quantitative risk assessment framework to assess coastal flood risk (from climate change and economic exposure growth) across the United States Gulf of Mexico coast to compare the cost effectiveness of different adaptation measures. These include nature-based (e.g. oyster reef restoration), structural or grey (e.g., seawalls) and policy measures (e.g. home elevation). We first find that coastal development will be a critical driver of risk, particularly for major disasters, but climate change will cause more recurrent losses through changes in storms and relative sea level rise. By 2030, flooding will cost $134 +/- 176.6 billion (for different economic growth scenarios), but as the effects of climate change, land subsidence and concentration of assets in the coastal zone increase, annualized risk will more than double by 2050 with respect to 2030. However, from the portfolio we studied, the set of cost-effective adaptation measures (with benefit to cost ratios above 1) could prevent up to $57 +/- 101 billion in losses, which represents 42.8 +/- 57.2% of the total risk. Nature-based adaptation options could avert more than $50 billion of these costs, and do so cost effectively with average benefit to cost ratios above 3.5. Wetland and oyster reef restoration are found to be particularly cost-effective. This study demonstrates that the cost effectiveness of nature-based, grey and policy measures can be compared quantitatively with one another, and that the cost effectiveness of adaptation becomes more attractive as climate change and coastal development intensifies in the future. It also shows that investments in nature-based adaptation could meet multiple objectives for environmental restoration, adaptation and flood risk reduction.	[Reguero, Borja G.; Beck, Michael W.] Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA; [Reguero, Borja G.; Beck, Michael W.; Meliane, Imen] Nature Conservancy, Santa Cruz, CA USA; [Bresch, David N.] Swiss Fed Inst Technol, Swiss Fed Inst Technol, Zurich, Switzerland; [Calil, Juliano] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; Nature Conservancy; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Santa Cruz	Reguero, BG (corresponding author), Univ Calif Santa Cruz, Inst Marine Sci, Santa Cruz, CA 95064 USA.; Reguero, BG (corresponding author), Nature Conservancy, Santa Cruz, CA USA.	breguero@ucsc.edu	Beck, Michael W./AAB-2844-2019; Bresch, David N./D-5298-2018; Reguero, Borja/L-8621-2014	Beck, Michael W./0000-0002-5107-9973; Bresch, David N./0000-0002-8431-4263; Calil, Juliano/0000-0002-6568-4883; Reguero, Borja/0000-0001-5526-7157	Anne Ray Charitable Trust; Kingfisher Foundation; Lyda Hill Foundation; Science for Nature And People Partnership; Pew Marine Conservation Fellowship	Anne Ray Charitable Trust; Kingfisher Foundation; Lyda Hill Foundation; Science for Nature And People Partnership; Pew Marine Conservation Fellowship	This work was supported in part by the Anne Ray Charitable Trust, Kingfisher Foundation and the Lyda Hill Foundation as well as the Science for Nature And People Partnership; MWB was also supported by a Pew Marine Conservation Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JCJH, 2013, RISK ANAL, V33, P772, DOI 10.1111/risa.12008; Anderson DG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188142; Anel JA, 2011, COMMUN ACM, V54, P40, DOI 10.1145/1941487.1941502; [Anonymous], 2012, COASTAL LOUISIANA RI; Barbier EB, 2015, ECOSYST SERV, V11, P32, DOI 10.1016/j.ecoser.2014.06.010; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Blake E.S., 2011, DEADLIEST COSTLIEST; Borsje BW, 2011, ECOL ENG, V37, P113, DOI 10.1016/j.ecoleng.2010.11.027; Bresch D.N, 2014, CLIMADA THE OPEN SOU; Bresch D.N., 2016, CLIMATE CHANGE ADAPT, P241, DOI DOI 10.1007/978-3-319-40773-9_13; Bresch DN, 2014, CLIMADA MANUAL, P1; Bridges T., 2013, COASTAL RISK REDUCTI; Broekx S, 2011, NAT HAZARDS, V57, P245, DOI 10.1007/s11069-010-9610-x; Calil J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187011; Chapman MG, 2011, J EXP MAR BIOL ECOL, V400, P302, DOI 10.1016/j.jembe.2011.02.025; Cheong SM, 2013, NAT CLIM CHANGE, V3, P787, DOI 10.1038/NCLIMATE1854; Cobell Z, 2013, J COASTAL RES, P88, DOI 10.2112/SI_67_7; Cooper JAG, 2014, OCEAN COAST MANAGE, V94, P90, DOI 10.1016/j.ocecoaman.2013.09.006; ECA, 2009, SHAP CLIM RES DEV FR; Edwards PET, 2013, MAR POLICY, V38, P65, DOI 10.1016/j.marpol.2012.05.020; EU, 2015, EU RES INN POL AG NA, DOI DOI 10.2777/765301; EU, 2013, COMMUNICATION, P249; Exec. Office of the President, 2013, PRESIDENTS CLIMATE A; FEMA, 2015, GULF MEX COAST REG; FEMA, 2011, ENG NAT, P3; FEMA, 2014, HOM GUID RETR, V3rd; Ferrario F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4794; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Flores P., 2006, NAT HAZARDS REV, V7, P72, DOI [10.1061/(ASCE)1527-6988(2006)7:2(72), DOI 10.1061/(ASCE)1527-6988(2006)7:2(72)]; Gedan KB, 2011, CLIMATIC CHANGE, V106, P7, DOI 10.1007/s10584-010-0003-7; Gesch D, 2002, PHOTOGRAMM ENG REM S, V68, P5; Ghermandi A, 2013, ECOL ECON, V86, P1, DOI 10.1016/j.ecolecon.2012.11.006; Gittman RK, 2015, FRONT ECOL ENVIRON, V13, P301, DOI 10.1890/150065; Hallegatte S, 2013, NAT CLIM CHANGE, V3, P802, DOI [10.1038/nclimate1979, 10.1038/NCLIMATE1979]; Hauer ME, 2016, NAT CLIM CHANGE, V6, P691, DOI [10.1038/nclimate2961, 10.1038/NCLIMATE2961]; Hinkel J, 2014, P NATL ACAD SCI USA, V111, P3292, DOI 10.1073/pnas.1222469111; Houston JR, 2008, EC VALUE BEACHES 200, P76; Hsiang S, 2017, SCIENCE, V356, P1362, DOI 10.1126/science.aal4369; Ivins ER, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030003; James R, 2014, NAT CLIM CHANGE, V4, P938, DOI 10.1038/nclimate2411; Jongman B, 2012, GLOBAL ENVIRON CHANG, V22, P823, DOI 10.1016/j.gloenvcha.2012.07.004; Karp L, 2005, J PUBLIC ECON, V89, P261, DOI 10.1016/j.jpubeco.2004.02.005; Kroeger T, 2012, NATURE CONSERVANCY; Kron W, 2005, WATER INT, V30, P58, DOI 10.1080/02508060508691837; Kron W, 2013, NAT HAZARDS, V66, P1363, DOI 10.1007/s11069-012-0215-4; Lin N, 2012, NAT CLIM CHANGE, V2, P462, DOI 10.1038/NCLIMATE1389; Losada IJ, 2013, GLOBAL PLANET CHANGE, V104, P34, DOI 10.1016/j.gloplacha.2013.02.006; Louisiana CP, 2012, LOUISIANAS COMPREHEN; Martin D, 2005, COAST ENG, V52, P1027, DOI 10.1016/j.coastaleng.2005.09.006; Mechler R, 2016, SCIENCE, V354, P290, DOI 10.1126/science.aag2514; Mendelsohn R, 2008, REV ENV ECON POLICY, V2, P45, DOI 10.1093/reep/rem023; Moller I, 2014, NAT GEOSCI, V7, P848, DOI [10.1038/ngeo2251, 10.1038/NGEO2287, 10.1038/NGEO2251]; Narayan S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154735; NAS, 2014, NAT AC SCI WAT SCI T; National Oceanic and Atmospheric Administration (NOAA), 2010, RESORT WAR 1816 2007; National Research Council, 2014, RED COAST RISKS E GU, DOI [10.17226/18811, DOI 10.17226/18811]; Neumann JE, 2015, CLIMATIC CHANGE, V129, P337, DOI 10.1007/s10584-014-1304-z; Nicholls RJ, 2014, WIRES CLIM CHANGE, V5, P129, DOI 10.1002/wcc.253; NOAA, 2013, WHAT WILL AD COST EC; NOAA, 2011, EXPL COAST COMM EC E; NOAA, 2009, SEA LEV VAR US 1854; Nordhaus W, 2007, SCIENCE, V317, P201, DOI 10.1126/science.1137316; Peduzzi P, 2012, NAT CLIM CHANGE, V2, P289, DOI 10.1038/NCLIMATE1410; Peyronnin N, 2013, J COASTAL RES, P1, DOI 10.2112/SI_67_1.1; PINSKY ML, 2013, EC EC SOC AM, V4, DOI DOI 10.1890/ES13-00080.1; Possingham HP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002052; PwC Economics, 2013, WORLD 2050 BRICS PRO; Reddy SMW, 2016, INTEGR ENVIRON ASSES, V12, P328, DOI 10.1002/ieam.1678; Reguero BG, 2018, CLIMADA COASTAL AREA; Reguero BG, 2018, ASSESSING COASTAL RI, DOI [10.17504/protocols.io.miyc4fw, DOI 10.17504/PROTOCOLS.IO.MIYC4FW]; Reguero BG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133409; Res C, 2001, MAPS LANDS VULNERABL, V18, P205; Resio DT, 2015, CURR CLIM CHANGE REP, V1, P74, DOI 10.1007/s40641-015-0011-9; Resio DT, 2009, NAT HAZARDS, V51, P163, DOI 10.1007/s11069-009-9379-y; RESTORE, 2014, GULF COAST EC RES CO; Rodriguez AB, 2014, NAT CLIM CHANGE, V4, P493, DOI [10.1038/nclimate2216, 10.1038/NCLIMATE2216]; Sasmito SD, 2016, WETL ECOL MANAG, V24, P263, DOI 10.1007/s11273-015-9466-7; Shepard CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027374; Souvignet M., 2016, EC CLIMATE ADAPTATIO; Spalding MD, 2014, CONSERV LETT, V7, P293, DOI 10.1111/conl.12074; Stockdon BHF, 2012, NATL ASSESSMENT HURR; Sutton-Grier AE, 2015, ENVIRON SCI POLICY, V51, P137, DOI 10.1016/j.envsci.2015.04.006; Temmerman S, 2015, SCIENCE, V349, P588, DOI 10.1126/science.aac8312; Temmerman S, 2013, NATURE, V504, P79, DOI 10.1038/nature12859; Thomson G, 2010, BARRIER ISLAND RESTO; TNC, 2015, NAT CONS; Travis WR, 2014, CLIM RISK MANAG, V1, P1, DOI 10.1016/j.crm.2014.02.003; Tunstall S., 2007, FLOOD RISK MANAG HAZ, P189; USACE, 2015, N ATLANTIC COAST COM; USCensus, 2010, COAST POP TRENDS US; Walsh KJE, 2016, WIRES CLIM CHANGE, V7, P65, DOI 10.1002/wcc.371; Wamsley TV, 2010, OCEAN ENG, V37, P59, DOI 10.1016/j.oceaneng.2009.07.018; Wong PP, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P361; Woodruff JD, 2013, NATURE, V504, P44, DOI 10.1038/nature12855	98	89	90	6	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0192132	10.1371/journal.pone.0192132	http://dx.doi.org/10.1371/journal.pone.0192132			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641611	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900005
J	Wu, XZ; Gowda, NM; Kawasawa, YI; Gowda, DC				Wu, Xianzhu; Gowda, Nagaraj M.; Kawasawa, Yuka I.; Gowda, D. Channe			A malaria protein factor induces IL-4 production by dendritic cells via PI3K-Akt-NF-B signaling independent of MyD88/TRIF and promotes Th2 response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						malaria; protein complex; dendritic cell; interleukin; Toll-like receptor (TLR); PI3K-Akt-NF-kB; signaling; protein factor; dendritic cell; IL-4 production; signaling mechanism	INNATE IMMUNE-RESPONSES; PROTECTIVE-IMMUNITY; CEREBRAL MALARIA; T-CELLS; INFECTION; ACTIVATION; HEMOZOIN; HOST; PATHOGENESIS; INFLAMMATION	Dendritic cells (DC) and cytokines produced by DC play crucial roles in inducing and regulating pro-/anti-inflammatory and Th1/Th2 responses. DC are known to produce a Th1-promoting cytokine, interleukin (IL)-12, in response to malaria and other pathogenic infections, but it is thought that DC do not produce Th2-promoting cytokine, IL-4. Here, we show that a protein factor of malaria parasites induces IL-4 responses by CD11c(hi)MHCII(hi)CD3E(-)CD49b(-)CD19(-)FcERI(-) DC via PI3K-Akt-NF-B signaling independent of TLR-MyD88/TRIF. Malaria parasite-activated DC induced IL-4 responses by T cells both in vitro and in vivo, favoring Th2, and il-4-deficient DC were unable to induce IL-4 expression by T cells. Interestingly, lethal parasites, Plasmodium falciparum and Plasmodium berghei ANKA, induced IL-4 response primarily by CD8(-) DC, whereas nonlethal Plasmodium yoelii induced IL-4 by both CD8(+) and CD8(-) DC. In both P. berghei ANKA- and P. yoelii-infected mice, IL-4-expressing CD8(-) DC did not express IL-12, but a distinct CD8(-) DC subset expressed IL-12. In P. berghei ANKA infection, CD8(+) DC expressed IL-12 but not IL-4, whereas in P. yoelii infection, CD8(+) DC expressed IL-4 but not IL-12. These differential IL-4 and IL-12 responses by DC subsets may contribute to different Th1/Th2 development and clinical outcomes in lethal and nonlethal malaria. Our results for the first time demonstrate that a malaria protein factor induces IL-4 production by DC via PI3K-Akt-NF-B signaling, revealing signaling and molecular mechanisms that initiate and promote Th2 development.	[Wu, Xianzhu; Gowda, Nagaraj M.; Kawasawa, Yuka I.; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Kawasawa, Yuka I.] Penn State Univ, Coll Med, Dept Pharmacol, Hershey, PA 17033 USA; [Kawasawa, Yuka I.] Penn State Univ, Coll Med, Inst Personalized Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Gowda, DC (corresponding author), Hershey Med Ctr, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu			NIAID, National Institutes of Health [R01 AI41139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID, National Institutes of Health, Grant R01 AI41139. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baccarella A, 2013, INFECT IMMUN, V81, P4431, DOI 10.1128/IAI.00923-13; Barrera V, 2011, BLOOD, V117, P5674, DOI 10.1182/blood-2010-10-312413; Bernabeu M, 2017, TRENDS PARASITOL, V33, P295, DOI 10.1016/j.pt.2016.11.004; Coban C, 2005, J EXP MED, V201, P19, DOI 10.1084/jem.20041836; Couper KN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000744; d'Ostiani CF, 2000, J EXP MED, V191, P1661, DOI 10.1084/jem.191.10.1661; Deroost K, 2016, FEMS MICROBIOL REV, V40, P208, DOI 10.1093/femsre/fuv046; Gallego-Delgado J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-013-0401-8; Gazzinelli RT, 2014, NAT REV IMMUNOL, V14, P744, DOI 10.1038/nri3742; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; Gowda NM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020398; Howland SW, 2015, SEMIN IMMUNOPATHOL, V37, P221, DOI 10.1007/s00281-015-0476-6; Ing R, 2009, INFECT IMMUN, V77, P770, DOI 10.1128/IAI.00994-08; Kelleher P, 1999, EUR J IMMUNOL, V29, P2309, DOI 10.1002/(SICI)1521-4141(199907)29:07<2309::AID-IMMU2309>3.3.CO;2-X; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Ma YL, 2015, J IMMUNOL, V195, P3769, DOI 10.4049/jimmunol.1403240; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nakahara T, 2004, INT IMMUNOL, V16, P1701, DOI 10.1093/intimm/dxh171; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; Perry JA, 2005, J IMMUNOL, V174, P5921, DOI 10.4049/jimmunol.174.10.5921; Pichyangkul S, 2004, J IMMUNOL, V172, P4926, DOI 10.4049/jimmunol.172.8.4926; Riley EM, 2006, PARASITE IMMUNOL, V28, P35, DOI 10.1111/j.1365-3024.2006.00775.x; Rowe JA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001082; Sakanaka M, 2016, IMMUNOL LETT, V174, P1, DOI 10.1016/j.imlet.2016.04.003; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schofield L, 2007, IMMUNOL CELL BIOL, V85, P130, DOI 10.1038/sj.icb.7100040; Shortman K, 2010, IMMUNOL REV, V234, P18, DOI 10.1111/j.0105-2896.2009.00870.x; Sokol CL, 2009, NAT IMMUNOL, V10, P713, DOI 10.1038/ni.1738; Spaulding E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005975; Sponaas AM, 2006, J EXP MED, V203, P1427, DOI 10.1084/jem.20052450; Stevenson MM, 2006, PARASITE IMMUNOL, V28, P5, DOI 10.1111/j.1365-3024.2006.00772.x; Tedder Thomas F, 2001, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0732s23; Todryk SM, 2008, FUTURE MICROBIOL, V3, P279, DOI 10.2217/17460913.3.3.279; van der Heyde HC, 2006, TRENDS PARASITOL, V22, P503, DOI 10.1016/j.pt.2006.09.002; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Wu XZ, 2015, J BIOL CHEM, V290, P23135, DOI 10.1074/jbc.M115.671065; Wu XZ, 2010, J IMMUNOL, V184, P4338, DOI 10.4049/jimmunol.0903824; Yu X, 2016, IMMUNITY, V45, P1093, DOI 10.1016/j.immuni.2016.10.001	38	12	15	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 6	2018	293	27					10425	10434		10.1074/jbc.AC118.001720	http://dx.doi.org/10.1074/jbc.AC118.001720			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GM1LI	29666186	Green Published, hybrid			2022-12-26	WOS:000437828400002
J	Hamarat, Y; Bartusis, L; Deimantavicius, M; Siaudvytyte, L; Januleviciene, I; Ragauskas, A; Bershad, EM; Fandino, J; Kienzler, J; Remonda, E; Matijosaitis, V; Rastenyte, D; Petrikonis, K; Berskiene, K; Zakelis, R				Hamarat, Yasin; Bartusis, Laimonas; Deimantavicius, Mantas; Siaudvytyte, Lina; Januleviciene, Ingrida; Ragauskas, Arminas; Bershad, Eric M.; Fandino, Javier; Kienzler, Jenny; Remonda, Elke; Matijosaitis, Vaidas; Rastenyte, Daiva; Petrikonis, Kestutis; Berskiene, Kristina; Zakelis, Rolandas			Graphical and statistical analyses of the oculocardiac reflex during a non-invasive intracranial pressure measurement	PLOS ONE			English	Article							TRIGEMINO-CARDIAC REFLEX; HEART-RATE-VARIABILITY; STRABISMUS SURGERY; ADJUSTABLE SUTURES; ANESTHESIA; KNOWLEDGE; CHILDREN; ADULTS; DEPTH	Purpose This study aimed to examine the incidence of the oculocardiac reflex during a non-invasive intracranial pressure measurement when gradual external pressure was applied to the orbital tissues and eye. Methods Patients (n = 101) and healthy volunteers (n = 56) aged 20-75 years who underwent a non-invasive intracranial pressure measurement were included in this retrospective oculocardiac reflex analysis. Prespecified thresholds greater than a 10% or 20% decrease in the heart rate from baseline were used to determine the incidence of the oculocardiac reflex. Results None of the subjects had a greater than 20% decrease in heart rate from baseline. Four subjects had a greater than 10% decrease in heart rate from baseline, representing 0.9% of the total pressure steps. Three of these subjects were healthy volunteers, and one was a glaucoma patient. Conclusion The incidence of the oculocardiac reflex during a non-invasive intracranial pressure measurement procedure was very low and not associated with any clinically relevant effects.	[Hamarat, Yasin; Bartusis, Laimonas; Deimantavicius, Mantas; Ragauskas, Arminas; Zakelis, Rolandas] Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania; [Siaudvytyte, Lina; Januleviciene, Ingrida] Lithuanian Univ Hlth Sci, Eye Clin, Kaunas, Lithuania; [Bershad, Eric M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Fandino, Javier; Kienzler, Jenny; Remonda, Elke] Kantonsspital Aarau, Dept Neurosurg, Aarau, Switzerland; [Matijosaitis, Vaidas; Rastenyte, Daiva; Petrikonis, Kestutis] Lithuanian Univ Hlth Sci, Dept Neurol, Kaunas, Lithuania; [Berskiene, Kristina] Lithuanian Univ Hlth Sci, Sports Inst, Kaunas, Lithuania	Kaunas University of Technology; Lithuanian University of Health Sciences; Baylor College of Medicine; Kantonsspital Aarau AG (KSA); Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Bartusis, L (corresponding author), Kaunas Univ Technol, Hlth Telemat Sci Inst, Kaunas, Lithuania.	laimonas.bartusis@ktu.lt	Januleviciene, Ingrida/AAF-5758-2019; Hamarat, Yasin/H-9886-2018; Bartusis, Laimonas/H-9877-2018	Januleviciene, Ingrida/0000-0002-2660-7922; Hamarat, Yasin/0000-0002-1343-5068; Ragauskas, Arminas/0000-0001-9695-9512; Bartusis, Laimonas/0000-0001-5835-5697; Bershad, Eric/0000-0003-4091-2031	Vittamed Neuroscience (Waltham, MA, USA); European Commission's Seventh Framework Programme project 'BrainSafe' [232545]; Lithuanian-Swiss Programe project 'BrainCare' [CH-3SMM-01/06]; European Social Fund under the Global Grant measure [VP1-3.1-SMM-07-K-03-080]; National Space Biomedical Research Institute via NASA [NCC9-58]; Center for Space Medicine, Baylor College of Medicine	Vittamed Neuroscience (Waltham, MA, USA); European Commission's Seventh Framework Programme project 'BrainSafe'; Lithuanian-Swiss Programe project 'BrainCare'; European Social Fund under the Global Grant measure; National Space Biomedical Research Institute via NASA; Center for Space Medicine, Baylor College of Medicine	Professor Arminas Ragauskas is an inventor of patented the non-invasive ICP measurement method and a shareholder of Vittamed Neuroscience (Waltham, MA, USA). AR, LB, MD and RZ have received financial support from Vittamed Neuroscience (Waltham, MA, USA). AR, RZ, VM, DR and KP have received financial support from European Commission's Seventh Framework Programme project 'BrainSafe' (grant no. 232545). LB, AR, JF, JK, ER, VM and RZ have received financial support from Lithuanian-Swiss Programe project 'BrainCare' (grant no. CH-3SMM-01/06). LB, LS and IJ have received financial support from European Social Fund under the Global Grant measure (grant no. VP1-3.1-SMM-07-K-03-080). EB has received financial support from National Space Biomedical Research Institute via NASA NCC9-58, and Center for Space Medicine, Baylor College of Medicine. No funding bodies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, HEALTH, DOI DOI 10.4236/health.2012.47060; Bershad EM, 2016, WORLD NEUROSURG, V89, P647, DOI 10.1016/j.wneu.2015.11.102; Bhargava D, 2014, J MAXILLOFAC ORAL SU, V13, P373, DOI 10.1007/s12663-013-0541-4; BLANC VF, 1983, CAN ANAESTH SOC J, V30, P360, DOI 10.1007/BF03007858; Choi SH, 2007, ACTA ANAESTH SCAND, V51, P759, DOI 10.1111/j.1399-6576.2007.01329.x; EUSTIS HS, 1992, AM J OPHTHALMOL, V114, P307, DOI 10.1016/S0002-9394(14)71795-7; Hayreh SS, 2006, EYE, V20, P1130, DOI 10.1038/sj.eye.6702377; Hayreh S S, 1962, Br J Ophthalmol, V46, P65, DOI 10.1136/bjo.46.2.65; Karaman T, 2016, J CLIN MONIT COMPUT, V30, P889, DOI 10.1007/s10877-015-9789-1; KARHUNEN U, 1984, ANAESTHESIA, V39, P524, DOI 10.1111/j.1365-2044.1984.tb07354.x; Lai YH, 2014, J AAPOS, V18, P151, DOI 10.1016/j.jaapos.2013.11.024; LANG S, 1991, CAN J ANAESTH, V38, P757, DOI 10.1007/BF03008454; Nunan D, 2010, PACE, V33, P1407, DOI 10.1111/j.1540-8159.2010.02841.x; OHASHI T, 1986, INVEST OPHTH VIS SCI, V27, P1160; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Ragauskas A, 2005, ACT NEUR S, V95, P357; Ragauskas A, 2012, NEUROLOGY, V78, P1684, DOI 10.1212/WNL.0b013e3182574f50; Ragauskas A, 2014, NEUROL RES, V36, P607, DOI 10.1179/1743132813Y.0000000308; Sandu N, 2010, THESCIENTIFICWORLDJO, V10, P1416, DOI 10.1100/tsw.2010.136; Sandu N, 2010, THESCIENTIFICWORLDJO, V10, P811, DOI 10.1100/tsw.2010.71; Schaller B, 2009, J NEUROSURG ANESTH, V21, P187, DOI 10.1097/ANA.0b013e3181a2bf22; Schaller BJ, 2009, MOL MED, V15, P125, DOI 10.2119/molmed.2009.00013; Seshubabu G, 1998, BRIT J OPHTHALMOL, V82, P589, DOI 10.1136/bjo.82.5.589; Umetani K, 1998, J AM COLL CARDIOL, V31, P593, DOI 10.1016/S0735-1097(97)00554-8; VRABEC MP, 1987, AM J OPHTHALMOL, V104, P61, DOI 10.1016/0002-9394(87)90294-7; Yi C, 2008, BRIT J ANAESTH, V101, P234, DOI 10.1093/bja/aen129; Yu X M, 1991, Zhonghua Yan Ke Za Zhi, V27, P34; Zhang K, 2008, FRONT MED-PRC, V2, P295	28	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196155	10.1371/journal.pone.0196155	http://dx.doi.org/10.1371/journal.pone.0196155			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672564	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800096
J	Hyett, MP; Perry, A; Breakspear, M; Wen, W; Parker, GB				Hyett, Matthew P.; Perry, Alistair; Breakspear, Michael; Wen, Wei; Parker, Gordon B.			White matter alterations in the internal capsule and psychomotor impairment in melancholic depression	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; MAJOR DEPRESSION; FRACTIONAL ANISOTROPY; MEAN DIFFUSIVITY; ABNORMALITIES; INTEGRITY; DTI; CLASSIFICATION; DENSITY	Emerging evidence suggests that structural brain abnormalities may play a role in the pathophysiology of melancholic depression. We set out to test whether diffusion-derived estimates of white matter structure were disrupted in melancholia in regions underpinning psychomotor function. We hypothesized that those with melancholia (and evidencing impaired psychomotor function) would show disrupted white matter organization in internal capsule subdivisions. Diffusion magnetic resonance imaging (dMRI) data were acquired from 22 melancholic depressed, 23 non-melancholic depressed, and 29 healthy control participants. Voxel-wise fractional anisotropy (FA), radial diffusivity (RD), and axial diffusivity (AD) values were derived for anterior, posterior, and retrolenticular limbs of the internal capsule and compared between groups. Neuropsychological (reaction time) and psychomotor functioning were assessed and correlated against FA. Fractional anisotropy was distinctly increased, whilst RD was decreased, in the right anterior internal capsule in those with melancholia, compared to controls. The right anterior limb of the internal capsule correlated with clinical ratings of psychomotor disturbance, and reduced psychomotor speed was associated with increased FA values in the right retrolenticular limb in those with melancholia. Our findings highlight a distinct disturbance in the local white matter arrangement in specific regions of the internal capsule in melancholia, which in turn is associated with psychomotor dysfunction. This study clarifies the contribution of structural brain integrity to the phenomenology of melancholia, and may assist future efforts seeking to integrate neurobiological markers into depression subtyping.	[Hyett, Matthew P.; Perry, Alistair; Wen, Wei; Parker, Gordon B.] Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia; [Hyett, Matthew P.; Perry, Alistair; Breakspear, Michael] QIMR Berghofer Med Res Inst, Syst Neurosci Grp, Herston, Qld, Australia; [Perry, Alistair; Wen, Wei] Univ New South Wales, Sch Psychiat, Ctr Hlth Brain Ageing CHeBA, Sydney, NSW, Australia; [Breakspear, Michael] Royal Brisbane & Womens Hosp, Metro North Mental Hlth Serv, Brisbane, Qld, Australia; [Breakspear, Michael; Parker, Gordon B.] Prince Wales Hosp, Black Dog Inst, Randwick, NSW, Australia	University of New South Wales Sydney; QIMR Berghofer Medical Research Institute; University of New South Wales Sydney; Royal Brisbane & Women's Hospital; Black Dog Institute	Hyett, MP (corresponding author), Univ New South Wales, Sch Psychiat, Sydney, NSW, Australia.; Hyett, MP (corresponding author), QIMR Berghofer Med Res Inst, Syst Neurosci Grp, Herston, Qld, Australia.	matthewhyett@gmail.com	Breakspear, Michael/ABF-6302-2020	Breakspear, Michael/0000-0003-4943-3969; Wen, Wei/0000-0003-2753-3870	National Health and Medical Research Council of Australia [510135, 1037196]; OLD Office of Health and Medical Research	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); OLD Office of Health and Medical Research	This work was supported by grants from the National Health and Medical Research Council of Australia (Program Grants 510135 and 1037196: MPH, GBP, MJB), and the OLD Office of Health and Medical Research (MJB).	Alba-Ferrara LM, 2013, FRONT INTEGR NEUROSC, V7, DOI 10.3389/fnint.2013.00009; APA, 1980, DIAGN STAT MAN MENT, DOI [10.1176/appi.books.9780890423349, DOI 10.1176/APPI.BOOKS.9780890423349]; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Bar-Shir A, 2009, NEUROIMAGE, V48, P109, DOI 10.1016/j.neuroimage.2009.06.019; Beaulieu C., 2014, DIFFUSION MRI QUANTI, P155, DOI [https://doi.org/10.1016/B978-0-12-396460-1.00008-1, DOI 10.1016/B978-0-12-396460-1.00008-1]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cotter D, 2002, CEREB CORTEX, V12, P386, DOI 10.1093/cercor/12.4.386; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hendelman WJ, 2016, ATLAS FUNCTIONAL NEU; Hickie IB, 2007, PSYCHIAT RES-NEUROIM, V155, P211, DOI 10.1016/j.pscychresns.2007.01.006; Holdnack HA, WECHSLER TEST ADULT; Hyett MP, 2015, JAMA PSYCHIAT, V72, P350, DOI 10.1001/jamapsychiatry.2014.2490; Jahanshad N, 2013, NEUROIMAGE, V81, P455, DOI 10.1016/j.neuroimage.2013.04.061; Jellison BJ, 2004, AM J NEURORADIOL, V25, P356; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Korgaonkar MS, 2014, BRIT J PSYCHIAT, V205, P321, DOI 10.1192/bjp.bp.113.140376; Korgaonkar MS, 2011, HUM BRAIN MAPP, V32, P2161, DOI 10.1002/hbm.21178; Le Bihan D, 2003, NAT REV NEUROSCI, V4, P469, DOI 10.1038/nrn1119; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lochner C, 2012, J PSYCHIATR NEUROSCI, V37, P193, DOI 10.1503/jpn.110059; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Naidich TP, 2004, AM J NEURORADIOL, V25, P222; Pannek K, 2012, PEDIATR RADIOL, V42, P1169, DOI 10.1007/s00247-012-2427-x; PARKER G, 1994, BRIT J PSYCHIAT, V164, P316, DOI 10.1192/bjp.164.3.316; Parker G., 1996, MELANCHOLIA DISORDER; Parker G, 2013, J AFFECT DISORDERS, V147, P331, DOI 10.1016/j.jad.2012.11.035; Parker G, 2010, AM J PSYCHIAT, V167, P745, DOI 10.1176/appi.ajp.2010.09101525; Pendlebury ST, 1999, STROKE, V30, P956, DOI 10.1161/01.STR.30.5.956; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Raffelt D, 2012, NEUROIMAGE, V59, P3976, DOI 10.1016/j.neuroimage.2011.10.045; ROBBINS TW, 1994, DEMENTIA, V5, P266, DOI 10.1159/000106735; Roberts G, 2018, MOL PSYCHIATR, V23, P413, DOI 10.1038/mp.2016.216; Rush AJ, 2003, BIOL PSYCHIAT, V54, P573, DOI 10.1016/S0006-3223(02)01866-8; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Soriano-Mas C, 2011, BIOL PSYCHIAT, V69, P318, DOI 10.1016/j.biopsych.2010.07.029; Spielberger C.D., 1983, MANUAL STATE TRAIT A, DOI DOI 10.1002/9780470479216.CORPSY0943; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stephan KE, 2016, LANCET PSYCHIAT, V3, P77, DOI 10.1016/S2215-0366(15)00361-2; Tham MW, 2011, J AFFECT DISORDERS, V132, P26, DOI 10.1016/j.jad.2010.09.013; Thomas AJ, 2002, BRIT J PSYCHIAT, V181, P129; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Versace A, 2010, BIOL PSYCHIAT, V68, P560, DOI 10.1016/j.biopsych.2010.04.036; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Zhang AF, 2013, NEUROPSYCHOPHARMACOL, V38, P1451, DOI 10.1038/npp.2013.41; Zhu XL, 2011, BRAIN RES, V1369, P223, DOI 10.1016/j.brainres.2010.10.104; Zou K, 2008, J PSYCHIATR NEUROSCI, V33, P525	51	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195672	10.1371/journal.pone.0195672	http://dx.doi.org/10.1371/journal.pone.0195672			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672517	Green Submitted, gold, Green Published			2022-12-26	WOS:000430446800032
J	Lamichhane, BR; Persoon, GA; Leirs, H; Poudel, S; Subedi, N; Pokheral, CP; Bhattarai, S; Thapaliya, BP; de Longh, HH				Lamichhane, Babu Ram; Persoon, Gerard A.; Leirs, Herwig; Poudel, Shashank; Subedi, Naresh; Pokheral, Chiranjibi Prasad; Bhattarai, Santosh; Thapaliya, Bishnu Prasad; de Longh, Hans H.			Spatio-temporal patterns of attacks on human and economic losses from wildlife in Chitwan National Park, Nepal	PLOS ONE			English	Article							TIGERS PANTHERA-TIGRIS; CONFLICT; PEOPLE; CONSERVATION; POPULATION	Wildlife attacks on humans and economic losses often result in reduced support of local communities for wildlife conservation. Information on spatial and temporal patterns of such losses in the highly affected areas contribute in designing and implementing effective mitigation measures. We analyzed the loss of humans, livestock and property caused by wildlife during 1998 to 2016, using victim family's reports to Chitwan National Park authorities and Buffer Zone User Committees. A total of 4,014 incidents were recorded including attacks on humans, livestock depredation, property damage and crop raiding caused by 12 wildlife species. In total > 400,000 US dollar was paid to the victim families as a relief over the whole period. Most of the attacks on humans were caused by rhino, sloth bear, tiger, elephant, wild boar and leopard. A significantly higher number of conflict incidents caused by rhino and elephant were observed during full moon periods. An increase in the wildlife population did not coincide with an equal rise in conflict incidents reported. Underprivileged ethnic communities were attacked by wildlife more frequently than expected. Number of attacks on humans by carnivores and herbivores did not differ significantly. An insignificant decreasing trend of wildlife attacks on humans and livestock was observed with significant variation over the years. Tiger and leopard caused > 90% of livestock depredation. Tigers killed both large (cattle and buffalo) and medium sized (goat, sheep, pig) livestock but leopard mostly killed medium sized livestock. Most (87%) of the livestock killing during 2012-2016 occurred within the stall but close (< 500m) to the forest edge. Both the percentage of households with livestock and average holding has decreased over the years in buffer zone. Decreased forest dependency as well as conflict mitigation measures (electric and mesh wire fences) have contributed to keep the conflict incidents in control. Strengthening mitigation measures like construction of electric or mesh wire fences and predator-proof livestock corrals along with educating local communities about wildlife behavior and timely management of problem animals (man-eater tiger, rage elephant etc.) will contribute to reduce the conflict.	[Lamichhane, Babu Ram; Persoon, Gerard A.] Leiden Univ, Inst Cultural Anthropol & Dev Sociol, Fac Social & Behav Sci, Leiden, Netherlands; [Lamichhane, Babu Ram; Leirs, Herwig; de Longh, Hans H.] Univ Antwerp, Evolutionary Ecol Grp, Fac Sci, Campus Drie Eiken, Antwerp, Belgium; [Lamichhane, Babu Ram; Poudel, Shashank; Subedi, Naresh; Pokheral, Chiranjibi Prasad; Bhattarai, Santosh] NTNC, Khumaltar, Lalitpur, Nepal; [Thapaliya, Bishnu Prasad] DNPWC, Kathmandu, Nepal; [de Longh, Hans H.] Leiden Univ, Fac Sci, Inst Environm Sci CML, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; University of Antwerp; Department of National Parks & Wildlife Conservation (DNPWC); Leiden University; Leiden University - Excl LUMC	Lamichhane, BR (corresponding author), Leiden Univ, Inst Cultural Anthropol & Dev Sociol, Fac Social & Behav Sci, Leiden, Netherlands.; Lamichhane, BR (corresponding author), Univ Antwerp, Evolutionary Ecol Grp, Fac Sci, Campus Drie Eiken, Antwerp, Belgium.; Lamichhane, BR (corresponding author), NTNC, Khumaltar, Lalitpur, Nepal.	baburaml@gmail.com	BHATTARAI, SANTOSH/D-4977-2018; Leirs, Herwig/B-8197-2008; BHATTARAI, SANTOSH/AAG-9139-2021; Lamichhane, Babu Ram/O-2741-2013	Leirs, Herwig/0000-0002-7612-5024; BHATTARAI, SANTOSH/0000-0001-7615-1954; Lamichhane, Babu Ram/0000-0003-0580-7682	US Fish and Wildlife Service (Tiger-Rhino Conservation Fund) [F15AP00804]; Rufford Small Grants Foundation [20823-1]; Leiden University (Louwis Fellowship Fund)	US Fish and Wildlife Service (Tiger-Rhino Conservation Fund); Rufford Small Grants Foundation; Leiden University (Louwis Fellowship Fund)	This work was funded by the US Fish and Wildlife Service (Tiger-Rhino Conservation Fund - Grant No. F15AP00804, URL: https://www.fws.gov/International/wildife-without-borders/rhino- and-tiger-conservation-fund.html; Rufford Small Grants Foundation (Grant No. 20823-1) (BRL), URL: http://www.rufford.org/projects/babu_ram_lamichhane; Leiden University (Louwis Fellowship Fund) (GAP).	Acharya KP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161717; [Anonymous], R LANG ENV STAT COMP, DOI DOI 10.1080/02705060.2017.1422558; [Anonymous], 2012, THESIS; Aryal A, 2017, CONSERV BIOL, V31, P1494, DOI 10.1111/cobi.12894; Barlow A.C.D., 2013, Wildlife Biology in Practice, V9, P30; Bhattarai BR, 2017, J MT SCI-ENGL, V14, P964, DOI 10.1007/s11629-016-3980-9; Carter NH, 2012, P NATL ACAD SCI USA, V109, P15360, DOI 10.1073/pnas.1210490109; CBS, 2011, STATISTICS; CNP, 2017, BIODIVERSITY, P1; CNP, LOSS WILDL REL DISTR; CNP, 2004, CNP ANN REP FY 2003; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; CTEVT, 2014, DYN DIM LAB MIGR NEP; DANGOL D R, 1991, International Journal of Pharmacognosy, V29, P203; Dhungana R, 2018, ORYX, V52, P55, DOI 10.1017/S0030605316001587; DNPWC, 2016, DNPWC ANN REP FY 201; DNPWC, 2006, TIG CONS ACT PLAN 20; DNPWC, 2015, DNPWC ANN REP FY 201; DNPWC, 2014, DNPWC ANN REP FY 201; DNPWC, 2015, REP NAT RHIN COUNT 2; Fox J, 2018, J PEASANT STUD, V45, P610, DOI 10.1080/03066150.2016.1246436; GON, 1996, BUFF ZON MAN RUL 205; Gunn J, 2014, AFR J ECOL, V52, P129, DOI 10.1111/aje.12091; Gurung B, 2008, BIOL CONSERV, V141, P3069, DOI 10.1016/j.biocon.2008.09.013; Gurung B, 2009, ENVIRON CONSERV, V36, P338, DOI 10.1017/S0376892910000160; Gurung H., 2003, SOCIAL DEMOGRAPHY NE; hapa T.B., 2011, THESIS SAURASHTRA U; Heinen J. T., 2000, Journal of Environment & Development, V9, P45; Inskip C, 2009, ORYX, V43, P18, DOI 10.1017/S003060530899030X; Joshi AR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501675; Karki J. B., 2009, TIGERS THEIR PREY BA; Karki JB, 2015, ORYX, V49, P150, DOI 10.1017/S0030605313000471; Lamichhane BR, 2017, GLOB ECOL CONSERV, V11, P177, DOI 10.1016/j.gecco.2017.06.003; Martin E.B., 2006, PACHYDERM, V41, P61; Miller JRB, 2016, REG ENVIRON CHANGE, V16, P17, DOI 10.1007/s10113-015-0871-5; MISHRA HR, 1982, AMBIO, V11, P246; NEPAL SK, 1995, INT J SUST DEV WORLD, V2, P11, DOI 10.1080/13504509.1995.10590662; Odden M, 2010, ECOL RES, V25, P875, DOI 10.1007/s11284-010-0723-1; Packer C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022285; Pant G, 2016, ORYX, V50, P724, DOI 10.1017/S0030605315000381; Peterson MN, 2010, CONSERV LETT, V3, P74, DOI 10.1111/j.1755-263X.2010.00099.x; QGIS Development Team, 2017, QGIS GEOGRAPHIC INFO; Redpath SM, 2015, ORYX, V49, P222, DOI 10.1017/S0030605314000799; SHARMA UR, 1990, LANDSCAPE URBAN PLAN, V19, P133, DOI 10.1016/0169-2046(90)90049-8; Silwal T, 2017, ORYX, V51, P370, DOI 10.1017/S0030605315001489; Subedi N, 2013, ORYX, V47, P352, DOI 10.1017/S0030605313000562; Traill LW, 2016, J ZOOL, V299, P221, DOI 10.1111/jzo.12343; Tumenta PN, 2012, THESIS; Wikramanayake E, 2004, CONSERV BIOL, V18, P839, DOI 10.1111/j.1523-1739.2004.00145.x	49	36	38	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195373	10.1371/journal.pone.0195373	http://dx.doi.org/10.1371/journal.pone.0195373			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672538	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800026
J	Lee, SH; Matsunaga, A; Oe, T				Lee, Seon Hwa; Matsunaga, Atsushi; Oe, Tomoyuki			Inhibition effect of pyridoxamine on lipid hydroperoxide-derived modifications to human serum albumin	PLOS ONE			English	Article							MASS-SPECTROMETRIC CHARACTERIZATION; LIPOXIDATION END-PRODUCTS; CHEMICAL-MODIFICATION; DIABETIC COMPLICATIONS; PROTEIN MODIFICATION; ANGIOTENSIN-II; IN-VITRO; MECHANISM; ACID; METHYLGLYOXAL	Pyridoxamine (PM) is a promising drug candidate for treating various chronic conditions/diseases in which oxidative stress and carbonyl compounds are important factors affecting pathogenicity. These abilities of PM are mainly attributed to its inhibition of advanced glycation and lipoxidation end product formation, by scavenging reactive carbonyl species. PM might therefore prevent protein damage from lipid hydroperoxide-derived aldehydes such as 4-oxo-2(E)-nonenal (ONE) and 4-hydroxy-2(E)-nonenal (HNE) by trapping them. It was previously reported that PM reacts with ONE to produce pyrrolo-1,3-oxazine (PO8) through the formation of pyrido-1,3-oxazine (PO1/PO2). In this study, we found that ONE and HNE yield an identical product containing a pyrrole ring (PO7, PH2) upon reaction with PM. The structure of PO7/PH2 was shown by LC-MS and NMR analyses to be 1-(2-hydroxy-6-hydroxymethyl-3-methylpyridin-4-ylmethyl)-2-pentylpyrrole. PO1, PO7/PH2, and PO8 were the main stable PM-ONE/HNE adducts. In the incubation of human serum albumin (HSA) with ONE or HNE, Lys residues provided the most favorable modification sites for both aldehydes, and the number of HNE-modified sites was higher than that of ONE-modified sites. When HSA was allowed to react with a linoleic acid hydroperoxide in the presence of ascorbic acid, ONE modified more residues (10 Lys, 3 His, 2 Arg) than did HNE (8 His, 2 Lys), indicating the relative reactivity of aldehydes towards amino acid residues. Upon treatment with increasing concentrations of PM, the concentrations of ONE-modified HSA peptides, but not of HNE-modified peptides, were reduced significantly and dose-dependently. Concomitantly, the formation of PM-ONE adducts increased in a dose-dependent manner. The inhibition effect of PM was also confirmed in the cell system subjected to oxidative stress. Our results demonstrate that PM can inhibit lipid hydroperoxide-derived damage to proteins by trapping ONE preferentially, and the resulting PM-ONE adducts can be used as a dosimeter for ONE production to determine the levels of lipid peroxidation.	[Lee, Seon Hwa; Matsunaga, Atsushi; Oe, Tomoyuki] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Bioanalyt Chem, Sendai, Miyagi, Japan	Tohoku University	Lee, SH; Oe, T (corresponding author), Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Bioanalyt Chem, Sendai, Miyagi, Japan.	sh-lee@m.tohoku.ac.jp; t-oe@mail.pharm.tohoku.ac.jp	Oe, Tomoyuki/AAE-1514-2019	Oe, Tomoyuki/0000-0002-3893-0815; Lee, Seon Hwa/0000-0003-1095-5516	Japan Society for the Promotion of Science (JSPS) [15K14935, 16K08391, 16H05078]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research (to T.O., 15K14935 for 2015-2016), and Grants-in-Aid for Scientific Research (C) (to S.H.L., 16K08391 for 2016-2018) and (B) (to T.O, 16H05078 for 2016-2018) from the Japan Society for the Promotion of Science (JSPS, http://www.isps.go.ip/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Aldini G, 2006, J MASS SPECTROM, V41, P1149, DOI 10.1002/jms.1067; Amarnath V, 2004, CHEM RES TOXICOL, V17, P410, DOI 10.1021/tx0300535; Amarnath V, 2015, CHEM RES TOXICOL, V28, P1888, DOI 10.1021/acs.chemrestox.5b00301; Ashrafi-Kooshk MR, 2015, BIOLOGICALS, V43, P333, DOI 10.1016/j.biologicals.2015.07.003; Baynes JW, 1999, DIABETES, V48, P1, DOI 10.2337/diabetes.48.1.1; Booth AA, 1997, J BIOL CHEM, V272, P5430, DOI 10.1074/jbc.272.9.5430; Curry S, 1998, NAT STRUCT BIOL, V5, P827, DOI 10.1038/1869; Davies SS, 2006, BIOCHEMISTRY-US, V45, P15756, DOI 10.1021/bi061860g; Degenhardt TP, 2002, KIDNEY INT, V61, P939, DOI 10.1046/j.1523-1755.2002.00207.x; Finkel T, 2011, J CELL BIOL, V194, P7, DOI 10.1083/jcb.201102095; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Goto T, 2013, ANAL BIOANAL CHEM, V405, P7383, DOI 10.1007/s00216-013-7146-0; Kang Z, 2006, AMINO ACIDS, V30, P55, DOI 10.1007/s00726-005-0209-6; Lee SH, 2014, CHEM RES TOXICOL, V27, P637, DOI 10.1021/tx400469x; Lee SH, 2010, CHEM RES TOXICOL, V23, P1771, DOI 10.1021/tx100228q; Lee SH, 2008, CHEM RES TOXICOL, V21, P2237, DOI 10.1021/tx800316v; Lee SH, 2001, SCIENCE, V292, P2083, DOI 10.1126/science.1059501; Liu QY, 2012, J MASS SPECTROM, V47, P411, DOI 10.1002/jms.2037; Metz TO, 2003, J BIOL CHEM, V278, P42012, DOI 10.1074/jbc.M304292200; Nagaraj RH, 2002, ARCH BIOCHEM BIOPHYS, V402, P110, DOI 10.1016/S0003-9861(02)00067-X; Oe T, 2003, CHEM RES TOXICOL, V16, P1598, DOI 10.1021/tx034178l; Onorato JM, 2000, J BIOL CHEM, V275, P21177, DOI 10.1074/jbc.M003263200; Osicka TM, 2000, DIABETES, V49, P87, DOI 10.2337/diabetes.49.1.87; PICARD S, 1992, P NATL ACAD SCI USA, V89, P6876, DOI 10.1073/pnas.89.15.6876; Rauniyar N, 2009, PROTEOMICS, V9, P5188, DOI 10.1002/pmic.200900116; Requena J R, 1992, Diabetes Res, V20, P43; Sayre LM, 2006, DRUG METAB REV, V38, P651, DOI 10.1080/03602530600959508; Shipanova IN, 1997, ARCH BIOCHEM BIOPHYS, V344, P29, DOI 10.1006/abbi.1997.0195; Speed N, 2011, CANCER METAST REV, V30, P437, DOI 10.1007/s10555-011-9298-8; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; STADTMAN ER, 1991, J BIOL CHEM, V266, P17201; Szapacs ME, 2006, BIOCHEMISTRY-US, V45, P10521, DOI 10.1021/bi060535q; Takahashi R, 2017, J PROTEOMICS, V166, P101, DOI 10.1016/j.jprot.2017.07.006; Vistoli G, 2013, FREE RADICAL RES, V47, P3, DOI 10.3109/10715762.2013.815348; Voziyan PA, 2002, J BIOL CHEM, V277, P3397, DOI 10.1074/jbc.M109935200; Voziyan PA, 2005, CELL MOL LIFE SCI, V62, P1671, DOI 10.1007/s00018-005-5082-7; Zhu XC, 2007, CHEM RES TOXICOL, V20, P165, DOI 10.1021/tx600295j	38	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196050	10.1371/journal.pone.0196050	http://dx.doi.org/10.1371/journal.pone.0196050			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672562	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800073
J	Cechova, J; Coufal, J; Jagelska, EB; Fojta, M; Brazda, V				Cechova, Jana; Coufal, Jan; Jagelska, Eva B.; Fojta, Miroslav; Brazda, Vaclav			p73, like its p53 homolog, shows preference for inverted repeats forming cruciforms	PLOS ONE			English	Article							SEQUENCE-SPECIFIC BINDING; DNA-BINDING; TRANSCRIPTIONAL ACTIVITY; SUPERCOILED DNA; BREAST-CANCER; MUTANT P53; TRANSACTIVATION; P63; PROTEIN; APOPTOSIS	p73 is a member of the p53 protein family and has essential functions in several signaling pathways involved in development, differentiation, DNA damage responses and cancer. As a transcription factor, p73 achieves these functions by binding to consensus DNA sequences and p73 shares at least partial target DNA binding sequence specificity with p53. Transcriptional activation by p73 has been demonstrated for more than fifty p53 targets in yeast and/or human cancer cell lines. It has also been shown previously that p53 binding to DNA is strongly dependent on DNA topology and the presence of inverted repeats that can form DNA cruciforms, but whether p73 transcriptional activity has similar dependence has not been investigated. Therefore, we evaluated p73 binding to a set of p53-response elements with identical theoretical binding affinity in their linear state, but different probabilities to form extra helical structures. We show by a yeast-based assay that transactivation in vivo correlated more with the relative propensity of a response element to form cruciforms than to its expected in vitro DNA binding affinity. Structural features of p73 target sites are therefore likely to be an important determinant of its transactivation function.	[Cechova, Jana; Coufal, Jan; Jagelska, Eva B.; Fojta, Miroslav; Brazda, Vaclav] Czech Acad Sci, Inst Biophys, Brno, Czech Republic; [Cechova, Jana] Masaryk Univ, Dept Biochem, Fac Sci, Brno, Czech Republic	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; Masaryk University Brno	Brazda, V (corresponding author), Czech Acad Sci, Inst Biophys, Brno, Czech Republic.	vaclav@ibp.cz	Václav, Brázda/F-9582-2011; Brazda, Vaclav/ABH-9460-2020	Václav, Brázda/0000-0003-2837-4226; Brazda, Vaclav/0000-0003-2837-4226	Grant Agency of the Czech Republic [15-21855S, 18-15548S]; SYMBIT project - ERDF [CZ.02.1.01/0.0/0.0/15_003/0000477]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); SYMBIT project - ERDF	This work was supported by the Grant Agency of the Czech Republic (15-21855S, 18-15548S) and by the SYMBIT project reg. no. CZ.02.1.01/0.0/0.0/15_003/0000477 financed from the ERDF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the Grant Agency of the Czech Republic (15-21855S, 18-15548S) and by the SYMBIT project reg. no. CZ.02.1.01/0.0/0.0/15_003/0000477 financed from the ERDF. The authors would like to thank Dr. Philip J. Coates for proofreading and editing the manuscript.	Adamik M, 2015, BIOCHEM BIOPH RES CO, V456, P29, DOI 10.1016/j.bbrc.2014.11.027; Bisso A, 2011, CURR PHARM DESIGN, V17, P578, DOI 10.2174/138161211795222667; Brandt T, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-628; Brazda V, 2000, BIOCHEM BIOPH RES CO, V267, P934, DOI 10.1006/bbrc.1999.2056; Brazda V, 2006, BIOCHEM BIOPH RES CO, V351, P499, DOI 10.1016/j.bbrc.2006.10.065; Brazda V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020375; Brazda V, 2017, BIOCHEM BIOPH RES CO, V483, P516, DOI 10.1016/j.bbrc.2016.12.113; Brazda V, 2016, BIOCHEM BIOPH RES CO, V478, P1739, DOI 10.1016/j.bbrc.2016.09.015; Brazda V, 2012, BIOCHEM BIOPH RES CO, V422, P716, DOI 10.1016/j.bbrc.2012.05.065; Brazda V, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-33; Cechova J, 2018, BIOINFORMATICS, V34, P1081, DOI 10.1093/bioinformatics/btx729; Chen YH, 2010, STRUCTURE, V18, P246, DOI 10.1016/j.str.2009.11.011; Ciribilli Y, 2013, NUCLEIC ACIDS RES, V41, P8637, DOI 10.1093/nar/gkt657; DeYoung MP, 2007, ONCOGENE, V26, P5169, DOI 10.1038/sj.onc.1210337; Dominguez G, 2001, BREAST CANCER RES TR, V66, P183, DOI 10.1023/A:1010624717311; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; Ethayathulla AS, 2012, P NATL ACAD SCI USA, V109, P6066, DOI 10.1073/pnas.1115463109; Harms KL, 2006, CELL DEATH DIFFER, V13, P890, DOI 10.1038/sj.cdd.4401904; Ho WC, 2006, J BIOL CHEM, V281, P20494, DOI 10.1074/jbc.M603634200; Ichimiya S, 2001, MED PEDIATR ONCOL, V36, P42, DOI 10.1002/1096-911X(20010101)36:1<42::AID-MPO1011>3.0.CO;2-K; Inga A, 2002, MOL CELL BIOL, V22, P8612, DOI 10.1128/MCB.22.24.8612-8625.2002; Jagelska EB, 2008, BIOCHEM J, V412, P57, DOI 10.1042/BJ20071648; Jagelska EB, 2010, BIOCHEM BIOPH RES CO, V391, P1409, DOI 10.1016/j.bbrc.2009.12.076; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Levrero M, 2000, J CELL SCI, V113, P1661; Lion M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116177; Lokshin M, 2007, NUCLEIC ACIDS RES, V35, P340, DOI 10.1093/nar/gkl1047; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakagawa T, 2002, MOL CELL BIOL, V22, P2575, DOI 10.1128/MCB.22.8.2575-2585.2002; Orzol P, 2015, HISTOL HISTOPATHOL, V30, P503, DOI 10.14670/HH-30.503; Ozaki T, 1999, CANCER RES, V59, P5902; Palecek E, 2004, ONCOGENE, V23, P2119, DOI 10.1038/sj.onc.1207324; Palecek E, 1997, ONCOGENE, V15, P2201, DOI 10.1038/sj.onc.1201398; Petitjean A, 2008, CARCINOGENESIS, V29, P273, DOI 10.1093/carcin/bgm258; Ramos A, 2015, BIOCHEMISTRY-US, V54, P6961, DOI 10.1021/acs.biochem.5b00152; Rufini Alessandro, 2011, Genes Cancer, V2, P491, DOI 10.1177/1947601911408890; Sasaki Y, 2002, J BIOL CHEM, V277, P719, DOI 10.1074/jbc.M108080200; Sauer M, 2008, NUCLEIC ACIDS RES, V36, P1900, DOI 10.1093/nar/gkn044; Stiewe T, 2002, J BIOL CHEM, V277, P14177, DOI 10.1074/jbc.M200480200; Tichy V, 2013, BIOCHEM BIOPH RES CO, V433, P445, DOI 10.1016/j.bbrc.2013.02.097; Todolli S, 2017, BIOPHYS J, V112, P416, DOI 10.1016/j.bpj.2016.11.017; Tozluoglu M, 2008, NUCLEIC ACIDS RES, V36, P5033, DOI 10.1093/nar/gkn481; van Doorn R, 2005, J CLIN ONCOL, V23, P3886, DOI 10.1200/JCO.2005.11.353; Veprintsev DB, 2008, NUCLEIC ACIDS RES, V36, P1589, DOI 10.1093/nar/gkm1040; Zaika AI, 1999, CANCER RES, V59, P3257; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	50	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195835	10.1371/journal.pone.0195835	http://dx.doi.org/10.1371/journal.pone.0195835			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668749	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200060
J	Hsu, J; Donnelly, JP; Chaudhary, NS; Moore, JX; Safford, MM; Kim, J; Wang, HE				Hsu, Joann; Donnelly, John P.; Chaudhary, Ninad S.; Moore, Justin X.; Safford, Monika M.; Kim, Junghyun; Wang, Henry E.			Aspirin use and long-term rates of sepsis: A population-based cohort study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; SEPTIC SHOCK; BIAS REDUCTION; ASSOCIATION; PREVENTION; MORTALITY; DISEASE; CLOPIDOGREL; MANAGEMENT; ADHESION	Objective Sepsis is the syndrome of life-threatening organ dysfunction resulting from dysregulated host response to infection. Aspirin, an anti-inflammatory agent, may play a role in attenuating the inflammatory response during infection. We evaluated the association between aspirin use and long-term rates of sepsis as well as sepsis outcomes. Methods We analyzed data from 30,239 adults >= 45 years old in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort. The primary exposure was aspirin use, identified via patient interview. The primary outcome was sepsis hospitalization, defined as admission for infection with two or more systemic inflammatory response syndrome criteria. We fit Cox proportional hazards models assessing the association between aspirin use and rates of sepsis, adjusted for participant demographics, health behaviors, chronic medical conditions, medication adherence, and biomarkers. We used a propensity-matched analysis and a series of sensitivity analyses to assess the robustness of our results. We also examined risk of organ dysfunction and hospital mortality during hospitalization for sepsis. Results Among 29,690 REGARDS participants with follow-up data available, 43% reported aspirin use (n = 12,869). Aspirin users had higher sepsis rates (hazard ratio 1.35; 95% CI: 1.22-1.49) but this association was attenuated following adjustment for potential confounders (adjusted HR 0.99; 95% CI: 0.88-1.12). We obtained similar results in propensity-matched and sensitivity analyses. Among sepsis hospitalizations, aspirin use was not associated with organ dysfunction or hospital death. Conclusions In the REGARDS cohort, baseline aspirin use was not associated with long-term rates of sepsis.	[Hsu, Joann] Univ Alabama Birmingham, Sch Med, Birmingham, AL USA; [Donnelly, John P.; Chaudhary, Ninad S.; Moore, Justin X.; Wang, Henry E.] Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35233 USA; [Donnelly, John P.] Univ Alabama Birmingham, Div Prevent Med, Dept Med, Sch Med, Birmingham, AL USA; [Donnelly, John P.; Chaudhary, Ninad S.; Moore, Justin X.] Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA; [Safford, Monika M.] Weill Cornell Med Coll, Dept Med, New York, NY USA; [Kim, Junghyun; Wang, Henry E.] Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cornell University; University of Texas System; University of Texas Health Science Center Houston	Wang, HE (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, Sch Med, Birmingham, AL 35233 USA.; Wang, HE (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Emergency Med, Houston, TX 77030 USA.	henry.e.wang@uth.tmc.edu	Chaudhary, NINAD/L-7532-2019	Donnelly, John/0000-0002-0646-9470; Moore, Justin Xavier/0000-0002-5496-752X; Chaudhary, Ninad/0000-0003-1350-1093	National Institute for Nursing Research [R01-NR012726]; National Center for Research Resources [UL1-RR025777]; Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service [U01-NS041588]; National Center For Advancing Translational Sciences of the National Institutes of Health [TL1TR001418]; National Institute of General Medical Sciences [1F31GM122180]; National Cancer Institute [R25-CA4788]; NATIONAL CANCER INSTITUTE [R25CA047888] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001417, TL1TR001418] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM122180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS041588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR012726] Funding Source: NIH RePORTER	National Institute for Nursing Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Center for Clinical and Translational Science; Lister Hill Center for Health Policy of the University of Alabama at Birmingham; National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center For Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR))	This study was supported by award R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham. The parent REGARDS study was supported by cooperative agreement U01-NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Representatives of the funding agencies have been involved in the review of the manuscript but not directly involved in the collection, management, analysis or interpretation of the data. Ms. Hsu received support from TL1TR001418 from the National Center For Advancing Translational Sciences of the National Institutes of Health. Mr. Donnelly received support from 1F31GM122180 from the National Institute of General Medical Sciences. Mr. Moore received grant support from R25-CA4788 funded by the National Cancer Institute.; This study was supported by award R01-NR012726 from the National Institute for Nursing Research, UL1-RR025777 from the National Center for Research Resources, as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham.; The parent REGARDS study was supported by cooperative agreement U01-NS041588 from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, Department of Health and Human Service.; Ms. Hsu received support from TL1TR001418 from the National Center For Advancing Translational Sciences of the National Institutes of Health.; Mr. Donnelly received support from 1F31GM122180 from the National Institute of General Medical Sciences. Mr. Moore received grant support from R25-CA4788 funded by the National Cancer Institute.	Al Harbi SA, 2016, BMC PHARMACOL TOXICO, V17, DOI 10.1186/s40360-016-0047-z; Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; Eisen DP, 2012, CRIT CARE MED, V40, P1761, DOI 10.1097/CCM.0b013e318246b9df; Evangelista V, 2005, THROMB HAEMOSTASIS, V94, P568, DOI 10.1160/TH05-01-0020; Falcone M, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.114.001595; Ford ES, 2004, J AM COLL CARDIOL, V43, P1791, DOI 10.1016/j.jacc.2003.11.061; Garcia CC, 2010, DISCOV MED, V10, P479; Gupta RG, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1011-9; Hennekens CH, 2014, TRENDS CARDIOVAS MED, V24, P360, DOI 10.1016/j.tcm.2014.08.006; Howard VJ, 2005, NEUROEPIDEMIOLOGY, V25, P135, DOI 10.1159/000086678; Ittaman SV, 2014, CLIN MED RES, V12, P147, DOI 10.3121/cmr.2013.1197; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Looney MR, 2009, J CLIN INVEST, V119, P3450, DOI 10.1172/JCI38432; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; McMahon AD, 2003, PHARMACOEPIDEM DR S, V12, P551, DOI 10.1002/pds.883; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; O'Gara PT, 2013, J AM COLL CARDIOL, V61, P485, DOI [10.1161/CIR.0b013e3182742c84, 10.1016/j.jacc.2012.11.018]; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; RUBIN DB, 1980, BIOMETRICS, V36, P293, DOI 10.2307/2529981; Saracco P, 2011, PEDIATRIC REP, V3, P119, DOI 10.4081/pr.2011.e30; Sarnak MJ, 2000, KIDNEY INT, V58, P1758, DOI 10.1111/j.1523-1755.2000.00337.x; Satran R, 2003, ISR MED ASSOC J, V5, P516; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sossdorf M, 2013, CRIT CARE, V17, DOI 10.1186/cc11886; Toner P, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1091-6; Trauer J, 2017, CRIT CARE MED, V45, P1871, DOI 10.1097/CCM.0000000000002654; Tsai MJ, 2015, INTENS CARE MED, V41, P806, DOI 10.1007/s00134-015-3760-y; Valerio-Rojas JC, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/782573; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; Wang HE, 2017, CRIT CARE MED, V45, P1443, DOI 10.1097/CCM.0000000000002538; Wang HE, 2016, CRIT CARE MED, V44, P1285, DOI 10.1097/CCM.0000000000001666; Wang HE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069232; Wiewel MA, 2016, INTENS CARE MED, V42, P352, DOI 10.1007/s00134-015-4171-9; Yaguchi A, 2004, J THROMB HAEMOST, V2, P2096, DOI 10.1111/j.1538-7836.2004.01009.x; Zhang QH, 2015, CEREBROVASC DIS, V39, P13, DOI 10.1159/000369778	40	10	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194829	10.1371/journal.pone.0194829	http://dx.doi.org/10.1371/journal.pone.0194829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668690	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200017
J	Lee, YS; Kim, SW; Han, SW				Lee, Yong Seung; Kim, Sang Woon; Han, Sang Won			Different managements for prepubertal epididymitis based on a preexisting genitourinary anomaly diagnosis	PLOS ONE			English	Article							CHILDREN; BOYS; HYPOSPADIAS	There is no clear consensus regarding investigating for accompanying genitourinary anomalies (GUAs) in patients with prepubertal acute epididymitis (AE). Moreover, risk factors for the recurrence and the need for a surgical intervention have never been discussed. The purpose of this study was to evaluate the different clinical courses of prepubertal AE based on knowledge of preexisting GUAs. Between January 2005 and December 2014, AE was diagnosed in 189 pediatric patients <10 years old. Clinical characteristics and treatments were retrospectively analyzed. The median age at first AE was 64.3 months. A GUA was detected prior to the development of AE in 49 patients (known GUA group) including 34 with hypospadias. Among the other 140 patients (unknown GUA status group), six patients were diagnosed with a GUA after the first AE episode. In the known GUA group, 35 patients (71.4%) experienced recurrence and the only risk factor associated with recurrence was the presence of cystic dilated prostatic utricle (p = 0.013). In the unknown GUA status group, the risk factors for an existing GUA were being <1-year-old (p<0.001) and positive urine culture (p = 0.015). Only nine patients (6.4%) in this group experienced recurrence. Vasectomy was recommended for patients with recurrent AE with an accompanying GUA and performed in 19 patients (10.1%). Most GUAs are diagnosed prior to AE development. Clinicians should consider different treatment approaches based on whether the AE patient has been diagnosed with a GUA previously, because the clinical characteristics and the recurrence rate are significantly different.	[Han, Sang Won] Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea; Yonsei Univ, Coll Med, Urol Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Han, SW (corresponding author), Yonsei Univ, Coll Med, Dept Urol, Seoul, South Korea.	swhan@yuhs.ac		Lee, Yong Seung/0000-0003-3778-9888; Han, Sang Won/0000-0003-0941-1300; Kim, Sang Woon/0000-0002-5790-1948				Cappele O, 2000, EUR UROL, V38, P627, DOI 10.1159/000020343; Cristoforo TA, 2021, PEDIATR EMERG CARE, V37, pE1675, DOI 10.1097/PEC.0000000000001018; DEVINE CJ, 1980, J UROLOGY, V123, P407, DOI 10.1016/S0022-5347(17)55959-5; GISLASON T, 1980, J UROLOGY, V124, P533, DOI 10.1016/S0022-5347(17)55528-7; Haecker FM, 2005, EUR J PEDIATR SURG, V15, P180, DOI 10.1055/s-2004-830355; Ikoma F, 2014, UROLOGE, V53, P1344, DOI 10.1007/s00120-014-3597-y; Kajbafzadeh AM, 2011, J PEDIATR UROL, V7, P552, DOI 10.1016/j.jpurol.2010.06.002; Kavoussi P, 2012, CAMPBELL WALSH WEIN, V10th, P67; Kojima Y, 2001, UROLOGY, V57, P1151, DOI 10.1016/S0090-4295(01)00954-2; Merlini E, 1998, SCAND J UROL NEPHROL, V32, P273; Moon SH, 2011, NUCL MED MOLEC IMAG, V45, P291, DOI 10.1007/s13139-011-0108-6; Redshaw JD, 2014, J UROLOGY, V192, P1203, DOI 10.1016/j.juro.2014.04.002; Santillanes G, 2011, PEDIATR EMERG CARE, V27, P174, DOI 10.1097/PEC.0b013e31820d647a; SIEGEL A, 1987, J UROLOGY, V138, P1100, DOI 10.1016/S0022-5347(17)43514-2; Somekh E, 2004, J UROLOGY, V171, P391, DOI 10.1097/01.ju.0000102160.55494.1f	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0194761	10.1371/journal.pone.0194761	http://dx.doi.org/10.1371/journal.pone.0194761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668706	gold, Green Submitted, Green Published			2022-12-26	WOS:000430290200015
J	Ander, M; Cederberg, JT; von Essen, L; Hoven, E				Ander, Malin; Cederberg, Jenny Thorsell; von Essen, Louise; Hoven, Emma			Exploration of psychological distress experienced by survivors of adolescent cancer reporting a need for psychological support	PLOS ONE			English	Article							QUALITATIVE CONTENT-ANALYSIS; YOUNG-ADULT SURVIVORS; LONG-TERM SURVIVORS; POSTTRAUMATIC STRESS; CHILDHOOD-CANCER; OF-LIFE; DSM-IV; ANXIETY; DEPRESSION; DISORDERS	Objective In this qualitative study, we aimed to provide an in-depth exploration of cancer-related psychological distress experienced by young survivors of cancer during adolescence reporting a need for psychological support. Methods Two individual interviews were held with ten young survivors of cancer diagnosed in adolescence. The interviews were audio-recorded and transcribed verbatim. Analysis followed the guidelines for inductive qualitative manifest content analysis. Results The survivors described distress experienced during and after the end of treatment. Five categories comprising 14 subcategories were generated. The categories included: A tough treatment, Marked and hindered, Not feeling good enough, Struggling with the fragility of life, and finally, An ongoing battle with emotions. Conclusion Young survivors of adolescent cancer reporting a need for psychological support described feeling physically, socially, and mentally marked by the cancer experience. They struggled with powerlessness, insecurity, social disconnection, loneliness, and feelings of being unimportant and a failure, and had difficulties understanding and managing their experiences. These concerns should be addressed in psychological treatments for the population irrespective of which approach or model is used to understand survivors' difficulties. A transdiagnostic approach targeting processes that underpin different manifestations of distress may be effective.	[Ander, Malin; von Essen, Louise; Hoven, Emma] Uppsala Univ, Dept Womens & Childrens Hlth, Clin Psychol Healthcare, Uppsala, Sweden; [Cederberg, Jenny Thorsell] Uppsala Univ, Dept Womens & Childrens Hlth, Pediat Oncol, Uppsala, Sweden	Uppsala University; Uppsala University	Ander, M (corresponding author), Uppsala Univ, Dept Womens & Childrens Hlth, Clin Psychol Healthcare, Uppsala, Sweden.	malin.ander@kbh.uu.se			Barncancerfonden (The Swedish Childhood Cancer Foundation) [2016-0004, 20130039]; Vetenskapsradet (The Swedish Research Council): SF0 grant; Uppsala University; U-CARE research programme at Uppsala University; Swedish Childhood Cancer Foundation	Barncancerfonden (The Swedish Childhood Cancer Foundation); Vetenskapsradet (The Swedish Research Council): SF0 grant; Uppsala University; U-CARE research programme at Uppsala University; Swedish Childhood Cancer Foundation(European Commission)	This work was supported by the Barncancerfonden (The Swedish Childhood Cancer Foundation): grant numbers 2016-0004, 20130039, (https://www.barncancerfonden.se/ent/for-researchers/) to LvE adn the Vetenskapsradet (The Swedish Research Council): SF0 grant to the research programme U-CARE, Uppsala University (no grant number), (https://www.vr.se/inenglish.4.12fff4451215cbd83e4800015152html) to LvE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the participating young survivors for sharing their stories. We also wish to acknowledge the U-CARE research programme at Uppsala University and the Swedish Childhood Cancer Foundation for financially supporting this study.	Abrams AN, 2007, CANCER TREAT REV, V33, P622, DOI 10.1016/j.ctrv.2006.12.006; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5; Ander M, 2016, PSYCHO-ONCOLOGY, V25, P582, DOI 10.1002/pon.3965; [Anonymous], 1986, World Health Organ Tech Rep Ser, V731, P1; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Carter-Sowell AR, 2008, SOC INFLUENCE, V3, P143, DOI 10.1080/15534510802204868; Chango JM, 2015, J RES ADOLESCENCE, V25, P685, DOI 10.1111/jora.12162; Compas BE, 2014, HEALTH PSYCHOL, V33, P853, DOI 10.1037/hea0000083; Compas BE, 2012, ANNU REV CLIN PSYCHO, V8, P455, DOI 10.1146/annurev-clinpsy-032511-143108; Corrigan, 2014, STIGMA DIS DISABILIT, P165, DOI DOI 10.1037/14297-009; Craig P, 2013, INT J NURS STUD, V50, P587, DOI 10.1016/j.ijnurstu.2012.09.010; Crawshaw MA, 2010, EUR J CANCER CARE, V19, P610, DOI 10.1111/j.1365-2354.2009.01118.x; Dieluweit U, 2011, KLIN PADIATR, V223, P152, DOI 10.1055/s-0031-1271779; Doukkali EB, 2013, CANCER NURS, V36, P400, DOI 10.1097/NCC.0b013e31829fd80e; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Erikson E.H., 1968, IDENTITY YOUTH CRISI; Frank R. I., 2014, TRANSDIAGNOSTIC ROAD; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Grinyer A, 2007, CHRONIC ILLN, V3, P265, DOI 10.1177/1742395307085335; Harvey A., 2004, COGNITIVE BEHAV PROC; Hayes S. C, 2011, ACCEPTANCE COMMITMEN; Hayes SC, 1996, J CONSULT CLIN PSYCH, V64, P1152, DOI 10.1037/0022-006X.64.6.1152; Howell D, 2011, CURR ONCOL, V18, P208; Jacobson NS, 2001, CLIN PSYCHOL-SCI PR, V8, P255, DOI 10.1093/clipsy/8.3.255; Kazak AE, 2010, J CLIN ONCOL, V28, P2002, DOI 10.1200/JCO.2009.25.9564; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; Larsson G, 2010, EUR J CANCER, V46, P1062, DOI 10.1016/j.ejca.2010.01.021; Lehmann V, 2014, PSYCHO-ONCOLOGY, V23, P1229, DOI 10.1002/pon.3549; Lewis P, 2013, J PEDIATR ONCOL NURS, V30, P311, DOI 10.1177/1043454213513839; MARCIA JE, 1966, J PERS SOC PSYCHOL, V3, P551, DOI 10.1037/h0023281; Meerwijk EL, 2011, J LOSS TRAUMA, V16, P402, DOI 10.1080/15325024.2011.572044; Meidlinger PC, 2014, WILEY BLACKWELL HANDBOOK OF SOCIAL ANXIETY DISORDER, P223; Ollendick TH, 2002, BIOL PSYCHIAT, V51, P44, DOI 10.1016/S0006-3223(01)01305-1; Palmer Susan, 2007, Palliat Support Care, V5, P127; Phipps S, 2014, J CLIN ONCOL, V32, P641, DOI 10.1200/JCO.2013.49.8212; Robichaud M, 2013, COGN BEHAV PRACT, V20, P251, DOI 10.1016/j.cbpra.2012.09.001; Sales J.M., 2013, HDB ADOLESCENT HLTH, DOI [10.1007/978-1-4614-6633-8_2, DOI 10.1007/978-1-4614-6633-8_2, DOI 10.1007/978-1-4614-6633-8]; Sauter FM, 2009, CLIN CHILD FAM PSYCH, V12, P310, DOI 10.1007/s10567-009-0058-z; Seitz DCM, 2010, EUR J CANCER, V46, P1596, DOI 10.1016/j.ejca.2010.03.001; Seitz DCM, 2009, PSYCHO-ONCOLOGY, V18, P683, DOI 10.1002/pon.1473; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Svedberg P, 2016, EUR J ONCOL NURS, V21, P105, DOI 10.1016/j.ejon.2016.02.008; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Wallace ML, 2007, PSYCHO-ONCOLOGY, V16, P1019, DOI 10.1002/pon.1176; Weathers F. W., 1993, ANN M INT SOC TRAUM, DOI [10.1037/t02622-000, DOI 10.1037/T02622-000]; Weems CF, 2006, J AFFECT DISORDERS, V91, P113, DOI 10.1016/j.jad.2006.01.009; Wicks L, 2010, EUR J CANCER CARE, V19, P778, DOI 10.1111/j.1365-2354.2009.01139.x; Wong J, 2014, WILEY BLACKWELL HANDBOOK OF SOCIAL ANXIETY DISORDER, P3; Yalom ID., 1980, EXISTENTIAL PSYCHOTH	52	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195899	10.1371/journal.pone.0195899	http://dx.doi.org/10.1371/journal.pone.0195899			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1LV	29664926	gold, Green Published, Green Submitted			2022-12-26	WOS:000430262300041
J	Marco, A				Marco, Antonio			SeedVicious: Analysis of microRNA target and near-target sites	PLOS ONE			English	Article							SELECTION; FAMILY	Here I describe seedVicious, a versatile microRNA target site prediction software that can be easily fitted into annotation pipelines and run over custom datasets. SeedVicious finds microRNA canonical sites plus other, less efficient, target sites. Among other novel features, seedVicious can compute evolutionary gains/losses of target sites using maximum parsimony, and also detect near-target sites, which have one nucleotide different from a canonical site. Near-target sites are important to study population variation in microRNA regulation. Some analyses suggest that near-target sites may also be functional sites, although there is no conclusive evidence for that, and they may actually be target alleles segregating in a population. SeedVicious does not aim to outperform but to complement existing microRNA prediction tools. For instance, the precision of TargetScan is almost doubled (from 11% to similar to 20%) when we filter predictions by the distance between target sites using this program. Interestingly, two adjacent canonical target sites are more likely to be present in bona fide target transcripts than pairs of target sites at slightly longer distances. The software is written in Perl and runs on 64-bit Unix computers (Linux and MacOS X). Users with no computing experience can also run the program in a dedicated web-server by uploading custom data, or browse pre-computed predictions. SeedVicious and its associated web-server and database (SeedBank) are distributed under the GPL/GNU license.	[Marco, Antonio] Univ Essex, Sch Biol Sci, Colchester, Essex, England	University of Essex	Marco, A (corresponding author), Univ Essex, Sch Biol Sci, Colchester, Essex, England.	amarco.bio@gmail.com	Marco, Antonio/N-1594-2019	Marco, Antonio/0000-0002-8603-7503	Wellcome Trust [200585/Z/16/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a grant from the Wellcome Trust to Antonio Marco [grant number 200585/Z/16/Z]; funders website: https://wellcome.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This software would not have been made publicly available without the encouragement and support of my colleagues, in particular Mohab Helmy and Sam Griffiths-Jones. I am also grateful to M. Helmy and Andrea Hatlen for discussion, to Roman Cheplyaka for feedback on the program, to Stuart Newman for his invaluable help setting up the web-server, and to the various anonymous reviewers (some more anonymous than others) for helpful comments and suggestions. This work was supported by the Wellcome Trust [grant number 200585/Z/16/Z].	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Chandradoss SD, 2015, CELL, V162, P96, DOI 10.1016/j.cell.2015.06.032; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chou CH, 2016, NUCLEIC ACIDS RES, V44, pD239, DOI 10.1093/nar/gkv1258; Clifton BD, 2017, MOL BIOL EVOL, V34, P51, DOI 10.1093/molbev/msw212; Concepcion CP, 2012, CANCER J, V18, P262, DOI 10.1097/PPO.0b013e318258b60a; Denzler R, 2016, MOL CELL, V64, P565, DOI 10.1016/j.molcel.2016.09.027; Felsenstein J, 2004, INFERRING PHYLOGENIE; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; HOFACKER IL, 2009, CURR PROTOC BIOINFOR, pCH12, DOI DOI 10.1002/0471250953.BI1202S26; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kinsella RJ, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar030; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Maragkakis M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-295; Marco A, 2015, G3-GENES GENOM GENET, V5, P2199, DOI 10.1534/g3.115.019497; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pW169, DOI 10.1093/nar/gkt393; Pinzon N, 2016, GENOME RES; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Zhang CL, 2013, NUCLEIC ACIDS RES, V41, P6793, DOI 10.1093/nar/gkt421	23	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195532	10.1371/journal.pone.0195532	http://dx.doi.org/10.1371/journal.pone.0195532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664927	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000430262300021
J	Gribsholt, SB; Pedersen, L; Richelsen, B; Dekkers, O; Thomsen, RW				Gribsholt, Sigrid Bjerge; Pedersen, Lars; Richelsen, Bjorn; Dekkers, Olaf; Thomsen, Reimar Wernich			Body Mass Index of 92,027 patients acutely admitted to general hospitals in Denmark: Associated clinical characteristics and 30-day mortality	PLOS ONE			English	Article							OBESITY PARADOX; RISK; POPULATION; FRACTURE; DISEASE; WOMEN; OVERWEIGHT; ASTHMA; BONE; OSTEOPOROSIS	Background Data are sparse on the range of BMI among patients acutely admitted to general hospitals. We investigated BMI values and associated patient characteristics, reasons for hospital admission, and mortality in Denmark. Methods We identified all persons with an acute inpatient admission 2011-2014 in Central Denmark Region and assessed BMI measurements recorded in the Clinical Information System. We used cross-sectional and cohort analyses to examine the BMI distribution and its association with demographic characteristics, comorbidities, medication use, tobacco smoking, reasons for admission, and 30-day mortality. Results Among 92,027 acutely admitted patients (median age 62 years, 49% female) with a BMI measurement, 4% had a BMI (kg/m(2)) < 18.5, 42% a BMI between 18.5 and 25, 34% a BMI between 25 and 30, and 20% a BMI >= 30. Compared with normal-weight patients, 30-day mortality was high among patients with BMI < 18.5 (7.5% vs. 2.8%, age-and smoking-adjusted odds ratio (aOR) 2.4; 95% confidence interval (CI): 2.0-2.9, whereas patients with overweight (aOR 0.7; 95% CI: 0.6-0.8) and obesity class I (aOR 0.8; 95% CI: 0.6-0.9)). Compared with the total population, patients with BMI < 18.5 were older (68 years median); more were female (73%); more had comorbidities (Charlson Comorbidity Index score > 0 in 42% vs. 33% overall), more were current smokers (45% vs. 27% overall), and acute admissions due to respiratory diseases or femoral fractures were frequent. In contrast, patients with BMI >= 30 were relatively young (59 years median), fewer smoked (24%): type 2 diabetes, sleep disorders, cholelithiasis, and heart failure were frequent diagnoses. Prevalence of therapies for metabolic syndrome, pain, and psychiatric disorders increased with higher BMI, while patients with BMI < 18.5 frequently used asthma medications, glucocorticoids, and antibiotics. Conclusion In patients acutely admitted to general hospitals, reasons for hospital admission and associated clinical characteristics differ substantially according to BMI range. BMI < 18.5 is a clinical predictor of high short-term mortality.	[Gribsholt, Sigrid Bjerge; Pedersen, Lars; Dekkers, Olaf; Thomsen, Reimar Wernich] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Gribsholt, Sigrid Bjerge; Richelsen, Bjorn] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark; [Dekkers, Olaf] Leiden Univ, Med Ctr, Dept Clin Epidemiol & Internal Med, Leiden, Netherlands	Aarhus University; Aarhus University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Gribsholt, SB (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark.; Gribsholt, SB (corresponding author), Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark.	sigrid.bjerge.gribsholt@ph.au.dk		Richelsen, Bjoern/0000-0001-8886-9736; Gribsholt, Sigrid Bjerge/0000-0002-8681-6822; Thomsen, Reimar/0000-0001-9135-3474	Department of Clinical Epidemiology, Aarhus University Hospital; Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation	Department of Clinical Epidemiology, Aarhus University Hospital; Program for Clinical Research Infrastructure (PROCRIN); Lundbeck Foundation(Lundbeckfonden)	The current research was supported by the Department of Clinical Epidemiology, Aarhus University Hospital and the Program for Clinical Research Infrastructure (PROCRIN) established by the Novo Nordisk Foundation and the Lundbeck Foundation to SBG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afzal S, 2016, JAMA-J AM MED ASSOC, V315, P1989, DOI 10.1001/jama.2016.4666; [Anonymous], 2014, OBESITY, V22, pS41, DOI 10.1002/oby.20660; Appari A, 2013, HEALTH SERV RES, V48, P354, DOI 10.1111/j.1475-6773.2012.01448.x; Aune D, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2156; Barba R, 2015, J STROKE CEREBROVASC, V24, P766, DOI 10.1016/j.jstrokecerebrovasdis.2014.11.002; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Coats AJS, 2017, INT J CARDIOL, V235, P33, DOI 10.1016/j.ijcard.2017.02.136; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Di Angelantonio E, 2016, LANCET, V388, P776, DOI 10.1016/S0140-6736(16)30175-1; Dicker D, 2016, EUR J INTERN MED, V32, P43, DOI 10.1016/j.ejim.2016.03.029; Doehner W, 2010, EUR HEART J, V31, P146, DOI 10.1093/eurheartj/ehp339; Ehrenstein Vera, 2010, Clin Epidemiol, V2, P273, DOI 10.2147/CLEP.S13458; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Fisher-Hoch SP, 2013, TROP MED INT HEALTH, V18, P1510, DOI 10.1111/tmi.12206; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gho JMIH, 2018, BMJ OPEN, V8; Halldin CN, 2015, CHRON RESP DIS, V12, P47, DOI 10.1177/1479972314562409; Harpsoe MC, 2016, AM J EPIDEMIOL, V183, P1008, DOI 10.1093/aje/kwv300; Jaramillo JD, 2015, ANN AM THORAC SOC, V12, P648, DOI 10.1513/AnnalsATS.201412-591OC; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592; Johannesdottir Sigrun Alba, 2012, Clin Epidemiol, V4, P13, DOI 10.2147/CLEP.S26958; Kaspersen KA, 2015, EPIDEMIOLOGY, V26, P580, DOI 10.1097/EDE.0000000000000301; Kornum JB, 2010, EUR RESPIR J, V36, P1330, DOI 10.1183/09031936.00184209; Krasagakis K, 2011, CLIN EXP DERMATOL, V36, P351, DOI 10.1111/j.1365-2230.2010.03978.x; Kwong JC, 2011, CLIN INFECT DIS, V53, P413, DOI 10.1093/cid/cir442; Lau DH, 2017, CIRCULATION, V136, P583, DOI 10.1161/CIRCULATIONAHA.116.023163; Leth RA, 2009, ACTA OBSTET GYN SCAN, V88, DOI 10.1080/00016340903147405; Liu Y, 2015, RESP MED, V109, P851, DOI 10.1016/j.rmed.2015.05.006; Lokkegaard EL, 2004, ACTA OBSTET GYN SCAN, V83, P476, DOI 10.1111/j.0001-6349.2004.00376.x; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Ng SSS, 2015, CHEST, V148, P1193, DOI 10.1378/chest.14-3016; Oreopoulos A, 2008, AM HEART J, V156, P13, DOI 10.1016/j.ahj.2008.02.014; Phung DT, 2013, OBES REV, V14, P839, DOI 10.1111/obr.12055; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Prieto-Alhambra D, 2014, J BONE MINER RES, V29, P1737, DOI 10.1002/jbmr.2209; Prieto-Alhambra D, 2014, J BONE MINER RES, V29, P268, DOI 10.1002/jbmr.2011; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Roth J, 2009, JAMA-J AM MED ASSOC, V301, P2586, DOI 10.1001/jama.2009.930; Sakr Y, 2015, CRIT CARE MED, V43, P2623, DOI 10.1097/CCM.0000000000001310; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2015, INT J CARDIOL, V187, P462, DOI 10.1016/j.ijcard.2015.03.328; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Shapses SA, 2006, J NUTR, V136, P1453, DOI 10.1093/jn/136.6.1453; Shen GS, 2015, INJURY, V46, P1333, DOI 10.1016/j.injury.2015.04.008; Stovitz SD, 2017, CAN J CARDIOL; The Danish Health and Medicines Authorities National Institute of Public Health, 2018, TAL FRA NAT SUNDH 20; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Wang Q, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2549-9; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Wogelius P, 2005, EUR J EPIDEMIOL, V20, P17, DOI 10.1007/s10654-004-1501-6; World Cancer Research Fund and American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P; Yang S, 2015, OSTEOPOROSIS INT, V26, P1381, DOI 10.1007/s00198-014-3009-6; Zeng FF, 2017, MEDICINE, V96, DOI [10.1097/MD.0000000000007784, 10.1097/md.0000000000007784]	55	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195853	10.1371/journal.pone.0195853	http://dx.doi.org/10.1371/journal.pone.0195853			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659630	gold, Green Published			2022-12-26	WOS:000430061100037
J	Blanc-Durand, P; Van der Gucht, A; Schaefer, N; Itti, E; Prior, JO				Blanc-Durand, Paul; Van der Gucht, Axel; Schaefer, Niklaus; Itti, Emmanuel; Prior, John O.			Automatic lesion detection and segmentation of F-18-FET PET in gliomas: A full 3D U-Net convolutional neural network study	PLOS ONE			English	Article							BRAIN; DIAGNOSIS	Introduction Amino-acids positron emission tomography (PET) is increasingly used in the diagnostic workup of patients with gliomas, including differential diagnosis, evaluation of tumor extension, treatment planning and follow-up. Recently, progresses of computer vision and machine learning have been translated for medical imaging. Aim was to demonstrate the feasibility of an automated F-18-fluoro-ethyl-tyrosine (F-18-FET) PET lesion detection and segmentation relying on a full 3D U-Net Convolutional Neural Network (CNN). Methods All dynamic F-18-FET PET brain image volumes were temporally realigned to the first dynamic acquisition, coregistered and spatially normalized onto the Montreal Neurological Institute template. Ground truth segmentations were obtained using manual delineation and thresholding (1.3 x background). The volumetric CNN was implemented based on a modified Keras implementation of a U-Net library with 3 layers for the encoding and decoding paths. Dice similarity coefficient (DSC) was used as an accuracy measure of segmentation. Results Thirty-seven patients were included (26 [70%] in the training set and 11 [30%] in the validation set). All 11 lesions were accurately detected with no false positive, resulting in a sensitivity and a specificity for the detection at the tumor level of 100%. After 150 epochs, DSC reached 0.7924 in the training set and 0.7911 in the validation set. After morphological dilatation and fixed thresholding of the predicted U-Net mask a substantial improvement of the DSC to 0.8231 (+ 4.1%) was noted. At the voxel level, this segmentation led to a 0.88 sensitivity [95% CI, 87.1 to, 88.2%] a 0.99 specificity [99.9 to 99.9%], a 0.78 positive predictive value: [76.9 to 78.3%], and a 0.99 negative predictive value [99.9 to 99.9%]. Conclusions With relatively high performance, it was proposed the first full 3D automated procedure for segmentation of F-18-FET PET brain images of patients with different gliomas using a U-Net CNN architecture.	[Blanc-Durand, Paul; Itti, Emmanuel] Henri Mondor Univ Hosp, Dept Nucl Med, Creteil, France; [Blanc-Durand, Paul; Van der Gucht, Axel; Schaefer, Niklaus; Prior, John O.] Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Blanc-Durand, P (corresponding author), Henri Mondor Univ Hosp, Dept Nucl Med, Creteil, France.; Blanc-Durand, P; Van der Gucht, A (corresponding author), Lausanne Univ Hosp, Dept Nucl Med & Mol Imaging, Lausanne, Switzerland.	paul.blancdurand@gmail.com; axel.vandergucht@gmail.com	PRIOR, John O/I-5364-2017	PRIOR, John O/0000-0003-1429-1374; Schaefer, Niklaus/0000-0002-9732-7696; Itti, Emmanuel/0000-0003-1578-4058	Lionel Perrier Foundation (Montreux, Switzerland)	Lionel Perrier Foundation (Montreux, Switzerland)	The PET data acquisition was supported by a grant from the Lionel Perrier Foundation (Montreux, Switzerland). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham A, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00014; Bette S, 2016, WORLD NEUROSURG, V89, P230, DOI 10.1016/j.wneu.2016.01.085; Borght TV, 2006, EUR J NUCL MED MOL I, V33, P1374, DOI 10.1007/s00259-006-0206-3; Breen SL, 2007, INT J RADIAT ONCOL, V68, P763, DOI 10.1016/j.ijrobp.2006.12.039; Buvat I, 2017, J NUCL MED, V58; C Nioche, 2016, MEADECINE NUCLEAAIRE, V40, P208, DOI DOI 10.1016/j.mednuc.2016.03.107; Ceccon G, 2017, NEURO-ONCOLOGY, V19, P281, DOI 10.1093/neuonc/now149; Cho J, 2015, ARXIV151106348; Christ Patrick Ferdinand, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P415, DOI 10.1007/978-3-319-46723-8_48; Dolecek TA, 2012, NEURO-ONCOLOGY, V14, pv1, DOI 10.1093/neuonc/nos218; Dunet V, 2016, NEURO-ONCOLOGY, V18, P426, DOI 10.1093/neuonc/nov148; Filss CP, 2017, EJNMMI RES, V7, DOI 10.1186/s13550-017-0316-x; Gempt J, 2015, WORLD NEUROSURG, V84, P1790, DOI 10.1016/j.wneu.2015.07.067; Goodfellow I.J., 2014, PROC NEURAL INFORM P, DOI DOI 10.1002/RCS.128; Hatt M, 2017, MED PHYS, V44, pE1, DOI 10.1002/mp.12124; Jansen NL, 2012, NEURO-ONCOLOGY, V14, P1473, DOI 10.1093/neuonc/nos259; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; la Fougere C, 2011, NEURO-ONCOLOGY, V13, P806, DOI 10.1093/neuonc/nor054; Langen KJ, 2006, NUCL MED BIOL, V33, P287, DOI 10.1016/j.nucmedbio.2006.01.002; Pisano ED, 1998, J DIGIT IMAGING, V11, P193, DOI 10.1007/BF03178082; Popperl G, 2007, EUR J NUCL MED MOL I, V34, P1933, DOI 10.1007/s00259-007-0534-y; Popperl G, 2004, EUR J NUCL MED MOL I, V31, P1464, DOI 10.1007/s00259-004-1590-1; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sasanelli M, 2014, EUR J NUCL MED MOL I, V41, P2017, DOI 10.1007/s00259-014-2822-7; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Suchorska B, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.2058; Wang Jason, 2017, TECHNICAL REPORT; Weller M, 2013, LANCET ONCOL, V14, pE370, DOI 10.1016/S1470-2045(13)70168-2	28	72	73	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195798	10.1371/journal.pone.0195798	http://dx.doi.org/10.1371/journal.pone.0195798			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652908	Green Submitted, gold, Green Published			2022-12-26	WOS:000430026900036
J	Calles-Escandon, J; Koch, KL; Hasler, WL; Van Natta, ML; Pasricha, PJ; Tonascia, J; Parkman, HP; Hamilton, F; Herman, WH; Basina, M; Buckingham, B; Earle, K; Kirkeby, K; Hairston, K; Bright, T; Rothberg, AE; Kraftson, AT; Siraj, ES; Subauste, A; Lee, LA; Abell, TL; McCallum, RW; Sarosiek, I; Nguyen, L; Fass, R; Snape, WJ; Vaughn, IA; Miriel, LA; Farrugia, G				Calles-Escandon, Jorge; Koch, Kenneth L.; Hasler, William L.; Van Natta, Mark L.; Pasricha, Pankaj J.; Tonascia, James; Parkman, Henry P.; Hamilton, Frank; Herman, William H.; Basina, Marina; Buckingham, Bruce; Earle, Karen; Kirkeby, Kjersti; Hairston, Kristen; Bright, Tamis; Rothberg, Amy E.; Kraftson, Andrew T.; Siraj, Elias S.; Subauste, Angela; Lee, Linda A.; Abell, Thomas L.; McCallum, Richard W.; Sarosiek, Irene; Nguyen, Linda; Fass, Ronnie; Snape, William J.; Vaughn, Ivana A.; Miriel, Laura A.; Farrugia, Gianrico		NIDDK Gastroparesis Clinical Re	Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study	PLOS ONE			English	Article							UPPER GASTROINTESTINAL DISORDERS; COMPLICATIONS TRIAL/EPIDEMIOLOGY; GLYCEMIC CONTROL; HYPERGLYCEMIA; SYMPTOMS; MELLITUS; INTERVENTIONS; VALIDATION; SEVERITY; MEAL	Erratic blood glucose levels can be a cause and consequence of delayed gastric emptying in patients with diabetes. It is unknown if better glycemic control increases risks of hypoglycemia or improves hemoglobin A1c levels and gastrointestinal symptoms in diabetic gastroparesis. This study investigated the safety and potential efficacy of continuous subcutaneous insulin infusion (CSII) and continuous glucose monitoring (CGM) in poorly controlled diabetes with gastroparesis. Forty-five type 1 or 2 patients with diabetes and gastroparesis and hemoglobin A1c > 8% from the NIDDK Gastroparesis Consortium enrolled in a 24 week open-label pilot prospective study of CSII plus CGM. The primary safety outcome was combined numbers of mild, moderate, and severe hypoglycemic events at screening and 24 weeks treatment. Secondary outcomes included glycemic excursions on CGM, hemoglobin A1c, gastroparesis symptoms, quality-of-life, and liquid meal tolerance. Combined mild, moderate, and severe hypoglycemic events occurred similarly during the screening/run-in (1.9/week) versus treatment (2.2/week) phases with a relative risk of 1.18 (95% CI 0.85-1.64, P = 0.33). CGM time in hypoglycemia (< 70 mg/dL) decreased from 3.9% to 1.8% (P<0.0001), time in euglycemia (70-180 mg/dL) increased from 44.0% to 52.0% (P = 0.02), time in severe hyperglycemia (> 300 mg/dL) decreased from 14.2% to 7.0% (P = 0.005), and hemoglobin A1c decreased from 9.4 +/- 1.4% to 8.3 +/- 1.3% (P = 0.001) on CSII plus CGM. Symptom scores decreased from 29.3 +/- 7.1 to 21.9 +/- 10.2 with lower nausea/vomiting, fullness/early satiety, and bloating/distention scores (P <= 0.001). Quality-of-life scores improved from 2.4 +/- 1.1 to 3.1 +/- 1.1 (P<0.0001) and volumes of liquid nutrient meals tolerated increased from 420 +/- 258 to 487 +/- 312 mL (P = 0.05) at 24 weeks. In conclusion, CSII plus CGM appeared to be safe with minimal risks of hypoglycemic events and associated improvements in glycemic control, gastroparesis symptoms, quality-of-life, and meal tolerance in patients with poorly controlled diabetes and gastroparesis. This study supports the safety, feasibility, and potential benefits of improving glycemic control in diabetic gastroparesis.	[Calles-Escandon, Jorge] Case Western Reserve Univ, Endocrinol Sect, MetroHlth Reg, Cleveland, OH 44106 USA; [Koch, Kenneth L.] Wake Forest Univ, Sect Gastroenterol, Winston Salem, NC 27109 USA; [Hasler, William L.] Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Van Natta, Mark L.; Vaughn, Ivana A.; Miriel, Laura A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Van Natta, Mark L.; Tonascia, James; Vaughn, Ivana A.; Miriel, Laura A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Pasricha, Pankaj J.; Lee, Linda A.] Johns Hopkins Sch Med, Sect Gastroenterol, Baltimore, MD USA; [Parkman, Henry P.] Temple Univ, Sch Med, Sect Gastroenterol, Philadelphia, PA USA; [Hamilton, Frank] Natl Inst Diabet & Digest & Kidney Dis, Bethesda, MD USA; [Herman, William H.; Rothberg, Amy E.; Kraftson, Andrew T.] Univ Michigan, Div Metab Endocrinol & Diabet, Ann Arbor, MI 48109 USA; [Basina, Marina; Buckingham, Bruce] Stanford Univ, Sch Med, Div Pediat Endocrinol, Palo Alto, CA 94304 USA; [Earle, Karen; Kirkeby, Kjersti] Calif Pacific Med Ctr, Div Endocrinol, San Francisco, CA USA; [Hairston, Kristen] Wake Forest Univ, Sect Endocrinol, Winston Salem, NC 27109 USA; [Bright, Tamis] Texas Tech Univ, Sch Med, Div Endocrinol Diabet & Metab, El Paso, TX USA; [Siraj, Elias S.] Temple Univ, Sch Med, Sect Endocrinol, Philadelphia, PA USA; [Subauste, Angela] Univ Mississippi, Div Endocrinol, Jackson, MS 39216 USA; [Abell, Thomas L.] Univ Louisville, Sch Med, Div Gastroenterol, Louisville, KY 40292 USA; [McCallum, Richard W.; Sarosiek, Irene] Texas Tech Univ, Sch Med, Sect Gastroenterol, El Paso, TX USA; [Nguyen, Linda] Stanford Univ, Sch Med, Div Gastroenterol, Palo Alto, CA 94304 USA; [Fass, Ronnie] Case Western Reserve Univ, Gastroenterol Div, MetroHlth Reg, Cleveland, OH 44106 USA; [Snape, William J.] Calif Pacific Med Ctr, Div Gastroenterol, San Francisco, CA USA; [Farrugia, Gianrico] Mayo Clin, Sect Gastroenterol, Rochester, MN USA	Case Western Reserve University; Wake Forest University; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Michigan System; University of Michigan; Stanford University; California Pacific Medical Center; Wake Forest University; Texas Tech University System; Texas Tech University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Mississippi; University of Louisville; Texas Tech University System; Texas Tech University; Stanford University; Case Western Reserve University; California Pacific Medical Center; Mayo Clinic	Hasler, WL (corresponding author), Univ Michigan, Div Gastroenterol, Ann Arbor, MI 48109 USA.	whasler@umich.edu	Basina, Marina/GSM-9201-2022; Siraj, Elias/S-8152-2019	Buckingham, Bruce/0000-0003-4581-4887; ROTHBERG, AMY/0000-0002-0243-9135; Kraftson, Andrew/0000-0002-8860-2588; Hasler, William/0000-0002-6158-2871	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U01DK073983, U01DK073975, U01DK074035, U01DK074007, U01DK073985, U01DK073974, U01DK074008]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, U01DK074008, U24DK074008, P30DK020572, U01DK074035, U01DK112193] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	All funding for this study was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(www.niddk.nih.gov) as part of the funding for the Gastroparesis Clinical Research Consortium including grant numbers U01DK073983 (California Pacific Medical Center-KE KK WJS, Johns Hopkins University-PJP, Stanford University-MB BB LN), U01DK073985 (MetroHealth Medical Center-JCE RF), U01DK073975 (Temple University-HPP ESS), U01DK074035 (Texas Tech Health Sciences Center-TB RWM IS), U01DK074007 (University of Louisville-TLA, University of Mississippi-AS), U01DK073985 (University of Michigan-WLH WHH AER ATK), U01DK073974 (Wake Forest University-KLK KH), U01DK074008 (Mayo Clinic College of Medicine-GF, Johns Hopkins University Bloomberg School of Public Health-MLV JT LAL IAV LAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello LP, 2014, DIABETES CARE, V37, P17, DOI 10.2337/dc13-2251; [Anonymous], 1997, DIABETES, V46, P271, DOI 10.2337/diab.46.2.271; [Anonymous], 1995, DIABETES, V44, P968; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bharucha AE, 2015, GASTROENTEROLOGY, V149, P330, DOI 10.1053/j.gastro.2015.05.007; Bharucha AE, 2015, CLIN GASTROENTEROL H, V13, P466, DOI 10.1016/j.cgh.2014.06.034; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; Camilleri M, 1996, ENDOCRIN METAB CLIN, V25, P361, DOI 10.1016/S0889-8529(05)70328-5; Camilleri M, 2007, NEW ENGL J MED, V356, P820, DOI 10.1056/NEJMcp062614; Cao J, 2014, JAMA-J AM MED ASSOC, V312, P543, DOI 10.1001/jama.2014.9440; Chang J, 2013, DIABETIC MED, V30, pE185, DOI 10.1111/dme.12147; Chang J, 2012, DIABETES CARE, V35, P2594, DOI 10.2337/dc12-0028; de la Loge C, 2004, QUAL LIFE RES, V13, P1751, DOI 10.1007/s11136-004-8751-3; Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703; FRASER RJ, 1990, DIABETOLOGIA, V33, P675, DOI 10.1007/BF00400569; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; HASLER WL, 1995, GASTROENTEROLOGY, V108, P727, DOI 10.1016/0016-5085(95)90445-X; Hebbard GS, 1996, EUR J GASTROEN HEPAT, V8, P211, DOI 10.1097/00042737-199603000-00005; Jacobs MAJM, 1997, DIABETES CARE, V20, P1279, DOI 10.2337/diacare.20.8.1279; Janssen P, 2013, AM J GASTROENTEROL, V108, P1382, DOI 10.1038/ajg.2013.118; Jones KL, 2002, AM J MED, V113, P449, DOI 10.1016/S0002-9343(02)01228-7; Koch KL, 1999, DIGEST DIS SCI, V44, P1061, DOI 10.1023/A:1026647417465; Lachin JM, 2015, DIABETES, V64, P631, DOI 10.2337/db14-0930; Laway BA, 2013, J DIABETES COMPLICAT, V27, P78, DOI 10.1016/j.jdiacomp.2012.08.001; Lee SW, 2004, DIABETES NUTR METAB, V17, P211; Lysy J, 2006, NEUROGASTROENT MOTIL, V18, P433, DOI 10.1111/j.1365-2982.2006.00800.x; Martin CL, 2014, DIABETES CARE, V37, P31, DOI 10.2337/dc13-2114; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Pasricha PJ, 2015, GASTROENTEROLOGY, V149, P1762, DOI 10.1053/j.gastro.2015.08.008; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Rentz AM, 2004, QUAL LIFE RES, V13, P1737, DOI 10.1007/s11136-004-9567-x; Revicki DA, 2004, QUAL LIFE RES, V13, P833, DOI 10.1023/B:QURE.0000021689.86296.e4; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sharma D, 2011, DIABETOLOGIA, V54, P2768, DOI 10.1007/s00125-011-2282-6; Tack J, 2003, GUT, V52, P1271, DOI 10.1136/gut.52.9.1271; Tougas G, 2000, AM J GASTROENTEROL, V95, P1456, DOI 10.1111/j.1572-0241.2000.02076.x; Uppalapati SS, 2009, DIGEST DIS SCI, V54, P2404, DOI 10.1007/s10620-009-0975-1	37	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194759	10.1371/journal.pone.0194759	http://dx.doi.org/10.1371/journal.pone.0194759			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652893	Green Submitted, gold, Green Published			2022-12-26	WOS:000430026900009
J	Gog, JR; Lever, AML; Skittrall, JP				Gog, Julia R.; Lever, Andrew M. L.; Skittrall, Jordan P.			A new method for detecting signal regions in ordered sequences of real numbers, and application to viral genomic data	PLOS ONE			English	Article							PROTEIN; CONSERVATION; CODON	We present a fast, robust and parsimonious approach to detecting signals in an ordered sequence of numbers. Our motivation is in seeking a suitable method to take a sequence of scores corresponding to properties of positions in virus genomes, and find outlying regions of low scores. Suitable statistical methods without using complex models or making many assumptions are surprisingly lacking. We resolve this by developing a method that detects regions of low score within sequences of real numbers. The method makes no assumptions a priori about the length of such a region; it gives the explicit location of the region and scores it statistically. It does not use detailed mechanistic models so the method is fast and will be useful in a wide range of applications. We present our approach in detail, and test it on simulated sequences. We show that it is robust to a wide range of signal morphologies, and that it is able to capture multiple signals in the same sequence. Finally we apply it to viral genomic data to identify regions of evolutionary conservation within influenza and rotavirus.	[Gog, Julia R.] Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England; [Lever, Andrew M. L.] Univ Cambridge, Dept Med, Cambridge, England; [Lever, Andrew M. L.] Natl Univ Singapore, Dept Med, Singapore, Singapore; [Skittrall, Jordan P.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England	University of Cambridge; University of Cambridge; National University of Singapore; University of Cambridge	Gog, JR (corresponding author), Univ Cambridge, Dept Appl Math & Theoret Phys, Cambridge, England.	jrg20@cam.ac.uk	Skittrall, Jordan/ABB-8244-2020	Skittrall, Jordan/0000-0002-8228-3758; Gog, Julia/0000-0003-1240-7214	National Institute for Health Research Academic Clinical Fellowship; National Institute for Health Research (NIHR); Biomedical Research Centre	National Institute for Health Research Academic Clinical Fellowship; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biomedical Research Centre	JPS is funded by a National Institute for Health Research Academic Clinical Fellowship. This article/paper/report presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. Work in the laboratory of AMLL is supported by the Biomedical Research Centre.; JPS is funded by a National Institute for Health Research Academic Clinical Fellowship. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. Work in the laboratory of AMLL is supported by the Biomedical Research Centre.	ADAMS R, 1994, IEEE T PATTERN ANAL, V16, P641, DOI 10.1109/34.295913; [Anonymous], 2010, ISAST T ELECT SIGNAL; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; BRICE CR, 1970, ARTIF INTELL, V1, P205, DOI 10.1016/0004-3702(70)90008-1; CHANG YL, 1994, IEEE T IMAGE PROCESS, V3, P868, DOI 10.1109/83.336259; Chen JL, 2015, BIOCHEMISTRY-US, V54, P3269, DOI 10.1021/acs.biochem.5b00012; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Erbas B, 2001, J Epidemiol Biostat, V6, P433, DOI 10.1080/135952201317225462; FitzGerald D., 2012, 23 IET IR SIGN SYST; Godreche C, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/07/P07026; Gog JR, 2007, NUCLEIC ACIDS RES, V35, P1897, DOI 10.1093/nar/gkm087; Hojjatoleslami SA, 1998, IEEE T IMAGE PROCESS, V7, P1079, DOI 10.1109/83.701170; Hutchinson EC, 2010, J GEN VIROL, V91, P313, DOI 10.1099/vir.0.017608-0; Hutchinson EC, 2008, J VIROL, V82, P11869, DOI 10.1128/JVI.01634-08; Jagger BW, 2012, SCIENCE, V337, P199, DOI 10.1126/science.1222213; Jiang T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156906; Jiang T, 2014, BIOCHEMISTRY-US, V53, P5236, DOI 10.1021/bi500611j; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Li W, 2010, NUCLEIC ACIDS RES, V38, P7718, DOI 10.1093/nar/gkq663; LUKAC LP, 1988, APPL ECON, V20, P623, DOI 10.1080/00036848800000113; Marx V, 2013, NATURE, V496, P253, DOI 10.1038/498255a; Moss WN, 2012, RNA BIOL, V9, P1305, DOI 10.4161/rna.22343; Ng D, 2016, CLIN CHEM, V62, P1361, DOI 10.1373/clinchem.2016.257055; PREWITT JMS, 1966, ANN NY ACAD SCI, V128, P1035; Priore SF, 2015, BIOCHEMISTRY-US, V54, P3413, DOI 10.1021/bi501564d; Priore SF, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070615PMID:24023714, DOI 10.1371/JOURNAL.P0NE.0070615]; SIERACKI ME, 1989, APPL ENVIRON MICROB, V55, P2762, DOI 10.1128/AEM.55.11.2762-2772.1989; Song HY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143618; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; TAYLOR MP, 1992, J INT MONEY FINANC, V11, P304, DOI 10.1016/0261-5606(92)90048-3; Vernikos GS, 2006, BIOINFORMATICS, V22, P2196, DOI 10.1093/bioinformatics/btl369; von Kirchbach JC, 2010, SILICO ANAL RNA SIGN; Wan SY, 2003, IEEE T IMAGE PROCESS, V12, P1007, DOI 10.1109/TIP.2003.815258; WESZKA JS, 1978, COMPUT VISION GRAPH, V7, P259, DOI 10.1016/0146-664X(78)90116-8; Williams B, 2011, J AM COLL CARDIOL, V57, P951, DOI 10.1016/j.jacc.2010.09.054; Wise HM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002998; Yakimovsky Y, 1973, AIM209 STANDF U	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195763	10.1371/journal.pone.0195763	http://dx.doi.org/10.1371/journal.pone.0195763			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652903	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900034
J	Lee, AD; Cassiday, PK; Pawloski, LC; Tatti, KM; Martin, MD; Briere, EC; Tondella, ML; Martin, SW				Lee, Adria D.; Cassiday, Pamela K.; Pawloski, Lucia C.; Tatti, Kathleen M.; Martin, Monte D.; Briere, Elizabeth C.; Tondella, M. Lucia; Martin, Stacey W.		Clinical Validation Study Grp	Clinical evaluation and validation of laboratory methods for the diagnosis of Bordetella pertussis infection: Culture, polymerase chain reaction (PCR) and anti-pertussis toxin IgG serology (IgG-PT)	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; UNITED-STATES; VACCINATION COVERAGE; MASSACHUSETTS; SERODIAGNOSIS; ADOLESCENTS; ANTIBODIES; DIPHTHERIA; ACCURACY; OUTBREAK	Introduction The appropriate use of clinically accurate diagnostic tests is essential for the detection of pertussis, a poorly controlled vaccine-preventable disease. The purpose of this study was to estimate the sensitivity and specificity of different diagnostic criteria including culture, multi-target polymerase chain reaction (PCR), anti-pertussis toxin IgG (IgG-PT) serology, and the use of a clinical case definition. An additional objective was to describe the optimal timing of specimen collection for the various tests. Methods Clinical specimens were collected from patients with cough illness at seven locations across the United States between 2007 and 2011. Nasopharyngeal and blood specimens were collected from each patient during the enrollment visit. Patients who had been coughing for <= 2 weeks were asked to return in 2 +/- 4 weeks for collection of a second, convalescent blood specimen. Sensitivity and specificity of each diagnostic test were estimated using three methods-pertussis culture as the "gold standard," composite reference standard analysis (CRS), and latent class analysis (LCA). Results Overall, 868 patients were enrolled and 13.6% were B. pertussis positive by at least one diagnostic test. In a sample of 545 participants with non-missing data on all four diagnostic criteria, culture was 64.0% sensitive, PCR was 90.6% sensitive, and both were 100% specific by LCA. CRS and LCA methods increased the sensitivity estimates for convalescent serology and the clinical case definition over the culture-based estimates. Culture and PCR were most sensitive when performed during the first two weeks of cough; serology was optimally sensitive after the second week of cough. Conclusions Timing of specimen collection in relation to onset of illness should be considered when ordering diagnostic tests for pertussis. Consideration should be given to including IgG-PT serology as a confirmatory test in the Council of State and Territorial Epidemiologists (CSTE) case definition for pertussis.	[Lee, Adria D.] Ctr Dis Control & Prevent, IHRC Inc, Contracting Agcy Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Cassiday, Pamela K.; Pawloski, Lucia C.; Tatti, Kathleen M.; Martin, Monte D.; Briere, Elizabeth C.; Tondella, M. Lucia; Martin, Stacey W.] Ctr Dis Control & Prevent, Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Martin, Stacey W.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Lee, AD (corresponding author), Ctr Dis Control & Prevent, IHRC Inc, Contracting Agcy Div Bacterial Dis, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA.	xda5@cdc.gov	Tatti, Kathleen M/H-5912-2012	Tatti, Kathleen M/0000-0001-9414-7887; Mathis, Adria/0000-0002-1119-095X	IHRC Inc	IHRC Inc	The authors received no specific funding for this work. The funder IHRC Inc provided support in the form of salaries for athor ADL, but did not have any additional roles in the study design, data collection and analysis, decision to publish or preparation of the mansucript. The specific roles of this author are articulated in the author contributions section.	Adams Deborah A, 2014, MMWR Morb Mortal Wkly Rep, V61, P1; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], EPIDEMIOLOGY PREVENT; Baughman AL, 2004, CLIN DIAGN LAB IMMUN, V11, P1045, DOI 10.1128/CDLI.11.6.1045-1053.2004; Baughman AL, 2008, CLIN VACCINE IMMUNOL, V15, P106, DOI 10.1128/CVI.00223-07; Burgos-Rivera B, 2015, J CLIN MICROBIOL, V53, P1842, DOI 10.1128/JCM.03567-14; CDC, 2014, DIAGN CONF 2014; CDC, 2015, BEST PRACT HEALTHC P; Davis JP, 2013, REVISION PERTUSSIS S; Elam-Evans LD, 2014, MMWR-MORBID MORTAL W, V63, P741; Faulkner AE, 2011, VPD SURVEILLANCE MAN, P1; Frumkin K, 2013, J EMERG MED, V44, P889, DOI 10.1016/j.jemermed.2012.09.037; Guiso N, 2011, EUR J CLIN MICROBIOL, V30, P307, DOI 10.1007/s10096-010-1104-y; Kirkland K. B., 2007, Morbidity and Mortality Weekly Report, V56, P837; Mandal S, 2012, PEDIATRICS, V129, pE424, DOI 10.1542/peds.2011-1710; Menzies SL, 2009, CLIN VACCINE IMMUNOL, V16, P1781, DOI 10.1128/CVI.00248-09; Pawloski LC, 2016, J PEDIAT INF DIS SOC; Pawloski LC, 2012, CLIN VACCINE IMMUNOL, V19, P875, DOI 10.1128/CVI.05686-11; Qu YS, 1996, BIOMETRICS, V52, P797, DOI 10.2307/2533043; Riffelmann M, 2010, J CLIN MICROBIOL, V48, P4459, DOI 10.1128/JCM.01371-10; Rodgers L, 2013, CLIN INFECT DIS, V56, P322, DOI 10.1093/cid/cis888; Salimnia H, 2012, J CLIN MICROBIOL, V50, P472, DOI 10.1128/JCM.01250-11; Seither R, 2014, MMWR-MORBID MORTAL W, V63, P913; Tatti KM, 2008, DIAGN MICR INFEC DIS, V61, P264, DOI 10.1016/j.diagmicrobio.2008.02.017; Tatti KM, 2013, PEDIATR INFECT DIS J, V32, P942, DOI 10.1097/INF.0b013e3182947ef8; Tatti KM, 2011, J CLIN MICROBIOL, V49, P4059, DOI 10.1128/JCM.00601-11; Vaz-de-Lima LRA, 2014, CLIN VACCINE IMMUNOL, V21, P636, DOI 10.1128/CVI.00760-13; Vermunt J, 2002, APPLIED LATENT CLASS; Vermunt J.K., 2005, LATENT GOLD 40 USERS; von Konig CHW, 2014, EXPERT REV VACCINES, V13, P1167, DOI 10.1586/14760584.2014.950237; Watanabe M, 2006, CLIN VACCINE IMMUNOL, V13, P341, DOI 10.1128/CVI.13.3.341-348.2006; Wei SC, 2010, CLIN INFECT DIS, V51, P315, DOI 10.1086/653938; Wendelboe AM, 2006, EXPERT REV MOL DIAGN, V6, P857, DOI 10.1586/14737159.6.6.857; Williams MM, 2015, J CLIN MICROBIOL, V53, P118, DOI 10.1128/JCM.02368-14; Yih WK, 2000, J INFECT DIS, V182, P1409, DOI 10.1086/315863	35	27	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195979	10.1371/journal.pone.0195979	http://dx.doi.org/10.1371/journal.pone.0195979			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652945	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900051
J	Bartelds, R; Nematollahi, MH; Pols, T; Stuart, MCA; Pardakhty, A; Asadikaram, G; Poolman, B				Bartelds, Rianne; Nematollahi, Mohammad Hadi; Pols, Tjeerd; Stuart, Marc C. A.; Pardakhty, Abbas; Asadikaram, Gholamreza; Poolman, Bert			Niosomes, an alternative for liposomal delivery	PLOS ONE			English	Article							LIPID-PROTEIN INTERACTIONS; OF-THE-ART; PHOSPHOLIPID-VESICLES; MEMBRANE-PROTEINS; DRUG-DELIVERY; UNILAMELLAR LIPOSOMES; SURFACTANT VESICLES; TRANSPORT-SYSTEM; INDUCED LEAKAGE; MELITTIN	Niosomes are used in studies for drug delivery or gene transfer. However, their physical properties and features relative to liposomes are not well documented. To characterize and more rationally optimize niosome formulations, the properties of these vesicle systems are compared to those of liposomes composed of phosphatidylcholine and phosphatidylethanolamine lipids plus cholesterol. Niosomes are highly stable and only slightly more leaky than liposomes as assayed by calcein leakage; the permeability for ions (KCl) is higher than that of liposomes. Contrary to liposomes, the size of niosomes decreases substantially upon freezing in liquid nitrogen and subsequent thawing, as shown by cryo-EM and dynamic light scattering. The packing of niosomal membranes was determined by laurdan fluorescence and is slightly lower than that of liposomes. We did not succeed in the functional reconstitution of the L-arginine/L-ornithine antiporter ArcD2 in niosomes, which we attribute to the non-ionic nature of the surfactants. The antimicrobial peptides alamethicin and melittin act similarly on niosomes and liposomes composed of unsaturated components, whereas both niosomes and liposomes are unaffected when saturated amphiphiles are used. In conclusion, in terms of stability and permeability for drug-size molecules niosomes are comparable to liposomes and they may offer an excellent, inexpensive alternative for delivery purposes.	[Bartelds, Rianne; Pols, Tjeerd; Poolman, Bert] Univ Groningen, Dept Biochem, Groningen, Netherlands; [Nematollahi, Mohammad Hadi] Sch Med, Dept Clin Biochem, Med Univ Campus, Kerman, Iran; [Stuart, Marc C. A.] Univ Groningen, Dept Electron Microscopy, Groningen, Netherlands; [Pardakhty, Abbas] Kerman Univ Med Sci, Pharmaceut Res Ctr, Inst Neuropharmacol, Med Univ Campus, Kerman, Iran; [Asadikaram, Gholamreza] Kerman Univ Med Sci, Inst Basic & Clin Physiol Sci, Endocrinol & Metab Res Ctr, Kerman, Iran	University of Groningen; University of Groningen; Kerman University of Medical Sciences; Kerman University of Medical Sciences	Poolman, B (corresponding author), Univ Groningen, Dept Biochem, Groningen, Netherlands.	bpoolman@rug.nl	Asadikaram, Gholamreza/AAG-4437-2021; Nematollahi, Hadi/AAD-5922-2019; Pardakhty, Abbas/Y-7245-2018	Asadikaram, Gholamreza/0000-0002-9100-0756; Pardakhty, Abbas/0000-0002-1848-5961; Poolman, Bert/0000-0002-1455-531X; Nematollahi, Mohammad Hadi/0000-0002-9529-4077	European Research Council; Netherlands Organization for Scientific Research (NWO)	European Research Council(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by the European Research Council, and the Netherlands Organization for Scientific Research (NWO).	ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2; Allende D, 2005, BIOPHYS J, V88, P1828, DOI 10.1529/biophysj.104.049817; BAILLIE AJ, 1985, J PHARM PHARMACOL, V37, P863, DOI 10.1111/j.2042-7158.1985.tb04990.x; BANGHAM AD, 1965, J MOL BIOL, V13, P238, DOI 10.1016/S0022-2836(65)80093-6; Chang HI, 2012, INT J NANOMED, V7, P49, DOI 10.2147/IJN.S26766; CLEMENT NR, 1981, BIOCHEMISTRY-US, V20, P1534, DOI 10.1021/bi00509a019; CROMMELIN DJA, 1984, PHARMACEUT RES, P159, DOI 10.1023/A:1016344523988; Dawidczyk CM, 2014, J CONTROL RELEASE, V187, P133, DOI 10.1016/j.jconrel.2014.05.036; DEAMER DW, 1983, P NATL ACAD SCI-BIOL, V80, P165, DOI 10.1073/pnas.80.1.165; DEAMER DW, 1986, CHEM PHYS LIPIDS, V40, P167, DOI 10.1016/0009-3084(86)90069-1; DEGIER J, 1968, BIOCHIM BIOPHYS ACTA, V150, P666, DOI 10.1016/0005-2736(68)90056-4; DEMEL RA, 1972, BIOCHIM BIOPHYS ACTA, V255, P321, DOI 10.1016/0005-2736(72)90031-4; DUFOURCQ J, 1986, BIOCHIM BIOPHYS ACTA, V859, P33, DOI 10.1016/0005-2736(86)90315-9; DUFOURCQ J, 1977, BIOCHIM BIOPHYS ACTA, V467, P1, DOI 10.1016/0005-2736(77)90236-X; Geertsma ER, 2008, P NATL ACAD SCI USA, V105, P5722, DOI 10.1073/pnas.0802190105; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Hamann S, 2002, J FLUORESC, V12, P139, DOI 10.1023/A:1016832027325; HAUSER H, 1973, BIOCHEMISTRY-US, V12, P4507, DOI 10.1021/bi00746a032; Hayashi K, 2013, COLLOID SURFACE B, V106, P258, DOI 10.1016/j.colsurfb.2012.12.022; Hayashi K, 2011, COLLOID SURFACE B, V87, P28, DOI 10.1016/j.colsurfb.2011.04.029; Jibry N, 2004, PHARM RES-DORDR, V21, P1852, DOI 10.1023/B:PHAM.0000045239.22049.70; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; KANO K, 1978, BIOCHIM BIOPHYS ACTA, V509, P289, DOI 10.1016/0005-2736(78)90048-2; Kato K, 2008, LANGMUIR, V24, P10762, DOI 10.1021/la801581f; KENDALL DA, 1982, J BIOL CHEM, V257, P3892; Knol J, 1998, BIOCHEMISTRY-US, V37, P16410, DOI 10.1021/bi981596u; Knol J, 1996, J BIOL CHEM, V271, P15358, DOI 10.1074/jbc.271.26.15358; Laouini A, 2012, J COLLOID SCI BIOTEC, V1, P147, DOI 10.1166/jcsb.2012.1020; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Manosroi A, 2003, COLLOID SURFACE B, V30, P129, DOI 10.1016/S0927-7765(03)00080-8; Moghassemi S, 2014, J CONTROL RELEASE, V185, P22, DOI 10.1016/j.jconrel.2014.04.015; MONETTE M, 1993, BIOCHIM BIOPHYS ACTA, V1149, P319, DOI 10.1016/0005-2736(93)90217-N; Muzzalupo R, 2005, COLLOID SURFACE B, V46, P78, DOI 10.1016/j.colsurfb.2005.09.003; NICHOLS JW, 1980, P NATL ACAD SCI-BIOL, V77, P2038, DOI 10.1073/pnas.77.4.2038; NOZAKI Y, 1981, P NATL ACAD SCI-BIOL, V78, P4324, DOI 10.1073/pnas.78.7.4324; PAPAHADJ.D, 1967, BIOCHIM BIOPHYS ACTA, V135, P639, DOI 10.1016/0005-2736(67)90095-8; PARASASSI T, 1991, BIOPHYS J, V60, P179, DOI 10.1016/S0006-3495(91)82041-0; POTT T, 1995, BIOPHYS J, V68, P965, DOI 10.1016/S0006-3495(95)80272-9; Raghuraman H, 2004, BIOPHYS J, V87, P2419, DOI 10.1529/biophysj.104.043596; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Rex S, 1996, BIOPHYS CHEM, V58, P75, DOI 10.1016/0301-4622(95)00087-9; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; SENIOR J, 1982, LIFE SCI, V30, P2123, DOI 10.1016/0024-3205(82)90455-6; Sezgin E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123930; STANKOWSKI S, 1989, FEBS LETT, V250, P556, DOI 10.1016/0014-5793(89)80795-1; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; SUBBARAO NK, 1994, BBA-BIOMEMBRANES, V1189, P101, DOI 10.1016/0005-2736(94)90286-0; Uchegbu IF, 1998, INT J PHARM, V172, P33, DOI 10.1016/S0378-5173(98)00169-0; van den Bogaart G, 2007, BIOPHYS J, V93, P154, DOI 10.1529/biophysj.107.106005; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Wessman P, 2008, BIOPHYS J, V95, P4324, DOI 10.1529/biophysj.108.130559; Wessman P, 2010, J COLLOID INTERF SCI, V346, P127, DOI 10.1016/j.jcis.2010.02.032; YAMAUCHI K, 1993, BIOCHIM BIOPHYS ACTA, V1146, P178, DOI 10.1016/0005-2736(93)90353-2; YOSHIOKA T, 1994, INT J PHARM, V105, P1, DOI 10.1016/0378-5173(94)90228-3	54	99	103	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0194179	10.1371/journal.pone.0194179	http://dx.doi.org/10.1371/journal.pone.0194179			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649223	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900007
J	Chard, M; French, K; Martin, J; Major, RE				Chard, Matthew; French, Kris; Martin, John; Major, Richard E.			Rain drives foraging decisions of an urban exploiter	PLOS ONE			English	Article							IBIS THRESKIORNIS-MOLUCCA; FLIGHT INITIATION DISTANCE; TITS PARUS-MAJOR; CLIMATE-CHANGE; ECOLOGICAL RESPONSES; FOOD AVAILABILITY; SUBURBAN; BEHAVIOR; BIRDS; POPULATION	Foraging decisions tend to drive individuals toward maximising energetic gains within a patchy environment. This study aims to determine the extent to which rainfall, and associated changes in food availability, can explain foraging decisions within a patchy urbanised landscape, using the Australian white ibis as a model species. Ibis density, food consumption rates and food abundance (both natural and anthropogenic) were recorded during dry and wet weather within urban parks in Sydney, Australia. Rainfall influenced ibis density in these urban parks. Of the four parks assessed, the site with the highest level of anthropogenic food and the lowest abundance of natural food (earthworms), irrespective of weather, was observed to have three times the density of ibis. Rainfall significantly increased the rate of earthworm consumption as well as their relative availability in all sites. Overall, these density and consumption measures indicate that anthropogenic derived foods, mainly from direct feeding by people, explain the apparent distribution of ibis across urban parks. However, there was evidence of prey-switching when the availability of natural foods increased following rainfall, perhaps reflecting selection of particular nutrients.	[Chard, Matthew; French, Kris] Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia; [Martin, John] Royal Bot Gardens & Domain Trust, Sydney, NSW, Australia; [Major, Richard E.] Australian Museum, Res Inst, Sydney, NSW, Australia	University of Wollongong; Australian Museum	Chard, M (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	Matthew.chard7@gmail.com	; French, Kris/I-8202-2012	Major, Richard/0000-0002-1334-9864; Martin, John/0000-0003-2731-9292; French, Kris/0000-0001-6938-2017				Adams LW, 1994, URBAN WILDLIFE HABIT; Ausden M, 2001, J APPL ECOL, V38, P320, DOI 10.1046/j.1365-2664.2001.00600.x; Barker D, 1998, ZOO BIOL, V17, P123, DOI 10.1002/(SICI)1098-2361(1998)17:2&lt;123::AID-ZOO7&gt;3.0.CO;2-B; Bell W.J., 2012, SEARCHING BEHAV BEHA; Bertrand R, 2011, NATURE, V479, P517, DOI 10.1038/nature10548; BIEBACH H, 1994, ANIM BEHAV, V48, P273, DOI 10.1006/anbe.1994.1241; Bonier F, 2007, BIOL LETTERS, V3, P670, DOI 10.1098/rsbl.2007.0349; Brandis KJ, 2011, ENVIRON MANAGE, V48, P489, DOI 10.1007/s00267-011-9705-5; BRITTINGHAM MC, 1991, NIUW SYMP S, V2, P185; Butt Kevin R., 2000, Field Studies, V9, P701; Canepuccia AD, 2007, WATERBIRDS, V30, P541, DOI 10.1675/1524-4695(2007)030[0541:WRTCIH]2.0.CO;2; CATTERALL CP, 1991, NAT CONSERV SER, P247; Chambers LE, 2006, INT J BIOMETEOROL, V50, P292, DOI 10.1007/s00484-005-0019-2; Chard M, 2017, URBAN ECOSYST, V20, P1285, DOI 10.1007/s11252-017-0680-3; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Chuang SC, 2008, INVERTEBR BIOL, V127, P80, DOI 10.1111/j.1744-7410.2007.00117.x; Coogan SC, 2017, BEHAV ECOLOGY; Corben D, 2006, CLUTCH SIZE FLEDGING; Couturier S, 2009, J MAMMAL, V90, P442, DOI 10.1644/07-MAMM-A-279.1; COWIE RJ, 1988, J ANIM ECOL, V57, P611, DOI 10.2307/4928; Crates RA, 2011, EMU, V111, P341, DOI 10.1071/MU10057; Davis A, 2011, LANDSCAPE URBAN PLAN, V100, P295, DOI 10.1016/j.landurbplan.2010.12.017; DILL LM, 1989, CAN J ZOOL, V67, P233, DOI 10.1139/z89-033; Epstein JH, 2006, ECOHEALTH, V3, P290, DOI 10.1007/s10393-006-0064-2; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; French K, 2005, BIOL CONSERV, V121, P545, DOI 10.1016/j.biocon.2004.06.004; GREEN RJ, 1989, EMU, V89, P216, DOI 10.1071/MU9890216; HALSE SA, 1989, EMU, V89, P232, DOI 10.1071/MU9890232; He S, 2006, IEEE C EVOL COMPUTAT, P1257; Jahn AE, 2010, J FIELD ORNITHOL, V81, P340, DOI 10.1111/j.1557-9263.2010.00290.x; Kingsford R. T., 2013, Pacific Conservation Biology, V19, P366; Kingsford RT, 1999, WILDLIFE RES, V26, P351, DOI 10.1071/WR96062; Kingsford RT, 1998, COLON WATERBIRD, V21, P159, DOI 10.2307/1521903; Kohlmann SG, 1998, BEHAV ECOL, V9, P177, DOI 10.1093/beheco/9.2.177; KOTLER BP, 1992, ANN ZOOL FENN, V29, P199; Lavergne S, 2010, ANNU REV ECOL EVOL S, V41, P321, DOI 10.1146/annurev-ecolsys-102209-144628; Machovsky-Capuska GE, 2016, BEHAV ECOL, V27, P219, DOI 10.1093/beheco/arv142; Maclean IMD, 2011, P NATL ACAD SCI USA, V108, P12337, DOI 10.1073/pnas.1017352108; MADDOCK M, 1991, COLON WATERBIRD, V14, P133, DOI 10.2307/1521502; Mainwaring MC, 2015, NESTS, EGGS, AND INCUBATION: NEW IDEAS ABOUT AVIAN REPRODUCTION, P65; Major RE, 1996, AUST J ECOL, V21, P399, DOI 10.1111/j.1442-9993.1996.tb00626.x; Marchant SJ, HDB AUSTR NZ ANTARCT, V1; Marshal JP, 2005, RANGELAND ECOL MANAG, V58, P360, DOI 10.2111/1551-5028(2005)058[0360:RTAFDA]2.0.CO;2; Martin GR, 2012, IBIS, V154, P626, DOI 10.1111/j.1474-919X.2012.01227.x; Martin J, 2010, WILDLIFE RES, V37, P230, DOI 10.1071/WR10047; Martin JM, 2007, WILDLIFE RES, V34, P319, DOI 10.1071/WR07005; Martin JM, 2010, WATERBIRDS, V33, P264, DOI 10.1675/063.033.0218; Marzluff John M., 2001, P19; McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005; McMahon CR, 2006, GLOBAL CHANGE BIOL, V12, P1330, DOI 10.1111/j.1365-2486.2006.01174.x; MCNAMARA J, 1980, J THEOR BIOL, V85, P673, DOI 10.1016/0022-5193(80)90265-9; Meyer-Gleaves Stephanie, 2007, P142; Moller AP, 2014, BEHAV ECOL, V25, P960, DOI 10.1093/beheco/aru073; Monson RK, 2006, NATURE, V439, P711, DOI 10.1038/nature04555; Morris A.K, 1983, AUSTR BIRDS, V17, P43; Morrison SA, 2002, OECOLOGIA, V133, P315, DOI 10.1007/s00442-002-1040-3; Murray Nicholas J., 2009, Notornis, V56, P201; Naef-Daenzer B, 2000, ANIM BEHAV, V59, P989, DOI 10.1006/anbe.1999.1380; Naef-Daenzer L, 2000, J AVIAN BIOL, V31, P206, DOI 10.1034/j.1600-048X.2000.310212.x; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Padgham M, 2011, ECOSYSTEMS, V14, P94, DOI 10.1007/s10021-010-9397-3; Parsons H, 2003, LANDSCAPE URBAN PLAN, V66, P43, DOI 10.1016/S0169-2046(03)00094-X; Parsons H, 2006, AUSTRAL ECOL, V31, P217, DOI 10.1111/j.1442-9993.2006.01584.x; Paton D.C., 1991, P WORKSH IMP CATS NA, P64; Penuelas J, 2004, NEW PHYTOL, V161, P837, DOI 10.1111/j.1469-8137.2004.01003.x; Pierotti Raymond, 2001, P307; Porter JL, 2006, AERIAL SURVEYS WETLA; Radford AN, 2001, BIRD STUDY, V48, P214, DOI 10.1080/00063650109461220; Sauter A, 2006, BEHAV ECOL SOCIOBIOL, V60, P465, DOI 10.1007/s00265-006-0187-z; Shochat E, 2004, AM NAT, V164, P232, DOI 10.1086/422222; Shochat E, 2006, TRENDS ECOL EVOL, V21, P186, DOI 10.1016/j.tree.2005.11.019; Shochat E, 2004, OIKOS, V106, P622, DOI 10.1111/j.0030-1299.2004.13159.x; Smith ACM, 2013, POPUL ECOL, V55, P567, DOI 10.1007/s10144-013-0385-2; SMITH GC, 1993, COLON WATERBIRD, V16, P9, DOI 10.2307/1521551; Sofaer HR, 2013, BEHAV ECOL, V24, P698, DOI 10.1093/beheco/ars212; Stephens D.W., 1986, pi; Tryjanowski P, 2015, ENVIRON SCI POLLUT R, V22, P15097, DOI 10.1007/s11356-015-4723-0; Tsurim I, 2008, CONDOR, V110, P772, DOI 10.1525/cond.2008.8572; TWEIT R C, 1986, American Birds, V40, P431; WOLF LL, 1991, ANIM BEHAV, V41, P803, DOI 10.1016/S0003-3472(05)80347-1; WOODALL PF, 1985, AUST WILDLIFE RES, V12, P495, DOI 10.1071/WR9850495	81	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194484	10.1371/journal.pone.0194484	http://dx.doi.org/10.1371/journal.pone.0194484			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641609	Green Published, Green Submitted, gold			2022-12-26	WOS:000429742900032
J	Herrera, JM; Alagador, D; Salgueiro, P; Mira, A				Herrera, Jose M.; Alagador, Diogo; Salgueiro, Pedro; Mira, Antonio			A distribution-oriented approach to support landscape connectivity for ecologically distinct bird species	PLOS ONE			English	Article							FUNCTIONAL CONNECTIVITY; PLANTATION FORESTS; FRAGMENTATION; CONSERVATION; HABITATS; ECOLOGY; DISPERSAL; REGION; MODEL	Managing landscape connectivity is a widely recognized overarching strategy for conserving biodiversity in human-impacted landscapes. However, planning the conservation and management of landscape connectivity of multiple and ecologically distinct species is still challenging. Here we provide a spatially-explicit framework which identifies and prioritizes connectivity conservation and restoration actions for species with distinct habitat affinities. Specifically, our study system comprised three groups of common bird species, forest-specialists, farmland-specialists, and generalists, populating a highly heterogeneous agricultural countryside in the southwestern Iberian Peninsula. We first performed a comprehensive analysis of the environmental variables underlying the distributional patterns of each bird species to reveal generalities in their guild-specific responses to landscape structure. Then, we identified sites which could be considered pivotal in maintaining current levels of landscape connectivity for the three bird guilds simultaneously, as well as the number and location of sites that need to be restored to maximize connectivity levels. Interestingly, we found that a small number of sites defined the shortest connectivity paths for the three bird guilds simultaneously, and were therefore considered key for conservation. Moreover, an even smaller number of sites were identified as critical to expand the landscape connectivity at maximum for the regional bird assemblage as a whole. Our spatially-explicit framework can provide valuable decision-making support to conservation practitioners aiming to identify key connectivity and restoration sites, a particularly urgent task in rapidly changing landscapes such as agroecosystems.	[Herrera, Jose M.; Alagador, Diogo; Salgueiro, Pedro; Mira, Antonio] Univ Evora, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, InBIO, Dom Augusto Eduardo Nunes 7, Evora, Portugal; [Herrera, Jose M.] CSIC, Dept Ecol Integrat, EBD, Avd Amer Vespucio 26, Seville, Spain	University of Evora; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Herrera, JM (corresponding author), Univ Evora, CIBIO, Ctr Invest Biodiversidade & Recursos Genet, InBIO, Dom Augusto Eduardo Nunes 7, Evora, Portugal.; Herrera, JM (corresponding author), CSIC, Dept Ecol Integrat, EBD, Avd Amer Vespucio 26, Seville, Spain.	herreramirlo@gmail.com	Herrera, José M./L-7432-2013; Mira, Antonio/E-5715-2010; Salgueiro, Pedro A./AAJ-4094-2020	Herrera, José M./0000-0001-7968-3438; Mira, Antonio/0000-0001-6152-0454; Salgueiro, Pedro A./0000-0001-5055-2805	ICDT Call [1/SAESCTN/ALENT-07-0224-FEDER-001755]	ICDT Call	This work was supported by IC&DT Call No 1/SAESCTN/ALENT-07-0224-FEDER-001755.	Alagador D, 2012, LANDSCAPE ECOL, V27, P291, DOI 10.1007/s10980-012-9704-9; Antongiovanni M, 2005, BIOL CONSERV, V122, P441, DOI 10.1016/j.biocon.2004.09.005; Baguette M, 2013, BIOL REV, V88, P310, DOI 10.1111/brv.12000; Barbaro L, 2007, J BIOGEOGR, V34, P652, DOI 10.1111/j.1365-2699.2006.01656.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Baudry J, 2003, LANDSCAPE ECOL, V18, P303, DOI 10.1023/A:1024465200284; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Bennett AF, 2006, BIOL CONSERV, V133, P250, DOI 10.1016/j.biocon.2006.06.008; Bibby CJ, 2000, BIRD CENSUS TECHNIQU, DOI 10.1016/b978-0-12-095830-6.50007-9; Birch CPD, 2007, ECOL MODEL, V206, P347, DOI 10.1016/j.ecolmodel.2007.03.041; Branco P, 2014, J APPL ECOL, V51, P1197, DOI 10.1111/1365-2664.12317; Bras R, 2013, ENVIRON MODELL SOFTW, V40, P336, DOI 10.1016/j.envsoft.2012.08.001; Brodie JF, 2015, CONSERV BIOL, V29, P122, DOI 10.1111/cobi.12337; Bunn AG, 2000, J ENVIRON MANAGE, V59, P265, DOI 10.1006/jema.2000.0373; Calvino-Cancela M, 2013, FOREST ECOL MANAG, V310, P692, DOI 10.1016/j.foreco.2013.09.014; Carvalho F, 2016, LANDSCAPE ECOL, V31, P1021, DOI 10.1007/s10980-015-0326-x; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Cushman SA, 2013, BIODIVERS CONSERV, V22, P2583, DOI 10.1007/s10531-013-0541-1; Cushman SA, 2012, ECOL MODEL, V231, P101, DOI 10.1016/j.ecolmodel.2012.02.011; Donald PF, 2006, J APPL ECOL, V43, P209, DOI 10.1111/j.1365-2664.2006.01146.x; FEO TA, 1995, J GLOBAL OPTIM, V6, P109, DOI 10.1007/BF01096763; Fischer J, 2006, OIKOS, V112, P473, DOI 10.1111/j.0030-1299.2006.14148.x; Frey-Ehrenbold A, 2013, J APPL ECOL, V50, P252, DOI 10.1111/1365-2664.12034; Goodwin BJ, 2002, OIKOS, V99, P552, DOI 10.1034/j.1600-0706.2002.11824.x; Gregory RD, 2005, PHILOS T R SOC B, V360, P269, DOI 10.1098/rstb.2004.1602; Guiomar N, CORINE LAND COVER NI; Herrera JM, 2016, J BIOGEOGR, V43, P1203, DOI 10.1111/jbi.12720; Herrera JM, 2014, J BIOGEOGR, V41, P700, DOI 10.1111/jbi.12236; Herrera JM, 2011, ECOGRAPHY, V34, P606, DOI 10.1111/j.1600-0587.2010.06521.x; Koen EL, 2014, METHODS ECOL EVOL, V5, P626, DOI 10.1111/2041-210X.12197; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; LaPoint S, 2013, LANDSCAPE ECOL, V28, P1615, DOI 10.1007/s10980-013-9910-0; Loos J, 2015, BIODIVERS CONSERV, V24, P33, DOI 10.1007/s10531-014-0786-3; Margosian ML, 2009, BIOSCIENCE, V59, P141, DOI 10.1525/bio.2009.59.2.7; Melia P, 2016, SCI REP-UK, V6, DOI 10.1038/srep23705; Mimet A, 2014, ECOL INDIC, V36, P19, DOI 10.1016/j.ecolind.2013.06.029; Mimet A, 2013, METHODS ECOL EVOL, V4, P453, DOI 10.1111/2041-210x.12024; Niebuhr BBS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11898; PALMEIRIM JM, 1994, J FIELD ORNITHOL, V65, P17; Paracchini ML, 2008, HIGH NATURE VALUE FA; Pinto-Correia T, 2011, AGROFOREST SYST, V82, P99, DOI 10.1007/s10457-011-9388-1; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; Quinn P.G., 2002, EXPT DESIGN DATA ANA; Smith AC, 2011, ECOGRAPHY, V34, P103, DOI 10.1111/j.1600-0587.2010.06201.x; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; Tischendorf L, 2000, LANDSCAPE ECOL, V15, P633, DOI 10.1023/A:1008177324187; Tischendorf L, 2000, OIKOS, V90, P7, DOI 10.1034/j.1600-0706.2000.900102.x; Vasudev D, 2015, ECOGRAPHY, V38, P967, DOI 10.1111/ecog.01306; Worboys G.L., 2010, CONNECTIVITY CONSERV; Zeller KA, 2012, LANDSCAPE ECOL, V27, P777, DOI 10.1007/s10980-012-9737-0	51	7	8	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194848	10.1371/journal.pone.0194848	http://dx.doi.org/10.1371/journal.pone.0194848			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641610	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900050
J	Zhang, CL; Sun, M; Zhang, XQ; Chen, SY; Nie, G; Peng, Y; Huang, LK; Ma, X				Zhang, Chenglin; Sun, Ming; Zhang, Xinquan; Chen, Shiyong; Nie, Gang; Peng, Yan; Huang, Linkai; Ma, Xiao			AFLP-based genetic diversity of wild orchardgrass germplasm collections from Central Asia and Western China, and the relation to environmental factors	PLOS ONE			English	Article							DACTYLIS-GLOMERATA L.; GALICIA NORTHWEST SPAIN; POPULATION-STRUCTURE; TALL FESCUE; MOLECULAR MARKERS; TIBETAN PLATEAU; ISSR MARKERS; SSR MARKERS; EVOLUTION; PLANTS	Dactylis glomerata L. (orchardgrass) is an important perennial forage species in temperate areas of the world. It is usually used for silage, grazing and hay because of its high nutritional value and reproducibility. Central Asia, Xinjiang and Tibetan Plateau in China possess various special micro-environments that harbor many valuable resources, while different degrees of degradation of the grassland ecosystem occurred due to climatic changing and human activities. Investigating the genetic diversity of wild D. glomerat could provide basis for collection, protection, and utilization of some excellent germplasm resources. Totally 210 individuals from 14 populations D five from Xinjiang, two from Kangding (Tibetan Plateau), and seven from Central Asia were identified using AFLP technology. The average values of Nei's genetic diversity (H-j) and Shannon information index (H-o) were 0.383 and 0.394 respectively. UPGMA tree, STRUCTURE analysis and principal coordinate analysis (PCoA) showed populations from same region clustered together. AMOVA revealed 35.10% of the genetic differentiation (F-st) occurred among populations. Gene flow (N-m) was limited among all populations. Genetic diversity of D. glomerata was high but limited under isolation-by-distance pattern, resulting in high genetic differentiation and low gene flow among populations. Adjacent regions also exhibited similar results because of the barriers of high mountains. The environmental factors, such as precipitation, elevation, latitude and longitude also had some impacts on genetic diversity and structure pattern of populations.	[Zhang, Chenglin; Sun, Ming; Zhang, Xinquan; Nie, Gang; Peng, Yan; Huang, Linkai; Ma, Xiao] Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Chengdu, Sichuan, Peoples R China; [Chen, Shiyong] Southwest Univ Nationalities, Coll Life Sci & Technol, Chengdu, Sichuan, Peoples R China	Sichuan Agricultural University; Southwest Minzu University	Ma, X (corresponding author), Sichuan Agr Univ, Anim Sci & Technol Coll, Dept Grassland Sci, Chengdu, Sichuan, Peoples R China.	maroar@126.com	Zhang, Cheng/GRS-8698-2022; sun, ming/GRE-6915-2022		National Basic S&T Resources Survey Project of China [2017FY100602]; Earmarked Fund for the Modern Agro-Industry Technology Research System [CARS-34]; National Key Basic Research Program of China (973 Program) [2014CB138705]	National Basic S&T Resources Survey Project of China; Earmarked Fund for the Modern Agro-Industry Technology Research System; National Key Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic S&T Resources Survey Project of China (#2017FY100602), the Earmarked Fund for the Modern Agro-Industry Technology Research System (#CARS-34) to XZ and the National Key Basic Research Program of China (973 Program) (#2014CB138705) to XM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberto F, 2010, MOL ECOL, V19, P2626, DOI 10.1111/j.1365-294X.2010.04631.x; Antao T, 2011, BIOINFORMATICS, V27, P1717, DOI 10.1093/bioinformatics/btr253; Arthur AD, 2008, BIOL CONSERV, V141, P1972, DOI 10.1016/j.biocon.2008.05.010; Bierne N, 2011, MOL ECOL, V20, P2044, DOI 10.1111/j.1365-294X.2011.05080.x; Bingham RA, 1998, NATURE, V391, P238, DOI 10.1038/34564; BORRILL M, 1962, GENETICA, V32, P94, DOI 10.1007/BF01816089; Brekke P, 2011, MOL ECOL, V20, P29, DOI 10.1111/j.1365-294X.2010.04923.x; Chen YY, 2010, PLANT SYST EVOL, V290, P127, DOI 10.1007/s00606-010-0355-5; Christensen S, 2011, GENET RESOUR CROP EV, V58, P657, DOI 10.1007/s10722-010-9607-z; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Duchesne P, 2002, MOL ECOL NOTES, V2, P380, DOI 10.1046/j.1471-8286.2002.00251.x; Feng XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13758; Fox Joseph L., 2005, Memorie della Societa Italiana di Scienze Naturali e del Museo Civico di Storia Naturale di Milano, V33, P49; Fu KX, 2016, HEREDITAS, V153, DOI 10.1186/s41065-016-0013-1; GOVINDARAJU DR, 1989, J EVOLUTION BIOL, V2, P173, DOI 10.1046/j.1420-9101.1989.2030173.x; HANCOCK JF, 1981, AM J BOT, V68, P1, DOI 10.2307/2442984; Hijmans RJ, 2004, HUMAN SCI RES, V19, P49; Hou Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024497; Hu YP, 2016, AQUAT BOT, V134, P54, DOI 10.1016/j.aquabot.2016.06.011; Hutchison DW, 1999, EVOLUTION, V53, P1898, DOI 10.1111/j.1558-5646.1999.tb04571.x; Jafari A, 2007, J AGR SCI-CAMBRIDGE, V145, P599, DOI 10.1017/S0021859607007332; Jamieson IG, 2011, CONSERV BIOL, V25, P115, DOI 10.1111/j.1523-1739.2010.01574.x; Kong P, 2009, QUATERNARY RES, V72, P229, DOI 10.1016/j.yqres.2009.06.002; Langridge P, 2005, BIOTECHNOL AGRIC FOR, V55, P3; Last L, 2014, ECOL INDIC, V38, P181, DOI 10.1016/j.ecolind.2013.11.004; Last L, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-102; Ligges U., 2003, J STAT SOFTW, V08, P11, DOI DOI 10.18637/JSS.V008.I11; Lindner R, 1997, GENET RESOUR CROP EV, V44, P499, DOI 10.1023/A:1008690831828; Lindner R, 2004, GENET RESOUR CROP EV, V51, P437, DOI 10.1023/B:GRES.0000023457.30193.63; [刘长娥 Liu Change], 2006, [中国草地学报, Chinese Journal of Grassland], V28, P18; LUMARET R, 1987, OECOLOGIA, V73, P436, DOI 10.1007/BF00385262; Ma X, 2008, BIOCHEM SYST ECOL, V36, P514, DOI 10.1016/j.bse.2008.03.003; Madesis P, 2014, GENET MOL RES, V13, P4226, DOI 10.4238/2014.June.9.8; McEwen JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068889; McVean GAT, 2002, GENETICS, V162, P987; Meng HH, 2015, J SYST EVOL, V53, P33, DOI 10.1111/jse.12088; Mian MAR, 2002, CROP SCI, V42, P944, DOI 10.2135/cropsci2002.0944; Mki PC, 2010, PLANT BREEDING, V127, P510; Mueller UG, 1999, TRENDS ECOL EVOL, V14, P389, DOI 10.1016/S0169-5347(99)01659-6; Niazkhani S. M., 2013, International Journal of Agronomy and Plant Production, V4, P3022; Null RCTR, 2013, COMPUTING, V14, P12; Oksanen J, 2016, J STAT SOFTW, V48, P21; Ortego J, 2015, PLANT BIOLOGY, V17, P676, DOI 10.1111/plb.12272; Palsboll PJ, 2013, MOL ECOL, V22, P22, DOI 10.1111/mec.12094; Parisod C, 2008, BOT HELV, V118, P1, DOI 10.1007/s00035-008-0825-3; Peng Yan, 2006, Yichuan, V28, P845; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; Richard CE, 2003, CONSERVING BIODIVERSITY IN ARID REGIONS: BEST PRACTICES IN DEVELOPING NATIONS, P249; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; Santiago M, 2016, AOB PLANTS, V8, P34; Schlick K., 2011, THESIS; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schluter D, 2010, PHILOS T R SOC B, V365, P2479, DOI 10.1098/rstb.2010.0036; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Shahidul I, 2013, METHODS MOL BIOL, V1069, P179, DOI 10.1007/978-1-62703-613-9_13; Soltis ED, 2000, PLANT MOL BIOL, V42, P45, DOI 10.1023/A:1006371803911; Stewart AV, 2014, CROP PASTURE SCI, V65, P780, DOI 10.1071/CP13407; Stewart AV, 2011, WILD CROP RELATIVES: GENOMIC AND BREEDING RESOURCES: MILLETS AND GRASSES, P73, DOI 10.1007/978-3-642-14255-0_5; Storz JF, 2010, SCIENCE, V329, P40, DOI 10.1126/science.1192481; Strasburg JL, 2012, PHILOS T R SOC B, V367, P364, DOI 10.1098/rstb.2011.0199; Sui XQ, 2009, AFR J BIOTECHNOL, V8, P3431; Sun M, 2017, CR BIOL, V340, P145, DOI 10.1016/j.crvi.2016.12.003; te Beest M, 2012, ANN BOT-LONDON, V109, P19, DOI 10.1093/aob/mcr277; Team R.C., 2012, COMPUTING, V1, P12; Tuna M, 2004, EUPHYTICA, V135, P39, DOI 10.1023/B:EUPH.0000009537.08697.4e; Turner LR, 2012, GRASS FORAGE SCI, V67, P507, DOI 10.1111/j.1365-2494.2012.00866.x; Vitalis Renaud, 2012, Methods Mol Biol, V888, P277, DOI 10.1007/978-1-61779-870-2_16; Wang IJ, 2014, MOL ECOL, V23, P5649, DOI 10.1111/mec.12938; Wright S., 2001, GENETICS, V28, P1054; Wu JB, 2010, BIOCHEM SYST ECOL, V38, P471, DOI 10.1016/j.bse.2010.04.008; Xie WG, 2010, CAN J PLANT SCI, V90, P13, DOI 10.4141/CJPS08192; Xu JH, 2016, THEOR APPL CLIMATOL, V123, P321, DOI 10.1007/s00704-014-1364-z; Young A, 1996, TRENDS ECOL EVOL, V11, P413, DOI 10.1016/0169-5347(96)10045-8; Zeng B, 2008, CAN J PLANT SCI, V88, P53, DOI 10.4141/CJPS07017; Zhang CL, 2017, MOLECULES, V22, P13; Zhang XQ, 2002, GENET RESOUR CROP EV, V49, P397	77	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195273	10.1371/journal.pone.0195273	http://dx.doi.org/10.1371/journal.pone.0195273			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641553	gold, Green Published, Green Submitted			2022-12-26	WOS:000429742900063
J	Alia-Klein, N; Preston-Campbell, RN; Moeller, SJ; Parvaz, MA; Bachi, K; Gan, G; Zilverstand, A; Konova, AB; Goldstein, RZ				Alia-Klein, Nelly; Preston-Campbell, Rebecca N.; Moeller, Scott J.; Parvaz, Muhammad A.; Bachi, Keren; Gan, Gabriela; Zilverstand, Anna; Konova, Anna B.; Goldstein, Rita Z.			Trait anger modulates neural activity in the fronto-parietal attention network	PLOS ONE			English	Article							INTERMITTENT EXPLOSIVE DISORDER; BRAIN ACTIVITY; FUNCTIONAL NEUROANATOMY; REACTIVE AGGRESSION; AMYGDALA RESPONSE; GENETIC RISK; EMOTION; MECHANISMS; FMRI; CONNECTIVITY	Anger is considered a unique high-arousal and approach-related negative emotion. The influence of individual differences in trait anger on the processing of visual stimuli is relevant to questions about emotional processing and remains to be explored. Using functional magnetic resonance imaging (fMRI), we explored the neural responses to standardized images, selected based on valence and arousal ratings in a group of men with high trait anger compared to those with normative to low anger scores (controls). Results show increased activation in the left-lateralized ventral fronto-parietal attention network to unpleasant images by individuals with high trait anger. There was also a group by arousal interaction in the left thalamus/pulvinar such that individuals with high trait anger had increased pulvinar activation to the high-arousal (versus low arousal) unpleasant images as compared to controls. Thus, individual differences in trait anger in men are associated with brain regions subserving executive attentional and sensory integration during the processing of unpleasant emotional stimuli, particularly to high arousal images.	[Alia-Klein, Nelly; Parvaz, Muhammad A.; Bachi, Keren; Zilverstand, Anna; Goldstein, Rita Z.] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Alia-Klein, Nelly; Parvaz, Muhammad A.; Bachi, Keren; Zilverstand, Anna; Goldstein, Rita Z.] Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA; [Preston-Campbell, Rebecca N.] Battelle Publ Hlth Res & Translat Sci, St Louis, MO USA; [Moeller, Scott J.] SUNY Stony Brook, Dept Psychiat, Sch Med, Stony Brook, NY 11794 USA; [Gan, Gabriela] Heidelberg Univ, Cent Inst Mental Hlth, Med Fac Manheim, Dept Psychiat & Psychotherapy, Heidelberg, Germany; [Konova, Anna B.] NYU, Ctr Neural Sci, New York, NY 10003 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; New York University	Alia-Klein, N (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Alia-Klein, N (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurosci, New York, NY 10029 USA.	nelly.alia-klein@mssm.edu	Konova, Anna/AAX-5209-2020; Zilverstand, Anna/AFR-0554-2022; Moeller, Scott J/AAV-1861-2021; Bachi, Keren/O-9024-2017; Parvaz, Muhammad/GPF-9163-2022; Moeller, Scott/L-5549-2016	Zilverstand, Anna/0000-0002-4889-9700; Bachi, Keren/0000-0001-9817-5957; Moeller, Scott/0000-0002-4449-0844; Alia-Klein, Nelly/0000-0003-1876-8133	National Institute of Health [R01MH090134]; National Institute on Drug Abuse [5T32DA007135-32, K01DA037452, F32DA033088, T32-DA007135-31]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007135, K01DA037452, F32DA033088, R01DA041528, K23DA045928] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute of Health (nih.gov; R01MH090134 to N.A.K.) and grants from the National Institute on Drug Abuse (drugabuse.gov; 5T32DA007135-32 to R.P-C., K01DA037452 to S.J.M., F32DA033088 to M.A.P.).; This work was supported by a grant from the National Institute of Health (nih.gov; R01MH090134 to N.A.K.) and grants from the National Institute on Drug Abuse (drugabuse. gov; 5T32DA007135-32 to R.P-C., K01DA037452 to S.J.M., F32DA033088 to M.A.P., and T32-DA007135-31 to K.B.).	Aldhafeeri FM, 2012, NEUROSCI LETT, V512, P94, DOI 10.1016/j.neulet.2012.01.064; Alia-Klein N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107260; Alia-Klein N, 2009, EMOTION, V9, P385, DOI 10.1037/a0015904; Anand A, 2005, BIOL PSYCHIAT, V57, P1079, DOI 10.1016/j.biopsych.2005.02.021; Anders S, 2004, HUM BRAIN MAPP, V23, P200, DOI 10.1002/hbm.20048; Augustine JR, 1996, BRAIN RES REV, V22, P229, DOI 10.1016/S0165-0173(96)00011-2; Britton JC, 2006, EMOTION, V6, P150, DOI 10.1037/1528-3542.6.1.150; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Carter CS, 2000, P NATL ACAD SCI USA, V97, P1944, DOI 10.1073/pnas.97.4.1944; Carver CS, 2009, PSYCHOL BULL, V135, P183, DOI 10.1037/a0013965; Coccaro EE, 2004, J CLIN PSYCHIAT, V65, P820; Coccaro EF, 2014, AGGRESSIVE BEHAV, V40, P526, DOI 10.1002/ab.21536; Coccaro EF, 2014, COMPR PSYCHIAT, V55, P260, DOI 10.1016/j.comppsych.2013.09.007; Cohen BM, 2003, PSYCHOPHARMACOLOGY, V167, P403, DOI 10.1007/s00213-003-1423-0; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Corbetta M, 2008, NEURON, V58, P306, DOI 10.1016/j.neuron.2008.04.017; DAVIDSON RJ, 1988, INT J NEUROSCI, V39, P71, DOI 10.3109/00207458808985694; Davidson RJ, 1999, CURR OPIN NEUROBIOL, V9, P228, DOI 10.1016/S0959-4388(99)80032-4; Davidson RJ, 1999, TRENDS COGN SCI, V3, P11, DOI 10.1016/S1364-6613(98)01265-0; Denny BT, 2014, SOC COGN AFFECT NEUR, V9, P1660, DOI 10.1093/scan/nst160; Denson TF, 2009, J COGNITIVE NEUROSCI, V21, P734, DOI 10.1162/jocn.2009.21051; Derntl B, 2010, PSYCHONEUROENDOCRINO, V35, P67, DOI 10.1016/j.psyneuen.2009.10.006; Eckhardt CI, 1997, PERS INDIV DIFFER, V23, P619, DOI 10.1016/S0191-8869(97)00074-3; Engels AS, 2007, PSYCHOPHYSIOLOGY, V44, P352, DOI 10.1111/j.1469-8986.2007.00518.x; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; First M.B., 2014, STRUCTURED CLIN INTE; First M. B., 1997, STRUCTURED CLIN INTE; Fischer J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2054; Forgays DG, 1997, J PERS ASSESS, V69, P497, DOI 10.1207/s15327752jpa6903_5; Frank DW, 2014, BRAIN RES, V1587, P69, DOI 10.1016/j.brainres.2014.08.061; Garavan H, 2001, NEUROREPORT, V12, P2779, DOI 10.1097/00001756-200108280-00036; Gerdes ABM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00175; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Grieve KL, 2000, TRENDS NEUROSCI, V23, P35, DOI 10.1016/S0166-2236(99)01482-4; Guyer AE, 2008, J COGNITIVE NEUROSCI, V20, P1565, DOI 10.1162/jocn.2008.20114; Hariri AR, 2000, NEUROREPORT, V11, P43, DOI 10.1097/00001756-200001170-00009; Harmon-Jones E, 1998, J PERS SOC PSYCHOL, V74, P1310, DOI 10.1037/0022-3514.74.5.1310; Harmon-Jones E, 2004, BIOL PSYCHOL, V67, P51, DOI 10.1016/j.biopsycho.2004.03.003; Hewig J, 2004, J PERS SOC PSYCHOL, V87, P926, DOI 10.1037/0022-3514.87.6.926; Kanai R., 2015, PHILOS T ROYAL SOC B, V370; Kessler RC, 2006, ARCH GEN PSYCHIAT, V63, P669, DOI 10.1001/archpsyc.63.6.669; Kilts CD, 2014, NEUROPSYCHOPHARMACOL, V39, P1135, DOI 10.1038/npp.2013.314; Laird AR, 2011, J COGNITIVE NEUROSCI, V23, P4022, DOI 10.1162/jocn_a_00077; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lang P. J., 2005, INT AFFECTIVE PICTUR; LANG PJ, 1993, PSYCHOPHYSIOLOGY, V30, P261, DOI 10.1111/j.1469-8986.1993.tb03352.x; Lang PJ, 1998, BIOL PSYCHIAT, V44, P1248, DOI 10.1016/S0006-3223(98)00275-3; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Lang PJ, 1998, J CLIN NEUROPHYSIOL, V15, P397, DOI 10.1097/00004691-199809000-00004; Liberzon I, 2003, NEUROPSYCHOPHARMACOL, V28, P726, DOI 10.1038/sj.npp.1300113; Look AE, 2015, PSYCHIAT RES, V225, P531, DOI 10.1016/j.psychres.2014.11.052; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Meyer-Lindenberg A, 2006, P NATL ACAD SCI USA, V103, P6269, DOI 10.1073/pnas.0511311103; Milham MP, 2003, COGNITIVE BRAIN RES, V17, P212, DOI 10.1016/S0926-6410(03)00108-3; Moeller SJ, 2014, J PSYCHIATR RES, V58, P55, DOI 10.1016/j.jpsychires.2014.07.016; Mohanty A, 2005, J ABNORM PSYCHOL, V114, P16, DOI 10.1037/0021-843X.114.1.16; Nielen MMA, 2009, BRAIN COGNITION, V71, P387, DOI 10.1016/j.bandc.2009.05.007; Ochsner KN, 2008, CURR DIR PSYCHOL SCI, V17, P153, DOI 10.1111/j.1467-8721.2008.00566.x; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Pessoa L, 2003, PROG BRAIN RES, V144, P171, DOI 10.1016/S0079-6123(03)14401-2; Pessoa L, 2010, NAT REV NEUROSCI, V11, P773, DOI 10.1038/nrn2920; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; ROBINSON DL, 1993, PROG BRAIN RES, V95, P371, DOI 10.1016/S0079-6123(08)60382-9; Robinson MD, 2010, J PERS, V78, P1, DOI 10.1111/j.1467-6494.2009.00606.x; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Rybak M, 2006, CLIN EEG NEUROSCI, V37, P16, DOI 10.1177/155005940603700105; Schienle A, 2002, NEUROREPORT, V13, P2023, DOI 10.1097/00001756-200211150-00006; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Seitz RJ, 2008, NEUROSCIENCE, V152, P713, DOI 10.1016/j.neuroscience.2007.10.066; Slotnick SD, 2003, COGNITIVE BRAIN RES, V17, P75, DOI 10.1016/S0926-6410(03)00082-X; Smith P, 2003, COGNITION EMOTION, V17, P681, DOI 10.1080/02699930302281; Spielberger C., 1983, STAI MANUAL; Spielberger C.D., 1988, STATE TRAIT ANGER EX; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Stewart JL, 2008, EMOTION, V8, P701, DOI 10.1037/a0013447; Stewart JL, 2010, INT J PSYCHOPHYSIOL, V76, P9, DOI 10.1016/j.ijpsycho.2010.01.008; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; Wacker J, 2003, EMOTION, V3, P167, DOI 10.1037/1528-3542.3.2.167; Wester K, 2001, J NEUROL, V248, P676, DOI 10.1007/s004150170113; Wilkowski BM, 2008, PERS SOC PSYCHOL REV, V12, P3, DOI 10.1177/1088868307309874; Wilkowski BM, 2010, J PERS, V78, P9, DOI 10.1111/j.1467-6494.2009.00607.x; Wright P, 2004, NEUROREPORT, V15, P2347, DOI 10.1097/00001756-200410250-00009	84	15	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0194444	10.1371/journal.pone.0194444	http://dx.doi.org/10.1371/journal.pone.0194444			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672547	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800010
J	Alzahrani, SM; Ebert, PR				Alzahrani, Saad M.; Ebert, Paul R.			Stress pre-conditioning with temperature, UV and gamma radiation induces tolerance against phosphine toxicity	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; RESISTANCE; LONGEVITY; IRRADIATION; PRETREATMENT; ACTIVATION; INCREASES; MUTANTS	Phosphine is the only general use fumigant for the protection of stored grain, though its long-term utility is threatened by the emergence of highly phosphine-resistant pests. Given this precarious situation, it is essential to identify factors, such as stress preconditioning, that interfere with the efficacy of phosphine fumigation. We used Caenorhabditis elegans as a model organism to test the effect of pre-exposure to heat and cold shock, UV and gamma irradiation on phosphine potency. Heat shock significantly increased tolerance to phosphine by 3-fold in wild-type nematodes, a process that was dependent on the master regulator of the heat shock response, HSF-1. Heat shock did not, however, increase the resistance of a strain carrying the phosphine resistance mutation, dld-1(wr4), and cold shock did not alter the response to phosphine of either strain. Pretreatment with the LD50 of UV (18 J cm(-2)) did not alter phosphine tolerance in wild-type nematodes, but the LD50 (33 J cm(-2)) of the phosphine resistant strain (dld-1(wr4)) doubled the level of resistance. In addition, exposure to a mild dose of gamma radiation (200 Gy) elevated the phosphine tolerance by similar to 2-fold in both strains.	[Alzahrani, Saad M.; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Alzahrani, Saad M.] KACST, NSRI, Riyadh, Saudi Arabia; [Ebert, Paul R.] Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia	University of Queensland; King Abdulaziz City for Science & Technology	Ebert, PR (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.; Ebert, PR (corresponding author), Plant Biosecur Cooperat Res Ctr, Bruce, ACT, Australia.	p.ebert@uq.edu.au		Ebert, Paul/0000-0002-4435-0737; Alzahrani, Saad/0000-0003-3696-2044	King Abdulaziz City for Science and Technology; Saudi Cultural Mission in Australia; King Abdulaziz City for Science and Technology, Saudi Arabia [AU5976671445]; Australian Plant Biosecurity Cooperative Research Centre grant [PBCRC3114]	King Abdulaziz City for Science and Technology; Saudi Cultural Mission in Australia; King Abdulaziz City for Science and Technology, Saudi Arabia; Australian Plant Biosecurity Cooperative Research Centre grant	We thank King Abdulaziz City for Science and Technology and the Saudi Cultural Mission in Australia for their support. We are grateful to Sushruth Sathyamurthy, Sinduja Sukumar and Tirosh Shapira for technical advice and assistance, as well as to Dr. David Schlipalius for supervision and guidance throughout this work. SA was the recipient of an AU5976671445 PhD scholarship from King Abdulaziz City for Science and Technology, Saudi Arabia. Financial support for the research was provided by the Australian Plant Biosecurity Cooperative Research Centre grant, PBCRC3114 awarded to PRE.	BALER R, 1993, MOL CELL BIOL, V13, P2486, DOI 10.1128/MCB.13.4.2486; Brunquell J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2837-5; Cheng Q, 2003, TOXICOL SCI, V73, P60, DOI 10.1093/toxsci/kfg049; Collins P, 2001, COMBATING RESISTANCE; Cypser JR, 2002, J GERONTOL A-BIOL, V57, pB109, DOI 10.1093/gerona/57.3.B109; Felix MA, 2010, CURR BIOL, V20, pR965, DOI 10.1016/j.cub.2010.09.050; Fields PG, 2002, ANNU REV ENTOMOL, V47, P331, DOI 10.1146/annurev.ento.47.091201.145217; Finney D.J., 1971, PROBIT ANAL; Follett P. A., 2004, International Atomic Energy Agency Technical Documents (IAEA-TECDOCs), P9; Follett PA, 2013, J STORED PROD RES, V52, P63, DOI 10.1016/j.jspr.2012.09.004; HARTMAN PS, 1984, PHOTOCHEM PHOTOBIOL, V39, P169, DOI 10.1111/j.1751-1097.1984.tb03424.x; Hsu CH, 2002, J PINEAL RES, V32, P53, DOI 10.1034/j.1600-079x.2002.10809.x; Ignatowicz S., 2004, International Atomic Energy Agency Technical Documents (IAEA-TECDOCs), P51; Kourtis N, 2012, NATURE, V490, P213, DOI 10.1038/nature11417; Le Bourg E, 2007, BIOGERONTOLOGY, V8, P431, DOI 10.1007/s10522-007-9086-6; Leung MCK, 2013, BMC PHARMACOL TOXICO, V14, DOI 10.1186/2050-6511-14-9; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Mathew MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033483; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Moskalev A, 2009, BIOGERONTOLOGY, V10, P3, DOI 10.1007/s10522-008-9147-5; Murakami S, 1996, GENETICS, V143, P1207; Nath NS, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/494168; Nishizawa J, 1999, CIRCULATION, V99, P934, DOI 10.1161/01.CIR.99.7.934; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Puckering T, 2017, F1000RESEARCH, V6; Saleki S, 2007, FORENSIC SCI INT, V166, P190, DOI 10.1016/j.forsciint.2006.05.033; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; SigmaPlot, 2006, SIGMAPLOT WIND VER 1; Stiernagel T., 2006, C ELEGANS RES COMMUN, V1; Valmas N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000130; Wang DY, 2010, ENVIRON TOXICOL PHAR, V29, P213, DOI 10.1016/j.etap.2010.01.002; Wang WX, 2004, TRENDS PLANT SCI, V9, P244, DOI 10.1016/j.tplants.2004.03.006; Yanase S, 1999, MUTAT RES-FUND MOL M, V426, P31, DOI 10.1016/S0027-5107(99)00079-2; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275; Zuryn S, 2008, TOXICOL SCI, V102, P179, DOI 10.1093/toxsci/kfm278	35	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195349	10.1371/journal.pone.0195349	http://dx.doi.org/10.1371/journal.pone.0195349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672544	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800025
J	Gent, TC; Detotto, C; Vyssotski, AL; Bettschart-Wolfensberger, R				Gent, Thomas C.; Detotto, Carlotta; Vyssotski, Alexei L.; Bettschart-Wolfensberger, Regula			Epileptiform activity during inert gas euthanasia of mice	PLOS ONE			English	Article							CARBON-DIOXIDE; RATS; XENON; ANESTHESIA; HELIUM; NITROGEN; SLEEP; ARGON; PAIN	Carbon dioxide (CO2) is one of the most commonly used euthanasia agents for mice, yet it is highly aversive and nociceptive. Inert gases are a possible alternative, however there are qualitative reports of seizures resulting from exposure. Here we evaluate epileptiform activity caused by inert gases (N-2, He, Ar and Xe) and CO2 in mice chronically instrumented for EEG/EMG undergoing single-gas euthanasia. We found that N-2, He and Ar caused epileptiform activity in all animals, CO2 in half of animals and no epileptiform activity produced by Xe. Atmospheric O-2 concentrations at epileptiform activity onset were significantly higher for CO2 than for all other gases and occurred soon after loss of motion, whereas N-2 and Ar epileptiform activity occurred at cessation of neocortical activity. Helium caused the longest epileptiform activity and these commenced significantly before isoelectric EEG. We did not detect any epileptiform activity during active behaviour. Taken together, these results demonstrate that whilst epileptiform activity from inert gases and particularly Ar and N-2 are more prevalent than for CO2, their occurrence at the onset of an isoelectric EEG is unlikely to impact on the welfare of the animal. Epileptiform activity from these gases should not preclude them from further investigation as euthanasia agents. The genesis of epileptiform activity from CO2 is unlikely to result from hypoxia as with the inert gases. Helium caused epileptiform activity before cessation of neocortical activity and for a longer duration and is therefore less suitable as an alternative to CO2.	[Gent, Thomas C.; Detotto, Carlotta; Bettschart-Wolfensberger, Regula] Univ Zurich, Vetsuisse Fac, Anaesthesiol Sect, Zurich, Switzerland; [Vyssotski, Alexei L.] ETH, Inst Neuroinformat, Zurich, Switzerland	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Gent, TC (corresponding author), Univ Zurich, Vetsuisse Fac, Anaesthesiol Sect, Zurich, Switzerland.	tgent@vetclinics.uzh.ch		Gent, Thomas/0000-0002-0478-5461	Swiss Federal Veterinary Office (Bundesamt fur Lebensmittelwirtschaft and Veterinarwiesen) [2.16.01]	Swiss Federal Veterinary Office (Bundesamt fur Lebensmittelwirtschaft and Veterinarwiesen)	Funding from this work was provided by a grant from the Swiss Federal Veterinary Office (Bundesamt fur Lebensmittelwirtschaft and Veterinarwiesen). Grant number: 2.16.01 "Tierschurtgerechte Euthanasie von Nagern mittels inerten Gasen" to Thomas C. Gent. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azzopardi D, 2013, ARCH DIS CHILD-FETAL, V98, pF437, DOI 10.1136/archdischild-2013-303786; Burkholder TH, 2010, J AM ASSOC LAB ANIM, V49, P448; Coburn M, 2008, CRIT CARE MED, V36, P588, DOI 10.1097/01.CCM.0B013E3181611F8A6; Conlee KM, 2005, LAB ANIM-UK, V39, P137, DOI 10.1258/0023677053739747; Danneman PJ, 1997, LAB ANIM SCI, V47, P376; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Fries M, 2012, CRIT CARE MED, V40, P1297, DOI 10.1097/CCM.0b013e31823c8ce7; Gent T, 2017, CLIN TRANSL IN PRESS, V1; Gent TC, 2016, ASS VET ANAESTHETIST; Hawkins P, 2016, ANIMALS, V6, DOI 10.3390/ani6090050; Hobbs C, 2008, STROKE, V39, P1307, DOI 10.1161/STROKEAHA.107.499822; Hwang E, 2010, J NEUROSCI METH, V188, P14, DOI 10.1016/j.jneumeth.2010.01.028; Koblin DD, 1998, ANESTH ANALG, V87, P419, DOI 10.1097/00000539-199808000-00035; Kroeger D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075257; Leary S, 2013, AVMA GUIDELINES EUTH; Misonou H, 2005, J NEUROSCI, V25, P11184, DOI 10.1523/JNEUROSCI.3370-05.2005; Pang DSJ, 2009, P NATL ACAD SCI USA, V106, P17546, DOI 10.1073/pnas.0907228106; Schob OM, 1996, AM J SURG, V172, P248, DOI 10.1016/S0002-9610(96)00101-8; Sekar K, 2013, P NATL ACAD SCI USA, V110, P5642, DOI 10.1073/pnas.1302229110; Sharp J, 2006, J AM ASSOC LAB ANIM, V45, P21; Thomas AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032290; Valentine H, 2012, J AM ASSOC LAB ANIM, V51, P50; Vyssotski AL, 2009, CURR BIOL, V19, P1159, DOI 10.1016/j.cub.2009.05.070	23	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195872	10.1371/journal.pone.0195872	http://dx.doi.org/10.1371/journal.pone.0195872			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672545	gold, Green Accepted, Green Published			2022-12-26	WOS:000430446800053
J	Kassardjian, A; Shintaku, PI; Moatamed, NA				Kassardjian, Ari; Shintaku, Peter I.; Moatamed, Neda A.			Expression of immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death-ligand 1 (PD-L1), in female breast carcinomas	PLOS ONE			English	Article							CANCER; IMMUNOTHERAPY; SUSCEPTIBILITY; IPILIMUMAB; BLOCKADE; VACCINES; GENE	Background Immune checkpoint regulators, cytotoxic T lymphocyte antigen 4 (CTLA-4) and the programmed cell death protein-1/programmed death-ligand 1 (PD-1/PD-L1) have emerged as promising new targets for cancer therapeutics. While tumor expression of PD-L1 has been shown to have objective responses to anti-PD-L1 immunotherapies, the clinical implications of CTLA-4 expression in tumor cells or immune cells in the tumor microenvironment is still controversial. We investigated the expression of CTLA-4 and PD-L1 in human breast tumors and provided a scoring system for the systematic evaluation of CTLA-4 staining. Methods Immunohistochemical staining for PD-L1 and CTLA-4 expression was performed on a tissue microarray of 102 cores, which included normal and neoplastic breast tissues. Neoplastic cores were divided into four groups: Ductal carcinoma in situ (DCIS), invasive ductal carcinoma (IDC), invasive lobular carcinoma (ILC) and invasive tubular carcinoma (ITC). PD-L1 and CTLA-4 expressions were scored based on a system which accounted for the percentage and intensity of positivity and results provided in conjunction with available clinical and demographic data. Results Overall, CTLA-4 was over-expressed in 49 of 93 (52.7%) breast tumors. Subcategorically, CTLA-4 was positive in 3 of 8 (37.5%) ductal carcinoma in situ, 40 of 73 (55%) of invasive ductal carcinomas, 4 of 10 (40%) of invasive lobular carcinomas and 2 of 2 (100%) of invasive tubular carcinomas. All 6 normal breast tissues were interpreted as negative for CTLA-4 staining. Only 4.1% of the invasive ductal carcinomas were positive for PD-L1 reactivity and the remaining carcinomas stained negative. Conclusions This study shows a significant overexpression of CTLA-4 in >50% of breast carcinomas with no such overexpression of CTLA-4 in benign breast tissues. PDL-1 staining is seen in only a small number of invasive ductal carcinomas (4.1%). These findings suggest the need for further investigation of anti-CTLA-4 and anti-PD-L1 immunotherapies and their efficacy in the treatment of breast carcinomas with overexpression of these immune modulators. In addition, the proposed scoring system will facilitate a more systematic correlation between tumor reactivity and clinical outcome which can be applied to all intracytoplasmic tumor markers.	[Kassardjian, Ari; Shintaku, Peter I.; Moatamed, Neda A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Moatamed, NA (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	nmoatamed@mednet.ucla.edu		Moatamed, Neda/0000-0002-9986-8058	Translational Research Fund, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA	Translational Research Fund, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA	This work was supported by the Translational Research Fund, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine at UCLA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abcam Inc, 2017, BREAST CANC TISS ARR; Bouwhuis MG, 2010, CANCER IMMUNOL IMMUN, V59, P303, DOI 10.1007/s00262-009-0751-2; BRUNET JF, 1987, NATURE, V328, P267, DOI 10.1038/328267a0; Contardi E, 2005, INT J CANCER, V117, P538, DOI 10.1002/ijc.21155; Dako Corporation, 2015, PD L1 IHC 28 8 PHARM; Domagala-Kulawik J, 2014, TRANSL LUNG CANCER R, V3, P15, DOI 10.3978/j.issn.2218-6751.2013.11.03; Dushyanthen S, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0431-3; Emens LA, 2012, EXPERT REV ANTICANC, V12, P1597, DOI [10.1586/era.12.147, 10.1586/ERA.12.147]; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Huang PY, 2016, ONCOTARGET, V7, P13060, DOI 10.18632/oncotarget.7421; Khan S, 2011, CLIN IMMUNOL, V138, P85, DOI 10.1016/j.clim.2010.09.011; Mansh Matthew, 2011, Yale Journal of Biology and Medicine, V84, P381; McArthur HL, 2016, CLIN ADV HEMATOL ONC, V14, P922; Monne M, 2004, AM J HEMATOL, V76, P14, DOI 10.1002/ajh.20045; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Philips GK, 2015, INT IMMUNOL, V27, P39, DOI 10.1093/intimm/dxu095; Postow MA, 2015, J CLIN ONCOL, V33, P1974, DOI 10.1200/JCO.2014.59.4358; Ralph C, 2010, CLIN CANCER RES, V16, P1662, DOI 10.1158/1078-0432.CCR-09-2870; Reddy OL, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0631-6; Salvi S, 2012, CANCER IMMUNOL IMMUN, V61, P1463, DOI 10.1007/s00262-012-1211-y; Santa Cruz-Biotechnology-Inc, 2017, CTLA 4 F 8 SC 376016; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Su TH, 2007, CARCINOGENESIS, V28, P1237, DOI 10.1093/carcin/bgm043; Thompson ED, 2017, MODERN PATHOL, V30, P1551, DOI 10.1038/modpathol.2017.79; TIBCO Software Inc, 2017, STAT DAT AN SOFTW SY; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van de Vijver M., 2012, WHO CLASSIFICATION T; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Welsh MM, 2009, CANCER RES, V69, P6158, DOI 10.1158/0008-5472.CAN-09-0415; Wolchok JD, 2014, NATURE, V515, P496, DOI 10.1038/515496a; Wolchok JD, 2010, LANCET ONCOL, V11, P155, DOI 10.1016/S1470-2045(09)70334-1; Yu HM, 2015, CANCER IMMUNOL IMMUN, V64, P853, DOI 10.1007/s00262-015-1696-2; Zhang XF, 2016, ONCOTARGET, V7, P26670, DOI 10.18632/oncotarget.8476; Zlobec I, 2006, MODERN PATHOL, V19, P1236, DOI 10.1038/modpathol.3800642	36	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195958	10.1371/journal.pone.0195958	http://dx.doi.org/10.1371/journal.pone.0195958			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672601	Green Submitted, Green Published, gold			2022-12-26	WOS:000430446800066
J	Lamsal, A; Welch, SM; White, JW; Thorpe, KR; Bello, NM				Lamsal, Abhishes; Welch, Stephen M.; White, Jeffrey W.; Thorpe, Kelly R.; Bello, Nora M.			Estimating parametric phenotypes that determine anthesis date in Zea mays: Challenges in combining ecophysiological models with genetics	PLOS ONE			English	Article							MAIZE PRODUCTION; CROP; PHENOLOGY; COEFFICIENTS; VARIABILITY	Ecophysiological crop models encode intra-species behaviors using parameters that are presumed to summarize genotypic properties of individual lines or cultivars. These geno-type- specific parameters (GSP's) can be interpreted as quantitative traits that can be mapped or otherwise analyzed, as are more conventional traits. The goal of this study was to investigate the estimation of parameters controlling maize anthesis date with the CERES-Maize model, based on 5,266 maize lines from 11 plantings at locations across the eastern United States. High performance computing was used to develop a database of 356 million simulated anthesis dates in response to four CERES-Maize model parameters. Although the resulting estimates showed high predictive value (R2 = 0.94), three issues presented serious challenges for use of GSP's as traits. First (expressivity), the model was unable to express the observed data for 168 to 3,339 lines (depending on the combination of site-years), many of which ended up sharing the same parameter value irrespective of genetics. Second, for 2,254 lines, the model reproduced the data, but multiple parameter sets were equally effective (equifinality). Third, parameter values were highly dependent (p<10(-6919)) on the sets of environments used to estimate them (instability), calling in to question the assumption that they represent fundamental genetic traits. The issues of expressivity, equifinality and instability must be addressed before the genetic mapping of GSP's becomes a robust means to help solve the genotype-to-phenotype problem in crops.	[Lamsal, Abhishes; Welch, Stephen M.] Kansas State Univ, Dept Agron, Throckmorton Plant Sci Ctr 2104, Manhattan, KS 66506 USA; [White, Jeffrey W.; Thorpe, Kelly R.] USDA ARS, Arid Land Agr Res Ctr, Maricopa, AZ USA; [Bello, Nora M.] Kansas State Univ, Dept Stat, Manhattan, KS 66506 USA	Kansas State University; United States Department of Agriculture (USDA); Kansas State University	Lamsal, A (corresponding author), Kansas State Univ, Dept Agron, Throckmorton Plant Sci Ctr 2104, Manhattan, KS 66506 USA.	abhilam@ksu.edu	Thorp, Kelly/C-2013-2009; White, Jeffrey/AAN-4296-2021	Thorp, Kelly/0000-0001-9168-875X; 	Higuchi-KU Endowment Research Achievement Award through the University of Kansas; University of Kansas Endowment Association; USDA Hatch project KS546 at Kansas State University (NIFA) [1007284]; USDA Agricultural Research Service [5347-13660-007-00-D, 5347-21410-004-00D]	Higuchi-KU Endowment Research Achievement Award through the University of Kansas; University of Kansas Endowment Association; USDA Hatch project KS546 at Kansas State University (NIFA); USDA Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Support derived from a Higuchi-KU Endowment Research Achievement Award through the University of Kansas and the University of Kansas Endowment Association. This research was also supported, in part, by USDA Hatch project KS546 at Kansas State University (NIFA Accession #1007284) and two USDA Agricultural Research Service projects: 5347-13660-007-00-D and 5347-21410-004-00D. Support for this effort was also supplied by the Department of Agronomy at Kansas State University. This paper is contribution number 17-134-J of the Kansas Agricultural Experiment Station at Kansas State University, Manhattan, KS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abatzoglou JT, 2013, INT J CLIMATOL, V33, P121, DOI 10.1002/joc.3413; AKAIKE H, 1973, BIOMETRIKA, V60, P255, DOI 10.2307/2334537; Batchelor WD, 2002, EUR J AGRON, V18, P141, DOI 10.1016/S1161-0301(02)00101-6; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burhenne S., 2011, PROC INT C BUILD SIM, P1816; Busetto AG, 2014, 2014 EUROPEAN CONTROL CONFERENCE (ECC), P540, DOI 10.1109/ECC.2014.6862425; Cooper M, 2016, CROP SCI; Das S, 2011, IEEE T EVOLUT COMPUT, V15, P4, DOI 10.1109/TEVC.2010.2059031; Dettori M, 2011, FIELD CROP RES, V120, P179, DOI 10.1016/j.fcr.2010.09.008; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Gill P.E., 1981, PRACTICAL OPTIMIZATI; GRIMM SS, 1993, CROP SCI, V33, P137, DOI 10.2135/cropsci1993.0011183X003300010025x; Gungula DT, 2003, AGRON J, V95, P892, DOI 10.2134/agronj2003.0892; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; Harrison SR, 1984, APPL STAT ANAL; He JQ, 2010, AGR SYST, V103, P256, DOI 10.1016/j.agsy.2010.01.006; Hoogenboom G., 2015, DECIS SUPPORT SYST; Hung HY, 2012, HEREDITY, V108, P490, DOI 10.1038/hdy.2011.103; Hung HY, 2012, P NATL ACAD SCI USA, V109, pE1913, DOI 10.1073/pnas.1203189109; Hunt LA, 2001, AGR SYST, V70, P477, DOI 10.1016/S0308-521X(01)00056-7; Irmak A, 2000, AGRON J, V92, P1140, DOI 10.2134/agronj2000.9261140x; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; Kiniry JR, 1991, PREDICTING CROP PHEN, V11, P5; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Koduru P, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P70; Kumudini S, 2014, AGRON J, V106, P2087, DOI 10.2134/agronj14.0200; Lamsal A, 2017, AGR SYST, V157, P170, DOI 10.1016/j.agsy.2017.07.016; Lee M, 2002, PLANT MOL BIOL, V48, P453, DOI 10.1023/A:1014893521186; Letham B, 2016, CHAOS, V26, DOI 10.1063/1.4953795; Li YQ, 2005, LECT NOTES COMPUT SC, V3469, P300; Lopez-Cedron FX, 2005, EUR J AGRON, V23, P89, DOI 10.1016/j.eja.2005.01.001; Luo YQ, 2009, ECOL APPL, V19, P571, DOI 10.1890/08-0561.1; Ma L, 2006, AGR SYST, V87, P274, DOI 10.1016/j.agsy.2005.02.001; Major DJ, 1991, PREDICTING CROP PHEN, P15; Mavromatis T, 2001, CROP SCI, V41, P40, DOI 10.2135/cropsci2001.41140x; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Meuwissen THE, 2001, GENETICS, V157, P1819; Mourice SK, 2014, MAIZE CULTIVAR SPECI; NRC, 2008, ACH NAT PLANT GEN IN; Press WH., 1992, NUMERICAL RECIPES FO; Saseendran S.A., 2005, AGRON J, V97, P58, DOI DOI 10.2134/AGR0NJ2005.0058; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stone T., 2011, SUSTAINABILITY NEEDS; Thorp KR, 2012, REMOTE SENS ENVIRON, V124, P224, DOI 10.1016/j.rse.2012.05.013; Vanlier J, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-20; Vucetic V, 2011, J AGR SCI, V149, P145, DOI 10.1017/S0021859610000808; Welch SM, 2005, AUST J AGR RES, V56, P919, DOI 10.1071/AR05155; Welch SM, 2002, T ASAE, V45, P1163, DOI 10.13031/2013.9925; Welch SM, 2000, 3 INT S SYST APPR AG; White JW, 1996, AGRON J, V88, P416, DOI 10.2134/agronj1996.00021962008800030009x; Xiong W, 2008, ECOL MODEL, V213, P365, DOI 10.1016/j.ecolmodel.2008.01.005; Yin XY, 2003, AGRON J, V95, P90, DOI 10.2134/agronj2003.0090; Zhang S, 2013, EUR J AGRON, V45, P165, DOI 10.1016/j.eja.2012.10.005	54	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195841	10.1371/journal.pone.0195841	http://dx.doi.org/10.1371/journal.pone.0195841			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672629	Green Submitted, gold, Green Published			2022-12-26	WOS:000430446800050
J	Shimizu, S; Miyazaki, A; Sonoda, T; Koike, K; Ogi, K; Kobayashi, J; Kaneko, T; Igarashi, T; Ueda, M; Dehari, H; Miyakawa, A; Hasegawa, T; Hiratsuka, H				Shimizu, Shota; Miyazaki, Akihiro; Sonoda, Tomoko; Koike, Kazushige; Ogi, Kazuhiro; Kobayashi, Jun-ichi; Kaneko, Takeshi; Igarashi, Tomohiro; Ueda, Megumi; Dehari, Hironari; Miyakawa, Akira; Hasegawa, Tadashi; Hiratsuka, Hiroyoshi			Tumor budding is an independent prognostic marker in early stage oral squamous cell carcinoma: With special reference to the mode of invasion and worst pattern of invasion	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; COLORECTAL-CANCER; TONGUE CANCER; RISK MODEL; CAVITY; CLASSIFICATION; MALIGNANCY; DEPTH	Pathologically proven regional lymph node metastasis affects the prognosis in early stage oral cancer. Therefore we investigated invasive tumor patterns predicting nodal involvement and survival in patients with clinically node-negative T1 and T2 oral squamous cell carcinoma (cT1,2N0M0 OSCC). Ninety-one cases of cT1,2N0M0 OSCC treated with transoral resection of the primary tumor were assessed based on 3 types of invasive tumor patterns on histopathologic and pancytokeratin-stained immunohistological sections: the mode of invasion, worst pattern of invasion (WPOI), and tumor budding. The correlations among invasive tumor patterns, regional metastasis, and disease-free survival were analyzed. Of the 91 cases, 22 (24%) had pathologically proven regional metastasis. The mode of invasion (p < 0.01) and tumor budding (p < 0.01) were associated with regional metastasis as well as lymphovascular invasion (p = 0.04) in univariate analysis. In logistic regression analysis, however, tumor budding was the only independent predictor of regional metastasis (hazard ratio (HR) = 3.05, 95% confidence interval (CI) = 0.29-5.30, p < 0.01). All three invasive patterns, the mode of invasion, WPOI, and tumor budding, were found to be significant predictors of 5-year disease-free survival (p < 0.01, p = 0.03, and p < 0.01, respectively) as well as lymphovascular invasion (p = 0.02) and perineural invasion (p = 0.02). A final model for Cox multivariate analysis identified the prognostic advantage of the intensity of tumor budding (HR = 2.19, 95% CI = 1.51-3.18, p < 0.01) compared with the mode of invasion and WPOI in disease-free survival. Our results indicate that the intensity of tumor budding may be a novel diagnostic biomarker, as well as a therapeutic tool, for regional metastasis in patients with cT1,2N0M0 OSCC. If the pancytokeratin-based immunohistochemical features of more than five buds, and a grade 4C or 4D mode of invasion are identified, careful wait-and-see follow-up in a short period with the use of imaging modalities is desirable. If there are more than ten buds, a grade 4D mode of invasion, or WPOI-5 in the same section, wide resection of the primary tumor with elective neck dissection should be recommended.	[Shimizu, Shota; Miyazaki, Akihiro; Koike, Kazushige; Ogi, Kazuhiro; Kobayashi, Jun-ichi; Kaneko, Takeshi; Igarashi, Tomohiro; Ueda, Megumi; Dehari, Hironari; Miyakawa, Akira; Hiratsuka, Hiroyoshi] Sapporo Med Univ, Sch Med, Dept Oral Surg, Sapporo, Hokkaido, Japan; [Sonoda, Tomoko] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan; [Hasegawa, Tadashi] Sapporo Med Univ, Sch Med, Dept Surg Pathol, Sapporo, Hokkaido, Japan	Sapporo Medical University; Sapporo Medical University; Sapporo Medical University	Hiratsuka, H (corresponding author), Sapporo Med Univ, Sch Med, Dept Oral Surg, Sapporo, Hokkaido, Japan.	hiratuka@sapmed.ac.jp			JSPS KAKENHI [16K15872, 16K11729]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Financial support for this study was provided by JSPS KAKENHI (grant numbers 16K15872 and 16K11729). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almangush A, 2017, BR J CANC; Almangush A, 2014, HEAD NECK-J SCI SPEC, V36, P811, DOI 10.1002/hed.23380; Attramadal CG, 2015, ANTICANCER RES, V35, P6111; Brandwein-Gensler A, 2005, AM J SURG PATHOL, V29, P167; Brierley JD, 2017, TNM CLASSIFICATION M, V8; BRYNE M, 1992, J PATHOL, V166, P375, DOI 10.1002/path.1711660409; D'Cruz AK, 2015, NEW ENGL J MED, V373, P521, DOI 10.1056/NEJMoa1506007; Edge SB, 2009, AM JOINT COMMITTEE C; Han GM, 2014, HISTOPATHOLOGY, V64, P389, DOI 10.1111/his.12254; Hiratsuka H, 1997, CANCER, V80, P351; HIRATSUKA H, 1984, CANCER, V53, P2456, DOI 10.1002/1097-0142(19840601)53:11<2456::AID-CNCR2820531116>3.0.CO;2-6; Hori Y, 2017, HEAD NECK PATHOL, V11, P477, DOI 10.1007/s12105-017-0814-1; Imai T, 2017, JPN J CLIN ONCOL, V47, P130, DOI 10.1093/jjco/hyw172; Izumo T, 2012, JPN J CLIN ONCOL, V42, P1099, DOI 10.1093/jjco/hys141; JAKOBSSON PA, 1973, ACTA RADIOL THER PHY, V12, P1; KIKUCHI K, 1979, IMMUNOBIOLOGY IMMUNO, P263; Koelzer VH, 2015, VIRCHOWS ARCH, V466, P485, DOI 10.1007/s00428-015-1740-9; Li YF, 2013, HEAD NECK PATHOL, V7, P211, DOI 10.1007/s12105-012-0412-1; Lim SC, 2004, CLIN CANCER RES, V10, P166, DOI 10.1158/1078-0432.CCR-0533-3; Lugli A, 2017, MODERN PATHOL, V30, P1299, DOI 10.1038/modpathol.2017.46; Luksic I, 2017, HEAD NECK-J SCI SPEC, V39, P649; Mayland MK, 2005, LARYNGOSCOPE, V115, P629, DOI 10.1097/01.mlg.0000161338.54515.b1; Mitrovic B, 2012, MODERN PATHOL, V25, P1315, DOI 10.1038/modpathol.2012.94; Nakagawa Y, 2013, ANTICANCER RES, V33, P5023; Park JH, 2017, BRIT J CANCER, V116, P1444, DOI 10.1038/bjc.2017.108; Pedersen NJ, 2017, ONCOTARGET, V8, P18227, DOI 10.18632/oncotarget.15314; Ridge JA, AJCC CANC STAGING MA, P8; Rivera C, 2017, ORAL ONCOL, V72, P38, DOI 10.1016/j.oraloncology.2017.07.003; Leao PLR, 2017, J ORAL PATHOL MED, V46, P949, DOI 10.1111/jop.12578; SHERWIN RP, 1961, AM J SURG, V102, P823, DOI 10.1016/0002-9610(61)90592-X; Shield KD, 2017, CA-CANCER J CLIN, V67, P51, DOI 10.3322/caac.21384; Sobin L, 2009, TNM CLASSIFICATION M; Xie N, 2015, J ORAL PATHOL MED, V44, P266, DOI 10.1111/jop.12242; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M	34	49	53	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195451	10.1371/journal.pone.0195451	http://dx.doi.org/10.1371/journal.pone.0195451			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672550	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800028
J	van der Kleij, LA; de Bresser, J; Hendrikse, J; Siero, JCW; Petersen, ET; de Vis, JB				van der Kleij, Lisa A.; de Bresser, Jeroen; Hendrikse, Jeroen; Siero, Jeroen C. W.; Petersen, Esben T.; de Vis, Jill B.			Fast CSF MRI for brain segmentation; Cross-validation by comparison with 3D T-1-based brain segmentation methods	PLOS ONE			English	Article							INTRACRANIAL VOLUME; CLINICAL-USE; ATROPHY; ACCURATE; DISEASE; ROBUST	Objective In previous work we have developed a fast sequence that focusses on cerebrospinal fluid (CSF) based on the long T-2 of CSF. By processing the data obtained with this CSF MRI sequence, brain parenchymal volume (BPV) and intracranial volume (ICV) can be automatically obtained. The aim of this study was to assess the precision of the BPV and ICV measurements of the CSF MRI sequence and to validate the CSF MRI sequence by comparison with 3D T-1-based brain segmentation methods. Materials and methods Ten healthy volunteers (2 females; median age 28 years) were scanned (3T MRI) twice with repositioning in between. The scan protocol consisted of a low resolution (LR) CSF sequence (0:57min), a high resolution (HR) CSF sequence (3:21min) and a 3D T-1-weighted sequence (6:47min). Data of the HR 3D-T-1-weighted images were downsampled to obtain LR T-1-weighted images (reconstructed imaging time:1:59 min). Data of the CSF MRI sequences was automatically segmented using in-house software. The 3D-T-1-weighted images were segmented using FSL (5.0), SPM12 and FreeSurfer (5.3.0). Results The mean absolute differences for BPV and ICV between the first and second scan for CSF LR (BPV/ICV: 12 +/- 9/7 +/- 4cc) and CSF HR (5 +/- 5/4 +/- 2cc) were comparable to FSL HR (9 +/- 11/19 +/- 23cc), FSL LR (7 +/- 4,6 +/- 5cc),FreeSurfer HR (5 +/- 3/14 +/- 8cc), FreeSurfer LR (9 +/- 8,12 +/- 10cc), and SPM HR (5 +/- 3/4 +/- 7cc), and SPM LR (5 +/- 4,5 +/- 3cc). The correlation between the measured volumes of the CSF sequences and that measured by FSL, FreeSurfer and SPM HR and LR was very good (all Pearson's correlation coefficients >0.83, R-2 .67-.97). The results from the downsampled data and the high-resolution data were similar. Conclusion Both CSF MRI sequences have a precision comparable to, and a very good correlation with established 3D T-1-based automated segmentations methods for the segmentation of BPV and ICV. However, the short imaging time of the fast CSF MRI sequence is superior to the 3D T-1 sequence on which segmentation with established methods is performed.	[van der Kleij, Lisa A.; de Bresser, Jeroen; Hendrikse, Jeroen; Siero, Jeroen C. W.] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Siero, Jeroen C. W.] Spinoza Ctr Neuroimaging, Amsterdam, Netherlands; [Petersen, Esben T.] Copenhagen Univ Hosp Hvidovre, Danish Res Ctr Magnet Resonance, Ctr Funct & Diagnost Imaging & Res, Hvidovre, Denmark; [Petersen, Esben T.] Tech Univ Denmark, Ctr Magnet Resonance, DTU Elektro, Lyngby, Denmark; [de Vis, Jill B.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Utrecht University; Utrecht University Medical Center; Royal Netherlands Academy of Arts & Sciences; Spinoza Centre for Neuroimaging (KNAW); University of Copenhagen; Technical University of Denmark; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	van der Kleij, LA (corresponding author), Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands.	L.vanderKleij-4@umcutrecht.nl	Siero, Jeroen Cornelis Willem/I-4841-2019; Petersen, Esben Thade/Q-8266-2019; de Bresser, Jeroen/AAL-4056-2021	Siero, Jeroen Cornelis Willem/0000-0001-5079-2868; Petersen, Esben Thade/0000-0001-7529-3432; de Bresser, Jeroen/0000-0003-0759-8407	Netherlands Organization for Scientific Research (NWO) [91712322]; European Research Council [637024]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Netherlands Organization for Scientific Research (NWO) under grant no91712322 (JH), and the European Research Council under grant agreements no637024 (JH).	Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2009, MAGN RESON IMAGING, V27, P1163, DOI 10.1016/j.mri.2009.01.006; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; de Boer R, 2010, NEUROIMAGE, V51, P1047, DOI 10.1016/j.neuroimage.2010.03.012; de Bresser J, 2011, NEUROIMAGE, V54, P760, DOI 10.1016/j.neuroimage.2010.09.060; De Vis JB, 2016, EUR RADIOL, V26, P1254, DOI 10.1007/s00330-015-3932-8; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Giorgio A, 2013, J MAGN RESON IMAGING, V37, P1, DOI 10.1002/jmri.23671; Heinen R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165719; Kitagaki H, 1998, RADIOLOGY, V208, P431, DOI 10.1148/radiology.208.2.9680572; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Mendrik AM, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/813696; Pasquier F, 1996, EUR NEUROL, V36, P268, DOI 10.1159/000117270; Qin Q, 2011, MAGN RESON MED, V65, P385, DOI 10.1002/mrm.22705; Sargolzaei S, 2015, NEUROINFORMATICS, V13, P427, DOI 10.1007/s12021-015-9266-5; SCHELTENS P, 1992, J NEUROL NEUROSUR PS, V55, P967, DOI 10.1136/jnnp.55.10.967; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Zaharchuk G, 2006, ACAD RADIOL, V13, P1016, DOI 10.1016/j.acra.2006.04.016; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	22	2	2	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196119	10.1371/journal.pone.0196119	http://dx.doi.org/10.1371/journal.pone.0196119			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672584	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800090
J	Karakavuk, M; Aldemir, D; Mercier, A; Sahar, EA; Can, H; Murat, JB; Donduren, O; Can, S; Ozdemir, HG; Doskaya, AD; Pektas, B; Darde, ML; Guruz, AY; Doskaya, M				Karakavuk, Muhammet; Aldemir, Duygu; Mercier, Aurelien; Sahar, Esra Atalay; Can, Huseyin; Murat, Jean-Benjamin; Donduren, Omer; Can, Sengul; Ozdemir, Huseyin Gokhan; Doskaya, Aysu Degirmenci; Pektas, Bayram; Darde, Marie-Laure; Guruz, Adnan Yuksel; Doskaya, Mert			Prevalence of toxoplasmosis and genetic characterization of Toxoplasma gondii strains isolated in wild birds of prey and their relation with previously isolated strains from Turkey	PLOS ONE			English	Article							FATAL TOXOPLASMOSIS; MOLECULAR CHARACTERIZATION; CONGENITAL TOXOPLASMOSIS; CLINICAL FINDINGS; DIVERSITY; GENOTYPES; BRAZIL; CATS; PCR; SEROPREVALENCE	Toxoplasma gondii is a protozoon parasite that causes congenital toxoplasmosis, as well as other serious clinical presentations, in immune compromised humans. Analyses of the prevalence and genotyping of strains from the definitive host and intermediate hosts will help to understanding the circulation of the different strains and elucidating the role of the genotype (s) in human toxoplasmosis. Turkey has a specific geographic location bridging Africa, Europe, and Asia. We hypothesized that T. gondii strains may have been transferred to Turkey from these continents via migratory birds or vice versa. The present study aimed to assess the prevalence of toxoplasmosis in wild birds of prey of Izmir and Manisa provinces as well as genetically characterize T. gondii strains from these wild birds to show the relation between bird strains and neighboring stray cats as well as human strains previously isolated in Turkey. Tissues obtained from 48 wild birds were investigated for the presence of T. gondii DNA and then bioassayed in mouse. Isolated strains were genotyped using 15 microsatellite markers. The prevalence of T. gondii DNA was found to be 89.6% (n: 43/48) in wild birds. Out of 43 positive samples, a total of 14 strains were genotyped by 15 microsatellite markers. Among them, eight were type II, three were type III and three were mixture of genotypes (two type II/II and one was II/III). These are the first data that showed the presence of T. gondii and types II and III genotypes in wild birds of Turkey. Moreover, Africa 1 was not detected. In addition, cluster analysis showed that T. gondiistrains within type II and III lineage have close relation with strains previously isolated from stray cats in Izmir. Further studies are required to isolate more strains from human cases, other intermediate hosts, and water sources to reveal this relation.	[Karakavuk, Muhammet; Sahar, Esra Atalay; Doskaya, Aysu Degirmenci; Guruz, Adnan Yuksel; Doskaya, Mert] Ege Univ, Dept Parasitol, Fac Med, Izmir, Turkey; [Aldemir, Duygu] Uludag Univ, Dept Internal Med, Fac Vet Med, Inst Hlth Sci, Gorukle Campus, Nilufer Bursa, Turkey; [Aldemir, Duygu] Municipal Izmir, Izmir Wildlife Pk, Izmir, Turkey; [Mercier, Aurelien; Murat, Jean-Benjamin; Darde, Marie-Laure] Univ Limoges, Ctr Hosp Univ Dupuytren, Toxoplasmose Toxoplasma Biol Resource Ctr BRC, Fac Med,CNR, Limoges, France; [Mercier, Aurelien; Murat, Jean-Benjamin; Darde, Marie-Laure] Univ Limoges, Lab Parasitol Mycol, Neuroepidemiol Trop, Fac Med,INSERM,UMR 1094, Limoges, France; [Can, Huseyin] Ege Univ, Mol Biol Sect, Dept Biol, Fac Sci, Izmir, Turkey; [Donduren, Omer; Ozdemir, Huseyin Gokhan] Protect & Dev Union Izmir Bird Paradise, Izmir, Turkey; [Can, Sengul] Manisa Celal Bayar Univ, Comp Res & Applicat Ctr, Muradiye, Manisa, Turkey; [Pektas, Bayram] Ataturk Training & Res Hosp, Dept Microbiol, Izmir, Turkey	Ege University; Uludag University; Izmir Metropolitan Municipality; CHU Limoges; Universite de Limoges; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Limoges; Ege University; Celal Bayar University; Izmir Ataturk Training & Research Hospital	Doskaya, M (corresponding author), Ege Univ, Dept Parasitol, Fac Med, Izmir, Turkey.	mert.doskaya@ege.edu.tr	Karakavuk, Muhammet/AAV-7794-2021; Can, Hüseyin/J-2987-2019; Can, Hüseyin/AAG-3152-2020; Degirmenci, Aysu/DET-8805-2022; karakavuk, muhammet/ABC-8038-2020; Mercier, Aurelien/Q-4683-2016; Doskaya, Mert/W-4682-2017	Can, Hüseyin/0000-0001-9633-9786; karakavuk, muhammet/0000-0002-2468-5564; Mercier, Aurelien/0000-0003-4332-5879; Doskaya, Mert/0000-0001-6868-008X	Scientific Research Projects Branch Directorate of Ege University, Turkey [2014-TIP-073]	Scientific Research Projects Branch Directorate of Ege University, Turkey(Ege University)	This study was supported by the grant given by the Scientific Research Projects Branch Directorate of Ege University, Turkey (Grant No: 2014-TIP-073) to A.Y.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2002, J INFECT DIS, V186, P684, DOI 10.1086/342663; Ajzenberg D, 2010, J CLIN MICROBIOL, V48, P4641, DOI 10.1128/JCM.01152-10; Ajzenberg D, 2009, J INFECT DIS, V199, P1155, DOI 10.1086/597477; Al-Kappany YM, 2010, J PARASITOL, V96, P1112, DOI 10.1645/GE-2608.1; Aubert D, 2010, VET PARASITOL, V171, P346, DOI 10.1016/j.vetpar.2010.03.033; Bontell IL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r53; Cabezon O, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029549; Can H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104930; Cassaing S, 2006, J CLIN MICROBIOL, V44, P720, DOI 10.1128/JCM.44.3.720-724.2006; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chaichan P, 2017, INFECT GENET EVOL, V53, P227, DOI 10.1016/j.meegid.2017.06.002; Darde ML, 2008, PARASITE, V15, P366, DOI 10.1051/parasite/2008153366; de Barros LD, 2014, REV BRAS PARASITOL V, V23, P443, DOI [10.1590/S1984-29612014073, 10.1590/s1984-29612014073]; Delhaes L, 2010, PRENATAL DIAG, V30, P902, DOI 10.1002/pd.2563; Doskaya M, 2013, PARASITOL INT, V62, P471, DOI 10.1016/j.parint.2013.06.008; Doskaya Mert, 2013, Turkiye Parazitoloji Dergisi, V37, P44, DOI 10.5152/tpd.2013.11; Dubey JP, 2008, J PARASITOL, V94, P68, DOI 10.1645/GE-1362.1; Dubey JP, 2013, VET PARASITOL, V195, P42, DOI 10.1016/j.vetpar.2012.12.051; Dubey JP, 2010, J PARASITOL, V96, P937, DOI 10.1645/GE-2501.1; Dubey JP, 2010, VET PARASITOL, V172, P195, DOI 10.1016/j.vetpar.2010.05.013; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Ferreira FC, 2012, AVIAN DIS, V56, P774, DOI 10.1637/10063-011912-Case.1; Galal L, 2018, TRENDS PARASITOL, V34, P140, DOI 10.1016/j.pt.2017.10.010; Gennari SM, 2014, VET PARASITOL, V200, P193, DOI 10.1016/j.vetpar.2013.10.003; Gennari SM, 2016, VET PARASITOL, V226, P50, DOI 10.1016/j.vetpar.2016.06.016; Gennari SM, 2016, J ZOO WILDLIFE MED, V47, P364, DOI 10.1638/2015-0103.1; Howe L, 2014, AVIAN DIS, V58, P171, DOI 10.1637/10625-080413-Case.1; Huang SY, 2012, J PARASITOL, V98, P681, DOI 10.1645/GE-3038.1; Inci A, 2002, FIRAT U SAGHK BILIML, V16, P177; Jokelainen P, 2014, J WILDLIFE DIS, V50, P117, DOI 10.7589/2013-03-057; Karatepe Mustafa, 2011, Turkiye Parazitoloji Dergisi, V35, P23, DOI 10.5152/tpd.2011.06; Khademvatan S, 2013, BRIT POULTRY SCI, V54, P76, DOI 10.1080/00071668.2013.763899; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Lindsay DS, 2003, J EUKARYOT MICROBIOL, V50, P687, DOI 10.1111/j.1550-7408.2003.tb00688.x; LITERAK I, 1992, AVIAN PATHOL, V21, P659, DOI 10.1080/03079459208418887; Lorenzi H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10147; Mercier A, 2011, INFECT GENET EVOL, V11, P1378, DOI 10.1016/j.meegid.2011.05.003; Mercier A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000876; Muz MN, 2015, KAFKAS UNIV VET FAK, V21, P173, DOI 10.9775/kvfd.2014.11983; Pena HFJ, 2008, INT J PARASITOL, V38, P561, DOI 10.1016/j.ijpara.2007.09.004; Rajendran C, 2012, INFECT GENET EVOL, V12, P359, DOI 10.1016/j.meegid.2011.12.010; Rigoulet J, 2014, PARASITE, V21, DOI 10.1051/parasite/2014062; Salant H, 2009, VET PARASITOL, V159, P24, DOI 10.1016/j.vetpar.2008.10.011; Shwab EK, 2014, PARASITOLOGY, V141, P453, DOI 10.1017/S0031182013001844; Straub MH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143018; Su CL, 2012, P NATL ACAD SCI USA, V109, P5844, DOI 10.1073/pnas.1203190109; Szabo KA, 2004, J PARASITOL, V90, P907, DOI 10.1645/GE-270R; Tidy A, 2017, VET PARASITOL, V235, P47, DOI 10.1016/j.vetpar.2017.01.004; Turcekova L, 2014, ANN AGR ENV MED, V21, P235, DOI 10.5604/1232-1966.1108582; Vilares A, 2014, VET PARASITOL, V205, P506, DOI 10.1016/j.vetpar.2014.08.006; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; Weiss L.M., 2007, MODEL APICOMPLEXAN P; Work TM, 2016, J WILDLIFE DIS, V52, P253, DOI 10.7589/2015-09-235; Yu L, 2013, PARASITOL RES, V112, P1333, DOI 10.1007/s00436-012-3187-0; Zhou YZ, 2013, VET PARASITOL, V193, P270, DOI 10.1016/j.vetpar.2012.11.031; Zia-Ali N, 2007, PARASITOL RES, V101, P111, DOI 10.1007/s00436-007-0461-7	56	21	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196159	10.1371/journal.pone.0196159	http://dx.doi.org/10.1371/journal.pone.0196159			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668747	gold, Green Submitted, Green Published			2022-12-26	WOS:000430290200079
J	Metwally, DM; Qassim, LE; Al-Turaiki, IM; Almeer, RS; El-Khadragy, MF				Metwally, Dina M.; Qassim, Latifa E.; Al-Turaiki, Isra M.; Almeer, Rafa S.; El-Khadragy, Manal F.			Gene-based molecular analysis of COX1 in Echinococcus granulosus cysts isolated from naturally infected livestock in Riyadh, Saudi Arabia	PLOS ONE			English	Article							CERVID STRAIN; HUMANS; IRAN; CATTLE; IDENTIFICATION; VARIANTS; GENOTYPE; SEQUENCE; POSITION; ANIMALS	The diversity and importance of Echinococcus species in domesticated animals in Saudi Arabia are poorly understood. In this study, 108 singular (hydatid) cysts were collected from goats (n = 25), sheep (n = 56) and camels (n = 27). DNA was extracted from the protoscoleces of individual fertile cysts and used for polymerase chain reaction (PCR) amplification of mitochondrial subunit 1 of the cytochrome c oxidase 1 (cox1) gene. Amplicon sequencing results revealed the presence of Echinococcus granulosus sensustricto (s.s.) (genotypes G1-G3) in 16 of the17 sheep cysts and 2 of the 27 camel cysts.of these samples, 18 (2 camel and 16 sheep) were divided into genotypes G1, G2, and G3.	[Metwally, Dina M.; Qassim, Latifa E.; Almeer, Rafa S.; El-Khadragy, Manal F.] King Saud Univ, Fac Sci, Zool Dept, Riyadh, Saudi Arabia; [Metwally, Dina M.] Zagazig Univ, Fac Vet Med, Parasitol Dept, Zagazig, Egypt; [Al-Turaiki, Isra M.] King Saud Univ, Coll Comp & Informat Sci, Informat Technol Dept, Riyadh, Saudi Arabia; [El-Khadragy, Manal F.] Helwan Univ, Fac Sci, Dept Zool & Entomol, Cairo, Egypt	King Saud University; Egyptian Knowledge Bank (EKB); Zagazig University; King Saud University; Egyptian Knowledge Bank (EKB); Helwan University	Metwally, DM (corresponding author), King Saud Univ, Fac Sci, Zool Dept, Riyadh, Saudi Arabia.; Metwally, DM (corresponding author), Zagazig Univ, Fac Vet Med, Parasitol Dept, Zagazig, Egypt.	molbody7@yahoo.com	Al-Turaiki, Isra/S-7930-2019	Al-Turaiki, Isra/0000-0003-0550-5115; metwally, dina/0000-0002-0595-0609; Metwally, Dina M./0000-0001-6042-4137	Deanship of Scientific Research at King Saud University [RG-1439-034]	Deanship of Scientific Research at King Saud University(King Saud University)	This research project was supported by a grant from the Deanship of Scientific Research at King Saud University for funding this research through the Research Group project no. RG-1439-034. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research through the Research Group project no. RG-1439-034.	Abushhewa MH, 2010, MOL CELL PROBE, V24, P346, DOI 10.1016/j.mcp.2010.07.005; Al-Malki JS, EPIDEMIOLOGICAL STUD; Alvarez Rojas CA, 2014, INT J PARASITOL, V44, P9, DOI 10.1016/j.ijpara.2013.08.008; Bardonnet K, 2002, T ROY SOC TROP MED H, V96, P383, DOI 10.1016/S0035-9203(02)90369-X; BOWLES J, 1994, PARASITOLOGY, V109, P215, DOI 10.1017/S0031182000076332; BOWLES J, 1992, MOL BIOCHEM PARASIT, V54, P165, DOI 10.1016/0166-6851(92)90109-W; Budke CM, 2006, EMERG INFECT DIS, V12, P296; Capuano F, 2006, VET PARASITOL, V137, P262, DOI 10.1016/j.vetpar.2006.01.016; Casulli A, 2008, VET PARASITOLOGY, V155; de la Rue ML, 2011, VET PARASITOL, V177, P97, DOI 10.1016/j.vetpar.2010.11.018; Eckert J, 2001, WHO/OIE MANUAL ON ECHINOCOCCOSIS IN HUMANS AND ANIMALS: A PUBLIC HEALTH PROBLEM OF GLOBAL CONCERN, P100; Elzein FE, 2016, WORLD J NEPHROLOGY U, V5, P16; Espinoza S, 2014, PARASITOL RES, V113, P139, DOI 10.1007/s00436-013-3636-4; Faraji R, ADV MICROBIOLOGY; Farhadi M, 2015, PARASITOL RES, V114, P4363, DOI 10.1007/s00436-015-4673-y; Giri DK, 2016, INTASPOLIVET, V17; Haag KL, 2004, J PARASITOL, V90, P234, DOI 10.1645/GE-173R; Hajialilo E, 2012, J HELMINTHOL, V86, P263, DOI 10.1017/S0022149X11000320; Huttner M, 2008, INT J PARASITOL, V38, P861, DOI 10.1016/j.ijpara.2007.10.013; Ibrahim MM, 2010, ACTA TROP, V113, P26, DOI 10.1016/j.actatropica.2009.08.029; Kamenetzky L, 2002, INFECT GENET EVOL, V2, P129, DOI 10.1016/S1567-1348(02)00131-4; Kedra AH, 1999, ACTA PARASITOL, V44, P248; Khalifa NO., 2014, AM J EPIDEMIOL INF D, V2, P74; Latif AA, 2010, VET PARASITOL, V170, P44, DOI 10.1016/j.vetpar.2010.02.003; Lavikainen A, 2003, PARASITOLOGY, V127, P207, DOI 10.1017/S0031182003003780; M'rad S, 2010, OPEN VET SCI J, V4; Maillard S, 2007, PARASITOL RES, V100, P495, DOI 10.1007/s00436-006-0286-9; McManus DP, 2010, ADV PARASIT, V72, P267, DOI 10.1016/S0065-308X(10)72010-8; Nakao M, 2007, PARASITOLOGY, V134, P713, DOI 10.1017/S0031182006001934; Nakao M, 2010, INT J PARASITOL, V40, P379, DOI 10.1016/j.ijpara.2009.09.006; Nejad MR, 2012, J HELMINTHOL, V86, P485, DOI 10.1017/S0022149X1100071X; Nikmanesh B, 2014, IRAN J PARASITOL, V9, P20; OKAMOTO M, 1995, PARASITOL RES, V81, P451, DOI 10.1007/BF00931785; Okamoto M, 2010, PARASITOL INT, V59, P70, DOI 10.1016/j.parint.2009.10.007; Pednekar RP, 2009, VET PARASITOL, V165, P58, DOI 10.1016/j.vetpar.2009.06.021; Pezeshki A, 2013, J HELMINTHOL, V87, P387, DOI 10.1017/S0022149X1200051X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Scott JC, 1997, PARASITOLOGY, V114, P37, DOI 10.1017/S0031182096008062; Sharbatkhori M, 2011, PARASITOL RES, V108, P521, DOI 10.1007/s00436-010-2092-7; Sharma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082904; Sharma M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002262; Simsek S, 2011, PARASITOL RES, V109, P411, DOI 10.1007/s00436-011-2269-8; Thompson RCA, 2002, TRENDS PARASITOL, V18, P452, DOI 10.1016/S1471-4922(02)02358-9; Toulah Fawzia H., 2012, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V42, P563; Utuk AE, 2008, ACTATROPICA, V107; Vural G, 2008, VET PARASITOL, V154, P347, DOI 10.1016/j.vetpar.2008.03.020; Zhang WB, 2015, ACTA TROP, V141, P235, DOI 10.1016/j.actatropica.2014.03.014	47	8	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195016	10.1371/journal.pone.0195016	http://dx.doi.org/10.1371/journal.pone.0195016			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668701	Green Published, Green Submitted, gold			2022-12-26	WOS:000430290200021
J	Teuliere, J; Kovacevic, I; Bao, ZR; Garriga, G				Teuliere, Jerome; Kovacevic, Ismar; Bao, Zhirong; Garriga, Gian			The Caenorhabditis elegans gene ham-1 regulates daughter cell size asymmetry primarily in divisions that produce a small anterior daughter cell	PLOS ONE			English	Article							C-ELEGANS; NEUROBLAST DIVISIONS; APOPTOSIS; LINEAGE; PROTEIN; EXPRESSION; MIGRATION; NEMATODE; POLARITY; FAMILY	C. elegans cell divisions that produce an apoptotic daughter cell exhibit Daughter Cell Size Asymmetry (DCSA), producing a larger surviving daughter cell and a smaller daughter cell fated to die. Genetic screens for mutants with defects in apoptosis identified several genes that are also required for the ability of these divisions to produce daughter cells that differ in size. One of these genes, ham-1, encodes a putative transcription factor that regulates a subset of the asymmetric cell divisions that produce an apoptotic daughter cell. In a survey of C. elegans divisions, we found that ham-1 mutations affect primarily anterior/posterior divisions that produce a small anterior daughter cell. The affected divisions include those that generate an apoptotic cell as well as those that generate two surviving cells. Our findings suggest that HAM-1 primarily promotes DCSA in a certain class of asymmetric divisions.	[Teuliere, Jerome; Garriga, Gian] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Kovacevic, Ismar; Bao, Zhirong] Sloan Kettering Inst, Dev Biol Program, New York, NY USA	University of California System; University of California Berkeley; Memorial Sloan Kettering Cancer Center	Garriga, G (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	garriga@berkeley.edu		Teuliere, Jerome/0000-0002-0965-4399	National Institute of Health Office of Research Infrastructure Programs [P40 OD010440]; National Institutes of Health [NS32057]; Association pour la Recherche sur le Cancer; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097576] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032057] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440, R24OD016474] Funding Source: NIH RePORTER	National Institute of Health Office of Research Infrastructure Programs; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the National Institute of Health Office of Research Infrastructure Programs (P40 OD010440). This work was supported by National Institutes of Health grant NS32057 to G.G. J.T. was supported by a fellowship from the Association pour la Recherche sur le Cancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Some nematode strains used in this work were provided by the Caenorhabditis Genetics Center, which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440). This work was supported by National Institutes of Health grant NS32057 to G.G. J.T. was supported by a fellowship from the Association pour la Recherche sur le Cancer.	Alkema MJ, 2005, NEURON, V46, P247, DOI 10.1016/j.neuron.2005.02.024; Arur S, 2009, P NATL ACAD SCI USA, V106, P4776, DOI 10.1073/pnas.0812285106; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; BRENNER S, 1974, GENETICS, V77, P71; Chakraborty S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10126; Chapman JO, 2008, DEV BIOL, V324, P245, DOI 10.1016/j.ydbio.2008.09.014; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Cordes S, 2006, DEVELOPMENT, V133, P2747, DOI 10.1242/dev.02447; Costa G, 2016, NAT CELL BIOL, V18, P1292, DOI 10.1038/ncb3443; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; Doitsidou M, 2008, NAT METHODS, V5, P869, DOI 10.1038/NMETH.1250; Feng GX, 2013, DEVELOPMENT, V140, P3838, DOI 10.1242/dev.098723; Feng HY, 2013, GENESIS, V51, P163, DOI 10.1002/dvg.22365; Frank CA, 2005, DEV BIOL, V284, P301, DOI 10.1016/j.ydbio.2005.05.026; Gallaud E, 2017, RESULTS PROBL CELL D, V61, P183, DOI 10.1007/978-3-319-53150-2_8; Guenther C, 1996, DEVELOPMENT, V122, P3509; Gurling Mark, 2015, Worm, V4, pe979697, DOI 10.4161/21624054.2014.979697; Gurling M, 2014, DEVELOPMENT, V141, P2724, DOI 10.1242/dev.110486; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; Kachur TM, 2008, DEV BIOL, V314, P287, DOI 10.1016/j.ydbio.2007.11.028; Kim K, 2004, J COMP NEUROL, V475, P540, DOI 10.1002/cne.20189; Kim K, 2009, SCIENCE, V326, P994, DOI 10.1126/science.1176331; Lam AK, 2017, RESULTS PROBL CELL D, V61, P83, DOI 10.1007/978-3-319-53150-2_4; Leung A, 2016, DEV BIOL, V410, P56, DOI 10.1016/j.ydbio.2015.12.011; Li C, 1999, BRAIN RES, V848, P26, DOI 10.1016/S0006-8993(99)01972-1; Offenburger SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04375-4; Ooi SL, 2006, PLOS GENET, V2, P883, DOI 10.1371/journal.pgen.0020097; Ou GS, 2010, SCIENCE, V330, P677, DOI 10.1126/science.1196112; Pacquelet A, 2017, RESULTS PROBL CELL D, V61, P115, DOI 10.1007/978-3-319-53150-2_5; Singhvi A, 2011, CURR BIOL, V21, P948, DOI 10.1016/j.cub.2011.04.025; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Teuliere J, 2017, RESULTS PROBL CELL D, V61, P141, DOI 10.1007/978-3-319-53150-2_6; Teuliere J, 2014, GENETICS, V198, P229, DOI 10.1534/genetics.114.167189; Wei H, 2017, GENETICS, V206, P2069, DOI 10.1534/genetics.117.202754	36	0	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195855	10.1371/journal.pone.0195855	http://dx.doi.org/10.1371/journal.pone.0195855			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668718	gold, Green Submitted, Green Published			2022-12-26	WOS:000430290200062
J	Marlet, J; Gaudy-Graffini, C; Marc, D; Boennec, R; Goudeau, A				Marlet, Julien; Gaudy-Graffini, Catherine; Marc, Daniel; Boennec, Ronan; Goudeau, Alain			Factors associated with influenza vaccination failure and severe disease in a French region in 2015	PLOS ONE			English	Article							SEASONAL INFLUENZA; A(H1N1)PDM09; PROTECTION; VIRUSES; RISK	Current influenza vaccination strategy is based on limited analyses of circulating strains and has some drawbacks, as illustrated during the 2014 +/- 2015 season with the circulation of A (H3N2) viruses belonging to divergent genetic subgroups. We reasoned that these strains, poorly neutralized in vitro, may have been associated with vaccination failure and more severe diseases. We conducted a study on a continuous series of 249 confirmed influenza infections. Incidence was three fold greater than in the previous three years. Most isolates were A(H3N2) viruses (78%) and clustered in subgroups 3C.2a (57%) and 3C.3b (43%). We identified 23 non-synonymous mutations that had already been identified during previous seasons at low frequencies, except mutation Q197H, present in 26% of 3C.3b isolates. We identified lung disorder, tobacco smoking and A(H1N1)pdm09 infection as risk factor of severe influenza disease. In contrast, young age (<5 years), A(H3N2) infection and initial admission to an emergency department were associated with a better outcome of influenza infection.	[Marlet, Julien; Gaudy-Graffini, Catherine; Goudeau, Alain] INSERM, French Natl Inst Hlth & Med Res, U1259, Tours, France; [Marlet, Julien; Gaudy-Graffini, Catherine; Boennec, Ronan; Goudeau, Alain] Univ Tours, Tours, France; [Marc, Daniel] INRA, French Natl Inst Agr Res, Avian Immune Response & Pathogenesis, Nouzilly, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; INRAE	Marlet, J (corresponding author), INSERM, French Natl Inst Hlth & Med Res, U1259, Tours, France.; Marlet, J (corresponding author), Univ Tours, Tours, France.	jul.marlet@gmail.com	Marlet, Julien/GZG-4349-2022; Marlet, Julien/ABF-1619-2020; Marc, Daniel/M-4296-2015	Marlet, Julien/0000-0002-8645-8703; Marc, Daniel/0000-0003-3604-1958				[Anonymous], 1980, B WORLD HEALTH ORGAN, V58, P585; Bonmarin I., 2015, Eurosurveillance, V20, P21310; Bonmarin I., 2015, SAISON 2014 2015, P593; CDC, PEOPL HIGH RISK DEV; CDC, SEAS INFL VACC EFF 2; ECDC ERLI-Net, 2014, INFL VIR CHAR SUMM E; ECDC ERLI-Net, 2015, INFL VIR CHAR; ECDC ERLI-Net, 2014, INFL VIR CHAR; Flannery B, 2016, J INFECT DIS, V214, P1010, DOI 10.1093/infdis/jiw181; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gostic KM, 2016, SCIENCE, V354, P722, DOI 10.1126/science.aag1322; Huang JW, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S31; INVS, 2015, BIL SAIS GRIPP 2014; INVS UPMC, 2015, B RES SENT 15 04 15; Kim HK, 2013, J CLIN MICROBIOL, V51, P1137, DOI 10.1128/JCM.02958-12; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klein SL, 2014, J INFECT DIS, V209, pS114, DOI 10.1093/infdis/jiu066; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lehners N, 2013, EMERG INFECT DIS, V19, P748, DOI [10.3201/eid1905.120034, 10.3201/eid1905.130034]; Lemaitre M, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-162; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Molinari NAM, 2007, VACCINE, V25, P5086, DOI 10.1016/j.vaccine.2007.03.046; Mostafa A, 2016, ARCH VIROL, V161, P1505, DOI 10.1007/s00705-016-2815-x; Poritz MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026047; Reed C, 2014, CLIN INFECT DIS, V59, P166, DOI 10.1093/cid/ciu285; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Song JY, 2010, VACCINE, V28, P3929, DOI 10.1016/j.vaccine.2010.03.067; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Van der Werf S., 2015, B EP HEBD, P599; WHO, 2015, WHO INF MOL DIAGN IN; Wong JY, 2015, AM J EPIDEMIOL, V182, P294, DOI 10.1093/aje/kwv054; Wong SS, 2013, CLIN MICROBIOL REV, V26, P476, DOI 10.1128/CMR.00097-12; Zost SJ, 2017, P NATL ACAD SCI USA, V114, P12578, DOI 10.1073/pnas.1712377114	33	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195611	10.1371/journal.pone.0195611	http://dx.doi.org/10.1371/journal.pone.0195611			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664931	Green Published, Green Submitted, gold			2022-12-26	WOS:000430262300023
J	Ning, HL; Yuan, JQ; Dong, QZ; Li, WB; Xuel, H; Wang, YS; Tian, Y; Li, WX				Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia			Identification of QTLs related to the vertical distribution and seed-set of pod number in soybean [Glycine max (L.) Merri]	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; YIELD COMPONENTS; AGRONOMIC TRAITS; POPULATION	Pod number is an important factor that influences yield in soybean. Here, we used two associated recombinant inbred line (RIL) soybean populations, RIL3613 (containing 134 lines derived from Dongnong L13 x Heihe 36) and RIL6013 (composed of 156 individuals from Dongnong L13 x Henong 60), to identify quantitative trait loci (QTLs) regulating the vertical distribution and quantity of seeds and seed pods. The numbers of pods were quantified in the upper, middle, and lower sections of the plant, as well as in the plants as a whole, and QTLs regulating these spatial traits were mapped using an inclusive complete interval mapping method. A total of 21 and 26 QTLs controlling pod-number-related traits were detected in RIL3613 and RIL6013, respectively, which explained 1.25 +/- 11.6698% and 0.0001 +/- 7.91% of the phenotypic variation. A total of 34 QTLs were verified by comparison with previous research, were identified in both populations, or were found to regulate multiple traits, indicating their authenticity. These results enhance our understanding of the vertical distribution of pod-number-related traits and support molecular breeding for seed yield.	[Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia] Minist Educ, Key Lab Soybean Biol, Harbin, Heilongjiang, Peoples R China; [Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia] Minist Agr, Key Lab Soybean Biol & Breeding Genet, Harbin, Heilongjiang, Peoples R China; [Ning, Hailong; Yuan, Jiaqi; Dong, Quanzhong; Li, Wenbin; Xue, Hong; Wang, Yanshu; Tian, Yu; Li, Wen-Xia] Northeast Agr Univ, Soybean Res Inst, Harbin, Heilongjiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Northeast Agricultural University - China	Li, WX (corresponding author), Minist Educ, Key Lab Soybean Biol, Harbin, Heilongjiang, Peoples R China.; Li, WX (corresponding author), Minist Agr, Key Lab Soybean Biol & Breeding Genet, Harbin, Heilongjiang, Peoples R China.; Li, WX (corresponding author), Northeast Agr Univ, Soybean Res Inst, Harbin, Heilongjiang, Peoples R China.	liwenixaneau@126.com			Natural Science Foundation of Heilongjiang Province [China] [LC201610, C2015007]; Scientific and Technological Foundation of Education Department of Heilongjiang Province [12541z001]; National Key Research and Development Program of China [2017YFD0101300]	Natural Science Foundation of Heilongjiang Province [China](Natural Science Foundation of Heilongjiang Province); Scientific and Technological Foundation of Education Department of Heilongjiang Province; National Key Research and Development Program of China	Natural Science Foundation of Heilongjiang Province [China] (LC201610) to H.N. and (C2015007) to W-X.L., and the Scientific and Technological Foundation of Education Department of Heilongjiang Province (12541z001) to H.N, grants from the National Key Research and Development Program of China (2017YFD0101300) to H.N.; The authors gratefully acknowledge the financial support for this study provided by Natural Science Foundation of Heilongjiang Province [China] (LC201610) to H.N and, (C2015007) to W-X.L., and the Scientific and Technological Foundation of Education Department of Heilongjiang Province (12541z001) to H.N, grants from the National Key Research and Development Program of China (2017YFD0101300) to H.N.	Bobby R., 2012, Journal of Agricultural Science (Toronto), V4, P98; Chen QingShan, 2007, Agricultural Sciences in China, V6, P399, DOI 10.1016/S1671-2927(07)60062-5; Rodrigues JID, 2016, CROP BREED APPL BIOT, V16, P265, DOI 10.1590/1984-70332016v16n4a41; Vieira Antonio José Dias, 2006, Braz. J. Plant Physiol., V18, P281, DOI 10.1590/S1677-04202006000200004; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Kuroda Y, 2013, ECOL EVOL, V3, P2150, DOI 10.1002/ece3.606; [李灿东 Li Candong], 2008, [分子植物育种, Molecular Plant Breeding], V6, P1091; Li DM, 2010, EUPHYTICA, V172, P49, DOI 10.1007/s10681-009-0036-z; Liu B, 2015, EMIR J FOOD AGR, V27, P258, DOI 10.9755/ejfa.v27i3.18889; Liu NX, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3854-8; Liu WeiXian, 2011, Journal of Crop Science and Biotechnology, V14, P65, DOI 10.1007/s12892-010-0115-7; Liu YuPing, 2010, Soybean Science, V29, P796; Machado BQV, 2017, GENET MOL RES, V16, DOI 10.4238/gmr16029696; Palomeque L, 2009, THEOR APPL GENET, V119, P429, DOI 10.1007/s00122-009-1048-8; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Sun DH, 2006, THEOR APPL GENET, V112, P665, DOI 10.1007/s00122-005-0169-y; Wang JianKang, 2009, Acta Agronomica Sinica, V35, P239, DOI 10.3724/SP.J.1006.2009.00239; Wang XianZhi, 2007, Acta Agronomica Sinica, V33, P441; Wu X L, 2001, Yi Chuan Xue Bao, V28, P947; Yang Z, 2013, MOL GENET GENOMICS, V288, P651, DOI 10.1007/s00438-013-0779-z; ZENG ZB, 1994, GENETICS, V136, P1457; Zhang D, 2010, J GENET GENOMICS, V37, P545, DOI 10.1016/S1673-8527(09)60074-6; Zhao GY, 2008, EUPHYTICA, V164, P275, DOI 10.1007/s10681-008-9728-z; Zhou Rong, 2009, Acta Agronomica Sinica, V35, P821, DOI 10.3724/SP.J.1006.2009.00821	24	19	22	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195830	10.1371/journal.pone.0195830	http://dx.doi.org/10.1371/journal.pone.0195830			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664958	Green Published, gold			2022-12-26	WOS:000430262300036
J	Ammar, E; Hall, DG; Hosseinzadeh, S; Heck, M				Ammar, El-Desouky; Hall, David G.; Hosseinzadeh, Saeed; Heck, Michelle			The quest for a non-vector psyllid: Natural variation in acquisition and transmission of the huanglongbing pathogen 'Candidatus Liberibacter asiaticus' by Asian citrus psyllid isofemale lines	PLOS ONE			English	Article							WHITEFLY BEMISIA-TABACI; DIAPHORINA-CITRI; VIRUS TRANSMISSION; HEMIPTERA LIVIIDAE; LUTEOVIRUS TRANSMISSION; RHOPALOSIPHUM-PADI; COUPLING GENETICS; FEEDING-BEHAVIOR; ABDOMINAL COLOR; MYZUS-PERSICAE	Genetic variability in insect vectors is valuable to study vector competence determinants and to select non-vector populations that may help reduce the spread of vector-borne pathogens. We collected and tested vector competency of 15 isofemale lines of Asian citrus psyllid, Diaphorina citri, vector of `Candidatus Liberibacter asiaticus' (CLas). CLas is associated with huanglongbing (citrus greening), the most serious citrus disease worldwide. D. citri adults were collected from orange jasmine (Murraya paniculata) hedges in Florida, and individual pairs (females and males) were caged on healthy Murraya plants for egg laying. The progeny from each pair that tested CLas-negative by qPCR were maintained on Murraya plants and considered an isofemale line. Six acquisition tests on D. citri adults that were reared as nymphs on CLas-infected citrus, from various generations of each line, were conducted to assess their acquisition rates (percentage of qPCR-positive adults). Three lines with mean acquisition rates of 28 to 32%, were classified as 'good' acquirers and three other lines were classified as 'poor' acquirers, with only 5 to 8% acquisition rates. All lines were further tested for their ability to inoculate CLas by confining CLas-exposed psyllids for one week onto healthy citrus leaves (6 +/- 10 adults/leaf/week), and testing the leaves for CLas by qPCR. Mean inoculation rates were 19 to 28% for the three good acquirer lines and 0 to 3% for the three poor acquirer lines. Statistical analyses indicated positive correlations between CLas acquisition and inoculation rates, as well as between CLas titer in the psyllids and CLas acquisition or inoculation rates. Phenotypic and molecular characterization of one of the good and one of the poor acquirer lines revealed differences between them in color morphs and hemocyanin expression, but not the composition of bacterial endosymbionts. Understanding the genetic architecture of CLas transmission will enable the development of new tools for combating this devastating citrus disease.	[Ammar, El-Desouky; Hall, David G.] USDA ARS, US Hort Res Lab, Ft Pierce, FL USA; [Ammar, El-Desouky] Univ Florida, Lake Alfred, FL USA; [Ammar, El-Desouky] Univ Florida, Ft Pierce, FL USA; [Heck, Michelle] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Heck, Michelle] USDA ARS, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA; [Heck, Michelle] Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA	United States Department of Agriculture (USDA); State University System of Florida; University of Florida; State University System of Florida; University of Florida; Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); Cornell University	Heck, M (corresponding author), Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA.; Heck, M (corresponding author), USDA ARS, Emerging Pests & Pathogens Res Unit, Robert W Holley Ctr Agr & Hlth, Ithaca, NY 14853 USA.; Heck, M (corresponding author), Cornell Univ, Sch Integrat Plant Sci, Plant Pathol & Plant Microbe Biol Sect, Ithaca, NY 14850 USA.	michelle.cilia@ars.usda.gov	Hosseinzadeh, Saeed/T-6370-2018	Hosseinzadeh, Saeed/0000-0001-7414-8591; Heck, Michelle/0000-0003-0921-4489	California Citrus Research Board grants [5300-163, 5300-155]; USDA National Institute of Food and Agriculture grant [2016-70016-24779]	California Citrus Research Board grants; USDA National Institute of Food and Agriculture grant	The authors received funding from California Citrus Research Board grants 5300-163, 5300-155, and USDA National Institute of Food and Agriculture grant 2016-70016-24779. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dossi FCA, 2014, MICROB ECOL, V68, P881, DOI 10.1007/s00248-014-0463-9; Ammar El-D., 1994, PROPAGATIVE TRANSMIS, P289; Ammar ED, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159594; Ammar E, 2013, J ECON ENTOMOL, V106, P25, DOI 10.1603/EC12245; Ammar ED, 2011, J PHYTOPATHOL, V159, P726, DOI 10.1111/j.1439-0434.2011.01836.x; Ammar E, 2011, ANN ENTOMOL SOC AM, V104, P526, DOI 10.1603/AN10134; Arp AP, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00570; Badillo-Vargas IE, 2012, J VIROL, V86, P8793, DOI 10.1128/JVI.00285-12; Barker H, 1999, LUTEOVIRIDAE, Vxviii; Bencharki B, 2000, EUR J PLANT PATHOL, V106, P455, DOI 10.1023/A:1008749231129; Bonani JP, 2010, ENTOMOL EXP APPL, V134, P35, DOI 10.1111/j.1570-7458.2009.00937.x; Bove JM, 2006, J PLANT PATHOL, V88, P7; Burrows ME, 2007, HEREDITY, V98, P106, DOI 10.1038/sj.hdy.6800909; Burrows ME, 2006, PHYTOPATHOLOGY, V96, P828, DOI 10.1094/PHYTO-96-0828; Cen YJ, 2012, ENTOMOL EXP APPL, V143, P13, DOI 10.1111/j.1570-7458.2012.01222.x; Chu CC, 2016, MICROB ECOL, V71, P999, DOI 10.1007/s00248-016-0733-9; Cilia M, 2011, J VIROL, V85, P2148, DOI 10.1128/JVI.01504-10; Cilia M, 2011, PROTEOMICS, V11, P2440, DOI 10.1002/pmic.201000519; COSTA A. S., 1965, Plant Protection Bulletin, F.A.O., V13, P121; Coy MR, 2015, FLA ENTOMOL, V98, P356, DOI 10.1653/024.098.0157; da Graca JV, 2016, J INTEGR PLANT BIOL, V58, P373, DOI 10.1111/jipb.12437; Dedryver CA, 2005, EUR J PLANT PATHOL, V111, P341, DOI 10.1007/s10658-004-4890-1; Douglas AE, 2011, P ROY SOC B-BIOL SCI, V278, P333, DOI 10.1098/rspb.2010.1563; Fagen Jennie R, 2012, Open Microbiol J, V6, P29, DOI 10.2174/1874285801206010029; Ghanim M, 2016, SCI REP-UK, V6, DOI 10.1038/srep33418; GLADDERS DW, 1986, ANN APPL BIOL, V109, P499, DOI 10.1111/j.1744-7348.1986.tb03207.x; Gotz M, 2012, J VIROL, V86, P13241, DOI 10.1128/JVI.00880-12; Gooding RH, 1996, CLIN MICROBIOL REV, V9, P301, DOI 10.1128/CMR.9.3.301; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gray S, 2014, ADV VIRUS RES, V89, P141, DOI 10.1016/B978-0-12-800172-1.00004-5; Gray SM, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.2501; Guo JQ, 1996, CAN ENTOMOL, V128, P209, DOI 10.4039/Ent128209-2; Haapalainen M, 2014, ANN APPL BIOL, V165, P172, DOI 10.1111/aab.12149; Hall DG, 2018, J APPL ENTOMOL, V142, P97, DOI 10.1111/jen.12466; Hall DG, 2016, J ECON ENTOMOL, V109, P558, DOI 10.1093/jee/tow009; Hall DG, 2015, J ECON ENTOMOL, V108, P1198, DOI 10.1093/jee/tov052; Hall DG, 2013, ENTOMOL EXP APPL, V146, P207, DOI 10.1111/eea.12025; Hall DG, 2010, ANN ENTOMOL SOC AM, V103, P611, DOI 10.1603/AN10004; Hogenhout SA, 2003, TRENDS MICROBIOL, V11, P264, DOI 10.1016/S0966-842X(03)00120-3; Inoue H, 2009, ANN APPL BIOL, V155, P29, DOI 10.1111/j.1744-7348.2009.00317.x; Ipe D., 1987, P 12 ANN SAS US GROU; Jain M, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00171-17; Killiny Nabil, 2018, Virulence, V9, P99, DOI 10.1080/21505594.2017.1339008; Kliot A, 2014, J VIROL, V88, P5652, DOI 10.1128/JVI.00071-14; Kruse A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179531; Liu WW, 2015, MOL CELL PROTEOMICS, V14, P2229, DOI 10.1074/mcp.M114.046763; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lucio-Zavaleta E, 2001, PHYTOPATHOLOGY, V91, P792, DOI 10.1094/PHYTO.2001.91.8.792; Mann M, 2018, INFECT IMMUN, V86, DOI [10.1128/IAI.00889-17, 10.1128/iai.00889-17]; Mann RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029197; Martini X, 2014, ANN ENTOMOL SOC AM, V107, P842, DOI 10.1603/AN14028; Marubayashi Julio Massaharu, 2010, Summa phytopathol., V36, P158, DOI 10.1590/S0100-54052010000200009; Nakabachi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082612; Nakabachi A, 2013, CURR BIOL, V23, P1478, DOI 10.1016/j.cub.2013.06.027; Ogada PA, 2016, ECOL EVOL, V6, P7911, DOI 10.1002/ece3.2484; Pelz-Stelinski KS, 2016, ANN ENTOMOL SOC AM, V109, P371, DOI 10.1093/aesa/saw007; Pelz-Stelinski KS, 2010, J ECON ENTOMOL, V103, P1531, DOI 10.1603/EC10123; Pinheiro PV, 2017, MOL CELL PROTEOMICS, V16, pS230, DOI [10.1074/mcp.M116.063495, 10.1074/mcp.m116.063495]; Pitino M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00982; Raiol LL, 2017, PLANT DIS, V101, P409, DOI 10.1094/PDIS-08-16-1093-RE; Ramsey JS, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160545; Ramsey JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140826; Saha S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050067; Storey HH, 1932, P R SOC LOND B-CONTA, V112, P46, DOI 10.1098/rspb.1932.0077; Storey HH, 1925, ANN APPL BIOL, V12, P422, DOI 10.1111/j.1744-7348.1925.tb04238.x; Symmes EJ, 2007, J ECON ENTOMOL, V100, P1764, DOI 10.1603/0022-0493(2007)100[1764:IVIZYM]2.0.CO;2; Tamborindeguy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071620; Thomas GH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-24; Turpin T, USDA NATL I FOOD AGR; Vyas M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130328; Walter AJ, 2012, PLANT DIS, V96, P827, DOI 10.1094/PDIS-08-11-0668; Walter AJ, 2012, HORTSCIENCE, V47, P1; Wang N, 2017, ANNU REV PHYTOPATHOL, V55, P451, DOI 10.1146/annurev-phyto-080516-035513; Wang NA, 2017, PHYTOPATHOLOGY, V107, P380, DOI 10.1094/PHYTO-12-16-0426-RVW; Wang YL, 2010, J PROTEOME RES, V9, P1257, DOI 10.1021/pr9007392; Wenninger EJ, 2008, ANN ENTOMOL SOC AM, V101, P585, DOI 10.1603/0013-8746(2008)101[585:DASPIA]2.0.CO;2; Wu TY, 2016, ENTOMOL EXP APPL, V161, P104, DOI 10.1111/eea.12496; Yan Q, 2013, MOL PLANT PATHOL, V14, P391, DOI 10.1111/mpp.12015; Yang XL, 2008, J VIROL, V82, P291, DOI 10.1128/JVI.01736-07	79	20	20	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195804	10.1371/journal.pone.0195804	http://dx.doi.org/10.1371/journal.pone.0195804			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652934	Green Submitted, gold, Green Published			2022-12-26	WOS:000430026900037
J	Martinez-Marquez, D; Mirnajafizadeh, A; Carty, CP; Stewart, RA				Martinez-Marquez, Daniel; Mirnajafizadeh, Ali; Carty, Christopher P.; Stewart, Rodney A.			Application of quality by design for 3D printed bone prostheses and scaffolds	PLOS ONE			English	Article							OF-THE-ART; PATIENT-SPECIFIC IMPLANTS; BY-DESIGN; FREEFORM FABRICATION; MECHANICAL-BEHAVIOR; CONTACT FORCES; FAILURE MODE; TISSUE; SURFACE; TITANIUM	3D printing is an emergent manufacturing technology recently being applied in the medical field for the development of custom bone prostheses and scaffolds. However, successful industry transformation to this new design and manufacturing approach requires technology integration, concurrent multi-disciplinary collaboration, and a robust quality management framework. This latter change enabler is the focus of this study. While a number of comprehensive quality frameworks have been developed in recent decades to ensure that the manufacturing of medical devices produces reliable products, they are centred on the traditional context of standardised manufacturing techniques. The advent of 3D printing technologies and the prospects for mass customisation provides significant market opportunities, but also presents a serious challenge to regulatory bodies tasked with managing and assuring product quality and safety. Before 3D printing bone prostheses and scaffolds can gain traction, industry stakeholders, such as regulators, clients, medical practitioners, insurers, lawyers, and manufacturers, would all require a high degree of confidence that customised manufacturing can achieve the same quality outcomes as standardised manufacturing. A Quality by Design (QbD) approach to custom 3D printed prostheses can help to ensure that products are designed and manufactured correctly from the beginning without errors. This paper reports on the adaptation of the QbD approach for the development process of 3D printed custom bone prosthesis and scaffolds. This was achieved through the identification of the Critical Quality Attributes of such products, and an extensive review of different design and fabrication methods for 3D printed bone prostheses. Research outcomes include the development of a comprehensive design and fabrication process flow diagram, and categorised risks associated with the design and fabrication processes of such products. An extensive systematic literature review and post-hoc evaluation survey with experts was completed to evaluate the likely effectiveness of the herein suggested QbD framework.	[Martinez-Marquez, Daniel; Stewart, Rodney A.] Griffith Univ, Sch Engn, Gold Coast, Qld, Australia; [Mirnajafizadeh, Ali] Univ Calif Berkeley, Mol Cell Biomech Lab, Berkeley, CA 94720 USA; [Carty, Christopher P.] Griffith Univ, Menzies Hlth Inst Queensland, Sch Allied Hlth Sci & Innovat Hlth Technol, Gold Coast, Qld, Australia; [Carty, Christopher P.] Griffith Univ, Ctr Musculoskeletal Res, Menzies Hlth Inst Queensland, Gold Coast, Qld, Australia; [Carty, Christopher P.] Childrens Hlth Queensland Hosp & Hlth Serv, Queensland Childrens Gait Lab, Queensland Paediat Rehabil Serv, Brisbane, Qld, Australia	Griffith University; University of California System; University of California Berkeley; Griffith University; Menzies Health Institute Queensland; Griffith University; Menzies Health Institute Queensland	Stewart, RA (corresponding author), Griffith Univ, Sch Engn, Gold Coast, Qld, Australia.	r.stewart@griffith.edu.au	Stewart, Rodney A/H-5561-2018	Stewart, Rodney A/0000-0002-6013-3505; Carty, Christopher/0000-0002-8969-5181; Martinez Marquez, Daniel/0000-0001-7326-1015	Griffith University International Postgraduate Award (GUIPA)	Griffith University International Postgraduate Award (GUIPA)	This is a PhD project by a Griffith University International Postgraduate Award (GUIPA). This is a scholarship stipend covering living costs and tuition.	Afshar M, 2016, J MECH BEHAV BIOMED, V62, P481, DOI 10.1016/j.jmbbm.2016.05.027; Ahn D, 2007, INT J MACH TOOL MANU, V47, P593, DOI 10.1016/j.ijmachtools.2006.05.004; Ahn SH, 2002, RAPID PROTOTYPING J, V8, P248, DOI 10.1108/13552540210441166; Almeida HA, 2014, MED ENG PHYS, V36, P1033, DOI 10.1016/j.medengphy.2014.05.006; Alvarez K, 2009, MATERIALS, V2, P790, DOI 10.3390/ma2030790; Amid A, 2006, INT J PROD ECON, V104, P394, DOI 10.1016/j.ijpe.2005.04.012; Amini AR, 2012, CRITICAL REV BIOMEDI, V40; An J, 2015, ENGINEERING-PRC, V1, P261, DOI 10.15302/J-ENG-2015061; Anderson C, 2010, AM J PHARM EDUC, V74, DOI 10.5688/aj7408141; [Anonymous], 2009, ICH GUID NONCL SAF S, P4; Arango-Ospina M, 2014, 15 INT C BIOM ENG; Arealis G, 2015, INJURY, V46, pS20, DOI 10.1016/S0020-1383(15)30050-4; Asiedu Y, 1998, INT J PROD RES, V36, P883, DOI 10.1080/002075498193444; Bachynskyi M, 2014, P 32 ANN ACM C HUM F; Badawy SIF, 2016, J PHARM SCI-US, V105, P168, DOI 10.1016/j.xphs.2015.11.023; Bagno A, 2004, J MATER SCI-MATER M, V15, P935, DOI 10.1023/B:JMSM.0000042679.28493.7f; Bandyopadhyay A, 2013, CHARACTERIZATION OF BIOMATERIALS, P1; Barrere F, 2008, MAT SCI ENG R, V59, P38, DOI 10.1016/j.mser.2007.12.001; Bauer S., 2010, EUROP CELLS MAT, V20, P16; Bell C., 2014, MAINTAINING TROUBLES, P327; Bellotti C, 2014, MED C CONTR AUTOMAT, P175, DOI 10.1109/MED.2014.6961367; Bhatia SK, 2014, CHEM ENG PROG, V110, P28; Bi G, 2013, J MATER PROCESS TECH, V213, P463, DOI 10.1016/j.jmatprotec.2012.10.006; Bibb R, 2010, RADIOGRAPHY, V16, P78, DOI 10.1016/j.radi.2009.10.005; Bikas H, 2016, INT J ADV MANUF TECH, V83, P389, DOI 10.1007/s00170-015-7576-2; Binder WJ, 2016, AM J COSMETIC SURG; Blackmon K., 2005, RES BUSINESS MANAGEM; Bogue R, 2013, ASSEMBLY AUTOM, V33, P307, DOI 10.1108/AA-06-2013-055; Bordat C, 2004, ANAL COST OVERRUNS T, P11; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Brown A, 2008, 2008 IEEE INT ENG MA; Butler J, 2011, ASSEMBLY AUTOM, V31, P212, DOI 10.1108/01445151111150541; Chae MP, 2015, FRONT SURG, V2, DOI 10.3389/fsurg.2015.00025; Chahine G, 2008, JOM-US, V60, P50, DOI 10.1007/s11837-008-0148-2; Chang PSH, 2003, J CRANIOFAC SURG, V14, P164, DOI 10.1097/00001665-200303000-00006; Chantarapanich N, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/407805; Chavan S.D., 2015, J PHARM QUALITY ASSU, V1; Chen JN, 2013, J MECH BEHAV BIOMED, V20, P387, DOI 10.1016/j.jmbbm.2012.08.019; Chia HN, 2015, J BIOL ENG, V9, DOI 10.1186/s13036-015-0001-4; Choi JY, 2002, INT J ORAL MAX SURG, V31, P23, DOI 10.1054/ijom.2000.0135; Chua CK, 2003, INT J ADV MANUF TECH, V21, P291, DOI 10.1007/s001700300034; CIMA LG, 1991, J BIOMECH ENG-T ASME, V113, P143, DOI 10.1115/1.2891228; Coelho PG, 2015, MED ENG PHYS, V37, P287, DOI 10.1016/j.medengphy.2015.01.004; Cogdill R.P., 2008, J PHARM INNOV, V3, P23, DOI [10.1007/s12247-008-9025-3, DOI 10.1007/s12247-008-9025-3, DOI 10.1007/S12247-008-9025-3]; Colasante C, 2016, CURR SURG REP, V4, DOI 10.1007/s40137-016-0127-4; Colledani M, 2014, CIRP ANN-MANUF TECHN, V63, P773, DOI 10.1016/j.cirp.2014.05.002; Colligan L, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-7; COOPER RG, 1986, J PROD INNOVAT MANAG, V3, P71, DOI 10.1111/1540-5885.320071; Cordonnier T, 2011, ADV ENG MATER, V13, pB135, DOI 10.1002/adem.201080098; Craeghs T., 2011, PROC ANN INT SOLID F, P212; Cun DM, 2011, EUR J PHARM BIOPHARM, V77, P26, DOI 10.1016/j.ejpb.2010.11.008; De Nardo L, 2012, COATINGS FOR BIOMEDICAL APPLICATIONS, P106; Denry I, 2016, DENT MATER, V32, P43, DOI 10.1016/j.dental.2015.09.008; Derand P, 2012, CRANIOMAX TRAUM REC, V5, P137, DOI 10.1055/s-0032-1313357; Devedzic G, 2012, COMPUT APPL ENG EDUC, V20, P434, DOI 10.1002/cae.20411; Dhandayuthapani B, 2011, INT J POLYM SCI, V2011, DOI 10.1155/2011/290602; Di Prima Matthew, 2016, 3D Print Med, V2, DOI 10.1186/s41205-016-0005-9; Lantada AD, 2012, ANNU REV BIOMED ENG, V14, P73, DOI [10.1146/annurev-bioeng-071811-150112, 10.1146/annurev.bioeng-071811-150112]; Dimitriou R, 2005, INJURY, V36, P1392, DOI 10.1016/j.injury.2005.07.019; Downey J, 2016, PROC CIRP, V41, P920, DOI 10.1016/j.procir.2015.12.008; Duan B, 2011, MRS BULL, V36, P998, DOI 10.1557/mrs.2011.270; Dubey A, 2012, AAPS PHARMSCITECH, V13, P231, DOI 10.1208/s12249-011-9723-x; EISENHARDT KM, 1989, ACAD MANAGE REV, V14, P532, DOI 10.2307/258557; Enab TA, 2013, MATER DESIGN, V44, P454, DOI 10.1016/j.matdes.2012.08.017; Erdman AG, 2013, IEEE T BIO-MED ENG, V60, P700, DOI 10.1109/TBME.2013.2244600; Fahmy R, 2012, AAPS PHARMSCITECH, V13, P1243, DOI 10.1208/s12249-012-9844-x; Fan HB, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0723-2; FDA, 2007, GUID IND REV STAFF T; Fernandez J, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0084; Ferraris S, 2016, MAT SCI ENG C-MATER, V61, P965, DOI 10.1016/j.msec.2015.12.062; Forging Industry Association, HEAT TREATM TIT ALL; Frazier WE, 2014, J MATER ENG PERFORM, V23, P1917, DOI 10.1007/s11665-014-0958-z; Gabbrielli R, 2008, KEY ENG MAT; Galloway F, 2012, J BIOMECH, V45, P191, DOI 10.1016/j.jbiomech.2011.09.009; Gardan N., 2014, INT J MANUFACTURING, V2014; Garvin D.A., 1984, SLOAN MANAGEMENT REV, V26; Garvin D. A., 1987, HARVARD BUSINESS REV; Gerus P, 2013, J BIOMECH, V46, P2778, DOI 10.1016/j.jbiomech.2013.09.005; Giannitelli SM, 2014, ACTA BIOMATER, V10, P580, DOI 10.1016/j.actbio.2013.10.024; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; Gogolewski S, 2000, INJURY, V31, pS28; Groen WM, 2017, J ORTHOP RES, V35, P2089, DOI 10.1002/jor.23602; Gulati K, 2012, THER DELIV, V3, P857, DOI 10.4155/TDE.12.66; Guo N, 2013, FRONT MECH ENG-PRC, V8, P215, DOI 10.1007/s11465-013-0248-8; Hallab NJ, 2001, TISSUE ENG, V7, P55, DOI 10.1089/107632700300003297; Hansen DC, 2008, ELECTROCHEM SOC INTE, V17, P31; Harrell Margaret, 2009, DATA COLLECTION METH; Hemmert M, 2004, RES POLICY, V33, P1019, DOI 10.1016/j.respol.2004.04.003; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Henkel J, 2013, BONE RES, V1, P216, DOI 10.4248/BR201303002; Heynick M, 2006, LAPA DIG TECHN SEM W; Hieu LC, 2005, ASSEMBLY AUTOM, V25, P284, DOI 10.1108/01445150510626415; Hieu LC, 2003, RAPID PROTOTYPING J, V9, P175, DOI 10.1108/13552540310477481; Hiller JD, 2009, P SOL FREEF FABR S C; Hillson D., 2002, INT J PROJ MANAG, V20, P235, DOI DOI 10.1016/S0263-7863(01)00074-6; Hitzler L, 2018, ADV ENG MATER, V20, DOI 10.1002/adem.201700658; Ho CMB, 2015, INT J PRECIS ENG MAN, V16, P1035, DOI 10.1007/s12541-015-0134-x; Hollister SJ, 2009, BIOFABRICATION, V1, DOI 10.1088/1758-5082/1/1/012001; Hollister SJ, 2009, ADV MATER, V21, P3330, DOI 10.1002/adma.200802977; Hollister SJ, 2000, INT J ORAL MAX SURG, V29, P67, DOI 10.1034/j.1399-0020.2000.290115.x; Hollister SJ, 2005, BONE TISSUE ENGINEERING, P167; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hubert C, 2014, J PHARMACEUT BIOMED, V88, P401, DOI 10.1016/j.jpba.2013.09.026; Huotilainen E, 2014, J CRANIO MAXILL SURG, V42, pE259, DOI 10.1016/j.jcms.2013.10.001; Imanishi J, 2015, INT J SURG CASE REP, V10, P83, DOI 10.1016/j.ijscr.2015.02.037; Jahed Z, 2014, BIOMATERIALS, V35, P9363, DOI 10.1016/j.biomaterials.2014.07.022; Jardini AL, 2014, VIRTUAL PHYS PROTOTY, V9, P115, DOI 10.1080/17452759.2014.900857; Junker R, 2009, CLIN ORAL IMPLAN RES, V20, P185, DOI 10.1111/j.1600-0501.2009.01777.x; Kang Y-H, 2014, J NANOMATER, V2014, P1; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Karatas Orhan Hakki, 2014, Eur J Dent, V8, P132, DOI 10.4103/1305-7456.126269; Kircher R, 2009, ELECT BEAM MELTED EB, P436; Kirk D, 2015, EVALUATION HUMAN WOR; Konrath JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176016; Kroonenburgh I, 2012, DIGITAL DENT NEWS, V6, P60; Krucoff MW, 2012, JACC-CARDIOVASC INTE, V5, P790, DOI 10.1016/j.jcin.2012.03.023; Kruth JP, 2011, CIRP ANN-MANUF TECHN, V60, P821, DOI 10.1016/j.cirp.2011.05.006; Kulkarni M., 2014, NANOMEDICINE, V111, P111, DOI DOI 10.1016/J.CARBON.2011.02.021; Kummer KM, 2013, J BIOMED MATER RES B, V101B, P677, DOI 10.1002/jbm.b.32870; Kuznetsova D, 2017, BIOFABRICATION, V9, DOI 10.1088/1758-5090/aa6725; Lambert WJ, 2010, AAPS PHARMSCITECH, V11, P1476, DOI 10.1208/s12249-010-9521-x; Lamecker H, 2007, P COMP AID SURG HEAD, P94; Larson E.W., 2011, PROJECT MANAGEMENT M, P211; Lavenus S, 2010, NANOMEDICINE-UK, V5, P937, DOI [10.2217/nnm.10.54, 10.2217/NNM.10.54]; Le C, 2011, ROMANIAN REV PRECISI, V40, P11; Lee MH, 2010, TISSUE ENG PART B-RE, V16, P41, DOI [10.1089/ten.teb.2009.0449, 10.1089/ten.TEB.2009.0449]; Lee MY, 2002, IEEE ENG MED BIOL, V21, P38, DOI 10.1109/MEMB.2002.1000184; Leong KF, 2003, BIOMATERIALS, V24, P2363, DOI 10.1016/S0142-9612(03)00030-9; Leutenecker-Twelsiek B, 2016, PROC CIRP, V50, P408, DOI 10.1016/j.procir.2016.05.016; Li J, 2012, AUSTRALASIAN J CONST, V8, P34, DOI [10.5130/ajceb.v8i1.2996, DOI 10.5130/AJCEB.V8I1.2996]; Li L, 2002, ROBOT CIM-INT MANUF, V18, P53, DOI 10.1016/S0736-5845(01)00026-6; Li WJ, 2002, J BIOMED MATER RES, V60, P613, DOI 10.1002/jbm.10167; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lichte P, 2011, INJURY, V42, P569, DOI 10.1016/j.injury.2011.03.033; Little TA, 2014, BIOPROCESS INT, V12, P3; Liu H., 2014, NUMERICAL ANAL THERM; Liu HC, 2013, EXPERT SYST APPL, V40, P828, DOI 10.1016/j.eswa.2012.08.010; Liu XS, 2013, REV ADV MATER SCI, V33, P266; Liu XY, 2004, MAT SCI ENG R, V47, P49, DOI 10.1016/j.mser.2004.11.001; Lord MS, 2010, NANO TODAY, V5, P66, DOI 10.1016/j.nantod.2010.01.001; Ma Z, 2010, COMPUT METHOD BIOMEC, V13, P235, DOI 10.1080/10255840903131878; Maji PK, 2014, RAPID PROTOTYPING J, V20, P480, DOI 10.1108/RPJ-07-2012-0066; Majstorovic V, 2013, CIRP ANN-MANUF TECHN, V62, P167, DOI 10.1016/j.cirp.2013.03.081; Mallepree T, 2009, RAPID PROTOTYPING J, V15, P325, DOI 10.1108/13552540910993842; Marro A, 2015, CURRENT PROBLEMS DIA; Mauch PD, 2009, QUALITY MANAGEMENT T; Mazumder S, 2017, INT J PHARM; Mazzoli A, 2013, MED BIOL ENG COMPUT, V51, P245, DOI 10.1007/s11517-012-1001-x; McConnell J., 2010, J VAL TECHNOL, V16, P30; McCutcheon D. M., 1993, Journal of Operations Management, V11, P239, DOI 10.1016/0272-6963(93)90002-7; McGurk M, 1997, ANN ROY COLL SURG, V79, P169; Pinto JM, 2015, MED ENG PHYS, V37, P328, DOI 10.1016/j.medengphy.2015.01.009; Miles M.B., 1994, QUALITATIVE DATA ANA, DOI DOI 10.1016/0149-7189(96)88232-2; Miron RJ, 2012, J DENT RES, V91, P736, DOI 10.1177/0022034511435260; Mitsouras D, 2015, RADIOGRAPHICS, V35, P1966, DOI 10.1148/rg.2015140320; Monzon MD, 2015, INT J ADV MANUF TECH, V76, P1111, DOI 10.1007/s00170-014-6334-1; Morrison RJ, 2015, CTS-CLIN TRANSL SCI, V8, P594, DOI 10.1111/cts.12315; Moursi AM, 1997, J CELL SCI, V110, P2187; Murr LE, 2009, J MECH BEHAV BIOMED, V2, P20, DOI 10.1016/j.jmbbm.2008.05.004; Naidu NVR, 2006, TOTAL QUALITY MANAGE; Neacsu P, 2014, INT J BIOCHEM CELL B, V55, P187, DOI 10.1016/j.biocel.2014.09.006; Negi S, 2014, RAPID PROTOTYPING J, V20, P256, DOI 10.1108/RPJ-07-2012-0065; Oh S, 2006, J BIOMED MATER RES A, V78A, P97, DOI 10.1002/jbm.a.30722; Omar M, 2017, INT J MED ROBOT COMP, V13, DOI 10.1002/rcs.1803; Orlandini S, 2013, ANAL BIOANAL CHEM, V405, P443, DOI 10.1007/s00216-012-6302-2; Oropallo W, 2016, ENG COMPUT-GERMANY, V32, P135, DOI 10.1007/s00366-015-0407-0; Oyegoke A, 2011, INT J MANAG PROJ BUS, V4, P573, DOI 10.1108/17538371111164029; Padala S, 2012, J COMPUTER TECHNOLOG, V3, P17; Pankaj P, 2013, INT J NUMER METH BIO, V29, P233, DOI 10.1002/cnm.2536; Park JH, 2012, ACTA BIOMATER, V8, P1966, DOI 10.1016/j.actbio.2011.11.026; Pasko A, 2011, GRAPH MODELS, V73, P165, DOI 10.1016/j.gmod.2011.03.001; Pham DT, 1998, INT J MACH TOOL MANU, V38, P1257, DOI 10.1016/S0890-6955(97)00137-5; Pizzolato C, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00096; Podshivalov L, 2013, PROC CIRP, V5, P247, DOI 10.1016/j.procir.2013.01.049; Poelert S, 2013, P I MECH ENG H, V227, P464, DOI 10.1177/0954411912467884; Popov I., 2009, Journal of Medical Engineering & Technology, V33, P454, DOI 10.1080/03091900902952634; Prince J. Dale, 2014, Journal of Electronic Resources in Medical Libraries, V11, P39, DOI 10.1080/15424065.2014.877247; Qian B, 2013, J ASIAN CERAM SOC, V1, P315, DOI 10.1016/j.jascer.2013.08.004; Rahmati S, 2011, INT J ADV DESIGN MAN, V3, P11; Raina H, 2017, J DRUG DELIV SCI TEC, V39, P180, DOI 10.1016/j.jddst.2017.02.013; Ramin E, 2009, P I MECH ENG H, V223, P289, DOI 10.1243/09544119JEIM452; Ramsden JJ, 2007, CIRP ANN-MANUF TECHN, V56, P687, DOI 10.1016/j.cirp.2007.10.001; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Robbins J, 2016, ADDITIVE MANUFACTURI; Robiony M, 2007, J ORAL MAXIL SURG, V65, P1198, DOI 10.1016/j.joms.2005.12.080; Rose K. H., 2013, GUID PROJ MAN BOD KN; Russell RK, 2008, EMJ-ENG MANAG J, V20, P36, DOI 10.1080/10429247.2008.11431775; Saijo H, 2009, J ARTIF ORGANS, V12, P200, DOI 10.1007/s10047-009-0462-7; Saini M, 2015, WORLD J CLIN CASES, V3, P52, DOI 10.12998/wjcc.v3.i1.52; Salgado AJ, 2004, MACROMOL BIOSCI, V4, P743, DOI 10.1002/mabi.200400026; Salmi M, 2012, RAPID PROTOTYPING J, V18, P209, DOI 10.1108/13552541211218126; Sangshetti JN, 2014, ARABIAN J CHEM; Saxby DJ, 2016, GAIT POSTURE, V49, P78, DOI 10.1016/j.gaitpost.2016.06.014; Schmidt AH, 2013, J PHARMACEUT BIOMED, V78-79, P65, DOI 10.1016/j.jpba.2013.01.032; Schmidt-Bleek K, 2012, CELL TISSUE RES, V347, P567, DOI 10.1007/s00441-011-1205-7; Sebastianelli R., 2002, INT J QUAL RELIAB MA, V19, P442, DOI [10.1108/02656710210421599, DOI 10.1108/02656710210421599]; Sharkey PF, 1999, J ARTHROPLASTY, V14, P281, DOI 10.1016/S0883-5403(99)90052-9; Sharples S, 2012, DISPLAYS, V33, P221, DOI 10.1016/j.displa.2011.12.001; SHAW B, 1985, R&D MANAGE, V15, P283, DOI 10.1111/j.1467-9310.1985.tb00039.x; Shirazi SFS, 2016, SCI TECHNOLOGY ADV M; Shrivats AR, 2014, DRUG DISCOV TODAY, V19, P781, DOI 10.1016/j.drudis.2014.04.010; Siitonen, 1993, J MANAGEMENT ACCOUNT, V5, P243; Silva DN, 2008, J CRANIO MAXILL SURG, V36, P443, DOI 10.1016/j.jcms.2008.04.003; Simonelli M, 2014, MAT SCI ENG A-STRUCT, V616, P1, DOI 10.1016/j.msea.2014.07.086; Singare S, 2004, MED ENG PHYS, V26, P671, DOI 10.1016/j.medengphy.2004.06.001; Singare S, 2009, RAPID PROTOTYPING J, V15, P19, DOI 10.1108/13552540910925027; Sipe JD, 2002, ANN NY ACAD SCI, V961, P1, DOI 10.1111/j.1749-6632.2002.tb03040.x; Slotwinski JA, 2014, J RES NATL INST STAN, V119, P460, DOI 10.6028/jres.119.018; Stamatis D.H., 2003, FAILURE MODE EFFECT; Starly B, 2006, COMPUT AIDED DESIGN, V38, P115, DOI 10.1016/J.CAD.2005.08.001; Starly B, 2004, P 9 ACM S SOL MOD AP; Stemler S., 2001, PRACT ASSESS RES EVA, V7, P137, DOI DOI 10.7275/Z6FM-2E34; Stoor P, 2014, J CRANIO MAXILL SURG, V42, P1644, DOI 10.1016/j.jcms.2014.05.006; Straub J, 2015, MACHINES, V3, P55, DOI 10.3390/machines3020055; Sun P, 2016, POWDER TECHNOL, V301, P331, DOI 10.1016/j.powtec.2016.06.022; Sun T, 2007, J MATER SCI-MATER M, V18, P321, DOI 10.1007/s10856-006-0696-3; Sun W, 2005, COMPUT AIDED DESIGN, V37, P1097, DOI 10.1016/j.cad.2005.02.002; Suska F, 2016, J ORAL MAXILLOFACIAL; Tang HP, 2015, JOM-US, V67, P555, DOI 10.1007/s11837-015-1300-4; Tang Y, 2004, ACCURACY ANAL IMPROV; Tapia G, 2014, J MANUF SCI E-T ASME, V136, DOI 10.1115/1.4028540; Tetsworth K, 2017, SICOT-J, V3, DOI 10.1051/sicotj/2016043; Thambyah A, 2005, KNEE, V12, P383, DOI 10.1016/j.knee.2004.12.005; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tontowi AE, 2001, RAPID PROTOTYPING J, V7, P180, DOI 10.1108/13552540110395637; Toth T, 2015, QUAL INNOV PROSPER, V19, P9, DOI 10.12776/QIP.V19I1.393; Tsuchiya H, 2006, J BIOMED MATER RES A, V77A, P534, DOI 10.1002/jbm.a.30677; Tuomi J, 2014, SURG INNOV, V21, P553, DOI 10.1177/1553350614524838; U. S. Department of Health and Human Services, 2013, ISO10993 US DEP HLTH; U. S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation Research Center for Drug Evaluation Research, 2006, GUID IND Q9 QUAL RIS; U.S. Food and Drug Administration, 2011, MED DEV INN IN WHIT; Vasconcelos DM, 2016, BIOMATERIALS, V84, P262, DOI 10.1016/j.biomaterials.2016.01.046; Verma S, 2009, INT J PHARMACEUT, V377, P185, DOI 10.1016/j.ijpharm.2009.05.006; Vogt FG, 2011, J PHARM SCI-US, V100, P797, DOI 10.1002/jps.22325; Von Woedtke T, 2008, GMS KRANKENHHYG INTE, V3, P3; Nguyen VH, 2017, COMPUT METHOD BIOMEC, V20, P1312, DOI 10.1080/10255842.2017.1357703; Walker J., 2014, ADDITIVE MANUFACTURI; Wang CS, 2010, COMPUT IND, V61, P187, DOI 10.1016/j.compind.2009.09.005; Wang XJ, 2016, BIOMATERIALS, V83, P127, DOI 10.1016/j.biomaterials.2016.01.012; Wegner A, 2011, SFF S AUST TEX US; Wettergreen MA, 2005, COMPUT AIDED DESIGN, V37, P1141, DOI 10.1016/j.cad.2005.02.005; Winder J, 2005, J ORAL MAXIL SURG, V63, P1006, DOI 10.1016/j.joms.2005.03.016; Wu SL, 2013, SURF COAT TECH, V233, P13, DOI 10.1016/j.surfcoat.2012.10.023; Xue C, 2012, INT J ADV COMPUTING, V4; Yan CZ, 2015, J MECH BEHAV BIOMED, V51, P61, DOI 10.1016/j.jmbbm.2015.06.024; Yavari SA, 2016, ACS APPL MATER INTER, V8, P17080, DOI 10.1021/acsami.6b03152; Yeong WY, 2014, HIGH VALUE MANUFACTURING: ADVANCED RESEARCH IN VIRTUAL AND RAPID PROTOTYPING, P115, DOI 10.1201/b15961-23; Yin R.K., 2009, CASE STUDY RES DESIG, V4th ed; Yoo DJ, 2011, BIOMATERIALS, V32, P7741, DOI 10.1016/j.biomaterials.2011.07.019; Yoo DJ, 2012, INT J PRECIS ENG MAN, V13, P527, DOI 10.1007/s12541-012-0068-5; Yoo DJ, 2011, INT J PRECIS ENG MAN, V12, P61, DOI 10.1007/s12541-011-0008-9; Yoo D, 2013, MAT SCI ENG C-MATER, V33, P1759, DOI 10.1016/j.msec.2012.12.092; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zachow S, 2007, 3D RECONSTRUCTION IN; Zadpoor AA, 2016, J BIOMED MATER RES A, V104, P3164, DOI 10.1002/jbm.a.35855; Zarringhalam H, 2006, MAT SCI ENG A-STRUCT, V435, P172, DOI 10.1016/j.msea.2006.07.084; Zhang J, 2014, MAP CLIENT USER FRIE; Zhang LC, 2011, SCRIPTA MATER, V65, P21, DOI 10.1016/j.scriptamat.2011.03.024; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8; Zhao FH, 2015, BIOMECH MODEL MECHAN, V14, P231, DOI 10.1007/s10237-014-0599-z	263	33	33	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195291	10.1371/journal.pone.0195291	http://dx.doi.org/10.1371/journal.pone.0195291			47	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649231	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900037
J	Tomoshige, K; Guo, MZ; Tsuchiya, T; Fukazawa, T; Fink-Baldauf, IM; Stuart, WD; Naomoto, Y; Nagayasu, T; Maeda, Y				Tomoshige, Koichi; Guo, Minzhe; Tsuchiya, Tomoshi; Fukazawa, Takuya; Fink-Baldauf, Iris M.; Stuart, William D.; Naomoto, Yoshio; Nagayasu, Takeshi; Maeda, Yutaka			An EGFR ligand promotes EGFR-mutant but not KRAS-mutant lung cancer in vivo	ONCOGENE			English	Article							TRANSFORMING-GROWTH-FACTOR; FACTOR-ALPHA; TRANSGENIC MICE; CONDITIONAL EXPRESSION; KINASE INHIBITORS; EPITHELIAL-CELLS; FACTOR RECEPTOR; STEM-CELLS; TGF-ALPHA; MUTATIONS	EGFR ligands (e.g., EGF and TGFA) have been shown to be clinically associated with poor survival in lung cancer. Since TGFA itself initiates autochthonous tumors in liver, breast, and pancreas but not in the lung in transgenic mice in vivo, it would appear that an EGFR ligand may not initiate but rather promote lung cancer. However, it has not been proven in vivo whether lung cancer is promoted by an EGFR ligand. Using transgenic mouse models conditionally expressing EGFR(L858R) or Kras(G12D) with TGFA (an EGFR ligand) in lung epithelium, we determined that TGFA promoted the growth of EGFR(L858R)-lung tumors in airway regions but not that of Kras(G12D)-lung tumors. Analysis of TCGA datasets identified Delta Np63 and AGR2 as potential key tumor-promoting regulators, which were highly induced in the TGFA-induced EGFR(L858R)-lung tumors. The expression of AGR2 was positively correlated with the expression of TGFA in human EGFR-mutant lung adenocarcinomas. The expression of TGFA in human EGFR-mutant lung adenocarcinomas but not in the EGFR wild-type lung adenocarcinoma was associated with poor survival. These results suggest that targeting EGFR ligands may benefit patients who carry EGFR-mutant lung tumors but will not benefit patients with KRAS-mutant lung tumors.	[Tomoshige, Koichi; Guo, Minzhe; Fink-Baldauf, Iris M.; Stuart, William D.; Maeda, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Neonatol Perinatal & Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA; [Tomoshige, Koichi; Guo, Minzhe; Fink-Baldauf, Iris M.; Stuart, William D.; Maeda, Yutaka] Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Tsuchiya, Tomoshi; Nagayasu, Takeshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 8528501, Japan; [Fukazawa, Takuya; Naomoto, Yoshio] Kawasaki Med Sch, Dept Gen Surg, Okayama 7010192, Japan; [Tomoshige, Koichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Clin Oncol, Nagasaki 8528501, Japan; [Tomoshige, Koichi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Surg Oncol, Nagasaki 8528501, Japan	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Nagasaki University; Kawasaki Medical School; Nagasaki University; Nagasaki University	Maeda, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neonatol Perinatal & Pulm Biol, Perinatal Inst, Cincinnati, OH 45229 USA.; Maeda, Y (corresponding author), Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA.	yutaka.maeda@cchmc.org	Fukazawa, Takuya/GLR-7099-2022; Guo, Minzhe/Y-3982-2018	Tomoshige, Koichi/0000-0002-0712-2989; GUO, MINZHE/0000-0002-5502-9172; Tsuchiya, Tomoshi/0000-0002-8419-1478	American Lung Association [RG309608]; CF-RDP Pilot & Feasibility Grant; Cincinnati Children's Hospital Medical Center; Rotary Foundation Global Grant; AMED; Ministry of Education, Science and Culture, Japan	American Lung Association; CF-RDP Pilot & Feasibility Grant; Cincinnati Children's Hospital Medical Center; Rotary Foundation Global Grant; AMED(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by the American Lung Association (RG309608), Trustee Award Grant, CF-RDP Pilot & Feasibility Grant, Cincinnati Children's Hospital Medical Center (YM), the Rotary Foundation Global Grant (KT), AMED (TF), and the Ministry of Education, Science and Culture, Japan (TT, TF, YN, and TN)	Ceteci F, 2011, NEOPLASIA, V13, P1005, DOI 10.1593/neo.11652; Chen Z, 2010, CANCER RES, V70, P9827, DOI 10.1158/0008-5472.CAN-10-1671; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Cross DAE, 2014, CANCER DISCOV, V4, P1046, DOI 10.1158/2159-8290.CD-14-0337; Dave V, 2008, AM J RESP CELL MOL, V38, P337, DOI 10.1165/rcmb.2007-0182OC; Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890; Fessart D, 2016, ELIFE, V5, DOI 10.7554/eLife.13887; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; Gazdar AF, 2008, CANCER PREV RES, V1, P156, DOI 10.1158/1940-6207.CAPR-08-0080; Giannou AD, 2017, EMBO MOL MED, V9, P672, DOI 10.15252/emmm.201606978; Green JA, 2017, J EXP MED, V214, P3565, DOI 10.1084/jem.20170356; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han XK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4261; Hardie WD, 2004, AM J PHYSIOL-LUNG C, V286, pL741, DOI 10.1152/ajplung.00208.2003; Hogan BLM, 2014, CELL STEM CELL, V15, P123, DOI 10.1016/j.stem.2014.07.012; Huang QL, 2016, MOL CANCER THER, V15, P2521, DOI 10.1158/1535-7163.MCT-16-0258; JHAPPAN C, 1990, CELL, V61, P1137, DOI 10.1016/0092-8674(90)90076-Q; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Ji HB, 2007, CANCER RES, V67, P4933, DOI 10.1158/0008-5472.CAN-06-4592; Jia Y, 2016, NATURE, V534, P129, DOI 10.1038/nature17960; Klijn C, 2015, NAT BIOTECHNOL, V33, P306, DOI 10.1038/nbt.3080; KORFHAGEN TR, 1994, J CLIN INVEST, V93, P1691, DOI 10.1172/JCI117152; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Linardou H, 2009, NAT REV CLIN ONCOL, V6, P352, DOI 10.1038/nrclinonc.2009.62; Liu J, 2015, CELL REP, V10, P1599, DOI 10.1016/j.celrep.2015.02.014; Maeda Y, 2006, J BIOL CHEM, V281, P9600, DOI 10.1074/jbc.M510435200; Maeda Y, 2012, J CLIN INVEST, V122, P4388, DOI 10.1172/JCI64048; Perera SA, 2009, P NATL ACAD SCI USA, V106, P474, DOI 10.1073/pnas.0808930106; Perl AK, 2009, AM J RESP CELL MOL, V40, P1, DOI 10.1165/rcmb.2008-0011ED; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Regales L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000810; Rodriguez PC, 2016, CLIN CANCER RES, V22, P3782, DOI 10.1158/1078-0432.CCR-15-0855; Rusch V, 1997, CLIN CANCER RES, V3, P515; Saito M, 2016, CANCER SCI, V107, P713, DOI 10.1111/cas.12941; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Schneider MR, 2005, ENDOCRINOLOGY, V146, P5237, DOI 10.1210/en.2005-0418; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Siveke JT, 2007, CANCER CELL, V12, P266, DOI 10.1016/j.ccr.2007.08.002; Sordella R, 2004, SCIENCE, V305, P1163, DOI 10.1126/science.1101637; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; TATEISHI M, 1991, BRIT J CANCER, V63, P130, DOI 10.1038/bjc.1991.26; VELU TJ, 1987, SCIENCE, V238, P1408, DOI 10.1126/science.3500513; Wagner M, 1998, GASTROENTEROLOGY, V115, P1254, DOI 10.1016/S0016-5085(98)70098-8; Watanabe H, 2014, J CLIN INVEST, V124, P1636, DOI 10.1172/JCI71545; Wilson TR, 2012, NATURE, V487, P505, DOI 10.1038/nature11249; Xu CX, 2015, MOL CANCER THER, V14, P2382, DOI 10.1158/1535-7163.MCT-15-0077; Yanagi S, 2007, J CLIN INVEST, V117, P2929, DOI 10.1172/JCI31854; Yoh K, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00051; Zhang J, 2008, CANCER PREV RES, V1, P201, DOI 10.1158/1940-6207.CAPR-08-0014; Zhang X, 2017, NAT COMMUN, V8, P1, DOI [10.1038/s41467-017-01968-5, 10.1038/ncomms14542, 10.1038/s41467-017-00321-0]; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao R, 2014, DEV CELL, V30, P151, DOI 10.1016/j.devcel.2014.06.004; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	56	15	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 12	2018	37	28					3894	3908		10.1038/s41388-018-0240-1	http://dx.doi.org/10.1038/s41388-018-0240-1			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	GM8HR	29662194				2022-12-26	WOS:000438465600010
J	Oganesyan, V; Peng, L; Bee, JS; Li, J; Perry, SR; Comer, F; Xu, LD; Cook, K; Senthil, K; Clarke, L; Rosenthal, K; Gao, CS; Damschroder, M; Wu, H; Dall'Acqua, W				Oganesyan, Vaheh; Peng, Li; Bee, Jared S.; Li, John; Perry, Samuel R.; Comer, Frank; Xu, Linda; Cook, Kimberly; Senthil, Kannaki; Clarke, Lori; Rosenthal, Kim; Gao, Changshou; Damschroder, Melissa; Wu, Herren; Dall'Acqua, William			Structural insights into the mechanism of action of a biparatopic anti-HER2 antibody	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						analytical ultracentrifugation; antibody; crystallography; epitope mapping; phosphorylation	EPIDERMAL-GROWTH-FACTOR; BREAST-CANCER; FACTOR-RECEPTOR; LIGAND; COMBINATION; ACTIVATION; SURVIVAL; LINKERS; BINDING; DESIGN	Pathways of human epidermal growth factor (EGF) receptors are activated upon ligand-dependent or -independent homo- or heterodimerization and their subsequent transphosphorylation. Overexpression of these receptors positively correlates with transphosphorylation rates and increased tumor growth rates. MEDI4276, an anti-human epidermal growth factor receptor 2 (HER2) biparatopic antibody-drug conjugate, has two paratopes within each antibody arm. One, 39S, is aiming at the HER2 site involved in receptor dimerization and the second, single chain fragment (scFv), mimicking trastuzumab. Here we present the cocrystal structure of the 39S Fab-HER2 complex and, along with biophysical and functional assays, determine the corresponding epitope of MEDI4276 and its underlying mechanism of action. Our results reveal that MEDI4276's uniqueness is based first on the ability of its 39S paratope to block HER2 homo- or heterodimerization and second on its ability to cluster the receptors on the surface of receptor-overexpressing cells.	[Oganesyan, Vaheh; Peng, Li; Xu, Linda; Cook, Kimberly; Senthil, Kannaki; Clarke, Lori; Rosenthal, Kim; Gao, Changshou; Damschroder, Melissa; Wu, Herren; Dall'Acqua, William] MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA; [Bee, Jared S.] MedImmune, Dept Analyt Sci, Gaithersburg, MD 20878 USA; [Li, John; Perry, Samuel R.; Comer, Frank] MedImmune, Dept Biosuper, Gaithersburg, MD 20878 USA; [Peng, Li] Palleon Pharmaceut, 266 Second Ave, Waltham, MA 02451 USA; [Bee, Jared S.] MacroGenics, 9704 Med Ctr Dr, Rockville, MD 20850 USA; [Li, John] Salubris Biotherapeut Inc, 45 W Watkins Mill Rd, Gaithersburg, MD 20878 USA; [Perry, Samuel R.] Agilis Biotherapeut, 245 First St,Ste 1800, Cambridge, MA 02142 USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; AstraZeneca; Medimmune	Oganesyan, V; Dall'Acqua, W (corresponding author), MedImmune, Dept Antibody Discovery & Prot Engn, Gaithersburg, MD 20878 USA.	oganesyanv@medimmune.com; dallacquaw@medimmune.com		Bee, Jared/0000-0002-4391-0560; Oganesyan, Vaheh/0000-0001-8910-9202	MedImmune LLC.	MedImmune LLC.(AstraZenecaMedimmune)	This work was supported by MedImmune LLC. The authors declare that they have no conflicts of interest with the contents of this article.	Adolf-Bryfogle J, 2015, NUCLEIC ACIDS RES, V43, pD432, DOI 10.1093/nar/gku1106; Arkhipov A, 2013, ELIFE, V2, DOI 10.7554/eLife.00708; Balbo A, 2005, P NATL ACAD SCI USA, V102, P81, DOI 10.1073/pnas.0408399102; Bostrom J, 2009, SCIENCE, V323, P1610, DOI 10.1126/science.1165480; Brennan PJ, 2000, ONCOGENE, V19, P6093, DOI 10.1038/sj.onc.1203967; Brinkmann U, 2017, MABS-AUSTIN, V9, P182, DOI 10.1080/19420862.2016.1268307; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; Chung I, 2010, NATURE, V464, P783, DOI 10.1038/nature08827; Dimasi N, 2009, J MOL BIOL, V393, P672, DOI 10.1016/j.jmb.2009.08.032; Evers TH, 2006, BIOCHEMISTRY-US, V45, P13183, DOI 10.1021/bi061288t; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kasturirangan S, 2017, J BIOL CHEM, V292, P4361, DOI 10.1074/jbc.M116.770628; Klein JS, 2014, PROTEIN ENG DES SEL, V27, P325, DOI 10.1093/protein/gzu043; Kurata T, 2014, INVEST NEW DRUG, V32, P946, DOI 10.1007/s10637-014-0112-7; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li JY, 2016, CANCER CELL, V29, P117, DOI 10.1016/j.ccell.2015.12.008; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Maly JJ, 2014, BREAST CANCER-BASIC, V8, P81, DOI 10.4137/BCBCR.S9032; Mitri Zahi, 2012, Chemother Res Pract, V2012, P743193, DOI 10.1155/2012/743193; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nahta R., 2012, MOL MECH TRASTUZUMAB, V2012, DOI [10.5402/2012/428062, DOI 10.5402/2012/428062]; Nordstrom JL, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3069; North B, 2011, J MOL BIOL, V406, P228, DOI 10.1016/j.jmb.2010.10.030; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel TA, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0419-5; SCHREIBER AB, 1983, J BIOL CHEM, V258, P846; Schuck P, 2000, BIOPOLYMERS, V54, P328, DOI 10.1002/1097-0282(20001015)54:5<328::AID-BIP40>3.0.CO;2-P; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Stein RA, 2000, J MOL EVOL, V50, P397, DOI 10.1007/s002390010043; USHIRO H, 1980, J BIOL CHEM, V255, P8363; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	36	27	32	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8439	8448		10.1074/jbc.M117.818013	http://dx.doi.org/10.1074/jbc.M117.818013			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29669810	Green Published, hybrid			2022-12-26	WOS:000434205700009
J	Brustio, PR; Lupo, C; Ungureanu, AN; Frati, R; Rainoldi, A; Boccia, G				Brustio, Paolo Riccardo; Lupo, Corrado; Ungureanu, Alexandru Nicolae; Frati, Riccardo; Rainoldi, Alberto; Boccia, Gennaro			The relative age effect is larger in Italian soccer top-level youth categories and smaller in Serie A	PLOS ONE			English	Article							SELECTION BIAS; SPORT	The relative age effect (RAE; i.e., an asymmetry in the birth distribution) is a bias observed in sport competitions that may favour relatively older athletes in talent identification. Therefore, the aim of this study was to investigate the presence of RAE in elite soccer players competing in the Italian championships, even considering the discriminations of younger and older Serie A players (in relation to the median age of the sample), and different positional roles (i.e., goalkeeper, defender, midfielder, forward) for each observed category. A total of 2051 players competing into the 2017-2018 Italian under-15 (n = 265), under-16 (n = 362), under-17 (n = 403), Primavera (n = 421) and Serie A (n = 600) championships were analysed. The birth-date distributions, grouped in four quartiles (i.e., January-March, Q1; April-June, Q2; July-September, Q3; October-December, Q4), were compared to a uniform distribution using Chi-squared analysis. The week of birth was analysed using Poisson regression. The results showed a large over-representation of players born in Q1 in all soccer player categories. However, the effect size of this trend resulted smaller as age increased. Individuals born in Q1 have about two-folds more chances to become a Serie A player compared to those born in Q4. The Poisson regression analysis showed that RAE was greater for defenders than for forwards among all categories. Therefore, a strongly biased selection emerged among elite soccer players competing in Italian championships, highlighting how young individuals born in the first three months have many more chances to become elite players compared to the others.	[Brustio, Paolo Riccardo; Lupo, Corrado; Ungureanu, Alexandru Nicolae; Rainoldi, Alberto; Boccia, Gennaro] Univ Turin, Sch Exercise & Sport Sci, Dept Med Sci, NeuroMuscularFunct Res Grp,SUISM, Turin, Italy; [Frati, Riccardo] Univ Turin, SUISM, Sch Exercise & Sport Sci, Turin, Italy	University of Turin; University of Turin	Lupo, C (corresponding author), Univ Turin, Sch Exercise & Sport Sci, Dept Med Sci, NeuroMuscularFunct Res Grp,SUISM, Turin, Italy.	corrado.lupo@unito.it		Lupo, Corrado/0000-0003-1546-8573; Ungureanu, Alexandru Nicolae/0000-0002-8780-1737; Boccia, Gennaro/0000-0001-8706-4098; BRUSTIO, PAOLO RICCARDO/0000-0001-8422-5132	Department of Medical Sciences, University of Torino, Turin, Italy	Department of Medical Sciences, University of Torino, Turin, Italy	All the funding regarding the realization of this study were received internally to the authors' organization (Dr. Lupo's and Prof. Rainoldi's Departmental funding; Department of Medical Sciences, University of Torino, Turin, Italy). There was no additional external funding received for this study.	Ashworth J, 2007, J SPORT ECON, V8, P355, DOI 10.1177/1527002506287695; Barnsley R. H., 1985, CANADIAN ASS HLTH PH, V51, P23, DOI [10.1177/1012690210371560, DOI 10.1177/1012690210371560]; Barnsley R.H., 1992, RELAT AGE EFF FOOTBA, V27, P77, DOI [DOI 10.1177/101269029202700105, 10.1177/101269029202700105]; Boccia G, 2017, SPORT SCI HLTH, V13, P349, DOI [10.1007/s11332-017-0364-7, DOI 10.1007/S11332-017-0364-7]; Brazo-Sayavera J, 2017, J SPORT SCI, V35, P2172, DOI 10.1080/02640414.2016.1260151; Carling C, 2009, SCAND J MED SCI SPOR, V19, P3, DOI 10.1111/j.1600-0838.2008.00867.x; Cobley S, 2009, J EDUC PSYCHOL, V101, P520, DOI 10.1037/a0013845; Cobley S, 2009, SPORTS MED, V39, P235, DOI 10.2165/00007256-200939030-00005; Cohen J., 2013, APPL MULTIPLE CORREL, DOI DOI 10.4324/9780203774441; Costa AM, 2013, EUR J SPORT SCI, V13, P437, DOI 10.1080/17461391.2012.742571; Delorme N, 2015, INT REV SOCIOL SPORT, V50, P740, DOI 10.1177/1012690213493104; Delorme N, 2009, RES Q EXERCISE SPORT, V80, P336, DOI 10.1080/02701367.2009.10599568; Doyle JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192209; Fukuda DH, 2017, SPORT SCI HLTH, V13, P99, DOI [10.1007/s11332-017-0351-z, DOI 10.1007/S11332-017-0351-Z]; Fumarco L, 2015, WORKING PAPERS MANAG, V1501; Fumarco L, 2018, EUR SPORT MANAG Q, V18, P501, DOI 10.1080/16184742.2018.1424225; Furley P, 2016, J SPORT SCI, V34, P459, DOI 10.1080/02640414.2015.1061198; Gonzalez-Villora S, 2015, J HUM KINET, V47, P237, DOI 10.1515/hukin-2015-0079; Gutierrez Diaz del Campo D, 2010, J SPORT SCI MED, V9, P190; Hancock DJ, 2013, EUR J SPORT SCI, V13, P630, DOI 10.1080/17461391.2013.775352; Helsen WF, 1998, AM J HUM BIOL, V10, P791, DOI 10.1002/(SICI)1520-6300(1998)10:6&lt;791::AID-AJHB10&gt;3.0.CO;2-1; Helsen WF, 2005, J SPORT SCI, V23, P629, DOI 10.1080/02640410400021310; Sierra-Diaz MJ, 2017, SPORTS, V5, DOI 10.3390/sports5010005; Jones BD, 2018, J SPORT SCI, V36, P697, DOI 10.1080/02640414.2017.1332420; le Gall F, 2010, J SCI MED SPORT, V13, P90, DOI 10.1016/j.jsams.2008.07.004; Loffing F, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00620; Mann DL, 2017, J SPORT SCI, V35, P784, DOI 10.1080/02640414.2016.1189588; Muller L, 2016, PERCEPT MOTOR SKILL, V122, P701, DOI 10.1177/0031512516640390; Mujika I, 2009, J SPORT SCI, V27, P1153, DOI 10.1080/02640410903220328; Musch J, 2001, DEV REV, V21, P147, DOI 10.1006/drev.2000.0516; Reed KE, 2017, SCAND J MED SCI SPOR, V27, P2070, DOI 10.1111/sms.12815; Rubajczyk K, 2017, J SPORT SCI MED, V16, P280; Salinero JJ, 2013, J HUM SPORT EXERC, V8, P966, DOI 10.4100/jhse.2013.84.07; Vaeyens R, 2005, J SPORT SCI, V23, P747, DOI 10.1080/02640410400022052; Vincent J, 2006, J SPORT SCI, V24, P405, DOI 10.1080/02640410500244655; Votteler A, 2014, EUR J SPORT SCI, V14, P433, DOI 10.1080/17461391.2013.837510; Wattie N, 2015, SPORTS MED, V45, P83, DOI 10.1007/s40279-014-0248-9	37	50	54	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196253	10.1371/journal.pone.0196253	http://dx.doi.org/10.1371/journal.pone.0196253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD4BF	29672644	Green Published, gold, Green Submitted			2022-12-26	WOS:000430446800104
J	Kschowak, MJ; Wortmann, H; Dickschat, JS; Schrader, J; Buchhaupt, M				Kschowak, Max J.; Wortmann, Hannah; Dickschat, Jeroen S.; Schrader, Jens; Buchhaupt, Markus			Heterologous expression of 2-methylisoborneol / 2 methylenebornane biosynthesis genes in Escherichia coli yields novel C11-terpenes	PLOS ONE			English	Article							STREPTOMYCES-COELICOLOR; VOLATILE COMPOUNDS; MUSTY ODOR; SYNTHASE; GEOSMIN; EARTHY; 2-METHYLENEBORNANE; IDENTIFICATION; METABOLISM; CLONING	The structural diversity of terpenoids is limited by the isoprene rule which states that all primary terpene synthase products derive from methyl-branched building blocks with five carbon atoms. With this study we discover a broad spectrum of novel terpenoids with eleven carbon atoms as byproducts of bacterial 2-methylisoborneol or 2-methylenebornane synthases. Both enzymes use 2-methyl-GPP as substrate, which is synthesized from GPP by the action of a methyltransferase. We used E. coli strains that heterologously produce different C11-terpene synthases together with the GPP methyltransferase and the mevalonate pathway enzymes. With this de novo approach, 35 different C11-terpenes could be produced. In addition to eleven known compounds, it was possible to detect 24 novel C11-terpenes which have not yet been described as terpene synthase products. Four of them, 3,4-dimethylcumene, 2-methylborneol and the two diastereomers of 2-methylcitronellol could be identified. Furthermore, we showed that an E. coli strain expressing the GPP-methyltransferase can produce the C16-terpene 6-methylfarnesol which indicates the condensation of 2-methyl-GPP and IPP to 6-methyl-FPP by the E. coli FPP-synthase. Our study demonstrates the broad range of unusual terpenes accessible by expression of GPP-methyltransferases and C11-terpene synthases in E. coli and provides an extended mechanism for C11-terpene synthases.	[Kschowak, Max J.; Wortmann, Hannah; Schrader, Jens; Buchhaupt, Markus] DECHEMA Res Inst, Ind Biotechnol, Frankfurt, Germany; [Kschowak, Max J.] Goethe Univ, Fac Biol Sci, Frankfurt, Germany; [Dickschat, Jeroen S.] Rheinische Friedrich Wilhelms Univ, Kekule Inst Organ Chem & Biochem, Bonn, Germany	Goethe University Frankfurt; University of Bonn	Buchhaupt, M (corresponding author), DECHEMA Res Inst, Ind Biotechnol, Frankfurt, Germany.	buchhaupt@dechema.de		Lepple, Max J/0000-0003-4378-3706; Buchhaupt, Markus/0000-0003-2720-5973	German Federal Ministry of Food and Agriculture [FKZ 22008713]	German Federal Ministry of Food and Agriculture	This work was funded by the German Federal Ministry of Food and Agriculture (https://internationalfnr.de/; FKZ 22008713). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams R.P, 2017, IDENTIFICATION ESSEN, V5th; Alonso-Gutierrez J, 2013, METAB ENG, V19, P33, DOI 10.1016/j.ymben.2013.05.004; Asikainen M, 2013, GREEN CHEM, V15, P3230, DOI 10.1039/c3gc41224e; AUSUBEL FM, 1999, SHORT PROTOCOLS MOL; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; Borujeni AE, 2014, NUCLEIC ACIDS RES, V42, P2646, DOI 10.1093/nar/gkt1139; Brock NL, 2013, ANGEW CHEM INT EDIT, V52, P2100, DOI 10.1002/anie.201209173; Buckingham J, DICT NATURAL PRODUCT; Chou WKW, 2017, J ANTIBIOT, V70, P625, DOI 10.1038/ja.2017.24; Chou WKW, 2011, TETRAHEDRON, V67, P6627, DOI 10.1016/j.tet.2011.05.084; Citron CA, 2012, CHEMBIOCHEM, V13, P202, DOI 10.1002/cbic.201100641; Dickschat JS, 2007, ANGEW CHEM INT EDIT, V46, P8287, DOI 10.1002/anie.200702496; Dickschat JS, 2016, NAT PROD REP, V33, P87, DOI 10.1039/c5np00102a; Fischer MJC, 2011, BIOTECHNOL BIOENG, V108, P1883, DOI 10.1002/bit.23129; Fravel DR, 2002, J AGR FOOD CHEM, V50, P3761, DOI 10.1021/jf0117098; GERBER NN, 1969, J ANTIBIOT, V22, P508, DOI 10.7164/antibiotics.22.508; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; GRANGER R, 1964, CR HEBD ACAD SCI, V258, P5539; Hanahan D., 1985, DNA CLONING PRACTICA, V1, P109; KARAHADIAN C, 1985, J AGR FOOD CHEM, V33, P339, DOI 10.1021/jf00063a005; Koksal M, 2012, BIOCHEMISTRY-US, V51, P3003, DOI 10.1021/bi300109c; Koksal M, 2012, BIOCHEMISTRY-US, V51, P3011, DOI 10.1021/bi201827a; Komatsu M, 2008, P NATL ACAD SCI USA, V105, P7422, DOI 10.1073/pnas.0802312105; KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1; KOYAMA T, 1980, J AM CHEM SOC, V102, P3614, DOI 10.1021/ja00530a050; MARTIN JF, 1988, J AGR FOOD CHEM, V36, P1257, DOI 10.1021/jf00084a032; MEDSKER LL, 1969, ENVIRON SCI TECHNOL, V3, P476, DOI 10.1021/es60028a008; Nagaki M, 2000, J MOL CATAL B-ENZYM, V9, P33, DOI 10.1016/S1381-1177(99)00081-8; Piriou P, 2009, J WATER SUPPLY RES T, V58, P532, DOI 10.2166/aqua.2009.124; RUZICKA L, 1953, EXPERIENTIA, V9, P357, DOI 10.1007/BF02167631; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; SCHRADER J, 2015, BIOTECHNOLOGY ISOPRE; Steyer D, 2013, FOOD MICROBIOL, V33, P228, DOI 10.1016/j.fm.2012.09.021; TABACHEK JAL, 1976, J FISH RES BOARD CAN, V33, P25, DOI 10.1139/f76-004; TOYOTA M, 1990, PHYTOCHEMISTRY, V29, P2334, DOI 10.1016/0031-9422(90)83066-A; Tseng HC, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-96; Wallach O., 1887, LIEBIGS ANN CHEM, V239, P1; Wang CM, 2008, J AM CHEM SOC, V130, P8908, DOI 10.1021/ja803639g; Wang CL, 2016, BIOTECHNOL J, V11, P1291, DOI 10.1002/biot.201600250; Wang Z, 2006, WA SCI TECHNOL, V6, P147, DOI 10.2166/ws.2006.732; Zhou J, 2014, J BIOTECHNOL, V169, P42, DOI 10.1016/j.jbiotec.2013.11.009	42	18	18	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196082	10.1371/journal.pone.0196082	http://dx.doi.org/10.1371/journal.pone.0196082			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672609	Green Published, Green Submitted, gold			2022-12-26	WOS:000430446800083
J	Lee, HH; Kim, SY; Na, JC; Yoon, YE; Han, WK				Lee, Hyung Ho; Kim, Sook Young; Na, Joon Chae; Yoon, Young Eun; Han, Woong Kyu			Exogenous pentraxin-3 inhibits the reactive oxygen species-mitochondrial and apoptosis pathway in acute kidney injury	PLOS ONE			English	Article							LONG PENTRAXIN; INNATE IMMUNITY; PTX3; PROGRESSION; CALCIUM; BIOLOGY	Pentraxin-3 (PTX3) is a long-form member of the pentraxin family of proteins that has been studied in inflammatory diseases and in various organs. We found that PTX3 protects kidney cells during ischemia and proinflammatory acute kidney injury. The aim of this study was to develop an in vitro experimental model of acute kidney injury and to analyze the protective mechanism of exogenous recombinant PTX3. In this study, cells of the HK-2 renal tubular cell line were treated with a calcium ionophore (A23187), which induced injury by increasing intracellular calcium concentrations and inducing calpain activity and the generation of reactive oxygen species. Exposure of cells to PTX3 significantly attenuated these effects. In addition, the activity of caspase-3 and PARP-1 were decreased in ischemic cells exposed to exogenous recombinant PTX3. PTX3 stabilized the mitochondrial membrane potential and suppressed apoptosis, resulting in the protection of renal tubular cells from ischemic injury.	[Lee, Hyung Ho] Natl Hlth Insurance Serv Ilsan Hosp, Dept Urol, Gyeonggi Do, South Korea; [Lee, Hyung Ho; Kim, Sook Young; Na, Joon Chae; Han, Woong Kyu] Yonsei Univ, Urol Sci Inst, Dept Urol, Coll Med, Seoul, South Korea; [Yoon, Young Eun] Hanyang Univ, Dept Urol, Coll Med, Seoul, South Korea; [Han, Woong Kyu] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea	National Health Insurance Service; Yonsei University; Yonsei University Health System; Hanyang University; Yonsei University; Yonsei University Health System	Han, WK (corresponding author), Yonsei Univ, Urol Sci Inst, Dept Urol, Coll Med, Seoul, South Korea.; Han, WK (corresponding author), Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea.	hanwk@yuhs.ac	Na, Joon Chae/GNW-2299-2022	Na, Joon Chae/0000-0003-4449-8472; Han, Woong Kyu/0000-0002-2527-4046; Yoon, Young Eun/0000-0001-8059-6649	"Dongwha Holdings" Faculty Research Assistance Program of Yonsei University College of Medicine [6-2015-0064]	"Dongwha Holdings" Faculty Research Assistance Program of Yonsei University College of Medicine	We acknowledge funding by the "Dongwha Holdings" Faculty Research Assistance Program of Yonsei University College of Medicine with the grant agreement 6-2015-0064 to WKH. The funders had the decision to publish the manuscript.	Anders HJ, 2011, KIDNEY INT, V80, P915, DOI 10.1038/ki.2011.217; Bottazzi B, 2010, ANNU REV IMMUNOL, V28, P157, DOI 10.1146/annurev-immunol-030409-101305; Bove T, 2004, J CARDIOTHOR VASC AN, V18, P442, DOI 10.1053/j.jvca.2004.05.021; Bussolati B, 2003, J IMMUNOL, V170, P1466, DOI 10.4049/jimmunol.170.3.1466; Chen JL, 2012, KIDNEY INT, V82, P1195, DOI 10.1038/ki.2012.268; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Chiarugi A, 2002, SCIENCE, V297, P200, DOI 10.1126/science.1074592; Dias AAM, 2001, J LEUKOCYTE BIOL, V69, P928; Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Inforzato A, 2011, TISSUE ANTIGENS, V77, P271, DOI 10.1111/j.1399-0039.2011.01645.x; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Latini R, 2004, CIRCULATION, V110, P2349, DOI 10.1161/01.CIR.0000145167.30987.2E; Lech M, 2013, KIDNEY INT, V83, P647, DOI 10.1038/ki.2012.463; Lee WK, 2006, AM J PHYSIOL-RENAL, V291, pF823, DOI 10.1152/ajprenal.00276.2005; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Nauta AJ, 2005, KIDNEY INT, V67, P543, DOI 10.1111/j.1523-1755.2005.67111.x; Peri G, 2000, CIRCULATION, V102, P636, DOI 10.1161/01.CIR.102.6.636; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Salio M, 2008, CIRCULATION, V117, P1055, DOI 10.1161/CIRCULATIONAHA.107.749234; Smith MA, 2012, CARDIOVASC RES, V96, P32, DOI 10.1093/cvr/cvs163; Speeckaert MM, 2013, J CLIN IMMUNOL, V33, P881, DOI 10.1007/s10875-013-9879-0; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Vindis C, 2005, ARTERIOSCL THROM VAS, V25, P639, DOI 10.1161/01.ATV.0000154359.60886.33; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zhu HF, 2014, TRANSPL INT, V27, P87, DOI 10.1111/tri.12197	28	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0195758	10.1371/journal.pone.0195758	http://dx.doi.org/10.1371/journal.pone.0195758			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672566	gold, Green Published, Green Submitted			2022-12-26	WOS:000430446800044
J	Boswihi, SS; Udo, EE; Monecke, S; Mathew, B; Noronha, B; Verghese, T; Tappa, SB				Boswihi, Samar S.; Udo, Edet E.; Monecke, Stefan; Mathew, Bindu; Noronha, Bobby; Verghese, Tina; Tappa, Sajida B.			Emerging variants of methicillin-resistant Staphylococcus aureus genotypes in Kuwait hospitals	PLOS ONE			English	Article							MEC SCCMEC TYPE; FUSIDIC ACID; SEQUENCE TYPE; MULTIRESISTANT; IDENTIFICATION; EMERGENCE; CLONES	Background Frequent changes in the epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) occurring worldwide demand regular surveillance to study their composition and distribution in healthcare facilities. We investigated the genotypic characteristics of MRSA obtained in Kuwait hospitals to better understand their clonal distribution. Materials and methods A total of 1,327 MRSA isolates obtained from clinical samples in 13 Kuwait hospitals from 1 January to 31 December 2016 were investigated using antibiogram, SCCmec typing, spa typing and DNA microarray. Results The isolates belonged to six SCCmec types with the majority belonging to type IV (658; 49.5%) and type V (355; 26.7%). Two hundred and sixty-one spa types were identified with spa types t688, t304, t860, t127, t044, t311, t002, t223, t267, t019, t3841, t005, t084, t852, and t657 constituting 51.0% (n = 677) of the isolates. Among the 1,327 MRSA isolates, 102 (7.68%) isolates were identified as novel variants of internationally recognized MRSA clones. These 102 isolates were investigated further and belonged to 14 clonal complexes (CCs) with CC361 (32; 32.3%), CC30 (15; 14.7%), CC22 (13; 12.7%) and CC1 (11, 10.7%) as the dominant CCs. Eighty-one (79.4%) of the novel isolates harbored SCCmec IV or V +fusC composite genetic elements. Four isolates (3.9%) harbored unusual combinations of ccrand mec complexes comprising of CC6-MRSA [IV+fusC+ccrC], CC97-MRSA [V/V-r+fusC+ccrAB2], CC121-MRSA [VN-r+fusC+ccrB4] and CC1-MRSA-pseudoSCCmec [class B mec+fusc+ccrAB1]. Forty-six (45.1%) of these isolates were positive for PVL and 89 (87.2%) were resistant to fusidic acid mediated by fusC. Conclusions The study showed the emergence of novel variants of previously recognized MRSA genotypes with unusual genetic characteristics including high prevalence of PVL and fusidic acid resistance in Kuwait hospitals. This has added to the dynamic lists of known variations in MRSA genomes which can impose serious challenges for infection control and treatment of MRSA infections.	[Boswihi, Samar S.; Udo, Edet E.; Mathew, Bindu; Noronha, Bobby; Verghese, Tina; Tappa, Sajida B.] Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait; [Monecke, Stefan] Alere Technol GmbH, Jena, Germany; [Monecke, Stefan] InfectoGnost Res Campus, Jena, Germany; [Monecke, Stefan] Tech Univ Dresden, Inst Med Microbiol & Hyg, Dresden, Germany	Kuwait University; Alere; Technische Universitat Dresden	Udo, EE (corresponding author), Kuwait Univ, Fac Med, Dept Microbiol, Jabriya, Kuwait.	EDET@hsc.edu.kw	Udo, Edet E/H-7367-2016	Udo, Edet E/0000-0002-7269-7949	Kuwait University [YM02/12]	Kuwait University	This work was funded by Research Sector, Kuwait University Grant no. YM02/12 to SSB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires-De-Sousa M, 2008, J CLIN MICROBIOL, V46, P2912, DOI 10.1128/JCM.00692-08; Albrecht N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028189; [Anonymous], 2015, M100S25 CLSI; Aqel AA, 2015, J INFECT PUBLIC HEAL, V8, P90, DOI 10.1016/j.jiph.2014.05.007; Balakuntla J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094293; Boswihi SS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162744; Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Coll F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aak9745; Collignon P, 1998, LANCET, V352, P145, DOI 10.1016/S0140-6736(98)85051-4; Coombs GW, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-215; D'Souza N, 2010, J CLIN MICROBIOL, V48, P1806, DOI 10.1128/JCM.01867-09; El-Mahdy TS, 2014, CLIN MICROBIOL INFEC, V20, P169, DOI 10.1111/1469-0691.12240; Ellington MJ, 2015, INT J ANTIMICROB AG, V45, P477, DOI 10.1016/j.ijantimicag.2015.01.009; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Ghaznavi-Rad E, 2010, J CLIN MICROBIOL, V48, P867, DOI 10.1128/JCM.01112-09; Gosbell IB, 2001, MED J AUSTRALIA, V174, P627, DOI 10.5694/j.1326-5377.2001.tb143470.x; Goudarzi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155529; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Khairalla AS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07713-8; Kinnevey PM, 2013, ANTIMICROB AGENTS CH, V57, P524, DOI 10.1128/AAC.01689-12; Meric G, 2015, GENOME BIOL EVOL, V7, P1313, DOI 10.1093/gbe/evv066; Monecke S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162654; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Nadig S, 2010, J MED MICROBIOL, V59, P815, DOI 10.1099/jmm.0.017632-0; Raji MA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00911; Senok A., 2016, New Microbes and New Infections, V14, P13, DOI 10.1016/j.nmni.2016.07.009; Shore AC, 2008, ANTIMICROB AGENTS CH, V52, P4407, DOI 10.1128/AAC.00447-08; Shore AC, 2012, ANTIMICROB AGENTS CH, V56, P5340, DOI 10.1128/AAC.01247-12; Sonnevend A, 2012, J CLIN PATHOL, V65, P178, DOI 10.1136/jclinpath-2011-200436; Udo E. E., 2016, New Microbes and New Infections, V12, P24, DOI 10.1016/j.nmni.2016.03.008; Udo E E, 1998, Int J Infect Dis, V3, P82, DOI 10.1016/S1201-9712(99)90014-0; Udo EE, 2013, MED PRIN PRACT, V22, P20, DOI 10.1159/000354201; Udo EE, 2017, J INFECT DEV COUNTR, V11, P513, DOI 10.3855/jidc.8954; UDO EE, 1993, J HOSP INFECT, V25, P97, DOI 10.1016/0195-6701(93)90100-E; Vogel A, 2016, NEW ZEAL MED J, V129, P77; Weber S, 2010, GENETIC FINGERPRINTI; Williamson DA, 2014, CLIN INFECT DIS, V59, P1451, DOI 10.1093/cid/ciu658; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	40	32	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195933	10.1371/journal.pone.0195933	http://dx.doi.org/10.1371/journal.pone.0195933			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668723	Green Submitted, Green Published, gold			2022-12-26	WOS:000430290200067
J	Dimitrov, D; Du, ZB; da Fonseca, CM				Dimitrov, Darko; Du, Zhibin; da Fonseca, Carlos M.			The minimal-ABC trees with B-1-branches	PLOS ONE			English	Article							ATOM-BOND CONNECTIVITY; DEGREE SEQUENCE; STRUCTURAL-PROPERTIES; EXTREMAL TREES; PENDENT PATHS; LENGTH 3; INDEX; CONJECTURE; ALKANES; GRAPHS	The atom-bond connectivity index (or, for short, ABC index) is a molecular structure descriptor bridging chemistry to graph theory. It is probably the most studied topological index among all numerical parameters of a graph that characterize its topology. For a given graph G = (V, E), the ABC index of G is defined as ABC(G) = Sigma(ij is an element of E)root(d(i) + d(j) 2)/(d(i)d(j)), where d(i) denotes the degree of the vertex i, and ij is the edge incident to the vertices land j. A combination of physicochemical and the ABC index properties are commonly used to foresee the bioactivity of different chemical composites. Additionally, the applicability of the ABC index in chemical thermodynamics and other areas of chemistry, such as in dendrimer nanostars, benzenoid systems, fluoranthene congeners, and phenylenes is well studied in the literature. While finding of the graphs with the greatest ABC-value is a straightforward assignment, the characterization of the tree(s) with minimal ABC index is a problem largely open and has recently given rise to numerous studies and conjectures. A B-1-branch of a graph is a pendent path of order 2. In this paper, we provide an important step forward to the full characterization of these minimal trees. Namely, we show that a minimal-ABC tree contains neither 4 nor 3 B-1-branches. The case when the number of B-1-branches is 2 is also considered.	[Dimitrov, Darko] Hsch Tech & Wirtschaft Berlin, Wilhelminenhofstr 75A, D-12459 Berlin, Germany; [Du, Zhibin] Zhaoqing Univ, Sch Math & Stat, Zhaoqing 526061, Guangdong, Peoples R China; [da Fonseca, Carlos M.] Univ Primorska, Dept Math, Glagoljsaska 8, Koper 6000, Slovenia; [Dimitrov, Darko] Fac Informat Studies, Novo Mesto, Slovenia	Zhaoqing University; University of Primorska	Du, ZB (corresponding author), Zhaoqing Univ, Sch Math & Stat, Zhaoqing 526061, Guangdong, Peoples R China.	zhibindu@126.com	Dimitrov, Darko/AAI-9957-2020; da Fonseca, Carlos M./K-2142-2019; du, zhibin/GPT-2615-2022; Du, Zhibin/T-8529-2019	da Fonseca, Carlos M./0000-0001-7742-4416; du, zhibin/0000-0001-5795-3580; 	National Natural Science Foundation of China [11701505]; Guangdong Provincial Natural Science Foundation of China [2014A030310277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Natural Science Foundation of China(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (grant number 11701505 to Dr. Zhibin Du) and the Guangdong Provincial Natural Science Foundation of China (grant number 2014A030310277 to Dr. Zhibin Du). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi MB, 2013, MATCH-COMMUN MATH CO, V69, P565; Ahmadi MB, 2010, OPTOELECTRON ADV MAT, V4, P1040; Das KC, 2016, MATCH-COMMUN MATH CO, V76, P159; Dimitrov D., 2017, MATH CHEM MONOGRPAHS, V20, P53; Dimitrov D, 2018, DISCRETE APPL MATH, V236, P165, DOI 10.1016/j.dam.2017.11.003; Dimitrov D, 2017, APPL MATH COMPUT, V313, P418, DOI 10.1016/j.amc.2017.06.014; Dimitrov D, 2017, DISCRETE APPL MATH, V222, P222, DOI 10.1016/j.dam.2017.01.019; Dimitrov D, 2016, DISCRETE APPL MATH, V204, P90, DOI 10.1016/j.dam.2015.10.010; Dimitrov D, 2016, APPL MATH COMPUT, V282, P276, DOI 10.1016/j.amc.2016.02.019; Dimitrov D, 2014, DISCRETE APPL MATH, V172, P28, DOI 10.1016/j.dam.2014.03.009; Dimitrov D, 2013, APPL MATH COMPUT, V224, P663, DOI 10.1016/j.amc.2013.08.089; Du ZB, 2016, DISCRETE APPL MATH, V202, P37, DOI 10.1016/j.dam.2015.08.017; Estrada E, 1998, INDIAN J CHEM A, V37, P849; Estrada E, 2008, CHEM PHYS LETT, V463, P422, DOI 10.1016/j.cplett.2008.08.074; Furtula B, 2009, DISCRETE APPL MATH, V157, P2828, DOI 10.1016/j.dam.2009.03.004; Gan L, 2012, MATCH-COMMUN MATH CO, V68, P137; Gao YB, 2016, MATCH-COMMUN MATH CO, V76, P141; Gutman I, 2013, FILOMAT, V27, P1075, DOI 10.2298/FIL1306075G; Gutman I, 2012, MATCH-COMMUN MATH CO, V68, P131; Gutman I, 2012, MATCH-COMMUN MATH CO, V67, P467; Hosseini SA, 2014, MATCH-COMMUN MATH CO, V71, P5; Ke XL, 2012, POLYCYCL AROMAT COMP, V32, P27, DOI 10.1080/10406638.2011.637101; Lin WS, 2016, MATCH-COMMUN MATH CO, V76, P131; Lin WS, 2013, MATCH-COMMUN MATH CO, V69, P571; Lin WS, 2013, MATCH-COMMUN MATH CO, V69, P549; Liu JP, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/609208; RANDIC M, 1975, J AM CHEM SOC, V97, P6609, DOI 10.1021/ja00856a001; Wang H, 2008, DISCRETE MATH, V308, P3407, DOI 10.1016/j.disc.2007.06.026; Xing RD, 2012, FILOMAT, V26, P683, DOI 10.2298/FIL1204683X; Yang J., 2011, INT MATH FORUM, V6, P2001	30	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195153	10.1371/journal.pone.0195153	http://dx.doi.org/10.1371/journal.pone.0195153			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668696	Green Published, gold, Green Submitted			2022-12-26	WOS:000430290200030
J	Lawrence, DW; Richards, D; Comper, P; Hutchison, MG				Lawrence, David Wyndham; Richards, Doug; Comper, Paul; Hutchison, Michael G.			Earlier time to aerobic exercise is associated with faster recovery following acute sport concussion	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; REST; SYMPTOMS; METAANALYSIS; OUTCOMES; CHILDREN; ADULTS	Objective To determine whether earlier time to initiation of aerobic exercise following acute concussion is associated with time to full return to (1) sport and (2) school or work. Methods A retrospective stratified propensity score survival analysis of acute (<= 14 days) concussion was used to determine whether time (days) to initiation of aerobic exercise post-concussion was associated with, both, time (days) to full return to (1) sport and (2) school or work. Results A total of 253 acute concussions [median (IQR) age, 17.0 (15.0-20.0) years; 148 (58.5%) males] were included in this study. Multivariate Cox regression models identified that earlier time to aerobic exercise was associated with faster return to sport and school/work adjusting for other covariates, including quintile propensity strata. For each successive day in delay to initiation of aerobic exercise, individuals had a less favourable recovery trajectory. Initiating aerobic exercise at 3 and 7 days following injury was associated with a respective 36.5% (HR, 0.63; 95% CI, 0.53-0.76) and 73.2% (HR, 0.27; 95% CI, 0.16-0.45) reduced probability of faster full return to sport compared to within 1 day; and a respective 45.9% (HR, 0.54; 95% CI, 0.44-0.66) and 83.1% (HR, 0.17; 95% CI, 0.10-0.30) reduced probability of faster full return to school/work. Additionally, concussion history, symptom severity, LOC deleteriously influenced concussion recovery. Conclusion Earlier initiation of aerobic exercise was associated with faster full return to sport and school or work. This study provides greater insight into the benefits and safety of aerobic exercise within the first week of the injury.	[Lawrence, David Wyndham; Richards, Doug; Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Lawrence, David Wyndham; Comper, Paul] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Lawrence, David Wyndham] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto Rehabilitation Institute; University of Toronto	Lawrence, DW (corresponding author), Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada.; Lawrence, DW (corresponding author), Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada.; Lawrence, DW (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	dw.lawrence@mail.utoronto.ca		Richards, Douglas/0000-0001-5098-4341				Austin PC, 2006, STAT MED, V25, P2084, DOI 10.1002/sim.2328; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Baker JG, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/705309; Bidonde J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012700; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Chieffi S, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00188; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P167, DOI 10.1136/jnnp.73.2.167; DiFazio M, 2016, CLIN PEDIATR, V55, P443, DOI 10.1177/0009922815589914; Dobney DM, 2017, BRAIN INJURY, V31, P1753, DOI 10.1080/02699052.2017.1346294; Edmonds M, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD003200.PUB2; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Hsu CL, 2018, BRIT J SPORT MED, V52, P184, DOI 10.1136/bjsports-2016-096846; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Krogh J, 2011, J CLIN PSYCHIAT, V72, P529, DOI 10.4088/JCP.08r04913blu; Kurowski BG, 2017, J HEAD TRAUMA REHAB, V32, P79, DOI 10.1097/HTR.0000000000000238; Lal A, 2018, AM J SPORT MED, V46, P743, DOI 10.1177/0363546517706137; Leddy J, 2016, PM&R, V8, pS91, DOI 10.1016/j.pmrj.2015.10.017; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P., 2017, 5 INT C CONC SPORT H; McDonnell MN, 2011, ARCH PHYS MED REHAB, V92, P1044, DOI 10.1016/j.apmr.2011.01.021; Moor HM, 2015, INT J SPORTS PHYS TH, V10, P225; Pang MYC, 2013, CEREBROVASC DIS, V35, P7, DOI 10.1159/000346075; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Schneider KJ, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097475; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966; Winters-Stone KM, 2014, BRIT J SPORT MED, V48, P987, DOI 10.1136/bjsports-2012-091732; Wipfli BM, 2008, J SPORT EXERCISE PSY, V30, P392, DOI 10.1123/jsep.30.4.392	34	52	53	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0196062	10.1371/journal.pone.0196062	http://dx.doi.org/10.1371/journal.pone.0196062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GD1VU	29668716	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200076
J	Su, HL; Huo, CC; Wang, BT; Li, WH; Xu, GC; Liu, QY; Li, ZY				Su, Honglun; Huo, Congcong; Wang, Bitian; Li, Wenhao; Xu, Gongcheng; Liu, Qianying; Li, Zengyong			Alterations in the coupling functions between cerebral oxyhaemoglobin and arterial blood pressure signals in post-stroke subjects	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; LOW-FREQUENCY OSCILLATIONS; WAVELET COHERENCE ANALYSIS; ELDERLY SUBJECTS; PREFRONTAL CORTEX; INTRACRANIAL-PRESSURE; TRANSCRANIAL DOPPLER; TISSUE OXYGENATION; AUTOREGULATION; SYNCHRONIZATION	Cerebral autoregulation (CA) is the complex homeostatic regulatory relationship between blood pressure (BP) and cerebral blood flow (CBF). This study aimed to analyze the frequency-specific coupling function between cerebral oxyhemoglobin concentrations (delta [HbO(2)]) and mean arterial pressure (MAP) signals based on a model of coupled phase oscillators and dynamical Bayesian inference. Delta [HbO(2)] was measured by 24-channel near infrared spectroscopy (NIRS) and arterial BP signals were obtained by simultaneous resting-state measurements in patients with stroke, that is, 9 with left hemiparesis (L-H group), 8 with right hemiparesis (R-H group), and 17 age-matched healthy individuals as control (healthy group). The coupling functions from MAP to delta [HbO(2)] oscillators were identified and analyzed in four frequency intervals (I, 0.6-2 Hz; II, 0.145-0.6 Hz; III, 0.052-0.145 Hz; and IV, 0.021-0.052 Hz). In L-H group, the CS from MAP to delta [HbO(2)] in interval III in channel 8 was significantly higher than that in healthy group (p = 0.003). Compared with the healthy controls, the coupling in MAP)delta [HbO(2)] showed higher amplitude in interval I and IV in patients with stroke. The increased CS and coupling amplitude may be an evidence of impairment in CA, thereby confirming the presence of impaired CA in patients with stroke. In interval III, the CS in L-H group from MAP to delta [HbO(2)] in channel 16 (p = 0.001) was significantly lower than that in healthy controls, which might indicate the compensatory mechanism in CA of the unaffected side in patients with stroke. No significant difference in region-wise CS between affected and unaffected sides was observed in stroke groups, indicating an evidence of globally impaired CA. These findings provide a method for the assessment of CA and will contribute to the development of therapeutic interventions in stroke patients.	[Su, Honglun; Wang, Bitian; Li, Wenhao; Liu, Qianying] Beihang Univ, Sch Biol Sci & Med Engn, Minist Educ, Key Lab Biomech & Mechanobiol, Beijing, Peoples R China; [Huo, Congcong; Xu, Gongcheng] Shandong Univ, Sch Mech Engn, Jinan, Shandong, Peoples R China; [Li, Zengyong] Natl Res Ctr Rehabil Tech Aids, Beijing Key Lab Rehabil Tech Aids Old Age Disabil, Beijing, Peoples R China; [Li, Zengyong] Minist Civil Affairs, Key Lab Rehabil Aids Technol & Syst, Beijing, Peoples R China	Beihang University; Shandong University	Li, ZY (corresponding author), Natl Res Ctr Rehabil Tech Aids, Beijing Key Lab Rehabil Tech Aids Old Age Disabil, Beijing, Peoples R China.; Li, ZY (corresponding author), Minist Civil Affairs, Key Lab Rehabil Aids Technol & Syst, Beijing, Peoples R China.	lizengyong@nrcrta.cn	liu, qian/HDM-2936-2022		National Natural Science Foundation of China (NSFC) [31771071, 61761166007]; Fundamental Research Funds for Central Public Welfare Research Institutes [118009001000160001]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for Central Public Welfare Research Institutes	The project was supported by the National Natural Science Foundation of China (NSFC No. 31771071 and 61761166007) and Fundamental Research Funds for Central Public Welfare Research Institutes (118009001000160001) to ZL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalkjaer C, 2005, BRIT J PHARMACOL, V144, P605, DOI 10.1038/sj.bjp.0706084; Addison Paul S, 2015, IEEE Rev Biomed Eng, V8, P78, DOI 10.1109/RBME.2015.2436978; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bandrivskyy A., 2004, CARDIOVASC ENG, V4, P89, DOI [10.1023/B:CARE.0000025126.63253.43, DOI 10.1023/B:CARE.0000025126.63253.43]; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; Bernjak A, 2012, FLUCT NOISE LETT, V11, DOI 10.1142/S0219477512400135; Brady KM, 2007, STROKE, V38, P2818, DOI 10.1161/STROKEAHA.107.485706; Cheng R, 2012, NEUROIMAGE, V62, P1445, DOI 10.1016/j.neuroimage.2012.05.069; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; CORBETTA M, 1991, J NEUROSCI, V11, P2383; Daunizeau J, 2009, PHYSICA D, V238, P2089, DOI 10.1016/j.physd.2009.08.002; Dawson SL, 2000, CEREBROVASC DIS, V10, P126, DOI 10.1159/000016041; Eames PJ, 2002, J NEUROL NEUROSUR PS, V72, P467; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; FOLKOW B, 1964, CIRC RES, V15, P279; Gagnon L, 2011, NEUROIMAGE, V56, P1362, DOI 10.1016/j.neuroimage.2011.03.001; Gao YJ, 2015, BEHAV BRAIN RES, V278, P330, DOI 10.1016/j.bbr.2014.10.019; GILLER CA, 1990, NEUROSURGERY, V27, P362, DOI 10.1227/00006123-199009000-00004; Han QY, 2014, MICROVASC RES, V95, P108, DOI 10.1016/j.mvr.2014.08.001; Hogenhout M., 2013, MOL CELL BIOL, V8, P4889, DOI [10.1152/jn.00516.2003, DOI 10.1152/JN.00516.2003]; Irani F, 2007, CLIN NEUROPSYCHOL, V21, P9, DOI 10.1080/13854040600910018; Johnson PC, 1991, MYOGENIC RESPONSE, P159; Kainerstorfer JM, 2015, J CEREBR BLOOD F MET, V35, P959, DOI 10.1038/jcbfm.2015.5; Katsogridakis E, 2013, J CEREBR BLOOD F MET, V33, P519, DOI 10.1038/jcbfm.2012.191; Katura T, 2006, NEUROIMAGE, V31, P1592, DOI 10.1016/j.neuroimage.2006.02.010; Kralemann B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3418; Kurths J, 2002, AM J PHYS, V70, P47; Kvernmo HD, 1998, MICROVASC RES, V56, P173, DOI 10.1006/mvre.1998.2108; Latka M, 2005, AM J PHYSIOL-HEART C, V289, pH2272, DOI 10.1152/ajpheart.01307.2004; Laurent S, 2001, HYPERTENSION, V37, P1236, DOI 10.1161/01.HYP.37.5.1236; LEVINE BD, 1994, CIRCULATION, V90, P298, DOI 10.1161/01.CIR.90.1.298; Li ZY, 2014, PHYSIOL MEAS, V35, P777, DOI 10.1088/0967-3334/35/5/777; Li ZY, 2013, MICROVASC RES, V88, P32, DOI 10.1016/j.mvr.2013.04.003; Li ZY, 2010, MICROVASC RES, V80, P142, DOI 10.1016/j.mvr.2010.02.004; Medvedev AV, 2008, BRAIN RES, V1236, P145, DOI 10.1016/j.brainres.2008.07.122; Mertins A., 1999, SIGNAL ANAL WAVELETS; MEYER JU, 1988, MICROVASC RES, V35, P193, DOI 10.1016/0026-2862(88)90062-3; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MORAN J, 1985, SCIENCE, V229, P782, DOI 10.1126/science.4023713; Moro SB, 2014, NEUROIMAGE, V85, P451, DOI 10.1016/j.neuroimage.2013.05.031; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 1999, AM J PHYSIOL-HEART C, V277, pH1089, DOI 10.1152/ajpheart.1999.277.3.H1089; Panerai RB, 2008, CARDIOVASC ENG, V8, P42, DOI 10.1007/s10558-007-9044-6; Panerai RB, 2009, CLIN AUTON RES, V19, P197, DOI 10.1007/s10286-009-0011-8; Papademetriou MD, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.6.067008; Peng TY, 2008, PHYSIOL MEAS, V29, P1055, DOI 10.1088/0967-3334/29/9/005; Penny WD, 2009, J NEUROSCI METH, V183, P19, DOI 10.1016/j.jneumeth.2009.06.029; Reinhard M, 2012, ACTA NEUROL SCAND, V125, P156, DOI 10.1111/j.1600-0404.2011.01515.x; Reinhard M, 2008, CEREBROVASC DIS, V26, P147, DOI 10.1159/000139662; Reinhard M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.097005; Ronney BP, 1998, PHYSIOL MEAS, V19, P305; Rowley AB, 2007, PHYSIOL MEAS, V28, P161, DOI 10.1088/0967-3334/28/2/005; Sasai S, 2012, NEUROIMAGE, V63, P179, DOI 10.1016/j.neuroimage.2012.06.011; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Schwabedal JTC, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046218; Schwarz S, 2002, STROKE, V33, P998, DOI 10.1161/01.STR.0000014584.17714.2E; Schwarz S, 2002, STROKE, V33, P497, DOI 10.1161/hs0202.102376; Shiogai Y, 2010, PHYS REP, V488, P51, DOI 10.1016/j.physrep.2009.12.003; Smelyanskiy VN, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098101; Stankovski T, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/3/035002; Stankovski T, 2014, EUR PHYS J-SPEC TOP, V223, P2685, DOI 10.1140/epjst/e2014-02286-7; Stankovski T, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.024101; Stefanovska A, 1999, CONTEMP PHYS, V40, P31, DOI 10.1080/001075199181693; Steiner LA, 2009, NEUROCRIT CARE, V10, P122, DOI 10.1007/s12028-008-9140-5; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; Tan QT, 2015, MED PHYS, V42, P5391, DOI 10.1118/1.4928672; Tarumi T, 2014, J ALZHEIMERS DIS, V41, P765, DOI 10.3233/JAD-132018; Terborg C, 2000, STROKE, V31, P924, DOI 10.1161/01.STR.31.4.924; Ticcinelli V, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00749; Tomislav S, 2016, PHILOS T, V374; Tong YJ, 2010, NEUROIMAGE, V53, P553, DOI 10.1016/j.neuroimage.2010.06.049; Townsend NW, 2003, LOCATING FEATURES PH; van Beek AHEA, 2008, J CEREBR BLOOD F MET, V28, P1071, DOI 10.1038/jcbfm.2008.13; von Toussaint U, 2011, REV MOD PHYS, V83, P943, DOI 10.1103/RevModPhys.83.943; Willie CK, 2014, J PHYSIOL-LONDON, V592, P841, DOI 10.1113/jphysiol.2013.268953; WOLLNER L, 1979, BRIT MED J, V1, P1117, DOI 10.1136/bmj.1.6171.1117; Xu GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188329; Yokota, 2013, BONFERRONI CORRECTIO; Zhang Q, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804706; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Zhang R, 2007, HYPERTENSION, V49, P1149, DOI 10.1161/HYPERTENSIONAHA.106.084939	84	8	9	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0195936	10.1371/journal.pone.0195936	http://dx.doi.org/10.1371/journal.pone.0195936			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668713	Green Submitted, gold, Green Published			2022-12-26	WOS:000430290200068
J	Martin, AR; De Leener, B; Cohen-Adad, J; Kalsi-Ryan, S; Cadotte, DW; Wilson, JR; Tetreauttl, L; Nouri, A; Crawley, A; Mikulis, DJ; Ginsberg, H; Massicotte, EM; Fehlings, MG				Martin, Allan R.; De Leener, Benjamin; Cohen-Adad, Julien; Kalsi-Ryan, Sukhvinder; Cadotte, David W.; Wilson, Jefferson R.; Tetreault, Lindsay; Nouri, Aria; Crawley, Adrian; Mikulis, David J.; Ginsberg, Howard; Massicotte, Eric M.; Fehlings, Michael G.			Monitoring for myelopathic progression with multiparametric quantitative MRI	PLOS ONE			English	Article							CERVICAL SPONDYLOTIC MYELOPATHY; OF-THE-ART; SPINAL-CORD; CONSERVATIVE TREATMENT; NATURAL-HISTORY; RELIABILITY; MILD; VALIDATION; MANAGEMENT; STRENGTH	Background Patients with mild degenerative cervical myelopathy (DCM) are often managed non-operatively, and surgery is recommended if neurological progression occurs. However, detection of progression is often subjective. Quantitative MRI (qMRI) directly measures spinal cord (SC) tissue changes, detecting axonal injury, demyelination, and atrophy. This longitudinal study compared multiparametric qMRI with clinical measures of progression in non-operative DCM patients. Methods 26 DCM patients were followed. Clinical data included modified Japanese Orthopedic Association (mJOA) and additional assessments. 3T qMRI data included cross sectional area, diffusion fractional anisotropy, magnetization transfer ratio, and T2*-weighted white/grey matter signal ratio, extracted from the compressed SC and above/below. Progression was defined as 1) patients' subjective impression, 2) 2-point mJOA decrease, 3) >= 3 clinical measures worsening >= 5%, 4) increased compression on MRI, or 5) >= 1 of 10 qMRI measures or composite score worsening (p < 0.004, corrected). Results Follow-up (13.5 +/- 4.9 months) included mJOA in all 26 patients, MRI in 25, and clinical/qMRI in 22. 42.3% reported subjective worsening, compared with mJOA (11.5%), MRI (20%), comprehensive assessments (54.6%), and qMRI (68.2%). Relative to subjective worsening, qMRI showed 100% sensitivity and 53.3% specificity compared with comprehensive assessments (75%, 60%), mJOA (27.3%, 100%), and MRI (18.2%, 81.3%). A decision-making algorithm incorporating qMRI identified progression and recommended surgery for 11 subjects (42.3%). Conclusions Quantitative MRI shows high sensitivity to detect myelopathic progression. Our results suggest that neuroplasticity and behavioural adaptation may mask progressive SC tissue injury. qMRI appears to be a useful method to confirm subtle myelopathic progression in individual patients, representing an advance toward clinical translation of qMRI.	[Martin, Allan R.; Kalsi-Ryan, Sukhvinder; Cadotte, David W.; Wilson, Jefferson R.; Tetreault, Lindsay; Nouri, Aria; Crawley, Adrian; Mikulis, David J.; Ginsberg, Howard; Massicotte, Eric M.; Fehlings, Michael G.] Univ Toronto, Toronto, ON, Canada; [De Leener, Benjamin; Cohen-Adad, Julien] Polytech Montreal, Montreal, PQ, Canada	University of Toronto; Universite de Montreal; Polytechnique Montreal	Fehlings, MG (corresponding author), Univ Toronto, Toronto, ON, Canada.	Michael.Fehlings@uhn.ca	Nouri, Aria/I-1642-2019; Mikulis, David J/H-5167-2019; De Leener, Benjamin/H-3765-2019	Nouri, Aria/0000-0002-4965-3059; De Leener, Benjamin/0000-0002-1378-2756; Fehlings, Michael/0000-0002-5722-6364; Mikulis, David/0000-0003-3956-0892; Kalsi-Ryan, Sukhvinder/0000-0003-2332-5986				Bartels RHMA, 2010, NEUROSURGERY, V66, P1013, DOI 10.1227/01.NEU.0000368391.79314.6F; Beaton DE, 2005, J BONE JOINT SURG AM, V87A, P1038, DOI 10.2106/JBJS.D.02060; Bednarik J, 1999, SPINE, V24, P1593, DOI 10.1097/00007632-199908010-00014; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; BERG KO, 1992, CAN J PUBLIC HEALTH, V83, pS7; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Cadotte DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045560; Cohen-Adad J, 2014, NEUROIMAGE, V93, P189, DOI 10.1016/j.neuroimage.2013.01.023; De Leener B, 2017, NEUROIMAGE, V145, P24, DOI 10.1016/j.neuroimage.2016.10.009; Ellaway PH, 2013, SPINAL CORD, V51, P120, DOI 10.1038/sc.2012.96; Fehlings MG, 2017, GLOB SPINE J, V7, p70S, DOI 10.1177/2192568217701914; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Grabher P, 2016, SCI REP-UK, V6, DOI 10.1038/srep24636; HAMILTON GF, 1992, J ORTHOP SPORT PHYS, V16, P215, DOI 10.2519/jospt.1992.16.5.215; Jutzeler C, 2017, J NEUROTRAUMA; Kadanka Z, 2000, EUR SPINE J, V9, P538, DOI 10.1007/s005860000132; Kadanka Z, 2011, EUR SPINE J, V20, P1533, DOI 10.1007/s00586-011-1811-9; Kalsi-Ryan S, 2013, SPINE, V38, pS111, DOI 10.1097/BRS.0b013e3182a7f499; Kalsi-Ryan S, 2012, J NEUROTRAUM, V29, P905, DOI 10.1089/neu.2010.1504; Karadimas SK, 2013, SPINE, V38, pS21, DOI 10.1097/BRS.0b013e3182a7f2c3; Kerkovsky M, 2012, SPINE, V37, P48, DOI 10.1097/BRS.0b013e31820e6c35; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Levy S, 2015, NEUROIMAGE, V119, P262, DOI 10.1016/j.neuroimage.2015.06.040; Martin AR, 2017, AM J NEURORADIOL, V38, P1257, DOI 10.3174/ajnr.A5163; Martin AR, 2017, AM J NEURORADIOL, V38, P1266, DOI 10.3174/ajnr.A5162; Martin AR, 2016, NEUROIMAGE-CLIN, V10, P192, DOI 10.1016/j.nicl.2015.11.019; Matsumoto M, 2001, SPINE, V26, P1592, DOI 10.1097/00007632-200107150-00021; Matsumoto M, 2000, SPINE, V25, P677, DOI 10.1097/00007632-200003150-00005; Matz PG, 2009, J NEUROSURG-SPINE, V11, P104, DOI 10.3171/2009.1.SPINE08716; Nouri A, 2015, SPINE, V40, pE675, DOI 10.1097/BRS.0000000000000913; Oh J, 2013, MULT SCLER J, V19, P427, DOI 10.1177/1352458512456614; Pascual-Leone A, 2005, ANNU REV NEUROSCI, V28, P377, DOI 10.1146/annurev.neuro.27.070203.144216; Rhee JM, 2013, SPINE, V38, pS55, DOI 10.1097/BRS.0b013e3182a7f41d; Samson RS, 2013, NMR BIOMED, V26, P1823, DOI 10.1002/nbm.3022; Shimomura T, 2007, SPINE, V32, P2474, DOI 10.1097/BRS.0b013e3181573aee; Stroman PW, 2014, NEUROIMAGE, V84, P1070, DOI 10.1016/j.neuroimage.2013.04.124; Sumi M, 2012, J NEUROSURG-SPINE, V16, P8, DOI 10.3171/2011.8.SPINE11395; Taso M, 2016, NMR BIOMED, V29, P817, DOI 10.1002/nbm.3530; Webster KE, 2005, GAIT POSTURE, V22, P317, DOI 10.1016/j.gaitpost.2004.10.005; Yonenobu K, 2001, SPINE, V26, P1890, DOI 10.1097/00007632-200109010-00014; Yoshimatsu H, 2001, Spine J, V1, P269, DOI 10.1016/S1529-9430(01)00082-1	41	37	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2018	13	4							e0195733	10.1371/journal.pone.0195733	http://dx.doi.org/10.1371/journal.pone.0195733			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1LV	29664964	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000430262300029
J	Kolesnikova, TD; Goncharov, FP; Zhimulev, IF				Kolesnikova, Tatyana D.; Goncharov, Fedor P.; Zhimulev, Igor F.			Similarity in replication timing between polytene and diploid cells is associated with the organization of the Drosophila genome	PLOS ONE			English	Article							OVARIAN PSEUDONURSE CELLS; INTERCALARY HETEROCHROMATIN; DNA-REPLICATION; GENETIC ORGANIZATION; MELANOGASTER; CHROMOSOMES; CHROMATIN; DOMAINS; TRANSCRIPTION; SUUR	Morphologically, polytene chromosomes of Drosophila melanogaster consist of compact "black" bands alternating with less compact "grey" bands and interbands. We developed a comprehensive approach that combines cytological mapping data of FlyBase-annotated genes and novel tools for predicting cytogenetic features of chromosomes on the basis of their protein composition and determined the genomic coordinates for all black bands of polytene chromosome 2R. By a PCNA immunostaining assay, we obtained the replication timetable for all the bands mapped. The results allowed us to compare replication timing between polytene chromosomes in salivary glands and chromosomes from cultured diploid cell lines and to observe a substantial similarity in the global replication patterns at the band resolution level. In both kinds of chromosomes, the intervals between black bands correspond to early replication initiation zones. Black bands are depleted of replication initiation events and are characterized by a gradient of replication timing; therefore, the time of replication completion correlates with the band length. The bands are characterized by low gene density, contain predominantly tissue-specific genes, and are represented by silent chromatin types in various tissues. The borders of black bands correspond well to the borders of topological domains as well as to the borders of the zones showing H3K27me3, SUUR, and LAMIN enrichment. In conclusion, the characteristic pattern of polytene chromosomes reflects partitioning of the Drosophila genome into two global types of domains with contrasting properties. This partitioning is conserved in different tissues and determines replication timing in Drosophila.	[Kolesnikova, Tatyana D.; Goncharov, Fedor P.; Zhimulev, Igor F.] SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia; [Kolesnikova, Tatyana D.; Zhimulev, Igor F.] Novosibirsk State Univ, Novosibirsk, Russia	Russian Academy of Sciences; Novosibirsk State University	Kolesnikova, TD (corresponding author), SB RAS, Inst Mol & Cellular Biol, Novosibirsk, Russia.; Kolesnikova, TD (corresponding author), Novosibirsk State Univ, Novosibirsk, Russia.	kolesnikova@mcb.nsc.ru	Kolesnikova, Tatyana/N-5461-2015; Zhimulev, Igor F/N-7978-2015	Kolesnikova, Tatyana/0000-0002-5107-1445; Zhimulev, Igor/0000-0002-6220-3028	Russian Science Foundation [14-14-00934]; Russian Foundation for Basic Research (RFBR) [15-04-03898]; Russian Science Foundation [17-14-00038] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research (RFBR)(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF))	Genome mapping of bands and data analysis were funded by a grant from the Russian Science Foundation to I.F.Z. (14-14-00934, http://www.rscf.ru/). Analysis of replication was funded by a grant from the Russian Foundation for Basic Research (RFBR) project to I.F.Z. (15-04-03898, http:/www.rfbr.ru/rffi/eng). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreyenkova NG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083319; [Anonymous], 2017, R LANG ENV STAT COMP; Audit Benjamin, 2013, Subcell Biochem, V61, P57, DOI 10.1007/978-94-007-4525-4_3; BEERMANN W, 1952, CHROMOSOMA, V5, P139; BEERMANN W., 1965, Genetics today. Proceedings of the XI International Congress of Genetics, The Hague, the Netherlands, September, 1963., V2, P375; Belyaeva ES, 2008, CHROMOSOMA, V117, P411, DOI 10.1007/s00412-008-0163-7; Belyaeva ES, 2012, PLOS ONE, V7, P352, DOI 10.1371/journal.pone.0030035; Belyaeva ES, 1998, P NATL ACAD SCI USA, V95, P7532, DOI 10.1073/pnas.95.13.7532; Belyakin SN, 2010, CHROMOSOMA, V119, P589, DOI 10.1007/s00412-010-0280-y; Boldyreva LV, 2017, CURR GENOMICS, V18, P214, DOI 10.2174/1389202917666160512164913; Boulos RE, 2015, FEBS LETT, V589, P2944, DOI 10.1016/j.febslet.2015.04.015; Bridges CB, 1939, J HERED, V30, P475, DOI 10.1093/oxfordjournals.jhered.a104634; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chintapalli V., 2010, FLYATLAS SURVEY ADUL; Comoglio F, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003419; Cuenca JB, 1998, CHROMOSOMA, V107, P113, DOI 10.1007/s004120050287; De Ferrari L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-277; Demakov S, 2004, GENETICA, V122, P311, DOI 10.1007/s10709-004-2839-0; Demakov SA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-566; Demakova O V, 2016, Tsitologiia, V58, P248; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Drysdale Rachel, 2008, V420, P45, DOI 10.1007/978-1-59745-583-1_3; Eagen KP, 2015, CELL, V163, P934, DOI 10.1016/j.cell.2015.10.026; Eaton ML, 2011, GENOME RES, V21, P164, DOI 10.1101/gr.116038.110; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Edgar BA, 2014, NAT REV MOL CELL BIO, V15, P197, DOI 10.1038/nrm3756; El-Sharnouby S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172725; Filion GJ, 2010, CELL, V143, P212, DOI 10.1016/j.cell.2010.09.009; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gortchakov AA, 2005, CHROMOSOMA, V114, P54, DOI 10.1007/s00412-005-0339-3; Graveley BR, 2011, D MELANOGASTER TRANS; Guilbaud G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002322; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Hou CH, 2012, MOL CELL, V48, P471, DOI 10.1016/j.molcel.2012.08.031; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kharchenko PV, 2011, NATURE, V471, P480, DOI 10.1038/nature09725; Khoroshko VA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157147; Kolesnikova T D, 2016, Tsitologiia, V58, P262; Kolesnikova TD, 2013, CHROMOSOMA, V122, P55, DOI 10.1007/s00412-012-0390-9; Koryakov DE, 2015, CHROMOSOMA, V124, P95, DOI 10.1007/s00412-014-0487-4; Koryakov DE, 2012, CHROMOSOMA, V121, P573, DOI 10.1007/s00412-012-0382-9; KOZLOVA TY, 1994, GENETICS, V136, P1063; LAKHOTIA SC, 1983, CHROMOSOMA, V88, P265, DOI 10.1007/BF00292903; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lefevre G., 1976, GENET BIOL DROSOPHIL, P31; Maksimov DA, 2014, CHROMOSOMA, V123, P253, DOI 10.1007/s00412-013-0445-6; Makunin IV, 2002, GENETICS, V160, P1023; MALCEVA NI, 1995, CHROMOSOME RES, V3, P191, DOI 10.1007/BF00710713; Maqbool SB, 2010, J CELL SCI, V123, P4095, DOI 10.1242/jcs.064519; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Milon B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-988; MISHRA A, 1982, CHROMOSOMA, V85, P221, DOI 10.1007/BF00294967; Nordman JT, 2014, CELL REP, V9, P841, DOI 10.1016/j.celrep.2014.10.005; Pavan C., 1959, Proceedings 10th Internat Congr Genetics, V1, P321; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Petryk N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10208; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pokholkova GV, 2015, CHROMOSOMA, V124, P209, DOI 10.1007/s00412-014-0491-8; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Posukh OV, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0163-z; Posukh OV, 2017, NUCLEUS, V6, P249; Powell SK, 2015, EMBO J, V34, P531, DOI 10.15252/embj.201488307; Prioleau MN, 2016, GENE DEV, V30, P1683, DOI 10.1101/gad.285114.116; REDFERN CPF, 1981, CHROMOSOMA, V84, P33, DOI 10.1007/BF00293361; Rhind N, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010132; Richards S, 2005, GENOME RES, V15, P1, DOI 10.1101/gr.3059305; RUDKIN GT, 1959, P NATL ACAD SCI USA, V45, P997, DOI 10.1073/pnas.45.7.997; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Saura A., 1986, THESIS; SAURA AO, 1991, HEREDITAS, V114, P15, DOI 10.1111/j.1601-5223.1991.tb00549.x; Schwaiger M, 2009, GENE DEV, V23, P589, DOI 10.1101/gad.511809; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; SINHA P, 1987, CHROMOSOMA, V95, P108, DOI 10.1007/BF00332183; SORSA V, 1973, HEREDITAS, V74, P297; SPIERER A, 1984, NATURE, V307, P176, DOI 10.1038/307176a0; Spradling AC, 1999, GENETICS, V153, P135; Stadler MR, 2017, ELIFE, V6, DOI 10.7554/eLife.29550; Ulianov SV, 2016, GENOME RES, V26, P70, DOI 10.1101/gr.196006.115; van Bemmel JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015013; Van Bortle K, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r82; Vatolina T Iu, 2011, Genetika, V47, P597; Vatolina TY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025960; White R, 2012, BRIEF FUNCT GENOMICS, V11, P347, DOI 10.1093/bfgp/els020; Yarosh W, 2014, GENE DEV, V28, P1840, DOI 10.1101/gad.245811.114; ZHIMULEV IF, 1982, CHROMOSOMA, V87, P197, DOI 10.1007/BF00338489; Zhimulev IF, 2003, CHROMOSOMA, V111, P377, DOI 10.1007/s00412-002-0218-0; Zhimulev IF, 1999, ADV GENET, V39, P1, DOI 10.1016/S0065-2660(08)60476-9; Zhimulev IF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101631; Zhimulev IF, 2012, BIOESSAYS, V34, P498, DOI 10.1002/bies.201100142; Zielke T, 2016, CHROMOSOMA, V125, P423, DOI 10.1007/s00412-015-0554-5	93	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195207	10.1371/journal.pone.0195207	http://dx.doi.org/10.1371/journal.pone.0195207			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659604	gold, Green Published, Green Submitted			2022-12-26	WOS:000430061100010
J	Borner, R; Kowerko, D; Hadzic, MCAS; Konig, SLB; Ritter, M; Sigel, RKO				Boerner, Richard; Kowerko, Danny; Hadzic, Melodie C. A. S.; Koenig, Sebastian L. B.; Ritter, Marc; Sigel, Roland K. O.			Simulations of camera-based single-molecule fluorescence experiments	PLOS ONE			English	Article							ALTERNATING-LASER EXCITATION; ABSOLUTE FRET EFFICIENCY; CONFORMATIONAL DYNAMICS; SPECTROSCOPY; LOCALIZATION; ORIENTATION; DEPENDENCE; MARKOV; TIME	Single-molecule microscopy has become a widely used technique in (bio) physics and ( bio) chemistry. A popular implementation is single-molecule Forster Resonance Energy Transfer (smFRET), for which total internal reflection fluorescence microscopy is frequently combined with camera-based detection of surface-immobilized molecules. Camera-based smFRET experiments generate large and complex datasets and several methods for video processing and analysis have been reported. As these algorithms often address similar aspects in video analysis, there is a growing need for standardized comparison. Here, we present a Matlab-based software (MASH-FRET) that allows for the simulation of camer-abased smFRET videos, yielding standardized data sets suitable for benchmarking video processing algorithms. The software permits to vary parameters that are relevant in cameras-based smFRET, such as video quality, and the properties of the system under study. Experimental noise is modeled taking into account photon statistics and camera noise. Finally, we survey how video test sets should be designed to evaluate currently available data analysis strategies in camera-based sm fluorescence experiments. We complement our study by pre-optimizing and evaluating spot detection algorithms using our simulated video test sets.	[Boerner, Richard; Hadzic, Melodie C. A. S.; Koenig, Sebastian L. B.; Sigel, Roland K. O.] Univ Zurich, Dept Chem, Zurich, Switzerland; [Kowerko, Danny] Tech Univ Chemnitz, Dept Comp Sci, Chemnitz, Germany; [Koenig, Sebastian L. B.] Univ Zurich, Dept Biochem, Zurich, Switzerland; [Ritter, Marc] Mittweida Univ Appl Sci, Dept Appl Comp & Biosci, Mittweida, Germany	University of Zurich; Technische Universitat Chemnitz; University of Zurich	Borner, R; Sigel, RKO (corresponding author), Univ Zurich, Dept Chem, Zurich, Switzerland.	richard.boerner@ozh.ch; roland.sigel@chem.uzh.ch	Börner, Richard/AAV-4493-2020; Kowerko, Danny/J-4847-2019; Sigel, Roland/O-9883-2016	Kowerko, Danny/0000-0002-4538-7814; Sigel, Roland/0000-0002-1307-7993	European Research Council (ERC) [MIRNA 259092]; University of Zurich [FK-14-096, FK-15-095, FK-13-108, FK-13-091, FK-57010302]; Swiss National Science Foundation; Swiss State Secretariat for Education and Research (COST Action) [CM1105]; Federal Ministry of Education and Research (BMBF, Germany) [03IPT608X]	European Research Council (ERC)(European Research Council (ERC)European Commission); University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss State Secretariat for Education and Research (COST Action); Federal Ministry of Education and Research (BMBF, Germany)(Federal Ministry of Education & Research (BMBF))	Financial support by the European Research Council (ERC Starting Grant MIRNA 259092, to RKOS, http://erc.europa.eu/), the University of Zurich (to RKOS and Forschungskredit Grants FK-14-096 and FK-15-095, to RB; FK-13-108, to DK; FK-13-091, to MCASH; FK-57010302, to SLBK, http://www.researchers.uzh.ch/en/funding.html), as well as from the Swiss National Science Foundation, and the Swiss State Secretariat for Education and Research (COST Action CM1105, to RKOS) is gratefully acknowledged. This work was also partially accomplished within the project localizeIT (funding code 03IPT608X, to MR, http://localize-it.de/) funded by the Federal Ministry of Education and Research (BMBF, Germany, https://www.bmbf.de/) in the program of Entrepreneurial Regions InnoProfile-Transfer (https://www.unternehmen-region.de/de/1849.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andriluka Mykhaylo, 2014, IEEE C COMP VIS PATT; [Anonymous], 1288 EMVA STAND; AUBIN JE, 1979, J HISTOCHEM CYTOCHEM, V27, P36, DOI 10.1177/27.1.220325; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Blanco M, 2010, METHOD ENZYMOL, V472, P153, DOI 10.1016/S0076-6879(10)72011-5; Borner R, 2016, J FLUORESC, V26, P963, DOI 10.1007/s10895-016-1784-5; Borner R, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4759108; Borner R, 2016, COORDIN CHEM REV, V327, P123, DOI 10.1016/j.ccr.2016.06.002; Chen J, 2014, P NATL ACAD SCI USA, V111, P664, DOI 10.1073/pnas.1315735111; Chen JX, 2016, J PHYS CHEM B, V120, P7128, DOI 10.1021/acs.jpcb.6b05697; CLEGG RM, 1992, METHOD ENZYMOL, V211, P353; Cordes T, 2010, BIOCHEMISTRY-US, V49, P9171, DOI 10.1021/bi101184g; Doose S, 2009, CHEMPHYSCHEM, V10, P1389, DOI 10.1002/cphc.200900238; FICHTHORN KA, 1991, J CHEM PHYS, V95, P1090, DOI 10.1063/1.461138; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; GALE D, 1962, AM MATH MON, V69, P9, DOI 10.2307/2312726; Gopich IV, 2010, J PHYS CHEM B, V114, P15221, DOI 10.1021/jp105359z; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Ha T, 1996, IEEE J SEL TOP QUANT, V2, P1115, DOI 10.1109/2944.577342; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; Hadzic MCAS, 2016, PROC SPIE, V9711, DOI 10.1117/12.2211191; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hirsch M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053671; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Hohlbein J, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/3/031001; Holden SJ, 2010, BIOPHYS J, V99, P3102, DOI 10.1016/j.bpj.2010.09.005; Iqbal A, 2008, P NATL ACAD SCI USA, V105, P11176, DOI 10.1073/pnas.0801707105; J Janesick, 1985, 29 ANN TECHN S SPIE, P7; Jahne B, 2004, VDI BERICHT, V1829, P317; Joo C., 2012, COLD SPRING HARB PRO, V7, P1223, DOI DOI 10.1101/PDB.TOPO72058.PDB.TOPO72058; Juette MF, 2016, NAT METHODS, V13, P341, DOI [10.1038/NMETH.3769, 10.1038/nmeth.3769]; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Konig I, 2015, NAT METHODS, V12, P773, DOI [10.1038/nmeth.3475, 10.1038/NMETH.3475]; Konig SLB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084157; Koh HR, 2013, P NATL ACAD SCI USA, V110, P151, DOI 10.1073/pnas.1212917110; Kowerko D, 2015, P NATL ACAD SCI USA, V112, P3403, DOI 10.1073/pnas.1322759112; Lakowicz JR, 2010, PRINCIPLES FLUORESCE, VXXVI; Lee NK, 2005, BIOPHYS J, V88, P2939, DOI 10.1529/biophysj.104.054114; McCann JJ, 2010, BIOPHYS J, V98, p186A, DOI 10.1016/j.bpj.2009.12.998; McCann JJ, 2010, BIOPHYS J, V99, P961, DOI 10.1016/j.bpj.2010.04.063; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Preus S, 2016, BIOPHYS J, V111, P1278, DOI 10.1016/j.bpj.2016.07.047; Preus S, 2015, NAT METHODS, V12, P593, DOI 10.1038/nmeth.3435; Preus S, 2012, CHEMBIOCHEM, V13, P1990, DOI 10.1002/cbic.201200400; Sage D, 2015, NAT METHODS, V12, P717, DOI [10.1038/NMETH.3442, 10.1038/nmeth.3442]; Saurabh S, 2012, OPT EXPRESS, V20, P7338, DOI 10.1364/OE.20.007338; Schmied JJ, 2012, NAT METHODS, V9, P1133, DOI 10.1038/nmeth.2254; Schuler B, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-S1-S2; Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008; Schuler Benjamin, 2007, V350, P115; Selvin P., 2008, SINGLE MOL TECHNIQUE; Selvin PR, 2008, SINGLE MOL TECHNIQUE, VVii; Seneta E, 1996, INT STAT REV, V64, P255, DOI 10.2307/1403785; Small A, 2014, NAT METHODS, V11, P267, DOI [10.1038/NMETH.2844, 10.1038/nmeth.2844]; Sobral A., 2013, 9 WORKSH VIS COMP WV; Steffen FD, 2016, PHYS CHEM CHEM PHYS, V18, P29045, DOI 10.1039/c6cp04277e; Steiner M, 2009, ANGEW CHEM INT EDIT, V48, P9739, DOI 10.1002/anie.200903809; Tan P, 2005, INTRO DATA MINING, VXxi; Valeur B., 2002, MOL FLUORESCENCE PRI, Vxiv; von Borczyskowski C, 2016, SELF ASSEMBLED ORGAN; Zhang B, 2007, APPL OPTICS, V46, P1819, DOI 10.1364/AO.46.001819; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; Zhu P, 2012, ANNU REV BIOPHYS, V41, P269, DOI 10.1146/annurev-biophys-050511-102338	67	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195277	10.1371/journal.pone.0195277	http://dx.doi.org/10.1371/journal.pone.0195277			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652886	Green Published, gold, Green Accepted			2022-12-26	WOS:000430026900020
J	Carter, H; Weston, D; Betts, N; Wilkinson, S; Amlot, R				Carter, Holly; Weston, Dale; Betts, Naomi; Wilkinson, Simon; Amlot, Richard			Public perceptions of emergency decontamination: Effects of intervention type and responder management strategy during a focus group study	PLOS ONE			English	Article								In the event of an incident involving the release of a hazardous chemical, first responders may decide to initiate emergency decontamination in order to remove any contaminant from affected casualties. Recent initiatives such as the UK Home Office-led Initial Operational Response Programme have introduced new evidence-based decontamination protocols that reduce the time taken to initiate the decontamination process, including an increased emphasis on rapidly removing contaminated clothing (disrobe), and the use of improvised dry decontamination methods. The current study used a series of focus groups to examine public perceptions of different decontamination interventions and responder management strategies. Results revealed that a decontamination shower was perceived to be more effective than dry decontamination methods and that a management strategy that included effective responder communication resulted in increased willingness to comply with the need for decontamination. This study demonstrates that public understanding and acceptance of novel decontamination methods such as dry decontamination may present additional challenges for first responders. Increased emphasis on effective communication during decontamination is needed. Furthermore, provision of information during the focus group study resulted in an increase in participants' knowledge and confidence in taking recommended decontamination actions, which was maintained three months after the study. The longitudinal nature of these effects suggest that it may be possible to increase public awareness about actions to take during chemical incidents by developing pre-incident public education; however, further research is needed to examine this more fully.	[Carter, Holly; Weston, Dale; Betts, Naomi; Amlot, Richard] Publ Hlth England, Emergency Response Dept Sci &Technol, Salisbury, Wilts, England; [Wilkinson, Simon] Newcastle Univ, Med Toxicol Ctr, Wolfson Bldg,Claremont Pl, Newcastle Upon Tyne, Tyne & Wear, England	Public Health England; Newcastle University - UK	Carter, H (corresponding author), Publ Hlth England, Emergency Response Dept Sci &Technol, Salisbury, Wilts, England.	holly.carter@phe.gov.uk		Carter, Holly/0000-0002-2084-7263	National Institute for Health Research Health Protection Research Unit in Modelling Methodologies at Imperial College; Public Health England	National Institute for Health Research Health Protection Research Unit in Modelling Methodologies at Imperial College; Public Health England	This research was funded by the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) in Emergency Preparedness and Response at King's College London in partnership with Public Health England. Dale Weston and Richard AmIot are part-funded by the National Institute for Health Research Health Protection Research Unit in Modelling Methodologies at Imperial College in partnership with Public Health England. The views expressed in this paper are those of the author(s) and not necessarily those of the NHS, the NIHR, the Department of Health, or Public Health England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amlot R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179309; Carter H, 2015, J APPL SOC PSYCHOL, V45, P173, DOI 10.1111/jasp.12286; Carter H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089846; Carter H, 2013, BASIC APPL SOC PSYCH, V35, P575, DOI 10.1080/01973533.2013.840634; Chilcott RP, 2014, ENVIRON INT, V72, P37, DOI 10.1016/j.envint.2014.02.006; Cibulsky SM, 2010, SUMM S CHEM DEC HUM; Fire and Rescue Service, 2003, NAT GUID DOC FIR SER; Haslam SA, 2006, J APPL PSYCHOL, V91, P1037, DOI 10.1037/0021-9010.91.5.1037; National Ambulance Resilience Unit, 2013, WAY NHS RESP HAZMAT; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Rubin GJ, 2012, BIOSECUR BIOTERROR, V10, P383, DOI 10.1089/bsp.2012.0043; Spencer M., 2012, COUNTERPROLIFERATION, V52; Truitt A., 2008, SCI PSYCHOSOCIAL PRO, V21, P15; Vogt B. M., 2002, CLEAN IS SAFE IMPROV	14	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195922	10.1371/journal.pone.0195922	http://dx.doi.org/10.1371/journal.pone.0195922			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC8EX	29652927	gold, Green Published, Green Submitted			2022-12-26	WOS:000430026900047
J	Dalaba, MA; Welaga, P; Oduro, A; Danchaka, LL; Matsubara, C				Dalaba, Maxwell Ayindenaba; Welaga, Paul; Oduro, Abraham; Danchaka, Laata Latif; Matsubara, Chieko			Cost of malaria treatment and health seeking behaviour of children under-five years in the Upper West Region of Ghana	PLOS ONE			English	Article							NORTHERN GHANA; INSURANCE SCHEME; DISTRICT; PROGRAM	Background There is limited knowledge on cost of treating malaria in children under-five years in northern Ghana which poses a challenge in determining whether interventions such as the National Health Insurance Scheme (NHIS) and Community-based Health Planning and Services (CHPS) have reduced the economic burden of malaria to households or not. This study examined the malaria care seeking and cost of treatment in children under-five years in the Upper West Region of Ghana. Methods The study used a cross-sectional, quantitative design and data were collected between July and August 2016 in three districts in the Upper West Region of Ghana. A total of 574 women who had under-five children were interviewed. Socio-demographic characteristics of respondents, malaria seeking patterns for under-five children with malaria as well as direct medical and non-medical costs associated with treating under-five children with malaria were collected from the patient perspective. Analysis was performed using STATA 12. Results Out of 574 women visited, about 63% (360) had children who had malaria and sought treatment. Most treatment was done at formal health facilities such as the health centres (37%) and the CHPS (35%) while 3% had self-treatment at home. The main reason for choice of place of treatment outside home was nearness to home (53%). The average direct medical and non-medical costs associated with treating an under-five child with malaria were US $4.13 and US$3.04 respectively. The average cost on transportation alone was US$2.64. Overall, the average direct medical and non-medical cost associated with treating an under-five child with malaria was US$4.91(range: minimum = US$0.13-maximum = US$46.75). Children who were enrolled into the NHIS paid an average amount of US$4.76 compared with US$5.88 for those not enrolled, though the difference was not statistically significant (p-value = 0.15). Conclusions The average cost to households in treating an under-five child with malaria was US$4.91. This amount is considerably high given the poverty level in the area. Children not insured paid a little over one US dollar for malaria treatment compared to those insured. Efforts to improve enrolment into the NHIS may be needed to reduce the cost of malaria treatment to households. Construction of more health facilities near to community members and at hard to reach areas will improve access to health care and reduce direct non-medical cost such as transportation costs.	[Dalaba, Maxwell Ayindenaba; Welaga, Paul; Oduro, Abraham] Navrongo Hlth Res Ctr, Navrongo, Ghana; [Danchaka, Laata Latif] Community Dev Alliance Ghana, Wa, Ghana; [Matsubara, Chieko] Bur Int Med Cooperat, Natl Ctr Global Hlth & Med, Tokyo, Japan	Navrongo Health Research Center; National Center for Global Health & Medicine - Japan	Dalaba, MA (corresponding author), Navrongo Hlth Res Ctr, Navrongo, Ghana.	madalaba@yahoo.com		ODURO, ABRAHAM/0000-0002-4191-7419; Dalaba, Maxwell/0000-0002-7101-769X	Ministry of Health, Labor and Welfare, Japan [H26-1]	Ministry of Health, Labor and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This research was funded by Research Grant for International Health, H26-1, by the Ministry of Health, Labor and Welfare, Japan (http://www.ncgm.go.jp/kaihatsu/).	Adams I, 2004, B HLTH INFORM, V1, P28; Akazili J, 2008, AFR J HLTH SCI, V14; Akazili J, 2017, BMC INT HEALTH HUM R, V17, DOI 10.1186/s12914-017-0121-7; Akazili J, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1289735; Akazili J, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0637-7; Akweongo P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079880; Alhassan RK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165151; Asante Felix Ankomah, 2003, EC BURDEN MALARIA GH; Awoonor-Williams JK, 2013, GLOB HEALTH-SCI PRAC, V1, P117, DOI 10.9745/GHSP-D-12-00012; Blanchet N J, 2012, Ghana Med J, V46, P76; Chankova S, 2008, HEALTH POLICY PLANN, V23, P264, DOI 10.1093/heapol/czn011; Dalaba M, 2012, AFR J HLTH SCI, V21, DOI [10.1093/heapol/czh031, DOI 10.1093/HEAPOL/CZH031]; Dalaba MA, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2676-3; Dalaba MA, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-014-0659-1; Dalaba MA, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.23848; Dalinjong PA, 2017, HEALTH ECON REV, V7, DOI 10.1186/s13561-017-0180-4; Dalinjong PA, 2012, HEALTH ECON REV, V2, DOI 10.1186/2191-1991-2-13; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Fenny Ama Pokuaa, 2016, Glob Health Res Policy, V1, P18, DOI 10.1186/s41256-016-0018-3; Fenny AP, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1696-3; Franco LM, 2008, B WORLD HEALTH ORGAN, V86, P830, DOI 10.2471/BLT.08.051045; Ghana Health Service, 2014, NAT MAL CONTR PROGR; Ghana Health Service, 2014, UPP W REG HLTH SERV; Ghana Statistical Service, 2014, GHAN DEM HLTH SURV; Ghana Statistical Service, 2014, 6 GHAN STAT SERV; Ghana Statistical Service Ghana Health Service & ICF International, 2014, GHAN DEM HLTH SURV; Jehu-Appiah C, 2012, HEALTH POLICY PLANN, V27, P222, DOI 10.1093/heapol/czr032; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Kotoh AM, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0320-1; Kusi A, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-014-0130-2; Maka DE, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1639-1; Matovu F, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-222; Mitiku I, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1798-8; Nest GH, 2012, GHANA HLTH NEST; NHIS, 2015, NHIS SUBSCR HDB; Nonvignon J, 2016, MALARIA J, V15, DOI [10.1186/s12936-015-1079, DOI 10.1186/S12936-015-1079-]; Nonvignon J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1506-0; Nonvignon J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1418-z; Onwujekwe O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078362; Roca-Feltrer A, 2012, AM J TROP MED HYG, V86, P96, DOI 10.4269/ajtmh.2012.11-0397; Sarpong N, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0772-6; Sicuri E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-307; Tawiah T, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1116-x; WHO, 2015, WORLD MAL REP 2015; World Economic Forum, 2006, BUS MAL NEGL THREAT	45	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195533	10.1371/journal.pone.0195533	http://dx.doi.org/10.1371/journal.pone.0195533			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652938	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900025
J	Huang, HY; Li, YP; Luo, XY; Cheng, X; Shi, B; Li, JT				Huang, Hanyao; Li, Yeping; Luo, Xiangyou; Cheng, Xu; Shi, Bing; Li, Jingtao			Mechanical analyses of critical surgical maneuvers in the correction of cleft lip nasal deformity	PLOS ONE			English	Article							FINITE-ELEMENT-ANALYSIS; CEPHALIC TRIM; TIP SUPPORT; PALATE; SEPTUM; STABILITY; SKELETON; MODEL; NOSE	The relapse of nasal deformity is a challenge for modern correction of cleft lip. A comprehensive understanding in the biomechanical perspective of both the formation and correction of the cleft lip nasal deformity would lead to improved stability of the corrective outcome. In this study, a finite element model of secondary cleft lip nasal deformity was constructed, on which two critical corrective maneuvers were mimicked in the form of force-loading. The intercrural suture was simulated by a force loaded at the intermediate crus of the alar cartilage directing anteriorly and medially, and the suture suspending the alar cartilage to the upper lateral cartilage was simulated by a force loaded at the lateral crus directing superiorly and medially. The equivalent von-mises stress and the total deformation consequent to different patterns of loading were captured. Our biomechanical analyses suggested that the intercrural suture at the nasal tip might be more effective in generating widespread morphological change than the suspension suture, but left much higher level of stress within the skin envelope if placed too high. Synergistic effect was observed between the two sutures in both the resultant deformation and stress. In addition, our simulations were partially supported by clinical photogrammetry data.	[Li, Jingtao] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China; Sichuan Univ, West China Hosp Stomatol, Natl Clin Res Ctr Oral Dis, Chengdu, Sichuan, Peoples R China; Sichuan Univ, West China Hosp Stomatol, Dept Oral Maxillofacial Surg, Chengdu, Sichuan, Peoples R China	Sichuan University; Sichuan University; Sichuan University	Li, JT (corresponding author), Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu, Sichuan, Peoples R China.	lijingtao86@163.com	li, ye/GWN-2672-2022; Huang, Hanyao/AAX-9478-2020	Huang, Hanyao/0000-0002-6805-0157; Li, Jingtao/0000-0002-0774-194X	National Natural Science Foundation of China [81500829]; Sichuan Science and Technology Program [2017RZ0036]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program	This work was supported by the National Natural Science Foundation of China (grant No. 81500829) and Sichuan Science and Technology Program (grant No. 2017RZ0036) grant to J.L.	Byrd HS, 2000, PLAST RECONSTR SURG, V106, P1276, DOI 10.1097/00006534-200011000-00007; Fisher DM, 1998, PLAST RECONSTR SURG, V101, P1448, DOI 10.1097/00006534-199805000-00003; HUFFMAN WC, 1949, PLAST RECONSTR SURG, V4, P225, DOI 10.1097/00006534-194905000-00001; Jung JW, 2014, INT J PRECIS ENG MAN, V15, P2611, DOI 10.1007/s12541-014-0634-0; Leary RP, 2015, JAMA FACIAL PLAST SU, V17, P413, DOI 10.1001/jamafacial.2015.0941; Lee JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153056; Lee JS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119996; Lee SJ, 2010, LARYNGOSCOPE, V120, P1931, DOI 10.1002/lary.21072; Lee SJ, 2010, LARYNGOSCOPE, V120, P1508, DOI 10.1002/lary.20976; Liong Kyrin, 2013, J Med Eng, V2013, P250274, DOI 10.1155/2013/250274; Luo XY, 2015, BIOMATERIALS, V57, P59, DOI 10.1016/j.biomaterials.2015.03.062; Manuel CT, 2017, ANN BIOMED ENG, V45, P829, DOI 10.1007/s10439-016-1729-9; Manuel CT, 2014, LARYNGOSCOPE, V124, P649, DOI 10.1002/lary.24321; Mau T, 2007, LARYNGOSCOPE, V117, P1902, DOI 10.1097/MLG.0b013e3181255ec4; MCCOMB H, 1985, PLAST RECONSTR SURG, V75, P791, DOI 10.1097/00006534-198506000-00003; McComb HK, 1996, CLEFT PALATE-CRAN J, V33, P23, DOI 10.1597/1545-1569(1996)033<0023:PROTUC>2.3.CO;2; Nagasao T, 2009, CLEFT PALATE-CRAN J, V46, P154, DOI 10.1597/07-177.1; Oliaei S, 2012, ARCH FACIAL PLAST S, V14, P27, DOI 10.1001/archfacial.2011.1354; Olmez S, 2014, ANGLE ORTHOD, V84, P815, DOI 10.2319/080613-586.1; Pan XG, 2007, CLEFT PALATE-CRAN J, V44, P149, DOI 10.1597/05-161.1; Rifley W, 1996, CLIN PLAST SURG, V23, P81; Shamouelian D, 2015, LARYNGOSCOPE, V125, P326, DOI 10.1002/lary.24845; Smahel Z, 1991, Acta Chir Plast, V33, P47; Smahel Z, 1999, CLEFT PALATE-CRAN J, V36, P310, DOI 10.1597/1545-1569(1999)036<0310:EOPROT>2.3.CO;2; Tjoa T, 2016, JAMA FACIAL PLAST SU, V18, P136, DOI 10.1001/jamafacial.2015.1954; Wolfe SA, 2004, PLAST RECONSTR SURG, V114, P1, DOI 10.1097/01.PRS.0000130416.86351.24; Yin Ningbei, 2015, Zhonghua Kou Qiang Yi Xue Za Zhi, V50, P278	27	10	11	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195583	10.1371/journal.pone.0195583	http://dx.doi.org/10.1371/journal.pone.0195583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652906	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900030
J	Kalsbeek, A; Veenstra, J; Westra, J; Disselkoen, C; Koch, K; McKenzie, KA; O'Bott, J; Vander Woude, J; Fischer, K; Shearers, GC; Harris, WS; Tintle, NL				Kalsbeek, Anya; Veenstra, Jenna; Westra, Jason; Disselkoen, Craig; Koch, Kristin; McKenzie, Katelyn A.; O'Bott, Jacob; Vander Woude, Jason; Fischer, Karen; Shearers, Greg C.; Harris, William S.; Tintle, Nathan L.			A genome-wide association study of red-blood cell fatty acids and ratios incorporating dietary covariates: Framingham Heart Study Offspring Cohort	PLOS ONE			English	Article							GENETIC-VARIANTS; AGING RESEARCH; PLASMA; LOCI; METAANALYSES; CHINESE; MICE	Recent analyses have suggested a strong heritable component to circulating fatty acid (FA) levels; however, only a limited number of genes have been identified which associate with FA levels. In order to expand upon a previous genome wide association study done on participants in the Framingham Heart Study Offspring Cohort and FA levels, we used data from 2,400 of these individuals for whom red blood cell FA profiles, dietary information and genotypes are available, and then conducted a genome-wide evaluation of potential genetic variants associated with 22 FAs and 15 FA ratios, after adjusting for relevant dietary covariates. Our analysis found nine previously identified loci associated with FA levels (FADS, ELOVL2, PCOLCE2, LPCAT3, AGPAT4, NTAN1/PDXDC1, PKD2L1, HBS1L/MYB and RAB3GAP1/MCM6), while identifying four novel loci. The latter include an association between variants in CALN1 (Chromosome 7) and eicosapentaenoic acid (EPA), DHRS4L2 (Chromosome 14) and a FA ratio measuring delta-9-desaturase activity, as well as two loci associated with less well understood proteins. Thus, the inclusion of dietary covariates had a modest impact, helping to uncover four additional loci. While genome-wide association studies continue to uncover additional genes associated with circulating FA levels, much of the heritable risk is yet to be explained, suggesting the potential role of rare genetic variation, epistasis and gene-environment interactions on FA levels as well. Further studies are needed to continue to understand the complex genetic picture of FA metabolism and synthesis.	[Kalsbeek, Anya; Veenstra, Jenna; Westra, Jason; Disselkoen, Craig; Vander Woude, Jason; Fischer, Karen; Tintle, Nathan L.] Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA 51250 USA; [Koch, Kristin] Baylor Univ, Dept Stat, Waco, TX 76798 USA; [McKenzie, Katelyn A.] Duke Univ, Dept Stat, Durham, NC USA; [O'Bott, Jacob] Univ Maryland Baltimore Cty, Dept Math & Stat, Baltimore, MD 21228 USA; [Shearers, Greg C.] Penn State Univ, Dept Nutr Sci, State Coll, PA USA; [Harris, William S.] OmegaQuant, Sioux Falls, SD USA	Baylor University; Duke University; University System of Maryland; University of Maryland Baltimore County; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Tintle, NL (corresponding author), Dordt Coll, Dept Math Stat & Comp Sci, Sioux Ctr, IA 51250 USA.	nathan.tintle@doradt.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353; Kalsbeek, Anya/0000-0001-7215-1236; Tintle, Nathan/0000-0003-1447-9107; Vander Woude, Jason/0000-0002-7672-6321	National Human Genome Research Institute (NT) [1R15HG006915, 2R15HG006915]; National Heart Lung and Blood Institute (NHLBI) [R01-HL089590]; Framingham Heart Study (NHLBI); Boston University School of Medicine;  [N01-HC-25195]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R15HG006915] Funding Source: NIH RePORTER	National Human Genome Research Institute (NT); National Heart Lung and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Framingham Heart Study (NHLBI); Boston University School of Medicine; ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was funded by the National Human Genome Research Institute (1R15HG006915 and 2R15HG006915; NT). The Framingham Heart Study is supported in part by the National Heart Lung and Blood Institute (NHLBI; R01-HL089590) and by Contract N01-HC-25195, the Framingham Heart Study (NHLBI) and Boston University School of Medicine. Omega Quant provided support in the form of salaries for author WH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Andersen MK, 2016, PLOS GENET, V193, P1, DOI DOI 10.1097/YPG.0B013E32834ACD07; Bray JE, 2009, CHEM-BIOL INTERACT, V178, P99, DOI 10.1016/j.cbi.2008.10.058; Cupples LA, 2007, BMC MED GENET S1, V8, pS1; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; Demirkan A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002490; Emsley R, 2003, CNS DRUGS, V17, P1081, DOI 10.2165/00023210-200317150-00003; Enattah NS, 2002, NAT GENET, V30, P233, DOI 10.1038/ng826; Ferreira MAR, 2008, NAT GENET, V40, P1056, DOI 10.1038/ng.209; Gonzalez-Baro MR, 2017, BBA-MOL CELL BIOL L, V1862, P49, DOI 10.1016/j.bbalip.2016.06.023; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; Guan WH, 2014, CIRC-CARDIOVASC GENE, V7, P321, DOI 10.1161/CIRCGENETICS.113.000208; Harris WS, 2013, J CLIN LIPIDOL, V7, P433, DOI 10.1016/j.jacl.2013.05.001; Harris WS, 2012, ATHEROSCLEROSIS, V225, P425, DOI 10.1016/j.atherosclerosis.2012.05.030; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hu Y, 2016, HUM MOL GENET, V25, P1215, DOI 10.1093/hmg/ddw002; Huertas-Vazquez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059905; Ingason A, 2011, MOL PSYCHIATR, V16, P17, DOI 10.1038/mp.2009.101; Kabir I, 2016, J BIOL CHEM; Kullo IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013011; Lai YL, 2016, HEMOGLOBIN, V40, P405, DOI 10.1080/03630269.2016.1253586; Laugharne JDE, 1996, LIPIDS, V31, pS163, DOI 10.1007/BF02637070; Lemaitre RN, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002193; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li ZQ, 2015, GASTROENTEROLOGY, V149, P1519, DOI 10.1053/j.gastro.2015.07.012; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loh PR, 2016, NAT GENET, V48, P1443, DOI 10.1038/ng.3679; Magiera R, 2014, CLIN LAB, V60, P1617, DOI 10.7754/Clin.Lab.2014.140219; Meierhofer D, 2014, J PROTEOME RES, V13, P5592, DOI 10.1021/pr5005828; Ohi K, 2016, PSYCHIAT GENET, V26, P142, DOI 10.1097/YPG.0000000000000127; Pollard RD, 2015, J BIOL CHEM, V290, P15496, DOI 10.1074/jbc.M115.646240; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Psaty BM, 2009, CIRC-CARDIOVASC GENE, V2, P73, DOI 10.1161/CIRCGENETICS.108.829747; Ripke S, 2011, NAT GENET, V43, P969, DOI 10.1038/ng.940; Rong X, 2015, ELIFE, V4; Schuchardt JP, 2016, J NUTR HEALTH AGING, V20, P611, DOI 10.1007/s12603-016-0720-3; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Shin SY, 2014, NAT GENET, V46, P543, DOI 10.1038/ng.2982; Smith CE, 2015, MOL NUTR FOOD RES, V59, P1373, DOI 10.1002/mnfr.201400734; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thom CS, 2014, DEV CELL, V30, P688, DOI 10.1016/j.devcel.2014.07.021; Tintle NL, 2015, PROSTAG LEUKOTR ESS, V94, P65, DOI 10.1016/j.plefa.2014.11.007; Tintle NL, 2015, METABOLOMICS, V11, P1327, DOI 10.1007/s11306-015-0787-6; Wang B, 2016, CELL METAB; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797; WILLETT WC, 1985, AM J EPIDEMIOL, V122, P51, DOI 10.1093/oxfordjournals.aje.a114086; Wu JHY, 2013, CIRC-CARDIOVASC GENE, V6, P171, DOI 10.1161/CIRCGENETICS.112.964619; Xia SH, 2015, NEUROSCI LETT, V602, P110, DOI 10.1016/j.neulet.2015.07.001; Zhang JY, 2016, CURR OPIN CLIN NUTR, V19, P103, DOI 10.1097/MCO.0000000000000254; Zhang RY, 2014, CARCINOGENESIS, V35, P1528, DOI 10.1093/carcin/bgu076	49	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194882	10.1371/journal.pone.0194882	http://dx.doi.org/10.1371/journal.pone.0194882			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652918	Green Published, gold, Green Submitted			2022-12-26	WOS:000430026900013
J	Mba, JME; Bisseye, C; Ndong, JMN; Mombo, LE; Bengone, C; Migolet, GM; M'batchi, B; Kosiorek, HE; Butterfield, RJ; Roberts, LR; Borad, MJ; Nagalo, BM				Mba, Jean Marie Eko; Bisseye, Cyrille; Ndong, Jophrette Mireille Ntsame; Mombo, Landry Erik; Bengone, Calixte; Migolet, Guy Mouelet; M'batchi, Bertrand; Kosiorek, Heidi E.; Butterfield, Richard J.; Roberts, Lewis R.; Borad, Mitesh J.; Nagalo, Bolni Marius			Prevalent hepatitis B surface antigen among first-time blood donors in Gabon	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; RURAL POPULATIONS; DELTA-VIRUS; C VIRUSES; SEROPREVALENCE; SYPHILIS; DIVERSITY; DISEASES; MARKERS; URBAN	Despite chronic Hepatitis B virus (HBV) infection being the main cause of younger-onset complex liver disease including cirrhosis and hepatocellular carcinoma (HCC) in Africa, very little is known regarding the seroprevalence of HBV in the Gabonese general population. This investigation aimed to provide strong epidemiological data and risk factors associated with HBV infection in first-time blood donors representative of the urban adult population. The screening of HBsAg was carried out using 4th generation ELISA kits. The overall seroprevalence of HBsAg was 7.28%. The frequency of HBsAg was differential and marked by annual variations in blood donors from 2009 to 2016. Seroprevalence was 2-fold higher among males versus females (OR = 1.90 (95% CI: 1.75-2.06), P<0.001). HBsAg seroprevalence was significantly higher in donors of the age group 25-35 years old compared to donors of the age group < 18 years (OR = 1.64 (95% CI: 1.03-2.60), P = 0.04). The seroprevalence of HBsAg in family/replacement donors (FRD) was significantly higher than that of voluntary non-remunerated donors (VNRD) (OR = 0.88 (95% CI: 0.83-0.94), P < 0.001). The simultaneous comparison of HBsAg seroprevalence with blood donation type, gender and age showed that the higher prevalence in FRD was significant only in males between 18 and 45 years and in females between 25 and 34 years of age. This study confirms the high endemicity of HBV in Gabon while identifying the most infected age groups for both men and women.	[Mba, Jean Marie Eko; Ndong, Jophrette Mireille Ntsame; Bengone, Calixte; Migolet, Guy Mouelet] Ctr Natl Transfus Sanguine, Libreville, Gabon; [Mba, Jean Marie Eko; Bisseye, Cyrille; Mombo, Landry Erik; M'batchi, Bertrand; Nagalo, Bolni Marius] Univ Sci & Tech Masuku, Lab Biol Mol & Cellulaire LABMC, Franceville, Gabon; [Kosiorek, Heidi E.; Butterfield, Richard J.] Mayo Clin, Div Biostat, Scottsdale, AZ USA; [Roberts, Lewis R.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA; [Borad, Mitesh J.; Nagalo, Bolni Marius] Mayo Clin, Div Hematol Oncol, Scottsdale, AZ USA	Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Bisseye, C (corresponding author), Univ Sci & Tech Masuku, Lab Biol Mol & Cellulaire LABMC, Franceville, Gabon.	cbisseye@gmail.com	Bisseye, C./AFO-0118-2022; Bisseye, Cyrille/AGP-8782-2022	Bisseye, Cyrille/0000-0002-6888-6317; Butterfield, Richard/0000-0001-6758-2875; Roberts, Lewis/0000-0001-7885-8574	Centre National de Transfusion Sanguine (CNTS); Agence Universitaire de la Francophonie [G950/442/BACGL 2016/AO/PFD]	Centre National de Transfusion Sanguine (CNTS); Agence Universitaire de la Francophonie	This work was supported by Centre National de Transfusion Sanguine (CNTS) and Agence Universitaire de la Francophonie (Ref.: G950/442/BACGL 2016/AO/PFD) to CB. The sponsors had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adouani B, 2013, TRANSFUSION MED, V23, P432, DOI 10.1111/tme.12054; Allain Jean-Pierre, 2016, Asian J Transfus Sci, V10, P5, DOI 10.4103/0973-6247.164270; Allain JP, 2011, BRIT J HAEMATOL, V154, P763, DOI 10.1111/j.1365-2141.2011.08708.x; Ankouane F, 2016, TRANSFUS CLIN BIOL, V23, P72, DOI 10.1016/j.tracli.2015.11.008; Arivelo RZ, 2011, BLOOD TRANSFUS-ITALY, V9, P475, DOI 10.2450/2011.0102-10; Bertherat E, 1998, INT J STD AIDS, V9, P31, DOI 10.1258/0956462981921008; Bivigou-Mboumba B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0143869; Coppola N, 2016, WORLD J HEPATOL, V8, P273, DOI 10.4254/wjh.v8.i5.273; Diarra A, 2009, TRANSFUS CLIN BIOL, V16, P444, DOI 10.1016/j.tracli.2009.09.004; DUPONT A, 1988, ANN SOC BELG MED TR, V68, P157; Farshadpour F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157615; Fessehaye N, 2011, PAN AFR MED J, V9; Francois-Souquiere S, 2016, INFECT GENET EVOL, V39, P12, DOI 10.1016/j.meegid.2015.12.021; Nebenzahl HG, 2013, SAMJ S AFR MED J, V103, P186, DOI [10.7196/SAMJ.6097, 10.7196/samj.6097]; Kabinda JM, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.385.4328; Kolou Malewe, 2017, Open Virol J, V11, P1, DOI 10.2174/1874357901710011001; Lopez-Balderas N, 2015, J INFECT DEV COUNTR, V9, P274, DOI 10.3855/jidc.4812; Makuwa M, 2008, J CLIN MICROBIOL, V46, P754, DOI 10.1128/JCM.02142-07; Makuwa M, 2009, J CLIN MICROBIOL, V47, P2265, DOI 10.1128/JCM.02012-08; Mavenyengwa RT, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-424; Mueller A, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1129-z; Nagalo BM, 2012, TROP MED INT HEALTH, V17, P247, DOI 10.1111/j.1365-3156.2011.02902.x; Nambei WS, 2016, MED SANTE TROP, V26, P192, DOI 10.1684/mst.2016.0553; Noah Dominique Noah, 2013, Pan Afr Med J, V16, P111, DOI 10.11604/pamj.2013.16.111.2760; Nzaji MK, 2013, SANTE PUBLIQUE, V25, P213; Rerambiah LK, 2014, BLOOD TRANSFUS-ITALY, V12, P330, DOI 10.2450/2013.0144-13; RICHARDLENOBLE D, 1995, AM J TROP MED HYG, V53, P338, DOI 10.4269/ajtmh.1995.53.338; Rufai T, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.53.3390; Tao Issoufou, 2014, Hepat Res Treat, V2014, P781843, DOI 10.1155/2014/781843; Tauma G, 2016, PUBLIC HEALTH ACTION, V6, P261, DOI 10.5588/pha.16.0068; Twagirumugabe T, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2149-z; UNICEF, 2014, DIV DONN DLREDP; WHO, 2014, IMP VACC HEP B MEILL; Xie DD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139947; Yang JD, 2017, LANCET GASTROENTEROL, V2, P103, DOI 10.1016/S2468-1253(16)30161-3; Yildiz SM, 2015, TRANSFUS APHER SCI, V53, P308, DOI 10.1016/j.transci.2015.05.022; Ziraba AK, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-191	37	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0194285	10.1371/journal.pone.0194285	http://dx.doi.org/10.1371/journal.pone.0194285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652917	Green Submitted, Green Published, gold			2022-12-26	WOS:000430026900005
J	Peter, A; Routledge, E				Peter, Aji; Routledge, Edwin			Present-day monitoring underestimates the risk of exposure to pathogenic bacteria from cold water storage tanks	PLOS ONE			English	Article							PLATE-COUNT BACTERIA; LEGIONELLA-PNEUMOPHILA; DRINKING-WATER; PSEUDOMONAS-AERUGINOSA; BIOFILM FORMATION; LEGIONNAIRES-DISEASE; POTABLE WATER; DISTRIBUTION-SYSTEMS; MICROBIAL-GROWTH; LOW-TEMPERATURES	Water-borne bacteria, found in cold water storage tanks, are causative agents for various human infections and diseases including Legionnaires' disease. Consequently, regular microbiological monitoring of tank water is undertaken as part of the regulatory framework used to control pathogenic bacteria. A key assumption is that a small volume of water taken from under the ball valve (where there is easy access to the stored water) will be representative of the entire tank. To test the reliability of this measure, domestic water samples taken from different locations of selected tanks in London properties between November 2015 and July 2016 were analysed for TVCs, Pseudomonas and Legionella at an accredited laboratory, according to regulatory requirements. Out of similar to 6000 tanks surveyed, only 15 were selected based on the ability to take a water sample from the normal sampling hatch (located above the ball valve) and from the far end of the tank (usually requiring disassembly of the tank lid with risk of structural damage), and permission being granted by the site manager to undertake the additional investigation and sampling. Despite seasonal differences in water temperature, we found 100% compliance at the ball valve end. In contrast, 40% of the tanks exceeded the regulatory threshold for temperature at the far end of the tank in the summer months. Consequently, 20% of the tanks surveyed failed to trigger appropriate regulatory action based on microbiological analyses of the water sample taken under the ball valve compared to the far end sample using present-day standards. These data show that typical water samples collected for routine monitoring may often underestimate the microbiological status of the water entering the building, thereby increasing the risk of exposure to water bourne pathogens with potential public health implications. We propose that water storage tanks should be redesigned to allow access to the far end of tanks for routine monitoring purposes, and that water samples used to ascertain the regulatory compliance of stored water in tanks should be taken at the point at which water is abstracted for use in the building.	[Peter, Aji; Routledge, Edwin] Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England; [Peter, Aji] Aqua Technol Europe Ltd, Hounslow, Middx, England	Brunel University	Peter, A (corresponding author), Brunel Univ London, Inst Environm Hlth & Soc, Uxbridge, Middx, England.; Peter, A (corresponding author), Aqua Technol Europe Ltd, Hounslow, Middx, England.	ajipeter2012@gmail.com	Routledge, Edwin John/V-2336-2019; Routledge, Edwin/AGI-0283-2022	Routledge, Edwin/0000-0001-7695-364X	Europe Ltd	Europe Ltd	The authors received no specific funding for this work. Aqua Technologies Europe Ltd provided support in the form of salaries for authors [AP] and access to sites, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Al-Harbi AH, 2003, AQUAC RES, V34, P517, DOI 10.1046/j.1365-2109.2003.00832.x; Allen MJ, 2004, INT J FOOD MICROBIOL, V92, P265, DOI 10.1016/j.ijfoodmicro.2003.08.017; Anaissie EJ, 2003, BLOOD, V101, P2542, DOI 10.1182/blood-2002-02-0530; Armon R, 1997, WATER SCI TECHNOL, V35, P293, DOI 10.1016/S0273-1223(97)00275-8; ASHRAE, 2000, MIN RISK LEG ASS BUI; BARKO JW, 1986, ECOLOGY, V67, P1328, DOI 10.2307/1938689; Betancourt WQ, 2004, VET PARASITOL, V126, P219, DOI 10.1016/j.vetpar.2004.09.002; Borella P, 2004, EMERG INFECT DIS, V10, P457, DOI 10.3201/eid1003.020707; Brandsema PS, 2014, EPIDEMIOL INFECT, V142, P2360, DOI 10.1017/S0950268813003476; Brown J, 2001, Commun Dis Intell Q Rep, V25, P63; CIESIELSKI CA, 1984, APPL ENVIRON MICROB, V48, P984, DOI 10.1128/AEM.48.5.984-987.1984; Cramer M, 2003, AM J CRIT CARE, V12, P234, DOI 10.4037/ajcc2003.12.3.234; Declerck P, 2010, ENVIRON MICROBIOL, V12, P557, DOI 10.1111/j.1462-2920.2009.02025.x; Declerck P, 2009, MICROBIOL RES, V164, P593, DOI 10.1016/j.micres.2007.06.001; Donlan RM, 2001, CLIN INFECT DIS, V33, P1387, DOI 10.1086/322972; DWI (Drinking Water Inspectorate), 2010, WATER, P1; DWI (Drinking Water Inspectorate), 2005, COLD WAT SERV STOR C; Edberg SC, 2000, J APPL MICROBIOL, V88, p106S, DOI 10.1111/j.1365-2672.2000.tb05338.x; Falkinham JO, 2015, ENVIRON HEALTH PERSP, V123, P749, DOI 10.1289/ehp.1408692; Fisman DN, 2005, J INFECT DIS, V192, P2066, DOI 10.1086/498248; GIVSKOV M, 1994, J BACTERIOL, V176, P7, DOI 10.1128/JB.176.1.7-14.1994; Gray J.R., 2000, 004191 US GEOL SURV; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; HSE, 2000, LEG DIS CONTR LEG BA; HSE (Health and Safety Executive), 2002, POT WAT LEG CONTR; Figueras MJ, 2010, INT J ENV RES PUB HE, V7, P4179, DOI 10.3390/ijerph7124179; KAPPERUD G, 1982, ACTA PATH MICRO IM B, V90, P185; Karlowsky JA, 2003, ANTIMICROB AGENTS CH, V47, P1681, DOI 10.1128/AAC.47.5.1681-1688.2003; Kennedy Emily, 2012, THESIS; Kilb B, 2003, INT J HYG ENVIR HEAL, V206, P563, DOI 10.1078/1438-4639-00258; Klausen M, 2003, MOL MICROBIOL, V48, P1511, DOI 10.1046/j.1365-2958.2003.03525.x; Konishi T, 2006, J BIOSCI BIOENG, V101, P478, DOI 10.1263/jbb.101.478; Lautenschlager K, 2010, WATER RES, V44, P4868, DOI 10.1016/j.watres.2010.07.032; Lee HKH, 2010, J CLASSIF, V27, P41, DOI 10.1007/s00357-010-9044-x; Liu Z, 2006, J APPL MICROBIOL, V101, P437, DOI 10.1111/j.1365-2672.2006.02970.x; Manuel CM, 2007, WATER RES, V41, P551, DOI 10.1016/j.watres.2006.11.007; MARSTON BJ, 1994, ARCH INTERN MED, V154, P2417, DOI 10.1001/archinte.154.21.2417; Moritz MM, 2010, INT J HYG ENVIR HEAL, V213, P190, DOI 10.1016/j.ijheh.2010.05.003; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2014, LEG QUEST ANSW; Pepper IL, 2004, INT J FOOD MICROBIOL, V92, P289, DOI 10.1016/j.ijfoodmicro.2003.08.021; Peter A., 2017, Environmental Technology Reviews, V6, P145, DOI 10.1080/21622515.2017.1335352; Ramsey CA, 2005, ENVIRON FORENSICS, V6, P71, DOI 10.1080/15275920590913877; ROGERS J, 1994, APPL ENVIRON MICROB, V60, P1842, DOI 10.1128/AEM.60.6.1842-1851.1994; ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995; Soderberg MA, 2004, J BACTERIOL, V186, P3712, DOI 10.1128/JB.186.12.3712-3720.2004; Soderberg MA, 2008, APPL ENVIRON MICROB, V74, P5583, DOI 10.1128/AEM.00067-08; Sousa AM, 2014, PATHOGENS, V3, P680, DOI 10.3390/pathogens3030680; Stojek NM, 2006, ANN AGR ENV MED, V13, P323; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Storey MV, 2011, WATER RES, V45, P741, DOI 10.1016/j.watres.2010.08.049; STOUT JE, 1985, APPL ENVIRON MICROB, V49, P221, DOI 10.1128/AEM.49.1.221-228.1985; Temmerman R, 2006, APPL ENVIRON MICROB, V72, P4323, DOI 10.1128/AEM.00070-06; Turetgen I, 2007, ENVIRON MONIT ASSESS, V125, P271, DOI 10.1007/s10661-006-9519-8; WADOWSKY RM, 1985, APPL ENVIRON MICROB, V49, P1197, DOI 10.1128/AEM.49.5.1197-1205.1985; WHO (World Health Organisation), 1997, WAT SAMPL AN; Worrall E., 2015, CLIMATE CHANGE INCRE; Yang CY, 1998, STROKE, V29, P411, DOI 10.1161/01.STR.29.2.411	58	8	9	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195635	10.1371/journal.pone.0195635	http://dx.doi.org/10.1371/journal.pone.0195635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649274	Green Published, gold, Green Submitted			2022-12-26	WOS:000429791900064
J	Sarandy, MM; Miranda, LL; Altoe, LS; Novaes, RD; Zanuncio, VV; Leite, JPV; Goncalves, RV				Sarandy, Mariaurea Matias; Miranda, Lyvia Lopes; Altoe, Luciana Schultheis; Novaes, Romulo Dias; Zanuncio, Virginia Vinha; Viana Leite, Joo Paulo; Goncalves, Reggiani Vilela			Strychnos pseudoquina modulates the morphological reorganization of the scar tissue of second intention cutaneous wounds in rats	PLOS ONE			English	Article							MAST-CELLS; OXIDATIVE DAMAGE; REACTIVE OXYGEN; HUMAN BLOOD; LATE-PHASE; EXTRACT; PROLIFERATION; INFLAMMATION; ANTIOXIDANTS; MODEL	Natural substances are used in folk medicines to treat injuries. Strychnos pseudoquina has scarring, antipyretic, and antimalarial actions. The present study aimed to analyze the effect of S. pseudoquina on cutaneous wound healing in rats. The S. pseudoquina extract was submitted to phytochemical prospection. The levels of flavonoids and total phenolic compounds in the extract were 50.7 mg/g and 2.59 mg/g, respectively. Thirty Wistar rats were individualized in cages with food and water ad libitum (registration no. 730/2014). After anesthesia, three circular wounds (12mm diameter) were made in the animals, which were randomly separated into five treatments: Sal, saline; VO, ointment vehicles (lanolin and Vaseline); SS, positive control (silver sulfadiazine 1%); LE 5, freeze-dried extract 5%; and LE 10, lyophilized extract 10%. The animals were treated with the ointment daily for 21 days. Every seven days, the area and the rate of wound contraction were evaluated. Tissue samples were removed for histopathological analysis of the number of mast cells, elastic and collagen fibers, and biochemical analyses, quantification of malondialdehyde (MDA), carbonylated proteins (PCN), superoxide dismutase (SOD), catalase (CAT), transforming growth factor beta (TGF-beta), Interleukin 10 (IL-10) and tumor necrosis factor (TNF). The number of mast cells, collagen and elastic fibers in the rat wounds were higher in the treatments with the plant. The extract also stimulated the activity of antioxidant enzymes, particularly SOD, presenting high levels, and maintained low levels of PCN. The TGF-beta and IL-10 concentration was higher in the LE5 and LE10 treatment of the extract than in the Sal, OV and SS treatments on day 7. The ointment based on S. pseudoquina closed the wound faster and accelerated wound healing in animals.	[Sarandy, Mariaurea Matias; Goncalves, Reggiani Vilela] Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil; [Miranda, Lyvia Lopes; Altoe, Luciana Schultheis] Univ Fed Vicosa, Inst Biomed Sci, Dept Gen Biol, Vicosa, MG, Brazil; [Novaes, Romulo Dias] Univ Fed Alfenas, Dept Biol Struct, Alfenas, MG, Brazil; [Zanuncio, Virginia Vinha] Univ Fed Vicosa, Dept Med & Nursing, Vicosa, MG, Brazil; [Viana Leite, Joo Paulo] Univ Fed Vicosa, Dept Agr Biochem, Vicosa, MG, Brazil	Universidade Federal de Vicosa; Universidade Federal de Vicosa; Universidade Federal de Alfenas; Universidade Federal de Vicosa; Universidade Federal de Vicosa	Goncalves, RV (corresponding author), Univ Fed Vicosa, Dept Anim Biol, Vicosa, MG, Brazil.	reggiani.goncalves@ufv.br	SOUZA, MARIAUREA/GQP-7833-2022; Gonçalves, Reggiani V/J-1550-2016; Novaes, Romulo D/F-1210-2015	Gonçalves, Reggiani V/0000-0002-5831-3590; Novaes, Romulo D/0000-0002-3186-5328	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [PPM 00687-17]; CNPq [303972/2017-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported by the following Brazilian agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (RVG), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) (edital PPM 00687-17) (RVG). The author Romulo Dias Novaes thanks CNPq for the fellowship granted to the research in productivity (process 303972/2017-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abood WN, 2015, BOSNIAN J BASIC MED, V15, P25, DOI 10.17305/bjbms.2015.39; AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Khamis A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006213.pub3; Andrade-Neto VF, 2003, J ETHNOPHARMACOL, V87, P253, DOI 10.1016/S0378-8741(03)00141-7; Arcanjo DDR, 2012, BRAZ J BIOL, V72, P505, DOI 10.1590/S1519-69842012000300013; de Brito TLA, 2014, LIFE SCI, V100, P138, DOI [10.1016/j.lfs.2014.02.007, 10.1016/j.lfs2014.02.007]; Baltzis D, 2014, ADV THER, V31, P817, DOI 10.1007/s12325-014-0140-x; Barreiros A.L.B.S, 2003, Rev. bras. farmacogn., V13, P8; Belhadj F, 2016, FOOD CHEM, V204, P29, DOI 10.1016/j.foodchem.2016.02.111; Bladt S, 2009, SSBM, V2, P74; Bonamin F, 2011, J ETHNOPHARMACOL, V138, P47, DOI 10.1016/j.jep.2011.08.020; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bryan N, 2012, EUR CELLS MATER, V24, P249, DOI 10.22203/eCM.v024a18; Carocho M, 2013, FOOD CHEM TOXICOL, V51, P15, DOI 10.1016/j.fct.2012.09.021; Cheng PG, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/671252; Cortes MA, 2013, POLIMEROS, V23, P402, DOI 10.4322/polimeros.2013.085; Curtis BJ, 2014, ALCOHOL CLIN EXP RES, V38, P1347, DOI 10.1111/acer.12369; da Silva MA, 2005, CHEM PHARM BULL, V53, P881, DOI 10.1248/cpb.53.881; da Silva MAB, 2010, REV BRAS FARMACOGN, V20, P549, DOI 10.1590/S0102-695X2010000400014; Dalmolin F, 2016, ARQ BRAS MED VET ZOO, V68, P687, DOI 10.1590/1678-4162-8276; Carvalho Camilo Amaro de, 2011, Arq. Gastroenterol., V48, P276, DOI 10.1590/S0004-28032011000400011; DOLBER PC, 1993, J HISTOCHEM CYTOCHEM, V41, P465, DOI 10.1177/41.3.7679127; Dong XL, 2012, MOL MED REP, V5, P1487, DOI 10.3892/mmr.2012.851; Fujiwara T, 2016, EXP DERMATOL, V25, P206, DOI 10.1111/exd.12909; Gharibi S, 2013, IND CROP PROD, V50, P154, DOI 10.1016/j.indcrop.2013.07.038; Goncalves RV, 2010, BRAZ J MED BIOL RES, V43, P350, DOI 10.1590/S0100-879X2010007500022; Goncalves RV, 2016, LIFE SCI, V152, P67, DOI 10.1016/j.lfs.2016.03.019; Goncalves RV, 2014, CELLS TISSUES ORGANS, V199, P266, DOI 10.1159/000365504; Goncalves RV, 2012, INT J EXP PATHOL, V93, P370, DOI 10.1111/j.1365-2613.2012.00835.x; Goncalves RV, 2010, PHOTOMED LASER SURG, V28, P597, DOI 10.1089/pho.2009.2669; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hartmann RM, 2012, DIGEST DIS SCI, V57, P2038, DOI 10.1007/s10620-012-2134-3; Heal C, 2014, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD011426; Houreld NN, 2010, LASER SURG MED, V42, P494, DOI 10.1002/lsm.20812; Iba Y, 2004, INT IMMUNOPHARMACOL, V4, P1873, DOI 10.1016/j.intimp.2004.08.009; Jana K, 2014, MOL REPROD DEV, V81, P833, DOI 10.1002/mrd.22354; Junqueira LCU, 2005, BIOL CELULAR MOL; Kant V, 2015, J SURG RES, V193, P978, DOI 10.1016/j.jss.2014.10.019; Kiraithe MN, 2016, J ETHNOPHARMACOL, V178, P266, DOI 10.1016/j.jep.2015.12.013; Kurek-Gorecka A, 2014, MOLECULES, V19, P78, DOI 10.3390/molecules19010078; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lee Soo-Jin, 2012, Evid Based Complement Alternat Med, V2012, P190370, DOI 10.1155/2012/190370; Lorenzi H., 2002, PLANTAS MED BRASIL N; Martin A, 1996, DERMATOL SURG, V22, P156, DOI 10.1111/j.1524-4725.1996.tb00499.x; Martinez Carlos Augusto Real, 2015, J. Coloproctol. (Rio J.), V35, P90, DOI 10.1016/j.jcol.2015.02.007; Mohan S., 2015, INTERNATIONALJOURNAL, V3, P599; Mukai K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115564; Muthusubramaniam L, 2014, TISSUE ENG PT A, V20, P2728, DOI [10.1089/ten.tea.2013.0539, 10.1089/ten.TEA.2013.0539]; Ng MFY, 2010, INT WOUND J, V7, P55, DOI 10.1111/j.1742-481X.2009.00651.x; Novaes RD, 2016, INT J EXP PATHOL, V97, P114, DOI 10.1111/iep.12183; Nunan R, 2014, DIS MODEL MECH, V7, P1205, DOI 10.1242/dmm.016782; Pomari E, 2015, FASEB J, V29, P508, DOI 10.1096/fj.14-251363; Reddy GK, 2003, LASER SURG MED, V33, P344, DOI 10.1002/lsm.10227; Sarandy M. M., 2015, EVID-BASED COMPL ALT, V2015, P1; Schreml S, 2010, BRIT J DERMATOL, V163, P257, DOI 10.1111/j.1365-2133.2010.09804.x; Shiota N, 2010, INT ARCH ALLERGY IMM, V151, P80, DOI 10.1159/000232573; Siddiqui IA, 2005, CANCER LETT, V227, P125, DOI 10.1016/j.canlet.2004.10.046; SILAEVA S A, 1990, Byulleten' Eksperimental'noi Biologii i Meditsiny, V109, P180; Su YJ, 2015, ADV WOUND CARE, V4, P631, DOI 10.1089/wound.2014.0559; Sydow AKV, 2016, J CELL BIOCHEM, V117, P1622, DOI [10.1002/jcb.25455, DOI 10.1002/JCB.25455]; de Jesus NZT, 2009, REV BRAS FARMACOGN, V19, P130, DOI 10.1590/S0102-695X2009000100023; Urb M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002619; Vasconcelos SML, 2007, QUIM NOVA, V30, P1323, DOI 10.1590/S0100-40422007000500046; Webster J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009261.pub2; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wetzler C, 2000, J INVEST DERMATOL, V115, P245, DOI 10.1046/j.1523-1747.2000.00029.x; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Xie ZW, 2013, ACTA BIOMATER, V9, P9351, DOI 10.1016/j.actbio.2013.07.030; Younan GJ, 2011, PLAST RECONSTR SURG, V128, p649E, DOI 10.1097/PRS.0b013e318230c55d	70	12	12	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195786	10.1371/journal.pone.0195786	http://dx.doi.org/10.1371/journal.pone.0195786			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649320	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900089
J	Tolley, EE; Guthrie, KM; Zissette, S; Fava, JL; Gill, K; Louw, CE; Kotze, P; Reddy, K; MacQueen, K				Tolley, Elizabeth E.; Guthrie, Kate Morrow; Zissette, Seth; Fava, Joseph L.; Gill, Katherine; Louw, Cheryl E.; Kotze, Philip; Reddy, Krishnaveni; MacQueen, Kathleen			Optimizing adherence in HIV prevention product trials: Development and psychometric evaluation of simple tools for screening and adherence counseling	PLOS ONE			English	Article							VACCINE EFFICACY TRIAL; PREEXPOSURE PROPHYLAXIS; ANTIRETROVIRAL THERAPY; MEDICATION-ADHERENCE; CLINICAL-TRIALS; AFRICAN WOMEN; SELF-EFFICACY; DRUG-USERS; HIGH-RISK; PARTICIPATION	Background Low adherence in recent HIV prevention clinical trials highlights the need to better understand, measure, and support product use within clinical trials. Conventional self-reported adherence instruments within HIV prevention trials, often relying on single-item questions, have proven ineffective. While objective adherence measures are desirable, none currently exist that apply to both active and placebo arms. Scales are composed of multiple items in the form of questions or statements that, when combined, measure a more complex construct that may not be directly observable. When psychometrically validated, such measures may better assess the multiple factors contributing to adherence/non-adherence. This study aimed to develop and psychometrically evaluate tools to screen and monitor trial participants' adherence to HIV prevention products within the context of clinical trial research. Methods and findings Based on an extensive literature review and conceptual framework, we identified and refined 86 items assessing potential predictors of adherence and 48 items assessing adherence experience. A structured survey, including adherence items and other variables, was administered to former ASPIRE and Ring Study participants and similar non-trial participants (n = 709). We conducted exploratory factor analyses (EFA) to identify a reduced set of constructs and items that could be used at screening to predict potential adherence, and at follow-up to monitor and intervene on adherence. We examined associations with other variables to assess content and construct validity. The EFA of screener items resulted in a 6-factor solution with acceptable to very good internal reliability (alpha: .62-.84). Similar to our conceptual framework, factors represent trial-related commitment (Distrust of Research and Commitment to Research); alignment with trial requirements (Visit Adherence and Trial Incompatibility); Belief in Trial Benefits and Partner Disclosure. The EFA on monitoring items resulted in 4 Product-specific factors that represent Vaginal Ring Doubts, Vaginal Ring Benefits, Ring Removal, and Side Effects with good to very good internal reliability (alpha = .71-.82). Evidence of content and construct validity was found; relationship to social desirability bias was examined. Conclusions These scales are easy and inexpensive to administer, available in several languages, and are applicable regardless of randomization. Once validated prospectively, they could (1) screen for propensity to adhere, (2) target adherence support/counselling, and (3) complement biomarker measures in determining true efficacy of the experimental product.	[Tolley, Elizabeth E.; Zissette, Seth; MacQueen, Kathleen] FHI 360, Durham, NC 27701 USA; [Guthrie, Kate Morrow; Fava, Joseph L.] Miriam Hosp, Ctr Behav Med, Providence, RI 02906 USA; [Guthrie, Kate Morrow; Fava, Joseph L.] Miriam Hosp, Ctr Prevent Med, Providence, RI 02906 USA; [Guthrie, Kate Morrow] Brown Univ, Deptartment Psychiat & Human Behav, Alpert Med Sch, Providence, RI 02912 USA; [Gill, Katherine] Desmond Tutu HIV Ctr, Cape Town, South Africa; [Louw, Cheryl E.] Madibeng Ctr Res, Brits, South Africa; [Louw, Cheryl E.] Univ Pretoria, Dept Family Med, Fac Hlth Sci, Hatfield, South Africa; [Kotze, Philip] Qhakaza Mbokodo Res Clin, Ladysmith, South Africa; [Reddy, Krishnaveni] Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa	FHI 360; Lifespan Health Rhode Island; Miriam Hospital; Lifespan Health Rhode Island; Miriam Hospital; Brown University; University of Pretoria	Tolley, EE (corresponding author), FHI 360, Durham, NC 27701 USA.	btolley@fhi360.org	Gill, Katherine/ABG-3230-2021	Gill, Katherine/0000-0002-3372-9506; Fava, Joseph/0000-0001-7129-7903; Zissette, Seth/0000-0002-6502-2986; Kotze, Philip/0000-0003-1346-7833	United States Agency for International Development [AID-OAA-A-14-00003]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069463] Funding Source: NIH RePORTER	United States Agency for International Development(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by the United States Agency for International Development under the terms of the Adherence Measurement and Optimization of Long-Acting ARV-Based Vaginal Ring Agreement, AID-OAA-A-14-00003. KM was principal investigator of the award. ET was a co-principal investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RA, 2010, SOC INDIC RES, V97, P357, DOI 10.1007/s11205-009-9506-x; Aby JS, 1996, ANN ALLERG ASTHMA IM, V76, P348, DOI 10.1016/S1081-1206(10)60036-1; af Wahlberg AE, 2010, J SAFETY RES, V41, P99, DOI 10.1016/j.jsr.2010.02.005; Amico KR, 2017, AIDS BEHAV, V21, P1361, DOI 10.1007/s10461-016-1458-y; Amico KR, 2014, JAIDS-J ACQ IMM DEF, V66, P530, DOI 10.1097/QAI.0000000000000216; Aragones C, 2011, MEDICC REV, V13, P17, DOI 10.37757/MR2011V13.N2.6; AVAC CONRAD., 2014, WORKSH ALT TRIAL DES; Baeten JM, 2016, NEW ENGL J MED, V375, P2121, DOI 10.1056/NEJMoa1506110; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Balfour L, 2010, AIDS CARE, V22, P1403, DOI 10.1080/09540121003693522; Bova C, 2006, RES NURS HEALTH, V29, P477, DOI 10.1002/nur.20158; Bowling A, 2005, J EPIDEMIOL COMMUN H, V59, P342, DOI 10.1136/jech.2004.021204; Braunstein JB, 2008, MEDICINE, V87, P1, DOI 10.1097/MD.0b013e3181625d78; BUCKSHEE K, 1990, Advances in Contraception, V6, P177, DOI 10.1007/BF01849492; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Coetzee B, 2013, AIDS BEHAV, V17, P319, DOI 10.1007/s10461-012-0374-z; Colfax G, 2005, JAIDS-J ACQ IMM DEF, V39, P359, DOI 10.1097/01.qai.0000152039.88422.ec; Colwell HH, 2006, QUAL LIFE RES, V15, P1621, DOI 10.1007/s11136-006-0026-8; Corneli A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125458; Corneli AL, 2014, JAIDS-J ACQ IMM DEF, V66, P324, DOI 10.1097/QAI.0000000000000158; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; CROWNE DP, 1960, J CONSULT PSYCHOL, V24, P349, DOI 10.1037/h0047358; Leite JCD, 2011, EUR J PSYCHOL ASSESS, V27, P228, DOI 10.1027/1015-5759/a000077; DeVellis R., 2017, SCALE DEV THEORY APP, V4; Dhalla S, 2011, AIDS CARE, V23, P1430, DOI 10.1080/09540121.2011.555750; DiMatteo MR, 1993, ADHERENCE DETERMINAN; Doshi MS, 2013, J MED ETHICS, V39, P391, DOI 10.1136/medethics-2012-100755; Gabbay M, 2004, CONTROL CLIN TRIALS, V25, P388, DOI 10.1016/j.cct.2004.06.004; Gilmore HJ, 2013, AIDS PATIENT CARE ST, V27, P560, DOI 10.1089/apc.2013.0116; Haberer JE, 2015, AIDS, V29, P1277, DOI 10.1097/QAD.0000000000000647; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Horne R., 2005, CONCORDANCE ADHERENC, P40; Horne R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080633; Horne R, 2007, JAIDS-J ACQ IMM DEF, V45, P334; Huang L, 2013, J ASSOC NURSE AIDS C, V24, P145, DOI 10.1016/j.jana.2012.04.006; Johnson MO, 2007, J BEHAV MED, V30, P359, DOI 10.1007/s10865-007-9118-3; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Koblin BA, 1998, AIDS, V12, P785, DOI 10.1097/00002030-199807000-00015; Lee SJ, 2005, J RHEUMATOL, V32, P2317; MacPhail C, 2012, PATIENT PREFER ADHER, V6, P579, DOI 10.2147/PPA.S30759; MacQueen KM, 1999, J ACQ IMMUN DEF SYND, V21, P243, DOI 10.1097/00126334-199907010-00010; MacQueen KM, 2014, J INT AIDS SOC S2, V17, P19158, DOI DOI 10.7448/IAS.17.3.19158; Magazi B, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-88; MAHONEY CA, 1995, HEALTH EDUC RES, V10, P1, DOI 10.1093/her/10.1.1-a; Marrazzo JM, 2015, NEW ENGL J MED, V372, P509, DOI 10.1056/NEJMoa1402269; Montgomery ET, 2015, AIDS BEHAV, V19, P784, DOI 10.1007/s10461-014-0950-5; Montgomery ET, 2011, AIDS BEHAV, V15, P959, DOI 10.1007/s10461-010-9806-9; MORISKY DE, 1986, MED CARE, V24, P67, DOI 10.1097/00005650-198601000-00007; Murphy DA, 2003, ARCH PEDIAT ADOL MED, V157, P249, DOI 10.1001/archpedi.157.3.249; Newman PA, 2006, JAIDS-J ACQ IMM DEF, V41, P210, DOI 10.1097/01.qai.0000179454.93443.60; Newman PA, 2007, PREV MED, V44, P554, DOI 10.1016/j.ypmed.2006.12.007; Newman PA, 2011, AM J PUBLIC HEALTH, V101, P1749, DOI 10.2105/AJPH.2011.300208; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; PAULHUS DL, 1984, J PERS SOC PSYCHOL, V46, P598, DOI 10.1037/0022-3514.46.3.598; Perisse AR, 2000, J ACQ IMMUN DEF SYND, V25, P459, DOI 10.1097/00126334-200012150-00012; Rosenbaum JR, 2005, J CLIN EPIDEMIOL, V58, P1109, DOI 10.1016/j.jclinepi.2005.03.014; Schuber PA, 2008, J NURS MEAS, V16, P136, DOI 10.1891/1061-3749.16.2.136; Sengupta S, 2000, J ACQ IMMUN DEF SYND, V24, P275; Stalter RM, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20746; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; Tolley E, 2015, DRUG DELIVERY AND DEVELOPMENT OF ANTI-HIV MICROBICIDES, P569; Van Damme L, 2012, NEW ENGL J MED, V367, P411, DOI 10.1056/NEJMoa1202614; van der Straten A, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20642; van der Straten A, 2015, AIDS, V29, P2161, DOI 10.1097/QAD.0000000000000801; van der Straten Ariane, 2014, J Int AIDS Soc, V17, P19146, DOI 10.7448/IAS.17.3.19146; van der Straten A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089118; Voytek CD, 2011, VACCINE, V29, P6130, DOI 10.1016/j.vaccine.2011.06.064; Williams AB, 2013, AIDS BEHAV, V17, P284, DOI 10.1007/s10461-012-0172-7; Wilson K J, 2004, Sex Health, V1, P251, DOI 10.1071/SH04020; Woodsong C, 2013, J INT AIDS SOC, V16, DOI [10.7448/IAS.16.1.18505, 10.7448/IAS.17.3.19158]; Wu JR, 2008, HEART LUNG, V37, P334, DOI 10.1016/j.hrtlng.2007.10.001	72	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195499	10.1371/journal.pone.0195499	http://dx.doi.org/10.1371/journal.pone.0195499			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4YG	29649249	gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900049
J	Robia, SL; Young, HS				Robia, Seth L.; Young, Howard S.			Skin cells prefer a slower calcium pump	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CA2+ PUMP	Naturally occurring mutations of a calcium ion transporter can cause a skin condition known as Darier's disease. In this issue of JBC, Mikkelsen et al. describe a particularly interesting Darier's mutation that alters calcium transport by disrupting a kinetic braking mechanism that is unique to the SERCA2b calcium pump isoform. The study provides new insight into the intrinsic regulation of this transporter and reveals how disruption of regulation can lead to disease in Darier's patients.	[Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA; [Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada	Loyola University Chicago; University of Alberta	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60153 USA.; Young, HS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2R3, Canada.	srobia@luc.edu; hyoung@ualberta.ca		Young, Howard/0000-0002-5990-8422	National Institutes of Health [HL092321]; Heart and Stroke Foundation of Canada [G-16-00014670]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL092321 (to S.L.R.) and Heart and Stroke Foundation of Canada Grant G-16-00014670 (to H.S.Y.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Clausen JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.397331; Gorski PA, 2012, J BIOL CHEM, V287, P19876, DOI 10.1074/jbc.M111.335620; Mikkelsen SA, 2018, J BIOL CHEM, V293, P3880, DOI 10.1074/jbc.RA117.000941; Sakuntabhai A, 1999, NAT GENET, V21, P271, DOI 10.1038/6784; Vandecaetsbeek Ilse, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a004184; Vandecaetsbeek I, 2009, P NATL ACAD SCI USA, V106, P18533, DOI 10.1073/pnas.0906797106	6	1	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 16	2018	293	11					3890	3891		10.1074/jbc.H118.002088	http://dx.doi.org/10.1074/jbc.H118.002088			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	FZ4UM	29667928	Green Published, hybrid			2022-12-26	WOS:000427587500003
J	Kang, XM; Yang, W; Wang, RQ; Xie, TP; Li, HX; Feng, DX; Jin, XX; Sun, HZ; Wu, SF				Kang, Xiaomin; Yang, Wei; Wang, Ruiqi; Xie, Tianping; Li, Huixia; Feng, Dongxu; Jin, Xinxin; Sun, Hongzhi; Wu, Shufang			Sirtuin-1 (SIRT1) stimulates growth-plate chondrogenesis by attenuating the PERK-eIF-2-CHOP pathway in the unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chondrocyte; chondrogenesis; endoplasmic reticulum stress (ER stress); growth plate; sirtuin 1 (SIRT1); unfolded protein response (UPR); PERK; bone growth	ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTORS; ARTICULAR-CARTILAGE; HUMAN CHONDROCYTES; INDUCED APOPTOSIS; GENE-EXPRESSION; BONE-FORMATION; CELL-SURVIVAL; DEACETYLATION	The NAD(+)-dependent deacetylase sirtuin-1 (SIRT1) has emerged as an important regulator of chondrogenesis and cartilage homeostasis, processes that are important for physiological skeletal growth and that are dysregulated in osteoarthritis. However, the functional role and underlying mechanism by which SIRT1 regulates chondrogenesis remain unclear. Using cultured rat metatarsal bones and chondrocytes isolated from rat metatarsal rudiments, here we studied the effects of the SIRT1 inhibitor EX527 or of SIRT1 siRNA on chondrocyte proliferation, hypertrophy, and apoptosis. We show that EX527 or SIRT1 siRNA inhibits chondrocyte proliferation and hypertrophy and induces apoptosis. We also observed that SIRT1 inhibition mainly induces the PERK-eIF-2-CHOP axis of the endoplasmic reticulum (ER) stress response in growth-plate chondrocytes. Of note, EX527- or SIRT1 siRNA-mediated inhibition of metatarsal growth and growth-plate chondrogenesis were partly neutralized by phenylbutyric acid, a chemical chaperone that attenuates ER stress. Moreover, EX527-mediated impairment of chondrocyte function (i.e. of chondrocyte proliferation, hypertrophy, and apoptosis) was partly reversed in CHOP-/- cells. We also present evidence that SIRT1 physically interacts with and deacetylates PERK. Collectively, our findings indicate that SIRT1 deacetylates PERK and attenuates the PERK-eIF-2-CHOP axis of the unfolded protein response pathway and thereby promotes growth-plate chondrogenesis and longitudinal bone growth.	[Kang, Xiaomin; Yang, Wei; Wang, Ruiqi; Xie, Tianping; Feng, Dongxu; Jin, Xinxin; Wu, Shufang] Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Ctr Translat Med, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Li, Huixia; Sun, Hongzhi] Xi An Jiao Tong Univ, Med Sch, Minist Educ, Key Lab Environm & Genes Related Dis, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China; [Feng, Dongxu] Xi An Jiao Tong Univ, Sch Med, Hong Hui Hosp, Xian 710054, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Wu, SF (corresponding author), Xi An Jiao Tong Univ, Sch Med, Affiliated Hosp 1, Ctr Translat Med, 277 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.; Sun, HZ (corresponding author), Xi An Jiao Tong Univ, Med Sch, Minist Educ, Key Lab Environm & Genes Related Dis, 76 West Yanta Rd, Xian 710061, Shaanxi, Peoples R China.	sunhongzhi@mail.xjtu.edu.cn; shufangw@hotmail.com	jin, xin/GQZ-5811-2022		National Natural Science Foundation of China [81672221, 81472038, 81370899, 81170741]; National Excellent Young Scientist Program [81222026]; Ministry of Education of China New Century Excellent Talents Grant [NCET-11-0437]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Excellent Young Scientist Program; Ministry of Education of China New Century Excellent Talents Grant	This work was supported by National Natural Science Foundation of China Program Grants 81672221, 81472038, 81370899, and 81170741; National Excellent Young Scientist Program Grant 81222026; and Ministry of Education of China New Century Excellent Talents Grant NCET-11-0437. The authors declare that they have no conflicts of interest with the contents of this article.	AHARINEJAD S, 1995, ANAT REC, V242, P111, DOI 10.1002/ar.1092420115; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Cameron TL, 2015, OSTEOARTHR CARTILAGE, V23, P661, DOI 10.1016/j.joca.2015.01.001; Cohen-Kfir E, 2011, ENDOCRINOLOGY, V152, P4514, DOI 10.1210/en.2011-1128; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Fujita N, 2011, J ORTHOP RES, V29, P511, DOI 10.1002/jor.21284; Gabay O, 2013, ARTHRITIS RHEUM-US, V65, P159, DOI 10.1002/art.37750; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Ghosh HS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00150; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Hirata M, 2012, HUM MOL GENET, V21, P1111, DOI 10.1093/hmg/ddr540; Hirata M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004543; Hong EH, 2010, J BIOL CHEM, V285, P1283, DOI 10.1074/jbc.M109.058628; Kang XM, 2017, J BONE MINER RES, V32, P2128, DOI 10.1002/jbmr.3134; Lee NK, 2007, CELL, V130, P456, DOI 10.1016/j.cell.2007.05.047; Lemieux ME, 2005, MECH AGEING DEV, V126, P1097, DOI 10.1016/j.mad.2005.04.006; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Liu ZJ, 2017, ONCOTARGET, V8, P9267, DOI 10.18632/oncotarget.14035; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Matsuzaki T, 2014, ANN RHEUM DIS, V73, P1397, DOI 10.1136/annrheumdis-2012-202620; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; Prola A, 2017, CELL DEATH DIFFER, V24, P343, DOI 10.1038/cdd.2016.138; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Sun TJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10159; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; Tsuchimochi K, 2010, J BIOL CHEM, V285, P8395, DOI 10.1074/jbc.M109.038638; Uehara Y, 2014, OSTEOARTHR CARTILAGE, V22, P1007, DOI 10.1016/j.joca.2014.04.025; Ushijima T, 2014, J BIOL CHEM, V289, P2852, DOI 10.1074/jbc.M113.492843; Vaquero A, 2007, ONCOGENE, V26, P5505, DOI 10.1038/sj.onc.1210617; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang FM, 2011, BIOCHEM J, V433, P245, DOI 10.1042/BJ20101293; Wang WG, 2009, DEVELOPMENT, V136, P4143, DOI 10.1242/dev.043281; Woehlbier U, 2011, TRENDS BIOCHEM SCI, V36, P329, DOI 10.1016/j.tibs.2011.03.001; Wu SF, 2006, J BIOL CHEM, V281, P5120, DOI 10.1074/jbc.M506667200; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Yang W, 2016, ENDOCRINOLOGY, V157, P3096, DOI 10.1210/en.2015-2042; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244	46	34	37	3	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 1	2018	293	22					8614	8625		10.1074/jbc.M117.809822	http://dx.doi.org/10.1074/jbc.M117.809822			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	GI2MV	29653943	Green Published, hybrid			2022-12-26	WOS:000434205700024
J	Brunner, M; Mandier, N; Gautier, T; Chevalier, G; Ribbal, AS; Guardiola, P; Block, MR; Bouvard, D				Brunner, Molly; Mandier, Noernie; Gautier, Thierry; Chevalier, Genevieve; Ribbal, Anne-Sophie; Guardiola, Philippe; Block, Marc R.; Bouvard, Daniel			beta 1 integrins mediate the BMP2 dependent transcriptional control of osteoblast differentiation and osteogenesis	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; INTEGRIN RECEPTORS; BONE-FORMATION; FIBRONECTIN; MINERALIZATION; YAP/TAZ; OSTERIX; ROLES; BETA	Osteoblast differentiation is a highly regulated process that requires coordinated information from both soluble factors and the extracellular matrix. Among these extracellular stimuli, chemical and physical properties of the matrix are sensed through cell surface receptors such as integrins and transmitted into the nucleus to drive specific gene expression. Here, we showed that the conditional deletion of beta 1 integrins in the osteo-precursor population severely impacts bone formation and homeostasis both in vivo and in vitro. Mutant mice displayed a severe bone deficit characterized by bone fragility and reduced bone mass. We showed that beta 1 integrins are required for proper BMP2 dependent signaling at the pre-osteoblastic stage, by positively modulating Smad1/5-dependent transcriptional activity at the nuclear level. The lack of beta 1 integrins results in a transcription modulation that relies on a cooperative defect with other transcription factors rather than a plain blunted BMP2 response. Our results point to a nuclear modulation of Smad1/5 transcriptional activity by beta 1 integrins, allowing a tight control of osteoblast differentiation.	[Brunner, Molly; Mandier, Noernie; Gautier, Thierry; Chevalier, Genevieve; Ribbal, Anne-Sophie; Block, Marc R.; Bouvard, Daniel] Univ Grenoble Alpes, Inst Adv Bioscie, CNRS 5309, Ctr Rech NSERM 1209, Grenoble, France; [Guardiola, Philippe] CHU Angers, Angers, France; [Guardiola, Philippe] Univ Angers, Inst Biol Hlth, SNP Plateform, Angers, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers	Bouvard, D (corresponding author), Univ Grenoble Alpes, Inst Adv Bioscie, CNRS 5309, Ctr Rech NSERM 1209, Grenoble, France.	daniel.bouvard@unw-grenoble-alpes.fr	Block, Marc R/M-2740-2013; Bouvard, Daniel/B-1260-2017; GAUTIER, Thierry/N-7693-2013	Block, Marc R/0000-0003-2214-9706; Bouvard, Daniel/0000-0002-0845-6681; GAUTIER, Thierry/0000-0002-2292-4680; Ribba, Anne-Sophie/0000-0001-5342-8455	Institut National du Cancer (INCa); Association pour la Recherche sur le Cancer; Societe Francaise contre les cancer de l'enfant (SFCE), SFCE-CRAUFESD16; French Research Ministry (MRT); INCa; SFCE	Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Societe Francaise contre les cancer de l'enfant (SFCE), SFCE-CRAUFESD16; French Research Ministry (MRT); INCa(Institut National du Cancer (INCA) France); SFCE	This work was supported by Institut National du Cancer (INCa) to DB, Association pour la Recherche sur le Cancer to DB, and Societe Francaise contre les cancer de l'enfant (SFCE), SFCE-CRAUFESD16, to DB. MB was supported by a fellowship from the French Research Ministry (MRT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We are extremely grateful to Pr. Reinhard Fassler for providing us with 131 integrin derived tools. We thank Alexei Grichine for microscopy assistance. M. Brunner was supported by a fellowship from the French Research Ministry (MRT). We thank I. Nakchbandi for the histomorphometric analysis. This work was supported by INCa and SFCE grants.	Aplin AE, 2001, J CELL BIOL, V153, P273, DOI 10.1083/jcb.153.2.273; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Bentmann A, 2010, J BONE MINER RES, V25, P706, DOI 10.1359/jbmr.091011; Bouvard D, 2007, DEVELOPMENT, V134, P2615, DOI 10.1242/dev.000877; Brunner M, 2013, INT REV CEL MOL BIO, V305, P1, DOI 10.1016/B978-0-12-407695-2.00001-9; Brunner M, 2011, J CELL BIOL, V194, P307, DOI 10.1083/jcb.201007108; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Devlin RD, 2003, ENDOCRINOLOGY, V144, P1972, DOI 10.1210/en.2002-220918; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Fromigue O, 2012, J CELL BIOCHEM, V113, P3029, DOI 10.1002/jcb.24181; Ghosh-Choudhury N, 2001, BIOCHEM BIOPH RES CO, V286, P101, DOI 10.1006/bbrc.2001.5351; Globus RK, 1998, J CELL SCI, V111, P1385; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hesse E, 2010, J CELL BIOL, V191, P1271, DOI 10.1083/jcb.201009107; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Kawelke N, 2008, J BONE MINER RES, V23, P1278, DOI 10.1359/JBMR.080313; Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013; Long FX, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008334; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Martin TJ, 2005, TRENDS MOL MED, V11, P76, DOI 10.1016/j.molmed.2004.12.004; Millon-Fremillon A, 2008, J CELL BIOL, V180, P427, DOI 10.1083/jcb.200707142; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; Moursi AM, 1997, J CELL SCI, V110, P2187; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nistala H, 2010, J CELL BIOL, V190, P1107, DOI 10.1083/jcb.201003089; Phillips JA, 2008, MATRIX BIOL, V27, P609, DOI 10.1016/j.matbio.2008.05.003; Quelo I, 2004, J BIOL CHEM, V279, P43893, DOI 10.1074/jbc.M406310200; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sabra H, 2017, J BIOL CHEM; Shekaran A, 2014, BONE, V68, P131, DOI 10.1016/j.bone.2014.08.008; Uemura M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27473; Zhao M, 2002, J CELL BIOL, V157, P1049, DOI 10.1083/jcb.200109012; Zimmerman D, 2000, DEV BIOL, V220, P2, DOI 10.1006/dbio.2000.9633	36	16	17	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0196021	10.1371/journal.pone.0196021	http://dx.doi.org/10.1371/journal.pone.0196021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	29677202	gold, Green Published, Green Submitted			2022-12-26	WOS:000430638900021
J	Malcolm, KC; Caceres, SM; Pohl, K; Poch, KR; Bernut, A; Kremer, L; Bratton, DL; Herrmann, JL; Nick, JA				Malcolm, Kenneth C.; Caceres, Silvia M.; Pohl, Kerstin; Poch, Katie R.; Bernut, Audrey; Kremer, Laurent; Bratton, Donna L.; Herrmann, Jean-Louis; Nick, Jerry A.			Neutrophil killing of Mycobacterium abscessus by intra- and extracellular mechanisms	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; BACTERIAL LIPOPOLYSACCHARIDE; TRAP FORMATION; INFECTION; RELEASE; PHAGOCYTOSIS; TUBERCULOSIS; AUTOPHAGY; VARIANTS; SMOOTH	Mycobacterium abscessus, a rapidly growing nontuberculous mycobacterium, are increasingly present in soft tissue infections and chronic lung diseases, including cystic fibrosis, and infections are characterized by growth in neutrophil-rich environments. M. abscessus is observed as two distinct smooth and rough morphotypes. The environmental smooth morphotype initiates infection and has a relatively limited ability to activate neutrophils. The rough morphotype has increased virulence and immunogenicity. However, the neutrophil response to the rough morphotype has not been explored. Killing of the smooth and rough strains, including cystic fibrosis clinical isolates, was equivalent. Neutrophil uptake of M. abscessus was similar between morphotypes. Mechanistically, both rough and smooth morphotypes enhanced neutrophil reactive oxygen species generation but inhibition of NADPH oxidase activity did not affect M. abscessus viability. However, inhibition of phagocytosis and extracellular traps reduced killing of the smooth morphotype with lesser effects against the rough morphotype. Neutrophils treated with M. abscessus released a heat-labile mycobactericidal activity against the rough morphotype, but the activity was heat-tolerant against the smooth morphotype. Overall, M. abscessus stimulates ineffective neutrophil reactive oxygen species generation, and key mechanisms differ in killing of the smooth (phagocytosis-dependent, extracellular traps, and heat-tolerant secreted factor) and rough (extracellular traps and a heat-labile secreted factor) morphotypes. These studies represent an essential advancement in understanding the host response to M. abscessus, and help explain the recalcitrance of infection.	[Malcolm, Kenneth C.; Caceres, Silvia M.; Pohl, Kerstin; Poch, Katie R.; Nick, Jerry A.] Natl Jewish Hlth, Dept Med, Denver, CO USA; [Malcolm, Kenneth C.; Nick, Jerry A.] Univ Colorado, Dept Med, Denver, CO 80309 USA; [Bernut, Audrey; Kremer, Laurent] Univ Montpellier, CNRS, IRIM, UMR 9004, Montpellier, France; [Kremer, Laurent] INSERM, IRIM, Montpellier, France; [Bratton, Donna L.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Herrmann, Jean-Louis] Univ Paris Saclay, INSERM, Univ Versailles St Quentin, Infect & Inflammat Chron 2I, Versailles, France	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; National Jewish Health; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Malcolm, KC (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO USA.; Malcolm, KC (corresponding author), Univ Colorado, Dept Med, Denver, CO 80309 USA.	malcolmk@njhealth.org	Kremer, Laurent/M-4935-2017	Kremer, Laurent/0000-0002-6604-4458; Bernut, Audrey/0000-0002-1928-8329; Herrmann, Jean-Louis/0000-0003-2347-6418; Malcolm, Kenneth/0000-0002-8097-6059	Cystic Fibrosis Foundation Research Grant [MALCOL14G0, NICK14G0]; Cystic Fibrosis Foundation Pilot Grant [MALCOL16I0]; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NIH [HL34303]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI110408] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation Research Grant; Cystic Fibrosis Foundation Pilot Grant; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Cystic Fibrosis Foundation Research Grant MALCOL14G0 (KCM); Cystic Fibrosis Foundation Pilot Grant MALCOL16I0 (KCM); Cystic Fibrosis Foundation Research Grant NICK14G0 (JAN); Rebecca Runyon Bryan Chair for Cystic Fibrosis (JAN) and the NIH HL34303 (DLB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-On O, 2015, J CYST FIBROS, V14, P53, DOI 10.1016/j.jcf.2014.05.008; Bernut A, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00100; Bernut A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005986; Bernut A, 2016, MOL MICROBIOL, V99, P866, DOI 10.1111/mmi.13283; Bernut A, 2014, P NATL ACAD SCI USA, V111, pE943, DOI 10.1073/pnas.1321390111; Branzk N, 2014, NAT IMMUNOL, V15, P1017, DOI 10.1038/ni.2987; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Byrd AS, 2013, J IMMUNOL, V190, P4136, DOI 10.4049/jimmunol.1202671; Byrd TF, 1999, INFECT IMMUN, V67, P4700, DOI 10.1128/IAI.67.9.4700-4707.1999; Catherinot E, 2007, INFECT IMMUN, V75, P1055, DOI 10.1128/IAI.00835-06; Catherinot E, 2009, J CLIN MICROBIOL, V47, P271, DOI 10.1128/JCM.01478-08; Caverly LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117657; Champion JA, 2006, P NATL ACAD SCI USA, V103, P4930, DOI 10.1073/pnas.0600997103; Davidson LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029148; Deretic V, 2008, FUTURE MICROBIOL, V3, P517, DOI 10.2217/17460913.3.5.517; Esther CR, 2010, J CYST FIBROS, V9, P117, DOI 10.1016/j.jcf.2009.12.001; Fisher CW, 2012, AM J INFECT CONTROL, V40, P880, DOI 10.1016/j.ajic.2011.11.004; Fuchs TA, 2007, J CELL BIOL, V176, P231, DOI 10.1083/jcb.200606027; Greendyke R, 2008, ANTIMICROB AGENTS CH, V52, P2019, DOI 10.1128/AAC.00986-07; GUTHRIE LA, 1984, J EXP MED, V160, P1656, DOI 10.1084/jem.160.6.1656; HASLETT C, 1985, AM J PATHOL, V119, P101; Heydari H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062443; Honda JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126994; Howard ST, 2006, MICROBIOL-SGM, V152, P1581, DOI 10.1099/mic.0.28625-0; Jena P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050345; JONES GS, 1990, J INFECT DIS, V162, P700, DOI 10.1093/infdis/162.3.700; Jonsson BE, 2007, J CLIN MICROBIOL, V45, P1497, DOI 10.1128/JCM.02592-06; Kreutzfeldt KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063237; Levy I, 2008, EMERG INFECT DIS, V14, P378, DOI 10.3201/eid1403.061405; Li GL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084065; Malcolm KC, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/aem.00562-17, 10.1128/AEM.00562-17]; Malcolm KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057402; Maurer FP, 2014, ANTIMICROB AGENTS CH, V58, P3828, DOI 10.1128/AAC.02448-14; MOORE M, 1953, J INVEST DERMATOL, V20, P133, DOI 10.1038/jid.1953.18; Oberley-Deegan RE, 2010, FREE RADICAL BIO MED, V49, P1666, DOI 10.1016/j.freeradbiomed.2010.08.026; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Ordway D, 2008, J LEUKOCYTE BIOL, V83, P1502, DOI 10.1189/jlb.1007696; Palmer LJ, 2012, CLIN EXP IMMUNOL, V167, P261, DOI 10.1111/j.1365-2249.2011.04518.x; Pawlik A, 2013, MOL MICROBIOL, V90, P612, DOI 10.1111/mmi.12387; Pennelly KP, 2016, AM J RESP CRIT CARE, V193, P692, DOI 10.1164/rccm.201508-1586IM; Pilsczek FH, 2010, J IMMUNOL, V185, P7413, DOI 10.4049/jimmunol.1000675; Renna M, 2011, J CLIN INVEST, V121, P3554, DOI 10.1172/JCI46095; Rhoades ER, 2009, J IMMUNOL, V183, P1997, DOI 10.4049/jimmunol.0802181; Rottman M, 2007, INFECT IMMUN, V75, P5898, DOI 10.1128/IAI.00014-07; Roux AL, 2011, CELL MICROBIOL, V13, P692, DOI 10.1111/j.1462-5822.2010.01565.x; Sampaio EP, 2008, AM J RESP CELL MOL, V39, P431, DOI 10.1165/rcmb.2007-0413OC; Sanguinetti M, 2001, J CLIN MICROBIOL, V39, P816, DOI 10.1128/JCM.39.2.816-819.2001; Sohn H, 2009, MICROB PATHOGENESIS, V47, P321, DOI 10.1016/j.micpath.2009.09.010; Young RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023637	49	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2018	13	4							e0196120	10.1371/journal.pone.0196120	http://dx.doi.org/10.1371/journal.pone.0196120			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD4BF	29672589	gold, Green Published, Green Accepted			2022-12-26	WOS:000430446800091
J	Zhao, HQ; Wang, ZH; Gao, XC; Liu, CH; Qi, HB				Zhao, Hai-qian; Wang, Zhong-hua; Gao, Xing-cun; Liu, Cheng-hao; Qi, Han-bing			Optimization of NO oxidation by H2O2 thermal decomposition at moderate temperatures	PLOS ONE			English	Article							GAS-PHASE OXIDATION; HYDROGEN-PEROXIDE; NITROGEN-OXIDES; NITRIC-OXIDE; KINETIC DATA; COMBUSTION; ABSORPTION; EMISSIONS; REMOVAL; ACID	H2O2 was adopted to oxidize NO in simulated flue gas at 100-500 degrees C. The effects of the H2O2 evaporation conditions, gas temperature, initial NO concentration, H2O2 concentration, and H2O2:NO molar ratio on the oxidation efficiency of NO were investigated. The reason for the narrow NO oxidation temperature range near 500 degrees C was determined. The NO oxidation products were analyzed. The removal of NOx using NaOH solution at a moderate oxidation ratio was studied. It was proven that rapid evaporation of the H2O2 solution was critical to increase the NO oxidation efficiency and broaden the oxidation temperature range. the NO oxidation efficiency was above 50% at 300-500 degrees C by contacting the outlet of the syringe needle and the stainless -steel gas pipe together to spread H2O2 solution into a thin film on the surface of the stainless-steel gas pipe, which greatly accelerated the evaporation of H2O2. The NO oxidation efficiency and the NO oxidation rate increased with increasing initial NO concentration. This method was more effective for the oxidation of NO at high concentrations. H2O2 solution with a concentration higher than 15% was more efficient in oxidizing NO. High temperatures decreased the influence of the H2O2 concentration on the NO oxidation efficiency. The oxidation efficiency of NO increased with an increase in the H2O2:NO molar ratio, but the ratio of H2O2 to oxidized NO decreased. Over 80% of the NO oxidation product was NO2, which indicated that the oxidation ratio of NO did not need to be very high. An 86.7% NO removal efficiency was obtained at an oxidation ratio of only 53.8% when combined with alkali absorption.	[Zhao, Hai-qian; Wang, Zhong-hua; Gao, Xing-cun; Liu, Cheng-hao; Qi, Han-bing] Northeast Petr Univ, Dept Civil Engn & Architecture, Daqing, Peoples R China	Northeast Petroleum University	Zhao, HQ (corresponding author), Northeast Petr Univ, Dept Civil Engn & Architecture, Daqing, Peoples R China.	dqzhaohaiqian@163.com		Zhao, Hai qian/0000-0002-5629-3100	National Natural Science Foundation of China [51606036]; Natural Science Foundation of Heilongjiang Province [QC2014C047]; Heilongjiang Provincial Department of Education Project [12541093]; National Natural Science Foundation of China; Science and Technology Department of Heilongjiang Province; Education Department of Heilongjiang Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Heilongjiang Province(Natural Science Foundation of Heilongjiang Province); Heilongjiang Provincial Department of Education Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Heilongjiang Province; Education Department of Heilongjiang Province	This work is supported by National Natural Science Foundation of China (no. 51606036, to HZ), Natural Science Foundation of Heilongjiang Province (no. QC2014C047, to HZ) and Heilongjiang Provincial Department of Education Project (no. 12541093, to HZ). Publishing fee and material fee (including chemical reagents and personal protective equipment) are supported by (no. 51606036). Experimental system renovation fee is supported by Natural Science Foundation of Heilongjiang Province (no. QC2014C047) and Heilongjiang Provincial Department of Education Project (no. 12541093). National Natural Science Foundation of China is sponsored by National Natural Science Foundation of China, http//www.nsfc.gov.cn/. Natural Science Foundation of Heilongjiang Province is sponsored by Science and Technology Department of Heilongjiang Province, http/www.hlikjt.gov.cn/. Heilongjiang Provincial Department of Education Project is sponsored by Education Department of Heilongjiang Province, https//www.hljedu.gov.cn/.	Ali-Zade NI, 2006, KINET CATAL+, V47, P64, DOI 10.1134/S0023158406010101; [Anonymous], GB132232011; Atkinson R, 2004, ATMOS CHEM PHYS, V4, P1461, DOI 10.5194/acp-4-1461-2004; BAULCH DL, 1992, J PHYS CHEM REF DATA, V21, P411, DOI 10.1063/1.555908; Bokare AD, 2014, J HAZARD MATER, V275, P121, DOI 10.1016/j.jhazmat.2014.04.054; Chakraborty D, 1998, CHEM PHYS, V231, P39, DOI 10.1016/S0301-0104(98)00033-0; Collins MM, 2001, J ENVIRON ENG-ASCE, V127, P329, DOI 10.1061/(ASCE)0733-9372(2001)127:4(329); CONWAY DC, 1957, J PHYS CHEM-US, V61, P1579, DOI 10.1021/j150557a034; Ding J, 2014, CHEM ENG J, V243, P176, DOI 10.1016/j.cej.2013.12.101; Glemser O., 1963, HDB PREPARATIVE INOR, P658; Haywood JM, 1998, J AIR WASTE MANAGE, V48, P238, DOI 10.1080/10473289.1998.10463679; Kasper JM, 1996, J AIR WASTE MANAGE, V46, P127, DOI 10.1080/10473289.1996.10467444; Lange N.A., 1944, HDB CHEM, V14th; Limvoranusorn P, 2005, J ENVIRON ENG, V131, P518, DOI 10.1061/(ASCE)0733-9372(2005)131:4(518); LIN CC, 1991, INT J CHEM KINET, V23, P971, DOI 10.1002/kin.550231103; Mok JS, 2005, J PROPUL POWER, V21, P942, DOI 10.2514/1.13284; National Bureau of Statistics of China, 2016, DISCH MAJ POLL WAST, V11, P22; Pradhan MP, 1997, CHEM ENG SCI, V52, P4569, DOI 10.1016/S0009-2509(97)00300-X; Pradhan MP, 1999, AICHE J, V45, P38, DOI 10.1002/aic.690450105; Thomas D, 2000, CHEM ENG TECHNOL, V23, P449, DOI 10.1002/(SICI)1521-4125(200005)23:5<449::AID-CEAT449>3.0.CO;2-L; TSANG W, 1991, J PHYS CHEM REF DATA, V20, P609, DOI 10.1063/1.555890; Vorontsov A, 2007, CATAL COMMUN, V8, P2100, DOI 10.1016/j.catcom.2007.04.027; Zamansky VM, 1996, TWENTY-SIXTH SYMPOSIUM (INTERNATIONAL) ON COMBUSTION, VOLS 1 AND 2, P2125; Zhang XH, 2010, ASIA-PAC J CHEM ENG, V5, P473, DOI 10.1002/apj.335; Zhu RS, 2003, J CHEM PHYS, V119, P10667, DOI 10.1063/1.1619373	25	8	10	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 18	2018	13	4							e0192324	10.1371/journal.pone.0192324	http://dx.doi.org/10.1371/journal.pone.0192324			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD1VU	29668672	gold, Green Published, Green Submitted			2022-12-26	WOS:000430290200001
J	Taylor, DL; Knowles, DA; Scott, LJ; Ramirez, AH; Casale, FP; Wolford, BN; Guan, L; Varshney, A; Albanus, RD; Parker, SCJ; Narisu, N; Chines, PS; Erdos, MR; Welch, RP; Kinnunen, L; Saramies, J; Sundvall, J; Lakka, TA; Laakso, M; Tuomilehto, J; Koistinen, HA; Stegle, O; Boehnke, M; Birney, E; Collins, FS				Taylor, D. Leland; Knowles, David A.; Scott, Laura J.; Ramirez, Andrea H.; Casale, Francesco Paolo; Wolford, Brooke N.; Guan, Li; Varshney, Arushi; Albanus, Ricardo D'Oliveira; Parker, Stephen C. J.; Narisu, Narisu; Chines, Peter S.; Erdos, Michael R.; Welch, Ryan P.; Kinnunen, Leena; Saramies, Jouko; Sundvall, Jouko; Lakka, Timo A.; Laakso, Markku; Tuomilehto, Jaakko; Koistinen, Heikki A.; Stegle, Oliver; Boehnke, Michael; Birney, Ewan; Collins, Francis S.			Interactions between genetic variation and cellular environment in skeletal muscle gene expression	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; TRANSCRIPTION FACTORS; HUMAN GENOME; CHROMATIN; DISCOVERY; GENOTYPE; PLASTICITY; FORMINS; FHOD3; PHOSPHORYLATION	From whole organisms to individual cells, responses to environmental conditions are influenced by genetic makeup, where the effect of genetic variation on a trait depends on the environmental context. RNA-sequencing quantifies gene expression as a molecular trait, and is capable of capturing both genetic and environmental effects. In this study, we explore opportunities of using allele-specific expression (ASE) to discover cis-acting genotype-environment interactions (GxE)-genetic effects on gene expression that depend on an environmental condition. Treating 17 common, clinical traits as approximations of the cellular environment of 267 skeletal muscle biopsies, we identify 10 candidate environmental response expression quantitative trait loci (reQTLs) across 6 traits (12 unique gene-environment trait pairs; 10% FDR per trait) including sex, systolic blood pressure, and low-density lipoprotein cholesterol. Although using ASE is in principle a promising approach to detect GxE effects, replication of such signals can be challenging as validation requires harmonization of environmental traits across cohorts and a sufficient sampling of heterozygotes for a transcribed SNP. Comprehensive discovery and replication will require large human transcriptome datasets, or the integration of multiple transcribed SNPs, coupled with standardized clinical phenotyping.	[Taylor, D. Leland; Narisu, Narisu; Chines, Peter S.; Erdos, Michael R.; Collins, Francis S.] NHGRI, NIH, Bethesda, MD 20892 USA; [Taylor, D. Leland; Casale, Francesco Paolo; Stegle, Oliver; Birney, Ewan] European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Hinxton, Cambs, England; [Knowles, David A.] Stanford Univ, Dept Comp Sci, Stanford, CA 94305 USA; [Scott, Laura J.; Welch, Ryan P.; Boehnke, Michael] Univ Michigan, Dept Biostat, Ann Arbor, MI 48109 USA; [Scott, Laura J.; Welch, Ryan P.; Boehnke, Michael] Univ Michigan, Ctr Stat Genet, Ann Arbor, MI 48109 USA; [Ramirez, Andrea H.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Wolford, Brooke N.; Guan, Li; Albanus, Ricardo D'Oliveira; Parker, Stephen C. J.] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Varshney, Arushi; Parker, Stephen C. J.] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA; [Kinnunen, Leena; Sundvall, Jouko; Tuomilehto, Jaakko; Koistinen, Heikki A.] Natl Inst Hlth & Welf, Dept Publ Hlth Solut, Helsinki, Finland; [Saramies, Jouko] South Karelia Social & Hlth Care Dist, Lappeenranta, Finland; [Lakka, Timo A.] Univ Eastern Finland, Inst Biomed Physiol, Kuopio, Finland; [Lakka, Timo A.] Kuopio Res Inst Exercise Med, Kuopio, Finland; [Lakka, Timo A.] Univ Eastern Finland, Kuopio Univ Hosp, Dept Clin Physiol & Nucl Med, Kuopio, Finland; [Laakso, Markku] Univ Eastern Finland, Dept Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Tuomilehto, Jaakko] Danube Univ Krems, Dept Neurosci & Prevent Med, Krems, Austria; [Tuomilehto, Jaakko] King Abdulaziz Univ, Diabet Res Grp, Jeddah, Saudi Arabia; [Tuomilehto, Jaakko] Dasman Diabet Inst, Dasman, Kuwait; [Koistinen, Heikki A.] Univ Helsinki, Dept Med, Haartmaninkatu 4, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Abdominal Ctr Endocrinol, Haartmaninkatu 4, Helsinki, Finland; [Koistinen, Heikki A.] Univ Helsinki, Cent Hosp, Haartmaninkatu 4, Helsinki, Finland; [Koistinen, Heikki A.] Minerva Fdn, Biomed 2U, Tukholmankatu 8, Helsinki, Finland	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); European Molecular Biology Laboratory (EMBL); Stanford University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Finland National Institute for Health & Welfare; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Danube University Krems; King Abdulaziz University; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Collins, FS (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.; Birney, E (corresponding author), European Bioinformat Inst, European Mol Biol Lab, Wellcome Genome Campus, Hinxton, Cambs, England.	birney@ebi.ac.uk; Francis.Collins3@nih.gov	Albanus, Ricardo D'Oliveira/AAQ-2431-2021; Parker, Stephen/ABF-1063-2021; Narisu, Narisu/T-6908-2019; Stegle, Oliver/AAU-9177-2020; Wolford, Brooke/GQZ-2025-2022; Kinnunen, Leena/B-7059-2012; Wolford, Brooke/Y-3162-2019; Taylor, Leland/Q-5705-2019; Koistinen, Heikki/J-7313-2016	Stegle, Oliver/0000-0002-8818-7193; Kinnunen, Leena/0000-0001-8739-4812; Wolford, Brooke/0000-0003-3153-1552; Taylor, Leland/0000-0001-6498-6970; Koistinen, Heikki/0000-0001-7870-070X; Varshney, Arushi/0000-0001-9177-9707; Birney, Ewan/0000-0001-8314-8497; D'Oliveira Albanus, Ricardo/0000-0003-3651-0136	US National Institutes of Health [1-ZIA-HG000024, U01DK062370, R00DK099240]; American Diabetes Association Pathway to Stop Diabetes Grant [1-14-INI-07]; Academy of Finland [271961, 272741, 258753]; European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020572, U01DK062370] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Pathway to Stop Diabetes Grant; Academy of Finland(Academy of Finland); European Molecular Biology Laboratory; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported in part by US National Institutes of Health grants 1-ZIA-HG000024 (to F.S.C.), U01DK062370 (to M.B.), R00DK099240 (to S.C.J.P.), the American Diabetes Association Pathway to Stop Diabetes Grant 1-14-INI-07 (to S.C.J.P.), Academy of Finland Grants 271961, 272741 (to M.L.), 258753 (to H.A.K.), and the European Molecular Biology Laboratory (O.S. and E.B.).	Albert FW, 2015, NAT REV GENET, V16, P197, DOI 10.1038/nrg3891; Allum F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8211; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Barreiro LB, 2012, P NATL ACAD SCI USA, V109, P1204, DOI 10.1073/pnas.1115761109; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buil A, 2015, NAT GENET, V47, P88, DOI 10.1038/ng.3162; Campellone KG, 2010, NAT REV MOL CELL BIO, V11, P237, DOI 10.1038/nrm2867; Casale FP, 2015, NAT METHODS, V12, P755, DOI [10.1038/nmeth.3439, 10.1038/NMETH.3439]; Castel SE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0762-6; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Fuchsberger C, 2015, BIOINFORMATICS, V31, P782, DOI 10.1093/bioinformatics/btu704; Gagneur J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003803; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grundberg E, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001279; Hunter DJ, 2005, NAT REV GENET, V6, P287, DOI 10.1038/nrg1578; Idaghdour Y, 2012, P NATL ACAD SCI USA, V109, P16786, DOI 10.1073/pnas.1204945109; Iskratsch T, 2013, CELL MOL LIFE SCI, V70, P893, DOI 10.1007/s00018-012-1154-7; Iskratsch T, 2010, J CELL BIOL, V191, P1159, DOI 10.1083/jcb.201005060; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Kan-o M, 2012, BIOL OPEN, V1, P889, DOI 10.1242/bio.20121370; Kanaya H, 2005, GENES CELLS, V10, P665, DOI 10.1111/j.1365-2443.2005.00867.x; Keen JC, 2015, J PERS MED, V5, P22, DOI 10.3390/jpm5010022; Kheradpour P, 2014, NUCLEIC ACIDS RES, V42, P2976, DOI 10.1093/nar/gkt1249; Knowles DA, 2017, NAT METHODS, V14, P699, DOI 10.1038/nmeth.4298; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980; Lemon B, 2000, GENE DEV, V14, P2551, DOI 10.1101/gad.831000; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li S, 2014, NAT BIOTECHNOL, V32, P888, DOI 10.1038/nbt.3000; Li Y, 2006, PLOS GENET, V2, P2155, DOI 10.1371/journal.pgen.0020222; Lippert C., 2014, LIMIX GENETIC NALYSI, DOI [10.1101/003905v2, DOI 10.1101/003905V2]; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mangravite LM, 2013, NATURE, V502, P377, DOI 10.1038/nature12508; Maranville JC, 2012, TRANSCR-AUSTIN, V3, P56, DOI 10.4161/trns.19497; Mathelier A, 2016, NUCLEIC ACIDS RES, V44, pD110, DOI 10.1093/nar/gkv1176; Mikkelsen TS, 2010, CELL, V143, P156, DOI 10.1016/j.cell.2010.09.006; Moyerbrailean GA, 2016, GENOME RES, V26, P1627, DOI 10.1101/gr.209759.116; Nica AC, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0362; Parker SCJ, 2013, P NATL ACAD SCI USA, V110, P17921, DOI 10.1073/pnas.1317023110; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Romanoski CE, 2010, AM J HUM GENET, V86, P399, DOI 10.1016/j.ajhg.2010.02.002; Rosado M, 2014, MOL BIOL CELL, V25, P811, DOI 10.1091/mbc.E13-08-0443; Runcie DE, 2012, MOL ECOL, V21, P4547, DOI 10.1111/j.1365-294X.2012.05717.x; Sambandan D, 2008, GENETICS, V179, P1079, DOI 10.1534/genetics.108.086769; Scott LJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11764; Smirnov DA, 2009, NATURE, V459, P587, DOI 10.1038/nature07940; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Stegle O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000770; Varshney A, 2017, P NATL ACAD SCI USA, V114, P2301, DOI 10.1073/pnas.1621192114; Wooten EC, 2013, CIRC-CARDIOVASC GENE, V6, P10, DOI 10.1161/CIRCGENETICS.112.965277; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737	64	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2018	13	4							e0195788	10.1371/journal.pone.0195788	http://dx.doi.org/10.1371/journal.pone.0195788			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8QO	29659628	gold, Green Published, Green Submitted			2022-12-26	WOS:000430061100032
J	Hu, Y; Hao, XR; Chen, LF; Akhberdi, O; Yu, X; Liu, YJ; Zhu, XD				Hu, Yang; Hao, Xiaoran; Chen, Longfei; Akhberdi, Oren; Yu, Xi; Liu, Yanjie; Zhu, Xudong			G alpha-cAMP/PKA pathway positively regulates pigmentation, chaetoglobosin A biosynthesis and sexual development in Chaetomium globosum	PLOS ONE			English	Article							G-PROTEIN; SECONDARY METABOLITES; PESTALOTIOPSIS-MICROSPORA; PENICILLIUM-CHRYSOGENUM; SIGNALING PATHWAY; GENE; FUNGUS; CONIDIATION; SUBUNITS; GROWTH	Sensing the environmental signals, the canonical G alpha-cAMP/PKA pathway modulates mycelial growth and development, and negatively regulates some secondary metabolism in filamentous fungi, e.g. aflatoxin in Aspergillus nidulans. Here we report the characterization of this signaling pathway in Chaetomium globosum, a widely spread fungus known for synthesizing abundant secondary metabolites, e.g. chaetoglobosin A (ChA). RNAi-mediated knockdown of a putative Ga-encoding gene gna-1, led to plural changes in phenotype, e.g. albino mycelium, significant restriction on perithecium development and decreased production of ChA. RNA-seq profiling and qRT-PCR verified significantly fall in expression of corresponding genes, e.g. pks-1 and CgcheA. These defects could be restored by simultaneous knock-down of the pkaR gene encoding a regulatory subunit of cAMP-dependent protein kinase A (PKA), suggesting that pkaR had a negative effect on the above mentioned traits. Confirmatively, the intracellular level of cAMP in wild-type strain was about 3.4-fold to that in gna-1 silenced mutant pG14, and addition of a cAMP analog, 8-Br-cAMP, restored the same defects, e.g., the expression of CgcheA. Furthermore, the intracellular cAMP in gna-1 and pkaR double silenced mutant was approaching the normal level. The following activity inhibition experiment proved that the expression of CgcheA was indeed regulated by PKA. Down-regulation of LaeA/VeA/SptJ expression in gna-1 mutant was also observed, implying that Ga signaling may crosstalk to other regulatory pathways. Taken together, this study proposes that the heterotrimeric G alpha protein-cAMP/PKA signaling pathway positively mediates the sexual development, melanin biosynthesis, and secondary metabolism in C. globosum.	[Hu, Yang] Tianjin Med Univ, Sch Basic Med Sci, Dept Pathogen Biol, Tianjin, Peoples R China; [Hao, Xiaoran] Beijing Normal Univ, Sch Life Sci, Natl Expt Teaching Demonstrating Ctr, Beijing, Peoples R China; [Chen, Longfei; Akhberdi, Oren; Yu, Xi] Nankai Univ, Dept Microbiol, Coll Life Sci, Tianjin, Peoples R China; [Liu, Yanjie; Zhu, Xudong] Beijing Normal Univ, Inst Biochem & Biotechnol, Sch Life Sci, Beijing Key Lab Genet Engn Drug & Biotechnol, Beijing, Peoples R China; [Chen, Longfei] Zhejiang Med Co LTD, Xinchang Pharmaceut Factory, Dept Biopharmaceut, Shaoxing, Peoples R China; [Yu, Xi] Karlsruhe Inst Technol, Inst Appl Biosci, Dept Microbiol, Karlsruhe, Germany	Tianjin Medical University; Beijing Normal University; Nankai University; Beijing Normal University; Helmholtz Association; Karlsruhe Institute of Technology	Hao, XR (corresponding author), Beijing Normal Univ, Sch Life Sci, Natl Expt Teaching Demonstrating Ctr, Beijing, Peoples R China.; Zhu, XD (corresponding author), Beijing Normal Univ, Inst Biochem & Biotechnol, Sch Life Sci, Beijing Key Lab Genet Engn Drug & Biotechnol, Beijing, Peoples R China.	2015xrhao@bnu.edu.cn; zhu11187@briu.edu.en			National Natural Science Foundation of China (NSFC) [31470251]; National Basic Research Program of China ("973" Program) [2007CB707801]; Fundamental Research Funds for the Central Universities [2015NT10]; Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education [201502]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China ("973" Program)(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education	This work is supported by a National Natural Science Foundation of China (NSFC grant #31470251 to XZ), a National Basic Research Program of China ("973" Program #2007CB707801 to XZ), a grant from the Fundamental Research Funds for the Central Universities (# 2015NT10 to XH), and an Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education (#201502 to XH).; Our sincere thanks are given to Dr. Jinzhu Song and Dr. Qian Yang (Harbin Institute of Technology, China) for the kind gift of the vector pSilent-1. This work is supported by a National Natural Science Foundation of China (NSFC grant #31470251), a National Basic Research Program of China ("973" Program #2007CB707801), a grant from the Fundamental Research Funds for the Central Universities (#2015NT10), and an Open Fund of Key Laboratory of Cell Proliferation and Regulation Biology, Ministry of Education (#201502).	Abdel-Azeem AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01477; Aghcheh RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112799; Amare MG, 2014, FUNGAL GENET BIOL, V66, P11, DOI 10.1016/j.fgb.2014.02.008; Bayram O, 2008, SCIENCE, V320, P1504, DOI 10.1126/science.1155888; Carrasco-Navarro U, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0564-x; CHIJIWA T, 1990, J BIOL CHEM, V265, P5267; Garcia-Rico RO, 2008, MICROBIOL-SGM, V154, P3567, DOI 10.1099/mic.0.2008/019091-0; Hao X., 2012, AFR J BIOTECHNOL, V11, P771, DOI DOI 10.5897/AJB11.2715; Hoff B, 2010, EUKARYOT CELL, V9, P1236, DOI 10.1128/EC.00077-10; Hu Y, 2013, J AGR FOOD CHEM, V61, P41, DOI 10.1021/jf304314g; Hu Y, 2012, SCI CHINA LIFE SCI, V55, P1100, DOI 10.1007/s11427-012-4409-5; Hua CY, 2013, IMMUNOBIOLOGY, V218, P292, DOI 10.1016/j.imbio.2012.05.015; Huang S, 2016, MAR DRUGS, V14, DOI 10.3390/md14100172; Ichihara A, 1996, BIOSCI BIOTECH BIOCH, V60, P360, DOI 10.1271/bbb.60.360; Jiang T, 2016, J NAT PROD, V79, P2487, DOI 10.1021/acs.jnatprod.6b00333; Jiao WX, 2004, J NAT PROD, V67, P1722, DOI 10.1021/np030460g; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Leeder AC, 2011, NAT REV MICROBIOL, V9, P440, DOI 10.1038/nrmicro2580; Li SJ, 2006, MOL MICROBIOL, V62, P1418, DOI 10.1111/j.1365-2958.2006.05447.x; Liu H, 2007, EMBO J, V26, P690, DOI 10.1038/sj.emboj.7601536; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longoni P, 2012, APPL ENVIRON MICROB, V78, P3693, DOI 10.1128/AEM.00124-12; Lu KY, 2013, MOLECULES, V18, P10944, DOI 10.3390/molecules180910944; Macheleidt J, 2016, ANNU REV GENET, V50, P371, DOI 10.1146/annurev-genet-120215-035203; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nakazawa T, 2013, J AM CHEM SOC, V135, P13446, DOI 10.1021/ja405128k; Niu XL, 2015, J MICROBIOL BIOTECHN, V25, P579, DOI 10.4014/jmb.1409.09067; Park G, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P50; Scherlach K, 2010, NAT PROD REP, V27, P869, DOI 10.1039/b903913a; Schumann J, 2007, J AM CHEM SOC, V129, P9564, DOI 10.1021/ja072884t; SEKITA S, 1982, CHEM PHARM BULL, V30, P1609, DOI 10.1248/cpb.30.1609; Serena C, 2003, ANTIMICROB AGENTS CH, V47, P3161, DOI 10.1128/AAC.47.10.3161-3164.2003; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Tag A, 2000, MOL MICROBIOL, V38, P658, DOI 10.1046/j.1365-2958.2000.02166.x; TURGEON BG, 1987, MOL CELL BIOL, V7, P3297, DOI 10.1128/MCB.7.9.3297; Yu HY, 2008, MICROBIOL-SGM, V154, P392, DOI 10.1099/mic.0.2007/012260-0; Yu JH, 2006, J MICROBIOL, V44, P145; Yu X, 2017, MICROBIOL RES, V203, P29, DOI 10.1016/j.micres.2017.06.003; Zhang Q, 2012, MINI-REV MED CHEM, V12, P127, DOI 10.2174/138955712798995066	40	7	8	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2018	13	4							e0195553	10.1371/journal.pone.0195553	http://dx.doi.org/10.1371/journal.pone.0195553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC8EX	29652900	Green Published, Green Submitted, gold			2022-12-26	WOS:000430026900026
J	Gardner, PC; Goossens, B; Wern, JGE; Kretzschmar, P; Bohm, T; Vaughan, IP				Gardner, Penny C.; Goossens, Benoit; Wern, Jocelyn Goon Ee; Kretzschmar, Petra; Bohm, Torsten; Vaughan, Ian P.			Spatial and temporal behavioural responses of wild cattle to tropical forest degradation	PLOS ONE			English	Article							HEAT-STRESS; RAIN-FOREST; LOGGING INTENSITY; ACTIVITY PATTERNS; BODY-TEMPERATURE; DAIRY-CATTLE; SABAH; VEGETATION; IMPACTS; BIODIVERSITY	Identifying the consequences of tropical forest degradation is essential to mitigate its effects upon forest fauna. Large forest-dwelling mammals are often highly sensitive to environmental perturbation through processes such as fragmentation, simplification of habitat structure, and abiotic changes including increased temperatures where the canopy is cleared. Whilst previous work has focused upon species richness and rarity in logged forest, few look at spatial and temporal behavioural responses to forest degradation. Using camera traps, we explored the relationships between diel activity, behavioural expression, habitat use and ambient temperature to understand how the wild free-ranging Bornean banteng (Bos javanicus lowi) respond to logging and regeneration. Three secondary forests in Sabah, Malaysian Borneo were studied, varying in the time since last logging (6-23 years). A combination of generalised linear mixed models and generalised linear models were constructed using >36,000 trap-nights. Temperature had no significant effect on activity, however it varied markedly between forests, with the period of intense heat shortening as forest regeneration increased over the years. Bantengs regulated activity, with a reduction during the wet season in the most degraded forest (z = -2.6, Std. Error = 0.13, p = 0.01), and reductions during midday hours in forest with limited regeneration, however after >20 years of regrowth, activity was more consistent throughout the day. Foraging and use of open canopy areas dominated the activity budget when regeneration was limited. As regeneration advanced, this was replaced by greater investment in travelling and using a closed canopy. Forest degradation modifies the ambient temperature, and positively influences flooding and habitat availability during the wet season. Retention of a mosaic of mature forest patches within commercial forests could minimise these effects and also provide refuge, which is key to heat dissipation and the prevention of thermal stress, whilst retention of degraded forest could provide forage.	[Gardner, Penny C.; Goossens, Benoit; Wern, Jocelyn Goon Ee] Danau Girang Field Ctr, Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Gardner, Penny C.; Goossens, Benoit; Vaughan, Ian P.] Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales; [Goossens, Benoit] Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia; [Goossens, Benoit] Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales; [Kretzschmar, Petra; Bohm, Torsten] Leibniz Inst Zoo & Wildlife Res, Berlin, Germany	Cardiff University; Cardiff University; Leibniz Institut fur Zoo und Wildtierforschung	Gardner, PC; Goossens, B (corresponding author), Cardiff Univ, Cardiff Sch Biosci, Organisms & Environm Div, Cardiff, S Glam, Wales.; Goossens, B (corresponding author), Sabah Wildlife Dept, Kota Kinabalu, Sabah, Malaysia.; Goossens, B (corresponding author), Cardiff Univ, Sustainable Places Res Inst, Cardiff, S Glam, Wales.	pennygardner14@hotmail.com; GoossensBR@cardiff.ac.uk	Vaughan, Ian/A-4782-2010	Vaughan, Ian/0000-0002-7263-3822; Gardner, Penny/0000-0002-3360-8747; Bohm, Torsten/0000-0001-5446-2321	Federal Ministry of Education and Research (BMBF) (Bundesministerium fur Bildung und Forschung); Zoo Leipzig; SOS Rhino; Houston Zoo; Malaysian Palm Oil Council; Woodland Park Zoo; Mohamed bin Zayed Species Conservation Fund; Yayasan Sime Darby	Federal Ministry of Education and Research (BMBF) (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); Zoo Leipzig; SOS Rhino; Houston Zoo; Malaysian Palm Oil Council; Woodland Park Zoo; Mohamed bin Zayed Species Conservation Fund; Yayasan Sime Darby	This work was supported by the Federal Ministry of Education and Research (BMBF) (Bundesministerium fur Bildung und Forschung) to PK - https://www.bmbf.de/en/index.html; Zoo Leipzig to PK - http://www.zoo-leipzig.de/en/ homepage/; SOS Rhino to PK - now defunct; Houston Zoo to PCG - https://www.houstonzoo.org/; Malaysian Palm Oil Council to PCG - http://www.mpoc.org.my/; Woodland Park Zoo to PCG https:/www.zoo.org/; Mohamed bin Zayed Species Conservation Fund to PCG - https://www.speciesconservation.org/; and Yayasan Sime Darby to PCG - http://ww.yayasansimedarby.com/our-projects/environment.	Allred BW, 2013, GLOBAL CHANGE BIOL, V19, P1875, DOI 10.1111/gcb.12183; Ancrenaz M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04024; Ancrenaz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011510; Bagchi R, 2011, PHILOS T R SOC B, V366, P3246, DOI 10.1098/rstb.2011.0034; Bergstedt J, 2001, FOREST ECOL MANAG, V154, P105, DOI 10.1016/S0378-1127(00)00642-3; Berry NJ, 2010, BIODIVERS CONSERV, V19, P985, DOI 10.1007/s10531-010-9779-z; Bischoff W, 2005, FOREST ECOL MANAG, V218, P174, DOI 10.1016/j.foreco.2005.07.009; Boan JJ, 2011, FOREST ECOL MANAG, V262, P1704, DOI 10.1016/j.foreco.2011.07.022; Bradshaw CJA, 2007, GLOBAL CHANGE BIOL, V13, P2379, DOI 10.1111/j.1365-2486.2007.01446.x; Brian A, 2017, PACKAGE MASS; Brodie Jedediah, 2011, Small Carnivore Conservation, V44, P1; Brodie JF, 2015, CONSERV BIOL, V29, P110, DOI 10.1111/cobi.12389; Bryan JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069679; BUCKLAND ST, 1984, BIOMETRICS, V40, P811, DOI 10.2307/2530926; Burivalova Z, 2017, CONSERV LETT, V10, P4, DOI 10.1111/conl.12244; Burivalova Z, 2014, CURR BIOL, V24, P1893, DOI 10.1016/j.cub.2014.06.065; Costa FRC, 2003, BIOTROPICA, V35, P103, DOI 10.1111/j.1744-7429.2003.tb00267.x; Dash S, 2016, VET WORLD, V9, P235, DOI 10.14202/vetworld.2016.235-244; Douglas A, 2017, PACKAGE IME4, DOI [10.2307/2533043, DOI 10.2307/2533043]; Edwards DP, 2014, ECOL APPL, V24, P2029, DOI 10.1890/14-0010.1; Estes JG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044601; Gine GAF, 2012, J ZOOL, V286, P131, DOI 10.1111/j.1469-7998.2011.00855.x; Fewster RM, 2000, ECOLOGY, V81, P1970, DOI 10.2307/177286; FINCH VA, 1986, J ANIM SCI, V62, P531, DOI 10.2527/jas1986.622531x; Gardner PC, 2015, NATURAL HIST NONINVA; Gardner PC, 2014, ECOLOGY, EVOLUTION AND BEHAVIOUR OF WILD CATTLE: IMPLICATIONS FOR CONSERVATION, P216; Gokbulak F, 2008, WATER RESOUR MANAG, V22, P635, DOI 10.1007/s11269-007-9183-y; Gray TNE, 2011, RAFFLES B ZOOL, V59, P311; Guo ST, 2008, CONSERV BIOL, V22, P1055, DOI 10.1111/j.1523-1739.2008.00975.x; Hansen PJ, 2004, ANIM REPROD SCI, V82-3, P349, DOI 10.1016/j.anireprosci.2004.04.011; Hardus ME, 2012, BIOL CONSERV, V146, P177, DOI 10.1016/j.biocon.2011.12.014; Heydon MJ, 1997, J APPL ECOL, V34, P484, DOI 10.2307/2404892; Hopkin M, 2007, NATURE, DOI [10.1038/news070806-13, DOI 10.1038/NEWS070806-13]; Journeaux KL, 2018, ENDANGER SPECIES RES, V35, P141, DOI 10.3354/esr00882; Meijaard E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012813; Meijaard Erik, 2005, pi; Melletti M, 2014, ECOLOGY, EVOLUTION AND BEHAVIOUR OF WILD CATTLE: IMPLICATIONS FOR CONSERVATION, P1; Neumann W, 2013, LANDSCAPE URBAN PLAN, V114, P9, DOI 10.1016/j.landurbplan.2013.02.002; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Pandit BR, 2000, BARK STRIPPING SAMBA, V126, P865; PAYNE J, 1985, FIELD GUIDE MAMMALS; Pinard M, 1996, BIOTROPICA, V28, P2, DOI 10.2307/2388766; Prosser NS, 2016, BMC ZOOL, V1, DOI 10.1186/s40850-016-0007-5; R Core Team, 2013, R LANG ENV STAT COMP; Ramesh T, 2012, J ZOOL, V287, P269, DOI 10.1111/j.1469-7998.2012.00908.x; Reimoser F, 1996, FOREST ECOL MANAG, V88, P107, DOI 10.1016/S0378-1127(96)03816-9; Reynolds G, 2011, PHILOS T R SOC B, V366, P3168, DOI 10.1098/rstb.2011.0154; Ross J, 2013, J ZOOL, V290, P96, DOI 10.1111/jzo.12018; Rowe MF, 2013, J EXP BIOL, V216, P1774, DOI 10.1242/jeb.076521; Schnitzer SA, 2002, TRENDS ECOL EVOL, V17, P223, DOI 10.1016/S0169-5347(02)02491-6; Shrestha AK, 2014, INT J BIOMETEOROL, V58, P41, DOI 10.1007/s00484-012-0622-y; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Soriani N, 2013, J DAIRY SCI, V96, P5082, DOI 10.3168/jds.2013-6620; Timmins R., 2008, IUCN 2012 IUCN RED L; Tucker CB, 2007, APPL ANIM BEHAV SCI, V105, P1, DOI [10.1016/j.applanim.2006.06.009, 10.1016/j.applanim.2007.03.015]; van Beest FM, 2012, ANIM BEHAV, V84, P723, DOI 10.1016/j.anbehav.2012.06.032; van Strien N.J., 1974, Mededelingen LandbHoogesch Wageningen, V74, P1; Wearn OR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077598; Yadav B, 2016, ASIAN AUSTRAL J ANIM, V29, P1585, DOI 10.5713/ajas.15.0693	59	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195444	10.1371/journal.pone.0195444	http://dx.doi.org/10.1371/journal.pone.0195444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649279	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000429791900045
J	Poobathy, R; Zakaria, R; Murugaiyah, V; Subramaniam, S				Poobathy, Ranjetta; Zakaria, Rahmad; Murugaiyah, Vikneswaran; Subramaniam, Sreeramanan			Autofluorescence study and selected cyanidin quantification in the Jewel orchids Anoectochilus sp and Ludisia discolor	PLOS ONE			English	Article							HAEMARIA-DISCOLOR; FUNCTIONAL-ROLE; ANTHOCYANINS; LEAVES; PLANTS; LIGHT; CHLOROPLAST; RED; ARABIDOPSIS; FORMOSANUS	Anoectochilus sp. and Ludisia discolor are known as Jewel orchids. Both species are terrestrial wild orchids that grow in shaded areas of forests. The Jewel orchids are renowned for the beauty of their leaves, which are dark-green laced with silvery or golden veins. The orchids are used as a cure in various parts of Asia. Overharvesting and anthropogenic disturbances threaten the existence of the Jewel orchids in the wild, necessitating human intervention in their survival. An understanding of the structure and adaptations of a plant may assist in its survival when propagated outside of its habitat. In this study, ex vitro leaves of Anoectochilus sp. and L. discolorwere subjected to freehand sectioning, and then inspected through brightfield and fluorescence microscopy. The study indicated that all parts of both plants presented typical monocotyledonous characteristics except the leaves. The leaves displayed dorsiventrality with distinct palisade and spongy mesophyll layers. The spongy mesophyll layer contained cells which fluoresced a bright red when exposed to ultraviolet, blue, and green light wavelengths, hinting at the presence of anthocyanins for photoprotection. Cyanidin was detected in the leaves of L. discolor, as enumerated through high performance liquid chromatography (HPLC). The observations indicated that Anoectochilus sp. and L. discolorare well-adapted to live under shaded conditions with minimal exposure to light.	[Poobathy, Ranjetta; Zakaria, Rahmad; Subramaniam, Sreeramanan] Univ Sains Malaysia, Sch Biol Sci, Gelugor, Pulau Pinang, Malaysia; [Murugaiyah, Vikneswaran] Univ Sains Malaysia, Sch Pharmaceut Sci, Gelugor, Pulau Pinang, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia	Subramaniam, S (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Gelugor, Pulau Pinang, Malaysia.	sreeramanan@usm.my	Subramaniam, Sreeramanan/AAA-5094-2022; Poobathy, Ranjetta/AAH-8924-2020; Subramaniam, Sreeramanan Sree/I-1130-2012	Poobathy, Ranjetta/0000-0002-0416-1122; Subramaniam, Sreeramanan Sree/0000-0003-4392-285X; Murugaiyah, Vikneswaran/0000-0003-1768-7577	Universiti Sains Malaysia Research University Grant Scheme (USM-RU) [1001/PBIOLOGI/811211]	Universiti Sains Malaysia Research University Grant Scheme (USM-RU)(Universiti Sains Malaysia)	The authors would like to thank the Universiti Sains Malaysia Research University Grant Scheme (USM-RU) 1001/PBIOLOGI/811211 for supporting this study.	[Anonymous], 2010, AGR IN LAO PDR T; Arditti J, 1977, ORCHID BIOL REV PERS, V1; Benzing DH, 1987, ORCHID BIOL REV PERS, V4; Bolhar-Nordenkampf H. R., 1993, P91; Brouillard R., 1988, FLAVONOIDS ADV RES 1, P525, DOI DOI 10.1007/978-1-4899-2913-6_16; Cai ZQ, 2005, PHOTOSYNTHETICA, V43, P91, DOI 10.1007/s11099-005-1098-3; Chou LC, 2004, BOT BULL ACAD SINICA, V45, P143; Feild TS, 2001, PLANT PHYSIOL, V127, P566, DOI 10.1104/pp.010063; Figueroa C, 2008, ANN BOT-LONDON, V101, P509, DOI 10.1093/aob/mcm328; FOYER CH, 1994, PHYSIOL PLANTARUM, V92, P696, DOI 10.1111/j.1399-3054.1994.tb03042.x; Gould K.S., 2003, ENCY APPL PLANT SCI, P9, DOI [10.1016/B0-12-227050-9/00124-1, DOI 10.1016/B0-12-227050-9/00124-1]; GOULD KS, 1995, NATURE, V378, P241, DOI 10.1038/378241b0; Gould KS, 2002, PHYSIOL PLANTARUM, V116, P127, DOI 10.1034/j.1399-3054.2002.1160116.x; Gould KS, 2000, J EXP BOT, V51, P1107, DOI 10.1093/jexbot/51.347.1107; Hatier Jean-Hugues B., 2009, P1, DOI 10.1007/978-0-387-77335-3_1; Hawkes AD, 1970, ENCY CULTIVATED ORCH, P238; Hayden WJ., 2016, SEMPERVIRENS, P6; Hoch WA, 2003, PLANT PHYSIOL, V133, P1296, DOI 10.1104/pp.103.027631; Hsieh CC, 2005, INT J APPL SCI ENG T, V3, P175; Hughes NM, 2008, J EXP BOT, V59, P3435, DOI 10.1093/jxb/ern193; Hughes NM, 2005, NEW PHYTOL, V168, P575, DOI 10.1111/j.1469-8137.2005.01546.x; IUCN/SSC Orchid Specialist Group, 1996, ORCH STAT SURV CONS; Jing P, 2008, J AGR FOOD CHEM, V56, P9391, DOI 10.1021/jf8005917; KAN WS, 1979, PHARM BOT; Ket NV, 2004, BIOL PLANTARUM, V48, P339, DOI 10.1023/B:BIOP.0000041084.77832.11; Kong SG, 2014, BBA-BIOENERGETICS, V1837, P522, DOI 10.1016/j.bbabio.2013.12.004; Lai YS, 2016, J AGR FOOD CHEM, V64, P2719, DOI 10.1021/acs.jafc.5b04036; Lambers H., 2008, PLANT PHYSL ECOLOGY, p11Routl, DOI [DOI 10.1007/978-0-387-78341-3_2, 10.1007/978-0-387-78341-3_2]; LIN C-C, 1981, Shoyakugaku Zasshi, V35, P272; LIN C-C, 1981, Shoyakugaku Zasshi, V35, P262; Lorrain B, 2013, MOLECULES, V18, P1076, DOI 10.3390/molecules18011076; Luttge U, 2008, PHYSL ECOLOGY TROPIC, P103, DOI DOI 10.1007/978-3-540-71793-5_4; Ma ZQ, 2010, HORTSCIENCE, V45, P863, DOI 10.21273/HORTSCI.45.6.863; Ong PT, 2013, MALESIAN ORCHID J, V11, P15; Ormerod Paul, 2005, Taiwania, V50, P1; Poustka F, 2007, PLANT PHYSIOL, V145, P1323, DOI 10.1104/pp.107.105064; Robards K, 2003, J CHROMATOGR A, V1000, P657, DOI 10.1016/S0021-9673(03)00058-X; Rohr GE, 2000, STUD NAT PROD CHEM, V21, P497; Roshchina VV, 2012, INT J SPECTROSC, DOI 10.1155/2012/124672; Shiau YJ, 2005, BIOL PLANTARUM, V49, P341, DOI 10.1007/s10535-005-0005-x; Shiau YJ, 2002, BOT BULL ACAD SINICA, V43, P123; Simoes C, 2009, PLANT PHYSIOL BIOCH, V47, P895, DOI 10.1016/j.plaphy.2009.06.005; Staiger CJ, 1997, TRENDS PLANT SCI, V2, P275, DOI 10.1016/S1360-1385(97)86350-9; Stern WL., 2014, ANATOMY MONOCOTYLEDO, VX; Stintzing FC, 2004, TRENDS FOOD SCI TECH, V15, P19, DOI 10.1016/j.tifs.2003.07.004; Suetsugu N, 2012, ADVANCES IN PHOTOSYNTHESIS - FUNDAMENTAL ASPECTS, P215; Sumathi R, 2003, BLUMEA, V48, P285; Teo C. K. H., 1978, American Orchid Society Bulletin, V47, P1028; Teoh E.S., 2015, MED ORCHID ASIA, V5, P59, DOI [10.1007/978-3-319-24274-3_5, DOI 10.1007/978-3-319-24274-3_5]; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Tomlinson PB., 1982, ANATOMY MONOCOTYLEDO; Tsui PYC, 1992, CONSERVATION PROPAGA; Vogelmann TC, 1996, PHYSIOL PLANTARUM, V98, P43, DOI 10.1111/j.1399-3054.1996.tb00674.x; W. C. S. P, 2011, WORLD CHECKL SEL PLA; Wada M, 2003, ANNU REV PLANT BIOL, V54, P455, DOI 10.1016/j.plantsci.2013.05.016; Wada M, 2013, PLANT SCI CELL BIOL, DOI DOI 10.1007/978-1-4614-7881-2_10-3; Wada M, 2016, P JPN ACAD B-PHYS, V92, P387, DOI 10.2183/pjab.92.387; Watson J., 2011, A FOOLPROOF ORCHID, P10; Xu MJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01474; Yeung E.C., 1998, TESTED STUDIES LAB T, V19, P125, DOI DOI 10.1007/1-4020-2985-3_41; Zheng XL, 2009, J ETHNOPHARMACOL, V124, P197, DOI 10.1016/j.jep.2009.04.042	61	6	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195642	10.1371/journal.pone.0195642	http://dx.doi.org/10.1371/journal.pone.0195642			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649288	Green Published, Green Submitted, gold			2022-12-26	WOS:000429791900066
J	Turakhia, MP; Shafrin, J; Bognar, K; Trocio, J; Abdulsattar, Y; Wiederkehr, D; Goldman, DP				Turakhia, Mintu P.; Shafrin, Jason; Bognar, Katalin; Trocio, Jeffrey; Abdulsattar, Younos; Wiederkehr, Daniel; Goldman, Dana P.			Estimated prevalence of undiagnosed atrial fibrillation in the United States	PLOS ONE			English	Article							MEDICARE BENEFICIARIES; RISK-FACTORS; STROKE; ANTICOAGULATION; PROJECTIONS; MORTALITY; SCHEMES; DISEASE; ADULTS	Introduction As atrial fibrillation (AF) is often asymptomatic, it may remain undiagnosed until or even after development of complications, such as stroke. Consequently the observed prevalence of AF may underestimate total disease burden. Methods To estimate the prevalence of undiagnosed AF in the United States, we performed a retrospective cohort modeling study in working age (18-64) and elderly (>= 65) people using commercial and Medicare administrative claims databases. We identified patients in years 2004-2010 with incident AF following an ischemic stroke. Using a back-calculation methodology, we estimated the prevalence of undiagnosed AF as the ratio of the number of post stroke AF patients and the CHADS(2)-specific stroke probability for each patient, adjusting for age and gender composition based on United States census data. Results The estimated prevalence of AF (diagnosed and undiagnosed) was 3,873,900 (95%/CI: 3,675,200-4,702,600) elderly and 1,457,100 (95%CI: 1,218,500-1,695,800) working age adults, representing 10.0% and 0.92% of the respective populations. Of these, 698,900 were undiagnosed: 535,400 (95%CI: 331,900-804,400) elderly and 163,500 (95%CI: 17,700-400,000) working age adults, representing 1.3% and 0.09% of the respective populations. Among all undiagnosed cases, 77% had a CHADS(2) score >= 1, and 56% had CHADS(2) score >= 2. Conclusions Using a back-calculation approach, we estimate that the total AF prevalence in 2009 was 5.3 million of which 0.7 million (13.1% of AF cases) were undiagnosed. Over half of the modeled population with undiagnosed AF was at moderate to high risk of stroke.	[Turakhia, Mintu P.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Shafrin, Jason; Bognar, Katalin] Precis Hlth Econ, Los Angeles, CA USA; [Trocio, Jeffrey; Abdulsattar, Younos; Wiederkehr, Daniel] Pfizer Inc, New York, NY USA; [Goldman, Dana P.] Univ Southern Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA	Stanford University; Pfizer; University of Southern California	Turakhia, MP (corresponding author), Stanford Univ, Sch Med, Stanford, CA 94305 USA.	mintu@stanford.edu	Goldman, Dana P/E-7667-2013; Shafrin, Jason/AAI-7041-2020	Goldman, Dana P/0000-0001-8498-6396; Shafrin, Jason/0000-0001-8444-5979; Bognar, Katalin/0000-0001-8357-8569; Turakhia, Minang/0000-0001-8025-0904	Bristol-Myers Squibb; Pfizer	Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer)	The research reported in this manuscript was funded by Bristol-Myers Squibb and Pfizer based on a proposal that co-author Dana P. Goldman and Mintu P. Turakhia presented to the sponsors. Jason Shafrin and Katalin Bognar are employees of; Dana P. Goldman serves as a consultant to Precision Health Economics, who were paid consultants to Pfizer in connection with the development of this manuscript. Jeffrey Trocio, Younos Abdulsattar, and Daniel Wiederkehr are employees and shareholders of Pfizer, Inc. Bristol-Myers Squibb provided funding but was not involved in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication. Through Pfizer affiliated coauthors, Pfizer was involved in the design of the study, the interpretation of data, and the preparation, review, and approval of the manuscript for publication.	BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Claes N, 2012, ACTA CARDIOL, V67, P273, DOI 10.1080/AC.67.3.2160714; Clua-Espuny JL, 2013, REV ESP CARDIOL, V66, P545, DOI 10.1016/j.rec.2013.03.003; DiCiccio TJ, 1996, STAT SCI, V11, P189; Egan JR, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0096; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Lip GYH, 2010, STROKE, V41, P2731, DOI 10.1161/STROKEAHA.110.590257; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Marfella R, 2013, J AM COLL CARDIOL, V62, P525, DOI 10.1016/j.jacc.2013.02.091; Miyasaka Y, 2006, CIRCULATION, V114, P119, DOI 10.1161/CIRCULATIONAHA.105.595140; Naccarelli GV, 2009, AM J CARDIOL, V104, P1534, DOI 10.1016/j.amjcard.2009.07.022; Piccini JP, 2012, CIRC-CARDIOVASC QUAL, V5, P85, DOI 10.1161/CIRCOUTCOMES.111.962688; Pope GC, 2011, EVALUATION CMS HCC R; Samol A, 2013, EUROPACE, V15, P657, DOI 10.1093/europace/eus366; Suissa L, 2013, J STROKE CEREBROVASC, V22, P991, DOI 10.1016/j.jstrokecerebrovasdis.2012.01.015; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Turakhia MP, 2013, AM HEART J, V166, P573, DOI 10.1016/j.ahj.2013.07.003; U. S. Census, 2012, AG SEX COMP US 2012; Weber-Kruger M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067602	20	65	70	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 12	2018	13	4							e0195088	10.1371/journal.pone.0195088	http://dx.doi.org/10.1371/journal.pone.0195088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4YG	29649277	Green Published, gold			2022-12-26	WOS:000429791900022
J	Bianchi, CM; Huneau, JF; Barbillon, P; Lluch, A; Egnell, M; Fouillet, H; Verger, EO; Mariotti, F				Bianchi, Clelia M.; Huneau, Jean-Francois; Barbillon, Pierre; Lluch, Anne; Egnell, Manon; Fouillet, Helene; Verger, Eric O.; Mariotti, Francois			A clear trade-off exists between the theoretical efficiency and acceptability of dietary changes that improve nutrient adequacy during early pregnancy in French women: Combined data from simulated changes modeling and online assessment survey	PLOS ONE			English	Article							NUTRITION AWARENESS; PHYSICAL-ACTIVITY; RISK-FACTORS; ADULTS; FOOD; INTERVENTION; FEASIBILITY; ENERGY	Background During pregnancy, the diet of a mother-to-be should be adapted to meet increases in nutrient requirements. We analyzed the theoretical efficiency and acceptability of different types of tailored dietary changes for pregnant women. Methods The nutrient adequacy of the diet was evaluated using the PANDiet score, by comparing the nutrient intakes of 344 non-pregnant premenopausal women (18-44y) with dietary reference intakes for the first trimester of pregnancy. Simulations were performed to evaluate the theoretical efficiency of three types of ten successive tailored dietary changes in improving nutrient adequacy, with graded difficulty in implementation. The acceptability (declared intention to use in the diet) of most efficient dietary changes was evaluated during an online randomized study including 115 French pregnant women (22-41y). Results Modifying the amount consumed of foods (type-1) did not modify the food repertoire and resulted in the smallest theoretical efficiency (increase in the PANDiet score of 9.8 +/- 0.2 points), but changes were the most acceptable (probability of the intention to use: 0.30-0.78). Conversely, replacing food items by items from the same group or eaten at the same time (type-3) broadened the food repertoire (3.6 +/- 1.3 food subgroups added) and resulted in the greatest theoretical efficiency (+23.9 +/- 0.3) but changes were the least acceptable (0.07-0-23). Replacing food items within the same subgroup (type-2) slightly broadened the food repertoire (+8.0 +/- 1.3 foods) and resulted in moderate theoretical efficiency (+14.8 +/- 0.2) and intermediate acceptability (0.11-0.35). Conclusion A clear trade-off exists between the theoretical efficiency and acceptability of dietary changes, with a graded broadening of the food repertoire.	[Bianchi, Clelia M.; Huneau, Jean-Francois; Egnell, Manon; Fouillet, Helene; Mariotti, Francois] Univ Paris Saclay, INRA, AgroParisTech, UMR PNCA, Paris, France; [Barbillon, Pierre] Univ Paris Saclay, INRA, AgroParisTech, UMR MIA, Paris, France; [Lluch, Anne] Danone Nutr Res, Ctr Daniel Carasso, Global Nutr Dept, Palaiseau, France; [Verger, Eric O.] Univ Montpellier, SupAgro, IRD, NUTRIPASS, Montpellier, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Danone Nutricia; Institut Agro; Montpellier SupAgro; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Mariotti, F (corresponding author), Univ Paris Saclay, INRA, AgroParisTech, UMR PNCA, Paris, France.	francois.mariotti@agroparistech.fr	Fouillet, Helene/K-7314-2012; Verger, Eric/J-9163-2016; Barbillon, Pierre/O-7790-2019; Mariotti, François/F-9651-2017	Fouillet, Helene/0000-0003-3932-251X; Verger, Eric/0000-0002-8689-8290; Barbillon, Pierre/0000-0002-7766-7693; Mariotti, François/0000-0002-4516-3853	Fonds Francais Alimentation Sante; Danone Nutricia Research	Fonds Francais Alimentation Sante; Danone Nutricia Research(Danone Nutricia)	This study was carried out within the framework of the ECAP project (http://alimentation-sante.org/aap2013-projet2-2/) supported by grants from the Fonds Francais Alimentation & Sante (FFAS: http://alimentation-sante.org) and from Danone Nutricia Research. The Fonds Francais Alimentation & Sante (FFAS) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. One of the authors of this manuscript is A Lluch who is employed by Danone Nutricia Research. A Lluch contributed to writing the manuscript, offered critical comments, read and approved the final manuscript.	Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Afssa (Agence Francaise de Securite Sanitaire des Aliments), 2001, APP NUTR CONS POP FR; Arnault N, 2005, TABLE COMPOSITION AL; Ax E, 2016, BRIT J NUTR, V115, P95, DOI 10.1017/S0007114515004110; Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Bellisle F, 2014, BRIT J NUTR, V112, P1674, DOI 10.1017/S0007114514002670; Bernard JY, 2013, J NUTR, V143, P1481, DOI 10.3945/jn.113.178640; Berry AC, 1941, T AM MATH SOC, V49, P122, DOI 10.2307/1990053; Bianchi CM, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1078-6; Bianchi CM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149858; Black AE, 2000, INT J OBESITY, V24, P1119, DOI 10.1038/sj.ijo.0801376; Blumfield ML, 2013, NUTR REV, V71, P118, DOI 10.1111/nure.12003; Blumfield ML, 2012, NUTR REV, V70, P322, DOI 10.1111/j.1753-4887.2012.00481.x; Bresson J, 2001, APPORTS NUTR CONSEIL; Brug J, 1999, PATIENT EDUC COUNS, V36, P145, DOI 10.1016/S0738-3991(98)00131-1; Caron P, 2006, ANN ENDOCRINOL-PARIS, V67, P281, DOI 10.1016/S0003-4266(06)72599-9; Castetbon K, 2009, BRIT J NUTR, V102, P733, DOI 10.1017/S0007114509274745; de Vries H, 1999, PATIENT EDUC COUNS, V36, P99; De-Regil LM, 2016, J NUTR; Devine CM, 2000, SOC SCI MED, V50, P567, DOI 10.1016/S0277-9536(99)00314-7; Dodd JM, 2014, BMC MED, pcited 2019 Jun 18 12; Dubuisson C, 2010, BRIT J NUTR, V103, P1035, DOI 10.1017/S0007114509992625; Gazan R., 2016, BR J NUTR, P1; Hawkins M, 2015, DIABETIC MED, V32, P108, DOI 10.1111/dme.12601; King JC, 2016, J NUTR S, VS1, pS8; Krebs P, 2010, PREV MED, V51, P214, DOI 10.1016/j.ypmed.2010.06.004; Lairon D, 2005, AM J CLIN NUTR, V82, P1185, DOI 10.1093/ajcn/82.6.1185; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Maillot M, 2009, J NUTR, V139, P1721, DOI 10.3945/jn.109.107318; Meldrum SJ, 2012, PROSTAG LEUKOTR ESS, V86, P233, DOI 10.1016/j.plefa.2012.03.006; Pouchieu C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070733; Refsum H, 2001, BRIT J NUTR, V85, pS109, DOI 10.1079/BJN2000302; Shay CM, 2012, AM J CLIN NUTR, V96, P483, DOI 10.3945/ajcn.111.025056; Szwajcer E, 2012, FAM PRACT, V29, pi82, DOI 10.1093/fampra/cmr107; Szwajcer EM, 2007, EUR J OBSTET GYN R B, V135, P58, DOI 10.1016/j.ejogrb.2006.11.012; Tulchinsky TH, 2010, PUBLIC HEALTH REV, V32, P243, DOI 10.1007/BF03391600; Vandelanotte C, 2004, HEALTH PROMOT INT, V19, P463, DOI 10.1093/heapro/dah408; Verger EO, 2014, J NUTR, V144, P929, DOI 10.3945/jn.113.188284; Verger EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042155; Weinrich N.K., 2011, HANDS ON SOCIAL MARK, V2nd ed.; Whitaker KM, 2016, MIDWIFERY, V34, P211, DOI 10.1016/j.midw.2015.11.005; Willett WC, 2013, ANNU REV PUBL HEALTH, V34, P77, DOI 10.1146/annurev-publhealth-031811-124646; World Health Organization & Food and Agriculture Organization, 2003, DIET NUTR PREV CHRON, V916	43	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0194764	10.1371/journal.pone.0194764	http://dx.doi.org/10.1371/journal.pone.0194764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GC4GL	29641596	Green Submitted, Green Published, gold			2022-12-26	WOS:000429742900045
J	Figueroa, DB; Tillotson, J; Li, MJ; Piwowar-Manning, E; Hendrix, CW; Holtz, TH; Bokoch, K; Bekker, LG; van Griensven, F; Mannheimer, S; Hughes, JP; Grant, RM; Bumpus, NN				Figueroa, Dominique B.; Tillotson, Joseph; Li, Maoji; Piwowar-Manning, Estelle; Hendrix, Craig W.; Holtz, Timothy H.; Bokoch, Kevin; Bekker, Linda-Gail; van Griensven, Frits; Mannheimer, Sharon; Hughes, James P.; Grant, Robert M.; Bumpus, Namandje N.			Discovery of genetic variants of the kinases that activate tenofovir among individuals in the United States, Thailand, and South Africa: HPTN067	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTIONS; BLOOD SPOT SAMPLES; PYRUVATE-KINASE; PREEXPOSURE PROPHYLAXIS; CREATINE-KINASE; MUTATIONS	Tenofovir (TFV), a nucleotide reverse transcriptase inhibitor, requires two phosphorylation steps to form a competitive inhibitor of HIV reverse transcriptase. Adenylate kinase 2 (AK2) has been previously demonstrated to phosphorylate tenofovir to tenofovir-monophosphate, while creatine kinase, muscle (CKM), pyruvate kinase, muscle (PKM) and pyruvate kinase, liver and red blood cell (PKLR) each have been found to phosphorylate tenofovir-monophosphate to the pharmacologically active tenofovir-diphosphate. In the present study, genomic DNA isolated from dried blood spots collected from 505 participants from Bangkok, Thailand; Cape Town, South Africa; and New York City, USA were examined for variants in AK2, CKM, PKM, and PKLR using next-generation sequencing. The bioinformatics tools SIFT and PolyPhen predicted that 19 of the 505 individuals (3.7% frequency) carried variants in at least one kinase that would result in a decrease or loss of enzymatic activity. To functionally test these predictions, AK2 and AK2 variants were expressed in and purified from E. coli, followed by investigation of their activities towards tenofovir. Interestingly, we found that purified AK2 had the ability to phosphorylate tenofovir-monophosphate to tenofovir- diphosphate in addition to phosphorylating tenofovir to tenofovir-monophosphate. Further, four of the six AK2 variants predicted to result in a loss or decrease of enzyme function exhibited a >= 30% decrease in activity towards tenofovir in our in vitro assays. Of note, an AK2 K28R variant resulted in a 72% and 81% decrease in the formation of tenofovir-monophosphate and tenofovir-diphosphate, respectively. These data suggest that there are naturally occurring genetic variants that could potentially impact TFV activation.	[Figueroa, Dominique B.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Tillotson, Joseph; Hendrix, Craig W.; Bumpus, Namandje N.] Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA; [Li, Maoji] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA; [Piwowar-Manning, Estelle] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Holtz, Timothy H.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, HIV STD Res Program, Nonthaburi, Thailand; [Holtz, Timothy H.] US Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA USA; [Bokoch, Kevin] FHI 360, Res Triangle Pk, NC USA; [Bekker, Linda-Gail] Univ Cape Town, Desmond Tutu HIV Ctr, Cape Town, South Africa; [van Griensven, Frits] Univ Calif San Francisco, Sch Med, Dept Epidemiol & Biostat, San Francisco, CA USA; [Mannheimer, Sharon] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Mannheimer, Sharon] Columbia Univ, Dept Med, Mailman Sch Publ Hlth, New York, NY USA; [Hughes, James P.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Grant, Robert M.] Univ Calif San Francisco, Gladstone Inst, San Francisco, CA 94143 USA	Johns Hopkins University; Johns Hopkins University; Fred Hutchinson Cancer Center; Johns Hopkins University; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; FHI 360; University of Cape Town; University of California System; University of California San Francisco; Columbia University; Columbia University; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; The J David Gladstone Institutes	Bumpus, NN (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Clin Pharmacol, Baltimore, MD 21205 USA.	nbumpus1@jhmi.edu	Hendrix, Craig W/G-4182-2014; Bekker, Linda-Gail/AAZ-8929-2020	Hendrix, Craig W/0000-0002-5696-8665; BEKKER, LINDA-GAIL/0000-0002-0755-4386	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA); National Institute of Mental Health (NIMH); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) [UM1AI068613, UM1AI068617, UM1AI068619]; Division of Intramural Research, NIAID;  [R01 AI128781]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI068613, U19AI113127, UM1AI069470, UM1AI068617] Funding Source: NIH RePORTER	HIV Prevention Trials Network (HPTN) - National Institute of Allergy and Infectious Diseases (NIAID); National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the HIV Prevention Trials Network (HPTN), sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), the National Institute on Drug Abuse (NIDA), the National Institute of Mental Health (NIMH), and the Office of AIDS Research, of the National Institutes of Health (NIH), Dept. of Health and Human Services (DHHS) [grant numbers UM1AI068613 (HPTN Laboratory Center), UM1AI068617 (HPTN Statistical and Data Management Center), and UM1AI068619 (HPTN Core and Operations Center). Additional funding was provided by the Division of Intramural Research, NIAID. Support was also provided by R01 AI128781 awarded to NNB. The findings and conclusions in this article are those of the authors and do not necessarily represent the views of the United States Centers for Disease Control and Prevention, the National Institutes of Health, or the United States Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Amico KR, 2014, JAIDS-J ACQ IMM DEF, V66, P530, DOI 10.1097/QAI.0000000000000216; Anastasiou D, 2012, NAT CHEM BIOL, V8, P839, DOI 10.1038/NCHEMBIO.1060; Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Feng S, 2007, INT J BIOCHEM CELL B, V39, P392, DOI 10.1016/j.biocel.2006.09.004; Fonner VA, 2016, AIDS, V30, P1973, DOI 10.1097/QAD.0000000000001145; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Hoenig M, 2017, BLOOD, V129, P2928, DOI 10.1182/blood-2016-11-745638; Hollegaard MV, 2009, GENET TEST MOL BIOMA, V13, P173, DOI 10.1089/gtmb.2008.0073; Hollegaard MV, 2013, MOL GENET METAB, V110, P65, DOI 10.1016/j.ymgme.2013.06.004; Jaouani M, 2017, INT J LAB HEMATOL, V39, P223, DOI 10.1111/ijlh.12610; Ji HZ, 2011, ANTIVIR THER, V16, P871, DOI 10.3851/IMP1839; Kim H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4351; Kitzenberg D, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0114-5; Lade JM, 2015, EBIOMEDICINE, V2, P1145, DOI 10.1016/j.ebiom.2015.07.008; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Lu Y, 2014, DRUG METAB DISPOS, V42, P1796, DOI 10.1124/dmd.114.060194; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Ning XL, 2017, EUR J MED CHEM, V138, P343, DOI 10.1016/j.ejmech.2017.06.064; Panayiotou C, 2014, INT J BIOCHEM CELL B, V49, P75, DOI 10.1016/j.biocel.2014.01.014; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rehm HL, 2013, GENET MED, V15, P733, DOI 10.1038/gim.2013.92; ROBBINS BL, 1995, ANTIMICROB AGENTS CH, V39, P2304, DOI 10.1128/AAC.39.10.2304; Saavedra-Matiz CA, 2013, CLIN CHEM, V59, P1045, DOI 10.1373/clinchem.2012.198945; Schooley RT, 2002, AIDS, V16, P1257, DOI 10.1097/00002030-200206140-00008; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; USFDA A, 2012, FDA APPR 1 MED RED H; van Wijk R, 2009, HUM MUTAT, V30, P446, DOI 10.1002/humu.20915; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 11	2018	13	4							e0195764	10.1371/journal.pone.0195764	http://dx.doi.org/10.1371/journal.pone.0195764			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GC4GL	29641561	Green Published, gold, Green Submitted			2022-12-26	WOS:000429742900090
